pathway,pval,padj,ES,NES,nMoreExtreme,size,leadingEdge
PROLINE BIOSYNTHESIS I%HUMANCYC%PROSYN-PWY,0.72975697166536,0.972554563883587,0.3818576716121811,0.8091928830915409,6515,4,PYCR2|ALDH18A1|PYCR1
MOLYBDENUM COFACTOR BIOSYNTHESIS%HUMANCYC%PWY-6823,0.633777578676224,0.9584504137025791,0.41554573251664206,0.8805811021993409,5658,4,GPHN|MOCS2
GLYCEROL DEGRADATION I%HUMANCYC%PWY-4261,0.710293939760494,0.9700296616429409,0.524290046870692,0.856937678520014,5871,2,GK5|GK
OXIDATIVE ETHANOL DEGRADATION III%HUMANCYC%PWY66-161,0.303769884506428,0.8064657033201279,0.4951547108721261,1.14125820608245,2787,5,ALDH3A2|ACSS1|CYP2E1|ACSS2
TETRAPYRROLE BIOSYNTHESIS II%HUMANCYC%PWY-5189,0.16418411916228,0.6664346072172851,0.6051398003639771,1.28234904293683,1465,4,ALAS1|UROS|ALAD|HMBS
ASPARAGINE DEGRADATION I%HUMANCYC%ASPARAGINE-DEG1-PWY,0.0755704697986577,0.525408291492683,0.962946625496251,1.27923163187709,562,1,ASRGL1
TETRAHYDROBIOPTERIN BIOSYNTHESIS I%HUMANCYC%PWY-5663,0.7846032992930091,0.981487311948134,-0.37079276386864496,-0.7525128975345841,4993,3,SPR
UREA CYCLE%HUMANCYC%PWY-4984,0.144069128043991,0.6340340930337739,-0.667452354764444,-1.3545747231140801,916,3,ASS1|ASL
KETOGENESIS%HUMANCYC%REACT_1464.NULL,0.731799450549451,0.972734844328856,-0.31011471431722903,-0.7850348066177879,4261,5,HADHB|HMGCL|ACAA1|ACAT1|BDH1
CDP-DIACYLGLYCEROL BIOSYNTHESIS I%HUMANCYC%PWY-5667,0.12433745583038901,0.607607158836689,-0.317910536160077,-1.33773097094132,562,17,AGPAT6|LPCAT3|AGPAT4|MBOAT7|ABHD5|AGPAT3|GPAT2|CDS2
SELENOCYSTEINE BIOSYNTHESIS II (ARCHAEA AND EUKARYOTES)%HUMANCYC%PWY-6281,0.809581043956044,0.984682960940884,-0.288274873152438,-0.729748698949169,4714,5,SEPHS1|PSTK|SARS2|SEPSECS|SARS
CATECHOLAMINE BIOSYNTHESIS%HUMANCYC%PWY66-301,0.0643522438611346,0.495456803258629,0.841521918941274,1.37544445855006,531,2,PNMT|DDC
RAPOPORT-LUEBERING GLYCOLYTIC SHUNT%HUMANCYC%PWY-6405,0.524123168121192,0.92593403131991,-0.40408091377773203,-0.929301686228999,3182,4,PGAM2
L-CARNITINE BIOSYNTHESIS%HUMANCYC%PWY-6100,0.6467706013363029,0.96344123684964,-0.503859749279008,-0.861825116139668,4355,2,TMLHE
ASPARAGINE BIOSYNTHESIS I%HUMANCYC%ASPARAGINE-BIOSYNTHESIS,0.0299328859060403,0.35509922886098294,0.9850573445081601,1.3086047356553,222,1,ASNS
UDP-D-XYLOSE AND UDP-D-GLUCURONATE BIOSYNTHESIS%HUMANCYC%PWY-4821,0.0846325167037862,0.545178773025535,-0.824317617866005,-1.4099511377320901,569,2,UXS1|UGDH
4-HYDROXY-2-NONENAL DETOXIFICATION%HUMANCYC%PWY-7112,0.115035684044998,0.593398236603313,0.7939895230217808,1.2977540632109499,950,2,GSTA4|GSTP1
GDP-MANNOSE BIOSYNTHESIS%HUMANCYC%PWY-5659,0.37188049209138796,0.852609194081082,-0.380506860438415,-1.04446578273618,2115,6,PMM1|GPI|PMM2
GUANINE AND GUANOSINE SALVAGE I%HUMANCYC%PWY-6620,0.0405345211581292,0.401971380179507,-0.87648194099807,-1.49917541870705,272,2,PNP|HPRT1
THREONINE DEGRADATION II%HUMANCYC%THREONINE-DEG2-PWY,0.503376141930359,0.9164921159310329,-0.7447066607851791,-0.99621680604807,3801,1,GCAT
"SUPERPATHWAY OF D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE METABOLISM%HUMANCYC%PWY-6358",0.509250902527076,0.918404893008545,-0.217463296169555,-0.9536794617178459,2256,19,MINPP1|IMPA1|IMPA2|INPP5F|OCRL|IMPAD1|INPPL1|INPP5J|PTEN|IPMK|SYNJ1|INPP5D|INPP5B|ITPKC|SYNJ2|INPP1|INPP5K|INPP5A|ITPKB
S-ADENOSYL-L-METHIONINE BIOSYNTHESIS%HUMANCYC%SAM-PWY,0.21700737873472797,0.733424818109987,0.724901022759092,1.18483080750371,1793,2,MAT2A|MAT2B
"D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE DEGRADATION%HUMANCYC%PWY-6363",0.365013488275576,0.850174896280676,-0.280787905539616,-1.05744188517799,1758,13,IMPA1|IMPA2|INPP5F|OCRL|IMPAD1|INPPL1|INPP5J|SYNJ1|INPP5B|SYNJ2|INPP1|INPP5K|INPP5A
MAP KINASE CASCADE%HUMANCYC%REACT_634.NULL,0.17661856216073105,0.68038613815861,-0.9094067048963391,-1.21654107671782,1333,1,YWHAB
GUANOSINE NUCLEOTIDES DEGRADATION III%HUMANCYC%PWY-6608,0.304083147735709,0.806909310951943,-0.6781362007168461,-1.15991565267438,2047,2,NT5C2|PNP
ASPARTATE BIOSYNTHESIS%HUMANCYC%ASPARTATESYN-PWY,0.7171492204899781,0.971081608033886,-0.47306313757926705,-0.809149161188282,4829,2,GOT1|GOT2
XANTHINE AND XANTHOSINE SALVAGE%HUMANCYC%SALVPURINE2-PWY,0.24678935522308998,0.758826975311078,-0.876433612704014,-1.17243196595099,1863,1,PNP
GLYCINE BIOSYNTHESIS I%HUMANCYC%GLYSYN-PWY,0.27720861172977,0.7884684708511421,-0.693168064088269,-1.18562684991609,1866,2,SHMT2
GALACTOSE DEGRADATION I (LELOIR PATHWAY)%HUMANCYC%PWY-6317,0.0547653712621794,0.456473845459404,0.6976782661445979,1.4784468916607902,488,4,GALM|GALE|GALK1|GALT
BMP SIGNALLING PATHWAY%HUMANCYC%REACT_12034.NULL,0.0527129120879121,0.447918405077224,-0.6184773537411,-1.5656343519868001,306,5,SMAD4|UBE2D1|SKI|UBE2D3
GDP-GLUCOSE BIOSYNTHESIS%HUMANCYC%PWY-5661,0.15220069436667,0.648319130045528,0.61265066080462,1.29826527368532,1358,4,PGM5|GCK|PGM2|PGM1
DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE BIOSYNTHESIS%HUMANCYC%MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,0.14352226720647798,0.6334904564746021,0.46813303613184704,1.3358917349316202,1417,9,ALG6|ALG13|DPAGT1|ALG5|ALG1|ALG3|ALG8
GLUTATHIONE BIOSYNTHESIS%HUMANCYC%GLUTATHIONESYN-PWY,0.111861743912019,0.586618853998399,-0.698577258189037,-1.41774178985279,711,3,GCLM|GCLC|GSS
SUPEROXIDE RADICALS DEGRADATION%HUMANCYC%DETOX1-PWY,0.27893956858224894,0.788692060817727,-0.497902762120902,-1.1450723373476202,1693,4,SOD1|SOD3|SOD2
<I>MYO< I>-INOSITOL BIOSYNTHESIS%HUMANCYC%PWY-2301,0.323104490984433,0.823600658025734,0.527314626119027,1.11743006446379,2884,4,ISYNA1|IMPA1|IMPA2|IMPAD1
PYRIDOXAL 5'-PHOSPHATE SALVAGE PATHWAY%HUMANCYC%PLPSAL-PWY,0.00801781737193764,0.19847993048827997,-0.9344361731458509,-1.5983030289656899,53,2,PNPO|PDXK
ARGININE DEGRADATION VI (ARGINASE 2 PATHWAY)%HUMANCYC%ARG-PRO-PWY,0.87611680104598,0.9941329456747149,0.28892390364327597,0.6659267673844661,8040,5,PYCR2|ARG2|PYCR1|OAT|PYCRL
CITRULLINE-NITRIC OXIDE CYCLE%HUMANCYC%PWY-4983,0.0036135113904163397,0.143595610377104,-0.8853534796514828,-1.7967985819455798,22,3,ASS1|NOS3|ASL
PHOSPHATIDYLGLYCEROL BIOSYNTHESIS II (NON-PLASTIDIC)%HUMANCYC%PWY4FS-8,0.16685181070873098,0.669063640955763,-0.294549250508438,-1.26708543316612,750,18,AGPAT6|LPCAT3|AGPAT4|MBOAT7|ABHD5|AGPAT3|GPAT2|CDS2
L-DOPA DEGRADATION%HUMANCYC%PWY-6334,0.722818791946309,0.971955586175348,0.64170710189678,0.852479256286393,5384,1,COMT
SALVAGE PATHWAYS OF PYRIMIDINE RIBONUCLEOTIDES%HUMANCYC%PWY0-163,0.688795050574487,0.96731875442989,0.25390205717427,0.8194363142771949,7013,13,NME3|NME4|NME7|UCKL1
SULFATE ACTIVATION FOR SULFONATION%HUMANCYC%PWY-5340,0.986331196322729,1.0,0.331653416330512,0.542078397939901,8153,2,PAPSS2|PAPSS1
TYROSINE DEGRADATION I%HUMANCYC%TYRFUMCAT-PWY,0.7116245312689009,0.970341332123494,0.5235180590019299,0.85567588555627,5882,2,GSTZ1|FAH
SPERMINE BIOSYNTHESIS%HUMANCYC%ARGSPECAT-PWY,0.124721603563474,0.607607158836689,-0.7868210642404191,-1.34581529094249,839,2,AMD1|SMS
PURINE NUCLEOTIDES <I>DE NOVO< I> BIOSYNTHESIS II%HUMANCYC%PWY-841,0.9228702229299359,1.0,0.19820702632161102,0.604684202483191,9272,11,IMPDH1|ADSSL1|PAICS|ADSS|PPAT
GLUTAMINE DEGRADATION I%HUMANCYC%GLUTAMINDEG-PWY,0.00474701864073174,0.159787349002354,0.8862358001544058,1.6846410275867099,40,3,ASNS|GLS|GLS2
SEROTONIN DEGRADATION%HUMANCYC%PWY-6313,0.657538659793814,0.9643779777660141,0.34309313091104,0.8437875887749692,6122,6,ADH1B|ALDH3A2|MAOA
EUMELANIN BIOSYNTHESIS%HUMANCYC%PWY-6498,0.48604026845637605,0.9067604918222419,0.760917512130569,1.01084496792853,3620,1,TRPC1
COLANIC ACID BUILDING BLOCKS BIOSYNTHESIS%HUMANCYC%COLANSYN-PWY,0.8063913675036309,0.984682960940884,-0.19784421305728397,-0.745077524706035,3885,13,PMM1|GPI|UGDH|PMM2
D-MANNOSE DEGRADATION%HUMANCYC%MANNCAT-PWY,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
GLUCONEOGENESIS I%HUMANCYC%GLUCONEO-PWY,0.0446113074204947,0.41504430757275895,-0.373352608415635,-1.5710248341937199,201,17,GPI|ME2|FBP1|ENO1|GAPDH|PGK1|ALDOA|PGAM2
FLAVIN BIOSYNTHESIS IV (MAMMALIAN)%HUMANCYC%11070,0.808636748518205,0.984682960940884,0.483326076525165,0.7899831943363449,6684,2,RFK|FLAD1
"FATTY ACID &BETA;-OXIDATION III (UNSATURATED, ODD NUMBER)%HUMANCYC%PWY-5137",0.128516846127127,0.608357435641882,0.6916841292599539,1.31481876728393,1109,3,EHHADH|ECI1|ECI2
<I>S< I>-METHYL-5-THIO-&ALPHA;-D-RIBOSE 1-PHOSPHATE DEGRADATION%HUMANCYC%PWY-6755,0.630753723821257,0.9575013258325501,0.4168642805933929,0.883375231528251,5631,4,APIP|ENOPH1|MRI1|ADI1
GLYCINE DEGRADATION (CREATINE BIOSYNTHESIS)%HUMANCYC%GLYCGREAT-PWY,0.405346558606508,0.866234596232951,0.640085921080453,1.04620285381712,3350,2,GAMT|GATM
TRIACYLGLYCEROL BIOSYNTHESIS%HUMANCYC%TRIGLSYN-PWY,0.19866482504604102,0.711592141628341,-0.274121325471574,-1.22310344712646,862,20,AGPAT6|LPCAT3|PPAPDC1A|AGPAT4|MBOAT7|ABHD5|PPAP2B|DGAT2|AGPAT3|GPAT2
TREHALOSE DEGRADATION II (TREHALASE)%HUMANCYC%PWY0-1182,0.0943510342324906,0.5630268609168221,0.811304108078302,1.3260542768263501,779,2,GALM|GCK
SPERMINE AND SPERMIDINE DEGRADATION I%HUMANCYC%PWY-6117,0.9143200549450551,1.0,-0.25412672109912,-0.6433049195801309,5324,5,SMOX
NAD SALVAGE PATHWAY III%HUMANCYC%PWY3O-4106,0.11262967232010498,0.588016986131645,-0.607519899462053,-1.3971688534101498,683,4,NMNAT3|NMNAT2
PYRUVATE FERMENTATION TO LACTATE%HUMANCYC%PWY-5481,0.7998147504920691,0.9839175016931591,0.40465851781525003,0.769213273888537,6907,3,LDHAL6A|LDHB
NAD BIOSYNTHESIS FROM 2-AMINO-3-CARBOXYMUCONATE SEMIALDEHYDE%HUMANCYC%PWY-5653,0.20655906593406603,0.7211951452265429,-0.48511948663411697,-1.22804776682335,1202,5,NMNAT3|NMNAT2
FATTY ACID BIOSYNTHESIS INITIATION II%HUMANCYC%PWY-5966,0.374017176726745,0.852609194081082,0.65429150133416,1.06942148449168,3091,2,OXSM|FASN
PUTRESCINE DEGRADATION III%HUMANCYC%PWY-0,0.6431319538317559,0.9621972042482541,0.31581164103996096,0.8609872605259208,6184,8,SAT2|ALDH3A2|SAT1|MAOA
DIPHTHAMIDE BIOSYNTHESIS%HUMANCYC%PWY-6482,0.32362416107382597,0.8239107965478291,0.8423577415086021,1.11903467935102,2410,1,DPH5
CHOLESTEROL BIOSYNTHESIS III (VIA DESMOSTEROL)%HUMANCYC%PWY66-4,0.0993318923167616,0.570215774831708,0.450622159096826,1.4205220826023102,1010,12,TM7SF2|EBP|LBR|DHCR24|NSDHL|DHCR7|HSD17B7
TAURINE BIOSYNTHESIS%HUMANCYC%PWY-5331,0.8312568041611229,0.9879179006160809,0.4722524084792539,0.771883588126761,6871,2,CDO1|CSAD
4-AMINOBUTYRATE DEGRADATION I%HUMANCYC%PWY-6535,0.638321035442119,0.9601484712040809,0.552081610146126,0.9023622252148059,5276,2,ABAT|ALDH5A1
TRNA SPLICING%HUMANCYC%PWY-6689,0.4913924602309871,0.909315999193258,0.42552010189876793,0.980760755137852,4509,5,TSEN54|TRPT1|TSEN15
TETRAHYDROBIOPTERIN BIOSYNTHESIS II%HUMANCYC%PWY-5664,0.7846032992930091,0.981487311948134,-0.37079276386864496,-0.7525128975345841,4993,3,SPR
NAD SALVAGE PATHWAY II%HUMANCYC%NAD-BIOSYNTHESIS-II,0.0835611089418196,0.544318908798516,-0.450078300270146,-1.45289308575563,427,9,NMNAT3|NT5E|NMNAT2
PUTRESCINE BIOSYNTHESIS III%HUMANCYC%PWY-46,0.6832962138084631,0.9663106118043521,-0.48818871506372896,-0.835020651401342,4601,2,ODC1
ADENOSINE NUCLEOTIDES DEGRADATION II%HUMANCYC%SALVADEHYPOX-PWY,0.086115992970123,0.5498451960578621,-0.5355200119672671,-1.46996647531091,489,6,NT5C2|NT5C1A|ADA|PNP|NT5E
LYSINE DEGRADATION II%HUMANCYC%LYSINE-DEG1-PWY,0.9355852317360559,1.0,-0.302746222565347,-0.614414463711071,5954,3,AASS|SCCPDH|ALDH7A1
ZYMOSTEROL BIOSYNTHESIS%HUMANCYC%PWY-6074,0.0541512312050556,0.454914205138535,0.650249835739922,1.4987294773685402,496,5,TM7SF2|LBR|NSDHL|HSD17B7
TRYPTOPHAN DEGRADATION III (EUKARYOTIC)%HUMANCYC%TRYPTOPHAN-DEGRADATION-1,0.377659574468085,0.85375124052253,-0.310200253765102,-1.04945388925651,1916,10,HADHB|ACAT2|AFMID|ACAA1|ACAT1|KMO|KYNU|HAAO|TDO2|GCDH
ADENINE AND ADENOSINE SALVAGE I%HUMANCYC%P121-PWY,0.5417714815305179,0.928807195199472,-0.724415527128364,-0.96907273788387,4091,1,APRT
COENZYME A BIOSYNTHESIS%HUMANCYC%COA-PWY,0.773995600324187,0.980173768720877,0.41516996891880603,0.7891944366732461,6684,3,PPCS|COASY|PPCDC
INOSITOL PYROPHOSPHATES BIOSYNTHESIS%HUMANCYC%PWY-6369,0.963487972508591,1.0,0.224398551637398,0.551875557251567,8971,6,PPIP5K2|PPIP5K1|IP6K2|IPPK
"D-<I>MYO< I>-INOSITOL (1,3,4)-TRISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6364",0.18544303797468398,0.6921618552848171,-0.32204261697146996,-1.2476783549388502,878,14,IPMK|SYNJ1|INPP5D|INPP5B|ITPKC|SYNJ2|INPP5K|INPP5A|ITPKB
HISTIDINE DEGRADATION III%HUMANCYC%PWY-5030,0.268227125097995,0.7831645660697991,0.5505250611300511,1.16661519342843,2394,4,FTCD|MTHFD1|MTHFD2L
SUPERPATHWAY OF GERANYLGERANYLDIPHOSPHATE BIOSYNTHESIS I (VIA MEVALONATE)%HUMANCYC%PWY-5910,0.261642758891727,0.771967970256231,0.37653686063714703,1.18697874627574,2662,12,MVD|GGPS1|IDI1|HMGCR|HADHB|ACAT2|MVK|ACAA1|HMGCS1|FDPS|ACAT1
L-CYSTEINE DEGRADATION II%HUMANCYC%LCYSDEG-PWY,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
PHOSPHATIDYLETHANOLAMINE BIOSYNTHESIS III%HUMANCYC%PWY-6273,0.0288590604026846,0.348603135907264,0.985663872959859,1.30941048164423,214,1,PTDSS2
THIOSULFATE DISPROPORTIONATION III (RHODANESE)%HUMANCYC%PWY-5350,0.19046979865771801,0.698434241409875,0.9068151742390821,1.20466350308352,1418,1,TST
UDP-<I>N< I>-ACETYL-D-GALACTOSAMINE BIOSYNTHESIS I%HUMANCYC%PWY-5512,0.23395973154362398,0.7481332891296201,0.8850352889280991,1.17572989711745,1742,1,GALE
L-CYSTEINE DEGRADATION III%HUMANCYC%PWY-5329,0.9922147651006709,1.0,0.5042456991618879,0.669867915341043,7391,1,MPST
GLUTATHIONE-MEDIATED DETOXIFICATION I%HUMANCYC%PWY-4061,0.12096620202406,0.607251067511504,0.386276016608652,1.36233972748366,1266,17,MGST1|GSTA4|GSTO2|GGH|GGT1|MGST3|GSTP1|MGST2|GSTZ1
PHOSPHOLIPASES%HUMANCYC%LIPASYN-PWY,0.328685258964143,0.828303707528737,-0.220977294982008,-1.08506332789988,1319,26,PLD6|PLCD1|PLA2G2A|PLCB4|PLD2|PLCB1
SUPERPATHWAY OF CHOLESTEROL BIOSYNTHESIS%HUMANCYC%PWY66-5,0.10142136634571301,0.57169477469413,0.353083551039215,1.38955953526979,1105,24,TM7SF2|EBP|MVD|LBR|DHCR24|NSDHL|GGPS1|IDI1|HMGCR|DHCR7|HADHB|ACAT2|HSD17B7
CHONDROITIN SULFATE DEGRADATION (METAZOA)%HUMANCYC%PWY-6573,0.587189198089906,0.945418171231938,-0.38416147355649893,-0.883491135036988,3565,4,HEXA|ARSB|HYAL1|GALNS
DOLICHOL AND DOLICHYL PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6129,0.511057080004631,0.918404893008545,0.512227881784218,0.973691318921201,4413,3,SRD5A3|DOLK|DHDDS
ACETYL-COA BIOSYNTHESIS III (FROM CITRATE)%HUMANCYC%PWY-5172,0.118231166423938,0.602190989258993,-0.940063961182179,-1.25755222318329,892,1,ACLY
TRYPTOPHAN DEGRADATION TO 2-AMINO-3-CARBOXYMUCONATE SEMIALDEHYDE%HUMANCYC%PWY-5651,0.655048076923077,0.9640743070248079,-0.331016986543128,-0.837947520775381,3814,5,AFMID|KMO|KYNU|HAAO|TDO2
ACYL-COA HYDROLYSIS%HUMANCYC%PWY-5148,0.2356637863315,0.750277765814412,-0.5905044457471539,-1.19841122798626,1499,3,ACOT9|ACOT8
DOPAMINE DEGRADATION%HUMANCYC%PWY6666-2,0.756482893876662,0.977664504547119,0.33524844032032697,0.7726979572061979,6942,5,ALDH3A2|COMT|MAOA
STEARATE BIOSYNTHESIS I (ANIMALS)%HUMANCYC%PWY-5972,0.46153846153846206,0.891063005541905,0.350566050421692,1.00039572762402,4559,9,SLC27A2|ELOVL6|ACOT1|ACOT2
SUPERPATHWAY OF INOSITOL PHOSPHATE COMPOUNDS%HUMANCYC%PWY-6371,0.11624600071098501,0.5955006947384001,-0.201037880344403,-1.2859375767637,326,60,INPP5B|ITPKC|PIP5K1A|PI4K2B|PI4K2A|PIK3CD|PIK3R2|TMEM55A|PIK3R5|SYNJ2|PLCE1|PIK3C3|IP6K1|ITPK1|CDIPT|INPP5K|INPP5A|PIP4K2A|PLCD1|ITPKB|PLCB4|PLCB1|MTMR14|PIK3R1
METHYLTHIOPROPIONATE BIOSYNTHESIS%HUMANCYC%PWY-5389,0.8303985171455049,0.9879179006160809,-0.583204675782973,-0.7801706765563778,6271,1,ADI1
"1D-<I>MYO< I>-INOSITOL HEXAKISPHOSPHATE BIOSYNTHESIS V (FROM INS(1,3,4)P3)%HUMANCYC%PWY-6554",0.33731343283582105,0.831781977545269,-0.53534796514834,-1.08647278938198,2146,3,IPPK|IPMK|ITPK1
<I>S< I>-METHYL-5'-THIOADENOSINE DEGRADATION II%HUMANCYC%PWY-6756,0.446442953020134,0.8841834184365509,0.782697397441553,1.0397785738946,3325,1,MTAP
GLYCEROL-3-PHOSPHATE SHUTTLE%HUMANCYC%PWY-6118,0.619896065330364,0.9532238181782521,-0.5135373586986489,-0.8783781487523571,4174,2,GPD1|GPD2
PHOSPHATIDYLCHOLINE BIOSYNTHESIS I%HUMANCYC%PWY3O-450,0.7716924398625429,0.979693198874896,0.307411750313288,0.7560344296872521,7185,6,CEPT1|CHKB|CHKA|CHPT1|PCYT1B
TRIACYLGLYCEROL DEGRADATION%HUMANCYC%LIPAS-PWY,0.8422465635738828,0.9909381457336658,0.283547389959712,0.6973435109068871,7842,6,PNPLA2|LIPE
GLUTARYL-COA DEGRADATION%HUMANCYC%PWY-5177,0.731799450549451,0.972734844328856,-0.31011471431722903,-0.7850348066177879,4261,5,HADHB|ACAT2|ACAA1|ACAT1|GCDH
"<I>TRANS, TRANS< I>-FARNESYL DIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5123",0.481069815908302,0.9046812288131709,0.523602073453182,0.9953124607638492,4154,3,GGPS1|IDI1|FDPS
GLUTAMATE REMOVAL FROM FOLATES%HUMANCYC%PWY-2161B,0.0953020134228188,0.566542092411725,0.9525253639170709,1.2653874507945901,709,1,GGH
ACYL CARRIER PROTEIN METABOLISM%HUMANCYC%PWY-6012,0.967297762478485,1.0,-0.514997794441994,-0.6889282517761719,7305,1,AASDHPPT
GERANYLGERANYLDIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5120,0.463758389261745,0.8921382338742359,0.773323775915307,1.0273261358838899,3454,1,GGPS1
1D-<I>MYO< I>-INOSITOL HEXAKISPHOSPHATE BIOSYNTHESIS II (MAMMALIAN)%HUMANCYC%PWY-6362,0.0263713080168776,0.337668602007655,-0.43417217784740597,-1.6820979586837,124,14,INPPL1|INPP5J|IPPK|IPMK|SYNJ1|INPP5D|INPP5B|ITPKC|SYNJ2|ITPK1|INPP5K|INPP5A|ITPKB
CHOLESTEROL BIOSYNTHESIS I%HUMANCYC%PWY66-341,0.0993318923167616,0.570215774831708,0.450622159096826,1.4205220826023102,1010,12,TM7SF2|EBP|LBR|DHCR24|NSDHL|DHCR7|HSD17B7
ALANINE BIOSYNTHESIS II%HUMANCYC%ALANINE-SYN2-PWY,0.5532841417684771,0.932706603479095,0.584255379553973,0.9549493674467829,4573,2,GPT
FATTY ACID &ALPHA;-OXIDATION II%HUMANCYC%PWY66-387,0.0973073351903435,0.570215774831708,-0.458398948710585,-1.4249035229028701,523,8,ACSL5|ACSL6|HACL1|PHYH|ACSL1|ACSL4|ACSL3
GLUTAMINE BIOSYNTHESIS I%HUMANCYC%GLNSYN-PWY,0.00516351118760757,0.16737273925846302,-0.9975738861932071,-1.3344850033334599,38,1,GLUL
PHENYLETHYLAMINE DEGRADATION I%HUMANCYC%2PHENDEG-PWY,0.35927875461977793,0.847459828408795,0.512021050934451,1.08502151772926,3207,4,AOC2|ALDH3A2|AOC3
MEVALONATE PATHWAY I%HUMANCYC%PWY-922,0.409228289341124,0.867015886388254,0.354126765241453,1.04511957341555,4061,10,MVD|IDI1|HMGCR|HADHB|ACAT2|MVK|ACAA1|HMGCS1|ACAT1
SPHINGOMYELIN METABOLISM%HUMANCYC%PWY3DJ-11281,0.39376770538243605,0.8633315826167591,0.459477336960686,1.05902714808406,3613,5,SMPD3|SMPD1|SMPD4
CYSTEINE BIOSYNTHESIS HOMOCYSTEINE DEGRADATION%HUMANCYC%HOMOCYSDEGR-PWY,0.461231401959598,0.8908856132322029,0.618954095104579,1.01166346478477,3812,2,CTH
GDP-L-FUCOSE BIOSYNTHESIS I (FROM GDP-D-MANNOSE)%HUMANCYC%PWY-66,0.5655530809205639,0.938638245695344,-0.5357595809208711,-0.916388069717374,3808,2,GMDS|TSTA3
SUPERPATHWAY OF SERINE AND GLYCINE BIOSYNTHESIS I%HUMANCYC%SER-GLYSYN-PWY,0.47029532967033,0.8974030366021809,-0.383545855136828,-0.9709208635240351,2738,5,SHMT2|PSPH
5-AMINOIMIDAZOLE RIBONUCLEOTIDE BIOSYNTHESIS I%HUMANCYC%PWY-6121,0.60267085624509,0.9508825506493929,-0.43465313775228903,-0.882115628956404,3835,3,PPAT|PFAS|GART
GDP-L-FUCOSE BIOSYNTHESIS II (FROM L-FUCOSE)%HUMANCYC%PWY-6,0.398814563928874,0.8638522656500329,0.642790184725669,1.05062289845475,3296,2,FPGT|FUK
<I>N< I>-ACETYLGLUCOSAMINE DEGRADATION I%HUMANCYC%GLUAMCAT-PWY,0.375477596387635,0.852871276063039,0.5626647009080121,1.06956640632132,3242,3,AMDHD2|GNPDA1|GNPDA2
"D-<I>MYO< I>-INOSITOL (1,4,5,6)-TETRAKISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6366",0.9901586198911659,1.0,0.26507731373404103,0.503884088321682,8551,3,MINPP1|IPMK
FORMALDEHYDE OXIDATION II (GLUTATHIONE-DEPENDENT)%ECOCYC%PWY-1801,0.805939123979213,0.984682960940884,-0.43622828784119105,-0.7461451234596691,5427,2,ADH5|ESD
UDP-<I>N< I>-ACETYL-D-GALACTOSAMINE BIOSYNTHESIS II%HUMANCYC%PWY-5514,0.7293334719767081,0.972554563883587,0.28861211831117606,0.78683406438422,7013,8,GALE|GCK|PGM3|UAP1
L-SERINE DEGRADATION%HUMANCYC%SERDEG-PWY,0.0369710467706013,0.386113929236656,-0.8817755720981529,-1.50822989119499,248,2,SDS|SDSL
ACETATE CONVERSION TO ACETYL-COA%HUMANCYC%PWY0-1313,0.568646425547357,0.940076901516441,0.5788806175902951,0.946164466670499,4700,2,ACSS1|ACSS2
THYROID HORMONE BIOSYNTHESIS%HUMANCYC%PWY-6241,0.42698265589831896,0.875860872092455,-0.785950595500662,-1.051390075034,3224,1,CTSD
ANDROGEN BIOSYNTHESIS%HUMANCYC%PWY66-378,0.454988216810683,0.88900512246363,-0.485453492660529,-0.9852134398978492,2895,3,SRD5A1
FOLATE POLYGLUTAMYLATION%HUMANCYC%PWY-2161,0.38289835164835206,0.8582519754973359,-0.412399201479019,-1.04396119382854,2229,5,SHMT2|FPGS
CHOLINE BIOSYNTHESIS III%HUMANCYC%PWY-3561,0.320187426786412,0.822183858873702,-0.34096590837342305,-1.10066850691711,1639,9,PLD6|PCYT1A|PLD2
INOSINE-5'-PHOSPHATE BIOSYNTHESIS II%HUMANCYC%PWY-6124,0.799528672427337,0.9839175016931591,-0.364821527164027,-0.740394450055795,5088,3,ADSL|ATIC
DERMATAN SULFATE BIOSYNTHESIS (LATE STAGES)%HUMANCYC%PWY-6568,0.36135232140789597,0.848418604328854,0.5693544699896079,1.08228295360813,3120,3,CHST15|CHST14|DSE
URATE BIOSYNTHESIS INOSINE 5'-PHOSPHATE DEGRADATION%HUMANCYC%PWY-5695,0.5739894551845339,0.941545103735249,-0.325910506321406,-0.8946024565620809,3265,6,PNP|NT5E
URIDINE-5'-PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5686,0.18700858836337197,0.693783430081947,0.7417700578990899,1.2124027820205299,1545,2,CAD|UMPS
METHYLGLYOXAL DEGRADATION III%HUMANCYC%PWY-5453,0.33978468610136703,0.8330383695817521,0.669203198235456,1.09379424342857,2808,2,AKR1B1|CYP2E1
PURINE NUCLEOTIDES DEGRADATION II (AEROBIC)%HUMANCYC%PWY-6353,0.692893401015228,0.96731875442989,-0.252050231263385,-0.8136407332810259,3548,9,NT5C3A|NT5C3B|IMPDH2|NT5C2|NT5C1A|ADA|PNP|NT5E
FATTY ACID ACTIVATION%HUMANCYC%PWY-5143,0.300878734622144,0.8038155709110071,-0.407573815415826,-1.11876275673605,1711,6,ACSL5|ACSL6|ACSL1|ACSL4|ACSL3
CERAMIDE DEGRADATION%HUMANCYC%PWY-6483,0.035350191976697996,0.382137421231133,-0.9820247022496691,-1.3136843858815401,266,1,ASAH2
SALVAGE PATHWAYS OF PYRIMIDINE DEOXYRIBONUCLEOTIDES%HUMANCYC%PWY0-181,0.842983536790234,0.991298302704726,0.334718754719291,0.709301015251552,7526,4,TK1|TK2|TYMP
3-PHOSPHOINOSITIDE BIOSYNTHESIS%HUMANCYC%PWY-6352,0.259724571152452,0.771256701247223,-0.245038305911493,-1.1514145086275702,1074,23,PIP4K2B|FIG4|PIP5KL1|PIP5K1C|PIK3C2B|PIK3C2A|PIKFYVE|PIK3R4|PIK3R6|SACM1L|PIK3CB|PIK3CA|PI4KB|PIP5K1A|PI4K2B|PI4K2A|PIK3CD|PIK3R2|PIK3R5|PIK3C3|CDIPT|PIK3R1
SPERMIDINE BIOSYNTHESIS I%HUMANCYC%BSUBPOLYAMSYN-PWY,0.249740163325909,0.7613646381106121,-0.707306313757927,-1.20980956877982,1681,2,SRM|AMD1
ADENINE AND ADENOSINE SALVAGE III%HUMANCYC%PWY-6609,0.104163393558523,0.5762893149145369,-0.7071798830925329,-1.43520056149923,662,3,ADA|PNP|HPRT1
PENTOSE PHOSPHATE PATHWAY%HUMANCYC%PENTOSE-P-PWY,0.767502321262767,0.9792236089291529,-0.24543031530429102,-0.762904282149747,4132,8,G6PD|PGD|TKT
NAD BIOSYNTHESIS II (FROM TRYPTOPHAN)%HUMANCYC%NADSYN-PWY,0.124704491725768,0.607607158836689,-0.4032945075442971,-1.36440568413799,632,10,TDO2|NMNAT3|NMNAT2
"D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6351",0.354922279792746,0.842911430859438,-0.235293371123383,-1.06865448905977,1506,21,PIP5K1A|PI4K2B|PI4K2A|PLCE1|CDIPT|PIP4K2A|PLCD1|PLCB4|PLCB1
PROLINE BIOSYNTHESIS II (FROM ARGININE)%HUMANCYC%PWY-4981,0.9371710157912421,1.0,0.286935421607015,0.6080435678848379,8367,4,PYCR2|PYCR1|OAT|PYCRL
GLUTAMATE DEGRADATION II%HUMANCYC%GLUTDEG-PWY,0.7171492204899781,0.971081608033886,-0.47306313757926705,-0.809149161188282,4829,2,GOT1|GOT2
PENTOSE PHOSPHATE PATHWAY (OXIDATIVE BRANCH)%HUMANCYC%OXIDATIVEPENT-PWY,0.6095867398364879,0.9508825506493929,0.424269202358841,0.899066968104216,5442,4,H6PD|PGLS
KETOLYSIS%HUMANCYC%REACT_59.NULL,0.518101933216169,0.9236324326350509,-0.341668731037653,-0.937857725320766,2947,6,BDH1|OXCT1
SPHINGOSINE AND SPHINGOSINE-1-PHOSPHATE METABOLISM%HUMANCYC%PWY3DJ-11470,0.0913649025069638,0.5622489437340121,-0.464154154804511,-1.4427932093023201,491,8,SPHK1|SGPP2|ASAH2|PTGR1
HEME BIOSYNTHESIS II%HUMANCYC%PWY-5920,0.23801601330976396,0.7507739897770379,0.443460613266992,1.20899260492928,2288,8,ALAS1|CPOX|UROD|UROS|ALAD|HMBS|PPOX
HEME BIOSYNTHESIS FROM UROPORPHYRINOGEN-III I%HUMANCYC%HEME-BIOSYNTHESIS-II,0.8564228917011981,0.991298302704726,0.32741262164650603,0.693818621352126,7646,4,CPOX|UROD|PPOX
TYROSINE BIOSYNTHESIS IV%HUMANCYC%PWY-6134,0.125645438898451,0.607607158836689,-0.934825760917512,-1.25054492297786,948,1,PAH
FATTY ACID &BETA;-OXIDATION I%HUMANCYC%FAO-PWY,0.7587824255767209,0.977664504547119,0.22080553160028302,0.76547289782855,7926,16,SLC27A2|HADH|EHHADH|ECI1|ECI2|HADHB|ECHS1|ACAA1|HSD17B10
CMP-<I>N< I>-ACETYLNEURAMINATE BIOSYNTHESIS I (EUKARYOTES)%HUMANCYC%PWY-6138,0.0121850815083155,0.23962061927625303,-0.773115575838888,-1.77800431492831,73,4,GNE|CMAS|NANS
ARGININE BIOSYNTHESIS IV%HUMANCYC%ARGININE-SYN4-PWY,0.0671826115593611,0.501960209022281,-0.666464457067225,-1.53272902195263,407,4,OAT|GLUD1|ASS1|ASL
NORADRENALINE AND ADRENALINE DEGRADATION%HUMANCYC%PWY-6342,0.0989913694499324,0.570215774831708,0.5181641420883669,1.4126544662201899,951,8,PNMT|ADH1B|ALDH3A2|LRTOMT|COMT|MAOA
CARDIOLIPIN BIOSYNTHESIS II%HUMANCYC%PWY-5269,0.664328051288254,0.964618776001639,0.5424869037772271,0.886679941236842,5491,2,CRLS1|PGS1
SERINE BIOSYNTHESIS%HUMANCYC%SERSYN-PWY,0.80606692138474,0.984682960940884,0.401630892600077,0.7634580768487119,6961,3,PSAT1|PHGDH
SEROTONIN AND MELATONIN BIOSYNTHESIS%HUMANCYC%PWY-6030,0.325503355704698,0.826621597878865,0.8414755183061321,1.1178626851853102,2424,1,DDC
ETHANOL DEGRADATION II%HUMANCYC%PWY66-21,0.20407496186533,0.720304973077154,0.54269493618812,1.25083137800144,1872,5,ADH1B|ALDH3A2|ACSS1|ACSS2
D-GLUCURONATE DEGRADATION I%HUMANCYC%PWY-5525,0.8295471417965851,0.9876441563834109,-0.426413013509788,-0.729356622388272,5586,2,DCXR|CRYL1
L-CYSTEINE DEGRADATION I%HUMANCYC%CYSTEINE-DEG-PWY,0.7047296479980649,0.968941691852291,0.526992004411359,0.861353953893119,5825,2,CDO1|GOT1
METHYLGLYOXAL DEGRADATION I%HUMANCYC%PWY-5386,0.9086730373775249,1.0,0.43003181320205097,0.7028751850137751,7511,2,HAGH|GLO1
<I>N< I>-ACETYLGLUCOSAMINE DEGRADATION II%HUMANCYC%PWY-6517,0.320304625377982,0.822183858873702,0.5285671253296289,1.12008422993602,2859,4,AMDHD2|GNPDA1|GNPDA2|NAGK
METHYLMALONYL PATHWAY%HUMANCYC%PROPIONMET-PWY,0.292865942434763,0.8004058897916541,0.538853744602907,1.14188255880516,2614,4,PCCB|MCEE|PCCA|MUT
GLUTATHIONE REDOX REACTIONS I%HUMANCYC%PWY-4081,0.73128295254833,0.9726603499749559,-0.28608460647509804,-0.7852830355975821,4160,6,GPX7|GPX8|GPX3|GPX4|GPX1|GSR
LACTOSE DEGRADATION III%HUMANCYC%BGALACT-PWY,0.803521779425394,0.984522820758988,-0.596162329069255,-0.7975045244329729,6068,1,GLB1
GLUTAMATE DEGRADATION X%HUMANCYC%PWY-5766,0.56533827618165,0.9386032272525608,-0.7113475959417729,-0.951591367897687,4269,1,GLUD1
PRPP BIOSYNTHESIS I%HUMANCYC%PWY0-662,0.340014847809948,0.8332325975999629,-0.6561896884477529,-1.12237731881811,2289,2,PRPS2|PRPS1
SORBITOL DEGRADATION I%HUMANCYC%PWY-4101,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
"1,25-DIHYDROXYVITAMIN D<SUB>3< SUB> BIOSYNTHESIS%HUMANCYC%PWY-6076",0.18131295588746105,0.6873049536419911,0.6565972895517729,1.2481223759956799,1565,3,POR|CYP2R1|CYP27B1
CERAMIDE BIOSYNTHESIS%HUMANCYC%PWY3DJ-12,0.00832678711704635,0.20219929830704503,-0.8543938153110379,-1.7339668630186698,52,3,KDSR|SPTLC1
L-GLUTAMINE BIOSYNTHESIS II (TRNA-DEPENDENT)%HUMANCYC%PWY-5921,0.8077900084674001,0.984682960940884,0.48381582575131,0.79078367599228,6677,2,QRSL1|GATB
ANANDAMIDE DEGRADATION%HUMANCYC%PWY6666-1,0.213015604209508,0.7281220683825921,0.727047146401985,1.18833858764055,1760,2,FAAH2|FAAH
PYRIMIDINE RIBONUCLEOTIDES INTERCONVERSION%HUMANCYC%PWY-5687,0.42513263902534904,0.875263753716907,0.326747817176898,1.03002588836772,4326,12,NME3|NME4|NME7|CTPS2|CANT1|CTPS1|NME2|NME1
UDP-<I>N< I>-ACETYL-D-GLUCOSAMINE BIOSYNTHESIS II%HUMANCYC%UDPNACETYLGALSYN-PWY,0.6794299450549449,0.9647315640607691,-0.32445400397088,-0.821333766198194,3956,5,PGM3|UAP1|GFPT1|GNPNAT1|GFPT2
"TRYPTOPHAN DEGRADATION X (MAMMALIAN, VIA TRYPTAMINE)%HUMANCYC%PWY-6307",0.20843320984964,0.7238327250928481,0.5400569341821301,1.24475117443901,1912,5,DDC|ALDH3A2|AKR1A1|MAOA
DERMATAN SULFATE DEGRADATION (METAZOA)%HUMANCYC%PWY-6576,0.7454831107619799,0.9749763305090959,-0.38414028895996505,-0.77960130313503,4744,3,HEXA|HYAL1|IDUA
ALL-<I>TRANS< I>-DECAPRENYL DIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5806,0.376194508285956,0.853374872190571,0.6534168337323989,1.06799186432513,3109,2,PDSS1|PDSS2
THYMINE DEGRADATION%HUMANCYC%PWY-6430,0.938312829525483,1.0,-0.220451160994981,-0.6051236347182449,5338,6,DPYSL3|DPYSL5|DPYD|CRMP1|DPYSL2|DPYSL4
ALANINE BIOSYNTHESIS III%HUMANCYC%PWY0-1021,0.575400503111347,0.941940408834489,-0.706495368328187,-0.945100395075812,4345,1,NFS1
LANOSTEROL BIOSYNTHESIS%HUMANCYC%PWY-6132,0.553687276578843,0.932816793297168,-0.71746801940891,-0.9597788449798229,4181,1,LSS
URACIL DEGRADATION II (REDUCTIVE)%ARACYC%PWY-3982,0.938312829525483,1.0,-0.220451160994981,-0.6051236347182449,5338,6,DPYSL3|DPYSL5|DPYD|CRMP1|DPYSL2|DPYSL4
PYRIMIDINE RIBONUCLEOTIDES <I>DE NOVO< I> BIOSYNTHESIS%HUMANCYC%PWY0-162,0.272656402260768,0.7881764143551371,0.35539634761346506,1.1775385415200101,2797,14,NME3|NME4|NME7|CAD|CTPS2|UMPS|CANT1|CTPS1
GLUCOSE AND GLUCOSE-1-PHOSPHATE DEGRADATION%HUMANCYC%GLUCOSE1PMETAB-PWY,0.15220069436667,0.648319130045528,0.61265066080462,1.29826527368532,1358,4,PGM5|GCK|PGM2|PGM1
OLEATE BIOSYNTHESIS II (ANIMALS)%HUMANCYC%PWY-5996,0.0128865979381443,0.24668080085844798,0.6956067989031701,1.7107436165318302,119,6,SCD5|FADS2|ACOT1|FADS1|ACOT2
PHOSPHATIDYLETHANOLAMINE BIOSYNTHESIS II%HUMANCYC%PWY4FS-6,0.498496563573883,0.913423777265461,0.39444305913509004,0.9700752588454409,4641,6,CEPT1|CHKB|ETNK1|ETNK2|EPT1
PHENYLALANINE DEGRADATION I (AEROBIC)%HUMANCYC%PHENYLALANINE-DEG1-PWY,0.00148196937263297,0.0973924396038672,-0.85537663972266,-1.96718757692279,8,4,PAH|PCBD1|QDPR
CALCIUM TRANSPORT I%HUMANCYC%PWY-6166,0.303169447866502,0.8055436753253159,0.53502207257348,1.13376287975443,2706,4,ATP2A1|ATP2A2|ATP2C1|ATP2A3
PURINE RIBONUCLEOSIDES DEGRADATION TO RIBOSE-1-PHOSPHATE%HUMANCYC%PWY0-1296,0.24988864142539002,0.7613646381106121,-0.7071408877860491,-1.2095266165145702,1682,2,ADA|PNP
4-HYDROXYPROLINE DEGRADATION I%HUMANCYC%HYDROXYPRODEG-PWY,0.26201509334039497,0.771967970256231,-0.869155271283635,-1.16269550671818,1978,1,ALDH4A1
ASPARTATE DEGRADATION II%HUMANCYC%MALATE-ASPARTATE-SHUTTLE-PWY,0.40885888358307304,0.867015886388254,-0.44438316880824996,-1.0219884533632,2482,4,MDH1|GOT1|MDH2|GOT2
GLUTAMATE BIOSYNTHESIS II%HUMANCYC%GLUTAMATE-SYN2-PWY,0.56533827618165,0.9386032272525608,-0.7113475959417729,-0.951591367897687,4269,1,GLUD1
"CHOLESTEROL BIOSYNTHESIS II (VIA 24,25-DIHYDROLANOSTEROL)%HUMANCYC%PWY66-3",0.0993318923167616,0.570215774831708,0.450622159096826,1.4205220826023102,1010,12,TM7SF2|EBP|LBR|DHCR24|NSDHL|DHCR7|HSD17B7
GLUTAMATE DEGRADATION III (VIA 4-AMINOBUTYRATE)%HUMANCYC%GLUDEG-I-PWY,0.638321035442119,0.9601484712040809,0.552081610146126,0.9023622252148059,5276,2,ABAT|ALDH5A1
GLYCOGEN DEGRADATION III%HUMANCYC%PWY-5767,0.28678382031818705,0.796019542850327,0.42452344486575105,1.15736480333776,2757,8,GAA|PGM5|AGL
ETHANOL DEGRADATION IV%HUMANCYC%PWY66-162,0.30050119851819607,0.8034550126993599,0.49678099404661297,1.14500654771699,2757,5,ALDH3A2|ACSS1|CAT|ACSS2
"TETRAHYDROFOLATE SALVAGE FROM 5,10-METHENYLTETRAHYDROFOLATE%HUMANCYC%PWY-6613",0.52055101355135,0.9249983657048559,0.453728571343242,0.96149418508771,4647,4,MTHFD1|MTHFD2L|GART
EPOXYSQUALENE BIOSYNTHESIS%HUMANCYC%PWY-5670,0.30913140311803994,0.8114708447293539,-0.6756548111386821,-1.15567136869565,2081,2,SQLE|FDFT1
NAD PHOSPHORYLATION AND DEPHOSPHORYLATION%HUMANCYC%NADPHOS-DEPHOS-PWY,0.0517415164072125,0.44586532408291796,0.701474237163087,1.48649091685901,461,4,NNT|PXYLP1|NADK
CREATINE-PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6158,0.5022577283779089,0.9160672070117349,0.5159369140840411,0.9807417991476121,4337,3,CKB|CKMT1B|CKMT1A
ADENINE AND ADENOSINE SALVAGE VI%HUMANCYC%PWY-6619,0.743016020124454,0.974505008828563,-0.6239523599470671,-0.8346800960491609,5611,1,ADK
D-<I>MYO< I>-INOSITOL-5-PHOSPHATE METABOLISM%HUMANCYC%PWY-6367,0.10379858657243801,0.5762751358718871,-0.32861386755627303,-1.38276935838794,469,17,PIP4K2A|PLCD1|PLCB4|PLCB1|MTMR14
PENTOSE PHOSPHATE PATHWAY (NON-OXIDATIVE BRANCH)%HUMANCYC%NONOXIPENT-PWY,0.659805697348921,0.9643779777660141,-0.3635360944135,-0.836057071800721,4006,4,RPE|RPIA|TALDO1|TKT
SULFITE OXIDATION IV%HUMANCYC%PWY-5326,0.599865771812081,0.9503391896930079,0.705227172474636,0.9368628362178171,4468,1,SUOX
NAD BIOSYNTHESIS III%HUMANCYC%NAD-BIOSYNTHESIS-III,0.0408364893792195,0.402256981537283,-0.7053791868070991,-1.62222477078253,247,4,NAMPT|NMNAT3|NMNAT2
&GAMMA;-GLUTAMYL CYCLE%HUMANCYC%PWY-4041,0.173561859732073,0.676682497340677,-0.37890945206008597,-1.28190739148018,880,10,GCLC|GSS|DPP8|CNDP2|ANPEP
LEUKOTRIENE BIOSYNTHESIS%HUMANCYC%15354,0.7932011331444759,0.9819233677232551,0.322989628047543,0.7444432121821679,7279,5,DPEP1|LTA4H|DPEP2|LTC4S
NADH REPAIR%HUMANCYC%PWY-6938,0.12709725315516002,0.6076669536424699,-0.783622828784119,-1.34034488048102,855,2,APOA1BP|GAPDH
SUCROSE DEGRADATION V (MAMMALIAN)%HUMANCYC%PWY66-373,0.261814589165157,0.771967970256231,-0.507239972739954,-1.16654597115982,1589,4,TPI1|ALDOA
2-OXOBUTANOATE DEGRADATION I%HUMANCYC%PWY-5130,0.19725486118332103,0.7110878876919859,0.462017590672457,1.25958390386734,1896,8,BCKDHA|PCCB|DLD|MCEE|PCCA
3-PHOSPHOINOSITIDE DEGRADATION%HUMANCYC%PWY-6368,0.150045126353791,0.644423583388259,-0.29490862191065503,-1.29331386378149,664,19,INPP5F|OCRL|TMEM55B|MTMR3|INPPL1|INPP5J|INPP4B|SACM1L|PTEN|SYNJ1|INPP4A|PTPMT1|INPP5D|INPP5B|TMEM55A|SYNJ2|INPP5K|MTMR14
DTMP <I>DE NOVO< I> BIOSYNTHESIS%HUMANCYC%PWY66-385,0.8500391981184899,0.991298302704726,0.330514258955967,0.700391287094706,7589,4,DHFR|TYMS
ARGININE DEGRADATION I (ARGINASE PATHWAY)%HUMANCYC%ARGASEDEG-PWY,0.6524744697564809,0.9640743070248079,-0.4172273078195661,-0.8467504248520871,4152,3,ARG2|OAT|ALDH4A1
MITOCHONDRIAL L-CARNITINE SHUTTLE PATHWAY%HUMANCYC%PWY-6111,0.681602408243603,0.965271928233355,0.451472372339252,0.8582014867060171,5886,3,CPT1C|CPT2|CPT1A
&BETA;-ALANINE DEGRADATION I%HUMANCYC%BETA-ALA-DEGRADATION-I-PWY,0.9530664086125559,1.0,0.38941614207787395,0.636489986339062,7878,2,ABAT|ALDH6A1
ALANINE DEGRADATION III%HUMANCYC%ALANINE-DEG3-PWY,0.5532841417684771,0.932706603479095,0.584255379553973,0.9549493674467829,4573,2,GPT
GLYCOGEN DEGRADATION II%HUMANCYC%PWY-5941,0.7215669755686609,0.9713770803161691,0.303406662359973,0.789703796347825,6851,7,PGM5|AGL|PYGL|PGM2|PYGM|PGM1
HISTAMINE DEGRADATION%HUMANCYC%PWY-6181,0.580379823394218,0.942746898746279,0.574188224001077,0.938494878256515,4797,2,AOC2|HNMT
THIAMIN SALVAGE III%HUMANCYC%PWY-6898,0.478352972328876,0.9046812288131709,-0.759759594177327,-1.01635357400684,3612,1,TPK1
"D-<I>MYO< I>-INOSITOL (3,4,5,6)-TETRAKISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6365",0.33808463251670395,0.832232043362884,-0.656851392335263,-1.1235091278791,2276,2,IPMK|ITPK1
FATTY ACID &ALPHA;-OXIDATION III%HUMANCYC%PWY66-388,0.7887988387565021,0.9819233677232551,0.490620920531081,0.8019064164629279,6520,2,ALDH3A2|HACL1
GLYCOLYSIS I%HUMANCYC%GLYCOLYSIS,0.000662544169611308,0.0806484601749226,-0.5245719075787729,-2.2073382522325398,2,17,PFKL|GPI|FBP1|PKM|ENO1|GAPDH|PGK1|TPI1|ALDOA|PGAM2
OXIDIZED GTP AND DGTP DETOXIFICATION%HUMANCYC%PWY-6502,0.485767244803389,0.9067327323518829,-0.7555690339655929,-1.01074773384249,3668,1,NUDT1
TRNA CHARGING%HUMANCYC%TRNA-CHARGING-PWY,0.48290598290598297,0.905913681797234,-0.176185863336284,-0.9787047885455641,1694,37,QARS|DARS|AARS|CARS|WARS|NARS|HARS|FARS2|GARS|YARS|KARS|SARS
ALPHA6BETA4INTEGRIN%IOB%ALPHA6BETA4INTEGRIN,0.00035549235691432595,0.0784645998831315,-0.355985424921318,-2.27705860160428,0,60,RTKN|PIK3CD|EIF6|PLEC|PIK3R2|EIF4E|LAMA5|PRKCD|GRB2|ABL1|FYN|RHOA|CASP3|VIM|EIF4EBP1|YWHAH|LAMC1|ITGA6|SMAD2|MST1R|YES1|YWHAQ|YWHAB|SHC1|PRKCA|YWHAZ|YWHAE|RAC1|MET|LAMC2|PIK3R1|EPHB2
ANDROGENRECEPTOR%IOB%ANDROGENRECEPTOR,0.33644859813084105,0.8311444145897029,-0.137129635559293,-1.06174908438419,539,128,SMAD4|NCOR2|TGFB1I1|GSN|RAN|WHSC1|SMAD3|CCND3|HSP90AA1|PARK7|CDK11B|PLAGL1|PNRC1|IL6ST|RELA|MAGEA11|CALR|XRCC6|HSPB1|AHR|NELFCD|SIN3A|CDK9|CTNNB1|HSPA5|COX5B|CEBPA|STUB1|PA2G4|UBE2I|FOXO1|CASP3|RUNX1|PXN|SLC25A4|CDC37|VIP|TCF4|CDC25B|GAPDH|NRIP1|NR3C1|JUN|STAT3|PRDX1|RAD54L2|RNF4|BAG1|PIK3R1|CAV1|APPL1
BDNF%IOB%BDNF,0.29842931937172806,0.8023890191280308,-0.189303054512738,-1.11256476618309,968,45,MAPK7|SIRPA|CTNNB1|PTK2B|SYN1|FYN|EIF4EBP1|RELB|CAMK4|SHC1|MAPK3|KCNA3|FOXO3
CCR1%IOB%CCR1,0.8554366757899978,0.991298302704726,-0.147912985865724,-0.7175660389346249,3437,25,SRC|CCL5|CCL3L3|GNA14|MAPK9|ZAP70|PTK2|STAT1|MAPK14|CCR1|CCL4|CCL8|JAK1|MAPK8|MAPK1|NFKB1|CCL3|RELA|CREB3|PRKCD|PTK2B|CCL14|PXN|STAT3|MAPK3
CCR7%IOB%CCR7,0.848621673003802,0.991298302704726,-0.155429320062441,-0.720063690212045,3570,22,ADRB2|MAPK3|FOXO3
CCR9%IOB%CCR9,0.9694623655913979,1.0,-0.144141788558837,-0.5748503302524339,4507,15,FOXO1|MSN|MAPK3
CD40%IOB%CD40,0.0343625498007968,0.378473112045903,-0.320570973536044,-1.5740974990278798,137,26,NFKBIA|FGR|TRAF3|FYN|LYN|JUN|STAT3|MAPK3|MAP2K1|PIK3R1
CXCR4%IOB%CXCR4,0.0036968576709796703,0.143595610377104,-0.234053580472193,-1.6827201259387,7,93,ITK|CXCL12|RELA|VCAM1|RPS6KA3|PIK3R2|SOCS3|CRKL|PTPN6|GNA13|PIM1|NFKBIA|DOK1|PRKCD|CTNNB1|BCAR1|PTK2B|ARRB2|VAV1|FYN|RHOA|FOXO1|PXN|LYN|ICAM1|CRK|LIMK1|YWHAB|VAV2|CDC42|MAP2K3|NFKBIB|STAT3|ACKR3|MAPK3|RAC1|MAP2K1|PIK3R1|RPS6KA2|FOXO3
EGFR1%IOB%EGFR1,0.003952569169960471,0.14776184655466199,-0.165028208768393,-1.5675741257653502,0,434,ASAP3|SIAH1|PLSCR1|SMU1|AHNAK|RELA|ACTN1|ABL2|RPS6KA3|PVRL1|RIN1|AP2A1|PDCD6IP|PIK3CD|ARHGEF5|SH2D2A|FLOT1|PRKX|HAT1|ENSA|PLEC|PIK3R2|CDK5|SOCS3|EEF1A2|CRKL|S100A10|SLC12A7|SRI|APLP2|NCK2|ITCH|RALBP1|CALM3|PTPN6|LAPTM4A|ARHGAP5|MAGI1|USP31|LDHA|ESYT1|PTTG1IP|PLCE1|RBM3|MAPK7|DOK1|PRKCD|SIRPA|WBP2|OTUD6B|ABI1|CRIM1|BCAR1|PTK2B|PRKAA1|KRT17|ANKS1A|VASP|GRB2|PFN1|TNK2|CEBPA|ABL1|VAV1|LIMD1|FLNB|CTBP1|DYRK1A|TNS1|CDV3|FYN|RHOA|DDX3X|FOXO1|EIF4G1|PKM|VIM|PTRF|EIF4EBP1|MAP2K5|TJP2|UBASH3B|PTPN5|PXN|MPRIP|LYN|ENO1|SMAD2|CYLD|TOM1|IL17RD|CAMK2A|PTPN12|TNIP1|CRK|CLTA|CALM1|ZPR1|PTPN1|YWHAB|VAV3|SNCA|KLF11|VAV2|CDC42|MAP2K3|AP2S1|SHB|PDLIM1|TFRC|NEDD4|ADAM17|CSTB|STAT5A|BCL2|PYGB|SHC1|JUN|PRKCA|STAT3|PDLIM4|SH3GL3|TP53|YWHAZ|GAB2|NOS3|RBCK1|ASAP1|RALB|HTT|MAPK3|CAV2|ALDOA|RAB5A|TKT|MYH9|PKP4|PDZD11|PITPNA|TRIM29|RAC1|PLD2|MET|DDX6|TAGLN2|ACTR2|RFXANK|MAP2K1|PTPRA|PIK3R1|PEAK1|DYRK3|CAV1|RPS6KA2|EPHB2|PARD3|UBB|APPL1
EPO%IOB%EPO,0.0155440414507772,0.26480477175586303,-0.269062031518827,-1.62983269135342,47,50,STAT5A|SHC1|JUN|STAT3|GAB2|NOS3|MAPK3|MAP2K1|PIK3R1|BCL2L11|FOXO3
FAS%IOB%FAS,0.112660944206009,0.588016986131645,-0.162448333194633,-1.2297736062746698,209,113,MAX|SATB1|CAST|CDK11B|RELA|CDC27|EZR|EIF2AK2|CSNK1A1|DEDD2|PLEC|HSPB1|BAX|RFC1|PTPN6|EIF2S1|PKN1|PRKCD|IGF1R|SRP72|TRAF3|PSME3|FYN|UBE2I|CASP3|VIM|DFFA|LYN|BCL2L1|TCP1|BID|RIPK2|CDC42|EIF4B|NEDD4|STK4|BCL2|CFLAR|MAPK3|PARK2|STK24|RAC1|MET|MAP2K1|CSNK2A1|PAK2
FLK2 FLT3%IOB%FLK2 FLT3,0.00522813688212928,0.16770443270936902,-0.41575913441778994,-1.9261041381894402,21,22,STAT5A|SHC1|JUN|STAT3|GAB2|MAPK3|FOXO3
G-CSF%IOB%G-CSF,0.12171549380851698,0.607607158836689,-0.225954047124964,-1.30105973164373,402,42,SOCS3|CDKN1B|SOD1|NOTCH1|GRB2|VAV1|IL3RA|FTH1|LYN|REL|STAT5A|SHC1|STAT3|GAB2|NOS3|MAPK3
GDNF%IOB%GDNF,0.00626780626780627,0.17975028050367198,-0.332203083699655,-1.84537364479626,21,37,NFKBIA|MAPK7|DOK1|BCAR1|PTK2B|RET|FYN|PXN|CRK|SHC1|JUN|GAB2|MAPK3|MET|MAP2K1|DOK5|PIK3R1
GM-CSF%IOB%GM-CSF,0.00415800415800416,0.152010390420986,-0.24164302188287,-1.6705588718596798,9,79,NFKBIA|MAPK7|BCAR1|DPYSL2|GRB2|PFN1|VAV1|PXN|LYN|YES1|CSF2RB|MAP2K3|STAT5A|SHC1|PRKCA|STAT3|YWHAZ|BCL3|MAPK3|SLC2A1|MAP2K1|PIK3R1|RPS6KA2|EPHB2|FOXO3
HEDGEHOG%IOB%HEDGEHOG,0.21481678173128002,0.731747191309112,-0.226025607199485,-1.18856349483048,808,31,PRKACA|CREBBP|HHAT|SIN3A|CTNNB1|SKI|ARRB2|BOC|DYRK1A|CDON|SMAD1|YWHAE|SDC2|SAP18|KIF7
ID%IOB%ID,0.930550390479732,1.0,0.159052070941371,0.601301603846015,10008,21,HES1|RB1|ATF3|TCF12|CDK2|ID4|ELK1|ID3|RBL2|ELK4|SREBF1|PSMD4
IFN-ALPHA%IOB%IFN-ALPHA,0.258689458689459,0.770254607219728,-0.206592606999841,-1.14761292376183,907,37,NFKBIA|PRKCD|IFNAR2|VAV1|IFNAR1|FOXO1|TNFRSF10D|EIF4EBP1|CRK|MAP2K3|EIF4B|STAT5A|STAT3
IFN-GAMMA%IOB%IFN-GAMMA,0.557290132547865,0.9361453421204542,-0.165062160669137,-0.9387260740342371,1891,40,CRK|EIF4B|STAT5A|JUN|STAT3|MAPK3|MAP3K11
KITRECEPTOR%IOB%KITRECEPTOR,0.0039215686274509795,0.147602495543672,-0.242426017638386,-1.72953940634453,8,88,GRB2|PTPRU|FGR|ABL1|VAV1|FYN|MITF|TNFRSF10A|EIF4EBP1|KITLG|LYN|YES1|CSF2RB|WIPF1|CRK|STAT5A|SHC1|JUN|PRKCA|STAT3|NFATC2|GAB2|SOCS5|MAPK3|ACTR2|MAP2K1|PIK3R1|SPRED2
LEPTIN%IOB%LEPTIN,0.209354120267261,0.7248363921442859,-0.19677961950442702,-1.18292468823228,657,48,MAP2K3|LEPR|STAT3|MAPK3|MAP2K1|PIK3R1|PDE3A|RPS6KA2
M-CSF%IOB%M-CSF,0.0032526201662450302,0.137762274603971,-0.27718886562033695,-1.7870134018597998,8,62,PRKCD|BCAR1|PTK2B|GRB2|MITF|LILRA6|THOC5|VIM|EIF4EBP1|PXN|TFE3|LYN|PPP2CA|STAT5A|SHC1|STAT3|GAB2|MAPK3|MAP2K1|ETS2|PIK3R1|PAK2
NGF%IOB%NGF,0.8075836081017429,0.984682960940884,-0.165377707919146,-0.751111810394079,3428,21,SHC1|MAPK3|MAP2K1
NOTCH%IOB%NOTCH,0.226880394574599,0.7398172623753029,-0.167438300758672,-1.1498199022936102,551,77,GSK3B|TCF3|SMAD4|NCOR2|NOTCH3|PSEN1|PSENEN|SKP1|MFNG|NOTCH4|SMAD3|APH1B|RELA|DLL1|RING1|PIK3R2|BLOC1S1|ITCH|FBXW7|NOTCH1|FURIN|WDR12|MAGEA1|HIVEP3|SIN3A|ADAM10|NCSTN|SMAD1|PSEN2|ADAM17|STAT3|CIR1|MAPK3|ASCL1|PIK3R1|DLL3|RBPJ
TGF_BETA_RECEPTOR%IOB%TGF_BETA_RECEPTOR,0.0346020761245675,0.37924883037654705,-0.16239001230726902,-1.34077717315362,39,180,PRKCD|CTNNB1|SKI|TGFBR1|ANAPC1|BCAR1|FOXO4|ARRB2|GRB2|PML|RHOA|SMAD6|SNIP1|FOXO1|PXN|SMAD2|SUMO1|CAMK2A|PPP2CA|PRKAR2A|CRK|ETS1|PPM1A|DYNLRB2|SMAD7|IRF2BP1|MAP2K3|DYNLRB1|SHC1|JUN|PJA1|TP53|SNX6|PRKAR1B|EIF3I|UBE2D3|MAPK3|NFYA|CDKN1A|SDC2|ACVRL1|PIK3R1|TFDP2|CAV1|FKBP1A|PARD3|FOXO3
THROMBOPOIETIN%IOB%THROMBOPOIETIN,0.0086682427107959,0.20506001864802398,-0.5626726639761379,-1.9036058430668898,43,10,SHC1|STAT3|MAPK3|MAP2K1|FOXO3
TIE1 TEK%IOB%TIE1 TEK,0.0923221855864343,0.5622489437340121,-0.30821984959727505,-1.3998716764389199,391,21,FOXO1|PXN|STAT5A|SHC1|NOS3|MAPK3|MAP2K1
TNFALPHA%IOB%TNFALPHA,0.00325732899022801,0.137762274603971,-0.182197523171594,-1.5504180579006601,2,211,NFKBIE|KTN1|HSPB1|BAX|POLR1C|FBXW7|COPS3|PKN1|CDK9|NFKBIA|TBKBP1|PSMD12|DOK1|PRKCD|MAP3K8|TNFAIP3|HSPA5|PML|TRAF3|NKIRAS1|BAG4|DDX3X|TNFRSF1B|UBE2I|CASP3|RELB|MAP2K5|YWHAH|AZI2|RPL8|REL|TANK|POLR1B|PFDN2|SUMO1|CDC37|G3BP2|BID|CRADD|YWHAQ|YWHAB|TNFRSF11A|IRAK1BP1|STAT5A|JUN|CFLAR|NFKBIB|RASA3|POLR1E|TP53|COMMD1|YWHAZ|BCL3|YWHAE|UBE2D3|MAPK3|TNIP2|PSMD6|SMARCC1|GLG1|USP2|MAP3K11|MAP2K1|CSNK2A1|HSP90AB1|TNF|CAV1|TRIB3
TNFSF1%IOB%TNFSF1,0.32265901060070695,0.8230985635487221,-0.25883002207505496,-1.08912696295439,1460,17,LTA|LTB|TRAF5|TNFRSF19|AKT1|TNFRSF14|LTBR|IKBKG|TNFRSF1A|NFKB2|NFKB1|RELA|NFKBIA|TRAF3|TNFRSF1B|RELB|JUN
TNFSF3%IOB%TNFSF3,0.4379746835443039,0.878999860395433,-0.258787176516029,-1.00261003252061,2075,14,LTA|LTB|TRAF5|TRAF2|LTBR|TNFRSF1A|NFKB2|NFKB1|RELA|NFKBIA|TRAF3|TNFRSF1B|RELB|JUN
TNFSF8%IOB%TNFSF8,0.388537906137184,0.8602318600740309,-0.23680807533902698,-1.03851547271535,1721,19,NFKBIA|TRAF3|RELB|REL|NFKBIB|BCL3
TRAIL%IOB%TRAIL,0.9207853757616791,1.0,-0.11219797305845099,-0.7013108723015,2719,55,BCL10|CASP3|TNFRSF10D|TNFRSF10A|BID|JUN|CFLAR|TNFRSF10B|MAPK3|CSNK2A1
WNT%IOB%WNT,0.8867807153965791,0.996643473105967,0.12893223778045698,0.7097681221058841,11403,94,WNT4|WNT5B|CDK6|BTRC|ILK|CDH2|MARK2|DVL1|PRKCB|PRKCQ|MAP3K7|SRC|APC|FRAT2|NLK|DAAM1|LEF1|MAP3K4|PIN1|RYK|ARHGEF4|BCL9|RPS6KB2|MESDC2|MAP3K1|GPC3|FZD6|CHD7|DAB2|FZD3|GSK3A|DVL3
BIOCARTA_IL5_PATHWAY%MSIGDB_C2%BIOCARTA_IL5_PATHWAY,0.7717047451669599,0.979693198874896,-0.275660471016491,-0.7566694836932171,4390,6,CCL11|HLA-DRB1|HLA-DRA|CD4|IL1B|IL6
PID_E2F_PATHWAY%MSIGDB_C2%PID_E2F_PATHWAY,0.0382031566167544,0.3927265529050711,0.288292867241985,1.4908066319372402,471,69,SIRT1|KAT2A|CDK1|RRM1|APAF1|CDKN2C|DHFR|E2F3|ORC1|TK1|TRRAP|E2F7|CDKN2A|CCNE1|E2F2|RB1|E2F5|CDC6|E2F6|TOPBP1|MCM3|CCNE2|E2F1|TYMS|RRM2|XRCC1|SERPINE1|MYBL2|SP1|WASF1|CDK2|ATM|UXT|BRCA1
ST_GAQ_PATHWAY%MSIGDB_C2%ST_GAQ_PATHWAY,0.996905152011651,1.0,0.100458924382624,0.403892995216944,10951,26,VN1R1|PHKA2|TONSL|AKT3|AKT2|ITPR2|PLD1|AKT1|ADRBK1|IKBKG|PDK1|ITPR1
PID_MTOR_4PATHWAY%MSIGDB_C2%PID_MTOR_4PATHWAY,0.000755572346052135,0.0849637591935908,-0.29251544755387,-1.9529135600428602,1,69,RRN3|MAPKAP1|EIF4A1|RRAGD|EEF2K|NRAS|DDIT4|RRAGC|RB1CC1|PML|ATG13|RHOA|EIF4EBP1|YWHAH|PXN|PRR5|YWHAQ|YWHAB|EIF4B|PPARGC1A|PDCD4|KRAS|PRKCA|YWHAZ|YWHAE|MAPK3|RAC1|PLD2|MAP2K1
PID_IL8_CXCR2_PATHWAY%MSIGDB_C2%PID_IL8_CXCR2_PATHWAY,0.00929368029739777,0.212136117579847,-0.338121509353078,-1.77802368418973,34,31,ARRB2|VASP|FGR|GNAI2|GNA15|LYN|ARRB1|PPP2CA|CXCL8|PRKCA|RAB7A|RAB5A|PLD2|PLCB1
PID_CONE_PATHWAY%MSIGDB_C2%PID_CONE_PATHWAY,0.650379106992418,0.963755998259649,0.325241035521037,0.846534082281722,6175,7,GUCA1B|GNB3|RGS9
BIOCARTA_TALL1_PATHWAY%MSIGDB_C2%BIOCARTA_TALL1_PATHWAY,0.808995384464303,0.984682960940884,0.22381310836261603,0.7223280923545429,8237,13,TNFSF13B|TNFRSF13C|TRAF5|TRAF2|CHUK|MAPK14
PID_GMCSF_PATHWAY%MSIGDB_C2%PID_GMCSF_PATHWAY,0.00749791724520966,0.196165888622302,-0.328913101856391,-1.78797391146119,26,35,PIM1|NRAS|GRB2|LYN|CSF2RB|KRAS|STAT5A|SHC1|STAT3|YWHAZ|GAB2|MAPK3|MAP2K1|PIK3R1
PID_NEPHRIN_NEPH1_PATHWAY%MSIGDB_C2%PID_NEPHRIN_NEPH1_PATHWAY,0.856924254016833,0.991600879311246,-0.144849288492127,-0.721812547303991,3359,27,PIK3CD|PIK3R2|NCK2|ARRB2|GRB2|FYN|JUN|RAC1|PIK3R1
PID_ERA_GENOMIC_PATHWAY%MSIGDB_C2%PID_ERA_GENOMIC_PATHWAY,0.9943559096945551,1.0,0.0964733340510022,0.474290131846004,11979,55,COL18A1|SAFB|DSCAM|UBA3|MTA1|PDIA2|SRA1|DDX17|MED1|APBB1|LCOR|CEBPB|ABCA3|MPG|CHUK|BRCA1|GREB1|NCOA3
PID_ARF_3PATHWAY%MSIGDB_C2%PID_ARF_3PATHWAY,0.237138989169675,0.7507739897770379,-0.267519863997407,-1.17320119941968,1050,19,CLTA|COPA|ASAP1|RAC1|PLD2
PID_ECADHERIN_NASCENT_AJ_PATHWAY%MSIGDB_C2%PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.00521587945523037,0.16770443270936902,-0.33215629694857396,-1.8593171022560502,17,38,AP1M1|CTNNB1|ABI1|CYFIP2|RHOA|CSNK2A2|CRK|RAP1A|CTNNA1|VAV2|CDC42|RAPGEF1|RAC1|CSNK2A1|PIK3R1|DLG1
BIOCARTA_CACAM_PATHWAY%MSIGDB_C2%BIOCARTA_CACAM_PATHWAY,0.10852874040257302,0.58452352834625,-0.36781003347314395,-1.3851655556024098,522,13,CAMK2D|CALM3|CAMK2A|CALM1|CAMK4|CAMKK1
BIOCARTA_MYOSIN_PATHWAY%MSIGDB_C2%BIOCARTA_MYOSIN_PATHWAY,0.8144008318170001,0.986276922067025,-0.14860849765049403,-0.7605413033170221,3132,29,ARHGEF2|GNGT1|PRKCA|GNA12|PLCB1
SA_G1_AND_S_PHASES%MSIGDB_C2%SA_G1_AND_S_PHASES,0.496413502109705,0.911815944636073,-0.24750213457759399,-0.9588887924761279,2352,14,TP53|ARF3|CDKN1A
BIOCARTA_MPR_PATHWAY%MSIGDB_C2%BIOCARTA_MPR_PATHWAY,0.21729957805907196,0.734050632047527,-0.22881318890338603,-1.1870901568723602,823,30,ARPC5|PRKAR2A|ARPC4|GNGT1|PRKAR1B|MAPK3|GNAS|ACTR2
BIOCARTA_IL12_PATHWAY%MSIGDB_C2%BIOCARTA_IL12_PATHWAY,0.12185316358763301,0.607607158836689,0.396023573925731,1.37290633320782,1272,16,MAP2K6|ETV5|JAK2|CCR5|CD3D|IL12RB1|CD3G|CD3E|TYK2|CXCR3|MAPK14
BIOCARTA_AT1R_PATHWAY%MSIGDB_C2%BIOCARTA_AT1R_PATHWAY,0.0506398039749524,0.44185763626406,-0.276477955240496,-1.47881712134964,185,33,PTK2B|GRB2|GNAQ|MEF2D|CALM1|SHC1|JUN|PRKCA|MAPK3|RAC1|MAP2K1
BIOCARTA_CHEMICAL_PATHWAY%MSIGDB_C2%BIOCARTA_CHEMICAL_PATHWAY,0.5777091254752851,0.942692029750853,-0.196697695564142,-0.9112493605918209,2430,22,CASP3|PXN|BCL2L1|BID|BCL2|PRKCA|TP53
BIOCARTA_CXCR4_PATHWAY%MSIGDB_C2%BIOCARTA_CXCR4_PATHWAY,0.0381734718531046,0.3927265529050711,-0.334676226903666,-1.57261560357344,157,23,BCAR1|PTK2B|GNAQ|PXN|CRK|GNGT1|PRKCA|MAPK3|MAP2K1|PIK3R1
BIOCARTA_IL4_PATHWAY%MSIGDB_C2%BIOCARTA_IL4_PATHWAY,0.543144208037825,0.929698169790548,-0.271473492580129,-0.9184354595467329,2756,10,IRS1|RPS6KB1|AKT1|JAK3|STAT6|JAK1|IL2RG|IL4R|GRB2|SHC1
BIOCARTA_TCR_PATHWAY%MSIGDB_C2%BIOCARTA_TCR_PATHWAY,0.188285801901257,0.6952510959390681,-0.21009636121151,-1.21456933946852,613,43,SHC1|JUN|PRKCA|NFATC2|MAPK3|RAC1|MAP2K1|PIK3R1
BIOCARTA_G2_PATHWAY%MSIGDB_C2%BIOCARTA_G2_PATHWAY,0.33058230169646996,0.8293509737209019,0.28361674168112894,1.1161730604703,3604,24,CCNB1|CDC34|CDK1|ATR|WEE1|CDC25C|CHEK2|PLK1|PRKDC|CHEK1|ATM|CDKN2D|BRCA1|MDM2
BIOCARTA_GRANULOCYTES_PATHWAY%MSIGDB_C2%BIOCARTA_GRANULOCYTES_PATHWAY,0.0524828421477594,0.447307566936778,-0.444585446950441,-1.56455157840222,259,11,SELL|ITGAM|ICAM1|CXCL8|PECAM1|TNF
BIOCARTA_NO1_PATHWAY%MSIGDB_C2%BIOCARTA_NO1_PATHWAY,0.00463753966316817,0.15901096141144502,-0.408241882392134,-1.9568919437397798,18,24,PRKAR2A|CALM1|PRKAR1B|NOS3|FLT1|BDKRB2|CHRM1|SLC7A1|PDE3A|CAV1
PID_ECADHERIN_KERATINOCYTE_PATHWAY%MSIGDB_C2%PID_ECADHERIN_KERATINOCYTE_PATHWAY,0.100631768953069,0.570947005522165,-0.31605695790448496,-1.38605932493323,445,19,CTNNB1|VASP|FYN|RHOA|CTNNA1|ZYX|RAC1|PIK3R1
ST_TYPE_I_INTERFERON_PATHWAY%MSIGDB_C2%ST_TYPE_I_INTERFERON_PATHWAY,0.380857246640029,0.856651359297142,-0.3571428571428571,-1.04180155927305,2096,7,STAT2|TYK2|STAT1|IRF9|JAK1|PTPRU|IFNAR1
ST_GA13_PATHWAY%MSIGDB_C2%ST_GA13_PATHWAY,0.9202739485468431,1.0,0.144380128565699,0.627909910201576,10480,34,PHKA2|MAP3K5|TONSL|ARHGEF11|SRF|DLG4|AKT3|MAP3K1|AKT2|PTK2|PLD1|AKT1|PRKD1|IKBKG|PDK1|MAP2K4|ROCK1
BIOCARTA_PITX2_PATHWAY%MSIGDB_C2%BIOCARTA_PITX2_PATHWAY,0.180300500834725,0.685796186110214,0.397800354905437,1.2838496082689599,1835,13,DVL1|TRRAP|APC|LEF1|MED1
PID_RAC1_PATHWAY%MSIGDB_C2%PID_RAC1_PATHWAY,0.00420984455958549,0.15257126011092098,-0.30930184838428804,-1.8735838020218,12,50,PIP5K1A|ARPC1B|NCF2|CYBA|ARHGAP5|ARHGDIA|CTNNB1|ABI1|BCAR1|CYFIP2|ARPC5|CRK|CTNNA1|LIMK1|ARPC4|MAP2K3|STAT5A|JUN|STAT3|RAC1|MAP3K11|ACTR2|BRK1|PAK2
PID_TRAIL_PATHWAY%MSIGDB_C2%PID_TRAIL_PATHWAY,0.43426807306406,0.878651088001772,-0.199351764829186,-1.00797152576884,1687,28,TNFRSF10D|TNFRSF10A|CFLAR|TNFRSF10B|MAPK3|PIK3R1
PID_P53_REGULATION_PATHWAY%MSIGDB_C2%PID_P53_REGULATION_PATHWAY,0.47023026315789496,0.8973822756577429,0.199882071820184,0.9963721855376441,5717,58,PPP1R13L|ATR|CDKN2A|HUWE1|PIN1|SETD8|CHEK2|E4F1|KAT8|SMYD2|MAPK9|CHEK1|CSE1L|SKP2|CDK2|ATM|AKT1|PPM1D|CCNG1|FBXO11|MDM2|YY1|RPL5|CCNA2|KAT2B|PPP2R4|CSNK1E|MAPK14|RCHY1
PID_ALPHA_SYNUCLEIN_PATHWAY%MSIGDB_C2%PID_ALPHA_SYNUCLEIN_PATHWAY,0.00185873605947955,0.11072851755770098,-0.3978357166117071,-2.09203291416034,6,31,PRKCD|PTK2B|FGR|FYN|STUB1|LYN|YES1|SNCA|UCHL1|UBE2L3|MAPK3|PARK2|PLD2|CSNK2A1|FKBP1A
BIOCARTA_SODD_PATHWAY%MSIGDB_C2%BIOCARTA_SODD_PATHWAY,0.6122931442080379,0.9508825506493929,-0.25641308545264,-0.8674838479929321,3107,10,RIPK1|TRAF2|TRADD|BIRC3|FADD|TNFRSF1A|CASP8|BAG4|TNFRSF1B|TNF
PID_CMYB_PATHWAY%MSIGDB_C2%PID_CMYB_PATHWAY,0.890069209721552,0.997300970905927,0.133865130152545,0.698959592277758,11059,72,ATP2B1|CDK6|CCNA1|MAT2A|HES1|CCNB1|CASP6|CEBPD|YEATS4|CDKN2A|MAP3K7|NLK|LEF1|KIT|HRAS|PTGS2|H2AFZ
PID_AR_PATHWAY%MSIGDB_C2%PID_AR_PATHWAY,0.9480782198246801,1.0,-0.10544585757881099,-0.654059012707386,2811,54,PA2G4|UBE2I|TCF4|VAV3|NRIP1|SNURF|PRDX1|FKBP4|APPL1
BIOCARTA_RANKL_PATHWAY%MSIGDB_C2%BIOCARTA_RANKL_PATHWAY,0.128316749585406,0.608160579951936,-0.36966265710711704,-1.3467181406784698,618,12,RELA|TRAF6|EIF2AK2|IFNAR2|IFNAR1|FOSL1|TNFRSF11A
BIOCARTA_HDAC_PATHWAY%MSIGDB_C2%BIOCARTA_HDAC_PATHWAY,0.215761285386381,0.7322272196643679,-0.239531711928387,-1.1936337205861498,845,27,CALM3|MAPK7|IGF1R|HDAC5|YWHAH|MEF2D|IGF1|CALM1|NFATC2|PIK3R1
SIG_CD40PATHWAYMAP%MSIGDB_C2%SIG_CD40PATHWAYMAP,0.836245500043902,0.98866024827725,0.165617518109121,0.720271424861525,9523,34,MAPK11|MAPK12|MAPK10|TONSL|MAP2K7|MAPK13|MAPK9|SYT1|TRAF5|TRAF2|DUSP1
BIOCARTA_LEPTIN_PATHWAY%MSIGDB_C2%BIOCARTA_LEPTIN_PATHWAY,0.9109311740890691,1.0,0.21705696662961302,0.619406419435356,8999,9,PRKAA2|ACACA|PRKAB2
BIOCARTA_AGPCR_PATHWAY%MSIGDB_C2%BIOCARTA_AGPCR_PATHWAY,0.0180348258706468,0.283230741510052,-0.480498807043346,-1.75050535286319,86,12,ARRB1|PRKAR2A|GNGT1|PRKCA|PRKAR1B|GNAS
PID_TCR_CALCIUM_PATHWAY%MSIGDB_C2%PID_TCR_CALCIUM_PATHWAY,0.48217680608365,0.9053012218786121,-0.20938697505966297,-0.9700354983424508,2028,22,FOSL1|CHP1|JUN|NFATC2|RCAN2|FKBP1A
PID_EPO_PATHWAY%MSIGDB_C2%PID_EPO_PATHWAY,0.0350504514073287,0.381265913354899,-0.29712441786613203,-1.5624390566806798,131,31,SOCS3|CRKL|SH2B3|PTPN6|GRB2|LYN|BCL2L1|RAP1A|VAV2|STAT5A|BCL2|RAPGEF1|SHC1|PIK3R1
PID_TGFBR_PATHWAY%MSIGDB_C2%PID_TGFBR_PATHWAY,0.0531482735274205,0.44950045432031394,-0.224662950299064,-1.4042906957506498,156,55,ITCH|PPP2R2A|NEDD4L|CTNNB1|TGFBR1|ARRB2|GRB2|PML|RHOA|SMAD2|CAMK2A|PPP2CA|PPP2CB|SMAD7|DYNLRB1|SHC1|YWHAE|CAV1|DACT2|FKBP1A
BIOCARTA_PS1_PATHWAY%MSIGDB_C2%BIOCARTA_PS1_PATHWAY,0.34867330016583803,0.842847021021096,-0.29591409510180894,-1.07804473157965,1681,12,AXIN1|GSK3B|PSEN1|DLL1|NOTCH1|FZD1|CTNNB1|ADAM17|RBPJ
PID_AURORA_B_PATHWAY%MSIGDB_C2%PID_AURORA_B_PATHWAY,0.0310398344542162,0.36099065898614796,0.349123645866575,1.5746377330011398,359,39,KIF2C|KIF23|BIRC5|BUB1|SMC2|NDC80|CENPA|AURKB|INCENP|CDCA8|KIF20A|STMN1|NCAPG|NCAPH|RACGAP1|PEBP1|AURKA|PSMA3|MYLK|SEPT1|SMC4|KLHL9
PID_DELTA_NP63_PATHWAY%MSIGDB_C2%PID_DELTA_NP63_PATHWAY,0.9362503622138509,1.0,-0.116280314695365,-0.650904347606817,3230,38,HBP1|PPP2R5A|ITCH|DLX5|FBXW7|NOTCH1|MRE11A|ADRM1|STXBP4|IGFBP3|RUNX1|RRAD|SEC14L2|BDKRB2
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY%MSIGDB_C2%PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.000309789343246592,0.0784645998831315,-0.401751643166731,-2.34185582423877,0,44,GRB2|FYN|MMP2|ITGA5|FOXO1|FGF2|PXN|CRK|ETS1|STAT5A|SHC1|NOS3|MAPK3|CDKN1A|TNIP2|RAC1|PLD2|PIK3R1|TNF|ANGPT2
SA_FAS_SIGNALING%MSIGDB_C2%SA_FAS_SIGNALING,0.195059934616782,0.7071776657593091,-0.430103203523755,-1.2546301266222701,1073,7,CASP3|BCL2|CFLAR
PID_ANTHRAX_PATHWAY%MSIGDB_C2%PID_ANTHRAX_PATHWAY,0.105159165751921,0.578008942587973,-0.339239901497515,-1.38930141193078,478,16,MAP2K3|NLRP1|MAPK3|MAP2K1|TNF
SA_CASPASE_CASCADE%MSIGDB_C2%SA_CASPASE_CASCADE,0.273783449195315,0.7884684708511421,0.325964453011525,1.16930094765623,2874,18,DFFB|APAF1|PARP1|FAS|SREBF2|PRF1|BIRC2|CASP9
PID_INSULIN_PATHWAY%MSIGDB_C2%PID_INSULIN_PATHWAY,0.0297397769516729,0.354139215474632,-0.262839541528221,-1.5321214527370601,95,44,EIF4EBP1|EXOC3|EXOC4|CRK|PTPN1|RAPGEF1|SHC1|RHOQ|PTPRA|PIK3R1|CAV1|FOXO3
BIOCARTA_RHO_PATHWAY%MSIGDB_C2%BIOCARTA_RHO_PATHWAY,0.22147127631921001,0.73556947110949,-0.230915587591393,-1.18176850395197,851,29,DIAPH1|BAIAP2|GSN|PIP5K1A|ARPC1B|ARHGEF5|OPHN1|ARHGAP5|PFN1|RHOA|ARHGAP1|ARPC5|LIMK1|ARPC4|ACTR2
PID_EPHRINB_REV_PATHWAY%MSIGDB_C2%PID_EPHRINB_REV_PATHWAY,0.19765365978066798,0.711592141628341,-0.244302447130392,-1.2174072341775501,774,27,NCK2|BLK|FGR|FYN|LYN|YES1|EFNB1|RAC1|PIK3R1|EPHB2
PID_UPA_UPAR_PATHWAY%MSIGDB_C2%PID_UPA_UPAR_PATHWAY,0.29660116834838,0.8013070063650121,-0.21178733800549102,-1.11369106244004,1116,31,BCAR1|ITGAM|ITGA5|PLAU|HGF|MMP9|CRK|PLAUR|MMP12|RAC1
BIOCARTA_ACH_PATHWAY%MSIGDB_C2%BIOCARTA_ACH_PATHWAY,0.40654016955995204,0.8664565508572991,-0.29196021470564804,-1.02744437066401,2013,11,PIK3R1|FOXO3
BIOCARTA_VIP_PATHWAY%MSIGDB_C2%BIOCARTA_VIP_PATHWAY,0.8079082255308759,0.984682960940884,-0.15608912306310702,-0.7482072776016709,3309,24,CALM3|NFKBIA|GNAQ|VIP|PRKAR2A|CALM1|NFATC2|PRKAR1B
PID_S1P_META_PATHWAY%MSIGDB_C2%PID_S1P_META_PATHWAY,0.186999528968441,0.693783430081947,-0.272780028431471,-1.23891123883929,793,21,SGPL1|GNAI3|GNA13|GNAZ|ABCC1|GNAQ|SPHK1|GNAI2|GNA15|GNA12|S1PR1
PID_ECADHERIN_STABILIZATION_PATHWAY%MSIGDB_C2%PID_ECADHERIN_STABILIZATION_PATHWAY,0.018213866039952998,0.284804933176101,-0.293967900090352,-1.65864247330047,61,39,CTNNB1|IGF1R|ABI1|VASP|CYFIP2|RHOA|EXOC3|HGF|EFNA1|EXOC4|IGF1|CTNNA1|ZYX|AQP5|MET
PID_IL12_2PATHWAY%MSIGDB_C2%PID_IL12_2PATHWAY,0.7512137954126898,0.9765189690604059,0.165729142628596,0.8006319193899358,8973,51,MAP2K6|JAK2|CCR5|GZMA|FOS|GADD45B|GADD45G|CD8B|CD3D|IL12RB1|SOCS1|CD3G|CD3E|CD8A|LCK|HLA-DRB1|TYK2|IL1R1|STAT1|IL2RA|HLX|MAPK14|PPP3CA|PPP3CB|CCL4|CD247|MTOR|IL2RB|STAT6|HLA-DRA
PID_CXCR4_PATHWAY%MSIGDB_C2%PID_CXCR4_PATHWAY,0.0833734939759036,0.543815846291824,-0.17579199496263598,-1.2883647478136202,172,100,PIK3R5|ITCH|RAP1B|GNAI3|PTPN6|BLK|MAPKAP1|GNA13|GNAZ|BCAR1|PTK2B|ARRB2|FGR|VAV1|VPS4A|GNAI2|FYN|RHOA|ITGA5|FOXO1|PXN|LYN|ITGA6|MMP9|YES1|VPS4B|CRK|RHOC|LIMK1|CDC42|STAT5A|STAT3|RALB|RAC1|PLCB1|PIK3R1|ITGA7
PID_GLYPICAN_1PATHWAY%MSIGDB_C2%PID_GLYPICAN_1PATHWAY,0.0116944513560587,0.23446950230954997,-0.36440077151790606,-1.76780704325852,46,25,BLK|VEGFA|TGFBR1|FGR|FYN|FGF2|LYN|PRNP|SMAD2|YES1|PLA2G2A|FGFR1|FLT1
PID_FANCONI_PATHWAY%MSIGDB_C2%PID_FANCONI_PATHWAY,0.0008476731372382809,0.0849637591935908,0.42923392814207895,2.0254593127030103,9,46,FANCL|SSPO|HES1|XRCC3|FANCA|ATR|BLM|BRIP1|RFC4|RAD9A|UBE2T|FANCG|FANCC|H2AFX|FANCM|FANCF|TOPBP1|FANCD2|RMI1|FANCI|PALB2|BRCA2|CHEK1|RFC3|FAAP100|RAD17|RFC5|RAD1|ATM|BRCA1
PID_FRA_PATHWAY%MSIGDB_C2%PID_FRA_PATHWAY,0.12597984322508402,0.607607158836689,-0.23609919142976002,-1.2987561576682398,449,36,HMOX1|LIF|MMP2|FOSL1|PLAU|IL6|MMP9|PLAUR|THBD|CXCL8|JUN|NFATC2|NOS3
BIOCARTA_CTCF_PATHWAY%MSIGDB_C2%BIOCARTA_CTCF_PATHWAY,0.790161596958175,0.9819233677232551,-0.16496984884427,-0.764262483325582,3324,22,CD79B|CDKN1B|TGFBR1|SMAD1|PPP2CA|TP53|PIK3R1
BIOCARTA_AKT_PATHWAY%MSIGDB_C2%BIOCARTA_AKT_PATHWAY,0.131526327482782,0.615486722080346,-0.30832881697311104,-1.32636206657324,591,18,NFKBIA|FOXO4|FOXO1|YWHAH|PPP2CA|PIK3R1|FOXO3
BIOCARTA_SARS_PATHWAY%MSIGDB_C2%BIOCARTA_SARS_PATHWAY,0.31086350974930393,0.8143712300420921,-0.35763426575669705,-1.11168301459006,1673,8,FBL|EIF4E|NCL|LDHA|ANPEP
BIOCARTA_CTL_PATHWAY%MSIGDB_C2%BIOCARTA_CTL_PATHWAY,0.797504421300845,0.9831888870926351,0.23111107286819702,0.728544692966695,8116,12,FAS|CD3D|PRF1|CD3G|CD3E
PID_TNF_PATHWAY%MSIGDB_C2%PID_TNF_PATHWAY,0.936962994470438,1.0,0.131526921467165,0.616517850605988,11013,45,NSMAF|MAP3K5|MAP3K7|TRAF1|MAP4K3|MAP2K7|BIRC2|RIPK1|MAP3K1|SMPD1|MADD|TRAF2|TRADD|CHUK|TNIK|TAB1|STAT1|MAP4K2|BIRC3
BIOCARTA_BAD_PATHWAY%MSIGDB_C2%BIOCARTA_BAD_PATHWAY,0.00265764677458323,0.127945605331026,-0.43652149185875394,-2.0511779869857,10,23,IGF1R|IL3RA|YWHAH|KITLG|BCL2L1|CSF2RB|PRKAR2A|IGF1|BCL2|PRKAR1B|MAPK3|PIK3R1
PID_BETA_CATENIN_NUC_PATHWAY%MSIGDB_C2%PID_BETA_CATENIN_NUC_PATHWAY,0.420059215396003,0.872709803390378,-0.155003860315032,-1.02355638175463,1134,67,ID2|ZCCHC12|ADCY7|CTNNB1|CTBP1|MITF|MMP2|TCF7L2|TBL1X|YWHAH|MMP9|TCF4|RUVBL2|CAMK4|YWHAQ|YWHAB|CXCL8|JUN|TCF7|DKK1|YWHAZ|YWHAE
PID_KIT_PATHWAY%MSIGDB_C2%PID_KIT_PATHWAY,0.0429900545396214,0.4089601731625301,-0.244177315335653,-1.47234478407325,133,49,CREBBP|SNAI2|CRKL|SH2B3|PTPN6|MATK|DOK1|GRB2|VAV1|MITF|KITLG|LYN|STAT5A|BCL2|SHC1|STAT3|MAPK3|MAP2K1|PIK3R1|SPRED2|FOXO3
BIOCARTA_CYTOKINE_PATHWAY%MSIGDB_C2%BIOCARTA_CYTOKINE_PATHWAY,0.141118779513258,0.630107155356772,-0.46068111947797796,-1.34382726407948,776,7,IL6|CXCL8|TNF
BIOCARTA_CREB_PATHWAY%MSIGDB_C2%BIOCARTA_CREB_PATHWAY,0.0102091633466135,0.221106802361923,-0.36117815506209394,-1.77349066983702,40,26,CAMK2A|PRKAR2A|PRKCA|PRKAR1B|MAPK3|GNAS|RAC1|PIK3R1
BIOCARTA_MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_MAPK_PATHWAY,0.9578574241827491,1.0,0.11351276778298701,0.615707611248823,12159,87,MAPK11|MAP3K10|MAP2K6|MAPK12|MAP2K2|MAP3K9|MAPK10|TGFB2|MAP3K5|MAP3K7|FOS|HRAS|MAP4K3|MAP3K4|MAP2K7|RPS6KB2|RIPK1|ARAF|MAP3K1|MAP3K12|MAPK13|MAPK9|RPS6KA4|TRAF2|RPS6KB1|SP1|TRADD|CHUK|TGFB3|MAPKAPK5|STAT1|MAP4K2
BIOCARTA_ACE2_PATHWAY%MSIGDB_C2%BIOCARTA_ACE2_PATHWAY,0.45205927217258707,0.886927331649118,0.43867233668610106,1.01107470661562,4148,5,AGTR1|COL4A2|COL4A1
BIOCARTA_PPARA_PATHWAY%MSIGDB_C2%BIOCARTA_PPARA_PATHWAY,0.0511658031088083,0.443570638584446,-0.238135569845936,-1.4424968640803,157,50,CITED2|FAT1|PPARA|RXRA|PRKAR2A|NRIP1|PPARGC1A|STAT5A|JUN|PRKCA|PRKAR1B|ACOX1|MAPK3|CD36|PIK3R1|TNF
BIOCARTA_EGFR_SMRTE_PATHWAY%MSIGDB_C2%BIOCARTA_EGFR_SMRTE_PATHWAY,0.15892229597813398,0.661359103221672,-0.40241507606127597,-1.29903192680546,813,9,THRA|NCOR2|ZBTB16|RARA|RXRA|MAP2K1
BIOCARTA_FEEDER_PATHWAY%MSIGDB_C2%BIOCARTA_FEEDER_PATHWAY,0.198329095532147,0.711592141628341,-0.428307447716119,-1.2493918272609599,1091,7,HK1|TPI1
ST_MYOCYTE_AD_PATHWAY%MSIGDB_C2%ST_MYOCYTE_AD_PATHWAY,0.55437725631769,0.9335070403535591,-0.21031747600318598,-0.9223416587422042,2456,19,GNAQ|PLN|RYR1|RAC1|EPHB2
BIOCARTA_P35ALZHEIMERS_PATHWAY%MSIGDB_C2%BIOCARTA_P35ALZHEIMERS_PATHWAY,0.45232466509062297,0.887237803928201,-0.291474670247849,-0.9861024373725921,2295,10,GSK3B|CSNK1D|CSNK1A1|CDK5|CAPNS1|PPP2CA
BIOCARTA_TEL_PATHWAY%MSIGDB_C2%BIOCARTA_TEL_PATHWAY,0.0502110642079538,0.440437200396145,-0.357791282010317,-1.53913860166524,225,18,PPP2CA|POLR2A|KRAS|BCL2|PRKCA|TP53
PID_LIS1_PATHWAY%MSIGDB_C2%PID_LIS1_PATHWAY,0.0841622035195103,0.545178773025535,-0.281605100395088,-1.4032937059336799,329,27,LRPAP1|CDC42|PAFAH1B2|RELN|YWHAE|RAC1|CSNK2A1|NUDC
BIOCARTA_CASPASE_PATHWAY%MSIGDB_C2%BIOCARTA_CASPASE_PATHWAY,0.260977630488815,0.771967970256231,0.30389329660974396,1.18190280540374,2834,23,DFFB|APAF1|CASP6|PARP1|LMNB1|LMNB2|PRF1|BIRC2|CASP9|CASP2|XIAP|BIRC3|CYCS
PID_MAPK_TRK_PATHWAY%MSIGDB_C2%PID_MAPK_TRK_PATHWAY,0.22679008984481397,0.7398172623753029,-0.22006401605816603,-1.1770719096092,832,33,CDK5|RAP1B|MAPK7|PRKCD|NRAS|RIT1|MAP2K5|EHD4|RAP1A|MAP2K3|KRAS|MAPK3|MAP2K1
PID_RHOA_PATHWAY%MSIGDB_C2%PID_RHOA_PATHWAY,0.946842422675971,1.0,0.131914232214181,0.598517850984639,10989,40,ITGB1|CYR61|MAP2K6|MAPK12
BIOCARTA_CELLCYCLE_PATHWAY%MSIGDB_C2%BIOCARTA_CELLCYCLE_PATHWAY,0.0334161833747584,0.37444991734936,0.40897741151502603,1.59059628958222,362,23,CDK6|CCNA1|CCNB1|CDK1|CDKN2C|CDKN2A|CCNE1|RB1|CDKN2B|CDK7|E2F1|CDK2|CDKN2D|CCND2
BIOCARTA_LYM_PATHWAY%MSIGDB_C2%BIOCARTA_LYM_PATHWAY,0.490543735224586,0.908938677284213,-0.282783652459742,-0.956699423324019,2489,10,ITGB2|CD34|VCAM1|SELL|ICAM1|CXCL8|PECAM1
PID_IL6_7_PATHWAY%MSIGDB_C2%PID_IL6_7_PATHWAY,0.5323520392517629,0.9265056012720759,-0.164215511054595,-0.949331647830262,1735,43,PRKCD|GRB2|VAV1|MITF|FOXO1|IL6|BCL2L1|JUN|STAT3|GAB2|RAC1|PIK3R1
BIOCARTA_TRKA_PATHWAY%MSIGDB_C2%BIOCARTA_TRKA_PATHWAY,0.38826699834162504,0.860097613635053,-0.286502481622019,-1.04375727959443,1872,12,SHC1|PRKCA|PIK3R1
BIOCARTA_AHSP_PATHWAY%MSIGDB_C2%BIOCARTA_AHSP_PATHWAY,0.0390892605279065,0.396089810860281,0.534632477880699,1.5778385653391698,387,10,ALAS1|HBB|HBA2|CPOX|HBA1|UROD|UROS|ALAD|HMBS
BIOCARTA_SHH_PATHWAY%MSIGDB_C2%BIOCARTA_SHH_PATHWAY,0.698829228905935,0.96731875442989,-0.23020926289105398,-0.8101350777214241,3461,11,GSK3B|PRKAR1A|DYRK1B|DYRK1A|PRKAR2A|PRKAR1B
BIOCARTA_TNFR1_PATHWAY%MSIGDB_C2%BIOCARTA_TNFR1_PATHWAY,0.6664276109368,0.964618776001639,0.205528909510785,0.8513699536263392,7433,29,DFFB|MAP3K7|PARP1|RB1|LMNB1|LMNB2|SPTAN1|RIPK1|MAP3K1|MADD|TRAF2|PRKDC|CASP2|TRADD
BIOCARTA_VDR_PATHWAY%MSIGDB_C2%BIOCARTA_VDR_PATHWAY,0.8814262023217251,0.9956508825790341,-0.18444137931034502,-0.6719384461304261,4251,12,MED1|CARM1|NCOA3|KAT2B|NCOR1|EP300|NCOA2|TSC2|NCOA1|HDAC1|CREBBP|RXRA
BIOCARTA_EPHA4_PATHWAY%MSIGDB_C2%BIOCARTA_EPHA4_PATHWAY,0.32621457489878497,0.826621597878865,0.393346486420282,1.1224764748823501,3222,9,ITGB1|ITGA1
PID_BMP_PATHWAY%MSIGDB_C2%PID_BMP_PATHWAY,0.961086226203807,1.0,-0.109541412896201,-0.602575483876426,3432,36,SKI|RGMA|SMAD6|SMAD1|CHRDL1|PPM1A|SMAD7|GREM1
BIOCARTA_RB_PATHWAY%MSIGDB_C2%BIOCARTA_RB_PATHWAY,0.495629971521163,0.911498395855878,0.301799019742838,0.9740176158588549,5046,13,CDK1|WEE1|CDC25C|RB1|CHEK1|CDK2|ATM
BIOCARTA_41BB_PATHWAY%MSIGDB_C2%BIOCARTA_41BB_PATHWAY,0.9854741647644741,1.0,-0.13838004855440303,-0.52113661780829,4748,13,MAP3K5|MAP3K1|TRAF2|CHUK|MAPK14|MAP4K5|MAPK8|ATF2|NFKB1|IKBKB|RELA|NFKBIA|JUN
BIOCARTA_BCELLSURVIVAL_PATHWAY%MSIGDB_C2%BIOCARTA_BCELLSURVIVAL_PATHWAY,0.520382534775889,0.924920262043165,0.28128051561743395,0.953713098473765,5386,15,ITGB1|ITGA1|BIRC5|FOS|DPF2|AKT1|XIAP|JUND|CASP7|ZBTB7A|MTOR
BIOCARTA_CERAMIDE_PATHWAY%MSIGDB_C2%BIOCARTA_CERAMIDE_PATHWAY,0.914118954974986,1.0,0.163859814986439,0.627545080972299,9866,22,NSMAF|AIFM1|BAD|RIPK1|MAP3K1|SMPD1|TRAF2|TRADD
PID_TXA2PATHWAY%MSIGDB_C2%PID_TXA2PATHWAY,0.0166884816753927,0.275276837675476,-0.26459471841793697,-1.6123875243168,50,51,PRKACA|VCAM1|RAB11A|TBXA2R|PIK3R5|BLK|PRKCH|GNA13|PRKCD|ARRB2|FGR|GNAQ|GNAI2|FYN|RHOA|GNA15|LYN|YES1|ICAM1|GNB5|PRKCA|NOS3|GNA12|SLC9A3R1|RAC1
NABA_SECRETED_FACTORS%MSIGDB_C2%NABA_SECRETED_FACTORS,0.25781990521327003,0.7686328443270871,0.188532962635867,1.1388921800474299,3535,163,INSL3|CXCL13|LEFTY1|FGF19|MEGF6|WNT4|FST|PSPN|FGF12|CRHBP|WNT5B|FIGF|INHA|BRINP3|IL17B|NRG2|SCUBE2|ARTN|NRG3|BMP4|INS|CXCL9|CFC1|FGF17|S100A1|FGF13|FGF11|C1QTNF9B|HCFC2|TGFB2|TNFSF13B|GDF11|XCL2|CCL21|CRLF3|EBI3|CCL5
SA_TRKA_RECEPTOR%MSIGDB_C2%SA_TRKA_RECEPTOR,0.635379858657244,0.95916055221954,-0.20525520623989102,-0.863690299952164,2876,17,PIK3CD|NTRK1|GRB2|RHOA|SHC1|CDKN1A|MAP2K1
BIOCARTA_WNT_PATHWAY%MSIGDB_C2%BIOCARTA_WNT_PATHWAY,0.775882622650161,0.980614374126555,0.193779981090421,0.762620687585325,8460,24,BTRC|DVL1|MAP3K7|APC|NLK|LEF1
BIOCARTA_BARRESTIN_SRC_PATHWAY%MSIGDB_C2%BIOCARTA_BARRESTIN_SRC_PATHWAY,0.0479569892473118,0.431337225587021,-0.39011968616205395,-1.5558321613075603,222,15,ARRB1|GNGT1|MAPK3|GNAS|PLCB1|MAP2K1
NABA_CORE_MATRISOME%MSIGDB_C2%NABA_CORE_MATRISOME,0.510752688172043,0.918404893008545,0.15847561428910098,0.98321311080945,7124,198,CTGF|COL9A2|VWDE|ESM1|FBN3|CYR61|COL18A1|ELN|LGI1|LAMC3|NOV|NTN5|SLIT1|ASPN|SSPO|VCAN|WISP1|COL26A1|TNC|HAPLN2|DDX26B|SMOC1|BGLAP|DPT|EMID1|EFEMP1|COL8A1|LAMA1|FNDC1|LAMB2|MGP|PAPLN|IGFBP5|FBN1|COL4A2|NTN3|ZP3|COL20A1|IGFBP7|LTBP2|HMCN1|TNXB|FBLN5|COL4A1|COL5A2|CRELD2|COL27A1|MFAP4|PRELP|COL28A1|EFEMP2|COL5A1|IGFBPL1|COL11A2|NTN1|FN1|LGI4|LAMA2|IGFBP2|LTBP1|THBS2|NID1|AEBP1|SPARC|AGRN|FMOD|THBS1|MFAP2|SPOCK2|COL12A1|MFAP1|CRELD1|TECTA|BGN|COL11A1|VWA7|LTBP4|COL1A1|DCN|FBLN2|OGN|NELL2|CTHRC1|NTN4|LUM|MFAP3|COL3A1|TGFBI|LAMB3|THSD4|VWA5B2|MFGE8
PID_NFKAPPAB_CANONICAL_PATHWAY%MSIGDB_C2%PID_NFKAPPAB_CANONICAL_PATHWAY,0.10147338403041803,0.571746500995146,-0.297975002477833,-1.3804408318130401,426,22,IKBKB|ERC1|RAN|RELA|TRAF6|NFKBIA|TNFAIP3|BCL10|CYLD|RIPK2|PRKCA|UBE2D3|TNF
PID_PDGFRB_PATHWAY%MSIGDB_C2%PID_PDGFRB_PATHWAY,0.000616903146206046,0.0806484601749226,-0.242914896123191,-1.88033278515165,0,127,DOK1|PRKCD|DNM2|ABI1|BCAR1|NRAS|GRB2|FGR|ABL1|CYFIP2|SPHK1|FYN|RHOA|YWHAH|LYN|ARPC5|YES1|PPP2CA|CRK|RAP1A|YWHAQ|PTPN1|YWHAB|VAV2|ARPC4|KRAS|STAT5A|RAPGEF1|SHC1|JUN|PRKCA|STAT3|YWHAZ|YWHAE|MAPK3|RAB5A|S1PR1|SLC9A3R1|RAC1|ACTR2|BRK1|MAP2K1|PIK3R1
BIOCARTA_CLASSIC_PATHWAY%MSIGDB_C2%BIOCARTA_CLASSIC_PATHWAY,0.23576831210191102,0.750277765814412,0.397715988083416,1.21334031155289,2368,11,C7|C5|C4A|C4B|C2|C1QB|C1S|C1R|C3|C1QC|C1QA
BIOCARTA_MCALPAIN_PATHWAY%MSIGDB_C2%BIOCARTA_MCALPAIN_PATHWAY,0.9484893976355792,1.0,0.15324451262743,0.569073382999195,10108,20,ITGB1|ITGA1|PRKAR2B|HRAS|MYLK|PTK2|TLN1
BIOCARTA_PYK2_PATHWAY%MSIGDB_C2%BIOCARTA_PYK2_PATHWAY,0.00926164136866478,0.212136117579847,-0.35214663688384495,-1.78053995748829,35,28,CRKL|CALM3|BCAR1|PTK2B|GRB2|GNAQ|CALM1|MAP2K3|SHC1|JUN|PRKCA|MAPK3|RAC1|MAP2K1
PID_FAS_PATHWAY%MSIGDB_C2%PID_FAS_PATHWAY,0.448311869126349,0.8850378987593649,0.227171137316629,1.01002613662044,5151,37,MAPK11|MAP2K6|PIK3R3|MAPK10|PDPK1|SRC|FAS|MAP2K7|BIRC2|RIPK1|CLTC|MAP3K1|SMPD1|MAPK9|BTK|CHUK|AKT1|BIRC3|MAPK14|IKBKG|FADD
PID_THROMBIN_PAR1_PATHWAY%MSIGDB_C2%PID_THROMBIN_PAR1_PATHWAY,0.00347725297015358,0.142189596144971,-0.347104170350841,-1.9429910741618002,11,38,GNAI3|ARHGDIA|GNA13|PKN1|PRKCD|DNM2|GNAZ|VASP|GNAQ|GNAI2|RHOA|GNA15|ARRB1|AKAP13|PRKCA|ZYX|NOS3|GNA12|PLCB1|PIK3R1
BIOCARTA_EIF4_PATHWAY%MSIGDB_C2%BIOCARTA_EIF4_PATHWAY,0.141338487557381,0.630107155356772,-0.274359741454992,-1.2891934822986,584,23,EIF4A2|EIF4G1|EIF4EBP1|PRKCA|MAPK3|PABPC1|PIK3R1
BIOCARTA_FREE_PATHWAY%MSIGDB_C2%BIOCARTA_FREE_PATHWAY,0.00445682451253482,0.155321503601441,-0.6523801643775171,-2.02788160205921,23,8,NFKB1|GPX1|RELA|SOD1|GSS|GSR|CXCL8|TNF
BIOCARTA_CK1_PATHWAY%MSIGDB_C2%BIOCARTA_CK1_PATHWAY,0.0780244864079685,0.531535795722898,-0.38729899736622797,-1.45856062110448,375,13,PPP2CA|PRKAR2A|PRKAR1B|DRD2|PLCB1
PID_ERB_GENOMIC_PATHWAY%MSIGDB_C2%PID_ERB_GENOMIC_PATHWAY,0.6786205541363729,0.9647315640607691,0.262009644625188,0.825948033249937,6906,12,UBA3|ZNF14|SMARCA4|NCOA3|UBE2M|C3|SMARCE1|NCOA2|SMARCB1|NCOA1|DDX54
PID_HDAC_CLASSI_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSI_PATHWAY,0.45729667999021095,0.8899283569116201,0.197769347170815,1.00627825736853,5605,64,RBBP7|SIRT4|SIRT1|HDAC10|MBD3|SSPO|MTA2|NR2C1|SIRT6
PID_HES_HEY_PATHWAY%MSIGDB_C2%PID_HES_HEY_PATHWAY,0.8678383733953651,0.993084774742015,0.15245388202333202,0.6917098201710279,10072,40,GAA|HES1|MAML1|BGLAP|JAK2|PARP1|RB1|HES6|HEY2|KDM1A|GATA6|E2F1|TLE1|SPEN
ST_GA12_PATHWAY%MSIGDB_C2%ST_GA12_PATHWAY,0.6266114180478821,0.954674488895214,-0.19720157298621804,-0.879894781200505,2721,20,MAPK7|VAV1|MAP2K5|JUN|PLD2|EPHB2
BIOCARTA_RANMS_PATHWAY%MSIGDB_C2%BIOCARTA_RANMS_PATHWAY,0.6007455168245011,0.950415218201239,0.302111587746008,0.8916093464263279,5962,10,RCC1|NUMA1|KIF15|AURKA|TPX2|KPNA2
BIOCARTA_RNA_PATHWAY%MSIGDB_C2%BIOCARTA_RNA_PATHWAY,0.0169424743892829,0.277340114229305,-0.528430294895387,-1.78775878306943,85,10,RELA|EIF2AK2|EIF2S2|DNAJC3|EIF2S1|NFKBIA|TP53
PID_CXCR3_PATHWAY%MSIGDB_C2%PID_CXCR3_PATHWAY,0.680609015481995,0.9650163074981261,0.18329592279198498,0.8435929895846859,7956,42,CXCL13|MAPK11|GNAI1|MAP2K6|CXCL9|MAP2K2|PIK3R3|PDPK1|SRC
PID_RB_1PATHWAY%MSIGDB_C2%PID_RB_1PATHWAY,0.801601056367088,0.9841161968820359,0.154196593139548,0.7655342662073109,9712,57,SIRT1|CDK6|MAPK11|CEBPD|E2F3|BGLAP|TGFB2|CDKN2A|CCNE1|E2F2|RB1|PPP2R3B|HDAC3|CEBPB|SMARCA4|MAPK9|E2F1|SKP2|CDK2|CCND2|DNMT1|SUV39H1|MDM2|TAF1|CCNA2
BIOCARTA_DREAM_PATHWAY%MSIGDB_C2%BIOCARTA_DREAM_PATHWAY,0.0932835820895522,0.5622489437340121,-0.391907735835778,-1.4277591938893899,449,12,PRKAR2A|POLR2A|JUN|PRKAR1B|MAPK3
PID_TELOMERASE_PATHWAY%MSIGDB_C2%PID_TELOMERASE_PATHWAY,0.8054744525547449,0.984682960940884,-0.125302517620416,-0.811336588447586,2206,63,SMG6|NCL|CDKN1B|XRCC6|TERF2|PINX1|SIN3A|ZNFX1|MRE11A|IFNAR2|ABL1|MXD1|HNRNPC|JUN|YWHAE|MAPK3|SAP18|HUS1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY%MSIGDB_C2%PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.355660116246886,0.8439729452879621,-0.19843820831815,-1.06777354414308,1284,34,PIK3CD|PIK3R2|NCK2|GNAI3|PTPN6|NRAS|GRB2|PTPN1|KRAS|SHC1|STAT3|MAPK3|PIK3R1
BIOCARTA_G1_PATHWAY%MSIGDB_C2%BIOCARTA_G1_PATHWAY,0.10364372469635601,0.575794607412397,0.33809634927051396,1.38640746526765,1151,28,CDK6|CCNA1|CDK1|ATR|DHFR|TGFB2|CDKN2A|CCNE1|RB1|CDKN2B|E2F1|SKP2|CDK2|ATM|TGFB3
PID_ALK2_PATHWAY%MSIGDB_C2%PID_ALK2_PATHWAY,0.0577311263625353,0.468669207691151,-0.43662821831266296,-1.53654909944044,285,11,TLX2|BMPR2|BMP7|AMH|AMHR2|SMAD4|SMAD9|ACVR1|SMAD1|FKBP1A
PID_INTEGRIN2_PATHWAY%MSIGDB_C2%PID_INTEGRIN2_PATHWAY,0.260931558935361,0.771967970256231,-0.24907665624112602,-1.1539074877675,1097,22,ITGB2|FCGR2A|JAM3|VCAM1|GP1BA|THY1|F11R|ITGAX|ITGAM|PLAU|ICAM1|PLAUR|PROC
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES%MSIGDB_C2%SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,0.000361402240693892,0.0784645998831315,-0.317013920823906,-2.04376219737622,0,62,YWHAH|NOLC1|BCL2L1|IGF1|YWHAQ|PTPN1|YWHAB|CDC42|GADD45A|SHC1|YWHAZ|YWHAE|MET|RPS6KA2|PAK2|PARD3|FOXO3|CREB5
PID_NFKAPPAB_ATYPICAL_PATHWAY%MSIGDB_C2%PID_NFKAPPAB_ATYPICAL_PATHWAY,0.11241166077738499,0.587656563188088,-0.323615087803329,-1.36173506813384,508,17,NFKBIA|ARRB2|CSNK2A2|REL|BCL3|CSNK2A1|PIK3R1
BIOCARTA_EPONFKB_PATHWAY%MSIGDB_C2%BIOCARTA_EPONFKB_PATHWAY,0.8739673584525491,0.9934031064448321,0.22272224838260302,0.657310895608437,8674,10,EPOR|JAK2|GRIN1
BIOCARTA_NTHI_PATHWAY%MSIGDB_C2%BIOCARTA_NTHI_PATHWAY,0.246521845252624,0.7585951535148171,-0.24323603858690698,-1.16594270423408,1009,24,SMAD4|SMAD3|RELA|CREBBP|IL1B|NFKBIA|TGFBR1|MAP2K3|CXCL8|NR3C1|MYD88|TNF
BIOCARTA_CARDIACEGF_PATHWAY%MSIGDB_C2%BIOCARTA_CARDIACEGF_PATHWAY,0.432499522627458,0.878651088001772,0.290513552345898,1.02459934532823,4529,17,EDN1|AGTR1|PRKCB|FOS|HRAS|PLCG1
ST_ERK1_ERK2_MAPK_PATHWAY%MSIGDB_C2%ST_ERK1_ERK2_MAPK_PATHWAY,0.004779607010090279,0.16055795475477697,-0.360974130881746,-1.89819498710843,17,31,RPS6KA3|DUSP4|EIF4E|CREB3|MAP3K8|EEF2K|GRB2|TRAF3|RAP1A|KLF6|SHC1|MAPK3|MAP2K1|RPS6KA2|CREB5
ST_TUMOR_NECROSIS_FACTOR_PATHWAY%MSIGDB_C2%ST_TUMOR_NECROSIS_FACTOR_PATHWAY,0.07954250064985699,0.533892166059414,-0.276913240155981,-1.4171730412703503,305,29,NFKBIE|RALBP1|NFKBIA|TNFAIP3|BAG4|TNFRSF1B|CASP3|AGFG1|JUN|CFLAR|NFKBIB|TNF
BIOCARTA_PAR1_PATHWAY%MSIGDB_C2%BIOCARTA_PAR1_PATHWAY,0.677830058123443,0.9647315640607691,-0.159384741371918,-0.8576312577070121,2448,34,ARHGEF2|GNGT1|PRKCA|GNA12|PLCB1|PIK3R1
ST_B_CELL_ANTIGEN_RECEPTOR%MSIGDB_C2%ST_B_CELL_ANTIGEN_RECEPTOR,0.0259259259259259,0.33512489842855103,-0.28537605148125,-1.5852515226368,90,37,NFKBIA|CD19|GRB2|VAV1|LYN|ITPKB|SHC1|NFKBIB|PRDX1|BCR|MAP2K1|PIK3R1|EPHB2
PID_SMAD2_3PATHWAY%MSIGDB_C2%PID_SMAD2_3PATHWAY,0.425795053003534,0.875696962448429,-0.23875086571720197,-1.00463618245145,1927,17,SMAD4|SMAD3|KPNB1|CTDSP2|UBE2I|SMAD2|PPM1A|MAPK3
BIOCARTA_BLYMPHOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_BLYMPHOCYTE_PATHWAY,0.251854744240531,0.763905256448548,-0.362626945053715,-1.1705922744131398,1289,9,HLA-DRA|PTPRC|ITGAL|CD40|ITGB2|CR2|FCGR2B|ICAM1
SA_MMP_CYTOKINE_CONNECTION%MSIGDB_C2%SA_MMP_CYTOKINE_CONNECTION,0.0962025316455696,0.5684612493613671,-0.36557986227522904,-1.4163531691916902,455,14,TGFB1|SPN|TNFSF8|CD44|IL6R|SELL|IL1B|TNFRSF1B|ACE|TNF
ST_GRANULE_CELL_SURVIVAL_PATHWAY%MSIGDB_C2%ST_GRANULE_CELL_SURVIVAL_PATHWAY,0.159140834757139,0.661359103221672,-0.26300009873850605,-1.26068097523074,651,24,GNAQ|CASP3|CERK|ITPKB|JUN|EPHB2|CREB5
BIOCARTA_STEM_PATHWAY%MSIGDB_C2%BIOCARTA_STEM_PATHWAY,0.768071195059935,0.9792236089291529,-0.260770338659345,-0.760678647196908,4228,7,IL11|IL6|CXCL8
PID_TRKR_PATHWAY%MSIGDB_C2%PID_TRKR_PATHWAY,0.0173310225303293,0.278447181841778,-0.24848357069461102,-1.56617783392267,49,57,CRKL|RHOG|RAP1B|MATK|NEDD4L|NRAS|SQSTM1|GRB2|ABL1|RIT1|RHOA|EHD4|CRK|RAP1A|CDC42|KRAS|RAPGEF1|SHC1|STAT3|GAB2|MAPK3|RAC1|MAP2K1|PIK3R1
PID_AVB3_OPN_PATHWAY%MSIGDB_C2%PID_AVB3_OPN_PATHWAY,0.00159320233669676,0.10266546263826899,-0.406329357845686,-2.1366970211789,5,31,RELA|PIP5K1A|CD44|NFKBIA|BCAR1|PTK2B|RHOA|MMP2|PLAU|MMP9|VAV3|CDC42|JUN|MAPK3|RAC1|PIK3R1
SIG_BCR_SIGNALING_PATHWAY%MSIGDB_C2%SIG_BCR_SIGNALING_PATHWAY,0.185093932861103,0.691482206657505,-0.20645790111160398,-1.2133865830539299,600,45,CD19|GRB2|CR2|VAV1|LYN|BCL2|SHC1|NFATC2|MAPK3|BCR|CD22|PIK3R1
BIOCARTA_IL10_PATHWAY%MSIGDB_C2%BIOCARTA_IL10_PATHWAY,0.061505376344085996,0.48343167424509204,-0.37713748199133396,-1.5040579712579,285,15,HMOX1|IL6|STAT5A|STAT3|BLVRA|TNF
BIOCARTA_INTEGRIN_PATHWAY%MSIGDB_C2%BIOCARTA_INTEGRIN_PATHWAY,0.007775617883921129,0.19847993048827997,-0.327739459023857,-1.78159398085307,27,35,CAPNS1|BCAR1|GRB2|TNS1|FYN|RHOA|PXN|RAP1A|RAPGEF1|SHC1|JUN|ZYX|MAPK3|BCR|MAP2K1|CAV1
BIOCARTA_PLATELETAPP_PATHWAY%MSIGDB_C2%BIOCARTA_PLATELETAPP_PATHWAY,0.25547680412371104,0.7667915624015121,0.485764695926378,1.19466752481851,2378,6,PLAT|COL4A2|COL4A1|SERPINE1
PID_HIV_NEF_PATHWAY%MSIGDB_C2%PID_HIV_NEF_PATHWAY,0.900957063833524,0.998912093067348,0.150205598882648,0.653244910107281,10260,34,DFFB|APAF1|CASP6|MAP3K5|TRAF1|FAS|MAP2K7|CASP9|RIPK1|TRAF2|CASP2|TRADD|CHUK|BIRC3|CYCS
PID_S1P_S1P3_PATHWAY%MSIGDB_C2%PID_S1P_S1P3_PATHWAY,0.0681050168962828,0.50364937614461,-0.283461124744944,-1.45068348487212,261,29,GNAI3|VEGFA|GNA13|GNAZ|GNAQ|GNAI2|RHOA|GNA15|MAPK3|FLT1|GNA12|S1PR1|RAC1
PID_CERAMIDE_PATHWAY%MSIGDB_C2%PID_CERAMIDE_PATHWAY,0.751977222397975,0.9769690538700708,-0.13745890732972502,-0.820992969914933,2376,47,IGF1|BID|MAP4K4|CRADD|BCL2|MAPK3|MAP2K1|TNF
BIOCARTA_NGF_PATHWAY%MSIGDB_C2%BIOCARTA_NGF_PATHWAY,0.0092756183745583,0.212136117579847,-0.44262833561750603,-1.86252912635018,41,17,SHC1|JUN|MAPK3|MAP2K1|CSNK2A1|PIK3R1
BIOCARTA_CD40_PATHWAY%MSIGDB_C2%BIOCARTA_CD40_PATHWAY,0.9680374196063142,1.0,0.159741764608509,0.529274107007758,9933,14,IKBKAP|MAP3K1|DUSP1|CHUK|IKBKG|MAP3K14|NFKB1|CD40|IKBKB|RELA|TRAF6|NFKBIA|TNFAIP3|TRAF3
SIG_CHEMOTAXIS%MSIGDB_C2%SIG_CHEMOTAXIS,0.8827380952380949,0.996220425464008,-0.123912185521608,-0.71011566917588,2965,41,ACTR2|PIK3R1|PAK2
PID_S1P_S1P4_PATHWAY%MSIGDB_C2%PID_S1P_S1P4_PATHWAY,0.14810126582278502,0.6402258061318559,-0.33727384766774604,-1.30668817493577,701,14,GNAI3|GNA13|GNAZ|GNAI2|RHOA|CDC42|MAPK3|GNA12
ST_INTEGRIN_SIGNALING_PATHWAY%MSIGDB_C2%ST_INTEGRIN_SIGNALING_PATHWAY,0.00498960498960499,0.16362940244128402,-0.23778632655502,-1.64389624967511,11,79,BCAR1|VASP|GRB2|TNK2|ABL1|FYN|ITGA5|ANGPTL2|P4HB|ITGA6|CRK|RALA|CDC42|SHC1|ZYX|RASGRF2|ASAP1|MAP3K11|ACTR2|TLN2|ARHGAP26|ITGA7|CAV1|EPHB2|PAK2
BIOCARTA_MEF2D_PATHWAY%MSIGDB_C2%BIOCARTA_MEF2D_PATHWAY,0.12080388692579501,0.607251067511504,-0.32018331097666997,-1.34729454596106,546,17,NFATC1|PPP3CA|PPP3CB|HDAC2|CABIN1|EP300|CAPN2|PPP3CC|HDAC1|CALM2|CALM3|CAPNS1|MEF2D|CALM1|PRKCA|NFATC2
BIOCARTA_CCR3_PATHWAY%MSIGDB_C2%BIOCARTA_CCR3_PATHWAY,0.00586642599277978,0.175005706363229,-0.444607578745448,-1.94981463006536,25,19,GNAQ|RHOA|LIMK1|GNGT1|PRKCA|MAPK3|GNAS|PLCB1|MAP2K1
PID_BETA_CATENIN_DEG_PATHWAY%MSIGDB_C2%PID_BETA_CATENIN_DEG_PATHWAY,0.725892686652664,0.972554563883587,0.225678034191886,0.7959338358599379,7602,17,SSPO|DVL1|APC|GSK3A|DVL3|DVL2|LRP6|CSNK1E
BIOCARTA_BIOPEPTIDES_PATHWAY%MSIGDB_C2%BIOCARTA_BIOPEPTIDES_PATHWAY,0.17185663924794398,0.6745953549621222,-0.219409354211433,-1.2379639879818702,584,39,AGT|CDK5|CAMK2D|CALM3|PTK2B|GRB2|FYN|CAMK2A|CALM1|GNGT1|STAT5A|SHC1|PRKCA|STAT3|MAPK3|MAP2K1
ST_ADRENERGIC%MSIGDB_C2%ST_ADRENERGIC,0.916894229018751,1.0,0.154771213719328,0.622254413598653,10072,26,GNAI1|MAPK10|PHKA2|SRC|APC|ASAH1|ITPR2|GNA11|AKT1|PTX3|MAPK14|ITPR1|KCNJ9|RAF1|CFB
PID_VEGF_VEGFR_PATHWAY%MSIGDB_C2%PID_VEGF_VEGFR_PATHWAY,0.252364066193853,0.763905256448548,-0.34804061903235695,-1.1774735089009198,1280,10,VEGFA|KDR|NRP1|FLT1|PGF
PID_ATF2_PATHWAY%MSIGDB_C2%PID_ATF2_PATHWAY,0.031413612565445004,0.3625267385964289,-0.24870704339795,-1.5155711965163299,95,51,HBG2|HRK|MMP2|PLAU|DDIT3|IL6|BCL2L1|RUVBL2|GADD45A|PPARGC1A|CXCL8|BCL2|JUN|PRKCA|MAPK3|DUSP10|CBFB
PID_P38_ALPHA_BETA_PATHWAY%MSIGDB_C2%PID_P38_ALPHA_BETA_PATHWAY,0.130111524163569,0.612163182799301,-0.248561123365946,-1.30706728820367,489,31,FGR|FYN|LYN|YES1|RALA|CDC42|MAP2K3|RALB|DUSP10|RAC1|PAK2
ST_G_ALPHA_S_PATHWAY%MSIGDB_C2%ST_G_ALPHA_S_PATHWAY,0.0767932489451477,0.527286041772797,-0.37899777765446,-1.46833772559762,363,14,RASGRF2|BFAR|CREB5
BIOCARTA_NKCELLS_PATHWAY%MSIGDB_C2%BIOCARTA_NKCELLS_PATHWAY,0.0215148188803513,0.30888933059776397,-0.420028744540397,-1.72015887655174,97,16,PTPN6|PTK2B|VAV1|B2M|MAPK3|RAC1|MAP2K1|PIK3R1
NABA_ECM_REGULATORS%MSIGDB_C2%NABA_ECM_REGULATORS,0.7070263488080301,0.9694538303204,-0.115149062143947,-0.8957669893939921,1126,130,CTSD|MMP1|ADAM28|SERPINB8|CTSL|ADAMTSL1|FAM20A|ITIH5|CTSK|KAZALD1|ADAM10|SERPINI1|MMP2|CPAMD8|PLAU|ADAMTS9|MMP9|ADAMTS14|ADAMTS4|SERPINF2|PRSS12|TIMP2|ADAMTS8|SERPINF1|SERPINA1|ADAM17|CSTB|CTSH|MMP12|CTSW|C17orf58|CTSV|FAM20C|SULF2|PRSS3|EGLN3
PID_IFNG_PATHWAY%MSIGDB_C2%PID_IFNG_PATHWAY,0.0898942420681551,0.559960743386206,-0.240228470214661,-1.35543079319738,305,39,CAMK2A|RAP1A|SMAD7|RAPGEF1|STAT3|MAPK3|MAP3K11|MAP2K1|PIK3R1
BIOCARTA_D4GDI_PATHWAY%MSIGDB_C2%BIOCARTA_D4GDI_PATHWAY,0.906609054306197,1.0,0.19241772381681402,0.621003516713671,9231,13,APAF1|PARP1|PRF1|CASP9
PID_IL2_PI3K_PATHWAY%MSIGDB_C2%PID_IL2_PI3K_PATHWAY,0.0245031309556221,0.32844020156674,-0.299575914754301,-1.60236280501019,89,33,BCL2|EIF3A|SHC1|GAB2|RAC1|PIK3R1|FOXO3
PID_EPHB_FWD_PATHWAY%MSIGDB_C2%PID_EPHB_FWD_PATHWAY,0.00587544065804935,0.175005706363229,-0.32679528106151895,-1.84386299686531,19,39,PXN|MAP4K4|CRK|RAP1A|CDC42|KRAS|SHC1|MAPK3|EFNB1|RAC1|MAP2K1|PIK3R1|EPHB2
PID_INSULIN_GLUCOSE_PATHWAY%MSIGDB_C2%PID_INSULIN_GLUCOSE_PATHWAY,0.10630587098332901,0.580379305095854,-0.288405589348635,-1.35519374699419,439,23,STXBP4|YWHAH|VAMP2|YWHAQ|YWHAB|YWHAZ|YWHAE|RHOQ
PID_CASPASE_PATHWAY%MSIGDB_C2%PID_CASPASE_PATHWAY,0.626573778747692,0.954674488895214,0.18516836451037302,0.8898171364037479,7464,50,DFFB|GAS2|PIDD1|APAF1|CASP6|NUMA1|PARP1|LMNB1|LMNB2|PRF1|BIRC2|SPTAN1|CASP9|RIPK1|MAP3K1|MADD|TRAF2|PTK2|CASP2|TRADD|XIAP|BIRC3|CYCS|TOP1
BIOCARTA_STATHMIN_PATHWAY%MSIGDB_C2%BIOCARTA_STATHMIN_PATHWAY,0.55632796876488,0.9353671528625591,0.25854512266274804,0.9274540648478571,5841,18,CCNB1|CDK1|CD2|PRKAR2B|CD3D|MAPK13|CD3G|CD3E
PID_HNF3A_PATHWAY%MSIGDB_C2%PID_HNF3A_PATHWAY,0.9584289722009691,1.0,-0.121667871555536,-0.606294978779471,3757,27,NFIB|SERPINA1|NRIP1|JUN|NDUFV3
BIOCARTA_PDGF_PATHWAY%MSIGDB_C2%BIOCARTA_PDGF_PATHWAY,0.00584174190122146,0.175005706363229,-0.349500747402741,-1.83786180214634,21,31,STAT5A|SHC1|JUN|PRKCA|STAT3|MAPK3|MAP2K1|CSNK2A1|PIK3R1
BIOCARTA_TH1TH2_PATHWAY%MSIGDB_C2%BIOCARTA_TH1TH2_PATHWAY,0.800423131170663,0.9841161968820359,0.24587631709604502,0.725644534270646,7944,10,IL12RB1|HLA-DRB1|IL2RA|HLA-DRA|IFNGR1|IL4R|CD40|IL18|IFNGR2|CD86
PID_HIF2PATHWAY%MSIGDB_C2%PID_HIF2PATHWAY,0.0037174721189591102,0.143595610377104,-0.370897946804505,-1.9503797173314898,13,31,APEX1|VEGFA|KDR|CITED2|EFNA1|ETS1|PGK1|FXN|VHL|TCEB1|FLT1|SLC2A1|TWIST1|EPAS1|EGLN3
PID_ARF6_TRAFFICKING_PATHWAY%MSIGDB_C2%PID_ARF6_TRAFFICKING_PATHWAY,0.8466184602296899,0.991298302704726,0.15299308832355898,0.717138125933861,9951,45,ITGB1|ITGA1|INS|ITGA9|KLC1|AGTR1|ITGA2|ITGA4|CTNND1|ITGA11
PID_NFAT_3PATHWAY%MSIGDB_C2%PID_NFAT_3PATHWAY,0.000666666666666667,0.0806484601749226,-0.352681912975772,-2.17530489408925,1,53,GSK3B|PRKCE|SFN|RAN|YWHAG|KPNB1|PRKACA|NFATC3|CSNK1A1|CREBBP|BAX|PRKCH|PIM1|PPP3R1|PRKCD|MAP3K8|CASP3|YWHAH|CHP1|BCL2L1|MEF2D|CAMK4|YWHAQ|YWHAB|BCL2|PRKCA|NFATC2|YWHAZ|YWHAE|MAPK3|FKBP8|RCAN2|CSNK2A1|FKBP1A
ST_INTERFERON_GAMMA_PATHWAY%MSIGDB_C2%ST_INTERFERON_GAMMA_PATHWAY,0.790900649953575,0.9819233677232551,-0.23896823021043498,-0.742817308038146,4258,8,PTPRU|PLA2G2A|ELP2
BIOCARTA_ETC_PATHWAY%MSIGDB_C2%BIOCARTA_ETC_PATHWAY,0.5008291873963521,0.9144253281295329,-0.26164829789951505,-0.9532109951717881,2415,12,MT-CO1|ATP5A1|CYCS|NDUFA1|SDHB|GPD2|SLC25A6|SDHD|SDHC|UQCRC1|SLC25A4
PID_ARF6_PATHWAY%MSIGDB_C2%PID_ARF6_PATHWAY,0.142668776371308,0.6324244126031129,-0.246196450300811,-1.2772750740885401,540,30,ARRB2|GNAQ|GNA15|HGF|PXN|ARRB1|EFNA1|KIF13B|IQSEC1|ADRB2|MET
BIOCARTA_RAB_PATHWAY%MSIGDB_C2%BIOCARTA_RAB_PATHWAY,0.0101575456053068,0.220543045578585,-0.50870186775234,-1.8532519320732501,48,12,RAB6A|RAB1A|RAB8A|RAB7A|RAB2A|RAB5A
SA_REG_CASCADE_OF_CYCLIN_EXPR%MSIGDB_C2%SA_REG_CASCADE_OF_CYCLIN_EXPR,0.0998231479662016,0.570215774831708,0.45025463847420094,1.4193635262603501,1015,12,CCNA1|CDKN2A|CCNE1|E2F2|CCNE2|E2F1|CDK2|CCNA2|CCND1|E2F4
BIOCARTA_NFAT_PATHWAY%MSIGDB_C2%BIOCARTA_NFAT_PATHWAY,0.0148698884758364,0.264326813346421,-0.27910274310525895,-1.62692149645001,47,44,AGT|NFATC3|CSNK1A1|CREBBP|CALR|HAND1|CALM3|LIF|FGF2|HBEGF|PRKAR2A|IGF1|CALM1|CAMK4|NFATC2|PRKAR1B|MAPK3|MAP2K1|PIK3R1|FKBP1A
BIOCARTA_IL2RB_PATHWAY%MSIGDB_C2%BIOCARTA_IL2RB_PATHWAY,0.37737961926091795,0.85375124052253,-0.190720512367223,-1.04913294421114,1347,36,STAT5A|BCL2|SHC1|CFLAR|MAPK3|PIK3R1
BIOCARTA_GH_PATHWAY%MSIGDB_C2%BIOCARTA_GH_PATHWAY,0.0971249093984054,0.569923978730193,-0.292621662834133,-1.37500472374162,401,23,STAT5A|SHC1|PRKCA|MAPK3|MAP2K1|PIK3R1
PID_INTEGRIN_A4B1_PATHWAY%MSIGDB_C2%PID_INTEGRIN_A4B1_PATHWAY,0.42977451779407794,0.8780284177741771,-0.191248920625947,-1.0124891110766099,1581,32,CD81|PRKAR1A|ARF6|PRKACA|VCAM1|ADAM28|ABI1|BCAR1|PTK2B|PXN|JAM2|CRK|YWHAZ|PRKAR1B|RAC1|PTPRA
PID_SYNDECAN_2_PATHWAY%MSIGDB_C2%PID_SYNDECAN_2_PATHWAY,0.19831223628692002,0.711592141628341,-0.23284956704968698,-1.20803101605033,751,30,RHOA|MMP2|ITGA5|CASP3|CXCL8|MAPK3|CAV2|SDC2|EPHB2
PID_IL8_CXCR1_PATHWAY%MSIGDB_C2%PID_IL8_CXCR1_PATHWAY,0.0893257029111719,0.5586567091812379,-0.28624347819079904,-1.38864480095549,358,25,ARRB2|FGR|GNAI2|GNA15|LYN|ARRB1|CXCL8|PRKCA|RAB5A|PLCB1
NABA_COLLAGENS%MSIGDB_C2%NABA_COLLAGENS,0.521420369225333,0.9251240799994541,0.223909532132948,0.957361896622762,5902,32,COL9A2|COL18A1|COL26A1|COL8A1|COL4A2|COL20A1|COL4A1|COL5A2|COL27A1|COL28A1|COL5A1|COL11A2
BIOCARTA_MONOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_MONOCYTE_PATHWAY,0.6162332545311271,0.9518465519698142,-0.255754847219433,-0.8652569295249041,3127,10,CD44|SELL|ITGAM|ICAM1|PECAM1
PID_IL27_PATHWAY%MSIGDB_C2%PID_IL27_PATHWAY,0.686736280826483,0.9665349594178531,-0.19350144405617004,-0.8324002204621391,3090,18,IL6|STAT5A|STAT3|TNF
PID_EPHA_FWDPATHWAY%MSIGDB_C2%PID_EPHA_FWDPATHWAY,0.0366748166259169,0.386113929236656,-0.29114123566251005,-1.5413280761475199,134,32,CDK5|CRKL|PIK3R5|BLK|FGR|FYN|RHOA|LYN|EFNA1|YES1|CRK|VAV3|VAV2|EPHA8|EPHA7
BIOCARTA_IGF1R_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1R_PATHWAY,0.0251901140684411,0.329326373353219,-0.35401800835837605,-1.64007352922629,105,22,IGF1R|GRB2|YWHAH|PRKAR2A|SHC1|PRKAR1B|MAPK3|MAP2K1|PIK3R1
BIOCARTA_INTRINSIC_PATHWAY%MSIGDB_C2%BIOCARTA_INTRINSIC_PATHWAY,0.174390489623212,0.676682497340677,0.43912444779315596,1.2959696939061,1730,10,F12|F2R|COL4A2|COL4A1|KLKB1
PID_AURORA_A_PATHWAY%MSIGDB_C2%PID_AURORA_A_PATHWAY,0.7733179067283729,0.979946273879301,0.18107489862652,0.7654022987319871,8688,31,CKAP5|BIRC5|DLGAP5|CENPA|GIT1|AURKB|AJUBA|AURKA|TPX2|BRCA1|AKT1|RASA1|MDM2|TACC3
PID_A6B1_A6B4_INTEGRIN_PATHWAY%MSIGDB_C2%PID_A6B1_A6B4_INTEGRIN_PATHWAY,0.0006040471156750231,0.0806484601749226,-0.38929445657776296,-2.24158561287172,1,42,RXRA|YWHAH|LAMC1|ITGA6|MST1R|YWHAQ|YWHAB|LAMA4|SHC1|PRKCA|CD9|YWHAZ|PMP22|YWHAE|RAC1|MET|LAMC2|PIK3R1
PID_SMAD2_3NUCLEAR_PATHWAY%MSIGDB_C2%PID_SMAD2_3NUCLEAR_PATHWAY,0.5803108808290159,0.942746898746279,-0.141179320499486,-0.932267068544855,1567,67,SKI|FOXO4|CTBP1|SNIP1|FOXO1|RUNX1|LAMC1|TFE3|SMAD2|SMAD7|NR3C1|JUN|CDKN1A|CBFB|SAP18|FOXO3
BIOCARTA_GSK3_PATHWAY%MSIGDB_C2%BIOCARTA_GSK3_PATHWAY,0.799053082035874,0.9839175016931591,0.185835489364231,0.740527692623155,8775,25,GNAI1|DVL1|PDPK1|APC|LEF1|GJA1
BIOCARTA_AKAP13_PATHWAY%MSIGDB_C2%BIOCARTA_AKAP13_PATHWAY,0.022655634357762,0.31609926985007897,-0.51171322003704,-1.73120241661214,114,10,GNA13|LPAR1|PRKAG1|RHOA|PRKAR2A|AKAP13|GNA12
BIOCARTA_CFTR_PATHWAY%MSIGDB_C2%BIOCARTA_CFTR_PATHWAY,0.0234436564223798,0.32193233334248106,-0.5102235564793329,-1.7261626618236003,118,10,PRKAR2A|ADRB2|PRKAR1B|GNAS|SLC9A3R1
BIOCARTA_EDG1_PATHWAY%MSIGDB_C2%BIOCARTA_EDG1_PATHWAY,0.0273699925354566,0.339785941813865,-0.33508788579264503,-1.62560227890663,109,25,SPHK1|RHOA|GNGT1|PRKCA|MAPK3|S1PR1|RAC1|PLCB1|PIK3R1
PID_BCR_5PATHWAY%MSIGDB_C2%PID_BCR_5PATHWAY,0.15665315149281198,0.6578589353509621,-0.186879956691823,-1.2237491182120301,424,65,NFKBIA|DOK1|CD19|GRB2|BCL10|LYN|FCGR2B|ETS1|VAV2|SHC1|JUN|NFKBIB|MAPK3|RAC1|CD22|MAP2K1|CSNK2A1|PIK3R1
PID_CD40_PATHWAY%MSIGDB_C2%PID_CD40_PATHWAY,0.948227492986483,1.0,-0.124517692242904,-0.620496196825641,3717,27,NFKBIA|TNFAIP3|TRAF3|BCL2L1|STAT5A|JUN|TDP2
BIOCARTA_FIBRINOLYSIS_PATHWAY%MSIGDB_C2%BIOCARTA_FIBRINOLYSIS_PATHWAY,0.293528001743299,0.8004058897916541,0.5001346060473979,1.15273612623432,2693,5,PLAT|F2R|SERPINE1
PID_TAP63_PATHWAY%MSIGDB_C2%PID_TAP63_PATHWAY,0.351326053042122,0.842847021021096,-0.181600072419791,-1.07395043336107,1125,46,PRKCD|GDF15|ABL1|BBC3|PML|IGFBP3|NQO1|YWHAQ|GADD45A|TP53I3|CDKN1A|EVPL|PMAIP1|SPATA18
PID_DNA_PK_PATHWAY%MSIGDB_C2%PID_DNA_PK_PATHWAY,0.903400309119011,1.0,0.18470432132175402,0.626260692826838,9351,15,LIG4|PNKP|DCLRE1C|XRCC4|PRKDC|POLL|CSNK2B|APLF
BIOCARTA_TNFR2_PATHWAY%MSIGDB_C2%BIOCARTA_TNFR2_PATHWAY,0.7584991905532809,0.977664504547119,0.214614490227062,0.769865930118426,7964,18,IKBKAP|TRAF1|RIPK1|LTA|MAP3K1|TRAF2|DUSP1|CHUK
BIOCARTA_TFF_PATHWAY%MSIGDB_C2%BIOCARTA_TFF_PATHWAY,0.591868473672517,0.9458918196441479,-0.207700057121692,-0.8934794992429541,2663,18,CTNNB1|GRB2|RHOA|SHC1|MAPK3|PIK3R1
BIOCARTA_IL22BP_PATHWAY%MSIGDB_C2%BIOCARTA_IL22BP_PATHWAY,0.912844988586844,1.0,-0.172465588923227,-0.649502111313615,4398,13,STAT5B|STAT2|TYK2|STAT1|IL10RA|JAK3|STAT6|JAK1|STAT4|SOCS3|STAT5A|STAT3
BIOCARTA_CSK_PATHWAY%MSIGDB_C2%BIOCARTA_CSK_PATHWAY,0.7637776731040979,0.978421368343614,-0.172389048355045,-0.782955888258989,3242,21,PRKAR2B|CD3D|ADCY1|CD3G|CD3E|ZAP70|LCK|HLA-DRB1|CSK|CD247|HLA-DRA|PTPRC|PRKACB|CD4|GNB1|PRKAR1A|CREBBP|PRKAR2A|GNGT1|PRKAR1B|GNAS
PID_IL5_PATHWAY%MSIGDB_C2%PID_IL5_PATHWAY,0.123341625207297,0.607607158836689,-0.371820303749677,-1.35457866383071,594,12,PIM1|GRB2|LYN|CSF2RB|STAT5A|PIK3R1
PID_P38_MK2_PATHWAY%MSIGDB_C2%PID_P38_MK2_PATHWAY,0.206547338671691,0.7211951452265429,-0.267028425476777,-1.21278863161292,876,21,TCF3|MAPKAPK2|SFN|YWHAG|MAPKAPK3|HSPB1|YWHAH|CDC25B|YWHAQ|YWHAB|YWHAZ|YWHAE
BIOCARTA_TOLL_PATHWAY%MSIGDB_C2%BIOCARTA_TOLL_PATHWAY,0.8672331386086031,0.993065231963537,-0.136095064846855,-0.715660618758097,3265,31,CHUK|ECSIT|TAB1|ELK1|TLR4|TOLLIP|MAPK14|IKBKG|MAP2K4|TLR2|CD14|MAPK8|MAP3K14|TIRAP|NFKB1|TAB2|IKBKB|LY96|RELA|TRAF6|EIF2AK2|IRAK1|NFKBIA|PPARA|MAP2K3|JUN|MYD88
ST_IL_13_PATHWAY%MSIGDB_C2%ST_IL_13_PATHWAY,0.9719716494845358,1.0,0.21658806524416196,0.5326668034551629,9050,6,JAK2|TYK2|IL13RA2|JAK1|IL4R
PID_CD8_TCR_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.121480544131604,0.607607158836689,-0.21582291040868398,-1.2890331782362,383,47,GZMB|PPP3R1|NRAS|IFNAR2|IFNAR1|FOSL1|TNFRSF18|KRAS|JUN|PRKCA|NFATC2|B2M|TNFRSF4|MAPK3|MAP2K1|TNF
BIOCARTA_IL1R_PATHWAY%MSIGDB_C2%BIOCARTA_IL1R_PATHWAY,0.457805907172996,0.890371861972445,-0.190933473142372,-0.9905689775621529,1735,30,RELA|TRAF6|IL1RN|IL1B|IRAK1|NFKBIA|IRAK2|IL6|MAP2K3|JUN|MYD88|TNF
BIOCARTA_CCR5_PATHWAY%MSIGDB_C2%BIOCARTA_CCR5_PATHWAY,0.623066641206798,0.9536478716552259,0.24844730396068104,0.8762377621667309,6525,17,CXCR4|PRKCB|CCR5|FOS|CCL2|PLCG1
BIOCARTA_CDK5_PATHWAY%MSIGDB_C2%BIOCARTA_CDK5_PATHWAY,0.786838918046024,0.9819033472805508,-0.21258706564876198,-0.7481203700888159,3897,11,MAPK3|MAP2K1
BIOCARTA_LAIR_PATHWAY%MSIGDB_C2%BIOCARTA_LAIR_PATHWAY,0.588818565400844,0.945418171231938,-0.230231520312931,-0.891977860633754,2790,14,IL6|ICAM1|CXCL8|TNF
PID_RAS_PATHWAY%MSIGDB_C2%PID_RAS_PATHWAY,0.2749298648304,0.7884684708511421,-0.22740975560629603,-1.13322762358532,1077,27,PLCE1|DAB2IP|NRAS|RABGEF1|GRB2|LGALS3|KRAS|PRKCA|RASGRF2|RASGRP3
PID_HEDGEHOG_2PATHWAY%MSIGDB_C2%PID_HEDGEHOG_2PATHWAY,0.40636663007683893,0.8664565508572991,-0.248567722272617,-1.01796836394935,1850,16,HHAT|PTHLH|ARRB2|BOC|CDON|LRPAP1|PIK3R1
PID_VEGFR1_PATHWAY%MSIGDB_C2%PID_VEGFR1_PATHWAY,0.0276394422310757,0.341482715993774,-0.32966666965426,-1.61876003460829,110,26,PRKCA|NOS3|MAPK3|FLT1|PGF|PIK3R1|CAV1
BIOCARTA_GABA_PATHWAY%MSIGDB_C2%BIOCARTA_GABA_PATHWAY,0.608173076923077,0.9508825506493929,-0.344813003449424,-0.872871221471024,3541,5,GABRA3|GABARAP
PID_ERBB1_INTERNALIZATION_PATHWAY%MSIGDB_C2%PID_ERBB1_INTERNALIZATION_PATHWAY,0.0503681885125184,0.44079050471084996,-0.25565055170547,-1.45391189449052,170,40,CDC42|KRAS|SHC1|UBE2D3|RAB5A|LRIG1|PIK3R1|AMPH
PID_IL3_PATHWAY%MSIGDB_C2%PID_IL3_PATHWAY,0.008459815874595671,0.20298122046820802,-0.37243960383850894,-1.8068056006346203,33,25,PIM1|GRB2|IL3RA|BCL2L1|CSF2RB|STAT5A|SHC1|ID1|YWHAZ|GAB2|PIK3R1
BIOCARTA_TCRA_PATHWAY%MSIGDB_C2%BIOCARTA_TCRA_PATHWAY,0.418889331210191,0.87173622607586,0.339997703673375,1.03725505652993,4208,11,CD3D|CD3G|CD3E|ZAP70|LCK|HLA-DRB1|CD247|HLA-DRA|PTPRC
BIOCARTA_VITCB_PATHWAY%MSIGDB_C2%BIOCARTA_VITCB_PATHWAY,0.575746924428823,0.941956986273961,-0.325286431548216,-0.892889413213231,3275,6,SLC2A3|P4HB|SLC2A1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES%MSIGDB_C2%SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.554315273618296,0.9334975845426681,-0.17404162278044,-0.930908691694101,2035,33,CFL2|VASP|PFN1|ANGPTL2|LIMK1|CDC42|FLNC|ACTR2|PAK2
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.133538633818589,0.6194479383419461,-0.23328433193224402,-1.2832719195256599,476,36,SLC9A1|MITF|EIF4EBP1|DDIT3|CSNK2A2|ATF6|PPARGC1A|JUN|TP53|RAB5A|CSNK2A1
BIOCARTA_AKAP95_PATHWAY%MSIGDB_C2%BIOCARTA_AKAP95_PATHWAY,0.753184713375796,0.9769690538700708,0.252126183038911,0.769179189786334,7567,11,CCNB1|CDK1|PRKAR2B
PID_ILK_PATHWAY%MSIGDB_C2%PID_ILK_PATHWAY,0.13150600554357902,0.615486722080346,-0.216834575995362,-1.27437198498271,426,45,RHOG|NCK2|PARVB|ZEB1|RUVBL1|CTNNB1|TNS1|PXN|CDC37|SNAI1|RUVBL2|CDC42|JUN|LIMS1|ZYX|RAC1|PARVA
PID_SYNDECAN_1_PATHWAY%MSIGDB_C2%PID_SYNDECAN_1_PATHWAY,0.814836279339322,0.986440323255739,-0.136814118190902,-0.7658467779155479,2811,38,COL6A2|LAMA5|MMP1|COL16A1|COL6A1|HGF|MMP9|COL15A1|COL8A2|COL9A1|MAPK3|MET
BIOCARTA_ARAP_PATHWAY%MSIGDB_C2%BIOCARTA_ARAP_PATHWAY,0.884496466431095,0.996643473105967,-0.16346578366445902,-0.687845216262454,4004,17,CLTB|CYTH3|GBF1|KDELR3|GPLD1|KDELR2|ARFGAP3|ARFGEF1|KDELR1|CYTH4|ARF1|ARFGAP1|CYTH2|CYTH1|ASAP2|ARFGEF2|COPA
BIOCARTA_IL2_PATHWAY%MSIGDB_C2%BIOCARTA_IL2_PATHWAY,0.0240226095148375,0.324501171431667,-0.368727492158738,-1.67468504469069,101,21,STAT5A|SHC1|JUN|MAPK3|MAP2K1|CSNK2A1
SA_PROGRAMMED_CELL_DEATH%MSIGDB_C2%SA_PROGRAMMED_CELL_DEATH,0.080016583747927,0.534767814144237,-0.401302123911863,-1.46198389200104,385,12,CES1|BCL10|BCL2L1|BID|BCL2|BCL2L11
PID_LYMPH_ANGIOGENESIS_PATHWAY%MSIGDB_C2%PID_LYMPH_ANGIOGENESIS_PATHWAY,0.36337976873349703,0.849828746111777,0.271927163959955,1.08359063157278,3990,25,ITGB1|FIGF|MAPK11|ITGA1|ITGA2|ITGA4
BIOCARTA_GPCR_PATHWAY%MSIGDB_C2%BIOCARTA_GPCR_PATHWAY,0.0315818132316907,0.363465190361383,-0.29039887982598,-1.5532769516248102,115,33,PRKAR2A|CALM1|GNGT1|JUN|PRKCA|NFATC2|PRKAR1B|MAPK3|GNAS|MAP2K1
PID_IL1_PATHWAY%MSIGDB_C2%PID_IL1_PATHWAY,0.29285520239065504,0.8004058897916541,-0.21035162722266298,-1.1136205703181201,1077,32,NFKB1|TAB2|CASP1|IKBKB|ERC1|PRKCI|RELA|TRAF6|UBE2N|IL1RN|IL1B|IRAK1|SQSTM1|IRAK4|UBE2V1|JUN|MYD88|PIK3R1
PID_RXR_VDR_PATHWAY%MSIGDB_C2%PID_RXR_VDR_PATHWAY,0.126842232423291,0.6076669536424699,-0.279821093722991,-1.314855919911,524,23,PPARD|RARA|NR1H3|PPARA|RXRA|PPARG|ABCA1|NR1H2|BCL2|TNF
PID_IL2_1PATHWAY%MSIGDB_C2%PID_IL2_1PATHWAY,0.11199999999999999,0.587157961380184,-0.209523888886361,-1.29232127918741,335,53,KRAS|STAT5A|BCL2|SHC1|JUN|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1
PID_HNF3B_PATHWAY%MSIGDB_C2%PID_HNF3B_PATHWAY,0.0488766620816139,0.43511944660534596,0.38855760409767204,1.5291675927308703,532,24,ALAS1|ACADVL|INS|CEBPD|KCNJ11|ACADM|DLK1|HADH|CPT1B|GCK|NF1|ABCC8|CEBPB|CPT1C|SP1|AKT1
PID_TCR_JNK_PATHWAY%MSIGDB_C2%PID_TCR_JNK_PATHWAY,0.7969206782303649,0.983076599789428,0.22018973899375,0.729557030772783,8177,14,GRAP2|PRKCB|MAP3K7|MAP3K1|LAT
BIOCARTA_ARENRF2_PATHWAY%MSIGDB_C2%BIOCARTA_ARENRF2_PATHWAY,0.75077816974476,0.97622649654938,-0.208398979757487,-0.784826574351272,3617,13,MAFF|JUN|PRKCA
PID_IL12_STAT4_PATHWAY%MSIGDB_C2%PID_IL12_STAT4_PATHWAY,0.9523809523809521,1.0,0.142339419132109,0.5672021096714649,10459,25,ETV5|FOS|CD3D|PRF1|MAPK9|CD3G|CD3E|HLA-DRB1|IL2RA|PPP3CA|PPP3CB
PID_S1P_S1P1_PATHWAY%MSIGDB_C2%PID_S1P_S1P1_PATHWAY,0.00989166274140367,0.218712719172745,-0.407005488796924,-1.8485358962650902,41,21,GNAI3|VEGFA|KDR|GNAZ|ABCC1|SPHK1|GNAI2|RHOA|MAPK3|S1PR1|RAC1
PID_NCADHERIN_PATHWAY%MSIGDB_C2%PID_NCADHERIN_PATHWAY,0.6696549850584079,0.964618776001639,-0.16304478813256398,-0.8631738786379141,2464,32,CTNNA1|PTPN1|CDC42|FGFR1|RAC1|PIK3R1
PID_P73PATHWAY%MSIGDB_C2%PID_P73PATHWAY,0.8545523233849641,0.991298302704726,-0.11541755723597,-0.770559348157631,2261,69,SERPINA1|TP53I3|HSF1|FBXO45|CDKN1A|PEA15|WWOX|BCL2L11|FOXO3
BIOCARTA_ALK_PATHWAY%MSIGDB_C2%BIOCARTA_ALK_PATHWAY,0.8248353036729541,0.9876441563834109,0.176792602030359,0.718752405190956,9139,27,BMP4|DVL1|TGFB2|MAP3K7|APC
BIOCARTA_TOB1_PATHWAY%MSIGDB_C2%BIOCARTA_TOB1_PATHWAY,0.8391615146831529,0.989395884107905,0.204287561032376,0.692659860865813,8686,15,TGFB2|CD3D|CD3G|CD3E|TGFB3|IL2RA|TOB1|CD247|TGFBR2|TGFB1|TGFBR3|SMAD4|SMAD3|TOB2
PID_AMB2_NEUTROPHILS_PATHWAY%MSIGDB_C2%PID_AMB2_NEUTROPHILS_PATHWAY,0.007692307692307691,0.198167223413272,-0.32143018015240005,-1.7855306353255502,26,37,THY1|RAP1B|BLK|ITGAM|FGR|FYN|RHOA|MMP2|PLAU|IL6|LYN|MMP9|MST1R|YES1|JAM2|ICAM1|RAP1A|PLAUR|TNF
BIOCARTA_GCR_PATHWAY%MSIGDB_C2%BIOCARTA_GCR_PATHWAY,0.000878155872667398,0.0849637591935908,-0.5460631585296,-2.2363121608031498,3,16,CALM1|GNGT1|ADRB2|NR3C1|NOS3|GNAS|PIK3R1
PID_FOXO_PATHWAY%MSIGDB_C2%PID_FOXO_PATHWAY,0.036380892122746006,0.38474071165057205,-0.251269642746489,-1.5007438532380601,114,47,FOXO1|YWHAH|SOD2|RALA|YWHAQ|YWHAB|GADD45A|YWHAZ|YWHAE|RALB|BCL6|BCL2L11|FOXO3
PID_ATR_PATHWAY%MSIGDB_C2%PID_ATR_PATHWAY,0.026297637523711004,0.337608662814091,0.354830377505346,1.6003765652942499,304,39,SSPO|ATR|RFC4|CDC25C|PPP2R2B|RAD9A|CDC6|RAD51|CEP164|TIMELESS|TOPBP1|FANCD2|PLK1|MCM2|BRCA2|CLSPN|CHEK1|RFC3|RAD17|RFC5|PPP2R1A|RAD1|CDK2|MDM2|MCM7|CCNA2
PID_MYC_ACTIV_PATHWAY%MSIGDB_C2%PID_MYC_ACTIV_PATHWAY,0.0157154673283706,0.265926367652717,-0.22146356913628798,-1.52601973942757,37,78,MAX|SMAD3|HSP90AA1|RPL11|HMGA1|CREBBP|EIF4E|NCL|TAF10|BMI1|HSPA4|BAX|MYCT1|PTMA|NDUFAF2|ID2|LDHA|EIF2S1|PIM1|POLR3D|MTDH|RUVBL1|EIF4A1|BCAT1|SUPT7L|SERPINI1|FOSL1|EIF4G1|ENO1|MMP9|SNAI1|RUVBL2|PDCD10|NPM1|GAPDH|DDX18|TFRC|ODC1|TP53|TAF4B|SLC2A1|PMAIP1
PID_FGF_PATHWAY%MSIGDB_C2%PID_FGF_PATHWAY,0.109828393135725,0.584830174998513,-0.22158137813026202,-1.3103927432234,351,46,PLAU|FGF2|HGF|MMP9|IL17RD|CAMK2A|PLAUR|FGFR1|SHC1|JUN|MAPK3|SDC2|MET|PIK3R1
BIOCARTA_AKAPCENTROSOME_PATHWAY%MSIGDB_C2%BIOCARTA_AKAPCENTROSOME_PATHWAY,0.7213018904696942,0.9713770803161691,0.23904260314699502,0.7920224283706,7401,14,AKAP9|CDK1|PRKAR2B|NUP85
BIOCARTA_NDKDYNAMIN_PATHWAY%MSIGDB_C2%BIOCARTA_NDKDYNAMIN_PATHWAY,0.0888691401910687,0.55727445312544,-0.327625198692093,-1.40937081348647,399,18,AP2M1|PPP3CA|PPP3CB|NME1|NME1-NME2|EPS15|PPP3CC|CALM2|SYNJ1|EPN1|AP2A1|CALM3|PICALM|SYNJ2|BIN1|CALM1|AMPH
ST_PAC1_RECEPTOR_PATHWAY%MSIGDB_C2%ST_PAC1_RECEPTOR_PATHWAY,0.452494648443932,0.8873610269840101,-0.429061926035585,-0.986752795705798,2747,4,GNAQ|ITPKB
BIOCARTA_EXTRINSIC_PATHWAY%MSIGDB_C2%BIOCARTA_EXTRINSIC_PATHWAY,0.7629939862542958,0.978421368343614,0.310012716085166,0.7624311262090129,7104,6,F2R|F3
PID_INTEGRIN_CS_PATHWAY%MSIGDB_C2%PID_INTEGRIN_CS_PATHWAY,0.359101329665291,0.8472826785278371,0.276773000031916,1.08923953032539,3915,24,ITGB1|ITGA1|ITGA9|ITGA2|ITGA4|ITGA11|ITGB5|ITGA2B|ITGA10|ITGA3|ITGA8
BIOCARTA_SPRY_PATHWAY%MSIGDB_C2%BIOCARTA_SPRY_PATHWAY,0.38309549945115295,0.8582519754973359,-0.25200283289577,-1.0320362964591099,1744,16,SHC1|MAPK3|MAP2K1
PID_SHP2_PATHWAY%MSIGDB_C2%PID_SHP2_PATHWAY,0.112565445026178,0.587889099677873,-0.213168948175532,-1.2990091210628703,343,51,FRS2|IL6ST|PRKACA|NTRK1|IL6R|GNAI3|VEGFA|KDR|IGF1R|NRAS|GRB2|RHOA|IL6|IGF1|KRAS|SHC1|GAB2|NOS3|SDC2|MAP2K1|PIK3R1
BIOCARTA_IGF1MTOR_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1MTOR_PATHWAY,0.103360957642726,0.5756137190742839,-0.307477006642461,-1.37193334407511,448,20,EIF2S2|EIF4E|EIF2S1|IGF1R|EIF4EBP1|PPP2CA|IGF1|EIF2S3|PIK3R1
BIOCARTA_ERK5_PATHWAY%MSIGDB_C2%BIOCARTA_ERK5_PATHWAY,0.10909893992932901,0.58452352834625,-0.32566246543196303,-1.37035019771123,493,17,MAPK7|GRB2|MEF2D|SHC1|MAPK3|PIK3R1
PID_AP1_PATHWAY%MSIGDB_C2%PID_AP1_PATHWAY,0.23035904728048298,0.743397546142977,-0.181080070539827,-1.15827756794526,647,60,TCF7L2|FOSL1|PLAU|IL6|MMP9|FABP4|ETS1|CXCL8|NR3C1|JUN|NFATC2|TP53|CBFB|BAG1|BCL2L11
BIOCARTA_MTOR_PATHWAY%MSIGDB_C2%BIOCARTA_MTOR_PATHWAY,0.0188451316743175,0.286396032442422,-0.361879978065302,-1.70044375542132,77,23,EIF4A2|EIF4G1|EIF4EBP1|PPP2CA|EIF4B|EIF3A|PIK3R1|FKBP1A
PID_ERBB4_PATHWAY%MSIGDB_C2%PID_ERBB4_PATHWAY,0.0383048084759576,0.393143354533675,-0.29009336798967894,-1.53578056976098,140,32,PIK3CD|PIK3R2|ITCH|CBFA2T3|GRB2|FYN|HBEGF|NEDD4|ADAM17|STAT5A|SHC1|MAPK3|LRIG1|WWOX|PIK3R1
BIOCARTA_EGF_PATHWAY%MSIGDB_C2%BIOCARTA_EGF_PATHWAY,0.00501054852320675,0.16399149030203,-0.362307478649739,-1.8796628102060602,18,30,STAT5A|SHC1|JUN|PRKCA|STAT3|MAPK3|MAP2K1|CSNK2A1|PIK3R1
PID_FOXM1_PATHWAY%MSIGDB_C2%PID_FOXM1_PATHWAY,0.0249343832020997,0.329326373353219,0.365166965903254,1.6118602818683703,284,36,CCNB1|CDK1|CENPF|ETV5|BIRC5|CDKN2A|NEK2|CCNE1|CENPA|RB1|FOS|AURKB|CCNB2|CHEK2|PLK1|GAS1|BRCA2|XRCC1|GSK3A|FOXM1|SP1|SKP2|CDK2
PID_BARD1_PATHWAY%MSIGDB_C2%PID_BARD1_PATHWAY,0.488749439713133,0.9084376510762291,0.23746577794711501,0.983663217208232,5451,29,FANCL|FANCA|ATR|CCNE1|FANCG|FANCC|RAD51|FANCF|TOPBP1|FANCD2|PRKDC|CDK2|ATM|BRCA1
PID_AVB3_INTEGRIN_PATHWAY%MSIGDB_C2%PID_AVB3_INTEGRIN_PATHWAY,0.427091043671355,0.875860872092455,-0.154492004941064,-1.02017638313076,1153,67,CDKN1B|COL6A2|EDIL3|VEGFA|KDR|F11R|IGF1R|COL16A1|BCAR1|PTK2B|RHOA|COL6A1|FGF2|PXN|COL15A1|COL8A2|IGF1|VAV3|COL9A1|MAPK3|RAC1|PIK3R1
BIOCARTA_CARM1_PATHWAY%MSIGDB_C2%BIOCARTA_CARM1_PATHWAY,0.5501658374792701,0.931421923167331,-0.251693371919561,-0.916944201248832,2653,12,PRKAR1A|CREBBP|RARA|RXRA|PRKAR2A|PRKAR1B
PID_PS1_PATHWAY%MSIGDB_C2%PID_PS1_PATHWAY,0.12164948453608199,0.607607158836689,-0.22907341033674103,-1.30276486312378,412,40,PSEN1|PSENEN|APH1B|DLL1|CSNK1A1|CREBBP|NOTCH1|PPARD|FZD1|FRAT1|CTNNB1|CTBP1|ADAM10|NCSTN|NEDD4|JUN|DKK1|MAPK3|CSNK2A1|RBPJ
PID_INTEGRIN4_PATHWAY%MSIGDB_C2%PID_INTEGRIN4_PATHWAY,0.686314089624546,0.9665006495129341,-0.232940317105852,-0.819745997763395,3399,11,LAMC1|ITGA6|LAMC2
BIOCARTA_THELPER_PATHWAY%MSIGDB_C2%BIOCARTA_THELPER_PATHWAY,0.8858479299363059,0.996643473105967,0.21209737569949202,0.6470604743624151,8900,11,CD2|CD3D|CD3G|CD3E|CD247|PTPRC|ITGAL
ST_WNT_CA2_CYCLIC_GMP_PATHWAY%MSIGDB_C2%ST_WNT_CA2_CYCLIC_GMP_PATHWAY,0.974313940724479,1.0,-0.136969232186106,-0.5609350398559351,4437,16,PDE6B|CAMK2A|ITPKB
PID_HDAC_CLASSIII_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSIII_PATHWAY,0.0468155893536122,0.42576220498911105,-0.331097243558602,-1.53388757616687,196,22,CREBBP|XRCC6|BAX|FOXO4|HDAC4|TUBB2A|FOXO1|MEF2D|PPARGC1A|TP53|CDKN1A|FOXO3
PID_INTEGRIN3_PATHWAY%MSIGDB_C2%PID_INTEGRIN3_PATHWAY,0.921410719244654,1.0,-0.12271780847897802,-0.667094861207153,3317,35,THY1|EDIL3|VEGFA|KDR|F11R|SPHK1|PLAU|LAMC1|PLAUR|LAMA4|PECAM1
BIOCARTA_RAS_PATHWAY%MSIGDB_C2%BIOCARTA_RAS_PATHWAY,0.0394486692015209,0.396089810860281,-0.338274926126684,-1.56713991616982,165,22,FOXO4|RHOA|BCL2L1|RALA|CDC42|MAPK3|RAC1|MAP2K1|PIK3R1
PID_CDC42_PATHWAY%MSIGDB_C2%PID_CDC42_PATHWAY,0.0058330295297119895,0.175005706363229,-0.259403507782626,-1.69003095282175,15,64,ARPC5|YES1|CTNNA1|LIMK1|VAV2|ARPC4|CDC42|MAP2K3|JUN|MAPK3|RAC1|MAP3K11|ACTR2|PIK3R1|DLG1|PAK2
BIOCARTA_CALCINEURIN_PATHWAY%MSIGDB_C2%BIOCARTA_CALCINEURIN_PATHWAY,0.591868473672517,0.9458918196441479,-0.207666914356772,-0.89333692643188,2663,18,CALM1|PRKCA|NFATC2|CDKN1A
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY%MSIGDB_C2%ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY,0.4224524076147821,0.873470206885489,-0.18613766536997103,-1.02392319774276,1508,36,A1BG|GRB2|FOXO1|YWHAH|YWHAQ|YWHAB|SHC1|YWHAZ|YWHAE|RPS6KA2
BIOCARTA_VEGF_PATHWAY%MSIGDB_C2%BIOCARTA_VEGF_PATHWAY,0.010547980447646,0.22424275249482103,-0.3474187681805269,-1.7566346911636999,40,28,EIF2S2|HIF1A|EIF2B3|VEGFA|EIF2S1|KDR|PXN|EIF1|VHL|EIF1AX|SHC1|PRKCA|NOS3|EIF2S3|FLT1|PIK3R1
BIOCARTA_TPO_PATHWAY%MSIGDB_C2%BIOCARTA_TPO_PATHWAY,0.00259067357512953,0.126473912512219,-0.457940321640132,-2.079871515741,10,21,STAT5A|SHC1|JUN|PRKCA|STAT3|MAPK3|MAP2K1|CSNK2A1|PIK3R1
BIOCARTA_CDC42RAC_PATHWAY%MSIGDB_C2%BIOCARTA_CDC42RAC_PATHWAY,0.00746432491767289,0.19559602050883,-0.467029954727452,-1.9126446289266301,33,16,RHOA|ARPC5|ARPC4|CDC42|RAC1|ACTR2|PIK3R1
BIOCARTA_MTA3_PATHWAY%MSIGDB_C2%BIOCARTA_MTA3_PATHWAY,0.134577387486279,0.621957763524714,-0.32330228281097806,-1.3240315069276298,612,16,PDZK1|SNAI2|HSPB1|CTSD|TUBA1C|TUBA3C|SNAI1|GAPDH|ALDOA
BIOCARTA_ARF_PATHWAY%MSIGDB_C2%BIOCARTA_ARF_PATHWAY,0.171679473106476,0.674379448319819,-0.309017034155113,-1.26552861254591,781,16,ABL1|POLR1B|TP53|RAC1|TWIST1|PIK3R1
BIOCARTA_EIF_PATHWAY%MSIGDB_C2%BIOCARTA_EIF_PATHWAY,0.000439077936333699,0.0784645998831315,-0.583181345623657,-2.3883236120223197,1,16,EIF6|EIF2S2|EIF4E|EIF5|EIF2S1|EIF4A1|EEF2K|EIF4A2|EIF4G1|EIF1|EIF1AX|EIF3A|EIF2S3
PID_PI3KCI_AKT_PATHWAY%MSIGDB_C2%PID_PI3KCI_AKT_PATHWAY,0.317187932466095,0.818598932456131,-0.20391536955382802,-1.09724552896914,1145,34,YWHAG|HSP90AA1|PRKACA|CDKN1B|MAPKAP1|KPNA1|FOXO4|FOXO1|YWHAH|BCL2L1|YWHAQ|YWHAB|YWHAZ|YWHAE|CDKN1A|FOXO3
PID_P53_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_P53_DOWNSTREAM_PATHWAY,0.00238095238095238,0.123131026996483,-0.210226577493168,-1.62829611059071,3,125,DDIT4|GDF15|LIF|BBC3|PML|ZNF385A|RRM2B|IGFBP3|MMP2|TNFRSF10D|TNFRSF10A|HGF|BCL2L1|RNF144B|POU4F2|BID|MAP4K4|PPM1J|GADD45A|TP53I3|BCL2|JUN|PMS2|TP53|DKK1|TADA2B|TNFRSF10B|HTT|NFYA|BCL6|CDKN1A|BNIP3L|BDKRB2|MET|JMY|PMAIP1|STEAP3|CAV1|NDRG1
BIOCARTA_RAC1_PATHWAY%MSIGDB_C2%BIOCARTA_RAC1_PATHWAY,0.8813000471031559,0.9956508825790341,-0.152206104409804,-0.691289074414864,3741,21,NCF2|CDK5|RALBP1|VAV1|TRIO|LIMK1|RAC1|PIK3R1
NABA_ECM_GLYCOPROTEINS%MSIGDB_C2%NABA_ECM_GLYCOPROTEINS,0.629809818664308,0.956994256986843,0.15320284684612398,0.909351599187373,8543,144,CTGF|VWDE|FBN3|CYR61|ELN|LGI1|LAMC3|NOV|NTN5|SLIT1|SSPO|WISP1|TNC|DDX26B|SMOC1|BGLAP|DPT|EMID1|EFEMP1|LAMA1|FNDC1|LAMB2|MGP|PAPLN|IGFBP5|FBN1|NTN3|ZP3|IGFBP7|LTBP2|HMCN1|TNXB|FBLN5|CRELD2|MFAP4|EFEMP2|IGFBPL1|NTN1|FN1|LGI4|LAMA2|IGFBP2|LTBP1|THBS2|NID1|AEBP1|SPARC|AGRN|THBS1|MFAP2|MFAP1|CRELD1|TECTA|VWA7
PID_RHOA_REG_PATHWAY%MSIGDB_C2%PID_RHOA_REG_PATHWAY,0.29070837166513297,0.800029528446767,-0.19364474420702302,-1.11946236339761,947,43,ARHGDIB|ARAP3|ARHGEF25|ARHGEF3|MYO9B|ARHGEF5|CDKN1B|OPHN1|ARHGAP5|ARHGDIA|ARHGAP8|ABR|DLC1|VAV1|TRIO|RHOA|VAV3|ARHGEF2|VAV2|AKAP13|NET1|BCR
ST_JNK_MAPK_PATHWAY%MSIGDB_C2%ST_JNK_MAPK_PATHWAY,0.718898796640984,0.971099752950353,0.181730862083601,0.814115608441012,8303,38,MAP3K10|MAP3K9|DUSP8|MAPK10|MAP3K5|MAP3K7|GCK|DLD|MAP3K4|MAP2K7|MAP3K1|MAP3K12|MYEF2|MAPK9
SA_G2_AND_M_PHASES%MSIGDB_C2%SA_G2_AND_M_PHASES,0.7585525631693879,0.977664504547119,0.28037952434749996,0.7643898045701542,7294,8,CDK1|WEE1|CDK7|CHEK1
PID_ERBB2_ERBB3_PATHWAY%MSIGDB_C2%PID_ERBB2_ERBB3_PATHWAY,0.23612388837779802,0.750277765814412,-0.202092398641757,-1.16829834517134,769,43,CDC42|KRAS|SHC1|JUN|STAT3|MAPK3|RAC1|MAP2K1|PIK3R1
BIOCARTA_CELL2CELL_PATHWAY%MSIGDB_C2%BIOCARTA_CELL2CELL_PATHWAY,0.480099502487562,0.9046812288131709,-0.266378102802399,-0.9704421488794179,2315,12,CTNNB1|BCAR1|PXN|CTNNA1|PECAM1
BIOCARTA_KERATINOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_KERATINOCYTE_PATHWAY,0.0818483841739656,0.5393915998030421,-0.237758552406293,-1.36903092609204,270,42,PRKCH|NFKBIA|PRKCD|CEBPA|TNFRSF1B|PPP2CA|ETS1|MAP2K3|BCL2|JUN|PRKCA|MAPK3|MAP2K1|ETS2|TNF
PID_INTEGRIN5_PATHWAY%MSIGDB_C2%PID_INTEGRIN5_PATHWAY,0.348329664018379,0.842847021021096,0.316681401846916,1.09784853940614,3638,16,CYR61|MADCAM1|ITGA4|FBN1|ITGB5
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES%MSIGDB_C2%SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,0.584544758990054,0.9439064862850342,-0.18368178873535898,-0.9153225480125791,2291,27,BCL2|SHC1|MAPK3|PIK3R1
PID_NOTCH_PATHWAY%MSIGDB_C2%PID_NOTCH_PATHWAY,0.9849624060150379,1.0,-0.0908914860418052,-0.570671793130355,2881,56,MYCBP|DNM1|SPEN|MFAP2|GATA3|SKP2|CNTN1|NEURL1|YY1|DLL4|JAG1|CBL|NOTCH2|NCOR1|CCND1|RBBP8|MIB1|EPS15|EP300|ADAM12|CUL1|MYC|NUMB|MAML2|HDAC1|LNX1|APH1A|NCOR2|NOTCH3|PSEN1|PSENEN|SKP1|NOTCH4|DNER|APH1B|RAB11A|DLL1|ITCH|FBXW7|NOTCH1|FURIN|CTBP1|ADAM10|MFAP5|NCSTN|ENO1|CDKN1A|DLL3|RBPJ
BIOCARTA_PLCE_PATHWAY%MSIGDB_C2%BIOCARTA_PLCE_PATHWAY,0.0995155429955591,0.570215774831708,-0.3998482751617,-1.4071158971053201,492,11,RAP2B|PRKAR2A|ADRB2|PRKAR1B|GNAS
PID_HIF1_TFPATHWAY%MSIGDB_C2%PID_HIF1_TFPATHWAY,0.000352982703847511,0.0784645998831315,-0.348731722422657,-2.22159399697982,0,59,SMAD3|BHLHE40|ENG|CXCL12|BNIP3|CREBBP|GATA2|HIF1A|FURIN|ID2|LDHA|VEGFA|FECH|PLIN2|HMOX1|PFKL|CP|CITED2|PKM|ENO1|ETS1|NPM1|PGK1|BHLHE41|TFRC|HK1|HK2|JUN|ALDOA|SLC2A1|NT5E|ADM|NDRG1|EGLN3
PID_RHODOPSIN_PATHWAY%MSIGDB_C2%PID_RHODOPSIN_PATHWAY,0.38150989099717403,0.8571679968531,-0.297480345602523,-1.04687039903928,1889,11,PDE6B|GNB5|GNGT1|GUCA1A
PID_MYC_REPRESS_PATHWAY%MSIGDB_C2%PID_MYC_REPRESS_PATHWAY,0.011963406052075999,0.23670963874364498,-0.25512160959580604,-1.6200055985233701,33,58,MXD4|SPI1|LGALS1|CDKN1B|ID2|CLU|CEBPA|FTH1|TJP2|DDIT3|ITGA6|SMAD2|SLC11A1|GADD45A|BCL2|CSDE1|CFLAR|DKK1|NFYA|CDKN1A|TMEFF2|NDRG1|FOXO3
PID_REG_GR_PATHWAY%MSIGDB_C2%PID_REG_GR_PATHWAY,0.423147806855879,0.873470206885489,-0.15569040771392598,-1.01951007762795,1147,65,YWHAH|IL6|ICAM1|VIPR1|CXCL8|STAT5A|NR3C1|JUN|TP53|MAPK3|CDKN1A|FKBP4|SMARCC1
BIOCARTA_CDMAC_PATHWAY%MSIGDB_C2%BIOCARTA_CDMAC_PATHWAY,0.020417124039517,0.299758857463157,-0.424020118047194,-1.73650489252468,92,16,JUN|PRKCA|MAPK3|PLCB1|MAP2K1|TNF
BIOCARTA_P53HYPOXIA_PATHWAY%MSIGDB_C2%BIOCARTA_P53HYPOXIA_PATHWAY,0.0484790874524715,0.43374509308502396,-0.329419317997913,-1.5261141826356799,203,22,HIC1|HSP90AA1|CSNK1D|CSNK1A1|HIF1A|BAX|IGFBP3|NQO1|GADD45A|NFKBIB|TP53|CDKN1A
PID_FCER1_PATHWAY%MSIGDB_C2%PID_FCER1_PATHWAY,0.00703729767769177,0.18934349444572798,-0.268978536188019,-1.70799617953796,19,58,FCER1G|DOK1|GRB2|VAV1|SPHK1|FYN|PXN|LYN|FCGR2B|WIPF1|SHC1|JUN|NFATC2|KLRG1|GAB2|MAPK3|S1PR1|PLD2|MAP2K1|PIK3R1|PAK2
PID_ERBB1_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_ERBB1_DOWNSTREAM_PATHWAY,0.000491883915395967,0.0784645998831315,-0.24539337477384998,-1.80741325882842,0,102,MAPK7|PRKCD|ABI1|NRAS|GRB2|CYFIP2|SLC9A1|MAP2K5|YWHAH|SMAD1|BCL2L1|ARPC5|PPP2CA|RALA|YWHAQ|YWHAB|VAV2|ARPC4|CDC42|KRAS|JUN|PRKCA|STAT3|YWHAZ|YWHAE|MAPK3|RAB5A|RAC1|PLD2|ACTR2|BRK1|MAP2K1|PIK3R1
BIOCARTA_NOS1_PATHWAY%MSIGDB_C2%BIOCARTA_NOS1_PATHWAY,0.677782685512368,0.9647315640607691,-0.19875688080262602,-0.8363460939321801,3068,17,PRKAR2A|CALM1|PRKCA|PRKAR1B
BIOCARTA_KREB_PATHWAY%MSIGDB_C2%BIOCARTA_KREB_PATHWAY,0.600395133617552,0.950415218201239,0.327908206469109,0.8939657431946372,5773,8,FH|SDHA|ACO2|SUCLA2|MDH1|CS|IDH2
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS%MSIGDB_C2%ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS,0.30427098674521397,0.807019828873716,-0.194510789426358,-1.10620355976987,1032,40,SHC1|JUN|RASGRF2|MAPK3|PIK3R1|CREB5
BIOCARTA_MAL_PATHWAY%MSIGDB_C2%BIOCARTA_MAL_PATHWAY,0.0510159010600707,0.443301756236231,-0.36701487758802204,-1.54435639181999,230,17,LIMK1|MAL|CDC42|MAPK3|RAC1|MAP2K1
PID_IL23_PATHWAY%MSIGDB_C2%PID_IL23_PATHWAY,0.518672199170125,0.9236324326350509,-0.19929392961010697,-0.955307875333702,2124,24,STAT5A|STAT3|PIK3R1|TNF
PID_CDC42_REG_PATHWAY%MSIGDB_C2%PID_CDC42_REG_PATHWAY,0.787270282384581,0.9819233677232551,0.182829310116133,0.757340569001269,8781,29,DOCK10|FARP2|FGD1|ARHGEF6|APC|GIT1|PLCG1|RACGAP1|ARHGAP17|ARHGEF9|MCF2L
BIOCARTA_SKP2E2F_PATHWAY%MSIGDB_C2%BIOCARTA_SKP2E2F_PATHWAY,0.0558130163207737,0.459403262071736,0.514478536500396,1.51835907752451,553,10,CCNA1|CDC34|CCNE1|RB1|E2F1|SKP2|CDK2
PID_IGF1_PATHWAY%MSIGDB_C2%PID_IGF1_PATHWAY,0.0226793248945148,0.31609926985007897,-0.317819296900177,-1.64885669756386,85,30,CRKL|NCK2|PRKCD|IGF1R|BCAR1|GRB2|PXN|IGF1|CRK|PTPN1|SHC1|YWHAZ|YWHAE|PIK3R1
NABA_MATRISOME_ASSOCIATED%MSIGDB_C2%NABA_MATRISOME_ASSOCIATED,0.599127946586728,0.949852376356769,0.14293436626378697,0.9539244109557791,8793,397,FREM1|SEMA3D|MUC15|INSL3|CXCL13|HPX|LEFTY1|FGF19|MMP17|COLEC11|MEGF6|SERPINA5|WNT4|FST|PSPN|FGF12|CRHBP|CLEC18A|WNT5B|ADAMTS10|FIGF|CD209|OGFOD2|INHA|BRINP3|IL17B|NRG2|SCUBE2|ARTN|SERPINE2|ELFN2|ADAMTS2|NRG3|BMP4|PLAT|F12|INS|CXCL9|LGALS2|CFC1|ADAMTSL2|FGF17|PLXNC1|OVGP1|MMP11|S100A1|FGF13|ADAMDEC1|HMSD|LOXL1|GPC2|C1QTNF3|FGF11|ADAM11|ELFN1|GPC6|SEMA5A|MUC1|C1QTNF9B|HCFC2|EGLN2|TGFB2|TNFSF13B|LOXL3|P3H2|GDF11|MMP23B|XCL2|CCL21|CLEC18B|CRLF3|P4HA3|EBI3|CCL5|PLXNA3|NGLY1|GPC1|PLXDC2|C1QTNF6|SEMA3E|LOXL2
BIOCARTA_SRCRPTP_PATHWAY%MSIGDB_C2%BIOCARTA_SRCRPTP_PATHWAY,0.250597133757962,0.7622386387061709,0.392610478804258,1.19776457307362,2517,11,CCNB1|CDK1|CDC25C|PRKCB|SRC
ST_JAK_STAT_PATHWAY%MSIGDB_C2%ST_JAK_STAT_PATHWAY,0.0362899032962462,0.384708132326922,0.5847657909624611,1.5942284291741398,348,8,PIAS1|CISH|JAK2|SOAT1
BIOCARTA_P38MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_P38MAPK_PATHWAY,0.783320410097355,0.981487311948134,0.16895800827183702,0.76659191597549,9091,40,MAP2K6|PLA2G4A|MAP3K9|TGFB2|MAP3K5|MAP3K7|HRAS|RIPK1|MAP3K1|HSPB2|TRAF2|TRADD|TGFB3|MAPKAPK5|STAT1|ELK1|HMGN1|MAPK14|MKNK1
PID_WNT_NONCANONICAL_PATHWAY%MSIGDB_C2%PID_WNT_NONCANONICAL_PATHWAY,0.872809346787042,0.9934031064448321,-0.135213241021587,-0.711023517588139,3286,31,ARRB2|RHOA|PPARG|YES1|CAMK2A|CDC42|NFATC2|RAC1
PID_ERBB_NETWORK_PATHWAY%MSIGDB_C2%PID_ERBB_NETWORK_PATHWAY,0.4968623481781379,0.911815944636073,0.340485669369174,0.9716297643322779,4908,9,NRG2|NRG3|NRG1|ERBB3|NRG4
BIOCARTA_PTC1_PATHWAY%MSIGDB_C2%BIOCARTA_PTC1_PATHWAY,0.39592988112029,0.8638522656500329,0.3583801546897971,1.05767242454724,3929,10,CCNB1|CDK1|CDC25C|CDK7|MNAT1|PTCH1
BIOCARTA_PGC1A_PATHWAY%MSIGDB_C2%BIOCARTA_PGC1A_PATHWAY,0.035884030418251,0.382648509404771,-0.34242755666260993,-1.5863779754149199,150,22,HDAC5|PPARA|YWHAH|CAMK2A|MEF2D|CALM1|CAMK4|PPARGC1A
BIOCARTA_P27_PATHWAY%MSIGDB_C2%BIOCARTA_P27_PATHWAY,0.5890209172149661,0.945418171231938,0.27791053699755197,0.8969206026549169,5997,13,CCNE1|RB1|E2F1|RBX1|SKP2|CDK2
BIOCARTA_PTDINS_PATHWAY%MSIGDB_C2%BIOCARTA_PTDINS_PATHWAY,0.738342594829669,0.9744283926676119,-0.17133140812062397,-0.805071959503886,3055,23,LYN|ARHGEF2|VAV2|RAB5A|RAC1
BIOCARTA_GLYCOLYSIS_PATHWAY%MSIGDB_C2%BIOCARTA_GLYCOLYSIS_PATHWAY,0.00018570102135561698,0.0784645998831315,-0.774107858751235,-2.4062642773158798,0,8,PFKL|GPI|ENO1|GAPDH|PGK1|HK1|TPI1
BIOCARTA_NUCLEARRS_PATHWAY%MSIGDB_C2%BIOCARTA_NUCLEARRS_PATHWAY,0.7125730404996979,0.9707100537727641,0.270921233050485,0.799558551644302,7072,10,ABCC3|ABCB4
SA_PTEN_PATHWAY%MSIGDB_C2%SA_PTEN_PATHWAY,0.9036223929747529,1.0,-0.162786947872892,-0.666667262681565,4115,16,PTK2B|GRB2|SHC1|MAPK3
PID_PDGFRA_PATHWAY%MSIGDB_C2%PID_PDGFRA_PATHWAY,0.00276243093922652,0.129967667001507,-0.463406733813115,-2.06767704983686,11,20,CRK|SHB|RAPGEF1|SHC1|JUN|CSNK2A1|PIK3R1|CAV1
PID_TCPTP_PATHWAY%MSIGDB_C2%PID_TCPTP_PATHWAY,0.7847061842442908,0.981487311948134,0.167086909299692,0.7689933479674509,9173,42,ITGB1|PIAS1|ITGA1|INS|ATR|PIK3R3
PID_AR_NONGENOMIC_PATHWAY%MSIGDB_C2%PID_AR_NONGENOMIC_PATHWAY,0.353002339485313,0.842847021021096,-0.207979764866637,-1.06438867181909,1357,29,CDC42|MAPK3|RAC1|PLCB1|MAP2K1|PIK3R1
PID_INTEGRIN1_PATHWAY%MSIGDB_C2%PID_INTEGRIN1_PATHWAY,0.437088815789474,0.878651088001772,0.20521136491644698,1.0229376466685,5314,58,ITGB1|COL18A1|ITGA1|TNC|ITGA9|ITGA2|ITGA4|LAMA1|LAMB2|FBN1|ITGA11|COL4A1|COL5A2|COL5A1|COL11A2|ITGA10|MDK|FN1|LAMA2|THBS2|NID1|THBS1|ITGA3|ITGA8|COL11A1|COL1A1|TGM2|COL3A1|TGFBI|LAMB3
PID_ER_NONGENOMIC_PATHWAY%MSIGDB_C2%PID_ER_NONGENOMIC_PATHWAY,0.000293772032902468,0.0784645998831315,-0.406806838209278,-2.2953087737661,0,39,GNAI3|GNA13|GNAZ|IGF1R|BCAR1|NRAS|GRB2|GNAQ|GNAI2|RHOA|MMP2|GNAL|STRN|GNA15|HBEGF|MMP9|IGF1|MSN|KRAS|SHC1|NOS3|PLCB1|PIK3R1
BIOCARTA_CBL_PATHWAY%MSIGDB_C2%BIOCARTA_CBL_PATHWAY,0.5603233830845771,0.936434965680841,-0.249839435107558,-0.9101901234744241,2702,12,GRB2|SH3GLB1|PRKCA|MET
PID_RAC1_REG_PATHWAY%MSIGDB_C2%PID_RAC1_REG_PATHWAY,0.0649819494584838,0.4956987271622679,-0.26308227627864006,-1.4301170853309801,233,35,PREX1|RALBP1|ARHGDIA|KALRN|ABR|ABI1|VAV1|TRIO|ARHGAP1|VAV3|ARHGEF2|VAV2|RASGRF2|BCR|RAC1
BIOCARTA_CHREBP2_PATHWAY%MSIGDB_C2%BIOCARTA_CHREBP2_PATHWAY,0.14691393798898902,0.638549298625996,-0.226443753128315,-1.26756815017031,506,38,PRKAA1|PRKAG1|PPP2R5C|YWHAH|PPP2CA|PRKAR2A|PPP2CB|YWHAQ|YWHAB|PPP2R1B|YWHAZ|PRKAR1B|YWHAE
PID_LYSOPHOSPHOLIPID_PATHWAY%MSIGDB_C2%PID_LYSOPHOSPHOLIPID_PATHWAY,0.000364564345607,0.0784645998831315,-0.30524863133957797,-1.9887149548596499,0,64,GNA13|ADCY7|NFKBIA|PRKCD|GNAZ|LPAR1|BCAR1|PTK2B|GNAQ|GNAI2|RHOA|ADRA1B|MMP2|CASP3|GNA15|PXN|IL6|HBEGF|LYN|MMP9|MAGI3|CRK|CXCL8|JUN|ADCY2|GNA12|RAC1|PLD2|PIK3R1
BIOCARTA_RARRXR_PATHWAY%MSIGDB_C2%BIOCARTA_RARRXR_PATHWAY,0.9905376344086021,1.0,-0.124599933782143,-0.496915667553685,4605,15,GTF2B|HDAC3|GTF2A1|NCOA3|KAT2B|GTF2E1|NCOA2|ERCC3|GTF2F1|NCOA1|NCOR2|TBP|RARA|RXRA|POLR2A
PID_S1P_S1P2_PATHWAY%MSIGDB_C2%PID_S1P_S1P2_PATHWAY,0.037344398340249,0.38702164012069,-0.328320587627138,-1.57379225552933,152,24,GNAI3|GNA13|GNAZ|GNAQ|GNAI2|RHOA|GNA15|CDH5|JUN|MAPK3|GNA12|RAC1
BIOCARTA_RELA_PATHWAY%MSIGDB_C2%BIOCARTA_RELA_PATHWAY,0.675740944017563,0.9647315640607691,-0.20528668395783897,-0.840717965705763,3077,16,HDAC3|RIPK1|TRADD|CHUK|IKBKG|FADD|EP300|TNFRSF1A|NFKB1|IKBKB|RELA|TRAF6|CREBBP|NFKBIA|TNFRSF1B|TNF
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES%MSIGDB_C2%SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,0.00811232449297972,0.200220873216449,-0.30150171531505104,-1.78302736065658,25,46,FOXO1|YWHAH|YWHAQ|PTPN1|YWHAB|CDC42|SHC1|YWHAZ|YWHAE|MAPK3|PIK3R1|RPS6KA2|PARD3
PID_VEGFR1_2_PATHWAY%MSIGDB_C2%PID_VEGFR1_2_PATHWAY,0.0011333585190782,0.0906741566881841,-0.283793019781716,-1.89468023385383,2,69,NCK2|PTPN6|VEGFA|KDR|PRKCD|DNM2|CTNNB1|PTK2B|PRKAA1|PRKAG1|GRB2|FYN|RHOA|CDH5|PXN|CTNNA1|CDC42|MAP2K3|SHB|NEDD4|PRKCA|NOS3|MAPK3|FLT1|MAP2K1|PIK3R1|HSP90AB1|CAV1|PAK2
BIOCARTA_ACTINY_PATHWAY%MSIGDB_C2%BIOCARTA_ACTINY_PATHWAY,0.650270758122744,0.963755998259649,-0.19634921573097303,-0.8610842273862809,2881,19,ARPC5|ARPC4|RAC1|ACTR2
BIOCARTA_LONGEVITY_PATHWAY%MSIGDB_C2%BIOCARTA_LONGEVITY_PATHWAY,0.00932835820895522,0.212136117579847,-0.512279810147635,-1.8662867351224899,44,12,SOD1|IGF1R|SOD3|IGF1|SOD2|SHC1|PIK3R1|FOXO3
PID_WNT_CANONICAL_PATHWAY%MSIGDB_C2%PID_WNT_CANONICAL_PATHWAY,0.583944386248929,0.9439064862850342,0.253033185206682,0.9076816214686642,6131,18,DVL1|NKD2|APC|KLHL12|GSK3A|RANBP3|DVL3|DVL2|LRP6
SA_B_CELL_RECEPTOR_COMPLEXES%MSIGDB_C2%SA_B_CELL_RECEPTOR_COMPLEXES,0.00048320850446967903,0.0784645998831315,-0.469532747970253,-2.2062951189517097,1,23,GRB2|VAV1|LYN|VAV3|VAV2|SHC1|JUN|MAPK3|BCR|RAC1|MAP2K1
PID_INTEGRIN_A9B1_PATHWAY%MSIGDB_C2%PID_INTEGRIN_A9B1_PATHWAY,0.443566381554481,0.880909323051177,0.2689169191012,1.0166492884992702,4770,21,ITGB1|FIGF|TNC|ITGA9|SRC
BIOCARTA_SET_PATHWAY%MSIGDB_C2%BIOCARTA_SET_PATHWAY,0.9765127388535029,1.0,0.167089699910322,0.5097523725999841,9811,11,DFFB|GZMA|PRF1
BIOCARTA_ASBCELL_PATHWAY%MSIGDB_C2%BIOCARTA_ASBCELL_PATHWAY,0.7850294181738939,0.981487311948134,0.325722479594088,0.750742029874938,7204,5,FAS|HLA-DRB1|HLA-DRA|CD40|CD4
PID_PI3KCI_PATHWAY%MSIGDB_C2%PID_PI3KCI_PATHWAY,0.160038180082724,0.661454203640901,-0.20541319844846598,-1.23482474630957,502,48,CYTH2|INPP5D|ARF6|HSP90AA1|ITK|CYTH1|PIK3CD|PIK3R2|PIK3R5|BLK|NRAS|PLEKHA2|FGR|FYN|RHOA|LYN|YES1|RAP1A|KRAS|RAC1|PIK3R1|FOXO3
NABA_ECM_AFFILIATED%MSIGDB_C2%NABA_ECM_AFFILIATED,0.36505003849114703,0.850174896280676,0.19111660533361602,1.07162268634221,4741,104,FREM1|SEMA3D|MUC15|HPX|COLEC11|CLEC18A|CD209|ELFN2|LGALS2|PLXNC1|OVGP1|GPC2|C1QTNF3|ELFN1|GPC6|SEMA5A|MUC1|CLEC18B|PLXNA3|GPC1|PLXDC2|C1QTNF6|SEMA3E|SEMA4G|SEMA6A|PLXNB2|SEMA4C|PLXNB3|LGALS8|PLXNA2|C1QTNF4|C1QL1|GPC3
PID_RETINOIC_ACID_PATHWAY%MSIGDB_C2%PID_RETINOIC_ACID_PATHWAY,0.900854700854701,0.998912093067348,0.157321159766289,0.645115603333639,10012,28,RBP1|CDK1|RARB|HDAC3|CDK7|RXRB|RXRG|AKT1|NCOA3|MNAT1|KAT2B|MAPK14
PID_WNT_SIGNALING_PATHWAY%MSIGDB_C2%PID_WNT_SIGNALING_PATHWAY,0.429991166077739,0.8781703910979691,-0.23775550404151,-1.00044781500398,1946,17,LRP5|FZD1|IGFBP4|ATP6AP2|DKK1|WNT3
BIOCARTA_NO2IL12_PATHWAY%MSIGDB_C2%BIOCARTA_NO2IL12_PATHWAY,0.0828257024955787,0.5420718842622351,0.461274885182935,1.45410328214998,842,12,CD2|JAK2|CCR5|CD3D|IL12RB1|CD3G|CD3E|TYK2|CXCR3
BIOCARTA_IL7_PATHWAY%MSIGDB_C2%BIOCARTA_IL7_PATHWAY,0.461690450054885,0.8912128193953879,-0.23933401350696304,-0.9801532231924671,2102,16,PTK2B|FYN|STAT5A|BCL2|PIK3R1
BIOCARTA_IL17_PATHWAY%MSIGDB_C2%BIOCARTA_IL17_PATHWAY,0.836510119866379,0.9887548422744341,0.218695544508233,0.689406510685885,8513,12,CD2|CD3D|CD3G|CD3E|CD8A
BIOCARTA_ATM_PATHWAY%MSIGDB_C2%BIOCARTA_ATM_PATHWAY,0.293772563176895,0.8004058897916541,-0.254047050983844,-1.11411653874856,1301,19,NFKBIA|MRE11A|ABL1|GADD45A|JUN|TP53|CDKN1A
BIOCARTA_NKT_PATHWAY%MSIGDB_C2%BIOCARTA_NKT_PATHWAY,0.365340030911901,0.8507306315989871,0.32041399938903803,1.0863995591053,3781,15,CXCR4|TGFB2|CCR5|IL12RB1|TGFB3|CXCR3|CCR1|CCL4|IFNGR1|CCR7|IL4R|CCL3|TGFB1|CD4|IFNGR2
PID_THROMBIN_PAR4_PATHWAY%MSIGDB_C2%PID_THROMBIN_PAR4_PATHWAY,0.390339966832504,0.8607749921056059,-0.28606896551724104,-1.04217793693876,1882,12,GNA14|GNA11|GNG2|ROCK1|PLCB2|ROCK2|F2RL3|GNB1|GNA13|GNAQ|RHOA|GNA15
BIOCARTA_MCM_PATHWAY%MSIGDB_C2%BIOCARTA_MCM_PATHWAY,0.23007332634987102,0.743397546142977,0.339015161904945,1.21611650111819,2415,18,ORC1|CCNE1|MCM6|CDC6|ORC6|MCM3|MCM2|CDK2|ORC2|MCM7|CDT1|ORC5|ORC3
BIOCARTA_MITOCHONDRIA_PATHWAY%MSIGDB_C2%BIOCARTA_MITOCHONDRIA_PATHWAY,0.566102640386761,0.9388612723386429,0.242471600634009,0.9166718891832819,6088,21,DFFB|AIFM1|APAF1|CASP6|ENDOG
BIOCARTA_PARKIN_PATHWAY%MSIGDB_C2%BIOCARTA_PARKIN_PATHWAY,0.00867985466289867,0.20506001864802398,-0.542022914128861,-1.9074461650675902,42,11,SUMO1|SNCA|UBE2E2|UBE2F|UBE2L3|PARK2
BIOCARTA_ATRBRCA_PATHWAY%MSIGDB_C2%BIOCARTA_ATRBRCA_PATHWAY,0.158981033841577,0.661359103221672,0.344766436364066,1.30340089199093,1709,21,ATR|RAD9A|FANCG|FANCC|RAD51|FANCF|CHEK2|FANCD2|BRCA2|CHEK1|RAD17|RAD1|ATM|BRCA1
ST_G_ALPHA_I_PATHWAY%MSIGDB_C2%ST_G_ALPHA_I_PATHWAY,0.0371718221991162,0.38668501723590704,-0.30663821248830503,-1.56929805132097,142,29,ITPKB|SHC1|STAT3|DRD2|PLCB4|PLCB1|EPHB2
BIOCARTA_EPO_PATHWAY%MSIGDB_C2%BIOCARTA_EPO_PATHWAY,0.0477671628526994,0.43054641249021397,-0.360223694700832,-1.54960230062995,214,18,STAT5A|SHC1|JUN|MAPK3|MAP2K1|CSNK2A1
BIOCARTA_IGF1_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1_PATHWAY,0.014963167587476999,0.264387156924099,-0.399031352842705,-1.7804401840456499,64,20,IGF1R|GRB2|IGF1|SHC1|JUN|MAPK3|MAP2K1|CSNK2A1|PIK3R1
BIOCARTA_EIF2_PATHWAY%MSIGDB_C2%BIOCARTA_EIF2_PATHWAY,0.0551069842551474,0.457996676929382,-0.43995047184444896,-1.5482405235359902,272,11,EIF2AK4|GSK3B|EIF2AK2|EIF2S2|EIF5|EIF2S1|EIF2AK3|EIF2AK1|EIF2S3
PID_IL2_STAT5_PATHWAY%MSIGDB_C2%PID_IL2_STAT5_PATHWAY,0.350420811017598,0.842847021021096,-0.21445101058083602,-1.06865164358527,1373,27,STAT5A|BCL2|SHC1|GAB2|PIK3R1
PID_PLK1_PATHWAY%MSIGDB_C2%PID_PLK1_PATHWAY,0.0036314500464487798,0.143595610377104,0.39166472495791704,1.85774339949443,42,47,SSPO|CCNB1|CDK1|BORA|ECT2|WEE1|CDC25C|BUB1|CENPU|PRC1|CDC20|NDC80|CENPE|FBXO5|BUB1B|ERCC6L|INCENP|KIF20A|PLK1|PPP1R12A|AURKA|CLSPN|NINL|SGOL1|TPX2|SPC24|PPP2R1A
BIOCARTA_CARM_ER_PATHWAY%MSIGDB_C2%BIOCARTA_CARM_ER_PATHWAY,0.907317503751434,1.0,0.14910216035070098,0.642708414611356,10278,33,HDAC10|HIST2H3C|SRA1|HDAC8|MED1|GRIP1|HDAC3|HDAC6|CARM1|SPEN|GTF2A1|BRCA1|HDAC9|HDAC7|CCND1|HDAC2|GTF2E1|EP300|MEF2C
BIOCARTA_INFLAM_PATHWAY%MSIGDB_C2%BIOCARTA_INFLAM_PATHWAY,0.9068817204301071,1.0,-0.166322214018253,-0.663307848561086,4216,15,IL6|CXCL8|TNF
BIOCARTA_IL3_PATHWAY%MSIGDB_C2%BIOCARTA_IL3_PATHWAY,0.0510548523206751,0.443301756236231,-0.401115414574039,-1.5540273063943202,241,14,PTPN6|GRB2|IL3RA|CSF2RB|STAT5A|SHC1|MAPK3|MAP2K1
BIOCARTA_PROTEASOME_PATHWAY%MSIGDB_C2%BIOCARTA_PROTEASOME_PATHWAY,0.32046783625731,0.822183858873702,0.27217141846925197,1.11607382692069,3561,28,PSMD11|PSMA4|PSMA1|PSMC3|PSMA3|PSMC6|RPN2|PSMA5|PSMC2|PSMA2|PSMB6|PSMB3|UBA1|PSMA7|PSMB4
PID_NETRIN_PATHWAY%MSIGDB_C2%PID_NETRIN_PATHWAY,0.00488997555012225,0.161608827499482,-0.354508651914557,-1.87680091825438,17,32,BCAR1|TRIO|FYN|RHOA|UNC5B|YES1|CAMK2A|UNC5C|CDC42|MAPK3|PITPNA|RAC1|MAP2K1|PIK3R1
BIOCARTA_LECTIN_PATHWAY%MSIGDB_C2%BIOCARTA_LECTIN_PATHWAY,0.23062342038753197,0.743397546142977,0.469277440706012,1.22143058291267,2189,7,C7|C5|C4A|C4B|C2|MASP2|C3
BIOCARTA_HCMV_PATHWAY%MSIGDB_C2%BIOCARTA_HCMV_PATHWAY,0.259495060373216,0.770912532778873,-0.28168062785888204,-1.1535768412571599,1181,16,MAP2K3|MAPK3|MAP2K1|PIK3R1
BIOCARTA_ECM_PATHWAY%MSIGDB_C2%BIOCARTA_ECM_PATHWAY,0.21981939163498104,0.734713083559597,-0.258153651850076,-1.19595885202485,924,22,PFN1|FYN|RHOA|PXN|SHC1|MAPK3|MAP2K1|PIK3R1
BIOCARTA_TGFB_PATHWAY%MSIGDB_C2%BIOCARTA_TGFB_PATHWAY,0.661852921572984,0.964618776001639,-0.197617721646119,-0.8501075321055709,2978,18,SMAD2|SMAD7|MAPK3|MAP2K1
BIOCARTA_AGR_PATHWAY%MSIGDB_C2%BIOCARTA_AGR_PATHWAY,0.534405087889762,0.9265056012720759,0.22153148132877598,0.94719415071905,6049,32,ITGB1|ITGA1|NRG2|NRG3|PAK3|DVL1|CTTN|SRC|DMD|NRG1|LAMA2|GIT2|PTK2|SP1
BIOCARTA_GATA3_PATHWAY%MSIGDB_C2%BIOCARTA_GATA3_PATHWAY,0.274668325041459,0.7884684708511421,-0.315453683986742,-1.14922941390236,1324,12,PRKAR2A|MAP2K3|NFATC2|PRKAR1B
PID_P38_MKK3_6PATHWAY%MSIGDB_C2%PID_P38_MKK3_6PATHWAY,0.11869652284726,0.602329212916938,0.33857938749981703,1.3612513151660999,1303,26,TAOK3|MAPK11|MAP3K10|MAP2K6|MAP3K5|MAP3K7|GADD45B|GADD45G|MAP3K4|TAOK1|MAP3K1|TAOK2|TRAF2|ATM|TAB1
ST_WNT_BETA_CATENIN_PATHWAY%MSIGDB_C2%ST_WNT_BETA_CATENIN_PATHWAY,0.9322537112010799,1.0,0.147122831262714,0.6032960486383101,10361,28,DVL1|NKD2|DACT1|APC|PIN1|AKT3|AKT2|CXXC4|GSK3A|AKT1|RPSA|LRP1
PID_ENDOTHELIN_PATHWAY%MSIGDB_C2%PID_ENDOTHELIN_PATHWAY,0.0322357019064125,0.366156007731205,-0.231746348986267,-1.46068407605457,92,57,GNAI3|MMP1|PRKCH|ADCY7|PRKCD|GNAZ|BCAR1|PTK2B|GNAQ|GNAI2|RHOA|SLC9A1|GNAL|GNA15|CRK|CDC42|EDNRA|JUN|PRKCA|ADCY2|MAPK3|GNA12|RAC1|PLCB1|MAP2K1
PID_IL4_2PATHWAY%MSIGDB_C2%PID_IL4_2PATHWAY,0.5842155919153029,0.9439064862850342,-0.15432037820659802,-0.9305238024112241,1820,49,MYBL1|LTA|IRS1|CCL11|TFF3|CEBPB|SOCS1|STAT5B|RPS6KB1|SP1|COL1A1|AKT1|CBL|PARP14|MAPK14|JAK3|GTF3A|MYB|MTOR|STAT6|COL1A2|IL13RA2|JAK1|PIK3CA|SELP|IL2RG|IL4R|ITGB3|IRS2|DOK2|INPP5D|FES|HMGA1|SOCS3|SPI1|THY1|PTPN6|IL13RA1|GRB2|BCL2L1|ETS1|FCER2|STAT5A|SHC1|SOCS5|BCL6|PIK3R1
NABA_BASEMENT_MEMBRANES%MSIGDB_C2%NABA_BASEMENT_MEMBRANES,0.456231781644731,0.88900512246363,0.23562148930157897,1.00743828873218,5164,32,COL18A1|LAMC3|NTN5|LAMA1|LAMB2|PAPLN|COL4A2|NTN3|HMCN1|COL4A1|NTN1|LAMA2|NID1|AGRN
PID_SYNDECAN_4_PATHWAY%MSIGDB_C2%PID_SYNDECAN_4_PATHWAY,0.730640596861333,0.972575443350537,-0.161788765610737,-0.8180437683340551,2839,28,PRKCD|DNM2|RHOA|ITGA5|FGF2|MMP9|FGFR1|PRKCA|RAC1
ST_STAT3_PATHWAY%MSIGDB_C2%ST_STAT3_PATHWAY,0.613439451944388,0.9508825506493929,0.298167442796755,0.8799691557052409,6088,10,CISH|JAK2|SRC
BIOCARTA_P53_PATHWAY%MSIGDB_C2%BIOCARTA_P53_PATHWAY,0.509110867178924,0.918404893008545,-0.23179285544667497,-0.949269646424221,2318,16,GADD45A|BCL2|TP53|CDKN1A
PID_P75_NTR_PATHWAY%MSIGDB_C2%PID_P75_NTR_PATHWAY,0.12047328791681598,0.6066999390482379,-0.198716001760154,-1.27502027533449,335,61,FURIN|ARHGDIA|BEX1|IRAK1|RTN4|SQSTM1|RHOA|CASP3|NCSTN|RIPK2|RHOC|ADAM17|SHC1|TP53|YWHAE|RAC1|MYD88|PIK3R1|BCL2L11|LINGO1
ST_INTERLEUKIN_4_PATHWAY%MSIGDB_C2%ST_INTERLEUKIN_4_PATHWAY,0.646377617194738,0.963344312748158,0.22416357336040302,0.858494486931622,6976,22,CISH|PPP1R13B|JAK2|SRC|AKT3|AKT2|RPS6KB1|AKT1|TYK2|JAK3|STAT6|IARS|SOS2
BIOCARTA_ERK_PATHWAY%MSIGDB_C2%BIOCARTA_ERK_PATHWAY,0.108567018266015,0.58452352834625,-0.265677573107504,-1.3433311160159098,421,28,PPP2CA|GNGT1|SHC1|STAT3|MAPK3|GNAS|MAP2K1
BIOCARTA_DEATH_PATHWAY%MSIGDB_C2%BIOCARTA_DEATH_PATHWAY,0.765042199836646,0.9791996190968929,-0.149933774593048,-0.8019613453228491,2809,33,CASP3|TNFRSF10A|DFFA|BID|LMNA|BCL2|CFLAR|TNFRSF10B
BIOCARTA_HER2_PATHWAY%MSIGDB_C2%BIOCARTA_HER2_PATHWAY,0.0351985559566787,0.38202776391712,-0.363818911088663,-1.5955180915646598,155,19,GRB2|IL6|SHC1|STAT3|MAPK3|MAP2K1|PIK3R1
WNT_SIGNALING%MSIGDB_C2%WNT_SIGNALING,0.43555900621118,0.878651088001772,-0.150452054356385,-1.0160622602913,1121,72,HPRT1|PPP2CA|WNT6|GAPDH|WNT11|JUN|TCF7|DKK1|B2M|WNT3|SLC9A3R1|CSNK2A1|SOX17
PID_HIF1A_PATHWAY%MSIGDB_C2%PID_HIF1A_PATHWAY,0.33641696750902506,0.8311444145897029,-0.245692051591785,-1.07747591266029,1490,19,VHL|TCEB1|TP53|EGLN3
PID_NECTIN_PATHWAY%MSIGDB_C2%PID_NECTIN_PATHWAY,0.0018008747105737102,0.110460318821523,-0.410818711997984,-2.07720039148794,6,28,RAP1B|PVRL2|F11R|CTNNB1|CRK|RAP1A|CTNNA1|VAV2|CDC42|RAPGEF1|PVRL3|PTPRM|RAC1|PIK3R1
BIOCARTA_ERYTH_PATHWAY%MSIGDB_C2%BIOCARTA_ERYTH_PATHWAY,0.28857938718663,0.7980646072929201,-0.36499952630477006,-1.13457745126268,1553,8,IL11|KITLG|IL6|IGF1
BIOCARTA_BCR_PATHWAY%MSIGDB_C2%BIOCARTA_BCR_PATHWAY,0.0960420703016884,0.5684612493613671,-0.251849926934133,-1.3551759580669298,346,34,GRB2|VAV1|LYN|CALM1|SHC1|JUN|PRKCA|NFATC2|MAPK3|RAC1|MAP2K1
BIOCARTA_DNAFRAGMENT_PATHWAY%MSIGDB_C2%BIOCARTA_DNAFRAGMENT_PATHWAY,0.667942776546444,0.964618776001639,0.283356583652178,0.8362584839616249,6629,10,DFFB|ENDOG|TOP2A|TOP2B|HMGB2|CASP7|HMGB1
BIOCARTA_IL6_PATHWAY%MSIGDB_C2%BIOCARTA_IL6_PATHWAY,0.0679657794676806,0.50364937614461,-0.31644272834272497,-1.4659970115013798,285,22,SHC1|JUN|STAT3|MAPK3|MAP2K1|CSNK2A1
PID_RANBP2_PATHWAY%MSIGDB_C2%PID_RANBP2_PATHWAY,0.398465886152604,0.8638522656500329,-0.294019160901317,-1.0346900588492,1973,11,HDAC4|UBE2I|SUMO1|RANGAP1
PID_ATM_PATHWAY%MSIGDB_C2%PID_ATM_PATHWAY,0.560189656686276,0.936434965680841,0.213079559621324,0.9266840837223309,6379,34,BLM|CDC25C|RAD9A|H2AFX|DCLRE1C|XRCC4|CHEK2|FANCD2|RAD17|SMC3|ATM|MDC1|UIMC1|BRCA1|MDM2|RNF8|TP53BP1|RBBP8|RAD50|NBN|SMC1A|RFWD2
BIOCARTA_TCAPOPTOSIS_PATHWAY%MSIGDB_C2%BIOCARTA_TCAPOPTOSIS_PATHWAY,0.103517270429655,0.575794607412397,0.541690162204538,1.4099056830520902,982,7,CCR5|FAS|CD3D|CD3G|CD3E
PID_EPHA2_FWD_PATHWAY%MSIGDB_C2%PID_EPHA2_FWD_PATHWAY,0.00225631768953069,0.11976563223178699,-0.48296450846503497,-2.11802791815791,9,19,BCAR1|GRB2|RHOA|EFNA1|VAV3|VAV2|SHC1|RAC1|PIK3R1
BIOCARTA_NFKB_PATHWAY%MSIGDB_C2%BIOCARTA_NFKB_PATHWAY,0.6492395437262359,0.963755998259649,-0.18604617459995498,-0.8619036291123149,2731,22,RIPK1|MAP3K1|TRADD|CHUK|IL1R1|TAB1|TLR4|IKBKG|FADD|TNFRSF1A|MAP3K14|NFKB1|IKBKB|RELA|TRAF6|IRAK1|NFKBIA|TNFAIP3|TNFRSF1B|MYD88|TNF
PID_RET_PATHWAY%MSIGDB_C2%PID_RET_PATHWAY,0.00279955207166853,0.13060107565888002,-0.35367143878033,-1.94550839469517,9,36,DOK1|BCAR1|GRB2|RET|RHOA|PXN|CRK|RAP1A|SHC1|JUN|PRKCA|MAPK3|RAC1|DOK5|PIK3R1
BIOCARTA_AMI_PATHWAY%MSIGDB_C2%BIOCARTA_AMI_PATHWAY,0.167827804928772,0.672026878249637,0.474863178440415,1.29460442238198,1613,8,PLAT|F2R|COL4A2|COL4A1
BIOCARTA_STRESS_PATHWAY%MSIGDB_C2%BIOCARTA_STRESS_PATHWAY,0.6227917392386171,0.9536478716552259,-0.182868566082742,-0.887145045728237,2502,25,RIPK1|LTA|MAP3K1|TRAF2|CASP2|TRADD|CHUK|MAP4K2|MAPK14|IKBKG|MAP2K4|TNFRSF1A|MAPK8|MAP3K14|NFKB1|IKBKB|ATF1|RELA|NFKBIA|TANK|CRADD|MAP2K3|JUN|TNF
PID_HDAC_CLASSII_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSII_PATHWAY,0.00950828579190437,0.21235063347774397,-0.33520508213573197,-1.77460607113054,34,32,HDAC4|TUBB2A|HDAC5|UBE2I|SUMO1|CAMK4|YWHAB|HDAC11|NR3C1|RANGAP1|YWHAE|BCL6|RFXANK
PID_ALK1_PATHWAY%MSIGDB_C2%PID_ALK1_PATHWAY,0.00273699925354566,0.129967667001507,-0.424189856689265,-2.05786012255261,10,25,TGFBR1|ACVR1|ARRB2|SMAD1|SMAD7|ID1|MAPK3|ACVRL1|CAV1|FKBP1A
BIOCARTA_INSULIN_PATHWAY%MSIGDB_C2%BIOCARTA_INSULIN_PATHWAY,0.0244014732965009,0.327926916046055,-0.373875457574724,-1.66819695683635,105,20,SHC1|JUN|MAPK3|MAP2K1|CSNK2A1|PIK3R1
NABA_PROTEOGLYCANS%MSIGDB_C2%NABA_PROTEOGLYCANS,0.566147859922179,0.9388612723386429,0.24005110054712198,0.9193400306402171,6110,22,ESM1|ASPN|VCAN|HAPLN2
PID_AR_TF_PATHWAY%MSIGDB_C2%PID_AR_TF_PATHWAY,0.9903870693321991,1.0,0.101579893848071,0.47614448145988003,11641,45,SIRT1|NR2C1|MAP2K6|SRC|CARM1|POU2F1|RXRB|EHMT2|TRIM24|DNAJA1|EGR1|RXRG|ZMIZ2|APPBP2|MDM2|KAT2B|MAPK14|RCHY1|HDAC7|MAP2K4|NR2C2|KAT7
BIOCARTA_UCALPAIN_PATHWAY%MSIGDB_C2%BIOCARTA_UCALPAIN_PATHWAY,0.543373261205564,0.929698169790548,0.275758068476152,0.934988622792583,5624,15,ITGB1|ITGA1|ACTN2|SRC|SPTAN1|PTK2|TLN1
PID_HEDGEHOG_GLI_PATHWAY%MSIGDB_C2%PID_HEDGEHOG_GLI_PATHWAY,0.874542202538114,0.993707953086361,0.14903657921460098,0.690948490663538,10267,43,RBBP7|PIAS1|SSPO|GNAI1
PID_REELIN_PATHWAY%MSIGDB_C2%PID_REELIN_PATHWAY,0.180776892430279,0.6863300746827521,-0.25240722163366197,-1.23939348571573,725,26,RAP1A|LRPAP1|ARHGEF2|RAPGEF1|RELN|MAP3K11|PIK3R1
PID_TCR_PATHWAY%MSIGDB_C2%PID_TCR_PATHWAY,0.98466808024792,1.0,0.105390214119382,0.535019105278941,12073,63,PAG1|STK39|GRAP2|RASGRP2|PDPK1|PRKCB|PRKCQ|CARD11|HRAS|PLCG1|CD3D|LAT|CD3G|CD3E|ZAP70|RASGRP1|LCK|HLA-DRB1|CHUK|AKT1|NCK1|SLA2|CSK|CBL|FLNA|IKBKG|WAS
BIOCARTA_CTLA4_PATHWAY%MSIGDB_C2%BIOCARTA_CTLA4_PATHWAY,0.5337634408602151,0.9265056012720759,-0.234135305153957,-0.933752514362394,2481,15,CD3D|CD3G|CD3E|CTLA4|LCK|HLA-DRB1|CD247|HLA-DRA|PTPN11|PIK3CA|ITK|CD86|ICOSLG|GRB2|PIK3R1
PID_TOLL_ENDOGENOUS_PATHWAY%MSIGDB_C2%PID_TOLL_ENDOGENOUS_PATHWAY,0.315120113047574,0.8164430838831159,-0.24291877816988,-1.10328753219328,1337,21,BGN|CHUK|TLR4|IKBKG|HSPD1|HMGB1|TLR2|CD14|TIRAP|IKBKB|LY96|S100A9|TLR1|IRAK1|IRAK2|IRAK4|S100A8|RHOA|TICAM1|MYD88
BIOCARTA_FMLP_PATHWAY%MSIGDB_C2%BIOCARTA_FMLP_PATHWAY,0.124965287420161,0.607607158836689,-0.240611217536374,-1.30796425357293,449,35,GNA15|CALM1|MAP2K3|GNGT1|NFATC2|MAPK3|RAC1|PLCB1|MAP2K1
BIOCARTA_NEUROTRANSMITTERS_PATHWAY%MSIGDB_C2%BIOCARTA_NEUROTRANSMITTERS_PATHWAY,0.269538034039597,0.784543299601953,0.608580566890923,1.15684763738703,2327,3,PNMT|TH|DBH
BIOCARTA_FAS_PATHWAY%MSIGDB_C2%BIOCARTA_FAS_PATHWAY,0.559211116091439,0.936434965680841,0.22408363758171398,0.928229885471925,6237,29,DFFB|CASP6|MAP3K7|PARP1|RB1|LMNB1|FAS|LMNB2|PTPN13|SPTAN1|MAP3K1
BIOCARTA_HSP27_PATHWAY%MSIGDB_C2%BIOCARTA_HSP27_PATHWAY,0.852819237147595,0.991298302704726,-0.191688317228884,-0.69833976790754,4113,12,CASP3|BCL2|TNF
PID_CD8_TCR_PATHWAY%MSIGDB_C2%PID_CD8_TCR_PATHWAY,0.6713110626154101,0.964618776001639,0.17851947783795896,0.857866250437001,7997,50,PAG1|GRAP2|RASGRP2|PDPK1|PRKCB|PRKCQ|CARD11|HRAS|CD8B|PLCG1|CD3D|PRF1|LAT|CD3G|CD3E|CD8A|ZAP70|RASGRP1|LCK|CHUK|AKT1|CSK|CBL
ST_P38_MAPK_PATHWAY%MSIGDB_C2%ST_P38_MAPK_PATHWAY,0.8765227984684999,0.99438923588415,0.15332155035502,0.681683311511077,10072,37,MAPK11|MAP3K10|MAP2K6|MAPK12|MAP3K5|MAP3K7|SRF|MAP3K4|MYEF2|MAPK13|DUSP1|AKT1|MAPKAPK5|IL1R1|TAB1|ELK1|MAPK14|MKNK1
PID_ARF6_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_ARF6_DOWNSTREAM_PATHWAY,0.0298924731182796,0.35509922886098294,-0.419634186645519,-1.67353862603087,138,15,ARF6|PIP5K1A|RAB11A|KALRN|RHOA|PLAUR|MAPK3|RAC1|PLD2
PID_AJDISS_2PATHWAY%MSIGDB_C2%PID_AJDISS_2PATHWAY,0.0023564064801178198,0.12234570424564199,-0.369767271841033,-2.1029058264750202,7,40,SNX1|CREBBP|PTPN6|CBLL1|GNA13|DNM2|CTNNB1|IGF1R|ABL1|ADAM10|RET|FYN|CASP3|RIN2|CTNNA1|PTPN1|CDC42|RAB7A|GNA12|RAB5A|RAC1|MET|IGF2
PID_MET_PATHWAY%MSIGDB_C2%PID_MET_PATHWAY,0.00124069478908189,0.0929735131311543,-0.267328369298298,-1.8420563257839297,2,78,EIF4EBP1|HGF|PXN|RIN2|SNAI1|CRK|RAP1A|ETS1|CTNNA1|PTPN1|CDC42|RAPGEF1|SHC1|JUN|GAB2|MAPK3|RAB5A|RAC1|MET|MAP2K1|PIK3R1|PAK2
PID_PRL_SIGNALING_EVENTS_PATHWAY%MSIGDB_C2%PID_PRL_SIGNALING_EVENTS_PATHWAY,0.133607151485866,0.6194479383419461,-0.277815524065607,-1.3054319158028,552,23,RHOC|PTP4A3|ATF5|MAPK3|CDKN1A|RAC1|PTP4A2
BIOCARTA_PTEN_PATHWAY%MSIGDB_C2%BIOCARTA_PTEN_PATHWAY,0.123233215547703,0.607607158836689,-0.31858798840040803,-1.34058161204989,557,17,SHC1|MAPK3|PIK3R1|FOXO3
BIOCARTA_SPPA_PATHWAY%MSIGDB_C2%BIOCARTA_SPPA_PATHWAY,0.20444403123837898,0.7206891446017,0.328825361166247,1.2431351310565,2198,21,ITGB1|ITGA1|GNAI1|F2R|PLA2G4A|PRKCB|SRC|HRAS
PID_LPA4_PATHWAY%MSIGDB_C2%PID_LPA4_PATHWAY,0.9654008438818559,1.0,-0.14934586636257,-0.578605423755686,4575,14,ADCY1|ADCY6|ADCY9|ADCY5|ADCY4|CREB1|ADCY3|RPS6KA5|PRKCE|PRKACA|ADCY7|GNAL|ADCY2
ST_T_CELL_SIGNAL_TRANSDUCTION%MSIGDB_C2%ST_T_CELL_SIGNAL_TRANSDUCTION,0.670492298399275,0.964618776001639,-0.151228936542523,-0.8707871449895509,2219,42,ITPKB|NFKBIB|PRDX1|RASGRP3|EPHB2|PAK2
PID_FAK_PATHWAY%MSIGDB_C2%PID_FAK_PATHWAY,0.0145565335138795,0.262734483145539,-0.255988061196093,-1.6000931710475201,42,55,BCAR1|GRB2|FYN|RHOA|ITGA5|PXN|YES1|CRK|RAP1A|ETS1|RAPGEF1|JUN|ASAP1|RAC1|MAP2K1|PIK3R1|ARHGAP26
BIOCARTA_BARRESTIN_PATHWAY%MSIGDB_C2%BIOCARTA_BARRESTIN_PATHWAY,0.0547675334909378,0.456473845459404,-0.461170683762614,-1.56020945118971,277,10,PPARA|ARRB1|GNGT1|GNAS|PLCB1
PID_P38_GAMMA_DELTA_PATHWAY%MSIGDB_C2%PID_P38_GAMMA_DELTA_PATHWAY,0.872355430183357,0.9934031064448321,0.223549560713895,0.659752508035477,8658,10,MAP2K6|MAPK12|STMN1|MAPK13|MAPT|CCND1
PID_PI3K_PLC_TRK_PATHWAY%MSIGDB_C2%PID_PI3K_PLC_TRK_PATHWAY,0.00305470702582616,0.133833341414569,-0.362531696279198,-1.97072482478364,10,35,EPB41L1|PRKCD|NRAS|GRB2|YWHAH|CAMK2A|CAMK4|YWHAQ|YWHAB|KRAS|STAT5A|SHC1|YWHAZ|YWHAE|PIK3R1|FOXO3
BIOCARTA_TCYTOTOXIC_PATHWAY%MSIGDB_C2%BIOCARTA_TCYTOTOXIC_PATHWAY,0.632862261146497,0.958316380324396,0.28340201756963695,0.864594591607262,6358,11,CD2|CD3D|CD3G|CD3E|CD8A|CD247|PTPRC|ITGAL
PID_PTP1B_PATHWAY%MSIGDB_C2%PID_PTP1B_PATHWAY,0.0137285491419657,0.256136946817111,-0.279638207225636,-1.6537304739618301,43,46,SOCS3|TXN|BLK|DOK1|BCAR1|GRB2|FGR|FYN|RHOA|LYN|YES1|YBX1|CRK|PTPN1|LEPR|STAT5A|SHC1|STAT3|PIK3R1|CAV1
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES%MSIGDB_C2%SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,0.8140484617478899,0.986276922067025,-0.143922661482818,-0.769809281054122,2989,33,BCR|RPS6KA2|FOXO3
BIOCARTA_PML_PATHWAY%MSIGDB_C2%BIOCARTA_PML_PATHWAY,0.5286021505376339,0.9265056012720759,-0.23509224244458604,-0.9375688657692229,2457,15,CREBBP|RARA|PML|TNFRSF1B|SUMO1|TP53|TNF
ST_INTERLEUKIN_13_PATHWAY%MSIGDB_C2%ST_INTERLEUKIN_13_PATHWAY,0.9719716494845358,1.0,0.21658806524416196,0.5326668034551629,9050,6,JAK2|TYK2|IL13RA2|JAK1|IL4R
BIOCARTA_RACCYCD_PATHWAY%MSIGDB_C2%BIOCARTA_RACCYCD_PATHWAY,0.423306772908367,0.873470206885489,-0.207599232421145,-1.01937311712811,1699,26,MAPK3|CDKN1A|RAC1|PIK3R1
BIOCARTA_ETS_PATHWAY%MSIGDB_C2%BIOCARTA_ETS_PATHWAY,0.7009553432570539,0.9687491813135329,-0.19094765291963198,-0.821414378390327,3154,18,HDAC5|ETS1|ETV3|JUN|ETS2
PID_LKB1_PATHWAY%MSIGDB_C2%PID_LKB1_PATHWAY,0.0177847113884555,0.282007307615586,-0.274785554947988,-1.62503275403756,56,46,GSK3B|SMAD4|SFN|AKT1S1|YWHAG|HSP90AA1|PRKACA|SIK1|EZR|CTSD|SIK3|STK26|PRKAA1|PRKAG1|SIK2|CRTC2|ETV4|YWHAH|PSEN2|CDC37|CAB39|YWHAQ|YWHAB|MARK4|TP53|YWHAZ|YWHAE
BIOCARTA_HIVNEF_PATHWAY%MSIGDB_C2%BIOCARTA_HIVNEF_PATHWAY,0.38557398696046896,0.859630103805729,0.213547943009239,1.0601937729176099,4671,57,DFFB|APAF1|CASP6|NUMA1|MAP3K5|PARP1|RB1|TRAF1|LMNB1|FAS|LMNB2|MAP2K7|BIRC2|SPTAN1|ACTG1|CASP9|RIPK1|CDK11A|MAP3K1|TRAF2|PRKDC|PTK2|CASP2|TRADD|CHUK|XIAP|RASA1|MDM2|BIRC3|CYCS
PID_SYNDECAN_3_PATHWAY%MSIGDB_C2%PID_SYNDECAN_3_PATHWAY,0.270911086717892,0.7859916652660799,-0.278206453148846,-1.1393489281825502,1233,16,FYN|NCSTN|CXCL8|MC4R|NCAN
PID_MYC_PATHWAY%MSIGDB_C2%PID_MYC_PATHWAY,0.7807912416023891,0.981487311948134,-0.16114317676541,-0.781749285744711,3137,25,HBP1|PPP2R5A|TAF10|FBXW7|RUVBL1|PML|SUPT7L|PPP2CA|RUVBL2|PAK2
BIOCARTA_HIF_PATHWAY%MSIGDB_C2%BIOCARTA_HIF_PATHWAY,0.0983122362869198,0.570215774831708,-0.363968895942349,-1.41011185913474,465,14,HSP90AA1|HIF1A|LDHA|VEGFA|P4HB|VHL|JUN|NOS3
BIOCARTA_COMP_PATHWAY%MSIGDB_C2%BIOCARTA_COMP_PATHWAY,0.46258039368544196,0.891507554237553,0.302587436056283,1.00256620679603,4746,14,C7|C5|C4A|C4B|C2|C1QB|C1S|MASP2|C1R|C3|CFB|C1QC|C1QA
BIOCARTA_MET_PATHWAY%MSIGDB_C2%BIOCARTA_MET_PATHWAY,0.0202721466259372,0.29842401801968604,-0.298324241710211,-1.6216926547583703,72,35,PTK2B|GRB2|HGF|PXN|CRK|RAP1A|RAPGEF1|JUN|STAT3|MAPK3|MET|MAP2K1|PIK3R1
PID_CIRCADIAN_PATHWAY%MSIGDB_C2%PID_CIRCADIAN_PATHWAY,0.29395285935084997,0.8004058897916541,0.33979052435301094,1.15209783763867,3042,15,ARNTL|NPAS2|ATR|CLOCK|TIMELESS|WDR5|NONO|CHEK1
ST_FAS_SIGNALING_PATHWAY%MSIGDB_C2%ST_FAS_SIGNALING_PATHWAY,0.8007299270072991,0.9841161968820359,-0.125705433218989,-0.8139454759095951,2193,63,MAPK10|MAP3K5|CAD|PARP1|TONSL|TNFRSF6B|ALG2|FAS|PTPN13|MAP2K7|RIPK1|MAP3K1|SMPD1|MAPK9|TRAF2|TPX2|BTK|PFN2|NFAT5|XIAP|FAF1|CDK2AP1|FADD|CASP8AP2|MAP2K4|ROCK1|DIABLO|TUFM|MAPK8IP1|CASP10|NFKBIL1|BAK1|DEDD|CD7|MAPK8|NFKB2|EGFR|DAXX|MAPK1|NFKB1|CASP8|MAPK8IP2|MAPK8IP3|EZR|CSNK1A1|DEDD2|NFKBIE|HSPB1|BAX|RALBP1|NFKBIA|PFN1|CASP3|FAIM2|DFFA|AGFG1|CXCL8|NFKBIB|TP53|NCS1|BFAR|MET|EPHB2
BIOCARTA_GLEEVEC_PATHWAY%MSIGDB_C2%BIOCARTA_GLEEVEC_PATHWAY,0.0591730038022814,0.475550457504474,-0.32302924019241197,-1.49651061103463,248,22,STAT5A|JUN|MAPK3|BCR|MAP2K1|PIK3R1
PID_NFAT_TFPATHWAY%MSIGDB_C2%PID_NFAT_TFPATHWAY,0.7217787913340941,0.971401508276304,0.18507145028291103,0.8108269401902181,8228,35,PTPRK|EGR3|EGR2|GBP3|PRKCQ|CREM|FOS|PTGS2|TLE4|POU2F1|E2F1|JUNB|CTLA4|EGR1|GATA3
BIOCARTA_BARR_MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_BARR_MAPK_PATHWAY,0.0122305140961857,0.239952309092092,-0.49895067892336503,-1.81772737302818,58,12,ARRB1|GNGT1|MAPK3|GNAS|PLCB1|MAP2K1
BIOCARTA_TID_PATHWAY%MSIGDB_C2%BIOCARTA_TID_PATHWAY,0.7545706901502819,0.9771370084125129,0.22178055352676002,0.7688530344315501,7882,16,LIN7A|DNAJA3|JAK2|RB1
PID_TCR_RAS_PATHWAY%MSIGDB_C2%PID_TCR_RAS_PATHWAY,0.176160337552743,0.67909482081261,-0.325517111565779,-1.26113946682658,834,14,MAP3K8|NRAS|KRAS|PRKCA|MAPK3|MAP2K1
BIOCARTA_SALMONELLA_PATHWAY%MSIGDB_C2%BIOCARTA_SALMONELLA_PATHWAY,0.0358623548922056,0.382648509404771,-0.446258286638539,-1.62576370236409,172,12,ARPC5|ARPC4|CDC42|RAC1|ACTR2
BIOCARTA_FCER1_PATHWAY%MSIGDB_C2%BIOCARTA_FCER1_PATHWAY,0.0881858902575588,0.556932119338259,-0.249257400051937,-1.3711380424533897,314,36,GRB2|VAV1|LYN|CALM1|SHC1|JUN|NFATC2|MAPK3|MAP2K1|PIK3R1|PAK2
BIOCARTA_DC_PATHWAY%MSIGDB_C2%BIOCARTA_DC_PATHWAY,0.966419367434596,1.0,-0.17661324770895198,-0.570123390297124,4949,9,ITGAX|ANPEP
HALLMARK_G2M_CHECKPOINT%MSIGDB_C2%HALLMARK_G2M_CHECKPOINT,0.000501648272896661,0.0784645998831315,0.282268375047288,1.75063602236062,6,197,SLC12A2|CDC7|CDK1|POLE|MKI67|CDKN2C|MEIS2|CENPF|RAD54L|KIF2C|TMPO|CDKN3|MTF2|EXO1|KIF20B|LBR|E2F3|NUMA1|KIF4A|CDC45|KIF23|BIRC5|CASC5|BUB1|TOP2A|PRC1|KIF11|EZH2|TTK|HMMR|NEK2|CDC20|STIL|SMC2|SRSF1|DTYMK|TROAP|NDC80|CENPA|POLQ|NUSAP1|CENPE|E2F2|PTTG1|FBXO5|POLA2|KIF15|MCM6|ESPL1|AURKB|CDC6|FANCC|PBK|LMNB1|ARID4A|INCENP|H2AFX|CCNB2|ORC6|KIF22|H2AFZ|DBF4|MT2A|SETD8|CHAF1A|STMN1|CCNF|DMD|NASP|SRSF2|PLK1|MEIS1|SFPQ|CKS2|RACGAP1|HIST1H2BK|TRAIP|MCM3|AURKA|MCM2|BRCA2|UBE2C|SMC4|EFNA5|E2F1|PRIM2|GINS2|CHEK1|HIRA|SNRPD1|TPX2|MYBL2|PDS5B
HALLMARK_XENOBIOTIC_METABOLISM%MSIGDB_C2%HALLMARK_XENOBIOTIC_METABOLISM,0.32749428789032803,0.828303707528737,-0.13331415859035903,-1.06694161291993,429,154,CDA|TPST1|PGD|SLC6A6|HPRT1|IGF1|NQO1|SHMT2|KARS|TDO2|GSTT2|ATOH8|NINJ1|ACOX1|DDAH2|CYB5A|UPP1|GABARAPL1|CNDP2|UGDH|SMOX|GSTM4|CD36|ETS2|PC|PTGR1|PTGES|ASL
HALLMARK_BILE_ACID_METABOLISM%MSIGDB_C2%HALLMARK_BILE_ACID_METABOLISM,0.11597183767107,0.594984387754212,0.24424713712462398,1.31060424886791,1465,82,FDXR|CROT|RBP1|SLC27A2|HSD17B4|PXMP2|FADS2|ABCA5|ALDH1A1|PEX11G|ABCA9|ABCA6|HSD17B11|ALDH8A1|PEX1|AMACR|DHCR24|IDH1|ABCA2|FADS1|LIPE|GNPAT|CYP7B1
HALLMARK_PROTEIN_SECRETION%MSIGDB_C2%HALLMARK_PROTEIN_SECRETION,0.831534490849366,0.9879179006160809,-0.11234171096411999,-0.8122108195916279,1771,95,NAPA|ABCA1|VPS4B|VAMP3|CLTA|YKT6|AP2S1|TMED2|CAV2|RAB22A|RAB2A|RAB5A|GNAS|TPD52
HALLMARK_ADIPOGENESIS%MSIGDB_C2%HALLMARK_ADIPOGENESIS,0.9385180913939741,1.0,0.112973695059356,0.69643094293138,13020,189,ENPP2|GPHN|PTGER3|LPL|UQCR11|AIFM1|ATP1B3|COQ3|ELOVL6|GPAM|CDKN2C|ELMOD3|DGAT1|PREB|TST|POR|SCARB1|ACADM|ME1|DECR1|IDH1|SLC25A10|PTCD3|COX6A1|NABP1|HADH|ETFB|PRDX3|MGST3|BCKDHA|LIPE|APOE|SDPR|SLC25A1|MAP4K3|DHRS7|SUCLG1|COL4A1|DLD|COX8A|RTN3|SLC5A6|ADIPOR2|MTCH2|ARAF|COX7B|MYLK|NDUFS3|UCK1|MCCC1|CAT|COQ9|ESRRA|NDUFB7|DHCR7|RMDN3|DNAJB9|COQ5|REEP6|ADCY6|HIBCH
HALLMARK_IL2_STAT5_SIGNALING%MSIGDB_C2%HALLMARK_IL2_STAT5_SIGNALING,0.0919148936170213,0.5622489437340121,-0.147204845218215,-1.2122210991721398,107,178,CD44|CD86|CD79B|PLEC|GUCY1B3|SLC39A8|EMP1|SELL|PRAF2|AHR|FURIN|SYT11|BATF|PRKCH|PIM1|SLC1A5|RRAGD|MAP3K8|IGF1R|PLIN2|ITIH5|SLC2A3|LIF|SHE|MYO1C|IRF6|AKAP2|NRP1|IL3RA|TNFRSF1B|CASP3|ETV4|COL6A1|IFITM3|MXD1|TNFRSF18|PNP|ITGA6|PRNP|BCL2L1|GLIPR2|MAFF|SWAP70|CAPG|CDKN1C|KLF6|ALCAM|HK2|ODC1|BCL2|LRRC8C|TNFRSF4|GABARAPL1|NCS1|ARL4A|LRIG1|NT5E|SPRED2|TNFRSF21|NDRG1
HALLMARK_IL6_JAK_STAT3_SIGNALING%MSIGDB_C2%HALLMARK_IL6_JAK_STAT3_SIGNALING,0.11867862969004901,0.602329212916938,-0.185052799486375,-1.2680965641606798,290,76,CD44|IL17RA|SOCS3|PIK3R5|HAX1|IL13RA1|IL1B|PIM1|MAP3K8|HMOX1|GRB2|IL3RA|IFNAR1|TNFRSF1B|IL6|CSF2RB|PTPN1|PLA2G2A|LEPR|JUN|STAT3|CD9|ACVRL1|MYD88|CD36|TNF|TNFRSF21
HALLMARK_UNFOLDED_PROTEIN_RESPONSE%MSIGDB_C2%HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0021141649048625802,0.115553415806697,-0.22487669169400099,-1.6992130961536003,3,112,EDEM1|GEMIN4|CEBPG|MTHFD2|TSPYL2|GOSR2|PARN|FUS|SPCS1|HSPA9|WIPI1|SDAD1|EIF4E|CALR|ATF4|DNAJC3|DCP1A|DCP2|VEGFA|EIF2S1|EIF4A1|BANF1|DDIT4|HSPA5|EIF2AK3|TATDN2|TUBB2A|EXOSC4|EIF4A2|HYOU1|EIF4G1|EIF4EBP1|NOLC1|ATF6|CHAC1|NPM1|EXOSC9|NHP2|BAG3|SHC1|ATP6V0D1|YWHAZ|NFYA|SSR1|RRP9|NOP14|STC2|NOP56|DNAJA4|EXOSC5|SLC7A5
HALLMARK_SPERMATOGENESIS%MSIGDB_C2%HALLMARK_SPERMATOGENESIS,0.11411977081861699,0.5906054764147239,0.23981703398073104,1.30719666889536,1453,89,NF2|HSPA2|SIRT1|SLC12A2|CCNA1|SNAP91|CCT6B|PARP2|IDE|CDK1|KIF2C|ZC2HC1C|CDKN3|PHKG2|RFC4|PCSK4|BUB1|EZH2|CLPB|TTK|NEK2|OAZ3|CCNB2|STRBP|CNIH2|DBF4|TLE4|TOPBP1|NCAPH|PEBP1|ZC3H14|TNNI3|AURKA|CHFR
HALLMARK_PEROXISOME%MSIGDB_C2%HALLMARK_PEROXISOME,0.925845147219193,1.0,0.121678292952481,0.6685526749707211,11885,93,SLC27A2|HSD17B4|IDE|SLC25A19|ABCB4|ALDH1A1|CLN6|HSD17B11|DHCR24|TOP2A|FABP6|IDH1|FADS1|GNPAT|HRAS|CDK7|ABCC8|DLG4|EHHADH|ABCC5|ALDH9A1|IDI1|RDH11|CEL|CAT|ECI2|HMGCL|LONP2|RXRG|PEX11B|CTPS1|ABCB9|ABCB1|SLC35B2|SLC23A2|ACAA1|PEX2
HALLMARK_WNT_BETA_CATENIN_SIGNALING%MSIGDB_C2%HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.20799059929494698,0.7238327250928481,-0.212930645371292,-1.2014094469891201,707,39,NOTCH1|PPARD|FZD1|FRAT1|CTNNB1|HDAC5|NCSTN|PSEN2|WNT6|HDAC11|ADAM17|TCF7|TP53|DKK1|RBPJ
HALLMARK_APICAL_SURFACE%MSIGDB_C2%HALLMARK_APICAL_SURFACE,0.967191601049869,1.0,0.124841831232099,0.55105638808535,11054,36,GHRL|SHROOM2|RTN4RL1
HALLMARK_TGF_BETA_SIGNALING%MSIGDB_C2%HALLMARK_TGF_BETA_SIGNALING,0.0598821989528796,0.47655410709209,-0.23216082216018805,-1.41474181920346,182,51,FURIN|ID2|CDK9|CTNNB1|SKI|TGFBR1|ACVR1|RHOA|SMAD6|KLF10|SMAD1|PPM1A|SMAD7|CDKN1C|ID1|UBE2D3|FKBP1A
HALLMARK_GLYCOLYSIS%MSIGDB_C2%HALLMARK_GLYCOLYSIS,0.069204152249135,0.5054741186916171,-0.15075377520969502,-1.24470229231483,79,180,TXN|GCLC|P4HA2|SOD1|HAX1|PSMC4|LDHA|IL13RA1|VEGFA|PDK3|LHPP|TPBG|RRAGD|GNE|CAPN5|ALDH7A1|DDIT4|HSPA5|DPYSL4|SDHC|IGFBP3|CITED2|PRPS1|ME2|G6PD|MXI1|PKM|ARPP19|ENO1|TPST1|PPP2CB|PGK1|HDLBP|GAL3ST1|SLC16A3|HK2|TPI1|PYGB|HS6ST2|NDUFV3|CYB5A|RBCK1|ALDOA|FKBP4|SLC25A13|PMM2|SDC2|STC2|MET|NT5E|BIK|PC|PGAM2|STC1|AK4|HOMER1|EGLN3|ADORA2B
HALLMARK_MTORC1_SIGNALING%MSIGDB_C2%HALLMARK_MTORC1_SIGNALING,0.000975609756097561,0.0849637591935908,-0.18908223409218503,-1.5907290232898799,0,200,WARS|DDIT4|HSPA5|SC5D|SQSTM1|PFKL|SLC2A3|GPI|GMPS|RIT1|FAM129A|PSME3|G6PD|NUFIP1|CACYBP|GSR|DDIT3|PNP|ENO1|NAMPT|SLC6A6|HPRT1|RAB1A|YKT6|GAPDH|SHMT2|PGK1|SORD|ARPC5L|MAP2K3|TFRC|PSPH|HK2|TPI1|ETF1|NFKBIB|ACLY|PRDX1|CD9|PNO1|UBE2D3|TES|SSR1|CDKN1A|ALDOA|TCEA1|SLC2A1|RRP9|SRD5A1|SLC9A3R1|ACSL3|ACTR2|QDPR|SLC7A5|STC1|TRIB3|AK4|EGLN3
HALLMARK_CHOLESTEROL_HOMEOSTASIS%MSIGDB_C2%HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.9593417231364959,1.0,0.11601455891519001,0.6022488160500971,11891,70,TM7SF2|MAL2|LPL|FABP5|GNAI1|EBP|FADS2|MVD|ABCA2|ATXN2|NSDHL|TNFRSF12A|SREBF2|ACTG1|IDI1|LDLR|HMGCR|TP53INP1|ATF3|DHCR7|ACAT2|HSD17B7
HALLMARK_ANGIOGENESIS%MSIGDB_C2%HALLMARK_ANGIOGENESIS,0.178173127987254,0.6837991059383349,-0.23393554338770498,-1.23015816862095,670,31,LRPAP1|VAV2|FGFR1|THBD|S100A4|TNFRSF21|STC1
HALLMARK_P53_PATHWAY%MSIGDB_C2%HALLMARK_P53_PATHWAY,0.250440917107584,0.761997433073433,-0.13270575610667698,-1.10306496367126,283,185,MAPKAPK3|PRMT2|CTSF|TSPYL2|TPRKB|CD82|BTG1|RNF19B|MXD4|S100A10|CCNK|ZBTB16|NUDT15|IFI30|BAX|HEXIM1|ZMAT3|FBXW7|NOTCH1|CTSD|DRAM1|IRAK1|VWA5A|PMM1|PLK3|GM2A|KRT17|DNTTIP2|HMOX1|DDIT4|TCN2|LIF|CEBPA|CYFIP2|PVT1|SPHK1|CCP110|RXRA|MXD1|DDIT3|HBEGF|ABHD4|RAP2B|KIF13B|RRAD|GADD45A|HSPA4L|STOM|NINJ1|JUN|TP53|UPP1|CDKN1A|S100A4|ZNF365|SLC3A2|PLK2|CDH13|IER5|STEAP3|NDRG1|TRIB3|INHBB|FOXO3
HALLMARK_MYC_TARGETS_V2%MSIGDB_C2%HALLMARK_MYC_TARGETS_V2,0.000351864883884588,0.0784645998831315,-0.37471099948539005,-2.3793904324935697,0,58,MYBBP1A|RABEPK|PA2G4|AIMP2|NOLC1|GRWD1|RCL1|PPAN|NPM1|PRMT3|WDR43|SORD|DDX18|HK2|MRTO4|BYSL|IMP4|NIP7|RRP9|NOP56|EXOSC5|RRP12
HALLMARK_KRAS_SIGNALING_DN%MSIGDB_C2%HALLMARK_KRAS_SIGNALING_DN,0.00659256420084324,0.18227680804153196,0.289559074028296,1.6329998361847702,85,107,ARPP21|RYR2|BTG2|NR4A2|EDN1|PNMT|CCDC132|GAMT|CCNA1|TAS2R4|DLK2|ZNF112|KCND1|GPR19|ZC2HC1C|EPHA5|CPEB3|TGFB2|TENM2|CELSR2|H2AFY2|KLHDC8A|FAM46C|DTNB|RGS11|RIBC2|BMPR1B|ITGB1BP2|SIDT1|ITIH3|SLC16A7|SEPP1|SNCB|MYOT|C5|LFNG|TGM1|IFI44L|TNNI3|SKIL|TFAP2B|PTPRJ|IGFBP2|STAG3|SPTBN2|KMT2D|TG|MAGIX|CCDC106|SOX10
HALLMARK_KRAS_SIGNALING_UP%MSIGDB_C2%HALLMARK_KRAS_SIGNALING_UP,0.0171428571428571,0.277422272849102,-0.173621818369945,-1.4239156488017601,20,171,CD37|MTMR10|ID2|ZNF639|IL1B|FCER1G|VWA5A|LAPTM5|CBX8|IKZF1|TRIB1|TNFAIP3|TMEM100|LIF|SCN1B|GUCY1A3|IGFBP3|ANO1|NRP1|YRDC|TNFRSF1B|PLAU|SPARCL1|ETV4|STRN|APOD|HBEGF|TOR1AIP2|NAP1L2|MMP9|TNNT2|TRIB2|GFPT2|ETS1|CDADC1|PLAUR|MPZL2|ADAM17|MALL|RELN|MAP7|PECAM1|GABRA3|TMEM158|PLVAP|PRRX1|ACE|SLMO2|USP12|IGF2|PCP4|GPRC5B|SNAP25|EPHB2
HALLMARK_UV_RESPONSE_UP%MSIGDB_C2%HALLMARK_UV_RESPONSE_UP,0.939164337207592,1.0,0.11444165794452199,0.6806216526245411,12766,146,HSPA2|BTG2|ASNS|CYB5B|ALAS1|GGH|PARP2|NR4A1|CDC34|CLCN2|DGAT1|TST|GLS|MARK2|RFC4|KCNH2|EPHX1|TYRO3|FEN1|CCNE1|PTPRD|CLTB|CDO1|E2F5|FOS|NAT1|BSG|NPTX2|CDKN2B|H2AFX|PSMC3|DLG4|POLG2|NTRK3|RXRB|ATF3|APOM|IGFBP2|JUNB|RASGRP1|DNAJA1|POLR2H|MRPL23|UROD|CDK2|WIZ|NUPL1|HLA-F|PRPF3|ABCB1|TGFBRAP1|STARD3|NPTXR|HYAL2|MAOA|ACAA1|SIGMAR1|GPX3|TAP1|FOSB|SHOX2|CYB5R1
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY%MSIGDB_C2%HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY,0.132869345143942,0.618625028093568,-0.21294527388855103,-1.2718460828424298,419,47,TXN|GCLC|SOD1|SCAF4|ABCC1|G6PD|GSR|PRNP|SBNO2|LAMTOR5|MBP|SOD2|NQO1|PDLIM1|FTL|PRDX1|OXSR1|SRXN1
HALLMARK_HYPOXIA%MSIGDB_C2%HALLMARK_HYPOXIA,0.000862068965517241,0.0849637591935908,-0.26391112851953497,-2.18271235803844,0,181,VEGFA|PDK3|NEDD4L|PIM1|TPBG|RRAGD|PLIN2|HMOX1|TNFAIP3|DDIT4|HSPA5|PFKL|SLC2A3|DPYSL4|GPI|IGFBP3|CP|CITED2|FBP1|CCRN4L|MXI1|PTRF|DDIT3|IL6|ENO1|EFNA1|MAFF|SLC6A6|SELENBP1|ETS1|GAPDH|PGK1|PLAUR|HDLBP|HK1|CDKN1C|VHL|PPARGC1A|KLF6|HK2|TPI1|NR3C1|BCL2|JUN|PRKCA|ACKR3|TES|CDKN1A|ALDOA|BNIP3L|SLC2A1|S100A4|MYH9|SDC2|NCAN|STC2|TPD52|ADM|PGF|RBPJ|PGAM2|CAV1|STC1|NDRG1|AK4|FOXO3|ADORA2B
HALLMARK_FATTY_ACID_METABOLISM%MSIGDB_C2%HALLMARK_FATTY_ACID_METABOLISM,0.45166567519333706,0.886411023801201,0.17246029498798401,1.0146872107774498,6073,137,ACSM3|CRYZ|D2HGDH|FH|ETFDH|HSD17B4|ACADVL|ALDH1A1|INMT|ERP29|HSD17B11|DHCR24|ACADM|ME1|DECR1|EPHX1|IDH1|CPOX|ALDH3A2|HADH|BMPR1B|NSDHL|PDHA1|NCAPH2|ACOT2|SUCLG1|DLD|H2AFZ|ACSS1|MCEE|SDHA|SETD8|GSTZ1|EHHADH|ADIPOR2|OSTC|ALDH9A1|IDI1|CD1D|RDH11|CEL|ECI1|ECI2|HADHB|METAP1|ACAT2|HSD17B7|PTS|REEP6|HMGCL|HIBCH|UROD|ACADS|ACO2|G0S2|ECHS1|UROS|AADAT|ALAD|BPHL|MAOA|ACAA1|HSD17B10|NTHL1|RAP1GDS1|CRAT|CCDC58|FASN|SUCLA2|GRHPR|AOC3|MDH1|SUCLG2|HSDL2
HALLMARK_ALLOGRAFT_REJECTION%MSIGDB_C2%HALLMARK_ALLOGRAFT_REJECTION,0.99868890669386,1.0,0.0794720002249132,0.481184326506576,13710,166,CARTPT|CXCL13|CD47|IGSF6|GLMN|F2R|TAP2|CXCL9|CD2|JAK2|TGFB2|PRKCB|CDKN2A|MAP3K7|CCR5|SIT1|CCL5|GZMA|ABCE1|FAS|IL7|CCL19|APBB1|RPS19|CCL2|STAB1|CD8B|CD3D|IL12RB1|PRF1|LTB|TRAT1|CD1D|CCL11|SOCS1|HLA-DMB|CD79A|RPS3A|CD3G|CD3E|CD8A|TRAF2|ACVR2A|ZAP70|LCK|GBP2|KLRD1|CCND2|BRCA1|AKT1|CSF1|NCF4|NCK1|STAT1|IL2RA|CSK|TAP1|CXCR3|FLNA|CCR1|HLA-DOB|IL16|LY75|HDAC9|CCL4|WAS|C2|TIMP1
HALLMARK_PANCREAS_BETA_CELLS%MSIGDB_C2%HALLMARK_PANCREAS_BETA_CELLS,0.9313484476008379,1.0,0.15029566085301999,0.598906588421432,10228,25,INS|PAK3|DCX|GCK|ELP4|ABCC8|AKT3
HALLMARK_ESTROGEN_RESPONSE_LATE%MSIGDB_C2%HALLMARK_ESTROGEN_RESPONSE_LATE,0.0489795918367347,0.4351668564421479,-0.15728589221113,-1.28994066159339,59,171,SORD|SERPINA1|HSPA4L|NRIP1|PDCD4|BCL2|CD9|CXCL14|HOMER2|UGDH|FKBP4|TPSAB1|ASCL1|TRIM29|SLC9A3R1|IGSF1|KCNK5|BAG1|LAMC2|HSPB8|PCP4|OLFM1|CHST8|GAL|CAV1|PTGES|NBL1|SLC7A5|RPS6KA2
HALLMARK_MYOGENESIS%MSIGDB_C2%HALLMARK_MYOGENESIS,0.00154679040989946,0.10045645481703899,-0.194581962028245,-1.57450499169572,1,162,FKBP1B|ACSL1|FOXO4|SOD3|KLF5|MYO1C|RIT1|IGFBP3|SPHK1|HDAC5|EIF4A2|APOD|FGF2|HBEGF|PSEN2|PRNP|APLNR|TNNT2|SLC6A8|LDB3|COL15A1|MEF2D|IGF1|BIN1|MYOM1|LPIN1|NQO1|VIPR1|TEAD4|CFD|RYR1|PTP4A3|CDKN1A|SORBS3|MYH11|BDKRB2|MYH9|STC2|BAG1|MYL4|HSPB8|CD36|PC|CDH13|ITGA7|GABARAPL2|DES|TPM3|PGAM2|FABP3
HALLMARK_MYC_TARGETS_V1%MSIGDB_C2%HALLMARK_MYC_TARGETS_V1,0.000975609756097561,0.0849637591935908,-0.186256999060412,-1.5669606169970602,0,200,PCNA|PTGES3|SNRPA|POLD2|MCM5|IFRD1|EXOSC7|SNRPB2|SNRPA1|VDAC1|RANBP1|MRPS18B|HNRNPR|SRM|GLO1|SRSF7|SET|RAN|CANX|NCBP1|SRSF3|HNRNPD|FBL|KPNB1|SYNCRIP|EIF2S2|EIF4E|SNRPD3|CSTF2|MCM4|POLE3|XRCC6|PHB2|CNBP|EIF3D|APEX1|PSMC4|CCT4|LDHA|EIF2S1|EIF4A1|HNRNPA3|PSMA6|RPS3|CCT7|RPL14|PPM1G|C1QBP|PA2G4|AIMP2|GSPT1|BUB3|NOLC1|SSBP1|TCP1|HPRT1|EIF3B|RSL1D1|RUVBL2|RAD23B|TRA2B|EIF4H|SERBP1|NPM1|YWHAQ|PGK1|MRPL9|NHP2|DDX18|KARS|DDX21|CYC1|TXNL4A|EIF1AX|HNRNPC|ETF1|ODC1|UBE2L3|UBE2E1|YWHAE|NCBP2|SF3A1|PCBP1|RNPS1|RRP9|SMARCC1|DHX15|NOP56|PABPC1|HSP90AB1
HALLMARK_INTERFERON_ALPHA_RESPONSE%MSIGDB_C2%HALLMARK_INTERFERON_ALPHA_RESPONSE,0.702767175572519,0.968941691852291,-0.121926618212157,-0.886003106225792,1472,97,SLC25A28|GBP4|LPAR6|MVB12A|TRIM21|GBP2|STAT2|DHX58|TRIM14|BATF2|CSF1|PARP9|BST2|CXCL11|TAP1|PARP14|CMTR1|DDX60|PSME2|IRF9|PROCR|PNPT1|IFIH1|LAMP3|HLA-C|IRF2|C1S|EPSTI1|ISG20|SAMD9|PSME1|CD74|OAS1|USP18|IFI35|PSMB8|SP110|IFIT2|IL15|IFIT3|IRF7|IFI44|HERC6|LGALS3BP|GMPR|LY6E|UBE2L6|ADAR|IL4R|CCRL2|TMEM140|TRIM26|IRF1|RSAD2|CASP8|NMI|CASP1|ISG15|MOV10|IFI27|NUB1|FAM46A|TXNIP|PLSCR1|MX1|EIF2AK2|ELF1|SELL|PARP12|IFI30|TDRD7|CMPK2|CNP|LAP3|WARS|NCOA7|IFITM2|IFITM3|OASL|RNF31|RIPK2|HELZ2|TRIM25|B2M|OGFR|IFITM1
HALLMARK_UV_RESPONSE_DN%MSIGDB_C2%HALLMARK_UV_RESPONSE_DN,0.0100401606425703,0.21951586544159402,-0.18977673734479103,-1.5071667151602097,14,141,KALRN|SYNJ2|ICA1|LPAR1|IGF1R|ABCC1|CAP2|DLC1|RGS4|PTGFR|DYRK1A|SFMBT1|CITED2|FYN|NRP1|CDON|MGLL|RXRA|RUNX1|MAP2K5|PAPD7|PPAP2B|PPARG|LAMC1|NFIB|ATP2B4|SMAD7|VAV2|NR3C1|ID1|PRKCA|PMP22|ATRN|SDC2|PTPRM|PLCB4|MET|NR1D2|SLC7A1|DLG1|AMPH|CAV1|DDAH1|ADORA2B
HALLMARK_OXIDATIVE_PHOSPHORYLATION%MSIGDB_C2%HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9085440091670841,1.0,0.11776260234139099,0.7312860513983249,12685,199,ALAS1|NDUFA7|FH|NDUFS7|FDX1|ETFDH|UQCR11|AIFM1|ACADVL|NDUFA4|MRPS11|BDH2|ETFA|ATP5G1|NDUFS2|COX5A|POR|ATP5D|NNT|NDUFC1|TIMM13|NDUFS4|RHOT1|ACADM|DECR1|IDH1|PDHX|PDK4|MRPL35|COX6A1|ETFB|PRDX3|MGST3|NQO2|NDUFS8|BCKDHA|PDHA1|NDUFB2|SUCLG1|TCIRG1|DLD|COX8A|SDHA
HALLMARK_COAGULATION%MSIGDB_C2%HALLMARK_COAGULATION,0.936690647482014,1.0,-0.099761975033571,-0.7284383632721529,1952,99,FYN|MMP2|WDR1|PLAU|MMP9|MAFF|CFD|SERPINA1|COMP|THBD|PROC|CTSH|CD9|PECAM1|CSRP1|CTSV|VWF|RAC1
HALLMARK_ANDROGEN_RESPONSE%MSIGDB_C2%HALLMARK_ANDROGEN_RESPONSE,0.882433045846573,0.9961599252653379,-0.107503837814274,-0.7726248214441271,1943,92,UBE2J1|PTK2B|ADRM1|GUCY1A3|PA2G4|UBE2I|H1F0|GSR|SMS|ARID5B|SORD|ZBTB10|MAP7|B2M|ABCC4|HOMER2|ACSL3|TPD52|RRP12|NDRG1
HALLMARK_HEDGEHOG_SIGNALING%MSIGDB_C2%HALLMARK_HEDGEHOG_SIGNALING,0.420637081404846,0.8727872721376851,-0.19019368501866898,-1.0173023651507098,1544,33,THY1|ACHE|OPHN1|VEGFA|DPYSL2|CELSR1|PML|NRP1|NKX6-1|UNC5C|SCG2|MYH9|ETS2|TLE3
HALLMARK_INTERFERON_GAMMA_RESPONSE%MSIGDB_C2%HALLMARK_INTERFERON_GAMMA_RESPONSE,0.7059925093632958,0.968941691852291,-0.108550585202615,-0.910879573481179,753,194,FPR1|PLSCR1|MX1|VCAM1|NUP93|LYSMD2|MTHFD2|EIF2AK2|BTG1|CD86|EIF4E3|SOCS3|HIF1A|PARP12|SRI|IFI30|TDRD7|NOD1|PTPN6|CMPK2|SECTM1|CD274|ZNFX1|LAP3|PIM1|NFKBIA|TNFAIP3|WARS|IFNAR2|PML|TAPBP|IFITM2|MX2|CASP3|IFITM3|P2RY14|IL6|OASL|PNP|BANK1|RNF31|NAMPT|CSF2RB|SOD2|ICAM1|RIPK2|ARID5B|PTPN1|HELZ2|OAS3|PDE4B|TRIM25|STAT3|B2M|UPP1|OGFR|RBCK1|CDKN1A|PELI1|ARL4A|MYD88
HALLMARK_APOPTOSIS%MSIGDB_C2%HALLMARK_APOPTOSIS,0.00151515151515152,0.0987890718205679,-0.20087310068937697,-1.60400807569879,1,152,CDKN1B|EMP1|HSPB1|BAX|SOD1|DNAJC3|RNASEL|ADD1|IL1B|RARA|CLU|BTG3|PPP3R1|CTNNB1|HMOX1|SC5D|SQSTM1|MMP2|BCL10|CASP3|IFITM3|H1F0|GNA15|HGF|GSR|DDIT3|DFFA|IL6|PSEN2|CYLD|BCL2L1|SOD2|BID|CDC25B|LMNA|TIMP2|SMAD7|GADD45A|LGALS3|NEFH|PDCD4|ETF1|JUN|CFLAR|CDKN1A|GSTM1|BNIP3L|BMF|PEA15|BCAP31|BIK|TNF|BCL2L11|PMAIP1|CAV1
HALLMARK_TNFA_SIGNALING_VIA_NFKB%MSIGDB_C2%HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.00088339222614841,0.0849637591935908,-0.19586548158128303,-1.6303845903131398,0,187,B4GALT1|BTG1|CD44|GPR183|RNF19B|DUSP4|SOCS3|FUT4|NFKBIE|B4GALT5|ID2|DRAM1|ICOSLG|IL1B|SERPINB8|VEGFA|BTG3|NFKBIA|MAP3K8|TRIB1|TNFAIP3|SQSTM1|SLC2A3|LIF|SLC2A6|TUBB2A|SPHK1|YRDC|KLF10|FOSL1|PLAU|RELB|MXD1|PPAP2B|EHD1|IL6|HBEGF|REL|TANK|EFNA1|NAMPT|MAFF|PANX1|ABCA1|LITAF|SOD2|ICAM1|EIF1|TNIP1|RIPK2|GFPT2|PLAUR|MAP2K3|PDE4B|GADD45A|KLF6|NINJ1|STAT5A|JUN|ZBTB10|CFLAR|ACKR3|KLF9|BCL3|BCL6|CDKN1A|TNIP2|SNN|ETS2|PLK2|TNF|IER5|FJX1
HALLMARK_APICAL_JUNCTION%MSIGDB_C2%HALLMARK_APICAL_JUNCTION,0.417658154381892,0.8711381227605179,0.17029731382190302,1.0365143077329,5756,172,NF2|ITGB1|CDH4|CDH6|CLDN15|NFASC|NEXN|SHROOM2|GAMT|VCAN|MAPK11|CD209|CDH3|CDK8|GNAI1|MADCAM1|ACTN2|EVL|CLDN11|ITGA9|PIK3R3|CLDN7|MVD|ITGA2|SGCE|TNFRSF11B|LIMA1|KCNH2|SRC|CTNND1|FBN1|TSPAN4|ARHGEF6|LDLRAP1|HADH|PBX2|TRAF1|NF1|HRAS|TRO|PLCG1|TIAL1|CALB2|CADM2|RAC2|ACTG1|CNN2|AKT3|ITGA10|MDK|IRS1|AKT2|ADAM23|MAPK13|TAOK2|CERCAM|ITGA3|PTK2|NEGR1|MPZL1|CLDN5|ADAM9|NLGN3|CNTN1|RASA1|MYL12B|SDC3|ADAM15|MAP4K2|EPB41L2|PCDH1|CDH8|MPP5|TGFBI|SKAP2|LAMB3|MAPK14|CRAT|MYL9|IKBKG|NRXN2|RSU1|NLGN2|SYMPK
HALLMARK_NOTCH_SIGNALING%MSIGDB_C2%HALLMARK_NOTCH_SIGNALING,0.7004460303300629,0.9683987722846401,0.196227282423389,0.8227675029223521,7851,30,DTX1|DTX4|KAT2A|HES1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION%MSIGDB_C2%HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.891667867954447,0.9975851479447528,0.12090984760447199,0.745353678417184,12370,189,ITGB1|CTGF|CDH6|CYR61|ELN|VCAN|OXTR|BASP1|TNC|SERPINE2|GEM|CDH2|MEST|TFPI2|LOXL1|ITGA2|TNFRSF11B|LAMA1|MGP|FBN1|COL4A2|ITGB5|GPC1|LOXL2|GJA1|QSOX1|FAS|P3H1|FBLN5|TNFRSF12A|GADD45B|SNTB1|COL4A1|COL5A2|ACTA2|DPYSL3|EFEMP2|COL5A1|FSTL3|GAS1|APLP1|MYLK|FN1|LAMA2|GPX7|IGFBP2|TPM2|THBS2|SPARC|DAB2|FMOD|FAP|THBS1|HTRA1|COL12A1|SERPINE1|DST|BGN|COL11A1|TAGLN|PFN2|GLIPR1|COL1A1|TGM2|SAT1|DCN|FBLN2|CALD1|TPM1|MCM7|CTHRC1|LUM|COL3A1|PTX3|TGFBI|LRP1|NOTCH2|MYL9|FLNA|COL6A3|MAGEE1|FBLN1|RHOB|CALU
HALLMARK_INFLAMMATORY_RESPONSE%MSIGDB_C2%HALLMARK_INFLAMMATORY_RESPONSE,0.00076103500761035,0.0849637591935908,-0.221440647218558,-1.77503358060832,0,156,FPR1|SCARF1|RELA|EIF2AK2|CD82|TLR1|GPR183|GP1BA|GPR132|HIF1A|SELL|SRI|RHOG|PIK3R5|GNAI3|AHR|ICOSLG|IL1B|ITGB8|PCDH7|NFKBIA|CX3CL1|TPBG|LPAR1|C5AR1|ABI1|IRAK2|ADRM1|PDPN|LIF|SCN1B|MARCO|CALCRL|SPHK1|TAPBP|EMP3|ITGA5|IFNAR1|TNFRSF1B|GNA15|MXD1|IL6|HBEGF|LYN|APLNR|NAMPT|VIP|RNF144B|ABCA1|ICAM1|RIPK2|PLAUR|PDE4B|KLF6|CXCL8|NLRP3|SLC31A1|KCNA3|CDKN1A|MET|IFITM1|ADM|BDKRB1|SLC7A1|HRH1|ADORA2B
HALLMARK_HEME_METABOLISM%MSIGDB_C2%HALLMARK_HEME_METABOLISM,0.0388663967611336,0.3958587925960229,-0.16298710693698998,-1.3310346941334699,47,170,GMPS|TNS1|KDM7A|NUDT4|EIF2AK1|BMP2K|BACH1|MXI1|TSPAN5|ARL2BP|H1F0|MARCH2|SLC30A1|KLF3|SLC6A8|NFE2L1|RCL1|SELENBP1|KHNYN|ACP5|FOXJ2|YPEL5|SNCA|MAP2K3|SLC25A38|TFRC|GLRX5|NR3C1|RBM38|CIR1|BLVRA|SMOX|TCEA1|BNIP3L|SLC2A1|FBXO7|MYL4|PC|ISCA1|TFDP2|FOXO3
HALLMARK_ESTROGEN_RESPONSE_EARLY%MSIGDB_C2%HALLMARK_ESTROGEN_RESPONSE_EARLY,0.47976878612716795,0.9046812288131709,-0.12260075384846499,-1.00425209346984,580,173,FKBP4|SLC2A1|STC2|SLC9A3R1|KCNK5|LRIG1|BAG1|HSPB8|OLFM1|RRP12|PMAIP1|PTGES|NBL1|SLC7A5|RPS6KA2|INHBB
HALLMARK_MITOTIC_SPINDLE%MSIGDB_C2%HALLMARK_MITOTIC_SPINDLE,0.0824926665235744,0.5415065964181729,0.208762861549176,1.2973722370257599,1152,200,FGD6|SHROOM2|CLIP1|CENPJ|PIF1|CDK1|ARFIP2|SAC3D1|PKD2|CENPF|KLC1|ECT2|KIF2C|CDC42BPA|CKAP5|KIF20B|ATG4B|CEP131|NUMA1|KIF4A|KIF23|BIRC5|BUB1|TOP2A|PRC1|CTTN|KIF11|TTK|DLGAP5|TUBGCP3|NEK2|ANLN|APC|NDC80|NUSAP1|CDK5RAP2|CENPE|FBXO5|KIF15|ESPL1|KIFAP3|LMNB1|NF1|ALMS1|INCENP|PALLD|CEP72|MID1|CCNB2|KIF22|ARHGEF11|TUBGCP6|SASS6|HDAC6|CNTROB|CEP192|FARP1|CNTRL|PLK1|TUBGCP2|KNTC1|SPTAN1|RACGAP1|TBCD|EPB41|AURKA|CDC42EP1|BRCA2|CEP57|DYNC1H1|SMC4
HALLMARK_PI3K_AKT_MTOR_SIGNALING%MSIGDB_C2%HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0274698795180723,0.3403540236452571,-0.190815732593904,-1.3984724574885703,56,100,SQSTM1|PRKAG1|IRAK4|GRB2|PFN1|RIT1|DDIT3|SMAD2|PRKAR2A|CAB39|CAMK4|YWHAB|VAV3|PPP2R1B|MAP2K3|GNGT1|DUSP3|NFKBIB|ADCY2|UBE2D3|RALB|CDKN1A|SLC2A1|RAC1|MYD88|PLCB1|ACTR2|TRIB3
HALLMARK_COMPLEMENT%MSIGDB_C2%HALLMARK_COMPLEMENT,0.34542456718878806,0.8412612142961059,-0.128317921280788,-1.05431026080477,418,175,SH2B3|RHOG|PIK3R5|PLA2G7|GNAI3|CALM3|CTSD|ZEB1|KLK1|GZMB|CLU|LAP3|PIM1|APOBEC3F|FCER1G|CTSL|PRKCD|VCPIP1|ITGAM|TNFAIP3|HSPA5|GRB2|PFN1|CR2|CP|GNAI2|FYN|CASP3|DOCK9|EHD1|IL6|LYN|CDA|MAFF|PPP2CB|CALM1|TIMP2|RBSN|PLAUR|LGALS3|SERPINA1|CTSH|MMP12|DGKG|CSRP1|ERAP2|CTSV|RNF4|CD36|CDH13|ZFPM2|PRSS3
HALLMARK_E2F_TARGETS%MSIGDB_C2%HALLMARK_E2F_TARGETS,0.000143092222937683,0.0784645998831315,0.297758131549241,1.8504399218998602,1,200,RBBP7|CDCA3|ASF1B|CDK1|POLE|TCF19|E2F8|MKI67|CDKN2C|SPAG5|MXD3|KIF2C|WEE1|TMPO|CDKN3|LBR|KIF4A|ASF1A|BIRC5|TK1|TOP2A|PRDX4|CDKN2A|POLD1|DONSON|EZH2|HMMR|DLGAP5|CDC20|CCNE1|SRSF1|RNASEH2A|DEPDC1|UBE2T|CENPE|POLD3|KIF18B|NUP205|PTTG1|BUB1B|POLA2|MCM6|ESPL1|AURKB|MMS22L|RAD51C|LMNB1|HELLS|DUT|CDCA8|ATAD2|MELK|H2AFX|DCK|CCNB2|ORC6|KIF22|LUC7L3|H2AFZ|PSMC3IP|TIMELESS|LIG1|RAD51AP1|STMN1|DSCC1|CHEK2|NASP|SRSF2|PLK1|CKS2|PNN|RACGAP1|MCM3|NAP1L1|AURKA|NUP107|MCM2|BRCA2|CENPM|SMC4|CIT|SPC25|WDR90|DIAPH3|PRIM2|LSM8|PRKDC|EED|RRM2|CHEK1|RFC3|GINS1|CSE1L|SMC6|MYBL2|PDS5B|SPC24|SMC3|RAD1|CTPS1|PAICS|BRCA1|AK2|DNMT1|PPM1D|UBR7|HMGB3|ORC2|SUV39H1|PSIP1
HALLMARK_DNA_REPAIR%MSIGDB_C2%HALLMARK_DNA_REPAIR,0.981718061674009,1.0,0.100503800799411,0.599183732346157,13370,149,NME3|NPR2|NME4|AK6|ZWINT|SAC3D1|UPF3B|GTF2B|RFC4|GTF2H1|DDB2|REV3L|POLD1|POLR3GL|AK3|FEN1|DCTN4|POLD3|POLA2|DDB1|RAD51|DUT|VPS37B|GUK1|LIG1|SRSF6|NUDT9|TSG101|MPC2|UMPS|POLR2J|ZNRD1|ERCC5|TYMS|DGCR8|POM121|MPG|RBX1|RFC3|SNAPC5|ADCY6|SEC61A1|POLR2G|RFC5|POLR2H|TARBP2|TCEB3|CANT1|STX3|SURF1|AAAS|CSTF3|GTF3C5|POLL|RAD52|MRPL40
FANCONI ANEMIA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FANCONI ANEMIA PATHWAY,0.0008476731372382809,0.0849637591935908,0.42860878849847994,2.022509417949,9,46,FANCL|HES1|BTRC|XRCC3|FANCA|ATR|BLM|BRIP1|RFC4|RAD9A|UBE2T|FANCG|FANCC|H2AFX|FANCM|FANCF|TOPBP1|FANCD2|RMI1|FANCI|PALB2|BRCA2|CHEK1|RFC3|FAAP100|RAD17|RFC5|RAD1|ATM|BRCA1
IL8-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8-MEDIATED SIGNALING EVENTS,0.137693631669535,0.6243233125849921,-0.928429642699603,-1.24198864062175,1039,1,CXCL8
FOXA2 AND FOXA3 TRANSCRIPTION FACTOR NETWORKS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXA2 AND FOXA3 TRANSCRIPTION FACTOR NETWORKS,0.0488766620816139,0.43511944660534596,0.38855760409767204,1.5291675927308703,532,24,ALAS1|ACADVL|INS|CEBPD|KCNJ11|ACADM|DLK1|HADH|CPT1B|GCK|NF1|ABCC8|CEBPB|CPT1C|SP1|AKT1
IL5-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL5-MEDIATED SIGNALING EVENTS,0.123341625207297,0.607607158836689,-0.371820303749677,-1.35457866383071,594,12,PIM1|GRB2|LYN|CSF2RB|STAT5A|PIK3R1
SYNDECAN-4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-4-MEDIATED SIGNALING EVENTS,0.730640596861333,0.972575443350537,-0.161788765610737,-0.8180437683340551,2839,28,PRKCD|DNM2|RHOA|ITGA5|FGF2|MMP9|FGFR1|PRKCA|RAC1
BCR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BCR SIGNALING PATHWAY,0.0838235294117647,0.54493407160435,-0.201066177824504,-1.32281598144602,227,66,CALM3|PTPN6|NFKBIA|DOK1|CD19|GRB2|BCL10|LYN|FCGR2B|CALM1|ETS1|VAV2|SHC1|JUN|NFKBIB|MAPK3|RAC1|CD22|MAP2K1|CSNK2A1|PIK3R1
AURORA B SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA B SIGNALING,0.0433728681499437,0.411224194190211,0.33937734858391905,1.5203383369545298,500,38,KIF2C|KIF23|BIRC5|BUB1|SMC2|NDC80|CENPA|AURKB|INCENP|CDCA8|KIF20A|STMN1|NCAPG|NCAPH|RACGAP1|PEBP1|AURKA|PSMA3|MYLK|SMC4|KLHL9
N-CADHERIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%N-CADHERIN SIGNALING EVENTS,0.42321577339627897,0.873470206885489,-0.187055563857124,-1.01683534733812,1523,35,CALM3|LRP5|MAPRE1|CTNNB1|RHOA|CALM1|CTNNA1|PTPN1|CDC42|FGFR1|RAC1|PIK3R1
REGULATION OF TELOMERASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF TELOMERASE,0.672569569931334,0.9647315640607691,-0.137010783741316,-0.8832970480149169,1860,62,SMG6|NCL|CDKN1B|XRCC6|TERF2|PINX1|SIN3A|ZNFX1|MRE11A|IFNAR2|ABL1|MXD1|HNRNPC|JUN|YWHAE|MAPK3|SAP18|HUS1
TRK RECEPTOR SIGNALING MEDIATED BY PI3K AND PLC-GAMMA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRK RECEPTOR SIGNALING MEDIATED BY PI3K AND PLC-GAMMA,0.00305470702582616,0.133833341414569,-0.362531696279198,-1.97072482478364,10,35,EPB41L1|PRKCD|NRAS|GRB2|YWHAH|CAMK2A|CAMK4|YWHAQ|YWHAB|KRAS|STAT5A|SHC1|YWHAZ|YWHAE|PIK3R1|FOXO3
MTOR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%MTOR SIGNALING PATHWAY,0.0036764705882352897,0.143595610377104,-0.264398363558215,-1.7394789345836899,9,66,RRN3|MAPKAP1|EIF4A1|RRAGD|EEF2K|NRAS|DDIT4|RRAGC|RB1CC1|PML|ATG13|EIF4EBP1|YWHAH|PRR5|YWHAQ|YWHAB|EIF4B|PPARGC1A|PDCD4|KRAS|PRKCA|YWHAZ|YWHAE|MAPK3|PLD2|MAP2K1
ROLE OF CALCINEURIN-DEPENDENT NFAT SIGNALING IN LYMPHOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ROLE OF CALCINEURIN-DEPENDENT NFAT SIGNALING IN LYMPHOCYTES,0.000663129973474801,0.0806484601749226,-0.372832103940239,-2.28350213413229,1,52,GSK3B|PRKCE|SFN|RAN|YWHAG|KPNB1|PRKACA|NFATC3|CSNK1A1|CREBBP|CALM3|PRKCH|PIM1|PRKCD|MAP3K8|CASP3|YWHAH|CHP1|BCL2L1|MEF2D|CALM1|CAMK4|YWHAQ|YWHAB|BCL2|PRKCA|NFATC2|YWHAZ|YWHAE|MAPK3|FKBP8|RCAN2|CSNK2A1|FKBP1A
IL6-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL6-MEDIATED SIGNALING EVENTS,0.5323520392517629,0.9265056012720759,-0.164215511054595,-0.949331647830262,1735,43,PRKCD|GRB2|VAV1|MITF|FOXO1|IL6|BCL2L1|JUN|STAT3|GAB2|RAC1|PIK3R1
SIGNALING EVENTS MEDIATED BY THE HEDGEHOG FAMILY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY THE HEDGEHOG FAMILY,0.40636663007683893,0.8664565508572991,-0.248567722272617,-1.01796836394935,1850,16,HHAT|PTHLH|ARRB2|BOC|CDON|LRPAP1|PIK3R1
SYNDECAN-3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-3-MEDIATED SIGNALING EVENTS,0.6265117607846871,0.954674488895214,0.244114115264573,0.875687099246478,6578,18,FGFR4|FGF19|CTTN|SRC|CASK
ATYPICAL NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATYPICAL NF-KAPPAB PATHWAY,0.4244725738396621,0.874230853794136,-0.261361533031939,-1.01258377119223,2011,14,NFKBIA|ARRB2|REL|BCL3|PIK3R1
ARF1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF1 PATHWAY,0.237138989169675,0.7507739897770379,-0.267519863997407,-1.17320119941968,1050,19,CLTA|COPA|ASAP1|RAC1|PLD2
EGFR-DEPENDENT ENDOTHELIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EGFR-DEPENDENT ENDOTHELIN SIGNALING EVENTS,0.624512534818942,0.953845991804527,-0.277260519189835,-0.8618464149334399,3362,8,GRB2|EDNRA|SHC1
ATR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATR SIGNALING PATHWAY,0.0264700810484566,0.3377111602831,0.3539571931434529,1.5964382784999298,306,39,BTRC|ATR|RFC4|CDC25C|PPP2R2B|RAD9A|CDC6|RAD51|CEP164|TIMELESS|TOPBP1|FANCD2|PLK1|MCM2|BRCA2|CLSPN|CHEK1|RFC3|RAD17|RFC5|PPP2R1A|RAD1|CDK2|MDM2|MCM7|CCNA2
S1P3 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P3 PATHWAY,0.0990296093555611,0.570215774831708,-0.28174553666953495,-1.36682406586667,397,25,GNAI3|VEGFA|GNA13|GNAZ|GNAQ|GNAI2|RHOA|GNA15|MAPK3|FLT1|GNA12|RAC1
SHP2 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SHP2 SIGNALING,0.172927461139896,0.676682497340677,-0.199906289227583,-1.21092449778619,533,50,FRS2|IL6ST|PRKACA|NTRK1|IL6R|GNAI3|VEGFA|KDR|IGF1R|NRAS|GRB2|RHOA|IL6|KRAS|SHC1|GAB2|NOS3|SDC2|MAP2K1|PIK3R1
IL2 SIGNALING EVENTS MEDIATED BY PI3K%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2 SIGNALING EVENTS MEDIATED BY PI3K,0.0188836434323799,0.286396032442422,-0.30170035218805796,-1.6400452148191598,67,35,BCL2L1|CALM1|BCL2|EIF3A|SHC1|GAB2|RAC1|PIK3R1|FOXO3
EPHA FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHA FORWARD SIGNALING,0.0624004248539565,0.48722934276585206,-0.278367354433846,-1.4638043880603302,234,31,CDK5|CRKL|BLK|FGR|FYN|RHOA|LYN|EFNA1|YES1|CRK|VAV3|VAV2|EPHA8|EPHA7
P38 MAPK SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P38 MAPK SIGNALING PATHWAY,0.234603316898252,0.748317706308157,0.29035684692001196,1.2027558355940702,2616,29,TAOK3|MAPK11|MAP3K10|MAP2K6|MAP3K5|MAP3K7|GADD45B|GADD45G|MAP3K4|TAOK1|MAP3K1|TAOK2|TRAF2|ATM|TAB1
REELIN SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REELIN SIGNALING PATHWAY,0.16446877332669801,0.6666097295798941,-0.25995067005675604,-1.2610912526663602,660,25,RAP1A|LRPAP1|ARHGEF2|RAPGEF1|RELN|MAP3K11|PIK3R1
IL3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL3-MEDIATED SIGNALING EVENTS,0.008542836221625579,0.20298122046820802,-0.386790498190191,-1.8540655490522098,34,24,PIM1|GRB2|IL3RA|BCL2L1|CSF2RB|STAT5A|SHC1|ID1|YWHAZ|GAB2|PIK3R1
VEGFR1 SPECIFIC SIGNALS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGFR1 SPECIFIC SIGNALS,0.0392513646997661,0.396089810860281,-0.304487334127862,-1.55829039121142,150,29,CALM1|PRKCA|NOS3|MAPK3|FLT1|PGF|PIK3R1|CAV1
ARF6 TRAFFICKING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 TRAFFICKING EVENTS,0.799165318116004,0.9839175016931591,0.16332769259990698,0.757203521982129,9382,43,ITGB1|ITGA1|INS|ITGA9|KLC1|AGTR1|ITGA2|ITGA4|CTNND1|ITGA11
CALCIUM SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CALCIUM SIGNALING IN THE CD4+ TCR PATHWAY,0.14201601507301,0.63219683908033,-0.287990076823758,-1.3079921756103898,602,21,FOSL1|CHP1|CALM1|JUN|NFATC2|RCAN2|FKBP1A
INTEGRIN FAMILY CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRIN FAMILY CELL SURFACE INTERACTIONS,0.359101329665291,0.8472826785278371,0.276773000031916,1.08923953032539,3915,24,ITGB1|ITGA1|ITGA9|ITGA2|ITGA4|ITGA11|ITGB5|ITGA2B|ITGA10|ITGA3|ITGA8
RAPID GLUCOCORTICOID SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAPID GLUCOCORTICOID SIGNALING,0.9747322449828429,1.0,0.19037830301675898,0.5190223293802929,9373,8,MAPK11|MAPK9|MAPK14|GNG2
VEGFR3 SIGNALING IN LYMPHATIC ENDOTHELIUM%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGFR3 SIGNALING IN LYMPHATIC ENDOTHELIUM,0.36337976873349703,0.849828746111777,0.271927163959955,1.08359063157278,3990,25,ITGB1|FIGF|MAPK11|ITGA1|ITGA2|ITGA4
GLYPICAN 3 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 3 NETWORK,0.765480202190396,0.9792236089291529,0.289677488151269,0.753969640383672,7268,7,BMP4|GPC3|MAPK9|PTCH1
GMCSF-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GMCSF-MEDIATED SIGNALING EVENTS,0.00664267921394963,0.18239572673498103,-0.338140082837984,-1.81949352258753,23,34,PIM1|NRAS|GRB2|LYN|CSF2RB|KRAS|STAT5A|SHC1|STAT3|YWHAZ|GAB2|MAPK3|MAP2K1|PIK3R1
PROTEOGLYCAN SYNDECAN-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PROTEOGLYCAN SYNDECAN-MEDIATED SIGNALING EVENTS,0.5636423513914051,0.9377667552605741,-0.391375306077058,-0.900081442811871,3422,4,SDC2
RAC1 SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAC1 SIGNALING PATHWAY,0.00420984455958549,0.15257126011092098,-0.30930184838428804,-1.8735838020218,12,50,PIP5K1A|ARPC1B|NCF2|CYBA|ARHGAP5|ARHGDIA|CTNNB1|ABI1|BCAR1|CYFIP2|ARPC5|CRK|CTNNA1|LIMK1|ARPC4|MAP2K3|STAT5A|JUN|STAT3|RAC1|MAP3K11|ACTR2|BRK1|PAK2
EPHA2 FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHA2 FORWARD SIGNALING,0.00225631768953069,0.11976563223178699,-0.48296450846503497,-2.11802791815791,9,19,BCAR1|GRB2|RHOA|EFNA1|VAV3|VAV2|SHC1|RAC1|PIK3R1
NETRIN-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NETRIN-MEDIATED SIGNALING EVENTS,0.00488997555012225,0.161608827499482,-0.354508651914557,-1.87680091825438,17,32,BCAR1|TRIO|FYN|RHOA|UNC5B|YES1|CAMK2A|UNC5C|CDC42|MAPK3|PITPNA|RAC1|MAP2K1|PIK3R1
ALPHA9 BETA1 INTEGRIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA9 BETA1 INTEGRIN SIGNALING EVENTS,0.443566381554481,0.880909323051177,0.2689169191012,1.0166492884992702,4770,21,ITGB1|FIGF|TNC|ITGA9|SRC
CANONICAL NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CANONICAL NF-KAPPAB PATHWAY,0.0922053231939164,0.5622489437340121,-0.302610987943018,-1.40191814896588,387,22,IKBKB|ERC1|RAN|RELA|TRAF6|NFKBIA|TNFAIP3|BCL10|CYLD|RIPK2|PRKCA|UBE2D3|TNF
VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL REPRESSION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL REPRESSION,0.011963406052075999,0.23670963874364498,-0.25512160959580604,-1.6200055985233701,33,58,MXD4|SPI1|LGALS1|CDKN1B|ID2|CLU|CEBPA|FTH1|TJP2|DDIT3|ITGA6|SMAD2|SLC11A1|GADD45A|BCL2|CSDE1|CFLAR|DKK1|NFYA|CDKN1A|TMEFF2|NDRG1|FOXO3
NONGENOTROPIC ANDROGEN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NONGENOTROPIC ANDROGEN SIGNALING,0.353002339485313,0.842847021021096,-0.207979764866637,-1.06438867181909,1357,29,CDC42|MAPK3|RAC1|PLCB1|MAP2K1|PIK3R1
FAS (CD95) SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FAS (CD95) SIGNALING PATHWAY,0.40021072965141796,0.8638522656500329,0.24125209312366697,1.04920657457575,4557,34,MAPK11|MAP2K6|MAPK10|PDPK1|SRC|FAS|MAP2K7|BIRC2|RIPK1|CLTC|MAP3K1|SMPD1|MAPK9|BTK|CHUK|AKT1|BIRC3|MAPK14|IKBKG|FADD
ALPHA-SYNUCLEIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA-SYNUCLEIN SIGNALING,0.00102907126318498,0.0872881177264294,-0.425130797925519,-2.1495658160011004,3,28,BLK|PRKCD|PTK2B|FGR|FYN|STUB1|LYN|YES1|SNCA|UCHL1|UBE2L3|PARK2|PLD2|CSNK2A1|FKBP1A
DNA-PK PATHWAY IN NONHOMOLOGOUS END JOINING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DNA-PK PATHWAY IN NONHOMOLOGOUS END JOINING,0.410493220672038,0.867015886388254,0.330995901887245,1.04341736949663,4177,12,LIG4|PNKP|DCLRE1C|XRCC4|PRKDC|POLL|APLF
SIGNALING EVENTS MEDIATED BY VEGFR1 AND VEGFR2%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY VEGFR1 AND VEGFR2,0.000370644922164566,0.0784645998831315,-0.29882906590025604,-1.98882355264994,0,68,NCK2|CALM3|PTPN6|VEGFA|KDR|PRKCD|DNM2|CTNNB1|PTK2B|GRB2|FYN|RHOA|CDH5|PXN|CALM1|CTNNA1|CDC42|MAP2K3|SHB|NEDD4|PRKCA|NOS3|MAPK3|FLT1|MAP2K1|PIK3R1|HSP90AB1|CAV1|PAK2
SIGNALING EVENTS MEDIATED BY HDAC CLASS III%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS III,0.0431505068884845,0.409991706586456,-0.30120921256194705,-1.54151378093953,165,29,HIST1H4E|CREBBP|XRCC6|BAX|FOXO4|HDAC4|TUBB2A|HIST2H4A|FOXO1|MEF2D|PPARGC1A|TP53|CDKN1A|HIST2H4B|FOXO3
ALPHA4 BETA1 INTEGRIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA4 BETA1 INTEGRIN SIGNALING EVENTS,0.42977451779407794,0.8780284177741771,-0.191248920625947,-1.0124891110766099,1581,32,CD81|PRKAR1A|ARF6|PRKACA|VCAM1|ADAM28|ABI1|BCAR1|PTK2B|PXN|JAM2|CRK|YWHAZ|PRKAR1B|RAC1|PTPRA
P75(NTR)-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P75(NTR)-MEDIATED SIGNALING,0.24991112691077103,0.7613646381106121,-0.17858726140013895,-1.1423323294711298,702,60,FURIN|ARHGDIA|BEX1|IRAK1|RTN4|SQSTM1|RHOA|CASP3|NCSTN|RIPK2|RHOC|ADAM17|SHC1|TP53|YWHAE|RAC1|MYD88|PIK3R1|BCL2L11
WNT SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%WNT SIGNALING NETWORK,0.256860592755214,0.7674783969184241,-0.282094664204807,-1.1552724592474,1169,16,LRP6|CTHRC1|ROR2|FZD2|KREMEN1|FZD4|FZD8|FZD5|FZD7|LRP5|FZD1|IGFBP4|ATP6AP2|DKK1|WNT3
TRK RECEPTOR SIGNALING MEDIATED BY THE MAPK PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRK RECEPTOR SIGNALING MEDIATED BY THE MAPK PATHWAY,0.22679008984481397,0.7398172623753029,-0.22006401605816603,-1.1770719096092,832,33,CDK5|RAP1B|MAPK7|PRKCD|NRAS|RIT1|MAP2K5|EHD4|RAP1A|MAP2K3|KRAS|MAPK3|MAP2K1
ARF6 DOWNSTREAM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 DOWNSTREAM PATHWAY,0.0298924731182796,0.35509922886098294,-0.419634186645519,-1.67353862603087,138,15,ARF6|PIP5K1A|RAB11A|KALRN|RHOA|PLAUR|MAPK3|RAC1|PLD2
SIGNALING EVENTS REGULATED BY RET TYROSINE KINASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS REGULATED BY RET TYROSINE KINASE,0.00279955207166853,0.13060107565888002,-0.35367143878033,-1.94550839469517,9,36,DOK1|BCAR1|GRB2|RET|RHOA|PXN|CRK|RAP1A|SHC1|JUN|PRKCA|MAPK3|RAC1|DOK5|PIK3R1
EFFECTS OF BOTULINUM TOXIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EFFECTS OF BOTULINUM TOXIN,0.87372330547818,0.9934031064448321,-0.218045816319511,-0.677781335890595,4704,8,VAMP2|SNAP25
NECTIN ADHESION PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NECTIN ADHESION PATHWAY,0.0018008747105737102,0.110460318821523,-0.410818711997984,-2.07720039148794,6,28,RAP1B|PVRL2|F11R|CTNNB1|CRK|RAP1A|CTNNA1|VAV2|CDC42|RAPGEF1|PVRL3|PTPRM|RAC1|PIK3R1
STABILIZATION AND EXPANSION OF THE E-CADHERIN ADHERENS JUNCTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%STABILIZATION AND EXPANSION OF THE E-CADHERIN ADHERENS JUNCTION,0.0289771080846132,0.34951921849182693,-0.276413050219117,-1.5472821568658501,99,38,CTNNB1|IGF1R|ABI1|VASP|CYFIP2|RHOA|EXOC3|HGF|EFNA1|EXOC4|CTNNA1|ZYX|AQP5|MET
IGF1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IGF1 PATHWAY,0.0454899922017156,0.4190278528102411,-0.29887217371787606,-1.52955339780887,174,29,CRKL|NCK2|PRKCD|IGF1R|BCAR1|GRB2|PXN|CRK|PTPN1|SHC1|YWHAZ|YWHAE|PIK3R1
SIGNALING EVENTS MEDIATED BY HEPATOCYTE GROWTH FACTOR RECEPTOR (C-MET)%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HEPATOCYTE GROWTH FACTOR RECEPTOR (C-MET),0.0012330456226880401,0.0929735131311543,-0.270508171427713,-1.85761368713918,2,77,EIF4EBP1|HGF|PXN|RIN2|SNAI1|CRK|RAP1A|ETS1|CTNNA1|PTPN1|CDC42|RAPGEF1|SHC1|JUN|GAB2|MAPK3|RAB5A|RAC1|MET|MAP2K1|PIK3R1|PAK2
ATM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATM PATHWAY,0.560189656686276,0.936434965680841,0.213079559621324,0.9266840837223309,6379,34,BLM|CDC25C|RAD9A|H2AFX|DCLRE1C|XRCC4|CHEK2|FANCD2|RAD17|SMC3|ATM|MDC1|UIMC1|BRCA1|MDM2|RNF8|TP53BP1|RBBP8|RAD50|NBN|SMC1A|RFWD2
TCR SIGNALING IN NAIVE CD8+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TCR SIGNALING IN NAIVE CD8+ T CELLS,0.6713110626154101,0.964618776001639,0.17851947783795896,0.857866250437001,7997,50,PAG1|GRAP2|RASGRP2|PDPK1|PRKCB|PRKCQ|CARD11|HRAS|CD8B|PLCG1|CD3D|PRF1|LAT|CD3G|CD3E|CD8A|ZAP70|RASGRP1|LCK|CHUK|AKT1|CSK|CBL
LPA RECEPTOR MEDIATED EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LPA RECEPTOR MEDIATED EVENTS,0.00144560896277557,0.0961252072968491,-0.287634182755778,-1.8543534866281297,3,62,GNA13|ADCY7|NFKBIA|PRKCD|GNAZ|LPAR1|BCAR1|PTK2B|GNAQ|GNAI2|RHOA|ADRA1B|MMP2|CASP3|GNA15|PXN|HBEGF|LYN|MMP9|CRK|CXCL8|JUN|ADCY2|GNA12|RAC1|PLD2|PIK3R1
RXR AND RAR HETERODIMERIZATION WITH OTHER NUCLEAR RECEPTOR%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RXR AND RAR HETERODIMERIZATION WITH OTHER NUCLEAR RECEPTOR,0.126842232423291,0.6076669536424699,-0.279821093722991,-1.314855919911,524,23,PPARD|RARA|NR1H3|PPARA|RXRA|PPARG|ABCA1|NR1H2|BCL2|TNF
NOTCH SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NOTCH SIGNALING PATHWAY,0.9851049424509141,1.0,-0.0908299250969933,-0.567746566755415,2909,55,MYCBP|DNM1|SPEN|MFAP2|GATA3|SKP2|CNTN1|NEURL1|YY1|DLL4|JAG1|CBL|NOTCH2|NCOR1|CCND1|RBBP8|MIB1|EPS15|EP300|ADAM12|CUL1|MYC|NUMB|MAML2|HDAC1|LNX1|APH1A|NCOR2|NOTCH3|PSENEN|SKP1|NOTCH4|DNER|APH1B|RAB11A|DLL1|ITCH|FBXW7|NOTCH1|FURIN|CTBP1|ADAM10|MFAP5|NCSTN|ENO1|CDKN1A|DLL3|RBPJ
DIRECT P53 EFFECTORS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DIRECT P53 EFFECTORS,0.00248601615910503,0.12586582153175,-0.21098005195260397,-1.64070793859601,3,129,CD82|CREBBP|TAF9|SNAI2|PYCARD|CCNK|CEBPZ|BAX|MLH1|CTSD|TP53BP2|PLK3|CX3CL1|DDIT4|GDF15|LIF|HSPA1B|BBC3|PML|ZNF385A|RRM2B|IGFBP3|MMP2|TNFRSF10D|TNFRSF10A|HGF|BCL2L1|RNF144B|POU4F2|BID|MAP4K4|PPM1J|GADD45A|TP53I3|BCL2|JUN|PMS2|TP53|DKK1|TADA2B|TNFRSF10B|HTT|NFYA|BCL6|CDKN1A|BNIP3L|BDKRB2|MET|JMY|PMAIP1|STEAP3|CAV1|NDRG1
BETA5 BETA6 BETA7 AND BETA8 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA5 BETA6 BETA7 AND BETA8 INTEGRIN CELL SURFACE INTERACTIONS,0.348329664018379,0.842847021021096,0.316681401846916,1.09784853940614,3638,16,CYR61|MADCAM1|ITGA4|FBN1|ITGB5
POSTTRANSLATIONAL REGULATION OF ADHERENS JUNCTION STABILITY AND DISSASSEMBLY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%POSTTRANSLATIONAL REGULATION OF ADHERENS JUNCTION STABILITY AND DISSASSEMBLY,0.0023564064801178198,0.12234570424564199,-0.369767271841033,-2.1029058264750202,7,40,SNX1|CREBBP|PTPN6|CBLL1|GNA13|DNM2|CTNNB1|IGF1R|ABL1|ADAM10|RET|FYN|CASP3|RIN2|CTNNA1|PTPN1|CDC42|RAB7A|GNA12|RAB5A|RAC1|MET|IGF2
VALIDATED NUCLEAR ESTROGEN RECEPTOR ALPHA NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED NUCLEAR ESTROGEN RECEPTOR ALPHA NETWORK,0.9943559096945551,1.0,0.0964733340510022,0.474290131846004,11979,55,COL18A1|SAFB|DSCAM|UBA3|MTA1|PDIA2|SRA1|DDX17|MED1|APBB1|LCOR|CEBPB|ABCA3|MPG|CHUK|BRCA1|GREB1|NCOA3
ERBB1 DOWNSTREAM SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB1 DOWNSTREAM SIGNALING,0.00048614487117160896,0.0784645998831315,-0.268815144530085,-1.97453078598077,0,101,MAPK7|PRKCD|ABI1|NRAS|GRB2|CYFIP2|SLC9A1|MAP2K5|YWHAH|SMAD1|BCL2L1|ARPC5|PPP2CA|CALM1|RALA|YWHAQ|YWHAB|VAV2|ARPC4|CDC42|KRAS|JUN|PRKCA|STAT3|YWHAZ|YWHAE|MAPK3|RAB5A|RAC1|PLD2|ACTR2|BRK1|MAP2K1|PIK3R1
INTERNALIZATION OF ERBB1%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTERNALIZATION OF ERBB1,0.0233618233618234,0.321093965761153,-0.28778517507234996,-1.59863409913959,81,37,CDC42|KRAS|SHC1|UBE2D3|RAB5A|LRIG1|PIK3R1|AMPH
VISUAL SIGNAL TRANSDUCTION: RODS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VISUAL SIGNAL TRANSDUCTION: RODS,0.263396375098503,0.77467054856079,-0.34449474174437394,-1.16547727528882,1336,10,PDE6B|GNB5|GNGT1|GUCA1A
CDC42 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CDC42 SIGNALING EVENTS,0.0058330295297119895,0.175005706363229,-0.259403507782626,-1.69003095282175,15,64,ARPC5|YES1|CTNNA1|LIMK1|VAV2|ARPC4|CDC42|MAP2K3|JUN|MAPK3|RAC1|MAP3K11|ACTR2|PIK3R1|DLG1|PAK2
REGULATION OF CYTOPLASMIC AND NUCLEAR SMAD2 3 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF CYTOPLASMIC AND NUCLEAR SMAD2 3 SIGNALING,0.0810018050541516,0.5374028338839121,-0.327212234466081,-1.43498049155752,358,19,SMAD4|SMAD3|KPNB1|CTDSP2|CALM3|UBE2I|SMAD2|CALM1|PPM1A|MAPK3
OSTEOPONTIN-MEDIATED EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%OSTEOPONTIN-MEDIATED EVENTS,0.00159320233669676,0.10266546263826899,-0.406329357845686,-2.1366970211789,5,31,RELA|PIP5K1A|CD44|NFKBIA|BCAR1|PTK2B|RHOA|MMP2|PLAU|MMP9|VAV3|CDC42|JUN|MAPK3|RAC1|PIK3R1
INTEGRINS IN ANGIOGENESIS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRINS IN ANGIOGENESIS,0.5737982396750171,0.941417936126209,-0.149929118597387,-0.9371552629756551,1694,55,COL4A1|COL5A2|COL5A1|COL11A2|IRS1|FN1|RPS6KB1|PTK2|TLN1|COL11A1|CSF1R|COL1A1|AKT1|CSF1|CBL|COL3A1|MFGE8|PIK3C2A|COL6A3|ADGRA2|ROCK1|VCL|COL1A2|VTN|SPP1|PTPN11|PIK3CA|TGFBR2|ITGB3|ITGAV|PI4KB|MAPK1|CASP8|COL7A1|SDC1|HSP90AA1|CDKN1B|COL6A2|EDIL3|VEGFA|KDR|F11R|IGF1R|BCAR1|PTK2B|RHOA|COL6A1|FGF2|PXN|VAV3|MAPK3|RAC1|PIK3R1
NOTCH-MEDIATED HES HEY NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NOTCH-MEDIATED HES HEY NETWORK,0.7929815485428521,0.9819233677232551,0.168074402872757,0.758058927971386,9196,39,GAA|HES1|MAML1|BGLAP|JAK2|PARP1|RB1|HES6|HEY2|KDM1A|GATA6|E2F1|TLE1|SPEN
ENDOTHELINS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ENDOTHELINS,0.0322357019064125,0.366156007731205,-0.231746348986267,-1.46068407605457,92,57,GNAI3|MMP1|PRKCH|ADCY7|PRKCD|GNAZ|BCAR1|PTK2B|GNAQ|GNAI2|RHOA|SLC9A1|GNAL|GNA15|CRK|CDC42|EDNRA|JUN|PRKCA|ADCY2|MAPK3|GNA12|RAC1|PLCB1|MAP2K1
CXCR4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CXCR4-MEDIATED SIGNALING EVENTS,0.00965575146935348,0.21484293761490603,-0.225899320603019,-1.5716000964739298,22,81,ITCH|RAP1B|GNAI3|PTPN6|BLK|MAPKAP1|GNA13|GNAZ|BCAR1|PTK2B|ARRB2|FGR|VAV1|VPS4A|GNAI2|FYN|RHOA|FOXO1|PXN|LYN|MMP9|YES1|VPS4B|CRK|RHOC|LIMK1|CDC42|STAT5A|STAT3|RALB|RAC1|PLCB1|PIK3R1
PDGFR-ALPHA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGFR-ALPHA SIGNALING PATHWAY,0.00276243093922652,0.129967667001507,-0.463406733813115,-2.06767704983686,11,20,CRK|SHB|RAPGEF1|SHC1|JUN|CSNK2A1|PIK3R1|CAV1
SIGNALING BY AURORA KINASES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING BY AURORA KINASES,0.218941762185944,0.7342840266426529,0.6361396927508821,1.2092346365355902,1890,3,AURKB|AURKA|AURKC
REGULATION OF P38-ALPHA AND P38-BETA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF P38-ALPHA AND P38-BETA,0.108122362869198,0.58452352834625,-0.26038130938228304,-1.35086657758945,409,30,FGR|FYN|LYN|YES1|RALA|CDC42|MAP2K3|RALB|DUSP10|RAC1|PAK2
PAR4-MEDIATED THROMBIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PAR4-MEDIATED THROMBIN SIGNALING EVENTS,0.390339966832504,0.8607749921056059,-0.28606896551724104,-1.04217793693876,1882,12,GNA14|GNA11|GNG2|ROCK1|PLCB2|ROCK2|F2RL3|GNB1|GNA13|GNAQ|RHOA|GNA15
BETA2 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA2 INTEGRIN CELL SURFACE INTERACTIONS,0.260931558935361,0.771967970256231,-0.24907665624112602,-1.1539074877675,1097,22,ITGB2|FCGR2A|JAM3|VCAM1|GP1BA|THY1|F11R|ITGAX|ITGAM|PLAU|ICAM1|PLAUR|PROC
REGULATION OF NUCLEAR BETA CATENIN SIGNALING AND TARGET GENE TRANSCRIPTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF NUCLEAR BETA CATENIN SIGNALING AND TARGET GENE TRANSCRIPTION,0.412657290895633,0.867591391966812,-0.155806782789838,-1.02885842017788,1114,67,ID2|ZCCHC12|ADCY7|CTNNB1|CTBP1|MITF|MMP2|TCF7L2|TBL1X|YWHAH|MMP9|TCF4|RUVBL2|CAMK4|YWHAQ|YWHAB|CXCL8|JUN|TCF7|DKK1|YWHAZ|YWHAE
PDGFR-BETA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGFR-BETA SIGNALING PATHWAY,0.000587199060481503,0.0806484601749226,-0.256774982218868,-1.97475680183666,0,123,DOK1|PRKCD|DNM2|ABI1|BCAR1|NRAS|GRB2|FGR|ABL1|CYFIP2|SPHK1|FYN|RHOA|YWHAH|LYN|ARPC5|YES1|PPP2CA|CRK|RAP1A|YWHAQ|PTPN1|YWHAB|VAV2|ARPC4|KRAS|STAT5A|RAPGEF1|SHC1|JUN|PRKCA|STAT3|YWHAZ|YWHAE|MAPK3|RAB5A|S1PR1|SLC9A3R1|RAC1|ACTR2|BRK1|MAP2K1|PIK3R1
S1P4 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P4 PATHWAY,0.14810126582278502,0.6402258061318559,-0.33727384766774604,-1.30668817493577,701,14,GNAI3|GNA13|GNAZ|GNAI2|RHOA|CDC42|MAPK3|GNA12
GLYPICAN PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN PATHWAY,0.0774574505036471,0.530071420574752,0.735248704091761,1.3976304412179499,668,3,GPC2|GPC1|GPC3
JNK SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%JNK SIGNALING IN THE CD4+ TCR PATHWAY,0.7969206782303649,0.983076599789428,0.22018973899375,0.729557030772783,8177,14,GRAP2|PRKCB|MAP3K7|MAP3K1|LAT
PLK1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK1 SIGNALING EVENTS,0.0033906925489531198,0.140033065594047,0.39651022475787995,1.8710434442916999,39,46,CCNB1|CDK1|BTRC|BORA|ECT2|WEE1|CDC25C|BUB1|CENPU|PRC1|CDC20|NDC80|CENPE|FBXO5|BUB1B|ERCC6L|INCENP|KIF20A|PLK1|PPP1R12A|AURKA|CLSPN|NINL|SGOL1|TPX2|SPC24|PPP2R1A
REGULATION OF CDC42 ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF CDC42 ACTIVITY,0.787270282384581,0.9819233677232551,0.182829310116133,0.757340569001269,8781,29,DOCK10|FARP2|FGD1|ARHGEF6|APC|GIT1|PLCG1|RACGAP1|ARHGAP17|ARHGEF9|MCF2L
FC-EPSILON RECEPTOR I SIGNALING IN MAST CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FC-EPSILON RECEPTOR I SIGNALING IN MAST CELLS,0.00991114149008886,0.218851218956482,-0.260856421841631,-1.63781459061482,28,56,FCER1G|DOK1|GRB2|VAV1|SPHK1|FYN|PXN|LYN|FCGR2B|WIPF1|SHC1|JUN|NFATC2|GAB2|MAPK3|S1PR1|PLD2|MAP2K1|PIK3R1|PAK2
BETA1 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA1 INTEGRIN CELL SURFACE INTERACTIONS,0.437088815789474,0.878651088001772,0.20521136491644698,1.0229376466685,5314,58,ITGB1|COL18A1|ITGA1|TNC|ITGA9|ITGA2|ITGA4|LAMA1|LAMB2|FBN1|ITGA11|COL4A1|COL5A2|COL5A1|COL11A2|ITGA10|MDK|FN1|LAMA2|THBS2|NID1|THBS1|ITGA3|ITGA8|COL11A1|COL1A1|TGM2|COL3A1|TGFBI|LAMB3
NONCANONICAL WNT SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NONCANONICAL WNT SIGNALING PATHWAY,0.872809346787042,0.9934031064448321,-0.135213241021587,-0.711023517588139,3286,31,ARRB2|RHOA|PPARG|YES1|CAMK2A|CDC42|NFATC2|RAC1
CXCR3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CXCR3-MEDIATED SIGNALING EVENTS,0.73990602158023,0.9744283926676119,0.17900738366527102,0.7958851563874809,8502,37,CXCL13|MAPK11|GNAI1|MAP2K6|CXCL9|MAP2K2|PDPK1|SRC|HRAS|CXCL10
NEUROTROPHIC FACTOR-MEDIATED TRK RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NEUROTROPHIC FACTOR-MEDIATED TRK RECEPTOR SIGNALING,0.0111712931618145,0.22992267312754103,-0.263891792373941,-1.64949667144664,32,55,CRKL|RHOG|RAP1B|MATK|NEDD4L|NRAS|SQSTM1|GRB2|ABL1|RIT1|RHOA|EHD4|CRK|RAP1A|CDC42|KRAS|RAPGEF1|SHC1|STAT3|GAB2|MAPK3|RAC1|MAP2K1|PIK3R1
AURORA C SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA C SIGNALING,0.108718304967002,0.58452352834625,0.708172333026366,1.3461611081499498,938,3,AURKB|INCENP|AURKC
CELLULAR ROLES OF ANTHRAX TOXIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CELLULAR ROLES OF ANTHRAX TOXIN,0.0681407942238267,0.50364937614461,-0.337086715925614,-1.4782847655612001,301,19,CALM1|MAP2K3|NLRP1|MAPK3|MAP2K1|TNF
SIGNALING EVENTS MEDIATED BY TCPTP%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY TCPTP,0.8311834473205779,0.9879179006160809,0.16211086176969197,0.726222180159013,9600,38,ITGB1|PIAS1|ITGA1|INS|ATR
INSULIN-MEDIATED GLUCOSE TRANSPORT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INSULIN-MEDIATED GLUCOSE TRANSPORT,0.0657370517928287,0.495991045493396,-0.29583127990367203,-1.4526183474881202,263,26,STXBP4|YWHAH|VAMP2|CALM1|YWHAQ|YWHAB|YWHAZ|YWHAE|RHOQ
RAS SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAS SIGNALING IN THE CD4+ TCR PATHWAY,0.176160337552743,0.67909482081261,-0.325517111565779,-1.26113946682658,834,14,MAP3K8|NRAS|KRAS|PRKCA|MAPK3|MAP2K1
COREGULATION OF ANDROGEN RECEPTOR ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%COREGULATION OF ANDROGEN RECEPTOR ACTIVITY,0.937666666666667,1.0,-0.10877892415699801,-0.670936947392415,2812,53,PA2G4|UBE2I|TCF4|VAV3|NRIP1|SNURF|PRDX1|FKBP4|APPL1
VISUAL SIGNAL TRANSDUCTION: CONES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VISUAL SIGNAL TRANSDUCTION: CONES,0.650379106992418,0.963755998259649,0.325241035521037,0.846534082281722,6175,7,GUCA1B|GNB3|RGS9
THROMBOXANE A2 RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%THROMBOXANE A2 RECEPTOR SIGNALING,0.0179659929419313,0.282827765314948,-0.26740089572752496,-1.61237874836873,55,49,PRKACA|VCAM1|RAB11A|TBXA2R|BLK|PRKCH|GNA13|PRKCD|ARRB2|FGR|GNAQ|GNAI2|FYN|RHOA|GNA15|LYN|YES1|ICAM1|GNB5|PRKCA|NOS3|GNA12|SLC9A3R1|RAC1
ALK2 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK2 SIGNALING EVENTS,0.0577311263625353,0.468669207691151,-0.43662821831266296,-1.53654909944044,285,11,TLX2|BMPR2|BMP7|AMH|AMHR2|SMAD4|SMAD9|ACVR1|SMAD1|FKBP1A
A6B1 AND A6B4 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%A6B1 AND A6B4 INTEGRIN SIGNALING,0.00029455081001472796,0.0784645998831315,-0.41814723829613,-2.3780478444165802,0,40,RXRA|YWHAH|LAMC1|ITGA6|MST1R|YWHAQ|YWHAB|LAMA4|SHC1|PRKCA|CD9|YWHAZ|PMP22|YWHAE|RAC1|MET|LAMC2|PIK3R1
P38 SIGNALING MEDIATED BY MAPKAP KINASES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P38 SIGNALING MEDIATED BY MAPKAP KINASES,0.206547338671691,0.7211951452265429,-0.267028425476777,-1.21278863161292,876,21,TCF3|MAPKAPK2|SFN|YWHAG|MAPKAPK3|HSPB1|YWHAH|CDC25B|YWHAQ|YWHAB|YWHAZ|YWHAE
POLO-LIKE KINASE SIGNALING EVENTS IN THE CELL CYCLE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%POLO-LIKE KINASE SIGNALING EVENTS IN THE CELL CYCLE,0.5325209945661121,0.9265056012720759,-0.40102934818297903,-0.9222837228554491,3233,4,PLK3|PLK2
IL4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL4-MEDIATED SIGNALING EVENTS,0.862551702195355,0.991943445125448,-0.12364401275156599,-0.7432759327631709,2710,48,BCL2L1|ETS1|FCER2|STAT5A|SHC1|SOCS5|BCL6|PIK3R1
EPHRINB-EPHB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRINB-EPHB PATHWAY,0.0734622144112478,0.5208081048222071,-0.546665824611977,-1.50056098263405,417,6,EFNB1|EPHB2
TGF-BETA RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TGF-BETA RECEPTOR SIGNALING,0.0337041884816754,0.37587925780947296,-0.24600309784431398,-1.49909389075912,102,51,STRAP|ITCH|PPP2R2A|NEDD4L|CTNNB1|TGFBR1|ARRB2|GRB2|PML|SMAD2|CAMK2A|PPP2CA|PPP2CB|SMAD7|DYNLRB1|SHC1|YWHAE|CAV1|DACT2|FKBP1A
SIGNALING MEDIATED BY P38-ALPHA AND P38-BETA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING MEDIATED BY P38-ALPHA AND P38-BETA,0.37054179145113,0.852609194081082,-0.19670013278386603,-1.05210386079246,1360,33,MAPKAPK3|HBP1|EIF4E|HSPB1|USF1|SLC9A1|MITF|EIF4EBP1|DDIT3|ATF6|PPARGC1A|JUN|TP53|RAB5A
VALIDATED TRANSCRIPTIONAL TARGETS OF AP1 FAMILY MEMBERS FRA1 AND FRA2%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF AP1 FAMILY MEMBERS FRA1 AND FRA2,0.12597984322508402,0.607607158836689,-0.23609919142976002,-1.2987561576682398,449,36,HMOX1|LIF|MMP2|FOSL1|PLAU|IL6|MMP9|PLAUR|THBD|CXCL8|JUN|NFATC2|NOS3
SYNDECAN-1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-1-MEDIATED SIGNALING EVENTS,0.7794826048171278,0.981487311948134,0.18156303777695498,0.7612813334102209,8737,30,FGFR4|FGF19|CCL5|BSG|CASK|COL4A1|COL5A2|COL5A1|COL11A2
IFN-GAMMA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IFN-GAMMA PATHWAY,0.0356387798248263,0.3821688062173221,-0.261952732242414,-1.5083427619518102,117,42,CREBBP|CAMK2D|CRKL|RAP1B|CALM3|IL1B|PRKCD|CAMK2A|CALM1|RAP1A|SMAD7|RAPGEF1|STAT3|MAPK3|MAP3K11|MAP2K1|PIK3R1
SYNDECAN-2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-2-MEDIATED SIGNALING EVENTS,0.5159309362762551,0.9221165805818109,0.227291055565927,0.960757662884042,5796,31,FGFR4|ITGB1|FGF19|ITGA2|LAMA1|SRC|NF1|HRAS|CASK
TRAIL SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRAIL SIGNALING PATHWAY,0.17317740731525302,0.676682497340677,-0.256625441696113,-1.2449596674013201,695,25,RIPK1|MAP3K1|SMPD1|TRAF2|TRADD|CHUK|IKBKG|FADD|MAP2K4|CASP10|TNFSF10|PIK3CB|PIK3CA|MAPK8|MAPK1|CASP8|IKBKB|TNFRSF10C|DAP3|TNFRSF10D|TNFRSF10A|CFLAR|TNFRSF10B|MAPK3|PIK3R1
VALIDATED NUCLEAR ESTROGEN RECEPTOR BETA NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED NUCLEAR ESTROGEN RECEPTOR BETA NETWORK,0.6786205541363729,0.9647315640607691,0.262009644625188,0.825948033249937,6906,12,UBA3|ZNF14|SMARCA4|NCOA3|UBE2M|C3|SMARCE1|NCOA2|SMARCB1|NCOA1|DDX54
SUMOYLATION BY RANBP2 REGULATES TRANSCRIPTIONAL REPRESSION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SUMOYLATION BY RANBP2 REGULATES TRANSCRIPTIONAL REPRESSION,0.398465886152604,0.8638522656500329,-0.294019160901317,-1.0346900588492,1973,11,HDAC4|UBE2I|SUMO1|RANGAP1
CASPASE CASCADE IN APOPTOSIS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CASPASE CASCADE IN APOPTOSIS,0.691204991989206,0.96731875442989,0.17654545166699898,0.840892419672264,8196,48,DFFB|GAS2|PIDD1|APAF1|CASP6|NUMA1|PARP1|LMNB1|PRF1|BIRC2|SPTAN1|CASP9|RIPK1|MAP3K1|MADD|TRAF2|PTK2|CASP2|TRADD|XIAP|BIRC3|CYCS|TOP1
IL12-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL12-MEDIATED SIGNALING EVENTS,0.68547095033308,0.966495577318169,0.17745989682542,0.8452479552845441,8128,48,MAP2K6|JAK2|CCR5|GZMA|FOS|GADD45B|GADD45G|CD8B|CD3D|IL12RB1|SOCS1|CD3G|CD3E|CD8A|LCK|HLA-DRB1|TYK2|IL1R1|STAT1|IL2RA|HLX
S1P2 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P2 PATHWAY,0.037344398340249,0.38702164012069,-0.328320587627138,-1.57379225552933,152,24,GNAI3|GNA13|GNAZ|GNAQ|GNAI2|RHOA|GNA15|CDH5|JUN|MAPK3|GNA12|RAC1
SPHINGOSINE 1-PHOSPHATE (S1P) PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SPHINGOSINE 1-PHOSPHATE (S1P) PATHWAY,0.186999528968441,0.693783430081947,-0.272780028431471,-1.23891123883929,793,21,SGPL1|GNAI3|GNA13|GNAZ|ABCC1|GNAQ|SPHK1|GNAI2|GNA15|GNA12|S1PR1
RHOA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RHOA SIGNALING PATHWAY,0.946842422675971,1.0,0.131914232214181,0.598517850984639,10989,40,ITGB1|CYR61|MAP2K6|MAPK12
VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL ACTIVATION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL ACTIVATION,0.0108108108108108,0.226917411708286,-0.225449818073651,-1.55860984855854,25,79,MAX|SMAD3|HSP90AA1|RPL11|HMGA1|CREBBP|TAF9|EIF4E|NCL|TAF10|BMI1|HSPA4|BAX|MYCT1|PTMA|NDUFAF2|ID2|LDHA|EIF2S1|PIM1|POLR3D|MTDH|RUVBL1|EIF4A1|BCAT1|SUPT7L|SERPINI1|FOSL1|EIF4G1|ENO1|MMP9|SNAI1|RUVBL2|PDCD10|NPM1|GAPDH|DDX18|TFRC|ODC1|TP53|TAF4B|SLC2A1|PMAIP1
C-MYB TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%C-MYB TRANSCRIPTION FACTOR NETWORK,0.890069209721552,0.997300970905927,0.133865130152545,0.698959592277758,11059,72,ATP2B1|CDK6|CCNA1|MAT2A|HES1|CCNB1|CASP6|CEBPD|YEATS4|CDKN2A|MAP3K7|NLK|LEF1|KIT|HRAS|PTGS2|H2AFZ
CD40 CD40L SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CD40 CD40L SIGNALING,0.762612851832183,0.978421368343614,-0.15227423879382998,-0.8007393661095642,2871,31,NFKBIA|TNFAIP3|TRAF3|BCL2L1|STAT5A|JUN|TDP2|PIK3R1
REGULATION OF RAS FAMILY ACTIVATION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RAS FAMILY ACTIVATION,0.11366033755274302,0.589886822378869,-0.25828976306967,-1.34001556829123,430,30,RIN1|LGALS1|CALM3|PLCE1|DAB2IP|NRAS|RABGEF1|GRB2|CALM1|LGALS3|KRAS|PRKCA|RASGRF2|RASGRP3
ALPHAE BETA7 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHAE BETA7 INTEGRIN CELL SURFACE INTERACTIONS,0.89040764485303,0.997300970905927,0.44113592500689297,0.721024550710992,7360,2,ITGAE|ITGB7
IL2 SIGNALING EVENTS MEDIATED BY STAT5%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2 SIGNALING EVENTS MEDIATED BY STAT5,0.350420811017598,0.842847021021096,-0.21445101058083602,-1.06865164358527,1373,27,STAT5A|BCL2|SHC1|GAB2|PIK3R1
FOXO FAMILY SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXO FAMILY SIGNALING,0.0333853354134165,0.37444991734936,-0.255716493986791,-1.51226172916855,106,46,FOXO1|YWHAH|SOD2|RALA|YWHAQ|YWHAB|GADD45A|YWHAZ|YWHAE|RALB|BCL6|BCL2L11|FOXO3
SIGNALING EVENTS MEDIATED BY HDAC CLASS II%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS II,0.00950828579190437,0.21235063347774397,-0.33520508213573197,-1.77460607113054,34,32,HDAC4|TUBB2A|HDAC5|UBE2I|SUMO1|CAMK4|YWHAB|HDAC11|NR3C1|RANGAP1|YWHAE|BCL6|RFXANK
CIRCADIAN RHYTHM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CIRCADIAN RHYTHM PATHWAY,0.29395285935084997,0.8004058897916541,0.33979052435301094,1.15209783763867,3042,15,ARNTL|NPAS2|ATR|CLOCK|TIMELESS|WDR5|NONO|CHEK1
P73 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P73 TRANSCRIPTION FACTOR NETWORK,0.8545523233849641,0.991298302704726,-0.11541755723597,-0.770559348157631,2261,69,SERPINA1|TP53I3|HSF1|FBXO45|CDKN1A|PEA15|WWOX|BCL2L11|FOXO3
CANONICAL WNT SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CANONICAL WNT SIGNALING PATHWAY,0.583944386248929,0.9439064862850342,0.253033185206682,0.9076816214686642,6131,18,DVL1|NKD2|APC|KLHL12|GSK3A|RANBP3|DVL3|DVL2|LRP6
BMP RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BMP RECEPTOR SIGNALING,0.961086226203807,1.0,-0.109541412896201,-0.602575483876426,3432,36,SKI|RGMA|SMAD6|SMAD1|CHRDL1|PPM1A|SMAD7|GREM1
ALK1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK1 PATHWAY,0.01885310290652,0.286396032442422,-0.8229293040697031,-1.67011057230607,119,3,ACVR1|ACVRL1|FKBP1A
VALIDATED TRANSCRIPTIONAL TARGETS OF TAP63 ISOFORMS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF TAP63 ISOFORMS,0.342277691107644,0.8364262715705619,-0.18276082492881898,-1.08081491663734,1096,46,PRKCD|GDF15|ABL1|BBC3|PML|IGFBP3|NQO1|YWHAQ|GADD45A|TP53I3|CDKN1A|EVPL|PMAIP1|SPATA18
GLUCOCORTICOID RECEPTOR REGULATORY NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLUCOCORTICOID RECEPTOR REGULATORY NETWORK,0.423147806855879,0.873470206885489,-0.15569040771392598,-1.01951007762795,1147,65,YWHAH|IL6|ICAM1|VIPR1|CXCL8|STAT5A|NR3C1|JUN|TP53|MAPK3|CDKN1A|FKBP4|SMARCC1
EPHRIN A REVERSE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRIN A REVERSE SIGNALING,0.7295357184207479,0.972554563883587,0.43314614197413703,0.823365250629005,6300,3,EPHA5|EFNA5
REGULATION OF ANDROGEN RECEPTOR ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF ANDROGEN RECEPTOR ACTIVITY,0.9903870693321991,1.0,0.101579893848071,0.47614448145988003,11641,45,SIRT1|NR2C1|MAP2K6|SRC|CARM1|POU2F1|RXRB|EHMT2|TRIM24|DNAJA1|EGR1|RXRG|ZMIZ2|APPBP2|MDM2|KAT2B|MAPK14|RCHY1|HDAC7|MAP2K4|NR2C2|KAT7
BETA3 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA3 INTEGRIN CELL SURFACE INTERACTIONS,0.96136623057336,1.0,0.128376420429,0.5583097024802329,10948,34,CD47|CYR61|TNC
EPHRINA-EPHA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRINA-EPHA PATHWAY,0.280058118416273,0.788916642629372,-0.39201489115921506,-1.14352482963019,1541,7,EPHA8|EPHA7
DEGRADATION OF BETA CATENIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DEGRADATION OF BETA CATENIN,0.739545541340462,0.9744283926676119,0.222110762460115,0.783352583620702,7745,17,BTRC|DVL1|APC|GSK3A|DVL3|DVL2|LRP6|CSNK1E
S1P1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P1 PATHWAY,0.0108303249097473,0.227039254215601,-0.41980265147827706,-1.84103328580733,47,19,GNAI3|VEGFA|KDR|GNAZ|ABCC1|SPHK1|GNAI2|RHOA|MAPK3|S1PR1|RAC1
REGULATION OF RHOA ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RHOA ACTIVITY,0.29070837166513297,0.800029528446767,-0.19364474420702302,-1.11946236339761,947,43,ARHGDIB|ARAP3|ARHGEF25|ARHGEF3|MYO9B|ARHGEF5|CDKN1B|OPHN1|ARHGAP5|ARHGDIA|ARHGAP8|ABR|DLC1|VAV1|TRIO|RHOA|VAV3|ARHGEF2|VAV2|AKAP13|NET1|BCR
AP-1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AP-1 TRANSCRIPTION FACTOR NETWORK,0.23035904728048298,0.743397546142977,-0.181080070539827,-1.15827756794526,647,60,TCF7L2|FOSL1|PLAU|IL6|MMP9|FABP4|ETS1|CXCL8|NR3C1|JUN|NFATC2|TP53|CBFB|BAG1|BCL2L11
AURORA A SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA A SIGNALING,0.7733179067283729,0.979946273879301,0.18107489862652,0.7654022987319871,8688,31,CKAP5|BIRC5|DLGAP5|CENPA|GIT1|AURKB|AJUBA|AURKA|TPX2|BRCA1|AKT1|RASA1|MDM2|TACC3
INSULIN PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INSULIN PATHWAY,0.0196315312594382,0.29263527379618104,-0.27980022127850296,-1.611109893549,64,42,EIF4EBP1|EXOC3|EXOC4|CRK|PTPN1|RAPGEF1|SHC1|RHOQ|PTPRA|PIK3R1|CAV1|FOXO3
RETINOIC ACID RECEPTORS-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RETINOIC ACID RECEPTORS-MEDIATED SIGNALING,0.900854700854701,0.998912093067348,0.157321159766289,0.645115603333639,10012,28,RBP1|CDK1|RARB|HDAC3|CDK7|RXRB|RXRG|AKT1|NCOA3|MNAT1|KAT2B|MAPK14
IL1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL1-MEDIATED SIGNALING EVENTS,0.29285520239065504,0.8004058897916541,-0.21035162722266298,-1.1136205703181201,1077,32,NFKB1|TAB2|CASP1|IKBKB|ERC1|PRKCI|RELA|TRAF6|UBE2N|IL1RN|IL1B|IRAK1|SQSTM1|IRAK4|UBE2V1|JUN|MYD88|PIK3R1
GLYPICAN 2 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 2 NETWORK,0.20551590661666896,0.7211951452265429,0.730410807830163,1.19383639983972,1698,2,GPC2|MDK
E2F TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E2F TRANSCRIPTION FACTOR NETWORK,0.0382031566167544,0.3927265529050711,0.288292867241985,1.4908066319372402,471,69,SIRT1|KAT2A|CDK1|RRM1|APAF1|CDKN2C|DHFR|E2F3|ORC1|TK1|TRRAP|E2F7|CDKN2A|CCNE1|E2F2|RB1|E2F5|CDC6|E2F6|TOPBP1|MCM3|CCNE2|E2F1|TYMS|RRM2|XRCC1|SERPINE1|MYBL2|SP1|WASF1|CDK2|ATM|UXT|BRCA1
LKB1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LKB1 SIGNALING EVENTS,0.0220238095238095,0.310715277412964,-0.277415986520769,-1.5898149006009599,73,41,GSK3B|SMAD4|SFN|AKT1S1|YWHAG|HSP90AA1|PRKACA|SIK1|EZR|CTSD|STK26|SIK2|CRTC2|ETV4|YWHAH|PSEN2|CDC37|CAB39|YWHAQ|YWHAB|MARK4|TP53|YWHAZ|YWHAE
HYPOXIC AND OXYGEN HOMEOSTASIS REGULATION OF HIF-1-ALPHA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HYPOXIC AND OXYGEN HOMEOSTASIS REGULATION OF HIF-1-ALPHA,0.33641696750902506,0.8311444145897029,-0.245692051591785,-1.07747591266029,1490,19,VHL|TCEB1|TP53|EGLN3
IL23-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL23-MEDIATED SIGNALING EVENTS,0.518672199170125,0.9236324326350509,-0.19929392961010697,-0.955307875333702,2124,24,STAT5A|STAT3|PIK3R1|TNF
TCR SIGNALING IN NAIVE CD4+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TCR SIGNALING IN NAIVE CD4+ T CELLS,0.974908050674295,1.0,0.11090896408370599,0.560784636786323,11927,62,PAG1|STK39|GRAP2|RASGRP2|PDPK1|PRKCB|PRKCQ|CARD11|HRAS|PLCG1|CD3D|LAT|CD3G|CD3E|ZAP70|RASGRP1|LCK|HLA-DRB1|CHUK|AKT1|NCK1|SLA2|CSK|CBL|FLNA|IKBKG|WAS
EPO SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPO SIGNALING PATHWAY,0.0313818565400844,0.3625267385964289,-0.307877488832541,-1.59727827870101,118,30,SOCS3|CRKL|SH2B3|PTPN6|GRB2|LYN|BCL2L1|RAP1A|VAV2|STAT5A|BCL2|RAPGEF1|SHC1|PIK3R1
HIF-1-ALPHA TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIF-1-ALPHA TRANSCRIPTION FACTOR NETWORK,0.000351864883884588,0.0784645998831315,-0.361213323317804,-2.2936810682684503,0,58,SMAD3|BHLHE40|ENG|CXCL12|BNIP3|CREBBP|GATA2|HIF1A|FURIN|ID2|LDHA|VEGFA|FECH|PLIN2|HMOX1|PFKL|CP|CITED2|PKM|ENO1|ETS1|NPM1|PGK1|BHLHE41|TFRC|HK1|HK2|JUN|ALDOA|SLC2A1|NT5E|ADM|NDRG1|EGLN3
LPA4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LPA4-MEDIATED SIGNALING EVENTS,0.9654008438818559,1.0,-0.14934586636257,-0.578605423755686,4575,14,ADCY1|ADCY6|ADCY9|ADCY5|ADCY4|CREB1|ADCY3|RPS6KA5|PRKCE|PRKACA|ADCY7|GNAL|ADCY2
NEPHRIN NEPH1 SIGNALING IN THE KIDNEY PODOCYTE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NEPHRIN NEPH1 SIGNALING IN THE KIDNEY PODOCYTE,0.7210153771051991,0.9713770803161691,-0.170519655822009,-0.817379487797986,2953,24,ARRB2|GRB2|FYN|JUN|RAC1|PIK3R1
ARF6 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 SIGNALING EVENTS,0.142668776371308,0.6324244126031129,-0.246196450300811,-1.2772750740885401,540,30,ARRB2|GNAQ|GNA15|HGF|PXN|ARRB1|EFNA1|KIF13B|IQSEC1|ADRB2|MET
PAR1-MEDIATED THROMBIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PAR1-MEDIATED THROMBIN SIGNALING EVENTS,0.00347725297015358,0.142189596144971,-0.347104170350841,-1.9429910741618002,11,38,GNAI3|ARHGDIA|GNA13|PKN1|PRKCD|DNM2|GNAZ|VASP|GNAQ|GNAI2|RHOA|GNA15|ARRB1|AKAP13|PRKCA|ZYX|NOS3|GNA12|PLCB1|PIK3R1
E-CADHERIN SIGNALING IN THE NASCENT ADHERENS JUNCTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING IN THE NASCENT ADHERENS JUNCTION,0.0163843376839767,0.27230872946709,-0.30629293804581703,-1.6650105435137998,58,35,AP1M1|CTNNB1|ABI1|CYFIP2|RHOA|CRK|RAP1A|CTNNA1|VAV2|CDC42|RAPGEF1|RAC1|PIK3R1|DLG1
PRESENILIN ACTION IN NOTCH AND WNT SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PRESENILIN ACTION IN NOTCH AND WNT SIGNALING,0.116642120765832,0.596135728622196,-0.23109073545040398,-1.31423760573373,395,40,PSEN1|PSENEN|APH1B|DLL1|CSNK1A1|CREBBP|NOTCH1|PPARD|FZD1|FRAT1|CTNNB1|CTBP1|ADAM10|NCSTN|NEDD4|JUN|DKK1|MAPK3|CSNK2A1|RBPJ
ALK1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK1 SIGNALING EVENTS,0.00273699925354566,0.129967667001507,-0.424189856689265,-2.05786012255261,10,25,TGFBR1|ACVR1|ARRB2|SMAD1|SMAD7|ID1|MAPK3|ACVRL1|CAV1|FKBP1A
CLASS I PI3K SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS I PI3K SIGNALING EVENTS,0.344306855934763,0.839897752413553,-0.18663457400308703,-1.0746553640334,1139,42,NRAS|FGR|FYN|RHOA|LYN|YES1|RAP1A|KRAS|RAC1|PIK3R1|FOXO3
E-CADHERIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING EVENTS,0.760801781737194,0.977763214485385,-0.45486628067273205,-0.778024412010973,5123,2,JUP|CTNNB1
CLASS IB PI3K NON-LIPID KINASE EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS IB PI3K NON-LIPID KINASE EVENTS,0.6087600856248969,0.9508825506493929,-0.3770415713731471,-0.867116847414944,3696,4,MAP2K1
IL27-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL27-MEDIATED SIGNALING EVENTS,0.686736280826483,0.9665349594178531,-0.19350144405617004,-0.8324002204621391,3090,18,IL6|STAT5A|STAT3|TNF
PLK2 AND PLK4 EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK2 AND PLK4 EVENTS,0.21232368225686699,0.727709540947015,-0.730803836666284,-1.25000082326774,1429,2,PLK2
PDGF RECEPTOR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGF RECEPTOR SIGNALING NETWORK,0.600085910652921,0.9503412745667059,0.361738035797507,0.889642016974435,5587,6,PDGFD|PDGFC|PDGFRA|PDGFB|PDGFA|PDGFRB
E-CADHERIN SIGNALING IN KERATINOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING IN KERATINOCYTES,0.100631768953069,0.570947005522165,-0.31605695790448496,-1.38605932493323,445,19,CTNNB1|VASP|FYN|RHOA|CTNNA1|ZYX|RAC1|PIK3R1
SIGNALING EVENTS MEDIATED BY PRL%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY PRL,0.133607151485866,0.6194479383419461,-0.277815524065607,-1.3054319158028,552,23,RHOC|PTP4A3|ATF5|MAPK3|CDKN1A|RAC1|PTP4A2
REGULATION OF NUCLEAR SMAD2 3 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF NUCLEAR SMAD2 3 SIGNALING,0.6089696071163829,0.9508825506493929,-0.13796265428487697,-0.9181950738334441,1642,68,SKI|FOXO4|CTBP1|SNIP1|FOXO1|RUNX1|LAMC1|TFE3|SMAD2|SMAD7|NR3C1|JUN|CDKN1A|CBFB|SAP18|FOXO3
IL2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2-MEDIATED SIGNALING EVENTS,0.10179045092838197,0.572767517465588,-0.21353614224449602,-1.3078547458129899,306,52,KRAS|STAT5A|BCL2|SHC1|JUN|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1
AMB2 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AMB2 INTEGRIN SIGNALING,0.0198928844682479,0.29493828082242896,-0.33467091600141496,-1.66773112179057,77,27,ITGAM|RHOA|MMP2|PLAU|IL6|MMP9|MST1R|JAM2|ICAM1|RAP1A|PLAUR|TNF
SIGNALING EVENTS MEDIATED BY PTP1B%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY PTP1B,0.0137285491419657,0.256136946817111,-0.279638207225636,-1.6537304739618301,43,46,SOCS3|TXN|BLK|DOK1|BCAR1|GRB2|FGR|FYN|RHOA|LYN|YES1|YBX1|CRK|PTPN1|LEPR|STAT5A|SHC1|STAT3|PIK3R1|CAV1
REGULATION OF RETINOBLASTOMA PROTEIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RETINOBLASTOMA PROTEIN,0.801601056367088,0.9841161968820359,0.154196593139548,0.7655342662073109,9712,57,SIRT1|CDK6|MAPK11|CEBPD|E2F3|BGLAP|TGFB2|CDKN2A|CCNE1|E2F2|RB1|PPP2R3B|HDAC3|CEBPB|SMARCA4|MAPK9|E2F1|SKP2|CDK2|CCND2|DNMT1|SUV39H1|MDM2|TAF1|CCNA2
CERAMIDE SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CERAMIDE SIGNALING PATHWAY,0.699785341919657,0.967789953250095,-0.14803523830353602,-0.855793315827027,2281,43,SMPD3|ASAH1|BAD|RIPK1|MAP3K1|SMPD1|MADD|TRAF2|TRADD|AKT1|BIRC3|CYCS|FADD|MAP2K4|PRKCZ|RAF1|MYC|SPHK2|TNFRSF1A|PAWR|PRKRA|PDGFA|MAPK8|KSR1|MAPK1|NFKB1|CASP8|RELA|EIF2AK2|BAX|CTSD|NFKBIA|PRKCD|BAG4|BID|MAP4K4|CRADD|BCL2|MAPK3|MAP2K1|TNF
CLASS I PI3K SIGNALING EVENTS MEDIATED BY AKT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS I PI3K SIGNALING EVENTS MEDIATED BY AKT,0.317187932466095,0.818598932456131,-0.20391536955382802,-1.09724552896914,1145,34,YWHAG|HSP90AA1|PRKACA|CDKN1B|MAPKAP1|KPNA1|FOXO4|FOXO1|YWHAH|BCL2L1|YWHAQ|YWHAB|YWHAZ|YWHAE|CDKN1A|FOXO3
PLK3 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK3 SIGNALING EVENTS,0.548485508825452,0.9307786158067751,0.40532359228226,0.934210794432711,5033,5,CDC25C|CCNE1|CHEK2
VALIDATED TRANSCRIPTIONAL TARGETS OF DELTANP63 ISOFORMS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF DELTANP63 ISOFORMS,0.9362503622138509,1.0,-0.116280314695365,-0.650904347606817,3230,38,HBP1|PPP2R5A|ITCH|DLX5|FBXW7|NOTCH1|MRE11A|ADRM1|STXBP4|IGFBP3|RUNX1|RRAD|SEC14L2|BDKRB2
INTEGRIN-LINKED KINASE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRIN-LINKED KINASE SIGNALING,0.289788408463661,0.7989507053958459,-0.193966216194446,-1.1213207964383798,944,43,RHOG|NCK2|PARVB|ZEB1|RUVBL1|CTNNB1|TNS1|PXN|CDC37|SNAI1|RUVBL2|CDC42|JUN|LIMS1|ZYX|RAC1
DOWNSTREAM SIGNALING IN NAIVE CD8+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DOWNSTREAM SIGNALING IN NAIVE CD8+ T CELLS,0.0680164504903512,0.50364937614461,-0.232057362955621,-1.38599576633158,214,47,NRAS|IFNAR2|IFNAR1|FOSL1|TNFRSF18|CALM1|KRAS|JUN|PRKCA|NFATC2|B2M|TNFRSF4|MAPK3|MAP2K1|TNF
LISSENCEPHALY GENE (LIS1) IN NEURONAL MIGRATION AND DEVELOPMENT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LISSENCEPHALY GENE (LIS1) IN NEURONAL MIGRATION AND DEVELOPMENT,0.0582805907172996,0.47220394465225,-0.28513867089564504,-1.479308562527,220,30,CALM1|LRPAP1|CDC42|PAFAH1B2|RELN|YWHAE|RAC1|CSNK2A1|NUDC
ERBB RECEPTOR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB RECEPTOR SIGNALING NETWORK,0.4968623481781379,0.911815944636073,0.340485669369174,0.9716297643322779,4908,9,NRG2|NRG3|NRG1|ERBB3|NRG4
EPHRIN B REVERSE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRIN B REVERSE SIGNALING,0.10707171314741,0.582527805990231,-0.275703333449434,-1.3537842271537,429,26,NCK2|BLK|FGR|FYN|LYN|YES1|EFNB1|RAC1|PIK3R1|EPHB2
FOXA1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXA1 TRANSCRIPTION FACTOR NETWORK,0.9584289722009691,1.0,-0.121667871555536,-0.606294978779471,3757,27,NFIB|SERPINA1|NRIP1|JUN|NDUFV3
P53 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P53 PATHWAY,0.47023026315789496,0.8973822756577429,0.199882071820184,0.9963721855376441,5717,58,PPP1R13L|ATR|CDKN2A|HUWE1|PIN1|SETD8|CHEK2|E4F1|KAT8|SMYD2|MAPK9|CHEK1|CSE1L|SKP2|CDK2|ATM|AKT1|PPM1D|CCNG1|FBXO11|MDM2|YY1|RPL5|CCNA2|KAT2B|PPP2R4|CSNK1E|MAPK14|RCHY1
PLASMA MEMBRANE ESTROGEN RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLASMA MEMBRANE ESTROGEN RECEPTOR SIGNALING,0.000869313242538395,0.0849637591935908,-0.39589866962888204,-2.21612889463109,2,38,GNAI3|GNA13|GNAZ|IGF1R|BCAR1|NRAS|GRB2|GNAQ|GNAI2|RHOA|MMP2|GNAL|STRN|GNA15|HBEGF|MMP9|MSN|KRAS|SHC1|NOS3|PLCB1|PIK3R1
ENDOGENOUS TLR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ENDOGENOUS TLR SIGNALING,0.315120113047574,0.8164430838831159,-0.24291877816988,-1.10328753219328,1337,21,BGN|CHUK|TLR4|IKBKG|HSPD1|HMGB1|TLR2|CD14|TIRAP|IKBKB|LY96|S100A9|TLR1|IRAK1|IRAK2|IRAK4|S100A8|RHOA|TICAM1|MYD88
IL8- AND CXCR2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8- AND CXCR2-MEDIATED SIGNALING EVENTS,0.00929368029739777,0.212136117579847,-0.338121509353078,-1.77802368418973,34,31,ARRB2|VASP|FGR|GNAI2|GNA15|LYN|ARRB1|PPP2CA|CXCL8|PRKCA|RAB7A|RAB5A|PLD2|PLCB1
EGF RECEPTOR (ERBB1) SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EGF RECEPTOR (ERBB1) SIGNALING PATHWAY,0.245884227296867,0.758407565545035,-0.22032201926089398,-1.15857097983468,925,31,NCK2|GNAI3|PTPN6|NRAS|GRB2|PTPN1|KRAS|SHC1|STAT3|MAPK3|PIK3R1
ATF-2 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATF-2 TRANSCRIPTION FACTOR NETWORK,0.031413612565445004,0.3625267385964289,-0.24870704339795,-1.5155711965163299,95,51,HBG2|HRK|MMP2|PLAU|DDIT3|IL6|BCL2L1|RUVBL2|GADD45A|PPARGC1A|CXCL8|BCL2|JUN|PRKCA|MAPK3|DUSP10|CBFB
ERBB4 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB4 SIGNALING EVENTS,0.022355081881986,0.31481506041459995,-0.321538578460666,-1.64555441576637,85,29,ITCH|CBFA2T3|GRB2|FYN|HBEGF|NEDD4|ADAM17|STAT5A|SHC1|MAPK3|LRIG1|WWOX|PIK3R1
ANGIOPOIETIN RECEPTOR TIE2-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ANGIOPOIETIN RECEPTOR TIE2-MEDIATED SIGNALING,0.000306654400490647,0.0784645998831315,-0.387853911554389,-2.2421876630821402,0,43,GRB2|FYN|MMP2|ITGA5|FOXO1|FGF2|PXN|CRK|ETS1|STAT5A|SHC1|NOS3|MAPK3|CDKN1A|RAC1|PLD2|PIK3R1|TNF|ANGPT2
CALCINEURIN-REGULATED NFAT-DEPENDENT TRANSCRIPTION IN LYMPHOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CALCINEURIN-REGULATED NFAT-DEPENDENT TRANSCRIPTION IN LYMPHOCYTES,0.46976483762598,0.897010893107789,-0.18052983209403303,-0.9930751124350709,1677,36,FOSL1|CASP3|PPARG|CALM1|PTPN1|CXCL8|JUN|NFATC2|SLC3A2|TNF
FOXM1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXM1 TRANSCRIPTION FACTOR NETWORK,0.0384382304562376,0.3936768921371371,0.343829478870102,1.54028293367981,443,38,CCNB1|CDK1|CENPF|ETV5|BIRC5|CDKN2A|NEK2|CCNE1|CENPA|RB1|FOS|AURKB|CCNB2|CHEK2|PLK1|GAS1|BRCA2|XRCC1|GSK3A|FOXM1|SP1|SKP2|CDK2
IL8- AND CXCR1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8- AND CXCR1-MEDIATED SIGNALING EVENTS,0.0893257029111719,0.5586567091812379,-0.28624347819079904,-1.38864480095549,358,25,ARRB2|FGR|GNAI2|GNA15|LYN|ARRB1|CXCL8|PRKCA|RAB5A|PLCB1
EPHB FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHB FORWARD SIGNALING,0.00347725297015358,0.142189596144971,-0.349808132823531,-1.9581270921013,11,38,PXN|MAP4K4|CRK|RAP1A|CDC42|KRAS|SHC1|MAPK3|EFNB1|RAC1|MAP2K1|PIK3R1|EPHB2
SIGNALING EVENTS MEDIATED BY STEM CELL FACTOR RECEPTOR (C-KIT)%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY STEM CELL FACTOR RECEPTOR (C-KIT),0.0295895641107222,0.353814275261856,-0.256439884884547,-1.54156752432663,92,48,CREBBP|SNAI2|CRKL|SH2B3|PTPN6|MATK|DOK1|GRB2|VAV1|MITF|KITLG|LYN|STAT5A|BCL2|SHC1|STAT3|MAPK3|MAP2K1|PIK3R1|SPRED2|FOXO3
SIGNALING EVENTS MEDIATED BY HDAC CLASS I%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS I,0.46879843380373604,0.896113819860135,0.19609910632679897,0.9977798370119629,5746,64,RBBP7|SIRT4|SIRT1|HDAC10|MBD3|MTA2|NR2C1|BTRC|SIRT6
ALTERNATIVE NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALTERNATIVE NF-KAPPAB PATHWAY,0.751396048109966,0.976602570455905,0.313819119275427,0.771792420506244,6996,6,BTRC|CHUK
A4B7 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%A4B7 INTEGRIN SIGNALING,0.301133409587189,0.804106030578379,0.41963233787736104,1.14403033348413,2895,8,ITGB1|MADCAM1|ITGA4
C-MYC PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%C-MYC PATHWAY,0.644173306772908,0.9625261061153929,-0.17786528849859398,-0.873370731920085,2586,26,HBP1|PPP2R5A|TAF9|TAF10|FBXW7|RUVBL1|PML|SUPT7L|PPP2CA|RUVBL2|PAK2
TNF RECEPTOR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TNF RECEPTOR SIGNALING PATHWAY,0.917020553762528,1.0,0.137991410790662,0.643640355571583,10796,44,NSMAF|MAP3K5|MAP3K7|TRAF1|MAP4K3|MAP2K7|BIRC2|RIPK1|MAP3K1|SMPD1|MADD|TRAF2|TRADD|CHUK|TNIK|TAB1|STAT1|MAP4K2|BIRC3
VEGF AND VEGFR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGF AND VEGFR SIGNALING NETWORK,0.252364066193853,0.763905256448548,-0.34804061903235695,-1.1774735089009198,1280,10,VEGFA|KDR|NRP1|FLT1|PGF
ERBB2 ERBB3 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB2 ERBB3 SIGNALING EVENTS,0.14698085419734902,0.638549298625996,-0.22265354946606503,-1.26625443113533,498,40,CDC42|KRAS|SHC1|JUN|STAT3|MAPK3|RAC1|MAP2K1|PIK3R1
S1P5 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P5 PATHWAY,0.389600742804085,0.8603316114971841,-0.33279128799671504,-1.0344602228948199,2097,8,GNAI3|GNAZ|GNAI2|RHOA|GNA12
FGF SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FGF SIGNALING PATHWAY,0.289285714285714,0.798876223826199,-0.19560011772583202,-1.1209447069718501,971,41,PTK2B|GRB2|PLAU|MMP9|IL17RD|CAMK2A|PLAUR|FGFR1|SHC1|JUN|MAPK3|SDC2|PIK3R1
BARD1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BARD1 SIGNALING EVENTS,0.36941070625281197,0.852268858837246,0.26165891745309194,1.07296596752237,4105,28,FANCL|FANCA|ATR|CCNE1|FANCG|FANCC|RAD51|FANCF|TOPBP1|FANCD2|PRKDC|CDK2|ATM|BRCA1
SIGNALING EVENTS MEDIATED BY FOCAL ADHESION KINASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY FOCAL ADHESION KINASE,0.0151719487525287,0.264387156924099,-0.260343502412805,-1.6148573122053,44,54,BCAR1|GRB2|FYN|RHOA|ITGA5|PXN|YES1|CRK|RAP1A|ETS1|RAPGEF1|JUN|ASAP1|RAC1|MAP2K1|PIK3R1|ARHGAP26
HIF-2-ALPHA TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIF-2-ALPHA TRANSCRIPTION FACTOR NETWORK,0.0037174721189591102,0.143595610377104,-0.370897946804505,-1.9503797173314898,13,31,APEX1|VEGFA|KDR|CITED2|EFNA1|ETS1|PGK1|FXN|VHL|TCEB1|FLT1|SLC2A1|TWIST1|EPAS1|EGLN3
GLYPICAN 1 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 1 NETWORK,0.00585794483768611,0.175005706363229,-0.40140605716360295,-1.9241246753739198,23,24,BLK|VEGFA|TGFBR1|FGR|FYN|FGF2|LYN|PRNP|SMAD2|YES1|PLA2G2A|FGFR1|FLT1
ALPHA6 BETA4 INTEGRIN-LIGAND INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA6 BETA4 INTEGRIN-LIGAND INTERACTIONS,0.686314089624546,0.9665006495129341,-0.232940317105852,-0.819745997763395,3399,11,LAMC1|ITGA6|LAMC2
SIGNALING MEDIATED BY P38-GAMMA AND P38-DELTA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING MEDIATED BY P38-GAMMA AND P38-DELTA,0.872355430183357,0.9934031064448321,0.223549560713895,0.659752508035477,8658,10,MAP2K6|MAPK12|STMN1|MAPK13|MAPT|CCND1
HEDGEHOG SIGNALING EVENTS MEDIATED BY GLI PROTEINS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HEDGEHOG SIGNALING EVENTS MEDIATED BY GLI PROTEINS,0.946938080231667,1.0,0.128937434412331,0.597766844668032,11117,43,RBBP7|PIAS1|GNAI1|BTRC
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UPAR-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UPAR-MEDIATED SIGNALING,0.29660116834838,0.8013070063650121,-0.21178733800549102,-1.11369106244004,1116,31,BCAR1|ITGAM|ITGA5|PLAU|HGF|MMP9|CRK|PLAUR|MMP12|RAC1
REGULATION OF RAC1 ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RAC1 ACTIVITY,0.0649819494584838,0.4956987271622679,-0.26308227627864006,-1.4301170853309801,233,35,PREX1|RALBP1|ARHGDIA|KALRN|ABR|ABI1|VAV1|TRIO|ARHGAP1|VAV3|ARHGEF2|VAV2|RASGRF2|BCR|RAC1
IL12 SIGNALING MEDIATED BY STAT4%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL12 SIGNALING MEDIATED BY STAT4,0.8220307578284229,0.9874792359292991,0.18799606406497896,0.71998131607737,8872,22,ETV5|FOS|CD3D|PRF1|MAPK9|CD3G|CD3E|HLA-DRB1|IL2RA
HIV-1 NEF: NEGATIVE EFFECTOR OF FAS AND TNF-ALPHA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIV-1 NEF: NEGATIVE EFFECTOR OF FAS AND TNF-ALPHA,0.930483172864588,1.0,0.14345320588371602,0.613357689389952,10533,32,APAF1|CASP6|MAP3K5|TRAF1|FAS|MAP2K7|CASP9|RIPK1|TRAF2|CASP2|TRADD|CHUK|BIRC3|CYCS
5-ARACHIDONYLGLYCEROL_BIOSYNTHESIS%PANTHER PATHWAY%P05726,0.282753436426117,0.791661819214357,0.47321754093872,1.16380962444344,2632,6,PLCB3|LPL
5HT1 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04373,0.15677491601343801,0.6578589353509621,-0.227632410663307,-1.25218131092918,559,36,GNB1|GNB4|GNG5|PRKACA|PRKX|KCNK9|GNG10|GNAI3|ADCY7|GNG4|GNAI2|VAMP2|HTR1B|VAMP1|PRKAR2A|VAMP3|GNB5|ADCY2|SNAP25
5HT2 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04374,0.9664857413629709,1.0,0.122791662435956,0.557127162751275,11217,40,PLCB3|GNG8|KCNK3|GNB3|PRKCB|PRKCQ
5HT3 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04375,0.200248756218905,0.7125740549508579,-0.340256327929625,-1.23958793373789,965,12,VAMP2|VAMP1|VAMP3|SNAP25
5HT4 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04376,0.26644138289576297,0.7803351796901099,-0.22256645658670604,-1.13903972951268,1024,29,GNB1|GNB4|GNG5|KCNK9|GNG10|ADCY7|GNG4|GNAL|VAMP2|VAMP1|VAMP3|GNB5|ADCY2|SNAP25
5-HYDROXYTRYPTAMINE BIOSYNTHESIS%PANTHER PATHWAY%P04371,0.325503355704698,0.826621597878865,0.8414755183061321,1.1178626851853102,2424,1,DDC
5-HYDROXYTRYPTAMINE DEGREDATION%PANTHER PATHWAY%P04372,0.447836166924266,0.8850378987593649,0.297809696344548,1.00975713740012,4635,15,ALDH1A2|ALDH1A1|ALDH8A1|ALDH3A2|ALDH9A1
ACETATE UTILIZATION%PANTHER PATHWAY%P02722,0.568646425547357,0.940076901516441,0.5788806175902951,0.946164466670499,4700,2,ACSS1|ACSS2
ADENINE AND HYPOXANTHINE SALVAGE PATHWAY%PANTHER PATHWAY%P02723,0.212912087912088,0.7279184739702909,-0.482252701038772,-1.2207906894530902,1239,5,ADA|APRT|PNP|HPRT1
ADRENALINE AND NORADRENALINE BIOSYNTHESIS%PANTHER PATHWAY%P00001,0.5537335556790811,0.932816793297168,0.242608005642669,0.9291323840330009,5976,22,PNMT|INMT|SLC6A17|SLC6A15|DDC|SLC6A2|TH|COMT|SLC18A2|DBH|MAOA
ALANINE BIOSYNTHESIS%PANTHER PATHWAY%P02724,0.9796782387806942,1.0,0.3448432506553111,0.563636819797839,8098,2,BCAT2|BCAT1
ALPHA ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00002,0.000920810313075506,0.0849637591935908,-0.504352937193376,-2.25037513950567,3,20,STX10|PLCE1|ADRA2C|PRKCD|ADRA1B|VAMP2|VAMP1|VAMP3|PRKCA|ADRA2A|PLCB4|PLCB1|SNAP25
ALZHEIMER DISEASE-AMYLOID SECRETASE PATHWAY%PANTHER PATHWAY%P00003,0.6214904679376079,0.9536478716552259,-0.144423812127199,-0.9102950855540691,1792,57,PRKCI|PSEN1|PSENEN|BACE2|PCSK6|APH1B|PKN3|CHRM4|PCSK2|CHRFAM7A|FURIN|PRKCH|PKN1|MAPK7|PRKCD|MAPK4|PCSK7|PCSK1|ADAM10|NCSTN|PSEN2|CHRNA7|ADAM17|PRKCA|MAPK3|CHRM1
ALZHEIMER DISEASE-PRESENILIN PATHWAY%PANTHER PATHWAY%P00004,0.947797716150082,1.0,-0.0991217989472431,-0.679244048332701,2323,76,FZD7|ACTG2|GSK3B|NOTCH3|PSEN1|PSENEN|NOTCH4|BACE2|APBB2|PCSK6|APH1B|PVRL1|CD44|PCSK2|NOTCH1|LRP5|MMP1|FURIN|FZD1|CTNNB1|PCSK7|PCSK1|MMP2|TCF7L2|NCSTN|PSEN2|MMP9|WNT6|WNT11|ADAM17|WNT3|ACTR2|RBPJ
AMINOBUTYRATE DEGRADATION%PANTHER PATHWAY%P02726,0.46295302013422795,0.891507554237553,0.773599470666079,1.02769238406067,3448,1,ABAT
ANANDAMIDE_DEGRADATION%PANTHER PATHWAY%P05728,0.552885906040268,0.9325128312387091,0.7270070577856199,0.9657964421838879,4118,1,FAAH
ANDROGEN ESTROGENE PROGESTERONE BIOSYNTHESIS%PANTHER PATHWAY%P02727,0.740657216494845,0.974505008828563,0.31680126682028603,0.7791265780848751,6896,6,SOAT1|HSD17B7|HSD17B3|HSD17B1|LIPA
ANGIOGENESIS%PANTHER PATHWAY%P00005,0.197060788243153,0.7110073451187049,-0.144847926844543,-1.14804029759175,294,140,CRKL|HIF1A|NCK2|HSPB1|NOTCH1|FZD1|PRKCH|VEGFA|KDR|PIK3C3|DOK1|PRKCD|ARHGAP8|CTNNB1|NRAS|PRKD2|SPHK1|RHOA|ARHGAP1|TCF7L2|PXN|CRK|RHOC|ETS1|PRR5|FGFR1|SHC1|JUN|TCF7|PRKCA|STAT3|NOS3|MAPK3|EFNB1|PLD2|MAP2K1|PIK3R1|DLL3|RBPJ|EPHB2|ANGPT2|PAK2
ANGIOTENSIN_II-STIMULATED_SIGNALING_THROUGH_G_PROTEINS_AND_BETA-ARRESTIN%PANTHER PATHWAY%P05911,0.9313218138759759,1.0,0.14069797166363598,0.6164197972221229,10617,35,PLCB3|GNG8|GNB3|MAP2K2|AGTR1
APOPTOSIS SIGNALING PATHWAY%PANTHER PATHWAY%P00006,0.0541072306935563,0.454914205138535,-0.17959691354066898,-1.32279790795989,109,102,PRKCH|GZMB|EIF2S1|NFKBIA|PRKCD|ATF7|HSPA5|BAG4|TNFRSF1B|CASP3|TNFRSF10D|TNFRSF10A|RELB|REL|BCL2L1|BOK|MAP4K4|ATF6|CRADD|MAP2K3|BAG3|BCL2|JUN|CFLAR|PRKCA|TP53|TNFRSF10B|HSPA6|MAPK3|BIK|TNF|BCL2L11
ARGININE BIOSYNTHESIS%PANTHER PATHWAY%P02728,0.44212086283550106,0.880423444399886,-0.43291816923272497,-0.9956213494617991,2684,4,ASS1|ASL
ASCORBATE DEGRADATION%PANTHER PATHWAY%P02729,0.7339597315436239,0.9734087938149171,0.6365240405822671,0.8455937905628209,5467,1,RPE
ASPARAGINE AND ASPARTATE BIOSYNTHESIS%PANTHER PATHWAY%P02730,0.0299328859060403,0.35509922886098294,0.9850573445081601,1.3086047356553,222,1,ASNS
ATP SYNTHESIS%PANTHER PATHWAY%P02721,0.463287770654409,0.8920484559711279,0.618329721928198,1.01064294398051,3829,2,ATP5C1|ATP5B
AXON GUIDANCE MEDIATED BY NETRIN%PANTHER PATHWAY%P00009,0.0670652456459579,0.501883205215865,-0.28417477996944895,-1.45433579468714,257,29,NFATC3|PIK3CD|PIK3R2|DCC|PIK3R5|VASP|UNC5B|UNC5C|CDC42|NFATC2|UNC5D|RAC1|PIK3R1|NTNG2
AXON GUIDANCE MEDIATED BY SEMAPHORINS%PANTHER PATHWAY%P00007,0.0185512367491166,0.285526981228736,-0.41457213217858396,-1.74447184922874,83,17,DPYSL2|DPYSL4|FYN|RHOA|NRP1|PLXNA1|SEMA3A|RAC1
AXON GUIDANCE MEDIATED BY SLIT ROBO%PANTHER PATHWAY%P00008,0.2099533437014,0.7248363921442859,-0.281320801837609,-1.21017958606157,944,18,RHOC|CDC42|RAC1|NTNG2|SLIT3
B CELL ACTIVATION%PANTHER PATHWAY%P00010,0.40589031821259297,0.8663957682383929,-0.16556683621942803,-1.03490124792856,1198,55,CALM3|PTPN6|NFKBIA|PRKCD|CD19|NRAS|GRB2|VAV1|LYN|CALM1|VAV3|VAV2|JUN|MAPK3|RAC1|CD22|MAP2K1
BETA1 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04377,0.0756856540084388,0.525661416287861,-0.276301643030003,-1.4334617787572899,286,30,GNB1|GNB4|GNG5|PRKACA|PRKX|GNG10|ADCY7|GNG4|GNAL|VAMP2|VAMP1|PRKAR2A|VAMP3|GNB5|ADCY2|SNAP25
BETA2 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04378,0.202222759120561,0.716346357311758,-0.257596149504058,-1.21042276554385,836,23,GNB1|GNB4|GNG5|PRKACA|PRKX|GNG10|ADCY7|GNG4|GNAL|PRKAR2A|GNB5|ADRB2|ADCY2
BETA3 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04379,0.11346105996516499,0.5898500977236399,-0.27607000150539696,-1.33929050441006,455,25,GNB1|GNB4|GNG5|GNG10|ADCY7|GNG4|GNAL|VAMP2|VAMP1|VAMP3|GNB5|ADCY2|SNAP25
BLOOD COAGULATION%PANTHER PATHWAY%P00011,0.38294273979222,0.8582519754973359,-0.223030825525809,-1.0480031986278802,1584,23,PLAU|SERPINF2|PLAUR|SERPINA1|THBD|PROC|VWF
CADHERIN SIGNALING PATHWAY%PANTHER PATHWAY%P00012,7.627765064836e-05,0.0784645998831315,0.438802800829707,2.49447815729795,0,112,PCDHGA5|PCDHA12|PCDHGA11|PCDH15|PCDHB4|PCDHB15|PCDHA10|PCDHA7|PCDHA2|CDH4|PCDHB8|CDH6|PCDH8|CDHR2|PCDHGA7|PCDHB6|PCDHB7|PCDHGA1|WNT4|PCDHB14|CDH10|WNT5B|PCDHA6|PCDHB13|CDH3|PCDHA11|DCHS1|PCDHGA2|PCDHB12|PCDHA1|PCDHA3|FAT3|CDH2|PCDHGB4|PCDH9|PCDH20|CDH23|PCDHAC2|PCDHGC5|PCDHGA3|CELSR2|PCDH18|SRC|CTNND1|CTNND2|PCDHGA6|CDH7|PCDHA5
GASTRIN_CCK2R_240212%PANTHER PATHWAY%P06959,0.00334001336005344,0.139681720343043,-0.198780625566666,-1.57550179351861,4,140,PRKCH|CLU|NFKBIA|MAPK7|PRKCD|CTNNB1|BCAR1|PTK2B|ARRB2|PRKD2|GRB2|RHOA|PLAU|FOXO1|CASP3|EIF4EBP1|MAP2K5|PXN|HBEGF|PPARG|LYN|BCL2L1|TPST1|YES1|SNAI1|MEF2D|TCF4|CRK|CALM1|CAMK4|YWHAB|CDC42|RYR1|CXCL8|ODC1|BCL2|SHC1|JUN|PRKCA|STAT3|NFATC2|MAPK3|RAC1|MAP3K11|MAP2K1|PIK3R1|CAMKK1|FOXO3
CELL CYCLE%PANTHER PATHWAY%P00013,0.5952056129409471,0.9475343800745,0.268716308733799,0.8903406362892221,6107,14,PSMD11|PSMD13|PSMD3|CCNE1
CHOLESTEROL BIOSYNTHESIS%PANTHER PATHWAY%P00014,0.9226711783439492,1.0,0.19829871128897897,0.6049639123017659,9270,11,MVD|GGPS1|HMGCR|PDSS1|MVK|HMGCS1|FDPS
CIRCADIAN CLOCK SYSTEM%PANTHER PATHWAY%P00015,0.8635298711440841,0.991943445125448,-0.212868547731923,-0.687158747686612,4422,9,PER3|PER2
COENZYME A BIOSYNTHESIS%PANTHER PATHWAY%P02736,0.40378006872852207,0.8655192490568291,0.42773751115771,1.05195811472528,3759,6,PANK4|PANK3|PANK1|PPCS
CORTOCOTROPIN RELEASING FACTOR RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04380,0.22173121913179103,0.73556947110949,-0.230847407225284,-1.1814195738078601,852,29,GNG10|GNG4|CRHR1|GNAQ|GNAL|VAMP2|VAMP1|VAMP3|CRH|GNB5|SNAP25
CYSTEINE BIOSYNTHESIS%PANTHER PATHWAY%P02737,0.230636833046472,0.743397546142977,-0.8842082046757829,-1.18283227467695,1741,1,CBS
CYTOSKELETAL REGULATION BY RHO GTPASE%PANTHER PATHWAY%P00016,0.00433333333333333,0.154998560115191,-0.291268592382854,-1.79651400084256,12,53,ARHGAP8|TUBB2B|CFL2|VASP|PFN1|TUBB2A|ARHGAP1|TUBB6|TUBB3|ARPC5|DIAPH2|RHOC|LIMK1|ARPC4|CDC42|TUBB4B|MYH11|MYH9|RAC1|PAK2
DE NOVO PURINE BIOSYNTHESIS%PANTHER PATHWAY%P02738,0.606419073819349,0.9508825506493929,0.226287200138037,0.8905527763494971,6612,24,NME3|NME4|RRM1|NME7|AK3|ADSSL1|GUK1
DE NOVO PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHESIS%PANTHER PATHWAY%P02739,0.0890724522292994,0.5575840828783879,0.469932832086741,1.4336573484027701,894,11,NME3|NME4|RRM1|DTYMK|DUT|TYMS|RRM2|ADAT2|NME2|NME1
DE NOVO PYRIMIDINE RIBONUCLEOTIDES BIOSYTHESIS%PANTHER PATHWAY%P02740,0.12488301965269802,0.607607158836689,0.498821827618962,1.3599221277528502,1200,8,NME3|NME4|CAD|CTPS2|CTPS1|NME2|NME1
DNA REPLICATION%PANTHER PATHWAY%P00017,0.512683066909161,0.9189160303470669,0.277042682941864,0.960431850582464,5355,16,RFC4|DNA2|TOP2A|POLD1|TOP2B|RFC3|RFC5
PNAT%PANTHER PATHWAY%P05912,0.9100708346165691,1.0,-0.117586666626679,-0.691075918444609,2954,45,PRKX|KCNK9|GNAI3|ADCY7|GNG4|EPB41L1|GNAZ|GNAI2|VAMP2|VAMP1|PRKAR2A|VAMP3|ADCY2|DRD2|SNAP25
EGF RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00018,0.821624314897857,0.987153241368501,-0.11239910692686099,-0.8282589802398861,1648,103,YWHAH|HBEGF|PPP2CA|PPP2CB|YWHAQ|YWHAB|MAP2K3|STAT5A|SHC1|PRKCA|STAT3|YWHAZ|GAB2|YWHAE|MAPK3|RAC1|RRAS2|MAP2K1
ENDOGENOUS_CANNABINOID_SIGNALING%PANTHER PATHWAY%P05730,0.0455995496340777,0.4193082406940371,0.416089367507041,1.54514755495946,485,20,PLCB3|CACNA1G|GNG8|GNAI1|GNB3|CNR1
UNTITLED%PANTHER PATHWAY%P00019,0.430856736580164,0.8785877309899279,-0.158556743808994,-1.01420724573888,1211,60,FURIN|PRKCH|ADCY7|PRKCD|PCSK1|GNAQ|GUCY1A3|GNAL|PRKAR2A|EDNRA|PRKCA|PRKAR1B|ADCY2|NOS3|MAPK3|GNAS|PLCB4|PLCB1|MAP2K1
ENKEPHALIN RELEASE%PANTHER PATHWAY%P05913,0.8416853428955621,0.990587908600638,0.17086554937613302,0.70778264330286,9388,29,GNG8|GNAI1|GNB3|PENK|PRKAR2B|CREM
FAS SIGNALING PATHWAY%PANTHER PATHWAY%P00020,0.40395861448493,0.865585453523601,0.255252727757489,1.04669656462267,4489,28,DFFB|PARP2|APAF1|CASP6|MAPK10|MAP3K5|PARP1|LMNB1|FAS
FGF SIGNALING PATHWAY%PANTHER PATHWAY%P00021,0.7802318295739351,0.981487311948134,0.145768525771272,0.797789791775332,9961,91,FGFR4|FGF12|MAPK11|MAP2K6|MAPK12|MAP2K2|FGF17|FGF13|FGF11|MAPK10|PPP2R2B|MAP3K5|PRKCB|PRKCQ|RASA4|HRAS|PPP2R2D|FGF9|MAP3K4|PLCG1|MAP2K7|RAC2|AKT3|ARAF|PEBP1|AKT2|MAPK13|MAPK9|FGFR2|RASA4B|SPRY4|PPP2R1A|SPRY1
FLAVIN BIOSYNTHESIS%PANTHER PATHWAY%P02741,0.808636748518205,0.984682960940884,0.483326076525165,0.7899831943363449,6684,2,RFK|FLAD1
FORMYLTETRAHYDROFORMATE BIOSYNTHESIS%PANTHER PATHWAY%P02743,0.652920962199313,0.9640743070248079,0.344719974012014,0.8477885724549431,6079,6,DHFR|MTR|TYMS
FRUCTOSE GALACTOSE METABOLISM%PANTHER PATHWAY%P02744,0.135306937885943,0.6224657604778089,-0.463889796540082,-1.3531871174256798,744,7,HK1|HK2|ALDOA
GABA-B_RECEPTOR_II_SIGNALING%PANTHER PATHWAY%P05731,0.584905660377359,0.9439064862850342,0.21527982317644,0.9099862696580819,6571,31,CACNA1G|GNG8|GNAI1|GNB3|ADCY8
GAMMA-AMINOBUTYRIC ACID SYNTHESIS%PANTHER PATHWAY%P04384,0.984253791825865,1.0,0.27468094069633997,0.522139572913377,8500,3,ABAT|ALDH5A1
GENERAL TRANSCRIPTION REGULATION%PANTHER PATHWAY%P00023,0.490187332738626,0.908938677284213,0.233921095140412,0.980815067877626,5494,30,AK6|TAF7|GTF2B|GTF2H1|BRF1|MTERF2|GTF2E2|TAF2|TAF4|POLR2H|GTF2A1|GTF2F2|TAF6|TBPL1|GTF2E1|GTF2H3|TAF12|BRF2|GTF2H4
GENERAL TRANSCRIPTION BY RNA POLYMERASE I%PANTHER PATHWAY%P00022,0.13375527426160302,0.6198988233488609,-0.343309031729159,-1.33007007572986,633,14,POLR1D|TBP|TTF1|RRN3|PTRF|POLR1B|TAF1B|POLR2K|TAF8
GLUTAMINE GLUTAMATE CONVERSION%PANTHER PATHWAY%P02745,0.128285077951002,0.608160579951936,-0.782394347665653,-1.3382436293211202,863,2,GLUL
GLYCOLYSIS%PANTHER PATHWAY%P00024,0.000210970464135021,0.0784645998831315,-0.7132842285932679,-2.76345193472922,0,14,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
UNTITLED%PANTHER PATHWAY%P06664,0.98318931657502,1.0,-0.267618837542737,-0.5431244794881289,6257,3,SKIL|TGIF1|RELA
HEDGEHOG SIGNALING PATHWAY%PANTHER PATHWAY%P00025,0.977299072642968,1.0,0.14798701339203,0.501766547057781,10116,15,BTRC|PRKAR2B|SUFU|UBR5|STK36|CSNK1E|PTCH1
HEME BIOSYNTHESIS%PANTHER PATHWAY%P02746,0.8324044585987259,0.9879918468324742,0.22962374401931,0.7005294065520319,8363,11,EPRS|RSAD1|CPOX|UROD|ALAD|HMBS|PPOX
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-GI ALPHA AND GS ALPHA MEDIATED PATHWAY%PANTHER PATHWAY%P00026,0.41753861484803206,0.8710929393673741,-0.13850266316333898,-1.02061375475895,837,103,HTR1B|PRKAR2A|CLTA|CALM1|RAP1A|GRM2|GNGT1|HRH3|ADRB2|PYGB|RGS12|PRKAR1B|ADCY2|DRD2|CHRM1|HRH1|GRM8|CREB5|ADORA2B
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-GQ ALPHA AND GO ALPHA MEDIATED PATHWAY%PANTHER PATHWAY%P00027,0.44139761167624897,0.880402968441571,-0.141905200755678,-1.0124300830278499,997,89,CLTA|RAP1A|GRM2|GNGT1|PRKCA|RGS12|DRD2|RASGRP3|BDKRB2|PLCB4|CHRM1|PLCB1|CACNA1E|BDKRB1|GRM8|ADORA2B
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-ROD OUTER SEGMENT PHOTOTRANSDUCTION%PANTHER PATHWAY%P00028,0.3467021019569939,0.842847021021096,-0.22954314386837898,-1.07860403793969,1434,23,GNB1|GNB4|PDE6G|GNG5|PRKACA|GNG10|CALM3|GNG4|PDE6B|CALM1|GNB5|GNGT1
HISTAMINE H1 RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04385,0.7752643948296121,0.9805314293977441,-0.14089292883007,-0.7949541289148531,2638,39,GNG10|PRKCH|PLCE1|GNG4|PRKCD|GNAQ|PLCD1|GNB5|PRKCA|PLCB4|PLCB1|HRH1
HISTAMINE H2 RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04386,0.36692015209125506,0.851186780857897,-0.22867859610955202,-1.0594085705387,1543,22,GNB1|GNB4|GNG5|PRKACA|PRKX|GNG10|ADCY7|GNG4|GNAL|PRKAR2A|GNB5|ADCY2
HUNTINGTON DISEASE%PANTHER PATHWAY%P00029,0.0103969754253308,0.22303667100894298,-0.210153481842912,-1.52433494257977,21,96,PACSIN1|ARPC1B|AP2A1|CREBBP|IFT57|RHOJ|RHOG|DYNC2H1|GRIN2C|KALRN|CAPNS1|TUBB2B|CAPN5|DYNC1LI2|ARL4C|TUBB2A|CYFIP2|TUBB6|CASP3|TUBB3|ARPC5|DNAL4|HAP1|GAPDH|RAB8A|ARPC5L|CDC42|CYC1|JUN|SH3GL3|DYNLL2|TP53|TUBB4B|ARF3|HTT|ARL4D|RHOQ|ARL4A|RAC1|DYNC1LI1|ACTR2
HYPOXIA RESPONSE VIA HIF ACTIVATION%PANTHER PATHWAY%P00030,0.9176344086021501,1.0,-0.16357298580804902,-0.6523436808455579,4266,15,RORC|CREBBP|HIF1A|TXN|VHL|EGLN3
INFLAMMATION MEDIATED BY CHEMOKINE AND CYTOKINE SIGNALING PATHWAY%PANTHER PATHWAY%P00031,0.136225266362253,0.6237835799077729,-0.14842451935981,-1.18974772409008,178,156,FPR1|RELA|PRKACA|ARPC1B|NFATC3|COL14A1|PIK3CD|PRKX|PREX1|PAK7|CAMK2D|MYH7B|GNG10|RHOG|COL6A2|SOCS6|GNAI3|CXCR5|PLCE1|GNG4|CX3CL1|C5AR1|PTK2B|NRAS|RGS4|VAV1|CCR10|PTGS1|GNAQ|GNAI2|RHOA|IFNAR1|COL6A1|RELB|GNA15|ARPC5|CAMK2A|RHOC|PLCD1|ARPC5L|ARPC4|CDC42|CXCL8|KRAS|SHC1|JUN|STAT3|NFATC2|SOCS5|ADCY2|MAPK3|MYH11|MYH9|VWF|RAC1|PLCB4|PLCB1|CCL18|PAK2
INSULIN IGF PATHWAY-MITOGEN ACTIVATED PROTEIN KINASE KINASE MAP KINASE CASCADE%PANTHER PATHWAY%P00032,0.288654489323386,0.7980646072929201,-0.22088790052705198,-1.11686352166937,1121,28,IGF1|MAP2K3|MAPK3|IGF2|MAP2K1|RPS6KA2
INSULIN IGF PATHWAY-PROTEIN KINASE B SIGNALING CASCADE%PANTHER PATHWAY%P00033,0.583608101742817,0.9439064862850342,-0.19909955826248601,-0.9042695750040941,2477,21,IGF1R|FOXO1|IGF1|IGF2|FOXO3
INTEGRIN SIGNALLING PATHWAY%PANTHER PATHWAY%P00034,0.0227272727272727,0.31609926985007897,-0.17190580215084802,-1.3726989525383502,29,152,COL16A1|ITGAX|BCAR1|PTK2B|NRAS|ITGAM|VASP|FLNB|FYN|RHOA|ITGA5|COL6A1|PXN|RND2|LAMC1|RAP2B|ITGA6|COL5A3|ARPC5|COL15A1|DNAJC27|COL8A2|PTPN12|CRK|RHOC|RAP1A|ARPC5L|CDC42|MAP2K3|COL9A1|LAMA4|RAPGEF1|SHC1|LIMS1|ASAP1|MAPK3|RAC1|LAMC2|MAP2K1|PIK3R1|ARHGAP26|ITGA7|CAV1|MICALL1
INTERFERON-GAMMA SIGNALING PATHWAY%PANTHER PATHWAY%P00035,0.161522352726942,0.664367762084791,0.324463053630769,1.2929385946068102,1773,25,PIAS1|MAPK11|MAPK12|CISH|MAPK10|SOCS2|JAK2|PIAS4|MAPK13|MAPK9|SOCS7
INTERLEUKIN SIGNALING PATHWAY%PANTHER PATHWAY%P00036,0.337157660991858,0.831781977545269,-0.163553975616314,-1.0800164277404398,910,67,CXCL8|STAT5A|SHC1|STAT3|NOS3|MAPK3|CDKN1A|RPS6KA2|FOXO3
IONOTROPIC GLUTAMATE RECEPTOR PATHWAY%PANTHER PATHWAY%P00037,0.748274316450022,0.9749763305090959,0.190104494610548,0.7874768330449801,8346,29,SLC1A2|GRIN3A|GRIA1|GRIK2|GRIA2|GRIN1|GRIA4|SLC1A3|GRIK5|SHANK1|SLC1A1
ISOLEUCINE BIOSYNTHESIS%PANTHER PATHWAY%P02748,0.5702211416000931,0.940402148292764,0.491104051518473,0.9335371397295541,4924,3,BCAT2|ILVBL
JAK STAT SIGNALING PATHWAY%PANTHER PATHWAY%P00038,0.9219474497681609,1.0,0.17847462845508502,0.6051382212849711,9543,15,PIAS1|JAK2|SOCS1|STAT5B|STAT1|MAPK14|JAK3|STAT6|PTPRC|JAK1|PIAS2
LEUCINE BIOSYNTHESIS%PANTHER PATHWAY%P02749,0.9796782387806942,1.0,0.3448432506553111,0.563636819797839,8098,2,BCAT2|BCAT1
LIPOATE_BIOSYNTHESIS%PANTHER PATHWAY%P02750,0.0406461008870647,0.401998427404428,-0.978881782090869,-1.30948000575828,306,1,LIAS
MANNOSE METABOLISM%PANTHER PATHWAY%P02752,0.87908611599297,0.9956508825790341,-0.244501654898059,-0.6711406256096241,5001,6,PMM1|PMM2
METABOTROPIC GLUTAMATE RECEPTOR GROUP III PATHWAY%PANTHER PATHWAY%P00039,0.5888870236696321,0.945418171231938,0.19067687030205605,0.91628798018087,7015,50,SLC1A2|GNG8|GRIN3A|GRIA1|GNAI1|GRM4|GNB3|GRIK2|GRIA2
METABOTROPIC GLUTAMATE RECEPTOR GROUP II PATHWAY%PANTHER PATHWAY%P00040,0.11595441595441601,0.594984387754212,-0.23591601353867497,-1.3105031684873603,406,37,GNB1|PRKAR1A|GNB4|GNG5|PRKACA|PRKX|GNG10|GNAI3|GNG4|GNAI2|VAMP2|VAMP1|PRKAR2A|VAMP3|GRM2|GNB5|PRKAR1B|CACNA1E|SNAP25
METABOTROPIC GLUTAMATE RECEPTOR GROUP I PATHWAY%PANTHER PATHWAY%P00041,0.265496556320818,0.7792338872944151,-0.26752561660343105,-1.15083576417819,1194,18,PRKAR1A|PRKACA|PRKX|GRIN2C|GNAQ|GNA15|PRKAR1B|GRINA|PLCB4|HOMER1
METHIONINE BIOSYNTHESIS%PANTHER PATHWAY%P02753,0.346174496644295,0.8422206315449059,0.83077856197618,1.10365225592602,2578,1,MTR
METHYLCITRATE CYCLE%PANTHER PATHWAY%P02754,0.398209749606871,0.8638522656500329,0.6430658946787979,1.05107353879895,3291,2,ACO1|IREB2
METHYLMALONYL PATHWAY%PANTHER PATHWAY%P02755,0.292865942434763,0.8004058897916541,0.538853744602907,1.14188255880516,2614,4,PCCB|MCEE|PCCA|MUT
MRNA SPLICING%PANTHER PATHWAY%P00058,0.585679945054945,0.9440768512804109,-0.350705934259872,-0.8877887845069391,3410,5,SNRNP40|PRPF3|SNRPA|SNRPB2|ZRSR2
MUSCARINIC ACETYLCHOLINE RECEPTOR 1 AND 3 SIGNALING PATHWAY%PANTHER PATHWAY%P00042,0.61758100737889,0.9529166894361422,-0.15126502617342802,-0.912100585564228,1924,49,PKN3|ACHE|GNG10|GRIN2C|PRKCH|PKN1|GNG4|PRKCD|GNAQ|VAMP2|VAMP1|VAMP3|GNB5|PRKCA|PLCB4|CHRM1|SNAP25
MUSCARINIC ACETYLCHOLINE RECEPTOR 2 AND 4 SIGNALING PATHWAY%PANTHER PATHWAY%P00043,0.10058264336093199,0.570947005522165,-0.22966640639252,-1.32770398259991,327,43,GNB1|PRKAR1A|GNB4|STX16|GNG5|PRKACA|PRKX|CHRM4|ACHE|GNG10|GNAI3|GNG4|GNAI2|VAMP2|SLC6A8|STX11|VAMP1|PRKAR2A|VAMP3|GNB5|PRKAR1B|SNAP25
N-ACETYLGLUCOSAMINE METABOLISM%PANTHER PATHWAY%P02756,0.962038664323374,1.0,-0.20796340421958398,-0.570845580861328,5473,6,NPL|GNPDA1|GNPDA2|GFPT1|GFPT2
NICOTINE_DEGRADATION%PANTHER PATHWAY%P05914,0.5641707995645339,0.9380162603437769,0.580155319968793,0.9482479326900309,4663,2,INMT|FMO3
NICOTINE PHARMACODYNAMICS PATHWAY%PANTHER PATHWAY%P06587,0.825646690601123,0.9876441563834109,0.18456398586704298,0.717806858875478,8968,23,CACNA1G|KCNK3|GNAI1|DDC|DRD4|TH|EPB41
NICOTINIC ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00044,0.0782198246797033,0.531991177215838,-0.21843358731697102,-1.35489871051491,231,54,MYO1B|STX16|CHRNB4|MYO9A|CHRNA5|CHRNB1|MYH7B|ACHE|MYO10|MYO1G|CHRFAM7A|CHRNB2|MYO1C|VAMP2|CHRNA7|SLC6A8|STX11|VAMP1|VAMP3|MYO15A|CHRNA3|MYH11|MYH9|SNAP25
NOTCH SIGNALING PATHWAY%PANTHER PATHWAY%P00045,0.490095189091845,0.908938677284213,-0.192858831679012,-0.9751416597292609,1904,28,ADAM17|NEURL2|CIR1|DLL3|RBPJ
O-ANTIGEN BIOSYNTHESIS%PANTHER PATHWAY%P02757,0.883424980361351,0.996316041142784,-0.329917484796229,-0.669557733114991,5622,3,GFPT2
UNTITLED%PANTHER PATHWAY%P05916,0.23668639053254395,0.7507686867668009,-0.231207095208005,-1.16903990654451,919,28,GNB1|GNB4|GNG5|GNG10|GNAI3|ADCY7|GNG4|GNAI2|VAMP2|VAMP1|VAMP3|GNB5|ADCY2|SNAP25
OPIOID PROENKEPHALIN PATHWAY%PANTHER PATHWAY%P05915,0.285310007718035,0.794258537514783,-0.22173541759199697,-1.12114877627847,1108,28,GNG10|GNAI3|ADCY7|GNG4|GNAI2|VAMP2|VAMP1|VAMP3|GNB5|ADCY2|SNAP25
OPIOID PROOPIOMELANOCORTIN PATHWAY%PANTHER PATHWAY%P05917,0.286716922277099,0.796019542850327,-0.21838878670793696,-1.11765945486715,1102,29,GNG10|GNAI3|ADCY7|GNG4|GNAI2|VAMP2|VAMP1|VAMP3|GNB5|ADCY2|SNAP25
ORNITHINE DEGRADATION%PANTHER PATHWAY%P02758,0.76967792615868,0.9792758096555699,-0.374830032449325,-0.7607064141665558,4898,3,ODC1
OXIDATIVE STRESS RESPONSE%PANTHER PATHWAY%P00046,0.543806906029892,0.929698169790548,0.20597604153087898,0.9406761825211329,6330,41,DUSP9|MAPK11|MAP2K6|MAPK12|PLA2G4A|DUSP16|DUSP8|DUSP19
OXYTOCIN RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04391,0.41542750929367994,0.870211862055735,-0.177081211219638,-1.03222643369715,1340,44,PRKCH|PLCE1|GNG4|PRKCD|GNAQ|VAMP2|VAMP1|VAMP3|PLCD1|GNB5|PRKCA|PLCB4|PLCB1|SNAP25
P38 MAPK PATHWAY%PANTHER PATHWAY%P05918,0.5655860789682889,0.938638245695344,0.216134513468346,0.9241185302322629,6402,32,MAPK11|MAP3K10|MAP2K6|MAPK12|MAP3K5|MAP3K7|SRF|MAP3K4|MAPK13|RPS6KA4|DUSP1|MEF2B|IL1R1|TAB1|ELK1|MAPK14|MKNK1
P53 PATHWAY BY GLUCOSE DEPRIVATION%PANTHER PATHWAY%P04397,0.720216606498195,0.9713637233549571,-0.185713300864586,-0.8144407075679101,3191,19,PRKAA1|PRKAG1|EIF4EBP1|PPP2CA|PPP2CB|TP53
P53 PATHWAY FEEDBACK LOOPS 1%PANTHER PATHWAY%P04392,0.5908117898896761,0.945418171231938,-0.382672475596978,-0.8800667507926581,3587,4,MDM2|RFWD2|MDM4|TP53
P53 PATHWAY FEEDBACK LOOPS 2%PANTHER PATHWAY%P04398,0.633451649207861,0.958362160385489,0.19565143317538802,0.8764768060620479,7316,38,CCNA1|MAPK11|MAPK12|ATR|PIK3R3|PDPK1|CCNE1|RB1|HRAS|AKT3|AKT2|MAPK13|CDK2|ATM|AKT1|CCNG1|CCNA2|PIK3C2B|PIK3C2A|MAPK14
P53 PATHWAY%PANTHER PATHWAY%P00059,0.211786844581302,0.726772054105044,0.265121665363798,1.2201841420211699,2475,42,SIRT1|MTA2|CCNB1|CDK1|ATR|PDPK1|CDC25C|CDKN2A|CCNE1|SUMO2|GTSE1|GADD45B|GADD45G|CHEK2|AKT3|AKT2|TRAF2|CDK2|ATM|CDKN2D|AKT1|MDM2
PARKINSON DISEASE%PANTHER PATHWAY%P00049,0.27455815865187,0.7884684708511421,-0.162311226278144,-1.1146116360155802,667,77,HSPA5|FGR|PSMA6|FYN|STUB1|YWHAH|CSNK2A2|LYN|YES1|SNCG|YWHAQ|YWHAB|SNCA|UCHL1|YWHAZ|UBE2L3|YWHAE|HSPA6|MAPK3|PARK2|PLD2
PDGF SIGNALING PATHWAY%PANTHER PATHWAY%P00047,0.820187534473249,0.987153241368501,-0.109686951210026,-0.83652140960205,1486,117,ETS1|ELF4|VAV3|ETV3|VAV2|STAT5A|SHC1|JUN|PRKCA|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1|ARHGAP26|RPS6KA2
PENTOSE PHOSPHATE PATHWAY%PANTHER PATHWAY%P02762,0.0143479840174355,0.261404800124037,-0.6206421969629959,-1.81044082393077,78,7,GPI|PGD|HK1|HK2|TKT
PHENYLETHYLAMINE DEGRADATION%PANTHER PATHWAY%P02766,0.618362162816016,0.9532238181782521,0.5594706368899921,0.914439386439215,5111,2,AOC2|AOC3
PI3 KINASE PATHWAY%PANTHER PATHWAY%P00048,0.360314104500151,0.848418604328854,-0.18457064405074203,-1.06277110622038,1192,42,NRAS|FOXO4|GNAQ|GNAI2|FOXO1|INPP5A|GNB5|GNGT1|YWHAZ|NOS3|PIK3R1|FOXO3
PLASMINOGEN ACTIVATING CASCADE%PANTHER PATHWAY%P00050,0.162731565564838,0.6647749031374661,-0.44879170476038105,-1.30914531386289,895,7,MMP1|PLAU|MMP9|SERPINF2|PLAUR
PURINE METABOLISM%PANTHER PATHWAY%P02769,0.0902746844840386,0.560121322881739,-0.817580028210561,-1.39842685146868,607,2,NT5E
PYRIDOXAL-5-PHOSPHATE BIOSYNTHESIS%PANTHER PATHWAY%P02759,0.7685226429101708,0.9792236089291529,-0.451431822714995,-0.772149955612067,5175,2,PNPO
PYRIDOXAL PHOSPHATE SALVAGE PATHWAY%PANTHER PATHWAY%P02770,0.00801781737193764,0.19847993048827997,-0.9344361731458509,-1.5983030289656899,53,2,PNPO|PDXK
PYRIMIDINE METABOLISM%PANTHER PATHWAY%P02771,0.584401114206128,0.9439064862850342,-0.285137173329768,-0.8863304855541259,3146,8,ALDH6A1|DPYSL2|CDA|NT5E
PYRUVATE METABOLISM%PANTHER PATHWAY%P02772,0.334907373774065,0.830921500684987,-0.36958566765018397,-1.07809778956022,1843,7,PKM|ACLY|PC
RAS PATHWAY%PANTHER PATHWAY%P04393,0.0264450321118247,0.337668602007655,-0.222244170176623,-1.48376318997125,69,69,RHOC|ETS1|RALA|CDC42|MAP2K3|KRAS|SHC1|JUN|STAT3|RALB|MAPK3|RAC1|PLD2|MAP2K1|RPS6KA2|PAK2
S-ADENOSYLMETHIONINE BIOSYNTHESIS%PANTHER PATHWAY%P02773,0.0736663844199831,0.520821259294202,0.830824372759857,1.35795961319531,608,2,MAT2A|MTR
SALVAGE PYRIMIDINE DEOXYRIBONUCLEOTIDES%PANTHER PATHWAY%P02774,0.971981011925437,1.0,0.290015341546351,0.551288655810828,8394,3,TK1|ADAT2
SALVAGE PYRIMIDINE RIBONUCLEOTIDES%PANTHER PATHWAY%P02775,0.539574898785425,0.9280749458041251,0.32769002245786605,0.935115360022846,5330,9,NME3|NME4|UCKL1|UCK1|ADAT2|NME2
SERINE GLYCINE BIOSYNTHESIS%PANTHER PATHWAY%P02776,0.80606692138474,0.984682960940884,0.401630892600077,0.7634580768487119,6961,3,PSAT1|PHGDH
SUCCINATE TO PROPRIONATE CONVERSION%PANTHER PATHWAY%P02777,0.6649299525298139,0.964618776001639,0.45797948604830696,0.8705708253442621,5742,3,PCCB|ECHDC1|MUT
SYNAPTIC_VESICLE_TRAFFICKING%PANTHER PATHWAY%P05734,0.5922293114941429,0.945987625636678,0.251343308018316,0.9016196874770189,6218,18,UNC13B|SYT3|SYT15|UNC13D|STX2|SYT1|RAB3A|SYT7|STX1A|RIMS1
TCA CYCLE%PANTHER PATHWAY%P00051,0.7356275303643729,0.974262605126702,0.274651777554451,0.7837623310052679,7267,9,FH|PDHA1|SUCLG1|ACO2|MDH1|CS
T CELL ACTIVATION%PANTHER PATHWAY%P00053,0.553244890641807,0.932706603479095,-0.14745401476998699,-0.9461082995124109,1542,61,CALM1|VAV3|VAV2|CDC42|JUN|MAPK3|RAC1|MAP2K1|PIK3R1|PAK2
TETRAHYDROFOLATE BIOSYNTHESIS%PANTHER PATHWAY%P02742,0.9783653846153849,1.0,-0.21251686607438602,-0.5379723346215141,5697,5,DHFRL1|FPGS
TGF-BETA SIGNALING PATHWAY%PANTHER PATHWAY%P00052,0.43067623724971704,0.8785877309899279,-0.152385506924466,-1.01736754525413,1139,69,FKBP1B|SKI|TGFBR1|ACVR1|NRAS|GDF15|CITED2|BMP8B|SMAD6|FOSL1|SNIP1|SMAD1|SMAD2|SMAD7|JUN|MAPK3|ACVRL1|FKBP1A|INHBB
THIAMINE METABOLISM%PANTHER PATHWAY%P02780,0.29101707498144,0.800055408161957,-0.685028949545079,-1.17170533039306,1959,2,THTPA|TPK1
THREONINE BIOSYNTHESIS%PANTHER PATHWAY%P02781,0.5904938435058921,0.945418171231938,-0.698610498456109,-0.9345525642402671,4459,1,THNSL1
THYROTROPIN-RELEASING HORMONE RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04394,0.23413212435233202,0.7481332891296201,-0.190570580626183,-1.1543738094946399,722,50,VAMP2|VAMP1|VAMP3|PLCD1|GNB5|PRKCA|PLCB4|PLCB1|CACNA1E|SNAP25|TRH
TOLL RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00054,0.0886039886039886,0.556932119338259,-0.24569911347453502,-1.3648478620554798,310,37,TRAF6|UBE2N|NFKBIE|IRAK1|NFKBIA|MAP3K8|TNFAIP3|IRAK4|UBE2V1|TANK|MAP2K3|JUN|MAPK3|TICAM1|MYD88|MAP2K1
TRANSCRIPTION REGULATION BY BZIP TRANSCRIPTION FACTOR%PANTHER PATHWAY%P00055,0.778256852479212,0.9811398289380491,-0.136562401049106,-0.8025993884973259,2526,45,PRKAR2A|TTF2|POLR2F|PRKAR1B|CFAP20|TAF8|CREB5
TRIACYLGLYCEROL METABOLISM%PANTHER PATHWAY%P02782,0.40013422818792,0.8638522656500329,0.8073445081605649,1.07252116089924,2980,1,LIPE
UBIQUITIN PROTEASOME PATHWAY%PANTHER PATHWAY%P00060,0.9139232860163091,1.0,-0.11812624707301,-0.6801794668979501,3025,42,ATG7|UBE2E2|UBE2L3|UBE2E1|UBE2D3|UBE2K
VALINE BIOSYNTHESIS%PANTHER PATHWAY%P02785,0.5702211416000931,0.940402148292764,0.491104051518473,0.9335371397295541,4924,3,BCAT2|ILVBL
VASOPRESSIN SYNTHESIS%PANTHER PATHWAY%P04395,0.287145748987854,0.796019542850327,0.4072661121495689,1.1621983307008301,2836,9,NHLRC3|PREP|SPCS2|SEC11C|SEC11A|CPE|PAM|PREPL
VEGF SIGNALING PATHWAY%PANTHER PATHWAY%P00056,0.0999296270232231,0.570399840799782,-0.204691192592307,-1.29977573633737,283,58,MAPKAPK3|PIK3CD|SH2D2A|PIK3R2|HIF1A|HSPB1|PRKCH|VEGFA|KDR|PIK3C3|PRKCD|ARHGAP8|NRAS|PRKD2|SPHK1|ARHGAP1|PXN|ETS1|PRR5|PRKCA|NOS3|MAPK3|RAC1|MAP2K1|PIK3R1
VITAMIN B6 METABOLISM%PANTHER PATHWAY%P02787,0.19277297721916697,0.7027916199946072,-0.6257553859080021,-1.26995196369128,1226,3,PNPO|PDXK
VITAMIN D METABOLISM AND PATHWAY%PANTHER PATHWAY%P04396,0.26296723201053795,0.774290656297867,-0.506358690777635,-1.16451920675273,1596,4,CYP27A1|RARA|RXRA
WNT SIGNALING PATHWAY%PANTHER PATHWAY%P00057,7.07513796519032e-05,0.0784645998831315,0.288804589841839,1.81750342127325,0,218,PCDHGA5|PCDHA12|PCDHGA11|PCDH15|PCDHB4|PCDHB15|PCDHA10|PLCB3|PCDHA7|PCDHA2|CDH4|PCDHB8|GNG8|CDH6|PCDH8|CDHR2|PCDHGA7|PCDHB6|PCDHB7|PCDHGA1|WNT4|PCDHB14|CDH10|WNT5B|PCDHA6|SIAH2|PCDHB13|CDH3|PCDHA11|DCHS1|PCDHGA2|PCDHB12|PCDHA1|PCDHA3|FAT3|BTRC|CDH2|PYGO1|GNB3|PCDHGB4|SMARCD3|PCDH9|PCDH20|CDH23|PCDHAC2|DVL1|PCDHGC5|PCDHGA3|CELSR2|PRKCB|PRKCQ|MAP3K7|PCDH18|EP400|NKD2|PCDHGA6|DACT1|CDH7|PCDHA5|HLTF|HDAC8|NLK|CTNNAL1|INO80|LEF1|BMPR1B|CHD1L|HELLS
XANTHINE AND GUANINE SALVAGE PATHWAY%PANTHER PATHWAY%P02788,0.269913589945012,0.7846089815823771,-0.56951799173658,-1.15581984310674,1717,3,PNP|HPRT1
CHONDROITIN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022870.1,0.178924259055982,0.68489956912038,-0.306523187923372,-1.2553154740689798,814,16,CSPG4|CSGALNACT1|CHSY1|NCAN
FGFR1 MUTANT RECEPTOR ACTIVATION%REACTOME%R-HSA-1839124.2,0.028041825095057003,0.34451087937629105,-0.351651313790654,-1.62910924769077,117,22,BAG4|FGF2|FGFR1|STAT5A|STAT3|GAB2|BCR|PIK3R1|LRRFIP1
INTERLEUKIN-10 SIGNALING%REACTOME%R-HSA-6783783.3,0.7376141710489901,0.974306231601101,-0.15235043915373098,-0.81978047345661,2664,34,CCR5|CCL5|PTGS2|CCL19|CXCL10|CCL2|CCL3L3|CSF1|TYK2|IL1R1|CCR1|CCL4|TIMP1|IL10RA|CXCL2|CXCL1|JAK1|TNFRSF1A|IL10RB|PTAFR|CCL3|IL18|FPR1|CD86|IL1RN|IL1B|LIF|TNFRSF1B|IL6|ICAM1|FCER2|CXCL8|STAT3|TNF
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN%REACTOME DATABASE ID RELEASE 66%1237044,0.6554080437329171,0.9640743070248079,-0.26063689092796,-0.8413592401472959,3356,9,CYB5R2|AQP1
ELECTRON TRANSPORT FROM NADPH TO FERREDOXIN%REACTOME%R-HSA-2395516.1,0.0603218710200301,0.479132137152383,0.7549482157061229,1.43507714048601,520,3,FDXR|FDX1
EGFR INTERACTS WITH PHOSPHOLIPASE C-GAMMA%REACTOME DATABASE ID RELEASE 66%212718,0.32587395669529495,0.826621597878865,0.6755779982221,1.10421367888074,2693,2,PLCG1|EGFR
CREATINE METABOLISM%REACTOME DATABASE ID RELEASE 66%71288,0.906908171861837,1.0,0.240440748705279,0.625816752250464,8611,7,GAMT|CKB|CKMT1B|GATM|CKMT1A
PHASE II - CONJUGATION OF COMPOUNDS%REACTOME DATABASE ID RELEASE 66%156580,0.33583489681050704,0.8311444145897029,0.216097583217709,1.09953490049219,4116,64,MGST1|GLYATL2|GSTA4|GSTO2|AS3MT|MAT2A|SLC35D1|GGT1|SLC35B3|N6AMT1|SLC26A2|SULT1A3|MTR|NAT1|MGST3|GSTP1|MGST2|OPLAH|GGT5|GSTZ1
PRE-NOTCH EXPRESSION AND PROCESSING%REACTOME DATABASE ID RELEASE 66%1912422,0.8592194659503871,0.99166790097654,0.13599158010273,0.7312878121789581,10875,83,HIST1H3E|HIST1H2BJ|HIST3H2BB|KAT2A|MAML1|SIRT6|ATP2A1|HIST2H3C|POGLUT1|E2F3|HIST2H3A|HIST1H4I|TNRC6A|H2AFX|H3F3A|ATP2A2|H2AFZ|RFNG|LFNG|HIST1H2BF|TNRC6C|ST3GAL4|HIST1H2BK|HIST1H2AC|MAML3|E2F1|HIST1H3H|HIST1H2BN|ST3GAL6|HIST1H2BG|HIST2H2BE|HIST1H2BH
CYTOSOLIC SULFONATION OF SMALL MOLECULES%REACTOME DATABASE ID RELEASE 66%156584,0.977754439564636,1.0,0.143254700357169,0.505238640386683,10240,17,SLC35B3|SLC26A2|SULT1A3|PAPSS2|SLC35B2|PODXL2|SULT1A4|BPNT1|IMPAD1|ABHD14B|TPST2
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS%REACTOME DATABASE ID RELEASE 66%168274,0.0345636675390308,0.379078740472774,0.38936628331046796,1.58297320937448,382,27,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
SIGNALING BY TGF-BETA FAMILY MEMBERS%REACTOME DATABASE ID RELEASE 66%9006936,0.124768946395564,0.607607158836689,-0.17269416343817498,-1.24157871827169,269,93,CDK9|NEDD4L|F11R|SKI|TGFBR1|RHOA|STUB1|SMAD6|NEDD8|SMAD1|SMAD2|CHRDL1|PPM1A|SMAD7|UBA52|UBE2D3|ACVRL1|PPP1CB|UBC|TFDP2|FKBP1A|PARD3|INHBB|UBB
G1 PHASE%REACTOME%R-HSA-69236.4,0.300815463606161,0.8038155709110071,-0.192677218262274,-1.10944934634224,995,42,LYN|PPP2CA|PPP2CB|PPP2R1B|CDKN1C|UBA52|CDKN1A|UBC|TFDP2|UBB
LOSS OF FUNCTION OF TGFBR2 IN CANCER%REACTOME%R-HSA-3642278.1,0.0785443767495472,0.532203813468543,-0.65105103235465,-1.4972813650909098,476,4,TGFBR1|FKBP1A
BIOSYNTHESIS OF DHA-DERIVED SULFIDO CONJUGATES%REACTOME%R-HSA-9026395.1,0.23815887156644397,0.7507739897770379,-0.714567427063418,-1.22222931420851,1603,2,GSTM4
BIOSYNTHESIS OF D-SERIES RESOLVINS%REACTOME DATABASE ID RELEASE 66%9018676,0.716703786191537,0.971081608033886,-0.47313953035419504,-0.8092798269384621,4826,2,ALOX5
GLYCOPROTEIN HORMONES%REACTOME DATABASE ID RELEASE 66%209822,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
GSD IV%REACTOME DATABASE ID RELEASE 66%3878781,0.8475167785234899,0.991298302704726,0.57713939126599,0.766703933283182,6313,1,GYG2
"TRISTETRAPROLIN (TTP, ZFP36) BINDS AND DESTABILIZES MRNA%REACTOME%R-HSA-450513.2",0.0177826564215148,0.282007307615586,-0.43075177004124,-1.76407326988439,80,16,EXOSC7|EXOSC1|DIS3|MAPKAPK2|EXOSC8|DCP1A|DCP2|EXOSC6|EXOSC4|EXOSC9|YWHAB|EXOSC5
PHOSPHORYLATION SITE MUTANTS OF CTNNB1 ARE NOT TARGETED TO THE PROTEASOME BY THE DESTRUCTION COMPLEX%REACTOME%R-HSA-4839743.1,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
SEMA4D INDUCED CELL MIGRATION AND GROWTH-CONE COLLAPSE%REACTOME DATABASE ID RELEASE 66%416572,0.154557761732852,0.6538333887772321,-0.292909544247422,-1.2845469622243701,684,19,MYL12B|MYL9|ARHGEF12|RHOB|MYL6|SEMA4D|ROCK1|LIMK2|PLXNB1|MYH10|ERBB2|ROCK2|RND1|RHOA|RHOC|LIMK1|MYH11|MYH9
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION%REACTOME DATABASE ID RELEASE 66%6804760,0.0187274368231047,0.286111698549296,-0.39848374358318606,-1.74753978615049,82,19,UBA52|TP53|SETD9|UBC|JMY|UBB
GENE AND PROTEIN EXPRESSION BY JAK-STAT SIGNALING AFTER INTERLEUKIN-12 STIMULATION%REACTOME%R-HSA-8950505.2,0.0019374481040686398,0.112582730005196,-0.370576436452273,-1.99402987096193,6,34,BOLA2|BOLA2B|AIP|HNRNPF|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|PITPNA|PAK2|FOXO3
NUCLEOTIDE SALVAGE%REACTOME DATABASE ID RELEASE 66%8956321,0.691945360339143,0.96731875442989,-0.18379891690092,-0.834777183448547,2937,21,PNP|CDA|HPRT1|UPP1
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696397,0.908494946735864,1.0,0.15775344805057098,0.628624797598652,9977,25,POLE|POLE2|RFC4|POLD1|POLD3|LIG1|XRCC1|RFC3|RFC5
MITOPHAGY%REACTOME%R-HSA-5205647.2,0.00994644223412395,0.219338255445175,-0.35408188321656203,-1.7644597963809299,38,27,TOMM22|SQSTM1|TOMM20|MAP1LC3A|MFN2|CSNK2A2|UBA52|PARK2|MAP1LC3B|UBC|CSNK2A1|UBB
CHK1 CHK2(CDS1) MEDIATED INACTIVATION OF CYCLIN B:CDK1 COMPLEX%REACTOME%R-HSA-75035.4,0.625846999901797,0.9543682073609309,0.269143418832831,0.868625853586379,6372,13,CCNB1|CDK1|WEE1|CDC25C
REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA-CARBOXYLATED PROTEINS%REACTOME DATABASE ID RELEASE 66%159782,0.8400702987697719,0.98953921193435,-0.257224374475357,-0.7060636365811609,4779,6,GAS6|FURIN|PROC
GENE SILENCING BY RNA%REACTOME%R-HSA-211000.2,0.29517188103514896,0.800447413278835,0.201202141764392,1.12248901210978,3820,101,HIST1H3E|HIST1H2BJ|HIST3H2BB|TPR|PIWIL4|NUP133|HIST2H3C|HIST2H3A|DROSHA|POLR2B|NUP205|HIST1H4I|NUP188|NUP160|TNRC6A|H2AFX|NUP85|H3F3A|H2AFZ|NUPL2|MYBL1|HIST1H2BF|POLR2L|NDC1|TNRC6C|HIST1H2BK|NUP107|DICER1|NUP35|POLR2J|NUP210|HIST1H2AC|DGCR8|POM121|HIST1H3H|NUP54|HIST1H2BN|POLR2G|POLR2H|TARBP2|HIST1H2BG|NUP37|HIST2H2BE|HIST1H2BH|PIWIL2|AAAS
S37 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358749.1,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
O-LINKED GLYCOSYLATION OF MUCINS%REACTOME DATABASE ID RELEASE 66%913709,0.0274841437632135,0.3403540236452571,-0.268698245672936,-1.54718391574119,90,42,GALNT18|MUC4|GALNT2|GALNT9|MUC3A|GALNT12|B3GNTL1|B3GNT5|B3GNT7|B3GNT8|B3GNT2|MUC12|GALNT6
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660517,0.8745023885350319,0.993707953086361,0.215671678357457,0.657964852437579,8786,11,MTMR4|MTMR7|FIG4|PIK3C2A|PIKFYVE|PIK3R4|MTM1|MTMR9|VAC14
DEADENYLATION-DEPENDENT MRNA DECAY%REACTOME DATABASE ID RELEASE 66%429914,0.550922761449077,0.931763873811087,-0.150833548376029,-0.947024361295756,1611,56,PARN|CNOT6L|EIF4E|LSM3|CNOT10|DCP1A|DCP2|EIF4A1|HBS1L|EXOSC6|EXOSC4|EIF4A2|EIF4G1|CNOT7|EXOSC9|EIF4B|PABPC1|EXOSC5|DDX6
CELLULAR SENESCENCE%REACTOME DATABASE ID RELEASE 66%2559583,0.516147845738864,0.922205682736145,0.16236725527083498,0.9786273702788991,7079,160,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|CDK6|CCNA1|MAPK11|EHMT1|ANAPC15|MAP2K6|ANAPC5|CDKN2C|HIST2H3C|E2F3|HIST2H3A|MAPK10|ASF1A|MAP3K5|CDKN2A|EP400|EZH2|CDC23|CCNE1|ANAPC7|E2F2|ANAPC16|RB1|FOS|HIST1H4I|IGFBP7|LMNB1|TNRC6A|CDKN2B|H2AFX|H3F3A|H2AFZ|HIST1H2BF|MAP2K7|TNRC6C|HIST1H2BK|UBE2C|CCNE2|EHMT2|CEBPB|HIST1H2AC|MAPK9|ANAPC10|E2F1|SUZ12|EED|HIST1H3H|ACD|HIRA|HIST1H2BN|SP1|PHC2|CDK2|ATM|HIST1H2BG|CDKN2D|HIST2H2BE|CDC16|HIST1H2BH|ANAPC2|TNIK|MAPKAPK5|MINK1
SEROTONIN RECEPTORS%REACTOME DATABASE ID RELEASE 66%390666,0.226664901363697,0.7398172623753029,-0.885917512130569,-1.1851188673755602,1711,1,HTR1B
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION%REACTOME%R-HSA-69273.6,0.21442228899207896,0.7314207060757599,0.308612598054544,1.2297768092285402,2354,25,CCNA1|CCNB1|CDK1|WEE1|CDC25C|PKMYT1|PPP2R3B|CCNB2|CDK7|PLK1|FOXM1|PPP2R1A|CDK2|CCNA2|MNAT1
FCERI MEDIATED MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%2871796,0.24129746835442997,0.7546982763772849,-0.22405203132770102,-1.1623891187875302,914,30,NRAS|VAV1|LYN|VAV3|VAV2|KRAS|JUN|MAPK3|RAC1|PAK2
TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT%REACTOME DATABASE ID RELEASE 66%159231,0.052755905511810995,0.4480464365031289,0.339836002449846,1.5000484869788302,602,36,TPR|NUP133|WDR33|CPSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|CPSF2|NUP37|AAAS|NUP62|CPSF4|RANBP2|SYMPK|NUP50|NXF1
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO%REACTOME DATABASE ID RELEASE 66%428542,0.610526315789474,0.9508825506493929,0.308953679028808,0.8816482376498191,6031,9,SLIT1|ROBO2|SRC|NTN1
FGFR2 MUTANT RECEPTOR ACTIVATION%REACTOME%R-HSA-1839126.2,0.0325570342205323,0.36828894094998404,-0.34718070797881295,-1.60839809153912,136,22,FGF7|FGF2|POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D|FGF10
INTERLEUKIN-20 FAMILY SIGNALING%REACTOME%R-HSA-8854691.6,0.902320675105485,0.999822188724968,-0.17063276170807998,-0.6610764917659029,4276,14,STAT5B|STAT2|TYK2|STAT1|IFNLR1|JAK3|JAK1|IL10RB|PTPN11|IL24|STAT4|STAT5A|STAT3
MINERALOCORTICOID BIOSYNTHESIS%REACTOME%R-HSA-193993.2,0.0276510067114094,0.341482715993774,0.9863255403617119,1.31028947726852,205,1,CYP21A2
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING%REACTOME%R-HSA-163210.2,0.704504332920674,0.968941691852291,0.22737283793451504,0.815632724402357,7397,18,ATP5G1|ATP5D|MT-ATP8|ATP5C1|ATP5E|ATP5H|MT-ATP6|ATP5A1
VITAMINS B6 ACTIVATION TO PYRIDOXAL PHOSPHATE%REACTOME%R-HSA-964975.1,0.00801781737193764,0.19847993048827997,-0.9344361731458509,-1.5983030289656899,53,2,PNPO|PDXK
DEFECTIVE EXT2 CAUSES EXOSTOSES 2%REACTOME%R-HSA-3656237.2,0.4689703808180539,0.896113819860135,0.33689287640795296,0.9942579150665172,4654,10,GPC2|GPC6|GPC1|GPC3|AGRN|SDC3
INTERLEUKIN-37 SIGNALING%REACTOME DATABASE ID RELEASE 66%9008059,0.8089705742310259,0.984682960940884,0.202849501316972,0.727662516357705,8494,18,SIGIRR|IL18BP|PTPN18|TBK1|PTPN13
ADENOSINE P1 RECEPTORS%REACTOME%R-HSA-417973.1,0.530086410054988,0.9265056012720759,-0.45971770475858004,-0.9329834229946821,3373,3,ADORA2B
MITOCHONDRIAL ABC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%1369007,0.161496248180087,0.664367762084791,0.606849390613798,1.28597182798477,1441,4,ABCB6|ABCB10|ABCB7|ABCB8
ABACAVIR METABOLISM%REACTOME%R-HSA-2161541.3,0.749218478638416,0.9749763305090959,0.42526191892264203,0.808378171997246,6470,3,GUK1|ADAL|NT5C2
AMYLOID FIBER FORMATION%REACTOME%R-HSA-977225.5,0.33192632386799703,0.8293509737209019,-0.160801481723796,-1.07437609652903,864,70,HIST2H4A|TSPAN5|HIST2H2AA4|NCSTN|TSPAN33|SNCA|UBA52|B2M|HIST2H4B|PARK2|HIST1H2BC|H3F3B|UBC|HIST2H2AC|HIST1H2BD|UBB
PI AND PC TRANSPORT BETWEEN ER AND GOLGI MEMBRANES%REACTOME%R-HSA-1483196.2,0.724083145769893,0.9725499575908509,-0.63266431407146,-0.8463343427066159,5468,1,PITPNB
CITRIC ACID CYCLE (TCA CYCLE)%REACTOME%R-HSA-71403.2,0.8474334600760458,0.991298302704726,-0.155552540009694,-0.720634536239623,3565,22,SDHC|ME2|IDH3A|FAHD1|OGDH|IDH3B
PLC-GAMMA1 SIGNALLING%REACTOME DATABASE ID RELEASE 66%167021,0.8531897649646871,0.991298302704726,0.378020574987721,0.718577346779808,7368,3,PLCG1|NGF
BETAKLOTHO-MEDIATED LIGAND BINDING%REACTOME DATABASE ID RELEASE 66%1307965,0.00108866577960566,0.0893009762660318,0.9782740556934101,1.59896206927046,8,2,FGFR4|FGF19
BUTYROPHILIN (BTN) FAMILY INTERACTIONS%REACTOME DATABASE ID RELEASE 66%8851680,0.0679005927004263,0.50364937614461,0.544541894202659,1.4845672951992899,652,8,CD209|PPL|BTN2A2|BTN2A1|BTN3A2|BTN3A3|BTN3A1|BTNL9
INFLUENZA LIFE CYCLE%REACTOME DATABASE ID RELEASE 66%168255,0.632324533161623,0.95809026474745,-0.11794789604407901,-0.9300880926489941,981,136,RPS4Y1|NUP188|NUP160|RPS24|RPL36A|NUP85|RPS19|RPLP0|NUPL2|RPS27L|POLR2L|RPL36|NDC1|GRSF1|CLTC|RPS15|NUP107|NUP35|POLR2J|NUP210|RPS10|RPL28|RPS3A|RPL26L1|POM121|NUP54|FAU|RPL37|RPL27A|POLR2G|POLR2H|NUP37|RPL7A|RPL19|AAAS|GTF2F2|RPLP1|RPSA|RPL6|RPL5|NUP62|RPL18|RPS27A|RPS26|RANBP2|RPL22|RPS12|RPL4|NUP50|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|NUP43|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|XPO1|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|NUP214|GTF2F1|RPS18|RPL10A|NUP153|RPL22L1|NUP88|RPL38|RPS13|RPS27|RPS23|NUP155|RPS21|POLR2C|RPL3|RPL29|RPL31|RPL17|RAE1|RPS14|RPS17|IPO5|RPL32|RAN|CANX|RPL18A|HSP90AA1|RPL11|KPNB1|NUP93|POLR2E|CALR|RPS16|RPL12|DNAJC3|RPS4X|RPL9|KPNA1|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|POLR2A|CLTA|RPL35A|POLR2K|UBA52|POLR2F|POLR2I|POLR2D
METABOLISM OF COFACTORS%REACTOME%R-HSA-8978934.2,0.22236012984533102,0.7355723797115551,0.34746976706780297,1.2254756894615801,2328,17,COQ3|DHFR|COQ2|IDH1|COQ6|COQ9|COQ5|PTS|PDSS1|AKT1
PYRIMIDINE SALVAGE%REACTOME%R-HSA-73614.3,0.6327825911746929,0.958316380324396,0.292149912866014,0.862209870241621,6280,10,TK1|UCKL1|DCK|UCK1
MITOTIC METAPHASE AND ANAPHASE%REACTOME DATABASE ID RELEASE 66%2555396,0.0251485722568488,0.329326373353219,0.235551159598441,1.43613952864304,346,174,CLIP1|ANAPC15|PSMD11|ZWINT|ANAPC5|CENPF|KIF2C|NUP133|PSMD13|KIF18A|CENPL|PSMB9|CENPT|CKAP5|NSL1|PSMA4|CENPK|PSMD3|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC23|CDC20|NDC80|ITGB3BP|CENPA|ANAPC7|CENPE|ANAPC16|PTTG1|FBXO5|PSMD1|BUB1B|LEMD3|ESPL1|AURKB|ERCC6L|LMNB1|NUP160|DSN1|PSMA1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|PSMC3|CDCA5|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|PSMA3|VRK1|CENPM|UBE2C|DYNC1H1|PSMC6|PSMC1|ANAPC10|SPC25|PSMD2|PSMA5|SGOL1|PDS5B|SPC24|PSMC2|SMC3|LEMD2|PPP2R1A|PSMC5|NUP37|CDC16|NDE1|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ZWILCH
HCN CHANNELS%REACTOME DATABASE ID RELEASE 66%1296061,0.0281843474053466,0.345491958731604,0.889605734767025,1.45403613457755,232,2,HCN2|HCN3
REACTIONS SPECIFIC TO THE COMPLEX N-GLYCAN SYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%975578,0.827279331638213,0.9876441563834109,-0.24539901442967502,-0.715839812455337,4554,7,CHST8
RESOLUTION OF D-LOOP STRUCTURES THROUGH HOLLIDAY JUNCTION INTERMEDIATES%REACTOME DATABASE ID RELEASE 66%5693568,0.00529614264277518,0.16770443270936902,0.428222490901938,1.8458632496079599,59,33,MUS81|EME2|XRCC3|BLM|EXO1|BRIP1|DNA2|GEN1|SLX1B|RAD51C|RAD51|RMI2|RAD51AP1|SLX4|EME1|RMI1|PALB2|BRCA2|XRCC2|SPIDR|ATM|BRCA1
NEGATIVE REGULATION OF NOTCH4 SIGNALING%REACTOME DATABASE ID RELEASE 66%9604323,0.898433594400933,0.998912093067348,0.138071848573996,0.6734213902901479,10782,53,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|PSMA7|TACC3|PSMB4
ORGANIC CATION ANION ZWITTERION TRANSPORT%REACTOME DATABASE ID RELEASE 66%549132,0.6984182776801411,0.96731875442989,-0.294186339373988,-0.8075217484134529,3973,6,SLC22A5|SLC22A18|RUNX1
NORC NEGATIVELY REGULATES RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%427413,0.96838351822504,1.0,0.111660819658044,0.5974942095334039,12220,81,GTF2H2|HIST1H3E|HIST1H2BJ|HIST3H2BB|TAF1D|HIST2H3C|HIST2H3A|GTF2H1|DNMT3B|HIST1H4I|H2AFX|H3F3A|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|HIST1H2AC|HIST1H3H|HIST1H2BN|SUDS3|POLR2H|SIN3B|HIST1H2BG|HIST2H2BE|HIST1H2BH|DNMT1
CELL-CELL COMMUNICATION%REACTOME%R-HSA-1500931.3,0.24287157175044702,0.7565220534116759,0.21172084778804398,1.16756842719418,3125,95,CLDN12|ITGB1|CDH4|CDH6|CLDN15|CD47|CDH10|SDK1|CDH3|SIRPG|ACTN2|ILK|CDH2|CLDN11|FBLIM1|CLDN7|KIRREL|CTNND1|KIRREL3|CDH7|ARHGEF6
PI3K AKT SIGNALING IN CANCER%REACTOME DATABASE ID RELEASE 66%2219528,0.60303928836175,0.9508825506493929,-0.138298620838947,-0.920431061800759,1626,68,PIK3CD|CD86|PIK3R2|CDKN1B|RHOG|MAPKAP1|CD19|FOXO4|VAV1|FGF7|FYN|FOXO1|FGF2|HGF|HBEGF|PRR5|CDKN1A|FGF10|RAC1|MET|PIK3R1|FOXO6|FOXO3
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS%REACTOME DATABASE ID RELEASE 66%5669034,0.861862442040185,0.991915800284466,0.197861872238021,0.670872843174807,8921,15,CD27|TNFRSF11B|TNFSF13B|TNFRSF6B
HDL CLEARANCE%REACTOME DATABASE ID RELEASE 66%8964011,0.16430557394412804,0.666438287523194,-0.9150308778120859,-1.22406470430681,1240,1,HDLBP
RETINOID METABOLISM AND TRANSPORT%REACTOME DATABASE ID RELEASE 66%975634,0.0416929879974732,0.402998391331252,0.380087039962284,1.5452483362843998,461,27,RBP1|LPL|BCO2|GPC2|GPC6|AKR1C1|GPC1|APOE|LRP8|LDLR|GPC3|RDH11|APOM|AGRN
FORMATION OF THE EDITOSOME%REACTOME DATABASE ID RELEASE 66%75094,0.7551596139569409,0.9771370084125129,-0.456717003068623,-0.7811899735507941,5085,2,APOBEC3B
IRAK1 RECRUITS IKK COMPLEX UPON TLR7 8 OR 9 STIMULATION%REACTOME%R-HSA-975144.1,0.11150512214342,0.5855068018166539,-0.411961668387355,-1.3937279865705499,565,10,TRAF6|UBE2N|IRAK1|UBE2V1|PELI2|PELI1
CHAPERONIN-MEDIATED PROTEIN FOLDING%REACTOME%R-HSA-390466.3,0.0148242270224481,0.264001457476971,-0.21470068420175303,-1.49679710735864,34,82,FBXO6|GNG5|FBXL5|GBA|FKBP9|FBXL3|FBXW2|GNG10|FBXW7|GNAI3|PFDN6|CCT4|PDCL|GNG4|GNAZ|TUBB2B|ARFGEF2|TUBB2A|CCT7|SPHK1|GNAI2|TUBB6|TUBA1C|CSNK2A2|PFDN1|TUBB3|PFDN2|TCP1|GNB5|GNGT1|STAT3|TP53|TUBB4B|NOP56|CSNK2A1|KIF13A
SIGNALING BY FGFR2%REACTOME DATABASE ID RELEASE 66%5654738,0.00134861766689144,0.0945022140486112,-0.322242214034963,-1.99880231622017,3,54,FGF7|HNRNPF|FGF2|PPP2CA|PPP2CB|POLR2A|POLR2K|KRAS|UBA52|POLR2F|MAPK3|NCBP2|POLR2I|POLR2D|FGF10|UBC|PIK3R1|UBB
INOSITOL TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%429593,0.14297810572154301,0.632949331968897,0.7717918919775459,1.2614726450737401,1181,2,SLC2A13|SLC5A3
ATF4 ACTIVATES GENES%REACTOME%R-HSA-380994.1,0.13912618989504502,0.6278116705318371,-0.271229268059927,-1.3001271855372298,569,24,EXOSC7|EXOSC1|DIS3|EXOSC8|PARN|ATF4|DCP2|EXOSC6|EXOSC4|DDIT3|ATF6|EXOSC9|CXCL8|NFYA|EXOSC5
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS%REACTOME DATABASE ID RELEASE 66%1839117,0.0243688254665203,0.327840876158443,-0.416187263004693,-1.7044267185776898,110,16,STAT5A|STAT3|GAB2|BCR|PIK3R1|LRRFIP1
GOLGI-TO-ER RETROGRADE TRANSPORT%REACTOME%R-HSA-8856688.1,0.888224471021159,0.997300970905927,0.12697156547063498,0.717012206219694,11585,108,KIF25|KIF21B|PLA2G4A|KLC1|KIF2C|KIF18A|KIF20B|KIFC2|COPB1|KIF4A|KIF23|USE1|KIF11|DCTN4|CENPE|KIF18B|COPB2|KIF15|KIFAP3|PAFAH1B3|ARF5|KIFC1|KIF22|KLC2|KIF20A|RACGAP1|GBF1|DYNC1H1|COPG2|TMED9|KIF16B
PKB-MEDIATED EVENTS%REACTOME%R-HSA-109703.4,0.21120116124349803,0.7258149888677271,0.728039702233251,1.18996089287965,1745,2,PDE3B|AKT2
INHIBITION OF ADENYLATE CYCLASE PATHWAY%REACTOME DATABASE ID RELEASE 66%997269,0.865947291969288,0.9929671171385601,-0.184451749393376,-0.694641762536278,4172,13,GNAI3|ADCY7|GNAI2|GNAL|ADCY2
GLUTATHIONE CONJUGATION%REACTOME DATABASE ID RELEASE 66%156590,0.168442942552638,0.672026878249637,-0.245019175101672,-1.25394715454125,647,29,CHAC1|GSTT2|GSTM5|GSTT2B|GSTM3|CNDP2|GSTM1|GSTM4
DEFECTIVE GALNT3 CAUSES FAMILIAL HYPERPHOSPHATEMIC TUMORAL CALCINOSIS (HFTC)%REACTOME%R-HSA-5083625.1,0.35026362038664305,0.842847021021096,-0.388780782837379,-1.06717714416807,1992,6,MUC4|MUC3A|MUC12
VLDLR INTERNALISATION AND DEGRADATION%REACTOME%R-HSA-8866427.3,0.38029874848607204,0.856455387424841,-0.29781349038510496,-1.04804277703545,1883,11,CLTA|AP2S1|NR1H2|MYLIP
NEF MEDIATED CD8 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%182218,0.788858466722831,0.9819233677232551,0.281800551468257,0.733467629143107,7490,7,AP2A2|CD8B|AP2M1|AP2B1
INTERLEUKIN-2 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020558,0.39967702866370597,0.8638522656500329,-0.293556217587995,-1.0330609036518499,1979,11,STAT5B|LCK|IL2RA|JAK3|IL2RB|JAK1|SYK|IL2RG|PTK2B|STAT5A|SHC1
SPRY REGULATION OF FGF SIGNALING%REACTOME%R-HSA-1295596.1,0.0021097046413502104,0.115553415806697,-0.531089905779553,-2.05758289446009,9,14,PPP2CA|PPP2CB|UBA52|MAPK3|UBC|UBB
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%73817,0.9851640793869131,1.0,0.154703448275862,0.4876805547491211,10026,12,IMPDH1|ADSSL1|PAICS|ADSS|PPAT
RAB REGULATION OF TRAFFICKING%REACTOME%R-HSA-9007101.2,0.0237175951461666,0.32397355287938,-0.187523282998572,-1.4301358484000901,42,117,GGA1|ARF6|RAB3GAP1|HPS1|DENND5B|RAB11A|RIN1|DENND2A|TRAPPC1|RAB10|MON1B|HPS4|TBC1D10A|RAB33B|RAB13|DENND1B|RAB21|RABGEF1|RAB8B|TRAPPC2L|TRAPPC6A|TBC1D20|TBC1D25|RAB18|RIN3|RAB6A|TBC1D14|RIN2|RAB1A|RAB39A|DENND1A|RAB8A|RAB12|RAB5C|ALS2CL|TBC1D2|TBC1D15|YWHAE|RINL|RAB3IL1|TRAPPC10|GABARAP|RAB7A|RAB5A|MAP1LC3B|DENND6A|GABARAPL2
TRANSFERRIN ENDOCYTOSIS AND RECYCLING%REACTOME%R-HSA-917977.1,0.23680278884462197,0.7507739897770379,-0.23917136179850898,-1.17440153203326,950,26,ATP6V0C|ATP6V1F|TFRC|ATP6V1E2|ATP6V0D1|ATP6V1E1|STEAP3
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER%REACTOME DATABASE ID RELEASE 66%5674400,0.703685258964144,0.968941691852291,-0.169731015810435,-0.8334290673532471,2825,26,CDKN1A|FOXO6|FOXO3
LGI-ADAM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%5682910,0.29897818824916494,0.8023890191280308,0.364885428032696,1.1502492668783,3042,12,LGI1|ADAM11|DLG4|ADAM23|LGI4|STX1A|ADAM22|STX1B|CACNG4
OPSINS%REACTOME DATABASE ID RELEASE 66%419771,0.527340129749768,0.9265056012720759,-0.731473312748125,-0.978514152897505,3982,1,OPN3
DOWNREGULATION OF SMAD2 3:SMAD4 TRANSCRIPTIONAL ACTIVITY%REACTOME%R-HSA-2173795.1,0.0964000966417009,0.569155793398648,-0.292997608114607,-1.37677125917688,398,23,UBE2D1|NEDD4L|SKI|SMAD2|PPM1A|UBA52|UBE2D3|UBC|UBB
BETA OXIDATION OF DECANOYL-COA TO OCTANOYL-COA-COA%REACTOME%R-HSA-77346.3,0.29402920962199297,0.8004058897916541,0.46861085244878703,1.1524801450020001,2737,6,ACADM|HADH|HADHB|ECHS1|MECR|HADHA
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS%REACTOME%R-HSA-111465.3,0.7720785013380909,0.979693198874896,0.18309287861829002,0.767695850868495,8654,30,OCLN|GAS2|CASP6|PRKCQ|APC|LMNB1|BIRC2|SPTAN1|ACIN1|CLSPN
MET INTERACTS WITH TNS PROTEINS%REACTOME DATABASE ID RELEASE 66%8875513,0.797177735468698,0.9831339686797859,0.354558384940824,0.751343086871202,7117,4,ITGB1|TNS3
FRS-MEDIATED FGFR3 SIGNALING%REACTOME DATABASE ID RELEASE 66%5654706,0.46710007880220705,0.8949379342993,-0.287722677253224,-0.973408883473522,2370,10,FGF1|FRS2|NRAS|FGF2|KRAS
MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS%REACTOME DATABASE ID RELEASE 66%174490,0.39831223628692003,0.8638522656500329,-0.265831116369313,-1.029900120308,1887,14,UBA52|UBC|UBB
SUMOYLATION OF IMMUNE RESPONSE PROTEINS%REACTOME%R-HSA-4755510.2,0.4085587404117879,0.867015886388254,-0.291536558737846,-1.02595347253031,2023,11,NFKBIA|UBE2I|SUMO1|SUMO3
NEDDYLATION%REACTOME DATABASE ID RELEASE 66%8951664,0.9827328927733959,1.0,0.0988451418519445,0.61986282498973,13829,214,RBBP7|SPSB4|COMMD3|DCAF6|BTRC|CISH|PSMD11|LMO7|KLHL42|PSMD13|PSMB9|UBA3|KLHL3|ASB2|PSMA4|SOCS2|DDB2|PSMD3|BIRC5|SPSB3|DTL|FBXL19|COMMD4|GAN|LRR1|KLHL20|UBD|CUL9|FBXL15|PSMD1|KLHL25|CAND1|NAE1|DDB1|RNF7|PSMA1|DCAF5|DCUN1D4|FBXL8|COMMD9|PSMC3|OBSL1|KLHL22|FBXW5|CCNF|CUL4B|COMMD8|GPR75-ASB3|KEAP1|PSMA3|FBXO9|CUL7|PSMC6|PSMC1|KLHL9|PSMD2|WDR5|DCAF17|DCUN1D1|COPS7B|BTBD6|RBX1|PSMA5|FBXL7|PSMC2|PSMC5|SKP2|COMMD5|SENP8|ASB1|SHFM1|PSMA2|PSMB6|CUL2|PSMB3|FBXO44|FBXO11|PSMA7|DCAF10|COMMD6|KBTBD7|PSMB4
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION%REACTOME%R-HSA-983231.2,0.18207475209763502,0.6875189360012,0.21421159638239398,1.21773641190403,2386,112,DOCK10|KIF25|HIST1H3E|KIF21B|KLC1|HBB|KIF2C|WEE1|KIF18A|HIST2H3C|KIF20B|KIFC2|HIST2H3A|JAK2|KIF4A|VPS45|KIF23|DOCK8|KIF11|AK3|AKAP1|CENPE|KIF18B|PRKAR2B|KIF15|KIFAP3|RAD51C|DOCK7|KIFC1|SH2B1|H3F3A|KIF22|KLC2|PHF21A|MAFK
FCERI MEDIATED NF-KB ACTIVATION%REACTOME DATABASE ID RELEASE 66%2871837,0.590458045566405,0.945418171231938,0.17283414002416397,0.9205305191732779,7437,79,IGKV4-1|CDC34|BTRC|PSMD11|RASGRP2|PSMD13|PSMB9|PSMA4|PDPK1|PSMD3|PRKCQ|MAP3K7|CARD11|IGKV3-11|PSMD1|IGKV2D-28|PSMA1|IGKV2-28|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|RASGRP1|PSMA5|PSMC2|PSMC5|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|TAB1|PSMA7|PSMB4
FOLDING OF ACTIN BY CCT TRIC%REACTOME DATABASE ID RELEASE 66%390450,0.706067769897557,0.968941691852291,-0.23796368212152,-0.8050667550173491,3583,10,CCT3|ACTB|CCT8|CCT6A|CCT4|CCT7|TCP1
SYNTHESIS OF VERY LONG-CHAIN FATTY ACYL-COAS%REACTOME%R-HSA-75876.5,0.970955147128845,1.0,0.145786200205482,0.5229648217176729,10195,18,HACD1|ELOVL6
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2%REACTOME%R-HSA-5654696.1,0.110867178924259,0.584830174998513,-0.33609146512552296,-1.3764075068280102,504,16,NRAS|FGF7|FGF2|KRAS|FGF10|PIK3R1
TRANSCRIPTIONAL REGULATION BY E2F6%REACTOME%R-HSA-8953750.2,0.18298358064799397,0.6891306172477071,0.290078685981048,1.26155367414615,2083,34,RBBP7|EHMT1|CDC7|APAF1|PCGF2|EZH2|RAD51|E2F6|EHMT2|E2F1|SUZ12|EED|RRM2|CHEK1|MGA|UXT|BRCA1
INTERLEUKIN-15 SIGNALING%REACTOME DATABASE ID RELEASE 66%8983432,0.0778481012658228,0.5314695499765479,-0.37854906551611295,-1.46659929598269,368,14,STAT5A|SHC1|STAT3|GAB2
GLUCAGON-TYPE LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%420092,0.0229524039623097,0.317291120216871,-0.3550353317401,-1.6682813347093999,94,23,ADCYAP1R1|VIP|GCGR|VIPR1|GNB5|GNGT1|GIPR|ADCYAP1|GNAS
ACTIVATION OF E2F1 TARGET GENES AT G1 S%REACTOME%R-HSA-539107.4,0.008007197480881691,0.19847993048827997,0.43614517916960405,1.78846927405723,88,28,CCNA1|CDK1|LIN52|DHFR|ORC1|LIN9|CDC45|TK1|CCNE1|FBXO5|E2F5|CDC6|E2F6|LIN37|E2F1|TYMS|RRM2
"TICAM1,TRAF6-DEPENDENT INDUCTION OF TAK1 COMPLEX%REACTOME%R-HSA-9014325.2",0.0651612903225806,0.4956987271622679,-0.373863551711485,-1.49100124481229,302,15,UBA52|TICAM1|UBC|UBB
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR4%REACTOME DATABASE ID RELEASE 66%5654228,0.0934278350515464,0.5622489437340121,0.5790047913418449,1.4239779603811598,869,6,FGFR4|FGF19|FGF9|PLCG1
SYNDECAN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000170,0.6866203790579849,0.9665349594178531,0.222853590373513,0.8275666411344759,7317,20,ITGB1|TNC|ITGA2|ITGB5|CASK
RAF ACTIVATION%REACTOME%R-HSA-5673000.1,0.0519892604344642,0.44586532408291796,-0.31286423924777096,-1.49970283715318,212,24,BRAP|NRAS|PPP2R5C|PPP2CA|PPP2CB|YWHAB|PPP2R1B|KRAS|MAP3K11|MAP2K1
HDACS DEACETYLATE HISTONES%REACTOME DATABASE ID RELEASE 66%3214815,0.340467084384409,0.83409399178849,0.21437046908181398,1.09433339894524,4183,65,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|HDAC10|MBD3|MTA2|MTA1|HIST2H3C|HIST2H3A|HIST1H2AK|HDAC8|HIST1H4I|ARID4A|HDAC3|PHF21A|HIST1H2BF|KDM1A|HIST1H2BK|HIST1H2AC|HIST1H3H|HIST1H2BN|SUDS3|HIST3H2A|CHD3|HIST1H2BG|HIST2H2BE|HIST1H2BH|REST|ARID4B
ACTIVATION OF BMF AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%139910,0.00612725844461901,0.17804916190196898,-0.8629851823168408,-1.7514027870962199,38,3,DYNLL2|BMF
CROSSLINKING OF COLLAGEN FIBRILS%REACTOME DATABASE ID RELEASE 66%2243919,0.159751474304971,0.661454203640901,0.505011359627653,1.31443846616516,1516,7,LOXL1|LOXL3|LOXL2
PARADOXICAL ACTIVATION OF RAF SIGNALING BY KINASE INACTIVE BRAF%REACTOME DATABASE ID RELEASE 66%6802955,0.27992224382116104,0.788916642629372,-0.208302625593673,-1.1323345228520902,1007,35,BRAP|NRAS|ARRB2|ARRB1|RAP1A|YWHAB|KRAS|MAPK3|VWF|MAP3K11|MAP2K1
DNA STRAND ELONGATION%REACTOME DATABASE ID RELEASE 66%69190,0.0537938344669199,0.45314328209901295,0.34881107955930396,1.49139893022353,608,32,RFC4|DNA2|CDC45|POLD1|FEN1|POLD3|POLA2|MCM6|LIG1|MCM3|MCM2|PRIM2|GINS2|RFC3|GINS1|RFC5
EFFECTS OF PIP2 HYDROLYSIS%REACTOME DATABASE ID RELEASE 66%114508,0.23407371247254102,0.7481332891296201,-0.245978867323909,-1.17909034951497,958,24,PRKCH|DGKI|PRKCD|DGKD|MGLL|DGKQ|DGKG|DGKB|DGKK
PHASE 4 - RESTING MEMBRANE POTENTIAL%REACTOME DATABASE ID RELEASE 66%5576886,0.0839068825910931,0.54493407160435,0.506850838706975,1.4463791145069,828,9,KCNK2|KCNK6|KCNK3
FGFR2C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190375,0.9621366849960721,1.0,-0.286655787492101,-0.5817594037977399,6123,3,FGF1|FGF2
FGFR1B LIGAND BINDING AND ACTIVATION%REACTOME%R-HSA-190370.2,0.0925373134328358,0.5622489437340121,-0.717933164221904,-1.4570240260572698,588,3,FGF1|FGF2|FGF10
NEGATIVE REGULATION OF TCF-DEPENDENT SIGNALING BY DVL-INTERACTING PROTEINS%REACTOME DATABASE ID RELEASE 66%5368598,0.26128345839399697,0.771967970256231,0.553326602191936,1.17255192655571,2332,4,DVL1|DVL3|DVL2|CCDC88C
ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE%REACTOME%R-HSA-2485179.1,0.6444639718804921,0.9625632908696992,-0.30732728030752005,-0.8435927489263398,3666,6,GNB1|PDE6G|PDE6B|GNGT1
IRF3-MEDIATED INDUCTION OF TYPE I IFN%REACTOME%R-HSA-3270619.1,0.818530163096876,0.987153241368501,0.22466191687214698,0.708214648556765,8330,12,DTX4|TBK1|NLRC3|PRKDC
DEPURINATION%REACTOME%R-HSA-73927.1,0.921978952461594,1.0,0.42055531207540003,0.687386104256977,7621,2,MPG|OGG1
HYALURONAN BIOSYNTHESIS AND EXPORT%REACTOME%R-HSA-2142850.2,0.958208955223881,1.0,-0.28922825735902397,-0.586980154961223,6098,3,CEMIP
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)%REACTOME%R-HSA-381771.2",0.9942575055410041,1.0,0.150202529851538,0.4432864706437629,9868,10,GNB3|SPCS2|SEC11C|SEC11A
RNA POLYMERASE II PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%73776,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
DEPOSITION OF NEW CENPA-CONTAINING NUCLEOSOMES AT THE CENTROMERE%REACTOME DATABASE ID RELEASE 66%606279,0.19368996356409401,0.7046839209256791,0.249044035711854,1.23017085567618,2338,56,RBBP7|HIST1H2BJ|HIST3H2BB|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|H2AFX|H2AFZ|MIS18BP1|HIST1H2BF|HJURP|HIST1H2BK|STRA13|CENPM|HIST1H2AC
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS%REACTOME DATABASE ID RELEASE 66%451306,0.5199031171019379,0.9244272624356009,0.365634149696525,0.9516688718825128,4936,7,GRIK2|DLG3|DLG4|GRIK5
INTRA-GOLGI AND RETROGRADE GOLGI-TO-ER TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811442,0.8029678483099749,0.984522820758988,-0.10451053149918099,-0.858699428902338,973,175,RAB43|DYNC1LI2|DCTN6|NAPB|STX18|COG5|RABEPK|DCTN5|RAB30|RAB18|GCC2|RAB6A|NAPA|TMED7|KIF13B|TGOLN2|NBAS|RAB1A|VAMP3|RAB39A|GALNT2|YKT6|COPA|RAB36|KIF3C|KIF3B|PAFAH1B2|DYNLL2|TMED2|AGPAT3|ARF3|KIF9|DYNC1LI1|VTI1A|VPS53|GOLIM4|BICD1
SYNTHESIS OF DNA%REACTOME DATABASE ID RELEASE 66%69239,0.0470088710288877,0.4265829660873479,0.246169495912707,1.40946067680854,619,117,CCNA1|ANAPC15|POLE|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|POLE2|ORC1|RFC4|DNA2|PSMD3|CDC45|POLD1|CDC23|FEN1|CCNE1|ANAPC7|ANAPC16|POLD3|PSMD1|POLA2|MCM6|CDC6|PSMA1|ORC6|PSMC3|LIG1|MCM3|PSMA3|MCM2|UBE2C|CCNE2|PSMC6|PSMC1|ANAPC10|PSMD2|PRIM2|GINS2|RBX1|RFC3|GINS1|PSMA5|RFC5|PSMC2|PSMC5|SKP2|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CCNA2|CDT1
MYD88 DEFICIENCY (TLR2 4)%REACTOME%R-HSA-5602498.1,0.182350644279578,0.6875931283957409,-0.391188000804231,-1.26278992179338,933,9,MYD88|CD36
CELLULAR RESPONSES TO EXTERNAL STIMULI%REACTOME%R-HSA-8953897.2,0.28996282527881,0.799280018216108,-0.11320847143578099,-1.0654110074432,77,423,HSPA13|PSMD12|PIK3C3|RRAGD|MAPK7|CBX8|HSPA12B|ANAPC1|MRE11A|PRKAA1|HIST2H2AA3|ERF|SOD3|HSPA5|DYNC1LI2|PRKAG1|RRAGC|DCTN6|RB1CC1|LIMD1|PSMA6|RPA3|ATG13|HIGD1A|ATG9B|CITED2|PSME3|BAG4|DCTN5|HIST2H4A|MAP1LC3A|ATG101|ATG3|HIST2H2AA4|P4HB|H1F0|IL6|CAMK2A|ATG7|PHC3|BAG5|LAMTOR5|BECN1|SOD2|MAP4K4|HSBP1|ST13|ETS1|HSPA12A|MAP2K3|HSPA4L|VHL|BAG3|TCEB1|CXCL8|HSF1|NR3C1|JUN|UBA52|ID1|STAT3|PRDX1|DNAJA2|DYNLL2|TP53|UBE2E1|YWHAE|UBE2D3|DNAJB6|GABARAPL1|HSPA6|CSRP1|MAPK3|GABARAP|CDKN1A|HIST2H4B|CHMP4B|FKBP4|PSMD6|WIPI2|MAP1LC3B|HIST1H2BC|H3F3B|DNAJA4|BAG1|DYNC1LI1|MTMR14|HSPB8|UBC|HIST2H2AC|ETS2|HSP90AB1|EPAS1|GABARAPL2|HIST1H2BD|TFDP2|PSMF1|RPS6KA2|UBB|EGLN3
THE AIM2 INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844615,0.30959824012967496,0.81178854572317,0.591669705368955,1.1247018685896297,2673,3,AIM2|CASP1|PYCARD
RHO GTPASES ACTIVATE FORMINS%REACTOME%R-HSA-5663220.1,0.0208127611090011,0.303415613315289,0.264411440517215,1.50963384497805,273,115,ITGB1|CLIP1|EVL|ZWINT|CENPF|KIF2C|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|DVL1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC20|NDC80|ITGB3BP|CENPA|CENPE|BUB1B|DAAM1|AURKB|ERCC6L|NUP160|DSN1|SCAI|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|SGOL2|SRF|TAOK1|SKA2|PLK1|KNTC1|ACTG1|SKA1|NUP107|CENPM|DYNC1H1|SPC25|DIAPH3|DVL3|SGOL1|SPC24|PPP2R1A|PFN2|DVL2|NUP37|NDE1
ACTIVATION OF CAMK IV%REACTOME%R-HSA-442745.1,0.185754005031113,0.6921962082288221,-0.9051058667842958,-1.21078771444388,1402,1,CAMK4
HUR (ELAVL1) BINDS AND STABILIZES MRNA%REACTOME%R-HSA-450520.2,0.373259052924791,0.852609194081082,-0.337733536794773,-1.0498228840510602,2009,8,XPO1|ANP32A|NUP214|SET|TNFSF13|PRKCD|PRKCA
HYDROLYSIS OF LPC%REACTOME DATABASE ID RELEASE 66%1483115,0.9787504540501272,1.0,-0.182586029598932,-0.532611548945401,5388,7,GPCPD1
THREONINE CATABOLISM%REACTOME%R-HSA-8849175.2,0.535484933311378,0.9265056012720759,-0.400325617918673,-0.920665290261948,3251,4,GCAT|SDS|SDSL
SYNTHESIS OF (16-20)-HYDROXYEICOSATETRAENOIC ACIDS (HETE)%REACTOME%R-HSA-2142816.1,0.183049670024314,0.6891306172477071,0.6555620280706379,1.24615445282546,1580,3,CYP2C8|CYP2U1
SIGNALLING TO ERK5%REACTOME DATABASE ID RELEASE 66%198765,0.0981440237564959,0.570215774831708,-0.8103666942376619,-1.38608883002949,660,2,MAPK7|MAP2K5
SELENOCYSTEINE SYNTHESIS%REACTOME%R-HSA-2408557.2,0.192290651307045,0.7023096717844329,-0.16374381603249,-1.17496403089092,433,90,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|SECISBP2|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|PSTK|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|RPS16|RPL12|SEPSECS|RPS4X|RPL9|EEFSEC|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52|SARS
ABC-FAMILY PROTEINS MEDIATED TRANSPORT%REACTOME%R-HSA-382556.3,0.37402903099254603,0.852609194081082,0.195368303194809,1.06641576809348,4766,90,ABCC3|ABCA10|PEX3|PSMD11|ABCA7|ABCA5|ABCB4|PSMD13|PSMB9|ABCA9|ABCA6|PSMA4|ABCB6|DERL3|KCNJ11|PSMD3|ABCC10|PSMD1|ABCA2|PSMA1|PSMC3|ABCB10|ABCC5|PSMA3|PSMC6|PSMC1|PSMD2|ABCA3|PSMA5|PSMC2|PSMC5|ABCB7|VCP|ABCB9|SHFM1|PSMA2|PSMB6|PSMB3|ABCB1|PSMA7|ERLIN1|ABCA8|PSMB4|ABCB8
COPI-INDEPENDENT GOLGI-TO-ER RETROGRADE TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811436,0.0201470187857337,0.297110220935473,-0.30581801712430606,-1.63575037780944,73,33,DCTN1|CAPZB|DCTN3|RAB3GAP1|CAPZA2|DYNC1LI2|DCTN6|DCTN5|RAB18|RAB6A|GALNT2|PAFAH1B2|DYNLL2|AGPAT3|DYNC1LI1|BICD1
SIGNALING BY NOTCH1 IN CANCER%REACTOME%R-HSA-2644603.2,0.7710184552289822,0.979355471471634,-0.131053788933517,-0.8228350529203409,2255,56,HDAC4|ADAM10|HDAC5|TBL1X|NCSTN|PSEN2|MAMLD1|HDAC11|ADAM17|UBA52|UBC|RBPJ|UBB
TICAM1-DEPENDENT ACTIVATION OF IRF3 IRF7%REACTOME DATABASE ID RELEASE 66%9013973,0.0104965684295519,0.22401246103325895,-0.53607566559373,-1.88651705650901,51,11,TRAF3|TANK|UBA52|TICAM1|UBC|UBB
INSULIN RECEPTOR SIGNALLING CASCADE%REACTOME DATABASE ID RELEASE 66%74751,0.176062204943071,0.67909482081261,-0.227389735310477,-1.23609218414994,633,35,KRAS|SHC1|GAB2|MAPK3|FGF10|PIK3R1|TRIB3
NONSENSE MEDIATED DECAY (NMD) ENHANCED BY THE EXON JUNCTION COMPLEX (EJC)%REACTOME%R-HSA-975957.1,0.471030042918455,0.898051355931307,-0.131532618612589,-0.9957340869736842,877,113,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|UPF3A|RPL26L1|FAU|RPL37|RPL27A|GSPT2|PPP2R1A|RPL7A|RPL19|UPF2|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|PNRC2|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|SMG8|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|SMG7|SMG1|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|CASC3|UPF1|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SMG5|MAGOHB|RPL29|RPL31|RPL17|EIF4A3|RPS14|RPS17|RPL32|RPL18A|NCBP1|RPL11|SMG6|RPS16|RPL12|PPP2R2A|DCP1A|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|MAGOH|GSPT1|EIF4G1|RPL15|RPL8|PPP2CA|RPL35A|ETF1|UBA52|NCBP2|RBM8A|RNPS1|PABPC1
DEFECTIVE MMADHC CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLD%REACTOME%R-HSA-3359473.1,0.6717149220489979,0.964671573446318,-0.4933002481389579,-0.84376365497032,4523,2,MMADHC|MMACHC
CREATION OF C4 AND C2 ACTIVATORS%REACTOME%R-HSA-166786.2,0.0308153013910356,0.35952485149978897,0.47882877345035607,1.62352259687563,318,15,IGKV4-1|COLEC11|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28
TRANS-GOLGI NETWORK VESICLE BUDDING%REACTOME%R-HSA-199992.2,0.122409823484267,0.607607158836689,-0.18824030639335698,-1.2577053608231499,318,70,AP1M1|DNM2|ACBD3|YIPF6|CLINT1|AP4S1|BLOC1S4|FTH1|ARRB1|NAPA|VAMP2|TGOLN2|CLTA|AP1S1|FTL|RAB5C|TFRC|BLOC1S6|BLOC1S3|TPD52|CLVS2
GPCR LIGAND BINDING%REACTOME DATABASE ID RELEASE 66%500792,0.0104562737642586,0.22344045136759502,-0.16983151794228302,-1.43026829515003,10,198,GNG4|OXER1|NMB|CX3CL1|ADRA2C|LPAR1|C5AR1|GNRH2|UCN2|HCRT|CXCL16|PTGFR|CRHR1|CCR10|CALCRL|ADRA1B|PSAP|ADCYAP1R1|P2RY14|APLNR|HTR1B|VIP|GCGR|WNT6|VIPR1|PNOC|WNT11|CRH|RAMP2|GRM2|GNB5|EDNRA|GNGT1|CXCL8|HRH3|ADRB2|GIPR|MC4R|ADM2|ACKR3|CALCB|ADCYAP1|DRD2|WNT3|MCHR1|UCN3|ADRA2A|TAC3|BDKRB2|GNAS|S1PR1|GPR4|CHRM1|NPB|ADM|BDKRB1|HRH1|GRM8|GAL|TRH|RAMP1|ADORA2B
PLUS-STRAND DNA SYNTHESIS%REACTOME%R-HSA-164525.1,0.673374817953131,0.9647315640607691,-0.658524481693869,-0.880928277405013,5085,1,PPIA
BIOSYNTHESIS OF DPAN-3 SPMS%REACTOME%R-HSA-9025094.1,0.7431328878990351,0.974505008828563,-0.46170341446025,-0.78971896318106,5004,2,ALOX5
DNA DAMAGE BYPASS%REACTOME%R-HSA-73893.1,0.67316949581961,0.9647315640607691,0.18004418369755498,0.853985239333039,7970,47,POLE|REV1|SPRTN|POLE2|RFC4|REV3L|DTL|POLD1|POLD3|DDB1|UBA7|CUL4B|UBE2B|NPLOC4|RBX1|RFC3|RFC5|VCP
APC C:CDC20 MEDIATED DEGRADATION OF SECURIN%REACTOME DATABASE ID RELEASE 66%174154,0.47375701847180396,0.8998407605598371,0.194916463042555,0.995023225098863,5821,65,ANAPC15|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|PSMD1|PSMA1|PSMC3|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|ANAPC4|PSME2
STIMULATION OF THE CELL DEATH RESPONSE BY PAK-2P34%REACTOME%R-HSA-211736.1,0.050927988121752005,0.44320463020721795,-0.8627515853322301,-1.4756903806914399,342,2,CASP3|PAK2
APC C:CDC20 MEDIATED DEGRADATION OF CYCLIN B%REACTOME%R-HSA-174048.2,0.395931142410016,0.8638522656500329,0.271883857043914,1.0574115881103199,4300,23,ANAPC15|CCNB1|CDK1|ANAPC5|CDC23|CDC20|ANAPC7|ANAPC16
REGULATION OF TNFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5357905,0.0426514534093996,0.40711857055508205,-0.28491118293975,-1.5083456126513402,156,32,CYLD|RNF31|UBA52|RBCK1|TAX1BP1|USP2|UBC|TNF|UBB
INTEGRATION OF VIRAL DNA INTO HOST GENOMIC DNA%REACTOME%R-HSA-175567.2,0.7567949725058921,0.977664504547119,-0.379397816256755,-0.7699765956889191,4816,3,PSIP1|HMGA1|BANF1
ACTIVATION OF DNA FRAGMENTATION FACTOR%REACTOME DATABASE ID RELEASE 66%211227,0.49492385786802,0.91071489001692,-0.29525609392860996,-0.9531131297345641,2534,9,KPNB1|KPNA1|CASP3|H1F0|DFFA
HH MUTANTS ABROGATE LIGAND SECRETION%REACTOME%R-HSA-5387390.3,0.936677220463256,1.0,0.127608848649871,0.622389930740058,11241,53,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|SYVN1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|PSME2|RPS27A|SEL1L|PSMD14|PSMD4|PSMB10|PSMD9|PSME1
VRNP ASSEMBLY%REACTOME%R-HSA-192905.3,0.25642167780252395,0.767319904137432,-0.703280948442239,-1.2029243969921102,1726,2,IPO5|HSP90AA1
NEUTROPHIL DEGRANULATION%REACTOME DATABASE ID RELEASE 66%6798695,0.0182926829268293,0.284990707385907,-0.14014274059753398,-1.3081092850028402,5,396,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
ACTIVATION AND OLIGOMERIZATION OF BAK PROTEIN%REACTOME DATABASE ID RELEASE 66%111452,0.324870081662955,0.8264475303256831,-0.664901053787511,-1.13727764268088,2187,2,BID
METABOLISM OF STEROIDS%REACTOME%R-HSA-8957322.1,0.0212846826301786,0.306784707605212,0.264230997893653,1.5072513568136001,279,114,ABCC3|FDXR|CYP21A2|STAR|TM7SF2|SLC27A2|FDX1|HSD17B4|AKR1B1|NFYB|EBP|ELOVL6|GPAM|SMARCD3|BZRAP1|OSBPL3|MVD|LBR|CYP2R1|STARD5|HSD17B11|AMACR|DHCR24|SRD5A3|HSD11B1|FABP6|PPAPDC2|AKR1C1|SUMO2|MED1|NSDHL|ACOX2|OSBPL9|ACACA|PIAS4|CYP7B1|SREBF2|GGPS1|SEC24D|IDI1|CARM1|SEC24C|ARV1|MSMO1|DHCR7|ACAT2|OSBPL6|HSD17B7|TGS1|OSBP
VEGFR2 MEDIATED CELL PROLIFERATION%REACTOME%R-HSA-5218921.3,0.7703622392974749,0.979355471471634,-0.18961547769049,-0.776539109097864,3508,16,KDR|PRKCD|NRAS|SPHK1|KRAS|PRKCA
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1%REACTOME DATABASE ID RELEASE 66%937041,0.107652091254753,0.58452352834625,-0.29558406185787,-1.36936422461179,452,22,UBA52|UBE2D3|TICAM1|UBC|UBB
MET PROMOTES CELL MOTILITY%REACTOME DATABASE ID RELEASE 66%8875878,0.20045906656465198,0.71301602263256,-0.24377904398690697,-1.21479901317627,785,27,HGF|LAMC1|CRK|RAP1A|LAMA4|RAPGEF1|RAC1|MET|LAMC2
E2F-ENABLED INHIBITION OF PRE-REPLICATION COMPLEX FORMATION%REACTOME%R-HSA-113507.3,0.18593117408906895,0.6922162303225631,0.446387949368655,1.27383868710071,1836,9,CCNB1|CDK1|ORC1|ORC6|ORC2|ORC5|ORC3
ION CHANNEL TRANSPORT%REACTOME%R-HSA-983712.2,0.955736750145603,1.0,-0.09395688923007499,-0.7196185481336049,1640,121,ANO1|ANO10|PLN|TTYH2|ASIC2|ATP6V0C|ATP6V1F|CAMK2A|ATP2B4|RYR1|STOM|UBA52|ATP6V1E2|ATP6V0D1|ANO6|ATP6V1E1|ATP2B2|PDZD11|UBC|TRPV2|ANO2|UBB
GLUCAGON-LIKE PEPTIDE-1 (GLP1) REGULATES INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%381676,0.9453193350831149,1.0,0.134498005449789,0.5936790926276321,10804,36,GNG8|AKAP5|GNB3|ADCY8
TCR SIGNALING%REACTOME DATABASE ID RELEASE 66%202403,0.927157862688385,1.0,0.119352606904453,0.679659574151713,12180,113,PAG1|CDC34|BTRC|EVL|GRAP2|PSMD11|CD101|PSMD13|PSMB9|PSMA4|PAK3|PDPK1|PSMD3|PRKCQ|MAP3K7|CARD11|PSMD1|PSMA1|PSMC3|PLCG1|CD3D|LAT|PSMA3|TRAT1|PTPRJ|PSMC6|PSMC1|PSMD2|CD3G|CD3E|PTPN22|ZAP70|PSMA5|LCK|PSMC2|PSMC5|HLA-DRB1|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|NCK1|PSMA7|PSMB4|CSK|PSME2|HLA-DRB5|RPS27A|IKBKG|WAS|HLA-DPB1|UBE2D2|HLA-DQA1
ACTIVATION OF BIM AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111446,0.126158680282797,0.607607158836689,-0.683929495577794,-1.38801459083742,802,3,BCL2L11
CYTOSOLIC IRON-SULFUR CLUSTER ASSEMBLY%REACTOME%R-HSA-2564830.1,0.444073455759599,0.88124764725951,0.31501414731404603,1.0166677446139,4521,13,MMS19|BRIP1|POLD1|NDOR1|ABCB7|NARFL
CD28 DEPENDENT PI3K AKT SIGNALING%REACTOME DATABASE ID RELEASE 66%389357,0.30225598526703495,0.805227617550042,-0.24781204769929,-1.10571393618881,1312,20,CD86|PIK3R2|THEM4|MAPKAP1|MAP3K8|FYN|PRR5|PIK3R1|TRIB3
PYRUVATE METABOLISM AND CITRIC ACID (TCA) CYCLE%REACTOME%R-HSA-71406.1,0.7800937552318771,0.981487311948134,0.16108052327381697,0.7781745954848058,9318,51,D2HGDH|FH|NNT|ME1|LDHAL6A|PDHX|PDK4|BSG|PDHA1|SUCLG1|DLD|SDHA|GSTZ1|MPC2|ME3
TRIGLYCERIDE METABOLISM%REACTOME%R-HSA-8979227.1,0.0100073224310471,0.21951586544159402,-0.378289351071503,-1.8133156235138799,40,24,ABHD5|MGLL|FABP4|LPIN1|PNPLA4|DGAT2|PPP1CB|GPAT2|CAV1|FABP3
NOSTRIN MEDIATED ENOS TRAFFICKING%REACTOME%R-HSA-203641.1,0.162431318681319,0.664367762084791,-0.512943166789769,-1.29848156554999,945,5,DNM2|NOS3|CAV1
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1%REACTOME DATABASE ID RELEASE 66%113501,0.41523137580410896,0.869911045501815,-0.26942147041242,-1.01463610775122,2000,13,PPP2CA|PPP2CB|PPP2R1B|TFDP2
CONDENSATION OF PROPHASE CHROMOSOMES%REACTOME%R-HSA-2299718.1,0.0570053204965797,0.464600390996799,0.30894594667381603,1.4653918432289499,674,47,HIST1H3E|HIST1H2BJ|HIST3H2BB|CCNB1|CDK1|NCAPD3|HIST2H3C|HIST2H3A|SMC2|RB1|HIST1H4I|NCAPH2|H2AFX|H3F3A|H2AFZ|SETD8|HIST1H2BF|PLK1|HIST1H2BK|SMC4|HIST1H2AC|HIST1H3H|HIST1H2BN|NCAPG2|HIST1H2BG|HIST2H2BE|HIST1H2BH
MITOCHONDRIAL UNCOUPLING PROTEINS%REACTOME%R-HSA-166187.2,0.9685295105834921,1.0,0.262452902721038,0.556162771673397,8647,4,UCP3|SLC25A27|SLC25A14|UCP2
MRNA EDITING: C TO U CONVERSION%REACTOME DATABASE ID RELEASE 66%72200,0.7551596139569409,0.9771370084125129,-0.456717003068623,-0.7811899735507941,5085,2,APOBEC3B
JNK (C-JUN KINASES) PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1%REACTOME DATABASE ID RELEASE 66%450321,0.932641342756184,1.0,-0.151235058380033,-0.6363797310109239,4222,17,TRAF6|UBE2N|NOD1|IRAK1|IRAK2|UBE2V1|RIPK2
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660516,0.544676180021954,0.9298388956432471,-0.22647106302873898,-0.927475117869048,2480,16,FIG4|INPP5F|PIK3C2A|PIKFYVE|PIK3R4|INPP4B|MTM1|VAC14|INPP4A|PI4K2B|PI4K2A|MTMR12|MTMR10|MTMR2|PIK3C3
SIGNALING BY FGFR3%REACTOME DATABASE ID RELEASE 66%5654741,0.012606122974016,0.24393333480627202,-0.340401704569202,-1.72115469267568,48,28,FGF2|PPP2CA|PPP2CB|KRAS|UBA52|MAPK3|UBC|PIK3R1|UBB
BBSOME-MEDIATED CARGO-TARGETING TO CILIUM%REACTOME%R-HSA-5620922.1,0.759268060836502,0.977664504547119,-0.16965481374962502,-0.7859667095096059,3194,22,TCP1|MKKS|MCHR1|BBS7
MEIOSIS%REACTOME%R-HSA-1500620.1,0.137242472266244,0.62388141596544,0.23950494530205899,1.28158487830235,1731,81,HSPA2|HIST1H3E|HIST1H2BJ|HIST3H2BB|SYCP2|MLH3|SYNE1|ATR|BLM|HIST2H3C|HIST2H3A|HIST1H4I|RAD51C|RAD51|LMNB1|MND1|H2AFX|H3F3A|REC8|H2AFZ|PSMC3IP|SYNE2|HIST1H2BF|HIST1H2BK|BRCA2|HIST1H2AC|STAG3|HIST1H3H|ACD|HIST1H2BN|SMC3|CDK2|ATM|HIST1H2BG|HIST2H2BE|BRCA1|HIST1H2BH
INTERFERON GAMMA SIGNALING%REACTOME%R-HSA-877300.1,0.8295218295218291,0.9876441563834109,-0.11481402325738599,-0.793747668242213,1994,79,TRIM17|PML|IRF6|HLA-DQB1|OASL|SUMO1|CAMK2A|ICAM1|TRIM35|PTPN1|OAS3|TRIM45|TRIM25|B2M|HLA-DQA2|HLA-DQB2|TRIM29
PREGNENOLONE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%196108,0.0116864799516422,0.23446950230954997,0.5935641928508331,1.7517612813141599,115,10,FDXR|STAR|FDX1|AKR1B1|BZRAP1
SEMET INCORPORATION INTO PROTEINS%REACTOME DATABASE ID RELEASE 66%2408517,0.847194186515947,0.991298302704726,-0.19962836572768103,-0.702517090551355,4196,11,QARS|DARS|AIMP2|KARS
PERK REGULATES GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%381042,0.0349400663096149,0.381265913354899,-0.31441026077371304,-1.5667682844014799,136,27,EXOSC7|EXOSC1|DIS3|EXOSC8|PARN|ATF4|DCP2|EIF2S1|HSPA5|EIF2AK3|EXOSC6|EXOSC4|DDIT3|ATF6|EXOSC9|CXCL8|NFYA|EXOSC5
YAP1- AND WWTR1 (TAZ)-STIMULATED GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%2032785,0.866814426758009,0.9929671171385601,0.22561913538601897,0.665860357570679,8603,10,CTGF|TEAD3|KAT2B|TEAD2|YAP1
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MLH1%REACTOME%R-HSA-5545483.1,0.12724573125464,0.6076669536424699,-0.783126550868486,-1.33949602368528,856,2,MLH1|PMS2
NONSENSE MEDIATED DECAY (NMD) INDEPENDENT OF THE EXON JUNCTION COMPLEX (EJC)%REACTOME DATABASE ID RELEASE 66%975956,0.17929759704251397,0.68489956912038,-0.16463850433757002,-1.1836628356394199,387,93,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|GSPT2|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|UPF1|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|NCBP1|RPL11|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|GSPT1|EIF4G1|RPL15|RPL8|RPL35A|ETF1|UBA52|NCBP2|PABPC1
GLYCOLYSIS%REACTOME DATABASE ID RELEASE 66%70171,0.6388986939639959,0.960516115253472,-0.14146574151668698,-0.9012069218953059,1809,59,ENO1|PPP2CA|PPP2CB|GAPDH|PGK1|PPP2R1B|HK1|HK2|TPI1|ALDOA|PGAM2
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION%REACTOME%R-HSA-2565942.1,0.0501777953378111,0.440378626703493,0.266817291876132,1.43719253449171,634,84,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDK1|BTRC|BORA|CKAP5|CEP290|CEP131|CEP152|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|CCNB2|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|AJUBA|SFI1|PPP1R12A|AURKA|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
BIOLOGICAL OXIDATIONS%REACTOME DATABASE ID RELEASE 66%211859,0.0286974067707944,0.347919292482523,0.25112627417243105,1.4623116470748099,383,127,FDXR|CYP21A2|DPEP1|AKR7A3|CYB5B|MGST1|GLYATL2|CYP2C8|GSTA4|GSTO2|FDX1|AS3MT|AKR7L|MAT2A|CYP3A5|SLC35D1|ACY1|GGT1|ALDH1A1|POR|SLC35B3|CYP2R1|N6AMT1|ADH1B|EPHX1|SLC26A2|ARNT2|SULT1A3|AOC2|MTR|NAT1|MGST3|NQO2|GSTP1|MGST2|CYP7B1|ACSS1|OPLAH|GGT5|GSTZ1|MARC1
INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION%REACTOME%R-HSA-168273.3,0.8735537806971709,0.9934031064448321,0.126457228539635,0.737438602513983,11702,128,TPR|NUP133|POLR2B|RPL23A|NUP205|RPS4Y1|NUP188|NUP160|RPS24|RPL36A|NUP85|RPS19|RPLP0|NUPL2|RPS27L|POLR2L|RPL36|NDC1|GRSF1|RPS15|NUP107|NUP35|POLR2J|NUP210|RPS10|RPL28|RPS3A|RPL26L1|POM121|NUP54|FAU|RPL37|RPL27A|POLR2G|POLR2H|NUP37|RPL7A|RPL19|AAAS|GTF2F2|RPLP1|RPSA|RPL6|RPL5|NUP62|RPL18|RPS27A|RPS26|RANBP2|RPL22|RPS12|RPL4|NUP50|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|NUP43|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A
MAPK3 (ERK1) ACTIVATION%REACTOME DATABASE ID RELEASE 66%110056,0.47774306911362796,0.9043208329627141,-0.29925724677409005,-0.9660292096716792,2446,9,IL6|MAPK3|MAP2K1
DEGRADATION OF BETA-CATENIN BY THE DESTRUCTION COMPLEX%REACTOME%R-HSA-195253.1,0.9242742953302479,1.0,-0.103033118251364,-0.7138508657200401,2196,80,FRAT1|PSMD12|CTNNB1|PSMA6|CTBP1|PPP2R5C|PSME3|TCF7L2|PPP2CA|PPP2CB|PPP2R1B|UBA52|TCF7|PSMD6|UBC|PSMF1|TLE3|UBB
DEFECTIVE MTRR CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLE%REACTOME DATABASE ID RELEASE 66%3359467,0.956453368815774,1.0,0.38485293908454904,0.6290315564049921,7906,2,MTR
METHIONINE SALVAGE PATHWAY%REACTOME%R-HSA-1237112.1,0.432237972508591,0.878651088001772,0.41691026418840704,1.02533007764088,4024,6,APIP|MTAP|ENOPH1|GOT1|MRI1|ADI1
SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT%REACTOME%R-HSA-2660825.1,0.697420995277879,0.96731875442989,-0.279118185020389,-0.8142001290519741,3839,7,DLL1|NOTCH1|ADAM10|ADAM17
SHC-MEDIATED CASCADE:FGFR2%REACTOME%R-HSA-5654699.1,0.0747754783287778,0.524399009933241,-0.46002411180942604,-1.4849990566699698,382,9,NRAS|FGF7|FGF2|KRAS|FGF10
RA BIOSYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%5365859,0.0610992009354902,0.48182086119899,0.453297866651864,1.50191669766936,626,14,ALDH1A2|ALDH1A1|DHRS4|ALDH8A1|RDH13|RDH14|RDH11
APOPTOSIS INDUCED DNA FRAGMENTATION%REACTOME%R-HSA-140342.2,0.49492385786802,0.91071489001692,-0.29525609392860996,-0.9531131297345641,2534,9,KPNB1|KPNA1|CASP3|H1F0|DFFA
TRANSCRIPTION-COUPLED NUCLEOTIDE EXCISION REPAIR (TC-NER)%REACTOME%R-HSA-6781827.1,0.907660521296885,1.0,0.129009783556258,0.6852946770848299,11421,78,GTF2H2|POLE|POLE2|RFC4|GTF2H1|POLR2B|POLD1|ZNF830|POLD3|DDB1|PPIE|LIG1|CDK7|POLR2L|CUL4B|POLR2J|ERCC5|XAB2|COPS7B|XPA|RBX1|XRCC1|RFC3|AQR|POLR2G|RFC5|POLR2H
MITOCHONDRIAL TRANSCRIPTION TERMINATION%REACTOME%R-HSA-163316.2,0.15046979865771803,0.645577807142609,0.925562417291575,1.2295683791049499,1120,1,MTERF1
OAS ANTIVIRAL RESPONSE%REACTOME DATABASE ID RELEASE 66%8983711,0.440452948067161,0.879896414106183,-0.3085424258838,-0.996002599902672,2255,9,RNASEL|OASL|OAS3|PDE12
THE CANONICAL RETINOID CYCLE IN RODS (TWILIGHT VISION)%REACTOME%R-HSA-2453902.3,0.685271005440258,0.966495577318169,0.278614581825755,0.822263611468471,6801,10,RBP1|NAPEPLD|RDH11|MYO7A
SIGNALING BY TGF-BETA RECEPTOR COMPLEX IN CANCER%REACTOME%R-HSA-3304351.1,0.00853614239011987,0.20298122046820802,-0.646484972842456,-1.88582534771083,46,7,TGFB1|SMAD4|SMAD3|TGFBR1|SMAD2|FKBP1A
NEGATIVE REGULATION OF FGFR3 SIGNALING%REACTOME%R-HSA-5654732.1,0.00866474116862919,0.20506001864802398,-0.43986170466889596,-1.8921873256561201,38,18,FGF2|PPP2CA|PPP2CB|UBA52|MAPK3|UBC|UBB
LOSS OF PHOSPHORYLATION OF MECP2 AT T308%REACTOME%R-HSA-9022535.1,0.20014847809948,0.7125234191327371,-0.737579266611525,-1.26158983332025,1347,2,PRKACA|CAMK4
MITOTIC PROMETAPHASE%REACTOME DATABASE ID RELEASE 66%68877,0.000144644536052651,0.0784645998831315,0.306372089889682,1.8734044007083797,1,178,AKAP9|CLIP1|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDK1|ZWINT|CENPF|KIF2C|MZT2B|NUP133|KIF18A|CENPL|CENPT|CKAP5|CEP290|NSL1|NME7|CEP131|CEP152|NUMA1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|TUBGCP3|NEK2|CDC20|SMC2|HAUS5|NDC80|ITGB3BP|CENPA|CDK5RAP2|CENPE|PRKAR2B|BUB1B|AURKB|ERCC6L|NUP160|DSN1|INCENP|CEP72|CDCA8|TUBG2|CENPQ|CENPI|NUP85|CCNB2|SPDL1|TUBGCP6|CDCA5|HAUS8|CEP164|CEP78|SGOL2|TAOK1|CEP192|SKA2|FGFR1OP|CNTRL|PLK1|TUBGCP2|KNTC1|NCAPG|NCAPH|SKA1|SFI1|NUP107|CEP41|CEP57|CENPM|MZT2A|DYNC1H1|SMC4|NINL|SPC25|TUBB4A|CEP135|TUBGCP4|PCM1|SGOL1|PDS5B|NEDD1|SPC24|SMC3|PPP2R1A
NUCLEAR PORE COMPLEX (NPC) DISASSEMBLY%REACTOME%R-HSA-3301854.2,0.008276966892132429,0.20219929830704503,0.421647754648087,1.78230203695146,92,31,CCNB1|TPR|CDK1|NUP133|NUP205|NUP188|NUP160|NUP85|CCNB2|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NEK9|NUP37|AAAS|NUP62|RANBP2|NEK7|NUP50
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%2979096,0.428944866920152,0.8774573162143371,-0.21791744524635198,-1.00955495219712,1804,22,ADAM10|NCSTN|PSEN2|UBA52|UBC|UBB
TERMINATION OF TRANSLESION DNA SYNTHESIS%REACTOME%R-HSA-5656169.1,0.871395514417942,0.9934031064448321,0.160780710300781,0.679618910127369,9790,31,POLE|REV1|POLE2|RFC4|POLD1|POLD3|UBA7
TOXICITY OF BOTULINUM TOXIN TYPE D (BONT D)%REACTOME%R-HSA-5250955.1,0.0643887362637363,0.495456803258629,-0.600777585861214,-1.52082856492391,374,5,VAMP2|VAMP1|SV2C
MOLYBDENUM COFACTOR BIOSYNTHESIS%REACTOME%R-HSA-947581.1,0.609470881092972,0.9508825506493929,0.4770003373379171,0.9067274627273599,5263,3,GPHN|MOCS2
SIGNALING BY RHO GTPASES%REACTOME%R-HSA-194315.4,0.787520503007108,0.9819233677232551,0.12914991326563,0.8574165135261971,11522,372,NF2|PPP1R14A|HIST1H3E|RHOBTB1|HIST1H2BJ|ITGB1|HIST3H2BB|CLIP1|ARAP1|RAC3|NOXA1|EVL|KIF14|ZWINT|ARHGAP24|CENPF|KLC1|DEPDC1B|ECT2|KIF2C|LIN7B|NUP133|KIF18A|CENPL|CENPT|ARHGAP25|CKAP5|NSL1|ARHGAP11B|HIST2H3C|TIAM2|PAK3|HIST2H3A|DVL1|ARHGAP33|PDPK1|CENPK|CDC25C|RHOT1|NUF2|BIRC5|CASC5|BUB1|CENPU|PRC1|MEN1|CTTN|OBSCN|FGD1|CDC20|ARHGEF6|NDC80|ITGB3BP|CENPA|ARHGEF17|CENPE|GOPC|BUB1B|CHN1|CHN2|HIST1H4I|DAAM1|AURKB|ERCC6L|ARHGEF39|NUP160|DSN1|SCAI|INCENP|CDCA8|CENPQ|CENPI|H2AFX|NUP85|SPDL1|H3F3A|ARHGEF11|KLC2|H2AFZ|SGOL2|SRF|TAOK1|SKA2|FGD2|ARHGEF4|IQGAP3|DLG4|HIST1H2BF|PLK1|KNTC1|RAC2|RHPN1|ACTG1|KDM1A|SKA1|ARHGAP28|RACGAP1|ARPC1A|ARHGEF18|HIST1H2BK|PPP1R12A|PKN2
"UNBLOCKING OF NMDA RECEPTORS, GLUTAMATE BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%438066",0.15132709566545702,0.6475783026655401,0.373491562669819,1.31725080467668,1584,17,GRIA1|LRRC7|ACTN2|GRIA2|DLG3|GRIN1|GRIA4|DLG4
MITOCHONDRIAL TRANSLATION ELONGATION%REACTOME DATABASE ID RELEASE 66%5389840,0.839621898385191,0.98953921193435,0.13809405537011998,0.74903962453061,10658,87,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|MRPS5|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
ORGANIC ANION TRANSPORTERS%REACTOME%R-HSA-428643.2,0.406540486056669,0.8664565508572991,0.49468875772484705,1.0482927327512,3629,4,SLC25A22|SLC25A10
METABOLISM OF INGESTED MESEO2H INTO MESEH%REACTOME DATABASE ID RELEASE 66%5263617,0.718120805369128,0.971081608033886,0.644353771504191,0.8559952387835351,5349,1,TXNRD1
TWIK RELATED POTASSIUM CHANNEL (TREK)%REACTOME%R-HSA-1299503.1,0.209991532599492,0.7248363921442859,0.7284031689994809,1.19055496932404,1735,2,KCNK2
PIWI-INTERACTING RNA (PIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%5601884,0.0173955061609084,0.278447181841778,-0.364113169629805,-1.7109373358366298,71,23,PIWIL1|PLD6|MOV10L1|POLR2A|POLR2K|POLR2F|TDRKH|POLR2I|POLR2D|HENMT1
MITOCHONDRIAL TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%5368286,0.768176447420244,0.9792236089291529,0.14830492464293998,0.804424671089962,9751,87,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|MRPS5|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MTIF3|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
IRS-RELATED EVENTS TRIGGERED BY IGF1R%REACTOME DATABASE ID RELEASE 66%2428928,0.0920945395273024,0.5622489437340121,-0.260874057627313,-1.3810908937186999,338,32,PIK3C3|IGF1R|NRAS|FGF7|FGF2|IGF1|KRAS|GAB2|FGF10|IGF2|PIK3R1|TRIB3
INTERLEUKIN-18 SIGNALING%REACTOME DATABASE ID RELEASE 66%9012546,0.79732914375491,0.9831410877615258,-0.3657453555318271,-0.7422693322801,5074,3,ALOX5
GLYCINE DEGRADATION%REACTOME%R-HSA-6783984.1,0.777376276512176,0.9810354732392099,-0.372802049382065,-0.7565906827855741,4947,3,AMT|GCSH
APC-CDC20 MEDIATED DEGRADATION OF NEK2A%REACTOME%R-HSA-179409.2,0.549940817627242,0.931359181171847,0.23409948807632502,0.9328527846995319,6039,25,ANAPC15|ANAPC5|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|BUB1B
INTERLEUKIN-6 SIGNALING%REACTOME%R-HSA-1059683.2,0.744650787242632,0.9749763305090959,-0.22054697809588297,-0.77613229371005,3688,11,TYK2|STAT1|CBL|JAK1|PTPN11|IL6ST|IL6R|SOCS3|IL6|STAT3
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX%REACTOME DATABASE ID RELEASE 66%445989,0.22269221199303302,0.7355723797115551,-0.24406480557776,-1.1840246125567901,894,25,RELA|TRAF6|UBE2N|NOD1|IRAK1|NFKBIA|IRAK2|NKIRAS1|UBE2V1|RIPK2|NFKBIB
SIGNALING BY NTRK2 (TRKB)%REACTOME%R-HSA-9006115.2,0.449900022217285,0.886062942999295,-0.23094845841600697,-0.9934889563153391,2024,18,DOCK3|KRAS|RAC1|PIK3R1
AMPK INHIBITS CHREBP TRANSCRIPTIONAL ACTIVATION ACTIVITY%REACTOME%R-HSA-163680.3,0.112113402061856,0.5871948297110661,0.563197691516614,1.38510270044331,1043,6,PRKAA2|STK11|ADIPOR2|PRKAB2
ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%139915,0.21521976026153303,0.732094216765764,-0.419320358660205,-1.2231760897639798,1184,7,TP53BP2|BBC3|TP53|TFDP2
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES%REACTOME DATABASE ID RELEASE 66%380320,0.0010330578512396699,0.0872881177264294,0.34981543503188395,1.8582052382478798,12,78,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|MZT2B|CKAP5|CEP290|NME7|CEP131|CEP152|NUMA1|TUBGCP3|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|TUBG2|TUBGCP6|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|TUBGCP2|SFI1|CEP41|CEP57|MZT2A|DYNC1H1|NINL|TUBB4A|CEP135|TUBGCP4|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
HEME BIOSYNTHESIS%REACTOME%R-HSA-189451.1,0.6858754785412049,0.9665006495129341,0.278479466563341,0.8218648514218541,6807,10,ALAS1|CPOX|UROD|UROS|ALAD|HMBS|PPOX
ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA%REACTOME%R-HSA-111448.2,0.0161401098901099,0.270269322436916,-0.7126095394261379,-1.80392372934982,93,5,TP53|PMAIP1|TFDP2
CONJUGATION OF CARBOXYLIC ACIDS%REACTOME%R-HSA-159424.1,0.40111285835248606,0.8638522656500329,0.6418524885943859,1.04909025988819,3315,2,GLYATL2|GLYATL1
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS%REACTOME%R-HSA-176187.2,0.0187226596675416,0.286111698549296,0.37555022717594805,1.6576923751419699,213,36,CDC7|ATR|ORC1|RFC4|CDC25C|CDC45|RAD9A|MCM6|CDC6|ORC6|DBF4|MCM10|MCM3|MCM2|CLSPN|CHEK1|RFC3|RAD17|RFC5|RAD1|CDK2|ORC2|MCM7
FRS-MEDIATED FGFR4 SIGNALING%REACTOME%R-HSA-5654712.3,0.36903124385930397,0.852268858837246,0.342603521419463,1.08000873443307,3755,12,FGFR4|FGF19|HRAS|FGF9
NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-112310.5,0.0838888407930049,0.54493407160435,0.315580699022648,1.41373440840705,968,38,SLC1A2|SLC6A13|UNC13B|LIN7A|GLS|LIN7B|PPFIA2|BZRAP1|GLS2|PPFIA3|CASK|ABAT|SLC1A3|SYT1|SLC6A1|RAB3A|SLC1A1|STX1A|PPFIA4|SLC18A2|RIMS1|MAOA|ARL6IP5|HSPA8|LIN7C|ALDH5A1|SLC38A2|SYN3
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE%REACTOME%R-HSA-6803204.1,0.116386925795053,0.595821909765648,-0.321847455840585,-1.35429707614292,526,17,CREBBP|BAX|TP53BP2|BBC3|BID|TP53|BNIP3L|PMAIP1|STEAP3
ESTROGEN BIOSYNTHESIS%REACTOME%R-HSA-193144.4,0.4180849832117629,0.871698849372662,0.547479872063527,1.04070164407198,3610,3,HSD17B11|HSD17B14|HSD17B1
INTERLEUKIN-12 FAMILY SIGNALING%REACTOME%R-HSA-447115.5,0.0139196456817463,0.256136946817111,-0.27789105247805795,-1.6597440276423001,43,47,BOLA2|BOLA2B|AIP|HNRNPF|P4HB|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|STAT3|PITPNA|PAK2|FOXO3
TRAIL SIGNALING%REACTOME%R-HSA-75158.3,0.0193129062209842,0.289864965388082,-0.568585647438492,-1.7674117586570501,103,8,TNFRSF10D|TNFRSF10A|CFLAR|TNFRSF10B
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA%REACTOME%R-HSA-159230.2,0.290454950936664,0.7998377855773342,0.273833358285893,1.14816444294227,3255,30,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50|NXF1
PKA-MEDIATED PHOSPHORYLATION OF CREB%REACTOME DATABASE ID RELEASE 66%111931,0.8553445229681981,0.991298302704726,-0.170084969615726,-0.7156979894243071,3872,17,PRKAR1A|PRKACA|PRKX|ADCY7|PRKAR2A|PRKAR1B|ADCY2
PI3K EVENTS IN ERBB4 SIGNALING%REACTOME DATABASE ID RELEASE 66%1250342,0.607203032855939,0.9508825506493929,0.339711284780079,0.88419710090195,5765,7,NRG2|NRG3
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8934593.1,0.9600265017667841,1.0,-0.13978185342892402,-0.588185961893683,4346,17,PML|RUNX1|AGO2|CBFB
HISTAMINE RECEPTORS%REACTOME%R-HSA-390650.1,0.0105419450631032,0.22424275249482103,-0.928701406120761,-1.58849401710375,70,2,HRH3|HRH1
CDT1 ASSOCIATION WITH THE CDC6:ORC:ORIGIN COMPLEX%REACTOME DATABASE ID RELEASE 66%68827,0.6330774944293139,0.958362160385489,0.17842906697302102,0.885840355315955,7670,57,PSMD11|PSMD13|PSMB9|PSMA4|ORC1|PSMD3|PSMD1|CDC6|PSMA1|ORC6|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|GMNN|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|CDT1|PSME2|RPS27A|ORC5|ORC3|PSMD14|PSMD4|PSMB10|PSMD9
CIRCADIAN CLOCK%REACTOME DATABASE ID RELEASE 66%400253,0.0357537781054184,0.382505374162683,-0.22108827029947697,-1.4477559852615702,96,65,CCRN4L|PPARA|RXRA|TBL1X|NAMPT|MEF2D|HELZ2|BHLHE41|NRIP1|PPARGC1A|NR3C1|UBA52|PER2|PPP1CB|NR1D1|UBC|UBB
TOXICITY OF BOTULINUM TOXIN TYPE E (BONT E)%REACTOME%R-HSA-5250992.1,0.32930086410055,0.828303707528737,-0.54003651723778,-1.0959880665445,2095,3,SNAP25
SYNTHESIS OF DOLICHYL-PHOSPHATE%REACTOME DATABASE ID RELEASE 66%446199,0.141215635738832,0.630107155356772,0.543157679828392,1.33581721024266,1314,6,MVD|SRD5A3|DOLPP1
OREXIN AND NEUROPEPTIDES FF AND QRFP BIND TO THEIR RESPECTIVE RECEPTORS%REACTOME DATABASE ID RELEASE 66%389397,0.6574610244988871,0.9643779777660141,-0.4989798731734221,-0.85347834941051,4427,2,NPFF|HCRT
"PLATELET ACTIVATION, SIGNALING AND AGGREGATION%REACTOME%R-HSA-76002.2",0.00108108108108108,0.0893009762660318,-0.19860149639075197,-1.69311301886707,0,213,GNG10|RHOG|APLP2|PIK3R5|RAP1B|SOD1|GNAI3|VTI1B|PTPN6|PRKCH|SRGN|CLU|FAM49B|VEGFA|GNA13|GNG4|FCER1G|PCDH7|DGKI|ADRA2C|PRKCD|DGKD|BCAR1|PDPN|ARRB2|HSPA5|A1BG|PFN1|VAV1|GNAQ|GNAI2|FYN|RHOA|PSAP|MGLL|DGKQ|WDR1|GNA15|HGF|LYN|ARRB1|HABP4|IGF1|SERPINF2|CRK|RAP1A|TMSB4X|PTPN1|VAV3|VAV2|CFD|CDC42|SERPINA1|GNB5|GNGT1|SHC1|PRKCA|DGKG|CLEC3B|CTSW|CD9|YWHAZ|ABCC4|MAPK3|ALDOA|GNA12|ADRA2A|DGKB|VWF|RAC1|IGF2|TAGLN2|CD36|PIK3R1|DGKK
NUCLEAR ENVELOPE BREAKDOWN%REACTOME%R-HSA-2980766.1,0.0137813696299447,0.256136946817111,0.361311508573344,1.69360760656483,161,45,CCNB1|TPR|CDK1|NUP133|PRKCB|NUP205|LEMD3|NUP188|LMNB1|NUP160|NUP85|CCNB2|NUPL2|NDC1|PLK1|NUP107|NUP35|VRK1|CNEP1R1|NUP210|POM121|NUP54|NEK9|LEMD2|NUP37|AAAS
TRANSLOCATION OF ZAP-70 TO IMMUNOLOGICAL SYNAPSE%REACTOME DATABASE ID RELEASE 66%202430,0.49549945115258,0.9113689927296609,-0.23414822581535197,-0.9589156797014929,2256,16,CD3D|CD3G|CD3E|PTPN22|ZAP70|LCK|HLA-DRB1|HLA-DRB5|HLA-DPB1|HLA-DQA1|HLA-DRA|HLA-DPA1|CD4|HLA-DQB1|HLA-DQA2|HLA-DQB2
CONSTITUTIVE SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT%REACTOME DATABASE ID RELEASE 66%2660826,0.697420995277879,0.96731875442989,-0.279118185020389,-0.8142001290519741,3839,7,DLL1|NOTCH1|ADAM10|ADAM17
ACTIVATED NTRK3 SIGNALS THROUGH PI3K%REACTOME DATABASE ID RELEASE 66%9603381,0.641098278492046,0.9611831061114229,0.373979493178272,0.861967292494331,5883,5,SRC|NTRK3|IRS1
CLASSICAL ANTIBODY-MEDIATED COMPLEMENT ACTIVATION%REACTOME%R-HSA-173623.2,0.0455885242680291,0.4193082406940371,0.495615543519798,1.5623573094183898,463,12,IGKV4-1|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|IGHG2
MET ACTIVATES PTPN11%REACTOME DATABASE ID RELEASE 66%8865999,0.190186069487897,0.698434241409875,-0.548213463179161,-1.26077643950801,1154,4,HGF|MET
O2 CO2 EXCHANGE IN ERYTHROCYTES%REACTOME%R-HSA-1480926.1,0.6554080437329171,0.9640743070248079,-0.26063689092796,-0.8413592401472959,3356,9,CYB5R2|AQP1
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS%REACTOME DATABASE ID RELEASE 66%6802946,0.27992224382116104,0.788916642629372,-0.208302625593673,-1.1323345228520902,1007,35,BRAP|NRAS|ARRB2|ARRB1|RAP1A|YWHAB|KRAS|MAPK3|VWF|MAP3K11|MAP2K1
LOCALIZATION OF THE PINCH-ILK-PARVIN COMPLEX TO FOCAL ADHESIONS%REACTOME%R-HSA-446343.1,0.11589672339932801,0.5949676491680961,0.7015853509021189,1.33363994805627,1000,3,ITGB1|ILK
REGULATION OF FZD BY UBIQUITINATION%REACTOME%R-HSA-4641263.2,0.059915611814345994,0.4765909929190129,-0.391712917059146,-1.51759954182694,283,14,RSPO4|UBA52|UBC|UBB
AQUAPORIN-MEDIATED TRANSPORT%REACTOME DATABASE ID RELEASE 66%445717,0.168625146886016,0.6724298236405779,-0.22011839369330202,-1.2419645710370801,573,39,GNB1|PRKAR1A|GNB4|GNG5|PRKACA|RAB11A|GNG10|ADCY7|GNG4|RAB11FIP2|PRKAR2A|GNB5|GNGT1|PRKAR1B|ADCY2|AQP5|GNAS|AQP1
SIGNALLING TO ERKS%REACTOME DATABASE ID RELEASE 66%187687,0.152257077276205,0.648319130045528,-0.256185995977083,-1.2766252997499399,596,27,CRK|RAP1A|RALA|YWHAB|KRAS|RAPGEF1|SHC1|RALB
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%8940973,0.41910294257689706,0.87173622607586,0.289578069591901,1.03877557220112,4400,18,HES1|BGLAP|SRC|RB1|HDAC3|HEY2|HDAC6
MAP KINASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%450294,0.007950849295265629,0.19847993048827997,-0.25453325630519397,-1.6409545860309198,21,62,TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|MAPK7|MAP3K8|IRAK2|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|MAPK3|TNIP2|UBC|MAP2K1|RPS6KA2|UBB
METAL ION SLC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%425410,0.8890124143042428,0.997300970905927,0.17098951983529598,0.654850196671684,9595,22,SLC39A3|SLC30A5|SLC39A7|SLC40A1|SLC41A2|HEPH|SLC39A10|SLC30A7
"GLUTAMATE BINDING, ACTIVATION OF AMPA RECEPTORS AND SYNAPTIC PLASTICITY%REACTOME DATABASE ID RELEASE 66%399721",0.530516431924883,0.9265056012720759,0.24460260410470702,0.9513092497452049,5762,23,GRIA1|AKAP5|GRIA2|PRKCB|GRIP1|GRIA4|DLG4|TSPAN7
P2Y RECEPTORS%REACTOME DATABASE ID RELEASE 66%417957,0.790695140553498,0.9819233677232551,0.32400688070661604,0.74678782876227,7256,5,P2RY11|P2RY6|LPAR6|P2RY13
RECEPTOR MEDIATED MITOPHAGY%REACTOME DATABASE ID RELEASE 66%8934903,0.28289730573994504,0.791899420871283,-0.353309334955035,-1.1405141940435302,1448,9,MAP1LC3A|CSNK2A2|MAP1LC3B|CSNK2A1
ARACHIDONIC ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%2142753,0.5628034248389089,0.937590536038343,0.214543471164761,0.924794744041231,6375,33,FAAH2|DPEP1|CYP2C8|PLA2G4A|GGT1|PTGS2|GGT5|LTA4H|PON2|FAAH
ACTIVATION OF THE AP-1 FAMILY OF TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%450341,0.654644368325609,0.9640743070248079,0.28678064799103803,0.846363782437825,6497,10,MAPK11|MAPK10|FOS|MAPK9
"DEFECTIVE POMT1 CAUSES MDDGA1, MDDGB1 AND MDDGC1%REACTOME DATABASE ID RELEASE 66%5083633",0.67840593141798,0.9647315640607691,-0.655877812086458,-0.8773877467749,5123,1,DAG1
FCGAMMA RECEPTOR (FCGR) DEPENDENT PHAGOCYTOSIS%REACTOME%R-HSA-2029480.1,0.021671826625387004,0.309421849543369,-0.20282645127675697,-1.44707593388297,48,89,PRKCD|ABI1|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|LYN|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|MYH9|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1-AMPK%REACTOME%R-HSA-380972.1,0.981219449446874,1.0,-0.10896222966748599,-0.5509398172783609,3813,28,RRAGD|PRKAA1|PRKAG1|RRAGC|LAMTOR5|CAB39|PPM1A
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS%REACTOME%R-HSA-3108214.2,0.402226524685382,0.865238688875249,0.201322934810612,1.04509727285225,4985,70,PIAS1|TDG|TPR|BLM|NUP133|PCGF2|CDKN2A|PARP1|SUMO2|NUP205|NUP188|NUP160|PIAS4|NSMCE4A|NUP85|NUPL2|XRCC4|NDC1|HERC2|NUP107|NUP35|NUP210|POM121|NUP54|SMC6|SMC3|PHC2|NUP37|MDC1|BRCA1|AAAS
FANCONI ANEMIA PATHWAY%REACTOME DATABASE ID RELEASE 66%6783310,0.0225088736905896,0.31540045468680394,0.362694650634961,1.6247948906121799,259,38,MUS81|FANCL|FAAP20|EME2|FANCA|ATR|DCLRE1A|UBE2T|POLN|FANCG|SLX1B|FANCC|FANCM|FANCF|SLX4|FANCD2|EME1|FANCI|STRA13
BIOSYNTHESIS OF E-SERIES 18(R)-RESOLVINS%REACTOME%R-HSA-9023661.1,0.716703786191537,0.971081608033886,-0.47313953035419504,-0.8092798269384621,4826,2,ALOX5
TRANSPORT AND SYNTHESIS OF PAPS%REACTOME%R-HSA-174362.2,0.417418384879725,0.8709670999109399,0.42227179798537,1.03851598918234,3886,6,SLC35B3|SLC26A2|PAPSS2|SLC35B2
INTERLEUKIN-23 SIGNALING%REACTOME%R-HSA-9020933.1,0.88365553602812,0.996316041142784,-0.24228159890152104,-0.665046720964985,5027,6,P4HB|STAT3
INTERLEUKIN-35 SIGNALLING%REACTOME DATABASE ID RELEASE 66%8984722,0.9899254483175501,1.0,0.1591055255453,0.46956151103852295,9825,10,JAK2|EBI3|TYK2|STAT1
SIGNALING BY WNT%REACTOME DATABASE ID RELEASE 66%195721,0.82453637660485,0.9876441563834109,-0.0983652924116356,-0.8715472542455649,577,262,CAMK2A|PPP2CA|PPP2CB|CLTA|WNT6|RSPO4|WNT11|PPP2R1B|AP2S1|GNB5|ASH2L|GNGT1|AGO2|SOX6|UBA52|TCF7|PRKCA|DKK1|YWHAZ|HIST2H4B|WNT3|PSMD6|SFRP2|HIST1H2BC|H3F3B|RAC1|PLCB1|SOX7|UBC|HIST2H2AC|CSNK2A1|SOX17|HIST1H2BD|PSMF1|CAV1|TLE3|UBB
TELOMERE MAINTENANCE%REACTOME DATABASE ID RELEASE 66%157579,0.43649563585936896,0.878651088001772,0.200940951898323,1.02241582835167,5350,64,HIST1H2BJ|HIST3H2BB|POLE|POLE2|RFC4|DNA2|POLD1|TERT|FEN1|POLD3|POLA2|HIST1H4I|H2AFX|H2AFZ|LIG1|HIST1H2BF|WRAP53|HIST1H2BK|HIST1H2AC|PRIM2|ACD|RFC3|HIST1H2BN|RFC5|HIST1H2BG|HIST2H2BE|HIST1H2BH
GAB1 SIGNALOSOME%REACTOME%R-HSA-180292.3,0.8951417004048579,0.9981901628831992,0.223712326221029,0.6383985417274181,8843,9,PAG1|SRC|CSK|GAB1
WAX BIOSYNTHESIS%REACTOME%R-HSA-8848584.2,0.0647151324543365,0.495491127404654,0.840970499035015,1.37454317786167,534,2,FAR2|FAR1
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT%REACTOME%R-HSA-201681.1,0.566379310344828,0.9388612723386429,-0.11682685281636801,-0.966232143462453,656,181,SOX6|UBA52|TCF7|DKK1|YWHAZ|HIST2H4B|WNT3|PSMD6|SFRP2|HIST1H2BC|H3F3B|SOX7|UBC|HIST2H2AC|CSNK2A1|SOX17|HIST1H2BD|PSMF1|CAV1|TLE3|UBB
PI-3K CASCADE:FGFR4%REACTOME%R-HSA-5654720.2,0.392806770098731,0.8621064456029929,0.35932638389285604,1.06046499138522,3898,10,FGFR4|FGF19
ACETYLATION%REACTOME%R-HSA-156582.1,0.37248322147651003,0.852609194081082,0.819144243493604,1.0881965828656701,2774,1,NAT1
INTERLEUKIN-1 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020702,0.377217553688142,0.85375124052253,-0.14577547324995002,-1.0499533817073299,807,94,PSME4|IL1RN|NOD1|PSMC4|IL1B|IRAK1|NFKBIA|PSMD12|MAP3K8|IRAK2|SQSTM1|IRAK4|PSMA6|NKIRAS1|PSME3|UBE2V1|RIPK2|UBA52|NFKBIB|PELI2|TNIP2|PSMD6|PELI1|MYD88|UBC|MAP2K1|PSMF1|UBB
INWARDLY RECTIFYING K+ CHANNELS%REACTOME DATABASE ID RELEASE 66%1296065,0.982768204558088,1.0,0.128107952516782,0.490623741043481,10607,22,GNG8|GNB3|KCNJ11|ABCC8|KCNJ8|GABBR1|GNG3|GNG2|GNGT2|GNG7|KCNJ9
CROSS-PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS (ENDOSOMES)%REACTOME%R-HSA-1236978.1,0.36846550122455896,0.851931544178381,0.225979123168561,1.07186375932895,4362,47,FCGR1B|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|MRC1|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
VLDL CLEARANCE%REACTOME%R-HSA-8964046.1,0.11457050061597,0.5918253392579251,0.6388915354294351,1.35387219367425,1022,4,VLDLR|LSR|APOC1
INTERLEUKIN-21 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020958,0.5017571261226079,0.9156583763874949,-0.293523830538394,-0.9475212282791009,2569,9,STAT5B|STAT1|JAK3|JAK1|IL2RG|STAT4|IL21R|STAT5A|STAT3
DEFECTIVE CSF2RB CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 5 (SMDP5)%REACTOME DATABASE ID RELEASE 66%5688849,0.109428359317001,0.584695818659266,-0.799786931022095,-1.3679927116651398,736,2,CSF2RB
HOMOLOGY DIRECTED REPAIR%REACTOME%R-HSA-5693538.1,0.0281541704305932,0.345491958731604,0.253912280129194,1.46563550158378,373,122,HIST1H2BJ|MUS81|HIST3H2BB|EME2|CCNA1|PARP2|POLE|SIRT6|XRCC3|ATR|BLM|EXO1|BRIP1|POLE2|RFC4|DNA2|RAD9A|POLD1|PARP1|FEN1|GEN1|POLQ|SUMO2|POLD3|SLX1B|HIST1H4I|RAD51C|RAD51|PIAS4|H2AFX|RMI2|TIMELESS|BRCC3|RAD51AP1|HIST1H2BF|SLX4|TOPBP1|EME1|HERC2|RMI1|HIST1H2BK|PALB2|BRCA2|CLSPN|XRCC2|CHEK1|XRCC1|RFC3|HIST1H2BN|RAD17|RFC5|SPIDR|RAD1|CDK2|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE
REGULATION OF SIGNALING BY NODAL%REACTOME DATABASE ID RELEASE 66%1433617,0.178906079755938,0.68489956912038,0.554934911999356,1.27904270777395,1641,5,LEFTY1|CFC1|ACVR2A|ACVR2B|ACVR1B
ORC1 REMOVAL FROM CHROMATIN%REACTOME%R-HSA-68949.3,0.40930797248077705,0.867015886388254,0.201163122051613,1.04024535648335,5056,69,CCNA1|PSMD11|PSMD13|PSMB9|PSMA4|ORC1|PSMD3|PSMD1|MCM6|CDC6|PSMA1|ORC6|PSMC3|MCM3|PSMA3|MCM2|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SKP2|CDK2|SHFM1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CCNA2|CDT1|PSME2|RPS27A|ORC5|ORC3|PSMD14|PSMD4|PSMB10|PSMD9
EPHA-MEDIATED GROWTH CONE COLLAPSE%REACTOME DATABASE ID RELEASE 66%3928663,0.0197136335339282,0.29306776028311,-0.464449619948104,-1.7491083910622,94,13,FYN|RHOA|LYN|YES1|MYH11|MYH9
BIOSYNTHESIS OF PROTECTIN AND RESOLVIN CONJUGATES IN TISSUE REGENERATION (PCTR AND RCTR)%REACTOME DATABASE ID RELEASE 66%9026766,0.9295644114921221,1.0,-0.532973092192325,-0.7129743556390229,7020,1,LTC4S
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%2644602,0.7710184552289822,0.979355471471634,-0.131053788933517,-0.8228350529203409,2255,56,HDAC4|ADAM10|HDAC5|TBL1X|NCSTN|PSEN2|MAMLD1|HDAC11|ADAM17|UBA52|UBC|RBPJ|UBB
DISEASES OF GLYCOSYLATION%REACTOME DATABASE ID RELEASE 66%3781865,0.734340183213667,0.9736136237452191,0.16438477305357502,0.8161151556788059,8897,57,MUC15|ADAMTS10|VCAN|ADAMTS2|THSD1|ADAMTSL2|GPC2|GPC6|SEMA5A|MUC1|GPC1|PRELP|GPC3|THBS2|AGRN|FMOD|THBS1|BGN|THSD7A|SDC3|ADAMTS13|DCN|OGN|LUM|THSD4|NOTCH2|SEMA5B
METALLOTHIONEINS BIND METALS%REACTOME%R-HSA-5661231.2,0.32184278350515505,0.822751772025005,0.458396380759165,1.1273591394758602,2996,6,MT1F|MT1E|MT2A
ACTIVATION OF NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629602,0.0172231985940246,0.27746438902299797,-0.6643318074016881,-1.82354620469884,97,6,CHRNE|CHRNB4|CHRNA5|CHRNB2|CHRNA7|CHRNA3
SIGNALING BY EGFRVIII IN CANCER%REACTOME DATABASE ID RELEASE 66%5637812,0.130317493255862,0.612163182799301,-0.356141523912076,-1.34122217163165,627,13,NRAS|CDC37|KRAS|SHC1|PIK3R1
BETA OXIDATION OF OCTANOYL-COA TO HEXANOYL-COA%REACTOME%R-HSA-77348.2,0.21224667683591197,0.727709540947015,0.53853764414073,1.2412494361154198,1947,5,ACADM|HADH|HADHB|ECHS1
RHO GTPASE EFFECTORS%REACTOME DATABASE ID RELEASE 66%195258,0.316867808026944,0.818410444281693,0.169940344922457,1.0875580575694102,4515,252,NF2|PPP1R14A|HIST1H3E|HIST1H2BJ|ITGB1|HIST3H2BB|CLIP1|NOXA1|EVL|KIF14|ZWINT|CENPF|KLC1|KIF2C|LIN7B|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|HIST2H3C|PAK3|HIST2H3A|DVL1|PDPK1|CENPK|CDC25C|NUF2|BIRC5|CASC5|BUB1|CENPU|PRC1|MEN1|CTTN|CDC20|NDC80|ITGB3BP|CENPA|CENPE|GOPC|BUB1B|HIST1H4I|DAAM1|AURKB|ERCC6L|NUP160|DSN1|SCAI|INCENP|CDCA8|CENPQ|CENPI|H2AFX|NUP85|SPDL1|H3F3A|KLC2|H2AFZ|SGOL2|SRF|TAOK1|SKA2|IQGAP3|DLG4|HIST1H2BF|PLK1|KNTC1|RAC2|RHPN1|ACTG1|KDM1A|SKA1|ARPC1A|HIST1H2BK|PPP1R12A|PKN2|NUP107|MYLK|CENPM|DYNC1H1|HIST1H2AC|CIT|SPC25|DIAPH3|HIST1H3H|HIST1H2BN|DVL3|SGOL1|PTK2|SPC24|KLC4|PPP2R1A|BTK|WASF1|WASF3|PFN2|DVL2|HIST1H2BG|NUP37|HIST2H2BE|NDE1|HIST1H2BH|NCF4|MYL12B|ZWILCH|NCK1|ACTR3
PERVASIVE DEVELOPMENTAL DISORDERS%REACTOME DATABASE ID RELEASE 66%9005895,0.5693459416863671,0.940076901516441,-0.265224386398329,-0.897293797967588,2889,10,NCOR1|GPS2|TBL1XR1|HDAC1|NCOR2|PRKACA|SIN3A|TBL1X|CAMK4
SIGNALING BY FGFR3 FUSIONS IN CANCER%REACTOME%R-HSA-8853334.2,0.28263695450325,0.791469496707528,-0.36712244639316605,-1.1411764112326002,1521,8,NRAS|KRAS|PIK3R1
DEFECTIVE B3GAT3 CAUSES JDSSDHD%REACTOME%R-HSA-3560801.1,0.5977792667751509,0.9492590312650558,0.25808748470964604,0.8947193187696441,6244,16,VCAN|GPC2|GPC6|GPC1|GPC3|AGRN|BGN|SDC3|DCN
C-TYPE LECTIN RECEPTORS (CLRS)%REACTOME%R-HSA-5621481.1,0.9924286546301692,1.0,-0.0805812965581461,-0.617174494718531,1703,121,RELA|PRKACA|TRAF6|NFATC3|UBE2N|CREBBP|PYCARD|PSME4|UBE2D1|CLEC7A|PSMC4|IL1B|FCER1G|NFKBIA|PSMD12|PPP3R1|PRKCD|NRAS|PSMA6|PSME3|FYN|BCL10|UBE2V1|RELB|LYN|MUC4|MUC3A|KRAS|UBA52|NFATC2|PSMD6|MUC12|UBC|PSMF1|PAK2|UBB
OTHER INTERLEUKIN SIGNALING%REACTOME DATABASE ID RELEASE 66%449836,0.19830428638718803,0.711592141628341,-0.26945380366952804,-1.22380420455905,841,21,CSF1R|STX3|STX1A|CSF1|TXLNA|TYK2|IFNLR1|IL16|IL34|STX4|FLT3LG|JAK1|IL10RB|IL32|SDC1|CD4|CSF3R|CASP3|VAMP2|SNAP25
SODIUM PROTON EXCHANGERS%REACTOME%R-HSA-425986.1,0.152061855670103,0.648319130045528,0.536753260493024,1.3200664736011398,1415,6,SLC9A5|SLC9A7
PURINE SALVAGE%REACTOME%R-HSA-74217.4,0.28088723051409603,0.789038489620028,-0.313543092886679,-1.14226893887356,1354,12,AMPD3|GMPR2|GMPR|ADK|AMPD2|DGUOK|ADA|APRT|PNP|HPRT1
GSD 0 (MUSCLE)%REACTOME DATABASE ID RELEASE 66%3828062,0.6680779000846739,0.964618776001639,0.5412004779449799,0.8845773135542199,5522,2,GYS1|GYG1
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION%REACTOME DATABASE ID RELEASE 66%112314,0.393999016232169,0.863476608623133,-0.140273550274827,-1.03316674650776,800,102,GNB5|GNGT1|GABRQ|CHRNA3|PRKCA|GABRG2|RASGRF2|ADCY2|GABRA3|HTR3A|PLCB1|CACNG3|DLG1|CAMKK1|RPS6KA2
TNFR2 NON-CANONICAL NF-KB PATHWAY%REACTOME%R-HSA-5668541.2,0.869173645125612,0.993332740109396,0.13442820215779,0.7228808267163259,11001,83,CD27|BTRC|PSMD11|PSMD13|PSMB9|UBA3|PSMA4|TNFRSF11B|PSMD3|TNFSF13B|TNFRSF6B|PSMD1|PSMA1|TNFRSF12A|TNFRSF13C|PSMC3|BIRC2|LTA|LTB|PSMA3|PSMC6|PSMC1|PSMD2|TRAF2|PSMA5|PSMC2|PSMC5|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|BIRC3|TNFRSF14
RRNA PROCESSING IN THE NUCLEUS AND CYTOSOL%REACTOME%R-HSA-8868773.2,0.0171171171171171,0.277422272849102,-0.16617526167702898,-1.3864244117626296,18,190,RIOK3|NCL|TEX10|RPS16|RPL12|UTP15|C1D|THUMPD1|RPS4X|TSR3|WDR12|RPL9|PES1|RRP1|RPS28|ISG20L2|MPHOSPH6|RPL35|UTP3|RPL7|EXOSC6|RRP36|RPS9|RPS3|RPL14|DHX37|GAR1|DDX47|EXOSC4|NOB1|NHP2L1|TRMT112|RPL15|RPL8|WBSCR22|PWP2|TBL3|RCL1|FCF1|RPL35A|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|DDX21|RRP7A|UBA52|CIRH1A|BYSL|IMP4|TSR1|PNO1|NOL9|RPP40|RPP14|NIP7|EMG1|RRP9|NOP14|NOP56|EXOSC5
"ANTIGEN PRESENTATION: FOLDING, ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC%REACTOME%R-HSA-983170.3",0.868084078279778,0.993084774742015,-0.149893980943914,-0.7043392818635731,3592,23,B2M|SEC23A|ERAP2
UNWINDING OF DNA%REACTOME%R-HSA-176974.2,0.36912949498919206,0.852268858837246,0.34246729387215,1.07957929652082,3756,12,CDC45|MCM6|MCM3|MCM2|GINS2|GINS1|MCM7
RESOLUTION OF D-LOOP STRUCTURES%REACTOME%R-HSA-5693537.1,0.00667310562823777,0.18239572673498103,0.41705464537823705,1.8137727645078001,75,34,MUS81|EME2|XRCC3|BLM|EXO1|BRIP1|DNA2|GEN1|SLX1B|RAD51C|RAD51|RMI2|RAD51AP1|SLX4|EME1|RMI1|PALB2|BRCA2|XRCC2|SPIDR|ATM|BRCA1
METABOLISM OF FAT-SOLUBLE VITAMINS%REACTOME%R-HSA-6806667.3,0.1028545941124,0.5745140527021371,0.33042028885050895,1.38542955197147,1152,30,RBP1|LPL|BCO2|GPC2|GPC6|AKR1C1|GPC1|APOE|LRP8|LDLR|GPC3|RDH11|APOM|AGRN|SDC3|APOC2|LRP1|GPIHBP1|VKORC1
SCAVENGING BY CLASS H RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000497,0.274706665053829,0.7884684708511421,0.698263027295285,1.1412917357066599,2270,2,STAB1|SPARC
U12 DEPENDENT SPLICING%REACTOME%R-HSA-72165.1,0.534814323607427,0.9265056012720759,-0.15665204483516798,-0.959454067707195,1612,52,EFTUD2|PRPF6|NHP2L1|POLR2A|YBX1|TXNL4A|POLR2K|SNRPB|POLR2F|NCBP2|POLR2I|POLR2D
PRPP BIOSYNTHESIS%REACTOME%R-HSA-73843.2,0.340014847809948,0.8332325975999629,-0.6561896884477529,-1.12237731881811,2289,2,PRPS2|PRPS1
ERYTHROPOIETIN ACTIVATES STAT5%REACTOME DATABASE ID RELEASE 66%9027283,0.806808419243986,0.984682960940884,0.295337279432598,0.7263390270334681,7512,6,EPOR|JAK2|STAT5B
REGULATION OF GAP JUNCTION ACTIVITY%REACTOME%R-HSA-191650.1,0.748881093504294,0.9749763305090959,0.5073386891172651,0.8292311499530759,6190,2,GJA1|TJP1
LATE PHASE OF HIV LIFE CYCLE%REACTOME%R-HSA-162599.2,0.796884735202492,0.983076599789428,-0.108837654729624,-0.842693702089912,1278,128,POLR2K|NELFE|TCEB1|UBA52|POLR2F|RANGAP1|TAF4B|NCBP2|TCEA1|POLR2I|POLR2D|CHMP4B|UBC|TAF13|UBB
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU-RICH ELEMENTS%REACTOME DATABASE ID RELEASE 66%450531,0.7399407030919101,0.9744283926676119,-0.12362172625370402,-0.861835363735256,1746,82,PSME4|HSPB1|DCP1A|PSMC4|DCP2|PSMD12|PRKCD|EXOSC6|PSMA6|PSME3|EXOSC4|EIF4G1|EXOSC9|YWHAB|UBA52|PRKCA|YWHAZ|PSMD6|PABPC1|EXOSC5|UBC|PSMF1|UBB
INTERLEUKIN-38 SIGNALING%REACTOME%R-HSA-9007892.2,0.7690983715080101,0.9792236089291529,-0.611656374062638,-0.8182313808300931,5808,1,MAPK8
POST-TRANSLATIONAL MODIFICATION: SYNTHESIS OF GPI-ANCHORED PROTEINS%REACTOME%R-HSA-163125.2,0.61215783860647,0.9508825506493929,-0.14330547406200198,-0.9166525917233409,1721,60,PIGA|DPM1|PIGG|PIGZ|PIGY|PRND|DPM2|PIGT|NRN1L|PLAUR|ULBP2|LY6K|PIGX|MFI2|NTNG2|RTN4RL2
SLC TRANSPORTER DISORDERS%REACTOME%R-HSA-5619102.4,0.391140939597315,0.861275178639796,0.8112593736215259,1.0777218850096,2913,1,GCK
RUNX3 REGULATES P14-ARF%REACTOME DATABASE ID RELEASE 66%8951936,0.0484185864896525,0.43367236931051095,-0.49126066643681,-1.5858334541819399,247,9,TGFB1|BRD2|RUNX3|HDAC4|RUNX1|KRAS|CBFB
P75NTR SIGNALS VIA NF-KB%REACTOME DATABASE ID RELEASE 66%193639,0.00241492864983535,0.124203830341376,-0.495259761022043,-2.02825517347188,10,16,PRKCI|RELA|TRAF6|IRAK1|NFKBIA|SQSTM1|RIPK2|UBA52|MYD88|UBC|UBB
FCERI MEDIATED CA+2 MOBILIZATION%REACTOME%R-HSA-2871809.1,0.9694973377853991,1.0,0.13196420716126803,0.536502038020752,10742,27,IGKV4-1|GRAP2|IGKV3-11|IGKV2D-28|IGKV2-28|PLCG1|BTK|ITPR2|NFATC1|PPP3CA|PPP3CB|AHCYL1|ITPR1
INTERLEUKIN RECEPTOR SHC SIGNALING%REACTOME DATABASE ID RELEASE 66%912526,0.210080075365049,0.724971062329774,-0.266030018334521,-1.20825407005946,891,21,PIK3CD|PIK3R2|PTPN6|IL3RA|CSF2RB|SHC1|GAB2|PIK3R1
ABACAVIR TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%2161522,0.285029418173894,0.794258537514783,0.5036388070750539,1.16081279013505,2615,5,SLC22A3|GUK1|ABCB1|ADAL
VITAMIN C (ASCORBATE) METABOLISM%REACTOME DATABASE ID RELEASE 66%196836,0.404286233200145,0.865585453523601,-0.35056234660505803,-1.02260591808359,2225,7,SLC2A3|CYB5A|SLC2A1
"CELL CYCLE, MITOTIC%REACTOME%R-HSA-69278.3",6.75447483958122e-05,0.0784645998831315,0.26707479253548,1.80770338216692,0,478,HIST1H3E|HIST1H2BJ|AKAP9|HIST3H2BB|CLIP1|CDK6|CCNA1|SDCCAG8|CEP63|ANAPC15|CEP70|CENPJ|CCNB1|TPR|CDC7|CDK1|BTRC|POLE|LIN52|PSMD11|NCAPD3|ZWINT|ANAPC5|CDKN2C|BORA|CENPF|KIF2C|DHFR|MZT2B|NUP133|PSMD13|WEE1|KIF18A|CENPL|PSMB9|CENPT|CKAP5|CEP290|NSL1|HIST2H3C|NME7|PSMA4|E2F3|CEP131|CEP152|HIST2H3A|NUMA1|POLE2|ORC1|CENPK|RFC4|CDC25C|JAK2|DNA2|LIN9|PSMD3|CDC45|NUF2|KIF23|BIRC5|TK1|CASC5|BUB1|CENPU|TOP2A|PRKCB|CDKN2A|POLD1|HMMR|TUBGCP3|NEK2|CDC23|CDC20|FEN1|SMC2|CCNE1|PKMYT1|HAUS5|NDC80|ITGB3BP|CENPA|ANAPC7|CDK5RAP2|CENPE|E2F2|ANAPC16|POLD3|NUP205|PRKAR2B|PTTG1|FBXO5|PSMD1|RB1|BUB1B|POLA2|E2F5|LEMD3|HIST1H4I|MCM6|GTSE1|ESPL1|AURKB|CDC6|ERCC6L|NUP188|LMNB1|E2F6|NUP160|PPP2R3B|DSN1|NCAPH2|PSMA1|NIPBL|INCENP|CDKN2B|CEP72|CDCA8|TUBG2|CENPQ|CENPI|H2AFX|NUP85|CCNB2|SPDL1|H3F3A|ORC6|PPP2R2D|TUBGCP6|PSMC3|CDCA5|USO1|ESCO2|HAUS8|H2AFZ|CEP164|CEP78|DBF4|SGOL2|NUPL2|LIG1|CDK7|TAOK1|CEP192|SETD8|SKA2|KIF20A|FGFR1OP|HIST1H2BF|NDC1|CNTRL|PLK1|TUBGCP2|KNTC1|NCAPG|MCM10|NCAPH|AJUBA|SKA1|AKT3|HIST1H2BK|MCM3|SFI1|CDK11A|PPP1R12A|LIN37|AURKA|NUP107|PSMA3|MCM2|AKT2|CEP41|NUP35|CEP57|VRK1|CENPM|UBE2C|MZT2A|CNEP1R1|CCNE2|DYNC1H1|NUP210|SMC4|HIST1H2AC|PSMC6|NINL|PSMC1|ANAPC10|SPC25|E2F1|TUBB4A|PSMD2|PRIM2|TYMS|GMNN|CEP135|RRM2|POM121|TUBGCP4|GINS2|HIST1H3H|NUP54|NEK9|RBX1|RFC3|GINS1|PSMA5|HIST1H2BN|PCM1|FBXL7|SGOL1|TPX2|NCAPG2|MYBL2|RFC5|FOXM1|PDS5B|NEDD1|SPC24|PSMC2|SMC3|LEMD2|PPP2R1A|PSMC5|SKP2|CDK2|SSNA1|HIST1H2BG|CDKN2D|NUP37|HIST2H2BE|CCND2|CDC16|NDE1|SHFM1|AKT1|CEP250|HIST1H2BH|ANAPC2|PSMA2|PSMB6|AAAS|PSMB3|ZWILCH|MASTL|ORC2
TANDEM OF PORE DOMAIN IN A WEAK INWARDLY RECTIFYING K+ CHANNELS (TWIK)%REACTOME%R-HSA-1299308.1,0.12059997580742698,0.6066999390482379,0.787987921732413,1.2879446107771102,996,2,KCNK6|KCNK7
SIGNALING BY PTK6%REACTOME%R-HSA-8848021.2,0.0212503849707422,0.306557165070089,-0.26909382733756504,-1.5815080842923501,68,45,SOCS3|CDKN1B|HIF1A|DOK1|BCAR1|NRAS|RHOA|PXN|HBEGF|CRK|PTPN1|KRAS|NR3C1|UBA52|STAT3|RAC1|UBC|EPAS1|UBB
CLATHRIN DERIVED VESICLE BUDDING%REACTOME DATABASE ID RELEASE 66%421837,0.122409823484267,0.607607158836689,-0.18824030639335698,-1.2577053608231499,318,70,AP1M1|DNM2|ACBD3|YIPF6|CLINT1|AP4S1|BLOC1S4|FTH1|ARRB1|NAPA|VAMP2|TGOLN2|CLTA|AP1S1|FTL|RAB5C|TFRC|BLOC1S6|BLOC1S3|TPD52|CLVS2
SIGNALING BY BMP%REACTOME DATABASE ID RELEASE 66%201451,0.255858903116695,0.767206100763278,-0.24598089019645603,-1.1558436333608402,1058,23,UBE2D1|SKI|SMAD6|SMAD1|CHRDL1|SMAD7|UBE2D3|ACVRL1
PENTOSE PHOSPHATE PATHWAY%REACTOME%R-HSA-71336.6,0.400498028636647,0.8638522656500329,-0.27276267674948895,-1.02721902695157,1929,13,DERA|PRPS1|G6PD|PGD|TKT
DEGRADATION OF THE EXTRACELLULAR MATRIX%REACTOME%R-HSA-1474228.4,0.0418806795732912,0.402998391331252,-0.208102941275469,-1.41488049140849,105,74,LAMA5|CTSD|MMP1|FURIN|CAPNS1|CTSL|COL16A1|CAPN5|CTSK|SPOCK3|COL23A1|ADAM10|MMP2|CASP3|ADAMTS9|NCSTN|LAMC1|MMP9|ADAMTS4|COL15A1|TIMP2|ADAMTS8|COL9A1|ADAM17|MMP12|TPSAB1|CTSV|LAMC2
SYNTHESIS OF PA%REACTOME%R-HSA-1483166.6,0.503164556962025,0.9164921159310329,-0.184917263575469,-0.9593566895258709,1907,30,FAM73A|PLD6|PLA2G2A|AGPAT3|LPCAT1|GPAT2|PLD2
"ROS, RNS PRODUCTION IN PHAGOCYTES%REACTOME%R-HSA-1222556.7",0.0998505976095617,0.570215774831708,-0.27879031167711893,-1.36894219561901,400,26,ATP6V1B2|NCF2|CYBA|ATP6V0E1|ATP6V1C1|ATP6V0C|ATP6V1F|SLC11A1|ATP6V1E2|ATP6V0D1|NOS3|ATP6V1E1
PHOSPHOLIPASE C-MEDIATED CASCADE: FGFR1%REACTOME%R-HSA-5654219.2,0.692479395604396,0.96731875442989,-0.32053420994373305,-0.8114110679061851,4032,5,FGF2|FGF10
SMAC-MEDIATED APOPTOTIC RESPONSE%REACTOME DATABASE ID RELEASE 66%111469,0.8720854216604929,0.9934031064448321,0.290766964878695,0.670174750313943,8003,5,CASP9|XIAP|CASP7|DIABLO
SIGNALING BY MST1%REACTOME%R-HSA-8852405.1,0.274941084053417,0.7884684708511421,-0.5669523803668821,-1.1506130110596,1749,3,MST1R|SPINT1
OPIOID SIGNALLING%REACTOME%R-HSA-111885.1,0.217003105590062,0.733424818109987,-0.17239545785198201,-1.1642547475896599,558,72,GNB1|PRKAR1A|GNB4|PDE4A|GNG5|PRKACA|PRKX|CDK5|GNG10|GNAI3|ADCY7|GNG4|PPP3R1|PRKCD|GNAZ|GNAI2|GNAL|PPP2CA|PRKAR2A|PPP2CB|CAMK4|PPP2R1B|PDE4B|GNB5|GNGT1|PRKCA|PRKAR1B|ADCY2|PLCB4|PLCB1|PDE4D
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS%REACTOME DATABASE ID RELEASE 66%9022699,0.512716996366572,0.9189160303470669,-0.268059821807669,-0.943335910323119,2539,11,SIN3A|SLC2A3|PTPN1|MET
RHO GTPASES ACTIVATE PAKS%REACTOME%R-HSA-5627123.2,0.0367779783393502,0.386113929236656,-0.36194649809949,-1.5873066745435802,162,19,LIMK1|CDC42|MYH11|MYH9|PPP1CB|RAC1|PAK2
SIGNAL AMPLIFICATION%REACTOME%R-HSA-392518.1,0.770778810576663,0.979355471471634,0.18876210545915398,0.7674145623151009,8540,27,GNG8|GNAI1|PLA2G4A|GNB3
DEATH RECEPTOR SIGNALLING%REACTOME DATABASE ID RELEASE 66%73887,0.000623052959501558,0.0806484601749226,-0.248377300867805,-1.94111775817862,0,131,KALRN|IRAK1|GNA13|NFKBIA|CLIP3|RTN4|ABR|TNFAIP3|SQSTM1|FGD4|VAV1|TRIO|RHOA|BAG4|CASP3|TNFRSF10D|TNFRSF10A|NCSTN|PSEN2|CYLD|RNF31|RIPK2|VAV3|ARHGEF2|VAV2|AKAP13|NET1|ADAM17|ARHGEF37|UBA52|CFLAR|RASGRF2|YWHAE|RBCK1|TNFRSF10B|ARHGEF33|TAX1BP1|RAC1|USP2|MYD88|UBC|AATF|TNF|BCL2L11|LINGO1|UBB
LIGAND-RECEPTOR INTERACTIONS%REACTOME DATABASE ID RELEASE 66%5632681,0.751193808661288,0.9765189690604059,-0.33723557734182597,-0.7755713769063429,4561,4,BOC|CDON
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES%REACTOME DATABASE ID RELEASE 66%1650814,0.6442323790390091,0.9625261061153929,0.181281401125703,0.875764357619537,7695,51,COL9A2|COL18A1|COL26A1|ADAMTS2|COL8A1|P3H2|COL4A2|P4HA3|COL20A1|P3H1|COL4A1|COL5A2|COL27A1|COL28A1|COL5A1|COL11A2
DIGESTION%REACTOME%R-HSA-8935690.5,0.15109412990621698,0.6474178228659421,0.674455223660671,1.28206843015254,1304,3,AMY2B|PIR
OLIGOMERIZATION OF CONNEXINS INTO CONNEXONS%REACTOME%R-HSA-190704.1,0.3822818791946311,0.857390330625986,0.8152293780326422,1.0829958587553101,2847,1,GJA1
BIOSYNTHESIS OF ELECTROPHILIC Ω-3 PUFA OXO-DERIVATIVES%REACTOME DATABASE ID RELEASE 66%9027604,0.7431328878990351,0.974505008828563,-0.46170341446025,-0.78971896318106,5004,2,ALOX5
ION TRANSPORT BY P-TYPE ATPASES%REACTOME DATABASE ID RELEASE 66%936837,0.5006415191172701,0.9144253281295329,0.211249910733837,0.9722471783930341,5852,42,ATP10A|ATP2B1|ATP11C|ATP1B3|ATP2A1|ATP10D|FXYD7|ATP2B3|ATP7B|ATP8B3|ATP2A2
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)%REACTOME DATABASE ID RELEASE 66%400511",0.49582172701949895,0.911498395855878,-0.306194495007998,-0.9517858098444809,2669,8,SPCS2|SEC11C|SEC11A|ISL1|DPP4|SPCS3|SPCS1|PCSK1
SYNTHESIS OF PIPS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%8847453,0.7834678083319608,0.981487311948134,-0.32802073567528806,-0.7543791661211601,4757,4,PIP4K2B|TMEM55B|PIP4K2C|PIP4K2A
SIGNAL TRANSDUCTION BY L1%REACTOME%R-HSA-445144.1,0.0338397790055249,0.37600329791737297,-0.35753614766696207,-1.5952925002513998,146,20,NRP1|ITGA5|CSNK2A2|VAV2|MAPK3|RAC1|MAP2K1|CSNK2A1
DEFECTIVE TPR MAY CONFER SUSCEPTIBILITY TOWARDS THYROID PAPILLARY CARCINOMA (TPC)%REACTOME%R-HSA-5619107.2,0.391140939597315,0.861275178639796,0.8112593736215259,1.0777218850096,2913,1,GCK
PD-1 SIGNALING%REACTOME%R-HSA-389948.1,0.40839350180505396,0.867015886388254,-0.23418699635721402,-1.0270208010327,1809,19,CD3D|CD3G|CD3E|LCK|HLA-DRB1|CSK|PDCD1LG2|HLA-DRB5|HLA-DPB1|HLA-DQA1|HLA-DRA|HLA-DPA1|PTPN11|CD4|PTPN6|CD274|HLA-DQB1|HLA-DQA2|HLA-DQB2
ACTIVATION OF TRKA RECEPTORS%REACTOME DATABASE ID RELEASE 66%187015,0.5279437609841829,0.9265056012720759,-0.33860013119318394,-0.929434624789111,3003,6,NTRK2|NTRK1|ADCYAP1R1|ADCYAP1
ACTIVATION OF BID AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%75108,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|NMT1|GZMB|BID
GOLGI ASSOCIATED VESICLE BIOGENESIS%REACTOME%R-HSA-432722.3,0.0434350132625995,0.411224194190211,-0.23676819524106302,-1.4501451817418602,130,52,PUM1|SNX9|DNAJC6|GAK|AP1G1|BLOC1S1|PICALM|AP1M1|DNM2|ACBD3|YIPF6|CLINT1|BLOC1S4|FTH1|ARRB1|NAPA|VAMP2|TGOLN2|AP1S1|FTL|RAB5C|TFRC|BLOC1S6|BLOC1S3|TPD52
MRNA DECAY BY 5' TO 3' EXORIBONUCLEASE%REACTOME%R-HSA-430039.1,0.9703225806451609,1.0,-0.143472022955524,-0.572179245190249,4511,15,LSM7|LSM4|XRN1|EDC4|LSM1|LSM2|PATL1|LSM6|EDC3|LSM5|DCP1B|LSM3|DCP1A|DCP2|DDX6
MHC CLASS II ANTIGEN PRESENTATION%REACTOME DATABASE ID RELEASE 66%2132295,0.888249400479616,0.997300970905927,-0.10600513739037899,-0.7740244592501558,1851,99,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|IFI30|SEC13|CTSD|KIF26A|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|CTSK|HLA-DQB1|DCTN5|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|CTSH|DYNLL2|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1
SIGNALING BY WNT IN CANCER%REACTOME DATABASE ID RELEASE 66%4791275,0.225370418507928,0.739227470966488,-0.23017722190808199,-1.17798973215905,866,29,CSNK1A1|AMER1|PPP2R5A|LRP5|CTNNB1|CTBP1|PPP2R5C|TCF7L2|PPP2CA|PPP2CB|PPP2R1B|DKK1
TOLL LIKE RECEPTOR 9 (TLR9) CASCADE%REACTOME DATABASE ID RELEASE 66%168138,0.00132684652808492,0.0945022140486112,-0.25146614634964803,-1.7940983844968799,2,89,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|PIK3C3|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|RBSN|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|TICAM1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
FORMATION OF HIV ELONGATION COMPLEX IN THE ABSENCE OF HIV TAT%REACTOME%R-HSA-167152.3,0.088909541511772,0.5573167740259111,-0.230903837330343,-1.34596461642033,286,44,CCNK|SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D
MITOCHONDRIAL TRANSCRIPTION INITIATION%REACTOME%R-HSA-163282.2,0.10269769595924501,0.574198697765381,0.7130300045695209,1.35539503074563,886,3,POLRMT|TFB2M|TFAM
RUNX2 REGULATES CHONDROCYTE MATURATION%REACTOME%R-HSA-8941284.1,0.07453600593912402,0.5239349721382991,-0.8358974358974358,-1.42975779629947,501,2,HDAC4|CBFB
DISEASES ASSOCIATED WITH SURFACTANT METABOLISM%REACTOME%R-HSA-5687613.1,0.070146550304627,0.5090696843097849,-0.6622140396126329,-1.5229539497503701,425,4,TTF1|CSF2RB
REPRESSION OF WNT TARGET GENES%REACTOME DATABASE ID RELEASE 66%4641265,0.259121061359867,0.770912532778873,-0.320131652179394,-1.16627172127487,1249,12,CTBP1|TCF7L2|TCF7|TLE3
INHIBITION OF SIGNALING BY OVEREXPRESSED EGFR%REACTOME DATABASE ID RELEASE 66%5638303,0.724745134383689,0.972554563883587,-0.6322232024702249,-0.845744254268264,5473,1,EGFR
SMAD2 3 MH2 DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3315487,0.0258347978910369,0.335048214687472,-0.6331145551817329,-1.73785694344026,146,6,TGFBR2|TGFB1|SMAD4|SMAD3|TGFBR1|SMAD2
MYOCLONIC EPILEPSY OF LAFORA%REACTOME%R-HSA-3785653.2,0.106989457243264,0.5822715745664481,-0.43401642509388394,-1.40104391334751,547,9,UBA52|UBC|UBB
E2F MEDIATED REGULATION OF DNA REPLICATION%REACTOME DATABASE ID RELEASE 66%113510,0.635260329812859,0.95916055221954,0.22623680425370302,0.866434480327307,6856,22,CCNB1|CDK1|ORC1|RB1|POLA2|PPP2R3B|ORC6|E2F1|PRIM2|PPP2R1A|ORC2
CYCLIN A:CDK2-ASSOCIATED EVENTS AT S PHASE ENTRY%REACTOME%R-HSA-69656.3,0.5476096404583171,0.9305779599215391,0.175892357472561,0.94743178471007,6929,84,CCNA1|LIN52|PSMD11|PSMD13|WEE1|PSMB9|PSMA4|LIN9|PSMD3|CCNE1|PSMD1|RB1|E2F5|PSMA1|PSMC3|CDK7|AKT3|LIN37|PSMA3|AKT2|CCNE2|PSMC6|PSMC1|E2F1|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDK2|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|LIN54|CCNA2|MNAT1
INFECTIOUS DISEASE%REACTOME DATABASE ID RELEASE 66%5663205,0.997635933806147,1.0,-0.0666024714665949,-0.612202161169253,421,350,RPL15|HBEGF|SLC25A4|RPL8|VAMP2|VAMP1|VPS4B|POLR2A|SUPT4H1|CLTA|AP1S1|RPL35A|NPM1|AP2S1|KPNA4|POLR2K|NELFE|TCEB1|UBA52|POLR2F|SH3GL3|CD9|RANGAP1|B2M|TAF4B|NCBP2|SYT2|TCEA1|POLR2I|POLR2D|CHMP4B|PSMD6|RAC1|MET|UBC|MAP2K1|HSP90AB1|TAF13|SV2C|SNAP25|PSMF1|PAK2|UBB
SIGNALING BY OVEREXPRESSED WILD-TYPE EGFR IN CANCER%REACTOME%R-HSA-5638302.1,0.724745134383689,0.972554563883587,-0.6322232024702249,-0.845744254268264,5473,1,EGFR
MAP3K8 (TPL2)-DEPENDENT MAPK1 3 ACTIVATION%REACTOME DATABASE ID RELEASE 66%5684264,0.0158068057080132,0.266846594628345,-0.435413546191866,-1.78316480999975,71,16,UBA52|TNIP2|UBC|MAP2K1|UBB
POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME%R-HSA-622327.1,0.0172231985940246,0.27746438902299797,-0.6643318074016881,-1.82354620469884,97,6,CHRNE|CHRNB4|CHRNA5|CHRNB2|CHRNA7|CHRNA3
HISTIDINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%70921,0.39921268959129297,0.8638522656500329,0.554442078998849,1.05393606705935,3447,3,FTCD|C9orf41|HNMT
REGULATION OF PYRUVATE DEHYDROGENASE (PDH) COMPLEX%REACTOME DATABASE ID RELEASE 66%204174,0.816460587326121,0.9866358717238399,0.210378031477419,0.713310283190853,8451,15,PDHX|PDK4|PDHA1|DLD|GSTZ1
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX%REACTOME DATABASE ID RELEASE 66%937042,0.10618597320725,0.579995350357937,-0.41558734823648497,-1.40599420419186,538,10,UBA52|UBC|UBB
SIGNALING BY TGF-BETA RECEPTOR COMPLEX%REACTOME%R-HSA-170834.1,0.132641291810842,0.618193911729853,-0.18509613319711,-1.24455636345099,344,71,STRAP|CCNK|UBE2D1|FURIN|CDK9|NEDD4L|F11R|SKI|TGFBR1|RHOA|STUB1|NEDD8|SMAD2|PPM1A|SMAD7|UBA52|UBE2D3|PPP1CB|UBC|TFDP2|FKBP1A|PARD3|UBB
REGULATION OF ACTIVATED PAK-2P34 BY PROTEASOME MEDIATED DEGRADATION%REACTOME%R-HSA-211733.1,0.608654152083996,0.9508825506493929,-0.15201862806593802,-0.9138476264121079,1912,48,PSMD6|UBC|PSMF1|PAK2|UBB
MMR%REACTOME DATABASE ID RELEASE 66%5358508,0.455564142194745,0.88900512246363,0.295758063265518,1.00280084561277,4715,15,EXO1|POLD1|POLD3|MSH6|LIG1
PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%5357801,0.0165787490580256,0.274095258901765,-0.17777262244614198,-1.4221054908307702,21,153,PSMC4|TP53BP2|ADD1|GZMB|KPNA1|PSMD12|PPP3R1|PRKCD|CTNNB1|STK26|BBC3|PSMA6|PSME3|CASP3|TNFRSF10A|VIM|H1F0|TJP2|YWHAH|DFFA|UNC5B|BCL2L1|BID|YWHAQ|YWHAB|DBNL|MLKL|BCL2|UBA52|STAT3|DYNLL2|TP53|YWHAZ|YWHAE|TNFRSF10B|BMF|PSMD6|STK24|TICAM1|UBC|BCAP31|BCL2L11|PMAIP1|TFDP2|PSMF1|PAK2|UBB|APPL1
DAP12 INTERACTIONS%REACTOME%R-HSA-2172127.1,0.15180660254744,0.6481463948883249,-0.249516756485742,-1.27696465664708,583,29,TYROBP|NRAS|FYN|VAV3|VAV2|KRAS|B2M|RAC1|PIK3R1
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12%REACTOME%R-HSA-392170.2,0.7197729422894991,0.9713637233549571,0.21985410508873002,0.803600391828896,7607,19,GNG8|GNAI1|GNB3
REVERSIBLE HYDRATION OF CARBON DIOXIDE%REACTOME%R-HSA-1475029.1,0.6436686975135849,0.9622492597510809,-0.36783764407434,-0.8459497373954499,3908,4,CA14|CA2|CA13|CA5B
FORMATION OF A POOL OF FREE 40S SUBUNITS%REACTOME DATABASE ID RELEASE 66%72689,0.14388489208633098,0.6340340930337739,-0.165655864638111,-1.20957997135494,299,99,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|EIF3F|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|EIF3J|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|EIF3M|RPS27|RPS23|RPS21|RPL3|RPL29|EIF3C|RPL31|RPL17|RPS14|RPS17|RPL32|EIF3L|RPL18A|RPL11|RPS16|RPL12|EIF3H|RPS4X|EIF3D|RPL9|RPS28|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|EIF3G|RPL15|RPL8|EIF3B|RPL35A|EIF1AX|EIF3A|UBA52|EIF3I
GLYCOGEN SYNTHESIS%REACTOME%R-HSA-3322077.2,0.18301075268817202,0.6891306172477071,-0.313620062671527,-1.2507448284293101,850,15,UBA52|UBC|UBB
RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASES%REACTOME DATABASE ID RELEASE 66%388844,0.10183200155915,0.572767517465588,0.42397203682196705,1.40475111023817,1044,14,SLITRK6|PPFIA2|PPFIA3|PTPRD|NTRK3|PTPRS|SLITRK1|PPFIBP1|PPFIA4|LRRC4B
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST%REACTOME DATABASE ID RELEASE 66%6804116,0.336873903722471,0.8314409418104092,0.33489077035818604,1.1095971918231102,3456,14,CCNA1|E2F8|E2F7|CCNE1|ARID3A|CCNE2|E2F1|CDK2|PCBP4|CCNA2
DCC MEDIATED ATTRACTIVE SIGNALING%REACTOME DATABASE ID RELEASE 66%418885,0.7748495538493458,0.9804617559060991,-0.20398393669139397,-0.768199606555138,3733,13,TRIO|ABLIM2|CDC42|RAC1
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES%REACTOME%R-HSA-2022090.3,0.852516749699364,0.991298302704726,0.154906733239318,0.7074467175277571,9924,41,COL9A2|COL18A1|LOXL1|COL8A1|LOXL3|COL4A2|LOXL2|COL4A1|COL5A2|COL27A1|COL5A1|COL11A2
OXIDATIVE STRESS INDUCED SENESCENCE%REACTOME%R-HSA-2559580.3,0.499302649930265,0.914249271904946,0.177848941616043,0.9849676205552371,6443,97,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|CDK6|MAPK11|MAP2K6|CDKN2C|HIST2H3C|E2F3|HIST2H3A|MAPK10|MAP3K5|CDKN2A|EZH2|E2F2|FOS|HIST1H4I|TNRC6A|CDKN2B|H2AFX|H3F3A|H2AFZ|HIST1H2BF|MAP2K7|TNRC6C|HIST1H2BK|HIST1H2AC|MAPK9|E2F1|SUZ12|EED|HIST1H3H|HIST1H2BN|PHC2|HIST1H2BG|CDKN2D|HIST2H2BE|HIST1H2BH|TNIK|MAPKAPK5|MINK1
ADRENALINE SIGNALLING THROUGH ALPHA-2 ADRENERGIC RECEPTOR%REACTOME DATABASE ID RELEASE 66%392023,0.0978470675575353,0.570215774831708,-0.81053212020954,-1.3863717822947401,658,2,ADRA2C|ADRA2A
"FORMATION OF THE ACTIVE COFACTOR, UDP-GLUCURONATE%REACTOME DATABASE ID RELEASE 66%173599",0.776658562000695,0.980802382590629,0.4142326168498521,0.7874126289959019,6707,3,SLC35D1
CAM-PDE 1 ACTIVATION%REACTOME DATABASE ID RELEASE 66%111957,0.11867546601829301,0.602329212916938,0.6990154537485359,1.32875484391034,1024,3,PDE1A|PDE1B
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER%REACTOME%R-HSA-76066.2,0.983846223265048,1.0,0.12139977508335,0.493552215017545,10901,27,BDP1|POLR3B|POLR3GL|BRF1|POLR3E|POLR2L|POLR3G|POLR2H|POLR3K|GTF3C5|GTF3C3
INTERLEUKIN-12 SIGNALING%REACTOME%R-HSA-9020591.1,0.00648011782032401,0.180973408469453,-0.31668152391237503,-1.80100152849282,21,40,BOLA2|BOLA2B|AIP|HNRNPF|P4HB|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|PITPNA|PAK2|FOXO3
CDC6 ASSOCIATION WITH THE ORC:ORIGIN COMPLEX%REACTOME DATABASE ID RELEASE 66%68689,0.10250796178343902,0.574106985152364,0.46121943742892496,1.4070747786656397,1029,11,E2F3|ORC1|E2F2|CDC6|ORC6|E2F1|ORC2|ORC5|ORC3
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE%REACTOME%R-HSA-392154.1,0.42919868276619105,0.877632841005648,-0.24504865248627697,-1.00355659044847,1954,16,PDE9A|NOS3|PDE10A|PDE3A
GAMMA-CARBOXYLATION OF PROTEIN PRECURSORS%REACTOME%R-HSA-159740.3,0.597891036906854,0.949262093257606,-0.31922870436853806,-0.876261358851649,3401,6,GGCX|PROC
CYCLIN D ASSOCIATED EVENTS IN G1%REACTOME DATABASE ID RELEASE 66%69231,0.300815463606161,0.8038155709110071,-0.192677218262274,-1.10944934634224,995,42,LYN|PPP2CA|PPP2CB|PPP2R1B|CDKN1C|UBA52|CDKN1A|UBC|TFDP2|UBB
BIOSYNTHESIS OF EPA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018679,0.777700590482807,0.9811398289380491,0.413933731929844,0.786844480204479,6716,3,PTGS2|LTA4H
COLLAGEN CHAIN TRIMERIZATION%REACTOME DATABASE ID RELEASE 66%8948216,0.521420369225333,0.9251240799994541,0.223909532132948,0.957361896622762,5902,32,COL9A2|COL18A1|COL26A1|COL8A1|COL4A2|COL20A1|COL4A1|COL5A2|COL27A1|COL28A1|COL5A1|COL11A2
TRANSPORT OF NUCLEOSIDES AND FREE PURINE AND PYRIMIDINE BASES ACROSS THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%83936,0.739500503975809,0.9744283926676119,0.378586825806003,0.8022616483807791,6602,4,SLC29A2|SLC29A1
S45 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358751.1,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
INVADOPODIA FORMATION%REACTOME%R-HSA-8941237.1,0.535110314704894,0.9265056012720759,0.449291347267413,0.9520912834053,4777,4,ADAM15|ADAM19|ADAM12|SH3PXD2A
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-210500.3,0.200225182961156,0.7125740549508579,0.33542296111144504,1.24559291515624,2133,20,SLC1A2|UNC13B|GLS|PPFIA2|BZRAP1|GLS2|PPFIA3|SLC1A3|SYT1|RAB3A|SLC1A1|STX1A|PPFIA4|RIMS1|ARL6IP5
PTK6 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%8849472,0.17781014166556303,0.6834499257291881,-0.9086898985443321,-1.21558218300549,1342,1,PTPN1
TANDEM PORE DOMAIN POTASSIUM CHANNELS%REACTOME DATABASE ID RELEASE 66%1296346,0.009450171821305841,0.21235063347774397,0.7129193843399,1.7533213990783,87,6,KCNK2|KCNK6|KCNK3
ER TO GOLGI ANTEROGRADE TRANSPORT%REACTOME%R-HSA-199977.3,0.9852952153467192,1.0,0.0984660884961098,0.574207544591497,13199,128,COG2|GRIA1|CNIH3|SEC22A|INS|GOLGB1|PREB|BET1|MIA3|COPB1|SPTBN5|TRAPPC5|DCTN4|COPB2|COG6|ARF5|SEC31A|USO1|CNIH2|ANK3|CD55|SEC24D|SPTBN4|SPTAN1|CTSC|GBF1|BET1L|SEC24C|DYNC1H1|LMAN2L|COPG2|TMED9|SPTBN2
DEFECTIVE CSF2RA CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 4 (SMDP4)%REACTOME%R-HSA-5688890.1,0.109428359317001,0.584695818659266,-0.799786931022095,-1.3679927116651398,736,2,CSF2RB
PROCESSING OF CAPPED INTRON-CONTAINING PRE-MRNA%REACTOME%R-HSA-72203.3,0.9993662418139571,1.0,0.0803378854822274,0.510160590269116,14191,235,NXF2|SKIV2L2|TPR|PPWD1|THOC3|U2AF1L4|CCAR1|ZC3H11A|DHX9|THOC1|NUP133|NXF2B|PRPF8|UPF3B|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|NUP205|NUP188|NUP160|PPIL1|PPIE|RNPC3|FIP1L1|NUP85|METTL3|NUPL2|GLE1|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|POLR2L|U2SURP|NDC1|SRSF2|THOC2|HNRNPH1|HNRNPA2B1|PABPN1|NUP107|NUP35|SRSF11|POLR2J|RBM5|NUP210|XAB2|LSM8|SF3B1|POM121|NUP54|AQR|SNRPD1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|CPSF7|DDX46|SNRNP40|DDX5|PRPF3|NUP37|DDX42|CHERP|AAAS|GTF2F2|PQBP1|CSTF3|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|RBM17|SRSF9|SRSF5|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|NUP62|SNRPN|SNRNP25|CPSF4|SARNP|SRSF10
SIGNALING BY FGFR2 IN DISEASE%REACTOME%R-HSA-5655253.1,0.0207116303770579,0.30257023005641803,-0.314169325959546,-1.6520702970679297,77,31,NRAS|FGF7|FGF2|POLR2A|POLR2K|KRAS|POLR2F|NCBP2|POLR2I|POLR2D|FGF10|PIK3R1
CA ACTIVATED K+ CHANNELS%REACTOME DATABASE ID RELEASE 66%1296052,0.550231676495366,0.931421923167331,0.35607795426853395,0.926796102941228,5224,7,KCNN2|KCNMA1
FGFR3C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190372,0.5693806697278531,0.940076901516441,0.437749894720571,0.927633842961552,5083,4,GALNT3|FGF9
KETONE BODY CATABOLISM%REACTOME DATABASE ID RELEASE 66%77108,0.0587588373919874,0.47468541758473404,-0.7530067483215881,-1.52820482290563,373,3,BDH1|OXCT1
ATTENUATION PHASE%REACTOME%R-HSA-3371568.1,0.14075456053068,0.6296802030037281,-0.36394664056844006,-1.3258941190548201,678,12,HSBP1|HSF1|FKBP4|HSP90AB1
TRNA MODIFICATION IN THE MITOCHONDRION%REACTOME%R-HSA-6787450.4,0.6505147135281271,0.963755998259649,0.313690646692264,0.855204860906322,6255,8,TRIT1|GTPBP3|TRMU|MTO1|HSD17B10
APC C:CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C:CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1%REACTOME DATABASE ID RELEASE 66%174178,0.29590190383994797,0.8006020093151399,0.217505802587478,1.1291049443897299,3667,70,ANAPC15|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|PSMD1|AURKB|PSMA1|PSMC3|PLK1|AURKA|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
TOLL-LIKE RECEPTOR CASCADES%REACTOME DATABASE ID RELEASE 66%168898,0.0025608194622279102,0.12621943783915598,-0.20460545974654998,-1.6073759513336399,3,134,RELA|TRAF6|MAPKAPK3|CTSS|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|UBE2D1|NOD1|IRAK1|NFKBIA|PIK3C3|CTSL|MAPK7|DNM2|MAP3K8|IRAK2|ITGAM|IRAK4|CTSK|TRAF3|NKIRAS1|S100A8|UBE2V1|TANK|PPP2CA|PPP2CB|CNPY3|RIPK2|RBSN|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|UBE2D3|MAPK3|TNIP2|CTSV|PELI1|TICAM1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
DECTIN-1 MEDIATED NONCANONICAL NF-KB SIGNALING%REACTOME DATABASE ID RELEASE 66%5607761,0.9233552631578951,1.0,0.13016400435297099,0.64884155099299,11227,58,BTRC|PSMD11|PSMD13|PSMB9|UBA3|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
ANTAGONISM OF ACTIVIN BY FOLLISTATIN%REACTOME DATABASE ID RELEASE 66%2473224,0.5208299028486749,0.9251240799994541,-0.405029646379054,-0.931483573014855,3162,4,INHBB
SIGNALING BY FGFR1%REACTOME%R-HSA-5654736.4,0.00111080255484588,0.0893009762660318,-0.40331948115891203,-2.1924475073390504,3,35,ANOS1|NRAS|FGF2|PPP2CA|PPP2CB|FLRT1|KRAS|UBA52|MAPK3|FGF10|UBC|PIK3R1|SPRED2|UBB
SCAVENGING BY CLASS F RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000484,0.0971840659340659,0.569923978730193,-0.563038764826763,-1.42529524546182,565,5,HSP90AA1|SCARF1|CALR|HYOU1
PLATELET CALCIUM HOMEOSTASIS%REACTOME%R-HSA-418360.1,0.6591624976838979,0.9643779777660141,0.221433948231808,0.848040655877987,7114,22,ATP2B1|SLC8A3|P2RX5|ATP2A1|ATP2B3|ATP2A2|SLC8A1|SLC8A2|ITPR2|P2RX3
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM%REACTOME DATABASE ID RELEASE 66%72202,0.325244649534569,0.826621597878865,0.207975965682255,1.10207369587535,4087,77,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUP37|AAAS|U2AF2|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP|RANBP2|SYMPK
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM%REACTOME%R-HSA-3560782.2,0.31234753237005103,0.8151256671258129,0.30476308161465304,1.13173747558167,3328,20,VCAN|GPC2|GPC6|GPC1|PRELP|GPC3|AGRN|FMOD|BGN|SDC3|DCN|OGN|LUM
SWITCHING OF ORIGINS TO A POST-REPLICATIVE STATE%REACTOME%R-HSA-69052.3,0.16494845360824698,0.667429120754799,0.22911207426921104,1.24518820453083,2095,88,CCNA1|ANAPC15|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|ORC1|PSMD3|CDC23|CCNE1|ANAPC7|ANAPC16|PSMD1|MCM6|CDC6|PSMA1|ORC6|PSMC3|MCM3|PSMA3|MCM2|UBE2C|CCNE2|PSMC6|PSMC1|ANAPC10|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SKP2|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CCNA2|CDT1|ANAPC4|PSME2
CATION-COUPLED CHLORIDE COTRANSPORTERS%REACTOME DATABASE ID RELEASE 66%426117,0.513401612551754,0.919680271008069,0.41800666187326396,0.9634433896826958,4711,5,SLC12A2|SLC12A5|SLC12A4
BILE ACID AND BILE SALT METABOLISM%REACTOME DATABASE ID RELEASE 66%194068,0.0733243364822312,0.520754220371606,0.352973289251835,1.4474122666946498,814,28,ABCC3|SLC27A2|HSD17B4|OSBPL3|STARD5|AMACR|FABP6|AKR1C1|ACOX2|OSBPL9|CYP7B1
APOPTOTIC EXECUTION PHASE%REACTOME%R-HSA-75153.4,0.48630338733431505,0.90704700953301,-0.172762722067011,-0.982519986216062,1650,40,ADD1|KPNA1|PRKCD|CTNNB1|STK26|CASP3|VIM|H1F0|TJP2|DFFA|DBNL|STK24|BCAP31|PAK2
CD22 MEDIATED BCR REGULATION%REACTOME%R-HSA-5690714.2,0.488056680161943,0.9079409787810301,0.34290978894957697,0.9785473733493729,4821,9,IGKV4-1|IGKV3-11|IGKV2D-28|IGKV2-28|CD79A
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION%REACTOME%R-HSA-6804758.2,0.422123104371097,0.873470206885489,0.246383476203633,1.03306897478202,4731,30,RBBP7|MBD3|MTA2|MAP2K6|ING5|PIN1|BRPF3|ING2|AKT3|AKT2|BRD1|PIP4K2B|CHD3|AKT1|MEAF6
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR (BCR)%REACTOME DATABASE ID RELEASE 66%1168372,0.558312655086849,0.936434965680841,-0.138437802478986,-0.9539213157713579,1349,78,KRAS|UBA52|NFKBIB|NFATC2|RASGRP3|PSMD6|UBC|PSMF1|FKBP1A|UBB
G-PROTEIN ACTIVATION%REACTOME%R-HSA-202040.1,0.8482490272373541,0.991298302704726,0.18203879814615698,0.697166369510329,9155,22,GNG8|GNAI1|GNB3
PROTEIN FOLDING%REACTOME%R-HSA-391251.1,0.0309368191721133,0.36029863734836,-0.199073407495878,-1.4202489748150102,70,88,FBXO6|GNG5|FBXL5|GBA|FKBP9|FBXL3|FBXW2|ARL2|GNG10|FBXW7|GNAI3|PFDN6|CCT4|PDCL|GNG4|GNAZ|TUBB2B|ARFGEF2|TUBB2A|CCT7|SPHK1|GNAI2|TUBB6|TUBA1C|CSNK2A2|PFDN1|TUBB3|PFDN2|TCP1|TBCB|GNB5|GNGT1|STAT3|TP53|TUBB4B|NOP56|CSNK2A1|KIF13A
RHO GTPASES ACTIVATE CIT%REACTOME DATABASE ID RELEASE 66%5625900,0.297489446789602,0.8023890191280308,-0.25942169438769697,-1.1159744913236698,1338,18,RHOC|MYH11|MYH9|PPP1CB|RAC1
CONSTITUTIVE SIGNALING BY EGFRVIII%REACTOME DATABASE ID RELEASE 66%5637810,0.130317493255862,0.612163182799301,-0.356141523912076,-1.34122217163165,627,13,NRAS|CDC37|KRAS|SHC1|PIK3R1
G0 AND EARLY G1%REACTOME DATABASE ID RELEASE 66%1538133,0.22281382546701603,0.7355723797115551,0.299023048234552,1.21568172343099,2468,27,CCNA1|CDK1|LIN52|LIN9|TOP2A|CCNE1|E2F5|CDC6|LIN37|CCNE2|E2F1|MYBL2|CDK2|LIN54|CCNA2
G2 PHASE%REACTOME%R-HSA-68911.3,0.107212900414034,0.583104382186144,0.601202294286345,1.38568216519924,983,5,CCNA1|E2F3|E2F1|CDK2|CCNA2
RAP1 SIGNALLING%REACTOME%R-HSA-392517.2,0.7970464135021099,0.9831339686797859,-0.19391852537503498,-0.751291704829008,3777,14,PRKACA|RAP1B|RAP1GAP2|RAP1A|YWHAB|YWHAZ
GRB7 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1306955.3,0.222994095171935,0.7355723797115551,0.634058857094364,1.20527918684824,1925,3,NRG2|NRG1|ERBB2
COMPLEMENT CASCADE%REACTOME DATABASE ID RELEASE 66%166658,0.0502672874633558,0.440696954833581,0.33129748842715,1.4942371629713798,582,39,IGKV4-1|COLEC11|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|CFHR3|C3AR1|C7|CD55|C5|GZMM|C4A|C4B|IGHG2|CD46
HDL REMODELING%REACTOME%R-HSA-8964058.1,0.652974504249292,0.9640743070248079,0.369909761794495,0.8525871649578158,5992,5,CETP|APOE|LCAT|APOC2
MISCELLANEOUS SUBSTRATES%REACTOME DATABASE ID RELEASE 66%211958,0.880125801378977,0.9956508825790341,0.447454544601922,0.7313521608564321,7275,2,CYP2D6|CYP2U1
PI-3K CASCADE:FGFR1%REACTOME%R-HSA-5654689.2,0.208902772354549,0.7243363294845151,-0.37946396885092,-1.2249436960323898,1069,9,FGF2|FGF10|PIK3R1
PROPIONYL-COA CATABOLISM%REACTOME%R-HSA-71032.2,0.7829592503813471,0.981487311948134,0.32647342730815,0.7524728530342341,7185,5,PCCB|MCEE|PCCA
SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE (SASP)%REACTOME DATABASE ID RELEASE 66%2559582,0.5229553536151721,0.9253834396004771,0.179067466241049,0.964534284275164,6617,84,HIST1H3E|HIST1H2BJ|HIST3H2BB|CDK6|CCNA1|EHMT1|ANAPC15|ANAPC5|CDKN2C|HIST2H3C|HIST2H3A|CDKN2A|CDC23|ANAPC7|ANAPC16|FOS|HIST1H4I|IGFBP7|CDKN2B|H2AFX|H3F3A|H2AFZ|HIST1H2BF|HIST1H2BK|UBE2C|EHMT2|CEBPB|HIST1H2AC|ANAPC10|HIST1H3H|HIST1H2BN|CDK2|HIST1H2BG|CDKN2D|HIST2H2BE|CDC16|HIST1H2BH|ANAPC2
APOPTOSIS%REACTOME%R-HSA-109581.2,0.0176730486008837,0.280886139999265,-0.17768439600644298,-1.4159559911818898,23,150,PSMC4|TP53BP2|ADD1|GZMB|KPNA1|PSMD12|PPP3R1|PRKCD|CTNNB1|STK26|BBC3|PSMA6|PSME3|CASP3|TNFRSF10A|VIM|H1F0|TJP2|YWHAH|DFFA|UNC5B|BCL2L1|BID|YWHAQ|YWHAB|DBNL|BCL2|UBA52|STAT3|DYNLL2|TP53|YWHAZ|YWHAE|TNFRSF10B|BMF|PSMD6|STK24|TICAM1|UBC|BCAP31|BCL2L11|PMAIP1|TFDP2|PSMF1|PAK2|UBB|APPL1
ACYL CHAIN REMODELLING OF PE%REACTOME DATABASE ID RELEASE 66%1482839,0.867194958945962,0.993065231963537,0.18939319243242397,0.667962438959947,9082,17,LPCAT4|PLA2G4A|RARRES3|PLA2G2D|PLA2G12A|PLA2G4B|PLA2G4C|PNPLA8
MYD88 CASCADE INITIATED ON PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%975871,0.0021034917963819897,0.115553415806697,-0.260612103680475,-1.80561531075436,4,80,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING%REACTOME%R-HSA-389958.2,0.0109665901555726,0.228061856776328,-0.35178560998566905,-1.7530170143876498,42,27,PFDN6|CCT4|TUBB2B|TUBB2A|CCT7|TUBB6|TUBA1C|PFDN1|TUBB3|PFDN2|TCP1|TUBB4B
GLYCEROPHOSPHOLIPID CATABOLISM%REACTOME DATABASE ID RELEASE 66%6814848,0.334729381443299,0.8307288005518471,0.45392138527876,1.11635353981211,3116,6,GDPD3|PNPLA6|GDPD1|GDPD5|PNPLA7
GLYCOSPHINGOLIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%1660662,0.8646723646723651,0.992572193202955,-0.13070423628490302,-0.7260563334247979,3034,37,SMPD3|ASAH1|B3GALNT1|SMPD1|GLB1L|SMPD4|CPTP|ARSA|HEXA|ARSE|ARSK|CTSA|NEU3|UGCG|ARSB|ARSG|GALC|SUMF1|GLB1|HEXB|SMPD2|GLA|ARSD|STS|GLTP|ARSF|NEU1|ESYT2|GBA|SUMF2|ESYT1|GM2A|PSAP|CERK|ASAH2
TAT-MEDIATED HIV ELONGATION ARREST AND RECOVERY%REACTOME%R-HSA-167243.3,0.004219409282700421,0.15257126011092098,-0.375095243294373,-1.9460061429955602,15,30,SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TCEA1|POLR2I|POLR2D
ERBB2 ACTIVATES PTK6 SIGNALING%REACTOME DATABASE ID RELEASE 66%8847993,0.319081718618366,0.821565973575677,0.434012990200141,1.12964462731105,3029,7,NRG2|NRG3|NRG1
VPR-MEDIATED NUCLEAR IMPORT OF PICS%REACTOME DATABASE ID RELEASE 66%180910,0.0692066337965038,0.5054741186916171,0.35202492339262603,1.45820577464004,771,29,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|PSIP1|NUP62|RANBP2|NUP50
SIGNALING BY NOTCH3%REACTOME DATABASE ID RELEASE 66%9012852,0.721189591078067,0.9713770803161691,-0.143687530263939,-0.8375708857510291,2327,44,NCSTN|PSEN2|YBX1|MAMLD1|UBA52|UBC|RBPJ|UBB
PTK6 PROMOTES HIF1A STABILIZATION%REACTOME%R-HSA-8857538.1,0.0946813765848839,0.564250720056934,-0.632398880689744,-1.4543853128326,574,4,GPNMB|HIF1A|HBEGF
PROTEIN LOCALIZATION%REACTOME%R-HSA-9609507.1,0.966654006836308,1.0,0.108330110588248,0.618501230712012,12725,115,CROT|SLC27A2|HSD17B4|IDE|ATP5G1|DECR2|DNAJC19|MPV17|DHRS4|COA6|TIMM13|PEX1|AMACR|COQ2|TAZ|TIMM44|IDH1|ZFAND6|PAM16|GNPAT|ACOX2|ACOT2
TRANSLESION SYNTHESIS BY POLH%REACTOME DATABASE ID RELEASE 66%110320,0.530685920577617,0.9265056012720759,-0.21389078936600198,-0.9380123288020469,2351,19,UBA52|UBC|UBB
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR%REACTOME%R-HSA-392851.2,0.9160186625194399,1.0,-0.15288868840007097,-0.657693168912186,4122,18,GNB5|GNGT1|GNAS
BETA DEFENSINS%REACTOME DATABASE ID RELEASE 66%1461957,0.6148478099480329,0.9511905259737851,-0.515632754342432,-0.881962210778835,4140,2,TLR2|TLR1
DAP12 SIGNALING%REACTOME DATABASE ID RELEASE 66%2424491,0.0816123413784524,0.539385377100419,-0.291004312160127,-1.4117408986605098,327,25,TYROBP|NRAS|FYN|VAV3|VAV2|KRAS|B2M|RAC1|PIK3R1
ALPHA-DEFENSINS%REACTOME DATABASE ID RELEASE 66%1462054,0.11135857461024501,0.5855068018166539,-0.798113274891243,-1.3651300124886,749,2,PRSS3
METHYLATION%REACTOME DATABASE ID RELEASE 66%156581,0.312536844173708,0.815491204720463,0.359628065674726,1.13367618192237,3180,12,AS3MT|MAT2A|N6AMT1|MTR
RRNA PROCESSING%REACTOME DATABASE ID RELEASE 66%72312,0.0107317073170732,0.225852279407131,-0.169442820140113,-1.42550469153836,10,200,RIOK3|NCL|TEX10|RPS16|RPL12|ELAC2|UTP15|C1D|THUMPD1|RPS4X|TSR3|FTSJ2|WDR12|RPL9|PES1|RRP1|RPS28|ISG20L2|MPHOSPH6|RPL35|UTP3|RPL7|EXOSC6|RRP36|RPS9|RPS3|KIAA0391|RPL14|DHX37|GAR1|DDX47|EXOSC4|NOB1|NHP2L1|TRMT112|RPL15|RPL8|WBSCR22|PWP2|TBL3|RCL1|FCF1|RPL35A|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|DDX21|RRP7A|UBA52|CIRH1A|BYSL|IMP4|TSR1|PNO1|NOL9|RNMTL1|RPP40|RPP14|NIP7|EMG1|RRP9|NOP14|NOP56|EXOSC5
RNF MUTANTS SHOW ENHANCED WNT SIGNALING AND PROLIFERATION%REACTOME%R-HSA-5340588.1,0.791564147627417,0.9819233677232551,-0.270806905300314,-0.743346771695417,4503,6,FZD6|LRP6|FZD4|FZD8|FZD5|LRP5
TRNA PROCESSING%REACTOME DATABASE ID RELEASE 66%72306,0.44967168791039,0.8860217517530009,0.18229173524727102,1.0169895211806301,5820,101,THADA|RPP30|RPP25|POP1|TPR|OSGEP|NSUN6|NUP133|TSEN54|TRIT1|EPRS|CPSF1|TRMT10A|NUP205|QTRT1|GTPBP3|NUP188|NUP160|RPP38|TRMT1|NUP85|TRMU|NUPL2|NDC1|LAGE3|NUP107|LCMT2|NUP35|NUP210|RPP21|TRMT13|POM121|NUP54|MTO1|TYW3
COMPLEX I BIOGENESIS%REACTOME%R-HSA-6799198.1,0.954515272244356,1.0,0.12097173477394699,0.5947311824554821,11499,55,NDUFA7|NDUFS7|NDUFB11|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|NDUFA11|NDUFS8|NDUFB2|MT-ND2|NDUFV1|NDUFS3|NDUFB7|NDUFA12|ECSIT|ACAD9|NDUFB1|TMEM126B|NDUFB3|NDUFA1|NDUFB6|NDUFAF7|MT-ND3
CONJUGATION OF BENZOATE WITH GLYCINE%REACTOME DATABASE ID RELEASE 66%177135,0.40111285835248606,0.8638522656500329,0.6418524885943859,1.04909025988819,3315,2,GLYATL2|GLYATL1
BINDING OF TCF LEF:CTNNB1 TO TARGET GENE PROMOTERS%REACTOME%R-HSA-4411364.2,0.154131847725163,0.652499368654503,-0.424026805161348,-1.31805993486499,829,8,RUNX3|AXIN2|CTNNB1|TCF7L2|TCF7
DEGRADATION OF DVL%REACTOME DATABASE ID RELEASE 66%4641258,0.6189409030544489,0.9532238181782521,0.181835890997621,0.8939565483453029,7456,55,PSMD11|PSMD13|PSMB9|PSMA4|DVL1|PSMD3|DACT1|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|KLHL12|PSMD2|RBX1|PSMA5|DVL3|PSMC2|PSMC5|DVL2|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL%REACTOME%R-HSA-1855167.2,0.8832487309644671,0.996316041142784,-0.20791727112946104,-0.67117558311933,4523,9,IP6K1|NUDT4|ITPK1
DOWNSTREAM SIGNAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%186763,0.102838645418327,0.5745140527021371,-0.277798776866735,-1.3640734688967902,412,26,PIK3R2|CRKL|NCK2|BCAR1|NRAS|CRK|KRAS|STAT5A|RAPGEF1|STAT3|PIK3R1
HOST INTERACTIONS OF HIV FACTORS%REACTOME DATABASE ID RELEASE 66%162909,0.9605580693815992,1.0,0.11027069617977198,0.634618559131737,12736,120,RCC1|TPR|BTRC|PSMD11|AP2A2|NUP133|PSMD13|PSMB9|PSMA4|PSMD3|PACS1|NUP205|PSMD1|NUP188|NUP160|PSMA1|NUP85|PSMC3|NUPL2|CD8B|NDC1|NUP107|PSMA3|AP1S3|NUP35|NUP210|PSMC6|PSMC1|PSMD2|POM121|NUP54|RBX1|PSMA5|LCK|ELMO1|PSMC2|PSMC5|NUP37|SHFM1|PSMA2|PSMB6|AAAS|PSMB3|PSIP1|PSMA7|PSMB4|AP2M1|AP2B1|PSME2|NUP62|AP1S2|RPS27A|TCEB2
DARPP-32 EVENTS%REACTOME DATABASE ID RELEASE 66%180024,0.0303815355628827,0.357919492624349,-0.35387213981656107,-1.6072150650170702,128,21,PPP2CA|PRKAR2A|PPP2CB|PPP2R1B|PDE4B|PRKAR1B|PDE4D
TNFR1-MEDIATED CERAMIDE PRODUCTION%REACTOME%R-HSA-5626978.1,0.633376288659794,0.958362160385489,0.35071496789080103,0.862532386813073,5897,6,NSMAF|SMPD3
AMINO ACID SYNTHESIS AND INTERCONVERSION (TRANSAMINATION)%REACTOME%R-HSA-70614.5,0.26606590205716396,0.78001724269228,0.291008129943862,1.16999207345523,2922,26,ASNS|SERINC5|RIMKLB|GPT|GLS|GLS2|PSAT1|NAALAD2|PYCR2|PHGDH|RIMKLA|CCBL1
CTLA4 INHIBITORY SIGNALING%REACTOME DATABASE ID RELEASE 66%389513,0.207581227436823,0.7232762929610351,-0.27520175615908,-1.2068899317748,919,19,PPP2R5C|FYN|LYN|YES1|PPP2CA|PPP2CB|PPP2R1B
TRANSCRIPTIONAL REGULATION BY RUNX2%REACTOME DATABASE ID RELEASE 66%8878166,0.7253281477880409,0.972554563883587,-0.11898934862344,-0.874013748263675,1491,101,ABL1|HDAC4|PSMA6|PSME3|STUB1|ITGA5|SMAD6|RUNX1|SMAD1|YES1|LGALS3|PPARGC1A|NR3C1|UBA52|MAPK3|CDKN1A|PSMD6|CBFB|UBC|TWIST1|PSMF1|UBB
MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS%REACTOME%R-HSA-9022702.1,0.22653778558875198,0.7398172623753029,-0.439525801703315,-1.20646881367622,1288,6,DLL1|SIN3A|CRH
GLYCOSAMINOGLYCAN METABOLISM%REACTOME%R-HSA-1630316.2,0.7931247585940521,0.9819233677232551,0.142059831411031,0.7925392762855259,10266,101,HS3ST4|GLCE|VCAN|B3GAT3|HS3ST5|CHST15|GPC2|SLC35B3|GPC6|EXT1|CHPF2|HMMR|SLC26A2|GPC1|XYLT2|B4GALT6|PRELP|B3GALT6|PAPSS2|B4GALT4|ABCC5|ST3GAL4|HS2ST1|GPC3|AGRN|GLB1L|B3GNT4|FMOD|ST3GAL6|LYVE1|BGN|B4GALT3|SDC3|DCN|SLC35B2|HEXA|HYAL2|OGN|ST3GAL3|LUM|GNS
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY%REACTOME DATABASE ID RELEASE 66%5357769,0.43544056626800104,0.878651088001772,-0.21126301366334196,-1.0126812247325299,1783,24,CASP3|TNFRSF10A|UNC5B|TNFRSF10B|TICAM1|APPL1
TRANSCRIPTION FROM MITOCHONDRIAL PROMOTERS%REACTOME%R-HSA-75944.2,0.0259827528278643,0.33512489842855103,0.746509464787004,1.58192486618318,231,4,POLRMT|MTERF1
LOSS OF FUNCTION OF SMAD4 IN CANCER%REACTOME%R-HSA-3304347.1,0.112804399057345,0.588394851272028,-0.697308922466086,-1.41516774018697,717,3,SMAD4|SMAD3|SMAD2
CREB3 FACTORS ACTIVATE GENES%REACTOME DATABASE ID RELEASE 66%8874211,0.221576462041409,0.73556947110949,-0.416436845008274,-1.21476475251144,1219,7,CREB3L1|CREB3L2|MBTPS1|MBTPS2|CREB3L4|CREB3|CREBRF
DSCAM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%376172,0.36772113640943,0.8512482163931461,0.367222452628837,1.08376833018646,3649,10,MAPK11|MAPK12|DSCAM|NTN1|MAPK13
ACYL CHAIN REMODELING OF CL%REACTOME%R-HSA-1482798.2,0.41355240549828204,0.868370912572213,0.42393742063947404,1.04261234552554,3850,6,PLA2G4A|TAZ|HADHB|LCLAT1|HADHA|PLA2G6
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL%REACTOME%R-HSA-198323.3,0.442701227830832,0.8805227338055791,0.30705913875277097,1.01738234744208,4542,14,BAD|CASP9|AKT3|AKT2|GSK3A|CHUK|AKT1|MDM2
LYSINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%71064,0.8142237982663522,0.986276922067025,-0.214983174270425,-0.727320257235038,4132,10,DLD|PHYKPL|AASS|AADAT|PIPOX|DLST|HYKK|ALDH7A1|GCDH|OGDH
TGF-BETA RECEPTOR SIGNALING ACTIVATES SMADS%REACTOME%R-HSA-2173789.1,0.0069038767923526295,0.186946165915992,-0.34185209554443,-1.79764110106695,25,31,STRAP|FURIN|NEDD4L|TGFBR1|STUB1|NEDD8|SMAD2|SMAD7|UBA52|PPP1CB|UBC|FKBP1A|UBB
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%450302,0.54010219951122,0.928637097809937,-0.214929993612104,-0.924581079688003,2430,18,TRAF6|MAPKAPK3|UBE2N|NOD1|IRAK1|IRAK2|UBE2V1|RIPK2|MAP2K3
CONJUGATION OF SALICYLATE WITH GLYCINE%REACTOME%R-HSA-177128.1,0.40111285835248606,0.8638522656500329,0.6418524885943859,1.04909025988819,3315,2,GLYATL2|GLYATL1
DEGRADATION OF GLI1 BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610780,0.905515071215634,1.0,0.135126289761627,0.6674659885962291,10934,56,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|SUFU|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
DAG AND IP3 SIGNALING%REACTOME DATABASE ID RELEASE 66%1489509,0.9045358649789029,1.0,-0.130741157911258,-0.6782893171428211,3429,30,PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2
CS DS DEGRADATION%REACTOME DATABASE ID RELEASE 66%2024101,0.858684374351525,0.99166790097654,-0.185777425654292,-0.6996342339954179,4137,13,BGN|DCN|HEXA|HYAL3|ARSB|CSPG5|HEXB|HYAL1|IDS|IDUA|CSPG4|NCAN
REGULATION OF KIT SIGNALING%REACTOME DATABASE ID RELEASE 66%1433559,0.11878109452736302,0.602329212916938,-0.373971445207042,-1.36241548794076,572,12,SH2B3|SOCS6|PTPN6|FYN|LYN|YES1|PRKCA
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%5250913,0.880158415841584,0.9956508825790341,0.133240675754196,0.7116549181699219,11111,80,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MBD3|MTA2|TAF1D|KAT2A|MTA1|HIST2H3C|HIST2H3A|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|EHMT2|HIST1H2AC|SF3B1|HIST1H3H|HIST1H2BN|POLR2H|CHD3|HIST1H2BG|HIST2H2BE|HIST1H2BH
TRANSCRIPTIONAL REGULATION BY RUNX1%REACTOME DATABASE ID RELEASE 66%8878171,0.984776403425309,1.0,-0.0813212927457547,-0.6814257647179369,1034,196,HIST2H4B|PSMD6|CTSV|SMARCC1|HIST1H2BC|CBFB|H3F3B|UBC|HIST2H2AC|CSNK2A1|HIST1H2BD|PSMF1|PBRM1|UBB
UCH PROTEINASES%REACTOME%R-HSA-5689603.2,0.157116451016636,0.6578589353509621,-0.167490364187309,-1.2041661834447799,339,93,INO80B|RUVBL1|PSMD12|TGFBR1|HIST2H2AA3|ADRM1|ACTR5|PSMA6|PSME3|HIST2H2AA4|INO80C|NEDD8|BAP1|KDM1B|SMAD7|INO80E|UBA52|FOXK1|ACTR8|UCHL1|PSMD6|TFPT|UBC|HIST2H2AC|PSMF1|UBB
METABOLISM OF FOLATE AND PTERINES%REACTOME%R-HSA-196757.5,0.915282071097372,1.0,0.180484475592907,0.6119528331576191,9474,15,DHFR|MTHFD1|SLC46A1|MTHFD2L|SLC19A1|MTHFR|ALDH1L2|FOLR2|MTHFS
ARMS-MEDIATED ACTIVATION%REACTOME%R-HSA-170984.3,0.0790047221213222,0.532203813468543,-0.5080761928830569,-1.4820807959302398,434,7,CRK|RAP1A|YWHAB
RAB GEFS EXCHANGE GTP FOR GDP ON RABS%REACTOME%R-HSA-8876198.3,0.0551962052608883,0.458057897476257,-0.191720676911211,-1.3548464081351,127,86,RAB3GAP1|HPS1|DENND5B|RIN1|DENND2A|TRAPPC1|RAB10|MON1B|HPS4|RAB13|DENND1B|RAB21|RABGEF1|RAB8B|TRAPPC2L|TRAPPC6A|RAB18|RIN3|RAB6A|RIN2|RAB1A|RAB39A|DENND1A|RAB8A|RAB12|RAB5C|ALS2CL|YWHAE|RINL|RAB3IL1|TRAPPC10|RAB7A|RAB5A|DENND6A
ROLE OF SECOND MESSENGERS IN NETRIN-1 SIGNALING%REACTOME%R-HSA-418890.1,0.7289169753758991,0.972554563883587,0.34477617056141396,0.794657963006867,6689,5,PLCG1|TRPC1|NTN1
S PHASE%REACTOME DATABASE ID RELEASE 66%69242,0.0757951561132186,0.525661416287861,0.22045375849595397,1.32672770438731,1038,158,CCNA1|ANAPC15|POLE|LIN52|PSMD11|ANAPC5|PSMD13|WEE1|PSMB9|PSMA4|POLE2|ORC1|RFC4|DNA2|LIN9|PSMD3|CDC45|POLD1|CDC23|FEN1|CCNE1|ANAPC7|ANAPC16|POLD3|PSMD1|RB1|POLA2|E2F5|MCM6|CDC6|PSMA1|ORC6|PSMC3|CDCA5|ESCO2|LIG1|CDK7|AKT3|MCM3|LIN37|PSMA3|MCM2|AKT2|UBE2C|CCNE2|PSMC6|PSMC1|ANAPC10|E2F1|PSMD2|PRIM2|GINS2|RBX1|RFC3|GINS1|PSMA5|RFC5|PDS5B|PSMC2|SMC3|PSMC5|SKP2|CDK2|CDC16|SHFM1|AKT1|ANAPC2|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|LIN54|CCNA2|CDT1|MNAT1
TRAF6-MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX%REACTOME DATABASE ID RELEASE 66%937072,0.0651612903225806,0.4956987271622679,-0.373863551711485,-1.49100124481229,302,15,UBA52|TICAM1|UBC|UBB
POST NMDA RECEPTOR ACTIVATION EVENTS%REACTOME%R-HSA-438064.2,0.649045114862995,0.963755998259649,-0.16263565212435502,-0.8751240406001991,2344,34,CAMK2A|CAMK4|RASGRF2|DLG1|CAMKK1|RPS6KA2
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY%REACTOME DATABASE ID RELEASE 66%442380,0.897993137152958,0.998912093067348,0.23447365516050397,0.6392380893793499,8635,8,SLC39A3|SLC39A7|SLC39A10
SIGNALING BY HIPPO%REACTOME DATABASE ID RELEASE 66%2028269,0.180505415162455,0.686059302700865,-0.283754037363412,-1.2443957319676202,799,19,CASP3|TJP2|SAV1|YWHAB|STK4|YWHAE
G ALPHA (Z) SIGNALLING EVENTS%REACTOME DATABASE ID RELEASE 66%418597,0.229166666666667,0.7432881250816031,-0.204264987237313,-1.17060132133601,769,41,GNG10|GNAI3|PRKCH|ADCY7|GNG4|ADRA2C|PRKCD|GNAZ|RGS4|GNAI2|GNB5|GNGT1|PRKCA|ADCY2|ADRA2A|GNAS
BETA-CATENIN INDEPENDENT WNT SIGNALING%REACTOME DATABASE ID RELEASE 66%3858494,0.9046801522728969,1.0,0.121831265983719,0.712209400906419,12119,131,PLCB3|GNG8|WNT4|WNT5B|RAC3|PSMD11|GNB3|AP2A2|PSMD13|PSMB9|PSMA4|DVL1|PSMD3|PRKCB|MAP3K7|CLTB|PSMD1|NLK|DAAM1|LEF1|TNRC6A|PSMA1|VANGL2|PSMC3|TNRC6C|RAC2|CLTC|PSMA3|FZD6|PSMC6|PSMC1|PSMD2|FZD3|PSMA5|DVL3|PSMC2|PSMC5|ITPR2|DVL2|SHFM1|GNAO1|PRKG1|PSMA2|PSMB6|PSMB3|PSMA7|SMURF2|GNG3|PSMB4|ROR2|AP2M1|SCRIB|GNG11|AP2B1|PSME2|NFATC1|PPP3CA|AGO4
REV-MEDIATED NUCLEAR EXPORT OF HIV RNA%REACTOME%R-HSA-165054.2,0.0716324710080285,0.515023940206536,0.34564354444941303,1.4492596159705902,802,30,RCC1|TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
SIGNALLING TO STAT3%REACTOME DATABASE ID RELEASE 66%198745,0.596229379418696,0.948252641174784,-0.436901576106281,-0.886678767791795,3794,3,NTRK1|STAT3
BETA OXIDATION OF PALMITOYL-COA TO MYRISTOYL-COA%REACTOME DATABASE ID RELEASE 66%77305,0.46393423642468495,0.892255822718523,0.52980764912121,1.00710860730671,4006,3,ACADVL|HADHB|HADHA
RELEASE OF HH-NP FROM THE SECRETING CELL%REACTOME DATABASE ID RELEASE 66%5362798,0.0960913876133946,0.5684612493613671,0.6546644406925389,1.3872964866331798,857,4,SCUBE2|NOTUM|DISP2
ENDOSOMAL VACUOLAR PATHWAY%REACTOME%R-HSA-1236977.1,0.187746256895193,0.6944976011707149,-0.37216685501399605,-1.25909617644143,952,10,LNPEP|CTSS|CTSL|B2M|CTSV
FGFR1 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190242,0.216174450549451,0.7328218014339442,-0.481023945954317,-1.21768017755033,1258,5,FGF1|ANOS1|FGF2|FGF10
MISSPLICED LRP5 MUTANTS HAVE ENHANCED BETA-CATENIN-DEPENDENT SIGNALING%REACTOME%R-HSA-5339717.2,0.266614296936371,0.7806336876737892,-0.570942121796025,-1.15871007274962,1696,3,LRP5|DKK1
REGULATION OF SIGNALING BY CBL%REACTOME DATABASE ID RELEASE 66%912631,0.00949646643109541,0.21235063347774397,-0.44128701580953206,-1.85688500687325,42,17,PIK3CD|PIK3R2|CRKL|VAV1|FYN|LYN|YES1|CRK|RAPGEF1|PIK3R1
ABC TRANSPORTERS IN LIPID HOMEOSTASIS%REACTOME%R-HSA-1369062.2,0.0434056761268781,0.411224194190211,0.4838426227606021,1.56153998867772,441,13,ABCA10|PEX3|ABCA7|ABCA5|ABCA9|ABCA6|ABCA2
SYNTHESIS OF PI%REACTOME%R-HSA-1483226.3,0.7426363534550341,0.974505008828563,0.37740746117868895,0.7997624620767209,6630,4,PITPNM2|CDS1|PITPNM1
ASSEMBLY OF VIRAL COMPONENTS AT THE BUDDING SITE%REACTOME DATABASE ID RELEASE 66%168316,0.23132887899034899,0.7440352621789029,-0.7181141439205959,-1.22829578344271,1557,2,CANX|CALR
NADE MODULATES DEATH SIGNALLING%REACTOME%R-HSA-205025.1,0.5249560632688929,0.9262380308863678,-0.339308366885445,-0.931378684209818,2986,6,CASP2|NGF|NGFR|NGFRAP1|CASP3|YWHAE
HDR THROUGH SINGLE STRAND ANNEALING (SSA)%REACTOME DATABASE ID RELEASE 66%5685938,0.261329833770779,0.771967970256231,0.265524034383993,1.17203275451372,2986,36,ATR|BLM|EXO1|BRIP1|RFC4|DNA2|RAD9A|RAD51|RMI2|TOPBP1|RMI1|RFC3|RAD17|RFC5|RAD1|ATM|BRCA1|RAD52
MRNA DECAY BY 3' TO 5' EXORIBONUCLEASE%REACTOME DATABASE ID RELEASE 66%429958,0.6103183315038421,0.9508825506493929,-0.215198537552137,-0.8813103374539609,2779,16,EXOSC7|EXOSC1|DIS3|EXOSC8|HBS1L|EXOSC6|EXOSC4|EXOSC9|EXOSC5
CALCITONIN-LIKE LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%419812,0.000544860152560843,0.0784645998831315,-0.773579702151131,-2.2565663117844905,2,7,RAMP3|CALCRL|RAMP2|ADM2|CALCB|ADM|RAMP1
VEGFR2 MEDIATED VASCULAR PERMEABILITY%REACTOME%R-HSA-5218920.2,0.00522908366533865,0.16770443270936902,-0.38087307722336106,-1.87019851389301,20,26,THEM4|MAPKAP1|CTNNB1|VAV1|CDH5|PRR5|CTNNA1|VAV3|VAV2|NOS3|RAC1|CAV1|PAK2|TRIB3
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM%REACTOME DATABASE ID RELEASE 66%1793185,0.9109104846265229,1.0,0.139399846315189,0.6462716328956971,10694,43,VCAN|B3GAT3|CHST15|GPC2|GPC6|CHPF2|GPC1|XYLT2
TELOMERE C-STRAND SYNTHESIS INITIATION%REACTOME%R-HSA-174430.2,0.31111573255693,0.8143712300420921,0.41628862122488497,1.13491446482549,2991,8,POLE|POLE2|POLA2|PRIM2
SYNTHESIS OF 5-EICOSATETRAENOIC ACIDS%REACTOME DATABASE ID RELEASE 66%2142688,0.8590509666080841,0.99166790097654,-0.25199933815013,-0.691721262703943,4887,6,PON2|GPX4|LTC4S|ALOX5AP|GPX1|ALOX5
PLATELET DEGRANULATION%REACTOME DATABASE ID RELEASE 66%114608,0.522872602065912,0.925335879762083,-0.131700686498952,-0.970024423823101,1062,102,APLP2|SOD1|VTI1B|SRGN|CLU|FAM49B|VEGFA|PCDH7|HSPA5|A1BG|PFN1|PSAP|WDR1|HGF|HABP4|IGF1|SERPINF2|TMSB4X|CFD|SERPINA1|CLEC3B|CTSW|CD9|ABCC4|ALDOA|VWF|IGF2|TAGLN2|CD36
TRAFFICKING OF GLUR2-CONTAINING AMPA RECEPTORS%REACTOME%R-HSA-416993.1,0.07979044932500501,0.534078458829271,0.491690274546301,1.4511050291158603,791,10,GRIA1|GRIA2|PRKCB|GRIP1|GRIA4|TSPAN7
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS%REACTOME%R-HSA-442742.1,0.649736027671582,0.963755998259649,0.21392034807164,0.86006226576173,7137,26,LRRC7|ACTN2|DLG3|PDPK1|RPS6KA6|GRIN1|HRAS|DLG4
INTERLEUKIN-6 FAMILY SIGNALING%REACTOME%R-HSA-6783589.6,0.557465850211964,0.9361453421204542,-0.203027952759626,-0.922111541371966,2366,21,TYK2|STAT1|CBL|CTF1|CNTFR|JAK1|CLCF1|PTPN11|OSM|LIFR|OSMR|IL6ST|IL6R|SOCS3|IL11|CRLF1|LIF|IL6|STAT3
RIPK1-MEDIATED REGULATED NECROSIS%REACTOME DATABASE ID RELEASE 66%5213460,0.74157084389008,0.974505008828563,0.234035757291781,0.775433192140248,7609,14,FAS|BIRC2|RIPK1|TRAF2|RIPK3|TRADD|XIAP|BIRC3|FADD
NEUROPHILIN INTERACTIONS WITH VEGF AND VEGFR%REACTOME DATABASE ID RELEASE 66%194306,0.178659641034085,0.684586375558882,-0.5564107073214959,-1.2796283885711002,1084,4,KDR|NRP1|FLT1
CERAMIDE SIGNALLING%REACTOME%R-HSA-193681.2,0.733356489521825,0.9734087938149171,0.431297809343836,0.819851764736097,6333,3,NGF|NGFR|SMPD2
LOSS OF FUNCTION OF TGFBR1 IN CANCER%REACTOME DATABASE ID RELEASE 66%3656534,0.0219683655536028,0.310715277412964,-0.6437166941548901,-1.76695910304001,124,6,TGFB1|SMAD3|TGFBR1|SMAD2|FKBP1A
INTERLEUKIN-9 SIGNALING%REACTOME DATABASE ID RELEASE 66%8985947,0.373592444605885,0.852609194081082,-0.35900915781270104,-1.04724564112722,2056,7,STAT5A|STAT3
PROLACTIN RECEPTOR SIGNALING%REACTOME DATABASE ID RELEASE 66%1170546,0.566392846001872,0.9388612723386429,0.337569867807688,0.9203060240678801,5446,8,BTRC|JAK2|STAT5B|RBX1
BIOSYNTHESIS OF E-SERIES 18(S)-RESOLVINS%REACTOME DATABASE ID RELEASE 66%9018896,0.716703786191537,0.971081608033886,-0.47313953035419504,-0.8092798269384621,4826,2,ALOX5
SIGNALING BY BRAF AND RAF FUSIONS%REACTOME%R-HSA-6802952.1,0.0620364126770061,0.485898561056649,-0.224215251937828,-1.39076118952123,183,54,QKI|CNKSR2|FAM131B|RAP1B|PAPSS1|NRAS|ARRB2|KDM7A|PAPD7|MPRIP|ARRB1|ATG7|LMNA|RAP1A|YWHAB|KRAS|TRAK1|MAPK3|ZC3HAV1|VWF|MAP2K1|BCL2L11
INACTIVATION OF CDC42 AND RAC1%REACTOME%R-HSA-428543.2,0.24446058844896498,0.757467559003634,-0.40551751254565,-1.18291257527125,1345,7,CDC42|RAC1
"SUMO IS TRANSFERRED FROM E1 TO E2 (UBE2I, UBC9)%REACTOME%R-HSA-3065678.1",0.29095532146749,0.800055408161957,-0.387290385367343,-1.12974323662805,1601,7,UBE2I|SUMO1|SUMO3
SIGNALING BY RECEPTOR TYROSINE KINASES%REACTOME DATABASE ID RELEASE 66%9006934,0.00275482093663912,0.129967667001507,-0.19134531363484,-1.76617820251587,0,378,CRKL|DUSP7|SH2B3|THEM4|COL6A2|LAMA5|NCK2|ITCH|HSPB1|SOCS6|BAX|RAP1B|MEMO1|PTPN6|FURIN|MATK|MAPKAP1|VEGFA|KDR|PIK3C3|MAPK7|PRKCD|DNM2|CTNNB1|IGF1R|PTPN3|ANOS1|ABI1|BCAR1|PTK2B|NRAS|PTPRU|VAV1|ADAM10|RIT1|CYFIP2|SPHK1|FGF7|FYN|RHOA|CUL5|STUB1|NRP1|COL6A1|HNRNPF|FGF2|MAP2K5|HGF|ATP6V0C|ADCYAP1R1|NCSTN|CDH5|PXN|ATP6V1F|HBEGF|LAMC1|LYN|PSEN2|MMP9|DOCK3|DNAL4|MST1R|YES1|CDC37|PTPN12|PPP2CA|PPP2CB|POLR2A|IGF1|CRK|CLTA|RAP1A|PRR5|RALA|CTNNA1|PTPN1|YWHAB|VAV3|VAV2|PPP2R1B|CDC42|AP2S1|SHB|NEDD4|POLR2K|COL9A1|ADAM17|LAMA4|FLRT1|KRAS|STAT5A|RAPGEF1|SHC1|UBA52|ATP6V1E2|ATP6V0D1|PRKCA|POLR2F|DUSP3|STAT3|SH3GL3|GAB2|NOS3|RALB|ADCYAP1|MAPK3|NCBP2|FLT1|POLR2I|POLR2D|ATP6V1E1|FGF10|SPINT1|THBS4|RAC1|MET|LRIG1|IGF2|LAMC2|WWOX|BRK1|UBC|PGF|PIK3R1|SPRED2|CAV1|RPS6KA2|PAK2|TRIB3|UBB
PAUSING AND RECOVERY OF HIV ELONGATION%REACTOME DATABASE ID RELEASE 66%167290,0.00488997555012225,0.161608827499482,-0.35510672950759997,-1.87996719521194,17,32,CCNK|SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TCEA1|POLR2I|POLR2D
GLUCURONIDATION%REACTOME DATABASE ID RELEASE 66%156588,0.8442154776570729,0.991298302704726,0.334159322221527,0.7081155243490129,7537,4,SLC35D1|ABHD10
SUMOYLATION OF DNA REPLICATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4615885,0.0200996392372445,0.296675691094479,0.35894375357397496,1.6392675446243798,233,41,TPR|NUP133|BIRC5|TOP2A|SUMO2|NUP205|AURKB|NUP188|NUP160|INCENP|CDCA8|PIAS4|NUP85|NUPL2|NDC1|AURKA|NUP107|NUP35|NUP210|TOP2B|POM121|NUP54
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE%REACTOME DATABASE ID RELEASE 66%442720,0.891217354675653,0.997300970905927,0.24660783232211803,0.6418683752001091,8462,7,ADCY8|ADCY1|PRKACB|CREB1|ADCY3|PRKACA|PRKX
PPARA ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-1989781.3,0.589386555271912,0.945418171231938,0.16635145330917803,0.9262374427442309,7618,100,ALAS1|ARNTL|CDK8|MED19|NFYB|NPAS2|SMARCD3|ABCB4|TIAM2|NRF1|ACADM|ME1|RORA|MED12|ARNT2|FADS1|MED1|MED21|CLOCK|HDAC3|MED17|MED24|SREBF2|FHL2|THRAP3|CARM1|RXRB|CCNC|ESRRA|MED7|GRHL1|MED23|TGS1|MED30|SP1|MED11|MED22|CHD9|GLIPR1|MED14|TXNRD1|FAM120B|G0S2
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE%REACTOME%R-HSA-1614558.6,0.115290189531572,0.593539945084925,0.42800125923283705,1.38131915225496,1173,13,CTH|TST|SLC25A10|CDO1|TXN2|ADO|SUOX
DEPYRIMIDINATION%REACTOME DATABASE ID RELEASE 66%73928,0.708298230834035,0.9695170059473192,0.306979585850268,0.799003365521418,6725,7,TDG|MBD4|NEIL1
MITOCHONDRIAL TRANSLATION TERMINATION%REACTOME DATABASE ID RELEASE 66%5419276,0.6756990941315479,0.9647315640607691,0.15962808264595002,0.8658429124207958,8577,87,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
DEFECTIVE B3GALT6 CAUSES EDSP2 AND SEMDJL1%REACTOME%R-HSA-4420332.1,0.5977792667751509,0.9492590312650558,0.25808748470964604,0.8947193187696441,6244,16,VCAN|GPC2|GPC6|GPC1|GPC3|AGRN|BGN|SDC3|DCN
SIGNALING BY FGFR2 FUSIONS%REACTOME%R-HSA-8853333.1,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
PI-3K CASCADE:FGFR2%REACTOME%R-HSA-5654695.2,0.113475177304965,0.5898500977236399,-0.410192207139299,-1.3877416343154498,575,10,FGF1|FRS2|FGF7|FGF2|FGF10|PIK3R1
PHASE I - FUNCTIONALIZATION OF COMPOUNDS%REACTOME%R-HSA-211945.5,0.18800033011471498,0.694597388648806,0.249181724766258,1.23710352438574,2277,57,FDXR|CYP21A2|CYB5B|CYP2C8|FDX1|CYP3A5|ALDH1A1|POR|CYP2R1|ADH1B|EPHX1|ARNT2|AOC2|NQO2|CYP7B1|ACSS1
TOLL LIKE RECEPTOR 4 (TLR4) CASCADE%REACTOME%R-HSA-166016.2,0.0126861555432984,0.24430577683365803,-0.195952603273837,-1.4944215888720802,22,117,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|UBE2D1|NOD1|IRAK1|NFKBIA|MAPK7|DNM2|MAP3K8|IRAK2|ITGAM|IRAK4|TRAF3|NKIRAS1|UBE2V1|TANK|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|UBE2D3|MAPK3|TNIP2|PELI1|TICAM1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
STAT6-MEDIATED INDUCTION OF CHEMOKINES%REACTOME DATABASE ID RELEASE 66%3249367,0.669329628343175,0.964618776001639,0.45603521752751996,0.866874975415618,5780,3,TBK1|STAT6|TMEM173
"GAMMA CARBOXYLATION, HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%163841",0.290759426447159,0.800029528446767,-0.21301260968604602,-1.12013419606902,1094,31,GGCX|DPH6|FN3KRP|DPH3|EIF5A|PROC|EIF5A2
INTERACTIONS OF TAT WITH HOST CELLULAR PROTEINS%REACTOME%R-HSA-176034.2,0.31358574610245,0.8163836065655741,-0.672800936762746,-1.15078996941935,2111,2,CDK9
PROCESSING OF CAPPED INTRONLESS PRE-MRNA%REACTOME DATABASE ID RELEASE 66%75067,0.857988165680473,0.99166790097654,-0.144057436431414,-0.7283898094533491,3334,28,SNRPB|NCBP2|NUDT21|SLBP
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%181429,0.675122044606107,0.9647315640607691,0.239675923170543,0.8308914279430741,7052,16,UNC13B|PPFIA2|BZRAP1|PPFIA3|SYT1|RAB3A|STX1A|PPFIA4|SLC18A2|RIMS1
ELASTIC FIBRE FORMATION%REACTOME%R-HSA-1566948.1,0.00831146106736658,0.20219929830704503,0.4054335712377371,1.7895985437721398,94,36,ITGB1|FBN3|ELN|BMP4|LOXL1|EFEMP1|TGFB2|LOXL3|FBN1|ITGB5|LOXL2|LTBP2|FBLN5|MFAP4|EFEMP2|LTBP1|MFAP2|MFAP1|ITGA8|LTBP4|TGFB3|FBLN2|MFAP3
"AXIN MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX, ACTIVATING WNT SIGNALING%REACTOME%R-HSA-4839735.1",0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
THE IPAF INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844623,0.68852062416838,0.96731875442989,0.5338225599561339,0.8725183092847149,5691,2,NLRC4|CASP1
SEMAPHORIN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%373755,0.18759124087591197,0.6942343106471479,-0.18453814992639103,-1.19488862508946,513,63,DPYSL2|DPYSL4|FYN|RHOA|NRP1|SEMA7A|RHOC|LIMK1|PLXNA1|PLXNA4|MYH11|MYH9|SEMA3A|RAC1|MET|HSP90AB1|PAK2
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER%REACTOME DATABASE ID RELEASE 66%76071,0.654251012145749,0.9640743070248079,0.209764972664263,0.8601681877987741,7271,28,SNAPC2|BDP1|POLR3B|POLR3GL|ZNF143|POLR3E|POLR2L|POLR3G|POU2F1|SNAPC3|SNAPC5|POLR2H|POLR3K
DEFECTIVE MTR CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLG%REACTOME DATABASE ID RELEASE 66%3359469,0.956453368815774,1.0,0.38485293908454904,0.6290315564049921,7906,2,MTR
REGULATION OF GENE EXPRESSION BY HYPOXIA-INDUCIBLE FACTOR%REACTOME DATABASE ID RELEASE 66%1234158,0.00917610308473253,0.21165103507835,-0.585612485507219,-1.89040958121047,46,9,CREBBP|HIF3A|HIF1A|VEGFA|HIGD1A|CITED2|EPAS1
TRYPTOPHAN CATABOLISM%REACTOME DATABASE ID RELEASE 66%71240,0.38038971807628497,0.856455387424841,-0.288219104000008,-1.05001110711172,1834,12,TDO2|SLC3A2|SLC7A5
SYNTHESIS AND PROCESSING OF ENV AND VPU%REACTOME DATABASE ID RELEASE 66%171286,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING%REACTOME DATABASE ID RELEASE 66%975110,0.00563022157646204,0.172670554681089,-0.6688637322971059,-1.95110518189529,30,7,TRAF6|UBE2N|IRAK1|IRAK4|UBE2V1|MYD88
THE NLRP3 INFLAMMASOME%REACTOME%R-HSA-844456.2,0.160759493670886,0.663263072915681,-0.331780127530922,-1.28540404873139,761,14,TXNIP|RELA|PYCARD|TXN|PANX1|NLRP3|HSP90AB1
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%190872,0.3822818791946311,0.857390330625986,0.8152293780326422,1.0829958587553101,2847,1,GJA1
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS%REACTOME DATABASE ID RELEASE 66%8866910,0.435235888795282,0.878651088001772,0.39411984190692795,1.0258111438589301,4132,7,KIT|ATAD2|TFAP2B|YY1
GROWTH HORMONE RECEPTOR SIGNALING%REACTOME DATABASE ID RELEASE 66%982772,0.239840989399293,0.7525035503527309,-0.281862868108458,-1.18604652988655,1085,17,LYN|PTPN1|ADAM17|STAT5A|STAT3|MAPK3
RHO GTPASES ACTIVATE WASPS AND WAVES%REACTOME DATABASE ID RELEASE 66%5663213,0.0447098028325465,0.41504430757275895,-0.27476946137492503,-1.4936487048761897,160,35,ABI1|ABL1|CYFIP2|ARPC5|WIPF1|ARPC4|CDC42|MAPK3|RAC1|ACTR2|BRK1
"PTK6 REGULATES RHO GTPASES, RAS GTPASE AND MAP KINASES%REACTOME DATABASE ID RELEASE 66%8849471",0.0147333471674621,0.264001457476971,-0.47980705533204704,-1.80694419917041,70,13,BCAR1|NRAS|RHOA|PXN|CRK|KRAS|RAC1
CYTOCHROME P450 - ARRANGED BY SUBSTRATE TYPE%REACTOME DATABASE ID RELEASE 66%211897,0.0621682411156095,0.48645662140978296,0.360674947871351,1.47899390615358,690,28,FDXR|CYP21A2|CYP2C8|FDX1|CYP3A5|POR|CYP2R1|ARNT2
CYTOSOLIC SENSORS OF PATHOGEN-ASSOCIATED DNA%REACTOME DATABASE ID RELEASE 66%1834949,0.11617067049121499,0.5954510906855529,-0.199579577311909,-1.2805612299029099,323,61,POLR3F|MB21D1|RELA|POLR2E|CREBBP|POLR3C|XRCC6|POLR1C|POLR3D|NFKBIA|CTNNB1|MRE11A|NKIRAS1|POLR3H|TREX1|POLR2K|UBA52|POLR2F|NFKBIB|TICAM1|MYD88|UBC|LRRFIP1|CRCP|UBB
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION%REACTOME DATABASE ID RELEASE 66%2730905,0.536901081916538,0.9265056012720759,0.277541880824174,0.941036838389006,5557,15,IGKV4-1|PDPK1|IGKV3-11|IGKV2D-28|IGKV2-28
B CELL ACTIVATION%REACTOME DATABASE ID RELEASE 66%983705,0.752604166666667,0.9769690538700708,-0.11571357339606199,-0.8694738565288872,1444,110,ORAI2|KRAS|UBA52|NFKBIB|NFATC2|RASGRP3|PSMD6|CD22|UBC|PIK3R1|PSMF1|FKBP1A|UBB
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE-3-KINASE (PI3K)%REACTOME DATABASE ID RELEASE 66%9027276,0.8266351457840819,0.9876441563834109,-0.21234674119515198,-0.7184008095201271,4195,10,IRS2|PIK3CD|PIK3R5|LYN|PIK3R1
ABASIC SUGAR-PHOSPHATE REMOVAL VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME%R-HSA-73930.1,0.820786933927246,0.987153241368501,-0.4303832368348499,-0.736147476754231,5527,2,POLB|APEX1
RAF-INDEPENDENT MAPK1 3 ACTIVATION%REACTOME%R-HSA-112409.2,0.3958680748564021,0.8638522656500329,0.276107224229643,1.05742662043508,4272,22,DUSP9|CDK1|MAP2K2|DUSP16|DUSP8|JAK2
CLEC7A (DECTIN-1) SIGNALING%REACTOME%R-HSA-5607764.1,0.999066874027994,1.0,0.076505595462153,0.42116102036658704,12847,94,CDC34|BTRC|PSMD11|PSMD13|PSMB9|UBA3|PSMA4|PDPK1|PSMD3|MAP3K7|CARD11|PSMD1|PSMA1|PSMC3|CARD9|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|ITPR2|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|TAB1|PSMA7|PSMB4|PSME2|NFATC1|PPP3CA|RPS27A|IKBKG|PPP3CB|AHCYL1|UBE2D2|ITPR1|PSMD14|PSMD4|PSMB10
ZINC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%435354,0.831189236963567,0.9879179006160809,0.217440312422583,0.7017607110782379,8463,13,SLC39A3|SLC30A5|SLC39A7|SLC39A10|SLC30A7
"WNT5A-DEPENDENT INTERNALIZATION OF FZD2, FZD5 AND ROR2%REACTOME%R-HSA-5140745.1",0.8736066878980892,0.9934031064448321,0.216047743168454,0.659112139970923,8777,11,AP2A2|CLTB|CLTC|ROR2|AP2M1|AP2B1
REGULATION OF CORTICAL DENDRITE BRANCHING%REACTOME%R-HSA-8985801.1,0.16418411916228,0.6664346072172851,0.605119846506624,1.28230675880701,1465,4,SLIT1|ROBO2
GLUTATHIONE SYNTHESIS AND RECYCLING%REACTOME DATABASE ID RELEASE 66%174403,0.857085183689948,0.991629714062402,-0.19736747138134603,-0.694560721663391,4245,11,GCLC|GSS|CHAC1|CNDP2
NON-CODING RNA METABOLISM%REACTOME DATABASE ID RELEASE 66%194441,0.22069835927639897,0.735557562482681,0.251792342682911,1.2043237220097198,2622,49,TPR|SMN1|DDX20|NUP133|NUP205|NUP188|NUP160|NUP85|GEMIN5|NUPL2|NDC1|SMN2|NUP107|NUP35|NUP210|POM121|NUP54|SNRPD1|TGS1|GEMIN8|NUP37|AAAS|SNRPE|NUP62|RANBP2|NUP50|GEMIN2|NUP43|CLNS1A|GEMIN6|SNRPD2|SNRPG
DNA DAMAGE RECOGNITION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696394,0.0185453491741524,0.285526981228736,-0.29334401294719104,-1.6420569025117,63,38,INO80B|RUVBL1|ACTR5|INO80C|RAD23B|COPS7A|CETN2|INO80E|UBA52|ACTR8|COPS2|COPS8|TFPT|UBC|UBB
CYTOSOLIC TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379716,0.00659018794239688,0.18227680804153196,-0.396358889491702,-1.8999312690091101,26,24,QARS|DARS|AARS|CARS|WARS|NARS|HARS|GARS|AIMP2|YARS|KARS|SARS
MITOCHONDRIAL BIOGENESIS%REACTOME%R-HSA-1592230.2,0.8232374950768021,0.987616425875001,0.140544833653478,0.762332955950663,10450,87,SIRT4|POLRMT|ALAS1|PRKAA2|MAPK11|MAPK12|MTERF1|ATP5G1|SMARCD3|ATP5D|NRF1|MT-ATP8|TFB1M|MED1|HDAC3|SIRT3|POLG2|MTX2|CARM1|PRKAB2|ATP5C1|ESRRA|TGS1|CHD9|ATP5E|C19orf70|TMEM11|ATP5H|MT-ATP6|ATP5A1|CYCS|PPRC1|MAPK14|NCOA6|ACSS2|NCOR1
SPHINGOLIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%428157,0.997500201596645,1.0,0.0855913832743812,0.44556931475244393,12369,71,SPTSSB|B4GALNT1|CERS4|PPAP2C|CERS6|GBA2|ORMDL1|CERS5|SMPD3|ASAH1|B3GALNT1|ACER2|SMPD1|PPM1L|GLB1L|OSBP|SMPD4|CERS2|CPTP|PRKD1|ARSA|HEXA|ARSE|ARSK|CERS1|PPAP2A|CTSA|NEU3|UGCG|VAPA|ORMDL2|DEGS1|ARSB|ARSG|CSNK1G2|GALC|SGPP1
EGFR TRANSACTIVATION BY GASTRIN%REACTOME%R-HSA-2179392.1,0.0339629495096259,0.376148295095164,-0.5689557712177901,-1.65966922691387,186,7,NRAS|HBEGF|KRAS|PRKCA
PROCESSIVE SYNTHESIS ON THE C-STRAND OF THE TELOMERE%REACTOME DATABASE ID RELEASE 66%174414,0.122312898089172,0.607607158836689,0.44895399081231296,1.36965571263601,1228,11,DNA2|POLD1|FEN1|POLD3|LIG1
REVERSE TRANSCRIPTION OF HIV RNA%REACTOME%R-HSA-162589.1,0.673374817953131,0.9647315640607691,-0.658524481693869,-0.880928277405013,5085,1,PPIA
PRE-MRNA SPLICING%REACTOME DATABASE ID RELEASE 66%72163,0.720575783234547,0.9713637233549571,-0.109490947186407,-0.9027944784580051,850,179,PCBP2|CDC5L|PRCC|CRNKL1|EFTUD2|BCAS2|PUF60|PRPF6|MAGOH|HNRNPF|NHP2L1|POLR2A|YBX1|TRA2B|PPIH|PPIL3|SNRNP27|TXNL4A|POLR2K|SNRPB|SYF2|HNRNPC|CTNNBL1|POLR2F|NCBP2|NUDT21|POLR2I|PRPF4|POLR2D|SF3A1|RBM8A|PCBP1|RNPS1|SLU7|DHX15|WBP11
SUMO E3 LIGASES SUMOYLATE TARGET PROTEINS%REACTOME%R-HSA-3108232.3,0.768876207199298,0.9792236089291529,0.13795860870459,0.824850477514361,10508,151,NR4A2|PIAS1|TDG|SAFB|NR2C1|TPR|BLM|TRIM27|NUP133|MTA1|PCGF2|BIRC5|ZNF131|DNMT3B|TOP2A|CDKN2A|RORA|PARP1|SUMO2|NUP205|HIST1H4I|DDX17|AURKB|NUP188|NUP160|INCENP|CDCA8|PIAS4|NSMCE4A|NUP85|NUPL2|XRCC4|NDC1|ING2|HERC2|AURKA|NUP107|NUP35|TFAP2B|NUP210|TOPORS|SUZ12|TOP2B|POM121|NUP54|SMC6|SMC3|CHD3|MBD1|PHC2|IKBKE|DDX5|NUP37|MDC1|BRCA1|ZNF350|DNMT1|AAAS|MDM2|RAD52|L3MBTL2|TOP1|HNRNPK|ZBED1|NUP62|UHRF2|TP53BP1|IKBKG|HDAC7|RANBP2|PHC1|HDAC2
CENTROSOME MATURATION%REACTOME DATABASE ID RELEASE 66%380287,0.00119198982835346,0.09181648161563599,0.34876954885954203,1.85264953381226,14,78,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|MZT2B|CKAP5|CEP290|NME7|CEP131|CEP152|TUBGCP3|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|TUBG2|TUBGCP6|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|TUBGCP2|SFI1|CDK11A|CEP41|CEP57|MZT2A|DYNC1H1|NINL|TUBB4A|CEP135|TUBGCP4|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
INTRACELLULAR OXYGEN TRANSPORT%REACTOME DATABASE ID RELEASE 66%8981607,0.659489536712229,0.9643779777660141,0.5445271574303829,0.8900146797838799,5451,2,CYGB|NGB
REGULATED NECROSIS%REACTOME DATABASE ID RELEASE 66%5218859,0.74157084389008,0.974505008828563,0.234035757291781,0.775433192140248,7609,14,FAS|BIRC2|RIPK1|TRAF2|RIPK3|TRADD|XIAP|BIRC3|FADD
RNA POLYMERASE I TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%73762,0.58128536441179,0.9430511832893861,0.19367989783228898,0.9186621334135991,6882,47,GTF2H2|RBBP7|MBD3|MTA2|TAF1D|KAT2A
BETA OXIDATION OF LAUROYL-COA TO DECANOYL-COA-COA%REACTOME%R-HSA-77310.2,0.3855974913204171,0.859630103805729,0.501906295859602,1.06358738551391,3442,4,HADH|HADHB|ECHS1|HADHA
PEROXISOMAL PROTEIN IMPORT%REACTOME DATABASE ID RELEASE 66%9033241,0.5288670115134321,0.9265056012720759,0.19668593027848497,0.954650197284843,6338,52,CROT|SLC27A2|HSD17B4|IDE|DECR2|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
DEFECTIVE PRO-SFTPB CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 1 (SMDP1) AND RESPIRATORY DISTRESS SYNDROME (RDS)%REACTOME DATABASE ID RELEASE 66%5688031,0.231031922791388,0.7440352621789029,-0.7186949768466792,-1.2292892670553501,1555,2,TTF1
RNA POLYMERASE II TRANSCRIPTION INITIATION AND PROMOTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%76042,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
PTK6 REGULATES CELL CYCLE%REACTOME DATABASE ID RELEASE 66%8849470,0.8597733711048159,0.9916689277956879,0.29611574861928697,0.682502903924275,7890,5,CCNE1|CDK2|CCND1|CDK4
SMOOTH MUSCLE CONTRACTION%REACTOME%R-HSA-445355.2,0.422732067510549,0.873470206885489,-0.19558227815171697,-1.01468712693222,1602,30,DYSF|SORBS3|MYH11|TPM3|PAK2
MICROTUBULE-DEPENDENT TRAFFICKING OF CONNEXONS FROM GOLGI TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%190840,0.3822818791946311,0.857390330625986,0.8152293780326422,1.0829958587553101,2847,1,GJA1
TOLL LIKE RECEPTOR 10 (TLR10) CASCADE%REACTOME DATABASE ID RELEASE 66%168142,0.0021034917963819897,0.115553415806697,-0.260612103680475,-1.80561531075436,4,80,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
GALACTOSE CATABOLISM%REACTOME%R-HSA-70370.2,0.44254725085910707,0.8804691280006801,0.41283241081874994,1.01530119116034,4120,6,GALE|GALK1|GALT|PGM2L1|PGM2|PGM1
OXYGEN-DEPENDENT ASPARAGINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA%REACTOME DATABASE ID RELEASE 66%1234162,0.121602513747054,0.607607158836689,-0.688761442594022,-1.3978208837434,773,3,HIF1AN|HIF1A|EPAS1
RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION%REACTOME DATABASE ID RELEASE 66%8941332,0.8500859106529209,0.991298302704726,0.28080138401233395,0.690590109196551,7915,6,ITGBL1|AKT3|AKT2|AKT1
INLA-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELLS%REACTOME DATABASE ID RELEASE 66%8876493,0.102506963788301,0.574106985152364,-0.454844886225538,-1.4138559492341203,551,8,CBLL1|CTNNB1|UBA52|UBC|UBB
MINUS-STRAND DNA SYNTHESIS%REACTOME DATABASE ID RELEASE 66%164516,0.673374817953131,0.9647315640607691,-0.658524481693869,-0.880928277405013,5085,1,PPIA
WNT LIGAND BIOGENESIS AND TRAFFICKING%REACTOME%R-HSA-3238698.1,0.46047333791613504,0.8904234666384399,0.310241898395526,1.00126592350175,4688,13,WNT4|WNT5B|PORCN|VPS29|WLS|WNT2B
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON%REACTOME%R-HSA-936964.2,0.0445664105378705,0.41504430757275895,-0.388723074665654,-1.59195163687732,202,16,TRAF3|TANK|UBA52|TICAM1|UBC|UBB
SIGNALING BY NTRKS%REACTOME DATABASE ID RELEASE 66%166520,0.004085338175215621,0.150016154145778,-0.237787329668897,-1.7089659017058199,8,92,FRS2|PCSK6|MAPKAPK3|RPS6KA3|AP2A1|NTRK1|PIK3R2|DUSP4|CDK5|CRKL|DUSP7|BAX|FURIN|MAPK7|DNM2|NRAS|RIT1|RHOA|MAP2K5|ADCYAP1R1|DOCK3|DNAL4|PPP2CA|PPP2CB|CRK|CLTA|RAP1A|RALA|YWHAB|PPP2R1B|AP2S1|KRAS|RAPGEF1|SHC1|DUSP3|STAT3|RALB|ADCYAP1|MAPK3|RAC1|PIK3R1|RPS6KA2
PINK PARKIN MEDIATED MITOPHAGY%REACTOME%R-HSA-5205685.1,0.0111692015209125,0.22992267312754103,-0.3852123872856861,-1.7845889886984598,46,22,TOMM22|SQSTM1|TOMM20|MAP1LC3A|MFN2|UBA52|PARK2|MAP1LC3B|UBC|UBB
BUTYRATE RESPONSE FACTOR 1 (BRF1) BINDS AND DESTABILIZES MRNA%REACTOME DATABASE ID RELEASE 66%450385,0.0242932862190813,0.327356479311802,-0.404409320222687,-1.7017079054178,109,17,EXOSC7|EXOSC1|DIS3|MAPKAPK2|EXOSC8|DCP1A|DCP2|EXOSC6|EXOSC4|EXOSC9|YWHAB|EXOSC5
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER%REACTOME DATABASE ID RELEASE 66%2219530,0.871268497134548,0.9934031064448321,0.15009467419858,0.690789042108776,10185,42,FGFR4|FGF19|NRG2|NRG3|PIK3R3|SRC|KIT|FGF9|RAC2|TRAT1|NRG1|IRS1
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS (PARS)%REACTOME%R-HSA-456926.1,0.288654489323386,0.7980646072929201,-0.22087405373144298,-1.11679350886708,1121,28,GNG10|GNA13|GNG4|ARRB2|GNAQ|GNA15|ARRB1|GNB5|GNGT1|MAPK3|GNA12
RNA POLYMERASE I TRANSCRIPTION%REACTOME%R-HSA-73864.2,0.7810454939683041,0.981487311948134,0.146752487388303,0.794310489421192,9905,86,GTF2H2|RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MBD3|MTA2|TAF1D|KAT2A|MTA1|HIST2H3C|HIST2H3A|GTF2H1|HIST1H4I|H2AFX|H3F3A|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|EHMT2|HIST1H2AC|HIST1H3H|HIST1H2BN|POLR2H|CHD3|HIST1H2BG|HIST2H2BE|HIST1H2BH
VPU MEDIATED DEGRADATION OF CD4%REACTOME DATABASE ID RELEASE 66%180534,0.8981870068826591,0.998912093067348,0.139772079477507,0.671667602825888,10700,50,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
ROBO RECEPTORS BIND AKAP5%REACTOME%R-HSA-9010642.1,0.783487784330244,0.981487311948134,0.28430538107699105,0.73998717434965,7439,7,AKAP5|ROBO2
CHOLESTEROL BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%191273,0.0319432937494247,0.365066918595497,0.41192215328278003,1.60204898891888,346,23,TM7SF2|EBP|MVD|LBR|DHCR24|PPAPDC2|NSDHL|GGPS1|IDI1|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4%REACTOME DATABASE ID RELEASE 66%5654716,0.5552790274720021,0.9343712161942179,0.26770644678264005,0.92806565171137,5800,16,FGFR4|FGF19|HRAS|FGF9|PLCG1
ACTIVATED NTRK3 SIGNALS THROUGH PLCG1%REACTOME DATABASE ID RELEASE 66%9034793,0.170194750211685,0.673117535978459,0.7520264681555,1.22916660282456,1406,2,PLCG1|NTRK3
RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111457,0.5519512596739671,0.9321968967758479,-0.395687420724646,-0.9099984056690191,3351,4,CYCS|DIABLO|BAK1|BAX
ERKS ARE INACTIVATED%REACTOME%R-HSA-202670.2,0.019298609670056,0.289864965388082,-0.465796473464623,-1.75418061566115,92,13,DUSP4|DUSP7|MAPK7|PPP2CA|PPP2CB|PPP2R1B|DUSP3|MAPK3
KSRP (KHSRP) BINDS AND DESTABILIZES MRNA%REACTOME%R-HSA-450604.2,0.18286219081272098,0.6891306172477071,-0.297532416451397,-1.2519821870440602,827,17,EXOSC7|EXOSC1|DIS3|EXOSC8|PARN|DCP2|EXOSC6|EXOSC4|EXOSC9|YWHAZ|EXOSC5
PHOSPHATE BOND HYDROLYSIS BY NUDT PROTEINS%REACTOME DATABASE ID RELEASE 66%2393930,0.43372303639058096,0.878651088001772,-0.43649699443004497,-1.00385189977286,2633,4,NUDT5|NUDT16|ADPRM|NUDT15
TRANSCRIPTIONAL REGULATION BY TP53%REACTOME%R-HSA-3700989.5,0.375886524822695,0.8533319722534141,-0.11378605085096401,-1.0442743851640102,158,349,POU4F2|PIP4K2A|PPP2CA|PPP2CB|LAMTOR5|POLR2A|COX4I1|SUPT4H1|BID|PHF20|PRR5|CRADD|CNOT7|NPM1|YWHAQ|YWHAB|PPP2R1B|GADD45A|TP53I3|POLR2K|AGO2|NELFE|TCEB1|JUN|UBA52|PMS2|POLR2F|PRDX1|TP53|YWHAZ|YWHAE|TAF4B|TNFRSF10B|BCL6|CDKN1A|TCEA1|POLR2I|BNIP3L|POLR2D|USP2|SETD9|UBC|SESN2|CSNK2A1|PLK2|GATAD2A|JMY|TAF13|COX7A2L|PMAIP1|STEAP3|TFDP2|HUS1|NDRG1|UBB
PYRIMIDINE BIOSYNTHESIS%REACTOME%R-HSA-500753.2,0.4969318050248929,0.911815944636073,0.517824136482535,0.984329210398804,4291,3,CAD|UMPS
MITOTIC ANAPHASE%REACTOME%R-HSA-68882.2,0.0305271553911972,0.35855334782526,0.23257538958831894,1.41703586011796,420,173,CLIP1|ANAPC15|PSMD11|ZWINT|ANAPC5|CENPF|KIF2C|NUP133|PSMD13|KIF18A|CENPL|PSMB9|CENPT|CKAP5|NSL1|PSMA4|CENPK|PSMD3|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC23|CDC20|NDC80|ITGB3BP|CENPA|ANAPC7|CENPE|ANAPC16|PTTG1|PSMD1|BUB1B|LEMD3|ESPL1|AURKB|ERCC6L|LMNB1|NUP160|DSN1|PSMA1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|PSMC3|CDCA5|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|PSMA3|VRK1|CENPM|UBE2C|DYNC1H1|PSMC6|PSMC1|ANAPC10|SPC25|PSMD2|PSMA5|SGOL1|PDS5B|SPC24|PSMC2|SMC3|LEMD2|PPP2R1A|PSMC5|NUP37|CDC16|NDE1|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ZWILCH
EUKARYOTIC TRANSLATION TERMINATION%REACTOME%R-HSA-72764.4,0.40913160250671404,0.867015886388254,-0.14317541648967902,-1.02717127167883,913,91,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|GSPT2|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|APEH|RPL32|RPL18A|RPL11|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|GSPT1|TRMT112|RPL15|RPL8|RPL35A|ETF1|UBA52
SOS-MEDIATED SIGNALLING%REACTOME DATABASE ID RELEASE 66%112412,0.8871704745166958,0.996908008445583,-0.24075864847691197,-0.660866324308077,5047,6,NRAS|KRAS
REGULATION OF PTEN LOCALIZATION%REACTOME%R-HSA-8948747.2,0.00800468566966029,0.19847993048827997,-0.5916561098791011,-1.90991894226507,40,9,PML|NEDD4|UBA52|UBC|UBB
AMPLIFICATION OF SIGNAL FROM UNATTACHED KINETOCHORES VIA A MAD2 INHIBITORY SIGNAL%REACTOME DATABASE ID RELEASE 66%141444,0.0103383458646617,0.22206659645222002,0.295316823666847,1.61626624138746,131,91,CLIP1|ZWINT|CENPF|KIF2C|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC20|NDC80|ITGB3BP|CENPA|CENPE|BUB1B|AURKB|ERCC6L|NUP160|DSN1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|CENPM|DYNC1H1|SPC25
FORMATION OF FIBRIN CLOT (CLOTTING CASCADE)%REACTOME DATABASE ID RELEASE 66%140877,0.49981405727036105,0.9143688619793578,0.25751912814462097,0.9735595635939019,5375,21,SERPINA5|SERPINE2|F12|F2R
RET SIGNALING%REACTOME DATABASE ID RELEASE 66%8853659,0.209997283346917,0.7248363921442859,-0.225610732141215,-1.19440365408269,772,32,SHC1|PRKCA|GAB2|DOK5|PIK3R1|GFRA2
NUCLEOBASE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%8956320,0.8373261205564141,0.9889652677625541,0.204979472816253,0.69500586528003,8667,15,IMPDH1|CAD|ADSSL1|UMPS|PAICS|ADSS
INTRACELLULAR SIGNALING BY SECOND MESSENGERS%REACTOME%R-HSA-9006925.2,0.32971506105834497,0.829093702731134,-0.11989074180715802,-1.05494576738778,242,250,PIK3CD|PPP2R5A|PRKX|CD86|RING1|SNAI2|PIK3R2|GATAD2B|CDKN1B|THEM4|BMI1|PSME4|RHOG|CBX4|PSMC4|MAPKAP1|IRAK1|ADCY7|PSMD12|RRAGD|CBX8|PRKCD|CD19|FOXO4|RRAGC|IRAK4|VAV1|PSMA6|PML|PPP2R5C|PSME3|FGF7|FYN|STUB1|HDAC5|FOXO1|FGF2|HGF|HBEGF|CSNK2A2|PPARG|PHC3|SNAI1|PIP4K2A|PPP2CA|PRKAR2A|PPP2CB|LAMTOR5|PRR5|CAMK4|PPP2R1B|NEDD4|AGO2|JUN|UBA52|MECOM|PRKCA|TP53|PRKAR1B|MAF1|ADCY2|MAPK3|CDKN1A|PSMD6|FGF10|RAC1|MET|MYD88|UBC|CSNK2A1|PIK3R1|GATAD2A|PSMF1|FOXO6|TRIB3|UBB|FOXO3
HIV INFECTION%REACTOME DATABASE ID RELEASE 66%162906,0.9990797111708909,1.0,0.0792479120993476,0.49838512719251,14112,217,GTF2H2|AK6|CXCR4|RCC1|TPR|BTRC|PSMD11|LIG4|AP2A2|NUP133|PSMD13|PSMB9|PSMA4|TAF7|GTF2B|GTF2H1|PSMD3|POLR2B|PACS1|CCR5|FEN1|TAF5|NUP205|PSMD1|NUP188|NUP160|VPS37B|PSMA1|NUP85|PSMC3|NUPL2|XRCC4|LIG1|CD8B|CDK7|GTF2E2|POLR2L|NDC1|TSG101|VPS37A|NUP107|PSMA3|AP1S3|NUP35|TAF2|POLR2J|NUP210|PSMC6|PSMC1|PSMD2|MVB12B|CCNT2|POM121|NUP54|RBX1|TAF4|PSMA5|LCK|MVB12A|POLR2G|ELMO1|POLR2H|PSMC2|PSMC5|TCEB3|GTF2A1|NUP37|SHFM1|PSMA2|PSMB6|AAAS|GTF2F2|PSMB3
M PHASE%REACTOME%R-HSA-68886.2,0.00020614306328591998,0.0784645998831315,0.256098819253755,1.68743501727375,2,339,HIST1H3E|HIST1H2BJ|AKAP9|HIST3H2BB|CLIP1|SDCCAG8|CEP63|ANAPC15|CEP70|CENPJ|CCNB1|TPR|CDK1|PSMD11|NCAPD3|ZWINT|ANAPC5|CENPF|KIF2C|MZT2B|NUP133|PSMD13|KIF18A|CENPL|PSMB9|CENPT|CKAP5|CEP290|NSL1|HIST2H3C|NME7|PSMA4|CEP131|CEP152|HIST2H3A|NUMA1|CENPK|PSMD3|NUF2|KIF23|BIRC5|CASC5|BUB1|CENPU|PRKCB|TUBGCP3|NEK2|CDC23|CDC20|SMC2|HAUS5|NDC80|ITGB3BP|CENPA|ANAPC7|CDK5RAP2|CENPE|ANAPC16|NUP205|PRKAR2B|PTTG1|FBXO5|PSMD1|RB1|BUB1B|LEMD3|HIST1H4I|ESPL1|AURKB|ERCC6L|NUP188|LMNB1|NUP160|DSN1|NCAPH2|PSMA1|NIPBL|INCENP|CEP72|CDCA8|TUBG2|CENPQ|CENPI|H2AFX|NUP85|CCNB2|SPDL1|H3F3A|PPP2R2D|TUBGCP6|PSMC3|CDCA5|USO1|HAUS8|H2AFZ|CEP164|CEP78|SGOL2|NUPL2|TAOK1|CEP192|SETD8|SKA2|KIF20A|FGFR1OP|HIST1H2BF|NDC1|CNTRL|PLK1|TUBGCP2|KNTC1|NCAPG|NCAPH|SKA1|HIST1H2BK|SFI1|NUP107|PSMA3|CEP41|NUP35|CEP57|VRK1|CENPM|UBE2C|MZT2A|CNEP1R1|DYNC1H1|NUP210|SMC4|HIST1H2AC|PSMC6|NINL|PSMC1|ANAPC10|SPC25|TUBB4A|PSMD2|CEP135|POM121|TUBGCP4|HIST1H3H|NUP54|NEK9|PSMA5|HIST1H2BN|PCM1|SGOL1|NCAPG2|PDS5B|NEDD1|SPC24|PSMC2|SMC3|LEMD2|PPP2R1A|PSMC5|SSNA1|HIST1H2BG|NUP37|HIST2H2BE|CDC16|NDE1|SHFM1|CEP250|HIST1H2BH|ANAPC2|PSMA2|PSMB6|AAAS|PSMB3|ZWILCH
DNA REPAIR%REACTOME DATABASE ID RELEASE 66%73894,0.12570200374402,0.607607158836689,0.187174800047874,1.21648621029124,1812,291,GTF2H2|HIST1H2BJ|MUS81|FANCL|HIST3H2BB|PIAS1|FAAP20|EME2|TDG|CCNA1|PARP2|POLE|SIRT6|REV1|XRCC3|LIG4|FANCA|ATR|BLM|SPRTN|EXO1|BRIP1|POLE2|RFC4|GTF2H1|DDB2|MBD4|DNA2|DCLRE1A|REV3L|PNKP|RAD9A|DTL|POLR2B|POLD1|PARP1|FEN1|RNF111|GEN1|ZNF830|POLQ|UBE2T|SUMO2|POLD3|POLN|FANCG|SLX1B|HIST1H4I|INO80|MSH6|DDB1|FANCC|RAD51C|RAD51|CHD1L|UBA7|PPIE|PIAS4|H2AFX|FANCM|APBB1|DCLRE1C|KDM4B|RMI2|XRCC4|TIMELESS|LIG1|CDK7|FANCF|NEIL1|ALKBH3|BRCC3|RAD51AP1|HIST1H2BF|POLR2L|CHEK2|SLX4|TOPBP1|FANCD2|CUL4B|EME1|HERC2|RMI1|HIST1H2BK|FANCI|PALB2|STRA13|PAXIP1|BRCA2|CLSPN|POLR2J|ERCC5|XAB2|XRCC2|RIF1|PRKDC|UBE2B|COPS7B|MPG|CHEK1|NPLOC4|XPA|RBX1|XRCC1|RFC3|AQR|FAAP100|HIST1H2BN|RAD17|POLR2G|RFC5|POLR2H|KDM4A|SPIDR|RAD1|CDK2|ATM|VCP|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|FTO|HIST1H2BH|BRE|NFRKB|EYA3|PARG|INO80D|POLL|RAD52|YY1|RNF8|CCNA2|NTHL1|MNAT1|KPNA2|COPS4|HMGN1|UBE2V2|ASCC1|MGMT|SMARCA5|RAD51D|RCHY1|USP1|TP53BP1|POLB
MET RECEPTOR RECYCLING%REACTOME%R-HSA-8875656.1,0.57848496680984,0.942692029750853,-0.276551377308015,-0.8927326283134341,2962,9,HGF|CRK|MET
LOSS OF MECP2 BINDING ABILITY TO THE NCOR SMRT COMPLEX%REACTOME%R-HSA-9022537.1,0.944802405498282,1.0,0.236874535396159,0.58255842235425,8797,6,HDAC3|NCOR1|GPS2|TBL1XR1
TRAF6 MEDIATED IRF7 ACTIVATION%REACTOME%R-HSA-933541.4,0.49462365591397905,0.91071489001692,-0.239930207964847,-0.9568631044829079,2299,15,RNF135|TRAF6|CREBBP|SIKE1|TANK|MAVS|TRIM25
SIGNALING BY RETINOIC ACID%REACTOME%R-HSA-5362517.2,0.0557555536043551,0.45915848992626795,0.341119019539975,1.48352834323686,634,34,ALDH1A2|FABP5|RARB|ALDH1A1|DHRS4|ALDH8A1|PDHX|PDK4|RDH13|CPT1B|PDHA1|DLD|RDH14|RDH11|RXRB
HIV ELONGATION ARREST AND RECOVERY%REACTOME%R-HSA-167287.3,0.00488997555012225,0.161608827499482,-0.35510672950759997,-1.87996719521194,17,32,CCNK|SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TCEA1|POLR2I|POLR2D
NEF-MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS%REACTOME%R-HSA-164938.1,0.962093862815884,1.0,-0.13391210091752,-0.587267932428249,4263,19,AP1S1|AP2S1|B2M
BETA-OXIDATION OF VERY LONG CHAIN FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%390247,0.611361683848797,0.9508825506493929,0.357952352431323,0.880331680066972,5692,6,HSD17B4|DECR2|EHHADH|ACAA1|ABCD1
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS%REACTOME%R-HSA-1971475.1,0.432108993832275,0.878651088001772,0.263602761154746,1.02520472283092,4693,23,VCAN|B3GAT3|GPC2|GPC6|GPC1|XYLT2|B3GALT6|GPC3|AGRN|BGN|SDC3|DCN
DEFECTS IN VITAMIN AND COFACTOR METABOLISM%REACTOME%R-HSA-3296482.1,0.7339699863574349,0.9734087938149171,0.23599984965122403,0.7819408404823861,7531,14,MCCC2|CD320|MTR|PCCB|ACACA|MCCC1|PCCA
VPR-MEDIATED INDUCTION OF APOPTOSIS BY MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION%REACTOME DATABASE ID RELEASE 66%180897,0.0873527101335428,0.55405907028786,-0.724826293150987,-1.47101342641499,555,3,SLC25A6|SLC25A5|SLC25A4
NS1 MEDIATED EFFECTS ON HOST PATHWAYS%REACTOME DATABASE ID RELEASE 66%168276,0.0763968072976055,0.52629264794328,0.32700647394536303,1.43266645550242,870,35,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|PABPN1|NUP107|NUP35|NUP210|POM121|NUP54|KPNA5|NUP37|AAAS|KPNA2|NUP62|CPSF4|RANBP2|NUP50
TGFBR2 MSI FRAMESHIFT MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3642279,0.3738678544914629,0.852609194081082,-0.632974910394265,-1.0826696842616,2517,2,TGFBR2|TGFB1
SIGNALING BY FGFR4%REACTOME%R-HSA-5654743.2,0.0410709643878347,0.402256981537283,-0.303228224517688,-1.55184658161048,157,29,FGF2|PPP2CA|PPP2CB|KRAS|UBA52|MAPK3|UBC|PIK3R1|UBB
NCAM SIGNALING FOR NEURITE OUT-GROWTH%REACTOME%R-HSA-375165.2,0.343088047639302,0.8377884336411808,0.23337605280699397,1.09392435293482,4032,45,CACNA1G|COL9A2|CACNB4|CACNB2|PSPN|CACNA1I|ARTN|CACNA1H|SPTBN5|COL4A2|CACNA1D|HRAS|COL4A1|SPTBN4|SPTAN1|CACNB1|SPTBN2|AGRN
IKBKB DEFICIENCY CAUSES SCID%REACTOME DATABASE ID RELEASE 66%5602636,0.600217733155921,0.9503412745667059,0.566363385718224,0.925705395044075,4961,2,CHUK|IKBKG
TOLL LIKE RECEPTOR 2 (TLR2) CASCADE%REACTOME DATABASE ID RELEASE 66%181438,0.0044306601683650896,0.155321503601441,-0.23551799087278602,-1.68998851137262,9,90,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
ACTIVATION OF NA-PERMEABLE KAINATE RECEPTORS%REACTOME%R-HSA-451307.2,0.17167785234899302,0.674379448319819,0.9154719894133221,1.21616369583459,1278,1,GRIK2
GLYCOGEN METABOLISM%REACTOME DATABASE ID RELEASE 66%8982491,0.5618313013187359,0.936738331587711,-0.1906520846243,-0.924905006668447,2257,25,PYGB|UBA52|UBC|UBB
ALPHA-LINOLENIC ACID (ALA) METABOLISM%REACTOME DATABASE ID RELEASE 66%2046106,0.6952627388535029,0.96731875442989,0.266981914103451,0.81450061989795,6985,11,HSD17B4|FADS2|FADS1|ELOVL2|ACAA1|ABCD1
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION%REACTOME%R-HSA-948021.2,0.9891026109851531,1.0,0.0962954150981032,0.577488894308277,13523,155,COG2|GRIA1|CNIH3|SEC22A|INS|GOLGB1|FUT8|PREB|BET1|MIA3|COPB1|SPTBN5|TRAPPC5|DCTN4|COPB2|COG6|B4GALT6|ARF5|MGAT2|ST8SIA3|SEC31A|USO1|CNIH2|ANK3|CD55|SEC24D|SPTBN4|SPTAN1|B4GALT4|CTSC|ST3GAL4|GBF1|BET1L|SEC24C|DYNC1H1|LMAN2L|MAN1C1|COPG2|TMED9|SPTBN2
CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION%REACTOME%R-HSA-109688.2,0.478672985781991,0.9046812288131709,-0.151753636570763,-0.988684945705383,1312,64,NCBP2|NUDT21|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
BREAKDOWN OF THE NUCLEAR LAMINA%REACTOME%R-HSA-352238.2,0.09652836579170199,0.5693042257394499,0.809870416322029,1.32371094703654,797,2,CASP6|LMNB1
SYNTHESIS OF PG%REACTOME%R-HSA-1483148.2,0.0857938718662953,0.549432448560602,-0.469803851080394,-1.4603549252475199,461,8,PLD6|PLD2|CDS2
PEPTIDE CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%156902,0.21629822280017302,0.7328218014339442,-0.16240394723977697,-1.15360396847234,498,87,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|EEF2|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|EEF1A1|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52
CASP8 ACTIVITY IS INHIBITED%REACTOME%R-HSA-5218900.1,0.9246388129636859,1.0,-0.19511253309797,-0.629840741293588,4735,9,FAS|RIPK1|TRAF2|TRADD|FADD|TNFSF10|CASP8|TNFRSF10A|TNFRSF10B
ACTIVATION OF THE PRE-REPLICATIVE COMPLEX%REACTOME%R-HSA-68962.3,0.0444307040014133,0.41504430757275895,0.35673276464978293,1.5252693929520402,502,32,CDC7|POLE|POLE2|ORC1|CDC45|POLA2|MCM6|CDC6|ORC6|DBF4|MCM10|MCM3|MCM2|PRIM2|GMNN|CDK2|ORC2|MCM7|CDT1
PROTEIN METHYLATION%REACTOME%R-HSA-8876725.2,0.787977409782713,0.9819233677232551,0.21366995418527696,0.7407357860272379,8231,16,ETFB|METTL20|METTL22|CAMKMT|VCP|EEF2KMT|HSPA8|KIN|EEF2|RPS2|N6AMT2|VCPKMT|EEF1A1
GP1B-IX-V ACTIVATION SIGNALLING%REACTOME%R-HSA-430116.1,0.0642934980021795,0.495456803258629,-0.521580850506885,-1.52147448136611,353,7,YWHAZ|VWF|PIK3R1
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES%REACTOME DATABASE ID RELEASE 66%380270,0.00119198982835346,0.09181648161563599,0.34876954885954203,1.85264953381226,14,78,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|MZT2B|CKAP5|CEP290|NME7|CEP131|CEP152|TUBGCP3|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|TUBG2|TUBGCP6|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|TUBGCP2|SFI1|CDK11A|CEP41|CEP57|MZT2A|DYNC1H1|NINL|TUBB4A|CEP135|TUBGCP4|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
INTRA-GOLGI TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811438,0.528541226215645,0.9265056012720759,-0.16614203784271,-0.9566578599534079,1749,42,CYTH2|STX16|CYTH1|GOSR2|COG8|COG3|RAB33B|NAPB|COG5|RAB30|NAPA|RAB39A|YKT6|RAB36|VTI1A|GOLIM4
INTESTINAL HEXOSE ABSORPTION%REACTOME%R-HSA-8981373.1,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
PASSIVE TRANSPORT BY AQUAPORINS%REACTOME%R-HSA-432047.1,0.0121850815083155,0.23962061927625303,-0.77368930082533,-1.7793237625417802,73,4,AQP5|AQP1
REGULATION OF INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%422356,0.19569396386005397,0.709010661887191,-0.17580510781644598,-1.18208501647705,508,71,GNAQ|GNAI2|ARL2BP|GNA15|SLC25A4|VAMP2|PRKAR2A|RAP1A|GNB5|GNGT1|PRKCA|PRKAR1B|ADRA2A|SLC2A1|GNAS|PLCB1|CACNA1E|SNAP25
PKMTS METHYLATE HISTONE LYSINES%REACTOME%R-HSA-3214841.3,0.4842140245928879,0.9064456896937672,0.201753172005504,0.98825079308169,5827,54,RBBP7|HIST1H3E|EHMT1|DOT1L|HIST2H3C|HIST2H3A|EZH2|KMT2B|HIST1H4I|SUV420H2|SETD8|NSD1|SMYD2|EHMT2|KMT2D|WDR5|SUZ12|EED|HIST1H3H|ATF7IP
CILIUM ASSEMBLY%REACTOME%R-HSA-5617833.3,0.7959109955208791,0.9828140955992151,0.13327716572555498,0.8166544652513091,11016,181,TMEM216|CEP83|AKAP9|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|CDK1|PKD2|AHI1|RAB3IP|CKAP5|CEP290|INPP5E|CEP131|CEP152|RAB11FIP3|MKS1|KIF24|NEK2|HAUS5|CDK5RAP2|BBS10|PRKAR2B|TCTE3|CEP162|KIFAP3|BBIP1|BBS5|SEPT2|CEP72|HAUS8|CEP164|CEP78|HDAC6|CEP192|ARL6|FGFR1OP|NPHP3|CEP97|CNTRL|NPHP4|PLK1|CNGB1|ATAT1|GBF1|SFI1|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|BBS1|CEP135|PCM1|WDR34|NEDD1|PPP2R1A|TNPO1|TMEM67|SSNA1|C2CD3|NDE1|CEP250|IFT80
SYNTHESIS OF IPS IN THE ER LUMEN%REACTOME DATABASE ID RELEASE 66%1855231,0.446174496644295,0.883874685872149,0.782752536391707,1.0398518235299599,3323,1,MINPP1
RUNX3 REGULATES NOTCH SIGNALING%REACTOME DATABASE ID RELEASE 66%8941856,0.555154940557396,0.9343712161942179,0.278120450011551,0.9214994787444499,5696,14,KAT2A|HES1|MAML1
G ALPHA (12 13) SIGNALLING EVENTS%REACTOME%R-HSA-416482.4,0.280276816608997,0.788916642629372,-0.165297342828924,-1.111432509831,728,71,KALRN|GNA13|GNG4|ABR|FGD4|VAV1|TRIO|RHOA|ADRA1B|RHOC|VAV3|ARHGEF2|VAV2|AKAP13|GNB5|GNGT1|NET1|ARHGEF37|RASGRF2|GNA12|ARHGEF33
REGULATION OF GENE EXPRESSION IN ENDOCRINE-COMMITTED (NEUROG3+) PROGENITOR CELLS%REACTOME DATABASE ID RELEASE 66%210746,0.0153581358400636,0.264745847609811,-0.992556241729157,-1.3277727473471999,115,1,INSM1
POLO-LIKE KINASE MEDIATED EVENTS%REACTOME%R-HSA-156711.2,0.007849143294725759,0.19847993048827997,0.5323375791923239,1.8454700224858898,81,16,CCNB1|LIN52|CENPF|WEE1|CDC25C|LIN9|PKMYT1|CCNB2|PLK1|LIN37|MYBL2|FOXM1
METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS%REACTOME%R-HSA-6799990.1,0.234446919079436,0.7482511903785959,-0.716625310173697,-1.22574921305547,1578,2,S100A9|S100A8
UBIQUINOL BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%2142789,0.0371217635437247,0.38661455345178203,0.5836110908786639,1.5910804069587299,356,8,COQ3|COQ2|COQ6|COQ9|COQ5|PDSS1
CONSTITUTIVE SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS%REACTOME DATABASE ID RELEASE 66%2894862,0.7710184552289822,0.979355471471634,-0.131053788933517,-0.8228350529203409,2255,56,HDAC4|ADAM10|HDAC5|TBL1X|NCSTN|PSEN2|MAMLD1|HDAC11|ADAM17|UBA52|UBC|RBPJ|UBB
SUMOYLATION%REACTOME%R-HSA-2990846.2,0.791754834002189,0.9819233677232551,0.13479374278832498,0.810314288319971,10850,157,NR4A2|PIAS1|TDG|SAFB|NR2C1|TPR|BLM|TRIM27|NUP133|MTA1|PCGF2|BIRC5|ZNF131|DNMT3B|TOP2A|CDKN2A|RORA|PARP1|SUMO2|NUP205|HIST1H4I|DDX17|AURKB|NUP188|NUP160|INCENP|CDCA8|PIAS4|NSMCE4A|NUP85|NUPL2|XRCC4|NDC1|ING2|HERC2|AURKA|NUP107|NUP35|TFAP2B|NUP210|TOPORS|SUZ12|TOP2B|POM121|NUP54|RWDD3|SAE1|SMC6|SMC3|CHD3|MBD1|PHC2|IKBKE|DDX5|NUP37|MDC1|BRCA1|ZNF350|DNMT1|AAAS
RUNX3 REGULATES WNT SIGNALING%REACTOME DATABASE ID RELEASE 66%8951430,0.46276694521819894,0.891507554237553,-0.312870525404288,-0.972537819109418,2491,8,RUNX3|CTNNB1|TCF7L2|TCF7
SUMOYLATION OF TRANSCRIPTION COFACTORS%REACTOME DATABASE ID RELEASE 66%3899300,0.622619047619048,0.9536478716552259,-0.15644911284238,-0.896578217794943,2091,41,CREBBP|RING1|BMI1|CBX4|SIN3A|MKL1|CBX8|CTBP1|UBE2I|SUMO1|PHC3|NPM1|NRIP1|PPARGC1A|SUMO3
CALCINEURIN ACTIVATES NFAT%REACTOME%R-HSA-2025928.1,0.16230269266480998,0.664367762084791,-0.41938330851122496,-1.30362592546345,873,8,NFATC1|PPP3CA|PPP3CB|PPIA|NFATC3|PPP3R1|NFATC2|FKBP1A
COPI-MEDIATED ANTEROGRADE TRANSPORT%REACTOME DATABASE ID RELEASE 66%6807878,0.9624554455445541,1.0,0.113822292959968,0.607938935492735,12150,80,COG2|INS|GOLGB1|BET1|COPB1|SPTBN5|DCTN4|COPB2|COG6|ARF5|USO1|ANK3|CD55|SPTBN4|SPTAN1|GBF1|BET1L|DYNC1H1|COPG2|TMED9|SPTBN2
PHOSPHORYLATION OF EMI1%REACTOME DATABASE ID RELEASE 66%176417,0.014282646048110002,0.260761633520319,0.6879573029220151,1.69193079520794,132,6,CCNB1|CDK1|CDC20|FBXO5|PLK1
ACYL CHAIN REMODELLING OF PG%REACTOME%R-HSA-1482925.1,0.5820063694267521,0.943249589738259,0.296810523946475,0.905500870942754,5847,11,LPCAT4|PLA2G4A|LPGAT1|PLA2G2D|PLA2G12A|PLA2G4B
NICOTINATE METABOLISM%REACTOME%R-HSA-196807.3,0.89829437776374,0.998912093067348,0.15893130800542002,0.646137104025566,9953,27,PARP16|CD38|NAPRT|BST1|RNLS|PTGS2|NADK|PARP10|NMNAT1|QPRT|NADSYN1|PARP9|PARP14|NUDT12
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE%REACTOME%R-HSA-110313.1,0.7629642455198691,0.978421368343614,0.17431247621432402,0.780882817618513,8812,38,POLE|REV1|SPRTN|POLE2|RFC4|REV3L|POLD1|POLD3|UBA7
PI3K CASCADE%REACTOME DATABASE ID RELEASE 66%109704,0.543667578999751,0.929698169790548,-0.19302690396474104,-0.936425899829596,2184,25,GAB2|FGF10|PIK3R1|TRIB3
HYPUSINYLATION%REACTOME DATABASE ID RELEASE 66%204626,0.12366211098304,0.607607158836689,-0.5965252372498979,-1.3718834271875802,750,4,EIF5A|EIF5A2
SIGNALING BY ERBB2%REACTOME DATABASE ID RELEASE 66%1227986,0.00755058894593778,0.19661211247433302,-0.306324307427659,-1.7638374983271101,24,42,MEMO1|MATK|PRKCD|NRAS|FYN|RHOA|CUL5|STUB1|HBEGF|YES1|CDC37|PTPN12|KRAS|SHC1|UBA52|PRKCA|UBC|PIK3R1|UBB
TBC RABGAPS%REACTOME DATABASE ID RELEASE 66%8854214,0.0153327200245324,0.264745847609811,-0.283823799428478,-1.64078845825535,49,43,RABGEF1|RAB8B|TBC1D20|TBC1D25|RAB6A|TBC1D14|RAB8A|RAB5C|TBC1D2|TBC1D15|GABARAP|RAB7A|RAB5A|MAP1LC3B|GABARAPL2
CLASS A 1 (RHODOPSIN-LIKE RECEPTORS)%REACTOME DATABASE ID RELEASE 66%373076,0.500111898545319,0.9143688619793578,0.16825282156914498,0.9844346959014091,6703,132,CYSLTR2|TAC1|INSL3|EDN1|CXCL13|PTGER3|GNRH1|NPY1R|OXTR|ADORA3|CXCR4|NPY2R|F2R|CXCL9|CNR1|PENK|AGTR1|S1PR5|NPY|XK|PROKR1|PTGER1|CCR5|XCL2|CCL21|F2RL1|SSTR2|CCL5|CCL19|CXCL10|C3AR1|MC1R|C5|DRD4|NLN|ADORA2A|P2RY11|HEBP1|S1PR4|PTGIR|NTS|LPAR2|OPRL1|CORT|FPR3|P2RY6|LPAR5
DUAL INCISION IN TC-NER%REACTOME DATABASE ID RELEASE 66%6782135,0.739523150785255,0.9744283926676119,0.159588913932727,0.8146806757759542,9087,65,GTF2H2|POLE|POLE2|RFC4|GTF2H1|POLR2B|POLD1|ZNF830|POLD3|DDB1|PPIE|CDK7|POLR2L|CUL4B|POLR2J|ERCC5|XAB2|XPA|RBX1|RFC3|AQR|POLR2G|RFC5|POLR2H
ACTIVATION OF THE TFAP2 (AP-2) FAMILY OF TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%8866907,0.589271255060729,0.945418171231938,0.3138969018989,0.8957545067365842,5821,9,CITED1|TFAP2E|YEATS4
ACTIVATION OF C3 AND C5%REACTOME DATABASE ID RELEASE 66%174577,0.29671391752577303,0.80135016114552,0.467817550052397,1.15052913329144,2762,6,C5|C4A|C4B|C2|C3|CFB
SCF(SKP2)-MEDIATED DEGRADATION OF P27 P21%REACTOME DATABASE ID RELEASE 66%187577,0.8226641466020219,0.987616425875001,0.149321149820295,0.746687245209223,10010,59,CCNA1|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CCNE1|PSMD1|PSMA1|PSMC3|PSMA3|CCNE2|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDK2|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|PSME2|RPS27A|CCND1|PSMD14|PSMD4|PSMB10|PSMD9
RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE DURING HIV INFECTION%REACTOME DATABASE ID RELEASE 66%167160,0.809487375669472,0.984682960940884,-0.152571971316174,-0.760296197581283,3173,27,POLR2A|POLR2K|POLR2F|POLR2I|POLR2D
ACTIVATION OF CASPASES THROUGH APOPTOSOME-MEDIATED CLEAVAGE%REACTOME%R-HSA-111459.2,0.7667247766397909,0.9792236089291529,0.331571917680063,0.7642241175336251,7036,5,APAF1|CASP9|CYCS|CASP7
COHESIN LOADING ONTO CHROMATIN%REACTOME DATABASE ID RELEASE 66%2470946,0.8802206461780929,0.9956508825790341,-0.197826446736912,-0.6692764799704499,4467,10,NIPBL|PDS5B|SMC3|MAU2|SMC1A|RAD21|WAPAL|STAG1|STAG2|PDS5A
XBP1(S) ACTIVATES CHAPERONE GENES%REACTOME DATABASE ID RELEASE 66%381038,0.99527983816588,1.0,-0.0811516622844797,-0.5033671054709671,2951,54,SEC61G|GFPT1|SRPR|ARFGAP1|WFS1|DCTN1|EDEM1|CTDSP2|TSPYL2|GOSR2|MYDGF|WIPI1|DNAJC3|ADD1|KLHDC3|TATDN2|SEC63|HYOU1|SEC62|LMNA|SHC1|ATP6V0D1|ASNA1|SSR1
NEGATIVE REGULATION OF MET ACTIVITY%REACTOME DATABASE ID RELEASE 66%6807004,0.00161141804788214,0.103037429694888,-0.47061406686187995,-2.0998354887374697,6,20,HGF|PTPN1|UBA52|SH3GL3|MET|LRIG1|UBC|UBB
AURKA ACTIVATION BY TPX2%REACTOME%R-HSA-8854518.3,0.00564698289770894,0.172864480164432,0.330987504360127,1.71820532260941,69,70,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|CKAP5|CEP290|CEP131|CEP152|HMMR|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|SFI1|AURKA|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|TPX2|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
MITOCHONDRIAL FATTY ACID BETA-OXIDATION OF UNSATURATED FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%77288,0.11669208977990801,0.596135728622196,0.594110231404037,1.3693360115935702,1070,5,ACADM|DECR1|ECI1|HADHB
G2 M DNA REPLICATION CHECKPOINT%REACTOME%R-HSA-69478.2,0.00348659838744825,0.14222058102101098,0.7900397088021178,1.8209244121162298,31,5,CCNB1|CDK1|WEE1|PKMYT1|CCNB2
RESOLUTION OF AP SITES VIA THE MULTIPLE-NUCLEOTIDE PATCH REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%110373,0.158062460165711,0.6597808951153779,0.32567843042173805,1.2977816962864799,1735,25,PARP2|POLE|POLE2|RFC4|POLD1|PARP1|FEN1|POLD3|LIG1
ERK1 ERK2 PATHWAY%REACTOME%R-HSA-5684996.3,0.290731707317073,0.800029528446767,-0.126841189683399,-1.06710163832541,297,200,RET|PPP2R5C|PSME3|FGF7|FYN|IL3RA|FGF2|HGF|IL6|HBEGF|ARRB1|IL17RD|CAMK2A|CSF2RB|PPP2CA|PPP2CB|RAP1A|YWHAB|PPP2R1B|KRAS|SHC1|UBA52|RASA3|RASGRF2|MAPK3|RASGRP3|PSMD6|FGF10|PEA15|VWF|DUSP10|SPRED3|MET|MAP3K11|UBC|MAP2K1|PTPRA|DLG1|SPRED2|PSMF1|GFRA2|UBB
THE CITRIC ACID (TCA) CYCLE AND RESPIRATORY ELECTRON TRANSPORT%REACTOME%R-HSA-1428517.1,0.896839811115147,0.998912093067348,0.12088588054447699,0.7340031710633391,12344,169,COX20|NDUFA7|D2HGDH|FH|NDUFS7|ETFDH|UQCR11|NDUFA4|NDUFB11|ETFA|ATP5G1|NDUFS2|COX5A|ATP5D|NNT|NDUFC1|NDUFAF1|NDUFS4|NDUFA11|ME1|MT-ATP8|LDHAL6A|PDHX|PDK4|COX16|COX6A1|UCP3|ETFB|NDUFS8|BSG|PDHA1|NDUFB2|SUCLG1|DLD|COX8A|SDHA|GSTZ1|MT-ND2|MPC2|ME3|NDUFV1|COX7B|NDUFS3|ATP5C1|NDUFB7|NDUFA12|MT-CO2|PDP1|COX11|MT-CYB|ACO2|ATP5E|SURF1|ECSIT|ATP5H|MT-ATP6|MT-CO1|ACAD9|ATP5A1|CYCS|NDUFB1|UQCR10|TMEM126B|NDUFB3|NDUFA1|NDUFB6|SCO2|SUCLA2|NDUFAF7|MT-ND3|SUCLG2|COX7C|PDK1|SDHB|UQCRB|IDH3G|ATP5G3
RECYCLING OF EIF2:GDP%REACTOME%R-HSA-72731.2,0.71529583030051,0.971081608033886,0.293365790933892,0.79979385128565,6878,8,EIF2B5|EIF2B1|EIF2B4
FGFR2B LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190377,0.0319368131868132,0.365066918595497,-0.6687557246747371,-1.6929107093497398,185,5,FGF1|FGF7|FGF2|FGF10
TRANSLESION SYNTHESIS BY POLI%REACTOME DATABASE ID RELEASE 66%5656121,0.39708480565371,0.8638522656500329,-0.244586140498628,-1.0291903475739799,1797,17,UBA52|UBC|UBB
ACTIVATION OF AMPA RECEPTORS%REACTOME%R-HSA-399710.1,0.04144957739956,0.402998391331252,0.7803021947722509,1.48327238755223,357,3,GRIA1|GRIA2|GRIA4
DNA REPLICATION%REACTOME DATABASE ID RELEASE 66%69306,0.00931000825887829,0.212136117579847,0.272356542593109,1.5779509053218501,123,124,CCNA1|ANAPC15|CDC7|POLE|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|E2F3|POLE2|ORC1|RFC4|DNA2|PSMD3|CDC45|POLD1|CDC23|FEN1|CCNE1|ANAPC7|E2F2|ANAPC16|POLD3|PSMD1|POLA2|MCM6|CDC6|PSMA1|ORC6|PSMC3|DBF4|LIG1|MCM10|MCM3|PSMA3|MCM2|UBE2C|CCNE2|PSMC6|PSMC1|ANAPC10|E2F1|PSMD2|PRIM2|GMNN|GINS2|RBX1|RFC3|GINS1|PSMA5|RFC5|PSMC2|PSMC5|SKP2|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CCNA2|CDT1
PRE-NOTCH TRANSCRIPTION AND TRANSLATION%REACTOME DATABASE ID RELEASE 66%1912408,0.49444855662472204,0.91071489001692,-0.14848199230871803,-0.9804897148648091,1335,67,AGO2|JUN|TP53|HIST2H4B|HIST1H2BC|H3F3B|HIST2H2AC|HIST1H2BD|RBPJ|TFDP2
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO-FACTORS%REACTOME%R-HSA-6804759.1,0.6392813887767459,0.9605460968546259,-0.24230518428896103,-0.8527021321428729,3166,11,TP53BP2|ZNF385A|POU4F2|PHF20|TP53
SIGNALING BY FGFR%REACTOME DATABASE ID RELEASE 66%190236,0.001458257382428,0.0962159382884067,-0.282586363974057,-1.8410687890994497,3,64,HNRNPF|FGF2|PPP2CA|PPP2CB|POLR2A|POLR2K|FLRT1|KRAS|UBA52|POLR2F|MAPK3|NCBP2|POLR2I|POLR2D|FGF10|UBC|PIK3R1|SPRED2|UBB
HEDGEHOG 'OFF' STATE%REACTOME%R-HSA-5610787.1,0.55083179297597,0.931763873811087,-0.13255351815215402,-0.952988936587149,1191,93,UBA52|GPR161|PRKAR1B|ADCY2|PSMD6|INTU|GNAS|UBC|KIF7|PSMF1|UBB
CALMODULIN INDUCED EVENTS%REACTOME%R-HSA-111933.1,0.647546985599219,0.9636261853025391,-0.180663401050941,-0.8660031449336321,2652,24,PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2
DEGRADATION OF GLI2 BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610783,0.9104836038423321,1.0,0.134123892044546,0.662514573261891,10994,56,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|SUFU|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
IL-6-TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS%REACTOME DATABASE ID RELEASE 66%6788467,0.9541999610212429,1.0,0.167301219444904,0.554320930033686,9791,14,JAK2|IL11RA|TYK2|CTF1|CNTFR|JAK1|CLCF1|OSM|LIFR|OSMR|IL6ST|IL11|CRLF1|LIF
SYNTHESIS OF 15-EICOSATETRAENOIC ACID DERIVATIVES%REACTOME%R-HSA-2142770.1,0.8374435567905519,0.9889652677625541,0.386681485665579,0.735040826884812,7232,3,PTGS2|GPX4|GPX1
REGULATION OF PAK-2P34 ACTIVITY BY PS-GAP RHG10%REACTOME DATABASE ID RELEASE 66%211728,0.108537490720119,0.58452352834625,-0.8005422929913799,-1.369284717859,730,2,PAK2
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8939902.1,0.44768501640539604,0.8850378987593649,-0.15427988839664,-1.00514364287895,1227,64,PPARGC1A|NR3C1|UBA52|PSMD6|CBFB|UBC|TWIST1|PSMF1|UBB
G2 M TRANSITION%REACTOME%R-HSA-69275.5,0.0126600593214208,0.24430577683365803,0.24615722420133396,1.50429848137029,174,177,AKAP9|CCNA1|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDK1|BTRC|LIN52|PSMD11|BORA|CENPF|MZT2B|PSMD13|WEE1|PSMB9|CKAP5|CEP290|NME7|PSMA4|CEP131|CEP152|CDC25C|LIN9|PSMD3|HMMR|TUBGCP3|NEK2|PKMYT1|HAUS5|CDK5RAP2|PRKAR2B|PSMD1|GTSE1|PPP2R3B|PSMA1|CEP72|TUBG2|CCNB2|TUBGCP6|PSMC3|HAUS8|CEP164|CEP78|CDK7|CEP192|FGFR1OP|CNTRL|PLK1|TUBGCP2|AJUBA|SFI1|CDK11A|PPP1R12A|LIN37|AURKA|PSMA3|CEP41|CEP57|MZT2A|DYNC1H1|PSMC6|NINL|PSMC1|TUBB4A|PSMD2|CEP135|TUBGCP4|RBX1|PSMA5|PCM1|FBXL7|TPX2|MYBL2|FOXM1|NEDD1|PSMC2|PPP2R1A|PSMC5|CDK2|SSNA1|NDE1|SHFM1|CEP250|PSMA2|PSMB6|PSMB3
APEX1-INDEPENDENT RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%5649702,0.898292771521976,0.998912093067348,-0.22414701294309802,-0.6538467812534461,4945,7,NEIL2
VOLTAGE GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296072.1,0.148555708390647,0.64074876264986,0.33274105819310495,1.30950169960378,1619,24,KCNH8|KCNH3|KCNQ1|KCNH1|KCNC3|KCNC1|KCND1|KCNB2|KCNH2
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION%REACTOME%R-HSA-164940.1,0.7297930495900041,0.972554563883587,-0.24530059333891102,-0.7918522972112649,3737,9,AP1M1|AP1S1|B2M
OXIDATIVE DEMETHYLATION OF DNA%REACTOME DATABASE ID RELEASE 66%5221030,0.489976481128906,0.908938677284213,0.4650161587411761,0.9854136610304591,4374,4,TDG|TET2|TET1|TET3
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME%R-HSA-9013695.1,0.80643330179754,0.984682960940884,0.199684849267427,0.729878675901168,8523,19,KAT2A|HES1|MAML1|HEY2|ACTA2|MAML3|KAT2B|NOTCH2|SNW1|HEY1|FLT4|EP300
MISSPLICED GSK3BETA MUTANTS STABILIZE BETA-CATENIN%REACTOME DATABASE ID RELEASE 66%5339716,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
CRISTAE FORMATION%REACTOME%R-HSA-8949613.2,0.9928800284798861,1.0,0.107588644648183,0.454776429840935,11155,31,ATP5G1|ATP5D|MT-ATP8|MTX2|ATP5C1|ATP5E|C19orf70|TMEM11|ATP5H|MT-ATP6|ATP5A1|ATP5G3|APOOL|ATP5L|MINOS1|DNAJC11|ATP5S|ATP5G2|ATP5B|ATP5O|APOO|IMMT|ATP5J2|HSPA9|ATP5F1|ATP5J|SAMM50|MTX1|CHCHD6|CHCHD3|ATP5I
SEMA4D MEDIATED INHIBITION OF CELL ATTACHMENT AND MIGRATION%REACTOME DATABASE ID RELEASE 66%416550,0.0566388115134633,0.463436441439954,-0.498529968459392,-1.5496482056265302,304,8,RND1|RHOA|RAC1|MET
CHYLOMICRON REMODELING%REACTOME DATABASE ID RELEASE 66%8963901,0.27181095307425196,0.7865607589760191,0.5486681740473169,1.1626802723210201,2426,4,LPL|APOE|APOC2|GPIHBP1
SIGNALING BY NODAL%REACTOME%R-HSA-1181150.1,0.9161347343611899,1.0,0.18894047506148104,0.6097811424816291,9328,13,LEFTY1|CFC1
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%381340,0.9123505976095619,1.0,0.128071544637553,0.6765085083308839,11449,76,EGR2|ZNF638|LPL|CDK8|MED19|SMARCD3|ZNF467|CEBPD|MED12|MED1|MED21|HDAC3|MED17|MED24|SREBF2|THRAP3|CARM1|CEBPB|CCNC|MED7|MED23|TGS1|MED30|MED11|MED22|CHD9|MED14|FAM120B|NCOA3|MED16|NCOA6|NCOR1|KLF4|MED20|MED13|MED31|TBL1XR1|MED13L|MED6
ACTIVATED NTRK2 SIGNALS THROUGH PLCG1%REACTOME%R-HSA-9026527.1,0.831740655618725,0.9879179006160809,0.47218628544662794,0.7717755118464391,6875,2,PLCG1|NTRK2
SUMOYLATION OF UBIQUITINYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%3232142,0.067702356783476,0.50364937614461,0.337647910113518,1.45543936114321,766,33,PIAS1|TPR|TRIM27|NUP133|NUP205|NUP188|NUP160|PIAS4|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|MDM2
"DEFECTIVE CYP11A1 CAUSES ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL (AICSR)%REACTOME%R-HSA-5579026.1",0.0603218710200301,0.479132137152383,0.7549482157061229,1.43507714048601,520,3,FDXR|FDX1
THE RETINOID CYCLE IN CONES (DAYLIGHT VISION)%REACTOME%R-HSA-2187335.3,0.7263339070567991,0.972554563883587,-0.631396118217909,-0.844637838446354,5485,1,DHRS3
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1%REACTOME%R-HSA-418592.2,0.8890124143042428,0.997300970905927,0.170999013857629,0.654886556574896,9595,22,GNG8|PLA2G4A|GNB3
DEGRADATION OF AXIN%REACTOME DATABASE ID RELEASE 66%4641257,0.8439426762206299,0.991298302704726,0.14843928344712698,0.723986747950763,10128,53,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|RNF146|PSMD1|PSMA1|PSMC3|TNKS2|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|SMURF2|PSMB4|PSME2|RPS27A|TNKS|PSMD14|PSMD4|PSMB10|PSMD9|PSME1
"DEFECTIVE CHST14 CAUSES EDS, MUSCULOCONTRACTURAL TYPE%REACTOME DATABASE ID RELEASE 66%3595174",0.508084358523726,0.9179996794142941,-0.34418151721731394,-0.944755154662683,2890,6,CSPG4|NCAN
TCF7L2 MUTANTS DON'T BIND CTBP%REACTOME DATABASE ID RELEASE 66%5339700,0.17564807541241198,0.678685257108795,-0.641241894283456,-1.30138137231489,1117,3,CTBP1|TCF7L2
MITOCHONDRIAL FATTY ACID BETA-OXIDATION%REACTOME DATABASE ID RELEASE 66%77289,0.0553446906170006,0.458062256682211,0.345280340867653,1.48833913575468,626,33,ACSM3|ACSF2|ACADVL|ACBD6|ACADM|ACOT1|DECR1|HADH|PCCB|ACOT2|MCEE|ACAD11|ACAD10|ECI1|HADHB|PCCA|ACADS|ACOT7|ECHS1|ACOT13
REGULATION OF IFNA SIGNALING%REACTOME DATABASE ID RELEASE 66%912694,0.49172576832151293,0.909315999193258,-0.282672256854416,-0.956322555317509,2495,10,SOCS1|STAT2|TYK2|USP18|JAK1|PTPN11|SOCS3|PTPN6|IFNAR1|PTPN1
RNA POLYMERASE III TRANSCRIPTION INITIATION%REACTOME%R-HSA-76046.2,0.8306211723534559,0.9879179006160809,0.164109208722987,0.724384021909333,9493,36,SNAPC2|BDP1|POLR3B|POLR3GL|BRF1|ZNF143|POLR3E|POLR2L|POLR3G|POU2F1|SNAPC3|SNAPC5|POLR2H|POLR3K|GTF3C5|GTF3C3|POLR3A|GTF3A|GTF3C1|BRF2
DIMERIZATION OF PROCASPASE-8%REACTOME DATABASE ID RELEASE 66%69416,0.9246388129636859,1.0,-0.19511253309797,-0.629840741293588,4735,9,FAS|RIPK1|TRAF2|TRADD|FADD|TNFSF10|CASP8|TNFRSF10A|TNFRSF10B
NTF3 ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9025046.1,0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
TOXICITY OF BOTULINUM TOXIN TYPE F (BONT F)%REACTOME%R-HSA-5250981.1,0.0643887362637363,0.495456803258629,-0.600777585861214,-1.52082856492391,374,5,VAMP2|VAMP1|SV2C
PLC BETA MEDIATED EVENTS%REACTOME%R-HSA-112043.1,0.706227967097532,0.9690009414334909,-0.14954858435947302,-0.8437915628350658,2403,39,GNAI3|ADCY7|PRKCD|GNAZ|GNAI2|PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2|PLCB4|PLCB1
TOLL LIKE RECEPTOR TLR6:TLR2 CASCADE%REACTOME DATABASE ID RELEASE 66%168188,0.0044306601683650896,0.155321503601441,-0.23551799087278602,-1.68998851137262,9,90,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
MET ACTIVATES STAT3%REACTOME DATABASE ID RELEASE 66%8875791,0.00534171249018068,0.168503048666442,-0.87267012242197,-1.7710580852873798,33,3,HGF|STAT3|MET
FORMATION OF THE BETA-CATENIN:TCF TRANSACTIVATING COMPLEX%REACTOME%R-HSA-201722.4,0.532427374074375,0.9265056012720759,0.18695813915228401,0.95439701538794,6542,65,HIST1H3E|HIST1H2BJ|HIST3H2BB|PYGO1|HIST2H3C|HIST2H3A|TRRAP|TERT|MEN1|HIST1H4I|LEF1|H2AFX|H3F3A|H2AFZ|TLE4|HIST1H2BF|BCL9|HIST1H2BK|CDC73|HIST1H2AC|SMARCA4|TLE1|KMT2D|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH
DEFENSINS%REACTOME DATABASE ID RELEASE 66%1461973,0.24765354849333104,0.7602206518254051,-0.515689626647549,-1.1859784099527502,1503,4,TLR2|CD4|TLR1|PRSS3
BIOSYNTHESIS OF DPA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018683,0.7431328878990351,0.974505008828563,-0.46170341446025,-0.78971896318106,5004,2,ALOX5
REGULATION OF MECP2 EXPRESSION AND ACTIVITY%REACTOME DATABASE ID RELEASE 66%9022692,0.9030100334448159,1.0,-0.134913237357526,-0.6821544911939971,3509,28,NCOR2|AGO1|MOV10|PRKACA|CAMK2D|SIN3A|TBL1X|CAMK2A|CAMK4|AGO2|HTT
PLATELET AGGREGATION (PLUG FORMATION)%REACTOME DATABASE ID RELEASE 66%76009,0.509818923743943,0.918404893008545,-0.19266640016312497,-0.9600946371869391,1998,27,CRK|RAP1A|PTPN1|SHC1|ADRA2A|VWF
DEFECTS IN BIOTIN (BTN) METABOLISM%REACTOME%R-HSA-3323169.1,0.311748281786942,0.8143712300420921,0.46273817150656893,1.1380371414982,2902,6,MCCC2|PCCB|ACACA|MCCC1|PCCA
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF KERATINOCYTES%REACTOME%R-HSA-8939242.1,0.00472212132219397,0.159787349002354,-0.6765127537975388,-1.9734177169682698,25,7,SOCS3|CTSL|CTSK|RUNX1|CTSV|CBFB
MICRORNA (MIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%203927,0.34391017817915603,0.8393009815539341,-0.22565175957773898,-1.08165313127826,1408,24,POLR2A|POLR2K|AGO2|POLR2F|POLR2I|POLR2D
NRAGE SIGNALS DEATH THROUGH JNK%REACTOME DATABASE ID RELEASE 66%193648,0.133513149022252,0.6194479383419461,-0.20364317264955603,-1.26315680393815,395,54,VAV3|ARHGEF2|VAV2|AKAP13|NET1|ARHGEF37|RASGRF2|ARHGEF33|RAC1|AATF|BCL2L11
SEMA3A PAK DEPENDENT AXON REPULSION%REACTOME DATABASE ID RELEASE 66%399954,0.0017563117453348,0.10934691283642699,-0.513184044531968,-2.1016611386259196,7,16,FYN|NRP1|LIMK1|PLXNA1|PLXNA4|SEMA3A|RAC1|HSP90AB1|PAK2
RHO GTPASES ACTIVATE ROCKS%REACTOME DATABASE ID RELEASE 66%5627117,0.0919795600977561,0.5622489437340121,-0.32585657630623305,-1.40176259293243,413,18,RHOA|RHOC|LIMK1|MYH11|MYH9|PPP1CB
TOXICITY OF BOTULINUM TOXIN TYPE B (BONT B)%REACTOME%R-HSA-5250958.1,0.25828750981932397,0.7696112720615029,-0.57609585110936,-1.16916941326701,1643,3,VAMP2|SYT2
TFAP2A ACTS AS A TRANSCRIPTIONAL REPRESSOR DURING RETINOIC ACID INDUCED CELL DIFFERENTIATION%REACTOME%R-HSA-8869496.2,0.7801745430594429,0.981487311948134,-0.329068549054211,-0.756788917996799,4737,4,MYBL2|HSPD1|NOP2|NPM1
NGF PROCESSING%REACTOME%R-HSA-167060.1,0.598715626543718,0.949445913591245,-0.38075194204486296,-0.875649924836307,3635,4,PCSK5|PCSK6|FURIN
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY%REACTOME DATABASE ID RELEASE 66%383280,0.279628618241398,0.788916642629372,0.28761614896046994,1.1563546851642301,3071,26,NR4A2|ESRRG|NR2C1|NR4A1|RARB|NR2F6|RORA|MED1|NR2F1|NR2C2AP|RXRB|ESRRA
L1CAM INTERACTIONS%REACTOME%R-HSA-373760.2,0.23659725299069603,0.7506297139423199,-0.15839359582941198,-1.13657286322255,533,90,VAV2|AP2S1|MSN|ALCAM|KCNQ2|MAPK3|NCAN|RAC1|SCN5A|MAP2K1|CSNK2A1|DLG1|KCNQ3|RPS6KA2|EPHB2
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES%REACTOME DATABASE ID RELEASE 66%6791312,0.7310896087505259,0.9726603499749559,0.170294545567088,0.81451945190241,8688,49,BTG2|CCNA1|CENPJ|CCNB1|CDK1|E2F8|CDC25C|E2F7|CCNE1|PRMT1|CARM1|AURKA|ARID3A|CCNE2|TNKS1BP1|CNOT3|E2F1
ERBB2 REGULATES CELL MOTILITY%REACTOME%R-HSA-6785631.3,0.5793874672577071,0.942746898746279,0.307677007234638,0.90803433717186,5750,10,NRG2|NRG3
INTERACTION BETWEEN PHLDA1 AND AURKA%REACTOME%R-HSA-8854521.2,0.858352485786863,0.99166790097654,0.45842419033486703,0.7492817454531351,7095,2,AURKA|PHLDA1
RNA POLYMERASE III TRANSCRIPTION TERMINATION%REACTOME DATABASE ID RELEASE 66%73980,0.5375694612225179,0.9265056012720759,-0.20014956886970497,-0.940486087001317,2224,23,NFIC|POLR3F|POLR2E|POLR3C|POLR1C|POLR3D|POLR3H|NFIB|POLR2K|POLR2F|CRCP
CHYLOMICRON ASSEMBLY%REACTOME DATABASE ID RELEASE 66%8963888,0.797177735468698,0.9831339686797859,0.35454612710114003,0.7513171113379828,7117,4,APOE|SAR1B|APOC2
RRNA PROCESSING IN THE MITOCHONDRION%REACTOME%R-HSA-8868766.2,0.704688731284476,0.968941691852291,-0.238329312345573,-0.806303736792848,3576,10,ELAC2|FTSJ2|KIAA0391|RNMTL1
INSULIN RECEPTOR RECYCLING%REACTOME DATABASE ID RELEASE 66%77387,0.5938688212927761,0.946771423703279,-0.19440976560585801,-0.900649975044443,2498,22,ATP6V0C|ATP6V1F|ATP6V1E2|ATP6V0D1|ATP6V1E1
BETA-OXIDATION OF PRISTANOYL-COA%REACTOME%R-HSA-389887.3,0.23388795282224104,0.7480529908631,0.468037642937897,1.21820364980392,2220,7,CROT|HSD17B4|AMACR|ACOX2|ACOX3|CRAT
FIBRONECTIN MATRIX FORMATION%REACTOME%R-HSA-1566977.1,0.167431963265763,0.67106503960414,0.6033106525590051,1.27847290400879,1494,4,ITGB1|CEACAM1|FN1
TRIF(TICAM1)-MEDIATED TLR4 SIGNALING%REACTOME DATABASE ID RELEASE 66%937061,0.0175600739371534,0.279896423939555,-0.20571778940285101,-1.4790009355696399,37,93,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|UBE2D1|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|TRAF3|NKIRAS1|UBE2V1|TANK|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|UBE2D3|MAPK3|TNIP2|TICAM1|UBC|MAP2K1|RPS6KA2|UBB
VIRUS ASSEMBLY AND RELEASE%REACTOME DATABASE ID RELEASE 66%168268,0.23132887899034899,0.7440352621789029,-0.7181141439205959,-1.22829578344271,1557,2,CANX|CALR
AMINE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375280.2,0.000830047727744345,0.0849637591935908,-0.611575738455686,-2.3031825411385296,3,13,CHRM4|ADRA2C|ADRA1B|HTR1B|HRH3|ADRB2|DRD2|ADRA2A|CHRM1|HRH1
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%2122948,0.322092405735528,0.822751772025005,-0.208212865775932,-1.0948945762455,1212,31,PSEN1|PSENEN|DNER|APH1B|DLL1|ITCH|NOTCH1|ARRB2|ADAM10|NCSTN|PSEN2|ARRB1|ADAM17|UBA52|UBC|UBB
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1%REACTOME DATABASE ID RELEASE 66%5654687,0.10797600533214802,0.58452352834625,-0.317098689154794,-1.36408810822148,485,18,NRAS|FGF2|FLRT1|KRAS|FGF10|PIK3R1
AUTODEGRADATION OF CDH1 BY CDH1:APC C%REACTOME%R-HSA-174084.3,0.590360463219703,0.945418171231938,0.180635170108345,0.9170041820372661,7238,63,ANAPC15|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|ANAPC7|ANAPC16|PSMD1|PSMA1|PSMC3|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|ANAPC4|PSME2
NUCLEOBASE CATABOLISM%REACTOME%R-HSA-8956319.1,0.0611258758154144,0.48182086119899,-0.314042815173778,-1.47566092728351,252,23,GPX1|SAMHD1|NT5C|NT5C2|ADPRM|NT5C1A|ENTPD6|NUDT15|ENTPD1|ENTPD4|PNP|UPP1|ENTPD3|ITPA|NT5E
GRB2 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1963640.3,0.626492834394905,0.954674488895214,0.28501068737922103,0.869502274442325,6294,11,NRG2|NRG3|HRAS|NRG1
P53-INDEPENDENT G1 S DNA DAMAGE CHECKPOINT%REACTOME DATABASE ID RELEASE 66%69613,0.783609576427256,0.981487311948134,0.160338190478202,0.7745884106922459,9360,51,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|PSMC6|PSMC1|PSMD2|CHEK1|PSMA5|PSMC2|PSMC5|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
INTERCONVERSION OF POLYAMINES%REACTOME%R-HSA-351200.1,0.9220999153259949,1.0,0.420210455813736,0.6868224461710429,7622,2,SAT1|PAOX
"ACTIVATION, TRANSLOCATION AND OLIGOMERIZATION OF BAX%REACTOME DATABASE ID RELEASE 66%114294",0.132739420935412,0.618193911729853,-0.7781086297215329,-1.3309131383060802,893,2,BAX|BID
ABNORMAL CONVERSION OF 2-OXOGLUTARATE TO 2-HYDROXYGLUTARATE%REACTOME DATABASE ID RELEASE 66%2978092,0.308859060402685,0.8114708447293539,0.849415527128364,1.12841063267674,2300,1,IDH1
ZINC EFFLUX AND COMPARTMENTALIZATION BY THE SLC30 FAMILY%REACTOME%R-HSA-435368.1,0.9929178470254959,1.0,0.20126344047370395,0.46388239469728204,9112,5,SLC30A5|SLC30A7|SLC30A6
SCF-BETA-TRCP MEDIATED DEGRADATION OF EMI1%REACTOME DATABASE ID RELEASE 66%174113,0.7957007165472421,0.982694209546621,0.156905179769466,0.7652776825643169,9549,53,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDC20|FBXO5|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
HIV TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%167161,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
TRAF6 MEDIATED NF-KB ACTIVATION%REACTOME%R-HSA-933542.1,0.7395437262357422,0.9744283926676119,-0.172706576695918,-0.8001047349984699,3111,22,MAP3K1|S100B|TRAF2|CHUK|IKBKG|DDX58|IFIH1|HMGB1|NFKB2|APP|NKIRAS2|NFKB1|IKBKB|RELA|RNF135|TRAF6|NFKBIA|NKIRAS1|MAVS|TRIM25|NFKBIB
NEGATIVE REGULATION OF MAPK PATHWAY%REACTOME%R-HSA-5675221.1,0.0329896907216495,0.371559593752943,-0.271847668896337,-1.54602662369082,111,40,PPP2CA|PPP2CB|YWHAB|PPP2R1B|KRAS|UBA52|MAPK3|DUSP10|UBC|MAP2K1|UBB
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH2%REACTOME%R-HSA-5632928.1,0.49797383350700497,0.913080675012124,0.51733928138917,0.9834075518711579,4300,3,MSH6|MSH3|MSH2
SIGNALING BY NTRK3 (TRKC)%REACTOME DATABASE ID RELEASE 66%9034015,0.357045410251413,0.844839125471303,0.328702633216856,1.08909397046741,3663,14,PTPRO|SRC|HRAS|PLCG1|NTRK3|IRS1|PTPRS
"INACTIVATION, RECOVERY AND REGULATION OF THE PHOTOTRANSDUCTION CASCADE%REACTOME DATABASE ID RELEASE 66%2514859",0.6720406360424029,0.9647315640607691,-0.199651502462224,-0.8401105589787758,3042,17,PPEF1|PDE6B|GNGT1|PRKCA|GUCA1A
"GABA SYNTHESIS, RELEASE, REUPTAKE AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%888590",0.556329113924051,0.9353671528625591,-0.23643155361251897,-0.9159984310183291,2636,14,SNAP25|CPLX1
VIRAL MRNA TRANSLATION%REACTOME%R-HSA-192823.3,0.214997832683138,0.732094216765764,-0.162676100384091,-1.15553715391917,495,87,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|GRSF1|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|RPS16|RPL12|DNAJC3|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52
EPH-EPHRIN MEDIATED REPULSION OF CELLS%REACTOME%R-HSA-3928665.3,0.00374414976599064,0.143595610377104,-0.32257975686889195,-1.9076791383762601,11,46,ADAM10|FYN|MMP2|NCSTN|LYN|PSEN2|MMP9|EFNA1|YES1|CLTA|VAV3|VAV2|AP2S1|EPHA8|EPHA7|EFNB1|RAC1|EPHB2
ESTABLISHMENT OF SISTER CHROMATID COHESION%REACTOME DATABASE ID RELEASE 66%2468052,0.7757367783609208,0.980614374126555,-0.21482952664680605,-0.7560118697275491,3842,11,CDCA5|ESCO2|PDS5B|SMC3|SMC1A|ESCO1|RAD21|WAPAL|STAG1|STAG2|PDS5A
REGULATION OF TP53 ACTIVITY%REACTOME%R-HSA-5633007.2,0.5853605084374319,0.9439064862850342,0.15653136407116,0.938528537947922,8012,154,RBBP7|NUAK1|MBD3|CCNA1|PRKAA2|MAPK11|EHMT1|MTA2|AK6|PPP1R13L|MAP2K6|CDK1|ATR|RNF34|BLM|PPP1R13B|EXO1|BRIP1|TAF7|PDPK1|CDK5R1|RFC4|DNA2|RAD9A|CDKN2A|TAF5|AURKB|ING5|STK11|RMI2|PIN1|SETD8|BRPF3|CHEK2|TOPBP1|ING2|RMI1|AKT3|TP53INP1|PRKAB2|AURKA|AKT2|TAF2|SMYD2|EHMT2|CHEK1|TAF4|RFC3|BRD1|RAD17|TPX2|PIP4K2B|RFC5|CHD3|PPP2R1A|RAD1|CDK2|ATM
"TRANSPORT OF VITAMINS, NUCLEOSIDES, AND RELATED MOLECULES%REACTOME%R-HSA-425397.2",0.7539595849262699,0.977083996023335,0.19389976115929297,0.779569916637713,8282,26,SLC35D1|SLC35A1|SLC33A1|SLC35B3|SLC16A2|SLC5A6|SLC29A2|SLC29A1|LCN1|SLC35B2|SLC35B4|SLCO2A1|SLCO2B1|SLC27A1|SLC35D2|LCN12
ER QUALITY CONTROL COMPARTMENT (ERQC)%REACTOME DATABASE ID RELEASE 66%901032,0.0569948186528497,0.464600390996799,-0.328189716207985,-1.4905707364998502,241,21,RNF185|EDEM2|DERL2|RNF5|EDEM1|UGGT1|TRIM13|OS9|RNF139|AMFR|RNF103|UBA52|UBC|UBB
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA%REACTOME%R-HSA-3134975.2,0.17700421940928301,0.681396298846381,-0.324915451984093,-1.2588084783252098,838,14,TREX1|UBA52|UBC|UBB
NA+ CL- DEPENDENT NEUROTRANSMITTER TRANSPORTERS%REACTOME%R-HSA-442660.1,0.334514170040486,0.830568091460343,0.390479266260651,1.11429440820932,3304,9,SLC6A13|SLC6A15|SLC6A9|SLC6A2|SLC6A1|SLC18A2
"GAMMA-CARBOXYLATION, TRANSPORT, AND AMINO-TERMINAL CLEAVAGE OF PROTEINS%REACTOME%R-HSA-159854.3",0.45168906647293894,0.886411023801201,-0.33895124629941603,-0.988735823354372,2486,7,GAS6|FURIN|GGCX|PROC
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES%REACTOME%R-HSA-425393.2,0.45476792560567697,0.88900512246363,0.198103850418869,1.00798025694709,5574,64,SLC15A2|SLC1A2|SLC12A2|SLC25A29|SLC9A5|SLC9A7|SLC36A1|SLC8A3|SLC25A22|SLC43A1|SLC6A15|SLC26A2|SLC25A10|SLC7A9|SLC15A4
INTERFERON SIGNALING%REACTOME DATABASE ID RELEASE 66%913531,0.6450079239302691,0.9626003629998371,-0.114272522007851,-0.930835148901353,813,167,MX1|KPNB1|VCAM1|NUP93|EIF2AK2|UBE2N|CD44|EIF4E|EIF4E3|CAMK2D|SOCS3|USP41|TRIM8|IFI30|RNASEL|PTPN6|KPNA1|EIF4A1|PRKCD|ARIH1|TRIM17|FLNB|PML|IRF6|HLA-DQB1|EIF4A2|IFNAR1|IFITM2|MX2|EIF4G1|IFITM3|OASL|SUMO1|CAMK2A|ICAM1|TRIM35|EIF4E2|PTPN1|OAS3|KPNA4|NEDD4|TRIM45|TRIM25|PDE12|UBA52|B2M|UBE2E1|MAPK3|HLA-DQA2|HLA-DQB2|TRIM29|IFITM1|UBC|UBB
DOWNREGULATION OF ERBB2 SIGNALING%REACTOME%R-HSA-8863795.2,0.181840371003173,0.6873049536419911,-0.25735469930300503,-1.23361996764917,744,24,CUL5|STUB1|HBEGF|CDC37|PTPN12|UBA52|UBC|UBB
NTRK3 AS A DEPENDENCE RECEPTOR%REACTOME%R-HSA-9603505.1,0.9932443047918299,1.0,-0.24804235138414002,-0.5033945824722029,6321,3,NTRK3|NELFB|BAX
RHO GTPASES ACTIVATE RHOTEKIN AND RHOPHILINS%REACTOME%R-HSA-5666185.1,0.9028783658310121,1.0,-0.20838806891596,-0.6477608519053331,4861,8,RTKN|RHPN2|RHOA|RHOC
COPI-DEPENDENT GOLGI-TO-ER RETROGRADE TRAFFIC%REACTOME%R-HSA-6811434.1,0.29088439721978104,0.800055408161957,0.214876730751155,1.1321314152938502,3640,75,KIF25|KIF21B|KLC1|KIF2C|KIF18A|KIF20B|KIFC2|COPB1|KIF4A|KIF23|USE1|KIF11|CENPE|KIF18B|COPB2|KIF15|KIFAP3|ARF5|KIFC1|KIF22|KLC2|KIF20A|RACGAP1|GBF1|COPG2|TMED9|KIF16B|KIF27
PEPTIDE HORMONE BIOSYNTHESIS%REACTOME%R-HSA-209952.1,0.5065247252747249,0.9172434440873181,-0.37314671798809707,-0.944596138370249,2949,5,PCSK1|INHBB
IRAK1 RECRUITS IKK COMPLEX%REACTOME DATABASE ID RELEASE 66%937039,0.11150512214342,0.5855068018166539,-0.411961668387355,-1.3937279865705499,565,10,TRAF6|UBE2N|IRAK1|UBE2V1|PELI2|PELI1
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 27-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193807,0.9747832939322301,1.0,-0.162740663099244,-0.550576022284671,4947,10,AKR1C1|CYP7B1|PTGIS|AKR1C3|NCOA2|NCOA1|HSD3B7|AKR1C2|CYP27A1|RXRA
FCGR ACTIVATION%REACTOME%R-HSA-2029481.1,0.13643307236967697,0.62388141596544,0.38005660137799396,1.3404047481265902,1428,17,IGKV4-1|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|CD3G|FCGR3A|IGHG2
AMER1 MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%4839748,0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
INHIBITION OF TSC COMPLEX FORMATION BY PKB%REACTOME DATABASE ID RELEASE 66%165181,0.8066458260970241,0.984682960940884,0.401124958641226,0.762496349615191,6966,3,AKT2|TSC1|TSC2
CELLULAR HEXOSE TRANSPORT%REACTOME%R-HSA-189200.4,0.775333064190553,0.9805314293977441,-0.21488004944449302,-0.7561896657472099,3840,11,SLC2A3|SLC2A6|SLC5A2|SLC2A1
MRNA 3'-END PROCESSING%REACTOME DATABASE ID RELEASE 66%72187,0.5849695328368311,0.9439064862850342,-0.148992997164384,-0.931303890434213,1727,55,NCBP2|NUDT21|RBM8A|RNPS1|SLU7|THOC7|FYTTD1
SIGNALING BY NUCLEAR RECEPTORS%REACTOME DATABASE ID RELEASE 66%9006931,0.8940677966101691,0.9976191001250191,0.12213515834048401,0.733452464656635,12237,156,ALDH1A2|HIST1H3E|CITED1|HIST1H2BJ|HIST3H2BB|FABP5|RARB|GPAM|ALDH1A1|DHRS4|HIST2H3C|HIST2H3A|ALDH8A1|POLR2B|PDHX|PDK4|RDH13|FOS|HIST1H4I|CPT1B|MED1|TNRC6A|PDHA1|H2AFX|H3F3A|DLD|KDM4B|H2AFZ|RDH14|HIST1H2BF|POLR2L|TNRC6C|PRMT1|KDM1A|HIST1H2BK|CARM1|POU2F1|RDH11|POLR2J|RXRB|HIST1H2AC|FKBP5|HIST1H3H|HIST1H2BN|POLR2G|POLR2H|SMC3|SP1|GATA3|RXRG|GTF2A1|DDX5|HIST1H2BG|HIST2H2BE|GREB1|HIST1H2BH|GTF2F2|NCOA3
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%212676,0.38945704722945296,0.8603316114971841,0.28008384389818197,1.05886621626834,4188,21,UNC13B|LIN7A|LIN7B|PPFIA2|BZRAP1|PPFIA3|CASK|SYT1|RAB3A|STX1A|PPFIA4|SLC18A2|RIMS1
TGFBR2 KINASE DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3645790,0.0785443767495472,0.532203813468543,-0.65105103235465,-1.4972813650909098,476,4,TGFBR1|FKBP1A
PROTEIN REPAIR%REACTOME DATABASE ID RELEASE 66%5676934,0.943621134020619,1.0,0.237957736575272,0.585222397901225,8786,6,MSRB2|MSRB3|MSRA|PCMT1|MSRB1
SIGNALING BY TYPE 1 INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R)%REACTOME DATABASE ID RELEASE 66%2404192,0.10781377620473699,0.58452352834625,-0.251548165510522,-1.34547339833107,395,33,PIK3C3|IGF1R|NRAS|FGF7|FGF2|IGF1|KRAS|GAB2|FGF10|IGF2|PIK3R1|TRIB3
FORMATION OF XYLULOSE-5-PHOSPHATE%REACTOME%R-HSA-5661270.2,0.45982142857142894,0.890371861972445,-0.386675650267416,-0.978843732068032,2677,5,SORD|XYLB
SIGNALING BY SCF-KIT%REACTOME%R-HSA-1433557.2,0.0145576707726764,0.262734483145539,-0.30485241514648304,-1.67696021724547,51,36,PIK3R2|SH2B3|SOCS6|PTPN6|NRAS|PTPRU|VAV1|FYN|LYN|MMP9|YES1|KRAS|STAT5A|PRKCA|STAT3|GAB2|RAC1|PIK3R1
TRUNCATIONS OF AMER1 DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%5467348,0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
INTEGRIN ALPHAIIB BETA3 SIGNALING%REACTOME%R-HSA-354192.1,0.6632036723846341,0.964618776001639,-0.182823107800095,-0.859070495326743,2744,23,CRK|RAP1A|PTPN1|SHC1|VWF
GPVI-MEDIATED ACTIVATION CASCADE%REACTOME%R-HSA-114604.5,0.0067585131271120395,0.184091670885037,-0.357429638384656,-1.8292359274132999,25,29,PIK3R2|RHOG|PIK3R5|PTPN6|FCER1G|PDPN|VAV1|FYN|RHOA|LYN|VAV3|VAV2|CDC42|RAC1|PIK3R1
INTESTINAL ABSORPTION%REACTOME DATABASE ID RELEASE 66%8963676,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
INTERCONVERSION OF NUCLEOTIDE DI- AND TRIPHOSPHATES%REACTOME%R-HSA-499943.6,0.643353487952351,0.9621972042482541,0.21341674755192802,0.8676483000382459,7128,27,NME3|NME4|AK6|RRM1|DTYMK|CTPS2|GUK1|NUDT13|TYMS|RRM2|CTPS1|TXNRD1|AK2
FORMATION OF THE CORNIFIED ENVELOPE%REACTOME DATABASE ID RELEASE 66%6809371,0.40987925356750804,0.867015886388254,-0.247741277552598,-1.01458379506068,1866,16,FURIN|CAPNS1|KAZN|SPINK5|PKP4|EVPL
ERYTHROPOIETIN ACTIVATES PHOSPHOLIPASE C GAMMA (PLCG)%REACTOME DATABASE ID RELEASE 66%9027277,0.30530498281786894,0.8085598515544019,0.464812126408434,1.1431377315369,2842,6,EPOR|JAK2|PLCG1
TRAFFICKING OF MYRISTOYLATED PROTEINS TO THE CILIUM%REACTOME%R-HSA-5624138.1,0.9613205491392459,1.0,0.241617030664019,0.55689143800916,8822,5,NPHP3|NPHP3-ACAD11|ARL3|UNC119B|RP2
MUSCLE CONTRACTION%REACTOME DATABASE ID RELEASE 66%397014,0.18590594132389804,0.6922162303225631,0.202405949105458,1.20140178392999,2521,144,KCNK2|RYR2|SCN1A|NEB|KCNK6|AKAP9|CACNB4|CACNB2|NPR2|KCNK3|ATP2B1|FGF12|KCNQ1|KCNIP4|MYL7|ITGA1|SLC8A3|ATP1B3|ACTN2|KCNIP1|MYH3|KCND1|TCAP|FGF13|ATP2A1|FGF11|CACNA2D1|KCNJ11|TNNC2|KCNH2|CACNA1D|FXYD7|ITGB5|ATP2B3|DMPK|ATP2A2|LMOD1|ACTA2|DMD|TRPC1|KCND2|SCN3B|TNNI3|CACNB1|SLC8A1|SCN8A|MYL5|MYLK
MECP2 REGULATES TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%9022707,0.99484824728413,1.0,0.22140574989939302,0.469179933815998,8882,4,RBFOX1|MEF2C|CREB1
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS%REACTOME DATABASE ID RELEASE 66%8939246,0.15951236263736301,0.661359103221672,-0.5153650265499821,-1.3046123427132,928,5,CREBBP|RUNX1|LGALS3|CBFB
SIGNALING BY NOTCH1%REACTOME%R-HSA-1980143.2,0.935382381413359,1.0,0.124075794725128,0.644095889105685,11594,70,HDAC10|DTX1|DTX4|CDK8|KAT2A|HES1|MAML1|JAG2|DTX2|DLK1|MIB2|HEYL|HDAC8|HDAC3|HEY2|HDAC6|TLE4|CCNC|MAML3|TLE1|RBX1|CNTN1|NEURL1|DLL4|JAG1|NEURL1B|KAT2B|NCOR1|HDAC9|RPS27A|HDAC7|HDAC2|SNW1|HEY1|TBL1XR1
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D1%REACTOME DATABASE ID RELEASE 66%69229,0.9467852946113821,1.0,0.126465167281328,0.607721914608088,11279,50,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|PSME2|RPS27A|CCND1|PSMD14|PSMD4|PSMB10|PSMD9|PSME1
B-WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION%REACTOME%R-HSA-5250924.2,0.592701806118688,0.9461312439065841,-0.140897760559764,-0.9226431410587209,1607,65,HIST2H4A|HIST2H2AA4|POLR1B|TAF1B|DDX21|POLR2K|POLR2F|POLR1E|HIST2H4B|HIST1H2BC|H3F3B|CD3EAP|HIST2H2AC|HIST1H2BD
HEMOSTASIS%REACTOME%R-HSA-109582.1,0.00975609756097561,0.21629281353054503,-0.13615963112029197,-1.3138937360949199,1,474,SELL|SRI|GNG10|RHOG|APLP2|PIK3R5|RAP1B|SOD1|GNAI3|KCNMB3|VTI1B|PTPN6|MMP1|PRKCH|SRGN|CLU|FAM49B|SERPINB8|VEGFA|GNA13|KIF26A|SIN3A|HMG20B|GNG4|SLC16A1|FCER1G|PCDH7|DGKI|ADRA2C|PRKCD|SIRPA|DGKD|F11R|ITGAX|ESAM|BCAR1|NRAS|ITGAM|PDPN|ARRB2|HSPA5|A1BG|PFN1|FGR|ABL1|VAV1|HBG2|GNAQ|PPP2R5C|GUCY1A3|GNAI2|FYN|RHOA|ITPK1|P2RX6|PSAP|ITGA5|C1QBP|SLC16A8|MGLL|DGKQ|WDR1|PLAU|MFN2|TNFRSF10D|TNFRSF10A|EHD3|DOCK9|GNA15|HGF|DOCK5|EHD1|LYN|ITGA6|ARRB1|DOCK3|HABP4|KIF13B|YES1|MAFF|JAM2|PPP2CA|PRKAR2A|PPP2CB|IGF1|SERPINF2|ATP2B4|CRK|RAP1A|TMSB4X|PTPN1|RBSN|VAV3|PLAUR|VAV2|PPP2R1B|CFD|EHD2|CDC42|SERPINA1|SLC16A3|GNB5|GNGT1|ORAI2|SLC7A8|THBD|KIF3C|PROC|KRAS|PDE9A|KIF3B|RAD51B|SHC1|PRKCA|DGKG|CLEC3B|CTSW|CD9|TP53|YWHAZ|PRKAR1B|NOS3|TNFRSF10B|ABCC4|MAPK3|ALDOA|PDE10A|GNA12|RAB5A|ADRA2A|ATP2B2|DGKB|VWF|SDC2|GNAS|GLG1|SLC3A2|H3F3B|RAC1|KIF9|IGF2|TAGLN2|CD36|PIK3R1|PDE3A|ZFPM2|DGKK|CAV1|SLC7A5|ANGPT2
ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE%REACTOME%R-HSA-1247673.1,0.37393767705382397,0.852609194081082,0.46809951324338706,1.07889998625133,3431,5,HBB|HBA2|HBA1
O-GLYCOSYLATION OF TSR DOMAIN-CONTAINING PROTEINS%REACTOME%R-HSA-5173214.1,0.6008996851102111,0.9504775248433821,0.219107879686119,0.898479976939207,6678,28,ADAMTS10|ADAMTS2|B3GLCT|THSD1|ADAMTSL2|SEMA5A
"SYNTHESIS, SECRETION, AND DEACYLATION OF GHRELIN%REACTOME%R-HSA-422085.2",0.8534812923499949,0.991298302704726,0.21099503107442003,0.680959392446963,8690,13,INS|BCHE|UCN|SPCS2|SEC11C|SEC11A
CARBOXYTERMINAL POST-TRANSLATIONAL MODIFICATIONS OF TUBULIN%REACTOME DATABASE ID RELEASE 66%8955332,0.301003344481605,0.8040187722515909,-0.21827779433396802,-1.10366618316516,1169,28,TUBB2B|TTLL12|TUBB2A|TUBB6|TUBA1C|TUBB3|AGBL2|TTLL5|TUBB4B|TTLL1
CD209 (DC-SIGN) SIGNALING%REACTOME%R-HSA-5621575.1,0.31353591160221,0.8163836065655741,-0.245661426165118,-1.09611806615795,1361,20,RELA|PRKACA|CREBBP|NRAS|FYN|RELB|LYN|KRAS|PAK2
OTHER SEMAPHORIN INTERACTIONS%REACTOME%R-HSA-416700.1,0.276442762535478,0.7884684708511421,0.319035411568377,1.16612324177513,2921,19,ITGB1|ITGA1|PLXNC1|SEMA5A|SEMA3E|SEMA6A|PLXNB3|PLXNA2|SEMA4A
STEROLS ARE 12-HYDROXYLATED BY CYP8B1%REACTOME%R-HSA-211994.1,0.996028068317225,1.0,-0.5022055580061761,-0.6718156870639589,7522,1,PTGIS
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND%REACTOME DATABASE ID RELEASE 66%69183,0.20595054095826898,0.7211951452265429,0.367638296028212,1.24651882713255,2131,15,DNA2|POLD1|FEN1|POLD3|POLA2|LIG1|PRIM2
CELL-CELL JUNCTION ORGANIZATION%REACTOME DATABASE ID RELEASE 66%421270,0.13618942168469503,0.6237835799077729,0.283959955488039,1.31646676062547,1598,43,CLDN12|CDH4|CDH6|CLDN15|CDH10|SDK1|CDH3|CDH2|CLDN11|CLDN7|CTNND1|CDH7
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN BCR SIGNALING%REACTOME DATABASE ID RELEASE 66%8939245,0.0285027472527473,0.347594990613216,-0.677274330542793,-1.7144749944401898,165,5,ELF1|BLK|RUNX1|CBFB
DOPAMINE RECEPTORS%REACTOME%R-HSA-390651.1,0.677951002227172,0.9647315640607691,-0.490674356538065,-0.839272208020751,4565,2,DRD2
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS%REACTOME DATABASE ID RELEASE 66%141405,0.237849502720961,0.7507739897770379,0.32363014038288396,1.20180028420298,2534,20,ANAPC15|ANAPC5|CDC23|CDC20|ANAPC7|ANAPC16|BUB1B|UBE2C|ANAPC10|CDC16|ANAPC2|ANAPC4
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES%REACTOME%R-HSA-5633008.2,0.0488954344624448,0.43511944660534596,-0.256547676364505,-1.45901393790059,165,40,BBC3|IGFBP3|TNFRSF10D|TNFRSF10A|BID|CRADD|TP53I3|TP53|TNFRSF10B|BCL6|BNIP3L|PMAIP1|STEAP3|NDRG1
SIGNALING BY ERBB4%REACTOME DATABASE ID RELEASE 66%1236394,0.00111080255484588,0.0893009762660318,-0.387276024996752,-2.1052351679530097,3,35,NCSTN|HBEGF|PSEN2|NEDD4|ADAM17|KRAS|STAT5A|SHC1|UBA52|WWOX|UBC|PIK3R1|UBB
ENOS ACTIVATION AND REGULATION%REACTOME DATABASE ID RELEASE 66%203765,0.020042194092827,0.296356050331525,-0.447290434753161,-1.73292155883252,94,14,NOSIP|SPR|DDAH2|NOS3|CAV1|DDAH1
MAPK6 MAPK4 SIGNALING%REACTOME%R-HSA-5687128.3,0.421389007243289,0.873054719602436,-0.14538818610309803,-1.02095322728947,988,84,CDC42|AGO2|JUN|UBA52|PSMD6|RAC1|UBC|PSMF1|PAK2|UBB|FOXO3
FRUCTOSE CATABOLISM%REACTOME%R-HSA-70350.5,0.0193750699966402,0.289864965388082,0.7644935250492451,1.62003480780581,172,4,ALDH1A1|TKFC|GLYCTK|KHK
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS%REACTOME DATABASE ID RELEASE 66%391160,0.531946656050955,0.9265056012720759,0.30978334832921994,0.9450779843852751,5344,11,CD47|SIRPG
G ALPHA (Q) SIGNALLING EVENTS%REACTOME%R-HSA-416476.6,0.007633587786259541,0.197647069623972,-0.19780422169003603,-1.5212355535534798,12,123,PRKCH|KALRN|GNG4|DGKI|NMB|MAPK7|PRKCD|DGKD|LPAR1|GNRH2|HCRT|NRAS|PTGFR|TRIO|GNAQ|ADRA1B|MGLL|DGKQ|GNA15|HBEGF|GCGR|GNB5|EDNRA|GNGT1|KRAS|PRKCA|DGKG|MAPK3|MCHR1|TAC3|DGKB|BDKRB2|GPR4|PLCB4|CHRM1|PLCB1|BDKRB1|PIK3R1|HRH1|DGKK|RPS6KA2|TRH
PHOSPHORYLATION OF THE APC C%REACTOME DATABASE ID RELEASE 66%176412,0.0935666982024598,0.5622489437340121,0.386899239929064,1.41417591761509,988,19,ANAPC15|CCNB1|CDK1|ANAPC5|CDC23|ANAPC7|ANAPC16|PLK1|UBE2C|ANAPC10|CDC16|ANAPC2|ANAPC4
POST-TRANSCRIPTIONAL SILENCING BY SMALL RNAS%REACTOME DATABASE ID RELEASE 66%426496,0.969487831456593,1.0,-0.191505791505792,-0.5586308901615501,5337,7,TNRC6A|TNRC6C|AGO4|AGO3|TNRC6B|AGO1|AGO2
HIGHLY CALCIUM PERMEABLE NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629597,0.0266754487073934,0.338782289910385,-0.732973032592511,-1.68568485153267,161,4,CHRNB4|CHRNA5|CHRNB2|CHRNA3
ER-PHAGOSOME PATHWAY%REACTOME DATABASE ID RELEASE 66%1236974,0.812474012474013,0.985971473561293,-0.11689341450864801,-0.808123194072817,1953,79,UBA52|B2M|PSMD6|MYD88|UBC|CD36|PSMF1|UBB
DOWNREGULATION OF ERBB2:ERBB3 SIGNALING%REACTOME%R-HSA-1358803.1,0.28959369817578806,0.7989014598698071,-0.31114388112211405,-1.1335283697504699,1396,12,UBA52|UBC|UBB
REGULATION OF TP53 EXPRESSION AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%6806003,0.0957264957264957,0.5679182161799671,-0.242537056152519,-1.3472827715078601,335,37,PPP2CA|PPP2CB|PHF20|PRR5|PPP2R1B|UBA52|TP53|USP2|UBC|UBB
MET ACTIVATES PTK2 SIGNALING%REACTOME%R-HSA-8874081.1,0.414912865441387,0.8695737743071128,0.29033129842351,1.04147755758163,4356,18,ITGB1|LAMC3|ITGA2|LAMA1|LAMB2|SRC
TELOMERE C-STRAND (LAGGING STRAND) SYNTHESIS%REACTOME DATABASE ID RELEASE 66%174417,0.059697386519945,0.476295606439141,0.378426104819359,1.4892950996982102,650,24,POLE|POLE2|RFC4|DNA2|POLD1|FEN1|POLD3|POLA2|LIG1|PRIM2|RFC3|RFC5
HEDGEHOG LIGAND BIOGENESIS%REACTOME DATABASE ID RELEASE 66%5358346,0.880351713370039,0.9956508825790341,0.13910693582464997,0.695610600543923,10712,59,SCUBE2|NOTUM|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|DISP2|PSMD1|PSMA1|SYVN1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
ACTIVATION OF BH3-ONLY PROTEINS%REACTOME DATABASE ID RELEASE 66%114452,0.00025726781579624397,0.0784645998831315,-0.47240450187687605,-2.38859328356038,0,28,TP53BP2|PPP3R1|BBC3|YWHAH|BID|YWHAQ|YWHAB|BCL2|DYNLL2|TP53|YWHAZ|YWHAE|BMF|BCL2L11|PMAIP1|TFDP2
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%5250941,0.8934018174634529,0.9976191001250191,0.129699654929475,0.698618048628305,11305,84,GTF2H2|HIST1H3E|HIST1H2BJ|SIRT1|HIST3H2BB|TAF1D|RRP8|HIST2H3C|HIST2H3A|GTF2H1|DNMT3B|HIST1H4I|H2AFX|H3F3A|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|HIST1H2AC|HIST1H3H|HIST1H2BN|SUDS3|POLR2H|SIN3B|HIST1H2BG|HIST2H2BE|HIST1H2BH|DNMT1|SUV39H1|ARID4B
METABOLISM OF VITAMINS AND COFACTORS%REACTOME%R-HSA-196854.3,0.51437417072092,0.920792511236057,0.165014129896768,0.979458711109032,6977,144,ENPP2|RBP1|GPHN|LPL|GSTO2|BCO2|MCCC2|PARP16|CD38|COQ3|CD320|SLC25A19|NAPRT|DHFR|ABCD4|GPC2|MTHFD1|GPC6|COQ2|IDH1|COQ6|AKR1C1|PANK4|MTR|BST1|GPC1|RFK|SLC46A1|PCCB|APOE|RNLS|ACACA|PTGS2|NADK|PANK3|SLC5A6|SLC19A2|LRP8|LDLR|GPC3|PARP10|NMNAT1|RDH11|MCCC1|COQ9|APOM|AGRN|MTHFD2L|COQ5|PTS|QPRT|PCCA|PANK1|PPCS|SLC19A1|PDSS1
REPRODUCTION%REACTOME DATABASE ID RELEASE 66%1474165,0.11207911466917801,0.5871948297110661,0.240325717546894,1.3099694054777902,1427,89,HSPA2|HIST1H3E|HIST1H2BJ|CATSPERG|HIST3H2BB|SYCP2|MLH3|SYNE1|ATR|OVGP1|BLM|HIST2H3C|HIST2H3A|IZUMO4|ZP3|HIST1H4I|RAD51C|RAD51|LMNB1|MND1|H2AFX|H3F3A|REC8|H2AFZ|PSMC3IP|SYNE2|HIST1H2BF|HIST1H2BK|BRCA2|HIST1H2AC|STAG3|HIST1H3H|ACD|HIST1H2BN|SMC3|CDK2|ATM|HIST1H2BG|HIST2H2BE|BRCA1|HIST1H2BH
PLCG1 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1251932.3,0.508857242097951,0.918404893008545,0.51294123021109,0.9750473192392459,4394,3,PLCG1|ERBB2|EGFR
NCAM1 INTERACTIONS%REACTOME%R-HSA-419037.1,0.0789923526765632,0.532203813468543,0.349616656562325,1.43364796362265,877,28,CACNA1G|COL9A2|CACNB4|CACNB2|PSPN|CACNA1I|ARTN|CACNA1H|COL4A2|CACNA1D
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS%REACTOME DATABASE ID RELEASE 66%176033,0.220386891617348,0.7354368651705759,0.28446092781823495,1.2162593114143898,2494,32,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|PSIP1|NUP62|RANBP2|NUP50
EXTRACELLULAR MATRIX ORGANIZATION%REACTOME%R-HSA-1474244.2,0.627793493635078,0.9553884638359259,0.146554681755017,0.923723674422258,8876,221,ITGB1|COL9A2|MMP17|FBN3|CD47|COL18A1|ELN|LAMC3|ASPN|CEACAM1|VCAN|COL26A1|ITGA1|TNC|ADAMTS2|BMP4|ITGA9|MMP11|DDR2|LOXL1|ITGA2|ITGA4|EFEMP1|TGFB2|COL8A1|LAMA1|DDR1|LAMB2|LOXL3|P3H2|FBN1|COL4A2|P4HA3|ITGA11|ITGB5|COL20A1|LOXL2|CAPN10|LTBP2|BSG|TNXB|CAPN15|CASK|P3H1|FBLN5|ITGA2B|COL4A1|COL5A2|KLKB1|DMD|COL27A1|MFAP4|COL28A1|EFEMP2|COL5A1|COL11A2|ITGA10|PTPRS|FN1|LAMA2|LTBP1|PHYKPL|NID1|SPARC|AGRN|P4HA1|FMOD|THBS1|HTRA1|MFAP2|ITGA3|ICAM3|COL12A1|SERPINE1|MFAP1|ADAM9|ITGA8|BGN|COL11A1|LTBP4|COL1A1|TGFB3|SDC3|ADAM15|DCN|FBLN2|SCUBE1|P3H3|NTN4|CAPN12|LUM|MFAP3|COL3A1|MMP24|LAMB3
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111447,0.0270967741935484,0.339785941813865,-0.4240706083358499,-1.69123147207729,125,15,YWHAH|BID|YWHAQ|YWHAB|BCL2|YWHAZ|YWHAE
GSD 0%REACTOME DATABASE ID RELEASE 66%3858516,0.8475167785234899,0.991298302704726,0.57713939126599,0.766703933283182,6313,1,GYG2
REGULATION BY C-FLIP%REACTOME DATABASE ID RELEASE 66%3371378,0.9246388129636859,1.0,-0.19511253309797,-0.629840741293588,4735,9,FAS|RIPK1|TRAF2|TRADD|FADD|TNFSF10|CASP8|TNFRSF10A|TNFRSF10B
AMINE-DERIVED HORMONES%REACTOME DATABASE ID RELEASE 66%209776,0.0832259450171821,0.543495613339729,0.5871647713046129,1.4440462427129999,774,6,PNMT|DDC|DUOX1|TH|DBH
SLC-MEDIATED TRANSMEMBRANE TRANSPORT%REACTOME DATABASE ID RELEASE 66%425407,0.40459467369037205,0.8656966913418921,0.174760434970923,1.04488751800225,5529,151,SLC15A2|SLC45A3|SLC1A2|SLC12A2|SLC47A1|SLC2A13|SLC25A29|RHBG|SLC9A5|SLC9A7|SLC36A1|SLC8A3|SLC25A22|SLC6A13|SLC35D1|SLC35A1|SLC39A3|SLC43A1|SLC33A1|SLC30A5|SLC35B3|SLC16A2|SLC50A1|SLC6A15|SLC26A2|SLC13A3|SLC25A10|SLC6A9|SLC39A7|SLC7A9|SLC15A4|SLC22A3|BSG|SLC40A1|SLC16A7|SLC6A2|SLC5A6|SLC41A2|SLC24A1|SLC29A2|SLC8A1|HEPH|SLC1A3|SLC44A3|SLC29A1|SLC6A1|SLC39A10|AHCYL2|SLC30A7|SLC8A2
GENERATION OF SECOND MESSENGER MOLECULES%REACTOME DATABASE ID RELEASE 66%202433,0.8317573595004458,0.9879179006160809,0.170840177869297,0.7163211191043729,9323,30,EVL|GRAP2|CD101|PAK3|PLCG1|CD3D|LAT|CD3G|CD3E|ZAP70|LCK|HLA-DRB1|NCK1|HLA-DRB5|WAS|HLA-DPB1|HLA-DQA1
"ADRENALINE,NORADRENALINE INHIBITS INSULIN SECRETION%REACTOME%R-HSA-400042.1",0.704268567818789,0.968941691852291,0.20201510306859802,0.8212947801431179,7803,27,GNG8|CACNB2|GNAI1|GNB3
BRANCHED-CHAIN AMINO ACID CATABOLISM%REACTOME DATABASE ID RELEASE 66%70895,0.586900129701686,0.945418171231938,0.235700978093029,0.902680070735347,6334,22,MCCC2|BCKDHA|DLD|BCAT2|IVD|ALDH9A1|MCCC1|PPM1K|HIBCH|HIBADH|HSD17B10|ACAD8|AUH|ACADSB|ACAT1
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR)%REACTOME DATABASE ID RELEASE 66%5685942,0.0244259892525647,0.327926916046055,0.303230969867137,1.5521702475061003,299,66,MUS81|EME2|POLE|XRCC3|ATR|BLM|EXO1|BRIP1|POLE2|RFC4|DNA2|RAD9A|POLD1|GEN1|POLD3|SLX1B|RAD51C|RAD51|RMI2|RAD51AP1|SLX4|TOPBP1|EME1|RMI1|PALB2|BRCA2|XRCC2|CHEK1|RFC3|RAD17|RFC5|SPIDR|RAD1|ATM
G ALPHA (I) SIGNALLING EVENTS%REACTOME%R-HSA-418594.5,0.822864410372359,0.987616425875001,0.12799749430903598,0.8092425116790849,11645,226,RGS16|PLCB3|GNG8|CXCL13|RBP1|PTGER3|LPL|BCO2|NPY1R|TAS2R4|GNAI1|ADORA3|GRM4|CXCR4|NPY2R|GUCA1B|CXCL9|PLA2G4A|GNB3|ADCY8|RGS14|NAPEPLD|CNR1|PDE1A|RGS1|PENK|GPC2|S1PR5|NPY|GPC6|PRKCQ|CCR5|PDE1B|CCL21|GPSM2|AKR1C1|SSTR2|CCL5|RGS11|GPC1|PRKAR2B|APOE|CCL19|TAS2R5|RGS9|CXCL10|C3AR1|TAS2R20|C5|DRD4|RGS7|HEBP1|CNGB1|LRP8|FNTB|S1PR4|RGS19|LDLR|GPC3|SLC24A1|RDH11|LPAR2|OPRL1|MYO7A|APOM|CORT|FPR3|RGS18|ADCY1|LPAR5
PCNA-DEPENDENT LONG PATCH BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%5651801,0.29081442915582,0.800029528446767,0.304522955537546,1.15125908445512,3127,21,POLE|POLE2|RFC4|POLD1|FEN1|POLD3|LIG1|RFC3|RFC5
SYNTHESIS OF GDP-MANNOSE%REACTOME DATABASE ID RELEASE 66%446205,0.785885989010989,0.981487311948134,-0.295475766363643,-0.7479772819494301,4576,5,PMM1|PMM2
INTRAFLAGELLAR TRANSPORT%REACTOME%R-HSA-5620924.3,0.007738095238095241,0.198167223413272,-0.306738215202411,-1.75785466161673,25,41,IFT74|IFT52|IFT27|IFT22|IFT88|TTC26|IFT57|DYNC2H1|IFT46|IFT122|WDR35|TCTEX1D2|IFT172|DYNLRB2|WDR19|TRAF3IP1|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B
TRANSPORT OF THE SLBP INDEPENDENT MATURE MRNA%REACTOME DATABASE ID RELEASE 66%159227,0.135096369341103,0.622258254449182,0.32112701043873304,1.3302162145274399,1506,29,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50|NXF1
METABOLISM OF NITRIC OXIDE%REACTOME%R-HSA-202131.2,0.020042194092827,0.296356050331525,-0.447290434753161,-1.73292155883252,94,14,NOSIP|SPR|DDAH2|NOS3|CAV1|DDAH1
INITIAL TRIGGERING OF COMPLEMENT%REACTOME DATABASE ID RELEASE 66%166663,0.0637391143227719,0.493955766167256,0.38513675194230695,1.4749844200852098,687,22,IGKV4-1|COLEC11|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|GZMM|C4A|C4B|IGHG2|C2|C1QB|FCN3|C1S|C1R|C3|CFB
AGMATINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%351143,0.666979865771812,0.964618776001639,0.6716475518306129,0.8922538082853191,4968,1,AZIN2
LIGAND-INDEPENDENT CASPASE ACTIVATION VIA DCC%REACTOME%R-HSA-418889.3,0.589046493301813,0.945418171231938,-0.26103697927223196,-0.883127172888968,2989,10,CASP3|UNC5B|APPL1
PEPTIDE HORMONE METABOLISM%REACTOME DATABASE ID RELEASE 66%2980736,0.844908968307485,0.991298302704726,-0.12322128367942199,-0.7643163325563809,2505,54,AGT|SPCS1|PCSK2|ACHE|PLA2G7|CTSD|CTNNB1|PCSK1|TCF7L2|ATP6AP2|MYRIP|EXOC3|VAMP2|EXOC4|IGF1|ANPEP|ACE|INHBB
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING%REACTOME%R-HSA-8939256.1,0.15675942697184303,0.6578589353509621,-0.571390231748605,-1.31407816542118,951,4,RUNX1|CBFB
GDP-FUCOSE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%6787639,0.5352233676975949,0.9265056012720759,0.382052837681319,0.939603313641805,4983,6,FPGT|FUK|GMDS|FUOM|SLC35C1|TSTA3
PKA ACTIVATION%REACTOME%R-HSA-163615.2,0.865591397849462,0.9929389166575431,-0.176481597182266,-0.7038243762480579,4024,15,PRKAR2A|PRKAR1B|ADCY2
P38MAPK EVENTS%REACTOME%R-HSA-171007.3,0.857794361525705,0.99166790097654,-0.19053261332058702,-0.694129422641029,4137,12,RALA|KRAS|RALB
BETA OXIDATION OF BUTANOYL-COA TO ACETYL-COA%REACTOME%R-HSA-77352.3,0.115690446858551,0.59427713722843,0.63828379198147,1.3525843272533402,1032,4,ACSM3|HADH|ACADS|ECHS1
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%198693,0.261229314420804,0.771967970256231,-0.34515177996231294,-1.1677001339255801,1325,10,FOXO6|FOXO3
SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1%REACTOME%R-HSA-1839122.1,0.47340688292442,0.899657490014426,-0.422733440525755,-0.9721986011001229,2874,4,FGF2|FGFR1
INTERLEUKIN-4 AND INTERLEUKIN-13 SIGNALING%REACTOME DATABASE ID RELEASE 66%6785807,0.000433463372345037,0.0784645998831315,-0.27461051720056895,-1.95064090381435,0,87,SOCS3|HIF1A|LAMA5|MMP1|ZEB1|BATF|IL13RA1|IL1B|VEGFA|PIM1|ITGAX|ITGAM|HMOX1|LIF|MMP2|TNFRSF1B|FOXO1|VIM|FGF2|HGF|IL6|MMP9|BCL2L1|ICAM1|FCER2|CXCL8|BCL2|STAT3|TP53|ALOX5|SOCS5|BCL6|CDKN1A|S1PR1|CD36|TWIST1|PIK3R1|TNF|FOXO3
EICOSANOID LIGAND-BINDING RECEPTORS%REACTOME DATABASE ID RELEASE 66%391903,0.361166401273885,0.848418604328854,0.356497363341795,1.0875917359756602,3628,11,CYSLTR2|PTGER3|PTGER1
AMINE OXIDASE REACTIONS%REACTOME DATABASE ID RELEASE 66%140179,0.720188531029065,0.9713637233549571,-0.392301753612,-0.7961647531585709,4583,3,MAOA|PAOX|MAOB
EGFR DOWNREGULATION%REACTOME DATABASE ID RELEASE 66%182971,0.0437303696545059,0.412001737413835,-0.329074337830638,-1.54629279526633,180,23,PTPN12|CDC42|UBA52|SH3GL3|UBC|UBB
SIGNALING BY PLASMA MEMBRANE FGFR1 FUSIONS%REACTOME%R-HSA-8853336.1,0.0447761194029851,0.415427066348928,-0.769990073894342,-1.56267197755878,284,3,ERLIN2|BAG4|FGFR1
S33 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358747.1,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS%REACTOME%R-HSA-2173782.1,0.0608048993875766,0.48170831577441997,0.33392614786478403,1.47396217368454,694,36,IGKV4-1|HPX|COLEC11|HBB|HBA2|HSP90B1|COL4A2|IGKV3-11|HBA1|APOE|IGKV2D-28|JCHAIN|IGKV2-28|STAB1|COL4A1
SEPARATION OF SISTER CHROMATIDS%REACTOME%R-HSA-2467813.1,0.0380917698470503,0.39255619193341595,0.23235564587715696,1.40584061846201,522,165,CLIP1|ANAPC15|PSMD11|ZWINT|ANAPC5|CENPF|KIF2C|NUP133|PSMD13|KIF18A|CENPL|PSMB9|CENPT|CKAP5|NSL1|PSMA4|CENPK|PSMD3|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC23|CDC20|NDC80|ITGB3BP|CENPA|ANAPC7|CENPE|ANAPC16|PTTG1|PSMD1|BUB1B|ESPL1|AURKB|ERCC6L|NUP160|DSN1|PSMA1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|PSMC3|CDCA5|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|PSMA3|CENPM|UBE2C|DYNC1H1|PSMC6|PSMC1|ANAPC10|SPC25|PSMD2|PSMA5|SGOL1|PDS5B|SPC24|PSMC2|SMC3|PPP2R1A|PSMC5|NUP37|CDC16|NDE1|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|ZWILCH
REELIN SIGNALLING PATHWAY%REACTOME%R-HSA-8866376.2,0.702453482628026,0.968941691852291,-0.352096610270057,-0.8097486480627478,4265,4,FYN|RELN
NUCLEOTIDE EXCISION REPAIR%REACTOME%R-HSA-5696398.2,0.514583333333333,0.920792511236057,-0.129920895520195,-0.976227928637058,987,110,RAD23A|POLR2E|UVSSA|UBE2N|CUL4A|POLE3|PRPF19|COPS3|RFC1|ERCC1|ISY1|USP45|INO80B|RUVBL1|ACTR5|RPA3|ELL|UBE2I|INO80C|SUMO1|POLR2A|RAD23B|COPS7A|CETN2|POLR2K|INO80E|UBA52|POLR2F|ACTR8|COPS2|TCEA1|POLR2I|POLR2D|COPS8|TFPT|UBC|SUMO3|UBB
MITOCHONDRIAL FATTY ACID BETA-OXIDATION OF SATURATED FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%77286,0.0632591093117409,0.492154125677625,0.5261148468032589,1.5013520115494299,624,9,ACSM3|ACADVL|ACADM|HADH|HADHB|ACADS|ECHS1
COLLAGEN FORMATION%REACTOME%R-HSA-1474290.1,0.850211313394018,0.991298302704726,0.142402894187584,0.7335209896530971,10460,68,COL9A2|COL18A1|COL26A1|ADAMTS2|LOXL1|COL8A1|LOXL3|P3H2|COL4A2|P4HA3|COL20A1|LOXL2|P3H1|COL4A1|COL5A2|COL27A1|COL28A1|COL5A1|COL11A2
G1 S TRANSITION%REACTOME DATABASE ID RELEASE 66%69206,0.0355409542298216,0.3821688062173221,0.24659486475396897,1.4387905879446496,475,129,CCNA1|CCNB1|CDC7|CDK1|POLE|LIN52|PSMD11|DHFR|PSMD13|WEE1|PSMB9|PSMA4|POLE2|ORC1|LIN9|PSMD3|CDC45|TK1|CCNE1|FBXO5|PSMD1|RB1|POLA2|E2F5|MCM6|CDC6|E2F6|PPP2R3B|PSMA1|ORC6|PSMC3|DBF4|CDK7|MCM10|AKT3|MCM3|LIN37|PSMA3|MCM2|AKT2|CCNE2|PSMC6|PSMC1|E2F1|PSMD2|PRIM2|TYMS|GMNN|RRM2|PSMA5|PSMC2|PPP2R1A|PSMC5|SKP2|CDK2|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|LIN54|CCNA2|CDT1|MNAT1
SUMOYLATION OF RNA BINDING PROTEINS%REACTOME DATABASE ID RELEASE 66%4570464,0.402508160109947,0.865238688875249,0.22921882551848496,1.0468241264767801,4685,41,TPR|NUP133|PCGF2|SUMO2|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|PHC2|NUP37|AAAS|HNRNPK|NUP62|RANBP2|PHC1|NUP50|CBX2
INLB-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL%REACTOME DATABASE ID RELEASE 66%8875360,0.00358649789029536,0.143595610377104,-0.526186885992151,-2.03858729778998,16,14,UBA52|SH3GL3|MET|UBC|UBB
PRE-NOTCH PROCESSING IN THE ENDOPLASMIC RETICULUM%REACTOME%R-HSA-1912399.2,0.97057560137457,1.0,0.217638299045833,0.5352497005385539,9037,6,POGLUT1|NOTCH2|POFUT1|NOTCH3|NOTCH4|NOTCH1
LIGAND-DEPENDENT CASPASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%140534,0.790084388185654,0.9819233677232551,-0.195166363184903,-0.7561261588540301,3744,14,FAS|RIPK1|TICAM2|TRAF2|TRADD|TLR4|FADD|CD14|TNFSF10|CASP8|LY96|TNFRSF10A|TNFRSF10B|TICAM1
FICOLINS BIND TO REPETITIVE CARBOHYDRATE STRUCTURES ON THE TARGET CELL SURFACE%REACTOME DATABASE ID RELEASE 66%2855086,0.701113585746103,0.9688061821895041,-0.479128756548111,-0.8195240775807191,4721,2,FCN3|FCN1
PAOS OXIDISE POLYAMINES TO AMINES%REACTOME DATABASE ID RELEASE 66%141334,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
PP2A-MEDIATED DEPHOSPHORYLATION OF KEY METABOLIC FACTORS%REACTOME%R-HSA-163767.3,0.10113324175824198,0.571596718470827,-0.5593147543199399,-1.41586816015081,588,5,PPP2CA|PPP2CB|PPP2R1B
SDK INTERACTIONS%REACTOME%R-HSA-373756.2,0.42639409701221703,0.875696962448429,0.631761786600496,1.03259728468698,3524,2,SDK1|SDK2
PLASMALOGEN BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%75896,0.6879158098463771,0.96731875442989,0.5340838034319,0.872945304569076,5686,2,GNPAT|AGPS
ACTIVATED NTRK2 SIGNALS THROUGH FYN%REACTOME DATABASE ID RELEASE 66%9032500,0.360612547340688,0.848418604328854,-0.46172552038052095,-1.0618722390352702,2189,4,DOCK3|RAC1
FRUCTOSE METABOLISM%REACTOME DATABASE ID RELEASE 66%5652084,0.0332903780068729,0.374031173793637,0.642927159938126,1.5811857165475902,309,6,AKR1B1|ALDH1A1|TKFC
BH3-ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI-APOPTOTIC BCL-2 MEMBERS%REACTOME DATABASE ID RELEASE 66%111453,0.000195236235845373,0.0784645998831315,-0.737080242717922,-2.37936107483781,0,9,BBC3|BCL2L1|BID|BCL2|STAT3|BMF|BCL2L11|PMAIP1
PLASMA LIPOPROTEIN REMODELING%REACTOME%R-HSA-8963899.1,0.664799072642968,0.964618776001639,0.248080199206295,0.8411437064372359,6881,15,LPL|CETP|APOE|LMF2|LMF1|LCAT|APOC2|GPIHBP1|MBTPS1|MBTPS2
INTEGRATION OF PROVIRUS%REACTOME DATABASE ID RELEASE 66%162592,0.971457489878543,1.0,0.18231465136804897,0.520263722321281,9597,9,LIG4|XRCC4|PSIP1|PPIA|XRCC5|HMGA1|XRCC6|KPNA1|BANF1
SUMOYLATION OF DNA METHYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4655427,0.532903225806452,0.9265056012720759,-0.23429907034258898,-0.934405624565277,2477,15,RING1|BMI1|CBX4|CBX8|UBE2I|SUMO1|PHC3
EICOSANOIDS%REACTOME%R-HSA-211979.1,0.64974016332591,0.963755998259649,-0.5022332506203471,-0.8590430772937259,4375,2,PTGIS|TBXAS1
PLASMA LIPOPROTEIN CLEARANCE%REACTOME%R-HSA-8964043.1,0.5751633986928101,0.941940408834489,0.23548107352318104,0.915833763105153,6247,23,VLDLR|AP2A2|LSR|SOAT1|LDLRAP1|APOE|APOC1|CLTC|LDLR
MUSCARINIC ACETYLCHOLINE RECEPTORS%REACTOME%R-HSA-390648.1,0.29540589494483804,0.800447413278835,-0.489494292174489,-1.12573461306177,1793,4,CHRM2|CHRM3|CHRM4|CHRM1
BIOSYNTHESIS OF DPAN-3-DERIVED PROTECTINS AND RESOLVINS%REACTOME%R-HSA-9026286.1,0.10565338276181697,0.578674426247723,-0.9454124393471551,-1.26470704549831,797,1,ALOX5
STRIATED MUSCLE CONTRACTION%REACTOME%R-HSA-390522.1,0.36057465850212,0.848418604328854,-0.234093590257034,-1.06320532913405,1530,21,VIM|TNNT2|TMOD1|MYL4|DES|TPM3
TAT-MEDIATED ELONGATION OF THE HIV-1 TRANSCRIPT%REACTOME%R-HSA-167246.2,0.0733917245545153,0.520754220371606,-0.24198973744596203,-1.39339439531197,242,42,SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D
P75 NTR RECEPTOR-MEDIATED SIGNALLING%REACTOME DATABASE ID RELEASE 66%193704,0.000442282176028306,0.0784645998831315,-0.284532517846862,-2.0300121428516102,0,89,KALRN|IRAK1|GNA13|NFKBIA|RTN4|ABR|SQSTM1|FGD4|VAV1|TRIO|RHOA|CASP3|NCSTN|PSEN2|RIPK2|VAV3|ARHGEF2|VAV2|AKAP13|NET1|ADAM17|ARHGEF37|UBA52|RASGRF2|YWHAE|ARHGEF33|RAC1|MYD88|UBC|AATF|BCL2L11|LINGO1|UBB
SEMA3A-PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION%REACTOME%R-HSA-399955.1,0.134177215189873,0.6210477531468679,-0.34278869290476,-1.3280541453708798,635,14,FYN|NRP1|PLXNA1|PLXNA4|SEMA3A|RAC1
TYSND1 CLEAVES PEROXISOMAL PROTEINS%REACTOME DATABASE ID RELEASE 66%9033500,0.9098567818028641,1.0,0.239043261707796,0.622179387208198,8639,7,HSD17B4
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-264642.2,0.590723055934516,0.945418171231938,0.269763936753074,0.893811753474743,6061,14,UNC13B|PPFIA2|BZRAP1|PPFIA3|SYT1|RAB3A|STX1A|PPFIA4|RIMS1
RESOLUTION OF SISTER CHROMATID COHESION%REACTOME DATABASE ID RELEASE 66%2500257,0.00892651019622932,0.207969158127386,0.287200918195604,1.6084058716876901,115,103,CLIP1|CCNB1|CDK1|ZWINT|CENPF|KIF2C|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC20|NDC80|ITGB3BP|CENPA|CENPE|BUB1B|AURKB|ERCC6L|NUP160|DSN1|INCENP|CDCA8|CENPQ|CENPI|NUP85|CCNB2|SPDL1|CDCA5|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|CENPM|DYNC1H1|SPC25|SGOL1|PDS5B|SPC24|SMC3|PPP2R1A
NUCLEOTIDE METABOLISM%REACTOME DATABASE ID RELEASE 66%15869,0.9923208191126279,1.0,-0.0806699448515894,-0.563827317336796,2325,83,NT5C2|AMPD2|UCK2|AK5|ADPRM|NT5C1A|DGUOK|ADA|DCTPP1|APRT|ADSL|ENTPD6|TAF9|AK9|DHODH|NUDT15|TXN|ENTPD1|LHPP|ENTPD4|CMPK1|GMPS|RRM2B|ATIC|PNP|CDA|DCTD|HPRT1|UPP1|AK7|ENTPD3|ITPA|NT5E|AK4
APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS%REACTOME DATABASE ID RELEASE 66%351906,0.387121377206363,0.859991269020751,0.46211248851537706,1.0651007817788,3552,5,OCLN
CLEARANCE OF SERATONIN%REACTOME%R-HSA-380615.3,0.8911655530809208,0.997300970905927,-0.39228012131237894,-0.670974138325381,6001,2,MAOA|ALDH2
FORMATION OF THE EARLY ELONGATION COMPLEX%REACTOME DATABASE ID RELEASE 66%113418,0.218350122515655,0.7341474817293291,-0.22228685007464896,-1.18896133854626,801,33,NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|POLR2F|NCBP2|POLR2I|POLR2D
TOLL LIKE RECEPTOR 3 (TLR3) CASCADE%REACTOME%R-HSA-168164.3,0.0167952791647753,0.27621312636330103,-0.207825189614065,-1.4936294673922699,36,92,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|UBE2D1|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|TRAF3|NKIRAS1|UBE2V1|TANK|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|UBE2D3|MAPK3|TNIP2|TICAM1|UBC|MAP2K1|RPS6KA2|UBB
POTASSIUM CHANNELS%REACTOME%R-HSA-1296071.1,0.0188323917137476,0.286396032442422,0.318481112375924,1.6043572167790703,229,61,KCNK2|KCNN2|KCNK6|KCNH8|GNG8|KCNH3|KCNK3|HCN2|KCNQ1|KCNH1|GNB3|KCNC3|KCNC1|KCND1|KCNB2|HCN3|KCNJ11|KCNH2
NF-KB ACTIVATION THROUGH FADD RIP-1 PATHWAY MEDIATED BY CASPASE-8 AND -10%REACTOME DATABASE ID RELEASE 66%933543,0.5244610281923721,0.925993329275615,-0.256441379310345,-0.9342416684457729,2529,12,RIPK1|CHUK|IKBKG|DDX58|IFIH1|FADD|CASP10|CASP8|IKBKB|RNF135|MAVS|TRIM25
PROCESSING AND ACTIVATION OF SUMO%REACTOME DATABASE ID RELEASE 66%3215018,0.123325453112687,0.607607158836689,-0.40412455100906,-1.3672138454201699,625,10,UBE2I|SUMO1|SENP5|SUMO3
COENZYME A BIOSYNTHESIS%REACTOME%R-HSA-196783.3,0.8254410399257199,0.9876441563834109,-0.23135766422362902,-0.71916035525414,4444,8,PANK2|SLC25A16
SPERM MOTILITY AND TAXES%REACTOME DATABASE ID RELEASE 66%1300642,0.5980085677897421,0.949262093257606,0.480516741107797,0.91341177638211,5164,3,CATSPERG|CATSPER2
SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%REACTOME%R-HSA-1799339.1,0.103125,0.575034722222222,-0.164468670204312,-1.23582052445359,197,110,SSR4|RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPN2|RPL26L1|SPCS2|FAU|RPL37|RPL27A|SEC61A1|SEC11C|SSR3|RPL7A|SEC11A|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|TRAM1|RPL18|RPS27A|SRPRB|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPN1|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|SSR2|SRP68|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SPCS3|RPL29|SEC61G|RPL31|RPL17|SRPR|RPS14|RPS17|RPL32|DDOST|RPL18A|RPL11|SRP14|SPCS1|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|SRP72|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52|SSR1|SRP54
ABC TRANSPORTER DISORDERS%REACTOME DATABASE ID RELEASE 66%5619084,0.88251702354582,0.9961599252653379,0.138448157719559,0.6948403562725961,10756,60,PSMD11|PSMD13|PSMB9|PSMA4|DERL3|KCNJ11|PSMD3|PSMD1|PSMA1|PSMC3|ABCC8|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|ERLIN1|PSMB4
TRIGLYCERIDE CATABOLISM%REACTOME DATABASE ID RELEASE 66%163560,0.029198682766191,0.350886057103154,-0.409605926014295,-1.6774739316773601,132,16,ABHD5|MGLL|FABP4|PNPLA4|PPP1CB|CAV1|FABP3
SUMO IS CONJUGATED TO E1 (UBA2:SAE1)%REACTOME DATABASE ID RELEASE 66%3065676,0.355769230769231,0.843990005840027,-0.423690865131298,-1.07254529055925,2071,5,SUMO1|SUMO3
PKA-MEDIATED PHOSPHORYLATION OF KEY METABOLIC FACTORS%REACTOME DATABASE ID RELEASE 66%163358,0.5616926503340761,0.936738331587711,-0.537027846705266,-0.918557370417611,3782,2,PRKACB|PRKACA
INOSITOL PHOSPHATE METABOLISM%REACTOME DATABASE ID RELEASE 66%1483249,0.886741165810933,0.996643473105967,-0.123981911984379,-0.713896808610213,2935,42,PLCE1|IP6K1|NUDT4|INPP1|ITPK1|INPP5A|PLCD1|ITPKB|PLCB4|PLCB1
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION%REACTOME%R-HSA-389661.5,0.7779656921961831,0.9811398289380491,-0.16541434309334602,-0.777268165743732,3219,23,DLAT|BCKDHB|AMT|GCSH|ALDH4A1|PDHB|OGDH|LIAS
CLOSTRIDIUM NEUROTOXICITY%REACTOME%R-HSA-168799.1,0.0285657998423956,0.347919292482523,-0.501811230906255,-1.69770250525312,144,10,VAMP2|VAMP1|SYT2|SV2C|SNAP25
BETA OXIDATION OF MYRISTOYL-COA TO LAUROYL-COA%REACTOME DATABASE ID RELEASE 66%77285,0.867908552074513,0.993084774742015,0.4542045767852221,0.7423849030258051,7174,2,HADHB|HADHA
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D%REACTOME%R-HSA-75815.2,0.9467852946113821,1.0,0.126465167281328,0.607721914608088,11279,50,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|PSME2|RPS27A|CCND1|PSMD14|PSMD4|PSMB10|PSMD9|PSME1
RUNX1 INTERACTS WITH CO-FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN%REACTOME DATABASE ID RELEASE 66%8939243,0.49356103023516207,0.910654969509744,-0.176964876213296,-0.97346467508506,1762,36,RYBP|YAF2|RING1|BMI1|CBX4|CBX8|RUNX1|CSNK2A2|PHC3|SMARCC1|CBFB|CSNK2A1|PBRM1
COSTIMULATION BY THE CD28 FAMILY%REACTOME%R-HSA-388841.2,0.0112954465231204,0.22992267312754103,-0.25539132314846696,-1.6269693690203402,31,59,PPP2R5A|CD86|PIK3R2|THEM4|PTPN6|CD274|MAPKAP1|ICOSLG|MAP3K8|VAV1|PPP2R5C|HLA-DQB1|FYN|LYN|YES1|PPP2CA|PPP2CB|PRR5|PPP2R1B|CDC42|HLA-DQA2|HLA-DQB2|RAC1|PIK3R1|PAK2|TRIB3
"ACTIVATION OF THE MRNA UPON BINDING OF THE CAP-BINDING COMPLEX AND EIFS, AND SUBSEQUENT BINDING TO 43S%REACTOME DATABASE ID RELEASE 66%72662",0.00635368866925521,0.180127205513166,-0.265769874060154,-1.6930858847263799,17,59,EIF2S2|EIF4E|RPS16|EIF3H|RPS4X|EIF3D|EIF2S1|RPS28|EIF4A1|EIF3K|RPS9|RPS3|EIF4A2|EIF4G1|EIF4EBP1|EIF3G|EIF3B|EIF4H|EIF4B|EIF1AX|EIF3A|EIF3I|EIF2S3|PABPC1
REGULATION OF CYTOSKELETAL REMODELING AND CELL SPREADING BY IPP COMPLEX COMPONENTS%REACTOME DATABASE ID RELEASE 66%446388,0.7315655648383579,0.9726603499749559,-0.270389406267718,-0.788737894169747,4027,7,ACTN1|PARVB|PXN|LIMS1
ASSEMBLY OF THE ORC COMPLEX AT THE ORIGIN OF REPLICATION%REACTOME DATABASE ID RELEASE 66%68616,0.30723797250859103,0.810217844381334,0.464007980332437,1.1411600513755802,2860,6,ORC1|ORC6|ORC2|ORC5|ORC3|ORC4
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING%REACTOME%R-HSA-879415.1,0.78663706096084,0.9818102154363779,-0.21266268238685002,-0.748386474811185,3896,11,LGALS3|MAPK3
TOLL LIKE RECEPTOR 7 8 (TLR7 8) CASCADE%REACTOME%R-HSA-168181.1,0.0021486892995272898,0.116289031011345,-0.251211310282699,-1.7663412253760702,4,85,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|TICAM1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
LYSOSOME VESICLE BIOGENESIS%REACTOME%R-HSA-432720.1,0.94851923609189,1.0,-0.117802460453249,-0.633881709440107,3426,34,AP1M1|DNM2|AP4S1|ARRB1|VAMP2|CLTA|AP1S1|CLVS2
IKBKG DEFICIENCY CAUSES ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNODEFICIENCY (EDA-ID) (VIA TLR)%REACTOME DATABASE ID RELEASE 66%5603027,0.8529582030797729,0.991298302704726,0.378176607320555,0.71887394783054,7366,3,CHUK|IKBKG|IKBKB
REMOVAL OF THE FLAP INTERMEDIATE FROM THE C-STRAND%REACTOME DATABASE ID RELEASE 66%174437,0.138525085633689,0.626567367071584,0.45626063495012104,1.3465430093663,1374,10,DNA2|POLD1|FEN1|POLD3
BIOSYNTHESIS OF MARESIN-LIKE SPMS%REACTOME DATABASE ID RELEASE 66%9027307,0.181660298714832,0.6873049536419911,0.656336164111614,1.2476260040033,1568,3,CYP2C8|CYP2E1|CYP2D6
DEFECTIVE MMACHC CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLC%REACTOME%R-HSA-3359474.1,0.338938170263471,0.832687903476431,-0.8315505072783421,-1.11239046734866,2559,1,MMACHC
CHREBP ACTIVATES METABOLIC GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%163765,0.9688927943760981,1.0,-0.20335337267663103,-0.558191353816905,5512,6,ACACA|MLX|FASN|AGPAT1|ACACB|ACLY
ION HOMEOSTASIS%REACTOME%R-HSA-5578775.1,0.625926241376373,0.9543682073609309,0.19066245962221104,0.8839302364319039,7348,43,RYR2|ATP2B1|SLC8A3|ATP1B3|ATP2A1|KCNJ11|FXYD7|ATP2B3|DMPK|ATP2A2|TRPC1|TNNI3|SLC8A1
METABOLISM OF STEROID HORMONES%REACTOME DATABASE ID RELEASE 66%196071,0.0192450725176646,0.289864965388082,0.44785779478469395,1.6931411751202101,206,21,FDXR|CYP21A2|STAR|FDX1|AKR1B1|BZRAP1|HSD17B11|SRD5A3|HSD11B1
FGFR3 MUTANT RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%2033514,0.9621366849960721,1.0,-0.286655787492101,-0.5817594037977399,6123,3,FGF1|FGF2
LIPOPROTEIN METABOLISM%REACTOME DATABASE ID RELEASE 66%174824,0.683540003397316,0.9663740819756659,0.18088822462970303,0.8437261460859891,8047,44,LPL|VLDLR|ZDHHC8|AP2A2|LSR|SOAT1|CETP|LDLRAP1|APOE|LMF2|APOC1|LMF1|CLTC|LDLR
ALPHA-OXIDATION OF PHYTANATE%REACTOME DATABASE ID RELEASE 66%389599,0.528437568097625,0.9265056012720759,0.4124104881090879,0.9505450387414709,4849,5,SLC27A2|SLC25A17|PECR|HACL1|PHYH
FGFR4 MUTANT RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%1839128,0.0100671140939597,0.21965938934132698,0.9947617997353331,1.32149667147816,74,1,FGFR4
SODIUM CALCIUM EXCHANGERS%REACTOME DATABASE ID RELEASE 66%425561,0.373315080033698,0.852609194081082,0.41403088447552294,1.07763540435262,3544,7,SLC8A3|SLC24A1|SLC8A1|SLC8A2|SLC24A3|SLC8B1
SYNTHESIS OF ACTIVE UBIQUITIN: ROLES OF E1 AND E2 ENZYMES%REACTOME DATABASE ID RELEASE 66%8866652,0.05537974683544301,0.458062256682211,-0.28797762811708005,-1.4940371635726801,209,30,UBE2Q2|UBA52|UBE2L3|UBE2E1|UBC|UBE2K|UBB
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING%REACTOME%R-HSA-112308.3,0.606289808917197,0.9508825506493929,0.29052564426926397,0.8863271437250791,6091,11,CACNB4|CACNB2|CACFD1|CACNB1|CACNG4|CACNA1B|CACNA2D2|CACNB3
EPH-EPHRIN SIGNALING%REACTOME%R-HSA-2682334.1,0.000866926744690074,0.0849637591935908,-0.264653461885755,-1.87991295218083,1,87,ADAM10|FYN|RHOA|MMP2|NCSTN|LYN|PSEN2|MMP9|EFNA1|ARPC5|YES1|CLTA|LIMK1|VAV3|VAV2|ARPC4|CDC42|AP2S1|EPHA8|MYH11|MYH9|EPHA7|SDC2|EFNB1|RAC1|ACTR2|EPHB2|PAK2
RIP-MEDIATED NFKB ACTIVATION VIA ZBP1%REACTOME DATABASE ID RELEASE 66%1810476,0.474423710208562,0.9003511540468891,-0.23771132488812302,-0.973507767928137,2160,16,NFKBIB|TICAM1|MYD88
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST%REACTOME%R-HSA-6804114.2,0.905056661270355,1.0,0.17475354874584698,0.626876606534709,9503,18,CCNB1|CDK1|CDC25C|PRMT1|CARM1|AURKA
ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX%REACTOME%R-HSA-68867.4,0.3774629539163,0.85375124052253,0.20836566486232602,1.06657636501587,4635,66,PSMD11|PSMD13|PSMB9|PSMA4|E2F3|ORC1|PSMD3|E2F2|PSMD1|MCM6|CDC6|PSMA1|ORC6|PSMC3|MCM3|PSMA3|MCM2|PSMC6|PSMC1|E2F1|PSMD2|GMNN|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CDT1|PSME2|RPS27A|ORC5|ORC3|PSMD14|PSMD4|PSMB10|PSMD9
SIGNALING BY LEPTIN%REACTOME%R-HSA-2586552.2,0.687465181058496,0.966986590843215,-0.262917638659177,-0.8172624972473371,3701,8,STAT5A|STAT3
DISEASES OF CARBOHYDRATE METABOLISM%REACTOME DATABASE ID RELEASE 66%5663084,0.106989457243264,0.5822715745664481,-0.43401642509388394,-1.40104391334751,547,9,UBA52|UBC|UBB
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER%REACTOME DATABASE ID RELEASE 66%76061,0.992982456140351,1.0,0.111615908416282,0.45769535519932597,11036,28,BDP1|POLR3B|POLR3GL|BRF1|POLR3E|POLR2L|POLR3G|POLR2H|POLR3K|GTF3C5|GTF3C3|POLR3A|GTF3A|GTF3C1
SMAD2 SMAD3:SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION%REACTOME%R-HSA-2173796.1,0.46866702071162997,0.89605323680621,-0.187045141618224,-0.983583364590223,1764,31,SMAD2|SMAD7|UBA52|UBC|TFDP2|UBB
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL%REACTOME%R-HSA-1855204.3,0.315114068441065,0.8164430838831159,-0.23836692404321802,-1.1042920787538701,1325,22,SYNJ1|PLCD3|INPP5D|INPP5B|ITPKC|PLCE1|ITPK1|PLCD1|ITPKB|PLCB4|PLCB1
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193775,0.4847874269595,0.9064456896937672,0.332633909409075,0.9816886031422309,4811,10,SLC27A2|AMACR|AKR1C1
RAF MAP KINASE CASCADE%REACTOME%R-HSA-5673001.4,0.281279397930386,0.7892585111044429,-0.128214821715825,-1.07341158707839,298,195,RET|PPP2R5C|PSME3|FGF7|FYN|IL3RA|FGF2|HGF|HBEGF|ARRB1|IL17RD|CAMK2A|CSF2RB|PPP2CA|PPP2CB|RAP1A|YWHAB|PPP2R1B|KRAS|SHC1|UBA52|RASA3|RASGRF2|MAPK3|RASGRP3|PSMD6|FGF10|PEA15|VWF|DUSP10|SPRED3|MET|MAP3K11|UBC|MAP2K1|PTPRA|DLG1|SPRED2|PSMF1|GFRA2|UBB
ANTIGEN PROCESSING: UBIQUITINATION & PROTEASOME DEGRADATION%REACTOME%R-HSA-983168.2,0.964750052144893,1.0,0.105075820284553,0.6815356355884039,13875,284,SH3RF1|HACE1|UBE3D|UBR4|SPSB4|GLMN|SIAH2|TRIM9|HERC4|CDC34|BTRC|PSMD11|LMO7|ANAPC5|RNF34|HECTD2|KLHL42|UBE2Z|PSMD13|PSMB9|UBA3|KLHL3|ASB2|PSMA4|THOP1|PSMD3|RNF182|DZIP3|FBXL19|RNF126|GAN|LRR1|KLHL20|CDC23|CDC20|RNF111|MIB2|ANAPC7|FBXL15|PSMD1|KLHL25|HUWE1|RNF7|PSMA1|UBA7|TRIM4|TRIM37|FBXL8|PSMC3|RNF14|KLHL22|UBE3B|FBXW5|CCNF|HECTD1|HERC2|GPR75-ASB3|KEAP1|TRAIP|PSMA3|UBE2C|FBXO9|CUL7|RNF123|SOCS1|PSMC6|UNKL|PSMC1|ANAPC10|KLHL9|PSMD2|UBE2B|UBE2H|UBR2|BTBD6|RBX1|PSMA5|FBXL7|HERC1|UFL1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TRIM21|ASB1|CDC16|TRIM41|SHFM1|UBE2O|ANAPC2|PSMA2|PSMB6|CUL2|PSMB3|FBXO44|UBA6|FBXO11|UBA5|UBA1|PSMA7|UBAC1|SMURF2|UBE2E3|TRIM69|KBTBD7|PSMB4
SMAC-MEDIATED DISSOCIATION OF IAP:CASPASE COMPLEXES%REACTOME DATABASE ID RELEASE 66%111464,0.8720854216604929,0.9934031064448321,0.290766964878695,0.670174750313943,8003,5,CASP9|XIAP|CASP7|DIABLO
CARGO CONCENTRATION IN THE ER%REACTOME DATABASE ID RELEASE 66%5694530,0.7442195231668921,0.9749763305090959,0.193064492308519,0.791685725066726,8271,28,GRIA1|CNIH3|PREB|MIA3|CNIH2|SEC24D|CTSC|SEC24C|LMAN2L|SEC22B|SAR1B|SEC24A|F8|CTAGE5
DISPLACEMENT OF DNA GLYCOSYLASE BY APEX1%REACTOME DATABASE ID RELEASE 66%110357,0.6777590564448189,0.9647315640607691,0.31569701627019,0.821693005371326,6435,7,TDG|MBD4|MPG|NTHL1
RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES (TREGS)%REACTOME%R-HSA-8877330.1,0.0706501997820559,0.512051623015592,-0.515479493671537,-1.5036765527848102,388,7,RUNX1|TNFRSF18|NFATC2|CBFB
ACTIVATION OF RAS IN B CELLS%REACTOME%R-HSA-1169092.1,0.32760989010989006,0.828303707528737,-0.43318846626428,-1.09658783715424,1907,5,NRAS|KRAS|RASGRP3
CELLULAR RESPONSES TO STRESS%REACTOME DATABASE ID RELEASE 66%2262752,0.622828784119107,0.9536478716552259,-0.104175141270738,-0.955307654029797,250,355,CAMK2A|PHC3|BAG5|SOD2|MAP4K4|HSBP1|ST13|ETS1|HSPA12A|MAP2K3|HSPA4L|VHL|BAG3|TCEB1|CXCL8|HSF1|NR3C1|JUN|UBA52|ID1|STAT3|PRDX1|DNAJA2|DYNLL2|TP53|UBE2E1|YWHAE|UBE2D3|DNAJB6|HSPA6|MAPK3|CDKN1A|HIST2H4B|FKBP4|PSMD6|HIST1H2BC|H3F3B|DNAJA4|BAG1|DYNC1LI1|HSPB8|UBC|HIST2H2AC|ETS2|HSP90AB1|EPAS1|HIST1H2BD|TFDP2|PSMF1|RPS6KA2|UBB|EGLN3
MITOTIC G2-G2 M PHASES%REACTOME%R-HSA-453274.2,0.0081759641125823,0.20119188955196998,0.25152907975055,1.5392292757309898,112,179,AKAP9|CCNA1|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDK1|BTRC|LIN52|PSMD11|BORA|CENPF|MZT2B|PSMD13|WEE1|PSMB9|CKAP5|CEP290|NME7|PSMA4|E2F3|CEP131|CEP152|CDC25C|LIN9|PSMD3|HMMR|TUBGCP3|NEK2|PKMYT1|HAUS5|CDK5RAP2|PRKAR2B|PSMD1|GTSE1|PPP2R3B|PSMA1|CEP72|TUBG2|CCNB2|TUBGCP6|PSMC3|HAUS8|CEP164|CEP78|CDK7|CEP192|FGFR1OP|CNTRL|PLK1|TUBGCP2|AJUBA|SFI1|CDK11A|PPP1R12A|LIN37|AURKA|PSMA3|CEP41|CEP57|MZT2A|DYNC1H1|PSMC6|NINL|PSMC1|E2F1|TUBB4A|PSMD2|CEP135|TUBGCP4|RBX1|PSMA5|PCM1|FBXL7|TPX2|MYBL2|FOXM1|NEDD1|PSMC2|PPP2R1A|PSMC5|CDK2|SSNA1|NDE1|SHFM1|CEP250|PSMA2|PSMB6|PSMB3
REGULATION OF APOPTOSIS%REACTOME DATABASE ID RELEASE 66%169911,0.704515706806283,0.968941691852291,-0.140898647853445,-0.858608302351515,2152,51,PSMD6|UBC|PSMF1|PAK2|UBB
SYNTHESIS OF EPOXY (EET) AND DIHYDROXYEICOSATRIENOIC ACIDS (DHET)%REACTOME%R-HSA-2142670.1,0.335648952182471,0.8311444145897029,0.5808307978173051,1.1040982455442199,2898,3,CYP2C8|EPHX2
NFG AND PRONGF BINDS TO P75NTR%REACTOME%R-HSA-205017.1,0.660336276763034,0.964586948392425,0.544086021505376,0.88929365523317,5458,2,NGF|NGFR
REGULATION OF TLR BY ENDOGENOUS LIGAND%REACTOME DATABASE ID RELEASE 66%5686938,0.76812450748621,0.9792236089291529,-0.225708792106795,-0.763606627785789,3898,10,TLR4|HMGB1|TLR2|CD14|LY96|S100A9|TLR1|S100A8|CD36
MET RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%6806942,0.0896291208791209,0.559264258791054,-0.570754848424999,-1.44482799871645,521,5,HGF|SPINT1|MET
RHO GTPASES ACTIVATE PKNS%REACTOME%R-HSA-5625740.1,0.11647622558053801,0.5959669927208161,-0.19352961659727697,-1.2672931963987,315,65,RHOA|HIST2H4A|HIST2H2AA4|YWHAH|RHOC|YWHAQ|YWHAB|YWHAZ|YWHAE|HIST2H4B|MYH11|MYH9|HIST1H2BC|PPP1CB|H3F3B|RAC1|HIST2H2AC|HIST1H2BD
INTERLEUKIN-2 FAMILY SIGNALING%REACTOME%R-HSA-451927.5,0.0795072788353864,0.533892166059414,-0.253570724350094,-1.3948651736575601,283,36,INPP5D|HAVCR2|PIK3CD|PIK3R2|PTPN6|IL21R|LGALS9|PTK2B|GRB2|IL3RA|CSF2RB|STAT5A|SHC1|STAT3|GAB2|PIK3R1
DIGESTION AND ABSORPTION%REACTOME DATABASE ID RELEASE 66%8963743,0.215141673199686,0.732094216765764,0.576905776850766,1.2225184500578898,1920,4,AMY2B|PIR
EARLY PHASE OF HIV LIFE CYCLE%REACTOME%R-HSA-162594.2,0.166049503020854,0.6682860217990739,0.394344028388962,1.30658431119079,1703,14,CXCR4|LIG4|CCR5|FEN1|XRCC4|LIG1
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL%REACTOME DATABASE ID RELEASE 66%6790901,0.00035549235691432595,0.0784645998831315,-0.333535192934172,-2.1334558294805603,0,60,DDX49|DCAF13|WDR3|NOP58|FBL|UTP11L|UTP15|THUMPD1|TSR3|UTP3|RRP36|RPS9|DHX37|GAR1|DDX47|NHP2L1|TRMT112|WBSCR22|PWP2|TBL3|RCL1|FCF1|UTP14A|WDR43|NHP2|RRP7A|CIRH1A|IMP4|PNO1|EMG1|RRP9|NOP14|NOP56
REGULATION OF ORNITHINE DECARBOXYLASE (ODC)%REACTOME DATABASE ID RELEASE 66%350562,0.7453933529659241,0.9749763305090959,0.168075820178472,0.8039072800243291,8858,49,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|OAZ3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
"DEFECTIVE EXT1 CAUSES EXOSTOSES 1, TRPS2 AND CHDS%REACTOME%R-HSA-3656253.3",0.4689703808180539,0.896113819860135,0.33689287640795296,0.9942579150665172,4654,10,GPC2|GPC6|GPC1|GPC3|AGRN|SDC3
"PI5P, PP2A AND IER3 REGULATE PI3K AKT SIGNALING%REACTOME%R-HSA-6811558.2",0.14359733530718,0.6334904564746021,-0.18554228170846104,-1.22521456008921,387,67,PIP5K1A|TRAF6|PIK3CD|PPP2R5A|CD86|PIK3R2|RHOG|IRAK1|CD19|IRAK4|VAV1|PPP2R5C|FGF7|FYN|FGF2|HGF|HBEGF|PIP4K2A|PPP2CA|PPP2CB|PPP2R1B|MAPK3|FGF10|RAC1|MET|MYD88|PIK3R1
REACTIONS SPECIFIC TO THE HYBRID N-GLYCAN SYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%975574,0.9582947173308621,1.0,-0.51896779885311,-0.694239047721342,7237,1,MGAT3
CA-DEPENDENT EVENTS%REACTOME%R-HSA-111996.1,0.7858565737051791,0.981487311948134,-0.15774334530209,-0.77456608934181,3155,26,PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2
POLYMERASE SWITCHING ON THE C-STRAND OF THE TELOMERE%REACTOME%R-HSA-174411.2,0.24975638277139,0.7613646381106121,0.363290600628611,1.2036946549529899,2562,14,RFC4|POLD1|POLD3|POLA2|PRIM2|RFC3|RFC5
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION%REACTOME DATABASE ID RELEASE 66%8936459,0.668231485228652,0.964618776001639,0.16748971935102802,0.866115026634473,8255,69,HIST1H3E|HIST1H2BJ|HIST3H2BB|NR4A3|HIST2H3C|HIST2H3A|PRKCQ|KMT2B|HIST1H4I|TNRC6A|H2AFX|H3F3A|ITGA2B|H2AFZ|HIST1H2BF|TNRC6C|PRMT1|HIST1H2BK|HIST1H2AC|KMT2D|WDR5|HIST1H3H|HIST1H2BN|THBS1|SIN3B|HIST1H2BG|HIST2H2BE|HIST1H2BH
SIGNALING BY ERYTHROPOIETIN%REACTOME DATABASE ID RELEASE 66%9006335,0.061074144486691996,0.48182086119899,-0.32142637723731105,-1.48908496306878,256,22,PIK3CD|CRKL|PIK3R5|NRAS|VAV1|LYN|KRAS|STAT5A|RAPGEF1|SHC1|PIK3R1
ARACHIDONATE PRODUCTION FROM DAG%REACTOME%R-HSA-426048.2,0.651957417582418,0.9640743070248079,-0.332285462166336,-0.841158582584417,3796,5,DAGLA|DAGLB|ABHD12|ABHD6|MGLL
MYD88 DEFICIENCY (TLR5)%REACTOME%R-HSA-5602680.1,0.27720861172977,0.7884684708511421,-0.6930996751547049,-1.18550987430791,1866,2,MYD88
VEGF BINDS TO VEGFR LEADING TO RECEPTOR DIMERIZATION%REACTOME DATABASE ID RELEASE 66%195399,0.291922005571031,0.8000726114371469,-0.363953248307694,-1.1313251636905501,1571,8,VEGFA|KDR|FLT1|PGF
"SYNTHESIS AND PROCESSING OF GAG, GAGPOL POLYPROTEINS%REACTOME DATABASE ID RELEASE 66%174495",0.39831223628692003,0.8638522656500329,-0.265831116369313,-1.029900120308,1887,14,UBA52|UBC|UBB
DISEASES ASSOCIATED WITH THE TLR SIGNALING CASCADE%REACTOME DATABASE ID RELEASE 66%5602358,0.0610036832412523,0.48170831577441997,-0.335486007617155,-1.49690685930156,264,20,BTK|CHUK|TLR4|IKBKG|TLR5|TLR2|CD14|NFKB2|TIRAP|NFKB1|IKBKB|LY96|RELA|TLR1|NFKBIA|IRAK4|TRAF3|TICAM1|MYD88|CD36
"DEFECTIVE B4GALT7 CAUSES EDS, PROGEROID TYPE%REACTOME%R-HSA-3560783.1",0.5977792667751509,0.9492590312650558,0.25808748470964604,0.8947193187696441,6244,16,VCAN|GPC2|GPC6|GPC1|GPC3|AGRN|BGN|SDC3|DCN
MEIOTIC RECOMBINATION%REACTOME DATABASE ID RELEASE 66%912446,0.26929107864983104,0.784543299601953,0.23236670119321104,1.15362258313951,3262,57,HIST1H3E|HIST1H2BJ|HIST3H2BB|MLH3|BLM|HIST2H3C|HIST2H3A|HIST1H4I|RAD51C|RAD51|MND1|H2AFX|H3F3A|H2AFZ|PSMC3IP|HIST1H2BF|HIST1H2BK|BRCA2|HIST1H2AC|HIST1H3H|HIST1H2BN|CDK2|ATM|HIST1H2BG|HIST2H2BE|BRCA1|HIST1H2BH
NEGATIVE REGULATION OF ACTIVITY OF TFAP2 (AP-2) FAMILY TRANSCRIPTION FACTORS%REACTOME%R-HSA-8866904.2,0.5982564475118051,0.949262093257606,-0.30178084434869396,-0.880308111763383,3293,7,UBE2I|SUMO1|WWOX
TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION%REACTOME DATABASE ID RELEASE 66%975138,0.00255645504899872,0.12621943783915598,-0.25406373124738296,-1.78410084964044,5,84,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|TICAM1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
MITOTIC PROPHASE%REACTOME%R-HSA-68875.4,0.0311996933691069,0.361580211256669,0.25971212759157003,1.46467474119215,406,107,HIST1H3E|HIST1H2BJ|HIST3H2BB|CCNB1|TPR|CDK1|NCAPD3|NUP133|HIST2H3C|HIST2H3A|NUMA1|PRKCB|SMC2|NUP205|RB1|LEMD3|HIST1H4I|NUP188|LMNB1|NUP160|NCAPH2|H2AFX|NUP85|CCNB2|H3F3A|PPP2R2D|USO1|H2AFZ|NUPL2|SETD8|HIST1H2BF|NDC1|PLK1|HIST1H2BK|NUP107|NUP35|VRK1|CNEP1R1|NUP210|SMC4|HIST1H2AC|POM121|HIST1H3H|NUP54|NEK9|HIST1H2BN|NCAPG2|LEMD2|PPP2R1A|HIST1H2BG|NUP37|HIST2H2BE|HIST1H2BH|AAAS|MASTL
GPCR DOWNSTREAM SIGNALLING%REACTOME DATABASE ID RELEASE 66%388396,0.00662251655629139,0.18239572673498103,-0.14740857626824402,-1.3902662386897502,1,413,KALRN|GNA13|ADCY7|GNG4|PPP3R1|OXER1|DGKI|NMB|CX3CL1|MAPK7|ADRA2C|PRKCD|GNAZ|DGKD|LPAR1|ABR|C5AR1|HSD17B6|GNRH2|HCRT|CXCL16|NRAS|PDE7B|ARRB2|RGS5|FGD4|RGS4|PTGFR|VAV1|CRHR1|CCR10|TRIO|PPEF1|GNAQ|CALCRL|GNAI2|RHOA|ADRA1B|PSAP|MGLL|DGKQ|GNAL|PDE8A|GNA15|RDH10|ADCYAP1R1|P2RY14|HBEGF|PDE6B|ARRB1|APLNR|HTR1B|VIP|PPP2CA|PRKAR2A|GCGR|PPP2CB|RHOC|VIPR1|CAMK4|PNOC|CRH|VAV3|ARHGEF2|VAV2|PPP2R1B|RAMP2|PDE4B|AKAP13|GRM2|GNB5|EDNRA|GNGT1|NET1|CXCL8|HRH3|ADRB2|GIPR|KRAS|ARHGEF37|PRKCA|DGKG|MC4R|RGS12|ADM2|ACKR3|PRKAR1B|CALCB|RASGRF2|ADCY2|ADCYAP1|GUCA1A|DRD2|MAPK3|PDE10A|GNA12|MCHR1|ADRA2A|TAC3|DGKB|BDKRB2|ARHGEF33|SDC2|GNAS|S1PR1|GPR4|PLCB4|CHRM1|PLCB1|NPB|ADM|BDKRB1|PIK3R1|PDE3A|PDE4D|HRH1|GRM8|GAL|DGKK|RPS6KA2|TRH|RAMP1|ADORA2B
INSULIN EFFECTS INCREASED SYNTHESIS OF XYLULOSE-5-PHOSPHATE%REACTOME DATABASE ID RELEASE 66%163754,0.421083890126206,0.8727872721376851,-0.602540700374069,-1.03061359797409,2835,2,TKT
REGULATION OF PTEN MRNA TRANSLATION%REACTOME DATABASE ID RELEASE 66%8943723,0.9336196798125731,1.0,-0.19152691968226002,-0.6182660598731511,4781,9,TNRC6A|TNRC6C|AGO4|AGO3|TNRC6B|PTEN|AGO1|MOV10|AGO2
CARDIAC CONDUCTION%REACTOME%R-HSA-5576891.2,0.0645934865011217,0.495456803258629,0.249647596462763,1.3856349632626497,834,98,KCNK2|RYR2|SCN1A|KCNK6|AKAP9|CACNB4|CACNB2|NPR2|KCNK3|ATP2B1|FGF12|KCNQ1|KCNIP4|SLC8A3|ATP1B3|KCNIP1|KCND1|FGF13|ATP2A1|FGF11|CACNA2D1|KCNJ11|KCNH2|CACNA1D|FXYD7|ATP2B3
INFLUENZA VIRUS INDUCED APOPTOSIS%REACTOME DATABASE ID RELEASE 66%168277,0.311655530809206,0.8143712300420921,-0.673614557485525,-1.15218162409093,2098,2,TGFB1|SLC25A6
HH MUTANTS THAT DON'T UNDERGO AUTOCATALYTIC PROCESSING ARE DEGRADED BY ERAD%REACTOME%R-HSA-5362768.1,0.936677220463256,1.0,0.127608848649871,0.622389930740058,11241,53,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|SYVN1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|PSME2|RPS27A|SEL1L|PSMD14|PSMD4|PSMB10|PSMD9|PSME1
NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY%REACTOME DATABASE ID RELEASE 66%168333,0.0345636675390308,0.379078740472774,0.38936628331046796,1.58297320937448,382,27,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
TRANSCRIPTIONAL ACTIVATION OF P53 RESPONSIVE GENES%REACTOME%R-HSA-69560.2,0.0899061419397333,0.559960743386206,-0.6383937427521551,-1.46817224320559,545,4,ZNF385A|TP53|CDKN1A
LIPID PARTICLE ORGANIZATION%REACTOME DATABASE ID RELEASE 66%8964572,0.668047933699183,0.964618776001639,0.4042750473924989,0.8566974437893431,5964,4,FITM1|HSD17B13|FITM2
FORMATION OF ANNULAR GAP JUNCTIONS%REACTOME%R-HSA-196025.2,0.330971659919028,0.8293509737209019,0.3919571395429529,1.11851175360202,3269,9,CLTB|GJA1|CLTC|DNM1|DAB2|CLTCL1|AP2M1
"DEFECTIVE POMT2 CAUSES MDDGA2, MDDGB2 AND MDDGC2%REACTOME%R-HSA-5083629.1",0.67840593141798,0.9647315640607691,-0.655877812086458,-0.8773877467749,5123,1,DAG1
INTERLEUKIN-17 SIGNALING%REACTOME%R-HSA-448424.5,0.0106617647058824,0.225216180222089,-0.24088642736559598,-1.58479371956218,28,66,TRAF6|MAPKAPK3|RPS6KA3|UBE2N|IL17RA|DUSP4|DUSP7|NOD1|IRAK1|MAPK7|MAP3K8|IRAK2|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|MAPK3|TNIP2|UBC|MAP2K1|RPS6KA2|UBB
ACTIVATION OF PKB%REACTOME%R-HSA-165158.3,0.579614687963115,0.942746898746279,-0.386494753402969,-0.8888571912446329,3519,4,TRIB3
MGMT-MEDIATED DNA DAMAGE REVERSAL%REACTOME%R-HSA-5657655.1,0.8391946308724829,0.989395884107905,0.580943978826643,0.7717581581228241,6251,1,MGMT
SYNTHESIS OF DOLICHYL-PHOSPHATE-GLUCOSE%REACTOME DATABASE ID RELEASE 66%480985,0.17962985363493397,0.68489956912038,0.746346843121037,1.21988341173416,1484,2,NUDT14|ALG5
FRS-MEDIATED FGFR2 SIGNALING%REACTOME%R-HSA-5654700.3,0.0943200663349917,0.5630268609168221,-0.39020363833744504,-1.4215509957650603,454,12,FGF1|FRS2|NRAS|FGF7|FGF2|KRAS|FGF10
SUMOYLATION OF TRANSCRIPTION FACTORS%REACTOME%R-HSA-3232118.6,0.8068344979419929,0.984682960940884,0.20878996712293302,0.7238181942852842,8428,16,PIAS1|MTA1|CDKN2A|SUMO2|PIAS4
GLUCONEOGENESIS%REACTOME DATABASE ID RELEASE 66%70263,0.0014929086837521801,0.0977235601249795,-0.432678876023201,-2.09904265931393,5,25,GPI|FBP1|ENO1|GAPDH|PGK1|TPI1|G6PC3|ALDOA|SLC25A13|PC|PGAM2
LEADING STRAND SYNTHESIS%REACTOME DATABASE ID RELEASE 66%69109,0.24975638277139,0.7613646381106121,0.363290600628611,1.2036946549529899,2562,14,RFC4|POLD1|POLD3|POLA2|PRIM2|RFC3|RFC5
ERYTHROPOIETIN ACTIVATES RAS%REACTOME DATABASE ID RELEASE 66%9027284,0.110903814262023,0.584830174998513,-0.37897241840752005,-1.3806345349574,534,12,CRKL|NRAS|VAV1|LYN|KRAS|RAPGEF1|SHC1
THE PROTON BUFFERING MODEL%REACTOME%R-HSA-167827.2,0.9685295105834921,1.0,0.262452902721038,0.556162771673397,8647,4,UCP3|SLC25A27|SLC25A14|UCP2
PHASE 1 - INACTIVATION OF FAST NA+ CHANNELS%REACTOME%R-HSA-5576894.2,0.0548754295532646,0.45690899388215994,0.614527604655011,1.51134114632554,510,6,KCNIP4|KCNIP1|KCND1|KCND2|KCNIP3|KCNIP2
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE%REACTOME DATABASE ID RELEASE 66%4641262,0.228768171384851,0.7427229339942198,-0.23628311844543398,-1.1774453391208701,896,27,CSNK1A1|AMER1|PPP2R5A|LRP5|FZD1|FRAT1|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B|CAV1
APC TRUNCATION MUTANTS ARE NOT K63 POLYUBIQUITINATED%REACTOME DATABASE ID RELEASE 66%5467333,0.32805369127516804,0.828303707528737,0.8401521835024258,1.11610469393674,2443,1,APC
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL (GPI)%REACTOME DATABASE ID RELEASE 66%162710,0.715768551236749,0.971081608033886,-0.19385916407942103,-0.8157370652832231,3240,17,PIGA|PIGG|PIGZ|PIGY|DPM2|PIGX
STABILIZATION OF P53%REACTOME%R-HSA-69541.4,0.879399070385126,0.9956508825790341,0.140849430965281,0.6924555457743471,10594,55,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDKN2A|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|ATM|SHFM1|PSMA2|PSMB6|PSMB3|MDM2|PSMA7|PSMB4
GRB2 EVENTS IN EGFR SIGNALING%REACTOME%R-HSA-179812.2,0.3928571428571429,0.8621064456029929,-0.408496802558507,-1.03408253009388,2287,5,NRAS|KRAS
TIE2 SIGNALING%REACTOME DATABASE ID RELEASE 66%210993,0.0489451476793249,0.4351668564421479,-0.40407307237146994,-1.56548605570481,231,14,KRAS|SHC1|PIK3R1|ANGPT2
UB-SPECIFIC PROCESSING PROTEASES%REACTOME%R-HSA-5689880.2,0.918637448470384,1.0,0.1169735893044,0.715270235772537,12701,178,HIST1H2BJ|HIST3H2BB|SIAH2|CCNA1|KAT2A|RCE1|IDE|PSMD11|PSMD13|PSMB9|WDR20|PSMA4|USP47|DDB2|USP44|RHOT1|PSMD3|TRRAP|MAP3K7|USP13|CDC20|RNF146|HIST1H2AK|PSMD1|PSMA1|PSMC3|TNKS2|HIST1H2BF|BIRC2|KEAP1|RIPK1|HIST1H2BK|PSMA3|CLSPN|RNF123|HIST1H2AC|PSMC6|PSMC1|USP48|PSMD2|TRAF2|VDAC3|STAM2|PSMA5|HIST1H2BN|SUDS3|HIST3H2A|PSMC2|GATA3|PSMC5|SKP2|HIST1H2BG|HIST2H2BE|SHFM1|HGS|USP34|HIST1H2BH|PSMA2|USP49|PTRH2|PSMB6|PSMB3|TAB1|USP24|MDM2|USP21|PSMA7|USP30|SMURF2|PSMB4|BIRC3|USP33
NOSIP MEDIATED ENOS TRAFFICKING%REACTOME%R-HSA-203754.1,0.0258351893095768,0.335048214687472,-0.8961124896608771,-1.53275242084984,173,2,NOSIP|NOS3
MACROAUTOPHAGY%REACTOME DATABASE ID RELEASE 66%1632852,0.00364564345607,0.143595610377104,-0.26904701931625197,-1.7528590661538797,9,64,PIK3C3|RRAGD|PRKAA1|PRKAG1|RRAGC|RB1CC1|ATG13|ATG9B|MAP1LC3A|ATG101|ATG3|ATG7|LAMTOR5|BECN1|DYNLL2|GABARAPL1|GABARAP|CHMP4B|WIPI2|MAP1LC3B|MTMR14|GABARAPL2
COX REACTIONS%REACTOME%R-HSA-140180.1,0.32808155699721997,0.828303707528737,-0.8377260696956329,-1.12065170548559,2477,1,PTGS1
REGULATION OF LIPID METABOLISM BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARALPHA)%REACTOME%R-HSA-400206.2,0.6274237157203549,0.955121257104955,0.16208329819626002,0.9042484323296229,8121,101,ALAS1|ARNTL|CDK8|MED19|NFYB|NPAS2|SMARCD3|ABCB4|TIAM2|NRF1|ACADM|ME1|RORA|MED12|ARNT2|FADS1|MED1|MED21|CLOCK|HDAC3|MED17|MED24|SREBF2|FHL2|THRAP3|CARM1|RXRB|CCNC|ESRRA|MED7|GRHL1|MED23|TGS1|MED30|SP1|MED11|MED22|CHD9|GLIPR1|MED14|TXNRD1|FAM120B|G0S2
MRNA EDITING: A TO I CONVERSION%REACTOME DATABASE ID RELEASE 66%75064,0.39272457312546405,0.8621064456029929,-0.6185277088502901,-1.05795851976325,2644,2,ADAR|ADARB1
EXTRINSIC PATHWAY OF FIBRIN CLOT FORMATION%REACTOME DATABASE ID RELEASE 66%140834,0.684149588977654,0.966495577318169,0.45081063196206006,0.85694358786145,5908,3,F3|F10|TFPI
EPIGENETIC REGULATION OF GENE EXPRESSION%REACTOME%R-HSA-212165.1,0.529695144900264,0.9265056012720759,0.167443192127288,0.965424959418935,7036,121,GTF2H2|RBBP7|HIST1H3E|HIST1H2BJ|SIRT1|HIST3H2BB|MBD3|TDG|MTA2|TAF1D|RRP8|KAT2A|MTF2|MTA1|HIST2H3C|HIST2H3A|GTF2H1|DNMT3B|EZH2|UHRF1|HIST1H4I|PHF19|H2AFX|H3F3A|JARID2|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|EHMT2|HIST1H2AC|SUZ12|SF3B1|EED|HIST1H3H|HIST1H2BN|SUDS3|POLR2H|CHD3|SIN3B|HIST1H2BG|HIST2H2BE|HIST1H2BH|DNMT1|SUV39H1|TET2|PHF1|ARID4B
HDL ASSEMBLY%REACTOME DATABASE ID RELEASE 66%8963896,0.8701242100675529,0.9934031064448321,0.291627295854342,0.672157685676053,7985,5,ZDHHC8
NEGATIVE REGULATION OF FGFR1 SIGNALING%REACTOME%R-HSA-5654726.2,0.00529465930018416,0.16770443270936902,-0.445407629403887,-1.98736674705307,22,20,FGF2|PPP2CA|PPP2CB|UBA52|MAPK3|FGF10|UBC|UBB
TNF SIGNALING%REACTOME%R-HSA-75893.5,0.13893083660525501,0.627473629755205,-0.222114880703338,-1.27895353395525,459,42,CYLD|RNF31|ADAM17|UBA52|RBCK1|TAX1BP1|USP2|UBC|TNF|UBB
MET ACTIVATES PI3K AKT SIGNALING%REACTOME%R-HSA-8851907.1,0.0396634615384615,0.396898239600279,-0.6506178886437359,-1.6469959818515199,230,5,HGF|MET|PIK3R1
PLATELET ADHESION TO EXPOSED COLLAGEN%REACTOME%R-HSA-75892.3,0.502720128954262,0.9164921159310329,0.327998167500777,0.9680073311198771,4989,10,ITGB1|ITGA1|ITGA2|ITGA10|GP1BB
TRP CHANNELS%REACTOME DATABASE ID RELEASE 66%3295583,0.406477732793522,0.8664565508572991,0.36702632390812,1.04736772406103,4015,9,MCOLN1|TRPM7|TRPC1|TRPV1|TRPC4AP|MCOLN2|TRPM2
ENDOGENOUS STEROLS%REACTOME%R-HSA-211976.3,0.29149604799542894,0.8000726114371469,0.32083084974699705,1.1508856661534599,3060,18,FDXR|CYP21A2|FDX1|ARNT2|CYP7B1
REGULATION OF GENE EXPRESSION IN LATE STAGE (BRANCHING MORPHOGENESIS) PANCREATIC BUD PRECURSOR CELLS%REACTOME%R-HSA-210744.2,0.45509923364118704,0.88900512246363,0.319026356422328,1.00568508468022,4631,12,KAT2A|HES1|MAML1
CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION%REACTOME DATABASE ID RELEASE 66%69202,0.4566885531207979,0.8894818557698579,0.18793783438291603,1.00845449885297,5772,82,CCNA1|LIN52|PSMD11|PSMD13|WEE1|PSMB9|PSMA4|LIN9|PSMD3|CCNE1|PSMD1|RB1|E2F5|PSMA1|PSMC3|CDK7|AKT3|LIN37|PSMA3|AKT2|CCNE2|PSMC6|PSMC1|E2F1|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDK2|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|LIN54|CCNA2|MNAT1
ROLE OF ABL IN ROBO-SLIT SIGNALING%REACTOME DATABASE ID RELEASE 66%428890,0.0761374187558032,0.525661416287861,-0.476812968237127,-1.4821423131923703,409,8,CLASP1|SLIT2|ROBO1|CAP1|ABL2|CAP2|ABL1
CROSS-PRESENTATION OF PARTICULATE EXOGENOUS ANTIGENS (PHAGOSOMES)%REACTOME DATABASE ID RELEASE 66%1236973,0.8854224698235841,0.996643473105967,-0.213851126910883,-0.6647424148096209,4767,8,CD36
RESPIRATORY ELECTRON TRANSPORT%REACTOME DATABASE ID RELEASE 66%611105,0.7840179469327758,0.981487311948134,0.143079880363358,0.796662366691779,10134,100,COX20|NDUFA7|NDUFS7|ETFDH|UQCR11|NDUFA4|NDUFB11|ETFA|NDUFS2|COX5A|NDUFC1|NDUFAF1|NDUFS4|NDUFA11|COX16|COX6A1|ETFB|NDUFS8|NDUFB2|COX8A|SDHA|MT-ND2|NDUFV1|COX7B|NDUFS3|NDUFB7|NDUFA12|MT-CO2|COX11|MT-CYB|SURF1|ECSIT|MT-CO1|ACAD9|CYCS|NDUFB1|UQCR10|TMEM126B|NDUFB3|NDUFA1|NDUFB6|SCO2|NDUFAF7|MT-ND3|COX7C|SDHB|UQCRB
SIGNALING BY INSULIN RECEPTOR%REACTOME%R-HSA-74752.1,0.106973595125254,0.5822715745664481,-0.20789435828199698,-1.29947600459192,315,55,KRAS|SHC1|ATP6V1E2|ATP6V0D1|GAB2|MAPK3|ATP6V1E1|FGF10|PIK3R1|TRIB3
RHO GTPASE CYCLE%REACTOME DATABASE ID RELEASE 66%194840,0.46177750155376,0.8912128193953879,-0.12952422990359,-1.00725841271048,742,129,ARHGEF5|RHOJ|PIK3R2|PREX1|ARHGAP42|RHOG|RALBP1|OPHN1|ARHGAP5|ARHGDIA|TAGAP|KALRN|GNA13|ARHGAP8|ABR|STARD8|DLC1|FGD4|VAV1|TRIO|ARHGAP23|RHOA|ARHGAP1|GMIP|ARHGAP29|RHOC|VAV3|ARHGEF2|VAV2|CDC42|AKAP13|ARHGAP36|NET1|ARHGAP31|ARHGEF37|RASGRF2|BCR|ARHGEF33|RHOQ|RAC1|ARHGAP26|ARHGAP22
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONE GENES%REACTOME%R-HSA-381183.2,0.147989066770793,0.6402258061318559,-0.407787818978045,-1.31637562240383,757,9,CALR|ATF4|HSPA5|DDIT3|ATF6|NFYA
CLASS I MHC MEDIATED ANTIGEN PROCESSING & PRESENTATION%REACTOME DATABASE ID RELEASE 66%983169,0.996360140100268,1.0,0.0895287517448796,0.5904141495138321,14507,342,SH3RF1|HACE1|UBE3D|UBR4|SPSB4|GLMN|SIAH2|TRIM9|HERC4|FCGR1B|CDC34|BTRC|TAP2|PSMD11|LMO7|ANAPC5|RNF34|HECTD2|KLHL42|UBE2Z|ERAP1|PSMD13|PSMB9|UBA3|KLHL3|ASB2|PSMA4|THOP1|PSMD3|RNF182|DZIP3|FBXL19|RNF126|GAN|LRR1|KLHL20|CDC23|CDC20|RNF111|MIB2|ANAPC7|ITGB5|FBXL15|PSMD1|KLHL25|HUWE1|RNF7|PSMA1|UBA7|TRIM4|TRIM37|SEC31A|FBXL8|PSMC3|RNF14|KLHL22|UBE3B|SEC24D|FBXW5|CCNF|MRC1|HECTD1|HERC2|GPR75-ASB3|KEAP1|TRAIP|PSMA3|SEC24C|UBE2C|FBXO9|CUL7|RNF123|SOCS1|PSMC6|UNKL|PSMC1|ANAPC10|KLHL9|PSMD2|UBE2B|UBE2H|UBR2|BTBD6|RBX1|PSMA5|FBXL7|HERC1|SEC61A1|UFL1|RNF19A|AREL1|PSMC2|BTK|PSMC5|SKP2|TRIM21|HLA-F|CHUK|ASB1|CDC16|TRIM41|SHFM1|UBE2O|SEC61A2|ANAPC2|PSMA2|NCF4|PSMB6|CUL2|PSMB3|FBXO44|UBA6|SEC22B|FBXO11|UBA5|UBA1|PSMA7|SAR1B|UBAC1|SMURF2|UBE2E3|TRIM69|KBTBD7|PSMB4|SEC24A|TLR4|HERC3|TAP1|NCF1|ANAPC4|FBXO41|WSB1|UBE2V2|PSME2|UBE2R2
RUNX2 REGULATES BONE DEVELOPMENT%REACTOME%R-HSA-8941326.1,0.7538433213661049,0.977083996023335,0.199797997409915,0.7770550265084599,8188,23,HES1|BGLAP|SRC|RB1|HDAC3|HEY2|HDAC6
SLBP INDEPENDENT PROCESSING OF HISTONE PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%111367,0.643223010244287,0.9621972042482541,-0.250454029555715,-0.84732346994224,3264,10,SNRPB|NCBP2
MULTIFUNCTIONAL ANION EXCHANGERS%REACTOME%R-HSA-427601.2,0.946354574980401,1.0,0.280205005582632,0.593781173406335,8449,4,SLC26A2|SLC26A6|SLC26A1
ASTROCYTIC GLUTAMATE-GLUTAMINE UPTAKE AND METABOLISM%REACTOME%R-HSA-210455.2,0.784455787913716,0.981487311948134,-0.32760312135732694,-0.7534187404325359,4763,4,GLUL
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS%REACTOME%R-HSA-202427.5,0.548912015137181,0.931134965065115,0.25482416781546896,0.931421321522916,5801,19,PAG1|CD3D|PTPRJ|CD3G|CD3E|PTPN22|LCK|HLA-DRB1|CSK|HLA-DRB5|HLA-DPB1|HLA-DQA1|HLA-DRA|PTPRC|HLA-DPA1
GABA RECEPTOR ACTIVATION%REACTOME%R-HSA-977443.2,0.885778275475924,0.996643473105967,-0.129068344612286,-0.7099910266957529,3163,36,GNG10|GNAI3|ADCY7|GNG4|GNAI2|GNAL|GNGT1|GABRQ|GABRG2|ADCY2|GABRA3
PI3K EVENTS IN ERBB2 SIGNALING%REACTOME DATABASE ID RELEASE 66%1963642,0.663006246222043,0.964618776001639,0.284856858029083,0.840686181246037,6580,10,NRG2|NRG3
NONCANONICAL ACTIVATION OF NOTCH3%REACTOME DATABASE ID RELEASE 66%9017802,0.00259981429897864,0.126473912512219,-0.66694246786916,-2.0731475818464498,13,8,APH1A|NOTCH3|PSEN1|PSENEN|APH1B|NCSTN|PSEN2|YBX1
"XAV939 INHIBITS TANKYRASE, STABILIZING AXIN%REACTOME DATABASE ID RELEASE 66%5545619",0.714769565743317,0.971081608033886,0.5224152191894129,0.853873324179492,5908,2,TNKS2|TNKS
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR%REACTOME%R-HSA-1679131.1,0.0769230769230769,0.527286041772797,-0.45802273911726105,-1.4785384462723499,393,9,CTSB|UNC93B1|CTSS|CTSL|CTSK|CNPY3|CTSV
P53-DEPENDENT G1 DNA DAMAGE RESPONSE%REACTOME%R-HSA-69563.3,0.75234521575985,0.9769690538700708,0.158290824824081,0.8054059824742609,9222,64,CCNA1|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDKN2A|CCNE1|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|CCNE2|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|CDK2|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PCBP4|MDM2|PSMA7|PSMB4|CCNA2
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION%REACTOME%R-HSA-6804756.1,0.569107605368495,0.940076901516441,0.17162200677289496,0.935478651531857,7250,89,NUAK1|CCNA1|PRKAA2|MAPK11|AK6|ATR|BLM|EXO1|BRIP1|TAF7|CDK5R1|RFC4|DNA2|RAD9A|TAF5|AURKB|STK11|RMI2|PIN1|CHEK2|TOPBP1|RMI1|TP53INP1|PRKAB2|AURKA|TAF2|CHEK1|TAF4|RFC3|RAD17|TPX2|RFC5|RAD1|CDK2|ATM
SIGNALING BY FGFR2 IIIA TM%REACTOME%R-HSA-8851708.1,0.06565884476534299,0.495991045493396,-0.339148425785686,-1.48732633894027,290,19,FGF2|POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
VEGFA-VEGFR2 PATHWAY%REACTOME DATABASE ID RELEASE 66%4420097,0.00134288272157565,0.0945022140486112,-0.25030012625705,-1.79570700957144,2,91,PRKACA|MAPKAPK3|NCF2|CYBA|SH2D2A|PIK3R2|THEM4|NCK2|HSPB1|MAPKAP1|KDR|PRKCD|CTNNB1|ABI1|BCAR1|PTK2B|NRAS|VAV1|CYFIP2|SPHK1|FYN|RHOA|CDH5|PXN|CRK|PRR5|CTNNA1|VAV3|VAV2|CDC42|SHB|KRAS|PRKCA|NOS3|RAC1|BRK1|PIK3R1|CAV1|PAK2|TRIB3
COMPETING ENDOGENOUS RNAS (CERNAS) REGULATE PTEN TRANSLATION%REACTOME DATABASE ID RELEASE 66%8948700,0.9446610956360258,1.0,-0.191516355011308,-0.595316219020003,5086,8,TNRC6A|TNRC6C|AGO4|AGO3|TNRC6B|AGO1|MOV10|AGO2
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4551638,0.619493209672077,0.9532238181782521,0.181248689932284,0.895290888404001,7480,56,PIAS1|TPR|NUP133|PCGF2|SUMO2|NUP205|HIST1H4I|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|SUZ12|POM121|NUP54|CHD3|PHC2|NUP37|AAAS|L3MBTL2|ZBED1|NUP62|RANBP2|PHC1|HDAC2|NUP50|CBX2|CBX5
AXONAL GROWTH STIMULATION%REACTOME%R-HSA-209563.2,0.608924748888523,0.9508825506493929,-0.3769922241217671,-0.867003359045772,3697,4,NGF|NGFR|ARHGDIA|RHOA
SYNTHESIS OF BILE ACIDS AND BILE SALTS%REACTOME%R-HSA-192105.2,0.357542411737735,0.845419584429298,0.27709577288381604,1.09050980217114,3898,24,SLC27A2|HSD17B4|OSBPL3|AMACR|AKR1C1|ACOX2|OSBPL9|CYP7B1
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE%REACTOME%R-HSA-1660499.6,0.86301803226827,0.991943445125448,-0.1237501759962,-0.7391156127475359,2727,47,MTMR1|PIP4K2B|PIP5K1C|PLEKHA5|PIK3C2B|OCRL|PIK3C2A|RUFY1|MTMR6|SBF2|MTMR3|PLEKHA8|INPPL1|INPP5J|PIK3R6|INPP4B|RAB14|MTM1|PIK3CB|PIK3CA|PTEN|MTMR9|PLEKHA4|PIP4K2C|PLEKHA3|ARF1|SYNJ1|INPP4A|INPP5D|PIP5K1A|PI4K2B|PI4K2A|PIK3CD|PIK3R2|PIK3R5|SYNJ2|MTMR2|INPP5K|PIP4K2A|RAB5A|MTMR14|PIK3R1
NONSENSE-MEDIATED DECAY (NMD)%REACTOME DATABASE ID RELEASE 66%927802,0.471030042918455,0.898051355931307,-0.131532618612589,-0.9957340869736842,877,113,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|UPF3A|RPL26L1|FAU|RPL37|RPL27A|GSPT2|PPP2R1A|RPL7A|RPL19|UPF2|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|PNRC2|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|SMG8|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|SMG7|SMG1|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|CASC3|UPF1|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SMG5|MAGOHB|RPL29|RPL31|RPL17|EIF4A3|RPS14|RPS17|RPL32|RPL18A|NCBP1|RPL11|SMG6|RPS16|RPL12|PPP2R2A|DCP1A|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|MAGOH|GSPT1|EIF4G1|RPL15|RPL8|PPP2CA|RPL35A|ETF1|UBA52|NCBP2|RBM8A|RNPS1|PABPC1
N-GLYCAN ANTENNAE ELONGATION%REACTOME%R-HSA-975577.1,0.6443188462288051,0.9625261061153929,0.257689678486462,0.8538059836780709,6611,14,B4GALT6|ST8SIA3|B4GALT4|ST3GAL4|MGAT4B|B4GALT3|ST8SIA2|MGAT4C|ST6GAL1|B4GALT2
PI3K AKT SIGNALING%REACTOME%R-HSA-1257604.8,0.29466357308584695,0.800447413278835,-0.12435887938934101,-1.06324124892683,253,221,PIK3CD|PPP2R5A|CD86|RING1|SNAI2|PIK3R2|GATAD2B|CDKN1B|THEM4|BMI1|PSME4|RHOG|CBX4|PSMC4|MAPKAP1|IRAK1|PSMD12|RRAGD|CBX8|CD19|FOXO4|RRAGC|IRAK4|VAV1|PSMA6|PML|PPP2R5C|PSME3|FGF7|FYN|STUB1|HDAC5|FOXO1|FGF2|HGF|HBEGF|CSNK2A2|PPARG|PHC3|SNAI1|PIP4K2A|PPP2CA|PPP2CB|LAMTOR5|PRR5|PPP2R1B|NEDD4|AGO2|JUN|UBA52|MECOM|TP53|MAF1|MAPK3|CDKN1A|PSMD6|FGF10|RAC1|MET|MYD88|UBC|CSNK2A1|PIK3R1|GATAD2A|PSMF1|FOXO6|TRIB3|UBB|FOXO3
PI5P REGULATES TP53 ACETYLATION%REACTOME DATABASE ID RELEASE 66%6811555,0.8709514170040491,0.9934031064448321,0.233378028424844,0.665981153271093,8604,9,MAP2K6|PIN1|ING2|PIP4K2B|TMEM55B|EP300
PTK6 REGULATES PROTEINS INVOLVED IN RNA PROCESSING%REACTOME%R-HSA-8849468.1,0.7706379529929369,0.979355471471634,0.41696629480789793,0.7926090632220191,6655,3,SFPQ|KHDRBS1
P75NTR NEGATIVELY REGULATES CELL CYCLE VIA SC1%REACTOME%R-HSA-193670.1,0.478307560137457,0.9046812288131709,0.401274495145976,0.986876180811408,4453,6,HDAC3|NGF|HDAC2|NGFR|PRDM4|HDAC1
CONVERSION FROM APC C:CDC20 TO APC C:CDH1 IN LATE ANAPHASE%REACTOME%R-HSA-176407.3,0.322043519394513,0.822751772025005,0.30662116413326196,1.12074726801702,3403,19,ANAPC15|ANAPC5|CDC23|CDC20|ANAPC7|ANAPC16|UBE2C|ANAPC10|CDC16|ANAPC2|ANAPC4
LEUKOTRIENE RECEPTORS%REACTOME%R-HSA-391906.1,0.259465092045849,0.770912532778873,0.613479341576004,1.16615969273161,2240,3,CYSLTR2|LTB4R|LTB4R2
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE%REACTOME%R-HSA-5620912.2,0.009323284904047859,0.212136117579847,0.29296579221094,1.6156066481268898,119,95,TMEM216|CEP83|AKAP9|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|CDK1|AHI1|RAB3IP|CKAP5|CEP290|CEP131|CEP152|MKS1|KIF24|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP162|SEPT2|CEP72|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CEP97|CNTRL|NPHP4|PLK1|SFI1|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|NEDD1|PPP2R1A|TMEM67|SSNA1|C2CD3|NDE1|CEP250
ELECTRIC TRANSMISSION ACROSS GAP JUNCTIONS%REACTOME%R-HSA-112303.1,0.291453976617817,0.8000726114371469,-0.49141817074912897,-1.13015913187113,1769,4,GJD2|PANX1|GJC1
PORPHYRIN METABOLISM%REACTOME DATABASE ID RELEASE 66%189445,0.968354430379747,1.0,-0.147097705935803,-0.569895455089782,4589,14,BLVRA|COX10
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%2122947,0.910140988618991,1.0,0.140043183449958,0.6532105431391579,10715,44,HDAC10|CDK8|KAT2A|HES1|MAML1|HEYL|HDAC8|HDAC3|HEY2|HDAC6|TLE4|CCNC|MAML3|TLE1|RBX1|KAT2B|NCOR1|HDAC9|RPS27A|HDAC7|HDAC2|SNW1|HEY1|TBL1XR1
PHOSPHO-PLA2 PATHWAY%REACTOME%R-HSA-111995.1,0.138623442603121,0.626567367071584,0.774855897248512,1.26648067751599,1145,2,PLA2G4A|MAPK1
TP53 REGULATES METABOLIC GENES%REACTOME%R-HSA-5628897.4,0.31384097602019395,0.816422962704093,-0.15621023121010502,-1.0822812186622799,745,80,RRAGD|PRKAA1|DDIT4|PRKAG1|RRAGC|COX5B|GPI|RRM2B|COX6B1|G6PD|YWHAH|LAMTOR5|COX4I1|YWHAQ|YWHAB|AGO2|PRDX1|TP53|YWHAZ|YWHAE|SESN2|COX7A2L
HOST INTERACTIONS WITH INFLUENZA FACTORS%REACTOME%R-HSA-168253.4,0.12191089453532901,0.607607158836689,0.30194527161365403,1.3424795938477,1400,37,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|PABPN1|NUP107|NUP35|NUP210|POM121|NUP54|KPNA5|NUP37|AAAS|KPNA2|NUP62|CPSF4|RANBP2|NUP50
SIGNALING BY FGFR1 IN DISEASE%REACTOME DATABASE ID RELEASE 66%5655302,0.0525084481414089,0.447307566936778,-0.292460690409456,-1.49674102201157,201,29,NRAS|BAG4|FGF2|FGFR1|KRAS|STAT5A|STAT3|GAB2|BCR|PIK3R1|LRRFIP1
TRUNCATED APC MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME%R-HSA-4839744.1,0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
DNA METHYLATION%REACTOME DATABASE ID RELEASE 66%5334118,0.30237972064149,0.805227617550042,0.250965573583304,1.13191949765434,3506,39,HIST1H3E|HIST1H2BJ|HIST3H2BB|HIST2H3C|HIST2H3A|DNMT3B|UHRF1|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|HIST1H2BK|HIST1H2AC|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH|DNMT1
PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1%REACTOME DATABASE ID RELEASE 66%8849469,0.148003714020427,0.6402258061318559,-0.427846469820228,-1.32993311573518,796,8,UBA52|UBC|UBB
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8941858.1,0.8431274900398409,0.991298302704726,0.147921777190004,0.727225195402205,10157,55,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDKN2A|SRC|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|MDM2|PSMA7|SMURF2|PSMB4
XENOBIOTICS%REACTOME%R-HSA-211981.1,0.214827295703454,0.731747191309112,0.476574732747098,1.2404239009337,2039,7,CYP2C8|CYP3A5|ARNT2|CYP2E1|CYP2D6
REGULATION OF TP53 EXPRESSION%REACTOME DATABASE ID RELEASE 66%6804754,0.244394951744618,0.757467559003634,-0.71050608756145,-1.2152826105018302,1645,2,TP53
LACTOSE SYNTHESIS%REACTOME DATABASE ID RELEASE 66%5653890,0.175204157386785,0.677933656654802,-0.7515301902398679,-1.28545214102286,1179,2,B4GALT1|SLC2A1
HEME DEGRADATION%REACTOME%R-HSA-189483.1,0.178330314506834,0.6837991059383349,-0.556499200352948,-1.27983190405659,1082,4,HMOX2|BLVRB|HMOX1|BLVRA
DECTIN-2 FAMILY%REACTOME%R-HSA-5621480.2,0.188185654008439,0.6950362658416049,-0.321042278889865,-1.2438027803836,891,14,FCER1G|FYN|LYN|MUC4|MUC3A|MUC12
TYPE I HEMIDESMOSOME ASSEMBLY%REACTOME%R-HSA-446107.1,0.388115134633241,0.859991269020751,-0.33316785261183696,-1.03563074967766,2089,8,DST|LAMB3|CD151|ITGB4|LAMA3|PLEC|ITGA6|LAMC2
MISMATCH REPAIR (MMR) DIRECTED BY MSH2:MSH6 (MUTSALPHA)%REACTOME%R-HSA-5358565.1,0.35597349444552706,0.84417352062618,0.328956485575327,1.0899350622174,3652,14,EXO1|POLD1|POLD3|MSH6|LIG1
REGULATION OF PTEN STABILITY AND ACTIVITY%REACTOME DATABASE ID RELEASE 66%8948751,0.7722353324110991,0.979693198874896,0.15505462995644298,0.791533745059223,9489,65,PSMD11|TRIM27|PSMD13|PSMB9|PSMA4|PSMD3|USP13|OTUD3|RNF146|PSMD1|PSMA1|PSMC3|TNKS2|AKT3|PSMA3|AKT2|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|SHFM1|AKT1|XIAP|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
AXIN MISSENSE MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%5467340,0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
ACYL CHAIN REMODELING OF DAG AND TAG%REACTOME%R-HSA-1482883.3,0.747004143801098,0.9749763305090959,0.37553871985527204,0.7958024207009301,6669,4,DGAT1|PNPLA2
BDNF ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9024909.1,0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
IRF3 MEDIATED ACTIVATION OF TYPE 1 IFN%REACTOME%R-HSA-1606341.1,0.0225109194758652,0.31540045468680394,0.7559299445148459,1.60188776261758,200,4,DTX4|ZBP1|TBK1
LAMININ INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000157,0.260333241277732,0.7717385447946792,0.304038200852773,1.18246636746076,2827,23,ITGB1|COL18A1|LAMC3|ITGA1|ITGA2|LAMA1|LAMB2
PROLONGED ERK ACTIVATION EVENTS%REACTOME%R-HSA-169893.1,0.012608353033885002,0.24393333480627202,-0.542078591655609,-1.8339330138861103,63,10,FRS2|NTRK1|CRKL|CRK|RAP1A|YWHAB|RAPGEF1
LYSOSOMAL OLIGOSACCHARIDE CATABOLISM%REACTOME DATABASE ID RELEASE 66%8853383,0.569570228881936,0.940076901516441,-0.3891248000882371,-0.8949057491847521,3458,4,MAN2C1|MANBA|MAN2B1|MAN2B2
LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE ORGANIZATION FROM THE CENTROSOME%REACTOME%R-HSA-380284.1,0.0150406504065041,0.264387156924099,0.314624748007248,1.6158020073255899,184,67,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|CKAP5|CEP290|CEP131|CEP152|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|SFI1|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
MET ACTIVATES RAS SIGNALING%REACTOME%R-HSA-8851805.1,0.162631784459196,0.6646952079044269,-0.400406377110499,-1.29254766658852,832,9,NRAS|HGF|KRAS|MET
HS-GAG DEGRADATION%REACTOME%R-HSA-2024096.1,0.822302637844015,0.987616425875001,0.19971197962474696,0.716407586397962,8634,18,GPC2|GPC6|GPC1|GPC3|AGRN|GLB1L|SDC3
RIBOSOMAL SCANNING AND START CODON RECOGNITION%REACTOME DATABASE ID RELEASE 66%72702,0.0165376495425757,0.273880014074595,-0.24632884021621,-1.5641720858544998,46,58,EIF2S2|EIF4E|RPS16|EIF5|EIF3H|RPS4X|EIF3D|EIF2S1|RPS28|EIF4A1|EIF3K|RPS9|RPS3|EIF4A2|EIF4G1|EIF3G|EIF3B|EIF4H|EIF4B|EIF1AX|EIF3A|EIF3I|EIF2S3
BIOSYNTHESIS OF MARESINS%REACTOME%R-HSA-9018682.1,0.7948354761385921,0.982260302987182,0.32249404546113697,0.7433009677864079,7294,5,CYP2C8|CYP2E1|CYP2D6
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193368,0.247439456303245,0.7599860600589841,0.345704693150357,1.19846441953175,2584,16,SLC27A2|HSD17B4|AMACR|AKR1C1|ACOX2|CYP7B1
DIGESTION OF DIETARY CARBOHYDRATE%REACTOME DATABASE ID RELEASE 66%189085,0.6344502237812989,0.959117312281341,0.5533608070072961,0.9044530373427941,5244,2,AMY2B
SIGNALING BY NOTCH2%REACTOME DATABASE ID RELEASE 66%1980145,0.19125237707144802,0.700272079743588,-0.22931061175288,-1.2139911519197701,703,32,NCSTN|PSEN2|MAMLD1|FCER2|UBA52|UBC|RBPJ|UBB
TRAF3-DEPENDENT IRF ACTIVATION PATHWAY%REACTOME%R-HSA-918233.1,0.490765719028844,0.9091242810779291,-0.254656543157565,-0.959031673931739,2364,13,RNF135|CREBBP|SIKE1|TRAF3|MAVS|TRIM25
ORGANELLE BIOGENESIS AND MAINTENANCE%REACTOME%R-HSA-1852241.4,0.8238584714355641,0.9876441563834109,0.127276444518265,0.819775645164865,11781,268,TMEM216|SIRT4|CEP83|POLRMT|AKAP9|ALAS1|PRKAA2|MAPK11|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|MAPK12|CDK1|MTERF1|ATP5G1|PKD2|SMARCD3|AHI1|RAB3IP|CKAP5|CEP290|ATP5D|NRF1|INPP5E|CEP131|CEP152|RAB11FIP3|MKS1|KIF24|MT-ATP8|TFB1M|NEK2|HAUS5|CDK5RAP2|BBS10|PRKAR2B|TCTE3|CEP162|KIFAP3|BBIP1|BBS5|MED1|SEPT2|CEP72|HDAC3|SIRT3|HAUS8|CEP164|CEP78|HDAC6|CEP192|ARL6|FGFR1OP|NPHP3|CEP97|POLG2|CNTRL|NPHP4|PLK1|CNGB1|ATAT1|GBF1|SFI1|MTX2|CARM1|PRKAB2|CEP41|CEP57|DYNC1H1|ATP5C1|ESRRA|NINL
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS%REACTOME DATABASE ID RELEASE 66%372708,0.6413764510779439,0.9612805315220849,-0.234555949143679,-0.854510851022525,3093,12,RAP1B|BCAR1|CRK|RAP1A|VWF
PHASE 3 - RAPID REPOLARISATION%REACTOME DATABASE ID RELEASE 66%5576890,0.12050555676617998,0.6066999390482379,0.591018228954619,1.36220940431075,1105,5,AKAP9|KCNQ1|KCNH2
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION%REACTOME%R-HSA-427359.2,0.268120262328592,0.7829905950315309,0.250514422750291,1.1614099250058703,3147,43,HIST1H3E|HIST1H2BJ|SIRT1|HIST3H2BB|TAF1D|RRP8|HIST2H3C|HIST2H3A|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|HIST1H2BK|TAF1A|HIST1H2AC|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH|SUV39H1
RAB GERANYLGERANYLATION%REACTOME%R-HSA-8873719.2,0.0028439388553146102,0.13103871184697197,-0.280168818437664,-1.79209814015784,7,60,RAB25|RAB10|RAB3C|RAB3D|RAB33B|RAB13|RAB21|RAB43|RAB8B|RAB30|RAB18|RAB6A|RAB1A|RAB39A|RAB8A|RAB37|RAB12|RAB2B|RAB36|RAB5C|RAB7A|RAB22A|RAB2A|RAB5A|PTP4A2
THE PHOTOTRANSDUCTION CASCADE%REACTOME%R-HSA-2514856.1,0.7960453232614979,0.9828568923066779,-0.17673609320104,-0.760279405984475,3582,18,PPEF1|PDE6B|GNGT1|PRKCA|GUCA1A
FGFR3 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190239,0.5693806697278531,0.940076901516441,0.437749894720571,0.927633842961552,5083,4,GALNT3|FGF9
MRNA SPLICING%REACTOME%R-HSA-72172.3,0.871024734982332,0.9934031064448321,-0.0992012710264862,-0.825751542922791,985,187,SNRPB2|SNRPA1|SART1|SF3B5|CLP1|HNRNPR|PPIL4|HNRNPUL1|HNRNPM|CDC40|SRSF7|DDX23|NCBP1|SRSF3|PPIL6|ZCRB1|HNRNPD|ZRSR2|POLR2E|CD2BP2|CSTF1|FUS|SF3B6|SNRPD3|WBP4|CSTF2|PDCD7|LSM3|PRPF19|GPKOW|ISY1|CPSF3|BUD31|HNRNPA3|PCBP2|CDC5L|PRCC|CRNKL1|EFTUD2|BCAS2|PUF60|PRPF6|MAGOH|HNRNPF|NHP2L1|POLR2A|YBX1|TRA2B|PPIH|PPIL3|SNRNP27|TXNL4A|POLR2K|SNRPB|SYF2|HNRNPC|CTNNBL1|POLR2F|NCBP2|NUDT21|POLR2I|PRPF4|POLR2D|SF3A1|RBM8A|PCBP1|RNPS1|SLU7|DHX15|WBP11
DEFECTIVE ST3GAL3 CAUSES MCT12 AND EIEE15%REACTOME DATABASE ID RELEASE 66%3656243,0.174375629969761,0.676682497340677,0.5996801411790661,1.2707795035901799,1556,4,PRELP|FMOD|OGN|LUM
TRANSCRIPTION OF THE HIV GENOME%REACTOME DATABASE ID RELEASE 66%167172,0.48665678280207597,0.907092544497897,-0.14831346182962601,-0.987083720163497,1312,68,POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TAF4B|NCBP2|TCEA1|POLR2I|POLR2D|TAF13
PHASE 0 - RAPID DEPOLARISATION%REACTOME DATABASE ID RELEASE 66%5576892,0.5576838202842261,0.9363140457955259,0.215486366560574,0.928859117109749,6317,33,SCN1A|CACNB4|CACNB2|FGF12|FGF13|FGF11|CACNA2D1|CACNA1D
NTF3 ACTIVATES NTRK3 SIGNALING%REACTOME%R-HSA-9034013.1,0.5033557046979871,0.9164921159310329,0.751985002205558,0.9989785270006719,3749,1,NTRK3
TRANSPORT OF NUCLEOTIDE SUGARS%REACTOME DATABASE ID RELEASE 66%727802,0.23957489878542498,0.7525035503527309,0.42443162896015796,1.21118285061973,2366,9,SLC35D1|SLC35A1|SLC35B3
SIGNALING BY FGFR3 IN DISEASE%REACTOME%R-HSA-5655332.3,0.491708126036484,0.909315999193258,-0.263531840788941,-0.9600729308560308,2371,12,FGF1|FRS2|NRAS|FGF2|KRAS|PIK3R1
DISORDERS OF TRANSMEMBRANE TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%5619115,0.823466797674609,0.9876441563834109,0.14884674348717003,0.749819495813083,10056,61,PSMD11|PSMD13|PSMB9|PSMA4|DERL3|KCNJ11|PSMD3|PSMD1|GCK|PSMA1|PSMC3|ABCC8|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|ERLIN1|PSMB4
CONDENSATION OF PROMETAPHASE CHROMOSOMES%REACTOME DATABASE ID RELEASE 66%2514853,0.199144108280255,0.711592141628341,0.411310740462567,1.25481478474843,2000,11,CCNB1|CDK1|SMC2|CCNB2|NCAPG|NCAPH|SMC4
SIGNALING BY NOTCH%REACTOME DATABASE ID RELEASE 66%157118,0.876019459150093,0.9941329456747149,0.122625281876089,0.76300307454704,12244,202,HIST1H3E|HIST1H2BJ|HIST3H2BB|HDAC10|DTX1|DTX4|CDK8|KAT2A|HES1|MAML1|SIRT6|PSMD11|PSMD13|PSMB9|ATP2A1|HIST2H3C|POGLUT1|PSMA4|E2F3|HIST2H3A|JAG2|PSMD3|DTX2|DLK1|DLGAP5|MIB2|HEYL|PSMD1|HDAC8|HIST1H4I|TNRC6A|PSMA1|HDAC3|H2AFX|HEY2|H3F3A|ATP2A2|PSMC3|H2AFZ|HDAC6|ACTA2|RFNG|TLE4|LFNG|HIST1H2BF|TNRC6C|ST3GAL4|HIST1H2BK|PSMA3|MDK|CCNC|HIST1H2AC|PSMC6|PSMC1|MAML3|E2F1|TLE1|PSMD2|HIST1H3H|RBX1|PSMA5|HIST1H2BN|ST3GAL6|PSMC2|PSMC5|HIST1H2BG|CNTN1|HIST2H2BE|SHFM1|AKT1|HIST1H2BH|PSMA2|PSMB6|PSMB3|NEURL1|STAT1|PSMA7|TACC3|PSMB4|DLL4|ST3GAL3|JAG1|NEURL1B|KAT2B|NOTCH2|PSME2|AGO4|NCOR1
MAP2K AND MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%5674135,0.399611219105804,0.8638522656500329,-0.190152359827703,-1.0336695517929202,1438,35,ARRB1|IL17RD|RAP1A|YWHAB|KRAS|MAPK3|VWF|MAP2K1
CA2+ PATHWAY%REACTOME%R-HSA-4086398.3,0.910333333333333,1.0,-0.113782560794511,-0.701798851179848,2730,53,TCF7L2|PDE6B|CAMK2A|WNT11|GNB5|GNGT1|AGO2|TCF7|PRKCA|PLCB1
REGULATION OF BETA-CELL DEVELOPMENT%REACTOME%R-HSA-186712.1,0.768222387504649,0.9792236089291529,0.20246011759112698,0.7654071569258102,8262,21,KAT2A|HES1|MAML1|INS
TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRON-CONTAINING TRANSCRIPT%REACTOME%R-HSA-159236.3,0.332899869960988,0.8293509737209019,0.213086672201257,1.0976149576641099,4095,68,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|SRSF1|NUP205|NUP188|NUP160|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|DDX39B|NUP37|AAAS|U2AF2|SRSF9|SRSF5|SRSF4|NUP62|SARNP
PHOSPHATE BOND HYDROLYSIS BY NTPDASE PROTEINS%REACTOME%R-HSA-8850843.3,0.301230228471002,0.804106030578379,-0.407438917733512,-1.11839247165581,1713,6,ENTPD6|ENTPD1|ENTPD4|ENTPD3
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR) OR SINGLE STRAND ANNEALING (SSA)%REACTOME DATABASE ID RELEASE 66%5693567,0.0749012458219386,0.524498745055867,0.235902572819596,1.34892102833329,985,116,HIST1H2BJ|MUS81|HIST3H2BB|EME2|CCNA1|POLE|SIRT6|XRCC3|ATR|BLM|EXO1|BRIP1|POLE2|RFC4|DNA2|RAD9A|POLD1|GEN1|SUMO2|POLD3|SLX1B|HIST1H4I|RAD51C|RAD51|PIAS4|H2AFX|RMI2|TIMELESS|BRCC3|RAD51AP1|HIST1H2BF|SLX4|TOPBP1|EME1|HERC2|RMI1|HIST1H2BK|PALB2|BRCA2|CLSPN|XRCC2|CHEK1|RFC3|HIST1H2BN|RAD17|RFC5|SPIDR|RAD1|CDK2|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE
RNA POLYMERASE II HIV PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%167162,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
BIOSYNTHESIS OF DPAN-3-DERIVED MARESINS%REACTOME DATABASE ID RELEASE 66%9026290,0.10565338276181697,0.578674426247723,-0.9454124393471551,-1.26470704549831,797,1,ALOX5
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS%REACTOME DATABASE ID RELEASE 66%5617472,0.15703320802005,0.6578589353509621,0.228830292217682,1.2523860704106202,2004,91,RBBP7|HIST1H3E|HOXD3|HIST1H2BJ|EGR2|HIST3H2BB|HOXB3|HOXB2|HOXD4|RARB|HOXC4|HIST2H3C|HIST2H3A|PCGF2|POLR2B|EZH2|PAGR1|HIST1H4I|HDAC3|H2AFX|H3F3A|H2AFZ|HIST1H2BF|POLR2L|ZNF335|MEIS1|AJUBA|HIST1H2BK|PAXIP1|POLR2J|HIST1H2AC|KMT2D|WDR5|SUZ12|EED|HIST1H3H|HIST1H2BN|POLR2G|POLR2H
LRR FLII-INTERACTING PROTEIN 1 (LRRFIP1) ACTIVATES TYPE I IFN PRODUCTION%REACTOME%R-HSA-3134973.1,0.12259615384615401,0.607607158836689,-0.539588488521286,-1.36593242817295,713,5,CREBBP|CTNNB1|LRRFIP1
BICARBONATE TRANSPORTERS%REACTOME%R-HSA-425381.2,0.67908611599297,0.9647315640607691,-0.298604599856599,-0.819649576773725,3863,6,AHCYL2|SLC4A2|SLC4A5|SLC4A3|SLC4A8|SLC4A7
TRAFFICKING OF AMPA RECEPTORS%REACTOME DATABASE ID RELEASE 66%399719,0.530516431924883,0.9265056012720759,0.24460260410470702,0.9513092497452049,5762,23,GRIA1|AKAP5|GRIA2|PRKCB|GRIP1|GRIA4|DLG4|TSPAN7
TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379724,0.48263364542434295,0.9056079539851059,-0.17039149062361802,-0.9811265161474828,1597,42,QARS|DARS|AARS|CARS|WARS|NARS|HARS|FARS2|GARS|AIMP2|YARS|KARS|SARS
TELOMERE EXTENSION BY TELOMERASE%REACTOME DATABASE ID RELEASE 66%171319,0.589455184534271,0.945418171231938,-0.321847570426612,-0.883449970337066,3353,6,RUVBL1|RUVBL2|NHP2
UPTAKE AND FUNCTION OF DIPHTHERIA TOXIN%REACTOME%R-HSA-5336415.1,0.109138840070299,0.58452352834625,-0.5154404298897151,-1.4148493707533703,620,6,HBEGF|CD9|HSP90AB1
HS-GAG BIOSYNTHESIS%REACTOME%R-HSA-2022928.1,0.36592916325229896,0.8510019955058101,0.271182890549122,1.08062480909457,4018,25,HS3ST4|GLCE|HS3ST5|GPC2|GPC6|EXT1|GPC1
TERMINATION OF O-GLYCAN BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%977068,0.536286919831224,0.9265056012720759,-0.240218578506567,-0.930670368025775,2541,14,ST3GAL2|MUC4|MUC3A|MUC12
NUCLEOTIDE-LIKE (PURINERGIC) RECEPTORS%REACTOME DATABASE ID RELEASE 66%418038,0.797546012269939,0.9831888870926351,0.268678345890542,0.7324892528634259,7669,8,ADORA3|ADORA2A|P2RY11|P2RY6|LPAR6
GLUCOCORTICOID BIOSYNTHESIS%REACTOME%R-HSA-194002.2,0.485944674655617,0.9067604918222419,0.4665620421150479,0.988689535570167,4338,4,CYP21A2|HSD11B1
THYROXINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%209968,0.40958025886053,0.867015886388254,0.638415726870652,1.04347296726412,3385,2,DUOX1|DIO2
RUNX3 REGULATES YAP1-MEDIATED TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8951671,0.8027451388166791,0.984522820758988,0.26714193152252397,0.7283005751015909,7719,8,CTGF|TEAD3|TEAD2|YAP1
RUNX3 REGULATES RUNX1-MEDIATED TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8951911,0.19020044543429798,0.698434241409875,-0.7434794596084922,-1.27168179744744,1280,2,RUNX3|CBFB
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%2197563,0.47941057731126396,0.9046812288131709,-0.27585368018829803,-0.970763468995807,2374,11,MAMLD1|FCER2|RBPJ
LAGGING STRAND SYNTHESIS%REACTOME%R-HSA-69186.2,0.125539500844436,0.607607158836689,0.36466447711369604,1.35418126295492,1337,20,RFC4|DNA2|POLD1|FEN1|POLD3|POLA2|LIG1|PRIM2|RFC3|RFC5
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES%REACTOME%R-HSA-5579029.2,0.0953074252435883,0.566542092411725,0.6554001463788941,1.38885551726084,850,4,FDXR|FDX1
ABORTIVE ELONGATION OF HIV-1 TRANSCRIPT IN THE ABSENCE OF TAT%REACTOME DATABASE ID RELEASE 66%167242,0.0152210678907949,0.264745847609811,-0.36910310159378,-1.7343846088620098,62,23,CTDP1|NELFCD|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|POLR2F|NCBP2|POLR2I|POLR2D
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES%REACTOME%R-HSA-6803207.1,0.385956074954665,0.859630103805729,0.36154183533190704,1.0670033609471101,3830,10,PIDD1|APAF1|CASP6|NLRC4|CASP2|ATM
HSP90 CHAPERONE CYCLE FOR SHRS%REACTOME DATABASE ID RELEASE 66%3371497,0.0505297473512632,0.441129755342262,-0.28095003870735197,-1.4873749562440801,185,32,NR3C1|DNAJA2|DYNLL2|FKBP4|DNAJA4|DYNC1LI1|HSP90AB1
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%181430,0.442329984544049,0.880423444399886,0.29922317736027504,1.01454970312827,4578,15,UNC13B|PPFIA2|BZRAP1|PPFIA3|SYT1|RAB3A|STX1A|PPFIA4|SLC18A2|RIMS1|MAOA
TRANSPORT OF FATTY ACIDS%REACTOME%R-HSA-804914.1,0.6995192307692311,0.967678885433393,-0.318552834767262,-0.8063953482170271,4073,5,LCN1|SLC27A1|LCN12|SLC27A4|APOD
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME%REACTOME DATABASE ID RELEASE 66%9005891,0.5693459416863671,0.940076901516441,-0.265224386398329,-0.897293797967588,2889,10,NCOR1|GPS2|TBL1XR1|HDAC1|NCOR2|PRKACA|SIN3A|TBL1X|CAMK4
ANTIMICROBIAL PEPTIDES%REACTOME%R-HSA-6803157.2,0.291519434628975,0.8000726114371469,-0.267102466472455,-1.1239364575042,1319,17,S100A9|TLR1|CLU|S100A8|SLC11A1|PLA2G2A|PDZD11|PRSS3
SULFIDE OXIDATION TO SULFATE%REACTOME%R-HSA-1614517.2,0.5660438144329899,0.9388612723386429,0.37227928747791605,0.915566690296995,5270,6,TST|SLC25A10|SUOX
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS%REACTOME DATABASE ID RELEASE 66%177243,0.16191149191767498,0.664367762084791,0.30147108775111703,1.28898903765726,1832,32,RCC1|TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH6%REACTOME%R-HSA-5632968.1,0.733218588640275,0.973373390498726,-0.6289148654609621,-0.8413185909806229,5537,1,MSH2
FORMATION OF INCISION COMPLEX IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696395,0.829230900264032,0.9876441563834109,0.157880179178797,0.731948304799737,9735,43,GTF2H2|PIAS1|PARP2|GTF2H1|DDB2|PARP1|RNF111|SUMO2|DDB1|CHD1L|CDK7|CUL4B|ERCC5|XPA|RBX1
TRANSCRIPTIONAL REGULATION BY RUNX3%REACTOME%R-HSA-8878159.2,0.25246363209760697,0.763941204306316,-0.155639283325682,-1.12524465566472,537,95,KRAS|UBA52|TCF7|TP53|CDKN1A|PSMD6|CBFB|UBC|BCL2L11|RBPJ|PSMF1|UBB|FOXO3
CELL JUNCTION ORGANIZATION%REACTOME DATABASE ID RELEASE 66%446728,0.21323888617489004,0.728584525261472,0.23473782156760997,1.2015694266363501,2618,66,CLDN12|ITGB1|CDH4|CDH6|CLDN15|CDH10|SDK1|CDH3|ILK|CDH2|CLDN11|FBLIM1|CLDN7|CTNND1|CDH7|ARHGEF6
ION INFLUX EFFLUX AT HOST-PATHOGEN INTERFACE%REACTOME%R-HSA-6803544.1,0.28025687469125604,0.788916642629372,-0.49695974506197105,-1.14290359511524,1701,4,SLC11A1|PDZD11
PROTON-COUPLED NEUTRAL AMINO ACID TRANSPORTERS%REACTOME%R-HSA-428559.1,0.0971812080536913,0.569923978730193,0.95125716806352,1.2637027091813797,723,1,SLC36A1
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR2%REACTOME%R-HSA-5654221.2,0.372934973637961,0.852609194081082,-0.38018728472499697,-1.04358856886078,2121,6,FGF7|FGF2|FGF10
ACTIVATION OF MATRIX METALLOPROTEINASES%REACTOME DATABASE ID RELEASE 66%1592389,0.23262635379061397,0.746122594132505,-0.26884635654027694,-1.17901849694317,1030,19,MMP1|FURIN|CTSK|SPOCK3|MMP2|MMP9|TIMP2|TPSAB1|CTSV
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS%REACTOME DATABASE ID RELEASE 66%5678895,0.9666118421052629,1.0,0.115676492497277,0.5766241994355881,11753,58,PSMD11|PSMD13|PSMB9|PSMA4|DERL3|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|VCP|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|ERLIN1|PSMB4
CHEMOKINE RECEPTORS BIND CHEMOKINES%REACTOME DATABASE ID RELEASE 66%380108,0.281252845306383,0.7892585111044429,0.29131071363434696,1.16083128869555,3088,25,CXCL13|CXCR4|CXCL9|CCR5|XCL2|CCL21|CCL5|CCL19|CXCL10
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKK%REACTOME DATABASE ID RELEASE 66%442717,0.006284367635506679,0.17975028050367198,-0.861852278162285,-1.74910359177461,39,3,CAMK4|CAMKK1
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH PMS2%REACTOME DATABASE ID RELEASE 66%5632987,0.12724573125464,0.6076669536424699,-0.783126550868486,-1.33949602368528,856,2,MLH1|PMS2
CLEAVAGE OF THE DAMAGED PYRIMIDINE%REACTOME DATABASE ID RELEASE 66%110329,0.708298230834035,0.9695170059473192,0.306979585850268,0.799003365521418,6725,7,TDG|MBD4|NEIL1
NEGATIVE REGULATION OF FGFR2 SIGNALING%REACTOME%R-HSA-5654727.1,0.00161141804788214,0.103037429694888,-0.4701864705061679,-2.09792759421029,6,20,FGF7|FGF2|PPP2CA|PPP2CB|UBA52|MAPK3|FGF10|UBC|UBB
RNA POLYMERASE I PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%73772,0.7972046413502109,0.9831339686797859,-0.148761264935189,-0.7717782098784921,3022,30,POLR1B|TAF1B|POLR2K|POLR2F|POLR1E|CD3EAP
RECYCLING PATHWAY OF L1%REACTOME DATABASE ID RELEASE 66%437239,0.9342629482071709,1.0,-0.130157345787001,-0.63911074113636,3751,26,CLTA|AP2S1|MSN|RPS6KA2
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53-DEPENDENT APOPTOSIS REMAIN UNCERTAIN%REACTOME DATABASE ID RELEASE 66%6803205,0.155631812676625,0.656198355453056,-0.369886402193305,-1.30167633320117,770,11,TP53I3|TP53|BCL6|NDRG1
NEUROTRANSMITTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%112311,0.488724226804124,0.9084376510762291,0.39765471944941205,0.977973869655253,4550,6,BCHE|LRTOMT|COMT|MAOA
DUAL INCISION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696400,0.18862738361106302,0.69611511841804,0.273323643098993,1.2482473168831398,2195,41,GTF2H2|PARP2|POLE|POLE2|RFC4|GTF2H1|DDB2|POLD1|PARP1|POLD3|DDB1|CHD1L|CUL4B|ERCC5|XPA|RBX1|RFC3|RFC5
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS%REACTOME DATABASE ID RELEASE 66%432040,0.277492877492878,0.7884684708511421,-0.20390075314596304,-1.13265979297729,973,37,GNB1|PRKAR1A|GNB4|GNG5|PRKACA|RAB11A|GNG10|ADCY7|GNG4|RAB11FIP2|PRKAR2A|GNB5|GNGT1|PRKAR1B|ADCY2|GNAS|AQP1
RNA POLYMERASE III ABORTIVE AND RETRACTIVE INITIATION%REACTOME DATABASE ID RELEASE 66%749476,0.964782683387734,1.0,0.123113254179708,0.5622484299571321,11231,41,SNAPC2|BDP1|POLR3B|POLR3GL|BRF1|ZNF143|POLR3E|POLR2L|POLR3G|POU2F1|SNAPC3|SNAPC5|POLR2H|POLR3K|GTF3C5|GTF3C3
N-GLYCAN TRIMMING AND ELONGATION IN THE CIS-GOLGI%REACTOME%R-HSA-964739.1,0.647308781869688,0.9636261853025391,0.37148152326224604,0.8562098421407021,5940,5,MAN1C1|MANEA|MAN1A1|MAN1A2|MGAT1
REGULATION OF GENE EXPRESSION IN BETA CELLS%REACTOME%R-HSA-210745.1,0.45461246840775105,0.8889877304641349,0.387479026065341,1.00852649545947,4316,7,INS|GCK|AKT3|AKT2|AKT1
TNFR1-INDUCED NFKAPPAB SIGNALING PATHWAY%REACTOME%R-HSA-5357956.1,0.769422310756972,0.9792236089291529,-0.160387610297236,-0.787550205993778,3089,26,CYLD|RNF31|RBCK1|USP2|TNF
IRS-MEDIATED SIGNALLING%REACTOME%R-HSA-112399.3,0.435144268260983,0.878651088001772,-0.196519512476068,-1.0057379524641,1673,29,PIK3R2|THEM4|PIK3C3|NRAS|FGF7|FGF2|KRAS|GAB2|FGF10|PIK3R1|TRIB3
ANTIGEN PROCESSING-CROSS PRESENTATION%REACTOME%R-HSA-1236975.1,0.881886087768441,0.9957670620803951,-0.10720591727690701,-0.772154690185261,1888,94,UBA52|B2M|PSMD6|CTSV|MYD88|UBC|CD36|PSMF1|UBB
OVARIAN TUMOR DOMAIN PROTEASES%REACTOME DATABASE ID RELEASE 66%5689896,0.0019374481040686398,0.112582730005196,-0.38102475351545095,-2.05025108277106,6,34,YOD1|RNF135|TRAF6|OTUD7B|UBE2D1|NOD1|OTUD5|OTUD7A|VCPIP1|TNFAIP3|TRAF3|RHOA|MAVS|TNIP1|RIPK2|TRIM25|UBA52|TP53|TNIP2|UBC|UBB
KETONE BODY METABOLISM%REACTOME%R-HSA-74182.3,0.6825281511078821,0.9659330636214009,-0.282239240789487,-0.8233043871990842,3757,7,BDH1|OXCT1
HEPARAN SULFATE HEPARIN (HS-GAG) METABOLISM%REACTOME DATABASE ID RELEASE 66%1638091,0.5293718742053061,0.9265056012720759,0.20172554830170103,0.9518979363685239,6244,46,HS3ST4|GLCE|VCAN|B3GAT3|HS3ST5|GPC2|GPC6|EXT1|GPC1|XYLT2
NEF MEDIATED DOWNREGULATION OF CD28 CELL SURFACE EXPRESSION%REACTOME%R-HSA-164939.1,0.8009395973154358,0.9841161968820359,0.6007388619320689,0.798054777216038,5966,1,AP2M1
MITOCHONDRIAL IRON-SULFUR CLUSTER BIOGENESIS%REACTOME DATABASE ID RELEASE 66%1362409,0.21517965280581303,0.732094216765764,-0.344771802788425,-1.2132949288853798,1065,11,HSCB|LYRM4|FDX1L|FXN|GLRX5|ISCA1
NIK-->NONCANONICAL NF-KB SIGNALING%REACTOME%R-HSA-5676590.1,0.897664438392341,0.998912093067348,0.136364671947837,0.6770047700192261,10876,57,BTRC|PSMD11|PSMD13|PSMB9|UBA3|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
CATECHOLAMINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%209905,0.159368350319185,0.661359103221672,0.6086141289361939,1.2897114770665101,1422,4,PNMT|DDC|TH|DBH
UREA CYCLE%REACTOME%R-HSA-70635.1,0.142882249560633,0.632949331968897,-0.488251307696983,-1.34021705595037,812,6,ASS1|SLC25A15|ASL
GLUCAGON SIGNALING IN METABOLIC REGULATION%REACTOME%R-HSA-163359.2,0.8198839662447259,0.987153241368501,-0.145073285595347,-0.752644854873662,3108,30,GNB1|PRKAR1A|GNB4|GNG5|PRKACA|GNG10|ADCY7|GNG4|PRKAR2A|GCGR|PRKAR1B|ADCY2|GNAS
PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC%REACTOME DATABASE ID RELEASE 66%389957,0.0119432694700174,0.23670963874364498,-0.36352106822385793,-1.76353936382217,47,25,PFDN6|CCT4|TUBB2B|TUBB2A|CCT7|TUBB6|TUBA1C|PFDN1|TUBB3|PFDN2|TCP1|TUBB4B
APC C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS%REACTOME%R-HSA-176409.2,0.20804237900313002,0.7238327250928481,0.23021547256751398,1.2060046563631799,2591,73,CCNA1|ANAPC15|CCNB1|CDK1|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|PSMD1|BUB1B|PSMA1|PSMC3|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE%REACTOME%R-HSA-110330.1,0.921978952461594,1.0,0.42055531207540003,0.687386104256977,7621,2,MPG|OGG1
HDMS DEMETHYLATE HISTONES%REACTOME DATABASE ID RELEASE 66%3214842,0.508999912195979,0.918404893008545,0.221634909418519,0.9638913433103811,5796,34,HIST1H3E|KDM5D|HIST2H3C|HIST2H3A|KDM5B|HIST1H4I|KDM4B|MINA|KDM1A|KDM3B|KDM8|PHF2|HIST1H3H|KDM4A
VEGF LIGAND-RECEPTOR INTERACTIONS%REACTOME%R-HSA-194313.1,0.291922005571031,0.8000726114371469,-0.363953248307694,-1.1313251636905501,1571,8,VEGFA|KDR|FLT1|PGF
SIGNAL ATTENUATION%REACTOME%R-HSA-74749.3,0.467981257321359,0.8957057061714878,-0.30202935192437996,-0.9749778135111129,2396,9,SHC1|MAPK3
RUNX3 REGULATES IMMUNE RESPONSE AND CELL MIGRATION%REACTOME%R-HSA-8949275.1,0.7747252747252751,0.9804101513665492,-0.298349809412352,-0.755252731080962,4511,5,CBFB
G2 M CHECKPOINTS%REACTOME%R-HSA-69481.3,0.10048372911169698,0.570947005522165,0.21685130386261703,1.2947208279279099,1370,150,HIST1H2BJ|HIST3H2BB|CCNB1|CDC7|CDK1|PSMD11|ATR|BLM|PSMD13|WEE1|PSMB9|EXO1|BRIP1|PSMA4|ORC1|RFC4|CDC25C|DNA2|PSMD3|CDC45|RAD9A|PKMYT1|PSMD1|HIST1H4I|MCM6|GTSE1|CDC6|PSMA1|PIAS4|H2AFX|CCNB2|ORC6|PSMC3|RMI2|DBF4|BRCC3|HIST1H2BF|CHEK2|TOPBP1|MCM10|HERC2|RMI1|HIST1H2BK|MCM3|PSMA3|MCM2|CLSPN|PSMC6|PSMC1|PSMD2|CHEK1|RFC3|PSMA5|HIST1H2BN|RAD17|RFC5|PSMC2|RAD1|PSMC5|CDK2|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|SHFM1|HIST1H2BH|BRE|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|RNF8
RNA POLYMERASE III TRANSCRIPTION%REACTOME%R-HSA-74158.2,0.964782683387734,1.0,0.123113254179708,0.5622484299571321,11231,41,SNAPC2|BDP1|POLR3B|POLR3GL|BRF1|ZNF143|POLR3E|POLR2L|POLR3G|POU2F1|SNAPC3|SNAPC5|POLR2H|POLR3K|GTF3C5|GTF3C3
"SYNTHESIS OF IP2, IP, AND INS IN THE CYTOSOL%REACTOME%R-HSA-1855183.5",0.9858891886283458,1.0,-0.13761570550032598,-0.5182581164765739,4750,13,IMPA1|IMPA2|MTMR7|OCRL|INPP5J|INPP4B|MTMR9|SYNJ1|INPP4A|INPP5B|INPP1|INPP5A
ACTIVATION OF RAC1%REACTOME%R-HSA-428540.3,0.214152313758041,0.730650281859687,-0.32155946932227397,-1.21098681506068,1031,13,RAC1|PAK2
FORMATION OF SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI (SAHF)%REACTOME DATABASE ID RELEASE 66%2559584,0.560210987261146,0.936434965680841,0.301969356607269,0.921239286836119,5628,11,ASF1A|EP400|RB1|LMNB1
MTOR SIGNALLING%REACTOME%R-HSA-165159.4,0.4562279670975321,0.88900512246363,-0.17672786047662803,-0.9971440266503921,1552,39,RRAGD|EEF2K|PRKAA1|PRKAG1|RRAGC|EIF4G1|EIF4EBP1|LAMTOR5|CAB39|PPM1A|YWHAB|EIF4B
"BIOSYNTHESIS OF A2E, IMPLICATED IN RETINAL DEGRADATION%REACTOME DATABASE ID RELEASE 66%2466712",0.18013422818791897,0.6854786197196999,0.9116122629025141,1.2110362213595902,1341,1,NAPEPLD
AUF1 (HNRNP D0) BINDS AND DESTABILIZES MRNA%REACTOME DATABASE ID RELEASE 66%450408,0.784358638743456,0.981487311948134,-0.13320012414777,-0.811695031924548,2396,51,PSMD6|PABPC1|UBC|PSMF1|UBB
NEGATIVE REGULATION OF TCF-DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS%REACTOME%R-HSA-3772470.2,0.481111514711224,0.9046812288131709,-0.331700269171409,-0.967584401375382,2648,7,DKK1|SFRP2
DOWNREGULATION OF TGF-BETA RECEPTOR SIGNALING%REACTOME%R-HSA-2173788.1,0.031102264244837002,0.361013617615581,-0.32987709408853,-1.60032331410885,124,25,NEDD4L|TGFBR1|STUB1|SMAD2|SMAD7|UBA52|PPP1CB|UBC|UBB
CHL1 INTERACTIONS%REACTOME%R-HSA-447041.1,0.128418425704482,0.608160579951936,0.49680212403368607,1.35441587392625,1234,8,ITGB1|ITGA1|ITGA2|ITGA10
PROCESSING OF DNA DOUBLE-STRAND BREAK ENDS%REACTOME DATABASE ID RELEASE 66%5693607,0.361284708488253,0.848418604328854,0.20100402138690698,1.07856627336762,4566,82,HIST1H2BJ|HIST3H2BB|CCNA1|SIRT6|ATR|BLM|EXO1|BRIP1|RFC4|DNA2|RAD9A|SUMO2|HIST1H4I|PIAS4|H2AFX|RMI2|TIMELESS|BRCC3|HIST1H2BF|TOPBP1|HERC2|RMI1|HIST1H2BK|CLSPN|CHEK1|RFC3|HIST1H2BN|RAD17|RFC5|RAD1|CDK2|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE
ECM PROTEOGLYCANS%REACTOME%R-HSA-3000178.3,0.11515203134315599,0.593398236603313,0.29045285754974104,1.34656850412496,1351,43,ITGB1|COL9A2|ASPN|VCAN|TNC|ITGA9|ITGA2|TGFB2|LAMA1|LAMB2|ITGB5|TNXB|ITGA2B|PTPRS|LAMA2|SPARC|AGRN|FMOD|SERPINE1|ITGA8|BGN|TGFB3|DCN
INTERLEUKIN-27 SIGNALING%REACTOME%R-HSA-9020956.1,0.9980858351803349,1.0,0.137557097353629,0.40596653237572705,9906,10,JAK2|EBI3|TYK2|STAT1
TGFBR1 LBD MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3656535,0.0785443767495472,0.532203813468543,-0.65105103235465,-1.4972813650909098,476,4,TGFBR1|FKBP1A
ACTIVATED NTRK2 SIGNALS THROUGH CDK5%REACTOME%R-HSA-9032845.1,0.6282623626373629,0.9555196058074541,-0.339333499973883,-0.8590002222804392,3658,5,TIAM1|NTRK2|CDK5|RAC1
RAS ACTIVATION UPON CA2+ INFLUX THROUGH NMDA RECEPTOR%REACTOME%R-HSA-442982.2,0.620848090360869,0.9536478716552259,0.251840222474552,0.8730617547949829,6485,16,LRRC7|ACTN2|DLG3|GRIN1|HRAS|DLG4
TRANSPORT OF CONNEXINS ALONG THE SECRETORY PATHWAY%REACTOME DATABASE ID RELEASE 66%190827,0.3822818791946311,0.857390330625986,0.8152293780326422,1.0829958587553101,2847,1,GJA1
SLBP DEPENDENT PROCESSING OF REPLICATION-DEPENDENT HISTONE PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%77588,0.16168752523213598,0.664367762084791,-0.367325158092106,-1.2926629961054699,800,11,SNRPB|NCBP2|SLBP
SIGNALING BY NON-RECEPTOR TYROSINE KINASES%REACTOME DATABASE ID RELEASE 66%9006927,0.0212503849707422,0.306557165070089,-0.26909382733756504,-1.5815080842923501,68,45,SOCS3|CDKN1B|HIF1A|DOK1|BCAR1|NRAS|RHOA|PXN|HBEGF|CRK|PTPN1|KRAS|NR3C1|UBA52|STAT3|RAC1|UBC|EPAS1|UBB
METABOLISM OF VITAMIN K%REACTOME DATABASE ID RELEASE 66%6806664,0.545797329143755,0.930420772651609,-0.454670784162347,-0.922740847595223,3473,3,VKORC1|UBIAD1|VKORC1L1
THE NLRP1 INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844455,0.00424194815396701,0.153052077075921,-0.882761663174148,-1.79153856741108,26,3,BCL2L1|NLRP1|BCL2
INTEGRATION OF ENERGY METABOLISM%REACTOME%R-HSA-163685.1,0.0615458015267176,0.483519933151788,-0.181769003472768,-1.3208592516870201,128,97,ARL2BP|GNA15|SLC25A4|VAMP2|PPP2CA|PRKAR2A|GCGR|PPP2CB|RAP1A|PPP2R1B|GNB5|GNGT1|PRKCA|ACLY|PRKAR1B|ADCY2|ADRA2A|TKT|SLC2A1|GNAS|PLCB1|CACNA1E|SNAP25
"INCRETIN SYNTHESIS, SECRETION, AND INACTIVATION%REACTOME%R-HSA-400508.1",0.9882922890593461,1.0,-0.145291638317109,-0.5112993770194549,4895,11,SPCS2|SEC11C|SEC11A|ISL1|DPP4|SPCS3|SPCS1|CTNNB1|PCSK1|TCF7L2
REGULATION OF MITOTIC CELL CYCLE%REACTOME DATABASE ID RELEASE 66%453276,0.0948241801659423,0.564479959643483,0.24929414598342198,1.34280534436348,1199,84,CCNA1|ANAPC15|CCNB1|CDK1|BTRC|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|FBXO5|PSMD1|BUB1B|AURKB|PSMA1|PSMC3|PLK1|AURKA|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
WNT MEDIATED ACTIVATION OF DVL%REACTOME DATABASE ID RELEASE 66%201688,0.9393428812131421,1.0,0.22548296828584302,0.5868847924500871,8919,7,DVL1|DVL3|DVL2|CSNK1E|CSNK2B
NEPHRIN FAMILY INTERACTIONS%REACTOME%R-HSA-373753.3,0.688457899716178,0.96731875442989,0.22667366005668302,0.8285269086302729,7276,19,ACTN2|KIRREL|KIRREL3|CASK|MAGI2|SPTAN1
UNCOATING OF THE HIV VIRION%REACTOME DATABASE ID RELEASE 66%162585,0.673374817953131,0.9647315640607691,-0.658524481693869,-0.880928277405013,5085,1,PPIA
SIGNALING BY HEDGEHOG%REACTOME%R-HSA-5358351.2,0.605989430416911,0.9508825506493929,-0.122932040378976,-0.945422645166884,1031,123,PRKAR1A|SPOPL|IFT52|SKP1|PSMB7|CUL3|ERLEC1|PSMD10|IFT88|PRKACA|CSNK1A1|IFT57|IQCE|HHAT|PSME4|ITCH|FUZ|DYNC2H1|PSMC4|ADCY7|PSMD12|IFT122|TULP3|ARRB2|OS9|WDR35|PSMA6|IFT172|BOC|PSME3|CDON|EVC|P4HB|ARRB1|PRKAR2A|WDR19|ADAM17|UBA52|GPR161|PRKAR1B|ADCY2|PSMD6|INTU|GNAS|UBC|KIF7|PSMF1|UBB
"METABOLISM OF INGESTED SEMET, SEC, MESEC INTO H2SE%REACTOME%R-HSA-2408508.2",0.8156065711878691,0.986631695793843,0.27346545832431396,0.7117731328934659,7744,7,CTH
TRANSCRIPTIONAL ACTIVATION OF CELL CYCLE INHIBITOR P21%REACTOME%R-HSA-69895.3,0.0899061419397333,0.559960743386206,-0.6383937427521551,-1.46817224320559,545,4,ZNF385A|TP53|CDKN1A
KANDUTSCH-RUSSELL PATHWAY%REACTOME%R-HSA-6807062.1,0.319744652256692,0.8219996514077841,0.528748656568539,1.1204689119720401,2854,4,EBP|DHCR24|DHCR7
ADENYLATE CYCLASE INHIBITORY PATHWAY%REACTOME%R-HSA-170670.1,0.865947291969288,0.9929671171385601,-0.184451749393376,-0.694641762536278,4172,13,GNAI3|ADCY7|GNAI2|GNAL|ADCY2
FRS-MEDIATED FGFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5654693,0.189140088817117,0.6966968440614512,-0.35521819732331894,-1.25005709276251,936,11,FGF1|FRS2|NRAS|FGF2|KRAS|FGF10
HSF1-DEPENDENT TRANSACTIVATION%REACTOME DATABASE ID RELEASE 66%3371571,0.0812737642585551,0.538175749540073,-0.30792794180293703,-1.4265502159113002,341,22,CAMK2A|HSBP1|HSF1|FKBP4|HSPB8|HSP90AB1
NEURONAL SYSTEM%REACTOME DATABASE ID RELEASE 66%112316,0.576914990538931,0.942692029750853,0.14899864373240804,0.954938876143418,8231,255,KCNK2|KCNN2|KCNK6|PLCB3|KCNH8|SLC1A2|GNG8|GRIA1|KCNH3|CACNB4|CACNB2|SLITRK6|KCNK3|HCN2|KCNQ1|LRRC7|GNAI1|LRRTM1|ACTN2|SLC6A13|AKAP5|APBA3|UNC13B|KCNH1|GNB3|ADCY8|GRIK2|KCNC3|LIN7A|KCNC1|GLS|KCND1|LIN7B|KCNB2|PPFIA2|GRIA2|DLG3|BZRAP1|HCN3|GLS2|DLGAP1|PDPK1|KCNJ11|PPFIA3|BCHE|KCNH2|PRKCB
ACTIVATED POINT MUTANTS OF FGFR2%REACTOME%R-HSA-2033519.1,0.340949033391916,0.8346573454550649,-0.392800851656121,-1.0782119631476401,1939,6,FGF7|FGF2|FGF10
NON-INTEGRIN MEMBRANE-ECM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000171,0.628414361793506,0.9555836714381641,0.193062699323748,0.8817019767799692,7315,41,ITGB1|LAMC3|TNC|DDR2|ITGA2|LAMA1|DDR1|LAMB2|ITGB5|CASK|DMD|LAMA2|AGRN|THBS1
INFLAMMASOMES%REACTOME DATABASE ID RELEASE 66%622312,0.104467509025271,0.576535954147525,-0.314024936442297,-1.37714794922803,462,19,BCL2L1|PANX1|NLRP1|NLRP3|BCL2|HSP90AB1
INTERFERON ALPHA BETA SIGNALING%REACTOME%R-HSA-909733.2,0.0748056994818653,0.524399009933241,-0.226836622253913,-1.3740539326885501,230,50,EGR1|GBP2|HLA-F|STAT2|TYK2|BST2|IFIT1|IP6K2|IRF9|HLA-C|IRF2|ISG20|OAS1|USP18|IFI35|PSMB8|IFIT2|IFIT3|IRF5|JAK1|IRF7|OAS2|IRF8|HLA-B|PTPN11|ADAR|HLA-A|HLA-E|IRF1|IRF3|RSAD2|IFI6|SAMHD1|ISG15|MX1|SOCS3|RNASEL|PTPN6|IRF6|IFNAR1|IFITM2|MX2|IFITM3|OASL|PTPN1|OAS3|IFITM1
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-LYMPHOID CELL%REACTOME DATABASE ID RELEASE 66%198933,0.576079207920792,0.942162964865338,0.17404672516582298,0.929605071833522,7272,80,IGKV4-1|ITGB1|PILRB|PILRA|KLRB1|KLRK1|ITGA4|SLAMF6|SIGLEC8|CD200|IGKV3-11|IGKV2D-28|CXADR|IGKV2-28|NPDC1|AMICA1|CD8B|CD3D|NCR3|SIGLEC10|CD1D|SH2D1A|CD3G|CD3E|FCGR3A|CD8A|CLEC2D|ICAM3
PROTEIN-PROTEIN INTERACTIONS AT SYNAPSES%REACTOME%R-HSA-6794362.3,0.0999517141477547,0.570399840799782,0.257424953017953,1.34411134549013,1241,72,GRIA1|SLITRK6|LRRTM1|APBA3|LIN7A|LIN7B|PPFIA2|DLG3|DLGAP1|PPFIA3|PTPRD|GRIN1|CASK|DLGAP2|GRIA4|RTN3|DLG4|NTRK3|NLGN4Y|EPB41|NRXN3|PTPRS|EPB41L5|SLITRK1|PPFIBP1|SYT1|DLGAP3|SHANK1|APBA2|NLGN3|SYT7|STX1A|PPFIA4|LRFN3|EPB41L2|SHARPIN|SIPA1L1|LRRC4B|LIN7C|PDLIM5|GRIN2D|NRXN2|NLGN2|HOMER3|LRRTM2|DLG2|LRFN1
TOLL LIKE RECEPTOR 5 (TLR5) CASCADE%REACTOME%R-HSA-168176.1,0.0021034917963819897,0.115553415806697,-0.260612103680475,-1.80561531075436,4,80,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
G PROTEIN GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296059.1,0.914072942524346,1.0,0.174911199898369,0.6168865426734511,9573,17,GNG8|GNB3|GABBR1|GNG3|GNG2|GNGT2|GNG7|KCNJ9|GNB2|KCNJ12|GNG12
DEFECTS IN COBALAMIN (B12) METABOLISM%REACTOME DATABASE ID RELEASE 66%3296469,0.384401114206128,0.8591183336528591,-0.334524318722063,-1.03984723696366,2069,8,TCN2|MMACHC|MTRR|MMAA
VISUAL PHOTOTRANSDUCTION%REACTOME%R-HSA-2187338.1,0.232967763376537,0.746122594132505,0.24314197172129798,1.19098621348299,2803,54,RBP1|LPL|BCO2|GUCA1B|NAPEPLD|GPC2|GPC6|PRKCQ|AKR1C1|GPC1|APOE|CNGB1|LRP8|FNTB|LDLR|GPC3|SLC24A1|RDH11|MYO7A|APOM|AGRN|METAP1
SIGNALING BY FGFR4 IN DISEASE%REACTOME DATABASE ID RELEASE 66%5655291,0.86973604674592,0.9934031064448321,0.224382134533694,0.662209648474415,8632,10,FGFR4|HRAS|PLCG1
MTORC1-MEDIATED SIGNALLING%REACTOME%R-HSA-166208.2,0.128533462188935,0.608357435641882,-0.279363527852364,-1.3127058561479699,531,23,SLC38A9|RHEB|AKT1S1|LAMTOR2|EIF4E|RRAGD|EEF2K|RRAGC|EIF4G1|EIF4EBP1|LAMTOR5|YWHAB|EIF4B
ENOS ACTIVATION%REACTOME%R-HSA-203615.3,0.0100472813238771,0.21951586544159402,-0.5527750967616171,-1.8701208917124599,50,10,SPR|DDAH2|NOS3|CAV1|DDAH1
REGULATION OF NECROPTOTIC CELL DEATH%REACTOME%R-HSA-5675482.2,0.6337197877775589,0.9584504137025791,0.273316323011849,0.8615907241493951,6449,12,FAS|BIRC2|RIPK1|TRAF2|TRADD|XIAP|BIRC3|FADD
NOD1 2 SIGNALING PATHWAY%REACTOME DATABASE ID RELEASE 66%168638,0.8649420160570921,0.992690647212272,0.163192086060948,0.6842531960227161,9695,30,MAPK11|MAP2K6|MAPK12|MAP3K7|CARD9|BIRC2|CASP9|MAPK13|CASP2|CHUK|TAB1|BIRC3|MAPK14|IKBKG
CREB PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%199920,0.0177987649836542,0.282007307615586,-0.6041367898510761,-1.7622938191069901,97,7,RPS6KA1|CREB1|RPS6KA5|ATF1|MAPKAPK2|RPS6KA3|RPS6KA2
APC C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS%REACTOME DATABASE ID RELEASE 66%174143,0.0948241801659423,0.564479959643483,0.24929414598342198,1.34280534436348,1199,84,CCNA1|ANAPC15|CCNB1|CDK1|BTRC|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|FBXO5|PSMD1|BUB1B|AURKB|PSMA1|PSMC3|PLK1|AURKA|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|SKP2|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
CLEARANCE OF NUCLEAR ENVELOPE MEMBRANES FROM CHROMATIN%REACTOME%R-HSA-2993913.1,0.611135323599913,0.9508825506493929,0.384122286137274,0.8853449266819741,5608,5,LEMD3|VRK1|LEMD2
POTASSIUM TRANSPORT CHANNELS%REACTOME%R-HSA-1296067.1,0.5771216735072161,0.942692029750853,-0.705558006175562,-0.943846457144314,4358,1,KCNJ10
ANDROGEN BIOSYNTHESIS%REACTOME%R-HSA-193048.2,0.914835164835165,1.0,-0.253623676483786,-0.6420314955402939,5327,5,SRD5A1
NEUROFASCIN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%447043,0.449241786015164,0.8858223310328521,0.38927788793608703,1.01320855496793,4265,7,NFASC|DCX|CNTN1|NRCAM|CNTNAP1
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN%REACTOME DATABASE ID RELEASE 66%170822,0.0111050427817222,0.22988826688512698,0.435822717618586,1.75221608119273,121,26,TPR|NUP133|NUP205|NUP188|GCK|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PYRIMIDINE%REACTOME DATABASE ID RELEASE 66%110328,0.708298230834035,0.9695170059473192,0.306979585850268,0.799003365521418,6725,7,TDG|MBD4|NEIL1
RECRUITMENT AND ATM-MEDIATED PHOSPHORYLATION OF REPAIR AND SIGNALING PROTEINS AT DNA DOUBLE STRAND BREAKS%REACTOME%R-HSA-5693565.2,0.165659438322076,0.6682860217990739,-0.190606114707627,-1.21921085142546,465,60,EYA4|UBA52|TP53|HIST2H4B|EYA1|HIST1H2BC|UBC|HIST1H2BD|RNF168|UBB
FASL  CD95L SIGNALING%REACTOME%R-HSA-75157.2,0.8209205958114009,0.987153241368501,0.344510009375172,0.7300496191767409,7329,4,FAS|FADD|CASP10|CASP8
TNFR1-INDUCED PROAPOPTOTIC SIGNALING%REACTOME DATABASE ID RELEASE 66%5357786,0.44926333264162704,0.8858223310328521,-0.262499269238233,-0.988567230442756,2164,13,TNFAIP3|CYLD|USP2|TNF
ALKBH2 MEDIATED REVERSAL OF ALKYLATION DAMAGE%REACTOME DATABASE ID RELEASE 66%112122,0.680656692704886,0.9650163074981261,-0.65477503308337,-0.8759125256790191,5140,1,ALKBH2
ACTIVATION OF HOX GENES DURING DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%5619507,0.15703320802005,0.6578589353509621,0.228830292217682,1.2523860704106202,2004,91,RBBP7|HIST1H3E|HOXD3|HIST1H2BJ|EGR2|HIST3H2BB|HOXB3|HOXB2|HOXD4|RARB|HOXC4|HIST2H3C|HIST2H3A|PCGF2|POLR2B|EZH2|PAGR1|HIST1H4I|HDAC3|H2AFX|H3F3A|H2AFZ|HIST1H2BF|POLR2L|ZNF335|MEIS1|AJUBA|HIST1H2BK|PAXIP1|POLR2J|HIST1H2AC|KMT2D|WDR5|SUZ12|EED|HIST1H3H|HIST1H2BN|POLR2G|POLR2H
ATP SENSITIVE POTASSIUM CHANNELS%REACTOME DATABASE ID RELEASE 66%1296025,0.440362862582596,0.879896414106183,0.48279081279767205,1.0230798508996,3931,4,KCNJ11|ABCC8|KCNJ8
FORMATION OF TC-NER PRE-INCISION COMPLEX%REACTOME DATABASE ID RELEASE 66%6781823,0.09300000000000001,0.5622489437340121,-0.21536215718601504,-1.3283311031618998,278,53,POLR2A|COPS7A|POLR2K|UBA52|POLR2F|COPS2|TCEA1|POLR2I|POLR2D|COPS8|UBC|UBB
INSULIN-LIKE GROWTH FACTOR-2 MRNA BINDING PROTEINS (IGF2BPS IMPS VICKZS) BIND RNA%REACTOME DATABASE ID RELEASE 66%428359,0.352089846011347,0.842847021021096,0.573067166648285,1.08934039939525,3040,3,IGF2BP3|IGF2BP1|IGF2BP2
NECTIN NECL TRANS HETERODIMERIZATION%REACTOME DATABASE ID RELEASE 66%420597,0.0443152924082819,0.41504430757275895,-0.5490939872720529,-1.60173152195695,243,7,CADM3|PVRL1|PVRL2|PVRL3|PVRL4
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS%REACTOME%R-HSA-159234.2,0.1259136790811,0.607607158836689,0.300604873474087,1.33652004647548,1446,37,TPR|NUP133|WDR33|CPSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|CPSF2|NUP37|AAAS|NUP62|CPSF4|RANBP2|SYMPK|NUP50|NXF1
RNA POLYMERASE I PROMOTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%73854,0.756617937574081,0.977664504547119,0.150526909515272,0.8108025873221519,9574,84,GTF2H2|RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MBD3|MTA2|TAF1D|KAT2A|MTA1|HIST2H3C|HIST2H3A|GTF2H1|HIST1H4I|H2AFX|H3F3A|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|EHMT2|HIST1H2AC|HIST1H3H|HIST1H2BN|POLR2H|CHD3|HIST1H2BG|HIST2H2BE|HIST1H2BH
TLR3-MEDIATED TICAM1-DEPENDENT PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%9013957,0.7839972527472528,0.981487311948134,-0.296085713351699,-0.74952132224713,4565,5,TICAM1
"PROGRESSIVE TRIMMING OF ALPHA-1,2-LINKED MANNOSE RESIDUES FROM MAN9 8 7GLCNAC2 TO PRODUCE MAN5GLCNAC2%REACTOME%R-HSA-964827.2",0.6619196480259351,0.964618776001639,0.459343761501629,0.873164169464636,5716,3,MAN1C1|MAN1A1|MAN1A2
THE ROLE OF NEF IN HIV-1 REPLICATION AND DISEASE PATHOGENESIS%REACTOME DATABASE ID RELEASE 66%164952,0.30554864394127895,0.80885407485798,-0.22820694820042398,-1.1070938424986798,1227,25,AP1S1|AP2S1|B2M|RAC1|PAK2
MAJOR PATHWAY OF RRNA PROCESSING IN THE NUCLEOLUS AND CYTOSOL%REACTOME DATABASE ID RELEASE 66%6791226,0.0449826989619377,0.417110009803276,-0.156257733498886,-1.29014586074177,51,180,RIOK3|NCL|TEX10|RPS16|RPL12|UTP15|C1D|RPS4X|WDR12|RPL9|PES1|RRP1|RPS28|ISG20L2|MPHOSPH6|RPL35|UTP3|RPL7|EXOSC6|RRP36|RPS9|RPS3|RPL14|DHX37|DDX47|EXOSC4|NOB1|NHP2L1|RPL15|RPL8|WBSCR22|PWP2|TBL3|RCL1|FCF1|RPL35A|EXOSC9|UTP14A|WDR43|EBNA1BP2|DDX21|RRP7A|UBA52|CIRH1A|BYSL|IMP4|TSR1|PNO1|NOL9|RPP40|RPP14|NIP7|EMG1|RRP9|NOP14|NOP56|EXOSC5
EUKARYOTIC TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%72613,0.33921676778819604,0.832810902324958,-0.138764263371781,-1.05827790742297,614,117,RPS4Y1|RPS24|RPL36A|EIF2B4|RPS19|RPLP0|RPS27L|RPL36|EIF5B|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|EIF3F|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|EIF3J|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|EIF3M|RPS27|RPS23|RPS21|RPL3|RPL29|EIF2B2|EIF3C|RPL31|RPL17|RPS14|RPS17|RPL32|EIF3L|RPL18A|RPL11|EIF2S2|EIF4E|RPS16|RPL12|EIF5|EIF3H|RPS4X|EIF3D|EIF2B3|RPL9|EIF2S1|RPS28|EIF4A1|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|EIF4A2|EIF4G1|EIF4EBP1|EIF3G|RPL15|RPL8|EIF3B|EIF4H|RPL35A|EIF4B|EIF1AX|EIF3A|UBA52|EIF3I|EIF2S3|PABPC1
RESPONSE TO METAL IONS%REACTOME DATABASE ID RELEASE 66%5660526,0.42925101214574896,0.877632841005648,0.359826659941927,1.02682234305952,4240,9,MT1F|MT1E|MT2A|SNCB
TNF RECEPTOR SUPERFAMILY (TNFSF) MEMBERS MEDIATING NON-CANONICAL NF-KB PATHWAY%REACTOME DATABASE ID RELEASE 66%5676594,0.30040263183737603,0.803321166778425,0.355587886956553,1.14761428376021,3058,13,TNFSF13B|TNFRSF12A|TNFRSF13C|BIRC2|LTA|LTB|TRAF2|BIRC3|LTBR|TNFSF12
TRNA PROCESSING IN THE NUCLEUS%REACTOME%R-HSA-6784531.5,0.21238126978836896,0.7277563022895039,0.248387064270887,1.2114646387293502,2548,53,RPP30|RPP25|POP1|TPR|NUP133|TSEN54|CPSF1|NUP205|NUP188|NUP160|RPP38|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|RPP21|POM121|NUP54|NUP37|AAAS|XPOT|TSEN15|NUP62|CPSF4|RANBP2|POP7|NUP50|C14orf166
HYDROLYSIS OF LPE%REACTOME DATABASE ID RELEASE 66%1483152,0.42910170749814397,0.877632841005648,-0.597200505040382,-1.02147947985838,2889,2,GPCPD1
SIGNALLING TO P38 VIA RIT AND RIN%REACTOME%R-HSA-187706.2,0.538679450860754,0.927442601695077,0.40903332905281703,0.9427611877518959,4943,5,RIT2|NGF
RNA POLYMERASE II PRE-TRANSCRIPTION EVENTS%REACTOME DATABASE ID RELEASE 66%674695,0.604989604989605,0.9508825506493929,-0.134940139158019,-0.9328862256559491,1454,79,POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TAF4B|NCBP2|TCEA1|POLR2I|POLR2D|TAF13|EAF1
HORMONE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375281.1,0.431837425910246,0.8785877309899279,0.6299191195944279,1.02958549608658,3569,2,GNRH1
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONES%REACTOME DATABASE ID RELEASE 66%381033,0.232741219216795,0.746122594132505,-0.33883856473504903,-1.1924151249576498,1152,11,CALR|ATF4|HSPA5|DDIT3|ATF6|NFYA
MITOTIC SPINDLE CHECKPOINT%REACTOME%R-HSA-69618.2,0.00505940973553085,0.16526407224877,0.293019470748435,1.65251511919251,65,107,CLIP1|ANAPC15|ZWINT|ANAPC5|CENPF|KIF2C|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC23|CDC20|NDC80|ITGB3BP|CENPA|ANAPC7|CENPE|ANAPC16|BUB1B|AURKB|ERCC6L|NUP160|DSN1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|CENPM|UBE2C|DYNC1H1|ANAPC10|SPC25
PROTON-COUPLED MONOCARBOXYLATE TRANSPORT%REACTOME%R-HSA-433692.2,0.5746924428822501,0.941940408834489,-0.32560924528709,-0.8937755152510831,3269,6,SLC16A1|SLC16A8|SLC16A3
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN INTERLEUKIN SIGNALING%REACTOME%R-HSA-8939247.1,0.0421537954882266,0.40376460791238894,-0.702090111950587,-1.61466058572436,255,4,LIFR|ELF1|RUNX1|CBFB
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP (SREBF)%REACTOME%R-HSA-1655829.2,0.887435427428762,0.997039752625282,0.14025039173566298,0.684046855074525,10650,53,TM7SF2|NFYB|ELOVL6|GPAM|SMARCD3|MVD|MED1|ACACA|SREBF2|GGPS1|SEC24D|IDI1|CARM1|SEC24C|DHCR7|TGS1|SP1|CHD9|MVK|SAR1B|SEC24A
FGFRL1 MODULATION OF FGFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5658623,0.0338255494505495,0.37600329791737297,-0.664239068093681,-1.6814770931362097,196,5,FGF2|FGF10|SPRED2
NEURODEGENERATIVE DISEASES%REACTOME DATABASE ID RELEASE 66%8863678,0.011279926335175,0.22992267312754103,-0.407296008911291,-1.8173162983334101,48,20,SOD2|CDC25B|JUN|PRDX1|YWHAE|BCL2L11|FOXO3
NUCLEAR IMPORT OF REV PROTEIN%REACTOME%R-HSA-180746.1,0.0554011653966831,0.458062256682211,0.36107239306979105,1.4956834407154298,617,29,RCC1|TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
CAP-DEPENDENT TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%72737,0.33921676778819604,0.832810902324958,-0.138764263371781,-1.05827790742297,614,117,RPS4Y1|RPS24|RPL36A|EIF2B4|RPS19|RPLP0|RPS27L|RPL36|EIF5B|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|EIF3F|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|EIF3J|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|EIF3M|RPS27|RPS23|RPS21|RPL3|RPL29|EIF2B2|EIF3C|RPL31|RPL17|RPS14|RPS17|RPL32|EIF3L|RPL18A|RPL11|EIF2S2|EIF4E|RPS16|RPL12|EIF5|EIF3H|RPS4X|EIF3D|EIF2B3|RPL9|EIF2S1|RPS28|EIF4A1|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|EIF4A2|EIF4G1|EIF4EBP1|EIF3G|RPL15|RPL8|EIF3B|EIF4H|RPL35A|EIF4B|EIF1AX|EIF3A|UBA52|EIF3I|EIF2S3|PABPC1
SULFUR AMINO ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%1614635,0.24330295498481103,0.7565220534116759,0.30819700750161605,1.19864081191292,2642,23,CTH|TST|APIP|SLC25A10|CDO1|MTR|TXN2|MTAP|ADO|SUOX
ONCOGENE INDUCED SENESCENCE%REACTOME%R-HSA-2559585.4,0.0392050095289954,0.396089810860281,-0.28496579204621997,-1.52421661217201,143,33,ETS1|UBA52|ID1|TP53|MAPK3|UBC|ETS2|TFDP2|UBB
N-GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE%REACTOME%R-HSA-532668.2,0.747570119411275,0.9749763305090959,-0.14995401927595597,-0.815151092707829,2691,35,RNF139|AMFR|RAD23B|RNF103|UBA52|UBC|UBB
MEIOTIC SYNAPSIS%REACTOME%R-HSA-1221632.1,0.421263122812865,0.873049502803635,0.211494012300804,1.0315252042513199,5055,53,HSPA2|HIST1H2BJ|HIST3H2BB|SYCP2|SYNE1|ATR|HIST1H4I|LMNB1|H2AFX|REC8|H2AFZ|SYNE2|HIST1H2BF|HIST1H2BK|HIST1H2AC|STAG3|ACD|HIST1H2BN|SMC3|HIST1H2BG|HIST2H2BE|BRCA1|HIST1H2BH
AFLATOXIN ACTIVATION AND DETOXIFICATION%REACTOME DATABASE ID RELEASE 66%5423646,9.820288716488259e-05,0.0784645998831315,0.692516756312831,2.2350089821394703,0,13,DPEP1|AKR7A3|MGST1|AKR7L|CYP3A5|ACY1|GGT1|MGST3|MGST2|GGT5
RRNA MODIFICATION IN THE MITOCHONDRION%REACTOME%R-HSA-6793080.3,0.963620386643234,1.0,-0.20676142439969297,-0.56754622696277,5482,6,RNMTL1
EPHRIN SIGNALING%REACTOME%R-HSA-3928664.2,0.0353356890459364,0.382137421231133,-0.384908000380756,-1.6196485945126498,159,17,EFNB1|RAC1|EPHB2|PAK2
ASYMMETRIC LOCALIZATION OF PCP PROTEINS%REACTOME DATABASE ID RELEASE 66%4608870,0.927699991812004,1.0,0.12758054659756699,0.6426904538465129,11329,61,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|VANGL2|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|FZD3|PSMA5|PSMC2|PSMC5|DVL2|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|SMURF2|PSMB4|SCRIB|PSME2|RPS27A|PSMD14|PSMD4|PSMB10|PSMD9|FZD2|PSME1
TOXICITY OF BOTULINUM TOXIN TYPE G (BONT G)%REACTOME DATABASE ID RELEASE 66%5250989,0.313904163393559,0.816422962704093,-0.5477741848901551,-1.11169143314879,1997,3,VAMP2|VAMP1
ACTIVATION OF G PROTEIN GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296041.1,0.914072942524346,1.0,0.174911199898369,0.6168865426734511,9573,17,GNG8|GNB3|GABBR1|GNG3|GNG2|GNGT2|GNG7|KCNJ9|GNB2|KCNJ12|GNG12
FERTILIZATION%REACTOME%R-HSA-1187000.1,0.26130810023916,0.771967970256231,0.43454978949046297,1.18469930868751,2512,8,CATSPERG|OVGP1|IZUMO4|ZP3
TRANSPORT OF ORGANIC ANIONS%REACTOME DATABASE ID RELEASE 66%879518,0.9877969056439309,1.0,0.211461028977209,0.48738632449203,9065,5,SLC16A2|SLCO2A1|SLCO2B1|SLCO4A1
CGMP EFFECTS%REACTOME DATABASE ID RELEASE 66%418457,0.699793773936954,0.967789953250095,0.251040317540777,0.810200416766993,7125,13,PDE3B|PDE2A|PDE1A|PDE1B|PDE5A|KCNMA1|MRVI1
PHOSPHORYLATION OF PROTEINS INVOLVED IN G1 S TRANSITION BY ACTIVE CYCLIN E:CDK2 COMPLEXES%REACTOME DATABASE ID RELEASE 66%69200,0.0914996080188151,0.5622489437340121,0.6580819500358461,1.3945385153891499,816,4,CCNE1|RB1|CCNE2|CDK2
RESOLUTION OF AP SITES VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%110381,0.824798287502058,0.9876441563834109,-0.31379253295097304,-0.7216572722309008,5008,4,XRCC1|POLB|LIG3|APEX1
FORMATION OF EDITOSOMES BY ADAR PROTEINS%REACTOME DATABASE ID RELEASE 66%77042,0.39272457312546405,0.8621064456029929,-0.6185277088502901,-1.05795851976325,2644,2,ADAR|ADARB1
FREE FATTY ACIDS REGULATE INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%400451,0.6638212858699599,0.964618776001639,-0.286618632640769,-0.836079267525218,3654,7,GNAQ|GNA15|PLCB1
"BMAL1:CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION%REACTOME%R-HSA-1368108.4",0.7036576262751929,0.968941691852291,-0.17196489794857997,-0.834248392286387,2827,25,CCRN4L|PPARA|RXRA|TBL1X|NAMPT|HELZ2|BHLHE41
DEFECTIVE GALNT12 CAUSES COLORECTAL CANCER 1 (CRCS1)%REACTOME%R-HSA-5083636.1,0.35026362038664305,0.842847021021096,-0.388780782837379,-1.06717714416807,1992,6,MUC4|MUC3A|MUC12
NUCLEAR ENVELOPE REASSEMBLY%REACTOME DATABASE ID RELEASE 66%2995410,0.625226677412855,0.954110852066186,0.294085370324786,0.8679219052308349,6205,10,LEMD3|LMNB1|VRK1|LEMD2|PPP2R1A|ANKLE2
APOPTOTIC FACTOR-MEDIATED RESPONSE%REACTOME DATABASE ID RELEASE 66%111471,0.5014743049705139,0.9152431082892529,0.370968564916724,0.9655532339394308,4761,7,APAF1|CASP9|XIAP|CYCS|CASP7|DIABLO
CLASS C 3 (METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS)%REACTOME%R-HSA-420499.1,0.52580971659919,0.9265056012720759,0.331944144113503,0.947255169693443,5194,9,TAS2R4|GRM4|TAS2R5|TAS2R20|GABBR1|TAS2R14|TAS2R19
LECTIN PATHWAY OF COMPLEMENT ACTIVATION%REACTOME%R-HSA-166662.3,0.320713210605534,0.822183858873702,0.587645052173743,1.11705142624315,2769,3,COLEC11|FCN3|FCN1
ADENYLATE CYCLASE ACTIVATING PATHWAY%REACTOME DATABASE ID RELEASE 66%170660,0.974192277383767,1.0,-0.163593986994995,-0.553462944749501,4944,10,ADCY7|GNAL|ADCY2
CLASS B 2 (SECRETIN FAMILY RECEPTORS)%REACTOME DATABASE ID RELEASE 66%373080,0.0006932409012131719,0.0806484601749226,-0.323984830277447,-2.0420579851187,1,57,PTHLH|RAMP3|GNG10|FZD1|GNG4|UCN2|CRHR1|CALCRL|ADCYAP1R1|VIP|GCGR|WNT6|VIPR1|WNT11|CRH|RAMP2|GNB5|GNGT1|GIPR|ADM2|CALCB|ADCYAP1|WNT3|UCN3|GNAS|ADM|RAMP1
SEMA4D IN SEMAPHORIN SIGNALING%REACTOME%R-HSA-400685.2,0.0495288717081421,0.437434563451949,-0.32341984571477006,-1.51972280965974,204,23,RHOC|LIMK1|MYH11|MYH9|RAC1|MET
OXYGEN-DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA%REACTOME%R-HSA-1234176.2,0.27415238789646396,0.7884684708511421,-0.17256410380699802,-1.12426651155449,751,64,VHL|TCEB1|UBA52|UBE2D3|PSMD6|UBC|EPAS1|PSMF1|UBB|EGLN3
DEFECTIVE CHST6 CAUSES MCDC1%REACTOME DATABASE ID RELEASE 66%3656225,0.174375629969761,0.676682497340677,0.5996801411790661,1.2707795035901799,1556,4,PRELP|FMOD|OGN|LUM
REGULATION BY TREX1%REACTOME%R-HSA-3248023.1,0.198728981861512,0.711592141628341,-0.8993162770180859,-1.2030428036905099,1500,1,TREX1
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629594,0.0113324175824176,0.22999530340982602,-0.7330134568718291,-1.8555748914737702,65,5,CHRNB4|CHRNA5|CHRNB2|CHRNA7|CHRNA3
GAP JUNCTION DEGRADATION%REACTOME%R-HSA-190873.2,0.321781180737457,0.822751772025005,0.382725710185279,1.1295224485256699,3193,10,CLTB|GJA1|CLTC|DNM1|DAB2|CLTCL1|AP2M1
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN%REACTOME%R-HSA-6804115.1,0.8101742816768721,0.9847556901908759,-0.16494115225571,-0.7491290636331809,3439,21,CNOT7|NPM1|TP53|PLK2
REGULATION OF HSF1-MEDIATED HEAT SHOCK RESPONSE%REACTOME DATABASE ID RELEASE 66%3371453,0.727372262773723,0.972554563883587,-0.131716277823532,-0.8528658284113091,1992,63,BAG5|ST13|HSPA12A|HSPA4L|BAG3|HSF1|YWHAE|DNAJB6|HSPA6|MAPK3|BAG1
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%205043,0.0300768386388584,0.35655155669157795,-0.40692922453005104,-1.66651193948551,136,16,PSEN1|PSENEN|APH1B|TRAF6|SQSTM1|NCSTN|PSEN2|UBA52|UBC|UBB
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%9013508,0.673019709929342,0.9647315640607691,0.22184353507503698,0.8386868064903109,7238,21,KAT2A|HES1|MAML1|DLGAP5|HEYL|HEY2
COMMON PATHWAY OF FIBRIN CLOT FORMATION%REACTOME DATABASE ID RELEASE 66%140875,0.22909530525891603,0.7432881250816031,0.415535981993088,1.2263540372141,2273,10,SERPINA5|SERPINE2|F2R
SHC-RELATED EVENTS TRIGGERED BY IGF1R%REACTOME DATABASE ID RELEASE 66%2428933,0.0148928441699964,0.264326813346421,-0.6181822729753951,-1.80326511652203,81,7,IGF1R|NRAS|IGF1|KRAS|IGF2
TRNA PROCESSING IN THE MITOCHONDRION%REACTOME DATABASE ID RELEASE 66%6785470,0.42067307692307704,0.8727872721376851,-0.39945951908228494,-1.01120524708032,2449,5,HSD17B10|TRNT1|TRMT10C|ELAC2|KIAA0391
P53-INDEPENDENT DNA DAMAGE RESPONSE%REACTOME DATABASE ID RELEASE 66%69610,0.783609576427256,0.981487311948134,0.160338190478202,0.7745884106922459,9360,51,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|PSMC6|PSMC1|PSMD2|CHEK1|PSMA5|PSMC2|PSMC5|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
HATS ACETYLATE HISTONES%REACTOME%R-HSA-3214847.1,0.6988977575066521,0.96731875442989,0.15112075125764202,0.86203722951327,9193,114,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|JADE3|AK6|KAT2A|IKBKAP|TADA1|OGT|TAF6L|HIST2H3C|HIST2H3A|YEATS4|TRRAP|EP400|HIST1H2AK|HIST1H4I|CLOCK|ING5|ELP4|YEATS2|BRPF3|HIST1H2BF|SUPT20H|HIST1H2BK|MSL1|KAT8|HIST1H2AC|SUPT3H|WDR5|HIST1H3H|ZZZ3|HIST1H2BN|BRD1|HIST3H2A
LOSS OF MECP2 BINDING ABILITY TO 5MC-DNA%REACTOME DATABASE ID RELEASE 66%9022538,0.380252412769117,0.856455387424841,-0.627367682959344,-1.07307882203806,2560,2,SIN3A
PACKAGING OF TELOMERE ENDS%REACTOME DATABASE ID RELEASE 66%171306,0.747301411569333,0.9749763305090959,-0.151241934336609,-0.813815734471563,2699,34,HIST2H4B|HIST1H2BC|HIST2H2AC|HIST1H2BD
ACYL CHAIN REMODELLING OF PS%REACTOME DATABASE ID RELEASE 66%1482801,0.489573182615475,0.908938677284213,0.29555347250345504,0.9792604996926141,5023,14,LPCAT4|PLA2G4A|OSBPL5|OSBPL8|PLA2G2D|PLA2G12A|PLA2G4B
PI METABOLISM%REACTOME DATABASE ID RELEASE 66%1483255,0.998419596997234,1.0,-0.072081049659525,-0.49007510580308505,2526,74,GDPD3|PIK3R3|PLEKHA6|INPP5E|PNPLA6|MTMR4|PLEKHA1|GDPD1|PTPN13|RAB4A|TNFAIP8L2|MTMR1|PIP4K2B|MTMR7|FIG4|PIP5K1C|PLEKHA5|GDPD5|PIK3C2B|INPP5F|OCRL|PIK3C2A|RUFY1|MTMR6|PIKFYVE|SBF2|TMEM55B|PNPLA7|PIK3R4|MTMR3|PLEKHA8|INPPL1|INPP5J|PIK3R6|INPP4B|SACM1L|RAB14|MTM1|PIK3CB|PIK3CA|SBF1|PTEN|MTMR9|VAC14|PLEKHA4|PITPNB|PIP4K2C|PI4KB|PLEKHA3|ARF1|SYNJ1|TNFAIP8|INPP4A|INPP5D|GDE1|TNFAIP8L3|PIP5K1A|PI4K2B|TNFAIP8L1|PI4K2A|PIK3CD|PIK3R2|MTMR12|PIK3R5|MTMR10|SYNJ2|MTMR2|PIK3C3|INPP5K|PIP4K2A|ARF3|RAB5A|MTMR14|PIK3R1
RMTS METHYLATE HISTONE ARGININES%REACTOME DATABASE ID RELEASE 66%3214858,0.6579993375289829,0.9643779777660141,0.175742128691626,0.8680908346709691,7945,56,RBBP7|HIST1H3E|SMARCD3|ACTL6B|HIST2H3C|HIST2H3A|JAK2|ARID2|HIST1H2AK|HIST1H4I|H2AFX|H2AFZ|PRMT1|CARM1|HIST1H2AC|SMARCA4|WDR5|HIST1H3H|HIST3H2A|ARID1A
G-PROTEIN MEDIATED EVENTS%REACTOME%R-HSA-112040.1,0.54079528718704,0.928807195199472,-0.166614116283526,-0.947552210776086,1835,40,ADCY7|PRKCD|GNAZ|GNAI2|GNAL|PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2|PLCB4|PLCB1
OLFACTORY SIGNALING PATHWAY%REACTOME DATABASE ID RELEASE 66%381753,0.6251990445859871,0.954110852066186,0.285386160894456,0.8706477580678409,6281,11,RTP5|RTP4|REEP2|REEP6|REEP1|REEP3
G1 S DNA DAMAGE CHECKPOINTS%REACTOME%R-HSA-69615.2,0.725940400586224,0.972554563883587,0.16141300959315302,0.8262364202465359,8915,66,CCNA1|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDKN2A|CCNE1|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|CCNE2|PSMC6|PSMC1|PSMD2|CHEK1|PSMA5|PSMC2|PSMC5|CDK2|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PCBP4|MDM2|PSMA7|PSMB4|CCNA2
METABOLISM OF POLYAMINES%REACTOME%R-HSA-351202.2,0.877315371662257,0.994743247302385,0.135727281174476,0.712394493080382,10940,74,GAMT|PSMD11|APIP|PSMD13|PSMB9|PSMA4|PSMD3|OAZ3|PSMD1|PSMA1|PSMC3|MTAP|PSMA3|NAGS|CKB|PSMC6|PSMC1|PSMD2|PSMA5|AZIN2|PSMC2|PSMC5|ENOPH1|SHFM1|PSMA2|PSMB6|PSMB3|SAT1|PSMA7|PSMB4|CKMT1B|PSME2|GATM|ARG2
NRCAM INTERACTIONS%REACTOME%R-HSA-447038.1,0.8165543386689129,0.986645002385515,0.27319698786855606,0.7110743607028019,7753,7,DLG3|DLG4|NRP2|NRCAM|CNTN2
GAP JUNCTION ASSEMBLY%REACTOME DATABASE ID RELEASE 66%190861,0.914626288659794,1.0,0.254106645963751,0.624938288680114,8516,6,GJC2|GJA1
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES%REACTOME%R-HSA-8963889.1,0.7992635350318471,0.9839175016931591,0.23930277832049998,0.730057921488357,8030,11,LPL|LMF2|LMF1|APOC2|GPIHBP1|MBTPS1|MBTPS2
CHROMATIN MODIFYING ENZYMES%REACTOME DATABASE ID RELEASE 66%3247509,0.698288611874076,0.96731875442989,0.139847712332059,0.888247170984432,9914,236,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|HDAC10|MBD3|JADE3|EHMT1|MTA2|AK6|KAT2A|IKBKAP|KDM5D|SMARCD3|DOT1L|TADA1|OGT|TAF6L|ACTL6B|MTA1|HIST2H3C|HIST2H3A|YEATS4|JAK2|KDM5B|TRRAP|EP400|EZH2|KMT2B|ARID2|HIST1H2AK|HDAC8|HIST1H4I|ARID4A|CLOCK|ING5|HDAC3|SUV420H2|H2AFX|ELP4|YEATS2|KDM4B|H2AFZ|PHF21A|SETD8|BRPF3|HIST1H2BF|SUPT20H|PRMT1|MINA|KDM1A|HIST1H2BK|CARM1|NSD1|MSL1|KAT8|KDM3B|SMYD2|EHMT2|HIST1H2AC|SMARCA4|SUPT3H|KMT2D|WDR5|SUZ12|EED|KDM8|PHF2|HIST1H3H|ZZZ3|HIST1H2BN|BRD1|SUDS3|HIST3H2A|ATF7IP|ARID1A|KDM4A|CHD3
CLEC7A (DECTIN-1) INDUCES NFAT ACTIVATION%REACTOME DATABASE ID RELEASE 66%5607763,0.265563435776202,0.7792338872944151,-0.343465548629117,-1.16199536093029,1347,10,ITPR2|NFATC1|PPP3CA|PPP3CB|AHCYL1|ITPR1|ITPR3|NFATC3|PPP3R1|NFATC2
MITOCHONDRIAL TRANSLATION%REACTOME DATABASE ID RELEASE 66%5368287,0.756582022121826,0.977664504547119,0.14827668507375502,0.8146956374590508,9712,93,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MTIF3|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
P75NTR RECRUITS SIGNALLING COMPLEXES%REACTOME%R-HSA-209543.1,0.00933803693712388,0.212136117579847,-0.4989068874251021,-1.87887380175158,44,13,IRAK1|SQSTM1|RIPK2|UBA52|MYD88|UBC|UBB
GLYCOGEN BREAKDOWN (GLYCOGENOLYSIS)%REACTOME DATABASE ID RELEASE 66%70221,0.33867851622874795,0.8326275783736579,0.32696884467001003,1.1086244963328502,3505,15,GAA|PHKG2|PHKA2|AGL|PHKB|PHKA1|PYGL|GYG2|PGM2L1
PLASMA LIPOPROTEIN ASSEMBLY%REACTOME%R-HSA-8963898.1,0.896534354221237,0.998912093067348,0.21450077119008198,0.63304719238218,8898,10,ZDHHC8|APOE|APOC1|SAR1B|APOC2
EXPRESSION AND PROCESSING OF NEUROTROPHINS%REACTOME DATABASE ID RELEASE 66%9036866,0.598715626543718,0.949445913591245,-0.38075194204486296,-0.875649924836307,3635,4,PCSK5|PCSK6|FURIN
INTERCONVERSION OF 2-OXOGLUTARATE AND 2-HYDROXYGLUTARATE%REACTOME%R-HSA-880009.1,0.176334375361815,0.6796075379024961,0.6586833088275831,1.252087679198,1522,3,D2HGDH|L2HGDH|ADHFE1
GLUCOSE METABOLISM%REACTOME DATABASE ID RELEASE 66%70326,0.31340935902477396,0.8162246256973241,-0.160730452108647,-1.08783273881613,796,73,PFKFB4|PFKL|GPI|FBP1|ENO1|PPP2CA|PPP2CB|GAPDH|PGK1|PPP2R1B|HK1|HK2|TPI1|G6PC3|ALDOA|SLC25A13|PC|PGAM2
MRNA EDITING%REACTOME DATABASE ID RELEASE 66%75072,0.434381689445085,0.878651088001772,-0.436166105994595,-1.00309092549634,2637,4,APOBEC3C|ADAR|ADARB1|APOBEC3B
DISEASES OF SIGNAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%5663202,0.00801603206412826,0.19847993048827997,-0.15296263960739,-1.39439023999586,3,318,CTNNB1|CD19|DAB2IP|TGFBR1|NRAS|FOXO4|ARRB2|OS9|VAV1|HDAC4|PSMA6|CTBP1|ADAM10|KDM7A|PPP2R5C|PSME3|FGF7|FYN|BAG4|HDAC5|TCF7L2|FOXO1|TBL1X|FGF2|PAPD7|HGF|NCSTN|HBEGF|MPRIP|PSEN2|ARRB1|SMAD2|CDC37|ATG7|PPP2CA|PPP2CB|POLR2A|MAMLD1|LMNA|RAP1A|PRR5|YWHAB|PPP2R1B|FGFR1|HDAC11|POLR2K|ADAM17|KRAS|STAT5A|SHC1|UBA52|POLR2F|STAT3|RASA3|DKK1|GAB2|TRAK1|MAPK3|NCBP2|BCR|CDKN1A|POLR2I|ZC3HAV1|POLR2D|PSMD6|FGF10|VWF|SPRED3|RAC1|MET|MAP3K11|UBC|MAP2K1|PIK3R1|BCL2L11|LRRFIP1|SPRED2|RBPJ|PSMF1|FKBP1A|FOXO6|UBB|FOXO3
"SODIUM-COUPLED SULPHATE, DI- AND TRI-CARBOXYLATE TRANSPORTERS%REACTOME%R-HSA-433137.1",0.653199467763397,0.9640743070248079,0.546920111920937,0.8939258981603859,5399,2,SLC13A3|SLC13A4
MYD88:MAL(TIRAP) CASCADE INITIATED ON PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%166058,0.0044306601683650896,0.155321503601441,-0.23551799087278602,-1.68998851137262,9,90,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII%REACTOME DATABASE ID RELEASE 66%442729,0.664412673879444,0.964618776001639,0.248180068988275,0.841482326120889,6877,15,LRRC7|ACTN2|DLG3|GRIN1|DLG4
INHIBITION OF PKR%REACTOME%R-HSA-169131.4,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
AKT-MEDIATED INACTIVATION OF FOXO1A%REACTOME DATABASE ID RELEASE 66%211163,0.6884309553141451,0.96731875442989,0.3968975997018921,0.8410639274024259,6146,4,AKT3|AKT2|AKT1
SYNTHESIS OF DOLICHYL-PHOSPHATE MANNOSE%REACTOME%R-HSA-162699.1,0.11516103692066,0.593398236603313,-0.695164857460899,-1.4108164239619199,732,3,DPM1|DPM2
DEFECTIVE ACTH CAUSES OBESITY AND PRO-OPIOMELANOCORTININ DEFICIENCY (POMCD)%REACTOME DATABASE ID RELEASE 66%5579031,0.92751677852349,1.0,0.539038376709307,0.716088435251398,6909,1,POMC
NF-KB IS ACTIVATED AND SIGNALS SURVIVAL%REACTOME%R-HSA-209560.1,0.0178460261465034,0.282280839553241,-0.47186499065060206,-1.77703453538766,85,13,RELA|TRAF6|IRAK1|NFKBIA|SQSTM1|UBA52|UBC|UBB
SHC-MEDIATED CASCADE:FGFR3%REACTOME DATABASE ID RELEASE 66%5654704,0.507809662186705,0.9179996794142941,-0.32365100589791196,-0.9441043432932629,2795,7,NRAS|FGF2|KRAS
ENZYMATIC DEGRADATION OF DOPAMINE BY MONOAMINE OXIDASE%REACTOME DATABASE ID RELEASE 66%379398,0.49038345228015007,0.908938677284213,0.607775020678246,0.9933915747420691,4053,2,COMT|MAOA
TRANSCRIPTIONAL REGULATION BY SMALL RNAS%REACTOME DATABASE ID RELEASE 66%5578749,0.15936033097302899,0.661359103221672,0.237159837676376,1.2567203040207,2002,77,HIST1H3E|HIST1H2BJ|HIST3H2BB|TPR|NUP133|HIST2H3C|HIST2H3A|POLR2B|NUP205|HIST1H4I|NUP188|NUP160|TNRC6A|H2AFX|NUP85|H3F3A|H2AFZ|NUPL2|HIST1H2BF|POLR2L|NDC1|HIST1H2BK|NUP107|NUP35|POLR2J|NUP210|HIST1H2AC|POM121|HIST1H3H|NUP54|HIST1H2BN|POLR2G|POLR2H|HIST1H2BG|NUP37|HIST2H2BE|HIST1H2BH|AAAS
CHOLINE CATABOLISM%REACTOME%R-HSA-6798163.1,0.999214454045562,1.0,-0.225432888496746,-0.4575093492988811,6359,3,SARDH|SLC44A1|ALDH7A1
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR (ANDROGEN RECEPTOR) REGULATED GENES KLK2 AND KLK3%REACTOME DATABASE ID RELEASE 66%5625886,0.525004311088119,0.9262380308863678,0.21161589527958602,0.954442294456905,6088,39,HIST1H3E|HIST1H2BJ|HIST3H2BB|HIST2H3C|HIST2H3A|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|KDM1A|HIST1H2BK|HIST1H2AC|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH
INSULIN PROCESSING%REACTOME%R-HSA-264876.2,0.9895292725120641,1.0,0.11506183745583,0.458504870580156,10867,25,INS|SLC30A5|MYO5A|SLC30A7|ERO1LB|STX1A|EXOC6|CPE|EXOC1|SLC30A6|EXOC7|EXOC8|EXOC2
LOSS OF FUNCTION OF SMAD2 3 IN CANCER%REACTOME%R-HSA-3304349.1,0.0258347978910369,0.335048214687472,-0.6331145551817329,-1.73785694344026,146,6,TGFBR2|TGFB1|SMAD4|SMAD3|TGFBR1|SMAD2
FGFR4 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190322,0.154173022444977,0.652506880836,0.569964797234792,1.31368436518887,1414,5,FGFR4|FGF19|FGF9
SHC-MEDIATED CASCADE:FGFR1%REACTOME DATABASE ID RELEASE 66%5654688,0.168430826369545,0.672026878249637,-0.414895955133314,-1.2896772773378797,906,8,NRAS|FGF2|KRAS|FGF10
STIMULI-SENSING CHANNELS%REACTOME DATABASE ID RELEASE 66%2672351,0.832207607536438,0.9879452371959629,-0.12254285737319599,-0.7838446405733509,2340,60,RYR1|STOM|UBA52|ANO6|UBC|TRPV2|ANO2|UBB
REMOVAL OF THE FLAP INTERMEDIATE%REACTOME DATABASE ID RELEASE 66%69166,0.22461508477879602,0.7385051457259549,0.371527992818875,1.23098769510601,2304,14,DNA2|POLD1|FEN1|POLD3|POLA2
RNA POLYMERASE I TRANSCRIPTION TERMINATION%REACTOME%R-HSA-73863.4,0.6903876792352629,0.96731875442989,-0.16088304008613502,-0.846009046289001,2599,31,PTRF|POLR1B|TAF1B|POLR2K|POLR2F|POLR1E|CD3EAP
MAPK FAMILY SIGNALING CASCADES%REACTOME%R-HSA-5683057.2,0.0809464508094645,0.5374028338839121,-0.140758312116387,-1.22025245727939,64,236,MAPK4|PSMA6|RET|PPP2R5C|PSME3|FGF7|FYN|IL3RA|FOXO1|ETV4|FGF2|HGF|IL6|HBEGF|ARRB1|IL17RD|CAMK2A|CSF2RB|PPP2CA|PPP2CB|RAP1A|YWHAB|PPP2R1B|CDC42|AGO2|KRAS|SHC1|JUN|UBA52|RASA3|RASGRF2|MAPK3|RASGRP3|PSMD6|FGF10|PEA15|VWF|DUSP10|SPRED3|RAC1|MET|MAP3K11|UBC|MAP2K1|PTPRA|DLG1|SPRED2|PSMF1|GFRA2|PAK2|UBB|FOXO3
RNA POLYMERASE I PROMOTER OPENING%REACTOME DATABASE ID RELEASE 66%73728,0.695610769630335,0.96731875442989,0.18575385586975102,0.832137764922386,8034,38,HIST1H3E|HIST1H2BJ|HIST3H2BB|HIST2H3C|HIST2H3A|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|HIST1H2BK|HIST1H2AC|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH
DDX58 IFIH1-MEDIATED INDUCTION OF INTERFERON-ALPHA BETA%REACTOME DATABASE ID RELEASE 66%168928,0.0265328074578702,0.3377111602831,-0.232186899097253,-1.4897793906570198,73,61,RELA|RNF135|TRAF6|CREBBP|ITCH|UBE2D1|OTUD5|NFKBIA|SIKE1|TNFAIP3|PCBP2|TRAF3|NKIRAS1|CYLD|TANK|RNF216|MAVS|TRIM25|UBA52|NFKBIB|UBE2D3|TAX1BP1|UBC|UBE2K|UBB
ACTIVATED NTRK2 SIGNALS THROUGH PI3K%REACTOME DATABASE ID RELEASE 66%9028335,0.327679894615511,0.828303707528737,-0.47533949583400803,-1.0931815385191999,1989,4,PIK3R1
SIGNALING BY NTRK1 (TRKA)%REACTOME DATABASE ID RELEASE 66%187037,0.00120724346076459,0.0925609210820478,-0.272908276449656,-1.8597017160948,2,75,MAPKAPK3|RPS6KA3|AP2A1|NTRK1|PIK3R2|DUSP4|CRKL|DUSP7|MAPK7|DNM2|NRAS|RIT1|RHOA|MAP2K5|ADCYAP1R1|DNAL4|PPP2CA|PPP2CB|CRK|CLTA|RAP1A|RALA|YWHAB|PPP2R1B|AP2S1|KRAS|RAPGEF1|SHC1|DUSP3|STAT3|RALB|ADCYAP1|MAPK3|PIK3R1|RPS6KA2
RHESUS GLYCOPROTEINS MEDIATE AMMONIUM TRANSPORT.%REACTOME DATABASE ID RELEASE 66%444411,0.0859060402684564,0.5495132996855571,0.9579289810322009,1.27256591505959,639,1,RHBG
TERMINAL PATHWAY OF COMPLEMENT%REACTOME DATABASE ID RELEASE 66%166665,0.5276137547759641,0.9265056012720759,0.5057839835115511,0.961442146177514,4556,3,C7|C5
INTERLEUKIN-1 PROCESSING%REACTOME%R-HSA-448706.1,0.0272407732864675,0.339785941813865,-0.630023532719139,-1.72937229432742,154,6,NFKB1|IL18|CASP1|RELA|IL1B
FMO OXIDISES NUCLEOPHILES%REACTOME%R-HSA-217271.1,0.753356719487118,0.9769690538700708,0.5053763440860221,0.8260237509082801,6227,2,FMO2|FMO3
GABA A RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%977441,0.0716002747252747,0.515023940206536,-0.5914145981267961,-1.4971267832086,416,5,GABRQ|GABRG2|GABRA3
ENTRY OF INFLUENZA VIRION INTO HOST CELL VIA ENDOCYTOSIS%REACTOME DATABASE ID RELEASE 66%168275,0.8816629547141801,0.9956508825790341,-0.39790401089174704,-0.680593500254629,5937,2,CLTA
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE%REACTOME DATABASE ID RELEASE 66%2559586,0.79937278204176,0.9839175016931591,0.154553087311518,0.7673041399690419,9685,57,HIST1H2BJ|HIST3H2BB|CCNA1|ASF1A|EP400|CCNE1|RB1|HIST1H4I|LMNB1|H2AFX|H2AFZ|HIST1H2BF|HIST1H2BK|CCNE2|HIST1H2AC|ACD|HIRA|HIST1H2BN|CDK2|ATM|HIST1H2BG|HIST2H2BE|HIST1H2BH
L13A-MEDIATED TRANSLATIONAL SILENCING OF CERULOPLASMIN EXPRESSION%REACTOME DATABASE ID RELEASE 66%156827,0.09010875194199901,0.560121322881739,-0.168066853958537,-1.26013307476877,173,109,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|EIF3F|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|EIF3J|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|EIF3M|RPS27|RPS23|RPS21|RPL3|RPL29|EIF3C|RPL31|RPL17|RPS14|RPS17|RPL32|EIF3L|RPL18A|RPL11|EIF2S2|EIF4E|RPS16|RPL12|EIF3H|RPS4X|EIF3D|RPL9|EIF2S1|RPS28|EIF4A1|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|EIF4A2|EIF4G1|EIF3G|RPL15|RPL8|EIF3B|EIF4H|RPL35A|EIF4B|EIF1AX|EIF3A|UBA52|EIF3I|EIF2S3|PABPC1
"TETRAHYDROBIOPTERIN (BH4) SYNTHESIS, RECYCLING, SALVAGE AND REGULATION%REACTOME%R-HSA-1474151.3",0.6789229340761371,0.9647315640607691,-0.264851149646181,-0.823272691260004,3655,8,GCH1|HSP90AA1|GCHFR|SPR|NOS3
NETRIN-1 SIGNALING%REACTOME DATABASE ID RELEASE 66%373752,0.7875288683602769,0.9819233677232551,0.16657110371182599,0.7666194273079829,9206,42,SLIT1|SIAH2|MAPK11|MAPK12|DSCAM|PRKCQ|SRC|ABLIM1|NEO1|PLCG1|UNC5A|TRPC1|NTN1|MAPK13
INTERLEUKIN-33 SIGNALING%REACTOME%R-HSA-9014843.2,0.6552363299351249,0.9640743070248079,-0.666299073665638,-0.89132858613097,4948,1,IL33
BIOSYNTHESIS OF ASPIRIN-TRIGGERED D-SERIES RESOLVINS%REACTOME DATABASE ID RELEASE 66%9020265,0.716703786191537,0.971081608033886,-0.47313953035419504,-0.8092798269384621,4826,2,ALOX5
KERATAN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022854.1,0.614781368821293,0.9511905259737851,-0.19122274358266603,-0.885885329365723,2586,22,B4GALT6|PRELP|B4GALT4|ST3GAL4|B3GNT4|FMOD|ST3GAL6|B4GALT3|OGN|ST3GAL3|LUM|CHST2|SLC35D2|B4GALT2|ST3GAL1|B4GAT1|CHST1|B4GALT1|B4GALT5|ST3GAL2|B3GNT7|B3GNT2
VITAMIN D (CALCIFEROL) METABOLISM%REACTOME DATABASE ID RELEASE 66%196791,0.33752147766323,0.8319981126097199,0.45291527439850204,1.1138791566280501,3142,6,CYP2R1|SUMO2|PIAS4
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC%REACTOME%R-HSA-389960.2,0.0303867403314917,0.357919492624349,-0.36333060720505894,-1.62114683107768,131,20,CCT4|TUBB2B|TUBB2A|CCT7|TUBB6|TUBA1C|TUBB3|TCP1|TUBB4B
PLATELET HOMEOSTASIS%REACTOME DATABASE ID RELEASE 66%418346,0.700115340253749,0.96807298571782,-0.129344391088776,-0.8696906965355429,1820,71,PPP2CA|PPP2CB|ATP2B4|PPP2R1B|GNB5|GNGT1|ORAI2|PDE9A|NOS3|PDE10A|ATP2B2|GNAS|PDE3A
PEROXISOMAL LIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%390918,0.304184650028148,0.8069200687355691,0.306636770130303,1.13869541648282,3241,20,CROT|SLC27A2|HSD17B4|DECR2|AMACR|ACOX2|EHHADH
FORMATION OF APOPTOSOME%REACTOME%R-HSA-111458.2,0.278916290378604,0.788692060817727,0.6044446895334731,1.14898576960848,2408,3,APAF1|CASP9|CYCS
TGF-BETA RECEPTOR SIGNALING IN EMT (EPITHELIAL TO MESENCHYMAL TRANSITION)%REACTOME DATABASE ID RELEASE 66%2173791,0.00197585071350165,0.112650093274223,-0.5062966913319861,-2.07345511249821,8,16,F11R|TGFBR1|RHOA|UBA52|UBC|FKBP1A|PARD3|UBB
RESOLUTION OF D-LOOP STRUCTURES THROUGH SYNTHESIS-DEPENDENT STRAND ANNEALING (SDSA)%REACTOME%R-HSA-5693554.1,0.0723648279628618,0.516566343057308,0.362436505138923,1.457168355486,794,26,XRCC3|BLM|EXO1|BRIP1|DNA2|RAD51C|RAD51|RMI2|RAD51AP1|RMI1|PALB2|BRCA2|XRCC2|ATM|BRCA1|RAD51D|RBBP8|RAD50|NBN
SUMOYLATION OF INTRACELLULAR RECEPTORS%REACTOME%R-HSA-4090294.2,0.0956272084805654,0.5678315524010911,-0.333010621987681,-1.40127039533236,432,17,RARA|HDAC4|UBE2I|PPARA|RXRA|PPARG|SUMO1|NR1H2|NR3C1|SUMO3
SIGNALING BY VEGF%REACTOME DATABASE ID RELEASE 66%194138,0.00048192771084337304,0.0784645998831315,-0.250044768561007,-1.8325570812123102,0,100,PRKACA|MAPKAPK3|NCF2|CYBA|SH2D2A|PIK3R2|THEM4|NCK2|HSPB1|MAPKAP1|VEGFA|KDR|PRKCD|CTNNB1|ABI1|BCAR1|PTK2B|NRAS|VAV1|CYFIP2|SPHK1|FYN|RHOA|NRP1|CDH5|PXN|CRK|PRR5|CTNNA1|VAV3|VAV2|CDC42|SHB|KRAS|PRKCA|NOS3|FLT1|RAC1|BRK1|PGF|PIK3R1|CAV1|PAK2|TRIB3
RAS SIGNALING DOWNSTREAM OF NF1 LOSS-OF-FUNCTION VARIANTS%REACTOME DATABASE ID RELEASE 66%6802953,0.8282002463881729,0.9876441563834109,0.34141408691756503,0.7234890637511501,7394,4,NF1|HRAS
INTERACTION BETWEEN L1 AND ANKYRINS%REACTOME%R-HSA-445095.1,0.376983035304906,0.853714761067216,0.272237287457045,1.07138924350488,4110,24,SCN1A|NFASC|SPTBN5|ANK3|SPTBN4|SCN3B|SPTAN1|SCN8A|SPTBN2|SCN9A|SPTB|L1CAM|SCN2A|ANK2|SCN3A|NRCAM|SCN7A
FC EPSILON RECEPTOR (FCERI) SIGNALING%REACTOME%R-HSA-2454202.1,0.8904761904761909,0.997300970905927,-0.101563653017581,-0.7866545855330129,1495,125,KRAS|JUN|UBA52|NFATC2|GAB2|MAPK3|PSMD6|RAC1|UBC|PIK3R1|PSMF1|PAK2|UBB
PTEN REGULATION%REACTOME%R-HSA-6807070.2,0.974953036944271,1.0,-0.08812615173911902,-0.690245790025995,1556,132,NEDD4|AGO2|JUN|UBA52|MECOM|TP53|MAF1|MAPK3|PSMD6|UBC|CSNK2A1|GATAD2A|PSMF1|UBB
C6 DEAMINATION OF ADENOSINE%REACTOME%R-HSA-75102.2,0.39272457312546405,0.8621064456029929,-0.6185277088502901,-1.05795851976325,2644,2,ADAR|ADARB1
NTRK2 ACTIVATES RAC1%REACTOME DATABASE ID RELEASE 66%9032759,0.0969363707776905,0.5696817730480239,-0.7137908237261,-1.44861726909538,616,3,DOCK3|RAC1
ACTIVATION OF SMO%REACTOME%R-HSA-5635838.1,0.294092827004219,0.800406131144927,-0.288868683086567,-1.1191537526809,1393,14,CSNK1A1|IQCE|ARRB2|BOC|CDON|EVC|ARRB1
RESOLUTION OF ABASIC SITES (AP SITES)%REACTOME%R-HSA-73933.1,0.11863517060367501,0.602329212916938,0.305692218381396,1.34933658105247,1355,36,TDG|PARP2|POLE|POLE2|RFC4|MBD4|PNKP|POLD1|PARP1|FEN1|POLD3|LIG1|NEIL1|MPG|XRCC1|RFC3|RFC5
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR%REACTOME DATABASE ID RELEASE 66%428930,0.6984315589353609,0.96731875442989,-0.17837311609392104,-0.8263563409890211,2938,22,GNB1|GNB4|GNG5|TBXA2R|GNG10|GNA13|GNG4|GNAQ|GNA15|GNB5|GNGT1
G BETA:GAMMA SIGNALLING THROUGH PLC BETA%REACTOME DATABASE ID RELEASE 66%418217,0.654683065279092,0.9640743070248079,0.23347458452199898,0.8533853280940391,6919,19,PLCB3|GNG8|GNB3
SCAVENGING OF HEME FROM PLASMA%REACTOME%R-HSA-2168880.1,0.00467745078931982,0.159623912678827,0.5700678805360171,1.88881204075815,47,14,IGKV4-1|HPX|HBB|HBA2|IGKV3-11|HBA1|IGKV2D-28|JCHAIN|IGKV2-28
SIGNALLING TO RAS%REACTOME%R-HSA-167044.4,0.738515901060071,0.9744283926676119,-0.190422856201965,-0.8012774769698359,3343,17,RALA|KRAS|SHC1|RALB
TRANSLATION%REACTOME%R-HSA-72766.3,0.9831649831649829,1.0,-0.08183886599800298,-0.737184243662343,583,289,EEF1A2|RPS16|RPL12|MRPL51|EIF5|MRPS33|EIF3H|MRPL37|QARS|RPS4X|EIF3D|EIF2B3|MTRF1L|RPL9|DARS|MRPL14|MRPL15|EIF2S1|AARS|RPS28|EIF4A1|MRPS2|CARS|RPL35|MRPL18|MRPS35|WARS|EIF3K|RPL7|SRP72|AURKAIP1|RPS9|RPS3|MRPL22|RPL14|NARS|HARS|FARS2|GARS|EIF4A2|AIMP2|GSPT1|EIF4G1|MRPL24|EIF4EBP1|MRPS17|EIF3G|TRMT112|RPL15|RPL8|YARS|EIF3B|MRPL41|EIF4H|RPL35A|MRPS30|MRPL9|KARS|EIF4B|MRPS10|EIF1AX|ETF1|EIF3A|UBA52|EIF3I|MRPL2|SARS|MRPS26|EIF2S3|SSR1|MRPL39|SRP54|PABPC1|MRPL30|MRPL36
DISEASES OF METABOLISM%REACTOME DATABASE ID RELEASE 66%5668914,0.333061668024993,0.8293509737209019,-0.204482242423148,-1.08254751548059,1225,32,EPM2A|TCN2|MMACHC|MTRR|FDX1L|CSF2RB|UBA52|MMAA|UBC|PC|UBB
TRANSLESION SYNTHESIS BY POLK%REACTOME%R-HSA-5655862.1,0.406139575971731,0.8664276075831311,-0.242764525792358,-1.0215252024072499,1838,17,UBA52|UBC|UBB
RETROGRADE TRANSPORT AT THE TRANS-GOLGI-NETWORK%REACTOME%R-HSA-6811440.1,0.86846326596086,0.993084774742015,-0.12152777923332599,-0.7327903971268991,2706,49,RAB43|NAPB|COG5|RABEPK|GCC2|RAB6A|NAPA|TGOLN2|VAMP3|VTI1A|VPS53
PYRUVATE METABOLISM%REACTOME%R-HSA-70268.6,0.6623950906957861,0.964618776001639,0.20972642889330498,0.852645266080126,7339,27,ME1|LDHAL6A|PDHX|PDK4|BSG|PDHA1|DLD|GSTZ1|MPC2
SYNTHESIS OF KETONE BODIES%REACTOME%R-HSA-77111.5,0.544351374570447,0.929758904310055,0.37936894986770503,0.9330026824348241,5068,6,BDH2|HMGCLL1|HMGCL|AACS
PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%622323,0.0338255494505495,0.37600329791737297,-0.6642951687624089,-1.68161910825383,196,5,CHRNE|CHRNB4|CHRNA5|CHRNB2|CHRNA3
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS%REACTOME DATABASE ID RELEASE 66%500657,0.6813661099643461,0.965271928233355,0.224147295983143,0.832370815948011,7261,20,PLCB3|GNG8|GNB3
GAP JUNCTION TRAFFICKING%REACTOME%R-HSA-190828.1,0.780525502318393,0.981487311948134,0.219987303297665,0.745891595770028,8079,15,GJC2|CLTB|GJA1|CLTC|DNM1|DAB2|CLTCL1|AP2M1
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS%REACTOME DATABASE ID RELEASE 66%452723,0.00903041825095057,0.20916469462096804,-0.395302407861721,-1.8313334346458403,37,22,FGF2|SMAD2|POLR2A|POLR2K|POLR2F|STAT3|POLR2I|POLR2D|EPAS1
NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY%REACTOME%R-HSA-5674499.1,0.16889279437609803,0.672849066072304,-0.470967833011004,-1.29277507843782,960,6,MAPK3|MAP2K1
FATTY ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%8978868,0.0884790562234003,0.556932119338259,0.226481983798091,1.3214393047188602,1184,129,ACSM3|FAAH2|DPEP1|HACD1|MORC2|CROT|CYP2C8|ACSF2|SLC27A2|HSD17B4|PRKAA2|CBR4|ACADVL|SCD5|PLA2G4A|ELOVL6|GGT1|FADS2|DECR2|ACBD6|AMACR|ACADM|ACOT1|DECR1|FADS1|HADH|CPT1B|PCCB|ACOX2|ACOT2|SLC25A1|ACACA|PTGS2|MCEE|GGT5|LTA4H|EHHADH|ACAD11|ACAD10|PON2|TECR|PRKAB2|FAAH
SNRNP ASSEMBLY%REACTOME DATABASE ID RELEASE 66%191859,0.22069835927639897,0.735557562482681,0.251792342682911,1.2043237220097198,2622,49,TPR|SMN1|DDX20|NUP133|NUP205|NUP188|NUP160|NUP85|GEMIN5|NUPL2|NDC1|SMN2|NUP107|NUP35|NUP210|POM121|NUP54|SNRPD1|TGS1|GEMIN8|NUP37|AAAS|SNRPE|NUP62|RANBP2|NUP50|GEMIN2|NUP43|CLNS1A|GEMIN6|SNRPD2|SNRPG
SCAVENGING BY CLASS A RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000480,0.630189046969402,0.957141460696787,0.261088009391713,0.865065710022033,6466,14,COLEC11|HSP90B1|COL4A2|APOE|COL4A1
TIGHT JUNCTION INTERACTIONS%REACTOME DATABASE ID RELEASE 66%420029,0.30621230975399605,0.809834248137326,0.327842695205868,1.13654171665161,3198,16,CLDN12|CLDN15|CLDN11|CLDN7
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3%REACTOME%R-HSA-9028731.1,0.326833797585887,0.8272496594558871,-0.35298027770268203,-1.09721639333719,1759,8,PTPN11|FRS3|SOS1|NTRK2|FRS2|NRAS|KRAS
FATTY ACIDS%REACTOME%R-HSA-211935.1,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
AMPLIFICATION OF SIGNAL FROM THE KINETOCHORES%REACTOME%R-HSA-141424.2,0.0103383458646617,0.22206659645222002,0.295316823666847,1.61626624138746,131,91,CLIP1|ZWINT|CENPF|KIF2C|NUP133|KIF18A|CENPL|CENPT|CKAP5|NSL1|CENPK|NUF2|BIRC5|CASC5|BUB1|CENPU|CDC20|NDC80|ITGB3BP|CENPA|CENPE|BUB1B|AURKB|ERCC6L|NUP160|DSN1|INCENP|CDCA8|CENPQ|CENPI|NUP85|SPDL1|SGOL2|TAOK1|SKA2|PLK1|KNTC1|SKA1|NUP107|CENPM|DYNC1H1|SPC25
DEFECTIVE CHST3 CAUSES SEDCJD%REACTOME DATABASE ID RELEASE 66%3595172,0.508084358523726,0.9179996794142941,-0.34418151721731394,-0.944755154662683,2890,6,CSPG4|NCAN
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS%REACTOME DATABASE ID RELEASE 66%8939236,0.900270374662032,0.998912093067348,0.12568314865108,0.7011752068394971,11653,101,HIST1H3E|HIST1H2BJ|HIST3H2BB|PSMD11|PSMD13|PSMB9|HIST2H3C|PSMA4|HIST2H3A|PSMD3|TAL1|PSMD1|HIST1H4I|PSMA1|H2AFX|H3F3A|PSMC3|H2AFZ|CDK7|HIST1H2BF|HIST1H2BK|PSMA3|HIST1H2AC|PSMC6|PSMC1|PSMD2|HIST1H3H|PSMA5|HIST1H2BN|PSMC2|TCF12|GATA3|PSMC5|HIST1H2BG|HIST2H2BE|SHFM1|HIST1H2BH|PSMA2|PSMB6|PSMB3
"DEFECTIVE POMGNT1 CAUSES MDDGA3, MDDGB3 AND MDDGC3%REACTOME DATABASE ID RELEASE 66%5083628",0.67840593141798,0.9647315640607691,-0.655877812086458,-0.8773877467749,5123,1,DAG1
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR3%REACTOME DATABASE ID RELEASE 66%5654227,0.74174039646097,0.974505008828563,0.377834124354941,0.800666602104189,6622,4,FGF9|PLCG1
PROCESSING OF INTRONLESS PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%77595,0.8519394512771999,0.991298302704726,0.18877381010983602,0.689997158388623,9004,19,WDR33|CPSF1|FIP1L1|PAPOLA|PABPN1|CPSF2|CPSF7|CSTF3|CPSF4|PCF11|SYMPK
DEFECTIVE MMAA CAUSES METHYLMALONIC ACIDURIA TYPE CBLA%REACTOME DATABASE ID RELEASE 66%3359475,0.34996288047513,0.842847021021096,-0.650330019664787,-1.11235466918863,2356,2,MMAA
TOXICITY OF BOTULINUM TOXIN TYPE A (BONT A)%REACTOME DATABASE ID RELEASE 66%5250968,0.0503869586695208,0.44079050471084996,-0.6914368879179069,-1.5901603959856498,305,4,SV2C|SNAP25
PROTEIN UBIQUITINATION%REACTOME DATABASE ID RELEASE 66%8852135,0.306288819875776,0.809874675097403,-0.162180506791289,-1.09526914079358,788,72,UBE2Q2|UBA52|UBE2L3|UBE2E1|UBE2D3|HIST1H2BC|UBC|UBE2K|HIST1H2BD|UBB
CASPASE-MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS%REACTOME DATABASE ID RELEASE 66%264870,0.8868146983690309,0.996643473105967,0.20389976065453,0.642764912465944,9025,12,GAS2|CASP6
ACTIVATED NTRK2 SIGNALS THROUGH RAS%REACTOME DATABASE ID RELEASE 66%9026519,0.5379464285714289,0.9266622429344109,-0.36339147385415993,-0.9199013856267192,3132,5,NTRK2|NRAS|KRAS
LOSS OF NLP FROM MITOTIC CENTROSOMES%REACTOME%R-HSA-380259.1,0.0150406504065041,0.264387156924099,0.314624748007248,1.6158020073255899,184,67,AKAP9|SDCCAG8|CEP63|CEP70|CENPJ|CDK1|CKAP5|CEP290|CEP131|CEP152|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP72|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CNTRL|PLK1|SFI1|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|NEDD1|PPP2R1A|SSNA1|NDE1|CEP250
CYTOCHROME C-MEDIATED APOPTOTIC RESPONSE%REACTOME%R-HSA-111461.2,0.7667247766397909,0.9792236089291529,0.331571917680063,0.7642241175336251,7036,5,APAF1|CASP9|CYCS|CASP7
VLDL ASSEMBLY%REACTOME%R-HSA-8866423.3,0.960059391239792,1.0,-0.34078942572553805,-0.582902061189349,6465,2,P4HB
TRANSLOCATION OF SLC2A4 (GLUT4) TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%1445148,0.00827235125676106,0.20219929830704503,-0.294319111601796,-1.76927541688088,25,48,PRKAG1|MYO1C|RALGAPA2|EXOC3|YWHAH|VAMP2|EXOC4|RALA|RAB8A|YWHAQ|YWHAB|KIF3B|YWHAZ|YWHAE|MYH9|RHOQ|RAC1|TBC1D1
DEFECTIVE CHSY1 CAUSES TPBS%REACTOME DATABASE ID RELEASE 66%3595177,0.508084358523726,0.9179996794142941,-0.34418151721731394,-0.944755154662683,2890,6,CSPG4|NCAN
NADPH REGENERATION%REACTOME DATABASE ID RELEASE 66%389542,0.308859060402685,0.8114708447293539,0.849415527128364,1.12841063267674,2300,1,IDH1
CARBOHYDRATE METABOLISM%REACTOME%R-HSA-71387.8,0.8021327014218008,0.9841546650056641,-0.10269667832669198,-0.880858509939333,676,228,ST3GAL2|CHST11|HS3ST2|ENO1|CHP1|PGD|PPP2CA|PPP2CB|CEMIP|GAPDH|PGK1|SORD|PPP2R1B|XYLB|HK1|HK2|MAN2B2|TPI1|G6PC3|PYGB|UBA52|HS6ST2|CSPG4|B3GNT7|CSGALNACT1|CHSY1|ALDOA|TKT|SLC25A13|SLC2A1|SDC2|NCAN|B3GNT2|UBC|HS6ST3|PC|PGAM2|UBB
BIOSYNTHESIS OF PROTECTINS%REACTOME DATABASE ID RELEASE 66%9018681,0.476241610738255,0.9024070154961379,0.7670379355977059,1.01897567745317,3547,1,LTA4H
RNA POLYMERASE II TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%75953,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
MRNA CAPPING%REACTOME%R-HSA-72086.3,0.527683909539901,0.9265056012720759,-0.184736970712085,-0.945437836311647,2029,29,POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
NR1D1 (REV-ERBA) REPRESSES GENE EXPRESSION%REACTOME%R-HSA-1368071.3,0.6842105263157899,0.966495577318169,-0.40641619944208796,-0.824809601612132,4354,3,NR1D1
RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE%REACTOME DATABASE ID RELEASE 66%77075,0.809487375669472,0.984682960940884,-0.152571971316174,-0.760296197581283,3173,27,POLR2A|POLR2K|POLR2F|POLR2I|POLR2D
CDK-MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6%REACTOME DATABASE ID RELEASE 66%69017,0.303888351080994,0.806650902749213,0.21639679429166297,1.1233479175183603,3766,70,CCNA1|ANAPC15|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|CCNE1|ANAPC7|ANAPC16|PSMD1|CDC6|PSMA1|PSMC3|PSMA3|UBE2C|CCNE2|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
REGULATION OF HYPOXIA-INDUCIBLE FACTOR (HIF) BY OXYGEN%REACTOME DATABASE ID RELEASE 66%1234174,0.405228758169935,0.866234596232951,-0.153834762063192,-1.0343599768334,1053,71,VHL|TCEB1|UBA52|UBE2D3|PSMD6|UBC|EPAS1|PSMF1|UBB|EGLN3
FGFR2 ALTERNATIVE SPLICING%REACTOME%R-HSA-6803529.2,0.190627288259702,0.6986011331863089,-0.25559628137587803,-1.2251910581625802,780,24,HNRNPF|POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
HYALURONAN METABOLISM%REACTOME%R-HSA-2142845.1,0.9637130801687759,1.0,-0.150030348176351,-0.58125728751035,4567,14,HMMR|ABCC5|LYVE1|HEXA|HYAL2|HYAL3|HAS3|GUSB|HEXB|HYAL1|CD44|SLC9A1|CHP1|CEMIP
RSK ACTIVATION%REACTOME DATABASE ID RELEASE 66%444257,0.550439367311072,0.931421923167331,-0.331673811482385,-0.910422342251326,3131,6,RPS6KA2
SIGNALING BY LIGAND-RESPONSIVE EGFR VARIANTS IN CANCER%REACTOME%R-HSA-5637815.1,0.0037544169611307397,0.143595610377104,-0.47837558771189104,-2.01294945160995,16,17,CDC37|KRAS|SHC1|UBA52|UBC|PIK3R1|UBB
METABOLISM OF SEROTONIN%REACTOME%R-HSA-380612.3,0.8911655530809208,0.997300970905927,-0.39228012131237894,-0.670974138325381,6001,2,MAOA|ALDH2
WNT5A-DEPENDENT INTERNALIZATION OF FZD4%REACTOME DATABASE ID RELEASE 66%5099900,0.9104389669056271,1.0,0.19108384671502898,0.6166985995020879,9270,13,AP2A2|PRKCB|CLTB|CLTC|DVL2|AP2M1|AP2B1
DEFECTIVE CD320 CAUSES METHYLMALONIC ACIDURIA%REACTOME%R-HSA-3359485.1,0.65573968791581,0.9640743070248079,0.545968025837624,0.8923697396125451,5420,2,CD320
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS%REACTOME%R-HSA-2029485.1,0.479530081879673,0.9046812288131709,0.234124183978054,0.9896412477091271,5387,31,IGKV4-1|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|PLCG1|CD3G|FCGR3A|IGHG2|PPAPDC1B|ITPR2|PLD1
SYNTHESIS OF 12-EICOSATETRAENOIC ACID DERIVATIVES%REACTOME%R-HSA-2142712.2,0.740163325909428,0.974456759704921,-0.46280672732285605,-0.7916061207428899,4984,2,GPX4|GPX1
ALTERNATIVE COMPLEMENT ACTIVATION%REACTOME DATABASE ID RELEASE 66%173736,0.9514243372303641,1.0,-0.256143908988365,-0.589077480336296,5777,4,CFD
MITOCHONDRIAL CALCIUM ION TRANSPORT%REACTOME DATABASE ID RELEASE 66%8949215,0.989369412901667,1.0,-0.10945657137237501,-0.514327275786437,4094,23,PARL|YME1L1|CCDC109B|PMPCA|LETM1
TRANSLESION SYNTHESIS BY REV1%REACTOME%R-HSA-110312.1,0.398902305159166,0.8638522656500329,-0.249553406397123,-1.02200507171825,1816,16,UBA52|UBC|UBB
RHO GTPASES ACTIVATE IQGAPS%REACTOME DATABASE ID RELEASE 66%5626467,0.5825849277625931,0.943680456638918,-0.275728470910329,-0.8900762127192942,2983,9,CTNNA1|CDC42|RAC1
TRANSLATION INITIATION COMPLEX FORMATION%REACTOME DATABASE ID RELEASE 66%72649,0.011963406052075999,0.23670963874364498,-0.254817027483968,-1.6180715219582098,33,58,EIF2S2|EIF4E|RPS16|EIF3H|RPS4X|EIF3D|EIF2S1|RPS28|EIF4A1|EIF3K|RPS9|RPS3|EIF4A2|EIF4G1|EIF3G|EIF3B|EIF4H|EIF4B|EIF1AX|EIF3A|EIF3I|EIF2S3|PABPC1
ASPARAGINE N-LINKED GLYCOSYLATION%REACTOME%R-HSA-446203.4,0.9960850111856819,1.0,0.089851963450763,0.578563853555531,14247,267,COG2|GRIA1|CNIH3|SEC22A|SLC35A1|INS|ALG6|GOLGB1|ASGR1|FUT8|PREB|ST3GAL5|BET1|MVD|MIA3|MOGS|ALG14|ALG13|COPB1|SRD5A3|SPTBN5|TRAPPC5|DPAGT1|EDEM3|DCTN4|GMPPB|FPGT|NUDT14|COPB2|NGLY1|MPDU1|AMDHD2|ALG2|COG6|GANAB|B4GALT6|ARF5|MGAT2|DOLPP1|ST8SIA3|SYVN1|SEC31A|USO1|CNIH2|ANK3|MLEC|CD55|SEC24D|SPTBN4|ENGASE|SPTAN1|B4GALT4|ALG5|CTSC|MAN1B1|ST3GAL4|GBF1|BET1L|SEC24C|DYNC1H1|ALG1|LMAN2L|MAN1C1|COPG2|TMED9|PSMC1|SPTBN2
PRESYNAPTIC PHASE OF HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE%REACTOME DATABASE ID RELEASE 66%5693616,0.0553198857241797,0.458062256682211,0.329636545876051,1.47670161266731,638,38,ATR|BLM|EXO1|BRIP1|RFC4|DNA2|RAD9A|RAD51C|RAD51|RMI2|TOPBP1|RMI1|BRCA2|XRCC2|CHEK1|RFC3|RAD17|RFC5|RAD1|ATM|BRCA1
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE%REACTOME%R-HSA-5620920.2,0.8975007908889592,0.998912093067348,-0.11838499895115198,-0.7070713260446909,2836,47,EXOC3|EXOC4|TCP1|RAB8A|MKKS|ASAP1|MCHR1|BBS7
HSF1 ACTIVATION%REACTOME DATABASE ID RELEASE 66%3371511,0.0532752902155887,0.449919470301053,-0.42749879455376,-1.5574209909358,256,12,RPA3|HSBP1|HSF1|YWHAE|HSP90AB1
NETRIN MEDIATED REPULSION SIGNALS%REACTOME DATABASE ID RELEASE 66%418886,0.53091922005571,0.9265056012720759,-0.298034419166541,-0.926420741171543,2858,8,UNC5B|UNC5C|UNC5D
ANTIGEN ACTIVATES B CELL RECEPTOR (BCR) LEADING TO GENERATION OF SECOND MESSENGERS%REACTOME DATABASE ID RELEASE 66%983695,0.843520782396088,0.991298302704726,-0.139969833787197,-0.7410129799682249,3104,32,STIM1|ORAI1|PIK3CD|CD79B|PTPN6|BLK|CD19|VAV1|FYN|LYN|ORAI2|CD22|PIK3R1
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS%REACTOME%R-HSA-390471.1,0.175531914893617,0.678685257108795,-0.222935446927006,-1.22634382060181,626,36,FBXO6|FBXL5|GBA|FKBP9|FBXL3|FBXW2|FBXW7|CCT4|ARFGEF2|CCT7|SPHK1|TCP1|STAT3|TP53|NOP56|KIF13A
SYNAPTIC ADHESION-LIKE MOLECULES%REACTOME%R-HSA-8849932.4,0.344157699266737,0.8397812962363971,0.30664420726068,1.09999528730984,3613,18,GRIA1|DLG3|PTPRD|GRIN1|GRIA4|RTN3|DLG4|PTPRS
MISMATCH REPAIR (MMR) DIRECTED BY MSH2:MSH3 (MUTSBETA)%REACTOME DATABASE ID RELEASE 66%5358606,0.7088286883648409,0.9695170059473192,0.24213197358678198,0.8022584726808771,7273,14,EXO1|POLD1|POLD3|LIG1
INTERACTION WITH THE ZONA PELLUCIDA%REACTOME DATABASE ID RELEASE 66%1300644,0.2316776658562,0.744434191743215,0.6293436781543791,1.19631612770154,2000,3,OVGP1|ZP3
SYNTHESIS OF PROSTAGLANDINS (PG) AND THROMBOXANES (TX)%REACTOME%R-HSA-2162123.1,0.399668325041459,0.8638522656500329,-0.284087963705846,-1.03496094862568,1927,12,PTGR2|PTGIS|AKR1C3|PTGES2|TBXAS1|CBR1|PTGES3|PTGDS|FAM213B|PTGS1|PTGES
CONSTITUTIVE SIGNALING BY LIGAND-RESPONSIVE EGFR CANCER VARIANTS%REACTOME%R-HSA-1236382.1,0.0037544169611307397,0.143595610377104,-0.47837558771189104,-2.01294945160995,16,17,CDC37|KRAS|SHC1|UBA52|UBC|PIK3R1|UBB
INTEGRIN SIGNALING%REACTOME DATABASE ID RELEASE 66%9006921,0.6632036723846341,0.964618776001639,-0.182823107800095,-0.859070495326743,2744,23,CRK|RAP1A|PTPN1|SHC1|VWF
HIV LIFE CYCLE%REACTOME%R-HSA-162587.2,0.9618473895582329,1.0,-0.0896852788622589,-0.7122615186258421,1436,141,POLR2K|NELFE|TCEB1|UBA52|POLR2F|RANGAP1|TAF4B|NCBP2|TCEA1|POLR2I|POLR2D|CHMP4B|UBC|TAF13|UBB
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX%REACTOME%R-HSA-1362277.2,0.625260170293283,0.954110852066186,0.239443008693254,0.875200831610273,6608,19,LIN52|LIN9|TOP2A|E2F5|CDC6|LIN37|E2F1|LIN54|RBL2|E2F4|RBBP4|MYC|CDC25A|TFDP1
SIGNALING BY GPCR%REACTOME%R-HSA-372790.3,0.0128755364806867,0.24668080085844798,-0.140109188493998,-1.3347493401096002,2,445,PPP3R1|OXER1|DGKI|NMB|CX3CL1|MAPK7|ADRA2C|PRKCD|GNAZ|DGKD|LPAR1|ABR|C5AR1|HSD17B6|GNRH2|UCN2|HCRT|CXCL16|NRAS|PDE7B|ARRB2|RGS5|FGD4|RGS4|PTGFR|VAV1|CRHR1|CCR10|TRIO|PPEF1|GNAQ|CALCRL|GNAI2|RHOA|ADRA1B|PSAP|MGLL|DGKQ|GNAL|PDE8A|GNA15|RDH10|ADCYAP1R1|P2RY14|HBEGF|PDE6B|ARRB1|APLNR|HTR1B|VIP|PPP2CA|PRKAR2A|GCGR|PPP2CB|RHOC|WNT6|VIPR1|CAMK4|PNOC|WNT11|CRH|VAV3|ARHGEF2|VAV2|PPP2R1B|RAMP2|PDE4B|AKAP13|GRM2|GNB5|EDNRA|GNGT1|NET1|CXCL8|HRH3|ADRB2|GIPR|KRAS|ARHGEF37|PRKCA|DGKG|MC4R|RGS12|ADM2|ACKR3|PRKAR1B|CALCB|RASGRF2|ADCY2|ADCYAP1|GUCA1A|DRD2|MAPK3|PDE10A|WNT3|GNA12|MCHR1|UCN3|ADRA2A|TAC3|DGKB|BDKRB2|ARHGEF33|SDC2|GNAS|S1PR1|GPR4|PLCB4|CHRM1|PLCB1|NPB|ADM|BDKRB1|PIK3R1|PDE3A|PDE4D|HRH1|GRM8|GAL|DGKK|RPS6KA2|TRH|RAMP1|ADORA2B
TICAM1 DEFICIENCY - HSE%REACTOME%R-HSA-5602566.2,0.0491195551436515,0.435709133762192,-0.9750220555800619,-1.3043167319227,370,1,TICAM1
GABA B RECEPTOR ACTIVATION%REACTOME%R-HSA-977444.1,0.80107047279215,0.9841161968820359,0.177070019577875,0.7424424170343359,8979,30,GNG8|GNAI1|GNB3|ADCY8
KERATAN SULFATE KERATIN METABOLISM%REACTOME DATABASE ID RELEASE 66%1638074,0.7043588123815541,0.968941691852291,0.20197954503436,0.821150218536247,7804,27,B4GALT6|PRELP|B4GALT4|ST3GAL4|GLB1L|B3GNT4|FMOD|ST3GAL6|B4GALT3|HEXA|OGN|ST3GAL3|LUM|GNS
MISCELLANEOUS TRANSPORT AND BINDING EVENTS%REACTOME DATABASE ID RELEASE 66%5223345,0.9342478713339641,1.0,0.16199181119748002,0.592104854711854,9874,19,LRRC8D|MRS2|PQLC2|NIPA1|LRRC8B|ADD2|CTNS|NIPAL2|NIPA2
PLATELET SENSITIZATION BY LDL%REACTOME DATABASE ID RELEASE 66%432142,0.43462365591397906,0.878651088001772,-0.250278475684007,-0.998132920650562,2020,15,PPP2R5A|PTPN6|FGR|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
POLB-DEPENDENT LONG PATCH BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%110362,0.17614640740355603,0.67909482081261,0.47117578573461705,1.2845516005993702,1693,8,PARP2|PARP1|FEN1|LIG1|PARG|POLB|ADPRHL2
INHIBITION OF HOST MRNA PROCESSING AND RNA SILENCING%REACTOME DATABASE ID RELEASE 66%168315,0.5726382000725779,0.940734934957679,0.577502067824649,0.9439112649495269,4733,2,PABPN1|CPSF4
SUMO IS PROTEOLYTICALLY PROCESSED%REACTOME%R-HSA-3065679.1,0.0885764499121265,0.556932119338259,-0.5335749405503479,-1.46462738487346,503,6,SUMO1|SENP5|SUMO3
MYOGENESIS%REACTOME DATABASE ID RELEASE 66%525793,0.457976617877198,0.890371861972445,0.258349885679501,1.00477522231251,4974,23,CDH4|MAPK11|MAP2K6|MAPK12|CDH2
IRAK4 DEFICIENCY (TLR2 4)%REACTOME%R-HSA-5603041.1,0.258471237194641,0.769881683305838,-0.34594713463792304,-1.17039093784184,1311,10,MYD88|CD36
MYD88 DEPENDENT CASCADE INITIATED ON ENDOSOME%REACTOME%R-HSA-975155.1,0.0021486892995272898,0.116289031011345,-0.251211310282699,-1.7663412253760702,4,85,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|TICAM1|MYD88|UBC|MAP2K1|RPS6KA2|UBB
VITAMIN B1 (THIAMIN) METABOLISM%REACTOME DATABASE ID RELEASE 66%196819,0.517751147944899,0.923376778065417,0.454595033013165,0.963330300135006,4622,4,SLC25A19|SLC19A2
NEGATIVE REGULATORS OF RIG-I MDA5 SIGNALING%REACTOME DATABASE ID RELEASE 66%936440,0.00326708412741628,0.137762274603971,-0.37112110319114,-1.98504159586912,11,33,ITCH|UBE2D1|OTUD5|TNFAIP3|PCBP2|TRAF3|CYLD|RNF216|MAVS|TRIM25|UBA52|UBE2D3|TAX1BP1|UBC|UBE2K|UBB
"CELL DEATH SIGNALLING VIA NRAGE, NRIF AND NADE%REACTOME%R-HSA-204998.1",0.00538254517493272,0.168826383791782,-0.252671098988761,-1.69891946781916,13,71,KALRN|GNA13|ABR|SQSTM1|FGD4|VAV1|TRIO|CASP3|NCSTN|PSEN2|VAV3|ARHGEF2|VAV2|AKAP13|NET1|ARHGEF37|UBA52|RASGRF2|YWHAE|ARHGEF33|RAC1|UBC|AATF|BCL2L11|UBB
DNA DOUBLE-STRAND BREAK REPAIR%REACTOME%R-HSA-5693532.2,0.0636563876651982,0.493545616162616,0.22666944479827697,1.35135828558494,866,149,HIST1H2BJ|MUS81|HIST3H2BB|EME2|CCNA1|PARP2|POLE|SIRT6|XRCC3|LIG4|ATR|BLM|EXO1|BRIP1|POLE2|RFC4|DNA2|RAD9A|POLD1|PARP1|FEN1|GEN1|POLQ|SUMO2|POLD3|SLX1B|HIST1H4I|RAD51C|RAD51|PIAS4|H2AFX|APBB1|DCLRE1C|KDM4B|RMI2|XRCC4|TIMELESS|BRCC3|RAD51AP1|HIST1H2BF|CHEK2|SLX4|TOPBP1|EME1|HERC2|RMI1|HIST1H2BK|PALB2|PAXIP1|BRCA2|CLSPN|XRCC2|RIF1|PRKDC|CHEK1|XRCC1|RFC3|HIST1H2BN|RAD17|RFC5|KDM4A|SPIDR|RAD1|CDK2|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE
PECAM1 INTERACTIONS%REACTOME DATABASE ID RELEASE 66%210990,0.354609929078014,0.842911430859438,-0.31623319021270696,-1.0698642162685899,1799,10,INPP5D|PTPN6|FYN|LYN|YES1
INTEGRIN CELL SURFACE INTERACTIONS%REACTOME%R-HSA-216083.2,0.256123979336777,0.767319904137432,0.23953666443328303,1.16829835519785,3073,53,ITGB1|COL9A2|CD47|COL18A1|ITGA1|TNC|ITGA9|ITGA2|ITGA4|FBN1|COL4A2|ITGA11|ITGB5|BSG|ITGA2B|COL4A1|ITGA10|FN1|AGRN|THBS1|ITGA3|ICAM3|ITGA8
RNA POLYMERASE I CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%73777,0.8562942468874599,0.991298302704726,0.142156873797389,0.7256923752252181,10522,65,GTF2H2|HIST1H3E|HIST1H2BJ|HIST3H2BB|TAF1D|HIST2H3C|HIST2H3A|GTF2H1|HIST1H4I|H2AFX|H3F3A|H2AFZ|CDK7|HIST1H2BF|POLR2L|HIST1H2BK|TAF1A|ZNRD1|HIST1H2AC|HIST1H3H|HIST1H2BN|POLR2H|HIST1H2BG|HIST2H2BE|HIST1H2BH
SIGNALING BY FGFR3 POINT MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%8853338,0.491708126036484,0.909315999193258,-0.263531840788941,-0.9600729308560308,2371,12,FGF1|FRS2|NRAS|FGF2|KRAS|PIK3R1
SIGNALING BY EGFR%REACTOME DATABASE ID RELEASE 66%177929,0.004464285714285711,0.155321503601441,-0.323188934895461,-1.8521304083811,14,41,PTPN3|NRAS|ADAM10|PXN|PTPN12|CDC42|ADAM17|KRAS|SHC1|UBA52|SH3GL3|LRIG1|UBC|PIK3R1|UBB
CONSTITUTIVE SIGNALING BY NOTCH1 HD DOMAIN MUTANTS%REACTOME DATABASE ID RELEASE 66%2691232,0.19419354838709696,0.7049178772406091,-0.30952160525710304,-1.2343998141086001,902,15,ADAM17|UBA52|UBC|UBB
DNA REPLICATION PRE-INITIATION%REACTOME DATABASE ID RELEASE 66%69002,0.152598686812752,0.648319130045528,0.235622290698153,1.26432423713292,1928,82,CDC7|POLE|PSMD11|PSMD13|PSMB9|PSMA4|E2F3|POLE2|ORC1|PSMD3|CDC45|E2F2|PSMD1|POLA2|MCM6|CDC6|PSMA1|ORC6|PSMC3|DBF4|MCM10|MCM3|PSMA3|MCM2|PSMC6|PSMC1|E2F1|PSMD2|PRIM2|GMNN|PSMA5|PSMC2|PSMC5|CDK2|SHFM1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|CDT1
SCAVENGING BY CLASS B RECEPTORS%REACTOME%R-HSA-3000471.2,0.0791388270230141,0.532203813468543,-0.830769230769231,-1.42098627607678,532,2,SSC5D|CD36
BASIGIN INTERACTIONS%REACTOME%R-HSA-210991.1,0.18417300380228102,0.6906809521658801,-0.26833611700156,-1.2431315696915601,774,22,SLC7A7|MMP1|SLC16A1|SLC16A8|ITGA6|SLC16A3|SLC7A8|SLC3A2|CAV1|SLC7A5
SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%2894858,0.7710184552289822,0.979355471471634,-0.131053788933517,-0.8228350529203409,2255,56,HDAC4|ADAM10|HDAC5|TBL1X|NCSTN|PSEN2|MAMLD1|HDAC11|ADAM17|UBA52|UBC|RBPJ|UBB
BIOSYNTHESIS OF DHA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018677,0.7682186234817809,0.9792236089291529,0.2650057795317,0.7562359484618871,7589,9,CYP2C8|PTGS2|LTA4H|CYP2E1|CYP2D6
SHC1 EVENTS IN ERBB2 SIGNALING%REACTOME DATABASE ID RELEASE 66%1250196,0.141163556531284,0.630107155356772,-0.32051816598893396,-1.31262961282623,642,16,PRKCD|NRAS|HBEGF|PTPN12|KRAS|SHC1|PRKCA
PHOSPHOLIPID METABOLISM%REACTOME%R-HSA-1483257.1,1.0,1.0,-0.0669141553312792,-0.550189165035297,1178,177,MBOAT7|CDIPT|INPP5K|MGLL|CPNE6|CPNE3|FAM73A|CSNK2A2|ABHD4|PLD6|PLA1A|PIP4K2A|LPIN1|PLA2G2A|DGAT2|PCYT1A|AGPAT3|ARF3|RAB5A|GPCPD1|LPCAT1|GPAT2|PLD2|MTMR14|CSNK2A1|PIK3R1|CDS2
ORGANIC CATION TRANSPORT%REACTOME%R-HSA-549127.1,0.6984182776801411,0.96731875442989,-0.294186339373988,-0.8075217484134529,3973,6,SLC22A5|SLC22A18|RUNX1
CHROMOSOME MAINTENANCE%REACTOME DATABASE ID RELEASE 66%73886,0.0967261904761905,0.5695985048856271,0.243741576598674,1.33399539175397,1234,91,RBBP7|HIST1H2BJ|HIST3H2BB|POLE|CENPL|CENPT|POLE2|CENPK|RFC4|DNA2|CASC5|CENPU|POLD1|TERT|OIP5|FEN1|ITGB3BP|CENPA|POLD3|POLA2|HIST1H4I|CENPQ|CENPI|H2AFX|H2AFZ|LIG1|MIS18BP1|HIST1H2BF|HJURP|WRAP53|HIST1H2BK|STRA13|CENPM|HIST1H2AC|PRIM2|ACD|RFC3|HIST1H2BN|RFC5
RORA ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-1368082.3,0.991143700599943,1.0,0.126494546402444,0.4537617265171339,10407,18,SMARCD3|RORA|MED1|CARM1|TGS1|CHD9|NCOA6|SREBF1|TBL1XR1|EP300|CPT1A|NCOA2
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR (GG-NER)%REACTOME%R-HSA-5696399.1,0.8346825734980831,0.988613522932093,-0.11398371816483502,-0.80042297822135,1958,84,POLE3|COPS3|RFC1|ERCC1|USP45|INO80B|RUVBL1|ACTR5|RPA3|UBE2I|INO80C|SUMO1|RAD23B|COPS7A|CETN2|INO80E|UBA52|ACTR8|COPS2|COPS8|TFPT|UBC|SUMO3|UBB
TOLL LIKE RECEPTOR TLR1:TLR2 CASCADE%REACTOME DATABASE ID RELEASE 66%168179,0.0044306601683650896,0.155321503601441,-0.23551799087278602,-1.68998851137262,9,90,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|TLR1|DUSP4|DUSP7|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|IRAK4|NKIRAS1|UBE2V1|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|PELI2|MAPK3|TNIP2|PELI1|MYD88|UBC|MAP2K1|CD36|RPS6KA2|UBB
BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%73884,0.11863517060367501,0.602329212916938,0.305692218381396,1.34933658105247,1355,36,TDG|PARP2|POLE|POLE2|RFC4|MBD4|PNKP|POLD1|PARP1|FEN1|POLD3|LIG1|NEIL1|MPG|XRCC1|RFC3|RFC5
RUNX1 REGULATES EXPRESSION OF COMPONENTS OF TIGHT JUNCTIONS%REACTOME DATABASE ID RELEASE 66%8935964,0.49357158422314207,0.910654969509744,0.4248423050612511,0.9791985339049971,4529,5,OCLN|CLDN5
SMAC BINDS TO IAPS%REACTOME%R-HSA-111463.2,0.8720854216604929,0.9934031064448321,0.290766964878695,0.670174750313943,8003,5,CASP9|XIAP|CASP7|DIABLO
POLYMERASE SWITCHING%REACTOME%R-HSA-69091.2,0.24975638277139,0.7613646381106121,0.363290600628611,1.2036946549529899,2562,14,RFC4|POLD1|POLD3|POLA2|PRIM2|RFC3|RFC5
ADRENOCEPTORS%REACTOME%R-HSA-390696.2,0.006257204017783629,0.17975028050367198,-0.8106215187779191,-1.86426014842215,37,4,ADRA2C|ADRA1B|ADRB2|ADRA2A
SEROTONIN AND MELATONIN BIOSYNTHESIS%REACTOME%R-HSA-209931.1,0.325503355704698,0.826621597878865,0.8414755183061321,1.1178626851853102,2424,1,DDC
DISEASES ASSOCIATED WITH VISUAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%2474795,0.0930878777353248,0.5622489437340121,0.7215273647931759,1.37154761864205,803,3,RBP1|NAPEPLD
TRKA ACTIVATION BY NGF%REACTOME DATABASE ID RELEASE 66%187042,0.914328136599852,1.0,-0.37695064791839006,-0.644753895079042,6157,2,NGF|NTRK1
"RESPIRATORY ELECTRON TRANSPORT, ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING, AND HEAT PRODUCTION BY UNCOUPLING PROTEINS.%REACTOME%R-HSA-163200.1",0.7693465823547121,0.9792236089291529,0.141228831541842,0.815202751318687,10219,122,COX20|NDUFA7|NDUFS7|ETFDH|UQCR11|NDUFA4|NDUFB11|ETFA|ATP5G1|NDUFS2|COX5A|ATP5D|NDUFC1|NDUFAF1|NDUFS4|NDUFA11|MT-ATP8|COX16|COX6A1|UCP3|ETFB|NDUFS8|NDUFB2|COX8A|SDHA|MT-ND2|NDUFV1|COX7B|NDUFS3|ATP5C1|NDUFB7|NDUFA12|MT-CO2|COX11|MT-CYB|ATP5E|SURF1|ECSIT|ATP5H|MT-ATP6|MT-CO1|ACAD9|ATP5A1|CYCS|NDUFB1|UQCR10|TMEM126B|NDUFB3|NDUFA1|NDUFB6|SCO2|NDUFAF7|MT-ND3|COX7C|SDHB|UQCRB
SIGNALING BY HIGH-KINASE ACTIVITY BRAF MUTANTS%REACTOME DATABASE ID RELEASE 66%6802948,0.406001062134891,0.8663957682383929,-0.19544232845039003,-1.02774026279148,1528,31,NRAS|ARRB2|ARRB1|RAP1A|YWHAB|KRAS|MAPK3|VWF|MAP2K1
PYROPHOSPHATE HYDROLYSIS%REACTOME DATABASE ID RELEASE 66%71737,0.8041611225353821,0.984530683443403,0.48541494347946,0.7933973899886079,6647,2,PPA2|PPA1
REGULATION OF EXPRESSION OF SLITS AND ROBOS%REACTOME DATABASE ID RELEASE 66%9010553,0.9982490698183409,1.0,0.0833547610933771,0.50265541581552,13682,161,SLIT1|PSMD11|PSMD13|PSMB9|ZSWIM8|PSMA4|UPF3B|ROBO2|PSMD3|RPL23A|PSMD1|RPS4Y1|RPS24|RPL36A|PSMA1|RPS19|RPLP0|PSMC3|MSI1|LHX4|RPS27L|RPL36|RPS15|PSMA3|RPS10|PSMC6|PSMC1|RPL28|PSMD2|RPS3A|UPF3A|RPL26L1|RBX1|PSMA5|FAU|RPL37|RPL27A|GSPT2|PSMC2|PSMC5|RPL7A|SHFM1|RPL19|PSMA2|PSMB6|CUL2|PSMB3|UPF2|PSMA7|RPLP1|PSMB4|RPSA|USP33|RPL6|RPL5|PSME2|RPL18|LDB1|RPS27A|TCEB2|RPS26|ISL1|RPL22|RPS12|RPL4|RPL37A|RPL23|PSMD14|PSMD4|PSMB10|RPL10|RPL24|PSMD9|RPL26|RPS25|RPL13|RPS5|PSME1|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|PSMB8|RPS15A|PSMB2|RPS11
NTF4 ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9026357.1,0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
TRIGLYCERIDE BIOSYNTHESIS%REACTOME%R-HSA-75109.6,0.311420612813371,0.8143712300420921,-0.357255436846473,-1.1105054493921698,1676,8,LPIN1|DGAT2|GPAT2
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT%REACTOME DATABASE ID RELEASE 66%8852276,0.558409570724842,0.936434965680841,-0.149077021480779,-0.946629373312095,1586,58,UBA52|TP53|CDKN1A|PSMD6|UBC|HSP90AB1|PSMF1|UBB
HYALURONAN UPTAKE AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%2160916,0.9192571659265241,1.0,-0.18182841529374105,-0.639876847291198,4553,11,LYVE1|HEXA|HYAL2|HYAL3|GUSB|HEXB|HYAL1|CD44|SLC9A1|CHP1
PHASE 2 - PLATEAU PHASE%REACTOME%R-HSA-5576893.2,0.25711836967907803,0.7676468938624871,0.330758535658721,1.18649829948622,2699,18,AKAP9|CACNB4|CACNB2|KCNQ1|CACNA2D1|CACNA1D
NEUREXINS AND NEUROLIGINS%REACTOME%R-HSA-6794361.4,0.232397335357113,0.746121572059682,0.25068364038488,1.1940153141588798,2755,48,LRRTM1|APBA3|LIN7A|LIN7B|DLG3|DLGAP1|GRIN1|CASK|DLGAP2|DLG4|NLGN4Y|EPB41|NRXN3|EPB41L5|SYT1|DLGAP3|SHANK1|APBA2|NLGN3|SYT7|STX1A|EPB41L2|SHARPIN|SIPA1L1|LIN7C|PDLIM5|GRIN2D|NRXN2|NLGN2|HOMER3|LRRTM2|DLG2
METABOLISM OF INGESTED H2SEO4 AND H2SEO3 INTO H2SE%REACTOME%R-HSA-2408550.2,0.878545791362742,0.9956508825790341,0.36359438163334706,0.6911546707917221,7587,3,PAPSS2|TXNRD1
REGULATION OF IFNG SIGNALING%REACTOME%R-HSA-877312.2,0.928244426751592,1.0,0.195656574786129,0.59690335948622,9326,11,PIAS1|JAK2
ATTACHMENT OF GPI ANCHOR TO UPAR%REACTOME%R-HSA-162791.2,0.931710860879041,1.0,-0.21181518476299102,-0.617874291338621,5129,7,PIGT|PLAUR
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 (RBL1) AND P130 (RBL2) IN COMPLEX WITH HDAC1%REACTOME%R-HSA-1362300.2,0.36565521202259005,0.8510019955058101,0.31204899299262895,1.08178923417081,3819,16,CDK1|LIN52|LIN9|E2F5|LIN37|E2F1|MYBL2|LIN54|CCNA2|RBL2|E2F4
ACTIVATION OF APC C AND APC C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS%REACTOME DATABASE ID RELEASE 66%176814,0.179215780611018,0.68489956912038,0.235699518227927,1.23712077155238,2234,74,CCNA1|ANAPC15|CCNB1|CDK1|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|PSMD1|BUB1B|PSMA1|PSMC3|PLK1|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
NUCLEAR SIGNALING BY ERBB4%REACTOME%R-HSA-1251985.4,0.31330570902394106,0.8160830209414109,-0.24575188861716502,-1.09652170106941,1360,20,NCSTN|HBEGF|PSEN2|ADAM17|STAT5A|WWOX
CAMK IV-MEDIATED PHOSPHORYLATION OF CREB%REACTOME%R-HSA-111932.2,0.10438010393467,0.576535954147525,-0.804380033531177,-1.3758489675160899,702,2,CAMK4
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE%REACTOME%R-HSA-352230.3,0.142110266159696,0.63219683908033,-0.282198019460837,-1.3073501652189399,597,22,SLC7A7|SLC7A3|SLC16A10|SLC1A5|SLC6A12|SLC43A2|SLC6A6|SLC7A8|SLC3A2|SLC7A1|SLC7A5
NICOTINAMIDE SALVAGING%REACTOME DATABASE ID RELEASE 66%197264,0.6880444146644971,0.96731875442989,0.23722263832145699,0.8223865546773601,7187,16,PARP16|NAPRT|RNLS|PTGS2|PARP10|PARP9|PARP14|NUDT12|PARP8|PTGIS|PARP6
JOSEPHIN DOMAIN DUBS%REACTOME DATABASE ID RELEASE 66%5689877,0.00847799757771498,0.20298122046820802,-0.5432884672610471,-1.91189980421411,41,11,JOSD2|JOSD1|RAD23B|UBA52|PARK2|UBC|UBB
GRB2:SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS%REACTOME%R-HSA-354194.1,0.808021496815287,0.984682960940884,0.236919959936915,0.722788488811422,8118,11,SRC|ITGA2B|FN1|PTK2|TLN1
RHO GTPASES ACTIVATE NADPH OXIDASES%REACTOME%R-HSA-5668599.4,0.996059889676911,1.0,-0.139263069164491,-0.471147807877505,5055,10,NCF2|CYBA|PIK3C3|RAC1
CYSTEINE FORMATION FROM HOMOCYSTEINE%REACTOME DATABASE ID RELEASE 66%1614603,0.461231401959598,0.8908856132322029,0.618954095104579,1.01166346478477,3812,2,CTH
EPHB-MEDIATED FORWARD SIGNALING%REACTOME DATABASE ID RELEASE 66%3928662,0.0312415104591144,0.3618116466527221,-0.295187746135135,-1.56275066916389,114,32,FYN|RHOA|LYN|ARPC5|YES1|LIMK1|ARPC4|CDC42|SDC2|RAC1|ACTR2
PHYSIOLOGICAL FACTORS%REACTOME DATABASE ID RELEASE 66%5578768,0.610932130584193,0.9508825506493929,0.35803405475716904,0.8805326150385929,5688,6,NPR2|KAT2B|HIPK2|NPR1|WWTR1|HIPK1
MAPK1 (ERK2) ACTIVATION%REACTOME DATABASE ID RELEASE 66%112411,0.6601850889050639,0.964478233711782,0.31057838308683505,0.846719995348963,6348,8,MAP2K2|JAK2
BIOSYNTHESIS OF DPAN-3-DERIVED 13-SERIES RESOLVINS%REACTOME%R-HSA-9026403.1,0.10565338276181697,0.578674426247723,-0.9454124393471551,-1.26470704549831,797,1,ALOX5
FORMATION OF RNA POL II ELONGATION COMPLEX%REACTOME%R-HSA-112382.2,0.356672443674177,0.844559957061487,-0.168918792605534,-1.0646855563618398,1028,57,POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D|EAF1
PTK6 ACTIVATES STAT3%REACTOME DATABASE ID RELEASE 66%8849474,0.670718999652657,0.964618776001639,0.45551103123496295,0.8658785524157941,5792,3,STAP2
PROLINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%70688,0.735115070527097,0.974251014964729,-0.46506754893851704,-0.795473135034616,4950,2,PRODH|ALDH4A1
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3:SMAD4 HETEROTRIMER%REACTOME DATABASE ID RELEASE 66%2173793,0.5213124808341,0.9251240799994541,-0.16535281683059802,-0.9559064248381479,1699,43,SMAD2|PPM1A|SMAD7|UBA52|UBE2D3|UBC|TFDP2|UBB
PRE-NOTCH PROCESSING IN GOLGI%REACTOME DATABASE ID RELEASE 66%1912420,0.9769545757546899,1.0,0.141500532371065,0.507591257472166,10258,18,ATP2A1|ATP2A2|RFNG|LFNG|ST3GAL4|ST3GAL6|ST3GAL3|NOTCH2
DISSOLUTION OF FIBRIN CLOT%REACTOME DATABASE ID RELEASE 66%75205,0.7999194035865401,0.9839175016931591,0.24605033244005803,0.7261580985079591,7939,10,SERPINE2|PLAT|SERPINB6|SERPINE1
TRANSFER OF LPS FROM LBP CARRIER TO CD14%REACTOME DATABASE ID RELEASE 66%166020,0.9418773997087249,1.0,-0.5261910013233351,-0.7039017458993589,7113,1,CD14
BIOGENIC AMINES ARE OXIDATIVELY DEAMINATED TO ALDEHYDES BY MAOA AND MAOB%REACTOME DATABASE ID RELEASE 66%141333,0.8911655530809208,0.997300970905927,-0.39228012131237894,-0.670974138325381,6001,2,MAOA|MAOB
PHENYLALANINE AND TYROSINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%71182,0.273537604456825,0.7884684708511421,-0.370611533417495,-1.1520220128786498,1472,8,PAH|PCBD1|QDPR
TRAF3 DEFICIENCY - HSE%REACTOME DATABASE ID RELEASE 66%5602571,0.0714179658500371,0.514687960157731,-0.8404190791287571,-1.4374918248829198,480,2,TRAF3|TICAM1
NONHOMOLOGOUS END-JOINING (NHEJ)%REACTOME DATABASE ID RELEASE 66%5693571,0.621053506148222,0.9536478716552259,0.18192762540382298,0.891139000698792,7474,54,HIST1H2BJ|HIST3H2BB|LIG4|HIST1H4I|PIAS4|H2AFX|DCLRE1C|XRCC4|BRCC3|HIST1H2BF|HERC2|HIST1H2BK|PAXIP1|RIF1|PRKDC|HIST1H2BN|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE|POLL|RNF8|UBE2V2|TP53BP1
REGULATION OF GENE EXPRESSION IN EARLY PANCREATIC PRECURSOR CELLS%REACTOME DATABASE ID RELEASE 66%210747,0.0525612472160356,0.447307566936778,-0.860876757650951,-1.4724835883519598,353,2,NKX6-1|FGF10
SHC-MEDIATED CASCADE:FGFR4%REACTOME%R-HSA-5654719.2,0.275404858299595,0.7884684708511421,0.411219118716075,1.1734788607910802,2720,9,FGFR4|FGF19|HRAS|FGF9
ALPHA-LINOLENIC (OMEGA3) AND LINOLEIC (OMEGA6) ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%2046104,0.6952627388535029,0.96731875442989,0.266981914103451,0.81450061989795,6985,11,HSD17B4|FADS2|FADS1|ELOVL2|ACAA1|ABCD1
RHO GTPASES REGULATE CFTR TRAFFICKING%REACTOME DATABASE ID RELEASE 66%5627083,0.637119524870082,0.9592996137261041,-0.5074286136995311,-0.8679294675948208,4290,2,RHOQ
IKBA VARIANT LEADS TO EDA-ID%REACTOME DATABASE ID RELEASE 66%5603029,0.40319651289502395,0.865238688875249,-0.35102040816326496,-1.02394210397123,2219,7,CHUK|IKBKG|NFKB2|NFKB1|IKBKB|RELA|NFKBIA
SUMOYLATION OF SUMOYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4085377,0.0243532560214095,0.327840876158443,0.387111416916401,1.62313155395907,272,30,TPR|NUP133|SUMO2|NUP205|NUP188|NUP160|PIAS4|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|TOPORS|POM121|NUP54|NUP37|AAAS
ONCOGENIC MAPK SIGNALING%REACTOME%R-HSA-6802957.2,0.0105780128447299,0.22430534023248602,-0.236792336528587,-1.58089074880651,27,69,BRAP|DAB2IP|NRAS|ARRB2|KDM7A|PAPD7|MPRIP|ARRB1|ATG7|LMNA|RAP1A|YWHAB|KRAS|RASA3|TRAK1|MAPK3|ZC3HAV1|VWF|SPRED3|MAP3K11|MAP2K1|BCL2L11|SPRED2
CLEAVAGE OF THE DAMAGED PURINE%REACTOME%R-HSA-110331.1,0.921978952461594,1.0,0.42055531207540003,0.687386104256977,7621,2,MPG|OGG1
BETA OXIDATION OF HEXANOYL-COA TO BUTANOYL-COA%REACTOME DATABASE ID RELEASE 66%77350,0.227936369579429,0.740988338612706,0.5303119997749729,1.22229054523422,2091,5,HADH|HADHB|ACADS|ECHS1|HADHA
UPTAKE AND FUNCTION OF ANTHRAX TOXINS%REACTOME DATABASE ID RELEASE 66%5210891,0.926537785588752,1.0,-0.226141675073124,-0.6207437137726689,5271,6,MAP2K1
AXONAL GROWTH INHIBITION (RHOA ACTIVATION)%REACTOME%R-HSA-193634.2,0.0417239010989011,0.402998391331252,-0.6449359817424101,-1.63261261182884,242,5,ARHGDIA|RTN4|RHOA|LINGO1
CD28 CO-STIMULATION%REACTOME DATABASE ID RELEASE 66%389356,0.0226150246945672,0.31605689786221697,-0.32083261751097897,-1.64194148333482,86,29,CD86|PIK3R2|THEM4|MAPKAP1|MAP3K8|VAV1|FYN|LYN|YES1|PRR5|CDC42|RAC1|PIK3R1|PAK2|TRIB3
CONSTITUTIVE SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS%REACTOME%R-HSA-2644606.1,0.7710184552289822,0.979355471471634,-0.131053788933517,-0.8228350529203409,2255,56,HDAC4|ADAM10|HDAC5|TBL1X|NCSTN|PSEN2|MAMLD1|HDAC11|ADAM17|UBA52|UBC|RBPJ|UBB
CYP2E1 REACTIONS%REACTOME DATABASE ID RELEASE 66%211999,0.181660298714832,0.6873049536419911,0.656336164111614,1.2476260040033,1568,3,CYP2C8|CYP2E1|CYP2D6
ACTIVATION OF GABAB RECEPTORS%REACTOME DATABASE ID RELEASE 66%991365,0.80107047279215,0.9841161968820359,0.177070019577875,0.7424424170343359,8979,30,GNG8|GNAI1|GNB3|ADCY8
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS%REACTOME DATABASE ID RELEASE 66%8866654,0.13129973474801102,0.614947654740329,-0.20627145680030398,-1.26336038886171,395,52,UBA52|UBE2L3|UBE2E1|UBE2D3|HIST1H2BC|UBC|HIST1H2BD|UBB
CD28 DEPENDENT VAV1 PATHWAY%REACTOME%R-HSA-389359.1,0.0527137836782507,0.447918405077224,-0.484418807978573,-1.5637473219651201,269,9,VAV1|FYN|CDC42|RAC1|PAK2
GASTRIN-CREB SIGNALLING PATHWAY VIA PKC AND MAPK%REACTOME%R-HSA-881907.1,0.00105485232067511,0.0882293398116183,-0.562472635182572,-2.17916789635603,4,14,MAPK7|NRAS|HBEGF|KRAS|PRKCA|MAPK3|RPS6KA2
METALLOPROTEASE DUBS%REACTOME DATABASE ID RELEASE 66%5689901,0.285337552742616,0.794258537514783,-0.217229899335543,-1.1269956793814,1081,30,NLRP3|UBA52|UBC|HIST2H2AC|UBB
ESR-MEDIATED SIGNALING%REACTOME DATABASE ID RELEASE 66%8939211,0.21944121071012804,0.734713083559597,-0.14763466907297798,-1.13474842648763,376,122,NRIP1|POLR2K|AGO2|BCL2|JUN|POLR2F|MAPK3|POLR2I|HIST2H4B|POLR2D|FKBP4|HIST1H2BC|CBFB|H3F3B|HIST2H2AC|HSP90AB1|HIST1H2BD|TLE3
ARL13B-MEDIATED CILIARY TRAFFICKING OF INPP5E%REACTOME%R-HSA-5624958.1,0.7295357184207479,0.972554563883587,0.4331621499555539,0.823395680117702,6300,3,INPP5E|ARL13B|PDE6D
PHOSPHORYLATION OF PROTEINS INVOLVED IN THE G2 M TRANSITION BY CYCLIN A:CDC2 COMPLEXES%REACTOME%R-HSA-170145.2,0.0884566400370499,0.556932119338259,0.7251975605692149,1.3785242747222,763,3,CCNA1|CDK1|CCNA2
KERATINIZATION%REACTOME DATABASE ID RELEASE 66%6805567,0.8882806668325451,0.997300970905927,-0.141003666143523,-0.68404705373008,3569,25,FURIN|CAPNS1|KRT17|KAZN|SPINK5|KRT9|PKP4|EVPL
O-LINKED GLYCOSYLATION%REACTOME DATABASE ID RELEASE 66%5173105,0.6141782178217821,0.951043054263351,0.16932353308491,0.9043779191279661,7753,80,GALNT10|GALNT8|MUC15|GALNT13|GALNT3|ADAMTS10|C1GALT1C1|ADAMTS2|B3GLCT|THSD1|ADAMTSL2
"TRANSPORT OF BILE SALTS AND ORGANIC ACIDS, METAL IONS AND AMINE COMPOUNDS%REACTOME%R-HSA-425366.3",0.248958506915514,0.7613646381106121,0.241131136259018,1.17607511378227,2987,53,SLC47A1|SLC2A13|RHBG|SLC6A13|SLC39A3|SLC30A5|SLC6A15|SLC13A3|SLC6A9|SLC39A7|SLC22A3|BSG|SLC40A1|SLC16A7|SLC6A2|SLC41A2|HEPH|SLC44A3|SLC6A1|SLC39A10|SLC30A7
SMAD2 3 PHOSPHORYLATION MOTIF MUTANTS IN CANCER%REACTOME%R-HSA-3304356.1,0.0467032967032967,0.425275525480742,-0.633079638208692,-1.60259906547494,271,5,TGFBR2|TGFB1|SMAD3|TGFBR1|SMAD2
UNFOLDED PROTEIN RESPONSE (UPR)%REACTOME%R-HSA-381119.2,0.41047448522828994,0.867015886388254,-0.143098988280944,-1.02662295925005,916,91,ARFGAP1|EXOSC7|EXOSC1|DIS3|WFS1|EXOSC8|DCTN1|EDEM1|CTDSP2|TSPYL2|GOSR2|PARN|MYDGF|WIPI1|CALR|ATF4|DNAJC3|CREB3|DCP2|ADD1|EIF2S1|KLHDC3|HSPA5|EIF2AK3|EXOSC6|TATDN2|EXOSC4|SEC63|HYOU1|SEC62|DDIT3|ATF6|LMNA|EXOSC9|CREBRF|CXCL8|SHC1|ATP6V0D1|ASNA1|NFYA|SSR1|EXOSC5
MET ACTIVATES RAP1 AND RAC1%REACTOME%R-HSA-8875555.1,0.0055161544523246704,0.171073097162825,-0.579821066461405,-1.96162145544716,27,10,CRKL|RAP1B|HGF|CRK|RAP1A|RAPGEF1|RAC1|MET
DEFECTIVE C1GALT1C1 CAUSES TN POLYAGGLUTINATION SYNDROME (TNPS)%REACTOME%R-HSA-5083632.1,0.35026362038664305,0.842847021021096,-0.388780782837379,-1.06717714416807,1992,6,MUC4|MUC3A|MUC12
PYRIMIDINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%73621,0.11296767163094802,0.588848744118853,-0.47912729719668,-1.3976355828674,621,7,UPP1|NT5E
DEFECTIVE B3GALTL CAUSES PETERS-PLUS SYNDROME (PPS)%REACTOME%R-HSA-5083635.1,0.766703076643,0.9792236089291529,0.191218240178409,0.768788917862722,8422,26,ADAMTS10|ADAMTS2|THSD1|ADAMTSL2|SEMA5A|THBS2|THBS1|THSD7A|ADAMTS13|THSD4|SEMA5B|ADAMTS1|SPON1|ADAMTS12|SPON2
"HISTIDINE, LYSINE, PHENYLALANINE, TYROSINE, PROLINE AND TRYPTOPHAN CATABOLISM%REACTOME%R-HSA-6788656.2",0.11162537435339,0.585750261301168,-0.24997142444475898,-1.33703977228678,409,33,TDO2|GCDH|PAH|PCBD1|OGDH|SLC3A2|QDPR|SLC7A5
NEF MEDIATED CD4 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%167590,0.9414979757085021,1.0,0.20117072022744,0.574072500165079,9301,9,AP2A2|LCK|AP2M1|AP2B1
PKA ACTIVATION IN GLUCAGON SIGNALLING%REACTOME%R-HSA-164378.2,0.40812294182217407,0.867015886388254,-0.24799102752532698,-1.01560660513759,1858,16,PRKAR2A|PRKAR1B|ADCY2|GNAS
GLYCOGEN STORAGE DISEASES%REACTOME%R-HSA-3229121.2,0.106989457243264,0.5822715745664481,-0.43401642509388394,-1.40104391334751,547,9,UBA52|UBC|UBB
REGULATED PROTEOLYSIS OF P75NTR%REACTOME%R-HSA-193692.1,0.00666128381106177,0.18239572673498103,-0.5548597696378841,-1.9526206589385102,32,11,NFKB1|APH1A|PSEN1|PSENEN|APH1B|RELA|TRAF6|NCSTN|PSEN2|ADAM17
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS%REACTOME%R-HSA-2151201.2,0.9276398822044591,1.0,0.13254013944751,0.633939985443194,11024,49,SIRT4|POLRMT|ALAS1|MTERF1|SMARCD3|NRF1|TFB1M|MED1|HDAC3|SIRT3|POLG2|CARM1|ESRRA|TGS1|CHD9|CYCS|PPRC1|NCOA6|ACSS2|NCOR1
ACTIVATED NTRK3 SIGNALS THROUGH RAS%REACTOME%R-HSA-9034864.1,0.833447802197802,0.98852173975491,-0.281566116187856,-0.7127659261777071,4853,5,NRAS|KRAS
GSD XV%REACTOME DATABASE ID RELEASE 66%3814836,0.6680779000846739,0.964618776001639,0.5412004779449799,0.8845773135542199,5522,2,GYS1|GYG1
FORMATION OF THE HIV-1 EARLY ELONGATION COMPLEX%REACTOME%R-HSA-167158.2,0.218350122515655,0.7341474817293291,-0.22228685007464896,-1.18896133854626,801,33,NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|POLR2F|NCBP2|POLR2I|POLR2D
IGF1R SIGNALING CASCADE%REACTOME%R-HSA-2428924.1,0.0920945395273024,0.5622489437340121,-0.260874057627313,-1.3810908937186999,338,32,PIK3C3|IGF1R|NRAS|FGF7|FGF2|IGF1|KRAS|GAB2|FGF10|IGF2|PIK3R1|TRIB3
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS%REACTOME DATABASE ID RELEASE 66%181431,0.0172231985940246,0.27746438902299797,-0.6643318074016881,-1.82354620469884,97,6,CHRNE|CHRNB4|CHRNA5|CHRNB2|CHRNA7|CHRNA3
DEFECTIVE LFNG CAUSES SCDO3%REACTOME%R-HSA-5083630.2,0.49695372962292106,0.911815944636073,-0.413445100093752,-0.950837358508799,3017,4,NOTCH2|NOTCH3|NOTCH4|NOTCH1
PEPTIDE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375276.5,0.19278922345483399,0.7027916199946072,0.22807928799834803,1.22044647630972,2432,81,TAC1|INSL3|EDN1|CXCL13|NPY1R|OXTR|CXCR4|NPY2R|F2R|CXCL9|PENK|AGTR1|NPY|XK|PROKR1|CCR5|XCL2|CCL21|F2RL1|SSTR2|CCL5|CCL19|CXCL10|C3AR1|MC1R|C5|NLN|HEBP1|NTS|OPRL1|CORT|FPR3
CAM PATHWAY%REACTOME%R-HSA-111997.1,0.647546985599219,0.9636261853025391,-0.180663401050941,-0.8660031449336321,2652,24,PRKAR2A|CAMK4|PRKCA|PRKAR1B|ADCY2
SELENOAMINO ACID METABOLISM%REACTOME%R-HSA-2408522.2,0.9466173361522199,1.0,-0.0970319178967231,-0.733192508271904,1790,112,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|SECISBP2|RPS27L|RPL36|PAPSS2|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|PSTK|TXNRD1|RPL7A|RPL19|GNMT|LARS|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|AIMP1|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|IARS|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|HNMT|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RARS|RPL38|RPS13|EEF1E1|RPS27|RPS23|RPS21|RPL3|NNMT|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|AHCY|RPS16|RPL12|SEPSECS|QARS|RPS4X|RPL9|DARS|PAPSS1|EEFSEC|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|AIMP2|RPL15|RPL8|SCLY|CBS|RPL35A|KARS|UBA52|SARS
VITAMIN B5 (PANTOTHENATE) METABOLISM%REACTOME DATABASE ID RELEASE 66%199220,0.7932176963554859,0.9819233677232551,0.22116029236934603,0.732772775712315,8139,14,ENPP2|PANK4|PANK3|SLC5A6|PANK1|PPCS|COASY|FASN|VNN2
DISEASES OF IMMUNE SYSTEM%REACTOME%R-HSA-5260271.1,0.0610036832412523,0.48170831577441997,-0.335486007617155,-1.49690685930156,264,20,BTK|CHUK|TLR4|IKBKG|TLR5|TLR2|CD14|NFKB2|TIRAP|NFKB1|IKBKB|LY96|RELA|TLR1|NFKBIA|IRAK4|TRAF3|TICAM1|MYD88|CD36
CARGO RECOGNITION FOR CLATHRIN-MEDIATED ENDOCYTOSIS%REACTOME DATABASE ID RELEASE 66%8856825,0.0712074303405573,0.514511211182091,-0.18438434358233802,-1.3154997511578799,160,89,NEDD8|ARRB1|VAMP2|AGFG1|TGOLN2|VAMP3|COPS7A|CLTA|AP2S1|TFRC|ADRB2|UBA52|SH3GL3|COPS2|SYT2|COPS8|UBC|SYT9|UBB
PI3K AKT ACTIVATION%REACTOME DATABASE ID RELEASE 66%198203,0.37953924248340504,0.855758937340731,-0.324770447782538,-1.04838810881971,1943,9,IRS2|NTRK1|PIK3R2|RHOA|PIK3R1
SIGNALING BY FGFR2 AMPLIFICATION MUTANTS%REACTOME DATABASE ID RELEASE 66%2023837,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
FORMYL PEPTIDE RECEPTORS BIND FORMYL PEPTIDES AND MANY OTHER LIGANDS%REACTOME%R-HSA-444473.1,0.676182174765744,0.9647315640607691,0.362290799710756,0.835026586801178,6205,5,HEBP1|FPR3|ANXA1|APP
SMALL INTERFERING RNA (SIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%426486,0.614603670441234,0.9511905259737851,-0.269141659311562,-0.8688133946201341,3147,9,DICER1|TARBP2|AGO4|AGO3|PRKRA|TSNAX|AGO1|TSN|AGO2
MTF1 ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-5660489.1,0.6692851531814611,0.964618776001639,-0.41217574745254904,-0.836498433175678,4259,3,CSRP1
NEUROTRANSMITTER UPTAKE AND METABOLISM IN GLIAL CELLS%REACTOME DATABASE ID RELEASE 66%112313,0.784455787913716,0.981487311948134,-0.32760312135732694,-0.7534187404325359,4763,4,GLUL
LINOLEIC ACID (LA) METABOLISM%REACTOME%R-HSA-2046105.1,0.7386267902274641,0.9744283926676119,0.29766398197334804,0.774756805839259,7013,7,FADS2|FADS1|ELOVL2|ABCD1|ELOVL1|ELOVL5
PROCESSING OF SMDT1%REACTOME DATABASE ID RELEASE 66%8949664,0.41514818880351295,0.869910465767785,-0.24700623585894801,-1.01157355228468,1890,16,SPG7|MICU1|MICU3|MICU2|MCU|STOML2|C2orf47|SMDT1|PHB|PMPCB|AFG3L2|PHB2|PARL|YME1L1|CCDC109B|PMPCA
PAUSING AND RECOVERY OF TAT-MEDIATED HIV ELONGATION%REACTOME%R-HSA-167238.2,0.004219409282700421,0.15257126011092098,-0.375095243294373,-1.9460061429955602,15,30,SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|TCEA1|POLR2I|POLR2D
FGFR3B LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190371,0.847586790855208,0.991298302704726,0.464085171433397,0.7585344635424341,7006,2,FGF9|FGF1
FATTY ACIDS BOUND TO GPR40 (FFAR1) REGULATE INSULIN SECRETION%REACTOME%R-HSA-434316.1,0.6638212858699599,0.964618776001639,-0.286618632640769,-0.836079267525218,3654,7,GNAQ|GNA15|PLCB1
CLASSICAL KIR CHANNELS%REACTOME%R-HSA-1296053.1,0.288492947290275,0.7980646072929201,-0.6866049644989071,-1.17440101956562,1942,2,KCNJ14
METHYLATION OF MESEH FOR EXCRETION%REACTOME DATABASE ID RELEASE 66%2408552,0.22013422818791897,0.735314515752205,0.891376268195854,1.18415360518352,1639,1,INMT
CELLULAR RESPONSE TO HEAT STRESS%REACTOME DATABASE ID RELEASE 66%3371556,0.210750853242321,0.7255949404689929,-0.166082538438772,-1.16080248073423,493,83,CAMK2A|BAG5|HSBP1|ST13|HSPA12A|HSPA4L|BAG3|HSF1|YWHAE|DNAJB6|HSPA6|MAPK3|FKBP4|BAG1|HSPB8|HSP90AB1
MITOCHONDRIAL PROTEIN IMPORT%REACTOME DATABASE ID RELEASE 66%1268020,0.424087591240876,0.8740879492662891,-0.15771475063259802,-1.02120651808248,1161,63,TIMM10|NDUFB8|PMPCB|CHCHD2|GRPEL1|TIMM8B|CHCHD5|VDAC1|TOMM6|TOMM5|CHCHD10|SLC25A6|CMC4|HSPA9|GFER|CHCHD7|TIMM8A|TOMM22|TIMM50|SAMM50|HSCB|TOMM20|MTX1|TIMM10B|TIMM23|SLC25A4|CHCHD3|PMPCA|FXN|CYC1|TIMM22|SLC25A13
INTRINSIC PATHWAY FOR APOPTOSIS%REACTOME%R-HSA-109606.2,0.000906070673512534,0.0849637591935908,-0.38012527032622295,-2.1887887758351,2,42,BAX|TP53BP2|GZMB|PPP3R1|BBC3|CASP3|YWHAH|BCL2L1|BID|YWHAQ|YWHAB|BCL2|STAT3|DYNLL2|TP53|YWHAZ|YWHAE|BMF|BCL2L11|PMAIP1|TFDP2
ANTIVIRAL MECHANISM BY IFN-STIMULATED GENES%REACTOME%R-HSA-1169410.2,0.307504078303426,0.8105323954771658,-0.15952441360716402,-1.0931602297099399,753,76,MX1|KPNB1|NUP93|EIF2AK2|UBE2N|EIF4E|EIF4E3|USP41|RNASEL|KPNA1|EIF4A1|ARIH1|FLNB|EIF4A2|MX2|EIF4G1|OASL|EIF4E2|OAS3|KPNA4|NEDD4|TRIM25|PDE12|UBA52|UBE2E1|MAPK3|UBC|UBB
FBXL7 DOWN-REGULATES AURKA DURING MITOTIC ENTRY AND IN EARLY MITOSIS%REACTOME%R-HSA-8854050.2,0.856940509915014,0.991600879311246,0.145998729746236,0.7120833724016831,10284,53,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|AURKA|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|FBXL7|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
NUCLEOSOME ASSEMBLY%REACTOME%R-HSA-774815.1,0.19368996356409401,0.7046839209256791,0.249044035711854,1.23017085567618,2338,56,RBBP7|HIST1H2BJ|HIST3H2BB|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|H2AFX|H2AFZ|MIS18BP1|HIST1H2BF|HJURP|HIST1H2BK|STRA13|CENPM|HIST1H2AC
ACTIVATION OF PPARGC1A (PGC-1ALPHA) BY PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%2151209,0.19817813765182202,0.711592141628341,0.441311349156634,1.25935180465202,1957,9,PRKAA2|MAPK11|MAPK12
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3%REACTOME%R-HSA-5654708.1,0.554641350210971,0.933856791464405,-0.236575904066811,-0.9165576828932491,2628,14,NRAS|FGF2|KRAS|PIK3R1
SIGNALING BY RAS MUTANTS%REACTOME%R-HSA-6802949.1,0.11388801012337901,0.590080021815051,-0.21817053921491394,-1.30305472680897,359,47,BRAP|DAB2IP|NRAS|ARRB2|ARRB1|RAP1A|YWHAB|KRAS|RASA3|MAPK3|VWF|SPRED3|MAP3K11|MAP2K1|SPRED2
RECYCLING OF BILE ACIDS AND SALTS%REACTOME%R-HSA-159418.2,0.230633253613393,0.743397546142977,0.44692178676982997,1.21842869247374,2217,8,ABCC3|STARD5|FABP6
SIGNALING BY ACTIVIN%REACTOME DATABASE ID RELEASE 66%1502540,0.8056116269681071,0.984682960940884,-0.20871323643018,-0.7344878824310089,3990,11,INHBB
GAP JUNCTION TRAFFICKING AND REGULATION%REACTOME DATABASE ID RELEASE 66%157858,0.852589260074663,0.991298302704726,0.19654228965723802,0.6813588179581259,8906,16,GJC2|CLTB|GJA1|CLTC|DNM1|DAB2|CLTCL1|AP2M1
SLIT2:ROBO1 INCREASES RHOA ACTIVITY%REACTOME DATABASE ID RELEASE 66%8985586,0.0803556726494319,0.536105877813735,-0.648817073843269,-1.49214372720502,487,4,SLIT2|ROBO1|MYO9B|RHOA
VXPX CARGO-TARGETING TO CILIUM%REACTOME DATABASE ID RELEASE 66%5620916,0.94556765163297,1.0,-0.14455413127262,-0.62183975590959,4255,18,EXOC3|EXOC4|RAB8A|ASAP1
SYNTHESIS OF LEUKOTRIENES (LT) AND EOXINS (EX)%REACTOME%R-HSA-2142691.1,0.7654259554140129,0.9792236089291529,0.24895796825613503,0.7595136927311981,7690,11,DPEP1|GGT1|GGT5|LTA4H
CELL-EXTRACELLULAR MATRIX INTERACTIONS%REACTOME DATABASE ID RELEASE 66%446353,0.66605486862442,0.964618776001639,0.24778142199859002,0.8401306688441809,6894,15,ITGB1|ILK|FBLIM1|ARHGEF6
VASOPRESSIN-LIKE RECEPTORS%REACTOME DATABASE ID RELEASE 66%388479,0.0939597315436242,0.562743160240921,0.95351786501985,1.26670594423102,699,1,OXTR
INTERLEUKIN-1 FAMILY SIGNALING%REACTOME DATABASE ID RELEASE 66%446652,0.45973884657236097,0.890371861972445,-0.131812330725938,-1.0036591408098101,844,116,PSME4|IL1RN|NOD1|PTPN6|PSMC4|IL1B|IRAK1|NFKBIA|PSMD12|MAP3K8|IRAK2|SQSTM1|IRAK4|PSMA6|NKIRAS1|PSME3|UBE2V1|PTPN5|PTPN12|RIPK2|UBA52|NFKBIB|STAT3|ALOX5|PELI2|TNIP2|PSMD6|PELI1|MYD88|UBC|MAP2K1|PSMF1|UBB
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS%REACTOME DATABASE ID RELEASE 66%8866911,0.7547525530243521,0.9771370084125129,-0.380389958938248,-0.771990119783155,4803,3,CDKN1A
VIRAL MESSENGER RNA SYNTHESIS%REACTOME%R-HSA-168325.3,0.132953957578893,0.618844994790344,0.293011860959831,1.3215591036207301,1541,39,TPR|NUP133|POLR2B|NUP205|NUP188|NUP160|NUP85|NUPL2|POLR2L|NDC1|NUP107|NUP35|POLR2J|NUP210|POM121|NUP54|POLR2G|POLR2H|NUP37|AAAS|GTF2F2
SIGNALING BY NOTCH4%REACTOME DATABASE ID RELEASE 66%9013694,0.977188118811881,1.0,0.107685798664013,0.575163160968039,12336,80,KAT2A|HES1|MAML1|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|HEY2|PSMC3|ACTA2|PSMA3|PSMC6|PSMC1|MAML3|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|PSMA7|TACC3|PSMB4|DLL4|JAG1|KAT2B|NOTCH2|PSME2|RPS27A|SNW1|HEY1|PSMD14|PSMD4|PSMB10|PSMD9|FLT4|PSME1|EP300
EUKARYOTIC TRANSLATION ELONGATION%REACTOME DATABASE ID RELEASE 66%156842,0.420769919427037,0.8727872721376851,-0.14238401140299403,-1.02149356115259,939,91,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|EEF1B2|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|EEF1D|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|EEF2|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|EEF1A1|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|EEF1A2|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52
THE FATTY ACID CYCLING MODEL%REACTOME%R-HSA-167826.2,0.9685295105834921,1.0,0.262452902721038,0.556162771673397,8647,4,UCP3|SLC25A27|SLC25A14|UCP2
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL%REACTOME DATABASE ID RELEASE 66%202733,0.0637767812655705,0.494016498848977,-0.177619355783664,-1.3088611690480099,127,103,SLC16A1|FCER1G|SIRPA|F11R|ITGAX|ESAM|NRAS|ITGAM|FYN|ITGA5|SLC16A8|TNFRSF10D|TNFRSF10A|LYN|ITGA6|YES1|JAM2|SLC16A3|SLC7A8|THBD|PROC|KRAS|SHC1|TNFRSF10B|SDC2|GLG1|SLC3A2|PIK3R1|CAV1|SLC7A5|ANGPT2
SENSING OF DNA DOUBLE STRAND BREAKS%REACTOME%R-HSA-5693548.1,0.515465729349736,0.9218820673607969,-0.34245215376978694,-0.940008168117484,2932,6,ATM|KPNA2|RAD50|NBN|KAT5|MRE11A
SIGNALING BY MET%REACTOME%R-HSA-6806834.2,0.00291970802919708,0.13103871184697197,-0.281540760510523,-1.8229826860584,7,63,HGF|LAMC1|CRK|RAP1A|PTPN1|LAMA4|KRAS|RAPGEF1|UBA52|STAT3|SH3GL3|SPINT1|RAC1|MET|LRIG1|LAMC2|UBC|PIK3R1|UBB
CHYLOMICRON CLEARANCE%REACTOME DATABASE ID RELEASE 66%8964026,0.0768785457913628,0.527286041772797,0.7367376199404431,1.40046071361822,663,3,LDLRAP1|APOE|LDLR
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS%REACTOME DATABASE ID RELEASE 66%8876384,0.030437680515441,0.35824396749211296,-0.37842464517849,-1.62789874572431,136,18,UBA52|SH3GL3|MET|UBC|UBB
"INTERLEUKIN-3, INTERLEUKIN-5 AND GM-CSF SIGNALING%REACTOME%R-HSA-512988.5",0.0031339031339031303,0.13515773385565,-0.352869397224776,-1.96017411530855,10,37,PRKACA|PIK3CD|PIK3R2|CRKL|PTPN6|VAV1|FYN|IL3RA|LYN|YES1|CSF2RB|CRK|STAT5A|RAPGEF1|SHC1|YWHAZ|GAB2|PIK3R1
SERINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%977347,0.9233648747010501,1.0,0.22246581068897198,0.606501483843466,8879,8,SERINC5|PSAT1|PHGDH
IRS ACTIVATION%REACTOME DATABASE ID RELEASE 66%74713,0.6089561996077579,0.9508825506493929,0.385045742118935,0.887473355825203,5588,5,INS|IRS1|INSR|IRS2|GRB10
SIALIC ACID METABOLISM%REACTOME%R-HSA-4085001.1,0.885773089786468,0.996643473105967,-0.138976603425923,-0.702699868854583,3442,28,GNE|CMAS|ST3GAL2|NEU4|NANS|ST6GALNAC5
SURFACTANT METABOLISM%REACTOME DATABASE ID RELEASE 66%5683826,0.167844522968198,0.672026878249637,-0.301792526868857,-1.26990824169422,759,17,ZDHHC2|TTF1|ADGRF5|ADRA2C|CSF2RB|CTSH|ADRA2A|ADORA2B
ERK MAPK TARGETS%REACTOME DATABASE ID RELEASE 66%198753,0.109077946768061,0.58452352834625,-0.294909179370409,-1.3662376692476899,458,22,PPP2CA|PPP2CB|PPP2R1B|DUSP3|MAPK3|RPS6KA2
"POU5F1 (OCT4), SOX2, NANOG ACTIVATE GENES RELATED TO PROLIFERATION%REACTOME DATABASE ID RELEASE 66%2892247",0.295899884735715,0.8006020093151399,-0.48920248964641294,-1.12506352820688,1796,4,FGF2|STAT3
BETA-CATENIN PHOSPHORYLATION CASCADE%REACTOME%R-HSA-196299.1,0.138913427561837,0.627473629755205,-0.31091156708320006,-1.30828011406854,628,17,CSNK1A1|AMER1|PPP2R5A|FRAT1|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
MOLECULES ASSOCIATED WITH ELASTIC FIBRES%REACTOME DATABASE ID RELEASE 66%2129379,0.0217489396263875,0.309969181714805,0.407353487698456,1.6561004006033702,240,27,ITGB1|BMP4|EFEMP1|TGFB2|ITGB5|LTBP2|FBLN5|MFAP4|EFEMP2|LTBP1|MFAP2|MFAP1|ITGA8|LTBP4|TGFB3|FBLN2|MFAP3|FBLN1
"TICAM1, RIP1-MEDIATED IKK COMPLEX RECRUITMENT%REACTOME%R-HSA-168927.2",0.0564319040213286,0.462200179276569,-0.351664402306759,-1.5127821264416998,253,18,UBA52|UBE2D3|TICAM1|UBC|UBB
SYNTHESIS OF DIPHTHAMIDE-EEF2%REACTOME%R-HSA-5358493.1,0.945332364693062,1.0,-0.20649440629382,-0.602353344482583,5204,7,DPH2|DPH6|DPH3
G-PROTEIN BETA:GAMMA SIGNALLING%REACTOME%R-HSA-397795.3,0.9103404332787179,1.0,0.15688168525475,0.630739520073764,10000,26,PLCB3|GNG8|GNB3|PDPK1
ZBP1(DAI) MEDIATED INDUCTION OF TYPE I IFNS%REACTOME DATABASE ID RELEASE 66%1606322,0.7436823104693142,0.9749763305090959,-0.18243077517380699,-0.800045279056537,3295,19,NFKBIB|TICAM1|MYD88
AXON GUIDANCE%REACTOME%R-HSA-422475.4,0.394594594594595,0.8636026273399079,-0.10691386985092599,-1.02477807059847,72,485,CAP2|VASP|RPL7|DPYSL2|DPYSL4|PFN1|ABL1|PSMA6|SCN1B|TRIO|RPS9|RPS3|ADAM10|RPL14|RET|PSME3|FYN|RHOA|NRP1|MMP2|ITGA5|ABLIM2|MAGOH|GSPT1|COL6A1|EIF4G1|SEMA7A|NCSTN|RPL15|CSNK2A2|UNC5B|LAMC1|LYN|PSEN2|RPL8|PRNP|MMP9|EFNA1|ARPC5|YES1|UNC5C|PRKAR2A|CLTA|RHOC|RPL35A|LIMK1|VAV3|VAV2|ARPC4|CDC42|AP2S1|MSN|ALCAM|COL9A1|PLXNA1|TCEB1|KRAS|ETF1|SHC1|UBA52|PRKCA|PLXNA4|EPHA8|RELN|KCNQ2|GAB2|UNC5D|MAPK3|NCBP2|MYH11|RBM8A|PSMD6|MYH9|EPHA7|RNPS1|SDC2|PITPNA|NCAN|EFNB1|SEMA3A|PABPC1|RAC1|MET|SCN5A|ACTR2|UBC|MAP2K1|DOK5|PTPRA|CSNK2A1|PIK3R1|DLG1|HSP90AB1|KCNQ3|PSMF1|GFRA2|SLIT3|RPS6KA2|EPHB2|PAK2|UBB
PCP CE PATHWAY%REACTOME%R-HSA-4086400.2,0.611992110453649,0.9508825506493929,0.16799050513700597,0.9074627777887951,7756,85,WNT4|WNT5B|RAC3|PSMD11|AP2A2|PSMD13|PSMB9|PSMA4|DVL1|PSMD3|PRKCB|CLTB|PSMD1|DAAM1|PSMA1|VANGL2|PSMC3|RAC2|CLTC|PSMA3|FZD6|PSMC6|PSMC1|PSMD2|FZD3|PSMA5|DVL3|PSMC2|PSMC5|DVL2|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|SMURF2|PSMB4|ROR2|AP2M1|SCRIB|AP2B1|PSME2
DISEASES ASSOCIATED WITH O-GLYCOSYLATION OF PROTEINS%REACTOME DATABASE ID RELEASE 66%3906995,0.684041072050122,0.966495577318169,0.188922504154338,0.8399687972935891,7860,37,MUC15|ADAMTS10|ADAMTS2|THSD1|ADAMTSL2|SEMA5A|MUC1
SIGNALING BY EGFR IN CANCER%REACTOME%R-HSA-1643713.1,0.0037544169611307397,0.143595610377104,-0.47837558771189104,-2.01294945160995,16,17,CDC37|KRAS|SHC1|UBA52|UBC|PIK3R1|UBB
SIGNALING BY INTERLEUKINS%REACTOME DATABASE ID RELEASE 66%449147,0.00264550264550265,0.127732272047141,-0.163019825275736,-1.5003517659228798,0,370,FPR1|IL6ST|RORC|RELA|PTPN9|PRKACA|TRAF6|VCAM1|MAPKAPK3|RPS6KA3|UBE2N|HSPA9|PIK3CD|CD86|IL6R|IL17RA|PIK3R2|DUSP4|SOCS3|CRKL|DUSP7|HIF1A|PSME4|LAMA5|IL1RN|RAP1B|NOD1|SOD1|PTPN6|MMP1|PSMC4|IL21R|ZEB1|BATF|IL13RA1|IL1B|IRAK1|IL11|VEGFA|PIM1|NFKBIA|PSMD12|CRLF1|MAPK7|MAP3K8|ITGAX|LGALS9|IRAK2|PTK2B|ITGAM|HMOX1|SQSTM1|IRAK4|GRB2|LIF|VAV1|BOLA2|PSMA6|NKIRAS1|PSME3|FYN|BOLA2B|MMP2|IL3RA|AIP|TNFRSF1B|FOXO1|CASP3|HNRNPF|VIM|UBE2V1|FGF2|P4HB|HGF|PTPN5|IL6|LYN|MMP9|VAMP2|BCL2L1|YES1|TCP1|CSF2RB|PTPN12|BRWD1|PPP2CA|PPP2CB|SOD2|ICAM1|CRK|RIPK2|RALA|PPP2R1B|CDC42|MAP2K3|FCER2|MSN|PDCD4|CXCL8|STAT5A|BCL2|RAPGEF1|SHC1|JUN|UBA52|DUSP3|NFKBIB|STAT3|TP53|YWHAZ|GAB2|ALOX5|PELI2|SOCS5|MAPK3|BCL6|CDKN1A|TNIP2|PSMD6|PITPNA|S1PR1|PELI1|MYD88|UBC|MAP2K1|CD36|TWIST1|PIK3R1|TNF|SNAP25|PSMF1|RPS6KA2|PAK2|UBB|FOXO3
DEFECTIVE TCN2 CAUSES HEREDITARY MEGALOBLASTIC ANEMIA%REACTOME%R-HSA-3359454.1,0.349794783529723,0.842847021021096,-0.8250441111601241,-1.10368666288296,2641,1,TCN2
FORMATION OF HIV-1 ELONGATION COMPLEX CONTAINING HIV-1 TAT%REACTOME%R-HSA-167200.3,0.0733917245545153,0.520754220371606,-0.24198973744596203,-1.39339439531197,242,42,SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF OTHER TRANSCRIPTION FACTORS%REACTOME%R-HSA-8866906.2,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
FRUCTOSE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%5652227,0.635538889560905,0.95916055221954,0.55292766709691,0.9037450820583179,5253,2,AKR1B1
TRANSMISSION ACROSS ELECTRICAL SYNAPSES%REACTOME DATABASE ID RELEASE 66%112307,0.291453976617817,0.8000726114371469,-0.49141817074912897,-1.13015913187113,1769,4,GJD2|PANX1|GJC1
HIGHLY SODIUM PERMEABLE ACETYLCHOLINE NICOTINIC RECEPTORS%REACTOME DATABASE ID RELEASE 66%629587,0.0683352544047423,0.50364937614461,-0.664258534164231,-1.5276558601091799,414,4,CHRNE|CHRNB4|CHRNB2|CHRNA3
AMINO ACID AND DERIVATIVE METABOLISM%REACTOME%R-HSA-71291.4,0.980919460767369,1.0,0.10054472591414301,0.655774446294203,14188,302,ASNS|CTH|PNMT|IDO1|GAMT|ASRGL1|SERINC5|MCCC2|RIMKLB|PSMD11|PXMP2|FTCD|GPT|TST|GLS|APIP|HRSP12|PSMD13|PSMB9|INMT|EPRS|GLS2|PSMA4|PSMD3|MARS|RPL23A|PDHX|DDC|DUOX1|SLC25A10|OAZ3|CDO1|MTR|PSMD1|RPS4Y1|TXN2|BCKDHA|PDHA1|RPS24|RPL36A|PSMA1|RPS19|RPLP0|PSMC3|DLD|MTAP|SECISBP2|SARDH|RPS27L|PSAT1|GSTZ1|BCAT2|TH|RPL36|NAALAD2|PYCR2|PAPSS2|PHGDH|IVD|ALDH9A1|DHTKD1|RPS15|PSMA3|ADO|NAGS|CKB|MCCC1|RPS10|RIMKLA|PSMC6|C9orf41|PSMC1|PHYKPL|SUOX|RPL28|PPM1K|PSMD2|RPS3A|CCBL1|AASS|RPL26L1|PSMA5|FAU|HIBCH|RPL37|RPL27A|AZIN2|PSTK|AFMID|PSMC2|PSMC5|ENOPH1|TXNRD1|RPL7A|HIBADH|SHFM1|RPL19|PSMA2|PSMB6|GNMT|PSMB3|SAT1|AADAT|CCBL2|LARS|PSMA7|RPLP1|PSMB4|RPSA|DBH|RPL6|RPL5|HSD17B10|LIPT1|SLC36A4|LIPT2|CKMT1B|PSME2|GATM|ARG2|RPL18|PIPOX|ACAD8|RPS27A|GRHPR|RPS26|NMRAL1|RPL22|RPS12|PYCR1|RPL4|RPL37A|PRODH|RPL23|GOT1|AUH|ACADSB|FAH|PSMD14|PSMD4|PSMB10|CKMT1A|RPL10|RPL24|PSMD9|AIMP1|MPST|RPL26|RPS25|RPL13|ACAT1|SLC44A1|RPS5|PSME1
2-LTR CIRCLE FORMATION%REACTOME%R-HSA-164843.2,0.959035383319292,1.0,0.21489896575357698,0.559336857558765,9106,7,LIG4|XRCC4|PSIP1
GSD II%REACTOME DATABASE ID RELEASE 66%5357609,0.688997749238713,0.96731875442989,-0.650419056021173,-0.8700854023502921,5203,1,GYG1
DETOXIFICATION OF REACTIVE OXYGEN SPECIES%REACTOME DATABASE ID RELEASE 66%3299685,0.723420847413569,0.97235201976979,-0.161586039319638,-0.82695713155663,2782,29,CCS|PRDX3|TXN2|GSTP1|CAT|GPX7|TXNRD1|GPX8|NCF4|ATOX1|CYCS|GPX3|NCF1|PRDX2|ATP7A|NUDT2|CYBB|PRDX6|ERO1L|NOX4|GPX1|NCF2|CYBA|TXN|SOD1|SOD3|P4HB|SOD2|PRDX1
"FORMATION OF THE TERNARY COMPLEX, AND SUBSEQUENTLY, THE 43S COMPLEX%REACTOME%R-HSA-72695.2",0.274541884816754,0.7884684708511421,-0.18389914851266198,-1.1206447905205,838,51,RPS4Y1|RPS24|RPS19|RPS27L|RPS15|RPS10|RPS3A|FAU|RPSA|EIF3F|RPS27A|RPS26|RPS12|RPS25|RPS5|EIF3E|RPS2|RPS8|RPS20|RPS15A|RPS11|RPS6|EIF3J|RPS29|RPS7|RPS18|RPS13|EIF3M|RPS27|RPS23|RPS21|EIF3C|RPS14|RPS17|EIF3L|EIF2S2|RPS16|EIF3H|RPS4X|EIF3D|EIF2S1|RPS28|EIF3K|RPS9|RPS3|EIF3G|EIF3B|EIF1AX|EIF3A|EIF3I|EIF2S3
INFLUENZA INFECTION%REACTOME%R-HSA-168254.2,0.544034090909091,0.929758904310055,-0.12233058614589801,-0.972964206803567,765,146,RPS4Y1|NUP188|NUP160|RPS24|RPL36A|NUP85|RPS19|RPLP0|NUPL2|RPS27L|POLR2L|RPL36|NDC1|GRSF1|CLTC|PABPN1|RPS15|NUP107|NUP35|POLR2J|NUP210|RPS10|RPL28|RPS3A|RPL26L1|POM121|NUP54|KPNA5|FAU|RPL37|RPL27A|POLR2G|POLR2H|NUP37|RPL7A|RPL19|AAAS|GTF2F2|RPLP1|RPSA|RPL6|RPL5|KPNA2|NUP62|RPL18|CPSF4|RPS27A|RPS26|RANBP2|RPL22|RPS12|RPL4|NUP50|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|NUP43|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|XPO1|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|NUP214|GTF2F1|RPS18|RPL10A|NUP153|RPL22L1|NUP88|RPL38|RPS13|KPNA3|RPS27|RPS23|NUP155|RPS21|POLR2C|RPL3|RPL29|TGFB1|RPL31|RPL17|RAE1|RPS14|RPS17|ISG15|IPO5|RPL32|RAN|CANX|RPL18A|SLC25A6|HSP90AA1|RPL11|KPNB1|NUP93|POLR2E|EIF2AK2|CALR|RPS16|RPL12|DNAJC3|RPS4X|RPL9|KPNA1|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|POLR2A|CLTA|RPL35A|KPNA4|POLR2K|UBA52|POLR2F|POLR2I|POLR2D
DEFECTIVE ABCC8 CAN CAUSE HYPOGLYCEMIAS AND HYPERGLYCEMIAS%REACTOME DATABASE ID RELEASE 66%5683177,0.13813959114551802,0.62557554524499,0.775461814171492,1.26747103208109,1141,2,KCNJ11|ABCC8
POST-TRANSLATIONAL PROTEIN PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%8957275,0.657411090778901,0.9643779777660141,0.164981501047025,0.8742441561143871,8262,77,CYR61|VCAN|TMEM132A|TNC|NOTUM|BMP4|CDH2|PENK|MIA3|HSP90B1|ANO8|LAMB2|MEN1|IGFBP5|FBN1|IGFBP7|PNPLA2|APOE|QSOX1|EVA1A|TF|FSTL3|GPC3|FN1|C4A|LTBP1
TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS%REACTOME%R-HSA-6803211.1,0.0957446808510638,0.5679182161799671,-0.423069982347423,-1.43130907538973,485,10,TP53BP2|IGFBP3|TNFRSF10D|TNFRSF10A|TP53|TNFRSF10B
ABACAVIR TRANSMEMBRANE TRANSPORT%REACTOME%R-HSA-2161517.1,0.44925607838393605,0.8858223310328521,0.622718500137855,1.0178162813974,3713,2,SLC22A3|ABCB1
SYNTHESIS OF PC%REACTOME%R-HSA-1483191.4,0.734316671219157,0.9736136237452191,0.19980692059717103,0.7962018362916641,8064,25,STARD10|MFSD2A|CEPT1|ABHD3|BCHE|CHKB
DEX H-BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION%REACTOME%R-HSA-3134963.2,0.606792589901925,0.9508825506493929,-0.299596130109012,-0.873935203399274,3340,7,MYD88
INITIATION OF NUCLEAR ENVELOPE REFORMATION%REACTOME%R-HSA-2995383.2,0.625226677412855,0.954110852066186,0.294085370324786,0.8679219052308349,6205,10,LEMD3|LMNB1|VRK1|LEMD2|PPP2R1A|ANKLE2
DEPOLYMERISATION OF THE NUCLEAR LAMINA%REACTOME DATABASE ID RELEASE 66%4419969,0.29588529902779104,0.8006020093151399,0.356941584333836,1.15198316836805,3012,13,CCNB1|CDK1|PRKCB|LEMD3|LMNB1|CNEP1R1|LEMD2
MITOTIC G1-G1 S PHASES%REACTOME%R-HSA-453279.3,0.0124319552743858,0.242128600684977,0.257063065208197,1.5288374129947502,168,146,CDK6|CCNA1|CCNB1|CDC7|CDK1|POLE|LIN52|PSMD11|CDKN2C|DHFR|PSMD13|WEE1|PSMB9|PSMA4|E2F3|POLE2|ORC1|JAK2|LIN9|PSMD3|CDC45|TK1|TOP2A|CDKN2A|CCNE1|E2F2|FBXO5|PSMD1|RB1|POLA2|E2F5|MCM6|CDC6|E2F6|PPP2R3B|PSMA1|CDKN2B|ORC6|PSMC3|DBF4|CDK7|MCM10|AKT3|MCM3|LIN37|PSMA3|MCM2|AKT2|CCNE2|PSMC6|PSMC1|E2F1|PSMD2|PRIM2|TYMS|GMNN|RRM2|PSMA5|MYBL2|PSMC2|PPP2R1A|PSMC5|SKP2|CDK2|CDKN2D|CCND2|SHFM1|AKT1|PSMA2|PSMB6|PSMB3|ORC2|PSMA7|PSMB4|MCM7|LIN54|CCNA2|CDT1|MNAT1
SYNTHESIS OF SUBSTRATES IN N-GLYCAN BIOSYTHESIS%REACTOME DATABASE ID RELEASE 66%446219,0.9954769736842101,1.0,0.0923757849427908,0.4604748284628771,12104,58,SLC35A1|ST3GAL5|MVD|SRD5A3|GMPPB|FPGT|NUDT14|AMDHD2|DOLPP1|ST8SIA3|ALG5|ST3GAL4
RNA POLYMERASE II TRANSCRIPTION ELONGATION%REACTOME%R-HSA-75955.2,0.356672443674177,0.844559957061487,-0.168918792605534,-1.0646855563618398,1028,57,POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D|EAF1
CLEARANCE OF DOPAMINE%REACTOME DATABASE ID RELEASE 66%379401,0.271506310061364,0.7864992130359009,0.607808536450866,1.15538008873503,2344,3,LRTOMT|COMT|MAOA
SODIUM-COUPLED PHOSPHATE COTRANSPORTERS%REACTOME%R-HSA-427652.1,0.5021529324424651,0.9159769483621171,-0.561345464571271,-0.960151353409105,3381,2,SLC20A1|SLC20A2
ACYL CHAIN REMODELLING OF PI%REACTOME DATABASE ID RELEASE 66%1482922,0.999899254483175,1.0,0.10480231845311999,0.309298717593414,9924,10,PLA2G4A|PLA2G2D|PLA2G12A|PLA2G4C|PLA2R1
CLATHRIN-MEDIATED ENDOCYTOSIS%REACTOME%R-HSA-8856828.3,0.0370141887723627,0.386113929236656,-0.174752547007229,-1.35270808283328,59,127,NEDD8|ARRB1|VAMP2|AGFG1|ARPC5|TGOLN2|VAMP3|BIN1|COPS7A|CLTA|ARPC4|AP2S1|RAB5C|TFRC|ADRB2|UBA52|SH3GL3|COPS2|SYT2|RAB5A|COPS8|ACTR2|UBC|AMPH|SYT9|UBB
C-SRC MEDIATED REGULATION OF CX43 FUNCTION AND CLOSURE OF GAP JUNCTIONS%REACTOME%R-HSA-191647.1,0.748881093504294,0.9749763305090959,0.5073386891172651,0.8292311499530759,6190,2,GJA1|TJP1
ACTIVATION OF NF-KAPPAB IN B CELLS%REACTOME%R-HSA-1169091.1,0.97811050532997,1.0,0.108412849006877,0.5534335118600401,12019,65,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PRKCB|MAP3K7|CARD11|PSMD1|PSMA1|PSMC3|PSMA3|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|CHUK|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
REDUCTION OF CYTOSOLIC CA++ LEVELS%REACTOME DATABASE ID RELEASE 66%418359,0.157145700636943,0.6578589353509621,0.43141227581069397,1.3161399612381202,1578,11,ATP2B1|SLC8A3|ATP2A1|ATP2B3|ATP2A2|SLC8A1|SLC8A2
CRMPS IN SEMA3A SIGNALING%REACTOME%R-HSA-399956.1,0.149286498353458,0.642331436537182,-0.31714407519805604,-1.2988115770378201,679,16,DPYSL2|DPYSL4|FYN|NRP1|PLXNA1|PLXNA4|SEMA3A
TOXICITY OF TETANUS TOXIN (TENT)%REACTOME%R-HSA-5250982.1,0.23566794651132003,0.750277765814412,-0.882002646669607,-1.1798818324851899,1779,1,VAMP2
ADHERENS JUNCTIONS INTERACTIONS%REACTOME%R-HSA-418990.2,0.39078575981061603,0.8608417878556021,0.265822351801766,1.05926383330154,4291,25,CDH4|CDH6|CDH10|CDH3|CDH2|CTNND1|CDH7
BUDDING AND MATURATION OF HIV VIRION%REACTOME DATABASE ID RELEASE 66%162588,0.120122417750574,0.606646975444992,-0.266707419276911,-1.3290556253136399,470,27,VPS28|NEDD4L|VPS4A|VPS37D|VPS4B|UBA52|CHMP4B|UBC|UBB
REUPTAKE OF GABA%REACTOME DATABASE ID RELEASE 66%888593,0.660182933889082,0.964478233711782,0.460176206503055,0.874746559842419,5701,3,SLC6A13|SLC6A1
MYD88-INDEPENDENT TLR4 CASCADE%REACTOME DATABASE ID RELEASE 66%166166,0.0175600739371534,0.279896423939555,-0.20571778940285101,-1.4790009355696399,37,93,RELA|TRAF6|MAPKAPK3|RPS6KA3|UBE2N|DUSP4|DUSP7|UBE2D1|NOD1|IRAK1|NFKBIA|MAPK7|MAP3K8|IRAK2|TRAF3|NKIRAS1|UBE2V1|TANK|PPP2CA|PPP2CB|RIPK2|PPP2R1B|MAP2K3|JUN|UBA52|DUSP3|NFKBIB|UBE2D3|MAPK3|TNIP2|TICAM1|UBC|MAP2K1|RPS6KA2|UBB
MITOCHONDRIAL TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379726,0.847856806406029,0.991298302704726,-0.15748509604769298,-0.7152651774584999,3599,21,VARS2|WARS2|HARS2|CARS2|NARS2|AARS2|DARS2|PPA2|YARS2|LARS2|IARS2|PARS2|TARS2|SARS2|EARS2|RARS2|MARS2|QARS|FARS2|GARS|KARS
NGF-INDEPENDANT TRKA ACTIVATION%REACTOME%R-HSA-187024.2,0.266311813186813,0.7803351796901099,-0.459316418496906,-1.16272901324586,1550,5,NTRK2|NTRK1|ADCYAP1R1|ADCYAP1
RUNX2 REGULATES GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS%REACTOME DATABASE ID RELEASE 66%8941333,0.00612725844461901,0.17804916190196898,-0.867596779530164,-1.7607618866240902,38,3,RUNX1|LGALS3|CBFB
G2 M DNA DAMAGE CHECKPOINT%REACTOME%R-HSA-69473.4,0.253869969040248,0.7641083395392759,0.21817779453708802,1.1620349917512098,3197,79,HIST1H2BJ|HIST3H2BB|CCNB1|CDK1|ATR|BLM|WEE1|EXO1|BRIP1|RFC4|CDC25C|DNA2|RAD9A|HIST1H4I|PIAS4|H2AFX|RMI2|BRCC3|HIST1H2BF|CHEK2|TOPBP1|HERC2|RMI1|HIST1H2BK|CHEK1|RFC3|HIST1H2BN|RAD17|RFC5|RAD1|ATM|HIST1H2BG|HIST2H2BE|MDC1|UIMC1|BRCA1|HIST1H2BH|BRE
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES%REACTOME%R-HSA-1834941.3,0.9343122102009269,1.0,0.172588143062504,0.585179433131601,9671,15,DTX4|TBK1|NLRC3|PRKDC|TRIM21
G ALPHA (S) SIGNALLING EVENTS%REACTOME DATABASE ID RELEASE 66%418555,0.00442282176028306,0.155321503601441,-0.239916617162293,-1.7116976639326102,9,89,ADCY7|GNG4|GNAZ|PDE7B|ARRB2|CRHR1|CALCRL|GNAI2|GNAL|PDE8A|ADCYAP1R1|ARRB1|VIP|GCGR|VIPR1|CRH|RAMP2|PDE4B|GNB5|GNGT1|ADRB2|GIPR|MC4R|ADM2|CALCB|ADCY2|ADCYAP1|PDE10A|GNAS|ADM|PDE3A|PDE4D|RAMP1|ADORA2B
RNA POLYMERASE II TRANSCRIBES SNRNA GENES%REACTOME DATABASE ID RELEASE 66%6807505,0.559079651673724,0.936434965680841,0.177757293186668,0.9365584407894059,6997,75,INTS7|POU2F2|SNAPC2|AK6|INTS9|INTS10|GTF2B|POLR2B|TAF5|INTS6|NABP1|ZNF143|INTS3|ASUN|CDK7|GTF2E2|SRRT|POLR2L|INTS1|INTS8|POU2F1|POLR2J|CCNT2|SNAPC3|INTS2|SNAPC5|POLR2G|POLR2H|SP1|GTF2A1
ARYL HYDROCARBON RECEPTOR SIGNALLING%REACTOME%R-HSA-8937144.1,0.430052724077329,0.8781878130018052,-0.36368533543751397,-0.998291826091508,2446,6,AHR|AIP|HSP90AB1
PROTON OLIGOPEPTIDE COTRANSPORTERS%REACTOME DATABASE ID RELEASE 66%427975,0.12029639921268999,0.606646975444992,0.6977867683995209,1.32641924231471,1038,3,SLC15A2|SLC15A4
POST-CHAPERONIN TUBULIN FOLDING PATHWAY%REACTOME DATABASE ID RELEASE 66%389977,0.170494699646643,0.673117535978459,-0.30134621267468603,-1.26803020289902,771,17,TUBB2B|TUBB2A|TUBB6|TUBA1C|TUBB3|TBCB|TUBB4B
DERMATAN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022923.1,0.5798516204607579,0.942746898746279,-0.276144832980239,-0.891420266792063,2969,9,CSPG4|NCAN
RECOGNITION OF DNA DAMAGE BY PCNA-CONTAINING REPLICATION COMPLEX%REACTOME DATABASE ID RELEASE 66%110314,0.727386262265834,0.972554563883587,0.19136221156192298,0.8023685953148351,8153,30,POLE|POLE2|RFC4|DTL|POLD1|POLD3|DDB1|CUL4B|UBE2B|RBX1|RFC3|RFC5
ELEVATION OF CYTOSOLIC CA2+ LEVELS%REACTOME DATABASE ID RELEASE 66%139853,0.947719014937424,1.0,-0.17063997802697503,-0.600503342590032,4694,11,ITPR2|P2RX3|P2RX7|P2RX4|ITPR1|ITPR3|STIM1|ORAI1|P2RX6|ORAI2
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER%REACTOME%R-HSA-2691230.1,0.19419354838709696,0.7049178772406091,-0.30952160525710304,-1.2343998141086001,902,15,ADAM17|UBA52|UBC|UBB
ETHANOL OXIDATION%REACTOME%R-HSA-71384.2,0.521482729570345,0.9251240799994541,0.365282290902619,0.95075305736755,4951,7,ALDH1A1|ADH1B|ACSS1|ACSS2|ADH5
KINESINS%REACTOME DATABASE ID RELEASE 66%983189,0.00752405949256343,0.19651475212530603,0.4099579588053379,1.80956935521166,85,36,KIF25|KIF21B|KLC1|KIF2C|KIF18A|KIF20B|KIFC2|KIF4A|KIF23|KIF11|CENPE|KIF18B|KIF15|KIFAP3|KIFC1|KIF22|KLC2|KIF20A|RACGAP1|KIF16B|KIF27
CALNEXIN CALRETICULIN CYCLE%REACTOME%R-HSA-901042.2,0.0809262948207171,0.5374028338839121,-0.28747681816674797,-1.41159549011349,324,26,RNF185|EDEM2|DERL2|RNF5|CANX|EDEM1|UGGT1|CALR|TRIM13|OS9|RNF139|AMFR|RNF103|UBA52|UBC|UBB
SYNTHESIS OF PIPS AT THE ER MEMBRANE%REACTOME%R-HSA-1483248.6,0.16334595751687803,0.665440683774265,-0.567253074505046,-1.3045635680434198,991,4,SACM1L|SBF1|PI4K2B|MTMR2
MASTL FACILITATES MITOTIC PROGRESSION%REACTOME DATABASE ID RELEASE 66%2465910,0.636327817178881,0.9592476055325171,-0.251761451769878,-0.85174667498769,3229,10,ARPP19|PPP2CA|PPP2CB|PPP2R1B
ACETYLCHOLINE REGULATES INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%399997,0.374507486209614,0.852609194081082,-0.311016425592148,-1.05221512071199,1900,10,GNAQ|GNA15|PRKCA|PLCB1
RNA POLYMERASE III CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%73780,0.6394134636747391,0.9605702441869879,-0.20150487188079896,-0.8668291887738191,2877,18,POLR3F|POLR2E|POLR3C|POLR1C|POLR3D|POLR3H|POLR2K|POLR2F|CRCP
TRANSCRIPTIONAL REGULATION BY THE AP-2 (TFAP2) FAMILY OF TRANSCRIPTION FACTORS%REACTOME%R-HSA-8864260.3,0.8777327935222671,0.995148407853924,0.163151459520773,0.669023495630627,9755,28,CITED1|TFAP2E|YEATS4|KDM5B|KIT|APOE|ATAD2
SYNTHESIS OF CL%REACTOME DATABASE ID RELEASE 66%1483076,0.8555704697986579,0.991298302704726,0.5733348037053371,0.761649708443539,6373,1,CRLS1
COPII-MEDIATED VESICLE TRANSPORT%REACTOME%R-HSA-204005.4,0.696422117817131,0.96731875442989,-0.134659033915696,-0.8681355138501221,1926,62,CSNK1D|GOSR2|TRAPPC1|PPP6R1|TMED10|SEC13|SEC22C|NAPB|TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|YKT6|SERPINA1|LMAN2|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
NOTCH-HLH TRANSCRIPTION PATHWAY%REACTOME%R-HSA-350054.2,0.892664244328783,0.9976191001250191,0.198008858057829,0.639048185142418,9089,13,KAT2A|MAML1
CHROMATIN ORGANIZATION%REACTOME%R-HSA-4839726.2,0.698288611874076,0.96731875442989,0.139847712332059,0.888247170984432,9914,236,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|HDAC10|MBD3|JADE3|EHMT1|MTA2|AK6|KAT2A|IKBKAP|KDM5D|SMARCD3|DOT1L|TADA1|OGT|TAF6L|ACTL6B|MTA1|HIST2H3C|HIST2H3A|YEATS4|JAK2|KDM5B|TRRAP|EP400|EZH2|KMT2B|ARID2|HIST1H2AK|HDAC8|HIST1H4I|ARID4A|CLOCK|ING5|HDAC3|SUV420H2|H2AFX|ELP4|YEATS2|KDM4B|H2AFZ|PHF21A|SETD8|BRPF3|HIST1H2BF|SUPT20H|PRMT1|MINA|KDM1A|HIST1H2BK|CARM1|NSD1|MSL1|KAT8|KDM3B|SMYD2|EHMT2|HIST1H2AC|SMARCA4|SUPT3H|KMT2D|WDR5|SUZ12|EED|KDM8|PHF2|HIST1H3H|ZZZ3|HIST1H2BN|BRD1|SUDS3|HIST3H2A|ATF7IP|ARID1A|KDM4A|CHD3
NEGATIVE REGULATION OF THE PI3K AKT NETWORK%REACTOME DATABASE ID RELEASE 66%199418,0.14144606874753102,0.6302094012719549,-0.18262720235718102,-1.2416723388529298,357,74,PIP5K1A|TRAF6|PIK3CD|PPP2R5A|CD86|PIK3R2|THEM4|RHOG|IRAK1|CD19|IRAK4|VAV1|PPP2R5C|FGF7|FYN|FGF2|HGF|HBEGF|PIP4K2A|PPP2CA|PPP2CB|PPP2R1B|MAPK3|FGF10|RAC1|MET|MYD88|PIK3R1|TRIB3
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN TC-NER%REACTOME DATABASE ID RELEASE 66%6782210,0.695244310302635,0.96731875442989,0.16592331767184199,0.8442411796981759,8522,64,GTF2H2|POLE|POLE2|RFC4|GTF2H1|POLR2B|POLD1|ZNF830|POLD3|DDB1|PPIE|LIG1|CDK7|POLR2L|CUL4B|POLR2J|XAB2|RBX1|XRCC1|RFC3|AQR|POLR2G|RFC5|POLR2H
TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS%REACTOME DATABASE ID RELEASE 66%168271,0.0472881508889089,0.4277111233594871,0.375728171722489,1.52752730613222,523,27,TPR|NUP133|NUP205|NUP188|NUP160|NUP85|NUPL2|NDC1|NUP107|NUP35|NUP210|POM121|NUP54|NUP37|AAAS|NUP62|RANBP2|NUP50
SPHINGOLIPID DE NOVO BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%1660661,0.964878391430327,1.0,0.126513805305772,0.550209179877957,10988,34,SPTSSB|CERS4|PPAP2C|CERS6
NUCLEAR EVENTS (KINASE AND TRANSCRIPTION FACTOR ACTIVATION)%REACTOME%R-HSA-198725.1,0.08111470515053501,0.537766465971981,-0.291469178444021,-1.4139960911712701,325,25,RPS6KA5|ATF1|DUSP6|MAPKAPK2|RPS6KA3|DUSP4|DUSP7|MAPK7|PPP2CA|PPP2CB|PPP2R1B|DUSP3|MAPK3|RPS6KA2
CLEC7A INFLAMMASOME PATHWAY%REACTOME DATABASE ID RELEASE 66%5660668,0.0460456942003515,0.421305382128188,-0.585626826981413,-1.60750631809815,261,6,MALT1|NFKB1|CASP8|RELA|PYCARD|IL1B
IRE1ALPHA ACTIVATES CHAPERONES%REACTOME DATABASE ID RELEASE 66%381070,0.996240601503759,1.0,-0.0804636934597419,-0.505199796243206,2914,56,EDEM1|CTDSP2|TSPYL2|GOSR2|MYDGF|WIPI1|DNAJC3|ADD1|KLHDC3|HSPA5|TATDN2|SEC63|HYOU1|SEC62|LMNA|SHC1|ATP6V0D1|ASNA1|SSR1
ALKBH3 MEDIATED REVERSAL OF ALKYLATION DAMAGE%REACTOME%R-HSA-112126.1,0.8771418971889351,0.9946827553646909,0.31907127190927903,0.676142504451699,7831,4,ALKBH3|ASCC1|ASCC3
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%9013700,0.037141703673798994,0.38661455345178203,-0.466354650210576,-1.6411601168841299,183,11,APH1A|PSEN1|PSENEN|NOTCH4|APH1B|ADAM10|NCSTN|PSEN2|YWHAZ
KERATAN SULFATE DEGRADATION%REACTOME%R-HSA-2022857.1,0.0720647773279352,0.5150905383374771,0.516075161858901,1.4727021810454601,711,9,PRELP|GLB1L|FMOD|HEXA|OGN|LUM|GNS
COLLAGEN DEGRADATION%REACTOME DATABASE ID RELEASE 66%1442490,0.0697195780807821,0.506859496310725,-0.284424359992729,-1.43811947866801,270,28,CTSD|MMP1|FURIN|CTSL|COL16A1|CTSK|COL23A1|ADAM10|MMP2|MMP9|COL15A1|COL9A1|ADAM17|MMP12
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH3%REACTOME%R-HSA-5632927.1,0.844562719245192,0.991298302704726,0.465486213980864,0.7608244290973779,6981,2,MSH3|MSH2
DISEASES OF MISMATCH REPAIR (MMR)%REACTOME DATABASE ID RELEASE 66%5423599,0.847699175824176,0.991298302704726,-0.27748696775062,-0.7024398327782329,4936,5,MLH1|PMS2
APC TRUNCATION MUTANTS HAVE IMPAIRED AXIN BINDING%REACTOME DATABASE ID RELEASE 66%5467337,0.166033755274262,0.6682860217990739,-0.32939483194014396,-1.2761627821352801,786,14,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
ANCHORING FIBRIL FORMATION%REACTOME%R-HSA-2214320.2,0.268715659340659,0.7843144226895771,-0.45813684968726504,-1.15974301313165,1564,5,LAMC2
CELLULAR RESPONSE TO HYPOXIA%REACTOME%R-HSA-2262749.1,0.405228758169935,0.866234596232951,-0.153834762063192,-1.0343599768334,1053,71,VHL|TCEB1|UBA52|UBE2D3|PSMD6|UBC|EPAS1|PSMF1|UBB|EGLN3
TACHYKININ RECEPTORS BIND TACHYKININS%REACTOME%R-HSA-380095.2,0.4534897786379579,0.8877670623536891,0.6213279306719011,1.01554343380648,3748,2,TAC1
CELL DIVISION%REACTOME%R-HSA-68884.2,0.717932489451477,0.971081608033886,-0.20887444175467398,-0.809234884277221,3402,14,PDS5A|NUDC
SYNTHESIS OF WYBUTOSINE AT G37 OF TRNA(PHE)%REACTOME DATABASE ID RELEASE 66%6782861,0.7942003514938492,0.9819883545684358,-0.270145055429927,-0.741530038241172,4518,6,LCMT2|TYW3|TYW5|TRMT5|TRMT12|TYW1
IRAK4 DEFICIENCY (TLR5)%REACTOME%R-HSA-5603037.1,0.18601728201099801,0.6922162303225631,-0.63238322421403,-1.2834029646116398,1183,3,IRAK4|MYD88
"BASE-EXCISION REPAIR, AP SITE FORMATION%REACTOME%R-HSA-73929.1",0.748362275137777,0.9749763305090959,0.28368333512246696,0.7733968791006149,7196,8,TDG|MBD4|NEIL1|MPG|NTHL1
FGFR2 LIGAND BINDING AND ACTIVATION%REACTOME%R-HSA-190241.1,0.157117750439367,0.6578589353509621,-0.478108160494169,-1.31237479794117,893,6,FGF7|FGF2|FGF10
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR (NLR) SIGNALING PATHWAYS%REACTOME%R-HSA-168643.1",0.596881959910913,0.948743846634479,-0.15309657913863098,-0.920327641668807,1875,48,TXNIP|RELA|TRAF6|UBE2N|PYCARD|TXN|ITCH|NOD1|IRAK1|IRAK2|TNFAIP3|UBE2V1|CYLD|BCL2L1|PANX1|RIPK2|NLRP1|NLRP3|BCL2|HSP90AB1
MITOTIC METAPHASE ANAPHASE TRANSITION%REACTOME DATABASE ID RELEASE 66%68881,0.164993347042458,0.667429120754799,0.755720981527433,1.2352051834367699,1363,2,FBXO5|PLK1
REGULATION OF THYROID HORMONE ACTIVITY%REACTOME DATABASE ID RELEASE 66%350864,0.80895008605852,0.984682960940884,-0.5935156594618439,-0.79396399380286,6109,1,DIO2
DEFECTIVE B4GALT1 CAUSES B4GALT1-CDG (CDG-2D)%REACTOME DATABASE ID RELEASE 66%3656244,0.174375629969761,0.676682497340677,0.5996801411790661,1.2707795035901799,1556,4,PRELP|FMOD|OGN|LUM
ASSEMBLY OF THE HIV VIRION%REACTOME DATABASE ID RELEASE 66%175474,0.367288693743139,0.851186780857897,-0.25512990436559496,-1.04484270510697,1672,16,FURIN|VPS28|VPS37D|UBA52|UBC|UBB
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION%REACTOME%R-HSA-140837.4,0.5362502436172291,0.9265056012720759,0.28308298858344705,0.937941911176376,5502,14,SERPINA5|SERPINE2|F12
RUNX3 REGULATES BCL2L11 (BIM) TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8952158,0.0209478021978022,0.30457994047216996,-0.6973858371939111,-1.76538593805476,121,5,SMAD4|SMAD3|RUNX3|BCL2L11|FOXO3
RETROGRADE NEUROTROPHIN SIGNALLING%REACTOME%R-HSA-177504.1,0.9637497563827709,1.0,0.162069374058698,0.536986200436993,9889,14,AP2A2|DNM3|CLTC|DNM1|NGF|AP2M1|AP2B1
VITAMIN B2 (RIBOFLAVIN) METABOLISM%REACTOME%R-HSA-196843.1,0.975794500246995,1.0,-0.23859352217537802,-0.5487152570706579,5925,4,FLAD1|ACP5
SMAD4 MH2 DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3311021,0.112804399057345,0.588394851272028,-0.697308922466086,-1.41516774018697,717,3,SMAD4|SMAD3|SMAD2
HDR THROUGH MMEJ (ALT-NHEJ)%REACTOME DATABASE ID RELEASE 66%5685939,0.204614144670562,0.721135316001102,0.42544200528161696,1.2555892711747298,2030,10,PARP2|PARP1|FEN1|POLQ|XRCC1|RBBP8|RAD50|NBN|LIG3
SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR3%REACTOME DATABASE ID RELEASE 66%1839130,0.9621366849960721,1.0,-0.286655787492101,-0.5817594037977399,6123,3,FGF1|FGF2
FRS2-MEDIATED ACTIVATION%REACTOME DATABASE ID RELEASE 66%170968,0.0641118779513258,0.49514893278583205,-0.52164123639561,-1.5216506296826002,352,7,FRS2|CRKL|RAP1A|YWHAB|RAPGEF1
BIOSYNTHESIS OF MARESIN CONJUGATES IN TISSUE REGENERATION (MCTR)%REACTOME%R-HSA-9026762.1,0.23815887156644397,0.7507739897770379,-0.714567427063418,-1.22222931420851,1603,2,GSTM4
TRANSCRIPTIONAL REGULATION BY MECP2%REACTOME DATABASE ID RELEASE 66%8986944,0.7666146645865841,0.9792236089291529,-0.13715388439228,-0.811103605948728,2456,46,TBL1X|PPARG|CAMK2A|CAMK4|PTPN1|CRH|AGO2|HTT|MET
ACTIVATION OF CA-PERMEABLE KAINATE RECEPTOR%REACTOME DATABASE ID RELEASE 66%451308,0.5199031171019379,0.9244272624356009,0.365634149696525,0.9516688718825128,4936,7,GRIK2|DLG3|DLG4|GRIK5
BINDING AND ENTRY OF HIV VIRION%REACTOME%R-HSA-173107.1,0.10090715645649001,0.5713242454960451,0.6494756769490151,1.37630100060412,900,4,CXCR4|CCR5
PTK6 EXPRESSION%REACTOME DATABASE ID RELEASE 66%8849473,0.07887370327679902,0.532203813468543,-0.650671231964915,-1.4964079035376001,478,4,HIF1A|NR3C1|EPAS1
ACTIVATION OF RRNA EXPRESSION BY ERCC6 (CSB) AND EHMT2 (G9A)%REACTOME DATABASE ID RELEASE 66%427389,0.37887158881634003,0.855068463121751,0.220069794933763,1.06314978478123,4525,51,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MBD3|MTA2|MTA1|HIST2H3C|HIST2H3A|HIST1H4I|H2AFX|H3F3A|H2AFZ|HIST1H2BF|HIST1H2BK|EHMT2|HIST1H2AC|HIST1H3H|HIST1H2BN|CHD3|HIST1H2BG|HIST2H2BE|HIST1H2BH
GLYCEROPHOSPHOLIPID BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%1483206,0.817594433399602,0.987153241368501,-0.112359142914803,-0.8320942068074441,1644,104,MBOAT7|CDIPT|MGLL|CPNE6|CPNE3|FAM73A|CSNK2A2|ABHD4|PLD6|PLA1A|LPIN1|PLA2G2A|DGAT2|PCYT1A|AGPAT3|GPCPD1|LPCAT1|GPAT2|PLD2|CSNK2A1|CDS2
"COBALAMIN (CBL, VITAMIN B12) TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%196741",0.169329736459846,0.673117535978459,-0.33850931567629194,-1.27481961244426,815,13,ABCC1|TCN2|MMACHC|MTRR|MMAA|PRSS3
DOWNREGULATION OF ERBB4 SIGNALING%REACTOME DATABASE ID RELEASE 66%1253288,0.0032691609153650603,0.137762274603971,-0.701178417415187,-2.04536855205691,17,7,NEDD4|UBA52|UBC|UBB
TRANSMISSION ACROSS CHEMICAL SYNAPSES%REACTOME DATABASE ID RELEASE 66%112315,0.801578024547048,0.9841161968820359,0.133672716309295,0.802738413463874,10971,156,PLCB3|SLC1A2|GNG8|GRIA1|CACNB4|CACNB2|LRRC7|GNAI1|ACTN2|SLC6A13|AKAP5|UNC13B|GNB3|ADCY8|GRIK2|LIN7A|GLS|LIN7B|PPFIA2|GRIA2|DLG3|BZRAP1|GLS2|PDPK1|PPFIA3|BCHE|PRKCB
REGULATION OF PTEN GENE TRANSCRIPTION%REACTOME%R-HSA-8943724.1,0.649566724436742,0.963755998259649,-0.142208786525858,-0.896333904987104,1873,57,RING1|SNAI2|GATAD2B|BMI1|CBX4|RRAGD|CBX8|RRAGC|HDAC5|PPARG|PHC3|SNAI1|LAMTOR5|JUN|MECOM|TP53|MAF1|MAPK3|GATAD2A
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS%REACTOME DATABASE ID RELEASE 66%442755,0.427079707622694,0.875860872092455,0.231025253567844,1.02716193209729,4907,37,GRIA1|LRRC7|ACTN2|ADCY8|GRIA2|DLG3|PDPK1|RPS6KA6|GRIN1|HRAS|GRIA4|DLG4
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660514,0.783333333333333,0.981487311948134,-0.19664057567450002,-0.7618376483182131,3712,14,FIG4|OCRL|PIK3C2A|PIKFYVE|PIK3R4|SACM1L|VAC14|PI4KB|ARF1|PI4K2B|PI4K2A|PIK3C3|ARF3
N-GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS-GOLGI%REACTOME DATABASE ID RELEASE 66%975576,0.789790624420975,0.9819233677232551,0.19564969403517202,0.7492929434569929,8524,22,FUT8|B4GALT6|MGAT2|ST8SIA3|B4GALT4|ST3GAL4|MGAT4B|B4GALT3|ST8SIA2|MAN2A1|MAN2A2|MGAT4C|MGAT3|ST6GAL1|B4GALT2|CHST10
CELL CYCLE CHECKPOINTS%REACTOME%R-HSA-69620.1,0.00468433195833042,0.159623912678827,0.235939469770334,1.5204096829790301,66,270,HIST1H2BJ|HIST3H2BB|CLIP1|CCNA1|ANAPC15|CCNB1|CDC7|CDK1|PSMD11|ZWINT|ANAPC5|ATR|BLM|CENPF|KIF2C|NUP133|PSMD13|WEE1|KIF18A|CENPL|PSMB9|CENPT|CKAP5|NSL1|EXO1|BRIP1|PSMA4|ORC1|CENPK|RFC4|CDC25C|DNA2|PSMD3|CDC45|NUF2|BIRC5|CASC5|BUB1|RAD9A|CENPU|CDKN2A|CDC23|CDC20|CCNE1|PKMYT1|NDC80|ITGB3BP|CENPA|ANAPC7|CENPE|ANAPC16|PSMD1|BUB1B|HIST1H4I|MCM6|GTSE1|AURKB|CDC6|ERCC6L|NUP160|DSN1|PSMA1|INCENP|CDCA8|PIAS4|CENPQ|CENPI|H2AFX|NUP85|CCNB2|SPDL1|ORC6|PSMC3|RMI2|DBF4|SGOL2|TAOK1|SKA2|BRCC3|HIST1H2BF|CHEK2|TOPBP1|PLK1|KNTC1|MCM10|HERC2|RMI1|SKA1|HIST1H2BK|MCM3|NUP107|PSMA3|MCM2|CLSPN|CENPM|UBE2C|CCNE2|DYNC1H1|PSMC6|PSMC1|ANAPC10|SPC25|PSMD2|CHEK1|RFC3|PSMA5|HIST1H2BN|RAD17|SGOL1|RFC5|SPC24|PSMC2|PPP2R1A|RAD1|PSMC5|CDK2|ATM|HIST1H2BG|NUP37|HIST2H2BE|MDC1|UIMC1|CDC16|BRCA1|NDE1|SHFM1|HIST1H2BH|ANAPC2|BRE|PSMA2|PSMB6|PSMB3|ZWILCH|ORC2|PCBP4|MDM2|PSMA7|PSMB4|MCM7|CENPH|RNF8|CCNA2
WNT LIGAND SECRETION IS ABROGATED BY THE PORCN INHIBITOR LGK974%REACTOME%R-HSA-5340573.1,0.217046979865772,0.733424818109987,0.892754741949713,1.1859848460674498,1616,1,PORCN
"ACTIVATION OF NIMA KINASES NEK9, NEK6, NEK7%REACTOME DATABASE ID RELEASE 66%2980767",0.221777590564448,0.73556947110949,0.47366751193622003,1.23285701597042,2105,7,CCNB1|CDK1|CCNB2|PLK1|NEK9
THE ACTIVATION OF ARYLSULFATASES%REACTOME%R-HSA-1663150.1,0.185185185185185,0.6916670843148071,-0.37353119655762107,-1.2637119480981398,939,10,ARSA|ARSE|ARSK|ARSB|ARSG|SUMF1|ARSD|STS|ARSF|SUMF2
INTERLEUKIN-7 SIGNALING%REACTOME%R-HSA-1266695.7,0.12086198991288401,0.607251067511504,0.344218191970586,1.35466993423585,1317,24,HIST1H3E|IL7R|CISH|PIK3R3|HIST2H3C|HIST2H3A|SOCS2|IL7|IRS1|SOCS1|SMARCA4|STAT5B|HIST1H3H
ISG15 ANTIVIRAL MECHANISM%REACTOME DATABASE ID RELEASE 66%1169408,0.580429948109711,0.942746898746279,-0.14006815715873097,-0.932208013615852,1565,68,MX1|KPNB1|NUP93|EIF2AK2|UBE2N|EIF4E|EIF4E3|USP41|KPNA1|EIF4A1|ARIH1|FLNB|EIF4A2|MX2|EIF4G1|EIF4E2|KPNA4|NEDD4|TRIM25|UBA52|UBE2E1|MAPK3|UBC|UBB
REGULATION OF IGF ACTIVITY BY IGFBP%REACTOME%R-HSA-381426.2,0.27417275461968205,0.7884684708511421,-0.157732118522545,-1.10906130459948,637,85,LGALS1|KTN1|APLP2|VWA1|DNAJC3|MMP1|KLK1|IGFBP4|CHGB|FAM20A|ADAM10|IGFBP3|CP|MMP2|SPARCL1|P4HB|IL6|LAMC1|TGOLN2|CHRDL1|IGF1|SERPINA1|PROC|SCG2|SHISA5|MFI2|SDC2|STC2|FAM20C|IGF2|VGF
FGFR1C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190373,0.567100279927548,0.938953543844111,-0.390045094794267,-0.897022234752323,3443,4,FGF1|ANOS1|FGF2
ACYL CHAIN REMODELLING OF PC%REACTOME DATABASE ID RELEASE 66%1482788,0.9212866603595079,1.0,0.16686990231260299,0.609935024086715,9737,19,LPCAT4|PLA2G4A|PLA2G2D|PLA2G12A|PLA2G4B|TMEM86B|LPCAT2|PLA2G4C|PNPLA8
SHC1 EVENTS IN EGFR SIGNALING%REACTOME%R-HSA-180336.2,0.11072056239015801,0.584830174998513,-0.514767947725993,-1.4130034523678299,629,6,NRAS|KRAS|SHC1
REGULATION OF TP53 DEGRADATION%REACTOME%R-HSA-6804757.1,0.0943449048152296,0.5630268609168221,-0.24617681243843698,-1.35419206263854,336,36,PPP2CA|PPP2CB|PHF20|PRR5|PPP2R1B|UBA52|TP53|USP2|UBC|UBB
SYNTHESIS OF PS%REACTOME DATABASE ID RELEASE 66%1483101,0.0488689972178541,0.43511944660534596,0.860857229932352,1.40704749319291,403,2,PTDSS2|PTDSS1
LOSS OF FUNCTION OF FBXW7 IN CANCER AND NOTCH1 SIGNALING%REACTOME%R-HSA-2644607.1,0.826609583401943,0.9876441563834109,-0.3130756080075,-0.7200084946317801,5019,4,RBX1|CUL1|SKP1|NOTCH1
RETINOID CYCLE DISEASE EVENTS%REACTOME%R-HSA-2453864.2,0.0930878777353248,0.5622489437340121,0.7215273647931759,1.37154761864205,803,3,RBP1|NAPEPLD
LYSOSPHINGOLIPID AND LPA RECEPTORS%REACTOME DATABASE ID RELEASE 66%419408,0.571591972548612,0.9405138747864158,0.3360157645309211,0.916069121595153,5496,8,S1PR5|S1PR4|LPAR2|LPAR5|S1PR2
DEACTIVATION OF THE BETA-CATENIN TRANSACTIVATING COMPLEX%REACTOME DATABASE ID RELEASE 66%3769402,0.0113010721529991,0.22992267312754103,-0.31292429090462104,-1.751661766269,38,38,ASH2L|SOX6|UBA52|TCF7|YWHAZ|SOX7|UBC|SOX17|TLE3|UBB
RELAXIN RECEPTORS%REACTOME%R-HSA-444821.1,0.0190604026845638,0.287747792943537,0.991288045875607,1.3168819444506599,141,1,INSL3
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE%REACTOME%R-HSA-5693579.1,0.0197560556605394,0.29343501147461304,0.35942986451095,1.64148757457096,229,41,XRCC3|ATR|BLM|EXO1|BRIP1|RFC4|DNA2|RAD9A|RAD51C|RAD51|RMI2|RAD51AP1|TOPBP1|RMI1|PALB2|BRCA2|XRCC2|CHEK1|RFC3|RAD17|RFC5|RAD1|ATM|BRCA1
SIGNALING BY FGFR IN DISEASE%REACTOME DATABASE ID RELEASE 66%1226099,0.0054539621430863,0.17009993795038097,-0.297733991244557,-1.79528179531192,16,49,FGF7|BAG4|FGF2|POLR2A|FGFR1|POLR2K|KRAS|STAT5A|POLR2F|STAT3|GAB2|NCBP2|BCR|POLR2I|POLR2D|FGF10|PIK3R1|LRRFIP1
SIGNALING BY PDGF%REACTOME DATABASE ID RELEASE 66%186797,0.220484513952775,0.7354368651705759,-0.204363542874296,-1.18142785457573,718,43,PIK3R2|CRKL|COL6A2|NCK2|FURIN|BCAR1|NRAS|COL6A1|PTPN12|CRK|COL9A1|KRAS|STAT5A|RAPGEF1|STAT3|THBS4|PIK3R1
IMPORT OF PALMITOYL-COA INTO THE MITOCHONDRIAL MATRIX%REACTOME DATABASE ID RELEASE 66%200425,0.9763827210335079,1.0,-0.154821276080127,-0.544835359598285,4836,11,SLC22A5|PPARD|RXRA|MID1IP1
REGULATION OF RAS BY GAPS%REACTOME%R-HSA-5658442.1,0.47143383708072295,0.898272347254494,-0.15164016425531898,-0.992987801249284,1278,65,KRAS|UBA52|RASA3|PSMD6|SPRED3|UBC|SPRED2|PSMF1|UBB
TGFBR1 KD MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3656532,0.0219683655536028,0.310715277412964,-0.6437166941548901,-1.76695910304001,124,6,TGFB1|SMAD3|TGFBR1|SMAD2|FKBP1A
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT (ESCRT)%REACTOME%R-HSA-917729.1,0.37895569620253206,0.855141747487413,-0.201272889344537,-1.04421020016921,1436,30,VPS4A|VPS37D|VPS4B|UBA52|CHMP4B|UBC|UBB
CARNITINE SYNTHESIS%REACTOME%R-HSA-71262.2,0.582246661429694,0.943501659485045,-0.44187836869173897,-0.896779020476981,3705,3,TMLHE
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%9013507,0.15157432267512802,0.647966535318223,-0.26697115677052397,-1.27971609094558,620,24,ADAM10|NCSTN|PSEN2|YBX1|UBA52|UBC|UBB
COOPERATION OF PDCL (PHLP1) AND TRIC CCT IN G-PROTEIN BETA FOLDING%REACTOME%R-HSA-6814122.2,0.704558404558405,0.968941691852291,-0.151597654917365,-0.842118362905833,2472,37,GNG10|GNAI3|CCT4|PDCL|GNG4|GNAZ|CCT7|GNAI2|CSNK2A2|TCP1|GNB5|GNGT1|CSNK2A1
METABOLISM OF WATER-SOLUBLE VITAMINS AND COFACTORS%REACTOME%R-HSA-196849.1,0.63855421686747,0.9603247716620201,-0.125965406329848,-0.917467608847747,1324,98,HLCS|ABCC1|TCN2|SLC2A3|MMACHC|MOCS3|SLC25A32|MTRR|NAMPT|ACP5|SHMT2|PANK2|NMNAT3|PNPO|MMAA|CYB5A|PDXK|SLC2A1|SLC25A16|PDZD11|NT5E|PC|PRSS3|NMNAT2
DEUBIQUITINATION%REACTOME DATABASE ID RELEASE 66%5688426,0.419225634178905,0.8717724419433509,-0.11609256455472698,-1.0224399398805502,313,251,TAF10|HIF1A|PSME4|UBE2D1|NOD1|STAMBP|OTUD5|TADA3|OTUD7A|PSMC4|INO80B|RUVBL1|NFKBIA|PSMD12|USP5|TGFBR1|VCPIP1|ATXN7|FOXO4|USP10|HIST2H2AA3|TNFAIP3|ADRM1|ARRB2|ACTR5|JOSD2|WDR48|TOMM20|USP3|PSMA6|TRAF3|PSME3|RHOA|CCP110|JOSD1|HIST2H2AA4|INO80C|NEDD8|SMAD1|ARRB1|SMAD2|CYLD|BECN1|MAVS|RAD23B|TNIP1|RIPK2|BAP1|KDM1B|SMAD7|INO80E|TRIM25|ADRB2|NLRP3|UBA52|FOXK1|ACTR8|TP53|UCHL1|TADA2B|PARK2|TNIP2|PSMD6|TFPT|HIST1H2BC|USP2|USP12|FKBP8|UBC|HIST2H2AC|HIST1H2BD|PSMF1|UBB
BLOCH PATHWAY%REACTOME DATABASE ID RELEASE 66%6807047,0.319744652256692,0.8219996514077841,0.528748656568539,1.1204689119720401,2854,4,EBP|DHCR24|DHCR7
SPERM:OOCYTE MEMBRANE BINDING%REACTOME DATABASE ID RELEASE 66%1300652,0.7919821826280621,0.9819233677232551,-0.4421368230155279,-0.75625135643447,5333,2,CD9
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL%REACTOME%R-HSA-6782315.5,0.580059523809524,0.942746898746279,-0.160791879657324,-0.9214657359182601,1948,41,TRMT44|TPRKB|CTU1|TRMT11|KIAA1456|METTL1|TP53RK|ADAT1|TRMT12|TRMT112|URM1|CDKAL1|NSUN2|TYW1|WDR4|TRMT6|TRDMT1
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS%REACTOME DATABASE ID RELEASE 66%2022377,0.24248340491995302,0.7565220534116759,-0.36603193387030797,-1.18158388344146,1241,9,CTSZ|AGT|CTSD|ATP6AP2|ANPEP|ACE
TWIK-RELEATED ACID-SENSITIVE K+ CHANNEL (TASK)%REACTOME DATABASE ID RELEASE 66%1299316,0.323575662271683,0.8239107965478291,0.6765091636277171,1.10573564315561,2674,2,KCNK3
T41 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358752.1,0.0978494623655914,0.570215774831708,-0.353138183837264,-1.4083466261467499,454,15,AXIN1|PPP2R5E|GSK3B|CSNK1A1|AMER1|PPP2R5A|CTNNB1|PPP2R5C|PPP2CA|PPP2CB|PPP2R1B
ACTIVATION OF GENE EXPRESSION BY SREBF (SREBP)%REACTOME DATABASE ID RELEASE 66%2426168,0.6685620746101489,0.964618776001639,0.18779291635216003,0.8520491749725709,7759,40,TM7SF2|NFYB|ELOVL6|GPAM|SMARCD3|MVD|MED1|ACACA|SREBF2|GGPS1|IDI1|CARM1|DHCR7|TGS1|SP1|CHD9|MVK|NCOA6|FASN|HMGCS1|TBL1XR1|FDPS
G1 S-SPECIFIC TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%69205,0.008007197480881691,0.19847993048827997,0.43614517916960405,1.78846927405723,88,28,CCNA1|CDK1|LIN52|DHFR|ORC1|LIN9|CDC45|TK1|CCNE1|FBXO5|E2F5|CDC6|E2F6|LIN37|E2F1|TYMS|RRM2
MAPK TARGETS  NUCLEAR EVENTS MEDIATED BY MAP KINASES%REACTOME%R-HSA-450282.1,0.142060541688794,0.63219683908033,-0.24429232583285898,-1.28461966831885,534,31,PPP2CA|PPP2CB|PPP2R1B|JUN|DUSP3|MAPK3|RPS6KA2
PI-3K CASCADE:FGFR3%REACTOME DATABASE ID RELEASE 66%5654710,0.524605385329619,0.925993329275615,-0.29922042023762396,-0.9301073488941529,2824,8,FGF1|FRS2|FGF2|PIK3R1
PRC2 METHYLATES HISTONES AND DNA%REACTOME%R-HSA-212300.1,0.11038030188042801,0.584830174998513,0.283739045863672,1.3514594150057098,1308,48,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MTF2|HIST2H3C|HIST2H3A|DNMT3B|EZH2|HIST1H4I|PHF19|H2AFX|H3F3A|JARID2|H2AFZ|HIST1H2BF|HIST1H2BK|HIST1H2AC|SUZ12|EED|HIST1H3H|HIST1H2BN|HIST1H2BG|HIST2H2BE|HIST1H2BH|DNMT1
AUTOINTEGRATION RESULTS IN VIRAL DNA CIRCLES%REACTOME%R-HSA-177539.2,0.7567949725058921,0.977664504547119,-0.379397816256755,-0.7699765956889191,4816,3,PSIP1|HMGA1|BANF1
SHC1 EVENTS IN ERBB4 SIGNALING%REACTOME%R-HSA-1250347.2,0.810396937336289,0.984954034876433,0.24274321907439803,0.71639795256813,8043,10,NRG2|NRG3|HRAS|NRG1
SYNTHESIS OF LIPOXINS (LX)%REACTOME%R-HSA-2142700.4,0.0367199077885724,0.386113929236656,-0.714936662155765,-1.64420496745792,222,4,ALOX5|PTGR1
RUNX3 REGULATES CDKN1A TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8941855,0.020704685797312,0.30257023005641803,-0.597769544517061,-1.7437202819786901,113,7,TGFB1|SMAD4|SMAD3|RUNX3|TP53|CDKN1A
GTP HYDROLYSIS AND JOINING OF THE 60S RIBOSOMAL SUBUNIT%REACTOME DATABASE ID RELEASE 66%72706,0.0838541666666667,0.54493407160435,-0.168147423347962,-1.263462741258,160,110,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPS27L|RPL36|EIF5B|RPS15|RPS10|RPL28|RPS3A|RPL26L1|FAU|RPL37|RPL27A|RPL7A|RPL19|RPLP1|RPSA|EIF3F|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|RPS8|RPL21|RPL39|RPL39L|RPS20|RPS15A|RPS11|RPS6|RPL30|EIF3J|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPL36AL|RPS18|RPL10A|RPL22L1|RPL38|RPS13|EIF3M|RPS27|RPS23|RPS21|RPL3|RPL29|EIF3C|RPL31|RPL17|RPS14|RPS17|RPL32|EIF3L|RPL18A|RPL11|EIF2S2|EIF4E|RPS16|RPL12|EIF5|EIF3H|RPS4X|EIF3D|RPL9|EIF2S1|RPS28|EIF4A1|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|EIF4A2|EIF4G1|EIF3G|RPL15|RPL8|EIF3B|EIF4H|RPL35A|EIF4B|EIF1AX|EIF3A|UBA52|EIF3I|EIF2S3
PROSTANOID LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%391908,0.459877843302443,0.890371861972445,0.38581184925382106,1.00418718449312,4366,7,PTGER3|PTGER1|PTGIR
DEFECTIVE HLCS CAUSES MULTIPLE CARBOXYLASE DEFICIENCY%REACTOME%R-HSA-3371599.2,0.311748281786942,0.8143712300420921,0.46273817150656893,1.1380371414982,2902,6,MCCC2|PCCB|ACACA|MCCC1|PCCA
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION%REACTOME%R-HSA-975163.1,0.0651612903225806,0.4956987271622679,-0.373863551711485,-1.49100124481229,302,15,UBA52|TICAM1|UBC|UBB
AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1%REACTOME%R-HSA-349425.2,0.792746113989637,0.9819233677232551,-0.132323774412921,-0.801546067886444,2447,50,UBA52|TP53|PSMD6|UBC|PSMF1|UBB
DEADENYLATION OF MRNA%REACTOME DATABASE ID RELEASE 66%429947,0.43966160736501597,0.879896414106183,-0.20764823463944698,-1.00735794325225,1766,25,TNKS1BP1|CNOT3|ZCCHC6|CNOT1|CNOT2|CNOT8|PAN2|CNOT6|PAIP1|CNOT4|PAN3|RQCD1|CNOT11|EIF4A3|PARN|CNOT6L|EIF4E|CNOT10|EIF4A1|EIF4A2|EIF4G1|CNOT7|EIF4B|PABPC1
SYNTHESIS OF IPS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%1855191,0.45562325045282404,0.88900512246363,-0.42794904318094107,-0.984193397629489,2766,4,IP6K2|IPPK|IPMK|IP6K1
NEGATIVE REGULATION OF FGFR4 SIGNALING%REACTOME%R-HSA-5654733.1,0.0692909760589319,0.5054741186916171,-0.32841238089282204,-1.46534500538402,300,20,FGF2|PPP2CA|PPP2CB|UBA52|MAPK3|UBC|UBB
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2+%REACTOME DATABASE ID RELEASE 66%76005,0.520918367346939,0.9251240799994541,-0.13082686630619803,-0.972023043262343,1020,106,APLP2|SOD1|VTI1B|SRGN|CLU|FAM49B|VEGFA|PCDH7|HSPA5|A1BG|PFN1|PSAP|WDR1|HGF|HABP4|IGF1|SERPINF2|TMSB4X|CFD|SERPINA1|PRKCA|CLEC3B|CTSW|CD9|ABCC4|ALDOA|VWF|IGF2|TAGLN2|CD36
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES%REACTOME%R-HSA-6796648.3,0.452491932592327,0.8873610269840101,-0.156699021617164,-1.00542698080303,1261,61,POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|JUN|PMS2|POLR2F|TP53|TCEA1|POLR2I|POLR2D
INHIBITION OF VOLTAGE GATED CA2+ CHANNELS VIA GBETA GAMMA SUBUNITS%REACTOME DATABASE ID RELEASE 66%997272,0.914072942524346,1.0,0.174911199898369,0.6168865426734511,9573,17,GNG8|GNB3|GABBR1|GNG3|GNG2|GNGT2|GNG7|KCNJ9|GNB2|KCNJ12|GNG12
REGULATION OF COMPLEMENT CASCADE%REACTOME DATABASE ID RELEASE 66%977606,0.0518921766616911,0.44586532408291796,0.34418259557416,1.49685185092195,590,34,IGKV4-1|IGHG1|IGHG4|IGKV3-11|IGKV2D-28|IGKV2-28|CFHR3|C3AR1|C7|CD55|C5|C4A|C4B|IGHG2|CD46
LDL REMODELING%REACTOME DATABASE ID RELEASE 66%8964041,0.345234899328859,0.8411448613059059,0.8313299514777241,1.1043847522796,2571,1,CETP
SIGNALING BY ROBO RECEPTORS%REACTOME%R-HSA-376176.4,1.0,1.0,-0.0703485467964853,-0.595385227692374,991,205,CAP2|VASP|RPL7|PFN1|ABL1|PSMA6|RPS9|RPS3|RPL14|PSME3|RHOA|NRP1|MAGOH|GSPT1|EIF4G1|RPL15|RPL8|PRKAR2A|RPL35A|CDC42|TCEB1|ETF1|UBA52|PRKCA|NCBP2|RBM8A|PSMD6|RNPS1|PABPC1|RAC1|UBC|PSMF1|SLIT3|PAK2|UBB
FBXW7 MUTANTS AND NOTCH1 IN CANCER%REACTOME%R-HSA-2644605.1,0.826609583401943,0.9876441563834109,-0.3130756080075,-0.7200084946317801,5019,4,RBX1|CUL1|SKP1|NOTCH1
ENZYMATIC DEGRADATION OF DOPAMINE BY COMT%REACTOME DATABASE ID RELEASE 66%379397,0.271506310061364,0.7864992130359009,0.607808536450866,1.15538008873503,2344,3,LRTOMT|COMT|MAOA
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A%REACTOME DATABASE ID RELEASE 66%69601,0.783609576427256,0.981487311948134,0.160338190478202,0.7745884106922459,9360,51,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|PSMC6|PSMC1|PSMD2|CHEK1|PSMA5|PSMC2|PSMC5|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
DISINHIBITION OF SNARE FORMATION%REACTOME%R-HSA-114516.4,0.927218837477359,1.0,-0.27193883512973605,-0.625402510785799,5630,4,PRKCA
RNA POLYMERASE II TRANSCRIPTION TERMINATION%REACTOME%R-HSA-73856.3,0.478672985781991,0.9046812288131709,-0.151753636570763,-0.988684945705383,1312,64,NCBP2|NUDT21|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
LDL CLEARANCE%REACTOME%R-HSA-8964038.1,0.53226429675425,0.9265056012720759,0.278417359959992,0.9440052484739979,5509,15,AP2A2|LSR|SOAT1|LDLRAP1|CLTC|LDLR|AP2M1|AP2B1|NPC2|LIPA|NPC1
CDO IN MYOGENESIS%REACTOME DATABASE ID RELEASE 66%375170,0.457976617877198,0.890371861972445,0.258349885679501,1.00477522231251,4974,23,CDH4|MAPK11|MAP2K6|MAPK12|CDH2
REVERSAL OF ALKYLATION DAMAGE BY DNA DIOXYGENASES%REACTOME%R-HSA-73943.2,0.886305848165638,0.996643473105967,-0.2284611141754,-0.666431205947333,4879,7,ALKBH3|FTO|ASCC1|ASCC3|ALKBH2|ASCC2|ALKBH5
PURINE CATABOLISM%REACTOME%R-HSA-74259.3,0.13951077943615303,0.6281603901381739,-0.3645434932156911,-1.32806851311901,672,12,GPX1|NT5C|NT5C2|ADPRM|NT5C1A|NUDT15|PNP|ITPA|NT5E
HIV TRANSCRIPTION ELONGATION%REACTOME DATABASE ID RELEASE 66%167169,0.0733917245545153,0.520754220371606,-0.24198973744596203,-1.39339439531197,242,42,SUPT16H|CTDP1|NELFCD|CDK9|ELL|NELFA|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|NCBP2|TCEA1|POLR2I|POLR2D
VIF-MEDIATED DEGRADATION OF APOBEC3G%REACTOME DATABASE ID RELEASE 66%180585,0.8916884816753929,0.9975851479447528,-0.118766452656093,-0.7237391120845009,2724,51,TCEB1|UBA52|PSMD6|UBC|PSMF1|UBB
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610785,0.9104836038423321,1.0,0.134123892044546,0.662514573261891,10994,56,BTRC|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|PSMC3|SUFU|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
DOWNSTREAM TCR SIGNALING%REACTOME DATABASE ID RELEASE 66%202424,0.965501588742624,1.0,-0.0921131615287316,-0.6620127841551421,2126,92,HLA-DQA2|PSMD6|HLA-DQB2|UBC|PIK3R1|PSMF1|UBB
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS (SPMS)%REACTOME DATABASE ID RELEASE 66%9018678,0.284618490109003,0.793663380147364,-0.322818490650844,-1.13603848832573,1409,11,ALOX5|GSTM4|PTGR1
FATTY ACYL-COA BIOSYNTHESIS%REACTOME%R-HSA-75105.6,0.492514567458539,0.910097257414447,0.236703819667902,0.9805069294315719,5493,29,HACD1|MORC2|CBR4|SCD5|ELOVL6
DNA REPLICATION INITIATION%REACTOME%R-HSA-68952.2,0.31111573255693,0.8143712300420921,0.41628862122488497,1.13491446482549,2991,8,POLE|POLE2|POLA2|PRIM2
BIOTIN TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%196780,0.6117635350318471,0.9508825506493929,0.28887054442580395,0.8812778134997808,6146,11,MCCC2|PCCB|ACACA|SLC5A6|MCCC1|PCCA
HEDGEHOG 'ON' STATE%REACTOME DATABASE ID RELEASE 66%5632684,0.9921706479188299,1.0,0.0961904854378126,0.506803459061507,12418,75,PSMD11|PSMD13|PSMB9|PSMA4|DZIP1|PSMD3|PSMD1|PSMA1|PSMC3|SUFU|GAS1|SPOP|CDC73|PSMA3|PSMC6|PSMC1|PSMD2|RBX1|PSMA5|PSMC2|PSMC5|GAS8|EFCAB7|SHFM1|PSMA2|PSMB6|PSMB3|PSMA7|SMURF2|PSMB4|PSME2|PTCH1|ADRBK1|RPS27A
PDE3B SIGNALLING%REACTOME DATABASE ID RELEASE 66%165160,0.21120116124349803,0.7258149888677271,0.728039702233251,1.18996089287965,1745,2,PDE3B|AKT2
DNA DOUBLE STRAND BREAK RESPONSE%REACTOME%R-HSA-5693606.1,0.17820007171029,0.6837991059383349,-0.18698860305529602,-1.1997738382424599,496,61,EYA4|UBA52|TP53|HIST2H4B|EYA1|HIST1H2BC|UBC|HIST1H2BD|RNF168|UBB
TOXICITY OF BOTULINUM TOXIN TYPE C (BONT C)%REACTOME DATABASE ID RELEASE 66%5250971,0.40864100549882204,0.867015886388254,-0.504083035290153,-1.02302154315665,2600,3,SNAP25
TRIF-MEDIATED PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%2562578,0.675712612260836,0.9647315640607691,-0.25639894086496,-0.8276787575721221,3460,9,RIPK1|TICAM2|RIPK3|TLR4|FADD|CD14|CASP8|LY96|TICAM1
TRANSPORT OF GAMMA-CARBOXYLATED PROTEIN PRECURSORS FROM THE ENDOPLASMIC RETICULUM TO THE GOLGI APPARATUS%REACTOME DATABASE ID RELEASE 66%159763,0.9541552197802199,1.0,-0.23281048938985102,-0.5893442944787111,5556,5,PROC
DNA DAMAGE REVERSAL%REACTOME%R-HSA-73942.1,0.8369545032497681,0.9889652677625541,-0.22847371614540196,-0.710195788934578,4506,8,ALKBH3|FTO|ASCC1|MGMT|ASCC3|ALKBH2|ASCC2|ALKBH5
RNA POLYMERASE II TRANSCRIPTION PRE-INITIATION AND PROMOTER OPENING%REACTOME DATABASE ID RELEASE 66%73779,0.891074001864881,0.997300970905927,0.142704547547199,0.673390978307913,10511,46,GTF2H2|AK6|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|CDK7|GTF2E2|POLR2L|TAF2|POLR2J|TAF4|POLR2G|POLR2H|GTF2A1|GTF2F2|TAF1|MNAT1
APC:CDC20 MEDIATED DEGRADATION OF CELL CYCLE PROTEINS PRIOR TO SATISFATION OF THE CELL CYCLE CHECKPOINT%REACTOME DATABASE ID RELEASE 66%179419,0.301346665591485,0.804157610193454,0.21561054916440198,1.12241958208118,3736,71,CCNA1|ANAPC15|CDK1|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|NEK2|CDC23|CDC20|ANAPC7|ANAPC16|PSMD1|BUB1B|PSMA1|PSMC3|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
REGULATION OF ACTIN DYNAMICS FOR PHAGOCYTIC CUP FORMATION%REACTOME%R-HSA-2029482.2,0.10136380390711401,0.57169477469413,-0.19662006345143,-1.2875304207623999,274,65,ABL1|VAV1|MYO1C|CYFIP2|ARPC5|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|MYH9|RAC1|ACTR2|BRK1|HSP90AB1
CDC20:PHOSPHO-APC C MEDIATED DEGRADATION OF CYCLIN A%REACTOME DATABASE ID RELEASE 66%174184,0.35406582768635,0.842911430859438,0.20851943001837,1.0824553489343298,4388,70,CCNA1|ANAPC15|CDK1|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|CDC20|ANAPC7|ANAPC16|PSMD1|BUB1B|PSMA1|PSMC3|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
IRON UPTAKE AND TRANSPORT%REACTOME DATABASE ID RELEASE 66%917937,0.0977979274611399,0.570215774831708,-0.21909093713950198,-1.32713474923805,301,50,CP|FTH1|NEDD8|ATP6V0C|ATP6V1F|FTL|TFRC|UBA52|ATP6V1E2|ATP6V0D1|ATP6V1E1|UBC|STEAP3|UBB
P53-DEPENDENT G1 S DNA DAMAGE CHECKPOINT%REACTOME%R-HSA-69580.2,0.75234521575985,0.9769690538700708,0.158290824824081,0.8054059824742609,9222,64,CCNA1|PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|CDKN2A|CCNE1|PSMD1|PSMA1|PSMC3|CHEK2|PSMA3|CCNE2|PSMC6|PSMC1|PSMD2|PSMA5|PSMC2|PSMC5|CDK2|ATM|SHFM1|PSMA2|PSMB6|PSMB3|PCBP4|MDM2|PSMA7|PSMB4|CCNA2
AMINO ACID CONJUGATION%REACTOME DATABASE ID RELEASE 66%156587,0.40111285835248606,0.8638522656500329,0.6418524885943859,1.04909025988819,3315,2,GLYATL2|GLYATL1
RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION%REACTOME%R-HSA-8931987.1,0.190418956043956,0.698434241409875,-0.4935581502042921,-1.24940968329516,1108,5,KCTD6|RUNX1|CBFB
G BETA:GAMMA SIGNALLING THROUGH PI3KGAMMA%REACTOME%R-HSA-392451.3,0.9831538249102459,1.0,0.125293334256598,0.487291246329891,10679,23,GNG8|GNB3|PDPK1|AKT3|AKT2|AKT1|GNG3|GNG11|GNG2|GNGT2|GNG7
RHO GTPASES ACTIVATE KTN1%REACTOME DATABASE ID RELEASE 66%5625970,0.3902679275019699,0.8607749921056059,-0.306636035985412,-1.03739560701576,1980,10,RHOG|KTN1|RHOA|CDC42|RAC1
REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE%REACTOME DATABASE ID RELEASE 66%176408,0.204227590591227,0.7203861827010242,0.22757541886657504,1.20887128778575,2569,78,CCNA1|ANAPC15|CCNB1|CDK1|BTRC|PSMD11|ANAPC5|PSMD13|PSMB9|PSMA4|PSMD3|CDC23|CDC20|ANAPC7|ANAPC16|FBXO5|PSMD1|BUB1B|PSMA1|PSMC3|PLK1|PSMA3|UBE2C|PSMC6|PSMC1|ANAPC10|PSMD2|PSMA5|PSMC2|PSMC5|CDK2|CDC16|SHFM1|ANAPC2|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4|CCNA2|ANAPC4|PSME2
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING%REACTOME DATABASE ID RELEASE 66%451326,0.595030038230475,0.9473459395438281,0.224420531857617,0.902278034103959,6536,26,PLCB3|GNG8|GNB3|GRIK2|DLG3
INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX%REACTOME DATABASE ID RELEASE 66%141430,0.237849502720961,0.7507739897770379,0.32363014038288396,1.20180028420298,2534,20,ANAPC15|ANAPC5|CDC23|CDC20|ANAPC7|ANAPC16|BUB1B|UBE2C|ANAPC10|CDC16|ANAPC2|ANAPC4
SYNTHESIS OF PE%REACTOME DATABASE ID RELEASE 66%1483213,0.9673566878980892,1.0,0.173634969764007,0.52972049055707,9719,11,CEPT1|CHKB|ETNK1|CHKA|ETNK2|EPT1|PISD|LPIN2
DEGRADATION OF GABA%REACTOME%R-HSA-916853.1,0.638321035442119,0.9601484712040809,0.552081610146126,0.9023622252148059,5276,2,ABAT|ALDH5A1
P75NTR REGULATES AXONOGENESIS%REACTOME DATABASE ID RELEASE 66%193697,0.104745166959578,0.576535954147525,-0.518936411386828,-1.4244456052249599,595,6,ARHGDIA|RTN4|RHOA|LINGO1
APOBEC3G MEDIATED RESISTANCE TO HIV-1 INFECTION%REACTOME DATABASE ID RELEASE 66%180689,0.602832208134365,0.9508825506493929,-0.37941873931506104,-0.8725838370735679,3660,4,PSIP1|PPIA|HMGA1|BANF1
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION%REACTOME%R-HSA-162658.1,0.460276932141805,0.8904234666384399,0.310339486429333,1.00158087636046,4686,13,CCNB1|CDK1|CCNB2|USO1|PLK1
SYNTHESIS OF UDP-N-ACETYL-GLUCOSAMINE%REACTOME DATABASE ID RELEASE 66%446210,0.9654596100278551,1.0,-0.181311710519058,-0.5635957407600091,5198,8,AMDHD2|PGM3|UAP1|RENBP|NAGK|GFPT1|GNPNAT1|GFPT2
UPTAKE AND ACTIONS OF BACTERIAL TOXINS%REACTOME%R-HSA-5339562.2,0.007842205323193921,0.19847993048827997,-0.39982300208872296,-1.8522761741478702,32,22,HBEGF|VAMP2|VAMP1|CD9|SYT2|MAP2K1|HSP90AB1|SV2C|SNAP25
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER'S DISEASE MODELS%REACTOME DATABASE ID RELEASE 66%8862803,0.011279926335175,0.22992267312754103,-0.407296008911291,-1.8173162983334101,48,20,SOD2|CDC25B|JUN|PRDX1|YWHAE|BCL2L11|FOXO3
"BIOSYNTHESIS OF THE N-GLYCAN PRECURSOR (DOLICHOL LIPID-LINKED OLIGOSACCHARIDE, LLO) AND TRANSFER TO A NASCENT PROTEIN%REACTOME DATABASE ID RELEASE 66%446193",0.737539128340958,0.974306231601101,0.156498424784385,0.819831208122295,9188,73,SLC35A1|ALG6|ST3GAL5|MVD|ALG14|ALG13|SRD5A3|DPAGT1|GMPPB|FPGT|NUDT14|MPDU1|AMDHD2|ALG2|DOLPP1|ST8SIA3
NEF AND SIGNAL TRANSDUCTION%REACTOME%R-HSA-164944.2,0.140755539411551,0.6296802030037281,-0.46085525745457895,-1.34433523228302,774,7,FYN|RAC1|PAK2
VITAMINS%REACTOME%R-HSA-211916.1,0.734861641773764,0.9740710460553309,0.430573022822435,0.8184740218035941,6346,3,CYP2R1|CYP27B1|CYP26B1
EXTENSION OF TELOMERES%REACTOME%R-HSA-180786.1,0.13978590544157,0.6281603901381739,0.314913756221492,1.32041172686277,1566,30,POLE|POLE2|RFC4|DNA2|POLD1|TERT|FEN1|POLD3|POLA2|LIG1|WRAP53|PRIM2|RFC3|RFC5
ESTROGEN-DEPENDENT GENE EXPRESSION%REACTOME%R-HSA-9018519.1,0.283507997793712,0.7927023385888341,-0.143370063262326,-1.0934037831473,513,117,ZNF217|NRIP1|POLR2K|AGO2|BCL2|JUN|POLR2F|POLR2I|HIST2H4B|POLR2D|FKBP4|HIST1H2BC|CBFB|H3F3B|HIST2H2AC|HSP90AB1|HIST1H2BD|TLE3
MICRORNAS IN CARDIOMYOCYTE HYPERTROPHY%WIKIPATHWAYS_20181110%WP1544%HOMO SAPIENS,0.38471023427866796,0.8593496731626808,-0.152822448107127,-1.0494510010828901,935,77,AGT|PIK3CD|PIK3R2|CAMK2D|CALM3|LRP5|FZD1|CDK9|MAPK7|CTNNB1|IGF1R|LIF|MAPK4|HDAC4|RHOA|HDAC5|FGF2|MAP2K5|IGF1|CALM1|PLA2G2A|MAP2K3|STAT3|MAPK3|RAC1|MAP2K1|PIK3R1|TNF
MELATONIN METABOLISM AND EFFECTS%WIKIPATHWAYS_20181110%WP3298%HOMO SAPIENS,0.446321809201976,0.8840492144712259,-0.19500931791645199,-0.998009152585285,1716,29,ECE1|GSK3B|PER1|CYP1B1|TRAF6|CSNK1D|ACHE|CALM3|IRAK1|SULT1A1|FOXO1|CAMK2A|PER3|CALM1|PRKCA|PER2
EXRNA MECHANISM OF ACTION AND BIOGENESIS%WIKIPATHWAYS_20181110%WP2805%HOMO SAPIENS,0.778135738831615,0.9811398289380491,0.304945178859617,0.749968256418473,7245,6,DROSHA|DICER1|DGCR8|XPO5|ERI1
ESC PLURIPOTENCY PATHWAYS%WIKIPATHWAYS_20181110%WP3931%HOMO SAPIENS,0.779992153785798,0.981487311948134,0.14588823040406,0.79632932639545,9940,90,FGFR4|FGF19|ERAS|WNT4|FGF12|WNT5B|MAP2K6|BMP4|MAPK12|MAP2K2|FGF17|FGF13|FGF11|DVL1
SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1422%HOMO SAPIENS,0.17965779467680604,0.68489956912038,-0.270048601551576,-1.25106506604874,755,22,SPHK1|CERK|PPP2CA|SGPP2|GAL3ST1|KDSR|SPTLC1|ASAH2
CATALYTIC CYCLE OF MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASES (FMOS)%WIKIPATHWAYS_20181110%WP688%HOMO SAPIENS,0.528076878545791,0.9265056012720759,0.5054042130804021,0.9607202425382491,4560,3,FMO5|FMO2|FMO3
PPAR ALPHA PATHWAY%WIKIPATHWAYS_20181110%WP2878%HOMO SAPIENS,0.9270604001148659,1.0,0.17214011481357902,0.596763095398469,9684,16,CDK1|ACADM|EHHADH|ACAA1|CCND1|PLTP|SLC27A1|CPT2|CPT1A|DBI|MYC
NANOPARTICLE TRIGGERED REGULATED NECROSIS%WIKIPATHWAYS_20181110%WP2513%HOMO SAPIENS,0.828423566878981,0.9876441563834109,0.23105033663892,0.704881613617877,8323,11,PLA2G4A|PARP1|RIPK1|RIPK3|TRADD
COPPER HOMEOSTASIS%WIKIPATHWAYS_20181110%WP3286%HOMO SAPIENS,0.354001898133502,0.842911430859438,-0.17921721676653102,-1.07040044120317,1118,47,SOD3|ADAM10|FOXO1|CASP3|PRNP|ADAM17|JUN|SLC31A1|TP53|COMMD1|STEAP3|FOXO3
"NAD METABOLISM, SIRTUINS AND AGING%WIKIPATHWAYS_20181110%WP3630%HOMO SAPIENS",0.29550827423167897,0.800447413278835,-0.333651741079708,-1.12879378106008,1499,10,FOXO1|PPARG|NAMPT|FOXO3
T-CELL ANTIGEN RECEPTOR (TCR) PATHWAY DURING STAPHYLOCOCCUS AUREUS INFECTION%WIKIPATHWAYS_20181110%WP3863%HOMO SAPIENS,0.664666666666667,0.964618776001639,-0.14368894677064198,-0.886258290081864,1993,53,CALM3|PTPN6|NFKBIA|MAP3K8|GRB2|FYN|BCL10|CHP1|CALM1|JUN|NFATC2|MAPK3|MAP2K1|DLG1|TNF
ESTROGEN RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2881%HOMO SAPIENS,0.246982358402971,0.7591452927824069,-0.382227973377645,-1.18813096615912,1329,8,PPARA|JUN|STAT3|ACOX1
IL1 AND MEGAKARYOCYTES IN OBESITY%WIKIPATHWAYS_20181110%WP2865%HOMO SAPIENS,0.0207182320441989,0.30257023005641803,-0.381866515468075,-1.7038523019239,89,20,TLR1|PLA2G7|IL1B|IRAK1|HBEGF|MMP9|SELENBP1|ICAM1|TIMP2|NLRP3|MYD88
PHOTODYNAMIC THERAPY-INDUCED HIF-1 SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3614%HOMO SAPIENS,0.002173322466721,0.11723906635624301,-0.380336553702943,-2.01353617007754,7,32,BCL2A1|BNIP3|HIF1A|BAX|LDHA|VEGFA|SLC16A1|PFKL|SLC2A3|IGFBP3|PKM|BCL2L1|BID|PGK1|HK1|TP53|BNIP3L|SLC2A1|PMAIP1|ANGPT2
ATR SIGNALING%WIKIPATHWAYS_20181110%WP3875%HOMO SAPIENS,0.557450348341479,0.9361453421204542,0.339942258695065,0.9267737981001879,5360,8,ATR|RAD9A|TOPBP1|CHEK1|RAD1
TRANSLATION FACTORS%WIKIPATHWAYS_20181110%WP107%HOMO SAPIENS,0.000654450261780105,0.0806484601749226,-0.337584381641938,-2.05717199730304,1,51,EIF2AK2|EIF6|EIF2S2|EIF4E|EEF1A2|EIF5|EIF3H|EIF3D|EIF2B3|EIF2S1|EIF4A1|EEF2K|EIF2AK3|EIF2AK1|EIF4A2|EIF4G1|EIF4EBP1|EIF3G|EIF3B|EIF1|EIF4H|EIF4B|EIF5A|EIF1AX|ETF1|EIF3A|EIF3I|EIF2S3|PABPC1
G1 TO S CELL CYCLE CONTROL%WIKIPATHWAYS_20181110%WP45%HOMO SAPIENS,0.0804110259337791,0.536105877813735,0.274069648305081,1.3913293491765601,985,63,CDK6|CCNA1|CCNB1|CDK1|POLE|CDKN2C|WEE1|E2F3|POLE2|ORC1|CDC45|CDKN2A|CCNE1|E2F2|RB1|POLA2|MCM6|CDKN2B|ORC6|CDK7|MCM3|MCM2|CCNE2|E2F1|PRIM2|CDK2|ATM|CDKN2D|CCND2|ORC2|MDM2|MCM7|MNAT1|ATF6B|CREB3L1
SELENIUM METABOLISM AND SELENOPROTEINS%WIKIPATHWAYS_20181110%WP28%HOMO SAPIENS,0.699037620297463,0.967390493001277,0.18735677551178698,0.8269996280725601,7989,36,CTH|CREM|FOS|SEPN1|NFE2L2|SECISBP2|SEPP1|POU2F1|VIMP|SEPHS1|TXNRD3|PSTK|SP1|TXNRD1|C11orf31
CELL DIFFERENTIATION - INDEX EXPANDED%WIKIPATHWAYS_20181110%WP2023%HOMO SAPIENS,0.8732200726701371,0.9934031064448321,0.20502721654156197,0.661699036703809,8891,13,LEFTY1|EZH2|TLX3|SRF
BENZO(A)PYRENE METABOLISM%WIKIPATHWAYS_20181110%WP696%HOMO SAPIENS,0.504617697594502,0.917139342610024,0.392069288402414,0.964237315434827,4698,6,EPHX1|AKR1C1|AKR1A1
APOPTOSIS MODULATION BY HSP70%WIKIPATHWAYS_20181110%WP384%HOMO SAPIENS,0.191696028949624,0.701276327686044,0.352036956112432,1.26282833170685,2012,18,AIFM1|APAF1|CASP6|MAPK10|FAS|CASP9|RIPK1|MAP3K1
BMP SIGNALING PATHWAY IN EYELID DEVELOPMENT%WIKIPATHWAYS_20181110%WP3927%HOMO SAPIENS,0.0491767288693743,0.435862257033585,-0.382176716725069,-1.56514210094209,223,16,SMAD1|FOXC2|JUN|MAPK3|FGF10|INHBB
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) MEDIATED LDL RECEPTOR DEGRADATION%WIKIPATHWAYS_20181110%WP2846%HOMO SAPIENS,0.532885906040268,0.9265056012720759,0.736656374062638,0.9786151283713871,3969,1,LDLR
TNF RELATED WEAK INDUCER OF APOPTOSIS (TWEAK) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2036%HOMO SAPIENS,0.338988095238095,0.832687903476431,-0.18836455481153,-1.0794791595833901,1138,41,NFKBIA|CTNNB1|TRAF3|CASP3|RELB|IL6|MMP9|JUN|NFKBIB|MAPK3|RAC1|TNF
NAD+ METABOLISM%WIKIPATHWAYS_20181110%WP3644%HOMO SAPIENS,0.37664219474497707,0.853374872190571,0.317513959549813,1.0765666491552701,3898,15,SIRT4|SIRT1|CD38|SIRT6|PARP1|SIRT3|NADK|NMNAT1
MESODERMAL COMMITMENT PATHWAY%WIKIPATHWAYS_20181110%WP2857%HOMO SAPIENS,0.9578899705682591,1.0,0.11112951404300801,0.638853243916352,12692,119,PBX3|TBX3|LEFTY1|TRIM5|PIAS1|BMP4|RARB|MTF2|PHF6|TBX6|JAK2|ZFHX4|EXT1|DNMT3B|MBTD1|NLK|LEF1|WDHD1|ACACA|ELP4|JARID2|SRF|NFE2L2|ZNF281|MACF1|CUL4B|MEIS1
NICOTINE ACTIVITY ON CHROMAFFIN CELLS%WIKIPATHWAYS_20181110%WP1603%HOMO SAPIENS,0.4711613842535561,0.8981198447183041,0.471919306230051,1.0000420899823899,4206,4,CACNA1G
EUKARYOTIC TRANSCRIPTION INITIATION%WIKIPATHWAYS_20181110%WP405%HOMO SAPIENS,0.48994953382944206,0.908938677284213,0.213399892294996,0.982142157752659,5727,42,GTF2H2|AK6|ILK|POLR3B|TAF7|GTF2B|GTF2H1|POLR2B|TAF5|POLR3E|GTF2H2C|CDK7|GTF2E2
ADIPOGENESIS%WIKIPATHWAYS_20181110%WP236%HOMO SAPIENS,0.0125,0.24266948074149697,-0.199413457549597,-1.4983962804946798,23,110,LPIN3|IL6ST|RBL1|HMGA1|AGT|ZMPSTE24|GATA2|SOCS3|HIF1A|AHR|PPARD|FZD1|RARA|MBNL1|SCD|CTNNB1|PLIN2|KLF5|NR1H3|LIF|CEBPA|PPARA|FOXO1|RXRA|DDIT3|IL6|PPARG|NAMPT|MEF2D|IGF1|SPOCK1|FOXC2|LPIN1|LMNA|CFD|GADD45A|NRIP1|PPARGC1A|KLF6|STAT5A|NR3C1|STAT3|CDKN1A|TWIST1|TNF|EPAS1|TRIB3
TGIF DISRUPTION OF SHH SIGNALING%WIKIPATHWAYS_20181110%WP3674%HOMO SAPIENS,0.39277297721916704,0.8621064456029929,-0.51053270100364,-1.03611094809419,2499,3,TGIF2|TGIF1|SMAD2
OXIDATIVE DAMAGE%WIKIPATHWAYS_20181110%WP3941%HOMO SAPIENS,0.133431516936672,0.6194479383419461,-0.22565606346143202,-1.2833300477616898,452,40,C5AR1|TNK2|CR2|TRAF3|BAG4|TNFRSF1B|CASP3|CDC42|GADD45A|CDKN1C|BCL2|TDP2|CDKN1A|TNF
MICRORNA NETWORK ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA%WIKIPATHWAYS_20181110%WP4399%HOMO SAPIENS,0.16416927383500698,0.6664346072172851,-0.567063715614301,-1.30412808215316,996,4,BCL2|TP53
OSTEOBLAST SIGNALING%WIKIPATHWAYS_20181110%WP322%HOMO SAPIENS,0.212753036437247,0.7279184739702909,0.434846474704061,1.24090326186187,2101,9,BGLAP|TNFRSF11B|PTH1R|COL1A1|PDGFRA|PDGFB|ITGB3|ITGAV|PDGFRB
LNCRNA-MEDIATED MECHANISMS OF THERAPEUTIC RESISTANCE%WIKIPATHWAYS_20181110%WP3672%HOMO SAPIENS,0.321448467966574,0.822751772025005,-0.354552524667942,-1.10210362147323,1730,8,BCL2L1|WNT6|TP53|CDKN1A
DRUG INDUCTION OF BILE ACID PATHWAY%WIKIPATHWAYS_20181110%WP2289%HOMO SAPIENS,0.514273262148616,0.920771046603905,0.417559629371703,0.9624130460353671,4719,5,ABCC3|ABCB1|NR1I3
APOPTOSIS-RELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER%WIKIPATHWAYS_20181110%WP2864%HOMO SAPIENS,0.00233333333333333,0.12234570424564199,-0.300362723834545,-1.85260564582497,6,53,SOCS3|CDKN1B|GCLC|HSPB1|PKN1|PTK2B|HSPA5|SQSTM1|ABL1|CUL5|VIM|NQO1|RIPK2|ETS1|SERBP1|CTNNA1|VAV3|SMAD7|NET1|BCL3|TNFRSF10B|CDKN1A|TNF|TNFRSF21|PAK2
NRF2 PATHWAY%WIKIPATHWAYS_20181110%WP2884%HOMO SAPIENS,0.0055452865064695,0.171334869092615,-0.227550202168119,-1.6359643124331698,11,93,HMOX1|SOD3|SQSTM1|SLC2A3|SLC2A6|CES1|G6PD|CBR3|FTH1|RXRA|HGF|GSR|HBEGF|SLC6A8|PGD|SLC39A4|MAFF|SLC6A6|NQO1|SLC5A2|SLC39A11|FTL|SERPINA1|GSTT2|GSTM5|PRDX1|ABCC4|GSTM3|GSTM1|SLC2A1|GSTM4|HSP90AB1|PTGR1
BONE MORPHOGENIC PROTEIN (BMP) SIGNALLING AND REGULATION%WIKIPATHWAYS_20181110%WP1425%HOMO SAPIENS,0.57387706855792,0.941454000236524,-0.264451043510142,-0.894677463222898,2912,10,TOB1|BMPR1A|BMPR2|SMURF1|BMP2|SMAD4|TOB2|SMAD6|SMAD1
ENDODERM DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2853%HOMO SAPIENS,0.9553051211284879,1.0,0.11261486547392098,0.635939494384386,12460,108,PBX3|TRIM5|PIAS1|SIAH2|BPTF|MTF2|PHF6|ZFHX4|EXT1|DNMT3B|EZH2|MBTD1|APC|TAF5|NLK|CAND1|LEF1|WDHD1|ACACA|ELP4|JARID2|ELAVL1|ZNF281|TNRC6C|CUL4B|BTAF1|CDC73|TOX|EPB41L5|GATA6|IQCJ-SCHIP1|DAB2|NCAPG2|KDM4A|RFX7|ATP8B2
NOTCH SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP268%HOMO SAPIENS,0.710101357155128,0.9700296616429409,0.18040771946309697,0.823907691305196,8266,41,DTX1|DTX4|KAT2A|HES1|MAML1|DVL1|JAG2|DTX2
PYRIMIDINE METABOLISM AND RELATED DISEASES%WIKIPATHWAYS_20181110%WP4225%HOMO SAPIENS,0.671177504393673,0.964618776001639,-0.301031382714688,-0.826310932772624,3818,6,TYMS|DPYD|NT5C3A|TYMP|NT5C|RRM2B
BDNF-TRKB SIGNALING%WIKIPATHWAYS_20181110%WP3676%HOMO SAPIENS,0.0431505068884845,0.409991706586456,-0.30143554020896,-1.5426720695055203,165,29,EEF2K|NRAS|GRB2|EIF4EBP1|ARC|KRAS|SHC1|GAB2|MAP2K1|HOMER1
NEURAL CREST DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2064%HOMO SAPIENS,0.517108804306036,0.9229269218786791,-0.14445837130211497,-0.9713146468940971,1344,71,MITF|PRTG|HDAC5|FGF2|SMAD1|SNAI1|MBP|TCF4|ETS1|FGFR1|HDAC11|ID1|PMP22|ASCL1|TWIST1|DLL3|RBPJ
IL-3 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP286%HOMO SAPIENS,0.000307976593778873,0.0784645998831315,-0.405564546423155,-2.3835686430145095,0,45,PRKACA|PIK3CD|CD86|PIK3R2|CRKL|PTPN6|GRB2|VAV1|FYN|IL3RA|LYN|BCL2L1|CSF2RB|YWHAQ|YWHAB|CXCL8|STAT5A|BCL2|RAPGEF1|SHC1|JUN|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1
ONE CARBON METABOLISM AND RELATED PATHWAYS%WIKIPATHWAYS_20181110%WP3940%HOMO SAPIENS,0.9808736107521321,1.0,0.114696225764369,0.5203967563490821,11384,40,CTH|MAT2A|CEPT1|CDO1|CHKB|MTR|SARDH|BCAT2|ETNK1|GPX7|TYMS|DNM1|PLD1|GNMT|GPX3|MTHFR|CHKA|AHCYL1|GPX4|ETNK2
RALA DOWNSTREAM REGULATED GENES%WIKIPATHWAYS_20181110%WP2290%HOMO SAPIENS,0.278192371475954,0.78848945131153,-0.31443306197303006,-1.1455111855278701,1341,12,RALBP1|NRAS|RALA|CDC42|KRAS|RAC1
NANOMATERIAL INDUCED APOPTOSIS%WIKIPATHWAYS_20181110%WP2507%HOMO SAPIENS,0.563103122043519,0.9377667552605741,0.251656351011082,0.9198424664261692,5951,19,AIFM1|APAF1|CASP6|ENDOG|FAS|PRF1|CASP9
GLUCOCORTICOID AND MINERALCORTICOID METABOLISM%WIKIPATHWAYS_20181110%WP237%HOMO SAPIENS,0.383582262359616,0.8582519754973359,0.559952490458605,1.06441077957082,3312,3,CYP21A2|HSD11B1
THYROXINE (THYROID HORMONE) PRODUCTION%WIKIPATHWAYS_20181110%WP1981%HOMO SAPIENS,0.31774313288789896,0.8195209505928199,-0.670379423026323,-1.1466480998611799,2139,2,TRH
RETT SYNDROME CAUSING GENES%WIKIPATHWAYS_20181110%WP4312%HOMO SAPIENS,0.767261904761905,0.9792236089291529,-0.14093567690199302,-0.807673854615065,2577,41,HDAC5|TBL1X|HAP1|TCF4|TAF1B|CRK|HTT|GABRA3|GABRD
TGF-BETA SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP366%HOMO SAPIENS,0.161856963613551,0.664367762084791,-0.150995570112785,-1.17462395900954,257,130,PIK3R2|STRAP|ZEB2|ITCH|DCP1A|MMP1|ZEB1|SIN3A|NEDD4L|SKI|TGFBR1|BCAR1|GRB2|MAPK4|PML|RHOA|KLF10|UBE2I|SNIP1|SMAD2|SUMO1|PRKAR2A|ETS1|PPM1A|SMAD7|KLF11|CDC42|MAP2K3|KLF6|MMP12|SHC1|JUN|PJA1|TP53|CDKN1A|RAC1|MET|MAP2K1|PIK3R1|CAV1|PAK2
TRANS-SULFURATION PATHWAY%WIKIPATHWAYS_20181110%WP2333%HOMO SAPIENS,0.94741084021761,1.0,0.191677412875329,0.5656895655460329,9403,10,CTH|MTR|DNMT1|GOT1|MPST|MAT2B
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN (NOD) PATHWAY%WIKIPATHWAYS_20181110%WP1433%HOMO SAPIENS,0.8606130200512321,0.9916689277956879,0.162217917650163,0.693589289515124,9742,32,AIM2|NAIP|SUGT1|NLRC4|ACAP1|CARD9|CARD6|ERBB2IP|CASP9
PURINE METABOLISM%WIKIPATHWAYS_20181110%WP4224%HOMO SAPIENS,0.10835303388494902,0.58452352834625,-0.414407254454517,-1.40200177029105,549,10,DGUOK|ADA|APRT|ADSL|RRM2B|ATIC|PRPS1|HPRT1
TLR4 SIGNALING AND TOLERANCE%WIKIPATHWAYS_20181110%WP3851%HOMO SAPIENS,0.14843152257077302,0.64074876264986,-0.25692254066566395,-1.28029564707027,581,27,IRAK1|NFKBIA|IRAK4|TRAF3|IL6|CXCL8|TICAM1|MYD88|TNF
CYTOSINE METHYLATION%WIKIPATHWAYS_20181110%WP3585%HOMO SAPIENS,0.364878542510122,0.850174896280676,0.37985293872755604,1.08397050019925,3604,9,MBD3|TDG|IDH1|DNMT1|TET2|TET1|IDH2
ULTRACONSERVED REGION 339 MODULATION OF TUMOR SUPPRESSOR MICRORNAS IN CANCER%WIKIPATHWAYS_20181110%WP4284%HOMO SAPIENS,0.684484038604306,0.966495577318169,-0.487188778546089,-0.833310313541093,4609,2,TP53
OVARIAN INFERTILITY GENES%WIKIPATHWAYS_20181110%WP34%HOMO SAPIENS,0.7340089252510229,0.9734087938149171,0.209378909806275,0.791563879255941,7894,21,INHA|ZP3|BMPR1B|SYNE2|SMPD1|CEBPB|EGR1|ATM|CCND2
ANGIOGENESIS%WIKIPATHWAYS_20181110%WP1539%HOMO SAPIENS,0.129741483450109,0.61127985986266,-0.278954984318764,-1.31078614424724,536,23,CREBBP|TIMP3|HIF1A|VEGFA|KDR|FGF2|SMAD1|MMP9|TIMP2|NOS3|FLT1
APOE AND MIR-146 IN INFLAMMATION AND ATHEROSCLEROSIS%WIKIPATHWAYS_20181110%WP3926%HOMO SAPIENS,0.9611105334303841,1.0,0.201169397098571,0.548441746919753,9242,8,APOE|TRAF4|TLR4|TLR2|NFKB2|RELA|SPI1|IRAK1
MIRNA REGULATION OF DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP1530%HOMO SAPIENS,0.131258127438231,0.6149266898174119,0.251703785069646,1.2965327044583,1614,68,CDK6|MIR17HG|CCNB1|PIDD1|CDK1|APAF1|ATR|CDC25C|DDB2|RAD9A|CCNE1|RB1|RAD51|FAS|GADD45B|H2AFX|CCNB2|GADD45G|CHEK2|FANCD2|CASP9|CCNE2|E2F1|PRKDC|CHEK1|RAD17|RAD1|CDK2|ATM|CCND2|BRCA1|CCNG1|MDM2|RAD52|TLK2|MCM7|CYCS
RAS SIGNALING%WIKIPATHWAYS_20181110%WP4223%HOMO SAPIENS,0.0060882800608828,0.17804916190196898,-0.18871094344446301,-1.5126773961764601,7,156,REL|BCL2L1|PLA1A|SHOC2|CALM1|RAP1A|ETS1|RALA|PLA2G2A|CDC42|FGFR1|GNB5|RAB5C|STK4|GNGT1|KRAS|SHC1|PRKCA|RASA3|GAB2|RASGRF2|RALB|MAPK3|FLT1|RAB5A|RASGRP3|RAC1|PLD2|MET|RRAS2|MAP2K1|ETS2|PIK3R1|PAK2
PARKINSONS DISEASE PATHWAY%WIKIPATHWAYS_20181110%WP2371%HOMO SAPIENS,0.24512704490080103,0.757467559003634,0.267268261860954,1.1883020578993202,2816,37,SNCAIP|MAPK11|MIR17HG|MAPK12|APAF1|CASP6|EPRS|CCNE1|DDC|ATXN2|UBA7|TH|CASP9|CCNE2|MAPK13|SEPT5
LEPTIN INSULIN OVERLAP%WIKIPATHWAYS_20181110%WP3935%HOMO SAPIENS,0.19236016371077802,0.7023096717844329,0.38434763417738704,1.2734631507191,1973,14,INS|PIK3R3|PDPK1|SOCS2|JAK2|IRS1|SOCS1|DGKZ
ECTODERM DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2858%HOMO SAPIENS,0.423941649748101,0.8740879492662891,0.178910538372354,1.03480011850026,5637,123,NF2|CDH6|HDAC10|POU2F2|SGSM3|BMP4|ANKS1B|CLDN11|OGT|AHI1|NUMA1|SOCS2|MKS1|ZFHX4|TNFRSF11B|CELSR2|CTNND2|MZF1|GRAMD1B|NLK|PTPN13|CCL2|SORCS1|TTC14|SERPINB6|ZNF219|HDAC6|FHL2|DMD|PDE7A|RHPN1|PLXNA2|CCDC130|SKIL|KIAA1161|GATA6|HESX1|ELOVL4|FGFR2|IQCJ-SCHIP1|CLVS1|ARHGEF9|NARS2|ELOVL2|ARHGAP15|PI4KA|GREB1|HIST1H2BH
MIRNA BIOGENESIS%WIKIPATHWAYS_20181110%WP2338%HOMO SAPIENS,0.215635738831615,0.7322272196643679,0.503563818633847,1.23844187492504,2007,6,DROSHA|DICER1|DGCR8|TARBP2|XPO5
NUCLEAR RECEPTORS IN LIPID METABOLISM AND TOXICITY%WIKIPATHWAYS_20181110%WP299%HOMO SAPIENS,0.6793337800325451,0.9647315640607691,0.23889421411162398,0.828181454627402,7096,16,ABCC3|RARB|ABCB4
HEMATOPOIETIC STEM CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2849%HOMO SAPIENS,0.24494047619047601,0.757467559003634,-0.20143333408637198,-1.15437368993971,822,41,GATA2|RIOK3|SPI1|NOTCH1|CBFA2T3|IL1B|PIM1|IKZF1|VAV1|MXI1|RUNX1|KITLG|IL6|STAT5A|SEC14L2|NFATC2|TRIM29
ARACHIDONATE EPOXYGENASE / EPOXIDE HYDROLASE%WIKIPATHWAYS_20181110%WP678%HOMO SAPIENS,0.0286554804968403,0.347919292482523,0.688031184963418,1.58580988656477,262,5,CYP2C8|COX5A|GSTP1|COX8A
DEVELOPMENT OF PULMONARY DENDRITIC CELLS AND MACROPHAGE SUBSETS%WIKIPATHWAYS_20181110%WP3892%HOMO SAPIENS,0.0833658727059742,0.543815846291824,-0.45027431040662197,-1.45352582404106,426,9,SPI1|ID2|IKZF1|TCF4|STAT3
SECRETION OF HYDROCHLORIC ACID IN PARIETAL CELLS%WIKIPATHWAYS_20181110%WP2597%HOMO SAPIENS,0.0467363961339865,0.425275525480742,-0.9760696956329951,-1.3057181919637901,352,1,CHRM1
NOTCH SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP61%HOMO SAPIENS,0.8125661842569709,0.985971473561293,-0.125095624124756,-0.796921156679793,2301,59,ADAM17|STAT3|CIR1|CDKN1A|PIK3R1|DLL3|RBPJ
PI3K/AKT/MTOR - VITD3 SIGNALLING%WIKIPATHWAYS_20181110%WP4141%HOMO SAPIENS,0.8796378091872791,0.9956508825790341,-0.164632730907393,-0.692755596041566,3982,17,HK3|MTOR|HLA-DRA|MYC|TSC1|PIK3CA|TSC2|GSK3B|RELA|CD86|LDHA|PFKFB4|SLC2A3|RXRA
HISTONE MODIFICATIONS%WIKIPATHWAYS_20181110%WP2369%HOMO SAPIENS,0.48952461085401794,0.908938677284213,0.20555218552218502,0.9831568764069091,5817,49,HIST1H3E|EHMT1|DOT1L|HIST2H3C|HIST2H3A|EZH2|KMT2B|SETBP1|SUV420H2|H3F3A|SETD8|NSD1|SMYD2|EHMT2|KMT2D|EED|HIST1H3H|SETDB2|SUV39H1|SETMAR|EZH1|SUV39H2|KMT2C|SMYD3|SETD1B
CORI CYCLE%WIKIPATHWAYS_20181110%WP1946%HOMO SAPIENS,0.0338244449055821,0.37600329791737297,-0.43719941258297795,-1.64648463099571,162,13,LDHA|GPI|G6PD|GAPDH|PGK1|HK1|TPI1|SLC2A1
HYPERTROPHY MODEL%WIKIPATHWAYS_20181110%WP516%HOMO SAPIENS,0.729907264296754,0.972554563883587,0.23225896786795397,0.7875000492211,7555,15,CYR61|NR4A3
HORMONAL CONTROL OF PUBERTAL GROWTH SPURT%WIKIPATHWAYS_20181110%WP4194%HOMO SAPIENS,0.4089754445385271,0.867015886388254,0.638657719713199,1.04386849791733,3380,2,GNRH1|SST
FELBAMATE METABOLISM%WIKIPATHWAYS_20181110%WP2816%HOMO SAPIENS,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
METABOLISM OF SPINGOLIPIDS IN ER AND GOLGI APPARATUS%WIKIPATHWAYS_20181110%WP4142%HOMO SAPIENS,0.602935222672065,0.9508825506493929,0.310980621428768,0.8874324387001521,5956,9,B4GALNT1|B3GALT1|B3GALNT1
MITOCHONDRIAL LC-FATTY ACID BETA-OXIDATION%WIKIPATHWAYS_20181110%WP368%HOMO SAPIENS,0.580932325069398,0.9427555350783241,0.26196615964167497,0.9081656329015279,6068,16,ACSF2|ACADVL|ACADM|HADH|EHHADH|ECI1|ACADS
INTERLEUKIN-1 INDUCED ACTIVATION OF NF-KAPPA-B%WIKIPATHWAYS_20181110%WP3656%HOMO SAPIENS,0.28913649025069604,0.7987305112663521,-0.36478941346501903,-1.13392432907204,1556,8,TRAF6|UBE2N|IRAK1|SQSTM1|UBE2V1
SYNTHESIS AND DEGRADATION OF KETONE BODIES%WIKIPATHWAYS_20181110%WP311%HOMO SAPIENS,0.164333937098633,0.666438287523194,-0.566668730189094,-1.3032196981905302,997,4,BDH1|OXCT1
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PATHWAY%WIKIPATHWAYS_20181110%WP2533%HOMO SAPIENS,0.45326887661141796,0.8877077061560501,-0.222996959999993,-0.994991360141356,1968,20,AGPS|PTPMT1|PIP5K1A|PEMT|PI4K2A|PCYT2|CDIPT|LPIN1|PLA2G2A|CDS2
VALPROIC ACID PATHWAY%WIKIPATHWAYS_20181110%WP3871%HOMO SAPIENS,0.276177602162837,0.7884684708511421,0.428619764137128,1.1685324686463898,2655,8,ABAT|EHHADH|IVD|HADHB|HSD17B10|ACADSB|HADHA|HDAC1
OXYTOCIN SIGNALING%WIKIPATHWAYS_20181110%WP2889%HOMO SAPIENS,0.26912308209206,0.784543299601953,0.550128953586801,1.16577580370612,2402,4,OXTR|CD38
LEPTIN AND ADIPONECTIN%WIKIPATHWAYS_20181110%WP3934%HOMO SAPIENS,0.691922005571031,0.96731875442989,-0.26208757427449303,-0.8146822957235309,3725,8,PRKAA1|PRKAG1|LEPR
DOPAMINE METABOLISM%WIKIPATHWAYS_20181110%WP2436%HOMO SAPIENS,0.7171982236576501,0.971081608033886,-0.22665950895137102,-0.797643051346369,3552,11,PPP2CA|PPP2CB|NQO1
HOMOLOGOUS RECOMBINATION%WIKIPATHWAYS_20181110%WP186%HOMO SAPIENS,0.3532357851320829,0.842847021021096,0.34089840389126597,1.10020586180562,3596,13,RAD54B|POLD1|POLD3|RAD51|BRCA2|ATM|RAD52|RAD50|NBN|POLD4
TRANSCRIPTIONAL CASCADE REGULATING ADIPOGENESIS%WIKIPATHWAYS_20181110%WP4211%HOMO SAPIENS,0.9738780320141409,1.0,0.15997156426866,0.516287699565563,9916,13,EGR2|CEBPD
NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP4336%HOMO SAPIENS,0.31861313868613106,0.8208699735191379,-0.168567909961483,-1.09148096612231,872,63,TCF7L2|FOSL1|PLAU|CSNK2A2|WNT6|WNT11|SERPINF1|JUN|TCF7|DKK1|WNT3|SFRP2|SOX7|CSNK2A1|SOX17
ERBB SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP673%HOMO SAPIENS,0.0762416956659285,0.525661416287861,-0.22870150201360398,-1.36595240722936,240,47,GRB2|ABL1|FOXO1|EIF4EBP1|HBEGF|CAMK2A|CRK|KRAS|STAT5A|JUN|PRKCA|TP53|CDKN1A|MAP2K1|BCL2L11
DOPAMINERGIC NEUROGENESIS%WIKIPATHWAYS_20181110%WP2855%HOMO SAPIENS,0.366915422885572,0.851186780857897,-0.291594121112086,-1.06230663299877,1769,12,MSX1|RET|NKX6-1|CDKN1C|STAT3|ASCL1
VITAMIN B6-DEPENDENT AND RESPONSIVE DISORDERS%WIKIPATHWAYS_20181110%WP4228%HOMO SAPIENS,0.39782644492013797,0.8638522656500329,-0.449076547002014,-1.03278224272781,2415,4,ALDH7A1|PNPO
"GPCRS, CLASS C METABOTROPIC GLUTAMATE, PHEROMONE%WIKIPATHWAYS_20181110%WP501%HOMO SAPIENS",0.007809662186705409,0.19847993048827997,-0.6527110819305,-1.90398718414799,42,7,GRM2|GPRC5C|GPRC5D|GPRC5B|GRM8
ERK PATHWAY IN HUNTINGTON'S DISEASE%WIKIPATHWAYS_20181110%WP3853%HOMO SAPIENS,0.860113039967703,0.9916689277956879,-0.19673397329802497,-0.692331362981109,4260,11,HRAS|MAP2K7|ELK1|CASP7|RAF1|CREB1|EGFR|MAPK1|RPS6KA5|NTRK2|CASP3
PDGFR-BETA PATHWAY%WIKIPATHWAYS_20181110%WP3972%HOMO SAPIENS,0.0246945671952171,0.329326373353219,-0.318098097788247,-1.62794689199749,94,29,STAT5A|SHC1|JUN|PRKCA|STAT3|MAPK3|MAP2K1|PIK3R1
MODEL FOR REGULATION OF MSMP EXPRESSION IN CANCER CELLS AND ITS PROANGIOGENIC ROLE IN OVARIAN TUMORS%WIKIPATHWAYS_20181110%WP4397%HOMO SAPIENS,0.8190604026845641,0.987153241368501,0.592137185707984,0.7866278341003241,6101,1,CTCF
PATHWAYS IN CLEAR CELL RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4018%HOMO SAPIENS,0.000407830342577488,0.0784645998831315,-0.302981259980334,-2.07621552255644,0,76,ZEB1|LDHA|VEGFA|KDR|SQSTM1|PFKL|GPI|PKM|ENO1|SDS|SDSL|BAP1|GAPDH|SHMT2|PGK1|BHLHE41|HK1|VHL|PSPH|HK2|TPI1|STAT3|ACLY|FLT1|ALDOA|SLC2A1|CDH13|PBRM1
IL-2 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP49%HOMO SAPIENS,0.00892857142857143,0.207969158127386,-0.301934760213841,-1.7303270327624198,29,41,STAT5A|BCL2|SHC1|JUN|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1|FOXO3
REGULATION OF ACTIN CYTOSKELETON%WIKIPATHWAYS_20181110%WP51%HOMO SAPIENS,0.0172732880937693,0.278000898076689,-0.184929545182618,-1.4314852333045602,27,127,CFL2|BCAR1|NRAS|PFN1|VAV1|MAPK4|CYFIP2|FGF7|RHOA|SLC9A1|FGF2|PXN|ARPC5|PIP4K2A|CRK|TMSB4X|LIMK1|CDC42|FGFR1|MSN|KRAS|SSH3|MAPK3|FGF14|GNA12|FGF10|BDKRB2|RAC1|CHRM1|RRAS2|BRK1|MAP2K1|BDKRB1|PIK3R1|PAK2
COMPOSITION OF LIPID PARTICLES%WIKIPATHWAYS_20181110%WP3601%HOMO SAPIENS,0.028328611898017005,0.346236266895247,0.688671961173616,1.5872867807396498,259,5,LPL|CETP|APOE|LDLR|LCAT
FLUOROPYRIMIDINE ACTIVITY%WIKIPATHWAYS_20181110%WP1601%HOMO SAPIENS,0.199169750022561,0.711592141628341,0.305183858675733,1.2407285708197902,2206,27,ABCC3|TDG|GGH|RRM1|XRCC3|DHFR|TK1|ABCC5|UMPS|UCK1|SLC29A1|TYMS|RRM2
TRIACYLGLYCERIDE SYNTHESIS%WIKIPATHWAYS_20181110%WP325%HOMO SAPIENS,0.21759832396914602,0.7341474817293291,0.342773764840708,1.2295993761189699,2284,18,LPL|GPAM|PPAP2C|DGAT1|PNPLA2|LIPE|GNPAT
NLR PROTEINS%WIKIPATHWAYS_20181110%WP288%HOMO SAPIENS,0.6946505271378369,0.96731875442989,-0.251783590216997,-0.812779992089008,3557,9,EPHB2
MTHFR DEFICIENCY%WIKIPATHWAYS_20181110%WP4288%HOMO SAPIENS,0.497303830420231,0.912054123542573,0.258015789140202,0.975437206880427,5348,21,EHMT1|MARS|DNMT3B|GRIN1|CASP9|EHMT2|COMT|DNMT1|CYCS|MTHFR|GRIN2D|NDUFAF7|CHKA
SIGNALING PATHWAYS IN GLIOBLASTOMA%WIKIPATHWAYS_20181110%WP2261%HOMO SAPIENS,0.893863618321823,0.9976191001250191,0.131050023682928,0.6979844741417989,11259,79,CDK6|MAP2K6|MAP2K2|CDKN2C|PDPK1|PRKCB|CDKN2A|PRKCQ|SRC|CCNE1|RB1|MSH6|NF1|HRAS|CDKN2B|PLCG1|MAP2K7|AKT3|ARAF|IRS1|AKT2|BRCA2|E2F1|FGFR2|CDK2|ATM|CCND2|ERBB3|BRCA1|AKT1|MDM2|CBL|PIK3C2B|GAB1
BENZENE METABOLISM%WIKIPATHWAYS_20181110%WP3891%HOMO SAPIENS,0.17084478021977997,0.673817672117118,-0.5071501012585949,-1.2838168048371599,994,5,NQO1|DHDH|GSTM1
EXERCISE-INDUCED CIRCADIAN REGULATION%WIKIPATHWAYS_20181110%WP410%HOMO SAPIENS,0.41917114837076896,0.871768603311353,-0.171432638063511,-1.0239059323126,1324,47,ETV6|TUBB3|SUMO1|PPP2CB|DAZAP2|KLF9|GSTM3|PER2|NR1D2|SUMO3
MET IN TYPE 1 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4205%HOMO SAPIENS,0.0020797227036395104,0.115553415806697,-0.28995292699848996,-1.82755683153052,5,57,NRAS|GRB2|PRCC|STRN|HGF|TFE3|CRK|RAP1A|ETS1|CDC42|KRAS|RAPGEF1|JUN|STAT3|MAPK3|CDKN1A|RAC1|MET|MAP2K1|PIK3R1|PAK2
COCAINE METABOLISM%WIKIPATHWAYS_20181110%WP2826%HOMO SAPIENS,0.832812319092277,0.9881090453690059,0.389540788231567,0.740476060275415,7192,3,BCHE|CES2
MIR-509-3P ALTERATION OF YAP1/ECM AXIS%WIKIPATHWAYS_20181110%WP3967%HOMO SAPIENS,0.8420851632614091,0.990889042828776,0.19586181911927,0.6907763511337399,8819,17,PBX3|GPC6|COL5A1|FN1|THBS2|SPARC|COL1A1|TEAD3|COL3A1|TEAD2|YAP1
ATM SIGNALING NETWORK IN DEVELOPMENT AND DISEASE %WIKIPATHWAYS_20181110%WP3878%HOMO SAPIENS,0.20655682011211102,0.7211951452265429,0.262864105011459,1.22609041423055,2431,44,CEP63|CDK1|ATR|LBR|CDK5R1|MAP3K5|BUB1|AURKB|STK11|H2AFX|DCLRE1C|CHEK2|RNF40|RIF1|PRKDC|CHEK1|ATM|MDC1|PPM1D|RNF8|HMGN1|PPP2R4|TP53BP1|IKBKG|RBBP8|RAD50|PPP5C|NBN|MTOR|SMC1A
NUCLEOTIDE GPCRS%WIKIPATHWAYS_20181110%WP80%HOMO SAPIENS,0.691212653778559,0.96731875442989,-0.295945223111818,-0.812349766173391,3932,6,ADORA2B
CHEMOKINE SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3929%HOMO SAPIENS,0.0553766902768835,0.458062256682211,-0.166628982396872,-1.3139669092497601,85,136,PIK3CD|PRKX|PIK3R2|PREX1|CRKL|GNG10|PIK3R5|RAP1B|GNAI3|CXCR5|ADCY7|GNG4|NFKBIA|CX3CL1|PRKCD|CXCL16|BCAR1|PTK2B|NRAS|ARRB2|GRB2|FGR|VAV1|CCR10|GNAI2|PXN|LYN|ARRB1|CRK|RAP1A|VAV3|VAV2|CDC42|GNB5|GNGT1|KRAS|SHC1|NFKBIB|STAT3|CXCL14|ADCY2|MAPK3|RAC1|PLCB4|PLCB1|MAP2K1|PIK3R1|PARD3|FOXO3
IL-1 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP195%HOMO SAPIENS,0.0805799055967633,0.5366274179649121,-0.21772870766712804,-1.3505264867174098,238,54,IL1B|IRAK1|NFKBIA|IRAK2|SQSTM1|IRAK4|UBE2V1|REL|MAP2K3|JUN|NFKBIB|PELI2|MAPK3|PELI1|MYD88|MAP2K1|PIK3R1
T-CELL RECEPTOR AND CO-STIMULATORY SIGNALING%WIKIPATHWAYS_20181110%WP2583%HOMO SAPIENS,0.29762815608263204,0.8023890191280308,-0.22274986195472102,-1.1100064552812,1166,27,CD8B|PLCG1|CD8A|ZAP70|RASGRP1|GSK3A|CTLA4|LCK|AKT1|RASA1|PPP3CA|PDK1|PTEN|CALM2|NFKB1|GSK3B|DYRK2|ITK|CSNK1A1|CALM3|PTPN6|NFKBIA|DYRK1A|FYN|CALM1|PRKCA|NFATC2
SEROTONIN RECEPTOR 2 AND STAT3 SIGNALING%WIKIPATHWAYS_20181110%WP733%HOMO SAPIENS,0.534956794972506,0.9265056012720759,-0.45843771277310497,-0.930385717290393,3404,3,GNAQ|STAT3
BLOOD CLOTTING CASCADE%WIKIPATHWAYS_20181110%WP272%HOMO SAPIENS,0.913146001179014,1.0,0.19430827309082602,0.612529115991676,9293,12,PLAT|F12|F3|KLKB1
SEROTONIN RECEPTOR 2 AND ELK-SRF/GATA4 SIGNALING%WIKIPATHWAYS_20181110%WP732%HOMO SAPIENS,0.547096774193548,0.9305779599215391,-0.231777781038647,-0.924350497571751,2543,15,NRAS|GNAQ|KRAS|MAPK3|MAP2K1
PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY  OF THE HEART%WIKIPATHWAYS_20181110%WP1528%HOMO SAPIENS,0.7116198059218709,0.970341332123494,-0.171181373657407,-0.830447303296564,2859,25,CALM1|MAP2K3|JUN|STAT3|RAC1
PPAR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3942%HOMO SAPIENS,0.835551411375774,0.988613522932093,0.15368452038247699,0.7252030247803379,9856,46,LPL|SLC27A2|FABP5|ILK|FADS2|PDPK1|ACADM|ME1|FABP6|CPT1B|ACOX2
CANONICAL AND NON-CANONICAL TGF-B SIGNALING%WIKIPATHWAYS_20181110%WP3874%HOMO SAPIENS,0.997145993413831,1.0,-0.10876883174217801,-0.44544492215216597,4541,16,LOXL1|LOXL2|MAPK9|MAPK14|BMPR1A|BMPR2|BMP1|LOX|MAPK8|TGFBR2|TGFB1|SMAD4|SMAD3|TGFBR1|SMAD2|GREM1
ENERGY METABOLISM%WIKIPATHWAYS_20181110%WP1541%HOMO SAPIENS,0.43556381660470894,0.878651088001772,-0.17467236721629803,-1.01818500921301,1405,44,PPARD|PPP3R1|PRKAA1|UCP2|PRKAG1|MYBBP1A|PPARA|FOXO1|RXRA|PPARG|MEF2D|CAMK4|PPARGC1A|FOXO3
ARYLAMINE METABOLISM%WIKIPATHWAYS_20181110%WP694%HOMO SAPIENS,0.394015622931286,0.863476608623133,-0.8011689457432729,-1.07174812615715,2975,1,SULT1A1
DISORDERS OF FOLATE METABOLISM AND TRANSPORT%WIKIPATHWAYS_20181110%WP4259%HOMO SAPIENS,0.21287818471337602,0.7279184739702909,0.405642279974592,1.2375216111758798,2138,11,FTCD|DHFR|MTHFD1|MTR|SLC46A1
IL-4 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP395%HOMO SAPIENS,0.299333333333333,0.802405201251754,-0.179266791451248,-1.10569868894401,897,53,STAT5A|SHC1|STAT3|GAB2|SOCS5|MAPK3|PIK3R1|HRH1
ALZHEIMERS DISEASE%WIKIPATHWAYS_20181110%WP2059%HOMO SAPIENS,0.76913152165148,0.9792236089291529,0.153158381163546,0.7973077701626659,9537,71,VMP1|PLCB3|LPL|IDE|APAF1|LINC00599|ERN1|ATP2A1|CDK5R1|CHPF2|CACNA1D|NAE1|APOE|FAS|GRIN1|APBB1|ATP2A2
TGF-B SIGNALING IN THYROID CELLS FOR EPITHELIAL-MESENCHYMAL TRANSITION%WIKIPATHWAYS_20181110%WP3859%HOMO SAPIENS,0.628477588871716,0.9555836714381641,0.256611349889708,0.8700695285261371,6505,15,CDH6|TNC|CDH2
TCA CYCLE AND DEFICIENCY OF PYRUVATE DEHYDROGENASE COMPLEX (PDHC)%WIKIPATHWAYS_20181110%WP2453%HOMO SAPIENS,0.7501931993817621,0.9759583326756759,0.227132551567337,0.7701183604702958,7765,15,FH|IDH1|PDHA1|DLD|SDHA|ACO1
LET-7 INHIBITION OF ES CELL REPROGRAMMING%WIKIPATHWAYS_20181110%WP3299%HOMO SAPIENS,0.6906333217552391,0.96731875442989,0.44849454064188793,0.8525409419054649,5964,3,EGR1|KLF4|MYC
ACRYLAMIDE BIOTRANSFORMATION AND EXPOSURE BIOMARKERS%WIKIPATHWAYS_20181110%WP4233%HOMO SAPIENS,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
TRYPTOPHAN CATABOLISM LEADING TO NAD+ PRODUCTION%WIKIPATHWAYS_20181110%WP4210%HOMO SAPIENS,0.370752688172043,0.852609194081082,-0.262176691324727,-1.04558406760015,1723,15,NAMPT|TDO2|NMNAT3|NMNAT2
MIRNA REGULATION OF P53 PATHWAY IN PROSTATE CANCER%WIKIPATHWAYS_20181110%WP3982%HOMO SAPIENS,0.18108365019011397,0.686812867800089,-0.269603159624203,-1.24900144923648,761,22,BAX|ZMAT3|BBC3|CASP3|BID|TP53|TNFRSF10B|SHISA5|PMAIP1
PATHWAYS AFFECTED IN ADENOID CYSTIC CARCINOMA%WIKIPATHWAYS_20181110%WP3651%HOMO SAPIENS,0.869472475182542,0.993389838333952,0.140926323889192,0.7072777183334091,10597,60,FGFR4|DTX4|CMTR2|MAP2K2|UHRF1|HRAS|MAGI2|MYBL1|CHEK2|ERBB2IP|MYCN|NSD1|MAML3|MYCBP|PRKDC|CHEK1|BRD1|ARID1A|MGA|ATM|BRCA1|AKT1|ARID4B|KANSL1|NCOR1|KMT2C|BCORL1|ATRX|MYB|BCOR|KDM6B|SMC1A|EP300|JMJD1C|RAF1
NON-SMALL CELL LUNG CANCER%WIKIPATHWAYS_20181110%WP4255%HOMO SAPIENS,0.16934306569343102,0.673117535978459,-0.187778851981258,-1.21587224297123,463,63,GADD45A|STK4|KRAS|STAT5A|PRKCA|STAT3|TP53|MAPK3|CDKN1A|MAP2K1|PIK3R1|FOXO3
EXTRACELLULAR VESICLE-MEDIATED SIGNALING IN RECIPIENT CELLS%WIKIPATHWAYS_20181110%WP2870%HOMO SAPIENS,0.27668574272206997,0.7884684708511421,-0.23316301712504,-1.13113707795977,1111,25,AXIN1|TGFB1|TGFBR3|SMAD4|SMAD3|TSPAN8|PIK3R5|CTNNB1|TGFBR1|NRAS|HGF|SMAD2|KRAS|MET
ETHANOL METABOLISM RESULTING IN PRODUCTION OF ROS BY CYP2E1%WIKIPATHWAYS_20181110%WP4269%HOMO SAPIENS,0.49586943381019605,0.911498395855878,0.329252213204562,0.97170834397636,4921,10,MAP2K2|PRKCQ|MAFK|NFE2L2|CYP2E1|SP1
TYROBP CAUSAL NETWORK%WIKIPATHWAYS_20181110%WP3945%HOMO SAPIENS,0.118249205788916,0.602190989258993,-0.20059663555406002,-1.27790003807321,334,59,PLEK|TMEM106A|GAPT|RUNX3|CD84|NCF2|PYCARD|SLC7A7|NRROS|SFT2D2|SH2B3|PPP1R18|CD37|IL13RA1|SLC1A5|TYROBP|KCNE3|TGFBR1|ITGAX|CXCL16|ITGAM|TNFRSF1B|ELF4|CAPG|STAT5A|ABCC4
ENDOCHONDRAL OSSIFICATION%WIKIPATHWAYS_20181110%WP474%HOMO SAPIENS,0.0256248022777602,0.333363983128034,-0.263808297418407,-1.57563276031443,80,47,IFT88|PRKACA|RUNX3|TIMP3|PTHLH|CALM3|VEGFA|IGF1R|HDAC4|PLAU|CHST11|FGF2|MMP9|ADAMTS4|IGF1|CAB39|CALM1|FGFR1|CDKN1C|SOX6|CTSV|ACAN|IGF2
GLIAL CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2276%HOMO SAPIENS,0.433919156414763,0.878651088001772,-0.362486361060884,-0.9950007219329009,2468,6,CNP|MBP|MSN
ESTROGEN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP712%HOMO SAPIENS,0.109077946768061,0.58452352834625,-0.29486346804116603,-1.36602590052602,458,22,GNGT1|BCL2|JUN|GNAS|MAP2K1
FARNESOID X RECEPTOR  PATHWAY%WIKIPATHWAYS_20181110%WP2879%HOMO SAPIENS,0.708225018196943,0.9695170059473192,0.295803689296352,0.8064402162696109,6810,8,FGF19|ABCB4
ACE INHIBITOR PATHWAY%WIKIPATHWAYS_20181110%WP554%HOMO SAPIENS,0.0107706592386258,0.226361532551881,-0.596553669698409,-1.8543485493256997,57,8,ATP6AP2|NOS3|BDKRB2|ACE|BDKRB1
GENE REGULATORY NETWORK MODELLING SOMITOGENESIS %WIKIPATHWAYS_20181110%WP2854%HOMO SAPIENS,0.20910886970988898,0.7243363294845151,0.456767377051809,1.24527041299179,2010,8,RIPPLY2|HES1|TBX6|LFNG
FOLATE-ALCOHOL AND CANCER PATHWAY HYPOTHESES%WIKIPATHWAYS_20181110%WP1589%HOMO SAPIENS,0.330248518248934,0.8291761235173739,0.409062319792553,1.11521362842354,3175,8,ALDH1A1|MTR|CEBPB|CYP2E1|MTHFR|ADH5
BIOGENIC AMINE SYNTHESIS%WIKIPATHWAYS_20181110%WP550%HOMO SAPIENS,0.394093792242903,0.863533645585435,0.387612047355891,1.05673443100713,3789,8,PNMT|DDC|TH|COMT|DBH|MAOA
SREBF AND MIR33 IN CHOLESTEROL AND LIPID HOMEOSTASIS%WIKIPATHWAYS_20181110%WP2011%HOMO SAPIENS,0.94505599693692,1.0,0.164017586270754,0.568604491688186,9872,16,SIRT1|SIRT6|SREBF2|LDLR|HMGCR
SULINDAC METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2542%HOMO SAPIENS,0.8036734236756641,0.984522820758988,0.35153414939971805,0.744934442869567,7175,4,MSRB2|MSRB3|MSRA
FACTORS AND PATHWAYS AFFECTING INSULIN-LIKE GROWTH FACTOR (IGF1)-AKT SIGNALING%WIKIPATHWAYS_20181110%WP3850%HOMO SAPIENS,0.868513672051259,0.993084774742015,0.16709617750793,0.679331477124906,9623,27,NEB|ITGB1|ILK|IGFBP5|IRS1|JKAMP|RPS6KB1|PLD1|AKT1
SEROTONIN AND ANXIETY-RELATED EVENTS%WIKIPATHWAYS_20181110%WP3944%HOMO SAPIENS,0.946052631578947,1.0,0.19891785549796998,0.56764359397874,9346,9,PRKCB|FOS|PLCD4|PPP3CA|GRIN2D
ONCOSTATIN M SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2374%HOMO SAPIENS,0.552189781021898,0.9321968967758479,-0.14610171496719299,-0.94601185386326,1512,63,IL6ST|RELA|TIMP3|SOCS3|CDKN1B|HIF1A|MMP1|PRKCH|VEGFA|NFKBIA|PRKCD|PTK2B|GRB2|CASP3|PXN|KRAS|SHC1|PRKCA|STAT3|TP53|MAPK3|MAP2K1|PIK3R1
SMALL LIGAND GPCRS%WIKIPATHWAYS_20181110%WP247%HOMO SAPIENS,0.64139543948548,0.9612805315220849,0.258514335327394,0.8565383280599029,6581,14,PTGER3|CNR1|PTGER1|S1PR4|PTGIR|S1PR2
CELL CYCLE%WIKIPATHWAYS_20181110%WP179%HOMO SAPIENS,0.0578851412944394,0.46945926786347203,0.24177579441814,1.3825048592497802,761,116,CDK6|CCNA1|CCNB1|CDC7|CDK1|ANAPC5|ATR|CDKN2C|WEE1|E2F3|ORC1|CDC25C|TGFB2|CDC45|BUB1|CDKN2A|TTK|CDC23|CDC20|CCNE1|PKMYT1|ANAPC7|E2F2|PTTG1|RB1|E2F5|MCM6|ESPL1|CDC6|CDKN2B|GADD45B|CCNB2|ORC6|GADD45G|DBF4|CDK7|CHEK2|PLK1|MCM3|MCM2|CCNE2|ANAPC10|E2F1|PRKDC|CHEK1|RBX1|SMC3|SKP2|CDK2|ATM|CDKN2D|CCND2|CDC16|TGFB3|ANAPC2|ORC2|MDM2|MCM7|ZBTB17|CCNA2
FABP4 IN OVARIAN CANCER%WIKIPATHWAYS_20181110%WP4400%HOMO SAPIENS,0.22971004898715697,0.743397546142977,-0.8844287604764008,-1.1831273188961202,1734,1,FABP4
MICROGLIA PATHOGEN PHAGOCYTOSIS PATHWAY%WIKIPATHWAYS_20181110%WP3937%HOMO SAPIENS,0.0573746740075341,0.466461451270875,-0.25792042348968397,-1.4437656573758701,197,38,ARPC1B|NCF2|PIK3CD|CYBA|PIK3R2|PTPN6|FCER1G|PIK3C3|TYROBP|ITGAM|VAV1|LYN|VAV3|VAV2|RAC1|PIK3R1
SLEEP REGULATION%WIKIPATHWAYS_20181110%WP3591%HOMO SAPIENS,0.102927552343895,0.5745140527021371,0.36189522525610296,1.3859747641947702,1110,22,STAR|GHRL|CACNA1I|OXTR|NPY2R|NPAS2
NO/CGMP/PKG MEDIATED NEUROPROTECTION%WIKIPATHWAYS_20181110%WP4008%HOMO SAPIENS,0.37558815388873495,0.8530054054513628,-0.19561847252682,-1.05260086492483,1356,34,GUCY1B3|CAMK2D|CALM3|GRIN2C|IL1B|NFKBIA|GUCY1A3|CAMK2A|CALM1|BCL2|NOS3|PDE3A|TNF
MICRORNA FOR TARGETING CANCER GROWTH AND VASCULARIZATION IN GLIOBLASTOMA%WIKIPATHWAYS_20181110%WP3593%HOMO SAPIENS,0.917860151642797,1.0,0.23501267546088397,0.6116886180341271,8715,7,HES1|VEGFB|HEY1|VEGFC|HIF1AN|HIF1A|VEGFA
CORTICOTROPIN-RELEASING HORMONE SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2355%HOMO SAPIENS,0.833029702970297,0.9882381741325991,0.14087204315345,0.7524149947103609,10516,80,NR4A2|CYP21A2|STAR|CRHBP|PRKAA2|GNAI1|NR4A1|GNB3|ERN1|CACNA1H|MAP3K5|PRKCB|PRKCQ|PARP1|FOS|GJA1|ACACA|ADRBK2|PLCG1
PI3K-AKT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4172%HOMO SAPIENS,0.0985714285714286,0.570215774831708,-0.135145698455329,-1.20472577270517,68,269,IL3RA|ITGA5|IFNAR1|COL6A1|EIF4EBP1|FGF2|HGF|KITLG|IL6|LAMC1|ITGA6|EFNA1|BCL2L1|TCL1A|CDC37|PPP2CA|PPP2CB|IGF1|EIF4E2|PPP2R1B|FGFR1|EIF4B|GNB5|GNGT1|COL9A1|COMP|LAMA4|KRAS|G6PC3|BCL2|PRKCA|RELN|TP53|NOS3|MAPK3|FGF14|FLT1|CDKN1A|FGF10|VWF|THBS4|RAC1|MET|CHRM1|IGF2|LAMC2|MAP2K1|PGF|PIK3R1|HSP90AB1|BCL2L11|ITGA7|ANGPT2|FOXO3|CREB5
RANKL/RANK (RECEPTOR ACTIVATOR OF NFKB (LIGAND)) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2018%HOMO SAPIENS,0.15966666666666698,0.661454203640901,-0.19918369294759103,-1.2285440396866298,478,53,SQSTM1|CTSK|TRAF3|MITF|RELB|LYN|ICAM1|ACP5|CDC42|TNFRSF11A|JUN|GAB2|MAPK3|RAC1|MAP2K1|PIK3R1
STATIN PATHWAY%WIKIPATHWAYS_20181110%WP430%HOMO SAPIENS,0.0109513379678126,0.228061856776328,0.49972729501111,1.7926236871157102,114,18,LPL|DGAT1|SCARB1|PDIA2|SOAT1|CETP|APOE|APOC4-APOC2|ACSS1|APOC1|LDLR|HMGCR|LCAT
MITOCHONDRIAL GENE EXPRESSION%WIKIPATHWAYS_20181110%WP391%HOMO SAPIENS,0.23550138082087396,0.750277765814412,0.337232773920492,1.20972271204071,2472,18,POLRMT|MTERF3|MTERF1|NRF1|TFB1M|MYEF2|ESRRA|SP1|PPRC1|PPP3CA|GABPB1
TUMOR SUPPRESSOR ACTIVITY OF SMARCB1%WIKIPATHWAYS_20181110%WP4204%HOMO SAPIENS,0.15357624831309,0.6507359320251149,0.318205771021073,1.30484359676385,1706,28,CDK6|DPF1|SMARCD3|ACTL6B|CDKN2A|EZH2|RB1|DPF2|H3F3A|SMARCA4|SUZ12|EED|ARID1A|GLI4|SMARCD1|PTCH1|ACTL6A|ARID1B|SMARCD2|SMARCC2|RBBP4|DPF3|SMARCE1
RETINOBLASTOMA GENE IN CANCER%WIKIPATHWAYS_20181110%WP2446%HOMO SAPIENS,0.00094525403702245,0.0849637591935908,0.34474635684138893,1.8699478481869798,11,87,RBBP7|RBP1|CDK6|CCNB1|CDC7|CDK1|POLE|RRM1|DHFR|WEE1|E2F3|POLE2|ORC1|RFC4|KIF4A|RABIF|CDC45|TOP2A|TTK|SMC2|CCNE1|ANLN|HLTF|E2F2|POLD3|RB1|FANCG|MCM6|MSH6|DCK|CCNB2|H2AFZ|STMN1|MCM3|CCNE2|MAPK13|E2F1|TYMS|PRKDC|RRM2|CHEK1|RFC3|RFC5|SMC3|SKP2|CDK2|DNMT1|FAF1|SUV39H1|MDM2|MCM7|CCNA2|CDT1
AMINO ACID CONJUGATION OF BENZOIC ACID%WIKIPATHWAYS_20181110%WP521%HOMO SAPIENS,0.339701285168461,0.8330383695817521,0.5789125399801479,1.10045183918893,2933,3,GLYATL2|GLYATL1|ACSS2
NAD BIOSYNTHESIS II (FROM TRYPTOPHAN)%WIKIPATHWAYS_20181110%WP2485%HOMO SAPIENS,0.6408542246982359,0.96102887115448,-0.27392575431628896,-0.8514805137250391,3450,8,NMNAT1|QPRT|AFMID|NADSYN1|KMO|KYNU|HAAO|TDO2
PRADER-WILLI AND ANGELMAN SYNDROME%WIKIPATHWAYS_20181110%WP3998%HOMO SAPIENS,0.617272809313239,0.9525396007302042,0.21831899211890002,0.887578433046529,6839,27,ATP10A|PWRN1|MAGEL2|NIPA1|MKRN3|HERC2|NDN|E2F1|PCM1|GABRB3|NGF|TUBGCP5|SNRPN|CCND1|BBS4|NIPA2|PRKCZ|FEZ2
G13 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP524%HOMO SAPIENS,0.0831643002028398,0.5433486826752679,-0.245406514678278,-1.3737163315528402,286,38,RTKN|PIK3CD|PIK3R2|RHPN2|CALM3|GNA13|PKN1|CFL2|PFN1|TNK2|RHOA|PIP4K2A|CALM1|LIMK1|CDC42|PPP1CB|RAC1
GLYCOGEN METABOLISM%WIKIPATHWAYS_20181110%WP500%HOMO SAPIENS,0.7765864966676329,0.980802382590629,-0.14218530621487302,-0.7959131708882171,2679,38,PPP2CA|PPP2CB|CALM1|PPP2R1B|HK1|HK2|PYGB
TYPE II INTERFERON SIGNALING (IFNG)%WIKIPATHWAYS_20181110%WP619%HOMO SAPIENS,0.9911000355998578,1.0,0.109776874849604,0.464026063219314,11135,31,CXCL9|PSMB9|JAK2|GBP1|CXCL10|SOCS1|STAT2|STAT1|CIITA|TAP1|IRF9|IRF2|CYBB|IFNGR1|OAS1|IFIT2|JAK1|IRF8|HLA-B|PTPN11
NAD+ BIOSYNTHETIC PATHWAYS%WIKIPATHWAYS_20181110%WP3645%HOMO SAPIENS,0.0273335812569729,0.339785941813865,0.43147159007881297,1.63119258738866,293,21,SIRT4|SIRT1|IDO1|CD38|PARP2|SIRT6|NAPRT|PARP1|BST1|SIRT3|TNKS2|NMNAT1|QPRT|NADSYN1
MATRIX METALLOPROTEINASES%WIKIPATHWAYS_20181110%WP129%HOMO SAPIENS,0.74171270718232,0.974505008828563,-0.179139352886699,-0.799302862171683,3221,20,TIMP3|MMP28|MMP1|MMP2|MMP9|TIMP2|MMP12|TNF
FOLLICLE STIMULATING HORMONE (FSH) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2035%HOMO SAPIENS,0.24631675874769798,0.7585951535148171,-0.261837915724133,-1.1682960337349,1069,20,FOXO1|EIF4EBP1|PRKCA|MAPK3|APPL1
FATTY ACID BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP357%HOMO SAPIENS,0.40351711026616,0.865506967418479,-0.22199705251482602,-1.02845471360104,1697,22,ECH1|SCD|ACSL1|ACSL4|ACAA2|ACLY|ACSL3|PC
ALPHA 6 BETA 4 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP244%HOMO SAPIENS,0.0490062619112442,0.43517035040864105,-0.277926934830134,-1.4865673805838,179,33,PRKCD|GRB2|RHOA|EIF4EBP1|LAMC1|ITGA6|SHC1|PRKCA|MAPK3|RAC1|LAMC2|PIK3R1
SEROTONIN TRANSPORTER ACTIVITY%WIKIPATHWAYS_20181110%WP1455%HOMO SAPIENS,0.29879294336118895,0.8023890191280308,-0.36152021622814295,-1.12376224062705,1608,8,STX1A|IL1R1|MAOA|SCAMP2|ITGB3|TGFB1I1|IL1B|PPP2CB
INTEGRIN-MEDIATED CELL ADHESION%WIKIPATHWAYS_20181110%WP185%HOMO SAPIENS,0.0411817367949866,0.402256981537283,-0.19307835693298803,-1.38518571335054,91,91,ITGB8|CAPNS1|MAPK7|ITGAX|BCAR1|CAPN5|ITGAM|VASP|GRB2|MAPK4|TNS1|FYN|ITGA5|MAP2K5|PXN|ITGA6|CRK|RAP1A|VAV3|VAV2|CDC42|MAP2K3|RAPGEF1|SHC1|ZYX|CAV2|RAC1|MAP2K1|ITGA7|CAV1|PAK2
DUAL HIJACK MODEL OF VIF IN HIV INFECTION%WIKIPATHWAYS_20181110%WP3300%HOMO SAPIENS,0.010213556174559,0.221106802361923,-0.599280312647981,-1.86282414281358,54,8,CUL5|RUNX1|TCEB1|CBFB|UBB
DNA IR-DAMAGE AND CELLULAR RESPONSE VIA ATR%WIKIPATHWAYS_20181110%WP4016%HOMO SAPIENS,0.00595379852345797,0.175567154622165,0.31913874060282,1.69976227228224,74,79,CDK1|FANCA|ATR|EXO1|BRIP1|CDC25C|CLK2|DCLRE1A|CDC45|RAD9A|PARP1|FEN1|POLN|RAD51|H2AFX|CEP164|BRCC3|TOPBP1|FANCD2|PLK1|HERC2|RMI1|FANCI|PALB2|MCM2|BRCA2|CLSPN|E2F1|PRKDC|CHEK1|XPA|RECQL5|RAD17|FOXM1|SP1|RAD1|CDK2|ATM|RFWD3|MDC1|UIMC1|BRCA1|SHFM1|PPM1D|MDM2|RAD52
SEROTONIN RECEPTOR 4/6/7 AND NR3C SIGNALING%WIKIPATHWAYS_20181110%WP734%HOMO SAPIENS,0.0531284302963776,0.44950045432031394,-0.377122441034697,-1.54444314329612,241,16,RAP1A|NR3C1|MAPK3|GNAS|MAP2K1
MIR-222 IN EXERCISE-INDUCED CARDIAC GROWTH%WIKIPATHWAYS_20181110%WP3938%HOMO SAPIENS,0.848135289506104,0.991298302704726,0.332023872466373,0.7035903023290541,7572,4,HMBOX1|HIPK2|CDKN1B|HIPK1
HEDGEHOG SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4249%HOMO SAPIENS,0.25400706329801703,0.764143683066023,-0.21668047500690402,-1.1471260638196399,934,32,ADRBK2|SUFU|GAS1|SPOP|CCND2|SMURF2|CSNK1E|PTCH1|ADRBK1|CCND1|CSNK1G3|CSNK1G2|PRKACB|SMO|SMURF1|KIF3A|FBXL17|CSNK1G1|PTCH2|SPOPL|CUL3|PRKACA|CSNK1D|CSNK1A1|ARRB2|BOC|CDON|EVC|ARRB1|BCL2|GPR161|KIF7
NOTCH1 REGULATION OF HUMAN ENDOTHELIAL CELL CALCIFICATION%WIKIPATHWAYS_20181110%WP3413%HOMO SAPIENS,0.7575380492007281,0.977664504547119,0.22113754437504396,0.766623896080136,7913,16,ITGA1|PLAT|JAG2|MGP
TCA CYCLE (AKA KREBS OR CITRIC ACID CYCLE)%WIKIPATHWAYS_20181110%WP78%HOMO SAPIENS,0.968764879535282,1.0,0.146984671795048,0.527263983643065,10172,18,FH|SUCLG1|DLD|SDHA|ACO2|SUCLA2|SUCLG2|SDHB|IDH3G|CS|MDH2|IDH2
PEPTIDE GPCRS%WIKIPATHWAYS_20181110%WP24%HOMO SAPIENS,0.46080305927342297,0.8905776011935059,0.25085849347377803,0.999635010420208,5060,25,NPY1R|OXTR|CXCR4|NPY2R|AGTR1|CCR5|SSTR2|C3AR1|MC1R|OPRL1|FPR3
EDA SIGNALLING IN HAIR FOLLICLE DEVELOPMENT%WIKIPATHWAYS_20181110%WP3930%HOMO SAPIENS,0.193062114057392,0.7033154110137328,-0.43102415456847,-1.25731658167859,1062,7,RELB|DKK1|WNT3
INTEGRATED BREAST CANCER PATHWAY%WIKIPATHWAYS_20181110%WP1984%HOMO SAPIENS,0.9684911242603549,1.0,0.10714289108536999,0.634334585180272,13093,142,SIRT1|PIAS1|ZMYND8|TPR|NOXA1|XRCC3|ATR|BLM|RAD54L|WEE1|ERAL1|RB1|MSH6|RAD51|NF1|RPP38|STK11|NUP85|SMEK1|CDK7|CHEK2|ALKBH1|PLK1|BAD|CASP9|ARAF|HMGCR|DHTKD1|AURKA|IRS1|BRCA2|IMPA1|SMARCA4|E2F1|MYCBP2|CHEK1|FAU|GSK3A|SP1|CDK2|ATM|TRADD|CHUK|BRCA1|AKT1|CCNB1IP1|TAB1|NCOA3|FER|STAT1|MDM2|USP21
PREGNANE X RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2876%HOMO SAPIENS,0.6103183315038421,0.9508825506493929,-0.215168559876693,-0.8811875687978059,2779,16,FOXO1|RXRA|NRIP1|PPARGC1A|ABCC4
THE HUMAN IMMUNE RESPONSE TO TUBERCULOSIS%WIKIPATHWAYS_20181110%WP4197%HOMO SAPIENS,0.889660922734853,0.997300970905927,0.17081307485225,0.654174453316412,9602,22,PIAS1|JAK2|SOCS1|STAT2|TYK2|STAT1|TAP1|IFIT1|IRF9|IFNGR1|PTPN2|OAS1|IFI35|PSMB8|IFIT3|JAK1
INTERFERON TYPE I SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP585%HOMO SAPIENS,0.00539447066756575,0.168880583602186,-0.28079828943810997,-1.7417341579544199,15,54,PIK3CD|PIK3R2|EIF4E|SOCS3|CRKL|PTPN6|MAPKAP1|EIF4A1|IFNAR2|VAV1|FYN|IFNAR1|EIF4EBP1|REL|CRK|RAP1A|MAP2K3|EIF4B|PDCD4|STAT5A|RAPGEF1|STAT3|GAB2|RAC1|PIK3R1
BLADDER CANCER%WIKIPATHWAYS_20181110%WP2828%HOMO SAPIENS,0.111702127659574,0.5859673538708311,-0.240348524115059,-1.32213127792,398,36,PIK3R2|RASSF1|MMP1|VEGFA|NRAS|MMP2|HBEGF|MMP9|CXCL8|KRAS|TP53|CDKN1A|MAP2K1|PIK3R1
ACETYLCHOLINE SYNTHESIS%WIKIPATHWAYS_20181110%WP528%HOMO SAPIENS,0.7745535714285708,0.9803119370598828,-0.298403715148753,-0.7553891898731371,4510,5,PEMT|ACHE|PCYT1A
PREIMPLANTATION EMBRYO%WIKIPATHWAYS_20181110%WP3527%HOMO SAPIENS,0.326226583407672,0.826621597878865,0.26571670159981303,1.11413185954607,3656,30,SIX3|TBX3|ZFP36|H2AFY2|E2F5|ELAVL1|MYBL1|KHSRP|TFAP2B|ESRRA|SMARCA4|EGR1|GATA3
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP1449%HOMO SAPIENS,0.334721499219157,0.8307288005518471,-0.140546372679833,-1.06168947648919,642,111,PIK3CD|TLR1|CD86|PIK3R2|PIK3R5|PTPN6|OTUD5|IL1B|IRAK1|NFKBIA|MAP3K8|IRAK2|TNFAIP3|SQSTM1|IFNAR2|IRAK4|TRAF3|SMAD6|IFNAR1|IL6|CYLD|RNF216|TMED7|RNF31|MAP2K3|CXCL8|JUN|PELI2|RBCK1|MAPK3|PELI1|RAC1|TICAM1|MYD88|MAP2K1|PIK3R1|TNF
OVERVIEW OF NANOPARTICLE EFFECTS%WIKIPATHWAYS_20181110%WP3287%HOMO SAPIENS,0.425795053003534,0.875696962448429,-0.238770320595753,-1.00471804634275,1927,17,PIK3CD|BAX|HMOX1|PTGS1|IL6|CXCL8|BCL2|TNF
TGF-BETA RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP560%HOMO SAPIENS,0.108268330733229,0.58452352834625,-0.22202991816296896,-1.31304532896352,346,46,CTNNB1|SKI|TGFBR1|LIF|SMAD6|ZNF423|SMAD1|TFE3|SMAD2|SMAD7|JUN|STAT3|MAPK3|TNF|FKBP1A
KIT RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP304%HOMO SAPIENS,0.0169844020797227,0.27739515073203896,-0.24963690033659,-1.5734472051548303,48,57,SNAI2|PIK3R2|CRKL|SOCS6|PTPN6|MATK|DOK1|GRB2|VAV1|FYN|MITF|KITLG|LYN|SNAI1|CRK|STAT5A|BCL2|SHC1|PRKCA|STAT3|GAB2|MAPK3|MAP2K1|PIK3R1|FOXO3
DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP707%HOMO SAPIENS,0.22898527138091002,0.7431364059061821,0.232966697738447,1.18926473067456,2813,65,CDK6|CCNB1|PIDD1|CDK1|APAF1|ATR|CDC25C|DDB2|RAD9A|CCNE1|RB1|RAD51|FAS|GADD45B|H2AFX|CCNB2|GADD45G|CHEK2|FANCD2|CASP9|CCNE2|E2F1|PRKDC|CHEK1|RAD17|RAD1|CDK2|ATM|CCND2|BRCA1|MDM2|RAD52|TLK2|CYCS
SIGNAL TRANSDUCTION OF S1P RECEPTOR%WIKIPATHWAYS_20181110%WP26%HOMO SAPIENS,0.827369571155422,0.9876441563834109,0.17994206465933302,0.717043242945125,9086,25,PLCB3|GNAI1|MAPK12|S1PR5|ASAH1|RACGAP1|AKT3|AKT2
MYOMETRIAL RELAXATION AND CONTRACTION PATHWAYS%WIKIPATHWAYS_20181110%WP289%HOMO SAPIENS,0.00193174500965873,0.112582730005196,-0.20832873436842397,-1.6427938241500601,2,136,CREB3|PRKCH|IL1B|ADCY7|GNG4|IGFBP4|PRKCD|LPAR1|ARRB2|RGS5|RGS4|CRHR1|GNAQ|GUCY1A3|IGFBP3|YWHAH|IL6|ARRB1|MAFF|CAMK2A|PRKAR2A|CALM1|YWHAQ|YWHAB|PLCD1|CRH|RAMP2|PDE4B|RYR1|GNB5|GNGT1|JUN|PRKCA|ATF5|ACKR3|YWHAZ|PRKAR1B|PKIG|ADCY2|YWHAE|NOS3|GNAS|MYL4|ADM|ETS2|PDE4D|CRCP|RAMP1
FTO OBESITY VARIANT MECHANISM%WIKIPATHWAYS_20181110%WP3407%HOMO SAPIENS,0.642342032967033,0.9620807249753851,-0.33517982992890505,-0.8484854823794559,3740,5,ARID5B|PPARGC1A
BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2380%HOMO SAPIENS,0.0160875160875161,0.269661289398132,-0.18152739595032996,-1.43647400479447,24,137,EIF2S1|NFKBIA|MAPK7|PRKCD|SIRPA|CTNNB1|PTK2B|PRKAA1|SQSTM1|DPYSL2|GRB2|SYN1|FYN|CASP3|EIF4EBP1|MAP2K5|DOCK3|CAMK2A|PPP2CA|YBX1|RAP1A|CAMK4|VAV3|VAV2|CDC42|ADAM17|STAT5A|SHC1|JUN|STAT3|MAPK3|KCNA3|RAC1|MAP2K1|DOK5|CSNK2A1|PIK3R1|DLG1|BCL2L11|LINGO1|FOXO3
CALORIC RESTRICTION AND AGING%WIKIPATHWAYS_20181110%WP4191%HOMO SAPIENS,0.23955431754874698,0.7525035503527309,-0.38500671598808506,-1.19676850807756,1289,8,NAMPT|IGF1|PPARGC1A|TP53
PDGF PATHWAY%WIKIPATHWAYS_20181110%WP2526%HOMO SAPIENS,0.064042303172738,0.49514893278583205,-0.250371331491873,-1.41265942431665,217,39,VAV2|CDC42|SHC1|JUN|STAT3|MAPK3|RAC1|MAP2K1|PIK3R1
NUCLEOTIDE METABOLISM%WIKIPATHWAYS_20181110%WP404%HOMO SAPIENS,0.33642384105960305,0.8311444145897029,0.30281627112726894,1.1068398019306,3555,19,POLG|IMPDH1|RRM1|DHFR|POLD1
HUMAN THYROID STIMULATING HORMONE (TSH) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2032%HOMO SAPIENS,0.0627737226277372,0.48922146844139097,-0.211334240047242,-1.3683939045942601,171,63,PAX8|RAP1A|TTF2|MAP2K3|JUN|STAT3|ADCY2|MAPK3|GNA12|GNAS|PLCB1|MAP2K1|PIK3R1|PDE4D
FOCAL ADHESION-PI3K-AKT-MTOR-SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3932%HOMO SAPIENS,0.0455172413793104,0.4190278528102411,-0.144881784663942,-1.27474528072574,32,257,LPAR1|IGF1R|ITGAX|PRKAA1|NRAS|DDIT4|PFKFB4|IFNAR2|SLC2A3|GRB2|CRTC2|PPP2R5C|FGF7|IL3RA|ITGA5|IFNAR1|FOXO1|EIF4EBP1|FGF2|HGF|KITLG|LAMC1|ITGA6|EFNA1|COL5A3|TCL1A|CDC37|PIK3IP1|PPP2CA|PPP2CB|IGF1|EIF4E2|CAB39|RAB8A|PPP2R1B|FGFR1|EIF4B|GNGT1|PPARGC1A|COMP|LAMA4|KRAS|RELN|NOS3|MAPK3|FGF14|FLT1|CDKN1A|RAB2A|SLC2A1|FGF10|VWF|THBS4|MET|CHRM1|LAMC2|MAP2K1|PGF|PIK3R1|HSP90AB1|EPAS1|ITGA7|TBC1D1|ANGPT2|FOXO3|CREB5
VITAMIN A AND CAROTENOID METABOLISM%WIKIPATHWAYS_20181110%WP716%HOMO SAPIENS,0.0100127434917167,0.21951586544159402,0.441494223605555,1.7750182518763797,109,26,ALDH1A2|RBP1|LPL|BCO2|RARB|ALDH1A1|DGAT1|RBP7|SCARB1
HIF1A AND PPARG REGULATION OF GLYCOLYSIS%WIKIPATHWAYS_20181110%WP2456%HOMO SAPIENS,0.004177261169633129,0.152378022533688,-0.6852042799161979,-1.9987712842643401,22,7,HIF1A|LDHA|PPARG|GAPDH|TPI1|SLC2A1
VIRAL ACUTE MYOCARDITIS%WIKIPATHWAYS_20181110%WP4298%HOMO SAPIENS,0.11008154188287599,0.584830174998513,-0.19246038190189102,-1.28089862786723,296,68,ABL1|FYN|CASP3|EIF4G1|DFFA|IL6|MMP9|BCL2L1|BID|CHRAC1|BCL2|STAT3|BNIP2|MAPK3|PABPC1|TICAM1|PIK3R1|TNF|CAV1
CARDIAC PROGENITOR DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2406%HOMO SAPIENS,0.155337227827934,0.6555911901270179,-0.24017402036442398,-1.2629634161756,584,31,FGF2|TNNT2|IGF1|TBX20|DKK1|ANPEP|IGF2|SCN5A|SOX17
POLYOL PATHWAY%WIKIPATHWAYS_20181110%WP690%HOMO SAPIENS,0.43591524835012196,0.878651088001772,0.5403311078504579,1.02711259532471,3764,3,AKR1B1
VITAMINS A AND D - ACTION MECHANISMS%WIKIPATHWAYS_20181110%WP4342%HOMO SAPIENS,0.113140311804009,0.588848744118853,-0.7965811965811971,-1.36250947459214,761,2,RARA|RXRA
MIR34A AND TGIF2 IN OSTEOCLASTOGENESIS%WIKIPATHWAYS_20181110%WP2866%HOMO SAPIENS,0.9777571825764599,1.0,-0.510476400529334,-0.682879845283062,7384,1,TGIF2
PATHOGENIC ESCHERICHIA COLI INFECTION%WIKIPATHWAYS_20181110%WP2272%HOMO SAPIENS,0.0089086859688196,0.207969158127386,-0.292567906117949,-1.75874818745424,27,48,CTNNB1|TUBB2B|ABL1|TUBB2A|FYN|RHOA|TUBB6|TUBA1C|TUBB3|TUBA3C|ARPC5|YWHAQ|ARPC5L|ARHGEF2|ARPC4|CDC42|PRKCA|YWHAZ|TUBB4B
LNCRNA INVOLVEMENT IN CANONICAL WNT SIGNALING AND COLORECTAL CANCER%WIKIPATHWAYS_20181110%WP4258%HOMO SAPIENS,0.906727828746177,1.0,0.13054110857165302,0.681603640311362,11266,72,WNT4|WNT5B|CDK6|CDK8|NOTUM|PORCN|DVL1|MAP3K7|EZH2|NKD2|H2AFY2|APC|FRAT2|NLK|LEF1|RYK|H19|APC2|FZD6|ATF3|WNT2B|CXXC4|FZD3|DVL3
MIRS IN MUSCLE CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2012%HOMO SAPIENS,0.8912780864943219,0.997300970905927,-0.14514724928293,-0.6820347867247911,3688,23,PRKCE|PRKCI|PRKAR1A|PRKACA|ID2|PRKCH|PRKCD|MEF2D|PRKAR2A|PRKCA|PRKAR1B
FATTY ACID BETA OXIDATION%WIKIPATHWAYS_20181110%WP143%HOMO SAPIENS,0.44469223907225697,0.881876203002712,0.24173150368276602,1.0135635738643198,4984,30,LPL|ACADVL|ACADM|DECR1|CHKB|HADH|CPT1B|PNPLA2|LIPE|DLD
H19 ACTION RB-E2F1 SIGNALING AND CDK-BETA-CATENIN ACTIVITY%WIKIPATHWAYS_20181110%WP3969%HOMO SAPIENS,0.814168778015981,0.986276922067025,0.215715228801948,0.714731588022307,8354,14,CDK8|RB1|MED1|H19|E2F1|JAG1|CCND1
HYPOXIA-MEDIATED EMT AND STEMNESS%WIKIPATHWAYS_20181110%WP2943%HOMO SAPIENS,0.994072819644369,1.0,0.30978355419855697,0.50633270908548,8217,2,DICER1|ZEB1
METASTATIC BRAIN TUMOR%WIKIPATHWAYS_20181110%WP2249%HOMO SAPIENS,0.10388666908826699,0.5762893149145369,-0.48476900225329794,-1.41409268681724,571,7,MIRLET7BHG|CDC42|TP53|PIK3R1
CYTOPLASMIC RIBOSOMAL PROTEINS%WIKIPATHWAYS_20181110%WP477%HOMO SAPIENS,0.403120936280884,0.865238688875249,-0.14548476454293602,-1.03342193697548,929,87,RPL23A|RPS6KA6|RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPL36|RPS6KB2|RPS15|RPS10|RPL28|RPS3A|MRPL19|FAU|RPL37|RPS6KB1|RPL27A|RPL7A|RPL19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|RPL39|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|RPS6KA1|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|RPS6KA3|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|RPL15|RPL8|RPL35A|UBA52|RPS6KA2
LIPID METABOLISM PATHWAY%WIKIPATHWAYS_20181110%WP3965%HOMO SAPIENS,0.550578166256943,0.931561607210996,0.23405721905640803,0.932684348735574,6046,25,PRKAA2|PRKAR2B|PNPLA2|BCKDHA|LIPE|PDHA1|ACACA|AKT3|PRKAB2|AKT2
SPLICING FACTOR NOVA REGULATED SYNAPTIC PROTEINS%WIKIPATHWAYS_20181110%WP4148%HOMO SAPIENS,0.28176122520013896,0.7899371443259041,0.25914923872135104,1.1522040497118,3237,37,GPHN|ATP2B1|CDH2|GRIK2|NEO1|GRIN1|CASK|STX2|ANK3|STXBP2|EPB41|MAPK9|EFNA5|RAP1GAP|KCNMA1|AGRN
TRYPTOPHAN METABOLISM%WIKIPATHWAYS_20181110%WP465%HOMO SAPIENS,0.066749733001068,0.4999739159795061,0.34502059162353704,1.45839956803294,749,31,ALDH1A2|IDO1|ALDH1A1|INMT|DHCR24|DDC|ALDH3A2|HADH|CYP7B1|PRMT1|ALDH9A1|CAT|CYP2E1|AFMID|ECHS1|AADAT|MDM2|UBR5|HSD17B10
EXTRACELLULAR VESICLES IN THE CROSSTALK OF CARDIAC CELLS%WIKIPATHWAYS_20181110%WP4300%HOMO SAPIENS,0.11441901799600099,0.5914149054406279,-0.31475108015221503,-1.35398921588072,514,18,HSPB1|SOD1|KDR|IL6|MMP9|IGF1|STAT3|ETS2
GABA RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP4159%HOMO SAPIENS,0.125220848056537,0.607607158836689,-0.31771465684616806,-1.3369067333178999,566,17,GABRP|AP2S1|GABRQ|GABRG2|GABRA3|GABRD
GLOBO SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1424%HOMO SAPIENS,0.49001097694840795,0.908938677284213,-0.23521346019129802,-0.9632781724861129,2231,16,ST3GAL2|GALNT2|ST6GALNAC5|A4GALT
PHOSPHODIESTERASES IN NEURONAL FUNCTION%WIKIPATHWAYS_20181110%WP4222%HOMO SAPIENS,0.12380952380952401,0.607607158836689,-0.22691890986757698,-1.30042636929502,415,41,CHRFAM7A|GRIN2C|ADCY7|PDE7B|GUCY1A3|PDE8A|PDE6B|CHRNA7|PDE4B|PDE12|PDE9A|ADCY2|DRD2|PDE10A|PDE3A|PDE4D
SOMATROPH AXIS (GH) AND ITS RELATIONSHIP TO DIETARY RESTRICTION AND AGING%WIKIPATHWAYS_20181110%WP4186%HOMO SAPIENS,0.6439003436426121,0.96242180424777,0.347630720067415,0.8549471284688771,5995,6,SIRT1|AKT1|MTOR
HFE EFFECT ON HEPCIDIN PRODUCTION%WIKIPATHWAYS_20181110%WP3924%HOMO SAPIENS,0.186563477688128,0.6929082202271999,-0.55063822961616,-1.2663528957616599,1132,4,SMAD7|ID1
DICLOFENAC METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2491%HOMO SAPIENS,0.0522147651006711,0.446196452441803,0.973753859726511,1.29358856040709,388,1,CYP2C8
GPR40 PATHWAY%WIKIPATHWAYS_20181110%WP3958%HOMO SAPIENS,0.923658872077029,1.0,0.190177737511907,0.5995081917331141,9400,12,PLCB3
LUNG FIBROSIS%WIKIPATHWAYS_20181110%WP3624%HOMO SAPIENS,0.34071762870514805,0.8344609063865659,-0.18306337008617302,-1.0826041147280798,1091,46,HMOX1|ATP11A|FGF7|MMP2|PLAU|FGF2|HGF|IL6|MMP9|IGF1|SMAD7|SERPINA1|CXCL8|GREM1|TNF
TARGET OF RAPAMYCIN (TOR) SIGNALING%WIKIPATHWAYS_20181110%WP1471%HOMO SAPIENS,0.145308607805148,0.636418541205714,-0.23684406918096101,-1.27443113552589,524,34,MAPKAP1|RRAGD|PRKAA1|DDIT4|PRKAG1|RRAGC|EIF4EBP1|PRR5|CDC42|PRKCA|RAC1|FKBP1A
REGULATION OF APOPTOSIS BY PARATHYROID HORMONE-RELATED PROTEIN%WIKIPATHWAYS_20181110%WP3872%HOMO SAPIENS,0.0664296822928238,0.49812594405445004,-0.342252773985793,-1.4722953924667002,298,18,GSK3B|BCL2L13|BCL2A1|PTHLH|BAX|ITGA6|BCL2L1|BOK|BID|BCL2
BUTYRATE-INDUCED HISTONE ACETYLATION%WIKIPATHWAYS_20181110%WP2366%HOMO SAPIENS,0.602821083890126,0.9508825506493929,-0.520186229693041,-0.889750686497512,4059,2,ACLY
MRNA PROCESSING%WIKIPATHWAYS_20181110%WP411%HOMO SAPIENS,0.9994745533703651,1.0,0.073519637191616,0.42639674408390404,13314,125,SUGP2|SFSWAP|CELF1|DDX20|DHX9|PRPF8|CLK4|CLK2|LSM7|SUGP1|CPSF1|SRSF1|METTL3|SRPK1|PAPOLA|SRSF6|SRSF2|PRMT1|SFPQ|HNRNPH1|HNRNPA2B1|PABPN1|SPOP|DICER1|RBM5|SF3B1|NONO|SNRPD1|CLK1|CPSF2|SNRNP40|PRPF4B|PRPF3|CSTF3|RBMX|U2AF2|SNRNP70|CLK3|RBM17|SRSF9|SRSF5|HNRNPK|PTBP2|SRSF4|SNRPE|SNRPN|CPSF4|SRSF10
TFS REGULATE MIRNAS RELATED TO CARDIAC HYPERTROPHY%WIKIPATHWAYS_20181110%WP1559%HOMO SAPIENS,0.7248456229567741,0.972554563883587,-0.272090457804744,-0.7936999369720409,3990,7,AKT2|MYEF2|AKT1|NFKB1|TGFB1|PPP3R1|STAT3
CELL DIFFERENTIATION - INDEX%WIKIPATHWAYS_20181110%WP2029%HOMO SAPIENS,0.9408623816240179,1.0,0.19558123264225,0.5772107462359871,9338,10,LEFTY1|TLX3|SRF|MEF2B|MEF2A|MEF2C|TLX2
HYPOTHETICAL CRANIOFACIAL DEVELOPMENT PATHWAY%WIKIPATHWAYS_20181110%WP3655%HOMO SAPIENS,0.114605631483616,0.5918253392579251,-0.6050745309723101,-1.3915450167391101,695,4,IRF6|RHOA|ARHGAP29
P38 MAPK SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP400%HOMO SAPIENS,0.7088004236914108,0.9695170059473192,0.189497126705864,0.8168318795118041,8029,33,MAP2K6|PLA2G4A|MAP3K9|TGFB2|MAP3K5|MAP3K7|HRAS|RIPK1|MAP3K1|TRAF2|TRADD|MAPKAPK5|STAT1|ELK1|HMGN1|MAPK14|MKNK1
ARIPIPRAZOLE METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2640%HOMO SAPIENS,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
HAIR FOLLICLE DEVELOPMENT: CYTODIFFERENTIATION (PART 3 OF 3)%WIKIPATHWAYS_20181110%WP2840%HOMO SAPIENS,0.08908685968819599,0.5575840828783879,-0.222506271968807,-1.33757836843722,279,48,KITLG|SMAD1|IGF1|SPINK5|TCF4|ADAM17|NR3C1|JUN|GPRC5D|DKK1|S100A4|LRIG1|RBPJ
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA PATHWAY%WIKIPATHWAYS_20181110%WP4206%HOMO SAPIENS,0.285424187725632,0.794258537514783,-0.25571004419243104,-1.12140955093012,1264,19,HIF1A|LDHA|VEGFA|PRKAA1|PRKAG1|PDHB|TP53|SLC2A1
INSULIN SIGNALLING IN HUMAN ADIPOCYTES (NORMAL CONDITION)%WIKIPATHWAYS_20181110%WP3634%HOMO SAPIENS,0.305075821398484,0.808356844223606,0.439779060248155,1.14465249619404,2896,7,TBC1D4|IRS1|AKT2|RPS6KB1|MTOR|RPS6
ANDROGEN RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP138%HOMO SAPIENS,0.16339590443686,0.665440683774265,-0.17299038711961298,-1.2090835821711001,382,83,RHOA|STUB1|UBE2I|FOXO1|SUMO1|CDC42|DSTN|JUN|STAT3|PRDX1|CDKN1A|BMF|FKBP4|RNF4|RAC1|BAG1|PIK3R1|CAV1
TYPE 2 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4241%HOMO SAPIENS,0.0785112741102961,0.532203813468543,-0.266967589592765,-1.4133506039582397,288,32,CREBBP|SETD2|HIF1A|VEGFA|CTSK|PRCC|TFE3|VHL|TCEB1|COL21A1|TFEB|CDKN1A|SLC2A1|EPAS1|EGLN3
INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS%WIKIPATHWAYS_20181110%WP4301%HOMO SAPIENS,0.0677627193956898,0.50364937614461,-0.340862274179865,-1.46631377124081,304,18,RAB5C|KRAS|MAPK3|RAB5A|RRAS2
EV RELEASE FROM CARDIAC CELLS AND THEIR FUNCTIONAL EFFECTS%WIKIPATHWAYS_20181110%WP3297%HOMO SAPIENS,0.629766833732839,0.956994256986843,0.3779435367913979,0.87110382538681,5779,5,RGS16
IL-5 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP127%HOMO SAPIENS,0.00341880341880342,0.140842794574138,-0.342892210263092,-1.90475127677481,11,37,LYN|CSF2RB|KRAS|STAT5A|BCL2|SHC1|JUN|STAT3|MAPK3|MAP2K1|PIK3R1|FOXO3
FAS LIGAND (FASL) PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS (HSP) REGULATION%WIKIPATHWAYS_20181110%WP314%HOMO SAPIENS,0.7566821865838941,0.977664504547119,0.174697750515577,0.787931934972334,8775,39,DFFB|APAF1|CASP6|MAP3K7|PARP1|RB1|LMNB1|FAS|LMNB2|SPTAN1|ACTG1|CASP9|MAP3K1
WNT/BETA-CATENIN SIGNALING PATHWAY IN LEUKEMIA%WIKIPATHWAYS_20181110%WP3658%HOMO SAPIENS,0.911814447934284,1.0,-0.140814225182316,-0.661674268816697,3773,23,GSK3B|TCF3|SALL4|AXIN2|CSNK1A1|ZBTB16|LRP5|PPARD|RARA|CTNNB1|PML|DKK1
PHOTODYNAMIC THERAPY-INDUCED UNFOLDED PROTEIN RESPONSE%WIKIPATHWAYS_20181110%WP3613%HOMO SAPIENS,0.0375715352077631,0.38859310205237607,-0.322801119236254,-1.5659958396370801,150,25,EDEM1|EIF2A|CALR|ATF4|DNAJC3|WARS|HSPA5|EIF2AK3|BBC3|NARS|DDIT3|ATF6|UBE2E1|BCL2L11|TRIB3
NCRNAS INVOLVED IN STAT3 SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP4337%HOMO SAPIENS,0.294044407553434,0.8004058897916541,-0.29809683763419503,-1.12262699259682,1416,13,IL6ST|RELA|IL6R|ZEB1|IL11|IL6|STAT3
IRINOTECAN PATHWAY%WIKIPATHWAYS_20181110%WP229%HOMO SAPIENS,0.5065506872852229,0.9172434440873181,0.391245930345665,0.962212386204802,4716,6,CYP3A5|BCHE
INITIATION OF TRANSCRIPTION AND TRANSLATION ELONGATION AT THE HIV-1 LTR%WIKIPATHWAYS_20181110%WP3414%HOMO SAPIENS,0.136218799787573,0.6237835799077729,-0.24652303417451396,-1.29634992550234,512,31,RELA|NFATC3|CREBBP|HEXIM1|NELFCD|CDK9|NFKBIA|PPP3R1|HDAC4|HDAC5|NELFA|SUPT4H1|NELFE|NFATC2
WNT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP428%HOMO SAPIENS,0.142224191404519,0.6324244126031129,-0.170785974619851,-1.22549591197483,320,90,FRAT1|PPP3R1|CTNNB1|PRICKLE1|CTBP1|RHOA|TCF7L2|FOSL1|PLAU|CSNK2A2|CAMK2A|WNT6|WNT11|SERPINF1|JUN|TCF7|PRKCA|NFATC2|DKK1|WNT3|SFRP2|RAC1|PLCB4|PLCB1|CSNK2A1|SOX17
GLUCURONIDATION%WIKIPATHWAYS_20181110%WP698%HOMO SAPIENS,0.500726480203415,0.9144253281295329,-0.32567235943591305,-0.950000721242909,2756,7,HK1|UGDH
FIBRIN COMPLEMENT RECEPTOR 3 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4136%HOMO SAPIENS,0.22995780590717302,0.743397546142977,-0.22593639485530603,-1.1721652571574799,871,30,IRAK1|TYROBP|IRAK2|ITGAM|IRAK4|RHOA|IL6|TICAM1|MYD88|TNF
PHYTOCHEMICAL ACTIVITY ON NRF2 TRANSCRIPTIONAL ACTIVATION%WIKIPATHWAYS_20181110%WP3%HOMO SAPIENS,0.13114754098360698,0.6149266898174119,-0.35510118584308104,-1.33730427834922,631,13,GCLC|HMOX1|AIMP2|NQO1|PRKCA|EPHB2
PYRIMIDINE METABOLISM%WIKIPATHWAYS_20181110%WP4022%HOMO SAPIENS,0.441346534653465,0.880402968441571,0.190883348974034,1.0195315606528599,5571,80,NME3|NME4|POLE|RRM1|POLR3B|NME7|POLE2|TK1|CAD|POLR2B|POLD1|POLR3GL|DTYMK|POLD3|CTPS2|POLA2|UCKL1|DUT|DCK|POLR3E|POLR2L|POLR3G|UMPS|POLR2J|UCK1|ZNRD1|POLR2J3|PRIM2|TYMS|RRM2|POLR2G|POLR2H
DEREGULATION OF RAB AND RAB EFFECTOR GENES IN BLADDER CANCER%WIKIPATHWAYS_20181110%WP2291%HOMO SAPIENS,0.7040879850591409,0.968941691852291,-0.21667402339439398,-0.815990230515612,3392,13,UNC13D|RAB27B|SYTL2|MADD|SYTL1|SYTL4|RAB27A|RPH3AL|TBC1D10A|RPH3A|GCC2|MYRIP|SYTL3
SULFATION BIOTRANSFORMATION REACTION%WIKIPATHWAYS_20181110%WP692%HOMO SAPIENS,0.24507486209613896,0.757467559003634,-0.34946769998854305,-1.1823015373811498,1243,10,PAPSS1|SULT1A1|G6PD|GSR|SULT4A1
CARDIAC HYPERTROPHIC RESPONSE%WIKIPATHWAYS_20181110%WP2795%HOMO SAPIENS,0.0600134861766689,0.477140347850127,-0.22490226918312803,-1.3950226164894501,177,54,CDK9|MAPK7|TGFBR1|HDAC4|HDAC5|FGF2|MAP2K5|IGF1|CALM1|PLA2G2A|MAP2K3|PRKCA|NFATC2|GUCA1A|MAPK3|RAC1|MAP2K1|TNF
SPINAL CORD INJURY%WIKIPATHWAYS_20181110%WP2431%HOMO SAPIENS,0.000907852927825692,0.0849637591935908,-0.249474534912611,-1.7929612738543599,1,92,RHOA|LILRA6|CASP3|VIM|CHST11|IL6|MMP9|MBP|ICAM1|RHOC|PLA2G2A|CDC42|GADD45A|LGALS3|CXCL8|MMP12|PRKCA|CSPG4|TP53|MAPK3|NCAN|RAC1|ACAN|PTPRA|AQP1|TNF|FKBP1A|SLIT3|FOXO3
ROLE OF OSX AND MIRNAS IN TOOTH DEVELOPMENT%WIKIPATHWAYS_20181110%WP3971%HOMO SAPIENS,0.138617727450215,0.626567367071584,-0.4135591350397179,-1.33500594783094,709,9,NOTCH2|KLF4|ALPL|BMP7|NOTCH3|NOTCH4|NOTCH1|CTNNB1|DKK1
HEPATITIS C AND HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP3646%HOMO SAPIENS,0.036817472698908,0.386113929236656,-0.253703953325633,-1.50035992270775,117,46,CD44|IL6R|HIF1A|MMP1|VEGFA|TGFBR1|GRB2|CASP3|IL6|PODXL|BCL2L1|VAV2|CXCL8|JUN|STAT3|TP53|UCHL1|MAPK3|CDKN1A|RAC1
ETHANOL EFFECTS ON HISTONE MODIFICATIONS%WIKIPATHWAYS_20181110%WP3996%HOMO SAPIENS,0.0531713900134953,0.44950045432031394,0.36767670332785496,1.50770550287984,590,28,ALDH1A2|HDAC10|ALDH1A1|DHFR|ADH1B|MTR|HDAC8|HDAC3|HDAC6|EHMT2|TYMS|CYP2E1|SLC19A1|MTHFR|KAT2B|ACSS2|HDAC9|HDAC7|HDAC2
REGULATION OF MICROTUBULE CYTOSKELETON%WIKIPATHWAYS_20181110%WP2038%HOMO SAPIENS,0.0748236737197179,0.524399009933241,-0.23884911207755102,-1.3807893036120802,243,43,CFL2|DPYSL2|ABL1|TRIO|GNAQ|TESK2|CAMK4|LIMK1|CDC42|PRKCA|STAT3|RAC1|PTPRA|EPHB2
ZINC HOMEOSTASIS%WIKIPATHWAYS_20181110%WP3529%HOMO SAPIENS,0.532533164876816,0.9265056012720759,0.233651602116603,0.9499133395253191,5900,27,SLC39A3|MT1F|SLC30A5|MT1E|SLC39A7|MT1L|SLC39A13|SLC39A9|MT2A|SLC39A10|SLC30A7
GLUTATHIONE METABOLISM%WIKIPATHWAYS_20181110%WP100%HOMO SAPIENS,0.40965971459934103,0.867015886388254,-0.247775143474235,-1.0147224873918,1865,16,GSS|G6PD|GSR|GSTT2|GSTM1|ANPEP
VITAMIN B12 DISORDERS%WIKIPATHWAYS_20181110%WP4271%HOMO SAPIENS,0.428543537680594,0.8770525861997421,-0.311314051248748,-1.00494965495203,2194,9,TCN2|MMACHC|MTRR|MMAA
CANNABINOID RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3869%HOMO SAPIENS,0.188898094449047,0.69611511841804,0.32400565519043395,1.2601238563285,2051,23,MAPK11|MAPK12|NAPEPLD|CNR1|MAPK10|PRKAR2B|ADORA2A|FAAH|MAPK13|MAPK9|ADCY1|DAGLA
OXIDATIVE PHOSPHORYLATION%WIKIPATHWAYS_20181110%WP623%HOMO SAPIENS,0.9368066398225,1.0,0.126138008361072,0.6307588850786179,11399,59,NDUFA7|NDUFS7|NDUFA4|ATP5G1|NDUFS2|ATP5D|NDUFC1|NDUFS4|NDUFA11
MAPK CASCADE%WIKIPATHWAYS_20181110%WP422%HOMO SAPIENS,0.571044374719857,0.9404752161333092,0.221862890269927,0.919030802285272,6369,29,PLCB3|MAP2K6|MAPK12|MAP2K2|MAPK10|HRAS|SIPA1|MAP2K7|ARAF|MAP3K1|MAP3K12
NON-HOMOLOGOUS END JOINING%WIKIPATHWAYS_20181110%WP438%HOMO SAPIENS,0.9104613149291679,1.0,-0.22013237727523396,-0.642135910897105,5012,7,XRCC4|PRKDC|RAD50|NHEJ1|XRCC5|XRCC6|MRE11A
ARYL HYDROCARBON RECEPTOR%WIKIPATHWAYS_20181110%WP2586%HOMO SAPIENS,0.0208578143360752,0.30380498084409996,-0.28918564045592,-1.6316597348940602,70,39,HSP90AA1|CYP1B1|PLAGL1|RELA|CDKN1B|GCLC|AHR|VEGFA|NRAS|RET|NCOA7|AIP|CDC37|NQO1|NRIP1|KLF6|KRAS|CDKN1A|MAP2K1|CD36|TNF
TRANS-SULFURATION AND ONE CARBON METABOLISM%WIKIPATHWAYS_20181110%WP2525%HOMO SAPIENS,0.584615384615385,0.9439064862850342,0.22171643329276397,0.9091766857371759,6497,28,CTH|MAT2A|DHFR|MTHFD1|DNMT3B|MTR|PSAT1|PHGDH|AHCYL2|TYMS|MTHFD2L
FOLATE METABOLISM%WIKIPATHWAYS_20181110%WP176%HOMO SAPIENS,0.636657040937659,0.959271399361425,0.18788629160130702,0.8763675857821909,7495,44,CTH|PLAT|INS|HBB|DHFR|SCARB1|MTHFD1|MTR|RFK|HBA1|SLC46A1|CCL2
COMPLEMENT AND COAGULATION CASCADES%WIKIPATHWAYS_20181110%WP558%HOMO SAPIENS,0.6448202959830871,0.9625632908696992,-0.15336478696941103,-0.8830855260922441,2134,42,SERPINF2|PLAUR|CFD|SERPINA1|THBD|PROC|VWF|BDKRB1
"GPCRS, CLASS B SECRETIN-LIKE%WIKIPATHWAYS_20181110%WP334%HOMO SAPIENS",0.19900394272670702,0.711592141628341,-0.32692183583188106,-1.2311813848376,958,13,CRHR1|CALCRL|ADCYAP1R1|GCGR|VIPR1|GIPR
TYPE III INTERFERON SIGNALING%WIKIPATHWAYS_20181110%WP2113%HOMO SAPIENS,0.345935130581297,0.8421727240261659,0.42454495311638196,1.10500131601772,3284,7,STAT2|TYK2|STAT1|IFNLR1|IRF9|JAK1|IL10RB
STEROID BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP496%HOMO SAPIENS,0.273938850935155,0.7884684708511421,0.547510064523245,1.16022612761112,2445,4,HSD17B4|HSD17B7|HSD17B3|HSD17B1
WNT SIGNALING IN KIDNEY DISEASE%WIKIPATHWAYS_20181110%WP4150%HOMO SAPIENS,0.650095602294455,0.963755998259649,0.21531769494776604,0.858010040849043,7139,25,WNT4|WNT5B|DVL1|MAPK10|FZD6|MAPK9|WNT2B|FZD3|DVL3|DVL2|LRP6
PROSTAGLANDIN SYNTHESIS AND REGULATION%WIKIPATHWAYS_20181110%WP98%HOMO SAPIENS,0.500569800569801,0.9144253281295329,-0.174589701381797,-0.9698381784863379,1756,37,PTGFR|PTGS1|MITF|PPARG|EDNRA|PPARGC1A|S100A6|ABCC4|HSD11B2|PTGES
ATM SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2516%HOMO SAPIENS,0.393947232281428,0.863476608623133,0.23300565646806698,1.05091563697045,4568,39,CCNB1|PIDD1|CDK1|CDC25C|RAD9A|CCNE1|AP3B2|RAD51|H2AFX|CHEK2|FANCD2|RIPK1|MAPK9|CHEK1|CASP2|CDK2|ATM|MDC1|BRCA1|MDM2
MEVALONATE PATHWAY%WIKIPATHWAYS_20181110%WP3963%HOMO SAPIENS,0.6653327716933449,0.964618776001639,0.320119025050562,0.8332025651620741,6317,7,MVD|HMGCR|ACAT2|MVK|HMGCS1|FDPS
EGF/EGFR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP437%HOMO SAPIENS,0.000773395204949729,0.0849637591935908,-0.226886740147459,-1.8285255073271498,0,159,MAPK7|PRKCD|ABI1|BCAR1|PTK2B|FOXO4|GRB2|TNK2|ABL1|VAV1|MAPK4|FOXO1|EIF4EBP1|MAP2K5|NEDD8|PTPN5|CAMK2A|PTPN12|MEF2D|CRK|RAP1A|RALA|VAV3|VAV2|CDC42|AP2S1|NEDD4|IQSEC1|KRAS|STAT5A|SHC1|JUN|PRKCA|STAT3|SH3GL3|GAB2|NOS3|ASAP1|RALB|CAV2|RAB5A|RAC1|PLD2|MAP2K1|TWIST1|PIK3R1|CAV1|RPS6KA2
ESTROGEN METABOLISM%WIKIPATHWAYS_20181110%WP697%HOMO SAPIENS,0.215041782729805,0.732094216765764,-0.39392804087101196,-1.22449987022488,1157,8,ARSD|STS|CYP1B1|SULT1A1|NQO1|GSTM1
THE EFFECT OF PROGERIN ON THE INVOLVED GENES IN HUTCHINSON-GILFORD PROGERIA SYNDROME%WIKIPATHWAYS_20181110%WP4320%HOMO SAPIENS,0.146212460779919,0.6375525442275519,0.317149670987948,1.31374073518086,1630,29,RBBP7|HIST1H3E|MBD3|MTA2|MTA1|HIST2H3C|HIST2H3A|RB1|LEF1|H3F3A|KDM1A|E2F1|HIST1H3H|CHD3|SUV39H1|CHD4|HDAC2|SREBF1|CBX5|CBX3|MBD2|RBBP4
NEUROTRANSMITTER DISORDERS%WIKIPATHWAYS_20181110%WP4220%HOMO SAPIENS,0.16048829656176503,0.662474247098552,0.6078420559201461,1.2880753805932499,1432,4,DDC|TH|DBH|MAOA
METHYLATION PATHWAYS%WIKIPATHWAYS_20181110%WP704%HOMO SAPIENS,0.107725902048456,0.58452352834625,0.512223529409089,1.3964587622881397,1035,8,PNMT|MAT2A|INMT
VITAMIN B12 METABOLISM%WIKIPATHWAYS_20181110%WP1533%HOMO SAPIENS,0.39174984542001595,0.861703969982851,0.247308241976548,1.05740691489869,4434,32,CTH|PLAT|INS|HBB|SCARB1|MTR|CCL5|HBA1|APOE|CCL2|MCEE
CALCIUM REGULATION IN THE CARDIAC CELL%WIKIPATHWAYS_20181110%WP536%HOMO SAPIENS,0.273047563123899,0.7884684708511421,-0.14283595024746698,-1.0984958965260898,464,123,CHRM4|CALR|CAMK2D|GJA4|GNAI3|CALM3|PRKCH|ADCY7|GNG4|PRKCD|GNAZ|ARRB2|RGS5|RGS4|GNAQ|GNAI2|ADRA1B|PLN|YWHAH|ARRB1|CAMK2A|PRKAR2A|CALM1|CAMK4|YWHAQ|YWHAB|RYR1|GNB5|GNGT1|ADRB2|PRKCA|YWHAZ|PRKAR1B|PKIG|ADCY2|YWHAE|ATP2B2|GNAS|CHRM1|GJC1|CACNA1E|FKBP1A
AMINO ACID METABOLISM%WIKIPATHWAYS_20181110%WP3925%HOMO SAPIENS,0.6088446215139439,0.9508825506493929,0.17125340395598598,0.9046067585482981,7640,76,ASNS|CTH|PNMT|FH|FTCD|ALDH1A1|GLS|EPRS|ACADM|CAD|IDH1|PDHX|PDK4|DDC|HADH|PDHA1|SUCLG1|DLD|ACSS1|SDHA|TH|EHHADH
OSTEOPONTIN SIGNALING%WIKIPATHWAYS_20181110%WP1434%HOMO SAPIENS,0.0174310022826313,0.278447181841778,-0.473112887441669,-1.78173409085005,83,13,ITGB3|ITGAV|MAP3K14|MAPK1|NFKB1|IKBKB|RELA|PLAU|MMP9|MAPK3|MAP2K1
PARKIN-UBIQUITIN PROTEASOMAL SYSTEM PATHWAY%WIKIPATHWAYS_20181110%WP2359%HOMO SAPIENS,0.586219467736055,0.9447006447658759,-0.141932822709726,-0.9247016960225691,1607,64,HSPA4|FBXW7|PSMC4|PSMD12|TUBB2B|UBE2J1|HSPA5|HSPA1B|TUBB2A|STUB1|TUBB6|TUBA1C|TUBB3|TUBA3C|SNCA|TUBB4B|UBE2L3|HSPA6|PARK2|PSMD6
DEVELOPMENT AND HETEROGENEITY OF THE ILC FAMILY%WIKIPATHWAYS_20181110%WP3893%HOMO SAPIENS,0.6924731182795699,0.96731875442989,-0.207152827017008,-0.826143980965275,3219,15,ZBTB16|AHR|ID2|IL1B|IL6|TNF
SEROTONIN AND ANXIETY%WIKIPATHWAYS_20181110%WP3947%HOMO SAPIENS,0.8213564796124351,0.987153241368501,-0.205070976615608,-0.7216703163569771,4068,11,ARC|CRH|FMR1
NANOPARTICLE-MEDIATED ACTIVATION OF RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP2643%HOMO SAPIENS,0.109195920945763,0.58452352834625,0.339079546785526,1.37853188993341,1209,27,ITGB1|MAPK11|ITGA1|MAPK12|MAP2K2|MAPK10|SRC|HRAS|AKT3|FN1|MAPK13|MAPK9|PTK2|TLN1|COL1A1
AMP-ACTIVATED PROTEIN KINASE (AMPK) SIGNALING%WIKIPATHWAYS_20181110%WP1403%HOMO SAPIENS,0.7497730461335309,0.975565007622361,0.16214859535870002,0.8050132849052679,9084,57,CCNA1|PRKAA2|CCNB1|PIK3R3|CAMKK2|STRADA|STRADB|CPT1B|LIPE|ACACA|STK11|ELAVL1|ADIPOR2|RPS6KB2|GYS1|HMGCR|PRKAB2|AKT2
PTF1A RELATED REGULATORY PATHWAY%WIKIPATHWAYS_20181110%WP4147%HOMO SAPIENS,0.25812441968430805,0.7692637240222829,-0.37717623381368803,-1.1724279600293799,1389,8,NOTCH1|CTNNB1|NKX6-1|FGF10|RBPJ
MECP2 AND ASSOCIATED RETT SYNDROME%WIKIPATHWAYS_20181110%WP3584%HOMO SAPIENS,0.918299012221664,1.0,0.134027525154013,0.647482470573194,10969,51,GRIA1|GAMT|FUT8|CEBPD|EZH2|RBFOX1|NF1|GRIN1|NREP|HNRNPH1|FKBP5|E2F1|SMC3|SP1|AKT1|TET2|REST|TAF1|TAP1|GPRIN1|SST|CTCF|NCOR1
INTERLEUKIN-11 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2332%HOMO SAPIENS,0.661363441963904,0.964618776001639,0.186363531491983,0.8577112152096179,7731,42,PIAS1|MAP2K2|ITGA2|BGLAP|PDPK1|JAK2|IL11RA|BIRC5|SRC
GASTRIC ACID PRODUCTION%WIKIPATHWAYS_20181110%WP2596%HOMO SAPIENS,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
MONOAMINE TRANSPORT%WIKIPATHWAYS_20181110%WP727%HOMO SAPIENS,0.7643458301453709,0.9787088902274829,-0.158644006621296,-0.790554346009458,2996,27,AGT|ACHE|PVRL2|IL1B|SYN1|PPP2CB|TDO2|HRH3|TNF|AMPH
LEPTIN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2034%HOMO SAPIENS,0.113789016199131,0.590080021815051,-0.187770416576349,-1.27664077042451,287,74,PIK3R2|EIF4E|SOCS3|IL1RN|BAX|IL1B|CFL2|PRKAA1|GRB2|FYN|RHOA|FOXO1|EIF4EBP1|REL|BCL2L1|PTPN1|CDC42|LEPR|KPNA4|SHC1|STAT3|NOS3|MAPK3|RAC1|MAP2K1|PIK3R1
TAMOXIFEN METABOLISM%WIKIPATHWAYS_20181110%WP691%HOMO SAPIENS,0.38742628475147395,0.859991269020751,0.40959050461958796,1.06607802851194,3678,7,CYP2C8|CYP3A5|CYP2E1|CYP2D6
IL-7 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP205%HOMO SAPIENS,0.272207016670814,0.7871521569906309,-0.23403825681807802,-1.1353831032561699,1093,25,PTK2B|FYN|BCL2L1|STAT5A|STAT3|MAPK3|MAP2K1|PIK3R1
GUT-LIVER INDOLE METABOLISM %WIKIPATHWAYS_20181110%WP3627%HOMO SAPIENS,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
ASSOCIATION BETWEEN PHYSICO-CHEMICAL FEATURES AND TOXICITY ASSOCIATED PATHWAYS%WIKIPATHWAYS_20181110%WP3680%HOMO SAPIENS,0.34732566012186894,0.842847021021096,-0.170876226044833,-1.06808841440174,1025,55,CDKN1B|SOD1|FZD1|CTNNB1|GRB2|PFN1|RHOA|PPP2CA|TMSB4X|WNT11|NEFH|STAT5A|SHC1|JUN|CDKN1A|ACTR2|MAP2K1
PHOTODYNAMIC THERAPY-INDUCED AP-1 SURVIVAL SIGNALING.%WIKIPATHWAYS_20181110%WP3611%HOMO SAPIENS,0.0278392913634926,0.342785505034052,-0.260440808526487,-1.55551995161953,87,47,FGF7|MMP2|IL6|HBEGF|BCL2L1|BID|MAP2K3|BCL2|JUN|CFLAR|TP53|BCL3|CDKN1A|BMF|TNF|BCL2L11
SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR%WIKIPATHWAYS_20181110%WP313%HOMO SAPIENS,0.053141433711597,0.44950045432031394,-0.27135249550825197,-1.4601170726979098,191,34,PTK2B|GRB2|HGF|PXN|CRK|RAP1A|RAPGEF1|JUN|STAT3|MAPK3|MET|MAP2K1
MEVALONATE ARM OF CHOLESTEROL BIOSYNTHESIS PATHWAY WITH INHIBITORS%WIKIPATHWAYS_20181110%WP4189%HOMO SAPIENS,0.196806580379823,0.7105545623872371,0.7358698649021229,1.20275907865477,1626,2,MVD|HMGCR
TP53 NETWORK%WIKIPATHWAYS_20181110%WP1742%HOMO SAPIENS,0.000878155872667398,0.0849637591935908,-0.545858008728229,-2.23547200341765,3,16,ABL1|BBC3|SUMO1|BOK|BID|GADD45A|BCL2|TP53|CDKN1A|PMAIP1
MIRNAS INVOLVED IN DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP1545%HOMO SAPIENS,0.9827956989247311,1.0,-0.13429831194570502,-0.5355936661131451,4569,15,TP53|CDKN1A
THIAMINE METABOLIC PATHWAYS%WIKIPATHWAYS_20181110%WP4297%HOMO SAPIENS,0.44586815227483706,0.883679089256054,-0.31731281423088303,-0.98634638698806,2400,8,BCKDK|OGDH|TKT
"PHASE I BIOTRANSFORMATIONS, NON P450%WIKIPATHWAYS_20181110%WP136%HOMO SAPIENS",0.9194711538461541,1.0,-0.25198544010589,-0.637884408934141,5354,5,PON2|LIPA|CES2|ESD|CES1
IL17 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2112%HOMO SAPIENS,0.900280540678398,0.998912093067348,-0.136722787849259,-0.681316593262663,3529,27,RELA|TRAF6|IL17D|IL17RA|TRAF3IP2|TRAF3|IL17RD|NFKBIB|STAT3|MAPK3
METHIONINE DE NOVO AND SALVAGE PATHWAY%WIKIPATHWAYS_20181110%WP3580%HOMO SAPIENS,0.8016379392438809,0.9841161968820359,0.20475519267225697,0.734498619764342,8417,18,MAT2A|APIP|MSRB2|MTR|MTAP|MSRB3|ENOPH1
PEROXISOMAL BETA-OXIDATION OF TETRACOSANOYL-COA%WIKIPATHWAYS_20181110%WP1941%HOMO SAPIENS,0.761227461081868,0.977763214485385,0.36893542965781206,0.781809417993366,6796,4,HSD17B4|ACAA1
COMPLEMENT ACTIVATION%WIKIPATHWAYS_20181110%WP545%HOMO SAPIENS,0.407581123767589,0.867015886388254,0.301552891381674,1.04540209632236,4257,16,C7|CD55|C5|C4A|C4B|C2|C1QB|C1S|MASP2|C1R|C3|CFB|C1QC|C1QA
ALLOGRAFT REJECTION%WIKIPATHWAYS_20181110%WP2328%HOMO SAPIENS,0.8563756204735941,0.991298302704726,0.14211708057811598,0.7254892360097809,10523,65,CXCL13|CXCL9|AGTR1|CCL21|FAS|CCL19|C7|CD55|C5|PRF1|COL5A1|CASP9|C4A|C4B|HLA-DMB|CTLA4|HLA-DRB1|HLA-F|STAT1|ABCB1|IL2RA|CXCL11|HLA-DRB5|HLA-DOB|C2|C1QB|HLA-DPB1|HLA-DQA1|MICA|PDGFRA|HLA-C|FOXP3|CASP7|PRKCZ
IL-9 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP22%HOMO SAPIENS,0.0339784946236559,0.376148295095164,-0.413458413882597,-1.6489090925151297,157,15,STAT5A|STAT3|MAPK3|MAP2K1|PIK3R1
APOPTOSIS%WIKIPATHWAYS_20181110%WP254%HOMO SAPIENS,0.00294488851493479,0.131456330716537,-0.247276288291969,-1.71321993806514,6,80,BBC3|TRAF3|IRF6|HRK|TNFRSF1B|CASP3|DFFA|BCL2L1|BOK|IGF1|BID|CRADD|BCL2|JUN|CFLAR|NFKBIB|TP53|TNFRSF10B|BNIP3L|IGF2|PIK3R1|TNF|BCL2L11|PMAIP1|TNFRSF21
GENOTOXICITY PATHWAY%WIKIPATHWAYS_20181110%WP4286%HOMO SAPIENS,0.929695263332229,1.0,0.129037932273628,0.6373921106201279,11226,56,BTG2|PCDH8|E2F8|CEBPD|DDB2|E2F7|CENPE|DAAM1|ACTA2|IKBIP|PRKAB2|TOPORS|HIST1H2BN|GXYLT1|COIL|SERTAD1|HIST1H2BG|PPM1D|MDM2|SMAD5|RBM12B|TRIAP1|TM7SF3|NLRX1|SEL1L|ITPR1|MEX3B|BLOC1S2|TRIM22
NONALCOHOLIC FATTY LIVER DISEASE%WIKIPATHWAYS_20181110%WP4396%HOMO SAPIENS,0.0890227576974565,0.5575840828783879,-0.157522762153764,-1.25101246506791,132,141,PRKAA1|PRKAG1|NR1H3|COX5B|CEBPA|EIF2AK3|BBC3|NDUFB10|SDHC|UQCRC1|COX6B1|PPARA|CASP3|RXRA|DDIT3|IL6|COX4I1|BID|NDUFA4L2|SMAD7|CDC42|LEPR|NDUFB9|CYC1|CXCL8|JUN|NDUFA9|NDUFS1|NDUFV3|NDUFS5|RAC1|MAP3K11|COX4I2|PIK3R1|NDUFS6|TNF|COX7A2L|BCL2L11
UREA CYCLE AND METABOLISM OF AMINO GROUPS%WIKIPATHWAYS_20181110%WP497%HOMO SAPIENS,0.626344676180022,0.954674488895214,-0.212482456401067,-0.870187072291336,2852,16,ASS1|SMS|ODC1|ASL
INTERACTOME OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) %WIKIPATHWAYS_20181110%WP2916%HOMO SAPIENS,0.247630898822629,0.7602206518254051,0.34565896868363394,1.19830590520564,2586,16,RBBP7|STK38|MTF2|EZH2|JARID2|THRAP3|SUZ12|EED|MORC3|EZH1|SETX
NICOTINE METABOLISM%WIKIPATHWAYS_20181110%WP1600%HOMO SAPIENS,0.9902013422818791,1.0,0.505348478164976,0.671332908048186,7376,1,FMO3
ONE CARBON METABOLISM%WIKIPATHWAYS_20181110%WP241%HOMO SAPIENS,0.9243376126741328,1.0,0.152615362408487,0.608150265430176,10151,25,FTCD|DHFR|MTHFD1|DNMT3B|MTR
EICOSANOID SYNTHESIS%WIKIPATHWAYS_20181110%WP167%HOMO SAPIENS,0.746690791353205,0.9749763305090959,0.21724376653763602,0.7792976802776881,7840,18,DPEP1|PLA2G4A|GGT1|PTGS2|LTA4H
TOLL-LIKE RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3858%HOMO SAPIENS,0.249003984063745,0.7613646381106121,-0.236120541176939,-1.1594211080185,999,26,TICAM2|IKBKE|CHUK|TLR4|TOLLIP|IKBKG|TLR5|TLR2|IRF7|NFKB2|TIRAP|IRF3|MAPK1|NFKB1|IKBKB|RELA|TRAF6|TLR1|IRAK1|IRAK4|TRAF3|RELB|REL|TICAM1|MYD88
OXIDATION BY CYTOCHROME P450%WIKIPATHWAYS_20181110%WP43%HOMO SAPIENS,0.278744361594403,0.788692060817727,0.299484316805349,1.1647553866948799,3027,23,CYP4X1|CYB5B|CYP2C8|CYP3A5|POR|CYP2R1
CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2875%HOMO SAPIENS,0.45281401771259894,0.8874890379518141,0.28152543929918,1.00988914564322,4754,18,ABCC3|ALAS1|CYP3A5
AGE/RAGE PATHWAY%WIKIPATHWAYS_20181110%WP2324%HOMO SAPIENS,0.000364963503649635,0.0784645998831315,-0.300409529790757,-1.94515838680853,0,63,NFKBIA|PRKCD|FOXO4|IRAK4|RHOA|MMP2|FOXO1|CASP3|MMP9|SMAD2|CDC42|LGALS3|MSN|STAT5A|SHC1|JUN|PRKCA|STAT3|NOS3|MAPK3|RAC1|MYD88|MAP2K1|INHBB
"GPCRS, CLASS A RHODOPSIN-LIKE%WIKIPATHWAYS_20181110%WP455%HOMO SAPIENS",0.334071671544973,0.8302162293601879,0.20443465792722895,1.09697470541313,4222,82,CYSLTR2|GPR12|PTGER3|NPY1R|OXTR|ADORA3|CXCR4|NPY2R|F2R|CNR1|GPR34|GPR19|GPR171|AGTR1|GPR85|RGL4|GPR27|PTGER1|CCR5|F2RL1|SSTR2|C3AR1|GPR22|MC1R|DRD4|ADORA2A|P2RY11|PTGIR|GPR173|OPRL1|FPR3|P2RY6|LPAR5
APOPTOSIS MODULATION AND SIGNALING%WIKIPATHWAYS_20181110%WP1772%HOMO SAPIENS,0.0216731686172518,0.309421849543369,-0.2027409162571,-1.44012956298776,49,87,BBC3|TRAF3|HRK|TNFRSF1B|CASP3|TNFRSF10D|TNFRSF10A|DFFA|BCL2L1|BOK|BID|CRADD|BAG3|BCL2|JUN|CFLAR|TP53|TNFRSF10B|MAPK3|BMF|PEA15|MYD88|BIK|BCL2L11|PMAIP1
MACROPHAGE MARKERS%WIKIPATHWAYS_20181110%WP4146%HOMO SAPIENS,0.879539242483405,0.9956508825790341,-0.208848190644307,-0.6741806747349511,4504,9,F3|RAC2|CD163|CD14|CD74|LYZ|CD83|CD86|CD68
SELENIUM MICRONUTRIENT NETWORK%WIKIPATHWAYS_20181110%WP15%HOMO SAPIENS,0.7453990261615909,0.9749763305090959,0.16278610746036998,0.8081783182501271,9031,57,CTH|PLAT|INS|GGT1|HBB|SCARB1|PRDX4|MTR|RFK|PRDX3|HBA1|PTGS2|SEPN1|CCL2|SEPP1|LDLR|VIMP|CAT
TRANSCRIPTION FACTOR REGULATION IN ADIPOGENESIS%WIKIPATHWAYS_20181110%WP3599%HOMO SAPIENS,0.00045126353790613704,0.0784645998831315,-0.526460577339974,-2.3087787633908903,1,19,CEBPA|FOXO1|RXRA|IL6|PPARG|LPIN1|NRIP1|PPARGC1A|NR3C1|TWIST1|TNF
TCA CYCLE NUTRIENT UTILIZATION AND INVASIVENESS OF OVARIAN CANCER%WIKIPATHWAYS_20181110%WP2868%HOMO SAPIENS,0.0228365384615385,0.31609926985007897,-0.6920801655604361,-1.75195498262934,132,5,STAT3|MAPK3
THYMIC STROMAL LYMPHOPOIETIN (TSLP) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2203%HOMO SAPIENS,0.143207605029132,0.632949331968897,-0.21887213215032,-1.26530216630576,466,43,FYN|EIF4EBP1|RELB|IL6|LYN|YES1|CXCL8|STAT5A|STAT3|GAB2|MAPK3|MAP2K1
PENTOSE PHOSPHATE PATHWAY%WIKIPATHWAYS_20181110%WP134%HOMO SAPIENS,0.5118053033054849,0.9184859575763928,-0.322127877611334,-0.9396613105062579,2817,7,G6PD|PGD|TKT
HEROIN METABOLISM%WIKIPATHWAYS_20181110%WP2645%HOMO SAPIENS,0.832812319092277,0.9881090453690059,0.389540788231567,0.740476060275415,7192,3,BCHE|CES2
TNF ALPHA SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP231%HOMO SAPIENS,0.322423706324635,0.822751772025005,-0.150590702903264,-1.07439725275519,728,89,TNFRSF1B|CASP3|IL6|REL|TANK|BCL2L1|CDC37|PPP2CA|BID|MAP2K3|KRAS|JUN|CFLAR|NFKBIB|MAPK3|RAC1|CSNK2A1|TNF|GLUL
STEROL REGULATORY ELEMENT-BINDING PROTEINS (SREBP) SIGNALLING%WIKIPATHWAYS_20181110%WP1982%HOMO SAPIENS,0.725426217472877,0.972554563883587,0.16192328158445002,0.823888433425743,8892,64,SIRT1|LPL|PRKAA2|CDK8|INS|GPAM|SEC31B|SCARB1|MVD|ACACA|SEC31A|ACSS1|SREBF2|SEC24D|IDI1|LDLR|HMGCR|PRKAB2|SEC24C
MIRNA TARGETS IN ECM AND MEMBRANE RECEPTORS%WIKIPATHWAYS_20181110%WP2911%HOMO SAPIENS,0.275381182595761,0.7884684708511421,0.308668286701629,1.16693064574121,2961,21,ITGA1|LAMB2|COL4A2|ITGA11|ITGB5|TNXB|COL4A1|COL5A2|COL5A1|FN1|THBS2|THBS1
INFLAMMATORY RESPONSE PATHWAY%WIKIPATHWAYS_20181110%WP453%HOMO SAPIENS,0.5634505703422049,0.9377667552605741,-0.199027712369103,-0.9220437235740601,2370,22,FN1|ZAP70|THBS1|LCK|COL1A1|IL2RA|COL3A1|LAMB1|IL2RB|COL1A2|THBS3|VTN|TNFRSF1A|IL2RG|IL4R|CD40|CD86|LAMA5|TNFRSF1B|LAMC1|LAMC2
BMP2-WNT4-FOXO1 PATHWAY IN HUMAN PRIMARY ENDOMETRIAL STROMAL CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP3876%HOMO SAPIENS,0.210406301824212,0.7251658659797621,-0.33603124350527,-1.22419552736202,1014,12,CTNNB1|FOXO1|SMAD1|DKK1|BCL2L11
DNA REPLICATION%WIKIPATHWAYS_20181110%WP466%HOMO SAPIENS,0.0672564851400103,0.502179734176606,0.317495545543609,1.4499768785228,782,41,CDC7|POLE|POLE2|ORC1|RFC4|CDC45|POLD1|POLD3|POLA2|MCM6|CDC6|ORC6|DBF4|MCM10|MCM3|MCM2|PRIM2|GMNN|RFC3|RFC5|CDK2|ORC2|MCM7|CDT1
EPO RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP581%HOMO SAPIENS,0.47644618013180395,0.9025881021691609,-0.20512345277082603,-0.9832514729925479,1951,24,STAT5A|SHC1|STAT3|MAPK3|MAP2K1
MIRNA REGULATION OF PROSTATE CANCER SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP3981%HOMO SAPIENS,0.0584080412931269,0.473005169611479,-0.27671910895844604,-1.4649760308724902,214,32,NFKBIA|CTNNB1|GRB2|FOXO1|MIRLET7BHG|KRAS|BCL2|TCF7|TP53|CDKN1A|MAP2K1
MAPK SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP382%HOMO SAPIENS,0.26299045599151605,0.774290656297867,-0.126839070005947,-1.07801863449086,247,210,FGF2|RELB|MAP2K5|DDIT3|PTPN5|ARRB1|CACNA2D3|MAP4K4|CRK|CDC25B|RAP1A|PPM1A|CDC42|FGFR1|MAP2K3|GADD45A|STK4|KRAS|FLNC|JUN|PRKCA|DUSP3|TP53|RASGRF2|HSPA6|MAPK3|FGF14|GNA12|RASGRP3|FGF10|DUSP10|RAC1|MAP3K11|CACNA1E|CACNG3|RRAS2|MAP2K1|CACNG7|TNF|PAK2
CANONICAL  AND NON-CANONICAL NOTCH SIGNALING%WIKIPATHWAYS_20181110%WP3845%HOMO SAPIENS,0.814582195521573,0.986276922067025,0.18117698160734602,0.7284182487067621,8948,26,DLK2|HES1|MAML1|JAG2|DLK1|LEF1|MAML3|MFAP2|MFAP1|CHUK|DLL4|JAG1|NOTCH2
DDX1 AS A REGULATORY COMPONENT OF THE DROSHA MICROPROCESSOR%WIKIPATHWAYS_20181110%WP2942%HOMO SAPIENS,0.6390058972198821,0.960516115253472,0.329101872425185,0.856583029580937,6067,7,DROSHA|DGCR8|ATM|RAD50|NBN|DDX1
MIRNAS INVOLVEMENT IN THE IMMUNE RESPONSE IN SEPSIS%WIKIPATHWAYS_20181110%WP4329%HOMO SAPIENS,0.00584174190122146,0.175005706363229,-0.35054437815394396,-1.8433497706483601,21,31,RELA|TRAF6|VCAM1|GZMB|IRAK1|NFKBIA|IRAK4|TRAF3|RELB|IL6|REL|ICAM1|CXCL8|MYD88|TNF
HEDGEHOG SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP47%HOMO SAPIENS,0.535263987391647,0.9265056012720759,-0.273664778563069,-0.9258489080186708,2716,10,SAP18|KIF7
SENESCENCE AND AUTOPHAGY IN CANCER%WIKIPATHWAYS_20181110%WP615%HOMO SAPIENS,0.000945179584120983,0.0849637591935908,-0.254668695807374,-1.8472232217906999,1,96,CD44|IL6R|CDKN1B|BMI1|SLC39A1|RNASEL|IL1B|PIK3C3|IGF1R|SQSTM1|LAMP1|RB1CC1|ATG13|IGFBP3|MAP1LC3A|PLAU|ATG3|IL6|SH3GLB1|SLC39A4|ATG7|IGF1|BECN1|RSL1D1|CDC25B|MAP2K3|CXCL8|BCL2|JUN|TP53|CXCL14|GABARAPL1|GABARAP|CDKN1A|MAP1LC3B|FKBP8|ING1|MAP2K1|GABARAPL2
NUCLEAR RECEPTORS%WIKIPATHWAYS_20181110%WP170%HOMO SAPIENS,0.799174690508941,0.9839175016931591,0.18820610788695,0.740684721903909,8714,24,NR4A2|NR4A1|RARB|NR2F6
ENDOMETRIAL CANCER%WIKIPATHWAYS_20181110%WP4155%HOMO SAPIENS,0.18531591951994397,0.6919993107485419,-0.18819478354738198,-1.19889409110037,524,59,CTNNA1|FGFR1|GADD45A|KRAS|TCF7|TP53|MAPK3|CDKN1A|MAP2K1|PIK3R1|FOXO3
PROTEASOME DEGRADATION%WIKIPATHWAYS_20181110%WP183%HOMO SAPIENS,0.686416303722574,0.9665349594178531,0.169883291806225,0.849509177491106,8352,59,PSMD11|PSMD13|PSMB9|PSMA4|PSMD3|PSMD1|PSMA1|UBA7|H2AFX|PSMC3|H2AFZ|PSMA3|PSMC6|PSMC1|PSMD2|RPN2|UBE2B|PSMA5|PSMC2|PSMC5|HLA-F|PSMA2|PSMB6|PSMB3|UBA1|PSMA7|PSMB4|PSME2|UBE2D2|RPN1|HLA-C|PSMD4|UCHL3|PSMB10|PSMD9
PHOTODYNAMIC THERAPY-INDUCED NF-KB SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3617%HOMO SAPIENS,0.008318170002599429,0.20219929830704503,-0.348983332017148,-1.7860098336533898,31,29,BCL2A1|RELA|TRAF6|VCAM1|MMP1|IL1B|VEGFA|MMP2|RELB|IL6|MMP9|REL|ICAM1|CXCL8|CFLAR|TNF
MISMATCH REPAIR%WIKIPATHWAYS_20181110%WP531%HOMO SAPIENS,0.17125506072874502,0.674379448319819,0.454311670972741,1.29645028120708,1691,9,EXO1|POLD1|MSH6|LIG1
B CELL RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP23%HOMO SAPIENS,0.0055452865064695,0.171334869092615,-0.228195849710964,-1.64060617312343,11,93,NFKBIA|PRKCD|CD19|GRB2|CR2|VAV1|MAPK4|FYN|BCL10|FOXO1|LYN|REL|CAMK2A|MEF2D|CRK|ETS1|KLF11|VAV2|CDC42|RAPGEF1|SHC1|JUN|NFATC2|GAB2|BCL6|RASGRP3|RAC1|CD22|MAP2K1|PIK3R1
HUMAN COMPLEMENT SYSTEM%WIKIPATHWAYS_20181110%WP2806%HOMO SAPIENS,0.3858413639733139,0.859630103805729,-0.15712527291261402,-1.04572974701685,1040,68,FKBP2|RPS19|ITGA2B|C3AR1|C7|KLKB1|CD55|C5|VSIG4|C4A|FCGR3A|CD46|THBS1|SELPLG|DCN|PTX3|WAS|C2|LAMB1|C1S|MASP2|CLEC4M|C1R|F10|TLR2|C3|CFB|ICAM2|SERPING1|F13A1|FCN1|SPP1|SELP|CFH|CD59|ITGB3|PROS1|CFP|CFI|CD40|ITGB2|FPR1|PRKACA|CSNK1A1|CALR|TXN|SELL|LAMA5|GNAI3|CD19|C5AR1|ITGAX|ARRB2|CR2|GNAI2|C1QBP|GNA15|LAMC1|PRNP|ICAM1|PLAUR|CD93|CFD|FCER2|PRKCA|ADM
STRUCTURAL PATHWAY OF INTERLEUKIN 1 (IL-1)%WIKIPATHWAYS_20181110%WP2637%HOMO SAPIENS,0.899140948138721,0.998912093067348,-0.117729965754011,-0.707724119936249,2825,48,IRAK1|NFKBIA|MAP3K8|IRAK2|IRAK4|TANK|MBP|MAP2K3|NFKBIB|MAPK3|MYD88|MAP2K1
G PROTEIN SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP35%HOMO SAPIENS,0.0915524104378594,0.5622489437340121,-0.179776820549104,-1.2826271368897,206,89,GNG10|GNAI3|CALM3|PRKCH|GNA13|ADCY7|GNG4|PRKCD|GNAZ|NRAS|PDE7B|GNAQ|GNAI2|AKAP2|RHOA|SLC9A1|GNAL|PDE8A|GNA15|PRKAR2A|CALM1|PDE4B|AKAP13|GNB5|GNGT1|KRAS|PRKCA|PRKAR1B|ADCY2|GNA12|GNAS|PDE4D
ALANINE AND ASPARTATE METABOLISM%WIKIPATHWAYS_20181110%WP106%HOMO SAPIENS,0.22191272051996302,0.73556947110949,-0.391283875695632,-1.21628065357062,1194,8,ASS1|PC|ASL
TOLL-LIKE RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP75%HOMO SAPIENS,0.768403639371381,0.9792236089291529,-0.12163118302795699,-0.8381134059858221,1857,78,RELA|TRAF6|PIK3CD|TLR1|CD86|PIK3R2|PIK3R5|IL1B|IRAK1|NFKBIA|MAP3K8|IFNAR2|IRAK4|TRAF3|IFNAR1|IL6|MAP2K3|CXCL8|JUN|MAPK3|RAC1|TICAM1|MYD88|MAP2K1|PIK3R1|TNF
FOCAL ADHESION%WIKIPATHWAYS_20181110%WP306%HOMO SAPIENS,0.0016597510373444,0.10497081150975199,-0.189895638336712,-1.5646443474031002,1,176,COL6A2|LAMA5|RAP1B|PARVB|BLK|ARHGAP5|VEGFA|ITGB8|KDR|CTNNB1|IGF1R|BCAR1|VASP|GRB2|TNK2|FGR|VAV1|FLNB|FYN|RHOA|TESK2|ITGA5|HGF|PXN|LAMC1|ITGA6|COL5A3|IGF1|CRK|RAP1A|VAV3|VAV2|CDC42|COMP|LAMA4|FLNC|BCL2|RAPGEF1|SHC1|JUN|PRKCA|RELN|ZYX|MAPK3|CAV2|FLT1|VWF|THBS4|PPP1CB|RAC1|MET|LAMC2|MAP2K1|PGF|PIK3R1|TLN2|ITGA7|CAV1|PARVA|PAK2
INTEGRATED CANCER PATHWAY%WIKIPATHWAYS_20181110%WP1971%HOMO SAPIENS,0.447511465941906,0.885029542329102,0.21654865310960897,1.0100588963284,5268,44,CDK1|NOXA1|ATR|BLM|MAP3K5|RB1|MSH6|CDKN2B|CHEK2|PLK1|BAD|CASP9|POU2F1|E2F1|CHEK1|CDK2|ATM|BRCA1|AKT1|STAT1|MDM2
ID SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP53%HOMO SAPIENS,0.907394677403516,1.0,0.192045387241925,0.619801848188441,9239,13,CCNE1|RB1|CDK2|ELK1|ID3|RBL2|ELK4|SREBF1
OXIDATIVE STRESS%WIKIPATHWAYS_20181110%WP408%HOMO SAPIENS,0.914072455852904,1.0,0.15574787509608898,0.6261810601479469,10041,26,MGST1|MAPK10|FOS|TXN2|NFE2L2|CAT|JUNB|SP1|TXNRD1|MAOA|GPX3|MAPK14
COMMON PATHWAYS UNDERLYING DRUG ADDICTION%WIKIPATHWAYS_20181110%WP2636%HOMO SAPIENS,0.103582338239378,0.575794607412397,-0.246113201622379,-1.3378730773671998,372,35,CAMK2A|CALM1|RAP1A|CAMK4|PRKCA|DRD2|MAPK3|GNAS|PPP1CB|MAP2K1
INSULIN SIGNALING%WIKIPATHWAYS_20181110%WP481%HOMO SAPIENS,0.22017673048600897,0.735314515752205,-0.141553760303892,-1.12803318401326,298,150,PIK3C3|MAPK7|PRKCD|MAP3K8|IGF1R|PRKAA1|PFKL|GRB2|MAPK4|MYO1C|MAP3K13|STXBP4|FOXO1|EIF4EBP1|MAP2K5|EHD1|VAMP2|MAP4K4|CRK|PTPN1|RRAD|EHD2|MAP2K3|RAPGEF1|SHC1|JUN|PRKCA|MAPK3|SLC2A1|RHOQ|RAC1|MAP3K11|MAP2K1|PIK3R1|SNAP25|RPS6KA2|TRIB3|FOXO3
GLUCOSE HOMEOSTASIS%WIKIPATHWAYS_20181110%WP661%HOMO SAPIENS,0.13771812080536902,0.6243233125849921,0.9323445081605649,1.2385780842538798,1025,1,INS
HYPOTHESIZED PATHWAYS IN PATHOGENESIS OF CARDIOVASCULAR DISEASE%WIKIPATHWAYS_20181110%WP3668%HOMO SAPIENS,0.869465156954801,0.993389838333952,0.17343864587621,0.6745381501118161,9444,23,CTGF|FBN3|AGTR1|FBN1|LTBP2
GLYCOLYSIS AND GLUCONEOGENESIS%WIKIPATHWAYS_20181110%WP534%HOMO SAPIENS,0.00111080255484588,0.0893009762660318,-0.3906694671970639,-2.12368194337778,3,35,PFKL|SLC2A3|GPI|FBP1|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|SLC2A1|PC|PGAM2
NRF2-ARE REGULATION%WIKIPATHWAYS_20181110%WP4357%HOMO SAPIENS,0.0970325011775789,0.569923978730193,-0.30593173051453004,-1.38947950636798,411,21,PGAM5|HMOX1|FYN|AIMP2|YES1|NQO1|PRKCA|EPHB2
MITOCHONDRIAL COMPLEX I ASSEMBLY MODEL OXPHOS SYSTEM%WIKIPATHWAYS_20181110%WP4324%HOMO SAPIENS,0.999750996015936,1.0,0.0696174536974753,0.342259046168164,12044,55,NDUFA7|NDUFB11|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|NDUFB2|MT-ND2|NDUFV1|NDUFS3|NDUFB7|NDUFA12|ECSIT|ACAD9|NDUFB1|TMEM126B|NDUFB3|NDUFA1|NDUFB6|NDUFAF7
CELL-TYPE DEPENDENT SELECTIVITY OF CCK2R SIGNALING%WIKIPATHWAYS_20181110%WP3679%HOMO SAPIENS,0.205823090872456,0.7211951452265429,0.425011746870764,1.2543194674463798,2042,10,RYR2|GNAI1|CD38|CNR1
NUCLEAR RECEPTORS META-PATHWAY%WIKIPATHWAYS_20181110%WP2882%HOMO SAPIENS,0.00753498385360603,0.19651475212530603,-0.166326081662195,-1.4221252859354299,6,214,HMOX1|TNFAIP3|SOD3|CAP2|SQSTM1|EPB41L4B|NR1H3|FGD4|SLC2A3|SLC2A6|CES1|G6PD|CBR3|AIP|SLC27A5|PPARA|FOXO1|FTH1|RXRA|AMIGO2|HGF|GSR|HBEGF|SLC6A8|CDC37|PGD|SLC39A4|MAFF|SLC6A6|NQO1|SLC5A2|SLC39A11|PDE4B|AKAP13|FTL|SERPINA1|GSTT2|NRIP1|CDKN1C|PPARGC1A|GSTM5|STOM|THBD|NR3C1|JUN|STAT3|B3GNT5|PRDX1|ACKR3|ACOX1|ABCC4|GSTM3|GSTM1|SLC2A1|SERTAD2|GSTM4|PLK2|HSP90AB1|TNF|PTGR1|SLC7A5
MFAP5-MEDIATED OVARIAN CANCER CELL MOTILITY AND INVASIVENESS%WIKIPATHWAYS_20181110%WP3301%HOMO SAPIENS,0.44489301574485296,0.882168730094648,-0.283289291289166,-0.9969303108572459,2203,11,MFAP5|JUN|MAPK3
DIFFERENTIATION OF WHITE AND BROWN ADIPOCYTE   %WIKIPATHWAYS_20181110%WP2895%HOMO SAPIENS,0.376582981559653,0.853374872190571,-0.24426688400000401,-1.0507818641094,1694,18,EBF3|CEBPA|ZNF423|SMAD1|PPARG|PPARGC1A|MPZL2
ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY%WIKIPATHWAYS_20181110%WP3915%HOMO SAPIENS,0.6897671900378989,0.96731875442989,-0.11867052545558199,-0.900004080129585,1273,114,MAPKAP1|SCD|PIK3C3|MAPK7|MAP3K8|PRKAA1|PRKAG1|NR1H3|MAPK4|MAP3K13|FBP1|FOXO1|RXRA|EIF4EBP1|MAP2K5|MAP4K4|CRK|PTPN1|MAP2K3|RAPGEF1|SHC1|MAPK3|SLC2A1|RHOQ|MAP3K11|MAP2K1|PIK3R1|RPS6KA2|FOXO3
FATTY ACID OMEGA OXIDATION%WIKIPATHWAYS_20181110%WP206%HOMO SAPIENS,0.138047504903029,0.6253295209789561,0.580813954932772,1.33869006538729,1266,5,ALDH1A1|ADH1B|CYP2E1|CYP2D6
METABOLIC REPROGRAMMING IN COLON CANCER%WIKIPATHWAYS_20181110%WP4290%HOMO SAPIENS,0.0068452380952381,0.186147763703182,-0.30929685986319,-1.77251773658247,22,41,LDHA|SLC1A5|PFKL|GPI|G6PD|PKM|ENO1|PGD|IDH3A|PDHB|GAPDH|SHMT2|PGK1|SLC16A3|PSPH|ACLY|TKT|SLC2A1
ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY%WIKIPATHWAYS_20181110%WP2118%HOMO SAPIENS,0.09910428137069599,0.570215774831708,0.27095421024960603,1.3549189319303,1205,59,RYR2|ITGB1|CACNB4|CACNB2|ITGA1|ACTN2|CDH2|ITGA9|ITGA2|CACNA2D1|ITGA4|CACNA1D|ITGA11|ITGB5|LEF1|GJA1|ITGA2B|ATP2A2|DMD|ACTG1|ITGA10|CACNB1|SLC8A1|LAMA2
REGULATION OF SISTER CHROMATID SEPARATION AT THE METAPHASE-ANAPHASE TRANSITION%WIKIPATHWAYS_20181110%WP4240%HOMO SAPIENS,0.15523570324575,0.655445617612729,0.38823350957617403,1.31634920583276,1606,15,BUB1|CDC20|CENPE|PTTG1|BUB1B|ESPL1
METABOLISM OF DICHLOROETHYLENE BY CYP450%WIKIPATHWAYS_20181110%WP3666%HOMO SAPIENS,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
SYNAPTIC VESICLE PATHWAY%WIKIPATHWAYS_20181110%WP2267%HOMO SAPIENS,0.9252193169236009,1.0,0.135443669048467,0.62793039931637,10862,43,UNC13B|AP2A2|DNM3|UNC13A|CPLX3|SLC22A3|STX2|CLTC|SLC1A3|SYT1|DNM1|RAB3A|SLC38A1|STX3|STX1A|SLC18A2|RIMS1|CLTCL1|AP2M1|AP2B1|STX1B
"GPCRS, OTHER%WIKIPATHWAYS_20181110%WP117%HOMO SAPIENS",0.255535452744034,0.7667915624015121,0.25930537396238,1.1765136526038,2965,40,ADGRD1|ADORA3|VN1R1|ADGRV1|F2R|ALG6|CNR1|ADGRL2|GPR176|CELSR2|CCR5|SSTR2|DRD4|ADORA2A|P2RY11|GPR162|GPR135|OR2A9P|CELSR3|ACKR1|ADGRG1|ADGRL3
BREAST CANCER PATHWAY%WIKIPATHWAYS_20181110%WP4262%HOMO SAPIENS,0.702950918398073,0.968941691852291,0.149090134580396,0.8605798587833199,9337,122,FGF19|WNT4|WNT5B|CDK6|HES1|MAP2K2|FGF17|ATR|PIK3R3|SHC2|E2F3|DVL1|JAG2|DDB2|PARP1|APC|FRAT2|E2F2|CETN3|HEYL|RB1|FOS|LEF1|KIT|RAD51|HRAS|GADD45B|HEY2|FGF9|GADD45G|APC2|RPS6KB2|AKT3|ARAF|FZD6|AKT2|BRCA2|E2F1|WNT2B|FZD3|DVL3|RPS6KB1|SP1|ATM|DVL2|BRCA1|AKT1|LRP6|NCOA3
EFFECTS OF NITRIC OXIDE%WIKIPATHWAYS_20181110%WP1995%HOMO SAPIENS,0.876512175962294,0.99438923588415,-0.332597105883716,-0.6749959444970078,5578,3,NOS3
CODEINE AND MORPHINE METABOLISM%WIKIPATHWAYS_20181110%WP1604%HOMO SAPIENS,0.078508231604883,0.532203813468543,0.6707081678306851,1.4212946770155799,700,4,ABCC3|CYP2C8|CYP2D6|ABCB1
VEGFA-VEGFR2 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3888%HOMO SAPIENS,0.00117785630153121,0.09181648161563599,-0.17504154358685697,-1.50204559124052,0,226,DOK1|PRKCD|CTNNB1|BCAR1|PTK2B|PRKAA1|FOXO4|ARRB2|PRKD2|GRB2|PFN1|EIF2AK3|HDAC4|FLNB|MMRN2|FYN|RHOA|MMP2|HDAC5|PLAU|FOXO1|CDH5|PXN|HBEGF|BCL2L1|SOD2|BIN1|ICAM1|ATF6|CRK|RHOC|RAP1A|ETS1|CTNNA1|LIMK1|PTPN1|PLAUR|VAV2|TEAD4|CDC42|MAP2K3|SHB|CXCL8|BCL2|RAPGEF1|SHC1|JUN|PRKCA|STAT3|NFATC2|ACKR3|DKK1|YWHAE|NOS3|MAPK3|FLT1|RAB5A|MYH9|RAC1|MAP2K1|RCAN2|PGF|PIK3R1|CAV1|NDRG1|PAK2|FOXO3
FERROPTOSIS%WIKIPATHWAYS_20181110%WP4313%HOMO SAPIENS,0.000279955207166853,0.0784645998831315,-0.44162518964101705,-2.4293324807862002,0,36,SLC39A8|GCLC|LPCAT3|ACSL1|HMOX1|GSS|PCBP2|CP|MAP1LC3A|FTH1|PRNP|ATG7|ACSL4|FTL|TFRC|TP53|PCBP1|MAP1LC3B|SLC3A2|ACSL3|STEAP3
CYTOKINES AND INFLAMMATORY RESPONSE%WIKIPATHWAYS_20181110%WP530%HOMO SAPIENS,0.5850210970464139,0.9439064862850342,-0.230970083745892,-0.8948392508985581,2772,14,HLA-DRB1|CSF1|CXCL2|CXCL1|HLA-DRA|IL15|PDGFA|TGFB1|CD4|IL1B|IL11|IL6|TNF
SRF AND MIRS IN SMOOTH MUSCLE DIFFERENTIATION AND PROLIFERATION%WIKIPATHWAYS_20181110%WP1991%HOMO SAPIENS,0.7795546558704449,0.981487311948134,0.261964802092225,0.747558037881006,7701,9,SRF|MEF2B|CCND2|ELK1|KLF4|MEF2A|MEF2C
EPITHELIAL TO MESENCHYMAL TRANSITION IN COLORECTAL CANCER%WIKIPATHWAYS_20181110%WP4239%HOMO SAPIENS,0.628212450028555,0.9555196058074541,-0.121523442775387,-0.9282361802216279,1099,119,MMP9|SMAD2|SNAI1|MEF2D|FOXC2|CLDN10|WNT6|WNT11|MAP2K3|KRAS|SHC1|ID1|TP53|MAPK3|WNT3|MAP2K1|TWIST1|PIK3R1|DLL3|EIF5A2|RBPJ
"NON-GENOMIC ACTIONS OF 1,25 DIHYDROXYVITAMIN D3%WIKIPATHWAYS_20181110%WP4341%HOMO SAPIENS",0.0681247759053424,0.50364937614461,-0.212092842361542,-1.3608500164505202,189,61,PRKCH|PLCE1|MAPK7|PRKCD|NRAS|RXRA|RELB|IL6|CAMK2A|ETS1|PLCD1|CXCL8|KRAS|JUN|PRKCA|MAPK3|PLCB4|PLCB1|TNF|CAV1
HEME BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP561%HOMO SAPIENS,0.23801601330976396,0.7507739897770379,0.443460613266992,1.20899260492928,2288,8,ALAS1|CPOX|UROD|UROS|ALAD|HMBS|PPOX
RAC1/PAK1/P38/MMP2 PATHWAY%WIKIPATHWAYS_20181110%WP3303%HOMO SAPIENS,0.104870245289726,0.576995392771813,-0.20289885241919,-1.2978412733017701,294,60,NFKBIA|CTNNB1|NRAS|GRB2|MMP2|FOXO1|EIF4EBP1|PXN|TNIP1|CRK|KRAS|STAT5A|STAT3|TP53|MAPK3|TNIP2|RAC1|PIK3R1|ANGPT2
OSTEOCLAST SIGNALING%WIKIPATHWAYS_20181110%WP12%HOMO SAPIENS,0.0423324341149616,0.40500718739334496,-0.422176207911499,-1.58990752936202,203,13,CTSK|SLC9A1|AIMP2|IFNAR1|ACP5|TNFRSF11A
AFLATOXIN B1 METABOLISM%WIKIPATHWAYS_20181110%WP699%HOMO SAPIENS,0.3775338783738379,0.85375124052253,0.505518362593438,1.0712416999655,3370,4,AKR7A3|EPHX1
EIF5A REGULATION IN RESPONSE TO INHIBITION OF THE NUCLEAR EXPORT SYSTEM%WIKIPATHWAYS_20181110%WP3302%HOMO SAPIENS,0.6013502387617321,0.9506035145731909,-0.37980477582308503,-0.873471640396172,3651,4,XPO4|IGF2BP1|XPO1|EIF5A
RIG-I-LIKE RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3865%HOMO SAPIENS,0.850614822200067,0.991298302704726,0.14683489479199402,0.719243716407567,10237,54,MAPK11|MAPK12|TKFC|MAPK10|MAP3K7|DDX17|TBK1|CXCL10|PIN1|DDX3Y|RIPK1|MAP3K1|MAPK13|MAPK9|TRAF2|ATG12|TRADD|IKBKE|CHUK|DHX58|ATG5|MAPK14|IKBKG|DDX58|IFIH1|FADD|SNW1|NLRX1
CIRCADIAN RYTHM RELATED GENES%WIKIPATHWAYS_20181110%WP3594%HOMO SAPIENS,0.7302444363371031,0.972554563883587,0.141464233844741,0.850414029608504,10007,157,CARTPT|SIRT1|SIX3|EGR3|STAR|GHRL|ARNTL|PRKAA2|NPY2R|BTRC|NPAS2|NR2F6|PROX1|RBM4B|OGT|DHX9|MTA1|MAPK10|MAGED1|MAGEL2|TOP2A|RORA|EZH2|ARNT2|DDC|CREM|CIPC|CLOCK|FAS|HDAC3|METTL3|TIMELESS|RAI1|DRD4|ADORA2A|TH|HEBP1|KCND2|PRF1|SFPQ|NTRK3
PRION DISEASE PATHWAY%WIKIPATHWAYS_20181110%WP3995%HOMO SAPIENS,0.21044303797468397,0.7251658659797621,-0.230356066485857,-1.19509465521526,797,30,BATF|HSPA5|FYN|CASP3|RXRA|PRNP|FGFR1|BCL2|STAT3|MAPK3
DIFFERENTIATION PATHWAY%WIKIPATHWAYS_20181110%WP2848%HOMO SAPIENS,0.464777748895243,0.8928412364521658,-0.19249287629584,-0.985130630696433,1787,29,FGF2|HGF|KITLG|IL6|IGF1|DKK1|FGF10|NT5E
SCFA AND SKELETAL MUSCLE SUBSTRATE METABOLISM%WIKIPATHWAYS_20181110%WP4030%HOMO SAPIENS,0.294729027468448,0.800447413278835,-0.6832092638544252,-1.16859285547533,1984,2,PYY|PPARD
VITAMIN D METABOLISM%WIKIPATHWAYS_20181110%WP1531%HOMO SAPIENS,0.7839347079037801,0.981487311948134,0.303254194361401,0.7458095263132779,7299,6,CYP2R1|RXRB|DHCR7|CYP27B1
MIR-517 RELATIONSHIP WITH ARCN1 AND USP1%WIKIPATHWAYS_20181110%WP3596%HOMO SAPIENS,0.123798076923077,0.607607158836689,-0.539146794732937,-1.36481430967772,720,5,ID2|ID1|CDKN1A
WHITE FAT CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP4149%HOMO SAPIENS,0.0361286919831224,0.38395931615660706,-0.303254288628659,-1.57329296788225,136,30,KLF5|NR1H3|CEBPA|FOXO1|ZNF423|DDIT3|PPARG|CTNNA1|STAT5A|NR3C1|MECOM|TLE3
NICOTINE ACTIVITY ON DOPAMINERGIC NEURONS%WIKIPATHWAYS_20181110%WP1602%HOMO SAPIENS,0.9191330914645791,1.0,0.172372101315968,0.6079315086509599,9626,17,KCNK3|GNAI1|DDC|DRD4|TH
GASTRIC CANCER NETWORK 2%WIKIPATHWAYS_20181110%WP2363%HOMO SAPIENS,0.880117479530082,0.9956508825790341,0.158611542951691,0.670449855289169,9888,31,LBR|RFC4|TOP2A|UBE2T|LMNB2|ATAD2|DSCC1|CHTF18|FANCI|UBE2C|RFC3|RAD17
IL-6 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP364%HOMO SAPIENS,0.0836605255209906,0.5446155515539021,-0.23733034332351602,-1.3665652672494,276,42,IL6ST|AGT|CREBBP|IL6R|PIK3R2|SOCS3|PRKCD|GRB2|VAV1|IL6|BCL2L1|VIP|SHC1|STAT3|MAPK3|RAC1|MAP2K1|PIK3R1
IMATINIB AND CHRONIC MYELOID LEUKEMIA%WIKIPATHWAYS_20181110%WP3640%HOMO SAPIENS,0.0185018050541516,0.285526981228736,-0.40122356405048604,-1.75955519543786,81,19,GADD45A|GAB2|BCR|FLT1|SPRED2|FOXO3
AMPLIFICATION AND EXPANSION OF ONCOGENIC PATHWAYS AS METASTATIC TRAITS%WIKIPATHWAYS_20181110%WP3678%HOMO SAPIENS,0.668602150537634,0.964618776001639,-0.21142516513541798,-0.843182447067807,3108,15,NOTCH1|VEGFA|TCF7L2|VHL|TCF7|EPAS1
GASTRIC CANCER NETWORK 1%WIKIPATHWAYS_20181110%WP2361%HOMO SAPIENS,0.00496345095208014,0.16309466511388698,0.45871683408481606,1.86491869011253,54,27,ESM1|CCNA1|CENPF|ECT2|KIF20B|LIN9|TOP2A|E2F7|APC|KIF15|H3F3A|CEP192|AURKA|NUP107|UBE2C|GATS|TPX2|MYBL2
DNA IR-DOUBLE STRAND BREAKS (DSBS) AND CELLULAR RESPONSE VIA ATM%WIKIPATHWAYS_20181110%WP3959%HOMO SAPIENS,0.303423064140911,0.8056741005671991,0.22945592422611602,1.12394762788445,3651,54,APAF1|ATR|BLM|EXO1|CDC25C|RAD9A|CDKN2A|PARP1|RAD51|H2AFX|DCLRE1C|CHEK2|FANCD2|CASP9|BRCA2|E2F1|RIF1|PRKDC|CHEK1|RAD17|SMC3|ATM|MDC1|BRCA1|MDM2|RAD52|RNF8
ENDOTHELIN PATHWAYS%WIKIPATHWAYS_20181110%WP2197%HOMO SAPIENS,0.00900437355286854,0.208853543990274,-0.353071166473145,-1.78521460635104,34,28,CALCRL|GNA15|CALM1|GNB5|EDNRA|PRKCA|NOS3|GNAS|PLCB1|MAP2K1|RIIAD1|RAMP1
INSULIN SIGNALLING IN HUMAN ADIPOCYTES (DIABETIC CONDITION)%WIKIPATHWAYS_20181110%WP3635%HOMO SAPIENS,0.305075821398484,0.808356844223606,0.439779060248155,1.14465249619404,2896,7,TBC1D4|IRS1|AKT2|RPS6KB1|MTOR|RPS6
STRIATED MUSCLE CONTRACTION%WIKIPATHWAYS_20181110%WP383%HOMO SAPIENS,0.36465706614596,0.85007225273817,-0.22243070629908604,-1.06621313483689,1493,24,VIM|TNNT2|MYOM1|TMOD1|MYL4|DES|TPM3
MIR-124 PREDICTED INTERACTIONS WITH CELL CYCLE AND DIFFERENTIATION %WIKIPATHWAYS_20181110%WP3595%HOMO SAPIENS,0.335803007191109,0.8311444145897029,0.48242116532540796,1.1119092712371799,3081,5,STRADB|STK11
SIMPLIFIED DEPICTION OF MYD88 DISTINCT INPUT-OUTPUT PATHWAY%WIKIPATHWAYS_20181110%WP3877%HOMO SAPIENS,0.0501658374792703,0.440378626703493,-0.43017216113617396,-1.5671603335607702,241,12,TRAF6|UBE2N|TLR1|IRAK1|UBE2V1|JUN|MYD88
GANGLIO SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1423%HOMO SAPIENS,0.0510549363057325,0.443301756236231,0.5041024958784339,1.5379011599489498,512,11,B4GALNT1|B3GALT1|SLC33A1|ST3GAL5|ST8SIA3
DISORDERS OF THE KREBS CYCLE%WIKIPATHWAYS_20181110%WP4236%HOMO SAPIENS,0.188816343723673,0.69611511841804,0.488869349935401,1.27242420637435,1792,7,FH|PDHX|SUCLG1|DHTKD1|SUCLA2|SUCLG2
TYPE II DIABETES MELLITUS%WIKIPATHWAYS_20181110%WP1584%HOMO SAPIENS,0.985376344086021,1.0,-0.131497627193467,-0.524424285110909,4581,15,KCNJ11|PHKA2|IRS1|SURF1|GK|PRKCZ|MTOR|SOCS4|MAPK8|MAPK1|INSR|IKBKB|PIK3R5|PRKCD|TNF
T-CELL ANTIGEN RECEPTOR (TCR)  SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP69%HOMO SAPIENS,0.24307304785894202,0.7565220534116759,-0.163660092253493,-1.1385966814239399,578,81,IL1B|NFKBIA|PRKCD|MAP3K8|PTK2B|GRB2|VAV1|FYN|BCL10|VIM|IL6|REL|CRK|RIPK2|VAV3|CDC42|DBNL|SHC1|JUN|NFATC2|GAB2|MAPK3|MAP2K1|PIK3R1
DNA DAMAGE RESPONSE (ONLY ATM DEPENDENT)%WIKIPATHWAYS_20181110%WP710%HOMO SAPIENS,0.00330812854442344,0.138698523605561,-0.232587264764647,-1.6870569631809398,6,96,FRAT1|PIK3C3|CTNNB1|NRAS|GRB2|ABL1|BBC3|PPP2R5C|RHOA|TCF7L2|FOSL1|PLAU|SOD2|WNT6|WNT11|CDC42|MLKL|KRAS|BCL2|SHC1|JUN|TCF7|TP53|BCL6|CDKN1A|WNT3|RAC1|BIK|PIK3R1|BCL2L11|PMAIP1|FOXO3
ROBO4 AND VEGF SIGNALING PATHWAYS CROSSTALK%WIKIPATHWAYS_20181110%WP3943%HOMO SAPIENS,0.252724077328647,0.7641083395392759,-0.427734412922383,-1.1741022432064199,1437,6,VEGFA|KDR|RAC1
VITAMIN D RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2877%HOMO SAPIENS,0.0016330974414806802,0.104022025878313,-0.220134022397349,-1.67305611787331,2,115,LGALS9|ITGAM|TNFAIP3|CEBPA|S100A8|IGFBP3|ADRA1B|G6PD|FOXO1|MX2|RXRA|MXD1|CBS|CDKAL1|CRACR2A|PNOC|TIMP2|GADD45A|NRIP1|S100A6|THBD|ADRB2|NINJ1|ID1|NFATC2|CD9|ALOX5|TRAK1|BCL6|HLA-DQA2|CDKN1A|CREG2|S100A4|CLPTM1L|DUSP10|ZNF257|BDKRB1|DACT2
LAMIN A-PROCESSING PATHWAY%WIKIPATHWAYS_20181110%WP4299%HOMO SAPIENS,0.175333857030636,0.6781186376189561,-0.641447005624793,-1.30179763968801,1115,3,ICMT|ZMPSTE24|LMNA
PHOTODYNAMIC THERAPY-INDUCED NFE2L2 (NRF2) SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3612%HOMO SAPIENS,0.248733345843498,0.7613646381106121,0.32054552689503496,1.19034557432346,2650,20,ABCC3|MAPK11|MAPK12|EPHX1|FOS|NQO2|GSTP1|NFE2L2|KEAP1|MAPK13
PI3K-AKT-MTOR SIGNALING PATHWAY AND THERAPEUTIC OPPORTUNITIES%WIKIPATHWAYS_20181110%WP3844%HOMO SAPIENS,0.011177540940993,0.22992267312754103,-0.342667279005439,-1.75368584636269,42,29,NRAS|FOXO4|RB1CC1|ATG13|FOXO1|EIF4EBP1|KRAS|TFEB|NOS3|PIK3R1|FOXO3
PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS%WIKIPATHWAYS_20181110%WP2572%HOMO SAPIENS,0.20654468684025304,0.7211951452265429,-0.18650734994028303,-1.18430952026254,586,58,CDKN1B|LAMA5|SYNPO|NOTCH1|LRP5|PLCE1|CTSL|CTNNB1|IRF6|FYN|FAT1|VIM|PODXL|YWHAQ|PLAUR|CDKN1C|LIMS1|DKK1|CDKN1A|MYH9|PARVA
SUDDEN INFANT DEATH SYNDROME (SIDS) SUSCEPTIBILITY PATHWAYS%WIKIPATHWAYS_20181110%WP706%HOMO SAPIENS,0.00814901047729918,0.20082702755141602,-0.197558659905911,-1.5184738102160902,13,122,ADCYAP1R1|YWHAH|IL6|SLC25A4|VAMP2|CHRNA7|PRKAR2A|YBX1|VIPR1|GAPDH|YWHAQ|YWHAB|CDCA7L|PPARGC1A|CXCL8|NR3C1|JUN|PAH|SNTA1|YWHAZ|PRKAR1B|YWHAE|ADCYAP1|NFYA|ALDOA|HTR3A|ASCL1|TSPYL1|SCN5A|TNF|SNAP25
"OLIGODENDROCYTE SPECIFICATION AND DIFFERENTIATION(INCLUDING REMYELINATION), LEADING TO MYELIN COMPONENTS FOR CNS%WIKIPATHWAYS_20181110%WP4304%HOMO SAPIENS",0.0319928904687847,0.36515110892732205,-0.37509085779291207,-1.61355753308755,143,18,IL1B|CNP|LIF|FGF2|MBP|IGF1|SOX6|ASCL1|TNF
INFLUENZA A VIRUS INFECTION%WIKIPATHWAYS_20181110%WP1438%HOMO SAPIENS,0.127763802462598,0.6076669536424699,-0.933722981914424,-1.24906970188198,964,1,BCL2
EVOLOCUMAB MECHANISM%WIKIPATHWAYS_20181110%WP3408%HOMO SAPIENS,0.532885906040268,0.9265056012720759,0.736656374062638,0.9786151283713871,3969,1,LDLR
LIVER X RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2874%HOMO SAPIENS,0.305116758241758,0.808356844223606,-0.442319129893594,-1.1197015058246003,1776,5,SCD|NR1H3|RXRA
PANCREATIC ADENOCARCINOMA PATHWAY%WIKIPATHWAYS_20181110%WP4263%HOMO SAPIENS,0.8347928994082842,0.988613522932093,0.13940693565412698,0.753058066993398,10580,85,CDK6|RAC3|MAP2K2|PIK3R3|E2F3|PAK3|MAPK10|DDB2|TGFB2|CDKN2A|ARHGEF6|E2F2|RB1|RAD51|GADD45B|GADD45G|BAD|RAC2|RPS6KB2|CASP9|AKT3|ARAF|PEBP1|AKT2|BRCA2|MAPK9|E2F1
CHOLESTEROL BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP197%HOMO SAPIENS,0.787963678516229,0.9819233677232551,0.217991568981619,0.7391248350005941,8156,15,MVD|NSDHL|IDI1|HMGCR|MSMO1|DHCR7|MVK|HMGCS1|FDPS
GENES TARGETED BY MIRNAS IN ADIPOCYTES%WIKIPATHWAYS_20181110%WP1992%HOMO SAPIENS,0.281986701591779,0.7899371443259041,0.395531910521295,1.1673168542185801,2798,10,HCN2|KCNQ1|GJA1|HAND2|SRF
AMYOTROPHIC LATERAL SCLEROSIS (ALS)%WIKIPATHWAYS_20181110%WP2447%HOMO SAPIENS,0.4364501679731239,0.878651088001772,-0.18454955644342702,-1.01518718202451,1558,36,CASP3|BCL2L1|BID|NEFH|BCL2|TP53|RAB5A|RAC1|TNF
ARYL HYDROCARBON RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2873%HOMO SAPIENS,0.25726781579624397,0.7678777890071629,-0.2274017929833,-1.14979936311248,999,28,HSP90AA1|CYP1B1|CDKN1B|BAX|AHR|IL1B|CAP2|AIP|CDC37|NQO1|JUN|TNF|SLC7A5
KENNEDY PATHWAY FROM SPHINGOLIPIDS%WIKIPATHWAYS_20181110%WP3933%HOMO SAPIENS,0.784346459785918,0.981487311948134,0.229908001500883,0.7419985779926601,7986,13,PTDSS2|CEPT1|CHKB|ETNK1|CHKA|ETNK2|CHPT1|PCYT1B
PROLACTIN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2037%HOMO SAPIENS,0.0226835832372165,0.31609926985007897,-0.22416964610664397,-1.5072803236655399,58,71,PTPN6|CTSD|NFKBIA|SIRPA|GRB2|VAV1|FYN|CASP3|EIF4EBP1|PXN|PTPN1|VAV2|STAT5A|SHC1|JUN|NFKBIB|STAT3|YWHAZ|GAB2|MAPK3|RAC1|MAP2K1|PIK3R1|RPS6KA2
"4-HYDROXYTAMOXIFEN, DEXAMETHASONE, AND RETINOIC ACIDS REGULATION OF P27 EXPRESSION%WIKIPATHWAYS_20181110%WP3879%HOMO SAPIENS",0.425905354365696,0.875696962448429,-0.23551276072441102,-1.01312357075609,1916,18,PRKAA1|EIF4EBP1|MAP2K3|MAPK3|MAP3K11|MAP2K1
NANOPARTICLE TRIGGERED AUTOPHAGIC CELL DEATH%WIKIPATHWAYS_20181110%WP2509%HOMO SAPIENS,0.510509784972216,0.918404893008545,-0.20381776704645102,-0.9577226434879291,2112,23,ATG9B|MAP1LC3A|ATG3|SH3GLB1|ATG7|BECN1|BCL2
HEMATOPOIETIC STEM CELL GENE REGULATION BY GABP ALPHA/BETA COMPLEX%WIKIPATHWAYS_20181110%WP3657%HOMO SAPIENS,0.356046931407942,0.84417352062618,-0.24272336640883901,-1.06445682329141,1577,19,DNMT3A|SMAD4|CREBBP|TERF2|GZMB|ETV6|BCL2L1|BCL2|FOXO3
WNT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP363%HOMO SAPIENS,0.946645865834633,1.0,-0.109456091977446,-0.647303802508704,3033,46,CSNK1D|PI4K2A|AXIN2|CSNK1A1|LRP5|FRAT1|CTNNB1|ARRB2|CTBP1|RHOA|TCF7L2|PPARG|TCF4|PRKCA|NFATC2|RAC1
SIMPLIFIED INTERACTION MAP BETWEEN LOXL4 AND OXIDATIVE STRESS PATHWAY%WIKIPATHWAYS_20181110%WP3670%HOMO SAPIENS,0.37293002775916495,0.852609194081082,0.31035553766980106,1.0759184838145401,3895,16,SIRT1|NRF1|DDR1|IGFBP7|NFE2L2|FN1|ECSIT|SUV39H1|EXOC6
CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER %WIKIPATHWAYS_20181110%WP4216%HOMO SAPIENS,0.0205745341614907,0.301753477122268,-0.223353552710477,-1.50839492742007,52,72,CTNNB1|TGFBR1|BBC3|RHOA|TCF7L2|CASP3|REL|SMAD2|RALA|GADD45A|KRAS|BCL2|JUN|TCF7|TP53|RALB|MAPK3|CDKN1A|RAC1|MAP2K1|BCL2L11|PMAIP1|APPL1
HEART DEVELOPMENT%WIKIPATHWAYS_20181110%WP1591%HOMO SAPIENS,0.927579635175606,1.0,-0.12290710608898402,-0.6574018990477,3406,33,NFATC3|FOXC1|HAND1|NOTCH1|VEGFA|CTNNB1|SMAD1|FOXC2|TBX20|NFATC2|FGF10
REGULATION OF WNT/B-CATENIN SIGNALING BY SMALL MOLECULE COMPOUNDS%WIKIPATHWAYS_20181110%WP3664%HOMO SAPIENS,0.92989247311828,1.0,-0.159971305595409,-0.6379798583871271,4323,15,APC|LEF1|DVL2|LRP1|TNKS|SFRP4|DKK3|FZD8|AXIN1|FZD7|GSK3B|CSNK1A1|FZD1|CTNNB1|TCF4
EBV LMP1 SIGNALING%WIKIPATHWAYS_20181110%WP262%HOMO SAPIENS,0.9112105511069242,1.0,-0.14556193420181102,-0.6611126088181091,3868,21,MAP3K7|CCL5|TRAF1|PDLIM7|TRADD|CHUK|IKBKG|MAP3K3|MAPK8|NFKB2|MAP3K14|MAPK1|NFKB1|IKBKB|HSP90AA1|RELA|TRAF6|IRAK1|NFKBIA|CXCL8|TNF
ELECTRON TRANSPORT CHAIN (OXPHOS SYSTEM IN MITOCHONDRIA)%WIKIPATHWAYS_20181110%WP111%HOMO SAPIENS,0.96750986307728,1.0,0.10873245277094301,0.6054174279480711,12506,100,NDUFA7|NDUFS7|UQCR11|NDUFA4|ATP5G1|NDUFS2|COX5A|ATP5D|NDUFC1|NDUFS4|MT-ATP8|COX6A1|UCP3|NDUFS8|NDUFB2|COX8A|SDHA|ATPIF1|MT-ND2|NDUFV1|COX7B|NDUFS3|ATP5C1|NDUFB7|NDUFA12|MT-CO2|COX11|MT-CYB|ATP5E|SURF1|ATP5H|MT-ATP6|MT-CO1|ATP5A1|NDUFB1|UQCR10|NDUFB3|NDUFA1|NDUFB6|MT-ND3|COX7C|SDHB|UQCRB|COX7A1|ATP5G3|COX17|UQCRFS1|MT-CO3|COX6C|MT-ND1|MT-ND4|UQCRQ|ATP5L|UQCRC2|COX7A2
MONOAMINE GPCRS%WIKIPATHWAYS_20181110%WP58%HOMO SAPIENS,0.00145107794361526,0.0961252072968491,-0.5972077579429449,-2.17568776805776,6,12,CHRM4|ADRA2C|ADRA1B|HTR1B|ADRB2|DRD2|ADRA2A|CHRM1|HRH1
IRON METABOLISM IN PLACENTA%WIKIPATHWAYS_20181110%WP2007%HOMO SAPIENS,0.6363455414012739,0.9592476055325171,0.28265411650777506,0.8623129169082321,6393,11,TFR2|MCOLN1|SLC40A1|TF|ACO1
"DEGRADATION PATHWAY OF SPHINGOLIPIDS, INCLUDING DISEASES%WIKIPATHWAYS_20181110%WP4153%HOMO SAPIENS",0.266666666666667,0.7806336876737892,-0.37348998841634995,-1.1609695043158001,1435,8,ARSA|HEXA|NEU3|GLB1|GLA|NEU1|GM2A|NEU4
WNT SIGNALING PATHWAY AND PLURIPOTENCY%WIKIPATHWAYS_20181110%WP399%HOMO SAPIENS,0.43542280185107296,0.878651088001772,-0.14691716837014498,-1.0178955039903,1034,80,AXIN2|CD44|CREBBP|FBXW2|PPP2R2A|LRP5|PPARD|FZD1|PRKCH|FRAT1|PRKCD|CTNNB1|CTBP1|PPP2R5C|RHOA|TCF7L2|FOSL1|PLAU|PPP2CA|PPP2CB|WNT6|WNT11|PPP2R1B|PPM1J|JUN|TCF7|PRKCA|TP53|NFYA|WNT3
MAPK  AND NFKB SIGNALLING PATHWAYS INHIBITED BY YERSINIA YOPJ%WIKIPATHWAYS_20181110%WP3849%HOMO SAPIENS,0.9118687364904701,1.0,0.194813793103448,0.614122695727228,9280,12,MAP2K6|MAP3K1|CHUK|IKBKG|RAF1|RRAS|MAP3K14|MAPK1|NFKB1|IKBKB
METAPATHWAY BIOTRANSFORMATION PHASE I AND II%WIKIPATHWAYS_20181110%WP702%HOMO SAPIENS,0.183569273613367,0.689876118998471,0.21993228652633898,1.22070418493554,2372,98,HS3ST4|CYP4X1|GAL3ST3|CYP21A2|AKR7A3|MGST1|GLYATL2|CYP2C8|GSTA4|GSTO2|AKR1B1|CYP3A5|NAT10|HS3ST5|GAL3ST4|NAA40|NAT9|INMT|CYP2R1|EPHX1|SULT1A3|AKR1C1|MGST3|FMO5|GSTP1|MGST2|CYP7B1
REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070873,0.8490288134032958,0.991298302704726,0.178339346562321,0.6935979712858139,9222,23,INS|PHKG2|PASK|GCK|IRS1|AKT2|VIMP|GSK3A|AKT1|PPP1R3B|PPP1R3E|SORBS1
MONOUBIQUITINATED PROTEIN DEUBIQUITINATION%GOBP%GO:0035520,0.9267206477732791,1.0,0.209271708499429,0.5971899527737429,9155,9,USP47|ATXN3|MYSM1|USP1|USP15|USP7
HISTONE H3-R2 METHYLATION%GOBP%GO:0034970,0.9990322970847951,1.0,0.28852457401805,0.47158548999878996,8258,2,CARM1
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0045938",0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
GLYCOPHAGY%GOBP%GO:0061723,0.28062360801781705,0.7890335436983149,-0.690763716570168,-1.181514342255,1889,2,FAM47E-STBD1|RB1CC1
REGULATION OF DNA-TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS%GOBP%GO:0043620,0.000364564345607,0.0784645998831315,-0.307431231222474,-2.0029347369715103,0,64,HIF3A|ATF4|HIF1A|NOTCH1|VEGFA|IMPACT|BCLAF1|MAPK7|HMOX1|HSPA5|LIMD1|HIGD1A|CITED2|BACH1|DDIT3|ATF6|NEDD4|VHL|BAG3|TCEB1|HSF1|JUN|UBA52|TP53|UBC|SESN2|EPAS1|RBPJ|UBB|EGLN3
NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010977,0.6841046277666,0.966495577318169,-0.130008867221811,-0.8859303082533849,1699,75,LPAR1|RTN4|SRGAP2C|SEMA3F|RHOA|SEMA7A|YWHAH|EFNA1|BAG5|SPOCK1|SEMA6B|FKBP4|MYLIP|ZNF365|SEMA3A|SEMA3G|LINGO1|RTN4RL2
DETECTION OF CELL DENSITY BY CONTACT STIMULUS%GOBP%GO:0060246,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
MULTI-ORGANISM LOCALIZATION%GOBP%GO:1902579,0.0363545816733068,0.384708132326922,-0.318600538872845,-1.56442208693075,145,26,UBA52|CAV2|RAB7A|THOC7|UBC|CAV1|UBB
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071880,0.000985027580772262,0.0849637591935908,-0.652777906762627,-2.20844536636492,4,10,ADRA2C|ADRA1B|AKAP13|ADRB2|DRD2|ADRA2A|PDE4D
LEFT/RIGHT AXIS SPECIFICATION%GOBP%GO:0070986,0.8676623827717959,0.993084774742015,0.370242879302632,0.7037927654653291,7493,3,AHI1|SETDB2
HISTONE H3-K36 DIMETHYLATION%GOBP%GO:0097676,0.706834249803614,0.969403752544852,-0.397595676629536,-0.8069086126332999,4498,3,SETMAR|ASH1L|SETD2
CELLULAR RESPONSE TO CGMP%GOBP%GO:0071321,0.332176055549334,0.8293509737209019,0.523398369909531,1.1091311434555902,2965,4,HCN2|PDE2A
REGULATION OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:1905550,0.0923533778767632,0.5622489437340121,-0.815219189412738,-1.39438876314344,621,2,RTN4|DDRGK1
NOR-SPERMIDINE METABOLIC PROCESS%GOBP%GO:0046204,0.337986577181208,0.832232043362884,0.835355094838994,1.10973197566067,2517,1,SAT2
ACTIN POLYMERIZATION-DEPENDENT CELL MOTILITY%GOBP%GO:0070358,0.38347978910369107,0.8582519754973359,-0.3771992719651429,-1.0353866744653701,2181,6,ACTR3|ARPC3|NCKAP1L|EPS8|ARPC2|JMY
REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002724,0.304828519855596,0.808356844223606,-0.25140115836114,-1.1025130475083,1350,19,TNFRSF1B|IL6|SMAD7|NLRP3|B2M
COENZYME METABOLIC PROCESS%GOBP%GO:0006732,0.7637378160757171,0.978421368343614,0.13416539882492198,0.8490065897112379,10812,228,ACSM3|FDXR|RGN|HACD1|CROT|GPHN|ACSF2|OXSM|GSTO2|GAMT|HSD17B4|MAT2A|MCCC2|GGH|NUDT17|PARP16|CD38|COQ3|SCD5|ELOVL6|FTCD|RBKS|DGAT1|NAPRT|DHFR|FAR2|ACBD6|MVD|NNT|MTHFD1|COQ2|ME1|ACOT1|PGLS|IDH1|PDHX|FAR1|COQ6|BST1|RFK|SLC46A1|GCK|PCCB|RNLS|PDHA1|ACOT2|SLC25A1|ACACA|PTGS2|SUCLG1|DLD|ACSS1|MCEE|NADK
CELLULAR RESPONSE TO STARVATION%GOBP%GO:0009267,0.000983767830791933,0.0849637591935908,-0.226755508508465,-1.67013845817264,1,102,EIF2S1|IMPACT|PIK3C3|RRAGD|STK26|PRKAA1|HSPA5|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|FAM65A|MAP1LC3A|KLF10|FOXO1|SEH1L|NUAK2|SH3GLB1|ATG7|BECN1|C12orf66|TP53|GABARAPL1|RALB|MAPK3|GABARAP|CDKN1A|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|PMAIP1|INHBB
NEGATIVE REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071901,0.932836406433896,1.0,0.120950344830794,0.660206147950667,11888,90,RGS2|SIRT1|BMP4|STK38|RGS14|DUSP16|DUSP8|DUSP19|CDKN2A|MEN1|APC|RGS3|PRKAR2B|NF1|APOE|ZNF675|GSTP1|PLK1|TESK1|SMPD1|PTPRJ|CDK5RAP3|PTPN22|DUSP1|SORL1|SPRY4|DNAJA1|PPP2R1A|SPRY1|INCA1|TFAP4
AUTOPHAGY OF MITOCHONDRION%GOBP%GO:0000422,0.000277700638711469,0.0784645998831315,-0.4398753009245461,-2.3911651980729602,0,35,SQSTM1|RB1CC1|CTSK|ATG13|MAP1LC3B2|ATG9B|MAP1LC3A|ATG3|ATG7|BECN1|GABARAPL1|GABARAP|PARK2|FBXO7|WIPI2|MAP1LC3B|GABARAPL2|SPATA18
COAGULATION%GOBP%GO:0050817,0.00182815356489945,0.11072851755770098,-0.19021102055889003,-1.59224848092834,1,192,GNA13|HMG20B|FCER1G|DGKI|PRKCD|DGKD|PDPN|ARRB2|VAV1|HBG2|GNAQ|FYN|ITPK1|P2RX6|C1QBP|DGKQ|MFN2|CLIC1|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|MAFF|PRKAR2A|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|THBD|PROC|RAD51B|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ANO6|CSRP1|MAPK3|GNA12|RAB5A|DGKB|BLOC1S3|MYH9|VWF|GNAS|H3F3B|RAC1|CD36|PIK3R1|ZFPM2|DGKK
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0010466,0.315019937970758,0.8164430838831159,-0.15063126074028502,-1.08087326645954,710,90,MAGEA3|SPOCK3|SERPINI1|DDX3X|MAP2K5|HGF|MMP9|LAMTOR5|BIN1|SPOCK1|SERPINF2|TIMP2|GAPDH|SERPINF1|PLAUR|SNCA|SERPINA1|CSTB|YWHAE|DNAJB6|CSNK2A1|AQP1|PAK2
SEGMENTATION%GOBP%GO:0035282,0.0942649360213569,0.5630268609168221,0.36088286337533293,1.4035468152928101,1023,23,RIPPLY2|TBX3|BASP1|HOXD8|HES1|BMP4|MTF2|LEF1|HES6|LFNG
FOREBRAIN CELL MIGRATION%GOBP%GO:0021885,0.183212996389892,0.689588734821136,-0.28260034568812703,-1.2393362480213401,811,19,DAB2IP|RTN4|SRGAP2C|MBOAT7|RELN|DRD2|SLIT3
PULMONARY VALVE MORPHOGENESIS%GOBP%GO:0003184,0.7151335311572701,0.971081608033886,0.230795479367496,0.80010533756456,7470,16,BMP4|ROBO2|TGFB2|HEYL|HEY2
ACTIN FILAMENT BUNDLE ORGANIZATION%GOBP%GO:0061572,0.846358940176637,0.991298302704726,0.14786783797810502,0.7211996222173279,10157,53,FSCN2|ITGB1|SHROOM2|HSP90B1|FHDC1|TNFAIP1|LIMA1|SRC|ITGB5|DPYSL3|SHTN1|KCTD13|PLS3|SPIRE2|SPIRE1|PDXP|FMN2|BAIAP2L2
POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070564,0.6542881335430021,0.9640743070248079,0.5464571271022879,0.8931691621932409,5408,2,CYP27B1|SNW1
POSITIVE REGULATION OF CELL GROWTH%GOBP%GO:0030307,0.14074427480916002,0.6296802030037281,-0.166911314609341,-1.21289301201468,294,97,MAP3K13|ADAM10|S100A8|SPHK1|NRP1|DDX3X|EXOSC4|CPNE6|EIF4G1|SEMA7A|POU4F2|ISLR2|IGF1|LIMK1|EXOSC9|CDC42|FXN|ADAM17|MTPN|SLC25A33|BCL2|TWF2|SYT2|SFRP2|H3F3B|CPNE9|CSNK2A1
POSITIVE REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070165,0.236510067114094,0.7504968809113829,0.8842082046757829,1.17463115258709,1761,1,C1QTNF3
DNA EXCISION%GOBP%GO:0044349,0.287114093959732,0.796019542850327,0.859505955006617,1.14181531594709,2138,1,PNKP
POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:2000786,0.256735650136665,0.767462394426418,-0.361453545095439,-1.16680443419693,1314,9,SH3GLB1|PIP4K2A|RALB
SPERMATID NUCLEUS DIFFERENTIATION%GOBP%GO:0007289,0.936118848653668,1.0,-0.195888474675606,-0.6089066705900501,5040,8,CHD5|PYGO2|PSME4|TSSK6|PIWIL1
CYSTEINE BIOSYNTHETIC PROCESS%GOBP%GO:0019344,0.169426890390063,0.673117535978459,0.561154933222505,1.29337893462802,1554,5,CTH|GGT1|GGT5
REGULATION OF T CELL MIGRATION%GOBP%GO:2000404,0.554101615377673,0.933232670829823,0.229388256734059,0.932580658674018,6139,27,CXCL13|STK39|DOCK8|XCL2|CCL21|CCL5|CD200|CXCL10
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071402,0.0418968692449355,0.402998391331252,-0.34963802356225104,-1.5600518169456201,181,20,PPARG|ABCA1|ADAM17|CD9|TICAM1|MYD88|CD36|CDH13
TRNA EXON LIGATION%GOBP%GO:0000968,0.22957765126439802,0.743365122901021,-0.884483899426555,-1.1832010799509198,1733,1,RTCB
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0019885,0.670298539986925,0.964618776001639,0.364523749535937,0.840173205132385,6151,5,TAP2|ERAP1
CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:0097709,0.499942109528772,0.9143688619793578,0.516605890646455,0.9820134532190681,4317,3,F2R|TGFB1|HIF1A
MESONEPHRIC TUBULE DEVELOPMENT%GOBP%GO:0072164,0.6046357615894039,0.9508825506493929,0.24351557120799103,0.8900866707046551,6390,19,CITED1|BMP4|PKD2|ROBO2
DNA TOPOLOGICAL CHANGE%GOBP%GO:0006265,0.905198468668144,1.0,0.21163983775834802,0.624603838698631,8984,10,TOP2A|TOP3B|TOP2B|TOP1|HMGB2|HMGB1|ERCC3
POSITIVE REGULATION OF TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:1904075,0.209982788296041,0.7248363921442859,-0.893581826202029,-1.19537165399193,1585,1,IGF1
NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010757,0.6875136195249509,0.966986590843215,0.35830167091384796,0.8258322362787479,6309,5,SERPINE2|THBS1|SERPINE1
ESTABLISHMENT OF MITOCHONDRION LOCALIZATION%GOBP%GO:0051654,0.743816254416961,0.9749763305090959,-0.189328915306775,-0.7966742995050329,3367,17,HAP1|TRAK1|UBB
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903392,0.20965971459934102,0.7248363921442859,-0.296185892152685,-1.2129807736213998,954,16,BCAS3|DLC1|APOD|ACVRL1|CORO1C
INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032366,0.844740116779937,0.991298302704726,0.198748839795865,0.689008328894637,8824,16,STAR|LDLRAP1|LDLR|ARV1|OSBP|SERAC1|SYT7|LRP6
ASPARAGINE METABOLIC PROCESS%GOBP%GO:0006528,0.0530276716452472,0.449202695711989,0.7656910405633409,1.4554981204368302,457,3,ASNS|ASRGL1|NIT2
CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086001,0.0419277959219702,0.402998391331252,0.355539020046135,1.53255941677074,474,33,RYR2|KCNN2|SCN1A|CACNA1G|CACNB2|FGF12|HCN2|KCNQ1|CACNA2D1|KCNH2|CACNA1D|GJA1|DMD|SCN3B|SLC8A1
INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032611,0.453559393428812,0.8877670623536891,0.3879406383003449,1.0097279751224,4306,7,AIM2|GBP5|F2RL1|NLRC4
PLATELET DEGRANULATION%GOBP%GO:0002576,0.562955760816723,0.9377499854039181,-0.129779742908966,-0.953272548012053,1157,101,APLP2|SOD1|VTI1B|SRGN|CLU|FAM49B|VEGFA|PCDH7|A1BG|PSAP|WDR1|HGF|LYN|HABP4|IGF1|SERPINF2|TMSB4X|CFD|SERPINA1|CLEC3B|CTSW|CD9|ABCC4|ALDOA|VWF|IGF2|TAGLN2|CD36
DNA GEOMETRIC CHANGE%GOBP%GO:0032392,0.21522309711286103,0.732094216765764,0.27676679757142797,1.22165872053026,2459,36,PIF1|MTERF1|BLM|DHX9|DNA2|RAD51|RTEL1-TNFRSF6B|ZRANB3|HNRNPA2B1|RECQL5|SUPV3L1|WRNIP1|HMGB3|POT1|ANXA1|HMGB2|DDX11|RAD50|NBN|HMGB1|PURA|ASCC3|DDX1|RTEL1|RECQL|ERCC3|RPA1
NUCLEOTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:1901679,0.8898664571877449,0.997300970905927,-0.326516456464395,-0.6626554471645251,5663,3,SLC25A33
MULTI-MULTICELLULAR ORGANISM PROCESS%GOBP%GO:0044706,0.33022934988791197,0.8291761235173739,0.245243542729346,1.1061116619528202,3829,39,TAC1|TEKT3|GHRL|IDO1|CRHBP|OXTR|OVGP1
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:1904406,0.293964716805942,0.8004058897916541,-0.36296550645072295,-1.12825483192893,1582,8,SIRPA|ATP2B4|CAV1
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS%GOBP%GO:0060560,0.0323375423467816,0.36706102728241996,-0.257779507666616,-1.5150119918144398,104,45,ALCAM|FLRT1|COBL|FGF10|S1PR1|SEMA3A|HSP90AB1|TMEM108|SLIT3
MECHANORECEPTOR DIFFERENTIATION%GOBP%GO:0042490,0.07676808382027,0.527286041772797,0.493690963332832,1.4570095786058999,761,10,STRC|ADGRV1|DFNB31|JAG2|PDZD7|MYO7A|LRTOMT
RESPONSE TO VIRUS%GOBP%GO:0009615,0.7652509652509649,0.9792236089291529,-0.108998482364019,-0.8821586935687651,990,161,PLSCR1|CXCL12|RELA|MX1|BNIP3|HMGA1|EIF2AK2|AGBL5|PYCARD|RIOK3|SETD2|SERINC3|ABCC9|HSPB1|RNASEL|CLU|APOBEC3F|BANF1|LGALS9|DDIT4|IFNAR2|FGR|DDX3X|EXOSC4|IFNAR1|IFITM2|FOSL1|MX2|IFITM3|IL6|OASL|ENO1|DFNA5|APOBEC3B|MST1R|ATG7|LAMTOR5|MAVS|AP1S1|CNOT7|FMR1|OAS3|PDE12|ODC1|BCL2|BCL3|ZC3HAV1|BNIP3L|EXOSC5|IFITM1|TNF|PMAIP1
ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0046165,0.412171052631579,0.867015886388254,0.208985995546096,1.04175342607189,5011,58,TM7SF2|C14orf1|EBP|PPIP5K2|DHFR|ISYNA1|MVD|LBR|CACNA1H|DHCR24|SRD5A3|PPAPDC2|PGP|APOE|NSDHL|GGPS1|ACER2|HMGCR|MOXD1|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7|PTS|PCK2|PPIP5K1
RESPONSE TO FORSKOLIN%GOBP%GO:1904321,0.623271290423209,0.9536478716552259,0.321644890384495,0.876890263203645,5993,8,GNAI1|ADCY8|ADCY1|ADCY6
TRANSEPITHELIAL AMMONIUM TRANSPORT%GOBP%GO:0070634,0.0033869602032176103,0.140033065594047,0.957981803143093,1.56579493993776,27,2,SLC12A2|RHBG
REGULATION OF ANGIOGENESIS%GOBP%GO:0045765,0.0150517403574788,0.264387156924099,-0.166464786460566,-1.3936394266751702,15,195,DLL1|TBXA2R|MYDGF|FAM129B|BTG1|GATA2|RHOJ|FOXC1|HTATIP2|HIPK1|HIF1A|MECP2|HSPB1|NOTCH1|IL1B|VEGFA|ITGB8|KDR|MTDH|CTNNB1|DAB2IP|FOXO4|HMOX1|TNFAIP3|WARS|PRKD2|PML|MMRN2|PDCL3|SPHK1|RHOA|ITGA5|HDAC5|PKM|RUNX1|FGF2|MAP2K5|ADAMTS9|CDH5|IL6|SMAD1|PPARG|APLNR|CHRNA7|ECSCR|SPINK5|MEOX2|FOXC2|ETS1|FOXJ2|PDCD10|PGK1|SERPINF1|RAMP2|AGO2|HK2|CXCL8|CTSH|PRKCA|ADM2|SARS|NOS3|FLT1|CHI3L1|SFRP2|BMPER|PTPRM|TMEM2|THBS4|PGF|TWIST1|AQP1|GLUL
RECOMBINATIONAL REPAIR%GOBP%GO:0000725,0.195878749303843,0.7094584893557679,0.229794520455386,1.2176911674355901,2461,77,MUS81|FBXO18|CDC7|XRCC3|RAD54B|BLM|CDC45|PARP1|TONSL|FEN1|GEN1|POLQ|NABP1|POLN|SLX1B|INO80|MMS22L|RAD51C|RAD51|NIPBL|RAD51AP1|SLX4|SFPQ|EXD2|RMI1|PALB2|BRCA2|XRCC2|GINS2|RECQL5|XRCC1|ZFYVE26|SPIDR|RFWD3|BRCA1|POLL|RAD52|YY1
REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901252,0.705270972531552,0.968941691852291,-0.477346039725816,-0.816474835932388,4749,2,FMR1
REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0006446,0.0018429782528566199,0.11072851755770098,-0.273637603609369,-1.79186565565633,4,65,EIF5|ATF4|PPP1R15B|EIF3H|NCK2|HSPB1|DNAJC3|EIF2S1|IMPACT|EIF2AK3|DDX3X|EIF2AK1|PAIP2B|EIF4A2|UHMK1|EIF4G1|YTHDF1|EIF4EBP1|HABP4|EIF3B|EIF1|EIF4H|NPM1|FMR1|EIF4B|AGO2|NCBP2|POLR2D|EIF1B
POSITIVE REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000052,0.800472508591065,0.9841161968820359,0.29741625687619605,0.731451969282101,7453,6,MLLT3|DAB2|CSNK1E
PEPTIDYL-LYSINE BUTYRYLATION%GOBP%GO:0140067,0.9867602277240831,1.0,-0.507002646669607,-0.678232898831038,7452,1,EP300
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0002053,0.46544318625536896,0.893601276092646,-0.302405119152692,-0.976190823797413,2383,9,FGFR2|STAT1|CHRD|MYC|PDGFA|TGFBR2|TBX1|LRP5|VEGFA
CELLULAR RESPONSE TO INTERLEUKIN-9%GOBP%GO:0071355,0.373592444605885,0.852609194081082,-0.35900915781270104,-1.04724564112722,2056,7,STAT5A|STAT3
REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050730,0.000626174076393237,0.0806484601749226,-0.301853334423807,-2.36425838618407,0,132,AGT|DUSP22|CD44|IL6R|RAP2C|SOCS3|THY1|NCK2|FBXW7|PTPN6|ZGPAT|HAX1|IL11|VEGFA|CRLF1|PRKCD|PTK2B|TNK2|LIF|ABL1|PDCL3|FGF7|FYN|NRP1|ITGA5|DGKQ|ARL2BP|HGF|TNFRSF18|IL6|LYN|RAP2B|PRNP|EFNA1|DOCK3|BANK1|PPP2CA|IGF1|RIPK2|CNOT7|PTPN1|ARHGEF2|ADAM17|SHC1|STAT3|CSPG4|RELN|TP53|SNX6|SOCS5|ADRA2A|FGF10|GREM1|EPHA7|SFRP2|THBS4|ACE|IGF2|GPRC5B|TNF|CAV1|PAK2
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086044,0.8529061300145641,0.991298302704726,-0.5721217468019411,-0.765344704542779,6441,1,GJA5
TOLL-LIKE RECEPTOR TLR1:TLR2 SIGNALING PATHWAY%GOBP%GO:0038123,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|CD14|TLR1
REGULATION OF APOPTOTIC PROCESS INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1902256,0.274765100671141,0.7884684708511421,0.865846934274371,1.15023902401317,2046,1,TGFB2
MORPHOGENESIS OF A BRANCHING EPITHELIUM%GOBP%GO:0061138,0.174244486795535,0.676682497340677,-0.231406762375117,-1.2377416561068701,639,33,RASIP1|NOTCH4|FGF1|ENG|NRARP|LRP5|VEGFA|CTNNB1|NRP1|FGF2|PAX8|NPNT|CTSH|FGF10|SFRP2|MET
REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034163,0.46676835911963394,0.8946422270258639,0.43353842018126204,0.99924179013146,4283,5,FCRL3|PTPRS|HMGB1|RAB7B|RSAD2
PRENYLATION%GOBP%GO:0097354,0.586352148272957,0.9447006447658759,0.345571923362951,0.8994511118123141,5567,7,CHML|RABGGTA|FNTB|CHM|FNTA|PGGT1B
POSITIVE REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900373,0.05416862929816299,0.454914205138535,-0.330500640012182,-1.5010664809632,229,21,PRKAA1|PFKFB4|ENO1|IGF1|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905064,0.797400185701021,0.9831554850651141,-0.237670758455413,-0.738784200894692,4293,8,PDCD4|NFATC2
LONG-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0035336,0.580794701986755,0.942746898746279,0.248144362496267,0.9070056110694541,6138,19,HACD1|ELOVL6|DGAT1|FAR2|FAR1
NEGATIVE REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061218,0.35030845530422194,0.842847021021096,0.664571271022884,1.08622348564611,2895,2,BMP4|GATA3
RESPONSE TO RAFFINOSE%GOBP%GO:1901545,0.925989672977625,1.0,-0.535233789148655,-0.7159985588855781,6993,1,ZFP36L1
REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000960,0.875883739198743,0.9941329456747149,-0.33318627991618,-0.676191655690763,5574,3,SUPV3L1|PNPT1|SLIRP
CELLULAR RESPONSE TO ETHANOL%GOBP%GO:0071361,0.39242685025817603,0.8621064456029929,-0.8016651962946629,-1.0724119756503,2963,1,ADCY7
NEGATIVE REGULATION OF HISTONE METHYLATION%GOBP%GO:0031061,0.12360668789808901,0.607607158836689,0.44818866617475606,1.3673208826015202,1241,11,MTF2|DNMT3B|JARID2|SUPT6H|BRCA1|DNMT1|PHF1|BCOR|PIH1D1|SMARCB1|H2AFY
NEGATIVE REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001797,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905453,0.401073825503356,0.8638522656500329,0.806517423908249,1.07142241636888,2987,1,DPF2
HISTIDINE CATABOLIC PROCESS%GOBP%GO:0006548,0.39921268959129297,0.8638522656500329,0.554442078998849,1.05393606705935,3447,3,FTCD|C9orf41|HNMT
SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0071173,0.10475192838777302,0.576535954147525,0.387052859176194,1.38843751472427,1099,18,TPR|CENPF|BUB1|CDC20|APC|BUB1B|KLHL22|PLK1|TEX14|ATM
NEGATIVE REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904733,0.5608053691275171,0.936434965680841,0.7230921923246579,0.960595718073531,4177,1,METTL20
CEREBELLAR GRANULAR LAYER MORPHOGENESIS%GOBP%GO:0021683,0.305077358901722,0.808356844223606,0.494767354471309,1.1403654070008702,2799,5,KIF14|PROX1
NEGATIVE REGULATION OF PROTEIN FOLDING%GOBP%GO:1903333,0.9887692485816841,1.0,0.26735820757475304,0.50821982757185,8539,3,PDCD5|SNRNP70
MANGANESE ION TRANSPORT%GOBP%GO:0006828,0.975135847192491,1.0,-0.239122042684608,-0.5499307438300861,5921,4,TRPC1|SLC30A10|SLC11A2|SLC11A1
PRENYLCYSTEINE CATABOLIC PROCESS%GOBP%GO:0030328,0.72299504052256,0.971955586175348,0.518356595015685,0.847239614464462,5976,2,PCYOX1L
NEGATIVE REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0045916,0.9374782910732891,1.0,0.325419165127764,0.6185876000966479,8096,3,CD55|SERPING1|A2M
CELL WALL MANNOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0000032,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
OOCYTE DIFFERENTIATION%GOBP%GO:0009994,0.7515923566878979,0.9767810577656971,0.252575317975684,0.770549397523617,7551,11,ZCCHC11|YTHDC2|ZP3|KMT2D|ZCCHC6|NPM2|C17orf104
NEGATIVE REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903901,0.144264602392681,0.6340340930337739,-0.19620247612311104,-1.24587293983902,409,58,IFI16|ISG15|TRIM11|GSN|PLSCR1|MX1|EIF2AK2|SNX3|CCNK|TRIM8|RNASEL|TRIM13|APOBEC3F|BANF1|PML|INPP5K|IFITM2|IFITM3|OASL|MAVS|TRIM35|TNIP1|OAS3|ZC3HAV1|PARK2|IFITM1|TNF
REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:1901623,0.13643307236967697,0.62388141596544,0.38007852221102795,1.34048205973905,1428,17,CXCL13|STK39|KLRK1|XCL2|CCL21|CCL5|CXCL10|CCL2
"BLOOD COAGULATION, FIBRIN CLOT FORMATION%GOBP%GO:0072378",0.992658423493045,1.0,0.134249750750833,0.45518881916459397,10275,15,F12|F3|KLKB1|GP1BB|F8|FBLN1|F10|SERPING1|TFPI|F13A1|PRCP
RESPONSE TO CAPSAZEPINE%GOBP%GO:1901594,0.675704697986577,0.9647315640607691,0.666795324217027,0.885807840373891,5033,1,TRPV1
CEREBELLAR CORTEX STRUCTURAL ORGANIZATION%GOBP%GO:0021698,0.416596104995766,0.8709670999109399,0.6357077650432099,1.03904687804923,3443,2,KIF14|DLL1
"COMPLEMENT ACTIVATION, ALTERNATIVE PATHWAY%GOBP%GO:0006957",0.21834348756792396,0.7341474817293291,-0.5309656427507861,-1.2211100557186498,1325,4,C3|CFB|CFP|CFD
TRACHEA SUBMUCOSA DEVELOPMENT%GOBP%GO:0061152,0.37449664429530205,0.852609194081082,0.8182620202911339,1.08702458869995,2789,1,LEF1
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:2000810,0.15702296819788,0.6578589353509621,-0.305157178499949,-1.28406630876462,710,17,PRKACA|SNAI2|PRKCH|MYO1C|NPHP1|RUNX1|SNAI1|CBFB|TNF
LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002443,0.0740740740740741,0.52179529593396,-0.124180802082,-1.19089119942857,13,481,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|IGHV2-26|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|IRAK4|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|EXOSC6|GPI|NFAM1|ULBP3|ADAM10|IGHV1-69-2|GNL1|S100A8|IGHV3-15|HLA-DQB1|RHOA|STK10|IGHV3-73|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|IL6|PNP|CD68|FCGR2B|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|CAMK4|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|RFTN1|STOM|ADAM17|IGHV1-3|ULBP2|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|ACE|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4|RNF168
POSITIVE REGULATION OF RNA BINDING%GOBP%GO:1905216,0.0128133704735376,0.246174278900529,-0.59051030010742,-1.8355631253088602,68,8,EIF3C|NCBP1|EIF3D|CDK9|EIF4G1|FMR1|LARP6
ELECTRON TRANSPORT CHAIN%GOBP%GO:0022900,0.5625268586162441,0.937224075004388,-0.135463098458106,-0.9524812201109271,1308,85,NDUFB9|CYC1|PPARGC1A|NDUFA9|NDUFS1|CYB561|NDUFV3|NDUFS5|COX10|SLC25A13|SLC25A18|COX4I2|NDUFS6
REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000479,0.0159618573797678,0.268309042246402,-0.48432463327512304,-1.76444322159394,76,12,PRKAR2A|ATP2B4|ADRB2|PRKAR1B|PKIG|HTT
ESTABLISHMENT OF SERTOLI CELL BARRIER%GOBP%GO:0097368,0.38368860055606996,0.8582519754973359,-0.8059108954565501,-1.07809157686944,2897,1,RAB13
POSITIVE REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070101,0.24487669329628303,0.757467559003634,0.6212975617826679,1.18102130689859,2114,3,EDN1|TREM2
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0061394,0.9923793395427599,1.0,0.315855206025531,0.516256657198635,8203,2,ATF3|ATF4
ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034314,0.10822784810126598,0.58452352834625,-0.35739909539878795,-1.38465871255572,512,14,WHAMM|ARPC5|ARPC5L|ARPC4|ACTR2|JMY
PHOSPHOLIPID HOMEOSTASIS%GOBP%GO:0055091,0.0570054945054945,0.464600390996799,-0.6105569890956739,-1.54558447482617,331,5,ABCA1|ABCG1|FABP3
CELLULAR RESPONSE TO PURINE-CONTAINING COMPOUND%GOBP%GO:0071415,0.49108676975945004,0.9092105079917561,0.3969839039614289,0.9763240966574208,4572,6,RYR2|SLC8A1|P2RY6|GSTM2|TRPM2
NEURAL RETINA DEVELOPMENT%GOBP%GO:0003407,0.0798166889440519,0.534078458829271,0.4118873537174729,1.4526672148686002,835,17,TSPAN12|SDK1|DSCAM|SMARCD3|AHI1|FOXN4|TGFB2|TFAP2B|SMARCA4|TOPORS
POLYUBIQUITINATED PROTEIN TRANSPORT%GOBP%GO:0070844,0.45006711409396,0.886062942999295,0.7804367004852231,1.03677533884496,3352,1,HDAC6
FERROUS IRON TRANSPORT%GOBP%GO:0015684,0.398389261744966,0.8638522656500329,0.808226731363035,1.07369315506495,2967,1,SLC40A1
REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010632,0.000809716599190283,0.0849637591935908,-0.21349056345610198,-1.74347132218275,0,170,RAB11A|MAPRE2|TBXA2R|AGT|PPM1F|GATA2|RHOJ|RREB1|STRAP|CALR|RAB25|HIF1A|MECP2|HSPB1|NOTCH1|VEGFA|KDR|BCAS3|PTPRG|DAB2IP|RTN4|BCAR1|PTK2B|HMOX1|EPB41L4B|PRKD2|PFN1|ABL1|GPI|MMRN2|FGF7|ZNF580|RHOA|NRP1|HDAC5|AAMP|FGF2|MAP2K5|PPAP2B|DOCK5|ADAMTS9|PPARG|MMP9|GLIPR2|MEOX2|FOXC2|MAP4K4|FOXP1|ETS1|TMSB4X|PDCD10|FGFR1|MAP2K3|ATOH8|IQSEC1|ADAM17|STAT5A|CTSH|PRKCA|NOS3|FGF10|BMPER|PTPRM|ACVRL1|DUSP10|MET|CORO1C|SH3BP1|STC1|GLUL|ANGPT2
MIDDLE EAR MORPHOGENESIS%GOBP%GO:0042474,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
POSITIVE REGULATION OF METANEPHRIC CAP MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0090096,0.8932874354561099,0.9976191001250191,-0.551554918394354,-0.737831831104609,6746,1,MYC
PROTEIN LOCALIZATION BY THE CVT PATHWAY%GOBP%GO:0032258,0.93170007423905,1.0,-0.3648094734970301,-0.623987066471015,6274,2,BECN1
HEART PROCESS%GOBP%GO:0003015,0.11723163841807901,0.59848124656036,0.272445770787241,1.3345254816856,1410,54,RYR2|KCNN2|SCN1A|CACNA1G|GAA|CACNB2|FGF12|MYLK2|KCNQ1|TCAP|CACNA2D1|TAZ|KCNH2|SRC|CACNA1D
REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:1905666,0.5339629495096261,0.9265056012720759,-0.31621621621621604,-0.92241673194014,2939,7,SORL1|MGAT3|RDX|ROCK2|DTX3L|EZR|MSN
RRNA ACETYLATION INVOLVED IN MATURATION OF SSU-RRNA%GOBP%GO:1904812,0.12093959731543599,0.607251067511504,0.940174239082488,1.24897953247459,900,1,NAT10
REGULATION OF METANEPHRIC URETERIC BUD DEVELOPMENT%GOBP%GO:2001074,0.102281879194631,0.573450707099996,0.9485553595059549,1.2601134770488798,761,1,BASP1
NEGATIVE REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001920,0.9686233645941881,1.0,0.29530164332193704,0.5613373593881421,8365,3,TRAT1|AP1AR|OPTN
TRNA N2-GUANINE METHYLATION%GOBP%GO:0002940,0.448893189790734,0.8856469044703779,0.6230493520816099,1.01835704981044,3710,2,TRMT1|TRMT1L
REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034391,0.34988179669030706,0.842847021021096,-0.317155268085857,-1.07298374373006,1775,10,MFN2|PPARG|IGF1|SOD2|PDCD4
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0060973,0.752577319587629,0.9769690538700708,0.31348716744266997,0.770976033317703,7007,6,DCHS1|FLRT3|PDGFRB|MESP1|SNAI2|NOTCH1
DORSAL ROOT GANGLION DEVELOPMENT%GOBP%GO:1990791,0.21647027671124106,0.7328218014339442,-0.890604322893692,-1.19138855703305,1634,1,POU4F2
MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904948,0.773697973414687,0.980096450857848,0.329361249878708,0.7591288559642171,7100,5,NR4A2
POSITIVE REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900227,0.7375267577803392,0.974306231601101,-0.341679720772185,-0.785791978382084,4478,4,CD36
PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019363,0.0302652106084243,0.35738308321874895,-0.258958188557386,-1.53143253258578,96,46,PFKL|GPI|PKM|PNP|ENO1|NAMPT|GAPDH|PGK1|HK1|NMNAT3|HK2|TPI1|ALDOA|PGAM2|NMNAT2
PROLINE BIOSYNTHETIC PROCESS%GOBP%GO:0006561,0.72975697166536,0.972554563883587,0.3818576716121811,0.8091928830915409,6515,4,PYCR2|ALDH18A1|PYCR1
MALONATE CATABOLIC PROCESS%GOBP%GO:0090410,0.5890374685555411,0.945418171231938,-0.699658138509043,-0.935954024281354,4448,1,ACSF3
POSITIVE REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000481,0.631985664688095,0.9580150657116279,0.41641521691266203,0.8824236226919829,5642,4,SIRT1
REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051769,0.507757404795487,0.9179996794142941,0.326900218225137,0.964766999150597,5039,10,EDN1|JAK2|GSTP1|CCL2|VIMP
LYSINE BIOSYNTHETIC PROCESS VIA AMINOADIPIC ACID%GOBP%GO:0019878,0.805491714043789,0.984682960940884,0.48502894954507897,0.792766493506736,6658,2,AASS|AASDHPPT
FLAVONOID METABOLIC PROCESS%GOBP%GO:0009812,0.8480706423128102,0.991298302704726,0.463821613432426,0.7581036852302091,7010,2,SULT1A3
NEGATIVE REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900126,0.989159465828751,1.0,-0.25747215175912697,-0.5225320821615639,6295,3,CLTC|TGFB1|AP2A1
POSITIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STARVATION%GOBP%GO:0071264,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|IMPACT
REGULATION OF PROTEINASE ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:1900276,0.025949953660797002,0.33512489842855103,-0.987704014115571,-1.32128177452533,195,1,BICD1
NEGATIVE REGULATION OF PROTEIN PHOSPHORYLATION%GOBP%GO:0001933,0.00143266475644699,0.0961252072968491,-0.16663844380273998,-1.48671282753745,0,267,PYCARD|PIK3R2|DUSP4|STRAP|SOCS3|THY1|CDKN1B|CRKL|DUSP7|PPP1R15B|NCK2|ITCH|HSPB1|HEXIM1|GPER1|DNAJC3|FLCN|PTPN6|QARS|ZGPAT|LRP5|IL1B|HEG1|IMPACT|PRKCD|SIRPA|DAB2IP|IGF1R|TRIB1|CNKSR3|WARS|DDIT4|RGS4|CEBPA|ABL1|GNAQ|FAM129A|IGFBP3|SMAD6|INPP5K|DGKQ|FOXO1|MYADM|EIF4G1|PPAP2B|UBASH3B|RASSF2|LYN|PRNP|CHP1|CYLD|LDLRAD4|TRIB2|PPP2CA|PRKAR2A|TNIP1|NPM1|PTPN1|SMAD7|TRAF3IP1|CDKN1C|PDCD4|MECOM|DUSP3|UCHL1|DKK1|SNX6|PRKAR1B|PKIG|SOCS5|CDKN1A|DBNDD2|PARK2|GREM1|SFRP2|DUSP10|SLC9A3R1|CORO1C|FKBP8|SNX25|TWIST1|DLG1|PDE4D|SPRED2|INSM1|CAV1|EPHB2|PAK2|PARD3|TRIB3
MITOCHONDRIAL RIBOSOME ASSEMBLY%GOBP%GO:0061668,0.870787700084246,0.9934031064448321,0.253886840811063,0.660814104976299,8268,7,MTERF3|MTERF4|MPV17L2|FASTKD2
REGULATION OF THYMIDYLATE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0050758,0.705576388048869,0.968941691852291,0.526661152467604,0.860813185480085,5832,2,APBB1|FOLR2
POSITIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045870,0.27906132817225104,0.788692060817727,0.6957816377171221,1.1372359726089099,2306,2,TOP2A|TOP2B
OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0002072,0.5518930957683741,0.9321968967758479,-0.540998070030328,-0.9253482247835692,3716,2,SOX11|PHACTR4
B CELL HOMEOSTASIS%GOBP%GO:0001782,0.524071955911407,0.92593403131991,0.34915407944988697,0.9518876928573051,5039,8,DOCK10
POSITIVE REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050857,0.9354430379746841,1.0,-0.161295721734842,-0.624902327043968,4433,14,TRAT1|TESPA1|SLC39A10|LCK|RAB29|PTPRC|KCNN4|RELA|PVRL2|PRKCH|PRKD2|NFAM1|RPS3
IMPORT INTO CELL%GOBP%GO:0098657,0.0313390313390313,0.3625267385964289,-0.135979767824627,-1.2661403803126499,10,389,ABI1|IGHV2-26|CXCL16|ITGAM|ARRB2|NR1H3|DPYSL2|GRB2|FGR|HP|ABL1|VAV1|MYO1C|MARCO|IGHV1-69-2|CYFIP2|CALCRL|RABEPK|IGHV3-15|FYN|IGHV3-73|SLC9A1|HYOU1|RIN3|HEATR5A|EHD1|LYN|FCGR2B|ARRB1|TOM1|ARPC5|SLC11A1|YES1|SLC39A4|RAB1A|BIN1|RAB39A|ATP2B4|WIPF1|CRK|CLTA|DENND1A|AP1S1|LIMK1|VAV3|SNCA|CD93|VAV2|ARPC4|RAMP2|CDC42|AP2S1|TFRC|NEDD4|CXCL8|IGHV1-3|ADRB2|KCNJ14|ANXA11|CD9|ACKR3|COLEC12|RINL|MAPK3|CAV2|RAB7A|SYT2|RAB22A|RAB5A|MYH9|RHOQ|SLC3A2|RAC1|PLD2|MET|CORO1C|CACNG3|ACTR2|BRK1|CD36|ADM|SH3BP1|SLC7A1|PIK3R1|CACNG7|HSP90AB1|TMEM108|AMPH|SNAP25|CAV1|MICALL1|GLUL|RAMP1
POSITIVE REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014049,0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
LUNG GROWTH%GOBP%GO:0060437,0.0653303637713437,0.495991045493396,-0.84637441411635,-1.44767810643186,439,2,FGF7|FGF10
ANTIBACTERIAL HUMORAL RESPONSE%GOBP%GO:0019731,0.258371796130806,0.7697239279946541,0.368522566671032,1.1893593030387,2630,13,HIST1H2BJ|JCHAIN|HIST1H2BF|RNASE6|HIST1H2BK|HIST1H2BG|HIST2H2BE
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING%GOBP%GO:0021914,0.7946308724832221,0.9821540323303699,0.603992059991178,0.802376505702109,5919,1,CHRD
EMBRYONIC HINDGUT MORPHOGENESIS%GOBP%GO:0048619,0.316510067114094,0.8176737565328901,0.8458314953683279,1.12364940637852,2357,1,DACT1
POSITIVE REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901582,0.912080536912752,1.0,0.545710189677989,0.7249516411296121,6794,1,ATRX
RESPONSE TO IRON(II) ION%GOBP%GO:0010040,0.9760333449114279,1.0,0.286362403154294,0.5443448042022211,8429,3,ACO1|IREB2
NEGATIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045079,0.775855812265634,0.980614374126555,0.49587821062997295,0.810499312703359,6413,2,SIGIRR
EXOSOMAL SECRETION%GOBP%GO:1990182,0.190259230164965,0.698434241409875,-0.628487923238116,-1.2754975670155,1210,3,COPS5|RAB27A|RAB11A
GENERATION OF CATALYTIC SPLICEOSOME FOR FIRST TRANSESTERIFICATION STEP%GOBP%GO:0000349,0.9970968912543849,1.0,0.29707143781917306,0.485555104085641,8242,2,XAB2|PRPF19
ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0003228,0.419983065198984,0.872690030459269,0.634322990443826,1.03678350200852,3471,2,PROX1|ENG
REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031279,0.5726020777965689,0.940734934957679,-0.19506949371178198,-0.916615238645616,2369,23,STIM1|ORAI1|CAP1|GNAI3|CAP2|CRHR1|GNAI2|GRM2|NOS3|GUCA1A|MAPK3
CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO SPINDLE MIDZONE%GOBP%GO:0035853,0.38130544154640506,0.8569411612769741,-0.80690339655933,-1.07941927585573,2879,1,KLHL21
METANEPHRIC TUBULE MORPHOGENESIS%GOBP%GO:0072173,0.420935412026726,0.8727872721376851,-0.602768145766519,-1.03100263113668,2834,2,PAX8
REGULATION OF PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:2000167,0.8069432684165959,0.984682960940884,0.48431210366694205,0.7915948286118301,6670,2,NPHP3|NPHP3-ACAD11
DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0050651,0.298817181987964,0.8023890191280308,-0.296577743137262,-1.11690611175791,1439,13,CSPG4|CSGALNACT1|NCAN
NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION%GOBP%GO:1904761,0.8590942835931701,0.99166790097654,-0.4101593676933739,-0.701555631708886,5785,2,PDCD4
POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:0001941,0.35075653370013804,0.842847021021096,0.34792422500041603,1.09678149355986,3569,12,GPHN|DNAJA3|APOE|DLG4|NLGN4Y|NLGN3|NRXN2|NLGN2
LATE ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0034499,0.638805970149254,0.960516115253472,-0.422300650711371,-0.857046623515369,4065,3,SGSM2|RAB7B|GCC2
PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060389,0.5568137446310041,0.935991922942961,-0.281486431038928,-0.9086634239975899,2851,9,TGFBR1|ACVR1|SMAD7
NEGATIVE REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060546,0.170826010544815,0.673817672117118,-0.469710813815144,-1.2893246451478502,971,6,SLC25A4|ARHGEF2|PELI1
NEGATIVE REGULATION OF OOGENESIS%GOBP%GO:1905880,0.209982788296041,0.7248363921442859,-0.893581826202029,-1.19537165399193,1585,1,IGF1
REGULATION OF AXONOGENESIS%GOBP%GO:0050770,0.428118964851294,0.8769245997339999,0.18465857752872103,1.0301939256219899,5541,101,SEMA3D|BRSK2|ZSWIM5|CDH2|DSCAM|PLXNC1|PTPRO|MARK2|FGF13|ZSWIM8|PAK3|ROBO2|SEMA5A|CTTN|MAP6|PLXNA3|SEMA3E|CHN1|RUFY3|APOE|SEMA4G|TRIM46|SEMA6A|PLXNB2|SEMA4C|SHTN1|RTN4R|LRRC4C|GOLGA4|PLXNB3|MACF1|BRSK1|PLXNA2|NTN1|PTPRS|SLITRK1
NEGATIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000342,0.803711952487008,0.984522820758988,-0.437275985663082,-0.747937154472908,5412,2,KLF4|MAP2K5
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION%GOBP%GO:0090500,0.0816967792615868,0.539385377100419,-0.7310576817028791,-1.4836598443383702,519,3,ENG|EFNA1|ACVRL1
CELLULAR RESPONSE TO HIGH DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071403,0.139414802065404,0.6281603901381739,-0.9276025584472869,-1.2408822247998401,1052,1,ADAM17
OXIDATIVE SINGLE-STRANDED RNA DEMETHYLATION%GOBP%GO:0035553,0.8732128829536528,0.9934031064448321,-0.334433538109486,-0.6787229291364089,5557,3,ALKBH5
SPHINGOSINE-1-PHOSPHATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0003376,0.5874312647289871,0.945418171231938,-0.43986854124696395,-0.892700135392404,3738,3,S1PR1
POSITIVE REGULATION OF ERAD PATHWAY%GOBP%GO:1904294,0.322301875675145,0.822751772025005,0.34933984614500896,1.1274495336552,3281,13,TMEM259|SGTA|ATXN3|USP13|NFE2L2|HERPUD1|BAG6
REGULATION OF FASL BIOSYNTHETIC PROCESS%GOBP%GO:0045219,0.9103355704697991,1.0,0.5467026907807679,0.726270134566041,6781,1,JAK3
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900035,0.5998940818217929,0.9503391896930079,-0.693978826643141,-0.9283566356375691,4530,1,CD34
NEGATIVE REGULATION OF HAIR CYCLE%GOBP%GO:0042636,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
AMINE CATABOLIC PROCESS%GOBP%GO:0009310,0.9902953586497891,1.0,-0.130715849671626,-0.506427807028955,4693,14,TDO2|SMOX
NEGATIVE REGULATION OF ANDROGEN BIOSYNTHETIC PROCESS%GOBP%GO:2000180,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
REGULATION OF CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:1905304,0.593538991129353,0.9464278097528599,-0.6972320247022501,-0.932708537870417,4482,1,SMAD4
SPLICEOSOME CONFORMATIONAL CHANGE TO RELEASE U4 (OR U4ATAC) AND U1 (OR U11)%GOBP%GO:0000388,0.838342380511055,0.989395884107905,-0.579179532421703,-0.7747861195564141,6331,1,SNRNP200
REGULATION OF OPIOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000474,0.6957500330994311,0.96731875442989,-0.647441552712836,-0.866102305391414,5254,1,SYP
NEGATIVE REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002695,0.997939778129953,1.0,0.0843249403946395,0.45122061399284297,12593,81,PAG1|CEACAM1|GLMN|INHA|BMP4|THOC1|MARCH7|LOXL3|CD200|DLG5|TIGIT|BTN2A2|LDLR|TNFAIP8L2|PLA2G2D|CEBPB|SOCS1|PTPN22|CTLA4|ATM|MILR1|RC3H1|FER|SLA2|TNFRSF14|XCL1|PIBF1|MNDA|PDCD1LG2|ANXA1|NDFIP1|JAK3|MICA|FOXP3|HMGB1|SDC4|ZC3H8|LILRB2|KIAA0922|PTPN2|ZC3H12A|PTPRC
GLYCEROL-3-PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046168,0.8290745399179141,0.9876441563834109,-0.5837009263343629,-0.7808345260495241,6261,1,GPD2
NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0006289,0.541669873028088,0.928807195199472,0.171165495662127,0.958574888906857,7038,103,GTF2H2|SIRT1|MMS19|POLE|LIG4|BRIP1|RFC4|GTF2H1|DDB2|ATXN3|PNKP|POLR2B|POLD1|PARP1|RNF111|ZNF830|POLD3|DDB1|FANCC|CHD1L|PPIE|GTF2H2C|LIG1|CDK7|POLR2L|SLX4|CUL4B|BRCA2|POLR2J|ERCC5|XAB2|COPS7B|XPA|RBX1|XRCC1|RFC3|AQR|POLR2G|RFC5|POLR2H
POSITIVE REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031937,0.36206717271498406,0.848718251568698,0.39829725688390905,1.08586517884587,3481,8,SIRT1|SIRT6
NEGATIVE REGULATION OF SNARE COMPLEX ASSEMBLY%GOBP%GO:0035544,0.24966735212289803,0.7613646381106121,0.709456851392335,1.15958773368095,2063,2,PRRT2|ANKRD27
NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045650,0.24862806585283898,0.7613646381106121,0.55955748112153,1.18575575421208,2219,4,INHA|PTPN2|C1QC|INHBA
REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043405,0.105204872646733,0.5780683131727099,-0.14016023616856302,-1.19468678577439,94,216,IL1B|IRAK1|VEGFA|PKN1|PLCE1|PRKCD|DAB2IP|IGF1R|C5AR1|TGFBR1|TRIB1|IRAK2|PRKAA1|GDF15|RGS4|MAP3K13|RPS3|RET|INPP5K|UBE2V1|FGF2|MAP2K5|LYN|TRIB2|CHRNA7|MST1R|PPP2CA|IGF1|DIRAS1|CRK|RIPK2|PDCD10|PTPN1|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|PDCD4|RAPGEF1|SHC1|UBA52|DUSP3|UCHL1|DKK1|MAPK3|FLT1|ADRA2A|FGF10|PEA15|DUSP10|MAP3K11|UBC|MAP2K1|TNF|SPRED2|CAV1|EPHB2|TRIB3|UBB|ADORA2B
POSITIVE REGULATION OF MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1903438,0.564775613886537,0.9380162603437769,0.5800385993934379,0.948057156116115,4668,2,KIF20B|NUP62
POSITIVE REGULATION OF CELL MOTILITY%GOBP%GO:2000147,0.0024330900243309,0.12475047644874301,-0.16535489505373901,-1.5157010187467,0,351,DAB2IP|IGF1R|RTN4|NSMF|TGFBR1|CXCL16|LGALS9|BCAR1|PTK2B|ACVR1|HMOX1|PDPN|HSPA5|ELP6|AKIRIN1|EPB41L4B|PRKD2|PFN1|SRGAP2C|FGR|ABL1|SEMA3F|GPI|MYO1C|MGAT5|ADAM10|CAMK1D|RET|SPHK1|FGF7|ZNF580|RHOA|FAM65A|NRP1|C1QBP|ZNF703|AAMP|PLAU|MYADM|CPNE3|PTRF|SEMA7A|FGF2|PPAP2B|HGF|DOCK5|TNFRSF18|IL6|HBEGF|PODXL|ITGA6|MMP9|ELP3|GLIPR2|SNAI1|IGF1|SOD2|ICAM1|FOXC2|MAP4K4|FOXP1|CEMIP|RHOC|ETS1|TMSB4X|PDCD10|WNT11|ARHGEF2|KARS|FGFR1|MAP2K3|LGALS3|ATOH8|SEMA6B|IQSEC1|AGO2|ADAM17|CXCL8|STAT5A|CTSH|PRKCA|STAT3|NOS3|ANO6|OXSR1|FLT1|PLVAP|ADRA2A|FGF10|CFAP20|THBS4|SEMA3A|RAC1|MET|DDRGK1|CFAP69|SEMA3G|LAMC2|PGF|TWIST1|CDH13|TNF|CAV1
"CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043367",0.965563208175961,1.0,-0.13516198465699,-0.581436827902531,4345,18,SLAMF6|RORA|LEF1|PLA2G2D|ZFPM1|ATP7A|FOXP3|HMGB1|LY9|PTGER4|RSAD2|SPN|RORC|GPR183|BATF|IL6|FOXP1|STAT3
REGULATION OF INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060730,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048745,0.0816133108677338,0.539385377100419,0.5586593607183779,1.4540729415530198,774,7,BMP4|PROX1|PKD2|NF1|MYLK
NEGATIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1902010,0.0328346352442738,0.3701663677878951,-0.983623731804146,-1.3158234564705702,247,1,SESN2
TRNA WOBBLE BASE CYTOSINE METHYLATION%GOBP%GO:0002127,0.269694161260426,0.784543299601953,-0.8652955447728281,-1.1575322328826,2036,1,NSUN3
ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045197,0.31012496812037704,0.8127836045326109,-0.22044326439645603,-1.0985122251302,1215,27,CDC42|MSN|SLC9A3R1|SH3BP1|DLG1|PARD3
ABSCISSION%GOBP%GO:0009838,0.85083896273698,0.991298302704726,0.29978002218994104,0.6909485113072161,7808,5,AURKB|SPG20|ZFYVE19|IST1
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902110,0.0392405063291139,0.396089810860281,-0.415435305124813,-1.6095063534015501,185,14,BNIP3L|BMF|BCL2L11|PMAIP1
DNA CLAMP UNLOADING%GOBP%GO:0090618,0.67122293455909,0.964618776001639,0.5399689389639729,0.88256439692212,5548,2,ATAD5
SEPTUM PRIMUM DEVELOPMENT%GOBP%GO:0003284,0.792288989232372,0.9819233677232551,0.4074674848754051,0.774552824777648,6842,3,TGFB2|SOX4
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045638,0.0968949383241174,0.5696404237080971,0.29272360223508803,1.3721094058806202,1138,45,CARTPT|HOXA5|CEACAM1|CDK6|INHA|WDR61|MEIS2|TMEM178A|FBN1|HIST1H4I|ZNF675|MEIS1|PRMT1|FSTL3|CDC73
DUTP CATABOLIC PROCESS%GOBP%GO:0046081,0.405369127516779,0.866234596232951,0.8044221438023821,1.06863893022531,3019,1,DUT
GANGLIOSIDE GM1 TRANSPORT TO MEMBRANE%GOBP%GO:1905572,0.292334171852244,0.8002225157099201,-0.8538266431407149,-1.14218993348544,2207,1,PSAP
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903321,0.110836569008119,0.584830174998513,-0.202588320093791,-1.29058805620532,313,59,VPS28|PINX1|MAGEA2|CTNNB1|TNFAIP3|ARRB2|ABL1|RPS3|TRIP12|ARRB1|CHP1|BAG5|LIMK1|PRMT3|SMAD7|GNL3L|NXN|PER2|CAV1
SIGNAL RELEASE%GOBP%GO:0023061,0.490728762397585,0.9091242810779291,-0.139317230335938,-0.9845231727373449,1137,86,NAAA|RAB11FIP2|IL6|VAMP2|VIP|STX11|RAB1A|BLOC1S6|HRH3|OTOF|SNPH|ADCYAP1|SYT2|PDZD11|RAB11FIP5|GAL|SYT9|SNAP25|CPLX1
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION%GOBP%GO:0010626,0.561205062157017,0.936434965680841,0.43993581520359204,0.932266017275077,5010,4,DICER1|RNF10|CERS2
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001237,0.000364963503649635,0.0784645998831315,-0.30877348513196995,-1.9993151836657599,0,63,MAPK7|TGFBR1|ACVR1|HMOX1|TNFAIP3|PSME3|TCF7L2|FAIM2|TNFRSF10A|MAP2K5|UNC5B|ITGA6|BCL2L1|IGF1|ICAM1|ARHGEF2|LGALS3|EYA4|BCL2|CFLAR|TNFRSF4|NOS3|TNFRSF10B|SCG2|HTT|EYA1|PEA15|TNF
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902230,0.782453455751084,0.981487311948134,-0.156030822296056,-0.7775323335852871,3067,27,CCAR2|CXCL12|CD44|TAF9|SNAI2|CLU|ZNF385A|BCL2L1|SNAI1|BCL2|ACKR3|SFRP2
RESPONSE TO COCAINE%GOBP%GO:0042220,0.512747875354108,0.9189160303470669,0.41819955241888596,0.963887973795971,4705,5,CRHBP|ABAT|DRD4
PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0006611,0.7666765490661129,0.9792236089291529,0.139687194488042,0.8236654503971809,10343,138,RANBP17|EGR2|NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|DUSP16|CCHCR1|UPF3B|WDR33|CPSF1|STRADA|SRSF1|NUP205|STRADB|ANKLE1|NUP188|NUP160|ABCE1|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|RANBP3|CSE1L|CPSF2|DDX39B|XPO6|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|XPOT|UPF2|XPO4|U2AF2|RPSA|XPO5|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
L-LYSINE CATABOLIC PROCESS%GOBP%GO:0019477,0.855838926174497,0.991298302704726,0.5731693868548741,0.761429959537468,6375,1,PIPOX
POSITIVE REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0045838,0.27095141700404896,0.7859916652660799,0.41253359059914,1.17722991442083,2676,9,LINC00116|ANK3|BAD|AKT2|VCP|AKT1|STOML2|GLRX
NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903799,0.26713532513181,0.781492336955999,-0.42192929237218,-1.15816757708145,1519,6,NCOR1|ZC3H12A|BCDIN3D|ZC3H10|TGFB1|NCOR2
ENDOCARDIUM FORMATION%GOBP%GO:0060214,0.660487038491752,0.964586948392425,-0.414598499936113,-0.841415337357933,4203,3,SOX17
RENAL SODIUM ION ABSORPTION%GOBP%GO:0070294,0.670950561537571,0.964618776001639,0.45538766957097204,0.8656440548697071,5794,3,KLHL3|SGK1|MAGED2
REGULATION OF PYRUVATE KINASE ACTIVITY%GOBP%GO:1903302,0.245369127516779,0.757844460290484,0.8800727834142041,1.1691374299353101,1827,1,JMJD8
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090200,0.000510073960724305,0.0784645998831315,-0.46954782299411296,-2.3398493270116805,1,27,MFF|MOAP1|APOPT1|DNM1L|CHCHD10|BNIP3|PYCARD|BAX|GPER1|PPIF|CIDEB|BBC3|HRK|MMP9|BID|PLAUR|TP53|BMF|BIK|BCL2L11|PMAIP1
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032784",0.8246180963572272,0.9876441563834109,-0.134480831658409,-0.7587754280819441,2806,39,CCNK|SUPT16H|HTATSF1|CDK9|TCEA2|ELL3|ELL|THOC5|SUPT4H1|TCEB1|EAPP|RNF168
REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0048167,0.713130837453889,0.971081608033886,0.15448510184481,0.842068668657293,9085,89,CALB1|RIMS2|SLC8A3|KAT2A|INS|AGER|ADCY8|RGS14|GRIK2|ADGRB1|CPEB3|PPFIA3|CDC20|JPH4|APOE|GRIN1|SHISA7|PRRT2|CALB2|DLG4|BRSK1|SLC24A1|RIMS4|NPAS4|ADCY1|SLC8A2|TSHZ3|SHANK1|RAB3A|SYNGR1|SYT7|ANAPC2|MPP2|RIMS1|NEURL1|PICK1|SIPA1L1|RIMS3|DBN1|MAPT|GRIN2D|PPP3CB|GIPC1|NPTN|SYNGAP1
FUNGIFORM PAPILLA MORPHOGENESIS%GOBP%GO:0061197,0.7701559020044542,0.9792758096555699,-0.450785773366419,-0.771044922801516,5186,2,HDAC2|HDAC1
PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER%GOBP%GO:1905508,0.0713194577047928,0.514511211182091,0.417182603760766,1.47134279707086,746,17,CEP83|CCDC14|GOLGB1|SPAG5|CEP131|STIL|CEP192|PCM1|C2CD3|HOOK3|SNX10|PIBF1|BBS4|KIAA0753
"MRNA CIS SPLICING, VIA SPLICEOSOME%GOBP%GO:0045292",0.793159462142406,0.9819233677232551,0.18385565045193103,0.747467311712403,8788,27,SFSWAP|RBM4B|PRPF39|SRSF1|SRSF6|SRSF2|RBM4|PSIP1|SRSF9|SRSF5|CWC15|SRSF4|SRSF10|SRSF12|DCPS
GUANOSINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901070,0.7141897188934929,0.971081608033886,0.387712334773075,0.8215994735960409,6376,4,IMPDH1
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION IN THYMUS%GOBP%GO:0033088,0.360711261642676,0.848418604328854,0.660051674938655,1.078836330007,2981,2,BMP4|KIAA0922
POSITIVE REGULATION OF MICROTUBULE NUCLEATION%GOBP%GO:0090063,0.23132887899034899,0.7440352621789029,-0.718224427901847,-1.22848441828621,1557,2,DCTN1|MECP2
PANTOTHENATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015887,0.48,0.9046812288131709,0.764005293339215,1.01494694750853,3575,1,SLC5A6
PYRIMIDINE NUCLEOTIDE IMPORT INTO MITOCHONDRION%GOBP%GO:1990519,0.42895322939866404,0.8774573162143371,-0.597611723889682,-1.02218284767664,2888,2,SLC25A33
PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:0031848,0.8242417860151641,0.9876441563834109,0.27095595245042303,0.7052414163512041,7826,7,DCLRE1A|DCLRE1C|ACD
NEGATIVE REGULATION OF ACTIN FILAMENT SEVERING%GOBP%GO:1903919,0.0688468158347676,0.5040280242137971,-0.964435377150419,-1.29015460940225,519,1,MYH9
MRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:1990481,0.8015907605142729,0.9841161968820359,0.320152217074785,0.737903400512024,7356,5,PUS1|TRUB1|DKC1|PUS7|PUS3
CARDIAC JELLY DEVELOPMENT%GOBP%GO:1905072,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
ESCRT COMPLEX DISASSEMBLY%GOBP%GO:1904896,0.0437352245862884,0.412001737413835,-0.475809565841011,-1.60973498040857,221,10,CHMP5|IST1|CHMP2B|CHMP7|CHMP2A|CHMP1A|VTA1|VPS4A|VPS4B|CHMP1B
RESPONSE TO ORGANIC CYCLIC COMPOUND%GOBP%GO:0014070,0.27714285714285697,0.7884684708511421,-0.120353490621011,-1.07286398045505,193,269,POU4F2|MAVS|RUVBL2|ATP2B4|RAP1A|CTNNA1|NPM1|SHMT2|SNCA|PDE4B|RYR1|MSN|NRIP1|NEDD4|RFTN1|PPARGC1A|PDE12|NR3C1|RAPGEF1|JUN|GABRG2|STAT3|COLEC12|KLF9|UBE2L3|ADCY2|RALB|ADCYAP1|DRD2|MAPK3|PARK2|RNF4|SLC3A2|TICAM1|PMVK|PDE3A|AQP1|TNF|BCL2L11|HRH1|PMAIP1|CAV1|SLIT3|VGF
RESPONSE TO LIPOTEICHOIC ACID%GOBP%GO:0070391,0.37070741758241793,0.852609194081082,-0.416887271122877,-1.05532244410881,2158,5,MAPK14|TLR2|CD14|TIRAP|RELA
REGULATION OF GAMMA-DELTA T CELL DIFFERENTIATION%GOBP%GO:0045586,0.9899328859060401,1.0,0.505458756065285,0.6714794073189001,7374,1,NCKAP1L
NEGATIVE REGULATION OF PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:1905765,0.548032665181886,0.9305779599215391,-0.542597187758478,-0.9280834300143019,3690,2,ERCC4|ERCC1
METHYLATION%GOBP%GO:0032259,0.9231378763866881,1.0,-0.0944385720017476,-0.769272793552574,1164,167,METTL1|CBLL1|METTL16|DPY30|METTL21A|FAM103A1|ZC3H13|NSUN5|PRMT6|TRMT12|METTL10|TRMT61B|GSPT1|WDR82|NSUN3|RAB6A|TRMT112|METTL12|MTRR|WBSCR22|RBM15B|PLD6|MOV10L1|DYDC2|NSUN2|PRMT3|COPRS|ASH2L|SNRPB|ETF1|RBM15|RNMTL1|TDRKH|TRMT6|EMG1|HENMT1|SETD7|GATAD2A|TRDMT1|METTL21B
VESICLE ORGANIZATION%GOBP%GO:0016050,0.93125,1.0,-0.09206639989442698,-0.7946437604306491,744,234,STX16|SAR1A|HPS1|AP1G1|RILP|PI4K2B|TSNARE1|RAB11A|USP8|CSNK1D|PI4K2A|GOSR2|PDCD6IP|TRAPPC1|CALR|SNX3|STX10|S100A10|BLOC1S1|PPP6R1|TMED10|VTI1B|SEC13|PICALM|HPS4|VPS28|SRGN|PMEL|VPS33B|AP1M1|DNM2|PTPRN|BLOC1S5|ARFGEF2|SQSTM1|RAB8B|VPS4A|VPS18|TAPBP|TRAPPC2L|TRAPPC6A|RFX2|VPS37D|BLOC1S4|VPS11|TBC1D20|STX8|NAPA|STX11|ABCA1|RAB1A|VPS4B|RAB39A|SNX11|RAB8A|SERPINA1|BLOC1S6|ALS2CL|SEC23IP|PLEKHF1|TMED2|SEC23A|TRAPPC10|CAV2|RAB7A|VAPB|RAB22A|CHMP4B|BLOC1S3|CHMP1B|VTI1A|KIF13A|ANKRD28|SNAP25|CAV1
MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0007517,0.8155601819723959,0.986631695793843,0.13885739064610197,0.7761531288550791,10576,102,RYR2|NEB|EGR3|IGSF22|MYLK2|BASP1|BMP4|MAPK12|MYH3|PROX1|TCAP|DISP1|CACNA1H|SGCE|TGFB2|TAZ|ITGA11|ITGB1BP2|SEPN1|CXCL10|HEY2|OBSL1|DMD|TNNI3|SVIL|KIAA1161|NRG1|MYLK|LAMA2|MYOM2|AEBP1|FGFR2|FHL1|LARGE|TCF12|MRAS|LEMD2|FKTN|MEF2B|TAGLN
ONCOSTATIN-M-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038165,0.13535320270047801,0.622489416807167,-0.587492417140021,-1.35110982795708,821,4,OSM|LIFR|OSMR|IL6ST
REGULATION OF TOLERANCE INDUCTION TO TUMOR CELL%GOBP%GO:0002843,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
BRASSINOSTEROID BIOSYNTHETIC PROCESS%GOBP%GO:0016132,0.5883221476510071,0.945418171231938,0.710410233789149,0.943748301941389,4382,1,DHCR7
NEGATIVE REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903597,0.0591817820733483,0.475550457504474,-0.970280105866784,-1.2979732812104199,446,1,ACE
TRANS-GOLGI NETWORK MEMBRANE ORGANIZATION%GOBP%GO:0098629,0.666979865771812,0.964618776001639,0.6716475518306129,0.8922538082853191,4968,1,AZIN2
ISOTYPE SWITCHING%GOBP%GO:0045190,0.8685271005440259,0.993084774742015,0.224973096984637,0.663953731343196,8620,10,LIG4|EXO1|MSH6
REGULATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1900019,0.575547064953109,0.941940408834489,0.48916723851155197,0.9298554619484781,4970,3,C8orf4
POSITIVE REGULATION OF AXONOGENESIS%GOBP%GO:0050772,0.750748438970148,0.97622649654938,0.172790160091045,0.7952417353409591,8776,42,DSCAM|PLXNC1|ROBO2|SEMA5A|MAP6|PLXNA3|RUFY3|PLXNB2|SHTN1|GOLGA4|PLXNB3|MACF1|PLXNA2|NTN1|SLITRK1
NEGATIVE REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001814,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
MENAQUINONE BIOSYNTHETIC PROCESS%GOBP%GO:0009234,0.561101549053356,0.936434965680841,-0.7133877370974859,-0.954320526925065,4237,1,UBIAD1
ANTEROGRADE AXONAL TRANSPORT%GOBP%GO:0008089,0.33990147783251196,0.8332013579609591,-0.19346925015513897,-1.0829861992042802,1172,38,BLOC1S1|HSPB1|SOD1|RAB21|BLOC1S5|BLOC1S4|HAP1|AP3S2|FMR1|BLOC1S6|KIF3B|TRAK1|BLOC1S3
NEGATIVE REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046426,0.23247311827957,0.746121572059682,-0.29658658760109496,-1.18281380809521,1080,15,PPP2CA|LEPROT|VHL|BCL3|CAV1
SENSORY ORGAN DEVELOPMENT%GOBP%GO:0007423,0.166131081384052,0.6682860217990739,0.210522046199205,1.2258726855149398,2222,127,SIX3|TSPAN12|GNG8|NHS|SMG9|SHROOM2|TBX2|SDK1|WNT5B|KCNQ1|STRC|ADGRV1|PROX1|DSCAM|SMARCD3|AHI1|MPV17|CEP290|DFNB31|SMOC1|ZDHHC16|FOXN4|JAG2|EFEMP1|TGFB2|PDZD7|DCX|FBN1|MAB21L2|MED1|BMPR1B|NF1|NIPBL|COL4A1|COL5A2|TH|COL5A1|MCM2|TFAP2B|MYO7A|SMARCA4|CHD7|MDM1|TOPORS|FGFR2|WNT2B|LRTOMT
REGULATION OF MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905000,0.8472483221476509,0.991298302704726,0.5773599470666079,0.7669969318246099,6311,1,FLNA
L-XYLITOL CATABOLIC PROCESS%GOBP%GO:0051160,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ISCHEMIC CONDITIONS%GOBP%GO:0001980,0.535302013422819,0.9265056012720759,0.735498456109396,0.977076886028887,3987,1,TNNI3
POSITIVE REGULATION OF INSULIN SECRETION%GOBP%GO:0032024,0.9915346805024581,1.0,0.11264804649789098,0.452899104633855,10892,26,GHRL|ADCY8|CAPN10|GCK|BAD|MCU|BAIAP3|NNAT|TM7SF3|PPP3CB|NLGN2|ISL1|GPLD1|PSMD9
POSITIVE REGULATION OF NEURON MIGRATION%GOBP%GO:2001224,0.489842454394693,0.908938677284213,-0.26372470261909103,-0.960775545849226,2362,12,DAB2IP|NSMF|SRGAP2C|ARHGEF2|SEMA3A
CELLULAR RESPONSE TO ACID CHEMICAL%GOBP%GO:0071229,0.24794104898136102,0.7606801986254759,-0.158439705145702,-1.12544476736032,571,87,ADNP2|GATSL3|TESC|RARA|VEGFA|PDK3|KDR|RRAGD|CPEB1|NSMF|PTK2B|RRAGC|PTGFR|RET|FYN|PTK7|SH3BP4|LYN|LAMTOR5|WNT6|WNT11|SHMT2|DGAT2|TWF2|WNT3|SESN2|AQP1
CERAMIDE CATABOLIC PROCESS%GOBP%GO:0046514,0.0259664193674346,0.33512489842855103,-0.5336406770167009,-1.7226399260976397,132,9,NEU4|ASAH2|ASAH2B
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902930,0.923743500866551,1.0,-0.11038781953860902,-0.695768157279523,2664,57,ERLIN2|GPER1|SOD1|IL1B|SCD|PTK2B|PRKAA1|SC5D|FDFT1|DGKQ|SNCA|SEC14L2|NFYA|ABCG1|PMVK|TNF|HRH1
ATRIOVENTRICULAR CANAL MORPHOGENESIS%GOBP%GO:1905222,0.528399311531842,0.9265056012720759,-0.7309770621967359,-0.9778503034043591,3990,1,ENG
REPLICATION FORK PROCESSING%GOBP%GO:0031297,0.0163247100802855,0.27198543625715,0.404004962175524,1.6939650276570002,182,30,FBXO18|EME2|BLM|THOC1|DNA2|TONSL|GEN1|MMS22L|RAD51|FANCM|PRIMPOL|ZRANB3|EME1|STRA13|BRCA2
POSITIVE REGULATION OF BLEB ASSEMBLY%GOBP%GO:1904172,0.560541913632515,0.936434965680841,0.581362007168459,0.9502202297682479,4633,2,ANLN|P2RX7
NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010713,0.7382560879811471,0.9744283926676119,-0.386070365060108,-0.783518335235192,4698,3,CIITA|CST3|IL6
NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070862,0.893596251464272,0.9976191001250191,-0.20494014602761398,-0.66156515650399,4576,9,DERL2|ERLEC1|INSIG1|UBE2J1|OS9
REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0010939,0.0187096774193548,0.286111698549296,-0.443787122900734,-1.7698626936152602,86,15,FTH1|SLC25A4|CYLD|ARHGEF2|CFLAR|PELI1|SPATA2
POSITIVE REGULATION OF HISTONE METHYLATION%GOBP%GO:0031062,0.134807937374841,0.622228052080473,0.332095907705601,1.33518462084693,1480,26,SIRT1|WDR61|OGT|MTF2|DNMT3B|PHF19|JARID2|PAXIP1|RIF1|BRCA1|DNMT1|PHF1|TET1|SNW1|ZNF304|WHSC1L1|MYB|KMT2E|AUTS2|CTR9|PAF1
MYOBLAST MIGRATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014839,0.8182628062360799,0.987153241368501,-0.43148607664736705,-0.7380338251892191,5510,2,ANXA1|AKIRIN1
TRANSCRIPTIONAL ACTIVATION BY PROMOTER-ENHANCER LOOPING%GOBP%GO:0071733,0.9937156323644929,1.0,-0.245844412136359,-0.498933930072475,6324,3,RUVBL2
SYMPATHETIC NEURON PROJECTION EXTENSION%GOBP%GO:0097490,0.118557549810637,0.602329212916938,-0.6010285060216071,-1.3822400045967098,719,4,SEMA3F|NRP1|SEMA3A
DENSE CORE GRANULE PRIMING%GOBP%GO:0061789,0.0416112253538164,0.402998391331252,0.8712985938792389,1.4241136157230498,343,2,UNC13B|UNC13A
NEGATIVE REGULATION OF MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034128,0.6536028119507911,0.9640743070248079,-0.305431444746675,-0.838388807607869,3718,6,TICAM1
SUPPRESSION BY VIRUS OF HOST APOPTOTIC PROCESS%GOBP%GO:0019050,0.341648106904232,0.8356275732448649,-0.655583126550869,-1.1213398271788702,2300,2,CASP8|BCL2L1
CELLULAR RESPONSE TO SALT%GOBP%GO:1902075,0.64481546572935,0.9625632908696992,-0.30723686126845,-0.843344554735287,3668,6,ZNF16|HSF1
SPHINGOLIPID CATABOLIC PROCESS%GOBP%GO:0030149,0.45053003533568897,0.88620227509476,-0.23432391991112198,-0.986008103674943,2039,17,NEU4|ASAH2|ASAH2B
PROGESTERONE SECRETION%GOBP%GO:0042701,0.7215675890374692,0.9713770803161691,-0.634318482576092,-0.848547174350437,5449,1,INHBA
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:0010998,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|EIF2AK3
PEPTIDE STABILIZATION%GOBP%GO:0050822,0.30888388719714,0.8114708447293539,-0.846162329069255,-1.13193714686907,2332,1,TAPBP
CELL FATE SPECIFICATION%GOBP%GO:0001708,0.14029067420266503,0.628783181453404,-0.378665367099291,-1.33257060447031,694,11,ASCL1|SOX17|RBPJ
NEGATIVE REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002692,0.575333443108842,0.941940408834489,-0.387503889959118,-0.8911779945077659,3493,4,PLCB1
REGULATION OF BLOOD MICROPARTICLE FORMATION%GOBP%GO:2000332,0.0239639878194095,0.32397355287938,-0.9888067931186592,-1.32275699562121,180,1,TNF
CELLULAR RESPONSE TO AMINO ACID STIMULUS%GOBP%GO:0071230,0.6136919315403421,0.9508825506493929,-0.16937377153336303,-0.896680090105779,2258,32,KLHL22|RRAGB|GATS|LAMTOR4|UBR2|NEURL1|LAMTOR3|LARS|LAMTOR1|XBP1|MTOR|CPEB4|SESN1|CAPN2|SESN3|GATSL2|RPTOR|RRAGA|SLC38A9|IPO5|LAMTOR2|UBR1|GATSL3|RRAGD|CPEB1|NSMF|RRAGC|FYN|SH3BP4|LAMTOR5|SESN2
ORGANIC ACID TRANSPORT%GOBP%GO:0015849,0.544493260853377,0.929758904310055,0.163574017775896,0.958791316432965,7311,133,ABCC3|SLC16A9|SLC1A2|SLC27A2|CEACAM1|SLC25A29|SLC36A1|SLC25A22|SLC16A13|MFSD2A|ABCB4|SLC43A1|GLS|SLC16A14|EPRS|GLS2|LRRC8D|STARD5|SLC16A2|SLC6A17|SLC6A15|SLC13A3|SLC25A10|AKR1C1|SLC6A9|SLC7A9|CPT1B|SLC15A4|PQLC2|SLC46A1|APOE|SLC25A1|ACACA|SLC38A6|SLC16A7
CLEAVAGE INVOLVED IN RRNA PROCESSING%GOBP%GO:0000469,0.00658616904500549,0.18227680804153196,-0.47192550844522496,-1.9326935667498601,29,16,EXOSC9|NHP2|KRI1|RRS1|NOL9|NOP14
GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0043000,0.7319462924882059,0.972769769206295,0.515136476426799,0.841976419092761,6050,2,SEC16A|KRT18
GLYCOLIPID CATABOLIC PROCESS%GOBP%GO:0019377,0.0967502321262767,0.5695985048856271,-0.459209002151249,-1.4274215216997501,520,8,NEU3|GALC|GLA|NAGA|FUCA1|NEU1|GBA|NEU4
POSITIVE REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043123,0.006973500697350071,0.18839827903558604,-0.18932164453177103,-1.50790083270058,9,145,LGALS1|MIER1|TRIM8|IL1RN|NOD1|TRAF3IP2|SECTM1|IL1B|IRAK1|TRIM13|MTDH|LURAP1|CX3CL1|LPAR1|LGALS9|HMOX1|IRAK4|C18orf32|RHOA|BCL10|TMED4|UBE2V1|NEK6|REL|RNF31|LITAF|MAVS|RIPK2|RHOC|PPM1A|AKAP13|DDX21|TRIM25|CFLAR|PELI2|RBCK1|TNFRSF10B|SHISA5|PARK2|TNIP2|S100A4|EDA2R|PELI1|TICAM1|MYD88|DDRGK1|GPRC5B|PLK2|TNF|FKBP1A
POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010560,0.132067510548523,0.616625329065152,-0.344583670765958,-1.3350083648033,625,14,CTNNB1|TCF7L2|CHP1|IGF1|PLCB1|RAMP1
RESPONSE TO GLUCAGON%GOBP%GO:0033762,0.5021106420795379,0.9159769483621171,-0.22104328185737399,-0.950879087477722,2259,18,PRKAR2A|GCGR|PRKAR1B|ADCY2
'DE NOVO' L-METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0071266,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006163,0.789156626506024,0.9819233677232551,-0.0979880141363201,-0.88451461961457,392,306,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GMPS|GTPBP1|GUCY1A3|UQCRC1|PRPS1|ACOT11|NUDT4|PKM|ACOT9|PNP|ENO1|SULT4A1|TPST1|MT-ND5|ACSL4|HPRT1|ATP5I|EFTUD1|COX4I1|PRPSAP1|NUDT18|PDHB|GAPDH|PGK1|PANK2|DGAT2|TDO2|NDUFB9|CYC1|HK1|HK2|TPI1|PDE9A|NDUFA9|OGDH|ACLY|NDUFS1|NDUFV3|ADCY2|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|ACOT8|ITPA|RHOQ|ACSL3|PMVK|NT5E|ADM|COX4I2|NDUFS6|PDE4D|PGAM2|AK4
GLYCOLIPID TRANSLOCATION%GOBP%GO:0034203,0.793591950218456,0.9819233677232551,-0.600132333480371,-0.8028153203781428,5993,1,RFT1
LYMPH VESSEL DEVELOPMENT%GOBP%GO:0001945,0.8243010752688169,0.9876441563834109,-0.18421808882843,-0.734678196103203,3832,15,FLT4|SOX18|CCBE1|ACVR2B|BMPR2|SYK|NR2F2|TBX1|VEGFA|PDPN|FOXC2|ACVRL1
REGULATION OF PYRROLINE-5-CARBOXYLATE REDUCTASE ACTIVITY%GOBP%GO:1903167,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
ANAPHASE-PROMOTING COMPLEX-DEPENDENT CATABOLIC PROCESS%GOBP%GO:0031145,0.290201224846894,0.799622947490088,0.259177270898506,1.14401790942672,3316,36,ANAPC15|CCNB1|CDK1|ANAPC5|CDC23|CDC20|ANAPC7|ANAPC16|PTTG1|FBXO5|BUB1B|AURKB|PLK1|AURKA|UBE2C|ANAPC10|CDK2|CDC16|ANAPC2
AGING%GOBP%GO:0007568,0.652806311118416,0.9640743070248079,0.174774464732951,0.873967711616343,7943,59,SIRT1|TBX3|ARNTL|TBX2|IDE|AGER|ATR|CISD2|CDKN2A|TERT|LOXL2|MSH6|HRAS|CDKN2B|SRF|TPRA1|CHEK2
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS%GOBP%GO:0031400,0.0028409090909090897,0.13103871184697197,-0.164052105368616,-1.5108498623715,0,379,ENSA|PYCARD|PIK3R2|DUSP4|STRAP|SENP2|SOCS3|SPI1|THY1|CDKN1B|CRKL|DUSP7|PPP1R15B|NCK2|ITCH|HSPB1|HEXIM1|GPER1|DNAJC3|FLCN|PTPN6|QARS|ZGPAT|LRP5|VPS28|PINX1|IL1B|HEG1|SIN3A|IMPACT|MAGEA2|PRKCD|SIRPA|FKBP1B|CTNNB1|DAB2IP|IGF1R|TRIB1|PRKAA1|CNKSR3|TNFAIP3|WARS|ARRB2|DDIT4|RGS4|CEBPA|ABL1|CTBP1|MGAT5|RPS3|GNAQ|FAM129A|IGFBP3|CDYL|G6PD|SMAD6|INPP5K|DGKQ|TRIP12|FOXO1|MYADM|EIF4G1|ARPP19|PPAP2B|UBASH3B|RASSF2|LYN|PRNP|ARRB1|CHP1|CYLD|LDLRAD4|TRIB2|PPP2CA|BAG5|PRKAR2A|TNIP1|ATP2B4|KDM5A|LIMK1|NPM1|PTPN1|YWHAB|PRMT3|SMAD7|SNCA|LGALS3|TRAF3IP1|GNL3L|CDKN1C|PDCD4|MECOM|DUSP3|SNTA1|NXN|UCHL1|DKK1|SNX6|PRKAR1B|PKIG|SOCS5|YWHAE|PPP1R11|CDKN1A|DBNDD2|PARK2|GREM1|SFRP2|PER2|DUSP10|SLC9A3R1|CORO1C|FKBP8|SNX25|TWIST1|DLG1|TNF|PDE4D|SPRED2|INSM1|CAV1|FKBP1A|EPHB2|PAK2|PARD3|TRIB3
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051151,0.42336485421591796,0.873470206885489,-0.298555133653473,-1.01005670487747,2148,10,PDCD4|NFATC2|RBPMS2
POSITIVE REGULATION OF GLUTAMATE-CYSTEINE LIGASE ACTIVITY%GOBP%GO:0035229,0.590891036674169,0.945418171231938,-0.6985002205558011,-0.934405042130679,4462,1,GCLM
RESPONSE TO GLYCOPROTEIN%GOBP%GO:1904587,0.5108074812409,0.918404893008545,0.457237750997105,0.9689304719885521,4560,4,EDEM3|MAN1B1
REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002828,0.0847799757771498,0.545265264053164,-0.409798080105925,-1.44213050034315,419,11,XCL1|ANXA1|NDFIP1|PRKCZ|RSAD2|IL18|CD86|RARA|IL6|NLRP3|SOCS5
POSITIVE REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0010536,0.9441935857357879,1.0,0.31928000667274,0.606917705688875,8154,3,CCL5|AGT|IL6R
HISTONE H3-K36 DEMETHYLATION%GOBP%GO:0070544,0.6216075699282521,0.9536478716552259,0.32196632042901696,0.8777665677393879,5977,8,C14orf169|KDM4B|KDM8|KDM4A|PHF8|KDM4C|KDM2A
PROTEIN K27-LINKED DEUBIQUITINATION%GOBP%GO:1990167,0.66336034837305,0.964618776001639,0.54270240256774,0.887032168089838,5483,2,OTUD3|YOD1
FRUCTOSELYSINE METABOLIC PROCESS%GOBP%GO:0030393,0.940818217926652,1.0,-0.526852668725188,-0.704786878556887,7105,1,FN3K
CELLULAR RESPONSE TO AMINO ACID STARVATION%GOBP%GO:0034198,0.490292668791655,0.908938677284213,-0.174720534487307,-0.9780361861929859,1691,38,EIF2S1|IMPACT|RRAGD|RRAGC|EIF2AK3|SEH1L|SH3GLB1|C12orf66|MAPK3|CDKN1A|SESN2
REGULATION OF ALDOSTERONE SECRETION%GOBP%GO:2000858,0.734514298946393,0.9736885699872909,0.430924955368421,0.819143008551599,6343,3,AGTR1|C1QTNF1
PEPTIDE HORMONE SECRETION%GOBP%GO:0030072,0.16207224334600798,0.664367762084791,-0.276128026184874,-1.2792294621489197,681,22,PTPRN|CRHR1|RAB11FIP2|IL6|VIP|RAB1A|ADCYAP1|RAB11FIP5|GAL
CRANIAL NERVE MORPHOGENESIS%GOBP%GO:0021602,0.14831107619795802,0.640631124912461,-0.6641116135436199,-1.3477947880641898,943,3,TBX1|MAFB|CHRNB2
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902203,0.98738255033557,1.0,0.507057785619762,0.6736036467442571,7355,1,ADAMTS12
REGULATION OF DNA STRAND ELONGATION%GOBP%GO:0060382,0.6958993588968189,0.96731875442989,0.530962227736421,0.8678431748495179,5752,2,POT1|NUCKS1
VEGF-ACTIVATED NEUROPILIN SIGNALING PATHWAY%GOBP%GO:0038190,0.11017074981440199,0.584830174998513,-0.799283154121864,-1.3671310282578601,741,2,VEGFA|NRP1
TRNA WOBBLE URIDINE MODIFICATION%GOBP%GO:0002098,0.37222446507872403,0.852609194081082,-0.30040843120395194,-1.0571746970788,1843,11,CTU1|KIAA1456|MOCS3|ELP3|URM1|DPH3
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903204,0.600741897696213,0.950415218201239,-0.272004617209697,-0.878055279271121,3076,9,PARK2|FBXO7
PROTEIN HETEROTRIMERIZATION%GOBP%GO:0070208,0.643362136684996,0.9621972042482541,-0.421136000512044,-0.8546830005391121,4094,3,COL6A2|COL6A1
PROTEIN REPAIR%GOBP%GO:0030091,0.8705970790378009,0.9934031064448321,0.27328884231426803,0.672114106986451,8106,6,MSRB2|MSRB3|MSRA|PCMT1|MSRB1|PARK7
METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION%GOBP%GO:0072162,0.43171646304584493,0.8785877309899279,0.630033254719761,1.02977204681347,3568,2,WNT4|STAT1
NEGATIVE REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070667,0.24414140076790697,0.7571583779245891,-0.8775363917071021,-1.1739071870468702,1843,1,LYN
KETONE BIOSYNTHETIC PROCESS%GOBP%GO:0042181,0.512204351939451,0.9187280702338628,0.262863674519985,0.960806948574332,5413,19,FDXR|COQ3|CACNA1H|COQ2|COQ6
CELLULAR RESPONSE TO STEM CELL FACTOR STIMULUS%GOBP%GO:0036216,0.44816741260433,0.8850378987593649,0.623269920044114,1.01871756208579,3704,2,KIT|FER
L-ASCORBIC ACID METABOLIC PROCESS%GOBP%GO:0019852,0.506983805668016,0.917492632242256,0.33748298326999,0.9630611241533259,5008,9,RGN|GSTO2
ACTIVATION OF PROTEIN KINASE A ACTIVITY%GOBP%GO:0034199,0.8499818379949151,0.991298302704726,-0.238998932378957,-0.697170489167579,4679,7,PRKAR2A|PRKAR1B
PROTEIN MATURATION BY PROTEIN FOLDING%GOBP%GO:0022417,0.0151142355008787,0.264387156924099,-0.6709050727196539,-1.8415893766341698,85,6,WFS1|CALR|FKBP1B|AIP|FKBP1A
INHIBITION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:0097340,0.168763647707185,0.672658187648302,0.4741629634496529,1.29269544846104,1622,8,NOL3|BIRC2|CARD16|BCL2L12|XIAP|BIRC3
REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:0090237,0.6204899777282851,0.9536478716552259,-0.5131513647642679,-0.877717926800111,4178,2,PLA2R1|SYK
POSITIVE REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000576,0.45578791371645005,0.88900512246363,-0.427898870307061,-0.9840780105010459,2767,4,DNAL4|DYNLL2
GLOMERULAR VISCERAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072015,0.920562390158172,1.0,-0.22888974684242497,-0.628286986259874,5237,6,MAGI2|JAG1|IQGAP1|MYO1E|NUP93|PODXL
MITOCHONDRIAL TRANSMEMBRANE TRANSPORT%GOBP%GO:1990542,0.610411418975651,0.9508825506493929,-0.133744868167995,-0.9304740145061999,1453,81,MRPL18|ROMO1|UCP2|COX5B|TOMM20|C19orf52|TIMM23|SLC25A32|CCDC109B|ATP5I|SLC25A15|DNLZ|CYC1|TIMM22|SLC25A33|SLC25A13|TIMM23B|SLC25A18|LETM1|MID1IP1
COPII VESICLE COATING%GOBP%GO:0048208,0.8828289936664321,0.996220425464008,-0.116208625763548,-0.737917202043048,2508,58,TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:0072655,0.0167883211678832,0.27621312636330103,-0.24002325917009198,-1.55415594148767,45,63,HSPA4|BAX|TOMM34|TOMM22|TIMM50|ROMO1|SAMM50|TOMM20|TIMM10B|AIP|C19orf52|TIMM23|MFN2|PMPCA|DNLZ|HK1|HK2|TIMM22|BMF|TIMM23B|FBXO7|BCL2L11|PMAIP1
NEGATIVE REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032096,0.494845360824742,0.91071489001692,0.39587068791828295,0.9735863039236009,4607,6,CARTPT|BBS2|BBS4
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001022,0.7352215768955369,0.974262605126702,0.15544955228361498,0.823733944666994,9240,77,SIRT1|FBXO18|MMS19|NPAS2|ATR|BLM|DHX9|FAM178A|PARP1|TMEM161A|ANKLE1|NSMCE4A|H2AFX|TIMELESS|BRCC3|WRAP53|ANKRD32|RIF1|C5orf45|XRCC1|SPIRE2|SPIRE1|FOXM1|SPIDR|FMN2|ATM|DDX5|UIMC1|BRCA1|FAM35A|BRE|PARP9|EYA3|RNF8|SETMAR|FAM168A
REGULATION OF ORGAN GROWTH%GOBP%GO:0046620,0.657379586633889,0.9643779777660141,0.21430003656920102,0.8539548186009359,7219,25,EDN1|TBX2|BASP1|PROX1
PROTEIN LOCALIZATION TO GOLGI MEMBRANE%GOBP%GO:1903292,0.386718277488811,0.859991269020751,0.648114870887592,1.0593259517087301,3196,2,ARL5B|ARL5A
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:1904282,0.9364490930755991,1.0,-0.5291685046316721,-0.7078848428582359,7072,1,HFE
PIRNA METABOLIC PROCESS%GOBP%GO:0034587,0.0360520094562648,0.38384589896147103,-0.486290439089547,-1.64519334338531,182,10,PIWIL1|PLD6|MOV10L1|TDRKH|HENMT1|GPAT2
NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902037,0.5068456375838929,0.917441329747287,0.7502756947507719,0.996707788304601,3775,1,N4BP2L2
CHORIONIC TROPHOBLAST CELL DIFFERENTIATION%GOBP%GO:0060718,0.0518930688278698,0.44586532408291796,0.8569616763165151,1.40068031782494,428,2,E2F8|E2F7
REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900112,0.5931575506646329,0.9464278097528599,0.39146260754467205,0.902263279385761,5443,5,ZNF274|ATRX|ZNF304|PIH1D1|SMARCB1
TYROSINE CATABOLIC PROCESS%GOBP%GO:0006572,0.957852348993289,1.0,0.52348919276577,0.695432038080685,7135,1,FAH
NEGATIVE REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002893,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
NEGATIVE REGULATION OF GTP CYCLOHYDROLASE I ACTIVITY%GOBP%GO:0043105,0.49490268767377205,0.91071489001692,-0.749834583149537,-1.00307658414391,3737,1,GCHFR
NEGATIVE REGULATION OF MITOTIC CELL CYCLE DNA REPLICATION%GOBP%GO:1903464,0.664587973273942,0.964618776001639,-0.496163512896391,-0.8486611159912572,4475,2,BCL6
POSITIVE REGULATION OF B CELL TOLERANCE INDUCTION%GOBP%GO:0002663,0.3738678544914629,0.852609194081082,-0.632974910394265,-1.0826696842616,2517,2,TGFBR2|FOXJ1
ESTABLISHMENT OF ENDOTHELIAL BLOOD-BRAIN BARRIER%GOBP%GO:0014045,0.528399311531842,0.9265056012720759,-0.7309770621967359,-0.9778503034043591,3990,1,ENG
RNA LOCALIZATION%GOBP%GO:0006403,0.880897138437742,0.9956508825790341,-0.0988272395901653,-0.796468441883832,1138,159,TOMM20|ZNF385A|PRPF18|ZNHIT6|PA2G4|PRPF6|MAGOH|DDX19B|THOC5|SEH1L|NMD3|RBM15B|AGFG1|TCP1|ARC|ZNF593|NPM1|FMR1|PHAX|RFTN1|EIF5A|RRS1|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|SLBP|BICD1|FYTTD1
CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0044262,0.784568703944517,0.981487311948134,-0.117682090810888,-0.835931202935144,1809,87,FBP1|INPP1|ITPK1|INPP5K|INPP5A|FGGY|SORD|HK1|TPI1|PYGB|B3GNT5|B3GNT7|CSGALNACT1|SLC2A1|PER2|B3GNT8|B3GNT2|NR1D1
DAMP PHOSPHORYLATION%GOBP%GO:0061565,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
REGULATION OF POTASSIUM ION IMPORT%GOBP%GO:1903286,0.916701769165965,1.0,0.235616716775199,0.613260810666139,8704,7,ATP1B3|WNK3|WNK2|WNK1
RIBOSOMAL PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006610,0.6176897929531421,0.9529166894361422,-0.297242140099283,-0.867068510103858,3400,7,RANBP6|TNPO1|TNPO2|RPL23|IPO4|IPO5|KPNB1
MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0019048,0.100474683544304,0.570947005522165,-0.263041645684126,-1.3646684875799702,380,30,CASP8|DAG1|RRAGA|EIF2AK4|INSR|TGFB1|CD4|SMAD3|SLC25A6|KPNB1|EIF2AK2|CCNK|KPNA1|RXRA|BCL2L1|ATG7|KPNA4|VAPB|PARK2
CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021814,0.0938381588715665,0.562743160240921,-0.814281775572098,-1.3927853669737,631,2,DAB2IP|SRGAP2C
ACTIVE INDUCTION OF HOST IMMUNE RESPONSE BY VIRUS%GOBP%GO:0046732,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
RESPONSE TO MONOSACCHARIDE%GOBP%GO:0034284,0.622641509433962,0.9536478716552259,0.19520312812295001,0.885670596633831,7226,40,LPL|PRKAA2|UNC13B|AGER|ADCY8|ERN1|EIF2B5|EIF2B1|GCK|EIF2B4
MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS%GOBP%GO:0051457,0.117779783393502,0.6006198777217571,-0.307183429441925,-1.3471447034924098,521,19,PML|SUPT7L|ARL2BP|BCL3|RANGAP1|TAF8
POSITIVE REGULATION BY HOST OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:0044791,0.109718406593407,0.584830174998513,-0.549828552123838,-1.3918544692076102,638,5,CAV2|PC
REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000482,0.9783272866144741,1.0,0.14293182023566697,0.5040998888260779,10246,17,F2R|CD2|F2RL1|MAPKBP1|PTPN22|HYAL2|ANXA1
RENAL SYSTEM DEVELOPMENT%GOBP%GO:0072001,0.6054548272121489,0.9508825506493929,0.16555067866576098,0.916857061757234,7813,97,GREB1L|CITED1|WNT4|BASP1|BMP4|PYGO1|PROX1|PKD2|CENPF|AHI1|MPV17|PTPRO|CEP290|AGTR1|KLHL3|ROBO2|TGFB2|CEP55|C5orf42|NF1|NIPBL|VANGL2|COL4A1|ACTA2|MAGI2|NPHP3|GPC3|TFAP2B|BAG6|FGFR2|ITGA3|SEC61A1|EGR1|GATA3|ITGA8|SULF1
ACTIN FILAMENT NETWORK FORMATION%GOBP%GO:0051639,0.313884007029877,0.816422962704093,-0.403058142136693,-1.1063675367901202,1785,6,LCP1|ACTN1|RLTPR|COBL
CELL MIGRATION IN HINDBRAIN%GOBP%GO:0021535,0.41048862679022796,0.867015886388254,0.40213382582779206,1.0466698602659799,3897,7,LEF1|SEMA4C|CEND1|PHOX2B|ARL13B
POSITIVE REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035066,0.164390014130947,0.666453616651802,-0.27979618652251004,-1.2707771975109798,697,21,IL1B|WBP2|LIF|ARRB1|RUVBL2|PPARGC1A|TADA2B|MAPK3
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032481,0.706333333333333,0.9690652251953721,-0.139394134329562,-0.859768339283285,2118,53,PTPN22|PRKDC|CHUK|DHX58|PQBP1|STAT1|TLR4|HSPD1|DDX58|IFIH1|POLR3A|HMGB1|STAT6|EP300|TLR2|DDX41|CD14|IRF5|IRF7|PTPN11|NFKB2|TMEM173|IRF1|IRF3|NFKB1|DHX36|XRCC5|IFI16|DHX33|POLR3F|MB21D1|RELA|RNF135|CREBBP|FLOT1|RIOK3|SETD2|POLR3C|XRCC6|IRAK1|POLR3D|CTNNB1|MRE11A|DDX3X|MAVS|RIPK2|MYD88|LRRFIP1
POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002732,0.144069128043991,0.6340340930337739,-0.66743417229994,-1.3545378223425901,916,3,MAVS|TICAM1
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061213,0.9341709621993131,1.0,0.243823002753882,0.59964716587379,8698,6,BASP1|GATA3
EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0001837,0.433705080545229,0.878651088001772,-0.174872881103863,-1.01935382737075,1399,44,HGF|NOLC1|EFNA1|SNAI1|PDCD4|LIMS1|S100A4|ACVRL1|OLFM1|RBPJ
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903569,0.705369127516779,0.968941691852291,0.6505844728716371,0.8642724475788921,5254,1,EFCAB7
GLIAL CELL PROLIFERATION%GOBP%GO:0014009,0.350185225539333,0.842847021021096,0.47672533444416904,1.09878122541445,3213,5,NF2|SOX11|SOX4|CLU|CX3CL1
PURINE NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0006145,0.930872483221476,1.0,0.537163652404058,0.713597947649256,6934,1,DPYD
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING%GOBP%GO:1905595,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046825,0.666066375096476,0.964618776001639,-0.170468800536786,-0.86193215856543,2588,28,IWS1|SP100|EMD|ANP32B|GSK3B|GAS6|PARK7|SETD2|IL1B|TCF7L2|UHMK1|BAG3|TP53|RANGAP1|YWHAE
POSITIVE REGULATION OF GLUCONEOGENESIS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0035948,0.49718120805369104,0.9119302233444659,0.754907366563741,1.0028607576746,3703,1,SUPT20H
MONOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046364,0.00115908432338453,0.09181648161563599,-0.381195058951805,-2.1338222364465,3,38,GPI|CRTC2|FBP1|G6PD|ENO1|GAPDH|PGK1|SORD|PPARGC1A|TPI1|G6PC3|ALDOA|TKT|SLC25A13|PER2|PC|PGAM2
CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0003300,0.418913226621735,0.87173622607586,0.39996348567809903,1.04102092084505,3977,7,RYR2|TCAP|SORBS2|INPP5F|PDLIM5
CELLULAR RESPONSE TO LIPID%GOBP%GO:0071396,0.785,0.981487311948134,-0.10254022793128699,-0.8850454933848899,627,234,RAMP3|ADNP2|IL1RN|INSIG1|GPER1|AHR|TESC|TADA3|CD274|IL1B|RARA|IRAK1|PDK3|PIM1|MTDH|SIRPA|CTNNB1|WBP2|DAB2IP|PTK2B|TNFAIP3|NR1H3|PTGFR|RET|RHOA|ZNF703|TNFRSF1B|BCL10|VIM|PTK7|YWHAH|IL6|LYN|SBNO2|POU4F2|RUVBL2|WNT6|WNT11|LDOC1|PDE4B|DGAT2|MSN|NRIP1|NEDD4|NR1H2|PPARGC1A|PDCD4|CXCL8|NLRP3|NR3C1|KLF9|UBE2L3|TWF2|ADCY2|ADCYAP1|WNT3|TNIP2|RNF4|TICAM1|NR1D1|AQP1|TNF|BCL2L11
TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:0036363,0.42435040831477394,0.8740879492662891,-0.600716845878136,-1.0274939925381898,2857,2,LTBP3|NRROS
REGULATION OF PLASMA MEMBRANE ORGANIZATION%GOBP%GO:1903729,0.0238188207731355,0.32397355287938,-0.537448255877731,-1.73493113186637,121,9,PRKCD|DNM2|PLEKHM2|SH3GLB1|ASAP1|TMEFF2
INTERCELLULAR BRIDGE ORGANIZATION%GOBP%GO:0043063,0.6187919463087249,0.9532238181782521,0.695191883546537,0.923531402582818,4609,1,TEX14
ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:0072577,0.291437549096622,0.8000726114371469,-0.558729458475791,-1.1339248353953701,1854,3,BMPR2|HIPK1|DAB2IP
HINDGUT MORPHOGENESIS%GOBP%GO:0007442,0.316510067114094,0.8176737565328901,0.8458314953683279,1.12364940637852,2357,1,DACT1
NEGATIVE REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010801,0.00040371417036738,0.0784645998831315,-0.669012576375323,-2.3543386080642996,1,11,DDIT4|INPP5K|DGKQ|EIF4G1|SMAD7|SPRED2|PARD3
LIPOPROTEIN CATABOLIC PROCESS%GOBP%GO:0042159,0.0597079037800687,0.476295606439141,0.6088504555191321,1.49737902482296,555,6,LYPLAL1|NOTUM|APOE
SA NODE CELL ACTION POTENTIAL%GOBP%GO:0086015,0.545652647635651,0.930420772651609,0.406546670434363,0.9370298082623671,5007,5,CACNA1G|CACNA1D|SCN3B
NEGATIVE REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0001100,0.6544419435985699,0.9640743070248079,-0.666629907366564,-0.891771152459734,4942,1,RGCC
PYRIDOXAL PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0032361,0.682953020134228,0.9661822799536179,0.6633215703573,0.881193113346391,5087,1,PDXP
TOLL-LIKE RECEPTOR 5 SIGNALING PATHWAY%GOBP%GO:0034146,0.9702105123791871,1.0,-0.513233348037053,-0.686567898022763,7327,1,TLR5
LYSINE CATABOLIC PROCESS%GOBP%GO:0006554,0.6367598982927719,0.959271399361425,-0.29310535024820694,-0.855001310575599,3505,7,PHYKPL|AASS|AADAT|PIPOX|HYKK|ALDH7A1|GCDH
EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX ASSEMBLY%GOBP%GO:1905143,0.575532900834106,0.941940408834489,-0.706440229378033,-0.945026634021018,4346,1,CDC123
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING%GOBP%GO:0086026,0.24251012145748999,0.7565220534116759,0.423137328530543,1.2074893594260099,2395,9,KCNN2|CACNB2|KCNQ1|GJA1|SCN3B
MEDIUM-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0036112,0.4002661183016811,0.8638522656500329,0.6421836228287839,1.04963148969753,3308,2,HSD17B4|ACOT7
LATERAL MESODERM MORPHOGENESIS%GOBP%GO:0048369,0.11981993909704801,0.6056190749402529,-0.938795765328628,-1.25585571892303,904,1,TBX20
RENAL SYSTEM VASCULATURE MORPHOGENESIS%GOBP%GO:0061438,0.0656288498152089,0.495991045493396,0.6838458700852579,1.4491347230717297,585,4,BMP4|PKD2
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000677,0.0823145884270579,0.540742522388142,-0.26467561540721,-1.40121668498945,302,32,PSEN1|MAD2L2|PARK7|TRAF6|FAM129B|FOXC1|HAND1|SIN3A|CTNNB1|H1F0|DDIT3|POU4F2|IGF1|ZNF593|TMSB4X|PER2|DDRGK1|TWIST1
CLATHRIN COAT ASSEMBLY%GOBP%GO:0048268,0.698026121967986,0.96731875442989,0.251375356375083,0.811281711619737,7107,13,FCHO1|HIP1R|CLTB|CALY|CLTC|HIP1|PIK3C2A|FCHO2|EPS15
DIADENOSINE POLYPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0015960,0.0568671121009651,0.4641578331710611,-0.856079404466501,-1.4642779726597601,382,2,GARS|KARS
QUINONE METABOLIC PROCESS%GOBP%GO:1901661,0.0708727070594775,0.5132410216418211,0.38033503321683293,1.45659495121737,764,22,FDXR|AKR1B1|CBR4|COQ3|COQ2|COQ6|AKR1C1
EMBRYONIC SKELETAL JOINT MORPHOGENESIS%GOBP%GO:0060272,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902307,0.734157650695518,0.9735274924468309,0.23107733005065803,0.7834935738293249,7599,15,ATP1B3|WNK3|ANK3|DRD4|DMD|WNK2|WNK1|GLRX|ACTN4|FXYD1|ATP1B1
REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032483,0.760667487960578,0.9777564629086558,0.36915597666801,0.782276778175725,6791,4,SGSM3|MADD|DENND4B
TRNA PROCESSING%GOBP%GO:0008033,0.861873638344227,0.991915800284466,-0.109866833214156,-0.78382270741916,1977,88,KIAA1456|METTL1|AARS|ADAT1|C9orf64|TRMT12|POP5|MOCS3|KIAA0391|TSEN2|FARS2|TRMT61B|NSUN3|TRMT112|RTCB|ELP3|URM1|CDKAL1|DPH3|NSUN2|KARS|SARS|RPP14|WDR4|TRDMT1
REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0033047,0.000574288292722947,0.0806484601749226,0.39136733129218,1.96418515340126,6,60,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|NAA10|NUMA1|USP44|FAM178A|BUB1|DLGAP5|CDC23|CDC20|GEN1|APC|NDC80|CDK5RAP2|CENPE|PTTG1|FBXO5|RB1|BUB1B|ESPL1|CDC6|NIPBL
REGULATION OF IMMATURE T CELL PROLIFERATION IN THYMUS%GOBP%GO:0033084,0.360711261642676,0.848418604328854,0.660051674938655,1.078836330007,2981,2,BMP4|KIAA0922
PLATELET DENSE GRANULE ORGANIZATION%GOBP%GO:0060155,0.5680140597539539,0.9398422263548051,-0.327635100613766,-0.8993363520965709,3231,6,BLOC1S1|ABCA1|BLOC1S3
POSITIVE REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043507,0.651605231866825,0.9640743070248079,0.185516021437548,0.8653118141058141,7671,44,EDN1|TAOK3|MAP3K10|ERN1|MAP3K9|DUSP19|MAP3K5|MAP3K7|CCL19|MAP3K4|TAOK1|MAP2K7|RIPK1|MAP3K12|TRAF2|DVL3|DVL2|SPAG9|TNIK|MAP4K2
POSITIVE REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901079,0.9768303985171459,1.0,-0.510752095280106,-0.6832486505570319,7377,1,CHGA
TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0006383,0.845809054235769,0.991298302704726,0.169938653958279,0.703943130356514,9434,29,SNAPC2|BDP1|POLR3GL|BRF1|ZNF143|POLR3G|TROVE2|SNAPC3|POLR3K|GTF3C5|GTF3C3|TBPL1|IVNS1ABP|GTF3A|GTF3C1|ZC3H8|ICE2|GTF3C2
IMMUNOGLOBULIN V(D)J RECOMBINATION%GOBP%GO:0033152,0.440083362278569,0.879896414106183,0.538191623334567,1.02304566032532,3800,3,LIG4|PRKDC
POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040018,0.27531147937583195,0.7884684708511421,0.6977655313515171,1.14047859225358,2275,2,GHRL|PPIB
REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001112,0.67260579064588,0.9647315640607691,-0.4929693961952029,-0.8431977504398229,4529,2,ADAMTS12|CNKSR3
REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051794,0.541970591640616,0.928956216948897,0.500833186704602,0.952031202251779,4680,3,CDH3|TGFB2
HEAT ACCLIMATION%GOBP%GO:0010286,0.419083883973569,0.87173622607586,0.490325770698253,1.03904714646761,3741,4,RBBP7|HSBP1L1
POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0045725,0.970048119414711,1.0,0.16192380849997198,0.522588317352119,9877,13,INS|GCK|IRS1|AKT2|AKT1|PPP1R3E|SORBS1
OLIGOSACCHARIDE TRANSPORT%GOBP%GO:0015772,0.505382847465828,0.9172434440873181,0.601988280657825,0.9839333071497379,4177,2,SLC45A3
REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING%GOBP%GO:0014722,0.220181431291298,0.735314515752205,0.5741208604255171,1.21661694612371,1965,4,DMPK|DMD|GSTM2
ASPARAGINE BIOSYNTHETIC PROCESS%GOBP%GO:0006529,0.0299328859060403,0.35509922886098294,0.9850573445081601,1.3086047356553,222,1,ASNS
MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098914,0.0033869602032176103,0.140033065594047,0.959525778880618,1.56831852586525,27,2,KCNN2|KCNQ1
MRNA 3'-END PROCESSING BY STEM-LOOP BINDING AND CLEAVAGE%GOBP%GO:0006398,0.8145604395604399,0.986276922067025,-0.287045939720713,-0.726637735572135,4743,5,SLBP
HISTONE H4 DEACETYLATION%GOBP%GO:0070933,0.479959514170041,0.9046812288131709,0.345170610789721,0.9849989864108171,4741,9,HDAC8|HDAC3|SMARCAD1|REST|HDAC9|HDAC2|SIRT2
REGULATION OF PROTEIN HETERODIMERIZATION ACTIVITY%GOBP%GO:0043497,0.0286959680348711,0.347919292482523,-0.577203955535433,-1.68372954650709,157,7,BAX|DAB2IP|HSF1|BCL2|CD36
POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000503,0.521894949042446,0.9251240799994541,0.45333294746617203,0.9606558203002359,4659,4,CCL5|XCL1|CCL4|CCL3
CLEAVAGE FURROW FORMATION%GOBP%GO:0036089,0.8096040438079191,0.984682960940884,0.275315417080818,0.716588186860095,7687,7,AURKB|SPIRE2|SPIRE1|SNX18|SNX33
CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS%GOBP%GO:0042219,0.747295208655332,0.9749763305090959,0.22772957121086,0.7721426224524109,7735,15,GGT1|PCYOX1L|SARDH|GGT5|PM20D2|GGACT|CHAC2|PRODH|MTHFS
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002706,0.9994386977788471,1.0,0.0785730648364205,0.41240801561447704,12463,74,CEACAM1|AGER|THOC1|KLRK1|CD1E|SLAMF6|MAP3K7|ZP3|ZBTB1|IL12RB1|NCR3|CD1D|PAXIP1|RIF1|TRAF2|RASGRP1|SUPT6H|RIPK3|BTK|HLA-F|FAM35A|IL1R1|XCL1|TP53BP1|HSPD1|NDFIP1|WAS|FADD|MICA|HLA-C|FOXP3|PRKCZ|HMGB1|STX7|CADM1
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND%GOBP%GO:0071407,0.488865323435843,0.9084491271791959,-0.11657802055381099,-0.9908088929000741,460,210,POU4F2|MAVS|RUVBL2|ATP2B4|RAP1A|CTNNA1|NPM1|SHMT2|SNCA|PDE4B|RYR1|MSN|NRIP1|NEDD4|PPARGC1A|PDE12|NR3C1|RAPGEF1|GABRG2|COLEC12|KLF9|UBE2L3|ADCY2|RALB|ADCYAP1|MAPK3|PARK2|RNF4|PDE3A|AQP1|TNF|BCL2L11|HRH1|CAV1
REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904732,0.970823202500868,1.0,0.291333287022026,0.553793931517426,8384,3,METTL20|COX17|CHCHD10
CYTIDINE METABOLIC PROCESS%GOBP%GO:0046087,0.22525934464021102,0.7390599693491929,-0.526973287958441,-1.21192847372839,1367,4,CDA|CDADC1
POSITIVE REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032075,0.43409490333919204,0.878651088001772,-0.36236280403728405,-0.9946615661993671,2469,6,AKT1|HMGB2|DDX11|PCNA|PRKCD|RPS3
MICROTUBULE NUCLEATION%GOBP%GO:0007020,0.290809709097647,0.800029528446767,0.300213836108464,1.1497493519401398,3138,22,AKAP9|CENPJ|TUBGCP3|CETN3|TUBG2|TUBGCP6|CEP192|TUBGCP2
PRONEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0039007,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000561",0.8750454050127131,0.9937342763776691,-0.232046332046332,-0.6768894455384911,4817,7,CD55|XCL1|TWSG1|TGFBR2|C10orf54|CD274|LGALS9
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0010715,0.641687780159813,0.961457642922886,0.258398195913694,0.856153522091189,6584,14,FGFR4|DDR2|DDR1
AMINO ACID ACTIVATION%GOBP%GO:0043038,0.851482059282371,0.991298302704726,-0.1265031697274,-0.7481171793601321,2728,46,QARS|DARS|AARS|CARS|WARS|NARS|HARS|FARS2|GARS|AIMP2|YARS|KARS|SARS
"MRNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0070054",0.20416107382550303,0.720304973077154,0.899867666519629,1.19543404902852,1520,1,ERN1
POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000271,0.15149384885764497,0.647957032781885,-0.48182670564227,-1.3225819546906599,861,6,STK17A|PRDM11|SFRP1|BTG1|STK17B|BCL2L11
CELL MIGRATION INVOLVED IN GASTRULATION%GOBP%GO:0042074,0.812144671585823,0.9859232289448421,0.481720430107527,0.7873588093764029,6713,2,GPC3|MEGF8
POSITIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060355,0.0182776222624732,0.284990707385907,-0.75348811559036,-1.7328652566767702,110,4,FLOT1|IL1B|COLEC12|CAV1
NEGATIVE REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904797,0.5775188666754929,0.942692029750853,-0.705227172474636,-0.9434038908155501,4361,1,PSEN1
PLASMACYTOID DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002470,0.889664429530201,0.997300970905927,0.556296868107631,0.739015571118183,6627,1,CLEC4A
REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048259,0.6357065413805569,0.95916055221954,-0.140083185086415,-0.9031045621706421,1758,62,PICALM|OPHN1|SGIP1|CLU|VEGFA|MTMR2|NECAB2|RAB21|ARRB2|TNK2|ARRB1|LRPAP1|TBC1D5|FMR1|DKK1|B2M|GREM1|RAC1|BICD1
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1900827,0.459060402684564,0.890371861972445,0.7758050286722541,1.0306223694749599,3419,1,ANK3
EMBRYONIC CAMERA-TYPE EYE FORMATION%GOBP%GO:0060900,0.694539835164835,0.96731875442989,-0.32004757908017495,-0.8101791941890379,4044,5,TWIST1
REGULATION OF SISTER CHROMATID SEGREGATION%GOBP%GO:0033045,0.00048402710551790896,0.0784645998831315,0.37955833290209,1.9703437115968898,5,70,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|NAA10|NUMA1|USP44|FAM178A|BUB1|DLGAP5|CDC23|CDC20|FEN1|GEN1|APC|NDC80|CDK5RAP2|CENPE|PTTG1|FBXO5|HDAC8|RB1|BUB1B|ESPL1|CDC6|NIPBL|CDCA5|RMI2|KLHL22
ALDEHYDE BIOSYNTHETIC PROCESS%GOBP%GO:0046184,0.0207381370826011,0.302594086541812,-0.649272452379834,-1.78220928632559,117,6,TPI1|PNPO|PDXK|TKT
ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042773,0.965958474167069,1.0,0.11411572627376,0.595840615236355,12002,72,NDUFA7|NDUFS7|NDUFA4|NDUFS2|COX5A|COA6|NDUFC1|NDUFAF1|NDUFS4|TAZ|COX6A1|NDUFS8|NDUFB2|UQCC3|SDHA|MT-ND2|NDUFV1|NDUFS3|NDUFB7|NDUFA12|MT-CO2|MT-CYB|LACE1|MT-CO1|CYCS|NDUFB1|UQCR10|NDUFB3|NDUFA1|NDUFB6
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009211,0.506439690894837,0.9172434440873181,0.458842949694878,0.9723320413657,4521,4,DTYMK|DUT
CELLULAR RESPONSE TO AMYLOID-BETA%GOBP%GO:1904646,0.5938688212927761,0.946771423703279,-0.194418058647375,-0.9006883945529089,2498,22,FCGR2B|PRNP|IGF1|ADRB2|CD36
REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001919,0.299231613611416,0.8023890191280308,-0.270073395507974,-1.1060413237,1362,16,TRAT1|KIF16B|INPP5F|SCRIB|LAMTOR1|RAB29|TBC1D16|ANXA2|NSF|ECE1|AP1AR|OPTN|RAMP3|BVES|VAMP3|SNCA
BRANCHED-CHAIN AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009083,0.307095553453169,0.8101040452554871,0.310484714395923,1.13486913535114,3245,19,MCCC2|BCKDHA|BCAT2|IVD|HMGCLL1|MCCC1|PPM1K|HMGCL|HIBCH|HIBADH|HSD17B10|ACAD8|AUH|ACADSB|ACAT1
METANEPHRIC RENAL VESICLE FORMATION%GOBP%GO:0072093,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
NEGATIVE REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090024,0.6921752945849329,0.96731875442989,-0.6487097485663871,-0.867798809651677,5227,1,SLIT2
REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032674,0.17998547039593202,0.685385002351581,-0.437354272975521,-1.2757818179137599,990,7,RARA|LGALS9|PDE4D|TNFRSF21
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001239,0.0009025270758122741,0.0849637591935908,-0.5009595371735039,-2.1969446346547903,3,19,SNAI2|IL1B|MAPK7|RET|MAP2K5|UNC5B|BCL2L1|PPP2R1B|EYA4|BCL2|EYA1|TNF
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE%GOBP%GO:0001990,0.7372488408037092,0.974306231601101,0.230158822328126,0.7803792705008291,7631,15,EDN1|OXTR|AGTR1
RESPONSE TO PEPTIDE HORMONE%GOBP%GO:0043434,0.0883567299752271,0.556932119338259,-0.147787274209641,-1.21056090484301,106,173,PRKCD|IGF1R|CPEB1|USF1|BCAR1|FOXO4|GRB2|CRHR1|RAB8B|INPP5K|HDAC5|FOXO1|PKM|CPEB2|ATP6V0C|PXN|ATP6V1F|PPARG|LYN|VAMP2|NAMPT|CAMK2A|PRKAR2A|GCGR|FOXC2|LPIN1|RAB8A|PTPN1|SLC25A33|STAT5A|SHC1|ATP6V1E2|ATP6V0D1|STAT3|PRKAR1B|ADCY2|CAV2|ATP6V1E1|RHOQ|IGF2|PIK3R1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010889,0.5216599190283401,0.9251240799994541,0.333221471145445,0.9509002246096191,5153,9,LPL|FITM1|PNPLA2|OSBPL8|OSBPL11
POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001171,0.28407039711191306,0.79342123536088,-0.256261559955033,-1.1238282085375,1258,19,PRKAA1|PFKFB4|ENO1|IGF1|TMSB4X|PPARGC1A|AAED1
NITRIC OXIDE TRANSPORT%GOBP%GO:0030185,0.32569179113118,0.826621597878865,0.585554870016173,1.11307820984052,2812,3,EDN1|HBB
REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002697,1.0,1.0,0.0663226092400771,0.41969339922842597,14157,228,IGKV4-1|CD47|NR4A3|AIM2|CEACAM1|MZB1|IGHG1|INS|AGER|IGHG4|ANKRD17|DHX9|TKFC|THOC1|KLRK1|CD1E|TGFB2|SLAMF6|MAP3K7|LOXL3|F2RL1|IGKV3-11|SUSD4|ZP3|ZBTB1|IGKV2D-28|CUEDC2|ELMOD2|CCL19|RPS19|IGKV2-28|UNC13D|C3AR1|C7|CD55|C5|STXBP2|IL12RB1|BIRC2|NCR3|C12orf4|CD1D|FCRL3|PAXIP1|C4A|C4B|PTPRJ|HLA-DMB|RIF1|IGHG2|TRAF2|CD46|NPLOC4|RASGRP1|DNASE1L3|ZNF683|SUPT6H|RIPK3|TARBP2|BTK|HLA-F|NFKBID|DHX58|TGFB3|FAM35A|PARP9|IL1R1|PQBP1|RC3H1|FER|STAT1|BST2|SLAMF8|BIRC3|TNFRSF14|DNASE1|XCL1|IFNLR1|DDX60|IFIT1|TP53BP1|ANXA1|HSPD1|NDFIP1|WAS|C2|C1QB|DDX58|FADD|JAK3|XBP1
SEPTIN RING ORGANIZATION%GOBP%GO:0031106,0.40723055934515706,0.8669681570015609,0.316231591795586,1.04777353477624,4178,14,SEPT12|SEPT11|ANLN|SEPT2|SEPT3|SEPT5
COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072049,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002733,0.144069128043991,0.6340340930337739,-0.66743417229994,-1.3545378223425901,916,3,MAVS|TICAM1
BOX C/D SNORNA 3'-END PROCESSING%GOBP%GO:0000494,0.420935412026726,0.8727872721376851,-0.602757099531293,-1.03098373714292,2834,2,FBLL1|FBL
CELL MATURATION%GOBP%GO:0048469,0.851545864917809,0.991298302704726,0.15370229904909302,0.7125792345687629,9997,43,SIX3|ROPN1B|ZCCHC11|CABYR|TMEM79|PCSK4|FARP2|CCL21
MEMBRANE ASSEMBLY%GOBP%GO:0071709,0.6296040515653779,0.956868818587551,-0.19626337853630102,-0.8757086462334609,2734,20,RFTN1|CAV2|CAV1
MITOCHONDRIAL TRNA MODIFICATION%GOBP%GO:0070900,0.45865549828178703,0.890371861972445,0.40757780952822603,1.00237826454525,4270,6,TRIT1|PUS1|MTO1|HSD17B10
PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0015911,0.287832649278432,0.797389846888611,-0.856473312748125,-1.1457304641155501,2173,1,SLC27A5
DIADENOSINE TETRAPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0015966,0.0568671121009651,0.4641578331710611,-0.856079404466501,-1.4642779726597601,382,2,GARS|KARS
POSITIVE REGULATION OF VITAMIN D 24-HYDROXYLASE ACTIVITY%GOBP%GO:0010980,0.838791946308725,0.989395884107905,0.581219673577415,0.77212440629961,6248,1,CYP27B1
CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:0071394,0.213825608798115,0.7299867877356379,-0.607960747097329,-1.23383827292696,1360,3,MSN
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000242,0.3661985662378471,0.8510019955058101,0.336996034432074,1.08761146504422,3728,13,WNT4|FBXO43|FBXO5|ZP3|DUSP1|RAD1|SULF1|HYAL3|TIMP1|TRIP13
MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010934,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
S-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072050,0.7723478891980159,0.979693198874896,0.497391121058716,0.812972123237057,6384,2,PKD2
SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0007183,0.0777333817653469,0.5314695499765479,-0.509343214164489,-1.48577675322079,427,7,TGFB1|SMAD4|SMAD3|SMAD1|SMAD2|FKBP1A
POSITIVE REGULATION OF NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043323,0.213956941351151,0.7301341244006608,-0.7295285359801491,-1.24781948974484,1440,2,AP1G1|LAMP1
NEURAL TUBE DEVELOPMENT%GOBP%GO:0021915,0.243349585150971,0.7565220534116759,0.257762375889072,1.18631407598458,2844,42,ALDH1A2|PROX1|PKD2|ZNF358|MTHFD1|DVL1|DEAF1|TGFB2|DACT1|STIL|VANGL2|PLXNB2|SEMA4C
REGULATION OF THYROID-STIMULATING HORMONE SECRETION%GOBP%GO:2000612,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
RESPONSE TO ANTICOAGULANT%GOBP%GO:0061476,0.803785418299922,0.984522820758988,0.351348370374455,0.7445407593684991,7176,4,EGR1|GPIHBP1|SFRP1|SLIT2
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051056,0.0879237288135593,0.556718035193165,-0.14350033451282998,-1.21521717851596,82,209,RHOG|RALBP1|FLCN|STAMBP|NOTCH1|OPHN1|ARHGAP5|ARHGDIA|TAGAP|MAPKAP1|HEG1|KALRN|GNA13|PLCE1|ARHGAP8|LPAR1|DAB2IP|ABR|STARD8|SQSTM1|DLC1|FGD4|GRB2|ABL1|VAV1|EPS8L1|TRIO|ARHGAP23|RHOA|FBP1|NRP1|ARHGAP1|GMIP|MFN2|ARHGAP29|LYN|ARRB1|SHOC2|ABCA1|IGF1|MAP4K4|RHOC|DENND1A|PDCD10|VAV3|ARHGEF2|VAV2|CDC42|AKAP13|ARHGAP36|NET1|ARHGAP31|RAPGEF1|SHC1|RELN|RASGRF2|BCR|FGF10|RHOQ|GPR4|RAC1|MET|SH3BP1|ARHGAP26|ARHGAP22|EPHB2
KIDNEY VASCULATURE DEVELOPMENT%GOBP%GO:0061440,0.8540197461212979,0.991298302704726,0.230053126204181,0.6789462100033411,8476,10,BMP4|PKD2|ACTA2|EGR1|PDGFRA|TEK|PDGFB
"NEGATIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032785",0.0687093779015785,0.5037729184803449,-0.486477398872568,-1.51218357157227,369,8,SUPT4H1|EAPP|RNF168
NEGATIVE REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070303,0.6948069980560961,0.96731875442989,-0.15650601117906102,-0.850767766305621,2501,35,PDCD4|MECOM|DUSP3|PARK2|DUSP10|DLG1
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043280,0.6818785999113871,0.9653437761269,-0.124332646434349,-0.892164302539847,1538,90,LGALS9|DLC1|EIF2AK3|BBC3|RPS3|S100A8|DDX3X|TNFRSF10A|PPARG|BOK|CRADD|SNCA|NLRP1|NLRP3|TNFRSF10B|MTCH1|SOX7|BCAP31|TNF|PMAIP1|EGLN3
RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0034976,0.795107033639144,0.98244927136446,-0.103290858532959,-0.875905992490099,779,206,CTDSP2|UGGT1|TMCO1|TSPYL2|GOSR2|MYDGF|WIPI1|FLOT1|PIK3R2|CALR|ERLIN2|ATF4|PPP1R15B|FOXRED2|BAX|DNAJC3|SEC13|CREB3|RHBDD1|ADD1|UFC1|EIF2S1|TRIM13|KLHDC3|HSPA13|DAB2IP|GORASP2|UBE2J1|HSPA5|OS9|EIF2AK3|BBC3|SGTB|TATDN2|FAM129A|STUB1|HYOU1|RNF139|P4HB|DDIT3|AMFR|ATF6|LMNA|CHAC1|PTPN1|RNF103|CREBRF|TRIM25|CXCL8|BCL2|SHC1|JUN|ATP6V0D1|ASNA1|TP53|RASGRF2|TNFRSF10B|SSR1|VAPB|PARK2|THBS4|DDRGK1|SESN2|PIK3R1|BCL2L11|TMEM33|TRIB3
REGULATION OF MATING TYPE SWITCHING%GOBP%GO:0031494,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000302,0.127114093959732,0.6076669536424699,0.9372518747243052,1.24509730180066,946,1,UNC13B
ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032924,0.106378683891805,0.5804736026135671,-0.395870332518251,-1.39311702133399,526,11,TGFBR1|ACVR1|CITED2|SMAD2|INHBB
POSTSYNAPTIC SPECIALIZATION ASSEMBLY%GOBP%GO:0098698,0.644866838487973,0.9625632908696992,0.347360873641829,0.854283480484494,6004,6,SHANK1|NRXN2|NLGN2|NRXN1|PTEN|SHANK2
LEARNING OR MEMORY%GOBP%GO:0007611,0.682461830551381,0.9659330636214009,0.16023523557785097,0.859805289998263,8626,82,CALB1|CRHBP|SLC8A3|KAT2A|VLDLR|AGER|ABCA7|ADCY8|RGS14|FGF13|CUX2|CPEB3|FEN1|NF1|APOE|GRIN1|SHISA7|DLG4|TH|NLGN4Y|BRSK1|LDLR|NRXN3|S100B|NPAS4|SLC8A2|SHANK1|CLDN5|NLGN3|CIC
NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902904,0.286066584463625,0.7952357288717371,-0.16112508882108598,-1.10646628068886,695,77,MAPRE1|PPFIA1|ADD1|CLU|CLIP3|PRKCD|SPEF1|DLC1|PFN1|DYRK1A|INPP5K|TMSB10|MYADM|TRIM54|TMSB4X|SNCA|ARHGEF2|TWF1|ARPIN|TWF2|PARK2|TMEFF2|MET|MID1IP1
CELLULAR ZINC ION HOMEOSTASIS%GOBP%GO:0006882,0.842934884593733,0.991298302704726,0.18814398964111897,0.698672564781108,8983,20,MT1F|SLC30A5|MT1E|SLC39A7|SLC39A13|MT2A|SLC39A10|LCK
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:2000655,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:0034501,0.370406759677736,0.852609194081082,0.34207305845580493,1.0783365256020898,3769,12,CDK1|CASC5|AURKB|SPDL1|MTBP|CHAMP1|IK|MIS12|GSG2|RCC2|ZW10
HEXOSE PHOSPHATE TRANSPORT%GOBP%GO:0015712,0.631121917332407,0.9575013258325501,0.47016902004521705,0.8937418471815419,5450,3,SLC37A2|SLC37A3|SLC37A1
ALDONIC ACID METABOLIC PROCESS%GOBP%GO:0019520,0.11073825503355698,0.584830174998513,0.944309660344067,1.25447325512638,824,1,IDNK
POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002833,0.9896200361870301,1.0,0.128935076992518,0.462516407297177,10391,18,ANKRD17|KLRK1|F2RL1|CD180|DHX58|DDX60|HSPD1|PUM2|LRSAM1|PVR|LY86|OPTN|PUM1|SASH1|CYBA|PVRL2|CD274
SENSORY PERCEPTION OF SMELL%GOBP%GO:0007608,0.114235500878735,0.5906506806283871,-0.511272452459603,-1.40340855256693,649,6,GNAL|MKKS|DRD2
PROTEIN LOCALIZATION TO VACUOLAR MEMBRANE%GOBP%GO:1903778,0.230504435323712,0.743397546142977,-0.884263343625938,-1.18290603573174,1740,1,SH3GLB1
FRUCTOSE IMPORT%GOBP%GO:0032445,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050907,0.15982115004679198,0.661454203640901,0.47855448881342894,1.3046679247764699,1536,8,RTP5|TAS2R4|RTP4|TAS2R5|TAS2R20|TAS2R14|TAS2R19
REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051282,0.7468302990897271,0.9749763305090959,0.15768335926729501,0.8122310603407399,9188,68,RYR2|NOL3|JSRP1|LIME1|F2R|CXCL9|PKD2|IBTK|PDPK1|CCR5|CCL21|JPH4|LINC00116|SEPN1|CCL19|CXCL10|PLCG1|DMD|TRPC1
VENOUS BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0048845,0.48347978910369105,0.9064456896937672,-0.35078225252353495,-0.9628737298712958,2750,6,ENG|NOTCH1|VEGFA|TBX20
REGULATION OF CELL KILLING%GOBP%GO:0031341,0.9912169580271941,1.0,0.10134148033849999,0.480682722228999,11736,47,CEACAM1|AGER|KLRK1|CD1E|TGFB2|SLAMF6|F2RL1|IL12RB1|PRF1|NCR3|CD1D|RASGRP1|DNASE1L3|RIPK3|HLA-F|DNASE1|XCL1|P2RX7|FADD|MICA|HLA-C|STX7|CADM1|PTPRC|HFE
BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:0051016,0.07446808510638299,0.5238006217712511,-0.441275445468086,-1.49290088212037,377,10,ADD2|EPS8|ADD3|CAPZA1|CAPZB|TRIOBP|CAPZA2|ADD1|TWF1|TWF2
NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902915,0.7203051216854341,0.9713637233549571,-0.273745173745174,-0.798526816783345,3965,7,PARP10|PLAA|UBR5|GPS2|TRIM44|OTUB1|TRIP12
MONOCYTE ACTIVATION%GOBP%GO:0042117,0.6939647168059421,0.96731875442989,-0.261458738651151,-0.812727600806482,3736,8,ADAM10|FOXP1|DYSF
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0098884,0.813192966737597,0.9860366614541909,0.347399458772657,0.736172638464598,7260,4,DNM3|DNM1
REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010728,0.41297546517371997,0.868150124237366,-0.443022905675456,-1.01886013232669,2507,4,ZNF205|FYN|MPV17L
NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902187,0.9554922381607389,1.0,0.17564540771251702,0.553697094841944,9724,12,TRIM5|MID2|TRIM21|CHMP3|TRIM32|TRIM26|TRIM28|TRIM11|TRIM8|TRIM13|PML|TRIM35
RESPONSE TO GLUCOCORTICOID%GOBP%GO:0051384,0.00373505976095618,0.143595610377104,-0.40140108513345896,-1.9709970533081103,14,26,NR3C1|KLF9|UBE2L3|ADCYAP1|AQP1|TNF|BCL2L11|SLIT3
PEPTIDYL-ASPARAGINE HYDROXYLATION%GOBP%GO:0042265,0.6096915133059712,0.9508825506493929,-0.688685487428319,-0.9212755743773431,4604,1,HIF1AN
LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002269,0.0997657165169856,0.570215774831708,-0.43793984258297897,-1.41370905658818,510,9,CLU|CX3CL1|ITGAM|SNCA|TNF
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043415,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|CAPN3
NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090206,0.9812595336674659,1.0,0.220604456210015,0.508460568828268,9005,5,APOE|ERLIN1|SCAP|ERLIN2|SOD1
GLYCOSYL COMPOUND METABOLIC PROCESS%GOBP%GO:1901657,0.763214439192093,0.978421368343614,-0.121573020668026,-0.8548159637309921,1775,85,DHFRL1|ENTPD4|DERA|TRMT12|MOCS3|GMPS|GTPBP1|OARD1|PNP|MTRR|CDA|HPRT1|EFTUD1|NUDT18|MACROD2|CDADC1|UPP1|RHOQ|NT5E|ENPP4|AK4
NEGATIVE REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000349,0.350456772143519,0.842847021021096,-0.824327304808116,-1.1027277691706399,2646,1,TNFAIP3
ENDOCANNABINOID SIGNALING PATHWAY%GOBP%GO:0071926,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
HEXADECANAL METABOLIC PROCESS%GOBP%GO:0046458,0.364697986577181,0.85007225273817,0.822783414203794,1.09303105879924,2716,1,ALDH3A2
DNA DAMAGE INDUCED PROTEIN PHOSPHORYLATION%GOBP%GO:0006975,0.456691275865655,0.8894818557698579,0.367363791254289,1.00153225260124,4391,8,MAP2K6|MAPK12|CHEK2|CHEK1|ATM
CELL-CELL SIGNALING BY WNT%GOBP%GO:0198738,0.624192601291838,0.9536478716552259,-0.12193819247980198,-0.937779346423659,1062,123,FRAT1|PPP3R1|CTNNB1|ARRB2|CELSR1|PRICKLE1|PFN1|RHOA|DDX3X|TCF7L2|STRN|PPAP2B|MST1R|CAMK2A|WNT6|WNT11|CDC42|AP2S1|AGO2|UBA52|TCF7|WNT3|RAB5A|SFRP2|RAC1|MET|PLCB1|UBC|CAV1|UBB
POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0032819,0.363919821826281,0.8499434076701009,-0.64063964709126,-1.09577980588477,2450,2,HLA-E|IL18
KERATINOCYTE PROLIFERATION%GOBP%GO:0043616,0.0270091354428704,0.339785941813865,-0.986876929863255,-1.32017535870342,203,1,CDH13
CYTOSINE METABOLIC PROCESS%GOBP%GO:0019858,0.233417185224414,0.7474006137374671,-0.882884869872078,-1.18106200936189,1762,1,CDA
PHOSPHATIDYLINOSITOL-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0036092,0.319683655536028,0.8219996514077841,-0.40025370911698205,-1.09866955645492,1818,6,PIK3C2B|PIK3C2A|PIK3CB|PIK3CA|PIK3CD|PIK3C3
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:2000463,0.6580836603809711,0.9643779777660141,0.24373085331291697,0.844948771090591,6874,16,RIMS2|CUX2|GRIN1|DLG4|SHANK1|NLGN3|RIMS1|STX1B|NLGN2|PRKCZ
'DE NOVO' ACTIN FILAMENT NUCLEATION%GOBP%GO:0070060,0.0263471468290745,0.337668602007655,-0.987483458314954,-1.3209867303061498,198,1,JMY
CORONARY ARTERY MORPHOGENESIS%GOBP%GO:0060982,0.0683352544047423,0.50364937614461,-0.6641482380190811,-1.527402202017,414,4,TBX1|NOTCH1|VEGFA|TGFBR1
PH REDUCTION%GOBP%GO:0045851,0.9610270518110959,1.0,0.140006666398129,0.550995926381314,10479,24,DMXL2|CLN6|TCIRG1|GPR89B|ATP6V0E2|ATP6AP1|ATP6V0A2|SLAMF8|DMXL1|TMEM199|RAB20|CLCN3|ATP6V0A1
LIMB DEVELOPMENT%GOBP%GO:0060173,0.671032871683631,0.964618776001639,0.17659043658237,0.8571131391212529,8042,52,TBX3|TBX2|KAT2A|BMP4|MYH3|ZNF141|ZNF358|SMOC1|TGFB2|LEF1|C5orf42|BMPR1B|NIPBL
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS%GOBP%GO:1902218,0.40415738678544894,0.865585453523601,-0.6119742487123521,-1.0467491771781898,2721,2,ARHGEF2
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002862,0.279968578161822,0.788916642629372,-0.5646697741035179,-1.14598052946731,1781,3,FCGR2B|ADCYAP1
REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:0072091,0.8867649736027672,0.996643473105967,0.16455777125319002,0.661601062584855,9741,26,SIX3|SMARCD3|TERT|NF1|ZNF335|N4BP2L2|KDM1A
EVASION OR TOLERANCE OF IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051805,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
GOLGI TRANSPORT VESICLE COATING%GOBP%GO:0048200,0.834622144112478,0.988613522932093,-0.259114224256798,-0.711251147337081,4748,6,GBF1|TMED9|ARFGAP2|ARFGAP3|TMED10|TMED2
B CELL ACTIVATION%GOBP%GO:0042113,0.690241011457922,0.96731875442989,-0.129920622689459,-0.8833231925906829,1746,74,GAPT|CEBPG|VCAM1|DLL1|PIK3CD|GPR183|CD79B|BATF|CHRNB2|IL11|PTK2B|VPRBP|CR2|EXOSC6|HDAC4|NFAM1|HDAC5|FCRL1|FCGR2B|BANK1|MS4A1|KLF6|ADAM17|BCL2|IRF2BP2|TPD52|RNF168
NEGATIVE REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:1904506,0.323487824037706,0.8239107965478291,-0.5426271092974521,-1.10124559615973,2058,3,ERCC4|RTEL1|ERCC1
REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042058,0.0754648195406489,0.525408291492683,-0.206045486537548,-1.34239992710305,206,64,SHKBP1|NCK2|GPER1|FBXW7|ZGPAT|DOK1|DAB2IP|PTPN3|GRB2|MMP9|HAP1|PTPN12|PLAUR|CDC42|ADAM17|SHC1|DUSP3|SNX6|SOCS5|RAB7A|ADRA2A|CDH13
"NEGATIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0042321",0.5006652957542039,0.9144253281295329,0.603662873716546,0.986670383500455,4138,2,GHRL
REGULATION OF CYTOPLASMIC TRANSLATIONAL ELONGATION%GOBP%GO:1900247,0.52869972666927,0.9265056012720759,-0.288172905538101,-0.93024796287027,2707,9,DPH2|AARS|CPEB2|DPH6|DPH3
NEGATIVE REGULATION OF CELL ADHESION%GOBP%GO:0007162,0.96928051738076,1.0,-0.08718304586845901,-0.711451565122343,1198,169,CX3CL1|MAPK7|BCAS3|PRKCD|LGALS9|CD164|DLC1|ADAM10|RHOA|ZNF703|PPARA|MYADM|RUNX1|APOD|MAP2K5|FCGR2B|PODXL|PRNP|ASS1|MBP|SPOCK1|MAP4K4|SMAD7|LGALS3|PLXNA1|MMP12|DUSP3|PLXNA4|CD9|FXYD5|SOCS5|MFI2|ACVRL1|CBFB|CORO1C|CDH13|TNFRSF21|DACT2
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION%GOBP%GO:0032446,0.9964712269272529,1.0,0.0911637918973153,0.6122018679965711,14683,427,SH3RF1|HIST1H2BJ|SIRT1|ENC1|HACE1|FANCL|UBE3D|FBXO18|TRIM5|PIAS1|SPSB4|SIAH2|WDR61|TRIM3|CDC34|BTRC|LMO7|ANAPC5|TRIM68|RNF34|HECTD2|KLHL42|UBE2Z|RNF208|TRIM27|UBA3|KLHL3|ASB2|NHLRC3|THOP1|PCGF2|TSPAN17|MARCH7|DDB2|RNF182|TNFAIP1|BIRC6|DTL|DZIP3|FBXL19|RNF126|GAN|KLHL20|CDC23|TTC3|UBD|RNF111|RNF146|MIB2|ANAPC7|UBE2T|HLTF|CUL9|ANAPC16|SUMO2|UHRF1|FBXL15|PPIL2|KLHL25|CAND1|NAE1|HUWE1|KLHL8|DDB1|RNF7|PIAS4|RNF144A|DCUN1D4|TRIM37|SYVN1|FBXL8|RNF14|NFE2L2|KLHL22|DCAF15|UBE3B|FBXW5|TNKS2|HIST1H2BF|CCNF|PLK1|CUL4B|HECTD1|BIRC2|HERC2|KEAP1|HIST1H2BK|RNF40|CDC73|CHFR|RNF112|VIMP|UBE2C|FBXO9|CUL7|UNKL|RNF10|ANAPC10|TRIM23|KLHL12|KLHL9|CDK5RAP3|KCTD13|TOPORS|TRAF2|PRKDC|DCUN1D1|UBE2B|UBE2H|MYCBP2|UBR2|TRIM24|RBX1|HIST1H2BN|FBXL7|UFL1|SAE1|ANKIB1|RNF19A|AREL1|SKP2|MARCH5|TRIM21|VCP|ZNF738|PCGF1|MARCH6|ARRDC1|HIST1H2BG|RFWD3|PCGF3|ASB1|ZFP91|UBR3|CDC16|BRCA1|UBE2O|HIST1H2BH|ANAPC2|TRPC4AP|PDZD4|RC3H1|TRIM56|FBXO44|UBA6|NEURL1|FBXO11|MDM2|UBA5|UBA1|PINK1|SMURF2|UBE2E3|TRIM69|SHARPIN|UBR5|RNF8|TAF1|CBL|PEX2|BCL11A|ANAPC4|FBXO41|MAGEF1|WSB1|UBE2V2|TMEM189-UBE2V1
POSITIVE REGULATION OF FERTILIZATION%GOBP%GO:1905516,0.0944424264438794,0.563219670269027,-0.49354185691129,-1.43968349307076,519,7,PLCB1|CFAP69|POMZP3
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE INVOLVED IN MEIOTIC CHROMOSOME SEGREGATION%GOBP%GO:0051316,0.9752416258440358,1.0,-0.511358623731804,-0.6840600221597659,7365,1,CENPC
REGULATION OF TRANSCRIPTION INVOLVED IN PRIMARY GERM LAYER CELL FATE COMMITMENT%GOBP%GO:0060796,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
RESPONSE TO ANGIOTENSIN%GOBP%GO:1990776,0.834626338014338,0.988613522932093,0.216648208346017,0.6992042967968829,8498,13,ACTN2|AGTR1|SRC
NEGATIVE REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0045930,0.0162985202659232,0.27198543625715,0.234678709443614,1.46237385048051,227,204,KIF25|BTG2|MUS81|TAOK3|EME2|BRINP3|CCNB1|PIDD1|TPR|BMP4|CDK1|E2F8|ZWINT|PKD2|BLM|CENPF|NAA10|WEE1|CDK2AP2|BRINP1|ORC1|CDC25C|USP47|MUC1|BUB1|RAD9A|TOP2A|E2F7|DONSON|PPP1R10|DACT1|CDC20|YTHDC2|APC|ZNF830|NEK11|NABP1|PTTG1|FBXO5|RB1|BUB1B|NAE1|GTSE1|AURKB|CDC6|MSH6|HRAS|CDKN2B|INTS3|CCL2|KLHL22|TAOK1|MAGI2|RPS27L|CHEK2|TOPBP1|PLK1|KNTC1|PRMT1|EME1|BRSK1|CARM1|GAS1|AURKA|CDC73|CHFR|ARID3A|E4F1|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|TOP2B|C5orf45|TEX14|PRKDC|DUSP1|FHL1|FZD3|CHEK1|RBX1|RECQL5|FAP|FBXL7|RAD17|MAD2L1BP|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1
REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050848,0.0181301102026306,0.284061263070734,-0.24061959246785197,-1.53912175720267,50,60,PRNP|CHP1|HAP1|IGF1|ATP2B4|CAMTA1|JPH3|HOMER2|HTT|JPH1|CD22|RCAN2|CDH13|TNF|PDE4D|FKBP1A
POSITIVE REGULATION OF LACTATION%GOBP%GO:1903489,0.9110067114093959,1.0,0.5462064402293779,0.7256108878478271,6786,1,XBP1
EMBRYONIC HEART TUBE LEFT/RIGHT PATTERN FORMATION%GOBP%GO:0060971,0.608017817371938,0.9508825506493929,-0.518334711883099,-0.886583764444557,4094,2,MEGF8|CITED2
REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051249,0.9109713487071981,1.0,0.11544961329841501,0.7422961543139571,13035,261,IGHV3-21|SH3RF1|IGHV4-61|CD47|IDO1|PAG1|CEACAM1|GLMN|CD209|MZB1|INHA|IGHG1|SIRPG|KAT2A|CD38|CD27|BMP4|IGLL5|GRAP2|AGER|CD320|IGHG4|BLM|CD2|THOC1|KLRK1|PAK3|PDPK1|MARCH7|TNFSF13B|DOCK8|CCDC88B|PRKCQ|IGHV1-18|LOXL3|SRC|CCL21|IGHV3-43|CARD11|SIT1|EBI3|CCL5|BST1|ZP3|DLG5|ZBTB1|TIGIT|IL7|CCL19|CCL2|METTL3|TMIGD2|BTN2A2|CD55|ZNF335|IL12RB1|IGHV1-24|LAT|CD1D|FCRL3|RASAL3|PAXIP1|TNFAIP8L2|PLA2G2D|TESPA1|CEBPB|SOCS1|HLA-DMB|IGFBP2|RIF1|CD3E|PTPN22|IGHG2|CD46|ZAP70|CTLA4|ZNF683|LCK|SUPT6H|RIPK3|IKZF3|BTK|GATA3|IGHV1OR15-1
PROTEIN HOMOTETRAMERIZATION%GOBP%GO:0051289,0.390660496424064,0.860837094563899,0.220468351520309,1.0545009544736401,4642,49,KIF25|CTH|CRYZ|CBR4|ACTN2|PKD2|GLS|APIP|GBP5|TK1|DECR1|MCOLN1
ARTERY DEVELOPMENT%GOBP%GO:0060840,0.6833786987444029,0.9663110168977159,0.19258101591358398,0.8375358133429108,7782,34,TBX2|HES1|BMP4|PROX1|PKD2|ROBO2|TGFB2|NF1|HEY2|MYLK|TFAP2B
EPICARDIUM MORPHOGENESIS%GOBP%GO:1905223,0.363166953528399,0.849828746111777,-0.817159241288046,-1.09313883204742,2742,1,TGFBR1
POSITIVE REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0120158,0.5430954587581089,0.929698169790548,-0.723588442876048,-0.96796632206196,4101,1,C10orf54
"TRANS-SYNAPTIC SIGNALING BY TRANS-SYNAPTIC COMPLEX, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099557",0.0048987157420892396,0.161608827499482,-0.997684164093516,-1.3346325254430502,36,1,EPHB2
NEGATIVE REGULATION OF CELL GROWTH%GOBP%GO:0030308,0.31163049526989395,0.8143712300420921,-0.14066764491106198,-1.07620690243755,559,118,OSGIN2|SEMA3F|PML|DCUN1D3|FBP1|DDX3X|CCDC85B|NME6|SEMA7A|SH3BP4|ENO1|CDA|PPP2CA|JADE1|WNT11|SEMA6B|TP53|BCL6|CDKN1A|SERTAD2|SFRP2|ACVRL1|SEMA3A|SEMA3G|ING1|SESN2|SOX17|GAL|SLIT3
REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0060556,0.0695957820738137,0.5065946660817761,-0.5517302132008051,-1.51446238926156,395,6,SNAI2|IL1B|SNAI1|TNF
PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE%GOBP%GO:0032978,0.892947865005443,0.9976191001250191,0.439757375241246,0.71877134899002,7381,2,C2orf47|COX18
REGULATION OF NEUROTRANSMITTER LEVELS%GOBP%GO:0001505,0.000809716599190283,0.0849637591935908,-0.20176898689152103,-1.6477470322643402,0,170,SDS|NAPA|VAMP2|ASS1|STX11|CAMK2A|SDSL|ATP2B4|NQO1|SHMT2|SNCA|FMR1|PNKD|BLOC1S6|SPR|HRH3|CHRNA3|OTOF|PAH|SNPH|DDAH2|NOS3|DRD2|SYT2|PARK2|RAB5A|PDZD11|PER2|RAC1|MCTP1|CD36|HSP90AB1|TNF|SYT9|SNAP25|CAV1|CPLX1|GLUL|DDAH1|TRH
REGULATION OF PROTEIN GLUTATHIONYLATION%GOBP%GO:0010732,0.5167037861915371,0.922701251144926,-0.555831265508685,-0.9507196112341629,3479,2,FXYD1|G6PD
MUSCLE ATROPHY%GOBP%GO:0014889,0.681705911411164,0.965271928233355,-0.357028621849666,-0.8210912443625401,4139,4,IREB2|GATM|GSN|CFLAR
NEGATIVE REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902623,0.894580549368968,0.9979675173277209,-0.390350151640474,-0.667673028564151,6024,2,SLAMF8|SLIT2
RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:0097120,0.58502119642016,0.9439064862850342,-0.19897971178102802,-0.9037252567353872,2483,21,CACNG3|DLG1|CACNG7
NEUTROPHIL CLEARANCE%GOBP%GO:0097350,0.729889923793396,0.972554563883587,0.515743038323684,0.8429678278499879,6033,2,ANXA1|HMGB1
SOMATIC STEM CELL DIVISION%GOBP%GO:0048103,0.330222047553547,0.8291761235173739,0.354323489868758,1.11695426330585,3360,12,FGF13|TGFB2|LEF1|DOCK7|SOX5|FGFR2|TEAD3
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR PRODUCTION%GOBP%GO:0090362,0.421476510067114,0.873054719602436,0.7958204675782969,1.0572119871096,3139,1,PTGS2
POSITIVE REGULATION OF INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032382,0.36853073984022205,0.851931544178381,0.5657719883987329,1.0754730329668,3182,3,LDLRAP1|ANXA2|SCP2
ZINC ION HOMEOSTASIS%GOBP%GO:0055069,0.968871595330739,1.0,0.139387471104548,0.533821680734027,10457,22,MT1F|SLC30A5|MT1E|SLC39A7|SLC39A13|MT2A|SLC39A10|LCK
CHEMOREPULSION INVOLVED IN EMBRYONIC OLFACTORY BULB INTERNEURON PRECURSOR MIGRATION%GOBP%GO:0021834,0.45043205027494104,0.88620227509476,-0.48748676924957796,-0.9893399143240219,2866,3,SLIT3
NUCLEOSOME POSITIONING%GOBP%GO:0016584,0.221031601888849,0.73556947110949,-0.416630299161631,-1.21532906685956,1216,7,RSF1|H1F0|H1FX
NEUROTROPHIN SIGNALING PATHWAY%GOBP%GO:0038179,0.0779826705176627,0.5314695499765479,-0.33367178702926004,-1.4353818930908102,350,18,NTRK2|FRS2|NTRK1|BCAR1|DDIT4|GRB2|CASP3|HAP1|RAP1A|RAPGEF1
RESPONSE TO TNF AGONIST%GOBP%GO:0061481,0.32172646630478,0.822751772025005,-0.8402073224525799,-1.1239709529513202,2429,1,RPS3
GDP-MANNOSE BIOSYNTHETIC PROCESS%GOBP%GO:0009298,0.8019100938580601,0.9841161968820359,-0.322318233222371,-0.7412646017739419,4869,4,PMM1|PMM2
T CELL LINEAGE COMMITMENT%GOBP%GO:0002360,0.785886722376973,0.981487311948134,-0.24050791235151897,-0.747603310521689,4231,8,ZFPM1|FOXP3|LY9|SPN|BATF|IL6|STAT3
MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002279,0.4470303285593929,0.88473565970262,0.390280680500403,1.0158186133260099,4244,7,NR4A3|KIT|MILR1|S100A13|SNAP23|CHGA
REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002739,0.186467486818981,0.692707054555662,-0.46101656627910903,-1.26545951943746,1060,6,TNFRSF1B|KARS|TNF
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098911,0.281994348001615,0.7899371443259041,-0.323635804067142,-1.1389147160661799,1396,11,BIN1|DLG1|CAV1
NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000402,0.35432198267177095,0.842911430859438,0.372076638173229,1.09809428581417,3516,10,KLRK1|MIA3|CD200|CCL2
REGULATION OF TRANSFERRIN RECEPTOR BINDING%GOBP%GO:1904435,0.35070527097253196,0.842847021021096,-0.649574373533067,-1.1110621769501399,2361,2,B2M
POSITIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071651,0.00911233307148468,0.210767245805667,-0.852321605823315,-1.7297613754313899,57,3,DDX3X|MAVS|ADCYAP1
MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002755,0.0502988047808765,0.44073995025190205,-0.30464404332282596,-1.4958916005359502,201,26,IRAK1|IRAK2|IRAK4|TNIP1|UBA52|MYD88|UBC|CD36|UBB
REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072124,0.561451296578775,0.9365627440210609,0.40133465696007103,0.925016889840826,5152,5,BMP4|EGR1|PDGFB|BMP7|PDGFA
REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000508,0.7564475118053029,0.977664504547119,-0.26406182591521,-0.7702800615522729,4164,7,GAS6|CALR|LGALS9|C1QBP
NICOTINAMIDE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0046496,0.0273453933529659,0.339785941813865,-0.206167069428287,-1.4284003385717,64,80,PFKL|DERA|GPI|G6PD|MDH1B|PKM|PNP|ENO1|NAMPT|PGD|PDHB|GAPDH|KCNAB2|PGK1|TP53I3|HK1|NMNAT3|HK2|TPI1|ALDOA|TKT|NT5E|PGAM2|NMNAT2
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:1904874,0.00774193548387097,0.198167223413272,-0.48504632038728296,-1.9344080592460802,35,15,NAF1|CCT4|RUVBL1|CCT7|SHQ1|TCP1|RUVBL2|NHP2
VASOCONSTRICTION%GOBP%GO:0042310,0.789490311710194,0.9819233677232551,0.281566196224209,0.732857651680916,7496,7,EDN1|SLC8A1|PIK3C2A|EDNRB
CYANATE METABOLIC PROCESS%GOBP%GO:0009439,0.503326478771017,0.9164921159310329,0.603007469664027,0.9855991435816149,4160,2,TST|MPST
REGULATION OF ZINC ION TRANSMEMBRANE IMPORT%GOBP%GO:0071581,0.25393883225208497,0.7641083395392759,-0.873842082046758,-1.16896519637567,1917,1,SLC30A1
TERPENE CATABOLIC PROCESS%GOBP%GO:0046247,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
"VESICLE TARGETING, TO, FROM OR WITHIN GOLGI%GOBP%GO:0048199",0.9299668263914491,1.0,-0.107610126408669,-0.7046651745561769,2522,65,TRAPPC2L|TRAPPC6A|TBC1D20|CEP19|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
REGULATION OF TRANSLATIONAL FIDELITY%GOBP%GO:0006450,0.188857938718663,0.69611511841804,-0.406029108688222,-1.26211525789566,1016,8,AARS|RPS9|YRDC|DTD2
PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE%GOBP%GO:0034497,0.490512716996367,0.908938677284213,-0.27300429697429196,-0.9607361344631,2429,11,WDR45|WIPI1|ATG13|ATG9B|MFN2|WIPI2
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010664,0.687199014447307,0.9668424839233579,0.397440830098301,0.842215084504486,6135,4,PPP1R10|HAND2
NEGATIVE REGULATION OF LIPOPROTEIN OXIDATION%GOBP%GO:0034443,0.26201509334039497,0.771967970256231,-0.869320688134098,-1.16291678988256,1978,1,APOD
CELLULAR LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0097384,0.440936426116839,0.880402968441571,0.413488016365641,1.01691355752317,4105,6,C14orf1|FAR1|GNPAT
NEGATIVE REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032689,0.245500999777827,0.7579381964753191,-0.272371429107737,-1.17168137293619,1104,18,TLR4|XCL1|PDCD1LG2|FOXP3|HMGB1|ZC3H12A|LILRB1|AXL|INHBA|HAVCR2|GAS6|C10orf54|CD274|RARA|LGALS9|C1QBP|PRNP
CHOLESTEROL BIOSYNTHETIC PROCESS VIA LATHOSTEROL%GOBP%GO:0033490,0.319744652256692,0.8219996514077841,0.528748656568539,1.1204689119720401,2854,4,EBP|DHCR24|DHCR7
POSITIVE REGULATION OF T-HELPER 1 CELL CYTOKINE PRODUCTION%GOBP%GO:2000556,0.632306932323399,0.95809026474745,-0.371256824573981,-0.853813138252799,3839,4,IL1R1|XCL1|IL18|IL1B
LENS FIBER CELL DEVELOPMENT%GOBP%GO:0070307,0.0103045038786616,0.22191532995385502,0.8602976925800191,1.6353354136743,88,3,WNT5B|PROX1
HSP90 DEACETYLATION%GOBP%GO:0070846,0.45006711409396,0.886062942999295,0.7804367004852231,1.03677533884496,3352,1,HDAC6
SH2 DOMAIN-MEDIATED COMPLEX ASSEMBLY%GOBP%GO:0071538,0.19740500463392,0.7114690731572471,-0.899757388619321,-1.2036328921288602,1490,1,CRK
PROTEIN BIOTINYLATION%GOBP%GO:0009305,0.35098636303455605,0.842847021021096,-0.8240516100573442,-1.10235896389667,2650,1,HLCS
ADENINE METABOLIC PROCESS%GOBP%GO:0046083,0.15035349567949696,0.645245981328882,-0.6619090396877428,-1.3433247298650401,956,3,APRT|HPRT1
PEPTIDYL-LYSINE DESUCCINYLATION%GOBP%GO:0036049,0.9663709784191709,1.0,-0.515659461843847,-0.6898133844337,7298,1,SIRT5
REGULATION OF MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION%GOBP%GO:0071640,0.372037600953264,0.852609194081082,-0.8117556241729159,-1.0859102486776,2809,1,SIRPA
DUCTUS ARTERIOSUS CLOSURE%GOBP%GO:0097070,0.9970968912543849,1.0,0.29879768291503495,0.488376604272101,8242,2,TFAP2B|STRA6
RETINAL BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0061304,0.9576815412481471,1.0,-0.25229190512022,-0.580218676151359,5815,4,CYP1B1|LRP5
IRON ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098711,0.5820341499628809,0.943249589738259,-0.529197684036394,-0.905164296529193,3919,2,HFE|PICALM
CEREBELLAR PURKINJE CELL DIFFERENTIATION%GOBP%GO:0021702,0.606290136670509,0.9508825506493929,-0.37792974135554,-0.8691594528292391,3681,4,CEND1|AGTPBP1|ATP7A|FAIM2
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000137,0.543012620122728,0.929698169790548,0.500469904363695,0.9513406407375841,4689,3,BMP4|BMPR2
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS%GOBP%GO:0002562,0.856501814015658,0.991298302704726,0.19230044710549601,0.6782159063478829,8970,17,LIG4|EXO1|MSH6|LIG1|PRKDC|RNF8|HMGB2|HSPD1|EXOSC3|HMGB1|LIG3
CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990034,0.017135579483617,0.277422272849102,0.8297672879673541,1.5773003261836398,147,3,ATP2B1|SLC35G1|ATP2B3
RESPONSE TO CAMPTOTHECIN%GOBP%GO:1901563,0.163366909806646,0.665440683774265,0.6662071247380611,1.2663896617681,1410,3,BLM|RAD51|SPIDR
CELLULAR RESPONSE TO MECHANICAL STIMULUS%GOBP%GO:0071260,0.17357287742683303,0.676682497340677,-0.220805746294613,-1.23600818088825,598,38,SLC9A1|BCL10|TNFRSF10A|HABP4|CRADD|GADD45A|TNFRSF10B|MAPK3|MYD88|AQP1
CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009190,0.9772183401933571,1.0,0.144893138716234,0.50230521837365,10208,16,NPR2|ADCY8|ADORA2A|ADCY1|ADCY6
PROTEIN DEPALMITOYLATION%GOBP%GO:0002084,0.212229812968978,0.727709540947015,0.578565118458077,1.2260347534323501,1894,4,LYPLAL1|LYPLA1|PPT1|LYPLA2
POSITIVE REGULATION OF PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050942,0.0471327572663001,0.42721693308831105,-0.766957097165545,-1.55651664140138,299,3,ZEB2|BLOC1S5|BLOC1S6
POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0060732,0.45432692307692296,0.888760596723902,-0.388208632403539,-0.9827243745503779,2645,5,SNCA|HRH1
OXIDATION-REDUCTION PROCESS%GOBP%GO:0055114,0.621881657618033,0.9536478716552259,0.142532840689895,0.938950735591553,9048,338,MTFR1|CROT|CYP2D7|GAA|COX20|MGST1|CYP2C8|NR4A3|NDUFA7|D2HGDH|FH|GSTO2|SLC27A2|NDUFS7|ETFDH|TDG|BCO2|HSD17B4|AKR1B1|CBR4|PGM5|SLC25A22|ACADVL|CYP3A5|NDUFA4|BDH2|ETFA|NDUFS2|COX5A|DECR2|ALDH1A1|DHFR|POR|DHRS4|LOXL1|COA6|PHKG2|NNT|CYP2R1|NDUFC1|NDUFAF1|AMACR|DHCR24|NDUFS4|ACADM|TAZ|ADH1B|DECR1|LOXL3|IDH1|DUOX1|SLC25A10|AKR1C1|CDO1|FASTKD1|COX6A1|ALDH3A2|AGL|LOXL2|HADH|ETFB|PRDX3|AKR1E2|GCK|NQO2|NDUFS8|RNLS|PDHA1|NDUFB2|ACOX2|UQCC3|ECHDC2|SUCLG1|SIRT3|ACSS1|SDHA|ALKBH3|NDOR1|EHHADH|MT-ND2|ALKBH1|ADIPOR2|ACAD11|MARC1|ACAD10|MICAL3|ACO1|ME3|NDUFV1|IVD|ALDH9A1|GYS1|PDIA5|DHTKD1
REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900376,0.669615858438795,0.964618776001639,0.403800716089449,0.855692290447693,5978,4,CDH3|SP1
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0032823,0.7692307692307689,0.9792236089291529,0.33088154278335496,0.762632905738926,7059,5,ZBTB1|ZNF683|AXL|PRDM1|GAS6
NEGATIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000509,0.7844295302013421,0.981487311948134,0.60967137185708,0.8099212181438941,5843,1,SLAMF8
INTERLEUKIN-3-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038156,0.491165553080921,0.9092547199388691,-0.566583953680728,-0.9691115084753,3307,2,SYK|FCER1G
LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905146,0.6307934014139829,0.9575013258325501,-0.42533362744016795,-0.863201959672766,4014,3,TMEM199|LAMP2|CCDC115
MANNOSE TRIMMING INVOLVED IN GLYCOPROTEIN ERAD PATHWAY%GOBP%GO:1904382,0.5108074812409,0.918404893008545,0.457237750997105,0.9689304719885521,4560,4,EDEM3|MAN1B1
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0106015,0.539463087248322,0.9280749458041251,0.733403176003529,0.9742933998853159,4018,1,SIGLEC10
NEGATIVE REGULATION OF PRE-MIRNA PROCESSING%GOBP%GO:2000632,0.953396001588773,1.0,-0.5209528010586679,-0.6968944456939261,7200,1,BCDIN3D
"MITOCHONDRIAL ELECTRON TRANSPORT, UBIQUINOL TO CYTOCHROME C%GOBP%GO:0006122",0.84517561566411,0.991298302704726,-0.20026481297583604,-0.704756827712122,4186,11,UQCC3|MT-CYB|CYCS|UQCR10|UQCRB|UQCRFS1|UQCRQ|PMPCB|UQCRH|UQCRC1|CYC1
REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010453,0.720031237797735,0.9713637233549571,-0.24711172875883602,-0.797698804646519,3687,9,FGF2|DKK1|RTFDC1
RESPONSE TO PEPTIDE%GOBP%GO:1901652,0.0185387131952017,0.285526981228736,-0.1604841224804,-1.36855441400067,16,215,INPP5K|HDAC5|FOXO1|PKM|VIM|CPEB2|ATP6V0C|PXN|ATP6V1F|PPARG|LYN|FCGR2B|PRNP|VAMP2|CHRNA7|NAMPT|CAMK2A|PRKAR2A|GCGR|IGF1|FOXC2|LPIN1|RIPK2|RAB8A|PTPN1|LDOC1|ARHGEF2|ADRB2|NLRP1|SLC25A33|STAT5A|SHC1|ATP6V1E2|ATP6V0D1|STAT3|TP53|PRKAR1B|ADCY2|CAV2|ATP6V1E1|RHOQ|IGF2|CD36|PIK3R1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032653,0.952403962309737,1.0,-0.13054550926503802,-0.613422431422753,3941,23,TLR4|XCL1|PIBF1|PDCD1LG2|HSPD1|JAK3|FOXP3|PRKCZ|HMGB1|LILRB1|CD34|C10orf54|DLL1|PYCARD|CD274|LGALS9|FCGR2B|TRIB2|TNFRSF21
REGULATION OF ACONITATE HYDRATASE ACTIVITY%GOBP%GO:1904232,0.15808288097444698,0.6597808951153779,-0.918063520070578,-1.22812156232048,1193,1,FXN
RNA ACETYLATION%GOBP%GO:1990884,0.12093959731543599,0.607251067511504,0.940174239082488,1.24897953247459,900,1,NAT10
METABOLISM BY HOST OF SYMBIONT PROTEIN%GOBP%GO:0052417,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
POSITIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010666,0.152635486265776,0.648319130045528,-0.7645437000275709,-1.3077110525557198,1027,2,CAMK2D|CAMK2A
NEGATIVE REGULATION OF AMINE TRANSPORT%GOBP%GO:0051953,0.0504642712959225,0.44079050471084996,-0.446307858301235,-1.57061295853966,249,11,CRH|SNCA|HRH3|ADRA2A|TRH
POSITIVE REGULATION OF IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002642,0.0883221476510067,0.556932119338259,0.9565505072783409,1.2707346741756598,657,1,MZB1
POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032816,0.326648096564531,0.8269060114957499,-0.353094179885781,-1.09757045091611,1758,8,AXL|HLA-E|IL18|GAS6|AP1G1|IL6R|LAMP1
MRNA 3'-END PROCESSING%GOBP%GO:0031124,0.521532990912683,0.9251240799994541,-0.14308844379767902,-0.9728504865644672,1319,74,NCBP2|NUDT21|POLR2D|RBM8A|RNPS1|SLU7|THOC7|PABPC1|SLBP
RANDOM INACTIVATION OF X CHROMOSOME%GOBP%GO:0060816,0.126057906458797,0.607607158836689,-0.785718224427902,-1.3439289425075,848,2,RLIM|CDYL
REGULATION OF TRANSLATIONAL INITIATION BY IRON%GOBP%GO:0006447,0.293128558188799,0.8004058897916541,-0.8533855315394799,-1.1415998450470901,2213,1,EIF2AK1
MYOSIN FILAMENT ORGANIZATION%GOBP%GO:0031033,0.462951030927835,0.891507554237553,0.40642550920516496,0.9995443497170571,4310,6,IGSF22|TCAP|OBSL1|MYOM2
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043923,0.842442806547334,0.991098623231541,0.199446841171439,0.691428110372829,8800,16,GTF2B|LEF1|SMARCA4|SP1|TFAP4|CHD1|SNW1|NUCKS1|EP300|RRP1B
MITOTIC SPINDLE CHECKPOINT%GOBP%GO:0071174,0.10475192838777302,0.576535954147525,0.387052859176194,1.38843751472427,1099,18,TPR|CENPF|BUB1|CDC20|APC|BUB1B|KLHL22|PLK1|TEX14|ATM
INORGANIC CATION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098659,0.488153280301086,0.9079409787810301,0.21377761622532399,0.983880577542745,5706,42,SLC12A2|HCN2|SLC9A5|SLC9A7|ATP1B3|CACNA2D1|KCNJ11|KCNH2
RESPONSE TO ACTIVITY%GOBP%GO:0014823,0.788187584485806,0.9819233677232551,0.271375057577756,0.739841212406009,7579,8,RYR2|FNDC5|PEBP1|IREB2
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002753,0.0244346243826358,0.327926916046055,-0.318588674872441,-1.6304575434130502,93,29,RELA|TRAF6|OTULIN|UBE2N|ITCH|NOD1|IRAK1|IRAK2|TNFAIP3|UBE2V1|CYLD|RIPK2|UBA52|UBC|UBB
MITOCHONDRION TRANSPORT ALONG MICROTUBULE%GOBP%GO:0047497,0.52989247311828,0.9265056012720759,-0.23482873350331798,-0.9365179685698279,2463,15,HAP1|TRAK1|UBB
REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900040,0.22695576378295898,0.7398172623753029,0.531031986188539,1.22395000718563,2082,5,TRIM27|GBP1
PRIMITIVE HEMOPOIESIS%GOBP%GO:0060215,0.11017074981440199,0.584830174998513,-0.799283154121864,-1.3671310282578601,741,2,VEGFA|THOC5
FIBRONECTIN FIBRIL ORGANIZATION%GOBP%GO:1905590,0.29906040268456396,0.8023890191280308,0.853936921041023,1.13441710277602,2227,1,LOXL3
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902993,0.0827114427860697,0.5420718842622351,-0.398853087135783,-1.4530618053630502,398,12,PICALM|CLU|CASP3|LYN|EFNA1|CHRNA7
CELLULAR RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0031669,0.00939261114589856,0.21235063347774397,-0.19258726904455603,-1.508434772735,14,132,EIF2S1|PIM1|IMPACT|PIK3C3|RRAGD|STK26|UCN2|USF1|PRKAA1|HSPA5|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|FYN|FAM65A|MAP1LC3A|KLF10|FOXO1|SEH1L|EIF4G1|NUAK2|SH3GLB1|ATG7|BECN1|C12orf66|TP53|GABARAPL1|RALB|MAPK3|GABARAP|CDKN1A|UCN3|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|PMAIP1|INHBB
REGULATION OF TISSUE REMODELING%GOBP%GO:0034103,0.57026875699888,0.940402148292764,-0.16822903249984197,-0.9254097421284101,2036,36,UBASH3B|IL6|LEPR|PRKCA|MC4R|GREM1|THBS4|S1PR1
SNRNA METABOLIC PROCESS%GOBP%GO:0016073,0.8342359312455849,0.988613522932093,0.13836316600728302,0.7541910876817371,10628,89,INTS7|POU2F2|SNAPC2|AK6|MEPCE|INTS9|DDX26B|INTS10|GTF2B|POLR2B|TAF5|INTS6|NABP1|ZNF143|INTS3|ASUN|CDK7|GTF2E2|SRRT|POLR2L|INTS1|INTS8|POU2F1|POLR2J|CCNT2|SNAPC3|INTS2|SNAPC5|POLR2G|POLR2H|SP1|GTF2A1|TOE1
REGULATION OF 1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE ACTIVITY%GOBP%GO:0090215,0.5981208053691279,0.949262093257606,0.7063850904278779,0.938401078560317,4455,1,DGKZ
APICAL PROTEIN LOCALIZATION%GOBP%GO:0045176,0.19744652256691697,0.7114690731572471,0.5864196655234211,1.24267928896924,1762,4,SHROOM2|GOPC|VANGL2
PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1902570,0.0966608084358524,0.5694769293867491,-0.526429222804647,-1.4450128694613702,549,6,RAN|PINX1|RPF2|RRS1
EPICARDIUM-DERIVED CARDIAC FIBROBLAST CELL DEVELOPMENT%GOBP%GO:0060939,0.7611940298507459,0.977763214485385,-0.377698312537799,-0.766527503385769,4844,3,PDCD4
TRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071431,0.615017289642681,0.951274991479634,-0.375392930017096,-0.86332531670927,3734,4,XPOT|NOL6|SSB|RAN
L-AMINO ACID TRANSPORT%GOBP%GO:0015807,0.515235202062045,0.9215693035262491,0.247128548502937,0.961133160979404,5596,23,SLC1A2|SLC25A29|SLC36A1|SLC25A22|SLC6A17|SLC6A9|SLC7A9
APOPTOTIC PROCESS%GOBP%GO:0006915,0.29552238805970193,0.800447413278835,-0.11464659207429599,-1.06210428028331,98,390,PPIF|TP53BP2|IL1B|SRGN|GZMB|CLU|KPNA1|TIMM50|NFKBIA|BCLAF1|CTSL|PLK3|PRKCD|DAB2IP|RTN4|PTK2B|DDIT4|CIDEB|RRAGC|DLC1|LAMP1|ABL1|BBC3|PML|ZNF385A|MYBBP1A|CYFIP2|CUL5|DDX47|DDX3X|ATG3|CASP3|TNFRSF10A|H1F0|DDIT3|DFFA|IL6|MAGI3|BCL2L1|YARS|EXOG|CAMK2A|POU4F2|PPP2CA|BOK|SOD2|BID|ACAA2|CRADD|ZPR1|JADE1|CHAC1|PDCD10|MAL|RELT|GAPDH|MRPS30|PPP2R1B|GADD45A|STK4|GNGT1|PDCD4|BAG3|EIF5A|HK2|NLRP1|NLRP3|BCL2|CFLAR|PRKCA|BNIP2|NDUFS1|TP53|BCL3|CDIP1|ZNF622|TNFRSF10B|GABARAP|CDKN1A|BNIP3L|BMF|TFPT|CRIP1|STK24|TICAM1|MYD88|BIK|JMY|TNF|BCL2L11|PMAIP1|TNFRSF21|CAV1|SLIT3|TRIB3|APPL1|EGLN3
RESPONSE TO PROSTAGLANDIN D%GOBP%GO:0071798,0.36622152395915203,0.8510019955058101,-0.521120547038712,-1.05759866704365,2330,3,AKR1C3|AKR1C2|PTGFR
REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031664,0.78999227202473,0.9819233677232551,0.21732442126390397,0.7368627959268759,8177,15,TRIM5|SIGIRR|CD55|CACTIN|CARD16|CD180
SYNAPSIS%GOBP%GO:0007129,0.30187567514484903,0.804920794730937,0.35510996457695393,1.14607185059678,3073,13,SYCP2|CCNE1|CCNE2|BAG6|STAG3|P3H4|CCNB1IP1|SYCE2
NEGATIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051280,0.584816563748638,0.9439064862850342,-0.30457530021817497,-0.8884596635133891,3219,7,SRI|FKBP1B|FKBP1A
POSITIVE REGULATION OF TRANSLATION%GOBP%GO:0045727,0.102286902286902,0.573450707099996,-0.185975700599102,-1.2857120978099,245,79,HNRNPD|POLDIP3|EIF6|YTHDF2|USP16|DNAJC3|RPS4X|EIF3D|IMPACT|RBM3|SAMD4A|RPS9|FAM129A|WIBG|DDX3X|C1QBP|UHMK1|YTHDF1|VIM|IL6|HABP4|UQCC2|RMND1|RPUSD3|NPM1|FMR1|EIF5A|BCL3|POLR2D|LARP6
RECOGNITION OF APOPTOTIC CELL%GOBP%GO:0043654,0.66840338080352,0.964618776001639,0.4566505769078879,0.86804470886432,5772,3,SCARB1|FCN3|FCN1
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903202,0.128119372266529,0.608160579951936,-0.258849648716192,-1.3088074519167199,497,28,TRAP1|PARK7|NUP93|ATF4|HIF1A|TXN|HSPB1|MAPK7|FYN|PDE8A|HGF|BAG5|SOD2|PARK2|FBXO7|MET
FOURTH VENTRICLE DEVELOPMENT%GOBP%GO:0021592,0.9798657718120809,1.0,0.512957653286281,0.6814413577274712,7299,1,KDM2B
POSITIVE REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051443,0.6922277099038211,0.96731875442989,-0.16557558120916901,-0.8473746139770358,2662,29,UBE2N|DCUN1D5|BMI1|FBXW7|MAGEA2|ARRDC3|DCUN1D3|RAB1A|UBE2L3|TRIB3
CITRATE METABOLIC PROCESS%GOBP%GO:0006101,0.5833536734195749,0.9439064862850342,-0.18993880325139897,-0.910464432772758,2389,24,SDHC|ME2|OGDHL|MDH1B|PDHB|FAHD1|OGDH|ACLY
REGULATION OF PLASMA CELL DIFFERENTIATION%GOBP%GO:1900098,0.9110067114093959,1.0,0.5462064402293779,0.7256108878478271,6786,1,XBP1
TRNA MODIFICATION%GOBP%GO:0006400,0.9592970984879442,1.0,0.11787794551341,0.596021623734264,11736,62,THADA|OSGEP|NSUN6|TARBP1|TRIT1|TRMT10A|QTRT1|GTPBP3|TRMT1|TRMU|ALKBH1|LCMT2|PUSL1|PUS1|SEPHS1|TRMT13|MTO1|TYW3|THUMPD2|AARS2|TYW5|PUS10|TRMT1L|TRUB1|HSD17B10
NEGATIVE REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070345,0.900927197802198,0.998912093067348,-0.25952779467466497,-0.656977378686889,5246,5,PER2
POSITIVE REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046321,0.61265130808278,0.9508825506493929,-0.269415647530886,-0.869697853144783,3137,9,PPARA|PPARGC1A|TWIST1
PEPTIDYL-CYSTEINE OXIDATION%GOBP%GO:0018171,0.400602060900776,0.8638522656500329,0.553898086140327,1.0529019938611999,3459,3,PRDX3|CHCHD4|TMX3
"REGULATION OF ATP-DEPENDENT MICROTUBULE MOTOR ACTIVITY, PLUS-END-DIRECTED%GOBP%GO:2000580",0.1057344854674,0.578674426247723,-0.705342325230754,-1.4314712924149902,672,3,DNAL4|DYNLL2
ACTOMYOSIN STRUCTURE ORGANIZATION%GOBP%GO:0031032,0.0479771148344912,0.431337225587021,0.291341280189255,1.4730974663913199,586,62,NEB|ITGB1|IGSF22|ACTN2|MYH3|PROX1|TCAP|CDC42BPA|FHDC1|FRMD5|FRMD3|TNFAIP1|OBSCN|SRC|KRT19|ANLN|ITGB5|NEBL|LMOD1|OBSL1|CDC42BPB|RACGAP1|EPB41|ALKBH4|EPB41L4A|EPB41L5|MYOM2|KCTD13
CELLULAR RESPONSE TO TRICHOSTATIN A%GOBP%GO:0035984,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:2000752,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
PRONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0039022,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO NON-ANTIGENIC STIMULUS%GOBP%GO:0002878,0.09108963325830802,0.5609783360513879,-0.9526907807675341,-1.2744435047311202,687,1,ADCYAP1
SNRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031120,0.257816182246661,0.7686328443270871,-0.5767067387228411,-1.1704091915283001,1640,3,DKC1|NOP10|NHP2
MO-MOLYBDOPTERIN COFACTOR METABOLIC PROCESS%GOBP%GO:0019720,0.670511815432859,0.964618776001639,0.403598796689159,0.8552644039501321,5986,4,GPHN|MOCS2
ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030521,0.121434820647419,0.607607158836689,0.304577182448101,1.3444147718486001,1387,36,PIAS1|MED12|CCNE1|RB1|DDX17|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2|THRAP3|ARID1A|MED30|DDX5|MED14|BRCA1|NCOA3|MED16
ORGANELLE FUSION%GOBP%GO:0048284,0.473083197389886,0.899200141394915,-0.145341201702448,-0.9959680643654871,1159,76,RAB8B|VPS4A|TAPBP|VPS11|STX8|MFN2|FAM73A|CHCHD3|PLD6|STX11|MIEF1|RAB39A|RAB8A|CAV2|RAB7A|VTI1A|SNAP25
POSITIVE REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043950,0.7876463463867579,0.9819233677232551,-0.212326727320358,-0.7472042070757979,3901,11,GPR61|PRKCA|ADCYAP1
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034248,0.0160513643659711,0.269327908069754,-0.152207733501075,-1.36586067939706,9,283,NOTCH4|MOV10|PUM1|RPUSD4|ZC3H12D|TIGAR|MTRF1|TRAP1|MTG2|NCBP1|SAMD8|HNRNPD|POLDIP3|RPS6KA3|EIF2A|EIF2AK2|SYNCRIP|EIF6|YTHDF2|TRNAU1AP|USP16|OGFOD1|EIF4E|CALR|EEF1A2|NCL|SEPSECS|EIF5|ATF4|PPP1R15B|TMED10|EIF3H|NCK2|HSPB1|DNAJC3|DPH2|CNOT10|PICALM|RPS4X|EIF3D|CLU|METTL16|EIF2S1|PDK3|AARS|EEFSEC|IMPACT|RBM3|PLK3|PRKCD|CPEB1|SAMD4A|PRKAA1|EIF2AK3|ZNF385A|RPS9|RPS3|FAM129A|WIBG|DDX3X|EIF2AK1|PAIP2B|C1QBP|EIF4A2|UHMK1|RNF139|CASP3|EIF4G1|YTHDF1|NSUN3|VIM|EIF4EBP1|CPEB2|IL6|NOLC1|PRNP|EFNA1|DPH6|CHRNA7|HABP4|EIF3B|HAP1|BIN1|UQCC2|EIF1|RMND1|EIF4E2|PDPR|RPUSD3|EIF4H|DPH3|CNOT7|NPM1|GAPDH|SHMT2|SNCA|FMR1|EIF4B|AGO2|EIF5A|MTPN|ETF1|STAT3|BCL3|NCBP2|POLR2D|PER2|SESN2|TNF|EIF1B|RBM24|LARP6|FOXO3
MESODERMAL CELL FATE DETERMINATION%GOBP%GO:0007500,0.8761073825503359,0.9941329456747149,0.562748125275695,0.747585778454968,6526,1,KLF4
TRIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072506,0.142121178183447,0.63219683908033,0.619688327524684,1.3131787617380901,1268,4,FGFR4|XPR1|TFAP2B
REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048742,0.816778025241277,0.9867712923855259,-0.43225806451612897,-0.7393542690937109,5500,2,HDAC9|FAM129B
TRIMMING OF TERMINAL MANNOSE ON C BRANCH%GOBP%GO:0036510,0.808636748518205,0.984682960940884,0.48333434592084495,0.78999671043641,6684,2,MAN1B1|EDEM2
GLUCONEOGENESIS%GOBP%GO:0006094,0.000527426160337553,0.0784645998831315,-0.45992283146215995,-2.3860943889039703,1,30,GPI|CRTC2|FBP1|ENO1|GAPDH|PGK1|PPARGC1A|TPI1|G6PC3|ALDOA|SLC25A13|PER2|PC|PGAM2
NEGATIVE REGULATION OF APPETITE%GOBP%GO:0032099,0.494845360824742,0.91071489001692,0.39587068791828295,0.9735863039236009,4607,6,CARTPT|BBS2|BBS4
NEGATIVE REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090233,0.803624161073826,0.984522820758988,0.599139832377592,0.795930537790681,5986,1,CDT1
PURINE RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009150,0.917081260364843,1.0,-0.0912874370813697,-0.820566296126072,552,286,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GMPS|GTPBP1|GUCY1A3|UQCRC1|ACOT11|NUDT4|PKM|ACOT9|ENO1|SULT4A1|TPST1|MT-ND5|ACSL4|HPRT1|ATP5I|EFTUD1|COX4I1|NUDT18|PDHB|GAPDH|PGK1|PANK2|DGAT2|TDO2|NDUFB9|CYC1|HK1|HK2|TPI1|PDE9A|NDUFA9|OGDH|ACLY|NDUFS1|NDUFV3|ADCY2|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|ACOT8|RHOQ|ACSL3|PMVK|ADM|COX4I2|NDUFS6|PDE4D|PGAM2|AK4
SUSCEPTIBILITY TO NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042271,0.0930362116991643,0.5622489437340121,-0.4623531358596721,-1.43719485824472,500,8,MICA|CADM1|HFE|MICB|PVR|PVRL2|ULBP3|ULBP2
REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032276,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
REGULATION OF ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0070235,0.753338570306363,0.9769690538700708,-0.38082095096930296,-0.772864805304845,4794,3,TNFRSF4
NEGATIVE REGULATION OF MAPK CASCADE%GOBP%GO:0043409,0.976201372997712,1.0,0.10454227947176199,0.594295278342247,12797,112,RGS2|LMO3|TAOK3|BMP4|STK38|RGS14|C3orf33|DUSP16|DUSP8|DUSP19|MEN1|GBP1|DACT1|F2RL1|RPS6KA6|RGS3|NF1|APOE|ZNF675|HDAC3|GSTP1|SEMA6A|PIN1|PEBP1|SMPD1|PTPRJ|CDK5RAP3|SYNJ2BP|PTPN22|DUSP1|SORL1|SPRY4|DNAJA1|FOXM1|PPP2R1A|FKTN|SPRY1|WNK2
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0051055,0.346632535969635,0.842847021021096,0.254602344887962,1.09746947364406,3926,33,SIRT1|FGF19|WNT4|CEACAM1|ACADVL|PROX1
NEGATIVE REGULATION OF RNA INTERFERENCE%GOBP%GO:1900369,0.29503355704698,0.800447413278835,0.856197617997353,1.13742033782567,2197,1,TERT
PEPTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0043043,0.9323467230443969,1.0,-0.0884171019943887,-0.808152547419602,440,327,EEF1A2|RPS16|RPL12|SEPSECS|MRPL51|EIF5|MRPS33|GCLC|EIF3H|MRPL37|QARS|FURIN|RPS4X|EIF3D|EIF2B3|MTRF1L|RPL9|DARS|MRPL14|MRPL15|EIF2S1|AARS|EEFSEC|RPS28|RPL17-C18orf32|EIF4A1|MRPS2|CARS|ABCF1|HBS1L|EEF2K|RPL35|MRPL18|MRPS35|GSS|WARS|EIF3K|RPL7|RSL24D1|PCSK1|AURKAIP1|RPS9|RPS3|GTPBP1|MRPL22|RPL14|NARS|HARS|FARS2|DDX3X|GARS|EIF4A2|AIMP2|GSPT1|EIF4G1|MRPL24|MRPS17|EIF3G|RPL15|RPL8|TMA7|YARS|EIF3B|TNIP1|MRPL41|EIF4H|CHAC1|RPL35A|MRPS30|MRPL9|NHP2|KARS|EIF4B|SRBD1|MRPS10|AGO2|EIF1AX|ETF1|EIF3A|UBA52|EIF3I|MRPL2|SARS|MRPS26|EIF2S3|CNDP2|MRPL39|PABPC1|MRPL30|MRPL36
ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:0001768,0.224962371193702,0.7390599693491929,0.633364677114204,1.20395962373095,1942,3,CCL21|CCL19|CCR7
POSITIVE REGULATION OF TYROSINE 3-MONOOXYGENASE ACTIVITY%GOBP%GO:1903178,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
CELLULAR RESPONSE TO ATP%GOBP%GO:0071318,0.16350997380616597,0.6656560167659561,0.44371436144730503,1.30951571491066,1622,10,HSP90B1|P2RY11|TRPV1|PDXP|P2RX3|TAF1|P2RX7|P2RX4|SSH1
UV PROTECTION%GOBP%GO:0009650,0.10840217610316301,0.58452352834625,0.47254430214069204,1.39460031815584,1075,10,FEN1|MC1R|MFAP4|CAT|ERCC5|XPA
NORADRENERGIC NEURON DEVELOPMENT%GOBP%GO:0003358,0.0653574234092694,0.495991045493396,-0.746935245986744,-1.5158828893093201,415,3,ASCL1|INSM1
DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0097028,0.903799155743168,1.0,-0.156686351343893,-0.674029871137316,4067,18,F2RL1|UBD|CCL19|BATF2|LTBR|TRPM2|DHRS2|CCR7|TREM2|BATF3|LILRB1|AXL|TGFBR2|GAS6|BATF|LGALS9|LYN|CAMK4
POSITIVE REGULATION OF MITOTIC CYTOKINESIS%GOBP%GO:1903490,0.564775613886537,0.9380162603437769,0.5800385993934379,0.948057156116115,4668,2,KIF20B|NUP62
ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT ORGANIZATION%GOBP%GO:0097111,0.8640377404136931,0.9921950946571959,0.45596912048524996,0.745269001228649,7142,2,GBF1|STX17
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902305,0.0190125728304201,0.287287608252361,-0.275747946397002,-1.59410186442039,61,43,NETO1|CAMK2D|HECW2|TESC|NEDD4L|PTPN3|SCN1B|SLC9A1|RANGRF|YWHAH|CHP1|ATP2B4|NEDD4|SLMAP|SNTA1|COMMD1|FXYD5|SLC9A3R1|SCN5A|DLG1
NEGATIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045744,0.0428462127008416,0.408506694610615,-0.307289727982146,-1.5312852663905099,167,27,ARRB1|ATP2B4|YWHAB|SNCA|CXCL8|ADRB2|DRD2|MET|ADM|BICD1
POSITIVE REGULATION OF PROTEIN IMPORT%GOBP%GO:1904591,0.661820964039786,0.964618776001639,-0.173430851406201,-0.8642401073403541,2594,27,IPO5|DMAP1|PSEN1|SMAD3|ARHGEF5|PIK3R2|PRKCD|IGF1|MAVS|ZPR1|BAG3|PIK3R1
REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900225,0.9654591406908171,1.0,0.21017400514148898,0.547038777800277,9167,7,GBP5|NLRC3|CPTP|TLR4
SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014909,0.0400558419243986,0.399136460956658,0.6336418322642221,1.55834980541132,372,6,NOV|PLAT|DDR1
SUBSTRATE LOCALIZATION TO AUTOPHAGOSOME%GOBP%GO:0061753,0.8015358135840059,0.9841161968820359,-0.596768857520953,-0.798315896035707,6053,1,SMURF1
MOLTING CYCLE%GOBP%GO:0042303,0.580870077580281,0.942746898746279,0.279500958171372,0.902053482944775,5914,13,CDH3|TGFB2|APCDD1|FGFR2|SNRPE|HDAC2|ATP7A|SOX18
INTRACELLULAR SIGNAL TRANSDUCTION INVOLVED IN G1 DNA DAMAGE CHECKPOINT%GOBP%GO:1902400,0.7554653858893671,0.9771370084125129,0.16167288265464003,0.7985947859638929,9122,56,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
POLYPRENOL BIOSYNTHETIC PROCESS%GOBP%GO:0016094,0.7645015630427231,0.9788102346772741,0.41948868740941897,0.7974038662117701,6602,3,SRD5A3|NUS1|DHDDS
POSITIVE REGULATION OF LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1903002,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
POLYKETIDE METABOLIC PROCESS%GOBP%GO:0030638,0.0751718213058419,0.524840022194793,0.593141402246151,1.4587448961012701,699,6,AKR1B1|CBR4|AKR1C1
RRNA (GUANINE-N7)-METHYLATION%GOBP%GO:0070476,0.0435040831477357,0.411371136387278,-0.872291149710505,-1.49200729465409,292,2,TRMT112|WBSCR22
POSITIVE REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050927,0.280590717299578,0.7890335436983149,-0.29217924076844504,-1.1319797295696101,1329,14,CXCL8|SCG2|PGF|CDH13
ATP GENERATION FROM POLY-ADP-D-RIBOSE%GOBP%GO:1990966,0.23978049053645398,0.7525035503527309,0.56366844978768,1.1944672895158401,2140,4,PARP1|NMNAT1|PARG|NUDT5
NMDA SELECTIVE GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0098989,0.31221476510067103,0.8149076004463699,0.8478164975738859,1.1262863932513798,2325,1,SULT1A3
REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032347,0.0768141207234692,0.527286041772797,0.627285225335568,1.44579945469484,704,5,WNT4|CLCN2|REST
NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042036,0.292645444566411,0.8004058897916541,-0.271662268658194,-1.11254829325528,1332,16,MAP2K5|IL6|TRIB2|BCL3|INHBB
POSITIVE REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905247,0.237434094903339,0.7507739897770379,-0.43436495689691296,-1.19230264120803,1350,6,PICALM|LYN|EFNA1
PROTEOGLYCAN CATABOLIC PROCESS%GOBP%GO:0030167,0.8523910852279091,0.991298302704726,0.32955225776242897,0.698352714670458,7610,4,GPC1|ADAMTS12|HPSE
IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002378,0.521603563474388,0.9251240799994541,-0.553946323449604,-0.9474955187931441,3512,2,GALNT2
IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098739,0.728211964672555,0.972554563883587,0.16730429372753602,0.8159975494434529,8739,53,SLC1A2|SLC12A2|HCN2|SLC9A5|SLC9A7|ATP1B3|CACNA2D1|KCNJ11|KCNH2
CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT%GOBP%GO:0021680,0.9023212627669449,0.999822188724968,-0.208526958451339,-0.648192581054829,4858,8,DLL1|AARS|ADCK4|FAIM2
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN%GOBP%GO:0050965,0.684524744697565,0.966495577318169,-0.40619830153303205,-0.824367384279735,4356,3,MMP24|EPHB1|ANO1
REGULATION OF MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:1905616,0.0492947290274685,0.435862257033585,-0.8641852770885029,-1.47814263365693,331,2,EIF4G1|AGO2
REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002923,0.332739420935412,0.8293509737209019,-0.659939343810312,-1.12879090349707,2240,2,FOXJ1|FCGR2B
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001187",0.295606326889279,0.800447413278835,-0.40968506977000696,-1.1245580081779099,1681,6,XCL1|NCKAP1L|HLA-E|RUNX3|RUNX1|CBFB
NEGATIVE REGULATION OF PROTEIN IMPORT%GOBP%GO:1904590,0.5520891364902509,0.9321968967758479,-0.29323442437199104,-0.9115002673966609,2972,8,APOD|CHP1|CABP1
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0042177,0.217553688141923,0.7341474817293291,-0.15950119543868602,-1.14881341698726,465,94,MAD2L2|ERLEC1|AZIN1|CCAR2|PARK7|RPL11|RILP|RYBP|MAP1A|TIMP3|TAF9|SNX3|OPHN1|FURIN|TRIM39|DAB2IP|PTPN3|UBE2J1|NELL1|STYX|FAM192A|OS9|PML|PDCL3|CSNK2A2|GLTSCR2|EFNA1|BAG5|TIMP2|SNCA|DDRGK1|CSNK2A1|HSP90AB1|GABARAPL2|SNX12|PSMF1
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:0070972,0.945171339563863,1.0,-0.0945982502803214,-0.7324427371940991,1516,128,GBF1|RER1|RPS15|RPS10|RPL28|RPS3A|SPCS2|RPL37|RPL27A|SEC61A1|SEC16A|RPL7A|TAPT1|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|GPAA1|ANKRD13C|KDELR3|RPL18|UBAC2|ANK2|RPS27A|RPS26|CTAGE5|RPL22|RPS12|RPL4|RPL37A|RPL23|VAPA|RAB3GAP2|RPL10|KDELR2|RPL24|RPL26|RPS25|RPL13|RPS5|BCAP29|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|KDELR1|RPS7|RPL27|SRP68|RPL13A|RPS18|RPL10A|RPL38|RPS13|RPS27|PPP1R15A|RPS23|RPS21|RPL3|SPCS3|RPL29|SEC61G|RPL31|RPL17|SRPR|RPS14|RPS17|CHMP4A|RPL32|RPL18A|RAB3GAP1|RPL11|SRP14|SPCS1|RPS16|RPL12|RAB10|INSIG1|RPS4X|RPL9|RPS28|PMM1|RPL35|HSPA5|RPL7|OS9|SRP72|SGTB|RPS9|RPS3|RPL14|SEC63|SEC62|RPL15|RPL8|RPL35A|UBA52|ASNA1|CHMP4B|PMM2|SRP54|BCAP31
FUSED ANTRUM STAGE%GOBP%GO:0048165,0.39557046979865795,0.8638522656500329,0.8097154830172031,1.0756708952196,2946,1,BMPR1B
RESPONSE TO LEUCINE%GOBP%GO:0043201,0.7803388494877859,0.981487311948134,-0.22276162630330398,-0.7536359247408471,3960,10,KLHL22|UBR2|LARS|MTOR|SESN1|SESN3|RPTOR|UBR1|RRAGD|SESN2
REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903624,0.854988216810683,0.991298302704726,-0.34277370267051505,-0.6956490453158471,5441,3,BAX|DFFA
POSITIVE REGULATION OF NEUTROPHIL DEGRANULATION%GOBP%GO:0043315,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
REGULATION OF TRANSCRIPTION BY GLUCOSE%GOBP%GO:0046015,0.5888618733356489,0.945418171231938,0.48410999280889205,0.920242169870001,5085,3,RRP8|USF2
PROTEIN-TETRAPYRROLE LINKAGE%GOBP%GO:0017006,0.159539255924798,0.661359103221672,-0.9173467137185709,-1.2271626686081598,1204,1,HCCS
INDUCTION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052251,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
NEGATIVE REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043305,0.312647289866457,0.8155492679436609,-0.5482519025035839,-1.11266094685163,1989,3,CD300A|CD84|LGALS9
"REGULATION OF PROTON-TRANSPORTING ATP SYNTHASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:1905271",0.188799152654574,0.69611511841804,-0.903727393030437,-1.20894368807403,1425,1,TMSB4X
REGULATION OF DOPAMINE SECRETION%GOBP%GO:0014059,0.42602150537634403,0.875696962448429,-0.25171939537862303,-1.00387943712298,1980,15,SNCA|SYT2|PARK2|SYT9
POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000003,0.5417714815305179,0.928807195199472,-0.7244706660785178,-0.969146498938664,4091,1,CCAR2
REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032070,0.858550039401103,0.99166790097654,-0.20421696206023301,-0.6908965498414791,4357,10,PRKCD|RPS3|DFFA|NPM1
REGULATION OF DENSE CORE GRANULE TRANSPORT%GOBP%GO:1904809,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:2000794,0.8038860530215709,0.984522820758988,-0.321525600588732,-0.73944171230333,4881,4,FGF7|NFIB
PHARYNGEAL ARCH ARTERY MORPHOGENESIS%GOBP%GO:0061626,0.0485944650250599,0.434073859374335,0.658847758301656,1.5185464143043899,445,5,HES1|BMP4|TGFB2
REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0010603,0.504317607413648,0.9170017397928191,0.370012201576301,0.9630640210963599,4788,7,ATXN2|ATXN2L|CNOT1|CNOT2|CNOT6|PAN3
MYELOID DENDRITIC CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002277,0.6195991091314029,0.9532238181782521,-0.5137027846705271,-0.878661101017606,4172,2,DOCK2|PYCARD
POSITIVE REGULATION OF AGGREPHAGY%GOBP%GO:1905337,0.0007855459544383349,0.0849637591935908,-0.926271092974523,-1.8798396624690101,4,3,BAG3|HTT|HSPB8
CELLULAR RESPONSE TO PROGESTERONE STIMULUS%GOBP%GO:0071393,0.30281879194630895,0.8054013181463249,0.8522827525363921,1.13221961371531,2255,1,SRC
FERRIC IRON TRANSPORT%GOBP%GO:0015682,0.392556370551481,0.8621064456029929,-0.196391158102612,-1.0397125821145201,1444,32,ARHGAP1|ATP6V0C|ATP6V1F|TFRC|ATP6V1E2|ATP6V0D1|ATP6V1E1|STEAP3
GALACTOSE METABOLIC PROCESS%GOBP%GO:0006012,0.30155254777070095,0.804577371295404,0.37404260911847204,1.1411182589588897,3029,11,GALM|PGM5|GALE|GALK1|GALT
CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1990036,0.438791946308725,0.879683533669264,0.787163652404058,1.0457117943585301,3268,1,ATP2A2
"ENERGY COUPLED PROTON TRANSPORT, DOWN ELECTROCHEMICAL GRADIENT%GOBP%GO:0015985",0.8497582744514692,0.991298302704726,0.18283675245849101,0.6912203773556179,9139,21,ATP5G1|ATP5D|MT-ATP8|ATP5C1|ATP5E|VPS9D1|ATP5H|MT-ATP6|ATP5A1|STOML2
NEGATIVE REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1905268,0.983464566929134,1.0,0.112594525585202,0.496996335081089,11240,36,SIRT1|MTF2|TAF7|ASF1A|DNMT3B|ATAD2|JARID2|ATAD2B|PHF2|SUPT6H|BRCA1|DNMT1|PHF1|UBR5
REGULATION OF AMPA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:1904717,0.4071140939597321,0.8669681570015609,0.8035950595500658,1.06754018569495,3032,1,SHISA7
2'-DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009265,0.775293750649891,0.9805314293977441,0.27546607086646696,0.750994412182381,7455,8,DTYMK|DUT|HDDC2|TYMS
RESPONSE TO GLYCOSIDE%GOBP%GO:1903416,0.827506955364703,0.9876441563834109,0.47477253928866797,0.776002672702705,6840,2,ATP1A3|ATP1A1
REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0010710,0.406428491432411,0.8664565508572991,0.494752401332903,1.04842759963622,3628,4,ITGB1|FAP
POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:1903003,0.22484562295677396,0.7390599693491929,-0.41498631309548206,-1.21053348656758,1237,7,WDR48|TANK|GLTSCR2|TNIP1
REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000322,0.059709351305813,0.476295606439141,0.579101934605552,1.50728066639418,566,7,LMO3|ARNTL|CLOCK
DORSAL AORTA MORPHOGENESIS%GOBP%GO:0035912,0.242281147838721,0.7565220534116759,-0.406929910802799,-1.18703260364976,1333,7,ACVRL1|RBPJ
POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071864,0.33368067616070396,0.8295413387957591,0.581502974185248,1.10537598210937,2881,3,LEF1|FGFR2|MAP3K3
ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051315,0.299164012738854,0.8023890191280308,0.37492049585185705,1.14379649014523,3005,11,KIF2C|NUF2|NDC80|CENPE|BOD1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN NEGATIVE REGULATION OF APOPTOTIC PROCESS%GOBP%GO:0044336,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
MODULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0052422,0.459900810451192,0.890371861972445,0.619439334235912,1.01245657481464,3801,2,SUGT1|PTX3
CERAMIDE TRANSLOCATION%GOBP%GO:0099040,0.44925607838393605,0.8858223310328521,0.622718500137855,1.0178162813974,3713,2,ABCB4|ABCB1
ARGININE CATABOLIC PROCESS TO ORNITHINE%GOBP%GO:0019547,0.83503355704698,0.988613522932093,0.5828187031318921,0.774248645724967,6220,1,ARG2
POSITIVE REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051343,0.8672050840725541,0.993065231963537,-0.5636303484781651,-0.7539855021044999,6549,1,GNB2L1
ANGIOGENESIS INVOLVED IN WOUND HEALING%GOBP%GO:0060055,0.8901642796967141,0.997300970905927,0.24694068951662998,0.642734732544089,8452,7,SRF|ADIPOR2
NEGATIVE REGULATION OF CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:1903249,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0050654,0.7782276203328841,0.9811398289380491,0.18637655255876898,0.764260969915362,8649,28,VCAN|B3GAT3|CHST15|PXYLP1|CHPF2|XYLT2
POSITIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0032058,0.0884241725671003,0.556932119338259,-0.641041195610213,-1.4742608317068502,536,4,PPP1R15A|EIF2AK4|DNAJC3|IMPACT
BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0031214,0.6987194974631551,0.96731875442989,-0.177013007004731,-0.831769317547677,2891,23,FAM20A|EIF2AK3|SBDS|IGF1|CLEC3B|FAM20C|TUFT1
MARGINAL ZONE B CELL DIFFERENTIATION%GOBP%GO:0002315,0.5291701769165971,0.9265056012720759,0.36317030596107697,0.945256004292999,5024,7,DOCK10|LFNG
NEGATIVE REGULATION OF CELL DIVISION%GOBP%GO:0051782,0.147692927664719,0.6402258061318559,0.451517232114137,1.3325440021319699,1465,10,E2F8|BLM|E2F7|AURKB|ORC6
DETECTION OF MECHANICAL STIMULUS%GOBP%GO:0050982,0.0423106646058733,0.40500718739334496,0.46198495739370005,1.56641175161764,437,15,SCN1A|PIEZO2|ADGRV1|PKD2|TCAP|DFNB31|PDZD7|KIT|PIEZO1
PROTEIN LOCALIZATION TO ACTIN CYTOSKELETON%GOBP%GO:1903119,0.748155316317891,0.9749763305090959,0.5080197697450349,0.8303443575287859,6184,2,ANLN|RTKN
NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904063,0.0006040471156750231,0.0806484601749226,-0.38869508428732896,-2.23813438391048,1,42,CAMK2D|SRI|HECW2|PPIF|NEDD4L|KCNE3|FKBP1B|CRHR1|KCNE4|SESTD1|PLN|SLC30A1|KCNAB1|MMP9|SUMO1|BIN1|CAB39|FMR1|GNB5|NEDD4|COMMD1|YWHAE|ADRA2A|CAV1|FKBP1A|EPHB2
PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009155,0.151270604395604,0.6475783026655401,-0.5183653209794841,-1.3122073888316899,880,5,NUDT16|SAMHD1|NUDT1|NUDT15|NUDT18
REGULATION OF TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0022898,0.0007496251874062969,0.0849637591935908,-0.21269108837388198,-1.69407528971725,0,151,YWHAH|KCNAB1|PRNP|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|CRACR2A|CAB39|TMSB4X|CRH|SNCA|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|BCL2|RELN|FXYD5|YWHAE|KCNG1|HTT|ADRA2A|JPH1|SLC9A3R1|CACNG3|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051797,0.10151642796967099,0.571746500995146,0.543487711303723,1.4145843256919899,963,7,FST|CDH3|NUMA1|TGFB2
GLYCEROL-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046167,0.710293939760494,0.9700296616429409,0.524290046870692,0.856937678520014,5871,2,GK5|GK
RESPONSE TO PROSTAGLANDIN E%GOBP%GO:0034695,0.6355027201289539,0.95916055221954,0.291554035416782,0.8604512819430921,6307,10,CCL21|CCL19|ADCY6|GNG2|PTGER2|CCR7|PTGER4|SFRP1|TGFBR3|GNB1
NEGATIVE REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS%GOBP%GO:0110091,0.37640672580431606,0.853374872190571,-0.809605205116895,-1.0830335675406402,2842,1,CX3CL1
DOPAMINE UPTAKE%GOBP%GO:0090494,0.866815144766147,0.9929671171385601,-0.406429802486307,-0.6951764101649339,5837,2,SNCA
CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:0072583,0.9122989593188271,1.0,0.170487841274646,0.62315914453849,9642,19,FCHO1|AP2A2|FNBP1L|CLTB|CLTC|PIP5K1C|AP2M1|INPP5F|AP2B1
ACTIVATION OF MAPK ACTIVITY%GOBP%GO:0000187,0.08,0.534767814144237,-0.177006766758463,-1.28922677883886,165,98,IL1B|IRAK1|PKN1|PLCE1|DAB2IP|C5AR1|IRAK2|PRKAA1|GDF15|MAP3K13|RET|UBE2V1|FGF2|MAP2K5|CHRNA7|IGF1|RIPK2|KARS|MAP2K3|DBNL|MLKL|SHC1|UBA52|MAPK3|FGF10|PEA15|MAP3K11|UBC|MAP2K1|TNF|UBB|ADORA2B
CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002367,0.8588056680161941,0.99166790097654,0.237504813153034,0.677757586858828,8484,9,SIRT1|KIT|CD55
ACTIN-MEDIATED CELL CONTRACTION%GOBP%GO:0070252,0.0935041017913946,0.5622489437340121,0.284428224026222,1.37406319322557,1116,51,RYR2|KCNN2|SCN1A|NEB|CACNA1G|CACNB2|FGF12|KCNQ1|ACTN2|MYH3|TCAP|CACNA2D1|TNNC2|KCNH2|CACNA1D
VITAMIN D METABOLIC PROCESS%GOBP%GO:0042359,0.347295329824168,0.842847021021096,0.5168096534919929,1.09516902397984,3100,4,CYP2R1|PIAS4|CYP27B1|LGMN
EMBRYONIC RETINA MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0060059,0.435103423249063,0.878651088001772,0.6284532671629449,1.02718960055665,3596,2,PROX1|LRP6
PROTEIN KINASE C SIGNALING%GOBP%GO:0070528,0.6480203414456961,0.963755998259649,-0.29026945536094395,-0.846728879372238,3567,7,PLEK|FLOT1|DGKQ|PLVAP
POSITIVE REGULATION OF NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY%GOBP%GO:2000327,0.752783964365256,0.9769690538700708,-0.457678522194651,-0.782834600520194,5069,2,CNOT6|RQCD1
EMBRYONIC EPITHELIAL TUBE FORMATION%GOBP%GO:0001838,0.951971200280973,1.0,0.13321836439378998,0.579367341300308,10841,34,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C|DVL3|GATA3|DVL2|LRP6|SCRIB|MTHFR
RIBOSOMAL LARGE SUBUNIT ASSEMBLY%GOBP%GO:0000027,0.298430666323643,0.8023890191280308,-0.218843305527557,-1.10652554676864,1159,28,RPF2|RSL24D1|GLTSCR2|PPAN|DDX28|RRS1|MRTO4|RPF1
INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098661,0.997063011747953,1.0,0.0979909712463895,0.414207133158001,11202,31,SLC12A2|SLC37A2|SLC26A2|SLC25A10|XPR1|SLC1A3|CLCN7|SLC1A1|GABRB3|SLC25A30|SLC37A3|SLC12A5|CLCN3|SLC12A9|SLC12A4|GLRB|SLC20A1|SLC25A3|APOL1
CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042089,0.0681705911411164,0.50364937614461,-0.6648100148899799,-1.52892415057004,413,4,IL18|PCSK5|NOD1|BCL10
NUCLEAR RETENTION OF PRE-MRNA WITH ABERRANT 3'-ENDS AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071049,0.715616305794121,0.971081608033886,0.522194651226909,0.8535128119041371,5915,2,EXOSC2|EXOSC3
CELLULAR RESPONSE TO DRUG%GOBP%GO:0035690,0.15651503469545097,0.6578589353509621,-0.14590186977444197,-1.17203701338845,202,157,NOD1|GATSL3|AHR|CIB2|PPIF|CHRNB2|IL1B|ADCY7|KDR|IMPACT|MAPK7|PRKCD|SIRPA|CTNNB1|TNFAIP3|ADIRF|ABL1|RPS3|GNAQ|FYN|ZNF580|FBP1|FOXO1|VIM|GNA15|IL6|CHRNA7|HTR1B|RIPK2|CTNNA1|PDCD10|LDOC1|ARHGEF2|FMR1|PDE4B|RYR1|FXN|TFRC|NET1|HRH3|CHRNA3|HSF1|NR3C1|TP53|KLF9|ADCY2|MAPK3|PARK2|CHRM1|PLCB1|AQP1|TNF
POSITIVE REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090297,0.8343624161073829,0.988613522932093,0.5830392589325101,0.774541644266396,6215,1,STOML2
"CHOLESTEROL BIOSYNTHETIC PROCESS VIA 24,25-DIHYDROLANOSTEROL%GOBP%GO:0033488",0.766980007943863,0.9792236089291529,-0.6125937362152629,-0.819485318761592,5792,1,CYP51A1
REGULATION OF STEROID HORMONE SECRETION%GOBP%GO:2000831,0.807173080797904,0.984682960940884,0.243629455360999,0.7190134648103829,8011,10,GHRL|AGTR1|UCN
PULMONARY VALVE FORMATION%GOBP%GO:0003193,0.27720861172977,0.7884684708511421,-0.693158382661717,-1.18561029035448,1866,2,TBX20
TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0036462,0.23918269230769199,0.75206086335821,-0.47094337811508097,-1.19216188944944,1392,5,TNFRSF10A|TNFRSF10B
REGULATION OF WNT-MEDIATED MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1905424,0.8481069042316259,0.991298302704726,-0.41659773917838394,-0.7125681213168751,5711,2,CSNK1E|CSNK1D
CHOLESTEROL ESTERIFICATION%GOBP%GO:0034435,0.297084794967945,0.801828762950478,0.6885580369451341,1.12542919559102,2455,2,SOAT1|LCAT
NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0045922,0.0854365118334479,0.547991507542111,0.445951512380437,1.4392512912983102,869,13,SIRT4|SIRT1|CEACAM1|ACADVL|INS|APOC1|METTL20|BRCA1|AKT1|ERLIN1|PIBF1
CELL PROJECTION ASSEMBLY%GOBP%GO:0030031,0.37864077669902896,0.854868503740915,-0.113050911927949,-1.0367529207853,155,353,C21orf59|FGD4|SRGAP2C|WDR35|TCTEX1D2|TCTN2|IFT172|RAB8B|CYFIP2|CCP110|NRP1|EMP3|RFX2|INPP5K|ABLIM2|RPGR|NPHP1|RILPL2|WHAMM|EHD3|EHD1|CEP19|RAP2B|UBXN10|RAB1A|CFAP46|MAP4K4|RAP1A|DYNLRB2|RAB8A|WDR19|MARK4|DNAI1|CETN2|CDC42|SEPT10|TRAF3IP1|NEFH|LRRC6|CCDC103|KIF3C|CC2D2A|DYNLRB1|SEPT9|KIF3B|ATP6V0D1|MKKS|DYNLL2|TMEM231|HAUS3|TTC30B|PMP22|TUBB4B|FXYD5|YWHAE|ASAP1|ABCC4|DYX1C1|WDPCP|ANO6|DNAL1|HAUS2|IQCG|INTU|CFAP20|S1PR1|SLC9A3R1|RHOQ|RSPH1|RAC1|CCDC113|ACTR2|B9D2|RILPL1|CDH13|RSG1|DNAAF1|BBS7
NEGATIVE REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:2000296,0.33470144313517797,0.8307288005518471,-0.8338112042346708,-1.11541467059521,2527,1,HP
CYTOLYSIS IN OTHER ORGANISM%GOBP%GO:0051715,0.35456110154905296,0.842911430859438,-0.82173577415086,-1.09926099959532,2677,1,ROMO1
POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003084,0.0591817820733483,0.475550457504474,-0.970280105866784,-1.2979732812104199,446,1,ACE
VENOUS BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060841,0.305349472862163,0.8085598515544019,-0.345394099664338,-1.11496310522392,1563,9,ENG|NOTCH1|VEGFA|TBX20|ACVRL1
RESPONSE TO DIAMIDE%GOBP%GO:0072737,0.16644394951744598,0.6682860217990739,-0.7561048016692671,-1.2932767688723301,1120,2,HSF1
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901137,0.930577170309222,1.0,0.112616109500835,0.76017981850652,13752,459,B3GALT2|GALNT10|GALNT8|GLCE|FUT9|MUC15|GAL3ST3|GALNT13|HACD1|FUT7|SDF2|GCNT2|NPR2|GALNT3|IMPDH1|TMEM165|VCAN|PGAP1|B3GAT3|C1GALT1C1|HS3ST5|B4GALNT1|SLC35D1|B3GLCT|RRM1|SCD5|FUT2|GAL3ST4|ALG6|ELOVL6|ASGR1|FUT8|ALG1L|ATP5G1|ADCY8|MGAT5B|B3GALT1|OGT|CHST15|ST3GAL5|PIGC|GPC2|ATP5D|POGLUT1|MVD|MOGS|SLC35B3|ALG14|ALG13|GPC6|DERL3|MUC1|EXT1|SRD5A3|PIGF|TK1|DPAGT1|CAD|PXYLP1|CHPF2|MT-ATP8|SLC26A2|PDHX|DTYMK|FUT10|GMPPB|NUDT14|CTPS2|GPC1|XYLT2|RFK|ADSSL1|PIGQ|MPDU1|AMDHD2|ALG2|GCK|PIGB|BMPR1B|UCKL1|B4GALT6|PDHA1|DUT|DPY19L3|SLC25A1|MGAT2|DOLPP1|ACACA|ST8SIA3|DCK|SYVN1|DLD|ACSS1|RFNG|PANK3|LFNG|ADORA2A|B3GALNT1|PRELP|B3GALT6|OSTC|PAPSS2|B4GALT4|ALG5|ABCC5|ST3GAL4|HS2ST1|UMPS|TECR|GPC3|HDDC2|LCMT2|PFKFB2|UCK1|ATP5C1|ALG1|MAN1C1|AKR1A1|ADCY1|TYMS|RPN2|AGRN|RRM2|PIGL|B3GNT4|POMT1|LARGE|FMOD|TYW3|ADCY6|PRPSAP2|PGM3|ST3GAL6|GXYLT1|FKTN|PPCS|BGN|CANT1|ENTPD5|POMGNT1|ELOVL2|PIGK|VCP|CTPS1|BPGM|ATP5E|B3GNT9|B4GALT3|FUK|PIGH|ACOT7|ADSS|ALG3|TYW5|VPS9D1|STT3A|SDC3|ATP5H|FKRP|MT-ATP6|DCN|SLC35B2|TET2|HEXA
PYRIMIDINE NUCLEOTIDE TRANSPORT%GOBP%GO:0006864,0.42895322939866404,0.8774573162143371,-0.597611723889682,-1.02218284767664,2888,2,SLC25A33
INTESTINAL CHOLESTEROL ABSORPTION%GOBP%GO:0030299,0.5525814760891479,0.9323791977088509,0.44294712296894395,0.9386472660849641,4933,4,LIMA1|AKR1C1|LDLR
NEGATIVE REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901675,0.394412816099563,0.863562957467761,-0.800838112042347,-1.07130555982839,2978,1,SIN3A
POSITIVE REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033235,0.823115970324092,0.987616425875001,-0.223400551485528,-0.721156999598736,4215,9,HDAC4|UBE2I|RASD2
RIBOSOMAL SMALL SUBUNIT BIOGENESIS%GOBP%GO:0042274,0.0374350086655113,0.38771806035618,-0.229207893834476,-1.4446843373997,107,57,UTP3|RRP36|DHX37|NOB1|PWP2|TBL3|SRFBP1|NPM1|RRP7A|KRI1|NOL10|RRS1|CIRH1A|TSR1|NOM1|TSR2|EMG1|NOP14
TISSUE REMODELING%GOBP%GO:0048771,0.7142080956261891,0.971081608033886,-0.15729882632928102,-0.832754236323361,2628,32,NOS3|ACVRL1|ACE|CAV1
MECHANOSENSORY BEHAVIOR%GOBP%GO:0007638,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
NEGATIVE REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904252,0.0136688036772711,0.256136946817111,0.919602977667494,1.5030658040258997,112,2,FGF19|PROX1
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY PROTEIN PHOSPHORYLATION%GOBP%GO:0100002,0.73248322147651,0.972811555656631,0.637737097485664,0.847205282540678,5456,1,AKT1
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070169,0.519086725024817,0.9238030410013001,0.23589447368926,0.9590317603125459,5751,27,CYR61|WNT4|BMP4|ADGRV1|PKDCC|FBXO5|BMPR1B|SLC8A1|CEBPB|ACVR2A
NEGATIVE REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060336,0.162431318681319,0.664367762084791,-0.5131023215309211,-1.29888445520879,945,5,NR1H3|PPARG|NR1H2
METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0009086,0.15464436832561,0.6538333887772321,0.448143941082875,1.32258854880386,1534,10,CTH|APIP|MTHFD1|MTR|MTAP|ENOPH1|MTHFR
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0019886,0.405848471422242,0.8663957682383929,-0.142887457333865,-1.02530664608086,915,90,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|HLA-DQB1|DCTN5|FCGR2B|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1
MESENCHYMAL CELL DEVELOPMENT%GOBP%GO:0014031,0.9589774078478001,1.0,0.124314859073311,0.5798481198091441,11290,44,SEMA3D|SEMA5A|HEYL|SEMA3E|SEMA4G|HAND2|HEY2|SEMA6A|SEMA4C|NRG1|FN1|KLHL12|SEMA4A|SOX10|TAPT1|PHOX2B|JAG1|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D|ANXA6
RRNA BASE METHYLATION%GOBP%GO:0070475,0.045125348189415,0.41796470434278704,-0.5150375925948939,-1.6009610889819499,242,8,METTL16|NSUN5|TRMT112|WBSCR22|EMG1
REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900221,0.596131849849225,0.948188586760759,0.32917884708017403,0.897429850392303,5732,8,ABCA7|APOE|SRF|LDLR|LRP1|ROCK1
STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0014706,0.291771620486986,0.8000726114371469,-0.158073448333865,-1.09972994158774,694,81,ADAMTS9|TNNT2|MYOM1|SMAD7|AKAP13|RYR1|ALPK3|POPDC3|CFLAR|TBX20|CAV2|MYH11|S1PR1|ZFPM2|RBPJ|CAV1|FKBP1A
POSITIVE REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031398,0.0474945533769063,0.428641579550379,-0.191444643697547,-1.36582310196753,108,88,TRAF6|NDFIP2|UBE2N|RNF20|AMER1|NDNL2|SENP2|DCUN1D5|BMI1|UBE2D1|FBXW7|PTTG1IP|CDK9|MAGEA2|ARRDC3|ARRB2|PRICKLE1|DCUN1D3|SPHK1|STUB1|BCL10|RAB1A|RIPK2|SMAD7|ADRB2|COMMD1|UBE2L3|TSPYL5|PARK2|HSPBP1|CAV1|FKBP1A|TRIB3|UBB
NEGATIVE REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001818,0.10681818181818198,0.5822715745664481,-0.153091739896738,-1.22246525928264,140,152,PTPN6|OTUD5|FURIN|CD274|SYT11|RARA|SRGN|ADCY7|CX3CL1|SIRPA|LGALS9|TNFAIP3|SSC5D|PCBP2|C1QBP|APOD|RELB|MAP2K5|IL6|FCGR2B|PRNP|ARRB1|REL|CYLD|TRIB2|RNF216|CHRNA7|SLC11A1|MAVS|GPATCH3|TMSB4X|SMAD7|TRAF3IP1|PDCD4|TRIM25|NLRP3|BCL3|SARS|TNFRSF4|HOMER2|PPP1R11|TAX1BP1|RAC1|HSP90AB1|TNF|TNFRSF21|INHBB
POSITIVE REGULATION OF RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:2000199,0.768590604026846,0.9792236089291529,0.617887075430084,0.8208354138121079,5725,1,RIOK2
POSITIVE REGULATION OF DNA DEMETHYLATION%GOBP%GO:1901537,0.42309505106048706,0.873470206885489,-0.49685673320833795,-1.00835597778447,2692,3,USP9X|USP7|OTUD4
POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002888,0.12257383966244699,0.607607158836689,-0.34986871961580607,-1.35548404319879,580,14,ITGAM|FGR|MAVS|GAB2|TICAM1
"NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900152",0.893959731543624,0.9976191001250191,0.5544221438023821,0.73652508351604,6659,1,TOB1
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055026,0.175808209226299,0.678685257108795,-0.439959920885508,-1.28338260846928,967,7,FZD7|SMAD4|FRS2|SOX6|DKK1
NON-CANONICAL WNT SIGNALING PATHWAY VIA MAPK CASCADE%GOBP%GO:0038030,0.42931573463008,0.8776568178260401,0.5431512410649451,1.03247337189857,3707,3,WNT4|DVL3
"ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I, TAP-DEPENDENT%GOBP%GO:0002479",0.9833293065957959,1.0,-0.115189549915879,-0.541266062553209,4069,23,TAPBP|VAMP3|B2M|CD36
PURINE NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034033,0.438285860918655,0.878999860395433,0.22149392522802497,1.01939377435037,5123,42,HACD1|SCD5|ELOVL6|SLC35B3|SLC26A2|PDHX|PDHA1|SLC25A1|ACACA|DLD|ACSS1|PANK3|PAPSS2|TECR
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048643,0.836397400185701,0.9886921730532041,-0.22880525018422498,-0.711226341079624,4503,8,DLL1|FAM129B|FLOT1|RBM24
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903565,0.694028862703561,0.96731875442989,-0.6481032201146889,-0.866987438048943,5241,1,LZTFL1
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010770,0.34371055952881796,0.839061110901644,-0.15341907669579002,-1.06294308641687,816,80,ABL1|MAP3K13|BHLHB9|RHOA|NRP1|C1QBP|MYADM|SEMA7A|DOCK5|POU4F2|ISLR2|CRK|LIMK1|AMIGO1|CDC42|PLXNA1|LIMS1|PLXNA4|RELN|TWF2|RAC1
IMP BIOSYNTHETIC PROCESS%GOBP%GO:0006188,0.219638648860958,0.734713083559597,-0.60251461343333,-1.22278550646761,1397,3,PFAS|AMPD2|HPRT1
REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120161,0.00792811839323467,0.19847993048827997,-0.20645103499107603,-1.5599851622179397,14,112,ACSL1|IGF1R|PGAM5|HCRT|IP6K1|ARRDC3|UCP2|NR1H3|ACOT11|MFN2|ZNF423|DDIT3|TFE3|FABP4|FOXC2|LPIN1|HOXC10|LEPR|NR1H2|PPARGC1A|ADAM17|LAMA4|ADRB2|HSF1|ID1|GPR3|ZNF516|ADCYAP1|GNAS|PER2|NR1D1|CD36|EBF2|TRPV2|EPAS1|RBPJ|CAV1|TLE3
PEPTIDYL-THREONINE DEPHOSPHORYLATION%GOBP%GO:0035970,0.177826564215148,0.6834499257291881,-0.306881518679985,-1.2567829589488602,809,16,DUSP1|PDP1|PPM1D|PPM1E|DUSP5|PPP5C|PPP1CA|PPM1B|DUSP18|PPM1F|DUSP4|PPM1G|PPP2CA|PPP2CB|PPM1A|DUSP10
CELLULAR RESPONSE TO STEROL DEPLETION%GOBP%GO:0071501,0.35413005272407705,0.842911430859438,-0.387347636644421,-1.06324325409713,2014,6,ERLIN1|SCAP|ARHGEF10L|INSIG2|ERLIN2|INSIG1
LATE ENDOSOME TO VACUOLE TRANSPORT%GOBP%GO:0045324,0.32294182217343603,0.8233331762466272,-0.265140579638165,-1.08583978484072,1470,16,LEPROTL1|PIK3R4|CHMP3|CHMP2B|CHMP7|CHMP2A|CHMP1A|VPS25|TMEM50A|TMEM50B|VPS28|BECN1|LEPROT|CHMP1B
REGULATION OF EIF2 ALPHA PHOSPHORYLATION BY DSRNA%GOBP%GO:0060735,0.180855289289024,0.6863300746827521,-0.907256285840318,-1.2136643955808502,1365,1,NPM1
POSITIVE REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0035470,0.5483110761979579,0.9305779599215391,-0.45384360869085705,-0.921062119552297,3489,3,XBP1|SMOC2|FOXC2
PROSTAGLANDIN CATABOLIC PROCESS%GOBP%GO:1905344,0.481476510067114,0.904752640722988,0.763288486987208,1.01399470224889,3586,1,ABHD16A
REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903900,0.00207146556188503,0.115553415806697,-0.224138601377177,-1.6805482953674702,3,109,FBXL2|SNX3|LGALS1|CCNK|TRIM8|RNASEL|PVRL2|TRIM13|APOBEC3F|BANF1|LGALS9|PML|VPS4A|DDX3X|INPP5K|IFITM2|TBC1D20|IFITM3|P4HB|OASL|VPS4B|MAVS|TRIM35|TNIP1|PPIH|CNOT7|FMR1|OAS3|TRIM25|CXCL8|PDE12|CAV2|VAPB|ZC3HAV1|PARK2|CHMP4B|STAU1|PABPC1|IFITM1|PC|TNF
REGULATION OF GRANZYME A PRODUCTION%GOBP%GO:2000511,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006636,0.207059477487493,0.721918317193763,0.32355417505416495,1.23913743586306,2234,22,EDN1|MGST1|SCD5|DECR2|FADS3|FADS1|PTGS2
BLOOD COAGULATION%GOBP%GO:0007596,0.00182815356489945,0.11072851755770098,-0.19021102055889003,-1.59224848092834,1,192,GNA13|HMG20B|FCER1G|DGKI|PRKCD|DGKD|PDPN|ARRB2|VAV1|HBG2|GNAQ|FYN|ITPK1|P2RX6|C1QBP|DGKQ|MFN2|CLIC1|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|MAFF|PRKAR2A|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|THBD|PROC|RAD51B|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ANO6|CSRP1|MAPK3|GNA12|RAB5A|DGKB|BLOC1S3|MYH9|VWF|GNAS|H3F3B|RAC1|CD36|PIK3R1|ZFPM2|DGKK
MODULATION OF PROGRAMMED CELL DEATH IN OTHER ORGANISM%GOBP%GO:0044531,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|SERPINB9|BCL2L1|GAPDH
HORMONE SECRETION%GOBP%GO:0046879,0.38913162206444607,0.8603316114971841,0.26342016197379803,1.05907522775081,4274,26,EDN1|TBX3|GHRL|RIMS2
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:2001053,0.326503340757238,0.826792328177465,-0.664074993107251,-1.1358647101282802,2198,2,TBX1|PAX8
REGULATION OF LIPID TRANSPORT%GOBP%GO:0032368,0.9184616654287371,1.0,0.130939950759672,0.65007285233151,11128,57,SIRT1|GHRL|ABCA7|ABCB4|AGTR1|CETP|ABCA2|LDLRAP1|PTCHD2|UCN|APOE|SREBF2|APOC1|AKT2|ARV1|THBS1|AKT1|APOC2|LRP1|HNRNPK|NCOR1|PTCH1|LAMTOR1|TRIAP1|GPS2|P2RX4|POMC|PLTP
REGULATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:1903108,0.551436515291937,0.932156795932405,-0.7185156594618441,-0.961180305020909,4164,1,CHCHD10
RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009158,0.381946966945151,0.857178152269066,-0.356811913954771,-1.04083618331079,2102,7,PRTFDC1|NUDT3|AMPD3|NUDT11|NUDT10|NUDT4|HPRT1
ENERGY RESERVE METABOLIC PROCESS%GOBP%GO:0006112,0.6597348583311671,0.9643779777660141,-0.169627810958866,-0.868112917263183,2537,29,GFPT2|LEPR|PYGB|PER2|NR1D1
NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002228,0.8070252469813392,0.984682960940884,-0.18337262540560897,-0.750972530828107,3675,16,GZMB|ULBP3|VAMP2|ULBP2|TUBB4B
CYANATE CATABOLIC PROCESS%GOBP%GO:0009440,0.503326478771017,0.9164921159310329,0.603007469664027,0.9855991435816149,4160,2,TST|MPST
NEGATIVE REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032691,0.9338056680161941,1.0,0.205271530011612,0.5857748101376209,9225,9,GHRL|GSTP1|CARD16|CPTP
MICROTUBULE ANCHORING%GOBP%GO:0034453,0.9368549446425221,1.0,0.15837224605284803,0.5881152172384089,9984,20,CCDC68|CAMSAP3
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0043471,0.539174389216512,0.928041735228137,0.36006278752958903,0.9371677867058209,5119,7,INS|PHKG2|GSK3A|PPP1R3B|SCARB2
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002286,0.47351720771296096,0.8997152910663541,-0.205573598125525,-0.9854092276378101,1939,24,SPN|LCP1|CD1C|RORC|GPR183|BATF|FCER1G|IL6|SLC11A1|ICAM1|FOXP1|STAT3
AMYLOID-BETA CLEARANCE%GOBP%GO:0097242,0.7728433876989591,0.979946273879301,0.23831117882550798,0.7512420000186519,7865,12,IDE|AGER
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0034637,0.0372340425531915,0.38702164012069,-0.277661250130111,-1.52738455463803,132,36,B3GNT5|B3GNT7|CSGALNACT1|SLC2A1|PER2|B3GNT8|B3GNT2|NR1D1
EPIBOLY INVOLVED IN WOUND HEALING%GOBP%GO:0090505,0.0610036832412523,0.48170831577441997,-0.33576981487907104,-1.4981731804816898,264,20,PDPN|RHOA|ITGA5|RHOC|PDCD10|ADAM17|MMP12|ACVRL1|TMEFF2
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048639,0.733808237124376,0.9734087938149171,0.162132302384147,0.816745858058857,8961,61,SYT17|EDN1|GHRL|RIMS2|TBX2|BASP1|SYT3|PROX1|DSCAM
HEART TRABECULA MORPHOGENESIS%GOBP%GO:0061384,0.137763713080169,0.6243233125849921,-0.34148413991326004,-1.32299996171757,652,14,S1PR1|RBPJ|FKBP1A
POSITIVE REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002741,0.986174391201885,1.0,-0.26257338175185996,-0.532884876867619,6276,3,KARS
NEGATIVE REGULATION OF CREATINE TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1905408,0.0895302013422819,0.5590911253505021,0.95577856197618,1.2697091792806598,666,1,STK39
REGULATION OF 3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:1905868,0.0145637495035085,0.262734483145539,-0.993162770180856,-1.3285841189499399,109,1,RBM24
REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002709,0.990317649057245,1.0,0.10316085937805802,0.481178443141596,11659,44,CEACAM1|AGER|CD1E|MAP3K7|ZP3|ZBTB1|IL12RB1|CD1D|TRAF2|RIPK3|HLA-F|IL1R1|XCL1|HSPD1|WAS|FADD|HLA-C|FOXP3|PRKCZ|HMGB1|STX7|PTPRC|HFE
DEFENSE RESPONSE TO VIRUS%GOBP%GO:0051607,0.371711944803795,0.852609194081082,-0.148421219162293,-1.0488589906564598,861,86,PLSCR1|RELA|MX1|BNIP3|AGBL5|PYCARD|SETD2|SERINC3|ABCC9|RNASEL|APOBEC3F|DDIT4|IFNAR2|EXOSC4|IFITM2|MX2|IFITM3|IL6|OASL|APOBEC3B|ATG7|MAVS|CNOT7|OAS3|PDE12|BCL2|BNIP3L|EXOSC5|IFITM1|PMAIP1
B CELL CHEMOTAXIS%GOBP%GO:0035754,0.439202440618871,0.879896414106183,0.44236794519751,1.0195925363918699,4030,5,CXCL13|CYP7B1
AGMATINE BIOSYNTHETIC PROCESS%GOBP%GO:0097055,0.666979865771812,0.964618776001639,0.6716475518306129,0.8922538082853191,4968,1,AZIN2
REGULATION OF EXCRETION%GOBP%GO:0044062,0.45990449530709704,0.890371861972445,-0.426485567070023,-0.9808277083052479,2792,4,STC1
ENDOSOME ORGANIZATION%GOBP%GO:0007032,0.861944344054933,0.991915800284466,-0.11783980473878698,-0.759703351970807,2384,62,RILP|PI4K2B|RAB11A|USP8|PI4K2A|PDCD6IP|SNX3|VPS28|VPS33B|ARFGEF2|SQSTM1|VPS4A|VPS18|VPS37D|VPS11|VPS4B|ALS2CL|PLEKHF1|RAB22A|CHMP4B|CHMP1B
PHENYLPROPANOID METABOLIC PROCESS%GOBP%GO:0009698,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION%GOBP%GO:0046856,0.17124039517014303,0.674379448319819,-0.30919927156338,-1.26627493598102,779,16,MTMR1|INPP5F|OCRL|MTMR6|TMEM55B|MTMR3|INPP5J|SACM1L|MTM1|PTEN|SYNJ1|INPP5B|TMEM55A|SYNJ2|MTMR2|INPP5K
D-GLUCURONATE METABOLIC PROCESS%GOBP%GO:0042839,0.591946308724832,0.9458918196441479,0.7087560652845171,0.941550812880674,4409,1,AKR1A1
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:1902547,0.7520729684908791,0.9769690538700708,-0.2128,-0.7752517459542491,3627,12,SEMA6A|KIAA1462|DCN|ADAMTS12|CCBE1|SMOC2|SPRY2|ROBO1|CD63|DLL1|DAB2IP|MYO1C
NEGATIVE REGULATION OF RNA-DIRECTED 5'-3' RNA POLYMERASE ACTIVITY%GOBP%GO:1900260,0.286508672050841,0.7957186177819849,-0.856693868548743,-1.14602550833473,2163,1,EIF4A2
REGULATION OF ENDOCANNABINOID SIGNALING PATHWAY%GOBP%GO:2000124,0.28518469482324893,0.794258537514783,-0.8574106749007501,-1.14698440204705,2153,1,MGLL
RESPONSE TO TETRAHYDROFOLATE%GOBP%GO:1904481,0.27720861172977,0.7884684708511421,-0.693168064088269,-1.18562684991609,1866,2,SHMT2
POSITIVE REGULATION OF PERIPHERAL TOLERANCE INDUCTION%GOBP%GO:0002660,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
TRYPTOPHAN CATABOLIC PROCESS TO ACETYL-COA%GOBP%GO:0019442,0.158480074142725,0.6604486079157379,-0.917732686369652,-1.22767899599171,1196,1,TDO2
REGULATION OF CELLULAR PH%GOBP%GO:0030641,0.962107604139937,1.0,0.123269162012586,0.567328499847804,11247,42,TMEM165|SLC9A5|SLC9A7|DMXL2
HISTONE PHOSPHORYLATION%GOBP%GO:0016572,0.590408729778884,0.945418171231938,0.259796572267407,0.9006442618451209,6167,16,JAK2|PRKCB|NEK11|AURKB|MAP3K12|VRK1|RPS6KA4|CDK2|CCNA2
PROTEIN POLYUFMYLATION%GOBP%GO:1990564,0.639938186813187,0.96058002537611,-0.33588750175215304,-0.8502769066081809,3726,5,UFC1|DDRGK1
REGULATION OF HEART INDUCTION%GOBP%GO:0090381,0.8267742466655691,0.9876441563834109,-0.31280895061539193,-0.7193952383366109,5020,4,DKK1
REGULATION OF TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE%GOBP%GO:0002652,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
REGULATION OF ERAD PATHWAY%GOBP%GO:1904292,0.434188967777171,0.878651088001772,0.25518028829558,1.02594698871623,4769,26,TMEM259|BRSK2|SGTA|DERL3|ATXN3|USP13|NFE2L2|HERPUD1|SVIP|BAG6
AUDITORY RECEPTOR CELL STEREOCILIUM ORGANIZATION%GOBP%GO:0060088,0.0418859894725053,0.402998391331252,0.714961286984638,1.515071263781,373,4,STRC|DFNB31|PDZD7
NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0001781,0.252350059578975,0.763905256448548,-0.874834583149537,-1.17029289536196,1905,1,IL6
RESPONSE TO MITOTIC CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:0072414,0.14255033557047,0.6324244126031129,0.929863255403617,1.23528185066281,1061,1,APAF1
CELLULAR KETONE METABOLIC PROCESS%GOBP%GO:0042180,0.37321615036547207,0.852609194081082,0.24116103754432197,1.0722266654622201,4288,37,FDXR|AKR1B1|CBR4|COQ3|DHRS4|CACNA1H|COQ2|COQ6|AKR1C1
ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:0060612,0.00197005516154452,0.112650093274223,-0.6232705595624289,-2.10861759412738,9,10,DYRK1B|RORC|SH3PXD2B|LRP5|NAMPT|ARID5B|DGAT2|ZNF516
REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046637,0.659839468585663,0.9643779777660141,-0.161563064897092,-0.8693525701018292,2383,34,RUNX1|PNP|SMAD7|NLRP3|SOCS5|NKAP|CBFB
REGULATION OF PLASMA MEMBRANE STEROL DISTRIBUTION%GOBP%GO:0097036,0.5636241610738261,0.9377667552605741,0.721879135421262,0.958984226095674,4198,1,ARV1
NEGATIVE REGULATION OF STEROL TRANSPORT%GOBP%GO:0032372,0.33083212005823703,0.8293509737209019,0.523872176870467,1.1101351856662098,2953,4,SREBF2|APOC1|APOC2
CELL COMPETITION IN A MULTICELLULAR ORGANISM%GOBP%GO:0035212,0.345293260955912,0.8411448613059059,-0.827911336568152,-1.10752223773225,2607,1,VPRBP
REGULATION OF CHROMATIN DISASSEMBLY%GOBP%GO:0010848,0.611677479147359,0.9508825506493929,-0.6875827084252321,-0.919800353281463,4619,1,MAP1S
POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033601,0.0548311076197958,0.45676960427134705,-0.758078747104886,-1.53849829374064,348,3,RREB1|RTN4|ZNF703
REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903644,0.618882293649905,0.9532238181782521,0.42122988254066207,0.89262635907854,5525,4,SGTA|PDCD5|DNAJB2
NEGATIVE REGULATION OF T CELL MIGRATION%GOBP%GO:2000405,0.9821928547429721,1.0,0.24608635692424,0.5214804977160701,8769,4,CD200
INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032615,0.745494133301077,0.9749763305090959,0.50902624513976,0.831989413911968,6162,2,CCL19|CCR7
REGULATION OF DIACYLGLYCEROL KINASE ACTIVITY%GOBP%GO:1905687,0.827114093959732,0.9876441563834109,0.58756065284517,0.780548114365681,6161,1,MAPT
POSITIVE REGULATION BY ORGANISM OF APOPTOTIC PROCESS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052501,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE%GOBP%GO:0072594,0.9781553398058249,1.0,-0.0823667779587233,-0.7553587686121841,402,353,RPS16|RPL12|RAB10|PHYH|PHB2|HSPA4|BAX|UBE2D1|ECH1|VTI1B|RPS4X|PEX16|NUDT7|TOMM34|RPL9|VPS28|TOMM22|CLU|KPNA1|PTTG1IP|TIMM50|RPS28|PMM1|RGPD8|RPL35|ROMO1|SAMM50|RPL7|PRICKLE1|LAMP1|SRP72|TOMM20|SGTB|RAB8B|RPS9|RPS3|VPS4A|RPL14|TIMM10B|AIP|C19orf52|SEC63|TIMM23|SEC62|MFN2|GCC2|RPL15|RPL8|PEX26|RGPD1|RUVBL2|RPL35A|PMPCA|DNLZ|KPNA4|NEDD4|HK1|HK2|PEX7|TIMM22|MMP12|UBA52|PEX19|STAT3|ASNA1|ACOX1|BCL3|UBE2D3|BCL6|RAB7A|BMF|CHMP4B|TIMM23B|ACOT8|PMM2|FBXO7|SRP54|RGPD6|PEX5|VTI1A|NUTF2|CACNG3|UBC|CACNG7|TNF|BCL2L11|PMAIP1|UBB
REGULATION OF CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:2000690,0.341983317886932,0.8359038216207221,-0.8303925893250992,-1.11084148519798,2582,1,PRICKLE1
REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0007096,0.41245212609250703,0.8672701447712049,0.323529956764604,1.04415142705001,4199,13,CDC23|ANLN|CDCA5|KNTC1|UBE2C|MAD2L1BP|NPM2|SIRT2|CDC14B|ZW10
PROTEIN LOCALIZATION TO PHOTORECEPTOR CONNECTING CILIUM%GOBP%GO:1903621,0.744295302013423,0.9749763305090959,0.6308998676665201,0.838122327756393,5544,1,SPATA7
PITUITARY GLAND DEVELOPMENT%GOBP%GO:0021983,0.425480769230769,0.875696962448429,-0.398481071666117,-1.00872837241854,2477,5,ADCYAP1|DRD2
HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0045143,0.212309753996363,0.727709540947015,0.35715060403483795,1.23814428855284,2217,16,SYCP2|CCNE1|PTTG1|CCNE2|BAG6|STAG3|P3H4|FMN2|CCNB1IP1|SYCE2|TRIP13|CENPC
POSITIVE REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000196,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
PARAXIAL MESODERM DEVELOPMENT%GOBP%GO:0048339,0.968186766662635,1.0,0.3650502132134171,0.5966645449813299,8003,2,LEF1
POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:1904407,0.12737642585551298,0.6076669536424699,-0.28774493308878,-1.33304757607179,535,22,DDAH2|CD36|HSP90AB1|TNF|DDAH1
STRESS RESPONSE TO ACID CHEMICAL%GOBP%GO:0097532,0.612769116555308,0.9508825506493929,-0.516349600220568,-0.883188337261578,4126,2,KLF2|VEGFA
REGULATION OF OOGENESIS%GOBP%GO:1905879,0.113946978429112,0.590080021815051,-0.605645332811064,-1.3928577417235601,691,4,YTHDF2|IGF1|PDE3A
TRNA SELENO-MODIFICATION%GOBP%GO:0070329,0.5845637583892621,0.9439064862850342,0.7117887075430078,0.9455795428253171,4354,1,SEPHS1
PROTEIN MATURATION BY [2FE-2S] CLUSTER TRANSFER%GOBP%GO:0106034,0.555276049251953,0.9343712161942179,-0.7163101014556679,-0.958229862829149,4193,1,CISD3
PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0071168,0.449303036089364,0.8858223310328521,0.28613869225503996,1.0091698455723601,4705,17,LRWD1|H2AFY2|NIPBL|PLK1|C5orf45|LEMD2|CCDC101|MAU2
POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061003,0.876417004048583,0.99438923588415,0.23128256820091103,0.6600014257620911,8658,9,CUX2|CAPRIN2|LRP8
"CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0036037",0.577376276512176,0.942692029750853,-0.44375206793867894,-0.900581637428595,3674,3,CLEC4A|HLA-E|TNFSF8
POSITIVE REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032735,0.865128745094286,0.992690647212272,0.193061366869421,0.669291402643861,9037,16,MAPK11|AGER|CCL19|LTB|TLR4|MAPK14|HSPD1|ISL1|HMGB1|TLR2|IRF5|CCR7
"PROTEIN IMPORT INTO PEROXISOME MATRIX, DOCKING%GOBP%GO:0016560",0.64745595257698,0.9636261853025391,-0.366736697307576,-0.8434177898277299,3931,4,PEX5
GLUTAMINYL-TRNAGLN BIOSYNTHESIS VIA TRANSAMIDATION%GOBP%GO:0070681,0.5895565589903901,0.945418171231938,0.483842505790228,0.9197337051860991,5091,3,GATC|QRSL1|GATB
GLUCOSAMINE CATABOLIC PROCESS%GOBP%GO:0006043,0.413363028953229,0.8683189983530021,-0.6074441687344909,-1.03900071799162,2783,2,GNPDA1|GNPDA2
POSITIVE REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905523,0.726421961110534,0.972554563883587,0.289721481754783,0.789858486755395,6985,8,RARRES2|CCL5|THBS1|CSF1|P2RX4|CMKLR1
CELLULAR RESPONSE TO HEPARIN%GOBP%GO:0071504,0.8975338659256691,0.998912093067348,0.35132899525752703,0.667839461561504,7751,3,EGR1|SFRP1|SLIT2
MITOTIC RECOMBINATION%GOBP%GO:0006312,0.695807573415765,0.96731875442989,0.240514609295168,0.815491726313106,7202,15,XRCC3|RAD54B|GEN1|RAD51|SMC6|RAD52|MSH3|TEP1|RAD50
REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051960,0.6194029850746271,0.9532238181782521,-0.10147772414807599,-0.957927334051377,165,422,ARHGDIA|ID2|RNF6|FZD1|ZEB1|PRKCH|CHRNB2|IL1B|VEGFA|NEDD4L|IMPACT|IGSF10|CX3CL1|ADRA2C|DNM2|LPAR1|CTNNB1|DAB2IP|TUBB2B|RTN4|SKI|NSMF|PTK2B|SRGAP2C|EIF2AK3|ABL1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|RHOA|SERPINI1|HES7|NRP1|TENM4|CPNE6|TNFRSF1B|EIF4G1|SEMA7A|PTK7|YWHAH|IL6|LYN|EFNA1|ULK4|KIF13B|CAMK2A|POU4F2|BAG5|ISLR2|ARC|BIN1|SPOCK1|TCF4|RAP1A|ZPR1|LIMK1|AMIGO1|SERPINF1|SNCA|ARHGEF2|FMR1|TWF1|C21orf91|FGFR1|BHLHE41|NEDD4|SEMA6B|PLXNA1|CHRNA3|RAPGEF1|ID1|SSH3|PLXNA4|RELN|GPR161|DKK1|YWHAZ|TWF2|ADCYAP1|COBL|DRD2|NCS1|SYT2|WNT3|FKBP4|ASCL1|SDC2|SYNDIG1|FBXO7|PER2|STK24|MYLIP|ZNF365|SEMA3A|SEMA3G|CPNE9|PCP4|OLFM1|GPRC5B|TNF|TNFRSF21|NBL1|LINGO1|EPHB2|FOXO6|PARD3|RTN4RL2
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032388,0.0346954510408635,0.379769573488262,-0.16690529420449401,-1.34075857177549,44,157,PLK3|BCAS3|RAB21|PRKCD|TMEM30A|ITGAM|UBL5|FGR|MYO1C|ATG13|STX18|FYN|FAM65A|ICE1|TCF7L2|VPS11|TBC1D20|EHD1|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|MIEF1|IGF1|MAVS|CEMIP|BAP1|LEPROT|ZPR1|PDCD10|EHD2|MSN|NEDD4|BAG3|TP53|GAB2|UBE2L3|YWHAE|UBE2D3|NCBP2|ARIH2|PARK2|BCAP31|PIK3R1
LIVER DEVELOPMENT%GOBP%GO:0001889,0.697624383684446,0.96731875442989,0.19942644159068498,0.8260914765376041,7781,29,WNT4|RARB|E2F8|PROX1|PKD2|LSR|E2F7|NF1|NPHP3|AURKA|CEBPB|PHF2
D-GLUCONATE METABOLIC PROCESS%GOBP%GO:0019521,0.11073825503355698,0.584830174998513,0.944309660344067,1.25447325512638,824,1,IDNK
LYSOSOMAL MEMBRANE ORGANIZATION%GOBP%GO:0097212,0.695704697986577,0.96731875442989,0.656760035288928,0.872476406738892,5182,1,LAPTM4B
MICROTUBULE CYTOSKELETON ORGANIZATION%GOBP%GO:0000226,0.0133983784526591,0.25329970953708497,0.213483455953903,1.4068227424809199,194,340,KIF25|CCDC78|AKAP9|NCKAP5|CALML4|CNTLN|CCDC68|CLIP1|CAMSAP3|SDCCAG8|CEP63|BRSK2|ASPM|CENPJ|CCNB1|RCC1|FSD1|PSRC1|CDK1|KIF14|CEP126|SPAG5|RGS14|PKD2|SKAP1|SAPCD2|TBCE|WDR62|KIF2C|MTCL1|HOOK1|CCSAP|LRRC49|KIF18A|MARK2|FGF13|DCLK2|CKAP5|CEP152|NUMA1|CDK5R1|KIF4A|KIF24|DYNLT1|MAP10|CROCC|ATXN3|NUF2|KIF23|CCDC88B|DCX|PRC1|KIF11|TTK|TUBGCP3|NEK2|STIL|EML3|HAUS5|NDC80|CENPA|GPSM2|WRAP73|NUSAP1|CDK5RAP2|CUL9|CENPE|KIF18B|CETN3|INO80|ESPL1|AURKB|DNAH1|GOLGA8A|DOCK7|CEP72|KIFC1|MID1|TUBG2|HDAC3|TUBE1|RSPH4A|SPDL1|ASUN|TUBGCP6|CCDC120|HAUS8|OBSL1|SASS6|CNTROB|PIN1|TAOK1|CEP192|KIF20A|STMN1|SYNE2|SON|CHEK2|TACC2|HOOK2|NAV1|PLK1|TUBGCP2|MARK3|FAM179B|RTTN|BRSK1|APC2|RACGAP1|CAMSAP2|PPP1R12A|TBCD|AURKA|BRCA2|GOLGA8N|DYNC1H1|CUL7|NINL|LLGL2|SPC25|TUBB4A|XRCC2|CEP135|TUBGCP4|FAM175B|TTLL3|GOLGA8B|SPIRE2|PCM1|SPIRE1|SGOL1|TPX2|RNF19A|DST|CCDC69|CHD3|FMN2|CAMSAP1|FIGN|CDK2|CEP120|MAP7D1|GAS8|VCP|UXT
REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051584,0.45123626373626397,0.886411023801201,-0.389196883739802,-0.9852260671848639,2627,5,SNCA|DRD2
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903650,0.152635486265776,0.648319130045528,-0.7647642679900749,-1.30808832224272,1027,2,SNX3|SNX12
POSITIVE REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000825,0.7040062843676349,0.968941691852291,-0.3988640123524871,-0.809482662299121,4480,3,TAF1|PARK7|BUD31
REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070666,0.24414140076790697,0.7571583779245891,-0.8775363917071021,-1.1739071870468702,1843,1,LYN
DNA DUPLEX UNWINDING%GOBP%GO:0032508,0.31275607757443297,0.8155492679436609,0.284097000125734,1.1320856780586699,3434,25,PIF1|BLM|DHX9|RAD51|RTEL1-TNFRSF6B|RECQL5|SUPV3L1|POT1|ANXA1|DDX11|RAD50|NBN|PURA|ASCC3|DDX1|RTEL1|RECQL|ERCC3|RPA1
MYELINATION%GOBP%GO:0042552,0.589583333333333,0.945418171231938,-0.159750354717398,-0.9154969671763841,1980,41,MBP|MAL|AMIGO1|MALL|CD9|PMP22|TNFRSF21|PARD3
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0006688,0.25014321176245896,0.76165135686672,0.33836792217288597,1.19337479693762,2619,17,B3GALT2|B4GALNT1|B3GALT1|ST3GAL5|B4GALT6|ST8SIA3
RESPONSE TO GONADOTROPIN%GOBP%GO:0034698,0.0462703770788737,0.4228938823417371,-0.6967958969833999,-1.60248499730008,280,4,TGFBR3|NOTCH1|NSMF|PAX8
CELL ADHESION%GOBP%GO:0007155,0.003785062521122,0.14377160645023299,0.211335520656308,1.42911678849612,55,472,PCDHGA5|TENM1|PCDHA12|CLDN12|PCDHGA11|PCDH15|PTPRK|PCDHB4|VMP1|PCDHB15|PCDHA10|HOXD3|CUZD1|ITGB1|PCDHA7|PCDHA2|CTGF|CDH4|PCDHB8|PCDH17|LRRN2|CDH6|PCDH8|CLDN15|CDHR2|PCDHGA7|PCDHB6|CYR61|ROPN1B|PCDHB7|PCDHGA1|PCDHB14|NOV|CDH10|NEXN|SDK1|CEACAM1|CAMSAP3|PCDHA6|CD209|PCDHB13|CDH3|WISP1|ITGA1|LRRC7|PCDHB9|STRC|PCDHA11|MADCAM1|ACTN2|DCHS1|PCDHGA2|PCDHB12|PCDHA1|PCDHA3|ADGRV1|KIF14|ILK|IGSF9|CDH2|CLDN11|ITGA9|DSCAM|PCDHGB4|PLXNC1|ADGRB1|PCDH9|CD2|HBB|FBLIM1|DDR2|PPFIA2|PCDH20|DLG3|CLDN7|FIBP|ITGA2|CDH23|PCDHAC2|BGLAP|SGCE|PCDHGC5|CDK5R1|ROBO2|SEMA5A|ITGA4|TGFB2|TENM2|PCDHGA3|CELSR2|DDR1|FARP2|CTTN|PCDH18|CTNND1|TYRO3|KIRREL3|CTNND2|FBN1|PCDHGA6|CDH7|CCL21|APC|PCDHA5|ITGB3BP|PTPRD|ITGA11|ITGB5|CCL5|CD200|LOXL2|LEF1|CORO1A|IGFBP7|DLG5|KIT|HMCN1|BSG|TNXB|ITGBL1|PALLD|CASK|FBLN5|CCL2|ADGRL1|CXADR|STAB1|ATP2A2|PLXNB2
REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048710,0.23442719591275302,0.7482511903785959,0.385563443014566,1.2154337597248202,2385,12,HES1|SERPINE2|AGER
AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM%GOBP%GO:0032291,0.809662186705412,0.984682960940884,-0.24997242140099302,-0.7291806434942819,4457,7,MYRF|PLP1|SOX10|CNTNAP1|PTEN|CLU|TENM4
SREBP SIGNALING PATHWAY%GOBP%GO:0032933,0.35413005272407705,0.842911430859438,-0.387347636644421,-1.06324325409713,2014,6,ERLIN1|SCAP|ARHGEF10L|INSIG2|ERLIN2|INSIG1
REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901339,0.317822802197802,0.8195987896601998,-0.436576218839621,-1.10516370784037,1850,5,STIM2|TMEM110|UBQLN1|STIM1|CRACR2A
PROTEIN MATURATION BY [4FE-4S] CLUSTER TRANSFER%GOBP%GO:0106035,0.518446836821096,0.9236324326350509,0.596739360071327,0.9753540906473901,4285,2,ORAOV1|YAE1D1
REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033632,0.310296191819464,0.81310367606363,0.38631390641984603,1.1401121426298302,3079,10,CXCL13|SKAP1|CCL5|PIEZO1|CD3E
DETECTION OF TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0042495,0.6148478099480329,0.9511905259737851,-0.515632754342432,-0.881962210778835,4140,2,TLR2|TLR1
HYDROXYLYSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046947,0.244933228593873,0.757467559003634,-0.584647623249145,-1.1865249807404,1558,3,PLOD1|PLOD3|PLOD2
NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0001779,0.6126206384558279,0.9508825506493929,-0.5164047422111939,-0.8832826546833271,4125,2,PTPRC|PIK3CD
DENDRITIC SPINE MAINTENANCE%GOBP%GO:0097062,0.0718804920913884,0.515023940206536,-0.548167427692593,-1.5046827822650701,408,6,MTMR2|IGF1R|FYN|PRNP
REELIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038026,0.7184207479448879,0.971081608033886,0.437754689238538,0.8321256141776558,6204,3,VLDLR|LRP8
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE%GOBP%GO:0051204,0.0343546889507892,0.378473112045903,-0.535304090318719,-1.66395818809138,184,8,BMF|BCL2L11|PMAIP1
MANNOPROTEIN METABOLIC PROCESS%GOBP%GO:0006056,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
REGULATION OF LIPID TRANSPORT BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072368,0.570702794242168,0.9404752161333092,0.578218913702785,0.9450829298444329,4717,2,SREBF2|NCOR1
"NEGATIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000143",0.899204838167768,0.998912093067348,0.30805713340318797,0.652802492831963,8028,4,HEY2|HMGB1|ZNF451|THRA
NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002323,0.996873914553665,1.0,0.24217441616023605,0.46034808932827004,8609,3,CORO1A|VAMP7
CELL-MATRIX ADHESION%GOBP%GO:0007160,0.379009900990099,0.855147543637198,0.19896179627006896,1.06267954618248,4784,80,PTPRK|HOXD3|ITGB1|ITGA1|STRC|MADCAM1|ACTN2|ILK|PPFIA2|ITGA2|SGCE|ITGA4|DDR1|CTTN|CCL21|ITGA11|ITGB5
REGULATION OF DENSE CORE GRANULE EXOCYTOSIS%GOBP%GO:1905413,0.82,0.987153241368501,0.591696074106749,0.786041837017467,6108,1,BAIAP3
INDUCTION OF HOST IMMUNE RESPONSE BY VIRUS%GOBP%GO:0046730,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
POSITIVE REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903893,0.199788163643585,0.711592141628341,-0.898434053815615,-1.20186262681381,1508,1,ATF6
PLATELET AGGREGATION%GOBP%GO:0070527,0.75097478554718,0.9763615499644251,-0.158147619877702,-0.8093601566523391,2888,29,GAS6|PLEK|ACTN1|STXBP3|GP1BA|HSPB1|CLIC1|UBASH3B|RAP2B|CSRP1|MYH9|GNAS
BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:0007339,0.753457419153582,0.9769690538700708,0.28223360700557204,0.769444531315832,7245,8,OVGP1|PCSK4|ZP3
DNA DEPHOSPHORYLATION%GOBP%GO:0098502,0.944309366678245,1.0,0.319130042870788,0.6066326402769641,8155,3,PNKP|POLB
NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019184,0.563961485557084,0.9380162603437769,0.29135677561392304,0.9184606777991441,5739,12,BDH2|GGT1|MGST2|OPLAH|HAGH
POSITIVE REGULATION OF LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032761,0.48775321064477706,0.907808599852568,-0.7542456991618879,-1.00897746852744,3683,1,CD86
PRE-MIRNA EXPORT FROM NUCLEUS%GOBP%GO:0035281,0.8740905716406829,0.9934031064448321,-0.401985111662531,-0.687574004553279,5886,2,XPO5|RAN
MITOCHONDRIAL TYROSYL-TRNA AMINOACYLATION%GOBP%GO:0070184,0.9943624161073821,1.0,0.502922364358183,0.668109924092472,7407,1,YARS2
NEGATIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033633,0.825503355704698,0.9876441563834109,0.58893912659903,0.78237935524961,6149,1,WNK1
ASYMMETRIC NEUROBLAST DIVISION%GOBP%GO:0055059,0.62682560137457,0.9548215347474809,0.35306280372498294,0.868306547117897,5836,6,FGF13|DOCK7|SOX5|TEAD3
RESPONSE TO DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072423,0.0186855670103093,0.286111698549296,0.671131267416147,1.65054961135725,173,6,MUS81|FBXO18|APAF1|SLX4|EME1
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN AXON GUIDANCE%GOBP%GO:1902287,0.299392712550607,0.8024344898123659,0.402502823541449,1.1486055325183702,2957,9,PLXNC1|PLXNA3|PLXNB2|PLXNB3|PLXNA2
CATECHOLAMINE TRANSPORT%GOBP%GO:0051937,0.522641198748559,0.9251240799994541,-0.404457356449779,-0.930167425733078,3173,4,VIP|SNCA
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0032881,0.943589743589744,1.0,0.14372930250773003,0.5893804485152659,10487,28,INS|PHKG2|PASK|GCK|CLTC|IRS1|AKT2|VIMP|GSK3A|AKT1|PPP1R3B|PPP1R3E|SORBS1
ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055009,0.419983065198984,0.872690030459269,0.634322990443826,1.03678350200852,3471,2,PROX1|ENG
REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905153,0.7940292096219929,0.9819233677232551,0.29961283036869896,0.7368541218868029,7393,6,ABCA7|F2RL1
REGULATION OF ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0050812,0.9535198086721429,1.0,0.20634994721185104,0.562565316384647,9169,8,PDK4|GSTZ1|PDP1|PDK1
NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING%GOBP%GO:0010944,0.40074280408542295,0.8638522656500329,-0.330240525931944,-1.02653134377674,2157,8,SMAD7|BHLHE41
NEGATIVE REGULATION OF CARDIAC CHAMBER FORMATION%GOBP%GO:1901211,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
MODULATION BY HOST OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:0044789,0.109718406593407,0.584830174998513,-0.549828552123838,-1.3918544692076102,638,5,CAV2|PC
POSITIVE REGULATION OF INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE ACTIVITY%GOBP%GO:0010925,0.5371375612339471,0.9265056012720759,-0.7271724746360829,-0.972760790623571,4056,1,PLEK
NEGATIVE REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090258,0.5456634813112371,0.930420772651609,0.5875930521091811,0.9604047015470409,4510,2,PINK1|MAPT
REGULATION OF ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071580,0.25393883225208497,0.7641083395392759,-0.873842082046758,-1.16896519637567,1917,1,SLC30A1
REGULATION OF MEMBRANE REPOLARIZATION%GOBP%GO:0060306,0.16839378238342,0.672026878249637,-0.278469940965318,-1.2647536607597198,714,21,NEDD4L|KCNE3|SCN1B|KCNE4|SNTA1|YWHAE|SCN5A|DLG1|CAV1
REGULATION OF BLOOD VESSEL BRANCHING%GOBP%GO:1905553,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
POSITIVE REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046598,0.419723937522703,0.8725068208993679,-0.346854904530757,-1.01179114506862,2310,7,CD4|TRIM11|LGALS1|LGALS9|P4HB
BONE MORPHOGENESIS%GOBP%GO:0060349,0.8268041237113399,0.9876441563834109,-0.133234992277198,-0.757721580266104,2806,40,SCARA3|COL14A1|FOXC1|COL6A2|VWA1|DLX5|LRP5|RARA|SKI|COL6A1|COMP|COL21A1|TWIST1|STC1
OLFACTORY BULB INTERNEURON DIFFERENTIATION%GOBP%GO:0021889,0.511331444759207,0.918404893008545,0.4187492534243789,0.965154953125129,4692,5,SLIT1|ROBO2
POSITIVE REGULATION OF SECRETION BY CELL%GOBP%GO:1903532,0.9271929824561401,1.0,-0.0940884424537361,-0.781134709921502,1056,184,VIP|PANX1|VPS4B|VAMP3|MBP|IGF1|MAVS|MYOM1|RIPK2|GAPDH|CRH|RAB2B|KARS|NLRP1|NLRP3|GAB2|TNFRSF4|ADCYAP1|DRD2|RAB7A|RAB5A|TWIST1|TNF|GAL|INHBB|TRH
RESPONSE TO NERVE GROWTH FACTOR%GOBP%GO:1990089,0.435243682310469,0.878651088001772,-0.22905397946793202,-1.0045100929261601,1928,19,MAGI2|NTRK3|ACAP2|WASF1|AKT1|NGF|STMN2|MAPT|CIB1|KIDINS220|SH3GL2|RAPGEF2|NTRK2|RAB35|NTRK1|EHD1|RAP1A|RAPGEF1|TMEM108
MITOCHONDRIAL RESPIRATORY CHAIN SUPERCOMPLEX ASSEMBLY%GOBP%GO:0097250,0.28478099480326696,0.7938491928861969,-0.688394462723484,-1.17746186043936,1917,2,COX7A2L
VOCAL LEARNING%GOBP%GO:0042297,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
ACTION POTENTIAL PROPAGATION%GOBP%GO:0098870,0.5893095768374169,0.945418171231938,-0.525999448580094,-0.899693886067727,3968,2,CNTNAP1|SCN1B
RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0016601,0.280035335689046,0.788916642629372,-0.270295429275415,-1.13737207773301,1267,17,DBNL|RAC1|BRK1|CDH13
POSITIVE REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0045917,0.78829604130809,0.9819233677232551,-0.6028892809880899,-0.8065033731178441,5953,1,PHB
DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:0000729,0.36983509357050204,0.852479840097272,0.28171644170917604,1.07890862221615,3991,22,BLM|EXO1|DNA2|SLX1B|SMARCAD1|SLX4|EXD2|ATM|BRCA1|RAD52|SETMAR|UBE2V2|RBBP8|RAD50|NBN
DNA-TEMPLATED TRANSCRIPTIONAL OPEN COMPLEX FORMATION%GOBP%GO:0001112,0.724573125463994,0.972554563883587,-0.469864902122967,-0.8036787507268159,4879,2,GTF2E1|ERCC3
NEGATIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0045914,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
EPINEPHRINE TRANSPORT%GOBP%GO:0048241,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0045954,0.9989247311827959,1.0,-0.10787992495309599,-0.430234778594976,4644,15,KLRK1|SLAMF6|NCR3|RASGRP1|MICA|CADM1|HFE|MICB|PVR|HLA-E|AP1G1|PVRL2|LAMP1|ULBP3|ULBP2
CELLULAR RESPONSE TO COLD%GOBP%GO:0070417,0.0224931318681319,0.31540045468680394,-0.692701549357908,-1.75352797445063,130,5,DNAJC3|NFKBIA|EIF2AK3|FOXO1
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090026,0.9347014925373129,1.0,-0.169655172413793,-0.6180708112028299,4508,12,CCL5|CXCL10|MOSPD2|SERPINE1|CCR1|HMGB1|AIF1|LGMN|CXCL12|PLA2G7|CREB3|ANO6
GLOMERULAR EPITHELIUM DEVELOPMENT%GOBP%GO:0072010,0.8159756337197879,0.9866358717238399,0.225627598141587,0.711258821019889,8304,12,BASP1|PTPRO|MAGI2
PANCREATIC A CELL DIFFERENTIATION%GOBP%GO:0003310,0.0153581358400636,0.264745847609811,-0.992556241729157,-1.3277727473471999,115,1,INSM1
REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000050,0.852975270479135,0.991298302704726,0.20053037960607897,0.6799207163440661,8829,15,MLLT3|DACT1|NPHP3|GPC3|DAB2|CSNK1E|RNF213|NPHP3-ACAD11|SFRP4
DIVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0072511,0.685499196023973,0.966495577318169,0.146832331577302,0.878567323905168,9378,152,RYR2|CRACR2B|CACNA1G|GRIN3A|CACNB2|ATP2B1|TMEM165|NOL3|CACNA1I|SLC8A3|F2R|SLC39A3|PKD2|SLC35G1|IBTK|SLC30A5|ATP2A1|CDH23|NPY|CACNA1H|CACNA2D1|MRS2|CCR5|CACNA1D|CCL21|JPH4|MCOLN1|CCL5|ATP2B3|NALCN|SLC39A7|SLC40A1|GRIN1|NIPA1|CCL19|TRPM7|ATP2A2|PLCG1|SLC39A13
POSITIVE REGULATION OF CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002648,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1905515,0.29590513248100797,0.8006020093151399,0.298935802226031,1.14485477863489,3193,22,TMEM216|BBS10|TMEM80|VANGL2|FAM179B|BBS1|PCM1|TBC1D32|C2CD3|CEP250|PIBF1|ARL13B|BBS4|TTC8
REGULATION OF ENDORIBONUCLEASE ACTIVITY%GOBP%GO:0060699,0.897721916732129,0.998912093067348,-0.32299554070986697,-0.6555098532517111,5713,3,TMBIM6|NPM1
LENS MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0002089,0.22411941580756,0.7376076401408991,0.4995218356504779,1.22850120643555,2086,6,SHROOM2|PROX1
MULTI-ORGANISM MEMBRANE FUSION%GOBP%GO:0044800,0.5800336983993261,0.942746898746279,0.34716906916801604,0.903608146782379,5507,7,CXCR4|CCR5
GAMMA-AMINOBUTYRIC ACID SIGNALING PATHWAY%GOBP%GO:0007214,0.17557117750439402,0.678685257108795,-0.467453038558454,-1.28312720366675,998,6,GNAI2|GABRG2|GABRA3
REGULATION OF GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0042999,0.35785234899328905,0.8457817541997791,0.825981473312748,1.09727953764995,2665,1,GOPC
EPITHELIAL CELL PROLIFERATION INVOLVED IN RENAL TUBULE MORPHOGENESIS%GOBP%GO:2001013,0.635931700074239,0.95916055221954,-0.508078301626689,-0.869040723999165,4282,2,MEF2C|MTSS1
NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045347,0.9057718120805369,1.0,0.54923908248787,0.7296396177924691,6747,1,HDAC2
SPHINGOLIPID METABOLIC PROCESS%GOBP%GO:0006665,0.6364126250962281,0.9592476055325171,0.160255240689375,0.8985778667854899,8266,104,SPTSSB|B3GALT2|NSMAF|HACD1|FUT7|B4GALNT1|CERS4|ELOVL6|PPAP2C|B3GALT1|ST3GAL5|CERS6|CLN6|GBA2|ALDH3A2|B4GALT6|SMPDL3A|ST8SIA3|PDXDC1|ORMDL1|CERS5|SMPD3|ASAH1|B3GALNT1|ACER2|SMPD1|ARV1|PPM1L|ELOVL4|LARGE|PPP2R1A|SMPD4|TEX2|CERS2|ELOVL2|CPTP|B4GALT3|PRKD1|ARSA
MICROGLIAL CELL ACTIVATION%GOBP%GO:0001774,0.0997657165169856,0.570215774831708,-0.43793984258297897,-1.41370905658818,510,9,CLU|CX3CL1|ITGAM|SNCA|TNF
ATTACHMENT OF GPI ANCHOR TO PROTEIN%GOBP%GO:0016255,0.6890034364261172,0.96731875442989,0.33410627156682104,0.821685717027836,6415,6,PGAP1|PIGK|GPAA1|PIGU|PIGS
TRANSCRIPTION-DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY%GOBP%GO:0000972,0.7524699312714781,0.9769690538700708,0.313606530252055,0.771269588763867,7006,6,NUP107|LDB1|PCID2|NUP98|NUP155|RAE1
"MAPK PHOSPHATASE EXPORT FROM NUCLEUS, LEPTOMYCIN B SENSITIVE%GOBP%GO:0045209",0.23812080536912802,0.7507739897770379,0.8835465372739301,1.17375215696281,1773,1,DUSP16
PHOSPHOLIPID TRANSPORT%GOBP%GO:0015914,0.240323804705287,0.7525432574322471,0.24913065431130202,1.18661838489903,2849,48,ATP10A|ATP11C|SLMO1|STARD10|MFSD2A|ABCA7|ABCB4|SCARB1|ATP10D|CETP|OSBPL5|APOE|ATP8B3|PRELID2|OSBPL8|APOC1|LDLR
MEMBRANE PROTEIN PROTEOLYSIS%GOBP%GO:0033619,0.30317848410758,0.8055436753253159,-0.20884078905141898,-1.1056220561723797,1115,32,NFKB1|DAG1|APH1A|TGFB1|PSEN1|PSENEN|BACE2|APH1B|RELA|TRAF6|RHBDD1|PARL|ADAM10|RET|NCSTN|PSEN2|ADAM17|CTSH|MYH9
CYCLOOXYGENASE PATHWAY%GOBP%GO:0019371,0.326044129235619,0.826621597878865,-0.324381522295067,-1.0974312433454398,1654,10,PTGIS|AKR1C3|PTGES2|TBXAS1|CBR1|PTGES3|PTGDS|PTGS1|PTGES
CELLULAR RESPONSE TO SALT STRESS%GOBP%GO:0071472,0.632554945054945,0.958176387547329,-0.337940900433768,-0.855474949018002,3683,5,AQP1
PROTEIN UBIQUITINATION%GOBP%GO:0016567,0.982952608250937,1.0,0.0991037523578604,0.660331128441684,14414,388,SH3RF1|HIST1H2BJ|SIRT1|ENC1|HACE1|FANCL|UBE3D|FBXO18|TRIM5|SPSB4|SIAH2|WDR61|TRIM3|CDC34|BTRC|LMO7|ANAPC5|TRIM68|RNF34|HECTD2|KLHL42|UBE2Z|RNF208|TRIM27|KLHL3|ASB2|NHLRC3|THOP1|PCGF2|TSPAN17|MARCH7|DDB2|RNF182|TNFAIP1|BIRC6|DTL|DZIP3|FBXL19|RNF126|GAN|KLHL20|CDC23|TTC3|UBD|RNF111|RNF146|MIB2|ANAPC7|UBE2T|HLTF|CUL9|ANAPC16|UHRF1|FBXL15|PPIL2|KLHL25|CAND1|HUWE1|KLHL8|DDB1|RNF144A|TRIM37|SYVN1|FBXL8|RNF14|NFE2L2|KLHL22|DCAF15|UBE3B|FBXW5|TNKS2|HIST1H2BF|CCNF|PLK1|CUL4B|HECTD1|BIRC2|HERC2|KEAP1|HIST1H2BK|RNF40|CDC73|CHFR|RNF112|VIMP|UBE2C|FBXO9|CUL7|UNKL|RNF10|ANAPC10|TRIM23|KLHL12|KLHL9|KCTD13|TOPORS|TRAF2|PRKDC|UBE2B|UBE2H|MYCBP2|UBR2|TRIM24|RBX1|HIST1H2BN|FBXL7|SAE1|ANKIB1|RNF19A|AREL1|SKP2|MARCH5|TRIM21|VCP|ZNF738|PCGF1|MARCH6|ARRDC1|HIST1H2BG|RFWD3|PCGF3|ASB1|ZFP91|UBR3|CDC16|BRCA1|UBE2O|HIST1H2BH|ANAPC2|TRPC4AP|PDZD4|RC3H1|TRIM56|FBXO44|UBA6|NEURL1|FBXO11|MDM2|UBA1|PINK1|SMURF2|UBE2E3|TRIM69|SHARPIN|UBR5|RNF8|TAF1|CBL|PEX2|ANAPC4|FBXO41|MAGEF1|WSB1|UBE2V2|TMEM189-UBE2V1|UBE2R2|UHRF2|PEX14|RCHY1|PEX12|FBXO10
TRAM-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035668,0.950405225595742,1.0,0.393624952743464,0.643369171749176,7856,2,TICAM2|PRKCE
NEURON PROJECTION ORGANIZATION%GOBP%GO:0106027,0.456186935740839,0.88900512246363,-0.18871384818532103,-0.9923583159499821,1717,31,MTMR2|IGF1R|FYN|PRNP|CHRNA7|ARC|CDC42|ZNF365|EPHB2
POSITIVE REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060252,0.0183722527472527,0.285037997475661,-0.703673064195897,-1.7813016357169398,106,5,PRKCI|PRKCH|IL1B|IL6|TNF
TELOMERE-TELOMERASE COMPLEX ASSEMBLY%GOBP%GO:1905324,0.631140939597315,0.9575013258325501,0.6890163211292459,0.915327443422818,4701,1,ACD
POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905332,0.453224522292994,0.8877077061560501,0.330735032617485,1.00899677041243,4553,11,BMP4|SIRT6|AHI1
MAMMALIAN OOGENESIS STAGE%GOBP%GO:0022605,0.0966493286561026,0.5694769293867491,0.8097601323407769,1.32353069089886,798,2,ZNF830|BMPR1B
MINERALOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0006705,0.0361678964557881,0.38395931615660706,0.878191342707472,1.43537962432791,298,2,CYP21A2|CACNA1H
MITOCHONDRIAL FUSION%GOBP%GO:0008053,0.0458836443468716,0.42075251053629,-0.3861817780475689,-1.5815441731206799,208,16,USP30|MFN1|STOML2|FAM73B|GDAP1|MFF|FIS1|AFG3L2|OPA1|MIEF2|BAX|MFN2|FAM73A|CHCHD3|PLD6|MIEF1
"BASE-EXCISION REPAIR, AP SITE FORMATION VIA DEAMINATED BASE REMOVAL%GOBP%GO:0097510",0.8542281879194631,0.991298302704726,0.573886193206881,0.762382204797111,6363,1,UNG
VASCULAR PROCESS IN CIRCULATORY SYSTEM%GOBP%GO:0003018,0.00248844649840028,0.12586582153175,-0.29158832673635104,-1.8651429554149899,6,60,DOCK5|C2CD4A|YES1|VIP|SOD2|SERPINF2|RAMP2|EDNRA|ADRB2|NOS3|ADCYAP1|BDKRB2|PER2|ACE|ADM|PDE3A|CAV1|DDAH1
PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:0071108,0.283745247148289,0.7932053053075551,-0.245108077671882,-1.13552209350393,1193,22,YOD1|USP8|OTUD7B|OTUD5|OTUD7A|USP5|VCPIP1|TNFAIP3|BAP1|USP27X
CELLULAR LIPID CATABOLIC PROCESS%GOBP%GO:0044242,0.0570889894419306,0.465052018764296,0.24069048154918998,1.3851970821735902,756,120,ENPP2|CROT|GLYATL2|LPL|SLC27A2|ETFDH|BCO2|FABP5|HSD17B4|ACADVL|BDH2|PLA2G4A|ETFA|DECR2|ABHD3|AMACR|PNPLA6|ACADM|SRD5A3|DECR1|FABP6|AIG1|ALDH3A2|HADH|ETFB|PNPLA2|APOE|ACOX2|SMPDL3A|MGST2|ECHDC2|MCEE|PDXDC1|SMPD3|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|SMPD1|FAAH|AOAH|ECI1|ECI2|HADHB|ACAT2|HIBCH|PLA2G4B|ABHD2|DAGLA|ACADS|SMPD4|PCK2
COPII-COATED VESICLE BUDDING%GOBP%GO:0090114,0.900473933649289,0.998912093067348,-0.11267963772330901,-0.734115267495575,2469,64,TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|VAPB|ANKRD28
NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0009164,0.007731336071514859,0.198167223413272,-0.39934259009229495,-1.87647743659827,31,23,ENTPD4|DERA|PNP|CDA|HPRT1|NUDT18|CDADC1|UPP1|NT5E|ENPP4
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905065,0.6464371322728261,0.963344312748158,0.371966795672502,0.857328323108833,5932,5,CTH|KIT
PHYTOSPHINGOSINE METABOLIC PROCESS%GOBP%GO:0006671,0.146961472262677,0.638549298625996,-0.9235774150860171,-1.23549766779988,1109,1,ACER3
REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:1902816,0.269636228656273,0.784543299601953,-0.6969396195202651,-1.19207789349093,1815,2,TTBK2|MAP1A
GASTRIC ACID SECRETION%GOBP%GO:0001696,0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
"DNA REPLICATION, SYNTHESIS OF RNA PRIMER%GOBP%GO:0006269",0.305891594658288,0.809555201431097,-0.551781184515275,-1.1198235198347901,1946,3,POLA1|HELB|PRIM1
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002717,0.9989247311827959,1.0,-0.10787992495309599,-0.430234778594976,4644,15,KLRK1|SLAMF6|NCR3|RASGRP1|MICA|CADM1|HFE|MICB|PVR|HLA-E|AP1G1|PVRL2|LAMP1|ULBP3|ULBP2
POSITIVE REGULATION OF NEURON DEATH%GOBP%GO:1901216,0.007838745800671891,0.19847993048827997,-0.323423984485336,-1.77912041478928,27,36,CDK5|ATF4|BAX|FBXW7|PICALM|CLU|EIF2S1|CTNNB1|ITGAM|DDIT4|FYN|DDIT3|FCGR2B|PRNP|SNCA|DKK1|EPHA7|FOXO3
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 SIGNALING PATHWAY%GOBP%GO:0036323,0.0853965311796637,0.547991507542111,-0.955943978826643,-1.27879540696397,644,1,FLT1
DICARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0043650,0.13486534262243902,0.622258254449182,0.492874406294656,1.34370786162781,1296,8,GLS|GLS2|MTHFD1
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0098970,0.277328646748682,0.7884684708511421,-0.41768604362807504,-1.1465201441922,1577,6,CACNG3|CACNG7
SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION%GOBP%GO:0000393,0.40470467032967,0.865820184127331,-0.404671013194885,-1.02439779836536,2356,5,PRPF19|ISY1|PRPF18
PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903441,0.6402695871946079,0.960810495970452,0.328584512227148,0.855236449682884,6079,7,TUB|BBIP1|RABEP1|RAB29|ARL13B|ARL3
REPLACEMENT OSSIFICATION%GOBP%GO:0036075,0.948083403538332,1.0,0.221395728636853,0.576246566373292,9002,7,BMP4|SCX|COL13A1|MEF2C|INPPL1
REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051900,0.9901578458681519,1.0,-0.160123203037356,-0.497732633873188,5331,8,DCN|ABCD1|GNB2L1|MLLT11|IFI6|KDR|BCL2
MAST CELL CHEMOTAXIS%GOBP%GO:0002551,0.9572768322334151,1.0,0.30750134038612,0.584527700147194,8267,3,KIT|CHGA
POSITIVE REGULATION OF HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:1904828,0.678255033557047,0.9647315640607691,0.665527128363476,0.884123098760677,5052,1,SP1
PROTEIN DEPOLYMERIZATION%GOBP%GO:0051261,0.41174361272971793,0.867015886388254,0.251106093032479,1.0401659955731701,4592,29,NCKAP5|KIF14|KIF2C|CCSAP|KIF18A|CKAP5|KIF24|KIF18B|STMN1|MICAL3
FOREBRAIN NEURON DEVELOPMENT%GOBP%GO:0021884,0.450748620961387,0.88620227509476,-0.292205402256195,-0.988574613132784,2287,10,DRD2|SLIT3
POSITIVE REGULATION OF IP-10 PRODUCTION%GOBP%GO:0071660,0.209056004236727,0.7243363294845151,-0.8939126599029559,-1.1958142203207,1578,1,MAVS
ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE%GOBP%GO:0002251,0.933582236195716,1.0,0.18616536976392803,0.586859774706866,9501,12,HIST1H2BJ|HIST1H2BF|HIST1H2BK|HIST1H2BG|HIST2H2BE|IFNLR1
REGULATION OF GRANZYME B PRODUCTION%GOBP%GO:0071661,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
REGULATION OF MICROVILLUS ORGANIZATION%GOBP%GO:0032530,0.93955349620893,1.0,0.22531676079343502,0.58645218926756,8921,7,CDHR2|RAP1GAP|PLD1
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902962,0.982182628062361,1.0,-0.316129032258065,-0.5407217788894301,6614,2,SORL1|PICALM
REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000668,0.8898739164696609,0.997300970905927,-0.195192446782658,-0.660365263868139,4516,10,CCR7|LILRB1|AXL|RAPGEF2|GAS6|CXCL12|LGALS9|LYN
NEGATIVE REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045629,0.48403860430586504,0.9064456896937672,-0.5703808828471569,-0.975605952463958,3259,2,SOCS5
NEGATIVE REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033624,0.11406798112979302,0.59052198671163,0.7953605774288571,1.29999501397424,942,2,KIF14|PTGER4
MRNA 5'-SPLICE SITE RECOGNITION%GOBP%GO:0000395,0.214616680707666,0.731747191309112,0.476613348041919,1.24052440843305,2037,7,SFSWAP|PRPF39|SRSF1|PSIP1|SRSF10|SRSF12|SNRPC
REGULATION OF RNA BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:1905255,0.943892617449665,1.0,0.5309329510366121,0.7053207388538991,7031,1,NUCKS1
NUCLEAR EXPORT%GOBP%GO:0051168,0.827387971698113,0.9876441563834109,0.131780591620583,0.782546601346855,11225,145,RANBP17|EGR2|NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|RITA1|THOC1|NUP133|NXF2B|DUSP16|CCHCR1|UPF3B|WDR33|CPSF1|STRADA|SRSF1|NUP205|STRADB|ANKLE1|NUP188|NUP160|ABCE1|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|RANBP3|CSE1L|CPSF2|DDX39B|XPO6|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|XPOT|UPF2|XPO4|U2AF2|NEMF|RPSA|XPO5|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
GERM-LINE STEM CELL DIVISION%GOBP%GO:0042078,0.511275167785235,0.918404893008545,0.748180414644905,0.993924302161029,3808,1,ING2
POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033034,0.381980240549828,0.857178152269066,0.43680648083866,1.07426192488738,3556,6,SIRT1|CDKN2A|ANXA1|MEF2C|PIK3CB
POSITIVE REGULATION OF CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1905312,0.93503355704698,1.0,0.535399205999118,0.7112539593178271,6965,1,SEMA3C
BIOTIN TRANSPORT%GOBP%GO:0015878,0.48,0.9046812288131709,0.764005293339215,1.01494694750853,3575,1,SLC5A6
INTRA-GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006891,0.17391304347826098,0.676682497340677,-0.245619987463617,-1.2419150326316999,675,28,COPZ1|GOSR2|COG8|VTI1B|COG3|RAB33B|COG5|RAB6A|NAPA|COPA|TRAPPC10|VTI1A|GABARAPL2
SMOOTH MUSCLE ADAPTATION%GOBP%GO:0014805,0.0192656018442286,0.289864965388082,-0.751006452324491,-1.72715794960288,116,4,CYBA|IL1B|HMOX1|NOS3
THORAX AND ANTERIOR ABDOMEN DETERMINATION%GOBP%GO:0007356,0.102281879194631,0.573450707099996,0.9485553595059549,1.2601134770488798,761,1,BASP1
PLACENTA BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060674,0.798066783831283,0.9835585148939309,-0.269446214271719,-0.7396117661856451,4540,6,RBPJ
NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048712,0.532885906040268,0.9265056012720759,0.736656374062638,0.9786151283713871,3969,1,LDLR
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051968",0.0580168776371308,0.470297361991446,-0.393608964537849,-1.52494533171451,274,14,RELN|ADCYAP1|CACNG3|CACNG7
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, WAKEFULNESS%GOBP%GO:0010840",0.174632596319343,0.677040796053356,-0.910123511248346,-1.21749997043014,1318,1,CRH
GLUTAMATE HOMEOSTASIS%GOBP%GO:0090461,0.8911409395973149,0.997300970905927,0.5556352007057789,0.7381365754938969,6638,1,KCTD7
REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0061178,0.816110108303249,0.9866358717238399,-0.17052472911467298,-0.747831632906292,3616,19,PIM3|LRP5|C2CD2L|STXBP4|ANO1|ADRA2A|NR1D1
DOLICHOL METABOLIC PROCESS%GOBP%GO:0019348,0.864811460563148,0.992663057831044,-0.30009338567680394,-0.690152095352422,5251,4,DPM1|DPM2
RESPONSE TO CARBON MONOXIDE%GOBP%GO:0034465,0.619463087248322,0.9532238181782521,0.694640494044993,0.922798906229247,4614,1,KCNMA1
REGULATION OF HEART LOOPING%GOBP%GO:1901207,0.310027821458812,0.812657605441499,0.6826027019575409,1.11569536415642,2562,2,TBX2|RNF207
RESPONSE TO HYDROPEROXIDE%GOBP%GO:0033194,0.24722949828732602,0.7594820480683381,0.40856022844270296,1.2057667862903898,2453,10,MGST1|STX2|RNF112|XRCC1|SP1|PRKD1|GPX3
GENE SILENCING%GOBP%GO:0016458,0.496062992125984,0.911504921234493,0.174514874822774,0.989950485181617,6488,111,LIN28B|SIRT4|HIST1H3E|SIRT1|MBD3|ZCCHC11|RRP8|CELF1|PIWIL4|DOT1L|DHX9|HIST2H3C|HIST2H3A|PCGF2|DROSHA|TERT|HIST1H4I|TNRC6A|HELLS|C9orf114|H3F3A|METTL3|SRRT|SCMH1|NRDE2|TNRC6C|AJUBA|HNRNPA2B1|DICER1|KMT2D|RIF1|DGCR8|EED|HIST1H3H|UBR2|HIRA|TARBP2|MBD1|ZCCHC6|PCGF1|CNOT1|RBM4|PPM1D|PIWIL2
TUBULIN COMPLEX ASSEMBLY%GOBP%GO:0007021,0.8966346153846151,0.998912093067348,-0.26136112949481605,-0.661618344044407,5221,5,TBCD|VBP1|TBCC|ARL2|TCP1
PROTEIN TRANS-AUTOPHOSPHORYLATION%GOBP%GO:0036290,0.20416107382550303,0.720304973077154,0.899867666519629,1.19543404902852,1520,1,ERN1
POSITIVE REGULATION OF PLATELET AGGREGATION%GOBP%GO:1901731,0.353377876763177,0.842847021021096,-0.6472566859663629,-1.1070978964947,2379,2,DMTN|PDPN
ICOSANOID TRANSPORT%GOBP%GO:0071715,0.0443186255368996,0.41504430757275895,-0.49823752027079204,-1.6083553635688999,226,9,ABCC4|DRD2|BDKRB2|ACE
EXOCYTIC PROCESS%GOBP%GO:0140029,0.22179675994109002,0.73556947110949,-0.207744430452286,-1.18146468463997,752,40,RAB10|RAB3C|VTI1B|RAB3D|RAB8B|VPS18|RABEPK|VPS11|STX11|VAMP3|YKT6|RAB8A|BLOC1S6|SNPH|SNAP25
POSITIVE REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000758,0.18769831584085897,0.694475381733796,-0.256124162101783,-1.2277214343545702,768,24,IL1B|WBP2|PRKAA1|LIF|ARRB1|RUVBL2|PPARGC1A|TADA2B|MAPK3
FUMARATE METABOLIC PROCESS%GOBP%GO:0006106,0.0695302013422819,0.506371884093901,0.966254962505514,1.28362660999852,517,1,FH
BASAL DENDRITE DEVELOPMENT%GOBP%GO:0150018,0.311861743912019,0.8143712300420921,-0.548859102404894,-1.11389324101064,1984,3,NRP1|SEMA3A
JNK CASCADE%GOBP%GO:0007254,0.744897959183674,0.9749763305090959,-0.132600870150354,-0.8420068858650529,2116,58,TRAF6|UBE2N|MUL1|CRKL|NOD1|IRAK1|PKN1|DAB2IP|TRIB1|IRAK2|MAP3K13|UBE2V1|RIPK2|DBNL|MLKL|UBA52|MAP3K11|UBC|UBB|ADORA2B
REGULATION OF CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:1901219,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
CYSTEINE CATABOLIC PROCESS%GOBP%GO:0009093,0.8257659073055771,0.9876441563834109,-0.354533784720133,-0.7195157824281629,5255,3,CSAD|CBS
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051058,0.659562690285082,0.9643779777660141,-0.16160858377104503,-0.869597502011759,2382,34,FLCN|STAMBP|MAPKAP1|HEG1|DAB2IP|DLC1|FBP1|MFN2|MET|SH3BP1|EPHB2
UREA METABOLIC PROCESS%GOBP%GO:0019627,0.22442882249560603,0.738039263175087,-0.44081447912733,-1.21000614667678,1276,6,ASS1|SLC25A15|ASL
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030949,0.0902301170771094,0.560121322881739,-0.406659519782008,-1.4310855155323001,446,11,GRB10|HIF1A|IL1B|VEGFA|PRKD2|ITGA5|FLT1
ISOQUINOLINE ALKALOID METABOLIC PROCESS%GOBP%GO:0033076,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
SYNAPTONEMAL COMPLEX ASSEMBLY%GOBP%GO:0007130,0.475568660488627,0.9014412940771601,0.380035044333383,0.98915137499261,4515,7,SYCP2|BAG6|STAG3|P3H4|SYCE2|TRIP13
REGULATION OF SUMO TRANSFERASE ACTIVITY%GOBP%GO:1903182,0.279359195021846,0.788692060817727,-0.860222761358624,-1.15074621584155,2109,1,UBE2I
REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1903789,0.79986560645089,0.9839175016931591,0.35335482813218805,0.748792635023966,7141,4,STK39|ARL6IP5|ARL6IP1
ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002250,0.7156361382302808,0.971081608033886,0.152736253051013,0.8458878775054129,9235,97,IGHV3-21|IGKV4-1|IGHV4-61|CXCL13|IGHG1|CD27|IGLL5|LIG4|IGHG4|IL18BP|EXO1|SLAMF6|IGHV1-18|RORA|IGHV3-43|EBI3|IGKV3-11|ZP3|LEF1|MSH6|IGKV2D-28|JCHAIN
NEGATIVE REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031441,0.639203436157751,0.960516115253472,-0.264507943512798,-0.8538553447844941,3273,9,ZC3H14|RNF40|CTR9|BARD1|CCNT1|SUPT5H|RNF20|CDK9|NELFE
POSITIVE REGULATION OF NEURONAL ACTION POTENTIAL%GOBP%GO:1904457,0.522573811730438,0.9251240799994541,-0.734395677106308,-0.9824234888015879,3946,1,GBA
RESPONSE TO GLUCOSE%GOBP%GO:0009749,0.5695610769630339,0.940076901516441,0.205712661078952,0.921548967072351,6578,38,LPL|PRKAA2|UNC13B|AGER|ADCY8|ERN1|EIF2B5|EIF2B1|GCK|EIF2B4
REGULATION OF ANGIOTENSIN METABOLIC PROCESS%GOBP%GO:0060177,0.0591817820733483,0.475550457504474,-0.970280105866784,-1.2979732812104199,446,1,ACE
POSITIVE REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR SECRETION%GOBP%GO:1900168,0.275278396436526,0.7884684708511421,-0.6940170940170939,-1.18707907013821,1853,2,CD34|DRD2
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0043162,0.6168936291781739,0.9520939168601509,0.24639285166962302,0.883861391299696,6477,18,UBAP1L|RNF126|VPS36|TSG101|VPS37A|MVB12B|MVB12A|PLAA|SNF8
PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006164,0.718075262183837,0.971081608033886,-0.114337166636401,-0.88505038768286,1163,127,LDHA|PAPSS1|SCD|ADCY7|ACSL1|PFKL|COX5B|GPI|GMPS|GUCY1A3|PRPS1|PKM|ENO1|ACSL4|HPRT1|ATP5I|PRPSAP1|PDHB|GAPDH|PGK1|PANK2|CYC1|HK1|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900181,0.12172043010752698,0.607607158836689,-0.339216033959713,-1.35282384864446,565,15,GSK3B|POLR1A|GAS6|MFHAS1|OTUD7B|FLCN|SIN3A|APOD|CHP1|CABP1
NEGATIVE REGULATION OF EPITHELIUM REGENERATION%GOBP%GO:1905042,0.06130014563749501,0.48227634769717603,-0.968405381561535,-1.29546540534742,462,1,DUSP10
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902166,0.27996491911908,0.788916642629372,0.35287830647542295,1.16919548873095,2872,14,SIRT1|AK6|MARCH7|MUC1|ING2|KDM1A
NEGATIVE REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0098736,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0086011,0.514003626838606,0.920459998277914,0.325254460773677,0.9599099437274,5101,10,KCNN2|KCNQ1|KCNH2
POSITIVE REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000243,0.00945508833043046,0.21235063347774397,-0.37133861962157105,-1.80146442738432,37,25,CITED2|C1QBP|VIP|CDC25B|AGO2|PLCB1|CFAP69|POMZP3|PDE3A|INHBB
MESENCHYMAL-EPITHELIAL CELL SIGNALING%GOBP%GO:0060638,0.25632199126175004,0.767319904137432,-0.8725738861932071,-1.16726869211541,1935,1,HGF
NEGATIVE REGULATION OF CELL MOTILITY%GOBP%GO:2000146,0.20680851063829803,0.7211951452265429,-0.136815726410209,-1.12666746809294,242,178,CX3CL1|PTPRG|DAB2IP|STK26|TRIB1|HMOX1|DLC1|PTPRU|SRGAP2C|SPOCK3|MMRN2|IGFBP3|CITED2|RHOA|MITF|HDAC5|CLIC4|APOD|FGF2|MAP2K5|ADAMTS9|PPARG|LDLRAD4|MEOX2|CRK|PDCD10|WNT11|SMAD7|ARPIN|DUSP3|DRD2|GREM1|SFRP2|PTPRM|ACVRL1|DUSP10|STK24|TMEFF2|IFITM1|CORO1C|MCTP1|PLCB1|NBL1|STC1|ANGPT2|FOXO3
SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:0061669,0.056241610738255,0.46132606014672706,0.9719342743714158,1.2911713224403,418,1,RIMS2
RETINAL CONE CELL DEVELOPMENT%GOBP%GO:0046549,0.9940608760207871,1.0,-0.297325613454646,-0.508559538072878,6694,2,TOPORS|THY1
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I ASSEMBLY%GOBP%GO:0032981,0.895423770291215,0.9981901628831992,0.134952984478627,0.6866597680101719,10976,64,NDUFA7|NDUFS7|NDUFB11|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|TAZ|NDUFA11|NDUFS8|NDUFB2|BCS1L|MT-ND2|NDUFV1|NDUFS3|NDUFB7|NDUFA12|OXA1L|ECSIT|TIMM21|ACAD9|NDUFB1|TMEM126B|NDUFB3|NDUFA1|NDUFB6|NDUFAF7|MT-ND3|FOXRED1|C17orf89
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002437,0.32760989010989006,0.828303707528737,-0.4332671519964699,-1.09678702486028,1907,5,HMGB2|HMGB1|CD6|PNMA1|TNF
ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0001714,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030811,0.6949757714868661,0.96731875442989,-0.169245670655751,-0.8433845269653459,2724,27,EIF6|HIF1A|CBFA2T3|PRKAA1|PFKFB4|PRKAG1|HDAC4|FBP1|PPARA|IGF1|AAED1
FLAVIN ADENINE DINUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0072389,0.6985234899328859,0.96731875442989,0.6546096162329069,0.8696196709599631,5203,1,VCP
VITAMIN D3 METABOLIC PROCESS%GOBP%GO:0070640,0.838791946308725,0.989395884107905,0.581219673577415,0.77212440629961,6248,1,CYP27B1
CELLULAR RESPONSE TO LEUCINE%GOBP%GO:0071233,0.7803388494877859,0.981487311948134,-0.22276162630330398,-0.7536359247408471,3960,10,KLHL22|UBR2|LARS|MTOR|SESN1|SESN3|RPTOR|UBR1|RRAGD|SESN2
MEIOTIC CHROMOSOME SEPARATION%GOBP%GO:0051307,0.000687420210154179,0.0806484601749226,0.6312488353276899,2.03727462774222,6,13,MUS81|EME2|BLM|TOP2A|ESPL1|FANCM|SLX4|EME1|RMI1|STRA13|TOP2B
CEREBELLAR CORTEX DEVELOPMENT%GOBP%GO:0021695,0.156970362239297,0.6578589353509621,-0.314343887550037,-1.2873438675027902,714,16,TTBK2|CLP1|DLL1|OPHN1|AARS|ADCK4|FAIM2|CBLN1|ZNF365|TRNP1
REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902510,0.854988216810683,0.991298302704726,-0.34277370267051505,-0.6956490453158471,5441,3,BAX|DFFA
POSITIVE REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050716,0.681537102473498,0.965271928233355,-0.19834884638785102,-0.834629132045833,3085,17,PANX1|RIPK2|NLRP1|NLRP3
POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120034,0.939079349750523,1.0,0.122977961513709,0.642113638860396,11668,72,TENM1|WASH1|ARAP1|C15orf62|FNBP1L|TENM2|CROCC|CCL21|F2RL1|ANLN|APC|WRAP73|HRAS|PALM|CCL19|DPYSL3|RAC2|CDC42EP1|DEF8|MIEN1|CEP135|AGRN
TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:0097050,0.08673037377525099,0.552202694227509,0.817535153019024,1.33623874860515,716,2,RYR2|CAPN10
NEGATIVE REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046325,0.740212912087912,0.974456759704921,-0.308202296382831,-0.7801936476079421,4310,5,PEA15
REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051140,0.8711358110455021,0.9934031064448321,0.367934522590859,0.699404822186261,7523,3,RASAL3|ZBTB7B|IL18
REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000015,0.0865627319970304,0.5515834569460639,-0.8228839261097328,-1.40749888476661,582,2,ACVR1|DDIT3
KUPFFER'S VESICLE DEVELOPMENT%GOBP%GO:0070121,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0045880,0.7429519071310121,0.974505008828563,-0.21474657646775,-0.7823433192872231,3583,12,GAS8|STK36|TUBD1|RAB34|ULK3|SMO|SFRP1|NDST1|PDCL|EVC|KIF7
RIBOSOME LOCALIZATION%GOBP%GO:0033750,0.10188835858061801,0.572767517465588,-0.370700293729656,-1.39605022048293,490,13,PA2G4|NMD3|ZNF593|NPM1|RRS1
PURINE RIBONUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0034035,0.965253182731885,1.0,0.15336115012680201,0.5316615174949351,10083,16,SLC35B3|SLC26A2|SULT1A3|PAPSS2|SLC35B2|SULT1A4|BPNT1|IMPAD1|ABHD14B|TPST2
MONOUNSATURATED FATTY ACID METABOLIC PROCESS%GOBP%GO:1903964,0.0781521361583883,0.5317491893669141,0.7346636545037439,1.39651832349603,674,3,GLYATL2|SCD5
CELL CHEMOTAXIS TO VASCULAR ENDOTHELIAL GROWTH FACTOR%GOBP%GO:0090667,0.8044295302013421,0.984565623358542,0.59886413762682,0.7955642896138949,5992,1,GAB1
NEGATIVE REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904534,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032623,0.24847686481146106,0.7613646381106121,-0.514978625855559,-1.1843432566644398,1508,4,PNP|SLC11A1
DNA REPLICATION PROOFREADING%GOBP%GO:0045004,0.0518930688278698,0.44586532408291796,0.856355114419631,1.39968890906771,428,2,POLE|POLD1
REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0000820,0.640691280439906,0.96102887115448,-0.42185938434782705,-0.8561510865411569,4077,3,SLC7A7|ATP2B4
CENTROSOME CYCLE%GOBP%GO:0007098,0.0273573452043707,0.339785941813865,0.29708885167409804,1.5362920164743603,337,69,CNTLN|CEP63|CENPJ|CDK1|PKD2|WDR62|CKAP5|CEP152|CROCC|NEK2|STIL|HAUS5|CDK5RAP2|CETN3|CEP72|TUBE1|HAUS8|SASS6|CNTROB|SYNE2|PLK1|RTTN|BRSK1|PPP1R12A|BRCA2|XRCC2|CEP135|PCM1|SGOL1|CHD3|CDK2|CEP120|UXT|C2CD3|NDE1|CEP250
POSITIVE REGULATION OF IMMUNE RESPONSE%GOBP%GO:0050778,0.07423580786026202,0.5224901036862729,-0.12445578588764901,-1.18333402663743,16,448,ITK|FPR1|IL6ST|IGHV5-51|PLSCR1|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|MFHAS1|CTSS|RPS6KA3|SCARA3|ARPC1B|UBE2N|TNFSF13|PIK3CD|CYBA|TLR1|CREBBP|FLOT1|CD86|CD79B|IL6R|PYCARD|PIK3R2|RIOK3|PJA2|THY1|POLR3C|XRCC6|MYO10|ITCH|BAX|MYO1G|HEXIM1|NOD1|PPAPDC1A|PVRL2|BLK|IGHV4-4|CD274|EIF2B3|PRKCH|ICOSLG|IL1B|RARA|CLU|FAM49B|IRAK1|SIN3A|POLR3D|FCER1G|PIK3C3|DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|LGALS9|BCAR1|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|NR1H3|PRKD2|IRAK4|LAMP1|GRB2|FGR|ABL1|VAV1|MYO1C|NFAM1|ULBP3|RPS3|TRAF3|IGHV1-69-2|CYFIP2|S100A8|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|C20orf196|BCL10|UBE2V1|SEMA7A|RELB|IL6|LYN|FCGR2B|CYLD|TANK|ARPC5|SLC11A1|RNF31|CD276|YES1|MAVS|CNPY3|TNIP1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CFD|KARS|CDC42|PDE4B|MUC3A|TFRC|RFTN1|IGHV1-3|ULBP2|KRAS|NLRP3|BCL2|UBA52|WDFY1|NFATC2|COLEC12|GAB2|SOCS5|B2M|RBCK1|MAPK3|HLA-DQA2|TNIP2|HLA-DQB2|RAC1|PLD2|TICAM1|MUC12|MYD88|ACTR2|BRK1|UBC|CD36|GPRC5B|PIK3R1|HSP90AB1|UBE2K|PDE4D|TNFRSF21|CAV1|PAK2|UBB
DEOXYRIBOSE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019692,0.9054491166956959,1.0,-0.137635451519862,-0.667706930436403,3638,25,NUDT1|AK9|NUDT15|CMPK2|SMUG1|DCTD|NUDT18|CDADC1|NEIL2
CHITIN METABOLIC PROCESS%GOBP%GO:0006030,0.75962293794187,0.977664504547119,-0.37828052886863106,-0.7677090941307869,4834,3,CTBS|CHIT1
PHOSPHATIDYLINOSITOL 5-PHOSPHATE METABOLIC PROCESS%GOBP%GO:1904562,0.7737994435708241,0.980106507455175,0.49671905155776097,0.811873644100577,6396,2,PIKFYVE|MTMR3
NEGATIVE REGULATION OF IRON ION TRANSPORT%GOBP%GO:0034757,0.8550335570469799,0.991298302704726,0.5735553595059549,0.761942706984968,6369,1,HAMP
MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032762,0.793153501874924,0.9819233677232551,0.48927488282327003,0.799706354807329,6556,2,KIT|CHGA
SPERMINE METABOLIC PROCESS%GOBP%GO:0008215,0.25394917582417603,0.7641083395392759,-0.46412236910070703,-1.17489495806785,1478,5,AMD1|SMS|SMOX
REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032386,0.00143266475644699,0.0961252072968491,-0.176910062743882,-1.57835403163709,0,267,RINT1|PLK3|BCAS3|RAB21|PRKCD|TMEM30A|UBE2J1|LGALS9|ITGAM|UBL5|OS9|PARL|LAMP1|FGR|TCTEX1D2|NAPB|MYO1C|ATG13|STX18|SYN1|DNAJC30|VPS18|FYN|FAM65A|BAG4|ARHGAP1|PLN|INPP5K|ICE1|TCF7L2|UHMK1|VPS11|RNF139|MX2|TBC1D20|APOD|GCC2|EHD1|CSNK2A2|LYN|PRNP|CHP1|NAPA|VAMP2|SH3GLB1|RNF31|MIEF1|HAP1|VAMP3|IGF1|MAVS|CEMIP|BAP1|LEPROT|ZPR1|PDCD10|PTPN1|FMR1|EHD2|NEFH|MSN|NEDD4|BAG3|TP53|SNX6|GAB2|RANGAP1|UBE2L3|YWHAE|UBE2D3|SEC23A|SIAH3|MAPK3|NCBP2|CABP1|ARIH2|PARK2|RAB5A|MAP2K1|BCAP31|PIK3R1|SNX12
ESCRT COMPLEX ASSEMBLY%GOBP%GO:1904895,0.9664429530201339,1.0,0.51896779885311,0.6894255679814001,7199,1,CHMP6
GAMMA-AMINOBUTYRIC ACID RECEPTOR CLUSTERING%GOBP%GO:0097112,0.244828837546873,0.757467559003634,0.711964142128752,1.16368583151032,2023,2,GPHN|LHFPL4
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045824,0.972702943800178,1.0,0.126117524959355,0.5288021105121721,10903,30,CEACAM1|INS|TYRO3|TRAFD1|RPS19|NLRC3|CACTIN|FAM3A
ACTIVATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0002218,0.0105960264900662,0.224399993225047,-0.19045673199600802,-1.50416258688116,15,138,RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|UBE2N|TLR1|CREBBP|PYCARD|XRCC6|ITCH|HEXIM1|NOD1|IRAK1|SIN3A|FCER1G|PIK3C3|PRKCD|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|IRAK4|TRAF3|S100A8|FYN|BCL10|UBE2V1|RELB|LYN|CYLD|TANK|MAVS|CNPY3|TNIP1|RIPK2|MUC4|MUC3A|RFTN1|KRAS|UBA52|COLEC12|TNIP2|TICAM1|MUC12|MYD88|UBC|CD36|PAK2|UBB
ACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0006639,0.154065169250237,0.6523838578248989,-0.20804330743607,-1.24256838760662,486,47,SLC27A5|MGLL|DGKQ|FABP4|LPIN1|PNPLA4|DGAT2|DGKG|DGKB|GPAT2|DGKK|CAV1|FABP3
CARDIAC CHAMBER FORMATION%GOBP%GO:0003207,0.0788231020704686,0.532203813468543,-0.508218422504137,-1.4824956860450802,433,7,MEF2C|SOX11|SOX4|MESP1|HAND1|NOTCH1|TBX20
POSTTRANSCRIPTIONAL GENE SILENCING BY RNA%GOBP%GO:0035194,0.8513581069821701,0.991298302704726,0.146935751077481,0.7166535307224101,10217,53,LIN28B|ZCCHC11|CELF1|DHX9|DROSHA|TERT|TNRC6A|C9orf114|METTL3|SRRT|NRDE2|TNRC6C|AJUBA|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6|CNOT1|RBM4|ZC3H7A|XPO5|AGO4|CNOT8|WTIP
REGULATION OF WNT-FRIZZLED-LRP5/6 COMPLEX ASSEMBLY%GOBP%GO:1904711,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
URACIL METABOLIC PROCESS%GOBP%GO:0019860,0.930872483221476,1.0,0.537163652404058,0.713597947649256,6934,1,DPYD
NEGATIVE REGUATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106119,0.9812595336674659,1.0,0.220604456210015,0.508460568828268,9005,5,APOE|ERLIN1|SCAP|ERLIN2|SOD1
NEGATIVE REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033128,0.0188567186340015,0.286396032442422,-0.9086603118989242,-1.55421479876965,126,2,TWIST1
REGULATION OF ROOT MORPHOGENESIS%GOBP%GO:2000067,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
REGULATION OF MESODERM FORMATION%GOBP%GO:1905902,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
NEGATIVE REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000483,0.917398945518453,1.0,-0.22982736749214103,-0.630860691986722,5219,6,MAPKBP1|PTPN22|ANXA1|ANXA4|SSC5D|TMSB4X
POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030813,0.9035647648040849,1.0,0.193927714471585,0.6258768178224079,9200,13,PRKAA2|INS
NEGATIVE REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060283,0.209982788296041,0.7248363921442859,-0.893581826202029,-1.19537165399193,1585,1,IGF1
ITP METABOLIC PROCESS%GOBP%GO:0046041,0.306845637583893,0.8099570615280279,0.850463167181297,1.12980237574852,2285,1,AK3
POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0090336,0.0805864614744723,0.5366274179649121,0.5336587394143311,1.4548968954755,774,8,INS|NAPEPLD|FNDC5|PTGS2
POSITIVE REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090197,0.81456592807846,0.986276922067025,-0.24867869833640602,-0.7254067959176099,4484,7,MBP|TNF
N-TERMINAL PEPTIDYL-ASPARTIC ACID ACETYLATION%GOBP%GO:0017190,0.26386866145902305,0.775497586942835,-0.8682730480811651,-1.16151532984148,1992,1,NAT6
RESPONSE TO MECHANICAL STIMULUS%GOBP%GO:0009612,0.413767579570688,0.868602149902778,-0.15572173862149202,-1.02829683738204,1117,67,SLC9A1|BCL10|TNFRSF10A|HABP4|CRADD|GADD45A|JUN|MKKS|PKD2L1|TNFRSF10B|HTT|MAPK3|CHI3L1|TMC2|MYD88|AQP1
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002690,0.33800410116199603,0.832232043362884,-0.17130141189890102,-1.07553400380256,988,56,IL6R|CALR|PLA2G7|CREB3|VEGFA|LGALS9|PTK2B|AKIRIN1|ADAM10|CAMK1D|ZNF580|C1QBP|IL6|KARS|ADAM17|CXCL8|ANO6|OXSR1|THBS4|RAC1|PGF
POSITIVE REGULATION OF GAMMA-DELTA T CELL DIFFERENTIATION%GOBP%GO:0045588,0.9899328859060401,1.0,0.505458756065285,0.6714794073189001,7374,1,NCKAP1L
POSITIVE REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901860,0.8343624161073829,0.988613522932093,0.5830392589325101,0.774541644266396,6215,1,STOML2
PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009218,0.531275303643725,0.9265056012720759,0.33033149603283396,0.942653223075619,5248,9,CAD|AK3|CTPS2|UMPS|CTPS1
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS%GOBP%GO:0021955,0.47178924259056004,0.898272347254494,-0.23806633188013895,-0.974961640874909,2148,16,SPTBN4|SZT2|MYCBP2|PHOX2B|PAFAH1B1|EPHB1|PTEN|ARHGAP35|SLIT2|EPHA4|C12orf57|HSP90AA1|CHRNB2|SCN1B|NFIB|HSP90AB1
POSITIVE REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030887,0.0272166444901415,0.339785941813865,0.8922525503170671,1.45836228188182,224,2,CD2|KLRK1
NEGATIVE ADAPTATION OF SIGNALING PATHWAY%GOBP%GO:0022401,0.270474516695958,0.7852960152527629,-0.42058544688090505,-1.15447881144053,1538,6,ARRB2|ARRB1|ADRB2|ADM
REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904177,0.0671967745548214,0.501960209022281,0.68211767170159,1.44547250561063,599,4,SIRT1|TRPM4|KLF7
CANNABINOID SIGNALING PATHWAY%GOBP%GO:0038171,0.400370499015862,0.8638522656500329,0.553986985772582,1.05307098271023,3457,3,CNR1|DAGLA|DAGLB
N-TERMINAL PROTEIN AMINO ACID MODIFICATION%GOBP%GO:0031365,0.958685672867843,1.0,-0.128716582799722,-0.604828458902641,3967,23,NAT6|NAA50|PPM1A|NAA20
POSITIVE REGULATION OF FOCAL ADHESION DISASSEMBLY%GOBP%GO:0120183,0.122467893552231,0.607607158836689,-0.9375827084252321,-1.25423297571756,924,1,DUSP3
NEGATIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000642,0.152635486265776,0.648319130045528,-0.7647642679900749,-1.30808832224272,1027,2,SNX3|SNX12
REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000341,0.0525483304042179,0.447307566936778,-0.573660072400111,-1.5746583802812901,298,6,MAP2K5|MBP|TNF
EMBRYO DEVELOPMENT%GOBP%GO:0009790,0.43438914027149295,0.878651088001772,0.158604318472184,1.02581397860384,6239,277,ALDH1A2|RYR2|RIPPLY2|HOXD3|ITGB1|SIX3|TBX3|HOPX|NR4A3|TBX2|HOXB3|CAMSAP3|HOXD4|BASP1|STRC|HOXD8|HES1|BMP4|RARRES2|RARB|HOXC4|E2F8|FUT8|LIG4|MYH3|PROX1|CELF1|PKD2|ZNF358|AHI1|CEP290|DFNB31|ITGA2|MTHFD1|DVL1|PKDCC|DEAF1|FOXN4|ITGA4|EFEMP1|TGFB2|COL8A1|PDZD7|E2F7|LOXL3|ARNT2|FBN1|COL4A2|DACT1|STIL|TAL1|ITGB5|ZP3|LEF1|BBS5|C5orf42|KIT|RAI2|NIPBL|VANGL2|HES6|HEY2|PLXNB2|COL5A2|SEMA4C|SRF|ZNF281|STOX2|LFNG|TH|NASP|NPHP3
ESTROGEN BIOSYNTHETIC PROCESS%GOBP%GO:0006703,0.273938850935155,0.7884684708511421,0.547510064523245,1.16022612761112,2445,4,HSD17B11|HSD17B14|HSD17B8|HSD17B1
HISTONE H2B CONSERVED C-TERMINAL LYSINE DEUBIQUITINATION%GOBP%GO:0035616,0.63905812613206,0.960516115253472,-0.368995753598412,-0.848613147363262,3880,4,USP49|USP15|USP7|C17orf96
MUCOSAL IMMUNE RESPONSE%GOBP%GO:0002385,0.647289945597421,0.9636261853025391,0.288846221836672,0.8524598245004359,6424,10,HIST1H2BJ|HIST1H2BF|HIST1H2BK|HIST1H2BG|HIST2H2BE|IFNLR1
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900544,0.222941030106992,0.7355723797115551,-0.24397666807565196,-1.1835970336130002,895,25,PRKAA1|PFKFB4|ENO1|IGF1|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
RIBOSOMAL SMALL SUBUNIT ASSEMBLY%GOBP%GO:0000028,0.401383745858507,0.864185675398172,0.317756780888078,1.05282696020274,4118,14,MRPS11|ERAL1|RPS19|RPS27L|RPS15|RPS10|MRPS7|RPSA
REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070163,0.753323164088037,0.9769690538700708,0.336443897474714,0.7754533087306971,6913,5,C1QTNF3|RAB11FIP3
"RETROGRADE VESICLE-MEDIATED TRANSPORT, GOLGI TO ER%GOBP%GO:0006890",0.8541004450095359,0.991298302704726,0.13827969377259,0.734536059817142,10747,78,KLC1|KIF2C|KIF18A|ERGIC2|COPB1|KIF4A|KIF23|USE1|SCYL1|KIF11|CENPE|COPB2|KIF15|KIFAP3|ARF5|KIF22|KLC2|RACGAP1|GBF1|RER1|COPG2|TMED9
HINDBRAIN MORPHOGENESIS%GOBP%GO:0021575,0.22258064516129003,0.7355723797115551,-0.29996912576553003,-1.1963036724874698,1034,15,DLL1|OPHN1|DLC1|ADCK4|FAIM2|CBLN1|ZNF365|TRNP1
RESPONSE TO CORTICOSTEROID%GOBP%GO:0031960,0.0036017494211474104,0.143595610377104,-0.378503753964802,-1.91380802031043,13,28,NR3C1|KLF9|UBE2L3|ADCYAP1|AQP1|TNF|BCL2L11|SLIT3
REGULATION OF LYSOSOME ORGANIZATION%GOBP%GO:1905671,0.8535139712108379,0.991298302704726,0.4613178935759579,0.75401142390602,7055,2,LAPTM4B|SCARB2
REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051196,0.8041147493480151,0.984530683443403,-0.13821879147630897,-0.773709742088234,2774,38,CBFA2T3|PDK3|PRKAA1|PFKFB4|PRKAG1|HDAC4|ME2|FBP1|PPARA|IGF1|PDPR|AAED1
MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER%GOBP%GO:0051418,0.219403140272434,0.734713083559597,0.451235568946,1.2301892200025402,2109,8,TUBGCP3|TUBGCP6|CEP192|TUBGCP2|TUBGCP4|TUBGCP5
ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009068,0.9308985266652829,1.0,-0.166665646263131,-0.62765963811795,4485,13,ALDH7A1|SDS|SDSL|GCDH
NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032108,0.524071955911407,0.92593403131991,0.349218935919201,0.9520645089925759,5039,8,CARTPT
POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION%GOBP%GO:0045636,0.464186415993645,0.8923263186617242,-0.7668725187472429,-1.0258687500752701,3505,1,ZEB2
DETECTION OF HYPOXIA%GOBP%GO:0070483,0.7307382550335569,0.972575443350537,0.6385641817379799,0.848304027071035,5443,1,TGFB3
CALCIUM ION IMPORT%GOBP%GO:0070509,0.14854255031134397,0.64074876264986,0.32191857293571197,1.3087637486858799,1645,27,CACNA1G|CACNB2|CACNA1I|ATP2A1|CACNA1H|CACNA2D1|CACNA1D|ATP2A2|SLC8A1|MICU1|TRPV1|MCUR1|MICU2|MCU|FAM155B|C2orf47|TRPM2|FAM155A|ANXA6|CACNA1B
REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903335,0.7592838998427479,0.977664504547119,0.5021212176643011,0.8207033361955309,6276,2,SNAPIN|VPS35
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010523,0.384215413184773,0.858819200668514,-0.334578300553791,-1.04001503600077,2068,8,CLIC2|TMBIM6|SRI|FKBP1B|FKBP1A
REGULATION OF GLUCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010962,0.8815515610217599,0.9956508825790341,0.180670572134121,0.660378583790079,9317,19,INS|PASK|GCK|IRS1|AKT2|VIMP|GSK3A|AKT1|PPP1R3E|SORBS1
ER OVERLOAD RESPONSE%GOBP%GO:0006983,0.17944061024337102,0.68489956912038,-0.437868198637203,-1.2772809618696999,987,7,GSK3B|WFS1|TMCO1|EIF2AK3|TP53
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002686,0.881088955658745,0.9956508825790341,0.165466417235281,0.65935987028669,9676,25,NOV|KLRK1|MIA3|CCL21|CD200|CCL2|C5|DUSP1|AKT1|DDT|SLAMF8
REGULATION OF THYMOCYTE MIGRATION%GOBP%GO:2000410,0.8261763638562959,0.9876441563834109,0.475489385166805,0.77717433759761,6829,2,XCL1|ADAM8
PYRIDOXINE METABOLIC PROCESS%GOBP%GO:0008614,0.471946308724832,0.898272347254494,0.7691883546537271,1.0218324132321,3515,1,PSAT1
RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0009607,0.387811634349031,0.859991269020751,-0.110627247977543,-1.021487078634,139,381,IGHV4-4|CD274|BATF|IL1B|CLU|IRAK1|APOBEC3F|MTDH|FCER1G|PRKCD|SIRPA|DAB2IP|TRIB1|BANF1|IGHV2-26|LGALS9|ROMO1|TNFAIP3|DDIT4|NR1H3|IFNAR2|SSC5D|FGR|EIF2AK3|IGHV1-69-2|S100A8|IGHV3-15|RHOA|IGHV3-73|DDX3X|EXOSC4|IFNAR1|IFITM2|FOSL1|TNFRSF1B|BCL10|CCRN4L|MX2|IFITM3|VIM|IL6|OASL|LYN|FCGR2B|SBNO2|ENO1|DFNA5|CHIT1|APOBEC3B|SLC11A1|MST1R|ATG7|RAB1A|LAMTOR5|MAVS|FOXP1|AP1S1|CNOT7|GAPDH|LDOC1|PLA2G2A|SNCA|FMR1|OAS3|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|IGHV1-3|NLRP1|PDE12|ODC1|NLRP3|BCL2|SHC1|JUN|TP53|BCL3|NOS3|PPP1R11|ZC3HAV1|BNIP3L|TNIP2|HIST1H2BC|EXOSC5|TICAM1|IFITM1|MYD88|RBMS3|NR1D1|LIAS|CD36|TNF|PRSS3|PMAIP1|CAV1
LAYER FORMATION IN CEREBRAL CORTEX%GOBP%GO:0021819,0.597562983698337,0.9492590312650558,-0.381128329564882,-0.876515537502242,3628,4,ADGRG1|PAFAH1B1|DAB2IP|MBOAT7
CELLULAR RESPONSE TO GONADOTROPIN-RELEASING HORMONE%GOBP%GO:0097211,0.0122727799004284,0.23996399991852999,0.8492081990587659,1.61425545306133,105,3,MGARP|CRHBP
NEGATIVE REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010916,0.9808326787117049,1.0,-0.270231425702308,-0.548426649534574,6242,3,LRPAP1
TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:0001834,0.18747517542698303,0.6940517434063481,-0.9043890604322891,-1.20982882073156,1415,1,ZPR1
NOSE MORPHOGENESIS%GOBP%GO:0043585,0.120564216778025,0.6066999390482379,-0.7894127377998349,-1.3502482097647102,811,2,STRA6|SKI
LIPOSACCHARIDE METABOLIC PROCESS%GOBP%GO:1903509,0.9110233109442909,1.0,0.126107544457534,0.679269398782403,11528,84,B3GALT2|PGAP1|B4GALNT1|B3GALT1|ST3GAL5|PIGC|CLN6|GBA2|PIGF|PIGQ|PIGB|B4GALT6|ST8SIA3|ASAH1|B3GALNT1|ST3GAL4|SMPD1|AOAH|PIGL|LARGE|ST3GAL6|SMPD4|PIGK|CPTP|B4GALT3|PIGH|ARSA|HEXA|ST8SIA2|GPAA1|SCCPDH|ALDH5A1|CTSA|PIGN|NEU3|UGCG|GPLD1|PIGU
CELLULAR RESPONSE TO THYROID HORMONE STIMULUS%GOBP%GO:0097067,0.18606013276064,0.6922162303225631,-0.388790520647506,-1.25505064100412,952,9,RDX|GAS2L1|LMO2|CTSB|CTSS|CTSL|CTSH|KLF9
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904683,0.156063268892794,0.657649820899127,-0.478755230430649,-1.31415096146924,887,6,TIMP3|PICALM|MBP|STAT3
REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0001672,0.13632109805552697,0.62388141596544,0.49222234912265994,1.34193017884077,1310,8,TPR|SIRT6|TAL1|PARP10|TLK2
REGULATION OF ECTODERM DEVELOPMENT%GOBP%GO:2000383,0.61935654706739,0.9532238181782521,-0.6834472871636529,-0.9142682741719109,4677,1,FZD7
LEUKOCYTE CHEMOTAXIS%GOBP%GO:0030595,0.580142868609038,0.942746898746279,0.17611190623654802,0.922578211592555,7227,73,EDN1|CXCL13|SLC12A2|CXCR4|CXCL9|PTPRO|TGFB2|CCR5|XCL2|CCL21|AZU1|CCL5|KIT|CCL19|CYP7B1|CXCL10|RPS19|CCL2|CXADR|AMICA1
REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:2001260,0.700495947744043,0.9683987722846401,0.5289219740832639,0.8645084363024791,5790,2,HAND2|NCAM1
REGULATION OF ESTROGEN RECEPTOR BINDING%GOBP%GO:0071898,0.9397178916109871,1.0,-0.35847767612949394,-0.61315686618322,6328,2,RUVBL2
FOREBRAIN MORPHOGENESIS%GOBP%GO:0048853,0.0871318176727517,0.553293724109832,0.661886600541173,1.40260093324909,777,4,SLIT1|NF1|SMO|PTEN
L-ASPARTATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0140009,0.35659852425305394,0.844559957061487,0.661759029500965,1.08162695413533,2947,2,SLC1A3|SLC1A1
VASCULAR SMOOTH MUSCLE CELL DEVELOPMENT%GOBP%GO:0097084,0.778734622144112,0.9814327553627009,-0.2741819027556,-0.752610913095669,4430,6,ENG|NOTCH1|VEGFA|RAMP2
HORMONE CATABOLIC PROCESS%GOBP%GO:0042447,0.8126477541371159,0.985971473561293,-0.21539313385243503,-0.72870721186372,4124,10,ACHE|HSD17B6|YWHAH|ACE
THYROID HORMONE MEDIATED SIGNALING PATHWAY%GOBP%GO:0002154,0.38120805369127503,0.8569411612769741,0.8156704896338771,1.08358185583817,2839,1,MED1
NEURON DEVELOPMENT%GOBP%GO:0048666,0.5791245791245789,0.942692029750853,-0.101606238344789,-0.958490498822805,171,415,EHD1|IL6|PARD6B|LYN|TUBB3|NRL|NFIB|EFNA1|CHRNA7|CAMK2A|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|ZPR1|RAB8A|AMIGO1|CDC42|DBNL|NEFH|NEDD4|BLOC1S6|GNGT1|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|ADCYAP1|COBL|DRD2|MAPK3|MTCH1|TDP2|BLOC1S3|MAP4|ASCL1|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|CDHR1|INSM1|GFRA2|NBL1|MICALL1|SLIT3|EPHB2|PARD3|UBB|RTN4RL2
ELASTIN METABOLIC PROCESS%GOBP%GO:0051541,0.396072270227808,0.8638522656500329,-0.509307328072823,-1.03362409013852,2520,3,HIF1A|MMP12
POSITIVE REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046641,0.3830344549667539,0.8582519754973359,0.362435454857313,1.0696406630345399,3801,10,BLM|EBI3|CD55|RASAL3|XCL1
REGULATION OF DEFENSE RESPONSE TO FUNGUS%GOBP%GO:1900150,0.58,0.942746898746279,0.714214821349802,0.9488025267810309,4320,1,FAM3A
LUTEINIZING HORMONE SECRETION%GOBP%GO:0032275,0.0318120805369128,0.36484755247355394,0.9839545655050731,1.30713974294816,236,1,TBX3
RESPONSE TO INTERLEUKIN-4%GOBP%GO:0070670,0.6668016194331979,0.964618776001639,0.293948952430031,0.8388298747035869,6587,9,CITED1|LEF1|GATA3|XCL1|JAK3|XBP1|STAT6
SINUS VENOSUS MORPHOGENESIS%GOBP%GO:0003236,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
CALCIUM ION TRANSPORT FROM CYTOSOL TO ENDOPLASMIC RETICULUM%GOBP%GO:1903515,0.438791946308725,0.879683533669264,0.787163652404058,1.0457117943585301,3268,1,ATP2A2
APELIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060183,0.8390604026845642,0.989395884107905,0.5810542567269521,0.7719046573935391,6250,1,APLN
S-ADENOSYLMETHIONINE CYCLE%GOBP%GO:0033353,0.245068184827221,0.757467559003634,-0.877040141155712,-1.1732433375537201,1850,1,MTRR
ERYTHROSE 4-PHOSPHATE/PHOSPHOENOLPYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:1902222,0.273537604456825,0.7884684708511421,-0.370611533417495,-1.1520220128786498,1472,8,PAH|PCBD1|QDPR
TRNA-GUANINE TRANSGLYCOSYLATION%GOBP%GO:0101030,0.9646868125506541,1.0,0.30024380192232697,0.5707318829919139,8331,3,QTRT1|QTRTD1|C9orf64
ADENOSINE 5'-(HEXAHYDROGEN PENTAPHOSPHATE) CATABOLIC PROCESS%GOBP%GO:1901911,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE-EPINEPHRINE%GOBP%GO:0001993,0.0696525605137494,0.5065946660817761,-0.662843254245984,-1.52440101195954,422,4,ADRA1B|ADRB2|PDE4D
REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0010874,0.655332302936631,0.9640743070248079,0.25033741682441,0.848797055634836,6783,15,SIRT1|ABCA7|CETP|APOE|SREBF2|LRP1|PTCH1|LAMTOR1|GPS2|PLTP
NEGATIVE REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060169,0.574606116774791,0.941940408834489,-0.707101896779885,-0.9459117666785469,4339,1,ADA
ADENINE SALVAGE%GOBP%GO:0006168,0.22286562731997,0.7355723797115551,-0.72445547284257,-1.23914228694389,1500,2,APRT|HPRT1
RESPONSE TO CADMIUM ION%GOBP%GO:0046686,0.336313119110896,0.8311444145897029,-0.231043252936203,-1.0856529250057,1391,23,PRNP|MMP9|SUMO1|HSF1|JUN|MAPK3
REGULATION OF HAIR CYCLE%GOBP%GO:0042634,0.00707408135193555,0.18964101805215697,0.5754566060794721,1.8140448711036998,71,12,FST|ARNTL|CDH3|NUMA1|TGFB2|TERT|CLOCK|NIPBL
NEGATIVE REGULATION OF VASOCONSTRICTION%GOBP%GO:0045906,0.124485427301169,0.607607158836689,-0.595399969108757,-1.3692955455397,755,4,DOCK5|ADM
POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046985,0.375014472617807,0.8526379298494648,0.5628101908018089,1.06984296730446,3238,3,PRMT1|LDB1|KLF4
ENDOSOME TO MELANOSOME TRANSPORT%GOBP%GO:0035646,0.10454967502321301,0.576535954147525,-0.45371784859952397,-1.4103526255719,562,8,CD63|AP1G1|AP1M1|BLOC1S5|BLOC1S6|BLOC1S3
REGULATION OF SEROTONIN SECRETION%GOBP%GO:0014062,0.0595443833464258,0.476295606439141,-0.752572996763223,-1.52732453700526,378,3,HTR1B|HRH3
PROTEIN LOCALIZATION TO VACUOLE%GOBP%GO:0072665,0.292667706708268,0.8004058897916541,-0.18831975441483498,-1.1136894339818602,937,46,GCC2|SH3BP4|SH3GLB1|LAMTOR5|BECN1|NEDD4|C12orf66|RAB7A|VTI1A|CACNG3|CACNG7
FOLATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0098838,0.898112770637953,0.998912093067348,0.350943676782502,0.667107011674463,7756,3,SLC46A1|SLC19A1
NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045019,0.293964716805942,0.8004058897916541,-0.36296550645072295,-1.12825483192893,1582,8,SIRPA|ATP2B4|CAV1
ESTABLISHMENT OF SPINDLE LOCALIZATION%GOBP%GO:0051293,0.0391752577319588,0.396089810860281,0.374981046141243,1.55329776537969,436,29,KIF25|SAPCD2|NUMA1|DYNLT1|NDC80|CENPA|GPSM2|NUSAP1|CDK5RAP2|ESPL1|SPDL1|DYNC1H1|LLGL2|SPIRE2|SPIRE1|FMN2|NDE1
NEUROBLAST PROLIFERATION%GOBP%GO:0007405,0.167890262751159,0.672026878249637,0.383306770867823,1.29964454632729,1737,15,ARTN|FGF13|LEF1|DOCK7|PLXNB2|SOX5|RACGAP1|FGFR2|TEAD3
GOLGI ORGANIZATION%GOBP%GO:0007030,0.278406296114117,0.7885559551814421,-0.150493351144599,-1.1084393719877,565,102,STX16|GAK|ATL3|PI4K2B|CSNK1D|PI4K2A|UBXN2A|CSNK1A1|SURF4|TMED10|DYNC2H1|ATP8B1|COG3|RINT1|TANGO2|PLK3|BCAS3|GORASP2|VCPIP1|RAB43|DYM|PLEKHM2|TMED4|TBC1D20|RAB30|GCC2|TMED7|RAB1A|BAG5|ATL2|PDCD10|CDC42|LMAN2|SEC23IP|YWHAZ|TMED2|SEC23A|HTT|RAB2A|NSFL1C|VTI1A
"PROTEIN ALPHA-1,2-DEMANNOSYLATION%GOBP%GO:0036508",0.818139963167588,0.987153241368501,-0.166544248433671,-0.743104696461972,3553,20,MAN1A2|RNF185|EDEM2|DERL2|RNF5|EDEM1|UGGT1|TRIM13|OS9|RNF139|AMFR|RNF103
CELLULAR RESPONSE TO RADIATION%GOBP%GO:0071478,0.773166096541239,0.979946273879301,0.14260886156028602,0.8134829062216801,10170,114,PTPRK|SIRT1|INTS7|LIG4|ATR|BLM|ECT2|USP47|ST20|DDB2|RAD9A|POLD1|PARP1|TMEM161A|GEN1|INO80|AURKB|DDB1|RAD51|ZBTB1|CLOCK|HRAS|NIPBL|STK11|METTL3|RAD51AP1|MC1R|MFAP4|CUL4B|CNGB1|KDM1A|CASP9|CARD16|MAPK13|TNKS1BP1|CHEK1|XPA|HIST3H2A|CRYAB|SPIDR|RAD1|ATM
AXON ENSHEATHMENT%GOBP%GO:0008366,0.372676579925651,0.852609194081082,-0.182187966672561,-1.06199428954492,1202,44,SOD1|PPARD|CLU|SKI|PLLP|TENM4|MBP|MAL|AMIGO1|MALL|CD9|PMP22|POU3F1|TNFRSF21|PARD3
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0061000,0.5264423076923079,0.9265056012720759,-0.36681931994043,-0.9285787503734242,3065,5,SRGAP2C|EFNA1
GLUTATHIONE METABOLIC PROCESS%GOBP%GO:0006749,0.135042735042735,0.622258254449182,-0.230749349377295,-1.28180257435457,473,37,GSS|MMACHC|G6PD|GSR|CHAC1|GSTT2|GSTM5|GSTT2B|GSTM3|CNDP2|GSTM1|GSTM4|PTGES
REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045540,0.9242698371672271,1.0,0.13905230826151702,0.6309045454626071,10727,40,TM7SF2|NFYB|ELOVL6|GPAM|MVD|APOE|ACACA|SREBF2|GGPS1|IDI1|HMGCR|DHCR7
FORMATE TRANSPORT%GOBP%GO:0015724,0.9139414802065401,1.0,-0.541574768416409,-0.724481080186891,6902,1,SLC26A6
PURINE RIBONUCLEOSIDE SALVAGE%GOBP%GO:0006166,0.21580828809744498,0.7322272196643679,-0.8911557123952359,-1.19212616758099,1629,1,HPRT1
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035886,0.918893625870854,1.0,0.224936153528756,0.613236301176929,8836,8,HES1|HEY2|GATA6
RESPONSE TO LIPOPOLYSACCHARIDE%GOBP%GO:0032496,0.0321001088139282,0.365598374354954,-0.183638953700215,-1.39828279702592,58,116,CD274|IL1B|IRAK1|MTDH|SIRPA|DAB2IP|TRIB1|LGALS9|TNFAIP3|NR1H3|RHOA|IFNAR1|TNFRSF1B|BCL10|CCRN4L|VIM|IL6|LYN|SBNO2|SLC11A1|FOXP1|LDOC1|SNCA|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|NLRP3|JUN|NOS3|TNIP2|TICAM1|NR1D1|LIAS|TNF
POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0010606,0.5716002747252751,0.9405138747864158,-0.35456651224354707,-0.8975615813170479,3328,5,CNOT1|CNOT2|CNOT6|PAN3|CNOT6L
REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000736,0.85327380952381,0.991298302704726,-0.129577365684499,-0.7425816706868571,2866,41,ENG|EIF2AK2|GATA2|YTHDF2|FOXC1|ITCH|NOTCH1|PRICKLE1|ABL1|RUNX1|SOX6|NUDT21|CBFB|RBM24
NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032105,0.524071955911407,0.92593403131991,0.349218935919201,0.9520645089925759,5039,8,CARTPT
FATTY ACID CATABOLIC PROCESS%GOBP%GO:0009062,0.0220232333010649,0.310715277412964,0.30213071260073304,1.56840542822888,272,70,CROT|GLYATL2|SLC27A2|ETFDH|HSD17B4|ACADVL|BDH2|ETFA|DECR2|ABHD3|AMACR|ACADM|DECR1|AIG1|ALDH3A2|HADH|ETFB|ACOX2|ECHDC2|MCEE|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|FAAH|ECI1|ECI2|HADHB|ACAT2|HIBCH|ABHD2|ACADS|PCK2|ACOT7|ECHS1
VIRAL LIFE CYCLE%GOBP%GO:0019058,0.0018484288354898301,0.11072851755770098,-0.240155734205335,-1.7265913492612202,3,93,ITCH|PVRL2|FURIN|HTATSF1|ZNF639|VPS28|KPNA1|NEDD4L|RAB43|PCBP2|CTBP1|VPS4A|VPS37D|TBC1D20|RAB1A|VPS4B|ICAM1|CDC42|UBA52|CAV2|RAB7A|RAB5A|CHMP4B|CHMP1B|PCBP1|DDX6|UBC|PC|HSP90AB1|CAV1|UBB
MULTI-ORGANISM CELLULAR LOCALIZATION%GOBP%GO:1902581,0.8586017282010999,0.99166790097654,-0.341478683942827,-0.6930208432846999,5464,3,RAB7A
POTASSIUM ION EXPORT%GOBP%GO:0071435,0.373420387531592,0.852609194081082,0.413956913929872,1.07744287456351,3545,7,KCNT2|KCNQ1|KCNH2
CELLULAR RESPONSE TO ANISOMYCIN%GOBP%GO:0072740,0.579060402684564,0.942692029750853,0.714545655050728,0.949242024593174,4313,1,MAPK13
FEAR RESPONSE%GOBP%GO:0042596,0.790877655195126,0.9819233677232551,-0.325788717648334,-0.749245990944065,4802,4,ADCYAP1
NEGATIVE REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903720,0.372037600953264,0.852609194081082,-0.8117556241729159,-1.0859102486776,2809,1,SIRPA
REGULATION OF PROTEIN LOCALIZATION TO SPINDLE POLE BODY%GOBP%GO:1902363,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
PRE-B CELL DIFFERENTIATION%GOBP%GO:0002329,0.939397604935285,1.0,0.406735524756544,0.664798041536073,7765,2,ATM|LRRC8A
ACETYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0006581,0.442316258351893,0.880423444399886,-0.590239867659223,-1.0095736824058001,2978,2,COLQ|ACHE
ADULT LOCOMOTORY BEHAVIOR%GOBP%GO:0008344,0.330534947286216,0.8293509737209019,-0.33813937635292896,-1.09154420826335,1692,9,DRD2|PARK2
CELLULAR RESPONSE TO AMMONIUM ION%GOBP%GO:0071242,0.0265707168557985,0.3377111602831,-0.295583715290955,-1.5905025243988502,95,34,ABL1|GNAQ|CASP3|GNA15|CHRNA7|HRH3|CHRNA3|GABRG2|MAPK3|PARK2|CHRM1|PLCB1|HRH1
REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0043502,0.24052034320509302,0.7529787152777959,-0.21640901590826803,-1.16447242624974,868,34,HDAC4|SLC9A1|FOXO1|IGF1|ATP2B4|LMNA|MTPN|PDE9A|PRKCA|NOS3|SCN5A
CONVERGENT EXTENSION%GOBP%GO:0060026,0.9423076923076921,1.0,-0.240183101698654,-0.608007572971807,5487,5,NPHP3|LRP6|NPHP3-ACAD11|MESP1|MKKS
POSITIVE REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046628,0.26415474511384196,0.7757876811190542,0.40254313226040006,1.18800878093047,2621,10,SIRT1|INS|FAM132A|GKAP1|IRS1
AMYLIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0097647,0.010044459081179001,0.21951586544159402,-0.7883816389463709,-1.81311307088323,60,4,RAMP2|ADM|RAMP1
MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021815,0.338805772540712,0.8326275783736579,-0.8318813409792679,-1.11283303367742,2558,1,SRGAP2C
OMEGA-HYDROXYLASE P450 PATHWAY%GOBP%GO:0097267,0.183049670024314,0.6891306172477071,0.6555620280706379,1.24615445282546,1580,3,CYP2C8|CYP2U1
MAGNESIUM ION TRANSPORT%GOBP%GO:0015693,0.869433198380567,0.993389838333952,0.233914718987105,0.667512684761084,8589,9,MRS2|NIPA1|SLC41A1|NIPAL2|NIPA2|MAGT1
D-ASPARTATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0070779,0.17008220446914402,0.673117535978459,0.6617955222234481,1.25800366947098,1468,3,SLC1A2|SLC1A3|SLC1A1
"RNA SPLICING, VIA TRANSESTERIFICATION REACTIONS WITH BULGED ADENOSINE AS NUCLEOPHILE%GOBP%GO:0000377",0.999161132471164,1.0,0.0805865412739391,0.519437011531824,14292,271,CELF5|NOL3|SKIV2L2|ZCCHC8|PPWD1|SFSWAP|U2AF1L4|CELF1|RBM4B|SMN1|CCAR1|DDX20|DHX9|PRPF39|PRPF8|UPF3B|SART3|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|DDX17|PPIL1|C7orf55-LUC7L2|PPIE|RNPC3|FIP1L1|LUC7L|METTL3|GEMIN5|LUC7L3|SRPK1|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|CDK13|POLR2L|U2SURP|SRSF2|SMN2|CACTIN|SFPQ|HNRNPH1|PNN|HNRNPA2B1|TRA2A|PABPN1|SRSF11|POLR2J|RBM5|XAB2|LSM8|SF3B1|DHX40|RBM41|AQR|SNRPD1|TGS1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|MFAP1|CPSF7|GEMIN8|DDX46|SNRNP40|PRPF4B|DDX5|PRPF3|DDX42|RBM4|YTHDC1|CHERP|USP49|GTF2F2|PQBP1|CSTF3|CELF3|RBPMS|PSIP1|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|RBM17|SRSF9|WDR83|SRSF5|PRMT7|SETX|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|SNRPN|SNRNP25|CPSF4|SRSF10|CELF6|CWC27|PCF11|SYMPK|SNRNP48|PLRG1|SNW1|CWC22|SRSF12|DCPS|GEMIN2|PRPF40A|PHF5A|SF3B2|DBR1
EXTRACELLULAR POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045226,0.974050046339203,1.0,-0.5117445963828849,-0.6845763495433239,7356,1,HAS3
NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:0046209,0.0437329168293635,0.412001737413835,-0.49900488381301394,-1.61083248184829,223,9,GCH1|CYP1B1|GCHFR|NQO1|SPR|DDAH2|NOS3
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042536,0.0805612676908189,0.5366274179649121,0.823769073075652,1.3464279196818998,665,2,GHRL|LILRB1
REGULATION OF PROTEIN PROCESSING%GOBP%GO:0070613,0.5852778445994711,0.9439064862850342,0.175315497073934,0.9201819530045,7298,74,IGKV4-1|NOL3|IGHG1|SERPINE2|F12|IGHG4|NKD2|IGKV3-11|SUSD4|IGKV2D-28|IGKV2-28|C3AR1|C7|KLKB1|CD55|C5|BIRC2|GAS1|CARD16|C4A|C4B|IGHG2|CD46|THBS1|SERPINE1|TMEM59|PLGRKT|BCL2L12
REGULATION OF GLIOGENESIS%GOBP%GO:0014013,0.579185520361991,0.942692029750853,0.20559088575357898,0.914078128563657,6655,37,SLC45A3|CXCR4|HES1|SERPINE2|CDK1|AGER
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001238,0.007120253164556959,0.190063443902894,-0.351695488560152,-1.8246074655358002,26,30,AGT|TIMP3|DEDD2|PYCARD|GPER1|PML|RET|BCL10|CYLD|BID|PPP2R1B|WWOX|PMAIP1|CAV1|PAK2
CELLULAR RESPONSE TO GAMMA RADIATION%GOBP%GO:0071480,0.7535335689045942,0.9769690538700708,-0.18768501188692302,-0.7897569429916771,3411,17,HSF1|TP53|TSPYL5
DEPURINATION%GOBP%GO:0045007,0.376056501099919,0.853374872190571,0.5624727403955411,1.0692015095806,3247,3,MUTYH|MPG
REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032350,0.601473384030418,0.9506035145731909,-0.193357093975351,-0.89577322065512,2530,22,STUB1|DGKQ|TCF7L2|PAX8|STC2|TNF
GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0008211,0.25201568969274396,0.763905256448548,0.518115579002058,1.19417960336838,2312,5,CYP21A2|CACNA1H|HSD11B1
MITOCHONDRION MORPHOGENESIS%GOBP%GO:0070584,0.348496680983991,0.842847021021096,-0.33329655781112105,-1.07591115603502,1784,9,SUPV3L1|PNPT1|MTM1|PID1|MFF|FIS1|DNM1L|SLIRP|NUBPL
RESPIRATORY BURST AFTER PHAGOCYTOSIS%GOBP%GO:0045728,0.889802830531027,0.997300970905927,0.44150410973675197,0.72162633853732,7355,2,C17orf62|HCK
EXOCYST LOCALIZATION%GOBP%GO:0051601,0.2286596440247,0.7426617698946971,-0.413789299503585,-1.2070417448133501,1258,7,EXOC3L4|EXOC1|EXOC3L2|EXOC8|TNFAIP2|EXOC3L1|EXOC3
CELLULAR RESPONSE TO LEUKEMIA INHIBITORY FACTOR%GOBP%GO:1990830,0.227965435978005,0.740988338612706,-0.596007499724275,-1.2095795125299198,1450,3,SHMT1|HNRNPU|SBNO2
MITOTIC DNA REPLICATION CHECKPOINT%GOBP%GO:0033314,0.21659919028340102,0.7328375889887759,0.43375041607711895,1.23777548503836,2139,9,ORC1|ZNF830|NAE1|CDC6|TOPBP1|CLSPN|RAD17
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010769,0.469084913437758,0.896126296767273,-0.122436206200299,-1.00598378778687,568,175,RREB1|CDK5|CALR|THY1|CRKL|S100A10|DCC|HECW2|ARHGDIA|RNF6|CHRNB2|VEGFA|NEDD4L|DNM2|TUBB2B|RTN4|NSMF|PDPN|ABL1|SEMA3F|MAP3K13|BHLHB9|RHOA|NRP1|C1QBP|MYADM|SEMA7A|DOCK5|YWHAH|EFNA1|KIF13B|POU4F2|ISLR2|ARC|CRK|LIMK1|AMIGO1|FMR1|CDC42|NEDD4|SEMA6B|PLXNA1|CHRNA3|SSH3|LIMS1|PLXNA4|RELN|TWF2|MFI2|SDC2|SEMA3A|RAC1|CORO1C|SEMA3G|OLFM1|LINGO1
CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055008,0.38905526817315506,0.8603316114971841,-0.194163524118791,-1.0385361232822,1428,33,TNNT2|MYOM1|SMAD7|TBX20|S1PR1|ZFPM2|RBPJ|FKBP1A
REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050678,0.12106918238993698,0.607551029913022,-0.148509602883825,-1.20564239419103,153,165,PTPRN|DAB2IP|RTN4|C5AR1|TGFBR1|NRAS|HMOX1|EPB41L4B|PRKD2|STXBP4|PDCL3|FGF7|ZNF580|NRP1|ZNF703|FGF2|PPARG|LAMC1|APLNR|NFIB|VIP|IGF1|PDCD10|FGFR1|ATOH8|CDKN1C|ADAM17|STAT5A|MMP12|PRKCA|LIMS1|KLF9|SCG2|CAV2|FLT1|FGF10|SFRP2|PTPRM|ACVRL1|DUSP10|THBS4|NR1D1|SCN5A|PGF|CDH13|SULF2|CAV1
NEGATIVE REGULATION OF INTESTINAL ABSORPTION%GOBP%GO:1904479,0.8550335570469799,0.991298302704726,0.5735553595059549,0.761942706984968,6369,1,HAMP
NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033689,0.0662565905096661,0.49786383970143805,-0.5567812034636811,-1.52832701838396,376,6,PLXNB1|SFRP1|ATRAID|EIF2AK2|NELL1|GREM1
PROTEIN MATURATION BY IRON-SULFUR CLUSTER TRANSFER%GOBP%GO:0097428,0.385654008438819,0.859630103805729,-0.268367529011685,-1.03972685436836,1827,14,FAM96B|HSCB|BOLA2|BOLA2B|CIAO1|ISCA1
COLLATERAL SPROUTING IN ABSENCE OF INJURY%GOBP%GO:0048669,0.0711210096510765,0.514407987767174,-0.8414006695798921,-1.43917078277897,478,2,COBL
REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042984,0.40809716599190293,0.867015886388254,0.366608959295087,1.04617670805924,4031,9,ABCA7|SOAT1|ITM2C|NECAB1
CELLULAR RESPONSE TO LEAD ION%GOBP%GO:0071284,0.8633655501125379,0.991943445125448,-0.565725628584032,-0.756788422186673,6520,1,ANXA5
LYMPHATIC ENDOTHELIAL CELL MIGRATION%GOBP%GO:1904977,0.496644295302014,0.911815944636073,0.755348478164976,1.00344675475746,3699,1,LGALS8
REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION BY PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:1900238,0.41728201099764295,0.8709670999109399,-0.49961398477997104,-1.01395173792756,2655,3,PDGFB|PDGFA|PDGFRB
TONGUE DEVELOPMENT%GOBP%GO:0043586,0.5583660644147679,0.936434965680841,-0.45081063196206006,-0.9149067833949,3553,3,HDAC2|HDAC1|TBX1
OXYGEN METABOLIC PROCESS%GOBP%GO:0072592,0.509664429530201,0.918404893008545,0.749007498897221,0.9950230466913872,3796,1,ME3
POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010661,0.0804085422469824,0.536105877813735,-0.474866605560558,-1.4760921705328198,432,8,MFN2|PPARG|CAMK2A|SOD2|PDCD4
"POSITIVE REGULATION OF PROTON-TRANSPORTING ATP SYNTHASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:1905273",0.188799152654574,0.69611511841804,-0.903727393030437,-1.20894368807403,1425,1,TMSB4X
BASOPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002276,0.16404077849860998,0.666385698695266,-0.915141155712395,-1.22421222641639,1238,1,KARS
NEGATIVE REGULATION BY HOST OF SYMBIONT MOLECULAR FUNCTION%GOBP%GO:0052405,0.341583603987009,0.8356275732448649,0.518950251087093,1.09970515476439,3049,4,SUGT1|PTX3|RAB9A|ANXA2
SYNCYTIUM FORMATION%GOBP%GO:0006949,0.6274220724515589,0.955121257104955,0.333239294468354,0.867351869886451,5957,7,KCNH1|CACNA1H
DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046386,0.988734008019859,1.0,0.133304985069841,0.470147431431789,10355,17,TDG|MBD4|DUT|NEIL1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION%GOBP%GO:0044340,0.6688621768483449,0.964618776001639,-0.360794718662286,-0.829752480266384,4061,4,CTNNB1|WNT3
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN PROGRAMMED CELL DEATH%GOBP%GO:1902686,0.0711306256860593,0.514407987767174,-0.358201198373953,-1.46695429535101,323,16,BNIP3L|BMF|BCL2L11|PMAIP1
REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060544,0.0159618573797678,0.268309042246402,-0.485373480281218,-1.76826427644692,76,12,SLC25A4|CYLD|ARHGEF2|CFLAR|PELI1|SPATA2
RESPONSE TO ZINC ION%GOBP%GO:0010043,0.598297067171239,0.949262093257606,0.24463791862600698,0.89418902223692,6323,19,D2HGDH|MT1F|SLC30A5|MT1E|ZACN|MT2A
GLOMERULAR VISCERAL EPITHELIAL CELL MIGRATION%GOBP%GO:0090521,0.571584223142297,0.9405138747864158,0.39859176328583895,0.918694926532399,5245,5,ANLN|NUP188|KANK1|KANK2|NUP93
NEGATIVE REGULATION OF COLLAGEN BINDING%GOBP%GO:0033342,0.958162319608103,1.0,-0.519078076753419,-0.6943865698309301,7236,1,GTPBP4
NEGATIVE REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031936,0.9193028410235741,1.0,0.20599520327529397,0.607945064039243,9124,10,ASF1A|ATAD2|ATAD2B|PHF2|TET1|PHF8
NEGATIVE REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042130,0.9071524966261808,1.0,0.15538522025128,0.6371770349293759,10082,28,GLMN|BMP4|MARCH7|DLG5|BTN2A2|PLA2G2D|CEBPB|RC3H1|TNFRSF14|XCL1|PDCD1LG2|NDFIP1|FOXP3|SDC4|LILRB2|KIAA0922
PROTEIN HEXAMERIZATION%GOBP%GO:0034214,0.14243498817966901,0.6324244126031129,-0.393968803832674,-1.3328554326103799,722,10,C10orf2|YME1L1|PANX1|LRRC8C|LETM1
REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905774,0.292231098761144,0.8000726114371469,0.598819896327341,1.13829362942966,2523,3,GTF2H2|POT1|MNAT1
POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0045799,0.0167882366562464,0.27621312636330103,0.8318076541303628,1.5811788476210502,144,3,TPR|SIRT6|TAL1
ACTIVATED T CELL PROLIFERATION%GOBP%GO:0050798,0.7742832950284259,0.980173768720877,0.496443341604632,0.811423003756382,6400,2,BTN3A1|CADM1
POSITIVE REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031666,0.715297217190845,0.971081608033886,-0.34818762067303194,-0.8007587886061222,4343,4,LY86|SASH1|PRKCA
REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046596,0.292538022813688,0.8004058897916541,-0.24295397996229998,-1.12554271802178,1230,22,TRIM11|GSN|TRIM62|SNX3|LGALS1|PVRL2|LGALS9|IFITM2|IFITM3|P4HB|TRIM25|IFITM1
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009123,0.7759336099585059,0.980614374126555,-0.10595032645051401,-0.8729772881479629,934,176,PFKL|COX5B|GPI|NDUFB10|SDHC|GMPS|ATIC|UQCRC1|NUDT4|PKM|ENO1|MT-ND5|DCTD|HPRT1|ATP5I|COX4I1|GAPDH|PGK1|CDADC1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|COX4I2|NDUFS6|PGAM2|AK4
CELLULAR TRIGLYCERIDE HOMEOSTASIS%GOBP%GO:0035356,0.38025713663107397,0.856455387424841,0.46489373740717205,1.07151114817788,3489,5,SIRT1|C1QTNF3
LACRIMAL GLAND DEVELOPMENT%GOBP%GO:0032808,0.714375490966222,0.971081608033886,-0.39457675997448993,-0.8007818109778381,4546,3,FGF10
DNA-TEMPLATED VIRAL TRANSCRIPTION%GOBP%GO:0039695,0.19409395973154395,0.7049101024373008,0.9051058667842958,1.20239276438745,1445,1,DHX9
NEGATIVE REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010730,0.0650334075723831,0.4956987271622679,-0.8465949820788531,-1.4480553761188601,437,2,FYN|MPV17L
REGULATION OF DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:1903072,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010712,0.384875211109026,0.8593496731626808,0.28767577935416805,1.0682837914204302,4101,20,ITGB1|WNT4|BMP4|F2R|SUCO
RESPONSE TO FOLLICLE-STIMULATING HORMONE%GOBP%GO:0032354,0.269933184855234,0.7846089815823771,-0.696719051557761,-1.19170062380393,1817,2,TGFBR3|NOTCH1
PEPTIDYL-PROLINE HYDROXYLATION TO 4-HYDROXY-L-PROLINE%GOBP%GO:0018401,0.7916434540389972,0.9819233677232551,-0.238798652881612,-0.7422901878649351,4262,8,EGLN3
PEPTIDYL-L-CYSTEINE S-PALMITOYLATION%GOBP%GO:0018230,0.481939163498099,0.9052279104788491,-0.209453466762978,-0.970343537142582,2027,22,CLIP3|ZDHHC3|ZDHHC9|ZDHHC11B|ZDHHC7|ZDHHC4|GOLGA7
VIRION ASSEMBLY%GOBP%GO:0019068,0.00797720797720798,0.19847993048827997,-0.320203207883551,-1.77871485787215,27,37,RAB43|VPS4A|VPS37D|TBC1D20|RAB1A|VPS4B|UBA52|CHMP4B|CHMP1B|DDX6|UBC|PC|UBB
BMP SIGNALING PATHWAY%GOBP%GO:0030509,0.207787958115183,0.7233921325090501,-0.19313670001293695,-1.17693658985547,634,51,UBE2D1|DLX5|ZCCHC12|SKI|RGMA|ACVR1|GDF15|TMEM100|FAM83G|BMP8B|SMAD6|SMAD1|CHRDL1|SMAD7|PDCD4|UBE2D3|MAPK3|ACVRL1
PROTEIN DESUMOYLATION%GOBP%GO:0016926,0.878859426080639,0.9956508825790341,-0.230838649451871,-0.673366581830445,4838,7,SENP5
MITOTIC DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:1990505,0.555570469798658,0.934566028474918,0.725738861932069,0.9641117005706741,4138,1,BRCA2
POSITIVE REGULATION OF CELL KILLING%GOBP%GO:0031343,0.9851370594517621,1.0,0.11673910168997301,0.493455346175333,11068,31,KLRK1|CD1E|SLAMF6|F2RL1|IL12RB1|PRF1|NCR3|CD1D|RASGRP1|HLA-F|XCL1|FADD|MICA|HLA-C|STX7|CADM1
CARDIAC PACEMAKER CELL DEVELOPMENT%GOBP%GO:0060926,0.13033557046979902,0.612163182799301,0.9357079841199821,1.2430463120106598,970,1,MAML1
POSITIVE REGULATION OF AMPA RECEPTOR ACTIVITY%GOBP%GO:2000969,0.0556561831055492,0.45915848992626795,-0.6829940096087199,-1.5707435396535803,337,4,ARC|ADRB2|RELN
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002221,0.0012620950778292,0.0937289532911629,-0.27587750164426694,-1.9113795323654,2,80,RELA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|UBE2N|TLR1|ITCH|NOD1|IRAK1|PIK3C3|LGALS9|IRAK2|ITGAM|TNFAIP3|CD300LF|IRAK4|TRAF3|S100A8|BCL10|UBE2V1|CYLD|TANK|CNPY3|TNIP1|RIPK2|RFTN1|UBA52|COLEC12|TNIP2|TICAM1|MYD88|UBC|CD36|UBB
MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0007064,0.3703230874987721,0.852609194081082,0.335967726857732,1.08429273427835,3770,13,RB1|BOD1|NIPBL|CDCA5|DSCC1|POGZ|SGOL1|PDS5B
MULTI-ORGANISM MEMBRANE ORGANIZATION%GOBP%GO:0044803,0.5800336983993261,0.942746898746279,0.34716906916801604,0.903608146782379,5507,7,CXCR4|CCR5
NEURAL FOLD FORMATION%GOBP%GO:0001842,0.5036377134372679,0.9168675576821579,-0.560794044665012,-0.9592081791916109,3391,2,BMP7|LUZP1
CARBAMOYL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0070409,0.288456375838926,0.7980646072929201,0.8590097044552271,1.1411560692288798,2148,1,CAD
CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042033,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
NEGATIVE REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035509,0.225274725274725,0.7390599693491929,-0.47727774101036796,-1.20819690849553,1311,5,ROCK1|NCKAP1L|ROCK2|IKBKB|TNF
TOXIN METABOLIC PROCESS%GOBP%GO:0009404,0.38787023977433005,0.859991269020751,0.36094542131192103,1.06524318908966,3849,10,CTH|AS3MT|N6AMT1|ARL1|FMO2|ACAA1
NEGATIVE REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000059,0.40973630831643,0.867015886388254,-0.18390235290906304,-1.02943341146981,1413,38,CCAR2|PARK7|RPL11|RYBP|MAP1A|TAF9|TRIM39|STYX|PML|PDCL3|CSNK2A2|GLTSCR2|BAG5|DDRGK1|CSNK2A1|HSP90AB1
CONTACT INHIBITION%GOBP%GO:0060242,0.480025773195876,0.9046812288131709,0.40063160034190604,0.985295074669407,4469,6,CDHR2|PTPRJ|FAP|YAP1|SMO
ARGININE METABOLIC PROCESS%GOBP%GO:0006525,0.0547675334909378,0.456473845459404,-0.46086866485233097,-1.55918767601004,277,10,ASS1|DDAH2|NOS3|ASL|DDAH1
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000107,0.20959664936720399,0.7248363921442859,0.309853771023198,1.23472270496551,2301,25,CD27|BMP4|BLM|MERTK|PRKCQ|CCL21|CCL5|AURKB|CCL19
CARBOHYDRATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0034219,0.9760702524698129,1.0,-0.136287212443892,-0.5581419397912349,4445,16,PPARD|SLC2A3|SLC2A6|SLC5A2|SLC2A1
ACTIVATION OF JNKK ACTIVITY%GOBP%GO:0007256,0.945930299872641,1.0,0.318026721782218,0.604535342952614,8169,3,MAP3K12|TNIK
INNER MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007007,0.9994047619047621,1.0,-0.0785978853351988,-0.450428581383394,3357,41,IMMT|ATP5J2|ATP5F1|ATP5J|ROMO1|SAMM50|CHCHD6|C19orf52|CHCHD3|ATP5I|TIMM22|LETM1
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0032223",0.462465245597776,0.891507554237553,-0.7678098808998679,-1.02712268800677,3492,1,ACHE
POSITIVE REGULATION OF AXON GUIDANCE%GOBP%GO:1902669,0.658612542955327,0.9643779777660141,0.342672382248148,0.842752818714725,6132,6,DSCAM|SEMA5A
"WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:0060071",0.846024636058231,0.991298302704726,-0.135653926544773,-0.7462176017841781,3021,36,ARRB2|CELSR1|PRICKLE1|PFN1|RHOA|WNT11|CDC42|AP2S1|RAC1
AMP CATABOLIC PROCESS%GOBP%GO:0006196,0.798755461406064,0.983870923215532,-0.597871636524041,-0.799791117131588,6032,1,AMPD3
EXIT FROM HOST CELL%GOBP%GO:0035891,0.0597539543057996,0.476295606439141,-0.564586846383722,-1.5497529840888797,339,6,VPS4A|VPS4B|RAB7A
NUCLEOSOME ORGANIZATION%GOBP%GO:0034728,0.281156759238008,0.7892585111044429,0.200223177190058,1.1329325018949599,3674,109,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|ASF1B|SMARCD3|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|ASF1A|CASC5|CENPU|OIP5|ARID2|ITGB3BP|CENPA|HIST1H4I|INO80|CENPQ|CENPI|H2AFX|H3F3A|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|HIST1H2BK|STRA13|CENPM|SMARCA4|HIST1H3H|HIRA|HIST1H2BN|HIST3H2A|ARID1A|SUPT6H|HIST1H2BG|HIST2H2BE|SMARCD1|HIST1H2BH
REGULATION OF CRISTAE FORMATION%GOBP%GO:1903850,0.900816629547142,0.998912093067348,-0.38682106424041895,-0.661636713572188,6066,2,PINK1|CHCHD10
NEGATIVE REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045085,0.8082738599250029,0.984682960940884,0.483650399779432,0.7905132917857641,6681,2,FOXP3|PTPRC
PEPTIDYL-GLUTAMINE MODIFICATION%GOBP%GO:0018199,0.769265033407572,0.9792236089291529,-0.4509511993382961,-0.7713278750667649,5180,2,QPCT|QPCTL
ARGINYL-TRNA AMINOACYLATION%GOBP%GO:0006420,0.38574610244988894,0.859630103805729,-0.623380204025365,-1.0662584528772,2597,2,RARS|RARS2
NEGATIVE REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032929,0.0271415331656296,0.339785941813865,-0.986821790913101,-1.3201015976486201,204,1,AATF
POSITIVE REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000120,0.573422818791946,0.9412682428400659,0.717743714159682,0.953490503443888,4271,1,CEBPB
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007196,0.6443949517446179,0.9625529715741509,-0.5049870446282649,-0.863753294460496,4339,2,GRM8
NUCLEAR POLYADENYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:0071042,0.396344475547505,0.8638522656500329,-0.44973253184801204,-1.0342908708335699,2406,4,PNPT1|EXOSC7|EXOSC8|EXOSC9
EXCRETION%GOBP%GO:0007588,0.00645161290322581,0.180481691368788,-0.494737642790254,-1.9730579188019401,29,15,CHRNB4|SLC22A18|CHRNB2|NEDD4L|HMOX1|NPHP1|CHRNA3|AQP5|KCNK5|ADORA2B
FATTY ACID BETA-OXIDATION USING ACYL-COA OXIDASE%GOBP%GO:0033540,0.27986747222763597,0.788916642629372,0.35294848237500304,1.1694280032939,2871,14,CROT|HSD17B4|DECR2|AMACR|ACOX2|EHHADH|ECI2|ACOX3|ACAA1|CRAT
REGULATION OF CHOLESTEROL TRANSPORTER ACTIVITY%GOBP%GO:0060694,0.24904011650999602,0.7613646381106121,-0.875606528451698,-1.17132555012908,1880,1,PPARG
CORECEPTOR-MEDIATED VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0046814,0.43201376936316704,0.878651088001772,-0.7818703131892372,-1.0459317569792401,3262,1,PVRL2
REGULATION OF LYMPHANGIOGENESIS%GOBP%GO:1901490,0.835248578686343,0.988613522932093,0.47039565041883297,0.76884876808513,6904,2,VASH1|FOXC1
MEDIUM-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0001579,0.665478841870824,0.964618776001639,-0.495836779707748,-0.848102256370793,4481,2,SLC27A1|SLC27A4
CELLULAR RESPONSE TO HEAT%GOBP%GO:0034605,0.302678571428571,0.8054013181463249,-0.193903830940091,-1.1112236305426002,1016,41,HSPA13|HMOX1|HSPA5|ANO1|STUB1|SUMO1|HSBP1|BAG3|HSF1|YWHAE|HSPA6|POLR2D|SLU7|IER5
EMBRYONIC HEMOPOIESIS%GOBP%GO:0035162,0.559692671394799,0.936434965680841,-0.26760517750452695,-0.905348370636631,2840,10,VEGFA|KDR|THOC5|KITLG
VESTIBULAR REFLEX%GOBP%GO:0060005,0.0749371110816894,0.524528105081935,-0.9615130127922359,-1.28624527349817,565,1,TMC2
POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010986,0.303987796905644,0.8067855616273029,0.49513123188050606,1.1412040904873302,2789,5,LDLRAP1|LDLR|GPIHBP1|GPLD1|ANXA2
RAP PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032486,0.0858944050433412,0.5495132996855571,-0.42982360274576203,-1.4541575840791001,435,10,RAP2C|RAP1B|RAP2B|RAP1A|RAPGEF1|PLK2
POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0043634,0.301307664366146,0.804157610193454,-0.382956425813569,-1.11710088432939,1658,7,EXOSC10|EXOSC2|EXOSC3|PAPD5|EXOSC7|EXOSC8|EXOSC9
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0002237,0.0150784077201448,0.264387156924099,-0.18758690057582897,-1.4525847912825098,24,126,CD274|IL1B|IRAK1|MTDH|SIRPA|DAB2IP|TRIB1|LGALS9|TNFAIP3|NR1H3|SSC5D|RHOA|IFNAR1|TNFRSF1B|BCL10|CCRN4L|VIM|IL6|LYN|FCGR2B|SBNO2|SLC11A1|FOXP1|LDOC1|SNCA|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|NLRP3|JUN|NOS3|TNIP2|TICAM1|NR1D1|LIAS|CD36|TNF
NEGATIVE REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000757,0.878856356848104,0.9956508825790341,0.206161503404722,0.6498947338849621,8944,12,SIRT1|TAF7
DNA REPLICATION INITIATION%GOBP%GO:0006270,0.0252125193199382,0.329326373353219,0.4886422997785229,1.6567964572453897,260,15,LRWD1|CDC7|CDC34|ORC1|CDC45|POLA2|ORC6|MCM10|MCM2
TRICARBOXYLIC ACID TRANSPORT%GOBP%GO:0006842,0.25240245455598,0.763905256448548,0.61779942994351,1.1743717262620001,2179,3,SLC13A3|SLC25A1|SLC13A4
VESICLE-MEDIATED TRANSPORT TO THE PLASMA MEMBRANE%GOBP%GO:0098876,0.9524846724749921,1.0,0.118569976381786,0.61551436787533,11806,70,WASH1|LRRC7|CCDC93|OSBPL5|GGA3|GOPC|ARF5|ANK3|RAB26|VPS29|GOLGA4|MACF1|GGA2|TRIM23|ANKRD27|BBS1|RABEP1|SEC16A|STX3|ANKRD50|FAM21C|C16orf70|ARHGAP44|BBS2|EXOC6|SCRIB|SDCCAG3|VAMP5|STX1B|VAMP4|EXOC1|RAB11B|GOLPH3L|RAB34|KRT18|VPS39|BLZF1|EXOC6B|RAB31|CCDC22
DOUBLE-STRAND BREAK REPAIR VIA BREAK-INDUCED REPLICATION%GOBP%GO:0000727,0.10993680540422801,0.584830174998513,0.5992485639408139,1.38117910637671,1008,5,MUS81|CDC7|CDC45|GINS2
SULFUR COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0044272,0.332907875966664,0.8293509737209019,0.18885000701034602,1.09413945666511,4433,124,GLCE|HACD1|CTH|MGST1|GSTA4|GSTO2|VCAN|MAT2A|SCD5|ELOVL6|GGT1|APIP|CHST15|MTHFD1|SLC35B3|CHPF2|SLC26A2|PDHX|CDO1|MTR|MGST3|B4GALT6|PDHA1|SLC25A1|ACACA|GSTP1|MGST2|DLD|ACSS1|MTAP|OPLAH|GGT5|GSTZ1|PRELP|HAGH|PAPSS2|B4GALT4|ST3GAL4|TECR
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN MAMMARY GLAND SPECIFICATION%GOBP%GO:0060595,0.5594654788418709,0.936434965680841,-0.53783549128184,-0.919938803211163,3767,2,FGF10
PROTEIN LOCALIZATION TO NUCLEAR BODY%GOBP%GO:1903405,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS%GOBP%GO:0050687,0.552766051988447,0.9324056413710201,-0.212958212762993,-0.9160989165625091,2487,18,MUL1|RIOK3|ITCH|PCBP2|C1QBP|GPATCH3|TRAF3IP1
POSITIVE REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051973,0.8615941389354749,0.991915800284466,0.160970341076666,0.6938664903948679,9760,33,NVL|HMBOX1|PNKP|PRKCQ|NEK2|AURKB|MAP3K4|MAP2K7|WRAP53|HNRNPA2B1
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING%GOBP%GO:1905597,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
POSITIVE REGULATION OF GLUTAMATE NEUROTRANSMITTER SECRETION IN RESPONSE TO MEMBRANE DEPOLARIZATION%GOBP%GO:0061646,0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
PIGMENTATION%GOBP%GO:0043473,0.881968859869412,0.9957926294175992,0.142967211923239,0.690669796973779,10535,51,CITED1|SHROOM2|USP13|AP3D1|LEF1|BBS5|KIT|NF1|C10orf11|ARL6|MC1R|MYO5A|TH|RAB27B
GENETIC IMPRINTING AT MATING-TYPE LOCUS%GOBP%GO:0071515,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
PROTEIN TRANSPORT INTO PLASMA MEMBRANE RAFT%GOBP%GO:0044861,0.885211174367801,0.996643473105967,-0.556131451257168,-0.7439539986525129,6685,1,ATP1B1
CELLULAR RESPONSE TO INTERLEUKIN-1%GOBP%GO:0071347,0.14737754659731303,0.639410493426798,-0.171719145625665,-1.21977261774292,339,87,HIF1A|IL1RN|NOD1|IL1B|IRAK1|NFKBIA|CX3CL1|SIRPA|MAP3K8|DAB2IP|IRAK2|USP10|SQSTM1|IRAK4|CCL14|UBE2V1|TANK|RIPK2|CXCL8|UBA52|PELI2|MAPK3|TNIP2|PELI1|MYD88|PLCB1|UBC|CCL18|UBB
REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903975,0.6160714285714289,0.9518465519698142,-0.342874476064417,-0.8679639681207171,3587,5,CERS2|CSF1|P2RX4|GPR183|CRKL
FC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038093,0.0183639398998331,0.285037997475661,-0.189422915013817,-1.4492191772073897,32,118,FCER1G|PPP3R1|PRKCD|ABI1|GRB2|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|BCL10|LYN|FCGR2B|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|SHC1|JUN|NFATC2|GAB2|MAPK3|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1|PAK2
NEGATIVE REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051460,0.07624161073825501,0.525661416287861,0.962781208645787,1.27901188297102,567,1,CRHBP
PROTEIN PRENYLATION%GOBP%GO:0018342,0.586352148272957,0.9447006447658759,0.345571923362951,0.8994511118123141,5567,7,CHML|RABGGTA|FNTB|CHM|FNTA|PGGT1B
REGULATION OF TUMOR NECROSIS FACTOR (LIGAND) SUPERFAMILY MEMBER 11 PRODUCTION%GOBP%GO:2000307,0.9458493313915,1.0,-0.5245368328187029,-0.701688914255538,7143,1,ADAM8
LIPID CATABOLIC PROCESS%GOBP%GO:0016042,0.13823616894705498,0.625841769801034,0.212739252950923,1.2494713350262299,1858,135,ENPP2|CROT|GLYATL2|LPL|SLC27A2|ETFDH|BCO2|FABP5|HSD17B4|ACADVL|BDH2|PLA2G4A|ETFA|DECR2|ABHD3|HSD17B11|AMACR|PNPLA6|ACADM|SRD5A3|DECR1|FABP6|AIG1|ALDH3A2|HADH|ETFB|PNPLA2|LIPE|APOE|ACOX2|SMPDL3A|MGST2|ECHDC2|MCEE|PDXDC1|SMPD3|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|SMPD1|FAAH|AOAH|ECI1|ECI2|HADHB|ACAT2|HIBCH|PLA2G4B|ABHD2|DAGLA|ACADS|SMPD4
HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031507,0.335825610783488,0.8311444145897029,0.42746654460838507,1.11260560484469,3188,7,CDKN2A|HELLS|CENPV
METANEPHRIC EPITHELIUM DEVELOPMENT%GOBP%GO:0072207,0.7830265138358229,0.981487311948134,0.41170874221997095,0.782615008826143,6762,3,PKD2|PKD1
REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048713,0.38127530364372497,0.8569411612769741,0.375152554692587,1.07055721017553,3766,9,SLC45A3|CXCR4|HES1
BEHAVIOR%GOBP%GO:0007610,0.21661931818181798,0.7328375889887759,-0.14203071994851998,-1.129650491592,304,146,ANXA7|BHLHB9|FYN|GRID1|NPHP1|STRN|PRNP|CHRNA7|VIP|ARC|CAMK4|CIART|CRH|DYNLRB1|CHRNA3|STAT3|MKKS|TP53|DKK1|ADCYAP1|HTT|DRD2|PARK2|MCHR1|THBS4|USP2|PLCB1|CFAP69|ATXN1L|RASD2|GPRC5B|PLK2|EPHB2|TRH
AORTIC VALVE DEVELOPMENT%GOBP%GO:0003176,0.0765885479584441,0.527286041772797,-0.30450414118461305,-1.43083949586144,316,23,SMAD6|TNFRSF1B|EFNA1|SNAI1|TBX20|NOS3|TWIST1|SLIT3
VIRAL RELEASE FROM HOST CELL%GOBP%GO:0019076,0.0597539543057996,0.476295606439141,-0.564586846383722,-1.5497529840888797,339,6,VPS4A|VPS4B|RAB7A
BASEMENT MEMBRANE DISASSEMBLY%GOBP%GO:0034769,0.511584800741427,0.918404893008545,-0.7404609616232909,-0.99053720482893,3863,1,CTSS
REGULATION OF LIPID TRANSPORTER ACTIVITY%GOBP%GO:0110112,0.0965107646622123,0.5693042257394499,-0.811634960022057,-1.3882581307297301,649,2,PRKCD|PPARG
CLOSURE OF OPTIC FISSURE%GOBP%GO:0061386,0.5518930957683741,0.9321968967758479,-0.540998070030328,-0.9253482247835692,3716,2,SOX11|PHACTR4
LYMPHOCYTE MIGRATION INTO LYMPH NODE%GOBP%GO:0097022,0.8803677271077779,0.9956508825790341,0.44720154397573797,0.7309386382832679,7277,2,WNK1|CCR7
CELL DEATH%GOBP%GO:0008219,0.269607843137255,0.784543299601953,-0.111490985553882,-1.0683766907295502,54,464,PPIF|TP53BP2|IL1B|SRGN|GZMB|CLU|KPNA1|PARP4|TIMM50|CAPNS1|NFKBIA|BCLAF1|CTSL|PLK3|PRKCD|DAB2IP|RTN4|PGAM5|PTK2B|KRT17|HMOX1|DDIT4|CIDEB|RRAGC|DLC1|PRKD2|LAMP1|ABL1|BBC3|PML|ZNF385A|MYBBP1A|CYFIP2|CUL5|DDX47|ITPK1|EMP3|DDX3X|BCL10|ATG3|CASP3|PKM|TNFRSF10A|H1F0|KAZN|DDIT3|DFFA|IL6|DFNA5|CYLD|MAGI3|BCL2L1|SH3GLB1|YARS|EXOG|CAMK2A|POU4F2|PPP2CA|BAG5|BOK|SPINK5|SOD2|BID|ACAA2|CRADD|ZPR1|JADE1|CHAC1|KRT9|PDCD10|MAL|RELT|GAPDH|MRPS30|PPP2R1B|GADD45A|MLKL|STK4|GNGT1|PDCD4|BAG3|EIF5A|HK2|NLRP1|NLRP3|BCL2|CFLAR|PRKCA|BNIP2|NDUFS1|TP53|BCL3|PMP22|CDIP1|ZNF622|TNFRSF10B|GABARAP|CDKN1A|BNIP3L|BMF|TFPT|PKP4|CRIP1|EVPL|STK24|TICAM1|MYD88|BIK|JMY|TNF|BCL2L11|PMAIP1|TNFRSF21|CAV1|SLIT3|TRIB3|APPL1|EGLN3
NEGATIVE REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046725,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071875,0.000985027580772262,0.0849637591935908,-0.652777906762627,-2.20844536636492,4,10,ADRA2C|ADRA1B|AKAP13|ADRB2|DRD2|ADRA2A|PDE4D
REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900117,0.10086647411686302,0.5713242454960451,-0.321380098607677,-1.3825057804504999,453,18,BAX|TP53BP2|DLC1|RPS3|DFFA|BCL2L1|BOK|TP53|PAK2
MESENCHYMAL TO EPITHELIAL TRANSITION%GOBP%GO:0060231,0.0545492839090143,0.45643561302544805,0.585672086241549,1.5243813907130501,517,7,CITED1|BASP1|BMP4
RESPONSE TO FRUCTOSE%GOBP%GO:0009750,0.383171414457435,0.8582519754973359,-0.453868637291127,-1.04380304929004,2326,4,XBP1|SLC2A5|SLC26A6|KHK
HORMONE METABOLIC PROCESS%GOBP%GO:0042445,0.0992255566311713,0.570215774831708,0.25967386483543203,1.34800562204107,1229,70,ALDH1A2|FDXR|CYP21A2|STAR|CRHBP|FDX1|BCO2|HSD17B4|AKR1B1|IDE|BZRAP1|CACNA1H|HSD17B11|ALDH8A1|SRD5A3|HSD11B1|DUOX1|AKR1C1
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097296,0.299745977984759,0.802472218138634,0.687033972781276,1.1229381545836898,2477,2,JAK2|CASP8
REGULATION OF TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002649,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
NEGATIVE REGULATION OF PLANT ORGAN MORPHOGENESIS%GOBP%GO:1905422,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
RELAXATION OF SKELETAL MUSCLE%GOBP%GO:0090076,0.21865771812080498,0.7341474817293291,0.891982796647552,1.1849593511724499,1628,1,ATP2A1
PEPTIDE AMIDATION%GOBP%GO:0001519,0.91566265060241,1.0,-0.541023378914866,-0.723743469638951,6915,1,PAM
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX%GOBP%GO:0002503,0.672918837559338,0.9647315640607691,0.4547259291937801,0.86438615602514,5811,3,HLA-DMB|HLA-DRA|HLA-DMA
ATRIOVENTRICULAR VALVE DEVELOPMENT%GOBP%GO:0003171,0.270758122743682,0.7857061977848471,-0.25955541434998103,-1.13827331877763,1199,19,NOTCH1|ACVR1|SMAD6|EFNA1|TBX20|OLFM1|SLIT3
PSEUDOPODIUM ORGANIZATION%GOBP%GO:0031268,0.146844840386043,0.638549298625996,-0.7687896333057621,-1.3149734940304298,988,2,RAB25|SRGAP2C
GOLGI APPARATUS MANNOSE TRIMMING%GOBP%GO:1904381,0.6619196480259351,0.964618776001639,0.459343761501629,0.873164169464636,5716,3,MAN1C1|MAN1A1|MAN1A2
NEGATIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032792,0.32570393545200105,0.826621597878865,-0.476424198974246,-1.09567612913932,1977,4,FOXP3|EIF2AK4|SIK1|DDIT3
VACUOLAR PROTEIN PROCESSING%GOBP%GO:0006624,0.8626577579806981,0.991943445125448,-0.408547008547009,-0.6987977777414599,5809,2,TMEM208|LGMN
SITE-SPECIFIC DNA REPLICATION TERMINATION AT RTS1 BARRIER%GOBP%GO:0071171,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
"SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, TRANSLOCATION%GOBP%GO:0006616",0.9893937818446501,1.0,0.17490445115333803,0.47683645782154,9514,8,ZFAND2B|SEC61A1|SEC61A2|SRP19|SEC61B|SRP9
REGULATION OF NK T CELL DIFFERENTIATION%GOBP%GO:0051136,0.927868472849369,1.0,0.331995780169899,0.6310890534578111,8013,3,ZNF683|TGFBR2|PRDM1
NEGATIVE REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001024,0.653978494623656,0.9640743070248079,-0.21368325672082,-0.852187918045979,3040,15,TRAP1|PARK7|NUP93|TXN|PDE8A|HGF|SNCA|MET
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION UNCOUPLER ACTIVITY%GOBP%GO:2000276,0.408446974712035,0.867015886388254,-0.794441993824438,-1.06274927747228,3084,1,PPIF
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905007,0.621565934065934,0.9536478716552259,-0.34125693023743897,-0.8638692582702909,3619,5,ENG|TGFBR1|ACVR1
ALANYL-TRNA AMINOACYLATION%GOBP%GO:0006419,0.929769858945805,1.0,-0.36559139784946204,-0.625324506198661,6261,2,AARS2|AARS
NEGATIVE REGULATION OF CHLORIDE TRANSPORT%GOBP%GO:2001226,0.21664449014152698,0.7328375889887759,0.7250794939443721,1.18512251375316,1790,2,ANO9|GABRE
GOLGI VESICLE BUDDING%GOBP%GO:0048194,0.981930026912726,1.0,-0.0908442792447652,-0.610822192037864,2553,71,TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|VAPB|ANKRD28
NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902564,0.5254639940608761,0.9265056012720759,-0.5523987115933591,-0.9448484115978271,3538,2,FCGR2B
NEGATIVE REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901898,0.0155902004454343,0.264809548283936,-0.915963606286187,-1.56670669267963,104,2,PDE4B|PDE4D
NEGATIVE REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000706,0.7809395973154358,0.981487311948134,0.610994706660785,0.811679209392466,5817,1,REST
TARGETING OF MRNA FOR DESTRUCTION INVOLVED IN RNA INTERFERENCE%GOBP%GO:0030423,0.284578340239669,0.793663380147364,0.542558813285211,1.14973395326957,2540,4,DHX9|DICER1|TARBP2
SPECIFICATION OF SYMMETRY%GOBP%GO:0009799,0.0251352211263124,0.329326373353219,-0.261690225163555,-1.5731295181616598,78,48,DNAI1|LRRC6|CCDC103|KIF3B|TBX20|MKKS|DYX1C1|GREM1|SOX17|DNAAF1|BBS7|NBL1
"DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:0006352",0.7340093603744151,0.9734087938149171,-0.11015731693217698,-0.8921964532994059,940,164,RSF1|POLR3H|PPARA|RXRA|PTRF|NRBF2|PPARG|POLR1B|POLR2A|TCF4|TAF1B|TEAD4|NR1H2|POLR2K|PPARGC1A|NR3C1|POLR2F|POLR1E|TP53|TAF4B|MAPK3|CDKN1A|POLR2I|POLR2D|CBFB|NR1D1|NR1D2|CD3EAP|TAF13|RBPJ|CRCP|MED10
RELAXATION OF SMOOTH MUSCLE%GOBP%GO:0044557,0.9908068223055521,1.0,0.318422812104277,0.52045333879808,8190,2,SLC8A1|SOD1
POSITIVE REGULATION OF PROTEIN PROCESSING%GOBP%GO:0010954,0.462236286919831,0.8913711164042071,-0.25390914201432296,-0.983711235461824,2190,14,ENO1|CLEC3B|MFI2|MYH9
POSITIVE REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010971,0.0841059602649007,0.545178773025535,0.3922158024947629,1.43360876722803,888,19,CCNB1|CDC7|CDK1|CDC25C|DTL|DBF4B|FBXO5|RAD51C
NEGATIVE REGULATION OF ANGIOGENESIS%GOBP%GO:0016525,0.53607060629317,0.9265056012720759,-0.143075000600745,-0.9559387078307621,1396,70,CTNNB1|DAB2IP|FOXO4|PML|MMRN2|RHOA|HDAC5|MAP2K5|ADAMTS9|PPARG|ECSCR|SPINK5|MEOX2|FOXJ2|PDCD10|PGK1|SERPINF1|SARS|PTPRM|THBS4
MAINTENANCE OF LOCATION IN CELL%GOBP%GO:0051651,0.7416498993963779,0.974505008828563,-0.125439740367289,-0.854794524601261,1842,75,HSPA5|OS9|FLNB|PML|SUPT7L|FTH1|TMSB10|ARL2BP|TMSB4X|TWF1|FTL|HK1|HK2|BCL3|RANGAP1|TWF2|TAF8|CAV1
REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032663,0.624208860759494,0.9536478716552259,-0.171773334962393,-0.891165566654001,2366,30,HAVCR2|TRAF6|EZR|CD86|IL1B|TNFAIP3|PRKD2|RPS3|RUNX1|PRNP|PDE4B|HOMER2|PDE4D
SODIUM-INDEPENDENT ORGANIC ANION TRANSPORT%GOBP%GO:0043252,0.974094355518113,1.0,0.201741928338505,0.525091853462431,9249,7,SLC16A2|SLCO3A1|SLCO2A1|SLCO2B1|SLCO4A1
PHOTORECEPTOR CELL MORPHOGENESIS%GOBP%GO:0008594,0.173273942093541,0.676682497340677,-0.752798456024262,-1.28762144172309,1166,2,C8orf37|CDHR1
POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042998,0.714846818538885,0.971081608033886,-0.3943341916140471,-0.800289525697341,4549,3,ACSL3
REGULATION OF NADP METABOLIC PROCESS%GOBP%GO:1902031,0.9105878478511441,1.0,-0.280309743325118,-0.6446538508912011,5529,4,PGAM1|TIGAR|ME2
NEUROMUSCULAR SYNAPTIC TRANSMISSION%GOBP%GO:0007274,0.9580825897489108,1.0,-0.156442865382629,-0.589160840724005,4616,13,CHRNB4|FCHSD1|CHRNA5|CHRNB1|CHRNB2|CHRNA3
CELLULAR PHOSPHATE ION HOMEOSTASIS%GOBP%GO:0030643,0.364026845637584,0.8499434076701009,0.823279664755183,1.09369030551745,2711,1,XPR1
INTERMEDIATE MESODERM DEVELOPMENT%GOBP%GO:0048389,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
VITAMIN METABOLIC PROCESS%GOBP%GO:0006766,0.8649667227968891,0.992690647212272,0.138025732139307,0.724458418591837,10786,74,ALDH1A2|RGN|RBP1|GSTO2|MCCC2|CD320|SLC25A19|DHFR|ABCD4|MTHFD1|CYP2R1|MTR|RFK|SLC46A1|PCCB|PIAS4
REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032677,0.0963455149501661,0.569036402671078,-0.23293472589352499,-1.34125498444349,318,42,TLR1|IL17D|OTUD7B|PYCARD|IL1B|LGALS9|PRKD2|SSC5D|ZNF580|BCL10|MAP2K5|DDIT3|ARRB1|MAVS|TMSB4X|BCL3|MYD88|TNF
REGULATION OF G2/MI TRANSITION OF MEIOTIC CELL CYCLE%GOBP%GO:0110030,0.9100382077110111,1.0,0.34328562477571695,0.652549860406397,7859,3,CDC25C|CDC25A
DEFENSE RESPONSE TO OTHER ORGANISM%GOBP%GO:0098542,0.9198380566801619,1.0,-0.0952385218300579,-0.777765672120325,1135,170,IGHV5-51|PLSCR1|RELA|MX1|BNIP3|AGBL5|IL6R|PYCARD|SETD2|SERINC3|ABCC9|NOD1|RNASEL|CLEC7A|IGHV4-4|BATF|APOBEC3F|FCER1G|PRKCD|IGHV2-26|ROMO1|DDIT4|IFNAR2|FGR|IGHV1-69-2|S100A8|IGHV3-15|IGHV3-73|EXOSC4|IFITM2|MX2|IFITM3|IL6|OASL|APOBEC3B|SLC11A1|ATG7|RAB1A|MAVS|CNOT7|GAPDH|PLA2G2A|OAS3|ADAM17|IGHV1-3|NLRP1|PDE12|BCL2|SHC1|PPP1R11|BNIP3L|HIST1H2BC|EXOSC5|IFITM1|MYD88|PMAIP1
CAMP BIOSYNTHETIC PROCESS%GOBP%GO:0006171,0.7200242228502219,0.9713637233549571,-0.225905232896362,-0.794988659934077,3566,11,ADCY2|ADM
CYTOSKELETON-DEPENDENT INTRACELLULAR TRANSPORT%GOBP%GO:0030705,0.19210174029451102,0.7022951260524071,-0.144675219789462,-1.1489800005308701,286,141,HIF1A|BLOC1S1|MYO10|HSPB1|SOD1|DYNC2H1|LOH12CR1|IFT46|IFT122|RAB21|BLOC1S5|WDR35|IFT172|RPGR|BLOC1S4|RAB6A|TUBA1C|HAP1|RAB1A|DYNLRB2|WDR19|AP3S2|FMR1|CDC42|TRAF3IP1|BLOC1S6|BAG3|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B|TRAK1|HTT|BLOC1S3|KIF13A|BICD1|TMEM108|UBB
ESTABLISHMENT OF CHROMATIN SILENCING%GOBP%GO:0006343,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
PYRIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072526,0.416451890034364,0.8709670999109399,0.422753160909095,1.03969983118949,3877,6,NUDT17|MTAP|QPRT|PDXP|NUDT12
GLYCEROL ETHER METABOLIC PROCESS%GOBP%GO:0006662,0.7459706769262759,0.9749763305090959,0.284276592351284,0.7750142574674951,7173,8,TMEM86A|FAR1|GNPAT
POSITIVE REGULATION OF AMINE TRANSPORT%GOBP%GO:0051954,0.693161721359796,0.96731875442989,0.258246593328595,0.8140855507757309,7054,12,CARTPT|DRD4|RAB3B
POSITIVE REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903301,0.9820539539191852,1.0,0.27964045439505897,0.5315670867333839,8481,3,BAD|DUSP12|TIGAR
REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901894,0.0170197985411601,0.277422272849102,0.8311041521680359,1.5798415643963,146,3,THADA|RYR2
THIAMINE METABOLIC PROCESS%GOBP%GO:0006772,0.616046603998411,0.9518465519698142,-0.684991177767975,-0.916333583706144,4652,1,THTPA
CORONARY VEIN MORPHOGENESIS%GOBP%GO:0003169,0.128285077951002,0.608160579951936,-0.7824648469809761,-1.33836421462428,863,2,NOTCH1|VEGFA
POSITIVE REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0045901,0.160059391239792,0.661454203640901,-0.7598566308243729,-1.29969407170702,1077,2,USP16|EIF5A
CELLULAR RESPONSE TO PEPTIDOGLYCAN%GOBP%GO:0071224,0.520587845889051,0.9249983657048559,-0.7353330392589329,-0.983677426733087,3931,1,RELA
EVASION OR TOLERANCE BY VIRUS OF HOST IMMUNE RESPONSE%GOBP%GO:0030683,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
CELL-CELL ADHESION VIA PLASMA-MEMBRANE ADHESION MOLECULES%GOBP%GO:0098742,0.00045610034207525704,0.0784645998831315,0.32106310092502,1.83143839424466,5,114,TENM1|CLDN12|PCDHB4|ITGB1|PCDHA7|CDH4|CDH6|CLDN15|PCDHB6|PCDHB14|CDH10|NEXN|SDK1|CEACAM1|CD209|PCDHB13|CDH3|PCDHB9|DCHS1|IGSF9|CDH2|CLDN11|DSCAM|PCDHGB4|CLDN7|CDH23|ROBO2|TGFB2|TENM2|CELSR2|KIRREL3|CDH7|PTPRD|HMCN1|BSG|PALLD|ADGRL1|CXADR|PLXNB2|AMICA1|TRO|LRRC4C|MYOT|PLXNB3|CDHR3
GLYCOSAMINOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0006024,0.718752486275758,0.971081608033886,0.157592444590289,0.8350892242856359,9033,77,GLCE|GCNT2|VCAN|B3GAT3|HS3ST5|CHST15|GPC2|GPC6|EXT1|PXYLP1|CHPF2|GPC1|XYLT2|B4GALT6|PRELP|B3GALT6|B4GALT4|ABCC5|ST3GAL4|HS2ST1|GPC3|AGRN|B3GNT4|FMOD|ST3GAL6|BGN|B4GALT3|SDC3|DCN|HEXA|OGN|ST3GAL3|LUM
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046578,0.0149393090569561,0.264326813346421,-0.207022147396755,-1.4910848780085302,31,94,FLCN|STAMBP|NOTCH1|OPHN1|ARHGDIA|MAPKAP1|HEG1|PLCE1|LPAR1|DAB2IP|SQSTM1|DLC1|GRB2|ABL1|VAV1|EPS8L1|FBP1|NRP1|MFN2|LYN|ARRB1|SHOC2|ABCA1|IGF1|MAP4K4|DENND1A|PDCD10|ARHGEF2|AKAP13|RAPGEF1|SHC1|FGF10|GPR4|RAC1|MET|EPHB2
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:1903750,0.7355852317360569,0.974262605126702,-0.386842395500165,-0.7850851480752571,4681,3,PINK1|TRAP1|PARK7
INFERIOR ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905317,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
NEURON PROJECTION RETRACTION%GOBP%GO:0106028,0.610883092810804,0.9508825506493929,-0.6881340979267759,-0.9205379638294029,4613,1,GSK3B
NEGATIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048297,0.201879194630873,0.7160679679335791,0.9010807234230259,1.1970455410063798,1503,1,THOC1
POSITIVE REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000416,0.9054069700127361,1.0,0.346454020053012,0.658572646525864,7819,3,PAXIP1|WHSC1L1|BRD4
REGULATION OF T CELL TOLERANCE INDUCTION%GOBP%GO:0002664,0.555829320192631,0.934906497228332,0.441976066173536,0.9365895039753149,4962,4,IL2RA|FOXP3|LILRB2|TGFBR2
CELL CYCLE DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:1902298,0.555570469798658,0.934566028474918,0.725738861932069,0.9641117005706741,4138,1,BRCA2
BRAIN-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0031547,0.329027468448404,0.828303707528737,-0.662200165425972,-1.1326579177888,2215,2,RAPGEF2|NTRK2
CYTIDINE DEAMINATION%GOBP%GO:0009972,0.22525934464021102,0.7390599693491929,-0.526973287958441,-1.21192847372839,1367,4,CDA|CDADC1
TRNA WOBBLE POSITION URIDINE THIOLATION%GOBP%GO:0002143,0.991437510291454,1.0,-0.21502233496939302,-0.49450645069038396,6020,4,TRMU|CTU2|CTU1|MOCS3
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048661,0.0249203129527673,0.329326373353219,-0.283569970090476,-1.5873445721761799,85,38,MMP2|MFN2|FGF2|IL6|MMP9|HTR1B|MEF2D|IGF1|SERPINF2|FOXP1|FOXJ2|JUN|RBPMS2|CDH13|TNF
CYTOSOLIC CALCIUM ION TRANSPORT%GOBP%GO:0060401,0.5308371897349601,0.9265056012720759,0.19940263747578896,0.9537435649733721,6308,49,RYR2|NOL3|F2R|PKD2|IBTK|CACNA2D1|CCR5|CCL21|JPH4|GRIN1|CCL19|ATP2A2|SLC8A1|MICU1|LCK|TRPV1|ITPR2|MCUR1|CHERP|MICU2|MCU|FAM155B|XCL1|C2orf47|GRIN2D|TRPM2|FAM155A
REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010908,0.714375490966222,0.971081608033886,-0.394588764262067,-0.800806173322811,4546,3,CTNNB1|TCF7L2
CELLULAR RESPONSE TO GLYCINE%GOBP%GO:1905430,0.308089500860585,0.8111717366855571,-0.8465483017203349,-1.1324534742526298,2326,1,FYN
PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009128,0.381946966945151,0.857178152269066,-0.356811913954771,-1.04083618331079,2102,7,PRTFDC1|NUDT3|AMPD3|NUDT11|NUDT10|NUDT4|HPRT1
TRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031119,0.431248638047505,0.8785877309899279,0.44550249960499705,1.0268172196300698,3957,5,PUSL1|PUS1|PUS10|PUS7|PUS3
POSITIVE REGULATION OF BEHAVIORAL FEAR RESPONSE%GOBP%GO:2000987,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002889,0.8209286825149972,0.987153241368501,-0.17279210920926902,-0.743313263120462,3694,18,PAXIP1|RIF1|SUPT6H|FAM35A|XCL1|TP53BP1|NDFIP1|CLCF1|HLA-E|FOXJ1|TGFB1|MAD2L2|TNFSF13|PVRL2|C20orf196|FCGR2B|TFRC
HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0050665,0.966177623474073,1.0,0.264810051480887,0.5611577950620991,8626,4,DUOX1|MAOB|CYBA|SOD1
ERAD PATHWAY%GOBP%GO:0036503,0.828451218544098,0.9876441563834109,0.14198195931020902,0.7562089683137441,10435,79,SDF2|BRSK2|SGTA|POMT2|HSP90B1|DERL3|ATXN3|EDEM3|USP13|RNF121|SYVN1|AUP1|MAN1B1|UBXN4|HERPUD1|TMUB1|JKAMP|VIMP|ANKZF1|PSMC6|BAG6|GET4|DNAJB9|NPLOC4|TMEM67|VCP|MARCH6
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:2000791,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
DUMP BIOSYNTHETIC PROCESS%GOBP%GO:0006226,0.6110653713156601,0.9508825506493929,-0.376396920433492,-0.8656342849260351,3710,4,DCTD|CDADC1
REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071622,0.8071920428462129,0.984682960940884,-0.152993719953133,-0.762397854145388,3164,27,AKIRIN1|CAMK1D|C1QBP|KARS|CXCL8|THBS4|RAC1
POLYAMINE METABOLIC PROCESS%GOBP%GO:0006595,0.199419568822554,0.711592141628341,-0.340770821748785,-1.24146228632993,961,12,SRM|AZIN1|OAZ2|AMD1|SMS|ODC1|SMOX
PENTOSE METABOLIC PROCESS%GOBP%GO:0019321,0.08274231678486998,0.5420718842622351,-0.432524229831469,-1.4632942097398702,419,10,G6PD|FGGY|DHDH|XYLB|TKT
PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION%GOBP%GO:0003402,0.468053691275168,0.8957057061714878,0.7711733568592851,1.02446940010496,3486,1,MAGI2
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070167,0.8527486910994772,0.991298302704726,-0.123792986349891,-0.7543698074623141,2605,51,GPM6B|NOTCH1|SRGN|NELL1|PTK2B|ACVR1|FAM101B|BMP2K|WNT6|FAM101A|NOS3|ANO6|GREM1|S1PR1|TWIST1
SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:0061302,0.527156163057941,0.9265056012720759,0.593994716350391,0.9708680458852941,4357,2,DDR1|VTN
POST-EMBRYONIC ANIMAL MORPHOGENESIS%GOBP%GO:0009886,0.145536644668288,0.636418541205714,0.6786147568104111,1.28997526510373,1256,3,EFEMP1|FBN1|MFAP2
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090199,0.00029455081001472796,0.0784645998831315,-0.438109036623234,-2.49157271588502,0,40,MFF|GPX1|MOAP1|APOPT1|PRELID1|DNM1L|OPA1|CHCHD10|PSMD10|BNIP3|PYCARD|BAX|GPER1|PPIF|CLU|CIDEB|BBC3|HRK|HGF|MMP9|BCL2L1|IGF1|BID|PLAUR|FXN|TP53|PARK2|BMF|BIK|BCL2L11|PMAIP1
PROTEIN RETENTION IN GOLGI APPARATUS%GOBP%GO:0045053,0.22739158858139,0.7401399564654879,0.530561386750278,1.2228653452428002,2086,5,VPS13A|VPS13C|SORL1|VPS13D|GOLPH3
LUNG VASCULATURE DEVELOPMENT%GOBP%GO:0060426,0.49146250927988105,0.909315999193258,-0.5664185277088499,-0.968828556210052,3309,2,ERRFI1|STRA6
POSITIVE REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000318,0.287535410764873,0.7968329882324392,0.502575482870298,1.15836198547186,2638,5,PRKCQ|IL12RB1|NFKBID|MALT1|NFKBIZ
RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0051123,0.873362885351602,0.9934031064448321,0.22308752077468302,0.658388908806141,8668,10,TAF7|GTF2B|TAF1|TAF6|MED6|TAF12|GTF2A2|TAF11
POSITIVE REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033625,0.0564862542955327,0.46241663736446703,0.612009874775702,1.50514915635941,525,6,CXCL13|SKAP1|SRC|PIEZO1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN UNFOLDED PROTEIN RESPONSE%GOBP%GO:0006990,0.5483110761979579,0.9305779599215391,-0.45384360869085705,-0.921062119552297,3489,3,XBP1|EP300|CREB3
RESPONSE TO IRON(III) ION%GOBP%GO:0010041,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
RESPONSE TO DSDNA%GOBP%GO:1990784,0.4719978816364361,0.898272347254494,-0.7626819585355089,-1.0202629099109202,3564,1,RIOK3
REGULATION OF PROGESTERONE SECRETION%GOBP%GO:2000870,0.6867469879518069,0.9665349594178531,-0.6514666960741071,-0.871486862391378,5186,1,GDF9
PROTEIN DEGLYCOSYLATION%GOBP%GO:0006517,0.8663893943332471,0.9929671171385601,-0.14004859730505897,-0.7167338638508589,3332,29,EDEM3|NGLY1|SYVN1|ENGASE|MAN1B1|MAN1C1|MARCH6|MAN1A1|MAN2A1|SEL1L|MAN2B1|MAN2A2|UGGT2|MAN1A2|MGEA5|RNF185|EDEM2|DERL2|RNF5|PARK7|EDEM1|UGGT1|TRIM13|OS9|RNF139|AGA|AMFR|RNF103|MAN2B2
LIPOXYGENASE PATHWAY%GOBP%GO:0019372,0.956308563957289,1.0,0.245960915396805,0.566903448374235,8776,5,PTGS2|PON2|GPX4
C21-STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0006700,0.0163216560509554,0.27198543625715,0.565449563051276,1.7250569993584999,163,11,FDXR|STAR|FDX1|AKR1B1|BZRAP1|CACNA1H
COENZYME TRANSPORT%GOBP%GO:0051182,0.801881509687535,0.9841161968820359,0.3525500327899171,0.7470871968156371,7159,4,SLC25A42|SLC5A6|SLC23A2
POSITIVE REGULATION OF TELOMERASE CATALYTIC CORE COMPLEX ASSEMBLY%GOBP%GO:1904884,0.36663844199830703,0.8510019955058101,0.657678522194651,1.07495747704125,3030,2,ATR|ATM
NATURAL KILLER CELL ACTIVATION%GOBP%GO:0030101,0.7407918968692451,0.974505008828563,-0.179214459993098,-0.799637982982083,3217,20,PIK3CD|SNX27|IL21R|ULBP3|VAMP2|ELF4|ULBP2|PRDX1
REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904251,0.00790267235104502,0.19847993048827997,0.657425343415772,1.79231786252058,75,8,FGFR4|SIRT1|STAR|FGF19|PROX1
SHORT-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0051790,0.302770049594774,0.8054013181463249,0.685775276312003,1.12088084978307,2502,2,OXSM
RESPONSE TO TRICHOSTATIN A%GOBP%GO:0035983,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
L-METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0071265,0.174828178694158,0.677587050632799,0.524386297461538,1.2896517290998502,1627,6,CTH|APIP|MTAP|ENOPH1
NEGATIVE REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000773,0.34773089171974503,0.842847021021096,0.360794283296778,1.10070065377909,3493,11,SIRT1|CDK6|TERT|FBXO5|AKT3
MAMMARY GLAND LOBULE DEVELOPMENT%GOBP%GO:0061377,0.12249443207127002,0.607607158836689,-0.7881996140060659,-1.34817322648622,824,2,ID2|VEGFA
POSITIVE REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:1902425,0.29146250927988104,0.8000726114371469,-0.6847814486831459,-1.17128199342402,1962,2,BECN1
ARTERIAL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060844,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
REGULATION OF PLATELET AGGREGATION%GOBP%GO:0090330,0.5603233830845771,0.936434965680841,-0.249770094664462,-0.909937509284691,2702,12,PRKCD|PDPN|LYN|PRKCA|CD9
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL-3-KINASE ACTIVITY%GOBP%GO:0061903,0.997219647822057,1.0,-0.5016541685046321,-0.6710780765160179,7531,1,AGAP2
BRAIN MORPHOGENESIS%GOBP%GO:0048854,0.599626829028773,0.9503391896930079,0.27544472779887796,0.888962519825815,6105,13,SLIT1|NF1|FZD6|FZD3|SHANK1|BBS2|BBS4|PAFAH1B1|SMO|CTNNA2|PTEN
FEMALE GONAD DEVELOPMENT%GOBP%GO:0008585,0.361485557083906,0.848418604328854,0.27635575648226895,1.0875974692573,3941,24,INHA|EIF2B5|ROBO2|ZNF830|KIT|BMPR1B|EIF2B4|FANCF|NUP107|BRCA2|CEBPB
MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING%GOBP%GO:0098787,0.9421584994598841,1.0,0.177226844788167,0.5719769036156871,9593,13,ERN1|CPSF1|FIP1L1|CPSF6|CPSF7|TUT1|CPSF4
REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045066,0.7111406798112979,0.9703327035763342,0.523683484973808,0.8559462697627859,5878,2,PLA2G2D|FOXP3
AMINO SUGAR CATABOLIC PROCESS%GOBP%GO:0046348,0.7335020242914979,0.9734087938149171,0.275368109729019,0.785806498277412,7246,9,OVGP1|AMDHD2
PLACENTA DEVELOPMENT%GOBP%GO:0001890,0.798296727924697,0.9835585148939309,0.18029821468673002,0.7468559194038771,8904,29,CITED1|GHRL|E2F8|PKD2|E2F7|LEF1|HEY2|STOX2|CUL7|FGFR2|PTK2
REGULATION OF TRANSCRIPTION INVOLVED IN G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000117,0.282933933536343,0.791899420871283,-0.8586788707543009,-1.14868090630732,2136,1,BACH1
LIPID HYDROXYLATION%GOBP%GO:0002933,0.00653199467763397,0.18180901488453102,0.9470085470085471,1.54785945423882,53,2,CYP2C8|CYP3A5
SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014037,0.8709613869188342,0.9934031064448321,-0.200463762074038,-0.6781989125092679,4420,10,PARD3
REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043266,0.0133333333333333,0.252358095238095,-0.26657848915729104,-1.64422804455699,39,53,KCNAB1|VAMP2|SUMO1|VIP|BIN1|CAB39|KCNAB2|AMIGO1|NEDD4|YWHAE|KCNG1|ANO6|ADCYAP1|DRD2|ADRA2A|DLG1|GAL|CAV1
POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902952,0.0996734002661183,0.570215774831708,0.807003032809485,1.3190242874569198,823,2,INS|APOE
REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0050691,0.9770916334661349,1.0,-0.115095921291599,-0.565154729559586,3923,26,TARBP2|PARP9|PQBP1|STAT1|IFNLR1|IFIT1|DDX58|ZC3H12A|TRIM44|APOBEC3G|MICB|LILRB1|TMEM173|DTX3L|EIF2AK4|MB21D1|MUL1|TRAF3IP2|SIN3A|APOBEC3F|TNFAIP3|RNF216|MAVS
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN%GOBP%GO:0003100,0.48836401528308504,0.9081289531892159,0.521071969168459,0.9905029986755709,4217,3,EDN1
NEGATIVE REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045626,0.9103355704697991,1.0,0.5467026907807679,0.726270134566041,6781,1,JAK3
PROTOPORPHYRINOGEN IX METABOLIC PROCESS%GOBP%GO:0046501,0.863610049785805,0.991943445125448,0.3727641151394,0.70858536956697,7458,3,CPOX|IREB2
D-AMINO ACID TRANSPORT%GOBP%GO:0042940,0.17008220446914402,0.673117535978459,0.6617955222234481,1.25800366947098,1468,3,SLC1A2|SLC1A3|SLC1A1
POSITIVE REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902512,0.729889923793396,0.972554563883587,0.515820047597244,0.8430936973920551,6033,2,ST20
HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT%GOBP%GO:0048534,0.7339699863574349,0.9734087938149171,-0.102704315806816,-0.903483680606571,537,255,ITK|RORC|ACTN1|CEBPG|VCAM1|MFHAS1|DLL1|RUNX3|HSPA9|PIK3CD|GPR183|GATA2|PRKX|CD79B|NRROS|ZBTB16|HIPK1|BMI1|SOD1|FLCN|LRP5|CBFA2T3|BATF|IL11|VEGFA|KDR|FCER1G|TYROBP|IKZF1|TGFBR1|LGALS9|PTK2B|CD164|PDPN|VPRBP|CR2|CEBPA|HDAC4|ZNF385A|NFAM1|RET|TCTA|CITED2|MFAP5|G6PD|MEOX1|HDAC5|THOC5|CASP3|RUNX1|RELB|KITLG|IL6|PPARG|SNRK|LYN|ETV6|FCGR2B|SBNO2|MMP9|SBDS|FOXP1|CAMK4|CDC42|SLC25A38|TNFRSF11A|LEPR|ASH2L|KLF6|GLRX5|ADAM17|MECOM|MLF1|STAT3|GAB2|OSCAR|ARIH2|LYAR|FGF10|MYH9|SFRP2|IRF2BP2|ACE|TPD52|DYRK3
REGULATION OF MYELINATION%GOBP%GO:0031641,0.129324894514768,0.6100112725887421,-0.34605685484546994,-1.34071586993456,612,14,EIF2AK3|TENM4|TNFRSF1B|ZPR1|TNFRSF21|PARD3
BONE TRABECULA MORPHOGENESIS%GOBP%GO:0061430,0.732293986636971,0.972769769206295,-0.46622553074166,-0.797453800891354,4931,2,SEMA4D|PLXNB1
VIRAL GENE EXPRESSION%GOBP%GO:0019080,0.361687725631769,0.848418604328854,-0.241609858004435,-1.05957356200349,1602,19,MON1B|FURIN|EIF3D|USF1|PCBP2|EIF3G|EIF3B|EIF3A
REGULATION OF CHORIONIC TROPHOBLAST CELL PROLIFERATION%GOBP%GO:1901382,0.212630742751225,0.7279184739702909,-0.8928098808998679,-1.1943389992248201,1605,1,BOK
PEPTIDYL-LYSINE TRIMETHYLATION%GOBP%GO:0018023,0.91286660359508,1.0,0.17036084764819298,0.62269496340375,9648,19,WDR61|OGT|ZNF335|METTL20|SUV39H1|TET2|EEF2KMT|SUV39H2
PROTEIN LOCALIZATION TO EXTRACELLULAR REGION%GOBP%GO:0071692,0.641363411822822,0.9612805315220849,-0.368562186287839,-0.847616033124328,3894,4,NBL1
INTERLEUKIN-7-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038111,0.0410958904109589,0.402256981537283,0.420756462220614,1.5624788076868399,437,20,HIST1H3E|IL7R|CISH|HIST2H3C|HIST2H3A|SOCS2|IL7|IRS1|SOCS1|SMARCA4|STAT5B|HIST1H3H
POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903307,0.6015702553921128,0.9506035145731909,0.22111881470488395,0.898961144736232,6665,27,CACNA1G|CACNA1I|UNC13B|CACNA1H|F2RL1|ZP3|UNC13D|SCAMP5|RAB3A|STX1A|RAB15|SYT4|HYAL3
MRNA TRANSPORT%GOBP%GO:0051028,0.917678708685626,1.0,0.12199479911711199,0.6853239246184251,11938,105,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|UPF2|U2AF2|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS%GOBP%GO:0015980,0.930383912248629,1.0,0.116014914811415,0.69469924422104,12722,153,MTFR1|GAA|COX20|NR4A3|NDUFA7|D2HGDH|FH|NDUFS7|ETFDH|PGM5|SLC25A22|ACADVL|NDUFA4|NDUFS2|COX5A|COA6|PHKG2|NNT|NDUFC1|NDUFAF1|NDUFS4|TAZ|FASTKD1|COX6A1|AGL|NDUFS8|PDHA1|NDUFB2|UQCC3|SUCLG1|SIRT3|SDHA|MT-ND2|ACO1|ME3|NDUFV1|GYS1|DHTKD1|PPP1R3C|NDUFS3
REGULATION OF NMDA RECEPTOR ACTIVITY%GOBP%GO:2000310,0.280265339966833,0.788916642629372,-0.3137466001191889,-1.14301033613539,1351,12,CRH|RELN|EPHB2
REGULATION OF BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0098905,0.480920564216778,0.9046812288131709,-0.5721532947339399,-0.9786375680719921,3238,2,GJA5|RANGRF
REGULATION OF RENAL ALBUMIN ABSORPTION%GOBP%GO:2000532,0.544287038262942,0.929758904310055,-0.722761358623732,-0.966859906240049,4110,1,GAS6
ODONTOGENESIS%GOBP%GO:0042476,0.173285198555957,0.676682497340677,-0.22802886203717398,-1.2395664814856298,623,35,AQP5|FAM20C|SCN5A|AQP1|TUFT1
ENDOSOMAL LUMEN ACIDIFICATION%GOBP%GO:0048388,0.989530201342282,1.0,0.505679311865902,0.6717724058603289,7371,1,CLCN3
RESPONSE TO UNFOLDED PROTEIN%GOBP%GO:0006986,0.769895126465145,0.9792758096555699,-0.11061927178086599,-0.856271256801303,1247,127,DCTN1|YOD1|HSP90AA1|EDEM1|TMBIM6|CTDSP2|TSPYL2|GOSR2|MYDGF|HSPA9|WIPI1|HSPB7|CALR|ATF4|HSPA4|HSPB1|BAX|DNAJC3|CREB3|RHBDD1|ADD1|EIF2S1|KLHDC3|HSPA13|DAB2IP|HSPA5|EIF2AK3|TATDN2|HYOU1|DDIT3|AMFR|ATF6|LMNA|PTPN1|HSPA4L|BAG3|CREBRF|CXCL8|HSF1|SHC1|ATP6V0D1|ASNA1|HSPA6|SSR1|VAPB|PARK2|HSPB8|HSP90AB1
POSITIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901995,0.9100382077110111,1.0,0.34328562477571695,0.652549860406397,7859,3,CDC25C|CDC25A
ESTABLISHMENT OF GLIAL BLOOD-BRAIN BARRIER%GOBP%GO:0060857,0.8804026845637579,0.9956508825790341,0.5608182620202911,0.7450220412174681,6558,1,MXRA8
LIPOPROTEIN LOCALIZATION%GOBP%GO:0044872,0.4684413018612871,0.896021389039524,0.36376518035199606,0.99172147383368,4504,8,UNC119|MIA3|PRKCB|ZDHHC17
FLAVIN-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042727,0.808636748518205,0.984682960940884,0.483326076525165,0.7899831943363449,6684,2,RFK|FLAD1
VALINE CATABOLIC PROCESS%GOBP%GO:0006574,0.939123979213066,1.0,-0.35891921698373297,-0.613912098166981,6324,2,HIBADH|ALDH6A1
PROSTATE GLAND DEVELOPMENT%GOBP%GO:0030850,0.4763708216696861,0.902548584563741,-0.4214163827337021,-0.9691696433214121,2892,4,PSAP|CRIP1
POSITIVE REGULATION OF CELL AGING%GOBP%GO:0090343,0.6893001975668089,0.96731875442989,0.30146391491680896,0.821871509856093,6628,8,SIRT1|CDKN2A|ARG2|YPEL3
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0043618,0.000351864883884588,0.0784645998831315,-0.34250987476039296,-2.17491538854927,0,58,HIF3A|ATF4|HIF1A|NOTCH1|VEGFA|IMPACT|MAPK7|HMOX1|HSPA5|LIMD1|HIGD1A|CITED2|BACH1|DDIT3|ATF6|NEDD4|VHL|BAG3|TCEB1|HSF1|JUN|UBA52|TP53|UBC|SESN2|EPAS1|RBPJ|UBB|EGLN3
VACUOLAR PROTON-TRANSPORTING V-TYPE ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070072,0.397624350408315,0.8638522656500329,-0.615778094241732,-1.05325545123526,2677,2,VMA21
NEGATIVE REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032715,0.863029465930018,0.991943445125448,-0.15850401500643202,-0.7072299347897859,3748,20,GAS6|GBA|PTPN6|SYT11|CX3CL1|SIRPA|TNFAIP3|ARRB1|TNF
SYNAPTIC VESICLE RECYCLING%GOBP%GO:0036465,0.6054068105016899,0.9508825506493929,-0.17623052219763,-0.901903950012639,2328,29,SYT2|RAB5A|PLD2|AMPH
AMINERGIC NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE%GOBP%GO:0015842,0.9217520415738679,1.0,-0.371546732837055,-0.635510787747598,6207,2,SLC18A2|SLC18A1
POSITIVE REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010753,0.551833708460215,0.9321968967758479,-0.7183502426113809,-0.9609590218565279,4167,1,MB21D1
POSITIVE REGULATION OF SARCOMERE ORGANIZATION%GOBP%GO:0060298,0.0136688036772711,0.256136946817111,0.919602977667494,1.5030658040258997,112,2,EDN1|PROX1
CYTOPLASMIC SEQUESTERING OF CFTR PROTEIN%GOBP%GO:0043004,0.35785234899328905,0.8457817541997791,0.825981473312748,1.09727953764995,2665,1,GOPC
NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033085,0.5721290041403361,0.940729590703743,0.39831164750516207,0.9180493011827231,5250,5,BMP4|ZC3H8|KIAA0922|PTPN2|FOXJ1
REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903670,0.051948051948052,0.44586532408291796,-0.22261682164162197,-1.39772322270947,151,56,EPN1|FGF1|SRPX2|DLL1|TBXA2R|GATA2|RHOJ|NOTCH1|VEGFA|KDR|HMOX1|MMRN2|RHOA|ITGA5|HDAC5|PKM|FGF2|MAP2K5|ADAMTS9|SMAD1|APLNR|MEOX2|FOXC2|PDCD10|BMPER|TMEM2|GLUL
REGULATION OF RAP PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032487,0.229466553767993,0.743365122901021,0.719173599625797,1.1754694917338602,1896,2,KIF14|RDX
D-XYLOSE METABOLIC PROCESS%GOBP%GO:0042732,0.196478220574606,0.7100128962886071,-0.9003639170710191,-1.2044442637316,1483,1,DHDH
HISTONE H3-K4 METHYLATION%GOBP%GO:0051568,0.7000828500414251,0.96807298571782,0.210842371339315,0.820008841800568,7604,23,WDR61|OGT|KMT2B|PAGR1|ZNF335|PAXIP1|KMT2D|WDR5|TET2|SETMAR
RESPONSE TO INTRA-S DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072429,0.025086795833799996,0.329326373353219,0.748855677494072,1.5868967150313702,223,4,MUS81|FBXO18|SLX4|EME1
REGULATION OF INTRACELLULAR CALCIUM ACTIVATED CHLORIDE CHANNEL ACTIVITY%GOBP%GO:1902938,0.7759767751300349,0.980614374126555,0.49584456982929603,0.8104443277388191,6414,2,ANO9
NEGATIVE REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050672,0.9775153105861769,1.0,0.118110191405499,0.521342684816765,11172,36,GLMN|BMP4|MARCH7|DLG5|BTN2A2|PLA2G2D|CEBPB|CTLA4|ATM|RC3H1|TNFRSF14|XCL1|MNDA|PDCD1LG2|NDFIP1|FOXP3|SDC4|LILRB2|KIAA0922|LST1|SOX11|CD300A
POSITIVE REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010650,0.459060402684564,0.890371861972445,0.7758050286722541,1.0306223694749599,3419,1,ANK3
NEGATIVE REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900113,0.506458797327394,0.9172434440873181,-0.559746346843121,-0.9574161481783721,3410,2,PIH1D1|SMARCB1
REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000501,0.219501718213058,0.734713083559597,0.501875588584353,1.23428991898533,2043,6,KLRK1|CCL5|CCL2|XCL1|CCL4
EMBRYONIC HINDLIMB MORPHOGENESIS%GOBP%GO:0035116,0.287008166295471,0.796019542850327,-0.6873800158163691,-1.17572670333504,1932,2,AFF3
PYRIDINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0070638,0.961098737936154,1.0,-0.340225806213163,-0.581938020198962,6472,2,PNP
MYOFIBRIL ASSEMBLY%GOBP%GO:0030239,0.0918689648948651,0.5622489437340121,0.347780601638471,1.4139061308882401,1017,27,NEB|IGSF22|ACTN2|MYH3|PROX1|TCAP|OBSCN|KRT19|NEBL|LMOD1|OBSL1
MICROTUBULE ORGANIZING CENTER ORGANIZATION%GOBP%GO:0031023,0.03897029702970299,0.396089810860281,0.2765831601735,1.47726484503552,491,80,CCDC78|CALML4|CNTLN|SDCCAG8|CEP63|CENPJ|CDK1|PKD2|WDR62|CKAP5|CEP152|CROCC|NEK2|STIL|HAUS5|CDK5RAP2|CETN3|CEP72|TUBE1|HAUS8|SASS6|CNTROB|SYNE2|PLK1|RTTN|BRSK1|PPP1R12A|BRCA2|XRCC2|CEP135|PCM1|SGOL1|CHD3|CDK2|CEP120|UXT|C2CD3|NDE1|CEP250
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050679,0.276144578313253,0.7884684708511421,-0.151649752242849,-1.11142828116766,572,100,VEGFA|KDR|PTPRN|RTN4|C5AR1|TGFBR1|NRAS|HMOX1|PRKD2|STXBP4|PDCL3|FGF7|ZNF580|NRP1|ZNF703|FGF2|LAMC1|APLNR|VIP|IGF1|FGFR1|ADAM17|STAT5A|MMP12|PRKCA|SCG2|FGF10|THBS4|SCN5A|PGF|CDH13
NEGATIVE REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048671,0.545675581799236,0.930420772651609,0.4998444095985421,0.9501516409886078,4712,3,FGF13|PTPRS
REGULATION OF HISTONE H3-K79 METHYLATION%GOBP%GO:2001160,0.23575662271682601,0.750277765814412,0.716190924099935,1.1705943905257299,1948,2,WDR61|CTR9
POSITIVE REGULATION OF ATPASE ACTIVITY%GOBP%GO:0032781,0.283491561181435,0.7927023385888341,-0.21751813861164898,-1.1284910739831298,1074,30,TOR1AIP2|TNNT2|DNAL4|TMSB4X|DYNLL2|FGF10|MYL4|GABARAPL2
POSITIVE REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902117,0.278,0.788483986984073,-0.18145852683978503,-1.11921708198267,833,53,SH3GLB1|HAP1|VPS4B|PIP4K2A|MARK4|CAPG|SEPT9|ASAP1|RALB|HTT|KCTD17|TNF
EYE PIGMENT BIOSYNTHETIC PROCESS%GOBP%GO:0006726,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
CARDIAC MUSCLE TISSUE GROWTH INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003245,0.0598437706871442,0.47655410709209,-0.9695081605646229,-1.2969406264433,451,1,S1PR1
NEGATIVE REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902116,0.302834008097166,0.8054013181463249,0.27624091503600606,1.13276131979721,3365,28,TBC1D30|KAT2A|EVI5L|CDK10|CDK5RAP2|TRIM37|CEP97|TCHP|MDM1|STYXL1|TBC1D7|BRCA1|SEC22B|PINK1|KAT2B|SCFD1|ODF2L
RESPONSE TO VITAMIN K%GOBP%GO:0032571,0.309576837416481,0.81178854572317,-0.675213675213675,-1.1549168293216598,2084,2,POSTN|GAS6
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0040019,0.8250215372834309,0.9876441563834109,0.204084987791478,0.707507306885995,8618,16,WNT4|HES1
TRNA TRANSPORT%GOBP%GO:0051031,0.497081043956044,0.911847493238374,-0.375413633355394,-0.9503346840916391,2894,5,XPOT|NOL6|SSB|RAN|TOMM20
"WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:0035313",0.0326236263736264,0.36828894094998404,-0.666741365909127,-1.6878114938948998,189,5,ITGA5|ADAM17|MMP12|ACVRL1
REGULATION OF CENTROMERIC SISTER CHROMATID COHESION%GOBP%GO:0070602,0.939522902900661,1.0,0.284867318989442,0.603661060882746,8388,4,NAA10|CTCF
NEGATIVE REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070885,0.13178445919562698,0.6161723401295239,-0.418378464846251,-1.3505631763169301,674,9,PRNP|CHP1|ATP2B4|HOMER2
MULTINUCLEAR OSTEOCLAST DIFFERENTIATION%GOBP%GO:0072674,0.528285077951002,0.9265056012720759,-0.550813344361731,-0.9421367258549659,3557,2,SH3PXD2A|TCTA
ENDOTHELIAL TO HEMATOPOIETIC TRANSITION%GOBP%GO:0098508,0.912059997580743,1.0,0.42795881882888304,0.6994869326593169,7539,2,METTL3|YTHDF2
PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046122,0.5781808552892889,0.942692029750853,-0.7047860608734009,-0.942813802377198,4366,1,DGUOK
POSITIVE REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032728,0.9801884513167429,1.0,-0.118220165878976,-0.555506673534453,4056,23,POLR3F|RNF135|FLOT1|RIOK3|POLR3C|POLR3D|DDX3X|MAVS|RIPK2
POSITIVE REGULATION OF TIGHT JUNCTION DISASSEMBLY%GOBP%GO:1905075,0.937045285820341,1.0,-0.36145574855252294,-0.618250699567454,6310,2,TGFB3|TGFBR1
RESPONSE TO NITROGEN COMPOUND%GOBP%GO:1901698,0.00529100529100529,0.16770443270936902,-0.138955996884333,-1.33258499722125,0,481,ADCY7|TRIM13|IMPACT|FCER1G|HSPA13|RAB13|RRAGD|PRKCD|CTNNB1|IGF1R|CPEB1|NSMF|UBE2J1|USF1|BCAR1|FOXO4|HLCS|HSPA5|RRAGC|OS9|GRB2|ABL1|CRHR1|SGTB|RAB8B|GNAQ|FYN|STUB1|SLC9A1|INPP5K|HDAC5|DGKQ|FOXO1|RNF139|CASP3|PKM|VIM|CPEB2|GNA15|ATP6V0C|PXN|ATP6V1F|IL6|PPARG|SH3BP4|LYN|FCGR2B|PRNP|AMFR|VAMP2|CHRNA7|HTR1B|NAMPT|CAMK2A|ABCA1|PRKAR2A|GCGR|LAMTOR5|IGF1|MAVS|FOXC2|LPIN1|ATP2B4|RIPK2|RAP1A|CTNNA1|NPM1|RAB8A|PTPN1|SHMT2|RNF103|LDOC1|SNCA|ARHGEF2|FMR1|PDE4B|RYR1|RFTN1|TRIM25|HRH3|ADRB2|CHRNA3|NLRP1|PDE12|SLC25A33|STAT5A|HSF1|RAPGEF1|SHC1|JUN|ATP6V1E2|ATP6V0D1|GABRG2|STAT3|CD9|TP53|COLEC12|PRKAR1B|ADCY2|GSTM3|RALB|DRD2|MAPK3|CAV2|GSTM1|PARK2|ATP6V1E1|RHOQ|SLC3A2|TICAM1|CHRM1|MYD88|PLCB1|IGF2|CD36|SESN2|PIK3R1|CDH13|PDE3A|AQP1|HRH1|PMAIP1|CAV1|FOXO6|VGF|TRIB3|INHBB|APPL1|FOXO3
PROTEIN LOCALIZATION TO PERICENTRIOLAR MATERIAL%GOBP%GO:1905793,0.335309060118544,0.8311444145897029,0.6716562491209079,1.0978036877116,2771,2,GOLGB1|NUDCD3
SENSORY PERCEPTION OF TASTE%GOBP%GO:0050909,0.189722931813716,0.6980674236318481,0.404238715532705,1.27430489261318,1930,12,RTP5|TAS2R4|RTP4|TAS2R5|ASIC1|ASIC3|TAS2R20
GLYCINE TRANSPORT%GOBP%GO:0015816,0.018927091499608,0.286396032442422,0.766877881887572,1.6250874877118602,168,4,SLC36A1|SLC6A17|SLC6A9
POSITIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904031,0.6976948408342479,0.96731875442989,-0.20200730617460003,-0.8272878115157729,3177,16,CCNYL1|CCNY|HSP90AB1
REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030852,0.865482233502538,0.9929389166575431,-0.212189465377023,-0.684966608990967,4432,9,TESC|HAX1|RARA|RUNX1
POSITIVE REGULATION OF CARDIAC MUSCLE MYOBLAST PROLIFERATION%GOBP%GO:0110024,0.14692601597777,0.638549298625996,0.677605102486215,1.28805601844508,1268,3,MEIS2|GATA6|ATF2
ACTIN FILAMENT REORGANIZATION%GOBP%GO:0090527,0.792589901925173,0.9819233677232551,-0.254620290755048,-0.7427386846072671,4363,7,GSN|EFS|BCAR1|WHAMM
DIPHOSPHOINOSITOL POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0071544,0.9340939597315441,1.0,0.5357300397000441,0.71169345712997,6958,1,NUDT3
LYSINE METABOLIC PROCESS%GOBP%GO:0006553,0.5530176415970289,0.9326400369132779,-0.293121518009819,-0.911149305262758,2977,8,PHYKPL|AASS|AADAT|PIPOX|AASDHPPT|HYKK|ALDH7A1|GCDH
DYNAMIN FAMILY PROTEIN POLYMERIZATION INVOLVED IN MEMBRANE FISSION%GOBP%GO:0003373,0.0520335913057797,0.44586532408291796,-0.688027353443997,-1.5823191789723603,315,4,DNM1L|OPA1|MX1|MX2
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903818,0.6564647766323021,0.9643779777660141,0.343600054215485,0.845034292815985,6112,6,LRRC55|RNF207|KCNIP2
REGULATION OF ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032012,0.11783189316575,0.6006198777217571,-0.691959854417117,-1.4043119655093799,749,3,ARFGAP1|MAPRE2|MAP4K4
ENZYME ACTIVE SITE FORMATION VIA CYSTEINE MODIFICATION TO L-CYSTEINE PERSULFIDE%GOBP%GO:0018192,0.33019992056136604,0.8291761235173739,-0.836733568592854,-1.11932400649929,2493,1,MOCS3
DOLICHOL BIOSYNTHETIC PROCESS%GOBP%GO:0019408,0.6453368815773559,0.9627442659042059,0.550003226127059,0.8989651636321899,5334,2,SRD5A3|NUS1
AMYLOID-BETA FORMATION%GOBP%GO:0034205,0.0326236263736264,0.36828894094998404,-0.666832120008824,-1.6880412318719,189,5,APH1A|PSEN1|PSENEN|DYRK1A|NCSTN
CALCIUM ION REGULATED EXOCYTOSIS%GOBP%GO:0017156,0.668355713199899,0.964618776001639,0.18069070585220498,0.8570518220219859,7913,47,SYT17|RIMS2|UNC13B|SYT3|SYT15|UNC13A|CPLX3|PCLO|SNAP47|PRRT2|STX2|SYT1|SEPT5|RIMS4|ARHGAP17|RAB3A|SYT7|STX3|SNAPIN|PIP5K1C|STX1A|RIMS1|RIMS3|SYT4|STX1B|PPP3CB
PYRAMIDAL NEURON DEVELOPMENT%GOBP%GO:0021860,0.701705576388049,0.968941691852291,0.528535980148883,0.863877539820607,5800,2,FGFR2|ATP7A
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION%GOBP%GO:0086070,0.48038503450781,0.9046812288131709,-0.331845561409831,-0.9680082252808889,2644,7,GJC1|SCN5A
TRIMMING OF SECOND MANNOSE ON A BRANCH%GOBP%GO:0036512,0.808636748518205,0.984682960940884,0.48333434592084495,0.78999671043641,6684,2,MAN1B1|EDEM2
PHENOL-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0046189,0.246832976028065,0.758826975311078,0.364191530217422,1.2066797146508301,2532,14,CITED1|PNMT|TGFB2|DDC|HAND2|TH|TRPC1|MOXD1
CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072111,0.35290913052952705,0.842847021021096,0.475606731993068,1.0962030125879698,3238,5,GPC3|EGR1|STAT1|BMP2|PDGFRB
POSITIVE REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000774,0.479780960404381,0.9046812288131709,0.37878255363346097,0.985891404849155,4555,7,SIRT1|CDKN2A|ARG2|YPEL3
POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090277,0.968248399263222,1.0,0.12527362507493597,0.548843324838991,11038,35,GHRL|TFR2|INS|ADCY8|CAPN10|UCN|GCK
DICHOTOMOUS SUBDIVISION OF TERMINAL UNITS INVOLVED IN LUNG BRANCHING%GOBP%GO:0060448,0.127763802462598,0.6076669536424699,-0.933833259814733,-1.24921722399157,964,1,CTSH
POSITIVE REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070886,0.034517561566411004,0.379078740472774,-0.47071732624642604,-1.65651291739698,170,11,SLC9A1|IGF1|CAMTA1|TNF
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000586,0.9095663543255609,1.0,0.273985636850699,0.631496276898676,8347,5,HIP1R|HIP1|LRP1|PTPN2
ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL%GOBP%GO:0075509,0.0350353495679497,0.381265913354899,-0.7883523769120501,-1.5999377259652299,222,3,CAV2|CAV1
OXYGEN TRANSPORT%GOBP%GO:0015671,0.17010309278350502,0.673117535978459,0.52704129396013,1.29618130632515,1583,6,HBB|HBA2|HBA1|CYGB|NGB|MYC
N-TERMINAL PROTEIN AMINO ACID ACETYLATION%GOBP%GO:0006474,0.9737867862015199,1.0,0.155810440873338,0.516248409787057,9992,14,NAA40|NAA10
PROPIONATE CATABOLIC PROCESS%GOBP%GO:0019543,0.6981208053691271,0.96731875442989,0.655161005734451,0.870352167313535,5200,1,PCK2
PROTEIN KINASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007205,0.401103230890465,0.8638522656500329,-0.304436522946319,-1.02995432518143,2035,10,CHRM1|PARD3
REGULATION OF TORC2 SIGNALING%GOBP%GO:1903939,0.891859199225838,0.9976191001250191,0.44030879514750504,0.7196726296784091,7372,2,TELO2|PIH1D1
PATTERN SPECIFICATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061227,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
CELLULAR RESPONSE TO MONOAMINE STIMULUS%GOBP%GO:0071868,0.6663539125539499,0.964618776001639,0.22714798976272602,0.8435138900536651,7101,20,RYR2|NR4A3|KCNQ1
DETECTION OF OXYGEN%GOBP%GO:0003032,0.937045285820341,1.0,-0.36145574855252294,-0.618250699567454,6310,2,TGFB3|CYB5R4
REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032409,0.000778210116731518,0.0849637591935908,-0.206052473797183,-1.6615639826604098,0,160,PRKCD|KCNE3|FKBP1B|PTPN3|PTK2B|CRHR1|SCN1B|KCNE4|SLC9A1|PLN|RANGRF|YWHAH|KCNAB1|PPARG|PRNP|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|CRACR2A|CAB39|TMSB4X|CRH|SNCA|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|BCL2|RELN|FXYD5|YWHAE|KCNG1|HTT|ADRA2A|JPH1|SLC9A3R1|CACNG3|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
ATP BIOSYNTHETIC PROCESS%GOBP%GO:0006754,0.0392670157068063,0.396089810860281,-0.24180077278200698,-1.4734857586539,119,51,ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|PFKL|COX5B|GPI|PKM|ENO1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
NUCLEAR PROTEIN QUALITY CONTROL BY THE UBIQUITIN-PROTEASOME SYSTEM%GOBP%GO:0071630,0.692694422623724,0.96731875442989,-0.4029721782797229,-0.817820062989475,4408,3,KLHL15
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048662,0.0184262948207171,0.285441766913764,-0.347776401447528,-1.70768412904332,73,26,CDKN1B|GPER1|TRIB1|HMOX1|TNFAIP3|IGFBP3|MFN2|APOD|PPARG|VIP|SOD2|PDCD4|CDKN1A
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045662,0.277841322657793,0.7884684708511421,0.42798718242856304,1.1668078811976101,2671,8,TBX3|BMP4|SRA1
CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:0061577,0.549033229130485,0.931134965065115,0.49827638825385795,0.947170997362016,4741,3,CACNA2D1|CACNB3|CACNA1C
EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0009913,0.8606121932709341,0.9916689277956879,0.148536672204099,0.7074855824400631,10205,48,KRT7|CDH3|STRC|KRT8|DFNB31|JAG2|PDZD7|KRT19|PPL|MED1|KRTAP5-1|TGM1
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA%GOBP%GO:0071559,0.179537629119528,0.68489956912038,-0.160323399992858,-1.18084132921107,364,102,MAPK7|F11R|SKI|TGFBR1|ACVR1|ARRB2|GDF15|RHOA|KLF10|CDH5|PXN|SMAD1|SMAD2|SMAD7|MXRA5|SOX6|NR3C1|JUN|UBA52|ID1|LIMS1|CLEC3B|ZYX|ACVRL1|WWOX|UBC|PDE3A|PARD3|UBB
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001270,0.43405236291783295,0.878651088001772,-0.4362850857209871,-1.00336455401131,2635,4,RPS3|PAK2
SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT%GOBP%GO:0072395,0.53826304330296,0.926918400763264,0.182557336473663,0.950352058861375,6674,71,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|DTL|E2F7|GEN1|GTSE1|BRCC3|CHEK2|PLK1|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CHEK1|CASP2|CDK2|ATM|CNOT1|UIMC1|BRCA1|BRE|PCBP4|MDM2
POSITIVE REGULATION OF EOSINOPHIL DEGRANULATION%GOBP%GO:0043311,0.604088544816741,0.9508825506493929,0.5649361283526679,0.923372582089127,4993,2,F2RL1|STX4
NEGATIVE REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:0090086,0.854831107619796,0.991298302704726,-0.342781515385464,-0.695664900988709,5440,3,TRIM21|UBXN1|PARK7
NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002725,0.508315494813107,0.918237678197337,-0.409639883086086,-0.9420861543288459,3086,4,XCL1|FOXP3|HFE|SMAD7
HISTONE MODIFICATION%GOBP%GO:0016570,0.802032947774273,0.9841546650056641,0.129479141456151,0.828433920695121,11440,250,CPA4|SIRT1|PRMT9|HDAC10|JADE3|WDR61|EHMT1|MTA2|AK6|KAT2A|KDM5D|MIER2|NAA40|DOT1L|TADA1|OGT|TAF6L|C14orf169|MTA1|PCGF2|YEATS4|JAK2|DDB2|KDM5B|TRRAP|PRKCB|MAP3K7|EP400|EZH2|KMT2B|PAGR1|NEK11|UHRF1|HDAC8|LEF1|AURKB|HUWE1|DDB1|ING5|HDAC3|TRIM37|APBB1|YEATS2|SMARCAD1|KDM4B|HDAC6|BRCC3|BRPF3|ZNF335|CUL4B|PRMT1|SFPQ|KDM1A|CARM1|RNF40|NSD1|MYSM1|CDC73|MSL1|PAXIP1|KAT8|BRCA2|KDM3B|MAP3K12|VRK1|EHMT2|SUPT3H|RPS6KA4|KMT2D|WDR5|KDM8|UBE2B|UBR2|BRD1|SUDS3|KDM4A|SIN3B|CDK2|SETDB2|PCGF1|CCDC101|PCGF3|UIMC1
POSITIVE REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051586,0.8593261549149008,0.99166790097654,0.37498486242108203,0.712806776535603,7421,3,DRD4|RAB3B
MODULATION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0052031,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:2001054,0.326503340757238,0.826792328177465,-0.664074993107251,-1.1358647101282802,2198,2,TBX1|PAX8
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050856,0.960214791310715,1.0,-0.124051802656555,-0.594637600146646,3933,24,TRAT1|TESPA1|PTPRJ|PTPN22|LCK|PHPT1|RC3H1|RAB29|PTPN2|CD300A|LILRB4|PVRIG|KCNN4|RELA|EZR|THY1|PVRL2|PRKD2|RPS3|PRNP|LGALS3|DUSP3
ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0002363,0.785886722376973,0.981487311948134,-0.24050791235151897,-0.747603310521689,4231,8,ZFPM1|FOXP3|LY9|SPN|BATF|IL6|STAT3
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051279,0.7742483438083909,0.980173768720877,0.166340577977246,0.7758708179139928,9115,44,RYR2|JSRP1|LIME1|F2R|CXCL9|PKD2|PDPK1|JPH4|SEPN1|CXCL10|PLCG1|DMD|TRPC1
RNA TRANSPORT%GOBP%GO:0050658,0.845559845559846,0.991298302704726,-0.10329977680187,-0.8174382896869159,1313,137,PA2G4|MAGOH|DDX19B|THOC5|SEH1L|NMD3|RBM15B|AGFG1|ARC|ZNF593|NPM1|FMR1|PHAX|RFTN1|EIF5A|RRS1|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071624,0.37365532381997796,0.852609194081082,-0.253772043769754,-1.039281809603,1701,16,CAMK1D|C1QBP|CXCL8|THBS4|RAC1
"POSITIVE REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060100",0.744497711919808,0.9749763305090959,0.33960597786426094,0.782741435277057,6832,5,ABCA7|F2RL1
SYNAPTONEMAL COMPLEX ORGANIZATION%GOBP%GO:0070193,0.475568660488627,0.9014412940771601,0.380035044333383,0.98915137499261,4515,7,SYCP2|BAG6|STAG3|P3H4|SYCE2|TRIP13
AUTOPHAGOSOME MATURATION%GOBP%GO:0097352,0.0712151394422311,0.514511211182091,-0.29201459902050897,-1.43387732497287,285,26,VPS16|GABARAPL1|GABARAP|WIPI2|MAP1LC3B|GABARAPL2
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904752,0.322949840764331,0.8233331762466272,0.36810045917252204,1.1229901215876499,3244,11,NR4A3|IGFBP5|DOCK7|FGF9|PRKG1|TPM1|ADAMTS1|PDGFB|MEF2C|DOCK4
PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009126,0.7535657686212359,0.9769690538700708,-0.108853656036646,-0.8866944331408549,950,167,PFKL|COX5B|GPI|NDUFB10|SDHC|GMPS|ATIC|UQCRC1|NUDT4|PKM|ENO1|MT-ND5|HPRT1|ATP5I|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|COX4I2|NDUFS6|PGAM2|AK4
PROTEIN TRIMERIZATION%GOBP%GO:0070206,0.701748095024653,0.968941691852291,0.19875153743308102,0.8232957962475191,7827,29,SLC1A2|MGST1|TRIM27|DISP1|C1QTNF3|TRIM34|TRIM4|ASIC1
TYPE I INTERFERON PRODUCTION%GOBP%GO:0032606,0.5699406428491429,0.940399221502905,0.437577437047124,0.9272683886775022,5088,4,TBK1|TRIM56|IRF7|TMEM173
POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001200,0.686126373626374,0.9665006495129341,-0.322088470089954,-0.8153455742581591,3995,5,LGALS1|LGALS9|LGALS3
LIPID A BIOSYNTHETIC PROCESS%GOBP%GO:0009245,0.737587713491328,0.974306231601101,-0.626433612704014,-0.8379993435148921,5570,1,NDUFAB1
ACTIN FILAMENT BRANCHING%GOBP%GO:0090135,0.721435191314709,0.9713770803161691,-0.634428760476401,-0.848694696460025,5448,1,CORO1B
PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0030422,0.800185701021356,0.9840257959912879,-0.23711234181682,-0.737048398843187,4308,8,AGO2|HENMT1
REGULATION OF CELL MORPHOGENESIS%GOBP%GO:0022604,0.7634194831013921,0.978421368343614,-0.0996759893736391,-0.8992389091628599,383,307,CALR|THY1|CRKL|S100A10|DCC|RND1|BCL9L|RHOG|MYO10|HECW2|FMNL1|PARVB|ARHGDIA|RNF6|CDC42EP5|CHRNB2|VEGFA|BVES|NEDD4L|KDR|DNM2|LPAR1|TUBB2B|RTN4|NSMF|PTK2B|PDPN|DLC1|FGD4|FGR|ZMYM5|ABL1|SEMA3F|LIMD1|MAP3K13|BHLHB9|FYN|RHOA|NRP1|FMNL3|C1QBP|CPNE6|MYADM|SEMA7A|DOCK5|YWHAH|RND2|EFNA1|KIF13B|POU4F2|BRWD1|ISLR2|ARC|CRK|RHOC|LIMK1|AMIGO1|FMR1|CDC42|MSN|NEDD4|SEMA6B|PLXNA1|CHRNA3|ARPIN|SSH3|LIMS1|PLXNA4|RELN|PDZD8|TWF2|SEC23A|WDPCP|MFI2|SYT2|ALDOA|MYH9|SDC2|SLC9A3R1|RHOQ|SEMA3A|RAC1|CORO1C|SEMA3G|CPNE9|OLFM1|DLG1|LINGO1
REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090270,0.5181197174945,0.9236324326350509,0.509470807020339,0.9684504098284459,4474,3,PTGS2|ROCK2|RGCC
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:2000249,0.626880897730171,0.9548215347474809,-0.17736057426836,-0.883822690719683,2457,27,SEMA3E|HRAS|NTRK3|CSF1R|BAIAP2L2|PHPT1|BAIAP2L1|TRPM2|PDGFRA|DAPK3|TEK|HCLS1|RAPGEF3|HCK|ARHGDIB|BAIAP2|FES|ABL2|CDK5|ARHGDIA|HAX1|BCAS3|F11R|PTK2B|ABL1|NRP1|CDC42
SODIUM-DEPENDENT ORGANIC CATION TRANSPORT%GOBP%GO:0070715,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
SOMITE ROSTRAL/CAUDAL AXIS SPECIFICATION%GOBP%GO:0032525,0.014496644295302001,0.262734483145539,0.993162770180856,1.3193724320528,107,1,RIPPLY2
REGULATION OF DEFENSE RESPONSE TO VIRUS%GOBP%GO:0050688,0.972840314136126,1.0,-0.0983363792659343,-0.599242313160736,2972,51,ZMPSTE24|MUL1|RIOK3|ITCH|TRAF3IP2|SIN3A|APOBEC3F|TNFAIP3|PCBP2|TRAF3|C1QBP|GLTSCR2|RNF216|MAVS|GPATCH3|TRAF3IP1
BASAL DENDRITE ARBORIZATION%GOBP%GO:0150020,0.311861743912019,0.8143712300420921,-0.548859102404894,-1.11389324101064,1984,3,NRP1|SEMA3A
FACE DEVELOPMENT%GOBP%GO:0060324,0.941092228375024,1.0,0.16410033464722001,0.5787581821570021,9856,17,MYH3|LEF1|NIPBL|CHD7|CLDN5|TGFB3|LRP6
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002474,0.374509211718514,0.852609194081082,-0.18278130154842,-1.05246794278732,1239,42,B2M|SEC23A|ERAP2|ACE|CD36|BCAP31
REGULATION OF CELL MATURATION%GOBP%GO:1903429,0.15951236263736301,0.661359103221672,-0.514780498566071,-1.3031326489365902,928,5,SIRT2|EDNRB|YTHDF2|MAP3K13|GAL
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901570,0.32210943302797695,0.822751772025005,0.22358473392143696,1.11002306687024,3902,57,EDN1|HACD1|MGST1|BDH2|SCD5|ELOVL6|GGT1|FAR2|FAR1|FADS1|MGST3|SLC25A1|ACACA|PTGS2|MGST2|GGT5|LTA4H
REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000369,0.0861239320436021,0.5498451960578621,0.44547093582868896,1.4377002921347999,876,13,PROM2|UNC119|SNAP91|HIP1R
REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051095,0.35232855177834493,0.842847021021096,0.347486184536969,1.09540063347822,3585,12,GTF2H2|SIRT1|MSH6|POT1|MNAT1|IFIT1|MSH3
POSITIVE REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032755,0.0283254651485698,0.346236266895247,-0.287482763541235,-1.56275830395751,101,35,CYBA|TLR1|IL6R|IL17D|PYCARD|IL1RN|IL1B|LGALS9|IL6|MBP|MAVS|ARHGEF2|STAT3|ADCYAP1|MYD88|TWIST1|TNF
CHROMATIN REPROGRAMMING IN THE ZYGOTE%GOBP%GO:0044725,0.810936051899907,0.9852684165902109,-0.5920269078076751,-0.7919724453234219,6124,1,TET3
CELLULAR RESPONSE TO CORTICOTROPIN-RELEASING HORMONE STIMULUS%GOBP%GO:0071376,0.0111994624258036,0.22992267312754103,0.7897863915083749,1.6736328079332,99,4,NR4A2|NR4A3|NR4A1
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002589,0.5820341499628809,0.943249589738259,-0.529197684036394,-0.905164296529193,3919,2,HFE|TAPBPL
PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0045332,0.368080315256146,0.851675851059934,0.290988890312274,1.08058702648481,3922,20,ATP10A|ATP11C|ABCA7|ABCB4|ATP10D
LATERAL INHIBITION%GOBP%GO:0046331,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
INSULIN SECRETION%GOBP%GO:0030073,0.180535380784395,0.686059302700865,-0.333925940752063,-1.25755871008794,869,13,PARK7|CYB5R4|PTPRN|RAB11FIP2|ADCYAP1|RAB11FIP5|GAL
HEME BIOSYNTHETIC PROCESS%GOBP%GO:0006783,0.757189901207464,0.977664504547119,-0.191827186956073,-0.7855968018748359,3448,16,NFE2L1|SLC25A38|FXN|COX10
NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900425,0.804282085399782,0.984530683443403,0.48535980148883395,0.7933072619197691,6648,2,MAPKBP1|SIRT2
REGULATION OF MICROTUBULE-BASED MOVEMENT%GOBP%GO:0060632,0.0342314487632509,0.3781901420735139,-0.386787076906869,-1.6275555324081699,154,17,C21orf59|LAMP1|TCTEX1D2|HAP1|NEFH|MKKS|CFAP20|DNAAF1
CELLULAR RESPONSE TO ENVIRONMENTAL STIMULUS%GOBP%GO:0104004,0.9208794387792,1.0,0.11665458843118699,0.713319608873323,12732,178,PTPRK|SIRT1|INTS7|AKR1B1|STK39|PIEZO2|LIG4|ATR|PKD2|BLM|PDE2A|ECT2|LRRC8D|USP47|TMEM150C|ST20|DDB2|RAD9A|POLD1|PARP1|TMEM161A|GEN1|MCOLN1|INO80|AURKB|DDB1|RAD51|ZBTB1|CLOCK|FAS|HRAS|NIPBL|STK11|ASIC1|METTL3|SERPINB6|PIEZO1|RAD51AP1|MC1R|MFAP4|CUL4B|BAD|CNGB1|CNN2|KDM1A|CASP9|MAP3K1|MYLK|CARD16|MAPK13|TNKS1BP1
URATE BIOSYNTHETIC PROCESS%GOBP%GO:0034418,0.0648849294729028,0.4956987271622679,-0.8468155500413559,-1.44843264580586,436,2,PRPS1|PNP
RNA FOLDING%GOBP%GO:0034337,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
RESPONSE TO PEPTIDOGLYCAN%GOBP%GO:0032494,0.184587518524617,0.6906809521658801,-0.5521976506921079,-1.2699392384618702,1120,4,IRF5|IRAK3|RELA|IL6
POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090154,0.708824768323505,0.9695170059473192,0.306808372145427,0.798557732219736,6730,7,NSMAF|SMPD3
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051251,0.816379310344828,0.9866358717238399,-0.10355070967230301,-0.85643002230827,946,181,IGHV4-4|CD274|CHRNB2|ICOSLG|IL1B|RARA|FAM49B|SIRPA|MAP3K8|IGHV2-26|LGALS9|LAMP1|GRB2|VAV1|RPS3|IGHV1-69-2|IGHV3-15|FYN|IGHV3-73|C20orf196|RUNX1|IL6|PNP|LYN|CD276|YES1|IGF1|VAV3|CDC42|TFRC|IGHV1-3|NLRP3|BCL2|NFATC2|SOCS5|TNFRSF4|BCL6|NKAP|TNIP2|FGF10|DUSP10|CBFB|RAC1|IGF2|PIK3R1|CAV1|PAK2
CELLULAR RESPONSE TO TUMOR CELL%GOBP%GO:0071228,0.945445748155316,1.0,0.400512775762601,0.654627129254389,7815,2,IGFBPL1|TXNIP
CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:0002190,0.73006711409396,0.972554563883587,0.638674459638289,0.84845052634175,5438,1,RBM4
CALCIUM-MEDIATED SIGNALING%GOBP%GO:0019722,0.588542078229949,0.945418171231938,0.17085173187000302,0.9202808102202791,7447,84,RYR2|EDN1|CALML4|MCTP2|CXCR4|ADGRB2|AGTR1|PPP1R9A|PDPK1|CCR5|SULT1A3|CAMKK2|AZU1|CETN3|DMPK|ADGRL1|ATP2A2|PLCG1|KSR2|DMD|P2RY11|NFATC4|TNNI3|LAT|SLC8A1|PTPRJ|SAMD14|PLA2G4B|BTK|NFAT5|GSTM2|MCU|CXCR3|P2RX7|NFATC1|PPP3CA|CCR1|ANK2|PPP3CB|TRPM2
REGULATION OF T-HELPER 2 CELL ACTIVATION%GOBP%GO:2000569,0.297986577181208,0.8023890191280308,0.854708866343185,1.13544259767102,2219,1,PRKCQ
PLASMA MEMBRANE ORGANIZATION%GOBP%GO:0007009,0.571912534647367,0.9405604256499541,-0.158374593909384,-0.9307931850105401,1856,45,EMP2|CHMP4A|SNX9|PLSCR1|PACSIN1|FLOT1|SOD1|XKR8|SGIP1|SYT11|CLU|WHAMM|BIN1|EHD2|ANO6|CAV2|A4GALT|CAV1|MICALL1
CILIUM OR FLAGELLUM-DEPENDENT CELL MOTILITY%GOBP%GO:0001539,0.8149880573248409,0.9864798433969221,0.23483888639590497,0.716439610480476,8188,11,TEKT3|DNAH1|DNAH17|GAS8|CCDC65
RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009161,0.821862348178138,0.987367598707155,-0.104157510940217,-0.8506026232468291,1014,170,PFKL|COX5B|GPI|NDUFB10|SDHC|GMPS|ATIC|UQCRC1|NUDT4|PKM|ENO1|MT-ND5|HPRT1|ATP5I|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|COX4I2|NDUFS6|PGAM2|AK4
REGULATION OF OLIGODENDROCYTE PROGENITOR PROLIFERATION%GOBP%GO:0070445,0.35560504825538203,0.843963199220033,-0.645535204285637,-1.1041533942764798,2394,2,ADCYAP1
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, EXONUCLEOLYTIC%GOBP%GO:0000291",0.514579283532352,0.920792511236057,-0.176393278382839,-0.958875089273066,1852,35,EXOSC2|EDC4|CNOT8|CNOT6|SKIV2L|DCPS|EXOSC3|NT5C3B|LSM1|LSM2|PATL1|LSM6|EDC3|LSM5|DCP1B|DIS3L2|EXOSC7|EXOSC1|DIS3|EXOSC8|LSM3|DCP1A|DCP2|HBS1L|EXOSC6|EXOSC4|CNOT7|EXOSC9|EXOSC5|DDX6
GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009084,0.4701492537313429,0.8973822756577429,-0.26864637980288897,-0.9787057095229208,2267,12,ASL|GLUL
CAROTENE CATABOLIC PROCESS%GOBP%GO:0016121,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
POSITIVE REGULATION OF PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:1902530,0.510467706013363,0.918404893008545,-0.558484254312792,-0.9552574064985971,3437,2,PARK2
REGULATION OF VASCULOGENESIS%GOBP%GO:2001212,0.7817178881008672,0.981487311948134,-0.222431501342268,-0.752519062584563,3967,10,RAPGEF2|HIF1AN|CD34|EMP2|KDR|TMEM100|RAP1A
TELOMERIC LOOP DISASSEMBLY%GOBP%GO:0090657,0.180732484076433,0.6863300746827521,0.419976421351759,1.2812517907148702,1815,11,XRCC3|BLM|SLX1B|RTEL1-TNFRSF6B|SLX4
RESPONSE TO TUMOR NECROSIS FACTOR%GOBP%GO:0034612,0.14668218859138502,0.638549298625996,-0.154560587376552,-1.18798236500837,251,122,NFKBIA|CX3CL1|DAB2IP|CXCL16|PTK2B|RPS3|TRAF3|ADAM10|CCL14|BAG4|COMMD7|INPP5K|TNFRSF1B|CASP3|TNFRSF18|DFNA5|TANK|TCL1A|TMSB4X|ARHGEF2|KARS|NPNT|TNFRSF11A|ADAM17|CXCL8|LIMS1|CDIP1|TNFRSF4|AFF3|CHI3L1|PLVAP|EDA2R|CCL18|TNF|TNFRSF21|FOXO3
RESPONSE TO DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071724,0.29379418695993703,0.8004058897916541,-0.557388744676568,-1.1312038965742,1869,3,CD36
T CELL RECEPTOR V(D)J RECOMBINATION%GOBP%GO:0033153,0.151812080536913,0.6481463948883249,0.9246250551389499,1.22832313530388,1130,1,LIG4
NEURAL PLATE ANTERIOR/POSTERIOR REGIONALIZATION%GOBP%GO:0021999,0.285503355704698,0.794258537514783,0.859947066607852,1.14240131302995,2126,1,CELSR2
RESPONSE TO MINERALOCORTICOID%GOBP%GO:0051385,0.986815047780332,1.0,0.329951016409753,0.5392958720370821,8157,2,PEBP1|GPER1
CRANIOFACIAL SUTURE MORPHOGENESIS%GOBP%GO:0097094,0.441818792697951,0.880423444399886,0.4822437917410661,1.02192066102647,3944,4,FREM1|RAB23|MEGF8
REGULATION OF ANOIKIS%GOBP%GO:2000209,0.935469314079422,1.0,-0.14326424296106,-0.6282815009112621,4145,19,SIK1|SNAI2|NOTCH1|MYBBP1A|ITGA5|BCL2|CAV1
COCAINE METABOLIC PROCESS%GOBP%GO:0050783,0.27691275167785195,0.7884684708511421,0.864633877370975,1.14862753203531,2062,1,BCHE
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE INVOLVED IN HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0051455,0.9752416258440358,1.0,-0.511358623731804,-0.6840600221597659,7365,1,CENPC
POSITIVE REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010909,0.714375490966222,0.971081608033886,-0.394588764262067,-0.800806173322811,4546,3,CTNNB1|TCF7L2
NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903979,0.9858601728201101,1.0,-0.263372670122422,-0.5345070088677729,6274,3,LDLR|PTPRC|CX3CL1
POSITIVE REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904980,0.613928240434265,0.9508825506493929,-0.686204234671372,-0.917956326911612,4636,1,SYNJ1
POSITIVE REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0010902,0.7877852348993291,0.9819233677232551,0.607962064402294,0.807650479447823,5868,1,APOC2
EYE PIGMENTATION%GOBP%GO:0048069,0.44182007641542204,0.880423444399886,0.537434524931332,1.02160649590454,3815,3,AP3D1|LEF1
REGULATION OF AMINE TRANSPORT%GOBP%GO:0051952,0.0282051282051282,0.345491958731604,-0.282887660096558,-1.5714286169969498,98,37,VIP|CRH|SNCA|HRH3|CHRNA3|DRD2|SYT2|PARK2|ADRA2A|PER2|SYT9|TRH
LYSOSOMAL MICROAUTOPHAGY%GOBP%GO:0016237,0.0147682639434407,0.264001457476971,-0.8332965699790451,-1.69115063044408,93,3,RB1CC1|ATG13|ATG7
POSITIVE REGULATION OF MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000529,0.319865771812081,0.8219996514077841,0.843625937362153,1.12071942096424,2382,1,CCL21
N-ACETYLMANNOSAMINE METABOLIC PROCESS%GOBP%GO:0006051,0.440089086859688,0.879896414106183,-0.5915081334436171,-1.01174298310604,2963,2,RENBP|NAGK
REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045073,0.623022847100176,0.9536478716552259,-0.312317500500845,-0.8572905682882349,3544,6,HMOX1|IL6|TNF
CORTICOTROPIN HORMONE SECRETING CELL DIFFERENTIATION%GOBP%GO:0060128,0.793856745663975,0.9819233677232551,-0.5999117776797529,-0.802520276158967,5995,1,BMP2
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903362,0.0017331022530329301,0.108719342471509,-0.187687299894198,-1.5577777618784499,1,183,CCAR2|HSP90AA1|PSMD10|PARK7|RPL11|EDEM1|RYBP|GBA|RNF217|PRKACA|RAD23A|EZR|CSNK1D|MAP1A|CSNK1A1|AMER1|TAF9|RNF19B|NUDT15|FBXW7|OPHN1|FURIN|TRIM39|CBFA2T3|CLU|PTTG1IP|PLK3|USP5|DAB2IP|TRIB1|UBE2J1|NELL1|PTK2B|STYX|FAM192A|ARIH1|OS9|PRICKLE1|CEBPA|PML|PDCL3|PSME3|STUB1|VPS11|RNF139|CSNK2A2|GLTSCR2|EFNA1|TRIB2|SUMO1|ECSCR|RNF144B|BAG5|UQCC2|RAD23B|SMAD7|FMR1|MSN|COMMD1|SOCS5|DYX1C1|ARIH2|GNA12|PARK2|HSPBP1|DDRGK1|BCAP31|CSNK2A1|HSP90AB1|GABARAPL2|BBS7|PSMF1|CAV1|TRIB3|UBB
NEGATIVE REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051283,0.404385885750384,0.865585453523601,0.257304274313931,1.04607355684088,4480,27,RYR2|NOL3|F2R|PKD2|IBTK|CCR5|CCL21|CCL19
CEREBELLAR MOLECULAR LAYER FORMATION%GOBP%GO:0021688,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
NEGATIVE REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051974,0.6082006850695141,0.9508825506493929,0.299946953032189,0.8852209501491821,6036,10,PIF1|MEN1|SRC|PARP3|POT1|CERS1
NEGATIVE REGULATION OF LYASE ACTIVITY%GOBP%GO:0051350,0.868332006369427,0.993084774742015,0.21725069182946696,0.6627820605848,8724,11,AKAP5|ADGRV1|PALM|PHPT1|GABBR1
NUCLEAR MIGRATION ALONG MICROTUBULE%GOBP%GO:0030473,0.8814765100671141,0.9956508825790341,0.560101455668284,0.744069795957826,6566,1,TMEM201
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903377,0.71875,0.971081608033886,-0.31371880973504807,-0.7941583348437511,4185,5,PARK7|HIF1A|PARK2
STEROL ESTERIFICATION%GOBP%GO:0034434,0.297084794967945,0.801828762950478,0.6885580369451341,1.12542919559102,2455,2,SOAT1|LCAT
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045684,0.111132273116846,0.5853885416946839,0.383971839745247,1.3773852698949,1166,18,FST|BMP4|TMEM79|NUMA1|TGFB2|H2AFY2|MED1
NUCLEOSIDE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006753,0.98897359106997,1.0,0.0958445254226798,0.640351367547985,14529,402,ACSM3|HACD1|CROT|GPHN|NPR2|ACSF2|NDUFA7|OXSM|IMPDH1|NDUFS7|TDG|HSD17B4|NDUFA4|NUDT17|PARP16|CD38|RRM1|SCD5|ELOVL6|MYH3|ATP5G1|DNPH1|NDUFS2|ADCY8|RBKS|COX5A|DGAT1|PDE2A|TEFM|NAPRT|FAR2|ACBD6|COA6|ATP5D|MVD|NNT|MTHFD1|SLC35B3|NDUFC1|NDUFAF1|NDUFS4|MBD4|TAZ|ME1|PNKP|CAD|ACOT1|PARP1|AK3|PGLS|MT-ATP8|SLC26A2|IDH1|SULT1A3|PDHX|DTYMK|FAR1|COX6A1|BST1|NUDT14|CTPS2|RFK|ADSSL1|GCK|NDUFS8|RNLS|PDHA1|NDUFB2|DUT|SMPDL3A|ACOT2|SLC25A1|UQCC3|ACACA|PTGS2|GUK1|DCK|SUCLG1|SMARCAD1|DLD|ACSS1|MCEE|NADK
NEGATIVE REGULATION OF ENDOTHELIAL CELL-MATRIX ADHESION VIA FIBRONECTIN%GOBP%GO:1904905,0.126175029789488,0.607607158836689,-0.9345500661667401,-1.25017611770389,952,1,MMP12
GLOBAL GENOME NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0070911,0.8021117786273441,0.9841546650056641,0.18392992646897502,0.7394864056939471,8811,26,GTF2H2|GTF2H1|DDB2|PARP1|RNF111|DDB1|CHD1L|CUL4B|XPA|RBX1
"DNA CATABOLIC PROCESS, ENDONUCLEOLYTIC%GOBP%GO:0000737",0.22192264782447,0.73556947110949,0.323662253063701,1.22361583046195,2386,21,MUS81|FBXO18|DFFB|ENDOG|DNASE1L2|FEN1|GEN1
REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071156,0.977263848738183,1.0,0.10574293357366599,0.5797115644833629,12507,92,BTG2|RRP8|CCNB1|PIDD1|CDK1|E2F8|PKD2|CDC25C|MUC1|E2F7|CRLF3|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|AKT2|GATA6|TNKS1BP1|CNOT3|E2F1|FAP|ZNF268|FOXM1|CASP2|CDK2|ATM|TFAP4|CNOT1|BRCA1|PHOX2B|PCBP4|MDM2|ZBTB17|SETMAR|CNOT2|UHRF2|CNOT8|TRIAP1|HMGN5|RBL2|CCND1|EVI2B|CNOT6|E2F4|RPL23
NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009143,0.8588672237697309,0.99166790097654,-0.222337782535869,-0.691122635645036,4624,8,DCTPP1|NUDT1|NUDT15|ITPA
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090100,0.81724560686555,0.987153241368501,0.14923346511529903,0.7545633053419,9998,62,CITED1|LEFTY1|CYR61|INHA|BMP4|NUMA1|TGFB2|MEN1|GDF11|TTK|RNF111|FBXL15|CDKN2B|STK11|RNF165
REGULATION OF MITOTIC SPINDLE CHECKPOINT%GOBP%GO:1903504,0.00633404794387059,0.17992824699561,0.561298204299322,1.85975537814835,64,14,ANAPC15|CCNB1|TPR|XRCC3|USP44|GEN1|NDC80|CDK5RAP2
REGULATION OF PROTEIN LOCALIZATION TO PHAGOCYTIC VESICLE%GOBP%GO:1905169,0.41096253144445893,0.867015886388254,-0.793063520070578,-1.0609052511024302,3103,1,SYT11
NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043922,0.8951930654058309,0.9981901628831992,-0.19346462077704002,-0.654519769870163,4543,10,TFAP4|TARDBP|REST|CCL4|HDAC1|CCL3|ZNF639|INPP5K|JUN
VENTRAL MIDLINE DETERMINATION%GOBP%GO:0007371,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
AMINO ACID TRANSPORT%GOBP%GO:0006865,0.58078017746526,0.942746898746279,0.19024425571700196,0.9190636069900949,6937,51,SLC1A2|SLC25A29|SLC36A1|SLC25A22|SLC43A1|GLS|GLS2|LRRC8D|SLC6A17|SLC6A15|SLC6A9|SLC7A9|SLC15A4|PQLC2|SLC38A6
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:0061951,0.7648809523809521,0.9790689018689871,-0.1413308412839,-0.809938461750447,2569,41,ANK3|RAB26|GOLGA4|MACF1|GGA2|BBS1|SEC16A|C16orf70|ARHGAP44|BBS2|SCRIB|MLLT4|VAMP5|VAMP4|GOLPH3L|RAB34|KRT18|BLZF1|RAB31|GORASP1|GOLPH3|SYS1|VPS35|SPTBN1|NSF|ARFRP1|OPTN|GGA1|SYS1-DBNDD2|RAB11A|RAB10|GORASP2|RILPL2|GCC2|VAMP2|PVRL3|KIF13A|RILPL1|GOLGA7
POSITIVE REGULATION OF GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046645,0.669042316258352,0.964618776001639,-0.49456851392335294,-0.845932955670557,4505,2,NCKAP1L|LILRB1
PRIMARY ALCOHOL METABOLIC PROCESS%GOBP%GO:0034308,0.0578055307760928,0.469043309741731,0.35471488464535206,1.4872951216811001,647,30,AKR1B1|CBR4|NAPEPLD|ALDH1A1|CACNA1H|ADH1B|SULT1A3|AKR1C1|ALDH3A2|GDPD1|ACSS1
POSITIVE REGULATION OF CILIUM ASSEMBLY%GOBP%GO:0045724,0.223950233281493,0.7373438992792851,-0.277831999809023,-1.19517153487152,1007,18,CCP110|HAP1|MARK4|SEPT9|HTT|KCTD17
NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090051,0.0592827004219409,0.476130359693387,-0.392575267517082,-1.5209405157975802,280,14,TBXA2R|NOTCH1|MMRN2|RHOA|HDAC5|MAP2K5|MEOX2|PDCD10
MODULATION BY HOST OF VIRAL RNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:1990969,0.943892617449665,1.0,0.5309329510366121,0.7053207388538991,7031,1,NUCKS1
TYPE B PANCREATIC CELL MATURATION%GOBP%GO:0072560,0.278167615517013,0.78848945131153,-0.860829289810322,-1.15155758744428,2100,1,NKX6-1
REGULATION OF GROWTH HORMONE SECRETION%GOBP%GO:0060123,0.44936604643504,0.8858411016558391,-0.430125946476928,-0.9891998204392309,2728,4,ADCYAP1|DRD2
MACROPINOCYTOSIS%GOBP%GO:0044351,0.12350163458045801,0.607607158836689,-0.4715388858246,-1.3754998502278502,679,7,RAB34|SNX33|DOCK2|LRRC16A|MAPKAPK2|MAPKAPK3|PYCARD
ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:0003203,0.622568093385214,0.9536478716552259,0.22882029879378601,0.8763286651247341,6719,22,TBX2|DCHS1|BMP4|ROBO2|TGFB2|HEYL
NUCLEAR PORE ORGANIZATION%GOBP%GO:0006999,0.37799649191190793,0.854043118220915,0.32365312753771996,1.07236338898356,3878,14,TPR|NUP133|NUP205|NDC1|NUP107|NUP35|NUP54
POSITIVE REGULATION OF CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0055020,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
SPERMINE TRANSPORT%GOBP%GO:0000296,0.249127516778524,0.7613646381106121,0.8780326422584909,1.16642719342709,1855,1,TAF7
REGULATION OF FERROPTOSIS%GOBP%GO:0110075,0.930738255033557,1.0,0.537218791354213,0.7136711972846129,6933,1,GPX4
LIPID STORAGE%GOBP%GO:0019915,0.0986997635933806,0.570215774831708,-0.42001177043677396,-1.42096268674289,500,10,DGAT2|CD36|TNF|CAV1
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1902402,0.7554653858893671,0.9771370084125129,0.16167288265464003,0.7985947859638929,9122,56,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
NEGATIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902227,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048295,0.840857937243479,0.990143309585111,-0.578076753418615,-0.773310898460534,6350,1,CLCF1
GROWTH FACTOR DEPENDENT REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:0014843,0.261617900172117,0.771967970256231,-0.8695963828848701,-1.16328559515653,1975,1,FGF2
PEPTIDYL-TRYPTOPHAN MODIFICATION%GOBP%GO:0018211,0.9905563186813191,1.0,-0.19832340613280397,-0.50204253327362,5768,5,DPY19L3|DPY19L2|DPY19L4|DPM3|DPY19L1
NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:0038107,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
REGULATION OF STEM CELL DIVISION%GOBP%GO:2000035,0.923294835476139,1.0,0.267526109723101,0.6166080244395611,8473,5,CDK2AP2|NCOA3|EVI2B|PRDM15
REGULATION OF SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:2000754,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
REGULATION OF NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072182,0.36658653846153794,0.8510019955058101,-0.418748125910813,-1.06003307443736,2134,5,CTNNB1|LIF|PAX8
SYNAPTIC SIGNALING BY NITRIC OXIDE%GOBP%GO:0099163,0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
POSITIVE REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043902,0.00561797752808989,0.172670554681089,-0.215739825235062,-1.6133662968802198,10,108,DDX3X|RSF1|C1QBP|TBC1D20|P4HB|VIP|VPS4B|PPIH|CNOT7|GAPDH|FMR1|FCER2|AGO2|PDE12|JUN|PRKCA|CAV2|RAB7A|VAPB|CHMP4B|STAU1|PABPC1|PLCB1|CFAP69|POMZP3|PC|PDE3A|INHBB
NAD METABOLIC PROCESS%GOBP%GO:0019674,0.0352016404647984,0.38202776391712,-0.23275749323073397,-1.46139250012279,102,56,PFKL|GPI|MDH1B|PKM|PNP|ENO1|NAMPT|GAPDH|PGK1|HK1|NMNAT3|HK2|TPI1|ALDOA|NT5E|PGAM2|NMNAT2
EOSINOPHIL ACTIVATION%GOBP%GO:0043307,0.29540589494483804,0.800447413278835,-0.489439144101914,-1.12560778401569,1793,4,VAMP7|CCL3|VAMP8|VAMP2
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051589,0.00040371417036738,0.0784645998831315,-0.665592101595781,-2.3423015311605804,1,11,GPM6B|SYT11|SLC30A1|HTR1B|SNCA|FMR1|PNKD|HRH3|PARK2
VITAMIN B6 CATABOLIC PROCESS%GOBP%GO:0042820,0.682953020134228,0.9661822799536179,0.6633215703573,0.881193113346391,5087,1,PDXP
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000698,0.0770601336302895,0.5275704311910809,-0.8328646264130141,-1.42457033810325,518,2,LIF|PAX8
DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009189,0.8861873335648951,0.996643473105967,0.358648129385516,0.6817523655948001,7653,3,DTYMK|AK5|CMPK2
FASCICULATION OF SENSORY NEURON AXON%GOBP%GO:0097155,0.374234092694423,0.852609194081082,-0.5183632954670779,-1.05200290690056,2381,3,MEGF8|EPHA3|EPHA4
NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051005,0.466597198101193,0.894572377605215,0.528827307686544,1.0052450813674598,4029,3,APOC1|SORT1|ANGPTL4
LIPID HYDROPEROXIDE TRANSPORT%GOBP%GO:1901373,0.696941612604263,0.96731875442989,-0.6469453021614471,-0.865438455898268,5263,1,SCP2
REGULATION OF CD24 BIOSYNTHETIC PROCESS%GOBP%GO:2000559,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
SPHINGOID BIOSYNTHETIC PROCESS%GOBP%GO:0046520,0.0406828913912096,0.401998427404428,-0.5566303434311639,-1.62371540723079,223,7,SPHK1|ACER3|ASAH2|ASAH2B
SULFUR AMINO ACID METABOLIC PROCESS%GOBP%GO:0000096,0.0671057315770737,0.501959358919565,0.344772673830077,1.4573516212968098,753,31,DPEP1|CTH|GGT1|TST|APIP|PCYOX1L|MTHFD1|CDO1|MTR|TXN2|MTAP|GGT5
"PROTEIN IMPORT INTO PEROXISOME MATRIX, SUBSTRATE RELEASE%GOBP%GO:0044721",0.851677852348993,0.991298302704726,0.574823555359506,0.7636274485981821,6344,1,PEX14
POSITIVE REGULATION OF CENTRAL B CELL TOLERANCE INDUCTION%GOBP%GO:0002897,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
EMBRYONIC HEART TUBE DEVELOPMENT%GOBP%GO:0035050,0.675328083989501,0.9647315640607691,0.191347608483538,0.8446153101012579,7718,36,RYR2|TBX2|HES1|PKD2|AHI1|FOXN4|STIL|BBS5|VANGL2|SRF|NPHP3
POSITIVE REGULATION OF ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032014,0.191536748329621,0.701003334604831,-0.7426523297491039,-1.2702670361212,1289,2,MAPRE2|MAP4K4
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000514",0.998694744169857,1.0,0.0883770211887762,0.39293328515104703,11476,37,SH3RF1|AGER|PRKCQ|LOXL3|CCL19|CD55|IL12RB1|SOCS1|NFKBID|RC3H1|XCL1|ANXA1|JAK3|MYB|FOXP3|PRKCZ|HMGB1|NCKAP1L|ZC3H12A
CELLULAR RESPONSE TO NOREPINEPHRINE STIMULUS%GOBP%GO:0071874,0.53758389261745,0.9265056012720759,0.734505955006617,0.9757583925924592,4004,1,APLP1
INTRACELLULAR PH REDUCTION%GOBP%GO:0051452,0.9311427881130708,1.0,-0.135749110786351,-0.637873719830372,3853,23,SLC11A1|RAB39A|ATP6V0D1|RAB7A
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060501,0.818455482227625,0.987153241368501,0.39619049830942793,0.7531164596101859,7068,3,SRSF6|FGFR2
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0006469,0.33232856066315003,0.8293509737209019,-0.133500700446643,-1.06794891430734,440,153,ADARB1|SMCR8|DUSP6|PKIB|HHEX|PRKAG2|IPO5|SFN|AKT1S1|CBLB|GSKIP|PRKAR1A|RASIP1|WWTR1|YWHAG|PARK7|AIDA|GBA|DUSP22|PPM1F|PYCARD|DUSP4|THY1|CDKN1B|DUSP7|HSPB1|HEXIM1|QARS|ZGPAT|LRP5|IL1B|HEG1|PRKCD|DAB2IP|IGF1R|TRIB1|WARS|RGS4|CEBPA|ABL1|GNAQ|INPP5K|UBASH3B|LYN|CHP1|TRIB2|PPP2CA|PRKAR2A|NPM1|PTPN1|CDKN1C|PDCD4|DUSP3|UCHL1|SNX6|PRKAR1B|PKIG|SOCS5|CDKN1A|DBNDD2|DUSP10|CORO1C|SPRED2|CAV1|EPHB2|PAK2|TRIB3
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034144,0.0291739894551845,0.350886057103154,-0.624292097100707,-1.71363988839259,165,6,MFHAS1|DAB2IP|TNFAIP3|LYN|NR1D1
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN%GOBP%GO:0019884,0.8447412353923209,0.991298302704726,-0.106299571995489,-0.8132668545068291,1517,118,CD1C|KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|CALR|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|TAPBP|HLA-DQB1|DCTN5|FCGR2B|VAMP3|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|B2M|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1|CD36
MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034086,0.204390189270915,0.720652741008223,0.582390612528695,1.23414134079822,1824,4,RB1|NIPBL|DSCC1|MAU2
POSITIVE REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051351,0.6358173076923079,0.95916055221954,-0.33718151012939096,-0.8535526028885829,3702,5,MID1IP1
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM%GOBP%GO:0010880,0.942603780939388,1.0,0.173281800102198,0.5741364522581639,9672,14,RYR2|DMD|SLC8A1|GSTM2|ANK2
REGULATION OF PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0061091,0.17409395973154398,0.676682497340677,0.914203793559771,1.2144789542213799,1296,1,ABCB4
SIGNAL COMPLEX ASSEMBLY%GOBP%GO:0007172,0.956507731958763,1.0,0.22963198055755002,0.5647464135051871,8906,6,SRC|CD3E|NCK1
FOLIC ACID CATABOLIC PROCESS%GOBP%GO:0046657,0.7358171041490258,0.974262605126702,0.513096222773642,0.838641680545723,6082,2,PM20D2|MTHFS
NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001021,0.619947109935776,0.9532238181782521,-0.136447092312799,-0.910958306764333,1640,69,CCAR2|PSMD10|CXCL12|HELB|CD44|TAF9|SNAI2|TERF2|ERCC1|CLU|PTTG1IP|RNF169|ZNF385A|RPS3|DYRK1A|C20orf196|TRIP12|THOC5|C7orf49|BCL2L1|SNAI1|CXorf57|HSF1|BCL2|ACKR3|KLHL15|SFRP2|TWIST1
SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0072425,0.109157005305561,0.58452352834625,0.443877249399456,1.39925971683345,1110,12,DTL|BRCC3|PLK1|CHEK1|ATM|UIMC1|BRCA1|BRE
VESICLE DOCKING%GOBP%GO:0048278,0.0973478939157566,0.570215774831708,-0.22530347629257802,-1.33240456778474,311,46,RAB10|STX10|RAB3C|VTI1B|RAB3D|RAB8B|VPS18|RABEPK|VPS11|STX8|STX11|VAMP3|YKT6|RAB8A|BLOC1S6|SNPH|CAV2|SNAP25
CRISTAE FORMATION%GOBP%GO:0042407,0.989473684210526,1.0,0.11303247066055902,0.473937377545045,11091,30,ATP5G1|ATP5D|TAZ|MT-ATP8|UQCC3|ATP5C1|ATP5E|C19orf70|ATP5H|MT-ATP6|ATP5A1
REGULATION OF SECRETION BY CELL%GOBP%GO:1903530,0.010443864229765,0.22344045136759502,-0.145538728154758,-1.33937460169294,3,366,CD274|SYT11|RAB3D|RAB33B|CHRNB2|IL1B|SRGN|C2CD2L|IL11|CX3CL1|ADRA2C|RAB21|LGALS9|ITGAM|TNFAIP3|NR1H3|PFKL|SSC5D|LAMP1|LIF|FGR|NAPB|CRHR1|GPI|RAB8B|VPS4A|SYN1|STXBP4|VPS18|ANO1|RAB11FIP1|TCF7L2|TNFRSF1B|ARL2BP|MYRIP|SLC30A1|IL6|SLC25A4|LYN|FCGR2B|NAPA|VAMP2|HTR1B|VIP|PANX1|CAMK2A|HAP1|VPS4B|VAMP3|MBP|IGF1|MAVS|PAX8|UQCC2|MYOM1|FOXP1|RIPK2|RAP1A|TMSB4X|RALA|DPH3|GAPDH|RAB8A|CRH|SNCA|RAB2B|FMR1|KARS|PNKD|HRH3|GIPR|CHRNA3|NLRP1|NLRP3|PRKCA|SNX6|GAB2|TNFRSF4|RALB|ADCYAP1|DRD2|PPP1R11|RAB7A|SYT2|PARK2|RAB5A|ADRA2A|SLC2A1|PER2|RAB11FIP5|MCTP1|CD22|NR1D1|CACNA1E|TWIST1|TNF|RSG1|GAL|SYT9|SNAP25|TNFRSF21|CPLX1|INHBB|TRH
DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:0097026,0.319865771812081,0.8219996514077841,0.843625937362153,1.12071942096424,2382,1,CCL21
RENAL WATER HOMEOSTASIS%GOBP%GO:0003091,0.593138439236531,0.9464278097528599,-0.192467490049233,-0.9043886410227808,2454,23,RAB11FIP2|PRKAR2A|PRKAR1B|ADCY2|AQP1
TACHYKININ RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007217,0.234919532244993,0.748893623389667,0.626947348623224,1.19176095734722,2028,3,TAC1|GRK5|ADRBK1
INTERFERON-GAMMA SECRETION%GOBP%GO:0072643,0.25452168228372196,0.764845931807465,0.51651876114911,1.19049917493201,2335,5,TRIM27|F2RL1|BTN3A2|BTN3A1
PYRIMIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072528,0.687449392712551,0.966986590843215,0.203795861851607,0.835691082945284,7640,28,TK1|CAD|DTYMK|CTPS2|UCKL1|DUT|DCK|UMPS|HDDC2|UCK1|TYMS|CTPS1|CDS1
MANNOSE METABOLIC PROCESS%GOBP%GO:0006013,0.192091388400703,0.7022951260524071,-0.4581104186200429,-1.2574823392468701,1092,6,MAN2A1|MAN2B1|MAN2A2|PMM1|MAN2B2|PMM2
THYROID-STIMULATING HORMONE-SECRETING CELL DIFFERENTIATION%GOBP%GO:0060129,0.793856745663975,0.9819233677232551,-0.5999117776797529,-0.802520276158967,5995,1,BMP2
INTERLEUKIN-12-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035722,0.00763807285546416,0.197647069623972,-0.31568817345730604,-1.78119384005532,25,39,BOLA2|BOLA2B|AIP|HNRNPF|P4HB|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|PITPNA|PLCB1|PAK2
INOSITOL PHOSPHATE-MEDIATED SIGNALING%GOBP%GO:0048016,0.845147679324895,0.991298302704726,-0.183740054219933,-0.711857612950059,4005,14,PLCE1|PPP3R1|INPP5A|NFATC2|HRH1
RECIPROCAL MEIOTIC RECOMBINATION%GOBP%GO:0007131,0.0216097987751531,0.30931709379024297,0.37017187089509895,1.6339521147123501,246,36,MUS81|EME2|MLH3|RAD54B|BLM|C11orf80|BRIP1|TOP2A|RAD51C|RAD51|MND1|FANCM|REC8|SLX4|EME1|RMI1|STRA13|TOP2B|UBR2
REGULATION OF ECTODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042665,0.61935654706739,0.9532238181782521,-0.6834472871636529,-0.9142682741719109,4677,1,FZD7
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002921,0.9551854395604399,1.0,-0.23202073681888397,-0.5873450882875749,5562,5,CD55|SERPING1|FOXJ1|A2M|FCGR2B
MEIOTIC CELL CYCLE PROCESS%GOBP%GO:1903046,0.00015841584158415801,0.0784645998831315,0.38718315117071295,2.06799306745852,1,80,HSPA2|MUS81|SYCP2|EME2|MLH3|CCNA1|NCAPD3|RAD54B|BLM|C11orf80|EXO1|BRIP1|NUF2|BUB1|TOP2A|CCNE1|PTTG1|BUB1B|ESPL1|MSH6|RAD51C|RAD51|PIM2|NCAPH2|MND1|TUBG2|FANCM|REC8|MYBL1|SLX4|EME1|ING2|RMI1|STRA13|SPDYA|CCNE2|BAG6|STAG3|TOP2B|TEX14|P3H4|UBR2|SPIRE2|SPIRE1|SGOL1|RAD1|FMN2|ATM
POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060161,0.0256087981146897,0.333363983128034,-0.802302043439259,-1.6282481597194098,162,3,CAV2
TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034134,0.0171703296703297,0.277422272849102,-0.710012730957357,-1.79735008114805,99,5,IRAK1|LGALS9|RIPK2|TNIP2
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043552,0.8410171102661601,0.990143309585111,-0.156555340877726,-0.725280252332907,3538,22,CCL21|KIT|AMBRA1|CCL19|IRS1|PTK2|PRKD1|PDGFRA|TEK|PIK3R4|PDGFB|AGAP2|CCR7|ATG14|PDGFRB|TGFB1|TNFAIP8L3|PTK2B|FGR|FGF2|EPHA8|FLT1
FATTY ACID ALPHA-OXIDATION%GOBP%GO:0001561,0.542438921651222,0.929662732222486,0.35886000791098205,0.934037204062726,5150,7,SLC27A2|ALDH3A2
REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032960,0.202700477523465,0.7169847518722969,-0.5406424962511961,-1.24336479720409,1230,4,GPER1|PTK2B|HRH1
INDOLE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042430,0.6813419302841021,0.965271928233355,0.27955695469490194,0.825044797268787,6762,10,IDO1|DDC|CCBL1|AFMID|AADAT|ATP7A
POSITIVE REGULATION OF CHOLESTEROL ESTERIFICATION%GOBP%GO:0010873,0.308346044889954,0.8114601699384292,0.49364906871404296,1.13778792410673,2829,5,AGTR1|APOE|APOC1
REGULATION OF BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0090335,0.0517831956477937,0.44586532408291796,0.5187018529026789,1.53082317532786,513,10,SIRT1|INS|NAPEPLD|FNDC5|PTGS2
NEGATIVE REGULATION OF PLANT EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:1903889,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
MALATE METABOLIC PROCESS%GOBP%GO:0006108,0.7112468407750631,0.9703327035763342,0.30622173071061604,0.7970308278183571,6753,7,FH|ME1|ME3|MDH1|MDH2
AXON MIDLINE CHOICE POINT RECOGNITION%GOBP%GO:0016199,0.44013887333407997,0.879896414106183,0.482914144102911,1.0233412017166201,3929,4,ROBO2|ROBO3|APP|ROBO1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO THAPSIGARGIN%GOBP%GO:1905892,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
PROPYLENE METABOLIC PROCESS%GOBP%GO:0018964,0.40604026845637603,0.8663957682383929,0.8040913101014558,1.06819943241317,3024,1,GRIN1
TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0071830,0.160152312688991,0.661454203640901,0.608062648210445,1.28854283672847,1429,4,APOE|APOC1|LDLR|APOC2
T CELL SELECTION%GOBP%GO:0045058,0.690054561118024,0.96731875442989,0.23681575577592,0.8209760032344191,7208,16,JAG2|SLAMF6|CD3D|CD1D|CD3G|CD3E|ZAP70
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000737,0.868566080898409,0.993084774742015,0.24503233225711,0.6680238758634991,8352,8,HES1|N4BP2L2|REST|JAG1
MACROMOLECULE DEPALMITOYLATION%GOBP%GO:0098734,0.212229812968978,0.727709540947015,0.578565118458077,1.2260347534323501,1894,4,LYPLAL1|LYPLA1|PPT1|LYPLA2
CARNITINE METABOLIC PROCESS%GOBP%GO:0009437,0.409919028340081,0.867015886388254,0.36581828381748793,1.0439203904016199,4049,9,CROT|ACADM|CPT1B|ALDH9A1|CPT1C|CRAT
CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033627,0.147019867549669,0.638551278911636,0.36149711669152795,1.32132727065108,1553,19,ITGB1|NOV|ITGA2|FBN1|ITGA11|ITGB5|ITGBL1
PROTEIN LOCALIZATION TO MICROTUBULE PLUS-END%GOBP%GO:1904825,0.423880597014925,0.8740879492662891,-0.4966361530826071,-1.00790831697302,2697,3,MAPRE3|MAPRE2|MAPRE1
MIDBRAIN-HINDBRAIN BOUNDARY MORPHOGENESIS%GOBP%GO:0021555,0.9798657718120809,1.0,0.512957653286281,0.6814413577274712,7299,1,KDM2B
REGULATION OF NEURAL CREST FORMATION%GOBP%GO:0090299,0.43664768965973794,0.878651088001772,-0.7796647551830609,-1.04298131478748,3297,1,FUZ
CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:0002191,0.11907943578322198,0.6036346911557819,-0.790239867659223,-1.35166297109095,801,2,EIF3D|EIF4G1
PROTEIN C-LINKED GLYCOSYLATION VIA 2'-ALPHA-MANNOSYL-L-TRYPTOPHAN%GOBP%GO:0018406,0.9905563186813191,1.0,-0.19832340613280397,-0.50204253327362,5768,5,DPY19L3|DPY19L2|DPY19L4|DPM3|DPY19L1
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001269,0.631658075601375,0.9579569038493009,0.35119519665545196,0.8637134395211509,5881,6,JAK2|FAS
NEGATIVE REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:1905709,0.100549882168107,0.570947005522165,-0.7103231498841949,-1.4415797280623501,639,3,RASIP1|HEG1|ACAA2
PERIPHERAL NERVOUS SYSTEM NEURON AXONOGENESIS%GOBP%GO:0048936,0.8997315436241609,0.998912093067348,0.551720335244817,0.73293585138354,6702,1,ISL1
ACTIVATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:0032237,0.43306438333607794,0.878651088001772,-0.43655214250262,-1.00397872881895,2629,4,STIM2|TMEM110|STIM1|CRACR2A
D-XYLOSE CATABOLIC PROCESS%GOBP%GO:0042843,0.196478220574606,0.7100128962886071,-0.9003639170710191,-1.2044442637316,1483,1,DHDH
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042304,0.30538867649735996,0.8085598515544019,0.28155794262237893,1.13199779384202,3354,26,SLC45A3|SIRT1|CEACAM1|PRKAA2|ACADVL|PDK4|PTGS2|LPGAT1|ADIPOR2|APOC1|PRKAB2
REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033146,0.6513944223107572,0.963985859176228,-0.17673661720049602,-0.867828624822979,2615,26,WBP2|KCTD6|RUNX1|UFSP2|DYX1C1|CBFB|DDRGK1
RETINOL TRANSPORT%GOBP%GO:0034633,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
REGULATION OF VITAMIN D 24-HYDROXYLASE ACTIVITY%GOBP%GO:0010979,0.838791946308725,0.989395884107905,0.581219673577415,0.77212440629961,6248,1,CYP27B1
POSITIVE REGULATION OF KINASE ACTIVITY%GOBP%GO:0033674,0.0148148148148148,0.264001457476971,-0.14460896511129503,-1.3263941327230702,5,358,MAPKAP1|IL1B|CLU|IRAK1|VEGFA|PKN1|PLCE1|CACUL1|ADRA2C|ZNF16|PRKCD|MAP3K8|DAB2IP|STK26|C5AR1|TGFBR1|IRAK2|PTK2B|MRE11A|PRKAA1|GDF15|PRKAG1|FGR|ABL1|MAP3K13|ATG13|RPS3|RET|FYN|RHOA|STK10|DDX3X|TNFRSF10A|UBE2V1|FGF2|MAP2K5|RASSF2|PRNP|EFNA1|DOCK3|CHRNA7|SLC11A1|MST1R|TCL1A|PPP2CA|PRKAR2A|IGF1|DIRAS1|MAP4K4|ATP2B4|CEMIP|CRK|RIPK2|CAB39|RAP1A|PRR5|PDCD10|PTPN1|CCNYL1|SNCA|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|STK4|CCNY|ADAM17|ADRB2|CHRNA3|RAPGEF1|SHC1|UBA52|EPHA8|RELN|DKK1|PRKAR1B|ZNF622|TNFRSF10B|RALB|ADCYAP1|MAPK3|OXSR1|FLT1|CDKN1A|CHI3L1|ADRA2A|COPS8|FGF10|PEA15|STK24|ACE|MAP3K11|UBC|MAP2K1|GPRC5B|HSP90AB1|CAMKK1|TNF|PAK2|UBB|ADORA2B
POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:1903348,0.966378633150039,1.0,-0.283315314255667,-0.5749800126142149,6150,3,NPHP1
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902255,0.16910917174378398,0.673117535978459,-0.56303862627718,-1.2948712175483998,1026,4,MSX1|UBB
NEURON PROJECTION ARBORIZATION%GOBP%GO:0140058,0.042530755711775,0.40620060285046505,-0.590377591251494,-1.62054684702903,241,6,NRP1|CHRNA7|ZNF365|SEMA3A
MENAQUINONE METABOLIC PROCESS%GOBP%GO:0009233,0.561101549053356,0.936434965680841,-0.7133877370974859,-0.954320526925065,4237,1,UBIAD1
"RNA SPLICING, VIA TRANSESTERIFICATION REACTIONS%GOBP%GO:0000375",0.9987431045318059,1.0,0.0833650203767259,0.538191115382346,14302,274,CELF5|NOL3|SKIV2L2|ZCCHC8|PPWD1|SFSWAP|U2AF1L4|CELF1|RBM4B|SMN1|CCAR1|DDX20|DHX9|PRPF39|PRPF8|UPF3B|SART3|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|DDX17|PPIL1|C7orf55-LUC7L2|PPIE|RNPC3|FIP1L1|LUC7L|METTL3|GEMIN5|LUC7L3|SRPK1|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|CDK13|POLR2L|U2SURP|SRSF2|KHSRP|SMN2|CACTIN|SFPQ|HNRNPH1|PNN|HNRNPA2B1|TRA2A|PABPN1|SRSF11|POLR2J|RBM5|MPHOSPH10|XAB2|LSM8|SF3B1|DHX40|RBM41|AQR|SNRPD1|TGS1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|MFAP1|CPSF7|GEMIN8|DDX46|SNRNP40|PRPF4B|DDX5|PRPF3|DDX42|RBM4|YTHDC1|CHERP|USP49|GTF2F2|PQBP1|CSTF3|CELF3|RBPMS|PSIP1|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|RBM17|SRSF9|WDR83|SRSF5|PRMT7|SETX|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|SNRPN|SNRNP25|CPSF4|SRSF10|CELF6|CWC27|PCF11|SYMPK|SNRNP48|PLRG1|SNW1|CWC22|SRSF12|DCPS|GEMIN2|PRPF40A|PHF5A|SF3B2|DBR1
CYSTEINE BIOSYNTHETIC PROCESS FROM SERINE%GOBP%GO:0006535,0.230636833046472,0.743397546142977,-0.8842082046757829,-1.18283227467695,1741,1,CBS
NEURON FATE SPECIFICATION%GOBP%GO:0048665,0.840831043956044,0.990143309585111,-0.279401390543302,-0.707286066953697,4896,5,ASCL1
MITOCHONDRIAL TRANSLATIONAL TERMINATION%GOBP%GO:0070126,0.7068544896513729,0.969403752544852,0.155776509319483,0.8466209062368689,8981,88,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0050810,0.251453369360518,0.763905256448548,0.23253930806179396,1.1714230532873302,3070,61,FGFR4|SIRT1|STAR|TM7SF2|FGF19|WNT4|NFYB|ELOVL6|CLCN2|GPAM|PROX1
SIDEROPHORE TRANSPORT%GOBP%GO:0015891,0.437442075996293,0.878651088001772,-0.7793339214821351,-1.04253874845872,3303,1,SLC22A17
T CELL AGGREGATION%GOBP%GO:0070489,0.7474387527839641,0.9749763305090959,-0.459819613298375,-0.7864968221836091,5033,2,MSN
RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0042455,0.6354498407643311,0.95916055221954,0.28286075623981605,0.8629433273628421,6384,11,IMPDH1|CAD|CTPS2|UMPS|CTPS1|ADAL
DIAPHRAGM CONTRACTION%GOBP%GO:0002086,0.045503355704698,0.4190278528102411,0.9769519188354651,1.2978370392578,338,1,GAA
ANOIKIS%GOBP%GO:0043276,0.836032388663968,0.988613522932093,0.24575840441018498,0.7013105162462472,8259,9,MAP3K7|STK11|AKT1|IKBKG|DAPK2|MTOR|PIK3CA|TSC2
L-ALANINE METABOLIC PROCESS%GOBP%GO:0042851,0.446180325698398,0.883874685872149,-0.775474194971328,-1.0373754746231398,3369,1,GPT2
TETRATERPENOID METABOLIC PROCESS%GOBP%GO:0016108,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
CIRCADIAN BEHAVIOR%GOBP%GO:0048512,0.327996876220227,0.828303707528737,-0.338880263828521,-1.09393585942708,1679,9,CIART|TP53|USP2
ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION%GOBP%GO:0051905,0.33633369923161405,0.8311444145897029,-0.262106003139032,-1.07341217418452,1531,16,BLOC1S6|MKKS|BLOC1S3|BBS7
RESPONSE TO CORTICOSTERONE%GOBP%GO:0051412,0.533422818791946,0.9265056012720759,0.7364358182620201,0.9783221298299591,3973,1,PEBP1
REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905245,0.22191272051996302,0.73556947110949,-0.391362460641247,-1.21652492979806,1194,8,PICALM|LYN|EFNA1|BIN1
PHAGOSOME MATURATION%GOBP%GO:0090382,0.6656982776509649,0.964618776001639,-0.223994589702127,-0.843559343302512,3207,13,SYT7|SLAMF8|RAB34|RAB20|RAB7B|RAB31|RAB14|MREG|RAB32|RAB43|RAB39A|RAB7A
PROSTATE GLANDULAR ACINUS DEVELOPMENT%GOBP%GO:0060525,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
ADHERENS JUNCTION ASSEMBLY%GOBP%GO:0034333,0.27867628763374,0.788692060817727,-0.232820101293951,-1.12947350019368,1119,25,ACTN1|PIP5K1A|THY1|LAMA5|CTNNB1|DLC1|TESK2|ZNF703|WHAMM|SMAD7|RAMP2|PEAK1
POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072126,0.763880488689972,0.978421368343614,0.50046870692032,0.81800235278162,6314,2,EGR1|PDGFB
NEGATIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046986,0.293128558188799,0.8004058897916541,-0.8533855315394799,-1.1415998450470901,2213,1,EIF2AK1
CEREBELLAR CORTEX FORMATION%GOBP%GO:0021697,0.897110503709489,0.998912093067348,-0.203637719214735,-0.657360806038752,4594,9,DLL1|OPHN1|FAIM2|CBLN1
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903020,0.0634467618002195,0.49330601979973493,-0.363898599811721,-1.4902870690810002,288,16,CTNNB1|TCF7L2|CHP1|RAB1A|IGF1|PLCB1|RAMP1
AXON DEVELOPMENT%GOBP%GO:0061564,0.9282927867224631,1.0,0.11356457495423701,0.713448730730562,13087,216,SLITRK6|LGI1|PSPN|SLIT1|NEXN|RTN4RL1|BRSK2|VLDLR|ARTN|CXCR4|EFNA2|EVL|IGSF9|DSCAM|PLXNC1|ADGRB1|DHFR|PTPRO|MARK2|EPHA5|PAK3|CDK5R1|ROBO2|SEMA5A|SPTBN5|PRKCQ|GFRA3|SRC|NTN3|MTR|PLXNA3|GPC1|CHN1|DOCK7|BSG|PALLD|ULK1|NREP|APBB1|SEMA6A|PLXNB2|RNF165|SHTN1|PLCG1|ANK3|GAP43|UNC5A|PLXNB3|SPTBN4|EFNA4|SZT2|SPTAN1|BRSK1|CAMSAP2|PLXNA2|NRXN3|S100B|DOK6|SLITRK1|EFNA5|SPTBN2|TAOK2|RAP1GAP|FGFR2|NRP2|MYCBP2|PLP1|VSTM2L|RAB3A|PTK2|PDLIM7
WAX METABOLIC PROCESS%GOBP%GO:0010166,0.0647151324543365,0.495491127404654,0.840970499035015,1.37454317786167,534,2,FAR2|FAR1
PROTEIN TARGETING%GOBP%GO:0006605,0.32664233576642304,0.8269060114957499,-0.116368809386316,-1.04884533806565,178,299,UBE2D1|ECH1|VTI1B|HPS4|RPS4X|PEX16|NUDT7|TOMM34|RPL9|TOMM22|CLU|TIMM50|RPS28|PMM1|ZDHHC3|RPL35|ROMO1|SAMM50|RABGEF1|RPL7|AP4S1|SRP72|TOMM20|SGTB|MYO1C|RAB8B|RPS9|RPS3|VPS4A|RPL14|ZDHHC9|TIMM10B|AIP|C19orf52|SEC63|TIMM23|ZDHHC11B|SEC62|ATG3|MFN2|GCC2|RPL15|RPL8|PEX26|EXOC4|KIF13B|CDC37|ZDHHC7|HAP1|RPL35A|PMPCA|DNLZ|NEDD4|ZDHHC4|PEX7|TIMM22|UBA52|PEX19|ASNA1|ACOX1|UBE2D3|TRAK1|GABARAP|SSR1|RAB7A|CHMP4B|TIMM23B|ACOT8|PMM2|FBXO7|SRP54|PEX5|VTI1A|CACNG3|UBC|GOLGA7|MICALL1|PARD3|UBB
MOTOR NEURON MIGRATION%GOBP%GO:0097475,0.11017074981440199,0.584830174998513,-0.799283154121864,-1.3671310282578601,741,2,VEGFA|NRP1
REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0010533,0.9837607794825849,1.0,0.243975073071196,0.5170064855511289,8783,4,CCL5|CD300A|AGT|IL6R
RESPONSE TO ESTROGEN%GOBP%GO:0043627,0.158888038765621,0.661359103221672,-0.254270634322431,-1.26708067520021,622,27,RARA|BCAS3|WBP2|CITED2|ARID5A|ASH2L|SFR1|TRIM25|GSTM3|CAV1|CITED4
GERM CELL MIGRATION%GOBP%GO:0008354,0.848839123991438,0.991298302704726,-0.305886678849736,-0.7034754593888299,5154,4,TGFBR1|PPAP2B
DESENSITIZATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002029,0.270474516695958,0.7852960152527629,-0.42058544688090505,-1.15447881144053,1538,6,ARRB2|ARRB1|ADRB2|ADM
"CELLULAR RESPONSE TO 2,3,7,8-TETRACHLORODIBENZODIOXINE%GOBP%GO:1904613",0.608927059392766,0.9508825506493929,0.5631370180707571,0.9204319857577931,5033,2,PDE2A
MITOTIC SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0007094,0.10475192838777302,0.576535954147525,0.387052859176194,1.38843751472427,1099,18,TPR|CENPF|BUB1|CDC20|APC|BUB1B|KLHL22|PLK1|TEX14|ATM
PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009151,0.0541227751543771,0.454914205138535,-0.5357852678478879,-1.56290939694249,297,7,SAMHD1|AK5|NUDT1|AK9|NUDT15|NUDT18
NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903363,0.138602941176471,0.626567367071584,-0.187676171625543,-1.2347230242749498,376,66,ERLEC1|CCAR2|PARK7|RPL11|RYBP|MAP1A|TAF9|OPHN1|FURIN|TRIM39|DAB2IP|UBE2J1|NELL1|STYX|FAM192A|OS9|PML|PDCL3|CSNK2A2|GLTSCR2|EFNA1|BAG5|DDRGK1|CSNK2A1|HSP90AB1|GABARAPL2|PSMF1
DATP CATABOLIC PROCESS%GOBP%GO:0046061,0.32917594654788396,0.828303707528737,-0.6620898814447199,-1.1324692829453,2216,2,SAMHD1|NUDT1
REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0150031,0.744869588243082,0.9749763305090959,-0.622684164093516,-0.8329835917888979,5625,1,ROCK2
REGULATION OF MEDIATOR COMPLEX ASSEMBLY%GOBP%GO:2001176,0.880125801378977,0.9956508825790341,0.44742211193824105,0.7312991505586229,7275,2,CDT1|MED25
TRANSLOCATION OF MOLECULES INTO HOST%GOBP%GO:0044417,0.7565290648694191,0.977664504547119,0.292538071426213,0.761415137639471,7183,7,THOC3|THOC1|THOC2|DDX39B
NEGATIVE REGULATION OF ECTODERM DEVELOPMENT%GOBP%GO:2000384,0.61935654706739,0.9532238181782521,-0.6834472871636529,-0.9142682741719109,4677,1,FZD7
FORAMEN OVALE CLOSURE%GOBP%GO:0035922,0.11981993909704801,0.6056190749402529,-0.938795765328628,-1.25585571892303,904,1,TBX20
POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0045860,0.00849256900212314,0.20298122046820802,-0.149974940153506,-1.36994809489397,3,333,MAPKAP1|IL1B|CLU|IRAK1|VEGFA|PKN1|PLCE1|CACUL1|ADRA2C|PRKCD|MAP3K8|DAB2IP|STK26|C5AR1|TGFBR1|IRAK2|PTK2B|PRKAA1|GDF15|PRKAG1|ABL1|MAP3K13|ATG13|RPS3|RET|FYN|RHOA|STK10|DDX3X|TNFRSF10A|UBE2V1|FGF2|MAP2K5|RASSF2|PRNP|EFNA1|DOCK3|CHRNA7|SLC11A1|MST1R|TCL1A|PPP2CA|PRKAR2A|IGF1|DIRAS1|MAP4K4|ATP2B4|CEMIP|CRK|RIPK2|CAB39|RAP1A|PRR5|PDCD10|PTPN1|CCNYL1|SNCA|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|STK4|CCNY|ADAM17|ADRB2|CHRNA3|RAPGEF1|SHC1|UBA52|RELN|DKK1|PRKAR1B|TNFRSF10B|RALB|ADCYAP1|MAPK3|OXSR1|FLT1|CDKN1A|CHI3L1|ADRA2A|COPS8|FGF10|PEA15|STK24|ACE|MAP3K11|UBC|MAP2K1|GPRC5B|HSP90AB1|CAMKK1|TNF|PAK2|UBB|ADORA2B
SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0051124,0.8629490746340871,0.991943445125448,0.456533952775618,0.7461922040904059,7133,2,SHANK1|SHANK2
POSITIVE REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045410,0.0454470607607443,0.4190278528102411,-0.698416977436847,-1.6062131436874398,275,4,STAT3|TNF
CORTICOSTEROID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0031958,0.509841827768014,0.918404893008545,-0.343736678173621,-0.943534101356503,2900,6,RBM14|CALR|YWHAH|NEDD4
NEGATIVE REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051622,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
VESICLE TETHERING%GOBP%GO:0099022,0.653243127147766,0.9640743070248079,0.34456118958929705,0.8473980652919929,6082,6,WDR11|STARD3NL|STARD3|C17orf75
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903725,0.815445026178011,0.986631695793843,-0.128907493997944,-0.7855365985987809,2491,51,EPHA8|FLT1|KIAA0226|ACSL3|PIK3R1|FABP3
PRONEPHRIC NEPHRON DEVELOPMENT%GOBP%GO:0039019,0.325511068102093,0.826621597878865,0.6757099531293079,1.10442935555156,2690,2,AHI1|SEC61A1
RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090670,0.9194711538461541,1.0,-0.25215089344804803,-0.638303243083146,5354,5,WRAP53|CCT2|DKC1|CCT4|TCP1
REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903121,0.9110818376420219,1.0,-0.28009706060773204,-0.644164725072188,5532,4,ATF3|PTEN|PARK7|TIMP3
REGULATION OF NITROSATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1905258,0.9766889383815891,1.0,-0.32368348497380794,-0.5536432656691012,6577,2,DNAJA1|PARK7
OLIGOSACCHARIDE METABOLIC PROCESS%GOBP%GO:0009311,0.38670668196663394,0.859991269020751,0.247180212250603,1.0654761940754,4380,33,B3GALT2|GAL3ST3|GAA|GAL3ST4|FUT8|B3GALT1|MPDU1|ST8SIA3|B3GALNT1|MAN1B1|ST3GAL4
NEGATIVE REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043901,0.42921686746987997,0.877632841005648,-0.137187281388236,-1.01801958156687,854,105,TRIM62|PLSCR1|MX1|EIF2AK2|MUL1|RIOK3|CALR|SNX3|CCNK|TRIM8|ITCH|RNASEL|ZNF639|TRIM13|APOBEC3F|TRIB1|BANF1|TNFAIP3|PCBP2|PML|C1QBP|INPP5K|IFITM2|IFITM3|OASL|IGF1|MAVS|TRIM35|TNIP1|GPATCH3|OAS3|TRAF3IP1|JUN|ZC3HAV1|PARK2|IFITM1|TNF
NEGATIVE REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904027,0.6852906130014561,0.966495577318169,-0.651962946625496,-0.8721507118845241,5175,1,CHADL
NEGATIVE REGULATION OF VESICLE FUSION%GOBP%GO:0031339,0.24966735212289803,0.7613646381106121,0.709456851392335,1.15958773368095,2063,2,PRRT2|ANKRD27
PURINE NUCLEOTIDE TRANSPORT%GOBP%GO:0015865,0.9885595990411851,1.0,0.20986726016404997,0.48371292364038,9072,5,SLC25A42|SLC35B2|SLC25A17|SLC25A24
MITOCHONDRIAL GLYCYL-TRNA AMINOACYLATION%GOBP%GO:0070150,0.28889183106050603,0.798187790155662,-0.85603220114689,-1.1451403756772,2181,1,GARS
POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060999,0.6658031088082901,0.964618776001639,-0.18776617819314997,-0.8527956748704391,2826,21,FMR1|C21orf91|RELN|FOXO6
HISTIDYL-TRNA AMINOACYLATION%GOBP%GO:0006427,0.980549368968077,1.0,-0.318228849314288,-0.544313403505092,6603,2,HARS
MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033028,0.12725844461901,0.6076669536424699,-0.682861598602475,-1.3858473256546202,809,3,CTSL|IL6
NEGATIVE REGULATION OF RRNA PROCESSING%GOBP%GO:2000233,0.608166295471418,0.9508825506493929,-0.518279569892473,-0.8864894470228081,4095,2,NUDT16|SHQ1
INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060729,0.801744966442953,0.9841161968820359,0.6000771945302161,0.7971757815917521,5972,1,TLR4
ADENOSINE 5'-(HEXAHYDROGEN PENTAPHOSPHATE) METABOLIC PROCESS%GOBP%GO:1901910,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
REGULATION OF TIGHT JUNCTION DISASSEMBLY%GOBP%GO:1905073,0.937045285820341,1.0,-0.36145574855252294,-0.618250699567454,6310,2,TGFB3|TGFBR1
CARDIOBLAST MIGRATION TO THE MIDLINE INVOLVED IN HEART FIELD FORMATION%GOBP%GO:0060975,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090205,0.511444096821999,0.918404893008545,-0.40810594700140507,-0.9385584217845521,3105,4,FGF1|PRKAA1|ABCG1
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903599,0.0983606557377049,0.570215774831708,-0.37255988058285705,-1.40305338902725,473,13,MFN2|HK2|HTT|PARK2|FBXO7
REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032651,0.964692382381499,1.0,0.128190018858263,0.552566130467921,10928,33,GHRL|AIM2|F2R|GSDMD|AZU1|CCL19|GSTP1
NEGATIVE REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0090074,0.941414843116823,1.0,0.321470953279492,0.611082464709379,8130,3,ITGA4|ISL1
NEGATIVE REGULATION OF WOUND HEALING%GOBP%GO:0061045,0.19271445358401898,0.7027916199946072,-0.21545033134445604,-1.21562616307678,655,39,PLAU|FGF2|SERPINF2|CRK|PLAUR|THBD|PROC|CD9|NOS3|CDKN1A|DUSP10
PANTOTHENATE METABOLIC PROCESS%GOBP%GO:0015939,0.55490966221524,0.9341186131273208,-0.451858387559281,-0.9170331722492729,3531,3,VNN2|AASDHPPT|PANK2
REGULATION OF PROTEIN PROCESSING IN PHAGOCYTIC VESICLE%GOBP%GO:1903921,0.246473645137342,0.7585951535148171,-0.709181141439206,-1.2130163611193,1659,2,GSN|MYH9
REPLICATION FORK ARREST%GOBP%GO:0043111,0.792765308346045,0.9819233677232551,0.323193166204595,0.74491233746137,7275,5,MSH6|TIMELESS|MSH3|SLFN11
LYMPH VESSEL MORPHOGENESIS%GOBP%GO:0036303,0.671174808235769,0.964618776001639,-0.235935449417537,-0.8302862415296101,3324,11,VEGFA|PDPN|FOXC2|ACVRL1
CANALICULAR BILE ACID TRANSPORT%GOBP%GO:0015722,0.00335570469798658,0.13998444711172697,0.997959858844288,1.3257451503288702,24,1,ABCC3
WATER-SOLUBLE VITAMIN CATABOLIC PROCESS%GOBP%GO:0042365,0.508394118328123,0.918237678197337,0.513124517480975,0.9753957290582008,4390,3,PDXP|PM20D2|MTHFS
PIGMENT GRANULE TRANSPORT%GOBP%GO:0051904,0.217849462365591,0.7341474817293291,-0.301848625181218,-1.2037992840697902,1012,15,BLOC1S6|MKKS|BLOC1S3|BBS7
CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072203,0.918229103665175,1.0,0.42319666872293604,0.691703329135064,7590,2,STAT1|PDGFRB
RNA 3' URIDYLATION%GOBP%GO:0071076,0.371839845167534,0.852609194081082,0.655472842569617,1.0713523542877,3073,2,ZCCHC11|ZCCHC6
RESPONSE TO TESTOSTERONE%GOBP%GO:0033574,0.962912087912088,1.0,-0.227002500459085,-0.574641756170779,5607,5,MSN
NEGATIVE REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051964,0.10269769595924501,0.574198697765381,0.712985996630328,1.35531137628268,886,3,SLIT1|ROBO2
REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS%GOBP%GO:0045343,0.7382560879811471,0.9744283926676119,-0.386070365060108,-0.783518335235192,4698,3,CIITA|HSPH1|NLRC5
ENTRY OF ORGANISM INTO CELL OF OTHER ORGANISM BY PROMOTION OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052370,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
CENTRAL NERVOUS SYSTEM MYELIN FORMATION%GOBP%GO:0032289,0.29524692175294603,0.800447413278835,-0.852668725187473,-1.14064095133477,2229,1,TENM4
REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS%GOBP%GO:0002023,0.348073613133854,0.842847021021096,-0.82625716806352,-1.10530940608843,2628,1,GDF15
POSITIVE REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050715,0.9252990479290419,1.0,0.127824297626341,0.65252643560637,11370,65,LPL|AIM2|GLMN|MAPK11|F2R|INS|CD2|DHX9|C1QTNF3|GSDMD|F2RL1
MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0001773,0.8157044812272909,0.986631695793843,-0.206790609948856,-0.72772192030457,4040,11,BATF2|LTBR|DHRS2|HMGB1|DOCK2|BATF3|TGFBR2|PYCARD|BATF|CAMK4
NEGATIVE REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051956,0.280750864482134,0.789038489620028,-0.49646860147175104,-1.14177406746123,1704,4,HRH3|TRH
REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900449,0.0754151919411925,0.525408291492683,-0.264774709462819,-1.4162191459836297,276,33,SHISA9|NECAB2|CX3CL1|PTK2B|FYN|PRNP|ARC|CRH|ADRB2|RELN|CACNG3|CACNG7|EPHB2
POSITIVE REGULATION OF COHESIN LOADING%GOBP%GO:1905309,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0042104,0.711350902676904,0.9703327035763342,-0.21554833708845605,-0.8117509174042359,3427,13,IL6R|PYCARD|ICOSLG|RPS3|IGF1|IGF2
PEPTIDYL-HISTIDINE HYDROXYLATION%GOBP%GO:0036138,0.6096915133059712,0.9508825506493929,-0.688685487428319,-0.9212755743773431,4604,1,HIF1AN
POSITIVE REGULATION OF TISSUE REMODELING%GOBP%GO:0034105,0.33928200871550107,0.832810902324958,-0.286581328625028,-1.07925980578001,1634,13,DEF8|ATP6AP1|ROCK1|ADAM8|IL15|SYK|SPP1|ROCK2|IL18|TMBIM1|PLEKHM1|PRKCA|MC4R
ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032341,0.249127516778524,0.7613646381106121,0.8781429201588,1.16657369269781,1855,1,CACNA1H
RESPONSE TO HOST DEFENSES%GOBP%GO:0052200,0.0622427136505846,0.48645662140978296,-0.673688854574533,-1.54934362698993,377,4,TGFB1|SMAD3|SLC25A6|EIF2AK2
NUCLEOTIDE-SUGAR BIOSYNTHETIC PROCESS%GOBP%GO:0009226,0.571530418250951,0.9405138747864158,-0.19768460987282,-0.915821478379793,2404,22,GFPT2|NANS|UGDH|PMM2
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052192,0.0597539543057996,0.476295606439141,-0.564586846383722,-1.5497529840888797,339,6,VPS4A|VPS4B|RAB7A
EMBRYONIC ORGAN MORPHOGENESIS%GOBP%GO:0048562,0.119123505976096,0.6036733116493629,0.24853622964028302,1.31283552842252,1494,76,RYR2|HOXD3|SIX3|TBX2|HOXB3|HOXD4|STRC|HES1|HOXC4|PROX1|PKD2|AHI1|CEP290|DFNB31|MTHFD1|FOXN4|EFEMP1|PDZD7|FBN1|STIL|BBS5|NIPBL|VANGL2|SRF|TH|NPHP3
POSITIVE REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN SERINE 2 RESIDUES%GOBP%GO:2001165,0.4591553025287971,0.890371861972445,-0.7696846052051171,-1.02963056386976,3467,1,CCNK
TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0000722,0.9184968768889781,1.0,0.20626689468748302,0.6087468955884999,9116,10,XRCC3|RAD51|SMC6|TEP1|RAD50|ERCC4
METABOLISM BY HOST OF SYMBIONT MACROMOLECULE%GOBP%GO:0052416,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
POSITIVE REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901628,0.187371476956574,0.6940517434063481,0.741218637992832,1.2115015013321397,1548,2,APOE|MESDC2
POSITIVE REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071902,0.10955056179775301,0.584830174998513,-0.142618483381904,-1.1967532286533602,116,194,IL1B|IRAK1|VEGFA|PKN1|PLCE1|DAB2IP|C5AR1|TGFBR1|IRAK2|PRKAA1|GDF15|MAP3K13|RPS3|RET|RHOA|DDX3X|UBE2V1|FGF2|MAP2K5|CHRNA7|MST1R|TCL1A|PPP2CA|IGF1|DIRAS1|ATP2B4|CEMIP|CRK|RIPK2|CAB39|PDCD10|CCNYL1|SNCA|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|CCNY|ADRB2|RAPGEF1|SHC1|UBA52|DKK1|RALB|MAPK3|FLT1|ADRA2A|FGF10|PEA15|MAP3K11|UBC|MAP2K1|TNF|UBB|ADORA2B
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STARVATION%GOBP%GO:0071262,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|IMPACT
CELLULAR MONOVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0030320,0.6904560299987901,0.96731875442989,0.532947339398952,0.871087785327717,5707,2,XPR1|SLC12A5
PEROXISOME LOCALIZATION%GOBP%GO:0060151,0.443328898028305,0.8808089923737601,0.6254338729947221,1.0222544837363001,3664,2,PEX1|PEX13
OUTER EAR MORPHOGENESIS%GOBP%GO:0042473,0.107795100222717,0.58452352834625,-0.8015012515031209,-1.3709249650348,725,2,TWIST1
REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051569,0.422800804058581,0.873470206885489,0.297919683827921,1.0328067510226802,4416,16,WDR61|DNMT3B|PAXIP1|BRCA1|DNMT1|SNW1|MYB|BCOR|KMT2E|AUTS2|CTR9|PIH1D1
MICROGLIA DIFFERENTIATION%GOBP%GO:0014004,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|APP|NRROS
"MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000398",0.999161132471164,1.0,0.0805865412739391,0.519437011531824,14292,271,CELF5|NOL3|SKIV2L2|ZCCHC8|PPWD1|SFSWAP|U2AF1L4|CELF1|RBM4B|SMN1|CCAR1|DDX20|DHX9|PRPF39|PRPF8|UPF3B|SART3|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|DDX17|PPIL1|C7orf55-LUC7L2|PPIE|RNPC3|FIP1L1|LUC7L|METTL3|GEMIN5|LUC7L3|SRPK1|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|CDK13|POLR2L|U2SURP|SRSF2|SMN2|CACTIN|SFPQ|HNRNPH1|PNN|HNRNPA2B1|TRA2A|PABPN1|SRSF11|POLR2J|RBM5|XAB2|LSM8|SF3B1|DHX40|RBM41|AQR|SNRPD1|TGS1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|MFAP1|CPSF7|GEMIN8|DDX46|SNRNP40|PRPF4B|DDX5|PRPF3|DDX42|RBM4|YTHDC1|CHERP|USP49|GTF2F2|PQBP1|CSTF3|CELF3|RBPMS|PSIP1|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|RBM17|SRSF9|WDR83|SRSF5|PRMT7|SETX|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|SNRPN|SNRNP25|CPSF4|SRSF10|CELF6|CWC27|PCF11|SYMPK|SNRNP48|PLRG1|SNW1|CWC22|SRSF12|DCPS|GEMIN2|PRPF40A|PHF5A|SF3B2|DBR1
POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT%GOBP%GO:2001140,0.26965206185567003,0.784543299601953,0.479310561708798,1.17879452166446,2510,6,ABCA7|ABCB4|APOE
FRUCTOSE CATABOLIC PROCESS%GOBP%GO:0006001,0.0193750699966402,0.289864965388082,0.7644935250492451,1.62003480780581,172,4,ALDH1A1|TKFC|GLYCTK|KHK
MEDIUM-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0051792,0.1278056221399,0.6076913316850071,0.586545800135065,1.35190111888124,1172,5,OXSM|ABHD3|ABHD2|ACOT7
TELOMERE ASSEMBLY%GOBP%GO:0032202,0.48639265315264896,0.907092544497897,0.466362562775326,0.9882668197940371,4342,4,WRAP53|ACD|POT1|TINF2
REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046425,0.383007417397168,0.8582519754973359,-0.16882752889135,-1.04720251131698,1135,54,CYP1B1|IL6ST|AGT|IL6R|SOCS3|NOTCH1|VEGFA|CRLF1|PTK2B|LIF|ARL2BP|TNFRSF18|IL6|LYN|PPP2CA|IGF1|LEPROT|CNOT7|VHL|STAT3|BCL3|TNF|CAV1
RESPONSE TO CYTOCHALASIN B%GOBP%GO:1901328,0.6577518866675489,0.9643779777660141,-0.6648654609616229,-0.889410798706325,4967,1,ACTB
REGULATION OF STRESS GRANULE ASSEMBLY%GOBP%GO:0062028,0.693020134228188,0.96731875442989,0.658138509042788,0.87430764762282,5162,1,STYXL1
REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002712,0.7601534296028879,0.977664504547119,-0.17919826564169,-0.7858691950695451,3368,19,PAXIP1|RIF1|SUPT6H|BTK|FAM35A|XCL1|TP53BP1|NDFIP1|CLCF1|HLA-E|FOXJ1|TGFB1|MAD2L2|TNFSF13|PVRL2|C20orf196|FCGR2B|TFRC
POSITIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033634,0.10824742268041199,0.58452352834625,0.565717492234062,1.3912997833342498,1007,6,CXCL13|SKAP1|CCL5|PIEZO1|CD3E
'DE NOVO' COTRANSLATIONAL PROTEIN FOLDING%GOBP%GO:0051083,0.8693601064473209,0.993389838333952,0.453322304935208,0.740942853924383,7186,2,DNAJC2|HSPA14
POSITIVE REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090309,0.7087019823048492,0.9695170059473192,0.389813080213551,0.826051153858068,6327,4,DNMT1|ZNF304|SETDB1|TRIM28
URETER DEVELOPMENT%GOBP%GO:0072189,0.33124927636910995,0.8293509737209019,0.5825412800113791,1.10734969225918,2860,3,BMP4|NPHP3|NPHP3-ACAD11
POSITIVE REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903615,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0099170,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:2000045,0.7598779557589631,0.977664504547119,0.144171048364749,0.8195743745951609,9961,112,BTG2|CCNB1|PIDD1|CDK1|KIF14|E2F8|PKD2|ANKRD17|WEE1|LSM11|CDK2AP2|CDC25C|MUC1|CDC45|CDK10|E2F7|DACT1|CCNE1|RB1|INO80|GTSE1|CDC6|CCL2|RPS27L|CHEK2|PRMT1|CARM1|AURKA|CDC73|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|FHL1|CASP2|CDK2|ATM|RFWD3|CNOT1|CCND2|PCBP4|MDM2|CNOT2|PSME2|ADAMTS1|ANXA1|CNOT8|TRIAP1|KLF4|RBL2|CCND1|SLFN11|CNOT6|E2F4
LEUCINE BIOSYNTHETIC PROCESS%GOBP%GO:0009098,0.9796782387806942,1.0,0.3448432506553111,0.563636819797839,8098,2,BCAT2|BCAT1
ADP BIOSYNTHETIC PROCESS%GOBP%GO:0006172,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
"ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS, MEVALONATE PATHWAY%GOBP%GO:0019287",0.7885310290651999,0.9819233677232551,-0.369011840424769,-0.7488985663187958,5018,3,PMVK
GENE SILENCING BY MIRNA%GOBP%GO:0035195,0.887792428753722,0.9972009232630479,0.144609081398682,0.677839023733851,10435,45,LIN28B|ZCCHC11|DROSHA|TNRC6A|C9orf114|METTL3|SRRT|TNRC6C|AJUBA|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6|CNOT1|RBM4|ZC3H7A|XPO5|AGO4|CNOT8|WTIP|CNOT6
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1901964,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000270,0.35397178916109895,0.842911430859438,-0.646760408050731,-1.10624903969896,2383,2,SFRP1|GAS6
N-ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006045,0.610883092810804,0.9508825506493929,-0.6880789589766211,-0.920464202774609,4613,1,GNPNAT1
GOLGI TO SECRETORY GRANULE TRANSPORT%GOBP%GO:0055107,0.26013422818792,0.7716430150492808,0.872022496691663,1.15844298317317,1937,1,CCDC64
MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032943,0.14641217685431301,0.638087384443229,-0.273192884571092,-1.28371051937729,605,23,SLC11A1|MS4A1|ELF4|MSN|BCL2|TNFRSF4|ACE
PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0006208,0.740014847809948,0.9744283926676119,-0.46286186931348205,-0.791700438164639,4983,2,DPYD|ALDH6A1
L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098712,0.17008220446914402,0.673117535978459,0.6617955222234481,1.25800366947098,1468,3,SLC1A2|SLC1A3|SLC1A1
NEGATIVE REGULATION OF BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904864,0.316510067114094,0.8176737565328901,0.8458314953683279,1.12364940637852,2357,1,DACT1
INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0042095,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
POSITIVE REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001137,0.782644492013832,0.981487311948134,-0.32848121058065805,-0.755438162206934,4752,4,EHD1|EHD2
LENS DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0002088,0.015720180782079,0.265926367652717,0.546880747150874,1.7239635517146101,159,12,SIX3|NHS|SHROOM2|WNT5B|PROX1|MED1
PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061004,0.6955364703036171,0.96731875442989,0.531019651819463,0.867937032935718,5749,2,BMP4
SENSORY PERCEPTION OF PAIN%GOBP%GO:0019233,0.863529180585577,0.991943445125448,0.210871754456059,0.664743128483304,8788,12,SCN1A|OPRL1|SCN9A|FAM134B|MMP24|P2RX7|P2RX4|NIPSNAP1
MYELOID CELL DEVELOPMENT%GOBP%GO:0061515,0.7541935483870971,0.977083996023335,-0.196548997568501,-0.783854961789366,3506,15,ZNF385A|G6PD|FOXP1|LYAR
REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:0003254,0.0674904942965779,0.502793556475766,-0.317232531954023,-1.46965596659856,283,22,CAMK2D|NEDD4L|KDR|PTPN3|SCN1B|RANGRF|SMAD7|SLMAP|BCL2|SCN5A
SHORT-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0046459,0.3613616838487971,0.848418604328854,0.443839408445106,1.0915583860881999,3364,6,OXSM|MCEE|ACADS|PCK2|ALDH5A1
SENSORY PERCEPTION OF LIGHT STIMULUS%GOBP%GO:0050953,0.172066476414303,0.6752589848097779,0.261237955959151,1.25536568034287,2049,50,PCDH15|RGS16|FSCN2|SIX3|GPR179|CRYZ|COL18A1|ADGRV1|DNAJC19|DFNB31|CDH23|EFEMP1|ABLIM1|RABGGTA|TH|CNGB1|SLC24A1|PRR4|MYO7A|CRYGC|BEST1|REEP6
POSITIVE REGULATION OF ENDOCYTOSIS%GOBP%GO:0045807,0.358440407620736,0.846205501155666,-0.14680437897489199,-1.05341300240953,808,90,DLL1|CYBA|GATA2|FLOT1|PYCARD|CALR|PICALM|SGIP1|VPS28|IL1B|CLU|CBLL1|VEGFA|NEDD4L|FCER1G|CLIP3|RAB21|SIRPA|ITGAM|ARRB2|CD300LF|CAMK1D|FCGR2B|ARRB1|SLC11A1|SNCA|TBC1D5|FMR1|LMAN2|B2M|ANO6|LYAR|GREM1|BICD1|TNF
PYRIDOXINE BIOSYNTHETIC PROCESS%GOBP%GO:0008615,0.471946308724832,0.898272347254494,0.7691883546537271,1.0218324132321,3515,1,PSAT1
NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030809,0.0466763530693789,0.425275525480742,-0.544137703399012,-1.5872738220089702,256,7,FLCN|CBFA2T3|HDAC4|FBP1|PPARA
REGULATION OF GROWTH RATE%GOBP%GO:0040009,0.606338895733005,0.9508825506493929,0.425492270736225,0.901658766829472,5413,4,BNIPL|NOTCH2
CELLULAR ION HOMEOSTASIS%GOBP%GO:0006873,0.9181379310344828,1.0,0.11461486285838099,0.7512530958299559,13312,320,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|CXCR4|F2R|DMXL2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|TMEM178A|MT1E|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|XPR1|SLC39A7|SLC46A1|DMPK|SLC40A1|GRIN1|CCL19|CXCL10|ATP2A2|TCIRG1|PLCG1|C3AR1|SLC39A13|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1|ACO1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|GPR89B|FPR3|MICU1|SLC39A10|P2RY6|ATP6V0E2|SLC8A2|RMDN3|KCNMA1|ISCU
METHYLGLYOXAL BIOSYNTHETIC PROCESS%GOBP%GO:0019242,0.13531047265987,0.6224657604778089,-0.93002867225408,-1.24412771121078,1021,1,TPI1
REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045580,0.6519644180874721,0.9640743070248079,-0.134349456819061,-0.894147840681133,1758,68,RUNX1|TNFRSF18|PNP|SPINK5|CAMK4|SMAD7|NLRP3|NFATC2|SOCS5|BCL6|NKAP|DUSP10|CBFB
MICROTUBULE-BASED PROTEIN TRANSPORT%GOBP%GO:0099118,0.973201692524683,1.0,0.17544779227148702,0.5177917621969461,9659,10,CAMSAP3|RAB27B
PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:0036010,0.6835220616946509,0.9663740819756659,-0.25485539203323104,-0.822696043622571,3500,9,RAB35|ARF6|TMEM30A|NRP1|MICALL1
INTERLEUKIN-21-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038114,0.315837268434435,0.817022961971678,-0.377164920022063,-1.1002068049898301,1738,7,STAT1|JAK3|JAK1|IL2RG|STAT4|IL21R|STAT3
NEGATIVE REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905522,0.24536936151667002,0.757844460290484,0.521534167053665,1.20205894205071,2251,5,CD200|C5|DDT|SLAMF8|MIF
REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010866,0.991492010790621,1.0,-0.132157902611449,-0.497704135119531,4777,13,LDLR|CNEP1R1|GPLD1|SREBF1|SLC27A1|C3|FITM2|CTDNEP1|SIK1|FBXW7|NR1H3|NR1H2
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1904878,0.0617668893838159,0.484567245421779,-0.8503446374414121,-1.45446896079782,415,2,SESTD1|BIN1
RESPONSE TO STAUROSPORINE%GOBP%GO:0072733,0.8100034734282741,0.984682960940884,0.39999178170020794,0.760342299456055,6995,3,CASP6|CASP7
PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042270,0.363919821826281,0.8499434076701009,-0.64063964709126,-1.09577980588477,2450,2,HLA-E|SERPINB9
NEGATIVE REGULATION OF PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:1903094,0.553377876763177,0.932706603479095,-0.540226082161566,-0.924027780879077,3726,2,UBXN1|PARK7
REGULATION OF JNK CASCADE%GOBP%GO:0046328,0.8926345821758391,0.9976191001250191,0.12412030354889099,0.719115257849331,11888,124,SH3RF1|EDN1|CTGF|TPD52L1|FGF19|TAOK3|MAP3K10|CD27|AGER|ERN1|MAP3K9|DUSP19|MAP3K5|MAP3K7|MEN1|DACT1|CCL21|F2RL1|HRAS|ZNF675|HDAC3|CCL19|GSTP1|GADD45B|GADD45G|MAP3K4|TAOK1|MAP2K7|CARD9|TRAF4|RIPK1|MAP3K12|TAOK2|PTPN22|TRAF2|RASGRP1|DVL3|DNAJA1|UNC5CL|FKTN|PHLPP1|TNFRSF19|DVL2|SPAG9|TNIK|MINK1
TOLL SIGNALING PATHWAY%GOBP%GO:0008063,0.12876667215544196,0.608939136940685,-0.592293390453287,-1.3621510636191398,781,4,PELI2|PELI1
RECEPTOR-MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL%GOBP%GO:0019065,0.0350353495679497,0.381265913354899,-0.7883523769120501,-1.5999377259652299,222,3,CAV2|CAV1
REGULATION OF CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903674,0.758120805369128,0.977664504547119,0.623897220996912,0.8288196240660359,5647,1,NCK1
D-SERINE BIOSYNTHETIC PROCESS%GOBP%GO:0070179,0.9756388190123131,1.0,-0.511027790030878,-0.6836174558310022,7368,1,SRR
DORSAL/VENTRAL PATTERN FORMATION%GOBP%GO:0009953,0.141290322580645,0.630107155356772,-0.329673070640314,-1.31476565836813,656,15,SMAD6|SMAD2|TBX20|GREM1|ASCL1|NBL1
RESPONSE TO HEAT%GOBP%GO:0009408,0.665511265164645,0.964618776001639,-0.140826366165854,-0.887620587970006,1919,57,GCLC|SOD1|EIF2B3|HSPA13|HMOX1|HSPA5|ANO1|STUB1|SUMO1|IGF1|HSBP1|BAG3|HSF1|YWHAE|NOS3|HSPA6|POLR2D|SLU7|IER5
REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002694,0.9926719668164541,1.0,0.0936360139912713,0.610714333049712,14358,302,IGHV3-21|SH3RF1|IGHV4-61|CD47|NR4A3|IDO1|PAG1|CEACAM1|GLMN|CD209|MZB1|INHA|IGHG1|SIRPG|KAT2A|CD38|CD27|BMP4|IGLL5|GRAP2|AGER|CD320|IGHG4|BLM|CD2|THOC1|KLRK1|PAK3|PDPK1|MARCH7|TNFSF13B|DOCK8|CCDC88B|PRKCQ|IGHV1-18|LOXL3|SRC|CCL21|F2RL1|IGHV3-43|CARD11|SIT1|EBI3|CCL5|BST1|CD200|ZP3|DLG5|ZBTB1|TIGIT|IL7|CCL19|CCL2|METTL3|TMIGD2|UNC13D|BTN2A2|CD55|STXBP2|ZNF335|IL12RB1|IGHV1-24|C12orf4|LDLR|LAT|CD1D|FCRL3|RASAL3|PAXIP1|TNFAIP8L2|PLA2G2D|TESPA1|CEBPB|SOCS1|HLA-DMB|IGFBP2|RIF1|CD3E|PTPN22|IGHG2|CD46|ZAP70|CTLA4|ZNF683|THBS1|LCK|SUPT6H|RIPK3|IKZF3|BTK|GATA3|IGHV1OR15-1
REGULATION OF EXOCYST ASSEMBLY%GOBP%GO:0001928,0.0928108036541771,0.5622489437340121,-0.952249669166299,-1.2738534162927702,700,1,RALB
LUNG EPITHELIUM DEVELOPMENT%GOBP%GO:0060428,0.18301812450748603,0.6891306172477071,-0.37462496649241106,-1.267412335503,928,10,PKD1|ERRFI1|FOXJ1|THRA|RCN3|STRA6|NFIB|FGF10|ASCL1
NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009165,0.817813765182186,0.987153241368501,-0.104523485682098,-0.853591357066177,1009,170,HSD17B12|APOA1BP|CMPK2|ATP5J|LDHA|PAPSS1|SCD|ADCY7|CMPK1|ACSL1|PFKL|COX5B|GPI|GMPS|RRM2B|GUCY1A3|PRPS1|GARS|PKM|PNP|ENO1|NAMPT|DCTD|ACSL4|HPRT1|ATP5I|PRPSAP1|PDHB|GAPDH|PGK1|CDADC1|PANK2|KARS|CYC1|HK1|NMNAT3|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2|NMNAT2
MONOUNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:1903966,0.552316438853272,0.9323119502445251,0.584793503841784,0.95582891681207,4565,2,SCD5
REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070129,0.21245247148289004,0.727849685607807,-0.259922685568946,-1.20415432600111,893,22,C1QBP|NSUN3|UQCC2|RMND1|RPUSD3|SHMT2
REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903894,0.00847799757771498,0.20298122046820802,-0.544115561143507,-1.91481045063352,41,11,BAX|DAB2IP|HSPA5|PTPN1|BFAR|BCL2L11|TMEM33
PEPTIDYL-ARGININE ADP-RIBOSYLATION%GOBP%GO:0018120,0.0228187919463087,0.31609926985007897,0.988861932068813,1.31365896049494,169,1,ART4
ARGININOSUCCINATE METABOLIC PROCESS%GOBP%GO:0000053,0.227326889977492,0.7400748230621691,-0.885255844728716,-1.18423373471803,1716,1,ASS1
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:1903373,0.433887699654207,0.878651088001772,-0.43638669828489507,-1.00359824168069,2634,4,KIAA1715|RAB3GAP2|RAB3GAP1|ATL3
CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION%GOBP%GO:0021930,0.825835189309577,0.9876441563834109,-0.42832272411671796,-0.7326230801038679,5561,2,ATF5
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031110,0.491293224395477,0.909315999193258,0.197848182093947,0.982249735976131,5952,57,AKAP9|NAV3|CLIP1|CAMSAP3|PSRC1|FGF13|NUMA1|CDK5R1|APC|CDK5RAP2|SKA3|TAOK1|SKA2|STMN1|FAM179B|SKA1|APC2|CAMSAP2|TBCD|TUBB4A|PRUNE
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, EXONUCLEOLYTIC, 3'-5'%GOBP%GO:0034427",0.134713002733307,0.622136653169633,-0.416206972639012,-1.3435534048798798,689,9,EXOSC2|SKIV2L|EXOSC3|EXOSC7|EXOSC8|EXOSC6|EXOSC4|EXOSC9|EXOSC5
REMOVAL OF NONHOMOLOGOUS ENDS%GOBP%GO:0000735,0.90013422818792,0.998912093067348,0.551499779444199,0.7326428528421121,6705,1,MSH3
RIG-I SIGNALING PATHWAY%GOBP%GO:0039529,0.8995973154362421,0.998912093067348,0.5519960299955889,0.7333020995603259,6701,1,DDX58
MITOTIC SPINDLE ELONGATION%GOBP%GO:0000022,0.0151821862348178,0.264387156924099,0.600144842370477,1.71260832456772,149,9,KIF4A|MAP10|KIF23|PRC1|AURKB|RACGAP1
ETHANOLAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042439,0.29843103072564797,0.8023890191280308,0.49816458797131,1.14819552660737,2738,5,NAPEPLD|GDPD1|MOXD1|DBH
"NEGATIVE REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0045976",0.985746102449889,1.0,-0.31089054314860803,-0.531761623823235,6638,2,FZD3|CTNNB1
REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002858,0.0991152424683615,0.570215774831708,0.651030018412327,1.3795947986433101,884,4,CEACAM1|KLRK1
REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031935,0.4536779692421721,0.8878942151523991,0.26350863905479605,1.0091769616988,4896,22,SIRT1|SIRT6|NAA40|ASF1A|CDC45|ATAD2|ATAD2B|PHF2|HIRA|DNMT1|TET1|PHF8|ZNF304
UDP-GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015786,0.78180855289289,0.981487311948134,-0.605977062196736,-0.810633992186309,5904,1,SLC35C2
SCF COMPLEX ASSEMBLY%GOBP%GO:0010265,0.7831829896907221,0.981487311948134,0.303559801546507,0.7465611226776471,7292,6,CAND1|RBX1|FBXL7
NEGATIVE REGULATION OF TELOMERE SINGLE STRAND BREAK REPAIR%GOBP%GO:1903824,0.4120217132265329,0.867015886388254,-0.7927878253198059,-1.06053644582846,3111,1,TERF2
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902109,0.19224149344631303,0.7023096717844329,-0.9025143361270401,-1.20732094486856,1451,1,ACAA2
TRACHEA MORPHOGENESIS%GOBP%GO:0060439,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050707,0.6498599439775911,0.963755998259649,-0.12628659589182098,-0.909584002471896,1391,94,CD274|SYT11|SRGN|CX3CL1|LGALS9|TNFAIP3|SSC5D|FGR|TNFRSF1B|FCGR2B|PANX1|MBP|MAVS|FOXP1|RIPK2|TMSB4X|GAPDH|KARS|NLRP1|NLRP3|TNFRSF4|DRD2|PPP1R11|TWIST1|TNF|TNFRSF21
POSITIVE REGULATION OF GASTRULATION%GOBP%GO:2000543,0.464728986645719,0.8928412364521658,-0.481857284658652,-0.977915042606072,2957,3,SCX|GNB2L1|TENM4
REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048145,0.9703602759560509,1.0,0.118669356557339,0.550163008527197,11392,43,CDK6|LIG4|DHX9|DDR2|NDUFS4|NF1|GSTP1|NLRC3|CDC73|PARP10|FN1|E2F1
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030518,0.35058182718494707,0.842847021021096,0.219221990297407,1.08836351090424,4247,57,PIAS1|SAFB|RHOXF1|EGLN2|MED12|SRC|CCNE1|RB1|DDX17|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2|THRAP3|ARID1A|MED30|TRIP4|DDX5|MED14|BRCA1|RBFOX2|NCOA3|MED16|UBR5
SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071670,0.7087250099298291,0.9695170059473192,-0.641100573445082,-0.857619784090102,5352,1,PDGFRB
PROTEIN N-LINKED GLYCOSYLATION VIA ASPARAGINE%GOBP%GO:0018279,0.48010561777292204,0.9046812288131709,0.24720544151229698,0.985078123846374,5272,25,ASGR1|FUT8|DERL3|NUDT14|MGAT2|SYVN1|OSTC|ALG5|RPN2|VCP|STT3A
"PENTOSE-PHOSPHATE SHUNT, NON-OXIDATIVE BRANCH%GOBP%GO:0009052",0.536916208791209,0.9265056012720759,-0.363556143834105,-0.920318236746303,3126,5,RPE|RPIA|TALDO1|SHPK|TKT
NEGATIVE REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905463,0.513608322245071,0.919851565340177,0.598786876206231,0.9787006995213321,4245,2,TOP2A|MNAT1
ELASTIN BIOSYNTHETIC PROCESS%GOBP%GO:0051542,0.948322147651007,1.0,0.528506837229819,0.7020977548981849,7064,1,ATP7A
NEGATIVE REGULATION OF GTP BINDING%GOBP%GO:1904425,0.5174496644295301,0.9231373362724822,0.745202911336568,0.9899688218517441,3854,1,ARHGAP28
AMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0043604,1.0,1.0,0.0717062663664445,0.478557814285274,14677,397,B3GALT2|HACD1|ASNS|MRPL50|MTERF3|NDUFA7|MRPS36|MRPS11|B4GALNT1|CERS4|BDH2|SCD5|CHCHD1|MRPL42|ELOVL6|GGT1|EIF3CL|B3GALT1|TARSL2|MRPL46|DENR|DHFR|ST3GAL5|CERS6|EPRS|MRPL17|GFM2|MTHFD1|MRPS5|EIF2B5|EEF1G|MRRF|EIF2B1|MARS|ORAOV1|CAD|RPL23A|PDHX|VARS2|MRPL38|MRPL35|PTCD3|WARS2|ERAL1|NOA1|MRPL16|RPS4Y1|IGF2BP3|B4GALT6|ABCE1|PDHA1|RPS24|RPL36A|SLC25A1|ACACA|MRPS31|EIF2B4|ST8SIA3|MGST2|RPS19|RPLP0|DLD|ACSS1|SECISBP2|OPLAH|GGT5|CERS5|GATC|RPL36|DMD|MCTS1|MTIF3|MRPL33|HAGH|MRPL34|RPS6KB2|MRPS14|ICT1|TECR|MRPL57|SMPD1|RPS15|ZC3H15|NAGS|HARS2|RPS10|EIF2D|MTERF4|RPL28|IGHMBP2|RPS3A|CARS2|RPL26L1|MRPL21|MRPS9|MRPL19|MRPS34|RPL37|MRPS18C|RPL27A|NARS2|GSPT2|MRPL55|MRPL23|MRPL1|SMPD4|MRPS27|CERS2|EEF1B2|ELOVL2|MRPS7|OXA1L|B4GALT3|RPL7A|RBM4|RWDD1|AARS2|QRSL1|MRPL52|RPL19|MRPS28|LARS|GADD45GIP1|DARS2|LARP1|MRPL45|NEMF|MRPL27|RPLP1|MRPL40|RPSA|ST8SIA2|EIF3F|RPL6
CARDIOBLAST MIGRATION%GOBP%GO:0003260,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0090394,0.0398485097974642,0.398259330633433,-0.7078299800202851,-1.62786108318422,241,4,NLGN4X|MTMR2|CBLN1
REGULATION OF C-C CHEMOKINE RECEPTOR CCR7 SIGNALING PATHWAY%GOBP%GO:1903080,0.8583344366476899,0.99166790097654,-0.56908910454345,-0.7612878465291079,6482,1,TREM2
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001015,0.389012620638456,0.8603316114971841,-0.621252693217147,-1.0626194595819398,2619,2,AKIRIN1
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS%GOBP%GO:0048701,0.9644731530076709,1.0,-0.162095506322701,-0.570434282113057,4777,11,TWIST1
B-1 B CELL DIFFERENTIATION%GOBP%GO:0001923,0.7844295302013421,0.981487311948134,0.60967137185708,0.8099212181438941,5843,1,SLAMF8
REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903311,0.4253554502369671,0.8756136247824,-0.118394458270205,-1.01654662592856,358,227,EXOSC4|C1QBP|MAGOH|CCRN4L|EIF4G1|VIM|RBM15B|SLC11A1|VIP|NBAS|YBX1|TRA2B|SERBP1|CNOT7|NPM1|EXOSC9|YWHAB|FMR1|AGO2|NELFE|HNRNPC|PDE12|HSF1|UBA52|RBM38|PRKCA|RBM15|YWHAZ|RBM7|NCBP2|NUDT21|ZC3HAV1|C9orf78|RBM8A|RNPS1|SAP18|PABPC1|EXOSC5|CARHSP1|MYD88|UBC|RBM24|UBB
REGULATION OF MISMATCH REPAIR%GOBP%GO:0032423,0.691610987379362,0.96731875442989,-0.48431210366694205,-0.828389915225164,4657,2,HMGB1|AXIN2
ETHER LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008611,0.610061813186813,0.9508825506493929,-0.34434198614274303,-0.8716788724363179,3552,5,DHRS7B|PEX7
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046474,1.0,1.0,0.0564100758626814,0.339997397299388,13716,160,PTDSS2|LPCAT4|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|GPAM|CEPT1|ABHD3|PIGC|INPP5E|TAZ|PIGF|FAR1|CHKB|CPNE7|PIGQ|PIGB|GNPAT|MTMR4|PLEKHA1|PTPN13|AGK|RAB4A|CPNE1|ETNK1|PLA2G2D|IMPA1|SLC44A3|DGKZ|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|PIP4K2B|MTMR7|FIG4|PIGK|LPCAT2|PLD1|PIGH|PIP5K1C|CDS1|GPAA1|PIK3C2B|INPP5F|TAMM41|OCRL|PIK3C2A|RUFY1|MTMR6|CRLS1|DGKA|CHKA|PIKFYVE|PGS1|PIGN|STARD7|LCLAT1|PIGU|ETNK2|AGPAT2|PIGS|PIGO|SLC27A1|AGPAT1|SLC44A1|MTMR3|PLEKHA8|GPD1|INPPL1|PCTP|CHPT1|AGPAT5|PYURF|PCYT1B
TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0061370,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
POSITIVE REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000741,0.7443833464257661,0.9749763305090959,-0.384330264228101,-0.7799868522973001,4737,3,SOX6
CHROMATIN SILENCING AT CENTROMERE%GOBP%GO:0030702,0.9835189309576841,1.0,-0.313592500689275,-0.536383177488957,6623,2,HIRA|ZNFX1
REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903567,0.9087940002419259,1.0,0.42996726392946005,0.7027696810009971,7512,2,EFCAB7|LZTFL1
REGULATION OF RESTING MEMBRANE POTENTIAL%GOBP%GO:0060075,0.6952945445748161,0.96731875442989,0.5311827956989249,0.868203687124873,5747,2,NALCN|ATP1A3
POSITIVE REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090280,0.246425255338904,0.7585951535148171,-0.3824621926578,-1.18885902166266,1326,8,CXCL12|RAMP3|LGALS3|STC1
KERATAN SULFATE METABOLIC PROCESS%GOBP%GO:0042339,0.519765365978067,0.9243808232348331,-0.191275538376588,-0.953163698833432,2037,27,B4GALT6|PRELP|B4GALT4|ST3GAL4|B3GNT4|FMOD|ST3GAL6|B4GALT3|HEXA|OGN|ST3GAL3|LUM|GNS|CHST2|SLC35D2|B4GALT2|GLB1|HEXB|ST3GAL1|B4GAT1|CHST1|B4GALT1|B4GALT5|GALNS|ST3GAL2|B3GNT7|B3GNT2
DEVELOPMENT INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0044111,0.15291936978683998,0.6488592577606589,-0.920875606528452,-1.23188337611497,1154,1,NEDD4
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS%GOBP%GO:0016445,0.7042879360142191,0.968941691852291,-0.190371642238966,-0.818936508419313,3169,18,CTNNBL1|PMS2|RNF168
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903588,0.808496624403096,0.984682960940884,-0.32035515358738204,-0.736749928715168,4909,4,THBS1|DLL4|NGFR|PDCD10
PEPTIDE ANTIGEN STABILIZATION%GOBP%GO:0050823,0.30888388719714,0.8114708447293539,-0.846162329069255,-1.13193714686907,2332,1,TAPBP
NEGATIVE REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0045818,0.13771812080536902,0.6243233125849921,0.9323445081605649,1.2385780842538798,1025,1,INS
NEGATIVE REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072217,0.8445061942804208,0.991298302704726,0.382229677632785,0.7265784081270971,7293,3,BMP4|STAT1
PROTEIN-COFACTOR LINKAGE%GOBP%GO:0018065,0.39628597957288797,0.8638522656500329,-0.331497445691571,-1.03043839766187,2133,8,SDHAF2|GCSH|GLRX5|LIAS
PROTEIN ADP-RIBOSYLATION%GOBP%GO:0006471,0.07981220657277,0.534078458829271,0.36926674840317397,1.43615344842731,866,23,SIRT4|ART4|SIRT1|PARP16|PARP2|SIRT6|PARP1|SIRT3|TNKS2|PARP10|PARP9|PARP3|PARP14|PARP8|TNKS|SIRT2|SIRT5|PARP6
POSITIVE REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:1904692,0.37031643055739394,0.852609194081082,-0.8132443758270841,-1.0879017971570402,2796,1,PTPRN
REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903903,0.7263971329376191,0.972554563883587,0.38316174882274606,0.8119563472726742,6485,4,DOCK8|FLOT2|FAM65B|GSN
VESICLE FUSION WITH ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT (ERGIC) MEMBRANE%GOBP%GO:1990668,0.9720790378006869,1.0,0.21598074827423996,0.531173195814834,9051,6,TAP2|SEC22B|TAP1|STX4
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1900740,0.00047528517110266203,0.0784645998831315,-0.512378139276586,-2.37371490529111,1,22,TP53BP2|GZMB|BBC3|YWHAH|BID|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|PMAIP1|TFDP2
RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE%GOBP%GO:0002679,0.79732914375491,0.9831410877615258,-0.365721848461454,-0.7422216253792021,5074,3,C17orf62|HCK|PIK3CD
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0045923,0.537436125305488,0.9265056012720759,-0.21566030565501298,-0.9277227198369359,2418,18,NR1H3|PPARA|NR1H2|PPARGC1A|TWIST1|MID1IP1
NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090315,0.558867116746254,0.936434965680841,-0.3929851651684771,-0.9037837824107909,3393,4,GDI1|ITGB1BP1|DMTN|INPP5K
POSITIVE REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032349,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
NEGATIVE REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046627,0.6022008253094909,0.9508825506493929,0.227051796986626,0.893561845558379,6566,24,GRB14|CISH|SOCS2|PRKCB|PRKCQ|IRS1|SOCS1|GSK3A|RPS6KB1|NCK1|SLA2|PTPRE|PRKCZ|KANK1|PTPN2
LIPOPOLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0009104,0.592348993288591,0.945987625636678,0.708645787384208,0.9414043136099599,4412,1,AOAH
MYELOID LEUKOCYTE MIGRATION%GOBP%GO:0097529,0.6451718762818941,0.962671541860027,0.17512668268280301,0.8789216743110619,7863,60,EDN1|CXCL13|CD47|CXCL9|PTPRO|TGFB2|XCL2|CCL21|AZU1|CCL5|KIT|CCL19|CXCL10|RPS19|CCL2|CXADR|AMICA1|GBF1|CCL3L3|CCL11
ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030042,0.0273330730183522,0.339785941813865,-0.530330071791809,-1.71195299576124,139,9,CFL2|WDR1|MICAL2|TWF1|DSTN|TWF2
NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902260,0.236456446566771,0.7504968809113829,-0.520099513376636,-1.1961202281720502,1435,4,KCNE3|KCNE4|SUMO1
CELLULAR RESPONSE TO TETRAHYDROFOLATE%GOBP%GO:1904482,0.27720861172977,0.7884684708511421,-0.693168064088269,-1.18562684991609,1866,2,SHMT2
AMINOGLYCAN METABOLIC PROCESS%GOBP%GO:0006022,0.903125,1.0,-0.10352681594617,-0.7779023434595249,1733,110,ST3GAL2|CHST11|FGF2|HS3ST2|CHP1|CHIT1|CEMIP|HS6ST2|B3GNT5|CSPG4|B3GNT7|CSGALNACT1|CHSY1|UGDH|SDC2|TMEM2|NCAN|B3GNT8|B3GNT2
REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0006937,0.769433570344332,0.9792236089291529,0.151867294492254,0.800150553525859,9630,75,RGS2|RYR2|TNNI3K|AKAP9|MYLK2|KCNQ1|SLC8A3|F2R|KCNB2|FGF13|ATP2A1
NEGATIVE REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045077,0.09378256339006599,0.562743160240921,0.721135599600376,1.3708029142226899,809,3,INHA|LILRB1|INHBA
DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING%GOBP%GO:0110025,0.32917594654788396,0.828303707528737,-0.6620898814447199,-1.1324692829453,2216,2,SAMHD1|MRE11A
RESPONSE TO OXYGEN LEVELS%GOBP%GO:0070482,0.0007235890014471781,0.0832177600900466,-0.21356157978884,-1.7011149203689098,0,149,CBFA2T3|CHRNB2|VEGFA|PDK3|PLK3|CPEB1|USF1|PRKAA1|HMOX1|DDIT4|UCP2|LIMD1|PML|HIGD1A|CITED2|STUB1|MMP2|HYOU1|BACH1|FOXO1|CPEB2|P4HB|GLTSCR2|CHRNA7|ATG7|LMNA|ACAA2|PGK1|RYR1|VHL|GNGT1|TCEB1|ADAM17|MMP12|UBA52|ATP6V0D1|TP53|ALKBH5|BNIP3L|UBC|PGF|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|CAV1|NDRG1|UBB|EGLN3
SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:0016079,0.686853134890086,0.966602206569912,0.182403524918295,0.8394858573653861,8029,42,SYT17|RIMS2|UNC13B|SYT3|UNC13A|CPLX3|PCLO|SNAP47|PRRT2|STX2|SYT1|SEPT5|RIMS4|RAB3A|SYT7|STX3|SNAPIN|PIP5K1C|STX1A|RIMS1|RIMS3|SYT4|STX1B
REGULATION OF T CELL CHEMOTAXIS%GOBP%GO:0010819,0.18501194267515902,0.691482206657505,0.41780165491485,1.27461707683568,1858,11,CXCL13|STK39|XCL2|CCL21|CCL5|CXCL10
NEGATIVE REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000065,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
POSITIVE REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904531,0.33324506818482696,0.8293509737209019,-0.8344728716365241,-1.11629980325274,2516,1,ABL1
CHROMATIN SILENCING BY SMALL RNA%GOBP%GO:0031048,0.8344069128043989,0.988613522932093,-0.35152763517448204,-0.713414891241891,5310,3,FAM172A|ZNFX1
RESPONSE TO DIURETIC%GOBP%GO:0036270,0.661104266995184,0.964618776001639,0.4065415024789771,0.86150027862066,5902,4,RYR2|SLC8A1|GSTM2
'DE NOVO' IMP BIOSYNTHETIC PROCESS%GOBP%GO:0006189,0.7892228253674041,0.9819233677232551,-0.602448169386855,-0.8059132846794921,5960,1,PFAS
MITOCHONDRIAL MRNA 3'-END PROCESSING%GOBP%GO:0090616,0.9029530201342281,1.0,0.5503418614909571,0.7311046104996121,6726,1,PNPT1
OOGENESIS%GOBP%GO:0048477,0.753926206244087,0.977083996023335,0.211961068403643,0.7747501351084399,7968,19,ZCCHC11|YTHDC2|ZNF830|ZP3|BMPR1B|KMT2D|FMN2|ZCCHC6|PIWIL2|NPM2|C17orf104
POSITIVE REGULATION OF T-HELPER 2 CELL ACTIVATION%GOBP%GO:2000570,0.297986577181208,0.8023890191280308,0.854708866343185,1.13544259767102,2219,1,PRKCQ
CYCLIC-NUCLEOTIDE-MEDIATED SIGNALING%GOBP%GO:0019935,0.000442282176028306,0.0784645998831315,-0.309492212626353,-2.2080883918078302,0,89,TBXA2R|AKAP6|ADGRE5|GUCY1B3|PTHLH|RAMP3|GPER1|AHR|GNA13|ADCY7|MAPK7|ADRA2C|UCN2|PTGFR|CRHR1|GNAQ|CALCRL|ADRA1B|NUDT4|DGKQ|GNAL|VIP|ABCA1|PRKAR2A|GCGR|RAMP2|AKAP13|ADRB2|PDE9A|MC4R|GPR161|GPR3|PRKAR1B|CALCB|ADCY2|ADCYAP1|DRD2|UCN3|ADRA2A|GNAS|CD36|ADM|PDE3A|AQP1|PDE4D|GAL|RAMP1
MULTI-CILIATED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:1903251,0.0375898888646764,0.38859310205237607,0.6724726373026619,1.54994974062919,344,5,CCDC78|CEP63|CEP152
REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903798,0.8850044191299219,0.996643473105967,0.200817665402623,0.648113250481972,9011,13,BMP4|MAP2K2|MYCN|DDX5|NCOR1|ZC3H12A|BCDIN3D
NEGATIVE REGULATION OF SEROTONIN UPTAKE%GOBP%GO:0051612,0.138975501113586,0.627473629755205,-0.773917838433968,-1.3237450142531202,935,2,GPM6B|SNCA
ACTIN FILAMENT SEVERING%GOBP%GO:0051014,0.246473645137342,0.7585951535148171,-0.709181141439206,-1.2130163611193,1659,2,GSN|FMNL1
ACTIVATION OF MEIOSIS%GOBP%GO:0090427,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
CELLULAR PIGMENT ACCUMULATION%GOBP%GO:0043482,0.44416243654822296,0.88124764725951,-0.30782811747142697,-0.99369674833682,2274,9,AP1M1|BLOC1S5|BLOC1S6|BLOC1S3
CHEMOKINE METABOLIC PROCESS%GOBP%GO:0050755,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
AGE-DEPENDENT RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0001315,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
REGULATION OF ACTIVATED T CELL AUTONOMOUS CELL DEATH%GOBP%GO:0070239,0.354958294717331,0.842911430859438,-0.821460079400088,-1.09889219432135,2680,1,LGALS9
REGULATION OF TWITCH SKELETAL MUSCLE CONTRACTION%GOBP%GO:0014724,0.21865771812080498,0.7341474817293291,0.891982796647552,1.1849593511724499,1628,1,ATP2A1
OXALATE METABOLIC PROCESS%GOBP%GO:0033609,0.7169336687408979,0.971081608033886,-0.636854874283194,-0.8519401828709621,5414,1,HOGA1
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0050428,0.417418384879725,0.8709670999109399,0.42227179798537,1.03851598918234,3886,6,SLC35B3|SLC26A2|PAPSS2|SLC35B2
MAINTENANCE OF ER LOCATION%GOBP%GO:0051685,0.491857540050311,0.909315999193258,-0.7517644464049399,-1.00565822106171,3714,1,POLR2M
CELLULAR RESPONSE TO INTERLEUKIN-15%GOBP%GO:0071350,0.0597634363975929,0.476295606439141,-0.401961964439882,-1.5137810748304599,287,13,STAT5A|SHC1|STAT3|PLCB1
ACTIN CORTICAL PATCH LOCALIZATION%GOBP%GO:0051666,0.22337434094903302,0.7360157208449051,-0.441453863548618,-1.21176121398169,1270,6,WAS|WASL|WIPF3|TIGD5|WIPF2|WIPF1
PROLINE CATABOLIC PROCESS TO GLUTAMATE%GOBP%GO:0010133,0.936375838926175,1.0,0.534958094397883,0.7106679622349701,6975,1,PRODH
POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS%GOBP%GO:1902174,0.9234687970360079,1.0,0.334774548688823,0.636371200096811,7975,3,PIAS4|SFRP4|GSN
MELANOSOME LOCALIZATION%GOBP%GO:0032400,0.455232170628749,0.88900512246363,-0.230113259922409,-0.989896117959058,2048,18,BLOC1S6|MKKS|BLOC1S3|BBS7
TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032905,0.463656825102608,0.8921382338742359,-0.767313630348478,-1.02645883851362,3501,1,NRROS
BOX C/D SNORNA METABOLIC PROCESS%GOBP%GO:0033967,0.420935412026726,0.8727872721376851,-0.602757099531293,-1.03098373714292,2834,2,FBLL1|FBL
MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL%GOBP%GO:0086045,0.0659185007626934,0.495991045493396,0.638840160821239,1.4724318680683202,604,5,CACNA1G|CACNB2
NEGATIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051387,0.50006619886138,0.9143688619793578,-0.746471107190119,-0.998577159801479,3776,1,AGT
NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001258,0.0030893536121673,0.134638908345007,-0.438373903121515,-2.03087249077282,12,22,KCNE3|FKBP1B|CRHR1|KCNE4|KCNAB1|MMP9|SUMO1|FMR1|GNB5|CAV1|FKBP1A|EPHB2
VERY LONG-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042761,0.18633603238866397,0.692707054555662,0.44628415880251,1.27354250428776,1840,9,HACD1|ELOVL6|TECR|ELOVL4|ELOVL2|HACD2|HACD3
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CGMP NUCLEOTIDE SECOND MESSENGER%GOBP%GO:0007199,0.50006619886138,0.9143688619793578,-0.746471107190119,-0.998577159801479,3776,1,AGT
MESONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0072177,0.789338111770635,0.9819233677232551,0.357374305318842,0.757310291142953,7047,4,PKD2|GPC3
GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042921,0.509841827768014,0.918404893008545,-0.343736678173621,-0.943534101356503,2900,6,RBM14|CALR|YWHAH|NEDD4
NEGATIVE REGULATION OF AXON EXTENSION%GOBP%GO:0030517,0.761059530311305,0.977763214485385,0.192617220392826,0.7744134884274821,8360,26,SEMA3D|SEMA5A|SEMA3E|SEMA4G|TRIM46|SEMA6A|SEMA4C|RTN4R|PTPRS|SEMA4A|CDKL3|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D
REGULATION OF SUPEROXIDE METABOLIC PROCESS%GOBP%GO:0090322,0.8363013046376542,0.98866024827725,0.19559275250955604,0.7016310789447578,8781,18,DHFR|F2RL1|BST1|FBLN5|GSTP1|SZT2
POLYPRENOL METABOLIC PROCESS%GOBP%GO:0016093,0.934094903339192,1.0,-0.22270401249094396,-0.6113075608067479,5314,6,NUS1|AKR1C3|DHDDS|DPM1|DPM2
PROTEIN MANNOSYLATION%GOBP%GO:0035268,0.572573839662447,0.940734934957679,-0.23312623064653,-0.903192734804797,2713,14,GYLTL1B|POMGNT2|TMEM5|DPM1|DPM2|DPY19L1
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL ELONGATION%GOBP%GO:1900248,0.8839966130397969,0.996316041142784,0.44479311860484005,0.727002133177851,7307,2,CPEB3
NEGATIVE REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000016,0.25420362769760396,0.7644572867804641,-0.873566387295986,-1.1685963911016999,1919,1,DDIT3
PROTEIN POLYGLUTAMYLATION%GOBP%GO:0018095,0.21281337047353802,0.7279184739702909,-0.394641831155599,-1.22671864121897,1145,8,TTLL5|TTLL1|CFAP20
REGULATION OF NEURONAL SIGNAL TRANSDUCTION%GOBP%GO:1902847,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
STEM CELL DEVELOPMENT%GOBP%GO:0048864,0.9816182786462809,1.0,0.111964673622724,0.511333750167537,11427,41,SEMA3D|SEMA5A|SEMA3E|SEMA4G|HAND2|SEMA6A|SEMA4C|NRG1|FN1|KLHL12|SEMA4A|SOX10|TAPT1|PHOX2B|JAG1|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D|ANXA6
POSITIVE REGULATION OF MALE GERM CELL PROLIFERATION%GOBP%GO:2000256,0.710710975771217,0.97016506841811,-0.640052933392148,-0.8562183240490151,5367,1,CIB1
MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002372,0.185754005031113,0.6921962082288221,-0.9051058667842958,-1.21078771444388,1402,1,CAMK4
N-TERMINAL PEPTIDYL-SERINE METHYLATION%GOBP%GO:0035570,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
NOTCH SIGNALING PATHWAY INVOLVED IN ARTERIAL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060853,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
CYSTEINE BIOSYNTHETIC PROCESS VIA CYSTATHIONINE%GOBP%GO:0019343,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904352,0.8469375940720161,0.991298302704726,0.38120969664010895,0.7246395315579921,7314,3,LDLR|LRP1|CD81
BEHAVIORAL RESPONSE TO ETHANOL%GOBP%GO:0048149,0.6973486164177379,0.96731875442989,0.446263794760168,0.8483005286499721,6022,3,CRHBP|DRD4
CEREBRAL CORTEX DEVELOPMENT%GOBP%GO:0021987,0.8965338851526129,0.998912093067348,0.146142333324175,0.659139634812995,10397,39,BTBD3|KIF14|WDR62|FGF13|ARHGAP11B|NPY|CCDC85C|NF1
HEPARIN BIOSYNTHETIC PROCESS%GOBP%GO:0030210,0.48590782629732704,0.9067604918222419,0.609336129903282,0.99594316488421,4016,2,GLCE
N-ACETYLNEURAMINATE BIOSYNTHETIC PROCESS%GOBP%GO:0046380,0.722494373096783,0.9716768972596899,-0.6336016762240849,-0.847588280638115,5456,1,NANP
CELLULAR RESPONSE TO MANGANESE ION%GOBP%GO:0071287,0.720188531029065,0.9713637233549571,-0.3922938709488811,-0.796148755527976,4583,3,PARK2
PEPTIDYL-DIPHTHAMIDE BIOSYNTHETIC PROCESS FROM PEPTIDYL-HISTIDINE%GOBP%GO:0017183,0.8483304042179259,0.991298302704726,-0.254650160876719,-0.698997593098702,4826,6,DPH2|DPH6|DPH3
DEPHOSPHORYLATION%GOBP%GO:0016311,0.8755426917510849,0.994094509672955,-0.100789292025588,-0.802832460069234,1209,149,DUSP22|PPP2R5A|PPM1F|THNSL2|DUSP4|TMEM55A|DUSP7|PPP1R15B|SDHAF2|PPP2R2A|PPAPDC1A|PTPN6|CTDP1|APEX1|RPRD1B|SYNJ2|MTMR2|TIMM50|RPAP2|LHPP|PTPN3|PTPRU|PPEF1|PPM1G|FBP1|INPP1|INPP5K|PPAP2B|UBASH3B|PTPN5|INPP5A|SHOC2|PTPN12|PPP2CA|PPP2CB|DUSP28|PPM1A|PPM1M|PTPN1|PSPH|EYA4|DUSP3|EYA1|PTPRM|DUSP10|PPP1CB
NEGATIVE REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048022,0.6654309545875811,0.964618776001639,-0.662163652404058,-0.8857965070214191,5025,1,RAPGEF2
CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:0003206,0.8560872624912029,0.991298302704726,-0.120070664457794,-0.762440896120961,2432,58,SFRP2|ZFPM2|RBPJ|FKBP1A|SLIT3
SYNAPTIC VESICLE MATURATION%GOBP%GO:0016188,0.16252469585109697,0.664421497899289,0.477069775178594,1.30062019708375,1562,8,UNC13B|UNC13A|ZDHHC15|DLG4
PROTEIN DEGLYCOSYLATION INVOLVED IN GLYCOPROTEIN CATABOLIC PROCESS%GOBP%GO:0035977,0.5108074812409,0.918404893008545,0.457237750997105,0.9689304719885521,4560,4,EDEM3|MAN1B1
NUCLEAR FRAGMENTATION INVOLVED IN APOPTOTIC NUCLEAR CHANGE%GOBP%GO:0030264,0.437177280550775,0.878651088001772,-0.7793890604322891,-1.04261250951351,3301,1,GPER1
FAD METABOLIC PROCESS%GOBP%GO:0046443,0.5008605851979351,0.9144253281295329,-0.7461954124393471,-0.9982083545275091,3782,1,FLAD1
POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903955,0.0881571959638874,0.556932119338259,-0.266074653329465,-1.3991627929483401,331,31,FBXW7|HPS4|UBL5|ATG13|VPS11|CSNK2A2|SH3GLB1|RNF31|BAP1|LEPROT|UBE2L3|UBE2D3|ARIH2
SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014834,0.209982788296041,0.7248363921442859,-0.893581826202029,-1.19537165399193,1585,1,IGF1
RESPONSE TO THYROID HORMONE%GOBP%GO:0097066,0.144011032308905,0.6340340930337739,-0.393751791149104,-1.3321212462194099,730,10,ANXA5|RDX|GAS2L1|LMO2|CTSB|CTSS|CTSL|CTSH|KLF9
INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:0036297,0.0396297854438368,0.39680101374569604,0.317836052548483,1.5202110346783102,470,49,MUS81|FANCL|FAAP20|XRCC3|FANCA|ATR|DCLRE1A|UBE2T|POLN|FANCG|SLX1B|MSH6|FANCC|RAD51|FANCM|DCLRE1C|FANCF|RAD51AP1|SLX4|FANCD2|EME1|FANCI|STRA13
FERTILIZATION%GOBP%GO:0009566,0.618561163535625,0.9532238181782521,0.197838768195263,0.8862756017104741,7144,38,CATSPERG|ROPN1B|SERPINA5|CDK1|OVGP1|PCSK4|TUBGCP3|FUT10|ZP3
REGULATION OF HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031445,0.0112495463892585,0.22992267312754103,0.9312379376895501,1.5220828265509,92,2,TPR|SIRT6
RRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071428,0.17311827956989198,0.676682497340677,-0.316863746345332,-1.2636809287078201,804,15,PA2G4|NMD3|ZNF593|NPM1|RRS1
LYSINE BIOSYNTHETIC PROCESS%GOBP%GO:0009085,0.805491714043789,0.984682960940884,0.48502894954507897,0.792766493506736,6658,2,AASS|AASDHPPT
POSITIVE REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032376,0.41605486862442004,0.8709670999109399,0.30651309047813596,1.03926697020231,4306,15,SIRT1|ABCA7|ABCB4|LDLRAP1|APOE
TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032201,0.178247174356124,0.6837991059383349,0.332186147970288,1.27219588978019,1923,22,RFC4|DNA2|POLD1|FEN1|POLD3|POLA2|PRIM2|ACD|RFC3|RFC5
INTERLEUKIN-13 BIOSYNTHETIC PROCESS%GOBP%GO:0042231,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
NOREPINEPHRINE TRANSPORT%GOBP%GO:0015874,0.46442953020134203,0.892601032770994,0.773213498014998,1.02717963661317,3459,1,SLC6A2
NEGATIVE REGULATION OF SEROTONIN SECRETION%GOBP%GO:0014063,0.0595443833464258,0.476295606439141,-0.752572996763223,-1.52732453700526,378,3,HTR1B|HRH3
RNA 3'-END PROCESSING%GOBP%GO:0031123,0.9499273755829071,1.0,0.11395188773685301,0.64640178475914,12425,111,LIN28B|INTS7|ZCCHC11|THOC3|DDX26B|U2AF1L4|ZC3H11A|THOC1|LSM11|ATP5J2-PTCD1|UPF3B|WDR33|CPSF1|SRSF1|INTS6|FIP1L1|CPSF6|PAPOLA|SRSF6|SRSF2|THOC2|INTS1|GRSF1|PABPN1|CDC73|SRSF11|INTS2|CPSF2|DDX39B|CPSF7|SUPV3L1|ZCCHC6|ZC3H3|TOE1|CSTF3|U2AF2|RPSA|HSD17B10|SRSF9|SRSF5|EXOSC2|SRSF4|CPSF3L|TUT1|CPSF4|SARNP|PCF11|SYMPK|AHCYL1|PNPT1
NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0055118,0.25655930871956,0.767319904137432,-0.577964333997546,-1.17296144377352,1632,3,KCNE3|BIN1
INSULIN PROCESSING%GOBP%GO:0030070,0.8470675575352641,0.991298302704726,-0.41725944306589496,-0.7136999303778679,5704,2,CPE|PCSK2
SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS%GOBP%GO:0016447,0.960797799174691,1.0,0.17257485976289302,0.544017630394673,9778,12,LIG4|EXO1|MSH6|PRKDC|RNF8|HSPD1|EXOSC3
PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060512,0.542687453600594,0.929698169790548,-0.545035708738884,-0.932254389552457,3654,2,CRIP1
MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0060537,0.8363106948925791,0.98866024827725,0.138736723875249,0.754012343765535,10626,88,RYR2|NEB|IGSF22|MYLK2|TBX2|BMP4|MAML1|PROX1|PKD2|TCAP|POGLUT1|SGCE|TGFB2|TAZ|NF1|NEBL|SEPN1|HEY2|CXADR|OBSL1|TNNI3|SVIL|KIAA1161|NRG1|SLC8A1|MYLK
POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033008,0.140773286467487,0.6296802030037281,-0.489493133307595,-1.34362578386901,800,6,VAMP7|SNX4|SYK|VAMP8|FGR|GAB2
POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901165,0.45484203296703296,0.88900512246363,-0.387932936245312,-0.982026468032993,2648,5,SMURF2|SYDE1|ACVR1B|C1QBP|AGO2
HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0042541,0.0446352969638321,0.41504430757275895,0.867186975988873,1.4173932892340002,368,2,INHA|INHBA
MAINTENANCE OF CENTROSOME LOCATION%GOBP%GO:0051661,0.0845559413148169,0.545178773025535,0.6644345085858879,1.4080001937847,754,4,AKAP9|GPSM2|C9orf114
"PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0000060",0.10186608122941801,0.572767517465588,-0.340674125146543,-1.39517503980246,463,16,BCL3|BCL6|NUTF2|TNF
CHEMOREPULSION OF AXON%GOBP%GO:0061643,0.9072483221476508,1.0,0.548411998235554,0.728540873262112,6758,1,SEMA3B
DNA METHYLATION INVOLVED IN EMBRYO DEVELOPMENT%GOBP%GO:0043045,0.9384299020200799,1.0,0.40799558864075,0.666857581338829,7757,2,PICK1|TET3
POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905908,0.971777354686975,1.0,0.25922046312918,0.549312923399533,8676,4,APOE|APP|PSEN1|CLU
DISSEMINATION OR TRANSMISSION OF SYMBIONT FROM HOST%GOBP%GO:0044007,0.15291936978683998,0.6488592577606589,-0.920875606528452,-1.23188337611497,1154,1,NEDD4
INOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0006021,0.22134228187919502,0.73556947110949,0.8907146007940009,1.1832746095592401,1648,1,ISYNA1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0090288,0.131070047271165,0.6149266898174119,-0.175707974006002,-1.23545487567756,304,85,SMAD2|LDLRAD4|PPM1A|PTPN1|SMAD7|NEDD4|ADAM17|UBA52|SNX6|RBPMS2|GREM1|BMPER|UBC|SNX25|SULF2|CAV1|NBL1|UBB
MUSCLE SYSTEM PROCESS%GOBP%GO:0003012,0.22693835515668698,0.7398172623753029,0.19592143400018397,1.1652083042908998,3084,146,RGS2|RYR2|KCNN2|SCN1A|NEB|EDN1|CACNA1G|IGSF22|CCDC78|GAA|PTGER3|CACNB2|FGF12|MYLK2|GAMT|KCNQ1|MYL7|OXTR|ITGA1|JSRP1|ACTN2
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061036,0.535470668485675,0.9265056012720759,0.28331661558042,0.9387159900185551,5494,14,BMP4|PKDCC|LOXL2|BMPR1B|SOX5
POSITIVE REGULATION OF LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902608,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030948,0.0638422491214369,0.494292420617166,-0.47089995222992,-1.52010724415475,326,9,EPN2|HHEX|FAM129B|DAB2IP|MMRN2|PTPN1|NEDD4
UTP BIOSYNTHETIC PROCESS%GOBP%GO:0006228,0.288456375838926,0.7980646072929201,0.8590097044552271,1.1411560692288798,2148,1,CAD
PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0071947,0.653502747252747,0.9640743070248079,-0.331968874824568,-0.840357162751212,3805,5,OTUD7B|OTUD7A|TNFAIP3
NEGATIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060633,0.899204838167768,0.998912093067348,0.30805713340318797,0.652802492831963,8028,4,HEY2|HMGB1|ZNF451|THRA
N-TERMINAL PROTEIN LIPIDATION%GOBP%GO:0006498,0.253416762720237,0.7641083395392759,-0.5121050019301819,-1.1777345219571398,1538,4,NMT2|PPM1B|NMT1|PPM1A
REGULATION OF CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:1905203,0.705864884929473,0.968941691852291,-0.47719878687620604,-0.816222967819489,4753,2,ROCK1|ROCK2
MODULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052203,0.42016904017598705,0.8727479586547751,0.546536106596064,1.03890764519874,3628,3,SUGT1|PTX3|CASP8
AXONEME ASSEMBLY%GOBP%GO:0035082,0.0511843179961884,0.443570638584446,-0.27626671932359403,-1.4776872689160703,187,33,CFAP43|TTC26|DNAAF5|SPAG16|LRGUK|RSPH9|DNAAF2|DNALI1|CFAP46|DNAI1|LRRC6|CCDC103|DYX1C1|DNAL1|IQCG|RSPH1|DNAAF1
REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060147,0.225193525686137,0.7390599693491929,-0.18388196389556602,-1.1676384899352201,639,58,HIST2H4A|EIF4G1|PPARG|POLR2A|FMR1|POLR2K|AGO2|POLR2F|STAT3|TP53|POLR2I|HIST2H4B|POLR2D|H3F3B|MAP2K1
POSITIVE REGULATION OF INTERMEDIATE FILAMENT DEPOLYMERIZATION%GOBP%GO:0030844,0.37097841917119007,0.852609194081082,-0.8125275694750771,-1.08694290344472,2801,1,NES
NORADRENERGIC NEURON DIFFERENTIATION%GOBP%GO:0003357,0.27642571739920097,0.7884684708511421,-0.39329084525611696,-1.14724684433979,1521,7,ASCL1|INSM1
AMINO ACID HOMEOSTASIS%GOBP%GO:0080144,0.6296117092052739,0.956868818587551,0.555665839536807,0.908220549689333,5204,2,PQLC2|KCTD7
MYELINATION IN PERIPHERAL NERVOUS SYSTEM%GOBP%GO:0022011,0.7104921077065921,0.9700296616429409,-0.257929723824275,-0.8017578861652571,3825,8,PARD3
SYNAPSE PRUNING%GOBP%GO:0098883,0.0227808326787117,0.31609926985007897,-0.809694496525863,-1.6432509236192399,144,3,CX3CL1|ITGAM|DKK1
DETECTION OF TEMPERATURE STIMULUS%GOBP%GO:0016048,0.684524744697565,0.966495577318169,-0.40619830153303205,-0.824367384279735,4356,3,MMP24|EPHB1|ANO1
RENAL SYSTEM PATTERN SPECIFICATION%GOBP%GO:0072048,0.6955364703036171,0.96731875442989,0.531019651819463,0.867937032935718,5749,2,BMP4
POSITIVE REGULATION OF BONE MINERALIZATION%GOBP%GO:0030501,0.49463548830811604,0.91071489001692,0.248042477551452,0.9761706225597641,5393,24,CYR61|WNT4|BMP4|ADGRV1|PKDCC
REGULATION OF LIPOPHAGY%GOBP%GO:1904502,0.0013173061090070801,0.0945022140486112,-0.862128719719724,-1.9827159503571101,7,4,ADRB2|HTT|SPTLC1
TERMINATION OF RNA POLYMERASE I TRANSCRIPTION%GOBP%GO:0006363,0.6751054852320669,0.9647315640607691,-0.16533529942885,-0.8577648319844209,2559,30,PTRF|POLR1B|TAF1B|POLR2K|POLR2F|POLR1E|CD3EAP
INTERACTION WITH HOST%GOBP%GO:0051701,0.0131524866420058,0.250097661198388,-0.22473922730018697,-1.5433125826347602,31,77,CASP8|DAG1|RRAGA|PPIA|EIF2AK4|INSR|VAMP8|TGFB1|CD4|WWP2|SERPINB9|CD81|SMAD3|GAS6|SLC25A6|KPNB1|PVRL1|EIF2AK2|SLC22A5|CCNK|ITCH|PVRL2|ZNF639|CBLL1|KPNA1|CTNNB1|GRB2|VPS4A|THOC5|RXRA|BCL2L1|ATG7|VPS4B|TNIP1|GAPDH|KPNA4|NEDD4|CAV2|RAB7A|VAPB|PARK2|THOC7|MET|CAV1
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010513,0.770170557638805,0.9792758096555699,0.49837331127653706,0.8145774861657429,6366,2,ZP3|AGAP2
COBALAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0009236,0.338938170263471,0.832687903476431,-0.8315505072783421,-1.11239046734866,2559,1,MMACHC
ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0009887,0.10020040080160302,0.570947005522165,-0.128966727846287,-1.17564620390074,49,318,NRL|ITGA6|MICAL2|SMAD2|TNNT2|EFNA1|SNAI1|PAX8|MYOM1|WNT6|WNT11|SMAD7|NPNT|FGFR1|HCCS|RYR1|BHLHE41|MSN|CCDC103|GNGT1|PDCD4|FAM101A|COL9A1|COMP|COL21A1|CTSH|STAT3|TBX20|MKKS|RBPMS2|NOS3|FGF10|SFRP2|CRIP1|PTPRM|ACVRL1|AQP5|S1PR1|SLC9A3R1|FAM20C|SCN5A|WWOX|OLFM1|TWIST1|SOX17|AQP1|ZFPM2|DNAAF1|BBS7|TUFT1|RBPJ|CAV1|FKBP1A|TLE3|STC1|SLIT3|EPHB2
POSITIVE REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905026,0.895004233700254,0.998125596923226,0.43804795714577704,0.715977352073438,7398,2,RNF207|NOS1AP
POSITIVE REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003331,0.6544419435985699,0.9640743070248079,-0.666629907366564,-0.891771152459734,4942,1,RGCC
NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045656,0.19426636022741,0.7049178772406091,0.73711712763418,1.20479769532601,1605,2,CDK6|MYC
MAINTENANCE OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035090,0.10824823252160301,0.58452352834625,-0.702470381353921,-1.4256427676461598,688,3,PDCD6IP|WDR1
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010745,0.0171578522406136,0.277422272849102,-0.506986622979608,-1.78414909136685,84,11,NFKBIA|NR1H3|PPARA|PPARG|ABCA1|NR1H2|ABCG1
ISOPRENOID METABOLIC PROCESS%GOBP%GO:0006720,0.0557068581332013,0.45915848992626795,0.294277419461544,1.4609884938573,674,57,ALDH1A2|RBP1|BCO2|RARRES2|NAPEPLD|ALDH1A1|GPC2|MVD|ALDH8A1|GPC6|SRD5A3|AKR1C1|GPC1|ALDH3A2|APOE|GGPS1|LRP8|IDI1|HMGCR|GPC3|RDH11|APOM|AGRN|CYP2E1|PDSS1|CYP2D6|SDC3|MVK
POSITIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043243,0.7708079082255308,0.979355471471634,-0.162835225232672,-0.780544461895241,3157,24,PLEK|GBA|BNIP3|RLTPR|NES|IGF1R|CFL2|WDR1|ADRB2|TNF
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032229",0.886667549318152,0.996643473105967,-0.554973533303926,-0.742405016501838,6696,1,STXBP1
POSITIVE REGULATION OF FAST-TWITCH SKELETAL MUSCLE FIBER CONTRACTION%GOBP%GO:0031448,0.21865771812080498,0.7341474817293291,0.891982796647552,1.1849593511724499,1628,1,ATP2A1
PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:0072659,0.736164736164736,0.974262605126702,-0.110760313555076,-0.8764754782704269,1143,137,GGA1|GAS6|GAK|SYS1-DBNDD2|PIP5K1A|RAB11A|TSPAN14|PACSIN1|EZR|ANKRD9|FLOT1|RAB10|S100A10|RAMP3|RAB3C|TESC|TSPAN15|RAB3D|TMEM88|RAB13|F11R|GORASP2|RAB8B|INPP5K|RILPL2|MYADM|TSPAN5|GCC2|EHD3|TSPAN33|VAMP2|RAB8A|EHD2|RAMP2|SLMAP|PVRL3|PLEKHF1|MAP7|TMED2|SLC9A3R1|KIF13A|DLG1|RILPL1|GOLGA7|TNF|RAMP1
GLYCOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0009247,0.860253629234106,0.9916689277956879,0.146250105996743,0.7098509402530071,10310,52,B3GALT2|PGAP1|B4GALNT1|B3GALT1|ST3GAL5|PIGC|PIGF|PIGQ|PIGB|B4GALT6|ST8SIA3|ST3GAL4|PIGL|LARGE|ST3GAL6|PIGK|B4GALT3|PIGH
METANEPHRIC CORTEX DEVELOPMENT%GOBP%GO:0072214,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
GLYCOGEN METABOLIC PROCESS%GOBP%GO:0005977,0.9084319884029959,1.0,-0.14153251070253697,-0.665049432410989,3759,23,PYGB|PER2|NR1D1
POSITIVE REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000667,0.8700706991358991,0.9934031064448321,-0.335502371236352,-0.680892094210957,5537,3,GATA3|PRKCZ|LGALS9
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902932,0.0744852644327816,0.5238006217712511,-0.41977854202517206,-1.47725298929561,368,11,GPER1|IL1B|PRKAA1|SNCA|ABCG1|TNF|HRH1
CELL MIGRATION INVOLVED IN CORONARY ANGIOGENESIS%GOBP%GO:0060981,0.7087250099298291,0.9695170059473192,-0.641100573445082,-0.857619784090102,5352,1,PDGFRB
DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051583,0.866815144766147,0.9929671171385601,-0.406429802486307,-0.6951764101649339,5837,2,SNCA
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0033157,0.0396196513470681,0.39680101374569604,-0.162622471373691,-1.32468164433646,49,167,TXN|INSIG1|FBXW7|OAZ2|HPS4|HAX1|IL1B|PLK3|BCAS3|PRKCD|TMEM30A|UBE2J1|ITGAM|UBL5|OS9|PARL|MYO1C|ATG13|FYN|FAM65A|BAG4|INPP5K|ICE1|TCF7L2|UHMK1|VPS11|APOD|GCC2|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|MIEF1|IGF1|MAVS|CEMIP|BAP1|LEPROT|ZPR1|PDCD10|PTPN1|BAG3|TP53|RANGAP1|UBE2L3|YWHAE|UBE2D3|SIAH3|CABP1|ARIH2|PARK2|BCAP31|PIK3R1
FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:0010994,0.131895274164334,0.616407751583866,-0.5900412075489161,-1.35697151343657,800,4,PARK2|UBE2K
REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010310,0.34515366430260097,0.8411448613059059,-0.318722938390766,-1.07828740702043,1751,10,HP|FYN|MPV17L|SNCA|RAC1
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901890,0.00047528517110266203,0.0784645998831315,-0.514789142519512,-2.3848844574162595,1,22,AGT|PPM1F|FLOT1|THY1|S100A10|VEGFA|KDR|COL16A1|ABL1|NRP1|NPHP1|MAP4K4|LIMS1|RAC1|CAV1
NITRIC OXIDE STORAGE%GOBP%GO:0035732,0.425503355704698,0.875696962448429,0.7939457432730479,1.05472149950746,3169,1,GSTP1
UBIQUINONE-6 BIOSYNTHETIC PROCESS%GOBP%GO:1901006,0.120481927710843,0.6066999390482379,-0.938575209528011,-1.2555606747038501,909,1,NDUFA9
REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010755,0.41663302381913603,0.8709670999109399,-0.29004681133295,-1.02071086580592,2063,11,ENO1|SERPINF2|CLEC3B|MFI2
INTERACTION WITH SYMBIONT%GOBP%GO:0051702,0.937301188682404,1.0,0.12915592308315801,0.6239479246591229,11196,51,SUGT1|NAPEPLD|GTF2B|YTHDC2|AZU1|CCL5|LEF1|DDB1|APOE|PSMC3|FN1|SMARCA4|SMC3|SP1|TFAP4|TARDBP|REST|PTX3|RAB9A|CCL4|HSPD1|CHD1|PPIB|SNW1|NUCKS1|VAPA|CFL1
REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000058,0.008047210300429179,0.19891022356031002,-0.204583919595777,-1.54875029887606,14,113,CCAR2|PSMD10|PARK7|RPL11|RYBP|RNF217|RAD23A|CSNK1D|MAP1A|CSNK1A1|TAF9|RNF19B|FBXW7|TRIM39|CBFA2T3|CLU|PLK3|USP5|TRIB1|PTK2B|STYX|ARIH1|PRICKLE1|CEBPA|PML|PDCL3|STUB1|RNF139|CSNK2A2|GLTSCR2|TRIB2|SUMO1|RNF144B|BAG5|RAD23B|SMAD7|COMMD1|SOCS5|ARIH2|GNA12|PARK2|HSPBP1|DDRGK1|BCAP31|CSNK2A1|HSP90AB1|BBS7|CAV1|TRIB3
MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:0044772,0.006367173682348779,0.180127205513166,0.24503495330504999,1.5428202030713,89,219,TPD52L1|AKAP9|CDK6|CCNA1|SDCCAG8|CEP63|BRSK2|CEP70|CENPJ|CCNB1|RCC1|CDC7|CDC34|CDK1|BTRC|POLE|CDKN2C|BORA|DHFR|WEE1|CDKN3|CKAP5|CEP290|CEP131|CEP152|POLE2|ORC1|CDC25C|CDC45|E2F7|CDKN2A|NEK2|CDC23|CCNE1|PKMYT1|HAUS5|CRLF3|NEK11|CDK5RAP2|FBXL15|PRKAR2B|FBXO5|RB1|POLA2|MCM6|CDC6|CDK3|PIM2|CDKN2B|CEP72|MELK|CCNB2|ORC6|PPP2R2D|HAUS8|CEP164|CEP78|DBF4|CEP192|FGFR1OP|CHEK2|NASP|CNTRL|PLK1|CUL4B|MCM10|AJUBA|MCM3|SFI1|AURKA|MCM2|CEP41|SPDYA|TAF2|CEP57|UBE2C|CCNE2|DYNC1H1|NINL|E2F1|TUBB4A|PRIM2|TYMS|GMNN|CEP135|CDK14|KDM8|RRM2|PCM1|FBXL7|RPS6KB1|FOXM1|NEDD1|PPP2R1A|SKP2|CDK2|SSNA1
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING%GOBP%GO:0009792,0.210870696706075,0.7257004702836279,0.20077726510057103,1.1802186180021101,2835,136,ALDH1A2|RIPPLY2|HOXD3|HOPX|HOXB3|CAMSAP3|HOXD4|HES1|BMP4|RARRES2|HOXC4|E2F8|FUT8|LIG4|PROX1|CELF1|PKD2|ZNF358|MTHFD1|DVL1|DEAF1|TGFB2|E2F7|ARNT2|DACT1|STIL|ZP3|LEF1|RAI2|NIPBL|VANGL2|HES6|HEY2|PLXNB2|SEMA4C|SRF|STOX2|LFNG|NASP
N-ACETYLGLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006044,0.845936464626778,0.991298302704726,0.207140098217734,0.686319515615586,8680,14,EXTL2|AMDHD2|LARGE|CHST2|MGAT3|RENBP|GNPDA1|GNPDA2|NAGK|CHST3|MGEA5|GNPNAT1|CHST1|CHST7
CONTRACTILE RING CONTRACTION%GOBP%GO:0036213,0.31709254600820896,0.818598932456131,-0.842302602558447,-1.12677387303349,2394,1,VPS4A
SELF PROTEOLYSIS%GOBP%GO:0097264,0.44846371758553105,0.885221409646481,0.439439041230289,1.01284184693254,4115,5,ADGRV1|CAPN1|LGMN|CAPN7|CAPN3
INTERLEUKIN-27-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070106,0.9980858351803349,1.0,0.137557097353629,0.40596653237572705,9906,10,JAK2|EBI3|TYK2|STAT1
COFACTOR METABOLIC PROCESS%GOBP%GO:0051186,0.7579971230906228,0.977664504547119,0.131558807758662,0.870401646838122,11065,355,ACSM3|FDXR|RGN|DPEP1|HACD1|CROT|HPX|GPHN|MGST1|ALAS1|GSTA4|ACSF2|D2HGDH|OXSM|GSTO2|GAMT|HSD17B4|AKR1B1|MRPS36|MAT2A|MCCC2|GGH|CBR4|NUDT17|PARP16|GLRX2|CD38|COQ3|MMS19|BDH2|SCD5|ELOVL6|GGT1|CD320|FTCD|RBKS|DGAT1|HBB|NAPRT|DHFR|FAR2|ABCD4|ACBD6|HBA2|MVD|NNT|MTHFD1|ABCB6|COQ2|ME1|ACOT1|PRDX4|PGLS|IDH1|PDHX|CPOX|FAR1|COQ6|DUOX1|AKR1C1|MTR|BST1|RFK|PRDX3|HBA1|SLC46A1|GCK|PCCB|RNLS|PDHA1|ACOT2|SLC25A1|ACACA|PTGS2|GSTP1|MGST2|SUCLG1|DLD|ACSS1|MCEE|NADK|OPLAH|GGT5|ATPIF1|PSAT1|GSTZ1|PANK3
UREA TRANSPORT%GOBP%GO:0015840,0.8183503243744209,0.987153241368501,-0.5882223202470229,-0.786882932542634,6180,1,AQP11
"GERMLINE CELL CYCLE SWITCHING, MITOTIC TO MEIOTIC CELL CYCLE%GOBP%GO:0051729",0.5906616668682719,0.945418171231938,0.5708298869589189,0.9330057686200229,4882,2,YTHDC2|C17orf104
"REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902956",0.7222309505106049,0.971401508276304,-0.391444619913617,-0.794425225784265,4596,3,PARK7|SNCA
PIGMENT METABOLIC PROCESS%GOBP%GO:0042440,0.790463692038495,0.9819233677232551,0.17167574049974402,0.757782968641226,9034,36,CITED1|HPX|ALAS1|BDH2|MTHFD1|CPOX|AP3D1|ATPIF1|TRPC1|UROD|PAICS|PRTFDC1|IREB2|UROS|ALAD|HMBS
FEMALE GENITALIA DEVELOPMENT%GOBP%GO:0030540,0.282327325511068,0.7907361470977171,0.694213542823799,1.13467296458386,2333,2,TBX3
ARACHIDONIC ACID METABOLIC PROCESS%GOBP%GO:0019369,0.561441835062807,0.9365627440210609,0.23076454652809303,0.927784011822771,6167,26,FAAH2|CYP2D7|CYP2C8|PLA2G4A|PTGS2|FAAH|PLA2G4B|CYP2E1|DAGLA|CYP2D6|PLA2G4C|PNPLA8|DAGLB|PTGIS|EPHX2|AKR1C3
CELLULAR RESPONSE TO CAMPTOTHECIN%GOBP%GO:0072757,0.163366909806646,0.665440683774265,0.6662071247380611,1.2663896617681,1410,3,BLM|RAD51|SPIDR
CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS%GOBP%GO:0060029,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN ORBITOFRONTAL CORTEX DEVELOPMENT%GOBP%GO:0035607,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
CELLULAR HEAT ACCLIMATION%GOBP%GO:0070370,0.419083883973569,0.87173622607586,0.490325770698253,1.03904714646761,3741,4,RBBP7|HSBP1L1
UMBILICAL CORD MORPHOGENESIS%GOBP%GO:0036304,0.6782387806943271,0.9647315640607691,0.537358698649021,0.8782980308348269,5606,2,HEY2|HEY1
IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002381,0.880804311774461,0.9956508825790341,-0.184668269502573,-0.672765029860052,4248,12,BATF|EXOSC6|HLA-DQB1|RNF168
TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032640,0.458130400628437,0.890371861972445,-0.48433881107312204,-0.982951226734851,2915,3,HMGB1|TLR2|APP
COMPLEMENT-MEDIATED SYNAPSE PRUNING%GOBP%GO:0150062,0.35125115848007393,0.842847021021096,-0.8239413321570359,-1.10221144178708,2652,1,ITGAM
PYRIMIDINE RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046132,0.09743532310449099,0.570215774831708,0.653173771576683,1.3841376163805499,869,4,CAD|CTPS2|UMPS|CTPS1
URETERIC BUD FORMATION%GOBP%GO:0060676,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904019,0.156908171861837,0.6578589353509621,0.506920810749241,1.31940836625875,1489,7,RYR2|SIX3|CAPN10
SEQUESTERING OF NEUROTRANSMITTER%GOBP%GO:0042137,0.749261744966443,0.9749763305090959,0.628473753859726,0.8348993438006791,5581,1,SLC18A2
REGULATION OF AMPA RECEPTOR ACTIVITY%GOBP%GO:2000311,0.23261497445012197,0.746122594132505,-0.275799202652655,-1.18642689314872,1046,18,ARC|ADRB2|RELN|CACNG3|CACNG7
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060644,0.576801405975395,0.942692029750853,-0.325072881981392,-0.8923032339911041,3281,6,ID2|IRF6|ZNF703
POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION%GOBP%GO:0051561,0.553395029635021,0.932706603479095,0.34136028886289194,0.9306397287717758,5321,8,ATP2A1|MICU1|MCUR1|TGM2|MCU|RAP1GDS1
REGULATION OF ANION TRANSPORT%GOBP%GO:0044070,0.8191828455520141,0.987153241368501,-0.136233617432752,-0.7625972986871942,2826,38,TNFRSF11A|HRH3|PER2|STC1|TRH
ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:0071786,0.784203980099503,0.981487311948134,-0.206381410560189,-0.751868180776724,3782,12,RAB10|RTN4|RAB18|ATL2|TMEM170A
SEPTUM DIGESTION AFTER CYTOKINESIS%GOBP%GO:0000920,0.585764499121265,0.944121252549613,-0.322967199900479,-0.88652327806521,3332,6,CHMP1B
REGULATION OF ISOMERASE ACTIVITY%GOBP%GO:0010911,0.7206192080876159,0.9713637233549571,0.30359433133684305,0.790192259265341,6842,7,DHX9|UHRF1
POSITIVE REGULATION OF RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000202,0.768590604026846,0.9792236089291529,0.617887075430084,0.8208354138121079,5725,1,RIOK2
NEURON RECOGNITION%GOBP%GO:0008038,0.324085637823372,0.8248320651594999,0.266173796675527,1.1160484277693998,3632,30,NEXN|IGSF9|DSCAM|CDK5R1|ROBO2|SEMA5A|BSG|PALLD|GAP43
POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030836,0.657666733830345,0.9643779777660141,0.286096440198659,0.844344508476393,6527,10,ACTN2|SEMA5A|F2RL1|PDXP|FAM21C
PROTEIN LOCALIZATION TO NUCLEAR INNER MEMBRANE%GOBP%GO:0036228,0.770775371960808,0.979355471471634,0.49826200395044,0.8143955573990279,6371,2,NUP54|NUP155
RIBONUCLEOPROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0032988,0.41325347758887204,0.8683189983530021,0.307264351066669,1.04181420338722,4277,15,KLC1|DENR|GFM2|MRRF|MCTS1|MTIF3|EIF2D|VCP|PELO|ZFAND1|TFIP11|MTIF2
TRNA WOBBLE CYTOSINE MODIFICATION%GOBP%GO:0002101,0.969561989606533,1.0,-0.33062711711981607,-0.565519976577698,6529,2,NSUN3
REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902803,0.46443711728685794,0.892601032770994,-0.216735079006588,-0.9843665123725881,1971,21,NAPB|SYN1|VPS18|NAPA|FMR1|PARK2|RAB5A
CHROMATIN-MEDIATED MAINTENANCE OF TRANSCRIPTION%GOBP%GO:0048096,0.344501718213058,0.840249330681364,0.449918603336884,1.10650928057509,3207,6,KMT2B|CHEK1|ARID1A|SMARCD1|ARID1B
SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT%GOBP%GO:0099514,0.535698924731183,0.9265056012720759,-0.233652378967996,-0.931826561588652,2490,15,BLOC1S1|BLOC1S5|BLOC1S4|AP3S2|BLOC1S6|BLOC1S3
INDOLALKYLAMINE METABOLIC PROCESS%GOBP%GO:0006586,0.6813419302841021,0.965271928233355,0.27955695469490194,0.825044797268787,6762,10,IDO1|DDC|CCBL1|AFMID|AADAT|ATP7A
MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:0002009,0.0373191165270373,0.38702164012069,-0.16496040706235002,-1.32021328147032,48,154,RAB10|HAND1|MTSS1|NRARP|FUZ|NOTCH1|OPHN1|LRP5|VEGFA|IFT122|CTNNB1|SKI|KRT17|ACVR1|PDPN|DLC1|CELSR1|PRKD2|PRICKLE1|RHOA|NRP1|ITGA5|BCL10|FGF2|PTK7|PODXL|MICAL2|PAX8|RHOC|PDCD10|WNT11|CDC42|NPNT|TRAF3IP1|MSN|CCDC103|ADAM17|CTSH|MMP12|TBX20|MKKS|COBL|FGF10|SFRP2|ACVRL1|SLC9A3R1|TMEFF2|MET|SH3BP1|SOX17|DNAAF1|BBS7|RBPJ
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0016480,0.624823252160251,0.954056599578271,-0.42735734461024605,-0.8673090335421629,3976,3,MAF1
CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0061323,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
VERY LONG-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0036111,0.338575057457361,0.8326275783736579,0.6699008820241321,1.0949345884146702,2798,2,HSD17B4|ABCD1
POSITIVE REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904716,0.37720111214087104,0.85375124052253,-0.8087781208645791,-1.08192715171872,2848,1,PLK3
NEGATIVE REGULATION OF HORMONE SECRETION%GOBP%GO:0046888,0.324408630101378,0.8255272469435949,-0.212153819401476,-1.08575044403422,1247,29,IL1B|IL11|ADRA2C|PFKL|LIF|RAB11FIP1|CRH|PARK2|ADRA2A|RAB11FIP5|INHBB
PEPTIDYL-ASPARTIC ACID AUTOPHOSPHORYLATION%GOBP%GO:1990938,0.7891275167785241,0.9819233677232551,0.6070247022496689,0.8064052356467521,5878,1,ATP13A2
CARGO LOADING INTO VESICLE%GOBP%GO:0035459,0.29326816263052696,0.8004058897916541,-0.260178611880257,-1.1192305822058402,1319,18,TMED10|SEC13|PICALM|TBC1D20|RAB1A|TMED2|SEC23A|KIF13A
L-ALANINE TRANSPORT%GOBP%GO:0015808,0.491026976959592,0.9092105079917561,0.5202133681187889,0.9888708884015891,4240,3,SLC36A1|SLC36A4|SLC1A4
RIBOFLAVIN TRANSPORT%GOBP%GO:0032218,0.92837283198729,1.0,-0.534020732245258,-0.71437581568011,7011,1,SLC52A2
NEPHRIC DUCT FORMATION%GOBP%GO:0072179,0.35030845530422194,0.842847021021096,0.664571271022884,1.08622348564611,2895,2,BMP4|GATA3
COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006613,0.36247637051039705,0.8493168041910981,-0.145418262074386,-1.0547821345872501,766,96,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL37|RPL27A|SEC61A1|RPL7A|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|TRAM1|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|SSR2|SRP68|RPL13A|ARL6IP1|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|SRPR|RPS14|RPS17|RPL32|RPL18A|RPL11|SRP14|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|SRP72|RPS9|RPS3|RPL14|SEC63|SEC62|RPL15|RPL8|RPL35A|UBA52|SSR1|SRP54
BOX H/ACA SNORNA METABOLIC PROCESS%GOBP%GO:0033979,0.47260579064588004,0.898911737554429,-0.5766749379652609,-0.986371596655444,3182,2,DKC1|PARN
METANEPHRIC NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0072282,0.420935412026726,0.8727872721376851,-0.602768145766519,-1.03100263113668,2834,2,PAX8
SUCCINYL-COA METABOLIC PROCESS%GOBP%GO:0006104,0.9690934065934069,1.0,-0.220842533691965,-0.5590482093426489,5643,5,OGDH
PYRIMIDINE DIMER REPAIR BY NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0000720,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:1900274,0.10124968120377499,0.571655361840848,-0.27341580915534996,-1.3624848539751797,396,27,LPAR1|C5AR1|ABL1|GNAQ|FGF2|GNA15|FGFR1|EDNRA|FLT1|BICD1
ACID SECRETION%GOBP%GO:0046717,0.481522237505731,0.904752640722988,0.250318621761436,0.985128383070906,5250,24,ABCC3|SLC1A2|GHRL|ABCB4|GLS|GLS2|SLC6A9|DRD4|SLC1A3|SYT1|RAB3A|SLC1A1
CELLULAR RESPONSE TO FOLLICLE-STIMULATING HORMONE STIMULUS%GOBP%GO:0071372,0.43148417847213,0.8785877309899279,-0.7824217026907809,-1.04666936752718,3258,1,NOTCH1
RESPONSE TO SODIUM DODECYL SULFATE%GOBP%GO:0072706,0.374685555408447,0.852609194081082,-0.810542567269519,-1.08428750547213,2829,1,ZNF16
NEGATIVE REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000616,0.8502581755593801,0.991298302704726,-0.573389942655492,-0.767041208803042,6421,1,ZNF451
VACUOLAR ACIDIFICATION%GOBP%GO:0007035,0.9083947544749691,1.0,0.178615436438065,0.61921127942875,9489,16,DMXL2|CLN6|TCIRG1|ATP6V0E2|ATP6V0A2|DMXL1|TMEM199
TETRAHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0046653,0.9859500884260171,1.0,0.15383286205725,0.484936155869965,10034,12,DHFR|MTHFD1|TYMS|MTHFD2L
PLASMA MEMBRANE TO ENDOSOME TRANSPORT%GOBP%GO:0048227,0.873973172507019,0.9934031064448321,0.242895449461578,0.662198160072491,8404,8,SGSM3|USP6NL
ENDOCRINE HORMONE SECRETION%GOBP%GO:0060986,0.0411854434517324,0.402256981537283,0.6671931236981329,1.5377812444137702,377,5,TBX3|GHRL
REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0032306,0.36040848389630803,0.848418604328854,-0.52405597495123,-1.06355603077671,2293,3,IL1B|TNFRSF11A
POSITIVE REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032743,0.24390779363336998,0.7571583779245891,-0.28620795988128,-1.17211778748204,1110,16,TRAF6|CD86|IL1B|PRKD2|RPS3|RUNX1|PDE4B|PDE4D
STRESS RESPONSE TO COPPER ION%GOBP%GO:1990169,0.583861911198919,0.9439064862850342,0.33260225378472197,0.9067629755124201,5614,8,MT1F|MT1E|MT2A|ATP7A|MT1X|MT1G
ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009240,0.8729980960913879,0.9934031064448321,0.320607530171789,0.6793979824609939,7794,4,MVD|IDI1|MVK
REPRODUCTIVE BEHAVIOR%GOBP%GO:0019098,0.0481432200314503,0.43167291117533796,0.8616258120782241,1.4083037195961499,397,2,OXTR|APP
REGULATION OF CHOLESTEROL ESTERIFICATION%GOBP%GO:0010872,0.815290648694187,0.986631695793843,0.27348718987578,0.7118296955561321,7741,7,AGTR1|APOE|APOC1
CELLULAR RESPONSE TO JASMONIC ACID STIMULUS%GOBP%GO:0071395,0.859905059627185,0.9916689277956879,0.374680811343878,0.7122288074228109,7426,3,AKR1C1|AKR1C3|AKR1C2
ADHESION OF SYMBIONT TO HOST CELL%GOBP%GO:0044650,0.33962949509625895,0.8330383695817521,-0.36807294545081803,-1.07368511179128,1869,7,CD81|GAS6|PVRL2|ICAM1|HSP90AB1
MITOTIC METAPHASE PLATE CONGRESSION%GOBP%GO:0007080,0.133560187154402,0.6194479383419461,0.280286869976993,1.31381360335751,1569,45,CCNB1|PSRC1|KIF14|KIF2C|KIF18A|NUF2|CDC23|NDC80|CENPE|CEP55|BOD1|KIFC1|CDCA8|SPDL1|KIF22|CDCA5
RIBONUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0033875,0.15564140976109803,0.656198355453056,0.23243063735634398,1.2580508623781799,1973,86,ACSM3|HACD1|CROT|ACSF2|OXSM|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|ACBD6|MVD|SLC35B3|ACOT1|SLC26A2|SULT1A3|PDHX|FAR1|PDHA1|ACOT2|SLC25A1|ACACA|SUCLG1|DLD|ACSS1|MCEE
PURINE RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046128,0.0846719303022053,0.5451990037849229,-0.26016848858964203,-1.39158152781965,310,33,MOCS3|GMPS|GTPBP1|PNP|MTRR|HPRT1|EFTUD1|NUDT18|RHOQ|ENPP4|AK4
REGULATION OF POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:1901873,0.6583304388097719,0.9643779777660141,0.461098753000317,0.8765002236854671,5685,3,P3H1|PPIB|CRTAP
O-GLYCAN PROCESSING%GOBP%GO:0016266,0.0591133004926108,0.475550457504474,-0.25612389550557996,-1.43370920131524,203,38,MUC4|GALNT2|GALNT9|MUC3A|GALNT12|B3GNT5|B3GNT7|B3GNT8|B3GNT2|MUC12|GALNT6
POSITIVE REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903902,0.0349740932642487,0.381265913354899,-0.247666818632618,-1.50023202936642,107,50,VPS4A|DDX3X|TBC1D20|P4HB|VPS4B|PPIH|CNOT7|FMR1|PDE12|CAV2|VAPB|CHMP4B|STAU1|PABPC1|PC
REGULATION OF INTRALUMENAL VESICLE FORMATION%GOBP%GO:1905365,0.00400890868596882,0.148195394527521,-0.956217259443066,-1.63555841055671,26,2,RAB7A|PARK2
POSITIVE REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002827,0.854609929078014,0.991298302704726,-0.20538423346389398,-0.6948456037172299,4337,10,CCL19|IL12RB1|IL1R1|XCL1|ANXA1|IL18|IL6R|IL1B|SLC11A1|SOCS5
NEGATIVE REGULATION OF ANION TRANSPORT%GOBP%GO:1903792,0.9196063145585659,1.0,0.18227313149284802,0.603927527273894,9436,14,STK39|ANO9|GOPC|AKT2|THBS1|AKT1|ARL6IP5
REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1902513,0.231971153846154,0.745232643811087,-0.47389191164213396,-1.19962590628047,1350,5,LAMP1|HAP1|NEFH
PLASMINOGEN ACTIVATION%GOBP%GO:0031639,0.8461193862694592,0.991298302704726,0.33352674565605106,0.7067750341799078,7554,4,PLAT|KLKB1
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1902742,0.44109311740890705,0.880402968441571,0.35641482035227096,1.01708611861701,4357,9,SIX3|BMP4|ROBO2|LEF1
NEGATIVE REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045071,0.12113095238095199,0.607551029913022,-0.22732475829307,-1.3027522045229298,406,41,PLSCR1|MX1|EIF2AK2|CCNK|RNASEL|APOBEC3F|BANF1|INPP5K|IFITM2|IFITM3|OASL|MAVS|TNIP1|OAS3|ZC3HAV1|PARK2|IFITM1|TNF
REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046324,0.349601593625498,0.842847021021096,-0.217911578564269,-1.0700097611572,1403,26,PEA15|RHOQ|PIK3R1|APPL1
POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903598,0.184409799554566,0.6906809521658801,-0.746512269092914,-1.27686925564366,1241,2,AGT|CAV1
SUCROSE BIOSYNTHETIC PROCESS%GOBP%GO:0005986,0.301999205613663,0.8050049522572289,-0.8498566387295992,-1.13687913754027,2280,1,FBP1
CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0035766,0.0355704697986577,0.3821688062173221,0.981859285399206,1.30435625680459,264,1,CXCL13
RIBOSOME ASSEMBLY%GOBP%GO:0042255,0.23769386378961604,0.7507739897770379,-0.1854870769528,-1.1505382687134198,704,54,RPS28|MRPS2|RPF2|RSL24D1|MRPL22|DDX3X|C1QBP|SBDS|GLTSCR2|EFTUD1|PPAN|NPM1|DDX28|RRP7A|RRS1|MRTO4|RPF1
REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032872,0.286044718581342,0.7952357288717371,-0.135501767212832,-1.08849246962018,370,157,RASSF2|FCGR2B|CYLD|ULK4|SERPINF2|MAP4K4|RIPK2|PDCD10|KARS|GADD45A|DBNL|MLKL|TNFRSF11A|PDCD4|MECOM|DUSP3|DKK1|ZNF622|MAPK3|PARK2|GREM1|RELL2|DUSP10|EDA2R|SEMA3A|MAP3K11|PLCB1|RELL1|MAP2K1|DLG1|TNF
DNA REPAIR%GOBP%GO:0006281,0.0113512035010941,0.23009459140957103,0.21136241641509398,1.40266505091207,165,370,GTF2H2|XRCC6BP1|POLG|BTG2|SIRT1|MUS81|FANCL|FBXO18|FAAP20|EME2|MLH3|C9orf142|TDG|PARP2|CDC7|MMS19|NEIL3|CDK1|POLE|MUTYH|REV1|XRCC3|LIG4|FANCA|ATR|RAD54B|BLM|SPRTN|RAD54L|MTA1|EXO1|BRIP1|POLE2|RFC4|USP47|GTF2H1|DDB2|MBD4|DNA2|DCLRE1A|ASF1A|REV3L|WDR33|CDC45|ATXN3|PNKP|DTL|POLR2B|POLD1|MEN1|PARP1|TONSL|MGME1|FEN1|RNASEH2A|RNF111|GEN1|ZNF830|POLQ|UBE2T|POLD3|MUM1|NABP1|POLN|FANCG|SLX1B|HIST1H4I|INO80|HUWE1|MSH6|MMS22L|DDB1|FANCC|RAD51C|RAD51|WDHD1|ZBTB1|CHD1L|NIPBL|PPIE|INTS3|PIAS4|NSMCE4A|H2AFX|FANCM|SMARCAD1|REC8|CDCA5|DCLRE1C|RMI2|GTF2H2C|XRCC4|PRIMPOL|TIMELESS|LIG1|CDK7|FANCF|NEIL1|ALKBH3|PMS1|BRCC3|RAD51AP1|MC1R|POLR2L|CHEK2|ALKBH1|SLX4|TOPBP1|FANCD2|POLG2|ZRANB3|CUL4B|SFPQ|EXD2|EME1|HERC2|RMI1|FANCI|PALB2|STRA13|PAXIP1|BRCA2|POLR2J|ERCC5|TNKS1BP1|XAB2|XRCC2|IGHMBP2|RIF1|PRKDC|ENDOV|UBE2B|COPS7B|GINS2|MPG|CHEK1|NPLOC4|XPA|RBX1|RECQL5|XRCC1|ZFYVE26|RFC3|AQR|FAAP100|HIST3H2A|POLR2G|RFC5|POLR2H|PDS5B|EXO5|SPIDR
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:0060561,0.6664800089595699,0.964618776001639,0.404898283758829,0.8580181411842359,5950,4,BMP4|LEF1|SCRIB
4-HYDROXYPROLINE CATABOLIC PROCESS%GOBP%GO:0019470,0.35139140457763895,0.842847021021096,-0.465118844096399,-1.06967617469164,2133,4,PRODH|HOGA1|GOT2|ALDH4A1
"PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:0070198",0.7158448645488209,0.971081608033886,0.24034724588719,0.7963451151956341,7345,14,ATR|TERT|TNKS2|BRCA2|ACD|POT1|ATRX|TNKS
SPLEEN DEVELOPMENT%GOBP%GO:0048536,0.6559065934065931,0.9640743070248079,-0.330851533200971,-0.8375286866263759,3819,5,RIPK3|FADD|PCID2|CITED2|ADAM17
VIRAL LATENCY%GOBP%GO:0019042,0.953423566878981,1.0,0.182334767736952,0.556261579925412,9579,11,LIG4|XRCC4|PSIP1|NUCKS1|IRF7|PPIA|XRCC5|HCFC1|HMGA1|XRCC6|BANF1
REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0019216,0.702668627862996,0.968941691852291,0.13864958010414,0.889790213546447,10031,257,FGFR4|NSMAF|SIRT4|SLC45A3|SIRT1|WASH1|STAR|TM7SF2|FGF19|ALAS1|NR4A3|WNT4|CEACAM1|PRKAA2|ACADVL|PDE3B|NFYB|RARRES2|INS|NPAS2|ELOVL6|CLCN2|GPAM|GNB3|PROX1|SMARCD3|ABCB4|PIK3R3|SERPINA3|AGTR1|SCARB1|TIAM2|MVD|ACADM|ME1|RORA|IDH1|PDK4|CCL21|ZFP69|RB1|ZP3|FADS1|LDLRAP1|PNPLA2|MED1|PTCHD2|KIT|APOE|MTMR4|AMBRA1|ACACA|PTGS2|HDAC3|CCL19|LPGAT1|SREBF2|GGPS1|ORMDL1|GSTZ1|FHL2|SMPD3|ADIPOR2|APOC1|IDI1|CARM1|LDLR|HMGCR|PRKAB2|IRS1|AKT2|METTL20|ARV1|CNEP1R1|HSD17B13
PROSTAGLANDIN METABOLIC PROCESS%GOBP%GO:0006693,0.8372243839169909,0.9889652677625541,0.18481208128190302,0.70778740060404,9036,22,EDN1|MGST1
COLLAGEN-ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038063,0.23621704074961897,0.7504297739985492,0.525761420615555,1.21180213485645,2167,5,DDR2|DDR1|COL4A2|COL1A1
"COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001867",0.524914089347079,0.9262380308863678,0.38518731292123204,0.947312099002029,4887,6,COLEC11|COL20A1|FCN3|MASP2|FCN1
MEMBRANE DEPOLARIZATION DURING BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0086048,0.43189316575019604,0.8785877309899279,-0.49383828267253294,-1.00223012210416,2748,3,SCN5A
ESTABLISHMENT OF SYNAPTIC VESICLE LOCALIZATION%GOBP%GO:0097480,0.524608093328473,0.925993329275615,-0.147528323106108,-0.961156749954745,1438,64,VAMP2|STX11|AP3S2|BLOC1S6|OTOF|SNPH|SYT2|BLOC1S3|TMEM230|SYT9|SNAP25|CPLX1
PEPTIDYL-TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:1990264,0.00219952867242734,0.11826751410412101,-0.908790118010367,-1.84436254316183,13,3,PTPN1|DUSP3|DUSP10
REGULATION OF BLOOD COAGULATION%GOBP%GO:0030193,0.15494750238625501,0.65461367015785,-0.206301876280652,-1.24016696086525,486,48,FCER1G|PRKCD|USF1|PDPN|PLAU|LYN|SERPINF2|PLAUR|THBD|PROC|PRKCA|CD9|NOS3|ANO6|CAV1|ENPP4
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002891,0.394895206474372,0.8638039247684692,-0.273670271463253,-1.0306370112955,1902,13,PAXIP1|RIF1|FAM35A|XCL1|TP53BP1|CLCF1|HLA-E|TGFB1|MAD2L2|TNFSF13|PVRL2|C20orf196|TFRC
POSITIVE REGULATION OF WNT SIGNALING PATHWAY BY BMP SIGNALING PATHWAY%GOBP%GO:0060804,0.793856745663975,0.9819233677232551,-0.5999117776797529,-0.802520276158967,5995,1,BMP2
NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048642,0.212580273341018,0.7279184739702909,-0.533888490597254,-1.22783199516122,1290,4,USP19|EPHB1|TGFB1|AKIRIN1
TUBE CLOSURE%GOBP%GO:0060606,0.7912730544309491,0.9819233677232551,0.183688607671823,0.753238706984895,8794,28,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C|DVL3|DVL2|LRP6|SCRIB|MTHFR
POSITIVE REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070668,0.24414140076790697,0.7571583779245891,-0.8775363917071021,-1.1739071870468702,1843,1,LYN
REGULATION OF RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:1902145,0.5474645836091621,0.9305779599215391,-0.720390383767093,-0.9636881808839058,4134,1,TIGAR
NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1903573,0.29006085192697806,0.7994171690402192,-0.20028953070331199,-1.1211642026981201,1000,38,DERL2|WFS1|OPA1|ERLEC1|PARK7|TMBIM6|PPP1R15B|NCK2|DNAJC3|CREB3|CLU|UBE2J1|HSPA5|OS9|MAGEA3|BCL2L1|PTPN1|PARK2|BFAR
GPI ANCHOR BIOSYNTHETIC PROCESS%GOBP%GO:0006506,0.9454592230511959,1.0,-0.125145054067963,-0.63276415535821,3674,28,PIGA|DPM1|PIGG|PIGZ|PIGY|DPM2|MPPE1|PIGT
FAS SIGNALING PATHWAY%GOBP%GO:0036337,0.40389261744966404,0.865585453523601,0.8049735333039258,1.0693714265788798,3008,1,FAS
MEIOTIC CHROMOSOME CONDENSATION%GOBP%GO:0010032,0.22426768553895998,0.737948964873976,0.633842831363075,1.2048685446581202,1936,3,NCAPD3|NCAPH2|NCAPD2
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:0000288",0.819333333333333,0.987153241368501,-0.127431350723527,-0.785983149944904,2457,53,ZCCHC6|CNOT1|RC3H1|SAMD4B|CNOT2|EXOSC2|EDC4|CNOT8|PATL2|PAN2|CNOT6|SKIV2L|DCPS|EXOSC3|NT5C3B|CNOT4|LSM1|LSM2|PAN3|PATL1|LSM6|EDC3|RQCD1|CNOT11|LSM5|DCP1B|EXOSC7|EXOSC1|DIS3|EXOSC8|PARN|CNOT6L|LSM3|CNOT10|DCP1A|DCP2|HBS1L|SAMD4A|EXOSC6|EXOSC4|CNOT7|EXOSC9|PDE12|POLR2D|EXOSC5|DDX6
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031953,0.274791136941518,0.7884684708511421,-0.393932517364233,-1.14911863034757,1512,7,ENG|IMPACT|CHP1|CAV1
OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007008,0.0123626373626374,0.241435893116318,-0.725954114273108,-1.8377046344495702,71,5,HSP90AA1|HSPA4|TOMM22|SAMM50|TOMM20
MITOCHONDRION ORGANIZATION%GOBP%GO:0007005,0.0182291666666667,0.284804933176101,-0.140079496433047,-1.29178543656731,6,367,RB1CC1|CTSK|TOMM20|BBC3|MTFP1|NDUFB10|ATG13|MAP1LC3B2|ATG9B|CHCHD6|MPV17L|TIMM10B|AIP|C19orf52|YME1L1|MAP1LC3A|TIMM23|ATG3|MX2|EIF4G1|MFN2|MT-ND6|FAM73A|YWHAH|SLC25A4|CHCHD3|SSBP1|BCL2L1|MT-ND5|PLD6|CAMK2A|MIEF1|ATG7|HAP1|ATP5I|BOK|BECN1|SOD2|UQCC2|BID|ACAA2|YWHAQ|YWHAB|PMPCA|DNLZ|FXN|NDUFB9|PPARGC1A|HK2|SMIM20|TIMM22|SLC25A33|BCL2|NDUFA9|NDUFS1|TP53|YWHAZ|NDUFV3|NDUFAF5|YWHAE|NOS3|SLC35F6|TRAK1|GABARAPL1|NDUFS5|GABARAP|CAV2|PARK2|BNIP3L|BMF|TIMM23B|FBXO7|WIPI2|MAP1LC3B|LETM1|BIK|NDUFS6|COX7A2L|BCL2L11|GABARAPL2|PMAIP1|TFDP2|SPATA18
NEGATIVE REGULATION OF BONE TRABECULA FORMATION%GOBP%GO:1900155,0.0693764067258043,0.5054741186916171,-0.964214821349801,-1.28985956518307,523,1,GREM1
PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009153,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
VITAMIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0035461,0.372257460746595,0.852609194081082,0.39508052736771204,1.07709551118928,3579,8,SCARB1|SLC46A1|SLC5A6|SLC19A2|SLC19A1|SLC23A2
CELLULAR RESPONSE TO ETHER%GOBP%GO:0071362,0.803193419620177,0.984522820758988,0.48574579542321505,0.793938158401641,6639,2,LARP1|ZC3H12A
ENDODERMAL CELL FATE COMMITMENT%GOBP%GO:0001711,0.629525483304042,0.956868818587551,-0.310525265818139,-0.852371004423965,3581,6,SOX17
POSITIVE REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010763,0.728092783505155,0.972554563883587,0.32130838005856,0.7902111666966021,6779,6,DDR2|THBS1|ARHGEF7|DMTN|TGFB1|PRKCE
NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045617,0.468187919463087,0.89575556079346,0.771118217909131,1.0243961504696,3487,1,SRSF6
ACTIVATION OF MAPKKK ACTIVITY%GOBP%GO:0000185,0.4905557573556121,0.908938677284213,-0.328926481696552,-0.9594931402494671,2700,7,DAB2IP|GADD45A|TNF
POSITIVE REGULATION OF UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050677,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
SUBSTRATE-INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION%GOBP%GO:0021826,0.196485061511424,0.7100128962886071,-0.45487072671987494,-1.24858960251031,1117,6,DRD2|SLIT3
REGULATION OF FEVER GENERATION%GOBP%GO:0031620,0.613324175824176,0.9508825506493929,-0.343365215095028,-0.8692062413899609,3571,5,TNFRSF11A|TNF
NEGATIVE REGULATION OF DNA REPAIR%GOBP%GO:0045738,0.534702365479595,0.9265056012720759,-0.184056533445214,-0.9419555277360709,2056,29,RNF169|RPS3|C20orf196|TRIP12|C7orf49|CXorf57|HSF1|KLHL15|TWIST1
REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008277,0.0294368600682594,0.35249735328304,-0.203778732809142,-1.4242728994230403,68,83,RAMP3|FRMPD1|GPER1|PDCL|PLCE1|GNG4|NECAB2|TULP3|ARRB2|RGS5|RGS4|PPEF1|MGLL|DGKQ|PDE6B|ARRB1|APLNR|ATP2B4|YWHAB|SNCA|CXCL8|ADRB2|PRKCA|RGS12|ADCYAP1|GUCA1A|DRD2|CAV2|MET|PLCB1|ADM|BICD1
REGULATION OF TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION%GOBP%GO:0032909,0.437392611683849,0.878651088001772,0.414989198768872,1.02060549701776,4072,6,CDH3|TGFB2|GATA6
CLOACAL SEPTATION%GOBP%GO:0060197,0.17926651661591395,0.68489956912038,-0.907973092192325,-1.2146232892931699,1353,1,WNT11
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:1905668,0.5339629495096261,0.9265056012720759,-0.31621621621621604,-0.92241673194014,2939,7,SORL1|MGAT3|RDX|ROCK2|DTX3L|EZR|MSN
CELLULAR AMIDE CATABOLIC PROCESS%GOBP%GO:0043605,0.0296644295302013,0.353942807960853,0.985277900308778,1.30889773419673,220,1,DPEP1
REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045088,0.0827586206896552,0.5420718842622351,-0.138099475310013,-1.2150709961951,59,257,PLSCR1|RELA|RNF135|PRKACA|TRAF6|OTULIN|MAPKAPK3|MFHAS1|CTSS|RPS6KA3|SCARA3|UBE2N|CYBA|TLR1|CREBBP|FLOT1|MUL1|PYCARD|RIOK3|PJA2|SOCS3|POLR3C|XRCC6|ITCH|HEXIM1|NOD1|RNASEL|PVRL2|PTPN6|IRAK1|SIN3A|POLR3D|FCER1G|PIK3C3|PRKCD|DAB2IP|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|ARRB2|CD300LF|NR1H3|IFNAR2|IRAK4|LAMP1|FGR|ULBP3|TRAF3|S100A8|FYN|C1QBP|BCL10|UBE2V1|RELB|PPARG|LYN|FCGR2B|CYLD|TANK|GLTSCR2|SUMO1|CDC37|MAVS|CNPY3|TNIP1|GPATCH3|RIPK2|MUC4|CNOT7|PTPN1|MUC3A|NR1H2|RFTN1|ULBP2|KRAS|UBA52|WDFY1|COLEC12|TNIP2|TICAM1|MUC12|MYD88|NR1D1|UBC|CD36|HSP90AB1|UBE2K|CAV1|PAK2|UBB
PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035590,0.650903377847604,0.963755998259649,-0.41871622366824796,-0.849772135329355,4142,3,P2RX7|P2RX4|ANO6
GONADOTROPIN SECRETION%GOBP%GO:0032274,0.21108019837909803,0.7257004702836279,0.728135464867522,1.19011741427462,1744,2,TBX3|FAM129B
REGULATION OF UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050675,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
BRAIN DEVELOPMENT%GOBP%GO:0007420,0.783359057106777,0.981487311948134,0.13166761918442899,0.840261975331424,11165,245,NR4A2|SIX3|EGR2|BTBD3|SMG9|SLIT1|SHROOM2|CDK6|BASP1|CXCR4|HES1|CCDC14|BMP4|KIF14|MFSD2A|BPTF|PROX1|CENPF|WDR62|AHI1|S100A1|FGF13|CEP290|ARHGAP11B|ADGRL2|EPHA5|NPY|ZDHHC16|CDK5R1|ROBO2|ABCB6|SEMA5A|NDUFS4|SLC6A17|RORA|PCDH18|TYRO3|KIRREL3|ARNT2|H2AFY2|STIL|CDK5RAP2|CCDC85C|LEF1|C5orf42|INA|DOCK7|PAFAH1B3|NF1|GRIN1|NIPBL|KLHL17|METTL3|COL4A1|PLXNB2|FGF9|SEMA4C|RTN4R
IRON ION TRANSPORT%GOBP%GO:0006826,0.332413370131861,0.8293509737209019,-0.18874903687745298,-1.09116022630576,1083,43,ARHGAP1|FTH1|ATP6V0C|ATP6V1F|SLC11A1|TFRC|ATP6V1E2|ATP6V0D1|MFI2|ATP6V1E1|STEAP3
POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070230,0.918421052631579,1.0,0.21297003435111198,0.607743711122375,9073,9,IDO1|CCL5
ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071881,0.0769230769230769,0.527286041772797,-0.960465372739303,-1.28484381345708,580,1,ADRA2A
REGULATION OF KINETOCHORE ASSEMBLY%GOBP%GO:0090234,0.20597014925373103,0.7211951452265429,-0.613764167737141,-1.24561614268825,1310,3,RNF4
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904780,0.0746844840386043,0.5243110386449029,-0.8356532385549709,-1.42934010982356,502,2,NSFL1C
REGULATION OF CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:1903242,0.006284367635506679,0.17975028050367198,-0.8619168412925992,-1.7492346207293301,39,3,FOXO1|ATP2B4|LMNA
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GALACTOSE%GOBP%GO:0000435,0.758771349132795,0.977664504547119,-0.617390824878694,-0.825902530528672,5730,1,NCOA1
PROTEIN GLYCOSYLATION%GOBP%GO:0006486,0.24657434402332398,0.7585951535148171,0.18967221085109803,1.1468879069928701,3382,164,B3GALT2|GALNT10|GALNT8|FUT9|MUC15|GALNT13|FUT7|SDF2|GCNT2|GALNT3|TMEM165|C1GALT1C1|B3GLCT|FUT2|ALG6|ASGR1|FUT8|ALG1L|MGAT5B|B3GALT1|OGT|ST3GAL5|POGLUT1|MVD|MOGS|ALG14|ALG13|DERL3|MUC1|SRD5A3|DPAGT1|FUT10|NUDT14|MPDU1|ALG2|DPY19L3|MGAT2|DOLPP1|ST8SIA3|SYVN1|RFNG|LFNG|B3GALNT1|B3GALT6|OSTC|ALG5|ST3GAL4
NEGATIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002890,0.9035726285138309,1.0,0.305569707373008,0.647531399462698,8067,4,THOC1|NDFIP1
L-LYSINE TRANSPORT%GOBP%GO:1902022,0.08174496644295301,0.539385377100419,0.9600242611380679,1.2753494012031599,608,1,SLC25A29
DNA-DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:0045005,0.00413543551305247,0.151519795424031,0.41459102125868297,1.88107168511116,47,40,FBXO18|EME2|POLE|BLM|THOC1|DNA2|POLD1|DONSON|TONSL|GEN1|ZNF830|MSH6|MMS22L|RAD51|FANCM|PRIMPOL|TIMELESS|ZRANB3|EME1|STRA13|BRCA2
MAMMARY GLAND BUD FORMATION%GOBP%GO:0060615,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT%GOBP%GO:0072239,0.3528733739502721,0.842847021021096,-0.464512215298075,-1.06828105518469,2142,4,PDGFRA|PDGFB|PDGFRB|CD34
COENZYME BIOSYNTHETIC PROCESS%GOBP%GO:0009108,0.221351025331725,0.73556947110949,-0.146595194677764,-1.1351642871136498,366,126,PNP|ENO1|NAMPT|ACSL4|PDHB|GAPDH|PGK1|PANK2|FPGS|HK1|NMNAT3|SPR|HK2|TPI1|PNPO|NDUFA9|ACLY|PDXK|ALDOA|SLC25A16|ACSL3|LIAS|QDPR|PGAM2|NMNAT2
NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033033,0.9742340926944228,1.0,-0.277048637917724,-0.56226197917749,6200,3,VIMP|IRF7|MAEA
PEPTIDYL-LYSINE DEMALONYLATION%GOBP%GO:0036047,0.9663709784191709,1.0,-0.515659461843847,-0.6898133844337,7298,1,SIRT5
REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000316,0.7952826433121021,0.9825058878489269,0.240530854758483,0.733804501189752,7990,11,PRKCQ|LOXL3|IL12RB1|NFKBID|RC3H1|FOXP3|ZC3H12A
T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:0002291,0.49161098737936204,0.909315999193258,-0.566328188694177,-0.968674036163701,3310,2,ICAM1
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:2000098,0.9153674832962141,1.0,-0.376427132690708,-0.6438584503197751,6164,2,APOD
NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070874,0.328715635738832,0.828303707528737,0.45577550136540995,1.1209134683012298,3060,6,INS|PASK|VIMP|GSK3A
TETRAPYRROLE METABOLIC PROCESS%GOBP%GO:0033013,0.37806267806267796,0.854057565324787,-0.18879421351175601,-1.04874362400446,1326,37,FECH|HMOX1|ABCC1|TCN2|MMACHC|MTRR|NFE2L1|SLC25A38|FXN|MMAA|BLVRA|COX10|PRSS3
L-SERINE BIOSYNTHETIC PROCESS%GOBP%GO:0006564,0.607388316151203,0.9508825506493929,0.35964961776686294,0.88450585697685,5655,6,SERINC5|PSAT1|PHGDH
REGULATION OF IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034759,0.8550335570469799,0.991298302704726,0.5735553595059549,0.761942706984968,6369,1,HAMP
POSITIVE REGULATION OF MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0110028,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE%GOBP%GO:0044743,0.354100260793973,0.842911430859438,-0.19096254792557998,-1.06895438837155,1221,38,PEX16|TIMM50|ROMO1|TOMM20|C19orf52|TIMM23|PEX26|DNLZ|PEX7|TIMM22|TIMM23B|PEX5
REGULATION OF B CELL ACTIVATION%GOBP%GO:0050864,0.8650335835638091,0.992690647212272,0.134897540541443,0.726616093073381,10946,84,IGHV3-21|IGHV4-61|MZB1|INHA|IGHG1|CD38|CD27|IGLL5|CD320|IGHG4|THOC1
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043154,0.8121468926553671,0.9859232289448421,0.153715935275411,0.7529492271926931,9774,54,SH3RF1|DPEP1|SIAH2|NOL3|NAIP|RNF34|CAAP1|USP47|DHCR24|SRC
POSTERIOR COMPARTMENT SPECIFICATION%GOBP%GO:0007388,0.0307382550335571,0.35952485149978897,0.9847265108072341,1.3081652378431599,228,1,PBX3
POLYAMINE ACETYLATION%GOBP%GO:0032917,0.437280754808274,0.878651088001772,0.6278467052660601,1.02619819179942,3614,2,SAT2|SAT1
CELLULAR RESPONSE TO LEPTIN STIMULUS%GOBP%GO:0044320,0.5682645315586979,0.940076901516441,0.337036228049125,0.918851178919296,5464,8,SIRT1|NR4A3|GCK
MEIOSIS II%GOBP%GO:0007135,0.0791097133180114,0.532203813468543,0.825034463744141,1.3484961659672299,653,2,BUB1|BUB1B
TRNA CATABOLIC PROCESS%GOBP%GO:0016078,0.810973041280539,0.9852684165902109,0.27481071723948497,0.715274559210602,7700,7,POP1|SLFN13|EXOSC2|EXOSC3
REGULATION OF LYSOSOMAL MEMBRANE PERMEABILITY%GOBP%GO:0097213,0.695704697986577,0.96731875442989,0.656760035288928,0.872476406738892,5182,1,LAPTM4B
HISTONE H4-K20 TRIMETHYLATION%GOBP%GO:0034773,0.84866940288627,0.991298302704726,-0.574217026907808,-0.7681476246249521,6409,1,BEND3
MITOCHONDRIAL MEMBRANE FISSION%GOBP%GO:0090149,0.675723830734967,0.9647315640607691,-0.492087124345189,-0.841688671691833,4550,2,SLC25A46|DNM1L
MEMBRANE FISSION%GOBP%GO:0090148,0.055338904363974005,0.458062256682211,-0.500061460431957,-1.5544087495002499,297,8,DNM1L|OPA1|MX1|MX2|SH3GLB1|CHMP4B
POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070131,0.0262365591397849,0.337085846325817,-0.42644186936545697,-1.70068827290939,121,15,MPV17L2|FASTKD2|NGRN|TRUB2|WBSCR16|COA3|FASTKD3|TRMT10C|UQCC1|RPUSD4|C1QBP|UQCC2|RMND1|RPUSD3
REGULATION OF EIF2 ALPHA PHOSPHORYLATION BY AMINO ACID STARVATION%GOBP%GO:0060733,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|IMPACT
TELOMERASE RNA STABILIZATION%GOBP%GO:0090669,0.148526263790548,0.64074876264986,-0.5767385429879229,-1.32637816397026,901,4,DKC1|DHX36|PARN|NAF1
CHOLESTEROL ESTER HYDROLYSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:0090122,0.307427512246789,0.8104595718432149,-0.84698941332157,-1.13304356269098,2321,1,CES1
IMMUNOGLOBULIN TRANSCYTOSIS IN EPITHELIAL CELLS%GOBP%GO:0002414,0.647557262015093,0.9636261853025391,-0.670544772827525,-0.89700818735011,4890,1,FCGRT
NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044828,0.23592032967033,0.750277765814412,-0.472148687403486,-1.1952130498763798,1373,5,VAPA|ZC3H12A|EIF2AK4|CCNK|PARK2
POSITIVE REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032901,0.215411094929167,0.7321649081295791,-0.8913211292456991,-1.19234745074538,1626,1,HAP1
REGULATION OF GLYCOLYTIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072361,0.839049740163326,0.989395884107905,-0.421836228287841,-0.7215282763830699,5650,2,NCOR1|PPARA
PURINE NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0034032,0.15564140976109803,0.656198355453056,0.23243063735634398,1.2580508623781799,1973,86,ACSM3|HACD1|CROT|ACSF2|OXSM|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|ACBD6|MVD|SLC35B3|ACOT1|SLC26A2|SULT1A3|PDHX|FAR1|PDHA1|ACOT2|SLC25A1|ACACA|SUCLG1|DLD|ACSS1|MCEE
PEROXISOME MEMBRANE BIOGENESIS%GOBP%GO:0016557,0.422878326492784,0.873470206885489,-0.7874944861049851,-1.05345538456823,3193,1,PEX16
CREATINE BIOSYNTHETIC PROCESS%GOBP%GO:0006601,0.405346558606508,0.866234596232951,0.640085921080453,1.04620285381712,3350,2,GAMT|GATM
MAINTENANCE OF TRANSCRIPTIONAL FIDELITY DURING DNA-TEMPLATED TRANSCRIPTION ELONGATION%GOBP%GO:0001192,0.0810274063286112,0.5374028338839121,-0.957984119982356,-1.2815245659913501,611,1,POLR2I
SNRNA (ADENINE-N6)-METHYLATION%GOBP%GO:0120049,0.39851714550509704,0.8638522656500329,-0.7989633877370981,-1.06879768396539,3009,1,METTL16
MALATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071423,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045637,0.9586527122641508,1.0,0.110104820391348,0.653830370083856,13006,145,CARTPT|HIST1H3E|NR4A3|HOXA5|CEACAM1|CDK6|MAPK11|INHA|WDR61|MEIS2|HIST2H3C|BGLAP|HIST2H3A|TMEM178A|PRKCB|PRKCQ|FBN1|KMT2B|TAL1|HIST1H4I|LEF1|MED1|TNRC6A|ZNF675|H3F3A|ITGA2B|TNRC6C|MEIS1|PRMT1|RIPK1|ACIN1|FSTL3|CDC73|CEBPB|STAT5B|KMT2D|WDR5|HIST1H3H|ACVR2A|LRRC17|THBS1|ATP6AP1
ERYTHROSE 4-PHOSPHATE/PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:1902221,0.273537604456825,0.7884684708511421,-0.370611533417495,-1.1520220128786498,1472,8,PAH|PCBD1|QDPR
MORPHOGENESIS OF EMBRYONIC EPITHELIUM%GOBP%GO:0016331,0.9109727216910799,1.0,0.146555413393232,0.6420821646358461,10385,35,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C|FGFR2|DVL3|GATA3|DVL2|LRP6|SCRIB|MTHFR
RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES%GOBP%GO:0000712,0.00206327372764787,0.115553415806697,0.625478291815099,1.9717311006021898,20,12,MUS81|EME2|BLM|TOP2A|FANCM|SLX4|EME1|RMI1|STRA13|TOP2B
MRNA CLEAVAGE INVOLVED IN GENE SILENCING BY SIRNA%GOBP%GO:0090625,0.4790054338877,0.9046812288131709,-0.420614349528484,-0.9673251345000151,2908,4,AGO4|AGO3|AGO1|AGO2
REGULATION OF MONOCYTE AGGREGATION%GOBP%GO:1900623,0.27760977379944396,0.7884684708511421,0.6962974428838989,1.13807904198401,2294,2,NR4A3|CD44
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001034,0.652631578947369,0.9640743070248079,0.29805040993722404,0.8505340330563199,6447,9,WRAP53|RIF1|FAM35A|PARP9|SETMAR
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905460,0.805493689680772,0.984682960940884,-0.43660342564617605,-0.746786776584,5424,2,IGF1
G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007213,0.213291139240506,0.728612738647283,-0.311660181309951,-1.20745405056496,1010,14,GNAQ|GNA15|HRH3|CHRM1|PLCB1
INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048009,0.0411948457633737,0.402256981537283,-0.503864896494699,-1.6265210383009499,210,9,IGF1R|EIF2AK3|IGF1|PLCB1|PIK3R1
REGULATION OF INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000659,0.955219001961212,1.0,0.24677707848049302,0.568784583292895,8766,5,ZNF675|VRK2
REGULATION OF HOMOPHILIC CELL ADHESION%GOBP%GO:1903385,0.335911963390717,0.8311444145897029,0.48226515526961294,1.1115496911857399,3082,5,CEACAM1
POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002863,0.875013999328032,0.9937342763776691,0.31994461062115803,0.6779931926078321,7812,4,ZP3|CCR7|HLA-E
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0072434,0.693825503355705,0.96731875442989,0.6576422584913979,0.8736484009046059,5168,1,ATM
CHOLESTEROL HOMEOSTASIS%GOBP%GO:0042632,0.145387956732817,0.636418541205714,0.28132501725949893,1.30425092340218,1706,43,ACSM3|FGFR4|SIRT1|LPL|SCARB1|LIMA1|SOAT1|RORA|GRAMD1B|AKR1C1|CETP|ABCA2|LDLRAP1|PTCHD2|APOE|CYP7B1
HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:0097198,0.469085131735734,0.896126296767273,-0.7638950154389059,-1.02188565311639,3542,1,SETD2
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE RELAXATION%GOBP%GO:0086030,0.9768303985171459,1.0,-0.510752095280106,-0.6832486505570319,7377,1,CHGA
POSITIVE REGULATION OF LYS63-SPECIFIC DEUBIQUITINASE ACTIVITY%GOBP%GO:1903007,0.6985234899328859,0.96731875442989,0.6546096162329069,0.8696196709599631,5203,1,VCP
IRON CHELATE TRANSPORT%GOBP%GO:0015688,0.437442075996293,0.878651088001772,-0.7793339214821351,-1.04253874845872,3303,1,SLC22A17
NEGATIVE REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905450,0.0515436241610738,0.4457514150034171,0.9740295544772829,1.2939548085838701,383,1,CD47
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904871,0.13315111284654402,0.6189080538796391,-0.41708958517210903,-1.3464025572295202,681,9,CCT2|CCT5|DKC1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1
REGULATION OF MELANOSOME ORGANIZATION%GOBP%GO:1903056,0.464186415993645,0.8923263186617242,-0.7668725187472429,-1.0258687500752701,3505,1,ZEB2
POSITIVE REGULATION OF DNA METHYLATION%GOBP%GO:1905643,0.526651818856719,0.9265056012720759,-0.551585332230494,-0.943457169759458,3546,2,MYC|MECP2
POSITIVE REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060316,0.770620581304006,0.979355471471634,-0.37454505349068107,-0.760128057837084,4904,3,GSTM2|GSTO1|AKAP6
CROSS-RECEPTOR INHIBITION WITHIN G PROTEIN-COUPLED RECEPTOR HETERODIMER%GOBP%GO:0038041,0.451476234608765,0.886411023801201,-0.773323775915307,-1.03449879348617,3409,1,RAMP3
AUTOPHAGOSOME ORGANIZATION%GOBP%GO:1905037,0.0233333333333333,0.321093965761153,-0.24960599450001,-1.53954348508705,69,53,RB1CC1|ATG13|MAP1LC3B2|ATG9B|MAP1LC3A|ATG101|ATG3|MFN2|ATG7|RAB1A|BECN1|GABARAPL1|GABARAP|RAB7A|WIPI2|MAP1LC3B|NSFL1C|GABARAPL2
HEMATOPOIETIC STEM CELL MIGRATION TO BONE MARROW%GOBP%GO:0097241,0.74521158129176,0.9749763305090959,-0.4607664736697,-0.788116376138162,5018,2,GPLD1|GAS6
PHOSPHATIDYLINOSITOL-MEDIATED SIGNALING%GOBP%GO:0048015,0.9523606975755,1.0,0.126333018162405,0.592172005162438,11194,45,EDN1|PITPNM2|KCNH1|OGT|TYRO3|ZP3|NF1|PLEKHA1|IRS1|RPS6KB1|GATA3|NYAP1|CSF1R|ERBB3|AKT1|NGF|PIK3C2B|INPP5F|PIK3C2A
REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030885,0.0860252402454556,0.549638890318283,0.7276510012659889,1.38318800739449,742,3,CD2|KLRK1
EPOXIDE METABOLIC PROCESS%GOBP%GO:0097176,0.6391677754929239,0.960516115253472,0.5517022361646129,0.9017421488640359,5283,2,EPHX1|EPHX2
POSITIVE REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032729,0.9831400535236401,1.0,0.119035685088083,0.49910844286808503,11020,30,CD2|KLRK1|SLAMF6|EBI3|ZP3|IL12RB1|PTPN22|RASGRP1|IL1R1|TLR4|ZFPM1|HSPD1|ISL1|HLA-DPB1|FADD
REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033131,0.8812856982864821,0.9956508825790341,0.316742856604265,0.671208369998556,7868,4,MIDN|BAD
LEAD ION TRANSPORT%GOBP%GO:0015692,0.766582814775586,0.9792236089291529,-0.6130348478164979,-0.8200754071999441,5789,1,SLC11A2
REGULATION OF BODY FLUID LEVELS%GOBP%GO:0050878,0.00144927536231884,0.0961252072968491,-0.199962024423332,-1.77920830715974,0,266,VEGFA|GNA13|HMG20B|ADCY7|FCER1G|DGKI|PRKCD|DGKD|USF1|PDPN|ARRB2|NR1H3|VAV1|GPI|HBG2|GNAQ|FYN|ITPK1|P2RX6|C1QBP|INPP5K|DGKQ|PLAU|MFN2|CLIC1|RAB11FIP2|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|VAMP2|VIP|MAFF|PRKAR2A|VAMP3|SERPINF2|COPA|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|THBD|PROC|RAD51B|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ADCY2|NOS3|ANO6|CSRP1|MAPK3|GNA12|RAB5A|DGKB|FGF10|BLOC1S3|MYH9|VWF|AQP5|GNAS|H3F3B|RAC1|MET|CD36|ADM|PIK3R1|AQP1|ZFPM2|DGKK|CAV1|ENPP4|EPHB2
NEGATIVE REGULATION OF ACTION POTENTIAL%GOBP%GO:0045759,0.008397826444920141,0.202735282440703,-0.7950697623118069,-1.82849435742582,50,4,CHRNB2|KCNE3|SUMO1|BIN1
TRANSPOSITION%GOBP%GO:0032196,0.463650659247611,0.8921382338742359,0.618141714915909,1.01033565168378,3832,2,PGBD5|THAP9
POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035307,0.699538168975822,0.967678885433393,-0.159047670716465,-0.842012776937321,2574,32,PIN1|MAGI2|PPP1R12A|SMPD1|FCRL3|CNEP1R1|CDCA2|ANKLE2|PPP2R4|SYMPK|MTOR|LILRB2|PTPRC|CD300A|SPPL3|PTBP1|PPP1R15A|PDGFRB|DUSP26|PPP1R16B|TGFB1|GBA|AKAP6|PPP2R5A|PPP1R15B|PRKCD|NSMF|DLC1|CAMTA1|PPP1R7|HSP90AB1
SUPEROXIDE METABOLIC PROCESS%GOBP%GO:0006801,0.41597605893185996,0.8709670999109399,-0.228182401177747,-1.01812830860194,1806,20,SH3PXD2B|NCF2|CYBA|CYB5R4|PREX1|NRROS|SOD1|SOD3|SOD2|NOS3
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN RENAL SYSTEM DEVELOPMENT%GOBP%GO:2001012,0.43171646304584493,0.8785877309899279,0.630033254719761,1.02977204681347,3568,2,WNT4|STAT1
DTDP BIOSYNTHETIC PROCESS%GOBP%GO:0006233,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060243,0.0409395973154362,0.402256981537283,0.9789920599911779,1.30054727576602,304,1,CDHR2
MUSCLE ORGAN MORPHOGENESIS%GOBP%GO:0048644,0.7304211625478589,0.972554563883587,0.180678104279359,0.8033133513032241,8393,37,RYR2|IGSF22|MYLK2|BMP4|PROX1|TCAP|TGFB2|HEY2|OBSL1|TNNI3|NRG1|MYLK|MYOM2|FGFR2
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010822,0.000491883915395967,0.0784645998831315,-0.342628695999065,-2.52358747897946,0,102,FIS1|RHOU|APOPT1|HTRA2|DNM1L|GSK3B|NMT1|SFN|OPTN|CHCHD10|YWHAG|PARK7|ABLIM3|BNIP3|MIEF2|MUL1|PYCARD|ZNF205|BAX|GPER1|FBXW7|HPS4|PPIF|TP53BP2|GZMB|KDR|CIDEB|UBL5|BBC3|ATG13|HRK|VPS11|MFN2|YWHAH|CSNK2A2|MMP9|SH3GLB1|RNF31|PLD6|MIEF1|BOK|BID|BAP1|LEPROT|YWHAQ|YWHAB|PLAUR|PPARGC1A|HK2|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|UBE2D3|HTT|ARIH2|PARK2|BMF|FBXO7|BIK|BCL2L11|PMAIP1|TFDP2
COPI COATING OF GOLGI VESICLE%GOBP%GO:0048205,0.834622144112478,0.988613522932093,-0.259114224256798,-0.711251147337081,4748,6,GBF1|TMED9|ARFGAP2|ARFGAP3|TMED10|TMED2
OTIC VESICLE FORMATION%GOBP%GO:0030916,0.12029639921268999,0.606646975444992,0.6978052277489799,1.3264543315961799,1038,3,PROX1|CEP290|FGFR2
CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0035787,0.41758389261745,0.8710929393673741,0.798026025584473,1.06014197252388,3110,1,VANGL2
POSITIVE REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032079,0.663922278939569,0.964618776001639,-0.362322836816853,-0.8332668327868231,4031,4,AKT1|DDX11|PRKCD|RPS3
ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0042976,0.946856547412296,1.0,0.317149222964303,0.6028673100091689,8177,3,JAK2|PIBF1
NEGATIVE REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090285,0.35647756138865394,0.844559957061487,0.661814171491591,1.0817170822041702,2946,2,ACER2|TMEM59
NEUROMUSCULAR PROCESS CONTROLLING BALANCE%GOBP%GO:0050885,0.38512145748987897,0.8594725939233921,0.373773605489515,1.06662216030489,3804,9,PCDH15|CDH23|MYO7A|SHANK1
NEGATIVE REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000466,0.9046347211311859,1.0,-0.319124296900849,-0.647653278961014,5757,3,GSK3A|GSK3B|INPP5K
REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901222,0.15223000368595702,0.648319130045528,-0.187878430589941,-1.23028744139024,412,65,IL1B|IRAK1|NFKBIA|LGALS9|RPS3|SPHK1|RHOA|TNFRSF10A|CYLD|PPM1A|TMSB4X|PDCD4|PTP4A3|NLRP3|LIMS1|BCL3|TNFRSF10B|CHI3L1|COPS8|DLG1|TNF
BLASTODERM SEGMENTATION%GOBP%GO:0007350,0.0131837001525387,0.250097661198388,0.733051236243746,1.6895744309259297,120,5,TBX3|BASP1|HOXD8
FORMATE METABOLIC PROCESS%GOBP%GO:0015942,0.685077951002227,0.966495577318169,-0.486958919216984,-0.832917151469136,4613,2,MTHFS|MTHFD1L
CHOLESTEROL EFFLUX%GOBP%GO:0033344,0.277528746832976,0.7884684708511421,0.353763203348638,1.17212742705974,2847,14,ABCA7|ABCA5|SCARB1|SOAT1|APOE|APOC1|APOM
REGULATION OF STORE-OPERATED CALCIUM ENTRY%GOBP%GO:2001256,0.0908100254268071,0.560322217247896,-0.49762811373347104,-1.45160328551179,499,7,STIM1|CD84|SARAF|HOMER2|HOMER1
SARCOSINE METABOLIC PROCESS%GOBP%GO:1901052,0.433047054554252,0.878651088001772,0.6291701130410811,1.02836126545155,3579,2,SARDH|GNMT
REGULATION OF RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900052,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
MATERNAL BEHAVIOR%GOBP%GO:0042711,0.0939597315436242,0.562743160240921,0.95351786501985,1.26670594423102,699,1,OXTR
REGULATION OF WATER LOSS VIA SKIN%GOBP%GO:0033561,0.8385269121813029,0.989395884107905,0.305558788251021,0.704267710425048,7695,5,TMEM79|STMN1
NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051045,0.29927884615384603,0.8023890191280308,-0.44506949040370597,-1.12666386082261,1742,5,TIMP1|ROCK1|TIMP3|PTPN3|TIMP2
TERPENOID TRANSPORT%GOBP%GO:0046865,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
POSTSYNAPSE ORGANIZATION%GOBP%GO:0099173,0.625036221385106,0.954110852066186,-0.159763230017264,-0.894309421834495,2156,38,LHFPL4|NLGN4X|CHRNB1|MTMR2|IGF1R|FYN|PRNP|CHRNA7|ARC|CDC42|ZNF365|TMEM108|EPHB2
TERMINATION OF RNA POLYMERASE III TRANSCRIPTION%GOBP%GO:0006386,0.720805369127517,0.9713770803161691,0.642865019850022,0.8540174986288929,5369,1,POLR3K
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035025,0.49462365591397905,0.91071489001692,-0.23992063691510604,-0.956824934281475,2299,15,ARRB1|AKAP13|GPR4|RAC1
NEGATIVE REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032688,0.669424743892829,0.964618776001639,-0.24499365587245497,-0.828850208463126,3397,10,NLRC3|CACTIN|PTPRS|YY1|PPM1B|LILRB1|PYCARD|SIRPA|RELB|REL
MAINTENANCE OF SYNAPSE STRUCTURE%GOBP%GO:0099558,0.8966221523959151,0.998912093067348,-0.323591044446895,-0.6567184103928161,5706,3,RAB3A|DCTN1|CHCHD10
POSITIVE REGULATION OF B CELL ACTIVATION%GOBP%GO:0050871,0.71895800805325,0.971100527801148,0.165597672001992,0.8280787394755369,8748,59,IGHV3-21|IGHV4-61|IGHG1|CD38|CD27|IGLL5|CD320|IGHG4|TNFSF13B|IGHV1-18|IGHV3-43|BST1
N-ACETYLNEURAMINATE METABOLIC PROCESS%GOBP%GO:0006054,0.541174152876281,0.928807195199472,-0.272058757540963,-0.9204154985116841,2746,10,NPL|ST6GAL1|RENBP|GNPDA1|GNPDA2|NAGK|NANP|ST3GAL1|GNE
PROTEIN N-LINKED GLYCOSYLATION VIA ARGININE%GOBP%GO:0042543,0.237521514629948,0.7507739897770379,-0.881175562417292,-1.17877541666328,1793,1,KRTCAP2
PLASMA LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034381,0.74361519718437,0.9749763305090959,0.19373102993608102,0.7876157832824259,8239,27,VLDLR|AP2A2|SCARB1|SOAT1|LDLRAP1|APOE|APOC1|CLTC|LDLR|APOM
REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0005981,0.142526340164409,0.6324244126031129,0.681229443607986,1.29494550965119,1230,3,INS|PHKG2|PPP1R3B
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002698,0.996024575352367,1.0,-0.0801754254440255,-0.51688425308009,2755,62,LGALS9|ARRB2|PCBP2|C1QBP|FCGR2B|GPATCH3|SMAD7|LGALS3|TRAF3IP1|SOCS5|CD22|TNF
ESCRT III COMPLEX ASSEMBLY%GOBP%GO:1904902,0.9664429530201339,1.0,0.51896779885311,0.6894255679814001,7199,1,CHMP6
HISTAMINE SECRETION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002441,0.961744966442953,1.0,0.521449051610057,0.6927218015724711,7164,1,SNAP23
NEGATIVE REGULATION OF CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:1903126,0.313020134228188,0.8158652929227931,0.8473753859726509,1.12570039616852,2331,1,NEK2
SCHWANN CELL PROLIFERATION%GOBP%GO:0014010,0.00630872483221477,0.17992824699561,0.9963608292898101,1.32362091090352,46,1,NF2
NEGATIVE REGULATION OF ACTIN BINDING%GOBP%GO:1904617,0.621872103799815,0.9536478716552259,-0.682454786060873,-0.912940575185619,4696,1,CRMP1
RHYTHMIC BEHAVIOR%GOBP%GO:0007622,0.327996876220227,0.828303707528737,-0.338880263828521,-1.09393585942708,1679,9,CIART|TP53|USP2
POSITIVE REGULATION OF HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031453,0.0112495463892585,0.22992267312754103,0.9312379376895501,1.5220828265509,92,2,TPR|SIRT6
ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD%GOBP%GO:0043153,0.0473826714801444,0.42809843010511295,-0.34985821160428004,-1.53429381784129,209,19,PER1|BHLHE40|SIK1|FBXL3|ID2|PML|PER3|TP53|PER2|PPP1CB|USP2
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086053,0.525530243519246,0.9265056012720759,-0.461306036844669,-0.936206895771981,3344,3,GJC1
ATP HYDROLYSIS COUPLED CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0099132,0.502435192458759,0.9160882111977869,-0.468898202271975,-0.951614969933558,3197,3,ATP1A3|ATP1A1|ATP6V1H
LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032802,0.64681764935572,0.96344123684964,-0.262489203149749,-0.847338669988909,3312,9,CLTA|AP2S1|MYLIP
REGULATION OF MITOTIC SPINDLE ASSEMBLY%GOBP%GO:1901673,0.926016440790935,1.0,-0.150633285932392,-0.6479909285982479,4167,18,VPS4B|CHMP4B|CHMP1B
MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:0006390,0.269208095893103,0.784543299601953,0.37416022040295294,1.17948672692667,2739,12,POLRMT|MTERF3|MTERF1|TEFM
PROPRIOCEPTION%GOBP%GO:0019230,0.261073825503356,0.771967970256231,0.8715262461402741,1.15778373645495,1944,1,TMEM150C
SPHINGOMYELIN BIOSYNTHETIC PROCESS%GOBP%GO:0006686,0.5215146299483651,0.9251240799994541,-0.735112483458315,-0.9833823825139101,3938,1,SAMD8
AUTOPHAGY%GOBP%GO:0006914,0.0154679040989946,0.264745847609811,-0.175375830045741,-1.41338880535236,19,159,VPS33B|PIK3C3|PGAM5|PRKAA1|SQSTM1|PRKAG1|RB1CC1|TRIM17|CTSK|ATG13|ANXA7|VPS4A|TMEM74|S100A8|MAP1LC3B2|ATG9B|MAP1LC3A|VPS37D|ATG101|ATG3|MFN2|NRBF2|ATG7|RAB1A|VPS4B|BECN1|VPS16|TBC1D5|C6orf106|DYNLL2|TP53|SEC23A|GABARAPL1|GABARAP|RAB7A|PARK2|CHMP4B|FBXO7|WIPI2|MAP1LC3B|NSFL1C|VTI1A|MTMR14|GABARAPL2|SPATA18
NEGATIVE REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0072096,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903726,0.9073515649370909,1.0,0.23027196130649696,0.627783144688214,8725,8,WASH1|APOC1
POSITIVE REGULATION OF MITOPHAGY%GOBP%GO:1901526,0.609880130766437,0.9508825506493929,-0.298504058237629,-0.8707495812996279,3357,7,MFN2|PARK2
CILIARY BASAL BODY ORGANIZATION%GOBP%GO:0032053,0.9885671863400151,1.0,-0.307334002859599,-0.525678352135,6657,2,CCP110
RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0009991,0.00176678445229682,0.109586956234036,-0.18960247310483103,-1.57825129747067,1,187,EIF2S1|KIF26A|PIM1|IMPACT|PIK3C3|RRAGD|BCAS3|STK26|UCN2|USF1|PRKAA1|HLCS|HSPA5|GDF15|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|GNAI2|FYN|FAM65A|EIF2AK1|DGKQ|MAP1LC3A|KLF10|BCL10|CCRN4L|PPARA|FOXO1|SEH1L|EIF4G1|NUAK2|PPARG|CBS|SH3GLB1|ATG7|GCGR|BECN1|TBC1D5|C12orf66|PPARGC1A|GIPR|MKKS|TP53|GABARAPL1|RALB|ADCYAP1|MAPK3|GABARAP|CDKN1A|UCN3|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|NENF|PMAIP1|INHBB
NEUROPEPTIDE CATABOLIC PROCESS%GOBP%GO:0010813,0.29962880475129905,0.802472218138634,-0.680397022332506,-1.1637826669661102,2017,2,ECE1|CTSH
RENAL PROTEIN ABSORPTION%GOBP%GO:0097017,0.569575003309943,0.940076901516441,-0.709142037935598,-0.948640925705926,4301,1,GSN
NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070942,0.334496644295302,0.830568091460343,0.837284958094398,1.1122957128981699,2491,1,AZU1
TERPENOID CATABOLIC PROCESS%GOBP%GO:0016115,0.60014847809948,0.9503412745667059,-0.521091811414392,-0.891299635532028,4041,2,AKR1C3|CYP26B1
URINARY BLADDER SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014832,0.619463087248322,0.9532238181782521,0.694640494044993,0.922798906229247,4614,1,KCNMA1
REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045622,0.9150552486187841,1.0,-0.14621626097035903,-0.652403137592932,3974,20,LOXL3|CCL19|IL12RB1|NFKBID|RC3H1|ANXA1|JAK3|MYB|FOXP3|PRKCZ|ZC3H12A|MALT1|NFKBIZ|IL18|RC3H2|CD86|RARA|SMAD7|NLRP3|SOCS5
SENSORY PERCEPTION OF CHEMICAL STIMULUS%GOBP%GO:0007606,0.732166508987701,0.972769769206295,0.21695669309492896,0.7930099076868391,7738,19,RTP5|TAS2R4|RTP4|TAS2R5|ASIC1|ASIC3|TAS2R20
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002715,0.982428412049089,1.0,0.13081660587671698,0.494556496232968,10566,21,CEACAM1|KLRK1|SLAMF6
NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090032,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
POSITIVE REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032352,0.8805154236626321,0.9956508825790341,-0.208611163044261,-0.6734155284014499,4509,9,HIF1A|IL1B|PAX8|TNF
POSITIVE REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043117,0.45298863823481,0.8874890379518141,-0.42889147080687107,-0.9863607842891021,2750,4,PDE3A
METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072278,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
CELLULAR RESPONSE TO IONOMYCIN%GOBP%GO:1904637,0.9688865351515951,1.0,-0.514280988089987,-0.68796935806385,7317,1,ZC3H12A
METANEPHROS MORPHOGENESIS%GOBP%GO:0003338,0.22948883161512,0.743365122901021,0.496889436794132,1.2220272048203302,2136,6,BMP4|PKD2
POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001016,0.7056003486598392,0.968941691852291,0.352608390746155,0.812710069472614,6475,5,ARNTL|GPC1
CHROMATIN MAINTENANCE%GOBP%GO:0070827,0.30612481185596896,0.8097321528744119,0.592919377964045,1.12707736473227,2643,3,SUPT6H|SUPV3L1|MTHFR
ESTABLISHMENT OR MAINTENANCE OF ACTIN CYTOSKELETON POLARITY%GOBP%GO:0030950,0.0281923714759536,0.345491958731604,-0.460724948525394,-1.67846720276782,135,12,RND1|MAPKAP1|RHOA|RND2|RHOC|AQP1
PROTEIN GLYCOSYLATION IN ENDOPLASMIC RETICULUM%GOBP%GO:0033577,0.375838926174497,0.8533319722534141,0.81771063078959,1.0862920923463801,2799,1,ALG2
'DE NOVO' PROTEIN FOLDING%GOBP%GO:0006458,0.697453048623617,0.96731875442989,-0.166283736966165,-0.8407714484190542,2710,28,HSPA8|CCT2|DNAJC2|HSPD1|HSPE1|DNAJB12|HSPA1L|HSPA14|ERO1L|DNAJB1|CHCHD4|DNAJB14|PTGES3|DNAJC7|GAK|UGGT1|HSPA9|HSPA13|FKBP1B|HSPA5|ST13|HSPA6|BAG1|FKBP1A
REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000401,0.54612864286946,0.930420772651609,0.20830469395074397,0.939507922019837,6333,39,CXCL13|STK39|KLRK1|MIA3|DOCK8|XCL2|CCL21|CCL5|CD200|CXCL10|CCL2
PHASIC SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014821,0.11053869414268101,0.584830174998513,0.6425886590179261,1.36170675172591,986,4,EDN1|PTGER3
TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090671,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0042454,0.0126582278481013,0.24430577683365803,-0.48677195798232203,-1.8331738894216103,60,13,ENTPD4|PNP|CDA|HPRT1|NUDT18|CDADC1|ENPP4
POSITIVE REGULATION OF FRACTALKINE PRODUCTION%GOBP%GO:0032724,0.5276911655530809,0.9265056012720759,-0.551172267749639,-0.942750645087274,3553,2,TNF
ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER%GOBP%GO:0090557,0.207643814026793,0.7232762929610351,-0.36282111404702394,-1.2274781358798,1053,10,RAP2C|F11R|TJP2|RAP2B|RAB1A
POSITIVE REGULATION OF METANEPHRIC DCT CELL DIFFERENTIATION%GOBP%GO:2000594,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051883,0.917297698589458,1.0,-0.374155206518955,-0.6399724422795731,6177,2,GAPDH
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0036003,0.0992784274695198,0.570215774831708,-0.281528811644995,-1.36577267395211,398,25,ATF4|HIF1A|NOTCH1|VEGFA|MAPK7|HSPA5|DDIT3|ATF6|HSF1|TP53|SESN2|RBPJ
"MATURATION OF SSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000462",0.017668776371308,0.280886139999265,-0.326054945994597,-1.69158350899591,66,30,UTP3|RRP36|DHX37|PWP2|TBL3|KRI1|NOL10|RRS1|CIRH1A|TSR1|TSR2|NOP14
TRNA 3'-END PROCESSING%GOBP%GO:0042780,0.92860151642797,1.0,0.23050193050193002,0.599948096614014,8817,7,ATP5J2-PTCD1|HSD17B10|PTCD1|SSB|TRNT1
REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904029,0.196678321678322,0.7103495916316691,0.22911901218103897,1.21707079213981,2474,78,CCNA1|CCNB1|PSRC1|PROX1|CDKN2C|BLM|CDKN3|CDK5R1|CDC25C|GTF2H1|CDKN2A|MEN1|CCNE1|PKMYT1|APC|CDC6|CDKN2B|CCNB2|CCNI2|CDK7|CCNF|PLK1|CKS2|CCNE2|CDK5RAP3|CCNT2|INCA1|TFAP4|SERTAD1|CDKN2D|CCND2|CAMK2N1|CCNJ|CCNG1|DIRAS3|CCNA2|MNAT1
ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:0030968,0.997009522310537,1.0,0.0885764217296641,0.48139896550248495,12668,88,ASNS|CTH|ACADVL|PARP16|PREB|ERN1|HSP90B1|DERL3|YIF1A|EXTL2|SULT1A3|RNF121|SYVN1|SEC31A|CCL2|NFE2L2|PDIA5|HERPUD1|VIMP|ATF3|CUL7|CDK5RAP3|EXTL1|DNAJB9|GSK3A|PLA2G4B|TLN1|VCP
POSITIVE REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051944,0.8593261549149008,0.99166790097654,0.37498486242108203,0.712806776535603,7421,3,DRD4|RAB3B
GASTRULATION WITH MOUTH FORMING SECOND%GOBP%GO:0001702,0.6309896262143921,0.9575013258325501,-0.371642861082005,-0.8547009415754029,3831,4,LRP6|MEGF8|LRP5L|LRP5
POSITIVE REGULATION OF ACTION POTENTIAL%GOBP%GO:0045760,0.656063268892794,0.9640743070248079,-0.304758366012421,-0.836541251676275,3732,6,SCN5A
TRANSITION METAL ION TRANSPORT%GOBP%GO:0000041,0.339748334566987,0.8330383695817521,-0.16314591250729998,-1.07732181356412,917,67,ARHGAP1|FTH1|ATP6V0C|SLC30A1|ATP6V1F|SLC11A1|SLC39A4|SLC39A11|TFRC|ATP6V1E2|ATP6V0D1|SLC31A1|MFI2|ATP6V1E1|SLC30A9|STEAP3
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:2000607,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0060947,0.762390910587848,0.978421368343614,-0.333679315711864,-0.767392718086509,4629,4,MESP1|NOTCH1|VEGFA
STRESS FIBER ASSEMBLY%GOBP%GO:0043149,0.349602278306982,0.842847021021096,0.342073669273483,1.10399888004194,3559,13,ITGB1|FHDC1|TNFAIP1|SRC|ITGB5
MITOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0007093,0.00573385955767369,0.17352934538701598,0.276377840743559,1.6199924496717097,76,133,BTG2|MUS81|TAOK3|EME2|CCNB1|PIDD1|TPR|CDK1|E2F8|ZWINT|BLM|CENPF|WEE1|ORC1|CDC25C|MUC1|BUB1|RAD9A|TOP2A|E2F7|DONSON|CDC20|APC|ZNF830|NEK11|NABP1|RB1|BUB1B|NAE1|GTSE1|AURKB|CDC6|MSH6|HRAS|CDKN2B|INTS3|KLHL22|TAOK1|RPS27L|CHEK2|TOPBP1|PLK1|KNTC1|PRMT1|EME1|BRSK1|CARM1|AURKA|CHFR|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|TOP2B|C5orf45|TEX14|PRKDC|RAD17|MAD2L1BP|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1
MICROTUBULE BUNDLE FORMATION%GOBP%GO:0001578,0.24834217506631304,0.7613646381106121,-0.18561963694104,-1.13687322688195,748,52,CHP1|CFAP46|MARK4|DNAI1|LRRC6|CCDC103|TPPP3|DYX1C1|DNAL1|IQCG|RSPH1|DNAAF1
SNORNA PROCESSING%GOBP%GO:0043144,0.0166009545548869,0.27410609011314296,-0.47616844782855494,-1.79324127286195,79,13,FBL|PARN|CPSF3|EXOSC6|RNF113A|EXOSC4|PAPD7|EXOSC5
REGULATION OF EPIDERMAL CELL DIVISION%GOBP%GO:0010482,0.5783132530120481,0.942692029750853,-0.704620644022938,-0.942592519212816,4367,1,SFN
CELLULAR HYPOTONIC SALINITY RESPONSE%GOBP%GO:0071477,0.622798887859129,0.9536478716552259,-0.682068813409793,-0.9124242478020609,4703,1,SLC12A6
"TRANS-SYNAPTIC SIGNALING BY NEUROPEPTIDE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099551",0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
LATERAL MESODERM FORMATION%GOBP%GO:0048370,0.11981993909704801,0.6056190749402529,-0.938795765328628,-1.25585571892303,904,1,TBX20
B-1 B CELL HOMEOSTASIS%GOBP%GO:0001922,0.350456772143519,0.842847021021096,-0.824327304808116,-1.1027277691706399,2646,1,TNFAIP3
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901379,0.121480544131604,0.607607158836689,-0.215823972405931,-1.2890395211665402,383,47,KCNAB1|VAMP2|SUMO1|BIN1|CAB39|KCNAB2|AMIGO1|NEDD4|YWHAE|KCNG1|ANO6|DLG1|GAL|CAV1
"ANTIGEN PROCESSING AND PRESENTATION, ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048006",0.418663887924048,0.871698849372662,0.547041584527522,1.03986850557216,3615,3,CD1E|CD1D
TRNA METHYLATION%GOBP%GO:0030488,0.9043634727845259,1.0,0.156241096298933,0.6406866644902081,10051,28,THADA|TARBP1|TRMT10A|GTPBP3|TRMT1|LCMT2|TRMT13|MTO1|TYW3|THUMPD2|TRMT1L|HSD17B10
REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061001,0.9868784530386742,1.0,-0.116851575867969,-0.521380687914019,4286,20,CUX2|CDK5R1|CAPRIN2|LRP8|ARHGAP44|SIPA1L1|DBN1|PDLIM5|CFL1|CAMK2B|NGEF|PTEN|CAPRIN1|DHX36|EPHA4|CDK5|BHLHB9|EFNA1|ARC|RELN
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034250,0.012881679389313,0.24668080085844798,-0.20508359953965,-1.4902792260827198,26,97,DNAJC3|PICALM|RPS4X|EIF3D|CLU|IMPACT|RBM3|PLK3|PRKCD|SAMD4A|RPS9|FAM129A|WIBG|DDX3X|C1QBP|UHMK1|CASP3|YTHDF1|VIM|IL6|EFNA1|CHRNA7|HABP4|UQCC2|RMND1|RPUSD3|NPM1|FMR1|EIF5A|BCL3|POLR2D|TNF|LARP6
REGULATION OF TRANSLATION%GOBP%GO:0006417,0.0284653465346535,0.347394697096828,-0.15020992835739802,-1.30794787157592,22,237,NOTCH4|MOV10|PUM1|RPUSD4|ZC3H12D|MTRF1|TRAP1|MTG2|NCBP1|HNRNPD|POLDIP3|RPS6KA3|EIF2A|EIF2AK2|SYNCRIP|EIF6|YTHDF2|TRNAU1AP|USP16|OGFOD1|EIF4E|CALR|NCL|SEPSECS|EIF5|ATF4|PPP1R15B|EIF3H|NCK2|HSPB1|DNAJC3|DPH2|CNOT10|RPS4X|EIF3D|METTL16|EIF2S1|AARS|EEFSEC|IMPACT|RBM3|CPEB1|SAMD4A|EIF2AK3|ZNF385A|RPS9|RPS3|FAM129A|WIBG|DDX3X|EIF2AK1|PAIP2B|C1QBP|EIF4A2|UHMK1|RNF139|EIF4G1|YTHDF1|NSUN3|VIM|EIF4EBP1|CPEB2|IL6|NOLC1|DPH6|HABP4|EIF3B|UQCC2|EIF1|RMND1|EIF4E2|RPUSD3|EIF4H|DPH3|CNOT7|NPM1|GAPDH|SHMT2|FMR1|EIF4B|AGO2|EIF5A|MTPN|ETF1|STAT3|BCL3|NCBP2|POLR2D|PER2|SESN2|EIF1B|RBM24|LARP6|FOXO3
STILBENE CATABOLIC PROCESS%GOBP%GO:0046272,0.956043956043956,1.0,-0.519629466254963,-0.6951241803788699,7220,1,EPHX2
POSITIVE REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001921,0.12962962962963,0.6111005682596911,-0.4010040271418329,-1.35665664609738,657,10,INPP5F|SCRIB|RAB29|ANXA2|NSF|ECE1|RAMP3|BVES|VAMP3|SNCA
HORMONE TRANSPORT%GOBP%GO:0009914,0.45311794964353397,0.887637374502788,0.248676463506407,1.01099709041512,5020,27,EDN1|TBX3|GHRL|RIMS2
PHOSPHOLIPASE C-INHIBITING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030845,0.5371375612339471,0.9265056012720759,-0.7271724746360829,-0.972760790623571,4056,1,PLEK
CELLULAR SODIUM ION HOMEOSTASIS%GOBP%GO:0006883,0.9732764895497561,1.0,0.19124260942844898,0.521378660537704,9359,8,ATP1B3|SLC8A1|ATP1A3|ATP1A1|ATP1B1
TRABECULAR MESHWORK DEVELOPMENT%GOBP%GO:0002930,0.5371375612339471,0.9265056012720759,-0.7271173356859291,-0.972687029568777,4056,1,CYP1B1
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007200,0.28037641848878997,0.788916642629372,-0.20961104173454698,-1.12789329646426,1012,34,DRD2|ADRA2A|GPR4|CHRM1|HRH1|HOMER1
REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032645,0.535052669814748,0.9265056012720759,-0.315830115830116,-0.92129045998417,2945,7,RASGRP1|DDX58|ISL1|IL18|CD84|IL17D|IL1B
SNRNA MODIFICATION%GOBP%GO:0040031,0.7689039006319459,0.9792236089291529,0.33102539997736896,0.76296447524552,7056,5,MEPCE
POSITIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071879,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046125,0.9393307861525991,1.0,0.32379038991429304,0.61549146975656,8112,3,TK1|DPYD
GALACTOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0006683,0.934992718125248,1.0,-0.5296647551830611,-0.7085486923513821,7061,1,GALC
CELLULAR DETOXIFICATION OF ALDEHYDE%GOBP%GO:0110095,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
WATER HOMEOSTASIS%GOBP%GO:0030104,0.4720561476475179,0.8982789683086909,-0.191505034266793,-0.9800751010590241,1815,29,WFS1|SFN|PRKAR1A|PRKACA|RAB11A|ADCY7|NEDD4L|RAB11FIP2|PRKAR2A|PRKAR1B|ADCY2|MET|AQP1
RESPONSE TO MUSCLE ACTIVITY%GOBP%GO:0014850,0.565829037800687,0.9387592361267459,0.37234479938000004,0.9157278072792799,5268,6,RYR2|FNDC5
REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060314,0.26568021201413394,0.7794384395334059,-0.27415940786279297,-1.15363125520421,1202,17,PRKACA|AKAP6|CAMK2D|SRI|FKBP1B|JPH3|JPH1|PDE4D|FKBP1A
REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033032,0.8766874874068101,0.99444152362265,0.221730462971518,0.654383880631056,8701,10,SIRT1|CDKN2A|VIMP|ANXA1|MEF2C|IRF7|PIK3CB
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014874,0.0382018771612053,0.3927265529050711,-0.711961616941488,-1.6373629849738003,231,4,FBXO32|AGT|HDAC4|SCN5A
CELLULAR RESPONSE TO MONOSACCHARIDE STIMULUS%GOBP%GO:0071326,0.450252177900046,0.88620227509476,0.256937925718374,1.01117863917358,4909,24,PRKAA2|UNC13B|AGER|ADCY8|ERN1
SIDEROPHORE METABOLIC PROCESS%GOBP%GO:0009237,0.135838926174497,0.623227463256235,0.933006175562417,1.23945707987816,1011,1,BDH2
GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT%GOBP%GO:0032836,0.643174707722707,0.9621972042482541,-0.36794338517235703,-0.8461929198308019,3905,4,SULF2
CELLULAR RESPONSE TO NITROGEN COMPOUND%GOBP%GO:1901699,0.00212314225053079,0.115662364510001,-0.177426046700112,-1.62134483877998,0,328,RRAGD|PRKCD|CTNNB1|IGF1R|CPEB1|NSMF|USF1|BCAR1|FOXO4|RRAGC|GRB2|ABL1|CRHR1|RAB8B|GNAQ|FYN|SLC9A1|INPP5K|HDAC5|FOXO1|CASP3|PKM|VIM|CPEB2|GNA15|ATP6V0C|PXN|ATP6V1F|PPARG|SH3BP4|LYN|FCGR2B|PRNP|VAMP2|CHRNA7|HTR1B|NAMPT|CAMK2A|PRKAR2A|GCGR|LAMTOR5|IGF1|MAVS|FOXC2|LPIN1|ATP2B4|RIPK2|RAP1A|CTNNA1|NPM1|RAB8A|PTPN1|SHMT2|LDOC1|SNCA|ARHGEF2|FMR1|PDE4B|RYR1|HRH3|ADRB2|CHRNA3|PDE12|SLC25A33|STAT5A|HSF1|RAPGEF1|SHC1|ATP6V1E2|ATP6V0D1|GABRG2|STAT3|TP53|COLEC12|PRKAR1B|ADCY2|RALB|MAPK3|CAV2|PARK2|ATP6V1E1|RHOQ|CHRM1|PLCB1|IGF2|CD36|SESN2|PIK3R1|PDE3A|AQP1|HRH1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
NEGATIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002731,0.653441393492198,0.9640743070248079,0.546732837055418,0.893619802537435,5401,2,BST2|JAK3
CELLULAR RESPONSE TO DIAMIDE%GOBP%GO:0072738,0.16644394951744598,0.6682860217990739,-0.7561048016692671,-1.2932767688723301,1120,2,HSF1
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES%GOBP%GO:0007156,0.00592105263157895,0.175567154622165,0.35516885863914,1.7704457868314698,71,58,ITGB1|PCDHA7|CDH4|CDH6|PCDHB6|CDH10|NEXN|SDK1|CEACAM1|CDH3|IGSF9|CDH2|DSCAM|ROBO2|CELSR2|KIRREL3|CDH7|HMCN1|BSG|PALLD|PLXNB2|TRO|MYOT|PLXNB3|CDHR3
REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE%GOBP%GO:0042749,0.5314217032967029,0.9265056012720759,-0.365422738963951,-0.9250433983692141,3094,5,PTGDS|CHRNB2|PER3|CRH
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001027,0.54775963876346,0.9305779599215391,0.498970186387382,0.948489834629022,4730,3,CXCL13|THBS1
ABDUCENS NERVE DEVELOPMENT%GOBP%GO:0021560,0.6536475572620151,0.9640743070248079,-0.6671812968681079,-0.8925087630076741,4936,1,MAFB
"MATERNAL DETERMINATION OF ANTERIOR/POSTERIOR AXIS, EMBRYO%GOBP%GO:0008358",0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
REGULATION OF GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:1902659,0.7053421435771079,0.968941691852291,0.3914410191363811,0.829500911944374,6297,4,SMARCA4|UBTF|PIH1D1|SMARCB1
COMPLEMENT ACTIVATION%GOBP%GO:0006956,0.12223446638976,0.607607158836689,0.28297921565990103,1.3353158967201202,1441,46,IGHV3-21|IGKV4-1|IGHV4-61|COLEC11|IGHG1|IGLL5|IGHG4|IGHV1-18|IGHV3-43|IGKV3-11|COL20A1|IGKV2D-28|IGKV2-28|C7|IGHV1-24|C4A|C4B
ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099624,0.0033869602032176103,0.140033065594047,0.959525778880618,1.56831852586525,27,2,KCNN2|KCNQ1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902966,0.5339629495096261,0.9265056012720759,-0.31621621621621604,-0.92241673194014,2939,7,SORL1|MGAT3|RDX|ROCK2|DTX3L|EZR|MSN
ALDEHYDE CATABOLIC PROCESS%GOBP%GO:0046185,0.26811513047373703,0.7829905950315309,0.550688144707258,1.16696078310708,2393,4,AKR1A1|PDXP|ALDH3B1|HOGA1
ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007189,0.00111028867505551,0.0893009762660318,-0.298695624802622,-1.9724141859921203,2,67,PTHLH|RAMP3|GPER1|GNA13|ADCY7|ADRA2C|UCN2|PTGFR|CRHR1|GNAQ|CALCRL|ADRA1B|GNAL|VIP|ABCA1|GCGR|RAMP2|AKAP13|ADRB2|MC4R|GPR161|GPR3|CALCB|ADCY2|ADCYAP1|DRD2|UCN3|ADRA2A|GNAS|ADM|PDE4D|RAMP1
REGULATION OF DNA DEMETHYLATION%GOBP%GO:1901535,0.42309505106048706,0.873470206885489,-0.49685673320833795,-1.00835597778447,2692,3,USP9X|USP7|OTUD4
REGULATION OF CELLULAR RESPONSE TO VERY-LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:1905890,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0097623,0.373420387531592,0.852609194081082,0.413956913929872,1.07744287456351,3545,7,KCNT2|KCNQ1|KCNH2
NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS%GOBP%GO:2000672,0.18747517542698303,0.6940517434063481,-0.9043890604322891,-1.20982882073156,1415,1,ZPR1
ECTODERMAL PLACODE FORMATION%GOBP%GO:0060788,0.43487321986801,0.878651088001772,0.5408044290019051,1.02801232904209,3755,3,PROX1|HDAC2|HDAC1
WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002246,0.7531638481352891,0.9769690538700708,0.37218588655236995,0.788697446652755,6724,4,F2R
INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:0072332,0.14072262972018498,0.6296802030037281,-0.24217756297867202,-1.28210995732913,517,32,DDIT4|PML|MYBBP1A|POU4F2|BOK|TP53|BCL3|CDIP1|JMY|PMAIP1
SYNTHESIS OF RNA PRIMER INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1902981,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032656,0.4996367598982929,0.9143688619793578,-0.326040151384354,-0.9510735866739569,2750,7,RARA|LGALS9|TNFRSF21
POSITIVE REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0051000,0.24878191385694798,0.7613646381106121,0.36353712967406293,1.20451148229118,2552,14,INS|DHFR|S100A1|SCARB1|TERT|APOE
DEADENYLATION-INDEPENDENT DECAPPING OF NUCLEAR-TRANSCRIBED MRNA%GOBP%GO:0031087,0.365041208791209,0.850174896280676,-0.41958967571144895,-1.06216340187589,2125,5,EDC4|PNRC2|EDC3|DCP1B|DCP1A
NEGATIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901257,0.54627300410433,0.930420772651609,-0.721217468019409,-0.964794596705817,4125,1,HAVCR2
DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009262,0.849233168702885,0.991298302704726,-0.14332967247134698,-0.7335255899143229,3266,29,NUDT1|AK9|NUDT15|CMPK2|SMUG1|DERA|RRM2B|DCTD|NUDT18|CDADC1|NEIL2
ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING%GOBP%GO:0000478,0.00668523676880223,0.18239572673498103,-0.62648698771544,-1.94739433491185,35,8,KRI1|RRS1|NOL9|NOP14
SERTOLI CELL DEVELOPMENT%GOBP%GO:0060009,0.38368860055606996,0.8582519754973359,-0.8059108954565501,-1.07809157686944,2897,1,RAB13
DOUBLE-STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING%GOBP%GO:0097680,0.6817112778586629,0.965271928233355,0.399738302760909,0.847083648542576,6086,4,LIG4|ZBTB7A|UVRAG
CHAPERONE COFACTOR-DEPENDENT PROTEIN REFOLDING%GOBP%GO:0051085,0.7843873146931879,0.981487311948134,0.202252222215333,0.751063475891032,8359,20,HSPA2|DNAJB5
REGULATION OF MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034124,0.190186069487897,0.698434241409875,-0.548282137539293,-1.26093437618974,1154,4,CD300A|IRF7|IRF1|CD300LF
REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903719,0.136505845545859,0.62388141596544,-0.586367790741038,-1.3485234221821103,828,4,CX3CL1|SIRPA|DDRGK1
RECEPTOR LOCALIZATION TO NON-MOTILE CILIUM%GOBP%GO:0097500,0.516855190950834,0.922736477156771,0.454826848450697,0.9638215391913021,4614,4,TUB|BBIP1|ARL13B
"POSITIVE REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0045977",0.11355704697986599,0.589850135782669,0.943317159241288,1.2531547616899499,845,1,HES1
REPRODUCTION%GOBP%GO:0000003,0.0271653812026483,0.339785941813865,0.200904706185889,1.33832417854406,397,389,TAC1|HSPA2|INSL3|CITED1|TEKT3|MUS81|TBX3|GHRL|CATSPERG|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|WNT4|IDO1|ARNTL|SYCP2|GNRH1|EME2|MLH3|CRHBP|CCNA1|INHA|ZCCHC11|OXTR|BASP1|HERC4|CCT6B|CABYR|CDK1|E2F8|NCAPD3|GGT1|PYGO1|RHOXF1|CELF1|PKD2|USP9Y|PIWIL4|OVGP1|RAD54B|DNAJC19|BLM|TRIM27|RAD54L|C11orf80|EXO1|MTL5|BRIP1|EIF2B5|TSSK3|PDIK1L|SPATA25|DEAF1|ROBO2|JAG2|PCSK4|LIN9|DZIP1|TGFB2|WDR33|NUF2|CASC5|BUB1|TOP2A|E2F7|DAZAP1|TYRO3|TUBGCP3|MMP23B|YTHDC2|CCNE1|PKMYT1|ZNF830|FUT10|PTTG1|BUB1B|ZP3|ESPL1|LEF1|MSH6|KIT|DNAH1|RAD51C|RAD51|BMPR1B|PIM2|CLOCK|NCAPH2|NIPBL|MND1|TUBG2|EIF2B4|CENPI|FANCM|HEY2|CXADR|METTL3|REC8|TUBGCP6|FGF9|SRPK1|STX2|TRO|FANCF|MYBL1|STOX2|SLX4|TUBGCP2|MYCBPAP|EME1|ING2|RMI1|RACGAP1|TDRP|PEBP1|STRA13|NUP107|CDKL2|SPDYA|BRCA2|CEP57|CCNE2|CUL7|CEBPB|GATA6|BAG6|STAG3|CHD7|XRCC2|KMT2D|FGFR2|TOP2B|TEX14|MYCBP|WNT2B|P3H4|TUBGCP4|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|SGOL1|EGR1|PLA2G4B|ABHD2|AZIN2|ZNF35|PTK2|SMC3|GATA3|RAD1|C1orf111|FMN2|CDK2|ATM|ZCCHC6
REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033135,0.0169561621174524,0.277340114229305,-0.217731912351852,-1.50030633683036,40,78,CD44|PPM1F|TXN|RAMP3|NCK2|HAX1|IL11|VEGFA|CNKSR3|DDIT4|PRKD2|LIF|INPP5K|EIF4G1|RASSF2|IL6|TCL1A|ATP2B4|RIPK2|PDCD10|SMAD7|SNCA|STK4|DKK1|SFRP2|HSP90AB1|TNF|PDE4D|CAV1
HISTONE H2A MONOUBIQUITINATION%GOBP%GO:0035518,0.926102275973717,1.0,0.166935044817146,0.5988300389761271,9724,18,PCGF2|DDB2|DDB1|TRIM37|CUL4B|PCGF1|PCGF3|PCGF5|KDM2B|BCOR|COMMD3-BMI1|PCGF6
LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0042109,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060759,0.145518044237485,0.636418541205714,-0.154713452569067,-1.1891573162428,249,122,MUL1|TAF9|PYCARD|SOCS3|ELF1|HIPK1|HIF1A|IL1RN|RNASEL|PTPN6|IRAK1|CLIP3|MAPK7|IRAK2|TNFAIP3|CD300LF|NR1H3|IFNAR2|RNF113A|SPHK1|RUNX1|MAP2K5|IL6|PPARG|CYLD|SUMO1|RNF31|CDC37|MAVS|CNOT7|PTPN1|NR1H2|ADAM17|RBCK1|PARK2|TAX1BP1|CBFB|HSP90AB1|UBE2K|TNF|SPATA2|SLIT3
POSITIVE REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000549,0.424161073825503,0.8740879492662891,0.79471768857521,1.05574699440246,3159,1,CCL19
POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:2001280,0.49368993863610106,0.91071489001692,0.519080180875703,0.9867168186593058,4263,3,PTGS2|ANXA1|ABCD1
ACTIN FILAMENT-BASED PROCESS%GOBP%GO:0030029,0.8245350109409191,0.9876441563834109,0.125688559613798,0.8341073728241261,12057,370,NF2|RYR2|KCNN2|SCN1A|NEB|FSCN2|RHOBTB1|CACNA1G|ITGB1|FGD6|WASH1|IGSF22|GHRL|CACNB2|FGF12|SHROOM2|KCNQ1|BRSK2|ARAP1|RAC3|ACTN2|EVL|TTC17|HIP1R|ARFIP2|MYH3|PROX1|TRIM27|TCAP|CDC42BPA|ARHGAP25|FNBP1L|MYO19|PPP1R9A|TBCK|HSP90B1|FHDC1|PDPK1|CACNA2D1|JAK2|FRMD5|AMOT|FRMD3|TNNC2|ATXN3|SPTBN5|TNFAIP1|LIMA1|KCNH2|AMOTL2|FARP2|CTTN|OBSCN|SRC|FGD1|KRT19|CACNA1D|ANLN|MSRB2|ARHGEF17|ITGB5|CORO1A|CAPN10|GJA1|KIT|RUFY3|NF1|TNXB|KLHL17|RHOBTB3|NEBL|IQSEC3|CXADR|ARHGEF11|LMOD1|OBSL1|MICALL2|DPYSL3|SRF|SHTN1|FGD2|SYNE2|MYO5A|DMD|CDC42BPB|ANTXR1|MICAL3|NPHP4|RAC2|SCN3B|TESK1|RACGAP1|ARPC1A|ARHGEF18|EPB41|TNNI3|ALKBH4|EPB41L4A|MYO7A|EPB41L5|LLGL2|MYOM2|TPM2|TAOK2|ARHGAP17|SAMD14|KCTD13|DIAPH3
REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010594,0.0018094089264173699,0.11057424808264998,-0.21282846294324398,-1.64804358659586,2,126,VEGFA|KDR|BCAS3|DAB2IP|BCAR1|PTK2B|HMOX1|PRKD2|ABL1|GPI|MMRN2|ZNF580|RHOA|NRP1|HDAC5|AAMP|FGF2|MAP2K5|PPAP2B|ADAMTS9|PPARG|MEOX2|FOXC2|FOXP1|ETS1|TMSB4X|PDCD10|FGFR1|MAP2K3|ATOH8|ADAM17|STAT5A|PRKCA|NOS3|BMPER|PTPRM|ACVRL1|MET|SH3BP1|STC1|GLUL|ANGPT2
TRANSPORT ALONG MICROTUBULE%GOBP%GO:0010970,0.0145602795573675,0.262734483145539,-0.19195832836042198,-1.4702144216228898,24,121,OPA1|IFT52|KIF5A|IFT27|DCTN1|IFT22|IFT88|TTC26|RABL2B|MAP1A|IFT57|HIF1A|BLOC1S1|HSPB1|SOD1|DYNC2H1|LOH12CR1|IFT46|IFT122|RAB21|BLOC1S5|WDR35|IFT172|RPGR|BLOC1S4|RAB6A|HAP1|RAB1A|DYNLRB2|WDR19|AP3S2|FMR1|CDC42|TRAF3IP1|BLOC1S6|BAG3|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B|TRAK1|HTT|BLOC1S3|KIF13A|BICD1|TMEM108|UBB
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0035850,0.638510618036378,0.9603247716620201,0.241376223635278,0.8658657237954499,6704,18,BASP1|BMP4|PTPRO|ACTA2|MAGI2
NEGATIVE REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901223,0.6501075268817211,0.963755998259649,-0.21431626514468,-0.8547124121926579,3022,15,CYLD|PPM1A|TMSB4X|NLRP3
VIRAL GENOME REPLICATION%GOBP%GO:0019079,0.9232414448669202,1.0,-0.138129751384165,-0.639919279514293,3884,22,HTATSF1|PCBP2|CTBP1|CDC42|RAB5A|PCBP1
REGULATION OF SYNAPTIC ACTIVITY%GOBP%GO:0060025,0.785653804282085,0.981487311948134,0.491976840363937,0.8041226301804342,6494,2,STX1B|MEF2C
REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034315,0.37697307335190294,0.853714761067216,-0.33636714656075895,-1.04557554826728,2029,8,WASF1|PICK1|NCKAP1|ABI2|CORO1B|ARF1|CYFIP1|BRK1
MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:0035278,0.851457840819543,0.991298302704726,-0.206211641476452,-0.697644848870135,4321,10,AGO2|STAT3
PIGMENT GRANULE MATURATION%GOBP%GO:0048757,0.10454967502321301,0.576535954147525,-0.45371784859952397,-1.4103526255719,562,8,CD63|AP1G1|AP1M1|BLOC1S5|BLOC1S6|BLOC1S3
MALE GENITALIA DEVELOPMENT%GOBP%GO:0030539,0.0318120805369128,0.36484755247355394,0.9839545655050731,1.30713974294816,236,1,TBX3
PYRIMIDINE NUCLEOSIDE TRANSPORT%GOBP%GO:0015864,0.236361437038829,0.7504566255368191,0.7157981803143101,1.16995246159742,1953,2,SLC29A2|SLC29A1
AMMONIUM ION METABOLIC PROCESS%GOBP%GO:0097164,0.814139110604333,0.986276922067025,0.137281720712434,0.78309532741802,10709,114,ENPP2|SNCAIP|CROT|LPCAT4|AKR1B1|CBR4|STARD10|MFSD2A|PLA2G4A|CEPT1|ABHD3|RARRES3|ACADM|TGFB2|BCHE|SULT1A3|AKR1C1|CHKB|SAT2|CETP|CPT1B|SMPDL3A|SARDH|SMPD3|DRD4|TH|ACER2|ALDH9A1|SMPD1|MOXD1|PLA2G2D|SLC44A3|LCAT|LRTOMT|PLA2G12A|CPT1C|PLA2G4B|AZIN2|SMPD4|TMEM86B|LPCAT2|COMT
DATP METABOLIC PROCESS%GOBP%GO:0046060,0.32917594654788396,0.828303707528737,-0.6620898814447199,-1.1324692829453,2216,2,SAMHD1|NUDT1
POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0045723,0.9153737658674191,1.0,0.207860814284544,0.613450964110978,9085,10,SLC45A3|PTGS2|LPGAT1
RESPONSE TO MUSCLE STRETCH%GOBP%GO:0035994,0.126171279145783,0.607607158836689,0.587682105135957,1.35452013346073,1157,5,RYR2|TCAP|DMD|SLC8A1
POSITIVE REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905448,0.146040990032478,0.637320894898416,0.6166495143603001,1.3067392263601998,1303,4,CCNB1|CDK1|PINK1
BLOOD VESSEL ENDOTHELIAL CELL FATE SPECIFICATION%GOBP%GO:0097101,0.0686567164179105,0.5037729184803449,-0.743410168743796,-1.5087288497794098,436,3,DLL1|NRP1|RBPJ
POSITIVE REGULATION OF HH TARGET TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0007228,0.926575541308818,1.0,0.417314585056521,0.6820892249725979,7659,2,STK36|SMO
NEURON PROJECTION GUIDANCE%GOBP%GO:0097485,0.6463748290013679,0.963344312748158,-0.117487641826981,-0.9322344976510691,944,143,ALCAM|PLXNA1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|MAPK3|PTPRM|EFNB1|SEMA3A|DOK5|PTPRA|PIK3R1|GFRA2|SLIT3|EPHB2
RESPONSE TO BRONCHODILATOR%GOBP%GO:0097366,0.7577627388535029,0.977664504547119,0.25098292860322097,0.76569138257026,7613,11,DPEP1|MTR|CCL19|DRD4|EGLN1|CDK2
RESPONSE TO SORBITOL%GOBP%GO:0072708,0.513604260738682,0.919851565340177,0.510973861255101,0.9713075578133571,4435,3,MAPK13|CDT1|KAT7
POSITIVE REGULATION OF EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1901189,0.0139017608897127,0.256136946817111,-0.993659020732245,-1.32924796844308,104,1,RBPJ
D-RIBOSE CATABOLIC PROCESS%GOBP%GO:0019303,0.8740939597315441,0.9934031064448321,0.563575209528011,0.748684522985326,6511,1,NUDT5
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002584,0.46994895438827594,0.897155577363025,-0.423647493520101,-0.97430073203476,2853,4,HLA-DOB|HFE|HLA-DOA|TAPBPL
"ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT, AGAINST ELECTROCHEMICAL GRADIENT%GOBP%GO:0015988",0.353414948453608,0.842847021021096,0.446525422053129,1.09816424537694,3290,6,NDUFS7|MT-CO1|ATP1A3|MT-ND4|ATP1A1|ATP6V1H
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905564,0.669187898089172,0.964618776001639,0.27402731213636605,0.835994514285916,6723,11,SIRT6|PDPK1|ITGA4|PLCG1|AKT3|SP1
INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032616,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
MITOTIC SPINDLE MIDZONE ASSEMBLY%GOBP%GO:0051256,0.0429447852760736,0.4089601731625301,0.5753114606952879,1.56845338842505,412,8,KIF4A|MAP10|KIF23|AURKB|RACGAP1
POSITIVE REGULATION OF VIRAL PROCESS%GOBP%GO:0048524,0.10971293747542302,0.584830174998513,-0.18936067926641104,-1.2816037262884,278,73,CTDP1|ZNF639|CDK9|C9orf69|LGALS9|VPS4A|DDX3X|RSF1|TBC1D20|P4HB|VPS4B|PPIH|CNOT7|FMR1|PDE12|JUN|CAV2|RAB7A|VAPB|CHMP4B|STAU1|PABPC1|PC
REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034765,0.000977517106549365,0.0849637591935908,-0.199879736634553,-1.6889748523626,0,201,CRHR1|SCN1B|DNAJC30|FYN|KCNE4|SESTD1|SLC9A1|PLN|RANGRF|UBASH3B|YWHAH|SLC30A1|KCNAB1|PRNP|APLNR|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|BIN1|CRACR2A|ATP2B4|CEMIP|CAB39|TMSB4X|KCNAB2|CRH|AMIGO1|SNCA|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|SNTA1|RELN|COMMD1|FXYD5|YWHAE|KCNG1|ANO6|HTT|ADRA2A|JPH1|PER2|SLC9A3R1|CACNG3|SCN5A|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
REGULATION OF MRNA EXPORT FROM NUCLEUS%GOBP%GO:0010793,0.281894329896907,0.7899371443259041,0.4735807805769171,1.16470295943283,2624,6,TPR|AKAP8L|SUPT6H|ZC3H3
TOR SIGNALING%GOBP%GO:0031929,0.668782035635831,0.964618776001639,-0.17768566090652696,-0.851729460751575,2739,24,TIPRL|CLEC16A|PRR5L|RPS6KB1|GATA3|AKT1|PINK1|LARP1|MLST8|CCDC88A|MTOR|RPS6|FNIP1|EIF4EBP2|RPTOR|NPRL3|AKT1S1|RHEBL1|SYAP1|FLCN|MAPKAP1|EIF4EBP1|PRR5
REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033182,0.6237194641449959,0.9536478716552259,-0.254316765046616,-0.860391682282146,3165,10,KDM1A|RNF40|UBR5|CTR9|OTUB1|UBE2N|RNF20|CDK9|WDR70|TRIP12
PRONEPHRIC NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0039008,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
PRE-MIRNA PROCESSING%GOBP%GO:0031054,0.443386035549445,0.8808089923737601,0.31529593223477803,1.01757716929298,4514,13,LIN28B|ZCCHC11|DROSHA|DICER1|TARBP2|ZCCHC6|AGO4
CELLULAR MAGNESIUM ION HOMEOSTASIS%GOBP%GO:0010961,0.917986577181208,1.0,0.54333921482135,0.721801906809255,6838,1,SLC41A1
ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY%GOBP%GO:0030952,0.293962678375412,0.8004058897916541,-0.271331496488709,-1.11119367005186,1338,16,RND1|MAPKAP1|RHOA|RND2|RHOC|LMNA|AQP1
EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:0030198,0.952192096913758,1.0,0.11005269363680499,0.677996395126165,13204,188,ITGB1|WASH1|COL9A2|CD47|COL18A1|ELN|LAMC3|VCAN|ITGA1|MADCAM1|TNC|ITGA9|MMP11|MPV17|DDR2|ITGA2|ST7|DPT|ITGA4|TGFB2|COL8A1|LAMA1|DDR1|LAMB2|LOXL3|FBN1|COL4A2|ITGA11|ITGB5|LOXL2|BSG|NF1|TNXB|FBLN5|ITGA2B|COL4A1|COL5A2|KLKB1|COL27A1|MFAP4|COL28A1|COL5A1|COL11A2|ITGA10|FN1|LAMA2|NID1|SPARC|AGRN|P3H4|THBS1|HTRA1|MFAP2|SPOCK2|ITGA3|ICAM3|COL12A1|SERPINE1|ITGA8|BGN|COL11A1|SULF1
DOUBLE-STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION%GOBP%GO:1990918,0.230201342281879,0.743397546142977,0.8864689016321129,1.17763438763674,1714,1,BRIP1
INDOLE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042436,0.7587605282312571,0.977664504547119,0.28037308805252503,0.764372257503298,7296,8,IDO1|CCBL1|AFMID|AADAT
PHOSPHATIDYLETHANOLAMINE ACYL-CHAIN REMODELING%GOBP%GO:0036152,0.781946970422131,0.981487311948134,0.21520281244691,0.7460497899246429,8168,16,LPCAT4|PLA2G4A|RARRES3|PLA2G2D|PLA2G12A|PLA2G4B|PLA2G4C|PNPLA8
RESPONSE TO AMINO ACID%GOBP%GO:0043200,0.741601343784994,0.974505008828563,-0.14871944537175,-0.8180896100147299,2648,36,GRIN1|KLHL22|RRAGB|GATS|LAMTOR4|UBR2|IREB2|NEURL1|LAMTOR3|LARS|LAMTOR1|XBP1|MTOR|CPEB4|SESN1|CAPN2|GLRB|SESN3|GATSL2|RPTOR|RRAGA|SLC38A9|IPO5|LAMTOR2|TMBIM6|UBR1|GATSL3|RRAGD|CPEB1|NSMF|RRAGC|FYN|SH3BP4|LAMTOR5|SESN2
GLUTAMINE CATABOLIC PROCESS%GOBP%GO:0006543,0.0302407161001573,0.35738308321874895,0.886186931348222,1.4484481943095402,249,2,GLS|GLS2
POSITIVE REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051549,0.010441292356185999,0.22344045136759502,-0.551012683544662,-1.8641583840015101,52,10,ARF6|MAPRE2|EPB41L4B|FGF7|MMP9|MAP4K4|IQSEC1|FGF10
REGULATION OF RAL PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032485,0.366577181208054,0.8510019955058101,0.8217909131010149,1.0917125653628101,2730,1,RALGPS1
PROTEIN IMPORT INTO MITOCHONDRIAL INTERMEMBRANE SPACE%GOBP%GO:0045041,0.798515219005197,0.98372465535558,-0.439316239316239,-0.751426899077637,5377,2,HSPD1|CHCHD4
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002639,0.438305709023941,0.878999860395433,-0.224971121989526,-1.0037998843611702,1903,20,GPI|C20orf196|IL6|VAMP3|TFRC|TNFRSF4
RESPONSE TO EPINEPHRINE%GOBP%GO:0071871,0.44826869085993604,0.8850378987593649,0.37006965909271206,1.00890917426846,4310,8,RYR2|KCNQ1
STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0051403,0.6087135224003289,0.9508825506493929,-0.13419008960669598,-0.9215002482778771,1480,77,IRAK1|PKN1|MAP3K8|DAB2IP|TRIB1|LGALS9|IRAK2|MAP3K13|UBE2V1|RIPK2|MAP2K3|DBNL|MLKL|UBA52|MAPK3|TNIP2|MAP3K11|UBC|UBB|ADORA2B
RENAL CORTEX DEVELOPMENT%GOBP%GO:0072055,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009204,0.956722508591065,1.0,0.22916551762175302,0.563599215848376,8908,6,DUT|NUDT16|SAMHD1|DCTPP1|NUDT1|NUDT15
CALCIUM IMPORT INTO THE MITOCHONDRION%GOBP%GO:0036444,0.512690355329949,0.9189160303470669,-0.291758605472198,-0.9418229235798091,2625,9,MICU1|MCUR1|MICU2|MCU|C2orf47|SMDT1|AFG3L2|SLC25A23|CCDC109B
MITOCHONDRIAL ALANYL-TRNA AMINOACYLATION%GOBP%GO:0070143,0.738657718120805,0.9744283926676119,0.634428760476401,0.8428103044192501,5502,1,AARS2
GLUTAMINE TRANSPORT%GOBP%GO:0006868,0.47379361544172205,0.8998407605598371,-0.57601323407775,-0.9852397875944509,3190,2,SLC1A4|SLC1A5
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION%GOBP%GO:0097345,0.0242537313432836,0.327248680533432,-0.46701089823835706,-1.70136754811536,116,12,BNIP3L|BMF|BCL2L11|PMAIP1
MEMBRANE DISRUPTION IN OTHER ORGANISM%GOBP%GO:0051673,0.29503355704698,0.800447413278835,0.856252756947508,1.1374935874610201,2197,1,GSDMD
REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904776,0.0478951890034364,0.431082731024951,0.622729095160121,1.53151151779084,445,6,GNAI1|SAPCD2|NUMA1|GPSM2|EPB41|EPB41L2
HISTONE H3-K27 DEMETHYLATION%GOBP%GO:0071557,0.5742340926944229,0.941759834532812,-0.44513069372449504,-0.903379517500139,3654,3,PHF8|KDM6B|KDM7A
PLATELET FORMATION%GOBP%GO:0030220,0.6807887543928149,0.965038308781941,-0.255295675198588,-0.8241173171350649,3486,9,CASP9|VPS33A|NBEAL2|ZFPM1|MEF2C|CIB1|ACTN1|CASP3|MYH9
NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030835,0.20107906204606799,0.71430080363469,-0.325799865463568,-1.2269560658762801,968,13,CAPZA1|GSN|CAPZB|TRIOBP|CAPZA2|ADD1|TWF1|TWF2
DEOXYNUCLEOTIDE TRANSPORT%GOBP%GO:0030302,0.172751677852349,0.676505210903938,0.91470004411116,1.2151382009395901,1286,1,SLC25A19
HOMOGENTISATE CATABOLIC PROCESS%GOBP%GO:1902000,0.957852348993289,1.0,0.52348919276577,0.695432038080685,7135,1,FAH
"REGULATION OF TRANSLATION, NCRNA-MEDIATED%GOBP%GO:0045974",0.851457840819543,0.991298302704726,-0.206211641476452,-0.697644848870135,4321,10,AGO2|STAT3
SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:0008295,0.249740163325909,0.7613646381106121,-0.707306313757927,-1.20980956877982,1681,2,SRM|AMD1
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903747,0.000364963503649635,0.0784645998831315,-0.363296798037307,-2.35235484738173,0,63,FBXW7|HPS4|HAX1|TP53BP2|GZMB|UBL5|PARL|BBC3|ATG13|BAG4|VPS11|YWHAH|CSNK2A2|SH3GLB1|RNF31|BID|BAP1|LEPROT|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|UBE2D3|SIAH3|ARIH2|PARK2|PMAIP1|TFDP2
POSITIVE REGULATION OF GLOMERULAR METANEPHRIC MESANGIAL CELL PROLIFERATION%GOBP%GO:0072303,0.6645637583892621,0.964618776001639,0.6734671371857079,0.8946710462521049,4950,1,EGR1
POSITIVE REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0060559,0.113140311804009,0.588848744118853,-0.7965260545905709,-1.36241515717039,761,2,IL1B|TNF
CELLULAR DETOXIFICATION OF NITROGEN COMPOUND%GOBP%GO:0070458,0.10840534171249,0.58452352834625,-0.702197877019139,-1.42508972819518,689,3,GSTM3|GSTM1
POSITIVE REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045579,0.319818871103623,0.8219996514077841,0.433590733590734,1.12854558207293,3036,7,CD27|BTK|XBP1|NCKAP1L|PPP2R3C|MMP14|SYK
PULMONARY VEIN MORPHOGENESIS%GOBP%GO:0060577,0.11981993909704801,0.6056190749402529,-0.938795765328628,-1.25585571892303,904,1,TBX20
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035023,0.129042192793348,0.6096268978024549,-0.21734515024922305,-1.27737271271438,418,45,ARHGDIB|ARAP3|FAM65B|KANK2|RASIP1|CUL3|MYO9B|FLCN|OPHN1|ARHGDIA|HEG1|LPAR1|DLC1|ABL1|EPS8L1|NRP1|ARRB1|ABCA1|PDCD10|ARHGEF2|AKAP13|GPR4|RAC1|MET
MEIOSIS I CELL CYCLE PROCESS%GOBP%GO:0061982,0.0031571950814224,0.13580859154139302,0.3797489882979339,1.8601305502506,37,54,MUS81|SYCP2|EME2|MLH3|CCNA1|RAD54B|BLM|C11orf80|BRIP1|TOP2A|CCNE1|PTTG1|MSH6|RAD51C|RAD51|MND1|FANCM|REC8|MYBL1|SLX4|EME1|ING2|RMI1|STRA13|CCNE2|BAG6|STAG3|TOP2B|P3H4|UBR2|FMN2|ATM
REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051489,0.949249275616823,1.0,0.134571728355277,0.585253128021579,10810,34,TENM1|ARAP1|FNBP1L|TENM2|CCL21|PALM|DPYSL3|GAP43
INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0060080,0.843879493784298,0.991298302704726,0.33435040621084305,0.708520449575667,7534,4,DRD4|NPAS4|NLGN3
NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1901799,0.44127568230604103,0.880402968441571,-0.17417914564641301,-1.00693152730989,1438,43,ERLEC1|CCAR2|PARK7|RPL11|RYBP|MAP1A|TAF9|OPHN1|UBE2J1|STYX|FAM192A|OS9|GLTSCR2|BAG5|DDRGK1|HSP90AB1|GABARAPL2|PSMF1
ACYLGLYCEROL ACYL-CHAIN REMODELING%GOBP%GO:0036155,0.747004143801098,0.9749763305090959,0.37553871985527204,0.7958024207009301,6669,4,DGAT1|PNPLA2
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0055015,0.30600903091351195,0.809555201431097,0.592981347079056,1.1271951615009999,2642,3,PROX1|HEY2|MEF2A
REGULATION OF POSITIVE THYMIC T CELL SELECTION%GOBP%GO:1902232,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
REGULATION OF WOUND HEALING%GOBP%GO:0061041,0.0900294488851494,0.560121322881739,-0.188082827596552,-1.30310614281631,213,80,FCER1G|PRKCD|USF1|TNFAIP3|PDPN|PLAU|FGF2|PPAP2B|HBEGF|LYN|SERPINF2|FOXC2|CRK|PLAUR|THBD|PROC|PRKCA|CD9|NOS3|ANO6|CDKN1A|ADRA2A|DUSP10|CAV1|ENPP4
RESPONSE TO GLYCINE%GOBP%GO:1905429,0.9662513608322242,1.0,0.368580928491178,0.602435402108408,7987,2,GRIN1
CELL MIGRATION INVOLVED IN HEART FORMATION%GOBP%GO:0060974,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
LINOLEIC ACID METABOLIC PROCESS%GOBP%GO:0043651,0.404896232117671,0.8661181219453299,0.355228952649352,1.04837241320805,4018,10,FADS2|FADS1|GSTP1|ELOVL2|GSTM2|PNPLA8|ABCD1
REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING%GOBP%GO:0006349,0.32293407613741903,0.8233331762466272,-0.35412874400132394,-1.10078632664413,1738,8,PCGF3|DIRAS3|PRMT7|PCGF5|PCGF6|DNMT3A|KDM1B|IGF2
ELASTIC FIBER ASSEMBLY%GOBP%GO:0048251,0.588799302680323,0.945418171231938,0.3930638336848661,0.905953868270741,5403,5,TNXB|FBLN5|MFAP4
POSITIVE REGULATION OF TRAIL PRODUCTION%GOBP%GO:0032759,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
NEGATIVE REGULATION OF CHEMOTAXIS%GOBP%GO:0050922,0.640353891084006,0.960849940223088,0.19120380116289398,0.873212536878846,7454,41,SEMA3D|CXCL13|NOV|PTPRO|KLRK1|ROBO2|SEMA5A|SEMA3E|SEMA4G|CCL2|SEMA6A|SEMA4C|C5
SENSORY PERCEPTION OF TEMPERATURE STIMULUS%GOBP%GO:0050951,0.7638728799604809,0.978421368343614,-0.3332598025699,-0.7664279254993559,4638,4,TRPV1|MMP24|EPHB1|ANO1
VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070561,0.39083807758506606,0.8608417878556021,-0.802216585796207,-1.0731495861982399,2951,1,PIM1
PURINE RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009181,0.49339272457312605,0.910654969509744,-0.5652562806304671,-0.9668405948284491,3322,2,NUDT18
POSITIVE REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010800,0.103310375472117,0.5756137190742839,-0.319628383329944,-1.37497029051923,464,18,SPHK1|CEMIP|RIPK2|CAB39|CHI3L1|UBE2K
MODULATION BY HOST OF VIRAL EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:0044866,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032230",0.7113585746102449,0.9703327035763342,-0.474967643548635,-0.812406716650072,4790,2,HAP1
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, REM SLEEP%GOBP%GO:0042320",0.624175060784995,0.9536478716552259,0.47289770954615795,0.8989287988754692,5390,3,GHRL
REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070099,0.569197239375227,0.940076901516441,-0.308297335911582,-0.899317006762759,3133,7,HIF1A|RNF113A|SLIT3
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901028,0.000284900284900285,0.0784645998831315,-0.431413523572229,-2.39648331238446,0,37,GSK3B|NMT1|SFN|CHCHD10|YWHAG|MUL1|SLC25A5|ZNF205|BAX|TP53BP2|GZMB|BBC3|MPV17L|YWHAH|BOK|BID|ACAA2|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|SLC35F6|PMAIP1|TFDP2
REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION%GOBP%GO:1902460,0.792532768436383,0.9819233677232551,-0.6006837229819139,-0.803552930926083,5985,1,LTBP3
POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0035774,0.9845868152274839,1.0,-0.164889628867256,-0.512548760689762,5301,8,BAIAP3|PPP3CB|GPLD1|STX4|TRPM4|C2CD2L|ANO1
REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900084,0.0052692244360283205,0.16770443270936902,-0.8162319274571741,-1.8771629163290102,31,4,GREM1|ACE|CAV1
PLUS-END-DIRECTED VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072383,0.17239010989010997,0.6757284283763572,-0.505267055804985,-1.27905000031199,1003,5,KIF3B|KIF13A
CELLULAR RESPONSE TO VITAMIN%GOBP%GO:0071295,0.0824962950765684,0.5415065964181729,-0.646831743230574,-1.48757788154591,500,4,SFRP1|POSTN|GAS6|PIM1
DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS%GOBP%GO:0046545,0.41964854775562205,0.8725068208993679,0.259116915033726,1.0325436323600798,4608,25,INHA|EIF2B5|ROBO2|ZNF830|KIT|BMPR1B|EIF2B4|FANCF|NUP107|BRCA2|CEBPB
REGULATION OF GRANULOSA CELL APOPTOTIC PROCESS%GOBP%GO:1904708,0.212630742751225,0.7279184739702909,-0.8928098808998679,-1.1943389992248201,1605,1,BOK
PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0018107,0.591256471361657,0.945418171231938,0.18306965178773002,0.915448174215794,7194,59,MYLK2|STK39|MAP3K10|CDC7|CDK1|MARK2|PDPK1|CDK5R1|CAD|CDK10|PRKCB|NLK|TBK1|ULK1|SBK1|VRK2|MAP3K12|VRK1|VRK3|CHEK1|GSK3A
CELLULAR RESPONSE TO TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071727,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|CD14|TLR1
POSITIVE REGULATION OF RRNA PROCESSING%GOBP%GO:2000234,0.578875439281531,0.942692029750853,-0.27643420412163106,-0.892354382767648,2964,9,UTP15|TRMT112|WBSCR22|WDR43
CHROMATIN REMODELING AT CENTROMERE%GOBP%GO:0031055,0.0347473702362476,0.37986475421241106,0.345024197615268,1.55614816353937,402,39,RBBP7|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|HELLS|CENPV|CENPQ|CENPI|MIS18BP1|NASP|HJURP|STRA13|CENPM
ISOCITRATE METABOLIC PROCESS%GOBP%GO:0006102,0.819364399802404,0.987153241368501,-0.315741943282603,-0.7261405087475671,4975,4,IDH3B
MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0006264,0.04065716959550799,0.401998427404428,0.579280823229425,1.57927493560756,390,8,POLG|TEFM|DNA2|MGME1|PRIMPOL|POLG2
POSITIVE REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002894,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0010803,0.8627016766845942,0.991943445125448,-0.12376232361071302,-0.739188166111369,2726,47,CYLD|RNF31|ADAM17|RBCK1|PARK2|TAX1BP1|TNF|SPATA2
REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000977,0.0136688036772711,0.256136946817111,0.919602977667494,1.5030658040258997,112,2,HES1|PROX1
NEGATIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010642,0.220449172576832,0.7354368651705759,-0.35792356767075606,-1.21090900342422,1118,10,APOD|PTPN12|SNCA|SLC9A3R1
CELLULAR RESPONSE TO INTERFERON-ALPHA%GOBP%GO:0035457,0.852548330404218,0.991298302704726,-0.253451284427607,-0.695706757744554,4850,6,IFNAR1|PDE12
PROMOTER CLEARANCE DURING DNA-TEMPLATED TRANSCRIPTION%GOBP%GO:0001109,0.863497947835297,0.991943445125448,-0.565560211733569,-0.7565671390222909,6521,1,ERCC3
RESPONSE TO CHEMOKINE%GOBP%GO:1990868,0.607699514521761,0.9508825506493929,0.193551184731785,0.897322655024176,7134,43,CXCL13|SLC12A2|STK39|CXCR4|CXCL9|DOCK8|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CCL3L3|CCL11|DUSP1|CCL4L2|CXCL11|XCL1|WNK1|CCR1|CCL4|CXCL2|CCL8|CXCL1|CCL24
CORPUS CALLOSUM MORPHOGENESIS%GOBP%GO:0021540,0.9828644205163829,1.0,0.27721407301202194,0.52695479096997,8488,3,SZT2|PAFAH1B1|C12orf57
"CARNITINE METABOLIC PROCESS, COA-LINKED%GOBP%GO:0019254",0.5657433168017421,0.938711057965499,0.5797077474496829,0.947516387703082,4676,2,ACADM|CRAT
REGULATION OF MATRIX METALLOPEPTIDASE SECRETION%GOBP%GO:1904464,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
NEURONAL DENSE CORE VESICLE EXOCYTOSIS%GOBP%GO:0099011,0.0416112253538164,0.402998391331252,0.8712985938792389,1.4241136157230498,343,2,UNC13B|UNC13A
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061418,0.0005145356315924879,0.0784645998831315,-0.4399094492021961,-2.22429030960627,1,28,CREBBP|HIF3A|HIF1A|NOTCH1|VEGFA|LIMD1|HIGD1A|CITED2|BACH1|VHL|TCEB1|UBA52|UBC|EPAS1|RBPJ|UBB|EGLN3
CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:0055007,0.29789332138054697,0.8023890191280308,0.27510252071195695,1.1395672796519098,3322,29,NEB|IGSF22|MAML1|PROX1|TCAP|NEBL|HEY2|CXADR|OBSL1|NRG1|SLC8A1|MYOM2
ARGININE BIOSYNTHETIC PROCESS%GOBP%GO:0006526,0.44212086283550106,0.880423444399886,-0.43291816923272497,-0.9956213494617991,2684,4,ASS1|ASL
ORGANELLE MEMBRANE FUSION%GOBP%GO:0090174,0.8585140419480981,0.99166790097654,-0.11928369473816698,-0.7629974266354219,2414,60,RAB8B|VPS4A|TAPBP|VPS11|STX8|STX11|RAB39A|RAB8A|CAV2|RAB7A|VTI1A|SNAP25
REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:0019430,0.322375590265165,0.822751772025005,-0.37342224188541395,-1.0892892468177,1774,7,SOD1|SOD3|SOD2|NOS3
POSITIVE REGULATION OF VACUOLE ORGANIZATION%GOBP%GO:0044090,0.24369582348305802,0.75705243532225,-0.350030765771045,-1.1842064732030302,1236,10,SH3GLB1|PIP4K2A|RALB
REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902036,0.7692490494296579,0.9792236089291529,-0.16847916091636803,-0.7805202151340028,3236,22,TAL1|METTL3|N4BP2L2|TCF12|GATA3|LDB1|YAP1|MYB|LMO1|KMT2A|PUS7|SETD1A|LMO2|TCF3|EIF2AK2|GATA2|YTHDF2|FOXC1|ITCH|ABL1|RUNX1|CBFB
NEGATIVE REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901078,0.0155902004454343,0.264809548283936,-0.915963606286187,-1.56670669267963,104,2,PDE4B|PDE4D
ADP METABOLIC PROCESS%GOBP%GO:0046031,0.00617442757910985,0.17908002651075003,-0.362155202585848,-1.83114572588994,23,28,AK5|PGAM1|PFKP|ENO3|AK9|LDHA|PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
D-GLUCONATE CATABOLIC PROCESS%GOBP%GO:0046177,0.11073825503355698,0.584830174998513,0.944309660344067,1.25447325512638,824,1,IDNK
MICTURITION%GOBP%GO:0060073,0.387617322575333,0.859991269020751,-0.452610715871731,-1.04091009281442,2353,4,CHRNB4|CHRNB2|CHRNA3
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086054,0.8529061300145641,0.991298302704726,-0.5721217468019411,-0.765344704542779,6441,1,GJA5
TRNA TRANSCRIPTION%GOBP%GO:0009304,0.547388374052233,0.9305779599215391,0.35705983013858295,0.92935171953873,5197,7,BRF1|GTF3C5|GTF3C3|GTF3C1|GTF3C2|GTF3C6|GTF3C4
POSITIVE REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905464,0.20200798354904997,0.716083967316356,0.7324338415649692,1.19714299290328,1669,2,GTF2H2|POT1
POSITIVE REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060340,0.32709478021978,0.827662288375761,-0.43355109210952103,-1.09750580040187,1904,5,MAVS|UBE2K
POSITIVE REGULATION OF HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070368,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
POSITIVE REGULATION OF POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030862,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902229,0.824492702029192,0.9876441563834109,0.17119360176110202,0.723634127701038,9263,31,SIRT1|FBXO18|AK6|MARCH7|MUC1|TMEM161A
NEGATIVE REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903122,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
REGULATION OF GOLGI INHERITANCE%GOBP%GO:0090170,0.15708875349909399,0.6578589353509621,-0.5713178074214339,-1.3139116045986599,953,4,MAPK3|MAP2K1
RETINOID METABOLIC PROCESS%GOBP%GO:0001523,0.015660542432196,0.26545981905793,0.38285337389665797,1.6899287306476,178,36,ALDH1A2|RBP1|BCO2|RARRES2|NAPEPLD|ALDH1A1|GPC2|ALDH8A1|GPC6|AKR1C1|GPC1|APOE|LRP8|GPC3|RDH11|APOM|AGRN
PROTEIN O-LINKED GLYCOSYLATION VIA THREONINE%GOBP%GO:0018243,0.156486941870261,0.6578589353509621,0.5072200964440561,1.32018734404239,1485,7,GALNT13|GALNT3
REGULATION OF AGGREPHAGY%GOBP%GO:1905335,0.0007855459544383349,0.0849637591935908,-0.926271092974523,-1.8798396624690101,4,3,BAG3|HTT|HSPB8
REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045664,0.462715105162524,0.891507554237553,-0.11077467359468302,-1.00426518440235,241,312,ARHGDIA|ID2|RNF6|FZD1|ZEB1|CHRNB2|VEGFA|NEDD4L|IMPACT|CX3CL1|ADRA2C|DNM2|LPAR1|DAB2IP|TUBB2B|RTN4|NSMF|PTK2B|SRGAP2C|ABL1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|RHOA|SERPINI1|NRP1|CPNE6|SEMA7A|PTK7|YWHAH|LYN|EFNA1|ULK4|KIF13B|POU4F2|BAG5|ISLR2|ARC|BIN1|SPOCK1|TCF4|RAP1A|LIMK1|AMIGO1|ARHGEF2|FMR1|TWF1|C21orf91|FGFR1|NEDD4|SEMA6B|PLXNA1|CHRNA3|RAPGEF1|ID1|SSH3|PLXNA4|RELN|DKK1|TWF2|ADCYAP1|COBL|NCS1|SYT2|FKBP4|ASCL1|SDC2|FBXO7|STK24|MYLIP|ZNF365|SEMA3A|SEMA3G|CPNE9|PCP4|OLFM1|GPRC5B|NBL1|LINGO1|FOXO6|RTN4RL2
ENTERIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035645,0.9439957632728722,1.0,-0.525529333921482,-0.7030166132418301,7129,1,EDNRB
REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046719,0.966400290592081,1.0,-0.19420911199853896,-0.5665165959743149,5320,7,TBC1D20|STAU1
DESENSITIZATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY BY ARRESTIN%GOBP%GO:0002032,0.0840386043058649,0.545178773025535,-0.8248138957816379,-1.41079999452784,565,2,ARRB2|ADRB2
REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1905897,0.0107327905255366,0.225852279407131,-0.24051242081398003,-1.58820575639258,28,67,PPP1R15B|NCK2|BAX|DNAJC3|CREB3|CLU|DAB2IP|UBE2J1|HSPA5|OS9|MAGEA3|EIF2AK3|DDIT3|FCGR2B|BCL2L1|BOK|ATF6|PTPN1|PARK2|BFAR|BCAP31|PIK3R1|BCL2L11|PMAIP1|TMEM33|CAV1
POSITIVE REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051461,0.420632163945815,0.8727872721376851,0.546461876834298,1.0387665422303,3632,3,GHRL|UCN
CELLULAR OXIDANT DETOXIFICATION%GOBP%GO:0098869,0.179078014184397,0.68489956912038,-0.376286047746375,-1.27303202201577,908,10,SOD1|SOD3|SOD2|NOS3|SESN2
POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0045989,0.0229801393365915,0.317409580945197,0.609538171695432,1.6617645850731102,220,8,RGS2|KCNQ1|ATP2A1
SOMITE SPECIFICATION%GOBP%GO:0001757,0.0896332583079571,0.559264258791054,-0.9533524481693871,-1.2753286373886499,676,1,COBL
PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902946,0.7472502026166491,0.9749763305090959,0.426068372109003,0.8099111546688291,6453,3,LRRC7|SCRIB
REGULATION OF ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0010510,0.9535198086721429,1.0,0.20634994721185104,0.562565316384647,9169,8,PDK4|GSTZ1|PDP1|PDK1
"O-GLYCAN PROCESSING, CORE 1%GOBP%GO:0016267",0.21954759888714198,0.734713083559597,0.723747165213333,1.18294485904349,1814,2,C1GALT1C1|C1GALT1
DERMATAN SULFATE CATABOLIC PROCESS%GOBP%GO:0030209,0.46153846153846206,0.891063005541905,-0.768416409351566,-1.0279340596095001,3485,1,IDUA
HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:0070814,0.5328238971865229,0.9265056012720759,0.5037541908134611,0.9575837237846221,4601,3,CTH|MPST
NEGATIVE REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061086,0.221973345279427,0.73556947110949,0.5731513594161539,1.2145624808733,1981,4,MTF2|SUPT6H|PHF1|H2AFY
REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0098903,0.20092850510677804,0.714072311818316,-0.4001573277511521,-1.2438632061261699,1081,8,DLG1|CAV1
RESPONSE TO MANGANESE ION%GOBP%GO:0010042,0.6416430594900849,0.961457642922886,0.37373888302758096,0.861412721765401,5888,5,D2HGDH|ADAM9|IREB2|ATP13A2
MITOTIC DNA REPLICATION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:1902977,0.280268456375839,0.788916642629372,0.8635862373180409,1.14723578896352,2087,1,CDC45
POSITIVE REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051957,0.105891594658288,0.578960283636811,-0.7049418792174891,-1.43065859912884,673,3,TRH
CELLULAR RESPONSE TO INTERLEUKIN-21%GOBP%GO:0098757,0.315837268434435,0.817022961971678,-0.377164920022063,-1.1002068049898301,1738,7,STAT1|JAK3|JAK1|IL2RG|STAT4|IL21R|STAT3
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010935,0.8643108160874658,0.992432325121301,-0.21241376119062197,-0.685690655976895,4426,9,SEMA7A|GPRC5B
CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:0061077,0.261309523809524,0.771967970256231,-0.199695768768318,-1.14441605459197,877,41,HSPB1|CLU|HSPA13|FKBP1B|HSPA5|DFFA|ST13|PEX19|HSPA6|FKBP4|BAG1|CSNK2A1|FKBP1A
POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900426,0.753477682351518,0.9769690538700708,0.5052347240367739,0.8257922768283149,6228,2,F2RL1|CYBA
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903427,0.572557628979144,0.940734934957679,-0.221012927723227,-0.90512221936571,2607,16,CD34|TRAP1|PARK7|SIRPA|FYN|MPV17L|ATP2B4|CAV1
RNA PHOSPHODIESTER BOND HYDROLYSIS%GOBP%GO:0090501,0.0880829015544041,0.556932119338259,-0.222264886336091,-1.34636082187303,271,50,EXOSC9|NHP2|KRI1|AGO2|RNASEH1|PDE12|RRS1|NOL9|NCBP2|NUDT21|NOP14
NEGATIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903645,0.41489932885906006,0.8695737743071128,0.799735333039259,1.06241271121996,3090,1,PDCD5
RNA STABILIZATION%GOBP%GO:0043489,0.134791032383061,0.622228052080473,-0.23917710263572398,-1.28698492454521,486,34,CCRN4L|SLC11A1|VIP|YBX1|HNRNPC|RBM38|PABPC1|MYD88|RBM24
SLIT DIAPHRAGM ASSEMBLY%GOBP%GO:0036060,0.20630872483221502,0.7211951452265429,0.898820026466696,1.19404230595674,1536,1,PTPRO
PRESYNAPSE ORGANIZATION%GOBP%GO:0099172,0.585421649162941,0.9439064862850342,0.33234716520254104,0.9060675356013371,5629,8,DVL1|PTPRD|NLGN4Y|NLGN3|NLGN2
POSITIVE REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070304,0.6436385892433629,0.9622492597510809,0.15787596465953302,0.8933172180212771,8412,109,SH3RF1|EDN1|CTGF|TPD52L1|FGF19|TAOK3|MAP3K10|CD27|AGER|ERN1|MAP3K9|DUSP19|TGFB2|MAP3K5|MAP3K7|CCL21|F2RL1|EMC10|HRAS|MID1|CCL19|HAND2|GADD45B|GADD45G|SEMA4C|MAP3K4|TAOK1|MAP2K7|CARD9|PRMT1|TRAF4|RIPK1
POSITIVE REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001190,0.998218262806236,1.0,-0.286903777226358,-0.4907335453622371,6722,2,HLA-DMB|LGALS9
MITOTIC G1/S TRANSITION CHECKPOINT%GOBP%GO:0044819,0.698927372471956,0.96731875442989,0.16716597907894598,0.8421031405425359,8535,61,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|RPS27L|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|RFWD3|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CCND1|CNOT6|E2F4
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902107,0.683837986629965,0.966495577318169,-0.130532834251388,-0.8834535629448391,1738,73,LEF1|ZBTB1|IL7|CCL19|IL12RB1|RIPK1|ACIN1|TESPA1|SOCS1|CD46|ZAP70|ATP6AP1|BTK|GATA3|NFKBID|CSF1|CCR1|ANXA1|ZMIZ1|EVI2B|FADD|XBP1|MYB|FOXP3|PRKCZ|HMGB1|NCKAP1L|LILRB2|IL34|ADAM8|CD74|PPP2R3C|ZFP36L1|HCLS1|MMP14|SYK|MALT1|ZBTB7B|AXL|LILRB4|TGFBR2|NFKBIZ|CASP8|IL18|TGFB1|CD4|CTNNBIP1|SART1|GAS6|C10orf54|TRAF6|RUNX3|CD86|LGALS1|TESC|HAX1|RARA|LGALS9|LIF|RUNX1|PNP|POU4F2|LGALS3|NLRP3|PRKCA|SOCS5|BCL6|NKAP|DUSP10|CBFB|TNF
DCDP PHOSPHORYLATION%GOBP%GO:0061570,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090050,0.5737632508833921,0.941417936126209,-0.21473897773003303,-0.9035969195846321,2597,17,SRPX2|GATA2|RHOJ|VEGFA|KDR|HMOX1|FGF2|FOXC2
POSITIVE REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045078,0.9993413469454959,1.0,-0.18470184596427697,-0.42477566015064394,6068,4,CEBPG|CD276
PROTEIN K11-LINKED UBIQUITINATION%GOBP%GO:0070979,0.668053028333767,0.964618776001639,-0.16863142055435099,-0.8630136391677641,2569,29,UBE2E2|UBE2L3|UBE2D3|PARK2|RNF4
POSITIVE REGULATION OF SINGLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:0060381,0.631140939597315,0.9575013258325501,0.6890163211292459,0.915327443422818,4701,1,ACD
GLYCOLIPID METABOLIC PROCESS%GOBP%GO:0006664,0.939958919260547,1.0,0.11995003188384401,0.645025201713731,11897,83,B3GALT2|PGAP1|B4GALNT1|B3GALT1|ST3GAL5|PIGC|CLN6|GBA2|PIGF|PIGQ|PIGB|B4GALT6|ST8SIA3|ASAH1|B3GALNT1|ST3GAL4|SMPD1|PIGL|LARGE|ST3GAL6|SMPD4|PIGK|CPTP|B4GALT3|PIGH|ARSA|HEXA|ST8SIA2|GPAA1|SCCPDH|ALDH5A1|CTSA|PIGN|NEU3|UGCG|GPLD1|PIGU
TELOMERE LOCALIZATION%GOBP%GO:0034397,0.8738249702105121,0.9934031064448321,-0.5609285399206,-0.750371210419593,6599,1,NUP98
NITRITE TRANSPORT%GOBP%GO:0015707,0.230372037600953,0.743397546142977,-0.884318482576092,-1.18297979678654,1739,1,SLC11A1
REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000674,0.0416598056973489,0.402998391331252,-0.703744554127833,-1.61846545710695,252,4,WFS1|CAST|TCF7L2|IL6
NEGATIVE REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044130,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
THREONYL-TRNA AMINOACYLATION%GOBP%GO:0006435,0.0846358689359731,0.545178773025535,0.728751741630455,1.3852803990338,730,3,TARSL2|TARS2|TARS
CELL PROJECTION MORPHOGENESIS%GOBP%GO:0048858,0.17,0.673117535978459,-0.12684120754639303,-1.1306972661264099,118,269,PARD6B|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|RAB8A|CDC42|DBNL|NEFH|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|GFRA2|NBL1|SLIT3|EPHB2|PARD3|UBB
RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN-ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001999,0.5820203892493051,0.943249589738259,-0.702801058667843,-0.940158404404613,4395,1,PCSK5
NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0072080,0.288829635272831,0.798187790155662,0.321636371906743,1.1537752383630901,3032,18,CITED1|BMP4|PKD2|AHI1|KLHL3
ANASTRAL SPINDLE ASSEMBLY%GOBP%GO:0055048,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
RESPONSE TO DIETARY EXCESS%GOBP%GO:0002021,0.5171934699548449,0.922978562060581,0.5097902963846279,0.969057725500939,4466,3,OMA1
POSITIVE REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002038,0.7844565073480742,0.981487311948134,-0.6048742831936479,-0.8091587710904291,5924,1,ARL6IP1
DETECTION OF HORMONE STIMULUS%GOBP%GO:0009720,0.0779822587051503,0.5314695499765479,-0.9598037053374499,-1.2839586807995502,588,1,ABCG1
PYRUVATE OXIDATION%GOBP%GO:0009444,0.0589261744966443,0.475380099992949,0.9705006616674019,1.28926683192102,438,1,NR4A3
MULTICELLULAR ORGANISMAL MOVEMENT%GOBP%GO:0050879,0.0636546376950321,0.493545616162616,0.433679975524992,1.50345086551674,664,16,CCDC78|GAA|JSRP1|MYH3|TCAP|TNNC2|STAC3
ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086098,0.477505567928731,0.9042847010254671,-0.574202100926688,-0.982141941337646,3215,2,CAV1
EPITHELIAL CELL FATE COMMITMENT%GOBP%GO:0072148,0.295264623955432,0.800447413278835,-0.36277268711109495,-1.1276554654664,1589,8,ACVR1|PDPN|NRP1|RBPJ
POSITIVE REGULATION OF HEART CONTRACTION%GOBP%GO:0045823,0.14741073992533701,0.639410493426798,0.38388746465469203,1.3308337335553702,1539,16,RGS2|RYR2|EDN1|KCNQ1|TGFB2|ATP2A2|SCN3B|RNF207|GSK3A
DOUBLE-STRAND BREAK REPAIR%GOBP%GO:0006302,0.10217216411906699,0.573450707099996,0.21464011179834697,1.2872085416564498,1396,155,XRCC6BP1|MUS81|FBXO18|EME2|C9orf142|PARP2|CDC7|XRCC3|LIG4|RAD54B|BLM|MTA1|EXO1|BRIP1|DNA2|DCLRE1A|CDC45|PARP1|TONSL|FEN1|GEN1|POLQ|NABP1|POLN|SLX1B|HIST1H4I|INO80|MMS22L|RAD51C|RAD51|NIPBL|PIAS4|H2AFX|SMARCAD1|REC8|CDCA5|DCLRE1C|XRCC4|BRCC3|RAD51AP1|CHEK2|SLX4|SFPQ|EXD2|EME1|HERC2|RMI1|PALB2|PAXIP1|BRCA2|TNKS1BP1|XRCC2|RIF1|PRKDC|GINS2|RECQL5|XRCC1|ZFYVE26|SPIDR|ATM|VCP|RFWD3|MDC1|UIMC1|BRCA1|BRE|PARP9|EYA3|POLL|RAD52|YY1|PARP3|RNF8|SETMAR
DEDIFFERENTIATION%GOBP%GO:0043696,0.43788556913027704,0.878999860395433,0.627736421284808,1.02601793566174,3619,2,CDK6|NCOA3
DCTP METABOLIC PROCESS%GOBP%GO:0046065,0.548258969945717,0.9305779599215391,-0.7201698279664759,-0.96339313666473,4140,1,DCTPP1
MAINTENANCE OF ANIMAL ORGAN IDENTITY%GOBP%GO:0048496,0.18991065591632197,0.698434241409875,0.5496392183133689,1.26683691886933,1742,5,IQCB1|ADGRV1|NPHP3|NPHP3-ACAD11|PKP2
RNA (GUANINE-N7)-METHYLATION%GOBP%GO:0036265,0.0290652003142184,0.350071841748197,-0.7975074445792429,-1.6185176637867902,184,3,METTL1|TRMT112|WBSCR22
DENDRITE SELF-AVOIDANCE%GOBP%GO:0070593,0.0857732363922185,0.549432448560602,0.45966067164673,1.4490147042185,872,12,NEXN|IGSF9|DSCAM|BSG|PALLD
GLYCOPROTEIN TRANSPORT%GOBP%GO:0034436,0.7919438732309179,0.9819233677232551,0.489548685229043,0.800153877317773,6546,2,VLDLR
CELL-CELL JUNCTION MAINTENANCE%GOBP%GO:0045217,0.41113360323886605,0.867015886388254,0.36548084226497096,1.04295744750668,4061,9,CAMSAP3|F2R|F2RL1|CSF1R|NLGN2|KIFC3|PLEKHA7
SEMI-LUNAR VALVE DEVELOPMENT%GOBP%GO:1905314,0.394317578332448,0.863562957467761,-0.19766676858935997,-1.0394375584137499,1484,31,SMAD6|TNFRSF1B|EFNA1|SNAI1|TBX20|NOS3|TWIST1|SLIT3
LUNG LOBE DEVELOPMENT%GOBP%GO:0060462,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
MAINTENANCE OF PROTEASE LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033379,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
PROTEIN TRANSPORT WITHIN PLASMA MEMBRANE%GOBP%GO:0099632,0.6259493670886079,0.9543682073609309,-0.22425648030526898,-0.868828973826285,2966,14,RAB8A|CACNG3|CACNG7
LIMBIC SYSTEM DEVELOPMENT%GOBP%GO:0021761,0.134994421718111,0.622258254449182,0.35339629081821705,1.3360263415907099,1451,21,CDK6|KIF14|MFSD2A|PROX1|FGF13|EPHA5|KIRREL3|LEF1|LRP8|PEBP1|FGFR2
PROTEIN-HEME LINKAGE%GOBP%GO:0017003,0.159539255924798,0.661359103221672,-0.9173467137185709,-1.2271626686081598,1204,1,HCCS
NEUROTRANSMITTER UPTAKE%GOBP%GO:0001504,0.484042553191489,0.9064456896937672,-0.283957627936005,-0.960671158080849,2456,10,SNCA|SNAP25|GLUL
METHOTREXATE TRANSPORT%GOBP%GO:0051958,0.38724832214765104,0.859991269020751,0.8129135421261581,1.07991937407031,2884,1,SLC46A1
REGULATION OF ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:1903115,0.0410609538383066,0.402256981537283,-0.30866886910275104,-1.5381577983561001,160,27,CAMK2D|SRI|KCNE3|PDPN|PLN|RANGRF|BIN1|PDE4B|SCN5A|DLG1|PDE4D|CAV1|STC1
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010613,0.379143798024149,0.855216622048207,-0.252432580778727,-1.03379625847399,1726,16,IL6ST|AGT|AKAP6|CAMK2D|SLC9A1|IGF1|MTPN|PDE9A|PRKCA
NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002091,0.6685434071921539,0.964618776001639,-0.285756982308336,-0.833565795277562,3680,7,SDCBP|UBQLN2|MTMR2|NECAB2|LRPAP1
POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901992,0.0563991323210412,0.462160331701516,0.30157877048267,1.46376628125135,675,52,CCNB1|CDC7|CDK1|ANAPC5|ANKRD17|LSM11|CDC25C|CDC45|DTL|CDK10|DLGAP5|CCNE1|DBF4B|FBXO5|RB1|ESPL1|CDC6|RAD51C
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902176,0.671663165934695,0.964671573446318,0.237707585083743,0.838360324637694,7034,17,SIRT1|NOL3|INS
NEPHRIC DUCT DEVELOPMENT%GOBP%GO:0072176,0.22609519797809602,0.7398172623753029,0.4717925432801571,1.22797686648982,2146,7,BMP4|PKD2|AHI1|GPC3|GATA3
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032804,0.36956198960653297,0.852268858837246,-0.635787151916184,-1.08747987277082,2488,2,ANXA2|FURIN
CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION%GOBP%GO:0060581,0.8276512175962291,0.9876441563834109,-0.353719760582354,-0.717863744626261,5267,3,ASCL1
POSITIVE REGULATION OF BLOOD MICROPARTICLE FORMATION%GOBP%GO:2000334,0.0239639878194095,0.32397355287938,-0.9888067931186592,-1.32275699562121,180,1,TNF
POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0090091,0.5168906647293859,0.922736477156771,-0.320540933267199,-0.9350321234481009,2845,7,FSCN1|RLTPR|PDPN|MFI2
RESPONSE TO ELECTRICAL STIMULUS%GOBP%GO:0051602,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|PTEN|NSMF
POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045591,0.42678641155798497,0.875729124248766,-0.311733697623981,-1.0063043110566998,2185,9,BCL6|DUSP10
POSITIVE REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902857,0.5223214285714289,0.9251240799994541,-0.36834195780590795,-0.932433207021527,3041,5,HAP1|SEPT9
RESPONSE TO L-ARGININE%GOBP%GO:1903576,0.9393558523173601,1.0,-0.300209551119444,-0.60926636437943,5978,3,GATS|GATSL2|GATSL3
RESPONSE TO VASOPRESSIN%GOBP%GO:1904116,0.64993288590604,0.963755998259649,0.680690339655933,0.90426674848389,4841,1,ADCY6
PROTEIN-LIPID COMPLEX REMODELING%GOBP%GO:0034368,0.19310278207109696,0.7033154110137328,0.37268643925462,1.2636351222567501,1998,15,LPL|ABCA5|AGTR1|SCARB1|CETP|APOE|APOC1|APOM|LCAT
POSITIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033148,0.963172804532578,1.0,0.239771852248529,0.552638575293473,8839,5,PAGR1|KMT2D|YAP1
DGDP CATABOLIC PROCESS%GOBP%GO:0046067,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
TENDON DEVELOPMENT%GOBP%GO:0035989,0.410789887504536,0.867015886388254,0.638082480104241,1.04292828457924,3395,2,BMP4|SCX
FOLIC ACID TRANSPORT%GOBP%GO:0015884,0.9732142857142858,1.0,-0.218156022556936,-0.552247484797839,5667,5,PDPN|SLC25A32
POSITIVE REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904877,0.637181208053691,0.9593052715070159,0.6862593736215261,0.9116649616549609,4746,1,XRCC1
GAMMA-AMINOBUTYRIC ACID CATABOLIC PROCESS%GOBP%GO:0009450,0.638321035442119,0.9601484712040809,0.552081610146126,0.9023622252148059,5276,2,ABAT|ALDH5A1
REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0034243,0.8493346007604559,0.991298302704726,-0.155208161572485,-0.719039120341086,3573,22,TCEB1|EAPP|RNF168
INTRACELLULAR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030522,0.9953040800615859,1.0,0.0897656576652504,0.503331016373965,12928,104,PIAS1|SAFB|MAP2K6|RARB|RHOXF1|RNF34|EGLN2|MAP3K7|RORA|MED12|SRC|CCNE1|RB1|DDX17|ALPK1|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2
REGULATION OF HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:2000471,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900119,0.183488090431974,0.689876118998471,-0.35742042627581894,-1.25780701082049,908,11,BAX|TP53BP2|DLC1|RPS3|BOK|TP53
POSITIVE REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1905636,0.0444856348470806,0.41504430757275895,-0.9771724746360829,-1.3071934130596699,335,1,DDRGK1
ESTABLISHMENT OF GOLGI LOCALIZATION%GOBP%GO:0051683,0.0293407613741876,0.3518554302084871,-0.546922433278563,-1.7000730567234799,157,8,FAM65A|PDCD10|CDC42|YWHAZ|SLC9A3R1
GROWTH PLATE CARTILAGE AXIS SPECIFICATION%GOBP%GO:0003421,0.007281874751754271,0.19188606346941398,-0.9966916629907371,-1.33330482645675,54,1,STC1
REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901888,0.00038372985418265497,0.0784645998831315,-0.37544704986171,-2.50850509310993,0,70,PRKACA|AGT|DUSP22|PPM1F|FLOT1|SNAI2|THY1|S100A10|GPM6B|RAP1B|PRKCH|VEGFA|KDR|BCAS3|COL16A1|DLC1|ABL1|MYO1C|RHOA|NRP1|SLC9A1|NPHP1|RUNX1|APOD|SNAI1|MAP4K4|RAP1A|RAPGEF1|DUSP3|LIMS1|ACVRL1|CBFB|ACE|RAC1|CORO1C|PEAK1|TNF|CAV1
NEGATIVE REGULATION OF RECEPTOR BINDING%GOBP%GO:1900121,0.5202108963093149,0.92477593964991,-0.34118396074855895,-0.936527063427148,2959,6,RUVBL2|B2M
CEREBELLUM MORPHOGENESIS%GOBP%GO:0021587,0.37172995780590706,0.852609194081082,-0.27150531667269895,-1.0518834744575198,1761,14,DLL1|OPHN1|ADCK4|FAIM2|CBLN1|ZNF365|TRNP1
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903651,0.31882255389718106,0.8211540147886801,-0.30351138411287704,-1.10572241753054,1537,12,EZR|MTMR2|RAB21|VPS11|MSN|PARK2
EXONUCLEOLYTIC TRIMMING INVOLVED IN RRNA PROCESSING%GOBP%GO:0000459,0.222302942244824,0.7355723797115551,-0.41616105901820205,-1.21396027254289,1223,7,EXOSC2|EXOSC3|ERI1|ERI3|EXOSC7|EXOSC8|EXOSC9
DTTP METABOLIC PROCESS%GOBP%GO:0046075,0.92265833043881,1.0,0.334986432442797,0.636773968823781,7968,3,DTYMK|DCTPP1|CMPK2
DGTP CATABOLIC PROCESS%GOBP%GO:0006203,0.14988216810683402,0.643890683791772,-0.662126392412044,-1.34376584076117,953,3,SAMHD1|NUDT1|NUDT15
PROSTATE GLAND EPITHELIUM MORPHOGENESIS%GOBP%GO:0060740,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
NEGATIVE REGULATION OF ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:1903225,0.306587935625796,0.809874675097403,0.592751825719936,1.12675886554205,2647,3,COL5A2|COL5A1
ENDOSOMAL TRANSPORT%GOBP%GO:0016197,0.42214532871972293,0.873470206885489,-0.12348527160786801,-1.0195592145114598,487,180,GCC2|EHD3|RAB6A|HEATR5A|EHD1|TBC1D14|TOM1|ABCA1|VPS4B|VAMP3|EHD4|YKT6|DENND1A|LEPROT|RBSN|VPS16|TBC1D5|EHD2|UBA52|SNX6|TRAPPC10|SNX8|RAB7A|CHMP4B|CHMP1B|AP5S1|VTI1A|VPS53|UBC|MICALL1|UBB
POSITIVE REGULATION OF NK T CELL DIFFERENTIATION%GOBP%GO:0051138,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000010,0.160874658336587,0.663407673484119,-0.401481827108964,-1.29601931555695,823,9,HSP90AB1|TNF
POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062013,0.0524068322981367,0.447307566936778,-0.20526287603702198,-1.3862214289613,134,72,PPARA|ARPP19|ENO1|IGF1|TMSB4X|SNCA|NR1H2|PPARGC1A|NOS3|GUCA1A|ABCG1|AAED1|IGF2|NR1D1|TWIST1|MID1IP1|TNF|HRH1|PMAIP1
REGULATION OF DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING%GOBP%GO:0110026,0.0550774526678141,0.457996676929382,-0.9721548301720341,-1.3004811570734098,415,1,ZNF365
NEURAL FOLD BENDING%GOBP%GO:0021503,0.84880180060903,0.991298302704726,-0.57399647110719,-0.7678525804057759,6410,1,LUZP1
REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071655,0.5660644147682641,0.9388612723386429,-0.44832910554759003,-0.9098705992661209,3602,3,ISL1|CD34|HAVCR2
POSITIVE REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014742,0.379143798024149,0.855216622048207,-0.252432580778727,-1.03379625847399,1726,16,IL6ST|AGT|AKAP6|CAMK2D|SLC9A1|IGF1|MTPN|PDE9A|PRKCA
POSITIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090031,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
REGULATION OF ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:1904913,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
PROTEIN LOCALIZATION TO T-TUBULE%GOBP%GO:0036371,0.863355704697987,0.991943445125448,0.569144243493604,0.756082736156396,6431,1,ANK2
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0006359,0.973689103756043,1.0,0.13694355411873801,0.517719626287191,10472,21,TENM1|ZNF143|ZNF76|POLR3G|NAB2|BRCA1|BRF2|MTOR|ZC3H8|ICE2
VITAMIN TRANSPORT%GOBP%GO:0051180,0.7519002143831609,0.9769690538700708,0.23172585631484802,0.7677797723859421,7715,14,CD320|SCARB1|SLC46A1|SLC5A6|SLC19A2|SLC19A1|SLC23A2
REGULATION OF SKELETAL MUSCLE FIBER DIFFERENTIATION%GOBP%GO:1902809,0.0834446919079436,0.543851846787664,-0.825547504391196,-1.4120547927649298,561,2,RBM24
NEURONAL SIGNAL TRANSDUCTION%GOBP%GO:0023041,0.80553268565783,0.984682960940884,-0.321200439893823,-0.7386939106334871,4891,4,OLFM1
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060445,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090313,0.405627490039841,0.8663957682383929,-0.20982201287719499,-1.03028762107762,1628,26,ITGAM|MYO1C|FYN|INPP5K|PRNP|CHP1|MIEF1|CEMIP
INTERLEUKIN-2 SECRETION%GOBP%GO:0070970,0.24678935522308998,0.758826975311078,-0.876433612704014,-1.17243196595099,1863,1,PNP
NERVOUS SYSTEM PROCESS%GOBP%GO:0050877,0.8732286746318421,0.9934031064448321,0.12084505333994999,0.784511873392165,12570,287,PCDH15|RGS16|SCN1A|CHRNA10|CALB1|FSCN2|RTP5|ZNF354A|CACNA1G|SIX3|GPR179|CRYZ|COL18A1|CRHBP|KCNQ1|PIEZO2|CACNA1I|TAS2R4|SLC8A3|KAT2A|VLDLR|ADGRV1|INS|AGER|ABCA7|ADCY8|RGS14|DNAJC19|FGF13|DFNB31|CUX2|CDH23|CACNA1H|TIMM13|TMEM150C|RTP4|CPEB3|KCNJ11|EFEMP1|LINS|BIRC5|PDZD7|CACNA1D|FEN1|ABLIM1|ZACN|KIT|NF1|APOE|GRIN1|SHISA7|NIPBL|TAS2R5|ASIC1|PRRT2|SERPINB6|RABGGTA|ANK3|ASIC3|TAS2R20|DRD4|DLG4|ADORA2A|TH|SPTBN4|CNGB1|NLGN4Y|BRSK1|ST3GAL4|COL11A2|LDLR|TNNI3|SLC24A1|NRXN3|PRR4|SCN8A|OPRL1|MYO7A|S100B|CRYGC|CHD7|NPAS4|SLC8A2|TSHZ3|BEST1|MYCBP2|LRTOMT|SHANK1|REEP6|GSK3A
POSITIVE REGULATION OF INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:1904582,0.566889383815887,0.938919400477539,-0.5352633030052389,-0.9155392129216291,3817,2,ZFP36L1|DHX36
TRANSLESION SYNTHESIS%GOBP%GO:0019985,0.428435937230557,0.8770491417151121,0.22688145273798802,1.02329389781832,4968,39,FAAP20|REV1|SPRTN|POLE2|RFC4|REV3L|DTL|POLD1|POLD3|POLN|ZBTB1|PRIMPOL
UNIDIMENSIONAL CELL GROWTH%GOBP%GO:0009826,0.7532106447769101,0.9769690538700708,-0.6193758270842521,-0.8285579285012572,5688,1,BIN3
PREGANGLIONIC PARASYMPATHETIC FIBER DEVELOPMENT%GOBP%GO:0021783,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
"POSITIVE REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048026",0.9675268817204301,1.0,-0.145293014016113,-0.5794415202253559,4498,15,DAZAP1|CIRBP|TRA2A|THRAP3|CELF3|RBMX|SNW1|NUP98|PRDX6|SF3B4|NCBP1|RBMXL1|CELF4|RBM3|TRA2B
REGULATION OF ENDOCYTOSIS%GOBP%GO:0030100,0.0212264150943396,0.306557165070089,-0.171232065094054,-1.39010968256218,26,165,PICALM|OPHN1|SGIP1|VPS28|IL1B|CLU|CBLL1|VEGFA|MTMR2|NEDD4L|FCER1G|NECAB2|CLIP3|RAB21|SIRPA|ITGAM|ARRB2|CD300LF|NR1H3|TNK2|FGR|ABL1|CAMK1D|BMP2K|FCGR2B|ARRB1|SLC11A1|PTPN1|LRPAP1|SNCA|TBC1D5|FMR1|AP2S1|LGALS3|LMAN2|RAB5C|NR1H2|DYSF|DKK1|B2M|ANO6|RAB5A|LYAR|KIAA0226|GREM1|RAC1|MCTP1|CD22|CDH13|BICD1|TNF|SNX12|CAV1
LONG-CHAIN FATTY ACID IMPORT%GOBP%GO:0044539,0.108160874658337,0.58452352834625,-0.43343562361543997,-1.3991690341282201,553,9,ACSL3|CD36|FABP3
AMINE METABOLIC PROCESS%GOBP%GO:0009308,0.9445935416847029,1.0,0.132957578975336,0.59562167406962,10910,38,IDO1|NAPEPLD|INMT|AOC2|DDC|SAT2|GDPD1|SARDH|MOXD1|CCBL1|AZIN2|AFMID|SAT1|AADAT|DBH|MAOA
NEGATIVE REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051771,0.09111960171355801,0.5609783360513879,0.7230616521451421,1.37446413749717,786,3,EDN1|GSTP1|VIMP
ADENOSINE CATABOLIC PROCESS%GOBP%GO:0006154,0.68483896307934,0.966495577318169,-0.406032866438734,-0.82403163867115,4358,3,ADAL|CECR1|ADA
REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:0010965,0.00134623474968448,0.0945022140486112,0.4118138108922271,1.96970700627423,15,49,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|USP44|BUB1|DLGAP5|CDC23|CDC20|GEN1|APC|NDC80|CDK5RAP2|CENPE|PTTG1|FBXO5|RB1|BUB1B|ESPL1|CDC6
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0043666,0.381019036954087,0.8566948330269879,-0.19011266436837196,-1.0457892380059002,1360,36,HTT|PPP1R11|HSP90AB1|TNF|FKBP1A
AGGRESOME ASSEMBLY%GOBP%GO:0070842,0.655044672041839,0.9640743070248079,0.36929660548412,0.8511739305576159,6011,5,UBD|TRIM37|HDAC6
CORNEA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061303,0.905891594658288,1.0,-0.31840296206705,-0.646189351347617,5765,3,WNT6
POSITIVE REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903337,0.716778523489933,0.971081608033886,0.645401411557124,0.8573869818553209,5339,1,SNAPIN
NEGATIVE REGULATION OF GLUTAMATE METABOLIC PROCESS%GOBP%GO:2000212,0.717315436241611,0.971081608033886,0.64485002205558,0.856654485501749,5343,1,ATCAY
IMMUNE RESPONSE-ACTIVATING SIGNAL TRANSDUCTION%GOBP%GO:0002757,0.007142857142857141,0.190147814924784,-0.155382585408021,-1.39943483121462,3,294,ITK|FPR1|IGHV5-51|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|ARPC1B|UBE2N|PIK3CD|TLR1|CREBBP|CD79B|PIK3R2|THY1|MYO10|ITCH|BAX|MYO1G|NOD1|PPAPDC1A|BLK|IGHV4-4|EIF2B3|ICOSLG|IRAK1|FCER1G|PIK3C3|DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|LGALS9|BCAR1|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|PRKD2|IRAK4|GRB2|FGR|ABL1|VAV1|MYO1C|TRAF3|IGHV1-69-2|CYFIP2|S100A8|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|BCL10|UBE2V1|RELB|LYN|FCGR2B|CYLD|TANK|ARPC5|RNF31|CD276|YES1|CNPY3|TNIP1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CDC42|PDE4B|MUC3A|RFTN1|IGHV1-3|KRAS|BCL2|UBA52|NFATC2|COLEC12|RBCK1|MAPK3|HLA-DQA2|TNIP2|HLA-DQB2|RAC1|PLD2|TICAM1|MUC12|MYD88|ACTR2|BRK1|UBC|CD36|PIK3R1|HSP90AB1|PDE4D|TNFRSF21|PAK2|UBB
CARNITINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902603,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
RENAL SYSTEM VASCULATURE DEVELOPMENT%GOBP%GO:0061437,0.8540197461212979,0.991298302704726,0.230053126204181,0.6789462100033411,8476,10,BMP4|PKD2|ACTA2|EGR1|PDGFRA|TEK|PDGFB
REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0072095,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:1900242,0.705864884929473,0.968941691852291,-0.47719878687620604,-0.816222967819489,4753,2,ROCK1|TOR1A
NEGATIVE REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070858,0.0136688036772711,0.256136946817111,0.919602977667494,1.5030658040258997,112,2,FGF19|PROX1
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903556,0.9547725245316679,1.0,0.135251665209175,0.567100932530566,10702,30,GHRL|TRIM27|GSTP1|MC1R|NLRC3|CACTIN|DICER1|VIMP|PTPN22|TLR4|ARG2|CLEC4A|POMC|ZC3H12A|NFKBIL1|LILRB1|IRAK3|CD34|HAVCR2|GAS6|C10orf54|PTPN6|CD274|SYT11|RARA|CX3CL1|SIRPA|LGALS9|TNFAIP3
MACROPHAGE ACTIVATION%GOBP%GO:0042116,0.00377693845812042,0.14377160645023299,-0.4684118074404339,-2.01500352455924,16,18,CLU|CX3CL1|ITGAM|SBNO2|SLC11A1|FOXP1|SNCA|CD93|DYSF|TNF
REGULATION OF CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0031938,0.0469335913874441,0.42636709104084497,0.8636338571822441,1.41158581415444,387,2,SIRT6|CDC45
CELLULAR RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0071216,0.337817638266069,0.832232043362884,-0.145060858717914,-1.06894051206833,677,103,CD274|IL1B|IRAK1|MTDH|SIRPA|DAB2IP|TNFAIP3|NR1H3|EIF2AK3|RHOA|TNFRSF1B|BCL10|VIM|IL6|LYN|FCGR2B|SBNO2|LDOC1|PDE4B|NR1H2|PDCD4|CXCL8|NLRP3|TP53|TNIP2|TICAM1|NR1D1|CD36|TNF
RESPIRATORY BURST%GOBP%GO:0045730,0.6907549454985871,0.96731875442989,-0.2320975394461,-0.816780158177658,3421,11,CD55|C17orf62|NCF1|CD52|CYBB|HCK|PGAM1|NCF2|PIK3CD|CYBA|SLC11A1
NEGATIVE REGULATION OF FASL BIOSYNTHETIC PROCESS%GOBP%GO:0045221,0.9103355704697991,1.0,0.5467026907807679,0.726270134566041,6781,1,JAK3
POSITIVE REGULATION OF PHOSPHOLIPID SCRAMBLASE ACTIVITY%GOBP%GO:1900163,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009129,0.5781786941580761,0.942692029750853,0.368491410806228,0.9062509592740691,5383,6,DUT|UMPS|HDDC2|TYMS
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002579,0.9514532434709351,1.0,0.21939577891326398,0.5710411174324611,9034,7,CCL21|CCL19
NEURONAL-GLIAL INTERACTION INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021812,0.9068456375838929,1.0,0.5485222761358621,0.7286873725328259,6755,1,LAMB1
"DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0006353",0.862745098039216,0.991943445125448,-0.113859141807524,-0.765570393211407,2243,71,POLR1B|POLR2A|TAF1B|TTF2|POLR2K|SNRPB|POLR2F|POLR1E|NCBP2|NUDT21|CD3EAP|SLBP
ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048003,0.418663887924048,0.871698849372662,0.547041584527522,1.03986850557216,3615,3,CD1E|CD1D
POSITIVE REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903899,0.0279138827023014,0.34344859690402196,-0.8928591122139509,-1.52718769296662,187,2,BOK|TMEM33
GLOMERULUS DEVELOPMENT%GOBP%GO:0032835,0.9253677465932679,1.0,0.151563654406291,0.6161838215682,10253,27,BASP1|BMP4|MPV17|PTPRO
NEGATIVE REGULATION OF ZINC ION TRANSMEMBRANE IMPORT%GOBP%GO:0071584,0.25393883225208497,0.7641083395392759,-0.873842082046758,-1.16896519637567,1917,1,SLC30A1
REGULATION OF UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000395,0.40778498609823904,0.867015886388254,-0.79471768857521,-1.06311808274625,3079,1,VPS28
LEADING STRAND ELONGATION%GOBP%GO:0006272,0.39458145189301796,0.8636026273399079,0.556077535547285,1.05704489791436,3407,3,POLE|POLA1|PCNA
RESPONSE TO STEM CELL FACTOR%GOBP%GO:0036215,0.44816741260433,0.8850378987593649,0.623269920044114,1.01871756208579,3704,2,KIT|FER
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010595,0.10292249047014,0.5745140527021371,-0.182890727862161,-1.27503232439426,242,82,AGT|GATA2|RHOJ|CALR|HIF1A|HSPB1|VEGFA|KDR|BCAS3|BCAR1|PTK2B|HMOX1|PRKD2|ABL1|GPI|ZNF580|NRP1|AAMP|FGF2|PPAP2B|FOXC2|FOXP1|ETS1|TMSB4X|FGFR1|MAP2K3|ATOH8|ADAM17|STAT5A|PRKCA|NOS3|MET
SPHINGOLIPID TRANSLOCATION%GOBP%GO:0099039,0.868935973138821,0.9931871192124442,0.36927817510876,0.701958964275852,7504,3,ABCB4|ABCB1
REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034114,0.0867932862190813,0.552202694227509,-0.33794620634029604,-1.42203876661044,392,17,CD44|FLOT1|THY1|IL1RN|IL1B|MAPK7|MYADM|MAP2K5|MBP|TNF
POST-CHAPERONIN TUBULIN FOLDING PATHWAY%GOBP%GO:0007023,0.577332288050174,0.942692029750853,0.4352193736185139,0.9222714270183221,5154,4,TBCE|TBCD
PURINE NUCLEOTIDE INTERCONVERSION%GOBP%GO:0015950,0.425983667409057,0.875696962448429,-0.5997794320374971,-1.02589059636845,2868,2,GMPR2|GMPR
NEGATIVE REGULATION OF OSSIFICATION%GOBP%GO:0030279,0.0392050095289954,0.396089810860281,-0.28466403744203495,-1.52260259605732,143,33,NOTCH1|LRP5|SRGN|SKI|PTK2B|FAM101B|LIMD1|SMAD6|CCRN4L|FAM101A|DKK1|CHSY1|GREM1|TWIST1|RBPJ
HINDBRAIN DEVELOPMENT%GOBP%GO:0030902,0.454873646209386,0.88900512246363,-0.18311329525350303,-0.995405147764236,1637,35,SDF4|DLL1|NLGN4X|FOXC1|OPHN1|AARS|DLC1|ADCK4|FAIM2|FCGR2B|CBLN1|ATF5|ZNF365|TRNP1|SCN5A
POSITIVE REGULATION OF GAMMA-DELTA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:2001193,0.820468687938567,0.987153241368501,-0.587450374944861,-0.785850277775518,6196,1,LILRB1
HISTONE H2A-K119 MONOUBIQUITINATION%GOBP%GO:0036353,0.548987854251012,0.931134965065115,0.32467073773542104,0.9264993530444721,5423,9,PCGF2|TRIM37|PCGF1|PCGF3|PCGF5|COMMD3-BMI1|PCGF6|RNF2
REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000665,0.413140128437346,0.8683189983530021,-0.44294135313485994,-1.01867257852025,2508,4,LGALS9|TNFRSF21
PRONUCLEAR FUSION%GOBP%GO:0007344,0.135704697986577,0.623227463256235,0.9331715924128801,1.2396768287842301,1010,1,CDK1
CANONICAL GLYCOLYSIS%GOBP%GO:0061621,0.00047528517110266203,0.0784645998831315,-0.4768837663179679,-2.2092786897554704,1,22,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086103,0.0690685413005272,0.505008438180146,-0.5526932302508489,-1.5171058064020602,392,6,AKAP13|PDE4D|CAV1
ORGANOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046434,0.127856101118133,0.607756857238061,-0.16662205060201302,-1.22389074883428,262,101,NUDT7|SMUG1|LDHA|SYNJ2|ENTPD4|PFKL|DERA|GPI|NUDT4|INPP1|INPP5K|PKM|PNP|ENO1|INPP5A|HPRT1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|PDE9A|ALDOA|GPCPD1|ITPA|NT5E|NEIL2|PDE4D|PGAM2
HISTONE DEACETYLATION%GOBP%GO:0016575,0.764097258147957,0.9785195400702371,0.173298307226647,0.781620084617786,8861,39,SIRT1|HDAC10|MTA2|MIER2|MTA1|HDAC8|HDAC3|SMARCAD1|HDAC6|SFPQ
CATION TRANSPORT%GOBP%GO:0006812,0.46291996722207107,0.891507554237553,0.152534673612361,1.01468704493217,6778,380,KCNK2|RYR2|KCNN2|SCN1A|CRACR2B|KCNK6|KCNH8|CACNA1G|KCNT2|GRIN3A|SLC12A2|SLC47A1|TFR2|KCNH3|CACNB2|KCNK3|ATP2B1|TMEM165|HCN2|NDUFS7|SLC25A29|KCNQ1|NOL3|RHBG|PIEZO2|CACNA1I|SLC9A5|SLC9A7|SLC36A1|SLC8A3|ATP1B3|P2RX5|F2R|KCNH1|SLC39A3|ATP5G1|LRRC55|PKD2|SLC25A19|KCNC3|KCNC1|SLC35G1|IBTK|KCND1|KCNB2|FGF13|SLC30A5|KLHL3|ATP2A1|HCN3|ATP5D|ATP10D|NNT|CDH23|NPY|CACNA1H|TAF7|CACNA2D1|KCNJ11|MRS2|SLC6A17|KCNH2|SLC6A15|MT-ATP8|CCR5|CACNA1D|CCL21|TTYH1|JPH4|MCOLN1|CCL5|ATP2B3|UCP3|SLC25A42|ATP7B|NALCN|SLC6A9|SLC39A7|SLC15A4|PQLC2|SLC46A1|SLC22A3|SLC40A1|GRIN1|NIPA1|CCL19|TRPM7|ASIC1|ATP2A2|TCIRG1|SCNN1D|PLCG1|SLC39A13|ABCC8|SLC6A2|PIEZO1
RESPONSE TO CAFFEINE%GOBP%GO:0031000,0.661104266995184,0.964618776001639,0.4065415024789771,0.86150027862066,5902,4,RYR2|SLC8A1|GSTM2
ATRIOVENTRICULAR CANAL DEVELOPMENT%GOBP%GO:0036302,0.493560309105163,0.910654969509744,0.46357489553125797,0.982359486612007,4406,4,TBX2|FOXN4
REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032344,0.0768141207234692,0.527286041772797,0.627285225335568,1.44579945469484,704,5,WNT4|CLCN2|REST
POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY%GOBP%GO:0099527,0.870378619153675,0.9934031064448321,-0.404190791287565,-0.6913467014232559,5861,2,KPNA2|KPNA1
REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045191,0.919571835411961,1.0,0.187546677446087,0.6052828395000871,9363,13,THOC1|PAXIP1|RIF1|SUPT6H|FAM35A|TP53BP1|NDFIP1
TRIMMING OF FIRST MANNOSE ON A BRANCH%GOBP%GO:0036511,0.808636748518205,0.984682960940884,0.48333434592084495,0.78999671043641,6684,2,MAN1B1|EDEM2
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009173,0.524161073825503,0.92593403131991,0.7417291574768421,0.9853540948242441,3904,1,UMPS
BRADYKININ CATABOLIC PROCESS%GOBP%GO:0010815,0.5677007503639829,0.9396054494081459,0.438331987570364,0.928867353314668,5068,4,IDE|XPNPEP1
REGULATION OF CHRONIC INFLAMMATORY RESPONSE%GOBP%GO:0002676,0.347114093959732,0.842847021021096,0.830447728275254,1.1032127581138798,2585,1,CCL5
RRNA TRANSPORT%GOBP%GO:0051029,0.984885764499121,1.0,-0.18878180219780502,-0.518193371261934,5603,6,MRPL18|NPM1
NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009124,0.11670020120724302,0.596135728622196,-0.186128244496872,-1.2683492791337199,289,75,PFKL|COX5B|GPI|GMPS|ATIC|PKM|ENO1|DCTD|HPRT1|ATP5I|GAPDH|PGK1|CDADC1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032667,0.0940227235303804,0.562743160240921,-0.633275538723964,-1.45640144317103,570,4,RAC1|MYD88
REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904467,0.900080742834074,0.998912093067348,-0.186188875067912,-0.655221848503078,4458,11,SYT11|CX3CL1|LGALS9|MAVS
UTERUS MORPHOGENESIS%GOBP%GO:0061038,0.9350429418168621,1.0,0.41134089981272,0.6723254005483399,7729,2,NIPBL|STRA6
GLOMERULUS VASCULATURE DEVELOPMENT%GOBP%GO:0072012,0.7817258883248729,0.981487311948134,-0.23342856652311703,-0.753528330772051,4003,9,ANGPT2
MAMMARY GLAND DUCT MORPHOGENESIS%GOBP%GO:0060603,0.460720303285594,0.8905215852839309,0.38553684860776094,1.0034714155891,4374,7,FGFR2|CSF1R|LRP6|SCRIB
REGULATION OF INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032380,0.232925257731959,0.746122594132505,0.49541443489602,1.21839965246525,2168,6,ABCA2|LDLRAP1|ARV1|NUS1|ANXA2|SCP2
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002699,0.7383720930232559,0.9744283926676119,-0.11606292189142801,-0.8769945669786291,1396,112,IL1B|RARA|FAM49B|LGALS9|ITGAM|LAMP1|FGR|GPI|ULBP3|C20orf196|BCL10|SEMA7A|IL6|LYN|VAMP2|VAMP3|MAVS|KARS|TFRC|ULBP2|NLRP3|SNX6|GAB2|SOCS5|B2M|TNFRSF4|TICAM1|GPRC5B
DRUG TRANSMEMBRANE TRANSPORT%GOBP%GO:0006855,0.361586525400706,0.848418604328854,-0.20047777104325898,-1.0613474812295,1330,32,PRAF2|SLC7A3|RALBP1|ATP8B1|STRA6|TMEM30A|ABCC1|SLC25A32|SLC6A8|SLC25A15|SLC25A13|SLC25A18|SLC7A1|AQP1
REGULATION OF MINERALOCORTICOID SECRETION%GOBP%GO:2000855,0.734514298946393,0.9736885699872909,0.430924955368421,0.819143008551599,6343,3,AGTR1|C1QTNF1
POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035022,0.8070642312809971,0.984682960940884,0.4842018196856911,0.791414572474152,6671,2,ALS2|AUTS2
RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009156,0.117805065234075,0.6006198777217571,-0.18916959306698003,-1.2639142799093501,306,70,ADSL|ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|LHPP|PFKL|COX5B|GPI|GMPS|ATIC|PKM|ENO1|HPRT1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
HIPPOCAMPUS DEVELOPMENT%GOBP%GO:0021766,0.0751357013617751,0.524840022194793,0.405531534507245,1.45472429040304,788,18,CDK6|KIF14|MFSD2A|PROX1|FGF13|EPHA5|KIRREL3|LEF1|LRP8|PEBP1
THIRD VENTRICLE DEVELOPMENT%GOBP%GO:0021678,0.684632516703786,0.966495577318169,-0.487069203198236,-0.833105786312635,4610,2,KDM2B|C12orf57
POSITIVE REGULATION OF CHEMOTAXIS%GOBP%GO:0050921,0.0418088737201365,0.402998391331252,-0.200098839689147,-1.3985529826715202,97,83,PPM1F|IL6R|CALR|HSPB1|PLA2G7|CREB3|VEGFA|KDR|TUBB2B|LGALS9|PTK2B|AKIRIN1|PRKD2|ADAM10|CAMK1D|ZNF580|NRP1|C1QBP|FGF2|IL6|TMSB4X|KARS|FGFR1|ADAM17|CXCL8|ANO6|SCG2|OXSR1|THBS4|RAC1|MET|PGF|CDH13
TRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042797,0.35817223198594006,0.846205501155666,-0.385251778721527,-1.0574902648253501,2037,6,GTF3C5|GTF3C3|GTF3C1|GTF3C2|GTF3C6|GTF3C4
REGULATION OF VESICLE SIZE%GOBP%GO:0097494,0.8605302157088751,0.9916689277956879,-0.30168406518143503,-0.693810325908484,5225,4,PICALM|RAB22A
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-INDEPENDENT DECAY%GOBP%GO:0031086",0.27328646748681895,0.7884684708511421,-0.419612817825823,-1.1518090099916,1554,6,EDC4|PNRC2|ZFP36L1|EDC3|DCP1B|DCP1A
GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071621,0.647188720910481,0.9636261853025391,0.186185382023884,0.8684339467322328,7619,44,EDN1|CXCL13|CXCL9|TGFB2|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CXADR|AMICA1|GBF1|CCL3L3|CCL11|CCL4L2|PIP5K1C|CXCL11|CKLF|XCL1|ANXA1|CCL4|CXCL2|CCL8|CXCL1|CCL24
SYNAPTIC MEMBRANE ADHESION%GOBP%GO:0099560,0.101052405498282,0.571491553833428,0.571866677789074,1.4064228096642102,940,6,PTPRD|LRRC4C|PTPRS|SLITRK1
NEGATIVE REGULATION OF METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072308,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
POSITIVE REGULATION OF INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032385,0.36853073984022205,0.851931544178381,0.5657719883987329,1.0754730329668,3182,3,LDLRAP1|ANXA2|SCP2
RESPONSE TO AMYLOID-BETA%GOBP%GO:1904645,0.21165338645418302,0.726464607889685,-0.245070887721667,-1.2033699345641,849,26,NTRK1|CDK5|RAMP3|IGF1R|FYN|FCGR2B|PRNP|CHRNA7|IGF1|ADRB2|CD36
MONOACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046462,0.284383694205879,0.7935431103190501,0.6931366766009951,1.1329128563259399,2350,2,ABHD16A|ABHD12
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010575,0.9246389891696751,1.0,-0.146870515509438,-0.6440967125967489,4097,19,RORA|PTGS2|C5|SULF1|BRCA1|ISL1|ARNT|FLT4|CCBE1|C3|HPSE|TGFB1|CYP1B1|IL6ST|ATF4|HIF1A|IL1B|EIF2AK3|SULF2
EMBRYONIC FORELIMB MORPHOGENESIS%GOBP%GO:0035115,0.0264307313248964,0.337668602007655,0.745192513387705,1.5791341203663103,235,4,TBX3|ZNF358|NIPBL
G1 TO G0 TRANSITION%GOBP%GO:0070314,0.560783839361316,0.936434965680841,0.5812517231872071,0.9500399736305709,4635,2,ZNF503|CYP27B1
RADIAL GLIAL CELL DIFFERENTIATION%GOBP%GO:0060019,0.6691365979381441,0.964618776001639,0.33976230121007106,0.835595898214047,6230,6,HES1|LEF1|METTL3
L-LYSINE CATABOLIC PROCESS TO ACETYL-COA VIA L-PIPECOLATE%GOBP%GO:0033514,0.855838926174497,0.991298302704726,0.5731693868548741,0.761429959537468,6375,1,PIPOX
PEPTIDYL-PROLINE MODIFICATION%GOBP%GO:0018208,0.739978902953587,0.9744283926676119,-0.156933264116475,-0.814174803521392,2805,30,PPIH|PPIL3|FKBP4|FKBP1A|EGLN3
RESPONSE TO MAGNESIUM ION%GOBP%GO:0032026,0.9027061855670101,1.0,0.259595096632314,0.638436333783613,8405,6,D2HGDH|ANK3|THBS1|SLC41A1
RESPONSE TO TUMOR CELL%GOBP%GO:0002347,0.8701230228471001,0.9934031064448321,-0.24786277646020602,-0.6803666786149088,4950,6,PRF1|IGFBPL1|ADAM15|MICA|TXNIP|RBMS3
SERYL-TRNA AMINOACYLATION%GOBP%GO:0006434,0.211581291759465,0.7263676975183471,-0.731101790801275,-1.25051045785824,1424,2,SARS
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007197,0.109203296703297,0.58452352834625,-0.5506450677587149,-1.3939214243178701,635,5,HRH3|CHRM1
LUNG-ASSOCIATED MESENCHYME DEVELOPMENT%GOBP%GO:0060484,0.819599109131403,0.987153241368501,-0.430960370310433,-0.7371346326549241,5519,2,WNT11
MOLYBDOPTERIN COFACTOR METABOLIC PROCESS%GOBP%GO:0043545,0.760201890034364,0.977664504547119,0.31072216408219705,0.7641759102365648,7078,6,GPHN|MOCS2|MBIP
REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902302,0.30322802197802196,0.8055436753253159,-0.443445838683325,-1.12255369430849,1765,5,KCNE3|ANO6|DLG1
NEGATIVE REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902894,0.865248226950355,0.9927515509577959,-0.20211957249270998,-0.6838007669973131,4391,10,RELA|NFATC3|PPARD|PPARA|NFIB
MITOCHONDRIAL CALCIUM ION HOMEOSTASIS%GOBP%GO:0051560,0.6976534296028879,0.96731875442989,-0.189356887162785,-0.8304195577039799,3091,19,PDZD8|LETM1|BCAP31
MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0050804,0.332782824112304,0.8293509737209019,-0.12923976491596698,-1.05863382077429,402,173,GPER1|SHISA9|OPHN1|GRIN2C|SYT11|CHRNB2|IL1B|MTMR2|NPTX1|CX3CL1|NSMF|PTK2B|SQSTM1|NAPB|ABL1|SYN1|VPS18|GRID1|PXK|YWHAH|SLC30A1|NAPA|VAMP2|CHRNA7|CAMK2A|HAP1|IQSEC2|ARC|CBLN1|SNCA|FMR1|GRM2|PNKD|JPH3|TPRG1L|CHRNA3|RELN|ADCYAP1|DRD2|PARK2|RAB5A|MCTP1|CACNG3|PLK2|CACNG7|TNF|TMEM108|GRM8|CPLX1|EPHB2|HOMER1
CAP1 MRNA METHYLATION%GOBP%GO:0097309,0.5346558606507801,0.9265056012720759,0.591673559415495,0.967074178641118,4419,2,CMTR2|CMTR1
REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:1902366,0.479060402684564,0.9046812288131709,0.764501543890604,1.01560619422674,3568,1,LFNG
REGULATION OF GLUCOCORTICOID SECRETION%GOBP%GO:2000849,0.5518453427065029,0.9321968967758479,-0.33128103445164697,-0.9093441956749979,3139,6,CRHR1|CRH|GAL
LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032641,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
RESPONSE TO LIPID HYDROPEROXIDE%GOBP%GO:0006982,0.36917866215072,0.852268858837246,0.6566965174505489,1.0733524172642601,3051,2,MGST1|GPX3
REGULATION OF LYASE ACTIVITY%GOBP%GO:0051339,0.31632902123505,0.8176737565328901,-0.23040414690093902,-1.10443351924778,1295,24,STIM1|ORAI1|PARK7|CAP1|GNAI3|CAP2|CRHR1|GNAI2|MTRR|GRM2|FXN|NOS3|GUCA1A
NEGATIVE REGULATION OF CD4 BIOSYNTHETIC PROCESS%GOBP%GO:0045225,0.0713623725671918,0.514511211182091,-0.9631120423467141,-1.2883843440871898,538,1,ACOT8
SPINAL CORD MOTOR NEURON DIFFERENTIATION%GOBP%GO:0021522,0.8094846039848509,0.984682960940884,-0.32000598830614096,-0.735946921511495,4915,4,TBX20
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SPINDLE POLE BODY%GOBP%GO:1902365,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
REGULATION OF METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072307,0.361194029850746,0.848418604328854,-0.523668748636855,-1.06277016647668,2298,3,LIF|PAX8
MEMBRANE LIPID METABOLIC PROCESS%GOBP%GO:0006643,0.812794811320755,0.985971473561293,0.133658229049593,0.793696488978743,11027,145,SPTSSB|B3GALT2|NSMAF|HACD1|FUT7|PGAP1|B4GALNT1|CERS4|ELOVL6|PPAP2C|B3GALT1|ST3GAL5|CERS6|PIGC|CLN6|GBA2|PIGF|ALDH3A2|PIGQ|PIGB|B4GALT6|SMPDL3A|ST8SIA3|MGST2|PDXDC1|ORMDL1|CERS5|SMPD3|ASAH1|B3GALNT1|ACER2|B4GALT4|ST3GAL4|SMPD1|ARV1|PPM1L|ELOVL4|PIGL|LARGE|ST3GAL6|PPP2R1A|SMPD4|TEX2|CERS2|ELOVL2|PIGK|CPTP|B4GALT3|PIGH
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010744,0.89609872611465,0.998875345169598,0.208330173496327,0.6355676039930379,9003,11,LPL|AGTR1
MRNA SPLICE SITE SELECTION%GOBP%GO:0006376,0.21586732406992398,0.73227749977919,0.29481805769033,1.22123567288646,2407,29,CELF5|NOL3|SFSWAP|CELF1|PRPF39|SRSF1|C7orf55-LUC7L2|LUC7L|LUC7L3|SRSF6|YTHDC1|CELF3|PSIP1|SRSF9|SRSF5|SETX|SRSF10|CELF6
REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905048,0.0169424743892829,0.277340114229305,-0.528894726593682,-1.7893300250208999,85,10,TIMP3|PICALM|MBP|TIMP2|KARS|STAT3|DDRGK1
ACTIVATION OF BLOOD COAGULATION VIA CLOTTING CASCADE%GOBP%GO:0002543,0.7051224944320709,0.968941691852291,-0.47755635421271997,-0.8168345675985141,4748,2,ANO6
REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000520,0.38619153674833,0.8596647264526249,-0.623185374823072,-1.06592520796107,2600,2,LGALS3
CELL CYCLE CHECKPOINT%GOBP%GO:0000075,0.00101892285298399,0.0872881177264294,0.287672524500615,1.7435474716383002,13,167,BTG2|MUS81|TAOK3|INTS7|EME2|CEP63|CCNB1|PIDD1|TPR|CDK1|E2F8|ZWINT|ATR|BLM|CENPF|DOT1L|WEE1|BRIP1|ORC1|CDC25C|DNA2|MUC1|CDC45|BUB1|RAD9A|DTL|TOP2A|E2F7|DONSON|CDC20|GEN1|APC|ZNF830|NEK11|NABP1|RB1|BUB1B|NAE1|GTSE1|AURKB|CDC6|MSH6|CLOCK|HRAS|CDKN2B|INTS3|H2AFX|TIMELESS|KLHL22|TAOK1|RPS27L|BRCC3|CHEK2|TOPBP1|PLK1|KNTC1|PRMT1|TIPRL|EME1|BRSK1|CARM1|AURKA|CHFR|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|TOP2B|C5orf45|TEX14|PRKDC|CHEK1|RAD17|MAD2L1BP|RAD1|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1|UIMC1|BRCA1
INTRALUMENAL VESICLE FORMATION%GOBP%GO:0070676,0.21380846325167,0.7299867877356379,-0.729749103942652,-1.24819675943184,1439,2,RILP|SNX3
DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007212,0.7959363957597171,0.9828140955992151,-0.18076281394260998,-0.760629130214715,3603,17,GNAI3|ARRB2|GNA15|GNB5|DRD2|GNAS
ABDUCENS NERVE FORMATION%GOBP%GO:0021599,0.6536475572620151,0.9640743070248079,-0.6671812968681079,-0.8925087630076741,4936,1,MAFB
REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903541,0.451634275618375,0.886411023801201,-0.234050772626932,-0.9848587313197391,2044,17,SMPD3|TSG101|SNF8|HGS|ATP13A2|CHMP6|SDC4|CHMP3|CHMP2A|STAM|SDC1|SDCBP|PDCD6IP|VPS4A|VPS4B|RAB7A|PARK2
HORMONE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0009755,0.7061941302112171,0.9690009414334909,0.157127109469935,0.8431274147485981,8926,82,GHRL|PIAS1|CRHBP|SAFB|BMP4|RARB|RHOXF1|EGLN2|MED12|SRC|CCNE1|RB1|DDX17|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2|ADIPOR2|THRAP3|ABHD2|ARID1A|MED30|TRIP4|DDX5|MED14|BRCA1|RBFOX2|NCOA3|MED16|UBR5|SST|LGR4|NCOA6|NUP62|CSNK2B
REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1901979,0.0481069042316258,0.43158095394363793,-0.86619795547418,-1.48158521224347,323,2,CAV1
T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:0072540,0.384787087912088,0.8593496731626808,-0.411808112050159,-1.04246489018974,2240,5,BATF|IL6|STAT3
POSITIVE REGULATION OF B CELL CHEMOTAXIS%GOBP%GO:2000538,0.860282108389013,0.9916689277956879,-0.4095947063689,-0.7005898087546989,5793,2,XCL1|PTK2B
DISRUPTION OF CELLS OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051818,0.917297698589458,1.0,-0.374155206518955,-0.6399724422795731,6177,2,GAPDH
CHROMOSOME CONDENSATION%GOBP%GO:0030261,0.0203442879499218,0.29895452771841496,0.430098628311959,1.67274099518885,220,23,DFFB|AIFM1|NCAPD3|TOP2A|SMC2|NUSAP1|AKAP8L|NCAPH2|NIPBL|CDCA5|NCAPG|NCAPH|ACIN1|SMC4
GLOMERULAR EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072310,0.8857609880130771,0.996643473105967,-0.22890237175951503,-0.667718373897014,4876,7,MAGI2|JAG1|IQGAP1|MYO1E|FOXJ1|NUP93|PODXL
REGULATION OF SNARE COMPLEX ASSEMBLY%GOBP%GO:0035542,0.771216341689879,0.979531699879292,-0.24453392106379102,-0.7601178985535542,4152,8,VPS18|VPS11|VPS16
L-FUCOSE CATABOLIC PROCESS%GOBP%GO:0042355,0.0044229149115417,0.155321503601441,0.704831306259653,1.8345278050541398,41,7,FUT9|FUT7|FUT2|FUT8|FUT10
NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009125,0.9740018570102141,1.0,-0.17482828440097398,-0.543442429453069,5244,8,NUDT4|HPRT1
NEGATIVE REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014745,0.0013173061090070801,0.0945022140486112,-0.8619643743451171,-1.98233799032847,7,4,FOXO1|ATP2B4|LMNA|NOS3
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002761,0.9360402739952131,1.0,0.12605660799279597,0.625828696571881,11341,57,CARTPT|CEACAM1|CDK6|INHA
"DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0050652",0.733615781808553,0.9734087938149171,-0.628584031760035,-0.840876024651859,5540,1,CSGALNACT2
REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032303,0.280391483516484,0.788916642629372,-0.453176704169424,-1.14718673412384,1632,5,P2RX4|PLA2R1|SYK|IL1B|TNFRSF11A
NEGATIVE REGULATION OF ELASTIN CATABOLIC PROCESS%GOBP%GO:0060311,0.8187475175426979,0.987153241368501,-0.588056903396559,-0.786661649378252,6183,1,CST3
REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000282,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|ATP2B4
REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:0061469,0.302135541512312,0.8052247671363699,0.49598179419463895,1.14316451053277,2772,5,NR4A3|NR4A1
POSITIVE REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001798,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE%GOBP%GO:0048790,0.6581208053691279,0.9643779777660141,0.6764446404940451,0.89862652656139,4902,1,RAB3A
POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990573,0.35241801000555895,0.842847021021096,0.28582691964545,1.09465079920791,3803,22,SLC12A2|HCN2|ATP1B3|KCNJ11|KCNH2
REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY%GOBP%GO:1901668,0.468813825608798,0.896113819860135,-0.48045886112986497,-0.975076983603387,2983,3,TNF
ENZYME-DIRECTED RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0000455,0.387676317743133,0.859991269020751,-0.622049085332116,-1.0639816456425601,2610,2,RPUSD2
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:0090178,0.225648289387666,0.7398172623753029,0.53169595131445,1.2254803483736598,2070,5,DVL1|NPHP3|DVL3|DVL2|NPHP3-ACAD11
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0015012,0.40825117258543103,0.867015886388254,0.301469632660526,1.04511346091506,4264,16,GLCE|B3GAT3|HS3ST5|EXT1|XYLT2
CLARA CELL DIFFERENTIATION%GOBP%GO:0060486,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
LYSOSOMAL LUMEN PH ELEVATION%GOBP%GO:0035752,0.659737852508937,0.9643779777660141,-0.663928098808999,-0.888156860774827,4982,1,CLN3
RESPONSE TO METHOTREXATE%GOBP%GO:0031427,0.19932885906040299,0.711592141628341,0.9026246140273491,1.19909653079638,1484,1,DHFR
NEUROTRANSMITTER RECEPTOR TRANSPORT TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098969,0.666280539174389,0.964618776001639,0.31977290153901194,0.8323016783821,6326,7,LRRC7|STX3|ARHGAP44|SCRIB|STX1B
PSYCHOMOTOR BEHAVIOR%GOBP%GO:0036343,0.544287038262942,0.929758904310055,-0.7228164975738859,-0.9669336672948431,4110,1,C12orf57
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001241,0.0931994072122509,0.5622489437340121,-0.63442342690123,-1.4590413461765,565,4,INHBA|HTRA2|RET|PPP2R1B
REGULATION OF PENILE ERECTION%GOBP%GO:0060405,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
TRANSSULFURATION%GOBP%GO:0019346,0.461231401959598,0.8908856132322029,0.618954095104579,1.01166346478477,3812,2,CTH
MALE GONAD DEVELOPMENT%GOBP%GO:0008584,0.3994771863117871,0.8638522656500329,-0.22259253913899302,-1.0312134485417699,1680,22,KITLG|MAMLD1|LRRC6|CSDE1|MEA1|BIK
PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0051260,0.593534326189611,0.9464278097528599,0.154001350318108,0.935075949088516,8169,169,KIF25|SLC1A2|CTH|CRYZ|MGST1|TMEM120A|DFFB|CBR4|ACTN2|TMCC1|FSD1|IDE|LONP1|ADCY8|PKD2|BLM|GLS|APIP|ECT2|DISP1|GBP5|SPTBN5|TK1|GSDMD|DECR1|GBP1|APC|IKZF4|AKR1C1|POLQ|MCOLN1|GOPC|RAD51|ZBTB1|LY6G5C|ACACA|ASIC1|SMARCAD1|DPYSL3|ELAVL1|NLRC4|ATPIF1|CD3D|TOR2A|PRMT1|PRF1|RIPK1|CAT|SYT1|CD79A|MICU1|IGHMBP2|CD3G|CD3E|TRAF2|CRYAB|RIPK3|TRPV1|PEX11B|IKBKE|P2RX3|GNMT|MPP2|LY6G6C|ALAD|ACOT13|RBMX|ATL1|RAD52|SCUBE1|HSD17B10|SIGMAR1|GPX3
APOPTOTIC NUCLEAR CHANGES%GOBP%GO:0030262,0.5589228748358039,0.936434965680841,0.24866674183228302,0.9234237597657071,5956,20,DFFB|ENDOG|BLCAP|TOP2A|FEN1|ACIN1|DICER1|CDK5RAP3|DNASE1L3
NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903051,0.0886932972241029,0.556932119338259,-0.212902856638433,-1.3307824021633101,261,55,ERLEC1|CCAR2|PARK7|RPL11|RYBP|MAP1A|TAF9|OPHN1|TRIM39|UBE2J1|STYX|FAM192A|OS9|PML|PDCL3|CSNK2A2|GLTSCR2|EFNA1|BAG5|DDRGK1|CSNK2A1|HSP90AB1|GABARAPL2|PSMF1
PHOSPHATIDYLSERINE BIOSYNTHETIC PROCESS%GOBP%GO:0006659,0.27651472729309,0.7884684708511421,0.54634166284484,1.1577501728430402,2468,4,PTDSS2|SLC27A1|PTDSS1
CELLULAR PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043624,0.8555155875299759,0.991298302704726,0.129650769538877,0.753287839188679,11415,126,NCKAP5|MRPL50|MRPS36|MRPS11|KIF14|CHCHD1|MRPL42|MRPL46|KIF2C|CCSAP|KIF18A|CKAP5|MRPL17|GFM2|MRPS5|MRRF|KIF24|MRPL38|MRPL35|PTCD3|ERAL1|KIF18B|MRPL16|ABCE1|MRPS31|STMN1|MICAL3|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|GSPT2|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40|MICAL1|MRPL13|STMN2
NEGATIVE REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905454,0.401073825503356,0.8638522656500329,0.806517423908249,1.07142241636888,2987,1,DPF2
POSITIVE REGULATION OF DOPAMINE SECRETION%GOBP%GO:0033603,0.407520190652721,0.867015886388254,-0.794938244375827,-1.0634131269654201,3077,1,CHRNB2
10-FORMYLTETRAHYDROFOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0009257,0.5363493407523889,0.9265056012720759,0.5910856801435961,0.9661133061211871,4433,2,MTHFD1|MTHFD1L
SUPERIOR ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905316,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
DITERPENOID METABOLIC PROCESS%GOBP%GO:0016101,0.0128993160765302,0.24668080085844798,0.385473336560465,1.7268385585897,148,38,ALDH1A2|RBP1|BCO2|RARRES2|NAPEPLD|ALDH1A1|GPC2|ALDH8A1|GPC6|AKR1C1|GPC1|ALDH3A2|APOE|LRP8|GPC3|RDH11|APOM|AGRN
PEPTIDYL-ASPARTIC ACID HYDROXYLATION%GOBP%GO:0042264,0.6096915133059712,0.9508825506493929,-0.688685487428319,-0.9212755743773431,4604,1,HIF1AN
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000351,0.12002124269782301,0.606367236216791,-0.25301964136537997,-1.33051255974095,451,31,GPER1|IL11|KDR|MAPK7|TNFAIP3|ECSCR|ICAM1|RAMP2|PDCD4|ANO6|SCG2|TNIP2|TNF
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061316,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
NEGATIVE REGULATION OF BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:2000813,0.8229379418695991,0.987616425875001,-0.355795742803573,-0.7220768888640849,5237,3,FAM21C|LRRC16A|RLTPR
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903078,0.12141347025068,0.607607158836689,-0.226101576862978,-1.30190921853627,401,42,ACSL3|PIK3R1|DLG1|TNF|STAC|EPHB2
REGULATION OF MAST CELL CHEMOTAXIS%GOBP%GO:0060753,0.8910438003922421,0.997300970905927,0.281479775609578,0.6487691557955091,8177,5,FIGF
COMPOUND EYE DEVELOPMENT%GOBP%GO:0048749,0.218059049384351,0.7341474817293291,-0.889997794441994,-1.19057718543032,1646,1,CHRDL1
POSITIVE REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034116,0.748178137651822,0.9749763305090959,0.270912165727023,0.773090756588318,7391,9,GCNT2|SKAP1
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032331,0.0545705279747833,0.45643561302544805,-0.461320398312303,-1.5607159579205803,276,10,SNAI2|PTHLH|TGFBR1|FAM101B|FAM101A|GREM1
VISUAL PERCEPTION%GOBP%GO:0007601,0.38603158517017105,0.859630103805729,0.22306784865649898,1.05805500744434,4570,47,RGS16|FSCN2|SIX3|GPR179|CRYZ|COL18A1|ADGRV1|DNAJC19|EFEMP1|ABLIM1|RABGGTA|TH|CNGB1|SLC24A1|PRR4|MYO7A|CRYGC|BEST1|REEP6|COL11A1|COL1A1|EYA3|BBS2
ZYMOGEN INHIBITION%GOBP%GO:0097341,0.168763647707185,0.672658187648302,0.4741629634496529,1.29269544846104,1622,8,NOL3|BIRC2|CARD16|BCL2L12|XIAP|BIRC3
REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032479,0.119836586472991,0.6056190749402529,-0.173579852456333,-1.24750990510746,263,92,IFI16|ISG15|RNF26|DHX33|POLR3F|MB21D1|HAVCR2|RELA|RNF135|CREBBP|FLOT1|PYCARD|RIOK3|SETD2|POLR3C|XRCC6|ITCH|OTUD5|IRAK1|POLR3D|SIRPA|CTNNB1|MRE11A|TNFAIP3|PCBP2|TRAF3|DDX3X|RELB|REL|CYLD|RNF216|MAVS|GPATCH3|TREX1|RIPK2|TRAF3IP1|TRIM25|TAX1BP1|MYD88|LRRFIP1
DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901950,0.522641198748559,0.9251240799994541,-0.404455964264049,-0.9301642239967359,3173,4,KIF1C|KIF1A|KIF5B|KIF5A
RESPONSE TO STARVATION%GOBP%GO:0042594,0.0005285412262156451,0.0784645998831315,-0.24877819350007502,-1.8798176069220303,0,112,EIF2S1|IMPACT|PIK3C3|RRAGD|BCAS3|STK26|PRKAA1|HSPA5|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|FAM65A|EIF2AK1|MAP1LC3A|KLF10|FOXO1|SEH1L|NUAK2|SH3GLB1|ATG7|GCGR|BECN1|TBC1D5|C12orf66|PPARGC1A|TP53|GABARAPL1|RALB|ADCYAP1|MAPK3|GABARAP|CDKN1A|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|PMAIP1|INHBB
POSITIVE REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000418,0.8261763638562959,0.9876441563834109,0.475489385166805,0.77717433759761,6829,2,DAPK2|ADAM8
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE-NOREPINEPHRINE%GOBP%GO:0001996,0.35560504825538203,0.843963199220033,-0.645561966284343,-1.10419916924199,2394,2,PDE4D
PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE%GOBP%GO:1903361,0.434798401743553,0.878651088001772,-0.34282365918953395,-1.00003182355818,2393,7,PDZD11|CAV1
NEGATIVE REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903723,0.7897524162584398,0.9819233677232551,-0.602117335685929,-0.805470718350728,5964,1,CHMP2A
CELL CHEMOTAXIS%GOBP%GO:0060326,0.635988065182465,0.95916055221954,0.158840271869335,0.8987736042155691,8312,109,EDN1|EGR3|CXCL13|SLC12A2|NOV|CXCR4|NR4A1|CXCL9|PTPRO|AGTR1|SEMA5A|TGFB2|PRKCQ|CCR5|XCL2|CCL21|AZU1|CCL5|LEF1|KIT|CCL19|CYP7B1|CXCL10|RPS19|CCL2|CXADR|AMICA1
POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0001956,0.872852233676976,0.9934031064448321,0.272564173271534,0.670331889013724,8127,6,UNC13B|BAIAP3|STX1B|DTNBP1
POSITIVE REGULATION OF TOR SIGNALING%GOBP%GO:0032008,0.35100210970464096,0.842847021021096,-0.205445407853316,-1.06585735991065,1330,30,HDAC3|KLHL22|RRAGB|WDR24|CLEC16A|TELO2|LAMTOR4|LAMTOR3|LARS|MLST8|LAMTOR1|RICTOR|PIH1D1|PIK3CA|GOLPH3|RPTOR|WDR59|MIOS|RRAGA|SLC38A9|SMCR8|RHEB|LAMTOR2|GAS6|FLCN|SEC13|RRAGD|RRAGC|SEH1L|LAMTOR5
AMYLOID-BETA CLEARANCE BY TRANSCYTOSIS%GOBP%GO:0150093,0.430822189858334,0.8785877309899279,-0.782752536391707,-1.04711193385595,3253,1,PICALM
EARLY ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0034498,0.00849917081260365,0.20298122046820802,-0.516750352382178,-1.8825733689227302,40,12,SNX1|SURF4|STX10|EHD3|RAB6A|RBSN|TRAPPC10|SNX8
SULFIDE OXIDATION%GOBP%GO:0019418,0.940945739812595,1.0,0.257008714665615,0.5923669879464909,8635,5,SLC25A10|SUOX
BLOOD VESSEL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060846,0.0686567164179105,0.5037729184803449,-0.743410168743796,-1.5087288497794098,436,3,DLL1|NRP1|RBPJ
HOMOLOGOUS RECOMBINATION%GOBP%GO:0035825,0.0216097987751531,0.30931709379024297,0.37017187089509895,1.6339521147123501,246,36,MUS81|EME2|MLH3|RAD54B|BLM|C11orf80|BRIP1|TOP2A|RAD51C|RAD51|MND1|FANCM|REC8|SLX4|EME1|RMI1|STRA13|TOP2B|UBR2
RECEPTOR CLUSTERING%GOBP%GO:0043113,0.0958492626979793,0.568131581797149,0.348892271047482,1.40271404683467,1052,26,GPHN|LRRC7|MADCAM1|DLG3|DNAJA3|DVL1|ITGA4|APOE|MAGI2|DLG4|SYNJ2BP-COX16|SYNJ2BP|AGRN|PICK1|SCRIB|FLNA|NRXN2|DLG2
LAGGING STRAND ELONGATION%GOBP%GO:0006273,0.400852656753665,0.8638522656500329,0.38548505413147205,1.05093567684019,3854,8,DNA2|FEN1|RNASEH2A|LIG1|WRNIP1
PYRIDINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0019362,0.0273453933529659,0.339785941813865,-0.206167069428287,-1.4284003385717,64,80,PFKL|DERA|GPI|G6PD|MDH1B|PKM|PNP|ENO1|NAMPT|PGD|PDHB|GAPDH|KCNAB2|PGK1|TP53I3|HK1|NMNAT3|HK2|TPI1|ALDOA|TKT|NT5E|PGAM2|NMNAT2
RESPONSE TO PROGESTERONE%GOBP%GO:0032570,0.958215583366976,1.0,-0.165380781018513,-0.58199557307765,4746,11,CAV1
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010574,0.573245407442299,0.9412569098405621,-0.20030689577155802,-0.9097530556594159,2433,21,CYP1B1|IL6ST|ATF4|HIF1A|IL1B|EIF2AK3|IL6|SARS|SULF2
FLAGELLATED SPERM MOTILITY%GOBP%GO:0030317,0.6708650190114069,0.964618776001639,-0.183003298821151,-0.847806775563308,2822,22,ATP2B4|SORD|DNAI1|LRRC6|IQCG
POSITIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032379,0.36853073984022205,0.851931544178381,0.5657719883987329,1.0754730329668,3182,3,LDLRAP1|ANXA2|SCP2
DYNAMIN FAMILY PROTEIN POLYMERIZATION INVOLVED IN MITOCHONDRIAL FISSION%GOBP%GO:0003374,0.0520335913057797,0.44586532408291796,-0.688027353443997,-1.5823191789723603,315,4,DNM1L|OPA1|MX1|MX2
REGULATION OF NEURON MATURATION%GOBP%GO:0014041,0.590200445434298,0.945418171231938,-0.525558312655087,-0.898939346693731,3974,2,EDNRB|MAP3K13
HISTONE H2A-K15 UBIQUITINATION%GOBP%GO:0036352,0.00595789752416258,0.175567154622165,-0.99724305249228,-1.33404243700469,44,1,RNF168
POSITIVE REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:2000105,0.0442307692307692,0.41504430757275895,0.545951015004413,1.5579576580374301,436,9,CDC7|E2F8|E2F7|DBF4B|INO80|WIZ|CDT1|STOML2|ATRX
POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0098779,0.5725834797891041,0.940734934957679,-0.326348110261223,-0.8958036499939219,3257,6,MFN2|PARK2
REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:1902473,0.905096660808436,1.0,-0.23467918605170898,-0.6441786081569439,5149,6,IQSEC2|RAP1A
POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION%GOBP%GO:2000848,0.594951923076923,0.9473459395438281,-0.347847619775427,-0.88055315119141,3464,5,CRH|GAL
ACTIVATION OF PLASMA PROTEINS INVOLVED IN ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002541,0.43020134228187895,0.878382989709062,0.7912439347154829,1.0511322673749601,3204,1,F3
NEGATIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031645,0.089901925172539,0.559960743386206,-0.498358373234789,-1.4537334848758001,494,7,NLGN4X|MTMR2|EIF2AK3|CBLN1|TNFRSF21
MALATE-ASPARTATE SHUTTLE%GOBP%GO:0043490,0.206652395850486,0.7211951452265429,-0.537790206924733,-1.2368051276173302,1254,4,SLC25A13|SLC25A18
ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0030036,0.984982088729678,1.0,0.0983535820293012,0.6454461686713411,14297,323,NF2|NEB|FSCN2|RHOBTB1|ITGB1|FGD6|WASH1|IGSF22|GHRL|SHROOM2|BRSK2|ARAP1|RAC3|ACTN2|EVL|TTC17|HIP1R|ARFIP2|MYH3|PROX1|TRIM27|TCAP|CDC42BPA|ARHGAP25|PPP1R9A|TBCK|HSP90B1|FHDC1|PDPK1|JAK2|FRMD5|AMOT|FRMD3|ATXN3|SPTBN5|TNFAIP1|LIMA1|AMOTL2|FARP2|CTTN|OBSCN|SRC|FGD1|KRT19|ANLN|MSRB2|ARHGEF17|ITGB5|CORO1A|CAPN10|KIT|RUFY3|NF1|TNXB|KLHL17|RHOBTB3|NEBL|IQSEC3|CXADR|ARHGEF11|LMOD1|OBSL1|MICALL2|DPYSL3|SRF|SHTN1|FGD2|CDC42BPB|ANTXR1|MICAL3|NPHP4|RAC2|TESK1|RACGAP1|ARPC1A|ARHGEF18|EPB41|ALKBH4|EPB41L4A|EPB41L5|LLGL2|MYOM2|TPM2|TAOK2|ARHGAP17|SAMD14|KCTD13|DIAPH3
ERK1 AND ERK2 CASCADE%GOBP%GO:0070371,0.0625686059275521,0.488082281095709,-0.36430110439582,-1.4919354606308401,284,16,KDR|LGALS9|IGF1|KARS|CTSH|FGF10|MAP2K1
DEVELOPMENT OF PRIMARY MALE SEXUAL CHARACTERISTICS%GOBP%GO:0046546,0.467504228074414,0.895274921500968,-0.210066857844144,-0.9870865985782559,1934,23,KITLG|MAMLD1|LRRC6|CSDE1|MEA1|BIK
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048146,0.728216334334881,0.972554563883587,0.20110998051704998,0.801394342626807,7997,25,CDK6|LIG4|DHX9|DDR2|NDUFS4
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000564",0.304875429553265,0.808356844223606,0.46513753802958,1.1439380340274699,2838,6,SH3RF1|XCL1|MAPK8IP1|HLA-E|IRF1
REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901298,0.42196836555360295,0.873470206885489,-0.36574263474795704,-1.00393897456113,2400,6,TRAP1|PARK7|HGF|MET
REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903069,0.387739164388911,0.859991269020751,-0.32266501787469704,-1.0415915924051,1985,9,BCAP31|CAV1
POSITIVE REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070346,0.38099480326651797,0.8566948330269879,-0.626854149434795,-1.07220045044742,2565,2,PID1|VSTM2A
RESPONSE TO HYPOXIA%GOBP%GO:0001666,0.000643500643500644,0.0806484601749226,-0.22410767832126102,-1.7640460036058603,0,135,CBFA2T3|CHRNB2|VEGFA|PDK3|PLK3|CPEB1|USF1|PRKAA1|HMOX1|DDIT4|UCP2|LIMD1|PML|HIGD1A|CITED2|STUB1|MMP2|HYOU1|BACH1|CPEB2|P4HB|GLTSCR2|CHRNA7|LMNA|ACAA2|PGK1|RYR1|VHL|GNGT1|TCEB1|ADAM17|MMP12|UBA52|TP53|ALKBH5|BNIP3L|UBC|PGF|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|CAV1|NDRG1|UBB|EGLN3
PROTEIN IMPORT%GOBP%GO:0017038,0.846702317290553,0.991298302704726,-0.10539310600136699,-0.813993605343096,1424,124,TOMM22|CLU|KPNA1|PTTG1IP|TIMM50|RGPD8|ROMO1|SAMM50|PRICKLE1|TOMM20|RAB8B|C19orf52|TIMM23|PEX26|RGPD1|DNLZ|KPNA4|PEX7|TIMM22|MMP12|PEX19|STAT3|BCL3|BCL6|TIMM23B|RGPD6|PEX5|NUTF2|TNF
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX II ASSEMBLY%GOBP%GO:0034553,0.926307537238213,1.0,0.29351058254767703,0.621976962010199,8270,4,SDHAF3|SDHAF1|SDHAF4
RESOLUTION OF RECOMBINATION INTERMEDIATES%GOBP%GO:0071139,0.0138937130948246,0.256136946817111,0.840796294253888,1.5982653069264299,119,3,XRCC3|BLM|GEN1
CELLULAR DIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072501,0.364026845637584,0.8499434076701009,0.823279664755183,1.09369030551745,2711,1,XPR1
POSITIVE REGULATION OF MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032765,0.47538405709447207,0.9012976954254781,0.613672197209136,1.00303034777689,3929,2,NR4A3
MITOTIC DNA REPLICATION%GOBP%GO:1902969,0.12355633035519699,0.607607158836689,0.58946691636176,1.3586338587531102,1133,5,CDC45|LIG1|BRCA2|GINS1
REGULATION OF KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0051709,0.686126373626374,0.9665006495129341,-0.322208962353078,-0.81565059242116,3995,5,GAPDH|FCER2
SERINE TRANSPORT%GOBP%GO:0032329,0.843638289421422,0.991298302704726,-0.575981473312748,-0.770507978378361,6371,1,SLC1A4
DNA METHYLATION ON CYTOSINE%GOBP%GO:0032776,0.741208053691275,0.974505008828563,0.632829730921923,0.8406860649938929,5521,1,DNMT1
CELLULAR RESPONSE TO PHORBOL 13-ACETATE 12-MYRISTATE%GOBP%GO:1904628,0.9092778516995279,1.0,0.4298869589192171,0.7026384246678621,7516,2,ADAM15|MAP4K1
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0045939,0.45720633693972207,0.88985710965551,0.295360602256042,1.00145320953482,4732,15,FGF19|WNT4|PROX1
POSITIVE REGULATION OF JNK CASCADE%GOBP%GO:0046330,0.5767543859649119,0.942692029750853,0.170248467337383,0.9317682852900719,7363,91,SH3RF1|EDN1|CTGF|TPD52L1|FGF19|TAOK3|MAP3K10|CD27|AGER|ERN1|MAP3K9|DUSP19|MAP3K5|MAP3K7|CCL21|F2RL1|HRAS|CCL19|GADD45B|GADD45G|MAP3K4|TAOK1|MAP2K7|CARD9|TRAF4|RIPK1|MAP3K12|TAOK2|TRAF2|RASGRP1|DVL3|UNC5CL|TNFRSF19|DVL2|SPAG9|TNIK|MINK1
REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0006110,0.6949757714868661,0.96731875442989,-0.169245670655751,-0.8433845269653459,2724,27,EIF6|HIF1A|CBFA2T3|PRKAA1|PFKFB4|PRKAG1|HDAC4|FBP1|PPARA|IGF1|AAED1
REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905024,0.356495965750041,0.844559957061487,-0.463362036379464,-1.06563588395268,2164,4,KCNE3|DLG1
POSITIVE REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051135,0.9252428783138481,1.0,-0.273203551535874,-0.628311094311403,5618,4,RASAL3|HSPH1|IL18|IL6R
NEGATIVE REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060051,0.35647756138865394,0.844559957061487,0.661814171491591,1.0817170822041702,2946,2,ACER2|TMEM59
FLAVIN ADENINE DINUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0072387,0.9551596139569409,1.0,-0.345409429280397,-0.5908043298383729,6432,2,VCP|FLAD1
NEGATIVE REGULATION BY HOST OF VIRAL GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0044871,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS%GOBP%GO:0071378,0.0524828421477594,0.447307566936778,-0.44475786607541395,-1.5651583427845701,259,11,PXN|LYN|PTPN1|STAT5A|STAT3|PIK3R1
REGULATION OF PODOSOME ASSEMBLY%GOBP%GO:0071801,0.00185701021355617,0.11072851755770098,-0.677346580145168,-2.10548809282812,9,8,CAPG|ASAP1|KIF9|TNF
REGULATION OF LONG-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048169,0.4667060677698979,0.8946422270258639,-0.28775573403008303,-0.973520719497575,2368,10,DRD2|RAB5A
ECTODERMAL CELL DIFFERENTIATION%GOBP%GO:0010668,0.018381775333856997,0.285037997475661,-0.824032204698357,-1.6723488763633,116,3,ITGAM|ITGA6|EDA2R
PROTEIN LOCALIZATION TO MEMBRANE RAFT%GOBP%GO:1903044,0.0537431318681319,0.45314328209901295,-0.6167324150589549,-1.5612171555828402,312,5,RFTN1|CAV1
NEGATIVE REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000961,0.49251952866410703,0.910097257414447,-0.7512681958535509,-1.00499437156856,3719,1,SLIRP
PYRIDOXAL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0042823,0.00801781737193764,0.19847993048827997,-0.9344361731458509,-1.5983030289656899,53,2,PNPO|PDXK
REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903010,0.6266745468873129,0.954682841596982,-0.253770382109388,-0.8585431870229159,3180,10,FBXW7|FAM101B|FAM101A|GREM1
POSITIVE REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904798,0.9092277411138129,1.0,0.343628636127395,0.653201888902499,7852,3,GTF2B|FOXC1|CTNNB1
MULTI-ORGANISM CATABOLIC PROCESS%GOBP%GO:0044035,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
CILIARY TRANSITION ZONE ASSEMBLY%GOBP%GO:1905349,0.670675575352635,0.964618776001639,-0.494017094017094,-0.844989781453062,4516,2,CBY3|CBY1
NEUTRAL LIPID METABOLIC PROCESS%GOBP%GO:0006638,0.154065169250237,0.6523838578248989,-0.20804330743607,-1.24256838760662,486,47,SLC27A5|MGLL|DGKQ|FABP4|LPIN1|PNPLA4|DGAT2|DGKG|DGKB|GPAT2|DGKK|CAV1|FABP3
EMBRYONIC FOREGUT MORPHOGENESIS%GOBP%GO:0048617,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061005,0.458716457121411,0.890371861972445,0.27040697812923803,1.0041561109905,4888,20,WNT4|BASP1|BMP4|PTPRO|ACTA2|MAGI2
SNRNA PROCESSING%GOBP%GO:0016180,0.447509787853956,0.885029542329102,0.25378244422165397,1.01128653353926,4914,25,INTS7|INTS9|DDX26B|INTS10|INTS6|INTS3|INTS1|INTS8|INTS2|TOE1|INTS4|EXOSC2|CPSF3L|TUT1|INTS5|EXOSC3
REGULATION OF CELLULAR RESPONSE TO X-RAY%GOBP%GO:2000683,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
BUD ELONGATION INVOLVED IN LUNG BRANCHING%GOBP%GO:0060449,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
POSITIVE REGULATION OF CHOLINE O-ACETYLTRANSFERASE ACTIVITY%GOBP%GO:1902771,0.642684563758389,0.9620807249753851,0.6838883987648879,0.908515227334604,4787,1,SORL1
REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904026,0.8157688430955309,0.986631695793843,0.346383882395588,0.734020535108678,7283,4,RB1|AEBP1
VESICLE FUSION WITH GOLGI APPARATUS%GOBP%GO:0048280,0.253416762720237,0.7641083395392759,-0.512228031617152,-1.1780174645353703,1538,4,GOSR2|VTI1B|VTI1A
NEGATIVE REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003105,0.0227410185073183,0.31609926985007897,0.8988695891921701,1.4691776501424798,187,2,F2R|PTPRO
SNORNA GUIDED RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0000454,0.128285077951002,0.608160579951936,-0.782189137027847,-1.33789262751554,863,2,NAF1|GAR1
REGULATION OF SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0090182,0.345028465510393,0.841038624862765,-0.828021614468461,-1.1076697598418401,2605,1,NR1H3
CELLULAR RESPONSE TO GLUCAGON STIMULUS%GOBP%GO:0071377,0.509989023051592,0.918404893008545,-0.23159489328678198,-0.948458924846262,2322,16,PRKAR2A|GCGR|PRKAR1B|ADCY2
REGULATION OF STAT CASCADE%GOBP%GO:1904892,0.39952153110047794,0.8638522656500329,-0.16488410417114902,-1.03524225957493,1168,56,CYP1B1|IL6ST|AGT|IL6R|SOCS3|NOTCH1|VEGFA|CRLF1|PTK2B|LIF|MGAT5|ARL2BP|TNFRSF18|IL6|LYN|PPP2CA|IGF1|LEPROT|CNOT7|VHL|STAT3|BCL3|TNF|CAV1
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION%GOBP%GO:0048934,0.975135847192491,1.0,-0.23906689461203304,-0.549803914784,5921,4,ETV1|ISL1|RUNX3|RUNX1
REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:2000359,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
RESPONSE TO LEUKEMIA INHIBITORY FACTOR%GOBP%GO:1990823,0.227965435978005,0.740988338612706,-0.596007499724275,-1.2095795125299198,1450,3,SHMT1|HNRNPU|SBNO2
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010522,0.23865944482058202,0.7514142710406201,-0.18493294851232997,-1.1559521433680702,704,55,TMBIM6|PRKACA|AKAP6|CAMK2D|THY1|RAMP3|SRI|GPER1|CX3CL1|FKBP1B|PTK2B|PML|FYN|UBASH3B|PRNP|APLNR|HAP1|CEMIP|SNCA|JPH3|HTT|JPH1|PDE4D|CAV1|FKBP1A
POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046833,0.6566975568660489,0.9643779777660141,0.323103800173041,0.8409713077042851,6235,7,DHX9|CPSF6|RBM26|RIOK2
BENZENE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042537,0.33208955223880604,0.8293509737209019,-0.30008275862069,-1.0932315909373,1601,12,CCBL1|CYP2E1|AFMID|AADAT|GSTM2|CCBL2|ACAA1|KMO|KYNU|TDO2|GSTM3|GSTM1
NEUTROPHIL ACTIVATION%GOBP%GO:0042119,0.0220125786163522,0.310715277412964,-0.136813108454336,-1.2854373205358798,6,406,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CXCL8|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
MACROPHAGE DIFFERENTIATION%GOBP%GO:0030225,0.619669876203576,0.9532238181782521,0.276551636462514,0.871789588337569,6306,12,SIRT1|BMP4|PARP1
REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046602,0.174586669439534,0.677040796053356,0.47187091855379104,1.2864467191571,1678,8,KIF25|CEP85|KIF11|NEK2
PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE%GOBP%GO:1904491,0.592335301609355,0.945987625636678,0.48270069096775003,0.9175632353229789,5115,3,C5orf42|SPATA7|TMEM107
"POSITIVE REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904154",0.13684210526315801,0.62388141596544,-0.6740928642329329,-1.3680514397821701,870,3,EDEM2|EDEM1|BCAP31
REGULATION OF GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0106104,0.4071140939597321,0.8669681570015609,0.8035950595500658,1.06754018569495,3032,1,SHISA7
POSITIVE REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902895,0.550400376825247,0.931421923167331,-0.20402825382432896,-0.926654704734804,2336,21,SMAD3|RELA|GATA2|SPI1|HIF1A|KLF5|ATOH8|JUN|STAT3|TP53
RUFFLE ORGANIZATION%GOBP%GO:0031529,0.8816116097002099,0.9956508825790341,0.18504949135989698,0.6526428325619871,9233,17,ARFIP2|LIMA1|CCL21|PLEKHA1
NEGATIVE REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016242,0.619170984455959,0.9532238181782521,-0.19430337822919,-0.882486303769338,2628,21,QSOX1|NRBP2|CLEC16A|AKT1|SEC22B|PINK1|SCFD1|FEZ2|MTOR|USP36|TSC1|PIK3CA|TSC2|LZTS1|UBQLN4|PHF23|SMCR8|FEZ1|CHMP4A|CHMP4B|KIAA0226
DETECTION OF CHEMICAL STIMULUS%GOBP%GO:0009593,0.30329510285818295,0.805592654119386,0.28203051335463397,1.1338977545441202,3331,26,RYR2|RTP5|TAS2R4|SCARB1|RTP4|GCK|TAS2R5|TAS2R20|C4B|SYT1|TGFB3|KCNIP2|TAS2R14|TLR4|TAS2R19
POSITIVE REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0045819,0.22872483221476503,0.7427229339942198,0.887351124834583,1.17880638180245,1703,1,PHKG2
SIRNA LOADING ONTO RISC INVOLVED IN RNA INTERFERENCE%GOBP%GO:0035087,0.932158735386135,1.0,-0.26906744609275896,-0.618798915854933,5660,4,DICER1|TARBP2|CLP1|AGO2
DADP BIOSYNTHETIC PROCESS%GOBP%GO:0006173,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
REGULATION OF RESPONSE TO DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:1902153,0.5474645836091621,0.9305779599215391,-0.720390383767093,-0.9636881808839058,4134,1,TIGAR
NEGATIVE REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032701,0.5029789487620809,0.9164921159310329,-0.7449823555359509,-0.9965856113220402,3798,1,CD84
"ADENOSINE 3',5'-BISPHOSPHATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071106",0.353020134228188,0.842847021021096,0.827911336568152,1.0998432748874498,2629,1,SLC25A42
TRNA WOBBLE BASE MODIFICATION%GOBP%GO:0002097,0.44324894514767893,0.8808089923737601,-0.25793798502333,-0.9993200398649721,2100,14,CTU1|KIAA1456|MOCS3|NSUN3|ELP3|URM1|DPH3
MULTI-ORGANISM TOXIN TRANSPORT%GOBP%GO:1990967,0.5904197411394699,0.945418171231938,0.5708850289495451,0.933095896688862,4880,2,RAB40B|RAB29
POSITIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:2000304,0.708824768323505,0.9695170059473192,0.306808372145427,0.798557732219736,6730,7,NSMAF|SMPD3
"ENDONUCLEOLYTIC CLEAVAGE IN 5'-ETS OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000480",0.32914375490966197,0.828303707528737,-0.5401540234430939,-1.0962265418969201,2094,3,NOP14
REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048293,0.7951002227171491,0.98244927136446,-0.44063964709126,-0.753690517199623,5354,2,NDFIP1|CLCF1
REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:2000169,0.0520260989010989,0.44586532408291796,-0.619769423884407,-1.56890514175671,302,5,ATP2B4|SNTA1|ACE
REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071863,0.33368067616070396,0.8295413387957591,0.581502974185248,1.10537598210937,2881,3,LEF1|FGFR2|MAP3K3
MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM%GOBP%GO:0035437,0.8999800955414009,0.998912093067348,0.20701268268270898,0.6315482415279611,9042,11,PDIA2|RER1|TAPT1|GPAA1|ANKRD13C|KDELR3|KDELR2
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902963,0.982182628062361,1.0,-0.316129032258065,-0.5407217788894301,6614,2,SORL1|PICALM
NUCLEAR MRNA SURVEILLANCE OF SPLICEOSOMAL PRE-MRNA SPLICING%GOBP%GO:0071030,0.9061618411284341,1.0,-0.38285084091535704,-0.65484585920623,6102,2,EXOSC10|PRPF18
PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002532,0.280911233307148,0.789038489620028,-0.5640592962339731,-1.14474158276916,1787,3,CD36
REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042534,0.7188312363522928,0.9710876992601619,0.29205257495431897,0.7962136722111609,6912,8,GHRL|AZU1|THBS1|TLR4
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1901343,0.719983207388749,0.9713637233549571,-0.12519581388493,-0.870997542863162,1714,81,CTNNB1|DAB2IP|FOXO4|PML|MMRN2|RHOA|HDAC5|MAP2K5|ADAMTS9|PPARG|ECSCR|SPINK5|MEOX2|FOXJ2|PDCD10|PGK1|SERPINF1|PDCD4|NFATC2|SARS|PTPRM|THBS4
TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION%GOBP%GO:0070127,0.9638795282224091,1.0,0.211889006534218,0.551502566103557,9152,7,WARS2|AARS2|DARS2|YARS2
REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0042391,0.419838523644752,0.8726086583936671,-0.118557801348106,-1.01273186920809,363,219,CBLN1|SMAD7|GABRP|FMR1|NEDD4|GABRQ|CHRNA3|SLC25A33|POPDC3|SLMAP|BCL2|GABRG2|SNTA1|RELN|NDUFS1|YWHAE|ADCYAP1|DRD2|GABRA3|HTR3A|GABRD|C15orf59|GJC1|CACNA1E|SCN5A|CD36|KCNH6|DLG1|TMEM108|PMAIP1|CAV1|UBB
POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS INVOLVED IN IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000526,0.8906394810009269,0.997300970905927,-0.552823114247905,-0.7395283353648711,6726,1,CCR7
"REGULATION OF GLYCOGEN SYNTHASE ACTIVITY, TRANSFERRING GLUCOSE-1-PHOSPHATE%GOBP%GO:1904226",0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0006694,0.0451905481740791,0.418334638519242,0.274807560195296,1.45621722454999,567,77,FDXR|CYP21A2|STAR|TM7SF2|C14orf1|SLC27A2|FDX1|HSD17B4|AKR1B1|EBP|BZRAP1|OSBPL3|MVD|LBR|CACNA1H|HSD17B11|AMACR|DHCR24|SRD5A3|HSD11B1|PPAPDC2|MED1|APOE|NSDHL|ACOX2|OSBPL9|CYP7B1|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|OSBPL6|HSD17B7
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034157,0.690983715080101,0.96731875442989,-0.649150860167622,-0.8683888980900291,5218,1,RSAD2
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL SIGNALING%GOBP%GO:0086029,0.506439690894837,0.9172434440873181,0.458875970322494,0.972402015229914,4521,4,RYR2
PURINERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035587,0.422031944673143,0.873470206885489,-0.4399027267983521,-1.0116843727375602,2562,4,GNAI2|ANO6
NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903019,0.8109076433121021,0.9852684165902109,0.23616052709112,0.7204716332830309,8147,11,ABCA7|ITM2C|ACER2|TMEM59|PTX3|ITM2B|JAK3
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901186,0.0407442298634009,0.402256981537283,-0.34217869785139193,-1.5541058372093501,172,21,AGT|SHKBP1|GPER1|FBXW7|DOK1|RTN4|MMP9|HAP1|PLAUR|ADAM17|ADRA2A|RBPJ
BEHAVIORAL DEFENSE RESPONSE%GOBP%GO:0002209,0.790877655195126,0.9819233677232551,-0.325788717648334,-0.749245990944065,4802,4,ADCYAP1
POSITIVE REGULATION OF ANION TRANSPORT%GOBP%GO:1903793,0.982436882546652,1.0,-0.131409142663565,-0.5381646045680221,4474,16,TRH
POSITIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000111,0.11520203774458698,0.593424866901434,0.7020820843880751,1.3345841861586698,994,3,SIRT1|CDKN2A
CELLULAR HORMONE METABOLIC PROCESS%GOBP%GO:0034754,0.00473851985870595,0.159787349002354,0.406734834460753,1.8454267970630198,54,40,ALDH1A2|FDXR|CYP21A2|STAR|FDX1|BCO2|HSD17B4|AKR1B1|BZRAP1|CACNA1H|HSD17B11|ALDH8A1|SRD5A3|AKR1C1|MED1
CARDIOBLAST DIFFERENTIATION%GOBP%GO:0010002,0.621541318477252,0.9536478716552259,-0.27809850628931604,-0.86445124370444,3346,8,GREM1|RBPJ
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009195,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
POSITIVE REGULATION OF GERM CELL PROLIFERATION%GOBP%GO:1905938,0.710710975771217,0.97016506841811,-0.640052933392148,-0.8562183240490151,5367,1,CIB1
ARGININE TRANSPORT%GOBP%GO:0015809,0.767289518900344,0.9792236089291529,0.308826035783428,0.7595126588302259,7144,6,SLC25A29|PQLC2
PEPTIDYL-LYSINE DEACETYLATION%GOBP%GO:0034983,0.136583824768324,0.62388141596544,0.518688760724695,1.3500378675971898,1296,7,SIRT4|SIRT1|SIRT3|HDAC6
REGULATION OF THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070494,0.215710919088767,0.7322272196643679,-0.6065700656606109,-1.2310159262701,1372,3,SNCA|MET
REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010675,0.720506410773325,0.9713637233549571,0.160003006992995,0.832939338714229,8934,71,SLC45A3|SIRT1|INS|GNB3|OGT|PHKG2|C1QTNF3|FAM132A|CLK2|SDHAF3|RORA|PTH1R|PDK4|PGP|PASK|GCK|MIDN|SUPT20H|BAD|IRS1|AKT2|VIMP
CHEMOREPULSION INVOLVED IN POSTNATAL OLFACTORY BULB INTERNEURON MIGRATION%GOBP%GO:0021836,0.351447661469933,0.842847021021096,-0.6487455197132621,-1.1096444668819399,2366,2,SLIT2|ROBO1
BRONCHUS DEVELOPMENT%GOBP%GO:0060433,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF TORC1 SIGNALING%GOBP%GO:1903432,0.7315400843881859,0.9726603499749559,-0.158210914440037,-0.8208032943452591,2773,30,GATSL3|SEC13|RRAGD|RRAGC|DGKQ|SEH1L|C12orf66|SESN2|DYRK3
SISTER CHROMATID SEGREGATION%GOBP%GO:0000819,0.00022789425706472202,0.0784645998831315,0.33015934244483097,1.88789327052023,2,116,KIF25|CCNB1|PSRC1|KIF14|NCAPD3|ZWINT|SPAG5|KIF2C|KIF18A|NSL1|KIF4A|MAP10|NUF2|KIF23|BUB1|TOP2A|PRC1|DLGAP5|CDC23|SMC2|NDC80|NUSAP1|CENPE|KIF18B|HDAC8|RB1|CEP55|BUB1B|AKAP8L|INO80|ESPL1|AURKB|RAD51C|BOD1|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|TUBG2|SPDL1|KIF22|REC8|CDCA5|ESCO2|KLHL22|DSCC1|PLK1|NCAPG|POGZ|NCAPH|RACGAP1
REGULATION OF PHOSPHATE TRANSPORT%GOBP%GO:0010966,0.789510246613407,0.9819233677232551,0.40862468291606896,0.776752536520287,6818,3,CEBPB|SFRP4|CRY2
REGULATION OF ACTIN BINDING%GOBP%GO:1904616,0.296065330363771,0.800773793263828,-0.6824924179762889,-1.16736672899258,1993,2,CRMP1|ABL1
CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071838,0.0591817820733483,0.475550457504474,-0.970280105866784,-1.2979732812104199,446,1,ACE
MITOPHAGY BY INDUCED VACUOLE FORMATION%GOBP%GO:0035695,0.00701707930623593,0.189266857313637,-0.996746801940891,-1.33337858751155,52,1,SPATA18
FIBRINOLYSIS%GOBP%GO:0042730,0.427351979658554,0.8760213064890849,-0.344970543836198,-1.00629438132111,2352,7,PLAU|SERPINF2|PLAUR
HETEROPHILIC CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES%GOBP%GO:0007157,0.228196552611268,0.741448520265885,-0.233266426534441,-1.1794523919366,886,28,TENM4|AMIGO2|ICAM1|AMIGO1|CBLN1|ALCAM|PVRL3|FAT4|PVRL4
FERRIC IRON IMPORT ACROSS CELL OUTER MEMBRANE%GOBP%GO:0098706,0.0962138084632517,0.5684612493613671,-0.811798529325703,-1.3885379072633999,647,2,STEAP3
RETROGRADE AXONAL PROTEIN TRANSPORT%GOBP%GO:0099642,0.76822568671121,0.9792236089291529,-0.451668045216432,-0.772554001549507,5173,2,DLG2|MAP1A
REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903891,0.389099291947966,0.8603316114971841,-0.45192303900858094,-1.0393285796899,2362,4,WFS1|HSPA5|ATF6
DIVALENT METAL ION EXPORT%GOBP%GO:0070839,0.9767751300350791,1.0,0.34873720616351594,0.570001383102786,8074,2,SLC40A1
POSITIVE REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033129,0.0866432337434095,0.551884074624848,-0.534928728755496,-1.46834344259637,492,6,IL1B|CDK9|FMR1|MAPK3
DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0071344,0.8041611225353821,0.984530683443403,0.48541494347946,0.7933973899886079,6647,2,PPA2|PPA1
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS%GOBP%GO:0071872,0.44826869085993604,0.8850378987593649,0.37006965909271206,1.00890917426846,4310,8,RYR2|KCNQ1
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0045980,0.00080742834073476,0.0849637591935908,-0.643854397548156,-2.26580384233195,3,11,FLCN|CBFA2T3|PPIF|HDAC4|FBP1|PPARA|CDA|SNCA|PDE12
NEGATIVE REGULATION OF LYMPHANGIOGENESIS%GOBP%GO:1901491,0.835248578686343,0.988613522932093,0.47039565041883297,0.76884876808513,6904,2,VASH1|FOXC1
ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:0061028,0.00821099776063698,0.201754204620043,-0.375757443383141,-1.82290134074782,32,25,ENG|EZR|RAP2C|RAP1B|F11R|MYADM|TJP2|RAP2B|RAB1A|ICAM1|RAP1A|MSN|RAPGEF1|PDE4D
NEGATIVE REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903312,0.0429925524712255,0.4089601731625301,-0.23051237927611198,-1.44085346089278,126,55,C1QBP|CCRN4L|SLC11A1|VIP|NBAS|YBX1|FMR1|NELFE|HNRNPC|RBM38|RNPS1|SAP18|PABPC1|MYD88|RBM24
GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0006704,0.13080972113338601,0.614041891068594,0.628004118602245,1.3308007173971899,1167,4,CYP21A2|CACNA1H|HSD11B1
REGULATION OF HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:2001253,0.527415553809898,0.9265056012720759,-0.460571302525642,-0.934715774301432,3356,3,WHSC1L1|IWS1|BRD4
REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010635,0.15819106429349802,0.660066065952285,-0.451001284609743,-1.31559075631362,870,7,BNIP3|MUL1|VAT1|PLD6|PARK2
ANTHRANILATE METABOLIC PROCESS%GOBP%GO:0043420,0.6531179663709781,0.9640743070248079,-0.6674569916188801,-0.892877568281645,4932,1,KYNU
BRANCHED-CHAIN AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009082,0.9796782387806942,1.0,0.3448432506553111,0.563636819797839,8098,2,BCAT2|BCAT1
PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0140066,0.9867602277240831,1.0,-0.507002646669607,-0.678232898831038,7452,1,EP300
MRNA DESTABILIZATION%GOBP%GO:0061157,0.996838973596132,1.0,0.10797744798079699,0.40821230598114,10721,21,MEX3D|CPEB3|METTL3|KHSRP|RBM23|FTO|RC3H1|METTL14|ZC3H12A|ZFP36L1|ZFP36L2|UPF1|DHX36|GIGYF2|YTHDF3|MOV10|PUM1|ZC3H12D
CELLULAR RESPONSE TO COBALT ION%GOBP%GO:0071279,0.22776540460282102,0.740919832179792,-0.7204301075268822,-1.2322571151561799,1533,2,TIGAR|BNIP3
GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:1904659,0.17395548613822698,0.676682497340677,-0.395079435127979,-1.2753518205102299,890,9,SLC2A9|SORT1|RAB4B|SLC2A10|SLC2A5|SLC45A1|PPARD|SLC2A3|SLC2A1
LATENT VIRUS REPLICATION%GOBP%GO:0019045,0.726503340757238,0.972554563883587,-0.469092914254205,-0.8023583068223241,4892,2,NUCKS1|HCFC1
POSITIVE REGULATION OF MYOSIN LIGHT CHAIN KINASE ACTIVITY%GOBP%GO:0035505,0.40368065669270503,0.8655192490568291,-0.79648213498015,-1.0654784364996601,3048,1,IL1B
PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006220,0.5891168599464761,0.945418171231938,0.21681235629707601,0.909079302277459,6603,30,TDG|MBD4|CAD|AK3|DTYMK|CTPS2|DUT|DCK|NEIL1|UMPS|HDDC2|TYMS|CTPS1|CDS1|NTHL1|UNG|NT5M
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046823,0.488818565400844,0.9084491271791959,-0.24884054904109001,-0.9640741644363541,2316,14,APOD|CHP1|RANGAP1|CABP1
REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060687,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
SPINDLE LOCALIZATION%GOBP%GO:0051653,0.0236396074933095,0.32381765070033003,0.38932938352832897,1.63243133545899,264,30,KIF25|ASPM|SAPCD2|NUMA1|DYNLT1|NDC80|CENPA|GPSM2|NUSAP1|CDK5RAP2|ESPL1|SPDL1|DYNC1H1|LLGL2|SPIRE2|SPIRE1|FMN2|NDE1
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902745,0.0931859205776173,0.5622489437340121,-0.32099851358222997,-1.40773038502388,412,19,CDC42|TWF2|RAC1|CORO1C|BRK1
SIGNAL TRANSDUCTION INVOLVED IN DNA DAMAGE CHECKPOINT%GOBP%GO:0072422,0.508954501452081,0.918404893008545,0.187012697296129,0.9708107032951179,6308,70,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|DTL|E2F7|GEN1|GTSE1|BRCC3|CHEK2|PLK1|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CHEK1|CASP2|CDK2|ATM|CNOT1|UIMC1|BRCA1|BRE|PCBP4|MDM2
OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:0097252,0.00638455827765405,0.180127205513166,-0.9424317617866009,-1.61197905511935,42,2,TP53|TNFRSF21
THIAMINE PYROPHOSPHATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0030974,0.172751677852349,0.676505210903938,0.91470004411116,1.2151382009395901,1286,1,SLC25A19
TRANS-GOLGI NETWORK TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:0044795,0.38368860055606996,0.8582519754973359,-0.8059108954565501,-1.07809157686944,2897,1,RAB13
SYMPATHETIC NEURON PROJECTION GUIDANCE%GOBP%GO:0097491,0.118557549810637,0.602329212916938,-0.6010285060216071,-1.3822400045967098,719,4,SEMA3F|NRP1|SEMA3A
RESPONSE TO TRIGLYCERIDE%GOBP%GO:0034014,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900271,0.450459748545693,0.88620227509476,0.27234058596941396,1.01133656225846,4800,20,CALB1|INS|AGER|ADCY8|APOE|SHISA7|CALB2
REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000739,0.9618818681318679,1.0,-0.22816015883520802,-0.577572291477466,5601,5,SOX5|REST|PDGFRA|LTBP3|SOX6
POSITIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050747,0.900708052033591,0.998912093067348,-0.285280979429769,-0.656086655404297,5469,4,SVIP|RAB3GAP2|RAB3GAP1|GBA
MITOTIC CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0007079,0.21095287715642003,0.7257004702836279,0.6401860807798809,1.21692639451467,1821,3,DLGAP5|CENPE
FACTOR XII ACTIVATION%GOBP%GO:0002542,0.145760251602758,0.636418541205714,0.76989247311828,1.2583680971283602,1204,2,F12|KLKB1
PROTEIN SIDE CHAIN DEGLUTAMYLATION%GOBP%GO:0035610,0.5352710133542811,0.9265056012720759,-0.45820006617403797,-0.9299034205783759,3406,3,AGTPBP1|AGBL4|AGBL2
LENS FIBER CELL MORPHOGENESIS%GOBP%GO:0070309,0.10632635780815301,0.580379305095854,0.801204445321593,1.30954665550448,878,2,PROX1|EPHA2
MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0007095,0.0431800618238022,0.410037272857791,0.46092123878457003,1.5628050945109702,446,15,TAOK3|BLM|DONSON|MSH6|TAOK1|BRSK1|CLSPN|CDK5RAP3|TAOK2|C5orf45|ATM
CHRONOLOGICAL CELL AGING%GOBP%GO:0001300,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:0007528,0.00466622226454623,0.159623912678827,0.5304642096679821,1.9028832663558999,48,18,GPHN|CACNB4|CACNB2|UNC13B|F2R|DNAJA3|DVL1|UNC13A|NRD1|ANK3|CACNB1|ZC4H2|SHANK1
NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048387,0.991610372630203,1.0,0.20312155305537197,0.46816506874862795,9100,5,EZH2|CNOT1|CYP26B1|CALR|PRAME
PURINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009205,0.6481051817478729,0.963755998259649,-0.11554310757022,-0.9311849570877521,837,159,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GTPBP1|UQCRC1|PKM|ENO1|MT-ND5|ATP5I|EFTUD1|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|RHOQ|COX4I2|NDUFS6|PGAM2|AK4
BLUE LIGHT SIGNALING PATHWAY%GOBP%GO:0009785,0.440089086859688,0.879896414106183,-0.591452991452992,-1.01164866568429,2963,2,CRY2|CRY1
REGULATION OF MOTILE CILIUM ASSEMBLY%GOBP%GO:1905503,0.937181208053691,1.0,0.5344067048963389,0.7099354658813991,6981,1,ZMYND10
REGULATION OF SERINE C-PALMITOYLTRANSFERASE ACTIVITY%GOBP%GO:1904220,0.31317285593322897,0.8158652929227931,0.681033924756165,1.1131312409176002,2588,2,SERINC5|SERINC1
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0043558,0.023769730733518995,0.32397355287938,-0.557073059805941,-1.73162562362883,127,8,ATF4|DNAJC3|EIF2S1|IMPACT|EIF2AK3
NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050995,0.8161081953976579,0.9866358717238399,-0.206583393340528,-0.726992699242893,4042,11,ADRA2A|TNF
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0044329,0.25738117304382396,0.7678777890071629,-0.872077635641817,-1.16660484262226,1943,1,PPAP2B
UDP PHOSPHORYLATION%GOBP%GO:0061569,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901988,0.0500956304251876,0.440378626703493,0.233273667042977,1.38735414732934,680,146,BTG2|TAOK3|CCNB1|PIDD1|TPR|CDK1|E2F8|PKD2|BLM|CENPF|WEE1|CDK2AP2|ORC1|CDC25C|USP47|MUC1|BUB1|DTL|E2F7|DONSON|DACT1|CDC20|APC|ZNF830|FBXO5|RB1|BUB1B|NAE1|GTSE1|AURKB|CDC6|MSH6|CCL2|KLHL22|TAOK1|RPS27L|BRCC3|CHEK2|TOPBP1|PLK1|PRMT1|BRSK1|CARM1|AURKA|CDC73|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|C5orf45|TEX14|PRKDC|FHL1|CHEK1|RBX1|FBXL7|RAD17|CASP2|CDK2|ATM|RFWD3|CNOT1|UIMC1|BRCA1|BRE
CORNIFIED ENVELOPE ASSEMBLY%GOBP%GO:1903575,0.448590604026846,0.88526084286089,0.7809329510366121,1.03743458556317,3341,1,STX2
MITOCHONDRION DISTRIBUTION%GOBP%GO:0048311,0.228132387706856,0.7413854930952201,-0.35532630882109595,-1.20212208797816,1157,10,ATCAY|MAPT|CLUH|MEF2A|MSTO1|MTM1|TRAK2|DNM1L|HAP1|TRAK1
NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC MEMBRANE TO ENDOSOME%GOBP%GO:0098968,0.48578686343292604,0.9067327323518829,0.6094719715617171,0.996165194343133,4015,2,LRRC7|SCRIB
DNA REPLICATION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0071163,0.291536413106403,0.8000726114371469,0.59920591154737,1.1390274037556598,2517,3,CDC45|GMNN|CDT1
REGULATION OF MYOBLAST FUSION%GOBP%GO:1901739,0.416713091922006,0.8709670999109399,-0.324908990456489,-1.00995861012885,2243,8,EHD1|EHD2|CFLAR
GLYCEROPHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:0006650,1.0,1.0,0.0674245659777809,0.42574707357532704,14139,224,ENPP2|PTDSS2|SERINC5|LPCAT4|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|CISH|GPAM|EFR3B|NAPEPLD|PIK3R3|CEPT1|ABHD3|PIGC|INPP5E|SOCS2|PNPLA6|RARRES3|TAZ|PIGF|FAR1|CHKB|CETP|CPNE7|PGP|OSBPL5|PIGQ|PIGB|GNPAT|MTMR4|PLEKHA1|LPGAT1|PTPN13|OSBPL8|AGK|RAB4A|CPNE1|ETNK1|PLA2G2D|IMPA1|SLC44A3|SOCS1|TTC7A|DGKZ|SOCS7|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|PIP4K2B|MTMR7|FIG4|SMPD4|CSF1R|SERAC1|PIGK|TMEM86B|LPCAT2|PLD1|PIGH|PIP5K1C
RESCUE OF STALLED RIBOSOME%GOBP%GO:0072344,0.574196438570949,0.941759834532812,0.43644184635747,0.92486196352885,5126,4,NEMF|ZNF598|LTN1|GNB2L1
"NUCLEOTIDE-EXCISION REPAIR, DNA DAMAGE REMOVAL%GOBP%GO:0000718",0.287114093959732,0.796019542850327,0.859505955006617,1.14181531594709,2138,1,PNKP
POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071639,0.0293794186959937,0.35206407599446604,-0.7965699790448879,-1.61661510533814,186,3,IL1B|LGALS9|TWIST1
REGULATION OF BEHAVIOR%GOBP%GO:0050795,0.484212464328454,0.9064456896937672,0.25346702908929103,0.9857848004547858,5259,23,GHRL|NR4A3|INS|GNB3|AHI1|UCN|APOE
NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0034242,0.30853749072011893,0.8114708447293539,-0.6759010141762729,-1.1560924858056598,2077,2,CFLAR
DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0015959,0.0929701230228471,0.5622489437340121,-0.5296667678733921,-1.45389971328982,528,6,NUDT4|GARS|KARS
CELLULAR TRIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072502,0.364026845637584,0.8499434076701009,0.823279664755183,1.09369030551745,2711,1,XPR1
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000651,0.750621890547264,0.97622649654938,-0.213020689655172,-0.776055740505407,3620,12,WNK3|ANK3|DRD4|DMD|WNK2|WNK1|GLRX|ACTN4|ATP1B1|TESC|SLC9A1|CHP1
REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902914,0.572890274800234,0.9408603570970521,0.273653020828443,0.9066974975762511,5878,14,SPSB4|MARCH7|BIRC2|PARP10|PTPN22|PLAA|XIAP|UBR5|GPS2
POSITIVE REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:2000764,0.428322147651007,0.8769245997339999,0.7929532421702691,1.05340300607103,3190,1,HAND2
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032803,0.8666203542896841,0.9929671171385601,0.37079180958593605,0.704836224188593,7484,3,APOE|ANXA2
IMMUNE RESPONSE-ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002429,0.36463414634146296,0.85007225273817,-0.121229538291875,-1.04261080863783,298,230,DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|BCAR1|NRAS|PRKD2|GRB2|FGR|ABL1|VAV1|MYO1C|IGHV1-69-2|CYFIP2|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|BCL10|RELB|LYN|FCGR2B|ARPC5|RNF31|CD276|YES1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CDC42|PDE4B|MUC3A|RFTN1|IGHV1-3|KRAS|BCL2|NFATC2|RBCK1|MAPK3|HLA-DQA2|HLA-DQB2|RAC1|PLD2|MUC12|ACTR2|BRK1|PIK3R1|HSP90AB1|PDE4D|TNFRSF21|PAK2
REGULATION OF VASOCONSTRICTION%GOBP%GO:0019229,0.0259476534296029,0.33512489842855103,-0.37869557007805293,-1.6607592811679799,114,19,BDKRB2|PER2|ACE|ADM|CAV1
POSITIVE REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090141,0.13459915611814302,0.621957763524714,-0.34254814324339194,-1.3271221923002001,637,14,MARCH5|DDHD1|DCN|PINK1|VPS35|MFF|FIS1|DNM1L|BNIP3|MIEF2|MUL1|KDR|MIEF1|PARK2
POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010867,0.9699392712550609,1.0,0.18352084235837002,0.523705779280201,9582,9,SCARB1|LDLR|CNEP1R1|GPLD1|SREBF1|SLC27A1
REGULATION OF NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070949,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
POSITIVE REGULATION OF NF-KAPPAB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051092,0.007076755579749591,0.18964101805215697,-0.20674212573808604,-1.5712754190440101,12,115,RHEBL1|TRIM62|RELA|TRAF6|EIF2AK2|AGT|UBE2N|NTRK1|PYCARD|TRIM8|NOD1|PRKCH|IL1B|CLU|IRAK1|TRIM13|MTDH|CX3CL1|LGALS9|IRAK2|PRKD2|IRAK4|PSMA6|MAP3K13|RPS3|S100A8|SPHK1|BCL10|UBE2V1|IL6|RNF31|CAMK2A|RIPK2|NPM1|ARHGEF2|TNFRSF11A|TRIM25|MTPN|NLRP3|UBA52|CFLAR|STAT3|RBCK1|EDA2R|MYD88|DDRGK1|UBC|CD36|TNF|UBB
"REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0032829",0.7085374907201191,0.9695170059473192,-0.476371657016818,-0.8148082064932479,4771,2,FOXP3|LGALS9
PROTEIN TRANSPORT ALONG MICROTUBULE%GOBP%GO:0098840,0.973201692524683,1.0,0.17544779227148702,0.5177917621969461,9659,10,CAMSAP3|RAB27B
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS%GOBP%GO:0071364,0.6698183627768101,0.964618776001639,-0.176458167978721,-0.8560464647039008,2691,25,SYAP1|DUSP22|SNAI2|FOXC1|DAB2IP|INPP5K|PDE8A|PTPN12|ZPR1|DUSP3
NEGATIVE REGULATION OF RIBONUCLEASE ACTIVITY%GOBP%GO:0060701,0.828474658279908,0.9876441563834109,0.47427631166358203,0.7751916022816708,6848,2,ABCE1|TMBIM6
NEGATIVE REGULATION OF NODAL SIGNALING PATHWAY%GOBP%GO:1900108,0.0112538064345293,0.22992267312754103,-0.995202911336568,-1.33131327797732,84,1,DACT2
POSITIVE REGULATION OF NATURAL KILLER CELL CYTOKINE PRODUCTION%GOBP%GO:0002729,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
HEMOPOIESIS%GOBP%GO:0030097,0.9209535759096609,1.0,-0.0928296560184869,-0.8076583119762599,733,239,CBFA2T3|BATF|IL11|VEGFA|KDR|FCER1G|TYROBP|IKZF1|LGALS9|PTK2B|CD164|VPRBP|CR2|CEBPA|HDAC4|ZNF385A|NFAM1|TCTA|MFAP5|G6PD|MEOX1|HDAC5|THOC5|CASP3|RUNX1|RELB|KITLG|IL6|PPARG|SNRK|LYN|ETV6|FCGR2B|SBNO2|MMP9|FOXP1|CAMK4|CDC42|SLC25A38|TNFRSF11A|LEPR|ASH2L|KLF6|GLRX5|ADAM17|MECOM|MLF1|STAT3|GAB2|OSCAR|ARIH2|LYAR|MYH9|SFRP2|IRF2BP2|ACE|TPD52|DYRK3
POSITIVE REGULATION OF SYNAPTIC VESICLE PRIMING%GOBP%GO:0010808,0.127114093959732,0.6076669536424699,0.9372518747243052,1.24509730180066,946,1,UNC13B
RNA IMPORT INTO NUCLEUS%GOBP%GO:0006404,0.31123745010281795,0.8143712300420921,0.682008771259198,1.11472460074621,2572,2,TPR|RAN
NEUTROPHIL EXTRAVASATION%GOBP%GO:0072672,0.922462803919197,1.0,0.4199924675915,0.686466150410286,7625,2,AMICA1|PIK3CD
LONG-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0042758,0.236084667935939,0.750277765814412,0.566039591091465,1.19949196444178,2107,4,GLYATL2|AIG1
PURINE RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046129,0.849620893007582,0.991298302704726,0.262507411964268,0.683251640505088,8067,7,IMPDH1
PROTEIN POLYUBIQUITINATION%GOBP%GO:0000209,0.575406032482599,0.941940408834489,-0.112772045999828,-0.9641763549307729,495,221,NEDD4|UBE2Q2|TRIM36|RNF114|BCL2|UBA52|PELI2|UBE2L3|UBE2E1|UBE2D3|RBCK1|ARIH2|PARK2|FBXO7|RNF4|BFAR|CBFB|MYLIP|PELI1|UBC|UBE2K|RMND5A|FBXO27|RNF168|UBB|UBOX5
MODIFICATION-DEPENDENT MACROMOLECULE CATABOLIC PROCESS%GOBP%GO:0043632,0.7358631966207929,0.974262605126702,0.133060674880077,0.887665106695355,10800,394,SIRT1|HACE1|FBXO18|ARNTL|UBR4|SPSB4|SIAH2|TRIM9|ZCCHC11|TRIM3|ANAPC15|CCNB1|SGTA|CDC34|CDK1|BTRC|KIF14|PSMD11|LONP1|ANAPC5|RNF34|KLHL42|UBE2Z|PCYOX1L|PSMD13|PSMB9|MTA1|KLHL3|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|FBXL19|RNF126|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|AUP1|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|PLK1|CUL4B|TSG101|BIRC2|HERC2|MAN1B1|ZRANB1|UBXN4|VPS37A|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|ANKZF1|PSMC6|ANAPC10|BAG6|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|ZCCHC6|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|UBA6|KCTD2|FBXO11|MDM2|EXOSC10|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|CBL
CIRCADIAN REGULATION OF GENE EXPRESSION%GOBP%GO:0032922,0.12997347480106097,0.612163182799301,-0.206735308445184,-1.26620136261319,391,52,PML|MYBBP1A|CCRN4L|PPARA|RELB|NAMPT|PER3|KDM5A|CIART|NRIP1|PPARGC1A|DRD2|PER2|PPP1CB|USP2|NR1D1
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901016,0.0693043016463091,0.5054741186916171,-0.274987866121991,-1.44603323155976,260,31,NEDD4L|KCNE3|KCNE4|KCNAB1|VAMP2|SUMO1|CAB39|NEDD4|YWHAE|KCNG1|DLG1|GAL|CAV1
CHROMATIN ORGANIZATION INVOLVED IN NEGATIVE REGULATION OF TRANSCRIPTION%GOBP%GO:0097549,0.208641005498822,0.7239270253647571,-0.6112525616798751,-1.2405189128181202,1327,3,POLE3|CTBP1
RIBOSOME-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1990116,0.886052981734608,0.996643473105967,0.443507030603805,0.7249000576710629,7324,2,NEMF|LTN1
REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000224,0.225595742107173,0.7398172623753029,0.7211537439834692,1.17870598328872,1864,2,WNT4|AKR1C3
PROTEIN NUCLEOTIDYLATION%GOBP%GO:0018175,0.423221476510067,0.873470206885489,0.7952690780767528,1.05647949075603,3152,1,FICD
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090201,0.059493670886076,0.476295606439141,-0.392224073018234,-1.51957989533465,281,14,GPX1|PRELID1|OPA1|PSMD10|PPIF|CLU|HGF|BCL2L1|IGF1|FXN|PARK2
POSITIVE REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000467,0.48421052631579,0.9064456896937672,-0.47427214942063795,-0.9625212360047869,3081,3,IGF2
RESPONSE TO INTERLEUKIN-6%GOBP%GO:0070741,0.8968349842957242,0.998912093067348,-0.143895539055168,-0.6761531050363628,3711,23,ST3GAL6|SELPLG|FER|STAT1|CBL|PTGIS|CTR9|JAK1|PTPN11|PHB|PID1|NFKB1|SMAD4|IL6ST|RELA|IL6R|SOCS3|IL6|SBNO2|STAT3|CHI3L1
POSITIVE REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1905269,0.8529268292682929,0.991298302704726,0.14200564279744002,0.7292910177503829,10490,67,SIRT1|WDR61|TPR|SIRT6|OGT|MTF2|SART3|MUC1|DNMT3B|TAL1|AKAP8L|PHF19|NIPBL|JARID2|ING2|KDM1A|RNF40|PAXIP1|RPS6KA4|RIF1
TYROSINE BIOSYNTHETIC PROCESS%GOBP%GO:0006571,0.125645438898451,0.607607158836689,-0.934825760917512,-1.25054492297786,948,1,PAH
POSITIVE REGULATION OF HIGH VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901843,0.26811513047373703,0.7829905950315309,0.55066477896027,1.1669112688572,2393,4,CACNB2|CACNA2D1|GBAS|CACNB3
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION, 5'-TO LESION%GOBP%GO:0006296",0.4806822137138879,0.9046812288131709,0.22184687375186,0.986353915658772,5523,37,GTF2H2|RFC4|GTF2H1|DDB2|POLD1|PARP1|POLD3|DDB1|CHD1L|CUL4B|ERCC5|XPA|RBX1|RFC3|RFC5
EOSINOPHIL MIGRATION%GOBP%GO:0072677,0.9630772292993629,1.0,0.17574984170713398,0.5361724800652959,9676,11,CCL5|CCL2|CCL11|CCL4L2|CCL4|CCL8|CCL24
THIOSULFATE TRANSPORT%GOBP%GO:0015709,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051125,0.386358586980671,0.8596647264526249,-0.24229837705073004,-1.04231378457361,1738,18,WASF1|PICK1|NCKAP1|WAS|WASL|WIPF3|TIGD5|ABI2|CORO1B|ARF1|CYFIP1|WIPF2|GSN|WHAMM|WIPF1|ARPIN|BRK1
PROTEIN K11-LINKED DEUBIQUITINATION%GOBP%GO:0035871,0.474424053104256,0.9003511540468891,-0.300488968852112,-0.9700053189167959,2429,9,YOD1|OTUD7B|OTUD7A|VCPIP1|TNFAIP3
NEGATIVE REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032966,0.853600593912398,0.991298302704726,-0.41351679512824496,-0.707298331523922,5748,2,IL6
POSITIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0060557,0.113140311804009,0.588848744118853,-0.7965260545905709,-1.36241515717039,761,2,IL1B|TNF
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:0090150,0.396955503512881,0.8638522656500329,-0.11909510873813302,-1.02149230866659,338,223,ZDHHC3|GORASP2|RPL35|ROMO1|SAMM50|RABGEF1|RPL7|SRP72|SGTB|MYO1C|RAB8B|RPS9|RPS3|RPL14|ZDHHC9|C19orf52|SEC63|ZDHHC11B|SEC62|ATG3|RILPL2|GCC2|RPL15|RPL8|VAMP2|EXOC4|ZDHHC7|BID|RPL35A|RAB8A|ZDHHC4|RFTN1|TIMM22|UBA52|PEX19|PVRL3|ASNA1|SSR1|BMF|CHMP4B|SRP54|PEX5|KIF13A|RILPL1|GOLGA7|BCL2L11|PMAIP1|MICALL1|PARD3
RESPONSE TO COBALT ION%GOBP%GO:0032025,0.38520319555401206,0.859519013954458,0.559186486845937,1.06295468728369,3326,3,D2HGDH|TIGAR|BNIP3
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0072330,0.631927212572374,0.9580150657116279,0.15638761170783402,0.904529831498432,8403,123,ACSM3|EDN1|HACD1|ASNS|MGST1|CYP2C8|LPL|OXSM|SLC27A2|VCAN|HSD17B4|CBR4|SCD5|ELOVL6|DECR2|FADS3|ABHD3
GLUTAMINE METABOLIC PROCESS%GOBP%GO:0006541,0.2667004048583,0.7806336876737892,0.414145493255382,1.18182973385203,2634,9,SIRT4|GLS|GLS2|CAD
REGULATION OF INTERLEUKIN-17 SECRETION%GOBP%GO:1905076,0.820468687938567,0.987153241368501,-0.587395235994707,-0.7857765167207241,6196,1,OSM
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, NON-REM SLEEP%GOBP%GO:0045188",0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042509,0.5425531914893621,0.929666156674115,-0.17119542538892701,-0.9417275490951871,1937,36,VEGFA|CRLF1|LIF|ARL2BP|TNFRSF18|IL6|LYN|PPP2CA|IGF1|CNOT7|STAT3|TNF
REGULATION OF INTERLEUKIN-15 PRODUCTION%GOBP%GO:0032658,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
CHLORIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902476,0.791666666666667,0.9819233677232551,-0.17132182518328198,-0.7644217923913321,3438,20,GABRG2|ANO6|GABRA3
WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904953,0.173390416598057,0.676682497340677,-0.560333504674359,-1.2886500029816101,1052,4,FZD1|CTNNB1|WNT3
RECEPTOR INTERNALIZATION%GOBP%GO:0031623,0.00185873605947955,0.11072851755770098,-0.34289785353633895,-1.99879041960704,5,44,RAMP3|PICALM|FCER1G|DNM2|ARRB2|GRB2|CALCRL|ARRB1|SNCA|RAMP2|TFRC|NEDD4|CXCL8|CD9|ACKR3|RAB5A|CACNG3|CD36|ADM|CACNG7|CAV1|RAMP1
REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903649,0.153556288271314,0.6507359320251149,-0.283510175375589,-1.28764537718477,651,21,EZR|SNX3|MTMR2|RAB21|VPS11|MSN|MAPK3|PARK2|MAP2K1|SNX12
LATE NUCLEOPHAGY%GOBP%GO:0044805,0.0747839748625295,0.524399009933241,-0.736368698229462,-1.49443839458184,475,3,ATG9B|ATG7
ROOF OF MOUTH DEVELOPMENT%GOBP%GO:0060021,0.7420353176770441,0.974505008828563,0.196219942249468,0.7888981559725021,8151,26,PKDCC|TGFB2|LOXL3|LRRC32|LEF1|C5orf42|COL11A2|CHD7|CLDN5|GABRB3|TGFB3|LRP6
INTESTINAL ABSORPTION%GOBP%GO:0050892,0.701234076433121,0.9688110069082271,0.26557421128902303,0.8102060412976191,7045,11,KCNQ1|LIMA1|AKR1C1|SLC46A1|LDLR
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032214,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
ORGANIC ANION TRANSPORT%GOBP%GO:0015711,0.393793054470563,0.8633315826167591,0.16715454906499402,1.04722399430711,5544,211,ABCC3|SLC16A9|SLC1A2|ATP10A|SLC27A2|CEACAM1|SLC25A29|ATP11C|SLC36A1|SLC25A22|SLMO1|SLC35A1|STARD10|SLC16A13|MFSD2A|SLC35B1|ABCA7|SLC25A19|ABCB4|SLC43A1|HBB|GLS|SCARB1|SLC16A14|HBA2|EPRS|GLS2|ATP10D|LRRC8D|STARD5|SLC16A2|SLC6A17|SLC6A15|SLC37A2|SLC13A3|SLC25A10|AKR1C1|CETP|SLC25A42|OSBPL5|SLC6A9|SLC7A9|HBA1|CPT1B|SLC15A4|PQLC2|SLC46A1|APOE|ATP8B3|SLC25A1|ACACA|SLC38A6|PRELID2|SLC16A7
POSITIVE REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:2000648,0.7937750620584301,0.9819233677232551,0.20862284658295602,0.7357826521459571,8313,17,SMARCD3|TERT|ZNF335|N4BP2L2|KDM1A|FZD3
NEGATIVE REGULATION OF HEART GROWTH%GOBP%GO:0061117,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
PRONEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0039023,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
GERMLINE STEM CELL ASYMMETRIC DIVISION%GOBP%GO:0098728,0.511275167785235,0.918404893008545,0.748180414644905,0.993924302161029,3808,1,ING2
REGULATION OF ACROSOMAL VESICLE EXOCYTOSIS%GOBP%GO:2000367,0.5703399056489661,0.940402148292764,0.578384339674662,0.945353314050949,4714,2,ZP3|HYAL3
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902237,0.0111607142857143,0.22992267312754103,-0.733442628444255,-1.8566613108109098,64,5,DDIT3|BOK|BCL2L11|PMAIP1
ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX%GOBP%GO:0098971,0.7464257659073059,0.9749763305090959,-0.38342340355134,-0.778146405497828,4750,3,KIF17|KIF5C|KIF5A
NEGATIVE REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0045950,0.6187250514092171,0.9532238181782521,0.559179308635434,0.913963218410396,5114,2,BLM
NEGATIVE REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043508,0.788434414668547,0.9819233677232551,0.24912303955011397,0.735226451028284,7825,10,DUSP19|ZNF675|GSTP1|PTPN22|DNAJA1
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR PRODUCTION%GOBP%GO:0032686,0.0029127499007017103,0.13103871184697197,-0.998786943096603,-1.33610774653893,21,1,INHBB
TELOMERE ORGANIZATION%GOBP%GO:0032200,0.356743752910135,0.8445764484419659,0.19537747968887198,1.07955393108215,4596,96,HIST1H3E|XRCC3|ATR|BLM|DOT1L|EXO1|RFC4|DNA2|DCLRE1A|ORAOV1|POLD1|TERT|PARP1|FEN1|POLD3|POLA2|SLX1B|HIST1H4I|RAD51|RTEL1-TNFRSF6B|H3F3A|DCLRE1C|SLX4|WRAP53|TEN1|TNKS1BP1|TELO2|CTC1|PRIM2|RIF1|PRKDC|HIST1H3H|ACD|RFC3|SMC6|RFC5
POSITIVE REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032305,0.385970689939075,0.859630103805729,-0.45315171234765395,-1.04215427169092,2343,4,P2RX4|PLA2R1|IL1B|TNFRSF11A
POSITIVE REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:1905492,0.326095591155832,0.826621597878865,-0.838608292898103,-1.12183188236229,2462,1,MAP3K13
TELENCEPHALON REGIONALIZATION%GOBP%GO:0021978,0.051530180234668,0.4457514150034171,0.857343180242015,1.40130387551064,425,2,SIX3|BMP2
NEGATIVE REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0032811,0.20286514078708998,0.717413964675423,-0.54033345908076,-1.24265407627221,1231,4,ADRA2C|CRH|ADRA2A
PERICENTRIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031508,0.111285835248579,0.5855068018166539,0.798180314309347,1.3046037964427,919,2,HELLS|CENPV
CELLULAR POLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0044247,0.960699548044803,1.0,0.172657685875463,0.5442787279007469,9777,12,GAA|AGL|AOAH|PYGL|PGM2L1|MANBA|PGM2|PYGM|PGM1
POSITIVE REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903724,0.36476649120842203,0.85011227989061,0.509707426783989,1.08011872714554,3256,4,CENPJ|CEP295|CEP120
POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:2000251,0.47419354838709704,0.9002773535296009,-0.243290356763172,-0.970263678082882,2204,15,BAIAP2|FES|CDK5|HAX1|BCAS3|ABL1|NRP1|CDC42
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905005,0.948056665455866,1.0,-0.205084645293333,-0.598241009098755,5219,7,TGFB1|ENG|TGFBR1|ACVR1
REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032650,0.7765404602821079,0.980802382590629,-0.448304383788255,-0.766800638822792,5229,2,ISL1|CX3CL1
EMBRYONIC PATTERN SPECIFICATION%GOBP%GO:0009880,0.25492658423493,0.7656581722007041,0.351415611583075,1.19151399818529,2638,15,RIPPLY2|TBX3|BASP1|HOXD8
"REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051966",0.0021097046413502104,0.115553415806697,-0.39632786045524204,-2.05616164127389,7,30,GRM2|TPRG1L|RELN|ADCYAP1|DRD2|CACNG3|CACNG7|TNF|GRM8|HOMER1
LAMELLIPODIUM ASSEMBLY%GOBP%GO:0030032,0.5751633986928101,0.941940408834489,0.23549515303436896,0.9158885211862171,6247,23,ITGB1|ARFIP2|PTPRO|ARHGEF6|ABLIM1|KIT|ARHGEF4
VIRAL RNA GENOME REPLICATION%GOBP%GO:0039694,0.232466509062254,0.746121572059682,-0.3534984158331071,-1.1959380524008,1179,10,PCBP2|CDC42|RAB5A|PCBP1
POSITIVE REGULATION OF ORGANELLE ORGANIZATION%GOBP%GO:0010638,0.272727272727273,0.7882436934792951,-0.112450733319951,-1.07534833101645,59,457,ARPC1B|PARN|UBE2N|RNF20|CNOT6L|PDCD6IP|ARHGEF5|PPM1F|SURF4|MUL1|PYCARD|ZNF205|CDK5|RLTPR|ARL2|NSMCE2|MIER1|S100A10|PHB2|MECP2|NCK2|BAX|GPER1|FUZ|FBXW7|SYNPO|NAF1|LRP5|HPS4|HAX1|CDC42EP5|MAPRE1|CCT4|ERCC1|PPIF|TP53BP2|IL1B|GZMB|ANKRD53|VEGFA|SIN3A|CDK9|KDR|CX3CL1|BCAS3|NES|LPAR1|CTNNB1|WBP2|TGFBR1|CFL2|PTK2B|MRE11A|CIDEB|VASP|UBL5|PRKD2|PFN1|LIF|ABL1|BBC3|PML|CTBP1|ATG13|RPS3|STX18|CCT7|RHOA|CCP110|NRP1|SLX1A|HRK|WDR1|VPS11|WHAMM|MFN2|YWHAH|PXN|CSNK2A2|ARRB1|MMP9|PFDN2|SLAIN2|ARPC5|SH3GLB1|RNF31|PLD6|TCP1|MIEF1|HAP1|VPS4B|PIP4K2A|BOK|IGF1|BECN1|BIN1|RUVBL2|SERPINF2|BID|WIPF1|RHOC|BAP1|LEPROT|LIMK1|WNT11|YWHAQ|YWHAB|MARK4|ARPC5L|PLAUR|FMR1|ARPC4|CDC42|CAPG|PPARGC1A|HK2|ADRB2|SEPT9|BCL2|TP53|YWHAZ|TADA2B|UBE2L3|YWHAE|UBE2D3|ASAP1|RALB|HTT|MAPK3|SORBS3|ARIH2|PARK2|BMF|FBXO7|KCTD17|RAC1|NSFL1C|MET|PLCB1|IGF2|ACTR2|BRK1|BIK|JMY|TNF|BCL2L11|PMAIP1|TFDP2
RESPONSE TO HYDROXYUREA%GOBP%GO:0072710,0.7894353748570241,0.9819233677232551,0.271008288541364,0.738841301614727,7591,8,BLM|TIMELESS|SPIDR|DDX11|ATRX|KAT7
CAMP-MEDIATED SIGNALING%GOBP%GO:0019933,0.00041580041580041604,0.0784645998831315,-0.285941735000579,-1.97681066276232,0,79,PTHLH|RAMP3|GPER1|AHR|GNA13|ADCY7|MAPK7|ADRA2C|UCN2|PTGFR|CRHR1|GNAQ|CALCRL|ADRA1B|DGKQ|GNAL|VIP|ABCA1|GCGR|RAMP2|AKAP13|ADRB2|MC4R|GPR161|GPR3|CALCB|ADCY2|ADCYAP1|DRD2|UCN3|ADRA2A|GNAS|ADM|PDE3A|PDE4D|GAL|RAMP1
REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050994,0.666817074271275,0.964618776001639,0.20877278670471697,0.8487682225338019,7388,27,PDE3B|RARRES2|INS|SCARB1|IDH1|PNPLA2|APOC1|LDLR|IRS1|AKT2|METTL20
REGULATION OF MITOTIC SPINDLE ELONGATION%GOBP%GO:0032888,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2000117,0.866447368421053,0.9929671171385601,0.142235376836463,0.7090149305977221,10535,58,SH3RF1|DPEP1|SIAH2|NOL3|NAIP|RNF34|CAAP1|USP47|DHCR24|SRC
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051198,0.008397826444920141,0.202735282440703,-0.793911652787735,-1.8258309474580101,50,4,CBFA2T3|HDAC4|FBP1|PPARA
REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905939,0.5032686859882329,0.9164921159310329,0.421569180484255,0.971654466967923,4618,5,WNT4|ZP3|HYAL3
FOLIC ACID-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0009397,0.7358171041490258,0.974262605126702,0.513096222773642,0.838641680545723,6082,2,PM20D2|MTHFS
REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035547,0.9663325343212029,1.0,0.23736971734921802,0.5471020104466471,8868,5,DHX9|DDX58|IFIH1|LILRB1
REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002886,0.051951476793249,0.44586532408291796,-0.29124536694811304,-1.51099029735024,196,30,LGALS9|ITGAM|FGR|LYN|FCGR2B|VAMP2|VAMP3|MAVS|SNX6|GAB2|TICAM1
REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000765,0.39139888862044,0.861275178639796,-0.221785585780712,-1.04215192119642,1619,23,YTHDF2|DPH2|AARS|CPEB1|ZNF385A|CPEB2|DPH6|DPH3|FMR1|RBM24
NEGATIVE REGULATION OF PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:1903704,0.29503355704698,0.800447413278835,0.856197617997353,1.13742033782567,2197,1,TERT
PROTEIN SECRETION%GOBP%GO:0009306,0.41381987577639795,0.868602149902778,-0.15239558398703698,-1.02918768498498,1065,72,RAB11FIP2|PNP|VIP|ABCA1|RAB1A|FOXP1|RAB8A|ADCYAP1|SCG2|ARL4D|CHI3L1|RAB11FIP5|CD36|GAL|STEAP3
NEGATIVE REGULATION OF SATELLITE CELL DIFFERENTIATION%GOBP%GO:1902725,0.389012620638456,0.8603316114971841,-0.621252693217147,-1.0626194595819398,2619,2,AKIRIN1
"POSITIVE REGULATION OF WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0045813",0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
GALACTOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0019375,0.0860252402454556,0.549638890318283,0.7272747028234109,1.3824727036402602,742,3,B3GALT2|B3GALT1|B4GALT3
NEGATIVE REGULATION OF TESTICULAR BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0061369,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
MITOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:0044774,0.042061151637436005,0.40376460791238894,0.260270000093707,1.43811611344026,541,96,BTG2|MUS81|TAOK3|EME2|CCNB1|PIDD1|CDK1|E2F8|BLM|ORC1|CDC25C|MUC1|RAD9A|TOP2A|E2F7|DONSON|ZNF830|NEK11|NAE1|GTSE1|CDC6|MSH6|TAOK1|RPS27L|CHEK2|TOPBP1|PRMT1|EME1|BRSK1|CARM1|AURKA|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|TOP2B|C5orf45|PRKDC|RAD17|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION, 3'-TO LESION%GOBP%GO:0006295",0.966849960722702,1.0,-0.28300430131245197,-0.57434882108656,6153,3,ERCC5|ERCC4|ERCC1
REGULATION OF AUTOPHAGOSOME SIZE%GOBP%GO:0016243,0.7891275167785241,0.9819233677232551,0.6070247022496689,0.8064052356467521,5878,1,ATP13A2
NEUROMUSCULAR PROCESS%GOBP%GO:0050905,0.718575678690963,0.971081608033886,0.212682884289781,0.8040546638413921,7728,21,PCDH15|CDH23|TMEM150C|PRRT2|MYO7A|MYCBP2|SHANK1
RESPONSE TO CISPLATIN%GOBP%GO:0072718,0.9975686002084059,1.0,0.23972043658904701,0.45568333231240205,8615,3,TIMELESS|DDX11
CYTOPLASMIC TRANSLATIONAL TERMINATION%GOBP%GO:0002184,0.300864100549882,0.8038155709110071,-0.5539610119839671,-1.1242474149169799,1914,3,GSPT1|ETF1
REGULATION OF LIPOPROTEIN LIPID OXIDATION%GOBP%GO:0060587,0.26201509334039497,0.771967970256231,-0.869320688134098,-1.16291678988256,1978,1,APOD
REGULATION OF NEUTROPHIL DIFFERENTIATION%GOBP%GO:0045658,0.8975838926174499,0.998912093067348,0.552823114247905,0.734400844090683,6686,1,EVI2B
MONOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002280,0.123129882166027,0.607607158836689,-0.936976179973533,-1.25342160411483,929,1,DYSF
ESTABLISHMENT OF NATURAL KILLER CELL POLARITY%GOBP%GO:0001770,0.46153846153846206,0.891063005541905,-0.768306131451257,-1.02778653749991,3485,1,SNX27
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002588,0.486711210096511,0.907092544497897,-0.569120485249518,-0.9734501098757741,3277,2,TREM2|PYCARD
WALKING BEHAVIOR%GOBP%GO:0090659,0.676911655530809,0.9647315640607691,-0.49142454122869395,-0.8405553587567499,4558,2,DRD2
HISTONE H2B CONSERVED C-TERMINAL LYSINE UBIQUITINATION%GOBP%GO:0071894,0.7406328611147891,0.974505008828563,-0.625,-0.836081556090247,5593,1,WAC
MITOCHONDRIAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0035694,0.0693681318681319,0.5054741186916171,-0.59388679012917,-1.5033849731006101,403,5,YME1L1|BNIP3L|SPATA18
REGULATION OF PROSTATIC BUD FORMATION%GOBP%GO:0060685,0.6920805369127521,0.96731875442989,0.6584142037935601,0.874673895799606,5155,1,SULF1
PULMONARY VALVE DEVELOPMENT%GOBP%GO:0003177,0.8428721074183408,0.991298302704726,0.19368715792358202,0.694795322669365,8850,18,BMP4|ROBO2|TGFB2|HEYL|HEY2
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN NEPHRON MORPHOGENESIS%GOBP%GO:0072039,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072304,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
SHORT-TERM MEMORY%GOBP%GO:0007614,0.345951394333072,0.8421727240261659,0.517312264805564,1.09623410536523,3088,4,CALB1|CUX2|NPAS4
GLUCOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006678,0.527886881382561,0.9265056012720759,-0.46035072239991204,-0.9342681134899851,3359,3,UGCG|CLN3|GBA
DICARBOXYLIC ACID TRANSPORT%GOBP%GO:0006835,0.584784766717805,0.9439064862850342,0.22395613784603802,0.910496315374529,6479,27,SLC1A2|SLC25A22|GLS|GLS2|LRRC8D|SLC25A10|SLC46A1|SLC1A3|SYT1|RAB3A|SLC1A1|SLC19A1|SLC25A30|ARL6IP5|GIPC1|SLC38A2|FOLR2
RENAL SYSTEM PROCESS%GOBP%GO:0003014,0.38580136249551794,0.859630103805729,-0.162838742667374,-1.0448212356923001,1075,61,INPP5K|RAB11FIP2|XPNPEP3|PRKAR2A|SERPINF2|CHRNA3|PRKAR1B|ADCY2|MCAM|SLC9A3R1|ADM|AQP1|SULF2
NEGATIVE REGULATION OF BLOOD COAGULATION%GOBP%GO:0030195,0.46207827260458795,0.8912739660615641,0.243713897222543,0.999380109332268,5135,28,EDN1|CEACAM1|SERPINE2|PLAT|F12
METANEPHRIC LOOP OF HENLE DEVELOPMENT%GOBP%GO:0072236,0.299262126527156,0.8023890191280308,0.68727731268848,1.1233358869770702,2473,2,PKD2|PKD1
REGULATION OF PROTEIN DEACETYLATION%GOBP%GO:0090311,0.604130380691714,0.9508825506493929,-0.18564556394041698,-0.900617016030228,2427,25,BEX4|CCAR2|CAMK2D|VEGFA|PRKAA1|PRKD2|CTBP1|DYRK1A|KDM5A|SPRED2
REGULATION OF PROGESTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000182,0.9429844097995551,1.0,-0.35601786443146505,-0.608949490012829,6350,2,DGKQ
REGULATION OF VIRAL-INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0039531,0.976739733894898,1.0,0.145655847849324,0.504949324099058,10203,16,ANKRD17|TKFC|BIRC2|NPLOC4|DHX58|BIRC3|DDX60
RENAL FILTRATION%GOBP%GO:0097205,0.29363529871144106,0.8004058897916541,-0.349377700739386,-1.12782252647323,1503,9,XPNPEP3|MCAM|SULF2
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE%GOBP%GO:1902285,0.478315003112679,0.9046812288131709,-0.256978354917857,-0.967775572641026,2304,13,SEMA3F|NRP1|PLXNA1|PLXNA4|SEMA3A
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN PROGRAMMED NECROTIC CELL DEATH%GOBP%GO:1902445,0.5854602636990439,0.9439064862850342,0.57257755094911,0.935862277400852,4839,2,ALKBH7
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM%GOBP%GO:1903514,0.0837873174983657,0.54493407160435,0.621455775117319,1.4323634361082198,768,5,RYR2|NOL3|CCR5
REGULATION OF PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904869,0.13315111284654402,0.6189080538796391,-0.41708958517210903,-1.3464025572295202,681,9,CCT2|CCT5|DKC1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002823,0.761558342107782,0.977763214485385,0.22008307842666197,0.762968348597609,7955,16,CEACAM1|THOC1|LOXL3|RC3H1|XCL1|NDFIP1|JAK3|FOXP3|ZC3H12A|PTPRC|HFE
CHROMATIN DISASSEMBLY%GOBP%GO:0031498,0.7848518111964871,0.981487311948134,-0.18714500485299104,-0.7664216925259242,3574,16,SMARCC1|PBRM1
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086055,0.8529061300145641,0.991298302704726,-0.5721217468019411,-0.765344704542779,6441,1,GJA5
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009157,0.8459359337546309,0.991298302704726,0.302324394779506,0.6968129129445501,7763,5,DUT|HDDC2|TYMS
PROTEASOMAL UBIQUITIN-INDEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0010499,0.107381926366679,0.583640329031366,0.36435567233028904,1.37745864512103,1154,21,ENC1|PSMB9|PSMA4|PSMA1|NFE2L2|KEAP1|PSMA3|PSMA5|PSMA2|PSMB6|PSMB3|PSMA7|PSMB4
SPHINGOMYELIN METABOLIC PROCESS%GOBP%GO:0006684,0.270745577085088,0.7857061977848471,0.453643707098821,1.1807392589824,2570,7,SMPDL3A|SMPD3|SMPD1|SMPD4
NEGATIVE REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043569,0.7567442398981129,0.977664504547119,0.42285209973954707,0.8037973592336459,6535,3,IGFBP5|CILP|BMP2
NEGATIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022408,0.9178789300797751,1.0,-0.102153411135392,-0.738551203024289,1955,95,ZNF703|PPARA|MYADM|RUNX1|MAP2K5|FCGR2B|PODXL|PRNP|ASS1|MBP|SMAD7|LGALS3|DUSP3|CD9|FXYD5|SOCS5|CBFB|TNFRSF21
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901389,0.0260823513835562,0.33575919472500804,-0.9875937362152621,-1.3211342524157401,196,1,HSP90AB1
THALAMUS DEVELOPMENT%GOBP%GO:0021794,0.6309896262143921,0.9575013258325501,-0.371642861082005,-0.8547009415754029,3831,4,LRP6|PTCHD1|CNTNAP2|CHRNB2
MULTI-LAYER FOLLICLE STAGE%GOBP%GO:0048162,0.331409395973154,0.8293509737209019,0.8383877370974859,1.11376070560531,2468,1,ZNF830
RESPONSE TO AMPHETAMINE%GOBP%GO:0001975,0.677951002227172,0.9647315640607691,-0.490674356538065,-0.839272208020751,4565,2,DRD2
AXONOGENESIS INVOLVED IN INNERVATION%GOBP%GO:0060385,0.0184422855260991,0.285441766913764,-0.752826338719462,-1.7313433081237302,111,4,NTRK1|NPTX1|NRP1|SEMA3A
REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010517,0.9200309225219029,1.0,0.13932571941806798,0.6362894679163511,10710,41,RGS2|AGTR1|PDPK1|CCL5|KIT|HRAS|PLCG1|NTRK3|ARL1|S1PR4|LPAR2|P2RY6|FGFR2|RASGRP1
LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0042157,0.9179405940594059,1.0,0.125551086960555,0.670583873965714,11588,80,LYPLAL1|PGAP1|NOTUM|ZDHHC8|ZDHHC21|GOLGA7B|PORCN|PIGC|ZDHHC16|PIGF|PIGQ|ZDHHC22|PIGB|ABHD17A|APOE|ZDHHC15
NEGATIVE REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903904,0.578975241625844,0.942692029750853,-0.7041795324217031,-0.9420024307744641,4372,1,FAM65B
SISTER CHROMATID COHESION%GOBP%GO:0007062,0.145247419010324,0.6363604513835911,0.31124684686048804,1.3156381909756798,1631,31,BUB1|HDAC8|RB1|BUB1B|RAD51C|BOD1|NIPBL|KIF22|REC8|CDCA5|ESCO2|DSCC1|PLK1|POGZ|SGOL1|PDS5B|SMC3
POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0060369,0.8082738599250029,0.984682960940884,0.483650399779432,0.7905132917857641,6681,2,PTPRJ|PTPRC
REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010837,0.505164685246541,0.9172434440873181,0.29173367573561,0.96660432597244,5183,14,PTPRK|CDH3|MED1|CASK|SRSF6|TGM1
PROTEIN KINASE D SIGNALING%GOBP%GO:0089700,0.79261586802828,0.9819233677232551,-0.36770706959303007,-0.746250572682226,5044,3,PRKD1|PRKD3|PRKD2
OVULATION CYCLE PROCESS%GOBP%GO:0022602,0.49083215796896995,0.909145662467746,0.33065950767138697,0.975861633524623,4871,10,ROBO2|TGFB2|ZNF830|BMPR1B
POSITIVE REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044128,0.66,0.9643779777660141,0.675727834142038,0.8976742813017479,4916,1,OSBP
PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0034638,0.30265138358226196,0.8054013181463249,0.594152104575167,1.12942064834204,2613,3,ENPP2|PNPLA8
PURINE RIBONUCLEOTIDE INTERCONVERSION%GOBP%GO:0015951,0.425983667409057,0.875696962448429,-0.5997794320374971,-1.02589059636845,2868,2,GMPR2|GMPR
NEGATIVE REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050928,0.00450152257381173,0.156288711414876,-0.9979047198941329,-1.33492756966222,33,1,ANGPT2
RESPONSE TO BACTERIAL LIPOPEPTIDE%GOBP%GO:0070339,0.15848214285714302,0.6604486079157379,-0.5157180675049641,-1.3055060424476101,922,5,TLR2|CD14|TIRAP|TLR1|CD36
REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901722,0.7660393053966931,0.9792236089291529,0.27841777394672995,0.759041546672397,7366,8,BMP4|EGR1|GATA3|PDGFB|MYC|BMP7|PDGFA
POSITIVE REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0010765,0.943706209229282,1.0,-0.132896957102673,-0.6244716881765581,3905,23,WNK3|ANK3|DRD4|DMD|SCN3B|WNK2|WNK1|AHCYL1|GLRX|PKP2|SCN4B|GPD1L|ACTN4|FXYD1|ATP1B1|ATP1B2|TESC|CNKSR3|SCN1B|SLC9A1|CHP1|SCN5A
REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904375,0.40067767894959794,0.8638522656500329,-0.148052022645614,-1.03215245940396,945,82,RHOQ|ACSL3|PIK3R1|DLG1|TNF|STAC|EPHB2|APPL1
SKELETAL MUSCLE MYOSIN THICK FILAMENT ASSEMBLY%GOBP%GO:0030241,0.462951030927835,0.891507554237553,0.40642550920516496,0.9995443497170571,4310,6,IGSF22|TCAP|OBSL1|MYOM2
REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000257,0.13993792033109198,0.6281603901381739,0.291257035264888,1.31364438690987,1622,39,IGKV4-1|IGHG1|IGHG4|IGKV3-11|SUSD4|IGKV2D-28|IGKV2-28|C3AR1|C7|CD55|C5|C4A|C4B|IGHG2|CD46
GLYCEROL BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0046327,0.6981208053691271,0.96731875442989,0.655161005734451,0.870352167313535,5200,1,PCK2
PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0046777,0.813905325443787,0.986276922067025,0.133666424091977,0.791365948967678,11003,142,FGFR4|TAOK3|MYLK2|STK39|MAP3K10|MAP2K2|ATR|ERN1|DDR2|MARK2|MAP3K9|PDPK1|JAK2|CLK2|DDR1|CAD|SRC|TYRO3|NEK2|CAMKK2|PASK|AURKB|KIT|GRK5|PIM2|STK11|ULK1|MELK|WNK3|TAOK1|CHEK2|ALK|MARK3|RIPK1|AURKA|VRK2|MAP3K12|VRK1|TAOK2|FGFR2|SLA|LCK|PTK2|RIPK3|BTK|CSF1R|ATM|WNK2|AKT1|TNIK|MAPKAPK5|MINK1|PRKD1|EPHA1|FER|RIOK2|PINK1|ATP13A2|TAF1
DETECTION OF EXTERNAL STIMULUS%GOBP%GO:0009581,0.494659722835202,0.91071489001692,0.226689782601952,0.9771517088820579,5603,33,SCN1A|UNC119|PIEZO2|ADGRV1|PKD2|TCAP|DFNB31|PDZD7
POSITIVE REGULATION OF BONE REMODELING%GOBP%GO:0046852,0.41727019498607204,0.8709670999109399,-0.324850551368351,-1.0097769559981,2246,8,PRKCA|MC4R
ETHANOL OXIDATION%GOBP%GO:0006069,0.521482729570345,0.9251240799994541,0.365282290902619,0.95075305736755,4951,7,ALDH1A1|ADH1B|ACSS1|ACSS2|ADH5
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045714,0.6745478317716279,0.9647315640607691,0.362748962007021,0.836082582975402,6190,5,CNPY2|HNRNPK|SCAP|ITGB3|ITGAV
SYMBIONT PROCESS%GOBP%GO:0044403,0.37372262773722603,0.852609194081082,-0.116530583118728,-1.03636493859738,255,265,PVRL2|MON1B|FURIN|CTDP1|EIF3D|HTATSF1|ZNF639|VPS28|CBLL1|KPNA1|NEDD4L|AP1M1|CTNNB1|BANF1|USF1|RAB43|GRB2|PCBP2|CTBP1|VPS4A|FYN|INPP5K|VPS37D|THOC5|TBC1D20|RXRA|SEH1L|EIF3G|BCL2L1|ATG7|EIF3B|RAB1A|VPS4B|ICAM1|TNIP1|AP1S1|GAPDH|FMR1|CDC42|AP2S1|KPNA4|NEDD4|EIF3A|JUN|UBA52|TP53|B2M|CAV2|RAB7A|VAPB|PARK2|RAB5A|CHMP4B|CHMP1B|PCBP1|THOC7|RAC1|MET|DDX6|UBC|PC|HSP90AB1|BICD1|AQP1|CAV1|PAK2|UBB
AMINO ACID IMPORT%GOBP%GO:0043090,0.529480671612651,0.9265056012720759,-0.288064131959692,-0.929896832011729,2711,9,SH3BP4|SLC3A2|SLC7A1
MITOCHONDRIAL OUTER MEMBRANE TRANSLOCASE COMPLEX ASSEMBLY%GOBP%GO:0070096,0.33298027273930897,0.8293509737209019,-0.8346382884869871,-1.11652108641712,2514,1,TOMM20
PUTRESCINE ACETYLATION%GOBP%GO:0032920,0.337986577181208,0.832232043362884,0.835355094838994,1.10973197566067,2517,1,SAT2
REGULATION OF AV NODE CELL ACTION POTENTIAL%GOBP%GO:0098904,0.143799930531435,0.6340340930337739,0.680451415238823,1.29346655956693,1241,3,RYR2|CXADR
REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0045898,0.88384041910135,0.996316041142784,0.218758662991447,0.6456133311208271,8772,10,PSMC3|PSMC6|ATF7IP|PSMC2|PSMC5
REGULATION OF HEMOSTASIS%GOBP%GO:1900046,0.15494750238625501,0.65461367015785,-0.206301876280652,-1.24016696086525,486,48,FCER1G|PRKCD|USF1|PDPN|PLAU|LYN|SERPINF2|PLAUR|THBD|PROC|PRKCA|CD9|NOS3|ANO6|CAV1|ENPP4
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905386,0.25302013422818803,0.7641083395392759,0.876157917953242,1.16393670582495,1884,1,DVL1
REGULATION OF PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:1903636,0.41489932885906006,0.8695737743071128,0.799735333039259,1.06241271121996,3090,1,PDCD5
POSITIVE REGULATION OF HEART RATE%GOBP%GO:0010460,0.21477732793522303,0.731747191309112,0.43429958045095796,1.2393426125245801,2121,9,RYR2|EDN1|KCNQ1|ATP2A2|SCN3B
BRANCH ELONGATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060667,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
POSITIVE REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900224,0.238448298689263,0.750892237039908,-0.880458756065285,-1.17781652295095,1800,1,SMAD2
NEGATIVE REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902807,0.620161162900932,0.953354591924472,0.167190329345375,0.8990575010018911,7849,83,BTG2|CCNB1|PIDD1|CDK1|E2F8|PKD2|WEE1|CDK2AP2|CDC25C|MUC1|E2F7|DACT1|RB1|GTSE1|CCL2|RPS27L|CHEK2|PRMT1|CARM1|AURKA|CDC73|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|FHL1|CASP2|CDK2|ATM|RFWD3|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|KLF4|RBL2|CCND1|SLFN11|CNOT6|E2F4
NUCLEAR MEMBRANE ORGANIZATION%GOBP%GO:0071763,0.6110653713156601,0.9508825506493929,-0.37638559532344296,-0.865608239538823,3710,4,TARDBP|TOR1A|TMEM43|GPER1
MONOAMINE TRANSPORT%GOBP%GO:0015844,0.7667998547039591,0.9792236089291529,-0.261142790051601,-0.761765104432285,4221,7,VIP|SNCA
REGULATION OF GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046317,0.35456110154905296,0.842911430859438,-0.8220114689016321,-1.09962980486929,2677,1,PRKAA1
PEPTIDYL-SERINE AUTOPHOSPHORYLATION%GOBP%GO:0036289,0.175126368997473,0.677933656654802,0.496904266335528,1.29333740562701,1662,7,MAP2K2|ERN1|MARK3|RIPK1|ATM|PINK1
STRIATED MUSCLE ATROPHY%GOBP%GO:0014891,0.7051060487038492,0.968941691852291,-0.39834646842451604,-0.808432322274208,4487,3,CFLAR
POSITIVE REGULATION OF PROTEIN OXIDATION%GOBP%GO:1904808,0.372434794121541,0.852609194081082,-0.811479929422144,-1.08554144340363,2812,1,TRABD2A
CELLULAR TRANSITION METAL ION HOMEOSTASIS%GOBP%GO:0046916,0.997746660228553,1.0,0.0856910728431291,0.447424936337226,12397,72,TFR2|FLVCR1|MT1F|SLC30A5|ABCB6|MT1E|ATP7B|CAND1|SLC39A7|SLC46A1|SLC40A1|SLC39A13|MT2A|FAM132B|TF|ACO1|SLC39A10|ISCU|ATP6AP1|LCK|ABCB7|IREB2|ATP6V0A2|ATP13A2|ATOX1|CYBRD1|COX19|TMEM199|HAMP
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000546,0.0457312546399406,0.41958742830584794,-0.869644334160463,-1.48748005841012,307,2,FGF2|FGFR1
POSITIVE REGULATION OF CRISTAE FORMATION%GOBP%GO:1903852,0.900816629547142,0.998912093067348,-0.38682106424041895,-0.661636713572188,6066,2,PINK1|CHCHD10
CELLULAR RESPONSE TO LIPID HYDROPEROXIDE%GOBP%GO:0071449,0.0480536912751678,0.431337225587021,0.975352889280988,1.29571279983245,357,1,MGST1
FAT CELL DIFFERENTIATION%GOBP%GO:0045444,0.529938349801537,0.9265056012720759,0.200991699625849,0.953343458166185,6274,47,NR4A2|SIRT1|EGR2|NR4A3|TMEM120A|WNT5B|NR4A1|ERAP1|C1QTNF3
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033143,0.6907894736842111,0.96731875442989,0.169546724403311,0.8451565405848279,8399,58,SAFB2|SIRT1|LMO3|ARNTL|GPAM|KDM5D|TRIM68|PAGR1|HEYL|CLOCK|HDAC6|RNF14|CARM1|SMARCA4|STRN3|KMT2D|DAB2|UFL1|DDX5|CNOT1|BRCA1|UBA5|TAF1|CNOT2|NCOR1
PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0061614,0.146930621140574,0.638549298625996,-0.45711407537632004,-1.33342203817959,808,7,RELA|SPI1|FOSL1|PPARG|ETS1
RESOLUTION OF MITOTIC RECOMBINATION INTERMEDIATES%GOBP%GO:0071140,0.0648360953187371,0.4956987271622679,0.8407499310725122,1.37418266558631,535,2,XRCC3|GEN1
PRONEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0039020,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071878,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX%GOBP%GO:0002502,0.46736396133986496,0.8952133430198359,-0.7644464049404499,-1.02262326366433,3529,1,CALR
NEGATIVE REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090198,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
7-METHYLGUANOSINE MRNA CAPPING%GOBP%GO:0006370,0.753056234718827,0.9769690538700708,-0.152817580111341,-0.809030112888478,2771,32,POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:0061351,0.0561623884944475,0.46132606014672706,0.37360644003986704,1.50207684411701,616,26,SIX3|ARTN|KIF14|FGF13|RORA|LEF1|DOCK7|MELK|PLXNB2|SOX5|RACGAP1|KCTD13|FGFR2|PCM1|HOOK3|TEAD3
STEROL TRANSPORT%GOBP%GO:0015918,0.11477549599721498,0.59233312222184,0.304877895073688,1.35551833802308,1318,37,STAR|ABCA7|ABCA5|SCARB1|STARD5|LIMA1|SOAT1|AKR1C1|CETP|OSBPL5|LDLRAP1|APOE|APOC1|LDLR|ARV1|APOM|LCAT|OSBP|SERAC1|SYT7|LRP6|STARD3|APOC2
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042035,0.69077380952381,0.96731875442989,-0.14939639067042998,-0.8561604937142671,2320,41,BCL10|MAP2K5|IL6|TRIB2|CD276|STAT3|BCL3|TNF|INHBB
POSITIVE REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001108,0.623063683304647,0.9536478716552259,-0.681682840758712,-0.9119079204185021,4705,1,EPHA4
POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0061081,0.0417805544709098,0.402998391331252,-0.502610501590323,-1.6224717391406,213,9,BCL10|SEMA7A|MAVS|TICAM1|GPRC5B
AMELOGENESIS%GOBP%GO:0097186,0.0456942003514939,0.41958742830584794,-0.586067182137914,-1.60871506343506,259,6,TBX1|STIM1|FAM20A|ITGA6|FAM20C
TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER%GOBP%GO:0006361,0.40945300053106704,0.867015886388254,-0.194915701288567,-1.02497097559573,1541,31,PTRF|POLR1B|TAF1B|POLR2K|POLR2F|POLR1E|MAPK3|CD3EAP
PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006606,0.954374148023414,1.0,0.11782361830695198,0.618423180000031,11901,74,SIX3|RANBP17|TPR|NUP133|NXT2|PPP1R10|NUP188|C11orf73|NUP85|IPO13|SPRN|NUP107|NUP35|CEP57|TNPO3|HEATR3|RANBP6|POM121|NUP54|KPNA5|CSE1L|IPO9|TNPO1|TNPO2|AKT1
"RNA PHOSPHODIESTER BOND HYDROLYSIS, ENDONUCLEOLYTIC%GOBP%GO:0090502",0.0314345991561182,0.3625267385964289,-0.427322121402716,-1.65555902654943,148,14,KRI1|RNASEH1|RRS1|NOL9|NOP14
PROTEASOME-MEDIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0043161,0.656022917831191,0.9640743070248079,0.142200518759772,0.915503596274448,9388,266,SIRT1|FBXO18|ARNTL|SPSB4|SIAH2|TRIM9|TRIM3|ANAPC15|CCNB1|SGTA|CDC34|CDK1|BTRC|KIF14|ANAPC5|RNF34|KLHL42|PSMB9|MTA1|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|ATXN3|TNFAIP1|EDEM3|SPSB3|FBXL19|RNF126|KLHL20|CDC23|CDC20|ANAPC7|ANAPC16|FBXL15|PTTG1|FBXO5|PSMD1|FBXL6|BUB1B|RNF121|AURKB|DDB1|RNF7|CLOCK|PSMA1|SYVN1|FBXL8|AUP1|NFE2L2|KLHL22|FBXW5|CCNF|PLK1|BIRC2|HERC2|MAN1B1|UBXN4|TMUB1|SPOP|AURKA|RMND5B|PSMA3|JKAMP|VIMP|UBE2C|FBXO9|ANKZF1|PSMC6|ANAPC10|BAG6|KCTD13|TOPORS|PSMD2|DNAJB9|UBE2B|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FBXL7|AREL1|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|UBR3|CDC16|PLAA|KCTD5|ANAPC2|PSMA2|PSMB6|PSMB3|FAF1|KCTD2|MDM2|PSMA7|ERLIN1|NEMF|SMURF2|PSMB4|SHARPIN
NEGATIVE REGULATION OF STAT CASCADE%GOBP%GO:1904893,0.23247311827957,0.746121572059682,-0.29658658760109496,-1.18281380809521,1080,15,PPP2CA|LEPROT|VHL|BCL3|CAV1
SELECTIVE AUTOPHAGY%GOBP%GO:0061912,0.8551236749116609,0.991298302704726,-0.170118310528341,-0.715838284149808,3871,17,SQSTM1|RB1CC1|ATG13|BECN1|RAB7A
GLUCOCORTICOID SECRETION%GOBP%GO:0035933,0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
REGULATION OF MESENCHYMAL STEM CELL MIGRATION%GOBP%GO:1905320,0.354765100671141,0.842911430859438,0.8271945302161451,1.09889102962781,2642,1,FBXO5
SREBP-SCAP COMPLEX RETENTION IN ENDOPLASMIC RETICULUM%GOBP%GO:0036316,0.4437971666887329,0.881002146821428,-0.776521835024261,-1.03877693466422,3351,1,INSIG1
CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0034599,0.6316155988857939,0.9579569038493009,-0.11815489820946401,-0.937379521391939,906,144,PPIF|EIF2S1|VKORC1L1|IMPACT|MAPK7|PRKCD|SIRPA|ROMO1|PRKAA1|HMOX1|TNFAIP3|SOD3|ABL1|RPS3|PYROXD1|ZNF580|G6PD|FOXO1|CPEB2|GSR|PXN|IL6|MMP9|SOD2|PDCD10|SNCA|FXN|PPARGC1A|NET1|JUN|PRDX1|TP53|NOS3|ZNF622|MAPK3|SRXN1|STK24|SESN2|AQP1|FOXO3
ENDOCARDIAL CUSHION FUSION%GOBP%GO:0003274,0.726525413916869,0.972554563883587,0.434498967298811,0.8259368292593271,6274,3,TGFB2|TGFBR2
PLATELET ACTIVATION%GOBP%GO:0030168,0.00046926325668700096,0.0784645998831315,-0.264540171784335,-1.91257893346923,0,95,PIK3R5|HSPB1|PTPN6|PRKCH|GNA13|FCER1G|DGKI|PRKCD|DGKD|PDPN|ARRB2|VAV1|GNAQ|FYN|DGKQ|CLIC1|GNA15|UBASH3B|IL6|LYN|RAP2B|ARRB1|VAV3|VAV2|PRKCA|DGKG|CD9|YWHAZ|CSRP1|MAPK3|GNA12|DGKB|BLOC1S3|MYH9|VWF|GNAS|PIK3R1|DGKK
REGULATION OF ACTIN FILAMENT ORGANIZATION%GOBP%GO:0110053,0.142621599340478,0.6324244126031129,-0.142984874062266,-1.17481968503722,172,175,ASAP3|TRIOBP|FCHSD1|CXCL12|KANK4|ARPC1B|ARHGEF5|PPM1F|PYCARD|CAPZA2|RLTPR|S100A10|NCK2|SYNPO|HAX1|CDC42EP5|PPFIA1|ADD1|CX3CL1|PRKCD|LPAR1|TGFBR1|CFL2|PTK2B|VASP|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|INPP5K|WDR1|TMSB10|MYADM|WHAMM|NAT6|PXN|ARPC5|BIN1|SERPINF2|WIPF1|RHOC|TMSB4X|LIMK1|WNT11|ARPC5L|ARPC4|TWF1|CDC42|MTPN|ARPIN|SSH3|TWF2|SORBS3|PARK2|TMEFF2|RAC1|MET|ACTR2|BRK1|SH3BP1|JMY
C-TERMINAL PROTEIN-TYROSINYLATION%GOBP%GO:0018166,0.4873560174764989,0.907789754052198,-0.75452139391266,-1.00934627380141,3680,1,TTL
STRAND DISPLACEMENT%GOBP%GO:0000732,0.374621991048748,0.852609194081082,0.6540037527155029,1.06895116727941,3096,2,BLM|RTEL1
NOSE DEVELOPMENT%GOBP%GO:0043584,0.332903780068729,0.8293509737209019,0.454497456207499,1.11777030236469,3099,6,GNG8|PROX1|CHD7
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042059,0.662053694990313,0.964618776001639,-0.161306767163835,-0.8679734610012428,2391,34,DAB2IP|PTPN3|GRB2|CDC42|DUSP3|SNX6|SOCS5|RAB7A
REGULATION OF EXOCYTOSIS%GOBP%GO:0017157,0.0781409601634321,0.5317491893669141,-0.171197127497012,-1.28026281343949,152,108,LGALS9|ITGAM|LAMP1|FGR|NAPB|RAB8B|VPS4A|SYN1|VPS18|LYN|FCGR2B|NAPA|VAMP2|HAP1|VPS4B|VAMP3|RALA|RAB8A|SNCA|RAB2B|FMR1|SNX6|GAB2|RALB|RAB7A|PARK2|RAB5A|ADRA2A|RSG1|CPLX1
CELLULAR RESPONSE TO STAUROSPORINE%GOBP%GO:0072734,0.8100034734282741,0.984682960940884,0.39999178170020794,0.760342299456055,6995,3,CASP6|CASP7
GLUTAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006542,0.00516351118760757,0.16737273925846302,-0.9975738861932071,-1.3344850033334599,38,1,GLUL
PROSTATE EPITHELIAL CORD ARBORIZATION INVOLVED IN PROSTATE GLANDULAR ACINUS MORPHOGENESIS%GOBP%GO:0060527,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010890,0.0906036510247508,0.560245248761167,0.658740288236884,1.39593359692489,808,4,LPL|FITM1|OSBPL11|FITM2
NEUTROPHIL MIGRATION%GOBP%GO:1990266,0.588657942006672,0.945418171231938,0.19768743573727898,0.909827847650486,6881,42,EDN1|CXCL13|CXCL9|TGFB2|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CXADR|AMICA1|GBF1|CCL3L3|CCL11|CCL4L2|PIP5K1C|CXCL11|CKLF|XCL1|CCL4|CXCL2|CCL8|CXCL1|CCL24
MINERALOCORTICOID METABOLIC PROCESS%GOBP%GO:0008212,0.0361678964557881,0.38395931615660706,0.878191342707472,1.43537962432791,298,2,CYP21A2|CACNA1H
POSITIVE REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046427,0.284365454040544,0.7935431103190501,-0.20732245544029299,-1.12700631107473,1023,35,CYP1B1|IL6ST|AGT|IL6R|SOCS3|NOTCH1|VEGFA|CRLF1|PTK2B|LIF|ARL2BP|TNFRSF18|IL6|LYN|IGF1|STAT3|TNF
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0045981,0.222941030106992,0.7355723797115551,-0.24397666807565196,-1.1835970336130002,895,25,PRKAA1|PFKFB4|ENO1|IGF1|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
PEPTIDYL-TYROSINE MODIFICATION%GOBP%GO:0018212,0.35655883398506893,0.844559957061487,-0.16622943573583301,-1.0632855729016601,1002,60,TNK1|FES|ITK|ABL2|NTRK1|TTL|PTPN6|BLK|KDR|IGF1R|ABI1|PTK2B|TNK2|FGR|ABL1|DYRK1A|FYN|LYN|TPST1|YES1|FGFR1|RELN|MAPK3|FLT1|EPHB2
CARDIAC VENTRICLE FORMATION%GOBP%GO:0003211,0.16912774725274696,0.673117535978459,-0.5081623648797711,-1.2863792829764,984,5,MEF2C|SOX11|SOX4|MESP1|HAND1
SUPEROXIDE ANION GENERATION%GOBP%GO:0042554,0.923646907216495,1.0,0.249186476200982,0.612837847702278,8600,6,DUOX1|NCF1|CYBB|NOX4|NCF2|CYBA
POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000510,0.444991212653779,0.882257808303511,-0.35955571831901,-0.9869563043847249,2531,6,GAS6|CALR|LGALS9|C1QBP
POSITIVE REGULATION OF HYALURANON CABLE ASSEMBLY%GOBP%GO:1900106,0.389630793401414,0.8603316114971841,-0.5118010367265909,-1.03868499776001,2479,3,HAS3|BMP7|HYAL1
UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:0070086,0.8163783718398451,0.9866358717238399,0.479735318444996,0.7841141988982041,6748,2,NEURL1B|LRSAM1
TONGUE MORPHOGENESIS%GOBP%GO:0043587,0.5583660644147679,0.936434965680841,-0.45081063196206006,-0.9149067833949,3553,3,HDAC2|HDAC1|TBX1
CELLULAR LACTAM METABOLIC PROCESS%GOBP%GO:0072338,0.0296644295302013,0.353942807960853,0.985277900308778,1.30889773419673,220,1,DPEP1
REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904749,0.5846219931271479,0.9439064862850342,0.366461243720311,0.9012580589916072,5443,6,NVL|TERT
DNA CATABOLIC PROCESS%GOBP%GO:0006308,0.311299280706547,0.8143712300420921,0.28446147556333,1.1335380602475802,3418,25,MUS81|FBXO18|DFFB|ENDOG|DNASE1L2|FEN1|GEN1
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS%GOBP%GO:0097006,0.534627447656184,0.9265056012720759,0.20092179656725698,0.948105210936316,6306,46,LPL|VLDLR|ZDHHC8|ABCA7|ABCA5|DGAT1|AP2A2|AGTR1|SCARB1|SOAT1|CETP|LDLRAP1|APOE|APOC1|CLTC|LDLR|APOM
RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:0090118,0.23283547528076898,0.746122594132505,0.628487923238116,1.19468942762776,2010,3,LDLRAP1|LDLR|LRP6
SQUAMOUS BASAL EPITHELIAL STEM CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND ACINUS DEVELOPMENT%GOBP%GO:0060529,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
TRANSLATIONAL ATTENUATION%GOBP%GO:0009386,0.5417714815305179,0.928807195199472,-0.724580943978827,-0.9692940210482521,4091,1,TRAP1
PROSTATE GLAND MORPHOGENETIC GROWTH%GOBP%GO:0060737,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
WOUND HEALING%GOBP%GO:0042060,0.00144508670520231,0.0961252072968491,-0.18328144524851397,-1.61926299891392,0,261,HMOX1|PDPN|ARRB2|AKIRIN1|EPB41L4B|VAV1|HBG2|GNAQ|FYN|RHOA|ITPK1|EYS|P2RX6|ITGA5|C1QBP|DGKQ|MFN2|CLIC1|APOD|FGF2|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|SLC11A1|MAFF|PRKAR2A|IGF1|RHOC|PDCD10|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|ADAM17|THBD|PROC|RAD51B|MMP12|CFLAR|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ANO6|CSRP1|MAPK3|GNA12|MCAM|RAB5A|DGKB|FGF10|BLOC1S3|MYH9|VWF|EVPL|ACVRL1|GNAS|TMEFF2|H3F3B|RAC1|CD36|PIK3R1|ZFPM2|DGKK
REGULATION OF PROTEIN COMPLEX STABILITY%GOBP%GO:0061635,0.9763959654778,1.0,0.18867226435885,0.5143712102968171,9389,8,TRAPPC11|NCLN|SNF8|HSPA8|SCOC|ATG14
IGG IMMUNOGLOBULIN TRANSCYTOSIS IN EPITHELIAL CELLS MEDIATED BY FCRN IMMUNOGLOBULIN RECEPTOR%GOBP%GO:0002416,0.647557262015093,0.9636261853025391,-0.670544772827525,-0.89700818735011,4890,1,FCGRT
POSITIVE REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904958,0.8481069042316259,0.991298302704726,-0.41659773917838394,-0.7125681213168751,5711,2,CSNK1E|CSNK1D
POSITIVE REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903518,0.301681383815169,0.804661845283139,0.686297215329473,1.1217339447686299,2493,2,PARP1|XRCC1
NEGATIVE REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900364,0.680222841225627,0.9647315640607691,-0.26449335319102,-0.822160504090125,3662,8,ZC3H14|RNF40|CTR9|CCNT1|SUPT5H|RNF20|CDK9|NELFE
NEGATIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033137,0.0037544169611307397,0.143595610377104,-0.475792467878425,-2.00207998045427,16,17,PPM1F|NCK2|CNKSR3|DDIT4|INPP5K|RASSF2|SMAD7|DKK1|PDE4D|CAV1
RHYTHMIC PROCESS%GOBP%GO:0048511,0.321564885496183,0.822751772025005,-0.148608983995391,-1.07989562380766,673,97,PML|DYRK1A|MYBBP1A|CCRN4L|PPARA|RELB|ASS1|NAMPT|PER3|KDM5A|CIART|TNFRSF11A|NRIP1|PPARGC1A|ID1|NDUFA9|TP53|KLF9|DRD2|PER2|PPP1CB|USP2|NR1D1|SLIT3
POSITIVE REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0045876,0.311336032388664,0.8143712300420921,0.39849352255467696,1.13716435738718,3075,9,FAM178A|FEN1|NIPBL|ANKRD32
GLYCEROLIPID CATABOLIC PROCESS%GOBP%GO:0046503,0.475933423301844,0.9020294602084971,0.24113644564906,0.9888109384123409,5289,28,ENPP2|LPL|FABP5|PLA2G4A|PNPLA6|FABP6|PNPLA2|APOE|ABHD16A|PLA2G4B|ABHD2|DAGLA|SMPD4|INPP5F|PLA2G4C|PNPLA8|DAGLB
POSITIVE REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901224,0.32614721281182596,0.826621597878865,-0.18561481678382602,-1.09088839462608,1058,45,SASH1|RELA|TRAF6|EIF2AK2|NOD1|IL1B|IRAK1|LGALS9|RPS3|SPHK1|RHOA|TNFRSF10A|PDCD4|PTP4A3|LIMS1|TNFRSF10B|CHI3L1|COPS8|TNF
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903384,0.900816629547142,0.998912093067348,-0.38682106424041895,-0.661636713572188,6066,2,PINK1|PARK7
NEGATIVE REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902303,0.830047175517116,0.9879179006160809,0.47343782835664006,0.7738211243509581,6861,2,KCNH2
POLY(A)+ MRNA EXPORT FROM NUCLEUS%GOBP%GO:0016973,0.391923757123207,0.861972024132461,0.33636591729185,1.06034557711395,3988,12,NXF2|ZC3H11A|NXF2B|THOC2|PABPN1|ZC3H3
REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032271,0.964237516869096,1.0,-0.0907202248883488,-0.720022772870135,1428,142,PYCARD|CAPZA2|RLTPR|ARL2|MECP2|NCK2|HAX1|CDC42EP5|MAPRE1|ADD1|ANKRD53|CLIP3|PRKCD|PTK2B|VASP|PFN1|ABL1|RPS3|DYRK1A|RANGRF|TMSB10|MYADM|WHAMM|SLAIN2|ARPC5|BIN1|WIPF1|TMSB4X|ARPC5L|SNCA|ARPC4|TWF1|MTPN|ARPIN|TPPP3|TWF2|RAC1|MET|ACTR2|BRK1|JMY
DIVALENT METAL ION TRANSPORT%GOBP%GO:0070838,0.685499196023973,0.966495577318169,0.146832331577302,0.878567323905168,9378,152,RYR2|CRACR2B|CACNA1G|GRIN3A|CACNB2|ATP2B1|TMEM165|NOL3|CACNA1I|SLC8A3|F2R|SLC39A3|PKD2|SLC35G1|IBTK|SLC30A5|ATP2A1|CDH23|NPY|CACNA1H|CACNA2D1|MRS2|CCR5|CACNA1D|CCL21|JPH4|MCOLN1|CCL5|ATP2B3|NALCN|SLC39A7|SLC40A1|GRIN1|NIPA1|CCL19|TRPM7|ATP2A2|PLCG1|SLC39A13
"NEGATIVE REGULATION OF TRANSPOSITION, RNA-MEDIATED%GOBP%GO:0010526",0.5958087298830611,0.9478856081493391,0.481322744555649,0.914943904148097,5145,3,ZCCHC11|ZCCHC6
RESPONSE TO DSRNA%GOBP%GO:0043331,0.000471031559114461,0.0784645998831315,-0.539807718193432,-2.45169652898561,1,21,MAVS|NPM1|RFTN1|PDE12|COLEC12|RALB|SLC3A2|TICAM1|PMAIP1|CAV1
REGULATION OF CELL AGING%GOBP%GO:0090342,0.40510981622590797,0.866234596232951,0.25225270399023997,1.04491564427349,4518,29,SIRT1|NUAK1|ARNTL|CDK6|CDKN2A|TERT|VASH1|FBXO5
NEGATIVE REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043031,0.8194696694515079,0.987153241368501,-0.24752667924514998,-0.722046305117978,4511,7,CX3CL1|NR1H3|FCGR2B
EPITHELIAL CELL MORPHOGENESIS%GOBP%GO:0003382,0.000390472471690746,0.0784645998831315,-0.699394583906572,-2.25770839110191,1,9,COL23A1|SIPA1L3|RILPL2|MET|RILPL1|DACT2|STC1
PYRIMIDINE DIMER REPAIR%GOBP%GO:0006290,0.0255347743308321,0.332715497791433,0.7474363709843491,1.5838890689580403,227,4,SIRT1|DDB2|MSH6
POSITIVE REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034112,0.512711389853287,0.9189160303470669,0.45658674882658296,0.9675509362022479,4577,4,CCL5|ANK3
NEGATIVE REGULATION OF CELL DIFFERENTIATION%GOBP%GO:0045596,0.29175475687103597,0.8000726114371469,-0.11741093651905699,-1.0731628305214,137,327,SDHAF2|GPER1|FUZ|FBXW7|NOTCH1|LRP5|ARHGDIA|ID2|RNF6|ZEB1|IL1B|RARA|PRAME|NFKBIA|CX3CL1|LPAR1|DAB2IP|RTN4|SKI|TGFBR1|PTK2B|FOXO4|AKIRIN1|NR1H3|PRICKLE1|FAM101B|SRGAP2C|SEMA3F|LIMD1|HDAC4|TRIO|TCTA|RHOA|SMAD6|HDAC5|HIST2H4A|EID2B|CCDC85B|CCRN4L|PPARA|FOXO1|RUNX1|SEMA7A|YWHAH|IL6|PPARG|FCGR2B|EFNA1|LDLRAD4|TRIB2|POU4F2|ABCA1|PPP2CA|BAG5|IGF1|SPOCK1|FOXJ2|SMAD7|BHLHE41|SEMA6B|NR1H2|PDCD4|FAM101A|SOX6|ID1|CFLAR|NFATC2|DKK1|RBPMS2|SOCS5|ADCYAP1|MFI2|HIST2H4B|ABCG1|FKBP4|GREM1|SFRP2|ASCL1|CBFB|MYLIP|ZNF365|SEMA3A|CORO1C|SEMA3G|TWIST1|TNF|ZFPM2|GAL|CAV1|LINGO1|TRIB3|RTN4RL2
NEGATIVE REGULATION BY SYMBIONT OF HOST APOPTOTIC PROCESS%GOBP%GO:0033668,0.156952081696779,0.6578589353509621,-0.655619278702989,-1.33055984682348,998,3,CASP8|SERPINB9|BCL2L1
REGULATION OF CELL-SUBSTRATE JUNCTION ASSEMBLY%GOBP%GO:0090109,0.0025308446694084197,0.12586582153175,-0.33438083120949,-1.99713730474226,7,47,DUSP22|PPM1F|THY1|S100A10|GPM6B|VEGFA|KDR|BCAS3|COL16A1|DLC1|ABL1|RHOA|NRP1|SLC9A1|APOD|MAP4K4|DUSP3|LIMS1|ACVRL1|RAC1|CORO1C|PEAK1
SKELETAL MUSCLE ATROPHY%GOBP%GO:0014732,0.628062360801782,0.955478665923049,-0.5107775550472761,-0.8736576524123141,4229,2,CFLAR
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002263,0.0319634703196347,0.365066918595497,-0.129017866783151,-1.2321023571409,6,455,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|PTK2B|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|EXOSC6|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|IL6|PNP|CD68|FCGR2B|RAP2B|SBNO2|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|ICAM1|CRACR2A|FOXP1|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|KARS|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|DYSF|STAT3|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4|RNF168
REGULATION OF ACTIN POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0008064,0.933079434167573,1.0,-0.0984380016443171,-0.74953685750986,1714,116,CAPZB|ARF6|PLEK|TRIOBP|FCHSD1|CXCL12|KANK4|ARPC1B|PYCARD|CAPZA2|RLTPR|NCK2|HAX1|CDC42EP5|ADD1|PRKCD|CFL2|PTK2B|VASP|PFN1|WDR1|TMSB10|MYADM|WHAMM|NAT6|ARPC5|BIN1|WIPF1|TMSB4X|ARPC5L|ARPC4|TWF1|MTPN|ARPIN|SSH3|TWF2|ACTR2|BRK1|SH3BP1|JMY
CYTOPLASMIC TRANSLATION%GOBP%GO:0002181,0.370091623036649,0.852609194081082,-0.17284494232410402,-1.0532826592722702,1130,51,EIF3D|RPL9|RPS28|RPL17-C18orf32|GSPT1|EIF4G1|RPL15|RPL8|TMA7|EIF4H|RPL35A|EIF4B|ETF1|EIF3A|EIF2S3
NEGATIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901837,0.863610049785805,0.991943445125448,0.37276449957992,0.708586100347957,7458,3,H2AFY2|H2AFY
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0106135,0.0960653303637713,0.5684612493613671,-0.8118555279845602,-1.3886354004167198,646,2,KCNE3|BIN1
REGULATION OF BONE RESORPTION%GOBP%GO:0045124,0.8857142857142858,0.996643473105967,0.17947275816198602,0.6560003904561049,9361,19,CARTPT|BGLAP|SRC|NF1|DEF8|ATP6AP1|CSF1R
POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034093,0.571802135541512,0.9405604256499541,0.3984262609112679,0.9183134680933341,5247,5,FAM178A|ANKRD32
TRACHEA GLAND DEVELOPMENT%GOBP%GO:0061153,0.37449664429530205,0.852609194081082,0.8182620202911339,1.08702458869995,2789,1,LEF1
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034164,0.7525099794363129,0.9769690538700708,0.505817480011029,0.8267447754589909,6220,2,PTPRS|RAB7B
RESPONSE TO INSECTICIDE%GOBP%GO:0017085,0.7632211538461541,0.978421368343614,-0.30228124816651597,-0.7652049072261659,4444,5,HSF1
CEREBELLAR CORTEX MATURATION%GOBP%GO:0021699,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
REGULATION OF ESTABLISHMENT OF CELL POLARITY%GOBP%GO:2000114,0.6036853160206229,0.9508825506493929,0.253112638827263,0.892691724508375,6322,17,KIF20B|DOCK8|KRIT1|RUFY3|SHTN1
NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0110111,0.42749114578347897,0.876089699952999,0.29687102395741494,1.0291713316375999,4465,16,ASPN|TBX2|CEACAM1|BMP4|TGFB2
POSITIVE REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051965,0.8004316006755491,0.9841161968820359,0.198535680136393,0.7372620996612479,8530,20,GHRL|CUX2|CLSTN2|PTPRD|DLG5|AGRN|NLGN3|IL1RAP|LRRC4B|NLGN2|EPHB3
SYMPATHETIC GANGLION DEVELOPMENT%GOBP%GO:0061549,0.027723545490043,0.3421234253804781,-0.529651303495562,-1.7097618708750701,141,9,CTNNB1|SEMA3F|NRP1|ASCL1|SEMA3A|INSM1
"ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB VIA ER PATHWAY, TAP-DEPENDENT%GOBP%GO:0002489",0.14,0.6281603901381739,0.9309108954565501,1.23667359373459,1042,1,TAP2
MAINTENANCE OF PROTEASE LOCATION IN MAST CELL SECRETORY GRANULE%GOBP%GO:0033373,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
SPERMIDINE CATABOLIC PROCESS%GOBP%GO:0046203,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
CELLULAR RESPONSE TO INSULIN-LIKE GROWTH FACTOR STIMULUS%GOBP%GO:1990314,0.182331106161841,0.6875931283957409,-0.747394540942928,-1.27837833439165,1227,2,SYAP1|SLC25A33
NEGATIVE REGULATION OF ENDORIBONUCLEASE ACTIVITY%GOBP%GO:0060702,0.828474658279908,0.9876441563834109,0.47427631166358203,0.7751916022816708,6848,2,ABCE1|TMBIM6
RETROGRADE TRANS-SYNAPTIC SIGNALING BY ENDOCANNABINOID%GOBP%GO:0098921,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
GANGLIOSIDE CATABOLIC PROCESS%GOBP%GO:0006689,0.5326001571091911,0.9265056012720759,-0.45908238667696,-0.9316940638241641,3389,3,NEU3|NEU1|NEU4
REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902099,0.000935772011909826,0.0849637591935908,0.430742935118962,2.01905971462697,10,45,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|USP44|BUB1|DLGAP5|CDC23|CDC20|GEN1|APC|NDC80|CDK5RAP2|CENPE|FBXO5|RB1|BUB1B|ESPL1|CDC6
POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE-NOREPINEPHRINE%GOBP%GO:0003321,0.225765907305577,0.7398172623753029,-0.59806020008276,-1.21374540691906,1436,3,ADRA1B|PDE4D
NEGATIVE REGULATION OF THYMIDYLATE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0050760,0.433422818791946,0.878651088001772,0.790086016762241,1.04959402503246,3228,1,APBB1
CELL FATE DETERMINATION%GOBP%GO:0001709,0.859282700421941,0.99166790097654,-0.180680873404808,-0.700005536592058,4072,14,GATA3|JAG1|NOTCH2|KLF4|ISL1|MEF2C|MCL1|CYP26B1|MESP1|IFRD1|NOTCH4|DLL1|SOX17
POSITIVE REGULATION OF CDP-DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE ACTIVITY%GOBP%GO:1904219,0.31317285593322897,0.8158652929227931,0.681033924756165,1.1131312409176002,2588,2,SERINC5|SERINC1
CELL CYCLE SWITCHING%GOBP%GO:0060184,0.5906616668682719,0.945418171231938,0.5708298869589189,0.9330057686200229,4882,2,YTHDC2|C17orf104
POSITIVE REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903766,0.518634001484781,0.9236324326350509,-0.555308315131595,-0.949825132621582,3492,2,ANO6
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1990440,0.38928289992119797,0.8603316114971841,-0.306900032966607,-1.0382887483182,1975,10,ATF4|HSPA5|DDIT3|ATF6|TP53
BUD OUTGROWTH INVOLVED IN LUNG BRANCHING%GOBP%GO:0060447,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903305,0.856361647830842,0.991298302704726,-0.11890551774430802,-0.774677286236123,2348,64,LGALS9|ITGAM|LAMP1|FGR|NAPB|SYN1|VPS18|LYN|FCGR2B|NAPA|VAMP2|VAMP3|FMR1|SNX6|GAB2|RAB5A|ADRA2A
"REGULATION OF SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0032222",0.148181143281366,0.640403944123879,-0.7678522194651229,-1.31337009786069,997,2,ACHE|CHRNA3
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:1904950,0.0383239652529382,0.393143354533675,-0.18488644807298002,-1.37747650608616,74,107,SYT11|IL1B|SRGN|CX3CL1|UBE2J1|TNFAIP3|NR1H3|OS9|PFKL|SSC5D|BAG4|INPP5K|RAB11FIP1|APOD|FCGR2B|CHP1|TMSB4X|DPH3|NLRP3|RANGAP1|TNFRSF4|SIAH3|DRD2|PPP1R11|CABP1|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|SNX12|TNFRSF21|INHBB
VIRAL MRNA EXPORT FROM HOST CELL NUCLEUS%GOBP%GO:0046784,0.7565290648694191,0.977664504547119,0.292538071426213,0.761415137639471,7183,7,THOC3|THOC1|THOC2|DDX39B
POSITIVE REGULATION OF CELL SIZE%GOBP%GO:0045793,0.0148199606344796,0.264001457476971,0.8370639737247909,1.5911705582259899,127,3,EDN1|PRR16
REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902308,0.0884241725671003,0.556932119338259,-0.641041195610213,-1.4742608317068502,536,4,PPP1R15A|DUSP26|PPP1R16B|YWHAE
PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048008,0.7474699255298841,0.9749763305090959,0.220008359557559,0.775937712196699,7828,17,NR4A3|PLAT|RGS14|PDGFD|PTPRJ|FER|PIK3C2A|PDGFC|PDGFRA|PDGFB
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0040036,0.539621920947107,0.9280749458041251,0.267644963213825,0.9439451339701159,5651,17,GPC1|FGFR2|THBS1|SPRY4|GATA3|SPRY1|SULF1|CREB3L1|APLN|DSTYK|NPTN
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002092,0.338396624472574,0.8326275783736579,-0.27825027531306396,-1.0780152298745,1603,14,VEGFA|ARRB2|ARRB1|TBC1D5|FMR1|GREM1
MAINTENANCE OF CHROMATIN SILENCING%GOBP%GO:0006344,0.23757106568283498,0.7507739897770379,0.7154678523319771,1.16941254958494,1963,2,SIRT1|HDAC2
REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033238,0.109657039711191,0.584830174998513,-0.31104254764119,-1.3640687630086898,485,19,AZIN1|PARK7|SLC7A7|OAZ2|CHRNB2|ITGAM|HPRT1|ATP2B4|NQO1|ODC1|PARK2
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033690,0.0671967745548214,0.501960209022281,0.682077425141426,1.44538721930509,599,4,CYR61|BMP2|HPSE|TMEM119
REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904475,0.297698589458055,0.8023890191280308,-0.6817204301075269,-1.1660462850880902,2004,2,EPHA4|FAM65B
POSITIVE REGULATION OF MYOBLAST PROLIFERATION%GOBP%GO:2000288,0.35927875461977793,0.847459828408795,0.511866794086427,1.0846946327329101,3207,4,MEIS2|GATA6|SOX15|ATF2
MITOCHONDRIAL MRNA SURVEILLANCE%GOBP%GO:0035946,0.675704697986577,0.9647315640607691,0.666850463167181,0.885881090009248,5033,1,SUPV3L1
CELLULAR COMPONENT MORPHOGENESIS%GOBP%GO:0032989,0.15974440894568698,0.661454203640901,-0.11911731768237001,-1.12052569820329,49,408,PARD6B|LAMC1|TUBB3|NFIB|TNNT2|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|VAMP3|MYOM1|MAP4K4|NYAP2|RAB8A|ARHGEF2|CDC42|DBNL|NEFH|STK4|VHL|ALCAM|S100A6|PLXNA1|COL21A1|FLRT1|SHC1|CFLAR|PRKCA|PLXNA4|EPHA8|RELN|CD9|GAB2|PMP22|TMOD1|COBL|DRD2|MAPK3|WNT3|MYH11|GREM1|MYH9|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|MET|DOK5|PTPRA|PIK3R1|RILPL1|HSP90AB1|PEAK1|TMEM108|NTNG2|CDHR1|GFRA2|DACT2|NBL1|STC1|SLIT3|EPHB2|PARD3|UBB
NEUROTRANSMITTER RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0099628,0.277328646748682,0.7884684708511421,-0.41768604362807504,-1.1465201441922,1577,6,CACNG3|CACNG7
RESPONSE TO INTERFERON-BETA%GOBP%GO:0035456,0.5074427904910019,0.9178418581609309,-0.219988393847317,-0.9463411936319309,2283,18,IFNAR2|IFITM2|IFITM3|IFITM1|UBE2K
NEGATIVE REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060339,0.8736379613356771,0.9934031064448321,-0.246704539187028,-0.67718739506998,4970,6,CACTIN|PTPN2|NLRC5|SAMHD1|MUL1|CNOT7
POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901534,0.7541577474065541,0.977083996023335,-0.336341764704644,-0.7735157945648241,4579,4,FOXC1|NUDT21
TOLERANCE INDUCTION TO LIPOPOLYSACCHARIDE%GOBP%GO:0072573,0.350456772143519,0.842847021021096,-0.824327304808116,-1.1027277691706399,2646,1,TNFAIP3
POSITIVE REGULATION OF DIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:2001150,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
POSITIVE REGULATION OF PINOCYTOSIS%GOBP%GO:0048549,0.5078152136158389,0.9179996794142941,0.513246463937417,0.97562753644361,4385,3,ANKFY1|AXL|PPT1
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903018,0.322889006903877,0.8233331762466272,-0.20813431263098497,-1.09448150180829,1215,31,NECAB2|CTNNB1|ITM2A|TCF7L2|CHP1|RAB1A|IGF1|ACOT8|PLCB1|RAMP1
REGULATION OF T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:2000551,0.32623626373626397,0.826621597878865,-0.433741573133801,-1.09798799046625,1899,5,IL6|NLRP3
REGULATION OF CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:0030997,0.886071552622438,0.996643473105967,0.35877645980425,0.6819963082209611,7652,3,NEK2|CEP250
PURINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0006195,0.0725240447101638,0.517256978658494,-0.28031771992112897,-1.4345963213562098,278,29,NUDT11|GPX1|SAMHD1|NT5C|NUDT10|NT5C2|NT5C1A|NUDT1|NUDT15|NUDT7|NUDT4|PNP|HPRT1|NUDT18|PDE9A|ITPA|NT5E|PDE4D
NEGATIVE REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051042,0.793856745663975,0.9819233677232551,-0.5999117776797529,-0.802520276158967,5995,1,BMP2
REGULATION OF SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014717,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|CAPN3
MIRNA TRANSPORT%GOBP%GO:1990428,0.43340994314745396,0.878651088001772,0.6289055040826329,1.0279287693782,3582,2,HNRNPA2B1|TGFBR2
SESQUITERPENOID CATABOLIC PROCESS%GOBP%GO:0016107,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
RESPONSE TO ISOQUINOLINE ALKALOID%GOBP%GO:0014072,0.889429199953688,0.997300970905927,0.356948758185233,0.678522039710204,7681,3,ADCY8|SRR
L-SERINE METABOLIC PROCESS%GOBP%GO:0006563,0.14331853048042,0.633270593192698,-0.37685119200564793,-1.326186296289,709,11,SDS|CBS|SDSL|SHMT2|PSPH
"PHOTOTRANSDUCTION, VISIBLE LIGHT%GOBP%GO:0007603",0.34815465729349704,0.842847021021096,-0.39001787683431,-1.07057288412486,1980,6,GNAQ|PDE6B|GNGT1
COGNITION%GOBP%GO:0050890,0.9487042275055421,1.0,0.11444198417486001,0.6491818985292889,12409,111,CALB1|CRHBP|SLC8A3|KAT2A|VLDLR|INS|AGER|ABCA7|ADCY8|RGS14|FGF13|CUX2|CPEB3|LINS|FEN1|NF1|APOE|GRIN1|SHISA7|NIPBL|DLG4|TH|NLGN4Y|BRSK1|ST3GAL4|LDLR|NRXN3|S100B|CHD7|NPAS4|SLC8A2
MYOTUBE DIFFERENTIATION%GOBP%GO:0014902,0.620675105485232,0.9536478716552259,-0.225150650246472,-0.8722932248989141,2941,14,IGF1|PGK1|RYR1|CAV2
DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009264,0.97133970228838,1.0,-0.13223465736813,-0.568844116295146,4371,18,SAMHD1|NT5C|OGG1|DCTPP1|NUDT1|NUDT15|SMUG1|DERA|NUDT18|NEIL2
PROTEIN SULFHYDRATION%GOBP%GO:0044524,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
REGULATION OF SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0010990,0.0189362753169768,0.286396032442422,-0.7520625713406679,-1.7295868027091001,114,4,SMAD6|LDLRAD4|PPM1A
TNFSF11-MEDIATED SIGNALING PATHWAY%GOBP%GO:0071847,0.15742089236065102,0.658345302622411,-0.9184494927216591,-1.22863788970404,1188,1,TNFRSF11A
REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903972,0.435659088363759,0.878651088001772,0.48447581757017605,1.02665053697257,3889,4,CSF1|TLR4|PTPN2|TLR2
DNA REPAIR COMPLEX ASSEMBLY%GOBP%GO:0090735,0.8565593087195601,0.991298302704726,-0.342196497968673,-0.6944776255229621,5451,3,DMC1
POSITIVE REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051623,0.6577518866675489,0.9643779777660141,-0.6648654609616229,-0.889410798706325,4967,1,ACTB
CELL-SUBSTRATE JUNCTION ASSEMBLY%GOBP%GO:0007044,0.275184901810763,0.7884684708511421,-0.227349813019537,-1.13292891786374,1078,27,ACTN1|PIP5K1A|PLEC|THY1|LAMA5|DLC1|TESK2|WHAMM|LAMC1|ITGA6|LAMC2|PEAK1
CEREBELLAR PURKINJE CELL LAYER FORMATION%GOBP%GO:0021694,0.606290136670509,0.9508825506493929,-0.37792974135554,-0.8691594528292391,3681,4,CEND1|AGTPBP1|ATP7A|FAIM2
NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034351,0.0906284053759535,0.560245248761167,-0.49786893141673105,-1.4523057613779597,498,7,PRKCI|GAS6|DLL1|PRKCH|PRKCD|PRKCA
REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000416,0.365881771776717,0.8510019955058101,-0.459714332984062,-1.0572469281751802,2221,4,DAPK2|ADAM8|CD300A|PTGER4
AROMATIC COMPOUND CATABOLIC PROCESS%GOBP%GO:0019439,0.9197860962566841,1.0,-0.08918994862328398,-0.821527950445293,343,371,RPL7|PFKL|DERA|EXOSC6|GPI|PRPF18|RPS9|RPS3|RPL14|WIBG|NUDT4|EXOSC4|MAGOH|GSPT1|CASP3|EIF4G1|PKM|H1F0|PAPD7|DFFA|RPL15|PNP|RPL8|ENO1|CDA|EXOG|NBAS|HPRT1|PPP2CA|ZPR1|NUDT18|RPL35A|CNOT7|GAPDH|EXOSC9|HELZ2|PGK1|CDADC1|TDO2|HK1|MTPAP|HK2|TPI1|RNASEH1|ETF1|PDE12|PDE9A|CSDE1|PAH|UBA52|MRTO4|PCBD1|BLVRA|UPP1|NCBP2|ENTPD3|ALDOA|POLR2D|RBM8A|RNPS1|ITPA|PABPC1|EXOSC5|DDX6|NT5E|QDPR|NEIL2|PDE4D|PGAM2|ENPP4
NEURAL NUCLEUS DEVELOPMENT%GOBP%GO:0048857,0.354100260793973,0.842911430859438,-0.190895877819165,-1.0685811879529399,1221,38,ATP5J|CHRNB2|MAPKAP1|CNP|HSPA5|RHOA|COX6B1|G6PD|YWHAH|NFIB|MBP|YWHAQ|CDC42|YWHAE
DIADENOSINE PENTAPHOSPHATE METABOLIC PROCESS%GOBP%GO:1901906,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000144",0.38898916967509,0.8603316114971841,-0.23671459598464603,-1.03810552151007,1723,19,PSMC4|BCLAF1|CTNNB1|MITF|FOSL1|JUN|TP53|TWIST1
PHAGOLYSOSOME ASSEMBLY INVOLVED IN APOPTOTIC CELL CLEARANCE%GOBP%GO:0090387,0.85184694823249,0.991298302704726,-0.572562858403176,-0.7659347929811321,6433,1,RAB14
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042108,0.52495247148289,0.9262380308863678,-0.20380453516738395,-0.9441735035295871,2208,22,CEBPG|TLR1|CD86|HSPB1|IL1B|HMOX1|BCL10|CD276|STAT3|TNF
EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0010669,0.516322662173547,0.922356132838748,0.3665627280190471,0.954085766161624,4902,7,PIWIL4|SERPINA3|CXADR|PBLD|TLR4
COLUMNAR/CUBOIDAL EPITHELIAL CELL MATURATION%GOBP%GO:0002069,0.278167615517013,0.78848945131153,-0.860829289810322,-1.15155758744428,2100,1,NKX6-1
REGULATION OF CYTOCHROME-C OXIDASE ACTIVITY%GOBP%GO:1904959,0.7266518188567191,0.972554563883587,-0.4689826302729529,-0.8021696719788249,4893,2,COX17|CHCHD10
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002208,0.8685271005440259,0.993084774742015,0.224973096984637,0.663953731343196,8620,10,LIG4|EXO1|MSH6
RECRUITMENT OF MRNA CAPPING ENZYME TO RNA POLYMERASE II HOLOENZYME COMPLEX%GOBP%GO:0036031,0.37759830530914895,0.85375124052253,-0.808392148213498,-1.08141082433517,2851,1,FAM103A1
GLYCEROL TRANSPORT%GOBP%GO:0015793,0.0942835931700074,0.5630268609168221,-0.813860134701837,-1.3920641728467602,634,2,AQP1
PEPTIDYL-ARGININE HYDROXYLATION%GOBP%GO:0030961,0.107506950880445,0.5839365738048701,-0.944695632995148,-1.26374815178599,811,1,NDUFAF5
NEGATIVE REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051352,0.987819409506157,1.0,-0.506396118217909,-0.677421527228304,7460,1,TFIP11
REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051193,0.397497593840231,0.8638522656500329,-0.17277004288622902,-1.04177192356291,1238,49,EIF6|ZNF205|HIF1A|CBFA2T3|PDK3|PRKAA1|PFKFB4|PRKAG1|HP|HDAC4|FYN|ME2|FBP1|MPV17L|PPARA|IGF1|PDPR|SNCA|AAED1|RAC1
MEIOTIC SISTER CHROMATID COHESION%GOBP%GO:0051177,0.0791097133180114,0.532203813468543,0.825034463744141,1.3484961659672299,653,2,BUB1|BUB1B
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002861,0.72611696331275,0.972554563883587,-0.27164496506422897,-0.792400414883246,3997,7,FCGR2B|ADCYAP1
REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901388,0.515641476274165,0.921938765246636,-0.342248487702051,-0.9394491184367258,2933,6,FURIN|ITGB8|HSP90AB1
MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0097029,0.552133497592116,0.9321968967758479,0.443091040887207,0.938952241901517,4929,4,F2RL1|CCL19
TRANS-SYNAPTIC SIGNALING BY NITRIC OXIDE%GOBP%GO:0099548,0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
SMALL-SUBUNIT PROCESSOME ASSEMBLY%GOBP%GO:0034462,0.885211174367801,0.996643473105967,-0.555855756506396,-0.743585193378543,6685,1,ABT1
POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045080,0.702453482628026,0.968941691852291,-0.35203289371529994,-0.809602113297662,4265,4,HMOX1|TNF
ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032011,0.509863630345558,0.918404893008545,-0.7414534627260699,-0.991864903815223,3850,1,MYO9B
MUSCLE STRUCTURE DEVELOPMENT%GOBP%GO:0061061,0.8095342066957791,0.984682960940884,0.132330347743119,0.802037815843062,11122,167,RYR2|NEB|EGR3|IGSF22|MYLK2|TBX2|GLMN|BASP1|ACTN2|HES1|BMP4|MAPK12|MAML1|KCNH1|SYNE1|MYH3|PROX1|TCAP|DISP1|CACNA1H|SGCE|TGFB2|TAZ|RORA|OBSCN|KRT19|ITGA11|RB1|DDX17|ITGB1BP2|NEBL|SEPN1|CXCL10|HEY2|CXADR|LMOD1|OBSL1|SEMA4C|SRF|DMD|KDM1A|TNNI3|SVIL|KIAA1161|NRG1|SLC8A1|MYLK|TMEM204|MYEF2|GATA6|LAMA2|MYOM2|AEBP1|FGFR2|FHL1|LARGE
DIACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0046340,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
REGULATION OF CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:2000654,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
PURINE NUCLEOTIDE SALVAGE%GOBP%GO:0032261,0.104163393558523,0.5762893149145369,-0.7071798830925329,-1.43520056149923,662,3,ADA|APRT|HPRT1
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043537,0.0265238459576639,0.3377111602831,-0.323603673380801,-1.61258087099696,103,27,MMRN2|RHOA|HDAC5|FGF2|MAP2K5|PPARG|MEOX2|PDCD10|ACVRL1|ANGPT2
PROTEIN DELIPIDATION%GOBP%GO:0051697,0.0797145276400145,0.534078458829271,0.824427901847257,1.34750475721,658,2,ATG4B|ATG4A
PUTRESCINE TRANSPORT%GOBP%GO:0015847,0.666979865771812,0.964618776001639,0.6716475518306129,0.8922538082853191,4968,1,AZIN2
CELLULAR RESPONSE TO NITROGEN LEVELS%GOBP%GO:0043562,0.000197005516154452,0.0784645998831315,-0.7149753260755649,-2.4188685456093504,0,10,MAP1LC3B2|MAP1LC3A|ATG7|BECN1|GABARAPL1|GABARAP|MAP1LC3B|GABARAPL2
NEGATIVE REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032945,0.9775153105861769,1.0,0.118110191405499,0.521342684816765,11172,36,GLMN|BMP4|MARCH7|DLG5|BTN2A2|PLA2G2D|CEBPB|CTLA4|ATM|RC3H1|TNFRSF14|XCL1|MNDA|PDCD1LG2|NDFIP1|FOXP3|SDC4|LILRB2|KIAA0922|LST1|SOX11|CD300A
PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009144,0.7187257187257191,0.971081608033886,-0.11096983711373,-0.900272665726658,924,163,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GTPBP1|UQCRC1|PKM|ENO1|MT-ND5|ATP5I|EFTUD1|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|RHOQ|COX4I2|NDUFS6|PGAM2|AK4
G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000086,0.0082801580066849,0.20219929830704503,0.278048941935934,1.58991934763693,108,116,TPD52L1|AKAP9|SDCCAG8|CEP63|BRSK2|CEP70|CENPJ|CCNB1|CDK1|BTRC|BORA|WEE1|CKAP5|CEP290|CEP131|CEP152|CDC25C|NEK2|PKMYT1|HAUS5|CDK5RAP2|FBXL15|PRKAR2B|CDKN2B|CEP72|MELK|CCNB2|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CHEK2|CNTRL|PLK1|AJUBA|SFI1|AURKA|CEP41|TAF2|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|CDK14|KDM8|PCM1|FBXL7|FOXM1|NEDD1|PPP2R1A|SKP2|CDK2|SSNA1|NDE1|CEP250|MASTL|ABCB1
POSITIVE REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900454,0.8331280098555269,0.988284003382092,0.33917912053819,0.718752956498141,7438,4,ADCY8|LILRB2|KCNB1
REGULATION OF PHOSPHOLIPID TRANSPORT%GOBP%GO:2001138,0.26965206185567003,0.784543299601953,0.479310561708798,1.17879452166446,2510,6,ABCA7|ABCB4|APOE
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010633,0.0404509283819629,0.40162339624321797,-0.23841852775352898,-1.46025305006762,121,52,PTPRG|DAB2IP|MMRN2|RHOA|HDAC5|FGF2|MAP2K5|ADAMTS9|PPARG|MEOX2|PDCD10|PTPRM|ACVRL1|DUSP10|CORO1C|STC1|ANGPT2
NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0046112,0.900115919629057,0.998912093067348,0.185790056741489,0.629942000396276,9317,15,MTHFD1|CAD|CTPS2|CTPS1|PAICS|PRTFDC1
NEGATIVE REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:2000647,0.5900568525462679,0.945418171231938,0.570995312930797,0.93327615282654,4877,2,NF1|FBLN1
POSITIVE REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0010862,0.7462087421944691,0.9749763305090959,0.18811172335167,0.7887395217476949,8364,30,LEFTY1|INHA|BMP4|TGFB2|GDF11|TTK
POSITIVE REGULATION OF TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002651,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
NUCLEOLAR CHROMATIN ORGANIZATION%GOBP%GO:1990700,0.885503355704698,0.996643473105967,0.5585024261138071,0.7419455565324691,6596,1,DDX11
2-OXOGLUTARATE METABOLIC PROCESS%GOBP%GO:0006103,0.611607581262889,0.9508825506493929,0.27269430310759196,0.880085877010048,6227,13,D2HGDH|MRPS36|IDH1
CYTIDINE CATABOLIC PROCESS%GOBP%GO:0006216,0.22525934464021102,0.7390599693491929,-0.526973287958441,-1.21192847372839,1367,4,CDA|CDADC1
CARDIOLIPIN BIOSYNTHETIC PROCESS%GOBP%GO:0032049,0.5303285593934289,0.9265056012720759,0.362671527194473,0.943957787957005,5035,7,TAZ|TAMM41|CRLS1|PGS1|SLC27A1|PLA2G6
REGULATION OF CELLULAR RESPONSE TO TUNICAMYCIN%GOBP%GO:1905894,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
REGULATION OF 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY%GOBP%GO:0043126,0.582417582417583,0.943593972061982,-0.7024150860167621,-0.9396420770210551,4398,1,CD81
"ANTIGEN PROCESSING AND PRESENTATION, EXOGENOUS LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048007",0.418663887924048,0.871698849372662,0.547041584527522,1.03986850557216,3615,3,CD1E|CD1D
REGULATION OF ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1903742,0.9373758771349129,1.0,-0.528617115130128,-0.7071472323102951,7079,1,MAP2
AMMONIUM TRANSPORT%GOBP%GO:0015696,0.738002594033723,0.9744283926676119,0.20598844220941398,0.788887950693478,7965,22,SLC12A2|SLC25A29|RHBG|TAF7|SLC22A3|SLC6A2
DIGESTION%GOBP%GO:0007586,0.0645243560316246,0.495456803258629,-0.291326114653014,-1.4517354355199,252,27,TJP2|CHIT1|MUC4|COPA|PPARGC1A|ADRA2A|AQP5|CD36|AQP1|PRSS3
SEPTUM TRANSVERSUM DEVELOPMENT%GOBP%GO:0003343,0.363166953528399,0.849828746111777,-0.817159241288046,-1.09313883204742,2742,1,TGFBR1
INNATE VOCALIZATION BEHAVIOR%GOBP%GO:0098582,0.9663709784191709,1.0,-0.5158248786943099,-0.690034667598082,7298,1,AUTS2
ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0071616,0.4664276109368,0.894350777437112,0.24158143983546104,1.00071167467031,5202,29,HACD1|SCD5|ELOVL6|PDHX|PDHA1|SLC25A1|ACACA|DLD|ACSS1|TECR
REGULATION OF CARBOHYDRATE METABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900402,0.558550824175824,0.936434965680841,-0.35788119511969,-0.905952480911739,3252,5,PPARA|NR1D1
NEGATIVE REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090194,0.240232248699649,0.7525035503527309,0.714172524578177,1.1672953719560901,1985,2,BMP4|BMP7
NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION%GOBP%GO:0010616,0.006284367635506679,0.17975028050367198,-0.8619168412925992,-1.7492346207293301,39,3,FOXO1|ATP2B4|LMNA
CHAPERONE-MEDIATED AUTOPHAGY TRANSLOCATION COMPLEX DISASSEMBLY%GOBP%GO:1904764,0.8311409395973149,0.9879179006160809,0.585465372739303,0.77776462822211,6191,1,HSPA8
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS%GOBP%GO:0022613,0.00257731958762887,0.126473912512219,-0.17295098971486497,-1.5790745914477,0,359,TAF9|CELF2|OGFOD1|SDAD1|STRAP|SNRPD3|RIOK3|TEX10|RPS16|RPL12|LSM3|PRPF19|URB1|NAF1|UTP15|C1D|THUMPD1|TSR3|CELF4|FTSJ2|WDR12|ISY1|PES1|METTL16|RRP1|EIF2S1|RPS28|RUVBL1|ISG20L2|FAM103A1|MRPS2|MPHOSPH6|RPF2|RPL35|NSUN5|UTP3|RPL7|RSL24D1|EXOSC6|LIMD1|POP5|RRP36|PRPF18|RPS9|MRPL22|CRNKL1|RPL14|DHX37|GAR1|DDX47|ZNHIT6|DDX3X|NUFIP1|EXOSC4|C1QBP|PA2G4|PRPF6|AAMP|NOB1|NSUN3|NMD3|NHP2L1|TRMT112|SHQ1|NOLC1|WBSCR22|SBDS|GLTSCR2|PWP2|TBL3|SRFBP1|RPUSD2|RCL1|EFTUD1|RSL1D1|RUVBL2|PPAN|EIF4H|ZNF593|FCF1|RPL35A|NPM1|EXOSC9|DDX28|UTP14A|WDR43|EBNA1BP2|NHP2|EIF4B|RRP7A|TXNL4A|KRI1|AGO2|NOL10|SNRPB|PIH1D2|EIF3A|RRS1|CIRH1A|MRTO4|BYSL|IMP4|TSR1|NOL9|NOM1|TSR2|RNMTL1|ZNF622|EIF2S3|NUDT21|POLR2D|SF3A1|NIP7|LYAR|EMG1|RRP9|RPF1|SLU7|NOP14|NOP56|EXOSC5|DDX6|HSP90AB1|BICD1
TRIGEMINAL SENSORY NUCLEUS DEVELOPMENT%GOBP%GO:0021730,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0050650,0.5280711506392439,0.9265056012720759,0.24796653239652303,0.9496542984872399,5699,22,VCAN|B3GAT3|CHST15|PXYLP1|CHPF2|XYLT2
REGULATION OF HISTONE DEUBIQUITINATION%GOBP%GO:1903584,0.253154362416107,0.7641083395392759,0.8758270842523159,1.16349720801281,1885,1,SART3
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090049,0.0438130642591609,0.41226599840679795,-0.290526187084261,-1.5277420312641001,164,31,SRPX2|TBXA2R|GATA2|RHOJ|NOTCH1|VEGFA|KDR|HMOX1|MMRN2|RHOA|HDAC5|FGF2|MAP2K5|MEOX2|FOXC2|PDCD10
CELLULAR RESPONSE TO MISFOLDED PROTEIN%GOBP%GO:0071218,0.7066225165562908,0.9693013746946691,0.222692337687312,0.813974566226967,7468,19,SDF2|POMT2|ATXN3|RNF126|ANKZF1|BAG6|VCP
NEGATIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045541,0.9812595336674659,1.0,0.220604456210015,0.508460568828268,9005,5,APOE|ERLIN1|SCAP|ERLIN2|SOD1
PROTEIN HETEROTETRAMERIZATION%GOBP%GO:0051290,0.5078963992419461,0.9179996794142941,0.23803465701728002,0.967732700832103,5627,27,HIST1H3E|CBR4|RCC1|PKD2|HIST1H4I|GRIN1|CPSF6
ERGOSTEROL METABOLIC PROCESS%GOBP%GO:0008204,0.0567785234899329,0.46412099087698794,0.971768857520953,1.29095157353423,422,1,C14orf1
ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086014,0.24251012145748999,0.7565220534116759,0.423137328530543,1.2074893594260099,2395,9,KCNN2|CACNB2|KCNQ1|GJA1|SCN3B
TUBULIN DEACETYLATION%GOBP%GO:0090042,0.804282085399782,0.984530683443403,0.48535980148883395,0.7933072619197691,6648,2,HDAC6|SIRT2
MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034088,0.204390189270915,0.720652741008223,0.582390612528695,1.23414134079822,1824,4,RB1|NIPBL|DSCC1|MAU2
MITOTIC SPINDLE MICROTUBULE DEPOLYMERIZATION%GOBP%GO:1990755,0.20644295302013396,0.7211951452265429,0.8987648875165419,1.1939690563213798,1537,1,CCSAP
NEGATIVE REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045581,0.924429657794677,1.0,-0.13775212334846898,-0.638169826857604,3889,22,RUNX1|SMAD7|SOCS5|CBFB
GLAND DEVELOPMENT%GOBP%GO:0048732,0.29809818664307797,0.8023890191280308,-0.153048464799929,-1.09193228366211,673,89,ADCYAP1|COBL|DRD2|WNT3|FGF10|CRIP1|SLC9A3R1|MET|SULF2|DNAAF1|INSM1|CAV1
ARGININE BIOSYNTHETIC PROCESS VIA ORNITHINE%GOBP%GO:0042450,0.007679067920031779,0.198167223413272,-0.9965262461402741,-1.3330835432923702,57,1,ASL
CAMP METABOLIC PROCESS%GOBP%GO:0046058,0.255485232067511,0.7667915624015121,-0.29907480146039,-1.15869495720443,1210,14,ADCY2|ADM|PDE4D
N-ACYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0070291,0.25749681602408203,0.768084432668377,0.614666293152142,1.16841596281523,2223,3,NAPEPLD|GDPD1
NEGATIVE REGULATION OF TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:1905839,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048743,0.4967562557924,0.911815944636073,-0.7489523599470671,-1.0018964072672099,3751,1,FAM129B
POSITIVE REGULATION OF NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:1905294,0.93503355704698,1.0,0.535399205999118,0.7112539593178271,6965,1,SEMA3C
KARYOGAMY%GOBP%GO:0000741,0.135704697986577,0.623227463256235,0.9331715924128801,1.2396768287842301,1010,1,CDK1
PURINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009179,0.00474683544303798,0.159787349002354,-0.367903558551818,-1.90869545207721,17,30,PFKL|GPI|PKM|ENO1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:0034394,0.996838973596132,1.0,0.10886790531676299,0.41157870933007595,10721,21,PTPRK|GGA3|FBLN5|GGA2|MESDC2|RIC3|FLNA|ANK2|GPIHBP1
POSITIVE REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090193,0.8898664571877449,0.997300970905927,-0.326568876144259,-0.662761831347352,5663,3,EGR1|PDGFB|RET
RHYTHMIC SYNAPTIC TRANSMISSION%GOBP%GO:0060024,0.687069069795573,0.9668239327797159,0.5343217453711839,0.8733342141321899,5679,2,NLGN3|PTEN
REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0046928,0.0319355734518189,0.365066918595497,-0.284292378928937,-1.5454153509947899,114,35,NAPB|SYN1|VPS18|SLC30A1|NAPA|CAMK2A|FMR1|PNKD|CHRNA3|PARK2|RAB5A|MCTP1|CPLX1
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION%GOBP%GO:0021799,0.23769730733518998,0.7507739897770379,-0.385495590983379,-1.19828814442274,1279,8,DAB2IP|RTN4|SRGAP2C|MBOAT7
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905930,0.969896954961213,1.0,0.292743860652271,0.556475283601744,8376,3,FGF9|DNMT1
REGULATION OF NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY%GOBP%GO:2000325,0.536213668499607,0.9265056012720759,-0.45770376089114395,-0.92889618375262,3412,3,CNOT6|RQCD1|NR1H3
XENOBIOTIC TRANSPORT%GOBP%GO:0042908,0.678240377062058,0.9647315640607691,-0.408850489608919,-0.829749921179779,4316,3,ABCC1|SLC6A6
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901863,0.31500373227170897,0.8164430838831159,-0.22709897025771397,-1.10171874078652,1265,25,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|FGF2|IGF1|TBX20|GREM1|RBM24|RBPJ
POSITIVE REGULATION OF MRNA 3'-UTR BINDING%GOBP%GO:1903839,0.39136766847610205,0.861275178639796,-0.8020511689457428,-1.0729283030338501,2955,1,CDK9
POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901798,0.0902021772939347,0.560121322881739,-0.32677117261313504,-1.4056969830410502,405,18,SPRED2|PMAIP1|UBB
SYNAPTIC VESICLE UNCOATING%GOBP%GO:0016191,0.123487824037706,0.607607158836689,-0.686279916179552,-1.3927846996146203,785,3,SYNJ1|DNAJC6|GAK
MALATE TRANSPORT%GOBP%GO:0015743,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060244,0.9657675093746221,1.0,0.36990927295675,0.604606544645627,7983,2,FAP|PAK1
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043378",0.15675942697184303,0.6578589353509621,-0.571530970140051,-1.31440183432023,951,4,RUNX3|RUNX1|CBFB
MODULATION BY VIRUS OF HOST APOPTOTIC PROCESS%GOBP%GO:0039526,0.341648106904232,0.8356275732448649,-0.655583126550869,-1.1213398271788702,2300,2,CASP8|BCL2L1
REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903995,0.387706043956044,0.859991269020751,-0.41027617204096506,-1.03858688578252,2257,5,NTRK2|DUSP22|FYN|DOCK3
REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905521,0.7384080370942808,0.9744283926676119,0.229913677662656,0.779548080050378,7643,15,RARRES2|CCL5|CD200|C5|THBS1|CSF1|DDT|SLAMF8|P2RX4|CMKLR1
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS%GOBP%GO:0031330,0.0178117048346056,0.282007307615586,-0.170289127946988,-1.4001706015101698,20,177,DAB2IP|PTPN3|UBE2J1|NELL1|STYX|FAM192A|OS9|HP|HDAC4|PML|PDCL3|FBP1|CCRN4L|PPARA|EIF4G1|HGF|DFFA|CSNK2A2|TBC1D14|GLTSCR2|EFNA1|SLC11A1|VIP|NBAS|ATG7|BAG5|YBX1|ATP2B4|TIMP2|SNCA|FMR1|LEPR|HNRNPC|BCL2|RBM38|BMF|CHMP4B|KIAA0226|PABPC1|MET|MYD88|DDRGK1|CSNK2A1|HSP90AB1|GABARAPL2|RBM24|PSMF1
MONOTERPENOID METABOLIC PROCESS%GOBP%GO:0016098,0.37075117938792795,0.852609194081082,0.656299972429005,1.07270427532028,3064,2,CYP2E1|CYP2D6
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CONTROLLING TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:2000080,0.6974712034953001,0.96731875442989,-0.646724746360829,-0.865143411679092,5267,1,SFRP1
NK T CELL DIFFERENTIATION%GOBP%GO:0001865,0.413214550853749,0.8683189983530021,-0.6074993107251171,-1.03909503541337,2782,2,ZBTB7B|ITK
HUMORAL IMMUNE RESPONSE%GOBP%GO:0006959,0.18575141415685698,0.6921962082288221,0.214052592136349,1.21297134460541,2429,110,IGHV3-21|IGKV4-1|HIST1H2BJ|IGHV4-61|CXCL13|COLEC11|POU2F2|IGHG1|LEAP2|RARRES2|IGLL5|CXCL9|IGHG4|EXO1|POU2AF1|IGHV1-18|IGHV3-43|AZU1|EBI3|BST1|IGKV3-11|ZP3|COL20A1|IGKV2D-28|JCHAIN|IL7|CXCL10|RPS19|CCL2|IGKV2-28|C7|HIST1H2BF|RNASE6|IGHV1-24
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS%GOBP%GO:0071380,0.597188049209139,0.949097926455788,-0.319397716617947,-0.8767252861279351,3397,6,ADCY6|GNG2|PTGER2|PTGER4|SFRP1|GNB1
DGDP PHOSPHORYLATION%GOBP%GO:0006186,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
RECEPTOR INTERNALIZATION INVOLVED IN CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000286,0.0821681068342498,0.539994451302385,-0.7304118735395959,-1.48234919585879,522,3,RAB5A|CAV1
PEPTIDE METABOLIC PROCESS%GOBP%GO:0006518,0.659016393442623,0.9643779777660141,-0.0999074597710064,-0.943080568629317,200,409,TRNAU1AP|EIF4E|PCSK2|EEF1A2|RPS16|RPL12|SEPSECS|MRPL51|EIF5|MRPS33|GCLC|EIF3H|SOD1|MRPL37|QARS|FURIN|RPS4X|EIF3D|EIF2B3|MTRF1L|RPL9|DARS|MRPL14|MRPL15|CLU|EIF2S1|AARS|EEFSEC|RPS28|RPL17-C18orf32|EIF4A1|MRPS2|CARS|ABCF1|HBS1L|EEF2K|RPL35|MRPL18|MRPS35|GSS|WARS|EIF3K|RPL7|RSL24D1|MMACHC|PCSK7|PCSK1|AURKAIP1|RPS9|RPS3|DYRK1A|GTPBP1|MRPL22|RPL14|NARS|TAPBP|HARS|G6PD|FARS2|DDX3X|GARS|EIF4A2|AIMP2|GSPT1|ATP6AP2|EIF4G1|MRPL24|MRPS17|EIF3G|GSR|NCSTN|RPL15|PSEN2|RPL8|TMA7|YARS|EIF3B|TNIP1|MRPL41|EIF4H|CHAC1|RPL35A|MRPS30|MRPL9|NHP2|KARS|EIF4B|SRBD1|GSTT2|MRPS10|GSTM5|AGO2|EIF1AX|ETF1|EIF3A|CTSH|UBA52|GSTT2B|EIF3I|MRPL2|SARS|MRPS26|EIF2S3|GSTM3|CNDP2|GSTM1|ANPEP|ERAP2|MRPL39|DNPEP|ACE|PABPC1|MRPL30|CPXM1|GSTM4|MRPL36|PTGES
REGULATION OF DIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:2001148,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
TRNA 5'-END PROCESSING%GOBP%GO:0099116,0.0685792886618196,0.5037729184803449,0.472873528722026,1.49066635154837,697,12,RPP30|RPP25|POP1
VASODILATION%GOBP%GO:0042311,0.0110324386629343,0.228957665033653,-0.7795731539182711,-1.79285539547557,66,4,SOD1|SOD2|ADRB2|NOS3
LACTOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0001572,0.39691275167785206,0.8638522656500329,0.808998676665196,1.07471864995995,2956,1,B4GALT6
CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051934,0.866815144766147,0.9929671171385601,-0.406429802486307,-0.6951764101649339,5837,2,SNCA
REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000618,0.38766615820440203,0.859991269020751,0.461733280588337,1.06422676372133,3557,5,SIRT1|BRCA1|AUTS2|PIH1D1|SMARCB1
NEGATIVE REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0045875,0.456090651558074,0.88900512246363,0.43766233280001393,1.00874679738268,4185,5,NAA10|ESPL1|ATRX|TNKS|WAPAL
RESPONSE TO GONADOTROPIN-RELEASING HORMONE%GOBP%GO:0097210,0.0122727799004284,0.23996399991852999,0.8492081990587659,1.61425545306133,105,3,MGARP|CRHBP
NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090027,0.27609841827768,0.7884684708511421,-0.418780289523831,-1.14952377570282,1570,6,GREM1|NBL1
PORPHYRIN-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0006778,0.90041265474553,0.998912093067348,0.16253293353634102,0.639648000950657,9818,24,HPX|ALAS1|BDH2|ABCB6|CPOX|ATPIF1|UROD|IREB2|UROS|ALAD|HMBS|SUCLA2|PPOX
HOMOCYSTEINE CATABOLIC PROCESS%GOBP%GO:0043418,0.0959937156323645,0.5684612493613671,-0.7142935921473481,-1.4496376226683998,610,3,BLMH|MTRR|CBS
POSITIVE REGULATION OF STRAND INVASION%GOBP%GO:0098530,0.713756123394678,0.971081608033886,-0.6384539038376711,-0.854079253459989,5390,1,WRN
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901299,0.13427197802197802,0.621139169838541,-0.5324668189780499,-1.3479043946274298,781,5,TRAP1|PARK7|HGF|MET
NUCLEUS ORGANIZATION%GOBP%GO:0006997,0.9637504903883879,1.0,0.11192592003078099,0.6109464228707429,12282,90,SPAG4|CCNB1|TPR|CDK1|SYNE1|PYGO1|NUP133|NUMA1|PRKCB|NUP205|CEP55|AKAP8L|LEMD3|DMPK|RPS19|CCNB2|SRPK1|NDC1|PLK1|WRAP53|NUP107|NUP35|VRK1|CNEP1R1
REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETER DEVELOPMENT%GOBP%GO:0072199,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
POSITIVE REGULATION OF FRACTALKINE BIOSYNTHETIC PROCESS%GOBP%GO:0050754,0.5276911655530809,0.9265056012720759,-0.551172267749639,-0.942750645087274,3553,2,TNF
POSITIVE REGULATION BY ORGANISM OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052522,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0007088,0.00095553105475928,0.0849637591935908,0.29288066700689,1.7443557711071203,12,148,KIF25|EDN1|CCNA1|ANAPC15|CCNB1|RCC1|TPR|BMP4|INS|XRCC3|ANAPC5|MKI67|CEP85|BORA|CENPF|NAA10|CCSAP|KIF20B|NUMA1|CDC25C|USP44|FAM178A|BUB1|KIF11|DLGAP5|NEK2|CDC23|CDC20|CCNE1|PKMYT1|GEN1|ANLN|APC|NDC80|NUSAP1|CDK5RAP2|CUL9|CENPE|PTTG1|FBXO5|RB1|BUB1B|ESPL1|CDC6|NIPBL|CCNB2|CDCA5|OBSL1|CCNI2|KLHL22|PIN1|CDK13|CCNF|CEP97|PLK1|KNTC1|PEBP1|AURKA|UBE2C|ANKRD32|CCNE2|CUL7
HOMOLOGOUS CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE INVOLVED IN HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0051758,0.685503355704698,0.966495577318169,0.661391707101897,0.8786293761088909,5106,1,FMN2
MYOBLAST MIGRATION%GOBP%GO:0051451,0.33258928571428603,0.8293509737209019,-0.43155746746084295,-1.09245907198723,1936,5,ANXA1|ROCK1|ITGB1BP1|AKIRIN1|THBS4
CELL WALL GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0031506,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0043550,0.8313532309475509,0.9879179006160809,-0.13435190304869501,-0.752063993228349,2868,38,TNFAIP8L3|RBL1|PPP2R5A|PIK3R2|EEF1A2|DAB2IP|PTK2B|FGR|FGF2|PIK3IP1|EPHA8|FLT1|KIAA0226|PIK3R1
REGULATION OF PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0120093,0.306765523632994,0.809874675097403,-0.847430524922805,-1.1336336511293301,2316,1,CDYL
OLFACTORY PLACODE DEVELOPMENT%GOBP%GO:0071698,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
REGULATION OF BONE REMODELING%GOBP%GO:0046850,0.458628264583842,0.890371861972445,-0.20804959846578602,-0.997277841142534,1878,24,UBASH3B|IL6|LEPR|PRKCA|MC4R|GREM1|S1PR1
REGULATION OF CHEMOTAXIS%GOBP%GO:0050920,0.156291390728477,0.6578589353509621,-0.15018012162821698,-1.18607159683472,235,138,LGALS9|PTK2B|AKIRIN1|PRKD2|SEMA3F|ADAM10|CAMK1D|ZNF580|NRP1|C1QBP|SEMA7A|FGF2|IL6|LYN|POU4F2|TMSB4X|KARS|FGFR1|SEMA6B|ADAM17|CXCL8|DUSP3|MTUS1|ANO6|SCG2|OXSR1|GREM1|THBS4|SEMA3A|RAC1|MET|SEMA3G|PGF|CDH13|NBL1|ANGPT2
NEGATIVE REGULATION OF DNA RECOMBINATION%GOBP%GO:0045910,0.649663827879875,0.963755998259649,0.208146194695144,0.862211630212564,7246,29,FBXO18|BLM|THOC1|POLQ|MSH6|RTEL1-TNFRSF6B|RMI2|PARPBP|ZRANB3|RIF1|RECQL5|FAM35A|MAGEF1|TP53BP1|NDFIP1|MSH3
REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001914,0.677203421346225,0.9647315640607691,0.22101161263907998,0.8355416962628509,7283,21,CEACAM1|AGER|CD1E|IL12RB1|CD1D|RIPK3|HLA-F|XCL1|FADD|HLA-C|STX7|PTPRC
CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:0044839,0.007042786823173041,0.18934349444572798,0.27967168064932896,1.60365615772423,92,118,TPD52L1|AKAP9|SDCCAG8|CEP63|BRSK2|CEP70|CENPJ|CCNB1|CDK1|BTRC|BORA|WEE1|CKAP5|CEP290|CEP131|CEP152|CDC25C|NEK2|PKMYT1|HAUS5|CDK5RAP2|FBXL15|PRKAR2B|AKAP8L|CDKN2B|CEP72|MELK|CCNB2|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CHEK2|CNTRL|PLK1|AJUBA|SFI1|AURKA|CEP41|TAF2|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|CDK14|KDM8|PCM1|FBXL7|FOXM1|NEDD1|PPP2R1A|SKP2|CDK2|SSNA1|NDE1|CEP250|MASTL|ABCB1
AMINO ACID IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0089718,0.447168059424327,0.88473565970262,-0.31683153008993203,-0.9848503463232909,2407,8,SLC3A2|SLC7A1
PURINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009152,0.747001713306682,0.9749763305090959,-0.11420070528929599,-0.872302693499908,1307,119,HSD17B12|ATP5J|LDHA|PAPSS1|SCD|ADCY7|ACSL1|PFKL|COX5B|GPI|GMPS|GUCY1A3|PKM|ENO1|ACSL4|HPRT1|ATP5I|PDHB|GAPDH|PGK1|PANK2|CYC1|HK1|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2
REGULATION OF ARGININE CATABOLIC PROCESS%GOBP%GO:1900081,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
PARAMESONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0061205,0.36639651626950503,0.8510019955058101,0.657798591847265,1.0751537275899399,3028,2,WNT4
ICOSANOID METABOLIC PROCESS%GOBP%GO:0006690,0.350947158524427,0.842847021021096,0.22190967249483898,1.086983702192,4223,54,FAAH2|EDN1|DPEP1|CYP2D7|MGST1|CYP2C8|PLA2G4A|GGT1|FADS1|MGST3|PTGS2|MGST2|GGT5|LTA4H|ABHD16A|PON2|FAAH|PLA2G4B|CYP2E1|DAGLA|CYP2D6|PLAA
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS%GOBP%GO:0060444,0.6309896262143921,0.9575013258325501,-0.371642861082005,-0.8547009415754029,3831,4,LRP6|LRP5L|EPHA2|LRP5
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000403,0.663388873713922,0.964618776001639,0.21327559564889498,0.8498725688996629,7285,25,CXCL13|STK39|DOCK8|XCL2|CCL21|CCL5|CXCL10
TRNA C5-CYTOSINE METHYLATION%GOBP%GO:0002946,0.269694161260426,0.784543299601953,-0.8652955447728281,-1.1575322328826,2036,1,NSUN3
BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0048514,0.25061224489795897,0.7622386387061709,-0.134469809449336,-1.10282030083522,306,171,NCL|THY1|HAND1|RAMP3|LAMA5|NRARP|NOTCH1|LRP5|STRA6|VEGFA|ITGB8|KDR|CTNNB1|TGFBR1|PTK2B|HMOX1|EIF2AK3|COL23A1|CALCRL|NRP1|ITGA5|AAMP|CLIC4|APOD|FGF2|ADAMTS9|APLNR|SERPINF2|SMAD7|RAMP2|FGFR1|LEPR|CXCL8|ID1|ADM2|TBX20|SCG2|FLT1|MCAM|GREM1|MYH9|SFRP2|BMPER|ACVRL1|ADM|PGF|SOX17|CDH13|RBPJ|CAV1|EPHB2|RAMP1
POSITIVE REGULATION OF MISMATCH REPAIR%GOBP%GO:0032425,0.9739597315436239,1.0,0.5157146007940011,0.685103839495328,7255,1,HMGB1
QUINONE BIOSYNTHETIC PROCESS%GOBP%GO:1901663,0.28419629057186996,0.79342123536088,0.342519365739083,1.1613502800548898,2941,15,FDXR|COQ3|COQ2|COQ6|COQ9|COQ5|PDSS1
CYTOSKELETAL ANCHORING AT PLASMA MEMBRANE%GOBP%GO:0007016,0.768724696356275,0.9792236089291529,0.26478874331930896,0.755616601267955,7594,9,ANK3|SPTBN4|SHANK1|TLN1|JUP
REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071649,0.00738324175824176,0.193777918792776,-0.755349658063093,-1.91211750158941,42,5,MUL1|SIRPA|DDX3X|MAVS|ADCYAP1
NEGATIVE REGULATION OF MACROPINOCYTOSIS%GOBP%GO:1905302,0.8511409395973148,0.991298302704726,0.575209528010587,0.764140196045682,6340,1,STX1B
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002763,0.563094947522577,0.9377667552605741,-0.19248606282246203,-0.9226746246913791,2306,24,RIPK1|ACIN1|ATP6AP1|CSF1|CCR1|EVI2B|FADD|IL34|CD74|ZFP36L1|HCLS1|CASP8|TGFB1|CD4|CTNNBIP1|TRAF6|TESC|HAX1|LIF|RUNX1|POU4F2|PRKCA|TNF
POSITIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1905206,0.183500665295754,0.689876118998471,0.7437551695616209,1.2156473924987299,1516,2,HDAC6|RIPK1
BEHAVIORAL RESPONSE TO PAIN%GOBP%GO:0048266,0.636763550667714,0.959271399361425,-0.423091165991818,-0.858650950789797,4052,3,THBS4
[2FE-2S] CLUSTER ASSEMBLY%GOBP%GO:0044571,0.0722871727317636,0.5162345267834141,-0.65798671533298,-1.51323198702615,438,4,HSCB|BOLA2|BOLA2B
NEGATIVE REGULATION OF IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034760,0.8550335570469799,0.991298302704726,0.5735553595059549,0.761942706984968,6369,1,HAMP
POSITIVE REGULATION OF HEAT GENERATION%GOBP%GO:0031652,0.6507908611599301,0.963755998259649,-0.306169054917712,-0.8404134980004659,3702,6,TNFRSF11A|TNF
LEUCINE CATABOLIC PROCESS%GOBP%GO:0006552,0.0324689474831118,0.36777884196014005,0.680288991837635,1.56796527912417,297,5,MCCC2|IVD|HMGCLL1|MCCC1|HMGCL
INNER EAR MORPHOGENESIS%GOBP%GO:0042472,0.22086853998821,0.73556947110949,0.39118389060909203,1.23315141910077,2247,12,STRC|PROX1|CEP290|DFNB31|PDZD7|CHD7|FGFR2
CATECHOLAMINE CATABOLIC PROCESS%GOBP%GO:0042424,0.08287700084246,0.5420718842622351,0.5570215236873121,1.44980999587091,786,7,SULT1A3|MOXD1|LRTOMT|COMT|DBH|MAOA
ALDITOL CATABOLIC PROCESS%GOBP%GO:0019405,0.345326001571092,0.8411448613059059,-0.531329167764386,-1.07831675949496,2197,3,SORD|TPI1
REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002825,0.8209527654420671,0.987153241368501,-0.205395564382655,-0.722812581149375,4066,11,CCL19|IL12RB1|IL1R1|XCL1|ANXA1|JAK3|IL18|IL6R|IL1B|SLC11A1|SOCS5
POSITIVE REGULATION OF TRANSFERRIN RECEPTOR BINDING%GOBP%GO:1904437,0.35070527097253196,0.842847021021096,-0.649574373533067,-1.1110621769501399,2361,2,B2M
POSITIVE REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032206,0.675183405008854,0.9647315640607691,0.17912746767499999,0.8531906560079999,8006,48,SIRT6|ATR|HMBOX1|PNKP|PPP1R10|PRKCQ|NEK2|SLX1B|AURKB|MAP3K4|TNKS2|MAP2K7|SLX4|HNRNPA2B1
REGULATION OF RNA BINDING%GOBP%GO:1905214,0.034556813744631,0.379078740472774,-0.5134814384679621,-1.6575640975496297,176,9,NCBP1|EIF3D|CDK9|EIF4G1|FMR1|LARP6
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002523,0.44866071428571397,0.8852937077666759,-0.390414736377675,-0.9883089802680641,2612,5,SLAMF8|ADAM8|S100A9|CX3CL1|S100A8
POSITIVE REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904849,0.0457312546399406,0.41958742830584794,-0.869644334160463,-1.48748005841012,307,2,FGF2|FGFR1
CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0019221,0.003952569169960471,0.14776184655466199,-0.159968604496472,-1.5172637648755198,0,432,FPR1|IL6ST|RORC|CXCL12|RELA|MX1|PRKACA|TRAF6|VCAM1|GPR75|UBE2N|TNFSF13|HSPA9|PIK3CD|CD44|CD86|IL6R|IL17RA|PYCARD|CAMK2D|SOCS3|FOXC1|CRKL|HIF1A|TRIM8|LAMA5|IL1RN|IFI30|RAP1B|NOD1|SOD1|RNASEL|PTPN6|MMP1|IL21R|ZEB1|BATF|IL13RA1|IL1B|IRAK1|IL11|VEGFA|PIM1|FCER1G|NFKBIA|CX3CL1|CRLF1|PRKCD|MAP3K8|ITGAX|IRAK2|PTK2B|ITGAM|HMOX1|SQSTM1|CD300LF|IFNAR2|IRAK4|GRB2|LIF|CEBPA|VAV1|BOLA2|PML|TRAF3|CCL14|IRF6|HLA-DQB1|FYN|BAG4|BOLA2B|MMP2|IL3RA|AIP|COMMD7|IFNAR1|IFITM2|TNFRSF1B|FOXO1|MX2|CASP3|HNRNPF|IFITM3|VIM|UBE2V1|FGF2|P4HB|HGF|TNFRSF18|IL6|OASL|MMP9|BCL2L1|TCP1|CAMK2A|CSF2RB|BRWD1|SOD2|ICAM1|CRK|RIPK2|TMSB4X|RALA|KARS|CDC42|OAS3|FCER2|TNFRSF11A|LEPR|MSN|KLF6|PDCD4|ADAM17|TRIM25|CXCL8|STAT5A|BCL2|RAPGEF1|SHC1|UBA52|STAT3|RBM15|LIMS1|MKKS|ACKR3|TP53|YWHAZ|GAB2|ALOX5|CDIP1|PELI2|SOCS5|B2M|TNFRSF4|MAPK3|OXSR1|BCL6|HLA-DQA2|CDKN1A|PLVAP|TNIP2|HLA-DQB2|PITPNA|S1PR1|EDA2R|PELI1|IFITM1|MYD88|PLCB1|UBC|CCL18|CD36|TWIST1|PIK3R1|TNF|PAK2|UBB|FOXO3
POSITIVE REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:0090044,0.9802684563758391,1.0,0.512351124834583,0.6806356117385429,7302,1,FNTA
HISTONE H3-Y41 PHOSPHORYLATION%GOBP%GO:0035409,0.262013422818792,0.771967970256231,0.871140273489193,1.15727098900745,1951,1,JAK2
REGULATION OF CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0090320,0.9067114093959731,1.0,0.548577415086017,0.728760622168183,6754,1,GPIHBP1
VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055010,0.45083353467021003,0.88620227509476,-0.21215992124330302,-0.9969217284625551,1865,23,ZFPM2|RBPJ|FKBP1A
EMBRYONIC PLACENTA DEVELOPMENT%GOBP%GO:0001892,0.5655323819978051,0.938638245695344,-0.22229368366987698,-0.9103673454171121,2575,16,TFEB|IGF2|RBPJ
ICOSANOID SECRETION%GOBP%GO:0032309,0.0141663639665819,0.259243632817479,-0.621318191014403,-1.81241272856985,77,7,ABCC4|DRD2|BDKRB2|ACE
BRASSINOSTEROID METABOLIC PROCESS%GOBP%GO:0016131,0.5883221476510071,0.945418171231938,0.710410233789149,0.943748301941389,4382,1,DHCR7
NEGATIVE REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0045932,0.0732135884420148,0.520754220371606,-0.462263751947752,-1.4922288157354502,374,9,SOD1|KCNE3|DOCK5|BIN1|ADRB2
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045346,0.19688385269121803,0.710678614738288,0.546326935804103,1.2592025987032098,1806,5,SIRT1|AZU1|CIITA|HDAC2|XBP1
REGULATION OF HYALURANON CABLE ASSEMBLY%GOBP%GO:1900104,0.389630793401414,0.8603316114971841,-0.5118010367265909,-1.03868499776001,2479,3,HAS3|BMP7|HYAL1
UBIQUITIN-DEPENDENT SMAD PROTEIN CATABOLIC PROCESS%GOBP%GO:0030579,0.9994552190019609,1.0,0.16972711670435903,0.391195843400929,9172,5,RNF111|SMURF2|SMURF1
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002857,0.5953456061132341,0.9475750680289541,0.481490127839195,0.9152620821620581,5141,3,KLRK1|PVR
GDP-L-FUCOSE BIOSYNTHETIC PROCESS%GOBP%GO:0042350,0.8449693180502491,0.991298302704726,0.381989632734091,0.7261221080264542,7297,3,FUK|GMDS|TSTA3
POSITIVE REGULATION OF PROTEIN KINASE D SIGNALING%GOBP%GO:1903572,0.39811995233682,0.8638522656500329,-0.79923908248787,-1.06916648923936,3006,1,VEGFA
NEURONAL ACTION POTENTIAL PROPAGATION%GOBP%GO:0019227,0.5893095768374169,0.945418171231938,-0.525999448580094,-0.899693886067727,3968,2,CNTNAP1|SCN1B
REGULATION OF LOCOMOTOR RHYTHM%GOBP%GO:1904059,0.840593141797961,0.989977458492109,-0.578187031318924,-0.773458420570122,6348,1,ZFHX3
PROTEIN INSERTION INTO ER MEMBRANE%GOBP%GO:0045048,0.34632731958762897,0.842468675042703,0.449153604576983,1.10462787753645,3224,6,SGTA|UBL4A|BAG6|GET4|TRAM2
IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0016064,0.0818004577434941,0.5393915998030421,0.29775484251907597,1.40503878920553,964,46,IGHV3-21|IGKV4-1|IGHV4-61|IGHG1|CD27|IGLL5|LIG4|IGHG4|EXO1|IGHV1-18|IGHV3-43|IGKV3-11|ZP3|MSH6|IGKV2D-28|IGKV2-28
PHOSPHATIDYLGLYCEROL ACYL-CHAIN REMODELING%GOBP%GO:0036148,0.42316878980891703,0.873470206885489,0.338896674573955,1.0338960691355399,4251,11,LPCAT4|PLA2G4A|LPGAT1|PLA2G2D|PLA2G12A|PLA2G4B|SERAC1
TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS%GOBP%GO:0070525,0.646761133603239,0.96344123684964,0.299411524088128,0.854418187781897,6389,9,OSGEP|TRIT1|PUS1|MTO1|HSD17B10
REGULATION OF MOTOR NEURON APOPTOTIC PROCESS%GOBP%GO:2000671,0.27824795842613204,0.788512053301707,-0.69253259133349,-1.18453990780279,1873,2,ZPR1
TIE SIGNALING PATHWAY%GOBP%GO:0048014,0.175204157386785,0.677933656654802,-0.7513414308121801,-1.28512927813111,1179,2,ANGPT2
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002856,0.0809395973154362,0.5374028338839121,0.960630789589766,1.2761551471920902,602,1,CEACAM1
CEREBELLAR GRANULAR LAYER FORMATION%GOBP%GO:0021684,0.8747900100795161,0.9937342763776691,0.319984448097149,0.6780776120249289,7810,4,PROX1
CENTROSOME-TEMPLATED MICROTUBULE NUCLEATION%GOBP%GO:0090222,0.868150477803314,0.993084774742015,0.45409002639174795,0.7421976735545541,7176,2,CEP192|NIN
"POSITIVE REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0045815",0.791600381800827,0.9819233677232551,-0.132266623976185,-0.795110059286626,2487,48,TWISTNB|WBP2|MYO1C|MYBBP1A|H1F0|POLR1B|TAF1B|DDX21|POLR2K|POLR2F|POLR1E|H1FX|CD3EAP
REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016241,0.0102960102960103,0.22191532995385502,-0.192486724891727,-1.51514415006199,15,135,ATG101|CASP3|MFN2|TBC1D25|ATP6V0C|TBC1D14|SH3GLB1|EXOC4|PIP4K2A|LAMTOR5|GAPDH|NEDD4|BAG3|ADRB2|ATP6V1E2|ATP6V0D1|PAFAH1B2|UCHL1|SNX6|RALB|HTT|PARK2|SPTLC1|BNIP3L|ATP6V1E1|RAB5A|CHMP4B|KIAA0226|HSPB8|SESN2
MAINTENANCE OF LOCATION%GOBP%GO:0051235,0.742284786139686,0.974505008828563,-0.115179530647652,-0.8735281750235291,1370,114,CALR|ARL2|NRROS|NFKBIE|SRI|INSIG1|IL1B|SRGN|NFKBIA|HSPA5|OS9|FLNB|PML|SUPT7L|S100A8|FTH1|TMSB10|MXI1|ARL2BP|G3BP2|TMSB4X|YWHAB|TWF1|FTL|DGAT2|HK1|HK2|BCL3|RANGAP1|TWF2|CD36|TAF8|TNF|CAV1|NBL1
G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0031572,0.0121973420717277,0.23962061927625303,0.43301164692593896,1.74091423052295,133,26,TAOK3|BLM|DTL|DONSON|MSH6|TAOK1|BRCC3|PLK1|BRSK1|CLSPN|CDK5RAP3|TAOK2|C5orf45|CHEK1|ATM|UIMC1|BRCA1|BRE
RESPONSE TO ORGANONITROGEN COMPOUND%GOBP%GO:0010243,0.0988142292490119,0.570215774831708,-0.122299992733731,-1.15998603603197,24,432,ADCY7|TRIM13|IMPACT|FCER1G|HSPA13|RAB13|RRAGD|PRKCD|CTNNB1|IGF1R|CPEB1|NSMF|UBE2J1|USF1|BCAR1|FOXO4|HLCS|HSPA5|RRAGC|OS9|GRB2|ABL1|CRHR1|SGTB|RAB8B|FYN|STUB1|SLC9A1|INPP5K|HDAC5|DGKQ|FOXO1|RNF139|CASP3|PKM|VIM|CPEB2|ATP6V0C|PXN|ATP6V1F|IL6|PPARG|SH3BP4|LYN|FCGR2B|PRNP|AMFR|VAMP2|CHRNA7|HTR1B|NAMPT|CAMK2A|ABCA1|PRKAR2A|GCGR|LAMTOR5|IGF1|FOXC2|LPIN1|ATP2B4|RIPK2|RAP1A|CTNNA1|RAB8A|PTPN1|SHMT2|RNF103|LDOC1|SNCA|ARHGEF2|PDE4B|RYR1|TRIM25|ADRB2|NLRP1|SLC25A33|STAT5A|RAPGEF1|SHC1|JUN|ATP6V1E2|ATP6V0D1|GABRG2|STAT3|CD9|TP53|PRKAR1B|ADCY2|DRD2|MAPK3|CAV2|PARK2|ATP6V1E1|RHOQ|TICAM1|MYD88|IGF2|CD36|SESN2|PIK3R1|CDH13|PDE3A|AQP1|HRH1|CAV1|FOXO6|VGF|TRIB3|INHBB|APPL1|FOXO3
MACROAUTOPHAGY%GOBP%GO:0016236,0.0947040498442368,0.564250720056934,-0.15887782641743697,-1.2416616541132601,151,131,VPS33B|PIK3C3|PGAM5|PRKAA1|SQSTM1|PRKAG1|RB1CC1|ATG13|VPS4A|TMEM74|MAP1LC3B2|ATG9B|MAP1LC3A|VPS37D|ATG101|ATG3|MFN2|ATG7|RAB1A|VPS4B|BECN1|VPS16|TBC1D5|C6orf106|DYNLL2|SEC23A|GABARAPL1|GABARAP|RAB7A|PARK2|CHMP4B|WIPI2|MAP1LC3B|NSFL1C|MTMR14|GABARAPL2
NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010829,0.787929433611885,0.9819233677232551,-0.23987726768551398,-0.7456429923123679,4242,8,IL1B|INPP5K|PEA15
NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033147,0.451804096911719,0.8865317119614899,0.36889594111455704,1.00570930417085,4344,8,STRN3|CNOT1|BRCA1|CNOT2|ISL1|RQCD1|CRIPAK
XYLULOSE CATABOLIC PROCESS%GOBP%GO:0005998,0.159539255924798,0.661359103221672,-0.917401852668725,-1.2272364296629499,1204,1,XYLB
NEUTROPHIL HOMEOSTASIS%GOBP%GO:0001780,0.328997200724518,0.828303707528737,-0.47461887907107303,-1.09152427050657,1997,4,IL6|PDE4B
SPERMINE ACETYLATION%GOBP%GO:0032919,0.337986577181208,0.832232043362884,0.835355094838994,1.10973197566067,2517,1,SAT2
ENGULFMENT OF TARGET BY AUTOPHAGOSOME%GOBP%GO:0061736,0.8015358135840059,0.9841161968820359,-0.596768857520953,-0.798315896035707,6053,1,SMURF1
REGULATION OF INSULIN SECRETION%GOBP%GO:0050796,0.0776196636481242,0.5309621023034221,-0.184937425976335,-1.3069107169375802,179,86,SLC25A5|ENSA|PIM3|ARL2|GPER1|BLK|LRP5|IL1B|C2CD2L|ADRA2C|PFKL|STXBP4|ANO1|TCF7L2|ARL2BP|MYRIP|SLC25A4|UQCC2|RAP1A|GIPR|PRKCA|PARK2|ADRA2A|SLC2A1|PER2|NR1D1|CACNA1E|TNF|SNAP25|INHBB|TRH
REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905664,0.0435192458758837,0.411371136387278,-0.773409065843167,-1.5696107201362,276,3,RAMP3|FYN|PRNP
SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0000768,0.6274220724515589,0.955121257104955,0.333239294468354,0.867351869886451,5957,7,KCNH1|CACNA1H
POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010750,0.11080236193122599,0.584830174998513,0.7058781953364591,1.3418001937356698,956,3,INS|EGFR|NOS1AP
POSITIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022409,0.191409193669932,0.700691347561394,-0.14334457669624698,-1.14669574423533,253,153,IL6ST|RELA|TRAF6|VCAM1|RUNX3|CD44|FLOT1|CD86|IL6R|PYCARD|THY1|NCK2|PTPN6|CD274|ICOSLG|IL1B|RARA|FAM49B|IRAK1|CX3CL1|SIRPA|MAP3K8|LGALS9|PDPN|GRB2|PTPRU|VAV1|RPS3|CITED2|FYN|RHOA|RUNX1|PPAP2B|IL6|PNP|LYN|PODXL|CD276|YES1|IGF1|SERPINF2|ETS1|SMAD7|CDC42|TFRC|NLRP3|SOCS5|BCL6|NKAP|DUSP10|DENND6A|CBFB|RAC1|IGF2|PIK3R1|TNF|CAV1|PAK2
NEGATIVE REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045415,0.20157109190887698,0.7154348163529591,-0.61903594900351,-1.25631506613685,1282,3,MAP2K5|BCL3
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION%GOBP%GO:0098909,0.6486254295532651,0.963755998259649,0.34611252195068604,0.851213341305035,6039,6,AKAP9|FGF13|ATP2A2
TYPE 2 IMMUNE RESPONSE%GOBP%GO:0042092,0.0521982545694056,0.446196452441803,-0.687669444405458,-1.5814960629535402,316,4,BATF|DENND1B|BCL6
HELPER T CELL EXTRAVASATION%GOBP%GO:0035684,0.434630872483221,0.878651088001772,0.789644905161006,1.0490080279496,3237,1,CCL2
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1990441,0.6123236822568671,0.9508825506493929,-0.516508383644068,-0.8834599278035791,4123,2,JUN
ASSEMBLY OF ACTOMYOSIN APPARATUS INVOLVED IN CYTOKINESIS%GOBP%GO:0000912,0.702878261843432,0.968941691852291,0.39235349094566596,0.8314345268720971,6275,4,ANLN|RACGAP1
REGULATION OF PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0010899,0.0768785457913628,0.527286041772797,0.7367376199404431,1.40046071361822,663,3,SCARB1|APOC1|LDLR
MITOTIC CYTOKINESIS CHECKPOINT%GOBP%GO:0044878,0.9776542781058242,1.0,0.284758072110831,0.54129513965789,8443,3,AURKB|ZFYVE19
IRIS MORPHOGENESIS%GOBP%GO:0061072,0.619865771812081,0.9532238181782521,0.694199382443758,0.9222129091463891,4617,1,WNT2B
NEURON PROJECTION EXTENSION%GOBP%GO:1990138,0.10241782124422699,0.573990368062824,-0.25606511927716696,-1.35563193845022,376,32,IMPACT|CTNNB1|SEMA3F|NRP1|ALCAM|FLRT1|SEMA3A|HSP90AB1|TMEM108|SLIT3
CELLULAR RESPONSE TO LIGHT STIMULUS%GOBP%GO:0071482,0.7261354581673309,0.972554563883587,0.15698484688213,0.8292363842049091,9112,76,PTPRK|SIRT1|ATR|USP47|ST20|DDB2|POLD1|PARP1|TMEM161A|GEN1|INO80|AURKB|DDB1|ZBTB1|STK11|METTL3|MC1R|MFAP4|CUL4B|CNGB1|KDM1A|CASP9|CARD16|MAPK13|CHEK1|XPA|HIST3H2A
REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010821,0.000696378830083565,0.0806484601749226,-0.300260677724226,-2.38211208035562,0,144,BAX|GPER1|FLCN|FBXW7|HPS4|HAX1|PPIF|TP53BP2|GZMB|CLU|KDR|CIDEB|SQSTM1|UBL5|PARL|BBC3|ATG13|BAG4|MPV17L|HRK|VAT1|VPS11|MFN2|HGF|YWHAH|CSNK2A2|MMP9|BCL2L1|SH3GLB1|RNF31|PLD6|MIEF1|BOK|IGF1|BID|BAP1|ACAA2|LEPROT|YWHAQ|YWHAB|PLAUR|FXN|PPARGC1A|HK2|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|UBE2D3|SLC35F6|SIAH3|HTT|ARIH2|PARK2|BMF|FBXO7|BIK|BCL2L11|PMAIP1|TFDP2
POSITIVE REGULATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1900020,0.575547064953109,0.941940408834489,0.48916723851155197,0.9298554619484781,4970,3,C8orf4
SUPPRESSION BY VIRUS OF HOST CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0039650,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
RECYCLING ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0071955,0.0457312546399406,0.41958742830584794,-0.8695891921698371,-1.4873857409883702,307,2,GCC2|TBC1D14
REGULATION OF CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:1900208,0.8343624161073829,0.988613522932093,0.5830392589325101,0.774541644266396,6215,1,STOML2
EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060664,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
REGULATION OF DOUBLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:1905767,0.911823116642394,1.0,-0.542567269519188,-0.725808779173183,6886,1,ERCC4
INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032609,0.46387952822240897,0.892254223796902,0.38420093584571396,0.999994315344914,4404,7,TRIM27|F2RL1|BTN3A2|BTN3A1
NEGATIVE REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032707,0.409354120267261,0.867015886388254,-0.6093035288381501,-1.0421810538679699,2756,2,RAC1
MIDGUT DEVELOPMENT%GOBP%GO:0007494,0.460430586488493,0.8904234666384399,-0.582740556934105,-0.996746513047881,3100,2,SMO|RET
"TRANSPOSITION, DNA-MEDIATED%GOBP%GO:0006313",0.463650659247611,0.8921382338742359,0.618141714915909,1.01033565168378,3832,2,PGBD5|THAP9
POSITIVE REGULATION OF TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE%GOBP%GO:0002654,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043534,0.825678690963183,0.9876441563834109,0.18903109440624,0.714638291538735,8880,21,EGR3|NR4A1|PIK3R3|MIA3
EPIBOLY INVOLVED IN GASTRULATION WITH MOUTH FORMING SECOND%GOBP%GO:0055113,0.9589567059446579,1.0,-0.518306131451257,-0.693353915063813,7242,1,MEGF8
OTIC VESICLE MORPHOGENESIS%GOBP%GO:0071600,0.12029639921268999,0.606646975444992,0.6978052277489799,1.3264543315961799,1038,3,PROX1|CEP290|FGFR2
ACTIVATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0032147,0.0387359836901121,0.395016395253662,-0.15413954574307,-1.3071026198603701,37,206,MAPKAP1|IL1B|IRAK1|VEGFA|PKN1|PLCE1|ADRA2C|PRKCD|MAP3K8|DAB2IP|STK26|C5AR1|TGFBR1|IRAK2|PTK2B|PRKAA1|GDF15|ABL1|MAP3K13|ATG13|RET|STK10|TNFRSF10A|UBE2V1|FGF2|MAP2K5|PRNP|CHRNA7|SLC11A1|PRKAR2A|IGF1|MAP4K4|CRK|RIPK2|PRR5|KARS|MAP2K3|GADD45A|DBNL|MLKL|STK4|ADRB2|CHRNA3|RAPGEF1|SHC1|UBA52|PRKAR1B|TNFRSF10B|MAPK3|OXSR1|CHI3L1|ADRA2A|COPS8|FGF10|PEA15|STK24|MAP3K11|UBC|MAP2K1|TNF|PAK2|UBB|ADORA2B
NEGATIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0033048,0.0410567983061769,0.402256981537283,0.3995085012032121,1.5537697725563402,445,23,TPR|CENPF|NAA10|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|KLHL22|PLK1
REGULATION OF PROTEIN SECRETION%GOBP%GO:0050708,0.18149882903981301,0.6873049536419911,-0.13223592092769998,-1.13420255112322,154,223,LGALS9|TNFAIP3|NR1H3|PFKL|SSC5D|FGR|GPI|STXBP4|ANO1|RAB11FIP1|TCF7L2|TNFRSF1B|ARL2BP|MYRIP|IL6|SLC25A4|FCGR2B|PANX1|VAMP3|MBP|IGF1|MAVS|UQCC2|MYOM1|FOXP1|RIPK2|RAP1A|TMSB4X|DPH3|GAPDH|KARS|GIPR|NLRP1|NLRP3|PRKCA|TNFRSF4|DRD2|PPP1R11|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|CD22|NR1D1|CACNA1E|TWIST1|TNF|SNAP25|TNFRSF21|INHBB|TRH
BLOOD CIRCULATION%GOBP%GO:0008015,0.25360524399126,0.7641083395392759,0.188728876436242,1.14188196016997,3481,165,CARTPT|ACSM3|RYR2|KCNN2|SCN1A|PLCB3|EDN1|CACNA1G|GAA|CACNB2|NPR2|ELN|FGF12|MYLK2|CEACAM1|KCNQ1|HOXB2|OXTR|F2R|INS|GNB3|PDE2A|ERAP1|TCAP|PTPRO|AGTR1|CACNA2D1|TAZ|KCNH2|SRC|CACNA1D|XCL2|F2RL1|AZU1
POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000646,0.7727646961962791,0.979946273879301,-0.33082719796061705,-0.760833443086909,4692,4,ITCH|PTPN1
REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050727,0.328125,0.828303707528737,-0.12464750179438401,-1.0542089745582301,335,202,IL1B|CLU|ADCY7|NFKBIA|CX3CL1|MAPK7|PRKCD|SIRPA|CD19|C5AR1|ITGAM|TNFAIP3|NR1H3|CR2|CEBPA|PSMA6|S100A8|CCL14|C1QBP|MGLL|TNFRSF1B|PPARA|SEMA7A|APOD|METRNL|CDH5|IL6|FCGR2B|SBNO2|MMP9|CYLD|C2CD4A|VAMP2|VAMP3|TNIP1|FOXP1|ETS1|TMSB4X|PLA2G2A|SNCA|KARS|TNFRSF11A|PDCD4|PROC|NLRP1|NLRP3|SNX6|ADCYAP1|BCL6|TICAM1|MYD88|NR1D2|CCL18|GPRC5B|TNF|SPATA2
MELANOCYTE DIFFERENTIATION%GOBP%GO:0030318,0.10055110741395401,0.570947005522165,0.5172739552128971,1.41022757797521,966,8,CITED1|USP13|KIT|C10orf11
COPPER ION IMPORT%GOBP%GO:0015677,0.46747900543388793,0.895274921500968,-0.424235264279899,-0.9756524819926821,2838,4,STEAP3
INOSITOL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0043647,0.36001226617602006,0.848418604328854,-0.18487168580863503,-1.06874521778593,1173,43,SYNJ2|PLCE1|IP6K1|NUDT4|INPP1|ITPK1|INPP5K|FGF2|INPP5A|PLCD1|ITPKB|PLCB4|PLCB1
REPLICATION-BORN DOUBLE-STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE%GOBP%GO:1990414,0.135695264559454,0.623227463256235,0.6863350612109851,1.30465075162368,1171,3,NIPBL|RECQL5|XRCC1
PERISTALSIS%GOBP%GO:0030432,0.0889712696941613,0.5574926967101801,-0.9537384208204681,-1.2758449647722099,671,1,DRD2
REGULATION OF IMMUNE COMPLEX CLEARANCE BY MONOCYTES AND MACROPHAGES%GOBP%GO:0090264,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0033262,0.7069312915575259,0.969403752544852,0.27293950196467603,0.8055149846329192,7016,10,CDC7|DBF4B|INO80|CHEK2|WIZ
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON DEATH%GOBP%GO:1903208,0.526262739388509,0.9265056012720759,0.452232539334771,0.9583239503533358,4698,4,NR4A3|PINK1|GNB2L1
PLASMA MEMBRANE REPAIR%GOBP%GO:0001778,0.7151325539272191,0.971081608033886,-0.348315226382838,-0.8010522550809089,4342,4,SYT7|MYOF|AHNAK2|SYT11
OXIDATIVE PHOSPHORYLATION%GOBP%GO:0006119,0.773732322837722,0.980096450857848,0.14623069667383498,0.801676509997944,9902,92,NDUFA7|NDUFS7|NDUFA4|NDUFS2|COX5A|TEFM|COA6|ATP5D|NDUFC1|NDUFAF1|NDUFS4|TAZ|MT-ATP8|COX6A1|NDUFS8|NDUFB2|UQCC3|SDHA|MT-ND2|NDUFV1|NDUFS3|ATP5C1|NDUFB7|NDUFA12|MT-CO2|MT-CYB|GBAS|ATP5E|SURF1|ATP5H|MT-ATP6|LACE1|MT-CO1|ATP5A1|CYCS|NDUFB1|UQCR10|NDUFB3|NDUFA1|STOML2|NDUFB6
HYALURONAN METABOLIC PROCESS%GOBP%GO:0030212,0.490113308153744,0.908938677284213,-0.22332353369260102,-0.960688224249859,2205,18,SLC9A1|FGF2|CHP1|CEMIP|TMEM2
T CELL HOMEOSTASIS%GOBP%GO:0043029,0.358258492776259,0.846205501155666,-0.33092453662842,-1.06825405909534,1834,9,RIPK3|AKT1|FADD|JAK3|FOXP3|ZC3H8|NCKAP1L|PPP2R3C|PMAIP1
RESPONSE TO WOUNDING%GOBP%GO:0009611,0.0034965034965035,0.14227418772873301,-0.166563375199959,-1.49868008287741,1,293,HMOX1|PDPN|ARRB2|AKIRIN1|EPB41L4B|VAV1|HBG2|GNAQ|FGF7|FYN|RHOA|FAM65A|ITPK1|EYS|P2RX6|ITGA5|C1QBP|DGKQ|MFN2|CLIC1|APOD|FGF2|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|SLC11A1|MAFF|PRKAR2A|IGF1|RHOC|PDCD10|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|ADAM17|THBD|PROC|RAD51B|MMP12|CFLAR|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ANO6|CSRP1|MAPK3|GNA12|MCAM|RAB5A|DGKB|FGF10|BLOC1S3|MYH9|VWF|EVPL|ACVRL1|GNAS|TMEFF2|H3F3B|RAC1|CD36|PIK3R1|SULF2|ZFPM2|DGKK|INHBB|RTN4RL2
REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035507,0.8705770850884581,0.9934031064448321,0.25407215002778305,0.6612964259339339,8266,7,NUAK1|PPP1R12A|ROCK1|NCKAP1L
NEGATIVE REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0010711,0.8187475175426979,0.987153241368501,-0.588056903396559,-0.786661649378252,6183,1,CST3
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901796,0.298282144716294,0.8023890191280308,-0.14313624670343802,-1.08125342498438,572,111,HIC1|DYRK2|PSMD10|RPL11|BRD7|TAF15|NOC2L|CD44|TAF9|SNAI2|TAF10|HIPK1|HEXIM1|SUPT16H|TP53BP2|PTTG1IP|PLK3|TP53RK|MSX1|RPF2|PML|ZNF385A|DYRK1A|BRPF1|CSNK2A2|GLTSCR2|POU4F2|SNAI1|PHF20|BCL2|RRS1|TP53|TAF4B|PARK2|SETD9|CSNK2A1|TWIST1|JMY|TAF13|SPRED2|PMAIP1|UBB
IMMUNE SYSTEM DEVELOPMENT%GOBP%GO:0002520,0.7456828885400308,0.9749763305090959,-0.10196356656816499,-0.9089900072090991,474,277,CBFA2T3|BATF|IL11|VEGFA|KDR|FCER1G|TYROBP|IKZF1|TGFBR1|LGALS9|PTK2B|CD164|TNFAIP3|PDPN|VPRBP|CR2|CEBPA|EXOSC6|HDAC4|ZNF385A|NFAM1|RET|TCTA|CITED2|MFAP5|G6PD|MEOX1|HDAC5|THOC5|CASP3|RUNX1|RELB|KITLG|IL6|PPARG|SNRK|LYN|ETV6|FCGR2B|SBNO2|MMP9|SBDS|FOXP1|CAMK4|CDC42|SLC25A38|TNFRSF11A|LEPR|ASH2L|KLF6|GLRX5|ADAM17|MECOM|MLF1|CTNNBL1|PMS2|STAT3|GAB2|OSCAR|ARIH2|LYAR|FGF10|MYH9|SFRP2|IRF2BP2|ACE|TPD52|DYRK3|RNF168
VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0042368,0.838791946308725,0.989395884107905,0.581219673577415,0.77212440629961,6248,1,CYP27B1
MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045342,0.230372037600953,0.743397546142977,-0.884318482576092,-1.18297979678654,1739,1,SLC11A1
NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062014,0.264205965672388,0.775800531471705,0.238022191228154,1.16091177595024,3170,53,SIRT4|SIRT1|FGF19|WNT4|CEACAM1|ACADVL|INS|PROX1|C1QTNF3|FAM132A|CLK2|PARP1|PGP|GCK|APOE
POSITIVE REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032754,0.54981063724683,0.931359181171847,-0.396506430409609,-0.911881956847318,3338,4,RARA|PDE4D
CRANIAL SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:1904888,0.360199100220159,0.848418604328854,0.31323860599922104,1.08591329985363,3762,16,FREM1|MTHFD1|TGFB2|CEP55|NIPBL
PYROPTOSIS%GOBP%GO:0070269,0.0139005897219882,0.256136946817111,0.663096997613777,1.72590216803204,131,7,AIM2|DHX9|APIP|GSDMB|GSDMD|NLRC4
COVALENT CHROMATIN MODIFICATION%GOBP%GO:0016569,0.747232730839288,0.9749763305090959,0.13483640552734402,0.8647836165334549,10665,256,CPA4|SIRT1|PRMT9|HDAC10|MBD3|JADE3|WDR61|EHMT1|MTA2|AK6|KAT2A|KDM5D|MIER2|NAA40|DOT1L|TADA1|OGT|TAF6L|C14orf169|MTA1|PCGF2|YEATS4|JAK2|DDB2|KDM5B|TRRAP|PRKCB|MAP3K7|EP400|EZH2|KMT2B|PAGR1|NEK11|UHRF1|HDAC8|LEF1|AURKB|HUWE1|DDB1|HELLS|ING5|HDAC3|TRIM37|APBB1|YEATS2|SMARCAD1|KDM4B|HDAC6|BRCC3|BRPF3|ZNF335|CUL4B|PRMT1|SFPQ|KDM1A|CARM1|RNF40|NSD1|MYSM1|CDC73|MSL1|PAXIP1|KAT8|BRCA2|KDM3B|MAP3K12|VRK1|EHMT2|SUPT3H|RPS6KA4|KMT2D|WDR5|KDM8|UBE2B|UBR2|BRD1|SUDS3|KDM4A|MBD1|SIN3B|CDK2|SETDB2|PCGF1|CCDC101|PCGF3|UIMC1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ATRIAL NATRIURETIC PEPTIDE%GOBP%GO:0003050,0.484310869853039,0.9064456896937672,-0.7562858403175999,-1.0117066275548199,3657,1,RASL10B
PEROXISOMAL TRANSPORT%GOBP%GO:0043574,0.7283222795381971,0.972554563883587,0.163006247282718,0.8211483791208729,8894,61,CROT|SLC27A2|HSD17B4|IDE|PEX3|DECR2|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
PROTEIN N-LINKED GLYCOSYLATION%GOBP%GO:0006487,0.0542325884847496,0.455180689373156,0.28611887380425105,1.4524978921929699,664,63,B3GALT2|TMEM165|ALG6|ASGR1|FUT8|MGAT5B|B3GALT1|MVD|MOGS|ALG14|ALG13|DERL3|SRD5A3|DPAGT1|NUDT14|MPDU1|ALG2|MGAT2|DOLPP1|SYVN1|B3GALNT1|OSTC|ALG5|ALG1|MAN1C1|RPN2|PGM3|ENTPD5|VCP|ALG3|STT3A
SYNAPSE ORGANIZATION%GOBP%GO:0050808,0.0981375902698594,0.570215774831708,0.230033081678375,1.3121763806504199,1290,114,DOCK10|PCDHB4|GPHN|CACNB4|PCDHB6|CACNB2|SLITRK6|PCDHB14|SDK1|PCDHB13|PCDHB9|UNC13B|F2R|CDH2|DSCAM|DNM3|DNAJA3|PAK3|DVL1|ELFN1|UNC13A|KIRREL3|CTNND2|PTPRD|SEMA3E|APOE|NRD1|PIN1|ANK3|LRRC4C|FARP1|MYOT|DLG4|NLGN4Y|CACNB1|PTPRS|PCDHB16|SLITRK1|PCDHB11|NPAS4|ZC4H2|AGRN|SHANK1|SPOCK2|RAB3A
DIVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0072507,0.580815550390873,0.942746898746279,0.149846928107983,0.951757506455191,8246,236,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|P2RX5|TMTC2|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|MT1F|SLC30A5|AGTR1|ATP2A1|CDH23|HSP90B1|PDPK1|CACNA2D1|PTGER1|TMEM178A|MT1E|CCR5|CNNM2|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|SLC39A7|DMPK|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|SLC39A13|ANK3|MT2A|CALB2|CD55|DRD4|DLG4|TRPC1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|TFAP2B|FPR3|MICU1|SLC39A10|P2RY6
OXALIC ACID SECRETION%GOBP%GO:0046724,0.9139414802065401,1.0,-0.541574768416409,-0.724481080186891,6902,1,SLC26A6
REGULATION OF ACTIN FILAMENT SEVERING%GOBP%GO:1903918,0.0688468158347676,0.5040280242137971,-0.964435377150419,-1.29015460940225,519,1,MYH9
PH ELEVATION%GOBP%GO:0045852,0.325844461901021,0.826621597878865,-0.541634498731664,-1.0992311225082199,2073,3,SLC26A6|CLN3|BCL2
RESPONSE TO INTERLEUKIN-13%GOBP%GO:0035962,0.21930215293244198,0.734713083559597,-0.7263303005238492,-1.24234907928337,1476,2,SHPK|CD300LF
V(D)J RECOMBINATION%GOBP%GO:0033151,0.621295622335448,0.9536478716552259,0.322096491816235,0.8781214498637809,5974,8,LIG4|LIG1|PRKDC|HMGB2|HMGB1|LIG3
REGULATION OF REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:2000121,0.76284751474305,0.978421368343614,0.290493788315627,0.7560942982067349,7243,7,DHFR|FBLN5|SZT2
SNRNA IMPORT INTO NUCLEUS%GOBP%GO:0061015,0.557526810538859,0.9361453421204542,-0.7151521835024258,-0.9566808806784741,4210,1,RAN
TELENCEPHALON DEVELOPMENT%GOBP%GO:0021537,0.418492655911389,0.871698849372662,0.197625941882366,1.03528144077456,5213,73,SIX3|BTBD3|SLIT1|CDK6|BMP4|KIF14|MFSD2A|PROX1|WDR62|FGF13|ARHGAP11B|EPHA5|NPY|ZDHHC16|ROBO2|KIRREL3|CCDC85C|LEF1|NF1|RTN4R|TACC2|LRP8|SZT2|PEBP1
NCRNA EXPORT FROM NUCLEUS%GOBP%GO:0097064,0.14720812182741103,0.638945026078465,-0.40885621784007303,-1.31982450967197,753,9,NPM1|PHAX|NCBP2
NEGATIVE REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043124,0.8815928270042191,0.9956508825790341,-0.135073343026128,-0.700764832353543,3342,30,OTUD7B|PYCARD|RIOK3|OTUD7A|SIRPA|DAB2IP|USP10|TNFAIP3|TANK|TNIP1|PPM1A
ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS%GOBP%GO:1901361,0.9617647058823531,1.0,-0.0864579250063277,-0.7986050811220391,326,386,RPL7|PFKL|DERA|EXOSC6|GPI|PRPF18|RPS9|RPS3|RPL14|WIBG|NUDT4|EXOSC4|MAGOH|GSPT1|CASP3|EIF4G1|PKM|ALDH4A1|H1F0|PAPD7|YWHAH|DFFA|RPL15|PNP|RPL8|ENO1|CDA|EXOG|NBAS|HPRT1|PPP2CA|ZPR1|NUDT18|RPL35A|CNOT7|GAPDH|EXOSC9|HELZ2|PGK1|CDADC1|TDO2|HK1|MTPAP|HK2|TPI1|RNASEH1|ETF1|PDE12|PDE9A|CSDE1|PAH|UBA52|MRTO4|PCBD1|BLVRA|UPP1|NCBP2|ENTPD3|ALDOA|POLR2D|RBM8A|RNPS1|ITPA|PABPC1|EXOSC5|DDX6|NT5E|QDPR|NEIL2|PDE4D|PGAM2|ENPP4
REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000348,0.721759622937942,0.971401508276304,-0.39169515826623996,-0.794933685927092,4593,3,SHARPIN|TREM2|TNFAIP3
NEGATIVE REGULATION OF OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:1900142,0.544287038262942,0.929758904310055,-0.722761358623732,-0.966859906240049,4110,1,GAS6
FATTY-ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0046949,0.8810641627543041,0.9956508825790341,0.17059059776539803,0.6634615120627181,9570,23,HACD1|SCD5|ELOVL6|SLC25A1|ACACA|TECR
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900102,0.385736800630418,0.859630103805729,-0.308159099685552,-1.04254835948548,1957,10,DNAJB9|NCK1|ATF6B|GNB2L1|PPP1R15A|WFS1|PPP1R15B|HSPA5|PTPN1|BFAR
OOCYTE CONSTRUCTION%GOBP%GO:0007308,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
INTERMEDIATE FILAMENT CYTOSKELETON ORGANIZATION%GOBP%GO:0045104,0.210786622703721,0.7255949404689929,-0.26595832563958,-1.20792845646518,894,21,KRT9|NEFH|DNAJB6|EVPL|DES
PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:0061512,0.921637426900585,1.0,0.150944588088211,0.618967652915431,10243,28,ROPN1B|TUB|BBIP1|C5orf42|ARL6|BBS1|RABEP1|SPATA7|IFT20|SNX10|RAB29|ARL13B|BBS4|ATP6V1D
HISTIDINE METABOLIC PROCESS%GOBP%GO:0006547,0.39921268959129297,0.8638522656500329,0.554442078998849,1.05393606705935,3447,3,FTCD|C9orf41|HNMT
INTERMEDIATE FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0045110,0.36423513914045796,0.85007225273817,-0.46054155407268504,-1.05914936386648,2211,4,NEFL|PKP2|NEFM|NEFH
L-XYLITOL METABOLIC PROCESS%GOBP%GO:0051164,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090284,0.9312855818879909,1.0,-0.531594618438465,-0.711130329269173,7033,1,ARFGEF1
ANDROGEN METABOLIC PROCESS%GOBP%GO:0008209,0.260476239991681,0.771966179402691,0.43477232961617107,1.18530601277403,2504,8,HSD17B4|HSD17B11|SRD5A3|MED1
DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048066,0.505960264900662,0.9172434440873181,0.264424743575214,0.966512894815125,5347,19,CITED1|USP13|AP3D1|LEF1|KIT|C10orf11
ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060839,0.11006175081728999,0.584830174998513,-0.480985656535705,-1.40305649950724,605,7,DLL1|ACVR1|PDPN|NRP1|RBPJ
PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:0070536,0.277390438247012,0.7884684708511421,-0.23027600356873498,-1.13072271424139,1113,26,YOD1|USP8|OTUD7B|USP16|OTUD5|OTUD7A|TNFAIP3|CYLD|SHMT2|USP27X|OTUD1|SPATA2
EVASION OR TOLERANCE OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051807,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
TREHALOSE METABOLIC PROCESS%GOBP%GO:0005991,0.9361316075964681,1.0,0.41003584229390705,0.6701923198858671,7738,2,ATHL1|BRAF
MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0030219,0.239153327716933,0.75206086335821,0.465841919676446,1.2124886434760802,2270,7,TAL1|MED1|KIT|CDKN2B
INTERSPECIES INTERACTION BETWEEN ORGANISMS%GOBP%GO:0044419,0.65149136577708,0.9640232763254308,-0.10569231049367402,-0.9422312038620579,414,277,PVRL2|MON1B|FURIN|CTDP1|EIF3D|HTATSF1|ZNF639|VPS28|CBLL1|KPNA1|NEDD4L|AP1M1|CTNNB1|BANF1|USF1|ROMO1|RAB43|GRB2|PCBP2|CTBP1|VPS4A|FYN|INPP5K|VPS37D|THOC5|TBC1D20|RXRA|SEH1L|EIF3G|BCL2L1|ATG7|EIF3B|RAB1A|VPS4B|ICAM1|TNIP1|AP1S1|GAPDH|FMR1|CDC42|AP2S1|KPNA4|NEDD4|EIF3A|JUN|UBA52|TP53|B2M|CAV2|RAB7A|VAPB|PARK2|RAB5A|CHMP4B|CHMP1B|PCBP1|THOC7|RAC1|MET|DDX6|UBC|PC|HSP90AB1|BICD1|AQP1|CAV1|PAK2|UBB
NEGATIVE REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045720,0.0554746458360916,0.458212274160356,-0.9719342743714158,-1.30018611285424,418,1,TMEFF2
NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032815,0.6772710777791221,0.9647315640607691,0.537854976564654,0.879109183454377,5598,2,PIBF1|MICA
REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002892,0.257015590200445,0.7674783969184241,-0.7030557576017329,-1.20253922011988,1730,2,FCGR2B
10-FORMYLTETRAHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0009256,0.5363493407523889,0.9265056012720759,0.5910856801435961,0.9661133061211871,4433,2,MTHFD1|MTHFD1L
CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0097720,0.7474124203821659,0.9749763305090959,0.253896844912287,0.7745810732747221,7509,11,ADGRB2|SULT1A3|NFATC4|NFAT5|NFATC1|PPP3CA|PPP3CB
REGULATION OF ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098910,0.27588058419244,0.7884684708511421,0.47612435502757794,1.1709585103583,2568,6,RYR2|RNF207|FLNA|ANK2|GJA5|TRPM4
RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:0002001,0.5820203892493051,0.943249589738259,-0.702801058667843,-0.940158404404613,4395,1,PCSK5
METANEPHRIC DISTAL TUBULE DEVELOPMENT%GOBP%GO:0072235,0.7830265138358229,0.981487311948134,0.41170874221997095,0.782615008826143,6762,3,PKD2|PKD1
REGULATION OF CD4 BIOSYNTHETIC PROCESS%GOBP%GO:0045223,0.0713623725671918,0.514511211182091,-0.9631120423467141,-1.2883843440871898,538,1,ACOT8
LEFT VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0003220,0.0918108140800774,0.5622489437340121,0.8136691034929121,1.32991979686131,758,2,RYR2|SMAD4
CELLULAR COPPER ION HOMEOSTASIS%GOBP%GO:0006878,0.955279747832939,1.0,-0.173167098802891,-0.585850214898841,4848,10,ATP7B|MT2A|ATOX1|COX19|ATP7A|CCDC22|APP|ARF1|PRND|PRNP
RENAL SYSTEM SEGMENTATION%GOBP%GO:0061150,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060761,0.911965811965812,1.0,-0.12266111601990899,-0.6813771510594561,3200,37,MAPK7|NR1H3|RNF113A|MAP2K5|IL6|PPARG|CNOT7|NR1H2|SLIT3
PROTEIN-CARBOHYDRATE COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071823,0.7904923188581109,0.9819233677232551,0.49004687069203207,0.800968147771073,6534,2,HLA-DRB1|HLA-DRA
RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009201,0.21599453178400502,0.73255896802681,-0.187275685944958,-1.17583017026227,631,56,PFKL|COX5B|GPI|PKM|ENO1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
CELLULAR RESPONSE TO SUPEROXIDE%GOBP%GO:0071451,0.322375590265165,0.822751772025005,-0.37342224188541395,-1.0892892468177,1774,7,SOD1|SOD3|SOD2|NOS3
TRIMMING OF TERMINAL MANNOSE ON B BRANCH%GOBP%GO:0036509,0.808636748518205,0.984682960940884,0.48333434592084495,0.78999671043641,6684,2,MAN1B1|EDEM2
REGULATION OF NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:1905292,0.5244304791830321,0.925993329275615,-0.4616742031542961,-0.9369540783586671,3337,3,BMPR1A|SEMA3C|ENG
EXPLORATION BEHAVIOR%GOBP%GO:0035640,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
NEGATIVE REGULATION OF BEHAVIOR%GOBP%GO:0048521,0.144137081420092,0.6340340930337739,0.6180951030429821,1.30980256686863,1286,4,GHRL|INS|UCN
REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT BY GTP HYDROLYSIS%GOBP%GO:0090113,0.950206043956044,1.0,-0.234874080149436,-0.594568137457125,5533,5,SEC23A
RESPONSE TO PROSTAGLANDIN%GOBP%GO:0034694,0.922910733575567,1.0,0.18628479251019395,0.601210267767434,9397,13,CCL21|CCL19|ADCY6|GNG2|PTGER2|AKR1C3|CCR7|PTGER4|SFRP1|TGFBR3|GNB1|AKR1C2
PROTEIN-CONTAINING COMPLEX DISASSEMBLY%GOBP%GO:0032984,0.960763520678685,1.0,-0.0894725361499397,-0.7604365219665359,905,210,MRPL51|DHX8|MRPS33|SUPT16H|MRPL37|VTI1B|FZD1|MTRF1L|MRPL14|MRPL15|FRAT1|VPS33B|MRPS2|CTNNB1|CFL2|MRPL18|MRPS35|NAPB|AURKAIP1|MRPL22|VPS4A|WIBG|WDR1|MAP1LC3A|GSPT1|MRPL24|MRPS17|MICAL2|NAPA|VPS4B|GRWD1|MRPL41|MRPS30|VPS16|MRPL9|TWF1|MRPS10|DSTN|ETF1|MRPL2|TWF2|MRPS26|GABARAPL1|GABARAP|MRPL39|CHMP1B|WIPI2|SMARCC1|MAP1LC3B|MRPL30|GABARAPL2|DYRK3|MRPL36|PBRM1|CAV1
REGULATION OF SEROTONIN UPTAKE%GOBP%GO:0051611,0.138975501113586,0.627473629755205,-0.773917838433968,-1.3237450142531202,935,2,GPM6B|SNCA
REGULATION OF GASTRIC ACID SECRETION%GOBP%GO:0060453,0.0247771216857705,0.329326373353219,0.8111923238624741,1.54199127343314,213,3,PTGER3|KCNQ1
REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904705,0.0233632165172507,0.321093965761153,-0.303581143781557,-1.60718607666383,85,32,MMP2|MFN2|FGF2|PPARG|MMP9|HTR1B|MEF2D|IGF1|SOD2|FOXJ2|PDCD4|JUN|CDKN1A
KILLING BY SYMBIONT OF HOST CELLS%GOBP%GO:0001907,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
PROTEIN C-LINKED GLYCOSYLATION%GOBP%GO:0018103,0.9905563186813191,1.0,-0.19832340613280397,-0.50204253327362,5768,5,DPY19L3|DPY19L2|DPY19L4|DPM3|DPY19L1
PLASMA LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034377,0.37994542974079104,0.856277647940315,0.323070406120263,1.07043265184281,3898,14,ZDHHC8|ABCA7|DGAT1|SOAT1|APOE|APOC1|APOM
NAD BIOSYNTHETIC PROCESS%GOBP%GO:0009435,0.009664753850800359,0.21484293761490603,-0.29627542402940305,-1.7059753015494499,31,42,PFKL|GPI|PKM|PNP|ENO1|NAMPT|GAPDH|PGK1|HK1|NMNAT3|HK2|TPI1|ALDOA|PGAM2|NMNAT2
MAPK EXPORT FROM NUCLEUS%GOBP%GO:0045204,0.7742832950284259,0.980173768720877,0.49636246244996796,0.8112908089999649,6400,2,DUSP16
NEGATIVE REGULATION OF PROTEIN HOMOTETRAMERIZATION%GOBP%GO:1901094,0.38752783964365295,0.859991269020751,-0.622260045037875,-1.06434248092098,2609,2,PEX5
"POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904816",0.38577943615257004,0.859630103805729,-0.287043544049648,-1.04572842429222,1860,12,CCT2|CCT5|GNL3|DKC1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1|GNL3L
REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003093,0.115442439862543,0.593539945084925,0.561467873024681,1.3808484637862,1074,6,F2R|PTPRO|F2RL1
LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034374,0.5272407732864679,0.9265056012720759,-0.33877456503905795,-0.929913433983659,2999,6,AGT|PLA2G7|PLA2G2A|ABCG1
ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0051017,0.799143864361256,0.9839175016931591,0.15869592173749303,0.7626051621334,9520,50,FSCN2|ITGB1|SHROOM2|HSP90B1|FHDC1|TNFAIP1|LIMA1|SRC|ITGB5|DPYSL3|KCTD13|PLS3|SPIRE2|SPIRE1|PDXP|FMN2|BAIAP2L2|BAIAP2L1
SMALL MOLECULE CATABOLIC PROCESS%GOBP%GO:0044282,0.974546213227624,1.0,0.102856688675969,0.6669522890151679,14012,283,FUT9|FUT7|CROT|CTH|GALM|GLYATL2|IDO1|SLC27A2|ASRGL1|ETFDH|HSD17B4|MCCC2|PGM5|ACADVL|IDNK|BDH2|FUT2|FUT8|ETFA|FTCD|DECR2|ALDH1A1|TST|GLS|HRSP12|ABHD3|PCYOX1L|TKFC|GLS2|GALE|AMACR|ACADM|SRD5A3|DECR1|HMMR|SULT1A3|AIG1|CDO1|FUT10|ALDH3A2|HADH|AMDHD2|ETFB|TXN2|GCK|BCKDHA|APOE|ACOX2|ECHDC2|MTAP|MCEE|SARDH|ABAT|NUDT9|GSTZ1|BCAT2|ABHD16A|EHHADH|ACAD11|ACAD10|GALK1|IVD|ABHD10|ADO|FAAH|HMGCLL1|MCCC1|IMPA1|C9orf41|AKR1A1|PHYKPL|ECI1|PPM1K|CCBL1|GALT|AASS|ECI2|HADHB|ACAT2|QPRT|HMGCL|HIBCH|IMPA2|ABHD2|AFMID|ACADS|PDXP|LYVE1|ENTPD5|PCK2|BPGM|PRTFDC1|ACOT7|PM20D2|HIBADH|ECHS1|RPE
WHITE FAT CELL DIFFERENTIATION%GOBP%GO:0050872,0.369848901098901,0.852479840097272,-0.417222950933284,-1.05617219525857,2153,5,CTBP1|PPARG|PER2
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB%GOBP%GO:0002475,0.38046558704453404,0.856455387424841,0.37541531550134005,1.07130703974444,3758,9,TAP2|CD1E|CD1D|HLA-F|HLA-C|HLA-B|HLA-A
CELLULAR RESPONSE TO CHOLESTEROL%GOBP%GO:0071397,0.364363942712721,0.85007225273817,0.41742967457253205,1.08648174088893,3459,7,GRAMD1B|LRP6|PTCH1|GPLD1|OSBPL7|GRAMD1A|SMO
REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902996,0.982182628062361,1.0,-0.316129032258065,-0.5407217788894301,6614,2,SORL1|CLU
LEUKOCYTE ADHESIVE ACTIVATION%GOBP%GO:0050902,0.9507052709725309,1.0,-0.34971050454921404,-0.598161088734828,6402,2,SELPLG|CX3CL1
SPINAL CORD PATTERNING%GOBP%GO:0021511,0.398008241758242,0.8638522656500329,-0.40648919087551794,-1.02900039443067,2317,5,RELN|ASCL1
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002585,0.486711210096511,0.907092544497897,-0.569120485249518,-0.9734501098757741,3277,2,TREM2|PYCARD
NEGATIVE REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902804,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
REGULATION OF TRANS-SYNAPTIC SIGNALING%GOBP%GO:0099177,0.41029900332225894,0.867015886388254,-0.125779226669944,-1.03117633964195,493,174,GPER1|SHISA9|OPHN1|GRIN2C|SYT11|CHRNB2|IL1B|MTMR2|NPTX1|CX3CL1|NSMF|PTK2B|SQSTM1|NAPB|ABL1|SYN1|VPS18|GRID1|PXK|YWHAH|SLC30A1|NAPA|VAMP2|CHRNA7|CAMK2A|HAP1|IQSEC2|ARC|CBLN1|SNCA|FMR1|GRM2|PNKD|JPH3|TPRG1L|CHRNA3|RELN|ADCYAP1|DRD2|PARK2|RAB5A|MCTP1|CACNG3|PLK2|CACNG7|TNF|TMEM108|GRM8|CPLX1|EPHB2|HOMER1
LIPID LOCALIZATION%GOBP%GO:0010876,0.64327917282127,0.9621972042482541,0.152279037001264,0.902617457395866,8709,143,ABCC3|STAR|GHRL|ATP10A|NME4|SLC27A2|CEACAM1|ATP11C|SLMO1|STARD10|ABCA10|MFSD2A|ABCA7|ABCA5|ABCB4|DGAT1|SCARB1|ABCA9|EPRS|ATP10D|ABCA6|STARD5|LIMA1|SOAT1|AKR1C1|CETP|OSBPL5|ABCA2|LDLRAP1|CPT1B|APOE|ATP8B3|ACACA|PRELID2
POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031394,0.595500181444297,0.94763446543375,0.568569065343259,0.92931051779763,4922,2,PTGS2|ANXA1
REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051459,0.136969425467578,0.62388141596544,0.623021555448234,1.32024219011461,1222,4,GHRL|CRHBP|UCN
GLUTATHIONE DEGLYCATION%GOBP%GO:0036531,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
EXTRACELLULAR POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0046379,0.974050046339203,1.0,-0.5117445963828849,-0.6845763495433239,7356,1,HAS3
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV ASSEMBLY%GOBP%GO:0033617,0.653937720217122,0.9640743070248079,0.23776253798970398,0.852902696659018,6866,18,COX20|COX16|BCS1L|PET100|SURF1|TIMM21|COX19|SCO2|COX17|COX18|PET117|SCO1|COA3|COX14|FASTKD3|COA5|COA1
VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0009110,0.8596153846153849,0.9916689277956879,0.23723031176085502,0.676974253676302,8492,9,RGN|RFK|PSAT1|AKR1A1
CONVERSION OF DS SIRNA TO SS SIRNA%GOBP%GO:0036404,0.543758389261745,0.929698169790548,0.7309770621967359,0.9710704159296021,4050,1,DICER1
MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000957,0.8400628436763551,0.98953921193435,-0.348593510455945,-0.7074601723022931,5346,3,PDE12
NEGATIVE REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0033604,0.412126537785589,0.867015886388254,-0.368371419947425,-1.0111548134236499,2344,6,ADRA2C|CRH|ADRA2A
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901185,0.593161402492031,0.9464278097528599,-0.16376252902959001,-0.916696367736063,2046,38,DAB2IP|PTPN3|GRB2|PTPN12|CDC42|DUSP3|SNX6|SOCS5|RAB7A
UDP-N-ACETYLGALACTOSAMINE METABOLIC PROCESS%GOBP%GO:0019276,0.7538233110616179,0.977083996023335,-0.45717536617696003,-0.7819739790992449,5076,2,CSGALNACT1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN-ANGIOTENSIN%GOBP%GO:0001991,0.592081365782782,0.945987625636678,-0.302734975454541,-0.8830913545300829,3259,7,PCSK5|CTSZ|ATP6AP2|ACE
MYELOID LEUKOCYTE ACTIVATION%GOBP%GO:0002274,0.0210970464135021,0.305676452890646,-0.13748132530980098,-1.3094960870175099,4,439,CX3CL1|TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|FCGR2B|RAP2B|SBNO2|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|FOXP1|CAB39|RAP1A|CAMK4|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|SNCA|CPPED1|CD93|CFD|KARS|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CXCL8|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|DYSF|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|TNF|PRSS3|SNAP25|ENPP4
CENTRAL NERVOUS SYSTEM MYELINATION%GOBP%GO:0022010,0.809662186705412,0.984682960940884,-0.24997242140099302,-0.7291806434942819,4457,7,MYRF|PLP1|SOX10|CNTNAP1|PTEN|CLU|TENM4
PHOTORECEPTOR CELL MAINTENANCE%GOBP%GO:0045494,0.47121329211746504,0.8981198447183041,0.291735231856357,0.9891609850648471,4877,15,PCDH15|IQCB1|ADGRV1|CDH23|BBS10|NPHP3|BBS1|SPATA7|BBS2|DRAM2|BBS4
POSITIVE REGULATION OF CD24 BIOSYNTHETIC PROCESS%GOBP%GO:2000560,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
LENS FIBER CELL APOPTOTIC PROCESS%GOBP%GO:1990086,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
NEGATIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000587,0.670384917517675,0.964618776001639,-0.41182309473916395,-0.835782734971635,4266,3,LRP1|PTPN2|PTPN12
FLAVIN-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042726,0.9979395604395601,1.0,-0.17604235605559196,-0.44563953454098904,5811,5,RFK|VCP|SLC52A2|FLAD1|ACP5
POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905278,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
ENDOCARDIAL CUSHION CELL FATE COMMITMENT%GOBP%GO:0061445,0.35350191976698,0.842847021021096,-0.822838553153948,-1.1007362206912,2669,1,ACVR1
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:1904694,0.557980697847068,0.936434965680841,-0.5385166804521639,-0.9211039408048449,3757,2,DOCK4|DOCK5
REGULATION OF RNA-DIRECTED 5'-3' RNA POLYMERASE ACTIVITY%GOBP%GO:1900259,0.286508672050841,0.7957186177819849,-0.856693868548743,-1.14602550833473,2163,1,EIF4A2
VESICLE TARGETING%GOBP%GO:0006903,0.9416873449131509,1.0,-0.100703989578494,-0.693912215608333,2276,78,TRAPPC2L|TRAPPC6A|TBC1D20|CEP19|FAM91A1|NAPA|RAB1A|YKT6|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
"DNA DAMAGE RESPONSE, DETECTION OF DNA DAMAGE%GOBP%GO:0042769",0.908078238750987,1.0,0.147285571610697,0.6452811018701771,10352,35,MRPS11|RFC4|PNKP|DTL|POLD1|POLD3|DDB1|CUL4B|MRPS9|UBE2B|RBX1|RFC3|RFC5
POSITIVE REGULATION OF CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903676,0.758120805369128,0.977664504547119,0.623897220996912,0.8288196240660359,5647,1,NCK1
NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009117,0.9927763391031759,1.0,0.09360294959739698,0.624613286939906,14567,396,ACSM3|HACD1|CROT|GPHN|NPR2|ACSF2|NDUFA7|OXSM|IMPDH1|NDUFS7|TDG|HSD17B4|NDUFA4|NUDT17|PARP16|CD38|RRM1|SCD5|ELOVL6|MYH3|ATP5G1|DNPH1|NDUFS2|ADCY8|RBKS|COX5A|DGAT1|PDE2A|TEFM|NAPRT|FAR2|ACBD6|COA6|ATP5D|MVD|NNT|MTHFD1|SLC35B3|NDUFC1|NDUFAF1|NDUFS4|MBD4|TAZ|ME1|PNKP|CAD|ACOT1|PARP1|AK3|PGLS|MT-ATP8|SLC26A2|IDH1|SULT1A3|PDHX|DTYMK|FAR1|COX6A1|BST1|CTPS2|RFK|ADSSL1|GCK|NDUFS8|RNLS|PDHA1|NDUFB2|DUT|ACOT2|SLC25A1|UQCC3|ACACA|PTGS2|GUK1|DCK|SUCLG1|SMARCAD1|DLD|ACSS1|MCEE|NADK
RESPONSE TO IRON ION STARVATION%GOBP%GO:1990641,0.293128558188799,0.8004058897916541,-0.8533855315394799,-1.1415998450470901,2213,1,EIF2AK1
FRUCTOSAMINE METABOLIC PROCESS%GOBP%GO:0030389,0.940818217926652,1.0,-0.526852668725188,-0.704786878556887,7105,1,FN3K
POSITIVE REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045582,0.337544065804935,0.8319981126097199,-0.191954912144988,-1.08305896713376,1148,39,ZBTB1|IL7|CCL19|IL12RB1|TESPA1|SOCS1|CD46|ZAP70|GATA3|NFKBID|ANXA1|ZMIZ1|XBP1|MYB|FOXP3|PRKCZ|NCKAP1L|LILRB2|ADAM8|MALT1|ZBTB7B|LILRB4|TGFBR2|NFKBIZ|IL18|SART1|C10orf54|RUNX3|CD86|RARA|LGALS9|RUNX1|PNP|NLRP3|SOCS5|BCL6|NKAP|DUSP10|CBFB
ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE%GOBP%GO:1903540,0.666280539174389,0.964618776001639,0.31977290153901194,0.8323016783821,6326,7,LRRC7|STX3|ARHGAP44|SCRIB|STX1B
SPINDLE ASSEMBLY%GOBP%GO:0051225,0.171616893156481,0.674379448319819,0.245142204388376,1.2514191105813002,2108,65,CEP63|RCC1|NUMA1|KIF4A|MAP10|KIF23|KIF11|TUBGCP3|NEK2|HAUS5|WRAP73|INO80|AURKB|GOLGA8A|KIFC1|HDAC3|TUBGCP6|HAUS8|CEP192|CHEK2|TUBGCP2|RACGAP1|GOLGA8N|TUBGCP4|FAM175B|GOLGA8B|TPX2|CCDC69
RESPONSE TO AXON INJURY%GOBP%GO:0048678,0.37022488461160796,0.852609194081082,0.33600328937089396,1.08440750772696,3769,13,RTN4RL1|DHFR|MTR|NREP|DPYSL3|GAP43
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0071169,0.36425863521482704,0.85007225273817,0.41765151065168604,1.0870591335951898,3458,7,LRWD1|H2AFY2|NIPBL|CCDC101
NEGATIVE REGULATION OF CHONDROCYTE PROLIFERATION%GOBP%GO:1902731,0.15109412990621698,0.6474178228659421,0.6744980030521031,1.28214974927543,1304,3,NOV|BMPR1B
"POSITIVE REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0032831",0.7085374907201191,0.9695170059473192,-0.476371657016818,-0.8148082064932479,4771,2,FOXP3|LGALS9
EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097191,0.169594836859089,0.673117535978459,-0.188538454908311,-1.2097181432750501,472,61,DDX47|DDX3X|CASP3|TNFRSF10A|BCL2L1|BOK|BID|CRADD|BAG3|BCL2|TNFRSF10B|GABARAP|TNF|APPL1
CELLULAR RESPONSE TO ACIDIC PH%GOBP%GO:0071468,0.033418089357065,0.37444991734936,-0.569656438901481,-1.66171310563299,183,7,IMPACT|SLC9A1|CHP1|PKD2L1|RAB11FIP5
POSITIVE REGULATION OF MESENCHYMAL STEM CELL MIGRATION%GOBP%GO:1905322,0.354765100671141,0.842911430859438,0.8271945302161451,1.09889102962781,2642,1,FBXO5
MONOSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0046365,0.62464327681719,0.9539083292744209,0.18547939375959002,0.89131177160565,7441,50,FUT9|FUT7|GALM|PGM5|FUT2|FUT8|ALDH1A1|TKFC|GALE
POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1901610,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043949,0.166707346839151,0.6686462511511679,-0.260602593711175,-1.24918862602451,682,24,APLNR|GPR61|ATP2B4|PRKCA|ADCYAP1|RASD2|PDE3A|PDE4D
NEUROTRANSMITTER METABOLIC PROCESS%GOBP%GO:0042133,0.0605387392391003,0.48039389580198294,-0.266040285254286,-1.44619684271514,217,35,ALDH7A1|GCSH|SLC25A32|SDS|SDSL|NQO1|SHMT2|SPR|PAH|DDAH2|NOS3|TRH
POLYOL CATABOLIC PROCESS%GOBP%GO:0046174,0.313978494623656,0.816422962704093,-0.274608829785973,-1.0951645464581201,1459,15,SYNJ2|INPP1|INPP5K|INPP5A|SORD|TPI1
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001911,0.7983209683717299,0.9835585148939309,-0.22959494977324602,-0.741153072364831,4088,9,LGALS9|ARRB2|FCGR2B
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051495,0.5804706914193829,0.942746898746279,0.1573463446446,0.9414776395339599,7941,152,TENM1|NF2|RHOBTB1|EDN1|CTGF|WASH1|AKAP9|CD47|NAV3|CLIP1|CENPJ|RAC3|ACTN2|KATNBL1|PSRC1|EVL|PROX1|SPAG5|TRIM27|CEP295|C15orf62|NUMA1|CDK5R1|SEMA5A|CTTN|CCL21|F2RL1|GPSM2|CDK5RAP2
PROTON-TRANSPORTING TWO-SECTOR ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070071,0.6926988739556851,0.96731875442989,-0.28019856591285197,-0.8173516480474301,3813,7,C7orf55|OXA1L|ATPAF1|TMEM70|TM9SF4|VMA21|ATPAF2
REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903564,0.17870682392586398,0.684608769612821,0.49470537955412897,1.28761416532139,1696,7,CROCC|GAS8|EFCAB7|SDCCAG3|CCDC66|CCDC88A
DENDRITIC CELL CHEMOTAXIS%GOBP%GO:0002407,0.115346337579618,0.593539945084925,0.45331700797566293,1.3829662778707599,1158,11,CXCR4|CCR5|CCL21|CCL5|CCL19
EPICARDIUM-DERIVED CARDIAC FIBROBLAST CELL DIFFERENTIATION%GOBP%GO:0060938,0.7611940298507459,0.977763214485385,-0.377698312537799,-0.766527503385769,4844,3,PDCD4
ENDOTHELIAL CELL CHEMOTAXIS TO VASCULAR ENDOTHELIAL GROWTH FACTOR%GOBP%GO:0090668,0.8044295302013421,0.984565623358542,0.59886413762682,0.7955642896138949,5992,1,GAB1
NAD CATABOLIC PROCESS%GOBP%GO:0019677,0.49848796419499203,0.913423777265461,0.604358334143756,0.9878070944633142,4120,2,NUDT17|NUDT12
INTERLEUKIN-21 PRODUCTION%GOBP%GO:0032625,0.199258572752549,0.711592141628341,-0.8990405822673141,-1.20267399841654,1504,1,FOXP1
POSITIVE REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046638,0.128630705394191,0.6084698977529829,-0.27513248036207,-1.3188370853251101,526,24,RUNX3|CD86|RARA|LGALS9|RUNX1|PNP|NLRP3|SOCS5|NKAP|CBFB
DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0000724,0.186932270916335,0.693783430081947,0.232633709481092,1.2288341195065702,2345,76,MUS81|FBXO18|CDC7|XRCC3|RAD54B|BLM|CDC45|PARP1|TONSL|FEN1|GEN1|POLQ|NABP1|POLN|SLX1B|INO80|MMS22L|RAD51C|RAD51|NIPBL|RAD51AP1|SLX4|SFPQ|EXD2|RMI1|PALB2|BRCA2|XRCC2|GINS2|RECQL5|XRCC1|ZFYVE26|SPIDR|RFWD3|BRCA1|POLL|RAD52|YY1
REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002691,0.509950248756219,0.918404893008545,-0.259447264482064,-0.9451924096464941,2459,12,ICAM1|PLVAP|PLCB1
PEPTIDYL-LYSINE MODIFICATION TO PEPTIDYL-HYPUSINE%GOBP%GO:0008612,0.37256562235393703,0.852609194081082,0.655099284320955,1.0707417835925,3079,2,DOHH|DHPS
TRAVERSING START CONTROL POINT OF MITOTIC CELL CYCLE%GOBP%GO:0007089,0.0879400024192573,0.556718035193165,0.8168734491315139,1.33515721177908,726,2,CDK10|CDC6
NUCLEAR SPECK ORGANIZATION%GOBP%GO:0035063,0.11358574610245001,0.589850135782669,-0.796102606091805,-1.3616908711916997,764,2,DYRK3
DUDP BIOSYNTHETIC PROCESS%GOBP%GO:0006227,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
REGULATION OF RESPIRATORY SYSTEM PROCESS%GOBP%GO:0044065,0.35008591065292105,0.842847021021096,0.447837612139632,1.10139138579262,3259,6,MTG1|TSHZ3|NLGN3|PHOX2B|NLGN2
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002590,0.5820341499628809,0.943249589738259,-0.529197684036394,-0.905164296529193,3919,2,HFE|TAPBPL
DETECTION OF MONOSACCHARIDE STIMULUS%GOBP%GO:0034287,0.966372323696625,1.0,0.368113385361802,0.6016712157076031,7988,2,GCK
REGULATION OF ANIMAL ORGAN FORMATION%GOBP%GO:0003156,0.876990445859873,0.994579112092402,0.21483351526114397,0.655407808962124,8811,11,BMP4|ROBO2|HAND2
REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060390,0.5119859676476319,0.9186348440100149,0.290100395230919,0.9611927601071709,5253,14,NOV|BMP4|FAM89B|DAB2|TGFB3|PBLD|RBPMS|BMPR1A|CILP
NEGATIVE REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090298,0.980805369127517,1.0,0.5117445963828849,0.6798298657496139,7306,1,LIG3
"NUCLEOTIDE-EXCISION REPAIR, PREINCISION COMPLEX STABILIZATION%GOBP%GO:0006293",0.105150613611008,0.578008942587973,0.36552010905861,1.3818608366057,1130,21,GTF2H2|GTF2H1|DDB2|PARP1|DDB1|CHD1L|CUL4B|ERCC5|XPA|RBX1
POSITIVE REGULATION OF DENSE CORE GRANULE TRANSPORT%GOBP%GO:1904811,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
NEGATIVE REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035067,0.866441082802548,0.9929671171385601,0.218068951865835,0.665278384386723,8705,11,SIRT1|TAF7
GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046629,0.499384029566581,0.914249271904946,0.46179844796881103,0.9785950245320709,4458,4,CXADR|AMICA1|MICA|MICB
EXTERNAL GENITALIA MORPHOGENESIS%GOBP%GO:0035261,0.435103423249063,0.878651088001772,0.6284532671629449,1.02718960055665,3596,2,NIPBL|LRP6
DERMATAN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0030208,0.571513002364066,0.9405138747864158,-0.264975095999321,-0.896450411233961,2900,10,CSPG4|NCAN
CARDIAC LEFT VENTRICLE FORMATION%GOBP%GO:0003218,0.454388984509467,0.888760596723902,-0.771890163211292,-1.03258100606152,3431,1,HAND1
NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905049,0.6098418277680141,0.9508825506493929,-0.31619877557774,-0.8679444077657491,3469,6,SORL1|TIMP1|RECK|TIMP3|PICALM|TIMP2
POSITIVE REGULATION OF MOTILE CILIUM ASSEMBLY%GOBP%GO:1905505,0.937181208053691,1.0,0.5344067048963389,0.7099354658813991,6981,1,ZMYND10
RESPIRATORY ELECTRON TRANSPORT CHAIN%GOBP%GO:0022904,0.7299488054607509,0.972554563883587,-0.124975219927662,-0.8734906552251309,1710,83,NDUFB9|CYC1|PPARGC1A|NDUFA9|NDUFS1|NDUFV3|NDUFS5|COX10|SLC25A13|SLC25A18|COX4I2|NDUFS6
URIDINE TRANSPORT%GOBP%GO:0015862,0.236361437038829,0.7504566255368191,0.7157981803143101,1.16995246159742,1953,2,SLC29A2|SLC29A1
SKELETAL MUSCLE SATELLITE CELL ACTIVATION%GOBP%GO:0014719,0.7713491327949159,0.979625229157715,-0.610608734009705,-0.8168299207890071,5825,1,EPHB1
CELLULAR RESPONSE TO ESTROGEN STIMULUS%GOBP%GO:0071391,0.527452563584982,0.9265056012720759,-0.264840481175851,-0.932006649544399,2612,11,RARA|BCAS3|WBP2|ARID5A|SFR1
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:0090324,0.0304791830322074,0.35824396749211296,-0.7945296128818791,-1.61247424283226,193,3,PPIF|SNCA|PDE12
ACTIVATION OF PHOSPHOLIPASE D ACTIVITY%GOBP%GO:0031584,0.673199686415052,0.9647315640607691,0.402836427679976,0.8536488711943929,6010,4,CCL5|ARL1
MALE PRONUCLEUS ASSEMBLY%GOBP%GO:0035039,0.9930201342281879,1.0,0.503749448610499,0.6692086686228289,7397,1,WBP2NL
RESPONSE TO ORGANOPHOSPHORUS%GOBP%GO:0046683,0.257610253815667,0.7682844252550459,0.24507938589793,1.1673220458164,3054,48,CITED1|AKAP9|CRHBP|HCN2|KCNQ1|PKD2|PDE2A|HCN3|HSP90B1|NDUFS4|KCNJ11|IGFBP5|DUOX1|AKR1C1
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0035795,0.19224149344631303,0.7023096717844329,-0.9025143361270401,-1.20732094486856,1451,1,ACAA2
CELLULAR RESPONSE TO INTERLEUKIN-11%GOBP%GO:0071348,0.240963855421687,0.753939620184877,-0.879300838112042,-1.17626754080028,1819,1,SBNO2
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION%GOBP%GO:0086066,0.24853919000604502,0.7613646381106121,0.40791255276625105,1.20385532804118,2466,10,KCNN2|CACNB2|KCNQ1|GJA1|SCN3B
ATRIOVENTRICULAR NODE CELL DIFFERENTIATION%GOBP%GO:0060922,0.13033557046979902,0.612163182799301,0.9357079841199821,1.2430463120106598,970,1,MAML1
"SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0007271",0.15253164556962,0.648319130045528,-0.335261866660592,-1.29889322786702,722,14,CHRNB4|CHRNA5|CHRNB1|ACHE|CHRFAM7A|CHRNB2|CHRNA7|NQO1|CHRNA3
POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071073,0.09748065206652401,0.570215774831708,-0.626153421752744,-1.44002206199958,591,4,ACSL3|FABP3
NEGATIVE REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903011,0.127240773286468,0.6076669536424699,-0.499905386671216,-1.37220672022046,723,6,FBXW7|FAM101B|FAM101A|GREM1
GENERATION OF CATALYTIC SPLICEOSOME FOR SECOND TRANSESTERIFICATION STEP%GOBP%GO:0000350,0.112249443207127,0.587535723436545,-0.797242900468707,-1.36364128365313,755,2,ISY1|PRPF18
REGULATION OF HISTONE H2B CONSERVED C-TERMINAL LYSINE UBIQUITINATION%GOBP%GO:2001173,0.358400635509069,0.846205501155666,-0.819640494044993,-1.09645807951315,2706,1,WDR70
CELLULAR RESPONSE TO WATER STIMULUS%GOBP%GO:0071462,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
LEUKOCYTE AGGREGATION%GOBP%GO:0070486,0.5935181569699339,0.9464278097528599,-0.27362639484586804,-0.883290522811662,3039,9,S100A9|CD44|IL1B|S100A8|MSN
MICROTUBULE SEVERING%GOBP%GO:0051013,0.8607717430748759,0.9916689277956879,0.457347670250896,0.7475222029496209,7115,2,KATNAL1|SPAST
REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060251,0.162689354637892,0.6647664451414079,-0.34064583847839,-1.2828657164786699,783,13,NOTCH1|PRKCH|IL1B|SKI|IL6|ADCYAP1|TNF
CYCLIC NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009187,0.427461139896373,0.876089699952999,-0.222181546567343,-1.00910325689085,1814,21,PDE9A|ADCY2|ADM|PDE4D
REGULATION OF RENAL WATER TRANSPORT%GOBP%GO:2001151,0.28942142195154197,0.7989014598698071,-0.8558116453462729,-1.14484533145803,2185,1,INPP5K
RESPONSE TO METHYLGLYOXAL%GOBP%GO:0051595,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0006919,0.9411333659013191,1.0,0.123169656513473,0.630477409083662,11558,66,IFI27L1|AIFM1|PIDD1|F2R|APAF1|HIP1R|JAK2|ST20|IFI27L2|FAS|F3|NLRC4|RPS27L|BAD|ACER2|CASP9|RIPK1|DAP
SYNAPTIC VESICLE MEMBRANE ORGANIZATION%GOBP%GO:0048499,0.586291857990816,0.9447006447658759,0.432412718219784,0.9163238561227209,5234,4,AP3D1|SYNGR1|SYP|SYNGR2
POSITIVE REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051091,0.00526315789473684,0.16770443270936902,-0.178965041059714,-1.48579147224175,5,184,FZD1|BEX1|PRKCH|IL1B|CLU|IRAK1|VEGFA|TRIM13|MTDH|CX3CL1|BUD31|CTNNB1|LGALS9|IRAK2|PRKD2|IRAK4|HDAC4|PSMA6|CRTC2|NFAM1|MAP3K13|RPS3|CAMK1D|S100A8|SPHK1|HDAC5|BCL10|NKX6-1|UBE2V1|PPAP2B|DDIT3|IL6|PPARG|RNF31|CAMK2A|MAVS|RIPK2|ARID5B|NPM1|ARHGEF2|TNFRSF11A|PPARGC1A|TRIM25|MTPN|NLRP3|UBA52|CFLAR|STAT3|RELN|RBCK1|EDA2R|MYD88|DDRGK1|UBC|CD36|JMY|TNF|UBB
NEGATIVE REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0009996,0.12930086410055,0.6100112725887421,-0.6810411381934489,-1.38215275534275,822,3,MESP1|FZD7|DKK1
NEGATIVE REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043951,0.43560758982640296,0.878651088001772,-0.285113320599394,-1.00334929725445,2157,11,APLNR|ATP2B4|PDE3A|PDE4D
REGULATION OF GENE SILENCING%GOBP%GO:0060968,0.757448494453249,0.977664504547119,0.151072103033208,0.808382985731318,9558,81,HIST1H3E|SIRT1|BMP4|SIRT6|MAP2K2|NAA40|DHX9|HIST2H3C|HIST2H3A|ASF1A|CDC45|POLR2B|TERT|DND1|HIST1H4I|TNRC6A|ATAD2|H3F3A|ELAVL1|POLR2L|ATAD2B|AJUBA|MYCN|POLR2J|PHF2|HIST1H3H|HIRA|POLR2G|POLR2H|CDK2|DDX5
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION%GOBP%GO:0002566,0.524641954507161,0.925993329275615,0.364316719825075,0.9482398787192992,4981,7,EXO1|POLQ|MSH6
REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010799,0.000519885625162464,0.0784645998831315,-0.4486827300049961,-2.29624653804381,1,29,DDIT4|SPHK1|INPP5K|DGKQ|EIF4G1|CEMIP|RIPK2|CAB39|SMAD7|CHI3L1|UBE2K|SPRED2|PARD3
PROTEIN HETEROOLIGOMERIZATION%GOBP%GO:0051291,0.0818393094289509,0.5393915998030421,0.28387694751057896,1.3956191748452902,985,55,HIST1H3E|TMEM120A|MAT2A|MCCC2|CBR4|TMCC1|SEPT11|RCC1|PKD2|HBB|HBA2|IKZF4|HIST1H4I|HBA1|GRIN1|CPSF6|MAGI2|RIPK1|MCCC1|HIST1H3H|HBQ1|RIPK3|CPSF7|WIZ
MITOTIC RECOMBINATION-DEPENDENT REPLICATION FORK PROCESSING%GOBP%GO:1990426,0.555570469798658,0.934566028474918,0.725738861932069,0.9641117005706741,4138,1,BRCA2
DNA LIGATION INVOLVED IN DNA REPAIR%GOBP%GO:0051103,0.108141832172195,0.58452352834625,0.511942192067957,1.3956917612180502,1039,8,C9orf142|LIG4|XRCC4|XRCC1|POLB|HMGB2|HMGB1|LIG3
L-ALPHA-AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1902475,0.23139407244785998,0.744100433749321,-0.28964042487911196,-1.18617488526694,1053,16,SLC25A15|SLC25A13|SLC25A18|SLC3A2|SLC7A1
MITOCHONDRIAL TRNA 3'-END PROCESSING%GOBP%GO:1990180,0.7024351924587591,0.968941691852291,-0.39941546266681394,-0.810601814327738,4470,3,HSD17B10|TRNT1|TRMT10C
REGULATION OF CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002646,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
HISTONE MRNA CATABOLIC PROCESS%GOBP%GO:0071044,0.993586675600651,1.0,0.126770604040121,0.4394793052998979,10379,16,ZCCHC11|PAPD4|XRN1|ATM|ZCCHC6|EXOSC10|TUT1|ERI1|LSM1
NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043320,0.996873914553665,1.0,0.24217441616023605,0.46034808932827004,8609,3,CORO1A|VAMP7
MITOCHONDRION LOCALIZATION%GOBP%GO:0051646,0.863379650380995,0.991943445125448,0.165689963945859,0.6863436256082212,9630,29,MGARP|MARK2|ATP2A1|MYO19|RHOT1
REGULATION OF BLOOD PRESSURE%GOBP%GO:0008217,0.43609756097561003,0.878651088001772,0.198888972845059,1.02142378688712,5363,67,CARTPT|ACSM3|PLCB3|EDN1|NPR2|OXTR|F2R|GNB3|ERAP1|PTPRO|AGTR1
REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0060696,0.265893470790378,0.779649746770441,0.48109724569271706,1.1831886107174598,2475,6,SCARB1|IDH1|APOC1|LDLR|APOC2
REGULATION OF VASCULAR PERMEABILITY INVOLVED IN ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002528,0.198743126472899,0.711592141628341,-0.620161023491783,-1.2585983713833702,1264,3,C2CD4B|CTNNBIP1|C2CD4A
IRON ION HOMEOSTASIS%GOBP%GO:0055072,0.9937600134918628,1.0,0.0967084791207058,0.46062601014510207,11784,48,TFR2|BDH2|FLVCR1|ABCB6|CAND1|SLC46A1|SLC40A1|NEO1|FAM132B|TF|ACO1|ISCU|ATP6AP1|ABCB7|IREB2|ATP6V0A2|ATP13A2|CYBRD1|TMEM199|HAMP|NDFIP1
PLASMA LIPOPROTEIN PARTICLE ORGANIZATION%GOBP%GO:0071827,0.17754711827369601,0.682851329709864,0.31929501366184493,1.2723446987548102,1949,25,LPL|ZDHHC8|ABCA7|ABCA5|DGAT1|AGTR1|SCARB1|SOAT1|CETP|APOE|APOC1|APOM|LCAT
TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:0043247,0.8436429578883741,0.991298302704726,0.232993286283295,0.687623381991631,8373,10,DCLRE1A|DCLRE1C|RIF1|ACD|TFIP11|RTEL1|TERF2IP|DCLRE1B|APEX1|TERF2
POSITIVE REGULATION OF AORTIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1904831,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
ENTRY INTO HOST CELL%GOBP%GO:0030260,0.38370253164557,0.8582519754973359,-0.200730186550715,-1.04139464068271,1454,30,PPIA|VAMP8|CD4|WWP2|CD81|GAS6|PVRL1|ITCH|PVRL2|ZNF639|CBLL1|CTNNB1|GRB2|CAV2|MET|CAV1
URONIC ACID METABOLIC PROCESS%GOBP%GO:0006063,0.6771528998242529,0.9647315640607691,-0.29961775373439004,-0.8224306161399529,3852,6,SORD|XYLB
REGULATION OF BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904863,0.316510067114094,0.8176737565328901,0.8458314953683279,1.12364940637852,2357,1,DACT1
INTRACILIARY TRANSPORT%GOBP%GO:0042073,0.0249920911104081,0.329326373353219,-0.264250931920635,-1.57827645814115,78,47,LCA5|TTC21A|IFT74|IFT52|IFT27|IFT22|IFT88|TTC26|RABL2B|IFT57|DYNC2H1|IFT46|IFT122|WDR35|IFT172|RPGR|DYNLRB2|WDR19|TRAF3IP1|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B
EOSINOPHIL CHEMOTAXIS%GOBP%GO:0048245,0.9630772292993629,1.0,0.17574984170713398,0.5361724800652959,9676,11,CCL5|CCL2|CCL11|CCL4L2|CCL4|CCL8|CCL24
D-RIBOSE METABOLIC PROCESS%GOBP%GO:0006014,0.6077174307487601,0.9508825506493929,0.5636062861869311,0.921198991602131,5023,2,RPIA|NUDT5
RESPONSE TO PH%GOBP%GO:0009268,0.309769484083425,0.812108979880576,-0.268214770392731,-1.09842962918689,1410,16,IMPACT|SLC9A1|CHP1|HVCN1|PKD2L1|RAB11FIP5
PYRIMIDINE NUCLEOBASE TRANSPORT%GOBP%GO:0015855,0.547785234899329,0.9305779599215391,0.7293228936921041,0.968872926868888,4080,1,SLC29A2
CYSTEINE METABOLIC PROCESS%GOBP%GO:0006534,0.355060728744939,0.8429129485012808,0.383402260978256,1.09409905318174,3507,9,CTH|GGT1|CDO1|GGT5
POSITIVE REGULATION OF SALIVA SECRETION%GOBP%GO:0046878,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
REGULATION OF SINGLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:0060380,0.631140939597315,0.9575013258325501,0.6890163211292459,0.915327443422818,4701,1,ACD
NEGATIVE REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031057,0.9829783360640821,1.0,0.12409343999567,0.49891506876709296,10798,26,SIRT1|MTF2|TAF7|DNMT3B|JARID2|SUPT6H|BRCA1|DNMT1|PHF1|UBR5
REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000779,0.478883554398242,0.9046812288131709,0.19419775448293,0.991354311258848,5884,65,FBXO18|MMS19|SIRT6|BLM|FAM178A|POLQ|RAD51|RTEL1-TNFRSF6B|RMI2|TIMELESS|PARPBP|RAD51AP1|WRAP53|KDM1A|NUDT16L1|ANKRD32|RIF1|C5orf45|CHEK1|RECQL5|SPIRE2|SPIRE1|FOXM1|SPIDR|FMN2|FIGN|FAM35A|PARP9|UBR5|SETMAR|MAGEF1|MGMT|TP53BP1|WAS|DDX11|AUNIP
CENTRIOLE ELONGATION%GOBP%GO:0061511,0.3948227894036529,0.8638039247684692,0.644609870416322,1.05359712472644,3263,2,CENPJ|C2CD3
POSITIVE REGULATION OF MRNA BINDING%GOBP%GO:1902416,0.00944424264438794,0.21235063347774397,-0.641099139109241,-1.8701146317633301,51,7,EIF3D|CDK9|EIF4G1|FMR1|LARP6
REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900027,0.9710712239831959,1.0,0.14830349529345999,0.523045011017754,10170,17,SH3YL1|EVL
MINUS-END-DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072385,0.221472089576815,0.73556947110949,-0.5290458662789861,-1.2166949708888601,1344,4,RAB6A|BICD1
POSITIVE REGULATION OF TORC1 SIGNALING%GOBP%GO:1904263,0.847370542010881,0.991298302704726,0.23182409305685897,0.6841727907175711,8410,10,KLHL22|RRAGB|CLEC16A|TELO2|LARS
PEPTIDYL-CYSTEINE MODIFICATION TO L-CYSTEINE PERSULFIDE%GOBP%GO:0098822,0.33019992056136604,0.8291761235173739,-0.836733568592854,-1.11932400649929,2493,1,MOCS3
SPHINGOID METABOLIC PROCESS%GOBP%GO:0046519,0.00370948848106209,0.143595610377104,-0.62491978430621,-2.01729706414512,18,9,SPHK1|SGPP2|ACER3|KDSR|ASAH2|ASAH2B
NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050859,0.6751373626373629,0.9647315640607691,-0.32544319337132505,-0.8238378334798651,3931,5,CD22
NEGATIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902576,0.458751852461716,0.890371861972445,-0.42701711117894203,-0.9820501487123071,2785,4,TERF2|BCL6
APOLIPOPROTEIN A-I-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038027,0.5122634113562551,0.9187344981016821,0.456724303158003,0.967842426970402,4573,4,ABCA7|ITGB3|ITGAV
SUBSTRATE-INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION%GOBP%GO:0021843,0.196485061511424,0.7100128962886071,-0.45487072671987494,-1.24858960251031,1117,6,DRD2|SLIT3
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060441,0.4347110159723371,0.878651088001772,-0.43579423368498205,-1.00223569687108,2639,4,CTSH|FGF10
NEURON PROJECTION REGENERATION%GOBP%GO:0031102,0.269210772590205,0.784543299601953,0.431320138917938,1.1758944147648602,2588,8,RTN4RL1|DHFR|MTR|NREP|GAP43
NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045869,0.45157967032967,0.886411023801201,-0.389035958526362,-0.984818695693025,2629,5,APOBEC3D|APOBEC3C|APOBEC3G|APOBEC3F|INPP5K
SNARE COMPLEX ASSEMBLY%GOBP%GO:0035493,0.8282108389012621,0.9876441563834109,-0.427405569341053,-0.7310543359797621,5577,2,VAMP4|UVRAG
EXON-EXON JUNCTION COMPLEX DISASSEMBLY%GOBP%GO:1903259,0.3113994439295639,0.8143712300420921,-0.844783855315395,-1.13009312049922,2351,1,WIBG
PROTEIN LOCALIZATION TO CYTOSKELETON%GOBP%GO:0044380,0.162246351014596,0.664367762084791,0.305496406962797,1.2913311227415,1822,31,CEP83|CCDC14|GOLGB1|SPAG5|KIF20B|CEP131|STIL|ANLN|MID1|CEP192|MID2|PCM1|FAM83D|C2CD3|HOOK3|CHAMP1|SNX10|PIBF1
NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010868,0.197772828507795,0.711592141628341,-0.7392886683209259,-1.26451367339449,1331,2,SIK1|FBXW7
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071636,0.9448384554767529,1.0,-0.177187474166452,-0.599451746523489,4795,10,FURIN|LGALS9|ATP6AP2|SERPINF2
MORPHOGENESIS OF AN EPITHELIAL BUD%GOBP%GO:0060572,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
ATP-DEPENDENT CHROMATIN REMODELING%GOBP%GO:0043044,0.45821138211382106,0.890371861972445,0.19604100681990802,1.00679763541818,5635,67,RBBP7|MBD3|MTA2|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|INO80|CENPQ|CENPI|SMARCAD1|MIS18BP1|NASP|HJURP|STRA13|CENPM|SMARCA4
POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034393,0.15940246045694198,0.661359103221672,-0.477271973165252,-1.31007951986917,906,6,MFN2|PPARG|SOD2|PDCD4
NCRNA PROCESSING%GOBP%GO:0034470,0.0035714285714285704,0.143595610377104,-0.171011006575426,-1.5401903533416799,1,294,NAF1|UTP15|C1D|THUMPD1|TSR3|FTSJ2|WDR12|KIAA1456|METTL1|PES1|METTL16|RRP1|AARS|RPS28|CPSF3|ISG20L2|MPHOSPH6|RPF2|ADAT1|RPL35|NSUN5|UTP3|RPL7|C9orf64|TRMT12|EXOSC6|POP5|MOCS3|RRP36|RNF113A|RPS9|KIAA0391|RPL14|DHX37|GAR1|DDX47|ZNHIT6|TSEN2|FARS2|EXOSC4|TRMT61B|NOB1|NSUN3|PAPD7|NHP2L1|TRMT112|SMAD1|NOLC1|WBSCR22|SMAD2|SBDS|GLTSCR2|RTCB|ELP3|PWP2|URM1|TBL3|CDKAL1|SRFBP1|RPUSD2|RCL1|RSL1D1|DPH3|FCF1|RPL35A|NSUN2|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|KARS|RRP7A|KRI1|AGO2|NOL10|PIH1D2|RRS1|CIRH1A|MRTO4|BYSL|IMP4|TSR1|NOL9|SARS|TSR2|RNMTL1|RPP14|WDR4|LYAR|EMG1|RRP9|RPF1|NOP14|NOP56|EXOSC5|TRDMT1
NEURON MATURATION%GOBP%GO:0042551,0.936174911660777,1.0,-0.149676392559617,-0.6298210445121939,4238,17,SCARF1|RND1|CX3CL1|ANKS1A|EPHA8|MTCH1
GALACTOLIPID CATABOLIC PROCESS%GOBP%GO:0019376,0.934992718125248,1.0,-0.5296647551830611,-0.7085486923513821,7061,1,GALC
CELLULAR RESPONSE TO LITHIUM ION%GOBP%GO:0071285,0.148032665181886,0.6402258061318559,-0.768072787427626,-1.31374736754768,996,2,CDKN1B|ADCY7
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM TUBULAR NETWORK%GOBP%GO:1903420,0.5256375838926179,0.9265056012720759,0.7409572121746801,0.984328599929244,3915,1,GBF1
CAAX-BOX PROTEIN PROCESSING%GOBP%GO:0071586,0.36724325632031,0.851186780857897,0.6575339481300461,1.07472117470433,3035,2,RCE1|ZMPSTE24
EVASION OR TOLERANCE OF HOST DEFENSES%GOBP%GO:0044415,0.137313432835821,0.62388141596544,-0.6736517039814711,-1.3671561181592802,873,3,TGFB1|SMAD3|EIF2AK2
'DE NOVO' NAD BIOSYNTHETIC PROCESS FROM ASPARTATE%GOBP%GO:0034628,0.1057344854674,0.578674426247723,-0.705390123917884,-1.43156829843036,672,3,NMNAT3|NMNAT2
ORGANELLE LOCALIZATION%GOBP%GO:0051640,0.924555111983219,1.0,0.113761869758812,0.7677363089303578,13663,456,TMEM216|SYT17|CEP83|KIF25|GRIA1|AKAP9|RIMS2|NR4A3|CNIH3|MGARP|SHROOM2|SDCCAG8|CEP63|ASPM|IQCB1|CEP70|CENPJ|CCNB1|UNC13B|PSRC1|CDK1|KIF14|GEM|SYT3|SAPCD2|PREB|CENPF|AHI1|KIF2C|DNM3|KIF18A|RAB3IP|MARK2|CKAP5|CEP290|BET1|ATP2A1|FNBP1L|MYO19|CEP131|CEP152|NUMA1|PEX1|MKS1|WDR11|UNC13A|KIF24|RHOT1|DYNLT1|NUF2|TRAPPC5|DLGAP5|NEK2|CDC23|CPLX3|HAUS5|NDC80|DCTN4|AP3D1|CENPA|MAP6|GPSM2|SPG11|NUSAP1|CDK5RAP2|AP3B2|CENPE|PRKAR2B|CEP55|ESPL1|CEP162|KIFAP3|BBS5|KIT|DOCK7|ABCE1|BOD1|C9orf114|CEP72|PCLO|KIFC1|CDCA8|CENPQ|SEC31A|SPDL1|KIF22|ASUN|SNAP47|PRRT2|CDCA5|USO1|HAUS8|CNIH2|CEP164|CEP78|STX2|HDAC6|CEP192|ARL6|SYNE2|SEC24D|FGFR1OP|MYO5A|RAB27B|CEP97|CNTRL|NPHP4|PLK1|CTSC|RAB3B|GBF1|SFI1|SYTL2|RPS15|AP3S1|CEP41|CEP57|SEC24C|DYNC1H1|NINL|DEF8|SYT1|SEPT5|LLGL2|COPG2|TMED9|KLHL12|RIMS4
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:0003299,0.914100123194087,1.0,0.300610484309057,0.6370223320605171,8161,4,TCAP|INPP5F
POSITIVE REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904744,0.985746102449889,1.0,-0.311000827129859,-0.5319502586667341,6638,2,ACD|PINX1
DISACCHARIDE CATABOLIC PROCESS%GOBP%GO:0046352,0.742013422818792,0.974505008828563,0.632112924569916,0.83973381973425,5527,1,ATHL1
L-THREONINE CATABOLIC PROCESS TO GLYCINE%GOBP%GO:0019518,0.483267871170464,0.9061819762742349,-0.474679818361231,-0.9633485880073441,3075,3,SDS|SDSL
PROTEIN DESUCCINYLATION%GOBP%GO:0036048,0.9663709784191709,1.0,-0.515659461843847,-0.6898133844337,7298,1,SIRT5
PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0099171,0.4657718120805371,0.8939277899536601,0.772331274812528,1.02600764244746,3469,1,RAB26
POSITIVE REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901899,0.9768303985171459,1.0,-0.510752095280106,-0.6832486505570319,7377,1,CHGA
CEREBRAL CORTEX TANGENTIAL MIGRATION USING CELL-CELL INTERACTIONS%GOBP%GO:0021823,0.351447661469933,0.842847021021096,-0.6487455197132621,-1.1096444668819399,2366,2,SLIT2|ROBO1
PHOSPHATIDYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046471,0.7754966887417221,0.9805314293977441,0.206670042150346,0.7554106246243849,8196,19,LPCAT4|PLA2G4A|TAZ|LPGAT1|PLA2G2D|PLA2G12A|PLA2G4B|SERAC1|TAMM41|CRLS1|PGS1|LCLAT1|SLC27A1
CELLULAR RESPONSE TO HISTAMINE%GOBP%GO:0071420,0.11131236621109801,0.5855068018166539,-0.609142691556068,-1.40090093621324,675,4,GABRG2|HRH1
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009140,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009132,0.00205640423031727,0.115553415806697,-0.368485091563252,-2.07908762642783,6,39,CMPK2|LDHA|ENTPD4|CMPK1|PFKL|GPI|PKM|ENO1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|AK7|ALDOA|PGAM2|AK4
ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009066,0.569564009997223,0.940076901516441,-0.170764726506781,-0.928278242090943,2050,35,MTRR|SDS|ASS1|SMS|SDSL|GCDH|NMNAT3|NMNAT2
L-PROLINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1904555,0.803221476510067,0.984522820758988,0.5993052492280551,0.796150286696752,5983,1,SLC36A4
RESPONSE TO DOPAMINE%GOBP%GO:1903350,0.182164911006175,0.6875189360012,-0.436026283633156,-1.2719080140845602,1002,7,ATF4|ABL1|MAPK3|PARK2
NUCLEOTIDE TRANSPORT%GOBP%GO:0006862,0.922533014453572,1.0,0.22284519484851104,0.607535786844876,8871,8,SLC25A19|SLC25A42
HAIR CYCLE PROCESS%GOBP%GO:0022405,0.543230497150717,0.929698169790548,0.29668771105343295,0.9352656914006271,5528,12,CDH3|TGFB2|APCDD1|FGFR2|HDAC2|ATP7A|SOX18
PARAXIAL MESODERM FORMATION%GOBP%GO:0048341,0.37449664429530205,0.852609194081082,0.8182620202911339,1.08702458869995,2789,1,LEF1
SUCCINATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071422,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
BONE DEVELOPMENT%GOBP%GO:0060348,0.32468495181616,0.8261034701225122,-0.162723939706551,-1.08299105006204,875,68,SCARA3|SH3PXD2B|COL14A1|FOXC1|COL6A2|VWA1|DLX5|LRP5|RARA|SKI|DYM|ZNF385A|RHOA|COL6A1|SBDS|IGF1|FOXP1|AKAP13|RYR1|COMP|COL21A1|GNAS|TWIST1|SULF2|STC1
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0060372,0.655280546533766,0.9640743070248079,0.40826019609948405,0.865142354580683,5850,4,KCNQ1|CACNA1D
MONOUBIQUITINATED HISTONE DEUBIQUITINATION%GOBP%GO:0035521,0.603161534661617,0.9508825506493929,-0.379323977210276,-0.8723659040290591,3662,4,ASXL1|USP16|BAP1
CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:0044331,0.0864711447492905,0.5512119431073901,0.390989454466958,1.4291262775548703,913,19,CDH4|CDH6|CDHR2|CDH10|CDH3|CDH2
REGULATION OF MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034127,0.603886669088267,0.9508825506493929,-0.3003861003861,-0.876239581745335,3324,7,TICAM2|TLR4|CD14|IRF7|SARM1|LY96|TICAM1
REGULATION OF WNT PROTEIN SECRETION%GOBP%GO:0061356,0.839966130397968,0.98953921193435,0.467734821333998,0.7644997160432191,6943,2,WLS|PTPN23
INTRACILIARY ANTEROGRADE TRANSPORT%GOBP%GO:0035720,0.672571494731967,0.9647315640607691,0.454883775395746,0.86468620505028,5808,3,ICK|IFT52|TTC26
REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902950,0.11006175081728999,0.584830174998513,-0.481076895393974,-1.4033226473047098,605,7,FYN|FCGR2B|PRNP|HOMER1
QUINOLINATE CATABOLIC PROCESS%GOBP%GO:0034213,0.650335570469799,0.963755998259649,0.68052492280547,0.9040469995778191,4844,1,QPRT
TIRAP-DEPENDENT TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0035665,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
FOLLICULAR B CELL DIFFERENTIATION%GOBP%GO:0002316,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
CELLULAR HOMEOSTASIS%GOBP%GO:0019725,0.8547031715912171,0.991298302704726,0.12231218360270402,0.8229785301523359,12611,438,CARTPT|THADA|TAC1|RYR2|CHRNA10|CALB1|SIRT1|EDN1|RGN|CXCL13|GHRL|SLC12A2|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|PRKAA2|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|CXCR4|GLRX2|IDE|UNC13B|F2R|DMXL2|CXCL9|OCM|AGER|GNB3|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|ERN1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|C1QTNF3|CDH23|HSP90B1|PDPK1|RFC4|CACNA2D1|ABCB6|PTGER1|DNA2|RHOT1|EGLN2|TMEM178A|PRDX4|POLD1|KRIT1|MT1E|TYRO3|CCR5|PTH1R|FEN1|CCL21|F2RL1|JPH4|POLD3|CCL5|ATP2B3|ATP7B|CAND1|POLA2|XPR1|SLC39A7|SLC46A1|GCK|DMPK|SLC40A1|GRIN1|CCL19|CXCL10|CCL2|ATP2A2|TCIRG1|SRF|NFE2L2|PLCG1|C3AR1|SLC39A13|SLC6A2|TAOK1|MT2A|ORMDL1|CALB2|CD55|FAM132B|TF|DRD4|DLG4|DMD|TRPC1
CELL CYCLE ARREST%GOBP%GO:0007050,0.880091533180778,0.9956508825790341,0.12772110402262,0.7260607808518729,11537,112,CDK6|PRKAA2|INHA|MAP2K6|MAPK12|CDKN2C|PKD2|ERN1|CDKN3|KIF20B|DHCR24|TGFB2|CDKN2A|STRADA|APC|PRR11|STRADB|RB1|PPP2R3B|HRAS|CDKN2B|STK11|APBB1|RRAGB|CDK7|MAGI2|TP53INP1|PRKAB2|EIF4G2|RNF112|E4F1|WDR6|DUSP1|LAMTOR4|FAP|THBS1
POSITIVE REGULATION OF CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0090321,0.9067114093959731,1.0,0.548577415086017,0.728760622168183,6754,1,GPIHBP1
VENOUS ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060843,0.43148417847213,0.8785877309899279,-0.7824217026907809,-1.04666936752718,3258,1,NOTCH1
MO-MOLYBDOPTERIN COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0006777,0.670511815432859,0.964618776001639,0.403598796689159,0.8552644039501321,5986,4,GPHN|MOCS2
ADENYLATE CYCLASE-MODULATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007188,0.000510204081632653,0.0784645998831315,-0.240101669440048,-1.78391764635906,0,106,GNA13|ADCY7|OXER1|ADRA2C|GNAZ|LPAR1|UCN2|PTGFR|CRHR1|MARCO|GNAQ|CALCRL|GNAI2|ADRA1B|PSAP|GNAL|GNA15|HTR1B|VIP|ABCA1|GCGR|RAMP2|AKAP13|HRH3|ADRB2|MC4R|GPR161|GPR3|CALCB|ADCY2|ADCYAP1|DRD2|GNA12|MCHR1|UCN3|ADRA2A|GNAS|CHRM1|ADM|PDE4D|GRM8|RAMP1
EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:0060287,0.0933229207340882,0.5622489437340121,-0.44185864573835204,-1.42635930434609,477,9,LRRC6|CCDC103|DNAAF1
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY%GOBP%GO:0007167,0.00483091787439614,0.161608827499482,-0.18710891712763,-1.8085592321278,0,473,PTPRG|DGKD|F11R|DAB2IP|IGF1R|SKI|TGFBR1|ANOS1|ABI1|RGMA|BCAR1|PTK2B|ANKS1A|ACVR1|FOXO4|ARRB2|DDIT4|GDF15|PRKD2|GRB2|PTPRU|TMEM100|LIF|FGR|EIF2AK3|ABL1|VAV1|MYO1C|TRIO|FAM83G|RET|CYFIP2|CITED2|FGF7|FYN|RHOA|CUL5|BMP8B|STUB1|NRP1|MMP2|SMAD6|KLF10|FOXO1|CASP3|HNRNPF|CPNE3|FGF2|UBASH3B|HGF|ATP6V0C|CDH5|PXN|ATP6V1F|HBEGF|SMAD1|LYN|MMP9|SMAD2|EFNA1|ARPC5|MST1R|YES1|NAMPT|CDC37|CHRDL1|SHOC2|HAP1|PTPN12|POLR2A|IGF1|FOXC2|CRK|PTPN1|VAV3|SMAD7|VAV2|ARPC4|CDC42|FGFR1|AP2S1|SHB|ATOH8|POLR2K|PDCD4|ADAM17|ADRB2|CHRNA3|FLRT1|STAT5A|RAPGEF1|SHC1|JUN|UBA52|ATP6V1E2|ID1|ATP6V0D1|PRKCA|POLR2F|STAT3|EPHA8|ZYX|UBE2D3|MAPK3|NCBP2|CAV2|FLT1|POLR2I|POLR2D|ATP6V1E1|FGF10|BDKRB2|EPHA7|SDC2|ACVRL1|EFNB1|RHOQ|RAC1|PLCB1|IGF2|CD3EAP|ACTR2|BRK1|UBC|PGF|PIK3R1|SULF2|SPRED2|GFRA2|FKBP1A|EPHB2|FOXO6|ANGPT2|PAK2|PARD3|INHBB|UBB|APPL1|FOXO3
REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:2000785,0.0140369118793865,0.25772205946177396,-0.332559271311671,-1.7019555788012901,53,29,SEC22B|PINK1|IFT20|SCFD1|KIAA1324|PIKFYVE|FEZ2|RAB3GAP2|MTMR3|LRSAM1|NPRL2|RAB1B|C9orf72|PIP4K2C|NPRL3|PHF23|SMCR8|FEZ1|CHMP4A|UBQLN2|IFT88|RAB3GAP1|TBC1D14|SH3GLB1|PIP4K2A|RALB|RAB5A|CHMP4B
THYROID HORMONE GENERATION%GOBP%GO:0006590,0.746671297904365,0.9749763305090959,0.42652969451496103,0.81078808003326,6448,3,DUOX1|CPQ|DIO2
PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:0007039,0.8575428379437791,0.99166790097654,0.32669718193349107,0.692302536257886,7656,4,TCIRG1|TMEM199|LAMP2|CCDC115
RESPONSE TO HYPEROXIA%GOBP%GO:0055093,0.10044459081178998,0.570947005522165,-0.6212369099728149,-1.4287151120010302,609,4,FOXO1|ATG7|CAV1
POSITIVE REGULATION OF PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:1903006,0.8711210096510771,0.9934031064448321,-0.4037702671392729,-0.690627417389435,5866,2,GLTSCR2
PROTEIN LOCALIZATION TO M-BAND%GOBP%GO:0036309,0.59416958993589,0.946977439989247,0.5691756272401429,0.930301926554857,4911,2,OBSCN|ANK2
CARDIAC VASCULAR SMOOTH MUSCLE CELL DEVELOPMENT%GOBP%GO:0060948,0.128285077951002,0.608160579951936,-0.7824648469809761,-1.33836421462428,863,2,NOTCH1|VEGFA
RESPONSE TO COPPER ION%GOBP%GO:0046688,0.707275157532939,0.9695156155378671,0.22985368059716002,0.8106607377156991,7407,17,MT1F|ATP5D|MT1E|ATP7B|LOXL2|MT2A
REGULATION OF CELL SIZE%GOBP%GO:0008361,0.247227356746765,0.7594820480683381,-0.157027862385158,-1.1289463884105402,534,93,DNM2|RTN4|RAP1GAP2|ABL1|VAV1|SEMA3F|MAP3K13|RHOA|NRP1|SEMA7A|POU4F2|LAMTOR5|ISLR2|LIMK1|VAV3|VAV2|MSN|SEMA6B|MTPN|TWF2|ANO6|SLC9A3R1|SEMA3A|RAC1|SEMA3G|OLFM1|AQP1
LONG-TERM MEMORY%GOBP%GO:0007616,0.218378483726369,0.7341474817293291,0.374168876554313,1.23973776359443,2240,14,CALB1|KAT2A|RGS14|CPEB3|APOE|LDLR|NPAS4|SHANK1
MESSENGER RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:1990120,0.865671641791045,0.9929621872628821,-0.33817722306036196,-0.6863206265144489,5509,3,NUDT21
NEGATIVE REGULATION OF FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:1901194,0.791605984377069,0.9819233677232551,-0.601179973533304,-0.804216780419229,5978,1,RPL13A
VESICLE TETHERING TO ENDOPLASMIC RETICULUM%GOBP%GO:0099044,0.45675577597677497,0.889502869937838,0.6205128205128211,1.01421115864385,3775,2,STARD3NL|STARD3
MULTI-ORGANISM TRANSPORT%GOBP%GO:0044766,0.0363545816733068,0.384708132326922,-0.318600538872845,-1.56442208693075,145,26,UBA52|CAV2|RAB7A|THOC7|UBC|CAV1|UBB
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION IN MUCOSAL TISSUE%GOBP%GO:2000558,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
RESPONSE TO INCREASED OXYGEN LEVELS%GOBP%GO:0036296,0.1980218005652,0.711592141628341,-0.35220963104694897,-1.23946957320084,980,11,FOXO1|ATG7|ATP6V0D1|CAV1
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035358,0.125315922493682,0.607607158836689,0.5268950113171429,1.37139701375513,1189,7,SIRT1|LMO3
MULTIVESICULAR BODY-LYSOSOME FUSION%GOBP%GO:0061763,0.48448403860430606,0.9064456896937672,-0.570223325062035,-0.9753364583107621,3262,2,CHMP3|CHMP2B
TIGHT JUNCTION ASSEMBLY%GOBP%GO:0120192,0.5499293452661329,0.931359181171847,-0.20413119140498898,-0.927122226225697,2334,21,PDCD6IP|ARL2|RAB13|F11R|STRN|PARD6B|RAMP2|DLG1|PARD3
POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905167,0.543365186887626,0.929698169790548,0.5882547559966921,0.9614862383731079,4491,2,LDLR|LRP1
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900017,0.11030640668523699,0.584830174998513,-0.450413061459897,-1.4000799082130502,593,8,KARS|TICAM1|MYD88
POSITIVE REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016239,0.0162265351574928,0.27144206943761495,-0.271745713616313,-1.63357726967657,50,48,MFN2|SH3GLB1|PIP4K2A|BAG3|ADRB2|PAFAH1B2|RALB|HTT|PARK2|SPTLC1|BNIP3L|HSPB8|SESN2
TETRAHYDROFOLYLPOLYGLUTAMATE BIOSYNTHETIC PROCESS%GOBP%GO:0046901,0.157950483251688,0.6597808951153779,-0.9181737979708872,-1.22826908443007,1192,1,FPGS
CIRCADIAN RHYTHM%GOBP%GO:0007623,0.143161482743928,0.632949331968897,-0.17489804158360098,-1.22817902050695,335,84,PML|DYRK1A|MYBBP1A|CCRN4L|PPARA|RELB|ASS1|NAMPT|PER3|KDM5A|CIART|TNFRSF11A|NRIP1|PPARGC1A|ID1|NDUFA9|TP53|KLF9|DRD2|PER2|PPP1CB|USP2|NR1D1
NEGATIVE REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000645,0.123487824037706,0.607607158836689,-0.686141399601527,-1.39250358433503,785,3,FURIN|MTMR2
NEGATIVE REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902823,0.722229577651264,0.971401508276304,-0.6338773709748571,-0.8479570859120851,5454,1,VPS35
REGULATION OF HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070366,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903959,0.27376352395672304,0.7884684708511421,0.34519656478270394,1.17042762332383,2833,15,STK39|ANO9|GOPC|TCAF1|RIPK1|AKT2|THBS1|AKT1|ABCB1|ARL6IP5
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001244,0.000284900284900285,0.0784645998831315,-0.461468535838219,-2.5634375950239,0,37,BAX|SOD1|FBXW7|BCLAF1|MSX1|RPS3|S100A8|DDIT3|DFNA5|BCL2L1|BOK|BID|BCL2|TP53|BMF|SLC9A3R1|BCAP31|BCL2L11|PMAIP1|CAV1|UBB
FORMATION OF RADIAL GLIAL SCAFFOLDS%GOBP%GO:0021943,0.685738478287166,0.9665006495129341,0.53471188309898,0.8739718835305609,5668,2,LEF1|ARL13B
RESPONSE TO TYPE III INTERFERON%GOBP%GO:0034342,0.7520261279787109,0.9769690538700708,0.505982905982906,0.827015159665508,6216,2,IFNLR1|C19orf66
ENDOTHELIAL CELL FATE SPECIFICATION%GOBP%GO:0060847,0.0686567164179105,0.5037729184803449,-0.743410168743796,-1.5087288497794098,436,3,DLL1|NRP1|RBPJ
POSITIVE REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0014810,0.7186548391367671,0.971081608033886,-0.635862373180415,-0.85061248388467,5427,1,GSTO1
REGULATION OF FRACTALKINE PRODUCTION%GOBP%GO:0032644,0.5276911655530809,0.9265056012720759,-0.551172267749639,-0.942750645087274,3553,2,TNF
NEGATIVE REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:1905875,0.993557046979866,1.0,0.503584031760035,0.6689889197167579,7401,1,LILRB2
REGULATION OF DENDRITE EXTENSION%GOBP%GO:1903859,0.5498454404945899,0.931359181171847,0.274304810654087,0.9300611893465771,5691,15,SYT17|RIMS2|SYT3|UNC13A|SYT1|PLAA|RIMS1|CPNE5|SYT4
REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070092,0.822074526040532,0.9874792359292991,0.312189937836987,0.7195515272091291,7544,5,PASK|UCN|SYT7|AIMP1
CELL AGGREGATION%GOBP%GO:0098743,0.214805689326912,0.731747191309112,0.577163806231312,1.22306523896351,1917,4,MGP|BMPR1B|BMP1|MPZ
NUCLEIC ACID TRANSPORT%GOBP%GO:0050657,0.845559845559846,0.991298302704726,-0.10329977680187,-0.8174382896869159,1313,137,PA2G4|MAGOH|DDX19B|THOC5|SEH1L|NMD3|RBM15B|AGFG1|ARC|ZNF593|NPM1|FMR1|PHAX|RFTN1|EIF5A|RRS1|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE%GOBP%GO:0032287,0.43691248510525604,0.878651088001772,-0.779444199382444,-1.0426862705683,3299,1,SOD1
ANATOMICAL STRUCTURE MATURATION%GOBP%GO:0071695,0.21885125184094298,0.7341474817293291,-0.20849359951140098,-1.18572528880751,742,40,CX3CL1|ANKS1A|RHOA|G6PD|NKX6-1|IGF1|RYR1|EPHA8|MTCH1|ACVRL1|S1PR1|PDE3A
DEPYRIMIDINATION%GOBP%GO:0045008,0.82874077155038,0.9876441563834109,0.257701052538723,0.702562206159735,7969,8,TDG|MBD4|NEIL1|NTHL1|UNG
POSITIVE REGULATION OF THYMOCYTE MIGRATION%GOBP%GO:2000412,0.8261763638562959,0.9876441563834109,0.475489385166805,0.77717433759761,6829,2,XCL1|ADAM8
REGULATION OF OOCYTE MATURATION%GOBP%GO:1900193,0.6169265033407572,0.9520939168601509,-0.5146953405017921,-0.880358814609095,4154,2,SIRT2|YTHDF2
NEGATIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904339,0.610883092810804,0.9508825506493929,-0.6881340979267759,-0.9205379638294029,4613,1,GSK3B
REGULATION OF HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:1904826,0.678255033557047,0.9647315640607691,0.665527128363476,0.884123098760677,5052,1,SP1
REGULATION OF AORTIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1904829,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
MELANOCYTE ADHESION%GOBP%GO:0097326,0.389664429530201,0.8603316114971841,0.8120864578738419,1.0788206295399498,2902,1,KIT
PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046131,0.823695345557123,0.9876441563834109,0.238740232726512,0.704584105677912,8175,10,CAD|AK3|CTPS2|UMPS|CTPS1|APOBEC3C
VIRAL TRANSCRIPTION%GOBP%GO:0019083,0.9714534757027671,1.0,0.23329811778925602,0.537717577040967,8915,5,DHX9|CCNT2
REGULATION OF FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:1901193,0.791605984377069,0.9819233677232551,-0.601179973533304,-0.804216780419229,5978,1,RPL13A
SECRETION BY TISSUE%GOBP%GO:0032941,0.00018162005085361398,0.0784645998831315,-0.8375232502886542,-2.44309247861883,0,7,VAMP2|VAMP3|COPA|FGF10|AQP5|AQP1
STILBENE METABOLIC PROCESS%GOBP%GO:0009810,0.956043956043956,1.0,-0.519629466254963,-0.6951241803788699,7220,1,EPHX2
SNORNA LOCALIZATION%GOBP%GO:0048254,0.950816151202749,1.0,0.23338334296441102,0.5739723430115611,8853,6,ZNHIT3|PRPF31|PIH1D1|NOP58|FBL|ZNHIT6
PENTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0019322,0.219324430479183,0.734713083559597,-0.602882510504634,-1.22353214264312,1395,3,G6PD|TKT
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT%GOBP%GO:0048566,0.647339699863574,0.9636261853025391,0.256944900386591,0.851338302388245,6642,14,RARRES2|RARB|PKDCC|TGFB2|NIPBL
NEGATIVE REGULATION OF MICROVILLUS ASSEMBLY%GOBP%GO:1903697,0.612348993288591,0.9508825506493929,0.6986104984561099,0.928072879974961,4561,1,RAP1GAP
HETEROCHROMATIN ORGANIZATION INVOLVED IN CHROMATIN SILENCING%GOBP%GO:0070868,0.43162583518931,0.8785877309899279,-0.595919492693686,-1.01928837684599,2906,2,SMCHD1|POLE3
CELL ADHESION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0061343,0.6960465897636909,0.96731875442989,0.39448370128307,0.8359486460653509,6214,4,TGFB2|FLRT2|TGFBR2
REGULATION OF METAL ION TRANSPORT%GOBP%GO:0010959,0.0010245901639344302,0.0872881177264294,-0.199269085073405,-1.68959670064602,0,207,CX3CL1|KCNE3|FKBP1B|CTNNB1|PTPN3|PTK2B|CNKSR3|CRHR1|PML|SCN1B|FYN|KCNE4|SESTD1|SLC9A1|PLN|INPP5K|RANGRF|UBASH3B|YWHAH|SLC30A1|KCNAB1|PRNP|APLNR|CHP1|VAMP2|SUMO1|VIP|CAMK2A|HAP1|BIN1|CRACR2A|ATP2B4|CEMIP|CAB39|KCNAB2|AMIGO1|SNCA|FMR1|PDE4B|LGALS3|GNB5|NEDD4|JPH3|SLMAP|BCL2|SNTA1|COMMD1|FXYD5|B2M|YWHAE|KCNG1|HOMER2|ANO6|ADCYAP1|HTT|DRD2|ADRA2A|JPH1|SLC9A3R1|SCN5A|DLG1|PDE4D|GAL|CAV1|STAC|FKBP1A|STC1|HOMER1
REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0010464,0.9983416252072971,1.0,-0.12109932256197299,-0.441176979558489,4815,12,FGFR2|STAT1|CHRD|MYC|PDGFA|TGFBR2|TBX1|CTNNBIP1|LRP5|VEGFA|NFIB
KILLING BY HOST OF SYMBIONT CELLS%GOBP%GO:0051873,0.917297698589458,1.0,-0.374155206518955,-0.6399724422795731,6177,2,GAPDH
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002830,0.18161559888579398,0.6873049536419911,-0.40973026642396204,-1.2736200676499398,977,8,XCL1|PRKCZ|RSAD2|IL18|CD86|RARA|IL6|NLRP3
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903077,0.91886487001238,1.0,0.169997023570435,0.6098139810128941,9648,18,PKDCC|GBP1|GOPC|CLTC|DAB2|TMEM59|CSK|AP2M1
EMBRYONIC PLACENTA MORPHOGENESIS%GOBP%GO:0060669,0.7015796703296701,0.968941691852291,-0.31794393885648103,-0.8048539686516529,4085,5,ZNF568|IGF2
REGULATION OF PERIPHERAL TOLERANCE INDUCTION%GOBP%GO:0002658,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000562",0.39045329670329704,0.860837094563899,-0.409662475181999,-1.03703335293561,2273,5,XCL1|TWSG1|C10orf54|CD274|LGALS9
SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:0048488,0.7049060288015621,0.968941691852291,-0.17281801185011997,-0.828396570045653,2887,24,CANX|DNAJC6|GAK|PACSIN1|NLGN4X|CDK5|OPHN1|DNM2|SNCA|SYT2|AMPH
"PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0006911",0.29556650246305394,0.800447413278835,0.243643787608768,1.1364401102269601,3479,44,IGHV3-21|RHOBTB1|IGHV4-61|IGHG1|RAC3|IGLL5|IGHG4|ADGRB1|ARHGAP25|IGHV1-18|IGHV3-43
ERYTHROPOIETIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038162,0.389664429530201,0.8603316114971841,0.8120864578738419,1.0788206295399498,2902,1,KIT
REGULATION OF MRNA STABILITY INVOLVED IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:2000815,0.956090480222572,1.0,0.385172551829757,0.629553954656759,7903,2,MYEF2|HNRNPM
HIGH-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034375,0.181543421317751,0.6873049536419911,0.43554722110235994,1.2854123737596101,1801,10,ABCA5|SCARB1|CETP|APOE|APOC1|APOM|LCAT|APOC2
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:1902035,0.8340389500423371,0.988613522932093,0.470967741935484,0.769783835952823,6894,2,N4BP2L2|PDCD2
PROXIMAL TUBULE DEVELOPMENT%GOBP%GO:0072014,0.868264265854627,0.993084774742015,-0.5633546537273929,-0.75361669683053,6557,1,PKD1
PHYTOL METABOLIC PROCESS%GOBP%GO:0033306,0.5976775130035079,0.9492590312650558,0.5676885295238271,0.927871306190501,4940,2,ALDH3A2|PECR
PROTEIN NEDDYLATION%GOBP%GO:0045116,0.6014934171742979,0.9506035145731909,0.281322338462259,0.886828545928414,6121,12,UBA3|NAE1|RNF7|DCUN1D4|DCUN1D1|RBX1
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007206,0.00198596584138753,0.112650093274223,-0.9991729157476841,-1.33662407392249,14,1,HOMER1
DIGESTIVE SYSTEM PROCESS%GOBP%GO:0022600,0.24585635359115998,0.758407565545035,-0.26198016202929103,-1.1689307233048603,1067,20,TJP2|MUC4|COPA|ADRA2A|AQP5|CD36|AQP1
HISTONE H2A UBIQUITINATION%GOBP%GO:0033522,0.740311147933352,0.974505008828563,0.202894953795499,0.789099719435775,8041,23,PCGF2|DDB2|DDB1|TRIM37|CUL4B|UBE2B|UBR2|PCGF1|PCGF3|RNF8|PCGF5|KDM2B|BCOR|COMMD3-BMI1
DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:0071550,0.7862332001452959,0.981626008042485,-0.256370656370656,-0.7478445787646559,4328,7,RIPK1|TRAF2|TRADD|FADD|TNFRSF1A|CASP8|TNF
HISTONE H3-R2 DEMETHYLATION%GOBP%GO:0070078,0.8375838926174499,0.9889652677625541,0.581550507278341,0.7725639041117529,6239,1,JMJD6
IRES-DEPENDENT TRANSLATIONAL INITIATION OF LINEAR MRNA%GOBP%GO:0002192,0.73006711409396,0.972554563883587,0.638674459638289,0.84845052634175,5438,1,RBM4
NEGATIVE REGULATION OF NEURON MATURATION%GOBP%GO:0014043,0.9439957632728722,1.0,-0.525529333921482,-0.7030166132418301,7129,1,EDNRB
INTESTINAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060575,0.573422818791946,0.9412682428400659,0.717633436259374,0.9533440041731741,4271,1,GATA6
GMP METABOLIC PROCESS%GOBP%GO:0046037,0.3632471595587029,0.849828746111777,-0.460787624592892,-1.05971527465702,2205,4,GMPS|HPRT1
TRANSCRIPTION INITIATION FROM MITOCHONDRIAL PROMOTER%GOBP%GO:0006391,0.10269769595924501,0.574198697765381,0.7130300045695209,1.35539503074563,886,3,POLRMT|TFB2M|TFAM
PROTEIN DEADENYLYLATION%GOBP%GO:0044602,0.423221476510067,0.873470206885489,0.7952690780767528,1.05647949075603,3152,1,FICD
ADULT BEHAVIOR%GOBP%GO:0030534,0.557444894287,0.9361453421204542,0.22682256780030605,0.930115045512998,6195,28,CARTPT|GHRL|CRHBP|NPY|ABAT|DRD4|SPTBN4|NRXN3|SHANK1|NLGN3
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043524,0.97593605384939,1.0,0.11346417419337598,0.542699571890515,11598,49,CITED1|NAIP|F2R|KIF14|LIG4
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903749,0.000666666666666667,0.0806484601749226,-0.3671447061478811,-2.26450987912531,1,53,FBXW7|HPS4|TP53BP2|GZMB|UBL5|BBC3|ATG13|VPS11|YWHAH|CSNK2A2|SH3GLB1|RNF31|BID|BAP1|LEPROT|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|UBE2D3|ARIH2|PMAIP1|TFDP2
POSITIVE REGULATION OF OVULATION%GOBP%GO:0060279,0.0118782479584261,0.23670963874364498,-0.925884460835633,-1.5836757830594799,79,2,INHBB
GLUCOSE CATABOLIC PROCESS%GOBP%GO:0006007,0.00144962551340904,0.0961252072968491,-0.452818147471731,-2.1277546089350303,5,23,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
NEGATIVE REGULATION OF ENDOCYTOSIS%GOBP%GO:0045806,0.0674521354933726,0.502793556475766,-0.247222782907201,-1.4059822764315,228,40,SNX3|PICALM|MTMR2|NECAB2|SIRPA|CD300LF|NR1H3|FCGR2B|LRPAP1|LGALS3|NR1H2|DYSF|KIAA0226|RAC1|MCTP1|CAV1
"FATTY ACID ELONGATION, UNSATURATED FATTY ACID%GOBP%GO:0019368",0.256591850076269,0.767319904137432,0.515488863315952,1.18812541310018,2354,5,ELOVL6|ELOVL4|ELOVL2|ELOVL1|ELOVL5
NEURON PROJECTION MAINTENANCE%GOBP%GO:1990535,0.8377586880124951,0.989101135821981,-0.219124766120142,-0.707354381276957,4290,9,ATP1A3|ABCD1|APP|INSR|PSEN1|DCTN1|MAP1A|PRNP
"RETROGRADE TRANSPORT, ENDOSOME TO PLASMA MEMBRANE%GOBP%GO:1990126",0.6183883902997901,0.9532238181782521,0.24991030821728,0.881397566903615,6476,17,WASH1|LRRC7|VPS29|ANKRD27|ANKRD50|FAM21C|ARHGAP44|SCRIB|SDCCAG3|RAB11B|VPS39
CARBOHYDRATE DERIVATIVE TRANSPORT%GOBP%GO:1901264,0.351459594161623,0.842847021021096,0.258617227999753,1.0931731692474,3948,31,VLDLR|SLC35A1|MFSD2A|SLC35B1|SLC25A19|SCARB1|SLC37A2|SLC25A42
CELLULAR RESPONSE TO HYDROXYUREA%GOBP%GO:0072711,0.7863310867733779,0.981626008042485,0.283111423586831,0.73687955385337,7466,7,BLM|TIMELESS|SPIDR|DDX11|ATRX
AUDITORY RECEPTOR CELL FATE COMMITMENT%GOBP%GO:0009912,0.264026845637584,0.775687172361899,0.8703131892368771,1.15617224447709,1966,1,JAG2
ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:0048490,0.535698924731183,0.9265056012720759,-0.233652378967996,-0.931826561588652,2490,15,BLOC1S1|BLOC1S5|BLOC1S4|AP3S2|BLOC1S6|BLOC1S3
SYNAPTIC SIGNALING VIA NEUROPEPTIDE%GOBP%GO:0099538,0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
POSITIVE REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045416,0.20408483896307897,0.720304973077154,-0.616770889921885,-1.2517181960285502,1298,3,BCL10|TNF
FUNGIFORM PAPILLA FORMATION%GOBP%GO:0061198,0.7701559020044542,0.9792758096555699,-0.450785773366419,-0.771044922801516,5186,2,HDAC2|HDAC1
REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010758,0.8896199548266719,0.997300970905927,0.199113223414782,0.6426123826435649,9058,13,RARRES2|CCL5|C5|THBS1|CSF1|DDT|SLAMF8
REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061183,0.717188823031329,0.971081608033886,0.521197574987296,0.8518831181817758,5928,2,WNT4
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010667,0.11648723841780599,0.5959669927208161,0.792996967190516,1.29613175797185,962,2,PPP1R10|HAND2
IMPORT INTO NUCLEUS%GOBP%GO:0051170,0.939191290824261,1.0,0.117936345949576,0.649236065654854,12077,94,SIX3|RANBP17|TPR|SMN1|DDX20|NUP133|NXT2|PPP1R10|NUP188|C11orf73|NUP85|GEMIN5|IPO13|SMN2|SPRN|NUP107|NUP35|CEP57|TNPO3|HEATR3|RANBP6|POM121|NUP54|KPNA5|SNRPD1|CSE1L|GEMIN8|IPO9|TNPO1
REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000118,0.789510246613407,0.9819233677232551,0.40862468291606896,0.776752536520287,6818,3,CEBPB|SFRP4|CRY2
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0090287,0.12358703843255499,0.607607158836689,-0.150432655083915,-1.2033973614801101,163,153,DAB2IP|SKI|TGFBR1|CNKSR3|PRKD2|MYO1C|MMRN2|CITED2|STUB1|ITGA5|SMAD6|ZNF703|FGF2|ZNF423|SMAD2|LDLRAD4|PPM1A|PTPN1|SMAD7|FGFR1|NEDD4|CDKN1C|ADAM17|UBA52|SNX6|RBPMS2|FLT1|GREM1|BMPER|ACVRL1|UBC|DOK5|SNX25|HSP90AB1|SULF2|TMEM108|RBPJ|CAV1|NBL1|UBB
CRD-MEDIATED MRNA STABILIZATION%GOBP%GO:0070934,0.9616474177380692,1.0,0.241422430782036,0.5564429141289671,8825,5,DHX9|IGF2BP1
REGULATION OF HEART MORPHOGENESIS%GOBP%GO:2000826,0.948010561777292,1.0,0.143945684119225,0.5736028445834029,10411,25,TBX2|BMP4|ROBO2|TGFB2
REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032330,0.14574538991335298,0.636418541205714,-0.303315734589914,-1.3047968999600301,655,18,SNAI2|PTHLH|ZBTB16|TGFBR1|FAM101B|FAM101A|SOX6|GREM1|ACVRL1
NITRATE METABOLIC PROCESS%GOBP%GO:0042126,0.8185557033990559,0.987153241368501,0.47886603854033905,0.7826933847745571,6766,2,MARC1|MARC2
INDUCTION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050929,0.6921752945849329,0.96731875442989,-0.6487097485663871,-0.867798809651677,5227,1,SLIT2
ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:0001885,0.000259942812581232,0.0784645998831315,-0.44937301374529703,-2.2997792384196805,0,29,ENG|EZR|RAP2C|RAP1B|F11R|COL23A1|MYADM|TJP2|RAP2B|RAB1A|ICAM1|RAP1A|MSN|RAPGEF1|GSTM3|MET|PDE4D|STC1
"POSITIVE REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903691",0.676020786933927,0.9647315640607691,-0.49170113041080793,-0.841028449739587,4552,2,MTOR|RREB1
NEGATIVE REGULATION OF BONE MINERALIZATION%GOBP%GO:0030502,0.0547675334909378,0.456473845459404,-0.461077734497218,-1.55989498991223,277,10,SRGN|PTK2B|FAM101B|FAM101A|GREM1
ORBITOFRONTAL CORTEX DEVELOPMENT%GOBP%GO:0021769,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032655,0.748488403573685,0.9749763305090959,0.19281398460735,0.7838875247007621,8293,27,CD47|MAPK11|AGER|TIGIT|CCL19|LTB|THBS1|TLR4|MAST2|PIBF1|MAPK14|HSPD1|ISL1|JAK3|CMKLR1|HMGB1|TLR2|IRF5|CCR7
NEGATIVE REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010754,0.9393307861525991,1.0,0.323700503626214,0.615320605378604,8112,3,PDE2A|THBS1
EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:0010172,0.8158680282796541,0.9866358717238399,-0.35887023420308,-0.728316477812233,5192,3,FUZ|IFT122
GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0006680,0.522573811730438,0.9251240799994541,-0.734395677106308,-0.9824234888015879,3946,1,GBA
CHIASMA ASSEMBLY%GOBP%GO:0051026,0.788373919874313,0.9819233677232551,-0.369030550347414,-0.748936537550908,5017,3,CCNB1IP1|MSH5|RNF212
REGULATION OF SHORT-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048172,0.146457489878543,0.6381169402469201,0.46684151292035,1.3322061689695002,1446,9,GRIK2|PPFIA3|SHISA7|SLC8A2|RAB3A|SYNGR1
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1904879,0.0547651006711409,0.456473845459404,0.9726510807234229,1.2921235676999498,407,1,CACNB2
GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY%GOBP%GO:0097116,0.59261586802828,0.9461312439065841,-0.43785154957538297,-0.888606710722386,3771,3,NRXN2|NLGN2|NRXN1
LATERAL VENTRICLE DEVELOPMENT%GOBP%GO:0021670,0.6567651098901099,0.9643779777660141,-0.33056184232309005,-0.8367953534054839,3824,5,AQP1
MRNA STABILIZATION%GOBP%GO:0048255,0.0657655315830517,0.495991045493396,-0.28516241149737204,-1.4593902470321798,252,29,CCRN4L|SLC11A1|VIP|YBX1|HNRNPC|RBM38|PABPC1|MYD88|RBM24
NEGATIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:1903243,0.006284367635506679,0.17975028050367198,-0.8619168412925992,-1.7492346207293301,39,3,FOXO1|ATP2B4|LMNA
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0060307,0.445569620253165,0.883193115620905,-0.257539104125794,-0.9977746696691411,2111,14,KCNE3|SCN1B|KCNE4|SNTA1|SCN5A|DLG1
EXTRACELLULAR STRUCTURE ORGANIZATION%GOBP%GO:0043062,0.745043700703475,0.9749763305090959,0.136813532706075,0.8579645017560791,10484,214,ITGB1|WASH1|COL9A2|CD47|LPL|COL18A1|ELN|LAMC3|VCAN|ITGA1|MADCAM1|TNC|ZDHHC8|ABCA7|ITGA9|ABCA5|DGAT1|MMP11|MPV17|DDR2|AGTR1|SCARB1|ITGA2|ST7|DPT|ITGA4|TGFB2|COL8A1|LAMA1|SOAT1|DDR1|LAMB2|LOXL3|FBN1|COL4A2|ITGA11|CETP|ITGB5|LOXL2|BSG|NF1|TNXB|APOE|FBLN5|ITGA2B|COL4A1|COL5A2|KLKB1|COL27A1|MFAP4|COL28A1|APOC1|COL5A1|COL11A2|ITGA10|FN1|APOM|LAMA2|NID1|SPARC|TEX14|AGRN|P3H4|LCAT|THBS1|HTRA1|MFAP2|SPOCK2|ITGA3|ICAM3|COL12A1|SERPINE1|ITGA8|BGN|COL11A1|SULF1
NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002887,0.141445743454635,0.6302094012719549,-0.582398376842459,-1.33939459945498,858,4,CD84|LGALS9|FCGR2B
CELL MIGRATION TO THE MIDLINE INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003318,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
POSITIVE REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903071,0.263167453686887,0.774572673283691,-0.397907307902266,-1.16071327069243,1448,7,BCAP31|CAV1
POLYOL BIOSYNTHETIC PROCESS%GOBP%GO:0046173,0.25011775788977897,0.76165135686672,-0.25597707363169897,-1.16259564613681,1061,21,SPHK1|FGF2|ACER3|SPR|ASAH2|QDPR|ASAH2B
RESPONSE TO KAINIC ACID%GOBP%GO:1904373,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903613,0.199685781618225,0.711592141628341,-0.6195885329491321,-1.2574365188365,1270,3,MGAT5|LGALS3
TRANS-SYNAPTIC SIGNALING BY NEUROPEPTIDE%GOBP%GO:0099540,0.577916059843771,0.942692029750853,-0.704951477723864,-0.94303508554158,4364,1,NTRK2
RESPONSE TO ETHANOL%GOBP%GO:0045471,0.258624049892808,0.7701983258900921,0.36025962292663,1.1936520839290101,2653,14,GRIN3A|CRHBP|CD27|GRIN1|DRD4|TH|PEBP1
REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032944,0.9187201455758589,1.0,0.12088771696070301,0.6921510836813479,12116,117,SH3RF1|IDO1|GLMN|CD209|MZB1|CD38|BMP4|AGER|CD320|BLM|MARCH7|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|DLG5|IL7|CCL19|TMIGD2|BTN2A2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|PLA2G2D|CEBPB|HLA-DMB|IGFBP2|CD3E|PTPN22|CD46|CTLA4|RIPK3|IKZF3
"WOUND HEALING, SPREADING OF CELLS%GOBP%GO:0044319",0.0610036832412523,0.48170831577441997,-0.33576981487907104,-1.4981731804816898,264,20,PDPN|RHOA|ITGA5|RHOC|PDCD10|ADAM17|MMP12|ACVRL1|TMEFF2
ALANINE METABOLIC PROCESS%GOBP%GO:0006522,0.446180325698398,0.883874685872149,-0.775474194971328,-1.0373754746231398,3369,1,GPT2
POSITIVE REGULATION OF HISTAMINE SECRETION BY MAST CELL%GOBP%GO:1903595,0.44446190102121,0.881524975187096,-0.48941215396492793,-0.9932474253981329,2828,3,VAMP7|SNX4|VAMP8
TORC2 SIGNALING%GOBP%GO:0038203,0.671016483516484,0.964618776001639,-0.326484297708813,-0.8264733199773309,3907,5,SYAP1|MAPKAP1|PRR5
"SUBSTRATE-DEPENDENT CELL MIGRATION, CELL EXTENSION%GOBP%GO:0006930",0.934094903339192,1.0,-0.22276763554133802,-0.611482201808104,5314,6,SHTN1|NTN1|CD2AP|SDCBP|OPHN1|NRP1
POSITIVE REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902949,0.294903339191564,0.800447413278835,-0.41023372179774104,-1.12606402115475,1677,6,HSP90AA1|CLU|DKK1|HSP90AB1
REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903827,0.0027027027027027,0.129737563650607,-0.158610304624548,-1.46041921614696,0,372,TXN|RAMP3|GPM6B|RHOG|INSIG1|GPER1|FLCN|FBXW7|OAZ2|VTI1B|PICALM|HPS4|HAX1|SYT11|CCT4|PPFIA1|PRKCH|TP53BP2|VPS28|PINX1|IL1B|GZMB|SIN3A|NEDD4L|NECAB2|CLIP3|PLK3|BCAS3|PRKCD|CTNNB1|TMEM30A|RTN4|UBE2J1|PRKAA1|ITGAM|SQSTM1|UBL5|OS9|PARL|LIF|EIF2AK3|BBC3|MYO1C|ATG13|VPS4A|CCT7|FYN|FAM65A|BAG4|INPP5K|ICE1|TCF7L2|UHMK1|VPS11|RANGRF|STX8|NMD3|APOD|GCC2|YWHAH|CSNK2A2|PRNP|CHP1|VAMP2|BCL2L1|SH3GLB1|RNF31|TCP1|MIEF1|IQSEC2|IGF1|MAVS|BID|CEMIP|CRIPT|BAP1|RAP1A|LEPROT|ZPR1|PDCD10|YWHAQ|KCNAB2|PTPN1|YWHAB|MARK4|LGALS3|MSN|GNL3L|BAG3|BCL2|TP53|COMMD1|YWHAZ|RANGAP1|UBE2L3|YWHAE|UBE2D3|RALB|SIAH3|CABP1|ARIH2|PARK2|RAB11FIP5|RHOQ|ACSL3|NSFL1C|DDRGK1|BCAP31|SESN2|PIK3R1|DLG1|HSP90AB1|BICD1|TNF|PMAIP1|TFDP2|STAC|EPHB2|APPL1
CELLULAR RESPONSE TO GLUCOSE STARVATION%GOBP%GO:0042149,0.0352679811163566,0.382137421231133,-0.281865679967417,-1.5322237985462002,126,35,IMPACT|PIK3C3|PRKAA1|HSPA5|SIK2|EIF2AK3|MYBBP1A|NUAK2|SH3GLB1|BECN1|C12orf66|TP53|SESN2|PMAIP1
NEUROTRANSMITTER-GATED ION CHANNEL CLUSTERING%GOBP%GO:0072578,0.131257699630418,0.6149266898174119,0.627249921219008,1.32920250109743,1171,4,GPHN|APOE|DLG4
DOSAGE COMPENSATION%GOBP%GO:0007549,0.882534775888717,0.9961599252653379,0.191770338242525,0.6502188147628121,9135,15,LRIF1|H2AFY2|METTL3|PCGF3|BRCA1|YTHDC1
ENDOCRINE SYSTEM DEVELOPMENT%GOBP%GO:0035270,0.533184656556646,0.9265056012720759,0.226562183836472,0.9499596587673609,5976,30,HOXD3|SIX3|WNT4|CDK6|BMP4
ORGANIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1903825,0.7771981489272191,0.9810334506628041,0.16278650135635,0.778608448205698,9236,49,SLC1A2|SLC25A29|SLC36A1|SLC25A22|LRRC8D|SLC25A10|CPT1B|SLC46A1|SLC25A1|ACACA|SLC38A6|SLC16A7|SLC5A6|MPC2|SLC38A10|SLC1A3|SLC1A1|SLC19A1|SLC38A1|SLC25A30|SLC23A2|SLC36A4|ARL6IP5
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0090176,0.17962985363493397,0.68489956912038,0.7462917011304109,1.21979328366532,1484,2,BRSK2|BRSK1
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002701,0.6709620084425679,0.964618776001639,-0.196222819432321,-0.844106972699143,3019,18,FCGR2B|SMAD7|CD22|TNF
MRNA CLEAVAGE%GOBP%GO:0006379,0.962788506829958,1.0,-0.12994214340456403,-0.590170705635892,4087,21,AGO2|NCBP2|NUDT21
OXIDATIVE SINGLE-STRANDED DNA DEMETHYLATION%GOBP%GO:0035552,0.407040038708117,0.8669681570015609,0.639426523297491,1.0451250862555799,3364,2,ALKBH3|FTO
NEGATIVE REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000225,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0062033,0.0797212144357457,0.534078458829271,0.4122448265927321,1.4539279700760799,834,17,ANAPC5|NUMA1|FAM178A|DLGAP5|RB1|ESPL1|NIPBL
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009183,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
IDP CATABOLIC PROCESS%GOBP%GO:0046709,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
"TRNA EXON LIGATION UTILIZING 2',3' CYCLIC PHOSPHATE OF 5'-EXON AS SOURCE OF LINKAGE PHOSPHATE%GOBP%GO:0000971",0.22957765126439802,0.743365122901021,-0.884483899426555,-1.1832010799509198,1733,1,RTCB
DIOL METABOLIC PROCESS%GOBP%GO:0034311,0.0122432039842291,0.239952309092092,-0.48835468436455703,-1.8391344067242898,58,13,SPHK1|SGPP2|ACER3|SPR|ASAH2|QDPR|ASAH2B
TEMPERATURE HOMEOSTASIS%GOBP%GO:0001659,0.0492513790386131,0.435862257033585,-0.467812068966743,-1.5826782514177098,249,10,FOXO1|TNFRSF11A|PPARGC1A|STAT3|DRD2|NR1D1
MUSCLE CELL PROLIFERATION%GOBP%GO:0033002,0.192332474226804,0.7023096717844329,0.5146456219917589,1.26569595637464,1790,6,NOV|TGFB2
GAMMA-AMINOBUTYRIC ACID METABOLIC PROCESS%GOBP%GO:0009448,0.638321035442119,0.9601484712040809,0.552081610146126,0.9023622252148059,5276,2,ABAT|ALDH5A1
NEGATIVE REGULATION OF RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900053,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0098953,0.277328646748682,0.7884684708511421,-0.41768604362807504,-1.1465201441922,1577,6,CACNG3|CACNG7
TRANS-SYNAPTIC SIGNALING BY ENDOCANNABINOID%GOBP%GO:0099542,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
POLYSACCHARIDE ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX%GOBP%GO:0002506,0.7904923188581109,0.9819233677232551,0.49004687069203207,0.800968147771073,6534,2,HLA-DRB1|HLA-DRA
REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010511,0.6772314928883411,0.9647315640607691,0.4013125241272821,0.850419573995381,6046,4,ZP3|PDGFB|AGAP2|PDGFA
NUCLEAR CELL CYCLE DNA REPLICATION INITIATION%GOBP%GO:1902315,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
POSITIVE REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0042660,0.261617900172117,0.771967970256231,-0.8695963828848701,-1.16328559515653,1975,1,FGF2
GDP METABOLIC PROCESS%GOBP%GO:0046710,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
RESPONSE TO INTERFERON-ALPHA%GOBP%GO:0035455,0.0937431394072448,0.562743160240921,-0.344854913066379,-1.41229677145717,426,16,IFNAR2|IFNAR1|IFITM2|MX2|IFITM3|PDE12|IFITM1
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010717,0.000364963503649635,0.0784645998831315,-0.32197761119297197,-2.0848121935839297,0,63,SMAD4|TGFB1I1|VASN|MAD2L2|SMAD3|WWTR1|ENG|AXIN2|STRAP|FOXC1|BCL9L|SDHAF2|FUZ|PHLDB1|NOTCH1|IL1B|CTNNB1|DAB2IP|TGFBR1|ACVR1|PDPN|ELL3|ZNF703|TCF7L2|SMAD2|EFNA1|LDLRAD4|GLIPR2|SNAI1|PPP2CA|SMAD7|GREM1|SFRP2|OLFM1|TWIST1
BASEMENT MEMBRANE ASSEMBLY%GOBP%GO:0070831,0.16430557394412804,0.666438287523194,-0.9149757388619321,-1.22399094325201,1240,1,RAMP2
RESPONSE TO EXTERNAL BIOTIC STIMULUS%GOBP%GO:0043207,0.294871794871795,0.800447413278835,-0.115549416839481,-1.06249159423527,114,364,IGHV4-4|CD274|BATF|IL1B|CLU|IRAK1|APOBEC3F|MTDH|FCER1G|PRKCD|SIRPA|DAB2IP|TRIB1|BANF1|IGHV2-26|LGALS9|ROMO1|TNFAIP3|DDIT4|NR1H3|IFNAR2|SSC5D|FGR|IGHV1-69-2|S100A8|IGHV3-15|RHOA|IGHV3-73|DDX3X|EXOSC4|IFNAR1|IFITM2|FOSL1|TNFRSF1B|BCL10|CCRN4L|MX2|IFITM3|VIM|IL6|OASL|LYN|FCGR2B|SBNO2|ENO1|DFNA5|CHIT1|APOBEC3B|SLC11A1|MST1R|ATG7|RAB1A|LAMTOR5|MAVS|FOXP1|AP1S1|CNOT7|GAPDH|LDOC1|PLA2G2A|SNCA|FMR1|OAS3|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|IGHV1-3|NLRP1|PDE12|ODC1|NLRP3|BCL2|SHC1|JUN|BCL3|NOS3|PPP1R11|ZC3HAV1|BNIP3L|TNIP2|HIST1H2BC|EXOSC5|TICAM1|IFITM1|MYD88|NR1D1|LIAS|CD36|TNF|PRSS3|PMAIP1|CAV1
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:1904181,0.9319859402460459,1.0,-0.22425679774971,-0.615569852080156,5302,6,ANK3|DCN|GNB2L1|MLLT11|TRPM4|KDR
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900182,0.742666666666667,0.974505008828563,-0.135254581077925,-0.834236010812987,2227,53,CCT4|PINX1|PRKCD|LIF|EIF2AK3|CCT7|NMD3|TCP1|IGF1|MAVS|ZPR1|BAG3|SESN2|PIK3R1
REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034135,0.0685236768802229,0.5037729184803449,-0.486838552551863,-1.51330619445652,368,8,MFHAS1|CYBA|TLR1|PJA2|TNFAIP3|LYN
GASTRULATION%GOBP%GO:0007369,0.6714038128249571,0.964618776001639,-0.14004871453004,-0.88271909387476,1936,57,MMP2|ITGA5|COL6A1|MMP9|SMAD2|SNAI1|ATOH8|TBX20|MKKS|SOX7|SOX17|ITGA7
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0045947,0.11771201413427601,0.600563359851429,-0.32139190696198805,-1.3523801788578,532,17,ATF4|EIF2S1|EIF2AK3|EIF2AK1|PAIP2B|EIF4EBP1|FMR1|AGO2
MEIOTIC MISMATCH REPAIR%GOBP%GO:0000710,0.989232372351511,1.0,0.26643195159958,0.506459112401518,8543,3,MSH6|MSH3
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032332,0.485806384527399,0.9067327323518829,0.358834503475079,0.9782791258479759,4671,8,PKDCC|LOXL2|BMPR1B|SOX5
LACTOSE METABOLIC PROCESS%GOBP%GO:0005988,0.175204157386785,0.677933656654802,-0.7515301902398679,-1.28545214102286,1179,2,B4GALT1|SLC2A1
NCRNA TRANSCRIPTION%GOBP%GO:0098781,0.809947273156528,0.984682960940884,0.14236754523250597,0.773745288618991,10291,88,INTS7|POU2F2|SNAPC2|AK6|INTS9|INTS10|GTF2B|MARS|POLR2B|TAF5|INTS6|NABP1|BRF1|ZNF143|INTS3|ASUN|CDK7|GTF2E2|SRRT|POLR2L|INTS1|INTS8|POU2F1|POLR2J|CCNT2|SNAPC3|INTS2|SNAPC5|POLR2G|POLR2H|SP1|GTF2A1
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0007422,0.570706614926451,0.9404752161333092,0.226342775869295,0.9201992203594421,6323,27,EGR2|NFASC|ADGRB2|ADGRB1|GFRA3|GPC1|ALDH3A2|NF1|ETV1|DICER1|SCN8A
REGULATION OF HISTONE H2B UBIQUITINATION%GOBP%GO:2001166,0.626201923076923,0.954665382313994,-0.34000065932159995,-0.8606890918675241,3646,5,RNF20|CDK9|WDR70
METAL INCORPORATION INTO METALLO-SULFUR CLUSTER%GOBP%GO:0018282,0.25107646622123203,0.7633701775454069,-0.7065343258891651,-1.20848912487533,1690,2,NFS1|FXN
LOCOMOTORY EXPLORATION BEHAVIOR%GOBP%GO:0035641,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
NEUROBLAST MIGRATION%GOBP%GO:0097402,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
LATERAL LINE SYSTEM DEVELOPMENT%GOBP%GO:0048925,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
POSITIVE REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:1900006,0.8161564775019741,0.9866358717238399,0.167837262595281,0.735321271173933,9304,35,VLDLR|CUX2|CPEB3|PTPRD|DLG5|CAPRIN2|APOE|OBSL1|LRP8|CUL7|CAMK1|SHANK1|CDKL3|SS18L1|NEURL1|DBN1
PROTEIN URMYLATION%GOBP%GO:0032447,0.33019992056136604,0.8291761235173739,-0.836733568592854,-1.11932400649929,2493,1,MOCS3
NUCLEAR PORE LOCALIZATION%GOBP%GO:0051664,0.45999768438115096,0.890371861972445,0.531122344080001,1.00960770412266,3972,3,NUP133|NDC1
FORMATION OF PRIMARY GERM LAYER%GOBP%GO:0001704,0.4428978171464729,0.8806621848706541,-0.168575090211504,-1.00683881936033,1399,47,MMP2|ITGA5|COL6A1|MMP9|SMAD2|SNAI1|ATOH8|TBX20|SOX7|SOX17|ITGA7
MEIOTIC CYTOKINESIS%GOBP%GO:0033206,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000179,0.8252129798028142,0.9876441563834109,0.20406446649009696,0.7074361650992759,8620,16,PROX1|SMARCD3|PTCHD2|ZNF335|KDM1A|NAP1L1|FZD3
NEGATIVE REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033183,0.7164179104477609,0.971081608033886,-0.3937355244292489,-0.7990745484329771,4559,3,UBR5|OTUB1|TRIP12
OVARIAN FOLLICLE ATRESIA%GOBP%GO:0001552,0.844832214765101,0.991298302704726,0.578352448169387,0.768315425261039,6293,1,HYAL3
ASCENDING AORTA MORPHOGENESIS%GOBP%GO:0035910,0.0321424571620562,0.365598374354954,0.72929186624061,1.54543913015266,286,4,HES1|TGFB2|HEY2
MODULATION BY SYMBIONT OF HOST SIGNAL TRANSDUCTION PATHWAY%GOBP%GO:0052027,0.20230372037601002,0.716346357311758,-0.897441552712836,-1.20053492782751,1527,1,TNIP1
CARNITINE TRANSPORT%GOBP%GO:0015879,0.48863254563780895,0.9084242914579891,0.46545105015281896,0.9863352374747221,4362,4,SLC25A29|SLC22A4|PDZK1|SLC22A5
N-GLYCAN PROCESSING%GOBP%GO:0006491,0.12915378670788302,0.6098990195806221,0.40026898627909796,1.35715683786073,1336,15,FUT8|GNPTAB|GANAB|ST8SIA3|MAN1B1|MAN1C1|MGAT4B|ST8SIA2|MAN1A1|MAN2A1|MAN2A2|PRKCSH|ST8SIA4
NEGATIVE REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000355,0.844832214765101,0.991298302704726,0.578352448169387,0.768315425261039,6293,1,HYAL3
NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002829,0.6111547525530239,0.9508825506493929,-0.431509870960626,-0.875736462393284,3889,3,ANXA1|NDFIP1|SOCS5
NEGATIVE REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905913,0.0998278829604131,0.570215774831708,-0.948279664755183,-1.2685426203476002,753,1,YWHAE
THYROID HORMONE TRANSPORT%GOBP%GO:0070327,0.24966442953020104,0.7613646381106121,0.8778672254080279,1.16620744452102,1859,1,SLC16A2
TRICUSPID VALVE DEVELOPMENT%GOBP%GO:0003175,0.947451669595782,1.0,-0.215165438474393,-0.5906146813095451,5390,6,TBX20
SPERMATID DEVELOPMENT%GOBP%GO:0007286,0.9682088394934091,1.0,0.122004238203066,0.553554481837533,11237,40,ROPN1B|CABYR|PYGO1|PCSK4|CASC5|YTHDC2|DNAH1|SRPK1|ING2|PEBP1|CEP57
REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0030449,0.13993792033109198,0.6281603901381739,0.291257035264888,1.31364438690987,1622,39,IGKV4-1|IGHG1|IGHG4|IGKV3-11|SUSD4|IGKV2D-28|IGKV2-28|C3AR1|C7|CD55|C5|C4A|C4B|IGHG2|CD46
REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0070472,0.437177280550775,0.878651088001772,-0.7793890604322891,-1.04261250951351,3301,1,GPER1
REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032680,0.9705786736020809,1.0,0.112851802257097,0.5813025511034801,11941,68,GHRL|CD47|CD2|TRIM27|DHX9|JAK2|AZU1|CCL19|GSTP1|MC1R|NLRC3|CACTIN|RIPK1|C1QTNF4|DICER1|VIMP|PTPRJ|PTPN22|RASGRP1|THBS1
REGULATION OF VIRAL TRANSLATION%GOBP%GO:1904971,0.19409395973154395,0.7049101024373008,0.9051058667842958,1.20239276438745,1445,1,DHX9
PLASMA MEMBRANE LACTATE TRANSPORT%GOBP%GO:0035879,0.348329621380846,0.842847021021096,-0.651668045216432,-1.11464329023466,2345,2,EMB|SLC16A1
POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010828,0.5093993580926179,0.918404893008545,0.24535306590201103,0.9655864489534142,5554,24,FGF19|NR4A3|INS|FAM132A|C2CD5|CAPN10|OSBPL8|IRS1|AKT2
INFLAMMATORY CELL APOPTOTIC PROCESS%GOBP%GO:0006925,0.12725844461901,0.6076669536424699,-0.682861598602475,-1.3858473256546202,809,3,CTSL|IL6
JAK-STAT CASCADE%GOBP%GO:0007259,0.9596515359926641,1.0,0.140845546400608,0.55429733677826,10464,24,PIAS1|PKD2|SOCS2|JAK2
MAMMARY GLAND FORMATION%GOBP%GO:0060592,0.5594654788418709,0.936434965680841,-0.53783549128184,-0.919938803211163,3767,2,FGF10
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION%GOBP%GO:0042772",0.4861465906857929,0.906856689383579,0.310940301631894,0.9801949502980849,4947,12,MUC1|RPS6KA6|RPS27L|FOXM1|TFAP4|BRCA1
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009193,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
UBIQUINONE-6 METABOLIC PROCESS%GOBP%GO:1901004,0.120481927710843,0.6066999390482379,-0.938575209528011,-1.2555606747038501,909,1,NDUFA9
REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048819,0.7263971329376191,0.972554563883587,0.383124001207339,0.8118763564697858,6485,4,CDH3|TGFB2
REGULATION OF CORTISOL SECRETION%GOBP%GO:0051462,0.569076239091059,0.940076901516441,-0.389468712991345,-0.895696677015979,3455,4,CRH|GAL
COMMISSURAL NEURON AXON GUIDANCE%GOBP%GO:0071679,0.0311072056239016,0.361013617615581,-0.616045411341313,-1.6910032897075,176,6,VEGFA|NRP1|NFIB|EPHB2
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS%GOBP%GO:1902850,0.0053371006985323,0.168503048666442,0.309592362690992,1.6875286067361799,67,89,CCNB1|RCC1|CEP126|SAPCD2|TBCE|WDR62|NUMA1|KIF4A|DYNLT1|MAP10|NUF2|KIF23|PRC1|KIF11|TTK|TUBGCP3|STIL|NDC80|CENPA|GPSM2|WRAP73|NUSAP1|CDK5RAP2|CENPE|ESPL1|AURKB|KIFC1|TUBG2|SPDL1|ASUN|TUBGCP6|CEP192|STMN1|CHEK2|TUBGCP2|RACGAP1|AURKA|DYNC1H1|SPC25|TUBGCP4|FAM175B
CHROMOSOME SEPARATION%GOBP%GO:0051304,0.000371885459278542,0.0784645998831315,0.579945555841491,2.19250331546705,3,21,MUS81|EME2|NCAPD3|BLM|TOP2A|ESPL1|NCAPH2|FANCM|SMARCAD1|SLX4|EME1|RMI1|STRA13|TOP2B|TEX14|RECQL5
POSITIVE REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903142,0.40436126373626397,0.865585453523601,-0.404935717568636,-1.02506787991023,2354,5,ADD1|CDH5|PROC
POSITIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902228,0.7375838926174499,0.974306231601101,0.634869872077636,0.8433963015021071,5494,1,CSF1
DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME%GOBP%GO:0009048,0.944515368751841,1.0,0.175688949811986,0.5670135448896789,9617,13,LRIF1|METTL3|PCGF3|BRCA1|YTHDC1
CGMP METABOLIC PROCESS%GOBP%GO:0046068,0.470468213058419,0.8975514817191559,0.403844342264105,0.9931963455362719,4380,6,NPR2|PDE2A
MAINTENANCE OF LENS TRANSPARENCY%GOBP%GO:0036438,0.210213909732333,0.7251658659797621,0.579357896316935,1.2277147254453602,1876,4,GCNT2|STK39
REGULATION OF ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1902612,0.7052826691380909,0.968941691852291,-0.642479047198941,-0.859463810459952,5326,1,DKK3
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032480,0.15937409446537198,0.661359103221672,-0.22368175219144298,-1.25210724930661,549,38,PYCARD|ITCH|OTUD5|SIRPA|TNFAIP3|PCBP2|RELB|REL|CYLD|RNF216|MAVS|GPATCH3|TRAF3IP1|TRIM25|TAX1BP1
FRUCTOSE METABOLIC PROCESS%GOBP%GO:0006000,0.299595141700405,0.802472218138634,0.40239180601451596,1.1482887264286201,2959,9,AKR1B1|ALDH1A1|TKFC
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014912,0.84727121809504,0.991298302704726,-0.18806143452385002,-0.7082357677407809,4082,13,SERPINE1|PRKG1|TPM1|LRP1|BMPR1A|MEF2C|AIF1|NDRG4|CORO1B|SLIT2|TRIB1|IGFBP3
NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030812,0.008397826444920141,0.202735282440703,-0.793911652787735,-1.8258309474580101,50,4,CBFA2T3|HDAC4|FBP1|PPARA
CELLULAR RESPONSE TO CADMIUM ION%GOBP%GO:0071276,0.538860103626943,0.927657190869626,-0.205603873965059,-0.933810849969175,2287,21,MMP9|SUMO1|HSF1|JUN|MAPK3
REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903140,0.25938991492010804,0.770912532778873,-0.30754912546169205,-1.15822412788063,1249,13,ADD1|IL1B|CDH5|PROC|TNF
REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903146,0.494771741902576,0.91071489001692,-0.19483614046556802,-0.970906880664266,1939,27,MFN2|CSNK2A2|HK2|HTT|PARK2|FBXO7
CELL PROLIFERATION IN EXTERNAL GRANULE LAYER%GOBP%GO:0021924,0.825835189309577,0.9876441563834109,-0.42832272411671796,-0.7326230801038679,5561,2,ATF5
NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901029,0.0291895604395604,0.350886057103154,-0.674829031546437,-1.7082848824071202,169,5,TMEM14A|SLC25A5|MPV17L|ACAA2|SLC35F6
REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905031,0.589800824175824,0.945418171231938,-0.349468682478197,-0.8846567637793741,3434,5,KCNE3|DLG1
SOMATIC DIVERSIFICATION OF T CELL RECEPTOR GENES%GOBP%GO:0002568,0.151812080536913,0.6481463948883249,0.9246250551389499,1.22832313530388,1130,1,LIG4
NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0046113,0.740014847809948,0.9744283926676119,-0.46286186931348205,-0.791700438164639,4983,2,DPYD|ALDH6A1
REGULATION OF NEURON PROJECTION ARBORIZATION%GOBP%GO:0150011,0.292086929395862,0.8000726114371469,0.4228890237275779,1.15290893282689,2808,8,DVL1|GRIP1|DLG4|DVL3|DVL2
POSITIVE REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050850,0.137596417019159,0.6243233125849921,-0.267362021262698,-1.29704572885298,552,25,SLC9A1|HAP1|IGF1|CAMTA1|HTT|CDH13|TNF
REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:1905874,0.571046770601336,0.9404752161333092,-0.533430089154805,-0.9124035988111171,3845,2,CRIPT
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0007175,0.535324989907146,0.9265056012720759,-0.26313278780716504,-0.9259970638196949,2651,11,CBL|CHMP6|SOCS4|ERRFI1|ZFYVE28|VPS25|CBLB|ZGPAT|SNX6|SOCS5
GMP BIOSYNTHETIC PROCESS%GOBP%GO:0006177,0.0715664439495174,0.515023940206536,-0.840308795147505,-1.43730319003943,481,2,GMPS|HPRT1
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000702,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION%GOBP%GO:0021892,0.0326787117046347,0.36865949900576,-0.7909505407493271,-1.60521062227815,207,3,DRD2|ASCL1
CADMIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0070574,0.0394344069128044,0.396089810860281,-0.7788478808830559,-1.58064863366537,250,3,SLC30A1|SLC11A1
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902931,0.858479299363057,0.99166790097654,0.22067747986318,0.6732364053560209,8625,11,APOE|ERLIN1|REST|CYP27B1|SCAP|BMP2|DKK3|NFKB1|PLEK|ERLIN2|SOD1
CHOLESTEROL STORAGE%GOBP%GO:0010878,0.710293939760494,0.9700296616429409,0.524292441281823,0.8569415921192289,5871,2,SOAT1|STARD4
GALACTOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006681,0.17364690721649498,0.676682497340677,0.524840714628839,1.2907693019433402,1616,6,B3GALT2|B3GALT1|B4GALT3|ALDH5A1|GALC
UMBILICAL CORD DEVELOPMENT%GOBP%GO:0061027,0.6782387806943271,0.9647315640607691,0.537358698649021,0.8782980308348269,5606,2,HEY2|HEY1
AORTIC VALVE MORPHOGENESIS%GOBP%GO:0003180,0.142487046632124,0.6324244126031129,-0.28791723502134303,-1.3076613430043897,604,21,SMAD6|EFNA1|SNAI1|TBX20|NOS3|TWIST1|SLIT3
UMP METABOLIC PROCESS%GOBP%GO:0046049,0.524161073825503,0.92593403131991,0.7417291574768421,0.9853540948242441,3904,1,UMPS
TELOMERIC 3' OVERHANG FORMATION%GOBP%GO:0031860,0.342828914869093,0.8374026045939591,-0.468427728450891,-1.0772859174568101,2081,4,RAD50|NBN|DCLRE1B|MRE11A
CEREBELLAR PURKINJE CELL LAYER STRUCTURAL ORGANIZATION%GOBP%GO:0021693,0.416596104995766,0.8709670999109399,0.6357077650432099,1.03904687804923,3443,2,KIF14|DLL1
CELLULAR RESPONSE TO INORGANIC SUBSTANCE%GOBP%GO:0071241,0.796208530805687,0.9828568923066779,0.14006710215858498,0.793717934198431,10415,110,SYT17|DPEP1|TFR2|CRHBP|PRKAA2|ADGRV1|KCNH1|SYT3|ADCY8|PKD2|BLM|RASGRP2|ECT2|MT1F|CACNA1H|SYT15|MT1E|HPCA|RASA4|MCOLN1|MTR|CPNE7|FOS
NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070571,0.321187868576243,0.822513111410415,0.43314850341565797,1.1273945498398201,3049,7,RTN4RL1|RTN4R|PTPRS|CERS2|INPP5F
POSITIVE REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903971,0.587935625795994,0.945418171231938,0.484449101135988,0.9208867791269519,5077,3,CSF1|TLR4|TLR2
DIRECTIONAL LOCOMOTION%GOBP%GO:0033058,0.12551304117569198,0.607607158836689,-0.934991177767975,-1.25076620614224,947,1,ARPIN
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009212,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:0035791,0.18063186813186802,0.6862477225455891,-0.49966909331568504,-1.26487912999416,1051,5,PDGFB|PDGFA|PDGFRB|ABL1|PTPN1
ADRENAL GLAND DEVELOPMENT%GOBP%GO:0030325,0.496750232126277,0.911815944636073,-0.306004115758904,-0.951194028245754,2674,8,STRA6|CITED2|WNT11|INSM1
REGULATION OF DEFINITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0010724,0.873825503355705,0.9934031064448321,0.5641817379797089,0.749490268974254,6509,1,ZFPM1
CYTOSKELETON-DEPENDENT CYTOKINESIS%GOBP%GO:0061640,0.133544554455446,0.6194479383419461,0.24102446049318302,1.2873414348757801,1685,80,SEPT12|ROPN1B|UNC119|SEPT11|ECT2|KIF4A|KIF23|ANLN|APC|CENPA|NUSAP1|CEP55|ESPL1|AURKB|INCENP|SEPT2|CNTROB|ANK3|KIF20A|STMN1|SON|PLK1|RACGAP1|SEPT3|ALKBH4|BRCA2|CUL7|SEPT5|CIT|KLHDC8B|SPIRE2|SPIRE1|MITD1|FMN2
CHORION DEVELOPMENT%GOBP%GO:0060717,0.0518930688278698,0.44586532408291796,0.8569616763165151,1.40068031782494,428,2,E2F8|E2F7
GROWTH PLATE CARTILAGE MORPHOGENESIS%GOBP%GO:0003422,0.18987341772151897,0.698434241409875,-0.33005656481223,-1.24298671425921,914,13,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1|STC1
GLOMERULUS VASCULATURE MORPHOGENESIS%GOBP%GO:0072103,0.36910964455250705,0.852268858837246,0.565384293331948,1.07473606542883,3187,3,BMP4|PDGFRA|PDGFRB
REGULATION OF EOSINOPHIL EXTRAVASATION%GOBP%GO:2000419,0.77545346220045,0.9805314293977441,-0.6090648434053821,-0.8147646112547751,5856,1,PTGER4
PROTON TRANSMEMBRANE TRANSPORT%GOBP%GO:1902600,0.99504784287393,1.0,0.0939263946337729,0.45135850136576794,11854,50,NDUFS7|SLC36A1|ATP5G1|ATP5D|NNT|MT-ATP8|UCP3|SLC46A1|TCIRG1|ATP5C1|ATP6V0E2|ATP6AP1|ATP5E|VPS9D1|ATP5H|MT-ATP6|MT-CO1|ATP5A1
NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0051481,0.9536712229345591,1.0,0.38865072025455294,0.6352389253962111,7883,2,SLC8A1|SMAD3
REGULATION OF MITOPHAGY%GOBP%GO:1901524,0.8360015618898872,0.988613522932093,-0.21966019417475702,-0.7090827910181129,4281,9,HDAC6|VPS13C|PINK1|VPS13D|TSC2|TOMM7|OPTN|MFN2|PARK2
HAIR FOLLICLE PLACODE FORMATION%GOBP%GO:0060789,0.7701559020044542,0.9792758096555699,-0.450785773366419,-0.771044922801516,5186,2,HDAC2|HDAC1
INTERSPECIES QUORUM SENSING%GOBP%GO:0052097,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
NEGATIVE REGULATION OF ARGININE CATABOLIC PROCESS%GOBP%GO:1900082,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:1902455,0.9941869599371559,1.0,-0.24405812038400895,-0.495308704034139,6327,3,PAX8
MELANOSOME TRANSPORT%GOBP%GO:0032402,0.217849462365591,0.7341474817293291,-0.301848625181218,-1.2037992840697902,1012,15,BLOC1S6|MKKS|BLOC1S3|BBS7
VIRAL CAPSID SECONDARY ENVELOPMENT%GOBP%GO:0046745,0.8620415728849459,0.991943445125448,-0.566442434936039,-0.7577473158989949,6510,1,IST1
POLE PLASM ASSEMBLY%GOBP%GO:0007315,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
LIPOATE METABOLIC PROCESS%GOBP%GO:0009106,0.0406461008870647,0.401998427404428,-0.978881782090869,-1.30948000575828,306,1,LIAS
CELLULAR RESPONSE TO PROSTAGLANDIN D STIMULUS%GOBP%GO:0071799,0.36622152395915203,0.8510019955058101,-0.521120547038712,-1.05759866704365,2330,3,AKR1C3|AKR1C2|PTGFR
CARBAMOYL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0070408,0.288456375838926,0.7980646072929201,0.8590097044552271,1.1411560692288798,2148,1,CAD
PROTEIN O-LINKED GLYCOSYLATION%GOBP%GO:0006493,0.293360160965795,0.8004058897916541,-0.16196535387085,-1.1036940706233402,728,75,GALNT14|B4GALT5|GYLTL1B|POMGNT2|TMEM5|POMK|DPM1|EOGT|DPM2|GALNT7|ST3GAL2|POFUT2|GALNT18|MUC4|GALNT2|GALNT9|MUC3A|GALNT12|B3GNT5|B3GNT7|TRAK1|B3GNT8|B3GNT2|MUC12|GALNT6
MANNOSAMINE METABOLIC PROCESS%GOBP%GO:0006050,0.440089086859688,0.879896414106183,-0.5915081334436171,-1.01174298310604,2963,2,RENBP|NAGK
REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051580,0.0797335486475575,0.534078458829271,-0.414837942746471,-1.45986640488812,394,11,SNCA|DRD2|PARK2|PER2
U6 SNRNA 3'-END PROCESSING%GOBP%GO:0034477,0.751357076658282,0.976602570455905,-0.6198720776356421,-0.829221777994403,5674,1,USB1
ESTROUS CYCLE%GOBP%GO:0044849,0.595500181444297,0.94763446543375,0.568569065343259,0.92931051779763,4922,2,EGR1|ANXA1
EVASION OR TOLERANCE OF HOST DEFENSES BY VIRUS%GOBP%GO:0019049,0.137313432835821,0.62388141596544,-0.6736517039814711,-1.3671561181592802,873,3,TGFB1|SMAD3|EIF2AK2
REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031946,0.590978426672478,0.945418171231938,0.39221993265436605,0.904008801496593,5423,5,WNT4|REST|BMP2|DKK3
NADH METABOLIC PROCESS%GOBP%GO:0006734,0.00659282700421941,0.18227680804153196,-0.353410827936678,-1.8335067011931898,24,30,PFKL|GPI|MDH1B|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
POSITIVE REGULATION OF NMDA GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:1904783,0.0048987157420892396,0.161608827499482,-0.997684164093516,-1.3346325254430502,36,1,EPHB2
CELL-CELL SIGNALING INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0060995,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
NEGATIVE REGULATION OF TOR SIGNALING%GOBP%GO:0032007,0.807960713362626,0.984682960940884,0.164426146011998,0.746030067453238,9377,40,SIRT1|ARNTL|PRKAA2|C7orf60|STK11|SZT2|DEPTOR|GATS|UBR2|GSK3A|KPTN|ATM|TBC1D7|MAPKAPK5
REGULATION OF TETRAPYRROLE METABOLIC PROCESS%GOBP%GO:1901401,0.920031775453462,1.0,-0.538597265108072,-0.7204979832280141,6948,1,CLYBL
REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904796,0.845875185246172,0.991298302704726,-0.306763077980575,-0.705490994303567,5136,4,PSEN1|FOXC1|CTNNB1
POSITIVE REGULATION OF T CELL MIGRATION%GOBP%GO:2000406,0.50491013526033,0.9172434440873181,0.252411599658285,0.9666778749812142,5449,22,CXCL13|STK39|DOCK8|XCL2|CCL21|CCL5|CXCL10
RESPONSE TO FLUID SHEAR STRESS%GOBP%GO:0034405,0.191068651410798,0.699908855566074,-0.28689466508176503,-1.23415710734515,859,18,MTSS1|MAPK7|CITED2|SMAD6|MAP2K5|ASS1|ABCA1|SMAD7|NOS3
POSITIVE REGULATION OF HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:1902073,0.6351677852348989,0.95916055221954,0.6873070136744599,0.9130567047267472,4731,1,RWDD3
POSITIVE REGULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052042,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
ICOSANOID BIOSYNTHETIC PROCESS%GOBP%GO:0046456,0.19269979974513002,0.7027916199946072,0.31065312403744,1.2489743595411698,2116,26,EDN1|MGST1|GGT1|FADS1|MGST3|PTGS2|MGST2|GGT5|LTA4H
MAMMARY GLAND ALVEOLUS DEVELOPMENT%GOBP%GO:0060749,0.12249443207127002,0.607607158836689,-0.7881996140060659,-1.34817322648622,824,2,ID2|VEGFA
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO CALCIUM ION%GOBP%GO:0061400,0.8233814378392691,0.987616425875001,-0.5859064843405379,-0.7837849682412851,6218,1,CARF
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072366,0.27777042234873606,0.7884684708511421,-0.86104984561094,-1.15185263166346,2097,1,PPARA
EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:0045022,0.9189825718323129,1.0,-0.14364524225645903,-0.6524073850297579,3901,21,EEA1|HOOK2|ANKRD27|KIF16B|FAM160A2|SNF8|HOOK3|SNX16|LMTK2|WDR91|AKTIP|PTPN23|WDR81|EMP2|RILP|PIK3C3|STX8|BECN1|RAB7A|RAB5A
SPINDLE POLE BODY DUPLICATION%GOBP%GO:0030474,0.7730736663844201,0.979946273879301,0.49712617508240997,0.812539076317278,6390,2,CETN3|EFCAB11
PROSTATE GLANDULAR ACINUS MORPHOGENESIS%GOBP%GO:0060526,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
FAT-SOLUBLE VITAMIN METABOLIC PROCESS%GOBP%GO:0006775,0.100019904458599,0.5705923657384959,0.462322816840703,1.4104409363242798,1004,11,ALDH1A2|RBP1|CYP2R1|PIAS4
POSITIVE REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001181,0.206652395850486,0.7211951452265429,-0.537436564500211,-1.2359918239194199,1254,4,PYCARD|CD274|LGALS9
POSITIVE REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045404,0.48775321064477706,0.907808599852568,-0.7542456991618879,-1.00897746852744,3683,1,CD86
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS%GOBP%GO:0051093,0.336322869955157,0.8311444145897029,-0.11026700491777901,-1.05418255469858,74,456,SDHAF2|GPER1|FUZ|FLCN|FBXW7|NOTCH1|LRP5|ARHGDIA|ID2|RNF6|ZEB1|TERF2|IL1B|RARA|WWC1|SRGN|PRAME|NFKBIA|CX3CL1|LPAR1|CTNNB1|DAB2IP|RTN4|SKI|TGFBR1|PTK2B|FOXO4|GDF15|AKIRIN1|NR1H3|PRICKLE1|FAM101B|SRGAP2C|EIF2AK3|SEMA3F|LIMD1|HDAC4|PML|TRIO|MMRN2|SFMBT1|TCTA|RHOA|SMAD6|HDAC5|HIST2H4A|EID2B|VAT1|CCDC85B|CCRN4L|PPARA|FOXO1|RUNX1|SEMA7A|MAP2K5|YWHAH|ADAMTS9|DDIT3|IL6|PPARG|FCGR2B|NFIB|EFNA1|LDLRAD4|TRIB2|ECSCR|POU4F2|ABCA1|PPP2CA|BAG5|IGF1|SPINK5|SPOCK1|PAX8|MEOX2|FOXJ2|PDCD10|WNT11|PGK1|SERPINF1|SMAD7|BHLHE41|SEMA6B|NR1H2|PDCD4|FAM101A|SOX6|ARPIN|ID1|CFLAR|NFATC2|GPR161|DKK1|RBPMS2|SOCS5|SARS|NOS3|ADCYAP1|CDKN1A|MFI2|HIST2H4B|PARK2|ABCG1|FKBP4|GREM1|SFRP2|ASCL1|PTPRM|DUSP10|THBS4|CBFB|MYLIP|ZNF365|SEMA3A|CORO1C|SEMA3G|TWIST1|TNF|ZFPM2|GAL|TNFRSF21|CAV1|LINGO1|TRIB3|RTN4RL2
REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002036,0.33809897879025896,0.832232043362884,-0.535049877444843,-1.08586782924431,2151,3,PER2
INTERMEDIATE MESODERMAL CELL DIFFERENTIATION%GOBP%GO:0048392,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF CARDIOBLAST PROLIFERATION%GOBP%GO:0003264,0.983503534956795,1.0,-0.267385527547559,-0.542650983784859,6259,3,GNG5|PIM1
DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002468,0.889664429530201,0.997300970905927,0.556296868107631,0.739015571118183,6627,1,CLEC4A
FIBROBLAST MIGRATION%GOBP%GO:0010761,0.0719463087248322,0.515023940206536,0.9648213498015,1.28172211947923,535,1,NOV
INDOLALKYLAMINE CATABOLIC PROCESS%GOBP%GO:0046218,0.7587605282312571,0.977664504547119,0.28037308805252503,0.764372257503298,7296,8,IDO1|CCBL1|AFMID|AADAT
CENP-A CONTAINING NUCLEOSOME ASSEMBLY%GOBP%GO:0034080,0.0812739296902193,0.538175749540073,0.320119370422614,1.4232834980029498,933,37,RBBP7|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|MIS18BP1|NASP|HJURP|STRA13|CENPM
VITAMIN A METABOLIC PROCESS%GOBP%GO:0006776,0.0009677029152050321,0.0849637591935908,0.980534877309071,1.6026573200928602,7,2,ALDH1A2|RBP1
REGULATION OF L-DOPA BIOSYNTHETIC PROCESS%GOBP%GO:1903195,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
CELLULAR RESPONSE TO MENADIONE%GOBP%GO:0036245,0.6799322607959359,0.9647315640607691,0.536917562724014,0.877577006284116,5620,2,NDOR1|DCPS
VIRAL GENOME PACKAGING%GOBP%GO:0019072,0.00193021529324425,0.112582730005196,-0.976344086021505,-1.66998426949525,12,2,DDX6|PC
REGULATION OF PROTEIN STABILITY%GOBP%GO:0031647,0.0117096018735363,0.23448937923535002,-0.162963340524642,-1.3977551278496398,9,223,TBRG1|CREBBP|FLOT1|MUL1|FBXL3|TAF9|PYCARD|SENP2|CALR|USP41|PHB2|FKBPL|FBXW7|HPS4|COG3|TESC|CCT4|TMEM88|PINX1|CLU|IFT46|NEDD4L|PRKCD|MSX1|RTN4|LAMP1|PFN1|HYPK|USP3|GNAQ|STXBP4|CCT7|DPM2|STUB1|VPS11|RNF139|CASP3|TBL1X|PPAP2B|RASSF2|PRNP|CHP1|GLTSCR2|EFNA1|SUMO1|SH3GLB1|CDC37|TCP1|BAG5|IGF1|PER3|PDCD10|GAPDH|SMAD7|SNCA|DNLZ|STK4|GNL3L|USP27X|VHL|PPARGC1A|BAG3|KRAS|CTSH|PEX19|SIAH3|HTT|CDKN1A|PARK2|TNIP2|ZSWIM7|FBXO7|USP2|SOX17|PIK3R1|HSP90AB1|GOLGA7
NEGATIVE REGULATION OF DNA LIGATION%GOBP%GO:0051107,0.987819409506157,1.0,-0.506396118217909,-0.677421527228304,7460,1,TFIP11
POSITIVE REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:2000753,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
REGULATION OF FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:1904735,0.5608053691275171,0.936434965680841,0.7230921923246579,0.960595718073531,4177,1,METTL20
NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042267,0.668602150537634,0.964618776001639,-0.21142197726781897,-0.843169733567023,3108,15,GZMB|ULBP3|VAMP2|ULBP2|TUBB4B
REGULATION OF SECRETION%GOBP%GO:0051046,0.00852272727272727,0.20298122046820802,-0.153072710447858,-1.41546859772297,2,384,ITGAM|TNFAIP3|NR1H3|PFKL|SSC5D|LAMP1|LIF|FGR|NAPB|CRHR1|GPI|RAB8B|VPS4A|SYN1|STXBP4|VPS18|ANO1|RAB11FIP1|TCF7L2|TNFRSF1B|ARL2BP|POFUT2|MYRIP|SLC30A1|IL6|SLC25A4|LYN|FCGR2B|NAPA|VAMP2|HTR1B|VIP|PANX1|CAMK2A|HAP1|VPS4B|VAMP3|MBP|IGF1|MAVS|PAX8|UQCC2|MYOM1|FOXP1|RIPK2|RAP1A|TMSB4X|RALA|DPH3|GAPDH|RAB8A|CRH|SNCA|RAB2B|FMR1|KARS|TNFRSF11A|PNKD|HRH3|GIPR|CHRNA3|NLRP1|NLRP3|PRKCA|SNX6|GAB2|TNFRSF4|RALB|ADCYAP1|DRD2|PPP1R11|RAB7A|SYT2|PARK2|RAB5A|ADRA2A|SLC2A1|FGF10|PER2|RAB11FIP5|ACSL3|MCTP1|CD22|NR1D1|CACNA1E|TWIST1|AQP1|TNF|RSG1|GAL|SYT9|SNAP25|TNFRSF21|CPLX1|STC1|INHBB|TRH
NEGATIVE REGULATION OF CELL MATURATION%GOBP%GO:1903430,0.181588715664439,0.6873049536419911,-0.7478040299032241,-1.27907874332741,1222,2,GAL
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030512,0.200569440050617,0.713102296410104,-0.19943801493036498,-1.19117204823155,633,47,SKI|TGFBR1|STUB1|SMAD6|SMAD2|LDLRAD4|PPM1A|SMAD7|ADAM17|UBA52|SNX6|UBC|SNX25|CAV1|UBB
NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:0014033,0.971637850268291,1.0,0.11812357735182799,0.54763272153141,11407,43,SEMA3D|SEMA5A|SEMA3E|SEMA4G|HAND2|SEMA6A|SEMA4C|NRG1|FN1|KLHL12|SEMA4A|SOX10|TAPT1|LRP6|PHOX2B|JAG1|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D|ANXA6
REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0002028,0.0734597156398104,0.5208081048222071,-0.217863984946917,-1.3617927058860901,216,55,NETO1|CAMK2D|HECW2|TESC|NEDD4L|PTPN3|CNKSR3|SCN1B|SLC9A1|RANGRF|YWHAH|CHP1|ATP2B4|NEDD4|SLMAP|SNTA1|COMMD1|FXYD5|DRD2|SLC9A3R1|SCN5A|DLG1
"NEGATIVE REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048025",0.791242996472297,0.9819233677232551,-0.20098779675179898,-0.7569162008119541,3812,13,RNPS1|SAP18
REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000662,0.367321288295365,0.851186780857897,-0.5203406874937461,-1.05601596526778,2337,3,TNFRSF21
REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120032,0.41004184100418395,0.867015886388254,-0.12897239813331401,-1.0272337693959699,587,145,AKIRIN1|PFN1|SRGAP2C|TCTEX1D2|EPS8L1|CCP110|NRP1|ATG3|TBC1D20|TBC1D8|TBC1D14|PODXL|CYLD|HAP1|TBC1D19|RALA|MARK4|TBC1D5|FMR1|TWF1|CDC42|TBC1D2|SEPT9|SSH3|TBC1D15|TWF2|HTT|RAB5A|MAP4|KCTD17|RHOQ|RAC1|BRK1|TBC1D1|CAV1
AUTOPHAGY OF PEROXISOME%GOBP%GO:0030242,0.953125,1.0,-0.233470043376712,-0.591013911599811,5550,5,PIK3C3|RB1CC1
CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0016052,0.8463635634672441,0.991298302704726,0.140987296049491,0.7400028382712389,10554,74,FUT9|FUT7|GALM|GAA|PGM5|IDNK|FUT2|FUT8|ALDH1A1|TKFC|GALE
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0036091,0.39277297721916704,0.8621064456029929,-0.510544806764989,-1.0361355163771702,2499,3,ATF4|SESN2
REGULATION OF CELLULAR RESPIRATION%GOBP%GO:0043457,0.614305203664003,0.951150755224342,0.26492123135491896,0.8777663655864091,6303,14,CCNB1|IDE|CDK1|NOA1
RNA SECONDARY STRUCTURE UNWINDING%GOBP%GO:0010501,0.9741875580315691,1.0,-0.174418142433229,-0.5421675296384559,5245,8,DDX3X|AGO2
PROTEIN TARGETING TO LYSOSOME INVOLVED IN CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061740,0.660487038491752,0.964586948392425,-0.41458034631079704,-0.841378495114723,4203,3,HSPA8|LAMP2|CLU
ESTABLISHMENT OF IMPRINTING AT MATING-TYPE LOCUS%GOBP%GO:0071516,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
DEFENSE RESPONSE TO FUNGUS%GOBP%GO:0050832,0.946771978021978,1.0,-0.23691397830983,-0.599732004193957,5513,5,S100A8|GAPDH
REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0098902,0.198748559196443,0.711592141628341,-0.54283643386575,-1.24841039538794,1206,4,PTPN3|RANGRF|SLMAP
GLYCYL-TRNA AMINOACYLATION%GOBP%GO:0006426,0.28889183106050603,0.798187790155662,-0.85603220114689,-1.1451403756772,2181,1,GARS
CORTICOSPINAL TRACT MORPHOGENESIS%GOBP%GO:0021957,0.166535742340927,0.6682860217990739,-0.648781294805338,-1.31668236166862,1059,3,SLIT2|EPHA4|SCN1B
REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0061043,0.661744505494506,0.964618776001639,-0.328976395323186,-0.832781899604323,3853,5,SERPINE1|XBP1|SMOC2|TNFAIP3|FOXC2
ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0099638,0.538134669862715,0.9267937050329059,0.40931399921581296,0.9434080908706359,4938,5,LRRC7|ARHGAP44|SCRIB
TOXIN CATABOLIC PROCESS%GOBP%GO:0009407,0.7995973154362421,0.9839175016931591,0.6015659461843851,0.7991535217463951,5956,1,ACAA1
"CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL LINEAGE COMMITMENT%GOBP%GO:0002362",0.957315436241611,1.0,0.523654609616233,0.695651786986756,7131,1,FOXP3
CYSTEINE TRANSPORT%GOBP%GO:0042883,0.68496644295302,0.966495577318169,0.661722540802823,0.879068873921034,5102,1,SLC1A1
REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0090259,0.3571428571428571,0.8449489795918371,-0.42319124703111605,-1.0712805405149899,2079,5,VEGFA|NRP1|POU4F2
PHAGOSOME MATURATION INVOLVED IN APOPTOTIC CELL CLEARANCE%GOBP%GO:0090386,0.85184694823249,0.991298302704726,-0.572562858403176,-0.7659347929811321,6433,1,RAB14
PYRIMIDINE DEOXYRIBONUCLEOTIDE SALVAGE%GOBP%GO:0010139,0.541610738255034,0.928807195199472,0.732245258050287,0.9727551575428159,4034,1,HDDC2
POSITIVE REGULATION OF APOPTOTIC PROCESS IN OTHER ORGANISM%GOBP%GO:0044533,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901184,0.0324896108802418,0.36777884196014005,-0.21795494556192202,-1.45512714704714,85,69,SHKBP1|NCK2|GPER1|FBXW7|ZGPAT|DOK1|DAB2IP|RTN4|PTPN3|GRB2|MMP9|HAP1|PTPN12|PLAUR|CDC42|ADAM17|SHC1|DUSP3|SNX6|SOCS5|RAB7A|ADRA2A|CDH13|RBPJ
CELLULAR RESPONSE TO SORBITOL%GOBP%GO:0072709,0.579060402684564,0.942692029750853,0.714545655050728,0.949242024593174,4313,1,MAPK13
REGULATION OF CORTICOSTERONE SECRETION%GOBP%GO:2000852,0.744766146993318,0.9749763305090959,-0.46098704163220294,-0.7884936458251591,5015,2,POMC|CRHR1
ACTIN NUCLEATION%GOBP%GO:0045010,0.16279569892473097,0.664859563055667,-0.321744908098576,-1.28314743785775,756,15,WHAMM|ARPC5|ARPC5L|ARPC4|ACTR2|JMY
NEURON REMODELING%GOBP%GO:0016322,0.140947075208914,0.6296802030037281,-0.4320725745207321,-1.34306968922175,758,8,SCARF1|RND1|CX3CL1|ANKS1A|EPHA8
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904751,0.8272682364564471,0.9876441563834109,-0.312659893124365,-0.7190524372464498,5023,4,PINX1|NMD3
DETERMINATION OF LEFT/RIGHT SYMMETRY%GOBP%GO:0007368,0.100092392978134,0.570809270010631,-0.22591391699790803,-1.3277327451965202,324,45,DNAI1|LRRC6|CCDC103|KIF3B|TBX20|MKKS|DYX1C1|SOX17|DNAAF1|BBS7
CYTIDINE TO URIDINE EDITING%GOBP%GO:0016554,0.45157967032967,0.886411023801201,-0.389035958526362,-0.984818695693025,2629,5,APOBEC3D|APOBEC3C|APOBEC3G|APOBEC3F|APOBEC3B
RETINA VASCULATURE MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0061299,0.495957820738137,0.9115034368265771,-0.34777622312779904,-0.954622381020113,2821,6,CYP1B1|LRP5|NRP1
REGULATION OF NEURAL RETINA DEVELOPMENT%GOBP%GO:0061074,0.5687159893481529,0.940076901516441,0.491630573012271,0.934538001701283,4911,3,SIX3|DLL4
MYELOID CELL HOMEOSTASIS%GOBP%GO:0002262,0.805654761904762,0.984682960940884,-0.135997671084712,-0.7793751421795451,2706,41,CEBPG|MFHAS1|HSPA9|SOD1|VEGFA|IKZF1|HMOX1|G6PD|CASP3|IL6|LYN|PDE4B|SLC25A38|LYAR|DYRK3
REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY%GOBP%GO:0022400,0.97242951907131,1.0,-0.153053934621962,-0.557590836658098,4690,12,PPEF1|PDE6B|GUCA1A
POSITIVE REGULATION OF PROSTAGLANDIN-E SYNTHASE ACTIVITY%GOBP%GO:2000363,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904668,0.91517227483377,1.0,0.207946843002507,0.613704857083337,9083,10,CDC20|PLK1|UBE2C|UBE2S|CDC14B|FZR1|GORASP1|PTEN
RESPONSE TO METAL ION%GOBP%GO:0010038,0.123401053423627,0.607607158836689,-0.150202672927715,-1.20360072805689,163,155,PRNP|MMP9|TNNT2|HVCN1|SUMO1|PPP2CA|PPP2CB|ITPKB|SNCA|RYR1|FXN|NEDD4|HSF1|BCL2|JUN|ANXA11|B2M|GUCA1A|MAPK3|SYT2|PARK2|SLC25A13|CRIP1|CPNE9|SCN5A|AQP1|CPNE8|SYT9|CAV1|NDRG1|HOMER1
CARDIAC CELL FATE COMMITMENT%GOBP%GO:0060911,0.272847027828092,0.7884522121551261,-0.501079728488265,-1.15237869630103,1656,4,ACVR1|SOX17
SPINDLE POLE BODY ORGANIZATION%GOBP%GO:0051300,0.17517656593724698,0.677933656654802,0.659187114016553,1.25304535986392,1512,3,CALML4|CETN3
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045742,0.183664259927798,0.689876118998471,-0.282289456328932,-1.23797285106216,813,19,AGT|SHKBP1|GPER1|FBXW7|DOK1|MMP9|HAP1|PLAUR|ADAM17|ADRA2A
STRIATED MUSCLE CELL PROLIFERATION%GOBP%GO:0014855,0.7742188374958001,0.980173768720877,0.363250553573205,0.769762622522428,6912,4,TGFB2|C3orf58|NDRG4|TGFBR3
METANEPHRIC GLOMERULUS VASCULATURE MORPHOGENESIS%GOBP%GO:0072276,0.7363028953229399,0.974262605126702,-0.464460987041632,-0.794435643395373,4958,2,PDGFRA|PDGFRB
POSITIVE REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0106134,0.8204237582493921,0.987153241368501,0.39536968415891105,0.7515561782564599,7085,3,RNF207|TRPM4|NOS1AP
TROPHOBLAST GIANT CELL DIFFERENTIATION%GOBP%GO:0060707,0.123422484659025,0.607607158836689,0.6955407414342409,1.3221497813268799,1065,3,E2F8|E2F7|PLK4
MAINTENANCE OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045199,0.10824823252160301,0.58452352834625,-0.702470381353921,-1.4256427676461598,688,3,PDCD6IP|WDR1
NEGATIVE REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903996,0.497021051237919,0.9118384435084941,-0.748786943096603,-1.0016751241028299,3753,1,DUSP22
PROTEIN DE-ADP-RIBOSYLATION%GOBP%GO:0051725,0.8922048997772829,0.9976191001250191,-0.39173600083014204,-0.6700434493817429,6008,2,MACROD2
MITOTIC NUCLEAR DIVISION%GOBP%GO:0140014,0.00141738157403954,0.0961252072968491,0.294652041609115,1.72398709437983,18,132,KIF25|CCNB1|PSRC1|KIF14|NCAPD3|ZWINT|SPAG5|KIF2C|KIF18A|NSL1|KIF4A|MAP10|NUF2|KIF23|PRC1|KIF11|DLGAP5|TUBGCP3|CDC23|SMC2|NDC80|WRAP73|NUSAP1|CENPE|KIF18B|RB1|CEP55|AKAP8L|INO80|ESPL1|AURKB|BOD1|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|TUBG2|SPDL1|KIF22|PPP2R2D|TUBGCP6|CDCA5|KLHL22|CEP192|DSCC1|CHEK2|PLK1|TUBGCP2|NCAPG|POGZ|NCAPH|RACGAP1|UBE2C|SMC4|KLHDC8B|TEX14|TUBGCP4|FAM175B|RECQL5|HIRA|SGOL1|TPX2|PDS5B
REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043122,0.0330228619813717,0.371559593752943,-0.16313144438314098,-1.34508076728249,38,179,MUL1|OTUD7B|PYCARD|RIOK3|LGALS1|MIER1|TRIM8|IL1RN|HSPB1|NOD1|TRAF3IP2|OTUD7A|SECTM1|IL1B|IRAK1|TRIM13|MTDH|LURAP1|CX3CL1|SIRPA|LPAR1|DAB2IP|LGALS9|USP10|HMOX1|TNFAIP3|SQSTM1|IRAK4|C18orf32|RHOA|BCL10|TMED4|UBE2V1|NEK6|REL|TANK|RNF31|LITAF|MAVS|TNIP1|RIPK2|RHOC|PPM1A|AKAP13|DDX21|TRIM25|CFLAR|PELI2|RBCK1|TNFRSF10B|SHISA5|PARK2|TNIP2|S100A4|EDA2R|PELI1|TICAM1|MYD88|DDRGK1|GPRC5B|PLK2|TNF|FKBP1A
"CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0035710",0.9589350180505408,1.0,-0.13516944475107598,-0.592781980138834,4249,19,SLAMF6|RORA|LEF1|PLA2G2D|STOML2|ZFPM1|ATP7A|FOXP3|HMGB1|LY9|PTGER4|RSAD2|SPN|RORC|GPR183|BATF|IL6|FOXP1|STAT3
RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0000302,0.453314659197012,0.8877077061560501,-0.139656025571086,-1.00587782742264,970,94,PPIF|IMPACT|PLK3|MAPK7|PRKCD|SIRPA|PTPRN|STK26|ROMO1|HMOX1|TNFAIP3|SOD3|HP|ABL1|RPS3|FYN|ZNF580|FOXO1|APOD|PXN|IL6|MMP9|SOD2|PDCD10|FXN|NET1|JUN|NOS3|MAPK3|STK24|AQP1
ECTODERMAL PLACODE MORPHOGENESIS%GOBP%GO:0071697,0.43487321986801,0.878651088001772,0.5408044290019051,1.02801232904209,3755,3,PROX1|HDAC2|HDAC1
MODULATION BY HOST OF VIRAL GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0044870,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
POSITIVE REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION%GOBP%GO:0072513,0.536078379451873,0.9265056012720759,-0.727723864137627,-0.973498401171511,4048,1,GNG5
TRNA 3'-TERMINAL CCA ADDITION%GOBP%GO:0001680,0.737587713491328,0.974306231601101,-0.626488751654169,-0.8380731045696859,5570,1,TRNT1
NEGATIVE REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905098,0.562325045282397,0.937076381054718,-0.391754105546941,-0.90095260245862,3414,4,FAM65B|GPSM1|MET
CARTILAGE DEVELOPMENT%GOBP%GO:0051216,0.963672721213131,1.0,0.11924615586858998,0.5816023534206899,11565,53,HOXD3|GHRL|NOV|WNT5B|BMP4
L-TRYPTOPHAN TRANSMEMBRANE TRANSPORT%GOBP%GO:1904556,0.803221476510067,0.984522820758988,0.5993052492280551,0.796150286696752,5983,1,SLC36A4
PYRIMIDINE RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046133,0.14320054945054903,0.632949331968897,-0.5255076038137889,-1.3302876035547602,833,5,ENTPD4|CDA|CDADC1
DITP METABOLIC PROCESS%GOBP%GO:0035862,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
MODULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052205,0.416881443298969,0.8709670999109399,0.422647345162305,1.03943959277084,3881,6,SUGT1|PTX3|RAB9A|NUCKS1|ANXA2|CASP8
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0046902,0.000683526999316473,0.0806484601749226,-0.35583057591188294,-2.23411984608595,1,56,MUL1|SLC25A5|ZNF205|THEM4|BAX|PPIF|TP53BP2|GZMB|BBC3|MPV17L|YWHAH|BCL2L1|CAMK2A|BOK|BID|ACAA2|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|SLC35F6|BNIP3L|BMF|BCL2L11|PMAIP1|TFDP2
NEGATIVE REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903579,0.00197005516154452,0.112650093274223,-0.6278937434183071,-2.1242585171099,9,10,FLCN|CBFA2T3|PPIF|HDAC4|FBP1|PPARA|SNCA|PDE12
POSITIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0033141,0.33615781808552897,0.8311444145897029,-0.8328187031318921,-1.11408697160892,2538,1,LIF
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055022,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
MESODERM DEVELOPMENT%GOBP%GO:0007498,0.543508527671424,0.929698169790548,0.21139714719764396,0.939893361448561,6245,37,ITGB1|TBX3|BMP4|MEST|TBX6|ITGA2|JAK2|GDF11|LEF1
NEGATIVE REGULATION OF MACROAUTOPHAGY BY TORC1 SIGNALING%GOBP%GO:1904766,0.581342281879195,0.9430511832893861,0.7131671812968678,0.9474107837092459,4330,1,CLEC16A
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033144,0.51802293828509,0.9236324326350509,0.23883321499361998,0.9602239238961059,5690,26,SIRT1|ARNTL|HEYL|CLOCK|SMARCA4|STRN3|DAB2|CNOT1|BRCA1|CNOT2|NCOR1|ISL1
CELL-CELL SIGNALING VIA EXOSOME%GOBP%GO:0099156,0.34767641996557697,0.842847021021096,-0.826477723864138,-1.1056044503076101,2625,1,KLF5
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090090,0.6894107221976079,0.96731875442989,-0.123805492961041,-0.8883816475064871,1555,90,TMEM170B|AXIN2|CSNK1A1|AMER1|SNAI2|SDHAF2|FUZ|TMEM88|IGFBP4|DAB2IP|PRICKLE1|PTPRU|LIMD1|TCF7L2|DDIT3|CYLD|RUVBL2|JADE1|WNT11|STK4|DKK1|PARK2|GREM1|SFRP2|SLC9A3R1|RBMS3|SOX17|CAV1|TLE3
CAMKK-AMPK SIGNALING CASCADE%GOBP%GO:0061762,0.8832708358533929,0.996316041142784,0.445399028836046,0.727992476805429,7301,2,CAMKK2
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007173,0.8325619384699159,0.9881079448903741,-0.141032692587368,-0.7543515007799549,3057,33,NCK2|PLCE1|DGKD|BCAR1|PTK2B|GRB2|HBEGF|ADAM17|SHC1|PIK3R1
GENE CONVERSION%GOBP%GO:0035822,0.726503340757238,0.972554563883587,-0.469092914254205,-0.8023583068223241,4892,2,NUCKS1|RNF212
POSITIVE REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0031536,0.606923700358921,0.9508825506493929,0.47762731586018303,0.907919282942522,5241,3,CDCA5|UBE2C
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901380,0.0785655058043118,0.532203813468543,-0.40219643149982304,-1.4652419442519098,378,12,NEDD4L|KCNE3|KCNE4|KCNAB1|SUMO1|BIN1|CAB39|CAV1
NEGATIVE REGULATION OF PLASMACYTOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002737,0.7605369127516779,0.977664504547119,0.622353330392589,0.8267686342760359,5665,1,BST2
METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072205,0.23418410547961802,0.7481332891296201,0.71718223974655,1.17221466871708,1935,2,BMP4|PKD1
NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0061179,0.161841128433556,0.664367762084791,-0.758864074993107,-1.29799635811553,1089,2,PIM3|ADRA2A
ALKALOID CATABOLIC PROCESS%GOBP%GO:0009822,0.37075117938792795,0.852609194081082,0.656299972429005,1.07270427532028,3064,2,CYP3A5|CYP2D6
PROSTATE GLAND STROMAL MORPHOGENESIS%GOBP%GO:0060741,0.0663312591023435,0.49796554034175394,-0.965924128804587,-1.29214615788169,500,1,CRIP1
REGULATION OF ACTIN PHOSPHORYLATION%GOBP%GO:0043538,0.165232358003442,0.668049608148938,-0.914479488310543,-1.22332709375887,1247,1,TWF1
CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:0006921,0.5392810820826389,0.928041735228137,0.245489878817736,0.940169289787769,5820,22,DFFB|ENDOG|BLCAP|TOP2A|FEN1|CAPN10|ACIN1|DICER1|CDK5RAP3|DNASE1L3
DUDP METABOLIC PROCESS%GOBP%GO:0046077,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072384,0.040207972270364,0.400170810558592,-0.22845937265945002,-1.43996645094439,115,57,BLOC1S4|RAB6A|HAP1|RAB1A|AP3S2|CDC42|BLOC1S6|KIF3B|TRAK1|HTT|BLOC1S3|KIF13A|BICD1|UBB
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT%GOBP%GO:0021954,0.809862869198312,0.984682960940884,-0.14684938336332,-0.7618593070130191,3070,30,DRD2|HSP90AB1|SLIT3
HINDBRAIN MATURATION%GOBP%GO:0021578,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
DENDRITE EXTENSION%GOBP%GO:0097484,0.49683655536028104,0.911815944636073,-0.347526336109426,-0.953936457933365,2826,6,CDKL3|SLC9A6|AUTS2|LLPH|SH3GL2|TMEM108
DETECTION OF BACTERIAL LIPOPROTEIN%GOBP%GO:0042494,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|TLR1|SSC5D
POSITIVE REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045666,0.933110853163088,1.0,0.11377856262455499,0.6925130257601729,12861,172,SYT17|RIT2|HOXD3|FAM150B|RIMS2|BRINP3|LRRC7|VLDLR|SYT3|PROX1|DSCAM|PLXNC1|ECT2|ZNF804A|MARK2|CUX2|BRINP1|DVL1|ROBO2|UNC13A|SEMA5A|CPEB3|MAP6|PTPRD|PLXNA3|HEYL|GRIP1|DLG5|CAPRIN2|RUFY3|APOE|P3H1|PLXNB2|OBSL1|DPYSL3|SHTN1|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|LRP8|PLXNA2|NTN1|CPNE1|CUL7|SLITRK1|SYT1|ZC4H2|CAMK1|SHANK1|DVL3|TCF12|STYXL1|CDKL3|DVL2|PLAA|SS18L1|PRKD1|ZFYVE27|RIMS1|NEURL1|NGF|REST|L1CAM|DBN1|STMN2|SETX|CPNE5|MAPT|SYT4|CSNK1E
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051353,0.125602140945584,0.607607158836689,0.320120260158663,1.34224223988031,1407,30,EDN1|CDH3|INS|DHFR|POR|S100A1|AGTR1|SCARB1|TERT|RFK|APOE
INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038110,0.442277383766746,0.880423444399886,-0.293540023169857,-0.993089835449739,2244,10,STAT5B|IL2RA|JAK3|IL2RB|JAK1|SYK|IL2RG|PTK2B|STAT5A|SHC1
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031111,0.859524876736889,0.9916689277956879,0.16679151867786499,0.6909066362490921,9587,29,NAV3|CAMSAP3|FGF13|APC|TAOK1|STMN1|APC2|CAMSAP2|TBCD|TUBB4A
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032231,0.032446226759023,0.36777884196014005,-0.22460950382379302,-1.46334572344425,88,64,ARHGEF5|PPM1F|S100A10|SYNPO|PPFIA1|CX3CL1|LPAR1|TGFBR1|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|INPP5K|PXN|SERPINF2|RHOC|LIMK1|WNT11|CDC42|SORBS3|PARK2|TMEFF2|RAC1|MET
POSITIVE REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901300,0.45006711409396,0.886062942999295,0.7804367004852231,1.03677533884496,3352,1,HDAC6
DELAMINATION%GOBP%GO:0060232,0.912059997580743,1.0,0.42795881882888304,0.6994869326593169,7539,2,METTL3|YTHDF2
CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:0032048,0.289574898785425,0.7989014598698071,0.406157594624027,1.1590350004376297,2860,9,PLA2G4A|TAZ|TAMM41|CRLS1|PGS1|LCLAT1|SLC27A1
BASAL DENDRITE MORPHOGENESIS%GOBP%GO:0150019,0.311861743912019,0.8143712300420921,-0.548859102404894,-1.11389324101064,1984,3,NRP1|SEMA3A
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING%GOBP%GO:0060054,0.181788243042977,0.6873049536419911,-0.5543805866778361,-1.27495953519774,1103,4,MMP12|FGF10
REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001959,0.0817282665278501,0.539385377100419,-0.16834624177816,-1.2716901183179599,156,111,MUL1|PYCARD|SOCS3|ELF1|HIPK1|HIF1A|IL1RN|RNASEL|PTPN6|IRAK1|CLIP3|IRAK2|TNFAIP3|CD300LF|NR1H3|IFNAR2|RNF113A|SPHK1|RUNX1|IL6|PPARG|CYLD|SUMO1|RNF31|CDC37|MAVS|CNOT7|PTPN1|NR1H2|ADAM17|RBCK1|PARK2|TAX1BP1|CBFB|HSP90AB1|UBE2K|TNF|SPATA2|SLIT3
GENE SILENCING BY RNA%GOBP%GO:0031047,0.9648043317745509,1.0,0.116445398661556,0.584413426838033,11759,60,LIN28B|ZCCHC11|CELF1|PIWIL4|DHX9|DROSHA|TERT|TNRC6A|C9orf114|METTL3|SRRT|NRDE2|TNRC6C|AJUBA|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6|CNOT1|RBM4|PIWIL2|ZC3H7A|XPO5|AGO4|CNOT8|WTIP
NEGATIVE REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001107,0.578975241625844,0.942692029750853,-0.7041795324217031,-0.9420024307744641,4372,1,FAM65B
NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901032,0.457504145936982,0.890018343810919,-0.271467984122952,-0.988985097095861,2206,12,TRAP1|PARK7|NUP93|TXN|PDE8A|HGF|MET
INOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046103,0.68483896307934,0.966495577318169,-0.406032866438734,-0.82403163867115,4358,3,ADAL|CECR1|ADA
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034145,0.8549183848797249,0.991298302704726,0.27885844106607105,0.6858117239825949,7960,6,F2RL1|TICAM2|PTPN22
'DE NOVO' AMP BIOSYNTHETIC PROCESS%GOBP%GO:0044208,0.773069352784532,0.979946273879301,0.41586435225472895,0.790514386348451,6676,3,ADSSL1|ADSS
REGULATION OF ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0032956,0.7582938388625591,0.977664504547119,-0.105030568503931,-0.901802935643812,639,227,ASAP3|TRIOBP|FCHSD1|CXCL12|ABL2|KANK4|EZR|ARPC1B|ARHGEF5|PPM1F|PYCARD|CAPZA2|CDK5|RLTPR|S100A10|RND1|GPM6B|NCK2|SYNPO|ARHGDIA|HAX1|CDC42EP5|PPFIA1|ADD1|CX3CL1|BCAS3|PRKCD|LPAR1|F11R|TGFBR1|CFL2|PTK2B|VASP|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|INPP5K|WDR1|TMSB10|MYADM|WHAMM|NAT6|PXN|RND2|ARPC5|BIN1|SERPINF2|WIPF1|CRK|RHOC|TMSB4X|LIMK1|WNT11|ARPC5L|ARPC4|TWF1|CDC42|AKAP13|MTPN|ARPIN|SSH3|TWF2|SORBS3|PARK2|TMEFF2|RHOQ|RAC1|MET|ACTR2|BRK1|SH3BP1|JMY
ENDOTHELIAL CELL MORPHOGENESIS%GOBP%GO:0001886,0.013668499607227,0.256136946817111,-0.8371015771478991,-1.69887277944154,86,3,COL23A1|MET|STC1
POSITIVE REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0045842,0.173481781376518,0.676682497340677,0.452844067529836,1.29226224242705,1713,9,ANAPC5|DLGAP5|RB1|ESPL1|CDT1|ANAPC4
POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010831,0.678689883913765,0.9647315640607691,-0.22703607906892703,-0.827115210022523,3273,12,EHD1|EHD2|RBM24
MODULATION BY ORGANISM OF APOPTOTIC PROCESS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052433,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|SERPINB9|BCL2L1|GAPDH
NEGATIVE REGULATION OF CELL CYCLE PROCESS%GOBP%GO:0010948,0.039624240711965,0.39680101374569604,0.21615843387460396,1.36703485058259,560,227,RBBP7|KIF25|BTG2|TAOK3|EHMT1|KAT2A|CCNB1|PIDD1|TPR|CDC7|BMP4|CDK1|APAF1|E2F8|FBXO43|PKD2|BLM|CENPF|NAA10|WEE1|CDK2AP2|PCGF2|ORC1|CDC25C|USP47|MUC1|BUB1|DTL|E2F7|DONSON|PPP1R10|EZH2|NEK2|DACT1|CDC20|APC|ZNF830|CDK5RAP2|PTTG1|FBXO5|RB1|BUB1B|NAE1|GTSE1|ESPL1|AURKB|CDC6|MSH6|RAD51|E2F6|TRIM37|CCL2|KLHL22|TAOK1|RPS27L|BRCC3|CCNF|CHEK2|TOPBP1|PLK1|PRMT1|BRSK1|CARM1|AURKA|CDC73|ARID3A|CLSPN|EHMT2|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|MDM1|SUZ12|C5orf45|TEX14|PRKDC|EED|FHL1|RRM2|CHEK1|RBX1|FBXL7|ZNF268|RAD17|SMC3|MGA|RAD1|CASP2|TMEM67|CDK2|ATM|TFAP4|UXT|RFWD3|CNOT1|UIMC1
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060760,0.9708490648871719,1.0,0.123233128609346,0.535941500313481,11056,34,EDN1|AK6|DHX9|ZBP1|IL7|C1QTNF4|CPNE1|TICAM2|CSF1|PARP9|TLR4|PARP14|DDX58|IFIH1|FADD|AGPAT2|AGPAT1|TLR2|CD74|TRIM44|TREM2|CASP4|TXK
POSITIVE REGULATION OF NEUTROPHIL DIFFERENTIATION%GOBP%GO:0045660,0.8975838926174499,0.998912093067348,0.552823114247905,0.734400844090683,6686,1,EVI2B
ESTABLISHMENT OF VIRAL LATENCY%GOBP%GO:0019043,0.971457489878543,1.0,0.18231465136804897,0.520263722321281,9597,9,LIG4|XRCC4|PSIP1|IRF7|PPIA|XRCC5|HMGA1|XRCC6|BANF1
ENDOTHELIUM DEVELOPMENT%GOBP%GO:0003158,0.000358551452133381,0.0784645998831315,-0.33119958477267103,-2.12507388447363,0,61,EZR|DLL1|RAP2C|LAMA5|RAP1B|NOTCH1|KDR|F11R|CTNNB1|ACVR1|PDPN|PRKD2|COL23A1|RHOA|NRP1|MYADM|TJP2|RAP2B|RAB1A|ICAM1|RAP1A|MSN|RAPGEF1|GSTM3|ACVRL1|MET|SOX17|PDE4D|RBPJ|STC1
LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034383,0.6712545126353789,0.964618776001639,-0.193257611212928,-0.8475260785650909,2974,19,EHD1|CLTA|AP2S1|DGAT2|CD36
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-ALPHA SIGNALING PATHWAY%GOBP%GO:2000583,0.7172034564022001,0.971081608033886,-0.39357008933495097,-0.798738802824392,4564,3,IFT20|CBL|CBLB
ACTION POTENTIAL%GOBP%GO:0001508,0.113814364272621,0.590080021815051,0.274549287375779,1.33906632465112,1365,53,RYR2|KCNN2|SCN1A|CACNA1G|CACNB2|FGF12|HCN2|KCNQ1|CACNA1I|CACNA1H|CACNA2D1|KCNH2|CACNA1D|GJA1|ANK3|DMD|KCND2|SCN3B|SLC8A1|SCN8A
PINOCYTOSIS%GOBP%GO:0006907,0.0636470128855916,0.493545616162616,-0.471590909090909,-1.5223377148201498,325,9,RAB34|SNX33|SNX5|DOCK2|LRRC16A|PPT1|MAPKAPK2|MAPKAPK3|PYCARD
2-OXOBUTYRATE BIOSYNTHETIC PROCESS%GOBP%GO:0046360,0.484575665298557,0.9064456896937672,-0.756175562417292,-1.01155910544523,3659,1,THNSL2
AXONEMAL DYNEIN COMPLEX ASSEMBLY%GOBP%GO:0070286,0.0318021201413428,0.36484755247355394,-0.3898831123971961,-1.64058329365374,143,17,DNAI1|LRRC6|CCDC103|DYX1C1|DNAL1|DNAAF1
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032911,0.8514530508278342,0.991298302704726,0.379138718291747,0.7207028195765022,7353,3,GATA6|LAPTM4B
CELLULAR CADMIUM ION HOMEOSTASIS%GOBP%GO:0006876,0.230372037600953,0.743397546142977,-0.884318482576092,-1.18297979678654,1739,1,SLC11A1
REGULATION OF NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070950,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
RESPONSE TO OTHER ORGANISM%GOBP%GO:0051707,0.294871794871795,0.800447413278835,-0.115549416839481,-1.06249159423527,114,364,IGHV4-4|CD274|BATF|IL1B|CLU|IRAK1|APOBEC3F|MTDH|FCER1G|PRKCD|SIRPA|DAB2IP|TRIB1|BANF1|IGHV2-26|LGALS9|ROMO1|TNFAIP3|DDIT4|NR1H3|IFNAR2|SSC5D|FGR|IGHV1-69-2|S100A8|IGHV3-15|RHOA|IGHV3-73|DDX3X|EXOSC4|IFNAR1|IFITM2|FOSL1|TNFRSF1B|BCL10|CCRN4L|MX2|IFITM3|VIM|IL6|OASL|LYN|FCGR2B|SBNO2|ENO1|DFNA5|CHIT1|APOBEC3B|SLC11A1|MST1R|ATG7|RAB1A|LAMTOR5|MAVS|FOXP1|AP1S1|CNOT7|GAPDH|LDOC1|PLA2G2A|SNCA|FMR1|OAS3|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|IGHV1-3|NLRP1|PDE12|ODC1|NLRP3|BCL2|SHC1|JUN|BCL3|NOS3|PPP1R11|ZC3HAV1|BNIP3L|TNIP2|HIST1H2BC|EXOSC5|TICAM1|IFITM1|MYD88|NR1D1|LIAS|CD36|TNF|PRSS3|PMAIP1|CAV1
REGULATION OF NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032903,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
L-PROLINE BIOSYNTHETIC PROCESS%GOBP%GO:0055129,0.561895935389911,0.936738331587711,-0.7131120423467141,-0.953951721651095,4243,1,PYCRL
SELENIUM COMPOUND METABOLIC PROCESS%GOBP%GO:0001887,0.6936947026542729,0.96731875442989,0.39516242013419606,0.8373869161454891,6193,4,SEPP1|SEPHS1|TXNRD1
POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046579,0.0268756998880179,0.339762187668294,-0.287329030717752,-1.58056597170747,95,36,MAPRE2|NTRK1|CRKL|NOTCH1|LPAR1|GRB2|VAV1|LYN|ARRB1|SHOC2|IGF1|MAP4K4|AKAP13|RAPGEF1|SHC1|FGF10|GPR4|RAC1
REGULATION OF ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:1904910,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
NEUROPILIN SIGNALING PATHWAY%GOBP%GO:0038189,0.0077391733904166,0.198167223413272,-0.799371311972647,-1.83838702302055,46,4,VEGFA|ABL1|NRP1|CDC42
REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905097,0.721968365553603,0.971401508276304,-0.28853532181400704,-0.7920100846493859,4107,6,EPHA4|FAM65B|GPSM1|MET
ACTIVATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:0007202,0.53247311827957,0.9265056012720759,-0.23442481332252302,-0.934907098803002,2475,15,LPAR1|C5AR1|GNAQ|GNA15|EDNRA
REGULATION OF KERATINOCYTE APOPTOTIC PROCESS%GOBP%GO:1902172,0.931123306081308,1.0,0.29090608283240504,0.6164577783187621,8313,4,PIAS4|ZFP36L1|SFRP4|GSN
POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034767,0.6166336633663371,0.95208559565634,0.16888784486880898,0.9020508545133349,7784,80,RYR2|AKAP9|CACNB2|KCNQ1|STK39|ATP1B3|ACTN2|F2R|CXCL9|LRRC55|PKD2|PDPK1|CACNA2D1|STAC2|KCNH2|STAC3|CXCL10|WNK3|PLCG1|ANK3|DRD4|DMD|TRPC1|TCAF1
NEGATIVE REGULATION OF OSTEOCLAST PROLIFERATION%GOBP%GO:0090291,0.0844840386043059,0.545178773025535,-0.824372759856631,-1.4100454551538402,568,2,TNFAIP3|GREM1
NEGATIVE REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000734,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
NEGATIVE REGULATION OF PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1905090,0.49342281879194605,0.910654969509744,0.757443758270843,1.00623024090103,3675,1,VPS13C
RESPONSE TO IONOMYCIN%GOBP%GO:1904636,0.9688865351515951,1.0,-0.514280988089987,-0.68796935806385,7317,1,ZC3H12A
RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0002138,0.7477823381437841,0.9749763305090959,-0.6211954124393471,-0.83099204330946,5647,1,ALDH1A3
ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046632,0.9940163858970821,1.0,0.111120479327497,0.43217013247789504,10797,23,BLM|SLAMF6|RORA|LEF1
REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000425,0.5066028907143599,0.9172434440873181,0.353602589352024,0.9640155243123192,4871,8,ABCA7|CCL2|C4A|C4B|C2|HMGB1|C3
FEMALE PREGNANCY%GOBP%GO:0007565,0.24933616569304298,0.7613646381106121,-0.21952719717205602,-1.1543913803132702,938,31,EMP2|LNPEP|PCSK5|APOL2|HAVCR2|PRLHR|PTHLH|SOD1|PPARD|IL1B|COL16A1|LGALS9|CRHR1|CRH|BCL2|BYSL|ADCYAP1|TAC3
REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032642,0.0333333333333333,0.37425988700565005,-0.27785633965670603,-1.5434798513358199,116,37,EIF2AK2|MUL1|IL6R|SNAI2|PYCARD|HIF1A|IL1B|SIRPA|LGALS9|HMOX1|DDX3X|APOD|MAP2K5|IL6|MBP|MAVS|ADAM17|ADCYAP1|TWIST1|TNF
TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002224,0.00294117647058824,0.131456330716537,-0.280837322911069,-1.8476309787791898,7,66,IKBKB|PIK3AP1|LY96|ITGB2|PRKCE|MAPKAPK2|S100A9|UNC93B1|TRAF6|MAPKAPK3|CTSS|RPS6KA3|SCARA3|TLR1|IRAK1|PIK3C3|LGALS9|IRAK2|ITGAM|CD300LF|IRAK4|TRAF3|S100A8|BCL10|TANK|CNPY3|TNIP1|RIPK2|RFTN1|UBA52|COLEC12|TNIP2|TICAM1|MYD88|UBC|CD36|UBB
REGULATION OF TRANSLATIONAL TERMINATION%GOBP%GO:0006449,0.566620879120879,0.9388612723386429,-0.35590402314859293,-0.9009474013578791,3299,5,MTRF1|OGFOD1|ETF1
POSITIVE REGULATION OF WHITE FAT CELL PROLIFERATION%GOBP%GO:0070352,0.622798887859129,0.9536478716552259,-0.682013674459638,-0.912350486747267,4703,1,VSTM2A
NEGATIVE REGULATION OF APPETITE BY LEPTIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038108,0.7376276512175959,0.974306231601101,-0.386346090217271,-0.784077911249501,4694,3,BBS2|BBS4|MKKS
GLYCOLYTIC PROCESS THROUGH FRUCTOSE-6-PHOSPHATE%GOBP%GO:0061615,0.00047528517110266203,0.0784645998831315,-0.4768837663179679,-2.2092786897554704,1,22,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
REGULATION OF PH%GOBP%GO:0006885,0.980859208847299,1.0,0.110926369652348,0.519955049739867,11529,45,TMEM165|SLC9A5|SLC9A7|DMXL2|CLN6|PDK4|TCIRG1|GPR89B|ATP6V0E2|ATP6AP1|SLC4A2|ATP6V0A2|SLAMF8|VPS33A|DMXL1|TMEM199|RAB20|SLC9A6|CLCN3|ATP6V0A1
ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE ORGANIZATION%GOBP%GO:1990809,0.411658159064713,0.867015886388254,-0.443498729736913,-1.0199544282649202,2499,4,RTN4|ATL2
GPI ANCHOR RELEASE%GOBP%GO:0006507,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
PROTEIN LOCALIZATION TO GOLGI APPARATUS%GOBP%GO:0034067,0.80952380952381,0.984682960940884,0.183647252819439,0.7318078847706708,8890,25,ARL5B|GBP5|VPS13A|OBSL1|VPS13C|ARL1|GBF1
MONOUNSATURATED FATTY ACID CATABOLIC PROCESS%GOBP%GO:1903965,0.0487248322147651,0.43467341919055,0.9750220555800619,1.2952733020203,362,1,GLYATL2
RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY%GOBP%GO:0007168,0.078732220853399,0.532203813468543,0.670458828865544,1.4207663039303502,702,4,NPR2|GUCA1B
HEXOSE BIOSYNTHETIC PROCESS%GOBP%GO:0019319,0.000544514021236047,0.0784645998831315,-0.412519616921571,-2.20647274342567,1,33,GPI|CRTC2|FBP1|ENO1|GAPDH|PGK1|SORD|PPARGC1A|TPI1|G6PC3|ALDOA|SLC25A13|PER2|PC|PGAM2
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002292,0.7365532381997809,0.974306231601101,-0.19518402632267104,-0.7993441872827829,3354,16,RORC|GPR183|BATF|FCER1G|IL6|FOXP1|STAT3
TRIPEPTIDE TRANSPORT%GOBP%GO:0042939,0.0846325167037862,0.545178773025535,-0.824262475875379,-1.4098568203103403,569,2,ABCC1|SLC9A3R1
CELLULAR RESPONSE TO ACETYLCHOLINE%GOBP%GO:1905145,0.0779826705176627,0.5314695499765479,-0.333684961132215,-1.43543856515472,350,18,CHRM4|CHRNB2|GNAQ|GNA15|CHRNA7|HRH3|CHRNA3|CHRM1|PLCB1
CELLULAR RESPONSE TO ANTIBIOTIC%GOBP%GO:0071236,0.26167907921462397,0.771967970256231,-0.180943808159097,-1.13101740145967,772,55,AHR|PPIF|ADCY7|IMPACT|MAPK7|PRKCD|SIRPA|TNFAIP3|ABL1|RPS3|ZNF580|IL6|PDCD10|FXN|NET1|HSF1|TP53|ADCY2|CRIP1|AQP1
GLYCOLYTIC PROCESS%GOBP%GO:0006096,0.00323463548146305,0.137762274603971,-0.41376340042257503,-2.00727855339812,12,25,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
C4-DICARBOXYLATE TRANSPORT%GOBP%GO:0015740,0.49263535031847105,0.910097257414447,0.31981646110096695,0.9756867115701701,4949,11,SLC1A2|SLC25A22|LRRC8D|SLC25A10|SLC1A3|SLC1A1|SLC25A30
POSITIVE REGULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0043947,0.0916778523489933,0.5622489437340121,0.9547860608734009,1.26839068584423,682,1,SUGT1
CELLULAR RESPONSE TO LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071404,0.222037767171612,0.73556947110949,-0.318778326769559,-1.20051308536694,1069,13,PPARG|ABCA1|CD9|CD36|CDH13
NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033629,0.235520432567329,0.750277765814412,0.44462543142987604,1.21216821174279,2264,8,KIAA2022|PDE3B|MUC1|ACER2|SERPINE1|WNK1
REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001014,0.47073072264836496,0.897820050418009,-0.27778979585219504,-0.97757690123633,2331,11,AKIRIN1|UQCC2|NR1D2|RBM24
REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904350,0.805075821398484,0.984682960940884,0.276763740185834,0.7203578676096,7644,7,LDLR|LAPTM4B|ATP13A2|LRP1|MGAT3
POSITIVE REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032727,0.928017612711783,1.0,0.171904126442639,0.595944987714084,9694,16,DHX9|TBK1|CHUK|STAT1|TLR4|HSPD1|DDX58|IFIH1|HMGB1|IRF5|IRF7
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901254,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
N-GLYCAN PROCESSING TO LYSOSOME%GOBP%GO:0016256,0.196241610738255,0.7100128962886071,0.903782531980591,1.2006347731388798,1461,1,GNPTAB
NEGATIVE REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032713,0.331504087803785,0.8293509737209019,0.523741245243479,1.1098577290413798,2959,4,LEF1|ZFPM1|NDFIP1|FOXP3
"NUCLEOTIDE-EXCISION REPAIR, DNA DAMAGE RECOGNITION%GOBP%GO:0000715",0.0188451316743175,0.286396032442422,-0.36184436565038397,-1.70027641566164,77,23,RAD23B|COPS7A|CETN2|UBA52|COPS2|COPS8|UBC|UBB
NEGATIVE REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905457,0.456392887383573,0.8891098233101229,0.620624788338597,1.01439416697914,3772,2,HES1
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:0061309,0.5073182532962379,0.9177168315498629,0.601378549765647,0.98293671875676,4193,2,HAND2|JAG1
RESPONSE TO ODORANT%GOBP%GO:1990834,0.0417052826691381,0.402998391331252,-0.978330392589325,-1.30874239521034,314,1,CFAP69
PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006646,0.9933189231676159,1.0,0.143420529011854,0.45211276109497206,10109,12,CEPT1|CHKB|ETNK1|CHKA|ETNK2|SLC27A1|EPT1|PISD
FILOPODIUM ASSEMBLY%GOBP%GO:0046847,0.206720377284339,0.7211951452265429,0.39635132491262504,1.24944101869187,2103,12,FGD6|DNM3|FGD1|FGD2|ARHGEF4|S1PR2
PROTEIN KINASE A SIGNALING%GOBP%GO:0010737,0.0286467486818981,0.347919292482523,-0.62622251010708,-1.7189387424773201,162,6,LCP1|EZR|RAB13|MYOM1|GAL
NEGATIVE REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032348,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:0006369,0.9158593966233051,1.0,-0.126065675097028,-0.67834513239168,3308,34,TTF2|SNRPB|NCBP2|NUDT21|SLBP
POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS%GOBP%GO:0040038,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
CHOLESTEROL BIOSYNTHETIC PROCESS VIA DESMOSTEROL%GOBP%GO:0033489,0.319744652256692,0.8219996514077841,0.528748656568539,1.1204689119720401,2854,4,EBP|DHCR24|DHCR7
PROTEASOME CORE COMPLEX ASSEMBLY%GOBP%GO:0080129,0.571296173705812,0.9405138747864158,-0.708480370533745,-0.947755793048397,4314,1,PSMG1
PROTEIN LOCALIZATION TO MITOTIC SPINDLE%GOBP%GO:1902480,0.671812080536913,0.964671573446318,0.668449492721659,0.888005329434605,5004,1,FAM83D
REGULATION OF HORMONE SECRETION%GOBP%GO:0046883,0.0388958594730238,0.3959153833637051,-0.17305132075461702,-1.34619994046704,61,130,PFKL|LIF|CRHR1|STXBP4|ANO1|RAB11FIP1|TCF7L2|ARL2BP|MYRIP|SLC25A4|VAMP2|VIP|VAMP3|PAX8|UQCC2|RAP1A|CRH|GIPR|CHRNA3|PRKCA|SNX6|ADCYAP1|DRD2|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|NR1D1|CACNA1E|TNF|GAL|SNAP25|INHBB|TRH
SYNAPTIC VESICLE TARGETING%GOBP%GO:0016080,0.581208053691275,0.9430181813638879,0.713277459197177,0.94755728297996,4329,1,SEPT5
CGMP CATABOLIC PROCESS%GOBP%GO:0046069,0.873956695294545,0.9934031064448321,0.450922596040298,0.737020595659511,7224,2,PDE2A
SPHINGANINE-1-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006668,0.893155037733351,0.9976191001250191,-0.5518306131451259,-0.7382006363785791,6745,1,SPHK2
POSITIVE REGULATION OF MONOCYTE AGGREGATION%GOBP%GO:1900625,0.27760977379944396,0.7884684708511421,0.6962974428838989,1.13807904198401,2294,2,NR4A3|CD44
POSITIVE REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001954,0.0450964411844608,0.41793070087065204,-0.28370204649447495,-1.50194433477411,165,32,PPM1F|THY1|S100A10|VEGFA|KDR|CX3CL1|COL16A1|PTK2B|ABL1|NRP1|MAP4K4|LIMS1|RAC1|CD36|CDH13
SYNAPTIC VESICLE BUDDING%GOBP%GO:0070142,0.370702206294098,0.852609194081082,0.507733688561364,1.07593618731049,3309,4,DNM3|AP3D1|DNM1
REGULATION OF BASE-EXCISION REPAIR%GOBP%GO:1905051,0.8752783964365258,0.9938625658817479,-0.401543975737524,-0.686819465179283,5894,2,FAM168A|RPS3
ADENYLATE CYCLASE-ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007191,0.42717989002356604,0.8758853731187671,-0.49556845070757893,-1.00574144672574,2718,3,GNAS
DETECTION OF MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0032490,0.994839932603201,1.0,0.169332597904026,0.44073717554559094,9446,7,SCARB1|C4B|TLR4|TLR2
NEGATIVE REGULATION OF ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042664,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
GOLGI LOCALIZATION%GOBP%GO:0051645,0.078150912106136,0.5317491893669141,-0.402521609054087,-1.4664265987006297,376,12,FAM65A|PDCD10|CDC42|YWHAZ|SLC9A3R1
DETECTION OF BACTERIUM%GOBP%GO:0016045,0.919683655536028,1.0,-0.229055209310022,-0.6287411696234351,5232,6,NLRC4|CD1D|TLR2|TLR1|NOD1|SSC5D
MITOCHONDRIAL TRNA PROCESSING%GOBP%GO:0090646,0.9667539794479151,1.0,0.18007185212652102,0.5314385574620439,9595,10,TRIT1|PUS1|MTO1|HSD17B10
REGULATION OF LYSOSOMAL LUMEN PH%GOBP%GO:0035751,0.371529583030051,0.852609194081082,0.39555978407970005,1.07840209356283,3572,8,TMEM165|CLN6|VPS33A|TMEM199|CLN5|PPT1|CLN3|CCDC115
CYTOCHROME C-HEME LINKAGE%GOBP%GO:0018063,0.159539255924798,0.661359103221672,-0.9173467137185709,-1.2271626686081598,1204,1,HCCS
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS%GOBP%GO:0071549,0.123802042419482,0.607607158836689,-0.6858120791406539,-1.3918352382442298,787,3,NR3C1|AQP1
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043268,0.575890011836475,0.941956986273961,0.229441379451572,0.914290891900271,6324,25,AKAP9|KCNQ1|ATP1B3|ACTN2|LRRC55|KCNH2|WNK3|FHL1|RNF207|WNK2|KCNIP2|WNK1|FLNA|ANK2
MAINTENANCE OF TRANSCRIPTIONAL FIDELITY DURING DNA-TEMPLATED TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0001193,0.0810274063286112,0.5374028338839121,-0.957984119982356,-1.2815245659913501,611,1,POLR2I
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002866,0.875013999328032,0.9937342763776691,0.31994461062115803,0.6779931926078321,7812,4,ZP3|CCR7|HLA-E
POSITIVE REGULATION OF DNA REPAIR%GOBP%GO:0045739,0.191176470588235,0.700148945026927,0.251931298046865,1.2340391113658502,2300,54,SIRT1|MMS19|NPAS2|BLM|DHX9|FAM178A|PARP1|TMEM161A|H2AFX|TIMELESS|BRCC3|WRAP53|ANKRD32|RIF1|C5orf45|XRCC1|SPIRE2|SPIRE1|FOXM1|SPIDR|FMN2|UIMC1|BRCA1|FAM35A|BRE|PARP9|EYA3|RNF8|SETMAR|FAM168A|MGMT|WAS|DDX11
POSITIVE REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032736,0.6414835164835171,0.961325537642161,-0.335539377895433,-0.849395654181509,3735,5,GATA3|PRKCZ|HLA-E|RARA|LGALS9
FORMALDEHYDE METABOLIC PROCESS%GOBP%GO:0046292,0.5058916986627829,0.9172434440873181,-0.743493603881782,-0.994594062842602,3820,1,KDM3A
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051209,0.34617135573158503,0.8422206315449059,0.275770833194553,1.09890710055963,3801,25,RYR2|NOL3|F2R|PKD2|IBTK|CCR5|CCL21|CCL19
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND%GOBP%GO:1901099,0.00645161290322581,0.180481691368788,-0.494629156197799,-1.9726252645791498,29,15,SNAI2|IL1B|MAPK7|MAP2K5|UNC5B|BCL2L1|EYA4|BCL2|EYA1|TNF
FATTY ACID DERIVATIVE METABOLIC PROCESS%GOBP%GO:1901568,0.24968671679198,0.7613646381106121,0.21263515931445603,1.16375025799311,3187,91,FAAH2|EDN1|DPEP1|HACD1|CYP2D7|MGST1|CYP2C8|HSD17B4|BDH2|SCD5|PLA2G4A|ELOVL6|GGT1|DGAT1|FAR2|FAR1|FADS1|MGST3|SLC25A1|ACACA|PTGS2|MGST2|GGT5|LTA4H|ABHD16A|PON2|TECR|FAAH|HMGCLL1|HMGCL|PLA2G4B|AACS|CYP2E1|DAGLA|CYP2D6|ELOVL2|PLAA|ACOT7
RETINA LAYER FORMATION%GOBP%GO:0010842,0.109107394720935,0.58452352834625,0.471884022809806,1.39265166326623,1082,10,TSPAN12|SDK1|DSCAM|AHI1|FOXN4|TFAP2B|TOPORS|SDK2
CONNECTIVE TISSUE DEVELOPMENT%GOBP%GO:0061448,0.40598618572524897,0.8663957682383929,-0.154442742133387,-1.0318909294351,1057,70,RORC|SCARA3|RUNX3|SH3PXD2B|COL14A1|CD44|ZBTB16|COL6A2|VWA1|LRP5|ITGB8|EIF2AK3|COL6A1|FGF2|NFIB|NAMPT|ARID5B|DGAT2|COMP|COL21A1|ZNF516|CHI3L1|CRIP1|DDRGK1|SULF2|STC1
DETERMINATION OF DORSAL IDENTITY%GOBP%GO:0048263,0.00296956198960653,0.13156768405007002,-0.9642679900744421,-1.64932875413212,19,2,GREM1|NBL1
CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY%GOBP%GO:0099004,0.48421052631579,0.9064456896937672,-0.47429181007954,-0.962561136727884,3081,3,PRKAA1|PCP4
OPTIC VESICLE MORPHOGENESIS%GOBP%GO:0003404,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048709,0.18579496506173998,0.6921962082288221,0.3662327022622439,1.26962946013397,1940,16,SLC8A3|PRDM8|EIF2B5|EIF2B1|EIF2B4|MYRF|PLP1|SOX10
REGULATION OF MATURE B CELL APOPTOTIC PROCESS%GOBP%GO:0002905,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900424,0.8903900631945959,0.997300970905927,0.282006606737555,0.64998342344726,8171,5,F2RL1|MAPKBP1
CORNIFICATION%GOBP%GO:0070268,0.69944431021986,0.967678885433393,-0.17688964795026102,-0.8311896636663849,2894,23,FURIN|CAPNS1|KRT17|KAZN|SPINK5|KRT9|PKP4|EVPL
TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:0010833,0.8315570574473621,0.9879179006160809,-0.14621585721962602,-0.748296365103994,3198,29,SMG6|DCLRE1B|RFC1|PINX1|MRE11A|GAR1|SLX1A|NHP2|HSP90AB1
ATP METABOLIC PROCESS%GOBP%GO:0046034,0.6221322537112011,0.9536478716552259,-0.11745581406311699,-0.932216173797271,921,142,PFKL|COX5B|GPI|NDUFB10|SDHC|UQCRC1|PKM|ENO1|MT-ND5|ATP5I|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|COX4I2|NDUFS6|PGAM2|AK4
NEURAL CREST CELL MIGRATION%GOBP%GO:0001755,0.9141774208103959,1.0,0.154856772112636,0.6295720303780129,10129,27,SEMA3D|SEMA5A|SEMA3E|SEMA4G|SEMA6A|SEMA4C|FN1|SEMA4A|SOX10|PHOX2B|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D|ANXA6
EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY%GOBP%GO:0060136,0.700913544287038,0.9687491813135329,-0.64485002205558,-0.862635535816095,5293,1,TLE6
ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:0015986,0.8497582744514692,0.991298302704726,0.18283675245849101,0.6912203773556179,9139,21,ATP5G1|ATP5D|MT-ATP8|ATP5C1|ATP5E|VPS9D1|ATP5H|MT-ATP6|ATP5A1|STOML2
REGULATION OF AMACRINE CELL DIFFERENTIATION%GOBP%GO:1902869,0.21647027671124106,0.7328218014339442,-0.890604322893692,-1.19138855703305,1634,1,POU4F2
REGULATION OF LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032681,0.48775321064477706,0.907808599852568,-0.7542456991618879,-1.00897746852744,3683,1,CD86
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032212,0.645158419366323,0.962671541860027,0.20480516144255198,0.865709949580756,7248,31,ATR|HMBOX1|PNKP|PRKCQ|NEK2|AURKB|MAP3K4|TNKS2|MAP2K7|ACD|ATM|MAPKAPK5|POT1|CCT2|FBXO4|NEK7|TNKS|CCT5
BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:0035630,0.298886414253898,0.8023890191280308,-0.6808317362332089,-1.16452622181147,2012,2,IGF1
LUNG DEVELOPMENT%GOBP%GO:0030324,0.0525878771104345,0.447307566936778,-0.271497969015245,-1.46089984917759,189,34,STRA6|VEGFA|PDPN|CEBPA|FGF7|NFIB|WNT11|CTSH|CHI3L1|FGF10|ASCL1|ATXN1L|DNAAF1
DISTAL TUBULE MORPHOGENESIS%GOBP%GO:0072156,0.375468731099552,0.852871276063039,0.653641521392171,1.0683591101324899,3103,2,KLHL3|PKD1
PLUS-END-DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072386,0.265553602811951,0.7792338872944151,-0.422866067075617,-1.16073896074257,1510,6,KIF3B|KIF13A
RESPONSE TO DISACCHARIDE%GOBP%GO:0034285,0.127691165553081,0.6076669536424699,-0.782890816063623,-1.33909281192671,859,2,CALCRL
LYMPHOCYTE CHEMOTAXIS%GOBP%GO:0048247,0.365811965811966,0.8510019955058101,0.262704635606495,1.07725406899869,4065,28,CXCL13|SLC12A2|XCL2|CCL21|CCL5|CCL19|CYP7B1|CXCL10|CCL2|CCL3L3|CCL11|CCL4L2|CXCL11|CKLF|XCL1|CCL4|CCL8|CCL24
METAPHASE/ANAPHASE TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0007091,0.9982080860118709,1.0,0.20424169651222102,0.432807665092775,8912,4,CDC23|TACC3
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002860,0.5953456061132341,0.9475750680289541,0.481490127839195,0.9152620821620581,5141,3,KLRK1|PVR
LUNG ALVEOLUS DEVELOPMENT%GOBP%GO:0048286,0.6405472636815921,0.96102887115448,-0.23475736616556397,-0.85524463343738,3089,12,FGF10|ATXN1L
CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:0010457,0.198762035763411,0.711592141628341,0.3999909165471289,1.2609143121908601,2022,12,CNTLN|CROCC|SYNE2|RTTN|CEP135|SGOL1|CEP250
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002716,0.781908171861837,0.981487311948134,0.28483145315506897,0.741356429441082,7424,7,CEACAM1|MICA|LILRB1|HLA-E|SERPINB9|LGALS9|ARRB2
PROTEIN LOCALIZATION TO NON-MOTILE CILIUM%GOBP%GO:0097499,0.868986254295533,0.9931871192124442,0.273840533721133,0.6734709116555229,8091,6,TUB|BBIP1|SPATA7|ARL13B
REGULATION OF PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:1903004,0.8711210096510771,0.9934031064448321,-0.4037702671392729,-0.690627417389435,5866,2,GLTSCR2
TRICARBOXYLIC ACID CYCLE%GOBP%GO:0006099,0.896345392617141,0.998912093067348,0.16576791285276699,0.6447051100906911,9736,23,FH|NNT|PDHA1|SUCLG1|SDHA|ACO1|ME3|DHTKD1
REGULATION OF MYOBLAST PROLIFERATION%GOBP%GO:2000291,0.360753976901286,0.848418604328854,0.472545671272183,1.08914772140256,3310,5,MEIS2|GATA6|SOX15|ATF2|ZNF609
REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905475,0.000623052959501558,0.0806484601749226,-0.240931501764482,-1.86545235356611,0,128,RAMP3|RHOG|GPER1|VTI1B|PICALM|PPFIA1|PRKCH|TP53BP2|GZMB|NECAB2|CLIP3|ITGAM|SQSTM1|BBC3|MYO1C|VPS4A|FYN|INPP5K|RANGRF|STX8|YWHAH|PRNP|CHP1|BCL2L1|MIEF1|IQSEC2|BID|CEMIP|CRIPT|RAP1A|YWHAQ|YWHAB|LGALS3|BCL2|TP53|YWHAZ|YWHAE|PARK2|RHOQ|ACSL3|PIK3R1|DLG1|TNF|PMAIP1|TFDP2|STAC|EPHB2|APPL1
TRICARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0072350,0.472837552742616,0.8990547397930471,-0.18892150756814396,-0.980130835685022,1792,30,SDHC|ME2|OGDHL|MDH1B|ASS1|PDHB|FAHD1|OGDH|ACLY|IDH3B
POSITIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900039,0.6351677852348989,0.95916055221954,0.6873070136744599,0.9130567047267472,4731,1,RWDD3
MOLYBDOPTERIN COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0032324,0.7022227064719979,0.968941691852291,0.35392193014442896,0.8157375830645841,6444,5,GPHN|MOCS2|MBIP
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0040037,0.503085191082803,0.9164921159310329,0.317183264619049,0.967653432709175,5054,11,GPC1|THBS1|SPRY4|GATA3|SPRY1|SULF1|CREB3L1|APLN
SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043403,0.172902288412641,0.676682497340677,-0.442639383819266,-1.29119872072401,951,7,AKIRIN1|EYS|IGF1|CFLAR
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903223,0.7011783189316579,0.9688110069082271,-0.39996691298114,-0.811720966356356,4462,3,TLR4|MCL1|FBXW7
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:1904850,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
FOREBRAIN ASTROCYTE DEVELOPMENT%GOBP%GO:0021897,0.40013422818792,0.8638522656500329,0.807234230260256,1.0723746616285301,2980,1,NF1
REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901990,0.00311763890813357,0.13515773385565,0.23341654448076002,1.5191686069081798,44,296,BTG2|AKAP9|TAOK3|SDCCAG8|CEP63|ANAPC15|CEP70|CENPJ|CCNB1|PIDD1|TPR|CDC7|CDK1|BTRC|KIF14|E2F8|XRCC3|ANAPC5|PKD2|ANKRD17|BLM|CENPF|WEE1|LSM11|CKAP5|CEP290|CDK2AP2|CEP131|CEP152|ORC1|CDC25C|USP47|USP44|MUC1|CDC45|BUB1|DTL|CDK10|E2F7|DONSON|HMMR|DLGAP5|NEK2|DACT1|CDC23|CDC20|CCNE1|UBD|GEN1|HAUS5|ANLN|APC|NDC80|ZNF830|DBF4B|ANAPC7|NEK11|CDK5RAP2|CENPE|ANAPC16|PRKAR2B|FBXO5|RB1|BUB1B|NAE1|INO80|GTSE1|ESPL1|AURKB|CDC6|MSH6|DDB1|RAD51C|CEP72|CCL2|CDCA5|HAUS8|CEP164|CEP78|KLHL22|TAOK1|CEP192|RPS27L|FGFR1OP|CHEK2|TOPBP1|CNTRL|PLK1|KNTC1|PRMT1|BRSK1|SFI1|CARM1|AURKA|CDC73|ARID3A|CEP41|CLSPN|CEP57|UBE2C|DYNC1H1|NINL|TNKS1BP1|CNOT3|ANAPC10|CDK5RAP3|TAOK2|E2F1|TUBB4A|CEP135|C5orf45|TEX14|PRKDC|DUSP1|FHL1|RBX1|PCM1|FBXL7|RAD17|TPX2|MAD2L1BP|NEDD1|PPP2R1A|CASP2|CDK2|ATM|SSNA1|TFAP4|RFWD3|CNOT1|CCND2|CDC16|NDE1|CEP250|ANAPC2
MYELOID CELL DIFFERENTIATION%GOBP%GO:0030099,0.748594787940726,0.9749763305090959,-0.116807259294012,-0.870259865419146,1464,107,ACTN1|CEBPG|MFHAS1|HSPA9|PIK3CD|GPR183|GATA2|PRKX|NRROS|ZBTB16|CBFA2T3|BATF|IL11|VEGFA|TYROBP|IKZF1|LGALS9|CEBPA|ZNF385A|TCTA|G6PD|THOC5|CASP3|PPARG|SNRK|LYN|SBNO2|MMP9|FOXP1|CAMK4|CDC42|SLC25A38|TNFRSF11A|GAB2|OSCAR|LYAR|MYH9|DYRK3
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY%GOBP%GO:0061339,0.109330406147091,0.5846370216990561,-0.337326222223455,-1.3814642521341398,497,16,FSCN1|MYO9A|EZR|RLTPR|OPHN1|RHOA|CDC42|MSN|SLC9A3R1|SH3BP1
POSITIVE REGULATION OF PEROXIDASE ACTIVITY%GOBP%GO:2000470,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
PROTEIN TETRAMERIZATION%GOBP%GO:0051262,0.416227276304399,0.8709670999109399,0.191210010932547,1.03919643240476,5288,88,KIF25|HIST1H3E|CTH|CRYZ|CBR4|ACTN2|RCC1|PKD2|KCNC3|KCNC1|GLS|APIP|DHRS4|GBP5|TK1|DECR1|MCOLN1|CCL5|HIST1H4I|GRIN1|ACACA|RPS19|CPSF6
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE%GOBP%GO:0060688,0.302344884830878,0.805227617550042,-0.29569573888072404,-1.11358450058674,1456,13,VEGFA|RTN4|MAP3K13|HGF|PAX8|TNF
NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045683,0.325923353016094,0.826621597878865,0.5854775466927571,1.11293122633682,2814,3,CDH3|SRSF6
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:1900215,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
NEGATIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060160,0.702004454342984,0.968941691852291,-0.478558469419462,-0.818548631989788,4727,2,DRD2
REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090192,0.897873711340206,0.998912093067348,0.26136227978173004,0.642782463374169,8360,6,BMP4|EGR1|PDGFB|BMP7|PDGFA
RETINAL METABOLIC PROCESS%GOBP%GO:0042574,0.28127274617864195,0.7892585111044429,0.426407450131811,1.16250110714056,2704,8,BCO2|ALDH8A1|AKR1C1|RDH11
REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045670,0.779893511415937,0.981487311948134,0.18664713997420396,0.7588161452334731,8641,27,CARTPT|BGLAP|TMEM178A|FBN1|ZNF675|FSTL3|CEBPB|LRRC17|ATP6AP1|CSF1|TLR4|NOTCH2|CCR1
DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:0009950,0.246006915857072,0.758407565545035,-0.5163069988573329,-1.18739823706168,1493,4,SMAD6|SMAD2
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042253,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING%GOBP%GO:0097119,0.59261586802828,0.9461312439065841,-0.43785154957538297,-0.888606710722386,3771,3,NRXN2|NLGN2|NRXN1
POSITIVE REGULATION OF APPETITE%GOBP%GO:0032100,0.0350792306761824,0.381265913354899,0.87968017645437,1.43781308218656,289,2,GHRL|NPY
MRNA EXPORT FROM NUCLEUS IN RESPONSE TO HEAT STRESS%GOBP%GO:0031990,0.8239990322970849,0.9876441563834109,0.476476646730549,0.7787879895018891,6811,2,TPR
CELLULAR RESPONSE TO TYPE I INTERFERON%GOBP%GO:0071357,0.0089086859688196,0.207969158127386,-0.292413248796078,-1.7578184775345,27,48,EGR1|GBP2|HLA-F|STAT2|TYK2|STAT1|BST2|IFIT1|IP6K2|IRF9|HLA-C|IRF2|ISG20|OAS1|IFI35|PSMB8|IFIT2|IFIT3|IRF5|JAK1|IRF7|OAS2|IRF8|HLA-B|ADAR|HLA-A|HLA-E|IRF1|IRF3|RSAD2|IFI6|SP100|SAMHD1|ISG15|MX1|RNASEL|IRAK1|IFNAR2|IRF6|IFNAR1|IFITM2|MX2|IFITM3|OASL|OAS3|IFITM1|MYD88
LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:0060291,0.9749856788237541,1.0,0.145208445778009,0.512129218340674,10211,17,SLC8A3|RGS14|SLC24A1|SLC8A2|TSHZ3|SHANK1|MPP2|GRIN2D|NPTN|PRKCZ
REGULATION OF MRNA BINDING%GOBP%GO:1902415,0.00944424264438794,0.21235063347774397,-0.641099139109241,-1.8701146317633301,51,7,EIF3D|CDK9|EIF4G1|FMR1|LARP6
IMIDAZOLE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0052805,0.39921268959129297,0.8638522656500329,0.554442078998849,1.05393606705935,3447,3,FTCD|C9orf41|HNMT
UDP-N-ACETYLGLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006047,0.895315091210614,0.9981901628831992,-0.18135172413793102,-0.660682522414212,4318,12,AMDHD2|PGM3|UAP1|RENBP|GNPDA1|GNPDA2|NAGK|GFPT1|GNPNAT1|SLC35A3|UAP1L1|GFPT2
ALPHA-AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:1901607,0.219576049320159,0.734713083559597,0.254530775846002,1.2072899055356898,2599,47,ASNS|CTH|GAMT|SERINC5|GGT1|GLS|APIP|GLS2|MTHFD1|CAD|MTR|MTAP|GGT5|PSAT1|BCAT2|PYCR2|PHGDH|NAGS|SEPHS1|AASS
VIRAL TRANSLATIONAL TERMINATION-REINITIATION%GOBP%GO:0075525,0.015625,0.26512871413934397,-0.715254798146923,-1.8106200261472698,90,5,EIF3L|EIF3D|EIF3G|EIF3B|EIF3A
REGULATION OF POLYNUCLEOTIDE ADENYLYLTRANSFERASE ACTIVITY%GOBP%GO:1904245,0.528456375838926,0.9265056012720759,0.73919276576974,0.9819846115978159,3936,1,PABPN1
RESPONSE TO HOST IMMUNE RESPONSE%GOBP%GO:0052572,0.22212323682256896,0.73556947110949,-0.724786324786325,-1.23970819147439,1495,2,SLC25A6|EIF2AK2
REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000064,0.590978426672478,0.945418171231938,0.39221993265436605,0.904008801496593,5423,5,WNT4|REST|BMP2|DKK3
POSITIVE REGULATION OF DIACYLGLYCEROL KINASE ACTIVITY%GOBP%GO:1905689,0.827114093959732,0.9876441563834109,0.58756065284517,0.780548114365681,6161,1,MAPT
ORNITHINE METABOLIC PROCESS%GOBP%GO:0006591,0.28646748681898104,0.7957186177819849,-0.41359407491179206,-1.13528796482161,1629,6,ODC1|ASL
NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070233,0.0595819902256421,0.476295606439141,0.552510108821291,1.50629078599015,572,8,CD27|BMP4|BLM|PRKCQ|CCL5
POSITIVE REGULATION OF T CELL COSTIMULATION%GOBP%GO:2000525,0.8906394810009269,0.997300970905927,-0.552823114247905,-0.7395283353648711,6726,1,CCR7
POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904179,0.00568525462682956,0.17352934538701598,0.9496511488629159,1.55217871437327,46,2,SIRT1|TRPM4
CREATINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015881,0.227326889977492,0.7400748230621691,-0.885366122629025,-1.1843812568276202,1716,1,SLC6A8
PSEUDOURIDINE SYNTHESIS%GOBP%GO:0001522,0.431177446102819,0.8785877309899279,-0.277627586206897,-1.01142514535696,2079,12,PUSL1|PUS1|PUS10|TRUB1|DKC1|NOP10|PUS7|PUS3|NAF1|GAR1|RPUSD2|NHP2
INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION%GOBP%GO:0060122,0.0176116838487973,0.280449130980703,0.677615933575891,1.6664977033765,163,6,STRC|ADGRV1|DFNB31|PDZD7
NEGATIVE REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051796,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
PROTEIN DEGLUTATHIONYLATION%GOBP%GO:0080058,0.948322147651007,1.0,0.5281760035288929,0.701658257086042,7064,1,GLRX
"ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU-RRNA FROM 5.8S RRNA AND LSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000447",0.0366872502724301,0.386113929236656,-0.562967530770879,-1.64220126385616,201,7,KRI1|RRS1|NOP14
PARANODAL JUNCTION ASSEMBLY%GOBP%GO:0030913,0.295679497250589,0.800514656525586,-0.556522929637081,-1.12944675067605,1881,3,CD9
LYSOPHOSPHOLIPID TRANSPORT%GOBP%GO:0051977,0.143087248322148,0.632949331968897,0.929642699603,1.2349888521213799,1065,1,MFSD2A
ERGOSTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006696,0.0567785234899329,0.46412099087698794,0.971768857520953,1.29095157353423,422,1,C14orf1
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070431,0.0758837391987431,0.525661416287861,-0.7354141391860591,-1.4925011453644499,482,3,RELA|OTULIN|RIPK2
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:1904914,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
NEGATIVE REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902951,0.0650334075723831,0.4956987271622679,-0.8465949820788531,-1.4480553761188601,437,2,FYN|PRNP
INTESTINAL FOLATE ABSORPTION%GOBP%GO:0098829,0.38724832214765104,0.859991269020751,0.8129135421261581,1.07991937407031,2884,1,SLC46A1
REGULATION OF PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905384,0.25302013422818803,0.7641083395392759,0.876157917953242,1.16393670582495,1884,1,DVL1
REGULATION OF VESICLE FUSION%GOBP%GO:0031338,0.8162447257383969,0.9866358717238399,-0.189994869769549,-0.736090424274162,3868,14,VPS18|VPS11|VPS16|RSG1
EPITHELIAL CELL MATURATION%GOBP%GO:0002070,0.15155725367604503,0.647966535318223,0.674228849429022,1.2816381165518502,1308,3,SIX3|TMEM79
OSSIFICATION INVOLVED IN BONE REMODELING%GOBP%GO:0043932,0.937045285820341,1.0,-0.36145574855252294,-0.618250699567454,6310,2,TGFB3|TGFB1
MITOCHONDRION DISASSEMBLY%GOBP%GO:0061726,0.000277700638711469,0.0784645998831315,-0.4398753009245461,-2.3911651980729602,0,35,SQSTM1|RB1CC1|CTSK|ATG13|MAP1LC3B2|ATG9B|MAP1LC3A|ATG3|ATG7|BECN1|GABARAPL1|GABARAP|PARK2|FBXO7|WIPI2|MAP1LC3B|GABARAPL2|SPATA18
POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900451,0.0131810193321617,0.250097661198388,-0.675997887829653,-1.85556881215359,74,6,NECAB2|ARC|ADRB2|RELN|EPHB2
CELL ENVELOPE ORGANIZATION%GOBP%GO:0043163,0.48563758389261796,0.9067242420344581,0.7610829289810319,1.0110647168345999,3617,1,TGM1
CELL WALL MACROMOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0044038,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
PUTRESCINE BIOSYNTHETIC PROCESS%GOBP%GO:0009446,0.742960645479993,0.974505008828563,-0.340151960255021,-0.7822784483529591,4511,4,ODC1
CELL JUNCTION MAINTENANCE%GOBP%GO:0034331,0.44731009470078603,0.884842627608662,0.343339088093102,1.0132823511379798,4439,10,CAMSAP3|F2R|F2RL1|CSF1R|NLGN2|KIFC3|PLEKHA7|PKP2
POSITIVE REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1902499,0.215436241610738,0.7321649081295791,0.89347154830172,1.18693709132709,1604,1,MTA1
MAST CELL ACTIVATION%GOBP%GO:0045576,0.7915150254757201,0.9819233677232551,0.270480920688885,0.7374035553647758,7611,8,NR4A3|KIT|MILR1|S100A13|SNAP23|CHGA
POSITIVE REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905099,0.623063683304647,0.9536478716552259,-0.681682840758712,-0.9119079204185021,4705,1,EPHA4
REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090279,0.226810954063604,0.7398172623753029,-0.284441224016829,-1.1968959549933702,1026,17,RAMP3|CTNNB1|FYN|PLN|SLC30A1|PRNP|LGALS3|STC1
APOPTOTIC PROCESS INVOLVED IN ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:0003277,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NON-CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE%GOBP%GO:0038031,0.961412846256199,1.0,0.37592863167614504,0.614445021111022,7947,2,DVL3|FZD7
RESPONSE TO LUTEINIZING HORMONE%GOBP%GO:0034699,0.5944657751886671,0.947176034529489,-0.6966806352007061,-0.9319709273224771,4489,1,TGFBR3
DENSE CORE GRANULE LOCALIZATION%GOBP%GO:0032253,0.522641198748559,0.9251240799994541,-0.404455964264049,-0.9301642239967359,3173,4,KIF1C|KIF1A|KIF5B|KIF5A
CELLULAR RESPONSE TO L-GLUTAMATE%GOBP%GO:1905232,0.308089500860585,0.8111717366855571,-0.8465483017203349,-1.1324534742526298,2326,1,FYN
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0045732,0.0180859080633007,0.283637048708639,-0.176167417785343,-1.4092645351728201,23,153,HSP90AA1|PSMD10|RILP|EDEM1|GBA|RNF217|RAD23A|EZR|CSNK1D|CSNK1A1|AMER1|RNF19B|CDKN1B|HECW2|ITCH|FBXW7|OAZ2|FURIN|CBFA2T3|VPS28|IL1B|CLU|PTTG1IP|NEDD4L|PLK3|USP5|DAB2IP|TRIB1|TNFAIP3|ARIH1|PRICKLE1|CEBPA|STUB1|TNFRSF1B|VPS11|FOXO1|RNF139|GLTSCR2|TRIB2|SUMO1|ECSCR|VIP|ATG7|RNF144B|UQCC2|SMAD7|FMR1|MSN|NEDD4|SOCS5|RAB7A|ARIH2|PARK2|ADRA2A|HSPBP1|DDRGK1|BCAP31|CSNK2A1|PLK2|TNF|BBS7|CAV1|TRIB3
NEGATIVE REGULATION OF CELL ADHESION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0106089,0.43825503355704704,0.878999860395433,0.787329069254521,1.0459315432646001,3264,1,SEMA6A
CYTOPLASM PROTEIN QUALITY CONTROL BY THE UBIQUITIN-PROTEASOME SYSTEM%GOBP%GO:0071629,0.30161073825503404,0.8046030019719091,0.85288928098809,1.13302535970424,2246,1,RNF126
PROTEIN LINEAR DEUBIQUITINATION%GOBP%GO:1990108,0.0728986645718775,0.5188116819831811,-0.738667696040587,-1.4991041423333,463,3,OTULIN|CYLD|SPATA2
ALPHA-LINOLENIC ACID METABOLIC PROCESS%GOBP%GO:0036109,0.845057968166634,0.991298302704726,0.21617358194000896,0.6814563834066589,8600,12,HSD17B4|FADS2|FADS1
CELLULAR SPHINGOLIPID HOMEOSTASIS%GOBP%GO:0090156,0.8100034734282741,0.984682960940884,0.39996691298114,0.7602950266371981,6995,3,ORMDL1|ORMDL2|ORMDL3
GLYOXYLATE CATABOLIC PROCESS%GOBP%GO:0009436,0.7169336687408979,0.971081608033886,-0.636854874283194,-0.8519401828709621,5414,1,HOGA1
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903378,0.500222717149221,0.9144253281295329,-0.562393162393162,-0.9619433844223442,3368,2,MCL1|FBXW7
DTTP CATABOLIC PROCESS%GOBP%GO:0046076,0.548258969945717,0.9305779599215391,-0.7201698279664759,-0.96339313666473,4140,1,DCTPP1
PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA%GOBP%GO:0070918,0.7314897413024091,0.9726603499749559,0.190614658788785,0.7992341579376179,8199,30,LIN28B|ZCCHC11|DROSHA|TERT|C9orf114|METTL3|SRRT|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6
MEMBRANE DOCKING%GOBP%GO:0022406,0.761438386200848,0.977763214485385,0.13858235417343,0.829203805038874,10417,152,TMEM216|CEP83|AKAP9|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|UNC13B|CDK1|AHI1|RAB3IP|CKAP5|CEP290|CEP131|CEP152|MKS1|UNC13A|KIF24|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP162|CEP72|USO1|HAUS8|CEP164|CEP78|STX2|CEP192|FGFR1OP|CEP97|CNTRL|NPHP4|PLK1|RAB3B|SFI1|SYTL2|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|RAB3A|NEDD1|PPP2R1A|TMEM67|SSNA1|STX3|C2CD3|NDE1|STX1A|CEP250
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032908,0.880584005229898,0.9956508825790341,0.286734825405781,0.660881266559285,8081,5,GATA6|THBS1|LAPTM4B
REGULATION OF HEART RATE BY HORMONE%GOBP%GO:0003064,0.794506310319228,0.9821466750165508,-0.441125715024544,-0.754521910367371,5350,2,YWHAE
REGULATION OF ATPASE ACTIVITY%GOBP%GO:0043462,0.782535258846381,0.981487311948134,0.162887416118143,0.7726072910617522,9265,47,THADA|RYR2|RGN|BRSK2|ATP1B3
EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0070278,0.8332885906040269,0.988403692092343,0.5837009263343629,0.775420639890682,6207,1,CREB3L1
ATP HYDROLYSIS COUPLED TRANSMEMBRANE TRANSPORT%GOBP%GO:0090662,0.342334925078215,0.836442710861658,-0.46892406110406504,-1.07842737887159,2078,4,ATP1A3|ATP1A1|ATP6V1H|FXYD2
INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY%GOBP%GO:0035735,0.0365243004418262,0.386010810221496,-0.26699992403232703,-1.51845698274063,123,40,IFT74|IFT52|IFT27|IFT22|IFT88|TTC26|IFT57|DYNC2H1|IFT46|IFT122|WDR35|IFT172|DYNLRB2|WDR19|TRAF3IP1|KIF3C|DYNLRB1|KIF3B|DYNLL2|TTC30B
ADRENAL CORTEX FORMATION%GOBP%GO:0035802,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0045992,0.6495363214837709,0.963755998259649,0.251829913685514,0.8538575334384342,6723,15,TBX2|RPS6KA6|COL5A2|LFNG|COL5A1|FZD3|GATA3|SULF1
GLUCURONOSIDE CATABOLIC PROCESS%GOBP%GO:0019391,0.707995645336882,0.9695170059473192,0.5253530165157729,0.8586750732034141,5852,2,ABHD10|GUSB
ATP TRANSPORT%GOBP%GO:0015867,0.38392960518698604,0.8584502501158281,0.559555330723426,1.06365582069388,3315,3,SLC25A42|SLC25A17|SLC25A24
POSITIVE REGULATION OF CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0031940,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0099590,0.260724233983287,0.771967970256231,-0.37566213977572205,-1.16772149651158,1403,8,CACNG3|CACNG7
REGULATION OF CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0055018,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045657,0.693344566133109,0.96731875442989,0.31130722559294,0.8102673025339789,6583,7,ACIN1|CSF1|IL34|CD74|ZFP36L1|CD4|CTNNBIP1
MODULATION BY HOST OF SYMBIONT MOLECULAR FUNCTION%GOBP%GO:0052428,0.320984964044454,0.822183858873702,0.488561871463038,1.1260626885769198,2945,5,SUGT1|PTX3|RAB9A|NUCKS1|ANXA2
CELLULAR CATION HOMEOSTASIS%GOBP%GO:0030003,0.9273253809556641,1.0,0.113175055125383,0.741446948984943,13448,318,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|CXCR4|F2R|DMXL2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|TMEM178A|MT1E|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|SLC39A7|SLC46A1|DMPK|SLC40A1|GRIN1|CCL19|CXCL10|ATP2A2|TCIRG1|PLCG1|C3AR1|SLC39A13|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1|ACO1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|GPR89B|FPR3|MICU1|SLC39A10|P2RY6|ATP6V0E2|SLC8A2|RMDN3|KCNMA1|ISCU
DIADENOSINE PENTAPHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901907,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
MAINTENANCE OF PROTEIN LOCATION IN MEMBRANE%GOBP%GO:0072658,0.459060402684564,0.890371861972445,0.7758050286722541,1.0306223694749599,3419,1,ANK3
LYMPHOCYTE ACTIVATION%GOBP%GO:0046649,0.986721991701245,1.0,-0.0811297488678222,-0.6684682391029421,1188,176,IL21R|BATF|CHRNB2|ICOSLG|IL11|FCER1G|IKZF1|PTK2B|VPRBP|CR2|EXOSC6|HDAC4|NFAM1|ULBP3|HDAC5|RELB|IL6|FCRL1|FCGR2B|VAMP2|BANK1|SLC11A1|CD276|KIF13B|MS4A1|ICAM1|FOXP1|ELF4|LEPR|MSN|KLF6|ADAM17|ULBP2|BCL2|STAT3|PRDX1|TNFRSF4|IRF2BP2|TPD52|FKBP1A|RNF168
POSITIVE REGULATION OF MAST CELL ACTIVATION BY FC-EPSILON RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038097,0.0589261744966443,0.475380099992949,0.9705006616674019,1.28926683192102,438,1,NR4A3
PARENTAL BEHAVIOR%GOBP%GO:0060746,0.0939597315436242,0.562743160240921,0.95351786501985,1.26670594423102,699,1,OXTR
T CELL EXTRAVASATION%GOBP%GO:0072683,0.434630872483221,0.878651088001772,0.789644905161006,1.0490080279496,3237,1,CCL2
CHRONIC INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002439,0.0239639878194095,0.32397355287938,-0.9888067931186592,-1.32275699562121,180,1,TNF
RESPONSE TO REDOX STATE%GOBP%GO:0051775,0.0297199274632279,0.354139215474632,0.549833574526959,1.6227009287687,294,10,RYR2|ARNTL|GLRX2|NPAS2|RNF7|CLOCK|VIMP
REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001182,0.8398343865765959,0.98953921193435,0.304861464434002,0.7026604823991489,7707,5,MAPK11
SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0031146,0.610936132983377,0.9508825506493929,0.201741251367923,0.890493228186823,6982,36,FBXO18|BTRC|KIF14|FBXL15|FBXL6|RNF7|FBXL8|FBXW5|CCNF|FBXO9|RBX1|FBXL7|SKP2
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072161,0.43171646304584493,0.8785877309899279,0.630033254719761,1.02977204681347,3568,2,WNT4|STAT1
POSITIVE REGULATION OF FLAGELLATED SPERM MOTILITY%GOBP%GO:1902093,0.0417052826691381,0.402998391331252,-0.978330392589325,-1.30874239521034,314,1,CFAP69
POSITIVE REGULATION OF T CELL ACTIVATION%GOBP%GO:0050870,0.74221961244862,0.974505008828563,-0.11376735501580902,-0.8749406044274859,1263,123,CD274|ICOSLG|IL1B|RARA|FAM49B|SIRPA|MAP3K8|LGALS9|GRB2|VAV1|RPS3|FYN|RUNX1|IL6|PNP|LYN|CD276|YES1|IGF1|CDC42|TFRC|NLRP3|SOCS5|BCL6|NKAP|DUSP10|CBFB|RAC1|IGF2|PIK3R1|CAV1|PAK2
RESPONSE TO UV-C%GOBP%GO:0010225,0.910840217610316,1.0,0.20940756219552398,0.618015816800955,9040,10,ST20|MAP3K4|CARD16|ERCC5|YY1|POLH
DOPAMINE METABOLIC PROCESS%GOBP%GO:0042417,0.4497941992916629,0.886062942999295,0.291598799673899,1.01089395982061,4698,16,SNCAIP|TGFB2|SULT1A3|DRD4|TH|MOXD1|LRTOMT|COMT|DBH|MAOA
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032102,0.887366818873668,0.997039752625282,0.12182473944795899,0.743592419924501,12242,176,CARTPT|SEMA3D|EDN1|CXCL13|GHRL|NOV|CEACAM1|RTN4RL1|AJAP1|SERPINE2|PLAT|F12|INS|FNDC4|SIGIRR|TKFC|PTPRO|KLRK1|C1QTNF3|ROBO2|SEMA5A|RORA|TYRO3|CHID1|CD200|RB1|SEMA3E|APOE|CUEDC2|SEMA4G|CASK|GSTP1|RPS19|CCL2|SEMA6A|SEMA4C|RTN4R|MAPKBP1|KLKB1|C5|NLRC3|CACTIN|LDLR|SIGLEC10|TNFAIP8L2|PTPRS|CARD16|VIMP
POSITIVE REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051127,0.17493255862212098,0.677832967557544,-0.336459942617524,-1.26710171267741,842,13,WASF1|NCKAP1|WAS|WASL|WIPF3|TIGD5|ABI2|CYFIP1|WIPF2|GSN|WHAMM|WIPF1|BRK1
NEGATIVE REGULATION OF SECRETION BY CELL%GOBP%GO:1903531,0.000479616306954437,0.0784645998831315,-0.26364619612093804,-1.92508221214184,0,99,SYT11|RAB33B|IL1B|SRGN|IL11|CX3CL1|ADRA2C|LGALS9|TNFAIP3|NR1H3|PFKL|SSC5D|LIF|RAB11FIP1|TNFRSF1B|SLC30A1|FCGR2B|HTR1B|VPS4B|VAMP3|TMSB4X|DPH3|CRH|SNCA|FMR1|PNKD|HRH3|NLRP3|TNFRSF4|DRD2|PPP1R11|RAB7A|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|TNFRSF21|INHBB|TRH
PEPTIDYL-LYSINE HYDROXYLATION%GOBP%GO:0017185,0.49266480965645293,0.910097257414447,-0.306690937172486,-0.953328968246318,2652,8,P3H4|P3H3|JMJD6|VIPAS39|PLOD1|PLOD3|PLOD2|VPS33B
REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000328,0.161727349703641,0.664367762084791,0.7580369451337191,1.238990562328,1336,2,LOXL3|IL12RB1
NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002710,0.9512321929915771,1.0,0.20742928642276298,0.56550788464249,9147,8,CEACAM1|XCL1|FOXP3|PTPRC|HFE|LILRB1
NEGATIVE REGULATION OF CORTICOTROPIN-RELEASING HORMONE RECEPTOR ACTIVITY%GOBP%GO:1900011,0.07624161073825501,0.525661416287861,0.962781208645787,1.27901188297102,567,1,CRHBP
REGULATION OF GTP BINDING%GOBP%GO:1904424,0.727738376674547,0.972554563883587,-0.233850057924643,-0.791149748632108,3693,10,STMN1|ARHGAP28|CTAGE5|CLN5|ARHGEF7|EPHA4|FAM65B|GPSM1|CSNK1A1|MET
POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0060907,0.10884241725671001,0.58452352834625,-0.611212062629866,-1.4056600573762101,660,4,SEMA7A|GPRC5B
AUTOPHAGIC CELL DEATH%GOBP%GO:0048102,0.9394039189856741,1.0,-0.264821044504495,-0.60903307930629,5704,4,TP53INP1|CDKN2D|CDKN1B|SH3GLB1
POLYAMINE TRANSPORT%GOBP%GO:0015846,0.27301146231330303,0.7884684708511421,0.6070916510422409,1.15401736498675,2357,3,TAF7|AZIN2|ATP13A2
RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009261,0.243005415162455,0.7565220534116759,-0.26551144026916196,-1.16439331094474,1076,19,NUDT7|ENTPD4|NUDT4|HPRT1|NUDT18|PDE9A|PDE4D
GLUCAGON SECRETION%GOBP%GO:0070091,0.252350059578975,0.763905256448548,-0.874834583149537,-1.17029289536196,1905,1,IL6
DNA STRAND ELONGATION INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902319,0.64,0.96058002537611,0.684880899867667,0.909833720771033,4767,1,GINS1
NECROTIC CELL DEATH%GOBP%GO:0070265,0.27932171455487503,0.788692060817727,-0.24973840951585397,-1.13426090648263,1185,21,PPIF|PGAM5|ITPK1|DFNA5|CYLD|MLKL|TICAM1|TNF
CELLULAR RESPONSE TO BENOMYL%GOBP%GO:0072755,0.38858731629815996,0.8602318600740309,-0.8031539479488309,-1.07440352412973,2934,1,IMPACT
SINOATRIAL NODE CELL DIFFERENTIATION%GOBP%GO:0060921,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
T CELL CHEMOTAXIS%GOBP%GO:0010818,0.835509688289806,0.988613522932093,0.267217484271678,0.695510969134534,7933,7,SLC12A2|CXCL10|CXCL11
POSITIVE REGULATION OF PLASMA CELL DIFFERENTIATION%GOBP%GO:1900100,0.9110067114093959,1.0,0.5462064402293779,0.7256108878478271,6786,1,XBP1
REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0014060,0.509664948453608,0.918404893008545,0.39026584254684704,0.959802002999644,4745,6,CARTPT|UCN
KYNURENINE METABOLIC PROCESS%GOBP%GO:0070189,0.6047947693425351,0.9508825506493929,-0.3,-0.8751133097893641,3329,7,CCBL1|AFMID|AADAT|CCBL2|KMO|KYNU|TDO2
VESICLE FUSION%GOBP%GO:0006906,0.729265003371544,0.972554563883587,-0.136850938045018,-0.848858281217017,2162,54,RAB8B|VPS4A|TAPBP|VPS11|STX8|STX11|RAB39A|RAB8A|CAV2|RAB7A|VTI1A|SNAP25
RESPONSE TO MUSCLE INACTIVITY INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014877,0.0991358994501178,0.570215774831708,-0.7119223557957429,-1.4448252689453402,630,3,FBXO32|HDAC4|SCN5A
CEREBELLAR MOLECULAR LAYER DEVELOPMENT%GOBP%GO:0021679,0.19049740163325898,0.698434241409875,-0.7433691756272399,-1.2714931626039399,1282,2,DLL1|ZNF365
REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070948,0.27544286210489805,0.7884684708511421,0.606099040476453,1.1521305167198999,2378,3,F2RL1|DNASE1L3|DNASE1
NOREPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:0042421,0.603092783505155,0.9508825506493929,0.360867089375079,0.887500051089601,5615,6,HAND2|TH|MOXD1|GATA3|DBH
LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008610,0.611240098333789,0.9508825506493929,0.142409659410385,0.9473336983310691,8950,380,SPTSSB|ACSM3|B3GALT2|FDXR|EDN1|CYP21A2|PTDSS2|HACD1|STAR|TM7SF2|MGST1|CYP2C8|LPL|C14orf1|OXSM|SLC27A2|FDX1|LPCAT4|FITM1|PITPNM2|HSD17B4|AKR1B1|PRKAA2|PGAP1|CBR4|EBP|B4GALNT1|CERS4|STARD10|SCD5|MFSD2A|PLA2G4A|ELOVL6|GPAM|PPAP2C|DECR2|B3GALT1|DGAT1|FADS3|CEPT1|ABHD3|ST3GAL5|BZRAP1|CERS6|PIGC|OSBPL3|MVD|INPP5E|LBR|CACNA1H|HSD17B11|AMACR|DHCR24|TAZ|SRD5A3|PIGF|DPAGT1|HSD11B1|PPAPDC2|FAR1|CHKB|CPNE7|FADS1|ALDH3A2|PIGQ|MED1|PIGB|B4GALT6|GNPAT|APOE|NSDHL|MTMR4|ACOX2|OSBPL9|DOLPP1|ACACA|PLEKHA1|PTGS2|ST8SIA3|PTPN13|CYP7B1|GGPS1|CERS5|LTA4H|AGK|ACER2|ST3GAL4|IDI1|TECR|RAB4A|HMGCR|SMPD1|CPNE1|ETNK1|DGKE|ARV1|MSMO1|PLA2G2D|IMPA1|SLC44A3|PPM1L|DHCR7|DGKZ|ELOVL4|PIGL|MTMR1|ACAT2|LARGE|OSBPL6|HSD17B7|LCAT|PLA2G12A|CECR5|OSBP|PLA2G4B|ABHD2|PIP4K2B|ST3GAL6|CYP2E1|MTMR7|FIG4|SMPD4|PDSS1|CERS2|CYP2D6|PCK2|ELOVL2|PIGK|LPCAT2|B4GALT3|PLD1|PIGH|ACOT7|STARD3NL|PIP5K1C
PLASMA MEMBRANE FUSION%GOBP%GO:0045026,0.21609098567818,0.732736038864935,0.47591612585229404,1.23870968555991,2051,7,ROPN1B|SERPINA5
NEGATIVE REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003340,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
ORGAN GROWTH%GOBP%GO:0035265,0.0202721466259372,0.29842401801968604,-0.299030979135715,-1.62553448432345,72,35,SCARA3|DLL1|COL14A1|NLGN4X|COL6A2|VWA1|NOTCH1|FGF7|PSAP|EVC|COL6A1|LEPR|COMP|COL21A1|FGF10|S1PR1|STC1
PROTEIN O-LINKED GLYCOSYLATION VIA SERINE%GOBP%GO:0018242,0.032085020242915,0.365598374354954,0.5641221156479069,1.6098117706308002,316,9,GALNT13|GALNT3|MGAT5B|POGLUT1
AXONOGENESIS%GOBP%GO:0007409,0.5216554379210779,0.9251240799994541,-0.116459339944815,-0.980337631313577,541,199,NEFH|ALCAM|S100A6|PLXNA1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|PTPRM|EFNB1|SEMA3A|DOK5|PTPRA|PIK3R1|HSP90AB1|NTNG2|GFRA2|SLIT3|EPHB2|PARD3
ACROSOME REACTION%GOBP%GO:0007340,0.21914490311710197,0.7346677612393371,0.474710862763242,1.2355726389650301,2080,7,ROPN1B|PCSK4|STX2
CATABOLISM BY ORGANISM OF MACROMOLECULE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052361,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
RESPIRATORY TUBE DEVELOPMENT%GOBP%GO:0030323,0.0249160134378499,0.329326373353219,-0.290147033573554,-1.59606750112456,88,36,STRA6|VEGFA|PDPN|CEBPA|FGF7|NFIB|WNT11|CTSH|CHI3L1|FGF10|ASCL1|ATXN1L|HECA|DNAAF1
REGULATION OF MICROGLIAL CELL MIGRATION%GOBP%GO:1904139,0.653078504898996,0.9640743070248079,0.546953405017921,0.8939803148127909,5398,2,CSF1|P2RX4
REGULATION OF PHENOTYPIC SWITCHING BY TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0100057,0.678255033557047,0.9647315640607691,0.665527128363476,0.884123098760677,5052,1,SP1
ENDOCARDIAL CELL DIFFERENTIATION%GOBP%GO:0060956,0.28137082601054497,0.7892585111044429,-0.41555136370032303,-1.1406605911238,1600,6,NOTCH1|ACVR1|SOX17
FORMIN-NUCLEATED ACTIN CABLE ASSEMBLY%GOBP%GO:0070649,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
POSITIVE REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION BY PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:0035793,0.41728201099764295,0.8709670999109399,-0.49961398477997104,-1.01395173792756,2655,3,PDGFB|PDGFA|PDGFRB
REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000625,0.585388445061943,0.9439064862850342,0.48577258189037203,0.9234025768160871,5055,3,PAPD4|PNPT1|ZC3H12A
POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051798,0.19655056557285303,0.71009465891187,0.58687139742751,1.24363655202568,1754,4,FST|NUMA1|TGFB2
REGULATION OF NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0033029,0.6111547525530239,0.9508825506493929,-0.431509870960626,-0.875736462393284,3889,3,ANXA1|PIK3CB|PIK3CD
GLIAL CELL DEVELOPMENT%GOBP%GO:0021782,0.9648491558261829,1.0,-0.112017960724377,-0.6027559709598951,3485,34,TNF|PARD3
MIDBRAIN DEVELOPMENT%GOBP%GO:0030901,0.616260677000949,0.9518465519698142,-0.15164732689705,-0.905735333616662,1947,47,ATP5J|FZD1|MAPKAP1|CNP|CTNNB1|HSPA5|KDM7A|RHOA|COX6B1|G6PD|YWHAH|MBP|YWHAQ|CDC42|YWHAE|WNT3
SINOATRIAL VALVE DEVELOPMENT%GOBP%GO:0003172,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL NEURAL TUBE PATTERNING%GOBP%GO:1901621,0.11253806434529301,0.587889099677873,-0.9423246581385091,-1.2605764264298502,849,1,GPR161
NEGATIVE REGULATION OF CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:1901220,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:0098532,0.261743912018853,0.771967970256231,-0.574280357339804,-1.16548492260238,1665,3,BEND3|HIST1H1C|CHD5
REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901836,0.7384857114799179,0.9744283926676119,0.241224491503899,0.778521097588713,7519,13,NOL11|MARS|H2AFY2|SMARCA4|DDX11|MTOR|IPPK|PWP1|PIH1D1|SMARCB1|H2AFY
RENAL VESICLE MORPHOGENESIS%GOBP%GO:0072077,0.663772143105245,0.964618776001639,0.458480948843475,0.871524053365971,5732,3,BMP4|SMO
CARDIAC MUSCLE CELL-CARDIAC MUSCLE CELL ADHESION%GOBP%GO:0086042,0.6063447956466371,0.9508825506493929,0.4778868423955,0.908412615584994,5236,3,CXADR|JUP|PKP2
PREANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:0001546,0.331409395973154,0.8293509737209019,0.8383877370974859,1.11376070560531,2468,1,ZNF830
TRANSLOCATION OF MOLECULES INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051836,0.7565290648694191,0.977664504547119,0.292538071426213,0.761415137639471,7183,7,THOC3|THOC1|THOC2|DDX39B
ISOPRENOID CATABOLIC PROCESS%GOBP%GO:0008300,0.135961473849255,0.623555239107592,0.623661480499874,1.3215982524278702,1213,4,BCO2|SRD5A3|AKR1C3|CYP26B1
POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033089,0.8261763638562959,0.9876441563834109,0.475489385166805,0.77717433759761,6829,2,TESPA1|ADAM8
COLLAGEN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038065,0.0356992417860152,0.3821688062173221,0.609430001851295,1.58621825350438,338,7,DDR2|ITGA2|DDR1|COL4A2|ITGA11
BMP SIGNALING PATHWAY INVOLVED IN URETER MORPHOGENESIS%GOBP%GO:0061149,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:1905035,0.58,0.942746898746279,0.714214821349802,0.9488025267810309,4320,1,FAM3A
NEGATIVE REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070317,0.30061242344706895,0.803622654512819,0.25704331182651197,1.13459853639342,3435,36,RBBP7|EHMT1|CDC7|APAF1|PCGF2|EZH2|RAD51|E2F6|EHMT2|E2F1|SUZ12|EED|RRM2|CHEK1|MGA|UXT|BRCA1
AMINO-ACID BETAINE BIOSYNTHETIC PROCESS%GOBP%GO:0006578,0.830888117370366,0.9879179006160809,0.340173643489448,0.720860445633639,7418,4,ACADM|ALDH9A1
MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT ASSEMBLY%GOBP%GO:1902775,0.338413197172035,0.8326275783736579,-0.534961949928312,-1.08568938296195,2153,3,FASTKD2|DHX30|DDX28
NEGATIVE REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050713,0.7673110720562389,0.9792236089291529,-0.27659809166620697,-0.7592431894200641,4365,6,CARD16|CPTP|ZC3H12A|CARD8|TNFAIP3|NLRP3
RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071426,0.9717531238167358,1.0,0.10689590570560999,0.61294828644182,12831,118,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|ABCE1|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|XPOT|UPF2|U2AF2|RPSA|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
POSITIVE REGULATION OF TYPE IV HYPERSENSITIVITY%GOBP%GO:0001809,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
PROTON-TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY%GOBP%GO:0043461,0.838427197802198,0.989395884107905,-0.28016765938672,-0.7092258256479391,4882,5,C7orf55|OXA1L|ATPAF1|TMEM70|ATPAF2
RENAL SODIUM ION TRANSPORT%GOBP%GO:0003096,0.670950561537571,0.964618776001639,0.45538766957097204,0.8656440548697071,5794,3,KLHL3|SGK1|MAGED2
L-GLUTAMATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015813,0.685222672064777,0.966495577318169,0.289800004526532,0.8269901949861629,6769,9,SLC1A2|SLC25A22
MATURE B CELL DIFFERENTIATION%GOBP%GO:0002335,0.7375579286721741,0.974306231601101,0.263519882677743,0.777715254544221,7320,10,DOCK10|LFNG|SLAMF8|NOTCH2
RESPONSE TO KETONE%GOBP%GO:1901654,0.613018134715026,0.9508825506493929,-0.151119265704367,-0.9153990183898041,1892,50,MSN|NR3C1|KLF9|ADCY2|AQP1|CAV1|SLIT3
PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0030166,0.317479191438763,0.8190953247261821,0.239617550253398,1.11766032655653,3737,44,GLCE|GAL3ST3|VCAN|B3GAT3|HS3ST5|GAL3ST4|CHST15|EXT1|PXYLP1|CHPF2|XYLT2|BMPR1B
SKELETAL MUSCLE SATELLITE CELL MIGRATION%GOBP%GO:1902766,0.0645879732739421,0.495456803258629,-0.847422111938241,-1.4494701374451,434,2,RHOA|RHOC
MITOCHONDRIAL CITRATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0006843,0.41342281879194603,0.8683189983530021,0.8005072783414209,1.06343820611496,3079,1,SLC25A1
AMINOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0006023,0.8194851485148521,0.987153241368501,0.142886729879587,0.7631756855362759,10345,80,GLCE|GCNT2|VCAN|B3GAT3|HS3ST5|CHST15|GPC2|GPC6|EXT1|PXYLP1|CHPF2|GPC1|XYLT2|B4GALT6|PRELP|B3GALT6|B4GALT4|ABCC5|ST3GAL4|HS2ST1|GPC3|AGRN|B3GNT4|FMOD|ST3GAL6|BGN|B3GNT9|B4GALT3|SDC3|DCN|HEXA|OGN|ST3GAL3|LUM
PEPTIDYL-LYSINE OXIDATION%GOBP%GO:0018057,0.0265427259491544,0.3377111602831,0.7448187429036359,1.57834206500615,236,4,LOXL1|LOXL3|LOXL2
NEGATIVE REGULATION OF PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0010748,0.401164744092284,0.8638522656500329,0.49663894853611895,1.05242537337221,3581,4,AKT2|THBS1|AKT1
MAINTENANCE OF PROTEIN LOCATION IN MAST CELL SECRETORY GRANULE%GOBP%GO:0033370,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
POSITIVE REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001206,0.653825503355705,0.9640743070248079,0.678760476400529,0.9017030112463901,4870,1,ATP6AP1
OCTOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006589,0.48796419499213706,0.9079409787810301,0.608547008547009,0.994653367705813,4033,2,MOXD1|DBH
TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1990774,0.9739597315436239,1.0,0.5157146007940011,0.685103839495328,7255,1,HMGB1
POSITIVE REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032278,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042532,0.549089068825911,0.931134965065115,0.324627574377308,0.9263761795683371,5424,9,NF2|SOCS1|PPP2R1A|INPP5F|PARP14|PIBF1
AVOIDANCE OF DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051832,0.137313432835821,0.62388141596544,-0.6736517039814711,-1.3671561181592802,873,3,TGFB1|SMAD3|EIF2AK2
PROPIONYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:1902860,0.999338011386204,1.0,-0.500551389501544,-0.669602855420138,7547,1,ACAT1
ACTIN FILAMENT REORGANIZATION INVOLVED IN CELL CYCLE%GOBP%GO:0030037,0.10442953020134199,0.576535954147525,0.947342302602559,1.25850198507102,777,1,ARAP1
POSITIVE REGULATION OF PROTEIN DEACETYLATION%GOBP%GO:0090312,0.9012243203984229,0.9991415162751558,-0.1760097108806,-0.662849206861421,4342,13,AKAP8L|NIPBL|ING2|PRKD1|FNTA|AKAP8|ZBTB7B|C6orf89|BRMS1|VEGFA|PRKD2|CTBP1|DYRK1A
RESPONSE TO INTERLEUKIN-8%GOBP%GO:0098758,0.6645637583892621,0.964618776001639,0.6734671371857079,0.8946710462521049,4950,1,EGR1
INVOLUNTARY SKELETAL MUSCLE CONTRACTION%GOBP%GO:0003011,0.045503355704698,0.4190278528102411,0.9769519188354651,1.2978370392578,338,1,GAA
REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045649,0.994497936726272,1.0,0.14099066109904998,0.44445294908114896,10121,12,INHA|RIPK1|CSF1|FADD|IL34|PTPN2
NEGATIVE REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032696,0.44780994803266494,0.8850378987593649,-0.5873962238636129,-1.0047097819892299,3015,2,TNFRSF21
LACTATE BIOSYNTHETIC PROCESS%GOBP%GO:0019249,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|PER2
RESPONSE TO XENOBIOTIC STIMULUS%GOBP%GO:0009410,0.000475435816164818,0.0784645998831315,0.362048791020501,1.93731388382958,5,81,RYR2|DPEP1|AKR7A3|CYP2D7|CRYZ|MGST1|CYP2C8|GSTA4|GSTO2|CRHBP|AS3MT|AKR7L|CYP3A5|ACY1|GGT1|ADCY8|ABCB4|PDE2A|POR|CYP2R1|N6AMT1|BCHE|EPHX1|RORA|ARNT2|SULT1A3|AOC2|AKR1C1|CDO1|NAT1|MGST3|NQO2|GRIN1|GSTP1|MGST2
REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001233,0.0013642564802182802,0.0949304687768696,-0.260323514568447,-2.29005027922234,0,255,YWHAG|CCAR2|TRAP1|PSMD10|PARK7|SIAH1|CXCL12|BCL2A1|RELA|TMBIM6|BNIP3|NOC2L|AGT|CD44|TIMP3|MUL1|DEDD2|TAF9|SLC25A5|SNAI2|PYCARD|ZNF205|HIF1A|HSPB1|BAX|GPER1|SOD1|FBXW7|QARS|CREB3|TRIM39|PPIF|TP53BP2|IL1B|GZMB|CLU|PTTG1IP|BCLAF1|CX3CL1|MAPK7|MSX1|DAB2IP|TGFBR1|LGALS9|ACVR1|HMOX1|TNFAIP3|CIDEB|MAGEA3|EIF2AK3|BBC3|PML|ZNF385A|RPS3|RET|S100A8|PSME3|MPV17L|HRK|DDX3X|HYOU1|TCF7L2|BCL10|FAIM2|TNFRSF10A|P4HB|MAP2K5|HGF|YWHAH|DDIT3|CSNK2A2|UNC5B|ITGA6|ENO1|DFNA5|MMP9|CYLD|BCL2L1|SNAI1|BAG5|BOK|IGF1|SOD2|ICAM1|BID|ACAA2|CRADD|YWHAQ|YWHAB|PLAUR|ARHGEF2|PPP2R1B|LGALS3|FXN|EYA4|BCL2|CFLAR|ACKR3|TP53|YWHAZ|YWHAE|TNFRSF4|NOS3|SLC35F6|TNFRSF10B|SCG2|HTT|PARK2|BMF|EYA1|PEA15|SFRP2|SLC9A3R1|WWOX|BCAP31|BIK|CSNK2A1|TNF|BCL2L11|PMAIP1|TFDP2|CAV1|PAK2|UBB
KERATINOCYTE DIFFERENTIATION%GOBP%GO:0030216,0.978443449048152,1.0,-0.102772970804751,-0.565343014799095,3494,36,CASP3|CLIC4|KAZN|SPINK5|KRT9|PKP4|EVPL
CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0036474,0.9265601844228549,1.0,-0.272541774664975,-0.626789145758368,5626,4,RNF112|SIGMAR1|STK25|PDCD10
T CELL MIGRATION%GOBP%GO:0072678,0.7483416252072971,0.9749763305090959,-0.21354368669276896,-0.7779610711751691,3609,12,PIK3CD|GPR183|MYO1G|CXCL16|MSN|S1PR1
MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:0071888,0.35219005196733505,0.842847021021096,-0.6483043837882551,-1.10888992750794,2371,2,IRF3|CTSL
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070228,0.7747495713383271,0.9804101513665492,0.18777451020222696,0.7633994821696691,8584,27,IDO1|CD27|BMP4|BLM|PRKCQ|CCL5|AURKB
NEURON CELLULAR HOMEOSTASIS%GOBP%GO:0070050,0.8644261982050792,0.9924959975370441,0.19038230942641396,0.6714509117568679,9053,17,CALB1|TYRO3|SLC6A2|TAOK1|CALB2
OCTOPAMINE METABOLIC PROCESS%GOBP%GO:0046333,0.48796419499213706,0.9079409787810301,0.608547008547009,0.994653367705813,4033,2,MOXD1|DBH
ERROR-PRONE TRANSLESION SYNTHESIS%GOBP%GO:0042276,0.5872467771639039,0.945418171231938,-0.20312595668931802,-0.9063288213719342,2550,20,UBA52|UBC|UBB
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002313,0.682995951417004,0.9661822799536179,0.29048682633962797,0.8289501497696729,6747,9,DOCK10|LFNG
POSITIVE REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002793,0.9493365500603141,1.0,-0.0941956797541292,-0.729407071577773,1573,126,MYRIP|IL6|PANX1|VAMP3|MBP|IGF1|MAVS|MYOM1|RIPK2|GAPDH|CRH|KARS|NLRP1|NLRP3|TNFRSF4|ADCYAP1|DRD2|TWIST1|TNF|TRH
RESPONSE TO BIOTIN%GOBP%GO:0070781,0.35098636303455605,0.842847021021096,-0.8240516100573442,-1.10235896389667,2650,1,HLCS
NADP METABOLIC PROCESS%GOBP%GO:0006739,0.53715518859073,0.9265056012720759,0.25288804166617496,0.9390995535408969,5724,20,NUDT17|RBKS|NNT|ME1|PGLS|IDH1
REGULATION OF CENTRAL B CELL TOLERANCE INDUCTION%GOBP%GO:0002895,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
NEGATIVE REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903614,0.0720118782479584,0.515023940206536,-0.838875103391233,-1.43485093707394,484,2,MGAT5|LGALS3
ESTABLISHMENT OR MAINTENANCE OF NEUROBLAST POLARITY%GOBP%GO:0045196,0.294894060437652,0.800447413278835,0.5979290560102349,1.13660023569973,2546,3,FGF13|DOCK7
NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:1901293,0.5275190516511429,0.9265056012720759,-0.11887534375275301,-0.980172395276407,622,179,HSD17B12|APOA1BP|CMPK2|ATP5J|LDHA|PAPSS1|SCD|ADCY7|LHPP|CMPK1|ACSL1|PFKL|COX5B|GPI|GMPS|RRM2B|GUCY1A3|ATIC|PRPS1|GARS|PKM|PNP|ENO1|NAMPT|DCTD|ACSL4|HPRT1|ATP5I|PRPSAP1|PDHB|GAPDH|PGK1|CDADC1|PANK2|KARS|CYC1|HK1|NMNAT3|HK2|TPI1|ACLY|ADCY2|AK7|ALDOA|SLC25A13|ACSL3|ADM|PGAM2|AK4|NMNAT2
WNT SIGNALING PATHWAY%GOBP%GO:0016055,0.521258008153757,0.9251240799994541,-0.127569361747838,-0.977057453046505,894,121,FRAT1|PPP3R1|CTNNB1|ARRB2|CELSR1|PRICKLE1|PFN1|RHOA|DDX3X|TCF7L2|STRN|PPAP2B|MST1R|CAMK2A|WNT6|WNT11|CDC42|AP2S1|AGO2|UBA52|TCF7|WNT3|RAB5A|SFRP2|RAC1|MET|PLCB1|UBC|CAV1|UBB
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000696,0.29982425307557103,0.80250393930618,-0.407958856228118,-1.11981966791219,1705,6,PRKX|CTNNB1|LIF|PAX8
MATURATION OF SSU-RRNA%GOBP%GO:0030490,0.0268041237113402,0.339762187668294,-0.277586220565073,-1.5786623777412798,90,40,RIOK3|RPS16|TSR3|RPS28|UTP3|RRP36|DHX37|NOB1|PWP2|TBL3|SRFBP1|KRI1|NOL10|RRS1|CIRH1A|TSR1|TSR2|NOP14
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000515",0.190402132859365,0.698434241409875,-0.28751402915832597,-1.23682147399312,856,18,RC3H1|XCL1|ANXA1|JAK3|FOXP3|HMGB1|ZC3H12A|TWSG1|RC3H2|C10orf54|RUNX3|CD274|LGALS9|RUNX1|SMAD7|SOCS5|CBFB
GOLGI INHERITANCE%GOBP%GO:0048313,0.7169030732860521,0.971081608033886,-0.23586092937091102,-0.7979528277220391,3638,10,PLK3|VCPIP1|PDCD10|YWHAZ
NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900118,0.321830730112604,0.822751772025005,-0.37386100682600604,-1.09056914361563,1771,7,DFFA|BCL2L1|PAK2
OOCYTE GROWTH%GOBP%GO:0001555,0.606308724832215,0.9508825506493929,0.7019188354653729,0.932467858096389,4516,1,KMT2D
INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032635,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
EXOCYTIC INSERTION OF NEUROTRANSMITTER RECEPTOR TO PLASMA MEMBRANE%GOBP%GO:0098881,0.579049231885811,0.942692029750853,0.5752412462089879,0.9402160141271328,4786,2,STX3|STX1B
REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903522,0.18554468752333303,0.6921962082288221,0.207023065914711,1.2079036561556598,2484,129,RGS2|RYR2|KCNN2|TNNI3K|KCNK6|EDN1|CACNA1G|AKAP9|CACNB2|NPR2|KCNK3|ATP2B1|TBX2|KCNQ1|OXTR|ADORA3|SLC8A3|F2R|S100A1|FGF13|AGTR1|ATP2A1|CACNA1H|FOXN4|CACNA2D1|TGFB2|KCNH2|CACNA1D|F2RL1|ATP2B3|GJA1|DMPK|RNLS|GJC3|CXADR|ATP2A2|TH|SPTBN4|DMD|TRPC1
CELLULAR RESPONSE TO VITAMIN K%GOBP%GO:0071307,0.309576837416481,0.81178854572317,-0.675213675213675,-1.1549168293216598,2084,2,POSTN|GAS6
POSITIVE REGULATION OF HEMOPOIESIS%GOBP%GO:1903708,0.749879518072289,0.975626891255808,-0.11735362263514901,-0.8600748314135921,1555,100,NLRP3|PRKCA|STAT3|SOCS5|NUDT21|BCL6|NKAP|DUSP10|CBFB|TNF|FOXO3
NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901977,0.501089561996078,0.914742530447205,0.422159713496406,0.9730155580194301,4598,5,THOC1|PPP1R10|DDX39B|CDT1
PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:0097039,0.202513747054203,0.716936760360122,-0.6177300993742241,-1.25366488311271,1288,3,RNF31|RBCK1
PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:0090179,0.196132916521941,0.709979722518001,0.648119554428146,1.2320070933499199,1693,3,DVL1|DVL3|DVL2
C-TERMINAL PROTEIN AMINO ACID MODIFICATION%GOBP%GO:0018410,0.340882467786021,0.834617763010688,-0.335392762577229,-1.0826778928654301,1745,9,ATG12|ATG5|AGTPBP1|GPLD1|LCMT1|AGBL4|TTL|FOLH1|ATG7
TAURINE BIOSYNTHETIC PROCESS%GOBP%GO:0042412,0.336510067114094,0.8311444145897029,0.836237318041465,1.1109039698263798,2506,1,CDO1
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0090317,0.152559814767173,0.648319130045528,-0.251754771522417,-1.27293400882842,592,28,ERLEC1|GAS6|PARK7|INSIG1|UBE2J1|OS9|BAG4|INPP5K|APOD|CHP1|RANGAP1|SIAH3|CABP1
REGULATION OF SUCCINATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904229,0.15808288097444698,0.6597808951153779,-0.918063520070578,-1.22812156232048,1193,1,FXN
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0050775,0.5409008665841349,0.928807195199472,0.261602962588597,0.9384231600668059,5679,18,CUX2|PTPRD|CAPRIN2|OBSL1|LRP8|CUL7|CDKL3|SS18L1|DBN1|FBXW8|CUX1|CAMK2B
REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051570,0.0798781685989389,0.534273970180544,0.463700104239965,1.46174843930906,812,12,SIRT1|DNMT3B|ZNF274|JARID2|RIF1|BRCA1|DNMT1|ATRX|ZNF304|MYB
POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0045915,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|HPRT1
ENDOCARDIUM MORPHOGENESIS%GOBP%GO:0003160,0.14440247252747304,0.634200145031176,-0.5244172678120229,-1.32752749036832,840,5,SOX17|RBPJ
REGULATION OF FOCAL ADHESION DISASSEMBLY%GOBP%GO:0120182,0.122467893552231,0.607607158836689,-0.9375827084252321,-1.25423297571756,924,1,DUSP3
NEUTROPHIL MEDIATED IMMUNITY%GOBP%GO:0002446,0.0064308681672025705,0.180481691368788,-0.148872310308403,-1.39092069468761,1,403,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|IRAK4|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|IL6|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|ADAM17|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|ACE|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
NEURON PROJECTION DEVELOPMENT%GOBP%GO:0031175,0.434567901234568,0.878651088001772,-0.11064041589380698,-1.01733233586566,175,356,EHD1|IL6|PARD6B|LYN|TUBB3|NFIB|EFNA1|CHRNA7|CAMK2A|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|ZPR1|RAB8A|AMIGO1|CDC42|DBNL|NEFH|NEDD4|BLOC1S6|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|ADCYAP1|COBL|DRD2|MAPK3|BLOC1S3|MAP4|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|GFRA2|NBL1|MICALL1|SLIT3|EPHB2|PARD3|UBB|RTN4RL2
GAMMA-TUBULIN COMPLEX LOCALIZATION%GOBP%GO:0033566,0.7863795814684891,0.981626008042485,0.491722238270614,0.8037064900532259,6500,2,CEP72|MZT1
SENSORY PERCEPTION OF SOUND%GOBP%GO:0007605,0.483088920912096,0.906154221228364,0.20926387981951503,0.987469643947856,5698,46,PCDH15|ZNF354A|KCNQ1|ADGRV1|DFNB31|CDH23|TIMM13|BIRC5|PDZD7|CACNA1D|KIT|NIPBL|SERPINB6|SPTBN4|COL11A2|MYO7A
NUCLEOBASE TRANSPORT%GOBP%GO:0015851,0.281926594882482,0.7899371443259041,0.6030660637476559,1.1463651470156397,2434,3,SLC29A2|VDAC3|SLC23A2
HEME TRANSPORT%GOBP%GO:0015886,0.0528614626497928,0.44848293183566496,0.7000134179736259,1.4833953014518202,471,4,FLVCR1|FLVCR2|ABCB6
REGULATION OF METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000004,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021801,0.177987649836542,0.683751674540239,-0.43890573920443604,-1.28030751373581,979,7,DAB2IP|RTN4|SRGAP2C|MBOAT7
SULFATION%GOBP%GO:0051923,0.49377147766323,0.91071489001692,0.39631222412155503,0.974672197911996,4597,6,HS3ST5|SULT1A3
RETINOL METABOLIC PROCESS%GOBP%GO:0042572,0.8559409340659341,0.991298302704726,-0.275259210236047,-0.6968004125608,4984,5,RDH11|RETSAT|DHRS3|CYP1B1|RDH10
URACIL CATABOLIC PROCESS%GOBP%GO:0006212,0.930872483221476,1.0,0.537163652404058,0.713597947649256,6934,1,DPYD
PROTEIN DEGLUTARYLATION%GOBP%GO:0061698,0.9663709784191709,1.0,-0.515659461843847,-0.6898133844337,7298,1,SIRT5
TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE%GOBP%GO:0019441,0.7484681853888449,0.9749763305090959,-0.382493383803873,-0.7762589580524429,4763,3,TDO2
"MEMBRANE PROTEIN PROTEOLYSIS INVOLVED IN RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904211",0.41380846325167,0.868602149902778,-0.606837606837607,-1.0379632263523801,2786,2,HM13|RHBDD1
LUTEINIZATION%GOBP%GO:0001553,0.514689709347997,0.920792511236057,-0.46448659975736206,-0.942661753704617,3275,3,PDGFRA|INHBA|PTPRN
REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010915,0.9808326787117049,1.0,-0.270231425702308,-0.548426649534574,6242,3,LRPAP1
SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0036376,0.854149115417018,0.991298302704726,0.260810721873292,0.678835512673063,8110,7,ATP1B3|ATP1A3|ATP1A1|ATP1B1|ATP1B2|FXYD2
PROTEIN DEMETHYLATION%GOBP%GO:0006482,0.6137346957562371,0.9508825506493929,0.22827011486117899,0.887788879037784,6666,23,KDM5D|C14orf169|KDM5B|KDM4B|KDM1A|ALKBH4|KDM3B|KDM8|PHF2|KDM4A
ACTIN FILAMENT UNCAPPING%GOBP%GO:0051695,0.150235877585581,0.645075542829871,0.7659843659599699,1.25198040334009,1241,2,ACTN2|LRRC16A
PYRIMIDINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009196,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
NEUROTRANSMITTER CATABOLIC PROCESS%GOBP%GO:0042135,0.768912529550828,0.9792236089291529,-0.22551994262702,-0.7629677217287231,3902,10,SARDH|ABAT|ALDH5A1|SLC44A1|HNMT|COLQ|ACHE|AMT|ALDH7A1|GCSH
CYTOKINETIC PROCESS%GOBP%GO:0032506,0.6905732138005981,0.96731875442989,-0.15995581331123998,-0.8468205661029009,2541,32,ANLN|CEP55|AURKB|CNTROB|KIF20A|RACGAP1|ALKBH4|KLHDC8B|SPIRE2|SPIRE1|MITD1|SNX18|CHMP5|CHMP6|SNX33|SPAST|CHMP3|CHMP2B|CHMP7|CHMP2A|CHMP1A|CHMP4A|SNX9|RTKN|PDCD6IP|VPS4A|RHOA|VPS4B|ANXA11|CHMP4B|CHMP1B|MYH9
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032720,0.9423576871358141,1.0,0.142800268881618,0.591526800706316,10511,29,GHRL|TRIM27|GSTP1|MC1R|NLRC3|CACTIN|DICER1|VIMP|PTPN22
PROTEIN DEPHOSPHORYLATION%GOBP%GO:0006470,0.9613500272182909,1.0,-0.0917023127613788,-0.696953218397212,1765,115,PTPN9|CTDSP2|DUSP22|PPP2R5A|PPM1F|DUSP4|DUSP7|PPP1R15B|SDHAF2|PPP2R2A|PTPN6|CTDP1|RPRD1B|MTMR2|TIMM50|RPAP2|LHPP|PTPN3|PTPRU|PPEF1|PPM1G|UBASH3B|PTPN5|SHOC2|PTPN12|PPP2CA|PPP2CB|PPM1A|PPM1M|PTPN1|EYA4|DUSP3|EYA1|PTPRM|DUSP10|PPP1CB
CELL PROLIFERATION IN FOREBRAIN%GOBP%GO:0021846,0.0727877716543621,0.5182451790059721,0.539739944993344,1.47147589337098,699,8,SIX3|KIF14|DOCK7|FGFR2|PCM1|HOOK3
NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035308,0.0206519034585718,0.30240156779611604,-0.344344975676277,-1.6705109343636297,82,25,PPP1R8|MFHAS1|ENSA|FKBP1B|MGAT5|ARPP19|YWHAB|LGALS3|YWHAE|PPP1R11|TNF|FKBP1A
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:0035924,0.6045542904748679,0.9508825506493929,-0.166769267814873,-0.906558900826842,2176,35,FOXC1|HSPB1|NOTCH1|VEGFA|KDR|DAB2IP|PRKD2|MYO1C|NRP1|RAMP2|MAP2K3|FLT1|PGF
PHAGOLYSOSOME ASSEMBLY%GOBP%GO:0001845,0.7777158774373258,0.9811398289380491,-0.24289718430258103,-0.75503020805236,4187,8,RAB39A|RAB7A
PEPTIDYL-SERINE MODIFICATION%GOBP%GO:0018209,0.5585059171597629,0.936434965680841,0.160684402173952,0.951324652204308,7550,142,GALNT13|GALNT3|STK39|MAP3K10|PARP2|CDC7|MAPK12|CDK1|MAP2K2|STK38|ATR|MGAT5B|NAA10|ERN1|MARK2|POGLUT1|PDPK1|CDK5R1|PRKCB|PRKCQ|PARP1|MAST1|NLK|AURKB|TBK1|DMPK|ULK1|SBK1|PLK1|MARK3|RIPK1|AKT3|PKN2|VRK2|AKT2|CLSPN|MAP3K12|VRK1|MAPK13|MAPK9|DCLK3|RPS6KA4|PRKDC|VRK3|RPS6KB1|CDK2|ATM|IKBKE|CHUK|AKT1|MAPKAPK5|PRKD1|MASTL|PINK1|TLK2|SGK2|MORC3|TAF1|MAST2|TOP1|WNK1|CSNK1E|MAPK14
HISTONE H3 ACETYLATION%GOBP%GO:0043966,0.7108031819348221,0.97016506841811,0.17886393178994,0.823195391633364,8309,42,JADE3|AK6|KAT2A|TADA1|TAF6L|MAP3K7|LEF1|ING5|YEATS2|BRPF3|BRCA2|SUPT3H|WDR5|BRD1|CCDC101|MEAF6
DENSE CORE GRANULE CYTOSKELETAL TRANSPORT%GOBP%GO:0099519,0.522641198748559,0.9251240799994541,-0.404455964264049,-0.9301642239967359,3173,4,KIF1C|KIF1A|KIF5B|KIF5A
REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062012,0.884272366930917,0.9964911995606228,0.12061696015388,0.759787694896501,12492,220,FGFR4|SIRT4|SLC45A3|SIRT1|STAR|TM7SF2|FGF19|NR4A3|WNT4|CEACAM1|PRKAA2|ACADVL|NFYB|CCNB1|CDK1|INS|ELOVL6|CLCN2|GPAM|GNB3|PROX1|OGT|PHKG2|MVD|C1QTNF3|JMJD8|FAM132A|CLK2|ME1|SDHAF3|RORA|PARP1|PTH1R|PDK4|OAZ3|PGP|PASK|LDLRAP1|GCK|APOE|MIDN|ACACA|PTGS2|LPGAT1|SREBF2|GGPS1|ATPIF1|GSTZ1|ADIPOR2|SUPT20H|BAD|APOC1|CLTC|IDI1|HMGCR|PRKAB2|IRS1|AKT2|PFKFB2|METTL20|VIMP|ARV1
IMMUNE RESPONSE-REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002768,0.36363636363636404,0.8499434076701009,-0.11886500695867999,-1.04299898015421,271,248,FCER1G|PPP3R1|DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|BCAR1|NRAS|PRKD2|GRB2|FGR|ABL1|VAV1|MYO1C|IGHV1-69-2|CYFIP2|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|BCL10|RELB|LYN|FCGR2B|ARPC5|RNF31|CD276|YES1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CDC42|PDE4B|MUC3A|RFTN1|IGHV1-3|KRAS|BCL2|SHC1|JUN|NFATC2|GAB2|RBCK1|MAPK3|HLA-DQA2|HLA-DQB2|RAC1|PLD2|MUC12|ACTR2|BRK1|PIK3R1|HSP90AB1|PDE4D|TNFRSF21|PAK2
NEGATIVE REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030889,0.301764159702878,0.8047530191367741,-0.36048894964829,-1.12055661507573,1624,8,LYN|FCGR2B|TNFRSF21
PIGMENT BIOSYNTHETIC PROCESS%GOBP%GO:0046148,0.78028545941124,0.981487311948134,0.181332461924871,0.7603145447164659,8746,30,CITED1|ALAS1|MTHFD1|CPOX|AP3D1|ATPIF1|TRPC1|UROD|PAICS|PRTFDC1|IREB2|UROS|ALAD|HMBS
POSITIVE REGULATION OF LIPOPHAGY%GOBP%GO:1904504,0.0013173061090070801,0.0945022140486112,-0.862128719719724,-1.9827159503571101,7,4,ADRB2|HTT|SPTLC1
"NEGATIVE REGULATION OF GLYCOGEN SYNTHASE ACTIVITY, TRANSFERRING GLUCOSE-1-PHOSPHATE%GOBP%GO:1904227",0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
T-HELPER CELL LINEAGE COMMITMENT%GOBP%GO:0002295,0.655466763530694,0.9640743070248079,-0.288795744402273,-0.8424299991231892,3608,7,BATF|IL6|STAT3
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0034614,0.576701268742791,0.942692029750853,-0.139534620154287,-0.938208143169604,1499,71,PPIF|IMPACT|MAPK7|PRKCD|SIRPA|ROMO1|TNFAIP3|SOD3|ABL1|RPS3|ZNF580|FOXO1|PXN|IL6|MMP9|SOD2|PDCD10|FXN|NET1|JUN|NOS3|MAPK3|AQP1
SEQUESTERING OF IRON ION%GOBP%GO:0097577,0.0421052631578947,0.40376460791238894,-0.774732546597551,-1.57229668500489,267,3,SRI|FTH1|FTL
POSITIVE REGULATION OF ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903949,0.486633603483731,0.907092544497897,0.6091478163594201,0.995635371570044,4022,2,RNF207|TRPM4
POSITIVE REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903543,0.5683544303797471,0.940076901516441,-0.23401202891353498,-0.9066245517952901,2693,14,SMPD3|TSG101|SNF8|HGS|ATP13A2|SDC4|CHMP2A|STAM|SDC1|SDCBP|PDCD6IP|VPS4A|VPS4B|RAB7A
REGULATION OF METAPHASE PLATE CONGRESSION%GOBP%GO:0090235,0.780433866891323,0.981487311948134,0.285090162166193,0.742029794642244,7410,7,SPAG5|NUMA1|DYNC1H1
REGULATION OF CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903677,0.849253212921153,0.991298302704726,0.37995841840133004,0.7222609832556041,7334,3,METTL3|NCK1
POSITIVE REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900738,0.9768303985171459,1.0,-0.510752095280106,-0.6832486505570319,7377,1,CHGA
NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009134,0.43372303639058096,0.878651088001772,-0.43649699443004497,-1.00385189977286,2633,4,NUDT5|NUDT16|ENTPD4|NUDT18
B CELL DIFFERENTIATION%GOBP%GO:0030183,0.654602184087364,0.9640743070248079,-0.14875840495668302,-0.8797306704813871,2097,46,CEBPG|VCAM1|DLL1|GPR183|CD79B|IL11|PTK2B|VPRBP|CR2|HDAC4|NFAM1|HDAC5|FCGR2B|KLF6|ADAM17|IRF2BP2|TPD52
MAINTENANCE OF DNA METHYLATION%GOBP%GO:0010216,0.33188058400523,0.8293509737209019,0.483759101454084,1.11499301567612,3045,5,UHRF1|HELLS|DNMT1|UHRF2|USP7
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002583,0.26362038664323395,0.7750430007453571,-0.42369422535988105,-1.16301219962611,1499,6,HLA-DOB|HFE|HLA-DOA|TREM2|PYCARD|TAPBPL
FARNESYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0045337,0.7116245312689009,0.970341332123494,0.5235732009925561,0.8557660136251078,5882,2,HMGCS1|FDPS
ACTIVATION OF PROTEIN KINASE B ACTIVITY%GOBP%GO:0032148,0.997511818860413,1.0,-0.0948947248435849,-0.46036006523198403,4008,25,OSBPL8|NTRK3|NRG1|AKT1|PINK1|MLST8|CCDC88A|RICTOR|MTOR|PDGFB|ITGB1BP1|ANG|IL18|INSR|FGF1|GAS6|PARK7|TXN|MAPKAP1|ADRA2C|IGF1|PRR5|ADRA2A
POSITIVE REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002696,0.76390243902439,0.978421368343614,-0.105276452272615,-0.885679762052072,782,200,IGHV4-4|CD274|CHRNB2|ICOSLG|IL1B|RARA|FAM49B|SIRPA|MAP3K8|IGHV2-26|LGALS9|ITGAM|LAMP1|GRB2|FGR|CEBPA|VAV1|RPS3|IGHV1-69-2|IGHV3-15|FYN|IGHV3-73|C20orf196|RUNX1|IL6|PNP|LYN|CD276|YES1|IGF1|VAV3|KARS|CDC42|TFRC|IGHV1-3|NLRP3|BCL2|NFATC2|GAB2|SOCS5|TNFRSF4|BCL6|NKAP|TNIP2|FGF10|DUSP10|CBFB|RAC1|IGF2|PIK3R1|CAV1|PAK2
CYTOSKELETAL ANCHORING AT NUCLEAR MEMBRANE%GOBP%GO:0090286,0.191870261162595,0.701758700334305,0.48743157232974604,1.26868197334407,1821,7,SPAG4|SYNE1|SYNE2
REGULATION OF LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:1903236,0.7117454941333009,0.970341332123494,0.5234680924338161,0.8555942165733491,5883,2,CCL21|CXCL12
NUCLEAR NCRNA SURVEILLANCE%GOBP%GO:0071029,0.363444639718805,0.849828746111777,-0.38293530417516997,-1.0511316977355,2067,6,EXOSC10|EXOSC2|EXOSC3|EXOSC7|EXOSC8|EXOSC9
NEGATIVE REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903892,0.867260579064588,0.993065231963537,-0.40590019299696706,-0.6942705414974879,5840,2,ATF6B|WFS1
NEGATIVE REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901581,0.912080536912752,1.0,0.545710189677989,0.7249516411296121,6794,1,ATRX
NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001170,0.0466763530693789,0.425275525480742,-0.544137703399012,-1.5872738220089702,256,7,FLCN|CBFA2T3|HDAC4|FBP1|PPARA
VESICLE CYTOSKELETAL TRAFFICKING%GOBP%GO:0099518,0.12279670975323201,0.607607158836689,-0.230438789402455,-1.30019489706658,417,39,HAP1|RAB1A|AP3S2|BLOC1S6|KIF3B|TRAK1|HTT|BLOC1S3|KIF13A
MYOBLAST DEVELOPMENT%GOBP%GO:0048627,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|SDC1
PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION%GOBP%GO:0046838,0.45962858296326203,0.890371861972445,-0.28075692375593103,-0.988018594001925,2276,11,IMPA1|IMPA2|OCRL|INPP5J|PTEN|SYNJ1|INPP5B|SYNJ2|INPP1|INPP5K|INPP5A
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000178,0.9873610808454999,1.0,0.21189058018972,0.488376376359551,9061,5,NF1|KDM2B|SIRT2|GATA2|ID2
PROTEASOME REGULATORY PARTICLE ASSEMBLY%GOBP%GO:0070682,0.438805970149254,0.879683533669264,-0.49150766515936894,-0.99750020310688,2792,3,PSMD9|PSMD5|PSMD10
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900175,0.238448298689263,0.750892237039908,-0.880458756065285,-1.17781652295095,1800,1,SMAD2
CHROMATIN REMODELING%GOBP%GO:0006338,0.575052694971394,0.941940408834489,0.162611985579192,0.938630848916126,7638,122,RBBP7|MBD3|MTA2|KAT2A|BPTF|SMARCD3|TAF6L|CENPL|CENPT|ACTL6B|CENPK|CASC5|CENPU|CDKN2A|OIP5|KMT2B|ITGB3BP|CENPA|RB1|HIST1H4I|INO80|ZBTB1|CHD1L|HELLS|CENPV|CENPQ|CENPI|SMARCAD1|MIS18BP1|NASP|HJURP|STRA13|MYSM1|CENPM|SMARCA4|CHEK1|ARID1A|SUPT6H|SMARCD1|HMGB3|NPM2|CENPH|CENPW|RNF8|SMARCA1|TOP1|KAT2B|CHD4|SMARCA5|SUV39H2|HMGB2|NUDT5|HDAC2|ATRX|ACTL6A|ARID1B|CENPP|CENPO|CENPN|MYB|FOXP3|HMGB1|ZBTB7A|KDM6B|MIS18A|CENPC|CBX3|HIST1H4H|SMARCD2|MBD2|TADA2A|SMARCC2|RBBP4
NEGATIVE REGULATION OF MESODERM FORMATION%GOBP%GO:1905903,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
NUCLEAR BODY ORGANIZATION%GOBP%GO:0030575,0.0544103992571959,0.455860713081275,-0.501372378836651,-1.55848365468566,292,8,PML|ETS1|ZPR1|DYRK3
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DIFFERENTIATION%GOBP%GO:1902811,0.0834446919079436,0.543851846787664,-0.825547504391196,-1.4120547927649298,561,2,RBM24
PYRIMIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072527,0.920567729083665,1.0,0.13126292225410302,0.64532556394783,11090,55,TDG|SLC25A19|MBD4|TK1|CAD|AK3|DTYMK|CTPS2|UCKL1|DUT|DCK|NEIL1|SLC19A2|UMPS|HDDC2|UCK1|TYMS|CTPS1|CDS1|TET2|NTHL1|UNG|NT5M|APOBEC3C|TET1|DPYD|ERH
POSITIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 1 PRODUCTION%GOBP%GO:2000340,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
REGULATION OF FIBRONECTIN-DEPENDENT THYMOCYTE MIGRATION%GOBP%GO:2000413,0.9458493313915,1.0,-0.5245368328187029,-0.701688914255538,7143,1,ADAM8
REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903722,0.34669862715188504,0.842847021021096,0.477979327773998,1.10167149414585,3181,5,CENPJ|CEP295|CEP120
RESPONSE TO ACID CHEMICAL%GOBP%GO:0001101,0.223734349482853,0.736779590730865,-0.148618476975848,-1.12952577446043,410,115,ADNP2|GATSL3|TESC|RARA|VEGFA|PDK3|SCD|KDR|RRAGD|CPEB1|NSMF|PTK2B|HLCS|RRAGC|PTGFR|RET|FYN|RXRA|PTK7|PPARG|SH3BP4|LYN|LAMTOR5|ATP2B4|WNT6|WNT11|SHMT2|DGAT2|CTSH|TWF2|WNT3|ASCL1|CD36|SESN2|AQP1
PEPTIDYL-LYSINE DIMETHYLATION%GOBP%GO:0018027,0.95203025477707,1.0,0.182888799465001,0.557951803727478,9565,11,EHMT1|SMYD2|EHMT2|SUV39H1|SETMAR|SUV39H2
CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003433,0.5572139303482591,0.9361453421204542,-0.250488266088233,-0.912553879821217,2687,12,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:0035701,0.772348782403771,0.979693198874896,-0.37410389323921894,-0.75923273621419,4915,3,BCL11B|GPLD1|GAS6
RESPONSE TO INTERLEUKIN-15%GOBP%GO:0070672,0.0597634363975929,0.476295606439141,-0.401961964439882,-1.5137810748304599,287,13,STAT5A|SHC1|STAT3|PLCB1
PROTEIN FOLDING IN ENDOPLASMIC RETICULUM%GOBP%GO:0034975,0.923524918846668,1.0,0.17083896976198998,0.602524375063481,9672,17,SUCO|HSP90B1|PDIA2
STRIATUM DEVELOPMENT%GOBP%GO:0021756,0.460508241758242,0.8904234666384399,-0.38638870505184203,-0.97811734930895,2681,5,BBS2|BBS4|INHBA|CNTNAP2|MKKS
FOREBRAIN REGIONALIZATION%GOBP%GO:0021871,0.277063795299294,0.7884684708511421,0.6052934711559179,1.15059921418428,2392,3,SIX3|WNT2B|BMP2
NEGATIVE REGULATION OF PROTEIN REFOLDING%GOBP%GO:0061084,0.780400890868597,0.981487311948134,-0.44653389974633595,-0.7637723206901509,5255,2,BAG5
CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:0036006,0.136633441594803,0.62388141596544,0.623338664313682,1.32091417409232,1219,4,PDE2A|PDE1B|CSF1R|FER
DETECTION OF FUNGUS%GOBP%GO:0016046,0.801744966442953,0.9841161968820359,0.6000771945302161,0.7971757815917521,5972,1,TLR4
GALL BLADDER DEVELOPMENT%GOBP%GO:0061010,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
PROTEIN LOCALIZATION TO JUXTAPARANODE REGION OF AXON%GOBP%GO:0071205,0.330479170097151,0.8293509737209019,-0.473887387635802,-1.08984199301936,2006,4,CNTN2|CNTNAP1|EPB41L3|CNTNAP2
PIGMENT GRANULE LOCALIZATION%GOBP%GO:0051875,0.455232170628749,0.88900512246363,-0.230113259922409,-0.989896117959058,2048,18,BLOC1S6|MKKS|BLOC1S3|BBS7
ANTERIOR COMMISSURE MORPHOGENESIS%GOBP%GO:0021960,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:0070203,0.571053693984659,0.9404752161333092,-0.256081612109157,-0.9011830980374581,2828,11,CCT2|CCT5|DKC1|TERF1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1
NK T CELL PROLIFERATION%GOBP%GO:0001866,0.17397060770554698,0.676682497340677,-0.9103992059991179,-1.21786877570411,1313,1,ELF4
RESPONSE TO INTERLEUKIN-18%GOBP%GO:0070673,0.964457417582418,1.0,-0.22513750653304898,-0.5699206478889871,5616,5,ALOX5
CITRATE TRANSPORT%GOBP%GO:0015746,0.25240245455598,0.763905256448548,0.61779942994351,1.1743717262620001,2179,3,SLC13A3|SLC25A1|SLC13A4
REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060393,0.12738095238095198,0.6076669536424699,-0.22566043230041102,-1.29321428893352,427,41,TGFBR1|ACVR1|GDF15|BMP8B|SMAD6|LDLRAD4|SMAD7|DKK1|GREM1|BMPER|ACVRL1|SNX25|INHBB
HAIR CELL DIFFERENTIATION%GOBP%GO:0035315,0.28025477707006397,0.788916642629372,0.38171544058232004,1.16452630891861,2815,11,STRC|DFNB31|JAG2|PDZD7
OXIDATIVE DNA DEMETHYLATION%GOBP%GO:0035511,0.237988576548326,0.7507739897770379,0.5645377404501579,1.19630939946861,2124,4,TDG|ALKBH3|FTO
REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901976,0.0111050427817222,0.22988826688512698,0.435506613689683,1.75094519198673,121,26,ANAPC15|CCNB1|TPR|XRCC3|THOC1|USP44|PPP1R10|GEN1|NDC80|CDK5RAP2|WDR76
EYE PHOTORECEPTOR CELL DEVELOPMENT%GOBP%GO:0042462,0.912854251012146,1.0,0.21583143306983502,0.615909165392109,9018,9,CEP290|TH|MYO7A|TOPORS
IRON ION IMPORT%GOBP%GO:0097286,0.571177504393673,0.9405138747864158,-0.32685990463980896,-0.8972084911986609,3249,6,STEAP3
POSITIVE REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:0061014,0.9625140680460571,1.0,0.125577519896554,0.562560579116528,11117,38,BTG2|NANOS3|MEX3D|CPEB3|TNRC6A|METTL3|KHSRP|TNRC6C|PRR5L|POLR2G|CNOT1|RBM23|FTO|RC3H1|CNOT8|TOB1|NANOS1|PNPT1
NEGATIVE REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071656,0.54627300410433,0.930420772651609,-0.721217468019409,-0.964794596705817,4125,1,HAVCR2
ESTABLISHMENT OF CHROMOSOME LOCALIZATION%GOBP%GO:0051303,0.0589309428950863,0.475380099992949,0.295059486790434,1.45059569329557,709,55,CCNB1|PSRC1|KIF14|GEM|CENPF|KIF2C|KIF18A|NUF2|DLGAP5|CDC23|NDC80|CENPE|CEP55|BOD1|KIFC1|CDCA8|CENPQ|SPDL1|KIF22|CDCA5
POSITIVE REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030177,0.9560871960336821,1.0,0.11447301403856801,0.622142884754427,12148,88,MLLT3|ARNTL|CDH3|ILK|DEPDC1B|USP47|SEMA5A|TERT|DACT1|RNF146|FAM53B|CAPRIN2|PIN1|TNKS2|MACF1|BAMBI|ZRANB1|GPC3|CDC73|WLS|ATP6V1C2|SMARCA4|FGFR2|UBE2B|DAB2|SULF1|VCP|WNK2|COL1A1|USP34|XIAP|SMURF2|UBR5|WNK1|LGR4|CSNK1E|ZBED3|ADGRA2|JUP|PRDM15|TBL1XR1|CSNK1G3|DAPK3|TNKS
LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060836,0.8421721758082091,0.990921023343499,-0.241324413026834,-0.7039540193896271,4636,7,SOX18|ACVR2B|BMPR2|NR2F2|PDPN|ACVRL1
CYTOPLASMIC SEQUESTERING OF NF-KAPPAB%GOBP%GO:0007253,0.22671353251318105,0.7398172623753029,-0.439447118011368,-1.20625283222505,1289,6,PSMD10|NFKBIA|G3BP2|TMSB4X
CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0006520,0.792782305005821,0.9819233677232551,-0.102489174175686,-0.8807134544567421,680,225,SEPSECS|SERINC3|ATF4|ALDH6A1|BCKDHB|CSAD|GCLC|P4HA2|GPT2|QARS|C14orf159|AMT|DARS|AARS|NAT8L|BCAT1|CARS|ALDH7A1|GSS|WARS|GCSH|PCYOX1|FOLH1|NARS|HARS|FARS2|GARS|AIMP2|SLC25A32|ALDH4A1|P4HB|MTRR|SDS|SCLY|CBS|ASS1|SLC6A8|YARS|SMS|SLC6A6|SDSL|SHMT2|KARS|TDO2|FPGS|BCKDK|GCDH|PSPH|SLC7A8|NMNAT3|ODC1|PAH|PCBD1|PEPD|DDAH2|SARS|NOS3|QDPR|SLC7A4|SLC7A5|ASL|GLUL|DDAH1|EGLN3|NMNAT2
PROSTANOID BIOSYNTHETIC PROCESS%GOBP%GO:0046457,0.5727002967359051,0.940734934957679,0.263864666070843,0.914747239835687,5982,16,EDN1|MGST1
CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION%GOBP%GO:0034401,0.208641005498822,0.7239270253647571,-0.6112525616798751,-1.2405189128181202,1327,3,POLE3|CTBP1
REGULATION OF CELL GROWTH BY EXTRACELLULAR STIMULUS%GOBP%GO:0001560,0.395339600158877,0.8638522656500329,-0.8003970004411121,-1.07071547139003,2985,1,KIF26A
PLASMA LIPOPROTEIN PARTICLE OXIDATION%GOBP%GO:0034441,0.43492651926386894,0.878651088001772,-0.7804918394353771,-1.04408773060939,3284,1,PLA2G7
NEGATIVE REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902430,0.5376280535854999,0.9265056012720759,-0.273293773069633,-0.924593740902279,2728,10,PRNP|CHRNA7|HAP1|BIN1
"REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032832",0.354958294717331,0.842911430859438,-0.821460079400088,-1.09889219432135,2680,1,LGALS9
COMMON MYELOID PROGENITOR CELL PROLIFERATION%GOBP%GO:0035726,0.034271158967234,0.378376442437575,0.7940333075989849,1.50937378857701,295,3,NR4A3|CEACAM1|GSTP1
NEGATIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032076,0.956574331680174,1.0,0.384784904877557,0.628920356362673,7907,2,GZMA
NEGATIVE REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001953,0.7383715699505171,0.9744283926676119,0.19402096360835103,0.7956078583676691,8206,28,NF2|KIAA2022|AJAP1|CDKN2A|SRC|SEMA3E|CASK|ACER2|THBS1|SERPINE1|RASA1|ADAM15|JAG1
AUTOPHAGY INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0075071,0.996752155896517,1.0,0.21352016642415603,0.452469629161792,8899,4,ULK1|ATG5|ULK2
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE%GOBP%GO:0003065,0.7825503355704699,0.981487311948134,0.6103881782090871,0.8108734634035369,5829,1,TPM1
POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032930,0.988561921597172,1.0,0.17612664791218502,0.48016849408137396,9506,8,F2RL1|GSTP1|MAPT|TGFB1|ITGB2|SOD1|PRKCD|ITGAM
NITRIC OXIDE-CGMP-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038060,0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
FOAM CELL DIFFERENTIATION%GOBP%GO:0090077,0.9994552190019609,1.0,0.174983332351962,0.40331064127935295,9172,5,SOAT1|STAT1|EP300
PHARYNX DEVELOPMENT%GOBP%GO:0060465,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
POSITIVE REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010636,0.0337045285820342,0.37587925780947296,-0.8858009374138409,-1.5151150629827,226,2,PLD6|PARK2
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010512,0.6561247216035639,0.9640743070248079,-0.4995864350703061,-0.854515841049754,4418,2,PDGFB|PDGFA
MODULATION BY HOST OF SYMBIONT TRANSCRIPTION%GOBP%GO:0052472,0.6627235213204951,0.964618776001639,0.215514882655552,0.848158344689672,7226,24,GTF2B|CCL5|LEF1|PSMC3|SMARCA4|SP1|TFAP4|TARDBP|REST|CCL4|CHD1|SNW1|NUCKS1|EP300|RRP1B
ALDITOL BIOSYNTHETIC PROCESS%GOBP%GO:0019401,0.47157577862683797,0.898272347254494,0.527021065402007,1.0018116047941101,4072,3,PGP|PCK2|GOT1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0061395,0.45703693896465003,0.889841141099643,-0.770456550507278,-1.03066321863688,3451,1,ATF4
POSITIVE REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:1900246,0.603726302026585,0.9508825506493929,0.387438095416701,0.8929873755305071,5540,5,ANKRD17|DHX58|DDX60|PUM2
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002587,0.869722995040523,0.9934031064448321,0.45310173697270506,0.7405823416490279,7189,2,HLA-DOB|HLA-DOA
CUTICLE DEVELOPMENT%GOBP%GO:0042335,0.32979865771812106,0.8291759588236239,0.8391596823996469,1.11478620050031,2456,1,DUOX1
AMACRINE CELL DIFFERENTIATION%GOBP%GO:0035881,0.258791946308725,0.7702827862722491,0.872849580943979,1.15954172770352,1927,1,FOXN4
REGULATION OF TRANSLATION AT POSTSYNAPSE%GOBP%GO:0140245,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0016479,0.984544741852391,1.0,0.24324066874803602,0.515450212636396,8790,4,H2AFY2|FLNA|H2AFY
MODULATION OF AGE-RELATED BEHAVIORAL DECLINE%GOBP%GO:0090647,0.36168717047451704,0.848418604328854,-0.38368724570958396,-1.05319572675828,2057,6,PSEN1|PICALM|PRNP|DKK1
"POSITIVE REGULATION OF SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:1904237",0.560671140939597,0.936434965680841,0.7233127481252758,0.9608887166149591,4176,1,FN1
SODIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098719,0.0366018508890506,0.386113929236656,0.5844535873021229,1.59337727823696,351,8,HCN2|SLC9A5|SLC9A7
REGULATION OF THYROID HORMONE GENERATION%GOBP%GO:2000609,0.837416481069042,0.9889652677625541,-0.422846211189705,-0.723255798045484,5639,2,PAX8
AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:0042987,0.00297121634168988,0.13156768405007002,-0.664184455844228,-2.06457447961401,15,8,CLN3|APH1A|PSEN1|PSENEN|DYRK1A|NCSTN|PSEN2|ABCG1
MITOCHONDRIAL ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0061732,0.6181544517772379,0.9532238181782521,0.474618249567026,0.9021993644611241,5338,3,PDHX|DLD
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043371",0.35505291554264395,0.8429129485012808,-0.28298848310473496,-1.0657292182255698,1710,13,RUNX1|SMAD7|SOCS5|CBFB
PURINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009167,0.7535657686212359,0.9769690538700708,-0.108853656036646,-0.8866944331408549,950,167,PFKL|COX5B|GPI|NDUFB10|SDHC|GMPS|ATIC|UQCRC1|NUDT4|PKM|ENO1|MT-ND5|HPRT1|ATP5I|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|COX4I2|NDUFS6|PGAM2|AK4
REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051972,0.86513520386539,0.992690647212272,0.148216287653269,0.699399652355095,10205,46,PIF1|NVL|HMBOX1|PNKP|PRKCQ|MEN1|SRC|NEK2|AURKB|MAP3K4|MAP2K7|WRAP53|HNRNPA2B1
NEGATIVE REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900240,0.42433772831740707,0.8740879492662891,0.632864626413014,1.03439984606376,3507,2,FGF9|DNMT1
POSITIVE REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000620,0.8070642312809971,0.984682960940884,0.4842018196856911,0.791414572474152,6671,2,BRCA1|AUTS2
REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904956,0.8481069042316259,0.991298302704726,-0.41659773917838394,-0.7125681213168751,5711,2,CSNK1E|CSNK1D
FAT-SOLUBLE VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0042362,0.8446919079435781,0.991298302704726,-0.41880341880341904,-0.716340818186852,5688,2,CYP27B1|UBIAD1
REGULATION OF SCHWANN CELL PROLIFERATION INVOLVED IN AXON REGENERATION%GOBP%GO:1905044,0.6948993288590601,0.96731875442989,0.657201146890163,0.873062403821749,5176,1,CERS2
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0043470,0.9370196979065452,1.0,0.14044408971998001,0.60049172012893,10607,32,PRKAA2|INS|OGT|PHKG2|JMJD8
REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010810,0.10892857142857101,0.58452352834625,-0.158031632455516,-1.2240236013259498,182,125,DUSP22|PPM1F|RREB1|MMRN1|CALR|ARL2|THY1|CRKL|S100A10|GPM6B|NOTCH1|VEGFA|KDR|CX3CL1|BCAS3|COL16A1|PTK2B|PDPN|DLC1|ABL1|MMRN2|RHOA|NRP1|SLC9A1|C1QBP|PLAU|MYADM|APOD|DOCK5|SPOCK1|MAP4K4|CRK|EMILIN2|CDC42|NPNT|MMP12|DUSP3|LIMS1|MFI2|ACVRL1|RAC1|CORO1C|CD36|CDH13|PEAK1|EMILIN3
POSITIVE REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090190,0.10209122344804901,0.573450707099996,-0.619538290420163,-1.42480864188398,619,4,AGT|VEGFA|PAX8
REGULATION OF MRNA CLEAVAGE%GOBP%GO:0031437,0.0871177015755329,0.553293724109832,-0.9551720335244821,-1.27776275219685,657,1,NUDT21
REGULATION OF INVADOPODIUM DISASSEMBLY%GOBP%GO:1905927,0.0520805369127517,0.44586532408291796,0.9738641376268191,1.2937350596778001,387,1,NAV3
NEGATIVE REGULATION OF PROTEIN TETRAMERIZATION%GOBP%GO:1901091,0.38752783964365295,0.859991269020751,-0.622260045037875,-1.06434248092098,2609,2,PEX5
RESPONSE TO DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052173,0.0622427136505846,0.48645662140978296,-0.673688854574533,-1.54934362698993,377,4,TGFB1|SMAD3|SLC25A6|EIF2AK2
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0048002,0.54047619047619,0.928807195199472,-0.125357859162059,-0.9709510421544659,907,125,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|CALR|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|TAPBP|HLA-DQB1|DCTN5|FCGR2B|SLC11A1|VAMP3|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|B2M|SEC23A|HLA-DQA2|RAB7A|ERAP2|HLA-DQB2|CTSV|ACE|DYNC1LI1|CD36|BCAP31
POSITIVE REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:2000504,0.5949953660797029,0.9473459395438281,-0.696404940449934,-0.931602122048506,4493,1,TMBIM1
ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038166,0.5338037068239261,0.9265056012720759,0.361536806769151,0.941004349094785,5068,7,ACTN2|AGTR1|SRC
POSITIVE REGULATION OF TRANSLATIONAL FIDELITY%GOBP%GO:0045903,0.322520852641335,0.822872876381627,-0.839986766651963,-1.12367590873214,2435,1,RPS9
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903428,0.271417545665037,0.7864992130359009,-0.22419595459575198,-1.13358985619572,1054,28,DDAH2|CD36|HSP90AB1|TNF|DDAH1
RESPIRATORY CHAIN COMPLEX III ASSEMBLY%GOBP%GO:0017062,0.9076532604451392,1.0,-0.200242718446602,-0.646401439325904,4648,9,UQCC3|BCS1L|UQCR10|UQCRB|UQCC1|LYRM7|TTC19|UQCC2|SLC25A33
EATING BEHAVIOR%GOBP%GO:0042755,0.0171249018067557,0.277422272849102,-0.8263482960185291,-1.6770493148835,108,3,GDF15|STAT3|TRH
NUCLEOTIDE-EXCISION REPAIR INVOLVED IN INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:1901255,0.860650780210475,0.9916689277956879,0.4574579542321479,0.7477024590872979,7114,2,XPA|ERCC4
MODULATION BY SYMBIONT OF HOST PHAGOCYTOSIS%GOBP%GO:0052190,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
POSITIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070245,0.434721131186174,0.878651088001772,-0.492831145913753,-1.0001861679755601,2766,3,ZC3H8|ADAM8|TP53
ANIMAL ORGAN FORMATION%GOBP%GO:0048645,0.260352831940576,0.7717385447946792,-0.376012594136001,-1.16881086125376,1401,8,PAX8|FGF10|SOX17
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032925,0.172996706915478,0.676682497340677,-0.30844320724626695,-1.2631785984964299,787,16,SKI|ACVR1|SMAD2|SMAD7|IGSF1|DACT2|FKBP1A
POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048386,0.29316575019638597,0.8004058897916541,-0.5576817028785711,-1.13179844654099,1865,3,CTBP2|ASXL1|TRIM16
INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0099587,0.488153280301086,0.9079409787810301,0.21377761622532399,0.983880577542745,5706,42,SLC12A2|HCN2|SLC9A5|SLC9A7|ATP1B3|CACNA2D1|KCNJ11|KCNH2
RESPONSE TO INTERLEUKIN-12%GOBP%GO:0070671,0.0169642857142857,0.277340114229305,-0.28684661150146,-1.6438599046553999,56,41,RAP1B|SOD1|SIRPA|BOLA2|BOLA2B|AIP|HNRNPF|P4HB|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|PITPNA|PLCB1|PAK2
AUXIN METABOLIC PROCESS%GOBP%GO:0009850,0.7995973154362421,0.9839175016931591,0.6015659461843851,0.7991535217463951,5956,1,ACAA1
REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902202,0.6360174711613841,0.95916055221954,0.41475352857999104,0.8789023463823141,5678,4,ESM1|ADAMTS12|PTPN2
NEGATIVE REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000195,0.844832214765101,0.991298302704726,0.578352448169387,0.768315425261039,6293,1,HYAL3
DNA LIGATION INVOLVED IN DNA RECOMBINATION%GOBP%GO:0051102,0.151812080536913,0.6481463948883249,0.9246250551389499,1.22832313530388,1130,1,LIG4
NEGATIVE REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000480,0.400557103064067,0.8638522656500329,-0.330413655122736,-1.02706950468346,2156,8,PRKAR2A|PRKAR1B|PKIG
GLUCAN CATABOLIC PROCESS%GOBP%GO:0009251,0.9399556719725971,1.0,0.196045826853635,0.578581883782405,9329,10,GAA|AGL|PYGL|PGM2L1|PGM2|PYGM|PGM1
ORGANIC HYDROXY COMPOUND TRANSPORT%GOBP%GO:0015850,0.43486402865982704,0.878651088001772,0.199879331246677,1.02313675673842,5340,66,ABCC3|STAR|GHRL|SLC2A13|CEACAM1|PGAP1|ABCA7|ABCA5|SCARB1|STARD5|LIMA1|SOAT1|AKR1C1|CETP|OSBPL5|LDLRAP1|APOE|SLC16A7|SLC6A2|APOC1|LDLR|ARV1|APOM|LCAT|OSBP|SERAC1|SYT7|SLC18A2|LRP6|STARD3|APOC2
SMALL MOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0044283,0.605282967220968,0.9508825506493929,0.142975119329798,0.9479599700159709,8844,365,ACSM3|FDXR|EDN1|RGN|HACD1|ASNS|CTH|TM7SF2|MGST1|CYP2C8|LPL|C14orf1|OXSM|IMPDH1|SLC27A2|GAMT|SERINC5|VCAN|TDG|HSD17B4|AKR1B1|CBR4|EBP|NUDT17|RIMKLB|SLC35D1|COQ3|BDH2|SCD5|ELOVL6|GGT1|DNPH1|GPT|PPIP5K2|DECR2|FADS3|PDE2A|GLS|APIP|ABHD3|DHFR|CHST15|ISYNA1|OSBPL3|GLS2|MVD|MTHFD1|LBR|CACNA1H|AMACR|DHCR24|COQ2|MBD4|SRD5A3|TK1|CAD|PPAPDC2|COQ6|SLC25A10|CDO1|MTR|CTPS2|PGP|RFK|FADS1|MGST3|GCK|UCKL1|APOE|NSDHL|DUT|ACOX2|SMPDL3A|SLC25A1|OSBPL9|ACACA|PTGS2|MGST2|DCK|CYP7B1|MTAP|GGPS1|GGT5|NEIL1|PSAT1|LTA4H|BCAT2|NAALAD2|ACER2|PYCR2|HINT1|PHGDH|ABCC5|UMPS|TECR|HMGCR|MOXD1|NAGS|PFKFB2|UCK1|ARV1|MSMO1|HMGCLL1|RIMKLA|COQ9|SEPHS1|DHCR7|AKR1A1|ELOVL4|CCBL1|AASS|ACAT2|OSBPL6|HSD17B7|COQ5|PTS|HMGCL|OSBP|ALDH18A1|ABHD2|AACS|CYP2E1|BGN|PDSS1|CYP2D6|PCK2|ELOVL2|VCP|CTPS1|PPIP5K1|BPGM|ENOPH1
LYSOSOME ORGANIZATION%GOBP%GO:0007040,0.9927847448891941,1.0,0.101493883596351,0.46351448576774,11557,41,GAA|TMEM165|GNPTAB|HOOK1|CLN6|CORO1A|HOOK2|MYO7A|CLVS1|LAPTM4B|FAM160A2|SYT7|HOOK3|VPS33A|TMEM199|LAMTOR1|TMEM106B|RAB34|RAB20|RAB7B|ARSB|MBTPS1|TPP1|ZKSCAN3|TPCN2|RAB14
ESTABLISHMENT OF CENTROSOME LOCALIZATION%GOBP%GO:0051660,0.19272457312546398,0.7027916199946072,-0.7421560518334709,-1.26941817932546,1297,2,EZR|DLG1
NEGATIVE REGULATION OF KINASE ACTIVITY%GOBP%GO:0033673,0.28393135725429,0.7932164655007249,-0.134160830869569,-1.08660796038839,363,164,IRS2|HHEX|PRKAG2|IPO5|SFN|AKT1S1|CBLB|GSKIP|PRKAR1A|RASIP1|WWTR1|YWHAG|PARK7|AIDA|GBA|DUSP22|PPP2R5A|PPM1F|PYCARD|DUSP4|THY1|CDKN1B|DUSP7|HSPB1|HEXIM1|QARS|ZGPAT|LRP5|IL1B|HEG1|PRKCD|DAB2IP|IGF1R|TRIB1|WARS|RGS4|CEBPA|ABL1|GNAQ|INPP5K|UBASH3B|LYN|CHP1|TRIB2|PIK3IP1|PPP2CA|PRKAR2A|NPM1|PTPN1|CDKN1C|PDCD4|DUSP3|UCHL1|SNX6|PRKAR1B|PKIG|SOCS5|CDKN1A|DBNDD2|PARK2|KIAA0226|DUSP10|CORO1C|SPRED2|CAV1|EPHB2|PAK2|TRIB3
CALCITRIOL BIOSYNTHETIC PROCESS FROM CALCIOL%GOBP%GO:0036378,0.838791946308725,0.989395884107905,0.581219673577415,0.77212440629961,6248,1,CYP27B1
MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:0051306,0.39747597545443997,0.8638522656500329,0.555164359882111,1.0553090470373399,3432,3,NCAPH2|TEX14|DIS3L2
L-ORNITHINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903352,0.3772321428571429,0.85375124052253,-0.41437711288885,-1.04896814522246,2196,5,SLC7A3|SLC25A15|SLC7A1
INNER CELL MASS CELL DIFFERENTIATION%GOBP%GO:0001826,0.8920805369127521,0.9976191001250191,0.555249228054698,0.7376238280463969,6645,1,TET1
SUCKLING BEHAVIOR%GOBP%GO:0001967,0.9423904974016329,1.0,-0.35709953129308,-0.61079962324925,6346,2,UBR3|PEX13
MODIFICATION BY VIRUS OF HOST MRNA PROCESSING%GOBP%GO:0046778,0.5726382000725779,0.940734934957679,0.577502067824649,0.9439112649495269,4733,2,PABPN1|CPSF4
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070961,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
RRNA 2'-O-METHYLATION%GOBP%GO:0000451,0.183974862529458,0.690416428359473,-0.6343258215843139,-1.28734540825753,1170,3,FTSJ2|RNMTL1
NEGATIVE REGULATION OF AXON REGENERATION%GOBP%GO:0048681,0.164626288659794,0.66708489515411,0.529741515427674,1.3028221077752,1532,6,RTN4RL1|RTN4R|PTPRS|CERS2|INPP5F
CELL-MATRIX ADHESION INVOLVED IN AMEBOIDAL CELL MIGRATION%GOBP%GO:0003366,0.474053465586065,0.9001145888065609,0.614268649098842,1.00400523200512,3918,2,ITGA4|ITGB7
CELLULAR HYPEROSMOTIC RESPONSE%GOBP%GO:0071474,0.38513049450549497,0.8594725939233921,-0.411633362169845,-1.04202252247171,2242,5,ARHGEF2|AQP1
NEGATIVE REGULATION OF CELLULAR RESPIRATION%GOBP%GO:1901856,0.222420193021529,0.7355723797115551,-0.724620898814447,-1.23942523920914,1497,2,TRAP1|SNCA
RESPONSE TO FOOD%GOBP%GO:0032094,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
"TRANSCRIPTION, DNA-TEMPLATED%GOBP%GO:0006351",0.9466019417475731,1.0,-0.0853916039619137,-0.8224688248254142,194,469,ICE1|POLR3H|FOSL1|CCRN4L|PPARA|KLF13|NELFA|RXRA|PTRF|DDIT3|NRBF2|PPARG|NRL|ARRB1|POLR1B|ELP3|MAFF|NFE2L1|POLR2A|TCF4|TAF1B|PAX8|SUPT4H1|YBX1|TTF2|ETS1|ZNF217|KLF11|TEAD4|DDX21|ASH2L|PHAX|NR1H2|POLR2K|PPARGC1A|NELFE|SNRPB|TCEB1|SLC25A33|TCFL5|HSF1|NR3C1|MLF1|POLR2F|NFKBIB|ELP2|POLR1E|TP53|COPS2|BCL3|TAF4B|MAPK3|NCBP2|NFYA|NUDT21|CDKN1A|TCEA1|POLR2I|POLR2D|RNPS1|CBFB|TRIM29|NR1D1|NR1D2|CD3EAP|SOX17|TAF8|SLBP|TAF13|EPAS1|RBPJ|PBRM1|CRCP|MED10|EAF1|FOXO3|CREB5
POSITIVE REGULATION OF THYROID HORMONE GENERATION%GOBP%GO:2000611,0.837416481069042,0.9889652677625541,-0.422846211189705,-0.723255798045484,5639,2,PAX8
REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051040,0.42568671121009605,0.875696962448429,-0.599944858009374,-1.0261735486337,2866,2,BMP2|CX3CL1
MITOCHONDRIAL PROTEIN PROCESSING%GOBP%GO:0034982,0.5664979757085021,0.9388612723386429,0.320220534317239,0.9137999930201579,5596,9,OMA1|MIPEP|IMMP1L|IMMP2L
OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035672,0.350589169866278,0.842847021021096,-0.8242170269078081,-1.1025802470610502,2647,1,ABCC1
REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043244,0.25240562546262,0.763905256448548,-0.17168657234120402,-1.13371942107932,681,67,UBQLN4|PHF23|CAPZA1|SMCR8|TTBK2|GSN|CAPZB|MTRF1|PLEK|TRIOBP|GBA|BNIP3|OGFOD1|CAPZA2|RLTPR|ADD1|NES|IGF1R|SPEF1|CFL2|WDR1|TBC1D25|TRIM54|ARHGEF2|TWF1|ADRB2|MTPN|ETF1|TWF2|KIAA0226|SH3BP1|MID1IP1|TNF
T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050852,0.9880043620501641,1.0,0.0983943943216662,0.540620959825298,12683,93,PAG1|ERMAP|GRAP2|SKAP1|EIF2B5|PAK3|PDPK1|EIF2B1|PRKCQ|MAP3K7|CARD11|EIF2B4|BTN2A2|PLCG1|PRAM1|CD3D|BTN2A1|LAT|TRAT1|PTPRJ|CD3G|CD3E|PTPN22|ZAP70|BTN3A2|LCK|BTK|GATA3|HLA-DRB1|CHUK|NFKBID|RC3H1|NCK1|BTN3A3|CSK|WNK1|BTN3A1|STOML2|HLA-DRB5|IKBKG|WAS|HLA-DPB1|BTNL9|HLA-DQA1
GLYCOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0046295,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009208,0.09743532310449099,0.570215774831708,0.653173771576683,1.3841376163805499,869,4,CAD|AK3|CTPS2|CTPS1
SEQUESTERING OF METAL ION%GOBP%GO:0051238,0.0149381868131868,0.264326813346421,-0.71674387822634,-1.81438953348831,86,5,S100A9|SRI|S100A8|FTH1|FTL
CREATINE METABOLIC PROCESS%GOBP%GO:0006600,0.651310137457045,0.963985859176228,0.34538077491771996,0.849413716046145,6064,6,GAMT|CKB|CKMT1B|GATM|CKMT1A
POSITIVE REGULATION OF PHOSPHOLIPID EFFLUX%GOBP%GO:1902995,0.0996734002661183,0.570215774831708,0.807003032809485,1.3190242874569198,823,2,ABCA7|APOE
HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE%GOBP%GO:0048873,0.823152292246281,0.987616425875001,0.476921195410781,0.7795145921072609,6804,2,F2R
RESPONSE TO FENOFIBRATE%GOBP%GO:1901557,0.17409395973154398,0.676682497340677,0.914203793559771,1.2144789542213799,1296,1,ABCB4
SOMATIC HYPERMUTATION OF IMMUNOGLOBULIN GENES%GOBP%GO:0016446,0.524641954507161,0.925993329275615,0.364316719825075,0.9482398787192992,4981,7,EXO1|POLQ|MSH6
POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031954,0.8991335258831371,0.998912093067348,-0.157677298022326,-0.6782927035808511,4046,18,TOM1L1|RAP2C|VEGFA|MRE11A|RASSF2|GREM1|ACE
EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:0085029,0.9267206477732791,1.0,0.20918512589430802,0.596942875601995,9155,9,TNXB|FBLN5|MFAP4
TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034370,0.0994770102418828,0.570215774831708,0.608096183542908,1.4015715579751202,912,5,LPL|CETP|APOE|LCAT|APOC2
LEUKOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002366,0.0220264317180617,0.310715277412964,-0.132045644637701,-1.25791856857667,4,451,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|PTK2B|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|EXOSC6|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|IL6|PNP|CD68|FCGR2B|RAP2B|SBNO2|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|ICAM1|CRACR2A|FOXP1|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|KARS|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|DYSF|STAT3|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4|RNF168
CELL PROLIFERATION INVOLVED IN ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905315,0.723818350324375,0.97235201976979,-0.632940008822232,-0.846703147980586,5466,1,TGFBR2
FC-EPSILON RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038095,0.44436544614290796,0.8814539233251801,-0.15720673244050598,-1.0055719062455402,1249,60,VAV3|VAV2|SHC1|JUN|NFATC2|GAB2|MAPK3|RAC1|PIK3R1|PAK2
RESPONSE TO INTERLEUKIN-21%GOBP%GO:0098756,0.315837268434435,0.817022961971678,-0.377164920022063,-1.1002068049898301,1738,7,STAT1|JAK3|JAK1|IL2RG|STAT4|IL21R|STAT3
SUPPRESSION BY VIRUS OF HOST MOLECULAR FUNCTION%GOBP%GO:0039507,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
NEGATIVE REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905662,0.7871140939597321,0.9819233677232551,0.608182620202911,0.807943477989251,5863,1,PARP3
NEGATIVE REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032693,0.320952765442067,0.822183858873702,-0.312771227853552,-1.10068091876076,1589,11,C10orf54|DLL1|CD274|FCGR2B|TRIB2|TNFRSF21
POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT%GOBP%GO:0051272,0.00260416666666667,0.126473912512219,-0.162330117180174,-1.48263695042146,0,361,DAB2IP|TUBB2B|IGF1R|RTN4|NSMF|TGFBR1|CXCL16|LGALS9|BCAR1|PTK2B|ACVR1|HMOX1|PDPN|HSPA5|ELP6|AKIRIN1|EPB41L4B|PRKD2|PFN1|SRGAP2C|FGR|ABL1|SEMA3F|GPI|MYO1C|MGAT5|ADAM10|CAMK1D|RET|SPHK1|FGF7|ZNF580|RHOA|FAM65A|NRP1|C1QBP|ZNF703|AAMP|PLAU|MYADM|CPNE3|PTRF|SEMA7A|FGF2|PPAP2B|HGF|DOCK5|TNFRSF18|IL6|HBEGF|LYN|PODXL|ITGA6|MMP9|ELP3|GLIPR2|SNAI1|IGF1|SOD2|ICAM1|FOXC2|MAP4K4|FOXP1|CEMIP|RHOC|ETS1|TMSB4X|PDCD10|WNT11|ARHGEF2|KARS|FGFR1|MAP2K3|LGALS3|ATOH8|SEMA6B|IQSEC1|AGO2|ADAM17|CXCL8|STAT5A|CTSH|PRKCA|STAT3|NOS3|ANO6|OXSR1|FLT1|PLVAP|ADRA2A|FGF10|CFAP20|THBS4|SEMA3A|RAC1|MET|DDRGK1|CFAP69|SEMA3G|LAMC2|PGF|TWIST1|CDH13|TNF|CAV1
MICROTUBULE NUCLEATION BY INTERPHASE MICROTUBULE ORGANIZING CENTER%GOBP%GO:0051415,0.21982388316151197,0.734713083559597,0.5016978003545479,1.23385267472648,2046,6,TUBGCP3|TUBGCP6|TUBGCP2|TUBGCP4|TUBGCP5|MZT1
NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000669,0.662068239258635,0.964618776001639,0.32145736693620697,0.8366859879046209,6286,7,CCL21|CCL19|CCR7|LILRB1|AXL|GAS6|CXCL12
REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000109,0.21834822401394602,0.7341474817293291,0.535438038051096,1.23410530356908,2003,5,SIRT1|CDKN2A|VIMP|MEF2C|IRF7
REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022407,0.47153465346534706,0.898272347254494,-0.114364994828694,-0.9958293250301941,380,237,CD274|ICOSLG|IL1B|RARA|FAM49B|IRAK1|CX3CL1|MAPK7|PRKCD|SIRPA|PTPRG|MAP3K8|LGALS9|PDPN|GRB2|PTPRU|VAV1|RPS3|CITED2|FYN|RHOA|ZNF703|PPARA|MYADM|RUNX1|MAP2K5|PPAP2B|IL6|PNP|LYN|FCGR2B|PODXL|PRNP|ASS1|CD276|YES1|MBP|IGF1|SERPINF2|ETS1|SMAD7|CDC42|LGALS3|TFRC|NLRP3|PRKCA|DUSP3|CD9|FXYD5|SOCS5|BCL6|NKAP|EPHA7|DUSP10|DENND6A|CBFB|RAC1|IGF2|PIK3R1|TNF|TNFRSF21|CAV1|PAK2
ALDONIC ACID CATABOLIC PROCESS%GOBP%GO:0046176,0.11073825503355698,0.584830174998513,0.944309660344067,1.25447325512638,824,1,IDNK
MITOCHONDRIAL MRNA PROCESSING%GOBP%GO:0090615,0.7732739420935408,0.979946273879301,-0.44968293355390104,-0.7691585743665279,5207,2,PNPT1|TBRG4
RESPONSE TO DEXAMETHASONE%GOBP%GO:0071548,0.123802042419482,0.607607158836689,-0.6858120791406539,-1.3918352382442298,787,3,NR3C1|AQP1
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETER DEVELOPMENT%GOBP%GO:0072200,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
"ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I, TAP-INDEPENDENT%GOBP%GO:0002480",0.40501271340356,0.866234596232951,-0.35030336458907896,-1.021850456053,2229,7,HLA-F|HLA-C|HLA-B|HLA-A|HLA-E|LNPEP|B2M
RESPONSE TO MYCOTOXIN%GOBP%GO:0010046,0.7541717997536121,0.977083996023335,0.37180478214685797,0.787889850012486,6733,4,EGR1|CERS1|PDGFB|ACTB
NEGATIVE REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090038,0.547438752783964,0.9305779599215391,-0.5428728977116071,-0.928555017123049,3686,2,GPD1L|MYADM
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL%GOBP%GO:0003044,0.103626943005181,0.575794607412397,-0.30265076708092603,-1.37457803980722,439,21,ADRA1B|ATP6AP2|SOD2|SERPINF2|ADRB2|NOS3|ACE|PDE4D
REGULATION OF N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000759,0.783000132397723,0.981487311948134,-0.605535950595501,-0.8100439037479571,5913,1,SOX4
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010660,0.14088397790055301,0.6296802030037281,-0.290519516901008,-1.29627062749623,611,20,MFN2|PPARG|CAMK2A|IGF1|SOD2|PDCD4|BAG3|ADCYAP1
ODONTOBLAST DIFFERENTIATION%GOBP%GO:0071895,0.37449664429530205,0.852609194081082,0.8182620202911339,1.08702458869995,2789,1,LEF1
NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0015931,0.987289064212141,1.0,0.0979147845185325,0.587076079627646,13514,154,NXF2|TPR|SLC35A1|THOC3|SLC35B1|U2AF1L4|SLC25A19|ZC3H11A|TST|THOC1|NUP133|CKAP5|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|SLC25A42|ATXN2|NUP188|NUP160|ABCE1|RBFOX1|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|RPS15|NUP107|SLC29A2|NUP35|SRSF11|NUP210|SLC29A1
REGULATION OF HEART RATE BY CHEMICAL SIGNAL%GOBP%GO:0003062,0.202953296703297,0.717572490756468,-0.487448150384961,-1.23394262447739,1181,5,YWHAE|PDE4D
GLUCOSAMINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:1901072,0.61071735395189,0.9508825506493929,0.358274517504168,0.881123998144813,5686,6,OVGP1|AMDHD2
REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0031114,0.509094371964575,0.918404893008545,0.26839844863677,0.9627999539242421,5345,18,NAV3|CAMSAP3|FGF13|APC|TAOK1|APC2|CAMSAP2
POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032430,0.44697054541382,0.88473565970262,0.48032521216095997,1.0178550076239599,3990,4,AGTR1|PLAA|EGFR|ANG
REGULATION OF HISTONE H3-K9 DIMETHYLATION%GOBP%GO:1900109,0.506458797327394,0.9172434440873181,-0.559746346843121,-0.9574161481783721,3410,2,PIH1D1|SMARCB1
NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032232,0.15718990120746398,0.657877673463942,-0.31402884549344395,-1.28605366439841,715,16,PPFIA1|DLC1|PFN1|INPP5K|PARK2|TMEFF2|MET
NEGATIVE REGULATION OF CYTOTOXIC T CELL DEGRANULATION%GOBP%GO:0043318,0.556066287649692,0.9351151289364891,0.5831556441818829,0.9531518801925991,4596,2,CEACAM1
"GUANINE DEGLYCATION, GLYOXAL REMOVAL%GOBP%GO:0106046",0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
TYPE I PNEUMOCYTE DIFFERENTIATION%GOBP%GO:0060509,0.27913882702301396,0.788692060817727,-0.692031982354563,-1.18368364295523,1879,2,THRA|NFIB
NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:1903347,0.16219331467149697,0.664367762084791,-0.567597367636168,-1.3053553703196399,984,4,TNF
POSITIVE REGULATION OF PODOSOME ASSEMBLY%GOBP%GO:0071803,0.0151098901098901,0.264387156924099,-0.715691678492535,-1.8117259597318403,87,5,CAPG|ASAP1|TNF
IMMUNE COMPLEX CLEARANCE%GOBP%GO:0002434,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
REGULATION OF PROTEIN MATURATION%GOBP%GO:1903317,0.491633466135458,0.909315999193258,0.18614720200653,0.9832798246932409,6169,76,IGKV4-1|TFR2|NOL3|IGHG1|SERPINE2|F12|IGHG4|NKD2|IGKV3-11|SUSD4|IGKV2D-28|IGKV2-28|C3AR1|C7|KLKB1|CD55|C5|BIRC2|GAS1|CARD16|C4A|C4B|IGHG2|CD46|THBS1|SERPINE1|TMEM59|PLGRKT|BCL2L12
MAINTENANCE OF SYMBIONT-CONTAINING VACUOLE BY HOST%GOBP%GO:0085018,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON%GOBP%GO:1905274,0.306765523632994,0.809874675097403,-0.8473753859726509,-1.13355989007454,2316,1,RHOA
POSITIVE REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001961,0.9556235654169859,1.0,-0.122632333320604,-0.6111010818033,3746,27,MAVS|ADAM17|PARK2|UBE2K
PYRIMIDINE NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0090481,0.244952749140893,0.757467559003634,0.49001486824010604,1.2051202046461598,2280,6,SLC35A1|SLC35B1
POSITIVE REGULATION OF MEDIATOR COMPLEX ASSEMBLY%GOBP%GO:2001178,0.880125801378977,0.9956508825790341,0.44742211193824105,0.7312991505586229,7275,2,CDT1|MED25
REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000705,0.707305577376277,0.9695156155378671,-0.39740884831622203,-0.806529450122343,4501,3,PRKCA
BASE CONVERSION OR SUBSTITUTION EDITING%GOBP%GO:0016553,0.791371158392435,0.9819233677232551,-0.220270265208879,-0.745207277251517,4016,10,APOBEC3D|APOBEC3C|ADAT2|NUDT16|APOBEC3G|ADAR|ADARB1|APOBEC3F|APOBEC3B
OLIGOSACCHARIDE-LIPID INTERMEDIATE BIOSYNTHETIC PROCESS%GOBP%GO:0006490,0.0260927530711361,0.33575919472500804,0.459031214123776,1.6466385482215198,273,18,ALG6|MVD|ALG14|ALG13|SRD5A3|DPAGT1|MPDU1|ALG2|DOLPP1
NEGATIVE REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903035,0.545986267695177,0.930420772651609,0.199323382109791,0.9405626490926009,6440,46,EDN1|CEACAM1|RTN4RL1|AJAP1|SERPINE2|PLAT|F12
CELLULAR RESPONSE TO OXYGEN LEVELS%GOBP%GO:0071453,0.000477099236641221,0.0784645998831315,-0.279042123001539,-2.02771299140775,0,97,VEGFA|PDK3|PLK3|CPEB1|HMOX1|LIMD1|HIGD1A|CITED2|STUB1|HYOU1|BACH1|FOXO1|CPEB2|P4HB|GLTSCR2|ATG7|LMNA|ACAA2|PGK1|VHL|GNGT1|TCEB1|UBA52|ATP6V0D1|TP53|BNIP3L|UBC|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|CAV1|NDRG1|UBB|EGLN3
PLATELET ALPHA GRANULE ORGANIZATION%GOBP%GO:0070889,0.38104064610088706,0.8566948330269879,-0.8069585355094839,-1.07949303691052,2877,1,VPS33B
REGULATION OF TERMINAL BUTTON ORGANIZATION%GOBP%GO:2000331,0.722229577651264,0.971401508276304,-0.6338773709748571,-0.8479570859120851,5454,1,VPS35
PROXIMAL/DISTAL PATTERN FORMATION%GOBP%GO:0009954,0.20771101076762802,0.7232762929610351,0.641728148372141,1.2198577027881399,1793,3,SIX3|CYP26B1
RESPONSE TO PSYCHOSOCIAL STRESS%GOBP%GO:1990911,0.13623725671918402,0.6237835799077729,-0.9293118659020729,-1.2431688174984599,1028,1,ADRB2
REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062042,0.9345958609918,1.0,-0.19109122150236998,-0.616859587104619,4786,9,TGFB1|ENG|NOTCH1|TGFBR1|ACVR1
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:1903912,0.30413304791701,0.8069124329627679,-0.48558402771141795,-1.1167418216795701,1846,4,PPP1R15B|NCK2|DNAJC3
PROTEIN LOCALIZATION TO SPINDLE MICROTUBULE%GOBP%GO:1902889,0.7910763934860321,0.9819233677232551,-0.60151080723423,-0.8046593467479929,5974,1,HNRNPU
TETRAHYDROFOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0046654,0.270131033710382,0.7848491314522171,0.54963611860698,1.1647314393058201,2411,4,DHFR|MTHFD1
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034141,0.25922671353251303,0.770912532778873,-0.4248948845818621,-1.16630792857208,1474,6,WDFY1|CAV1
NUCLEAR HISTONE MRNA CATABOLIC PROCESS%GOBP%GO:0071045,0.7840593141797958,0.981487311948134,-0.6050397000441109,-0.809380054254811,5921,1,SSB
DNA REPLICATION-DEPENDENT NUCLEOSOME ORGANIZATION%GOBP%GO:0034723,0.463765355680411,0.8921382338742359,0.27869339409757105,0.999730022133116,4869,18,HIST1H3E|ASF1B|ASF1A|HIST1H4I|CHAF1A|NASP
TRANSMISSION OF VIRUS%GOBP%GO:0019089,0.15291936978683998,0.6488592577606589,-0.920875606528452,-1.23188337611497,1154,1,NEDD4
POSITIVE REGULATION OF RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000208,0.768590604026846,0.9792236089291529,0.617887075430084,0.8208354138121079,5725,1,RIOK2
PROPIONATE METABOLIC PROCESS%GOBP%GO:0019541,0.6981208053691271,0.96731875442989,0.655161005734451,0.870352167313535,5200,1,PCK2
MODIFICATION OF SYNAPTIC STRUCTURE%GOBP%GO:0099563,0.5280750864482129,0.9265056012720759,-0.403073441238563,-0.926984709857295,3206,4,CYFIP1|SYNPO|CDC42
NEURON DIFFERENTIATION%GOBP%GO:0030182,0.39572192513369003,0.8638522656500329,-0.106761804389258,-1.02163570667652,73,482,UHMK1|BLOC1S4|CASP3|FAIM2|STRN|RUNX1|APOD|EHD1|IL6|PARD6B|LYN|TUBB3|NRL|NFIB|EFNA1|CHRNA7|CAMK2A|POU4F2|UNC5C|ARC|SPINK5|SPOCK1|MAP4K4|WNT6|NYAP2|ZPR1|WNT11|RAB8A|AMIGO1|CBLN1|CDC42|C21orf91|DBNL|NEFH|NEDD4|BLOC1S6|GNGT1|ALCAM|S100A6|PLXNA1|MTPN|FLRT1|SHC1|ID1|PRKCA|STAT3|TBX20|PLXNA4|EPHA8|RELN|GAB2|ADCYAP1|COBL|DRD2|MAPK3|MTCH1|TDP2|WNT3|ATP2B2|BLOC1S3|MAP4|ASCL1|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|MAP2K1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|CDHR1|INSM1|GFRA2|NBL1|MICALL1|SLIT3|EPHB2|PARD3|UBB|RTN4RL2
REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900034,0.00398650720637841,0.148195394527521,-0.324363809775661,-1.8751506971132401,12,43,BAG5|HSBP1|BAG3|HSF1|YWHAE|DNAJB6|MAPK3|FKBP4|BAG1|HSPB8|HSP90AB1|IER5
LEFT/RIGHT PATTERN FORMATION%GOBP%GO:0060972,0.6993475274725279,0.967678885433393,-0.318619932387844,-0.806565201388019,4072,5,CITED2|DNAAF1
DOPAMINE BIOSYNTHETIC PROCESS FROM TYROSINE%GOBP%GO:0006585,0.48228187919463106,0.9053012218786121,0.7630127922364358,1.0136284540721,3592,1,TH
REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070344,0.8685070831819829,0.993084774742015,-0.234261210120874,-0.683350343147132,4781,7,PER2
HISTONE H3-K9 DEMETHYLATION%GOBP%GO:0033169,0.767258780783206,0.9792236089291529,-0.216319099635882,-0.7612538626609449,3800,11,KDM4B|KDM1A|KDM3B|KDM4A|PHF8|JMJD1C|KDM4C|KDM3A|HR|KDM7A|KDM5A
POSITIVE REGULATION OF ION TRANSPORT%GOBP%GO:0043270,0.0857858484658735,0.549432448560602,-0.16052993506547303,-1.25734653863143,136,132,APLNR|CHP1|CAMK2A|HAP1|ARC|CRACR2A|CEMIP|TMSB4X|AMIGO1|SNCA|LGALS3|TNFRSF11A|ADRB2|RELN|ANO6|HTT|DRD2|ADRA2A|CHRM1|SCN5A|DLG1|GAL|CAV1|STAC|STC1|EPHB2|TRH
REGULATION OF CILIUM BEAT FREQUENCY%GOBP%GO:0003356,0.0848165637486378,0.5452822640687849,-0.502322696289717,-1.46529759110804,466,7,MKKS|CFAP20|DNAAF1
CELLULAR GLUCAN METABOLIC PROCESS%GOBP%GO:0006073,0.9084319884029959,1.0,-0.14153251070253697,-0.665049432410989,3759,23,PYGB|PER2|NR1D1
BLEB ASSEMBLY%GOBP%GO:0032060,0.221576462041409,0.73556947110949,-0.41635523862437396,-1.21452670306906,1219,7,EMP1|EMP3|PMP22|ANO6
DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009263,0.506667993630573,0.9172434440873181,0.316026115246485,0.9641232352258271,5090,11,RRM1|DTYMK|DUT|HDDC2|TYMS|RRM2
REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106056,0.00285171102661597,0.13103871184697197,-0.444217283436211,-2.05794335482229,11,22,SLC9A1|PRNP|CHP1|IGF1|ATP2B4|CAMTA1|HOMER2|RCAN2|TNF
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009200,0.84010152284264,0.98953921193435,-0.21868752827138896,-0.705942938319358,4302,9,DCTPP1|NUDT1|AK9|NUDT15|CMPK2
LACTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035873,0.9590135463702671,1.0,0.305852462640236,0.581393357007697,8282,3,SLC16A7|EMB
NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045605,0.9306882786984398,1.0,0.414771905284382,0.677933284736537,7693,2,SRSF6|DLL1
RESPONSE TO CORTICOTROPIN-RELEASING HORMONE%GOBP%GO:0043435,0.0111994624258036,0.22992267312754103,0.7897863915083749,1.6736328079332,99,4,NR4A2|NR4A3|NR4A1
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043377",0.7040038708116609,0.968941691852291,0.527378427508166,0.8619855518291859,5819,2,SOCS1|ZBTB7B
PROTEIN LOCALIZATION TO AXON%GOBP%GO:0099612,0.7670516452386141,0.9792236089291529,0.331458195455548,0.7639620046644731,7039,5,ANK3|CNTN2|CNTNAP1|EPB41L3|CNTNAP2
CERAMIDE METABOLIC PROCESS%GOBP%GO:0006672,0.402608329827514,0.865238688875249,0.21833100633070399,1.04427802439349,4784,49,B3GALT2|NSMAF|FUT7|B4GALNT1|CERS4|B3GALT1|ST3GAL5|CERS6|CLN6|B4GALT6|ST8SIA3|ORMDL1|CERS5|ASAH1
HISTONE H2A PHOSPHORYLATION%GOBP%GO:1990164,0.302004454342984,0.8050049522572289,-0.679404466501241,-1.16208495337462,2033,2,RPS6KA5|VPRBP
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0090316,0.0585533869115959,0.47368184492677795,-0.170178649098549,-1.3015359562246298,101,120,FBXW7|OAZ2|HPS4|IL1B|PLK3|BCAS3|PRKCD|TMEM30A|ITGAM|UBL5|MYO1C|ATG13|FYN|FAM65A|ICE1|TCF7L2|VPS11|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|MIEF1|IGF1|MAVS|CEMIP|BAP1|LEPROT|ZPR1|PDCD10|BAG3|TP53|UBE2L3|YWHAE|UBE2D3|ARIH2|BCAP31|PIK3R1
MITOTIC SISTER CHROMATID BIORIENTATION%GOBP%GO:1990758,0.39785234899328903,0.8638522656500329,0.808392148213498,1.07391290397103,2963,1,BOD1
IRES-DEPENDENT VIRAL TRANSLATIONAL INITIATION%GOBP%GO:0075522,0.690307328605201,0.96731875442989,-0.24054370885208898,-0.813795371625226,3503,10,EIF3D|PCBP2|EIF3B|EIF3A
NEGATIVE REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001180,0.0761692650334076,0.525661416287861,-0.8338742113962639,-1.42629717914719,512,2,TNFRSF21
REGULATION OF RNA INTERFERENCE%GOBP%GO:1900368,0.515180839482279,0.9215693035262491,0.5980700303280949,0.977529034626427,4258,2,TERT|XPO5
POSITIVE REGULATION OF CELL DEATH%GOBP%GO:0010942,0.0037735849056603796,0.14377160645023299,-0.193131315882316,-1.83207140887283,0,429,UTP11L|AGT|AXIN2|ADAMTSL4|PIK3CD|ARHGEF5|BTG1|NTRK1|PPM1F|TIMP3|IFT57|MUL1|DEDD2|PYCARD|PREX1|ZNF205|CDK5|CAMK2D|CDKN1B|ATF4|RAMP3|STK17B|BAX|NOD1|GPER1|SOD1|FLCN|FBXW7|NOTCH1|PICALM|TRIM39|CD274|PPIF|TP53BP2|GZMB|CLU|KALRN|GNA13|EIF2S1|TRIM13|BCLAF1|CLIP3|DNM2|MSX1|CTNNB1|DAB2IP|ABR|TGFBR1|LGALS9|ITGAM|DDIT4|CIDEB|SQSTM1|DLC1|FGD4|EIF2AK3|HP|ABL1|VAV1|BBC3|PML|TRIO|DCUN1D3|RPS3|MYBBP1A|RET|S100A8|IGFBP3|FYN|HRK|DDX3X|C1QBP|TNFRSF1B|BCL10|FOXO1|EIF4G1|MFN2|TNFRSF10A|YWHAH|RASSF2|DDIT3|SHQ1|IL6|PPARG|SAV1|LYN|FCGR2B|ITGA6|PRNP|DFNA5|MMP9|CYLD|BCL2L1|ECSCR|CAMK2A|ATG7|POU4F2|BOK|SOD2|BIN1|BID|TRIM35|ATF6|RIPK2|CRADD|GAPDH|YWHAQ|YWHAB|MARK4|VAV3|PLAUR|SNCA|ARHGEF2|KLF11|VAV2|PPP2R1B|GADD45A|AKAP13|STK4|USP27X|PDCD4|NET1|NLRP1|NLRP3|BCL2|JUN|UBA52|CTNNBL1|TP53|DKK1|YWHAZ|RASGRF2|YWHAE|ZNF622|TNFRSF10B|ANO6|HTT|MTCH1|BCL6|BNIP3L|BMF|EPHA7|SFRP2|RNPS1|SAP18|SLC9A3R1|MAP3K11|WWOX|SOX7|UBC|CD36|BCAP31|BIK|JMY|TNF|BCL2L11|PMAIP1|TFDP2|CAV1|RPS6KA2|PAK2|UBB|FOXO3|EGLN3
REGULATION OF HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:1905435,0.990604026845638,1.0,0.5050176444640491,0.670893410236043,7379,1,KMT2E
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048147,0.690735392135081,0.96731875442989,-0.192946630608753,-0.830013536278991,3108,18,NF1|GSTP1|NLRC3|CDC73|PARP10|MORC3|PEX2|CD300A|MYC|MED25|B4GALT7|TRIM32|SFRP1|EMD|DAB2IP|SKI|FTH1|TP53
MACROMOLECULE GLYCOSYLATION%GOBP%GO:0043413,0.24657434402332398,0.7585951535148171,0.18967221085109803,1.1468879069928701,3382,164,B3GALT2|GALNT10|GALNT8|FUT9|MUC15|GALNT13|FUT7|SDF2|GCNT2|GALNT3|TMEM165|C1GALT1C1|B3GLCT|FUT2|ALG6|ASGR1|FUT8|ALG1L|MGAT5B|B3GALT1|OGT|ST3GAL5|POGLUT1|MVD|MOGS|ALG14|ALG13|DERL3|MUC1|SRD5A3|DPAGT1|FUT10|NUDT14|MPDU1|ALG2|DPY19L3|MGAT2|DOLPP1|ST8SIA3|SYVN1|RFNG|LFNG|B3GALNT1|B3GALT6|OSTC|ALG5|ST3GAL4
REGULATION OF CILIUM-DEPENDENT CELL MOTILITY%GOBP%GO:1902019,0.387019230769231,0.859991269020751,-0.41067822950686894,-1.03960466755946,2253,5,MKKS|CFAP20
NEGATIVE REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905277,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
OXYGEN HOMEOSTASIS%GOBP%GO:0032364,0.741972665898238,0.974505008828563,-0.34037390393205796,-0.782788872444486,4505,4,EGLN1|NARFL|HIF1A|SOD2
EYE DEVELOPMENT%GOBP%GO:0001654,0.303360370799537,0.8056368025675309,0.200259413465845,1.1172296140375502,3926,101,SIX3|TSPAN12|NHS|SMG9|SHROOM2|TBX2|SDK1|WNT5B|PROX1|DSCAM|SMARCD3|AHI1|CEP290|SMOC1|ZDHHC16|FOXN4|EFEMP1|TGFB2|DCX|FBN1|MAB21L2|MED1|BMPR1B|NF1|NIPBL|COL4A1|COL5A2|TH|COL5A1|TFAP2B|MYO7A|SMARCA4|CHD7|MDM1|TOPORS|WNT2B
MITOCHONDRIAL MAGNESIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0045016,0.26899328859060395,0.784543299601953,0.868162770180856,1.15331550869817,2003,1,MRS2
REGULATION OF TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051969,0.0261494879058618,0.336228004044238,0.6930956920045219,1.59748282452438,239,5,CARTPT|FGF12
NEGATIVE REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014741,0.780566801619433,0.981487311948134,0.26166341777359503,0.7466979900116592,7711,9,RGS2
METHYL-BRANCHED FATTY ACID METABOLIC PROCESS%GOBP%GO:0097089,0.339663723236966,0.8330383695817521,0.669203735386874,1.09379512138781,2807,2,SLC27A2
MORPHOGENESIS OF AN EPITHELIAL FOLD%GOBP%GO:0060571,0.747365983559106,0.9749763305090959,0.4260505128487921,0.8098772060938921,6454,3,FGFR2|BMP7|LUZP1
POSITIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000670,0.143126472898665,0.632949331968897,-0.6685412800021611,-1.3567846645306298,910,3,LGALS9|LYN
DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION%GOBP%GO:0006271,0.121920947107122,0.607607158836689,0.385759491442564,1.36051801781557,1276,17,POLE|RFC4|DNA2|FEN1|RNASEH2A|LIG1|GINS2|RFC3|GINS1|WRNIP1
REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902259,0.0384160756501182,0.3936768921371371,-0.483201701393694,-1.63474368143803,194,10,AKAP6|KCNE3|KCNE4|KCNAB1|VAMP2|SUMO1|KCNG1
REGULATION OF BLOOD VESSEL DIAMETER BY RENIN-ANGIOTENSIN%GOBP%GO:0002034,0.9099224267685542,1.0,0.34334404564237697,0.652660912328274,7858,3,AGTR1
URATE METABOLIC PROCESS%GOBP%GO:0046415,0.5955545870560041,0.94763446543375,0.390410532839454,0.899838403151366,5465,5,SLC16A9|SLC2A9
APOPTOTIC CHROMOSOME CONDENSATION%GOBP%GO:0030263,0.199910404300594,0.7118288982201959,0.5854242678439809,1.24056994620116,1784,4,DFFB|TOP2A|ACIN1
CELLULAR RESPONSE TO PLATELET-DERIVED GROWTH FACTOR STIMULUS%GOBP%GO:0036120,0.858173076923077,0.99166790097654,-0.27478065569965304,-0.6955889835295761,4997,5,CORO1B|HYAL1|SYAP1|MTSS1L
NEGATIVE REGULATION OF FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:1904736,0.5608053691275171,0.936434965680841,0.7230921923246579,0.960595718073531,4177,1,METTL20
T CELL MEDIATED IMMUNITY%GOBP%GO:0002456,0.259927797833935,0.7715310051543051,-0.261883377696305,-1.14848253969043,1151,19,MYO1G|DENND1B|ULBP3|GNL1|SLC11A1|RFTN1|ULBP2|CTSH
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051354,0.530379746835443,0.9265056012720759,-0.24129093446156602,-0.934824958888386,2513,14,HP|NOSIP|ATP2B4|SNCA|PARK2
NEGATIVE REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061048,0.0239639878194095,0.32397355287938,-0.9888067931186592,-1.32275699562121,180,1,TNF
CORONARY VASCULATURE MORPHOGENESIS%GOBP%GO:0060977,0.0154131847725162,0.264745847609811,-0.579734127640796,-1.8020660892569802,82,8,SPRED1|PDGFRB|TBX1|TGFBR3|NOTCH1|VEGFA|TGFBR1|NRP1
HISTONE H3-K23 ACETYLATION%GOBP%GO:0043972,0.26942936581490806,0.784543299601953,-0.865405822673136,-1.15767975499219,2034,1,BRPF1
HISTONE LYSINE METHYLATION%GOBP%GO:0034968,0.608279975440751,0.9508825506493929,0.20389364208248603,0.8932899033387379,6934,35,WDR61|DOT1L|OGT|EZH2|KMT2B|PAGR1|ZNF335|PAXIP1|EHMT2|KMT2D|WDR5|SETDB2|SUV39H1|TET2|SETMAR|SUV39H2|SETD1B
L-GLUTAMATE IMPORT%GOBP%GO:0051938,0.17008220446914402,0.673117535978459,0.6617955222234481,1.25800366947098,1468,3,SLC1A2|SLC1A3|SLC1A1
POSITIVE REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032241,0.6566975568660489,0.9643779777660141,0.323103800173041,0.8409713077042851,6235,7,DHX9|CPSF6|RBM26|RIOK2
PHOSPHATE ION HOMEOSTASIS%GOBP%GO:0055062,0.142121178183447,0.63219683908033,0.619688327524684,1.3131787617380901,1268,4,FGFR4|XPR1|TFAP2B
NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905331,0.6066895023171469,0.9508825506493929,0.30030695902794297,0.8862834208507471,6021,10,TBX2|BMP4|GATA3|SULF1|STAT1|CLASP2
POSITIVE REGULATION OF EXOCYTOSIS%GOBP%GO:0045921,0.946197750545577,1.0,0.126547609027378,0.608118084216134,11272,50,CACNA1G|CACNA1I|UNC13B|CACNA1H|F2RL1|ZP3|UNC13D|SMPD3|RAB27B|TSG101|SCAMP5|ATP6AP1|RAB3A|STX1A|SNF8|HGS|ATP13A2|RAB15|SYT4|HYAL3|RAB9A
ALLANTOIS DEVELOPMENT%GOBP%GO:1905069,0.8740897656560309,0.9934031064448321,-0.5607631230701371,-0.7501499272552109,6601,1,BMP7
ORGAN INDUCTION%GOBP%GO:0001759,0.127494859078263,0.6076669536424699,0.7818332732196001,1.2778850068610002,1053,2,BMP4|BMP2
HORMONE-MEDIATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0008628,0.816644295302013,0.9866817082145358,0.592743714159682,0.7874335800892521,6083,1,SST
MORPHOGENESIS OF AN ENDOTHELIUM%GOBP%GO:0003159,0.163120567375887,0.665215394314715,-0.384033388331239,-1.29924243483619,827,10,CTNNB1|PRKD2|RHOA|ACVRL1|RBPJ
COBALT ION TRANSPORT%GOBP%GO:0006824,0.212885906040269,0.7279184739702909,0.8948500220555801,1.18876833221102,1585,1,SLC30A5
REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070243,0.496348797250859,0.911815944636073,0.39548769269522793,0.9726443829503789,4621,6,BMP4|BLM|JAK3|ZC3H8|ADAM8
REGULATION OF CELL ADHESION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0106088,0.43825503355704704,0.878999860395433,0.787329069254521,1.0459315432646001,3264,1,SEMA6A
PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905383,0.7849582172701949,0.981487311948134,-0.24066412929560396,-0.7480889008019219,4226,8,RAB27B|DLG2|KIF5C|KIF5B|MAPK8IP3|KIF5A|MAP1A|HSPB1
DEACTIVATION OF MITOTIC SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:1902426,0.803624161073826,0.984522820758988,0.599139832377592,0.795930537790681,5986,1,CDT1
REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000319,0.934716905097723,1.0,0.19879364649334602,0.5866914094425729,9277,10,LOXL3|IL12RB1|NFKBID|RC3H1|FOXP3|ZC3H12A|MALT1
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000780,0.654679928589646,0.9640743070248079,-0.174320117692444,-0.868671496475822,2566,27,C20orf196|TRIP12|C7orf49|CXorf57|HSF1|KLHL15|TWIST1
REGULATION OF EOSINOPHIL DEGRANULATION%GOBP%GO:0043309,0.604088544816741,0.9508825506493929,0.5649361283526679,0.923372582089127,4993,2,F2RL1|STX4
NEGATIVE REGULATION OF ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071583,0.25393883225208497,0.7641083395392759,-0.873842082046758,-1.16896519637567,1917,1,SLC30A1
POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:0140131,0.353432190906413,0.842847021021096,0.340812162854622,1.09992752992444,3598,13,CXCL13|STK39|XCL2|CCL21|CCL5
STEROID HORMONE SECRETION%GOBP%GO:0035929,0.0220152413209145,0.310715277412964,0.901442486372914,1.47338297990279,181,2,GHRL|INHBA
REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE%GOBP%GO:0099159,0.306765523632994,0.809874675097403,-0.8473753859726509,-1.13355989007454,2316,1,RHOA
DISSEMINATION OR TRANSMISSION OF ORGANISM FROM OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051821,0.15291936978683998,0.6488592577606589,-0.920875606528452,-1.23188337611497,1154,1,NEDD4
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001271,0.416339355852317,0.8709670999109399,-0.499984120491485,-1.01470291735686,2649,3,PAK2
INACTIVATION OF MAPK ACTIVITY INVOLVED IN OSMOSENSORY SIGNALING PATHWAY%GOBP%GO:0000173,0.9555704697986579,1.0,0.5248125275694749,0.697190029329256,7118,1,MBIP
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002859,0.0809395973154362,0.5374028338839121,0.960630789589766,1.2761551471920902,602,1,CEACAM1
POSITIVE REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033240,0.910258521323893,1.0,-0.280526251350595,-0.645151774119686,5527,4,PARK7|HPRT1
CYTOPLASMIC SEQUESTERING OF PROTEIN%GOBP%GO:0051220,0.9892153216809221,1.0,0.124241382515349,0.4696986472943421,10639,21,PKD2|TONSL|GOPC|KEAP1|SUFU|GET4|FAF1|DBN1|FLNA|MDFI
POSITIVE REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:2000601,0.560096153846154,0.936434965680841,-0.357176421363995,-0.904168392948582,3261,5,BRK1
MUSCLE CONTRACTION%GOBP%GO:0006936,0.146599609668218,0.6384002460466359,0.21490332862793804,1.2463891705683798,1952,125,RYR2|KCNN2|SCN1A|NEB|EDN1|CACNA1G|IGSF22|CCDC78|GAA|PTGER3|CACNB2|FGF12|MYLK2|GAMT|KCNQ1|MYL7|OXTR|ITGA1|JSRP1|ACTN2|MYH3|TCAP|CACNA1H|CACNA2D1|TAZ|TNNC2|KCNH2|CACNA1D|ITGB5|STAC3|GJA1|SNTB1|ARHGEF11|LMOD1|OBSL1|ACTA2|MYOT|DMD|SCN3B|PABPN1|TNNI3|SLC8A1|MYL5|MYLK
POSTSYNAPTIC SPECIALIZATION ORGANIZATION%GOBP%GO:0099084,0.5092626225935339,0.918404893008545,-0.32323538455576895,-0.94289195739879,2803,7,TMEM108
BEHAVIORAL RESPONSE TO NICOTINE%GOBP%GO:0035095,0.0212415610077392,0.306557165070089,-0.7450504604864059,-1.71346041262557,128,4,CHRNA5|CHRNB1|CHRNB2|CHRNA3
REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901993,0.9100382077110111,1.0,0.34328562477571695,0.652549860406397,7859,3,CDC25C|CDC25A
REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0043254,0.380042462845011,0.8563106431532271,-0.113452889449943,-1.03674888876519,178,328,MMP1|HAX1|CDC42EP5|MAPRE1|PSMC4|ERCC1|ADD1|CLU|ANKRD53|VEGFA|IMPACT|BCLAF1|CLIP3|TRABD2A|PRKCD|CTNNB1|DAB2IP|PTK2B|WARS|VASP|PFN1|NAPB|ABL1|RPA3|RPS3|DYRK1A|DR1|VPS18|STUB1|HRK|DDX3X|MITF|SMAD6|ICE1|FOSL1|VPS11|RANGRF|TMSB10|MYADM|EIF4G1|WHAMM|GLTSCR2|NAPA|LDLRAD4|SLAIN2|SUMO1|ARPC5|SH3GLB1|TCL1A|ABCA1|BIN1|BID|WIPF1|RHOC|PPM1A|TMSB4X|VPS16|ARPC5L|SNCA|ARPC4|TWF1|CDC42|TRAF3IP1|CAPG|MTPN|JUN|ARPIN|TP53|DKK1|TPPP3|TWF2|SEC23A|ASAP1|RALB|BMF|RNF4|PEX5|RAC1|KIF9|MET|ACTR2|BRK1|CD36|BIK|TWIST1|JMY|TNF|BCL2L11|PMAIP1|INSM1
PURINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009145,0.08199999999999999,0.539604343254557,-0.218354373476993,-1.34678677809861,245,53,ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|PFKL|COX5B|GPI|PKM|ENO1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:1902730,0.714375490966222,0.971081608033886,-0.394588764262067,-0.800806173322811,4546,3,CTNNB1|TCF7L2
PROTEIN K29-LINKED UBIQUITINATION%GOBP%GO:0035519,0.9114010989010991,1.0,-0.25527876092958995,-0.6462212319115861,5307,5,PARK2
PROTEIN DEGLYCATION%GOBP%GO:0036525,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
INDOLALKYLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0046219,0.325503355704698,0.826621597878865,0.8414755183061321,1.1178626851853102,2424,1,DDC
POSITIVE REGULATION OF PROTEIN MATURATION%GOBP%GO:1903319,0.684522502744237,0.966495577318169,-0.20380515951781697,-0.834650625197625,3117,16,ENO1|CLEC3B|MFI2|MYH9
"TRNA 3'-TRAILER CLEAVAGE, ENDONUCLEOLYTIC%GOBP%GO:0034414",0.459287700251556,0.890371861972445,-0.769574327304808,-1.02948304176017,3468,1,ELAC2
NEGATIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010751,0.8381588715664441,0.989395884107905,-0.42226340938648405,-0.722258946773943,5644,2,ATP2B4
VACUOLE ORGANIZATION%GOBP%GO:0007033,0.245564892623716,0.7579381964753191,-0.15656425290459303,-1.12765997685907,525,94,RB1CC1|ATG13|MAP1LC3B2|ATG9B|VPS18|MAP1LC3A|ATG101|ATG3|VPS11|MFN2|ATG7|ABCA1|RAB1A|BECN1|RAB39A|TFEB|GABARAPL1|GABARAP|RAB7A|WIPI2|MAP1LC3B|NSFL1C|CLVS2|GABARAPL2
UROPORPHYRINOGEN III BIOSYNTHETIC PROCESS%GOBP%GO:0006780,0.591387444054675,0.945418171231938,0.5704438930245379,0.932374872138151,4888,2,UROS|SUCLA2
REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001910,0.9770657962549392,1.0,0.11570409074617699,0.528411370449973,11374,41,CEACAM1|AGER|KLRK1|CD1E|SLAMF6|F2RL1|IL12RB1|NCR3|CD1D|RASGRP1|DNASE1L3|RIPK3|HLA-F|DNASE1|XCL1|FADD|MICA|HLA-C|STX7|CADM1|PTPRC|HFE
REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014910,0.9604886924876529,1.0,-0.118342142117138,-0.605645628790175,3694,29,TRIB1|IGFBP3|NRP1|PLAU|DOCK5|IGF1|ACE
CELL DIFFERENTIATION IN HINDBRAIN%GOBP%GO:0021533,0.939086294416244,1.0,-0.18889642855646105,-0.6097745987951121,4809,9,CEND1|PHOX2B|AGTPBP1|ATP7A|KNDC1|OPHN1|FAIM2|CBLN1
REGULATION OF PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:1903093,0.32882953652788693,0.828303707528737,-0.540255872945848,-1.09643324243668,2092,3,UBXN1|OTUD4|PARK7
POSITIVE REGULATION OF PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE ACTIVITY%GOBP%GO:0060585,0.0252348993288591,0.329326373353219,0.987759153065726,1.3121939677878,187,1,EDN1
NUCLEAR MRNA SURVEILLANCE OF MRNA 3'-END PROCESSING%GOBP%GO:0071031,0.715616305794121,0.971081608033886,0.522194651226909,0.8535128119041371,5915,2,EXOSC2|EXOSC3
REGULATION OF DNA METHYLATION%GOBP%GO:0044030,0.24555030875408604,0.7579381964753191,-0.405116415330844,-1.1817425569005902,1351,7,FAM129B|SPI1|MECP2|KDM1B
MOVEMENT IN HOST ENVIRONMENT%GOBP%GO:0052126,0.0597539543057996,0.476295606439141,-0.564586846383722,-1.5497529840888797,339,6,VPS4A|VPS4B|RAB7A
CELLULAR RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0071243,0.9286498353457739,1.0,-0.15577413540503302,-0.6379474386862329,4229,16,ATF4|PPIF|DDX3X|CPEB2|HSF1
INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045112,0.510872483221477,0.918404893008545,0.7482906925452142,0.994070801431744,3805,1,COL5A1
REGULATION OF CHOLESTEROL IMPORT%GOBP%GO:0060620,0.8539597315436239,0.991298302704726,0.57399647110719,0.7625287040678249,6361,1,LAMTOR1
POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060261,0.21772450383179395,0.7341474817293291,0.392672026160599,1.2378425541684699,2215,12,GTF2B|PSMC3|SRF|PAXIP1|PSMC6|PSMC2|PSMC5|TAF1|SUB1
REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:2000535,0.0497363796133568,0.438727695219498,-0.579222105444211,-1.58992578752414,282,6,CXCL8|CAV1
VESICLE DOCKING INVOLVED IN EXOCYTOSIS%GOBP%GO:0006904,0.0163223667431778,0.27198543625715,-0.341476163333375,-1.70164301022889,63,27,RAB10|RAB3C|VTI1B|RAB3D|RAB8B|VPS18|RABEPK|VPS11|VAMP3|YKT6|RAB8A|BLOC1S6|SNPH|SNAP25
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030858,0.8523632501327671,0.991298302704726,-0.138648412075269,-0.729087483717879,3209,31,TRIM16|BTG1|FOXC1|PRKCH|ADD1|TMEM100|LIF|NKX6-1|CDH5|PAX8|ATOH8|PROC
OXIDISED LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0150024,0.0350853965311797,0.381265913354899,-0.9821901191001321,-1.3139056690459299,264,1,CD36
SEMICIRCULAR CANAL DEVELOPMENT%GOBP%GO:0060872,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
POSITIVE REGULATION OF TOLERANCE INDUCTION%GOBP%GO:0002645,0.18612637362637402,0.6922162303225631,-0.496525479814692,-1.2569212811630701,1083,5,LILRB2|IRAK3|TGFBR2|FOXJ1|CD274
PYRIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072524,0.015040825096691001,0.264387156924099,-0.21077786854168698,-1.48204170498178,34,85,PFKL|DERA|GPI|G6PD|MDH1B|PKM|PNP|ENO1|NAMPT|PGD|PDHB|GAPDH|KCNAB2|PGK1|TP53I3|HK1|NMNAT3|HK2|TPI1|PNPO|PDXK|ALDOA|TKT|NT5E|PGAM2|NMNAT2
REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900125,0.904876373626374,1.0,-0.25750055151114104,-0.651845547234297,5269,5,CLTC|PDGFB|NFKB1|TGFB1|AP2A1
CELLULAR ALKENE METABOLIC PROCESS%GOBP%GO:0043449,0.40604026845637603,0.8663957682383929,0.8040913101014558,1.06819943241317,3024,1,GRIN1
DNA DEALKYLATION%GOBP%GO:0035510,0.849127416025521,0.991298302704726,0.186548828416287,0.692748934766041,9049,20,TDG|ALKBH3|ALKBH1|MPG|FTO|TET2|APOBEC3D|ASCC1|MGMT|APOBEC3C|TET1|ASCC3
MICROTUBULE-BASED PEROXISOME LOCALIZATION%GOBP%GO:0060152,0.443328898028305,0.8808089923737601,0.6254338729947221,1.0222544837363001,3664,2,PEX1|PEX13
CERAMIDE TRANSPORT%GOBP%GO:0035627,0.871761133603239,0.9934031064448321,0.23294198872045102,0.6647368449393989,8612,9,ABCB4|CPTP|ABCB1|PLTP|PLEKHA8|COL4A3BP
GLYCOSYL COMPOUND CATABOLIC PROCESS%GOBP%GO:1901658,0.0541688794476899,0.454914205138535,-0.283441396482526,-1.49048641415914,203,31,ENTPD4|DERA|PNP|CDA|HPRT1|NUDT18|CDADC1|UPP1|NT5E|ENPP4
AXO-DENDRITIC TRANSPORT%GOBP%GO:0008088,0.54630829015544,0.930420772651609,-0.15705824146491698,-0.9513741308687429,1686,50,HIF1A|BLOC1S1|HSPB1|SOD1|RAB21|BLOC1S5|BLOC1S4|HAP1|AP3S2|FMR1|BLOC1S6|KIF3B|TRAK1|BLOC1S3|TMEM108
DIENCEPHALON DEVELOPMENT%GOBP%GO:0021536,0.82438433589019,0.9876441563834109,-0.204318710220364,-0.719022997187783,4083,11,ADCYAP1|DRD2
CATECHOL-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0009712,0.39068000741152503,0.860837094563899,0.27745473906908,1.06258728968822,4216,22,SNCAIP|PNMT|TGFB2|SULT1A3|DDC|HAND2|DRD4|TH|MOXD1|LRTOMT|GATA3|COMT|DBH|MAOA
PROTEIN TRANSPORT WITHIN LIPID BILAYER%GOBP%GO:0032594,0.111086425238836,0.585333212974979,-0.315843037728524,-1.35868657476446,499,18,RILPL2|RAB8A|RFTN1|CACNG3|RILPL1|CACNG7
CHAPERONE-MEDIATED PROTEIN TRANSPORT INVOLVED IN CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061741,0.8518188567186341,0.991298302704726,-0.4145574855252279,-0.709078376712147,5736,2,HSPA8|CLU
DIADENOSINE HEXAPHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901909,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:1901970,0.173481781376518,0.676682497340677,0.452844067529836,1.29226224242705,1713,9,ANAPC5|DLGAP5|RB1|ESPL1|CDT1|ANAPC4
REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042306,0.637458006718925,0.9594603334792429,-0.16115091851271,-0.88647380139182,2276,36,APOD|CHP1|IGF1|MAVS|ZPR1|BAG3|CABP1|PIK3R1
TROPANE ALKALOID METABOLIC PROCESS%GOBP%GO:0046448,0.27691275167785195,0.7884684708511421,0.864633877370975,1.14862753203531,2062,1,BCHE
REGULATION OF GUANYLATE CYCLASE ACTIVITY%GOBP%GO:0031282,0.00549368968077209,0.170696050287554,-0.9505376344086022,-1.6258437161165202,36,2,NOS3|GUCA1A
RESPONSE TO ALKALOID%GOBP%GO:0043279,0.231598864711448,0.744434191743215,0.33183811251031897,1.21291907253418,2447,19,RYR2|CRHBP|CASP6|ADCY8|BLM|RAD51|ABAT|DRD4|SLC8A1|TRPV1|SPIDR|GSTM2
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030511,0.8625883227965792,0.991943445125448,0.179572022260108,0.6788779570853679,9277,21,CITED1|MEN1|RNF111|CDKN2B|STK11|ING2|DAB2|THBS1
OTIC VESICLE DEVELOPMENT%GOBP%GO:0071599,0.154608847243408,0.6538333887772321,0.569693865738594,1.31305990825343,1418,5,PROX1|AHI1|CEP290|FGFR2
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900103,0.0040371417036738,0.148761179457137,-0.577950478428886,-2.03387974002898,19,11,BAX|DAB2IP|BOK|ATF6|PTPN1|PIK3R1|BCL2L11|TMEM33
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE%GOBP%GO:0072666,0.710080533185226,0.9700296616429409,-0.154900115875176,-0.8420381082540579,2556,35,NAGPA|GOSR2|VTI1B|VPS28|CLU|VPS4A|GCC2|NEDD4|RAB7A|VTI1A|CACNG3|CACNG7
REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070663,0.931598793363499,1.0,0.117544391504882,0.676479381695686,12352,120,SH3RF1|IDO1|GLMN|CD209|MZB1|CD38|BMP4|AGER|CD320|BLM|MARCH7|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|DLG5|IL7|CCL19|GSTP1|TMIGD2|BTN2A2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|PLA2G2D|CEBPB|HLA-DMB|IGFBP2|CD3E|PTPN22|CD46|CTLA4|RIPK3|IKZF3
HEART MORPHOGENESIS%GOBP%GO:0003007,0.220468154599891,0.7354368651705759,-0.14917785703956699,-1.13377715835661,404,115,MICAL2|TNNT2|EFNA1|SNAI1|MYOM1|SMAD7|RYR1|CCDC103|PDCD4|TBX20|MKKS|NOS3|SFRP2|ACVRL1|S1PR1|OLFM1|SOX17|ZFPM2|DNAAF1|BBS7|RBPJ|FKBP1A|SLIT3
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086065,0.0537912578055308,0.45314328209901295,0.35780500453528596,1.50025178190782,602,30,RYR2|KCNN2|TNNI3K|CACNA1G|CACNB2|KCNQ1|CACNA2D1|CACNA1D|GJA1|GJC3|CXADR|SCN3B|SLC8A1
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010714,0.385987137010329,0.859630103805729,0.321522733241912,1.06530473064677,3960,14,WNT4|BMP4|F2R|SUCO
LYMPHOCYTE HOMEOSTASIS%GOBP%GO:0002260,0.9095826893353941,1.0,0.182567792326483,0.619016551925053,9415,15,DOCK10|RIPK3|AKT1|FADD|JAK3|FOXP3|ZC3H8|NCKAP1L|MEF2C|PPP2R3C
INTERLEUKIN-8 SECRETION%GOBP%GO:0072606,0.0288047512991834,0.348603135907264,-0.8914805624483041,-1.5248297574228897,193,2,RAB1A|CHI3L1
PTERIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042559,0.379693177230521,0.8558729696630809,-0.298139658467063,-1.04919060315292,1880,11,GCH1|MTHFD1L|ST20-MTHFS|DHFRL1|FPGS|SPR|QDPR
CELLULAR RESPONSE TO INTERLEUKIN-8%GOBP%GO:0098759,0.6645637583892621,0.964618776001639,0.6734671371857079,0.8946710462521049,4950,1,EGR1
PURINE RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009154,0.37169517884914505,0.852609194081082,-0.245386021071404,-1.05559614314233,1672,18,NUDT4|HPRT1|NUDT18|PDE9A|PDE4D
FACE MORPHOGENESIS%GOBP%GO:0060325,0.9925337417440409,1.0,0.128354421790527,0.44496997192517995,10368,16,MYH3|LEF1|NIPBL|CLDN5|TGFB3|LRP6
CENTROSOME DUPLICATION%GOBP%GO:0051298,0.00628243649276154,0.17975028050367198,0.462014425879775,1.8410610262111398,68,25,CEP63|CENPJ|PKD2|WDR62|CKAP5|CEP152|STIL|CDK5RAP2|CEP72|SASS6|CNTROB|RTTN|BRSK1|BRCA2|CEP135|CDK2|C2CD3|NDE1|USP33
LOOP OF HENLE DEVELOPMENT%GOBP%GO:0072070,0.299262126527156,0.8023890191280308,0.68727731268848,1.1233358869770702,2473,2,PKD2|PKD1
REGULATION OF BONE TRABECULA FORMATION%GOBP%GO:1900154,0.0693764067258043,0.5054741186916171,-0.964214821349801,-1.28985956518307,523,1,GREM1
REGULATION OF CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1905310,0.736005939123979,0.974262605126702,-0.46462641301351004,-0.794718595660621,4956,2,SEMA3C|ENG
REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031440,0.7305299825827319,0.972575443350537,-0.169178983352342,-0.8207331644655709,2935,25,NELFE|HSF1|NCBP2|NUDT21
PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:0070585,0.0441176470588235,0.414896282192604,-0.21465205525641698,-1.41219757701496,119,66,HSPA4|BAX|TOMM34|TOMM22|TIMM50|ROMO1|SAMM50|TOMM20|TIMM10B|AIP|C19orf52|TIMM23|MFN2|PMPCA|DNLZ|HK1|HK2|TIMM22|BMF|TIMM23B|FBXO7|BCL2L11|PMAIP1
NEGATIVE REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000740,0.7809395973154358,0.981487311948134,0.610994706660785,0.811679209392466,5817,1,REST
GLYCEROLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0045017,1.0,1.0,0.0612183958296594,0.371037100090966,13739,167,PTDSS2|LPL|LPCAT4|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|GPAM|DGAT1|CEPT1|ABHD3|PIGC|INPP5E|TAZ|PIGF|FAR1|CHKB|CPNE7|PIGQ|PIGB|GNPAT|MTMR4|PLEKHA1|PTPN13|AGK|RAB4A|CPNE1|ETNK1|PLA2G2D|IMPA1|SLC44A3|DGKZ|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|PIP4K2B|MTMR7|FIG4|PCK2|PIGK|LPCAT2|PLD1|PIGH|PIP5K1C|CDS1|GPAA1|PIK3C2B|INPP5F|TAMM41|OCRL|PIK3C2A|RUFY1|MTMR6|CRLS1|DGKA|CHKA|PIKFYVE|PGS1|PIGN|STARD7|LCLAT1|PIGU|ETNK2|AGPAT2|GK|PIGS|PIGO|SLC27A1|AGPAT1|SLC44A1|MTMR3|PLEKHA8|GPD1|INPPL1|PCTP|CHPT1|AGPAT5|PYURF|PCYT1B
NEGATIVE REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000258,0.9374782910732891,1.0,0.325419165127764,0.6185876000966479,8096,3,CD55|SERPING1|A2M
REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061050,0.654384589539702,0.9640743070248079,0.408588868276224,0.8658388423195981,5842,4,EDN1|GSK3A
"REGULATION OF PROTON-TRANSPORTING ATPASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:0010849",0.408446974712035,0.867015886388254,-0.794441993824438,-1.06274927747228,3084,1,PPIF
RESPONSE TO MUSCLE INACTIVITY%GOBP%GO:0014870,0.0991358994501178,0.570215774831708,-0.7119223557957429,-1.4448252689453402,630,3,FBXO32|HDAC4|SCN5A
GERMINAL CENTER FORMATION%GOBP%GO:0002467,0.5709158272548339,0.9404752161333092,0.49086805202652,0.9330885295215658,4930,3,CXCL13|MEF2C
POSITIVE REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000724,0.437177280550775,0.878651088001772,-0.7793890604322891,-1.04261250951351,3301,1,GPER1
GLUCOSE IMPORT%GOBP%GO:0046323,0.5798959719366149,0.942746898746279,0.5745244003308521,0.9390443492322281,4793,2,SORT1|RAB4B
GENITALIA MORPHOGENESIS%GOBP%GO:0035112,0.435103423249063,0.878651088001772,0.6284532671629449,1.02718960055665,3596,2,NIPBL|LRP6
GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009065,0.19009121061359902,0.698434241409875,-0.34471573292954805,-1.25583399347524,916,12,NOS3|GLUL|DDAH1
NEURON APOPTOTIC PROCESS%GOBP%GO:0051402,0.140285400658617,0.628783181453404,-0.3207678627315,-1.31365220490773,638,16,SIAH1|ATN1|BNIP3|CDK5|BID|GAPDH|NLRP1|BCL2|TNFRSF21
CELL PROLIFERATION%GOBP%GO:0008283,0.7613365155131272,0.977763214485385,-0.0980124383059563,-0.8954802212363009,318,347,OGFOD1|CHRM4|CDK5|PAK7|FOXC1|ACHE|RAB10|EMP1|TXN|MTSS1|LAMA5|INSIG1|NRARP|DLX5|VTI1B|PICALM|PTPN6|FURIN|ID2|PPARD|MAPRE1|FTSJ2|ZEB1|WDR12|CBFA2T3|MATK|PES1|CLU|PLCE1|CDK9|PIM1|IGFBP4|CX3CL1|BCAT1|NES|CTNNB1|SKI|OTUD6B|BCAR1|HLCS|HMOX1|DDIT4|CR2|CDV3|CITED2|FGF7|ADRA1B|CUL5|PA2G4|YME1L1|KLF10|TCF7L2|NKX6-1|RUNX1|FGF2|MXD1|KITLG|ETV6|SBDS|SLC11A1|CD276|TUSC2|MS4A1|BOK|IGF1|BIN1|ZPR1|YPEL5|ELF4|SERPINF1|ARHGEF2|BHLHE41|ATOH8|MSN|EDNRA|BCL2|MECOM|ATF5|TP53|UBE2L3|TNFRSF4|CSGALNACT1|PDXK|WNT3|ARIH2|FGF10|SFRP2|BMPER|CRIP1|ACVRL1|ACE|TRNP1|MET|MAP3K11|CHRM1|TWIST1|NUDC|DLG1|CDH13|STC1|GLUL|APPL1
REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002902,0.13998438110113198,0.6281603901381739,-0.41268621152445795,-1.33218807249913,716,9,BCL10|LYN|FOXP1|BCL6
CELLULAR RESPONSE TO TEMPERATURE STIMULUS%GOBP%GO:0071502,0.881073825503356,0.9956508825790341,0.56043228936921,0.744509293769968,6563,1,TRPM2
DTMP BIOSYNTHETIC PROCESS%GOBP%GO:0006231,0.26771406127258496,0.7826111979723571,-0.570363345656676,-1.157535463771,1703,3,DCTD|CDADC1
STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051146,0.263598326359833,0.7750430007453571,0.230526377251629,1.1569603578562,3212,60,NEB|IGSF22|ACTN2|MAML1|KCNH1|MYH3|PROX1|TCAP|CACNA1H|OBSCN|KRT19|NEBL|SEPN1|HEY2|CXADR|LMOD1|OBSL1|DMD|KIAA1161|NRG1|SLC8A1|MYEF2|MYOM2
CELL WALL MACROMOLECULE CATABOLIC PROCESS%GOBP%GO:0016998,0.938389261744966,1.0,0.533855315394795,0.709202969527827,6990,1,MANBA
ESTABLISHMENT OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045198,0.0684295518772709,0.5037729184803449,-0.426090185612053,-1.4994644494410199,338,11,MYO9A|EZR|OPHN1|RHOA|CDC42|MSN|SLC9A3R1|SH3BP1
DENDRITE ARBORIZATION%GOBP%GO:0140059,0.0288461538461538,0.348603135907264,-0.6754236519524711,-1.70979012448017,167,5,NRP1|CHRNA7|ZNF365|SEMA3A
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032413,0.0066647348594610295,0.18239572673498103,-0.32705776364183003,-1.8307769533540499,22,38,CAMK2D|SRI|HECW2|NEDD4L|KCNE3|FKBP1B|CRHR1|KCNE4|PLN|KCNAB1|MMP9|SUMO1|CAB39|FMR1|GNB5|NEDD4|YWHAE|ADRA2A|CAV1|FKBP1A|EPHB2
REGULATION OF EXOCYST LOCALIZATION%GOBP%GO:0060178,0.0928108036541771,0.5622489437340121,-0.952249669166299,-1.2738534162927702,700,1,RALB
REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036491,0.152553024351925,0.648319130045528,-0.660141171280468,-1.33973689345815,970,3,EIF2AK4|DNAJC3|EIF2AK3
ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0030218,0.918205105556046,1.0,0.146837623667858,0.627828322229585,10394,32,INHA|FLVCR1|JAK2|TAL1|MED1|KIT|RPS19|ATPIF1|ACIN1
NEGATIVE REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905819,0.0403452805404391,0.400814751667794,0.42191980436848103,1.5667988778826498,429,20,TPR|CENPF|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|KLHL22|PLK1|TEX14|ATM
"REGULATION OF CD8-POSITIVE, ALPHA-BETA CYTOTOXIC T CELL EXTRAVASATION%GOBP%GO:2000452",0.650901173339785,0.963755998259649,0.547670250896057,0.895151979707696,5380,2,RIPK3|FADD
VASCULATURE DEVELOPMENT%GOBP%GO:0001944,0.40061162079510704,0.8638522656500329,-0.120217362415511,-1.0194426654659,392,206,NCL|THY1|HAND1|RAMP3|LAMA5|NRARP|FBXW7|NOTCH1|AHR|LRP5|STRA6|VEGFA|ITGB8|KDR|CTNNB1|TGFBR1|PTK2B|HMOX1|PDPN|EIF2AK3|COL23A1|CALCRL|NRP1|ITGA5|AAMP|TCF7L2|CLIC4|APOD|FGF2|ADAMTS9|APLNR|SERPINF2|FOXC2|SMAD7|RAMP2|FGFR1|LEPR|CXCL8|ID1|ADM2|TBX20|SCG2|FLT1|MCAM|GREM1|MYH9|SFRP2|BMPER|ACVRL1|S1PR1|ADM|PGF|SOX17|CDH13|RBPJ|CAV1|EPHB2|ANGPT2|RAMP1
TRANSLATION REINITIATION%GOBP%GO:0002188,0.7268727567442399,0.972554563883587,0.434249549566299,0.8254627123875842,6277,3,DENR|MCTS1
TRABECULA FORMATION%GOBP%GO:0060343,0.28387946649102597,0.7932053053075551,-0.49470665389792606,-1.13772195612517,1723,4,FKBP1A
L-METHIONINE SALVAGE%GOBP%GO:0071267,0.368162998474613,0.851675851059934,0.47016180961613296,1.0836532736726,3378,5,APIP|MTAP|ENOPH1|MRI1|ADI1
PROTON-TRANSPORTING V-TYPE ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070070,0.397624350408315,0.8638522656500329,-0.615778094241732,-1.05325545123526,2677,2,VMA21
CELL RECOGNITION%GOBP%GO:0008037,0.0184937436058865,0.285526981228736,0.28627427515319,1.5558558047120299,234,88,IGHV3-21|PCDHA7|IGHV4-61|CATSPERG|PCDHB6|NEXN|VCAN|CD209|IGHG1|IGLL5|IGSF9|DSCAM|IGHG4|ADGRB1|OVGP1|SCARB1|CDK5R1|ROBO2|SEMA5A|PCSK4|IGHV1-18|CCL21|IGHV3-43|ZP3|CORO1A|BSG|PALLD|CCL19|GAP43|IGHV1-24|PRF1|NCR3
RESPONSE TO SALT STRESS%GOBP%GO:0009651,0.11387577188521601,0.590080021815051,-0.47858800140012,-1.39606243310245,626,7,AQP1|TNF
POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030859,0.0385572139303483,0.39440767134064103,-0.443540964986786,-1.6158642270124,185,12,MYO9A|EZR|RAB10|OPHN1|RHOA|CDC42|MSN|SLC9A3R1|SH3BP1
POSITIVE REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900026,0.00047528517110266203,0.0784645998831315,-0.478070948875555,-2.21477859835076,1,22,TRIOBP|RREB1|CALR|CRKL|S100A10|ABL1|NRP1|C1QBP|MYADM|DOCK5|CRK|CDC42|LIMS1|RAC1
PROTEIN K29-LINKED DEUBIQUITINATION%GOBP%GO:0035523,0.7643633105610931,0.9787088902274829,0.3675556160393921,0.7788854611292709,6824,4,USP13|ZRANB1
REGULATION OF SYNAPTIC MEMBRANE ADHESION%GOBP%GO:0099179,0.889530201342282,0.997300970905927,0.55640714600794,0.7391620703888969,6626,1,MDGA1
RNA INTERFERENCE%GOBP%GO:0016246,0.5958268933539411,0.9478856081493391,0.263991692326046,0.895093406334759,6167,15,CELF1|DHX9|DROSHA|TERT|NRDE2|DICER1|TARBP2
NEGATIVE REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000019,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0060681,0.552760492519529,0.9324056413710201,-0.7178539920599909,-0.9602951723633809,4174,1,FGF1
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902236,0.6063498651172441,0.9508825506493929,-0.234850695767375,-0.8844432312365991,2921,13,OPA1|PARK7|TMBIM6|CREB3|MAGEA3|BCL2L1|PARK2
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045672,0.521616871704745,0.9251240799994541,-0.34043866796871103,-0.9344812847892171,2967,6,POU4F2|TNF
PRIMITIVE STREAK FORMATION%GOBP%GO:0090009,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
NEGATIVE REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0045843,0.737341772151899,0.974306231601101,-0.20551889684634397,-0.7962346149634258,3494,14,SOX15|SIRT2|USP19|BMP2|EPHB1|TGFB1|FZD7|SMAD4|FRS2|AKIRIN1|SOX6|DKK1
POSITIVE REGULATION OF OOGENESIS%GOBP%GO:1905881,0.22642910170749803,0.7398172623753029,-0.721897247104406,-1.23476657882857,1524,2,PDE3A
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042307,0.527992037820353,0.9265056012720759,-0.194950184093947,-0.9457562537265091,2121,25,IGF1|MAVS|ZPR1|BAG3|PIK3R1
HYPOTONIC RESPONSE%GOBP%GO:0006971,0.873937677053825,0.9934031064448321,0.290097458815654,0.668631638087216,8020,5,STK39|MYLK|SLC12A5
NOREPINEPHRINE METABOLIC PROCESS%GOBP%GO:0042415,0.721988205560236,0.971401508276304,0.303291277855948,0.789403474726144,6855,7,HAND2|TH|MOXD1|GATA3|DBH|ATP7A
IMMUNE RESPONSE-INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002767,0.424037706205813,0.8740879492662891,-0.49647071798830894,-1.00757257136444,2698,3,LILRB2|LILRB1|LYN
CALCIUM ION REGULATED LYSOSOME EXOCYTOSIS%GOBP%GO:1990927,0.952041573867854,1.0,-0.348276812792942,-0.595708835769343,6411,2,SYT7|SYT11
NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS%GOBP%GO:0090305,0.9765395894428149,1.0,0.103960622756273,0.6012975296271059,12986,123,GTF2H2|MUS81|FBXO18|DFFB|DXO|C11orf80|ERN1|ENDOG|DNASE1L2|RFC4|GTF2H1|DDB2|DNA2|POLD1|PARP1|FEN1|CPSF1|GEN1|POLD3|DDB1|ANKLE1|CHD1L|FIP1L1|CPSF6|LACTB2|RNASE6|CUL4B|EXD2|DICER1|ERCC5|RNASE1|XPA|RBX1|RFC3|DNASE1L3|XRN1|RFC5|CPSF7
POSITIVE REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000193,0.385970689939075,0.859630103805729,-0.45315171234765395,-1.04215427169092,2343,4,P2RX4|PLA2R1|IL1B|TNFRSF11A
RDNA CONDENSATION%GOBP%GO:0070550,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
GLANDULAR EPITHELIAL CELL MATURATION%GOBP%GO:0002071,0.278167615517013,0.78848945131153,-0.860829289810322,-1.15155758744428,2100,1,NKX6-1
COPPER ION HOMEOSTASIS%GOBP%GO:0055070,0.912222452791035,1.0,-0.17319576252482902,-0.652251931140439,4395,13,ATP7B|MT2A|XIAP|ATOX1|COX19|ATP7A|CCDC22|APP|ARF1|CUTC|PRND|PRNP|COMMD1
APICAL JUNCTION ASSEMBLY%GOBP%GO:0043297,0.13377926421404698,0.6198988233488609,-0.25693937864347605,-1.29914865686428,519,28,RAB13|F11R|RHOA|WDR1|STRN|PARD6B|RHOC|CTNNA1|RAMP2|DLG1|PARD3
POSITIVE REGULATION OF PYRROLINE-5-CARBOXYLATE REDUCTASE ACTIVITY%GOBP%GO:1903168,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
DETERMINATION OF HEART LEFT/RIGHT ASYMMETRY%GOBP%GO:0061371,0.30801911842804,0.8111717366855571,-0.210253125391047,-1.10562335219504,1159,31,CCDC103|TBX20|MKKS|SOX17|DNAAF1|BBS7
IRON IMPORT INTO THE MITOCHONDRION%GOBP%GO:0048250,0.48735938067013396,0.907789754052198,0.608877860490764,0.9951941361188459,4028,2,SLC25A28|SLC25A37
REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051963,0.8808367905375591,0.9956508825790341,0.156823429812573,0.6759911305891441,9978,33,GHRL|SLIT1|CUX2|ROBO2|CLSTN2|PTPRD|DLG5|SLITRK1|AGRN|NLGN3|IL1RAP|LRRC4B|PDLIM5|NLGN2|MDGA1|EPHB3
REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:1904872,0.00866474116862919,0.20506001864802398,-0.43501849070909704,-1.8713528952592502,38,18,PARN|NAF1|CCT4|DCP2|RUVBL1|CCT7|SHQ1|TCP1|RUVBL2|NHP2
NEGATIVE REGULATION OF MONOCYTE EXTRAVASATION%GOBP%GO:2000438,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
NEGATIVE REGULATION OF NF-KAPPAB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032088,0.43585110227683393,0.878651088001772,-0.1572452166356,-1.01374674223404,1205,62,HAVCR2|PSMD10|CYP1B1|OTULIN|PRMT2|SETD6|PYCARD|ITCH|IRAK1|NFKBIA|DAB2IP|IRAK2|TNFAIP3|ARRB2|TRAF3|COMMD7|MAP2K5|ARRB1|CHP1|CYLD|G3BP2|TMSB4X|NLRP3|COMMD1|RBCK1|TAX1BP1
REGULATION OF B CELL CHEMOTAXIS%GOBP%GO:2000537,0.860282108389013,0.9916689277956879,-0.4095947063689,-0.7005898087546989,5793,2,XCL1|PTK2B
PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009220,0.5636057287278851,0.9377667552605741,0.352203164106034,0.916710838242105,5351,7,CAD|CTPS2|UMPS|CTPS1
INTERLEUKIN-23-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038155,0.88365553602812,0.996316041142784,-0.24228159890152104,-0.665046720964985,5027,6,P4HB|STAT3
BILE ACID AND BILE SALT TRANSPORT%GOBP%GO:0015721,0.339389178041834,0.8329318579654449,0.34483691345299294,1.11291689611123,3455,13,ABCC3|CEACAM1|STARD5|AKR1C1
NEURONAL STEM CELL DIVISION%GOBP%GO:0036445,0.4091275438243,0.867015886388254,0.3542636624547771,1.04552359245967,4060,10,FGF13|LEF1|DOCK7|SOX5|FGFR2|TEAD3
DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002371,0.9107646622123241,1.0,-0.379500441207577,-0.6491151799420029,6133,2,CAMK4
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043372",0.605421017551655,0.9508825506493929,-0.20547491583420702,-0.883907435802827,2724,18,CCL19|IL12RB1|SOCS1|NFKBID|ANXA1|MYB|FOXP3|PRKCZ|NCKAP1L|MALT1|ZBTB7B|NFKBIZ|IL18|CD86|RARA|LGALS9|NLRP3|SOCS5
SARCOSINE CATABOLIC PROCESS%GOBP%GO:1901053,0.461073825503356,0.8908856132322029,0.7745919717688579,1.0290108774970999,3434,1,SARDH
"REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904814",0.28945147679324895,0.7989014598698071,-0.29029219273377,-1.1246688059107,1371,14,CCT2|CCT5|GNL3|DKC1|H2AFY|TERF1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1|GNL3L
"REGULATION OF GLUTAMATE SECRETION, NEUROTRANSMISSION%GOBP%GO:1903294",0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
CENTROSOME LOCALIZATION%GOBP%GO:0051642,0.635876328132478,0.95916055221954,0.248081415006047,0.8600309886522901,6642,16,AKAP9|GPSM2|C9orf114|ASUN|SYNE2|NDE1|IFT20|RANBP2|TBCCD1
GLOMERULAR MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072144,0.763880488689972,0.978421368343614,0.50046870692032,0.81800235278162,6314,2,ACTA2|PDGFB
PEPTIDYL-ASPARTIC ACID PHOSPHORYLATION%GOBP%GO:0018217,0.7891275167785241,0.9819233677232551,0.6070247022496689,0.8064052356467521,5878,1,ATP13A2
POSITIVE REGULATION OF MICROGLIAL CELL MIGRATION%GOBP%GO:1904141,0.653078504898996,0.9640743070248079,0.546953405017921,0.8939803148127909,5398,2,CSF1|P2RX4
PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046135,0.0356920522930069,0.3821688062173221,-0.43235488854557497,-1.62824024607088,171,13,NT5M|APOBEC3C|DPYD|NT5C3A|APOBEC3G|TYMP|NT5C|NT5C1A|ENTPD4|CDA|CDADC1|UPP1|NT5E
RNA METHYLATION%GOBP%GO:0001510,0.460426454644019,0.8904234666384399,-0.155257067833327,-1.00092931341487,1273,62,FTSJ2|METTL1|CBLL1|METTL16|ZC3H13|NSUN5|TRMT12|TRMT61B|NSUN3|TRMT112|WBSCR22|RBM15B|NSUN2|RBM15|RNMTL1|TRMT6|EMG1|HENMT1|TRDMT1
PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL%GOBP%GO:0070646,0.0414438502673797,0.402998391331252,-0.146563244714676,-1.28036289735296,30,245,OTUD7B|USP16|SENP2|SNX3|USP41|TAF10|HIF1A|PSME4|UBE2D1|COPS3|C17orf96|STAMBP|OTUD5|TADA3|OTUD7A|USP31|PSMC4|USP45|INO80B|RUVBL1|NFKBIA|PSMD12|USP5|OTUD6B|TGFBR1|USP38|VCPIP1|ATXN7|FOXO4|USP10|TNFAIP3|ADRM1|ARRB2|ACTR5|JOSD2|WDR48|TOMM20|USP3|PSMA6|TRAF3|PSME3|RHOA|CCP110|JOSD1|INO80C|NEDD8|SMAD1|SMAD2|CYLD|BECN1|RAD23B|TNIP1|COPS7A|BAP1|SHMT2|KDM1B|SMAD7|USP27X|INO80E|ADRB2|NLRP3|UBA52|FOXK1|ACTR8|TP53|UCHL1|COPS2|TADA2B|PARK2|TNIP2|PSMD6|COPS8|TFPT|SENP5|USP2|USP12|UBC|OTUD1|SPATA2|PSMF1|UBB
EPIBOLY%GOBP%GO:0090504,0.0678285445124823,0.50364937614461,-0.321592327861182,-1.46060674457258,287,21,PDPN|RHOA|ITGA5|RHOC|PDCD10|ADAM17|MMP12|ACVRL1|TMEFF2
NEGATIVE REGULATION OF NEURAL CREST FORMATION%GOBP%GO:0090301,0.43664768965973794,0.878651088001772,-0.7796647551830609,-1.04298131478748,3297,1,FUZ
VIRAL BUDDING%GOBP%GO:0046755,0.5396631681718329,0.9280749458041251,-0.19643350080053001,-0.9415965185755379,2210,24,VPS37B|TSG101|VPS37A|MVB12B|MVB12A|MITD1|CHMP5|VPS37C|CHMP6|LRSAM1|CHMP3|CHMP2B|CHMP7|CHMP2A|CHMP1A|VTA1|CHMP4A|PDCD6IP|VPS28|VPS4A|VPS37D|VPS4B|CHMP4B|CHMP1B
POSITIVE REGULATION OF SHELTERIN COMPLEX ASSEMBLY%GOBP%GO:1904792,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
CAP MRNA METHYLATION%GOBP%GO:0036451,0.5346558606507801,0.9265056012720759,0.591673559415495,0.967074178641118,4419,2,CMTR2|CMTR1
CELLULAR RESPONSE TO PEPTIDE%GOBP%GO:1901653,0.0017497812773403301,0.10934691283642699,-0.19492862371246397,-1.61301826987905,1,182,INPP5K|HDAC5|FOXO1|PKM|VIM|CPEB2|ATP6V0C|PXN|ATP6V1F|PPARG|LYN|FCGR2B|PRNP|VAMP2|NAMPT|CAMK2A|PRKAR2A|GCGR|IGF1|FOXC2|LPIN1|RIPK2|RAB8A|PTPN1|LDOC1|ARHGEF2|ADRB2|SLC25A33|STAT5A|SHC1|ATP6V1E2|ATP6V0D1|STAT3|TP53|PRKAR1B|ADCY2|CAV2|ATP6V1E1|RHOQ|IGF2|CD36|PIK3R1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
STEROID METABOLIC PROCESS%GOBP%GO:0008202,0.0144431774990498,0.262561429815328,0.27081185214249304,1.5447904857372499,189,114,FDXR|CYP21A2|STAR|TM7SF2|CYP2C8|C14orf1|SLC27A2|FDX1|HSD17B4|AKR1B1|CYP3A5|EBP|DHRS4|BZRAP1|OSBPL3|CLN6|MVD|LBR|CYP2R1|CACNA1H|HSD17B11|GBA2|AMACR|DHCR24|SRD5A3|SOAT1|HSD11B1|PPAPDC2|AKR1C1|CETP|OSBPL5|LDLRAP1|MED1|APOE|NSDHL|ACOX2|OSBPL9|PIAS4|CYP7B1
NEGATIVE REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031348,0.963373493975904,1.0,-0.0933202535951614,-0.683936290811126,1998,100,GBA|OTULIN|MFHAS1|MUL1|PYCARD|RIOK3|ITCH|GPER1|PPARD|ADCY7|CX3CL1|MAPK7|PRKCD|SIRPA|LGALS9|TNFAIP3|ARRB2|NR1H3|PCBP2|C1QBP|PPARA|APOD|METRNL|CDH5|PPARG|FCGR2B|GPATCH3|CNOT7|TRAF3IP1|NR1H2|PDCD4|PROC|NLRP3|ADCYAP1
HISTONE H3-T3 PHOSPHORYLATION%GOBP%GO:0072355,0.8487964194992141,0.991298302704726,0.463303005238489,0.7572560343842191,7016,2,VRK1|GSG2
DETERMINATION OF INTESTINE LEFT/RIGHT ASYMMETRY%GOBP%GO:0071908,0.8069432684165959,0.984682960940884,0.48431210366694205,0.7915948286118301,6670,2,NPHP3|NPHP3-ACAD11
AZOLE TRANSPORT%GOBP%GO:0045117,0.29538753159224895,0.800447413278835,0.443591676537901,1.1545759353651202,2804,7,SLC25A29|SLC25A19|SLC15A4|SLC19A2
RENAL VESICLE FORMATION%GOBP%GO:0072033,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
POSITIVE REGULATION OF NAD+ ADP-RIBOSYLTRANSFERASE ACTIVITY%GOBP%GO:1901666,0.350556792873051,0.842847021021096,-0.649682933553901,-1.1112478630516798,2360,2,DTX3L|TGFB1
REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0032885,0.9307657038055941,1.0,0.152563197513604,0.6004121268530339,10149,24,INS|PASK|GCK|CLTC|IRS1|AKT2|VIMP|GSK3A|AKT1
REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051342,0.86127258444619,0.991915800284466,-0.34035513400242606,-0.690740632062792,5481,3,EGLN1|GNB2L1|MAPK7
DNA 3' DEPHOSPHORYLATION INVOLVED IN DNA REPAIR%GOBP%GO:0098504,0.287114093959732,0.796019542850327,0.859505955006617,1.14181531594709,2138,1,PNKP
IRON COORDINATION ENTITY TRANSPORT%GOBP%GO:1901678,0.118762257572456,0.602329212916938,0.59226181337224,1.36507568204254,1089,5,FLVCR1|FLVCR2|ABCB6
EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION%GOBP%GO:0045229,0.48563758389261796,0.9067242420344581,0.7610829289810319,1.0110647168345999,3617,1,TGM1
NEGATIVE CHEMOTAXIS%GOBP%GO:0050919,0.217629482071713,0.7341474817293291,-0.24354966195832997,-1.1959002699119499,873,26,SEMA3F|RHOA|SEMA7A|SEMA6B|EPHA7|SEMA3A|SEMA3G|SLIT3
D-AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0046437,0.9756388190123131,1.0,-0.511027790030878,-0.6836174558310022,7368,1,SRR
NEGATIVE REGULATION OF PROTEIN ADP-RIBOSYLATION%GOBP%GO:0010836,0.511635984716916,0.918404893008545,0.511965281478581,0.9731921433647,4418,3,PNKP|XRCC1|TINF2
REGULATION OF OXYGEN METABOLIC PROCESS%GOBP%GO:2000374,0.527277125922342,0.9265056012720759,0.593989523021781,0.970859557532351,4358,2,RNF34|LIPT2
T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:0072538,0.746640029059208,0.9749763305090959,-0.266787973115734,-0.7782323538843531,4110,7,RORC|BATF|IL6|STAT3
MITOCHONDRION MIGRATION ALONG ACTIN FILAMENT%GOBP%GO:0034642,0.236510067114094,0.7504968809113829,0.884153065725629,1.1745579029517401,1761,1,MYO19
POSITIVE REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032731,0.9455798479087449,1.0,-0.132329821470666,-0.61304970989379,3978,22,FZD5|CCL3|CASP1|IFI16|TRIM16|PYCARD|HSPB1|LGALS9|PANX1|RIPK2|NLRP1|NLRP3
NEGATIVE REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051581,0.504320502749411,0.9170017397928191,-0.468204369054355,-0.9502068560330871,3209,3,GPM6B|SNCA
POSITIVE REGULATION OF TRANSCRIPTION VIA SERUM RESPONSE ELEMENT BINDING%GOBP%GO:0010735,0.65451688923802,0.9640743070248079,-0.41655836313066497,-0.845392821481183,4165,3,MKL1|MICAL2
INOSINE CATABOLIC PROCESS%GOBP%GO:0006148,0.24678935522308998,0.758826975311078,-0.876433612704014,-1.17243196595099,1863,1,PNP
NEGATIVE REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905916,0.42433772831740707,0.8740879492662891,0.632864626413014,1.03439984606376,3507,2,FGF9|DNMT1
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900016,0.6926713947990539,0.96731875442989,-0.240113069212447,-0.8123384532661809,3515,10,PYCARD|ADCY7|SIRPA|APOD|PDCD4
POSITIVE REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042753,0.106781376518219,0.5822715745664481,0.489688191816556,1.39740278435958,1054,9,GHRL|ARNTL|BTRC|RORA|THRAP3
TRNA RE-EXPORT FROM NUCLEUS%GOBP%GO:0071528,0.7573154362416109,0.977664504547119,0.624669166299074,0.8298451189610359,5641,1,XPOT
GLOBOSIDE METABOLIC PROCESS%GOBP%GO:0001575,0.659737852508937,0.9643779777660141,-0.663928098808999,-0.888156860774827,4982,1,CLN3
ACTOMYOSIN CONTRACTILE RING CONTRACTION%GOBP%GO:0000916,0.31709254600820896,0.818598932456131,-0.842302602558447,-1.12677387303349,2394,1,VPS4A
NEGATIVE REGULATION OF WNT-FRIZZLED-LRP5/6 COMPLEX ASSEMBLY%GOBP%GO:1904723,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL-CELL SIGNALING%GOBP%GO:1905114,0.593038821954485,0.9464278097528599,-0.11937657962334698,-0.9480635503344008,885,141,FRAT1|PPP3R1|CTNNB1|ITGAM|ARRB2|CELSR1|PRICKLE1|PFN1|RHOA|DDX3X|TCF7L2|STRN|PPAP2B|MST1R|CAMK2A|WNT6|WNT11|CDC42|AP2S1|AGO2|CHRNA3|UBA52|TCF7|DRD2|WNT3|RAB5A|SFRP2|RAC1|MET|C15orf59|PLCB1|UBC|CAV1|UBB
METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0072234,0.7830265138358229,0.981487311948134,0.41170874221997095,0.782615008826143,6762,3,PKD2|PKD1
ASTROCYTE CELL MIGRATION%GOBP%GO:0043615,0.606991653562356,0.9508825506493929,0.563987600859235,0.9218222399586851,5017,2,CCL2|CCL3
PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0006029,0.363980263157895,0.8499434076701009,0.216384846061255,1.0786352173757499,4425,58,HS3ST4|GLCE|GAL3ST3|VCAN|B3GAT3|HS3ST5|GAL3ST4|CHST15|EXT1|PXYLP1|CHPF2|GPC1|XYLT2|BMPR1B
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086012,0.0896592359815379,0.559264258791054,0.44337046926807894,1.43092130579713,912,13,CACNA1G|CACNB2|HCN2|CACNA2D1|CACNA1D|SCN3B|SLC8A1
"PROTEIN DEGLYCATION, GLYOXAL REMOVAL%GOBP%GO:0036529",0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
DEFENSE RESPONSE TO PROTOZOAN%GOBP%GO:0042832,0.390625,0.860837094563899,-0.4096186660046311,-1.03692245291218,2274,5,CLEC7A|BATF|SLC11A1
REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034762,0.00128700128700129,0.0945022140486112,-0.199000857324663,-1.7328109341743703,0,242,DNAJC30|FYN|KCNE4|SESTD1|SLC9A1|PLN|INPP5K|RANGRF|ARPP19|UBASH3B|YWHAH|SLC30A1|KCNAB1|PRNP|APLNR|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|IGF1|BIN1|CRACR2A|ATP2B4|CEMIP|CAB39|TMSB4X|KCNAB2|CRH|AMIGO1|SNCA|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|BCL2|SNTA1|RELN|COMMD1|FXYD5|YWHAE|KCNG1|ANO6|HTT|ADRA2A|JPH1|SLC2A1|PEA15|PER2|SLC9A3R1|RHOQ|CACNG3|SCN5A|PIK3R1|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|TRIB3|HOMER1|APPL1
NMDA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097114,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
REGULATION OF IMMATURE T CELL PROLIFERATION%GOBP%GO:0033083,0.360711261642676,0.848418604328854,0.660051674938655,1.078836330007,2981,2,BMP4|KIAA0922
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904778,0.0901067770756156,0.560121322881739,0.6159827928524161,1.41974902331073,826,5,GNAI1|NUMA1|GPSM2|EPB41|EPB41L2
PROTEIN-PYRIDOXAL-5-PHOSPHATE LINKAGE VIA PEPTIDYL-N6-PYRIDOXAL PHOSPHATE-L-LYSINE%GOBP%GO:0018272,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
URETER EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072192,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
POSITIVE REGULATION OF FEVER GENERATION BY POSITIVE REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0071812,0.15742089236065102,0.658345302622411,-0.9184494927216591,-1.22863788970404,1188,1,TNFRSF11A
EMBRYONIC LUNG DEVELOPMENT%GOBP%GO:1990401,0.7963723023963991,0.9828568923066779,-0.598753859726511,-0.8009712940082919,6014,1,PDGFA
MITOCHONDRIAL L-ORNITHINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1990575,0.609773799443571,0.9508825506493929,0.562605779708036,0.919563691247897,5040,2,SLC25A29
DENSE CORE GRANULE EXOCYTOSIS%GOBP%GO:1990504,0.0416112253538164,0.402998391331252,0.8712985938792389,1.4241136157230498,343,2,UNC13B|UNC13A
ER-DEPENDENT PEROXISOME LOCALIZATION%GOBP%GO:0106101,0.422878326492784,0.873470206885489,-0.7874944861049851,-1.05345538456823,3193,1,PEX16
GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035860,0.10900708052033599,0.58452352834625,-0.6110937296440511,-1.40538791622946,661,4,GDF15|RET|SULF2
CELL CYCLE COMPRISING MITOSIS WITHOUT CYTOKINESIS%GOBP%GO:0033301,0.14416107382550303,0.6340340930337739,0.928870754300838,1.2339633572263797,1073,1,E2F8
SPLICEOSOMAL COMPLEX DISASSEMBLY%GOBP%GO:0000390,0.640237564959169,0.960810495970452,-0.5064240419079129,-0.8662112013466821,4311,2,TFIP11|DHX8
REGULATION OF MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0060236,0.43296162964263796,0.878651088001772,0.23526643413646303,1.0231749133319998,4930,34,GNAI1|TPR|FSD1|PSRC1|BORA|CCSAP|NUMA1|GPSM2|CEP97|PLK1|CLTC|DYNC1H1|TPX2|SMC3
TRANSDIFFERENTIATION%GOBP%GO:0060290,0.133927245731255,0.620064052713254,-0.7775192494740981,-1.32990503495803,901,2,INSM1
CELLULAR RESPONSE TO ALKALOID%GOBP%GO:0071312,0.146560124732021,0.638396166672015,0.40227266813384494,1.3328543585453,1503,14,RYR2|CRHBP|CASP6|ADCY8|BLM|RAD51|SLC8A1|TRPV1|SPIDR|GSTM2
NEGATIVE REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030886,0.54627300410433,0.930420772651609,-0.721217468019409,-0.964794596705817,4125,1,HAVCR2
REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010830,0.36587747132047793,0.8510019955058101,-0.22218511403073699,-1.06503589763486,1498,24,SIK1|FAM129B|FLOT1|NOTCH1|HDAC4|HDAC5|EHD1|EHD2|BHLHE41|CFLAR|RBM24
INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032607,0.8511849596186949,0.991298302704726,-0.5727282752536391,-0.7661560761455141,6428,1,IRF7
REGULATION OF XENOPHAGY%GOBP%GO:1904415,0.602227171492205,0.9508825506493929,-0.52031982354563,-0.8899791916275358,4055,2,LRSAM1|OPTN
MOTOR BEHAVIOR%GOBP%GO:0061744,0.0923802042419481,0.5622489437340121,-0.7182640344104999,-1.45769551727444,587,3,DCTN1|C12orf57|PRKAA1
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF GRAM-NEGATIVE BACTERIUM%GOBP%GO:0070963,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
CITRULLINE METABOLIC PROCESS%GOBP%GO:0000052,0.12225274725274698,0.607607158836689,-0.5401623354543289,-1.36738508357855,711,5,ASS1|DDAH2|DDAH1
POSITIVE REGULATION OF LIPID TRANSPORT%GOBP%GO:0032370,0.733963112910481,0.9734087938149171,0.19495728988293498,0.7994473844075402,8157,28,SIRT1|GHRL|ABCA7|ABCB4|LDLRAP1|UCN|APOE
SENSORY PROCESSING%GOBP%GO:0050893,0.815741808002635,0.986631695793843,-0.317211713450615,-0.72952067308825,4953,4,SHANK1|BBS4|TTC8|CHRNA7
INTRASPECIES INTERACTION BETWEEN ORGANISMS%GOBP%GO:0051703,0.6144849302744039,0.9511905259737851,0.21663310212185,0.8883318339693621,6829,28,GNG8|OXTR|MSS51|DNAJC9|DRD4|NLGN4Y|NRXN3|NPAS4|SHANK1|NLGN3|CIC
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, 3'-5' EXONUCLEOLYTIC NONSENSE-MEDIATED DECAY%GOBP%GO:0070478",0.9218791946308729,1.0,0.5419056021173361,0.7198974162899691,6867,1,SKIV2L
"CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0002361",0.7111406798112979,0.9703327035763342,0.523683484973808,0.8559462697627859,5878,2,PLA2G2D|FOXP3
MACROPHAGE CHEMOTAXIS%GOBP%GO:0048246,0.563395113732098,0.9377667552605741,0.352323933231785,0.9170251749028281,5349,7,AZU1|CCL5|CCL2
POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051388,0.0210512379187078,0.305521822078509,-0.990130127922364,-1.3245272609362702,158,1,TMEM108
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034123,0.19670691547749697,0.7103495916316691,-0.300770813303441,-1.2317575666820602,895,16,MFHAS1|CYBA|TLR1|FLOT1|PJA2|NR1H3|WDFY1|CAV1
REGULATION OF SPINDLE ASSEMBLY%GOBP%GO:0090169,0.7317744154057769,0.972734844328856,0.202062440493607,0.7952162882733421,7979,24,TPR|SPAG5|CCSAP|NUMA1|GPSM2|CEP97|PLK1|DYNC1H1
RESPONSE TO OLEIC ACID%GOBP%GO:0034201,0.160201244538594,0.661454203640901,-0.9171812968681079,-1.22694138544377,1209,1,DGAT2
REPLICATION FORK REVERSAL%GOBP%GO:0071932,0.26738255033557,0.782077431315327,0.868659020732245,1.15397475541638,1991,1,DNA2
MESENCHYMAL CELL DIFFERENTIATION%GOBP%GO:0048762,0.825085324232082,0.9876441563834109,-0.115861027855013,-0.8097887340763299,1933,83,SEMA7A|HGF|NOLC1|EFNA1|SNAI1|SEMA6B|PDCD4|LIMS1|S100A4|ACVRL1|SEMA3A|CORO1C|SEMA3G|OLFM1|RBPJ
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901031,0.888919770242728,0.997300970905927,0.171103674363467,0.655287382034245,9594,22,NR4A3|DHFR|FBLN5|HDAC6|NFE2L2|SZT2|RIPK1
RESPONSE TO LEAD ION%GOBP%GO:0010288,0.288576449912127,0.7980646072929201,-0.412553085875021,-1.13243051981298,1641,6,MAPT|PPP5C|PPP1CA|ANXA5|PPP2CA|PPP2CB
POSITIVE REGULATION OF HEART INDUCTION BY NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090082,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
SPECIFICATION OF AXIS POLARITY%GOBP%GO:0065001,0.53659126648119,0.9265056012720759,0.5908407776465251,0.9657130197175899,4435,2,AHI1|BCOR
"NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033159",0.44260312084190206,0.880474508620148,0.625831408637913,1.02290424482415,3658,2,PDE2A|GAS6
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1901228,0.636822568671121,0.959271399361425,-0.5075604003180779,-0.868154881547806,4288,2,GREM1
NEGATIVE REGULATION OF EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:1903016,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
NEGATIVE REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900272,0.43545962199312704,0.878651088001772,0.415731747476681,1.0224316874228199,4054,6,AGER|APOE
NEGATIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071650,0.16748329621380803,0.671108364044733,-0.7552247036118,-1.2917714082800702,1127,2,MUL1|SIRPA
REGULATION OF SECONDARY METABOLIC PROCESS%GOBP%GO:0043455,0.773410652920962,0.979988815839637,0.306724713829007,0.7543447635113871,7201,6,CDH3|SP1|RAPGEF2|PGAM1|TIGAR|ZEB2
MEMBRANE RAFT LOCALIZATION%GOBP%GO:0051665,0.45957516877984494,0.890371861972445,-0.42660349281577503,-0.9810989128849259,2790,4,RALA|MAL
"POSITIVE REGULATION OF INOSITOL 1,4,5-TRISPHOSPHATE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0031587",0.606784126461387,0.9508825506493929,-0.377627394630659,-0.868464118524457,3684,4,HAP1|HTT
SIGNAL TRANSDUCTION BY TRANS-PHOSPHORYLATION%GOBP%GO:0023016,0.828759986106287,0.9876441563834109,0.3910515141184871,0.7433477912640509,7157,3,STK39|WNK1
DIAPEDESIS%GOBP%GO:0050904,0.759194630872483,0.977664504547119,0.62323555359506,0.827940628441751,5655,1,FER
SOFT PALATE DEVELOPMENT%GOBP%GO:0060023,0.92115317818687,1.0,0.33599867651924603,0.6386981383290289,7955,3,COL11A2|SOX11|TBX1
NEGATIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0045736,0.8640443001718541,0.9921950946571959,0.19049281779006103,0.67184065879666,9049,17,CDKN2A|MEN1|APC|PLK1|INCA1|TFAP4
REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0007346,0.000743042420967306,0.0848656933354452,0.22363384219369398,1.51324671042306,10,476,KIF25|BTG2|SIRT1|EDN1|ASNS|MUS81|AKAP9|TAOK3|EME2|CCNA1|BRINP3|SDCCAG8|CEP63|GNAI1|ANAPC15|CEP70|CENPJ|HES1|CCNB1|RCC1|PIDD1|TPR|FSD1|CDC7|BMP4|PSRC1|CDK1|BTRC|INS|KIF14|E2F8|XRCC3|ZWINT|ANAPC5|MKI67|CEP85|PKD2|BORA|MEIS2|ANKRD17|BLM|CENPF|TTC28|NAA10|CCSAP|WEE1|LSM11|CKAP5|CEP290|CDK2AP2|KIF20B|BRINP1|CEP131|CEP152|NUMA1|ORC1|CDC25C|USP47|USP44|MUC1|FAM178A|CDC45|BUB1|RAD9A|DTL|TOP2A|CDK10|E2F7|DONSON|PPP1R10|KIF11|HMMR|DLGAP5|NEK2|DACT1|CDC23|CDC20|YTHDC2|CCNE1|PKMYT1|UBD|GEN1|HAUS5|ANLN|APC|NDC80|ZNF830|DBF4B|GPSM2|ANAPC7|NEK11|NUSAP1|CDK5RAP2|CUL9|CENPE|ANAPC16|TAL1|PRKAR2B|NABP1|PTTG1|FBXO5|RB1|BUB1B|NAE1|INO80|GTSE1|ESPL1|AURKB|CDC6|MSH6|DDB1|RAD51C|HRAS|NIPBL|CDKN2B|CEP72|INTS3|CCNB2|CCL2|ASUN|CDCA5|HAUS8|OBSL1|CEP164|CEP78|CCNI2|KLHL22|PIN1|TAOK1|CEP192|MAGI2|RPS27L|CDK13|FGFR1OP|CCNF|CHEK2|CEP97|TOPBP1|CNTRL|PLK1|KNTC1|PRMT1|EME1|CKS2|BRSK1|CLTC|GBF1|SFI1|PKN2|CARM1|GAS1|PEBP1|RNF40|AURKA|CDC73|CHFR|ARID3A|E4F1|CEP41|CLSPN|CEP57|UBE2C|ANKRD32|CCNE2|DYNC1H1|CUL7|NINL|TNKS1BP1|CNOT3|ANAPC10|CDK5RAP3|TAOK2|E2F1|TUBB4A|CEP135|TOP2B|C5orf45|TEX14|PRKDC|DUSP1|FHL1|FZD3|CHEK1|RBX1|RECQL5|FAP|PCM1|FBXL7|RPS6KB1|ZNF268|RAD17|TPX2|MAD2L1BP|NEDD1|SMC3|PPP2R1A|PDXP|CASP2|CDK2|ATM
CALCIUM EXPORT FROM THE MITOCHONDRION%GOBP%GO:0099093,0.314922048997773,0.8164430838831159,-0.6716094525481701,-1.1487519994821298,2120,2,LETM1
REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0060628,0.467939406515875,0.8957057061714878,-0.25890265148139896,-0.9750224367176071,2254,13,INSIG1|RINT1|STX18|RNF139|TBC1D20|SEC23A
POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032414,0.792164674634794,0.9819233677232551,0.157033848452773,0.772022708861458,9543,55,RYR2|AKAP9|CACNB2|STK39|ATP1B3|ACTN2|LRRC55|PKD2|CACNA2D1|STAC2|STAC3|WNK3|ANK3|DRD4|DMD|TCAF1|P2RY6|RNF207|GBAS|NLGN3|WNK2|GSTM2|ABCB1|KCNIP2
RESPONSE TO RADIATION%GOBP%GO:0009314,0.7060597559264972,0.968941691852291,0.13868523306417402,0.8863560712682779,10066,247,GTF2H2|PTPRK|SIRT1|UNC119|INTS7|REV1|LIG4|ATR|RGS14|RBM4B|BLM|SPRTN|ECT2|MTA1|MAPK10|USP47|ST20|DDB2|CLK2|MBD4|PNKP|RAD9A|DTL|POLD1|MEN1|PARP1|TMEM161A|FEN1|GEN1|NABP1|INO80|AURKB|MSH6|DDB1|RAD51|ZBTB1|NF1|CLOCK|GRIN1|HRAS|NIPBL|INTS3|STK11|H2AFX|MAP4K3|CIRBP|METTL3|XRCC4|PRIMPOL|MAP3K4|BRCC3|RAD51AP1|MC1R|MAP2K7|MFAP4|TOPBP1|FANCD2|ZRANB3|NPHP4|CUL4B|CNGB1|IKBIP|BRSK1|KDM1A|CASP9|SLC24A1|PAXIP1|CCL11|CARD16|CAT|ERCC5|MAPK13|TNKS1BP1|JUNB|C5orf45|UBE2B|CHEK1|XPA|RECQL5|REEP6|HIST3H2A|CRYAB|SPIDR|RAD1|ATM|GNA11|CDKN2D|RFWD3|UIMC1|BRCA1|RBM4|AKT1|BRE|PPM1D|EYA3|CDS1|MDM2|YY1|TLK2|HYAL2|RNF8|TAF1|COL3A1|MAPK14|CERS1|EEF1D|HYAL3|USP1|TICRR|RHOB|ANXA1|TRIAP1
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000565",0.5430954587581089,0.929698169790548,-0.723588442876048,-0.96796632206196,4101,1,C10orf54
REGULATION OF VESICLE-MEDIATED TRANSPORT%GOBP%GO:0060627,0.007952286282306159,0.19847993048827997,-0.155585718988008,-1.40363524960502,3,307,RAB3D|VPS28|RAB33B|IL1B|CLU|CBLL1|VEGFA|MTMR2|NEDD4L|FCER1G|NECAB2|CLIP3|RINT1|RAB21|SIRPA|LGALS9|ITGAM|ARRB2|CD300LF|NR1H3|LAMP1|TNK2|FGR|NAPB|ABL1|RAB8B|STX18|VPS4A|SYN1|CAMK1D|VPS18|NRP1|ARHGAP1|BMP2K|VPS11|RNF139|TBC1D20|EHD1|LYN|FCGR2B|ARRB1|NAPA|VAMP2|SLC11A1|HAP1|VPS4B|VAMP3|RALA|RAB8A|PTPN1|LRPAP1|VPS16|SNCA|TBC1D5|RAB2B|FMR1|EHD2|AP2S1|LGALS3|LMAN2|MSN|RAB5C|NR1H2|DYSF|DKK1|SNX6|GAB2|B2M|SEC23A|RALB|ANO6|MAPK3|RAB7A|PARK2|RAB5A|ADRA2A|LYAR|KIAA0226|GREM1|ACSL3|RAC1|MCTP1|CD22|MAP2K1|CDH13|BICD1|TNF|RSG1|SNX12|CAV1|CPLX1
NEUTRAL LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046460,0.544731415103604,0.9298388956432471,0.28896676488806605,0.932603159674112,5546,13,LPL|GPAM|DGAT1
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002762,0.07981220657277,0.534078458829271,0.36927812545847605,1.43619769610809,866,23,CARTPT|CEACAM1|CDK6|INHA|TMEM178A|FBN1|ZNF675
PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX%GOBP%GO:0030150,0.5176678445229679,0.923376778065417,-0.222608587599358,-0.936711332773254,2343,17,TIMM50|ROMO1|TOMM20|TIMM23|DNLZ|TIMM23B
GLUTATHIONE TRANSMEMBRANE TRANSPORT%GOBP%GO:0034775,0.350589169866278,0.842847021021096,-0.8242170269078081,-1.1025802470610502,2647,1,ABCC1
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS%GOBP%GO:1902219,0.40415738678544894,0.865585453523601,-0.6119742487123521,-1.0467491771781898,2721,2,ARHGEF2
REGULATION OF PROTEIN TETRAMERIZATION%GOBP%GO:1901090,0.38752783964365295,0.859991269020751,-0.622260045037875,-1.06434248092098,2609,2,PEX5
POSITIVE REGULATION OF BINDING%GOBP%GO:0051099,0.00544069640914037,0.17000636458825197,-0.208752859056081,-1.58950770392977,9,116,FAM65B|STK3|PSEN1|EDF1|GPSM1|RAN|NCBP1|PARK7|RPL11|CEBPG|TRAF6|SYAP1|FAM129B|FLOT1|FOXC1|TXN|EIF3D|ADD1|PINX1|RARA|CDK9|CTNNB1|SKI|ABL1|NRP1|TCF7L2|EIF4G1|NMD3|H1F0|PPARG|AMFR|MMP9|POU4F2|PPP2CA|PPP2CB|IGF1|RIPK2|DPH3|PLAUR|FMR1|LGALS3|STK4|GNL3L|B2M|RALB|PARK2|MET|DDRGK1|TWIST1|CAV1|FKBP1A|LARP6|TRIB3
LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002521,0.966666666666667,1.0,-0.08884889200481198,-0.7094744881395891,1275,152,CBFA2T3|BATF|IL11|VEGFA|FCER1G|TYROBP|IKZF1|LGALS9|PTK2B|VPRBP|CR2|CEBPA|HDAC4|NFAM1|TCTA|HDAC5|THOC5|RELB|IL6|PPARG|LYN|FCGR2B|SBNO2|MMP9|FOXP1|CAMK4|CDC42|TNFRSF11A|LEPR|KLF6|ADAM17|STAT3|GAB2|OSCAR|MYH9|IRF2BP2|TPD52
MICROTUBULE POLYMERIZATION%GOBP%GO:0046785,0.146208742194469,0.6375525442275519,0.312426014875385,1.30998079845172,1638,30,AKAP9|CENPJ|FGF13|CKAP5|TUBGCP3|CETN3|TUBG2|TUBGCP6|PIN1|CEP192|TUBGCP2
NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046597,0.776326699834162,0.980802382590629,-0.208306476872454,-0.7588813904555841,3744,12,TRIM11|GSN|SNX3|IFITM2|IFITM3|IFITM1
POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000353,0.7267827529021558,0.972554563883587,-0.21743967151203603,-0.792154534677747,3505,12,ECSCR|PDCD4|ANO6
STARTLE RESPONSE%GOBP%GO:0001964,0.18047093693397,0.686059302700865,-0.5553408183165339,-1.2771678673673301,1095,4,DRD2
ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050851,0.93759773624246,1.0,0.115182435828825,0.675143404679202,12590,133,IGHV3-21|IGHV4-61|PAG1|IGHG1|LIME1|CD38|ERMAP|IGLL5|GRAP2|IGHG4|SKAP1|EIF2B5|PAK3|PDPK1|EIF2B1|PRKCB|PRKCQ|MAP3K7|IGHV1-18|IGHV3-43|CARD11|PLEKHA1|EIF2B4|BTN2A2|PLCG1|PRAM1|CD3D|BTN2A1|IGHV1-24|LAT|TRAT1|PTPRJ|CD79A|CD3G|CD3E|PTPN22|IGHG2|ZAP70|BTN3A2|CTLA4|LCK|BTK|GATA3|IGHV1OR15-1|HLA-DRB1|CHUK|NFKBID|RC3H1|NCK1|SLA2|BTN3A3|CSK|WNK1|BTN3A1|STOML2|MNDA|HLA-DRB5|IKBKG|WAS|HLA-DPB1|IGHV3-74|BTNL9|HLA-DQA1
MATURATION OF 5S RRNA%GOBP%GO:0000481,0.5903614457831329,0.945418171231938,-0.698775915306573,-0.9347738474046491,4458,1,SART1
REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033860,0.23969072164948496,0.7525035503527309,0.492050290318378,1.210126028817,2231,6,INS|AGTR1|RFK
CYTOSOLIC TRANSPORT%GOBP%GO:0016482,0.996298581122764,1.0,-0.0783164794470914,-0.606224839531208,1614,127,STX8|GCC2|EHD3|RAB6A|HEATR5A|TBC1D14|VAMP3|BECN1|YKT6|RBSN|TBC1D5|SNX6|TRAPPC10|SNX8|RAB7A|RAB5A|VTI1A|VPS53|DOPEY2
5-METHYLCYTOSINE METABOLIC PROCESS%GOBP%GO:0019857,0.790783836980433,0.9819233677232551,0.40801808757031,0.775599462579433,6829,3,TET2|TET1|TET3
POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090314,0.5303213336554721,0.9265056012720759,-0.20097350934989497,-0.9443577144173159,2194,23,ITGAM|MYO1C|FYN|PRNP|CHP1|MIEF1|CEMIP
L-SERINE CATABOLIC PROCESS%GOBP%GO:0006565,0.0013736263736263698,0.0951825371281438,-0.813801317440765,-2.06008399591415,7,5,SDS|CBS|SDSL|SHMT2
DNA LIGATION%GOBP%GO:0006266,0.0965808606798978,0.569411047960053,0.45303705822845103,1.42813470766852,982,12,C9orf142|LIG4|TOP2A|XRCC4|LIG1|XRCC1|MGMT|POLB|HMGB2|HMGB1|LIG3
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:0044335,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION%GOBP%GO:0048667,0.8378225920180509,0.9891060697470021,0.12615348598930198,0.799402578011583,11881,231,DOCK10|BTBD3|SLITRK6|LGI1|PSPN|SLIT1|NEXN|BRSK2|VLDLR|STRC|ARTN|CXCR4|EFNA2|EVL|IGSF9|DSCAM|PLXNC1|ADGRB1|PTPRO|DFNB31|EPHA5|PAK3|DVL1|CDK5R1|ROBO2|SPTBN5|PDZD7|CELSR2|PRKCQ|GFRA3|SRC|CTNND2|NTN3|MAP6|PLXNA3|GPC1|RB1|CHN1|DOCK7|BSG|PALLD|ULK1|APBB1|SEMA6A|PLXNB2|RNF165|SHTN1|PLCG1|ANK3|GAP43|FARP1|UNC5A|PLXNB3|DLG4|SPTBN4|EFNA4|SZT2|SPTAN1|BRSK1|PLXNA2|TBCD|NRXN3|S100B|DOK6|SLITRK1|EFNA5|SPTBN2|TAOK2|RAP1GAP|FGFR2|NRP2|MYCBP2|SHANK1|VSTM2L|RAB3A|UNK|PTK2|PDLIM7
REGULATION OF CELLULAR GLUCURONIDATION%GOBP%GO:2001029,0.6084999338011391,0.9508825506493929,-0.6895125716806351,-0.9223819901992529,4595,1,PRKCE
NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050860,0.9099398215397391,1.0,-0.173537793882082,-0.65354001469414,4384,13,PRNP|LGALS3|DUSP3
PROTEIN IMPORT INTO MITOCHONDRIAL INNER MEMBRANE%GOBP%GO:0045039,0.673166202414113,0.9647315640607691,-0.266577310000083,-0.8286383492229809,3624,8,ROMO1|C19orf52|TIMM22
"NEUROTRANSMITTER RECEPTOR TRANSPORT, ENDOSOME TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098887",0.559077164296114,0.936434965680841,0.44084665080049795,0.9341961649124699,4991,4,LRRC7|ARHGAP44|SCRIB
PENTITOL METABOLIC PROCESS%GOBP%GO:0019519,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE ACTIVITY%GOBP%GO:0090216,0.5981208053691279,0.949262093257606,0.7063850904278779,0.938401078560317,4455,1,DGKZ
GLYCEROPHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0046475,0.532254921068018,0.9265056012720759,0.284502002659967,0.942643545780339,5461,14,ENPP2|PLA2G4A|PNPLA6|PLA2G4B|SMPD4|INPP5F|PLA2G4C|PNPLA8
REGULATION OF SYNAPTIC VESICLE RECYCLING%GOBP%GO:1903421,0.558550824175824,0.936434965680841,-0.357875579086698,-0.9059382642971421,3252,5,PLAA|ROCK1|TOR1A|CDK5|SNCA
"DNA REPLICATION, OKAZAKI FRAGMENT PROCESSING%GOBP%GO:0033567",0.247207903780069,0.7594820480683381,0.488873785210322,1.2023138771171398,2301,6,DNA2|FEN1|RNASEH2A|LIG1|WRNIP1
"REGULATION OF TRANSLATION AT POSTSYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099578",0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090084,0.547584453323647,0.9305779599215391,-0.312875106166374,-0.9126705656931791,3014,7,DNAJB6|DNAJA4
PLASMA MEMBRANE TUBULATION%GOBP%GO:0097320,0.7318565400843879,0.972734844328856,-0.206508881428557,-0.800070077321067,3468,14,CHMP4A|SNX9|PACSIN1|SGIP1|WHAMM|EHD2|MICALL1
ACTIN FILAMENT ORGANIZATION%GOBP%GO:0007015,0.8912185856224429,0.997300970905927,0.122515379575755,0.735735789179348,12198,156,NEB|FSCN2|RHOBTB1|ITGB1|WASH1|IGSF22|GHRL|SHROOM2|ARAP1|RAC3|EVL|TTC17|HIP1R|PROX1|TRIM27|TCAP|ARHGAP25|PPP1R9A|HSP90B1|FHDC1|JAK2|TNFAIP1|LIMA1|SRC|MSRB2|ITGB5|RUFY3|RHOBTB3|NEBL|LMOD1|OBSL1|MICALL2|DPYSL3|SHTN1|MICAL3|RAC2|ARPC1A|MYOM2|TPM2|ARHGAP17|SAMD14|KCTD13|DIAPH3|PLS3|HIP1|SPIRE2|SPIRE1|WASF1|PDXP|FMN2|WASF3
REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034139,0.25255338904364,0.7640731961913991,-0.379735098979195,-1.18038202711269,1359,8,FLOT1|TNFAIP3|WDFY1|CAV1
CELLULAR RESPONSE TO STEROL%GOBP%GO:0036315,0.789038887769494,0.9819233677232551,0.24897802542182895,0.7347984768710971,7831,10,RORA|GRAMD1B|LRP6|PTCH1|GPLD1|OSBPL7|GRAMD1A|SMO
CELL WALL ORGANIZATION OR BIOGENESIS%GOBP%GO:0071554,0.68852062416838,0.96731875442989,0.5338847532395921,0.872619962497978,5691,2,MPI|MANBA
MEMBRANOUS SEPTUM MORPHOGENESIS%GOBP%GO:0003149,0.0862358606786874,0.55013562738819,0.662417859896962,1.4037267225725503,769,4,BMP4|TGFB2|FGFR2
HEXOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0008645,0.936344086021505,1.0,-0.15764824328705,-0.628715278361386,4353,15,PPARD|SLC2A3|SLC2A6|SLC5A2|SLC2A1
PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0043328,0.9333631985664691,1.0,0.289680979725024,0.613861667806276,8333,4,VPS36|SNF8
SEQUESTERING OF ZINC ION%GOBP%GO:0032119,0.234446919079436,0.7482511903785959,-0.716625310173697,-1.22574921305547,1578,2,S100A9|S100A8
ESTABLISHMENT OF MELANOSOME LOCALIZATION%GOBP%GO:0032401,0.33633369923161405,0.8311444145897029,-0.262106003139032,-1.07341217418452,1531,16,BLOC1S6|MKKS|BLOC1S3|BBS7
L-PHENYLALANINE CATABOLIC PROCESS%GOBP%GO:0006559,0.273537604456825,0.7884684708511421,-0.370611533417495,-1.1520220128786498,1472,8,PAH|PCBD1|QDPR
MESONEPHRIC TUBULE MORPHOGENESIS%GOBP%GO:0072171,0.47199842798192204,0.898272347254494,0.31442621097378304,0.991183782289899,4803,12,CITED1|BMP4|PKD2
POSTSYNAPTIC CYTOSKELETON ORGANIZATION%GOBP%GO:0099188,0.33541202672605797,0.8311444145897029,-0.6583402260821619,-1.12605569826634,2258,2,NOS1AP|ACTB
ENDOCRINE PROCESS%GOBP%GO:0050886,0.23597297804466102,0.750277765814412,0.32408833809743604,1.20350180107319,2514,20,EDN1|TBX3|GHRL|OXTR|AGTR1
MODULATION BY SYMBIONT OF HOST IMMUNE RESPONSE%GOBP%GO:0052553,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001267,0.819765127388535,0.987153241368501,0.233368071263728,0.711952490665876,8236,11,CAAP1|JAK2|FAS
POSITIVE REGULATION OF MYOBLAST FUSION%GOBP%GO:1901741,0.87286596440247,0.9934031064448321,-0.232437936761261,-0.678031773865861,4805,7,FAM65B|FLOT1|EHD1|EHD2
PROTEIN POLY-ADP-RIBOSYLATION%GOBP%GO:0070212,0.6126650722678589,0.9508825506493929,0.324662758691424,0.8851177818525929,5891,8,PARP2|PARP1|PARP10|PARP9|PARP3|TNKS
DNA HYPOMETHYLATION%GOBP%GO:0044028,0.4967562557924,0.911815944636073,-0.7489523599470671,-1.0018964072672099,3751,1,FAM129B
POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION%GOBP%GO:1902732,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
CHEMOTAXIS%GOBP%GO:0006935,0.244107744107744,0.7571583779245891,-0.121610467325855,-1.0954369819740901,144,289,FCER1G|RAB13|CX3CL1|MAPK7|DOK1|PRKCD|LPAR1|C5AR1|ANOS1|CXCL16|BCAR1|ABCC1|ARRB2|VASP|GRB2|SEMA3F|CCR10|SCN1B|RET|CYFIP2|S100A8|CCL14|FGF7|FYN|RHOA|NRP1|FOSL1|PLAU|SEMA7A|FGF2|HGF|IL6|HBEGF|TUBB3|NFIB|SBDS|EFNA1|POU4F2|UNC5C|RALA|PLAUR|PDE4B|LGALS3|TNFRSF11A|SEMA6B|ALCAM|PLXNA1|CXCL8|SHC1|PRKCA|PLXNA4|EPHA8|RELN|ACKR3|CXCL14|GAB2|SCG2|MAPK3|FLT1|FGF10|EPHA7|PTPRM|S1PR1|EFNB1|SEMA3A|MET|SEMA3G|CCL18|MAP2K1|DOK5|PTPRA|PIK3R1|GFRA2|SLIT3|EPHB2
REGULATION OF RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000200,0.768590604026846,0.9792236089291529,0.617887075430084,0.8208354138121079,5725,1,RIOK2
OKAZAKI FRAGMENT PROCESSING INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1903461,0.454362416107383,0.888760596723902,0.7780657256285842,1.0336256045246,3384,1,LIG1
CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0060402,0.553629936195896,0.932816793297168,0.207222863082063,0.93462858563939,6420,39,RYR2|NOL3|F2R|PKD2|IBTK|CACNA2D1|CCR5|CCL21|JPH4|GRIN1|CCL19|SLC8A1|LCK|TRPV1|ITPR2|CHERP|FAM155B|XCL1|GRIN2D|TRPM2|FAM155A|ITPR1|SLC8B1
REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060159,0.11669595782073801,0.596135728622196,-0.5087776409002229,-1.3965604623507801,663,6,DRD2|CAV2
POSITIVE REGULATION OF CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:1904414,0.9284563758389258,1.0,0.5383767093074551,0.715209439627112,6916,1,BMPR1A
POSITIVE REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071158,0.825175389081526,0.9876441563834109,0.145534122716875,0.7576176111581221,10232,71,BTG2|RRP8|CCNB1|PIDD1|CDK1|E2F8|PKD2|CDC25C|MUC1|E2F7|CRLF3|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|GATA6|TNKS1BP1|CNOT3|E2F1|FAP|CASP2|CDK2|ATM|CNOT1|BRCA1|PCBP4|MDM2|ZBTB17|CNOT2|UHRF2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4|RPL23
NEGATIVE REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071623,0.6921752945849329,0.96731875442989,-0.6487097485663871,-0.867798809651677,5227,1,SLIT2
REGULATION OF APPETITE%GOBP%GO:0032098,0.296255060728745,0.801025316037346,0.40377502689687395,1.15223596621241,2926,9,CARTPT|GHRL|NPY
CATABOLISM BY ORGANISM OF PROTEIN IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052363,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
"REGULATION OF SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:1904235",0.560671140939597,0.936434965680841,0.7233127481252758,0.9608887166149591,4176,1,FN1
REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES%GOBP%GO:0048302,0.8838926174496641,0.996316041142784,0.559384649316277,0.7431175506981831,6584,1,NDFIP1
BONE MATURATION%GOBP%GO:0070977,0.0887650882079852,0.556932119338259,-0.466379833416074,-1.44971158750407,477,8,SEMA4D|MBTPS2|PLXNB1|BMP2|XYLT1|RHOA|IGF1|RYR1
POSITIVE REGULATION OF MICROGLIA DIFFERENTIATION%GOBP%GO:0014008,0.6409373758771351,0.96102887115448,-0.6735774150860171,-0.9010650453637808,4840,1,TGFB1
THREONINE METABOLIC PROCESS%GOBP%GO:0006566,0.483267871170464,0.9061819762742349,-0.474679818361231,-0.9633485880073441,3075,3,SDS|SDSL
REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045589,0.0887809187279152,0.556932119338259,-0.33606611629846506,-1.41412756395735,401,17,LGALS9|RUNX1|TNFRSF18|NFATC2|BCL6|DUSP10|CBFB
BOX C/D SNORNA PROCESSING%GOBP%GO:0034963,0.420935412026726,0.8727872721376851,-0.602757099531293,-1.03098373714292,2834,2,FBLL1|FBL
ENDOTHELIAL CELL-CELL ADHESION%GOBP%GO:0071603,0.794488827139053,0.9821466750165508,0.406833919488958,0.7733484836265899,6861,3,NOV|JUP
REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901897,0.0410370879120879,0.402256981537283,-0.6471065783692199,-1.6381073330545801,238,5,CAMK2D|PLN|PDE4B|PDE4D
SCARNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090666,0.9194711538461541,1.0,-0.25215089344804803,-0.638303243083146,5354,5,WRAP53|CCT2|DKC1|CCT4|TCP1
POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030810,0.05416862929816299,0.454914205138535,-0.330500640012182,-1.5010664809632,229,21,PRKAA1|PFKFB4|ENO1|IGF1|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
ATP HYDROLYSIS COUPLED ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0099131,0.502435192458759,0.9160882111977869,-0.468898202271975,-0.951614969933558,3197,3,ATP1A3|ATP1A1|ATP6V1H
"DNA CATABOLIC PROCESS, EXONUCLEOLYTIC%GOBP%GO:0000738",0.814120723469165,0.986276922067025,0.31535407015221695,0.7268443831400091,7471,5,GEN1|ISG20|ERI1|XRN2|ERI3
MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0007019,0.00135239567233385,0.0945022140486112,0.598287974447658,2.0285624001988403,13,15,NCKAP5|KIF14|KIF2C|CCSAP|KIF18A|CKAP5|KIF24|KIF18B|STMN1
DNA METHYLATION ON ADENINE%GOBP%GO:0032775,0.25503355704698,0.7658405690398971,0.8748897220996908,1.1622519642117402,1899,1,N6AMT1
POSITIVE REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048818,0.522197475872309,0.9251240799994541,-0.55376854133615,-0.9471914320094821,3516,2,GAL
CELLULAR RESPONSE TO VASOPRESSIN%GOBP%GO:1904117,0.64993288590604,0.963755998259649,0.680690339655933,0.90426674848389,4841,1,ADCY6
ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT%GOBP%GO:0010248,0.437861915367483,0.878999860395433,-0.592721257237386,-1.0138179663845301,2948,2,BAK1|BAX
PANCREATIC JUICE SECRETION%GOBP%GO:0030157,0.002356637863315,0.12234570424564199,-0.9066946068159258,-1.84010976545308,14,3,COPA|AQP5|AQP1
INORGANIC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098660,0.37816600014032103,0.85417445830931,0.16466252976529,1.05355824866626,5389,251,KCNK2|RYR2|KCNN2|SCN1A|KCNK6|KCNH8|CACNA1G|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|NDUFS7|KCNQ1|NOL3|SLC9A5|SLC9A7|SLC36A1|SLC8A3|ATP1B3|F2R|KCNH1|SLC39A3|ATP5G1|LRRC55|PKD2|KCNC3|KCNC1|IBTK|KCND1|KCNB2|ATP2A1|HCN3|ATP5D|NNT|CACNA1H|CACNA2D1|KCNJ11|MRS2|KCNH2|SLC37A2|MT-ATP8|SLC26A2|CCR5|CACNA1D|CCL21|SLC25A10|MCOLN1|UCP3|NALCN|XPR1|SLC39A7|SLC46A1|SLC40A1|GRIN1|CCL19|TRPM7|ASIC1|ATP2A2|TCIRG1
NEGATIVE REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032687,0.493111033923816,0.910654969509744,0.519234247917875,0.9870096838992309,4258,3,NLRC3|PTPRS
PATTERN SPECIFICATION PROCESS%GOBP%GO:0007389,0.35600686926006103,0.84417352062618,0.184542290503541,1.07673657729715,4767,129,RIPPLY2|HOXC6|HOXD3|SIX3|HOXC5|PBX3|TBX3|LEFTY1|HOXB6|HOXA5|TBX2|HOXB3|HOXD4|BASP1|HOXD8|HES1|BMP4|HOXC4|CFC1|PKD2|AHI1|MTF2|FOXN4|CELSR2|STIL|APC|FBXL15|LEF1|BBS5|BMPR1B|MID1|VANGL2|HES6|SRF|ARL6|LFNG|NPHP3
PHOSPHATIDYLSERINE METABOLIC PROCESS%GOBP%GO:0006658,0.28921475875118297,0.7988134789323442,0.31549363788996504,1.15317751708834,3056,19,PTDSS2|SERINC5|LPCAT4|PLA2G4A|OSBPL5|OSBPL8|PLA2G2D|PLA2G12A|PLA2G4B
ERYTHROCYTE MATURATION%GOBP%GO:0043249,0.684038604305865,0.966495577318169,-0.487565481113868,-0.83395464310838,4606,2,ZBTB7A|G6PD
WYBUTOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0031591,0.6747676111546651,0.9647315640607691,0.40204836987415393,0.851978901424652,6024,4,LCMT2|TYW3|TYW5
D-ASPARTATE TRANSPORT%GOBP%GO:0070777,0.17008220446914402,0.673117535978459,0.6617955222234481,1.25800366947098,1468,3,SLC1A2|SLC1A3|SLC1A1
POSITIVE REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION%GOBP%GO:2000591,0.41728201099764295,0.8709670999109399,-0.49961398477997104,-1.01395173792756,2655,3,PDGFB|PDGFA|PDGFRB
REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0090266,0.00633404794387059,0.17992824699561,0.561298204299322,1.85975537814835,64,14,ANAPC15|CCNB1|TPR|XRCC3|USP44|GEN1|NDC80|CDK5RAP2
PROTEIN METHYLATION%GOBP%GO:0006479,0.985525227460711,1.0,-0.0863486286130213,-0.5949949793091279,2382,78,GSPT1|WDR82|RAB6A|TRMT112|METTL12|DYDC2|PRMT3|COPRS|ASH2L|SNRPB|ETF1|SETD7|METTL21B
PROTEIN-CARBOHYDRATE COMPLEX ASSEMBLY%GOBP%GO:0065006,0.7904923188581109,0.9819233677232551,0.49004687069203207,0.800968147771073,6534,2,HLA-DRB1|HLA-DRA
EXOCRINE SYSTEM DEVELOPMENT%GOBP%GO:0035272,0.655539174389217,0.9640743070248079,0.32348190235769897,0.841955428251636,6224,7,TGFB2|RAB26|FGFR2|TGFB3|IGSF3
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001259,0.10999183228968101,0.584830174998513,-0.250377790169442,-1.33921332927316,403,33,HAP1|ARC|CRACR2A|ADRB2|RELN|HTT|GAL|STAC|EPHB2
SECONDARY PALATE DEVELOPMENT%GOBP%GO:0062009,0.63998821565354,0.96058002537611,0.26604283041724897,0.858619102275928,6516,13,TGFB2|LRRC32|LEF1|COL11A2|CHD7|TGFB3
RESPONSE TO IONIZING RADIATION%GOBP%GO:0010212,0.18786923985821202,0.694498726854041,0.22551632999932603,1.22322910059723,2384,87,SIRT1|INTS7|LIG4|ATR|BLM|ECT2|MTA1|CLK2|RAD9A|MEN1|NABP1|INO80|RAD51|CLOCK|HRAS|NIPBL|INTS3|STK11|H2AFX|XRCC4|BRCC3|RAD51AP1|TOPBP1|FANCD2|IKBIP|BRSK1|KDM1A|PAXIP1|TNKS1BP1|C5orf45|RECQL5|CRYAB|SPIDR|RAD1|ATM|RFWD3|UIMC1|BRCA1|BRE|EYA3|MDM2|TLK2|RNF8|MAPK14|EEF1D|TICRR|RHOB|ANXA1
POSITIVE REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902998,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
POSITIVE REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0060697,0.8913140311804009,0.997300970905927,-0.392059553349876,-0.670596868638383,6002,2,APOC2|PRKCD
LYMPHOCYTE AGGREGATION%GOBP%GO:0071593,0.932036586777816,1.0,0.329265090104617,0.6258982989015229,8049,3,RAC2|ZAP70
S-ADENOSYL-L-METHIONINE TRANSPORT%GOBP%GO:0015805,0.199258572752549,0.711592141628341,-0.8989854433171591,-1.20260023736175,1504,1,SLC25A26
PEPTIDYL-ASPARTIC ACID MODIFICATION%GOBP%GO:0018197,0.7181461115475258,0.971081608033886,-0.39301863902062395,-0.797619650795774,4570,3,ATP13A2|HIF1AN|NAT6
"REGULATION OF ACETYLCHOLINE SECRETION, NEUROTRANSMISSION%GOBP%GO:0014056",0.134383688600556,0.621482342059148,-0.930690339655933,-1.24501284386831,1014,1,CHRNA3
HISTONE H3-K36 METHYLATION%GOBP%GO:0010452,0.545529392392557,0.930420772651609,-0.397617603264766,-0.9144374222820391,3312,4,SETMAR|SETD3|ASH1L|SETD2
GDP-FUCOSE IMPORT INTO GOLGI LUMEN%GOBP%GO:0036085,0.775585859923209,0.980569312633657,-0.608954565505073,-0.8146170891451859,5857,1,SLC35C1
"REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060099",0.7940292096219929,0.9819233677232551,0.29961283036869896,0.7368541218868029,7393,6,ABCA7|F2RL1
NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009116,0.17579570688379,0.678685257108795,-0.18124561211343698,-1.19684182424031,474,67,DHFRL1|ENTPD4|DERA|MOCS3|GMPS|GTPBP1|OARD1|PNP|MTRR|CDA|HPRT1|EFTUD1|NUDT18|MACROD2|CDADC1|UPP1|RHOQ|NT5E|ENPP4|AK4
SPHINGOLIPID MEDIATED SIGNALING PATHWAY%GOBP%GO:0090520,0.5874312647289871,0.945418171231938,-0.43986854124696395,-0.892700135392404,3738,3,S1PR1
PEPTIDYL-LYSINE MODIFICATION%GOBP%GO:0018205,0.828381886357081,0.9876441563834109,0.129354433298735,0.795542097927853,11487,185,CPA4|SIRT4|SIRT1|CTH|PIAS1|JADE3|WDR61|EHMT1|AK6|KAT2A|NAA40|DOT1L|TADA1|OGT|TAF6L|LOXL1|YEATS4|TRRAP|MAP3K7|LOXL3|EP400|EZH2|KMT2B|PAGR1|SUMO2|LOXL2|LEF1|SENP7|DOHH|ING5|PIAS4|APBB1|YEATS2|SIRT3|HDAC6|SETD8|BRPF3|ZNF335|ATAT1|MSL1|PAXIP1|KAT8|BRCA2|METTL20|SMYD2|EHMT2|BAG6|SUPT3H|TOPORS|KMT2D|WDR5|P3H4|BRD1|SENP3|SAE1
CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS%GOBP%GO:0036295,0.1980218005652,0.711592141628341,-0.35220963104694897,-1.23946957320084,980,11,FOXO1|ATG7|ATP6V0D1|CAV1
REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901879,0.9503991846441309,1.0,0.12762583053773,0.5952916524061039,11189,44,NAV3|CAMSAP3|ACTN2|FGF13|SEMA5A|LIMA1|F2RL1|APC
CELLULAR RESPONSE TO COPPER ION%GOBP%GO:0071280,0.23980621719822398,0.7525035503527309,-0.33669009311182396,-1.18485438563897,1187,11,PRNP|SNCA|HSF1|AQP1
SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0007224,0.5225126088950021,0.9251240799994541,0.242872989206236,0.9558261125948591,5697,24,MAP3K10|BMP4|KIAA0586|DISP2|STIL|PTCHD2|SEPT2
NEGATIVE REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:1902083,0.266300078554595,0.7803351796901099,-0.571099253230697,-1.15902896632771,1694,3,ATP2B4|SNTA1
LATERAL MESODERM DEVELOPMENT%GOBP%GO:0048368,0.141116416927384,0.630107155356772,-0.5828048309711579,-1.34032935903975,856,4,SMO|MESP1|CITED2|TBX20
NEGATIVE REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000978,0.11355704697986599,0.589850135782669,0.943317159241288,1.2531547616899499,845,1,HES1
GLUCOSAMINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901073,0.610883092810804,0.9508825506493929,-0.6880789589766211,-0.920464202774609,4613,1,GNPNAT1
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2000116,0.511179645335389,0.918404893008545,-0.12244019934930699,-0.983568242037603,662,157,LGALS9|CIDEB|DLC1|MAGEA3|EIF2AK3|BBC3|RPS3|CYFIP2|S100A8|FYN|DDX3X|TNFRSF10A|MAP2K5|HGF|PPARG|MMP9|BOK|LAMTOR5|RIPK2|CRADD|PLAUR|SNCA|NLRP1|NLRP3|YWHAE|DNAJB6|TNFRSF10B|MTCH1|EPHA7|SOX7|BCAP31|CSNK2A1|AQP1|TNF|PMAIP1|PAK2|EGLN3
PROTEIN ARGINYLATION%GOBP%GO:0016598,0.128285077951002,0.608160579951936,-0.782133995037221,-1.33779831009379,863,2,ATE1|C17orf97
POSITIVE REGULATION OF OSSIFICATION%GOBP%GO:0045778,0.6730818578393639,0.9647315640607691,0.184499683556253,0.8491331245009741,7868,42,CYR61|WNT4|BMP4|ADGRV1|DDR2|SUCO|PKDCC|TGFB2|FBXO5|BMPR1B
REGULATION OF RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:1902866,0.5687159893481529,0.940076901516441,0.491630573012271,0.934538001701283,4911,3,SIX3|DLL4
CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0006348,0.518814403149242,0.9236815018871851,0.50914499123552,0.9678310682960392,4480,3,DOT1L|RIF1|SIRT2
REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0042069,0.0906284053759535,0.560245248761167,-0.497717067278469,-1.45186276694905,498,7,ITGB2|PARK7|CHRNB2|ITGAM|HPRT1|PARK2
NEGATIVE REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0090370,0.4620134228187921,0.8912739660615641,0.7738751654168509,1.02805863223746,3441,1,SREBF2
POSITIVE REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900086,0.0279654359780047,0.34382745748458504,-0.7993272306165209,-1.62221086548123,177,3,VEGFA|GREM1|ACE
CAROTENE METABOLIC PROCESS%GOBP%GO:0016119,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
MYELIN ASSEMBLY%GOBP%GO:0032288,0.30802760624773,0.8111717366855571,-0.380509049680392,-1.10996177956871,1695,7,TENM4|CD9|PMP22
REGULATION OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE ACTIVITY%GOBP%GO:0150073,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
HEAD DEVELOPMENT%GOBP%GO:0060322,0.819732885812181,0.987153241368501,0.12757233421921801,0.8202940721187779,11722,262,NR4A2|SIX3|EGR2|BTBD3|SMG9|SLIT1|SHROOM2|CDK6|BASP1|CXCR4|HES1|CCDC14|BMP4|KIF14|MFSD2A|MYH3|BPTF|PROX1|CENPF|WDR62|AHI1|S100A1|FGF13|CEP290|ARHGAP11B|ADGRL2|EPHA5|NPY|ZDHHC16|CDK5R1|ROBO2|WDR11|ABCB6|SEMA5A|NDUFS4|IL11RA|SLC6A17|RORA|PCDH18|TYRO3|KIRREL3|ARNT2|H2AFY2|STIL|CDK5RAP2|CCDC85C|LEF1|C5orf42|INA|DOCK7|PAFAH1B3|NF1|GRIN1|NIPBL|KLHL17|METTL3|COL4A1|PLXNB2|FGF9|SEMA4C|RTN4R
REGULATION OF B CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002622,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
BUTYRATE CATABOLIC PROCESS%GOBP%GO:0046359,0.678389261744966,0.9647315640607691,0.665416850463167,0.8839765994899631,5053,1,ACADS
CELLULAR AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009063,0.871049504950495,0.9934031064448321,0.134998791163039,0.721045229877146,10996,80,CTH|IDO1|ASRGL1|MCCC2|FTCD|TST|GLS|HRSP12|PCYOX1L|GLS2|CDO1|TXN2|BCKDHA|SARDH|ABAT|GSTZ1|BCAT2|IVD|ADO|HMGCLL1|MCCC1|C9orf41|PHYKPL|PPM1K|CCBL1|AASS|HMGCL|HIBCH|AFMID
T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:0072539,0.746640029059208,0.9749763305090959,-0.266787973115734,-0.7782323538843531,4110,7,RORC|BATF|IL6|STAT3
REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:1900214,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF BROOD SIZE%GOBP%GO:0060378,0.0260402684563758,0.335605358681743,0.987097485663873,1.31131497216352,193,1,TEKT3
REGULATION OF GROWTH%GOBP%GO:0040008,0.14428857715430898,0.6340340930337739,-0.12543892937364398,-1.1434871893103,71,318,ADNP2|ITCH|SOD1|FLCN|NOTCH1|LRP12|RNF6|ZNF639|RAB33B|WWC1|MT1M|VEGFA|KIF26A|PLCE1|NEDD4L|PIM1|GNG4|ATAD3A|DNM2|MSX1|RTN4|TGFBR1|CXCL16|BCAR1|GDF15|VPRBP|OSGIN2|ABL1|SEMA3F|PML|MAP3K13|DCUN1D3|ADAM10|S100A8|SPHK1|FBP1|NRP1|DDX3X|EXOSC4|CPNE6|CCDC85B|EIF4G1|NME6|SEMA7A|FGF2|SH3BP4|ENO1|CDA|POU4F2|PPP2CA|ISLR2|IGF1|SPOCK1|BAP1|ZPR1|JADE1|LIMK1|WNT11|EXOSC9|CDC42|FXN|TFRC|SEMA6B|RFTN1|NET1|ADAM17|MTPN|SLC25A33|STAT5A|BCL2|TBX20|TP53|TWF2|OGFR|BCL6|CDKN1A|MFI2|SYT2|SERTAD2|SFRP2|ACVRL1|DUSP10|H3F3B|SEMA3A|MUC12|PLCB1|SEMA3G|CPNE9|ING1|SESN2|CSNK2A1|OLFM1|SOX17|GAL|RBPJ|SLIT3
REGULATION OF DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:1903775,0.19524870081663,0.7075522394363679,-0.740722360077199,-1.26696592635997,1314,2,HELB|WDR70
POSITIVE REGULATION OF RNA SPLICING%GOBP%GO:0033120,0.922559760956175,1.0,-0.132798668629713,-0.6520804109569829,3704,26,CELF4|RBM3|DYRK1A|HABP4|POLR2A|TRA2B|ZPR1|PIK3R1
GTP METABOLIC PROCESS%GOBP%GO:0046039,0.708509220173295,0.9695170059473192,-0.18975665433824201,-0.816290967107509,3188,18,MOCS3|GTPBP1|EFTUD1|RHOQ|AK4
NEGATIVE REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904527,0.583518930957684,0.9439064862850342,-0.528646264130135,-0.904221122311699,3929,2,MAP2|TTBK2
NEGATIVE REGULATION OF TRANSCRIPTION BY TRANSCRIPTION FACTOR LOCALIZATION%GOBP%GO:0010621,0.815396700706991,0.986631695793843,-0.35908594009370404,-0.72875424650835,5189,3,ID1
LEADING EDGE CELL DIFFERENTIATION%GOBP%GO:0035026,0.628187919463087,0.9555196058074541,0.690008822232025,0.9166459368592471,4679,1,DAB2
PEPTIDYL-HISTIDINE DEPHOSPHORYLATION%GOBP%GO:0035971,0.715704697986577,0.971081608033886,0.6459528010586679,0.858119478208892,5331,1,PHPT1
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0045987,0.5460193765796121,0.930420772651609,0.357470976420096,0.930421846927627,5184,7,F2R|CTTN|SRF
REGULATION OF CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0090034,0.985000604814322,1.0,0.333219395622531,0.544637948072738,8142,2,HDAC6
BONE MINERALIZATION%GOBP%GO:0030282,0.658649789029536,0.9643779777660141,-0.21839639939117603,-0.8461254689812991,3121,14,EIF2AK3|SBDS|IGF1|CLEC3B|TUFT1
REGULATION OF INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE ACTIVITY%GOBP%GO:0010924,0.5371375612339471,0.9265056012720759,-0.7271724746360829,-0.972760790623571,4056,1,PLEK
MELANOSOME ASSEMBLY%GOBP%GO:1903232,0.113617651901861,0.589850135782669,-0.6058283986681601,-1.3932787549510801,689,4,HPS1|HPS4|TRAPPC6A
CELLULAR RESPONSE TO COCAINE%GOBP%GO:0071314,0.07624161073825501,0.525661416287861,0.962781208645787,1.27901188297102,567,1,CRHBP
REGULATION OF AEROBIC RESPIRATION%GOBP%GO:1903715,0.646119505494506,0.963344312748158,-0.33379185112344106,-0.8449719061999549,3762,5,CBFA2T3|GLTSCR2|SHMT2
REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0043496,0.6510600706713779,0.9638156637515591,-0.202822878093036,-0.853455342870083,2947,17,PARK7|AIDA|SYAP1|BAX|HSPA5|LGALS3|GNL3L|BCL2
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900748,0.6878434065934069,0.96731875442989,-0.321696448268255,-0.814353197048116,4005,5,KIAA1462|CCBE1|SMOC2|ROBO1|MYO1C
REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043523,0.3727569331158239,0.852609194081082,-0.15358047074920902,-1.05242864641771,913,76,NTRK1|CDK5|ATF4|HIF1A|BAX|SOD1|FBXW7|AARS|CX3CL1|CRLF1|CTNNB1|NSMF|PTK2B|BHLHB9|FAIM2|DDIT3|UNC5B|PRNP|SOD2|ZPR1|PPARGC1A|BCL2|PARK2|EPHA7|TOX3|FOXO3|EGLN3
ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE%GOBP%GO:0061844,0.403209536909675,0.865238688875249,0.266981624494522,1.05070559352389,4396,24,HIST1H2BJ|CXCL13|CXCL9|CXCL10|RPS19|HIST1H2BF|RNASE6|HIST1H2BK|FAM3A|HIST1H2BG|HIST2H2BE|HMGN2|CXCL11
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS%GOBP%GO:0071379,0.396915267473643,0.8638522656500329,-0.319450573698147,-1.0312150785499499,2032,9,ADCY6|GNG2|PTGER2|AKR1C3|PTGER4|SFRP1|GNB1|AKR1C2|PTGFR
ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION%GOBP%GO:0051295,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
NUCLEAR INNER MEMBRANE ORGANIZATION%GOBP%GO:0071765,0.7582550335570469,0.977664504547119,0.623676665196295,0.8285266255246079,5648,1,TARDBP
PEPTIDYL-THREONINE MODIFICATION%GOBP%GO:0018210,0.530532486565706,0.9265056012720759,0.1870336122869,0.957382448113783,6515,66,GALNT13|GALNT3|MYLK2|STK39|MAP3K10|CDC7|CDK1|MARK2|PDPK1|CDK5R1|CAD|CDK10|PRKCB|NLK|TBK1|ULK1|SBK1|VRK2|MAP3K12|VRK1|VRK3|CHEK1|GSK3A
CARDIAC CONDUCTION SYSTEM DEVELOPMENT%GOBP%GO:0003161,0.5068889660761839,0.917441329747287,0.513607605417866,0.976314028407286,4377,3,MAML1|BMPR1A|MESP1
GUANINE BIOSYNTHETIC PROCESS%GOBP%GO:0046099,0.829250185597624,0.9876441563834109,-0.42657159577855,-0.7296278688658671,5584,2,HPRT1
RESPONSE TO ACTINOMYCIN D%GOBP%GO:0072716,0.5908117898896761,0.945418171231938,-0.382672475596978,-0.8800667507926581,3587,4,MDM2|RPL23|KAT7|TP53
NEGATIVE REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051548,0.7465907586389509,0.9749763305090959,-0.6216916629907371,-0.8316558928026059,5638,1,PTEN
TRANSPORT OF VIRUS%GOBP%GO:0046794,0.0118143459915612,0.23601614471199603,-0.47723638441287103,-1.8489400956332498,55,14,UBA52|CAV2|UBC|CAV1|UBB
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051817,0.473083197389886,0.899200141394915,-0.145329600736052,-0.9958885673480441,1159,76,INPP5K|TBC1D20|RXRA|BCL2L1|ATG7|TNIP1|GAPDH|FMR1|KPNA4|JUN|CAV2|VAPB|PARK2|PC|AQP1
REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903076,0.14609765474817402,0.637387581739859,-0.18340807625946898,-1.2332061425289098,379,71,PPP2R5A|CDK5|RAMP3|RHOG|GPER1|VTI1B|PICALM|PPFIA1|PRKCH|CLIP3|SQSTM1|VPS4A|RANGRF|STX8|PRNP|BCL2L1|LGALS3|RHOQ|ACSL3|PIK3R1|DLG1|TNF|STAC|EPHB2|APPL1
NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:1904180,0.8067556952081701,0.984682960940884,-0.36191704024519505,-0.7344998801501229,5134,3,BCL2
GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006679,0.9265771812080541,1.0,0.53970004411116,0.716967430875684,6902,1,UGCG
MELANOCYTE PROLIFERATION%GOBP%GO:0097325,0.6508724832214771,0.963755998259649,0.6801940891045439,0.9036075017656758,4848,1,FAP
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051153,0.31800061330880103,0.819776173598052,-0.190323663072256,-1.1002631573908301,1036,43,HDAC4|HDAC5|EHD1|IGF1|EHD2|AKAP13|BHLHE41|SOX6|CFLAR|DKK1|GREM1|RBM24
CELLULAR RESPONSE TO METHYLGLYOXAL%GOBP%GO:0097238,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
PRE-REPLICATIVE COMPLEX ASSEMBLY%GOBP%GO:0036388,0.3849716336690979,0.8593496731626808,0.559295772594672,1.06316242799561,3324,3,CDC45|WDR18|ORC3
NEGATIVE REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046882,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
CARTILAGE MORPHOGENESIS%GOBP%GO:0060536,0.29873417721519,0.8023890191280308,-0.28796346730775607,-1.1156467071091298,1415,14,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1|STC1
MODULATION BY HOST OF VIRAL CATALYTIC ACTIVITY%GOBP%GO:0044867,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
POSITIVE REGULATION OF CONNECTIVE TISSUE GROWTH FACTOR PRODUCTION%GOBP%GO:0032723,0.744869588243082,0.9749763305090959,-0.622684164093516,-0.8329835917888979,5625,1,ROCK2
POSITIVE REGULATION OF MAST CELL CHEMOTAXIS%GOBP%GO:0060754,0.8910438003922421,0.997300970905927,0.281479775609578,0.6487691557955091,8177,5,FIGF
MAINTENANCE OF GOLGI LOCATION%GOBP%GO:0051684,0.8080351974065071,0.984682960940884,0.4006286533583321,0.761552925481766,6978,3,ARHGAP21|TBCCD1|UVRAG
VIRAL PROTEIN PROCESSING%GOBP%GO:0019082,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
ACTIVATION OF MAPKK ACTIVITY%GOBP%GO:0000186,0.159284731774415,0.661359103221672,0.329075281004919,1.2950750415761598,1736,24,CARTPT|TAOK3|BMP4|F2R|MAP3K5|MAP3K7|MAP3K4|TAOK1|MAP3K12|TAOK2|ADAM9|TNIK|NGF
SYNAPTIC VESICLE CLUSTERING%GOBP%GO:0097091,0.0640804978154376,0.49514893278583205,-0.967302602558447,-1.29399018425154,483,1,SYNDIG1
POLYAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006596,0.11323701679031599,0.5891668976011399,-0.42991921435225705,-1.38781774991368,579,9,SRM|AZIN1|AMD1|SMS|ODC1|SMOX
POSITIVE REGULATION OF FEVER GENERATION%GOBP%GO:0031622,0.613324175824176,0.9508825506493929,-0.343365215095028,-0.8692062413899609,3571,5,TNFRSF11A|TNF
TRANSCRIPTION-COUPLED NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0006283,0.57137239480928,0.9405138747864158,-0.139312008815667,-0.942871510107386,1452,73,POLR2A|COPS7A|POLR2K|UBA52|POLR2F|COPS2|TCEA1|POLR2I|POLR2D|COPS8|UBC|UBB
PHOSPHOLIPID EFFLUX%GOBP%GO:0033700,0.8125,0.985971473561293,0.29350830400265,0.72184092832812,7565,6,ABCA7|APOE|APOC1|APOC2
NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010936,0.302353453911528,0.805227617550042,0.49591438644661895,1.14300914566621,2774,5,TGFB2|CUEDC2|TGFB3
RETINOIC ACID CATABOLIC PROCESS%GOBP%GO:0034653,0.841255130411757,0.9901937608208321,-0.5775253639170711,-0.772573287912594,6353,1,CYP26B1
REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION%GOBP%GO:0070507,0.132736156351792,0.618193911729853,0.211848653610802,1.25263135539718,1792,141,KIF25|AKAP9|NAV3|CLIP1|CAMSAP3|PRKAA2|GNAI1|KAT2A|CENPJ|TPR|FSD1|PSRC1|XRCC3|CEP85|SPAG5|BORA|CEP295|CCSAP|MARK2|FGF13|CDK2AP2|CEP131|NUMA1|CDK5R1|KIF11|NEK2|STIL|GEN1|APC|MAP6|GPSM2|CDK5RAP2|SKA3|TRIM37|TAOK1|SKA2|STMN1|FBXW5|CCNF|CEP97|PLK1|FAM179B|SKA1|APC2|CAMSAP2|CLTC|TBCD|AURKA|DYNC1H1|EFNA5|TUBB4A|MDM1|PRUNE
POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0010571,0.19873610808454997,0.711592141628341,0.545830575777631,1.25805856242334,1823,5,CDC7|DBF4B|INO80|WIZ|ATRX
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN NOREPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:2000763,0.428322147651007,0.8769245997339999,0.7929532421702691,1.05340300607103,3190,1,HAND2
NEGATIVE REGULATION OF HYDROLASE ACTIVITY%GOBP%GO:0051346,0.938306825476072,1.0,0.111813402449464,0.697916202359,13155,206,THADA|RGS2|SH3RF1|TMEM132D|SIRT1|DPEP1|SERPINA5|CAMSAP3|SIAH2|NOL3|NAIP|SERPINE2|CNST|ELFN2|RNF34|CSRNP3|SERPINA3|CAAP1|DLG3|KLRK1|PPP1R35|ELFN1|USP47|DHCR24|TGFB2|CASC5|SRC|RASA4|PKMYT1|GZMA|ZCCHC9|LEF1|PAM16|ABCE1|BOD1|HRAS|LMTK3|FICD|SERPINB6|CEP192|NEIL1|ATPIF1|FARP1|PLXNB3|APOC1|TIPRL|BIRC2|SFI1|RIMBP2|TNNI3|SYTL2|CARD16|TFAP2B|CSTA
LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0030098,0.9996884249883159,1.0,0.0665223185066093,0.365502119595123,12833,93,DOCK10|ITGB1|LIG4|BLM|JAG2|ITGA4|SLAMF6|RORA|LEF1|KIT|CD3D|LFNG|CD1D|PLA2G2D|PTPRJ|CD79A|CHD7|CD3G|CD3E|PTPN22|CD8A|DNAJB9|ZAP70|LCK|RIPK3|ATM
REGULATION OF CYTOLYSIS%GOBP%GO:0042268,0.48394533179647603,0.9064456896937672,-0.418739315060939,-0.963012946933082,2938,4,P2RX7|GPLD1|LILRB1|RRAGA
DOUBLE-STRAND BREAK REPAIR VIA SYNTHESIS-DEPENDENT STRAND ANNEALING%GOBP%GO:0045003,0.316517759860536,0.8176737565328901,0.490320981005568,1.13011717529941,2904,5,XRCC3|BLM|RAD51
REGULATION OF HAIR FOLLICLE CELL PROLIFERATION%GOBP%GO:0071336,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
REGULATION OF EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:1905535,0.27181252482457297,0.7865607589760191,-0.864137626819585,-1.1559832507319199,2052,1,EIF4G1
MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION%GOBP%GO:0071694,0.641363411822822,0.9612805315220849,-0.368562186287839,-0.847616033124328,3894,4,NBL1
PROSTAGLANDIN SECRETION%GOBP%GO:0032310,0.0933403945452138,0.5622489437340121,-0.9519188354653729,-1.27341084996401,704,1,ABCC4
LONG-CHAIN FATTY-ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0035338,0.8608458390177349,0.9916853046725601,0.20287573912268603,0.6721903687545661,8833,14,HACD1|ELOVL6
REGULATION OF CELL PROLIFERATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1901963,0.54808273859925,0.9305779599215391,0.586269810874308,0.9582419001002049,4530,2,BMP4
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0030201,0.221697239206967,0.73556947110949,0.318570941640931,1.22005280784691,2392,22,HS3ST4|GLCE|B3GAT3|HS3ST5|EXT1|GPC1|XYLT2
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:0061756,0.643636717988696,0.9622492597510809,0.257968829909688,0.8547308990914549,6604,14,ITGB1|MADCAM1|ITGA4
REGULATION OF DIPEPTIDE TRANSPORT%GOBP%GO:0090089,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
CALCIUM-DEPENDENT SELF PROTEOLYSIS%GOBP%GO:1990092,0.6319343307295121,0.9580150657116279,-0.6777679752977499,-0.9066708855281271,4772,1,CAPN3
PROTEIN LOCALIZATION TO SECRETORY GRANULE%GOBP%GO:0033366,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
NEPHRON EPITHELIUM MORPHOGENESIS%GOBP%GO:0072088,0.16483200918924099,0.667429120754799,0.3746359466469079,1.2987612295406001,1721,16,CITED1|BMP4|PKD2|AHI1|KLHL3
EYELID DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061029,0.20263620386643202,0.7169847518722969,-0.450885224201644,-1.2376496657046898,1152,6,HDAC2|SOX11|HDAC1|INHBA|STRA6|TWIST1
DRUG CATABOLIC PROCESS%GOBP%GO:0042737,0.8074103585657371,0.984682960940884,0.146265254245464,0.772612599077082,10132,76,CYP2D7|CYP2C8|ASRGL1|CYP3A5|IDE|OVGP1|HBB|HRSP12|HBA2|CYP2R1|PRDX4|SULT1A3|AMDHD2|PRDX3|HBA1|XPNPEP1
T FOLLICULAR HELPER CELL DIFFERENTIATION%GOBP%GO:0061470,0.173422420193022,0.676682497340677,-0.7526881720430111,-1.2874328068796002,1167,2,GPR183|FOXP1
NEGATIVE REGULATION OF AXON GUIDANCE%GOBP%GO:1902668,0.6270918557084421,0.954953980159321,0.230852117653263,0.8727440502634101,6744,21,SEMA3D|PTPRO|SEMA5A|SEMA3E|SEMA4G|SEMA6A|SEMA4C
CELLULAR RESPONSE TO METAL ION%GOBP%GO:0071248,0.7566772470387858,0.977664504547119,0.147086933055457,0.8175904265407691,9773,99,SYT17|DPEP1|TFR2|CRHBP|PRKAA2|ADGRV1|KCNH1|SYT3|ADCY8|PKD2|RASGRP2|ECT2|MT1F|CACNA1H|SYT15|MT1E|HPCA|RASA4|MCOLN1|CPNE7|FOS
MAINTENANCE OF PROTEIN LOCATION%GOBP%GO:0045185,0.6952752492414389,0.96731875442989,-0.124923215250623,-0.887367082615749,1603,87,HSPA5|OS9|FLNB|PML|SUPT7L|TMSB10|MXI1|ARL2BP|G3BP2|TMSB4X|YWHAB|TWF1|HK1|HK2|BCL3|RANGAP1|TWF2|TAF8|CAV1|NBL1
CELLULAR SENESCENCE%GOBP%GO:0090398,0.568901723671149,0.940076901516441,0.226676351464879,0.921555375870957,6303,27,SIRT1|TBX3|ARNTL|TBX2|CDKN2A|HRAS|CDKN2B|SRF
NEGATIVE REGULATION OF INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903796,0.18644295302013397,0.692707054555662,0.9089104543449491,1.20744698922709,1388,1,ANO9
POSITIVE REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036494,0.436515291936979,0.878651088001772,-0.77977503308337,-1.04312883689707,3296,1,DNAJC3
POSITIVE REGULATION BY SYMBIONT OF HOST PHAGOCYTOSIS%GOBP%GO:0052191,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
RESPONSE TO POTASSIUM ION%GOBP%GO:0035864,0.174329919372412,0.676682497340677,0.557925823604897,1.2859363156474901,1599,5,CRHBP|CACNA1H|DLG4|DLG2|CARF
RENAL TUBULE DEVELOPMENT%GOBP%GO:0061326,0.42390692437605604,0.8740879492662891,0.278474775628322,1.0341158709678,4517,20,CITED1|BMP4|PKD2|AHI1|KLHL3|COL4A1|GPC3|TFAP2B|GATA3|STAT1
REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034182,0.543100759072476,0.929698169790548,0.34383509939734497,0.937386726239516,5222,8,NAA10|FAM178A|ANKRD32|ATRX|TNKS
NEGATIVE REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032345,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
CELLULAR RESPONSE TO SODIUM ARSENITE%GOBP%GO:1903936,0.7632211538461541,0.978421368343614,-0.30228124816651597,-0.7652049072261659,4444,5,HSF1
DOUBLE-STRAND BREAK REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:0045002,0.972938144329897,1.0,0.214990400474593,0.528737579631866,9059,6,SLX1B|SLX4|RAD52|RBBP8
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS INVOLVED IN CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:2000777,0.6169265033407572,0.9520939168601509,-0.5146953405017921,-0.880358814609095,4154,2,SIRT2|PLK3
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072216,0.7506833268254591,0.97622649654938,-0.240658444699822,-0.776867025411373,3844,9,LIF|RET|PAX8
MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1902410,0.541516245487365,0.928807195199472,-0.212434245616215,-0.9316246951933771,2399,19,VPS4A|RHOA|VPS4B|CHMP4B|CHMP1B
INTERLEUKIN-10 SECRETION%GOBP%GO:0072608,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
HISTAMINE TRANSPORT%GOBP%GO:0051608,0.40237564959168504,0.865238688875249,-0.613199314282982,-1.04884458622644,2709,2,ADCYAP1
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:0060734,0.335363431748974,0.8311444145897029,-0.833480370533745,-1.11497210426645,2532,1,EIF2AK3
SUPERIOR TEMPORAL GYRUS DEVELOPMENT%GOBP%GO:0071109,0.320118782479584,0.822183858873702,-0.668651778329198,-1.14369305613348,2155,2,CNTNAP2|GSK3B
COENZYME A TRANSPORT%GOBP%GO:0015880,0.353020134228188,0.842847021021096,0.827911336568152,1.0998432748874498,2629,1,SLC25A42
REGULATION OF INHIBITORY G PROTEIN-COUPLED RECEPTOR PHOSPHORYLATION%GOBP%GO:1904323,0.240169469085132,0.7525035503527309,-0.8796316718129692,-1.17671010712904,1813,1,APLNR
BASE-EXCISION REPAIR%GOBP%GO:0006284,0.148564404249715,0.64074876264986,0.301226983374636,1.31003767596031,1691,34,POLG|TDG|NEIL3|POLE|MUTYH|USP47|MBD4|DNA2|POLD1|POLQ|HUWE1|LIG1|NEIL1|MPG|XPA|XRCC1|POLL|NTHL1|UNG|POLB|APEX2
HISTONE H3-K27 METHYLATION%GOBP%GO:0070734,0.8016575204390191,0.9841161968820359,0.35259139180936894,0.747174840528675,7157,4,EZH2|BEND3|HIST1H1C|CHD5
INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX%GOBP%GO:0021830,0.495365278868814,0.911223412567636,-0.47079557906379,-0.955465639759005,3152,3,DRD2
REGULATION OF CELLULAR RESPONSE TO THAPSIGARGIN%GOBP%GO:1905891,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
PERIPHERAL NERVOUS SYSTEM AXON REGENERATION%GOBP%GO:0014012,0.26201509334039497,0.771967970256231,-0.869320688134098,-1.16291678988256,1978,1,APOD
SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:0071526,0.267077267637178,0.7814605352189592,-0.20763985509115698,-1.14220442155648,953,36,SEMA6B|PLXNA1|PLXNA4|SEMA3A|RAC1|MET|SEMA3G|SH3BP1
PYRUVATE METABOLIC PROCESS%GOBP%GO:0006090,0.0209424083769634,0.30457994047216996,-0.26975229162404196,-1.5853779857411598,67,45,LDHA|SLC16A1|PFKL|GPI|ME2|SLC16A8|PKM|ENO1|SDS|PDHB|GAPDH|PGK1|SLC16A3|HK1|HK2|TPI1|ALDOA|PGAM2
NEGATIVE REGULATION OF NEURON MIGRATION%GOBP%GO:2001223,0.685967073580468,0.9665006495129341,0.398030782296454,0.843465249567544,6124,4,KIAA2022|ADGRG1|COL3A1
SULFUR OXIDATION%GOBP%GO:0019417,0.8295471417965851,0.9876441563834109,-0.426430708564242,-0.7293868888312299,5586,2,MICAL2
NEGATIVE REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902960,0.8541945063103191,0.991298302704726,-0.41328466414915704,-0.7069012839163309,5752,2,BIN1
POSITIVE REGULATION OF GROWTH%GOBP%GO:0045927,0.09688784497944802,0.5696404237080971,-0.160617722750633,-1.2352486124484299,164,123,MAP3K13|ADAM10|S100A8|SPHK1|NRP1|DDX3X|EXOSC4|CPNE6|EIF4G1|SEMA7A|FGF2|POU4F2|ISLR2|IGF1|ZPR1|LIMK1|EXOSC9|CDC42|FXN|RFTN1|ADAM17|MTPN|SLC25A33|BCL2|TBX20|TWF2|SYT2|SFRP2|H3F3B|PLCB1|CPNE9|CSNK2A1|RBPJ
POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038089,0.10733745005448599,0.583590121586455,-0.48272537778996005,-1.40813134359031,590,7,HSPB1|VEGFA|KDR|PRKD2|MYO1C
REGULATION OF SENSORY PERCEPTION%GOBP%GO:0051931,0.126130810023916,0.607607158836689,0.49769226100080105,1.35684262610766,1212,8,ZFHX2|NOV|F2R
SEX DIFFERENTIATION%GOBP%GO:0007548,0.36319632455492695,0.849828746111777,0.21406544563646,1.0743466215923299,4426,60,TBX3|WNT4|INHA|BASP1|DNAJC19|EIF2B5|ROBO2|TGFB2|ZNF830|KIT|BMPR1B|NIPBL|EIF2B4|CENPI|FGF9|FANCF|ING2|NUP107|CDKL2|BRCA2|CEBPB|GATA6|CHD7|WNT2B
PROTEIN LOCALIZATION TO PARANODE REGION OF AXON%GOBP%GO:0002175,0.5893095768374169,0.945418171231938,-0.525999448580094,-0.899693886067727,3968,2,CNTNAP1|EPB41L3
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070373,0.31845238095238104,0.820583457437744,-0.191651562592626,-1.09831633625196,1069,41,EZR|TIMP3|DUSP4|GPER1|FLCN|SIRPA|DAB2IP|CNKSR3|LYN|TNIP1|PTPN1|DUSP3|DUSP10|SLC9A3R1|DLG1|EPHB2
TERTIARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902645,0.249127516778524,0.7613646381106121,0.8781429201588,1.16657369269781,1855,1,CACNA1H
REGULATION OF MACROPHAGE TOLERANCE INDUCTION%GOBP%GO:0010932,0.7615517013107371,0.977763214485385,-0.6161226290251429,-0.8242060262684101,5751,1,IRAK3
POSITIVE REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905941,0.948590782629733,1.0,0.39731753267543896,0.649404592206885,7841,2,ZP3
NEGATIVE REGULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM%GOBP%GO:0044362,0.442471126607104,0.880423444399886,0.44144020357821995,1.01745422948921,4060,5,SUGT1|PTX3|RAB9A|ANXA2|CASP8
REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060191,0.7124072825354009,0.9707100537727641,-0.138232966786408,-0.857430721850365,2112,54,FURIN|GNA13|LPAR1|C5AR1|NR1H3|ABL1|GNAQ|RHOA|FGF2|GNA15|RHOC|SNCA|FGFR1|EDNRA|NR1H2|FLT1|BICD1
MESODERM FORMATION%GOBP%GO:0001707,0.686147604327666,0.9665006495129341,0.24307894606818103,0.824186397410222,7102,15,ITGB1|BMP4|ITGA2|LEF1|ITGA3|ITGA8|KLF4|SCX|KDM6B
MITOCHONDRIAL TRNA METHYLATION%GOBP%GO:0070901,0.7024351924587591,0.968941691852291,-0.39941546266681394,-0.810601814327738,4470,3,HSD17B10|TRMT5|TRMT61B
SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENES INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002204,0.8685271005440259,0.993084774742015,0.224973096984637,0.663953731343196,8620,10,LIG4|EXO1|MSH6
PUTRESCINE METABOLIC PROCESS%GOBP%GO:0009445,0.9732142857142858,1.0,-0.21802376798148104,-0.55191269112223,5667,5,ODC1
REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000392,0.526595744680851,0.9265056012720759,-0.27558385770277505,-0.932341439996033,2672,10,CD44|RREB1|PDPN|ARPIN|CORO1C
CARDIAC LEFT VENTRICLE MORPHOGENESIS%GOBP%GO:0003214,0.7463176751592359,0.9749763305090959,0.254256451795678,0.7756781514435759,7498,11,RYR2|NPY2R
NEGATIVE REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903070,0.41901123075141794,0.87173622607586,0.5469284217492,1.0396533950348499,3618,3,SGTA|SVIP|USP14
CENTROMERIC SISTER CHROMATID COHESION%GOBP%GO:0070601,0.319895402048377,0.8219996514077841,0.48899723544659496,1.12706613802001,2935,5,BUB1|BUB1B|BOD1|SGOL1
CELLULAR RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0071346,1.0,1.0,-0.0618097473248007,-0.450190593860936,2074,98,CX3CL1|PRKCD|SIRPA|LGALS9|PML|CCL14|IRF6|HLA-DQB1|OASL|CAMK2A|ICAM1|GAPDH|OAS3|TRIM25|PDE12|B2M|HLA-DQA2|HLA-DQB2|CCL18
L-LYSINE CATABOLIC PROCESS TO ACETYL-COA%GOBP%GO:0019474,0.855838926174497,0.991298302704726,0.5731693868548741,0.761429959537468,6375,1,PIPOX
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009162,0.518470790378007,0.9236324326350509,0.38715533185666395,0.952152154959379,4827,6,DNPH1|DUT|HDDC2|TYMS
CAMP CATABOLIC PROCESS%GOBP%GO:0006198,0.0238315900966503,0.32397355287938,-0.9889170710189681,-1.3229045177308,179,1,PDE4D
NOTCH RECEPTOR PROCESSING%GOBP%GO:0007220,0.00312377977352597,0.13515773385565,-0.63399282749147,-2.0465856606020303,15,9,APH1A|PSEN1|PSENEN|APH1B|ADAM10|NCSTN|PSEN2|ADAM17
CENTRIOLE ASSEMBLY%GOBP%GO:0098534,0.0544192156126853,0.455860713081275,0.407242423592065,1.51229443534963,579,20,CCDC78|CEP63|CENPJ|WDR62|CEP152|CDK5RAP2|CEP72|SASS6|CNTROB|RTTN|CEP135|CDK2|C2CD3
SPINAL CORD DEVELOPMENT%GOBP%GO:0021510,0.9139888862043969,1.0,-0.14049326818862198,-0.6601661187427299,3782,23,ZPR1|TBX20|RELN|ASCL1
PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE%GOBP%GO:0016254,0.8472758887171559,0.991298302704726,0.201817126178023,0.6842835747432199,8770,15,PIGC|PIGF|PIGQ|PIGB
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034137,0.40228471001757504,0.865238688875249,-0.372011924014227,-1.02114775264505,2288,6,MFHAS1|CYBA|TLR1|PJA2
NEGATIVE REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070164,0.27893956858224894,0.788692060817727,-0.49790966066004905,-1.1450882025465,1693,4,IL1B|RAB11FIP1|RAB11FIP5
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEGATIVE REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0035602,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032071,0.925132577726942,1.0,0.221653493951652,0.6042868904863571,8896,8,SIRT1|GZMA|AKT1|DDX11|HMGB1
NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030853,0.38960287136737304,0.8603316114971841,0.55740416912296,1.0595666887851,3364,3,CEACAM1|C1QC
REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900542,0.012190749372534998,0.23962061927625303,-0.24751489251581896,-1.5881283017449799,33,61,HIF1A|FLCN|CBFA2T3|PPIF|PDK3|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|PPARA|ENO1|IGF1|UQCC2|PDPR|TMSB4X|SHMT2|SNCA|PPARGC1A|PDE12|SLC25A33|NOS3|GUCA1A|AAED1|COX7A2L
PROTEIN HOMOTRIMERIZATION%GOBP%GO:0070207,0.9116156877462941,1.0,0.168006960423892,0.62389372184752,9715,20,SLC1A2|MGST1|DISP1
NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904667,0.7245951417004051,0.972554563883587,0.27820287936661897,0.7938959622481608,7158,9,USP44|FBXO5|RPL5|RPL23|BAG2|RPS7|MAD2L1
PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006655,0.6726090993500461,0.9647315640607691,-0.266753432298012,-0.8291858140099029,3621,8,CDS2
REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000434,0.8827139052911891,0.996220425464008,0.361097895151203,0.6864091126096861,7623,3,DCUN1D1|RPL5|RPL11
PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT%GOBP%GO:0032292,0.7104921077065921,0.9700296616429409,-0.257929723824275,-0.8017578861652571,3825,8,PARD3
ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:0031532,0.942683130318705,1.0,0.12671154577774602,0.6150170579243729,11298,52,RHOBTB1|BRSK2|ARAP1|RAC3|CDC42BPA|FARP2|CTTN|CAPN10|KIT|CXADR|MICALL2|CDC42BPB|ANTXR1
CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061209,0.707995645336882,0.9695170059473192,0.5253240131888761,0.8586276680623691,5852,2,GPC3|BMP2
EPITHELIAL-MESENCHYMAL CELL SIGNALING%GOBP%GO:0060684,0.7963723023963991,0.9828568923066779,-0.598753859726511,-0.8009712940082919,6014,1,PDGFA
AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0003333,0.7131804114327329,0.971081608033886,0.20175677764179104,0.811158886359294,7834,26,SLC1A2|SLC25A29|SLC36A1|SLC25A22
NEGATIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031393,0.277246885206242,0.7884684708511421,0.6966391934603029,1.13863762391271,2291,2,SIRT1|PIBF1
MYOBLAST FUSION%GOBP%GO:0007520,0.38657659620832396,0.859991269020751,0.462391838897314,1.06574464299785,3547,5,KCNH1|CACNA1H
ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002438,0.629948364888124,0.957116960634149,-0.678539920599912,-0.9077035402952429,4757,1,CD6
SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:0044550,0.0768900343642612,0.527286041772797,0.591649325495714,1.4550753506336103,715,6,CITED1|CTH|BDH2|TRPC1
"REGULATION OF MOLECULAR FUNCTION, EPIGENETIC%GOBP%GO:0040030",0.8190604026845641,0.987153241368501,0.592137185707984,0.7866278341003241,6101,1,CTCF
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:1901394,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
POSITIVE REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0031915,0.7393673110720559,0.9744283926676119,-0.28364488781255104,-0.778586171684019,4206,6,EPHB2
POST-GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006892,0.972509398496241,1.0,0.10796018026097198,0.590865066890884,12416,91,CCDC93|DOPEY1|RABIF|KLHL20|AP3D1|AP3B2|OSBPL5|GGA3|GOPC|VPS13A|ARF5|ANKFY1|ANK3|RAB26|GOLGA4|MYO5A|MACF1|VPS13C|GGA2|GBF1|MON2|TRIM23|KIF16B|BBS1|RABEP1|SORL1|SEC16A|IGF2R|SCAMP1|C16orf70|VPS52|AP4M1|BBS2|EXOC6|VAMP5|SCFD1|SORT1|VAMP4|EXOC1|VPS54|GOLPH3L|RAB34|SCAMP2|SNAP23|KRT18
REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042129,0.733201267828843,0.973373390498726,0.15424785212015502,0.8253763384238091,9252,81,SH3RF1|IDO1|GLMN|CD209|BMP4|AGER|BLM|MARCH7|CCDC88B|EBI3|CCL5|ZP3|DLG5|CCL19|TMIGD2|BTN2A2|CD55|IL12RB1|CD1D|RASAL3|PLA2G2D|CEBPB|HLA-DMB|IGFBP2|CD3E|CD46
"SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0001963",0.56025277838309,0.936434965680841,0.401725414872894,0.925917528903345,5141,5,CRHBP|SLC6A2|TH
CELLULAR RESPONSE TO ERYTHROPOIETIN%GOBP%GO:0036018,0.286905175408128,0.796019542850327,0.601007377670519,1.1424518013486398,2477,3,KIT|MT2A|MT1X
RHODOPSIN MEDIATED SIGNALING PATHWAY%GOBP%GO:0016056,0.39650913881113103,0.8638522656500329,-0.44949300036763506,-1.03373999846858,2407,4,PDE6B|GNGT1
POSITIVE REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0090045,0.41458699472759203,0.8695737743071128,-0.367767911312117,-1.00949822274237,2358,6,PRKD1|FNTA|MAPK8|C6orf89|VEGFA|PRKD2
DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0060997,0.37341772151898706,0.852609194081082,-0.271146853474798,-1.05049469313016,1769,14,ARC|CDC42|ZNF365|EPHB2
SECOND-MESSENGER-MEDIATED SIGNALING%GOBP%GO:0019932,0.000865051903114187,0.0849637591935908,-0.215928765056128,-1.78282121604069,0,180,GNA13|PLCE1|ADCY7|KDR|PPP3R1|MAPK7|ADRA2C|FKBP1B|DGKD|UCN2|PRKAA1|PTGFR|EIF2AK3|CRHR1|CCR10|GNAQ|CALCRL|GUCY1A3|SPHK1|ADRA1B|NUDT4|SLC9A1|DGKQ|GNAL|PRNP|INPP5A|VIP|ABCA1|PPP2CA|PRKAR2A|GCGR|CETN2|RAMP2|AKAP13|CXCL8|ADRB2|PDE9A|MC4R|NFATC2|ACKR3|GPR161|GPR3|PRKAR1B|CALCB|DDAH2|ADCY2|NOS3|ADCYAP1|DRD2|UCN3|ADRA2A|GNAS|MCTP1|CD36|BCAP31|ADM|PDE3A|AQP1|PDE4D|HRH1|GAL|DDAH1|RAMP1
REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1901608,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
REGULATION OF MITOCHONDRIAL MRNA STABILITY%GOBP%GO:0044528,0.824962950765684,0.9876441563834109,-0.313750483285807,-0.7215605667855022,5009,4,PDE12
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010719,0.00728798586572438,0.19188606346941398,-0.45083672548845394,-1.8970690868200701,32,17,VASN|MAD2L2|STRAP|SDHAF2|FUZ|DAB2IP|EFNA1|LDLRAD4|PPP2CA|SMAD7|SFRP2
POSITIVE REGULATION OF BASE-EXCISION REPAIR%GOBP%GO:1905053,0.8752783964365258,0.9938625658817479,-0.401543975737524,-0.686819465179283,5894,2,FAM168A|RPS3
N-TERMINAL PROTEIN MYRISTOYLATION%GOBP%GO:0006499,0.253416762720237,0.7641083395392759,-0.5121050019301819,-1.1777345219571398,1538,4,NMT2|PPM1B|NMT1|PPM1A
KINETOCHORE ORGANIZATION%GOBP%GO:0051383,0.0386126940459815,0.394693762886429,0.504066689737251,1.58899834244982,392,12,CENPF|CENPT|NUF2|NDC80|CENPA|CENPE|POGZ|CENPH|CENPW|CDT1|MIS12|CENPC
SYNAPTIC VESICLE DOCKING%GOBP%GO:0016081,0.20087873462214398,0.714048663678328,-0.451500008875423,-1.2393372083544398,1142,6,BLOC1S6|SNPH|SNAP25
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEURAL PLATE ANTERIOR/POSTERIOR PATTERN FORMATION%GOBP%GO:2000313,0.43664768965973794,0.878651088001772,-0.7796647551830609,-1.04298131478748,3297,1,FUZ
RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0007266,0.32154575282537395,0.822751772025005,-0.167246587711757,-1.08962254366869,881,64,MYO9B|RTKN|RHOJ|RND1|RHOG|ARHGAP5|ARHGDIA|CDC42EP5|GNA13|PDPN|EPS8L1|RHOA|FAM65A|ARHGAP1|ARHGAP29|RND2|RHOC|LIMK1|CDC42|GNA12|ADRA2A|RHOQ|RAC1|CDH13
RESPONSE TO INTERLEUKIN-3%GOBP%GO:0036015,0.522056269538034,0.9251240799994541,0.508185630364514,0.966007424201231,4508,3,MT2A|GSK3A|GSK3B
CELLULAR RESPONSE TO ELECTRICAL STIMULUS%GOBP%GO:0071257,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|PTEN|NSMF
NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903960,0.109311740890688,0.5846370216990561,0.48779845925441706,1.39201013330497,1079,9,STK39|ANO9|GOPC|AKT2|THBS1|AKT1|ARL6IP5
NEGATIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051902,0.8067556952081701,0.984682960940884,-0.36191704024519505,-0.7344998801501229,5134,3,BCL2
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903844,0.863705360709435,0.991943445125448,0.13775607533109302,0.7258020912023679,10810,75,CITED1|SIRT1|ASPN|PEG10|ADAMTSL2|PDPK1|FAM89B|MEN1|FBN1|RNF111|LEMD3|MTMR4|CDKN2B|STK11|NREP|PIN1|HTRA3|BAMBI|BCL9|ING2|SKIL|EID2|LTBP1|WFIKKN1|DAB2|THBS1|ITGA3
PHOSPHATIDYLCHOLINE ACYL-CHAIN REMODELING%GOBP%GO:0036151,0.912393566698202,1.0,0.17046667360892903,0.6230817734816371,9643,19,LPCAT4|PLA2G4A|PLA2G2D|PLA2G12A|PLA2G4B|TMEM86B|LPCAT2|PLA2G4C|PNPLA8
CEREBELLAR GRANULE CELL PRECURSOR TANGENTIAL MIGRATION%GOBP%GO:0021935,0.5939361842976301,0.946787674285595,-0.696901191001323,-0.932265971541653,4485,1,TTBK2
MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0006851,0.92351083032491,1.0,-0.14736018902159698,-0.64624416267094,4092,19,SPG7|MICU1|MICU3|MCUR1|MICU2|MCU|STOML2|C2orf47|SLC8B1|SMDT1|PHB|PMPCB|AFG3L2|SLC25A23|PHB2|CCDC109B|PMPCA|LETM1
POSITIVE REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:1901409,0.4591553025287971,0.890371861972445,-0.7696846052051171,-1.02963056386976,3467,1,CCNK
UTERUS DEVELOPMENT%GOBP%GO:0060065,0.43890693246724205,0.8797794370116179,0.48332742423030195,1.02421698178513,3918,4,TGFB2|NIPBL|GATA3
REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001169,0.198488241881299,0.711592141628341,-0.218486063727093,-1.20186824407095,708,36,EIF6|HIF1A|FLCN|CBFA2T3|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|PPARA|ENO1|IGF1|TMSB4X|PPARGC1A|AAED1
REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902903,0.439450686641698,0.879896414106183,-0.11714405059141801,-1.0127536743347199,351,235,HAX1|CDC42EP5|MAPRE1|PPFIA1|ADD1|CLU|ANKRD53|CLIP3|CX3CL1|PRKCD|LPAR1|TGFBR1|SPEF1|CFL2|PTK2B|VASP|DLC1|PFN1|ABL1|RPS3|DYRK1A|RHOA|NRP1|SLC9A1|INPP5K|COLGALT1|WDR1|RANGRF|TMSB10|MYADM|WHAMM|TRIM54|NAT6|PXN|SLAIN2|CHRNA7|ARPC5|BIN1|SERPINF2|WIPF1|RHOC|TMSB4X|LIMK1|WNT11|ARPC5L|SNCA|ARHGEF2|ARPC4|TWF1|CDC42|AKAP13|MTPN|ARPIN|SSH3|TWF2|SORBS3|PARK2|TMEFF2|RAC1|MET|ACTR2|BRK1|SH3BP1|MID1IP1|JMY
POSITIVE REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905458,0.7077951002227171,0.9695170059473192,-0.476574346472471,-0.815154895951789,4766,2,NUDT21
DETERMINATION OF DIGESTIVE TRACT LEFT/RIGHT ASYMMETRY%GOBP%GO:0071907,0.22882249560632698,0.7427536945778871,-0.43845499918534897,-1.20352953266354,1301,6,CCDC103|DNAAF1
POSITIVE REGULATION OF CELL PROLIFERATION%GOBP%GO:0008284,0.0158730158730159,0.267691462192481,-0.13256763091588303,-1.26825490137667,2,488,PTHLH|RAB25|CRKL|HIF1A|BMI1|MECP2|RHOG|NCK2|NRARP|CNBP|GPER1|STAMBP|NOTCH1|PTPN6|LRP5|RPS4X|ID2|CD274|RPRD1B|MATK|PRKCH|CHRNB2|ICOSLG|IL1B|RARA|PRAME|IL11|VEGFA|PIM1|KDR|C9orf69|CAPNS1|CACUL1|CX3CL1|CRLF1|ZNF16|NES|PTPRN|CTNNB1|IGF1R|RTN4|C5AR1|TGFBR1|LGALS9|GID8|ROMO1|PTK2B|NRAS|HMOX1|PRKD2|PTGFR|LIF|HDAC4|RPS9|RPS3|ADAM10|STXBP4|PDCL3|CCL14|SPHK1|GNAI2|FGF7|ZNF580|NRP1|CIAO1|MMP2|ZNF703|FOSL1|EIF4G1|MFN2|TBC1D8|FGF2|KITLG|IL6|HBEGF|PNP|LAMC1|LYN|APLNR|MMP9|CHRNA7|HTR1B|CD276|MST1R|TCL1A|NAMPT|VIP|MEF2D|IGF1|SERPINF2|FOXP1|CDC25B|VIPR1|TIPIN|FOXJ2|PDCD10|CNOT7|NPM1|CDCA7L|VAV3|FGFR1|HOXC10|FXN|TNFRSF11A|TFRC|ASH2L|ACER3|S100A6|EIF5A|ADAM17|KRAS|SLC25A33|STAT5A|HSF1|BCL2|CTSH|MMP12|SHC1|JUN|PRKCA|TBX20|NFATC2|DNAJA2|MYEOV2|GAB2|RBPMS2|TNFRSF4|SLC35F6|ADCYAP1|SCG2|TSPYL5|DRD2|SSR1|FLT1|CDKN1A|ADRA2A|EAPP|FGF10|GREM1|SFRP2|THBS4|CHRM1|DDRGK1|IGF2|SCN5A|LAMC2|PGF|CSNK2A1|CDH13|AQP1|TNF|INSM1|EIF5A2|RBPJ
MITOTIC CENTROSOME SEPARATION%GOBP%GO:0007100,0.672814095175366,0.9647315640607691,-0.35956543318811,-0.826925380482509,4085,4,NDE1|NUP62|NDEL1|KIF3B
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0008631,0.384535655058043,0.8592509171259929,-0.28737899170667003,-1.04695049375549,1854,12,ARL6IP5|PDK1|PRODH|STK25|DIABLO|GSKIP|CYP1B1|PRKCD|PDCD10|ZNF622|STK24
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904995,0.9234687970360079,1.0,0.334786102897479,0.6363931634320079,7975,3,CCL21|KLF4
POSITIVE REGULATION OF CELL CYCLE%GOBP%GO:0045787,0.273870224208982,0.7884684708511421,0.172038100053448,1.10976503176426,3920,272,BTG2|EDN1|ASNS|TBX3|CCNA1|RRP8|CENPJ|HES1|CCNB1|PIDD1|TPR|CDC7|PSRC1|CDK1|INS|KIF14|E2F8|XRCC3|ANAPC5|PROX1|SPAG5|PKD2|MEIS2|ANKRD17|CEP295|ECT2|THOC1|LSM11|ATAD5|KIF20B|NUMA1|CSPP1|CDC25C|MUC1|MAP10|TGFB2|FAM178A|CDC45|KIF23|DTL|CDK10|E2F7|PPP1R10|EZH2|DLGAP5|YTHDC2|FEN1|CCNE1|GEN1|NDC80|PAGR1|CRLF3|DBF4B|GPSM2|NUSAP1|TAL1|FBXO5|RB1|INO80|GTSE1|ESPL1|AURKB|CDC6|RAD51C|NIPBL|CENPV|CCNB2|CDCA5|CCNI2|CCNF|CHEK2|TGM1|PRMT1|CKS2|RACGAP1|PKN2|CARM1|PEBP1|AURKA|SVIL|CDC73|ARID3A|UBE2C|ANKRD32|CCNE2|DYNC1H1|GATA6|TNKS1BP1|CNOT3|CIT|E2F1
RESPONSE TO AMINE%GOBP%GO:0014075,0.677951002227172,0.9647315640607691,-0.490674356538065,-0.839272208020751,4565,2,DRD2
CORTICAL CYTOSKELETON ORGANIZATION%GOBP%GO:0030865,0.142405063291139,0.6324244126031129,-0.24626621742159302,-1.277637028147,539,30,FMNL2|ARF6|PLEK|EZR|RTKN|PDCD6IP|FMNL1|RAB13|VPS4A|WIPF1|RHOQ|DLG1|TNF
CELLULAR RESPONSE TO ZINC ION%GOBP%GO:0071294,0.7862180132984079,0.981626008042485,0.24972594510865195,0.7370057810930981,7803,10,MT1F|MT1E|MT2A|ATP13A2|ZNF658|P2RX4|MT1X|MT1G
MYOBLAST FATE COMMITMENT%GOBP%GO:0048625,0.104163393558523,0.5762893149145369,-0.707235487876625,-1.4353134097564502,662,3,TCF7L2|EPAS1
RESPONSE TO ETHER%GOBP%GO:0045472,0.585388445061943,0.9439064862850342,0.48577258189037203,0.9234025768160871,5055,3,ABCB4|LARP1|ZC3H12A
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN%GOBP%GO:0035967,0.919047619047619,1.0,-0.0983060164393346,-0.761422775961982,1543,125,DCTN1|CUL3|YOD1|EDEM1|TMBIM6|CTDSP2|UGGT1|TSPYL2|GOSR2|MYDGF|HSPA9|WIPI1|CALR|ATF4|BAX|DNAJC3|CREB3|RHBDD1|ADD1|EIF2S1|KLHDC3|HSPA13|DAB2IP|HSPA5|EIF2AK3|TATDN2|STUB1|HYOU1|DDIT3|AMFR|ATF6|LMNA|PTPN1|BAG3|CREBRF|CXCL8|HSF1|SHC1|ATP6V0D1|ASNA1|HSPA6|KLHL15|SSR1|VAPB|PARK2|HSPB8
FOREBRAIN NEUROBLAST DIVISION%GOBP%GO:0021873,0.571508567588756,0.9405138747864158,0.43711108512370794,0.9262801444035259,5102,4,LEF1|FGFR2|NUMBL|NUMB
NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002832,0.972389063200359,1.0,0.128831691877831,0.53366425093535,10846,29,CEACAM1|SIGIRR|TKFC|MAPKBP1|CACTIN|CARD16|FAM3A|NPLOC4|TARBP2|DHX58
REGULATION OF FERTILIZATION%GOBP%GO:0080154,0.141318477251625,0.630107155356772,-0.431808129051194,-1.34224767756091,760,8,PLCB1|CFAP69|POMZP3
REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051896,0.0225370251126851,0.315499300837852,-0.17983988437824397,-1.4181425922262099,34,136,GAS6|HSP90AA1|FRS2|PARK7|ENG|TNFAIP8L3|MFHAS1|MYDGF|PIK3CD|CD86|MUL1|PIK3R2|THEM4|TXN|RAMP3|RHOG|PIK3R5|GPER1|FLCN|HAX1|MTDH|CX3CL1|CD19|RTN4|TGFBR1|ARRB2|GDF15|GRB2|VAV1|RET|FGF7|FYN|C1QBP|INPP5K|TCF7L2|FGF2|HGF|KITLG|DDIT3|HBEGF|GLTSCR2|MST1R|FGFR1|TSPYL5|DRD2|CHI3L1|FGF10|SLC9A3R1|RAC1|MET|IGF2|RASD2|PIK3R1|HSP90AB1|TNF|TRIB3
BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0002043,0.411775043936731,0.867015886388254,-0.368473824600417,-1.01143590732014,2342,6,BMPER|ACVRL1
REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1903025,0.0761374187558032,0.525661416287861,-0.47695762314315704,-1.48259196362414,409,8,DDIT3|ZNF593|TMSB4X|DDRGK1
PEPTIDE HORMONE PROCESSING%GOBP%GO:0016486,0.104281009879254,0.576535954147525,-0.339904174666119,-1.3920218338121,474,16,ECE1|PCSK5|CTSZ|BACE2|PCSK6|PCSK2|FURIN|PCSK7|PCSK1|ATP6AP2|ACE
ANTIBIOTIC BIOSYNTHETIC PROCESS%GOBP%GO:0017000,0.689103690685413,0.96731875442989,-0.296544350048467,-0.8139943293860601,3920,6,NANP|MAOB|KDM3A|CYBA|SOD1
T CELL ACTIVATION%GOBP%GO:0042110,0.9636138422234259,1.0,0.110148540112129,0.612266433342276,12446,99,INS|LIG4|BLM|CD2|JAG2|SLAMF6|DOCK8|RORA|CCL21|F2RL1|LEF1|KIT|CCL19|CXADR|AMICA1|CD8B|CD3D|LFNG|NLRC3|LAT|CD1D|PLA2G2D|CHD7|CD3G|CD3E|PTPN22|CD8A|ZAP70|LCK|RIPK3|CTPS1|NCK1|SLA2|DLL4|BTN3A1|STOML2|PPP3CA|RAB29|ANXA1|ZFPM1|PPP3CB|HSPD1|CLEC4A|FADD|MICA|ATP7A|FOXP3|HMGB1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TUNICAMYCIN%GOBP%GO:1905895,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
FIBROUS RING OF HEART MORPHOGENESIS%GOBP%GO:1905285,0.9284563758389258,1.0,0.5383767093074551,0.715209439627112,6916,1,BMPR1A
DISRUPTION OF CELLS OF OTHER ORGANISM%GOBP%GO:0044364,0.593351910828026,0.9464278097528599,0.29397584999174603,0.8968529304967199,5961,11,HIST1H2BJ|AZU1|RPS19|HIST1H2BK
CARDIAC MUSCLE CONTRACTION%GOBP%GO:0060048,0.028958351077421,0.34951921849182693,0.34147395620014503,1.58310742155227,339,43,RYR2|KCNN2|SCN1A|CACNA1G|GAA|CACNB2|FGF12|MYLK2|KCNQ1|TCAP|CACNA2D1|TAZ|KCNH2|CACNA1D|GJA1|DMD|SCN3B|TNNI3|SLC8A1
IMMUNE RESPONSE-REGULATING SIGNALING PATHWAY%GOBP%GO:0002764,0.0077821011673151795,0.19847993048827997,-0.154004802758363,-1.39687398131156,3,313,ITK|FPR1|IGHV5-51|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|ARPC1B|NFATC3|UBE2N|PIK3CD|TLR1|CREBBP|CD79B|PIK3R2|THY1|MYO10|ITCH|BAX|MYO1G|NOD1|PPAPDC1A|BLK|IGHV4-4|EIF2B3|ICOSLG|IRAK1|FCER1G|PPP3R1|PIK3C3|DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|LGALS9|BCAR1|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|PRKD2|IRAK4|GRB2|FGR|ABL1|VAV1|MYO1C|TRAF3|IGHV1-69-2|CYFIP2|S100A8|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|BCL10|UBE2V1|RELB|LYN|FCGR2B|CYLD|TANK|ARPC5|RNF31|CD276|YES1|CNPY3|TNIP1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CDC42|PDE4B|MUC3A|RFTN1|IGHV1-3|KRAS|BCL2|CTSH|SHC1|JUN|UBA52|NFATC2|COLEC12|GAB2|RBCK1|MAPK3|HLA-DQA2|TNIP2|HLA-DQB2|RAC1|PLD2|TICAM1|MUC12|MYD88|ACTR2|BRK1|UBC|CD36|PIK3R1|HSP90AB1|PDE4D|TNFRSF21|PAK2|UBB
APPENDAGE DEVELOPMENT%GOBP%GO:0048736,0.671032871683631,0.964618776001639,0.17659043658237,0.8571131391212529,8042,52,TBX3|TBX2|KAT2A|BMP4|MYH3|ZNF141|ZNF358|SMOC1|TGFB2|LEF1|C5orf42|BMPR1B|NIPBL
GERM CELL DEVELOPMENT%GOBP%GO:0007281,0.703882304863098,0.968941691852291,0.166013827352201,0.8394091915144691,8611,62,ROPN1B|NANOS3|ZCCHC11|CABYR|PYGO1|CELF1|DEAF1|PCSK4|DZIP1|CASC5|YTHDC2|ZNF830|ZP3|DNAH1|BMPR1B
TIGHT JUNCTION ORGANIZATION%GOBP%GO:0120193,0.5499293452661329,0.931359181171847,-0.20413119140498898,-0.927122226225697,2334,21,PDCD6IP|ARL2|RAB13|F11R|STRN|PARD6B|RAMP2|DLG1|PARD3
POSITIVE REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050718,0.681537102473498,0.965271928233355,-0.19834884638785102,-0.834629132045833,3085,17,PANX1|RIPK2|NLRP1|NLRP3
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR (LIGAND) SUPERFAMILY MEMBER 11 PRODUCTION%GOBP%GO:2000309,0.9458493313915,1.0,-0.5245368328187029,-0.701688914255538,7143,1,ADAM8
CELLULAR RESPONSE TO DSRNA%GOBP%GO:0071359,0.0272228320526894,0.339785941813865,-0.411160382176072,-1.6838399520977398,123,16,MAVS|NPM1|PDE12|COLEC12|RALB|CAV1
PRIMARY MIRNA METHYLATION%GOBP%GO:1990744,0.436241610738255,0.878651088001772,0.788376709307455,1.04732328633638,3249,1,METTL3
REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:1903233,0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:0097435,0.43207312006647297,0.878651088001772,0.15792329492797,1.02831599048029,6239,298,NEB|FSCN2|RHOBTB1|ITGB1|WASH1|IGSF22|GHRL|AKAP9|NCKAP5|SHROOM2|CAMSAP3|ARAP1|CENPJ|RAC3|ACTN2|FSD1|EVL|TTC17|KIF14|HIP1R|MYH3|CEP126|PROX1|TRIM27|KIF2C|TCAP|HOOK1|DDR2|CCSAP|KIF18A|FGF13|ARHGAP25|CKAP5|PPP1R9A|HSP90B1|NUMA1|FHDC1|DPT|JAK2|KIF24|MAP10|TGFB2|TNFAIP1|LIMA1|CCDC88B|LOXL3|OBSCN|SRC|KRT19|TUBGCP3|MSRB2|ITGB5|KIF18B|CETN3|LOXL2|LTBP2|RUFY3|NF1|TNXB|RHOBTB3|TUBG2|NEBL|FBLN5|TUBGCP6|LMOD1|OBSL1|COL5A2|MICALL2|DPYSL3|SHTN1|PIN1|CEP192|STMN1|HOOK2|MFAP4|MICAL3|TUBGCP2|RAC2|COL5A1|CAMSAP2|RIPK1|ARPC1A|COL11A2|DYNC1H1|MYOM2|TPM2|ARHGAP17|SAMD14|KCTD13|DIAPH3|P3H4|PLS3|TUBGCP4|HIP1|SPIRE2|PCM1|SPIRE1|COL12A1|RIPK3|DST|WASF1|PDXP|FMN2|WASF3|CAMSAP1|FIGN|COL11A1
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:1904283,0.9364490930755991,1.0,-0.5291685046316721,-0.7078848428582359,7072,1,HFE
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903426,0.170035290343279,0.673117535978459,-0.202214284982508,-1.2193153461034298,529,49,ASS1|ATP2B4|SNCA|SLC25A33|DDAH2|RAC1|CD36|HSP90AB1|TNF|CAV1|DDAH1
REGULATION OF TYPE I HYPERSENSITIVITY%GOBP%GO:0001810,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
RESPIRATORY CHAIN COMPLEX II ASSEMBLY%GOBP%GO:0034552,0.926307537238213,1.0,0.29351058254767703,0.621976962010199,8270,4,SDHAF3|SDHAF1|SDHAF4
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903829,0.0013440860215053801,0.0945022140486112,-0.18137327076959198,-1.5862499497212499,0,247,RAMP3|RHOG|GPER1|FBXW7|OAZ2|HPS4|SYT11|CCT4|PRKCH|TP53BP2|VPS28|PINX1|IL1B|GZMB|NECAB2|CLIP3|PLK3|BCAS3|PRKCD|TMEM30A|RTN4|PRKAA1|ITGAM|SQSTM1|UBL5|LIF|EIF2AK3|BBC3|MYO1C|ATG13|CCT7|FYN|FAM65A|ICE1|TCF7L2|VPS11|RANGRF|NMD3|YWHAH|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|TCP1|MIEF1|IGF1|MAVS|BID|CEMIP|BAP1|LEPROT|ZPR1|PDCD10|YWHAQ|YWHAB|MARK4|LGALS3|MSN|GNL3L|BAG3|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|UBE2D3|ARIH2|PARK2|ACSL3|DDRGK1|BCAP31|SESN2|PIK3R1|DLG1|HSP90AB1|BICD1|TNF|PMAIP1|TFDP2|STAC|EPHB2
POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0060456,0.16644394951744598,0.6682860217990739,-0.7559966914805619,-1.29309185218456,1120,2,SLC22A5|AQP1
POSTNATAL OLFACTORY BULB INTERNEURON MIGRATION%GOBP%GO:0021827,0.351447661469933,0.842847021021096,-0.6487455197132621,-1.1096444668819399,2366,2,SLIT2|ROBO1
"REGULATION OF VACUOLE FUSION, NON-AUTOPHAGIC%GOBP%GO:0032889",0.17569177810141698,0.678685257108795,-0.909682399647111,-1.21690988199179,1326,1,VPS16
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:0000184",0.434989429175476,0.878651088001772,-0.133748814403642,-1.01063269526811,822,112,RPL28|RPS3A|UPF3A|RPL37|RPL27A|GSPT2|PPP2R1A|RPL7A|RPL19|UPF2|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|PNRC2|RPS12|SKIV2L|RPL4|RPL37A|RPL23|RPL10|RPL24|SMG8|RPL26|RPS25|RPL13|RPS5|EIF3E|RPLP2|RPS2|SMG7|SMG1|RPS8|RPL21|RPL39|RPS20|RPS15A|RPS11|RPS6|CTIF|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|RPL13A|CASC3|UPF1|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SMG5|MAGOHB|RPL29|RPL31|RPL17|EIF4A3|RPS14|RPS17|RPL32|RPL18A|NCBP1|RPL11|SMG6|RPS16|RPL12|PPP2R2A|DCP1A|RPS4X|RPL9|RPS28|RPL35|RPL7|RPS9|RPS3|RPL14|WIBG|MAGOH|GSPT1|EIF4G1|RPL15|RPL8|PPP2CA|RPL35A|HELZ2|ETF1|UBA52|NCBP2|RBM8A|RNPS1|PABPC1
POSITIVE REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045070,0.35872108136209996,0.8467474099825749,-0.206996490347025,-1.05935651755815,1379,29,DDX3X|TBC1D20|PPIH|CNOT7|PDE12|VAPB|STAU1|PABPC1
APPENDAGE MORPHOGENESIS%GOBP%GO:0035107,0.412244539952636,0.867015886388254,0.237151757110008,1.03899890169066,4699,35,TBX3|TBX2|MYH3|ZNF141|ZNF358|TGFB2|LEF1|C5orf42|BMPR1B|NIPBL
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL EXTRAVASATION%GOBP%GO:2000451",0.908322147651007,1.0,0.547640052933392,0.7275153783671121,6766,1,FADD
TISSUE MIGRATION%GOBP%GO:0090130,0.669415561133023,0.964618776001639,-0.137805711357772,-0.8842019489206709,1866,61,VEGFA|PKN1|KDR|RAB13|ABL1|RHOA|NRP1|FGF2|PXN|PTP4A3|ID1|NOS3|SCG2|GREM1|MYH9|CDH13|PRSS3
INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070102,0.566715086117452,0.9388612723386429,-0.24134856899774498,-0.9089140976194091,2730,13,FER|STAT1|CBL|CTR9|JAK1|PTPN11|SMAD4|IL6ST|IL6R|SOCS3|IL6|STAT3
THIAMINE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009229,0.478352972328876,0.9046812288131709,-0.759759594177327,-1.01635357400684,3612,1,TPK1
POSITIVE REGULATION OF CELLULAR RESPIRATION%GOBP%GO:1901857,0.173131401176727,0.676682497340677,0.558916687172943,1.2882201092847398,1588,5,CCNB1|CDK1
SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042501,0.360536912751678,0.848418604328854,0.825264666960741,1.09632729239031,2685,1,NLK
CENTROMERE COMPLEX ASSEMBLY%GOBP%GO:0034508,0.0120943701558641,0.239015351015829,0.36917238677840397,1.7115201166278797,141,43,RBBP7|CENPF|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|CENPE|HIST1H4I|HELLS|CENPV|CENPQ|CENPI|MIS18BP1|NASP|HJURP|POGZ|STRA13|CENPM
MANNAN CATABOLIC PROCESS%GOBP%GO:0046355,0.938389261744966,1.0,0.533855315394795,0.709202969527827,6990,1,MANBA
NEGATIVE REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001039,0.457504145936982,0.890018343810919,-0.271467984122952,-0.988985097095861,2206,12,TRAP1|PARK7|NUP93|TXN|PDE8A|HGF|MET
PYRIDOXAL 5'-PHOSPHATE SALVAGE%GOBP%GO:0009443,0.0831457698927579,0.5433486826752679,-0.956936479929422,-1.28012310595026,627,1,PDXK
REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904978,0.048740326033262005,0.43467341919055,-0.692974501998626,-1.59369658715247,295,4,RAB7A|PARK2
GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097688,0.152413209144793,0.648319130045528,0.763992280121312,1.2487243937626,1259,2,APOE|DLG4
REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051492,0.0461005199306759,0.42157410854330396,-0.225989089875881,-1.42439639885471,132,57,LPAR1|TGFBR1|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|INPP5K|PXN|SERPINF2|RHOC|LIMK1|WNT11|CDC42|SORBS3|TMEFF2|RAC1|MET
REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900037,0.561859732072498,0.936738331587711,-0.267039901851006,-0.9034359584903181,2851,10,HYOU1|ENO1|DDAH1
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034392,0.7937156323644928,0.9819233677232551,-0.367210764310136,-0.7452433358564701,5051,3,DNMT1|LRP6|IGF1
RIBOFLAVIN METABOLIC PROCESS%GOBP%GO:0006771,0.975794500246995,1.0,-0.23859352217537802,-0.5487152570706579,5925,4,FLAD1|ACP5
REGULATION OF BASEMENT MEMBRANE ORGANIZATION%GOBP%GO:0110011,0.271978021978022,0.7866273178445721,-0.45659607324067897,-1.15584263986994,1583,5,CLASP2|CLASP1|PHLDB2|DAG1|PHLDB1
EPIDERMIS MORPHOGENESIS%GOBP%GO:0048730,0.961756373937677,1.0,0.24120121335666803,0.555933040757097,8826,5,TGFB2|FGFR2|ATP7A|KLK14
NEGATIVE REGULATION OF LOCOMOTION%GOBP%GO:0040013,0.314594594594595,0.8164430838831159,-0.12397591110769801,-1.0574560867226899,290,212,CX3CL1|PTPRG|DAB2IP|STK26|TRIB1|HMOX1|DLC1|PTPRU|SRGAP2C|SEMA3F|SPOCK3|PML|MMRN2|IGFBP3|CITED2|RHOA|MITF|HDAC5|CLIC4|SEMA7A|APOD|FGF2|MAP2K5|ADAMTS9|PPARG|LDLRAD4|MEOX2|TRIM35|CRK|PDCD10|WNT11|SMAD7|SEMA6B|ARPIN|DUSP3|DRD2|GREM1|SFRP2|PTPRM|ACVRL1|DUSP10|STK24|TMEFF2|SEMA3A|IFITM1|CORO1C|MCTP1|PLCB1|SEMA3G|NBL1|STC1|ANGPT2|FOXO3
TISSUE REGENERATION%GOBP%GO:0042246,0.428542591844974,0.8770525861997421,-0.287081894688984,-1.01027695473895,2122,11,AKIRIN1|EYS|APOD|IGF1|CFLAR
REGULATION OF VIRAL PROCESS%GOBP%GO:0050792,0.0323886639676113,0.36738949586822706,-0.173313118572948,-1.37554103688836,47,142,FBXL2|SNX3|LGALS1|CCNK|TRIM8|RNASEL|PVRL2|CTDP1|ZNF639|TRIM13|CDK9|APOBEC3F|C9orf69|BANF1|LGALS9|PML|VPS4A|DDX3X|RSF1|INPP5K|IFITM2|TBC1D20|IFITM3|P4HB|OASL|VPS4B|MAVS|TRIM35|TNIP1|PPIH|CNOT7|FMR1|OAS3|TRIM25|CXCL8|PDE12|JUN|CAV2|RAB7A|VAPB|ZC3HAV1|PARK2|CHMP4B|STAU1|PABPC1|IFITM1|PC|TNF
REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150077,0.110647639956092,0.584830174998513,-0.33611208079376004,-1.37649193491817,503,16,IL1B|CX3CL1|ITGAM|TNFRSF1B|IL6|MMP9|TNF
PROTEIN-FAD LINKAGE%GOBP%GO:0018293,0.440090030451476,0.879896414106183,-0.7784516982796651,-1.04135857158201,3323,1,SDHAF2
POSITIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106071,0.813982717989002,0.986276922067025,-0.35942237002291405,-0.7294370210539091,5180,3,PRKCA
NUCLEAR MATRIX ANCHORING AT NUCLEAR MEMBRANE%GOBP%GO:0090292,0.25645478754197104,0.767319904137432,0.615611959897031,1.1702135758168601,2214,3,SYNE1|SUN1|SUN2
NEUROEPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060563,0.418924186318456,0.87173622607586,0.313462923324412,1.0386000757483298,4298,14,STRC|DFNB31|JAG2|PDZD7|LEF1
PEPTIDYL-CYSTEINE MODIFICATION%GOBP%GO:0018198,0.105416887944769,0.578657302371004,-0.25840955552350303,-1.3588556102828402,396,31,CLIP3|ZDHHC3|MOCS3|S100A8|ZDHHC9|ZDHHC11B|RAB6A|ZDHHC7|GAPDH|ZDHHC4|GOLGA7
"CLEAVAGE IN ITS2 BETWEEN 5.8S RRNA AND LSU-RRNA OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000448",0.103270223752151,0.5756137190742839,-0.946515218350243,-1.26618226659419,779,1,NOL9
POSITIVE REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0072108,0.0770601336302895,0.5275704311910809,-0.8328646264130141,-1.42457033810325,518,2,LIF|PAX8
INOSITOL PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0071545,0.41728855721393,0.8709670999109399,-0.28077241379310397,-1.02288206771096,2012,12,IMPA1|IMPA2|OCRL|NUDT3|INPP5J|PTEN|SYNJ1|INPP5B|SYNJ2|INPP1|INPP5K|INPP5A
REGULATION OF LEUKOTRIENE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0035490,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000563",0.9792809945122629,1.0,0.25068669561852003,0.5312290548564981,8743,4,CD55|XCL1|TGFBR2
SPERMATID DIFFERENTIATION%GOBP%GO:0048515,0.9798636926889721,1.0,-0.0972227381145476,-0.566722350423602,3162,44,CHD5|CCDC136|C9orf117|PYGO2|CFAP43|PRKACA|PSME4|PVRL2|TSSK6|RHBDD1|CDYL|PIWIL1|RFX2|NPHP1|PLD6|MKKS|IQCG|SPAG6
POSITIVE REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010825,0.534042096219931,0.9265056012720759,0.382397261957349,0.940450374988136,4972,6,CENPJ|CEP295|CEP120|NUP62|PLK4
NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0032353,0.512134879725086,0.9187029617772041,0.38955036648300895,0.9580423938196851,4768,6,WNT4|REST|CYP27B1|BMP2|DKK3|NFKB1
SODIUM ION TRANSPORT%GOBP%GO:0006814,0.10501660846605901,0.5776087853890419,0.29421987362839,1.3640327675129398,1232,43,SCN1A|SLC12A2|HCN2|SLC9A5|SLC9A7|SLC8A3|ATP1B3|PKD2|FGF13|KLHL3|HCN3|NALCN|ASIC1|SCNN1D|SCN3B|SLC8A1|SCN8A
T CELL DIFFERENTIATION%GOBP%GO:0030217,0.66911396629401,0.964618776001639,0.176966308160616,0.8589374987783879,8019,52,LIG4|BLM|JAG2|SLAMF6|RORA|LEF1|KIT|CD3D|LFNG|CD1D|PLA2G2D|CHD7|CD3G|CD3E|PTPN22|CD8A|ZAP70|LCK|RIPK3
INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032367,0.9454211746522411,1.0,0.16780809640614902,0.568972149461508,9786,15,STAR|LDLRAP1|LDLR|OSBP|SERAC1|SYT7|LRP6
NEGATIVE REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1900045,0.815399484536082,0.986631695793843,0.2924207504935661,0.719166248859438,7592,6,PARP10|PLAA|UBR5|GPS2
POSITIVE REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001815,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
NEGATIVE REGULATION OF BONE RESORPTION%GOBP%GO:0045779,0.31117890607975607,0.8143712300420921,0.492278435848058,1.13462881853531,2855,5,CARTPT|P2RX7
REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:1905600,0.27119874198620997,0.786158299673311,0.699557656586115,1.14340777171697,2241,2,LDLRAP1|ANXA2
NEGATIVE REGULATION OF TRANSPOSON INTEGRATION%GOBP%GO:0070895,0.137050925365913,0.62388141596544,0.775902950096499,1.2681920566318001,1132,2,ZNF93|ZNF91
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045663,0.0159574468085106,0.268309042246402,-0.531868445122901,-1.79939055991139,80,10,HIF1AN|FAM65B|BTG1|AKIRIN1|BOC|IGFBP3|PLCB1|RBM24
MIDBODY ABSCISSION%GOBP%GO:0061952,0.518990120746433,0.9238030410013001,-0.230064958953354,-0.942193329554523,2363,16,VPS4A|VPS4B|CHMP4B|CHMP1B
POSITIVE REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000017,0.35350191976698,0.842847021021096,-0.822838553153948,-1.1007362206912,2669,1,ACVR1
LEUCINE METABOLIC PROCESS%GOBP%GO:0006551,0.0641322662173547,0.49514893278583205,0.5737792306645451,1.4934267863364599,608,7,MCCC2|BCAT2|IVD|HMGCLL1|MCCC1|HMGCL
RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009260,0.870928829915561,0.9934031064448321,-0.10339495438056,-0.800641930580003,1443,126,AK9|GUCY1B3|ATP5F1|DHODH|HSD17B12|ATP5J|LDHA|PAPSS1|SCD|ADCY7|CMPK1|ACSL1|PFKL|COX5B|GPI|GMPS|GUCY1A3|PKM|ENO1|ACSL4|HPRT1|ATP5I|PDHB|GAPDH|PGK1|PANK2|CYC1|HK1|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2
RESPONSE TO ACETYLCHOLINE%GOBP%GO:1905144,0.0779826705176627,0.5314695499765479,-0.333684961132215,-1.43543856515472,350,18,CHRM4|CHRNB2|GNAQ|GNA15|CHRNA7|HRH3|CHRNA3|CHRM1|PLCB1
FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006633,0.109280704615886,0.5846370216990561,0.26320426429549,1.33617064132217,1339,63,ACSM3|EDN1|HACD1|MGST1|CYP2C8|LPL|OXSM|CBR4|SCD5|ELOVL6|DECR2|FADS3|ABHD3
AMINO SUGAR BIOSYNTHETIC PROCESS%GOBP%GO:0046349,0.895315091210614,0.9981901628831992,-0.18135172413793102,-0.660682522414212,4318,12,AMDHD2|PGM3|UAP1|RENBP|GNPDA1|GNPDA2|NAGK|NANP|GFPT1|GNPNAT1|UAP1L1|GFPT2
POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903052,0.0921501706484642,0.5622489437340121,-0.184766905876582,-1.2913933319859099,215,83,PSMD10|EDEM1|GBA|RNF217|RAD23A|CSNK1D|CSNK1A1|RNF19B|FBXW7|CBFA2T3|CLU|PLK3|USP5|DAB2IP|TRIB1|ARIH1|PRICKLE1|CEBPA|STUB1|RNF139|GLTSCR2|TRIB2|SUMO1|ECSCR|RNF144B|SMAD7|FMR1|SOCS5|ARIH2|PARK2|HSPBP1|DDRGK1|BCAP31|BBS7|CAV1|TRIB3
REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000136,0.283287778211636,0.7924936804394509,-0.352909675161871,-1.13922405641683,1450,9,GNG5|ENG|NOTCH1|PIM1|CTNNB1|RBPJ
REGULATION OF FRACTALKINE BIOSYNTHETIC PROCESS%GOBP%GO:0050752,0.5276911655530809,0.9265056012720759,-0.551172267749639,-0.942750645087274,3553,2,TNF
PHOTOREACTIVE REPAIR%GOBP%GO:0000719,0.8115980405137029,0.9855701659458179,-0.591420379355977,-0.791161073720687,6129,1,CRY2
REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045598,0.28472755180353004,0.7938338359290009,-0.16613476622324697,-1.1100098066215902,741,70,ADIRF|ZNF385A|TRIO|CCDC85B|CCRN4L|FOXO1|METRNL|IL6|PPARG|CCDC71|TRIB2|MEDAG|SFRP2|NR1D1|TAF8|TNF|ZFPM2|TRIB3
NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019359,0.0302652106084243,0.35738308321874895,-0.258958188557386,-1.53143253258578,96,46,PFKL|GPI|PKM|PNP|ENO1|NAMPT|GAPDH|PGK1|HK1|NMNAT3|HK2|TPI1|ALDOA|PGAM2|NMNAT2
UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050674,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
PROTEIN STABILIZATION%GOBP%GO:0050821,0.000696378830083565,0.0806484601749226,-0.222976501601735,-1.7689796150689,0,144,TBRG1|FLOT1|MUL1|TAF9|CALR|PHB2|FKBPL|FBXW7|HPS4|COG3|TESC|CCT4|TMEM88|CLU|IFT46|PRKCD|MSX1|RTN4|LAMP1|PFN1|HYPK|GNAQ|STXBP4|CCT7|TBL1X|PPAP2B|RASSF2|CHP1|GLTSCR2|EFNA1|SUMO1|CDC37|TCP1|BAG5|IGF1|PER3|PDCD10|GAPDH|SMAD7|DNLZ|STK4|USP27X|VHL|PPARGC1A|BAG3|PEX19|CDKN1A|PARK2|TNIP2|ZSWIM7|USP2|SOX17|PIK3R1|HSP90AB1|GOLGA7
DTMP METABOLIC PROCESS%GOBP%GO:0046073,0.26771406127258496,0.7826111979723571,-0.570363345656676,-1.157535463771,1703,3,DCTD|CDADC1
REGULATION OF PROTEOLYSIS%GOBP%GO:0030162,0.018348623853211003,0.285037997475661,-0.13494553140091697,-1.2811570937522498,3,453,USP5|CLN8|CD19|DAB2IP|C5AR1|TRIB1|PTPN3|UBE2J1|LGALS9|PTK2B|STYX|CIDEB|FAM192A|ARIH1|DLC1|OS9|PARL|PRICKLE1|MAGEA3|WDR48|CR2|CEBPA|EIF2AK3|BBC3|SPOCK3|AURKAIP1|PML|RPS3|TRAF3|PDCL3|CYFIP2|S100A8|PSME3|FYN|SERPINI1|STUB1|DDX3X|C1QBP|TNFRSF1B|RNF139|TNFRSF10A|MAP2K5|NEDD8|HGF|CSNK2A2|PPARG|LYN|PRNP|ENO1|MMP9|TANK|GLTSCR2|EFNA1|TRIB2|SUMO1|ECSCR|RNF144B|BAG5|BOK|LAMTOR5|MBP|BIN1|SPOCK1|RAD23B|SERPINF2|TNIP1|RIPK2|CRADD|CHAC1|TIMP2|GAPDH|SERPINF1|SMAD7|PLAUR|SNCA|FMR1|KARS|SERPINA1|NLRP1|CSTB|NLRP3|CTSH|STAT3|CLEC3B|COMMD1|SOCS5|YWHAE|DNAJB6|TNFRSF10B|DYX1C1|MTCH1|MFI2|ARIH2|GNA12|PARK2|ADRA2A|MYH9|EPHA7|HSPBP1|DDRGK1|SOX7|BCAP31|CSNK2A1|HSP90AB1|AQP1|TNF|GABARAPL2|PMAIP1|SNX12|BBS7|PSMF1|CAV1|PAK2|TRIB3|UBB|EGLN3
POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010838,0.47767857142857106,0.9043208329627141,-0.381242480890219,-0.965090024570663,2781,5,STXBP4|FGF7|FGF10
PROTEIN LOCALIZATION TO CELL JUNCTION%GOBP%GO:1902414,0.6944226237234878,0.96731875442989,-0.402172714238447,-0.816197574470827,4419,3,SCRIB|KIF3A|HEG1
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000077,0.965888472239023,1.0,0.36912092065128604,0.603318004459651,7984,2,GSK3A|GSK3B
POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045348,0.276626721917348,0.7884684708511421,0.546296806926598,1.15765511886742,2469,4,SIRT1|AZU1|CIITA|XBP1
NITROBENZENE METABOLIC PROCESS%GOBP%GO:0018916,0.10840534171249,0.58452352834625,-0.702197877019139,-1.42508972819518,689,3,GSTM3|GSTM1
REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901987,0.004550782596704129,0.15733927053030702,0.22664772190811802,1.4860025796263001,65,321,BTG2|SIX3|AKAP9|TAOK3|SDCCAG8|CEP63|ANAPC15|CEP70|CENPJ|CCNB1|PIDD1|TPR|CDC7|CDK1|BTRC|C8orf4|KIF14|E2F8|XRCC3|ANAPC5|PKD2|ANKRD17|BLM|CENPF|WEE1|LSM11|CKAP5|CEP290|CDK2AP2|ATAD5|CEP131|CEP152|ORC1|CDC25C|USP47|USP44|MUC1|CDC45|BUB1|DTL|CDK10|E2F7|DONSON|EZH2|HMMR|DLGAP5|NEK2|DACT1|CDC23|CDC20|CCNE1|UBD|GEN1|HAUS5|ANLN|APC|NDC80|PAGR1|ZNF830|DBF4B|ANAPC7|NEK11|CDK5RAP2|CENPE|ANAPC16|PRKAR2B|FBXO5|RB1|BUB1B|NAE1|INO80|GTSE1|ESPL1|AURKB|CDC6|MSH6|DDB1|RAD51C|CEP72|CCL2|CDCA5|HAUS8|CEP164|CEP78|KLHL22|TAOK1|CEP192|RPS27L|BRCC3|FGFR1OP|CHEK2|TOPBP1|CNTRL|PLK1|KNTC1|PRMT1|BRSK1|SFI1|CARM1|AURKA|CDC73|ARID3A|CEP41|CLSPN|CEP57|UBE2C|DYNC1H1|NINL|TNKS1BP1|CNOT3|ANAPC10|CDK5RAP3|TAOK2|E2F1|TUBB4A|CEP135|C5orf45|TEX14|PRKDC|DUSP1|FHL1|CHEK1|RBX1|PCM1|FBXL7|RAD17|TPX2|MAD2L1BP|FAM83D|NEDD1|PPP2R1A|CASP2|CDK2|ATM|SSNA1|TFAP4|RFWD3|CNOT1|UIMC1|CCND2|CDC16|BRCA1|NDE1|CEP250|ANAPC2|BRE
REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045604,0.817854386416259,0.987153241368501,-0.149914432831483,-0.7580042229643521,3178,28,TRIM16|DLL1|FOXC1|PRKCH|CTSL|CTSK|RUNX1|MAFF|CTSV|CBFB
REGULATION OF DNA RECOMBINATION%GOBP%GO:0000018,0.511417387049421,0.918404893008545,0.19068821656068102,0.968039014475919,6270,63,FBXO18|IL7R|MMS19|SIRT6|BLM|THOC1|POLQ|MSH6|RAD51|RTEL1-TNFRSF6B|SMARCAD1|RMI2|PARPBP|RAD51AP1|ZRANB3|WRAP53|KDM1A|PAXIP1|RIF1|C5orf45|CHEK1|RECQL5|SUPT6H|SPIDR|FIGN
REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001286,0.0459177959457946,0.420832661128005,0.7093114773868969,1.5030987775454598,409,4,PROM2|UNC119|SRC
NEGATIVE REGULATION OF PROTEIN GLUTATHIONYLATION%GOBP%GO:0010734,0.5167037861915371,0.922701251144926,-0.555831265508685,-0.9507196112341629,3479,2,FXYD1|G6PD
ACTOMYOSIN CONTRACTILE RING ASSEMBLY%GOBP%GO:0000915,0.702878261843432,0.968941691852291,0.39235349094566596,0.8314345268720971,6275,4,ANLN|RACGAP1
POSITIVE REGULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0043946,0.0916778523489933,0.5622489437340121,0.9547860608734009,1.26839068584423,682,1,SUGT1
NEGATIVE REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903038,0.998371600716496,1.0,0.0862017932738455,0.44124733980819797,12261,66,PAG1|CEACAM1|GLMN|BMP4|MIA3|MARCH7|LOXL3|CCL21|DLG5|TIGIT|BTN2A2|TNFAIP8L2|PLA2G2D|CEBPB|SOCS1|PTPN22|CTLA4|AKT1|RC3H1|TNFRSF14|XCL1|WNK1|PDCD1LG2|ANXA1|KLF4|NDFIP1|JAK3|FOXP3|HMGB1|SDC4|ZC3H8|LILRB2|KIAA0922|PTPN2|ZC3H12A
NEGATIVE REGULATION BY ORGANISM OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052490,0.156952081696779,0.6578589353509621,-0.655619278702989,-1.33055984682348,998,3,CASP8|SERPINB9|BCL2L1
CEREBRAL CORTEX CELL MIGRATION%GOBP%GO:0021795,0.280590717299578,0.7890335436983149,-0.292162801064857,-1.1319160378057,1329,14,EFHC1|SLIT2|ROBO1|PEX13|LHX6|DAB2IP|RTN4|SRGAP2C|MBOAT7|RELN
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY%GOBP%GO:0051348,0.367567567567568,0.8512048542076959,-0.124597745144449,-1.03953713552493,407,190,ADARB1|GSK3B|SMCR8|DUSP6|PKIB|IRS2|HHEX|PRKAG2|IPO5|SFN|AKT1S1|CBLB|GSKIP|PRKAR1A|RASIP1|MAD2L2|WWTR1|YWHAG|PARK7|RPL11|AIDA|GBA|DUSP22|PPP2R5A|PPM1F|PYCARD|DUSP4|THY1|CDKN1B|DUSP7|HSPB1|HEXIM1|QARS|ZGPAT|LRP5|PINX1|IL1B|HEG1|PRKCD|DAB2IP|IGF1R|TRIB1|WARS|RGS4|CEBPA|ABL1|GNAQ|INPP5K|EIF4A2|UBASH3B|LYN|CHP1|TRIB2|PIK3IP1|PPP2CA|BAG5|PRKAR2A|LIMK1|NPM1|PTPN1|SMAD7|CDKN1C|PDCD4|DUSP3|TP53|UCHL1|SNX6|PRKAR1B|PKIG|SOCS5|CDKN1A|DBNDD2|PARK2|KIAA0226|DUSP10|CORO1C|SPRED2|CAV1|EPHB2|PAK2|TRIB3
PHENOL-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0019336,0.161276905479879,0.66423945079639,0.477718464689684,1.30238869872366,1550,8,SULT1A3|MOXD1|LRTOMT|COMT|DBH|MAOA|FAH
ACTIN CORTICAL PATCH ASSEMBLY%GOBP%GO:0000147,0.22337434094903302,0.7360157208449051,-0.441453863548618,-1.21176121398169,1270,6,WAS|WASL|WIPF3|TIGD5|WIPF2|WIPF1
FILTRATION DIAPHRAGM ASSEMBLY%GOBP%GO:0036058,0.20630872483221502,0.7211951452265429,0.898820026466696,1.19404230595674,1536,1,PTPRO
DIET INDUCED THERMOGENESIS%GOBP%GO:0002024,0.0369127516778524,0.386113929236656,0.9811424790471991,1.30340401154494,274,1,OMA1
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES%GOBP%GO:1902170,0.9018470790378009,0.9995642802800841,0.260100823887022,0.6396800963144879,8397,6,DPEP1|MTR
RESPONSE TO IRON ION%GOBP%GO:0010039,0.292703150912106,0.8004058897916541,-0.310110392987212,-1.1297632688058898,1411,12,SNCA|FXN|BCL2|B2M
PEROXISOME ORGANIZATION%GOBP%GO:0007031,0.7899322362052271,0.9819233677232551,0.150694398841816,0.782277018819763,9791,70,CROT|SLC27A2|HSD17B4|IDE|PEX3|DECR2|PEX11G|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
VIRAL RNA GENOME PACKAGING%GOBP%GO:0019074,0.00193021529324425,0.112582730005196,-0.976344086021505,-1.66998426949525,12,2,DDX6|PC
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0110059,0.18562160730835398,0.6921962082288221,-0.9052712836347601,-1.21100899760826,1401,1,FOXJ2
REGULATION OF SYNAPSE ORGANIZATION%GOBP%GO:0050807,0.12166050143855302,0.607607158836689,-0.18319092862928602,-1.25799518212497,295,77,ABL1|BHLHB9|FYN|RHOA|EIF4G1|FCGR2B|PRNP|EFNA1|ARC|CRIPT|SNCA|FMR1|NEDD4|RELN|YWHAZ|SYNDIG1|TNF|ARHGAP22|EPHB2|HOMER1
PROTEIN DEPALMITOLEYLATION%GOBP%GO:1990697,0.110469798657718,0.584830174998513,0.944530216144685,1.2547662536678,822,1,NOTUM
REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060338,0.0259476534296029,0.33512489842855103,-0.378245350775577,-1.65878485647378,114,19,MUL1|RNASEL|PTPN6|IFNAR2|CDC37|MAVS|CNOT7|PTPN1|HSP90AB1|UBE2K
REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0045761,0.746595562327397,0.9749763305090959,0.21727629673557897,0.7794143727296721,7839,18,AKAP5|ADGRV1|CACNA1D|NF1|PALM
METAL ION TRANSPORT%GOBP%GO:0030001,0.679822739232793,0.9647315640607691,0.13921290451404,0.9057909949865749,9817,294,KCNK2|RYR2|KCNN2|SCN1A|CRACR2B|KCNK6|KCNH8|CACNA1G|KCNT2|GRIN3A|SLC12A2|TFR2|KCNH3|CACNB2|KCNK3|ATP2B1|TMEM165|HCN2|KCNQ1|NOL3|CACNA1I|SLC9A5|SLC9A7|SLC8A3|ATP1B3|F2R|KCNH1|SLC39A3|LRRC55|PKD2|KCNC3|KCNC1|SLC35G1|IBTK|KCND1|KCNB2|FGF13|SLC30A5|KLHL3|ATP2A1|HCN3|CDH23|NPY|CACNA1H|CACNA2D1|KCNJ11|MRS2|KCNH2|CCR5|CACNA1D|CCL21|TTYH1|JPH4|MCOLN1|CCL5|ATP2B3|ATP7B|NALCN|SLC39A7|SLC40A1|GRIN1|NIPA1|CCL19|TRPM7|ASIC1|ATP2A2|TCIRG1|SCNN1D|PLCG1|SLC39A13|ABCC8
EOSINOPHIL MEDIATED IMMUNITY%GOBP%GO:0002447,0.29540589494483804,0.800447413278835,-0.489439144101914,-1.12560778401569,1793,4,VAMP7|CCL3|VAMP8|VAMP2
POSITIVE REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900365,0.216861518195291,0.7333966924305101,-0.531675323477062,-1.22274217313159,1316,4,CPEB1|HSF1|NUDT21
CELL DEATH IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0036473,0.6215053763440861,0.9536478716552259,-0.219482122665212,-0.875314313496961,2889,15,SIGMAR1|ARL6IP5|PDK1|PRODH|STK25|DIABLO|GSKIP|CYP1B1|GBA|PRKCD|PDCD10|ZNF622|STK24
PRIMARY AMINO COMPOUND METABOLIC PROCESS%GOBP%GO:1901160,0.701705576388049,0.968941691852291,0.528535980148883,0.863877539820607,5800,2,AZIN2|ATP7A
BILE ACID METABOLIC PROCESS%GOBP%GO:0008206,0.14480266814897197,0.6354205053564179,0.344639886859022,1.31989082084053,1562,22,SLC27A2|HSD17B4|OSBPL3|GBA2|AMACR|AKR1C1|ACOX2|OSBPL9|CYP7B1
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0001844,0.0235500878734622,0.32312593643115806,-0.63796528023467,-1.75117185800821,133,6,BMF|BCL2L11|PMAIP1
POSITIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0045737,0.9179497174040151,1.0,0.18273398112399203,0.605454465314088,9419,14,PSRC1|PROX1|CKS2|CCND2|CCND1|MAPRE3|PDGFB
REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050764,0.368437798281896,0.851931544178381,-0.176671131299366,-1.06204414582296,1157,48,CYBA|GATA2|PYCARD|CALR|SNX3|IL1B|FCER1G|SIRPA|ITGAM|CD300LF|FGR|CAMK1D|FCGR2B|SLC11A1|LMAN2|DYSF|ANO6|LYAR|TNF
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE%GOBP%GO:0050912,0.15982115004679198,0.661454203640901,0.47855448881342894,1.3046679247764699,1536,8,RTP5|TAS2R4|RTP4|TAS2R5|TAS2R20|TAS2R14|TAS2R19
MAGNESIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903830,0.661666868271441,0.964618776001639,0.54336917562724,0.8881219903382641,5469,2,MRS2|SLC41A1
INOSITOL METABOLIC PROCESS%GOBP%GO:0006020,0.508376288659794,0.918237678197337,0.390766557937607,0.961033439581048,4733,6,PPIP5K2|ISYNA1|PPIP5K1
NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033007,0.609748065206652,0.9508825506493929,-0.376826779904042,-0.866622871907513,3702,4,FER|CD300A|CD84|LGALS9
MANGANESE ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071421,0.8091275167785229,0.984682960940884,0.596162329069255,0.791975057481395,6027,1,SLC30A10
"NEGATIVE REGULATION OF TRANSLATION, NCRNA-MEDIATED%GOBP%GO:0040033",0.851457840819543,0.991298302704726,-0.206211641476452,-0.697644848870135,4321,10,AGO2|STAT3
VESICLE COATING%GOBP%GO:0006901,0.970003614022407,1.0,-0.0987193253811803,-0.63643522290812,2683,62,TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
POSITIVE REGULATION OF REGULATION OF VASCULAR SMOOTH MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:1904199,0.7322918045809609,0.972769769206295,-0.6292456991618879,-0.841761157309387,5530,1,TRPM4
WAX BIOSYNTHETIC PROCESS%GOBP%GO:0010025,0.0647151324543365,0.495491127404654,0.840970499035015,1.37454317786167,534,2,FAR2|FAR1
NEGATIVE REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900737,0.025949953660797002,0.33512489842855103,-0.987704014115571,-1.32128177452533,195,1,BICD1
POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035360,0.587709740684245,0.945418171231938,0.393481111015583,0.906915630660225,5393,5,LMO3|GPS2|PTGIS|ASXL2
B CELL COSTIMULATION%GOBP%GO:0031296,0.166577181208054,0.6682860217990739,0.918063520070578,1.21960642869638,1240,1,CD320
UV-DAMAGE EXCISION REPAIR%GOBP%GO:0070914,0.0424236472552293,0.4054114380807,0.485237353012789,1.56604130162485,431,13,SIRT1|DDB2|GEN1|INO80|DDB1|MC1R|CUL4B|XPA|HIST3H2A
POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050862,0.610698945724327,0.9508825506493929,-0.269969108561342,-0.871484474947927,3127,9,TRAT1|TESPA1|LCK|RAB29|KCNN4|RELA|PVRL2|PRKD2|RPS3
METANEPHRIC MESENCHYMAL CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072136,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000574,0.598242530755712,0.949262093257606,-0.31902583827729303,-0.875704505052643,3403,6,DNAL4|DYNLL2
CORTISOL METABOLIC PROCESS%GOBP%GO:0034650,0.249127516778524,0.7613646381106121,0.8781429201588,1.16657369269781,1855,1,CACNA1H
NEGATIVE REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903970,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
ENDOMITOTIC CELL CYCLE%GOBP%GO:0007113,0.364662212323682,0.85007225273817,-0.640088227185001,-1.09483663166728,2455,2,CIB1|PLK3
CARDIAC FIBROBLAST CELL DIFFERENTIATION%GOBP%GO:0060935,0.7611940298507459,0.977763214485385,-0.377698312537799,-0.766527503385769,4844,3,PDCD4
PROLACTIN SECRETION%GOBP%GO:0070459,0.738678544914625,0.9744283926676119,-0.463270717021072,-0.792399750271989,4974,2,VIP
UBIQUITIN RECYCLING%GOBP%GO:0010992,0.47275699237195795,0.8990547397930471,-0.333913974722193,-0.9740418786802021,2602,7,PARK2|UBE2K
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903846,0.8625883227965792,0.991943445125448,0.179572022260108,0.6788779570853679,9277,21,CITED1|MEN1|RNF111|CDKN2B|STK11|ING2|DAB2|THBS1
ENDOPLASMIC RETICULUM POLARIZATION%GOBP%GO:0061163,0.45610738255033595,0.88900512246363,0.7772937803264229,1.0326001096296,3397,1,SHTN1
TONIC SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014820,0.671182123422485,0.964618776001639,0.45529990120937197,0.865477216447192,5796,3,EDN1|MYLK
KIDNEY VASCULATURE MORPHOGENESIS%GOBP%GO:0061439,0.0656288498152089,0.495991045493396,0.6838458700852579,1.4491347230717297,585,4,BMP4|PKD2
PROTEASE LOCALIZATION TO MAST CELL SECRETORY GRANULE%GOBP%GO:0033368,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
SPHINGOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046512,0.0406828913912096,0.401998427404428,-0.5566303434311639,-1.62371540723079,223,7,SPHK1|ACER3|ASAH2|ASAH2B
TETRAHYDROFOLATE INTERCONVERSION%GOBP%GO:0035999,0.8164708329000729,0.9866358717238399,0.261837965134867,0.713840539762196,7851,8,MTHFD1|TYMS|MTHFD2L|MTHFR|MTHFS
DISACCHARIDE TRANSPORT%GOBP%GO:0015766,0.505382847465828,0.9172434440873181,0.601988280657825,0.9839333071497379,4177,2,SLC45A3
POSITIVE REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900241,0.586933927245731,0.945418171231938,-0.5268662492449709,-0.901176502182125,3952,2,SOD2
EMBRYO IMPLANTATION%GOBP%GO:0007566,0.27000928505106797,0.784633053119975,-0.3721125560015979,-1.15668784462643,1453,8,RPL29|EMP2|PCSK5|SOD1|PPARD|IL1B
ACETATE ESTER METABOLIC PROCESS%GOBP%GO:1900619,0.442316258351893,0.880423444399886,-0.590239867659223,-1.0095736824058001,2978,2,COLQ|ACHE
MITOTIC SPINDLE POLE BODY DUPLICATION%GOBP%GO:1903087,0.7730736663844201,0.979946273879301,0.49712617508240997,0.812539076317278,6390,2,CETN3|EFCAB11
NEGATIVE REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032272,0.25447928331467,0.764845931807465,-0.2095410792001,-1.1526628500823999,908,36,GSN|CAPZB|TRIOBP|KANK4|CAPZA2|MAPRE1|ADD1|CLIP3|PRKCD|PFN1|DYRK1A|TMSB10|MYADM|TMSB4X|SNCA|TWF1|TWF2
PHOSPHOLIPASE C-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071882,0.0769230769230769,0.527286041772797,-0.960465372739303,-1.28484381345708,580,1,ADRA2A
NEGATIVE REGULATION OF LIPOPROTEIN LIPID OXIDATION%GOBP%GO:0060588,0.26201509334039497,0.771967970256231,-0.869320688134098,-1.16291678988256,1978,1,APOD
GLYCEROL CATABOLIC PROCESS%GOBP%GO:0019563,0.8847223902262009,0.996643473105967,0.44420757869254707,0.7260450842769308,7313,2,TKFC
POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010663,0.152635486265776,0.648319130045528,-0.7645437000275709,-1.3077110525557198,1027,2,CAMK2D|CAMK2A
REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003330,0.0910027472527472,0.5609783360513879,-0.5693801014780501,-1.44134791810814,529,5,TNFRSF1A|RGCC|ADTRP|NOTCH1|TNFRSF1B
REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002883,0.9817448762459399,1.0,0.24715484409044103,0.523744724088463,8765,4,ZP3|CCR7|HLA-E
REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060334,0.45126353790613705,0.886411023801201,-0.22648110636597,-0.993226826838649,1999,19,NR1H3|PPARG|SUMO1|CDC37|NR1H2|HSP90AB1
DETECTION OF STIMULUS%GOBP%GO:0051606,0.373966782541522,0.852609194081082,0.19120184375641303,1.06669823109053,4840,101,TAC1|RYR2|SCN1A|RTP5|UNC119|PIEZO2|TAS2R4|MRPS11|ADGRV1|PKD2|TCAP|SCARB1|DFNB31|RFC4|RTP4|PDZD7|PNKP|DTL|POLD1|POLD3|DDB1|KIT|GCK|TAS2R5|TIMELESS|PIEZO1|NLRC4|TAS2R20|CUL4B|CNGB1|CD1D|C4B|SYT1|MRPS9|UBE2B|RBX1|RFC3|REEP6
REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036490,0.17239010989010997,0.6757284283763572,-0.505378103751797,-1.27933111081538,1003,5,DNAJC3|EIF2AK3|SESN2
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002581,0.6767396086604152,0.9647315640607691,0.4531267232822321,0.861346233817435,5844,3,THBS1|HLA-DOB|HLA-DOA
"CHEMICAL SYNAPTIC TRANSMISSION, POSTSYNAPTIC%GOBP%GO:0099565",0.6714063541435239,0.964618776001639,-0.19609249958607,-0.8435463656748441,3021,18,GRIN1|DRD4|NPAS4|GSK3A|NLGN3|AKT1|MPP2|GRIN2D|NPFF|MEF2C|MAPK8IP2|GSK3B|RAB3GAP1|GRIN2C|ARRB2|CHRNA3|DRD2|C15orf59
CEREBRAL CORTEX GABAERGIC INTERNEURON MIGRATION%GOBP%GO:0021853,0.24335560504825499,0.7565220534116759,-0.711000827129859,-1.2161288360370301,1638,2,LHX6|DRD2
REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010827,0.14781634938409902,0.6402258061318559,-0.23023178911826,-1.26648021112462,527,36,SLC2A1|PEA15|RHOQ|PIK3R1|TRIB3|APPL1
ACTIN FILAMENT-BASED TRANSPORT%GOBP%GO:0099515,0.0703454085930918,0.510289229833637,0.5673468230700329,1.4766845808175302,667,7,FNBP1L|MYO19|SYNE2|MYO5A
CARDIAC ATRIUM DEVELOPMENT%GOBP%GO:0003230,0.9167698314446241,1.0,0.170787908851582,0.612651047754951,9626,18,PROX1|TGFB2|HEY2|NPHP3|DLL4|NOTCH2|ANK2|ZFPM1|ISL1
REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000194,0.6657404191270121,0.964618776001639,0.45763660604597295,0.8699190465294481,5749,3,ZP3|HYAL3|GDF9
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043370",0.9659474915518579,1.0,-0.116141423900296,-0.594382900700375,3715,29,SMAD7|NLRP3|SOCS5|CBFB
NEGATIVE REGULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052041,0.156952081696779,0.6578589353509621,-0.655619278702989,-1.33055984682348,998,3,CASP8|SERPINB9|BCL2L1
REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033233,0.294193548387097,0.800447413278835,-0.278298040231602,-1.1098774473055801,1367,15,PARK7|MUL1|MAGEA2|CTNNB1|HDAC4|UBE2I|GNL3L|RASD2
REGULATION OF CENTROMERE COMPLEX ASSEMBLY%GOBP%GO:0090230,0.598880289807344,0.949550644279504,-0.380699837099564,-0.8755300943472241,3636,4,RNF4
REGULATION OF ELASTIN CATABOLIC PROCESS%GOBP%GO:0060310,0.8187475175426979,0.987153241368501,-0.588056903396559,-0.786661649378252,6183,1,CST3
NEURAL TUBE FORMATION%GOBP%GO:0001841,0.871831110325943,0.9934031064448321,0.15956192558680202,0.6822331602115961,9869,32,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C
TAIL-ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE%GOBP%GO:0071816,0.294617563739377,0.800447413278835,0.49960295780216096,1.15151075584138,2703,5,SGTA|UBL4A|BAG6|GET4
EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0022617,0.0136752136752137,0.256136946817111,-0.30550752924827196,-1.69708100383347,47,37,CTSS|SH3PXD2B|CD44|FLOT1|MMP1|FURIN|CTSL|CTSK|ADAM10|MMP2|LAMC1|MMP9|ADAMTS4|TIMP2|CAPG|MMP12|TPSAB1|CTSV|KIF9
DETECTION OF CELL DENSITY BY CONTACT STIMULUS INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060248,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
EXOCYST ASSEMBLY%GOBP%GO:0001927,0.773315592113221,0.979946273879301,0.497049903501516,0.81241441251361,6392,2,EXOC8|EXOC2
REGULATION OF MAST CELL DIFFERENTIATION%GOBP%GO:0060375,0.873825503355705,0.9934031064448321,0.5641817379797089,0.749490268974254,6509,1,ZFPM1
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090263,0.9548780487804879,1.0,0.118862755548019,0.610437291494678,11744,67,ARNTL|CDH3|ILK|USP47|SEMA5A|DACT1|RNF146|FAM53B|CAPRIN2|PIN1|TNKS2|BAMBI|GPC3|WLS|FGFR2|UBE2B|VCP|WNK2|COL1A1|USP34|XIAP|SMURF2|UBR5|WNK1|LGR4|CSNK1E|ZBED3|ADGRA2|JUP|PRDM15|TBL1XR1|CSNK1G3|DAPK3|TNKS
NEGATIVE REGULATION OF CELL CYCLE%GOBP%GO:0045786,0.0359057897237494,0.382648509404771,0.194770267719255,1.3071324039369,528,423,PTPRK|RBBP7|KIF25|BTG2|MUS81|TAOK3|INTS7|EME2|CDK6|PRKAA2|INHA|BRINP3|CEP63|EHMT1|KAT2A|CCNB1|MAP2K6|PIDD1|TPR|CDC7|BMP4|MAPK12|NR4A1|CDK1|APAF1|E2F8|ZWINT|FBXO43|ATR|CDKN2C|PKD2|BLM|CENPF|DOT1L|NAA10|PPP1R13B|ERN1|WEE1|CDKN3|CDK2AP2|KIF20B|BRIP1|BRINP1|PCGF2|ORC1|CDC25C|USP47|DHCR24|DNA2|MUC1|TGFB2|CDC45|BUB1|RAD9A|DTL|TOP2A|E2F7|CDKN2A|DONSON|PPP1R10|MEN1|EZH2|NEK2|DACT1|CDC20|YTHDC2|STRADA|GEN1|APC|PRR11|ZNF830|NEK11|CDK5RAP2|NABP1|PTTG1|STRADB|FBXO5|RB1|BUB1B|NAE1|GTSE1|ESPL1|AURKB|CDC6|MSH6|RAD51|E2F6|PPP2R3B|CLOCK|HRAS|CDKN2B|INTS3|STK11|TRIM37|H2AFX|APBB1|CCL2|TIMELESS|KLHL22|RRAGB|CDK7|TAOK1|MAGI2|SIPA1|RPS27L|BRCC3|CCNF|CHEK2|TOPBP1|PLK1|KNTC1|PRMT1|TIPRL|EME1|BRSK1|CARM1|GAS1|TP53INP1|PRKAB2|AURKA|EIF4G2|CDC73|CHFR|ARID3A|RNF112|E4F1|CLSPN|EHMT2|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|MDM1|WDR6|GMNN|SUZ12|TOP2B|C5orf45|TEX14|PRKDC|DUSP1|EED|LAMTOR4|FHL1|RRM2|FZD3|CHEK1|RBX1|RECQL5|FAP|THBS1|FBXL7|ZNF268|RAD17|MAD2L1BP|SMC3|MGA|GATA3|RAD1|CASP2|TMEM67|CDK2|ATM|INCA1|TFAP4|UXT|CDKN2D|RFWD3|MDC1|CNOT1|UIMC1
REGULATION OF ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:1905034,0.58,0.942746898746279,0.714214821349802,0.9488025267810309,4320,1,FAM3A
EXTRACELLULAR TRANSPORT%GOBP%GO:0006858,0.601250434178534,0.9506035145731909,0.479428888731461,0.91134388345247,5192,3,TSG101|ARRDC1|WWP2
RESPONSE TO GROWTH FACTOR%GOBP%GO:0070848,0.0139165009940358,0.256136946817111,-0.149547373305079,-1.34915958882466,6,307,F11R|CTNNB1|DAB2IP|SKI|TGFBR1|ANOS1|RGMA|BCAR1|ACVR1|ARRB2|DDIT4|GDF15|PRKD2|GRB2|TMEM100|MYO1C|FAM83G|FGF7|RHOA|BMP8B|NRP1|SMAD6|INPP5K|KLF10|CASP3|HNRNPF|CPNE3|PDE8A|FGF2|MAP2K5|HGF|CDH5|EHD1|PXN|SMAD1|SMAD2|CHRDL1|SHOC2|HAP1|PTPN12|POLR2A|RAP1A|ZPR1|SMAD7|RAMP2|FGFR1|MAP2K3|MXRA5|MTSS1L|POLR2K|PDCD4|CXCL8|SOX6|FLRT1|NR3C1|RAPGEF1|SHC1|JUN|UBA52|ID1|POLR2F|DUSP3|LIMS1|CLEC3B|TWF2|ZYX|UBE2D3|MAPK3|NCBP2|FLT1|POLR2I|POLR2D|FGF10|ACVRL1|WWOX|UBC|PGF|PDE3A|TMEM108|SPRED2|PARD3|UBB
RNA POLYMERASE II CORE COMPLEX ASSEMBLY%GOBP%GO:1990114,0.25355704697986603,0.7641083395392759,0.87549625055139,1.1630577102006698,1888,1,GTF2B
REGULATION OF NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:1902841,0.6566244820248629,0.9643779777660141,0.40792584638032503,0.8644338355870359,5862,4,SIAH2|NTN1
POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000347,0.9110067114093959,1.0,0.5462064402293779,0.7256108878478271,6786,1,XBP1
REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000241,0.171113155473781,0.674379448319819,-0.213234445096577,-1.2327106363929698,557,43,CITED2|C1QBP|VIP|IGF1|CDC25B|AGO2|RTFDC1|PLCB1|CFAP69|POMZP3|PDE3A|INHBB
CELLULAR RESPONSE TO CALCIUM ION%GOBP%GO:0071277,0.15122841965471398,0.6475783026655401,0.26108659787168303,1.28357538532171,1821,55,SYT17|DPEP1|CRHBP|PRKAA2|ADGRV1|KCNH1|SYT3|ADCY8|PKD2|RASGRP2|ECT2|SYT15|HPCA|RASA4|MCOLN1|CPNE7
INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032612,0.573671623167308,0.941417936126209,0.335244591445425,0.9139666968710799,5516,8,AIM2|GBP5|F2RL1|NLRC4|TLR4|S100A13
EMBRYONIC HEART TUBE MORPHOGENESIS%GOBP%GO:0003143,0.5592238124506099,0.936434965680841,0.21324903711857698,0.9274211422160329,6368,34,RYR2|TBX2|HES1|PKD2|AHI1|FOXN4|STIL|BBS5|VANGL2|SRF|NPHP3
REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905449,0.4121801551464629,0.867015886388254,0.54923022301782,1.04402887710609,3559,3,CD47|PTPRJ|PTPRC
POSITIVE REGULATION OF INHIBITORY G PROTEIN-COUPLED RECEPTOR PHOSPHORYLATION%GOBP%GO:1904325,0.240169469085132,0.7525035503527309,-0.8796316718129692,-1.17671010712904,1813,1,APLNR
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007179,0.6462411120875611,0.963344312748158,0.167175593969402,0.880806130759473,8088,75,PTPRK|CITED1|SIRT1|ITGB1|LEFTY1|GCNT2|USP9Y|CGN|TGFB2|MAP3K7|SRC|LRRC32|ITGB5|NLK|FOS|LTBP2|BMPR1B
SARCOMEROGENESIS%GOBP%GO:0048769,0.19973154362416098,0.711592141628341,0.902459197176886,1.19887678189031,1487,1,TCAP
REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902337,0.431833791208791,0.8785877309899279,-0.396546343223345,-1.00383073583824,2514,5,NOTCH1|TNFRSF1B|PAX8
COLUMNAR/CUBOIDAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002066,0.0676002417892404,0.503384714150904,0.5018719940418339,1.48115391380989,670,10,CDK6|STRC|BMP4|DFNB31|PDZD7
RNA DESTABILIZATION%GOBP%GO:0050779,0.9481193255512321,1.0,0.15168972947246698,0.5809364765384549,10233,22,MEX3D|DXO|CPEB3|METTL3|KHSRP|RBM23|FTO|RC3H1
NEGATIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071072,0.426551453260016,0.875696962448429,-0.49586412264255003,-1.00634150413296,2714,3,SLC27A1|PDGFB|PDGFA
REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902749,0.000665680473372781,0.0806484601749226,0.301818019336984,1.78689977614575,8,142,AKAP9|TAOK3|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDC7|CDK1|KIF14|BLM|CENPF|CKAP5|CEP290|ATAD5|CEP131|CEP152|ORC1|CDC25C|USP47|DTL|DONSON|HMMR|NEK2|HAUS5|ZNF830|DBF4B|CDK5RAP2|PRKAR2B|FBXO5|NAE1|GTSE1|AURKB|CDC6|MSH6|RAD51C|CEP72|HAUS8|CEP164|CEP78|TAOK1|CEP192|BRCC3|FGFR1OP|TOPBP1|CNTRL|PLK1|BRSK1|SFI1|AURKA|CEP41|CLSPN|CEP57|DYNC1H1|NINL|CDK5RAP3|TAOK2|TUBB4A|CEP135|C5orf45|FHL1|CHEK1|RBX1|PCM1|FBXL7|RAD17|TPX2|NEDD1|PPP2R1A|CDK2|ATM|SSNA1|UIMC1|BRCA1|NDE1|CEP250|BRE
MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007006,0.000510204081632653,0.0784645998831315,-0.25649044172774,-1.90568364721344,0,106,BNIP3|IMMT|ATP5J2|MUL1|SLC25A5|ZNF205|ATP5F1|THEM4|HSPA4|BAX|ATP5J|PPIF|TP53BP2|TOMM22|GZMB|TIMM50|ROMO1|SAMM50|TOMM20|BBC3|CHCHD6|MPV17L|C19orf52|MFN2|YWHAH|CHCHD3|BCL2L1|CAMK2A|ATP5I|BOK|BID|ACAA2|YWHAQ|YWHAB|TIMM22|BCL2|TP53|YWHAZ|YWHAE|SLC35F6|BNIP3L|BMF|LETM1|BCL2L11|PMAIP1|TFDP2
NEGATIVE REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120163,0.007952871870397641,0.19847993048827997,-0.30992031744586496,-1.76254982777406,26,40,ATF4|FLCN|NOTCH1|PGAM5|IP6K1|ARRDC3|NR1H3|ACOT11|ZNF423|DDIT3|TFE3|FOXC2|HOXC10|NR1H2|ADAM17|LAMA4|ID1|NR1D1|RBPJ|TLE3
DRINKING BEHAVIOR%GOBP%GO:0042756,0.8390604026845642,0.989395884107905,0.5810542567269521,0.7719046573935391,6250,1,APLN
PREPULSE INHIBITION%GOBP%GO:0060134,0.0882953652788688,0.556932119338259,-0.7237593013226321,-1.46884799820107,561,3,DRD2
ASTROCYTE ACTIVATION%GOBP%GO:0048143,0.384787087912088,0.8593496731626808,-0.411868519744099,-1.04261780825567,2240,5,LRP1|MAPT|APP|PSEN1|TNF
POSITIVE REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903012,0.576704874377677,0.942692029750853,0.48872699368440503,0.92901860284409,4980,3,ATP6AP1|TAPT1|TMEM119
CHONDROBLAST DIFFERENTIATION%GOBP%GO:0060591,0.261617900172117,0.771967970256231,-0.8695963828848701,-1.16328559515653,1975,1,FGF2
POSITIVE REGULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0097151,0.16116026430731303,0.663924163480949,0.607226902800508,1.2867718123702498,1438,4,RIMS2|UNC13B|RIMS1|NLGN2
NEGATIVE REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900041,0.23238884533542398,0.746121572059682,0.567946470541285,1.20353282415057,2074,4,TRIM27|GBP1
SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCUS ASSEMBLY%GOBP%GO:0035986,0.6955364703036171,0.96731875442989,0.5310297662972371,0.867953564771779,5749,2,CDKN2A|HMGA1
NEGATIVE REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0061044,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
DCMP PHOSPHORYLATION%GOBP%GO:0061567,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:0002183,0.194237147595357,0.7049178772406091,-0.34349105008253605,-1.25137235101571,936,12,EIF4G1|EIF4H|EIF4B|EIF3A|EIF2S3
SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033363,0.336772777167947,0.8313152426111751,-0.262033537368396,-1.07311540249872,1533,16,BLOC1S1|SRGN|VPS33B|PTPRN|RFX2|ABCA1|BLOC1S3
MODULATION BY ORGANISM OF IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052552,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0035481,0.37643643401475707,0.853374872190571,0.653221020852213,1.06767181355176,3111,2,ROBO2|ROBO1
REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905462,0.17527158696382597,0.6780361484951921,0.598852920090443,1.2690265430831202,1564,4,GTF2H2|TOP2A|POT1|MNAT1
INTERFERON-BETA PRODUCTION%GOBP%GO:0032608,0.7663786331500391,0.9792236089291529,-0.37575824418219894,-0.762590192300043,4877,3,TRIM56|IRF7|TMEM173
POSITIVE REGULATION OF TELOMERIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:1905549,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0032968,0.978046103183315,1.0,-0.13485416285108198,-0.5522731200743629,4454,16,SUPT16H|CDK9|ELL|TCEB1|EAPP
MONOCYTE AGGREGATION%GOBP%GO:0070487,0.285781618224666,0.794899123180836,-0.5608249696702329,-1.1381776131041101,1818,3,BMP7|CD44|IL1B
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060045,0.289598108747045,0.7989014598698071,-0.335932931410899,-1.13651138939903,1469,10,NOTCH1|PIM1|FGF2|TBX20|RBPJ
REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0050433,0.23456175298804802,0.748317706308157,-0.23966342635000895,-1.1768177132967501,941,26,VIP|CRH|SNCA|HRH3|SYT2|PARK2|ADRA2A|SYT9
REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070232,0.32862325759022304,0.828303707528737,0.315846674447569,1.11394560856068,3441,17,IDO1|CD27|BMP4|BLM|PRKCQ|CCL5
REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902965,0.5339629495096261,0.9265056012720759,-0.31621621621621604,-0.92241673194014,2939,7,SORL1|MGAT3|RDX|ROCK2|DTX3L|EZR|MSN
POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000643,0.104178272980501,0.5762893149145369,-0.45406505163848104,-1.41143188379177,560,8,EZR|MTMR2|RAB21|VPS11|MSN
NEGATIVE STRANDED VIRAL RNA REPLICATION%GOBP%GO:0039689,0.18495221966856196,0.691482206657505,0.742978200643797,1.2143774581471298,1528,2,ATG16L2|ATG16L1
REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030833,0.974457831325301,1.0,-0.0908817790447529,-0.66606491589525,2021,100,CDC42EP2|CYFIP1|CAPZA1|CDC42EP3|PRKCE|WIPF2|BAIAP2|GSN|CAPZB|ARF6|TRIOBP|FCHSD1|KANK4|ARPC1B|PYCARD|CAPZA2|RLTPR|NCK2|HAX1|CDC42EP5|ADD1|PRKCD|PTK2B|VASP|PFN1|TMSB10|MYADM|WHAMM|ARPC5|BIN1|WIPF1|TMSB4X|ARPC5L|ARPC4|TWF1|MTPN|ARPIN|TWF2|ACTR2|BRK1|JMY
PHOSPHOLIPASE C-ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060158,0.506504198913223,0.9172434440873181,-0.410188383484395,-0.9433475906592099,3075,4,GNA15|DRD2
SCHWANN CELL DEVELOPMENT%GOBP%GO:0014044,0.7104921077065921,0.9700296616429409,-0.257929723824275,-0.8017578861652571,3825,8,PARD3
POLYAMINE CATABOLIC PROCESS%GOBP%GO:0006598,0.100668151447661,0.570947005522165,-0.8079969186704921,-1.38203545583891,677,2,SMOX
C-TERMINAL PROTEIN METHYLATION%GOBP%GO:0006481,0.6803918972593671,0.9648886975948259,-0.6549955888839879,-0.8762075698981949,5138,1,LCMT1
REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904742,0.8323727976288492,0.9879918468324742,-0.31103512932223,-0.715315819926588,5054,4,ACD|TNKS|ERCC4|PINX1
REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0007063,0.0660096690219412,0.496451466245399,0.39134952952934793,1.4795098132178501,709,21,NAA10|FAM178A|BUB1|FEN1|HDAC8|RB1|ESPL1|NIPBL|CDCA5
RESPONSE TO STEROID HORMONE%GOBP%GO:0048545,0.713174526008751,0.971081608033886,-0.120010534803988,-0.8815146781507741,1466,101,NRIP1|NEDD4|PPARGC1A|NR3C1|KLF9|UBE2L3|ADCYAP1|RNF4|AQP1|TNF|BCL2L11|CAV1|SLIT3
POSITIVE REGULATION OF ABSCISIC ACID-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0009789,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
NEGATIVE REGULATION OF ION TRANSPORT%GOBP%GO:0043271,0.000393236335037357,0.0784645998831315,-0.32434119570346504,-2.19515945238865,0,73,CAMK2D|GPM6B|SRI|HECW2|PPIF|NEDD4L|KCNE3|FKBP1B|PTK2B|CRHR1|KCNE4|SESTD1|PLN|INPP5K|PXK|SLC30A1|KCNAB1|MMP9|SUMO1|HTR1B|VIP|BIN1|CAB39|SNCA|FMR1|GNB5|NEDD4|HRH3|COMMD1|YWHAE|ADCYAP1|ADRA2A|CAV1|FKBP1A|STC1|EPHB2|TRH
RENAL WATER ABSORPTION%GOBP%GO:0070295,0.782013422818792,0.981487311948134,0.610608734009704,0.8111664619449659,5825,1,HYAL2
HISTONE H3-S10 PHOSPHORYLATION%GOBP%GO:0043987,0.44182007641542204,0.880423444399886,0.537462243998981,1.0216591869362,3815,3,VRK1|RPS6KA4|RPS6KA5
ACTIN MODIFICATION%GOBP%GO:0030047,0.20831477357089803,0.7238327250928481,-0.733443617314585,-1.25451602668905,1402,2,TRIOBP|NAT6
"SPERMATOGENESIS, EXCHANGE OF CHROMOSOMAL PROTEINS%GOBP%GO:0035093",0.48378066853285,0.9064456896937672,-0.41923502345818103,-0.9641529726896279,2937,4,CHD5|PSME4|PIWIL1
POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045618,0.645275035260931,0.9627387260320971,0.2893364480943811,0.853906608837633,6404,10,NUMA1|H2AFY2|MED1|NCOA3|CYP27B1|NME2
DIBASIC PROTEIN PROCESSING%GOBP%GO:0090472,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002791,0.179775280898876,0.68489956912038,-0.129955303413259,-1.12351169663843,143,235,LGALS9|TNFAIP3|NR1H3|PFKL|SSC5D|FGR|GPI|STXBP4|ANO1|RAB11FIP1|TCF7L2|TNFRSF1B|ARL2BP|MYRIP|IL6|SLC25A4|FCGR2B|PANX1|VAMP3|MBP|IGF1|MAVS|PAX8|UQCC2|MYOM1|FOXP1|RIPK2|RAP1A|TMSB4X|DPH3|GAPDH|CRH|KARS|GIPR|NLRP1|NLRP3|PRKCA|TNFRSF4|ADCYAP1|DRD2|PPP1R11|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|CD22|NR1D1|CACNA1E|TWIST1|TNF|SNAP25|TNFRSF21|INHBB|TRH
CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010644,0.642387944358578,0.9620807249753851,0.25326522398122003,0.8587241137857571,6649,15,RYR2|GJC2|GJA1|GJC3|SLC8A1
NEGATIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000502,0.11878553284141802,0.602329212916938,0.7896884477529641,1.29072407384151,981,2,KLRK1|CCL2
MAST CELL MIGRATION%GOBP%GO:0097531,0.9572768322334151,1.0,0.30750134038612,0.584527700147194,8267,3,KIT|CHGA
POSITIVE REGULATION OF WNT PROTEIN SECRETION%GOBP%GO:0061357,0.839966130397968,0.98953921193435,0.467734821333998,0.7644997160432191,6943,2,WLS|PTPN23
MONOVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0055083,0.338674363057325,0.8326275783736579,0.363739277625231,1.10968515639672,3402,11,FGFR4|SLC12A2|XPR1|TFAP2B|SLC12A5|SLC12A9|SLC12A4|SFRP4
POSITIVE REGULATION OF CARDIOBLAST PROLIFERATION%GOBP%GO:1905062,0.39083807758506606,0.8608417878556021,-0.802216585796207,-1.0731495861982399,2951,1,PIM1
NEGATIVE REGULATION OF RHO-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:2000299,0.24454342984409802,0.757467559003634,-0.710283981251723,-1.21490270955429,1646,2,RASIP1|HEG1
VESICLE-MEDIATED TRANSPORT IN SYNAPSE%GOBP%GO:0099003,0.45280665280665294,0.8874890379518141,-0.145697563552509,-1.00725589137419,1088,79,SNCA|AP3S2|BLOC1S6|OTOF|SNPH|SYT2|BLOC1S3|AMPH|TMEM230|SYT9|SNAP25|CPLX1
AROMATIC AMINO ACID FAMILY BIOSYNTHETIC PROCESS%GOBP%GO:0009073,0.125645438898451,0.607607158836689,-0.934825760917512,-1.25054492297786,948,1,PAH
MODULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044827,0.320145337101332,0.822183858873702,-0.31299575002108504,-1.10147104024136,1585,11,PPIB|NUCKS1|VAPA|ZC3H12A|EIF2AK4|FBXL2|CCNK|TBC1D20|FMR1|PARK2
SIGNAL PEPTIDE PROCESSING%GOBP%GO:0006465,0.39302600472813204,0.8621064456029929,-0.306228278258951,-1.03601610159397,1994,10,SPCS2|SEC11C|SEC11A|SPPL3|CLN5|HM13|SPCS3|PCSK5|SPCS1|FURIN
DNA RECOMBINASE ASSEMBLY%GOBP%GO:0000730,0.8565593087195601,0.991298302704726,-0.342196497968673,-0.6944776255229621,5451,3,DMC1
SYNAPTIC VESICLE BUDDING FROM PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE%GOBP%GO:0016185,0.7242097950677321,0.972554563883587,0.43553459278629797,0.8279054443673279,6254,3,DNM3|DNM1
POSITIVE REGULATION OF DENDRITE EXTENSION%GOBP%GO:1903861,0.5498454404945899,0.931359181171847,0.274304810654087,0.9300611893465771,5691,15,SYT17|RIMS2|SYT3|UNC13A|SYT1|PLAA|RIMS1|CPNE5|SYT4
POSITIVE REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000979,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
POSITIVE REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0045964,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|HPRT1
MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER%GOBP%GO:0072393,0.9626645706425621,1.0,0.171697236885897,0.541251049453629,9797,12,CCDC68|CCDC120|NINL|PCM1|HOOK3
PLASMA MEMBRANE BOUNDED CELL PROJECTION MORPHOGENESIS%GOBP%GO:0120039,0.164051355206847,0.666385698695266,-0.127522278500335,-1.1377173492667,114,268,PARD6B|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|RAB8A|CDC42|DBNL|NEFH|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|GFRA2|NBL1|SLIT3|EPHB2|PARD3|UBB
VAGUS NERVE MORPHOGENESIS%GOBP%GO:0021644,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
REGULATION OF TRANSCRIPTION BY GALACTOSE%GOBP%GO:0000409,0.758771349132795,0.977664504547119,-0.617390824878694,-0.825902530528672,5730,1,NCOA1
SULFUR COMPOUND TRANSPORT%GOBP%GO:0072348,0.724293473257848,0.972554563883587,0.206308547492971,0.802375879234495,7867,23,SLC25A19|LRRC8D|SLC26A2|SLC25A10|SLC7A9|SLC5A6|SLC19A2|RACGAP1|SLC1A1|SLC35B2|SLC25A30
WNT SIGNALING PATHWAY INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061289,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
POSITIVE REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032946,0.8768075417432291,0.99444152362265,0.135477712126296,0.7137979688826421,10974,75,CD209|CD38|AGER|CD320|BLM|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|IL7|CCL19|TMIGD2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|HLA-DMB|IGFBP2|CD3E|CD46
REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901256,0.4006257204017779,0.8638522656500329,-0.44835383003364004,-1.03112014468141,2432,4,ISL1|CD34|HAVCR2|FOXP1
CHROMATIN ASSEMBLY%GOBP%GO:0031497,0.0986913849509269,0.570215774831708,0.242150791053584,1.33048019640096,1266,93,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|ASF1B|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|ASF1A|CASC5|CENPU|CDKN2A|OIP5|ITGB3BP|CENPA|HIST1H4I|HELLS|CENPV|CENPQ|CENPI|H2AFX|H3F3A|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|HIST1H2BK|STRA13|CENPM
CARBOHYDRATE HOMEOSTASIS%GOBP%GO:0033500,0.0199836867862969,0.296019532082167,-0.21831834183648702,-1.4960526938501697,48,76,PTPRN|IGF1R|USF1|PRKAA1|FOXO4|CEBPA|CRTC2|ADRA1B|INPP5K|TCF7L2|FOXO1|RAB11FIP2|PPARG|GCGR|TRA2B|LEPR|HK1|PPARGC1A|HK2|STAT3|ADRA2A|RAB11FIP5|GPRC5B|PIK3R1|FOXO6|FOXO3
BASIC AMINO ACID TRANSPORT%GOBP%GO:0015802,0.428812131423757,0.8774573162143371,0.39666613969319797,1.03243862201913,4071,7,SLC25A29|SLC15A4|PQLC2
EMBRYONIC MORPHOGENESIS%GOBP%GO:0048598,0.480675803059967,0.9046812288131709,0.164258257267392,1.00079308167722,6628,173,RYR2|HOXD3|ITGB1|SIX3|TBX3|NR4A3|TBX2|HOXB3|HOXD4|STRC|HES1|BMP4|HOXC4|MYH3|PROX1|PKD2|ZNF358|AHI1|CEP290|DFNB31|ITGA2|MTHFD1|DVL1|DEAF1|FOXN4|ITGA4|EFEMP1|TGFB2|COL8A1|PDZD7|FBN1|COL4A2|DACT1|STIL|ITGB5|LEF1|BBS5|C5orf42|NIPBL|VANGL2|PLXNB2|SEMA4C|SRF|ZNF281|TH|NPHP3
CALCITONIN CATABOLIC PROCESS%GOBP%GO:0010816,0.625446842314312,0.954110852066186,-0.680359505955007,-0.9101376551034459,4723,1,ECE1
CALCIUM ION-REGULATED EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:0048791,0.29787022292993603,0.8023890191280308,0.375349966243674,1.14510670586355,2992,11,SYT17|RIMS2|SYT1|RIMS4|SYT7|RIMS1|RIMS3|SYT4
LEUKOTRIENE D4 METABOLIC PROCESS%GOBP%GO:1901748,0.10362394349889999,0.575794607412397,0.7122364089366829,1.3538864889307298,894,3,GGT1|GGT5
NEGATIVE REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000521,0.16086323315239,0.663407673484119,-0.9167401852668721,-1.2263512970054198,1214,1,LGALS3
CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0016051,0.0029106029106029103,0.13103871184697197,-0.254362172384202,-1.75849060498797,6,79,GPI|CRTC2|FBP1|G6PD|ST3GAL2|ENO1|GAPDH|PGK1|SORD|PPARGC1A|TPI1|G6PC3|B3GNT5|B3GNT7|CSGALNACT1|ALDOA|TKT|SLC25A13|SLC2A1|ST6GALNAC5|PER2|B3GNT8|B3GNT2|NR1D1|PC|PGAM2
NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050748,0.185074626865672,0.691482206657505,-0.633340686004191,-1.28534610486733,1177,3,ITGB3|ITGAV|APOD
NEGATIVE REGULATION OF ATPASE ACTIVITY%GOBP%GO:0032780,0.7867950481430541,0.9819033472805508,0.23421417103405603,0.7383267673278859,8007,12,THADA|PAM16|ATPIF1|TNNI3|OXA1L
BARBED-END ACTIN FILAMENT UNCAPPING%GOBP%GO:0051638,0.8211306765523629,0.987153241368501,-0.5870092633436259,-0.785260189337165,6201,1,LRRC16A
ADRENAL CHROMAFFIN CELL DIFFERENTIATION%GOBP%GO:0061104,0.0153581358400636,0.264745847609811,-0.992556241729157,-1.3277727473471999,115,1,INSM1
RNA SPLICING%GOBP%GO:0008380,0.99986143827075,1.0,0.0751769684686004,0.489281900364341,14431,296,CELF5|NOL3|SKIV2L2|ZCCHC8|PPWD1|SFSWAP|U2AF1L4|CELF1|RBM4B|SMN1|CCAR1|DDX20|DHX9|PRPF39|ERN1|TSEN54|PRPF8|UPF3B|SART3|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|DDX17|PPIL1|C7orf55-LUC7L2|PPIE|RNPC3|FIP1L1|LUC7L|METTL3|GEMIN5|LUC7L3|SRPK1|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|CDK13|POLR2L|U2SURP|SRSF2|KHSRP|SMN2|CACTIN|SFPQ|HNRNPH1|PNN|HNRNPA2B1|TRA2A|NOVA1|PABPN1|SRSF11|POLR2J|RBM5|MPHOSPH10|XAB2|LSM8|SF3B1|DHX40|RBM41|AQR|SNRPD1|TGS1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|MFAP1|CPSF7|GEMIN8|PPP2R1A|DDX46|SNRNP40|PRPF4B|DDX5|PRPF3|DDX42|RBM4|YTHDC1|CHERP|USP49|GTF2F2|PQBP1|CSTF3|TARDBP|CELF3|RBPMS|PSIP1|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|RBM17|SRSF9|WDR83|SRSF5|PRMT7|SETX|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|SNRPN|CDK12|SNRNP25|CPSF4|SRSF10|CELF6|CWC27|PCF11|SYMPK|SNRNP48|PLRG1|SNW1|CWC22|SRSF12|DCPS|GEMIN2|PRPF40A|PHF5A|SF3B2|IVNS1ABP|DBR1|C14orf166
MEIOTIC DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:0000706,0.11961025870758198,0.6055840704543771,0.635635455839407,1.34697224998606,1067,4,BLM|EXO1|SLX4
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904954,0.0942835931700074,0.5630268609168221,-0.813785497656465,-1.39193651017795,634,2,CTNNB1|WNT3
NOREPINEPHRINE-EPINEPHRINE VASOCONSTRICTION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001994,0.306765523632994,0.809874675097403,-0.8476510807234229,-1.13392869534851,2316,1,ADRA1B
AXON REGENERATION%GOBP%GO:0031103,0.269210772590205,0.784543299601953,0.431320138917938,1.1758944147648602,2588,8,RTN4RL1|DHFR|MTR|NREP|GAP43
ACTIVATION OF IMMUNE RESPONSE%GOBP%GO:0002253,0.101293103448276,0.571655361840848,-0.129350724523142,-1.18158577029968,46,334,ITK|FPR1|IGHV5-51|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|ARPC1B|UBE2N|PIK3CD|TLR1|CREBBP|CD79B|PYCARD|PIK3R2|THY1|XRCC6|MYO10|ITCH|BAX|MYO1G|HEXIM1|NOD1|PPAPDC1A|BLK|IGHV4-4|EIF2B3|ICOSLG|CLU|IRAK1|SIN3A|FCER1G|PIK3C3|DENND1B|PRKCD|CD19|C5AR1|ABI1|IGHV2-26|LGALS9|BCAR1|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|PRKD2|IRAK4|GRB2|FGR|ABL1|VAV1|MYO1C|TRAF3|IGHV1-69-2|CYFIP2|S100A8|IGHV3-15|HLA-DQB1|FYN|IGHV3-73|BCL10|UBE2V1|RELB|LYN|FCGR2B|CYLD|TANK|ARPC5|RNF31|CD276|YES1|MAVS|CNPY3|TNIP1|WIPF1|CRK|RIPK2|MUC4|LIMK1|VAV3|VAV2|ARPC4|CFD|CDC42|PDE4B|MUC3A|RFTN1|IGHV1-3|KRAS|BCL2|UBA52|NFATC2|COLEC12|RBCK1|MAPK3|HLA-DQA2|TNIP2|HLA-DQB2|RAC1|PLD2|TICAM1|MUC12|MYD88|ACTR2|BRK1|UBC|CD36|PIK3R1|HSP90AB1|PDE4D|TNFRSF21|PAK2|UBB
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY%GOBP%GO:0043128,0.582417582417583,0.943593972061982,-0.7024150860167621,-0.9396420770210551,4398,1,CD81
SPERM AXONEME ASSEMBLY%GOBP%GO:0007288,0.9128295254833041,1.0,-0.231681232228369,-0.635949426209755,5193,6,IQCG
ALPHA-BETA T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002293,0.9288172043010748,1.0,-0.16044665225361998,-0.6398755833270551,4318,15,RORC|GPR183|BATF|IL6|FOXP1|STAT3
REGULATION OF CDP-DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE ACTIVITY%GOBP%GO:1904217,0.31317285593322897,0.8158652929227931,0.681033924756165,1.1131312409176002,2588,2,SERINC5|SERINC1
PROTEIN-DNA COMPLEX ASSEMBLY%GOBP%GO:0065004,0.0220090713064168,0.310715277412964,0.251386998531435,1.4777151976935903,295,136,GTF2H2|RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|BDP1|ASF1B|CENPF|CENPL|CENPT|NAP1L4|HIST2H3C|TAF7|HIST2H3A|SART3|GTF2B|CENPK|GTF2H1|DDB2|ASF1A|CDC45|CASC5|CENPU|PARP1|OIP5|ITGB3BP|CENPA|CENPE|HIST1H4I|DDB1|RAD51|CHD1L|HELLS|CENPV|CENPQ|CENPI|H2AFX|H3F3A|WDR18|CDK7|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|CUL4B|POGZ|HIST1H2BK|STRA13|CENPM|ERCC5|GMNN|HIST1H3H|ACD|XPA|RBX1|HIRA|HIST1H2BN
NEGATIVE REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900085,0.0115186018800477,0.23212667146341198,-0.995037494486105,-1.3310919948129298,86,1,CAV1
INACTIVATION OF X CHROMOSOME BY HETEROCHROMATIN ASSEMBLY%GOBP%GO:0060820,0.803918972593671,0.984522820758988,-0.5958866343184829,-0.7971357191590029,6071,1,SMCHD1
POLYUBIQUITINATED MISFOLDED PROTEIN TRANSPORT%GOBP%GO:0070845,0.45006711409396,0.886062942999295,0.7804367004852231,1.03677533884496,3352,1,HDAC6
EXOGENOUS DRUG CATABOLIC PROCESS%GOBP%GO:0042738,0.11604886267902302,0.595195173374821,0.5330484301920341,1.3874130702524399,1101,7,CYP2D7|CYP2C8|CYP2R1|CYP2E1|CYP2D6
PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036499,0.731190286624204,0.9726603499749559,0.258005093389567,0.7871143976486831,7346,11,ASNS|CCL2|NFE2L2|HERPUD1|ATF3
REGULATION OF PENTOSE-PHOSPHATE SHUNT%GOBP%GO:0043456,0.28760207869339305,0.7968843943853571,-0.686958919216984,-1.1750064401542901,1936,2,PGAM1|TIGAR
RESPONSE TO INTERLEUKIN-7%GOBP%GO:0098760,0.0410958904109589,0.402256981537283,0.420756462220614,1.5624788076868399,437,20,HIST1H3E|IL7R|CISH|HIST2H3C|HIST2H3A|SOCS2|IL7|IRS1|SOCS1|SMARCA4|STAT5B|HIST1H3H
PROTEIN AUTO-ADP-RIBOSYLATION%GOBP%GO:0070213,0.22006943666703999,0.735314515752205,0.574164355531556,1.21670911640827,1964,4,PARP16|TNKS2|PARP10|TNKS
REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:0039535,0.995482667190415,1.0,0.13554363572984302,0.437449694273089,10136,13,ANKRD17|BIRC2|NPLOC4|DHX58|BIRC3|DDX60|PUM2
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000767,0.808866891322662,0.984682960940884,0.27543968672969205,0.7169116346470459,7680,7,DHX9|METTL3|NCK1|MTOR|YBX3
REGULATION OF ATP CITRATE SYNTHASE ACTIVITY%GOBP%GO:2000983,0.715704697986577,0.971081608033886,0.6459528010586679,0.858119478208892,5331,1,PHPT1
REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903203,0.637023217247098,0.959271399361425,-0.23545266893737302,-0.857777691180854,3072,12,PARK7|ATF4|HIF1A|FBXW7|PARK2|FBXO7
DUMP METABOLIC PROCESS%GOBP%GO:0046078,0.6110653713156601,0.9508825506493929,-0.376396920433492,-0.8656342849260351,3710,4,DCTD|CDADC1
LUNG SECRETORY CELL DIFFERENTIATION%GOBP%GO:0061140,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
STORE-OPERATED CALCIUM ENTRY%GOBP%GO:0002115,0.753791069924179,0.977083996023335,0.293211724184609,0.763168514235052,7157,7,CRACR2B
POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032725,0.611247803163445,0.9508825506493929,-0.31581269648668,-0.8668846465841059,3477,6,RASGRP1|DDX58|ISL1|IL18|IL17D|IL1B
LUNG SACCULE DEVELOPMENT%GOBP%GO:0060430,0.120564216778025,0.6066999390482379,-0.7894127377998349,-1.3502482097647102,811,2,STRA6|FGF10
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055024,0.114456332421,0.5914231891495121,-0.27565400386881,-1.3372723869706398,459,25,TGFB1|FZD7|TGFBR3|SMAD4|FRS2|AKAP6|NOTCH1|PIM1|TGFBR1|FGF2|IGF1|SOX6|TBX20|DKK1|GREM1|RBPJ
POSITIVE REGULATION OF TELOMERE CAPPING%GOBP%GO:1904355,0.21077821384129397,0.7255949404689929,0.357775024887738,1.24030898631322,2201,16,PNKP|PRKCQ|NEK2|AURKB|MAP3K4|TNKS2|MAP2K7
POSITIVE REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090240,0.979675652906487,1.0,0.197679187351745,0.5145173922562489,9302,7,MUC1|BRCA1|KAT7|AUTS2|PIH1D1|SMARCB1
ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001935,0.36602150537634404,0.8510019955058101,-0.263269640035155,-1.0499428447002601,1701,15,BMPER|ACVRL1|DLG1
INTESTINAL HEXOSE ABSORPTION%GOBP%GO:0106001,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
NEGATIVE REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905447,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
ENDOCHONDRAL OSSIFICATION%GOBP%GO:0001958,0.948083403538332,1.0,0.221395728636853,0.576246566373292,9002,7,BMP4|SCX|COL13A1|MEF2C|INPPL1
SENSORY SYSTEM DEVELOPMENT%GOBP%GO:0048880,0.45434281322059994,0.888760596723902,0.180361712509754,1.01320873973837,5910,105,SIX3|TSPAN12|NHS|SMG9|SHROOM2|TBX2|SDK1|WNT5B|PROX1|DSCAM|SMARCD3|AHI1|CEP290|SMOC1|ZDHHC16|FOXN4|EFEMP1|TGFB2|DCX|FBN1|MAB21L2|MED1|BMPR1B|NF1|NIPBL|COL4A1|COL5A2|TH|COL5A1|TFAP2B|MYO7A|SMARCA4|CHD7|MDM1|TOPORS|WNT2B
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2001056,0.537120079720977,0.9265056012720759,-0.13070640367018999,-0.963163814861442,1077,103,LGALS9|CIDEB|DLC1|EIF2AK3|BBC3|RPS3|CYFIP2|S100A8|FYN|DDX3X|TNFRSF10A|PPARG|BOK|RIPK2|CRADD|SNCA|NLRP1|NLRP3|TNFRSF10B|MTCH1|SOX7|BCAP31|TNF|PMAIP1|EGLN3
PEPTIDYL-LYSINE PROPIONYLATION%GOBP%GO:0061921,0.9867602277240831,1.0,-0.507002646669607,-0.678232898831038,7452,1,EP300
NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048843,0.815610217596973,0.986631695793843,0.197723555469497,0.7227098469913229,8620,19,SEMA3D|SEMA5A|SEMA3E|SEMA4G|SEMA6A|SEMA4C|SEMA4A|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D
PROGRAMMED CELL DEATH%GOBP%GO:0012501,0.194331983805668,0.705001529858854,-0.11522317454090199,-1.09591838716741,47,436,PPIF|TP53BP2|IL1B|SRGN|GZMB|CLU|KPNA1|TIMM50|CAPNS1|NFKBIA|BCLAF1|CTSL|PLK3|PRKCD|DAB2IP|RTN4|PGAM5|PTK2B|KRT17|DDIT4|CIDEB|RRAGC|DLC1|LAMP1|ABL1|BBC3|PML|ZNF385A|MYBBP1A|CYFIP2|CUL5|DDX47|ITPK1|DDX3X|ATG3|CASP3|PKM|TNFRSF10A|H1F0|KAZN|DDIT3|DFFA|IL6|DFNA5|CYLD|MAGI3|BCL2L1|SH3GLB1|YARS|EXOG|CAMK2A|POU4F2|PPP2CA|BOK|SPINK5|SOD2|BID|ACAA2|CRADD|ZPR1|JADE1|CHAC1|KRT9|PDCD10|MAL|RELT|GAPDH|MRPS30|PPP2R1B|GADD45A|MLKL|STK4|GNGT1|PDCD4|BAG3|EIF5A|HK2|NLRP1|NLRP3|BCL2|CFLAR|PRKCA|BNIP2|NDUFS1|TP53|BCL3|CDIP1|ZNF622|TNFRSF10B|GABARAP|CDKN1A|BNIP3L|BMF|TFPT|PKP4|CRIP1|EVPL|STK24|TICAM1|MYD88|BIK|JMY|TNF|BCL2L11|PMAIP1|TNFRSF21|CAV1|SLIT3|TRIB3|APPL1|EGLN3
NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120033,0.20501419110690602,0.7211951452265429,0.339310205819664,1.24023071681186,2166,19,TBC1D30|EVI5L|EVL|CDK10|CCL21|PLXNB3|CEP97|TCHP|RAP1GAP|TBC1D7|PFN2
MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:0038145,0.6920805369127521,0.96731875442989,0.658359064843405,0.874600646164249,5155,1,CSF1R
NEGATIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000393,0.42331106161841103,0.873470206885489,-0.601144342822066,-1.02822520316551,2850,2,ARPIN
PEPTIDYL-PROLINE HYDROXYLATION%GOBP%GO:0019511,0.887509850275808,0.997039752625282,-0.195695286801922,-0.662066446918395,4504,10,EGLN3
"REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0009794",0.7059164061595459,0.968941691852291,0.44273698047070204,0.8415964256926359,6096,3,HES1|FZD3
MYELOID LEUKOCYTE CYTOKINE PRODUCTION%GOBP%GO:0061082,0.489864486504648,0.908938677284213,0.46502631286289503,0.985435178584354,4373,4,SIRT1|KIT
MRNA PROCESSING%GOBP%GO:0006397,0.995939156170418,1.0,0.0898436369300466,0.5902422849738239,14469,327,GTF2H2|PRMT9|CELF5|NOL3|SKIV2L2|ZCCHC8|PPWD1|SFSWAP|CMTR2|THOC3|U2AF1L4|CELF1|RBM4B|SMN1|CCAR1|ZC3H11A|DDX20|DHX9|PRPF39|THOC1|ERN1|LSM11|PRPF8|UPF3B|SART3|GTF2H1|WDR33|POLR2B|LSM7|SUGP1|CPSF1|ELAVL2|SRSF1|AKAP8L|DDX17|PPIL1|C7orf55-LUC7L2|PPIE|RNPC3|FIP1L1|LUC7L|METTL3|CPSF6|GEMIN5|LUC7L3|SRPK1|CDK7|LSM4|PAPOLA|ELAVL1|SRSF6|SRRT|CDK13|SON|POLR2L|U2SURP|SRSF2|THOC2|SMN2|CACTIN|SFPQ|HNRNPH1|PNN|HNRNPA2B1|TRA2A|GRSF1|PABPN1|CDC73|SRSF11|POLR2J|RBM5|SRRM4|XAB2|LSM8|SF3B1|DHX40|RBM41|AQR|SNRPD1|TGS1|CPSF2|POLR2G|DDX39B|POLR2H|GCFC2|MFAP1|CPSF7|GEMIN8|DDX46|ZC3H3|SNRNP40|PRPF4B|DDX5|PRPF3|DDX42|RBM4|YTHDC1|CHERP|USP49|GTF2F2|PQBP1|CSTF3|CELF3|RBPMS|PSIP1|RBMX|U2AF2|ZMAT5|SNRNP70|SMNDC1|MNAT1|RBM17|SRSF9|WDR83|SRSF5|CMTR1|PRMT7|SETX|HNRNPK|CWC15|HSPA8|SRSF4|SNRPE|TUT1|SNRPN|SNRNP25|CPSF4|SARNP|SRSF10|CELF6|CWC27|PCF11|SYMPK|SNRNP48|AHCYL1|PNPT1|PLRG1|SNW1|CWC22|KIN|SRSF12|DCPS|GEMIN2|PRPF40A|PHF5A|GTF2H3|SF3B2|DBR1
GLIOGENESIS%GOBP%GO:0042063,0.699478062306312,0.967678885433393,0.16563474202857198,0.840853699973054,8576,63,NF2|CDK6|SLC8A3|HES1|PRDM8|CDH2|EIF2B5|TGFB2|EIF2B1|AZU1|GPC1|LEF1|NF1|EIF2B4|CCL2|METTL3
INTERMEDIATE MESODERM FORMATION%GOBP%GO:0048391,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
POSITIVE REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061184,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
RIGHT VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0003221,0.0215808288097445,0.30931709379024297,-0.989689016321129,-1.3239371724979099,162,1,ZFPM2
METANEPHRIC TUBULE DEVELOPMENT%GOBP%GO:0072170,0.7830265138358229,0.981487311948134,0.41170874221997095,0.782615008826143,6762,3,PKD2|PKD1
BMP SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0003130,0.127494859078263,0.6076669536424699,0.7818332732196001,1.2778850068610002,1053,2,BMP4|BMP2
MIRNA METABOLIC PROCESS%GOBP%GO:0010586,0.526084043266009,0.9265056012720759,0.274203476871129,0.950589093099231,5495,16,LIN28B|ZCCHC11|DDX17|KHSRP|DICER1|TARBP2|ZCCHC6|XPO5
FORMALDEHYDE BIOSYNTHETIC PROCESS%GOBP%GO:0046293,0.5058916986627829,0.9172434440873181,-0.743493603881782,-0.994594062842602,3820,1,KDM3A
TELOMERASE RNA LOCALIZATION%GOBP%GO:0090672,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
POSITIVE REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1902523,0.277851699528245,0.7884684708511421,0.696277915632754,1.13804712522846,2296,2,BIRC2|PTPN22
GROWTH PLATE CARTILAGE CHONDROCYTE MORPHOGENESIS%GOBP%GO:0003429,0.5572139303482591,0.9361453421204542,-0.250488266088233,-0.912553879821217,2687,12,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
HYPOXANTHINE BIOSYNTHETIC PROCESS%GOBP%GO:0046101,0.104163393558523,0.5762893149145369,-0.7071798830925329,-1.43520056149923,662,3,ADA|PRPS1|HPRT1
MEIOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0033313,0.335271013354281,0.8311444145897029,-0.536378891375919,-1.0885650235306898,2133,3,HUS1
OLFACTORY BULB INTERNEURON DEVELOPMENT%GOBP%GO:0021891,0.511331444759207,0.918404893008545,0.4187492534243789,0.965154953125129,4692,5,SLIT1|ROBO2
REGULATION OF ZINC ION TRANSPORT%GOBP%GO:0071579,0.840089086859688,0.98953921193435,-0.421226292194312,-0.720485013361176,5657,2,SLC30A1
THYMINE CATABOLIC PROCESS%GOBP%GO:0006210,0.740014847809948,0.9744283926676119,-0.46286186931348205,-0.791700438164639,4983,2,DPYD|ALDH6A1
INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035771,0.773557517842023,0.980081287830567,0.496884477529639,0.8121440283070931,6394,2,JAK3|STAT6
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0010917,0.385817307692308,0.859630103805729,-0.41120670637546897,-1.04094247165965,2246,5,ARL6IP5|MAPT|HEBP2|PRELID1|PMAIP1
HYDROGEN SULFIDE METABOLIC PROCESS%GOBP%GO:0070813,0.557419917193288,0.9361453421204542,0.4026213858101261,0.927982609093588,5115,5,CTH
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION%GOBP%GO:1902532,0.155263157894737,0.655445617612729,-0.12416306413607302,-1.1331522151372801,58,362,DEPDC5|CCAR2|TRAP1|C9orf89|DYRK2|PSMD10|PARK7|PLEK|AIDA|GBA|CXCL12|BCL2A1|RELA|TMBIM6|SIK1|NOC2L|EZR|TNFAIP8L1|TMEM127|UBR1|DUSP22|CD44|TIMP3|MUL1|TAF9|OTUD7B|SNAI2|PYCARD|PIK3R2|DUSP4|RIOK3|SOCS3|DUSP7|THEM4|HIF1A|SRI|ITCH|HSPB1|GPER1|FLCN|STAMBP|GATSL3|QARS|OTUD7A|CREB3|PPIF|MAPKAP1|IL1B|WWC1|HEG1|CLU|PTTG1IP|MAPK7|PRKCD|SIRPA|FKBP1B|DAB2IP|IGF1R|PRKAA1|CNKSR3|USP10|TNFAIP3|ARRB2|DDIT4|DLC1|SIK2|RGS4|MAGEA3|LIMD1|ZNF385A|DYRK1A|FBP1|DDX3X|C1QBP|INPP5K|HYOU1|FOXO1|MYADM|MFN2|DDIT3|SH3BP4|LYN|PRNP|ENO1|APLNR|MMP9|CHP1|CYLD|TANK|GLTSCR2|BCL2L1|PIK3IP1|SNAI1|PPP2CA|BAG5|SOD2|TNIP1|ATP2B4|GPATCH3|PPM1A|LEPROT|TMSB4X|PTPN1|PLAUR|ARHGEF2|C12orf66|VHL|PDCD4|NLRP3|BCL2|MECOM|DUSP3|ACKR3|UCHL1|BCL3|HOMER2|DRD2|PDE10A|PARK2|SFRP2|DUSP10|SLC9A3R1|MET|CD22|SH3BP1|SESN2|TWIST1|DLG1|PDE3A|PDE4D|SPRED2|CAV1|FKBP1A|EPHB2|TRIB3
REGULATION OF HEMOPOIESIS%GOBP%GO:1903706,0.999086886282223,1.0,0.0816044044848643,0.520454067236186,14223,243,CARTPT|SH3RF1|HIST1H3E|NR4A3|HOXA5|CEACAM1|CDK6|MAPK11|INHA|WDR61|KAT2A|HES1|CD27|BMP4|AGER|MEIS2|CD2|HIST2H3C|BGLAP|HIST2H3A|TMEM178A|PRKCB|PRKCQ|LOXL3|FBN1|KMT2B|TAL1|HIST1H4I|LEF1|MED1|TNRC6A|ZBTB1|DPF2|IL7|ZNF675|CCL19|H3F3A|METTL3|ITGA2B|IL12RB1|TNRC6C|MEIS1|PRMT1|N4BP2L2|RIPK1|ACIN1|FSTL3|CDC73|FCRL3|TESPA1|CEBPB|SOCS1|STAT5B|KMT2D|WDR5|CD46|HIST1H3H|ACVR2A|ZAP70|LRRC17|CTLA4|ZNF683|THBS1|ATP6AP1|IKZF3|TCF12|BTK|GATA3
CELL PART MORPHOGENESIS%GOBP%GO:0032990,0.246056782334385,0.758411757349665,-0.12208468908916802,-1.0912570654102098,155,278,PARD6B|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|RAB8A|CDC42|DBNL|NEFH|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|GFRA2|NBL1|SLIT3|EPHB2|PARD3|UBB
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:0070201,0.003952569169960471,0.14776184655466199,-0.14632994280846803,-1.3879043368443602,0,432,GPER1|FBXW7|OAZ2|BLK|LRP5|HPS4|HAX1|CD274|SYT11|CCT4|TP53BP2|VPS28|IL1B|SRGN|GZMB|C2CD2L|PLK3|CX3CL1|ADRA2C|BCAS3|PRKCD|TMEM30A|UBE2J1|LGALS9|ITGAM|TNFAIP3|NR1H3|UBL5|OS9|PARL|PFKL|SSC5D|FGR|GPI|BBC3|MYO1C|ATG13|STXBP4|CCT7|ANO1|FYN|FAM65A|BAG4|INPP5K|ICE1|RAB11FIP1|TCF7L2|TNFRSF1B|UHMK1|VPS11|ARL2BP|APOD|GCC2|MYRIP|YWHAH|IL6|CSNK2A2|SLC25A4|FCGR2B|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|TCP1|PANX1|MIEF1|VAMP3|MBP|IGF1|MAVS|UQCC2|MYOM1|BID|FOXP1|CEMIP|RIPK2|BAP1|RAP1A|LEPROT|TMSB4X|ZPR1|DPH3|PDCD10|GAPDH|YWHAQ|PTPN1|YWHAB|KARS|BAG3|PTP4A3|GIPR|NLRP1|NLRP3|BCL2|PRKCA|TP53|YWHAZ|RANGAP1|UBE2L3|YWHAE|TNFRSF4|UBE2D3|SIAH3|DRD2|PPP1R11|CABP1|ARIH2|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|ACSL3|CD22|NR1D1|CACNA1E|BCAP31|TWIST1|PIK3R1|TNF|PMAIP1|SNX12|TFDP2|SNAP25|TNFRSF21|INHBB|TRH
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032760,0.992655699177438,1.0,-0.0909492761631119,-0.513159199741558,3378,39,CD2|DHX9|JAK2|AZU1|CCL19|RIPK1|C1QTNF4|PTPRJ|RASGRP1|THBS1|DDT|TLR4|DDX58|ISL1|IFIH1|FADD|HMGB1|TLR2|PTPRC|CD14|MIF|PTPN11|HLA-E|TIRAP|FZD5|CCL3|LY96|SPN|HAVCR2|CYBA|TLR1|PYCARD|HSPB1|CLU|LGALS9|ARFGEF2|MAVS|ARHGEF2|TWIST1
CARDIAC SEPTUM DEVELOPMENT%GOBP%GO:0003279,0.959963068658721,1.0,0.121339203436149,0.583089356654213,11436,50,TBX2|HES1|BMP4|MAML1|PROX1|ROBO2|TGFB2|HEYL|C5orf42|HEY2|NPHP3|GATA6|FGFR2|NRP2|GATA3|CRELD1|JAG1|NOTCH2|ANK2|ZFPM1|ISL1|BMPR1A|HEY1|SEMA3C
TRICARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0035674,0.41342281879194603,0.8683189983530021,0.8005072783414209,1.06343820611496,3079,1,SLC25A1
GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0005978,0.5889188628346129,0.945418171231938,-0.237079317343526,-0.8928361774936829,2837,13,PER2|NR1D1
CATECHOLAMINE SECRETION%GOBP%GO:0050432,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
POSITIVE REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903313,0.863490934944899,0.991943445125448,-0.11860445220108,-0.758652655885354,2428,60,TRA2B|CNOT7|AGO2|HSF1|NCBP2|NUDT21|ZC3HAV1|PABPC1|RBM24
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010718,0.0515792523906114,0.445826721733255,-0.261380183642448,-1.46313241718393,177,38,RGCC|TGFB1|SDCBP|SMAD4|TGFB1I1|SMAD3|WWTR1|ENG|AXIN2|FOXC1|BCL9L|NOTCH1|IL1B|CTNNB1|TGFBR1|ACVR1|PDPN|ZNF703|TCF7L2|SMAD2|GLIPR2|SNAI1|OLFM1|TWIST1
FOREBRAIN ASTROCYTE DIFFERENTIATION%GOBP%GO:0021896,0.40013422818792,0.8638522656500329,0.807234230260256,1.0723746616285301,2980,1,NF1
FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:0033539,0.0311740890688259,0.361536476938954,0.5654710542818879,1.6136611805911698,307,9,ETFDH|ACADVL|ETFA|ACADM|ETFB|ACAD11|IVD|ACADS
TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:0003323,0.16373614066524803,0.666085538088227,0.605498923502332,1.28311005917223,1461,4,CDK6|BMP4
CDC42 PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032488,0.9790804096753101,1.0,0.22462416163431398,0.517725393944108,8985,5,SHTN1|NTN1|WAS
CELLULAR UREA HOMEOSTASIS%GOBP%GO:0097277,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
EXTRACELLULAR EXOSOME BIOGENESIS%GOBP%GO:0097734,0.440418956043956,0.879896414106183,-0.39306198985219504,-0.995010326652139,2564,5,ATP13A2|COPS5|RAB27A|CD34|RAB11A
NEGATIVE REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000317,0.99914089347079,1.0,0.16152378746065302,0.39724423158609795,9303,6,LOXL3|RC3H1|FOXP3|ZC3H12A
CELLULAR RESPONSE TO DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071726,0.29379418695993703,0.8004058897916541,-0.557388744676568,-1.1312038965742,1869,3,CD36
RRNA IMPORT INTO MITOCHONDRION%GOBP%GO:0035928,0.8482111844390409,0.991298302704726,0.38059669551793,0.7234742809100271,7325,3,TST|PNPT1
AXON CHOICE POINT RECOGNITION%GOBP%GO:0016198,0.24972760950098102,0.7613646381106121,0.51905176574005,1.19633737501773,2291,5,ROBO2|GAP43|ROBO3|APP|ROBO1
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000641,0.0894434628975265,0.558971014734316,-0.335903673094052,-1.41344402163696,404,17,EZR|SNX3|MTMR2|RAB21|VPS11|MSN|MAPK3|MAP2K1|SNX12
SUBSTANCE P CATABOLIC PROCESS%GOBP%GO:0010814,0.625446842314312,0.954110852066186,-0.680359505955007,-0.9101376551034459,4723,1,ECE1
POSITIVE REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010983,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
REGULATION OF SKELETAL MUSCLE CONTRACTION%GOBP%GO:0014819,0.121840775063185,0.607607158836689,0.528687356547201,1.37606211181703,1156,7,SLC8A3|ATP2A1|DMPK|DMD|GSTM2
TOXIN BIOSYNTHETIC PROCESS%GOBP%GO:0009403,0.5328238971865229,0.9265056012720759,0.5037541908134611,0.9575837237846221,4601,3,CTH|MPST
NEGATIVE REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0043433,0.648859209794101,0.963755998259649,-0.120029339541131,-0.91830927994037,1165,118,MAD2L2|BHLHE40|HAVCR2|GAS6|PSMD10|CYP1B1|CEBPG|OTULIN|SIK1|PRMT2|SETD6|PYCARD|HAND1|PHB2|NFKBIE|ITCH|ID2|IRAK1|PIM1|NFKBIA|DAB2IP|TRIB1|IRAK2|TNFAIP3|ARRB2|HDAC4|TRAF3|COMMD7|TCF7L2|MXI1|MAP2K5|DDIT3|PRNP|ARRB1|CHP1|CYLD|SUMO1|G3BP2|POU4F2|TMSB4X|SMAD7|NLRP3|ID1|COMMD1|TNFRSF4|RBCK1|TAX1BP1
DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS%GOBP%GO:0045136,0.4873560174764989,0.907789754052198,-0.7545765328628141,-1.0094200348562,3680,1,IRF2BPL
RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032801,0.0612341026848799,0.48227634769717603,-0.325413445727924,-1.47796148237086,259,21,SH3GLB1|BECN1|CLTA|AP2S1|NEDD4|MYLIP|SNX25
REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0030656,0.163416898792943,0.665440683774265,-0.418942026587236,-1.30225422910626,879,8,CYP27B1|AKR1C3|CLYBL|NFKB1|SNAI2|IL1B|SNAI1|TNF
NERVE GROWTH FACTOR PROCESSING%GOBP%GO:0032455,0.7597315436241608,0.977664504547119,0.6230701367445961,0.8277208795356791,5659,1,NGF
LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:0061141,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
B CELL CYTOKINE PRODUCTION%GOBP%GO:0002368,0.8805369127516779,0.9956508825790341,0.560707984119982,0.744875541946754,6559,1,HSPD1
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000377,0.40933398152649497,0.867015886388254,-0.14018891570764003,-1.02973115745352,841,101,IL1B|CLU|PDK3|PRKCD|SIRPA|ROMO1|ITGAM|PARL|GRB2|HP|FYN|MPV17L|ASS1|ATP2B4|SNCA|GADD45A|SLC25A33|TP53|DDAH2|CDKN1A|PARK2|RAC1|CD36|AATF|HSP90AB1|TNF|CAV1|DDAH1
REGULATION OF HEPATOCYTE GROWTH FACTOR PRODUCTION%GOBP%GO:0032646,0.0029127499007017103,0.13103871184697197,-0.998786943096603,-1.33610774653893,21,1,INHBB
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051961,0.720736779560309,0.9713770803161691,-0.11475063233586098,-0.886265567780645,1212,124,CALR|THY1|DCC|NOTCH1|ARHGDIA|ID2|RNF6|IL1B|CX3CL1|LPAR1|RTN4|SKI|SRGAP2C|EIF2AK3|SEMA3F|RHOA|SEMA7A|YWHAH|IL6|EFNA1|POU4F2|BAG5|SPOCK1|SEMA6B|ID1|GPR161|ADCYAP1|FKBP4|ASCL1|MYLIP|ZNF365|SEMA3A|SEMA3G|TNF|TNFRSF21|LINGO1|RTN4RL2
NEGATIVE REGULATION OF GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046318,0.35456110154905296,0.842911430859438,-0.8220114689016321,-1.09962980486929,2677,1,PRKAA1
NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045653,0.9297149550956659,1.0,-0.19294288108458502,-0.622836910167204,4761,9,HIST2H4A|HIST2H4B
CHORIO-ALLANTOIC FUSION%GOBP%GO:0060710,0.6391677754929239,0.960516115253472,0.5517915298491689,0.9018880969384009,5283,2,LEF1|BMP7
BLOOD VESSEL LUMENIZATION%GOBP%GO:0072554,0.0139017608897127,0.256136946817111,-0.993659020732245,-1.32924796844308,104,1,RBPJ
POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION%GOBP%GO:1902527,0.43664148351648396,0.878651088001772,-0.39459834135197,-0.9988994984548331,2542,5,UBB
HYPERMETHYLATION OF CPG ISLAND%GOBP%GO:0044027,0.46630477955779204,0.894322345600068,-0.7651080723423029,-1.0235083963218599,3521,1,SPI1
MEIOTIC DNA DOUBLE-STRAND BREAK FORMATION%GOBP%GO:0042138,0.717067860166929,0.971081608033886,0.521445599119164,0.8522885068116909,5927,2,C11orf80
CHONDROITIN SULFATE METABOLIC PROCESS%GOBP%GO:0030204,0.329847908745247,0.8291759588236239,-0.235507765091344,-1.09104633757091,1387,22,CSPG4|CSGALNACT1|CHSY1|NCAN
NEPHRON TUBULE FORMATION%GOBP%GO:0072079,0.837416481069042,0.9889652677625541,-0.422846211189705,-0.723255798045484,5639,2,PAX8
REGULATION OF RESPONSE TO DNA INTEGRITY CHECKPOINT SIGNALING%GOBP%GO:1902151,0.5474645836091621,0.9305779599215391,-0.720390383767093,-0.9636881808839058,4134,1,TIGAR
CHEMOKINE (C-X-C MOTIF) LIGAND 12 SIGNALING PATHWAY%GOBP%GO:0038146,0.22690110874678002,0.7398172623753029,0.5706121225117491,1.20918159531232,2025,4,STK39|CXCR4
U2 SNRNA 3'-END PROCESSING%GOBP%GO:0034474,0.49449664429530205,0.91071489001692,0.756947507719453,1.00557099418281,3683,1,INTS1
HISTONE GLUTAMINE METHYLATION%GOBP%GO:1990258,0.420935412026726,0.8727872721376851,-0.602757099531293,-1.03098373714292,2834,2,FBLL1|FBL
POSITIVE REGULATION OF CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:1900210,0.8343624161073829,0.988613522932093,0.5830392589325101,0.774541644266396,6215,1,STOML2
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904706,0.120564432454866,0.6066999390482379,-0.361675126903553,-1.36206161472621,580,13,TGFB3|PRKG1|TPM1|APLN|MEF2C|PTEN|CNN1|CDKN1B|GPER1|PPARG|SOD2|PDCD4|CDKN1A
ESTABLISHMENT OF EPITHELIAL CELL POLARITY%GOBP%GO:0090162,0.0223375451263538,0.31481506041459995,-0.387056974546175,-1.6974279965458,98,19,MYO9A|CYTH1|EZR|OPHN1|RHOA|SIPA1L3|CDC42|MSN|SLC9A3R1|SH3BP1|PARD3
NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902988,0.827114093959732,0.9876441563834109,0.58756065284517,0.780548114365681,6161,1,MAPT
PROTEIN LOCALIZATION TO SITE OF DOUBLE-STRAND BREAK%GOBP%GO:1990166,0.270464281579252,0.7852960152527629,0.6082496967023271,1.15621868796475,2335,3,FAM178A|ANKRD32|PARP3
ASCENDING THIN LIMB DEVELOPMENT%GOBP%GO:0072021,0.299262126527156,0.8023890191280308,0.68727731268848,1.1233358869770702,2473,2,PKD2|PKD1
CONVERSION OF METHIONYL-TRNA TO N-FORMYL-METHIONYL-TRNA%GOBP%GO:0071951,0.5588507877664499,0.936434965680841,-0.7143250992501099,-0.955574464856564,4220,1,MTFMT
POSITIVE REGULATION OF FEAR RESPONSE%GOBP%GO:1903367,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
POSITIVE REGULATION OF CELL ACTIVATION%GOBP%GO:0050867,0.7858606557377049,0.981487311948134,-0.10420406976204598,-0.8835432370203559,766,207,IGHV4-4|CD274|CHRNB2|ICOSLG|IL1B|RARA|FAM49B|SIRPA|MAP3K8|IGHV2-26|LGALS9|ITGAM|PDPN|LAMP1|GRB2|FGR|CEBPA|VAV1|RPS3|IGHV1-69-2|IGHV3-15|FYN|IGHV3-73|C20orf196|RUNX1|IL6|PNP|LYN|CD276|YES1|IGF1|VAV3|KARS|CDC42|TFRC|IGHV1-3|NLRP3|BCL2|NFATC2|GAB2|SOCS5|TNFRSF4|BCL6|NKAP|TNIP2|FGF10|DUSP10|CBFB|RAC1|IGF2|PIK3R1|CAV1|PAK2
QUINOLINATE METABOLIC PROCESS%GOBP%GO:0046874,0.9036920659858599,1.0,-0.319510312120878,-0.648436685381046,5751,3,QPRT|KYNU|HAAO
INNATE IMMUNE RESPONSE-ACTIVATING SIGNAL TRANSDUCTION%GOBP%GO:0002758,0.00114220445459737,0.0909425383297456,-0.22332998637688298,-1.7058681744771298,1,119,RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|CTSS|RPS6KA3|SCARA3|UBE2N|TLR1|CREBBP|ITCH|NOD1|IRAK1|FCER1G|PIK3C3|PRKCD|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|IRAK4|TRAF3|S100A8|FYN|BCL10|UBE2V1|RELB|LYN|CYLD|TANK|CNPY3|TNIP1|RIPK2|MUC4|MUC3A|RFTN1|KRAS|UBA52|COLEC12|TNIP2|TICAM1|MUC12|MYD88|UBC|CD36|PAK2|UBB
REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903596,0.024980361351139,0.329326373353219,-0.8035799916842622,-1.6308417177131298,158,3,ACE|CAV1
CELLULAR RESPONSE TO GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:0097011,0.143577108298802,0.6334904564746021,0.6185031661193849,1.31066729150775,1281,4,NPR2|PDE1B
REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002822,0.9962549800796809,1.0,0.0894710960693302,0.472610507758676,12502,76,CEACAM1|AGER|THOC1|CD1E|PRKCQ|MAP3K7|LOXL3|ZP3|ZBTB1|CCL19|IL12RB1|CD1D|PAXIP1|RIF1|TRAF2|SUPT6H|RIPK3|BTK|HLA-F|NFKBID|FAM35A|IL1R1|RC3H1|XCL1|TP53BP1|ANXA1|HSPD1|NDFIP1|WAS|FADD|JAK3|HLA-C|FOXP3|PRKCZ|HMGB1|STX7|MEF2C|ZC3H12A|PTPRC
CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0006584,0.39068000741152503,0.860837094563899,0.27745473906908,1.06258728968822,4216,22,SNCAIP|PNMT|TGFB2|SULT1A3|DDC|HAND2|DRD4|TH|MOXD1|LRTOMT|GATA3|COMT|DBH|MAOA
REGULATION OF HEPARAN SULFATE BINDING%GOBP%GO:1905853,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:0070816,0.739258635214827,0.9744283926676119,0.297378833426037,0.7740146240803499,7019,7,GTF2H1|CDK13|CDK12|GTF2H3|GTF2H4|ERCC3
CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0006333,0.0947175292408837,0.564250720056934,0.232308605519293,1.31779034296782,1238,111,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|MTA2|ASF1B|SMARCD3|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|ASF1A|CASC5|CENPU|CDKN2A|OIP5|ARID2|ITGB3BP|CENPA|HDAC8|HIST1H4I|HELLS|CENPV|CENPQ|CENPI|H2AFX|H3F3A|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|HIST1H2BK|STRA13|CENPM|SMARCA4|HIST1H3H|HIRA|HIST1H2BN|HIST3H2A|ARID1A|CDAN1|HIST1H2BG|HIST2H2BE|HIRIP3|SMARCD1|HIST1H2BH
REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070861,0.7285911602209949,0.972554563883587,-0.18175552232888698,-0.810975962969302,3164,20,EDEM2|DERL2|ERLEC1|SAR1A|EDEM1|INSIG1|TMEM30A|UBE2J1|OS9|GCC2|BCAP31
AROMATIC AMINO ACID FAMILY METABOLIC PROCESS%GOBP%GO:0009072,0.87267780071308,0.9934031064448321,0.17957960700333603,0.666868736262747,9300,20,IDO1|ASRGL1|FTCD|GSTZ1|TH|C9orf41|CCBL1|AFMID|AADAT
NEGATIVE REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900222,0.880920564216778,0.9956508825790341,-0.398166971999335,-0.681043281145862,5932,2,LRPAP1
PATHOGENESIS%GOBP%GO:0009405,0.8732885906040269,0.9934031064448321,0.564402293780326,0.749783267515683,6505,1,TMEM181
REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901096,0.32860520094562606,0.828303707528737,-0.323836995090339,-1.09558902630702,1667,10,TBC1D25|ADRB2|KIAA0226
"ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000479",0.00668523676880223,0.18239572673498103,-0.62648698771544,-1.94739433491185,35,8,KRI1|RRS1|NOL9|NOP14
REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000638,0.18444619010212102,0.6906809521658801,-0.6338863934373721,-1.28645360188929,1173,3,INSIG1|FBXW7
NEGATIVE REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034111,0.565664968285328,0.938675104185703,0.337769917606967,0.920851413490773,5439,8,CEACAM1|SERPINE2
SYNAPTIC VESICLE BUDDING FROM ENDOSOME%GOBP%GO:0016182,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0001836,0.000662544169611308,0.0806484601749226,-0.5325307063189461,-2.2408279619314198,2,17,GGCT|IFI6|MFF|FIS1|DNM1L|SFN|BAX|CLU|TIMM50|BBC3|BCL2L1|BOK|SOD2|BID|BCL2
POSITIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033138,0.190188410949165,0.698434241409875,-0.18674985424226898,-1.19454430485376,534,60,MAD2L2|GAS6|HSP90AA1|PARK7|CD44|TXN|RAMP3|HAX1|IL11|VEGFA|PRKD2|LIF|EIF4G1|IL6|TCL1A|ATP2B4|RIPK2|PDCD10|SNCA|STK4|SFRP2|HSP90AB1|TNF|CAV1
REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902622,0.7823193916349809,0.981487311948134,-0.16607656169022303,-0.769389596636907,3291,22,CAMK1D|C1QBP|CXCL8|THBS4|RAC1
NONASSOCIATIVE LEARNING%GOBP%GO:0046958,0.6642393750827491,0.964618776001639,-0.6626599029554481,-0.8864603565145649,5016,1,MAPK8IP2
PRESYNAPTIC ACTIVE ZONE ORGANIZATION%GOBP%GO:1990709,0.9766889383815891,1.0,-0.32357320099255604,-0.5534546308256021,6577,2,RAB3A|CAST
CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:0019240,0.328051288254506,0.828303707528737,0.6749931072511721,1.1032576906566598,2711,2,CAD|ALDH18A1
RNA POLYADENYLATION%GOBP%GO:0043631,0.807937374840707,0.984682960940884,0.182481733784107,0.733663977425504,8875,26,WDR33|CPSF1|FIP1L1|PAPOLA|PAPD4|GRSF1|CDC73|ZC3H3|CSTF3|TUT1|PCF11|SYMPK|AHCYL1|PNPT1
"SULFIDE OXIDATION, USING SULFIDE:QUINONE OXIDOREDUCTASE%GOBP%GO:0070221",0.940945739812595,1.0,0.257008714665615,0.5923669879464909,8635,5,SLC25A10|SUOX
NEGATIVE REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0010766,0.7876463463867579,0.9819233677232551,-0.21224194466602697,-0.746905846352197,3901,11,CAMK2D|HECW2|NEDD4L|NEDD4|COMMD1
POSITIVE REGULATION OF VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:1903774,0.630195669792752,0.957141460696787,0.47035397796002903,0.8940934327207579,5442,3,VPS37B|TSG101
EMBRYONIC VISCEROCRANIUM MORPHOGENESIS%GOBP%GO:0048703,0.460339943342776,0.8904234666384399,0.43581003258499196,1.00447751997482,4224,5,MTHFD1|NIPBL
REGULATION OF TRAIL RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045560,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048747,0.46213292117465204,0.8912755686006071,0.293972872478435,0.996747956264285,4783,15,IGSF22|TCAP|SEPN1|CXADR|OBSL1|DMD|KIAA1161|MYOM2
POSITIVE REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031281,0.270690351231328,0.7857061977848471,-0.327665312472447,-1.1530950581780302,1340,11,NOS3|GUCA1A|MAPK3
LYMPHOCYTE PROLIFERATION%GOBP%GO:0046651,0.36311787072243296,0.849828746111777,-0.22938569422567498,-1.06268437254718,1527,22,SLC11A1|MS4A1|ELF4|MSN|BCL2|TNFRSF4
MATURE RIBOSOME ASSEMBLY%GOBP%GO:0042256,0.00789835164835165,0.19847993048827997,-0.752040591219943,-1.90374081860931,45,5,EIF6|DDX3X|C1QBP|SBDS|EFTUD1
REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140193,0.0036241610738255,0.143595610377104,0.9979047198941329,1.32567190069352,26,1,RGS2
BUTYRATE METABOLIC PROCESS%GOBP%GO:0019605,0.678389261744966,0.9647315640607691,0.665416850463167,0.8839765994899631,5053,1,ACADS
POSITIVE REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090261,0.40076790679200297,0.8638522656500329,-0.7980811645346271,-1.0676175070886802,3026,1,CLU
CARDIOCYTE DIFFERENTIATION%GOBP%GO:0035051,0.548783589048063,0.931093639814053,0.19891226542845603,0.938622681032708,6473,46,NEB|IGSF22|TBX2|MAML1|PROX1|TCAP|TGFB2|NEBL|HAND2|HEY2|CXADR|OBSL1|SRF|NRG1|SLC8A1|GATA6|MYOM2
RESPONSE TO NITRIC OXIDE%GOBP%GO:0071731,0.7103238866396759,0.9700296616429409,0.282771286024409,0.8069326339310121,7017,9,DPEP1|MTR|CCL19|EGLN1|CDK2
THYROID GLAND DEVELOPMENT%GOBP%GO:0030878,0.56221398997603,0.936985598067126,0.40108335850766597,0.924437684160894,5159,5,HOXD3|TG
NEGATIVE REGULATION OF CELL PROLIFERATION%GOBP%GO:0008285,0.17647058823529396,0.679974269838229,-0.12199949160670201,-1.12373640575073,65,371,CTNNB1|DAB2IP|SKI|TRIB1|ABI1|ZBTB7C|TMEM115|NELL1|LGALS9|PTK2B|CD164|FOXO4|HMOX1|TNFAIP3|WARS|PDPN|AKIRIN1|DLC1|PTPRU|CEBPA|PML|CTBP1|PPP2R5C|IGFBP3|IRF6|CUL5|EMP3|ZBTB49|SMAD6|KLF10|RNF139|FTH1|MXI1|MFN2|STRN|APOD|IL6|PPARG|SH3BP4|LYN|FCGR2B|PRNP|DFNA5|NFIB|VIP|SOD2|LMNA|BAP1|ETS1|PDCD10|CNOT7|NPM1|ADAMTS8|LDOC1|KLF11|KARS|ATOH8|CDKN1C|VHL|PDCD4|CXCL8|ATF5|TP53|KLF9|NOS3|ADCYAP1|SCG2|DRD2|TES|CAV2|FLT1|CDKN1A|COPS8|GREM1|SFRP2|PTPRM|ACVRL1|PER2|DUSP10|SLC9A3R1|IFITM1|TP53I11|SOX7|MAP2K1|CDH13|INSM1|PBRM1|TNFRSF21|CAV1|RPS6KA2|DDAH1|FABP3
UMP BIOSYNTHETIC PROCESS%GOBP%GO:0006222,0.524161073825503,0.92593403131991,0.7417291574768421,0.9853540948242441,3904,1,UMPS
GOLGI TO LYSOSOME TRANSPORT%GOBP%GO:0090160,0.280965645311049,0.7890574956751379,-0.367816517626808,-1.14333388683054,1512,8,GAK|AP1G1|LAMP1|EHD3|RBSN
REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902893,0.400311931375097,0.8638522656500329,-0.20155979525522696,-1.03153286523526,1539,29,SMAD3|RELA|NFATC3|GATA2|SPI1|HIF1A|PPARD|KLF5|PPARA|NFIB|ATOH8|JUN|STAT3|TP53
HEXITOL METABOLIC PROCESS%GOBP%GO:0006059,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
MITOTIC SPINDLE ASSEMBLY%GOBP%GO:0090307,0.209101983988862,0.7243363294845151,0.275800347471957,1.22623658412827,2402,37,KIF4A|MAP10|KIF23|KIF11|TUBGCP3|WRAP73|AURKB|KIFC1|TUBGCP6|CEP192|CHEK2|TUBGCP2|RACGAP1|TUBGCP4|FAM175B|TPX2
INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0035773,0.166552197802198,0.6682860217990739,-0.509728386815565,-1.2903435635176599,969,5,PTPRN|RAB11FIP2|RAB11FIP5
GLOMERULAR PARIETAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072139,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
DNA STRAND ELONGATION%GOBP%GO:0022616,0.29646099685010197,0.8013070063650121,0.298803599980398,1.14434847470096,3199,22,POLE|RFC4|DNA2|TERT|FEN1|RNASEH2A|LIG1|GINS2|RFC3|GINS1|WRNIP1
POSITIVE REGULATION OF CELL MIGRATION%GOBP%GO:0030335,0.0068649885583524,0.186378812319466,-0.158635888690144,-1.4511730405262,2,343,DAB2IP|IGF1R|RTN4|NSMF|TGFBR1|CXCL16|LGALS9|BCAR1|PTK2B|ACVR1|HMOX1|PDPN|HSPA5|ELP6|AKIRIN1|EPB41L4B|PRKD2|PFN1|SRGAP2C|FGR|ABL1|SEMA3F|GPI|MYO1C|MGAT5|ADAM10|CAMK1D|RET|SPHK1|FGF7|ZNF580|RHOA|FAM65A|NRP1|C1QBP|ZNF703|AAMP|PLAU|MYADM|CPNE3|SEMA7A|FGF2|PPAP2B|HGF|DOCK5|TNFRSF18|IL6|HBEGF|PODXL|ITGA6|MMP9|ELP3|GLIPR2|SNAI1|IGF1|SOD2|ICAM1|FOXC2|MAP4K4|FOXP1|CEMIP|RHOC|ETS1|TMSB4X|PDCD10|WNT11|ARHGEF2|KARS|FGFR1|MAP2K3|LGALS3|ATOH8|SEMA6B|IQSEC1|AGO2|ADAM17|CXCL8|STAT5A|CTSH|PRKCA|STAT3|NOS3|ANO6|OXSR1|FLT1|PLVAP|ADRA2A|FGF10|THBS4|SEMA3A|RAC1|MET|DDRGK1|SEMA3G|LAMC2|PGF|CDH13|TNF|CAV1
RRNA TRANSCRIPTION%GOBP%GO:0009303,0.8223929747530191,0.987616425875001,-0.180633026044048,-0.7397529506892779,3745,16,GTF3C5|GTF3C3|SIRT7|GTF3A|GTF3C1|GTF3C2|SPIN1|NIFK|GTF3C6|ANG|GTF3C4|PTRF|TAF1B|CD3EAP
CRANIAL NERVE FORMATION%GOBP%GO:0021603,0.6536475572620151,0.9640743070248079,-0.6671812968681079,-0.8925087630076741,4936,1,MAFB
NEGATIVE REGULATION OF BONE REMODELING%GOBP%GO:0046851,0.412278854254423,0.867015886388254,0.40171291475082105,1.0455743171661,3914,7,CARTPT
POSITIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904022,0.8390604026845642,0.989395884107905,0.5810542567269521,0.7719046573935391,6250,1,APLN
POST-EMBRYONIC ANIMAL ORGAN DEVELOPMENT%GOBP%GO:0048569,0.541948136848987,0.928956216948897,0.40807116939260996,0.9405435523671121,4973,5,EFEMP1|FBN1|MFAP2|KLF4
DEVELOPMENTAL MATURATION%GOBP%GO:0021700,0.7721257237386271,0.979693198874896,-0.12125739657835699,-0.835537788232322,1866,78,VEGFA|CX3CL1|AP1M1|PTPRN|BLOC1S5|ANKS1A|RHOA|G6PD|NKX6-1|PPARG|PLD6|IGF1|RYR1|BLOC1S6|EPHA8|MTCH1|BLOC1S3|ACVRL1|S1PR1|PDE3A
REGULATION OF MRNA 3'-UTR BINDING%GOBP%GO:1903837,0.39136766847610205,0.861275178639796,-0.8020511689457428,-1.0729283030338501,2955,1,CDK9
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0031668,0.0194109772423025,0.290131041615318,-0.18224807131965998,-1.4473756417052002,28,141,EIF2S1|KIF26A|PIM1|IMPACT|PIK3C3|RRAGD|STK26|UCN2|USF1|PRKAA1|HSPA5|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|FYN|FAM65A|MAP1LC3A|KLF10|FOXO1|SEH1L|EIF4G1|NUAK2|CBS|SH3GLB1|ATG7|BECN1|C12orf66|TP53|GABARAPL1|RALB|MAPK3|GABARAP|CDKN1A|UCN3|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|PMAIP1|INHBB
REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0030071,0.000935772011909826,0.0849637591935908,0.430742935118962,2.01905971462697,10,45,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|USP44|BUB1|DLGAP5|CDC23|CDC20|GEN1|APC|NDC80|CDK5RAP2|CENPE|FBXO5|RB1|BUB1B|ESPL1|CDC6
RNA SURVEILLANCE%GOBP%GO:0071025,0.462447257383966,0.891507554237553,-0.253881109722276,-0.983602630941235,2191,14,EXOSC6|PRPF18|EXOSC4|EXOSC9|EXOSC5
CDP-CHOLINE PATHWAY%GOBP%GO:0006657,0.416481069042316,0.8709670999109399,-0.6054762699879829,-1.03563473257963,2804,2,PCYT1A
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032769,0.0340949033391916,0.37718483246516493,-0.6079941342458169,-1.66890307468409,193,6,NOSIP|ATP2B4|SNCA
NEGATIVE REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070425,0.277851699528245,0.7884684708511421,0.696277915632754,1.13804712522846,2296,2,ERBB2IP|PTPN22
NUCLEAR CHROMOSOME SEGREGATION%GOBP%GO:0098813,7.30887297178775e-05,0.0784645998831315,0.35046378000056394,2.0969906424095903,0,152,KIF25|MUS81|SYCP2|EME2|CCNB1|PSRC1|KIF14|GEM|NCAPD3|ZWINT|SPAG5|BLM|CENPF|KIF2C|KIF18A|NSL1|KIF4A|MAP10|NUF2|KIF23|CASC5|BUB1|TOP2A|PRC1|DLGAP5|CDC23|SMC2|CCNE1|NDC80|NUSAP1|CENPE|KIF18B|PTTG1|HDAC8|RB1|CEP55|BUB1B|AKAP8L|INO80|ESPL1|AURKB|RAD51C|BOD1|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|TUBG2|CENPQ|FANCM|SPDL1|KIF22|REC8|CDCA5|ESCO2|KLHL22|DSCC1|SLX4|PLK1|NCAPG|POGZ|NCAPH|EME1|RMI1|RACGAP1|STRA13|CCNE2|SMC4|BAG6|STAG3|TOP2B|KLHDC8B|TEX14|P3H4|FAM175B|RECQL5|HIRA|SGOL1|PDS5B|FAM83D|SMC3|FMN2
MUCOSAL-ASSOCIATED LYMPHOID TISSUE DEVELOPMENT%GOBP%GO:0048537,0.314974182444062,0.8164430838831159,-0.843239964711072,-1.12802781096499,2378,1,RET
C21-STEROID HORMONE METABOLIC PROCESS%GOBP%GO:0008207,0.0318778979907264,0.365066918595497,0.47688565514826,1.6169342365957702,329,15,FDXR|STAR|FDX1|AKR1B1|BZRAP1|CACNA1H|AKR1C1
NEGATIVE REGULATION OF T CELL ACTIVATION%GOBP%GO:0050868,0.9896013864818021,1.0,-0.0892250738994397,-0.56238057341489,2854,57,RUNX1|FCGR2B|PRNP|SMAD7|LGALS3|DUSP3|SOCS5|CBFB|TNFRSF21
POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS%GOBP%GO:0045345,0.7382560879811471,0.9744283926676119,-0.386070365060108,-0.783518335235192,4698,3,CIITA|HSPH1|NLRC5
VERTEBRATE EYE-SPECIFIC PATTERNING%GOBP%GO:0150064,0.35125115848007393,0.842847021021096,-0.8239413321570359,-1.10221144178708,2652,1,ITGAM
REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001796,0.257015590200445,0.7674783969184241,-0.7030557576017329,-1.20253922011988,1730,2,FCGR2B
THIOESTER METABOLIC PROCESS%GOBP%GO:0035383,0.0733159354102104,0.520754220371606,0.27737676864342403,1.4081181239148501,898,63,ACSM3|HACD1|ACSF2|OXSM|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|ACBD6|MVD|ACOT1|PDHX|FAR1|PDHA1|ACOT2|SLC25A1|ACACA|SUCLG1|DLD|ACSS1|MCEE
RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:0022618,0.925022583559169,1.0,-0.0935408346629978,-0.782793438498242,1023,191,SNUPN|HSP90AA1|NCBP1|RPL11|SCAF11|GEMIN4|ZRSR2|EIF2A|CD2BP2|EIF6|TAF9|CELF2|OGFOD1|STRAP|SNRPD3|RPL12|LSM3|PRPF19|NAF1|CELF4|ISY1|EIF2S1|RPS28|RUVBL1|FAM103A1|MRPS2|RPF2|RSL24D1|LIMD1|PRPF18|MRPL22|CRNKL1|ZNHIT6|DDX3X|NUFIP1|C1QBP|PRPF6|SHQ1|SBDS|GLTSCR2|EFTUD1|RUVBL2|PPAN|EIF4H|NPM1|DDX28|EIF4B|RRP7A|TXNL4A|AGO2|SNRPB|PIH1D2|EIF3A|RRS1|MRTO4|EIF2S3|NUDT21|POLR2D|SF3A1|RPF1|SLU7|DDX6|HSP90AB1|BICD1
PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION%GOBP%GO:0035845,0.703220738413197,0.968941691852291,-0.399115684875236,-0.80999342420652,4475,3,CDHR1
NEGATIVE REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000974,0.456392887383573,0.8891098233101229,0.620624788338597,1.01439416697914,3772,2,HES1
UTERINE WALL BREAKDOWN%GOBP%GO:0042704,0.40921737026732796,0.867015886388254,0.638599393438103,1.043773165223,3382,2,TGFB2|TGFB3
PROTEIN OXIDATION%GOBP%GO:0018158,0.0115420609337631,0.23212667146341198,0.641771118919722,1.74964024677428,110,8,LOXL1|LOXL3|LOXL2|PRDX3
TERTIARY ALCOHOL METABOLIC PROCESS%GOBP%GO:1902644,0.0224304970513901,0.31540045468680394,0.638466788756485,1.66179490918627,212,7,AKR1B1|CBR4|CACNA1H|AKR1C1
REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0014061,0.11092032967033001,0.584830174998513,-0.548832285713997,-1.38933248694659,645,5,ADRA2C|HRH3|ADRA2A
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032826,0.651140939597315,0.96384922244111,0.679973533303926,0.9033145032242471,4850,1,ZNF683
MHC CLASS II PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002399,0.517303169447867,0.9230748614617091,0.45475100645232397,0.9636608227519459,4618,4,HLA-DMB|HLA-DRB1|HLA-DRA|HLA-DMA
POSITIVE REGULATION OF CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:1905959,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
POSITIVE REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902304,0.518634001484781,0.9236324326350509,-0.555308315131595,-0.949825132621582,3492,2,ANO6
GLYCERALDEHYDE-3-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019682,0.7321719153824058,0.972769769206295,0.22688489897584196,0.786548415856593,7648,16,RBKS|ALDH1A1|TKFC|PGLS
CELLULAR RESPONSE TO UV-C%GOBP%GO:0071494,0.627764270001158,0.9553884638359259,0.471600931210849,0.896463759676009,5421,3,ST20|CARD16
B-1 B CELL LINEAGE COMMITMENT%GOBP%GO:0002336,0.7844295302013421,0.981487311948134,0.60967137185708,0.8099212181438941,5843,1,SLAMF8
REGULATION OF LIPID STORAGE%GOBP%GO:0010883,0.740594925634296,0.974505008828563,0.180366001767355,0.7961420982565601,8464,36,SIRT1|LPL|FITM1|ALKBH7|MEST|SCARB1
RESPONSE TO DITHIOTHREITOL%GOBP%GO:0072720,0.741260433047055,0.974505008828563,0.510945685139234,0.8351266858610059,6127,2,CERS1|KAT7
RESPONSE TO VITAMIN%GOBP%GO:0033273,0.954804480251523,1.0,0.17605517241379298,0.554988819616421,9717,12,BGLAP|CDKN2D|CYP27B1|ALPL|SPP1|AQP3|SFRP1|KYNU|POSTN|GAS6|PIM1|HLCS
ADENINE NUCLEOTIDE TRANSPORT%GOBP%GO:0051503,0.9885595990411851,1.0,0.20986726016404997,0.48371292364038,9072,5,SLC25A42|SLC35B2|SLC25A17|SLC25A24
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0008608,0.136798648902233,0.62388141596544,0.359392495765009,1.3346037641605601,1457,20,KIF2C|NUF2|CASC5|NDC80|CENPE|RB1|AURKB|BOD1|TEX14|FAM175B|SGOL1|CHAMP1|CDT1
POSITIVE REGULATION OF GLUCONEOGENESIS%GOBP%GO:0045722,0.45545858718919796,0.88900512246363,-0.428014963721312,-0.98434500110106,2765,4,ARPP19|PPARGC1A
REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0071865,0.27531147937583195,0.7884684708511421,0.6977667493796529,1.14048058308711,2275,2,LEF1|FGFR2
NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045686,0.351601656134234,0.842847021021096,0.476090156439651,1.09731723427377,3226,5,HES1|NF1|LDLR
REGULATION OF INTERFERON-ALPHA SECRETION%GOBP%GO:1902739,0.788647851727043,0.9819233677232551,0.2819811537093211,0.7339376988320451,7488,7,DHX9|CHUK|DDX58|IFIH1|HMGB1
METABOLISM OF SUBSTANCE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052214,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS%GOBP%GO:0046543,0.4873560174764989,0.907789754052198,-0.7545765328628141,-1.0094200348562,3680,1,IRF2BPL
EMBRYONIC CLEAVAGE%GOBP%GO:0040016,0.550377333509864,0.931421923167331,-0.719011910013233,-0.9618441545140558,4156,1,CUL3
POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0006797,0.5050472508591071,0.9172434440873181,0.39181489162301103,0.9636116636052059,4702,6,BNIPL|MINPP1|PRUNE|ATCAY
NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010727,0.205499753005105,0.7211951452265429,-0.538247624379952,-1.23785709220648,1247,4,HP|FYN|MPV17L
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE%GOBP%GO:0048754,0.174244486795535,0.676682497340677,-0.231406762375117,-1.2377416561068701,639,33,RASIP1|NOTCH4|FGF1|ENG|NRARP|LRP5|VEGFA|CTNNB1|NRP1|FGF2|PAX8|NPNT|CTSH|FGF10|SFRP2|MET
TRYPTOPHAN TRANSPORT%GOBP%GO:0015827,0.4157386785449149,0.8706434313837041,-0.6060188368749799,-1.03656276418182,2799,2,SLC3A2
RESPONSE TO INDOLE-3-METHANOL%GOBP%GO:0071680,0.673637411493496,0.9647315640607691,-0.359234544752661,-0.8261644062059921,4090,4,BRCA1|JUP|CTNNB1|CTNNA1
CELLULAR RESPONSE TO BLEOMYCIN%GOBP%GO:1904976,0.6210233458328289,0.9536478716552259,0.558533223049352,0.912907209268955,5133,2,TIMELESS|DDX11
MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0007052,0.0101604709297637,0.220543045578585,0.31767370619944396,1.65373721245281,125,71,CCNB1|RCC1|CEP126|TBCE|WDR62|KIF4A|MAP10|NUF2|KIF23|PRC1|KIF11|TTK|TUBGCP3|STIL|NDC80|GPSM2|WRAP73|CENPE|AURKB|KIFC1|TUBG2|ASUN|TUBGCP6|CEP192|STMN1|CHEK2|TUBGCP2|RACGAP1|AURKA|DYNC1H1|SPC25|TUBGCP4|FAM175B
NEGATIVE REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000639,0.13511507052709698,0.622258254449182,-0.776564653984009,-1.3282722504971,909,2,INSIG1|FBXW7
REGULATION OF SYNAPTIC VESICLE PRIMING%GOBP%GO:0010807,0.9265635214643709,1.0,0.265712498645883,0.6124279197590029,8503,5,UNC13B|STX1B|STXBP1
PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0034502,0.08676789587852499,0.552202694227509,0.286252004648766,1.38937509319658,1039,52,LRWD1|CDK1|ATR|FAM178A|CASC5|TERT|H2AFY2|CENPA|RB1|AURKB|BOD1|NIPBL|SPDL1|TNKS2|PLK1|BRCA2|ANKRD32|MTBP|C5orf45|ACD|LEMD2|CCDC101|CHAMP1|PARP3|POT1|CTCF|MAU2
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051494,0.6520051746442429,0.9640743070248079,-0.128849945645218,-0.910553253088468,1511,86,MAPRE1|PPFIA1|ADD1|CLIP3|PRKCD|SPEF1|DLC1|PFN1|DYRK1A|INPP5K|TMSB10|MYADM|TRIM54|TMSB4X|NPM1|SNCA|ARHGEF2|TWF1|ARPIN|TWF2|PARK2|FKBP4|TMEFF2|MET|MID1IP1
ANTEROGRADE TRANS-SYNAPTIC SIGNALING%GOBP%GO:0098916,0.648499433748584,0.963755998259649,0.144883939566359,0.912649716343452,9161,220,SYT17|PCDHB4|CHRNA10|RIT2|SLC1A2|AKAP9|CACNB4|PCDHB6|CACNB2|RIMS2|PCDHB14|KCNK3|UNC119|CRHBP|PCDHB13|GRM4|PCDHB9|AKAP5|APBA3|UNC13B|SYT3|GRIK2|LIN7A|LIN7B|PENK|GRIA2|DLG3|BZRAP1|DLGAP1|NPY|GPR176|DVL1|UNC13A|PPFIA3|ATXN3|DOC2A|CPLX3|SPG11|ZACN|STAC3|SLC6A9|APOE|NPTX2|GRIN1|PCLO|CASK|DLGAP2|SNAP47|PRRT2|STX2|SLC6A2|DRD4|DLG4|TH|KCND2|MYCBPAP|BRSK1|NOVA1|RIMBP2|CACNB1|SYNJ2BP-COX16|PCDHB16|SLC1A3|SYT1|SEPT5|CORT|GRIK5|SLC6A1|RIMS4|PCDHB11|NPAS4|SYNJ2BP|PLP1|GSK3A|RIC3|APBA2|RAB3A|SLC1A1|NLGN3|SYT7|STX3|SNAPIN|GABRB3|PIP5K1C|STX1A|AKT1|MINK1|PCDHB3|SLC18A2|LRP6|DTNA|MPP2|RIMS1
CARDIAC SEPTUM CELL DIFFERENTIATION%GOBP%GO:0003292,0.13033557046979902,0.612163182799301,0.9357079841199821,1.2430463120106598,970,1,MAML1
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY%GOBP%GO:0050803,0.23549343498517603,0.750277765814412,-0.163256210635073,-1.1381492553013302,555,82,BHLHB9|FYN|RHOA|EIF4G1|FCGR2B|PRNP|EFNA1|ARC|CRIPT|SNCA|FMR1|NEDD4|RELN|YWHAZ|SYNDIG1|TNF|ARHGAP22|EPHB2|HOMER1
ESTABLISHMENT OF ANATOMICAL STRUCTURE ORIENTATION%GOBP%GO:0048560,0.961744966442953,1.0,0.521338773709749,0.692575302301756,7164,1,TTC8
MRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071427,0.801467748165315,0.9841161968820359,0.140696822288634,0.784935168546516,10374,101,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|UPF2|U2AF2|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
PYRIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072525,0.0115495668912416,0.23212667146341198,-0.279808886290483,-1.6871966738631201,35,49,PFKL|GPI|PKM|PNP|ENO1|NAMPT|GAPDH|PGK1|HK1|NMNAT3|HK2|TPI1|PNPO|PDXK|ALDOA|PGAM2|NMNAT2
DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:0006303,0.8137665107884158,0.986276922067025,0.151051471133535,0.758093569078223,9918,60,XRCC6BP1|C9orf142|LIG4|BLM|DCLRE1A|POLQ|HIST1H4I|PIAS4|H2AFX|DCLRE1C|XRCC4|BRCC3|HERC2|PAXIP1|RIF1|PRKDC|ATM|MDC1|UIMC1|BRCA1|BRE|POLL|RNF8|SETMAR|UBE2V2|TP53BP1|RAD50|PSMD14|NBN|ZBTB7A|LIG3
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010989,0.49261744966443,0.910097257414447,0.757719453021615,1.00659648907781,3669,1,KHSRP
DGTP METABOLIC PROCESS%GOBP%GO:0046070,0.14988216810683402,0.643890683791772,-0.662126392412044,-1.34376584076117,953,3,SAMHD1|NUDT1|NUDT15
NATURAL KILLER CELL TOLERANCE INDUCTION%GOBP%GO:0002519,0.176119402985075,0.67909482081261,-0.6406749751847359,-1.30023082684794,1120,3,HLA-E|HAVCR2|LGALS9
RESPONSE TO HEXOSE%GOBP%GO:0009746,0.622641509433962,0.9536478716552259,0.19520312812295001,0.885670596633831,7226,40,LPL|PRKAA2|UNC13B|AGER|ADCY8|ERN1|EIF2B5|EIF2B1|GCK|EIF2B4
CELLULAR BIOGENIC AMINE CATABOLIC PROCESS%GOBP%GO:0042402,0.9902953586497891,1.0,-0.130715849671626,-0.506427807028955,4693,14,TDO2|SMOX
POSITIVE REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001288,0.39136766847610205,0.861275178639796,-0.8021063078958979,-1.07300206408865,2955,1,NEDD4L
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034165,0.691610987379362,0.96731875442989,-0.48431210366694205,-0.828389915225164,4657,2,HMGB1|RSAD2
NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035024,0.8514767932489449,0.991298302704726,-0.182572142736838,-0.707332814674456,4035,14,ARAP3|FAM65B|RASIP1|CUL3|FLCN|HEG1|DLC1|MET
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901019,0.179708222811671,0.68489956912038,-0.196807227552546,-1.2053943836363799,541,52,HAP1|CRACR2A|FMR1|PDE4B|GNB5|JPH3|YWHAE|HTT|ADRA2A|JPH1|PDE4D|STAC|FKBP1A
NEGATIVE REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045403,0.873825503355705,0.9934031064448321,0.5641817379797089,0.749490268974254,6509,1,ZFPM1
NEGATIVE REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050849,0.0927716390423573,0.5622489437340121,-0.313041652979728,-1.3967622701188702,402,20,GSK3B|CLIC2|DYRK2|PLEK|SRI|FKBP1B|PRNP|CHP1|ATP2B4|HOMER2|CD22|FKBP1A
CELLULAR RESPONSE TO MERCURY ION%GOBP%GO:0071288,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
STRESS-INDUCED PREMATURE SENESCENCE%GOBP%GO:0090400,0.433235046335299,0.878651088001772,0.39501789427028,1.02814858547983,4113,7,SIRT1|ARNTL
REGULATION OF LIPID TRANSPORT BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072367,0.8798297681711279,0.9956508825790341,0.317778010744199,0.673401960504151,7855,4,SREBF2|HNRNPK|NCOR1
REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010665,0.9350300687285219,1.0,0.24322357013387802,0.5981729486438421,8706,6,PPP1R10|HAND2
REGULATION OF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:2000312,0.48047133589302293,0.9046812288131709,-0.7587119541243941,-1.01495211396575,3628,1,NETO1
SPERMIDINE METABOLIC PROCESS%GOBP%GO:0008216,0.9746563573883159,1.0,0.21328112073244698,0.524533855038669,9075,6,SAT2|SAT1|PAOX|DHPS|SRM|AMD1
REGULATION OF GASTRIC MOTILITY%GOBP%GO:1905333,0.766980007943863,0.9792236089291529,-0.6127040141155711,-0.81963284087118,5792,1,TYMP
MRNA ALTERNATIVE POLYADENYLATION%GOBP%GO:0110104,0.750811961025871,0.97622649654938,0.373202922747937,0.7908526435035209,6703,4,CPSF6|KIAA1429|CPSF7
REGULATION OF PLASMA LIPOPROTEIN OXIDATION%GOBP%GO:0034444,0.57744966442953,0.942692029750853,0.7155932951036609,0.95063376766496,4301,1,APOM
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:1901203,0.145168892380204,0.636290647310393,-0.666703430020955,-1.3530548025987,923,3,RGCC|TGFB1|SMAD3
REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0007176,0.0373250388802488,0.38702164012069,-0.36983923626856896,-1.59096622408741,167,18,NCK2|FBXW7|ZGPAT|ADAM17|SHC1|SNX6|SOCS5|ADRA2A
L-CYSTEINE METABOLIC PROCESS%GOBP%GO:0046439,0.36637576156759394,0.8510019955058101,-0.45958477398969605,-1.05694896955396,2224,4,CSAD|MTRR|CBS
REGULATION OF INTERLEUKIN-1 BIOSYNTHETIC PROCESS%GOBP%GO:0045360,0.331680174186525,0.8293509737209019,0.6735042735042739,1.10082423279801,2741,2,AZU1|EGR1
PHOSPHATIDYLINOSITOL METABOLIC PROCESS%GOBP%GO:0046488,1.0,1.0,-0.0618411576782084,-0.47869421805691703,1620,127,PLA2G2D|IMPA1|SOCS1|TTC7A|SOCS7|PIGL|MTMR1|PLA2G12A|PIP4K2B|MTMR7|FIG4|CSF1R|PIGK|PIGH|PIP5K1C|CDS1|SLA2|GPAA1|PIK3C2B|INPP5F|OCRL|PIK3C2A|PLA2G4C|RUFY1|MTMR6|IP6K2|FAM126A|PIKFYVE|PIGN|GPLD1|LCLAT1|PIGU|TMEM55B|PIGS|PIGO|SLC27A1|TTC7B|MTMR3|PLEKHA8|INPPL1|SMG1|PYURF|INPP5J|PGAP3|PITPNM1|PIGP|INPP4B|SACM1L|EFR3A|RAB14|MTM1|PIK3CB|PIGW|PIK3CA|DPM3|SBF1|PTEN|MTMR9|VAC14|TMEM150A|PLEKHA4|PIP4K2C|PDGFRB|PIGV|PI4KB|PLEKHA3|PLCG2|ARF1|PLBD1|FAM126B|SYNJ1|INPP4A|INPP5D|PGAP2|PLA2G4D|PLA2G16|PLEK|INPP5B|PIP5K1A|PI4K2B|PI4K2A|PIK3CD|PIK3R2|TMEM55A|SOCS3|MTMR12|SOCS6|SYNJ2|MTMR2|PIK3C3|PIGA|DPM1|PIGG|IP6K1|PIGZ|PIGY|DPM2|MBOAT7|CDIPT|INPP5K|MPPE1|FGF2|PIP4K2A|PIGT|PLA2G2A|SOCS5|ARF3|RAB5A|PLCB1|MTMR14|PIK3R1
CATECHOL-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0009713,0.5806641776380429,0.942746898746279,0.28675503868012603,0.9039543584785681,5909,12,PNMT|TGFB2|DDC|HAND2|TH|MOXD1|GATA3|DBH
REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071440,0.22056269538033998,0.7354411217837541,0.6355362519631539,1.2080875590777098,1904,3,SIRT1|KMT2A
APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097190,0.0801526717557252,0.535245321349421,-0.146259742011325,-1.2267399860686599,83,197,TP53BP2|SRGN|GZMB|CLU|TIMM50|PRKCD|DAB2IP|DDIT4|CIDEB|LAMP1|ABL1|BBC3|PML|MYBBP1A|CUL5|DDX47|DDX3X|CASP3|TNFRSF10A|DDIT3|BCL2L1|POU4F2|BOK|SOD2|BID|CRADD|CHAC1|PDCD10|BAG3|BCL2|PRKCA|TP53|BCL3|CDIP1|ZNF622|TNFRSF10B|GABARAP|CDKN1A|BNIP3L|BMF|TFPT|CRIP1|STK24|TICAM1|JMY|TNF|BCL2L11|PMAIP1|CAV1|TRIB3|APPL1
MICROGLIAL CELL PROLIFERATION%GOBP%GO:0061518,0.11135857461024501,0.5855068018166539,-0.7981251723187209,-1.36515036240112,749,2,CLU|CX3CL1
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905931,0.42433772831740707,0.8740879492662891,0.632864626413014,1.03439984606376,3507,2,FGF9|DNMT1
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000649,0.269316909294513,0.784543299601953,-0.20741995639702898,-1.1409947825851101,961,36,NETO1|CAMK2D|HECW2|TESC|NEDD4L|PTPN3|SCN1B|SLC9A1|RANGRF|YWHAH|CHP1|NEDD4|SLMAP|FXYD5|SLC9A3R1
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0045913,0.8190878888553309,0.987153241368501,-0.13425692218917598,-0.773061059880722,2711,42,IGF1|SNCA|PPARGC1A|AAED1|IGF2|HRH1|PMAIP1
ARTERY SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014824,0.473811539857264,0.8998407605598371,0.6144888321218149,1.00436511510739,3916,2,EDN1
NUCLEAR TRANSPORT%GOBP%GO:0051169,0.948085887837265,1.0,0.10953258997736698,0.691101987630024,13422,222,CITED1|SIX3|RANBP17|EGR2|NXF2|TPR|THOC3|U2AF1L4|RGS14|SMN1|ZC3H11A|DDX20|RITA1|THOC1|NUP133|NXF2B|DUSP16|CCHCR1|UPF3B|WDR33|NXT2|PPP1R10|CPSF1|STRADA|SRSF1|NUP205|STRADB|ANKLE1|NUP188|C11orf73|NUP160|ABCE1|FIP1L1|NUP85|GEMIN5|NUPL2|GLE1|SRSF6|IPO13|NDC1|SRSF2|THOC2|SMN2|SPRN|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|CEP57|TNPO3|NUP210|HEATR3|RANBP6|POM121|NUP54|KPNA5|SNRPD1|RANBP3|CSE1L|CPSF2|DDX39B|GEMIN8|IPO9|XPO6|TNPO1|NUPL1|ZC3H3|NUP37|TNPO2|AKT1|YTHDC1|AAAS|XPOT|UPF2|PSIP1|XPO4|U2AF2|NEMF|RPSA|RPAIN|XPO5|SRSF9|KPNA2|SRSF5|SRSF4|SNRPE|NUP62|CPSF4|SARNP
REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0010569,0.31607653017054804,0.817514198993354,0.250100391632238,1.12039655879334,3650,38,FBXO18|MMS19|SIRT6|BLM|POLQ|RAD51|RTEL1-TNFRSF6B|RMI2|PARPBP|RAD51AP1|WRAP53|KDM1A|RIF1|C5orf45|CHEK1|RECQL5|SPIDR|FIGN|FAM35A
NEGATIVE REGULATION OF INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032712,0.54627300410433,0.930420772651609,-0.721217468019409,-0.964794596705817,4125,1,HAVCR2
REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001936,0.426704014939309,0.875696962448429,-0.141732799198819,-1.02083586833903,913,94,TGFBR1|NRAS|HMOX1|PRKD2|PDCL3|ZNF580|NRP1|FGF2|PPARG|APLNR|VIP|PDCD10|FGFR1|ATOH8|ADAM17|STAT5A|PRKCA|SCG2|CAV2|FLT1|PTPRM|ACVRL1|THBS4|PGF|CDH13|CAV1
REGULATION OF ANGIOTENSIN LEVELS IN BLOOD%GOBP%GO:0002002,0.5808435852372579,0.942746898746279,-0.324042841497891,-0.8894758420260541,3304,6,ATP6AP2|ACE
"TRANS-SYNAPTIC SIGNALING, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099550",0.105891594658288,0.578960283636811,-0.705029226866659,-1.4308358685876204,673,3,NTRK2|GUCY1B3|EPHB2
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF-ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038033,0.0994162087912088,0.570215774831708,-0.560849658843362,-1.41975366902895,578,5,HSPB1|VEGFA|KDR|PRKD2
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL%GOBP%GO:0097553,0.42457410186247707,0.874331223693668,0.23964514221613797,1.03299609516572,4809,33,RYR2|NOL3|F2R|PKD2|IBTK|CACNA2D1|CCR5|CCL21|GRIN1|CCL19|LCK|TRPV1|ITPR2|CHERP|FAM155B|XCL1|GRIN2D|TRPM2|FAM155A|ITPR1|SLC8B1
COENZYME A METABOLIC PROCESS%GOBP%GO:0015936,0.9767117834394909,1.0,0.166831385778667,0.5089643153974289,9813,11,CROT|PANK3|PPCS|ACOT7|COASY|ACAT1
TRANSFERRIN TRANSPORT%GOBP%GO:0033572,0.36723313860860296,0.851186780857897,-0.20123288085999302,-1.05819008347433,1382,31,ARHGAP1|ATP6V0C|ATP6V1F|TFRC|ATP6V1E2|ATP6V0D1|ATP6V1E1|STEAP3
TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0007004,0.388070342205323,0.859991269020751,-0.224474611207237,-1.03993259984578,1632,22,SMG5|RPA2|TERF2IP|PTGES3|HSP90AA1|SMG6|RFC1|PINX1|MRE11A|GAR1|NHP2|HSP90AB1
REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000345,0.7744113288325379,0.9802068187706859,-0.33041518073310305,-0.75988588953704,4702,4,SULF2
ALANINE TRANSPORT%GOBP%GO:0032328,0.22958897972897302,0.743365122901021,0.569498528105537,1.20682178238948,2049,4,SLC36A1|SLC6A17|SLC36A4|SLC1A4
ANAEROBIC RESPIRATION%GOBP%GO:0009061,0.459060402684564,0.890371861972445,0.7757498897221,1.0305491198396,3419,1,SDHA
HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:0097411,0.761395694135115,0.977763214485385,-0.45470085470085503,-0.777741459745725,5127,2,PDK1|PDK3
TRACHEA DEVELOPMENT%GOBP%GO:0060438,0.23283547528076898,0.746122594132505,0.628487923238116,1.19468942762776,2010,3,BMP4|LEF1|LRP6
OOCYTE ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0007314,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905456,0.841709621993127,0.990587908600638,0.2838011416248,0.697967576171801,7837,6,HES1|ZBTB1
REGULATION OF CORTICOSTEROID HORMONE SECRETION%GOBP%GO:2000846,0.801923076923077,0.9841161968820359,0.25556540816892803,0.729296354148229,7922,9,GHRL|AGTR1|UCN
PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046134,0.394658753709199,0.8636289138713059,0.30461563186469803,1.05601978699272,4122,16,TK1|CAD|CTPS2|UCKL1|DCK|UMPS|UCK1|CTPS1
REGULATION OF CELL DIAMETER%GOBP%GO:0060305,0.5371375612339471,0.9265056012720759,-0.7271724746360829,-0.972760790623571,4056,1,PLEK
POSITIVE REGULATION OF HAIR FOLLICLE CELL PROLIFERATION%GOBP%GO:0071338,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
DEOXYRIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046120,0.37495035085396505,0.852609194081082,-0.810377150419056,-1.08406622230775,2831,1,DHFRL1
POSITIVE REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905820,0.0649808583518033,0.4956987271622679,0.504404602894443,1.4886282968372802,644,10,ANAPC5|NUMA1|DLGAP5|RB1|ESPL1
SUSCEPTIBILITY TO T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0060370,0.40593912397921295,0.8663957682383929,-0.6108629721532951,-1.04484839814009,2733,2,PVR|PVRL2
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:0036496,0.568671121009651,0.940076901516441,-0.534381031155225,-0.9140301341736379,3829,2,PPP1CA|PPP1R15A
THIAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071934,0.494765100671141,0.91071489001692,0.7567269519188349,1.00527799564139,3685,1,SLC19A2
NEURAL FOLD ELEVATION FORMATION%GOBP%GO:0021502,0.8740897656560309,0.9934031064448321,-0.5607631230701371,-0.7501499272552109,6601,1,BMP7
EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002064,0.0113757554212584,0.230310373510344,-0.25297060123707,-1.61812490954424,31,60,ENG|NUP93|EZR|DLL1|RAP2C|RAB25|RAP1B|SOD1|RAB13|F11R|SLC4A7|COL23A1|NKX6-1|SIPA1L3|RILPL2|MYADM|TJP2|RAP2B|PODXL|RAB1A|ICAM1|RAP1A|MSN|RAPGEF1|GSTM3|MET|RILPL1|PDE4D|DACT2|STC1
REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1904923,0.36081708449396505,0.848418604328854,-0.3418027108686861,-1.06247164882143,1942,8,MFN2|HK2|PARK2
NEGATIVE REGULATION OF RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:1902867,0.21647027671124106,0.7328218014339442,-0.890604322893692,-1.19138855703305,1634,1,POU4F2
REGULATION OF HIGH VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901841,0.632476832350463,0.958176387547329,0.33166146519506295,0.863245111790187,6005,7,CACNB2|CACNA2D1
VITAMIN A TRANSPORT%GOBP%GO:0071938,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
PROGESTERONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050847,0.9856520159825641,1.0,-0.17473791357628302,-0.509718246318097,5426,7,WBP2|NEDD4
POSITIVE REGULATION OF OPSONIZATION%GOBP%GO:1903028,0.918178207334834,1.0,-0.539644905161006,-0.7218994432691,6934,1,MYO18A
REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:1902683,0.6318681318681321,0.9580150657116279,-0.33836199735635397,-0.856540927915256,3679,5,IQSEC2|RAP1A
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR-BETA SECRETION%GOBP%GO:2001202,0.819765332043063,0.987153241368501,0.478373181205247,0.7818878229999329,6776,2,FN1|LILRB1
RAB PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032482,0.0032526201662450302,0.137762274603971,-0.275788847031982,-1.7779875992733798,8,62,RAB25|RAB10|RAB3C|RAB3D|RAB33B|RAB13|RAB21|RAB43|RAB8B|RAB30|RAB18|RAB6A|DNAJC27|RAB1A|RAB39A|RAB8A|RAB37|RAB12|RAB2B|RAB36|RAB5C|RAB7A|RAB22A|RAB2A|RAB5A
REGULATION OF MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1903436,0.564775613886537,0.9380162603437769,0.5800385993934379,0.948057156116115,4668,2,KIF20B|NUP62
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS%GOBP%GO:0010927,0.22690676131936602,0.7398172623753029,0.269866758450633,1.2089456778836598,2620,38,NEB|IGSF22|ACTN2|MYH3|PROX1|TCAP|CASC5|OBSCN|KRT19|GPC1|NEBL|LMOD1|OBSL1
REGULATION OF T CELL EXTRAVASATION%GOBP%GO:2000407,0.650901173339785,0.963755998259649,0.547670250896057,0.895151979707696,5380,2,RIPK3|FADD
LYSOSOMAL TRANSPORT%GOBP%GO:0007041,0.253126347563605,0.7641083395392759,-0.159236273520703,-1.1252865194308501,586,86,LAMP1|VPS4A|VPS18|VPS11|GCC2|EHD3|VPS4B|BIN1|RBSN|VPS16|RAB12|NEDD4|ADRB2|TRAK1|RAB7A|PARK2|CACNG3|VPS53|KIF13A|CACNG7
POSITIVE REGULATION OF RESPIRATORY BURST%GOBP%GO:0060267,0.288552405498282,0.7980646072929201,0.470915960479877,1.15814922249782,2686,6,INS|JCHAIN|RPS19
REGULATION OF FEAR RESPONSE%GOBP%GO:1903365,0.785653804282085,0.981487311948134,0.491976840363937,0.8041226301804342,6494,2,APOE|MEF2C
RESPONSE TO DECREASED OXYGEN LEVELS%GOBP%GO:0036293,0.000662251655629139,0.0806484601749226,-0.217974260499523,-1.72148668156998,0,138,CBFA2T3|CHRNB2|VEGFA|PDK3|PLK3|CPEB1|USF1|PRKAA1|HMOX1|DDIT4|UCP2|LIMD1|PML|HIGD1A|CITED2|STUB1|MMP2|HYOU1|BACH1|CPEB2|P4HB|GLTSCR2|CHRNA7|LMNA|ACAA2|PGK1|RYR1|VHL|GNGT1|TCEB1|ADAM17|MMP12|UBA52|TP53|ALKBH5|BNIP3L|UBC|PGF|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|CAV1|NDRG1|UBB|EGLN3
SERINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009069,0.17905839979418603,0.68489956912038,-0.244005557012841,-1.23375207542833,695,28,THNSL2|SEPSECS|SERINC3|CSAD|GCLC|AMT|GCSH|SLC25A32|MTRR|SDS|CBS|SDSL|SHMT2|PSPH|SARS
"NUCLEOTIDE-EXCISION REPAIR, DNA GAP FILLING%GOBP%GO:0006297",0.899220541036222,0.998912093067348,0.162797419717463,0.640688885732302,9805,24,POLE|LIG4|RFC4|POLD1|POLD3|LIG1|XRCC1|RFC3|RFC5
POSITIVE REGULATION OF AUTOPHAGY%GOBP%GO:0010508,0.00472711645896003,0.159787349002354,-0.23575683904175,-1.6576762546844301,10,85,FOXO1|MFN2|SH3BP4|DHRSX|SH3GLB1|PIP4K2A|BAG3|HK2|ADRB2|PAFAH1B2|PLEKHF1|TFEB|RALB|HTT|PARK2|SPTLC1|BNIP3L|FBXO7|TICAM1|HSPB8|SESN2|PLK2
PRIMARY MIRNA PROCESSING%GOBP%GO:0031053,0.623413258110014,0.9536478716552259,0.294890335703198,0.870297566026556,6187,10,DROSHA|METTL3|SRRT|HNRNPA2B1|DGCR8
MITOCHONDRIAL TRANSLATIONAL ELONGATION%GOBP%GO:0070125,0.7800424962619029,0.981487311948134,0.146359846867125,0.7954428221087171,9911,88,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070098,0.648906386701662,0.963755998259649,0.19535998072676997,0.8623260672584391,7416,36,CXCL13|STK39|CXCR4|CXCL9|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CCL3L3|CCL11|CCL4L2|CXCL11|XCL1|WNK1|CCR1|CCL4|CXCL2|CCL8|CXCL1|CCL24
CELL-CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086019,0.0407580230454242,0.402256981537283,0.4367636464143079,1.5667602431360301,427,18,RYR2|KCNN2|CACNA1G|CACNB2|KCNQ1|CACNA2D1|CACNA1D|GJA1
NEGATIVE REGULATION OF THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070495,0.215710919088767,0.7322272196643679,-0.6065700656606109,-1.2310159262701,1372,3,SNCA|MET
PROTEIN K33-LINKED DEUBIQUITINATION%GOBP%GO:1990168,0.962765121759623,1.0,-0.285909660593125,-0.5802451614246711,6127,3,YOD1|TNFAIP3
REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045072,0.628685762426285,0.955812440240678,0.33284362907667997,0.8663220360012691,5969,7,INHA|EBI3
PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904867,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
POSITIVE REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:1902336,0.11017074981440199,0.584830174998513,-0.799283154121864,-1.3671310282578601,741,2,VEGFA|NRP1
PURINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072521,0.7396694214876031,0.9744283926676119,-0.0988693345666063,-0.9049426177734069,357,325,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GMPS|GTPBP1|GUCY1A3|UQCRC1|PRPS1|ACOT11|NUDT4|OARD1|PKM|ACOT9|PNP|MTRR|ENO1|SULT4A1|TPST1|MT-ND5|ACSL4|HPRT1|ATP5I|EFTUD1|COX4I1|PRPSAP1|NUDT18|PDHB|GAPDH|MACROD2|PGK1|PANK2|DGAT2|TDO2|NDUFB9|CYC1|HK1|HK2|TPI1|PDE9A|NDUFA9|OGDH|ACLY|NDUFS1|NDUFV3|ADCY2|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|ACOT8|ITPA|RHOQ|ACSL3|PMVK|NT5E|ADM|COX4I2|NDUFS6|PDE4D|PGAM2|ENPP4|AK4
REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905906,0.9127000842459979,1.0,0.23785971012449697,0.619098851101197,8666,7,APOE|LDLR|CRYAB
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033628,0.46010498687664003,0.8904234666384399,0.22724332070661998,1.00306029068335,5258,36,CXCL13|KIAA2022|RAC3|PDE3B|SKAP1|MUC1|TGFB2|CCL21|CCL5|PIEZO1|ACER2|CD3E|SERPINE1|PTK2|ADAM9
POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900378,0.679634132221836,0.9647315640607691,0.451915593802939,0.859044004083338,5869,3,CDH3|SP1
POSITIVE REGULATION OF APOPTOTIC PROCESS%GOBP%GO:0043065,0.0029940119760479,0.13222355289421198,-0.18475273210520604,-1.7159115939848,0,391,PIK3CD|ARHGEF5|BTG1|PPM1F|TIMP3|IFT57|MUL1|DEDD2|PYCARD|PREX1|ZNF205|CDK5|CAMK2D|ATF4|STK17B|BAX|NOD1|GPER1|SOD1|FLCN|FBXW7|NOTCH1|TRIM39|CD274|PPIF|TP53BP2|GZMB|KALRN|GNA13|BCLAF1|CLIP3|DNM2|MSX1|CTNNB1|DAB2IP|ABR|TGFBR1|LGALS9|CIDEB|SQSTM1|DLC1|FGD4|EIF2AK3|ABL1|VAV1|BBC3|PML|TRIO|DCUN1D3|RPS3|MYBBP1A|RET|S100A8|IGFBP3|HRK|DDX3X|C1QBP|TNFRSF1B|BCL10|FOXO1|MFN2|TNFRSF10A|YWHAH|RASSF2|DDIT3|SHQ1|IL6|PPARG|SAV1|LYN|ITGA6|PRNP|DFNA5|MMP9|CYLD|BCL2L1|ECSCR|CAMK2A|ATG7|BOK|SOD2|BIN1|BID|TRIM35|ATF6|CRADD|GAPDH|YWHAQ|YWHAB|VAV3|PLAUR|SNCA|ARHGEF2|KLF11|VAV2|PPP2R1B|GADD45A|AKAP13|STK4|USP27X|PDCD4|NET1|NLRP1|NLRP3|BCL2|JUN|UBA52|CTNNBL1|TP53|YWHAZ|RASGRF2|YWHAE|ZNF622|TNFRSF10B|ANO6|HTT|MTCH1|BCL6|BNIP3L|BMF|EPHA7|SFRP2|RNPS1|SAP18|SLC9A3R1|MAP3K11|WWOX|SOX7|UBC|BCAP31|BIK|JMY|TNF|BCL2L11|PMAIP1|TFDP2|CAV1|RPS6KA2|PAK2|UBB|FOXO3|EGLN3
UREA HOMEOSTASIS%GOBP%GO:0097274,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
CLEAVAGE FURROW INGRESSION%GOBP%GO:0036090,0.551275167785235,0.932156795932405,0.727448169386855,0.966382439266745,4106,1,ALKBH4
SEROTONIN SECRETION%GOBP%GO:0001820,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045602,0.0367199077885724,0.386113929236656,-0.714719020570231,-1.6437044372781202,222,4,NOTCH4|S1PR3|ZEB1|FOXJ2
VIRUS MATURATION%GOBP%GO:0019075,0.328414176847708,0.828303707528737,0.674772539288668,1.1028971783813002,2714,2,MVB12B|MVB12A
ORNITHINE TRANSPORT%GOBP%GO:0015822,0.3772321428571429,0.85375124052253,-0.41437711288885,-1.04896814522246,2196,5,SLC7A3|SLC25A15|SLC7A1
INNER EAR RECEPTOR CELL DEVELOPMENT%GOBP%GO:0060119,0.11209316834771801,0.5871948297110661,0.50752742525911,1.38365592248806,1077,8,STRC|ADGRV1|DFNB31|PDZD7
REGULATION OF ARGININE METABOLIC PROCESS%GOBP%GO:0000821,0.15619896065330402,0.6578589353509621,-0.7628342983181691,-1.3047872124814899,1051,2,SLC7A7|ATP2B4
REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY%GOBP%GO:0099601,0.338223308883456,0.832414358510761,-0.20371360493216395,-1.07847827897228,1244,32,ARC|CRH|ADRB2|RELN|CACNG3|CACNG7|EPHB2
LYMPHOID LINEAGE CELL MIGRATION INTO THYMUS%GOBP%GO:0097535,0.754362416107383,0.977083996023335,0.6259373621526251,0.8315298605742509,5619,1,BCL11B
HISTONE H3-T11 PHOSPHORYLATION%GOBP%GO:0035407,0.39428041837680394,0.863562957467761,-0.8010586678429641,-1.07160060404756,2977,1,PKN1
REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:2000027,0.66304347826087,0.964618776001639,-0.12463225670935302,-0.904012163912891,1402,96,FBXW7|NOTCH1|FZD1|VEGFA|PIM1|CTNNB1|TGFBR1|ACVR1|ARRB2|CELSR1|PRICKLE1|PFN1|LIF|CITED2|FGF7|RHOA|HGF|NFIB|PAX8|WNT6|WNT11|CDC42|AP2S1|DKK1|GREM1|RAC1|SULF2|TNF|RBPJ
REGULATION OF SYSTEM PROCESS%GOBP%GO:0044057,0.40373280943025497,0.8655192490568291,0.162653401037263,1.04092419589863,5753,252,CARTPT|RGS2|RYR2|KCNN2|TNNI3K|KCNK6|EDN1|CACNA1G|GHRL|AKAP9|ZFHX2|PTGER3|CACNB2|NPR2|RIMS2|NR4A3|KCNK3|ATP2B1|NOV|FGF12|MYLK2|CRHBP|TBX2|KCNQ1|INHA|OXTR|ADORA3|SLC8A3|UNC13B|F2R|KCNB2|GTF2IRD2|PTPRO|S100A1|FGF13|AGTR1|ATP2A1|C1QTNF3|CUX2|CACNA1H|RAB11FIP3|FOXN4|CACNA2D1|TGFB2|TNNC2|KCNH2|CTTN|PARP1|CACNA1D|F2RL1
NEGATIVE REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0045955,0.715289982425308,0.971081608033886,-0.29008905306216,-0.796274972600142,4069,6,FMR1|ADRA2A
DSDNA LOOP FORMATION%GOBP%GO:0090579,0.9937156323644929,1.0,-0.245844412136359,-0.498933930072475,6324,3,RUVBL2
REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0010958,0.33809897879025896,0.832232043362884,-0.535049877444843,-1.08586782924431,2151,3,PER2
NEGATIVE REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000417,0.533778767631774,0.9265056012720759,-0.5482216708023161,-0.9377038070327429,3594,2,CD300A|PTGER4
FLAVIN ADENINE DINUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0072388,0.5008605851979351,0.9144253281295329,-0.7461954124393471,-0.9982083545275091,3782,1,FLAD1
ESTROGEN METABOLIC PROCESS%GOBP%GO:0008210,0.596566975568661,0.9484252359021391,0.34273766005564804,0.892074119902457,5664,7,HSD17B4|HSD17B11|HSD17B14|HSD17B8|HSD17B1
CHROMOSOME BREAKAGE%GOBP%GO:0031052,0.7134228187919459,0.971081608033886,0.6467798853109841,0.859218222739249,5314,1,RFWD3
NEGATIVE REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000548,0.319865771812081,0.8219996514077841,0.843625937362153,1.12071942096424,2382,1,CCL21
MATURATION OF LSU-RRNA%GOBP%GO:0000470,0.0200812274368231,0.29666833860947994,-0.395739109291226,-1.73550326596398,88,19,URB1|WDR12|PES1|RPF2|RPL35|RPL7|ZNHIT6|NHP2L1|RSL1D1|NHP2|NOL9
MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072143,0.763880488689972,0.978421368343614,0.50046870692032,0.81800235278162,6314,2,ACTA2|PDGFB
DEVELOPMENTAL INDUCTION%GOBP%GO:0031128,0.18038670834780604,0.685966538908844,0.6568920004636091,1.2486825904366499,1557,3,BMP4|BMP2|FZD5
DITERPENOID BIOSYNTHETIC PROCESS%GOBP%GO:0016102,0.7477823381437841,0.9749763305090959,-0.6211954124393471,-0.83099204330946,5647,1,ALDH1A3
EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0140115,0.37857418856259706,0.854868503740915,0.316768067243953,1.07403761773413,3918,15,KCNT2|KCNQ1|ATP1B3|KCNH2|SLC40A1
NEGATIVE REGULATION OF FERROPTOSIS%GOBP%GO:0110076,0.930738255033557,1.0,0.537218791354213,0.7136711972846129,6933,1,GPX4
CELLULAR RESPONSE TO CHEMOKINE%GOBP%GO:1990869,0.607699514521761,0.9508825506493929,0.193551184731785,0.897322655024176,7134,43,CXCL13|SLC12A2|STK39|CXCR4|CXCL9|DOCK8|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CCL3L3|CCL11|DUSP1|CCL4L2|CXCL11|XCL1|WNK1|CCR1|CCL4|CXCL2|CCL8|CXCL1|CCL24
DIAPHRAGM DEVELOPMENT%GOBP%GO:0060539,0.12458029408359401,0.607607158836689,0.6945439794715451,1.32025504169122,1075,3,BASP1|DISP1
NEURONAL ION CHANNEL CLUSTERING%GOBP%GO:0045161,0.7456587293334721,0.9749763305090959,0.284353003742686,0.77522257542037,7170,8,SPTBN4|AGRN|PICK1|KCNIP2|NRCAM|CNTN2
DELTOID TUBEROSITY DEVELOPMENT%GOBP%GO:0035993,0.410789887504536,0.867015886388254,0.638082480104241,1.04292828457924,3395,2,BMP4|SCX
REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051621,0.31210096510764695,0.814738979058597,-0.6733527910942951,-1.15173388669804,2101,2,SNCA
NEGATIVE REGULATION OF PHOSPHORYLATION%GOBP%GO:0042326,0.00518134715025907,0.16737273925846302,-0.16666885529633,-1.5001483005699399,2,291,PPP2R5A|PPM1F|TIMP3|PYCARD|PIK3R2|DUSP4|STRAP|SOCS3|THY1|CDKN1B|CRKL|DUSP7|PPP1R15B|NCK2|ITCH|HSPB1|HEXIM1|GPER1|DNAJC3|FLCN|PTPN6|QARS|ZGPAT|LRP5|CBFA2T3|PPIF|IL1B|HEG1|IMPACT|PRKCD|SIRPA|DAB2IP|IGF1R|TRIB1|CNKSR3|WARS|DDIT4|RGS4|CEBPA|ABL1|HDAC4|GNAQ|FAM129A|IGFBP3|FBP1|SMAD6|INPP5K|DGKQ|PPARA|FOXO1|MYADM|EIF4G1|PPAP2B|UBASH3B|RASSF2|LYN|PRNP|CHP1|CYLD|LDLRAD4|TRIB2|PIK3IP1|PPP2CA|PRKAR2A|TNIP1|NPM1|PTPN1|SMAD7|SNCA|TRAF3IP1|CDKN1C|PDCD4|PDE12|MECOM|DUSP3|UCHL1|DKK1|SNX6|PRKAR1B|PKIG|SOCS5|CDKN1A|DBNDD2|PARK2|KIAA0226|GREM1|SFRP2|DUSP10|SLC9A3R1|CORO1C|FKBP8|SNX25|TWIST1|DLG1|PDE4D|SPRED2|INSM1|CAV1|EPHB2|PAK2|PARD3|TRIB3
SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048741,0.38684752747252704,0.859991269020751,-0.410683986968204,-1.03961924219052,2252,5,SKI|RYR1|CAV2
REGULATION OF SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:1902504,0.37878988481398096,0.8550005836723921,-0.8077856197618,-1.08059945273243,2860,1,RINT1
HEART INDUCTION%GOBP%GO:0003129,0.127494859078263,0.6076669536424699,0.7818332732196001,1.2778850068610002,1053,2,BMP4|BMP2
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904753,0.5674423989811279,0.939365610708362,0.49200397044226296,0.935247790935762,4900,3,PRKG1|TPM1|MEF2C
CELLULAR RESPONSE TO INDOLE-3-METHANOL%GOBP%GO:0071681,0.673637411493496,0.9647315640607691,-0.359234544752661,-0.8261644062059921,4090,4,BRCA1|JUP|CTNNB1|CTNNA1
REGULATION OF INTRACILIARY RETROGRADE TRANSPORT%GOBP%GO:1905799,0.334833840857937,0.8308635358777792,-0.8337560652845171,-1.1153409095404199,2528,1,TCTEX1D2
"MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:0006120",0.6686995361621719,0.964618776001639,0.187068178865138,0.8543254791099459,7784,41,NDUFA7|NDUFS7|NDUFA4|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|NDUFS8|NDUFB2|MT-ND2|NDUFV1|NDUFS3|NDUFB7
NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009133,0.8861873335648951,0.996643473105967,0.358648129385516,0.6817523655948001,7653,3,DTYMK|AK5|CMPK2
NUCLEOBASE-CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0034404,0.0826330532212885,0.5420718842622351,-0.17969387351382002,-1.2942519476128,176,94,NUDT7|SMUG1|LDHA|DHFRL1|ENTPD4|PFKL|DERA|GPI|GMPS|NUDT4|PKM|PNP|ENO1|CDA|HPRT1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|PDE9A|UPP1|ALDOA|ITPA|NT5E|NEIL2|PDE4D|PGAM2
NEGATIVE REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903625,0.252747252747253,0.7641083395392759,-0.874614027348919,-1.16999785114279,1908,1,DFFA
FOLATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1904447,0.35684044998185604,0.8445764484419659,0.661648745519713,1.08144669799765,2949,2,SLC46A1|SLC19A1
NEGATIVE REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032690,0.37640672580431606,0.853374872190571,-0.809605205116895,-1.0830335675406402,2842,1,CX3CL1
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009174,0.524161073825503,0.92593403131991,0.7417291574768421,0.9853540948242441,3904,1,UMPS
REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045625,0.9310060925407541,1.0,-0.26940253187644897,-0.619569543155548,5653,4,SOCS5
AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0060414,0.21531389863311998,0.732094216765764,0.7258891645988421,1.18644589819494,1779,2,PROX1|MYLK
REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045655,0.9361066878980892,1.0,0.19162008712470002,0.5845889609117529,9405,11,CDK6|ACIN1|CSF1|IL34|CD74|ZFP36L1|MYC|IRF7
TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0007178,0.0878928987194412,0.556718035193165,-0.16264274311981197,-1.2501033665988501,150,122,F11R|SKI|TGFBR1|RGMA|ACVR1|ARRB2|GDF15|TMEM100|FAM83G|CITED2|RHOA|BMP8B|STUB1|SMAD6|KLF10|CDH5|PXN|SMAD1|SMAD2|CHRDL1|SMAD7|ATOH8|PDCD4|JUN|UBA52|ID1|ZYX|UBE2D3|MAPK3|ACVRL1|UBC|FKBP1A|PARD3|INHBB|UBB
BOX C/D SNORNP ASSEMBLY%GOBP%GO:0000492,0.229597813354159,0.743365122901021,-0.37152327036502003,-1.19931040973686,1175,9,TAF9|RUVBL1|ZNHIT6|NUFIP1|RUVBL2|PIH1D2
TRNA 5'-LEADER REMOVAL%GOBP%GO:0001682,0.0489623211767076,0.4351668564421479,0.521492536430969,1.53905920339717,485,10,RPP30|RPP25|POP1
NEGATIVE REGULATION OF CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:1905305,0.593538991129353,0.9464278097528599,-0.6972320247022501,-0.932708537870417,4482,1,SMAD4
INTRACELLULAR TRANSPORT OF VIRUS%GOBP%GO:0075733,0.14311667339523598,0.632949331968897,-0.377011261571299,-1.32674960103348,708,11,UBA52|UBC|UBB
PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT%GOBP%GO:0010623,0.979658500371195,1.0,-0.31976840363937103,-0.546946728724892,6597,2,DNASE1L3|NTRK1
POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901838,0.549768285311304,0.931359181171847,0.315781526102959,0.9319528661670409,5456,10,NOL11|MARS|SMARCA4|DDX11|MTOR|IPPK|PWP1|PIH1D1|SMARCB1
REGULATION OF MALE GERM CELL PROLIFERATION%GOBP%GO:2000254,0.364662212323682,0.85007225273817,-0.640088227185001,-1.09483663166728,2455,2,CIB1|RHBDD1
NEGATIVE REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033861,0.13771812080536902,0.6243233125849921,0.9323445081605649,1.2385780842538798,1025,1,INS
IMMUNE RESPONSE-INHIBITING SIGNAL TRANSDUCTION%GOBP%GO:0002765,0.280750864482134,0.789038489620028,-0.49649809739149603,-1.14184190191473,1704,4,LILRB2|LILRB1|CD33|LYN
ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:0061154,0.163120567375887,0.665215394314715,-0.384033388331239,-1.29924243483619,827,10,CTNNB1|PRKD2|RHOA|ACVRL1|RBPJ
CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:0045054,0.6743679690335072,0.9647315640607691,0.5390129583677971,0.8810018728999929,5574,2,RAB3A|RAB11B
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002708,0.9390000000000001,1.0,-0.108106613581066,-0.666790206569124,2816,53,KLRK1|CD1E|SLAMF6|MAP3K7|ZP3|ZBTB1|IL12RB1|NCR3|CD1D|PAXIP1|RIF1|TRAF2|RASGRP1|HLA-F|FAM35A|IL1R1|XCL1|TP53BP1|HSPD1|FADD|MICA|HLA-C|PRKCZ|STX7|CADM1|HFE|MICB|CLCF1|HLA-B|MALT1|PVR|HLA-A|HLA-E|RSAD2|FZD5|IL18|TGFB1|CD1C|MAD2L2|AP1G1|TRAF6|TNFSF13|PVRL2|IL1B|FAM49B|LAMP1|ULBP3|C20orf196|IL6|TFRC|ULBP2|NLRP3|B2M
ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060842,0.995856198902453,1.0,0.21761429438041102,0.461145477392575,8891,4,HEY2|HEY1|DLL1|NOTCH1
REGULATION OF HEART RATE BY CARDIAC CONDUCTION%GOBP%GO:0086091,0.26644432091902903,0.7803351796901099,0.306486339000516,1.17377158298939,2875,22,CACNA1G|AKAP9|CACNB2|KCNQ1|CACNA2D1|KCNH2|CACNA1D
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1901213,0.599442896935933,0.9502607271136201,-0.28208749454660603,-0.876850756043242,3227,8,GREM1|RBPJ
NEUROTRANSMITTER SECRETION%GOBP%GO:0007269,0.544503473641193,0.929758904310055,0.18717899311005498,0.9464257874235509,6661,62,SYT17|RIMS2|GRM4|UNC13B|SYT3|LIN7A|LIN7B|DVL1|UNC13A|PPFIA3|CPLX3|SLC6A9|PCLO|CASK|SNAP47|PRRT2|STX2|BRSK1|SYT1|SEPT5|RIMS4|RAB3A|SYT7|STX3|SNAPIN|PIP5K1C|STX1A|SLC18A2|RIMS1|RIMS3|SYT4|LIN7C|STX1B
STEM CELL PROLIFERATION%GOBP%GO:0072089,0.29023208365213,0.799622947490088,-0.22407663942323897,-1.11661804885011,1137,27,RUNX1|FGF2|ETV6|ARHGEF2|MECOM|WNT3|ARIH2|SFRP2
MIRNA CATABOLIC PROCESS%GOBP%GO:0010587,0.0708762886597938,0.5132410216418211,0.596689639922656,1.4674712699156,659,6,LIN28B|ZCCHC11
BUD DILATION INVOLVED IN LUNG BRANCHING%GOBP%GO:0060503,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032462,0.0125137211855104,0.24266948074149697,-0.449638550409182,-1.84142098315803,56,16,GBA|MIEF2|RIOK3|CLU|HRK|BID|RHOC|BMF|PEX5|BIK|BCL2L11
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CARDIAC OUTFLOW TRACT CELL PROLIFERATION%GOBP%GO:0061324,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
INSULIN RECEPTOR SIGNALING PATHWAY VIA PHOSPHATIDYLINOSITOL 3-KINASE%GOBP%GO:0038028,0.7162851967725999,0.971081608033886,-0.347968846482955,-0.800255653672473,4349,4,IGF2
T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045063,0.9101539886534681,1.0,0.34312687168251904,0.652248087476427,7860,3,LEF1|HMGB1|SPN
SEROTONIN SECRETION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002442,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
REGULATION OF RENAL SODIUM EXCRETION%GOBP%GO:0035813,0.6630774574505041,0.964618776001639,0.458752921053976,0.8720410439277301,5726,3,AGTR1|NPR1|AGT
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:0060371,0.387617322575333,0.859991269020751,-0.45260816237459206,-1.0409042203044399,2353,4,SCN1B|SCN5A
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION%GOBP%GO:0033683",0.550008622176237,0.931359181171847,0.207758785003358,0.9370457317972181,6378,39,GTF2H2|RFC4|GTF2H1|DDB2|POLD1|PARP1|POLD3|DDB1|CHD1L|CUL4B|ERCC5|XPA|RBX1|RFC3|RFC5
GDP PHOSPHORYLATION%GOBP%GO:0061568,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION%GOBP%GO:0098957,0.0257659073055774,0.334936570555469,-0.8022534014323058,-1.62814944221151,163,3,HAP1|TRAK1
ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0019882,0.47537619699042405,0.9012976954254781,-0.126072120961098,-1.00035015193388,694,143,RAB35|CD1C|KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|CALR|RAB10|IFI30|RAB3C|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|RAB8B|TAPBP|HLA-DQB1|DCTN5|RAB6A|FCGR2B|SLC11A1|VAMP3|CLTA|AP1S1|AP2S1|RFTN1|KIF3C|KIF3B|CTSH|DYNLL2|B2M|SEC23A|HLA-DQA2|RAB7A|ERAP2|HLA-DQB2|CTSV|ACE|DYNC1LI1|CD36|BCAP31
HISTONE H4-K5 ACETYLATION%GOBP%GO:0043981,0.955564142194745,1.0,0.162934418302634,0.552447397880818,9891,15,JADE3|OGT|KAT8|WDR5|MEAF6|KANSL1|KAT7|MCRS1|KANSL3|JADE2|HCFC1|KANSL2|ING4
POSITIVE REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046604,0.0746844840386043,0.5243110386449029,-0.8356532385549709,-1.42934010982356,502,2,NSFL1C
CYTOKINE METABOLIC PROCESS%GOBP%GO:0042107,0.0681705911411164,0.50364937614461,-0.6648100148899799,-1.52892415057004,413,4,IL18|PCSK5|NOD1|BCL10
TETRAPYRROLE CATABOLIC PROCESS%GOBP%GO:0033015,0.178330314506834,0.6837991059383349,-0.556499200352948,-1.27983190405659,1082,4,HMOX2|BLVRB|HMOX1|BLVRA
KIDNEY SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0072194,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
REGULATION OF CYTOKINESIS%GOBP%GO:0032465,0.38804143894281795,0.859991269020751,0.208119078581186,1.05893914661577,4756,64,FSD1|KIF14|E2F8|ECT2|KIF20B|MYO19|CSPP1|RAB11FIP3|MAP10|KIF23|BIRC6|E2F7|PRC1|GIT1|AURKB|CDC6|CENPV|PIN1|KIF20A|PLK1|RACGAP1|PKN2|AURKA|SVIL|KLHL9|CIT|ZFYVE26|RAB11FIP4|PDXP
BMP SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061312,0.7280305661688091,0.972554563883587,0.43384500179079294,0.8246937096231759,6287,3,BMP4|BMPR1A
NITRIC OXIDE HOMEOSTASIS%GOBP%GO:0033484,0.430734966592428,0.8785877309899279,-0.596461586208534,-1.02021559877047,2900,2,CAV1
REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900024,0.00971952235490142,0.215770790508743,-0.319243381286186,-1.73540924312458,34,35,RREB1|CALR|CRKL|S100A10|PDPN|ABL1|NRP1|C1QBP|MYADM|DOCK5|CRK|CDC42|LIMS1|MFI2|RAC1|CORO1C
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043535,0.00538254517493272,0.168826383791782,-0.253737957441471,-1.7060928509325,13,71,TBXA2R|GATA2|RHOJ|HIF1A|MECP2|HSPB1|NOTCH1|VEGFA|KDR|HMOX1|PRKD2|MMRN2|RHOA|HDAC5|FGF2|MAP2K5|PPARG|MEOX2|FOXC2|ETS1|TMSB4X|PDCD10|FGFR1|MAP2K3|ADAM17|STAT5A|PRKCA|NOS3|ACVRL1|SH3BP1|ANGPT2
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0035794,0.07553003533568901,0.525408291492683,-0.344795577177352,-1.45086013129645,341,17,BNIP3L|BMF|BCL2L11|PMAIP1
CEREBELLAR CORTEX MORPHOGENESIS%GOBP%GO:0021696,0.2587673791243,0.7702827862722491,-0.307806276392237,-1.15919255336979,1246,13,DLL1|OPHN1|ADCK4|FAIM2|CBLN1|ZNF365|TRNP1
BODY MORPHOGENESIS%GOBP%GO:0010171,0.790055248618785,0.9819233677232551,-0.171602802718375,-0.765675487597812,3431,20,RAB3GAP1|CRISPLD1|FUZ|STRA6|IFT122|MSX1|SKI|ATP6AP2|CRISPLD2
REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901532,0.8499734466277221,0.991298302704726,-0.138905965407085,-0.7304418368460941,3200,31,EIF2AK2|GATA2|YTHDF2|FOXC1|ITCH|FLCN|NOTCH1|ABL1|RUNX1|NUDT21|CBFB
GLUTAMATE CATABOLIC PROCESS VIA 2-OXOGLUTARATE%GOBP%GO:0006539,0.719449225473322,0.9713637233549571,-0.6355315394794879,-0.850169917555905,5433,1,ADHFE1
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051447,0.19089126171279103,0.699413757793261,0.549233923315788,1.26590277398144,1751,5,FBXO43|FBXO5|DUSP1|RAD1|TRIP13
KIT SIGNALING PATHWAY%GOBP%GO:0038109,0.44816741260433,0.8850378987593649,0.623269920044114,1.01871756208579,3704,2,KIT|FER
"POSITIVE REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION, POLY(A)-COUPLED%GOBP%GO:2000806",0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903393,0.00047528517110266203,0.0784645998831315,-0.5354997599479029,-2.48083137146096,1,22,ARF6|MAPRE2|PPM1F|THY1|S100A10|ADD1|VEGFA|KDR|COL16A1|ABL1|NRP1|MAP4K4|IQSEC1|DUSP3|LIMS1|RAC1
REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:0060964,0.156527682843472,0.6578589353509621,-0.19691673699564602,-1.23636252736585,457,56,HIST2H4A|EIF4G1|PPARG|POLR2A|FMR1|POLR2K|AGO2|POLR2F|STAT3|TP53|POLR2I|HIST2H4B|POLR2D|H3F3B|MAP2K1
TENDON CELL DIFFERENTIATION%GOBP%GO:0035990,0.410789887504536,0.867015886388254,0.638082480104241,1.04292828457924,3395,2,BMP4|SCX
PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT%GOBP%GO:1903546,0.891029230596931,0.997300970905927,0.31217660083609006,0.6615320378343149,7955,4,TUB|SPATA7
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0007194,0.731174089068826,0.9726603499749559,0.276110084785734,0.7879238415736279,7223,9,AKAP5|ADGRV1|PALM
WNT SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:0090244,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060266,0.267801319902744,0.7826111979723571,0.609738612551009,1.15904896036502,2312,3,INS|RPS19|SLAMF8
NUCLEAR ENVELOPE ORGANIZATION%GOBP%GO:0006998,0.9642673080226759,1.0,0.12326170734799301,0.562926403757327,11225,41,SPAG4|CCNB1|CDK1|PRKCB|AKAP8L|LEMD3|DMPK|CCNB2|PLK1|VRK1|CNEP1R1|NEK9|LEMD2|TARDBP|ANKLE2|REEP3
REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051940,0.45123626373626397,0.886411023801201,-0.389196883739802,-0.9852260671848639,2627,5,SNCA|DRD2
MULTIVESICULAR BODY ORGANIZATION%GOBP%GO:0036257,0.49762658227848106,0.9125449927044541,-0.18556359419009197,-0.962709873467681,1886,30,VPS36|VPS37B|TSG101|VPS37A|STAM2|MVB12A|SNF8|HGS|CHMP5|VPS37C|CHMP6|IST1|CHMP3|CHMP2B|CHMP7|CHMP2A|STAM|CHMP1A|RAB27A|VPS25|VTA1|CHMP4A|RAB11A|PDCD6IP|VPS28|VPS4A|VPS37D|VPS4B|CHMP4B|CHMP1B
NEGATIVE REGULATION OF TRANSPORT%GOBP%GO:0051051,0.00143472022955524,0.0961252072968491,-0.22484084592721398,-1.9792855035861001,0,260,SYT11|PPIF|RAB33B|IL1B|SRGN|IL11|MTMR2|NEDD4L|NECAB2|CX3CL1|ADRA2C|SIRPA|KCNE3|FKBP1B|UBE2J1|LGALS9|PTK2B|TNFAIP3|CD300LF|NR1H3|OS9|PFKL|SSC5D|LIF|CRHR1|KCNE4|BAG4|SESTD1|MPV17L|ARHGAP1|PLN|YRDC|INPP5K|RAB11FIP1|TNFRSF1B|PXK|APOD|SLC30A1|KCNAB1|FCGR2B|MMP9|CHP1|SUMO1|HTR1B|VIP|VPS4B|VAMP3|BIN1|CAB39|ACAA2|TMSB4X|DPH3|LRPAP1|CRH|SNCA|FMR1|LGALS3|GNB5|PNKD|NEDD4|NR1H2|HRH3|NLRP3|DYSF|COMMD1|RANGAP1|YWHAE|TNFRSF4|SLC35F6|ADCYAP1|SIAH3|DRD2|PPP1R11|RAB7A|CABP1|PARK2|ADRA2A|KIAA0226|PEA15|RAB11FIP5|RAC1|MCTP1|CD22|TNF|SNX12|TNFRSF21|CAV1|FKBP1A|STC1|EPHB2|INHBB|TRH
TRIGLYCERIDE HOMEOSTASIS%GOBP%GO:0070328,0.0398956723338485,0.398259330633433,0.46568180472267606,1.5789463266235302,412,15,SIRT1|LPL|SCARB1|C1QTNF3|RORA|CETP|APOE
INDUCTION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0044416,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION%GOBP%GO:0032912,0.233458328293214,0.7474006137374671,0.7176730079955891,1.17301681593794,1929,2,CDH3|GATA6
IRON ASSIMILATION%GOBP%GO:0033212,0.766582814775586,0.9792236089291529,-0.6130348478164979,-0.8200754071999441,5789,1,SLC11A2
RRNA MODIFICATION%GOBP%GO:0000154,0.00571874187678711,0.17352934538701598,-0.359663476901349,-1.84066815695431,21,29,NAF1|THUMPD1|TSR3|FTSJ2|METTL16|NSUN5|GAR1|NSUN3|TRMT112|WBSCR22|RPUSD2|NHP2|RNMTL1|EMG1
REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0044058,0.571052631578947,0.9404752161333092,0.31909275862928005,0.910581706541491,5641,9,PTGER3|KCNQ1
POSITIVE REGULATION OF AXON REGENERATION%GOBP%GO:0048680,0.523765391235271,0.92593403131991,-0.733458314953683,-0.98116955087009,3955,1,SCARF1
REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090239,0.827229299363057,0.9876441563834109,0.23143840195082602,0.706065511928629,8311,11,SIRT1|MUC1
MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE%GOBP%GO:0072595,0.23415444229172402,0.7481332891296201,-0.217465528175581,-1.1701573992076202,845,34,HSPA5|OS9|PML|SUPT7L|ARL2BP|HK1|HK2|BCL3|RANGAP1|TAF8
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032410,0.00526641883519207,0.16770443270936902,-0.315870235742982,-1.84124337475674,16,44,CAMK2D|SRI|HECW2|PPIF|NEDD4L|KCNE3|FKBP1B|CRHR1|KCNE4|PLN|KCNAB1|MMP9|SUMO1|CAB39|SNCA|FMR1|GNB5|NEDD4|YWHAE|ADRA2A|CAV1|FKBP1A|EPHB2
MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0071985,0.37586827887831203,0.8533319722534141,-0.20759668322299,-1.04965985985689,1460,28,MITD1|LAPTM4B|VCP|SNF8|SORT1|LEPROTL1|CHMP5|LYST|UBXN6|CHMP3|CHMP2B|SYTL4|UVRAG|CHMP2A|CHMP1A|RAB27A|VPS25|VTA1|TMEM50A|TMEM50B|RILP|VPS28|VPS4B|LEPROT|KIAA0226|CHMP1B
GMP CATABOLIC PROCESS%GOBP%GO:0046038,0.829250185597624,0.9876441563834109,-0.42657159577855,-0.7296278688658671,5584,2,HPRT1
RESPONSE TO AUDITORY STIMULUS%GOBP%GO:0010996,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
DNA METHYLATION%GOBP%GO:0006306,0.897660020030957,0.998912093067348,0.160765576230132,0.6406276950986229,9858,25,EHMT1|PIWIL4|N6AMT1|DNMT3B|FOS|EHMT2|ATF7IP|DNMT1|PPM1D|PIWIL2|PICK1|PRMT7|ATRX|KMT2E|TDRD12
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS%GOBP%GO:0039528,0.401119710192656,0.8638522656500329,-0.448078089670766,-1.03048599945098,2435,4,DDX58|IFIH1|IRF7|IRF3
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905006,0.274765100671141,0.7884684708511421,0.865846934274371,1.15023902401317,2046,1,TGFB2
DNA METHYLATION OR DEMETHYLATION%GOBP%GO:0044728,0.720976538827807,0.9713770803161691,0.18137530956237302,0.81252280877103,8327,38,TDG|EHMT1|PIWIL4|N6AMT1|DNMT3B|FOS|ALKBH3|ALKBH1|EHMT2|ATF7IP|FTO|DNMT1|PPM1D|PIWIL2|PICK1|TET2|APOBEC3D|PRMT7|APOBEC3C|TET1|ATRX
POSITIVE REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010811,0.00286841161706705,0.13103871184697197,-0.281952461062904,-1.80908986368176,7,61,PPM1F|RREB1|MMRN1|CALR|ARL2|THY1|CRKL|S100A10|VEGFA|KDR|CX3CL1|COL16A1|PTK2B|ABL1|MMRN2|NRP1|C1QBP|MYADM|DOCK5|MAP4K4|CRK|EMILIN2|CDC42|NPNT|LIMS1|RAC1|CD36|CDH13|EMILIN3
CELLULAR RESPONSE TO CORTISOL STIMULUS%GOBP%GO:0071387,0.108301337217,0.58452352834625,-0.944419938244376,-1.26337934651202,817,1,KLF9
REGULATION OF CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:1904412,0.9284563758389258,1.0,0.5383767093074551,0.715209439627112,6916,1,BMPR1A
G PROTEIN-COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0098664,0.226664901363697,0.7398172623753029,-0.885917512130569,-1.1851188673755602,1711,1,HTR1B
POSITIVE REGULATION OF COA-TRANSFERASE ACTIVITY%GOBP%GO:1905920,0.23116642393750797,0.7440352621789029,-0.8840427878253199,-1.18261099151257,1745,1,CHRNA7
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0045187",0.5314217032967029,0.9265056012720759,-0.365422738963951,-0.9250433983692141,3094,5,PTGDS|CHRNB2|PER3|CRH
REGULATION OF DNA LIGATION%GOBP%GO:0051105,0.236039518900344,0.750277765814412,0.493740003309249,1.2142816318350602,2197,6,RAD51|XRCC1|PARP3|APLF|HMGB1|TFIP11
CORTISOL SECRETION%GOBP%GO:0043400,0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032891,0.6516985552518549,0.9640743070248079,-0.261386363372258,-0.8437786043593251,3337,9,HRH3|TRH
RESPONSE TO PLATELET AGGREGATION INHIBITOR%GOBP%GO:0061478,0.66497975708502,0.964618776001639,0.29443139995323603,0.8402066150936991,6569,9,GNAI1|ADCY8|ADCY1|ADCY6
SPINDLE ASSEMBLY INVOLVED IN MEIOSIS%GOBP%GO:0090306,0.623063683304647,0.9536478716552259,-0.6816277018085579,-0.911834159363708,4705,1,GOLGA2
REGULATION OF EXTRATHYMIC T CELL DIFFERENTIATION%GOBP%GO:0033082,0.945445748155316,1.0,0.40060571582202004,0.654779037228297,7815,2,ZNF683|PRDM1
VESICLE TRANSPORT ALONG ACTIN FILAMENT%GOBP%GO:0030050,0.46500167991936403,0.8931622397044531,0.473862326173531,1.0041595348495602,4151,4,FNBP1L|MYO5A|WASL|ACTN4
"SYNAPTIC TRANSMISSION, GLYCINERGIC%GOBP%GO:0060012",0.662876496915447,0.964618776001639,0.5428937003319609,0.8873448390301999,5479,2,SLC6A9|GLRB
REGULATION OF RESPIRATORY BURST%GOBP%GO:0060263,0.377594197058231,0.85375124052253,0.36416032154869293,1.0747311902627399,3747,10,NOXA1|INS|JCHAIN|RPS19|RAC2
RESPONSE TO ANISOMYCIN%GOBP%GO:0072739,0.741260433047055,0.974505008828563,0.510945685139234,0.8351266858610059,6127,2,MAPK13|KAT7
RESPONSE TO COLD%GOBP%GO:0009409,0.323261497445012,0.823747293304639,-0.254221090860989,-1.09360265041425,1454,18,DNAJC3|NFKBIA|RBM3|UCP2|EIF2AK3|ACOT11|FOXO1|METRNL
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002586,0.46994895438827594,0.897155577363025,-0.423647493520101,-0.97430073203476,2853,4,HLA-DOB|HLA-DOA|TREM2|PYCARD
CELLULAR RESPONSE TO HYDROSTATIC PRESSURE%GOBP%GO:0071464,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
NEGATIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070563,0.24558277654045998,0.7579381964753191,-0.709511993382961,-1.2135822656498,1653,2,KANK2|SNAI2
L-ARGININE TRANSPORT%GOBP%GO:1902023,0.6797299522476539,0.9647315640607691,-0.35769069984137697,-0.822613885430537,4127,4,SLC7A1
REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001204,0.7859010677707561,0.981487311948134,0.32544006021395,0.7500910950699929,7212,5,FBN1|ATP6AP1|NOTCH2|LILRB1
PURINE RIBONUCLEOTIDE TRANSPORT%GOBP%GO:0015868,0.9885595990411851,1.0,0.20986726016404997,0.48371292364038,9072,5,SLC25A42|SLC35B2|SLC25A17|SLC25A24
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN METANEPHRIC KIDNEY DEVELOPMENT%GOBP%GO:0061290,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
ANIMAL ORGAN MATURATION%GOBP%GO:0048799,0.0887650882079852,0.556932119338259,-0.466379833416074,-1.44971158750407,477,8,SEMA4D|MBTPS2|PLXNB1|BMP2|XYLT1|RHOA|IGF1|RYR1
DETECTION OF DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0042496,0.96650337614193,1.0,-0.5156043228936921,-0.6897396233789059,7299,1,TLR2
REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045069,0.00667160859896219,0.18239572673498103,-0.253217318098054,-1.6852596472003,17,68,DDX3X|INPP5K|IFITM2|TBC1D20|IFITM3|OASL|MAVS|TNIP1|PPIH|CNOT7|FMR1|OAS3|CXCL8|PDE12|VAPB|ZC3HAV1|PARK2|STAU1|PABPC1|IFITM1|TNF
MAST CELL SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033364,0.684187082405345,0.966495577318169,-0.48740005514199103,-0.8336716908431321,4607,2,LYST|SRGN
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000781,0.0498042429208777,0.438727695219498,0.38228453274809204,1.5233488712514698,546,25,MMS19|BLM|FAM178A|TIMELESS|WRAP53|ANKRD32|RIF1|C5orf45|SPIRE2|SPIRE1|FOXM1|SPIDR|FMN2|FAM35A|PARP9|SETMAR|MGMT|WAS|DDX11
REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060998,0.8790593505039191,0.9956508825790341,-0.130140949297014,-0.7158913092447879,3139,36,SRGAP2C|BHLHB9|EFNA1|ARC|FMR1|C21orf91|RELN|FOXO6
RESPONSE TO VITAMIN B6%GOBP%GO:0034516,0.6531179663709781,0.9640743070248079,-0.6674569916188801,-0.892877568281645,4932,1,KYNU
CELLULAR BIOGENIC AMINE METABOLIC PROCESS%GOBP%GO:0006576,0.9639862300291291,1.0,0.12862100880181898,0.5544239228881321,10920,33,IDO1|NAPEPLD|DDC|SAT2|GDPD1|SARDH|MOXD1|CCBL1|AZIN2|AFMID|SAT1|AADAT|DBH|MAOA
REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903578,0.0356675392670157,0.3821688062173221,-0.244101253701066,-1.4875044312713999,108,51,HIF1A|FLCN|CBFA2T3|PPIF|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|PPARA|ENO1|IGF1|UQCC2|TMSB4X|SHMT2|SNCA|PPARGC1A|PDE12|SLC25A33|AAED1|COX7A2L
LUNG LOBE MORPHOGENESIS%GOBP%GO:0060463,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:0071971,0.5998940818217929,0.9503391896930079,-0.693978826643141,-0.9283566356375691,4530,1,CD34
GOLGI RIBBON FORMATION%GOBP%GO:0090161,0.489427860696517,0.908938677284213,-0.263754061385202,-0.960882502779144,2360,12,MYO18A|GOLPH3|STX6|PRMT5|GOLGA2|OPTN|TMED5|STX16|GCC2|VTI1A
ACTIVATION OF JUN KINASE ACTIVITY%GOBP%GO:0007257,0.798303402220016,0.9835585148939309,0.182872524114595,0.7434704000121851,8845,27,MAP3K10|ERN1|MAP3K9|MAP3K5|CCL19|TAOK1|MAP2K7|RIPK1|MAP3K12
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS%GOBP%GO:0044089,0.5968586387434561,0.948743846634479,-0.104622765335919,-0.962733615176917,227,369,MECP2|NCK2|BAX|FUZ|SYNPO|PHLDB1|UTP15|MMP1|CDC42EP5|MAPRE1|PSMC4|ERCC1|CLU|ANKRD53|VEGFA|KDR|BCLAF1|CX3CL1|BCAS3|TRABD2A|LPAR1|CTNNB1|TGFBR1|COL16A1|PTK2B|WARS|AKIRIN1|VASP|PFN1|ABL1|EPS8L1|RPA3|RPS3|STX18|VPS4A|BHLHB9|RHOA|CCP110|STUB1|NRP1|SLX1A|HRK|MITF|ICE1|FOSL1|NPHP1|EIF4G1|WHAMM|TRMT112|PXN|WBSCR22|SLAIN2|SUMO1|ARPC5|SH3GLB1|TCL1A|HAP1|VPS4B|PIP4K2A|BIN1|SERPINF2|BID|MAP4K4|WIPF1|RHOC|RALA|LIMK1|WNT11|WDR43|MARK4|ARPC5L|FMR1|ARPC4|CDC42|CAPG|SEPT9|JUN|PRKCA|LIMS1|TP53|TPPP3|TWF2|ASAP1|RALB|HTT|RAB7A|SORBS3|BMF|SYNDIG1|KCTD17|RHOQ|RAC1|MET|ACTR2|BRK1|CD36|BIK|TWIST1|JMY|TNF|BCL2L11|PMAIP1|CAV1|EPHB2
"MATURATION OF LSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000463",0.0157545605306799,0.266235996886317,-0.486503195668855,-1.77237994292576,75,12,URB1|WDR12|PES1|RPF2|RPL35|RPL7|ZNHIT6|NOL9
REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902991,0.0485624546992027,0.43406156654211997,-0.32402591468966807,-1.52257067709145,200,23,TMED10|PICALM|CLU|CASP3|LYN|PRNP|EFNA1|CHRNA7|HAP1|BIN1|FKBP1A
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903568,0.694028862703561,0.96731875442989,-0.6481032201146889,-0.866987438048943,5241,1,LZTFL1
CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0051131,0.5775677255895539,0.942692029750853,0.272674129554542,0.9034541265885759,5926,14,HOPX|CCT6B|LONP1|BBS10
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903555,0.990484638335618,1.0,0.0980771919058347,0.5105676005987261,12282,71,GHRL|CD47|CD2|TRIM27|DHX9|JAK2|AZU1|CCL19|GSTP1|MC1R|NLRC3|CACTIN|RIPK1|C1QTNF4|DICER1|VIMP|PTPRJ|PTPN22|RASGRP1|THBS1
CALCIUM ION TRANSPORT%GOBP%GO:0006816,0.716784266626633,0.971081608033886,0.147013405114584,0.852643452444774,9548,125,RYR2|CRACR2B|CACNA1G|GRIN3A|CACNB2|ATP2B1|TMEM165|NOL3|CACNA1I|SLC8A3|F2R|PKD2|SLC35G1|IBTK|ATP2A1|CDH23|NPY|CACNA1H|CACNA2D1|CCR5|CACNA1D|CCL21|JPH4|MCOLN1|CCL5|ATP2B3|NALCN
RESPONSE TO MISFOLDED PROTEIN%GOBP%GO:0051788,0.467018714100426,0.8949379342993,0.260429758742108,0.9973855643065229,5040,22,SDF2|F12|POMT2|ATXN3|RNF126|HDAC6|ANKZF1|BAG6
NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032902,0.214699331848552,0.731747191309112,-0.729032258064516,-1.2469706329490902,1445,2,PCSK6|FURIN
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000679,0.061505376344085996,0.48343167424509204,-0.377020485096846,-1.50359137719031,285,15,PARK7|TRAF6|FAM129B|FOXC1|CTNNB1|H1F0|POU4F2|IGF1|DDRGK1|TWIST1
REGULATION OF MITOTIC CELL CYCLE DNA REPLICATION%GOBP%GO:1903463,0.664587973273942,0.964618776001639,-0.496163512896391,-0.8486611159912572,4475,2,BCL6
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903845,0.200569440050617,0.713102296410104,-0.19943801493036498,-1.19117204823155,633,47,SKI|TGFBR1|STUB1|SMAD6|SMAD2|LDLRAD4|PPM1A|SMAD7|ADAM17|UBA52|SNX6|UBC|SNX25|CAV1|UBB
NEURAL PLATE AXIS SPECIFICATION%GOBP%GO:0021997,0.8487248322147649,0.991298302704726,0.576367445963829,0.7656784383881821,6322,1,PTCH1
NEGATIVE REGULATION OF NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032904,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
POSITIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:1905602,0.27119874198620997,0.786158299673311,0.699557656586115,1.14340777171697,2241,2,LDLRAP1|ANXA2
POSITIVE REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032464,0.000585708707536119,0.0806484601749226,-0.6944190845289511,-2.24164703324576,2,9,MIEF2|CLU|HRK|BID|RHOC|BMF|BIK|BCL2L11
"WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0007223",0.970115967885816,1.0,0.12760946318362199,0.5350577049032,10874,30,PLCB3|MAP3K7|NLK|LEF1|TNRC6A|TNRC6C|FZD6|FZD3|GNAO1|NFATC1|PPP3CA|AGO4|PPP3CB|GNG2
TRICUSPID VALVE FORMATION%GOBP%GO:0003195,0.873825503355705,0.9934031064448321,0.5641817379797089,0.749490268974254,6509,1,ZFPM1
ANTIFUNGAL HUMORAL RESPONSE%GOBP%GO:0019732,0.23999032297084802,0.7525035503527309,0.714254204576785,1.16742887566993,1983,2,RARRES2|FAM3A
PATTERN SPECIFICATION INVOLVED IN PRONEPHROS DEVELOPMENT%GOBP%GO:0039017,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
RETROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT%GOBP%GO:1990049,0.522641198748559,0.9251240799994541,-0.404455964264049,-0.9301642239967359,3173,4,KIF1C|KIF1A|KIF5B|KIF5A
THYMUS DEVELOPMENT%GOBP%GO:0048538,0.916582712069313,1.0,0.20729688903713503,0.611786675014931,9097,10,HES1|ZBTB1|HAND2|RIPK3|EPHB3|FADD
NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003085,0.0936933970031286,0.562743160240921,-0.633820120527229,-1.45765386755141,568,4,SOD2|ADRB2
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009185,0.00461831024178212,0.15878634024306199,-0.358882187320128,-1.8999548108910302,16,32,LDHA|ENTPD4|PFKL|GPI|PKM|ENO1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
MAINTENANCE OF GRANZYME B LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033382,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043267,0.00946236559139785,0.21235063347774397,-0.47600346959741896,-1.89834436241707,43,15,NEDD4L|KCNE3|PTK2B|KCNE4|KCNAB1|SUMO1|VIP|BIN1|CAB39|ADCYAP1|CAV1
REGULATION OF VESICLE DOCKING%GOBP%GO:0106020,0.0928108036541771,0.5622489437340121,-0.952249669166299,-1.2738534162927702,700,1,RALB
INNATE IMMUNE RESPONSE%GOBP%GO:0045087,1.0,1.0,-0.0622543401250812,-0.553659079483155,684,265,TRIM62|IGHV5-51|RNF135|CEBPG|MX1|VCAM1|OTULIN|MFHAS1|SCARA3|SYNCRIP|NCF2|PIK3CD|CYBA|CD44|CAPZA2|PJA2|SETD2|CAMK2D|SERINC3|NRROS|TRIM8|IFI30|RNASEL|IGHV4-4|GZMB|IRAK1|TRIM13|APOBEC3F|FCER1G|CX3CL1|TYROBP|PRKCD|SIRPA|IGHV2-26|CXCL16|LGALS9|IFNAR2|IRAK4|PML|ULBP3|IGHV1-69-2|CCL14|IRF6|IGHV3-15|HLA-DQB1|IGHV3-73|DDX3X|IFNAR1|IFITM2|BCL10|MX2|IFITM3|OASL|PPARG|CYLD|VAMP2|SLC11A1|CAMK2A|MAVS|ICAM1|TRIM35|RIPK2|GAPDH|SHMT2|SNCA|CFD|OAS3|TRIM25|IGHV1-3|ULBP2|PDE12|COLEC12|TUBB4B|B2M|HLA-DQA2|HLA-DQB2|HIST1H2BC|IFITM1|MYD88|CCL18
L-CYSTINE TRANSPORT%GOBP%GO:0015811,0.753386592566864,0.9769690538700708,0.424065291717216,0.80610350956019,6506,3,SLC7A9|CTNS|SLC1A4
NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060212,0.893959731543624,0.9976191001250191,0.5544221438023821,0.73652508351604,6659,1,TOB1
"TRANS-SYNAPTIC SIGNALING BY NITRIC OXIDE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099555",0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
INTERMEMBRANE LIPID TRANSFER%GOBP%GO:0120009,0.572115384615385,0.940729590703743,-0.354456210015442,-0.8972823585510451,3331,5,CPTP|PLEKHA8|COL4A3BP|PLEKHA3|GLTP
NEGATIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033600,0.526803288178766,0.9265056012720759,0.506129070358291,0.962098119971394,4549,3,BRCA2|GATA3|ROBO1
REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035020,0.857710481099656,0.99166790097654,0.277590866471789,0.6826943088724129,7986,6,OGT|ARHGAP44|ALS2|AUTS2|STMN3|ARF6
GOLGI REASSEMBLY%GOBP%GO:0090168,0.0876008562489709,0.555207723053657,-0.641546612617596,-1.47542318523852,531,4,VCPIP1|PDCD10|YWHAZ
PHYSIOLOGICAL MUSCLE HYPERTROPHY%GOBP%GO:0003298,0.57106568283537,0.9404752161333092,0.578108629721533,0.9449026737067551,4720,2,SORBS2|PDLIM5
OTIC PLACODE FORMATION%GOBP%GO:0043049,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032435,0.793972109761584,0.9819233677232551,0.18308693881280103,0.750771486621332,8824,28,PANO1|AK6|SGTA|OGT
"REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION, POLY(A)-COUPLED%GOBP%GO:2000804",0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
REGULATION OF NAD+ ADP-RIBOSYLTRANSFERASE ACTIVITY%GOBP%GO:1901664,0.350556792873051,0.842847021021096,-0.649682933553901,-1.1112478630516798,2360,2,DTX3L|TGFB1
T CELL PROLIFERATION%GOBP%GO:0042098,0.18301812450748603,0.6891306172477071,-0.37481660533486605,-1.26806067839152,928,10,SLC11A1|ELF4|MSN|TNFRSF4
ALDITOL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0052646,0.9266480965645308,1.0,-0.20009807506506896,-0.6219919414918089,4989,8,GPAT2
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901724,0.6906333217552391,0.96731875442989,0.44849454064188793,0.8525409419054649,5964,3,EGR1|PDGFB|MYC
POSITIVE REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051491,0.6583816625241651,0.9643779777660141,0.219178405181557,0.8524293719471709,7151,23,TENM1|ARAP1|FNBP1L|TENM2|CCL21|PALM|DPYSL3|MIEN1|AGRN|TGFB3|NEURL1
INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:0008298,0.673166202414113,0.9647315640607691,-0.266577542704686,-0.828639072570208,3624,8,ZNF385A|PRPF18|BICD1
SKIN EPIDERMIS DEVELOPMENT%GOBP%GO:0098773,0.9549164012738851,1.0,0.18107093702727803,0.552405922137009,9594,11,TGFB2|APCDD1|FGFR2|HDAC2|ATP7A
UDP-N-ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006048,0.921679450948728,1.0,-0.181341719077568,-0.6381641026693511,4565,11,AMDHD2|PGM3|UAP1|RENBP|GNPDA1|GNPDA2|NAGK|GFPT1|GNPNAT1|UAP1L1|GFPT2
NEGATIVE REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050732,0.653846153846154,0.9640743070248079,-0.15755612324603302,-0.875217394662622,2294,37,HYAL2|CBL|INPP5F|PARP14|PIBF1|SEMA4D|CHMP6|PRKCZ|MVP|SOCS4|PTPN2|PTPRC|CD300A|ERRFI1|ZFYVE28|SH3BP5|SFRP1|DMTN|SAMSN1|VPS25|CBLB|DUSP22|SOCS3|THY1|PTPN6|ZGPAT|PRKCD|PPP2CA|SNX6|SOCS5|SFRP2|CAV1
MULTICELLULAR ORGANISM REPRODUCTION%GOBP%GO:0032504,0.160996920432572,0.663746576869261,0.194245862006478,1.20623429342521,2247,199,TAC1|HSPA2|INSL3|TEKT3|GHRL|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|ZCCHC11|OXTR|HERC4|CCT6B|CABYR|GGT1|PYGO1|RHOXF1|CELF1|USP9Y|PIWIL4|TRIM27|MTL5|TSSK3|SPATA25|DEAF1|ROBO2|JAG2|PCSK4|DZIP1|TGFB2|WDR33|CASC5|DAZAP1|TYRO3|YTHDC2|ZNF830|PTTG1|ZP3|KIT|DNAH1|BMPR1B|PIM2|CLOCK|CXADR|METTL3|REC8|SRPK1|FANCF|MYBL1|STOX2|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|KMT2D|TEX14|MYCBP|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|EGR1|ABHD2|AZIN2|ZNF35|C1orf111|FMN2
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0072331,0.5940690325717061,0.946908301099137,-0.12848229739659,-0.9437424074695709,1221,101,POU4F2|BOK|CRADD|CNOT7|GADD45A|TP53|BCL3|CDIP1|CDKN1A|GREM1|SESN2|PLK2|JMY|PMAIP1|TFDP2|NDRG1
REGULATION OF EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1901187,0.0139017608897127,0.256136946817111,-0.993659020732245,-1.32924796844308,104,1,RBPJ
DIADENOSINE TETRAPHOSPHATE METABOLIC PROCESS%GOBP%GO:0015965,0.0568671121009651,0.4641578331710611,-0.856079404466501,-1.4642779726597601,382,2,GARS|KARS
POSITIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900409,0.8360015618898872,0.988613522932093,-0.21966019417475702,-0.7090827910181129,4281,9,HDAC6|SFPQ|RIPK1|TLR4|MCL1|PARK7|SOD1|FBXW7|TNF
REGULATION OF CHROMATIN SILENCING AT RDNA%GOBP%GO:0061187,0.34785530294545897,0.842847021021096,0.516623826988296,1.09477523986743,3105,4,NAA40|PHF2|PHF8|H2AFY
NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045647,0.575833514926999,0.941956986273961,0.39692092249961397,0.9148438862080981,5284,5,HOXA5|LDB1|ZFP36L1|MAFB|HSPA9
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT%GOBP%GO:1903513,0.727168841062756,0.972554563883587,0.22182922054192897,0.795746638632247,7635,18,HSP90B1|SYVN1|AUP1|HERPUD1|VIMP|NPLOC4|VCP|FAF2|SEL1L|SEC61B|DERL1|UFD1L
PROTEIN IMPORT INTO PEROXISOME MEMBRANE%GOBP%GO:0045046,0.137706043956044,0.6243233125849921,-0.5298001016719149,-1.3411537768460802,801,5,PEX16|RAB8B|PEX19|PEX5
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0048557,0.976449912126538,1.0,-0.19778280293420103,-0.542900513910339,5555,6,NIPBL|FGFR2|PDGFRA|SOX11|ID2|RBPMS2
EQUILIBRIOCEPTION%GOBP%GO:0050957,0.0940141252749797,0.562743160240921,0.720855850887835,1.3702711413486102,811,3,PCDH15|CDH23|MYO7A
"RESPONSE TO 2,3,7,8-TETRACHLORODIBENZODIOXINE%GOBP%GO:1904612",0.608927059392766,0.9508825506493929,0.5631370180707571,0.9204319857577931,5033,2,PDE2A
POSITIVE REGULATION OF LIPID STORAGE%GOBP%GO:0010884,0.4808029623855,0.9046812288131709,0.297481307828025,0.985648017211093,4933,14,LPL|FITM1|SCARB1|SREBF2|OSBPL11|IKBKE
PEPTIDYL-GLUTAMIC ACID MODIFICATION%GOBP%GO:0018200,0.1875,0.6940517434063481,-0.281380963661868,-1.23398868080004,830,19,VKORC1L1|FOLH1|NAT6|GGCX|AGBL2|TTLL5|TTLL1|CFAP20
REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0010919,0.23610606610969898,0.750277765814412,-0.409543723226492,-1.1946572104539799,1299,7,PLEK|GPER1|PTK2B|SNCA|HRH1
LEUKOCYTE HOMEOSTASIS%GOBP%GO:0001776,0.6611418047882139,0.964618776001639,-0.19125056885413003,-0.8533419631908171,2871,20,RIPK3|AKT1|ANXA1|FADD|JAK3|FOXP3|HMGB1|ZC3H8|NCKAP1L|MEF2C|PPP2R3C|DOCK11|GAPT|GPR183|TNFAIP3|IL6|LYN|PDE4B|PMAIP1
REGULATION OF ACTIN FILAMENT-BASED PROCESS%GOBP%GO:0032970,0.211538461538462,0.7263676975183471,-0.12577517222898799,-1.10764398423604,153,256,PYCARD|CAPZA2|CDK5|RLTPR|CAMK2D|S100A10|RND1|GPM6B|SRI|NCK2|SYNPO|ARHGDIA|HAX1|CDC42EP5|PPFIA1|ADD1|CX3CL1|BCAS3|PRKCD|KCNE3|LPAR1|F11R|TGFBR1|CFL2|PTK2B|PDPN|VASP|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|PLN|INPP5K|WDR1|RANGRF|TMSB10|MYADM|WHAMM|NAT6|PXN|RND2|ARPC5|BIN1|SERPINF2|WIPF1|CRK|RHOC|TMSB4X|LIMK1|WNT11|ARPC5L|ARPC4|TWF1|CDC42|PDE4B|AKAP13|MTPN|ARPIN|SSH3|TWF2|SORBS3|PARK2|MYH9|TMEFF2|RHOQ|RAC1|MET|SCN5A|ACTR2|BRK1|SH3BP1|DLG1|JMY|PDE4D|CAV1|STC1
MESANGIAL CELL-MATRIX ADHESION%GOBP%GO:0035759,0.5774767146486031,0.942692029750853,0.575875387551135,0.9412525007299909,4773,2,CCL21|CD34
"ENDONUCLEOLYTIC CLEAVAGE TO GENERATE MATURE 3'-END OF SSU-RRNA FROM (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000461",0.9513729285109471,1.0,0.393021025802948,0.642382069755748,7864,2,RPSA|RPS21
GENETIC IMPRINTING%GOBP%GO:0071514,0.183912534166341,0.6903572731305279,-0.390086647872364,-1.25923465583471,941,9,KDM1B|RTFDC1|IGF2
RETINAL ROD CELL DEVELOPMENT%GOBP%GO:0046548,0.9451688923802041,1.0,-0.297342009484945,-0.6034467738306178,6015,3,TOPORS|BBS4|NRL
RESPONSE TO TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071725,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|CD14|TLR1
GUANOSINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:1901069,0.23126472898664602,0.7440352621789029,-0.593729943033365,-1.2049572788949,1471,3,HPRT1|NUDT18
POSITIVE REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902565,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE%GOBP%GO:1902284,0.0434540389972145,0.411224194190211,-0.517202313447128,-1.60768998392625,233,8,SEMA3F|NRP1|ALCAM|SEMA3A|SLIT3
NEGATIVE REGULATION OF CALCIUM ION BINDING%GOBP%GO:1901877,0.292201774129485,0.8000726114371469,-0.853936921041023,-1.14233745559503,2206,1,PLN
REGULATION OF BINDING%GOBP%GO:0051098,0.00258732212160414,0.126473912512219,-0.16502726540583,-1.43541133841514,1,241,ADD1|PINX1|RARA|SIN3A|CDK9|NFKBIA|PRKCD|NES|CTNNB1|DAB2IP|SKI|STYX|ARRB2|HSPA5|FAM192A|ABL1|HDAC4|NRP1|RSF1|PLN|HDAC5|TCF7L2|EIF4G1|NMD3|H1F0|DDIT3|PPARG|AMFR|MMP9|SMAD2|SUMO1|HABP4|POU4F2|PPP2CA|PPP2CB|IGF1|RUVBL2|CRK|RIPK2|ZNF593|TMSB4X|DPH3|LRPAP1|PLAUR|FMR1|LGALS3|STK4|GNL3L|ADRB2|HSF1|BCL2|JUN|ID1|PEX19|DKK1|BCL3|B2M|RALB|PARK2|PER2|MET|DDRGK1|CD36|TWIST1|SUMO3|CAV1|FKBP1A|LARP6|TRIB3
METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:0044784,0.9982080860118709,1.0,0.20424169651222102,0.432807665092775,8912,4,CDC23|TACC3
POSITIVE REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070960,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
"POSITIVE REGULATION OF GLUTAMATE SECRETION, NEUROTRANSMISSION%GOBP%GO:1903296",0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
ACTIN-MYOSIN FILAMENT SLIDING%GOBP%GO:0033275,0.407206782854451,0.8669681570015609,-0.22513044505175897,-1.0224965521975,1728,21,VIM|TNNT2|TMOD1|MYL4|DES|TPM3
REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001813,0.257015590200445,0.7674783969184241,-0.7030557576017329,-1.20253922011988,1730,2,FCGR2B
NEGATIVE REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903765,0.830047175517116,0.9879179006160809,0.47343782835664006,0.7738211243509581,6861,2,KCNH2
POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900078,0.26415474511384196,0.7757876811190542,0.40254313226040006,1.18800878093047,2621,10,SIRT1|INS|FAM132A|GKAP1|IRS1
CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS%GOBP%GO:1901136,0.51588785046729,0.9221165805818109,-0.125713513227358,-0.9824759835784092,827,131,FGF2|ADAMTS9|PNP|CHP1|CHIT1|CDA|HPRT1|CEMIP|NUDT18|CDADC1|NEU4|PDE9A|MMP12|CSPG4|UPP1|SDC2|TMEM2|NCAN|NT5E|NEIL2|PDE4D|ENPP4
DISTAL TUBULE DEVELOPMENT%GOBP%GO:0072017,0.434081499237307,0.878651088001772,0.444395615767127,1.0242660164699,3983,5,PKD2|KLHL3|TFAP2B
NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0035567,0.9316176470588241,1.0,-0.10647023171955099,-0.7004685004248321,2533,66,PPP3R1|CTNNB1|ARRB2|CELSR1|PRICKLE1|PFN1|RHOA|TCF7L2|CAMK2A|WNT11|CDC42|AP2S1|AGO2|SFRP2|RAC1|PLCB1
BETA-CATENIN DESTRUCTION COMPLEX ASSEMBLY%GOBP%GO:1904885,0.830357142857143,0.9879179006160809,-0.28237657214984196,-0.714817541628432,4835,5,AXIN1|GSK3B|CSNK1A1|AMER1
REGULATION OF INTERLEUKIN-1 BETA BIOSYNTHETIC PROCESS%GOBP%GO:0050722,0.331680174186525,0.8293509737209019,0.6735042735042739,1.10082423279801,2741,2,AZU1|EGR1
SPECIFICATION OF URETERIC BUD ANTERIOR/POSTERIOR SYMMETRY BY BMP SIGNALING PATHWAY%GOBP%GO:0072101,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF GERM CELL PROLIFERATION%GOBP%GO:1905936,0.364662212323682,0.85007225273817,-0.640088227185001,-1.09483663166728,2455,2,CIB1|RHBDD1
NCRNA 3'-END PROCESSING%GOBP%GO:0043628,0.999912288395755,1.0,0.0691881992503757,0.303124311230587,11399,35,INTS7|DDX26B|ATP5J2-PTCD1|INTS6|INTS1|INTS2|TOE1|RPSA|HSD17B10|EXOSC2|CPSF3L|EXOSC3|PTCD1|ERI1
PROTEIN DEALKYLATION%GOBP%GO:0008214,0.6137346957562371,0.9508825506493929,0.22827011486117899,0.887788879037784,6666,23,KDM5D|C14orf169|KDM5B|KDM4B|KDM1A|ALKBH4|KDM3B|KDM8|PHF2|KDM4A
PEPTIDYL-SERINE ADP-RIBOSYLATION%GOBP%GO:0018312,0.10883408590945899,0.58452352834625,0.708122374930553,1.3460661430652099,939,3,PARP2|PARP1
REGULATION OF STEROL TRANSPORT%GOBP%GO:0032371,0.40312246187167206,0.865238688875249,0.257548686712821,1.04706721832639,4466,27,SIRT1|ABCA7|ABCB4|CETP|ABCA2|LDLRAP1|APOE|SREBF2|APOC1|ARV1|APOC2|LRP1|PTCH1|LAMTOR1|GPS2|PLTP
MORPHOGENESIS OF A POLARIZED EPITHELIUM%GOBP%GO:0001738,0.14083843617522399,0.6296802030037281,-0.288357891545864,-1.30966271503972,597,21,MYO9A|EZR|RAB10|FUZ|OPHN1|CELSR1|RHOA|PTK7|CDC42|TRAF3IP1|MSN|SLC9A3R1|SH3BP1
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000820,0.6782387806943271,0.9647315640607691,0.537358698649021,0.8782980308348269,5606,2,HEY2|HEY1
ATRIAL SEPTUM MORPHOGENESIS%GOBP%GO:0060413,0.9711538461538459,1.0,0.182429916798608,0.520592650476574,9594,9,TGFB2|HEY2|NOTCH2|ZFPM1|ISL1
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003071,0.18023372959903303,0.6856997004111149,0.43644857068024107,1.2880724892289699,1788,10,F2R|PTPRO|AGTR1|F2RL1
NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060766,0.7089801532717629,0.9696440926859079,0.25398540127063896,0.8006527506030351,7215,12,SIRT1|HEYL|SMARCA4|DAB2|NCOR1|ZBTB7A|PIAS2|PHB|HDAC1
FRUCTOSE CATABOLIC PROCESS TO HYDROXYACETONE PHOSPHATE AND GLYCERALDEHYDE-3-PHOSPHATE%GOBP%GO:0061624,0.0193750699966402,0.289864965388082,0.7644935250492451,1.62003480780581,172,4,ALDH1A1|TKFC|GLYCTK|KHK
PTERIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042560,0.7358171041490258,0.974262605126702,0.513096222773642,0.838641680545723,6082,2,PM20D2|MTHFS
POSITIVE REGULATION OF ERK5 CASCADE%GOBP%GO:0070378,0.0497986577181208,0.438727695219498,0.9746360829289809,1.2947605545728,370,1,FAM150B
POSITIVE REGULATION OF T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:2000553,0.32623626373626397,0.826621597878865,-0.433741573133801,-1.09798799046625,1899,5,IL6|NLRP3
HYPOXANTHINE METABOLIC PROCESS%GOBP%GO:0046100,0.104163393558523,0.5762893149145369,-0.7071798830925329,-1.43520056149923,662,3,ADA|PRPS1|HPRT1
MICROTUBULE PLUS-END DIRECTED MITOTIC CHROMOSOME MIGRATION%GOBP%GO:0099606,0.342013422818792,0.8359038216207221,0.8331495368328191,1.10680199024638,2547,1,CENPE
GLYOXYLATE METABOLIC PROCESS%GOBP%GO:0046487,0.439650913881113,0.879896414106183,-0.4336844427287271,-0.997383618422462,2669,4,GRHPR|HOGA1|GOT2|ALDH4A1
PROTEIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0071806,0.564443005181347,0.9380162603437769,-0.155421017310832,-0.9414567098400679,1742,50,PEX16|CLU|TIMM50|ROMO1|SRP72|TOMM20|C19orf52|TIMM23|PEX26|DNLZ|PEX7|TIMM22|TIMM23B|SRP54|PEX5
REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000628,0.8089840906727671,0.984682960940884,0.264769154393513,0.721831748070966,7779,8,HRAS|PAPD4|RC3H1|PNPT1|ZC3H12A|NFKB1|RC3H2|RELA
MEDULLA OBLONGATA DEVELOPMENT%GOBP%GO:0021550,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
AXON TARGET RECOGNITION%GOBP%GO:0007412,0.886667549318152,0.996643473105967,-0.554973533303926,-0.742405016501838,6696,1,STXBP1
REGULATION OF SKELETAL MUSCLE ADAPTATION%GOBP%GO:0014733,0.43252323888453403,0.878651088001772,0.485761107866552,1.02937418988792,3861,4,GTF2IRD2|GTF2IRD2B|CAMK2B|CAMK2G
ONE-CARBON COMPOUND TRANSPORT%GOBP%GO:0019755,0.00612725844461901,0.17804916190196898,-0.866243886725778,-1.7580162308737999,38,3,AQP5|AQP1
VENTRICULAR SYSTEM DEVELOPMENT%GOBP%GO:0021591,0.525839658937299,0.9265056012720759,0.34886994233508806,0.951113058853065,5056,8,CDK6|CENPF
POSITIVE REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001025,0.425623894674789,0.875696962448429,0.326638382408039,1.0296809108679899,4331,12,GHRL|UCN|HDAC6|DRD4|RAB3B|RIPK1
REGULATION OF FAST-TWITCH SKELETAL MUSCLE FIBER CONTRACTION%GOBP%GO:0031446,0.21865771812080498,0.7341474817293291,0.891982796647552,1.1849593511724499,1628,1,ATP2A1
SELENOCYSTEINE INCORPORATION%GOBP%GO:0001514,0.5848857644991209,0.9439064862850342,-0.323232024468327,-0.887250203722284,3327,6,TRNAU1AP|SEPSECS|EEFSEC
REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106070,0.575377747252747,0.941940408834489,-0.35365027939655197,-0.8952421987058701,3350,5,ATP2B4|PRKCA
CDP PHOSPHORYLATION%GOBP%GO:0061508,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
RESPONSE TO CGMP%GOBP%GO:0070305,0.332176055549334,0.8293509737209019,0.523398369909531,1.1091311434555902,2965,4,HCN2|PDE2A
POSITIVE REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043568,0.8137529398588871,0.986276922067025,0.34712234323421004,0.7355854041671729,7265,4,CDH3|KIAA1161|PHIP
NEGATIVE REGULATION OF HISTONE H3-K9 DIMETHYLATION%GOBP%GO:1900110,0.506458797327394,0.9172434440873181,-0.559746346843121,-0.9574161481783721,3410,2,PIH1D1|SMARCB1
POSITIVE REGULATION OF CELL MATURATION%GOBP%GO:1903431,0.6169265033407572,0.9520939168601509,-0.5146953405017921,-0.880358814609095,4154,2,SIRT2|MAP3K13
REGULATION OF METANEPHRIC CAP MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0090095,0.8932874354561099,0.9976191001250191,-0.551554918394354,-0.737831831104609,6746,1,MYC
REGULATION OF PROTEIN KINASE D SIGNALING%GOBP%GO:1903570,0.39811995233682,0.8638522656500329,-0.79923908248787,-1.06916648923936,3006,1,VEGFA
MODULATION OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052248,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|SERPINB9|BCL2L1|GAPDH
PROTEIN DESTABILIZATION%GOBP%GO:0031648,0.37639719261762394,0.853374872190571,-0.204841593567453,-1.0483282921796502,1447,29,GSN|CUL3|RAD23A|CREBBP|MUL1|FBXL3|SENP2|RNF139|PRNP|SNCA|CTSH|HTT|PARK2|SOX17
AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS%GOBP%GO:0030647,0.0751718213058419,0.524840022194793,0.593141402246151,1.4587448961012701,699,6,AKR1B1|CBR4|AKR1C1
REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903034,0.15833701901813402,0.6604486079157379,-0.16906693517592802,-1.2062168990700701,357,89,PLAU|FGF2|PPAP2B|HBEGF|LYN|SERPINF2|FOXC2|CRK|PLAUR|THBD|PROC|PRKCA|CD9|NOS3|ANO6|CDKN1A|ADRA2A|DUSP10|STK24|CAV1|ENPP4
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048641,0.5737632508833921,0.941417936126209,-0.214754317384995,-0.9036614670883851,2597,17,DLL1|FAM129B|FLOT1|AKIRIN1|UQCC2|NR1D2|RBM24
CELLULAR COMPONENT MACROMOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0070589,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051445,0.66895285935085,0.964618776001639,0.247088963499108,0.837782810729459,6924,15,FBXO43|CDC25C|YTHDC2|FBXO5|METTL3|DUSP1|RAD1|NPM2|C17orf104|TRIP13|SIRT2
ATP HYDROLYSIS COUPLED PROTON TRANSPORT%GOBP%GO:0015991,0.502435192458759,0.9160882111977869,-0.468898202271975,-0.951614969933558,3197,3,ATP1A3|ATP1A1|ATP6V1H
ENDOTHELIAL CELL-MATRIX ADHESION%GOBP%GO:0090673,0.255527604925195,0.7667915624015121,-0.872959858844288,-1.1677850194989698,1929,1,ADAMTS9
ISOLEUCYL-TRNA AMINOACYLATION%GOBP%GO:0006428,0.615738678544915,0.951768550997044,-0.515136476426799,-0.881113353983091,4146,2,IARS|IARS2
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000379,0.260663507109005,0.771967970256231,-0.18126927107539104,-1.1330517580127,769,55,SMAD3|HSP90AA1|PARK7|AGT|CYBA|ZNF205|SOD1|IL1B|CLU|PRKCD|ROMO1|ITGAM|GRB2|ASS1|SNCA|GADD45A|TP53|DDAH2|CDKN1A|CD36|HSP90AB1|TNF|DDAH1
KIDNEY EPITHELIUM DEVELOPMENT%GOBP%GO:0072073,0.28328958880140004,0.7924936804394509,0.260755911829827,1.15098608797002,3237,36,CITED1|BASP1|BMP4|PKD2|AHI1|PTPRO|KLHL3|ROBO2
MITOCHONDRION-DERIVED VESICLE MEDIATED TRANSPORT%GOBP%GO:0099075,0.35003927729772194,0.842847021021096,-0.5297712135960371,-1.07515493779915,2227,3,PARK2
POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901552,0.40436126373626397,0.865585453523601,-0.404935717568636,-1.02506787991023,2354,5,ADD1|CDH5|PROC
REGULATION OF MACROPHAGE FUSION%GOBP%GO:0034239,0.6846979865771811,0.966495577318169,0.66205337450375,0.879508371733177,5100,1,ADAM9
REGULATION OF LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1903000,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
PURINE RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046130,0.0358402971216342,0.382648509404771,-0.53132996274977,-1.6516048692424,192,8,PNP|HPRT1|NUDT18|ENPP4
CELL MIGRATION INVOLVED IN VASCULOGENESIS%GOBP%GO:0035441,0.7087250099298291,0.9695170059473192,-0.641100573445082,-0.857619784090102,5352,1,PDGFRB
POSITIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001912,0.885560053981107,0.996643473105967,0.160989861432273,0.660159585288881,9842,28,KLRK1|CD1E|SLAMF6|F2RL1|IL12RB1|NCR3|CD1D|RASGRP1|HLA-F|XCL1|FADD|MICA|HLA-C|STX7|CADM1|HFE
LYMPHOID LINEAGE CELL MIGRATION%GOBP%GO:0097534,0.754362416107383,0.977083996023335,0.6259373621526251,0.8315298605742509,5619,1,BCL11B
GDP-MANNOSE METABOLIC PROCESS%GOBP%GO:0019673,0.8630931458699471,0.991943445125448,-0.250119196633247,-0.686560400482372,4910,6,PMM1|PMM2
POSITIVE REGULATION OF SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903278,0.414828088251764,0.8695737743071128,0.491961412115926,1.04251322687626,3703,4,ATP1B3|FXYD1|ATP1B1|ATP1B2
NEGATIVE REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000824,0.353557046979866,0.842847021021096,0.82763564181738,1.09947702671067,2633,1,HEYL
RESPONSE TO WATER%GOBP%GO:0009415,0.7783960324180479,0.9811398289380491,0.49486701466309396,0.808846540674673,6434,2,PKD2
NEGATIVE REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001189,0.240062843676355,0.7525035503527309,-0.5875151648836441,-1.19234457128921,1527,3,LILRB1|HAVCR2|LGALS3
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0017015,0.863705360709435,0.991943445125448,0.13775607533109302,0.7258020912023679,10810,75,CITED1|SIRT1|ASPN|PEG10|ADAMTSL2|PDPK1|FAM89B|MEN1|FBN1|RNF111|LEMD3|MTMR4|CDKN2B|STK11|NREP|PIN1|HTRA3|BAMBI|BCL9|ING2|SKIL|EID2|LTBP1|WFIKKN1|DAB2|THBS1|ITGA3
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009130,0.5781786941580761,0.942692029750853,0.368491410806228,0.9062509592740691,5383,6,DUT|UMPS|HDDC2|TYMS
CYTOCHROME COMPLEX ASSEMBLY%GOBP%GO:0017004,0.9199564388783009,1.0,-0.124268592895624,-0.664684179468213,3378,33,UQCC2|HCCS|SMIM20|SLC25A33|COX10
COMPLEMENT COMPONENT C5A SIGNALING PATHWAY%GOBP%GO:0038178,0.366079703429101,0.8510019955058101,-0.8158359064843409,-1.09136856673236,2764,1,C5AR1
REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030510,0.47053571428571395,0.8975514817191559,-0.17327411561342002,-0.992998905165996,1580,41,SMAD6|ZNF423|SMAD2|SMAD7|RBPMS2|GREM1|BMPER|ACVRL1|RBPJ|NBL1
SUCCINATE METABOLIC PROCESS%GOBP%GO:0006105,0.161048269683055,0.663793029920627,0.6073750881265811,1.2870858312316,1437,4,SDHAF3|SUCLG1|SDHA|ALDH5A1
METAPHASE PLATE CONGRESSION%GOBP%GO:0051310,0.0546626485853005,0.456473845459404,0.305026601460901,1.47357326248843,652,51,CCNB1|PSRC1|KIF14|GEM|CENPF|KIF2C|KIF18A|NUF2|CDC23|NDC80|CENPE|CEP55|BOD1|KIFC1|CDCA8|CENPQ|SPDL1|KIF22|CDCA5
REGULATION OF CELL DEVELOPMENT%GOBP%GO:0060284,0.40969162995594705,0.867015886388254,-0.10807817124172801,-1.02959502250756,92,451,ARHGDIA|ID2|RNF6|FZD1|ZEB1|PRKCH|CHRNB2|ADD1|IL1B|VEGFA|NEDD4L|IMPACT|IGSF10|CX3CL1|ADRA2C|DNM2|LPAR1|CTNNB1|DAB2IP|TUBB2B|RTN4|SKI|NSMF|PTK2B|PDPN|FAM101B|SRGAP2C|ABL1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|RHOA|SERPINI1|HES7|NRP1|TENM4|C1QBP|CPNE6|NKX6-1|MYADM|SEMA7A|PTK7|DOCK5|YWHAH|CDH5|IL6|LYN|EFNA1|ULK4|KIF13B|CAMK2A|POU4F2|BAG5|ISLR2|ARC|IGF1|BIN1|SPOCK1|TCF4|CRK|RAP1A|LIMK1|AMIGO1|SERPINF1|ARHGEF2|FMR1|TWF1|CDC42|C21orf91|FGFR1|AKAP13|BHLHE41|NEDD4|SEMA6B|FAM101A|PLXNA1|PROC|CHRNA3|RAPGEF1|ID1|SSH3|LIMS1|PLXNA4|RELN|DKK1|TWF2|ADCYAP1|COBL|DRD2|MFI2|NCS1|SYT2|WNT3|FKBP4|ASCL1|SDC2|FBXO7|PER2|STK24|MYLIP|ZNF365|SEMA3A|RAC1|CORO1C|SEMA3G|CPNE9|PCP4|OLFM1|GPRC5B|PDE3A|TNF|GAL|TNFRSF21|NBL1|LINGO1|FOXO6|RTN4RL2
TERMINATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:0006393,0.122051530180235,0.607607158836689,0.7869313482216709,1.28621767039957,1008,2,MTERF1|MTERF2
REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001135,0.6859789320741011,0.9665006495129341,-0.281355360870713,-0.8207260702618341,3776,7,ARHGAP1|EHD1|EHD2
GDP CATABOLIC PROCESS%GOBP%GO:0046712,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
TRACHEA CARTILAGE MORPHOGENESIS%GOBP%GO:0060535,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
REGULATION OF PHAGOSOME MATURATION%GOBP%GO:1905162,0.41096253144445893,0.867015886388254,-0.793063520070578,-1.0609052511024302,3103,1,SYT11
POSITIVE REGULATION OF HEART GROWTH%GOBP%GO:0060421,0.366112828438949,0.8510019955058101,0.320257313243479,1.08586829717611,3789,15,EDN1|TBX2|BASP1|PROX1
NEGATIVE REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033132,0.6809205642167779,0.9650599455707372,-0.489153135505649,-0.8366702409161909,4585,2,PARK2
REGULATION OF TELOMERASE CATALYTIC CORE COMPLEX ASSEMBLY%GOBP%GO:1904882,0.36663844199830703,0.8510019955058101,0.657678522194651,1.07495747704125,3030,2,ATR|ATM
POSITIVE REGULATION OF CYTOKINE ACTIVITY%GOBP%GO:0060301,0.301204819277108,0.804106030578379,-0.850187472430525,-1.13732170386904,2274,1,NRP1
NEGATIVE REGULATION OF PROTEIN PROCESSING%GOBP%GO:0010955,0.6397998888271259,0.96058002537611,0.22554447272220898,0.863783011161257,6905,22,NOL3|SERPINE2|CD55|BIRC2|GAS1|CARD16|THBS1|SERPINE1|TMEM59|BCL2L12|XIAP|BIRC3
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:0055012,0.41449210437899003,0.8695723005599759,0.492031103512932,1.04266090960379,3700,4,PROX1|HEY2|MEF2A|MEF2C
"PENTOSE-PHOSPHATE SHUNT, OXIDATIVE BRANCH%GOBP%GO:0009051",0.542812254516889,0.929698169790548,-0.455536561851539,-0.924497917692053,3454,3,G6PD|PGD
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905446,0.33928960557855703,0.832810902324958,0.481126279785705,1.10892475202394,3113,5,CCNB1|CDK1
MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS%GOBP%GO:0048609,0.12414880653716599,0.607607158836689,0.200444112508848,1.24270539907156,1731,196,TAC1|HSPA2|INSL3|TEKT3|GHRL|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|ZCCHC11|OXTR|HERC4|CCT6B|CABYR|GGT1|PYGO1|RHOXF1|CELF1|USP9Y|PIWIL4|TRIM27|MTL5|TSSK3|SPATA25|DEAF1|ROBO2|JAG2|PCSK4|DZIP1|TGFB2|WDR33|CASC5|DAZAP1|TYRO3|YTHDC2|ZNF830|PTTG1|ZP3|KIT|DNAH1|BMPR1B|PIM2|CLOCK|CXADR|METTL3|REC8|SRPK1|FANCF|MYBL1|STOX2|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|KMT2D|TEX14|MYCBP|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|EGR1|ABHD2|AZIN2|ZNF35|C1orf111|FMN2
POSITIVE REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000630,0.9285247330573109,1.0,0.264725347452019,0.6101526825939211,8521,5,HRAS|PNPT1|ZC3H12A|NFKB1|RELA
REGULATION OF COLLAGEN BINDING%GOBP%GO:0033341,0.958162319608103,1.0,-0.519078076753419,-0.6943865698309301,7236,1,GTPBP4
CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO KINETOCHORE%GOBP%GO:0072356,0.562435040831477,0.9371653799386351,-0.5367521367521371,-0.9180857833088629,3787,2,GSG2|RCC2
ENDOCYTIC RECYCLING%GOBP%GO:0032456,0.145099048109082,0.636215339087768,-0.25417497493260605,-1.2851711521821698,563,28,RAB13|DENND1B|ARL4C|EHD3|EHD1|EHD4|DENND1A|EHD2|VPS53|MICALL1
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002312,0.9384529564894009,1.0,0.155825779291275,0.58910450177626,10093,21,DOCK10|LIG4|EXO1|MSH6|LFNG
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000738,0.134713002733307,0.622136653169633,-0.41613441381958,-1.3433191785086,689,9,SOX6|NUDT21|RBM24
NEGATIVE REGULATION OF DNA BINDING%GOBP%GO:0043392,0.18868980963045898,0.69611511841804,-0.220319919431323,-1.2119560862771102,673,36,HAND1|ID2|SIN3A|NFKBIA|RSF1|DDIT3|SUMO1|HABP4|ZNF593|TMSB4X|JUN|ID1|PER2|SUMO3
RRNA EXPORT FROM NUCLEUS%GOBP%GO:0006407,0.7228593872741559,0.971955586175348,-0.39108856292048105,-0.7937026186956129,4600,3,RPSA|TSC1|NPM1
PRE-B CELL ALLELIC EXCLUSION%GOBP%GO:0002331,0.693825503355705,0.96731875442989,0.6576422584913979,0.8736484009046059,5168,1,ATM
NADPH REGENERATION%GOBP%GO:0006740,0.318397591756397,0.820569952859896,0.588596456717967,1.11885994619772,2749,3,NNT|IDH1
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010634,0.00792811839323467,0.19847993048827997,-0.20644776121575895,-1.5599604249192398,14,112,FGF1|ARF6|SASH1|SRPX2|RAB11A|MAPRE2|AGT|PPM1F|GATA2|RHOJ|RREB1|CALR|RAB25|HIF1A|HSPB1|VEGFA|KDR|BCAS3|RTN4|BCAR1|PTK2B|HMOX1|EPB41L4B|PRKD2|PFN1|ABL1|GPI|FGF7|ZNF580|NRP1|AAMP|FGF2|PPAP2B|DOCK5|MMP9|GLIPR2|FOXC2|MAP4K4|FOXP1|ETS1|TMSB4X|FGFR1|MAP2K3|ATOH8|IQSEC1|ADAM17|STAT5A|CTSH|PRKCA|NOS3|FGF10|MET
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN HEMOPOIESIS%GOBP%GO:0035603,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
CHROMATIN SILENCING%GOBP%GO:0006342,0.23082088299479603,0.743846009588795,0.247785048857398,1.1907184210486599,2749,50,SIRT4|HIST1H3E|SIRT1|MBD3|RRP8|DOT1L|HIST2H3C|HIST2H3A|PCGF2|HIST1H4I|HELLS|H3F3A|NRDE2|KMT2D|RIF1|EED|HIST1H3H|UBR2|HIRA|MBD1|PCGF1|PPM1D|SUV39H1
DNA METHYLATION INVOLVED IN GAMETE GENERATION%GOBP%GO:0043046,0.499535747446611,0.9143688619793578,-0.305350697021343,-0.9491629183060392,2689,8,PLD6|MOV10L1|TDRKH
ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0095500,0.0779826705176627,0.5314695499765479,-0.333684961132215,-1.43543856515472,350,18,CHRM4|CHRNB2|GNAQ|GNA15|CHRNA7|HRH3|CHRNA3|CHRM1|PLCB1
NCRNA POLYADENYLATION%GOBP%GO:0043629,0.477951002227172,0.9044043130580649,-0.5740450776268821,-0.981873361392958,3218,2,PAPD7
VOCALIZATION BEHAVIOR%GOBP%GO:0071625,0.644208037825059,0.9625261061153929,-0.250234456887516,-0.8465806227400899,3269,10,NLGN4Y|NRXN3|SHANK1|NLGN3|NRXN2|AUTS2|NRXN1|SHANK2|CNTNAP2|NLGN4X
PROTEIN DENUCLEOTIDYLATION%GOBP%GO:0044601,0.423221476510067,0.873470206885489,0.7952690780767528,1.05647949075603,3152,1,FICD
OLEFIN METABOLIC PROCESS%GOBP%GO:1900673,0.8064594169589939,0.984682960940884,0.484426671757842,0.791782087009036,6666,2,GRIN1|EPHX2
STIMULATORY C-TYPE LECTIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002223,0.8585884138628891,0.99166790097654,0.14900380805332097,0.709710567512512,10181,48,MUC15|CD209|KLRK1|PAK3|PDPK1|MUC1|MAP3K7|SRC|CARD11
POSITIVE REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0010875,0.8670382165605091,0.993065231963537,0.217885270340208,0.664718014157192,8711,11,SIRT1|ABCA7|APOE|LRP1|PTCH1|GPS2|PLTP
NAIL DEVELOPMENT%GOBP%GO:0035878,0.0411658159064713,0.402256981537283,-0.705191118939515,-1.6217922539758403,249,4,MSX1|ITGA6|RSPO4
STRAND INVASION%GOBP%GO:0042148,0.9452346287378209,1.0,0.281286991665341,0.59607400527229,8439,4,RAD51|XRCC2|RAD51D
SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009070,0.14866692426584197,0.64074876264986,0.39145671186114506,1.32727783425716,1538,15,CTH|SERINC5|GGT1|MTHFD1|GGT5|PSAT1|PHGDH|SEPHS1
REGULATION OF CHLORIDE TRANSPORT%GOBP%GO:2001225,0.908388397356927,1.0,0.303284582498013,0.642689001566082,8110,4,ANO9|ABCB1|GABRE
NEGATIVE REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903973,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
POSITIVE REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030890,0.454699202705968,0.88900512246363,-0.21162401822278798,-0.9944035649830021,1881,23,VAV3|TFRC|BCL2|NFATC2|TNFRSF4
REGULATION OF ODONTOBLAST DIFFERENTIATION%GOBP%GO:1901329,0.33639772589814904,0.8311444145897029,0.6711331679073621,1.09694872583794,2780,2,CEBPB|SERPINE1
PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009136,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
CTP BIOSYNTHETIC PROCESS%GOBP%GO:0006241,0.37655739687915796,0.853374872190571,0.653101736972705,1.06747684732762,3112,2,CTPS2|CTPS1
DNA REWINDING%GOBP%GO:0036292,0.485544937704125,0.9067242420344581,0.609518782825079,0.9962417060671179,4013,2,ZRANB3|SMARCAL1
HEPATICOBILIARY SYSTEM DEVELOPMENT%GOBP%GO:0061008,0.584388938447814,0.9439064862850342,0.21770229518850098,0.912810754858408,6550,30,WNT4|RARB|E2F8|PROX1|PKD2|LSR|E2F7|NF1|NIPBL|NPHP3|AURKA|CEBPB|PHF2
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MYOCARDIAL PRECURSOR CELL DIFFERENTIATION%GOBP%GO:0003257,0.636822568671121,0.959271399361425,-0.5075604003180779,-0.868154881547806,4288,2,GREM1
MAINTENANCE OF PROTEIN LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033377,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
NUCLEOBASE-CONTAINING SMALL MOLECULE INTERCONVERSION%GOBP%GO:0015949,0.693519024212634,0.96731875442989,0.20587839813880301,0.827729774987817,7618,26,NME3|NME4|AK6|DTYMK|CTPS2|DUT|GUK1|NUDT13|TYMS|CTPS1|TXNRD1|AK2
CALCIUM-INDEPENDENT CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL-ADHESION MOLECULES%GOBP%GO:0016338,0.0179022746419545,0.282630667631467,0.6499379413340339,1.69165190925513,169,7,CLDN12|CLDN15|CLDN11|CLDN7
RESPONSE TO INTERLEUKIN-2%GOBP%GO:0070669,0.9197850318471341,1.0,0.19921042192171398,0.6077453324516059,9241,11,CITED1|STAT5B|IL2RA|JAK3|IL2RB|JAK1|SYK|IL2RG
LEUKOTRIENE BIOSYNTHETIC PROCESS%GOBP%GO:0019370,0.102631578947368,0.574198697765381,0.49189891213625103,1.40371142480019,1013,9,GGT1|MGST3|MGST2|GGT5|LTA4H
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEURAL PLATE ANTERIOR/POSTERIOR PATTERN FORMATION%GOBP%GO:2000314,0.43664768965973794,0.878651088001772,-0.7796647551830609,-1.04298131478748,3297,1,FUZ
NUCLEIC ACID-TEMPLATED TRANSCRIPTION%GOBP%GO:0097659,0.9567307692307689,1.0,-0.0846835131772942,-0.8152947624104799,198,470,ICE1|POLR3H|FOSL1|CCRN4L|PPARA|KLF13|NELFA|RXRA|PTRF|DDIT3|NRBF2|PPARG|NRL|ARRB1|POLR1B|ELP3|MAFF|NFE2L1|POLR2A|TCF4|TAF1B|PAX8|SUPT4H1|YBX1|TTF2|ETS1|ZNF217|KLF11|TEAD4|DDX21|ASH2L|PHAX|NR1H2|POLR2K|PPARGC1A|NELFE|SNRPB|TCEB1|SLC25A33|TCFL5|HSF1|NR3C1|MLF1|POLR2F|NFKBIB|ELP2|POLR1E|TP53|COPS2|BCL3|TAF4B|MAPK3|NCBP2|NFYA|NUDT21|CDKN1A|TCEA1|POLR2I|POLR2D|RNPS1|CBFB|TRIM29|NR1D1|NR1D2|CD3EAP|SOX17|TAF8|SLBP|TAF13|EPAS1|RBPJ|PBRM1|CRCP|MED10|EAF1|FOXO3|CREB5
OOCYTE AXIS SPECIFICATION%GOBP%GO:0007309,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
SENSORY PERCEPTION OF MECHANICAL STIMULUS%GOBP%GO:0050954,0.276567101388305,0.7884684708511421,0.24026676380379602,1.1491968348847499,3286,49,PCDH15|SCN1A|ZNF354A|KCNQ1|PIEZO2|ADGRV1|DFNB31|CDH23|TIMM13|BIRC5|PDZD7|CACNA1D|KIT|NIPBL|SERPINB6|SPTBN4|COL11A2|MYO7A
GROWTH%GOBP%GO:0040007,0.0072289156626506,0.19154891566265098,-0.211973707734448,-1.55353747800892,14,100,PRMT2|SCARA3|DLL1|COL14A1|NLGN4X|CDK5|COL6A2|VWA1|NOTCH1|STRA6|IMPACT|CTNNB1|AKIRIN1|SEMA3F|FGF7|NRP1|EYS|PSAP|EVC|COL6A1|APOD|PTK7|IGF1|ZPR1|LEPR|ALCAM|COMP|COL21A1|FLRT1|CFLAR|COBL|ARIH2|FGF10|GNAS|S1PR1|SEMA3A|HSP90AB1|TMEM108|STC1|SLIT3
CIRCULATORY SYSTEM DEVELOPMENT%GOBP%GO:0072359,0.17961165048543698,0.68489956912038,-0.12248572645856601,-1.12327651758669,73,353,ITGA5|SMAD6|CACYBP|AAMP|TCF7L2|TNFRSF1B|CLIC4|APOD|FGF2|TMEM65|ADAMTS9|MICAL2|APLNR|TNNT2|EFNA1|POU4F2|SNAI1|MEF2D|SERPINF2|MYOM1|FOXC2|SMAD7|RAMP2|FGFR1|AKAP13|RYR1|LEPR|CCDC103|ALPK3|PDCD4|CXCL8|POPDC3|ID1|ADM2|TBX20|MKKS|NXN|NOS3|DYX1C1|SCG2|FLT1|CDKN1A|MYH11|MCAM|GREM1|MYH9|SFRP2|BMPER|CRIP1|ACVRL1|S1PR1|SCN5A|ADM|PGF|OLFM1|TWIST1|SOX17|CDH13|ZFPM2|DNAAF1|BBS7|RBPJ|CAV1|FKBP1A|SLIT3|EPHB2|ANGPT2|RAMP1
REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090083,0.45254886157565993,0.887362265753552,0.34161625130415,1.00819781467628,4491,10,HSPA2|SNCAIP
CELLULAR RESPONSE TO ARSENITE ION%GOBP%GO:1903843,0.8491751767478399,0.991298302704726,-0.34542847689423195,-0.701036830726074,5404,3,VCP|ZFAND1|DHX36
RNA CAPPING%GOBP%GO:0036260,0.8115981486523279,0.9855701659458179,-0.14425198499725303,-0.7715707569417242,2980,33,POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051250,0.9936295460043549,1.0,0.0954055442421483,0.49665960924225205,12321,71,PAG1|CEACAM1|GLMN|INHA|BMP4|THOC1|MARCH7|LOXL3|DLG5|TIGIT|BTN2A2|TNFAIP8L2|PLA2G2D|CEBPB|SOCS1|PTPN22|CTLA4|ATM|RC3H1|SLA2|TNFRSF14|XCL1|PIBF1|MNDA|PDCD1LG2|ANXA1|NDFIP1|JAK3|MICA|FOXP3|HMGB1|SDC4|ZC3H8|LILRB2|KIAA0922|PTPN2|ZC3H12A|HFE|LST1|SOX11|CD300A
ASPARAGINE CATABOLIC PROCESS VIA L-ASPARTATE%GOBP%GO:0033345,0.0755704697986577,0.525408291492683,0.962946625496251,1.27923163187709,562,1,ASRGL1
REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0006109,0.8926127527216171,0.9976191001250191,0.127872848714575,0.7039362169065699,11478,94,SLC45A3|SIRT1|PRKAA2|INS|GNB3|OGT|PHKG2|C1QTNF3|JMJD8|FAM132A|CLK2|SDHAF3|RORA|PTH1R|PDK4|PGP|PASK|GCK|MIDN|SUPT20H|BAD|CLTC|IRS1|AKT2|PFKFB2|VIMP
CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010659,0.147226267708195,0.638945026078465,-0.9234671371857079,-1.23535014569029,1111,1,GNGT1
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001243,0.23468984591070702,0.7484495548097869,-0.168272286659296,-1.14407405382982,593,74,CCAR2|TRAP1|PARK7|CXCL12|BCL2A1|TMBIM6|NOC2L|CD44|TAF9|SNAI2|HIF1A|HSPB1|CREB3|PPIF|CLU|PTTG1IP|MAPK7|MAGEA3|ZNF385A|DDX3X|HYOU1|ENO1|MMP9|BCL2L1|SNAI1|BAG5|SOD2|PLAUR|ARHGEF2|BCL2|ACKR3|PARK2|SFRP2
REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1901342,0.0311059907834101,0.361013617615581,-0.155043475217776,-1.32138744685073,26,218,DLL1|TBXA2R|NFATC3|MYDGF|FAM129B|BTG1|GATA2|RHOJ|FOXC1|HTATIP2|HIPK1|HIF1A|MECP2|HSPB1|GPER1|NOTCH1|IL1B|VEGFA|ITGB8|KDR|MTDH|CTNNB1|DAB2IP|FOXO4|HMOX1|TNFAIP3|WARS|PRKD2|TMEM100|PML|MMRN2|PDCL3|SPHK1|RHOA|ITGA5|HDAC5|PKM|RUNX1|FGF2|MAP2K5|ADAMTS9|CDH5|IL6|SMAD1|PPARG|APLNR|CHRNA7|ECSCR|SPINK5|SOD2|MEOX2|FOXC2|RAP1A|ETS1|FOXJ2|PDCD10|PGK1|SERPINF1|RAMP2|PDCD4|AGO2|HK2|CXCL8|CTSH|PRKCA|ADM2|NFATC2|SARS|NOS3|FLT1|CHI3L1|SFRP2|BMPER|PTPRM|TMEM2|THBS4|PGF|TWIST1|AQP1|GLUL
REGULATION OF MONOPHENOL MONOOXYGENASE ACTIVITY%GOBP%GO:0032771,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:0090043,0.855670103092784,0.991298302704726,0.278524434920821,0.684990284511663,7967,6,PRKAA2|MAPT|FNTA|EP300
FMN BIOSYNTHETIC PROCESS%GOBP%GO:0009398,0.36348993288590603,0.849828746111777,0.82399647110719,1.0946425507771,2707,1,RFK
HISTONE H3-K9 MODIFICATION%GOBP%GO:0061647,0.49030289823491,0.908938677284213,0.425876902713435,0.9815831281229709,4499,5,SETDB2|SUV39H1|SUV39H2|PRDM5|BEND3
PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120031,0.5191873589164789,0.923826898284354,-0.108032272625577,-0.9879920775543779,229,341,C21orf59|FGD4|SRGAP2C|WDR35|TCTEX1D2|TCTN2|IFT172|RAB8B|CCP110|NRP1|EMP3|RFX2|INPP5K|ABLIM2|RPGR|NPHP1|RILPL2|WHAMM|EHD3|EHD1|CEP19|RAP2B|UBXN10|RAB1A|CFAP46|MAP4K4|RAP1A|DYNLRB2|RAB8A|WDR19|MARK4|DNAI1|CETN2|SEPT10|TRAF3IP1|LRRC6|CCDC103|KIF3C|CC2D2A|DYNLRB1|SEPT9|KIF3B|ATP6V0D1|MKKS|DYNLL2|TMEM231|HAUS3|TTC30B|PMP22|TUBB4B|FXYD5|YWHAE|ASAP1|ABCC4|DYX1C1|WDPCP|ANO6|DNAL1|HAUS2|IQCG|INTU|CFAP20|S1PR1|SLC9A3R1|RSPH1|RAC1|CCDC113|ACTR2|B9D2|RILPL1|CDH13|RSG1|DNAAF1|BBS7
POSITIVE REGULATION OF INTERLEUKIN-15 PRODUCTION%GOBP%GO:0032738,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
"REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904152",0.8621475953565509,0.991943445125448,-0.189316104518587,-0.6896975590474251,4158,12,EDEM2|DERL2|ERLEC1|EDEM1|UBE2J1|OS9|BCAP31
PROTEIN LOCALIZATION TO MAST CELL SECRETORY GRANULE%GOBP%GO:0033367,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
METALLO-SULFUR CLUSTER ASSEMBLY%GOBP%GO:0031163,0.0682995760715968,0.50364937614461,-0.321024758865129,-1.45802896198318,289,21,HSPA9|FAM96B|NUBPL|HSCB|BOLA2|BOLA2B|CIAO1|IBA57|FXN|ISCA1
POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE%GOBP%GO:0006620,0.16548463356973997,0.6682860217990739,-0.38243515643982895,-1.29383537712422,839,10,SGTB|SEC63|SEC62|ASNA1|CHMP4B
POSITIVE REGULATION OF ACROSOME REACTION%GOBP%GO:2000344,0.30322802197802196,0.8055436753253159,-0.44347385770723297,-1.12262462260695,1765,5,PLCB1|POMZP3
CARDIAC MUSCLE ADAPTATION%GOBP%GO:0014887,0.914100123194087,1.0,0.300610484309057,0.6370223320605171,8161,4,TCAP|INPP5F
NEGATIVE REGULATION OF BINDING%GOBP%GO:0051100,0.2359375,0.750277765814412,-0.149217916701987,-1.12122609033952,452,110,SIN3A|NFKBIA|PRKCD|NES|STYX|ARRB2|HSPA5|FAM192A|RSF1|PLN|DDIT3|SUMO1|HABP4|RUVBL2|ZNF593|TMSB4X|LRPAP1|GNL3L|ADRB2|JUN|ID1|PEX19|DKK1|B2M|RALB|PER2|MET|SUMO3|CAV1
ADHERENS JUNCTION MAINTENANCE%GOBP%GO:0034334,0.452906260499496,0.8874890379518141,0.47791319693376705,1.0127437169498401,4043,4,CAMSAP3|KIFC3|PLEKHA7|PKP2
REGULATION OF TRANSCRIPTION INVOLVED IN ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0044324,0.25420362769760396,0.7644572867804641,-0.873566387295986,-1.1685963911016999,1919,1,DDIT3
INOSINE METABOLIC PROCESS%GOBP%GO:0046102,0.518359953894286,0.9236324326350509,-0.40605525836872,-0.9338422663332391,3147,4,ADAL|CECR1|ADA|PNP
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME%GOBP%GO:0001977,0.115442439862543,0.593539945084925,0.561467873024681,1.3808484637862,1074,6,F2R|PTPRO|F2RL1
NEGATIVE REGULATION OF PROTEOLYSIS%GOBP%GO:0045861,0.18210116731517498,0.6875189360012,-0.14226151824830402,-1.14716708071476,233,160,CLN8|PTPN3|UBE2J1|STYX|FAM192A|OS9|MAGEA3|SPOCK3|PML|PDCL3|SERPINI1|DDX3X|MAP2K5|HGF|CSNK2A2|PRNP|MMP9|GLTSCR2|EFNA1|BAG5|LAMTOR5|BIN1|SPOCK1|SERPINF2|CHAC1|TIMP2|GAPDH|SERPINF1|PLAUR|SNCA|SERPINA1|CSTB|YWHAE|DNAJB6|DDRGK1|CSNK2A1|HSP90AB1|AQP1|GABARAPL2|SNX12|PSMF1|PAK2
POSITIVE REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0045821,0.9035647648040849,1.0,0.193927714471585,0.6258768178224079,9200,13,PRKAA2|INS
MALONYL-COA METABOLIC PROCESS%GOBP%GO:2001293,0.814378392691646,0.986276922067025,-0.590041905602117,-0.789317047350837,6150,1,MLYCD
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:0008625,0.00224103585657371,0.11976563223178699,-0.41475889196146504,-2.03658780249082,8,26,DEDD2|BAX|DAB2IP|DDX47|DDX3X|TNFRSF10A|BID|CRADD|BAG3|BCL2|TNFRSF10B|GABARAP|TNF
N-TERMINAL PEPTIDYL-GLYCINE METHYLATION%GOBP%GO:0018013,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:0010255,0.0139107294060723,0.256136946817111,0.9194375516956159,1.5027954198193798,114,2,AGER|ADCY8
NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090155,0.9841923266919151,1.0,-0.227430651298737,-0.523042986059796,5976,4,ORMDL1|ORMDL2|ORMDL3|PRKAA1
ANDROGEN CATABOLIC PROCESS%GOBP%GO:0006710,0.817066110918143,0.987047331163131,0.396781032113877,0.754239002250617,7056,3,HSD17B11|SPP1
SELENOCYSTEINE METABOLIC PROCESS%GOBP%GO:0016259,0.6362922230950511,0.9592476055325171,-0.423221829538495,-0.8589161285755931,4049,3,SEPSECS|SARS
PEPTIDYL-CYSTEINE S-TRANS-NITROSYLATION%GOBP%GO:0035606,0.234446919079436,0.7482511903785959,-0.716625310173697,-1.22574921305547,1578,2,S100A9|GAPDH
SULFUR COMPOUND METABOLIC PROCESS%GOBP%GO:0006790,0.6320774573773941,0.9580665176301509,0.144841091187452,0.9267349808355041,9008,251,ACSM3|GLCE|GAL3ST3|DPEP1|HACD1|CTH|MGST1|GSTA4|ACSF2|OXSM|GSTO2|GAMT|VCAN|HSD17B4|MAT2A|MCCC2|HS3ST5|GLRX2|MMS19|SCD5|GAL3ST4|ELOVL6|GGT1|SLC25A19|DGAT1|TST|APIP|PCYOX1L|FAR2|CHST15|ACBD6|MVD|MTHFD1|SLC35B3|ACOT1|CHPF2|SLC26A2|SULT1A3|PDHX|FAR1|SLC25A10|CDO1|MTR|MGST3|TXN2|B4GALT6|PCCB|PDHA1|ACOT2|SLC25A1|ACACA|GSTP1|MGST2|SUCLG1|DLD|ACSS1|MTAP|MCEE|OPLAH|GGT5|GSTZ1|PRELP|SLC19A2|HAGH|PAPSS2|B4GALT4|ST3GAL4|TECR
ASTRAL MICROTUBULE ORGANIZATION%GOBP%GO:0030953,0.24885764499121302,0.7613646381106121,-0.42972157321172705,-1.17955686477262,1415,6,KPNB1|RAB11A|EZR|DLG1
NK T CELL ACTIVATION%GOBP%GO:0051132,0.17397060770554698,0.676682497340677,-0.9103992059991179,-1.21786877570411,1313,1,ELF4
BASAL PROTEIN LOCALIZATION%GOBP%GO:0045175,0.515570469798658,0.921938765246636,0.74597485663873,0.9909943167467441,3840,1,ERBB2IP
NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002283,0.022508038585209,0.31540045468680394,-0.138120842886401,-1.28564190448437,6,401,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
NEGATIVE REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING BY BMP SIGNALING PATHWAY%GOBP%GO:0072097,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
POSITIVE REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035508,0.528859060402685,0.9265056012720759,0.7389170710189681,0.98161836342103,3939,1,PPP1R12A
REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0040020,0.7925442291491149,0.9819233677232551,0.28051792840170897,0.73012923078014,7525,7,FBXO43|FBXO5|RAD1|NPM2|TRIP13|SIRT2
REGULATION OF ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:1901074,0.159060402684564,0.661359103221672,0.9209858844287611,1.22348865937031,1184,1,ABCA7
EXTRACELLULAR MATRIX-CELL SIGNALING%GOBP%GO:0035426,0.759194630872483,0.977664504547119,0.62323555359506,0.827940628441751,5655,1,FER
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045599,0.235806772908367,0.750277765814412,-0.23946349420780302,-1.1758359878412301,946,26,TRIO|CCDC85B|FOXO1|IL6|TRIB2|TNF|ZFPM2|TRIB3
NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010923,0.34301419312494896,0.8377316107273671,0.21739088475449397,1.09103625719021,4180,60,TMEM132D|CAMSAP3|CNST|ELFN2|CSRNP3|DLG3|PPP1R35|ELFN1|TGFB2|CASC5|PKMYT1|ZCCHC9|BOD1|LMTK3|CEP192|FARP1|TIPRL|SFI1|RIMBP2|SYTL2
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902177,0.9336407047587679,1.0,-0.268339854898615,-0.617125608107526,5669,4,SOD1|FBXW7
TRYPTOPHAN CATABOLIC PROCESS%GOBP%GO:0006569,0.7587605282312571,0.977664504547119,0.28037308805252503,0.764372257503298,7296,8,IDO1|CCBL1|AFMID|AADAT
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:1902367,0.479060402684564,0.9046812288131709,0.764501543890604,1.01560619422674,3568,1,LFNG
PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:0035372,0.983074753173484,1.0,0.165667346014486,0.48892713849937997,9757,10,KIF20B|MID1|MID2|CHAMP1
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHRIC RENAL VESICLE FORMATION%GOBP%GO:0072285,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
REGIONALIZATION%GOBP%GO:0003002,0.041838351822504,0.402998391331252,0.273644824913934,1.4642665068693999,527,81,RIPPLY2|HOXC6|HOXD3|SIX3|HOXC5|PBX3|TBX3|HOXB6|HOXA5|HOXB3|HOXD4|BASP1|HOXD8|HES1|BMP4|HOXC4|CFC1|AHI1|MTF2
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001186",0.7442882249560631,0.9749763305090959,-0.282609894655562,-0.775745184962794,4234,6,SOCS1|HFE|LILRB1|ZBTB7B|C10orf54|CD274
NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009142,0.0950976778474014,0.565701380327161,-0.19864405868004,-1.30078418226857,257,65,ENO3|ATP5J2|AK9|ATP5F1|CMPK2|ATP5J|LDHA|CMPK1|PFKL|COX5B|GPI|PKM|ENO1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|AK7|ALDOA|SLC25A13|PGAM2|AK4
REGULATION OF CALCIUM:SODIUM ANTIPORTER ACTIVITY%GOBP%GO:1903279,0.516109873793615,0.922205682736145,-0.5561621174524399,-0.9512855157646601,3475,2,ATP1B1|SLC9A1
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS%GOBP%GO:0042982,0.19382255389718103,0.704851847846116,-0.343713730977099,-1.2521835998517201,934,12,CLN3|APH1A|PSEN1|PSENEN|ACHE|DYRK1A|NCSTN|PSEN2|ABCG1
PROTEIN POLYGLYCYLATION%GOBP%GO:0018094,0.635704697986577,0.95916055221954,0.6869210410233789,0.9125439572792471,4735,1,TTLL3
MONOCYTE EXTRAVASATION%GOBP%GO:0035696,0.38763459534560596,0.859991269020751,0.5584686330176191,1.06159012267145,3347,3,CD47|AMICA1
POSITIVE REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033005,0.8888426744306959,0.997300970905927,0.237875398746677,0.648512155026919,8547,8,NR4A3
POSITIVE REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001819,0.242574257425743,0.7565220534116759,-0.125598747049393,-1.0936468426041,195,237,IL6ST|RELA|RNF135|CEBPG|TRIM16|TRAF6|EIF2AK2|AGT|CYBA|TLR1|CREBBP|FLOT1|CD86|IL6R|IL17D|IL17RA|PYCARD|RIOK3|HILPDA|SETD2|POLR3C|ATF4|HIF1A|XRCC6|IL1RN|HSPB1|SOD1|FURIN|CD274|IL1B|RARA|CLU|FAM49B|IRAK1|POLR3D|FCER1G|LURAP1|CTNNB1|LGALS9|MRE11A|ARFGEF2|HMOX1|PRKD2|FGR|EIF2AK3|NFAM1|RPS3|ZNF580|DDX3X|BCL10|ATP6AP2|RUNX1|SEMA7A|DDIT3|IL6|SLC11A1|CD276|PANX1|MBP|MAVS|SERPINF2|RIPK2|GAPDH|ARHGEF2|KARS|PDE4B|ADAM17|NLRP1|NLRP3|STAT3|B2M|ADCYAP1|DRD2|ADRA2A|TICAM1|MYD88|PLCB1|TWIST1|GPRC5B|SULF2|TNF|PDE4D|LRRFIP1
CELLULAR RESPONSE TO HORMONE STIMULUS%GOBP%GO:0032870,0.0019880715705765397,0.112650093274223,-0.176569188076594,-1.59294013609018,0,307,PRKCD|CTNNB1|WBP2|IGF1R|CPEB1|NSMF|UCN2|USF1|BCAR1|FOXO4|GRB2|PTGFR|CRHR1|RAB8B|GNAQ|INPP5K|HDAC5|ZNF703|PPARA|FOXO1|PKM|CPEB2|GNA15|ATP6V0C|YWHAH|PXN|ATP6V1F|PPARG|LYN|VAMP2|CHRNA7|NAMPT|CAMK2A|POU4F2|PRKAR2A|GCGR|RUVBL2|PAX8|FOXC2|LPIN1|RAB8A|PTPN1|RAMP2|LEPR|MSN|NRIP1|NEDD4|PPARGC1A|HRH3|CHRNA3|SLC25A33|STAT5A|NR3C1|CTSH|SHC1|JUN|ATP6V1E2|ATP6V0D1|STAT3|MKKS|PRKAR1B|KLF9|UBE2L3|ADCY2|ADCYAP1|CAV2|ATP6V1E1|UCN3|ADRA2A|RNF4|RHOQ|CHRM1|PLCB1|IGF2|NR1D1|NR1D2|PIK3R1|AQP1|BCL2L11|CAV1|SLIT3|FOXO6|TRIB3|INHBB|APPL1|FOXO3|RAMP1
RESPONSE TO DNA INTEGRITY CHECKPOINT SIGNALING%GOBP%GO:0072402,0.0186855670103093,0.286111698549296,0.671131267416147,1.65054961135725,173,6,MUS81|FBXO18|APAF1|SLX4|EME1
'DE NOVO' PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0006207,0.735454215555824,0.974262605126702,0.513433725928857,0.839193320181167,6079,2,CAD|DHODH
ACTIVATION OF PHOSPHOLIPASE A2 ACTIVITY BY CALCIUM-MEDIATED SIGNALING%GOBP%GO:0043006,0.724745134383689,0.972554563883587,-0.6322232024702249,-0.845744254268264,5473,1,EGFR
VASCULAR WOUND HEALING%GOBP%GO:0061042,0.652160251374705,0.9640743070248079,-0.417376240644269,-0.847052679594836,4150,3,MCAM
FARNESYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0045338,0.527415553809898,0.9265056012720759,-0.46046101246277704,-0.934491943895708,3356,3,HMGCS1|FDPS|FDFT1
MITOCHONDRION TO LYSOSOME TRANSPORT%GOBP%GO:0099074,0.35003927729772194,0.842847021021096,-0.5297712135960371,-1.07515493779915,2227,3,PARK2
SEROTONIN TRANSPORT%GOBP%GO:0006837,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
RNA LOCALIZATION TO CHROMATIN%GOBP%GO:1990280,0.7910763934860321,0.9819233677232551,-0.60151080723423,-0.8046593467479929,5974,1,HNRNPU
TYPE I INTERFERON SIGNALING PATHWAY%GOBP%GO:0060337,0.0089086859688196,0.207969158127386,-0.292413248796078,-1.7578184775345,27,48,EGR1|GBP2|HLA-F|STAT2|TYK2|STAT1|BST2|IFIT1|IP6K2|IRF9|HLA-C|IRF2|ISG20|OAS1|IFI35|PSMB8|IFIT2|IFIT3|IRF5|JAK1|IRF7|OAS2|IRF8|HLA-B|ADAR|HLA-A|HLA-E|IRF1|IRF3|RSAD2|IFI6|SP100|SAMHD1|ISG15|MX1|RNASEL|IRAK1|IFNAR2|IRF6|IFNAR1|IFITM2|MX2|IFITM3|OASL|OAS3|IFITM1|MYD88
ANTEROGRADE DENDRITIC TRANSPORT%GOBP%GO:0098937,0.7464257659073059,0.9749763305090959,-0.38342340355134,-0.778146405497828,4750,3,KIF17|KIF5C|KIF5A
REGULATION OF CELL PROJECTION ASSEMBLY%GOBP%GO:0060491,0.41004184100418395,0.867015886388254,-0.12897239813331401,-1.0272337693959699,587,145,AKIRIN1|PFN1|SRGAP2C|TCTEX1D2|EPS8L1|CCP110|NRP1|ATG3|TBC1D20|TBC1D8|TBC1D14|PODXL|CYLD|HAP1|TBC1D19|RALA|MARK4|TBC1D5|FMR1|TWF1|CDC42|TBC1D2|SEPT9|SSH3|TBC1D15|TWF2|HTT|RAB5A|MAP4|KCTD17|RHOQ|RAC1|BRK1|TBC1D1|CAV1
MRNA CATABOLIC PROCESS%GOBP%GO:0006402,0.758555133079848,0.977664504547119,-0.105560584052142,-0.8889984522107929,797,198,RPS10|TNKS1BP1|CNOT3|RPL28|RPS3A|UPF3A|RPL37|RPL27A|XRN1|GSPT2|POLR2G|SUPV3L1|PPP2R1A|ATM|ZCCHC6|DDX5|CNOT1|RPL7A|RPL19|RC3H1|UPF2|EXOSC10|RPLP1|SAMD4B|RPSA|RPL6|RPL5|CNOT2|EXOSC2|EDC4|TUT1|RPL18|AGO4|RNH1|CNOT8|RPS27A|PELO|PATL2|RPS26|PAN2|PNPT1|RPL22|PNRC2|RPS12|CNOT6|SKIV2L|RPL4|DCPS|RPL37A|RPL23|EXOSC3|RPL10|RPL24|SMG8|RPL26|RPS25|NT5C3B|ERI1|RPL13|CNOT4|RPS5|EIF3E|RPLP2|RPS2|LSM1|PCID2|ZC3H12A|SMG7|LSM2|SMG1|NUDT16|PAN3|RPS8|RPL21|RPL39|RPS20|ZFP36L1|RPS15A|ZFP36L2|RPS11|RPS6|CTIF|PATL1|AGO3|RPL30|PAPD5|RPL41|RPS29|RPL34|LSM6|RPS7|RPL27|EDC3|RPL13A|CASC3|SSB|UPF1|RQCD1|CNOT11|RPS18|RPL10A|LSM5|DCP1B|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SMG5|DIS3L2|MAGOHB|RPL29|RPL31|RPL17|EIF4A3|EXOSC7|RPS14|RPS17|EXOSC1|DIS3|RPL32|EXOSC8|AGO1|RPL18A|NCBP1|RPL11|PARN|CNOT6L|SMG6|RPS16|RPL12|LSM3|CNOT10|PPP2R2A|DCP1A|RPS4X|DCP2|RPL9|METTL16|RPS28|HBS1L|SAMD4A|RPL35|RPL7|EXOSC6|PRPF18|RPS9|RPS3|RPL14|WIBG|EXOSC4|MAGOH|GSPT1|EIF4G1|PAPD7|RPL15|RPL8|NBAS|PPP2CA|RPL35A|CNOT7|EXOSC9|HELZ2|MTPAP|ETF1|PDE12|CSDE1|UBA52|MRTO4|NCBP2|POLR2D|RBM8A|RNPS1|PABPC1|EXOSC5|DDX6
ZINC ION TRANSPORT%GOBP%GO:0006829,0.6425905598243691,0.9620807249753851,-0.210039202698484,-0.8601811272249681,2926,16,SLC30A3|SLC39A8|SLC39A1|SLC30A1|SLC39A4|SLC39A11|SLC30A9
LIPID DROPLET ORGANIZATION%GOBP%GO:0034389,0.977130767680838,1.0,0.171950165360866,0.507469361566477,9698,10,FITM1|HSD17B13|FAF2|BSCL2|FITM2|PPID
VACUOLAR SEQUESTERING%GOBP%GO:0043181,0.045503355704698,0.4190278528102411,0.9769519188354651,1.2978370392578,338,1,GAA
PROTEIN LOCALIZATION TO CYTOSOLIC PROTEASOME COMPLEX INVOLVED IN ERAD PATHWAY%GOBP%GO:1904379,0.251239869360106,0.7634465094445358,0.70912599944858,1.1590469652679198,2076,2,ATXN3|BAG6
NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010897,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002418,0.441009609818224,0.880402968441571,0.537884636594243,1.02246211082576,3808,3,PRF1|ADAM15|MICA
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:1901296,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
"ESTABLISHMENT OF MITOCHONDRION LOCALIZATION, MICROTUBULE-MEDIATED%GOBP%GO:0034643",0.52989247311828,0.9265056012720759,-0.23482873350331798,-0.9365179685698279,2463,15,HAP1|TRAK1|UBB
CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046513,0.144030322173089,0.6340340930337739,0.323878564853792,1.3167321189066699,1595,27,B3GALT2|B4GALNT1|CERS4|B3GALT1|ST3GAL5|CERS6|B4GALT6|ST8SIA3|CERS5|SMPD1|SMPD4|CERS2|B4GALT3|ST8SIA2|CERS1
METANEPHRIC GLOMERULAR CAPILLARY FORMATION%GOBP%GO:0072277,0.7363028953229399,0.974262605126702,-0.464460987041632,-0.794435643395373,4958,2,PDGFRA|PDGFRB
REGULATION OF GLUCONEOGENESIS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0035947,0.532739420935412,0.9265056012720759,-0.549105898988235,-0.939216231988524,3587,2,NR1D1
CIRCADIAN REGULATION OF TRANSLATION%GOBP%GO:0097167,0.429606454799934,0.877926023931603,-0.437540159668969,-1.0062509618975402,2608,4,PER1|HNRNPD|PER2
SMOOTH MUSCLE HYPERPLASIA%GOBP%GO:0014806,0.0847809948032665,0.545265264053164,-0.8241521918941271,-1.40966818546685,570,2,HMOX1|NOS3
ESTABLISHMENT OF TISSUE POLARITY%GOBP%GO:0007164,0.390269587194608,0.8607749921056059,0.40861395503557796,1.06353627511795,3705,7,BRSK2|C5orf42|VANGL2|BRSK1
REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001198,0.4811513463324051,0.9046812288131709,-0.309130295812007,-0.9609115570128379,2590,8,LGALS1|LGALS9|FCGR2B|LGALS3
PROTEIN LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033374,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
REGULATION OF CELLULAR COMPONENT SIZE%GOBP%GO:0032535,0.748815165876777,0.9749763305090959,-0.10531074707533801,-0.9013730150804999,631,222,PRKCD|DNM2|RTN4|RAP1GAP2|CFL2|PTK2B|VASP|PFN1|ABL1|VAV1|SEMA3F|MAP3K13|RHOA|NRP1|WDR1|TMSB10|MYADM|WHAMM|NAT6|SEMA7A|ARPC5|POU4F2|LAMTOR5|ISLR2|BIN1|WIPF1|TMSB4X|LIMK1|VAV3|ARPC5L|VAV2|ARPC4|TWF1|MSN|SEMA6B|MTPN|ARPIN|SSH3|TWF2|ANO6|RAB22A|RAB5A|SLC9A3R1|SEMA3A|RAC1|SEMA3G|ACTR2|BRK1|SH3BP1|OLFM1|JMY|AQP1
VENTRAL MIDLINE DEVELOPMENT%GOBP%GO:0007418,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
REGULATION OF COMPLEMENT-DEPENDENT CYTOTOXICITY%GOBP%GO:1903659,0.7880730615700979,0.9819233677232551,0.49097285767399995,0.8024816480547491,6514,2,TGFB2
REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043030,0.161948482529967,0.664367762084791,-0.25324780745899,-1.26198372739027,634,27,SHPK|MFHAS1|PJA2|CX3CL1|ITGAM|NR1H3|CEBPA|IL6|FCGR2B|KARS|TNIP2|TNF
NEGATIVE REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060315,0.584816563748638,0.9439064862850342,-0.30457530021817497,-0.8884596635133891,3219,7,SRI|FKBP1B|FKBP1A
MUCOPOLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:1903510,0.705147058823529,0.968941691852291,-0.131890060670605,-0.8677057570629371,1917,66,B4GALT1|CD44|IDS|IDUA|B4GALT5|GALNS|CHST7|IL1B|SLC9A1|ST3GAL2|CHST11|FGF2|CHP1|CEMIP|CSPG4|B3GNT7|CSGALNACT1|CHSY1|TMEM2|NCAN|B3GNT2
MOTILE CILIUM ASSEMBLY%GOBP%GO:0044458,0.406225374310481,0.8664565508572991,-0.303290122862092,-1.02607588210334,2061,10,E2F4|ZMYND10|C21orf2|CCDC40|SPATA6|CCDC176|RSPH9|LRRC6|DNAAF1
ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION%GOBP%GO:0090158,0.13839285714285698,0.6263534045411271,-0.529555890529949,-1.34053557255665,805,5,RTN4|STX18|ATL2
POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0060143,0.9919227738376669,1.0,-0.147453802270362,-0.49885828396347204,5034,10,CAMK1|ADAM9|MAPK14|CD53|RAPGEF3|FAM65B|FLOT1|EHD1|EHD2
KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0031640,0.593351910828026,0.9464278097528599,0.29397584999174603,0.8968529304967199,5961,11,HIST1H2BJ|AZU1|RPS19|HIST1H2BK
CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:0071560,0.163988657844991,0.666385698695266,-0.16477522239472697,-1.1951866177282,346,96,MAPK7|F11R|SKI|TGFBR1|ACVR1|ARRB2|GDF15|RHOA|KLF10|CDH5|PXN|SMAD1|SMAD2|SMAD7|SOX6|NR3C1|JUN|UBA52|ID1|LIMS1|CLEC3B|ZYX|ACVRL1|WWOX|UBC|PDE3A|PARD3|UBB
RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0006979,0.954490592829251,1.0,0.10858230443778301,0.68149446037069,13443,215,PTPRK|SIRT1|DPEP1|MGST1|ARNTL|ETFDH|PRKAA2|GLRX2|LONP1|NDUFS2|RGS14|PKD2|HBB|NAPRT|ECT2|MPV17|HBA2|ETV5|DHCR24|MAP3K5|PNKP|SDHAF3|PRDX4|PARP1|TMEM161A|CAMKK2|MSRB2|CCS|MTR|FOS|PRDX3|HBA1|FANCC|NDUFS8|APOE|PLEKHA1|CCL19|GSTP1|STX2|HDAC6|NFE2L2|SEPP1|NEIL1|PYCR2|PEBP1|VRK2|RNF112|VIMP|CAT|MYEF2|CYGB|ANKZF1|MAPK13|GPX7|MAPK9|OXR1|NDUFA12|XRCC1|MSRB3|PRR5L|SP1|ADAM9|EGLN1|CDK2|CHUK|TXNRD1|GPX8|AKT1|PRKD1|FER|RBPMS|PSIP1|RAD52|PINK1|HYAL2|TPM1|RBM11|SGK2|ATP13A2|ATOX1|ATP5A1|CYCS|SLC23A2|SIGMAR1|GPX3|ERCC6L2|NCF1|SETX|ARL6IP5|MAPT
LACTOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0046478,0.39691275167785206,0.8638522656500329,0.808998676665196,1.07471864995995,2956,1,B4GALT6
LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:0007159,0.979877515310586,1.0,0.11631207344844699,0.513405726691547,11199,36,ITGB1|CD209|MADCAM1
CARDIAC RIGHT VENTRICLE MORPHOGENESIS%GOBP%GO:0003215,0.857085183689948,0.991629714062402,-0.197424482772963,-0.6947613518535009,4245,11,TBX20|ZFPM2
POSITIVE REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000330,0.492080536912752,0.9096267185860121,0.757995147772386,1.0069627372546,3665,1,IL12RB1
TETRAPYRROLE BIOSYNTHETIC PROCESS FROM GLUTAMATE%GOBP%GO:0033526,0.32362416107382597,0.8239107965478291,0.842247463608293,1.11888818008031,2410,1,CPOX
POSITIVE REGULATION OF ANGIOGENESIS%GOBP%GO:0045766,0.0295183842568617,0.35321818040309794,-0.18736243557718602,-1.40480764933157,56,109,CYP1B1|SASH1|SRPX2|DLL1|MYDGF|BTG1|GATA2|RHOJ|HIPK1|HIF1A|HSPB1|IL1B|VEGFA|ITGB8|KDR|MTDH|HMOX1|PRKD2|PDCL3|SPHK1|ITGA5|PKM|RUNX1|FGF2|CDH5|SMAD1|APLNR|CHRNA7|FOXC2|ETS1|RAMP2|AGO2|HK2|CXCL8|CTSH|PRKCA|ADM2|NOS3|FLT1|CHI3L1|SFRP2|BMPER|PGF|TWIST1|AQP1
IMMATURE B CELL DIFFERENTIATION%GOBP%GO:0002327,0.7281936813186809,0.972554563883587,-0.311005052637492,-0.7872886389540291,4240,5,IRF2BP2
DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050962,0.935945990449531,1.0,-0.26668934758732105,-0.613329786094605,5683,4,CACNA2D4|EYS
TREHALOSE CATABOLIC PROCESS%GOBP%GO:0005993,0.742013422818792,0.974505008828563,0.632112924569916,0.83973381973425,5527,1,ATHL1
POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051987,0.7448245805186321,0.9749763305090959,0.339533046417483,0.7825733391037,6835,5,CCNB1|SIRT2|RCC2|HNRNPU
PEPTIDYL-ARGININE N-METHYLATION%GOBP%GO:0035246,0.8225708502024291,0.987616425875001,0.249377142133052,0.711637157268655,8126,9,PRMT9|PRMT1|CARM1|PRMT7|NDUFAF7
RESPONSE TO LIPOPROTEIN PARTICLE%GOBP%GO:0055094,0.0956678700361011,0.567869389128269,-0.31990641659514,-1.4029410229331898,423,19,PPARG|ABCA1|CD9|TICAM1|MYD88|CD36|CDH13
HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:0010421,0.600742390497402,0.950415218201239,-0.5210174463884429,-0.8911724381378778,4045,2,PDCD10
INTERLEUKIN-13-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035772,0.34674963590626195,0.842847021021096,-0.826973974415527,-1.10626829980075,2618,1,CD300LF
NOREPINEPHRINE-EPINEPHRINE-MEDIATED VASODILATION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0002025,0.13623725671918402,0.6237835799077729,-0.9293118659020729,-1.2431688174984599,1028,1,ADRB2
XYLULOSE 5-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0051167,0.45982142857142894,0.890371861972445,-0.386675650267416,-0.978843732068032,2677,5,SORD|XYLB
MITOCHONDRIAL PROTON-TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY%GOBP%GO:0033615,0.527718669503864,0.9265056012720759,0.451866381739571,0.957548027431912,4711,4,C7orf55|OXA1L|ATPAF1|TMEM70
PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0030046,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
ACYL-COA METABOLIC PROCESS%GOBP%GO:0006637,0.0733159354102104,0.520754220371606,0.27737676864342403,1.4081181239148501,898,63,ACSM3|HACD1|ACSF2|OXSM|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|ACBD6|MVD|ACOT1|PDHX|FAR1|PDHA1|ACOT2|SLC25A1|ACACA|SUCLG1|DLD|ACSS1|MCEE
"PROTEIN DEGLYCATION, METHYLGLYOXAL REMOVAL%GOBP%GO:0036530",0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
NEGATIVE REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000575,0.9373758771349129,1.0,-0.528617115130128,-0.7071472323102951,7079,1,MAP2
REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900239,0.594394329896907,0.947176034529489,0.36324160045462495,0.8933398152755201,5534,6,OLFM2|FGF9|SP1|DNMT1|PDGFB
NUCLEAR POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0071046,0.363444639718805,0.849828746111777,-0.38293530417516997,-1.0511316977355,2067,6,EXOSC10|EXOSC2|EXOSC3|EXOSC7|EXOSC8|EXOSC9
REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903383,0.900816629547142,0.998912093067348,-0.38682106424041895,-0.661636713572188,6066,2,PINK1|PARK7
REGENERATION%GOBP%GO:0031099,0.570183702308055,0.940402148292764,-0.20065381872265697,-0.9113287089269909,2420,21,AKIRIN1|EYS|APOD|IGF1|CFLAR|SULF2|RTN4RL2
ADULT WALKING BEHAVIOR%GOBP%GO:0007628,0.676911655530809,0.9647315640607691,-0.49142454122869395,-0.8405553587567499,4558,2,DRD2
L-ARGININE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0097638,0.143597800471328,0.6334904564746021,-0.66794148556591,-1.35556739954294,913,3,SLC7A3|SLC7A1
PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014065,0.9765091505053259,1.0,0.12862273833496302,0.5125431098436621,10724,25,EDN1|TYRO3|NF1|PLEKHA1|IRS1|GATA3|NYAP1|ERBB3|AKT1|PIK3C2B|PIK3C2A
CELLULAR RESPONSE TO INTERLEUKIN-6%GOBP%GO:0071354,0.33702308054639696,0.8316851790983271,-0.23868515983261201,-1.08405930141276,1430,21,ST3GAL6|SELPLG|FER|STAT1|CBL|PTGIS|CTR9|JAK1|PTPN11|PHB|PID1|NFKB1|SMAD4|IL6ST|RELA|IL6R|SOCS3|IL6|SBNO2|STAT3
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904746,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900377,0.6654309545875811,0.964618776001639,-0.662163652404058,-0.8857965070214191,5025,1,RAPGEF2
NEGATIVE REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032700,0.418612637362637,0.871698849372662,-0.40001103022281104,-1.01260136091034,2437,5,TLR4|FOXP3|NCKAP1L|C10orf54|PRNP
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001026,0.0887809187279152,0.556932119338259,-0.336147635062083,-1.4144705855385802,401,17,HSPB1|NOTCH1|VEGFA|KDR|PRKD2|FGF2|TMSB4X|FGFR1|MET
TRANSLATIONAL ELONGATION%GOBP%GO:0006414,0.935300881563817,1.0,0.117532279010995,0.662836048276013,12200,107,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|EEF1G|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|MRPS31|SECISBP2|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|EEF1B2|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|NEMF|MRPL27|MRPL40
REGULATION OF HYPOXIA-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903297,0.8117370366222421,0.9855701659458179,0.348299652181219,0.7380802342882951,7247,4,NOL3
HEPATIC IMMUNE RESPONSE%GOBP%GO:0002384,0.16644394951744598,0.6682860217990739,-0.7561069754618142,-1.29328048702806,1120,2,IL6R|IL6
NEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0072178,0.0844439466905589,0.545178773025535,0.664644570672255,1.4084453354118898,753,4,BMP4|AHI1|GPC3|GATA3
MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052312,0.6627235213204951,0.964618776001639,0.215514882655552,0.848158344689672,7226,24,GTF2B|CCL5|LEF1|PSMC3|SMARCA4|SP1|TFAP4|TARDBP|REST|CCL4|CHD1|SNW1|NUCKS1|EP300|RRP1B
PURINE NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0034034,0.558550824175824,0.936434965680841,-0.35793073020075,-0.906077875680143,3252,5,ACOT7|ABCD1|ACAT1|MLYCD|NUDT7
NEGATIVE REGULATION OF EXONUCLEASE ACTIVITY%GOBP%GO:1905778,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
HISTONE H4-K12 ACETYLATION%GOBP%GO:0043983,0.8543814432989691,0.991298302704726,0.27926781493015196,0.6868185193817429,7955,6,JADE3|MEAF6|KAT7|JADE2|ING4
CARBOHYDRATE TRANSPORT%GOBP%GO:0008643,0.453499079189687,0.8877670623536891,-0.222946153321521,-0.9947646655437371,1969,20,PPARD|SLC2A3|SLC2A6|SLC5A2|SLC45A4|SLC2A1|AQP1
NUCLEAR POLYADENYLATION-DEPENDENT RRNA CATABOLIC PROCESS%GOBP%GO:0071035,0.363444639718805,0.849828746111777,-0.38293530417516997,-1.0511316977355,2067,6,EXOSC10|EXOSC2|EXOSC3|EXOSC7|EXOSC8|EXOSC9
GTP BIOSYNTHETIC PROCESS%GOBP%GO:0006183,0.12241441877343699,0.607607158836689,0.7866139998145841,1.28569897314626,1011,2,IMPDH1|IMPDH2
OSTEOCLAST FUSION%GOBP%GO:0072675,0.528285077951002,0.9265056012720759,-0.550813344361731,-0.9421367258549659,3557,2,SH3PXD2A|TCTA
STEROL METABOLIC PROCESS%GOBP%GO:0016125,0.13927781871776002,0.628153582730071,0.256380118430851,1.29152178028597,1700,61,FDXR|CYP21A2|TM7SF2|C14orf1|FDX1|EBP|CLN6|MVD|LBR|DHCR24|SOAT1|PPAPDC2|CETP|OSBPL5|LDLRAP1|APOE|NSDHL|CYP7B1|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7|LCAT
POSITIVE REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903984,0.9710547643857821,1.0,0.291078280909068,0.553309191722329,8386,3,ATF3|PTEN
POSITIVE REGULATION OF DNA LIGATION%GOBP%GO:0051106,0.255938112878623,0.76730468634737,0.5158283697330689,1.1889079250627,2348,5,RAD51|XRCC1|PARP3|APLF|HMGB1
MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION%GOBP%GO:0072656,0.28750205829079495,0.7968329882324392,-0.492793722361062,-1.1333226132157799,1745,4,HK1|HK2
REGULATION OF COA-TRANSFERASE ACTIVITY%GOBP%GO:1905918,0.23116642393750797,0.7440352621789029,-0.8840427878253199,-1.18261099151257,1745,1,CHRNA7
HAIR CYCLE%GOBP%GO:0042633,0.580870077580281,0.942746898746279,0.279500958171372,0.902053482944775,5914,13,CDH3|TGFB2|APCDD1|FGFR2|SNRPE|HDAC2|ATP7A|SOX18
REGULATION OF GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034350,0.0906284053759535,0.560245248761167,-0.49786893141673105,-1.4523057613779597,498,7,PRKCI|GAS6|DLL1|PRKCH|PRKCD|PRKCA
NEGATIVE REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0045963,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0150033,0.744869588243082,0.9749763305090959,-0.622684164093516,-0.8329835917888979,5625,1,ROCK2
REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002834,0.465353833192923,0.8935333137980291,0.383889919561145,0.9991848053007409,4418,7,CEACAM1|KLRK1
REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE%GOBP%GO:0031630,0.883875650175396,0.996316041142784,0.445051006341329,0.727423643598552,7306,2,RAB3A|STXBP1
PERICARDIUM MORPHOGENESIS%GOBP%GO:0003344,0.402636203866432,0.865238688875249,-0.3716838563785779,-1.02024722901332,2290,6,LRP6|DLL4|FLRT3|BMP7|NOTCH1|TBX20
PRONEPHROS DEVELOPMENT%GOBP%GO:0048793,0.456938066972785,0.889753242461646,0.47647644588979604,1.00969910424205,4079,4,AHI1|CEP290|SEC61A1
REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903969,0.435659088363759,0.878651088001772,0.48447581757017605,1.02665053697257,3889,4,CSF1|TLR4|PTPN2|TLR2
SECONDARY METABOLIC PROCESS%GOBP%GO:0019748,0.0272096078063427,0.339785941813865,0.440724056204575,1.63662845300845,289,20,CITED1|CTH|AS3MT|AKR1B1|CBR4|BDH2|N6AMT1|AKR1C1|TRPC1|ARL1|FMO2|CYP2D6
REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902959,0.22191272051996302,0.73556947110949,-0.391362460641247,-1.21652492979806,1194,8,PICALM|LYN|EFNA1|BIN1
PRIMARY HEART FIELD SPECIFICATION%GOBP%GO:0003138,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
REGULATION OF ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:2000387,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
ENDOCRINE PANCREAS DEVELOPMENT%GOBP%GO:0031018,0.292703150912106,0.8004058897916541,-0.31029063970498305,-1.13041992567927,1411,12,DLL1|IL6R|EIF2AK3|NKX6-1|FOXO1|IL6|INSM1
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0086004,0.0301069917890022,0.356653713174296,-0.33157472442652397,-1.6085589796258402,120,25,PLN|RANGRF|BIN1|PDE4B|SCN5A|DLG1|PDE4D|CAV1|STC1
REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070424,0.0983874482458052,0.570215774831708,0.609144054709905,1.40398674567705,902,5,BIRC2|ERBB2IP|PTPN22|XIAP|BIRC3
PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE%GOBP%GO:0070782,0.431219383026612,0.8785877309899279,-0.782587119541244,-1.04689065069156,3256,1,XKR8
ORGANELLE FISSION%GOBP%GO:0048285,7.092701610043271e-05,0.0784645998831315,0.290645999702961,1.8259304863647101,0,216,HSPA2|KIF25|MUS81|MTFR1|SYCP2|EME2|MLH3|CCNA1|CCNB1|PSRC1|KIF14|NCAPD3|ZWINT|SPAG5|RAD54B|BLM|PEX11G|KIF2C|C11orf80|KIF18A|NSL1|BRIP1|KIF4A|MAP10|NUF2|KIF23|BUB1|TOP2A|PRC1|KIF11|DLGAP5|TUBGCP3|CDC23|SMC2|CCNE1|NDC80|WRAP73|NUSAP1|CENPE|KIF18B|PTTG1|RB1|CEP55|BUB1B|AKAP8L|INO80|ESPL1|AURKB|RAD51C|RAD51|BOD1|PIM2|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|MND1|TUBG2|FANCM|SPDL1|KIF22|PPP2R2D|REC8|TUBGCP6|CDCA5|KLHL22|CEP192|MYBL1|DSCC1|CHEK2|SLX4|PLK1|TUBGCP2|NCAPG|POGZ|NCAPH|EME1|ING2|RMI1|RACGAP1|STRA13|SPDYA|UBE2C|CCNE2|SMC4|BAG6|STAG3|TOP2B|KLHDC8B|TEX14|P3H4|TUBGCP4|FAM175B|UBR2|RECQL5|HIRA|SPIRE2|MTFR1L|SPIRE1|SGOL1|TPX2|PDS5B|MTFR2|FMN2|ATM|PEX11B
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:1903917,0.7093869985436251,0.9698418353073279,-0.6409351565946179,-0.85739850092572,5357,1,PPP1R15A
REGULATION OF PROTON TRANSPORT%GOBP%GO:0010155,0.149777957206298,0.643776991770958,-0.37293272633765506,-1.3123967274044899,741,11,TESC|PPIF|DNAJC30|CHP1|TMSB4X|SLC9A3R1
ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032509,0.26634438305709,0.7803351796901099,-0.256877967702364,-1.14616521442503,1156,20,LAPTM4B|VCP|SNF8|SORT1|LEPROTL1|LYST|UBXN6|CHMP3|CHMP2B|CHMP2A|CHMP1A|VPS25|TMEM50A|TMEM50B|RILP|VPS28|VPS4B|LEPROT|CHMP1B
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0070199,0.13489880133621499,0.622258254449182,0.42990722695428796,1.35522121367243,1372,12,LRWD1|TERT|H2AFY2|NIPBL|BRCA2|ACD|CCDC101|POT1
WNT RECEPTOR CATABOLIC PROCESS%GOBP%GO:0038018,0.5748709122203101,0.941940408834489,-0.70666078517865,-0.9453216782401949,4341,1,ZNRF3
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905932,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
TERMINATION OF SIGNAL TRANSDUCTION%GOBP%GO:0023021,0.9300864100549879,1.0,-0.305378444531579,-0.619756479984789,5919,3,GBA|PRKCD
BASOPHIL ACTIVATION%GOBP%GO:0045575,0.16404077849860998,0.666385698695266,-0.915141155712395,-1.22421222641639,1238,1,KARS
"REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048024",0.8224950495049509,0.987616425875001,0.142461007784063,0.760901851203491,10383,80,CELF5|SFSWAP|CELF1|RBM4B|RBM25|SART3|DAZAP1|SRSF1|DDX17|RBFOX1|CIRBP|SRPK1|TIA1|SRSF6|SON|SRSF2|TRA2A|THRAP3|RBM5|SRRM4|MBNL3|DDX5|RBFOX2|RBM4|YTHDC1|NSRP1|CELF3|RBMX|U2AF2|REST|RBM11|RBM17|SRSF9|SRSF5|JMJD6|SRSF4|SRSF10|CELF6|SNW1|CWC22|SRSF12
PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0003301,0.57106568283537,0.9404752161333092,0.578108629721533,0.9449026737067551,4720,2,SORBS2|PDLIM5
AXIS ELONGATION%GOBP%GO:0003401,0.9068028643639431,1.0,0.24048390643218598,0.625929082746162,8610,7,BMP4|MAGI2|FGFR2|LRP6
REGULATION OF MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1904289,0.836821095923552,0.9889652677625541,0.469641504900874,0.767616137953615,6917,2,PPP1R10
DETECTION OF ABIOTIC STIMULUS%GOBP%GO:0009582,0.259450925357425,0.770912532778873,0.26817468711465803,1.1749152052207399,2957,35,TAC1|SCN1A|UNC119|PIEZO2|ADGRV1|PKD2|TCAP|DFNB31|PDZD7|KIT|TIMELESS|PIEZO1|CNGB1
CHEMOSENSORY BEHAVIOR%GOBP%GO:0007635,0.682858554256545,0.9661822799536179,-0.35666081753139506,-0.82024537126753,4146,4,CFAP69
NEGATIVE REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051945,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
"AROMATIC AMINO ACID FAMILY BIOSYNTHETIC PROCESS, PREPHENATE PATHWAY%GOBP%GO:0009095",0.125645438898451,0.607607158836689,-0.934825760917512,-1.25054492297786,948,1,PAH
POSITIVE REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051194,0.675740944017563,0.9647315640607691,-0.205248877072398,-0.840563133803347,3077,16,ZNF205|HIF1A|PRKAA1|PFKFB4|IGF1|SNCA|AAED1
LACTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0005989,0.175204157386785,0.677933656654802,-0.7515301902398679,-1.28545214102286,1179,2,B4GALT1|SLC2A1
MODULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM%GOBP%GO:0044359,0.416881443298969,0.8709670999109399,0.422647345162305,1.03943959277084,3881,6,SUGT1|PTX3|RAB9A|NUCKS1|ANXA2|CASP8
CHROMATIN ORGANIZATION%GOBP%GO:0006325,0.490992821346336,0.9092105079917561,0.14869436676694,1.00141112840029,7249,443,CPA4|RBBP7|SIRT4|HIST1H3E|HIST1H2BJ|SIRT1|PRMT9|HIST3H2BB|HDAC10|MBD3|JADE3|WDR61|EHMT1|MTA2|LRWD1|SAFB|RRP8|AK6|KAT2A|ASF1B|KDM5D|BPTF|SMARCD3|MIER2|NAA40|DOT1L|TADA1|OGT|TAF6L|CENPL|C14orf169|CENPT|NAP1L4|ACTL6B|MTA1|HIST2H3C|HIST2H3A|PCGF2|YEATS4|SART3|CENPK|JAK2|DDB2|ASF1A|KDM5B|CASC5|TRRAP|CENPU|PRKCB|CDKN2A|MAP3K7|EP400|EZH2|H2AFY2|OIP5|KMT2B|ARID2|PAGR1|ITGB3BP|CENPA|TAF5|NEK11|HIST1H2AK|UHRF1|MUM1|HDAC8|RB1|HIST1H4I|LOXL2|INO80|LEF1|AURKB|HUWE1|DDB1|ZBTB1|CHD1L|HELLS|NIPBL|CENPV|ING5|HDAC3|CENPQ|CENPI|TRIM37|H2AFX|APBB1|YEATS2|H3F3A|SMARCAD1|SRPK1|KDM4B|H2AFZ|HDAC6|CHAF1A|MIS18BP1|BRCC3|BRPF3|HIST1H2BF|NASP|HJURP|ZNF335|NRDE2|CUL4B|PRMT1|SFPQ|KDM1A|HIST1H2BK|CARM1|STRA13|RNF40|NSD1|MYSM1|CDC73|MSL1|PAXIP1|KAT8|BRCA2|KDM3B|MAP3K12|VRK1|CENPM|EHMT2|HIST1H2AC|SMARCA4|SUPT3H|RPS6KA4|KMT2D|RIF1|WDR5|EED|KDM8|UBE2B|HIST1H3H|UBR2|CHEK1|HIRA|HIST1H2BN|BRD1|SUDS3|HIST3H2A|ARID1A|SUPT6H|KDM4A|SUPV3L1|CDAN1|MBD1|SIN3B|CDK2|SETDB2|PCGF1|CCDC101|HIST1H2BG|HIST2H2BE|PCGF3|UIMC1|HIRIP3|SMARCD1|HIST1H2BH|PPM1D|USP49|EYA3|HMGB3|MEAF6|SUV39H1|TET2|HP1BP3|USP21|NPM2|REST|CENPH|CENPW|RNF8|SETMAR|SMARCA1|CCNA2|MTHFR|TOP1|CTCF|PRMT7|KAT2B|JMJD6|KANSL1|CHD4|SMARCA5|BRD8|LDB1|SUV39H2|HDAC9|GATAD1|HMGB2|TAF6|ZFPM1|NUDT5|L3MBTL1|CHD1|DDX11|SETD1B|ELK4|PHF8|PHC1|HDAC2|ATRX|SOX15|ACTL6A|ARID1B|WHSC1L1|TBL1XR1|CENPP|ING3|SIRT7|NUCKS1|CENPO|CENPN|MBIP|MYB|FOXP3|TAF12|MRGBP|PCGF5|HMGB1|USP15|KDM2B|ZBTB7A|BCOR|KDM6B|KAT7
PROGRAMMED NECROTIC CELL DEATH%GOBP%GO:0097300,0.44043321299639,0.879896414106183,-0.228280426268172,-1.0011176960842398,1951,19,PPIF|PGAM5|ITPK1|CYLD|MLKL|TICAM1|TNF
CELLULAR RESPONSE TO PHEROMONE%GOBP%GO:0071444,0.0288590604026846,0.348603135907264,0.9856087340097042,1.30933723200887,214,1,GNG8
REGULATION OF CARDIAC MUSCLE MYOBLAST PROLIFERATION%GOBP%GO:0110022,0.14692601597777,0.638549298625996,0.677605102486215,1.28805601844508,1268,3,MEIS2|GATA6|ATF2
FATTY ACID OMEGA-OXIDATION%GOBP%GO:0010430,0.89646498080233,0.998912093067348,-0.5494596382884871,-0.7350289110224358,6770,1,CYP4V2
NEGATIVE REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010887,0.000371402042711235,0.0784645998831315,-0.762087162590566,-2.36889871974804,1,8,PPARD|NR1H3|PPARA|PPARG|ABCA1|NR1H2|ABCG1
REGULATION OF BEHAVIORAL FEAR RESPONSE%GOBP%GO:2000822,0.785653804282085,0.981487311948134,0.491976840363937,0.8041226301804342,6494,2,APOE|MEF2C
REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:0051930,0.126130810023916,0.607607158836689,0.49769226100080105,1.35684262610766,1212,8,ZFHX2|NOV|F2R
"NEGATIVE REGULATION OF COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001869",0.533036377134373,0.9265056012720759,-0.548552522746071,-0.93826971156324,3589,2,SERPING1|A2M
TRIGLYCERIDE TRANSPORT%GOBP%GO:0034197,0.576243504083148,0.942162964865338,-0.530923591198437,-0.908116368296193,3880,2,CD36
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001937,0.218566692170365,0.7341474817293291,-0.23872234660042302,-1.18960049367038,856,27,PPARG|PDCD10|ATOH8|SCG2|CAV2|FLT1|PTPRM|CAV1
RNA CATABOLIC PROCESS%GOBP%GO:0006401,1.0,1.0,-0.06691331430891001,-0.5720942181611229,861,221,RPS10|TNKS1BP1|CNOT3|RPL28|RPS3A|UPF3A|SLFN13|RPL37|RPL27A|XRN1|GSPT2|POLR2G|SUPV3L1|PPP2R1A|ATM|ZCCHC6|DDX5|CNOT1|RPL7A|RNASET2|RPL19|RC3H1|UPF2|EXOSC10|RPLP1|SAMD4B|RPSA|RPL6|RPL5|RNASEH2C|CNOT2|EXOSC2|EDC4|TUT1|RPL18|AGO4|RNH1|CNOT8|RPS27A|PELO|PATL2|RPS26|PAN2|PNPT1|RPL22|PNRC2|RPS12|CNOT6|SKIV2L|RPL4|DCPS|RPL37A|SND1|RPL23|EXOSC3|RNASEH2B|RPL10|RPL24|SMG8|ISG20|RPL26|RPS25|NT5C3B|ERI1|RPL13|CNOT4|RPS5|EIF3E|RPLP2|RPS2|LSM1|PCID2|ZC3H12A|SMG7|LSM2|SMG1|NUDT16|PAN3|RPS8|RPL21|RPL39|RPS20|ZFP36L1|RPS15A|ZFP36L2|RPS11|RPS6|CTIF|PATL1|AGO3|RPL30|PAPD5|C19orf43|RPL41|RPS29|RPL34|LSM6|RPS7|RPL27|EDC3|RPL13A|CASC3|SSB|UPF1|RQCD1|CNOT11|RPS18|RPL10A|LSM5|DCP1B|RPL38|RPS13|RPS27|RPS23|DIS3L|RPS21|XRN2|RPL3|SMG5|DIS3L2|MAGOHB|RPL29|RPL31|RPL17|PABPC4|EIF4A3|EXOSC7|RPS14|RPS17|EXOSC1|DIS3|RPL32|EXOSC8|AGO1|RPL18A|NCBP1|RPL11|PPP1R8|HNRNPD|PARN|CNOT6L|DEDD2|SMG6|RPS16|RPL12|LSM3|CNOT10|PPP2R2A|DCP1A|RPS4X|DCP2|RPL9|METTL16|SIDT2|RPS28|HBS1L|SAMD4A|RPL35|RPL7|EXOSC6|PRPF18|RPS9|RPS3|RPL14|WIBG|EXOSC4|MAGOH|GSPT1|EIF4G1|PAPD7|RPL15|RPL8|NBAS|PPP2CA|ZPR1|RPL35A|CNOT7|EXOSC9|HELZ2|MTPAP|RNASEH1|ETF1|PDE12|CSDE1|UBA52|MRTO4|NCBP2|POLR2D|RBM8A|RNPS1|PABPC1|EXOSC5|DDX6
N-TERMINAL PEPTIDYL-GLUTAMIC ACID ACETYLATION%GOBP%GO:0018002,0.781299141163663,0.981487311948134,0.49362225007179206,0.8068120071458741,6458,2,NAA10
"NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, TELOMERIC%GOBP%GO:1904908",0.714769565743317,0.971081608033886,0.5224152191894129,0.853873324179492,5908,2,ATRX|TNKS
MODULATION OF SIGNAL TRANSDUCTION IN OTHER ORGANISM%GOBP%GO:0044501,0.20230372037601002,0.716346357311758,-0.897441552712836,-1.20053492782751,1527,1,TNIP1
REGULATION OF MESODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042661,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
CELLULAR RESPONSE TO L-ARGININE%GOBP%GO:1903577,0.9393558523173601,1.0,-0.300209551119444,-0.60926636437943,5978,3,GATS|GATSL2|GATSL3
POSITIVE REGULATION OF NEUTROPHIL EXTRAVASATION%GOBP%GO:2000391,0.592724573125464,0.9461312439065841,-0.5245657568238211,-0.897241633102242,3991,2,ADAM8|FAM65B
DIHYDROBIOPTERIN METABOLIC PROCESS%GOBP%GO:0051066,0.033761419303587996,0.37600329791737297,-0.983072342302603,-1.3150858459226298,254,1,QDPR
LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS%GOBP%GO:0097021,0.6722702278083271,0.9647315640607691,-0.41110620933053904,-0.834327837334432,4278,3,WNK1|CCR7|RET
POSITIVE REGULATION OF HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:1905437,0.990604026845638,1.0,0.5050176444640491,0.670893410236043,7379,1,KMT2E
REGULATION OF NEUTROPHIL MEDIATED KILLING OF GRAM-NEGATIVE BACTERIUM%GOBP%GO:0070951,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
MESENCHYME MIGRATION%GOBP%GO:0090131,0.7520261279787109,0.9769690538700708,0.506019178563261,0.827074446201631,6216,2,ACTA2|ACTG2
NEGATIVE REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:0039536,0.6209138840070301,0.9536478716552259,-0.312834372069935,-0.8587093460400009,3532,6,NPLOC4|DHX58|UFD1L|SEC14L1|C1QBP|GPATCH3
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002689,0.611664012738854,0.9508825506493929,0.288905309175154,0.881383872780952,6145,11,NOV|KLRK1|CCL2|C5|DUSP1|DDT|SLAMF8
MODIFICATION-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0019941,0.694892105981972,0.96731875442989,0.136321863939963,0.9072441252873349,10175,383,SIRT1|HACE1|FBXO18|ARNTL|UBR4|SPSB4|SIAH2|TRIM9|TRIM3|ANAPC15|CCNB1|SGTA|CDC34|CDK1|BTRC|KIF14|PSMD11|LONP1|ANAPC5|RNF34|KLHL42|UBE2Z|PCYOX1L|PSMD13|PSMB9|MTA1|KLHL3|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|FBXL19|RNF126|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|AUP1|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|PLK1|CUL4B|TSG101|BIRC2|HERC2|MAN1B1|ZRANB1|UBXN4|VPS37A|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|ANKZF1|PSMC6|ANAPC10|BAG6|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|UBA6|KCTD2|FBXO11|MDM2|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|CBL
REGULATION OF TYPE III INTERFERON PRODUCTION%GOBP%GO:0034344,0.6466674730857629,0.96344123684964,0.549545078577337,0.898216334048218,5345,2,DDX58|IFIH1
VITAMIN A IMPORT%GOBP%GO:0071939,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
KETONE BODY BIOSYNTHETIC PROCESS%GOBP%GO:0046951,0.774326032013479,0.980173768720877,0.286960000493777,0.746896590955694,7352,7,BDH2|HMGCLL1|HMGCL|AACS
REGULATION OF MITOTIC COHESIN LOADING%GOBP%GO:1905405,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
"CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002294",0.9288172043010748,1.0,-0.16044665225361998,-0.6398755833270551,4318,15,RORC|GPR183|BATF|IL6|FOXP1|STAT3
"NEUROTRANSMITTER RECEPTOR TRANSPORT, ENDOSOME TO PLASMA MEMBRANE%GOBP%GO:0099639",0.538134669862715,0.9267937050329059,0.40931399921581296,0.9434080908706359,4938,5,LRRC7|ARHGAP44|SCRIB
OSSIFICATION%GOBP%GO:0001503,0.942748091603053,1.0,-0.097794041872696,-0.710639121629838,1975,97,EIF2AK3|LIMD1|MYBBP1A|RHOA|COL6A1|SEMA7A|SBDS|SNAI1|IGF1|RSL1D1|ACP5|RYR1|DDX21|HNRNPC|CLEC3B|WNT3|RRAS2|TWIST1|TUFT1
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903322,0.0139165009940358,0.256136946817111,-0.20229598414592198,-1.49813635189322,27,104,TRAF6|NDFIP2|UBE2N|RNF20|AMER1|NDNL2|MUL1|SENP2|DCUN1D5|BMI1|UBE2D1|FBXW7|PTTG1IP|CDK9|MAGEA2|ARRDC3|ARRB2|PRICKLE1|WDR48|HDAC4|DCUN1D3|SPHK1|STUB1|UBE2I|BCL10|TANK|GLTSCR2|RAB1A|TNIP1|RIPK2|SMAD7|ADRB2|COMMD1|UBE2L3|TSPYL5|PARK2|HSPBP1|RASD2|CAV1|FKBP1A|TRIB3|UBB
POSITIVE REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051024,0.0270613875771885,0.339785941813865,-0.583191097751544,-1.70119430597682,148,7,GPI|IL6|VAMP3|TNFRSF4
PEPTIDYL-ARGININE OMEGA-N-METHYLATION%GOBP%GO:0035247,0.8319642300093579,0.9879179006160809,0.25649708870700894,0.699279877750859,8000,8,PRMT9|PRMT1|CARM1|PRMT7|NDUFAF7
MACROMOLECULE METHYLATION%GOBP%GO:0043414,0.788432267884323,0.9819233677232551,-0.107643312750331,-0.8628519527003442,1035,156,METTL1|CBLL1|METTL16|DPY30|METTL21A|ZC3H13|NSUN5|PRMT6|TRMT12|METTL10|TRMT61B|GSPT1|WDR82|NSUN3|RAB6A|TRMT112|METTL12|MTRR|WBSCR22|RBM15B|PLD6|MOV10L1|DYDC2|NSUN2|PRMT3|COPRS|ASH2L|SNRPB|ETF1|RBM15|RNMTL1|TDRKH|TRMT6|EMG1|HENMT1|SETD7|GATAD2A|TRDMT1|METTL21B
REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072215,0.6818272292993629,0.9653437761269,0.270325588041959,0.82470140261687,6850,11,BASP1|BMP4
RESPONSE TO HOST%GOBP%GO:0075136,0.0622427136505846,0.48645662140978296,-0.673688854574533,-1.54934362698993,377,4,TGFB1|SMAD3|SLC25A6|EIF2AK2
NEGATIVE REGULATION OF TYPE I HYPERSENSITIVITY%GOBP%GO:0001811,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:1901509,0.992919479664087,1.0,-0.21176607885471102,-0.487017741882346,6029,4,FOXP1
ETHER METABOLIC PROCESS%GOBP%GO:0018904,0.513298408220834,0.919594865701561,0.325533926177361,0.9607347183339859,5094,10,TMEM86A|EPHX1|FAR1|GNPAT
DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT%GOBP%GO:0060600,0.127763802462598,0.6076669536424699,-0.933833259814733,-1.24921722399157,964,1,CTSH
CELLULAR RESPONSE TO X-RAY%GOBP%GO:0071481,0.947918936587492,1.0,0.25232377416841,0.581568894603047,8699,5,NIPBL|ATM|NUCKS1
CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098655,0.32203866432337397,0.822751772025005,0.17030497655828403,1.08549226407042,4580,242,KCNK2|RYR2|KCNN2|SCN1A|KCNK6|KCNH8|CACNA1G|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|NDUFS7|SLC25A29|KCNQ1|NOL3|RHBG|SLC9A5|SLC9A7|SLC36A1|SLC8A3|ATP1B3|F2R|KCNH1|SLC39A3|ATP5G1|LRRC55|PKD2|SLC25A19|KCNC3|KCNC1|IBTK|KCND1|KCNB2|ATP2A1|HCN3|ATP5D|NNT|CACNA1H|CACNA2D1|KCNJ11|MRS2|KCNH2|MT-ATP8|CCR5|CACNA1D|CCL21|MCOLN1|UCP3|NALCN|SLC39A7|SLC46A1|SLC40A1|GRIN1|CCL19|TRPM7|ASIC1|ATP2A2|TCIRG1
REGULATION OF COHESIN LOADING%GOBP%GO:0071922,0.0191762911309654,0.289233658852384,0.7136953143900829,1.6449619004041498,175,5,HDAC8|RB1|NIPBL|CDCA5
NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009163,0.6369327073552429,0.959271399361425,0.22378074949217003,0.8703288245275059,6918,23,IMPDH1|TK1|CAD|CTPS2|UCKL1|DCK|UMPS|UCK1
NEGATIVE REGULATION OF NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:1902842,0.6566244820248629,0.9643779777660141,0.40792584638032503,0.8644338355870359,5862,4,SIAH2|NTN1
MESONEPHRIC EPITHELIUM DEVELOPMENT%GOBP%GO:0072163,0.6046357615894039,0.9508825506493929,0.24351557120799103,0.8900866707046551,6390,19,CITED1|BMP4|PKD2|ROBO2
POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0005976,0.176889714993804,0.6812722255842769,-0.20935343368313897,-1.2203448730930901,570,44,PYGB|B3GNT5|B3GNT7|CSGALNACT1|PER2|B3GNT8|B3GNT2|NR1D1
"BASE-EXCISION REPAIR, DNA LIGATION%GOBP%GO:0006288",0.511635984716916,0.918404893008545,0.5118010367265909,0.9728799313690659,4418,3,XRCC1|POLB|LIG3
LUNG EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060487,0.0903377847604085,0.560121322881739,-0.7211054908410791,-1.46346216867693,574,3,NFIB|ASCL1
MISMATCH REPAIR INVOLVED IN MAINTENANCE OF FIDELITY INVOLVED IN DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0070716,0.559645174103005,0.936434965680841,-0.714049404499338,-0.9552056595825942,4226,1,MCM9
SEXUAL REPRODUCTION%GOBP%GO:0019953,0.288790328349667,0.798187790155662,0.17846494389418502,1.1097946230287399,4036,201,TAC1|HSPA2|INSL3|CATSPERG|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|ZCCHC11|HERC4|CCT6B|CABYR|CDK1|GGT1|PYGO1|RHOXF1|CELF1|USP9Y|PIWIL4|OVGP1|TRIM27|MTL5|TSSK3|SPATA25|DEAF1|JAG2|PCSK4|DZIP1|WDR33|CASC5|DAZAP1|TYRO3|TUBGCP3|YTHDC2|ZNF830|FUT10|PTTG1|ZP3|KIT|DNAH1|BMPR1B|PIM2|CLOCK|CXADR|METTL3|REC8|SRPK1|STX2|FANCF|MYBL1|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|KMT2D|TEX14|MYCBP|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|ABHD2|AZIN2|ZNF35
REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902563,0.112293956043956,0.587583003489402,-0.5483123759099929,-1.38801636980154,653,5,CD300A|SYK|ITGB2|ITGAM|FCGR2B
NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070229,0.278308321964529,0.788548181360919,0.35348137384565503,1.1711936383358899,2855,14,CD27|BMP4|BLM|PRKCQ|CCL5|AURKB
REGULATION OF EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:1902954,0.30676182411999503,0.809874675097403,0.683926109732561,1.11785843780855,2535,2,DNAJC13|SORL1
NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS FROM ASPARTATE%GOBP%GO:0019355,0.1057344854674,0.578674426247723,-0.705390123917884,-1.43156829843036,672,3,NMNAT3|NMNAT2
CELLULAR RESPONSE TO OXYGEN-GLUCOSE DEPRIVATION%GOBP%GO:0090650,0.9263336155800171,1.0,0.417369727047146,0.682179353041437,7657,2,IREB2|TSC1
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0032057,0.0712991931500082,0.514511211182091,-0.660177576793691,-1.51827051069879,432,4,EIF2AK4|ATF4|EIF2S1|EIF2AK3
TRNA AMINOACYLATION FOR PROTEIN TRANSLATION%GOBP%GO:0006418,0.646734130634775,0.96344123684964,-0.15340474337561902,-0.8868344827994891,2108,43,QARS|DARS|AARS|CARS|WARS|NARS|HARS|FARS2|GARS|AIMP2|YARS|KARS|SARS
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010656,0.495900039047247,0.911498395855878,-0.29494551053784696,-0.9521105387171359,2539,9,IGF1|BAG3|ADCYAP1
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C%GOBP%GO:0008635,0.9743341924398621,1.0,0.21367163188990002,0.525494260357954,9072,6,APAF1|CASP9|CYCS|DIABLO
NEURAL CREST CELL DEVELOPMENT%GOBP%GO:0014032,0.969759627810804,1.0,0.12117764586241199,0.54980408839579,11255,40,SEMA3D|SEMA5A|SEMA3E|SEMA4G|HAND2|SEMA6A|SEMA4C|NRG1|FN1|KLHL12|SEMA4A|SOX10|TAPT1|PHOX2B|JAG1|SEMA4F|SEMA5B|SEMA3B|SEMA3C|SEMA4D|ANXA6
GUANINE DEGLYCATION%GOBP%GO:0106044,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
POSITIVE REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0010940,0.6445525066574039,0.9625632908696992,0.46552912602165797,0.884921896741287,5566,3,RIPK1|RIPK3|HEBP2
MHC PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002396,0.727943760984183,0.972554563883587,-0.286967072968948,-0.787705346869909,4141,6,HLA-DMB|HLA-DRB1|HLA-DRA|HLA-DMA|CALR|TAPBP
PIGMENT ACCUMULATION%GOBP%GO:0043476,0.44416243654822296,0.88124764725951,-0.30782811747142697,-0.99369674833682,2274,9,AP1M1|BLOC1S5|BLOC1S6|BLOC1S3
POSITIVE REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045086,0.659620832425365,0.9643779777660141,0.367904029431866,0.8479642491947329,6053,5,GLMN|PTPRC|CD4|CD86|IL1B
NEURAL PLATE REGIONALIZATION%GOBP%GO:0060897,0.285503355704698,0.794258537514783,0.859947066607852,1.14240131302995,2126,1,CELSR2
REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904779,0.213750985027581,0.7299867877356379,-0.360809799505609,-1.22067355773267,1084,10,MARK4|NSFL1C|BICD1
MUSCLE FILAMENT SLIDING%GOBP%GO:0030049,0.407206782854451,0.8669681570015609,-0.22513044505175897,-1.0224965521975,1728,21,VIM|TNNT2|TMOD1|MYL4|DES|TPM3
REGULATION OF NEUTROPHIL EXTRAVASATION%GOBP%GO:2000389,0.592724573125464,0.9461312439065841,-0.5245657568238211,-0.897241633102242,3991,2,ADAM8|FAM65B
POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032106,0.254563780938515,0.764845931807465,0.557168036200767,1.18069229217331,2272,4,GHRL|NPY|CYP27B1|SNW1
POSITIVE REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046607,0.753041489029843,0.9769690538700708,0.282442363393203,0.770013657234409,7241,8,CENPJ|CEP295
MITOTIC CYTOKINESIS%GOBP%GO:0000281,0.25473752116764803,0.7652291108393641,0.223649203774415,1.1642669934570702,3158,71,SEPT12|UNC119|SEPT11|ECT2|KIF4A|KIF23|ANLN|APC|CENPA|NUSAP1|CEP55|ESPL1|INCENP|SEPT2|CNTROB|ANK3|KIF20A|STMN1|SON|PLK1|RACGAP1|SEPT3|BRCA2|CUL7|SEPT5|CIT|KLHDC8B
UDP-GLUCOSE METABOLIC PROCESS%GOBP%GO:0006011,0.582560879811469,0.943680456638918,-0.441617184908793,-0.8962489557496031,3707,3,UGDH
NEGATIVE REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904743,0.7046770601336301,0.968941691852291,-0.477639922801213,-0.816977507193484,4745,2,TNKS|ERCC4
METANEPHRIC DISTAL CONVOLUTED TUBULE DEVELOPMENT%GOBP%GO:0072221,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032459,0.0274979580724204,0.3403540236452571,-0.29440192985767305,-1.57468834740621,100,33,SNX9|GBA|MIEF2|RIOK3|BAX|MMP1|CLU|TRABD2A|HRK|SH3GLB1|TCL1A|BID|RHOC|TP53|BMF|PEX5|BIK|BCL2L11|PMAIP1
PROTEIN-CONTAINING COMPLEX REMODELING%GOBP%GO:0034367,0.275730379988543,0.7884684708511421,0.33035040812937,1.16509818273559,2887,17,LPL|ABCA5|AGTR1|SCARB1|CETP|APOE|APOC1|APOM|LCAT
INTERACTION WITH OTHER ORGANISM VIA SECRETED SUBSTANCE INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052047,0.560671140939597,0.936434965680841,0.7233127481252758,0.9608887166149591,4176,1,FN1
SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0039692,0.7761154508142459,0.9807147856657049,-0.608623731804146,-0.814174522816422,5861,1,SMARCB1
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901292,0.0108695652173913,0.227160168781543,-0.23383317006322,-1.5791679304207098,27,72,NUDT7|SMUG1|LDHA|ENTPD4|PFKL|DERA|GPI|NUDT4|PKM|PNP|ENO1|HPRT1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|PDE9A|ALDOA|ITPA|NT5E|NEIL2|PDE4D|PGAM2
CELLULAR RESPONSE TO INTERFERON-BETA%GOBP%GO:0035458,0.83628841607565,0.98866024827725,-0.20982905456963502,-0.7098830988187049,4244,10,UBE2K
REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045661,0.22962788506829998,0.743365122901021,-0.261095785793646,-1.1858437924996001,974,21,TGFB1|HIF1AN|FAM65B|DLL1|BTG1|NOTCH1|AKIRIN1|PRICKLE1|BOC|IGFBP3|EID2B|PLCB1|RBM24
REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033688,0.658996683250415,0.9643779777660141,-0.23081807812581898,-0.8408934119588589,3178,12,PLXNB1|BMP2|HPSE|SFRP1|TMEM119|ATRAID|EIF2AK2|NELL1|RHOA|GREM1
ACETYL-COA METABOLIC PROCESS%GOBP%GO:0006084,0.7340080198586979,0.9734087938149171,0.223464978209727,0.788128707003869,7687,17,MVD|PDHX|PDHA1|ACACA|DLD|ACSS1
POSITIVE REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045726,0.274765100671141,0.7884684708511421,0.865846934274371,1.15023902401317,2046,1,TGFB2
CELLULAR RESPONSE TO CALORIC RESTRICTION%GOBP%GO:0061433,0.9683569442605591,1.0,-0.514666960741067,-0.688485685447408,7313,1,SIRT2
DOLICHYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046465,0.0478096040438079,0.43054641249021397,0.594467482016131,1.54727395800061,453,7,MVD|SRD5A3|DPAGT1|DOLPP1
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:0048706,0.545495293590318,0.930420772651609,0.226379396041656,0.937739690093719,6084,29,HOXD3|HOXB3|HOXD4|HOXC4|MTHFD1|DEAF1
POSITIVE REGULATION OF PROTEIN BINDING%GOBP%GO:0032092,0.0237226277372263,0.32397355287938,-0.23460706992865102,-1.51908599568778,64,63,ABL1|NRP1|TCF7L2|NMD3|AMFR|MMP9|PPP2CA|PPP2CB|RIPK2|LGALS3|STK4|GNL3L|B2M|RALB|PARK2|CAV1|FKBP1A|TRIB3
REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070562,0.48394533179647603,0.9064456896937672,-0.41884961120608794,-0.9632666050252541,2938,4,CYP27B1|SNW1|KANK2|SNAI2
NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002713,0.9035726285138309,1.0,0.305569707373008,0.647531399462698,8067,4,THOC1|NDFIP1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905341,0.803624161073826,0.984522820758988,0.599139832377592,0.795930537790681,5986,1,CDT1
GABAERGIC NEURON DIFFERENTIATION%GOBP%GO:0097154,0.0189362753169768,0.286396032442422,-0.751630641678136,-1.72859345471854,114,4,DRD2|ASCL1
"POSITIVE REGULATION OF RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:1905281",0.0791738382099828,0.532203813468543,-0.959142037935598,-1.28307354814202,597,1,PARK2
ETHER LIPID METABOLIC PROCESS%GOBP%GO:0046485,0.7459706769262759,0.9749763305090959,0.284276592351284,0.7750142574674951,7173,8,TMEM86A|FAR1|GNPAT
CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086064,0.8669849931787181,0.993065231963537,0.200839617250059,0.665444064251578,8896,14,RYR2|GJA1|GJC3|SLC8A1
EXIT FROM MITOSIS%GOBP%GO:0010458,0.7522802653399671,0.9769690538700708,-0.21274482758620702,-0.7750507473164591,3628,12,PPP2R2D|UBE2C|CLASP2|SIRT7|UBE2S|EPS8|SPAST|CHMP7|CHMP2A|CLASP1|CTDP1|CHMP4B
RESPONSE TO JASMONIC ACID%GOBP%GO:0009753,0.859905059627185,0.9916689277956879,0.374680811343878,0.7122288074228109,7426,3,AKR1C1|AKR1C3|AKR1C2
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903828,0.124061635717108,0.607607158836689,-0.185826643460921,-1.2634251635528002,313,74,GSK3B|DERL2|TMBIM1|TTBK2|FAM65B|POLR1A|ERLEC1|GAS6|PARK7|MFHAS1|MAP1A|PPP2R5A|OTUD7B|GPM6B|INSIG1|FLCN|PICALM|PPFIA1|SIN3A|NEDD4L|UBE2J1|OS9|BAG4|INPP5K|APOD|CHP1|BCL2L1|LEPROT|COMMD1|RANGAP1|SIAH3|CABP1|RHOQ|NSFL1C
REGULATION OF DNA REPAIR%GOBP%GO:0006282,0.561431870669746,0.9365627440210609,0.16868569944743697,0.9458488553301071,7292,104,SIRT1|FBXO18|MMS19|SIRT6|NPAS2|BLM|DHX9|FAM178A|PARP1|TMEM161A|POLQ|RAD51|RTEL1-TNFRSF6B|H2AFX|RMI2|TIMELESS|PARPBP|BRCC3|RAD51AP1|WRAP53|KDM1A|NUDT16L1|ANKRD32|RIF1|C5orf45|CHEK1|RECQL5|XRCC1|SPIRE2|SPIRE1|FOXM1|SPIDR|FMN2|FIGN|WRNIP1|UIMC1|BRCA1|FAM35A|BRE|PARP9|EYA3|PARG|RAD52|UBR5|RNF8|SETMAR|FAM168A|MAGEF1|UBE2V2|MGMT|USP1|TP53BP1|WAS|DDX11|AUNIP
POSITIVE REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903039,0.45581691036236505,0.88900512246363,-0.12813532177503598,-1.00330552220864,716,133,IL6ST|RELA|TRAF6|VCAM1|RUNX3|CD44|CD86|IL6R|PYCARD|THY1|NCK2|PTPN6|CD274|ICOSLG|IL1B|RARA|FAM49B|IRAK1|SIRPA|MAP3K8|LGALS9|GRB2|VAV1|RPS3|FYN|RHOA|RUNX1|IL6|PNP|LYN|CD276|YES1|IGF1|ETS1|CDC42|TFRC|NLRP3|SOCS5|BCL6|NKAP|DUSP10|CBFB|RAC1|IGF2|PIK3R1|TNF|CAV1|PAK2
POSITIVE REGULATION OF CELL CYCLE PROCESS%GOBP%GO:0090068,0.131983689820445,0.616407751583866,0.198571116885243,1.23482602801095,1844,201,BTG2|EDN1|RRP8|CENPJ|CCNB1|PIDD1|TPR|CDC7|CDK1|INS|KIF14|E2F8|XRCC3|ANAPC5|SPAG5|PKD2|ANKRD17|CEP295|ECT2|LSM11|ATAD5|KIF20B|NUMA1|CSPP1|CDC25C|MUC1|MAP10|FAM178A|CDC45|KIF23|DTL|CDK10|E2F7|EZH2|DLGAP5|FEN1|CCNE1|GEN1|NDC80|PAGR1|CRLF3|DBF4B|GPSM2|NUSAP1|FBXO5|RB1|INO80|GTSE1|ESPL1|AURKB|CDC6|RAD51C|NIPBL|CENPV|CDCA5|CHEK2|PRMT1|RACGAP1|PKN2|CARM1|PEBP1|AURKA|SVIL|CDC73|ARID3A|UBE2C|ANKRD32|DYNC1H1|GATA6|TNKS1BP1|CNOT3|CIT|E2F1
"REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032228",0.5003904724716911,0.9144253281295329,-0.29390997352162396,-0.948767732432071,2562,9,NPAS4|BAIAP3|CNTNAP4|NLGN2|SYN3|USP46|STXBP1|HAP1|DRD2
LATERAL GENICULATE NUCLEUS DEVELOPMENT%GOBP%GO:0021771,0.407520190652721,0.867015886388254,-0.794938244375827,-1.0634131269654201,3077,1,CHRNB2
SNORNA METABOLIC PROCESS%GOBP%GO:0016074,0.00570801317233809,0.17352934538701598,-0.47775053369898496,-1.95654900289949,25,16,FBL|PARN|NAF1|CPSF3|EXOSC6|RNF113A|GAR1|EXOSC4|PAPD7|EXOSC5
PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0046337,0.912384080370943,1.0,0.18160534445799897,0.6157532646093411,9444,15,NAPEPLD|CEPT1|CHKB|ETNK1|PNPLA8|CHKA|ETNK2|SLC27A1
RIPOPTOSOME ASSEMBLY%GOBP%GO:0097343,0.520671140939597,0.9249983657048559,0.7437141596824001,0.987991081697101,3878,1,RIPK1
HEME METABOLIC PROCESS%GOBP%GO:0042168,0.9078191587919209,1.0,0.16554082087432198,0.633982943581344,9798,22,HPX|ALAS1|BDH2|CPOX|ATPIF1|UROD|IREB2|UROS|ALAD|HMBS
TELOMERE MAINTENANCE%GOBP%GO:0000723,0.558650451157317,0.936434965680841,0.172825453310643,0.94336586603098,7119,90,XRCC3|ATR|BLM|EXO1|RFC4|DNA2|DCLRE1A|ORAOV1|POLD1|TERT|PARP1|FEN1|POLD3|POLA2|SLX1B|HIST1H4I|RAD51|RTEL1-TNFRSF6B|DCLRE1C|SLX4|WRAP53|TEN1|TNKS1BP1|TELO2|CTC1|PRIM2|RIF1|PRKDC|ACD|RFC3|SMC6|RFC5|ATM
REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902186,0.18949247640907899,0.6973744226246139,-0.24614041581569898,-1.2265661943106498,742,27,TRIM8|TRIM13|PML|VPS4A|VPS4B|TRIM35|TRIM25|CAV2|CHMP4B|PC
MEIOTIC CELL CYCLE%GOBP%GO:0051321,7.748334108166751e-05,0.0784645998831315,0.38019622896530003,2.10561261475758,0,97,HSPA2|MUS81|SYCP2|EME2|MLH3|CCNA1|NCAPD3|RAD54B|BLM|RAD54L|C11orf80|EXO1|BRIP1|PDIK1L|NUF2|BUB1|TOP2A|TUBGCP3|CCNE1|PKMYT1|PTTG1|BUB1B|ESPL1|MSH6|RAD51C|RAD51|PIM2|NCAPH2|MND1|TUBG2|FANCM|REC8|TUBGCP6|MYBL1|SLX4|TUBGCP2|EME1|ING2|RMI1|STRA13|SPDYA|CCNE2|BAG6|STAG3|XRCC2|TOP2B|TEX14|P3H4|TUBGCP4|UBR2|SPIRE2|SPIRE1|SGOL1|SMC3|RAD1|FMN2|CDK2|ATM
U5 SNRNA 3'-END PROCESSING%GOBP%GO:0034476,0.11547525530243499,0.593539945084925,-0.694441380831587,-1.40934814963816,734,3,EXOSC7|EXOSC8|EXOSC9
PYRUVATE TRANSPORT%GOBP%GO:0006848,0.39157114738914,0.861425315078579,0.5569465891858921,1.05869687746034,3381,3,SLC16A7|MPC2|MPC1
POSITIVE REGULATION OF SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:2000755,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
NEGATIVE REGULATION OF FERTILIZATION%GOBP%GO:0060467,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
ANION TRANSPORT%GOBP%GO:0006820,0.51740561742663,0.9231373362724822,0.153377943406143,0.984310179043897,7386,257,ABCC3|SLC16A9|SLC1A2|SLC12A2|ATP10A|SLC27A2|CEACAM1|SLC25A29|ATP11C|SLC36A1|SLC25A22|SLMO1|PIDD1|SLC35A1|STARD10|ANO4|SLC16A13|MFSD2A|SLC35B1|ABCA7|SLC25A19|ABCB4|SLC43A1|ANO9|HBB|GLS|SCARB1|SLC16A14|HBA2|EPRS|GLS2|ATP10D|LRRC8D|STARD5|SLC16A2|ANO8|SLC6A17|SLC6A15|SLC37A2|SLC26A2|SLC13A3|TTYH1|SLC25A10|AKR1C1|CETP|SLC25A42|OSBPL5|XPR1|SLC6A9|SLC7A9|HBA1|CPT1B|SLC15A4|PQLC2|SLC46A1|APOE|ATP8B3|SLC25A1|ACACA|SLC38A6|PRELID2|SLC16A7
RESPONSE TO RETINOIC ACID%GOBP%GO:0032526,0.0988604866030182,0.570215774831708,-0.226223258187376,-1.32955079355827,320,45,ADNP2|TESC|RARA|PTK2B|RET|RXRA|PTK7|PPARG|LYN|WNT6|WNT11|CTSH|TWF2|WNT3|ASCL1|AQP1
SYNTHESIS OF RNA PRIMER INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902318,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
CELLULAR RESPONSE TO OSMOTIC STRESS%GOBP%GO:0071470,0.749166746024188,0.9749763305090959,0.216599394157725,0.7769861851820951,7866,18,AKR1B1|STK39|PKD2|LRRC8D
AMPA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097113,0.152413209144793,0.648319130045528,0.763992280121312,1.2487243937626,1259,2,APOE|DLG4
AXONAL TRANSPORT%GOBP%GO:0098930,0.280258700338774,0.788916642629372,-0.19159674801785,-1.1260451750691398,909,45,HIF1A|BLOC1S1|HSPB1|SOD1|RAB21|BLOC1S5|BLOC1S4|HAP1|AP3S2|FMR1|BLOC1S6|KIF3B|TRAK1|BLOC1S3|TMEM108
PYRIMIDINE NUCLEOTIDE SALVAGE%GOBP%GO:0032262,0.541610738255034,0.928807195199472,0.732245258050287,0.9727551575428159,4034,1,HDDC2
ZINC ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0071578,0.790521978021978,0.9819233677232551,-0.294341495698213,-0.7451059510793409,4603,5,SLC39A10|SLC39A14|SLC39A6|SLC39A8|SLC39A4
GLUTAMATE CATABOLIC PROCESS%GOBP%GO:0006538,0.0820109976433622,0.539604343254557,-0.7309275801594379,-1.48339580712145,521,3,GLUL
REPRODUCTIVE SYSTEM DEVELOPMENT%GOBP%GO:0061458,0.440392374021043,0.879896414106183,0.19009944536078,1.02005347424051,5566,82,CITED1|TBX3|GHRL|WNT4|INHA|BASP1|E2F8|PKD2|DNAJC19|EIF2B5|ROBO2|TGFB2|E2F7|ZNF830|LEF1|KIT|BMPR1B|NIPBL|EIF2B4|HEY2|FGF9|FANCF|STOX2|ING2|NUP107|BRCA2|CUL7|CEBPB|GATA6|CHD7|FGFR2|WNT2B
NEGATIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:2000134,0.5818368799936711,0.943249589738259,0.172294250940774,0.924512688241978,7354,82,BTG2|CCNB1|PIDD1|CDK1|E2F8|PKD2|WEE1|CDK2AP2|CDC25C|MUC1|E2F7|DACT1|RB1|GTSE1|CCL2|RPS27L|CHEK2|PRMT1|CARM1|AURKA|CDC73|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|FHL1|CASP2|CDK2|ATM|RFWD3|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|KLF4|RBL2|CCND1|SLFN11|CNOT6|E2F4
REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000547,0.224962371193702,0.7390599693491929,0.633364677114204,1.20395962373095,1942,3,CCL21|CCL19|CCR7
KETONE BODY CATABOLIC PROCESS%GOBP%GO:0046952,0.0587588373919874,0.47468541758473404,-0.7530067483215881,-1.52820482290563,373,3,BDH1|OXCT1
CELLULAR RESPONSE TO VIRUS%GOBP%GO:0098586,0.998391674550615,1.0,0.106901633936439,0.390741828012721,10552,19,MAPK11|CCL19|LGALS8|GBF1|CHUK|MAPK14|DDX58|IFIH1|ZC3H12A|RRP1B
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000138,0.6340926944226241,0.9587518590644641,-0.42433802173638,-0.8611814074776751,4035,3,PIM1|RBPJ
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904707,0.10018050541516198,0.570947005522165,-0.31665986843341903,-1.3887033729120202,443,19,MMP2|MFN2|FGF2|MMP9|HTR1B|MEF2D|IGF1|FOXJ2|JUN
AMP SALVAGE%GOBP%GO:0044209,0.5417714815305179,0.928807195199472,-0.724415527128364,-0.96907273788387,4091,1,APRT
DIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072505,0.142121178183447,0.63219683908033,0.619688327524684,1.3131787617380901,1268,4,FGFR4|XPR1|TFAP2B
HISTAMINE CATABOLIC PROCESS%GOBP%GO:0001695,0.8885211174367801,0.997300970905927,-0.553981032201147,-0.741077317515546,6710,1,HNMT
COLLAGEN METABOLIC PROCESS%GOBP%GO:0032963,0.743004618310242,0.974505008828563,-0.15415499604232902,-0.816110513983942,2734,32,HIF1A|CTSD|MMP1|FURIN|VPS33B|CTSL|CTSK|MMP2|MMP9|COL15A1|MMP12
POSITIVE REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033133,0.843474053465586,0.991298302704726,0.46614575971251704,0.761902438476984,6972,2,BAD|DUSP12
MACROPHAGE PROLIFERATION%GOBP%GO:0061517,0.11135857461024501,0.5855068018166539,-0.7981251723187209,-1.36515036240112,749,2,CLU|CX3CL1
POSITIVE REGULATION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0052509,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
PYRIMIDINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009197,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
METANEPHRIC NEPHRON TUBULE FORMATION%GOBP%GO:0072289,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS%GOBP%GO:0002683,0.9786634744032109,1.0,0.10005609202344098,0.634626986253964,13897,232,CARTPT|CD47|HOXA5|NOV|PAG1|CEACAM1|CDK6|GLMN|INHA|WDR61|HES1|BMP4|INS|MEIS2|TRIM27|TKFC|THOC1|KLRK1|MIA3|MARCH7|TGFB2|TMEM178A|LOXL3|GBP1|TYRO3|FBN1|CCL21|F2RL1|TRAFD1|CD200|HIST1H4I|DLG5|DPF2|TIGIT|CUEDC2|ZNF675|RPS19|CCL2|BTN2A2|CD55|C5|NLRC3|MEIS1|CACTIN|PRMT1|N4BP2L2|ERBB2IP|FSTL3|LDLR|CDC73|FCRL3|TNFAIP8L2|PTPRS|VIMP|PLA2G2D|PTPRJ|CEBPB|SOCS1|FAM3A|TICAM2|PTPN22|DUSP1|NPLOC4|LRRC17|CTLA4|THBS1|TARBP2|ATM|PHPT1|DHX58|TGFB3|AKT1|MILR1|LRRC14|RC3H1|FER|BST2|DDT|SLA2|SLAMF8|TNFRSF14|TLR4|COL3A1|PARP14|XCL1|LGR4|PIBF1|MNDA|PDCD1LG2|HLA-DOB|IFIT1|LDB1|ANXA1
PROTEIN LIPIDATION%GOBP%GO:0006497,0.610825760568945,0.9508825506493929,-0.13587613307732302,-0.9238143812904909,1545,74,CLIP3|PIK3C3|ZDHHC3|PIGA|DPM1|PIGG|PIGZ|PIGY|DPM2|ZDHHC9|ZDHHC11B|MPPE1|ZDHHC7|ATG7|PIGT|PPM1A|ZDHHC4|WIPI2|GOLGA7|GLUL
SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0033299,0.655368727657884,0.9640743070248079,-0.6662439347154829,-0.8912548250761759,4949,1,M6PR
IMMUNE COMPLEX CLEARANCE BY MONOCYTES AND MACROPHAGES%GOBP%GO:0002436,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055025,0.431316254416961,0.8785877309899279,-0.23755073121068698,-0.999586154484297,1952,17,AKAP6|NOTCH1|PIM1|FGF2|IGF1|TBX20|GREM1|RBPJ
4-HYDROXYPROLINE METABOLIC PROCESS%GOBP%GO:0019471,0.615464344941957,0.951600300570769,-0.239141455360093,-0.871216310140754,2968,12,ALDH4A1|P4HB|EGLN3
OSTEOBLAST DIFFERENTIATION%GOBP%GO:0001649,0.976297507151614,1.0,0.110071383786364,0.556549612442665,11944,62,VCAN|HSD17B4|TNC|BMP4|DHX9|BGLAP|DNAJC13|MEN1|ITGA11|LEF1|NF1|RDH14|CLTC|RPS15|CAT|LRRC17|UFL1|PSMC2
PROLINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905647,0.803221476510067,0.984522820758988,0.5993052492280551,0.796150286696752,5983,1,SLC36A4
CARDIAC RIGHT VENTRICLE FORMATION%GOBP%GO:0003219,0.454388984509467,0.888760596723902,-0.771890163211292,-1.03258100606152,3431,1,HAND1
NEGATIVE REGULATION OF LIPID BINDING%GOBP%GO:1900131,0.124718654839137,0.607607158836689,-0.9357631230701371,-1.25179886090936,941,1,PEX19
CELLULAR RESPONSE TO ABIOTIC STIMULUS%GOBP%GO:0071214,0.9208794387792,1.0,0.11665458843118699,0.713319608873323,12732,178,PTPRK|SIRT1|INTS7|AKR1B1|STK39|PIEZO2|LIG4|ATR|PKD2|BLM|PDE2A|ECT2|LRRC8D|USP47|TMEM150C|ST20|DDB2|RAD9A|POLD1|PARP1|TMEM161A|GEN1|MCOLN1|INO80|AURKB|DDB1|RAD51|ZBTB1|CLOCK|FAS|HRAS|NIPBL|STK11|ASIC1|METTL3|SERPINB6|PIEZO1|RAD51AP1|MC1R|MFAP4|CUL4B|BAD|CNGB1|CNN2|KDM1A|CASP9|MAP3K1|MYLK|CARD16|MAPK13|TNKS1BP1
POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060148,0.276012891344383,0.7884684708511421,-0.25449420289047303,-1.1355290811233,1198,20,LIMD1|EIF4G1|FMR1|AGO2|STAT3|TP53|MAP2K1
NEGATIVE REGULATION OF DNA METHYLATION%GOBP%GO:1905642,0.7694955646762879,0.9792236089291529,-0.6113806793118659,-0.817862575556123,5811,1,KMT2A
LEUKOTRIENE SIGNALING PATHWAY%GOBP%GO:0061737,0.20201342281879198,0.716083967316356,0.9009704455227171,1.1968990417356598,1504,1,RGS1
REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050926,0.0787096774193548,0.532203813468543,-0.363232520969432,-1.4486037444475799,365,15,CXCL8|SCG2|PGF|CDH13|ANGPT2
SEMICIRCULAR CANAL MORPHOGENESIS%GOBP%GO:0048752,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000566",0.860282108389013,0.9916689277956879,-0.4095947063689,-0.7005898087546989,5793,2,XCL1|HLA-E
FERROUS IRON TRANSMEMBRANE TRANSPORT%GOBP%GO:1903874,0.398389261744966,0.8638522656500329,0.808226731363035,1.07369315506495,2967,1,SLC40A1
VENTRICULAR SEPTUM MORPHOGENESIS%GOBP%GO:0060412,0.694072657743786,0.96731875442989,0.20757785694848999,0.827167899800047,7622,25,HES1|BMP4|PROX1|ROBO2|TGFB2|HEYL|HEY2
POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:2000273,0.028438124861142004,0.34731842612490604,-0.382717557073949,-1.64636589890569,127,18,FBXW7|ADRA2C|BUD31|ARC|ADAM17|ADRB2|RELN|ADRA2A|GREM1|EPHB2
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY%GOBP%GO:0033108,0.92706065318818,1.0,0.120673190351158,0.664302312427942,11921,94,COX20|NDUFA7|NDUFS7|NDUFB11|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|TAZ|NDUFA11|SDHAF3|COX16|NDUFS8|NDUFB2|UQCC3|BCS1L|MT-ND2|NDUFV1|IMMP2L|NDUFS3|NDUFB7|NDUFA12|PET100|OXA1L|SURF1|ECSIT|AARS2|TIMM21|ACAD9|NDUFB1|UQCR10|TMEM126B|NDUFB3|NDUFA1|COX19|NDUFB6|SCO2|NDUFAF7|MT-ND3|FOXRED1|C17orf89|UQCRB
REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903897,0.017435524881947,0.278447181841778,-0.606880925207294,-1.77029858368729,95,7,PPP1R15B|HSPA5|BOK|PTPN1|TMEM33
"CD4-POSITIVE, ALPHA-BETA T CELL CYTOKINE PRODUCTION%GOBP%GO:0035743",0.9767751300350791,1.0,0.34871751511973104,0.5699691986326639,8074,2,CD55|DENND1B
POSITIVE REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0090218,0.8096541428215981,0.984682960940884,-0.156581272084806,-0.759618248009928,3253,25,CCL21|KIT|AMBRA1|CCL19|IRS1|DGKZ|PTK2|PRKD1|PDGFRA|TEK|PIK3R4|PDGFB|AGAP2|CCR7|ATG14|PDGFRB|TGFB1|CD81|TNFAIP8L3|EEF1A2|PTK2B|FGR|FGF2|EPHA8|FLT1
NADP BIOSYNTHETIC PROCESS%GOBP%GO:0006741,0.278389261744966,0.7885559551814421,0.8643030436700491,1.14818803422317,2073,1,ME1
ENKEPHALIN PROCESSING%GOBP%GO:0034230,0.47186548391367705,0.898272347254494,-0.7627370974856641,-1.02033667096572,3563,1,PCSK2
REGULATION OF HEART INDUCTION BY REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090081,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:1900211,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
GLANDULAR EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002068,0.16373614066524803,0.666085538088227,0.605498923502332,1.28311005917223,1461,4,CDK6|BMP4
POSITIVE REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033184,0.9380039224231859,1.0,0.258982580959184,0.596916457144265,8608,5,KDM1A|RNF40|CTR9|RNF20|CDK9
MEIOSIS I%GOBP%GO:0007127,0.00308693475721675,0.134638908345007,0.383906276457145,1.8633574960841701,36,52,MUS81|SYCP2|EME2|MLH3|CCNA1|RAD54B|BLM|C11orf80|BRIP1|TOP2A|CCNE1|PTTG1|RAD51C|RAD51|MND1|FANCM|REC8|MYBL1|SLX4|EME1|ING2|RMI1|STRA13|CCNE2|BAG6|STAG3|TOP2B|P3H4|UBR2|FMN2|ATM
CHAPERONE-MEDIATED PROTEIN TRANSPORT%GOBP%GO:0072321,0.161485668146952,0.664367762084791,-0.36749784241874,-1.29327069376552,799,11,TIMM10|TOR1A|TIMM8B|TIMM8A|CLU|CLIP3|BAG3|PEX19
SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0007435,0.31112106618882296,0.8143712300420921,0.5318489368604601,1.12703870206482,2777,4,TGFB2|FGFR2|TGFB3
DETOXIFICATION%GOBP%GO:0098754,0.488040589514375,0.9079409787810301,-0.20719279838488397,-0.973581633516808,2019,23,NOS3|GSTM3|GSTM1|SESN2
POSITIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031945,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
COMPARTMENT PATTERN SPECIFICATION%GOBP%GO:0007386,0.0307382550335571,0.35952485149978897,0.9847265108072341,1.3081652378431599,228,1,PBX3
STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0016126,0.182227718399435,0.6875931283957409,0.295645482038179,1.2640807057913201,2062,32,TM7SF2|C14orf1|EBP|MVD|LBR|DHCR24|PPAPDC2|APOE|NSDHL|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN RENAL VESICLE FORMATION%GOBP%GO:0072036,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
PEPTIDYL-THREONINE AUTOPHOSPHORYLATION%GOBP%GO:1990443,0.22057460611677498,0.7354411217837541,-0.8888950154389059,-1.18910196433444,1665,1,CAMK2A
PEROXISOME FISSION%GOBP%GO:0016559,0.4380687093779021,0.878999860395433,-0.31940000683478803,-0.9928342903801741,2358,8,PEX19|ACOT8
NADH REGENERATION%GOBP%GO:0006735,0.00047528517110266203,0.0784645998831315,-0.4768837663179679,-2.2092786897554704,1,22,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
PEPTIDYL-LYSINE METHYLATION%GOBP%GO:0018022,0.894068153134203,0.9976191001250191,0.14110669922617902,0.674913873082254,10625,49,WDR61|EHMT1|DOT1L|OGT|EZH2|KMT2B|PAGR1|SETD8|ZNF335|PAXIP1|METTL20|SMYD2|EHMT2|KMT2D|WDR5|SETDB2|SUV39H1|TET2|EEF2KMT|SETMAR
RESPONSE TO AMINO ACID STARVATION%GOBP%GO:1990928,0.567567567567568,0.9394789091940521,-0.16456290588129097,-0.9285062251373871,1931,39,EIF2S1|IMPACT|RRAGD|RRAGC|EIF2AK3|SEH1L|SH3GLB1|C12orf66|MAPK3|CDKN1A|SESN2
REGULATION OF CREATINE TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1905407,0.0895302013422819,0.5590911253505021,0.95577856197618,1.2697091792806598,666,1,STK39
CEREBELLAR GRANULAR LAYER DEVELOPMENT%GOBP%GO:0021681,0.639076635125299,0.960516115253472,0.31693294721508697,0.8640442419872559,6145,8,KIF14|PROX1
REGULATION OF INTERLEUKIN-10 BIOSYNTHETIC PROCESS%GOBP%GO:0045074,0.23381437839269198,0.747962124891127,-0.882774591971769,-1.1809144872523,1765,1,TRIB2
REGULATION OF PROTEIN HOMOTETRAMERIZATION%GOBP%GO:1901093,0.38752783964365295,0.859991269020751,-0.622260045037875,-1.06434248092098,2609,2,PEX5
"POSTTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, TRANSLOCATION%GOBP%GO:0031204",0.947305706341851,1.0,-0.523930304367005,-0.7008775426528029,7154,1,SEC61B
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:2001251,0.28537170263789,0.794258537514783,0.204254505133251,1.13368679581403,3688,98,SIRT1|NAT10|TPR|PIF1|CENPF|NAA10|MTF2|TAF7|ASF1A|DNMT3B|BUB1|TOP2A|PARP1|SRC|CDC20|APC|PTTG1|FBXO5|BUB1B|SLX1B|ESPL1|ATAD2|RTEL1-TNFRSF6B|JARID2|KLHL22|TNKS2|SLX4|PLK1|ATAD2B|TEN1|CTC1|TEX14|PHF2|ACD|XRN1|SUPT6H|ATM|BRCA1|DNMT1|EXOSC10|PHF1|POT1|UBR5|SETMAR|MNAT1
GLYOXAL METABOLIC PROCESS%GOBP%GO:1903189,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0043619,0.134973637961336,0.622258254449182,-0.49351522256096003,-1.35466614880595,767,6,ATF4|HIF1A|HMOX1|SESN2
MEMBRANE FUSION%GOBP%GO:0061025,0.6105860113421551,0.9508825506493929,-0.128100985730324,-0.9291723697140871,1291,96,RAB8B|VPS4A|TAPBP|VPS11|MX2|STX8|CHP1|NAPA|VAMP2|STX11|ATG7|VAMP3|RAB39A|RAB8A|OTOF|CD9|CAV2|RAB7A|NSFL1C|VTI1A|SNAP25
NEGATIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901551,0.547067390440884,0.9305779599215391,-0.7207763564181741,-0.964204508267465,4131,1,S1PR3
DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060996,0.24469964664311,0.757467559003634,-0.27985387120620697,-1.17759290199134,1107,17,CAMK2A|ARC|CDC42|ZNF365|EPHB2
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902254,0.6382470880274971,0.9601484712040809,0.244741360357703,0.8631674342637029,6684,17,SIRT1|AK6|MARCH7|MUC1|ING2|KDM1A
RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009199,0.7679814385150809,0.9792236089291529,-0.108644153285702,-0.8791193175555649,992,162,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GTPBP1|UQCRC1|PKM|ENO1|MT-ND5|ATP5I|EFTUD1|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|ALDOA|COX10|SLC25A13|RHOQ|COX4I2|NDUFS6|PGAM2|AK4
INNERVATION%GOBP%GO:0060384,0.0245125348189415,0.32844020156674,-0.554683635058426,-1.72419825114026,131,8,NTRK1|NPTX1|NRP1|FBXO45|SEMA3A|SULF2
NEGATIVE REGULATION OF ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:1904911,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:0070935,0.101534113847396,0.571746500995146,-0.398499186512335,-1.40236828606622,502,11,HNRNPC|RBM38|MYD88
PUTRESCINE CATABOLIC PROCESS%GOBP%GO:0009447,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
T-TUBULE ORGANIZATION%GOBP%GO:0033292,0.716258351893096,0.971081608033886,-0.473297120067411,-0.809549375702953,4823,2,BIN1
FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY%GOBP%GO:0002774,0.424037706205813,0.8740879492662891,-0.49647071798830894,-1.00757257136444,2698,3,LILRB2|LILRB1|LYN
POSITIVE REGULATION OF SUCCINATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904231,0.15808288097444698,0.6597808951153779,-0.918063520070578,-1.22812156232048,1193,1,FXN
INTERLEUKIN-15-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035723,0.0597634363975929,0.476295606439141,-0.401961964439882,-1.5137810748304599,287,13,STAT5A|SHC1|STAT3|PLCB1
NEGATIVE REGULATION OF ANOIKIS%GOBP%GO:2000811,0.959754433833561,1.0,0.16398180953470498,0.5433226934715739,9848,14,ITGB1|SRC|PDK4|TLE1|PTK2|PTRH2
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NO-GO DECAY%GOBP%GO:0070966",0.605184603299293,0.9508825506493929,-0.43377081724936606,-0.880324985710616,3851,3,PELO|CNOT6|CSDE1
RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048384,0.9570345408593092,1.0,0.21639897704726302,0.563241071803681,9087,7,RARB|SNW1|RARG|ACTN4
REGULATION OF INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032383,0.232925257731959,0.746122594132505,0.49541443489602,1.21839965246525,2168,6,ABCA2|LDLRAP1|ARV1|NUS1|ANXA2|SCP2
NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905208,0.291371158392435,0.8000726114371469,-0.335476658170676,-1.13496774873238,1478,10,FZD7|SMAD4|FRS2|PRICKLE1|SOX6|DKK1
POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0098735,0.511635984716916,0.918404893008545,0.5119688563514799,0.9731989388220191,4418,3,RYR2|SLC8A1
RELAXATION OF CARDIAC MUSCLE%GOBP%GO:0055119,0.703744939271255,0.968941691852291,0.284590334397242,0.812123576460487,6952,9,RGS2|SLC8A1|GSTM2|P2RX4|CHGA|ATP1A1|ATP1B1
CARDIAC FIBROBLAST CELL DEVELOPMENT%GOBP%GO:0060936,0.7611940298507459,0.977763214485385,-0.377698312537799,-0.766527503385769,4844,3,PDCD4
EAR DEVELOPMENT%GOBP%GO:0043583,0.0264328942684229,0.337668602007655,0.38068780735843605,1.60916463331772,296,31,SHROOM2|KCNQ1|STRC|ADGRV1|PROX1|AHI1|MPV17|CEP290|DFNB31|JAG2|TGFB2|PDZD7
NEGATIVE REGULATION OF VIRAL-INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0039532,0.993557204217103,1.0,-0.15194259071257402,-0.49048429872223,5088,9,RIOK3|C1QBP|GPATCH3
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002578,0.5168906647293859,0.922736477156771,-0.320408163265306,-0.93464482746211,2845,7,THBS1|HLA-DOB|LILRB2|HFE|HLA-DOA|TAPBPL|FCGR2B
NEGATIVE REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051053,0.9164256355609681,1.0,0.12142598590227802,0.6914665377637019,12039,113,FBXO18|ZNF93|NAT10|PIF1|ATR|BLM|THOC1|DONSON|MEN1|PARP1|SRC|ZNF830|POLQ|GZMA|FBXO5|SLX1B|CDC6|MSH6|RTEL1-TNFRSF6B|RMI2|TIMELESS|ZNF91|PARPBP|TNKS2|CHEK2|SLX4|ZRANB3|TEN1|NUDT16L1|CTC1|RIF1|GMNN|ACD|RECQL5|XRN1|RAD17|SMC3|CDAN1|ATM
REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030808,0.0886115444617785,0.556932119338259,-0.22782127484338102,-1.3472943792739098,283,46,HIF1A|FLCN|CBFA2T3|PDK3|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|PPARA|ENO1|IGF1|PDPR|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030947,0.0197833254828073,0.293576750287431,-0.378793562542504,-1.7204030827783898,83,21,HHEX|GRB10|FAM129B|HIF1A|IL1B|VEGFA|DAB2IP|PRKD2|MMRN2|ITGA5|PTPN1|NEDD4|FLT1
CELLULAR RESPONSE TO INTERLEUKIN-4%GOBP%GO:0071353,0.898305084745763,0.998912093067348,0.234370867723982,0.6389578632512191,8638,8,LEF1|GATA3|XCL1|JAK3|XBP1|STAT6
MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002444,0.00980392156862745,0.217062493446577,-0.144397683318036,-1.3643894276179498,2,412,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|IRAK4|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|IL6|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|CAMK4|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|ADAM17|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|ACE|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
REGULATION OF GENE SILENCING BY RNA%GOBP%GO:0060966,0.225193525686137,0.7390599693491929,-0.18388196389556602,-1.1676384899352201,639,58,HIST2H4A|EIF4G1|PPARG|POLR2A|FMR1|POLR2K|AGO2|POLR2F|STAT3|TP53|POLR2I|HIST2H4B|POLR2D|H3F3B|MAP2K1
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002244,0.572847049837693,0.9408603570970521,0.25984424221069197,0.916433117513883,5999,17,FST|BMP4|LIG4|PRRC2C
NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0042790,0.207467231563617,0.7230355264993821,-0.8946846052051171,-1.19684687508781,1566,1,TAF1B
RESPIRATORY SYSTEM PROCESS%GOBP%GO:0003016,0.0268537558969396,0.339762187668294,0.8931899641577059,1.4598944590520802,221,2,GAA|ECEL1
CELLULAR RESPONSE TO DSDNA%GOBP%GO:1990786,0.4719978816364361,0.898272347254494,-0.7626819585355089,-1.0202629099109202,3564,1,RIOK3
REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046640,0.580801828397296,0.942746898746279,0.253443040636612,0.909151856453465,6098,18,SH3RF1|BLM|EBI3|CD55|RASAL3|TNFRSF14|XCL1
ENDODERM FORMATION%GOBP%GO:0001706,0.195167286245353,0.707411999892601,-0.23011866541274104,-1.2100869834066998,734,31,MMP2|ITGA5|COL6A1|MMP9|TBX20|SOX7|SOX17|ITGA7
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902235,0.0286552346570397,0.347919292482523,-0.374365104430475,-1.64176814003974,126,19,OPA1|PARK7|TMBIM6|CREB3|MAGEA3|EIF2AK3|DDIT3|BCL2L1|BOK|PARK2|BCL2L11|PMAIP1
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034766,0.00518134715025907,0.16737273925846302,-0.301411499928959,-1.82578832606381,15,50,CAMK2D|SRI|HECW2|PPIF|NEDD4L|KCNE3|FKBP1B|CRHR1|KCNE4|SESTD1|PLN|SLC30A1|KCNAB1|MMP9|SUMO1|BIN1|CAB39|FMR1|GNB5|NEDD4|COMMD1|YWHAE|ADRA2A|CAV1|FKBP1A|EPHB2
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010640,0.869819086819183,0.9934031064448321,0.191569303838474,0.6641188247479871,9086,16,HIP1R|F3|PTGIR|PTPRJ|HIP1|HGS|IFT20|CBL|LRP1
POSITIVE REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BINDING%GOBP%GO:1905860,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
NUCLEAR MATRIX ORGANIZATION%GOBP%GO:0043578,0.0263187367006384,0.337617814484332,0.7455440762024219,1.5798791155537297,234,4,TPR|SYNE1
POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043302,0.201077943615257,0.71430080363469,-0.340113156933705,-1.23906634743828,969,12,VAMP7|STX4|SNX4|SYK|VAMP8|ITGB2|AP1G1|ITGAM|LAMP1|FGR|GAB2
HEXITOL CATABOLIC PROCESS%GOBP%GO:0019407,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:0097192,0.145081227436823,0.636215339087768,-0.29701129437386103,-1.3025350775596298,642,19,BCL2A1|DCC|BAX|CASP3|BCL2L1|BOK|BCL2|APPL1
HISTAMINE METABOLIC PROCESS%GOBP%GO:0001692,0.0974016332590943,0.570215774831708,-0.810926622450805,-1.38704655725023,655,2,TRH
LIPOPOLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0008653,0.592348993288591,0.945987625636678,0.708645787384208,0.9414043136099599,4412,1,AOAH
NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0015780,0.238942712721146,0.7520201948640999,0.46607725751796997,1.21310117843305,2268,7,SLC35A1|SLC35B1
CELLULAR RESPONSE TO INTERLEUKIN-2%GOBP%GO:0071352,0.442277383766746,0.880423444399886,-0.293540023169857,-0.993089835449739,2244,10,STAT5B|IL2RA|JAK3|IL2RB|JAK1|SYK|IL2RG|PTK2B|STAT5A|SHC1
POSITIVE REGULATION OF GLIOGENESIS%GOBP%GO:0014015,0.598545521494983,0.949383428931943,0.230909410707433,0.8980536370952259,6501,23,CXCR4|HES1|SERPINE2|AGER
VISUAL SYSTEM DEVELOPMENT%GOBP%GO:0150063,0.335261007016732,0.8311444145897029,0.19570267694426702,1.09389384554067,4347,102,SIX3|TSPAN12|NHS|SMG9|SHROOM2|TBX2|SDK1|WNT5B|PROX1|DSCAM|SMARCD3|AHI1|CEP290|SMOC1|ZDHHC16|FOXN4|EFEMP1|TGFB2|DCX|FBN1|MAB21L2|MED1|BMPR1B|NF1|NIPBL|COL4A1|COL5A2|TH|COL5A1|TFAP2B|MYO7A|SMARCA4|CHD7|MDM1|TOPORS|WNT2B
REGULATION OF EOSINOPHIL CHEMOTAXIS%GOBP%GO:2000422,0.9256375838926171,1.0,0.5403617115130129,0.71784642649997,6895,1,DAPK2
PROTEIN LOCALIZATION TO ADHERENS JUNCTION%GOBP%GO:0071896,0.806040268456376,0.984682960940884,0.597871636524041,0.7942457961774659,6004,1,SCRIB
ANTERIOR/POSTERIOR PATTERN SPECIFICATION%GOBP%GO:0009952,8.44523266615995e-05,0.0784645998831315,0.462947895843979,2.19585360388632,0,47,RIPPLY2|HOXC6|HOXD3|HOXC5|PBX3|TBX3|HOXB6|HOXA5|HOXB3|HOXD4|BASP1|HOXD8|HES1|BMP4|HOXC4|CFC1
MITOCHONDRIAL ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:0042776,0.9517853733053281,1.0,0.15913022194997,0.561229312420327,9968,17,ATP5D|MT-ATP8|ATP5C1|ATP5E|ATP5H|MT-ATP6|ATP5A1|STOML2
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS%GOBP%GO:0032469,0.7707597173144879,0.979355471471634,-0.18502812267144397,-0.7785770587612378,3489,17,WFS1|PSEN1|TMCO1|CAMK2D|BAX|PML|BCL2|KCTD17|BCAP31
ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0006086,0.26128345839399697,0.771967970256231,0.553318599161724,1.1725349673702,2332,4,PDHX|PDHA1|DLD
GLYCOSAMINOGLYCAN METABOLIC PROCESS%GOBP%GO:0030203,0.986225471335129,1.0,0.0992939582820305,0.556074077086202,12815,103,GLCE|GCNT2|VCAN|B3GAT3|HS3ST5|CHST15|GPC2|CLN6|GPC6|EXT1|PXYLP1|CHPF2|HMMR|GPC1|XYLT2|B4GALT6|PRELP|B3GALT6|B4GALT4|ABCC5|ST3GAL4|HS2ST1|GPC3|AGRN|B3GNT4|FMOD|ST3GAL6|LYVE1|BGN|B4GALT3|SDC3|DCN|HEXA|HYAL2|OGN|ST3GAL3|LUM|GNS
RESPONSE TO ANTINEOPLASTIC AGENT%GOBP%GO:0097327,0.8001029071263192,0.9840257959912879,-0.152496579602734,-0.771060191759049,3109,28,CTNNA1|FMR1|HSF1|NR3C1|AQP1
FATTY ACID TRANSPORT%GOBP%GO:0015908,0.028687337003767,0.347919292482523,-0.27718817913235805,-1.5516211095158001,98,38,SLC27A5|PPARA|PPARG|FABP4|ABCC4|DRD2|BDKRB2|ACE|ACSL3|CD36|MID1IP1|FABP3
REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000008,0.0477730778800697,0.43054641249021397,-0.313009400936701,-1.51849355663299,191,25,MAP1A|GPM6B|PICALM|NEDD4L|CTNNB1|RANGRF|LEPROT|KCNAB2|COMMD1|RAB11FIP5|HSP90AB1|TNF
GLIAL CELL DIFFERENTIATION%GOBP%GO:0010001,0.8695835086243159,0.993389838333952,0.146655705696001,0.7014547918964821,10334,49,CDK6|SLC8A3|HES1|PRDM8|CDH2|EIF2B5|EIF2B1|GPC1|LEF1|NF1|EIF2B4|METTL3|MYRF|DICER1|PLP1|SOX10|ERBB3|PHOX2B|PICK1|MMP24|LRP1|MAPT
NEURON DEATH%GOBP%GO:0070997,0.0658127208480565,0.495991045493396,-0.352887350647896,-1.48490938336633,297,17,BAG5|BID|GAPDH|NLRP1|BCL2|TNFRSF21
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060693,0.356050482553823,0.84417352062618,-0.6451932677240171,-1.10356853010078,2397,2,HGF
POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0002230,0.946900688735836,1.0,-0.14429464892915,-0.6207235205193891,4261,18,PARP9|PQBP1|STAT1|DDX58|ZC3H12A|TRIM44|APOBEC3G|LILRB1|TMEM173|DTX3L|EIF2AK4|MB21D1|TRAF3IP2|SIN3A|APOBEC3F|MAVS
POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032927,0.729395604395604,0.972554563883587,-0.310776527685859,-0.7867101432138071,4247,5,ACVR2A|CSNK2B|ACVR2B|ACVR1B|SMAD2
POSTSYNAPTIC ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0098974,0.33541202672605797,0.8311444145897029,-0.6583402260821619,-1.12605569826634,2258,2,NOS1AP|ACTB
CHROMOSOME LOCALIZATION%GOBP%GO:0050000,0.0635144087446174,0.49351130247002706,0.290699432507834,1.4359306723028702,766,56,CCNB1|PSRC1|KIF14|GEM|CENPF|KIF2C|KIF18A|NUF2|DLGAP5|CDC23|NDC80|CENPE|CEP55|BOD1|KIFC1|CDCA8|CENPQ|SPDL1|KIF22|CDCA5
DETERMINATION OF LIVER LEFT/RIGHT ASYMMETRY%GOBP%GO:0071910,0.7197802197802199,0.9713637233549571,-0.31346318033108694,-0.793511225982288,4191,5,DNAAF1
MITOCHONDRIAL NUCLEOID ORGANIZATION%GOBP%GO:0090144,0.551436515291937,0.932156795932405,-0.7185156594618441,-0.961180305020909,4164,1,CHCHD10
REGULATION OF IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002640,0.0883221476510067,0.556932119338259,0.9565505072783409,1.2707346741756598,657,1,MZB1
GLAND MORPHOGENESIS%GOBP%GO:0022612,0.0510997556098645,0.443301756236231,-0.356845834953544,-1.53507149848505,229,18,MSN|FGF10|CRIP1|SLC9A3R1|CAV1
REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002920,0.0950399184644131,0.5655609377251689,0.29594251863160803,1.38037974124174,1118,44,IGKV4-1|CXCL13|IGHG1|IGHG4|IGKV3-11|SUSD4|ZP3|IGKV2D-28|IGKV2-28|C3AR1|C7|CD55|C5|C4A|C4B|IGHG2|CD46
ZYMOGEN GRANULE EXOCYTOSIS%GOBP%GO:0070625,0.5201906527207729,0.92477593964991,-0.7355535950595501,-0.9839724709522629,3928,1,SDF4
PROTEIN LOCALIZATION TO MICROTUBULE CYTOSKELETON%GOBP%GO:0072698,0.12136752136752099,0.607607158836689,0.331066089488508,1.35757898289695,1348,28,CEP83|CCDC14|GOLGB1|SPAG5|KIF20B|CEP131|STIL|MID1|CEP192|MID2|PCM1|FAM83D|C2CD3|HOOK3|CHAMP1|SNX10|PIBF1
ACYLGLYCEROL TRANSPORT%GOBP%GO:0034196,0.576243504083148,0.942162964865338,-0.530923591198437,-0.908116368296193,3880,2,CD36
MODULATION OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052231,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
TELOMERIC LOOP FORMATION%GOBP%GO:0031627,0.151299183370453,0.6475783026655401,-0.765260545905707,-1.3089371790384599,1018,2,DCLRE1B|TERF2
CELLULAR ALCOHOL METABOLIC PROCESS%GOBP%GO:0044107,0.364582073303496,0.85007225273817,0.6583416905456011,1.07604140749258,3013,2,C14orf1|CYP27B1
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045620,0.9827915869980881,1.0,0.12275915178876198,0.48917756093581294,10793,25,INHA|BMP4|LOXL3|SOCS1|CTLA4|RC3H1|ANXA1|JAK3|FOXP3|HMGB1|ZC3H8|KIAA0922|PTPN2|ZC3H12A
POSITIVE REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001184,0.675234456408475,0.9647315640607691,0.45387533987407297,0.862769275207015,5831,3,MAPK11|MAPK14
GOLGI TO PLASMA MEMBRANE TRANSPORT%GOBP%GO:0006893,0.730246113989637,0.972554563883587,-0.13928402263366002,-0.8437074981932751,2254,50,OSBPL5|GGA3|GOPC|ARF5|ANK3|RAB26|GOLGA4|MACF1|GGA2|TRIM23|BBS1|RABEP1|SEC16A|C16orf70|BBS2|EXOC6|VAMP5|VAMP4|EXOC1|GOLPH3L|RAB34|KRT18|BLZF1|EXOC6B|RAB31|CCDC22|ARL3|EXOC5|GOLPH3|SYS1|LLGL1|SPTBN1|NSF|ARF1|ARFRP1|ARF4|OPTN|GGA1|SYS1-DBNDD2|C16orf62|RAB10|ARFGEF2|GCC2|VAMP2|EXOC4|COMMD1|ARF3|KIF13A|GOLGA7
COLUMNAR/CUBOIDAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0002065,0.249390129480203,0.7613646381106121,0.320266774273373,1.18931042667146,2657,20,CDK6|STRC|BMP4|DFNB31|JAG2|PDZD7|LEF1|GATA6|FGFR2|LRTOMT
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903727,0.6587552742616031,0.9643779777660141,-0.16758949078433302,-0.869459648977379,2497,30,PRKCD|PTK2B|FGR|FGF2|EPHA8|FLT1|ACSL3|FABP3
REGULATION OF AXON GUIDANCE%GOBP%GO:1902667,0.543679886935783,0.929698169790548,0.220062145425587,0.9409117642853292,6154,32,SEMA3D|ZSWIM5|DSCAM|PTPRO|ZSWIM8|SEMA5A|SEMA3E|SEMA4G|SEMA6A|SEMA4C
POSITIVE REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902310,0.36377134372680003,0.8499434076701009,-0.640970499035015,-1.09634571041527,2449,2,PPP1R15A|DUSP26
TRNA WOBBLE BASE 5-METHOXYCARBONYLMETHYL-2-THIOURIDINYLATION%GOBP%GO:0002926,0.227062094531974,0.73994005264542,-0.885531539479488,-1.184602539992,1714,1,ELP3
PENTITOL CATABOLIC PROCESS%GOBP%GO:0019527,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0001188,0.207467231563617,0.7230355264993821,-0.8946846052051171,-1.19684687508781,1566,1,TAF1B
REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045619,0.973583297827013,1.0,-0.0904135820779201,-0.63490742189875,2284,84,RUNX1|TNFRSF18|PNP|SPINK5|CAMK4|SMAD7|NLRP3|NFATC2|SOCS5|BCL6|NKAP|DUSP10|CBFB
REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0000019,0.9509235395189001,1.0,0.23330977876984102,0.5737914225886099,8854,6,BLM|RAD50|ERCC3|ERCC2|TERF2|MRE11A
PROSTATE EPITHELIAL CORD ELONGATION%GOBP%GO:0060523,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001234,0.000696378830083565,0.0806484601749226,-0.23465615786940802,-1.86163993443039,0,144,CCAR2|TRAP1|PSMD10|PARK7|CXCL12|BCL2A1|RELA|TMBIM6|NOC2L|CD44|TAF9|SLC25A5|SNAI2|HIF1A|HSPB1|QARS|CREB3|PPIF|IL1B|CLU|PTTG1IP|CX3CL1|MAPK7|TGFBR1|ACVR1|HMOX1|TNFAIP3|MAGEA3|ZNF385A|PSME3|MPV17L|DDX3X|HYOU1|TCF7L2|FAIM2|TNFRSF10A|MAP2K5|HGF|CSNK2A2|UNC5B|ITGA6|ENO1|MMP9|BCL2L1|SNAI1|BAG5|IGF1|SOD2|ICAM1|ACAA2|PLAUR|ARHGEF2|LGALS3|FXN|EYA4|BCL2|CFLAR|ACKR3|TNFRSF4|NOS3|SLC35F6|TNFRSF10B|SCG2|HTT|PARK2|EYA1|PEA15|SFRP2|CSNK2A1|TNF
CELLULAR RESPONSE TO BLUE LIGHT%GOBP%GO:0071483,0.440089086859688,0.879896414106183,-0.591452991452992,-1.01164866568429,2963,2,CRY2|CRY1
INTESTINAL LIPID ABSORPTION%GOBP%GO:0098856,0.5525814760891479,0.9323791977088509,0.44294712296894395,0.9386472660849641,4933,4,LIMA1|AKR1C1|LDLR
NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905907,0.826907491026977,0.9876441563834109,0.39186616256392404,0.7448963522610269,7141,3,LDLR|CRYAB
REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0019217,0.5835991270773879,0.9439064862850342,0.191469197137093,0.920095466396522,6952,50,SIRT4|SLC45A3|SIRT1|NR4A3|CEACAM1|PRKAA2|ACADVL|INS|PDK4|PTGS2|LPGAT1|GSTZ1|ADIPOR2|APOC1|PRKAB2|IRS1|AKT2|METTL20
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:1904851,0.6254925137903861,0.954110852066186,-0.25399658673947,-0.859308471144789,3174,10,CCT2|CCT5|DKC1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1
REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010752,0.93397003128602,1.0,-0.268092081738895,-0.6165557816017969,5671,4,PDE10A
REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0019218,0.279220260445794,0.788692060817727,0.217021268522092,1.14343044508305,3494,75,FGFR4|SIRT1|STAR|TM7SF2|FGF19|WNT4|ACADVL|NFYB|ELOVL6|CLCN2|GPAM|GNB3|PROX1|AGTR1|MVD|RORA|LDLRAP1|APOE|ACACA|SREBF2|GGPS1|APOC1|IDI1|HMGCR|ARV1|DHCR7
EPITHELIAL TUBE MORPHOGENESIS%GOBP%GO:0060562,0.127604166666667,0.6076669536424699,-0.161393125175833,-1.21271082419667,244,110,HAND1|MTSS1|NRARP|FUZ|NOTCH1|LRP5|VEGFA|IFT122|CTNNB1|SKI|ACVR1|DLC1|CELSR1|PRKD2|PRICKLE1|RHOA|NRP1|BCL10|FGF2|PODXL|MICAL2|PAX8|WNT11|NPNT|CCDC103|CTSH|TBX20|MKKS|COBL|FGF10|SFRP2|ACVRL1|MET|SOX17|DNAAF1|BBS7|RBPJ
ANTERIOR/POSTERIOR PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072098,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
PROTEIN POLYMERIZATION%GOBP%GO:0051258,0.8791056910569109,0.9956508825790341,0.137367977632663,0.705473601193003,10812,67,AKAP9|CENPJ|TTC17|FGF13|CKAP5|JAK2|TUBGCP3|MSRB2|CETN3|TUBG2|TUBGCP6|MICALL2|PIN1|CEP192|ARL6|TUBGCP2|UBE2C|DIAPH3|TUBGCP4|WASF1|WASF3|NDE1|PSTPIP1
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0006661,0.9956427015250551,1.0,-0.0741913002554767,-0.529302830817397,2284,88,PIGL|MTMR1|PIP4K2B|MTMR7|FIG4|PIGK|PIGH|PIP5K1C|CDS1|GPAA1|PIK3C2B|INPP5F|OCRL|PIK3C2A|RUFY1|MTMR6|PIKFYVE|PIGN|PIGU|PIGS|PIGO|SLC27A1|MTMR3|PLEKHA8|INPPL1|PYURF|INPP5J|PGAP3|PITPNM1|PIGP|INPP4B|SACM1L|RAB14|MTM1|PIK3CB|PIGW|PIK3CA|DPM3|SBF1|PTEN|MTMR9|VAC14|PLEKHA4|PIP4K2C|PIGV|PI4KB|PLEKHA3|PLCG2|ARF1|SYNJ1|INPP4A|INPP5D|PGAP2|PIP5K1A|PI4K2B|PI4K2A|PIK3CD|MTMR12|SYNJ2|MTMR2|PIK3C3|PIGA|DPM1|PIGG|PIGZ|PIGY|DPM2|CDIPT|INPP5K|MPPE1|FGF2|PIP4K2A|PIGT|ARF3|RAB5A|MTMR14
POSITIVE REGULATION OF URINE VOLUME%GOBP%GO:0035810,0.9145397661781658,1.0,-0.278663210720785,-0.640867169873945,5553,4,TFAP2B|HYAL2|NPR1|INPP5K
ORGANIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0016053,0.618686507368722,0.9532238181782521,0.149136739949597,0.928647267597813,8647,203,ACSM3|EDN1|RGN|HACD1|ASNS|CTH|MGST1|CYP2C8|LPL|OXSM|SLC27A2|GAMT|SERINC5|VCAN|HSD17B4|CBR4|RIMKLB|SLC35D1|SCD5|ELOVL6|GGT1|GPT|DECR2|FADS3|GLS|APIP|ABHD3|DHFR|OSBPL3|GLS2|MTHFD1|AMACR|CAD|CDO1|MTR|FADS1|MGST3|GCK|ACOX2|OSBPL9|ACACA|PTGS2|MGST2|CYP7B1|MTAP|GGT5|PSAT1|LTA4H|BCAT2|NAALAD2|PYCR2|PHGDH|ABCC5|TECR|NAGS|PFKFB2|RIMKLA|SEPHS1|AKR1A1|ELOVL4|CCBL1|AASS|OSBPL6|OSBP|ALDH18A1|ABHD2|CYP2E1|BGN|CYP2D6|ELOVL2|BPGM|ENOPH1
PROTEIN KINASE B SIGNALING%GOBP%GO:0043491,0.9434762129062649,1.0,-0.136461843790569,-0.619781854694468,4005,21,ADTRP|GAS6|THEM4|IL1B|KDR|PLK3|IGF1|TNF
"REGULATION OF RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:1905279",0.0791738382099828,0.532203813468543,-0.959142037935598,-1.28307354814202,597,1,PARK2
"NOTCH RECEPTOR PROCESSING, LIGAND-DEPENDENT%GOBP%GO:0035333",0.00599346167816927,0.17598886321305202,-0.6669056811913959,-1.94539345994911,32,7,APH1A|PSEN1|PSENEN|APH1B|ADAM10|NCSTN|PSEN2
MRNA POLYADENYLATION%GOBP%GO:0006378,0.7766162310866579,0.980802382590629,0.19363504626573,0.762050296902864,8468,24,WDR33|CPSF1|FIP1L1|PAPOLA|GRSF1|CDC73|ZC3H3|CSTF3|TUT1|PCF11|SYMPK|AHCYL1|PNPT1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:1902548,0.9783653846153849,1.0,-0.212717846900507,-0.538481104237028,5697,5,SEMA6A|DCN|ADAMTS12|SPRY2|DAB2IP
INTERMEDIATE-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0071831,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
SNRNA TRANSCRIPTION%GOBP%GO:0009301,0.450828907130211,0.88620227509476,0.193505168972156,1.0103623987388701,5601,72,INTS7|POU2F2|SNAPC2|AK6|INTS9|INTS10|GTF2B|POLR2B|TAF5|INTS6|NABP1|ZNF143|INTS3|ASUN|CDK7|GTF2E2|SRRT|POLR2L|INTS1|INTS8|POU2F1|POLR2J|CCNT2|SNAPC3|INTS2|SNAPC5|POLR2G|POLR2H|SP1|GTF2A1
REGULATION OF MYOSIN LIGHT CHAIN KINASE ACTIVITY%GOBP%GO:0035504,0.40368065669270503,0.8655192490568291,-0.79648213498015,-1.0654784364996601,3048,1,IL1B
MELANOSOME ORGANIZATION%GOBP%GO:0032438,0.033609576427256,0.375579079090274,-0.35896972425808504,-1.60168898351408,145,20,HPS1|AP1G1|BLOC1S1|HPS4|PMEL|AP1M1|BLOC1S5|TRAPPC6A|BLOC1S4|BLOC1S6|BLOC1S3|KIF13A
NEGATIVE REGULATION OF ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1902613,0.7052826691380909,0.968941691852291,-0.642479047198941,-0.859463810459952,5326,1,DKK3
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034372,0.0994770102418828,0.570215774831708,0.608096183542908,1.4015715579751202,912,5,LPL|CETP|APOE|LCAT|APOC2
MYOTUBE CELL DEVELOPMENT%GOBP%GO:0014904,0.161687170474517,0.664367762084791,-0.47542816325678794,-1.3050183854732198,919,6,SKI|IGF1|RYR1|CAV2
CELL WALL BIOGENESIS%GOBP%GO:0042546,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
NEGATIVE REGULATION OF PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901630,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
NEGATIVE REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0045841,0.0646168401135289,0.495456803258629,0.4056776926465,1.48281403540498,682,19,TPR|CENPF|BUB1|CDC20|APC|FBXO5|BUB1B|KLHL22|PLK1|TEX14|ATM
MITOCHONDRIAL TRANSLATIONAL INITIATION%GOBP%GO:0070124,0.842627313414782,0.991245271875423,0.466611524676041,0.762663718514552,6965,2,MTIF3|MTIF2
POSITIVE REGULATION OF ERBB3 SIGNALING PATHWAY%GOBP%GO:1905580,0.367536078379452,0.8512048542076959,-0.815174239082488,-1.09048343407483,2775,1,RTN4
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS%GOBP%GO:0060670,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
TRANS-SYNAPTIC SIGNALING BY TRANS-SYNAPTIC COMPLEX%GOBP%GO:0099545,0.42331106161841103,0.873470206885489,-0.60113132826612,-1.02820294246458,2850,2,EPHB2
L-LEUCINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903801,0.0542830663312591,0.455180689373156,-0.9724856638729599,-1.30092372340218,409,1,SLC3A2
MALE MEIOSIS I%GOBP%GO:0007141,0.47483111789060795,0.900764964878162,0.430508589451012,0.9922584794448911,4357,5,CCNA1|MYBL1|ING2|C17orf104
"MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:0071962",0.9092277411138129,1.0,0.343590392631344,0.653129192039569,7852,3,BOD1|SGOL1
REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904875,0.781299141163663,0.981487311948134,0.49363110008271294,0.8068264722455999,6458,2,XRCC1|TFIP11
REGULATION OF PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031272,0.0986441344075457,0.570215774831708,0.45113737534134796,1.4221462283259199,1003,12,WASH1|C15orf62|CCL21|F2RL1|APC
"NEGATIVE REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060101",0.898450946643718,0.998912093067348,-0.548191442434936,-0.733332406762173,6785,1,CD300A
DADP PHOSPHORYLATION%GOBP%GO:0006174,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0000079,0.10528425948199799,0.5783126438744189,0.254702913841361,1.3368642738733,1312,74,CCNA1|CCNB1|PSRC1|PROX1|CDKN2C|BLM|CDKN3|CDK5R1|CDC25C|GTF2H1|CDKN2A|MEN1|CCNE1|PKMYT1|APC|CDC6|CDKN2B|CCNB2|CCNI2|CDK7|CCNF|PLK1|CKS2|CCNE2|CDK5RAP3|CCNT2|INCA1|TFAP4|SERTAD1|CDKN2D|CCND2|CCNJ|CCNG1|DIRAS3|CCNA2|MNAT1
REGULATION OF OSTEOCLAST PROLIFERATION%GOBP%GO:0090289,0.0844840386043059,0.545178773025535,-0.824372759856631,-1.4100454551538402,568,2,TNFAIP3|GREM1
DEOXYRIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009192,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
MITOCHONDRIAL TRNA 5'-END PROCESSING%GOBP%GO:0097745,0.7024351924587591,0.968941691852291,-0.39941546266681394,-0.810601814327738,4470,3,HSD17B10|TRMT10C|KIAA0391
REGULATION OF CALCIUM-DEPENDENT CELL-CELL ADHESION%GOBP%GO:0046586,0.103402621474911,0.5756137190742839,-0.9464049404499342,-1.26603474448461,780,1,FXYD5
POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION%GOBP%GO:0150012,0.19629317607413602,0.7100128962886071,0.48567996417325,1.26412290532579,1863,7,DVL1|GRIP1|DLG4|DVL3|DVL2
EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050673,0.27795358649789004,0.788483986984073,-0.218500126869776,-1.1335856605363501,1053,30,FGF10|BMPER|ACVRL1|DLG1|CDH13
REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903391,0.00133333333333333,0.0945022140486112,-0.33534638174739895,-2.06838116328453,3,53,MAPRE2|DUSP22|PPM1F|THY1|S100A10|GPM6B|ADD1|VEGFA|KDR|BCAS3|COL16A1|DLC1|ABL1|RHOA|NRP1|SLC9A1|APOD|MAP4K4|IQSEC1|DUSP3|LIMS1|ACVRL1|RAC1|CORO1C|PEAK1
CELLULAR PIGMENTATION%GOBP%GO:0033059,0.18365061590145604,0.689876118998471,-0.22106237590445899,-1.21604025916413,655,36,HPS1|AP1G1|RAB11A|BLOC1S1|HPS4|PMEL|VPS33B|AP1M1|BLOC1S5|TRAPPC6A|BLOC1S4|BLOC1S6|MKKS|BLOC1S3|KIF13A|BBS7
CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS%GOBP%GO:0071385,0.0032258064516129,0.137762274603971,-0.509189133761491,-2.0306917558766497,14,15,NR3C1|KLF9|UBE2L3|ADCYAP1|AQP1|BCL2L11
SYNTHESIS OF RNA PRIMER INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902295,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
PRIMARY MIRNA MODIFICATION%GOBP%GO:1990729,0.436241610738255,0.878651088001772,0.788376709307455,1.04732328633638,3249,1,METTL3
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045089,0.0282685512367491,0.346012917244495,-0.16261263642344,-1.35358785261478,31,187,POLR3F|PUM1|S100A9|MB21D1|UNC93B1|AP1G1|PLSCR1|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|MFHAS1|CTSS|RPS6KA3|SCARA3|UBE2N|CYBA|TLR1|CREBBP|FLOT1|PYCARD|RIOK3|PJA2|POLR3C|XRCC6|ITCH|HEXIM1|NOD1|PVRL2|IRAK1|SIN3A|POLR3D|FCER1G|PIK3C3|PRKCD|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|NR1H3|IRAK4|LAMP1|ULBP3|TRAF3|S100A8|FYN|BCL10|UBE2V1|RELB|LYN|CYLD|TANK|MAVS|CNPY3|TNIP1|RIPK2|MUC4|MUC3A|RFTN1|ULBP2|KRAS|UBA52|WDFY1|COLEC12|TNIP2|TICAM1|MUC12|MYD88|UBC|CD36|UBE2K|CAV1|PAK2|UBB
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071634,0.698073003520474,0.96731875442989,0.21374634702315803,0.818598926535352,7534,22,CDH3|TGFB2|LRRC32|CD200|PTGS2|GATA6|LTBP1|CD46|THBS1|LAPTM4B
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904036,0.13235986811116301,0.617642089543245,-0.291851434759697,-1.32552967559352,561,21,WFS1|GAS6|CAST|GATA2|IL11|KDR|MAPK7|TNFAIP3|TCF7L2|ICAM1|RAMP2|SCG2|TNIP2
REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0006521,0.315704481227291,0.817022961971678,-0.31436339111863504,-1.10628393965707,1563,11,AZIN1|PARK7|SLC7A7|OAZ2|ATP2B4|NQO1|ODC1
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GLUCOSE%GOBP%GO:0000430,0.561098737936154,0.936434965680841,-0.537193272677144,-0.918840322682859,3778,2,USF2|USF1
NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032926,0.5008356545961,0.9144253281295329,-0.304925027740974,-0.9478397528430841,2696,8,SKI|ACVR1|IGSF1|DACT2
MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002573,0.796614347933273,0.982918359121065,0.154152334359796,0.770845804658027,9693,59,SIRT1|BMP4|EFNA2|PIR|FARP2|PARP1|SRC|PDE1B|F2RL1|UBD|TAL1|LEF1|KIT|CCL19
POSITIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:1900087,0.691032054845284,0.96731875442989,0.21537397413467602,0.8248323608131499,7458,22,ANKRD17|LSM11|CDC45|CDK10|CCNE1|CDC6
NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150079,0.778362638593348,0.9811398289380491,0.3614270865088429,0.765898521626394,6949,4,CD200|LDLR|PTPRC
NEGATIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0032055,0.0887521968365554,0.556932119338259,-0.53331840896178,-1.46392322288768,504,6,ATF4|EIF2S1|EIF2AK3|SESN2
RESPONSE TO BLEOMYCIN%GOBP%GO:1904975,0.6210233458328289,0.9536478716552259,0.558533223049352,0.912907209268955,5133,2,TIMELESS|DDX11
CELLULAR POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0033692,0.0231349103197297,0.31901519550794605,-0.320657221394504,-1.6410438496656201,88,29,B3GNT5|B3GNT7|CSGALNACT1|PER2|B3GNT8|B3GNT2|NR1D1
DADP METABOLIC PROCESS%GOBP%GO:0046056,0.123487824037706,0.607607158836689,-0.6864453512738499,-1.3931204452232098,785,3,AK5|AK9|NUDT18
ERBB2 SIGNALING PATHWAY%GOBP%GO:0038128,0.0185501586526727,0.285526981228736,-0.357491923136464,-1.7136239433312601,75,24,MATK|GRB2|CUL5|STUB1|CPNE3|HBEGF|CDC37|PTPN12|SHC1|PRKCA|PIK3R1
HEPARIN METABOLIC PROCESS%GOBP%GO:0030202,0.531318744934584,0.9265056012720759,0.504218589902439,0.9584664975998199,4588,3,GLCE
PROTEIN HYDROXYLATION%GOBP%GO:0018126,0.9581031307550649,1.0,-0.134238560468069,-0.598959769960744,4161,20,EGLN2|P3H2|P4HA3|P3H1|P3H4|P4HA1|EGLN1|P3H3|JMJD6|P4HTM|VIPAS39|PLOD1|PLOD3|HIF1AN|PLOD2|OGFOD1|P4HA2|VPS33B|P4HB|EGLN3
MITOCHONDRIAL RNA PROCESSING%GOBP%GO:0000963,0.9251054852320669,1.0,-0.164542388579683,-0.637480773915691,4384,14,KIAA0391|TRMT61B|FASTKD5
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION%GOBP%GO:0021953,0.484962406015038,0.9064456896937672,-0.15719019958587804,-0.9869352671704829,1418,56,OPHN1|FZD1|CHRNB2|CTNNB1|SCN1B|FAIM2|NFIB|SPOCK1|CBLN1|C21orf91|TBX20|DRD2|WNT3|ASCL1|HSP90AB1|SLIT3
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070962,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
SKELETAL SYSTEM MORPHOGENESIS%GOBP%GO:0048705,0.8454471544715451,0.991298302704726,0.143466243833417,0.736792150769262,10398,67,FREM1|HOXD3|HOXB3|HOXD4|BMP4|RARB|HOXC4
CALCIUM ION HOMEOSTASIS%GOBP%GO:0055074,0.637280670597428,0.959367801632944,0.146390008204215,0.9177859080958091,8970,213,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|P2RX5|TMTC2|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|AGTR1|ATP2A1|CDH23|HSP90B1|PDPK1|CACNA2D1|PTGER1|TMEM178A|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|DMPK|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|CALB2|CD55|DRD4|DLG4|TRPC1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|TFAP2B
CELLULAR RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0070301,0.18391741374626502,0.6903572731305279,-0.231175113027927,-1.22386199057546,676,32,PPIF|IMPACT|MAPK7|PRKCD|SIRPA|TNFAIP3|ABL1|RPS3|ZNF580|IL6|PDCD10|FXN|NET1|AQP1
SLEEP%GOBP%GO:0030431,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
FEEDING BEHAVIOR%GOBP%GO:0007631,0.494737867862015,0.91071489001692,0.294233446145047,0.974886842159873,5076,14,CARTPT|GHRL|NPY
POSITIVE REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000640,0.778366212101152,0.9811398289380491,-0.6074658138509039,-0.812625540665748,5878,1,ZBTB7B
RESPONSE TO ARSENITE ION%GOBP%GO:1903842,0.8491751767478399,0.991298302704726,-0.34542847689423195,-0.701036830726074,5404,3,VCP|ZFAND1|DHX36
VACUOLE FUSION%GOBP%GO:0097576,0.47731543624161105,0.904028012305274,0.766100573445082,1.0177304336521,3555,1,VPS41
CELLULAR RESPONSE TO BMP STIMULUS%GOBP%GO:0071773,0.33595352016404706,0.8311444145897029,-0.171630128802684,-1.07759788759502,982,56,UBE2D1|DLX5|ZCCHC12|SKI|RGMA|ACVR1|GDF15|TMEM100|FAM83G|BMP8B|SMAD6|SMAD1|CHRDL1|SMAD7|PDCD4|UBE2D3|MAPK3|ACVRL1
COENZYME A TRANSMEMBRANE TRANSPORT%GOBP%GO:0035349,0.353020134228188,0.842847021021096,0.827911336568152,1.0998432748874498,2629,1,SLC25A42
POLYNUCLEOTIDE 5' DEPHOSPHORYLATION%GOBP%GO:0098507,0.6867469879518069,0.9665349594178531,-0.651521835024261,-0.871560623446172,5186,1,DUSP11
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000516",0.9552529182879379,1.0,0.14793114120882503,0.5665419553653199,10310,22,PRKCQ|CCL19|CD55|IL12RB1|SOCS1|NFKBID|XCL1|ANXA1|MYB|FOXP3|PRKCZ|NCKAP1L
DENDRITIC SPINE ORGANIZATION%GOBP%GO:0097061,0.11790287509060199,0.600796773653986,-0.284285520643805,-1.3358338886829,487,23,MTMR2|IGF1R|FYN|PRNP|CHRNA7|ARC|CDC42|ZNF365|EPHB2
RESPONSE TO INSULIN-LIKE GROWTH FACTOR STIMULUS%GOBP%GO:1990418,0.6550139107294061,0.9640743070248079,0.546236559139785,0.892808649917886,5414,2,AKT1|XBP1
AORTA DEVELOPMENT%GOBP%GO:0035904,0.44959955813311203,0.8859850407237599,0.259910682602406,1.0108454788217098,4883,23,TBX2|HES1|PROX1|PKD2|ROBO2|TGFB2|HEY2|MYLK|TFAP2B|DLL4|JAG1|LRP1|BMPR1A|HEY1
MULTICELLULAR ORGANISMAL SIGNALING%GOBP%GO:0035637,0.0961507095090523,0.5684612493613671,0.267808848740047,1.35954606256306,1178,63,RYR2|KCNN2|SCN1A|TNNI3K|KCNK6|CACNA1G|AKAP9|CACNB2|KCNK3|KCNQ1|CACNA1I
TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:0061820,0.5892690028075279,0.945418171231938,0.331398634226455,0.9034815856853199,5666,8,BLM|SLX1B|SLX4|POT1
VALYL-TRNA AMINOACYLATION%GOBP%GO:0006438,0.743195838877465,0.9745103949049642,0.509892808304,0.8334057875980351,6143,2,VARS2|VARS
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902106,0.563448334322285,0.9377667552605741,0.19667985393572698,0.9280884283763391,6646,46,CARTPT|CEACAM1|CDK6|INHA|BMP4|TMEM178A|LOXL3|FBN1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904781,0.464039229930984,0.8923263186617242,-0.33637188937854,-0.981211724780519,2554,7,MARK4|BICD1
PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:0018119,0.0933228593872741,0.5622489437340121,-0.7166648284989521,-1.4544499763914498,593,3,S100A9|S100A8|GAPDH
POSITIVE REGULATION OF WNT-MEDIATED MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1905426,0.8481069042316259,0.991298302704726,-0.41659773917838394,-0.7125681213168751,5711,2,CSNK1E|CSNK1D
HISTONE H2B ACETYLATION%GOBP%GO:0043969,0.9867602277240831,1.0,-0.507002646669607,-0.678232898831038,7452,1,EP300
RESPONSE TO NUTRIENT%GOBP%GO:0007584,0.981651376146789,1.0,-0.0940298507462687,-0.5616067225069771,3102,47,OGT|BGLAP|HSP90B1|KCNJ11|GRIN1|CDKN2B|P2RY11|GATS|TRPV1|PDXP|CDKN2D|P2RX3|TAF1|SST|P2RX7|CYP27B1|P2RX4|XBP1|SSH1|MTOR|AKR1C3|USF2|ALPL|SPP1|AQP3|SLC27A4|NCOA1|PDK2|GATSL2|SFRP1|KYNU|POSTN|GAS6|TMBIM6|ENSA|BCKDHB|GATSL3|CIB2|PIM1|USF1|HLCS|GNAI2|FYN|DGKQ|PPARG|GCGR|GIPR
SYNCYTIOTROPHOBLAST CELL DIFFERENTIATION INVOLVED IN LABYRINTHINE LAYER DEVELOPMENT%GOBP%GO:0060715,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
"POSITIVE REGULATION OF ATP-DEPENDENT MICROTUBULE MOTOR ACTIVITY, PLUS-END-DIRECTED%GOBP%GO:2000582",0.1057344854674,0.578674426247723,-0.705342325230754,-1.4314712924149902,672,3,DNAL4|DYNLL2
MODIFIED AMINO ACID TRANSPORT%GOBP%GO:0072337,0.852908891328211,0.991298302704726,-0.17424280973657802,-0.713582867219375,3884,16,ABCC1|PDPN|SLC25A32|SLC6A8|SLC9A3R1
POSITIVE REGULATION OF C-C CHEMOKINE RECEPTOR CCR7 SIGNALING PATHWAY%GOBP%GO:1903082,0.8583344366476899,0.99166790097654,-0.56908910454345,-0.7612878465291079,6482,1,TREM2
NEGATIVE REGULATION OF NEURON DEATH%GOBP%GO:1901215,0.983867084035637,1.0,0.10377768872448599,0.543648845286168,12257,73,CITED1|NR4A3|NAIP|BTBD10|F2R|KIF14|LIG4
LIPID OXIDATION%GOBP%GO:0034440,0.0881914541238821,0.556932119338259,0.27977746460034003,1.38198082938442,1064,56,CROT|SLC27A2|ETFDH|HSD17B4|ACADVL|BDH2|ETFA|DECR2|AMACR|ACADM|DECR1|ALDH3A2|HADH|ETFB|ACOX2|ECHDC2|EHHADH|ADIPOR2|ACAD11|ACAD10|IVD|ECI1|ECI2|HADHB|ACAT2|HIBCH|ACADS
POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002726,0.785654008438819,0.981487311948134,-0.19622693699145605,-0.7602351025543851,3723,14,IL6|NLRP3|B2M
L-CYSTEINE CATABOLIC PROCESS%GOBP%GO:0019448,0.8257659073055771,0.9876441563834109,-0.354533784720133,-0.7195157824281629,5255,3,CSAD|CBS
REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1903205,0.6731182795698921,0.9647315640607691,-0.210513170966345,-0.8395453328449201,3129,15,TRAP1|PARK7|NUP93|TXN|STK26|PDE8A|HGF|MET
ANTEROGRADE AXONAL PROTEIN TRANSPORT%GOBP%GO:0099641,0.7849582172701949,0.981487311948134,-0.24066412929560396,-0.7480889008019219,4226,8,RAB27B|DLG2|KIF5C|KIF5B|MAPK8IP3|KIF5A|MAP1A|HSPB1
PYRIMIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072529,0.70262688089773,0.968941691852291,-0.168078906980909,-0.8375703136612529,2754,27,CDA|CDADC1|UPP1|NT5E|NEIL2
GRANZYME B LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033380,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
CELLULAR HYPOTONIC RESPONSE%GOBP%GO:0071476,0.7640273266883192,0.9785056497784591,0.367647238661902,0.7790796182186179,6821,4,STK39|MYLK
METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072273,0.21834822401394602,0.7341474817293291,0.5354391886761429,1.23410795558924,2003,5,BMP4|PKD2
POSITIVE REGULATION OF MACROPHAGE FUSION%GOBP%GO:0034241,0.6846979865771811,0.966495577318169,0.66205337450375,0.879508371733177,5100,1,ADAM9
REGULATION OF ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1904990,0.730173441016815,0.972554563883587,-0.630017644464049,-0.8427938120765028,5514,1,PRMT5
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS%GOBP%GO:0045137,0.728992483742927,0.972554563883587,0.17142927108939005,0.813123001773198,8631,47,WNT4|INHA|BASP1|EIF2B5|ROBO2|TGFB2|ZNF830|KIT|BMPR1B|EIF2B4|FGF9|FANCF|ING2|NUP107|BRCA2|CEBPB|GATA6
ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098656,0.7281813173841191,0.972554563883587,0.153201676790301,0.8326270951109971,9252,88,SLC1A2|SLC12A2|SLC25A29|SLC36A1|SLC25A22|PIDD1|SLC35A1|SLC35B1|SLC25A19|LRRC8D|SLC37A2|SLC26A2|SLC25A10|SLC25A42|XPR1|CPT1B|SLC46A1|SLC25A1|ACACA|SLC38A6|SLC16A7|SLC5A6|MPC2|LRRC8B|SLC38A10|SLC1A3
RESPONSE TO OSMOTIC STRESS%GOBP%GO:0006970,0.474947257383966,0.9008820901999621,-0.188647713657902,-0.978710384104335,1800,30,CAB39|ARHGEF2|MAP7|OXSR1|AQP1|TNF
MITOCHONDRIAL TRICARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1990546,0.41342281879194603,0.8683189983530021,0.8005072783414209,1.06343820611496,3079,1,SLC25A1
CELLULAR RESPONSE TO MYCOTOXIN%GOBP%GO:0036146,0.7541717997536121,0.977083996023335,0.37180478214685797,0.787889850012486,6733,4,EGR1|CERS1|PDGFB|ACTB
MODULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044788,0.291741877256318,0.8000726114371469,-0.25425723531016,-1.11503829648292,1292,19,TBC1D20|FMR1|CAV2|PARK2|PC
REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051955,0.0726480203414457,0.5174726300536271,-0.512808045384571,-1.49588381961035,399,7,HRH3|PER2|TRH
REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050706,0.568736409760812,0.940076901516441,-0.195681868528525,-0.9194927367008421,2353,23,LGALS9|TNFAIP3|PANX1|FOXP1|RIPK2|NLRP1|NLRP3
SNARE COMPLEX DISASSEMBLY%GOBP%GO:0035494,0.0983503534956795,0.570215774831708,-0.7126196734371372,-1.4462404543803302,625,3,NAPB|NAPA
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0090175,0.706498594668257,0.9692116655318921,0.178312249463233,0.826673426635996,8294,43,MLLT3|SAPCD2|AP2A2|DVL1|CELSR2|DACT1|DAAM1|MAGI2|NPHP3|CLTC|FZD6|DAB2|FZD3|DVL3|DVL2|CELSR3|SMURF2|ROR2|AP2M1|AP2B1
HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048012,0.0501757126122608,0.440378626703493,-0.48783402496450895,-1.5747719484406497,256,9,BCAR1|NRP1|HGF|MST1R|RAC1
CATABOLISM BY HOST OF SYMBIONT MACROMOLECULE%GOBP%GO:0052360,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
MODULATION OF APOPTOTIC PROCESS IN OTHER ORGANISM%GOBP%GO:0044532,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|SERPINB9|BCL2L1|GAPDH
REGULATION OF PEROXISOME ORGANIZATION%GOBP%GO:1900063,0.152081696779262,0.648319130045528,-0.660472041469064,-1.34040838467532,967,3,MFF|DNM1L|MAVS
REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002840,0.729889923793396,0.972554563883587,0.515743038323684,0.8429678278499879,6033,2,HSPD1|HMGB1
REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044126,0.831135841296722,0.9879179006160809,0.472414635772844,0.7721487441814878,6870,2,OSBP|TIRAP
EOSINOPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002278,0.29540589494483804,0.800447413278835,-0.489439144101914,-1.12560778401569,1793,4,VAMP7|CCL3|VAMP8|VAMP2
TORC1 SIGNALING%GOBP%GO:0038202,0.646147447228866,0.963344312748158,0.315096064294641,0.859036406340748,6213,8,CARD11|CLEC16A|LARP1|MLST8|MTOR|RPTOR|NPRL3|AKT1S1
CAROTENOID METABOLIC PROCESS%GOBP%GO:0016116,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
REGULATION OF REPLICATIVE CELL AGING%GOBP%GO:1900062,0.505494505494506,0.9172434440873181,-0.7436038817820909,-0.9947415849521899,3817,1,NEK4
POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902916,0.3358032646048111,0.8311444145897029,0.453645994725492,1.1156762568531202,3126,6,SPSB4|MARCH7|BIRC2|PTPN22|XIAP
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000727,0.47343246334615796,0.899657490014426,0.36219463684761705,0.9874397508898408,4552,8,EDN1|BMP4
ENDOSOMAL VESICLE FUSION%GOBP%GO:0034058,0.53582995951417,0.9265056012720759,0.32888172192004805,0.9385160631118791,5293,9,VPS8|ANKFY1|SAMD9L|VPS41|TGFBRAP1|VPS39|SAMD9
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0051480,0.547341211225997,0.9305779599215391,0.161851232907112,0.9593556092805551,7410,143,TAC1|RYR2|CHRNA10|CALB1|EDN1|CXCL13|GHRL|PTGER3|ATP2B1|NOL3|P2RX5|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|AGTR1|CDH23|PDPK1|CACNA2D1|PTGER1|TMEM178A|CCR5|CCL21|F2RL1|JPH4|ATP2B3|GRIN1|CCL19|CXCL10|PLCG1|C3AR1|CALB2|CD55|DLG4|TRPC1
POSITIVE REGULATION OF BEHAVIOR%GOBP%GO:0048520,0.39869418702611603,0.8638522656500329,0.405911498603026,1.05650234881043,3785,7,GHRL|NR4A3
CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS%GOBP%GO:0071375,0.00286327845382964,0.13103871184697197,-0.196080165828416,-1.5609864270267901,3,148,ADCY7|RAB13|PRKCD|IGF1R|CPEB1|USF1|BCAR1|FOXO4|GRB2|CRHR1|RAB8B|INPP5K|HDAC5|FOXO1|PKM|CPEB2|ATP6V0C|PXN|ATP6V1F|PPARG|LYN|VAMP2|NAMPT|CAMK2A|PRKAR2A|GCGR|FOXC2|LPIN1|RAB8A|PTPN1|SLC25A33|STAT5A|SHC1|ATP6V1E2|ATP6V0D1|STAT3|PRKAR1B|ADCY2|CAV2|ATP6V1E1|RHOQ|IGF2|PIK3R1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
REGULATION OF DNA RECOMBINATION AT TELOMERE%GOBP%GO:0072695,0.28968077208611703,0.7989014598698071,-0.685470085470086,-1.17245986976705,1950,2,TERF2IP|TERF2
SENSORY ORGAN MORPHOGENESIS%GOBP%GO:0090596,0.101074739519239,0.571491553833428,0.26979448250438,1.35403820051872,1231,60,SIX3|TSPAN12|SHROOM2|TBX2|SDK1|STRC|PROX1|DSCAM|AHI1|CEP290|DFNB31|FOXN4|EFEMP1|PDZD7|FBN1|NF1|NIPBL|COL5A2|TH|COL5A1|TFAP2B|MYO7A|CHD7|TOPORS|FGFR2|WNT2B|MFAP2
MANNAN METABOLIC PROCESS%GOBP%GO:0010412,0.938389261744966,1.0,0.533855315394795,0.709202969527827,6990,1,MANBA
NEGATIVE REGULATION OF CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090350,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0006942,0.6244202715237371,0.9537930378808901,0.18656097844410102,0.888596738681145,7404,48,RGS2|RYR2|TNNI3K|AKAP9|KCNQ1|SLC8A3|FGF13|ATP2A1
PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY%GOBP%GO:0071211,0.494154454141281,0.91071489001692,-0.41460320961782393,-0.9535007684766109,3000,4,HSPA8|SMURF1|LAMP2|CLU
REGULATION OF HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:1902071,0.6351677852348989,0.95916055221954,0.6873070136744599,0.9130567047267472,4731,1,RWDD3
POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:1905205,0.705864884929473,0.968941691852291,-0.47719878687620604,-0.816222967819489,4753,2,ROCK1|ROCK2
HISTONE H2A-K13 UBIQUITINATION%GOBP%GO:0036351,0.00595789752416258,0.175567154622165,-0.99724305249228,-1.33404243700469,44,1,RNF168
COENZYME A BIOSYNTHETIC PROCESS%GOBP%GO:0015937,0.8128133704735379,0.985971473561293,-0.234486182359755,-0.728885151801277,4376,8,PANK3|PPCS|ACOT7|COASY|ACAT1|DCAKD|PPCDC|PANK2
REGULATION OF SOMITOGENESIS%GOBP%GO:0014807,0.940486270714891,1.0,0.405958472457346,0.66352797089991,7774,2,LFNG|DLL1
MYELOID DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0043011,0.99108635097493,1.0,-0.158916652876607,-0.49398215063267,5336,8,UBD|BATF2|LTBR|DHRS2|BATF3|TGFBR2|BATF|CAMK4
NEGATIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034092,0.484543244182008,0.9064456896937672,0.522444027793096,0.993111137785857,4184,3,NAA10|ATRX|TNKS
VERY LONG-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0000038,0.3120151371807,0.814643337040765,0.309093386107204,1.1297836175823202,3297,19,HACD1|SLC27A2|ELOVL6|ACOT1|ACOT2|TECR|ELOVL4|ELOVL2|ACAA1|PEX2|HACD2|ABCD1|HACD3
RRNA ACETYLATION%GOBP%GO:1990882,0.12093959731543599,0.607251067511504,0.940174239082488,1.24897953247459,900,1,NAT10
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010649,0.16537785588752202,0.6682860217990739,-0.47325557248498606,-1.2990547696834298,940,6,PDE4D|CAV1
NEGATIVE REGULATION OF ZINC ION TRANSPORT%GOBP%GO:0071582,0.25393883225208497,0.7641083395392759,-0.873842082046758,-1.16896519637567,1917,1,SLC30A1
TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:0071706,0.30709698666227603,0.8101040452554871,-0.484365521425026,-1.11393951177575,1864,4,HMGB1|TLR2|APP|BCL10
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904689,0.791605984377069,0.9819233677232551,-0.601179973533304,-0.804216780419229,5978,1,RPL13A
STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0031098,0.288049029622063,0.7978558253171079,-0.145791359697784,-1.09027095881099,563,108,IRAK1|PKN1|MAP3K8|DAB2IP|STK26|TRIB1|LGALS9|IRAK2|MAP3K13|STK10|UBE2V1|MAP2K5|MAP4K4|RIPK2|MAP2K3|DBNL|MLKL|STK4|UBA52|MAPK3|OXSR1|TNIP2|STK24|MAP3K11|UBC|MAP2K1|PAK2|UBB|ADORA2B
MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031109,0.0036521148292848705,0.143595610377104,0.40191240265926204,1.8746604609229898,42,44,AKAP9|NCKAP5|CENPJ|KIF14|KIF2C|CCSAP|KIF18A|FGF13|CKAP5|KIF24|TUBGCP3|KIF18B|CETN3|TUBG2|TUBGCP6|PIN1|CEP192|STMN1|TUBGCP2
CHARGED-TRNA AMINO ACID MODIFICATION%GOBP%GO:0019988,0.5588507877664499,0.936434965680841,-0.7143250992501099,-0.955574464856564,4220,1,MTFMT
CENTRAL NERVOUS SYSTEM VASCULOGENESIS%GOBP%GO:0022009,0.528399311531842,0.9265056012720759,-0.7309770621967359,-0.9778503034043591,3990,1,ENG
POSITIVE REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051197,0.9035647648040849,1.0,0.193927714471585,0.6258768178224079,9200,13,PRKAA2|INS
LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0015909,0.0395569620253165,0.39679154942535794,-0.29944464983300106,-1.5535284397218,149,30,DRD2|BDKRB2|ACE|ACSL3|CD36|MID1IP1|FABP3
LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:0072673,0.40579064587973296,0.8663957682383929,-0.610973256134546,-1.0450370329835799,2732,2,SNX2|SNX1
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION%GOBP%GO:0023014,0.0760869565217391,0.525661416287861,-0.139643508349169,-1.22864350291583,55,253,UBE2V1|FGF2|MAP2K5|HGF|KITLG|HBEGF|IL17RD|CAMK2A|CSF2RB|POU4F2|MBP|IGF1|MAP4K4|RIPK2|CAB39|YWHAB|KARS|FGFR1|MAP2K3|DBNL|MLKL|STK4|KRAS|HSF1|CTSH|SHC1|UBA52|RASA3|RASGRF2|YWHAE|SCG2|MAPK3|OXSR1|PLVAP|TNIP2|RASGRP3|FGF10|PEA15|STK24|MET|MAP3K11|UBC|MAP2K1|PTPRA|DLG1|TNF|GFRA2|PAK2|UBB|ADORA2B
ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036500,0.738969152674736,0.9744283926676119,-0.243413390677637,-0.7857602379043859,3784,9,CALR|HSPA5|DDIT3|ATF6
NECROPTOTIC SIGNALING PATHWAY%GOBP%GO:0097527,0.7480652066523961,0.9749763305090959,-0.338351238988247,-0.77813716562323,4542,4,TNF
REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070884,0.00285171102661597,0.13103871184697197,-0.444217283436211,-2.05794335482229,11,22,SLC9A1|PRNP|CHP1|IGF1|ATP2B4|CAMTA1|HOMER2|RCAN2|TNF
ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003272,0.674653834822744,0.9647315640607691,0.25738834048045395,0.830687846362987,6869,13,DCHS1|BMP4|ROBO2|HEYL
OLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009312,0.31454384758911896,0.8164430838831159,0.352032619024683,1.1361401126456399,3202,13,B3GALT2|FUT8|B3GALT1|MPDU1|B3GALNT1|ST3GAL4
CXCL12-ACTIVATED CXCR4 SIGNALING PATHWAY%GOBP%GO:0038160,0.11154362416107401,0.5855068018166539,0.943978826643141,1.25403375731423,830,1,CXCR4
NON-RECOMBINATIONAL REPAIR%GOBP%GO:0000726,0.775199478912229,0.9805314293977441,0.154258110199682,0.789612120402387,9520,66,XRCC6BP1|C9orf142|LIG4|BLM|DCLRE1A|POLQ|SLX1B|HIST1H4I|PIAS4|H2AFX|DCLRE1C|XRCC4|BRCC3|SLX4|HERC2|PAXIP1|RIF1|PRKDC|ATM|MDC1|UIMC1|BRCA1|BRE|POLL|RAD52|RNF8|SETMAR|UBE2V2|TP53BP1|RBBP8|RAD50|PSMD14|NBN|ZBTB7A|LIG3
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009168,0.0551443375277572,0.457996676929382,-0.209401389833927,-1.38276639354136,148,67,ADSL|ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|LHPP|PFKL|COX5B|GPI|GMPS|ATIC|PKM|ENO1|HPRT1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
COMMON-PARTNER SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0007182,0.6543938867662379,0.9640743070248079,0.462194268984202,0.878582684326875,5651,3,BMP4
TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:0044342,0.223093291522007,0.7355723797115551,0.572462352563241,1.2131024095346201,1991,4,NOV|BTBD10|BAD
NEGATIVE REGULATION OF METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000007,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0051188,0.35725429017160704,0.8450918868064541,-0.130019604994498,-1.05306695611425,457,164,PNP|ENO1|NAMPT|ACSL4|NFE2L1|CHAC1|PDHB|GAPDH|PGK1|PANK2|SLC25A38|FXN|FPGS|HK1|NMNAT3|SPR|HK2|TPI1|PNPO|NDUFA9|ACLY|CNDP2|PDXK|ALDOA|COX10|SLC25A16|ACSL3|LIAS|QDPR|PGAM2|NMNAT2
INSULIN CATABOLIC PROCESS%GOBP%GO:1901143,0.00846740050804403,0.20298122046820802,0.938020402536532,1.53316857901809,69,2,CEACAM1|IDE
"REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:2000622",0.381775333857031,0.857178152269066,-0.515257993640766,-1.04570078910663,2429,3,NBAS|PABPC1
REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045414,0.0318101933216169,0.36484755247355394,-0.613010981225393,-1.68267398278639,180,6,BCL10|MAP2K5|BCL3|TNF
NEGATIVE REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000002,0.499384029566581,0.914249271904946,0.461835257797428,0.978673028075167,4458,4,THOC1|PPP1R10|DDX39B
POSITIVE REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902204,0.0426845637583893,0.40719991958679996,0.978109836788708,1.2993752816003001,317,1,ESM1
CHLORIDE ION HOMEOSTASIS%GOBP%GO:0055064,0.665964616680708,0.964618776001639,0.319909798143843,0.8326579914824809,6323,7,SLC12A2|SLC12A5|SLC12A9|SLC12A4|SLC12A6|SLC12A8|SLC12A7
MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:0097152,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:1905552,0.0923533778767632,0.5622489437340121,-0.815219189412738,-1.39438876314344,621,2,RTN4|DDRGK1
"BLOOD COAGULATION, EXTRINSIC PATHWAY%GOBP%GO:0007598",0.684149588977654,0.966495577318169,0.45081063196206006,0.85694358786145,5908,3,F3|F10|TFPI
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN DETERMINATION OF LEFT/RIGHT SYMMETRY%GOBP%GO:1900094,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
TELENCEPHALON GLIAL CELL MIGRATION%GOBP%GO:0022030,0.177987649836542,0.683751674540239,-0.43890573920443604,-1.28030751373581,979,7,DAB2IP|RTN4|SRGAP2C|MBOAT7
IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:0001771,0.26990311710193804,0.7846089815823771,0.454008285850134,1.18168818087403,2562,7,CCL21|CORO1A|CCL19|PRF1
POSITIVE REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0010950,0.181719260065288,0.6873049536419911,-0.152125613038538,-1.15833064506597,333,116,LGALS9|CIDEB|DLC1|EIF2AK3|BBC3|RPS3|CYFIP2|S100A8|PSME3|FYN|DDX3X|TNFRSF10A|PPARG|LYN|EFNA1|BOK|MBP|RIPK2|CRADD|SNCA|NLRP1|NLRP3|STAT3|TNFRSF10B|MTCH1|SOX7|BCAP31|TNF|PMAIP1|EGLN3
CATABOLISM OF SUBSTANCE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052227,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
POSITIVE THYMIC T CELL SELECTION%GOBP%GO:0045059,0.0646208981968865,0.495456803258629,0.685380245960404,1.4523862121223798,576,4,CD3D|CD3G|CD3E|ZAP70
PROTEIN SUMOYLATION%GOBP%GO:0016925,0.42087460739309007,0.8727872721376851,-0.21710162061070498,-1.02014236055001,1741,23,UBE2I|SUMO1|EYA1|SENP5|SUMO3
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072365,0.589434661723818,0.945418171231938,-0.699327304808116,-0.9355114579525899,4451,1,NCOR2
RESPONSE TO NICOTINE%GOBP%GO:0035094,0.00105485232067511,0.0882293398116183,-0.553988936767465,-2.1462998027418996,4,14,CHRNB4|RELA|CHRNA5|CHRNB1|CHRNB2|HMOX1|CHRNA7|CHRNA3|BCL2|TNF
REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902743,0.0368115139773042,0.386113929236656,-0.284722195864029,-1.53205791742742,132,34,TWF1|CDC42|ARPIN|SSH3|TWF2|RAC1|CORO1C|BRK1
GLUCOCORTICOID CATABOLIC PROCESS%GOBP%GO:0006713,0.255792400370714,0.767206100763278,-0.872849580943979,-1.16763749738938,1931,1,YWHAH
POSITIVE REGULATION OF HAIR CYCLE%GOBP%GO:0042635,0.07779472651993902,0.5314695499765479,0.6265904187150579,1.4441980284337401,713,5,FST|NUMA1|TGFB2|TERT
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000108,0.6008210807714339,0.95044396968724,0.25367914881604997,0.894689723427689,6292,17,SIRT1|IDO1|CDKN2A|CCL5
CALCIUM-MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE%GOBP%GO:0035584,0.8761042402826859,0.9941329456747149,-0.16564098947668898,-0.696998232133957,3966,17,PRKACA|VCAM1|KDR|FKBP1B|PTGFR|PRNP|BCAP31
CDP-DIACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046341,0.7553020134228191,0.9771370084125129,0.6253859726510811,0.8307973642206791,5626,1,CDS1
POSITIVE REGULATION OF HISTONE H4-K20 METHYLATION%GOBP%GO:0070512,0.7255033557046979,0.972554563883587,0.64082487869431,0.851307262120678,5404,1,BRCA1
ERK5 CASCADE%GOBP%GO:0070375,0.9804026845637579,1.0,0.5120754300838111,0.680269363561757,7303,1,MEF2A
DENTINOGENESIS%GOBP%GO:0097187,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045064,0.40884416788031197,0.867015886388254,-0.794386854874283,-1.06267551641748,3087,1,BATF
OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:0003151,0.726924712888133,0.972554563883587,0.173386447084551,0.812729732349603,8544,45,ELN|TBX2|NPY1R|HES1|NPY2R|BMP4|ROBO2|TGFB2|HEYL|NIPBL|HAND2|HEY2
NEGATIVE REGULATION OF STRESS GRANULE ASSEMBLY%GOBP%GO:0062030,0.693020134228188,0.96731875442989,0.658138509042788,0.87430764762282,5162,1,STYXL1
HEART VALVE MORPHOGENESIS%GOBP%GO:0003179,0.466273932253314,0.894322345600068,-0.174773972179459,-0.993958179647585,1582,40,SMAD6|ADAMTS9|EFNA1|SNAI1|TBX20|NOS3|OLFM1|TWIST1|SLIT3
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010988,0.19590324689474803,0.7094584893557679,0.547039537868398,1.2608450408242,1797,5,LDLRAP1|KHSRP|CNPY2|HNRNPK
REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903760,0.333228593872742,0.8293509737209019,-0.5377514848218871,-1.09135066114774,2120,3,DLG1
RESPONSE TO ALCOHOL%GOBP%GO:0097305,0.8667101721184441,0.9929671171385601,0.140578970515272,0.7152855763365021,10624,64,GRIN3A|CRHBP|GNAI1|CD27|ADCY8|BLM|CAD|CCR5|CCL21|GRAMD1B|ABCA2|RAD51|GRIN1|CCL19|DRD4|TH|PEBP1|ADCY1|ADCY6|SPIDR|IREB2|BRCA1|LRP6|ADAM15|LARP1
PRENYLCYSTEINE METABOLIC PROCESS%GOBP%GO:0030329,0.72299504052256,0.971955586175348,0.518356595015685,0.847239614464462,5976,2,PCYOX1L
ANATOMICAL STRUCTURE REGRESSION%GOBP%GO:0060033,0.36733481811432794,0.851186780857897,-0.637386269644334,-1.09021507800156,2473,2,AMH|AMHR2
NUCLEAR RNA SURVEILLANCE%GOBP%GO:0071027,0.33243411496161,0.8293509737209019,-0.28802474464351596,-1.08469568291564,1601,13,EXOSC6|PRPF18|EXOSC4|EXOSC9|EXOSC5
DRUG METABOLIC PROCESS%GOBP%GO:0017144,0.9785670545009192,1.0,0.101425575880333,0.6785755130642839,14381,411,DPEP1|SNCAIP|CTH|CYP2D7|CYP2C8|NDUFA7|FH|GAMT|ASRGL1|NDUFS7|VCAN|HSD17B4|AKR1B1|MAT2A|MCCC2|CBR4|CYP3A5|NDUFA4|IDE|BDH2|PLA2G4A|GGT1|MYH3|ATP5G1|NDUFS2|CD320|FADS2|COX5A|SLC25A19|OVGP1|ALDH1A1|HBB|TEFM|APIP|HRSP12|DHFR|ABCD4|COA6|HBA2|ATP5D|NNT|MTHFD1|CYP2R1|NDUFC1|CACNA1H|NDUFAF1|NDUFS4|TGFB2|TAZ|BCHE|SDHAF3|CAD|ADH1B|PRDX4|PARP1|AK3|MT-ATP8|SULT1A3|DUOX1|AKR1C1|SAT2|COX6A1|MTR|RFK|FADS1|ALDH3A2|ADSSL1|AMDHD2|PRDX3|HBA1|SLC46A1|GCK|NDUFS8|XPNPEP1|PCCB|PDHA1|NDUFB2|UQCC3|SUCLG1|ACSS1|MTAP|NADK|SDHA|GGT5|PSAT1|GSTZ1|DRD4|TH|MT-ND2|SLC19A2|BAD|ACO1|ME3|NDUFV1|DHTKD1|MOXD1|CKB|NMNAT1|PFKFB2|NDUFS3|HMGCLL1|MCCC1|ATP5C1|CAT|NDUFB7|C9orf41|NDUFA12|CCBL1|MT-CO2|MTHFD2L|LRTOMT|FMO2|PTS|QPRT|HMGCL|HBQ1|PCCA|AACS|MT-CYB|CYP2E1|PDXP|SLC19A1|BGN|GBAS|ACO2|ENTPD5|CYP2D6|PCK2|ELOVL2|BPGM|ENOPH1|ATP5E|LPCAT2|IREB2|PM20D2|COMT|ADSS|SURF1|AKT1|VPS9D1|GNMT|PARG|ATP5H|MT-ATP6|LACE1|DCN|MT-CO1|DBH|MAOA|ATP5A1|CYCS|NDUFB1|ACAA1|GPX3|UQCR10|ADAL|MTHFR|CKMT1B|NDUFB3|NDUFA1|HSPA8|STOML2|GATM|ARG2|NDUFB6|CYP27B1
CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0044106,0.9639862300291291,1.0,0.12862100880181898,0.5544239228881321,10920,33,IDO1|NAPEPLD|DDC|SAT2|GDPD1|SARDH|MOXD1|CCBL1|AZIN2|AFMID|SAT1|AADAT|DBH|MAOA
MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:0060916,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
EMBRYONIC SKELETAL LIMB JOINT MORPHOGENESIS%GOBP%GO:0036023,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0019433,0.251221794738484,0.7634465094445358,0.43822517050416104,1.19471938337492,2415,8,LPL|FABP5|FABP6|PNPLA2|APOE
BOX H/ACA SNORNP ASSEMBLY%GOBP%GO:0000493,0.128285077951002,0.608160579951936,-0.782189137027847,-1.33789262751554,863,2,NAF1|SHQ1
TRNA DEMETHYLATION%GOBP%GO:1990983,0.485503355704698,0.9067242420344581,0.76130348478165,1.01135771537603,3616,1,ALKBH1
REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050746,0.670722847802398,0.964618776001639,-0.285328185328185,-0.8323149754624709,3692,7,SVIP|RAB3GAP2|ITGB3|ITGAV|RAB3GAP1|GBA|APOD
DNA DEAMINATION%GOBP%GO:0045006,0.0736040609137056,0.520821259294202,-0.461620225739806,-1.4901514554684299,376,9,APOBEC3F|EXOSC6|EXOSC4|CDADC1|EXOSC5
REGULATION OF OSSIFICATION%GOBP%GO:0030278,0.665234207133648,0.964618776001639,-0.128609965987943,-0.9042948132513431,1547,85,IL6R|SNAI2|ZBTB16|GPM6B|NOTCH1|LRP5|SRGN|SKI|NELL1|PTK2B|ACVR1|FAM101B|LIMD1|SMAD6|BMP2K|CCRN4L|HGF|IL6|IGF1|NPNT|FAM101A|DKK1|ANO6|CHSY1|GREM1|S1PR1|IFITM1|TWIST1|RBPJ
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN%GOBP%GO:0019883,0.7775287468329759,0.9811398289380491,0.224871941087091,0.7450706213347521,7978,14,TAP2|ERAP1|CD1E|CD1D|HLA-F|TAP1|HLA-C|CD74
NEGATIVE REGULATION OF RNA CATABOLIC PROCESS%GOBP%GO:1902369,0.0725616921269095,0.51730270482727,-0.24673391129629002,-1.39213616436963,246,39,CCRN4L|SLC11A1|VIP|NBAS|YBX1|FMR1|HNRNPC|RBM38|PABPC1|MYD88|RBM24
NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0033865,0.15564140976109803,0.656198355453056,0.23243063735634398,1.2580508623781799,1973,86,ACSM3|HACD1|CROT|ACSF2|OXSM|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|ACBD6|MVD|SLC35B3|ACOT1|SLC26A2|SULT1A3|PDHX|FAR1|PDHA1|ACOT2|SLC25A1|ACACA|SUCLG1|DLD|ACSS1|MCEE
POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051901,0.60464350403425,0.9508825506493929,-0.378646666299013,-0.87080823042836,3671,4,DCN|GNB2L1|MLLT11|KDR
ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0009948,0.0465444287729196,0.42492959476754205,0.52509631609274,1.54969488822101,461,10,RIPPLY2|TBX3|BASP1|HOXD8
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS FROM GLUTAMATE%GOBP%GO:0019353,0.32362416107382597,0.8239107965478291,0.842247463608293,1.11888818008031,2410,1,CPOX
TOOTH ERUPTION%GOBP%GO:0044691,0.35985701045942003,0.8483404911343001,-0.8188685487428321,-1.09542542474603,2717,1,FAM20A
POSITIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048260,0.627939529675252,0.955467342057318,-0.162124456065518,-0.891829126345601,2242,36,PICALM|SGIP1|CLU|VEGFA|RAB21|ARRB2|ARRB1|TBC1D5|FMR1|B2M|GREM1|BICD1
TRANSLATIONAL TERMINATION%GOBP%GO:0006415,0.73999065274965,0.9744283926676119,0.15034055810404098,0.8260354401610541,9499,93,MRPL50|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|ERAL1|MRPL16|ABCE1|MRPS31|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|GSPT2|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|MRPL52|MRPS28|GADD45GIP1|MRPL45|MRPL27|MRPL40
ENERGY HOMEOSTASIS%GOBP%GO:0097009,0.0882220216606498,0.556932119338259,-0.32313086503673805,-1.41708175522358,390,19,FLCN|SGIP1|PRKAA1|FOXO1|EIF4G1|METRNL|LEPR|PPARGC1A|STAT3|NR1D2|CD36
DESMOSOME ORGANIZATION%GOBP%GO:0002934,0.49811126373626397,0.913231555268047,-0.375137877785131,-0.949636627176631,2900,5,PERP|JUP|PKP2|SNAI2|PRKCA
NEGATIVE REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050710,0.29158567064704305,0.8000726114371469,-0.20593951037057198,-1.11948861204818,1049,35,SYT11|SRGN|CX3CL1|TNFAIP3|SSC5D|FCGR2B|TMSB4X|NLRP3|TNFRSF4|PPP1R11|TNF|TNFRSF21
POSITIVE REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046726,0.460563148361601,0.890425671260386,-0.425926349492865,-0.979541624702428,2796,4,TBC1D20|STAU1
L-METHYLMALONYL-COA METABOLIC PROCESS%GOBP%GO:0046491,0.44684563758389295,0.88473565970262,0.7820357300397,1.03889957827031,3328,1,MCEE
GRANZYME-MEDIATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0008626,0.402460456942003,0.865238688875249,-0.37174334341048604,-1.02041051692165,2289,6,BNIP3|SRGN|GZMB|LAMP1
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002924,0.332739420935412,0.8293509737209019,-0.659939343810312,-1.12879090349707,2240,2,FOXJ1|FCGR2B
NUCLEOTIDE PHOSPHORYLATION%GOBP%GO:0046939,0.0016606698034874099,0.10497081150975199,-0.38814150976096007,-2.0885455428121698,5,34,CMPK2|LDHA|CMPK1|PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|AK7|ALDOA|PGAM2|AK4
SYNAPTIC VESICLE ENDOSOMAL PROCESSING%GOBP%GO:0099532,0.136808999637111,0.62388141596544,0.77601323407775,1.26837231276947,1130,2,AP3D1|EEA1
PRESYNAPSE ASSEMBLY%GOBP%GO:0099054,0.585421649162941,0.9439064862850342,0.33234716520254104,0.9060675356013371,5629,8,DVL1|PTPRD|NLGN4Y|NLGN3|NLGN2
CARDIAC ATRIUM MORPHOGENESIS%GOBP%GO:0003209,0.9657961411030992,1.0,0.16090718099837,0.533135493668585,9910,14,PROX1|TGFB2|HEY2|DLL4|NOTCH2|ZFPM1|ISL1
NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0009112,0.785603199289047,0.981487311948134,-0.17862700151082603,-0.7684136734139321,3535,18,ADA|MTHFD1L|APRT|DHODH|ALDH6A1|GMPS|PRPS1|CDA|HPRT1
POSITIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0090035,0.985000604814322,1.0,0.333219395622531,0.544637948072738,8142,2,HDAC6
AV NODE CELL-BUNDLE OF HIS CELL ADHESION INVOLVED IN CELL COMMUNICATION%GOBP%GO:0086072,0.435570469798658,0.878651088001772,0.7887626819585359,1.0478360337838801,3244,1,CXADR
POSITIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000343,0.0680059278774905,0.50364937614461,-0.6651622110765469,-1.5297341282227799,412,4,MBP|TNF
REGULATION OF SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1905512,0.441610738255034,0.880423444399886,0.7855094838994271,1.04351430529781,3289,1,PRRT2
REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0061945,0.838877464618362,0.989395884107905,0.46837606837606804,0.7655478167173959,6934,2,BIRC2|TRIM44
POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0045836,0.45844461901021205,0.890371861972445,-0.484163661815372,-0.98259576652016,2917,3,PLCB1
REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043551,0.549654806160382,0.931359181171847,-0.17714351991691898,-0.931515343450451,2069,31,DAB2IP|PTK2B|FGR|FGF2|PIK3IP1|EPHA8|FLT1|KIAA0226|PIK3R1
NEGATIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:1901624,0.11878553284141802,0.602329212916938,0.7896884477529641,1.29072407384151,981,2,KLRK1|CCL2
CEREBELLUM MATURATION%GOBP%GO:0021590,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
POSITIVE REGULATION OF DIPEPTIDE TRANSPORT%GOBP%GO:2000880,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
ACUTE-PHASE RESPONSE%GOBP%GO:0006953,0.6493709056878441,0.963755998259649,0.31432491001435703,0.8569340328847271,6244,8,INS|SIGIRR|CEBPB
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905063,0.9035647648040849,1.0,0.19394330828342798,0.62592714484947,9200,13,CTH|KIT|HEY2|FGF9
REGULATION OF METANEPHRIC GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072301,0.6645637583892621,0.964618776001639,0.6734671371857079,0.8946710462521049,4950,1,EGR1
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0035604,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
ONE-CARBON METABOLIC PROCESS%GOBP%GO:0006730,0.9450936933306469,1.0,0.192903986250882,0.5693095004643871,9380,10,MTHFD1|TYMS|MTHFD2L|GNMT|MTHFR|MTHFS
RESPONSE TO TYPE I INTERFERON%GOBP%GO:0034340,0.00431034482758621,0.15451000149276,-0.295729147719808,-1.81126607072321,12,52,EGR1|GBP2|HLA-F|STAT2|TYK2|TRIM56|STAT1|BST2|IFIT1|IP6K2|IRF9|HLA-C|IRF2|C19orf66|ISG20|OAS1|IFI35|PSMB8|IFIT2|IFIT3|IRF5|JAK1|IRF7|OAS2|IRF8|HLA-B|ADAR|HLA-A|HLA-E|IRF1|IRF3|RSAD2|IFI6|SP100|SAMHD1|ISG15|MX1|SETD2|RNASEL|IRAK1|IFNAR2|IRF6|IFNAR1|IFITM2|MX2|IFITM3|OASL|SHMT2|OAS3|IFITM1|MYD88
FAT PAD DEVELOPMENT%GOBP%GO:0060613,0.160201244538594,0.661454203640901,-0.9171812968681079,-1.22694138544377,1209,1,DGAT2
REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904533,0.317989002356638,0.819776173598052,-0.5456600860262489,-1.1074009323171299,2023,3,RTEL1|TERF1|TERF2
ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:0035635,0.468034871049764,0.8957057061714878,-0.335379146345266,-0.9783158493084558,2576,7,CBLL1|CTNNB1|GRB2|MET
KETONE BODY METABOLIC PROCESS%GOBP%GO:1902224,0.653296193129062,0.9640743070248079,-0.271148265491724,-0.8428468691190079,3517,8,SLC27A5|BDH1|OXCT1
TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB%GOBP%GO:0022028,0.41215214885559,0.867015886388254,-0.44336201248844803,-1.01964000715468,2502,4,SLIT3
INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097193,0.0356425702811245,0.3821688062173221,-0.18518351105582004,-1.37418307681615,70,105,PRKCD|DAB2IP|DDIT4|CIDEB|ABL1|BBC3|PML|MYBBP1A|CUL5|DDX3X|DDIT3|BCL2L1|POU4F2|BOK|CHAC1|PDCD10|BCL2|TP53|BCL3|CDIP1|ZNF622|TNFRSF10B|CDKN1A|CRIP1|STK24|JMY|BCL2L11|PMAIP1|TRIB3
SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035725,0.0990378674198958,0.570215774831708,0.322182254512151,1.3887742841979798,1121,33,SCN1A|SLC12A2|HCN2|SLC9A5|SLC9A7|SLC8A3|ATP1B3|PKD2|HCN3|NALCN|ASIC1|SCN3B|SLC8A1|SCN8A|SLC8A2|SCN9A
CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:0072567,0.9545179629853641,1.0,0.386676557966111,0.6320122113691651,7890,2,F2RL1
NEGATIVE REGULATION OF GENE SILENCING BY RNA%GOBP%GO:0060967,0.7594197058230909,0.977664504547119,0.25746901908551,0.7598575928337371,7537,10,TERT|DND1|ELAVL1|NCOR1|ZC3H12A|BCDIN3D
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032429,0.4295492839090139,0.8779175232404279,0.39631535062460294,1.0315255917744,4078,7,AGTR1|PLAA|LRP1|ANXA1|PLA2R1|EGFR|ANG
REGULATION OF PROTEIN FOLDING IN ENDOPLASMIC RETICULUM%GOBP%GO:0060904,0.349529988084205,0.842847021021096,-0.825319805910896,-1.10405546815693,2639,1,HSPA5
POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING%GOBP%GO:0010739,0.444372852233677,0.8814539233251801,0.41219385300844497,1.0137307512228801,4137,6,ADGRV1|C8orf4|MC1R
GLYCINE SECRETION%GOBP%GO:0061536,0.367651006711409,0.8512048542076959,0.821239523599471,1.09098006900924,2738,1,SLC6A9
ENDOPLASMIC RETICULUM STRESS-INDUCED PRE-EMPTIVE QUALITY CONTROL%GOBP%GO:0061857,0.37329139954034096,0.852609194081082,0.654645712710229,1.0700004332551099,3085,2,BAG6|VCP
NEGATIVE REGULATION OF CYTOKINESIS%GOBP%GO:0032466,0.253541076487252,0.7641083395392759,0.5171399713856121,1.19193097243801,2326,5,E2F8|E2F7|AURKB
REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031952,0.19288236892148897,0.7029764330345021,-0.229139346215413,-1.2130844566494399,709,32,TOM1L1|ENG|PPP2R5A|RAP2C|VEGFA|IMPACT|MRE11A|PPP2R5C|RASSF2|CHP1|GREM1|EPHA7|ACE|CAV1
GLYCOSPHINGOLIPID METABOLIC PROCESS%GOBP%GO:0006687,0.642364951084645,0.9620807249753851,0.18685022338113602,0.875839689845894,7550,45,B3GALT2|B4GALNT1|B3GALT1|ST3GAL5|CLN6|GBA2|B4GALT6|ST8SIA3|ASAH1|B3GALNT1|SMPD1|LARGE|SMPD4|CPTP|B4GALT3|ARSA|HEXA|ST8SIA2|ALDH5A1|CTSA|NEU3|UGCG
REGULATION OF CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090348,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
MESENDODERM DEVELOPMENT%GOBP%GO:0048382,0.925989672977625,1.0,-0.535233789148655,-0.7159985588855781,6993,1,ZFP36L1
NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0033869,0.558550824175824,0.936434965680841,-0.35793073020075,-0.906077875680143,3252,5,ACOT7|ABCD1|ACAT1|MLYCD|NUDT7
PIGMENT GRANULE AGGREGATION IN CELL CENTER%GOBP%GO:0051877,0.0071269487750556795,0.190063443902894,-0.939123242349049,-1.60632000981439,47,2,MKKS|BBS7
PHOSPHATIDYLETHANOLAMINE CATABOLIC PROCESS%GOBP%GO:0046338,0.8181143281366,0.987153241368501,-0.43159636062861895,-0.7382224600327181,5509,2,PNPLA8|PLA2G15
AMINO SUGAR METABOLIC PROCESS%GOBP%GO:0006040,0.698839662447257,0.96731875442989,-0.16302272792757,-0.845767136924138,2649,30,CHST2|MGAT3|FN3K|NPL|ST6GAL1|RENBP|GNPDA1|GNPDA2|NAGK|CHST3|NANP|MGEA5|GFPT1|GNPNAT1|ST3GAL1|SLC35A3|CHST1|CHST7|UAP1L1|CTBS|GNE|CHIT1|GFPT2|CSGALNACT1
POSITIVE REGULATION OF MRNA CAP BINDING%GOBP%GO:1905612,0.27181252482457297,0.7865607589760191,-0.864137626819585,-1.1559832507319199,2052,1,EIF4G1
REGULATION OF STRAND INVASION%GOBP%GO:0060542,0.713756123394678,0.971081608033886,-0.6384539038376711,-0.854079253459989,5390,1,WRN
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090207,0.999142938767736,1.0,0.102970991693465,0.36937794000504903,10491,18,GNB3|SCARB1|PNPLA2|LDLR|CNEP1R1|APOC2|GPLD1|SREBF1|SLC27A1|C3|FITM2
DETERMINATION OF STOMACH LEFT/RIGHT ASYMMETRY%GOBP%GO:0071909,0.8069432684165959,0.984682960940884,0.48431210366694205,0.7915948286118301,6670,2,NPHP3|NPHP3-ACAD11
NEGATIVE REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031397,0.177343223196224,0.682225579408284,-0.194890965092333,-1.20886865677591,525,54,VPS28|PINX1|TNFAIP3|ARRB2|ABL1|RPS3|TRIP12|ARRB1|CHP1|BAG5|LIMK1|PRMT3|SMAD7|GNL3L|NXN|PER2|CAV1
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032914,0.6270227808326789,0.95494981362608,-0.426323213301586,-0.8652102947766271,3990,3,FURIN|ATP6AP2
NUCLEAR MIGRATION ALONG MICROFILAMENT%GOBP%GO:0031022,0.468489173823636,0.896021389039524,0.6163719196937371,1.00744297001226,3872,2,SYNE2|SUN2
REGULATION OF FAS SIGNALING PATHWAY%GOBP%GO:1902044,0.33288789903489197,0.8293509737209019,-0.659718775847808,-1.12841363381007,2241,2,SP100|TMBIM1
POSITIVE REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:0002052,0.778406872315502,0.9811398289380491,-0.234514093694067,-0.7570325097562979,3986,9,VEGFA|CX3CL1|CTNNB1|DRD2
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001240,0.00645161290322581,0.180481691368788,-0.494629156197799,-1.9726252645791498,29,15,SNAI2|IL1B|MAPK7|MAP2K5|UNC5B|BCL2L1|EYA4|BCL2|EYA1|TNF
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902041,0.0249203129527673,0.329326373353219,-0.283389368455133,-1.5863336152490601,85,38,HMOX1|TNFAIP3|FAIM2|TNFRSF10A|BCL2L1|ICAM1|ARHGEF2|LGALS3|CFLAR|NOS3|TNFRSF10B|PEA15|PMAIP1
POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903800,0.7414994280960799,0.974505008828563,0.285398952386866,0.7780741120351641,7130,8,BMP4|MAP2K2|MYCN|DDX5
REGULATION OF PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE ACTIVITY%GOBP%GO:0060584,0.0252348993288591,0.329326373353219,0.987759153065726,1.3121939677878,187,1,EDN1
KIDNEY MORPHOGENESIS%GOBP%GO:0060993,0.306433618445519,0.809874675097403,0.300811102411208,1.1372263011980601,3295,21,CITED1|BMP4|PKD2|AHI1|KLHL3
SEQUESTERING OF TGFBETA IN EXTRACELLULAR MATRIX%GOBP%GO:0035583,0.609818223920343,0.9508825506493929,0.47683336995259595,0.9064100752921741,5266,3,FBN1|LTBP1
DOLICHOL-LINKED OLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006488,0.0151804468206989,0.264387156924099,0.48961960973721796,1.7268176563388402,158,17,ALG6|MVD|ALG14|ALG13|SRD5A3|DPAGT1|MPDU1|ALG2|DOLPP1
POSITIVE REGULATION OF MITOTIC SPINDLE ELONGATION%GOBP%GO:1902846,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
POSITIVE REGULATION OF DNA-DIRECTED DNA POLYMERASE ACTIVITY%GOBP%GO:1900264,0.0369415807560138,0.386113929236656,0.6387088724603679,1.57081145283043,343,6,RFC4|DSCC1|CHTF18|RFC3|RFC5
POSITIVE REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901727,0.506668862176848,0.9172434440873181,-0.4100098715907921,-0.942937050596364,3076,4,VEGFA|PRKD2
REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010559,0.40091813312930397,0.8638522656500329,-0.207466675829237,-1.03384732724546,1571,27,NECAB2|CTNNB1|ITM2A|TCF7L2|CHP1|IGF1|ACOT8|PLCB1|RAMP1
LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001909,0.804558011049724,0.984650105009938,-0.169128062412192,-0.754633430238619,3494,20,GZMB|ULBP3|VAMP2|ULBP2|CTSH|TUBB4B
NEGATIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042997,0.28609470881092997,0.7952357288717371,0.601466857836109,1.14332522480793,2470,3,PKDCC|GOPC|CSK
MISFOLDED PROTEIN TRANSPORT%GOBP%GO:0070843,0.45006711409396,0.886062942999295,0.7804367004852231,1.03677533884496,3352,1,HDAC6
REGULATION OF MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION%GOBP%GO:1903538,0.489209585595128,0.908887630979233,-0.7537494486104979,-1.00831361903429,3694,1,YTHDF2
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1905872,0.578975241625844,0.942692029750853,-0.7041795324217031,-0.9420024307744641,4372,1,FAM65B
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002504,0.43106535362578297,0.8785877309899279,-0.14163665921503302,-1.0161318956088699,962,91,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|HLA-DQB1|DCTN5|FCGR2B|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1
ESTABLISHMENT OF INTEGRATED PROVIRAL LATENCY%GOBP%GO:0075713,0.97119683893106,1.0,0.193292156766402,0.526966276440688,9339,8,LIG4|XRCC4|PSIP1|PPIA|XRCC5|HMGA1|XRCC6|BANF1
REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:0090085,0.516583747927032,0.9226858767708771,-0.258058291939716,-0.9401322433469731,2491,12,PARK7|ITCH|WDR48|TANK|GLTSCR2|TNIP1
STEM CELL DIFFERENTIATION%GOBP%GO:0048863,0.809782608695652,0.984682960940884,-0.11949641838086,-0.8070066007152529,2085,72,SETD6|SNAI2|SETD2|KBTBD8|FAM172A|C17orf96|NOTCH1|FZD1|BATF|FOXO4|SEMA3F|ELL3|NRP1|MEOX1|SEMA7A|NOLC1|SEMA6B|WNT3|GREM1|ACE|SEMA3A|CORO1C|SEMA3G|RBPJ
RELAXATION OF MUSCLE%GOBP%GO:0090075,0.7479100318471341,0.9749763305090959,0.253807796592116,0.7743094072623491,7514,11,RGS2|ATP2A1|SLC8A1|GSTM2|P2RX4|CHGA|ATP1A1|ATP1B1
G PROTEIN-COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035588,0.309148682642659,0.8114708447293539,-0.8459417732686371,-1.1316421026499,2334,1,GNAI2
POSITIVE REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031948,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000644,0.160733745005449,0.663263072915681,-0.449690372606964,-1.31176676784164,884,7,ITCH|FURIN|MTMR2|PTPN1
MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0035264,0.12029639921268999,0.606646975444992,0.6978052277489799,1.3264543315961799,1038,3,WDR11|STIL|FGFR2
HYPOXANTHINE TRANSPORT%GOBP%GO:0035344,0.547785234899329,0.9305779599215391,0.7293228936921041,0.968872926868888,4080,1,SLC29A2
ALKANESULFONATE METABOLIC PROCESS%GOBP%GO:0019694,0.9802889461305859,1.0,0.248891188961807,0.527424204735191,8752,4,CDO1|STAT5B
REGULATION OF MRNA STABILITY INVOLVED IN RESPONSE TO STRESS%GOBP%GO:0010610,0.8522635174250319,0.991298302704726,0.37862456100526104,0.719725460662207,7360,3,MYEF2|IGF2BP1|HNRNPM
HYPEROSMOTIC SALINITY RESPONSE%GOBP%GO:0042538,0.08724832214765099,0.5536089896886011,0.957432730480812,1.27190666834137,649,1,AKR1B1
ESTABLISHMENT OR MAINTENANCE OF MICROTUBULE CYTOSKELETON POLARITY%GOBP%GO:0030951,0.0528614626497928,0.44848293183566496,0.700075776338013,1.4835274447827398,471,4,CAMSAP3|KIF2C|CKAP5
NEGATIVE REGULATION OF TRANSLATION%GOBP%GO:0017148,0.999148409073314,1.0,0.07606662156684199,0.422820302799443,12905,99,BTG2|ENC1|NANOS3|ZNF540|MEX3D|TPR|HRSP12|DHFR|EPRS|CPEB3|EIF4EBP3|IGFBP5|IGF2BP3|TNRC6A|METTL3|KHSRP|TNRC6C|MALSU1|CNOT3|TYMS|UNK|CNOT1|RBM23|IREB2|FTO|RBM4|RC3H1|LARP1|SAMD4B|MRPL13|IGF2BP1|CNOT2|C8orf88|AGO4|IGF2BP2|FXR2|CNOT8|PATL2|TOB1|NANOS1
REGULATION OF INTESTINAL ABSORPTION%GOBP%GO:1904478,0.8550335570469799,0.991298302704726,0.5735553595059549,0.761942706984968,6369,1,HAMP
REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045408,0.26889279437609803,0.784543299601953,-0.42112709999041603,-1.15596561285679,1529,6,STAT3|TNF
REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071637,0.277328646748682,0.7884684708511421,-0.417681440673221,-1.14650750939019,1577,6,IL1B|LGALS9|APOD|TWIST1
RESPONSE TO TOXIC SUBSTANCE%GOBP%GO:0009636,0.025,0.329326373353219,-0.181483720022966,-1.40567020104074,41,125,BAX|SOD1|AHR|PPIF|CHRNB2|MT1M|ADCY7|KDR|IMPACT|MAPK7|PRKCD|SIRPA|STK26|HMOX1|TNFAIP3|SOD3|ADIRF|HP|ABL1|RPS3|FYN|ZNF580|CES1|IL6|CHRNA7|SOD2|NQO1|PDCD10|FXN|SLC7A8|NET1|CHRNA3|HSF1|BCL2|NOS3|GSTM3|ADCYAP1|DRD2|GSTM1|PARK2|STK24|SNN|SESN2|AQP1|TNF
"PROTEIN LOCALIZATION TO CHROMOSOME, CENTROMERIC REGION%GOBP%GO:0071459",0.16961807217382996,0.673117535978459,0.372530233211165,1.2914612921071,1771,16,CDK1|CASC5|CENPA|RB1|AURKB|BOD1|SPDL1|MTBP|CHAMP1|CTCF|IK|MIS12|GSG2|RCC2|ZW10
NEGATIVE REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902309,0.20994803266518203,0.7248363921442859,-0.73184454895356,-1.25178090589814,1413,2,YWHAE
NONFUNCTIONAL RRNA DECAY%GOBP%GO:0070651,0.8687248322147649,0.99309394259051,0.5662770180855761,0.752273755117825,6471,1,PELO
REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031943,0.7559063573883159,0.977478346584517,0.31223493353965504,0.767896346403537,7038,6,WNT4
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS BY EPITHELIAL-MESENCHYMAL SIGNALING%GOBP%GO:0060683,0.7963723023963991,0.9828568923066779,-0.598753859726511,-0.8009712940082919,6014,1,PDGFA
ENDOTHELIAL TUBE LUMEN EXTENSION%GOBP%GO:0097498,0.7897550111358579,0.9819233677232551,-0.44290046870692,-0.7575575314913492,5318,2,STARD13|RHOA
MICROVILLUS ORGANIZATION%GOBP%GO:0032528,0.0246835443037975,0.329326373353219,-0.43878162624202105,-1.69995618205877,116,14,EZR|RAP2C|RAP1B|STK26|RAP2B|MAP4K4|RAP1A|FXYD5|SLC9A3R1
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS%GOBP%GO:0033555,0.170972951150585,0.6741626295249631,-0.36280466094233504,-1.2767548034299199,846,11,RELN|ADCYAP1|THBS4
POSITIVE REGULATION OF ORGAN GROWTH%GOBP%GO:0046622,0.366112828438949,0.8510019955058101,0.320257313243479,1.08586829717611,3789,15,EDN1|TBX2|BASP1|PROX1
OPTIC NERVE MORPHOGENESIS%GOBP%GO:0021631,0.407520190652721,0.867015886388254,-0.794938244375827,-1.0634131269654201,3077,1,CHRNB2
REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002637,0.336653386454183,0.8311444145897029,-0.22009611028945897,-1.08073645262037,1351,26,GPI|C20orf196|IL6|FCGR2B|VAMP3|TFRC|TNFRSF4|CD22
POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000427,0.39300758213984793,0.8621064456029929,0.40769679578784795,1.06114910229137,3731,7,ABCA7|CCL2|C4A|C4B|C2|C3
REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050670,0.8968398663020359,0.998912093067348,0.124773103521563,0.71346853533198,11805,116,SH3RF1|IDO1|GLMN|CD209|MZB1|CD38|BMP4|AGER|CD320|BLM|MARCH7|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|DLG5|IL7|CCL19|TMIGD2|BTN2A2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|PLA2G2D|CEBPB|HLA-DMB|IGFBP2|CD3E|PTPN22|CD46|CTLA4|RIPK3|IKZF3
SYNAPTIC VESICLE PRIMING%GOBP%GO:0016082,0.5538121314237571,0.932839982557857,0.35508109778433294,0.9242014949525159,5258,7,UNC13B|UNC13A|SNAP47
REGULATION OF CELLULAR AMINE CATABOLIC PROCESS%GOBP%GO:0033241,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046718,0.45494080695820205,0.88900512246363,-0.211604939415775,-0.994313915264274,1882,23,ITGB3|WWP1|ITGAV|PPIA|VAMP8|CD4|WWP2|CD81|GAS6|PVRL1|ITCH|PVRL2|ZNF639|CAV2|CAV1
RESPONSE TO PHEROMONE%GOBP%GO:0019236,0.0288590604026846,0.348603135907264,0.9856087340097042,1.30933723200887,214,1,GNG8
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB%GOBP%GO:0002476,0.607710481099656,0.9508825506493929,0.35949478793227096,0.8841250755474649,5658,6,TAP2|HLA-F|HLA-C|HLA-B|HLA-A
VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS%GOBP%GO:0003223,0.5244304791830321,0.925993329275615,-0.4616742031542961,-0.9369540783586671,3337,3,BMPR1A|TGFBR3|TGFBR1
CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002508,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
LIPID TRANSLOCATION%GOBP%GO:0034204,0.368910375604314,0.852268858837246,0.284984991030445,1.07739516476849,3967,21,ATP10A|ATP11C|ABCA7|ABCB4|ATP10D
REGULATION OF SEQUESTERING OF ZINC ION%GOBP%GO:0061088,0.864652078267917,0.992572193202955,0.372313440366838,0.707728684233537,7467,3,AP3D1|SLC30A4
HOMOCYSTEINE METABOLIC PROCESS%GOBP%GO:0050667,0.20546948112717103,0.7211951452265429,0.45805389791065,1.2487778140053,1975,8,DPEP1|CTH
NEGATIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:1900138,0.7998064594169592,0.9839175016931591,0.48690377722635797,0.7958308478472571,6611,2,ANXA1|PLA2R1
S-ADENOSYLMETHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0006556,0.5053838138242449,0.9172434440873181,0.51412828988597,0.9773037948072021,4364,3,MAT2A|MAT2B
PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE%GOBP%GO:1903608,0.8815837268434441,0.9956508825790341,-0.23026292408367802,-0.671687165388815,4853,7,DCP1A|DDX3X|YBX1
ARACHIDONIC ACID SECRETION%GOBP%GO:0050482,0.0644991212653779,0.495456803258629,-0.559531822544421,-1.53587728307002,366,6,DRD2|BDKRB2|ACE
PEPTIDE CATABOLIC PROCESS%GOBP%GO:0043171,0.36372007366482506,0.8499434076701009,-0.23702540943950198,-1.0575849757157199,1579,20,CHAC1|CTSH|ANPEP|ERAP2|ACE
POSITIVE REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:1903862,0.276857703203312,0.7884684708511421,0.5075563439743229,1.1698421319463101,2540,5,CCNB1|CDK1|VCP|PINK1
BUNDLE OF HIS CELL-PURKINJE MYOCYTE ADHESION INVOLVED IN CELL COMMUNICATION%GOBP%GO:0086073,0.8206120720938671,0.987153241368501,0.47786049076371706,0.781049844557682,6783,2,JUP|PKP2
SIGNAL TRANSDUCTION DOWNSTREAM OF SMOOTHENED%GOBP%GO:0007227,0.926575541308818,1.0,0.417314585056521,0.6820892249725979,7659,2,STK36|SMO
COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072044,0.651407870904001,0.963985859176228,-0.36573355559032106,-0.8411107734416899,3955,4,DACT2
POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045687,0.140810758136815,0.6296802030037281,0.40435167317735604,1.33974274831967,1444,14,CXCR4|HES1|SERPINE2|AGER
"POSITIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900153",0.7375323059251461,0.974306231601101,0.22562280972271398,0.782173094681855,7704,16,BTG2|NANOS3|CPEB3|TNRC6A|TNRC6C|POLR2G|CNOT1|TOB1|NANOS1
SPERM-EGG RECOGNITION%GOBP%GO:0035036,0.566666666666667,0.9388612723386429,-0.23446260890810397,-0.908370217979716,2685,14,HVCN1|CD9|ALDOA|POMZP3
GLUTAMATE METABOLIC PROCESS%GOBP%GO:0006536,0.898647396701871,0.998912093067348,0.168270064800561,0.644435314718383,9699,22,GGT1|GLS|GLS2|CPOX|GGT5|NAGS|ALDH18A1|AADAT|ALDH5A1|PRODH|GOT1|MTHFS
HIGH-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034380,0.40657169595508,0.8664565508572991,0.38380574967710396,1.04635744236791,3909,8,ZDHHC8|ABCA7|APOE|APOM
GLYCOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006677,0.329043033994891,0.828303707528737,0.3550404279963811,1.1192143084935802,3348,12,B3GALT2|B3GALT1|B4GALT3|ALDH5A1|UGCG|GALC|ST6GALNAC6|GLA|ST6GALNAC3|NAGA|CLN3
SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048630,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
POSITIVE REGULATION OF DNA N-GLYCOSYLASE ACTIVITY%GOBP%GO:1902546,0.32172646630478,0.822751772025005,-0.8402073224525799,-1.1239709529513202,2429,1,RPS3
INTRACELLULAR PH ELEVATION%GOBP%GO:0051454,0.325844461901021,0.826621597878865,-0.541634498731664,-1.0992311225082199,2073,3,SLC26A6|CLN3|BCL2
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000378,0.224066390041494,0.737579702937225,-0.24825142534904898,-1.18998377001612,917,24,SIRPA|HP|FYN|MPV17L|ATP2B4|PARK2|AATF|CAV1
POSITIVE REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032732,0.9455798479087449,1.0,-0.132329821470666,-0.61304970989379,3978,22,FZD5|CCL3|CASP1|IFI16|TRIM16|PYCARD|HSPB1|LGALS9|PANX1|RIPK2|NLRP1|NLRP3
REGULATION OF PROTEIN TARGETING%GOBP%GO:1903533,0.005160339107998529,0.16737273925846302,-0.26108206361623804,-1.70964800499298,13,65,ITGAM|UBL5|PARL|MYO1C|ATG13|FYN|BAG4|INPP5K|VPS11|CSNK2A2|PRNP|CHP1|SH3GLB1|RNF31|MIEF1|CEMIP|BAP1|LEPROT|UBE2L3|UBE2D3|SIAH3|ARIH2|PARK2
NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030837,0.199800945508833,0.711592141628341,-0.250349180770383,-1.21451182223454,802,25,GSN|CAPZB|TRIOBP|KANK4|CAPZA2|ADD1|PRKCD|PFN1|TMSB10|MYADM|TMSB4X|TWF1|TWF2
CELLULAR RESPONSE TO BRAIN-DERIVED NEUROTROPHIC FACTOR STIMULUS%GOBP%GO:1990416,0.422196607936769,0.873470206885489,-0.439860401009801,-1.01158703226606,2563,4,TMEM108
URETER SMOOTH MUSCLE DEVELOPMENT%GOBP%GO:0072191,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
MODULATION OF SIGNAL TRANSDUCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052250,0.20230372037601002,0.716346357311758,-0.897441552712836,-1.20053492782751,1527,1,TNIP1
"NUCLEOTIDE-EXCISION REPAIR, DNA DUPLEX UNWINDING%GOBP%GO:0000717",0.49250185597624396,0.910097257414447,-0.565591397849462,-0.9674137948838109,3316,2,ERCC3|ERCC2
NEGATIVE REGULATION OF CELL DEVELOPMENT%GOBP%GO:0010721,0.40025740025740003,0.8638522656500329,-0.12992913305259698,-1.02816338612936,621,137,CALR|THY1|PTHLH|DCC|FBXW7|NOTCH1|ARHGDIA|ID2|RNF6|IL1B|CX3CL1|LPAR1|RTN4|SKI|FAM101B|SRGAP2C|SEMA3F|RHOA|SEMA7A|YWHAH|IL6|EFNA1|POU4F2|BAG5|IGF1|SPOCK1|SEMA6B|FAM101A|ID1|ADCYAP1|MFI2|FKBP4|ASCL1|MYLIP|ZNF365|SEMA3A|CORO1C|SEMA3G|TNF|GAL|LINGO1|RTN4RL2
RESPONSE TO FUNGICIDE%GOBP%GO:0060992,0.38858731629815996,0.8602318600740309,-0.8031539479488309,-1.07440352412973,2934,1,IMPACT
REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902226,0.801258013789767,0.9841161968820359,0.48640749931072497,0.795019695227707,6623,2,CSF1|PTPN2
CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:0003231,0.4793333333333329,0.9046812288131709,-0.16062796873409302,-0.990736393501675,1437,53,SFRP2|SCN5A|ZFPM2|RBPJ|FKBP1A|SLIT3
TRANS-SYNAPTIC SIGNALING BY SOLUBLE GAS%GOBP%GO:0099543,0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072110,0.7936373533325269,0.9819233677232551,0.489160827156566,0.799519933953394,6560,2,EGR1|PDGFRB
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009215,0.151270604395604,0.6475783026655401,-0.5183653209794841,-1.3122073888316899,880,5,NUDT16|SAMHD1|NUDT1|AK9|NUDT15
XDP CATABOLIC PROCESS%GOBP%GO:1901639,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0090329,0.0347500212929052,0.37986475421241106,0.334110189647351,1.54896826315194,407,43,FBXO18|CDC7|E2F8|BLM|RFC4|E2F7|DONSON|ZNF830|DBF4B|FBXO5|INO80|MSH6|WDR18|TIMELESS|DSCC1|CHEK2|ZRANB3|CHTF18|GMNN|RFC3|RFC5|SMC3|WIZ|WRNIP1|CDT1|STOML2|TICRR|MSH3|SLFN11|ATRX|NBN|LIG3|SMC1A
NEGATIVE REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:1902723,0.389012620638456,0.8603316114971841,-0.621252693217147,-1.0626194595819398,2619,2,AKIRIN1
RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000055,0.00390472471690746,0.147602495543672,-0.622089546791556,-2.00816080382415,19,9,PA2G4|NMD3|ZNF593|NPM1|RRS1
MITOCHONDRIA-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0072671,0.57503355704698,0.941940408834489,0.716696074106749,0.9520987603721031,4283,1,ANKZF1
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001033,0.549622252747253,0.931359181171847,-0.36062952282422794,-0.912909689997429,3200,5,C7orf49|HSF1
REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010885,0.0419174102510894,0.402998391331252,-0.423114343092835,-1.5934405285230702,201,13,PPARD|NR1H3|PPARA|EHD1|PPARG|ABCA1|NR1H2|ABCG1
TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0033209,0.0998010610079576,0.570215774831708,-0.214088194299719,-1.31123592472149,300,52,TRAF3|BAG4|COMMD7|TNFRSF1B|TNFRSF18|TMSB4X|KARS|TNFRSF11A|ADAM17|LIMS1|CDIP1|TNFRSF4|PLVAP|EDA2R|TNF|FOXO3
REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0046782,0.7652151328889271,0.9792236089291529,0.173804040458541,0.7786051335755999,8838,38,TRIM27|DHX9|GTF2B|CCL5|LEF1|PSMC3|SMARCA4|MID2|TARBP2|SP1|TRIM21|TFAP4|TRIM14|TARDBP|REST|CCL4|CHD1|SNW1|NUCKS1|MDFIC
REGULATION OF DNA TOPOISOMERASE (ATP-HYDROLYZING) ACTIVITY%GOBP%GO:2000371,0.442471126607104,0.880423444399886,0.441438673321355,1.01745070247399,4060,5,DHX9|UHRF1|SETMAR
REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901626,0.37742188374958,0.85375124052253,0.505613090261499,1.07144243694298,3369,4,APOE|SHISA7|MESDC2
POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904685,0.0274684484038604,0.3403540236452571,-0.8934656741108349,-1.5282251846058703,184,2,MBP|STAT3
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901862,0.737341772151899,0.974306231601101,-0.20551889684634397,-0.7962346149634258,3494,14,SOX15|SIRT2|USP19|BMP2|EPHB1|TGFB1|FZD7|SMAD4|FRS2|AKIRIN1|SOX6|DKK1
RESPONSE TO GROWTH HORMONE%GOBP%GO:0060416,0.13902953586497901,0.627546509528459,-0.34082065776592,-1.32042945623011,658,14,PXN|LYN|PTPN1|STAT5A|STAT3|PIK3R1
NEGATIVE REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032375,0.33083212005823703,0.8293509737209019,0.523872176870467,1.1101351856662098,2953,4,SREBF2|APOC1|APOC2
NEGATIVE REGULATION OF HEART CONTRACTION%GOBP%GO:0045822,0.140070921985816,0.628308380012755,-0.39527002783959003,-1.33725766819297,710,10,SRI|KCNE3|FKBP1B|PLN|BIN1|PDE4D
HISTONE SUCCINYLATION%GOBP%GO:0106077,0.6675999552021501,0.964618776001639,0.40454011884773106,0.857259155523925,5960,4,KAT2A|DLD
FARNESOL CATABOLIC PROCESS%GOBP%GO:0016488,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009216,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
POTASSIUM ION IMPORT%GOBP%GO:0010107,0.35241801000555895,0.842847021021096,0.28582691964545,1.09465079920791,3803,22,SLC12A2|HCN2|ATP1B3|KCNJ11|KCNH2
NEURAL PLATE PATTERN SPECIFICATION%GOBP%GO:0060896,0.5757832345469941,0.941956986273961,0.5763992280121311,0.9421087035727499,4759,2,CELSR2|PTCH1
SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006614,0.405848471422242,0.8663957682383929,-0.142875148515382,-1.02521832262944,915,90,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPL36|RPS15|RPS10|RPL28|RPS3A|RPL37|RPL27A|SEC61A1|RPL7A|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|SRP68|RPL13A|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|RPL29|RPL31|RPL17|RPS14|RPS17|RPL32|RPL18A|RPL11|SRP14|RPS16|RPL12|RPS4X|RPL9|RPS28|RPL35|RPL7|SRP72|RPS9|RPS3|RPL14|SEC63|RPL15|RPL8|RPL35A|UBA52|SRP54
POSITIVE REGULATION OF ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1903744,0.9373758771349129,1.0,-0.528617115130128,-0.7071472323102951,7079,1,MAP2
ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:0030048,0.172636334301388,0.676373393036498,0.240782760449998,1.2499390918022,2139,70,RYR2|KCNN2|SCN1A|NEB|CACNA1G|CACNB2|FGF12|KCNQ1|ACTN2|MYH3|TCAP|FNBP1L|MYO19|CACNA2D1|TNNC2|KCNH2|CACNA1D|GJA1|SHTN1|SYNE2|MYO5A|DMD|SCN3B|TNNI3|MYO7A|TPM2
REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902822,0.7592838998427479,0.977664504547119,0.5021212176643011,0.8207033361955309,6276,2,SNAPIN|VPS35
AXONAL TRANSPORT OF MITOCHONDRION%GOBP%GO:0019896,0.8975009761811792,0.998912093067348,-0.20350133858321998,-0.656920557138861,4596,9,HAP1|TRAK1
SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR%GOBP%GO:0035581,0.757039835164835,0.977664504547119,-0.304153021292589,-0.769943176602692,4408,5,NBL1
NEGATIVE REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901386,0.589279437609842,0.945418171231938,-0.321992402212383,-0.883847523864264,3352,6,CRHR1|FMR1|GNB5
INTERLEUKIN-18 SECRETION%GOBP%GO:0072616,0.256778523489933,0.767462394426418,0.873786943096603,1.16078697150459,1912,1,GBP5
ROUNDABOUT SIGNALING PATHWAY%GOBP%GO:0035385,0.0400068681318681,0.3988884666657849,-0.648852856827708,-1.6425279210133898,232,5,SLIT2|ROBO1|MYO9B|RHOA|SLIT3
ENDOPLASMIC RETICULUM MANNOSE TRIMMING%GOBP%GO:1904380,0.26,0.7715310051543051,-0.288516906477797,-1.15063119883845,1208,15,RNF185|EDEM2|DERL2|RNF5|UGGT1|TRIM13|OS9|RNF139|AMFR|RNF103
REGULATION OF GLYCOLYTIC PROCESS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072363,0.27777042234873606,0.7884684708511421,-0.86104984561094,-1.15185263166346,2097,1,PPARA
MITOTIC G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0031571,0.698927372471956,0.96731875442989,0.16716597907894598,0.8421031405425359,8535,61,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|RPS27L|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|RFWD3|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CCND1|CNOT6|E2F4
CELLULAR RESPONSE TO INTERLEUKIN-12%GOBP%GO:0071349,0.0169642857142857,0.277340114229305,-0.28684661150146,-1.6438599046553999,56,41,RAP1B|SOD1|SIRPA|BOLA2|BOLA2B|AIP|HNRNPF|P4HB|TCP1|SOD2|RALA|CDC42|MSN|PDCD4|PITPNA|PLCB1|PAK2
DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046385,0.775293750649891,0.9805314293977441,0.27546607086646696,0.750994412182381,7455,8,DTYMK|DUT|HDDC2|TYMS
RESPONSE TO INTERLEUKIN-9%GOBP%GO:0071104,0.8513049807632321,0.991298302704726,0.250097659622645,0.681833317205678,8186,8,CITED1|STAT5B|STAT1|JAK3
POSITIVE REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032757,0.283337665713543,0.7924936804394509,-0.21897461823940198,-1.1206575948356499,1089,29,TLR1|IL17D|PYCARD|IL1B|LGALS9|PRKD2|ZNF580|BCL10|DDIT3|MAVS|MYD88|TNF
POSITIVE REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106058,0.034517561566411004,0.379078740472774,-0.47071732624642604,-1.65651291739698,170,11,SLC9A1|IGF1|CAMTA1|TNF
INTRACELLULAR DEFENSE RESPONSE%GOBP%GO:0002818,0.66715212498345,0.964618776001639,-0.661226290251434,-0.8845425690899201,5038,1,GNLY
DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI-CILIATED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0098535,0.0151192742748348,0.264387156924099,0.777602734969028,1.6478144758828102,134,4,CCDC78|CEP63|CEP152
NEGATIVE REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090281,0.616025137470542,0.9518465519698142,-0.429870397044266,-0.8724091987909391,3920,3,PLN|SLC30A1
FUNGIFORM PAPILLA DEVELOPMENT%GOBP%GO:0061196,0.7701559020044542,0.9792758096555699,-0.450785773366419,-0.771044922801516,5186,2,HDAC2|HDAC1
PORE FORMATION IN MEMBRANE OF OTHER ORGANISM%GOBP%GO:0035915,0.29503355704698,0.800447413278835,0.856252756947508,1.1374935874610201,2197,1,GSDMD
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090271,0.25934438127494897,0.770912532778873,0.705335775656513,1.1528519486033202,2143,2,PTGS2|ROCK2
MITOCHONDRIAL RNA 5'-END PROCESSING%GOBP%GO:0000964,0.539272188374774,0.928041735228137,-0.399437489659736,-0.9186227808028861,3274,4,HSD17B10|PNPT1|TRMT10C|KIAA0391
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099623,0.5790178998755621,0.942692029750853,0.262364998023151,0.909548297409164,6048,16,AKAP9|KCNQ1|CACNA2D1|KCNH2|CACNA1D
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NEUROTRANSMITTER%GOBP%GO:0003070,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
NEGATIVE REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046832,0.0662876496915447,0.49786383970143805,0.8384124504929928,1.37036211779344,547,2,TPR|NUP153
REGULATION OF ERBB3 SIGNALING PATHWAY%GOBP%GO:1905578,0.367536078379452,0.8512048542076959,-0.815174239082488,-1.09048343407483,2775,1,RTN4
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002220,0.87219183845183,0.9934031064448321,0.146020263290124,0.698415468479358,10365,49,MUC15|CD209|KLRK1|PAK3|PDPK1|MUC1|MAP3K7|SRC|CARD11
"POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033160",0.197115384615385,0.7110494194326691,-0.49059499273777796,-1.2419086469324598,1147,5,IGF1|MAVS
REGULATION OF VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:1903772,0.630641729196999,0.9575013258325501,0.416977250744666,0.883614626070268,5630,4,VPS37B|TSG101|SNF8
POSITIVE REGULATION OF EOSINOPHIL CHEMOTAXIS%GOBP%GO:2000424,0.9256375838926171,1.0,0.5403617115130129,0.71784642649997,6895,1,DAPK2
CELLULAR ALDEHYDE METABOLIC PROCESS%GOBP%GO:0006081,0.534186565882151,0.9265056012720759,0.20754537651095603,0.94784321042974,6218,41,AKR7A3|BCO2|RBKS|ALDH1A1|TKFC|CACNA1H|ALDH8A1|PGLS|AKR1C1|ALDH3A2
PEPTIDYL-HISTIDINE MODIFICATION%GOBP%GO:0018202,0.904104613149292,1.0,-0.22213003047401503,-0.647963153905759,4977,7,DPH2|DPH6|DPH3
NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:0035747,0.860282108389013,0.9916689277956879,-0.4095947063689,-0.7005898087546989,5793,2,XCL1|PIK3CD
REGULATION OF NUCLEUS SIZE%GOBP%GO:0097298,0.770738255033557,0.979355471471634,0.6165637406263779,0.8190774225635371,5741,1,HP1BP3
NEGATIVE REGULATION OF SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1905513,0.441610738255034,0.880423444399886,0.7855094838994271,1.04351430529781,3289,1,PRRT2
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901018,0.12835117352450198,0.608160579951936,0.4212277008516239,1.35945836161697,1306,13,AKAP9|ATP1B3|ACTN2|LRRC55
RESPONSE TO LIGHT INTENSITY%GOBP%GO:0009642,0.540268456375839,0.928807195199472,0.7329620644022941,0.9737074028024592,4024,1,SLC24A1
LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:0060292,0.5145947802197801,0.920792511236057,-0.370774025186015,-0.938589824096685,2996,5,PLK2
PHOSPHATIDYLINOSITOL CATABOLIC PROCESS%GOBP%GO:0031161,0.803624161073826,0.984522820758988,0.599194971327746,0.796003787426038,5986,1,INPP5F
ANTERIOR COMPARTMENT PATTERN FORMATION%GOBP%GO:0007387,0.0307382550335571,0.35952485149978897,0.9847265108072341,1.3081652378431599,228,1,PBX3
RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0031667,0.000829875518672199,0.0849637591935908,-0.196635687199511,-1.62017895286729,0,176,EIF2S1|PIM1|IMPACT|PIK3C3|RRAGD|BCAS3|STK26|UCN2|USF1|PRKAA1|HLCS|HSPA5|GDF15|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|GNAI2|FYN|FAM65A|EIF2AK1|DGKQ|MAP1LC3A|KLF10|BCL10|PPARA|FOXO1|SEH1L|EIF4G1|NUAK2|PPARG|SH3GLB1|ATG7|GCGR|BECN1|TBC1D5|C12orf66|PPARGC1A|GIPR|MKKS|TP53|GABARAPL1|RALB|ADCYAP1|MAPK3|GABARAP|CDKN1A|UCN3|WIPI2|MAP1LC3B|STK24|SESN2|GABARAPL2|NENF|PMAIP1|INHBB
REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905207,0.733027301280503,0.9733535228116099,-0.17196879475032598,-0.8080669859766441,3033,23,TGFB1|FZD7|SMAD4|FRS2|ENG|AKAP6|GPER1|PRICKLE1|IGF1|SOX6|DKK1|GREM1
CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION%GOBP%GO:0086002,0.025395958492627005,0.331167298107398,0.40463460664283396,1.6268249361594,278,26,RYR2|KCNN2|SCN1A|CACNA1G|CACNB2|FGF12|KCNQ1|CACNA2D1|KCNH2|CACNA1D|GJA1
TELOMERASE HOLOENZYME COMPLEX ASSEMBLY%GOBP%GO:1905323,0.0520335913057797,0.44586532408291796,-0.687861909226273,-1.5819386918341003,315,4,PTGES3|HSP90AA1|NAF1|HSP90AB1
THYMINE TRANSPORT%GOBP%GO:0035364,0.547785234899329,0.9305779599215391,0.7293228936921041,0.968872926868888,4080,1,SLC29A2
REGULATION OF NEUROGENESIS%GOBP%GO:0050767,0.98320819112628,1.0,0.0984583949980974,0.655286303179555,14403,382,SEMA3D|SYT17|RIT2|HOXD3|SLC45A3|SIX3|C16orf52|FAM150B|RIMS2|DTX1|ARNTL|KIAA2022|RTN4RL1|BRINP3|BRSK2|LRRC7|VLDLR|CXCR4|HES1|SERPINE2|CDK1|ZSWIM5|AGER|LIG4|CDH2|SYT3|PROX1|DSCAM|RGS14|SMARCD3|PLXNC1|ECT2|ZNF804A|PTPRO|MARK2|FGF13|KIF20B|ZSWIM8|CUX2|BRINP1|PAK3|DVL1|CDK5R1|ROBO2|UNC13A|SEMA5A|CPEB3|DYNLT1|CTTN|MAP6|PTPRD|CDK5RAP2|ITM2C|PLXNA3|HEYL|SEMA3E|CHN1|MED1|GRIP1|DLG5|PTCHD2|CAPRIN2|RUFY3|DOCK7|NF1|APOE|NIPBL|SEMA4G|P3H1|HES6|NREP|HEY2|TRIM46|SEMA6A|PLXNB2|OBSL1|SEMA4C|DPYSL3|SHTN1|RTN4R|LRRC4C|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|ZNF335|LRP8|BRSK1|KDM1A|CAMSAP2|PLXNA2|NAP1L1|LDLR|NTN1|CPNE1|DICER1
TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0006366,0.9920634920634921,1.0,-0.0788886301297133,-0.726050928628795,374,370,SNRPD3|AFF4|CSTF2|SETD2|SPI1|CCNK|TAF10|ATF4|MED27|HIF1A|CEBPZ|HAND1|SNAPC1|MECP2|PMF1|ELL2|BAX|SUPT16H|MNT|NOTCH1|AHR|CTDP1|PPARD|NELFCD|RPRD1B|RARA|CDK9|CPSF3|RPAP2|C5AR1|RNGTT|USF1|FOXO4|ADRM1|ARRB2|KLF5|NR1H3|CEBPA|GMEB2|ELL3|ELL|ICE1|FOSL1|CCRN4L|PPARA|KLF13|NELFA|RXRA|DDIT3|NRBF2|PPARG|NRL|ARRB1|ELP3|MAFF|NFE2L1|POLR2A|TCF4|SUPT4H1|YBX1|TTF2|ETS1|KLF11|TEAD4|DDX21|PHAX|NR1H2|POLR2K|PPARGC1A|NELFE|SNRPB|TCEB1|TCFL5|NR3C1|POLR2F|ELP2|TP53|COPS2|TAF4B|NCBP2|NFYA|NUDT21|CDKN1A|TCEA1|POLR2I|POLR2D|CBFB|TRIM29|NR1D1|NR1D2|SOX17|TAF8|SLBP|TAF13|EPAS1|RBPJ|PBRM1|MED10|EAF1|CREB5
SUBSTRATE-DEPENDENT CEREBRAL CORTEX TANGENTIAL MIGRATION%GOBP%GO:0021825,0.351447661469933,0.842847021021096,-0.6487455197132621,-1.1096444668819399,2366,2,SLIT2|ROBO1
REGULATION OF TOLERANCE INDUCTION%GOBP%GO:0002643,0.8271255060728749,0.9876441563834109,0.24823870295831602,0.708388440842191,8171,9,MARCH7|IL2RA|FOXP3|HMGB1|LILRB2|IRAK3|TGFBR2
5-PHOSPHORIBOSE 1-DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006015,0.3754322410670179,0.852871276063039,-0.456539295033466,-1.0499450041774698,2279,4,PRPS1|PRPSAP1
POSITIVE REGULATION OF RECEPTOR CLUSTERING%GOBP%GO:1903911,0.525503355704698,0.9265056012720759,0.741177767975298,0.984621598470673,3914,1,MESDC2
POSITIVE REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901985,0.8807389296386849,0.9956508825790341,-0.133304318843414,-0.7057251400253391,3241,32,IL1B|WBP2|PRKAA1|LIF|ARRB1|RUVBL2|PPARGC1A|TADA2B|MAPK3
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061419,0.113324175824176,0.589435199693523,-0.547353997561839,-1.3855902986527802,659,5,HIF1A|NOTCH1|VEGFA|RBPJ
SEQUESTERING OF BMP FROM RECEPTOR VIA BMP BINDING%GOBP%GO:0038098,0.0108566132662518,0.227160168781543,-0.99547860608734,-1.3316820832512901,81,1,NBL1
FOLLICULAR DENDRITIC CELL ACTIVATION%GOBP%GO:0002266,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
ATRIOVENTRICULAR VALVE FORMATION%GOBP%GO:0003190,0.859375,0.99166790097654,-0.274290263016442,-0.6943475870157769,5004,5,OLFM1
HISTONE H4 ACETYLATION%GOBP%GO:0043967,0.8358742866876758,0.988613522932093,0.15680593255791,0.726967989999076,9813,43,JADE3|NAA40|OGT|YEATS4|TRRAP|EP400|LEF1|APBB1|MSL1|KAT8|BRCA2|WDR5
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070423,0.00362406378352259,0.143595610377104,-0.42938636654831996,-2.01765062981291,14,23,RELA|TRAF6|OTULIN|UBE2N|ITCH|NOD1|IRAK1|IRAK2|TNFAIP3|UBE2V1|CYLD|RIPK2|UBA52|UBC|UBB
REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010896,0.9381789674095641,1.0,0.286355155312531,0.606813928176902,8376,4,PNPLA2|APOC2|GPLD1
TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0007260,0.533542389965282,0.9265056012720759,0.449953124138311,0.953493651810954,4763,4,JAK2|FER|JAK3|IL15
OLFACTORY PLACODE MORPHOGENESIS%GOBP%GO:0071699,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
REGULATION OF CYTOPLASMIC TRANSLATIONAL FIDELITY%GOBP%GO:0140018,0.392691645703694,0.8621064456029929,-0.801554918394354,-1.07226445354071,2965,1,AARS
REGULATION OF MEMBRANE LIPID DISTRIBUTION%GOBP%GO:0097035,0.8312566749733001,0.9879179006160809,0.16949515002827897,0.7164547843991851,9339,31,ATP10A|ATP11C|ABCA7|ABCB4|ATP10D|ATP8B3|ARV1|PLSCR4|ATP8A2|ATP8B2|ABCB1|ATP8B4|P2RX7|TRIAP1
NEUROTRANSMITTER RECEPTOR TRANSPORT%GOBP%GO:0099637,0.6259493670886079,0.9543682073609309,-0.22425648030526898,-0.868828973826285,2966,14,RAB8A|CACNG3|CACNG7
GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046476,0.135289506103707,0.6224657604778089,0.62413464764489,1.32260093880744,1207,4,B3GALT2|B3GALT1|B4GALT3|UGCG
REGULATION OF TRANSCRIPTION INVOLVED IN LYMPHATIC ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060849,0.189306882786984,0.697156167630698,0.740204592318476,1.2098440715348702,1564,2,PROX1|NR2F2
PROTEIN MYRISTOYLATION%GOBP%GO:0018377,0.253416762720237,0.7641083395392759,-0.5121050019301819,-1.1777345219571398,1538,4,NMT2|PPM1B|NMT1|PPM1A
PROCESS UTILIZING AUTOPHAGIC MECHANISM%GOBP%GO:0061919,0.0154679040989946,0.264745847609811,-0.175375830045741,-1.41338880535236,19,159,VPS33B|PIK3C3|PGAM5|PRKAA1|SQSTM1|PRKAG1|RB1CC1|TRIM17|CTSK|ATG13|ANXA7|VPS4A|TMEM74|S100A8|MAP1LC3B2|ATG9B|MAP1LC3A|VPS37D|ATG101|ATG3|MFN2|NRBF2|ATG7|RAB1A|VPS4B|BECN1|VPS16|TBC1D5|C6orf106|DYNLL2|TP53|SEC23A|GABARAPL1|GABARAP|RAB7A|PARK2|CHMP4B|FBXO7|WIPI2|MAP1LC3B|NSFL1C|VTI1A|MTMR14|GABARAPL2|SPATA18
ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT%GOBP%GO:1990048,0.6895522388059699,0.96731875442989,-0.404433660527187,-0.8207860977881591,4388,3,KIF1C|KIF1A|KIF5B
REPRODUCTIVE PROCESS%GOBP%GO:0022414,0.0382935153583618,0.393143354533675,0.196794059443013,1.31019993436696,560,385,TAC1|HSPA2|INSL3|CITED1|TEKT3|MUS81|TBX3|GHRL|CATSPERG|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|WNT4|IDO1|ARNTL|SYCP2|EME2|MLH3|CRHBP|CCNA1|INHA|ZCCHC11|OXTR|BASP1|HERC4|CCT6B|CABYR|CDK1|E2F8|NCAPD3|GGT1|PYGO1|RHOXF1|CELF1|PKD2|USP9Y|PIWIL4|OVGP1|RAD54B|DNAJC19|BLM|TRIM27|RAD54L|C11orf80|EXO1|MTL5|BRIP1|EIF2B5|TSSK3|PDIK1L|SPATA25|DEAF1|ROBO2|JAG2|PCSK4|DZIP1|TGFB2|WDR33|NUF2|CASC5|BUB1|TOP2A|E2F7|DAZAP1|TYRO3|TUBGCP3|YTHDC2|CCNE1|PKMYT1|ZNF830|FUT10|PTTG1|BUB1B|ZP3|ESPL1|LEF1|MSH6|KIT|DNAH1|RAD51C|RAD51|BMPR1B|PIM2|CLOCK|NCAPH2|NIPBL|MND1|TUBG2|EIF2B4|CENPI|FANCM|HEY2|CXADR|METTL3|REC8|TUBGCP6|FGF9|SRPK1|STX2|TRO|FANCF|MYBL1|STOX2|SLX4|TUBGCP2|MYCBPAP|EME1|ING2|RMI1|RACGAP1|TDRP|PEBP1|STRA13|NUP107|CDKL2|SPDYA|BRCA2|CEP57|CCNE2|CUL7|CEBPB|GATA6|BAG6|STAG3|CHD7|XRCC2|KMT2D|FGFR2|TOP2B|TEX14|MYCBP|WNT2B|P3H4|TUBGCP4|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|SGOL1|EGR1|PLA2G4B|ABHD2|AZIN2|ZNF35|PTK2|SMC3|GATA3|RAD1|C1orf111|FMN2|CDK2|ATM|ZCCHC6
POSITIVE REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902101,0.173481781376518,0.676682497340677,0.452844067529836,1.29226224242705,1713,9,ANAPC5|DLGAP5|RB1|ESPL1|CDT1|ANAPC4
SISTER CHROMATID BIORIENTATION%GOBP%GO:0031134,0.23109876114391603,0.7440352621789029,0.629701113929635,1.19699557550947,1995,3,RB1|BOD1|CHAMP1
NEURONAL ACTION POTENTIAL%GOBP%GO:0019228,0.358409666731631,0.846205501155666,0.328369716587678,1.08799091421879,3677,14,SCN1A|CACNA1G|CACNA1I|CACNA1H|ANK3|SCN8A|SCN9A|SCN2A|SCN3A|SCN7A
NEGATIVE REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070130,0.5645637583892621,0.9380162603437769,0.721217468019409,0.958105230471388,4205,1,MALSU1
REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901163,0.229155060352832,0.7432881250816031,-0.38799713166749394,-1.20606402205838,1233,8,SMURF2|SYDE1|TIMP1|ACVR1B|ARHGDIB|CALR|C1QBP|AGO2
NADPH OXIDATION%GOBP%GO:0070995,0.803860430586489,0.984522820758988,-0.4372015993027079,-0.747809920587366,5413,2,KCNAB2
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002714,0.394895206474372,0.8638039247684692,-0.273670271463253,-1.0306370112955,1902,13,PAXIP1|RIF1|FAM35A|XCL1|TP53BP1|CLCF1|HLA-E|TGFB1|MAD2L2|TNFSF13|PVRL2|C20orf196|TFRC
REGULATION OF PROTEIN FOLDING%GOBP%GO:1903332,0.9193606974209949,1.0,-0.21722648483364998,-0.633659293722282,5061,7,HSPA5|SGTB|BAG5
REGULATION OF PROTEIN LIPIDATION%GOBP%GO:1903059,0.900708052033591,0.998912093067348,-0.285280979429769,-0.656086655404297,5469,4,SVIP|RAB3GAP2|RAB3GAP1|GBA
NIK/NF-KAPPAB SIGNALING%GOBP%GO:0038061,0.616424381535323,0.9519399648085121,-0.17858201263577103,-0.889909358790571,2416,27,TNFRSF10A|RELB|REL|TNFRSF10B|CHI3L1|COPS8
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902165,0.33877511591962894,0.8326275783736579,0.326920353562509,1.10846008180069,3506,15,SIRT1|AK6|MARCH7|MUC1|ING2|KDM1A
NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010839,0.299193724122903,0.8023890191280308,0.497520486678496,1.1467109686099801,2745,5,PTPRK|MED1|CASK
RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:0036005,0.136633441594803,0.62388141596544,0.623338664313682,1.32091417409232,1219,4,PDE2A|PDE1B|CSF1R|FER
MICROTUBULE SLIDING%GOBP%GO:0051012,0.0677876340526943,0.50364937614461,-0.9651521835024258,-1.2911135031145702,511,1,MAP4
CELLULAR DEFENSE RESPONSE%GOBP%GO:0006968,0.575422086908386,0.941940408834489,-0.17140999313365002,-0.922337776686718,2078,34,ITK|RELA|CD5L|NCF2|CD300C|TYROBP|CD19|C5AR1|PTK2B|FOSL1|BECN1|KLRG1|TNFRSF4|ADORA2B
URETERIC BUD DEVELOPMENT%GOBP%GO:0001657,0.583087325016665,0.9439064862850342,0.25322885552520497,0.9083835307927141,6122,18,CITED1|BMP4|PKD2|ROBO2
GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901659,0.629365580723761,0.956758158836627,0.215846638310512,0.8775270495279079,6973,27,IMPDH1|TK1|CAD|CTPS2|UCKL1|DCK|UMPS|LCMT2|UCK1|TYW3|CTPS1|TYW5
NEGATIVE REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:1900139,0.9706077055474649,1.0,-0.513123070136745,-0.6864203759131751,7330,1,PLA2R1
METAL ION HOMEOSTASIS%GOBP%GO:0055065,0.8477795427861039,0.991298302704726,0.123418212443322,0.807242428085906,12274,312,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|SLC12A2|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|ATP1B3|P2RX5|TMTC2|CXCR4|F2R|BDH2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|KCNH2|TMEM178A|MT1E|CCR5|CNNM2|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|SLC39A7|SLC46A1|DMPK|SLC40A1|NEO1|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|SLC39A13|ANK3|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1|ACO1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|TFAP2B
REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032652,0.899912510936133,0.998912093067348,0.148271017836936,0.654473670728665,10285,36,GHRL|AIM2|CEACAM1|F2R|GSDMD|AZU1|CCL19|GSTP1
HEXOSE CATABOLIC PROCESS%GOBP%GO:0019320,0.329227610982807,0.828303707528737,0.24031944998257102,1.10603553084056,3848,42,FUT9|FUT7|GALM|PGM5|FUT2|FUT8|ALDH1A1|TKFC|GALE
ESTABLISHMENT OF ORGANELLE LOCALIZATION%GOBP%GO:0051656,0.682481751824818,0.9659330636214009,-0.103549944710328,-0.933307450159016,373,299,FAM65A|TRAPPC2L|TRAPPC6A|PA2G4|BLOC1S4|TBC1D20|SEH1L|NMD3|RAB6A|CEP19|FAM91A1|NAPA|VAMP2|STX11|MAD1L1|HAP1|RAB1A|VPS4B|BECN1|YKT6|ZNF593|PDCD10|NPM1|AP3S2|CDC42|SERPINA1|BLOC1S6|OTOF|KIF3B|RRS1|SEC23IP|SNPH|MKKS|YWHAZ|TMED2|SEC23A|TRAK1|TRAPPC10|HTT|SYT2|CHMP4B|BLOC1S3|CHMP1B|MAP4|SLC9A3R1|NSFL1C|KIF13A|ANKRD28|DLG1|BICD1|BBS7|TMEM230|SYT9|SNAP25|CPLX1|UBB
SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035914,0.348494012338212,0.842847021021096,0.6652881169010201,1.08739515054101,2880,2,MYLK2|LEMD2
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072305,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
AXO-DENDRITIC PROTEIN TRANSPORT%GOBP%GO:0099640,0.7849582172701949,0.981487311948134,-0.24066412929560396,-0.7480889008019219,4226,8,RAB27B|DLG2|KIF5C|KIF5B|MAPK8IP3|KIF5A|MAP1A|HSPB1
POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0060452,0.0411297250859107,0.402256981537283,0.6321279133842901,1.55462654240717,382,6,RGS2|KCNQ1
NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:1902902,0.21105037094884802,0.7257004702836279,-0.37864077669902896,-1.22228635799807,1080,9,SEC22B|PINK1|SCFD1|FEZ2|PHF23|SMCR8|FEZ1|CHMP4A|CHMP4B
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION%GOBP%GO:0086069,0.482518955349621,0.905495344990943,0.377789864716385,0.983307644162063,4581,7,TNNI3K|CACNA2D1
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002275,0.0163934426229508,0.27230872946709,-0.138885252568964,-1.31491388181124,4,411,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|SBNO2|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|KARS|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|DYSF|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
NEGATIVE REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140194,0.0036241610738255,0.143595610377104,0.9979047198941329,1.32567190069352,26,1,RGS2
SIGNAL TRANSDUCTION INVOLVED IN DNA INTEGRITY CHECKPOINT%GOBP%GO:0072401,0.508954501452081,0.918404893008545,0.187012697296129,0.9708107032951179,6308,70,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|DTL|E2F7|GEN1|GTSE1|BRCC3|CHEK2|PLK1|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CHEK1|CASP2|CDK2|ATM|CNOT1|UIMC1|BRCA1|BRE|PCBP4|MDM2
THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070493,0.7421838177533391,0.974505008828563,-0.384912319400022,-0.7811681159750951,4723,3,IQGAP2|PLEK|DGKQ
"FATTY ACID ELONGATION, MONOUNSATURATED FATTY ACID%GOBP%GO:0034625",0.256591850076269,0.767319904137432,0.515488863315952,1.18812541310018,2354,5,ELOVL6|ELOVL4|ELOVL2|ELOVL1|ELOVL5
AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING%GOBP%GO:0086027,0.0907431271477663,0.560322217247896,0.5813065617993709,1.42963882960087,844,6,CACNA1G|CACNB2
NEGATIVE REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000323,0.271692439862543,0.7865607589760191,0.477911923704237,1.1753547751842501,2529,6,ARNTL|CLOCK|CRY2|CRY1|PHB
POLYURIDYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:1990074,0.456176913280074,0.88900512246363,0.532547593603279,1.01231695353579,3939,3,ZCCHC11|ZCCHC6
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902231,0.54675775562773,0.9305779599215391,0.445213231302865,0.9434493661144879,4881,4,FBXO18|RPL26|NACC2
ISOPENTENYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046490,0.8729980960913879,0.9934031064448321,0.320607530171789,0.6793979824609939,7794,4,MVD|IDI1|MVK
STEM CELL DIVISION%GOBP%GO:0017145,0.42940557097731397,0.8777321230505178,0.29641804592376003,1.02760097963798,4485,16,FGF13|TGFB2|LEF1|DOCK7|SOX5|ING2|FGFR2|TEAD3
PHOSPHATIDYLINOSITOL ACYL-CHAIN REMODELING%GOBP%GO:0036149,0.999798508966351,1.0,0.11597151390979199,0.342261898964675,9923,10,PLA2G4A|PLA2G2D|PLA2G12A|PLA2G4C|LCLAT1
ESTABLISHMENT OF VESICLE LOCALIZATION%GOBP%GO:0051650,0.31709331131296503,0.818598932456131,-0.130242433970083,-1.06684692277445,383,173,CEP19|FAM91A1|NAPA|VAMP2|STX11|HAP1|RAB1A|YKT6|AP3S2|SERPINA1|BLOC1S6|OTOF|KIF3B|SEC23IP|SNPH|MKKS|TMED2|SEC23A|TRAK1|TRAPPC10|HTT|SYT2|BLOC1S3|KIF13A|ANKRD28|BBS7|TMEM230|SYT9|SNAP25|CPLX1
ACYLGLYCEROL HOMEOSTASIS%GOBP%GO:0055090,0.0398956723338485,0.398259330633433,0.46568180472267606,1.5789463266235302,412,15,SIRT1|LPL|SCARB1|C1QTNF3|RORA|CETP|APOE
REGULATION OF CELL SHAPE%GOBP%GO:0008360,0.247514910536779,0.76007684654174,-0.15218642917029998,-1.12704175897229,497,104,RND1|RHOG|MYO10|FMNL1|PARVB|CDC42EP5|VEGFA|BVES|KDR|LPAR1|PTK2B|DLC1|FGD4|FGR|LIMD1|FYN|RHOA|FMNL3|RND2|BRWD1|CRK|RHOC|CDC42|MSN|PLXNA1|PLXNA4|SEC23A|WDPCP|ALDOA|MYH9|SLC9A3R1|RHOQ|DLG1
I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0007249,0.0286666666666667,0.347919292482523,-0.245879956158595,-1.51656167303081,85,53,NFKBIA|DAB2IP|IRAK2|NKIRAS1|BCL10|RELB|REL|TANK|RNF31|RIPK2|IRAK1BP1|UBA52|BCL3|RBCK1|TICAM1|UBC|TNF|UBB
URINARY TRACT SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014848,0.619463087248322,0.9532238181782521,0.694640494044993,0.922798906229247,4614,1,KCNMA1
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045601,0.0484790874524715,0.43374509308502396,-0.32936091905306103,-1.52584363548462,203,22,NOTCH4|S1PR3|BTG1|ZEB1|ADD1|IL1B|TMEM100|CDH5|FOXJ2|ATOH8|PROC|TNF
RESPONSE TO HYPOBARIC HYPOXIA%GOBP%GO:1990910,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
FATTY ALCOHOL METABOLIC PROCESS%GOBP%GO:1903173,0.5976775130035079,0.9492590312650558,0.5676885295238271,0.927871306190501,4940,2,ALDH3A2|PECR
NEUTROPHIL DIFFERENTIATION%GOBP%GO:0030223,0.701705576388049,0.968941691852291,0.528530341611124,0.8638683237855391,5800,2,LEF1|JAGN1
G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0044783,0.703064977523498,0.968941691852291,0.166121415134685,0.839953183391242,8601,62,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|RPS27L|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|RFWD3|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CCND1|CNOT6|E2F4
POSITIVE REGULATION OF PROTEIN SECRETION%GOBP%GO:0050714,0.981724728726442,1.0,-0.0862828100475167,-0.659056591783102,1718,119,MYRIP|IL6|PANX1|VAMP3|MBP|IGF1|MAVS|MYOM1|RIPK2|GAPDH|KARS|NLRP1|NLRP3|TNFRSF4|DRD2|TWIST1|TNF|TRH
SINOATRIAL VALVE MORPHOGENESIS%GOBP%GO:0003185,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014067,0.007614213197969541,0.197647069623972,-0.5944225938995191,-1.9188494005935601,38,9,STAMBP|DAB2IP|GLTSCR2|PIK3IP1|SLC9A3R1|TWIST1
DESMOSOME DISASSEMBLY%GOBP%GO:0035921,0.480206540447504,0.9046812288131709,-0.7588773709748571,-1.01517339713013,3626,1,SNAI2
SPERMIDINE ACETYLATION%GOBP%GO:0032918,0.437280754808274,0.878651088001772,0.6278467052660601,1.02619819179942,3614,2,SAT2|SAT1
LENS FIBER CELL DIFFERENTIATION%GOBP%GO:0070306,0.0138530927835052,0.256136946817111,0.692009520639834,1.70189663453626,128,6,SIX3|WNT5B|PROX1
3-KETO-SPHINGANINE METABOLIC PROCESS%GOBP%GO:0006666,0.0971799285052297,0.569923978730193,-0.9496029995588879,-1.2703128856626598,733,1,KDSR
TRNA AMINOACYLATION%GOBP%GO:0043039,0.851482059282371,0.991298302704726,-0.1265031697274,-0.7481171793601321,2728,46,QARS|DARS|AARS|CARS|WARS|NARS|HARS|FARS2|GARS|AIMP2|YARS|KARS|SARS
REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902882,0.421750663129974,0.873294915240747,-0.167039766088994,-1.02307622739032,1271,52,ATF4|HIF1A|TXN|HSPB1|SOD1|FBXW7|MAPK7|STK26|FYN|PDE8A|P4HB|HGF|BAG5|SOD2|PARK2|FBXO7|MET|MCTP1|TNF
NEURONAL STEM CELL POPULATION MAINTENANCE%GOBP%GO:0097150,0.24487886035146103,0.757467559003634,0.440810379053914,1.20176735545033,2354,8,HES1|CDH2|PROX1|SRRT|JAG1|MMP24
RESPONSE TO BLUE LIGHT%GOBP%GO:0009637,0.440089086859688,0.879896414106183,-0.591452991452992,-1.01164866568429,2963,2,CRY2|CRY1
MAPK PHOSPHATASE EXPORT FROM NUCLEUS%GOBP%GO:0045208,0.23812080536912802,0.7507739897770379,0.8835465372739301,1.17375215696281,1773,1,DUSP16
"NEUROTRANSMITTER RECEPTOR TRANSPORT, POSTSYNAPTIC ENDOSOME TO LYSOSOME%GOBP%GO:0098943",0.10851648351648402,0.58452352834625,-0.5521352446043299,-1.39769370804971,631,5,CACNG3|CACNG7
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0050689,0.769471430923761,0.9792236089291529,-0.331660508465229,-0.762749883162854,4672,4,TARBP2|IFIT1|MICB|MUL1
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051806,0.38370253164557,0.8582519754973359,-0.200730186550715,-1.04139464068271,1454,30,PPIA|VAMP8|CD4|WWP2|CD81|GAS6|PVRL1|ITCH|PVRL2|ZNF639|CBLL1|CTNNB1|GRB2|CAV2|MET|CAV1
REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048638,0.5756256800870511,0.941940408834489,-0.125035915364441,-0.9520614550543609,1057,116,CDKN1B|DCC|SOD1|NOTCH1|RNF6|WWC1|VEGFA|NEDD4L|PIM1|DNM2|RTN4|TGFBR1|GDF15|ABL1|SEMA3F|MAP3K13|NRP1|CPNE6|SEMA7A|FGF2|POU4F2|ISLR2|IGF1|LIMK1|SEMA6B|STAT5A|TBX20|TWF2|CDKN1A|SYT2|DUSP10|SEMA3A|PLCB1|SEMA3G|CPNE9|OLFM1|GAL|RBPJ
BILE ACID SECRETION%GOBP%GO:0032782,0.692851531814611,0.96731875442989,-0.40251109301498905,-0.816884304144143,4409,3,SLC9A3R1
POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0000271,0.0231349103197297,0.31901519550794605,-0.320657221394504,-1.6410438496656201,88,29,B3GNT5|B3GNT7|CSGALNACT1|PER2|B3GNT8|B3GNT2|NR1D1
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035235,0.0863055006758865,0.550367884749078,0.5282743755051339,1.44021767492306,829,8,GRIA2|CDK5R1|SULT1A3|GRIN1
POSITIVE REGULATION OF ANTEROGRADE DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901953,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE%GOBP%GO:0090151,0.137023217247098,0.62388141596544,-0.365546134681214,-1.3317212365528102,660,12,NDUFA13|TIMM10|HSP90AA1|HSPA4|TOMM22|ROMO1|SAMM50|C19orf52|TIMM22
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904376,0.8007130793769941,0.9841161968820359,0.198514585224645,0.73718376372225,8533,20,SAPCD2|PKDCC|GBP1|GOPC|CLTC|DAB2|TMEM59|CSK|AP2M1
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904690,0.8943890693246719,0.9979099492748029,0.310783535880127,0.6585800001201321,7985,4,METTL3|NCK1|MTOR
POSITIVE REGULATION OF GRANZYME A PRODUCTION%GOBP%GO:2000513,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
EYE PIGMENT GRANULE ORGANIZATION%GOBP%GO:0008057,0.0750335570469799,0.524840022194793,0.9633325981473309,1.2797443793245902,558,1,SHROOM2
TETRAHYDROBIOPTERIN METABOLIC PROCESS%GOBP%GO:0046146,0.38633241758241793,0.8596647264526249,-0.410807576457192,-1.0399321007751299,2249,5,SPR|QDPR
LEUKOCYTE MIGRATION%GOBP%GO:0050900,0.889720702562626,0.997300970905927,0.12081202677060099,0.745564506571837,12359,190,IGKV4-1|EDN1|ITGB1|CXCL13|SLC12A2|VPREB3|CD47|CEACAM1|GRB14|SIRPG|ATP1B3|MADCAM1|CXCR4|CXCL9|CD2|PTPRO|ITGA4|TGFB2|MERTK|SRC|CCR5|XCL2|CCL21|F2RL1|AZU1|CCL5|IGKV3-11|GPC1|PPIL2|SLC7A9|KIT|BSG|IGKV2D-28|JCHAIN|CCL19|CYP7B1|CXCL10|RPS19|CCL2|CXADR|IGKV2-28|AMICA1|PLCG1
CATABOLISM BY HOST OF SYMBIONT PROTEIN%GOBP%GO:0052362,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
KIDNEY MESENCHYME DEVELOPMENT%GOBP%GO:0072074,0.0197110538694143,0.29306776028311,0.762824940989114,1.61649891879094,175,4,WNT4|BASP1|PKD2
GPI ANCHOR METABOLIC PROCESS%GOBP%GO:0006505,0.966467377177021,1.0,-0.11594401556238901,-0.593372613960582,3717,29,PIGA|DPM1|PIGG|PIGZ|PIGY|DPM2|MPPE1|PIGT
REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0060558,0.302321752017125,0.805227617550042,-0.486797089249596,-1.11953160979995,1835,4,IL1B|TNF
NEGATIVE REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905154,0.898450946643718,0.998912093067348,-0.548191442434936,-0.733332406762173,6785,1,CD300A
POSITIVE REGULATION OF CELL PROLIFERATION BY VEGF-ACTIVATED PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038091,0.514689709347997,0.920792511236057,-0.46448659975736206,-0.942661753704617,3275,3,PDGFRA|PDGFRB|VEGFA
LIPOATE BIOSYNTHETIC PROCESS%GOBP%GO:0009107,0.0406461008870647,0.401998427404428,-0.978881782090869,-1.30948000575828,306,1,LIAS
NEGATIVE REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051025,0.0423672712829339,0.405106454801772,-0.978054697838553,-1.3083735899363702,319,1,CD22
NEGATIVE REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001287,0.00229829442361195,0.12160400622823499,0.966914805624483,1.5803956870896598,18,2,PROM2|UNC119
NEGATIVE REGULATION OF PROSTATIC BUD FORMATION%GOBP%GO:0060686,0.6920805369127521,0.96731875442989,0.6584142037935601,0.874673895799606,5155,1,SULF1
REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900101,0.007604562737642591,0.197647069623972,-0.40114884631648706,-1.8584184662643604,31,22,PPP1R15B|BAX|DAB2IP|HSPA5|BOK|ATF6|PTPN1|BFAR|PIK3R1|BCL2L11|TMEM33
TRIPARTITE REGIONAL SUBDIVISION%GOBP%GO:0007351,0.0131837001525387,0.250097661198388,0.733051236243746,1.6895744309259297,120,5,TBX3|BASP1|HOXD8
MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043653,0.0061281337047353794,0.17804916190196898,-0.634122124772464,-1.97112766528052,32,8,VPS35|MFF|FIS1|DNM1L|CCAR2|BNIP3|BAX|ATG3
AMMONIA HOMEOSTASIS%GOBP%GO:0097272,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX%GOBP%GO:0002501,0.8969207969701959,0.998912093067348,-0.286935421607015,-0.659891526786886,5446,4,HLA-DMB|HLA-DRA|HLA-DMA|CALR
IRON CATION EXPORT%GOBP%GO:1903414,0.398389261744966,0.8638522656500329,0.808226731363035,1.07369315506495,2967,1,SLC40A1
SNORNA POLYADENYLATION%GOBP%GO:0071050,0.477951002227172,0.9044043130580649,-0.5740450776268821,-0.981873361392958,3218,2,PAPD7
INORGANIC CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098662,0.345931462417149,0.8421727240261659,0.16937310994081103,1.0732743504527902,4905,231,KCNK2|RYR2|KCNN2|SCN1A|KCNK6|KCNH8|CACNA1G|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|NDUFS7|KCNQ1|NOL3|SLC9A5|SLC9A7|SLC36A1|SLC8A3|ATP1B3|F2R|KCNH1|SLC39A3|ATP5G1|LRRC55|PKD2|KCNC3|KCNC1|IBTK|KCND1|KCNB2|ATP2A1|HCN3|ATP5D|NNT|CACNA1H|CACNA2D1|KCNJ11|MRS2|KCNH2|MT-ATP8|CCR5|CACNA1D|CCL21|MCOLN1|UCP3|NALCN|SLC39A7|SLC46A1|SLC40A1|GRIN1|CCL19|TRPM7|ASIC1|ATP2A2|TCIRG1
PARACRINE SIGNALING%GOBP%GO:0038001,0.27597562983698304,0.7884684708511421,-0.49964153752826296,-1.14907115754165,1675,4,PDGFB|CD34|MB21D1|FGF2
POSITIVE REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903580,0.6227561447114061,0.9536478716552259,0.226691451148276,0.881649134950355,6764,23,PRKAA2|CCNB1|CDK1|INS
POSITIVE REGULATION OF CHROMATIN BINDING%GOBP%GO:0035563,0.34161752316765004,0.8356275732448649,0.425913182090309,1.10856252857179,3243,7,HMBOX1|GMNN|PARP9|CDT1|DDX11|MED25
POSITIVE REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0010701,0.944719970968913,1.0,0.401433691756272,0.6561323411470029,7809,2,STX1A|KCNB1
CARNITINE BIOSYNTHETIC PROCESS%GOBP%GO:0045329,0.830888117370366,0.9879179006160809,0.340173643489448,0.720860445633639,7418,4,ACADM|ALDH9A1
HEMOSTASIS%GOBP%GO:0007599,0.0009407337723424269,0.0849637591935908,-0.19061957023540602,-1.59586273003672,0,195,SH2B3|ENTPD1|PIK3R5|HSPB1|PTPN6|HPS4|PRKCH|GNA13|HMG20B|FCER1G|DGKI|PRKCD|DGKD|PDPN|ARRB2|VAV1|GPI|HBG2|GNAQ|FYN|ITPK1|P2RX6|C1QBP|DGKQ|MFN2|CLIC1|EHD3|DOCK9|GNA15|UBASH3B|EHD1|IL6|GGCX|LYN|RAP2B|ARRB1|MAFF|PRKAR2A|RBSN|VAV3|PLAUR|VAV2|EHD2|CDC42|THBD|PROC|RAD51B|PRKCA|DGKG|CD9|YWHAZ|PRKAR1B|ANO6|CSRP1|MAPK3|GNA12|RAB5A|DGKB|BLOC1S3|MYH9|VWF|GNAS|H3F3B|RAC1|CD36|PIK3R1|ZFPM2|DGKK
WYBUTOSINE METABOLIC PROCESS%GOBP%GO:0031590,0.6747676111546651,0.9647315640607691,0.40204836987415393,0.851978901424652,6024,4,LCMT2|TYW3|TYW5
POSITIVE REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902624,0.42623674911660797,0.875696962448429,-0.23858795311276998,-1.00395066494977,1929,17,CAMK1D|C1QBP|CXCL8|THBS4|RAC1
REGULATION OF MAPK CASCADE%GOBP%GO:0043408,0.0146341463414634,0.263430540827147,-0.13409629007246499,-1.2939832027315301,2,474,IL1B|WWC1|IRAK1|IL11|VEGFA|PKN1|PLCE1|KDR|NECAB2|CX3CL1|ADRA2C|PRKCD|SIRPA|ARHGAP8|LPAR1|DAB2IP|IGF1R|C5AR1|TGFBR1|TRIB1|LGALS9|IRAK2|PTK2B|PRKAA1|CNKSR3|STYX|ARRB2|GDF15|PRKD2|RGS4|LIF|MARCO|MAP3K13|RPS3|RET|CCL14|ADRA1B|BMP8B|NRP1|INPP5K|FOXO1|ATP6AP2|PDE8A|UBE2V1|SEMA7A|FGF2|MAP2K5|RASSF2|IL6|LYN|FCGR2B|ARRB1|DFNA5|CYLD|ULK4|TRIB2|CHRNA7|GLIPR2|MST1R|PPP2CA|IGF1|DIRAS1|SERPINF2|ICAM1|TNIP1|MAP4K4|CRK|RIPK2|RAP1A|PDCD10|PTPN1|PLA2G2A|KARS|NPNT|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|PDCD4|ADRB2|RAPGEF1|SHC1|UBA52|MECOM|PRKCA|DUSP3|EPHA8|ACKR3|UCHL1|DKK1|PELI2|ZNF622|ADCYAP1|MAPK3|CAV2|FLT1|PARK2|CHI3L1|ADRA2A|FGF10|PEA15|GREM1|EPHA7|BMPER|RELL2|DUSP10|AAED1|EDA2R|SLC9A3R1|SEMA3A|MET|MAP3K11|PLCB1|IGF2|RELL1|UBC|CCL18|MAP2K1|CD36|DLG1|TNF|SPRED2|CAV1|EPHB2|PAK2|TRIB3|INHBB|UBB|ADORA2B
NEGATIVE REGULATION OF LIPID TRANSPORT%GOBP%GO:0032369,0.6536625855986721,0.9640743070248079,-0.22627455307879102,-0.852145641798962,3149,13,SREBF2|APOC1|AKT2|THBS1|AKT1|APOC2|PLA2R1|ITGB3|ITGAV|NFKB1|IRS2|NR1H3|NR1H2
SKELETAL MYOFIBRIL ASSEMBLY%GOBP%GO:0014866,0.452947904752002,0.8874890379518141,0.3684922904151311,1.0046088440714,4355,8,IGSF22|PROX1|TCAP|OBSL1|MYOM2
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY%GOBP%GO:0043467,0.522491349480969,0.9251240799994541,-0.143871047664019,-0.967365578058501,1358,71,PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|INPP5K|PPARA|GLTSCR2|GCGR|IGF1|UQCC2|SHMT2|SNCA|PDE12|SLC25A33|AAED1|IGF2|COX7A2L
GOLGI TO ENDOSOME TRANSPORT%GOBP%GO:0006895,0.615179506713646,0.9513481941063309,0.246685837405564,0.8849123908658141,6459,18,DOPEY1|KLHL20|VPS13A|VPS13C|GBF1|MON2|KIF16B
"RETROGRADE TRANSPORT, PLASMA MEMBRANE TO GOLGI%GOBP%GO:0035526",0.867908552074513,0.993084774742015,0.454176490863094,0.7423389973576521,7174,2,USP6NL
REGULATION OF INTERLEUKIN-12 BIOSYNTHETIC PROCESS%GOBP%GO:0045075,0.30600903091351195,0.809555201431097,0.593029668026911,1.1272870145397,2642,3,LTB|TLR4|MAST2
CELLULAR RESPONSE TO RAPAMYCIN%GOBP%GO:0072752,0.7773154362416109,0.9810334506628041,0.6130348478164979,0.8143894459006801,5790,1,LARP1
ESTABLISHMENT OF NEUROBLAST POLARITY%GOBP%GO:0045200,0.294894060437652,0.800447413278835,0.5979290560102349,1.13660023569973,2546,3,FGF13|DOCK7
REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:0010359,0.520403780068729,0.924920262043165,0.386638302205658,0.9508805958308449,4845,6,ANO9|GOPC|TCAF1|ABCB1
DEFINITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0060318,0.5944657751886671,0.947176034529489,-0.6966806352007061,-0.9319709273224771,4489,1,TGFBR3
HINDBRAIN TANGENTIAL CELL MIGRATION%GOBP%GO:0021934,0.9092798812175201,1.0,-0.38125172318720707,-0.6521106539754971,6123,2,PHOX2B|TTBK2
REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071900,0.9148760330578509,1.0,0.114806544711232,0.7543906679318141,13283,330,CARTPT|RGS2|TENM1|SIRT1|EDN1|TPD52L1|DUSP9|GHRL|TAOK3|CCNA1|MAPK11|STK39|GRM4|MAP3K10|CXCR4|LIME1|CCNB1|MAP2K6|PARP16|BMP4|PSRC1|F2R|CDK1|C8orf4|MAP2K2|STK38|PROX1|CDKN2C|RGS14|BLM|ERN1|CDKN3|MAP3K9|DIRAS2|MTCP1|DUSP16|ERP29|DUSP8|CDK5R1|CDC25C|DUSP19|GTF2H1|MAP3K5|CDKN2A|MAP3K7|MEN1|SRC|EZH2|CCNE1|PKMYT1|APC|RGS3|PRKAR2B|CDC6|KIT|NF1|APOE|HRAS|CDKN2B|ZNF675|CCL19|GSTP1|GADD45B|CCNB2|GADD45G|CCNI2|MAP3K4|CDK7|TAOK1|C5|DRD4|MAP2K7|CCNF|PDGFD|ALK|PLK1|TSG101|NTRK3|TESK1|CKS2|RIPK1|SMPD1|NRG1|MAP3K12|CCNE2|PTPRJ|TELO2|CDK5RAP3|TAOK2|CCNT2|PTPN22|MADD|TRAF2|DUSP1|RASGRP1|SORL1|CAMK1|DVL3|THBS1|SPRY4|DNAJA1|S1PR2|PPP2R1A|ADAM9|SPRY1|CSF1R|INCA1|TFAP4|SERTAD1|DVL2|CDKN2D|SPAG9|CCND2|SNF8|HGS|AKT1|TNIK|LRP6|TAB1|CCNJ|CCNG1|NGF
CELLULAR BIOGENIC AMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042401,0.6940298507462691,0.96731875442989,-0.22394238551229,-0.8158445740674929,3347,12,SMS|ODC1|SMOX
PURINE NUCLEOBASE TRANSPORT%GOBP%GO:0006863,0.29043183742591,0.7998377855773342,0.690984284532672,1.12939483061993,2400,2,SLC29A2|VDAC3
MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0060415,0.7304211625478589,0.972554563883587,0.180678104279359,0.8033133513032241,8393,37,RYR2|IGSF22|MYLK2|BMP4|PROX1|TCAP|TGFB2|HEY2|OBSL1|TNNI3|NRG1|MYLK|MYOM2|FGFR2
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:1902403,0.7554653858893671,0.9771370084125129,0.16167288265464003,0.7985947859638929,9122,56,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0010498,0.661122661122661,0.964618776001639,0.140732939441135,0.915348858143015,9539,293,SIRT1|ENC1|FBXO18|SDF2|ARNTL|SPSB4|SIAH2|TRIM9|BRSK2|TRIM3|ANAPC15|CCNB1|SGTA|CDC34|CDK1|BTRC|KIF14|ANAPC5|RNF34|KLHL42|PSMB9|MTA1|POMT2|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|ATXN3|TNFAIP1|EDEM3|SPSB3|FBXL19|RNF126|USP13|KLHL20|CDC23|CDC20|ANAPC7|ANAPC16|FBXL15|PTTG1|FBXO5|PSMD1|FBXL6|BUB1B|RNF121|AURKB|DDB1|RNF7|CLOCK|PSMA1|SYVN1|FBXL8|AUP1|NFE2L2|KLHL22|FBXW5|CCNF|PLK1|CUL4B|BIRC2|HERC2|KEAP1|MAN1B1|UBXN4|HERPUD1|TMUB1|SPOP|AURKA|RMND5B|PSMA3|JKAMP|VIMP|UBE2C|FBXO9|ANKZF1|PSMC6|ANAPC10|BAG6|GET4|KCTD13|TOPORS|PSMD2|DNAJB9|UBE2B|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FBXL7|AREL1|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|UBR3|CDC16|PLAA|KCTD5|ANAPC2|PSMA2|PSMB6|PSMB3|FAF1|FBXO44|KCTD2|MDM2|PSMA7|ERLIN1|NEMF|SMURF2|PSMB4|SHARPIN
POSITIVE REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051142,0.817708963348252,0.987153241368501,0.47922490123991995,0.7832799359984879,6759,2,RASAL3|IL18
REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904666,0.78240302743614,0.981487311948134,0.205133303952578,0.7497936113902379,8269,19,USP44|CDC20|FBXO5|PLK1|UBE2C|RPL5|RPL23|UBE2S|BAG2|CDC14B|FZR1|GORASP1|RPS7
LEARNING%GOBP%GO:0007612,0.8098969423388129,0.984682960940884,0.161499441082361,0.748727565050894,9508,43,SLC8A3|RGS14|FGF13|NF1|GRIN1|DLG4|TH|NLGN4Y|BRSK1|NRXN3|NPAS4|SLC8A2|SHANK1|CLDN5|NLGN3|CIC
PLATELET ACTIVATING FACTOR METABOLIC PROCESS%GOBP%GO:0046469,0.8867945086075399,0.996643473105967,0.283815232341922,0.654152037351951,8138,5,PLA2G4A|LPCAT2|CHPT1|PAFAH1B1
HISTONE ARGININE METHYLATION%GOBP%GO:0034969,0.936328833366915,1.0,0.19770118470745102,0.5834672724732349,9293,10,PRMT9|PRMT1|CARM1
PERICYTE CELL DIFFERENTIATION%GOBP%GO:1904238,0.9588977654278108,1.0,0.306054924451307,0.58177821561236,8281,3,ACTA2|PDGFB|CD34
CELL REDOX HOMEOSTASIS%GOBP%GO:0045454,0.668065371024735,0.964618776001639,-0.20054952520801897,-0.8438893354049058,3024,17,GSR|DDIT3|SLC11A1|PRDX1|NOS3
POSITIVE REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070172,0.194624652455978,0.7059086441794671,-0.9013564181737981,-1.2057719627178898,1469,1,WNT6
POSITIVE REGULATION OF REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:1904833,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|TNF
REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006140,0.00921489126428308,0.212136117579847,-0.249774474013358,-1.6356023285567098,24,65,HIF1A|FLCN|CBFA2T3|PPIF|PDK3|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|ME2|FBP1|PPARA|ENO1|CDA|IGF1|UQCC2|PDPR|TMSB4X|SHMT2|SNCA|PPARGC1A|PDE12|SLC25A33|NOS3|GUCA1A|AAED1|COX7A2L
REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032649,0.992801047120419,1.0,-0.0831615847840269,-0.506770137400782,3033,51,HAVCR2|GAS6|C10orf54|CEBPG|IL6R|PYCARD|CD274|IL1B|RARA|FAM49B|SIRPA|LGALS9|C1QBP|PRNP|SLC11A1|CD276|PDE4B|PDE4D
MELANOCYTE MIGRATION%GOBP%GO:0097324,0.881335430022983,0.9956508825790341,0.446528173850587,0.7298380333122679,7285,2,KIT|ZEB2
REGULATION OF CARDIAC MUSCLE ADAPTATION%GOBP%GO:0010612,0.006284367635506679,0.17975028050367198,-0.8619168412925992,-1.7492346207293301,39,3,FOXO1|ATP2B4|LMNA
NEURON CELL-CELL ADHESION%GOBP%GO:0007158,0.742287286303793,0.974505008828563,0.246598372752368,0.777366196839125,7554,12,CDK5R1|NLGN4Y|NRXN3|NCAM2|NLGN3|NRXN2|NLGN2
LEUCINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098713,0.0542830663312591,0.455180689373156,-0.9724856638729599,-1.30092372340218,409,1,SLC3A2
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090092,0.15066751430387804,0.6462586646947739,-0.150824751593575,-1.1809648117578,236,133,CDKN1C|ADAM17|UBA52|DKK1|SNX6|RBPMS2|GREM1|BMPER|ACVRL1|IGSF1|UBC|SNX25|HSP90AB1|RBPJ|CAV1|DACT2|NBL1|FKBP1A|INHBB|UBB
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL%GOBP%GO:0060078,0.0658269961977186,0.495991045493396,-0.31842281502891195,-1.4751702390856103,276,22,CHRNA3|GABRG2|ADCYAP1|DRD2|GABRA3|C15orf59
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY%GOBP%GO:0007185,0.606151142355009,0.9508825506493929,-0.317160240002704,-0.8705835630546609,3448,6,FRS2|PTPRU|TRIO
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING%GOBP%GO:0010882,0.67185085007728,0.964671573446318,0.246484802533333,0.8357343352942479,6954,15,RYR2|ATP2A2|DMD|TNNI3|SLC8A1
MITOCHONDRIAL RNA MODIFICATION%GOBP%GO:1900864,0.45865549828178703,0.890371861972445,0.40757780952822603,1.00237826454525,4270,6,TRIT1|PUS1|MTO1|HSD17B10
METHYLGLYOXAL METABOLIC PROCESS%GOBP%GO:0009438,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|TPI1
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904427,0.604931884807725,0.9508825506493929,0.198980823626374,0.897454860864609,7015,39,RYR2|CACNB2|F2R|CXCL9|PKD2|PDPK1|CACNA2D1|STAC2|STAC3|CXCL10|PLCG1|TRPC1
NEGATIVE REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903336,0.722229577651264,0.971401508276304,-0.6338773709748571,-0.8479570859120851,5454,1,VPS35
PEPTIDE MODIFICATION%GOBP%GO:0031179,0.33639772589814904,0.8311444145897029,0.671188410688824,1.0970390186466301,2780,2,GGT1|PAM
POSITIVE REGULATION OF MYELINATION%GOBP%GO:0031643,0.6639766483516479,0.964618776001639,-0.328348459809993,-0.8311923225497378,3866,5,TENM4|PARD3
REGULATION OF TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0032207,0.4120217132265329,0.867015886388254,-0.7927878253198059,-1.06053644582846,3111,1,TERF2
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901390,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
HISTONE-SERINE PHOSPHORYLATION%GOBP%GO:0035404,0.186359054765371,0.692707054555662,0.592236698586722,1.25500613770233,1663,4,AURKB|VRK1|RPS6KA4
CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE%GOBP%GO:0032286,0.9687391455366451,1.0,0.29517401366273804,0.561094748832142,8366,3,MYRF|PTEN
NEGATIVE REGULATION OF URINE VOLUME%GOBP%GO:0035811,0.64993288590604,0.963755998259649,0.680690339655933,0.90426674848389,4841,1,ADCY6
PALLIUM DEVELOPMENT%GOBP%GO:0021543,0.274716028607488,0.7884684708511421,0.24072031477862,1.15136617090307,3264,49,BTBD3|CDK6|KIF14|MFSD2A|PROX1|WDR62|FGF13|ARHGAP11B|EPHA5|NPY|KIRREL3|CCDC85C|LEF1|NF1|TACC2|LRP8|PEBP1
PURINE NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0090480,0.760504825538233,0.977664504547119,-0.455086848635236,-0.778401681697971,5121,2,SLC35B4|SLC35C1
ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS%GOBP%GO:0060978,0.102906520031422,0.5745140527021371,-0.708400500901921,-1.43767776907723,654,3,TGFBR1|NRP1
RESPONSE TO BMP%GOBP%GO:0071772,0.33595352016404706,0.8311444145897029,-0.171630128802684,-1.07759788759502,982,56,UBE2D1|DLX5|ZCCHC12|SKI|RGMA|ACVR1|GDF15|TMEM100|FAM83G|BMP8B|SMAD6|SMAD1|CHRDL1|SMAD7|PDCD4|UBE2D3|MAPK3|ACVRL1
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0045839,0.0620086564791096,0.485898561056649,0.3434435305285589,1.46844909476391,701,32,KIF25|TPR|BMP4|CENPF|NAA10|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|KLHL22|PLK1|TEX14|CHEK1|ATM
MULTICELLULAR ORGANISMAL HOMEOSTASIS%GOBP%GO:0048871,0.6944339265429761,0.96731875442989,0.150717335129507,0.864223299245227,9169,118,PCDH15|OMA1|IRX3|GCNT2|NR4A3|PRKAA2|STK39|CDH3|IQCB1|ACADVL|ADGRV1|F2R|ADCY8|PIWIL4|NAPEPLD|SERPINA3|TMEM79|DFNB31|CDH23|NAPSA|SRC|BBS10|PRKAR2B|PASK|SLC40A1|JCHAIN|IL7|ZNF675|CXADR|STMN1|TF|NPHP3|CNGB1|ACTG1
REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0014809,0.423295125622323,0.873470206885489,0.5455136282368089,1.0369640213984799,3655,3,DMD|GSTM2|GSTO1
LEUKOCYTE DEGRANULATION%GOBP%GO:0043299,0.0377358490566038,0.38985863769583,-0.13284223752959198,-1.24992580919874,11,407,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0006360,0.450692746536267,0.88620227509476,-0.18862093903884103,-0.998576338485022,1658,32,PTRF|POLR1B|TAF1B|POLR2K|POLR2F|POLR1E|MAPK3|CD3EAP
NEGATIVE REGULATION OF POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:1901874,0.348494012338212,0.842847021021096,0.6652834435292161,1.08738751204319,2880,2,P3H1|CRTAP
NUCLEOTIDE SALVAGE%GOBP%GO:0043173,0.9047465635738828,1.0,0.25830040495446,0.6352522281556071,8424,6,NAPRT|HDDC2|FUK
REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900371,0.0886115444617785,0.556932119338259,-0.22782127484338102,-1.3472943792739098,283,46,HIF1A|FLCN|CBFA2T3|PDK3|PRKAA1|PFKFB4|PRKAG1|HDAC4|DNAJC30|FBP1|PPARA|ENO1|IGF1|PDPR|TMSB4X|PPARGC1A|NOS3|GUCA1A|AAED1
POSITIVE REGULATION OF MRNA CLEAVAGE%GOBP%GO:0031439,0.0871177015755329,0.553293724109832,-0.9551720335244821,-1.27776275219685,657,1,NUDT21
TROPHECTODERMAL CELL DIFFERENTIATION%GOBP%GO:0001829,0.33124927636910995,0.8293509737209019,0.582583686167636,1.1074303019012601,2860,3,HOPX|SRF
NEGATIVE REGULATION OF CELL ADHESION INVOLVED IN SUBSTRATE-BOUND CELL MIGRATION%GOBP%GO:0006933,0.6126206384558279,0.9508825506493929,-0.5164047422111939,-0.8832826546833271,4125,2,PTPRC|ITGB1BP1
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014068,0.7928232904536221,0.9819233677232551,-0.12837408779689802,-0.8024221921268522,2341,55,AGT|MYDGF|PIK3CD|PIK3R5|GPER1|PTPN6|HAX1|KDR|FGR|HGF|UNC5B|LYN|IGF1|BECN1|FGFR1|NEDD4|FLT1|PIK3R1|TNF
REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045113,0.677802524127691,0.9647315640607691,-0.490750975764302,-0.8394032611037672,4564,2,TMEFF2
PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006612,0.561977715877437,0.9367803676543771,-0.12153369732081801,-0.9641851565528711,806,144,RABGEF1|RPL7|SRP72|SGTB|MYO1C|RAB8B|RPS9|RPS3|RPL14|ZDHHC9|SEC63|ZDHHC11B|SEC62|ATG3|RPL15|RPL8|EXOC4|ZDHHC7|RPL35A|ZDHHC4|UBA52|PEX19|ASNA1|SSR1|CHMP4B|SRP54|PEX5|GOLGA7|MICALL1|PARD3
MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044144,0.831135841296722,0.9879179006160809,0.472414635772844,0.7721487441814878,6870,2,OSBP|TIRAP
REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031392,0.23126889909284398,0.7440352621789029,0.568631776319418,1.20498505255825,2064,4,SIRT1|PTGS2|PIBF1|ANXA1
REGULATION OF PROTEIN OXIDATION%GOBP%GO:1904806,0.372434794121541,0.852609194081082,-0.811479929422144,-1.08554144340363,2812,1,TRABD2A
CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090345,0.20308724832214803,0.7175864987119879,0.900639611821791,1.19645954392352,1512,1,POR
POSITIVE REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000436,0.621610738255034,0.9536478716552259,0.693537715041906,0.921333913522104,4630,1,DCUN1D1
NUCLEOLUS ORGANIZATION%GOBP%GO:0007000,0.669213847400718,0.964618776001639,0.45619137022765993,0.8671718052719359,5779,3,RPS19|NOL12|USP36
NEGATIVE REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031064,0.598218262806236,0.949262093257606,-0.521903919975912,-0.8926887037327559,4028,2,KDM5A
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043536,0.16542750929368,0.6682860217990739,-0.21172495060717497,-1.23416871380488,533,44,GATA2|RHOJ|HIF1A|HSPB1|VEGFA|KDR|HMOX1|PRKD2|FGF2|FOXC2|ETS1|TMSB4X|FGFR1|MAP2K3|ADAM17|STAT5A|PRKCA|NOS3
ENUCLEATE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0043353,0.518337084602145,0.9236324326350509,-0.736601235112484,-0.9853739309933491,3914,1,CEBPG
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061308,0.5073182532962379,0.9177168315498629,0.601378549765647,0.98293671875676,4193,2,HAND2|JAG1
MAINTENANCE OF PERMEABILITY OF BLOOD-BRAIN BARRIER%GOBP%GO:0035633,0.21037998146431897,0.7251658659797621,-0.893416409351566,-1.19515037082755,1588,1,MBP
RETROGRADE AXONAL TRANSPORT%GOBP%GO:0008090,0.8875285328906409,0.997039752625282,-0.179317596958364,-0.675306642602116,4276,13,DST|KIF1C|DLG2|NEFL|KIF1A|PAFAH1B1|KIF5B|KIF5A|MAP1A|SOD1|HAP1|TMEM108
POSITIVE REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032747,0.162880475129918,0.664859563055667,-0.758533223049352,-1.29743045358503,1096,2,IL17RA|MYD88
REGULATION OF AXON REGENERATION%GOBP%GO:0048679,0.702817926588333,0.968941691852291,0.297490634268212,0.8110392808423961,6758,8,RTN4RL1|RTN4R|PTPRS|CERS2|INPP5F
REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051893,0.0025308446694084197,0.12586582153175,-0.33438083120949,-1.99713730474226,7,47,DUSP22|PPM1F|THY1|S100A10|GPM6B|VEGFA|KDR|BCAS3|COL16A1|DLC1|ABL1|RHOA|NRP1|SLC9A1|APOD|MAP4K4|DUSP3|LIMS1|ACVRL1|RAC1|CORO1C|PEAK1
LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1990379,0.143087248322148,0.632949331968897,0.929642699603,1.2349888521213799,1065,1,MFSD2A
REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090140,0.40435458786936207,0.865585453523601,-0.23889142951529196,-1.02765785322678,1819,18,MARCH5|DDHD1|STAT2|DCN|PINK1|MAPT|VPS35|INF2|MFF|FIS1|DNM1L|BNIP3|MIEF2|MUL1|KDR|MIEF1|PARK2
NEGATIVE REGULATION OF GERMINAL CENTER FORMATION%GOBP%GO:0002635,0.916258351893096,1.0,-0.375020678246485,-0.641452785317812,6170,2,RC3H1|FOXJ1
ELECTRON TRANSPORT COUPLED PROTON TRANSPORT%GOBP%GO:0015990,0.548685886303115,0.9310232544124879,0.498372808537536,0.947354282178255,4738,3,NDUFS7|MT-CO1|MT-ND4
POSTSYNAPTIC DENSITY ASSEMBLY%GOBP%GO:0097107,0.644866838487973,0.9625632908696992,0.347360873641829,0.854283480484494,6004,6,SHANK1|NRXN2|NLGN2|NRXN1|PTEN|SHANK2
CORTICAL ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0030866,0.166029074215761,0.6682860217990739,-0.25172987958038895,-1.25441959366147,650,27,FMNL2|ARF6|PLEK|RTKN|PDCD6IP|FMNL1|RAB13|VPS4A|WIPF1|RHOQ|DLG1|TNF
SULFUR COMPOUND CATABOLIC PROCESS%GOBP%GO:0044273,0.8179866002405091,0.987153241368501,0.162569423041801,0.7424416117769641,9522,41,CTH|VCAN|GGT1|TST|PCYOX1L|CDO1|TXN2|GGT5|PRELP|ADO|FMOD|BGN|ACOT7|DCN|HEXA|OGN|LUM|GNS
NEGATIVE REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0032897,0.978524124881741,1.0,0.137875934000316,0.5039576338213589,10342,19,TRIM27|CCL5|MID2|TRIM21|TFAP4|TRIM14|TARDBP|REST|CCL4
NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072160,0.635931700074239,0.95916055221954,-0.508078301626689,-0.869040723999165,4282,2,MEF2C|MTSS1
PROMOTER CLEARANCE FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0001111,0.863497947835297,0.991943445125448,-0.565560211733569,-0.7565671390222909,6521,1,ERCC3
OUTER DYNEIN ARM ASSEMBLY%GOBP%GO:0036158,0.00524828421477594,0.16770443270936902,-0.5659314565333299,-1.99158330453715,25,11,DNAI1|LRRC6|CCDC103|DYX1C1|DNAL1|DNAAF1
REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010824,0.5128431459087299,0.9189780717804019,0.223413368519644,0.9630286479183691,5809,33,KAT2A|CENPJ|XRCC3|CEP295|CEP131|STIL|GEN1|CDK5RAP2|TRIM37|FBXW5|CCNF|MDM1|TMEM67|CEP120|BRCA1
MITOCHONDRIAL RNA METABOLIC PROCESS%GOBP%GO:0000959,0.8635207437944041,0.991943445125448,0.157843141244293,0.6915354640031159,9844,35,POLRMT|MTERF3|MTERF1|TEFM|TRIT1|WARS2|FASTKD1|MTERF2|PUS1|MTERF4|MTO1|SUPV3L1|AARS2|DARS2|HSD17B10
OSTEOBLAST DEVELOPMENT%GOBP%GO:0002076,0.18066783831282998,0.6862477225455891,-0.46394137506490996,-1.27348792316794,1027,6,ACHE|PTHLH|LRP5|LIMD1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN STEM CELL PROLIFERATION%GOBP%GO:1905474,0.080100622269297,0.5351135156925481,-0.958314953683282,-1.28196713232011,604,1,WNT3
RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0031290,0.11933216168717001,0.6045457111352801,-0.5064409496898761,-1.39014640187572,678,6,NRP1|ALCAM|PTPRM
PROTEIN FOLDING%GOBP%GO:0006457,0.0585774058577406,0.47368184492677795,-0.162280592434601,-1.2925254324114699,83,145,HSPB1|DNAJC3|GNAI3|PFDN6|CCT4|PDCL|CLU|HSPA13|GNAZ|FKBP1B|HSPA5|EMC3|TTC1|CCT7|SPHK1|GNAI2|EMC1|BAG4|AIP|P4HB|DFFA|AMFR|PFDN2|CDC37|TCP1|BAG5|RUVBL2|RAD23B|EMC4|ATF6|ST13|DNLZ|GNB5|HSPA4L|BAG3|PEX19|DNAJA2|DNAJB6|HSPA6|FKBP4|HSPBP1|DNAJA4|BAG1|CSNK2A1|NUDC|FKBP1A
SYNAPTIC VESICLE RECYCLING VIA ENDOSOME%GOBP%GO:0036466,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097756,0.6342937739270601,0.9589683394199421,0.291831228243538,0.861269349588039,6295,10,EDN1|INS|SLC8A1|SMTNL1|PIK3C2A|CHGA|EDNRB
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010592,0.041044776119403,0.402256981537283,-0.44055763208283605,-1.6049956459853798,197,12,WASF2|FSCN1|RLTPR|AKIRIN1|CDC42|TWF2|RAC1|BRK1
COMMISSURAL NEURON DIFFERENTIATION IN SPINAL CORD%GOBP%GO:0021528,0.9742281879194631,1.0,0.5156043228936921,0.684957340224614,7257,1,DRAXIN
SKELETAL MUSCLE ADAPTATION%GOBP%GO:0043501,0.628062360801782,0.955478665923049,-0.5107775550472761,-0.8736576524123141,4229,2,CFLAR
INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0007229,0.726600378009697,0.972554563883587,0.16453248183805802,0.822752207299161,8841,59,ITGB1|CD47|CEACAM1|MADCAM1|ILK|ITGA2|ADAM11|SRC|ITGA11|ITGB5|ITGBL1|ITGA2B|PRAM1|ERBB2IP|ITGA10|LAT|DAB2|PTK2|DST|ADAM9|PRKD1|ADAM15|ADAMTS13
REGULATION OF HEPATOCYTE GROWTH FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0048176,0.0029127499007017103,0.13103871184697197,-0.998786943096603,-1.33610774653893,21,1,INHBB
HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:0036124,0.747829107328934,0.9749763305090959,0.425829932723062,0.8094579064790359,6458,3,SUV39H1|SUV39H2|BEND3
PHOSPHOLIPID SCRAMBLING%GOBP%GO:0017121,0.635676625659051,0.95916055221954,-0.309194197782803,-0.8487173120416509,3616,6,PLSCR4|P2RX7|TMEM256-PLSCR3|PLSCR1|XKR8|ANO6
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE TRANSPORT%GOBP%GO:0046963,0.766442953020134,0.9792236089291529,0.618879576532863,0.822153907248537,5709,1,SLC35B2
REPRODUCTIVE STRUCTURE DEVELOPMENT%GOBP%GO:0048608,0.440392374021043,0.879896414106183,0.19009944536078,1.02005347424051,5566,82,CITED1|TBX3|GHRL|WNT4|INHA|BASP1|E2F8|PKD2|DNAJC19|EIF2B5|ROBO2|TGFB2|E2F7|ZNF830|LEF1|KIT|BMPR1B|NIPBL|EIF2B4|HEY2|FGF9|FANCF|STOX2|ING2|NUP107|BRCA2|CUL7|CEBPB|GATA6|CHD7|FGFR2|WNT2B
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:0072599,0.899335717935616,0.998912093067348,-0.10456171090893598,-0.7790257301951021,1759,107,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPL36|RPS15|RPS10|RPL28|RPS3A|SPCS2|RPL37|RPL27A|SEC61A1|RPL7A|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RAB3GAP2|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|SRP68|RPL13A|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SPCS3|RPL29|SEC61G|RPL31|RPL17|SRPR|RPS14|RPS17|CHMP4A|RPL32|RPL18A|RAB3GAP1|RPL11|SRP14|SPCS1|RPS16|RPL12|RAB10|RPS4X|RPL9|RPS28|PMM1|RPL35|RPL7|SRP72|SGTB|RPS9|RPS3|RPL14|SEC63|SEC62|RPL15|RPL8|RPL35A|UBA52|ASNA1|CHMP4B|PMM2|SRP54
NUCLEOSOME MOBILIZATION%GOBP%GO:0042766,0.7464397360194509,0.9749763305090959,0.42657522107905604,0.8108746212423891,6446,3,INO80|ARID1A
REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000823,0.9991040430059358,1.0,0.19657492482620298,0.41656104352191403,8920,4,HEYL|TAF1
MAINTENANCE OF PROTEIN LOCATION IN PLASMA MEMBRANE%GOBP%GO:0072660,0.459060402684564,0.890371861972445,0.7758050286722541,1.0306223694749599,3419,1,ANK3
"NON-REPLICATIVE TRANSPOSITION, DNA-MEDIATED%GOBP%GO:0098038",0.46926174496644296,0.8963602950852672,0.7707322452580501,1.0238834030221,3495,1,PGBD5
CELLULAR RESPONSE TO MOLECULE OF FUNGAL ORIGIN%GOBP%GO:0071226,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0060317,0.112863808042657,0.5885193718496371,-0.31513741221357106,-1.35565113057398,507,18,ENG|SNAI2|NOTCH1|TGFBR1|EFNA1|SNAI1|PDCD4|ACVRL1|OLFM1|RBPJ
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902167,0.9955704697986579,1.0,0.5018747243052489,0.666718181020686,7416,1,RPL26
NEGATIVE REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900226,0.393008346437644,0.8621064456029929,0.645657568238213,1.05530955803438,3248,2,NLRC3|CPTP
KERATINIZATION%GOBP%GO:0031424,0.8586382668851271,0.99166790097654,0.17116425062845003,0.6881622741358511,9432,26,KRT7|CDH3|KRT8|KRT19|PPL|KRTAP5-1|TGM1|CSTA|KRTAP5-2
AV NODE CELL ACTION POTENTIAL%GOBP%GO:0086016,0.0907431271477663,0.560322217247896,0.5813065617993709,1.42963882960087,844,6,CACNA1G|CACNB2
NEGATIVE REGULATION OF DOUBLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:1905768,0.911823116642394,1.0,-0.542567269519188,-0.725808779173183,6886,1,ERCC4
ARGININE CATABOLIC PROCESS TO PROLINE VIA ORNITHINE%GOBP%GO:0010121,0.655103932212366,0.9640743070248079,-0.666354212615792,-0.891402347185764,4947,1,OAT
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:1905581,0.27119874198620997,0.786158299673311,0.699557656586115,1.14340777171697,2241,2,LDLRAP1|ANXA2
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE N-END RULE PATHWAY%GOBP%GO:0071596,0.832812319092277,0.9881090453690059,0.38952089113030897,0.74043823797902,7192,3,UBR2|UBR3
RRNA PROCESSING%GOBP%GO:0006364,0.0008019246190858059,0.0849637591935908,-0.29078350401112396,-2.3686773338578195,0,168,RIOK3|TEX10|RPS16|URB1|NAF1|UTP15|C1D|THUMPD1|TSR3|FTSJ2|WDR12|PES1|METTL16|RRP1|RPS28|ISG20L2|MPHOSPH6|RPF2|RPL35|NSUN5|UTP3|RPL7|EXOSC6|POP5|RRP36|RPS9|RPL14|DHX37|GAR1|DDX47|ZNHIT6|EXOSC4|NOB1|NSUN3|NHP2L1|TRMT112|NOLC1|WBSCR22|SBDS|GLTSCR2|PWP2|TBL3|SRFBP1|RPUSD2|RCL1|RSL1D1|FCF1|RPL35A|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|RRP7A|KRI1|NOL10|PIH1D2|RRS1|CIRH1A|MRTO4|BYSL|IMP4|TSR1|NOL9|TSR2|RNMTL1|LYAR|EMG1|RRP9|RPF1|NOP14|NOP56|EXOSC5
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051057,0.0249203129527673,0.329326373353219,-0.283580057146861,-1.5874010366678102,85,38,MAPRE2|NTRK1|CRKL|NOTCH1|LPAR1|GRB2|VAV1|LYN|ARRB1|SHOC2|IGF1|MAP4K4|AKAP13|RAPGEF1|SHC1|RELN|FGF10|GPR4|RAC1
DOUBLE-STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING%GOBP%GO:0097681,0.511635984716916,0.918404893008545,0.5118010367265909,0.9728799313690659,4418,3,POLQ|PRKDC|LIG3
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0010918,0.311288963774221,0.8143712300420921,0.43749193533644604,1.13869959057407,2955,7,LINC00116|BAD|AKT2|VCP|AKT1|STOML2
DIHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0046452,0.686222329744768,0.9665006495129341,0.534622170588253,0.873825250896324,5672,2,DHFR
EMBRYONIC AXIS SPECIFICATION%GOBP%GO:0000578,0.10410031847133801,0.5762893149145369,0.460064142671838,1.4035502391889798,1045,11,RIPPLY2|TBX3|BASP1|HOXD8|STIL
AMMON GYRUS DEVELOPMENT%GOBP%GO:0021541,0.499865771812081,0.9143688619793578,0.7537494486104979,1.0013225153321,3723,1,LRP8
RESPONSE TO EPIDERMAL GROWTH FACTOR%GOBP%GO:0070849,0.6328788268587601,0.958316380324396,-0.17492552718784002,-0.884466464024158,2459,28,SYAP1|DUSP22|SNAI2|FOXC1|DAB2IP|INPP5K|PDE8A|PTPN12|ZPR1|DUSP3|MAPK3
RESPONSE TO SALT%GOBP%GO:1902074,0.64481546572935,0.9625632908696992,-0.30723686126845,-0.843344554735287,3668,6,ZNF16|HSF1
CELLULAR GLUCOSE HOMEOSTASIS%GOBP%GO:0001678,0.276758275529019,0.7884684708511421,0.266630649463762,1.15957804460325,3151,34,CARTPT|SIRT1|PRKAA2|UNC13B|AGER|ADCY8|ERN1
REGULATION OF RRNA PROCESSING%GOBP%GO:2000232,0.36297678275290207,0.849828746111777,-0.29278538124850606,-1.06664651317098,1750,12,TRMT112|SHQ1|WBSCR22|WDR43
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002460,0.40803733881813103,0.867015886388254,0.194298113347119,1.04258308161795,5157,82,IGHV3-21|IGKV4-1|IGHV4-61|CXCL13|IGHG1|CD27|IGLL5|LIG4|IGHG4|IL18BP|EXO1|SLAMF6|IGHV1-18|RORA|IGHV3-43|EBI3|IGKV3-11|ZP3|LEF1|MSH6|IGKV2D-28
POSITIVE REGULATION OF COAGULATION%GOBP%GO:0050820,0.25642151481888,0.767319904137432,-0.282295870736133,-1.15609646761677,1167,16,USF1|PDPN|SERPINF2|THBD|ANO6|ENPP4
MATING%GOBP%GO:0007618,0.0354289683918027,0.3821688062173221,0.7920966172493491,1.50569234395452,305,3,TAC1|KLK14|APP
ANGIOTENSIN MATURATION%GOBP%GO:0002003,0.443166208791209,0.8808089923737601,-0.392278894924267,-0.993027973842266,2580,5,ATP6AP2|ACE
NEURAL PLATE DEVELOPMENT%GOBP%GO:0001840,0.8487248322147649,0.991298302704726,0.576367445963829,0.7656784383881821,6322,1,PTCH1
PROTEIN SIALYLATION%GOBP%GO:1990743,0.840071676559525,0.98953921193435,0.335708671424595,0.711398743311862,7500,4,ST8SIA3|ST3GAL4|ST6GALNAC2
REGULATION OF MRNA PROCESSING%GOBP%GO:0050684,0.697835169008735,0.96731875442989,0.150804518339972,0.86100512298677,9186,115,SAFB2|CELF5|SAFB|SFSWAP|CELF1|RBM4B|DHX9|RBM25|SART3|CPEB3|DAZAP1|SRSF1|DDX17|RBFOX1|CIRBP|CPSF6|SRPK1|TIA1|PAPOLA|SRSF6|SON|SRSF2|TRA2A|THRAP3|PABPN1|CDK11A|ZC3H14|RNF40|CDC73|RBM5|KIAA1429|SRRM4|MBNL3|SUPT6H|CPSF7|DDX5|RBFOX2|RBM4|YTHDC1|NSRP1|CELF3|RBMX|U2AF2|REST|RBM11|SLTM|RBM17|SRSF9|SRSF5|JMJD6|SRSF4|CPSF4|SRSF10|CELF6
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901021,0.5984806373911429,0.9493714402140542,0.233549535681228,0.8944405453664659,6459,22,RYR2|CACNB2|PKD2|CACNA2D1|STAC2|STAC3
MODULATION BY HOST OF RNA BINDING BY VIRUS%GOBP%GO:1990968,0.943892617449665,1.0,0.5309329510366121,0.7053207388538991,7031,1,NUCKS1
ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:0035987,0.760072783987523,0.977664504547119,-0.15668393214405898,-0.801869367133609,2923,29,MMP2|ITGA5|COL6A1|MMP9|SOX17|ITGA7
RIBONUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0034031,0.558550824175824,0.936434965680841,-0.35793073020075,-0.906077875680143,3252,5,ACOT7|ABCD1|ACAT1|MLYCD|NUDT7
MEMBRANE DISASSEMBLY%GOBP%GO:0030397,0.148703956343793,0.64074876264986,0.401184236729731,1.3292480470658798,1525,14,CCNB1|CDK1|PRKCB|AKAP8L|CCNB2|PLK1|VRK1|CNEP1R1|NEK9
TRNA METABOLIC PROCESS%GOBP%GO:0006399,0.986768802228412,1.0,-0.0846171979991379,-0.6713088476564341,1416,144,QARS|THUMPD1|DARS|KIAA1456|METTL1|AARS|CARS|ADAT1|WARS|C9orf64|TRMT12|POP5|MOCS3|KIAA0391|NARS|HARS|TSEN2|FARS2|GARS|TRMT61B|AIMP2|NSUN3|TRMT112|RTCB|ELP3|YARS|URM1|CDKAL1|DPH3|NSUN2|EXOSC9|KARS|SARS|RPP14|WDR4|DTD2|TRDMT1
RESPONSE TO AMMONIUM ION%GOBP%GO:0060359,0.0272384815995364,0.339785941813865,-0.27956334484323303,-1.5649166160815098,93,38,ABL1|GNAQ|CASP3|GNA15|CHRNA7|HRH3|CHRNA3|GABRG2|DRD2|MAPK3|PARK2|CHRM1|PLCB1|HRH1
REGULATION OF CHROMATIN ASSEMBLY%GOBP%GO:0010847,0.0492776346735357,0.435862257033585,0.705764523971297,1.4955824444351598,439,4,TPR|SIRT6|PARP10
RRNA CATABOLIC PROCESS%GOBP%GO:0016075,0.18507135016465398,0.691482206657505,-0.304398212019204,-1.2466129835572601,842,16,SLFN13|XRN1|EXOSC10|EXOSC2|PELO|EXOSC3|C19orf43|DIS3L|EXOSC7|DIS3|EXOSC8|DEDD2|EXOSC6|EXOSC4|EXOSC9|EXOSC5
SPLICEOSOMAL COMPLEX ASSEMBLY%GOBP%GO:0000245,0.47783702716214,0.9043953150665369,0.20320883003880502,0.991115670987977,5734,53,CELF5|NOL3|SFSWAP|CELF1|SMN1|PRPF39|SRSF1|C7orf55-LUC7L2|LUC7L|LUC7L3|SRPK1|SRSF6|SMN2|RBM5|SF3B1|SNRPD1|DDX39B|GCFC2|YTHDC1|CELF3|PSIP1|SRSF9|SRSF5|SETX|SNRPE|SRSF10|CELF6
TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034142,0.33126036484245397,0.8293509737209019,-0.300468965517241,-1.0946385814018198,1597,12,TICAM2|TLR4|TRIL|CD14|TIRAP|PIK3AP1|LY96|ITGB2|PRKCE|IRAK1|LGALS9|ITGAM
5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042791,0.35817223198594006,0.846205501155666,-0.385251778721527,-1.0574902648253501,2037,6,GTF3C5|GTF3C3|GTF3C1|GTF3C2|GTF3C6|GTF3C4
REGULATION OF EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904889,0.620018535681186,0.9532238181782521,-0.683281870313189,-0.9140469910075291,4682,1,VSTM5
T CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002457,0.14788825632199099,0.6402258061318559,-0.9231914424349359,-1.2349813404163201,1116,1,RFTN1
INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008286,0.0124087591240876,0.242051189462915,-0.24361050778066895,-1.57738345602521,33,63,IGF1R|BCAR1|FOXO4|GRB2|FOXO1|ATP6V0C|ATP6V1F|NAMPT|FOXC2|SHC1|ATP6V1E2|ATP6V0D1|CAV2|ATP6V1E1|RHOQ|IGF2|PIK3R1|FOXO6|APPL1|FOXO3
MHC CLASS I PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002397,0.46736396133986496,0.8952133430198359,-0.7644464049404499,-1.02262326366433,3529,1,CALR
REGULATION OF CONNECTIVE TISSUE GROWTH FACTOR PRODUCTION%GOBP%GO:0032643,0.744869588243082,0.9749763305090959,-0.622684164093516,-0.8329835917888979,5625,1,ROCK2
CELL CYCLE DNA REPLICATION%GOBP%GO:0044786,0.0533848450259022,0.45061489218856604,0.34294446089487,1.4914671969324198,607,34,RFC4|DNA2|CDC45|POLD1|DONSON|FEN1|ZNF830|POLD3|POLA2|WDR18|LIG1|BRCA2|PRIM2|GMNN|ACD|RFC3|GINS1|RFC5
FORELIMB MORPHOGENESIS%GOBP%GO:0035136,0.0360645020701678,0.38384589896147103,0.674590330894814,1.55483071042902,330,5,TBX3|ZNF358|NIPBL|TFAP2B
RECEPTOR TRANSACTIVATION%GOBP%GO:0035624,0.116252264119875,0.5955006947384001,-0.602857655701709,-1.38644666673819,705,4,ADRA2C|ADAM17|ADRA2A
RELEASE OF MATRIX ENZYMES FROM MITOCHONDRIA%GOBP%GO:0032976,0.440354825896995,0.879896414106183,-0.7780657256285842,-1.04084224419845,3325,1,BAX
NEGATIVE REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002740,0.0932442464736451,0.5622489437340121,-0.814753093911272,-1.39359153175066,627,2,TNF
CARBON CATABOLITE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0000429,0.33369992144540506,0.8295413387957591,-0.537222896217051,-1.09027790627928,2123,3,USF2|NCOA1|USF1
"G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY, COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER%GOBP%GO:0007187",0.00108283703302653,0.0893009762660318,-0.230800365255849,-1.75040322462727,1,114,GNA13|ADCY7|OXER1|ADRA2C|GNAZ|LPAR1|UCN2|PTGFR|CRHR1|MARCO|GNAQ|CALCRL|GNAI2|ADRA1B|PSAP|GNAL|GNA15|HTR1B|VIP|ABCA1|GCGR|VIPR1|RAMP2|AKAP13|HRH3|ADRB2|MC4R|GPR161|GPR3|CALCB|ADCY2|ADCYAP1|DRD2|GNA12|MCHR1|UCN3|ADRA2A|GNAS|CHRM1|ADM|PDE4D|HRH1|GRM8|RAMP1
NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0031333,0.46943866943866996,0.8965948338800379,-0.14445187760195702,-0.9986440485821658,1128,79,CAPZB|PARK7|TRIOBP|GBA|KANK4|CAPZA2|RIOK3|INSIG1|MAPRE1|ADD1|CLU|IMPACT|CLIP3|PRKCD|PFN1|DYRK1A|DDX3X|SMAD6|TMSB10|MYADM|GLTSCR2|LDLRAD4|PPM1A|TMSB4X|SNCA|TWF1|CDC42|TRAF3IP1|DKK1|TWF2|PEX5
LYSYL-TRNA AMINOACYLATION%GOBP%GO:0006430,0.16404077849860998,0.666385698695266,-0.915141155712395,-1.22421222641639,1238,1,KARS
HISTONE METHYLATION%GOBP%GO:0016571,0.6800602712204922,0.9647315640607691,0.17592666389085398,0.849895801961987,8123,51,PRMT9|WDR61|EHMT1|DOT1L|OGT|EZH2|KMT2B|PAGR1|ZNF335|PRMT1|CARM1|NSD1|PAXIP1|EHMT2|KMT2D|WDR5|SETDB2|SUV39H1|TET2|SETMAR|PRMT7|SUV39H2|SETD1B
LYSOSOME LOCALIZATION%GOBP%GO:0032418,0.943687392834582,1.0,0.14450684264816901,0.587494270275444,10456,27,NR4A3|MAP6|KIT|HDAC6|DEF8|SNAPIN|MILR1|VPS33A|S100A13|LAMTOR1|TMEM106B|RAB34|SNAP23|BLOC1S2|CHGA
POSITIVE REGULATION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052510,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
PRESYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097105,0.501288659793814,0.9150051245283108,0.393357966376217,0.967406631233528,4667,6,PTPRD|NLGN4Y|NLGN3|NLGN2
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009148,0.23959468293745897,0.7525035503527309,0.5242448345472729,1.2083066287900601,2198,5,CAD|DTYMK|CTPS2|CTPS1
PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031269,0.338805772540712,0.8326275783736579,-0.8318813409792679,-1.11283303367742,2558,1,SRGAP2C
TELOMERE MAINTENANCE VIA BASE-EXCISION REPAIR%GOBP%GO:0097698,0.416920428968622,0.8709670999109399,-0.7903617115130129,-1.05729095941752,3148,1,APEX1
RESPONSE TO GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:0097012,0.143577108298802,0.6334904564746021,0.6185031661193849,1.31066729150775,1281,4,NPR2|PDE1B
NEGATIVE REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000329,0.29906040268456396,0.8023890191280308,0.853936921041023,1.13441710277602,2227,1,LOXL3
POSITIVE REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903626,0.729889923793396,0.972554563883587,0.515820047597244,0.8430936973920551,6033,2,ST20
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030520,0.266457064256239,0.7803351796901099,0.37512709414024203,1.1825346584746002,2711,12,SAFB|EGLN2|DDX17|ARID1A|TRIP4|DDX5|RBFOX2|NCOA6
REGULATION OF MELANOCYTE DIFFERENTIATION%GOBP%GO:0045634,0.464186415993645,0.8923263186617242,-0.7668725187472429,-1.0258687500752701,3505,1,ZEB2
NEGATIVE REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000051,0.414454045561665,0.8695723005599759,-0.500441160251461,-1.01563046597049,2637,3,RNF213|SFRP4|ZNRF3
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION%GOBP%GO:0010608,0.00709219858156028,0.18974782020875602,-0.15555266081656302,-1.42758851388211,2,349,EXOSC1|TCOF1|DIS3|MAPKAPK2|YTHDF3|PER1|CLP1|CDC123|HNRNPM|EXOSC8|AGO1|SET|NOTCH4|RAN|MOV10|PUM1|RPUSD4|ZC3H12D|SMAD3|MTRF1|TRAP1|MTG2|NCBP1|PPP1R8|HNRNPD|POLDIP3|RPS6KA3|EIF2A|EIF2AK2|SYNCRIP|PARN|AXIN2|TNFSF13|EIF6|YTHDF2|MRPL44|TRNAU1AP|USP16|OGFOD1|EIF4E|SMG6|CALR|NCL|SEPSECS|EIF5|ZC3H7B|ATF4|PPP1R15B|EIF3H|NCK2|HSPB1|TDRD7|DNAJC3|DPH2|CNOT10|DCP1A|NAF1|RPS4X|EIF3D|APEX1|DCP2|METTL16|EIF2S1|AARS|EEFSEC|IMPACT|RBM3|PRKCD|CPEB1|SAMD4A|EIF2AK3|EXOSC6|LIMD1|ZNF385A|RPS9|RPS3|FAM129A|WIBG|DDX3X|EIF2AK1|EXOSC4|PAIP2B|C1QBP|EIF4A2|UHMK1|CCRN4L|SNIP1|RNF139|EIF4G1|YTHDF1|NSUN3|VIM|EIF4EBP1|CPEB2|IL6|SMAD1|NOLC1|SMAD2|DPH6|SLC11A1|HABP4|MOV10L1|VIP|EIF3B|UQCC2|EIF1|RMND1|EIF4E2|YBX1|RPUSD3|EIF4H|SERBP1|DPH3|CNOT7|NPM1|GAPDH|EXOSC9|YWHAB|SHMT2|FMR1|EIF4B|AGO2|EIF5A|MTPN|HNRNPC|ETF1|PDE12|UBA52|RBM38|PRKCA|STAT3|YWHAZ|BCL3|NCBP2|NUDT21|POLR2D|HENMT1|PER2|PABPC1|EXOSC5|CARHSP1|MYD88|UBC|SESN2|EIF1B|RBM24|LARP6|UBB|FOXO3
REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905952,0.8448494453248809,0.991298302704726,0.138963122057647,0.7435881361287041,10661,81,SIRT1|GHRL|LPL|FITM1|ABCA7|ALKBH7|MEST|ABCB4|AGTR1|SCARB1|CETP|ABCA2|LDLRAP1|PNPLA2|PTCHD2|UCN|APOE
EIF2ALPHA PHOSPHORYLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036492,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|EIF2AK3
PROTEIN PROCESSING%GOBP%GO:0016485,0.948850305021117,1.0,-0.0972713750355262,-0.7032549403279279,2021,95,CLN3|CASP1|SPCS3|CPM|APH1A|AFG3L2|ECE1|HTRA2|IFI16|PCSK5|PSEN1|PSENEN|CTSZ|BACE2|C10orf54|PCSK6|APH1B|CTSS|DDI2|ZMPSTE24|SPCS1|PCSK2|FURIN|TBC1D10A|SRGN|KLK1|CIDEB|SDE2|PCSK7|PCSK1|CYFIP2|YME1L1|PLAU|ATP6AP2|NCSTN|XPNPEP3|PSEN2|RIPK2|PGK1|PMPCA|FXN|CTSH|ACE|CPXM1|PRSS3
GLUTAMINYL-TRNA AMINOACYLATION%GOBP%GO:0006425,0.9098737936154421,1.0,-0.38053487730907104,-0.650884527492754,6127,2,LARS|QARS
POSITIVE REGULATION OF FIBRONECTIN-DEPENDENT THYMOCYTE MIGRATION%GOBP%GO:2000415,0.9458493313915,1.0,-0.5245368328187029,-0.701688914255538,7143,1,ADAM8
PURINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009206,0.08199999999999999,0.539604343254557,-0.218354373476993,-1.34678677809861,245,53,ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|PFKL|COX5B|GPI|PKM|ENO1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
PROTEIN AUTOUBIQUITINATION%GOBP%GO:0051865,0.9234890339862719,1.0,0.132810492459301,0.641603026518439,11031,51,SH3RF1|UBE3D|TRIM68|RNF208|MARCH7|DDB2|RNF146|UBE2T|UHRF1|TRIM37|RNF112|RNF10|TRAF2|UBE2B|MARCH5|TRIM21|BRCA1|MDM2|RNF8
POSITIVE REGULATION OF HIPPO SIGNALING%GOBP%GO:0035332,0.7193661545905409,0.9713637233549571,0.5202446736922071,0.850325627192682,5946,2,DLG5|SOX11
APOPTOTIC PROCESS INVOLVED IN LUTEOLYSIS%GOBP%GO:0061364,0.33731343283582105,0.831781977545269,-0.535315658748622,-1.08640722450362,2146,3,SLIT3
PURINE RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009180,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
SUCCINATE TRANSPORT%GOBP%GO:0015744,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
NEGATIVE REGULATION OF DEVELOPMENT OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044147,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:1901291,0.256078383936132,0.767319904137432,0.706852631404558,1.15533120765304,2116,2,BLM|OGG1
PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:0072657,0.997368421052632,1.0,-0.0781642459143336,-0.718456972050848,378,368,RPS16|RPL12|THY1|RAB10|S100A10|RAMP3|HSPA4|FRMPD1|BAX|RAB3C|RPS4X|PEX16|TESC|TSPAN15|RAB3D|TMEM88|RPL9|TOMM22|RPS28|RAB13|ZDHHC3|F11R|GORASP2|TM9SF1|RPL35|ROMO1|TULP3|SAMM50|RABGEF1|RPL7|SRP72|SGTB|MYO1C|RAB8B|RPS9|RPS3|RPL14|ZDHHC9|INPP5K|C19orf52|SEC63|ZDHHC11B|SEC62|ATG3|RILPL2|MYADM|TSPAN5|GCC2|EHD3|RPL15|RPL8|TSPAN33|VAMP2|SH3GLB1|EXOC4|ZDHHC7|BID|RPL35A|RAB8A|EHD2|RAMP2|ZDHHC4|RFTN1|TIMM22|SLMAP|UBA52|PEX19|PVRL3|PLEKHF1|ASNA1|MAP7|TMED2|SSR1|BMF|CHMP4B|PDZD11|SRP54|SLC9A3R1|PEX5|KIF13A|DLG1|RILPL1|GOLGA7|TNF|BCL2L11|PMAIP1|CAV1|MICALL1|PARD3|RAMP1
EOSINOPHIL DIFFERENTIATION%GOBP%GO:0030222,0.489871574208924,0.908938677284213,-0.752977503308337,-1.00728096426717,3699,1,GATA2
POSITIVE REGULATION OF HISTONE DEUBIQUITINATION%GOBP%GO:1903586,0.253154362416107,0.7641083395392759,0.8758270842523159,1.16349720801281,1885,1,SART3
'DE NOVO' NAD BIOSYNTHETIC PROCESS FROM TRYPTOPHAN%GOBP%GO:0034354,0.561763537667152,0.936738331587711,-0.7131671812968678,-0.954025482705889,4242,1,HAAO
REGULATION OF HISTONE METHYLATION%GOBP%GO:0031060,0.0650918635170604,0.4956987271622679,0.331686987091296,1.4640784365108501,743,36,SIRT1|WDR61|OGT|MTF2|DNMT3B|ZNF274|PHF19|JARID2|NSD1|PAXIP1|RIF1|SUPT6H|BRCA1|DNMT1|PHF1|MTHFR|TET1|SNW1|ATRX|ZNF304|WHSC1L1|MYB|BCOR|KMT2E|AUTS2|CTR9|PAF1|PIH1D1
REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903214,0.0105757931844888,0.22430534023248602,-0.310976229268001,-1.75460783946886,35,39,FBXW7|HPS4|HAX1|UBL5|PARL|ATG13|BAG4|VPS11|CSNK2A2|SH3GLB1|RNF31|BAP1|LEPROT|UBE2L3|UBE2D3|SIAH3|ARIH2|PARK2
GRANULOCYTE MIGRATION%GOBP%GO:0097530,0.7300723096554659,0.972554563883587,0.17296268266742798,0.810743383663773,8581,45,EDN1|CXCL13|CXCL9|TGFB2|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CXADR|AMICA1|GBF1|CCL3L3|CCL11|CCL4L2|PIP5K1C|CXCL11|CKLF|XCL1|ANXA1|CCL4|CXCL2|CCL8|CXCL1|CCL24
CELLULAR RESPONSE TO NITROGEN STARVATION%GOBP%GO:0006995,0.000197005516154452,0.0784645998831315,-0.7149753260755649,-2.4188685456093504,0,10,MAP1LC3B2|MAP1LC3A|ATG7|BECN1|GABARAPL1|GABARAP|MAP1LC3B|GABARAPL2
REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032239,0.153496908809892,0.6507359320251149,0.38899893163925203,1.31894445508355,1588,15,TPR|DHX9|AKAP8L|CPSF6|RIPK1|SUPT6H|ZC3H3|RBM26|RIOK2
SPECIFICATION OF ANIMAL ORGAN IDENTITY%GOBP%GO:0010092,0.789683981111515,0.9819233677232551,-0.255303047243748,-0.7447303155759549,4347,7,PAX8|FGF10
SECONDARY HEART FIELD SPECIFICATION%GOBP%GO:0003139,0.657520439018927,0.9643779777660141,0.407519251474581,0.8635722221417959,5870,4,BMP4|ISL1|MEF2C|MESP1
NORADRENERGIC NEURON FATE COMMITMENT%GOBP%GO:0003359,0.0664636568251026,0.49812594405445004,-0.9658138509042791,-1.2919986357721,501,1,ASCL1
REGULATION OF RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000206,0.768590604026846,0.9792236089291529,0.617887075430084,0.8208354138121079,5725,1,RIOK2
NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043301,0.808346044889954,0.984682960940884,0.317814076812646,0.732514333817216,7418,5,CEACAM1
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0007264,0.00117785630153121,0.09181648161563599,-0.18666124137685103,-1.60175515434973,0,226,RAB25|RAB10|CRKL|RND1|RHOG|RASSF1|RAP1B|RALBP1|RAB3C|ARHGAP5|ARHGDIA|CDC42EP5|RAB3D|RAB33B|GNA13|PLCE1|RAB13|BRAP|RAB21|ABR|NRAS|PDPN|RAB43|RRAGC|GRB2|TNK2|EPS8L1|RAB8B|RIT1|RHOA|FAM65A|ARHGAP1|RANGRF|RAB30|ARHGAP29|RAB18|FGF2|RAB6A|RND2|RAP2B|CHP1|RIN2|DNAJC27|G3BP2|SHOC2|RAB1A|IGF1|RAB39A|RHOC|RAP1A|LIMK1|RAB8A|RAB37|RAB12|RAB2B|RRAD|CDC42|DBNL|RAB36|RAB5C|ARHGAP31|KRAS|RAPGEF1|SHC1|JUN|TP53|RAB7A|CDKN1A|RAB22A|RAB2A|GNA12|RAB5A|ADRA2A|RASGRP3|RHOQ|RAC1|PLD2|BRK1|PLK2|CDH13
NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901164,0.57439120188531,0.941780153808918,-0.44502040366163,-0.903155687094415,3655,3,TIMP1|ARHGDIB|CALR
NEGATIVE REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051344,0.9608017817371941,1.0,-0.340336366142818,-0.582127127037426,6470,2,EGLN1|MAPK7
NEGATIVE REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904476,0.578975241625844,0.942692029750853,-0.7041795324217031,-0.9420024307744641,4372,1,FAM65B
D-AMINO ACID METABOLIC PROCESS%GOBP%GO:0046416,0.9756388190123131,1.0,-0.511027790030878,-0.6836174558310022,7368,1,SRR
COPPER ION EXPORT%GOBP%GO:0060003,0.948322147651007,1.0,0.528506837229819,0.7020977548981849,7064,1,ATP7A
POSITIVE REGULATION OF HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:2001255,0.7459539717891608,0.9749763305090959,-0.46054590570719606,-0.7877391064511641,5023,2,WHSC1L1|BRD4
HISTONE H2A ACETYLATION%GOBP%GO:0043968,0.493914219474498,0.91071489001692,0.287509550742294,0.974833339868345,5112,15,NAA40|YEATS4|TRRAP|EP400
VENTRAL SPINAL CORD INTERNEURON FATE COMMITMENT%GOBP%GO:0060579,0.8276512175962291,0.9876441563834109,-0.353719760582354,-0.717863744626261,5267,3,ASCL1
BONE CELL DEVELOPMENT%GOBP%GO:0098751,0.35158934707903805,0.842847021021096,0.44713724743356703,1.09966894079635,3273,6,SRC|MED1|KIT
REGULATION OF TRANSFORMING GROWTH FACTOR-BETA SECRETION%GOBP%GO:2001201,0.819765332043063,0.987153241368501,0.478373181205247,0.7818878229999329,6776,2,FN1|LILRB1
POSITIVE REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902808,0.728010704727922,0.972554563883587,0.19121796490443804,0.8017637789981759,8160,30,ANKRD17|LSM11|CDC45|CDK10|EZH2|CCNE1|PAGR1|CDC6
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903306,0.683320063694268,0.9663106118043521,0.26997185605462903,0.8236222474092041,6865,11,C19orf26|CEACAM1
NEGATIVE REGULATION OF BLOOD VESSEL MORPHOGENESIS%GOBP%GO:2000181,0.635909265667051,0.95916055221954,-0.134417084320935,-0.903798662665741,1653,71,CTNNB1|DAB2IP|FOXO4|PML|MMRN2|RHOA|HDAC5|MAP2K5|ADAMTS9|PPARG|ECSCR|SPINK5|MEOX2|FOXJ2|PDCD10|PGK1|SERPINF1|SARS|PTPRM|THBS4
REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061217,0.44776748104465003,0.8850378987593649,0.389847990886058,1.01469241316801,4251,7,BASP1|BMP4
POSITIVE REGULATION OF ACTIN BINDING%GOBP%GO:1904618,0.33324506818482696,0.8293509737209019,-0.8344728716365241,-1.11629980325274,2516,1,ABL1
CYSTEINYL-TRNA AMINOACYLATION%GOBP%GO:0006423,0.993466963622866,1.0,-0.298814447201544,-0.5111061084601121,6690,2,CARS2|CARS
CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:0097306,0.930183727034121,1.0,0.139888841223878,0.617474437994749,10631,36,GNAI1|ADCY8|BLM|GRAMD1B|RAD51|ADCY1|ADCY6|SPIDR|IREB2|BRCA1|LRP6|ADAM15|LARP1|PTCH1|GNG2|JUP|GPLD1|OSBPL7|PTGER2|AKR1C3|GRAMD1A|ADCY5
COENZYME A CATABOLIC PROCESS%GOBP%GO:0015938,0.4200979743148421,0.872709803390378,-0.7888178209086899,-1.0552256498832902,3172,1,NUDT7
REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003339,0.361194029850746,0.848418604328854,-0.523668748636855,-1.06277016647668,2298,3,LIF|PAX8
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900746,0.786031489705289,0.9815614161521099,-0.212788259958071,-0.748828397929932,3893,11,SEMA6A|KIAA1462|DCN|CCBE1|SMOC2|SPRY2|ROBO1|CD63|DLL1|DAB2IP|MYO1C
PROTEIN TRANSPORT INTO MEMBRANE RAFT%GOBP%GO:0032596,0.36495916852264293,0.850174896280676,-0.639936850243807,-1.0945777095165998,2457,2,RFTN1
COMPLEMENT-DEPENDENT CYTOTOXICITY%GOBP%GO:0097278,0.6923076923076921,0.96731875442989,-0.648599470666079,-0.8676512875420891,5228,1,RAB27A
BASOPHIL DIFFERENTIATION%GOBP%GO:0030221,0.34429530201342307,0.839897752413553,0.8317159241288051,1.1048974997271002,2564,1,TAL1
NEGATIVE REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045409,0.0736663844199831,0.520821259294202,0.830774560509662,1.35787819644079,608,2,GHRL|FOXJ1
RESPIRATORY SYSTEM DEVELOPMENT%GOBP%GO:0060541,0.44526218951242,0.882689384787548,-0.173576658735943,-1.00344854395564,1451,43,STRA6|VEGFA|SKI|PDPN|CEBPA|FGF7|NFIB|WNT11|CTSH|CHI3L1|FGF10|ASCL1|ATXN1L|DNAAF1
POSITIVE REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050731,0.000435729847494553,0.0784645998831315,-0.32989083550382103,-2.3535394647568397,0,88,IL11|VEGFA|CRLF1|PTK2B|TNK2|LIF|ABL1|FGF7|FYN|NRP1|ITGA5|DGKQ|ARL2BP|HGF|TNFRSF18|IL6|LYN|PRNP|EFNA1|DOCK3|BANK1|IGF1|RIPK2|PTPN1|ARHGEF2|ADAM17|STAT3|CSPG4|RELN|TP53|ADRA2A|FGF10|GREM1|THBS4|ACE|IGF2|GPRC5B|TNF|PAK2
STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010658,0.147226267708195,0.638945026078465,-0.9234671371857079,-1.23535014569029,1111,1,GNGT1
UTP METABOLIC PROCESS%GOBP%GO:0046051,0.0563686948106931,0.462139581564301,0.850510063413289,1.39013533377079,465,2,CAD|AK3
RESPONSE TO DRUG%GOBP%GO:0042493,0.9710962769251941,1.0,0.10353293288489901,0.680343589248263,14110,328,RYR2|SLC15A2|SIRT1|EDN1|SLC1A2|DPEP1|GRIN3A|GHRL|SLC47A1|CYP2D7|CYP2C8|AIM2|CRHBP|SLC25A29|KCNQ1|SLC36A1|GNAI1|SLC25A22|GLRX2|CD38|CD27|ADCY8|CD320|ABCB4|BLM|CENPF|HBB|PDE2A|ECT2|DHFR|HBA2|CYP2R1|TAF7|HSP90B1|CDK5R1|USP47|KCNJ11|TGFB2|SLC6A17|MAP3K5|KCNH2|CAD|SRC|SLC13A3|SULT1A3|SLC25A10|MTR|SLC25A42|ABCA2|SLC6A9|PRDX3|HBA1|SLC46A1|RAD51|SLC22A3|GRIN1|SLC25A1|PLEKHA1|CCL19|HDAC6|NFE2L2|TIMELESS|ABCC8|ABAT|SLC6A2|MT2A|LY6H|NDOR1|DRD4|SLC5A6|TH|P2RY11|SLC19A2|BAD|ACER2|ERBB2IP|PEBP1|SLC8A1|RNF112|SLC1A3|CAT|GATA6|CYGB|ANKZF1|MAPK13|ADCY1|RPP21|GATS|JUNB|ABCA3|PTPN22|KCNMA1|AGRN|UBE2B|ADCY6|THBS1|LCK|EGR1|ABHD2|CYP2E1|TRPV1|SPIDR|PDXP|ADAM9|SLC1A1|SLC19A1|EGLN1|CDK2|CYP2D6|PCK2|GNA11|CTPS1
REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090276,0.100722891566265,0.5710618990855579,-0.17152315120124204,-1.25707875087574,208,100,RASL10B|SLC25A5|ENSA|PIM3|ARL2|GPER1|BLK|LRP5|IL1B|C2CD2L|ADRA2C|PFKL|STXBP4|ANO1|TCF7L2|ARL2BP|MYRIP|SLC25A4|PAX8|UQCC2|RAP1A|CRH|GIPR|PRKCA|ADCYAP1|DRD2|PARK2|ADRA2A|SLC2A1|PER2|NR1D1|CACNA1E|TNF|SNAP25|INHBB|TRH
GLANDULAR EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0002067,0.574347093513058,0.941780153808918,0.34892588749793396,0.9081807757874191,5453,7,CDK6|BMP4
REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090189,0.7214972527472528,0.9713770803161691,-0.312989298078386,-0.7923116245269759,4201,5,AGT|VEGFA|PAX8
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0045912,0.38899587345254494,0.8603316114971841,0.269981135412711,1.06251016211749,4241,24,INS|C1QTNF3|FAM132A|CLK2|PGP|PASK|GCK|MIDN|CLTC|VIMP|GSK3A
NEGATIVE REGULATION OF PROTEIN MATURATION%GOBP%GO:1903318,0.6397998888271259,0.96058002537611,0.22554447272220898,0.863783011161257,6905,22,NOL3|SERPINE2|CD55|BIRC2|GAS1|CARD16|THBS1|SERPINE1|TMEM59|BCL2L12|XIAP|BIRC3
PLATELET MORPHOGENESIS%GOBP%GO:0036344,0.6807887543928149,0.965038308781941,-0.255295675198588,-0.8241173171350649,3486,9,CASP9|VPS33A|NBEAL2|ZFPM1|MEF2C|CIB1|ACTN1|CASP3|MYH9
NEGATIVE REGULATION OF ATP CITRATE SYNTHASE ACTIVITY%GOBP%GO:2000984,0.715704697986577,0.971081608033886,0.6459528010586679,0.858119478208892,5331,1,PHPT1
PHOSPHATIDYLSERINE EXPOSURE ON BLOOD PLATELET%GOBP%GO:0097045,0.0914868264265855,0.5622489437340121,-0.95263564181738,-1.2743697436763302,690,1,ANO6
CYTOLYSIS%GOBP%GO:0019835,0.6493448314480911,0.963755998259649,0.41001368636443897,0.86885816795424,5797,4,GSDMD|PRF1
MULTI-ORGANISM METABOLIC PROCESS%GOBP%GO:0044033,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009127,0.0551443375277572,0.457996676929382,-0.209401389833927,-1.38276639354136,148,67,ADSL|ENO3|ATP5J2|AK9|ATP5F1|ATP5J|LDHA|LHPP|PFKL|COX5B|GPI|GMPS|ATIC|PKM|ENO1|HPRT1|ATP5I|GAPDH|PGK1|CYC1|HK1|HK2|TPI1|ALDOA|SLC25A13|PGAM2
CORTICAL COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072059,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
POSITIVE REGULATION OF EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:1905537,0.27181252482457297,0.7865607589760191,-0.864137626819585,-1.1559832507319199,2052,1,EIF4G1
POSITIVE REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000707,0.40163325909428405,0.864498102919214,-0.613663429007114,-1.04963842960567,2704,2,PRKCA
HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:0080182,0.623413258110014,0.9536478716552259,0.294907629799359,0.8703486053722851,6187,10,WDR61|OGT|ZNF335|TET2|CTR9|BEND3|TET3|KMT2A
VEGF-ACTIVATED PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038086,0.514689709347997,0.920792511236057,-0.46448659975736206,-0.942661753704617,3275,3,PDGFRA|PDGFRB|VEGFA
REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904997,0.31804008908686,0.819776173598052,-0.6702816050571829,-1.1464807874637601,2141,2,TNF
FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION%GOBP%GO:0021861,0.0991152424683615,0.570215774831708,0.651001697760094,1.3795347844758998,884,4,HES1|LEF1|METTL3
MICROVILLUS ASSEMBLY%GOBP%GO:0030033,0.0246835443037975,0.329326373353219,-0.43878162624202105,-1.69995618205877,116,14,EZR|RAP2C|RAP1B|STK26|RAP2B|MAP4K4|RAP1A|FXYD5|SLC9A3R1
POSITIVE REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045624,0.76779414816352,0.9792236089291529,-0.205418229971309,-0.7736011276316841,3699,13,CCL19|IL12RB1|NFKBID|ANXA1|MYB|PRKCZ|MALT1|NFKBIZ|IL18|CD86|RARA|NLRP3|SOCS5
REGULATION OF P38MAPK CASCADE%GOBP%GO:1900744,0.165987503395816,0.6682860217990739,-0.235314419009566,-1.24577585142292,610,32,SASH1|MFHAS1|EZR|PJA2|IL1B|VEGFA|DAB2IP|LGALS9|CYLD|ULK4|KARS|GADD45A|RELL2|DUSP10|RELL1|DLG1
WATER TRANSPORT%GOBP%GO:0006833,0.0854130052724077,0.547991507542111,-0.536140773315232,-1.4716704235299998,485,6,PDPN|AQP5|AQP1
NEGATIVE REGULATION OF HYPOXIA-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903298,0.8117370366222421,0.9855701659458179,0.348299652181219,0.7380802342882951,7247,4,NOL3
RESPONSE TO SINGLET OXYGEN%GOBP%GO:0000304,0.308089500860585,0.8111717366855571,-0.8465483017203349,-1.1324534742526298,2326,1,FYN
VESICLE FUSION TO PLASMA MEMBRANE%GOBP%GO:0099500,0.777957206297941,0.9811398289380491,-0.21444334105704502,-0.754652834522594,3853,11,SNAP47|PRRT2|STX2|STX3|STX1A|STX1B|SNAP23|STX4|SNAP29|STX11|SNAP25
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904754,0.259020484558594,0.770824482439331,0.43516962114089897,1.1863891360572,2490,8,NR4A3|IGFBP5|DOCK7|FGF9
REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002090,0.10303494006631,0.5747344012283481,-0.272982944487005,-1.36032780403625,403,27,SDCBP|CD63|MKLN1|UBQLN2|FLOT1|OPHN1|VEGFA|MTMR2|NECAB2|ARRB2|ARRB1|LRPAP1|TBC1D5|FMR1|DKK1|GREM1
REGULATION OF PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050932,0.0471327572663001,0.42721693308831105,-0.766957097165545,-1.55651664140138,299,3,ZEB2|BLOC1S5|BLOC1S6
POSITIVE REGULATION OF NEUROGENESIS%GOBP%GO:0050769,0.8646003262642741,0.992572193202955,0.12341484866451,0.775331278864735,12189,216,SYT17|RIT2|HOXD3|FAM150B|RIMS2|BRINP3|LRRC7|VLDLR|CXCR4|HES1|SERPINE2|AGER|LIG4|SYT3|PROX1|DSCAM|RGS14|SMARCD3|PLXNC1|ECT2|ZNF804A|MARK2|KIF20B|CUX2|BRINP1|DVL1|ROBO2|UNC13A|SEMA5A|CPEB3|MAP6|PTPRD|PLXNA3|HEYL|GRIP1|DLG5|CAPRIN2|RUFY3|APOE|NIPBL|P3H1|SEMA6A|PLXNB2|OBSL1|DPYSL3|SHTN1|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|ZNF335|LRP8|KDM1A|PLXNA2|NAP1L1|NTN1|CPNE1|DICER1
REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043506,0.6718046992167971,0.964671573446318,0.17565369538748998,0.856720301633764,8062,53,EDN1|TAOK3|MAP3K10|ERN1|MAP3K9|DUSP19|MAP3K5|MAP3K7|ZNF675|CCL19|GSTP1|MAP3K4|TAOK1|MAP2K7|RIPK1|MAP3K12|PTPN22|TRAF2|DVL3|DNAJA1|DVL2|SPAG9|TNIK|MAP4K2
CALCIUM ION EXPORT%GOBP%GO:1901660,0.29156679015035997,0.8000726114371469,0.500844503892355,1.1543723355306201,2675,5,ATP2B1|SLC35G1|ATP2B3
NEGATIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035359,0.583873957367933,0.9439064862850342,-0.7015328628142921,-0.9384619001443509,4409,1,ASXL1
TRANSLATION%GOBP%GO:0006412,0.946,1.0,-0.0873548589575863,-0.787742685374587,472,309,EIF2S2|MRPL44|TRNAU1AP|EIF4E|EEF1A2|RPS16|RPL12|SEPSECS|MRPL51|EIF5|MRPS33|EIF3H|MRPL37|QARS|RPS4X|EIF3D|EIF2B3|MTRF1L|RPL9|DARS|MRPL14|MRPL15|EIF2S1|AARS|EEFSEC|RPS28|RPL17-C18orf32|EIF4A1|MRPS2|CARS|ABCF1|HBS1L|EEF2K|RPL35|MRPL18|MRPS35|WARS|EIF3K|RPL7|RSL24D1|AURKAIP1|RPS9|RPS3|GTPBP1|MRPL22|RPL14|NARS|HARS|FARS2|DDX3X|GARS|EIF4A2|AIMP2|GSPT1|EIF4G1|MRPL24|MRPS17|EIF3G|RPL15|RPL8|TMA7|YARS|EIF3B|TNIP1|MRPL41|EIF4H|RPL35A|MRPS30|MRPL9|NHP2|KARS|EIF4B|SRBD1|MRPS10|AGO2|EIF1AX|ETF1|EIF3A|UBA52|EIF3I|MRPL2|SARS|MRPS26|EIF2S3|MRPL39|PABPC1|MRPL30|MRPL36
POSITIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:1904209,0.21037998146431897,0.7251658659797621,-0.893416409351566,-1.19515037082755,1588,1,MBP
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB VIA ER PATHWAY%GOBP%GO:0002488,0.14,0.6281603901381739,0.9309108954565501,1.23667359373459,1042,1,TAP2
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF BITTER TASTE%GOBP%GO:0001580,0.0504422914911542,0.44079050471084996,0.5912300055157199,1.5388474868642301,478,7,RTP5|TAS2R4|RTP4|TAS2R5|TAS2R20|TAS2R14|TAS2R19
NEGATIVE REGULATION OF AMACRINE CELL DIFFERENTIATION%GOBP%GO:1902870,0.21647027671124106,0.7328218014339442,-0.890604322893692,-1.19138855703305,1634,1,POU4F2
HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0042743,0.512086277426553,0.9187029617772041,0.25465966868196,0.962749282716361,5507,21,HBB|HBA2|PRDX4|DUOX1|PRDX3|HBA1
POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY%GOBP%GO:0061365,0.5601844228552609,0.936434965680841,-0.392617094017659,-0.9029372956566659,3401,4,NR1H3|NR1H2
REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032489,0.759642623665287,0.977664504547119,0.33415612997658894,0.770180343789607,6971,5,RIT2|APOE
NEGATIVE REGULATION OF NMDA GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:1904782,0.0048987157420892396,0.161608827499482,-0.997684164093516,-1.3346325254430502,36,1,EPHB2
REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1902498,0.312688990928435,0.8155492679436609,0.5314739182875421,1.1262440018851698,2791,4,MTA1|MARCH7|TAF1
POSITIVE REGULATION OF SERINE C-PALMITOYLTRANSFERASE ACTIVITY%GOBP%GO:1904222,0.31317285593322897,0.8158652929227931,0.681033924756165,1.1131312409176002,2588,2,SERINC5|SERINC1
TELOMERE CAPPING%GOBP%GO:0016233,0.9348303636807421,1.0,-0.132115055485011,-0.633288496051507,3829,24,DCLRE1A|HIST1H4I|DCLRE1C|TEN1|CTC1|PRKDC|ACD|POT1|RAD50|NBN|TFIP11|HIST1H4H|OBFC1|HIST1H4J|TINF2|HIST4H4|TERF1|TERF2IP|HIST1H4E|DCLRE1B|TERF2|MRE11A|HIST2H4A|HIST2H4B
STRIATED MUSCLE CONTRACTION%GOBP%GO:0006941,0.00999833361106482,0.21951586544159402,0.350115560786813,1.70762766010852,119,53,RYR2|KCNN2|SCN1A|CACNA1G|CCDC78|GAA|CACNB2|FGF12|MYLK2|KCNQ1|JSRP1|MYH3|TCAP|CACNA2D1|TAZ|TNNC2|KCNH2|CACNA1D|STAC3|GJA1|ARHGEF11|DMD|SCN3B|TNNI3|SLC8A1
DADP CATABOLIC PROCESS%GOBP%GO:0046057,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
DENTATE GYRUS DEVELOPMENT%GOBP%GO:0021542,0.230224449771192,0.743397546142977,0.529011052943722,1.2192920556425,2112,5,CDK6|PROX1|LEF1
NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150076,0.599789029535865,0.9503391896930079,-0.22869573820957798,-0.886027834186088,2842,14,CLU|CX3CL1|ITGAM|SNCA|TNF
NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900077,0.6022008253094909,0.9508825506493929,0.227051796986626,0.893561845558379,6566,24,GRB14|CISH|SOCS2|PRKCB|PRKCQ|IRS1|SOCS1|GSK3A|RPS6KB1|NCK1|SLA2|PTPRE|PRKCZ|KANK1|PTPN2
MODULATION BY SYMBIONT OF HOST APOPTOTIC PROCESS%GOBP%GO:0052150,0.156952081696779,0.6578589353509621,-0.655619278702989,-1.33055984682348,998,3,CASP8|SERPINB9|BCL2L1
THYMIDINE METABOLIC PROCESS%GOBP%GO:0046104,0.9393307861525991,1.0,0.32379038991429304,0.61549146975656,8112,3,TK1|DPYD
ESTABLISHMENT OR MAINTENANCE OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035088,0.223101265822785,0.7355723797115551,-0.227508840322618,-1.1803231546345,845,30,RHOA|WDR1|CLIC4|CDC42|MSN|SLC9A3R1|SH3BP1|DLG1|PARD3
BMP SIGNALING PATHWAY INVOLVED IN NEPHRIC DUCT FORMATION%GOBP%GO:0071893,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902253,0.9054481219784309,1.0,0.16782670522587,0.634474398373009,9738,21,SIRT1|AK6|MARCH7|MUC1
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031115,0.6812676624949541,0.965271928233355,-0.233862959285005,-0.822992890543164,3374,11,STMN1|TBCD|TUBB4A|STMN2|MAP2|INPP5J|EML2|MAPRE1|CLIP3|DYRK1A|SNCA
PROSTHETIC GROUP METABOLIC PROCESS%GOBP%GO:0051189,0.760201890034364,0.977664504547119,0.31072216408219705,0.7641759102365648,7078,6,GPHN|MOCS2|MBIP
REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002604,0.982624262847515,1.0,0.193894749396837,0.504667295370481,9330,7,CCL21|CCL19|THBS1
HYPOXANTHINE SALVAGE%GOBP%GO:0043103,0.24988864142539002,0.7613646381106121,-0.7071408877860491,-1.2095266165145702,1682,2,ADA|HPRT1
"NEGATIVE REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904153",0.991577414994281,1.0,0.170555463621821,0.464979951049048,9535,8,DERL3|SVIP|UBAC2|UBE2G2|DERL2|ERLEC1|UBE2J1|OS9
GLOMERULAR VISCERAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072112,0.611842105263158,0.9508825506493929,0.30867208813673397,0.8808446734569101,6044,9,BASP1|PTPRO|MAGI2
MIDBRAIN-HINDBRAIN BOUNDARY DEVELOPMENT%GOBP%GO:0030917,0.736179992742228,0.974262605126702,0.51298593879239,0.8384614244080452,6085,2,LRP6|KDM2B
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903748,0.588083791208791,0.945418171231938,-0.35004165563661,-0.886107207282521,3424,5,BAG4|SIAH3
RESPONSE TO ATP%GOBP%GO:0033198,0.261839261151503,0.771967970256231,0.37649867044344104,1.1868583571372902,2664,12,HSP90B1|KCNJ11|P2RY11|TRPV1|PDXP|P2RX3|TAF1|P2RX7|P2RX4|SSH1
SUBSTANTIA PROPRIA OF CORNEA DEVELOPMENT%GOBP%GO:1903701,0.274765100671141,0.7884684708511421,0.865846934274371,1.15023902401317,2046,1,TGFB2
"MATURATION OF 5.8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000466",0.0203068592057762,0.29866953402030105,-0.3957271376111379,-1.73545076448156,89,19,ERI3|EXOSC7|FTSJ3|EXOSC8|URB1|WDR12|PES1|EXOSC9|KRI1|RRS1|NOL9|NOP14
POSITIVE REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070859,0.692254254949635,0.96731875442989,0.44809302839873605,0.851777709368735,5978,3,STAR
POSITIVE REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0045931,0.0163720215219062,0.27230872946709,0.27453746266017703,1.5422550201049199,212,105,EDN1|ASNS|HES1|CCNB1|TPR|CDC7|CDK1|INS|XRCC3|ANAPC5|MEIS2|ANKRD17|LSM11|KIF20B|NUMA1|CDC25C|FAM178A|CDC45|DTL|CDK10|PPP1R10|DLGAP5|CCNE1|GEN1|NDC80|DBF4B|NUSAP1|TAL1|FBXO5|RB1|ESPL1|CDC6|RAD51C|NIPBL
PROTEIN K6-LINKED UBIQUITINATION%GOBP%GO:0085020,0.36991643454039,0.8525168483750899,-0.338862229502235,-1.05333135242705,1991,8,PARK2|RNF4
POSITIVE REGULATION OF WOUND HEALING%GOBP%GO:0090303,0.439600111080255,0.879896414106183,-0.185071905292429,-1.00605216557095,1582,35,USF1|PDPN|PPAP2B|HBEGF|SERPINF2|FOXC2|THBD|ANO6|ADRA2A|ENPP4
LYSINE TRANSPORT%GOBP%GO:0015819,0.38348993288590605,0.8582519754973359,0.8146779885310981,1.08226336240174,2856,1,PQLC2
POSITIVE REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:1902685,0.7588000483851459,0.977664504547119,0.502508960573477,0.8213370913286591,6272,2,DBN1|STX7
CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061307,0.5073182532962379,0.9177168315498629,0.601378549765647,0.98293671875676,4193,2,HAND2|JAG1
REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048670,0.6121159293963829,0.9508825506493929,0.38380707862332897,0.8846184200891659,5617,5,FGF13|PTPRS|NGF|SEMA4D
POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032962,0.4695993715632371,0.896798338613787,-0.48013162014536404,-0.974412857748097,2988,3,GPER1|HRH1
"FRUCTOSE 2,6-BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0006003",0.9235962456775891,1.0,-0.274361661059946,-0.630974504279215,5608,4,PFKFB2|PFKFB3|TIGAR|PFKFB4
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032436,0.017419125488802,0.278447181841778,-0.241500480604053,-1.5447563527989099,48,60,CBFA2T3|CLU|PLK3|USP5|TRIB1|ARIH1|PRICKLE1|CEBPA|STUB1|GLTSCR2|TRIB2|SUMO1|RNF144B|SMAD7|SOCS5|ARIH2|PARK2|HSPBP1|DDRGK1|BCAP31|BBS7|CAV1|TRIB3
POSITIVE REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905155,0.744497711919808,0.9749763305090959,0.33960597786426094,0.782741435277057,6832,5,ABCA7|F2RL1
REGULATION OF METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072298,0.969858945805494,1.0,-0.33039754822818,-0.565127311283478,6531,2,RET
REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032648,0.6354983202687571,0.95916055221954,-0.16129788792240196,-0.887282264244534,2269,36,RNF135|FLOT1|PYCARD|RIOK3|POLR3C|POLR3D|SIRPA|TRAF3|DDX3X|RELB|REL|RNF216|MAVS|RIPK2
LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902774,0.8110455019103859,0.9852684165902109,0.399525752729679,0.7594564274074871,7004,3,VPS41|VPS39|C9orf72
NEGATIVE REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905246,0.8541945063103191,0.991298302704726,-0.41328466414915704,-0.7069012839163309,5752,2,BIN1
NEGATIVE REGULATION OF MESODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042662,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
NEGATIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010614,0.780566801619433,0.981487311948134,0.26166341777359503,0.7466979900116592,7711,9,RGS2
NEGATIVE REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900028,0.5482227625332871,0.9305779599215391,0.498621374214183,0.9478267793814351,4734,3,EVL|PFN2|KANK1
ANIMAL ORGAN REGENERATION%GOBP%GO:0031100,0.715297217190845,0.971081608033886,-0.348249909403718,-0.800902039674128,4343,4,SULF2
ENDODERM DEVELOPMENT%GOBP%GO:0007492,0.16855798505397196,0.6723238898070389,-0.23156037297479504,-1.24600016413158,608,34,MMP2|ITGA5|COL6A1|LAMC1|MMP9|TBX20|SOX7|SOX17|ITGA7
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904064,0.6119677238955021,0.9508825506493929,0.17120411746859301,0.9020314071993192,7659,75,RYR2|AKAP9|CACNB2|KCNQ1|ATP1B3|ACTN2|F2R|CXCL9|LRRC55|PKD2|PDPK1|CACNA2D1|STAC2|KCNH2|STAC3|CXCL10|WNK3|PLCG1|ANK3|DRD4|DMD|TRPC1
SENSORY PERCEPTION%GOBP%GO:0007600,0.38178541932577503,0.857178152269066,0.183002944100078,1.06026335394738,5084,124,PCDH15|RGS16|SCN1A|FSCN2|RTP5|ZNF354A|SIX3|GPR179|CRYZ|COL18A1|KCNQ1|PIEZO2|TAS2R4|ADGRV1|DNAJC19|DFNB31|CDH23|TIMM13|TMEM150C|RTP4|EFEMP1|BIRC5|PDZD7|CACNA1D|ABLIM1|KIT|NIPBL|TAS2R5|ASIC1|SERPINB6|RABGGTA|ASIC3|TAS2R20|ADORA2A|TH|SPTBN4|CNGB1|COL11A2|SLC24A1|PRR4|OPRL1|MYO7A
CELLULAR RESPONSE TO HYDROGEN SULFIDE%GOBP%GO:1904881,0.39017608897127004,0.8607749921056059,-0.802492280546978,-1.07351839147221,2946,1,KDR
POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0090267,0.0736099410278012,0.520821259294202,0.564545919797558,1.4693944180693799,698,7,TPR|XRCC3|GEN1|NDC80
REGULATION OF MYOFIBROBLAST DIFFERENTIATION%GOBP%GO:1904760,0.8590942835931701,0.99166790097654,-0.4101593676933739,-0.701555631708886,5785,2,PDCD4
NEGATIVE REGULATION OF B CELL ACTIVATION%GOBP%GO:0050869,0.9408127208480559,1.0,-0.148289007942758,-0.623983089617719,4259,17,TNFAIP3|LYN|FCGR2B|TNFRSF21
NEGATIVE REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0061944,0.9311531841652321,1.0,-0.531649757388619,-0.711204090323967,7032,1,TRIM44
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901381,0.3460394198586839,0.8422206315449059,0.290340554008039,1.0976420473703101,3721,21,AKAP9|KCNQ1|ATP1B3|ACTN2|LRRC55|KCNH2|WNK3|RNF207|WNK2|KCNIP2|WNK1|FLNA|ANK2
G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007216,0.0472471690745802,0.4277111233594871,-0.493306051563832,-1.59243614066333,241,9,GRM2|HOMER2|GRM8|HOMER1
POSITIVE REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903524,0.14949829697137101,0.6430756613358101,0.33648890933898806,1.30867376928591,1623,23,RGS2|RYR2|EDN1|KCNQ1|OXTR|F2R|TGFB2|F2RL1|ATP2A2|SCN3B|RNF207|GSK3A|SMTNL1
REGULATION OF MICROTUBULE NUCLEATION BY RAN PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0090226,0.275652058784589,0.7884684708511421,-0.862042346713719,-1.15318033064975,2081,1,RANGRF
ACTIVATION OF GTPASE ACTIVITY%GOBP%GO:0090630,0.679186991869919,0.9647315640607691,0.166923981817479,0.857262839620136,8353,67,TBC1D3D|CXCL13|TBC1D30|TBC1D4|SGSM3|EVI5L|GRTP1|TBC1D3B|ECT2|TBCK|USP6NL|CCL21|DOCK7|TBC1D10C|TBC1D13|NTRK3|APC2|TBC1D9B|TBC1D22B|TBC1D10B|RASGRP1|CCDC125|TBC1D7|TBC1D12|TBC1D2B|EPHA1|SGSM1|SIPA1L1|SYDE1|SCRIB
CELLULAR RESPONSE TO TUMOR NECROSIS FACTOR%GOBP%GO:0071356,0.139427987742594,0.6281603901381739,-0.160666834844751,-1.2015141668095402,272,108,RPS3|TRAF3|CCL14|BAG4|COMMD7|INPP5K|TNFRSF1B|TNFRSF18|DFNA5|TANK|TCL1A|TMSB4X|ARHGEF2|KARS|NPNT|TNFRSF11A|ADAM17|CXCL8|LIMS1|CDIP1|TNFRSF4|CHI3L1|PLVAP|EDA2R|CCL18|TNF|TNFRSF21|FOXO3
NERVE DEVELOPMENT%GOBP%GO:0021675,0.229918772563177,0.743397546142977,-0.26929020863229897,-1.1809649984064399,1018,19,DICER1|CHD7|NRP2|SULF1|ERBB3|NGF|PHOX2B|TMEM126A|ISL1|TBX1|MAFB|NTRK1|CHRNB2|NPTX1|SEMA3F|NRP1|FBXO45|SEMA3A|SULF2
REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045628,0.173265528514348,0.676682497340677,-0.44245758710726596,-1.29066841164952,953,7,CD86|RARA|NLRP3|SOCS5
MITOCHONDRIAL DOUBLE-STRAND BREAK REPAIR%GOBP%GO:0097551,0.35456110154905296,0.842911430859438,-0.8218460520511691,-1.09940852170491,2677,1,MRE11A
METANEPHRIC SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0072208,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
REGULATION OF INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902205,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
TYPE II PNEUMOCYTE DIFFERENTIATION%GOBP%GO:0060510,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032604,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:0072697,0.9107328933657521,1.0,0.34260673012643106,0.6512593530951409,7865,3,ANLN|EZR|RTKN
ASPARTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015810,0.38804945054945095,0.859991269020751,-0.410227252029243,-1.0384630480213,2259,5,SLC25A13|SLC25A18
NEGATIVE REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002884,0.243479412154111,0.7565220534116759,-0.877977503308337,-1.1744972754852199,1838,1,FCGR2B
RETINA MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0060042,0.12113601236475999,0.607551029913022,0.404229557331543,1.37058559769452,1253,15,TSPAN12|SDK1|PROX1|DSCAM|AHI1|FOXN4|TFAP2B|TOPORS|SDK2|LRP6
EMBRYONIC CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0031076,0.35134604047946605,0.842847021021096,0.347734866829026,1.09618456893343,3575,12,SIX3|TBX2|PROX1
RRNA METABOLIC PROCESS%GOBP%GO:0016072,0.000900900900900901,0.0849637591935908,-0.25802684234660606,-2.1527555275624697,0,190,NAF1|UTP15|C1D|THUMPD1|TSR3|FTSJ2|WDR12|PES1|METTL16|RRP1|RPS28|ISG20L2|MPHOSPH6|RPF2|RPL35|NSUN5|UTP3|RPL7|EXOSC6|POP5|RRP36|RPS9|RPL14|DHX37|GAR1|DDX47|ZNHIT6|EXOSC4|NOB1|NSUN3|PTRF|NHP2L1|TRMT112|NOLC1|WBSCR22|SBDS|GLTSCR2|PWP2|TBL3|SRFBP1|RPUSD2|RCL1|RSL1D1|TAF1B|FCF1|RPL35A|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|RRP7A|KRI1|NOL10|PIH1D2|RRS1|CIRH1A|MRTO4|BYSL|IMP4|TSR1|NOL9|TSR2|RNMTL1|LYAR|EMG1|RRP9|RPF1|NOP14|NOP56|EXOSC5|CD3EAP
POSITIVE REGULATION OF ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:1901076,0.159060402684564,0.661359103221672,0.9209858844287611,1.22348865937031,1184,1,ABCA7
MICROSPIKE ASSEMBLY%GOBP%GO:0030035,0.5552854000231561,0.9343712161942179,0.496054627748572,0.942947664361902,4795,3,ACTN2|FSCN1|MTSS1
RESPONSE TO UV-B%GOBP%GO:0010224,0.6134751773049649,0.9508825506493929,-0.25621916920653304,-0.866827800306974,3113,10,CDKN1A|CRIP1
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002719,0.927993359618178,1.0,-0.167752380044461,-0.631752256766206,4471,13,SMAD7|TNF
POSITIVE REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032733,0.8226567105521708,0.987616425875001,0.22319962739497098,0.703604989551872,8372,12,TIGIT|CD46|TLR4|XCL1|PIBF1|HSPD1|PRKCZ|HMGB1
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905459,0.035779150018162,0.382529698806185,-0.565746979532506,-1.6503090392067599,196,7,MFN2|PPARG|IGF1|SOD2|PDCD4
NEGATIVE REGULATION OF INTERLEUKIN-10 BIOSYNTHETIC PROCESS%GOBP%GO:0045081,0.23381437839269198,0.747962124891127,-0.882774591971769,-1.1809144872523,1765,1,TRIB2
REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010869,0.7576856979186559,0.977664504547119,0.217375971040633,0.7666536580473741,7935,17,EDN1|HOXA5
SEPTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0032185,0.605003863987635,0.9508825506493929,0.262011879239815,0.888380628278577,6262,15,SEPT12|SEPT11|ANLN|SEPT2|SEPT3|SEPT5
PEPTIDYL-LYSINE DEGLYCATION%GOBP%GO:0036528,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
INTERMEMBRANE SPHINGOLIPID TRANSFER%GOBP%GO:0120012,0.966900569310208,1.0,-0.515273489192766,-0.6892970570501421,7302,1,COL4A3BP
POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090037,0.9220360824742271,1.0,0.24999903924502698,0.6148362281706999,8585,6,ADGRV1|MC1R
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL EXTRAVASATION%GOBP%GO:2000449",0.650901173339785,0.963755998259649,0.547670250896057,0.895151979707696,5380,2,RIPK3|FADD
DNA REPLICATION%GOBP%GO:0006260,0.0008749544294567991,0.0849637591935908,0.29168708312507896,1.76202682728542,11,163,POLG|FBXO18|EME2|FAM111A|LRWD1|PIF1|CDC7|CDC34|CDK1|POLE|REV1|ATR|BLM|TEFM|THOC1|EXO1|BRIP1|POLE2|ORC1|RFC4|DNA2|REV3L|CDC45|TNFAIP1|PNKP|POLD1|DONSON|TONSL|MGME1|FEN1|RNASEH2A|GEN1|ZNF830|POLQ|POLD3|POLN|POLA2|MCM6|CDC6|MSH6|MMS22L|RAD51|WDHD1|DUT|ING5|FANCM|ORC6|RMI2|DBF4|PRIMPOL|WDR18|TIMELESS|LIG1|NASP|POLG2|ZRANB3|MCM10|EME1|RMI1|MCM3|NAP1L1|STRA13|MCM2|BRCA2|CLSPN|KCTD13|IGHMBP2|PRIM2|GMNN|GINS2|ACD|CHEK1|RECQL5|RFC3|GINS1|RAD17|RFC5|CDK2|ATM|WRNIP1|RFWD3|BRCA1|ORC2|CDK2AP1|POLL|MCM7|RPAIN|SETMAR|CDT1|TOP1|NCOA6|POLB|TICRR|NT5M|DDX11|MCMBP|MSH3|ORC5|SLFN11|ATRX|RBBP8|KIN|ORC3|RAD50|NUCKS1|NBN|PURA|LIG3|PTMS|KAT7
ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:0070200,0.22989758117236897,0.743397546142977,0.5290897812594799,1.21947351273952,2109,5,TERT|BRCA2|ACD|POT1
PROLINE METABOLIC PROCESS%GOBP%GO:0006560,0.8112967671630951,0.985469103783777,-0.249476006618864,-0.72773257955089,4466,7,PYCR2|ALDH18A1|PYCR1|PRODH|OAT|PYCRL|ALDH4A1
CELLULAR RESPONSE TO PH%GOBP%GO:0071467,0.164971985889189,0.667429120754799,-0.339910776161105,-1.28009748584203,794,13,IMPACT|SLC9A1|CHP1|HVCN1|PKD2L1|RAB11FIP5
HALOGENATED HYDROCARBON METABOLIC PROCESS%GOBP%GO:0042197,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
REGULATION OF BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:2000812,0.663922278939569,0.964618776001639,-0.36238368225424394,-0.8334067645817651,4031,4,RLTPR|MTPN
MEMBRANE TO MEMBRANE DOCKING%GOBP%GO:0022614,0.0858516483516484,0.5495132996855571,-0.575374454516266,-1.4565222247788603,499,5,VCAM1|EZR|ICAM1|MSN
PEPTIDYL-TYROSINE SULFATION%GOBP%GO:0006478,0.421083890126206,0.8727872721376851,-0.6024941110676391,-1.0305339094606,2835,2,TPST1
REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001257,0.000924214417744917,0.0849637591935908,-0.265765505089396,-1.91071191174245,1,93,KCNAB1|MMP9|VAMP2|SUMO1|HAP1|ARC|CRACR2A|CRH|FMR1|PDE4B|GNB5|JPH3|ADRB2|SLMAP|RELN|KCNG1|HTT|JPH1|CACNG3|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032365,0.950300382304752,1.0,0.14265882073207,0.5735567920291099,10439,26,STAR|LDLRAP1|CPT1B|ACACA|LDLR|ARV1|OSBP|SERAC1|SYT7|LRP6|KIAA1468|CPT2|NPC2|PLEKHA8|COL4A3BP|NPC1|CPT1A|SLC25A20
REGULATION OF MRNA STABILITY%GOBP%GO:0043488,0.0035140562248996,0.142637953775888,-0.217572939113032,-1.61453387074056,6,105,EXOSC7|EXOSC1|DIS3|MAPKAPK2|YTHDF3|HNRNPM|EXOSC8|SET|MOV10|PUM1|ZC3H12D|HNRNPD|SYNCRIP|PARN|AXIN2|TNFSF13|YTHDF2|HSPB1|DCP1A|APEX1|DCP2|METTL16|PRKCD|SAMD4A|EXOSC6|EXOSC4|CCRN4L|EIF4G1|VIM|SLC11A1|VIP|YBX1|SERBP1|NPM1|EXOSC9|YWHAB|FMR1|HNRNPC|PDE12|UBA52|RBM38|PRKCA|YWHAZ|PABPC1|EXOSC5|CARHSP1|MYD88|UBC|RBM24|UBB
POSITIVE REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046601,0.534042096219931,0.9265056012720759,0.382397261957349,0.940450374988136,4972,6,CENPJ|CEP295|CEP120|NUP62|PLK4
REGULATION OF ION TRANSPORT%GOBP%GO:0043269,0.0018726591760299602,0.110761102193686,-0.192282483475829,-1.7339321591980201,0,303,CRHR1|PML|SCN1B|DNAJC30|FYN|KCNE4|SESTD1|SLC9A1|PLN|INPP5K|RANGRF|PXK|UBASH3B|YWHAH|SLC30A1|KCNAB1|PRNP|APLNR|MMP9|CHP1|VAMP2|SUMO1|HTR1B|VIP|CAMK2A|HAP1|ARC|VAMP3|BIN1|CRACR2A|ATP2B4|CEMIP|CLDN10|CAB39|TMSB4X|KCNAB2|CRH|AMIGO1|SNCA|FMR1|PDE4B|LGALS3|TNFRSF11A|GNB5|NEDD4|JPH3|HRH3|ADRB2|CHRNA3|SLMAP|BCL2|SNTA1|RELN|COMMD1|SNX6|FXYD5|B2M|YWHAE|KCNG1|HOMER2|ANO6|ADCYAP1|HTT|DRD2|SYT2|PARK2|ADRA2A|JPH1|PER2|SLC9A3R1|CHRM1|CACNG3|SCN5A|DLG1|CACNG7|PDE4D|GAL|SYT9|CAV1|STAC|FKBP1A|STC1|EPHB2|TRH|HOMER1
ESTABLISHMENT OF SISTER CHROMATID COHESION%GOBP%GO:0034085,0.9498264083324001,1.0,0.277684364980403,0.588439695186074,8480,4,NIPBL|MAU2|DDX11
FOREBRAIN DEVELOPMENT%GOBP%GO:0030900,0.5901525121932341,0.945418171231938,0.16689325429895702,0.9276849012659399,7622,99,SIX3|BTBD3|SLIT1|CDK6|HES1|BMP4|KIF14|MFSD2A|PROX1|WDR62|FGF13|ARHGAP11B|EPHA5|NPY|ZDHHC16|ROBO2|SEMA5A|TYRO3|KIRREL3|STIL|CCDC85C|LEF1|DOCK7|NF1|METTL3|RTN4R|TACC2|LRP8|SZT2
POSITIVE REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032753,0.8962440340319571,0.9989028499632031,-0.176877507306409,-0.666117311613635,4318,13,HAVCR2|CD86|RARA|FCER1G|LGALS9|NLRP3
REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION%GOBP%GO:0150003,0.742387403033461,0.974505008828563,0.4279293311056189,0.8134486419558571,6411,3,AGER
BODY FLUID SECRETION%GOBP%GO:0007589,0.0147091108671789,0.264001457476971,-0.43850164994165597,-1.7958116327373799,66,16,VAMP2|VIP|VAMP3|COPA|FGF10|AQP5|AQP1
REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR SECRETION%GOBP%GO:1900166,0.275278396436526,0.7884684708511421,-0.6940170940170939,-1.18707907013821,1853,2,CD34|DRD2
REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900452,0.499350046425255,0.914249271904946,-0.305464676671168,-0.9495172166852829,2688,8,ARC|CBLN1|FMR1
EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION%GOBP%GO:1900115,0.6776244097348351,0.9647315640607691,-0.28325765786030294,-0.82627515497771,3730,7,LRPAP1|NBL1
NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043242,0.6847290640394088,0.966495577318169,-0.153204490170055,-0.8575954492884581,2362,38,ARHGEF2|TWF1|TWF2|KIAA0226|MID1IP1|TNF
NEGATIVE REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0010951,0.350236355822948,0.842847021021096,-0.150810008893237,-1.0603898988771,814,85,MAGEA3|SPOCK3|SERPINI1|DDX3X|MAP2K5|HGF|MMP9|LAMTOR5|BIN1|SPOCK1|SERPINF2|TIMP2|GAPDH|SERPINF1|PLAUR|SNCA|SERPINA1|YWHAE|DNAJB6|CSNK2A1|AQP1|PAK2
POSITIVE REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051928,0.673641193297916,0.9647315640607691,0.16986957138437397,0.8589048385479341,8241,62,RYR2|CACNB2|P2RX5|F2R|CXCL9|PKD2|PDPK1|CACNA2D1|STAC2|CACNA1D|CCL5|STAC3|GRIN1|CXCL10|CCL2|WNK3|PLCG1|TRPC1
TRNA THIO-MODIFICATION%GOBP%GO:0034227,0.6557348901098901,0.9640743070248079,-0.330901947763675,-0.837656307744163,3818,5,CTU1|MOCS3|URM1
REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000733,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
DTTP BIOSYNTHETIC PROCESS%GOBP%GO:0006235,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
AUTOPHAGY OF HOST CELLS INVOLVED IN INTERACTION WITH SYMBIONT%GOBP%GO:0075044,0.996752155896517,1.0,0.21352016642415603,0.452469629161792,8899,4,ULK1|ATG5|ULK2
RESPONSE TO FUNGUS%GOBP%GO:0009620,0.9931550126369001,1.0,0.17664095750339,0.4597593000955279,9430,7,RARRES2|FAM3A|TLR4
NEGATIVE REGULATION OF GLIOGENESIS%GOBP%GO:0014014,0.6963057575162112,0.96731875442989,0.257592009633904,0.8120220690439759,7086,12,HES1|NF1|LDLR|DICER1|RNF10|CERS2
CHONDROCYTE DIFFERENTIATION%GOBP%GO:0002062,0.978996084015664,1.0,0.121483834438863,0.5135112974994299,10999,31,NOV|WNT5B|BMP4
DECIDUALIZATION%GOBP%GO:0046697,0.496920147832904,0.911815944636073,0.462648372510444,0.9803960958248129,4436,4,GHRL|CYP27B1|SPP1
ACTOMYOSIN CONTRACTILE RING ORGANIZATION%GOBP%GO:0044837,0.9322292438439749,1.0,0.262509566267138,0.605045635433501,8555,5,ANLN|RACGAP1
NEURON PROJECTION FASCICULATION%GOBP%GO:0106030,0.6859452736318411,0.9665006495129341,-0.22555044289023898,-0.82170288839949,3308,12,AMIGO1|EPHB2
REGULATION OF HEAT GENERATION%GOBP%GO:0031650,0.6507908611599301,0.963755998259649,-0.306169054917712,-0.8404134980004659,3702,6,TNFRSF11A|TNF
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION%GOBP%GO:0033087,0.360711261642676,0.848418604328854,0.660051674938655,1.078836330007,2981,2,BMP4|KIAA0922
MAMMARY GLAND SPECIFICATION%GOBP%GO:0060594,0.5594654788418709,0.936434965680841,-0.53783549128184,-0.919938803211163,3767,2,FGF10
POSITIVE REGULATION OF CYTOLYSIS%GOBP%GO:0045919,0.48394533179647603,0.9064456896937672,-0.418739315060939,-0.963012946933082,2938,4,P2RX7|GPLD1|LILRB1|RRAGA
GLUCOSE CATABOLIC PROCESS TO PYRUVATE%GOBP%GO:0061718,0.00047528517110266203,0.0784645998831315,-0.4768837663179679,-2.2092786897554704,1,22,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
NEGATIVE REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090241,0.459065964833688,0.890371861972445,0.475875736613834,1.00842614390355,4098,4,SIRT1
CHOLINE METABOLIC PROCESS%GOBP%GO:0019695,0.999214454045562,1.0,-0.225432888496746,-0.4575093492988811,6359,3,SARDH|SLC44A1|ALDH7A1
MEIOTIC CHROMOSOME SEGREGATION%GOBP%GO:0045132,0.000526824128545087,0.0784645998831315,0.484415104386586,2.10672374181506,5,34,MUS81|SYCP2|EME2|BLM|NUF2|BUB1|TOP2A|CCNE1|PTTG1|BUB1B|ESPL1|FANCM|SLX4|EME1|RMI1|STRA13|CCNE2|BAG6|STAG3|TOP2B|P3H4|SGOL1|FMN2
STRIATED MUSCLE HYPERTROPHY%GOBP%GO:0014897,0.418913226621735,0.87173622607586,0.39996348567809903,1.04102092084505,3977,7,RYR2|TCAP|SORBS2|INPP5F|PDLIM5
POSITIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903646,0.579170194750212,0.942692029750853,0.575210906291909,0.9401664243661528,4787,2,SGTA
NEGATIVE REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002037,0.825503355704698,0.9876441563834109,0.588883987648875,0.782306105614253,6149,1,ARL6IP5
NEGATIVE REGULATION OF PROTEIN SECRETION%GOBP%GO:0050709,0.0626389918458117,0.488401291882527,-0.205014521856571,-1.36445130755691,168,68,SYT11|IL1B|SRGN|CX3CL1|TNFAIP3|NR1H3|PFKL|SSC5D|RAB11FIP1|FCGR2B|TMSB4X|DPH3|NLRP3|TNFRSF4|DRD2|PPP1R11|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|TNFRSF21|INHBB
LIPID TUBE ASSEMBLY%GOBP%GO:0060988,0.23043801039346698,0.743397546142977,-0.7191066997518609,-1.2299934970342,1551,2,SNX9|BIN1
POSITIVE REGULATION OF ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:2000388,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
SMOOTH ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS%GOBP%GO:0051563,0.5775188666754929,0.942692029750853,-0.705227172474636,-0.9434038908155501,4361,1,PSEN1
NEUTROPHIL CHEMOTAXIS%GOBP%GO:0030593,0.5218175571207699,0.9251240799994541,0.20950169742437302,0.9567775722853309,6074,41,EDN1|CXCL13|CXCL9|TGFB2|XCL2|CCL21|CCL5|CCL19|CXCL10|CCL2|CXADR|AMICA1|GBF1|CCL3L3|CCL11|CCL4L2|PIP5K1C|CXCL11|CKLF|XCL1|CCL4|CXCL2|CCL8|CXCL1|CCL24
CHORDATE EMBRYONIC DEVELOPMENT%GOBP%GO:0043009,0.35445781331739,0.842911430859438,0.18511058014339102,1.0779013794255299,4742,127,ALDH1A2|RIPPLY2|HOXD3|HOPX|HOXB3|HOXD4|HES1|BMP4|RARRES2|HOXC4|E2F8|FUT8|LIG4|PROX1|PKD2|ZNF358|MTHFD1|DVL1|DEAF1|TGFB2|E2F7|ARNT2|DACT1|STIL|ZP3|LEF1|NIPBL|VANGL2|HES6|HEY2|PLXNB2|SEMA4C|SRF
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014911,0.43743909569284706,0.878651088001772,0.308418990678617,1.0218879594558101,4488,14,NR4A3|IGFBP5|CCL5|DOCK7|FGF9
GLOMERULAR MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072008,0.9588977654278108,1.0,0.306054924451307,0.58177821561236,8281,3,ACTA2|PDGFB|CD34
NEGATIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002605,0.901410541945063,0.999281075383372,-0.38633707672733003,-0.660808878851763,6070,2,FCGR2B
REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090183,0.7161552346570401,0.971081608033886,-0.18620265960203897,-0.8165867772060591,3173,19,AGT|PRKX|FLCN|VEGFA|CTNNB1|LIF|RET|PAX8
MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETERIC BUD DEVELOPMENT%GOBP%GO:0072138,0.707995645336882,0.9695170059473192,0.5253240131888761,0.8586276680623691,5852,2,GPC3|BMP2
DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042416,0.770187031022511,0.9792758096555699,0.3651092653083479,0.77370141024259,6876,4,TGFB2|TH
PROTEIN LOCALIZATION TO MICROTUBULE END%GOBP%GO:1905725,0.423880597014925,0.8740879492662891,-0.4966361530826071,-1.00790831697302,2697,3,MAPRE3|MAPRE2|MAPRE1
REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901077,0.0173989455184534,0.278447181841778,-0.6620623088766949,-1.81731658363342,98,6,CAMK2D|SRI|PLN|PDE4B|PDE4D
PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0097468,0.600742390497402,0.950415218201239,-0.5210174463884429,-0.8911724381378778,4045,2,PDCD10
REGULATION OF PRO-T CELL DIFFERENTIATION%GOBP%GO:2000174,0.39785234899328903,0.8638522656500329,0.8084472871636529,1.0739861536063802,2963,1,ZBTB1
POSITIVE REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042102,0.882029033872852,0.995792680480489,0.14203612764166001,0.689397645691783,10571,52,CD209|AGER|BLM|CCDC88B|EBI3|CCL5|ZP3|CCL19|TMIGD2|CD55|IL12RB1|CD1D|RASAL3|HLA-DMB|IGFBP2|CD3E|CD46
INACTIVATION OF MAPK ACTIVITY%GOBP%GO:0000188,0.226979742173112,0.7398172623753029,-0.267524508344901,-1.1936690725705301,985,20,PPP2CA|DUSP3|DUSP10|SPRED2|CAV1
GONAD DEVELOPMENT%GOBP%GO:0008406,0.6495959166312211,0.963755998259649,0.185694221199832,0.8704210578870281,7635,45,WNT4|INHA|BASP1|EIF2B5|ROBO2|TGFB2|ZNF830|KIT|BMPR1B|EIF2B4|FGF9|FANCF|ING2|NUP107|BRCA2|CEBPB|GATA6
MEIOTIC RECOMBINATION CHECKPOINT%GOBP%GO:0051598,0.7719850006048141,0.979693198874896,0.497601323407775,0.813315693201999,6381,2,RAD1|TRIP13
ENDOPLASMIC RETICULUM ORGANIZATION%GOBP%GO:0007029,0.41350333236743,0.868370912572213,-0.18330889677079604,-1.026111411684,1426,38,RTN4|EIF2AK3|STX18|RAB18|TOR1AIP2|ATL2|TMEM170A|LMAN2|ASNA1|CAV2|VAPB|DOPEY2
RESPONSE TO BACTERIUM%GOBP%GO:0009617,0.11509229098805601,0.593398236603313,-0.13956377777820803,-1.18762427463067,105,211,IGHV4-4|CD274|IL1B|IRAK1|MTDH|FCER1G|PRKCD|SIRPA|DAB2IP|TRIB1|IGHV2-26|LGALS9|ROMO1|TNFAIP3|NR1H3|SSC5D|FGR|IGHV1-69-2|S100A8|IGHV3-15|RHOA|IGHV3-73|IFNAR1|TNFRSF1B|BCL10|CCRN4L|VIM|IL6|LYN|FCGR2B|SBNO2|CHIT1|SLC11A1|RAB1A|MAVS|FOXP1|LDOC1|PLA2G2A|SNCA|PDE4B|TNFRSF11A|NR1H2|PDCD4|ADAM17|CXCL8|IGHV1-3|NLRP1|NLRP3|SHC1|JUN|NOS3|PPP1R11|TNIP2|HIST1H2BC|TICAM1|MYD88|NR1D1|LIAS|CD36|TNF|CAV1
CYTOKINE PRODUCTION%GOBP%GO:0001816,0.972894831947958,1.0,-0.0970301842915883,-0.62554547177047,2691,62,S100A8|BCL10|PNP|SLC11A1|ABCA1|RAB1A|FOXP1|CAMK4|RFTN1|NFATC2|CHI3L1|CD36
NOTCH SIGNALING PATHWAY%GOBP%GO:0007219,0.8201970443349751,0.987153241368501,-0.124844924257673,-0.792757134784016,2330,58,NOTCH3|PSEN1|PSENEN|NOTCH4|BHLHE40|APH1B|DLL1|CREBBP|SNAI2|ITCH|NRARP|NOTCH1|WWC1|ADAM10|HES7|ZNF423|NCSTN|PSEN2|SNAI1|YBX1|FCER2|BHLHE41|ASCL1|RBPJ
POSITIVE REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035306,0.5670820052158799,0.938953543844111,-0.16649293244553798,-0.931980394605251,1956,38,PIN1|MAGI2|PPP1R12A|SMPD1|FCRL3|CNEP1R1|CDCA2|RIPK3|ANKLE2|PPP2R4|SYMPK|GPLD1|MTOR|LILRB2|MEF2C|PTPRC|CD300A|SPPL3|BMP2|MTMR9|PTBP1|PPP1R15A|PDGFRB|DUSP26|PPP1R16B|TGFB1|PLEK|GBA|AKAP6|PPP2R5A|PPP1R15B|PRKCD|NSMF|DLC1|CAMTA1|PPP1R7|HSP90AB1
NEGATIVE REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051573,0.414251470908695,0.8693978722239121,0.451741318403394,1.04119677210851,3801,5,DNMT3B|BRCA1|DNMT1|PIH1D1|SMARCB1
SINGLE STRAND BREAK REPAIR%GOBP%GO:0000012,0.0980605796469819,0.570215774831708,0.609493569451629,1.40479232534414,899,5,SIRT1|LIG4|APLF|TDP1|APTX
METANEPHRIC CORTICAL COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072219,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
POSITIVE REGULATION OF CYTOCHROME-C OXIDASE ACTIVITY%GOBP%GO:1904960,0.7266518188567191,0.972554563883587,-0.4689826302729529,-0.8021696719788249,4893,2,COX17|CHCHD10
ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032510,0.504569420035149,0.917139342610024,-0.345485632342397,-0.9483348631161079,2870,6,VCP|LYST|UBXN6|CHMP3|CHMP2B|VPS4B
NEGATIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0010894,0.45720633693972207,0.88985710965551,0.295360602256042,1.00145320953482,4732,15,FGF19|WNT4|PROX1
CELLULAR RESPONSE TO ISOQUINOLINE ALKALOID%GOBP%GO:0071317,0.162953020134228,0.664859563055667,0.919386854874283,1.2213644199449498,1213,1,ADCY8
ENDOCARDIUM DEVELOPMENT%GOBP%GO:0003157,0.234540389972145,0.748317706308157,-0.38661896419852004,-1.20178007750045,1262,8,SOX17|RBPJ
HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:0071425,0.00563022157646204,0.172670554681089,-0.6690219878596689,-1.95156682039245,30,7,RUNX1|ETV6|MECOM|ARIH2|SFRP2
RENAL WATER TRANSPORT%GOBP%GO:0003097,0.359465478841871,0.8476588060800551,-0.6427553095716171,-1.09939853324979,2420,2,AQP1
POTASSIUM ION TRANSPORT%GOBP%GO:0006813,0.0057215511760966295,0.17352934538701598,0.319609442949471,1.6977522476332803,71,78,KCNK2|KCNN2|KCNK6|KCNH8|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|KCNQ1|SLC9A5|SLC9A7|ATP1B3|KCNH1|LRRC55|PKD2|KCNC3|KCNC1|KCND1|KCNB2|HCN3|KCNJ11|KCNH2
ENDOMEMBRANE SYSTEM ORGANIZATION%GOBP%GO:0010256,0.283849918433932,0.7932053053075551,-0.119008968770995,-1.07011460005272,173,285,CTDNEP1|GAK|RILP|ATL3|PLSCR1|PI4K2B|NUP93|RAB11A|PACSIN1|USP8|CSNK1D|PI4K2A|TMEM43|UBXN2A|CSNK1A1|PDCD6IP|SURF4|FLOT1|SNX3|RAB10|BLOC1S1|TMED10|GPER1|SOD1|DYNC2H1|XKR8|ATP8B1|COG3|SGIP1|SYT11|VPS28|SRGN|CLU|VPS33B|RINT1|TANGO2|PLK3|BCAS3|PTPRN|GORASP2|RTN4|BANF1|VCPIP1|ARFGEF2|RAB43|SQSTM1|DYM|PLEKHM2|EIF2AK3|STX18|VPS4A|VPS18|RFX2|VPS37D|VPS11|TMED4|TBC1D20|WHAMM|RAB30|RAB18|GCC2|NEK6|TOR1AIP2|TMED7|ABCA1|RAB1A|VPS4B|BAG5|ATL2|BIN1|LPIN1|TMEM170A|LMNA|PDCD10|EHD2|CDC42|LMAN2|ALS2CL|SEC23IP|PRKCA|PLEKHF1|ASNA1|YWHAZ|TMED2|SEC23A|ANO6|HTT|CAV2|VAPB|RAB22A|RAB2A|CHMP4B|BLOC1S3|CHMP1B|A4GALT|NSFL1C|VTI1A|DOPEY2|CAV1|MICALL1
NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046580,0.499356830460509,0.914249271904946,-0.191867159292543,-0.970127520379607,1940,28,STMN3|ARAP3|FAM65B|RASIP1|CUL3|FLCN|STAMBP|MAPKAP1|HEG1|DAB2IP|DLC1|FBP1|MFN2|MET|EPHB2
REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0005979,0.8815515610217599,0.9956508825790341,0.180670572134121,0.660378583790079,9317,19,INS|PASK|GCK|IRS1|AKT2|VIMP|GSK3A|AKT1|PPP1R3E|SORBS1
NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0032515,0.128415907576094,0.608160579951936,-0.30971167587678494,-1.3323108183352799,577,18,FKBP1B|MGAT5|LGALS3|PPP1R11|TNF|FKBP1A
BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:0048755,0.12930086410055,0.6100112725887421,-0.6810279682943999,-1.3821260274239298,822,3,DRD2|EPHA7
SECONDARY ALCOHOL METABOLIC PROCESS%GOBP%GO:1902652,0.16951280763435503,0.673117535978459,0.260475518498322,1.25834847765282,2024,51,TM7SF2|C14orf1|FDX1|EBP|CLN6|MVD|LBR|DHCR24|SOAT1|PPAPDC2|CETP|OSBPL5|LDLRAP1|APOE|NSDHL|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7|LCAT
SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0007519,0.367395437262357,0.8512048542076959,-0.22854874130874,-1.058806986957,1545,22,RYR1|POPDC3|CFLAR|CAV2|CAV1
DITERPENOID CATABOLIC PROCESS%GOBP%GO:0016103,0.841255130411757,0.9901937608208321,-0.5775253639170711,-0.772573287912594,6353,1,CYP26B1
NEGATIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000301,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
REGULATION OF AUTOPHAGY%GOBP%GO:0010506,0.0320427236315087,0.365468006929349,-0.14950416012609802,-1.31669952401785,23,251,C18orf8|PIK3R2|ATP6V1C1|EIF4E|CDK5|FBXL2|EEF1A2|TRIM8|HSPB1|FLCN|FBXW7|GNAI3|DRAM1|HAX1|TRIM13|KDR|MTDH|CAPNS1|PLK3|RRAGD|PRKAA1|USP10|RRAGC|RB1CC1|ABL1|ATG13|PSAP|ATG101|FOXO1|CASP3|EIF4G1|MFN2|TBC1D25|HGF|ATP6V0C|CSNK2A2|SH3BP4|TBC1D14|DHRSX|SH3GLB1|EXOC4|ATG7|PIP4K2A|BOK|LAMTOR5|GAPDH|RAB8A|SNCA|LEPR|NEDD4|BAG3|HK2|ADRB2|BCL2|ATP6V1E2|ATP6V0D1|PAFAH1B2|PLEKHF1|UCHL1|SNX6|TFEB|RALB|HTT|PARK2|SPTLC1|BNIP3L|ATP6V1E1|BMF|RAB5A|CHMP4B|KIAA0226|FBXO7|TICAM1|MET|HSPB8|SESN2|PLK2
GLUTATHIONE TRANSPORT%GOBP%GO:0034635,0.0846325167037862,0.545178773025535,-0.824262475875379,-1.4098568203103403,569,2,ABCC1|SLC9A3R1
OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:0001541,0.240050231839258,0.7525035503527309,0.35624164728823704,1.20787721287725,2484,15,INHA|EIF2B5|ZNF830|KIT|BMPR1B|EIF2B4|FANCF|CEBPB
POSITIVE REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY%GOBP%GO:1901671,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|TNF
REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001188,0.5118475274725279,0.9184859575763928,-0.371241391749546,-0.9397729315175279,2980,5,HAVCR2|LGALS9|LGALS3
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002495,0.43106535362578297,0.8785877309899279,-0.14163665921503302,-1.0161318956088699,962,91,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|HLA-DQB1|DCTN5|FCGR2B|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1
DETECTION OF LIGHT STIMULUS%GOBP%GO:0009583,0.870967741935484,0.9934031064448321,-0.174938455385827,-0.6976701889011501,4049,15,CACNA2D4|GNAQ|EYS|PDE6B|GNGT1
SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0030148,0.5884031968683741,0.945418171231938,0.180836677758436,0.918027146489508,7214,63,SPTSSB|B3GALT2|HACD1|B4GALNT1|CERS4|ELOVL6|PPAP2C|B3GALT1|ST3GAL5|CERS6
B CELL LINEAGE COMMITMENT%GOBP%GO:0002326,0.894580549368968,0.9979675173277209,-0.390350151640474,-0.667673028564151,6024,2,SLAMF8|TCF3
TETRAHYDROBIOPTERIN BIOSYNTHETIC PROCESS%GOBP%GO:0006729,0.38633241758241793,0.8596647264526249,-0.410807576457192,-1.0399321007751299,2249,5,SPR|QDPR
POSITIVE REGULATION OF G2/MI TRANSITION OF MEIOTIC CELL CYCLE%GOBP%GO:0110032,0.9100382077110111,1.0,0.34328562477571695,0.652549860406397,7859,3,CDC25C|CDC25A
COPI-COATED VESICLE BUDDING%GOBP%GO:0035964,0.834622144112478,0.988613522932093,-0.259114224256798,-0.711251147337081,4748,6,GBF1|TMED9|ARFGAP2|ARFGAP3|TMED10|TMED2
CELLULAR RESPONSE TO TRIGLYCERIDE%GOBP%GO:0071401,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
2'-DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009394,0.9054491166956959,1.0,-0.137635451519862,-0.667706930436403,3638,25,NUDT1|AK9|NUDT15|CMPK2|SMUG1|DCTD|NUDT18|CDADC1|NEIL2
MODIFICATION OF DENDRITIC SPINE%GOBP%GO:0098886,0.919227913882702,1.0,-0.372925282602702,-0.637868723291334,6190,2,ARHGAP44|SYNPO
SHORT-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0019626,0.18351279379414104,0.689876118998471,0.65523326348296,1.2455295059290201,1584,3,MCEE|ACADS|PCK2
NEGATIVE REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000119,0.908248378127896,1.0,-0.544331715924129,-0.7281691329265921,6859,1,SFRP4
ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032342,0.249127516778524,0.7613646381106121,0.8781429201588,1.16657369269781,1855,1,CACNA1H
CELLULAR COMPONENT DISASSEMBLY%GOBP%GO:0022411,0.17729083665338602,0.6821825152919921,-0.12339977173003501,-1.1253325758280601,88,320,SUPT16H|GPER1|MRPL37|VTI1B|MMP1|FURIN|FZD1|MTRF1L|MRPL14|MRPL15|KPNA1|FRAT1|VPS33B|CTSL|PLK3|MRPS2|CX3CL1|CTNNB1|CFL2|MRPL18|ITGAM|MRPS35|SQSTM1|RB1CC1|NAPB|CTSK|AURKAIP1|ATG13|MRPL22|ADAM10|VPS4A|MAP1LC3B2|WIBG|ATG9B|MMP2|WDR1|MAP1LC3A|ATG3|GSPT1|CASP3|MRPL24|H1F0|MRPS17|DFFA|NEK6|LAMC1|MICAL2|MMP9|NAPA|ADAMTS4|EXOG|ATG7|VPS4B|GRWD1|BOK|BECN1|LPIN1|MRPL41|TIMP2|MRPS30|VPS16|MRPL9|TWF1|MRPS10|CAPG|DSTN|ETF1|MMP12|PRKCA|DKK1|MRPL2|TWF2|MRPS26|GABARAPL1|GABARAP|PARK2|MRPL39|TPSAB1|CHMP1B|CTSV|FBXO7|WIPI2|SMARCC1|MAP1LC3B|MRPL30|KIF9|GABARAPL2|DYRK3|MRPL36|PBRM1|CAV1|SPATA18
RESPONSE TO STEROL%GOBP%GO:0036314,0.8972478811541759,0.998912093067348,0.17724803903017602,0.6358248517388659,9421,18,RORA|CCR5|GRAMD1B|ABCA2
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051967",0.5412411626080129,0.928807195199472,-0.456013152640009,-0.92546514453712,3444,3,DRD2
REGULATION OF ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0110061,0.705864884929473,0.968941691852291,-0.47719878687620604,-0.816222967819489,4753,2,ROCK1|ROCK2
REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0099509,0.142615217128342,0.6324244126031129,0.772208436724566,1.26215347601959,1178,2,CALB1|CALB2
REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032101,0.0467289719626168,0.425275525480742,-0.127377164236488,-1.22034485870742,9,461,IL1B|CLU|VEGFA|SIN3A|ADCY7|KDR|APOBEC3F|FCER1G|NFKBIA|CX3CL1|MAPK7|PRKCD|SIRPA|CD19|TUBB2B|C5AR1|TRIB1|USF1|LGALS9|PTK2B|ITGAM|TNFAIP3|PDPN|AKIRIN1|NR1H3|PRKD2|PCBP2|CR2|CEBPA|SEMA3F|PSMA6|TRAF3|PPEF1|ADAM10|CAMK1D|S100A8|CCL14|ZNF580|NRP1|C1QBP|MGLL|TNFRSF1B|PLAU|PPARA|SEMA7A|APOD|FGF2|METRNL|CDH5|IL6|PDE6B|LYN|FCGR2B|SBNO2|MMP9|CYLD|GLTSCR2|C2CD4A|VAMP2|RNF216|POU4F2|VAMP3|MAVS|SERPINF2|TNIP1|GPATCH3|FOXP1|CRK|ETS1|TMSB4X|PLA2G2A|PLAUR|SNCA|KARS|FGFR1|TNFRSF11A|TRAF3IP1|SEMA6B|PDCD4|ADAM17|THBD|CXCL8|PROC|NLRP1|NLRP3|PRKCA|DUSP3|MKKS|CD9|SNX6|MTUS1|NOS3|ANO6|ADCYAP1|SCG2|GUCA1A|DRD2|OXSR1|BCL6|CDKN1A|GREM1|DUSP10|STK24|THBS4|SEMA3A|RAC1|TICAM1|MET|MYD88|NR1D2|SEMA3G|CCL18|CD36|PGF|GPRC5B|CDH13|TNF|SPATA2|NENF|CAV1|ENPP4|NBL1|ANGPT2
GROWTH PLATE CARTILAGE DEVELOPMENT%GOBP%GO:0003417,0.152164310954064,0.648319130045528,-0.30624444595049,-1.2886414051419,688,17,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COMP|COL21A1|STC1
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0010881,0.8240445859872609,0.9876441563834109,0.232334927289844,0.7088006052282501,8279,11,RYR2|DMD|SLC8A1|GSTM2|ANK2
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0098679,0.839049740163326,0.989395884107905,-0.421836228287841,-0.7215282763830699,5650,2,NCOR1|PPARA
ISOPEPTIDE CROSS-LINKING VIA N6-GLYCYL-L-LYSINE%GOBP%GO:0018276,0.326227988878591,0.826621597878865,-0.8384980149977941,-1.1216843602527,2463,1,RNF113A
GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034349,0.00638455827765405,0.180127205513166,-0.9424317617866009,-1.61197905511935,42,2,TP53|TNFRSF21
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051281,0.847003590168462,0.991298302704726,0.178936762192804,0.6959214421143479,9200,23,F2R|CXCL9|PKD2|PDPK1|CXCL10|PLCG1|TRPC1|P2RY6|GSTM2|CXCL11|XCL1
FARNESOL METABOLIC PROCESS%GOBP%GO:0016487,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
REGULATION OF MRNA CAP BINDING%GOBP%GO:1905610,0.27181252482457297,0.7865607589760191,-0.864137626819585,-1.1559832507319199,2052,1,EIF4G1
CIRCULATORY SYSTEM PROCESS%GOBP%GO:0003013,0.30039956411187796,0.803321166778425,0.18246839187287398,1.1079240822028,4134,169,CARTPT|ACSM3|RYR2|KCNN2|SCN1A|PLCB3|EDN1|CACNA1G|GAA|CACNB2|NPR2|ELN|FGF12|MYLK2|CEACAM1|KCNQ1|HOXB2|OXTR|F2R|INS|GNB3|PDE2A|ERAP1|TCAP|PTPRO|AGTR1|CACNA2D1|TAZ|KCNH2|SRC|CACNA1D|XCL2|F2RL1|AZU1
ENTEROENDOCRINE CELL DIFFERENTIATION%GOBP%GO:0035883,0.474504249291785,0.9003511540468891,0.43070330502010296,0.9927072699667171,4354,5,CDK6|BMP4
NADH OXIDATION%GOBP%GO:0006116,0.3857030636292221,0.859630103805729,-0.5135656777324361,-1.04226628425158,2454,3,GPD1|GPD1L|GPD2
P38MAPK CASCADE%GOBP%GO:0038066,0.475053515560679,0.9009804479157579,-0.42200644307993,-0.9705266588498109,2884,4,LGALS9|MAP2K3
LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070227,0.566441626873045,0.9388612723386429,-0.390381291731109,-0.89779541747306,3439,4,TNFRSF21
CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:0034651,0.249127516778524,0.7613646381106121,0.8781429201588,1.16657369269781,1855,1,CACNA1H
INVADOPODIUM ORGANIZATION%GOBP%GO:1905863,0.35032437442076,0.842847021021096,-0.8247132774591971,-1.1032440965541999,2645,1,PDPN
EXTENSION OF A LEADING PROCESS INVOLVED IN CELL MOTILITY IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021816,0.338805772540712,0.8326275783736579,-0.8318813409792679,-1.11283303367742,2558,1,SRGAP2C
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:1901295,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
OOCYTE MATURATION%GOBP%GO:0001556,0.775412087912088,0.9805314293977441,-0.29816436078146996,-0.7547832801863059,4515,5,PDE3A
REGULATION OF DNA STABILITY%GOBP%GO:0097752,0.757986577181208,0.977664504547119,0.6240626378473749,0.829039372972108,5646,1,DDIAS
JAK-STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY%GOBP%GO:0060397,0.12077733381765303,0.607251067511504,-0.47377903051529296,-1.38203445167678,664,7,LYN|PTPN1|STAT5A|STAT3
PYRIDINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0070637,0.961098737936154,1.0,-0.340225806213163,-0.581938020198962,6472,2,PNP
FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:0044346,0.8932874354561099,0.9976191001250191,-0.551554918394354,-0.737831831104609,6746,1,MYC
CYTOPLASM ORGANIZATION%GOBP%GO:0007028,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
ATRIOVENTRICULAR NODE DEVELOPMENT%GOBP%GO:0003162,0.13033557046979902,0.612163182799301,0.9357079841199821,1.2430463120106598,970,1,MAML1
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0006511,0.7280114722753349,0.972554563883587,0.133702936871101,0.889415073304985,10660,380,SIRT1|HACE1|FBXO18|ARNTL|UBR4|SPSB4|SIAH2|TRIM9|TRIM3|ANAPC15|CCNB1|SGTA|CDC34|CDK1|BTRC|KIF14|PSMD11|ANAPC5|RNF34|KLHL42|UBE2Z|PSMD13|PSMB9|MTA1|KLHL3|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|FBXL19|RNF126|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|AUP1|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|PLK1|CUL4B|TSG101|BIRC2|HERC2|MAN1B1|ZRANB1|UBXN4|VPS37A|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|ANKZF1|PSMC6|ANAPC10|BAG6|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|UBA6|KCTD2|FBXO11|MDM2|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|CBL
REGULATION OF ASTROCYTE CHEMOTAXIS%GOBP%GO:2000458,0.49040116509996007,0.908938677284213,-0.7526466696074109,-1.0068383979384101,3703,1,GPR183
NEGATIVE REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000426,0.691610987379362,0.96731875442989,-0.48431210366694205,-0.828389915225164,4657,2,HMGB1|CD300LF
MITOCHONDRIAL GENOME MAINTENANCE%GOBP%GO:0000002,0.0794905169207884,0.533892166059414,0.38128836772764707,1.4414732589491102,854,21,POLG|LONP1|TEFM|MPV17|DNA2|PARP1|MGME1|PRIMPOL|POLG2|AKT3
BRANCHED-CHAIN AMINO ACID TRANSPORT%GOBP%GO:0015803,0.531781868704411,0.9265056012720759,0.5039767266428711,0.9580067409864399,4592,3,SLC6A17|SLC6A15
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902883,0.0693565400843882,0.5054741186916171,-0.279182760768045,-1.44840910991426,262,30,TRAP1|PARK7|NUP93|ATF4|HIF1A|TXN|HSPB1|MAPK7|FYN|PDE8A|HGF|BAG5|SOD2|PARK2|FBXO7|MET|MCTP1
CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:0032869,0.00199302441454908,0.112650093274223,-0.227282387558415,-1.67482361464059,3,103,IGF1R|CPEB1|USF1|BCAR1|FOXO4|GRB2|RAB8B|INPP5K|HDAC5|FOXO1|PKM|CPEB2|ATP6V0C|ATP6V1F|PPARG|VAMP2|NAMPT|FOXC2|LPIN1|RAB8A|SLC25A33|SHC1|ATP6V1E2|ATP6V0D1|CAV2|ATP6V1E1|RHOQ|IGF2|PIK3R1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
POSITIVE REGULATION OF TORC2 SIGNALING%GOBP%GO:1904515,0.5818791946308729,0.943249589738259,0.712836347595942,0.9469712858971031,4334,1,TELO2
POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0006798,0.7022227064719979,0.968941691852291,0.35388788802448795,0.8156591210245759,6444,5,BNIPL|PRUNE|ATCAY
CEREBELLAR GRANULE CELL DIFFERENTIATION%GOBP%GO:0021707,0.8747900100795161,0.9937342763776691,0.319984448097149,0.6780776120249289,7810,4,PROX1
TYROSYL-TRNA AMINOACYLATION%GOBP%GO:0006437,0.9943624161073821,1.0,0.502922364358183,0.668109924092472,7407,1,YARS2
POSITIVE REGULATION OF SODIUM:PROTON ANTIPORTER ACTIVITY%GOBP%GO:0032417,0.828914869092705,0.9876441563834109,-0.31217410419428304,-0.717935224192123,5033,4,TESC|CHP1
REGULATION OF RHO-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:2000298,0.100549882168107,0.570947005522165,-0.7103231498841949,-1.4415797280623501,639,3,RASIP1|THY1|HEG1
REGULATION OF SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014038,0.20406435224386105,0.720304973077154,0.7310173697270469,1.19482780859695,1686,2,CDK1|DICER1
REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000354,0.5703399056489661,0.940402148292764,0.578384339674662,0.945353314050949,4714,2,ZP3|HYAL3
MEIOTIC CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0016344,0.685503355704698,0.966495577318169,0.661391707101897,0.8786293761088909,5106,1,FMN2
HEME CATABOLIC PROCESS%GOBP%GO:0042167,0.178330314506834,0.6837991059383349,-0.556499200352948,-1.27983190405659,1082,4,HMOX2|BLVRB|HMOX1|BLVRA
POSITIVE REGULATION OF HEPARAN SULFATE BINDING%GOBP%GO:1905855,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION%GOBP%GO:0040001,0.0242655262179249,0.327248680533432,0.43665085540157794,1.65077297088754,260,21,SAPCD2|NUMA1|DYNLT1|NDC80|CENPA|GPSM2|NUSAP1|CDK5RAP2|ESPL1|SPDL1
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION BY IRON%GOBP%GO:0045993,0.293128558188799,0.8004058897916541,-0.8533855315394799,-1.1415998450470901,2213,1,EIF2AK1
NEGATIVE REGULATION OF CYSTATHIONINE BETA-SYNTHASE ACTIVITY%GOBP%GO:1904042,0.245068184827221,0.757467559003634,-0.877040141155712,-1.1732433375537201,1850,1,MTRR
REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ORGANIZATION%GOBP%GO:0120035,0.0970873786407767,0.569923978730193,-0.124716156963012,-1.16793753398237,29,404,CX3CL1|BCAS3|PRKCD|DNM2|LPAR1|DAB2IP|TUBB2B|RTN4|NSMF|PTK2B|PDPN|AKIRIN1|PFN1|SRGAP2C|TCTEX1D2|ABL1|EPS8L1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|FYN|RHOA|SERPINI1|CCP110|NRP1|CPNE6|ATG3|TBC1D20|TBC1D8|SEMA7A|PTK7|YWHAH|TBC1D14|LYN|FCGR2B|PODXL|PRNP|CYLD|EFNA1|ULK4|KIF13B|POU4F2|HAP1|BAG5|ISLR2|ARC|SPOCK1|TBC1D19|RAP1A|RALA|LIMK1|AMIGO1|MARK4|TBC1D5|FMR1|TWF1|CDC42|C21orf91|NEDD4|SEMA6B|PLXNA1|TBC1D2|CHRNA3|SEPT9|RAPGEF1|ARPIN|SSH3|PLXNA4|TBC1D15|RELN|TWF2|ADCYAP1|HTT|COBL|NCS1|SYT2|RAB5A|FKBP4|MAP4|SDC2|FBXO7|KCTD17|STK24|MYLIP|RHOQ|ZNF365|SEMA3A|RAC1|CORO1C|SEMA3G|CPNE9|BRK1|OLFM1|GPRC5B|TBC1D1|CAV1|LINGO1|FOXO6|HOMER1|RTN4RL2
MITOTIC TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:1902990,0.674655616530407,0.9647315640607691,0.40205182624418395,0.851986225802914,6023,4,DNA2|ACD|RTEL1|PCNA
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0042590,0.8877837286406529,0.9972009232630479,-0.139346110503445,-0.6943891269777378,3480,27,HLA-F|CHUK|SEC22B|TAP1|IKBKG|CLEC4A|HLA-C|SNAP23|FCGR1A|HLA-B|PDIA3|HLA-A|ITGAV|HLA-E|VAMP8|IKBKB|LNPEP|CALR|IFI30|FCER1G|TAPBP|VAMP3|B2M|CD36
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002674,0.439367311072056,0.879896414106183,-0.361163364457214,-0.991369185088552,2499,6,FCGR2B|NLRP3|ADCYAP1
POSITIVE REGULATION OF GAMMA-AMINOBUTYRIC ACID SECRETION%GOBP%GO:0014054,0.0025155567324242,0.12586582153175,-0.9989523599470671,-1.3363290297033101,18,1,TRH
PEPTIDYL-METHIONINE MODIFICATION%GOBP%GO:0018206,0.5602836879432621,0.936434965680841,-0.267391184421029,-0.904624400004677,2843,10,NAA25|METAP1|NAA16|PDF|NAA15|METAP1D|METAP2|NAA30|NAA60|NAA20
METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0006346,0.12671821305841902,0.6076669536424699,0.5541099383700699,1.36275269508313,1179,6,SIRT1|MBD3|HELLS|MBD1
CELLULAR EXTRAVASATION%GOBP%GO:0045123,0.43959607189179206,0.879896414106183,0.266689502308463,1.02135893009813,4744,22,ITGB1|CD47|MADCAM1|ITGA4|AZU1|CCL2|AMICA1
NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000279,0.9305952690408109,1.0,-0.127360537230266,-0.6517995303611109,3579,29,GNL3L|HNRNPC|TP53|ACVRL1
NEGATIVE REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0007026,0.509094371964575,0.918404893008545,0.26839844863677,0.9627999539242421,5345,18,NAV3|CAMSAP3|FGF13|APC|TAOK1|APC2|CAMSAP2
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031346,0.6978422355854261,0.96731875442989,0.14055285304095003,0.8849667296278722,9863,219,TENM1|ENPP2|SYT17|RIT2|WASH1|PROM2|FAM150B|NAV3|RIMS2|LRRC7|VLDLR|ARAP1|INS|SYT3|DSCAM|PLXNC1|C15orf62|ZNF804A|MARK2|FNBP1L|CUX2|DVL1|ROBO2|UNC13A|SEMA5A|CPEB3|TENM2|CROCC|SRC|CCL21|F2RL1|ANLN|APC|MAP6|PTPRD|WRAP73|PLXNA3|GRIP1|DLG5|CAPRIN2|RUFY3|APOE|HRAS|P3H1|PALM|CCL19|PLXNB2|OBSL1|DPYSL3|SHTN1|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|LRP8|RAC2|PLXNA2|NTN1|CDC42EP1|CUL7|SLITRK1|DEF8|SYT1|MIEN1
NEGATIVE REGULATION OF INTERLEUKIN-6 SECRETION%GOBP%GO:1900165,0.6349871134020619,0.95916055221954,0.350279765388663,0.8614620696402021,5912,6,C1QTNF3|CD200|PTPN22
NUCLEAR MRNA SURVEILLANCE%GOBP%GO:0071028,0.33243411496161,0.8293509737209019,-0.28802474464351596,-1.08469568291564,1601,13,EXOSC6|PRPF18|EXOSC4|EXOSC9|EXOSC5
ORGANIC CATION TRANSPORT%GOBP%GO:0015695,0.22304868624420396,0.7355723797115551,0.36196022178530796,1.22726668032929,2308,15,SLC47A1|SLC25A29|SLC25A19|SLC25A42|SLC22A3
CARDIAC VENTRICLE MORPHOGENESIS%GOBP%GO:0003208,0.713278495887192,0.971081608033886,-0.14876493592826,-0.839370016905234,2427,39,SMAD7|TBX20|SFRP2|ZFPM2|RBPJ|FKBP1A
PYRIMIDINE NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0006206,0.9584035383319292,1.0,0.215416105516023,0.560682863709288,9100,7,CAD|CTPS2|CTPS1|DPYD
NEGATIVE REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048294,0.8838926174496641,0.996316041142784,0.559384649316277,0.7431175506981831,6584,1,NDFIP1
REGULATION OF SHELTERIN COMPLEX ASSEMBLY%GOBP%GO:1904790,0.7303058387395741,0.972554563883587,-0.629962505513895,-0.8427200510217091,5515,1,TERF1
POSITIVE REGULATION OF INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070105,0.524026845637584,0.92593403131991,0.7418945743273051,0.9855738437303159,3903,1,C1QTNF4
REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON DEATH%GOBP%GO:1903207,0.526262739388509,0.9265056012720759,0.452232539334771,0.9583239503533358,4698,4,NR4A3|PINK1|GNB2L1
METABOLISM BY HOST OF SUBSTANCE IN SYMBIONT%GOBP%GO:0052419,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0000289,0.870766319772942,0.9934031064448321,0.183735531629378,0.671581479684764,9203,19,ZCCHC11|TNKS1BP1|CNOT3|ZCCHC6|CNOT1|SAMD4B|CNOT2|CNOT8|PAN2|CNOT6|CNOT4|PAN3
NEGATIVE REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031280,0.731174089068826,0.9726603499749559,0.276110084785734,0.7879238415736279,7223,9,AKAP5|ADGRV1|PALM
POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905050,0.000823316318129425,0.0849637591935908,-0.8935642199305129,-2.0550110337358998,4,4,MBP|KARS|STAT3|DDRGK1
REGULATION OF RESPIRATORY GASEOUS EXCHANGE%GOBP%GO:0043576,0.23167649536647,0.744434191743215,0.46882226089719103,1.2202458455036398,2199,7,PASK|MTG1|TSHZ3|NLGN3|PHOX2B|NLGN2
POSITIVE REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:0010863,0.33097388332926503,0.8293509737209019,-0.227819903532961,-1.0920460469046,1355,24,LPAR1|C5AR1|GNAQ|FGF2|GNA15|FGFR1|EDNRA|FLT1
CARBOHYDRATE PHOSPHORYLATION%GOBP%GO:0046835,0.41973684210526296,0.8725068208993679,0.36292803813107793,1.03567261674245,4146,9,RBKS|GNPTAB|TKFC|GNPTG
REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048385,0.925851299617167,1.0,0.20317758040492104,0.59962953101162,9189,10,EZH2|CNOT1|SNW1|AKR1C3|CTBP2|CYP26B1|ASXL1|TRIM16|CALR|PRAME
CELL-CELL SIGNALING INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072204,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
INTEGRIN ACTIVATION%GOBP%GO:0033622,0.8866590412810649,0.996643473105967,0.238707423666065,0.650780478175722,8526,8,MZB1|FN1|ITGB1BP1|FERMT3|FERMT2|CXCL12|CX3CL1|COL16A1
NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0060457,0.5665161514414729,0.9388612723386429,0.492423092980304,0.9360444987905409,4892,3,PTGER3|HAMP
MORPHOGENESIS OF AN EPITHELIAL SHEET%GOBP%GO:0002011,0.19967400162999202,0.711592141628341,-0.227644141658416,-1.20516870827378,734,32,CD44|RLTPR|NOTCH1|PDPN|RHOA|ITGA5|RHOC|PDCD10|ADAM17|MMP12|TBX20|ACVRL1|TMEFF2
ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046633,0.17397060770554698,0.676682497340677,-0.9103992059991179,-1.21786877570411,1313,1,ELF4
PROTEIN DEUBIQUITINATION%GOBP%GO:0016579,0.0984393757503001,0.570215774831708,-0.13891040086006,-1.1928909237943701,81,229,SNX3|USP41|TAF10|HIF1A|PSME4|UBE2D1|C17orf96|STAMBP|OTUD5|TADA3|OTUD7A|USP31|PSMC4|USP45|INO80B|RUVBL1|NFKBIA|PSMD12|USP5|OTUD6B|TGFBR1|USP38|VCPIP1|ATXN7|FOXO4|USP10|TNFAIP3|ADRM1|ARRB2|ACTR5|JOSD2|WDR48|TOMM20|USP3|PSMA6|TRAF3|PSME3|RHOA|CCP110|JOSD1|INO80C|NEDD8|SMAD1|SMAD2|CYLD|BECN1|RAD23B|TNIP1|BAP1|SHMT2|KDM1B|SMAD7|USP27X|INO80E|ADRB2|NLRP3|UBA52|FOXK1|ACTR8|TP53|UCHL1|TADA2B|PARK2|TNIP2|PSMD6|TFPT|USP2|USP12|UBC|OTUD1|SPATA2|PSMF1|UBB
CELLULAR RESPONSE TO NUTRIENT%GOBP%GO:0031670,0.871343420449335,0.9934031064448321,0.170627955591828,0.671505942370794,9501,24,HSP90B1|CDKN2B|P2RY11|GATS|TRPV1|PDXP|P2RX3|TAF1|P2RX7|P2RX4|XBP1|SSH1
FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0035337,0.38849241748438895,0.8602318600740309,0.253086810385115,1.06117559409427,4354,30,HACD1|HSD17B4|SCD5|ELOVL6|DGAT1|FAR2|FAR1|SLC25A1|ACACA
NEGATIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903817,0.0228471001757469,0.31609926985007897,-0.641058301495202,-1.75966199368718,129,6,KCNE3|KCNE4|KCNAB1|SUMO1|CAV1
REGULATION OF LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0043016,0.48775321064477706,0.907808599852568,-0.7542456991618879,-1.00897746852744,3683,1,CD86
NEGATIVE REGULATION OF CELLULAR AMINE CATABOLIC PROCESS%GOBP%GO:0033242,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
SULFUR AMINO ACID TRANSPORT%GOBP%GO:0000101,0.57184455146153,0.9405604256499541,0.43706922615906,0.9261914412588599,5105,4,SLC7A9|SLC1A1|CTNS|SLC1A4
N-TERMINAL PEPTIDYL-SERINE DIMETHYLATION%GOBP%GO:0035572,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
GDP-FUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015783,0.760504825538233,0.977664504547119,-0.455086848635236,-0.778401681697971,5121,2,SLC35B4|SLC35C1
NEUROTRANSMITTER TRANSPORT%GOBP%GO:0006836,0.429815613966261,0.8780284177741771,0.18862001909523105,1.02958033238727,5477,90,SYT17|EDN1|SLC1A2|RIMS2|SLC36A1|GRM4|SLC25A22|UNC13B|SYT3|LIN7A|HBB|LIN7B|DVL1|UNC13A|PPFIA3|SLC6A17|SLC6A15|CPLX3|SLC6A9|PCLO|CASK|SNAP47|PRRT2|STX2|SLC6A2|BRSK1|SLC29A2|SLC1A3|SLC29A1|SYT1|SEPT5|RIMS4|RAB3A|SLC1A1|SLC38A1|SYT7|STX3|SNAPIN|PIP5K1C|STX1A|SLC18A2|RIMS1
STEROL CATABOLIC PROCESS%GOBP%GO:0016127,0.886490549828179,0.996643473105967,0.266615189454525,0.655701229701817,8254,6,APOE|CYP46A1|HSD3B7|TRERF1|SNX17|SCARF1
HEART VALVE FORMATION%GOBP%GO:0003188,0.39281530652089,0.8621064456029929,-0.32095729407355106,-1.0360789069421998,2011,9,EFNA1|TBX20|OLFM1
IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034755,0.7214484679665741,0.9713770803161691,-0.255983784739092,-0.795709060212164,3884,8,STEAP3
REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:1904505,0.323487824037706,0.8239107965478291,-0.5426271092974521,-1.10124559615973,2058,3,ERCC4|RTEL1|ERCC1
RENAL VESICLE DEVELOPMENT%GOBP%GO:0072087,0.663772143105245,0.964618776001639,0.458480948843475,0.871524053365971,5732,3,BMP4|SMO
BONE RESORPTION%GOBP%GO:0045453,0.6123631002527379,0.9508825506493929,0.3380665561351451,0.879916217796867,5814,7,SRC|IL7|ZNF675
CORTICAL MICROTUBULE ORGANIZATION%GOBP%GO:0043622,0.19272457312546398,0.7027916199946072,-0.7421560518334709,-1.26941817932546,1297,2,EZR|DLG1
LACTATE METABOLIC PROCESS%GOBP%GO:0006089,0.739377098529582,0.9744283926676119,0.429052065720365,0.8155828423512399,6385,3,D2HGDH
HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002455,0.0302976768836675,0.35738308321874895,0.37070672533124893,1.58501735175443,342,32,IGHV3-21|IGKV4-1|IGHV4-61|IGHG1|IGLL5|IGHG4|EXO1|IGHV1-18|IGHV3-43|IGKV3-11|ZP3|IGKV2D-28|IGKV2-28|IGHV1-24
CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048739,0.3985650410731,0.8638522656500329,0.3866822454400879,1.05419954153415,3832,8,IGSF22|TCAP|CXADR|OBSL1|MYOM2
MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS%GOBP%GO:0050891,0.5171083097504501,0.9229269218786791,-0.189365903811697,-0.957480557833149,2009,28,RAB11FIP2|PRKAR2A|PRKAR1B|ADCY2|MET|AQP1
POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045603,0.0831706364701289,0.5433486826752679,-0.4508015940002821,-1.4552279427324097,425,9,BTG1|ADD1|TMEM100|CDH5|ATOH8|PROC
PLASMA LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034369,0.19310278207109696,0.7033154110137328,0.37268643925462,1.2636351222567501,1998,15,LPL|ABCA5|AGTR1|SCARB1|CETP|APOE|APOC1|APOM|LCAT
PROTEIN NITROSYLATION%GOBP%GO:0017014,0.0933228593872741,0.5622489437340121,-0.7166648284989521,-1.4544499763914498,593,3,S100A9|S100A8|GAPDH
BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0050873,0.00518460329929301,0.16737273925846302,-0.873442152862027,-1.77262489812744,32,3,METRNL|PPARGC1A|ZNF516
NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031665,0.7293597304128051,0.972554563883587,0.301043563924993,0.7835531476088271,6925,7,SIGIRR|CACTIN|CARD16
NEGATIVE REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000619,0.10777791218096001,0.58452352834625,0.8005601124623192,1.30849351114685,890,2,SIRT1|PIH1D1
HOMOGENTISATE METABOLIC PROCESS%GOBP%GO:1901999,0.957852348993289,1.0,0.52348919276577,0.695432038080685,7135,1,FAH
NEGATIVE REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033239,0.485427301169109,0.9067242420344581,-0.4175865439565779,-0.960361814215372,2947,4,ITGAM|ATP2B4
HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070365,0.148725212464589,0.64074876264986,0.5732264615989829,1.32120201803431,1364,5,E2F8|PROX1|E2F7|PCK2|ANXA1
NEGATIVE REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051784,0.0292387391342524,0.350886057103154,0.365422401345836,1.58922387377081,332,34,KIF25|TPR|BMP4|FBXO43|CENPF|NAA10|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|KLHL22|PLK1|TEX14|CHEK1|RAD1|ATM
ENDOTHELIN MATURATION%GOBP%GO:0034959,0.625446842314312,0.954110852066186,-0.680359505955007,-0.9101376551034459,4723,1,ECE1
POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051582,0.241414835164835,0.754922787984297,-0.469550661069339,-1.18863631872931,1405,5,DRD2|PARK2
INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0042094,0.6582814775585861,0.9643779777660141,-0.66470004411116,-0.889189515541943,4971,1,IL18
DETECTION OF ENDOGENOUS STIMULUS%GOBP%GO:0009726,0.893915567920648,0.9976191001250191,0.439093763500682,0.717686693830548,7389,2,PKD2
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0070202,0.547056384742952,0.9305779599215391,-0.252248275862069,-0.9189657719737678,2638,12,WRAP53|SPIDR|CCT2|CCT5|DKC1|TERF1|CCT3|CCT8|CCT6A|CCT4|CCT7|TCP1
AUTOPHAGOSOME ASSEMBLY%GOBP%GO:0000045,0.0195623342175066,0.291866501780295,-0.25686604592289003,-1.5732394229255,58,52,RB1CC1|ATG13|MAP1LC3B2|ATG9B|MAP1LC3A|ATG101|ATG3|MFN2|ATG7|RAB1A|BECN1|GABARAPL1|GABARAP|RAB7A|WIPI2|MAP1LC3B|NSFL1C|GABARAPL2
NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010519,0.626280235345391,0.954674488895214,0.37911144453943896,0.873795679613647,5747,5,RGS2
GOLGI VESICLE PREFUSION COMPLEX STABILIZATION%GOBP%GO:0048213,0.61796585003712,0.953164984862134,-0.5143644885580371,-0.8797929100785992,4161,2,DNAJC28|COG4
SORBITOL CATABOLIC PROCESS%GOBP%GO:0006062,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:1904207,0.21037998146431897,0.7251658659797621,-0.893416409351566,-1.19515037082755,1588,1,MBP
REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001038,0.6919868276619101,0.96731875442989,-0.20284494121036897,-0.830718208508404,3151,16,TRAP1|PARK7|NUP93|TXN|STK26|PDE8A|HGF|MET
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0045741,0.144409682199901,0.634200145031176,-0.580021983428287,-1.33392939104836,876,4,FBXW7|ADAM17|ADRA2A
POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002842,0.8805369127516779,0.9956508825790341,0.560707984119982,0.744875541946754,6559,1,HSPD1
ENDOCARDIAL CUSHION CELL DIFFERENTIATION%GOBP%GO:0061443,0.880623608017817,0.9956508825790341,-0.39867659222497903,-0.6819149592483139,5930,2,JAG1|ACVR1
TRNA-TYPE INTRON SPLICE SITE RECOGNITION AND CLEAVAGE%GOBP%GO:0000379,0.7943730461965959,0.982128556779532,0.406855264825034,0.773389058865026,6860,3,TSEN54|TSEN34
"MITOCHONDRIAL ELECTRON TRANSPORT, SUCCINATE TO UBIQUINONE%GOBP%GO:0006121",0.5894944837806689,0.945418171231938,-0.383352412965492,-0.88163046469635,3579,4,SDHD|SDHAF2|SDHC
PROTEIN PALMITOYLATION%GOBP%GO:0018345,0.9154503381986469,1.0,0.148964020362299,0.629669846447525,10285,31,ZDHHC8|ZDHHC21|GOLGA7B|ZDHHC16|ZDHHC22|ABHD17A|ZDHHC15|ZDHHC17
REGULATION OF ABSCISIC ACID-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0009787,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032227",0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
PRIMARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0034309,0.5648965767509371,0.938057977295927,0.579930778572208,0.9478809259458258,4669,2,CACNA1H|PARK7
OPSONIZATION%GOBP%GO:0008228,0.5691275167785239,0.940076901516441,0.719838994265549,0.95627398958746,4239,1,C4B
INOSITOL TRISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0032957,0.17251423275519698,0.6760549476239499,-0.91106087340097,-1.2187539083616399,1302,1,ITPKB
MRNA TRANSCRIPTION%GOBP%GO:0009299,0.45450530035335707,0.88888312224279,-0.233675320279873,-0.9832788710268431,2057,17,ATF4|HIF1A|C5AR1|DDIT3|HSF1|TP53|SOX17
CARDIOVASCULAR SYSTEM DEVELOPMENT%GOBP%GO:0072358,0.354872881355932,0.842911430859438,-0.12257231199291499,-1.03799046636293,334,209,NCL|THY1|HAND1|RAMP3|LAMA5|NRARP|FBXW7|NOTCH1|AHR|LRP5|STRA6|VEGFA|ITGB8|KDR|CTNNB1|TGFBR1|PTK2B|HMOX1|PDPN|EIF2AK3|COL23A1|CALCRL|NRP1|ITGA5|AAMP|TCF7L2|CLIC4|APOD|FGF2|ADAMTS9|APLNR|SERPINF2|FOXC2|SMAD7|RAMP2|FGFR1|LEPR|CXCL8|ID1|ADM2|TBX20|NXN|SCG2|FLT1|MCAM|GREM1|MYH9|SFRP2|BMPER|ACVRL1|S1PR1|ADM|PGF|SOX17|CDH13|RBPJ|CAV1|EPHB2|ANGPT2|RAMP1
HARD PALATE DEVELOPMENT%GOBP%GO:0060022,0.9157950483251691,1.0,-0.540968239964711,-0.7236697085841569,6916,1,SOX11
NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010891,0.40350274725274704,0.865506967418479,-0.405276612088201,-1.0259308317499498,2349,5,ABHD5|PPARA|PPARG
DEFENSE RESPONSE TO TUMOR CELL%GOBP%GO:0002357,0.536005939123979,0.9265056012720759,-0.5473449459037729,-0.936204216048168,3609,2,RBMS3
FOLATE IMPORT INTO MITOCHONDRION%GOBP%GO:1904947,0.272606911161128,0.7881709245355171,-0.8634759594177329,-1.1550981180743998,2058,1,SLC25A32
NEGATIVE REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902268,0.336510067114094,0.8311444145897029,0.836292456991619,1.11097721946174,2506,1,OAZ3
TISSUE MORPHOGENESIS%GOBP%GO:0048729,0.10141766630316199,0.57169477469413,-0.14033945336357298,-1.19676747699833,92,215,CTNNB1|SKI|TGFBR1|KRT17|ACVR1|PDPN|DLC1|CELSR1|PRKD2|PRICKLE1|RET|RHOA|NRP1|ITGA5|BCL10|COL6A1|FGF2|PTK7|PODXL|MICAL2|SMAD2|TNNT2|SNAI1|PAX8|MYOM1|RHOC|PDCD10|WNT11|SMAD7|CDC42|NPNT|TRAF3IP1|MSN|CCDC103|ADAM17|COL21A1|CTSH|MMP12|TBX20|MKKS|NOS3|COBL|FGF10|SFRP2|ACVRL1|S1PR1|SLC9A3R1|TMEFF2|MET|SH3BP1|SOX17|ZFPM2|DNAAF1|BBS7|RBPJ|FKBP1A|STC1
CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT%GOBP%GO:0021894,0.24335560504825499,0.7565220534116759,-0.711000827129859,-1.2161288360370301,1638,2,LHX6|DRD2
POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905209,0.5589506779327961,0.936434965680841,0.292477548165839,0.9219937534090121,5688,12,EDN1|BMP4|TGFB2
NEGATIVE REGULATION OF CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:1901303,0.4437971666887329,0.881002146821428,-0.776521835024261,-1.03877693466422,3351,1,INSIG1
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048640,0.7877976190476189,0.9819233677232551,-0.138141551208758,-0.791661285487497,2646,41,CDKN1B|DCC|RNF6|WWC1|RTN4|GDF15|SEMA3F|SEMA7A|SEMA6B|CDKN1A|DUSP10|SEMA3A|SEMA3G|GAL
FEMALE SEX DETERMINATION%GOBP%GO:0030237,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
SPINDLE MIDZONE ASSEMBLY%GOBP%GO:0051255,0.0736842105263158,0.520821259294202,0.5150882764948329,1.46988594741223,727,9,KIF4A|MAP10|KIF23|AURKB|RACGAP1|CCDC69
KIDNEY RUDIMENT FORMATION%GOBP%GO:0072003,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
NEGATIVE REGULATION OF CHONDROCYTE DEVELOPMENT%GOBP%GO:0061182,0.0460329929300864,0.421305382128188,-0.7686665931399579,-1.55998601269009,292,3,PTHLH|FAM101B|FAM101A
MEMBRANE RAFT DISTRIBUTION%GOBP%GO:0031580,0.8661572305198572,0.9929671171385601,0.371316625979342,0.7058338449438449,7480,3,CD2|PTPRC
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000573,0.720557893868119,0.9713637233549571,0.166558004347701,0.826904518726162,8730,57,FGFR4|ATR|NVL|HMBOX1|RFC4|PNKP|PRKCQ|NEK2|AURKB|MAP3K4|DSCC1|TNKS2|MAP2K7|WRAP53|CHTF18|HNRNPA2B1
POSITIVE REGULATION OF ESTRADIOL SECRETION%GOBP%GO:2000866,0.8550244935787099,0.991298302704726,-0.570963828848699,-0.763795722392105,6457,1,SPP1
GLYCINE CATABOLIC PROCESS%GOBP%GO:0006546,0.12249443207127002,0.607607158836689,-0.7881444720154399,-1.34807890906447,824,2,AMT|GCSH
SKIN MORPHOGENESIS%GOBP%GO:0043589,0.728493689938636,0.972554563883587,0.433660527186501,0.8243430428064151,6291,3,COL1A1|COL1A2|ERRFI1
ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:0061760,0.13006711409396,0.612163182799301,0.936038817820909,1.2434858098228,968,1,RARRES2
CILIUM ORGANIZATION%GOBP%GO:0044782,0.389337641357028,0.8603316114971841,-0.114038175563371,-1.02463119856408,240,284,DYNLRB2|RAB8A|WDR19|MARK4|DNAI1|CETN2|SEPT10|TRAF3IP1|LRRC6|CCDC103|KIF3C|CC2D2A|DYNLRB1|SEPT9|KIF3B|TTC30A|ATP6V0D1|MKKS|DYNLL2|TMEM231|HAUS3|TTC30B|TUBB4B|YWHAE|ASAP1|ABCC4|DYX1C1|WDPCP|DNAL1|HAUS2|IQCG|INTU|CFAP20|RSPH1|CCDC113|ACTR2|B9D2|RILPL1|RSG1|DNAAF1|BBS7|CFAP61
GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION%GOBP%GO:0003418,0.7040879850591409,0.968941691852291,-0.216632297024654,-0.815833089804744,3392,13,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0006898,0.7697793124155531,0.9792758096555699,0.14079390321925,0.816571792419002,10254,125,GTF2H2|IGKV4-1|ITGB1|HPX|TFR2|COLEC11|CEACAM1|VLDLR|FCHO1|FCGR1B|HIP1R|ASGR1|HBB|AP2A2|DNM3|SCARB1|FNBP1L|HBA2|HSP90B1|DNAJC13|CTTN|CLTB|IGKV3-11|LDLRAP1|HBA1|APOE|IGKV2D-28|JCHAIN|IGKV2-28|STAB1|ADRBK2
NEGATIVE REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0031999,0.411757590419741,0.867015886388254,0.637772263578715,1.0424212441904201,3403,2,METTL20|AKT1
POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010898,0.9686233645941881,1.0,0.295389638390699,0.5615046287571259,8365,3,PNPLA2|APOC2
FOREBRAIN GENERATION OF NEURONS%GOBP%GO:0021872,0.43679182403910205,0.878651088001772,-0.233372479068153,-1.00391655459551,1965,18,DRD2|ASCL1|SLIT3
DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009120,0.9622252747252751,1.0,-0.22768574994677598,-0.5763713568787691,5603,5,DGUOK|DHFRL1|DERA
MAINTENANCE OF UNFOLDED PROTEIN%GOBP%GO:0036506,0.111497047585967,0.5855068018166539,0.70524980699239,1.34060569359756,962,3,USP13|BAG6|GET4
REGULATION OF SALIVA SECRETION%GOBP%GO:0046877,0.00326651818856719,0.137762274603971,-0.962999724290047,-1.64715945343189,21,2,FGF10|AQP1
BASEMENT MEMBRANE ORGANIZATION%GOBP%GO:0071711,0.814411247803163,0.986276922067025,-0.26520317265714805,-0.727964901853057,4633,6,CTSS|NID2|RAMP2
REGULATION OF BONE MINERALIZATION%GOBP%GO:0030500,0.949790437088359,1.0,0.12856043898008299,0.591680837247025,11103,42,CYR61|WNT4|BMP4|ADGRV1|DDR2|PKDCC
MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS%GOBP%GO:0044068,0.0491920152091255,0.435862257033585,-0.328945296454388,-1.52391816388109,206,22,CASP8|EIF2AK4|CD4|SERPINB9|SLC25A6|KPNB1|CCNK|KPNA1|BCL2L1|ATG7|TNIP1|GAPDH|KPNA4|PARK2
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HEAT STRESS%GOBP%GO:0061408,0.6258259603539029,0.9543682073609309,0.41849957390288106,0.8868405742624108,5587,4,HSF4|HSF2|HSFX1
POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0070474,0.437177280550775,0.878651088001772,-0.7793890604322891,-1.04261250951351,3301,1,GPER1
NEGATIVE REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060400,0.0827023014105419,0.5420718842622351,-0.8263027295285359,-1.41334656491507,556,2,GDF15|LEPROT
SKIN DEVELOPMENT%GOBP%GO:0043588,0.94780487804878,1.0,0.121174252793773,0.622308328065298,11657,67,KRT7|CDH3|KRT8|TMEM79|ABCB6|DHCR24|TGFB2|KRT19|APCDD1|PPL|ASPRV1|MED1|COL5A2|KRTAP5-1|STMN1|TGM1|COL5A1|CSTA|FGFR2|KRTAP5-2
REGULATION OF PROTEIN BINDING%GOBP%GO:0043393,0.0701402805611223,0.5090696843097849,-0.160777147270391,-1.27429261860511,104,140,PRKCD|NES|DAB2IP|STYX|ARRB2|HSPA5|FAM192A|ABL1|HDAC4|NRP1|HDAC5|TCF7L2|NMD3|AMFR|MMP9|PPP2CA|PPP2CB|RUVBL2|CRK|RIPK2|LRPAP1|LGALS3|STK4|GNL3L|ADRB2|HSF1|BCL2|DKK1|B2M|RALB|PARK2|MET|CD36|CAV1|FKBP1A|TRIB3
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GALACTOSE%GOBP%GO:0000431,0.758771349132795,0.977664504547119,-0.617390824878694,-0.825902530528672,5730,1,NCOA1
POSITIVE REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901896,0.00939597315436242,0.21235063347774397,0.9953683281870308,1.32230241746709,69,1,RYR2
METENCEPHALON DEVELOPMENT%GOBP%GO:0022037,0.0386566803575743,0.394693762886429,-0.334134897658034,-1.5700719427158099,159,23,TTBK2|CLP1|SDF4|DLL1|NLGN4X|FOXC1|OPHN1|AARS|ADCK4|FAIM2|FCGR2B|CBLN1|ZNF365|TRNP1|SCN5A
REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010984,0.205015923566879,0.7211951452265429,0.40908890604351295,1.24803647724506,2059,11,LDLRAP1|KHSRP|APOC1|LDLR|CNPY2|APOC2|HNRNPK|GPIHBP1|GPLD1
TRANSFORMATION OF HOST CELL BY VIRUS%GOBP%GO:0019087,0.896213808463252,0.9989028499632031,-0.38941273779983504,-0.6660696323944111,6035,2,HYAL2|INSR
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION%GOBP%GO:0050805,0.00117757889778615,0.09181648161563599,-0.508635272432323,-2.3101176398799197,4,21,NLGN4X|ACHE|SYT11|IL1B|MTMR2|SLC30A1|CBLN1|SNCA|FMR1|PNKD|DRD2|PARK2|PLK2
FATTY ACID BETA-OXIDATION%GOBP%GO:0006635,0.0343307620581504,0.378473112045903,0.328331701101016,1.5493241751163402,404,46,CROT|SLC27A2|ETFDH|HSD17B4|ACADVL|BDH2|ETFA|DECR2|AMACR|ACADM|DECR1|HADH|ETFB|ACOX2|ECHDC2|EHHADH|ACAD11|ACAD10|IVD|ECI1|ECI2|HADHB|ACAT2|HIBCH|ACADS|ECHS1|ACOX3|ACAA1|PEX2
OXIDATIVE DEMETHYLATION%GOBP%GO:0070989,0.103036437246964,0.5747344012283481,0.491619159792979,1.4029131071973702,1017,9,CYP2C8|TDG|CYP3A5|ALKBH3|ALKBH1|CYP2D6|FTO
POSITIVE REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1901980,0.7847213027935921,0.981487311948134,-0.6047088663431851,-0.808937487926047,5926,1,ALG10B
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0072431,0.7554653858893671,0.9771370084125129,0.16167288265464003,0.7985947859638929,9122,56,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
POSITIVE REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050729,0.25951557093425603,0.770912532778873,-0.16762349793179998,-1.1270731992698,674,71,IL1B|NFKBIA|CX3CL1|ITGAM|CEBPA|S100A8|CCL14|IL6|C2CD4A|TNIP1|ETS1|PLA2G2A|SNCA|KARS|TNFRSF11A|PDCD4|TICAM1|MYD88|CCL18|GPRC5B|TNF
MINUS-END-DIRECTED VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072382,0.571006711409396,0.9404752161333092,0.7189567710630791,0.955101995421745,4253,1,DYNC1H1
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033598,0.36674090571640705,0.8511205352535608,-0.638323683484974,-1.0918184741713002,2469,2,EPHA2|ID2
HOST-MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION%GOBP%GO:0048874,0.18013422818791897,0.6854786197196999,0.9116122629025141,1.2110362213595902,1341,1,NAPEPLD
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM%GOBP%GO:0022412,0.550384585502292,0.931421923167331,0.17230996250115302,0.9502308063151491,7083,95,HSPA2|ROPN1B|NANOS3|SERPINA5|CCNA1|ZCCHC11|CABYR|PYGO1|CELF1|PIWIL4|DEAF1|ROBO2|PCSK4|DZIP1|CASC5|YTHDC2|ZNF830|ZP3|DNAH1|BMPR1B|PIM2|CXADR|SRPK1|MYBL1|ING2|PEBP1|SPDYA|CEP57|KMT2D|TEX14|UBR2|SPIRE2|SPIRE1|ABHD2|C1orf111|FMN2|ZCCHC6|PIWIL2|PICK1|BBS2|NPM2|RNF8|MAST2|PRMT7
RESPONSE TO LIGHT STIMULUS%GOBP%GO:0009416,0.552191990663068,0.9321968967758479,0.158556078716217,0.956966594140932,7569,162,GTF2H2|PTPRK|SIRT1|UNC119|REV1|ATR|RGS14|RBM4B|SPRTN|MTA1|MAPK10|USP47|ST20|DDB2|DTL|POLD1|MEN1|PARP1|TMEM161A|FEN1|GEN1|INO80|AURKB|MSH6|DDB1|ZBTB1|NF1|CLOCK|GRIN1|STK11|MAP4K3|CIRBP|METTL3|PRIMPOL|MAP3K4|MC1R|MAP2K7|MFAP4|ZRANB3|NPHP4|CUL4B|CNGB1|BRSK1|KDM1A|CASP9|SLC24A1|CARD16|CAT|ERCC5|MAPK13
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0050774,0.0687170474516696,0.5037729184803449,-0.5530307208648171,-1.51803219547657,390,6,NGEF|GORASP1|PTEN|RAPGEF2|YWHAH|EFNA1
NEUROLIGIN CLUSTERING INVOLVED IN POSTSYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097118,0.801336302895323,0.9841161968820359,-0.437827405569341,-0.748880328690403,5396,2,NRXN2|NRXN1
CELLULAR RESPONSE TO FATTY ACID%GOBP%GO:0071398,0.767299578059072,0.9792236089291529,-0.19975499847742398,-0.773903746761578,3636,14,GNG2|PTGER2|ZC3H12A|AKR1C3|PTGER4|PID1|SFRP1|GNB1|AKR1C2|PDK3|PTGFR|DGAT2
POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150078,0.145193065405831,0.636290647310393,-0.39242814465163,-1.3276431519950702,736,10,IL18|IL33|ITGB2|IL1B|ITGAM|IL6|TNF
MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:0032042,0.015523678522303002,0.26480477175586303,0.547413319909723,1.725642411374,157,12,POLG|LONP1|TEFM|DNA2|PARP1|MGME1|PRIMPOL|POLG2
SERINE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009071,0.0057131599684791205,0.17352934538701598,-0.578348523203952,-1.9566396211969501,28,10,THNSL2|CSAD|AMT|GCSH|SDS|CBS|SDSL|SHMT2
EMBRYONIC LIMB MORPHOGENESIS%GOBP%GO:0030326,0.35754596759512103,0.845419584429298,0.270119886777432,1.08601133058786,3927,26,TBX3|TBX2|MYH3|ZNF358|TGFB2|LEF1|C5orf42|NIPBL
POSTREPLICATION REPAIR%GOBP%GO:0006301,0.6832298136645961,0.9663106118043521,0.176865638990568,0.8499188121629191,8139,50,FAAP20|REV1|SPRTN|POLE2|RFC4|REV3L|WDR33|DTL|POLD1|POLD3|POLN|ZBTB1
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051150,0.8008761070374251,0.9841161968820359,0.20501297189789103,0.735423326400403,8409,18,CTH|OLFM2|KIT|HEY2|FGF9|SRF
RESPONSE TO SUPEROXIDE%GOBP%GO:0000303,0.322375590265165,0.822751772025005,-0.37342224188541395,-1.0892892468177,1774,7,SOD1|SOD3|SOD2|NOS3
MYO-INOSITOL TRANSPORT%GOBP%GO:0015798,0.0140094940372815,0.2575041406786,0.838722193839172,1.59432266022522,120,3,SLC2A13|PGAP1
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS%GOBP%GO:0071322,0.7254146122814878,0.972554563883587,0.19459084585228198,0.80606081063586,8091,29,PRKAA2|UNC13B|AGER|ADCY8|ERN1
INTERMEDIATE MESODERM MORPHOGENESIS%GOBP%GO:0048390,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900450,0.0994803266518189,0.570215774831708,-0.8096498483595259,-1.38486270354675,669,2,CX3CL1|EPHB2
AXIS SPECIFICATION%GOBP%GO:0009798,0.293901879871619,0.8004058897916541,0.291477307113078,1.14710829836634,3204,24,RIPPLY2|SIX3|TBX3|BASP1|HOXD8|AHI1
POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071677,0.55168776371308,0.9321968967758479,-0.236978668895797,-0.9181181004677379,2614,14,LGALS3|ANO6|TNF
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY%GOBP%GO:1905599,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043114,0.0562097311708509,0.46132606014672706,-0.35200324880178896,-1.5142397687789,252,18,C2CD4A|YES1|RAMP2|BDKRB2|PDE3A|DDAH1
NEGATIVE REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051895,0.182150537634409,0.6875189360012,-0.31392243080719395,-1.2519506995676102,846,15,BCAS3|DLC1|APOD|ACVRL1|CORO1C
NEGATIVE REGULATION OF TRANSPOSITION%GOBP%GO:0010529,0.375193199381762,0.852871276063039,0.317891953377381,1.07784827957215,3883,15,ZCCHC11|ZNF93|PIWIL4|ZNF91|MYBL1|UBR2|ZCCHC6|PIWIL2|APOBEC3D|APOBEC3C
GOLGI DISASSEMBLY%GOBP%GO:0090166,0.5267396907216501,0.9265056012720759,0.384594700418318,0.9458546548568091,4904,6,CDK1|GBF1|VRK1
NUCLEAR POLYADENYLATION-DEPENDENT TRNA CATABOLIC PROCESS%GOBP%GO:0071038,0.372081043956044,0.852609194081082,-0.41611515552614203,-1.05336788474679,2166,5,EXOSC2|EXOSC3|EXOSC7|EXOSC8|EXOSC9
COFACTOR TRANSPORT%GOBP%GO:0051181,0.334167129886974,0.83026598101629,0.28981503394225605,1.10992435184511,3606,22,SLC25A29|CD320|SLC25A19|FLVCR1|FLVCR2|ABCB6|SLC25A42|SLC46A1|SLC5A6
REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048296,0.601366215120991,0.9506035145731909,0.479404792030189,0.9112980781582289,5193,3,THOC1|TGFB1|TNFSF13
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING%GOBP%GO:0086018,0.545652647635651,0.930420772651609,0.406546670434363,0.9370298082623671,5007,5,CACNA1G|CACNA1D|SCN3B
ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046631,0.983535762483131,1.0,0.12166222086334899,0.498891548547988,10931,28,INS|BLM|SLAMF6|RORA|LEF1
DITP CATABOLIC PROCESS%GOBP%GO:0035863,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0060350,0.518675298804781,0.9236324326350509,-0.194623691040693,-0.955659403405975,2082,26,MATN2|COCH|ANXA6|SCX|COL13A1|MEF2C|INPPL1|THBS3|BMPR2|ANXA2|COL7A1|SCARA3|COL14A1|FOXC1|COL6A2|VWA1|DLX5|COL6A1|COMP|COL21A1|STC1
ACROSOME ASSEMBLY%GOBP%GO:0001675,0.966177623474073,1.0,0.264751713314838,0.561034170915489,8626,4,CASC5|PAFAH1B1
UBIQUITIN-DEPENDENT ERAD PATHWAY%GOBP%GO:0030433,0.970031933185949,1.0,0.1133018042728,0.570760903223024,11846,61,SGTA|HSP90B1|DERL3|EDEM3|RNF121|SYVN1|AUP1|MAN1B1|UBXN4|TMUB1|JKAMP|VIMP|ANKZF1|PSMC6|BAG6|DNAJB9|NPLOC4|TMEM67|VCP|MARCH6
REGULATION OF ARGINASE ACTIVITY%GOBP%GO:0150070,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:0036364,0.463656825102608,0.8921382338742359,-0.767313630348478,-1.02645883851362,3501,1,NRROS
REGULATION OF SODIUM:PROTON ANTIPORTER ACTIVITY%GOBP%GO:0032415,0.280391483516484,0.788916642629372,-0.453150868037391,-1.1471213316712099,1632,5,TESC|CHP1|SLC9A3R1
CARDIAC MUSCLE THIN FILAMENT ASSEMBLY%GOBP%GO:0071691,0.114188943994194,0.5906506806283871,0.7952577888061759,1.29982700879424,943,2,NEB|NEBL
REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0055117,0.624668548456077,0.9539083292744209,0.19218282567642897,0.884493675525991,7302,42,RGS2|RYR2|TNNI3K|AKAP9|KCNQ1
CELLULAR RESPONSE TO EXOGENOUS DSRNA%GOBP%GO:0071360,0.14567337621913298,0.636418541205714,-0.34743863530360697,-1.3084472594824,701,13,MAVS|COLEC12|RALB|CAV1
B CELL RECEPTOR APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1990117,0.440354825896995,0.879896414106183,-0.7780657256285842,-1.04084224419845,3325,1,BAX
REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070432,0.277851699528245,0.7884684708511421,0.696277915632754,1.13804712522846,2296,2,ERBB2IP|PTPN22
ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006888,0.9364944961896701,1.0,-0.0932433461267656,-0.7688268318007879,1105,179,TRAPPC2L|TRAPPC6A|DCTN5|HYOU1|MPPE1|RANGRF|TMED4|TBC1D20|WHAMM|RAB30|NAPA|TMED7|RAB1A|ATL2|YKT6|COPA|RAB12|SERPINA1|LMAN2|PROC|SEC23IP|DYNLL2|TMED2|SEC23A|TRAPPC10|VAPB|RAB2A|IER3IP1|DYNC1LI1|VTI1A|BCAP31|ANKRD28
PURINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0006152,0.0358402971216342,0.382648509404771,-0.53132996274977,-1.6516048692424,192,8,PNP|HPRT1|NUDT18|ENPP4
TRANSITION BETWEEN FAST AND SLOW FIBER%GOBP%GO:0014883,0.16487238417805702,0.667429120754799,0.7558312655086851,1.23538543957445,1362,2,GTF2IRD2|GTF2IRD2B
MICROTUBULE-BASED TRANSPORT%GOBP%GO:0099111,0.0145602795573675,0.262734483145539,-0.19195832836042198,-1.4702144216228898,24,121,OPA1|IFT52|KIF5A|IFT27|DCTN1|IFT22|IFT88|TTC26|RABL2B|MAP1A|IFT57|HIF1A|BLOC1S1|HSPB1|SOD1|DYNC2H1|LOH12CR1|IFT46|IFT122|RAB21|BLOC1S5|WDR35|IFT172|RPGR|BLOC1S4|RAB6A|HAP1|RAB1A|DYNLRB2|WDR19|AP3S2|FMR1|CDC42|TRAF3IP1|BLOC1S6|BAG3|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B|TRAK1|HTT|BLOC1S3|KIF13A|BICD1|TMEM108|UBB
"NUCLEOTIDE-EXCISION REPAIR, PREINCISION COMPLEX ASSEMBLY%GOBP%GO:0006294",0.7878978036754821,0.9819233677232551,0.182704313941784,0.75682279275552,8788,29,GTF2H2|GTF2H1|DDB2|PARP1|DDB1|CHD1L|CDK7|CUL4B|ERCC5|XPA|RBX1
REGULATION OF RENAL OUTPUT BY ANGIOTENSIN%GOBP%GO:0002019,0.184409799554566,0.6906809521658801,-0.746512269092914,-1.27686925564366,1241,2,AGT|ACE
MAINTENANCE OF PROTEIN LOCATION IN CELL%GOBP%GO:0032507,0.392482833393567,0.8621064456029929,-0.161700721757469,-1.0424710106025301,1085,62,HSPA5|OS9|FLNB|PML|SUPT7L|TMSB10|ARL2BP|TMSB4X|TWF1|HK1|HK2|BCL3|RANGAP1|TWF2|TAF8|CAV1
POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070234,0.9151502547572009,1.0,0.22642234154874302,0.617288048439131,8800,8,IDO1|CCL5
OSMOSENSORY SIGNALING PATHWAY%GOBP%GO:0007231,0.40103934669636204,0.8638522656500329,-0.6139369193741179,-1.05010622023122,2700,2,OXSR1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN-ANGIOTENSIN%GOBP%GO:0003081,0.47970843183609096,0.9046812288131709,-0.285093343324954,-0.964513453235524,2434,10,PCSK5|CTSZ|AGT|ATP6AP2|SERPINF2|ACE
CELL DEDIFFERENTIATION%GOBP%GO:0043697,0.43788556913027704,0.878999860395433,0.627736421284808,1.02601793566174,3619,2,CDK6|NCOA3
PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0006244,0.859766277128548,0.9916689277956879,0.209073657591605,0.67475840604051,8754,13,TDG|MBD4|DUT|NEIL1|NTHL1|UNG|NT5M
REGULATION OF CILIUM MOVEMENT INVOLVED IN CELL MOTILITY%GOBP%GO:0060295,0.387019230769231,0.859991269020751,-0.41067822950686894,-1.03960466755946,2253,5,MKKS|CFAP20
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003073,0.133538633818589,0.6194479383419461,-0.233650600666168,-1.2852867242806598,476,36,ADRA1B|ATP6AP2|SOD2|SERPINF2|ADRB2|NOS3|DRD2|ACE|ADM|PDE4D|DDAH1
N-TERMINAL PEPTIDYL-PROLINE METHYLATION%GOBP%GO:0035568,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032103,0.043581616481775,0.41172569911846796,-0.16129759552196898,-1.3138895397338501,54,167,IL1B|VEGFA|KDR|NFKBIA|CX3CL1|TUBB2B|USF1|LGALS9|PTK2B|ITGAM|AKIRIN1|PRKD2|CEBPA|ADAM10|CAMK1D|S100A8|CCL14|ZNF580|NRP1|C1QBP|FGF2|IL6|C2CD4A|SERPINF2|TNIP1|ETS1|TMSB4X|PLA2G2A|SNCA|KARS|FGFR1|TNFRSF11A|PDCD4|ADAM17|THBD|CXCL8|PRKCA|ANO6|SCG2|OXSR1|THBS4|RAC1|TICAM1|MET|MYD88|CCL18|PGF|GPRC5B|CDH13|TNF
PROTEIN SECRETION BY PLATELET%GOBP%GO:0070560,0.353377876763177,0.842847021021096,-0.6472566859663629,-1.1070978964947,2379,2,DMTN|PLEK
REGULATION OF SYNAPSE STRUCTURAL PLASTICITY%GOBP%GO:0051823,0.82088688201922,0.987153241368501,0.39494871512076796,0.75075596039923,7089,3,CAMK1|CAMK2B|CTNNA2
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901017,0.0821513002364066,0.539994451302385,-0.433075816446998,-1.4651603098216799,416,10,NEDD4L|KCNE3|KCNE4|KCNAB1|SUMO1|CAB39|CAV1
OXALOACETATE METABOLIC PROCESS%GOBP%GO:0006107,0.451506668862177,0.886411023801201,-0.429440234963301,-0.9876228272080441,2741,4,MDH1B|ACLY
REGULATION OF PROTEIN ADP-RIBOSYLATION%GOBP%GO:0010835,0.7108256107834878,0.97016506841811,0.30631793936227003,0.7972812387251641,6749,7,PNKP|KIAA0020|XRCC1|KAT2B|TINF2|C4orf27
AMP PHOSPHORYLATION%GOBP%GO:0006756,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
GLUCURONOSIDE METABOLIC PROCESS%GOBP%GO:0019389,0.707995645336882,0.9695170059473192,0.5253530165157729,0.8586750732034141,5852,2,ABHD10|GUSB
REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030856,0.312739831158864,0.8155492679436609,-0.163029237444142,-1.0892605830971198,814,70,ZEB1|PRKCH|ADD1|IL1B|CTSL|CTNNB1|TMEM100|LIF|CTSK|NKX6-1|RUNX1|CDH5|MAFF|PAX8|FOXJ2|ATOH8|PROC|CTSV|CBFB|TNF|CAV1
CARBON CATABOLITE ACTIVATION OF TRANSCRIPTION%GOBP%GO:0045991,0.33369992144540506,0.8295413387957591,-0.537222896217051,-1.09027790627928,2123,3,USF2|NCOA1|USF1
BLOOD VESSEL REMODELING%GOBP%GO:0001974,0.05759468957438501,0.46802043868566706,-0.477774911950178,-1.54230023021166,294,9,NOS3|ACVRL1|ACE
POSITIVE REGULATION OF GLUTATHIONE PEROXIDASE ACTIVITY%GOBP%GO:1903284,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
UBIQUINONE BIOSYNTHETIC PROCESS%GOBP%GO:0006744,0.28419629057186996,0.79342123536088,0.342519365739083,1.1613502800548898,2941,15,FDXR|COQ3|COQ2|COQ6|COQ9|COQ5|PDSS1
EMBRYONIC BRAIN DEVELOPMENT%GOBP%GO:1990403,0.7187680907722591,0.971081608033886,0.43757582441822,0.831785610970105,6207,3,RNF112|RPL10|TBC1D23
TRANSCYTOSIS%GOBP%GO:0045056,0.9666935809446908,1.0,-0.16070109272261499,-0.5655271669253621,4788,11,LRPAP1|RAB5A
POSITIVE REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050671,0.8430759361719191,0.991298302704726,0.14147492920178,0.742562288142543,10513,74,CD209|CD38|AGER|CD320|BLM|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|IL7|CCL19|TMIGD2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|HLA-DMB|IGFBP2|CD3E|CD46
MONOVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0015672,0.12431444241316301,0.607607158836689,0.210613452089757,1.2611568626962701,1699,153,KCNK2|KCNN2|SCN1A|KCNK6|KCNH8|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|NDUFS7|KCNQ1|SLC9A5|SLC9A7|SLC36A1|SLC8A3|ATP1B3|KCNH1|ATP5G1|LRRC55|PKD2|KCNC3|KCNC1|KCND1|KCNB2|FGF13|KLHL3|HCN3|ATP5D|NNT
GUANOSINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:1901068,0.21210641933121802,0.727709540947015,-0.25040784574117897,-1.20032048918846,868,24,MOCS3|GMPS|GTPBP1|HPRT1|EFTUD1|NUDT18|RHOQ|AK4
POSITIVE REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051770,0.86632764257174,0.9929671171385601,-0.23480763343525898,-0.6849442841977911,4769,7,KDR|NAMPT|FCER2
POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS%GOBP%GO:0031331,0.0028694404591104697,0.13103871184697197,-0.16827817570726503,-1.48136141533255,1,260,HIF1A|TRIM8|ITCH|BAX|FLCN|FBXW7|GNAI3|FURIN|CBFA2T3|IL1B|CLU|METTL16|PTTG1IP|TRIM13|KDR|MTDH|PLK3|USP5|PRKCD|DAB2IP|TRIB1|PRKAA1|PFKFB4|ARIH1|PRICKLE1|CEBPA|GTPBP1|STUB1|ABHD5|TNFRSF1B|PPARA|VPS11|FOXO1|RNF139|MFN2|SH3BP4|GLTSCR2|TRIB2|DHRSX|SUMO1|SH3GLB1|ECSCR|RNF144B|PIP4K2A|IGF1|UQCC2|CNOT7|PTPN1|SMAD7|SNCA|FMR1|MSN|AGO2|BAG3|HK2|ADRB2|PAFAH1B2|PLEKHF1|TFEB|SOCS5|RALB|HTT|ARIH2|ZC3HAV1|PARK2|SPTLC1|BNIP3L|ADRA2A|HSPBP1|FBXO7|AAED1|PABPC1|TICAM1|DDRGK1|HSPB8|BCAP31|SESN2|TWIST1|PLK2|TNF|BBS7|RBM24|CAV1|TRIB3
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010596,0.04212076583210601,0.40376460791238894,-0.26150620263803603,-1.4872136045163602,142,40,MMRN2|RHOA|HDAC5|FGF2|MAP2K5|ADAMTS9|PPARG|MEOX2|PDCD10|PTPRM|ACVRL1|STC1|ANGPT2
LAMELLIPODIUM ORGANIZATION%GOBP%GO:0097581,0.471054068814855,0.898051355931307,0.247803934660262,0.996290513874828,5174,26,ITGB1|ARFIP2|PTPRO|CTTN|ARHGEF6|ABLIM1|KIT|ARHGEF4
SULFUR AMINO ACID CATABOLIC PROCESS%GOBP%GO:0000098,0.302711731184909,0.8054013181463249,0.36358766320238106,1.14615824835586,3080,12,CTH|TST|PCYOX1L|CDO1|TXN2|ADO
GENERATION OF PRECURSOR METABOLITES AND ENERGY%GOBP%GO:0006091,0.377720870678617,0.85375124052253,-0.11976174002120402,-1.0393510845988,294,240,PFKL|COX5B|RB1CC1|CEBPA|GPI|NDUFB10|SDHC|UQCRC1|ME2|OGDHL|MDH1B|SLC27A5|ALDH1B1|PKM|SLC25A4|ENO1|MT-ND5|ATP5I|GCGR|COX4I1|GFPT2|PDHB|GAPDH|PGK1|XYLB|LEPR|NDUFB9|CYC1|HK1|FAHD1|PPARGC1A|HK2|TPI1|GIPR|PYGB|NDUFA9|OGDH|BDH1|NDUFS1|CYB561|NDUFV3|ACOX1|NDUFS5|ALDOA|MCHR1|COX10|SLC25A13|PER2|SLC25A18|OXCT1|NR1D1|COX4I2|NDUFS6|FASTKD5|PGAM2
CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060038,0.7742188374958001,0.980173768720877,0.363250553573205,0.769762622522428,6912,4,TGFB2|C3orf58|NDRG4|TGFBR3
POSITIVE REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035549,0.9445626609922719,1.0,0.281772496688008,0.597102836793178,8433,4,DHX9|DDX58|IFIH1
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903364,0.0390361445783133,0.396089810860281,-0.187276342852403,-1.3640251198858797,80,98,HSP90AA1|PSMD10|EDEM1|GBA|RNF217|RAD23A|EZR|CSNK1D|CSNK1A1|AMER1|RNF19B|FBXW7|CBFA2T3|CLU|PTTG1IP|PLK3|USP5|DAB2IP|TRIB1|ARIH1|PRICKLE1|CEBPA|STUB1|VPS11|RNF139|GLTSCR2|TRIB2|SUMO1|ECSCR|RNF144B|UQCC2|SMAD7|FMR1|MSN|SOCS5|ARIH2|PARK2|HSPBP1|DDRGK1|BCAP31|BBS7|CAV1|TRIB3
REGULATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106118,0.9242698371672271,1.0,0.13905230826151702,0.6309045454626071,10727,40,TM7SF2|NFYB|ELOVL6|GPAM|MVD|APOE|ACACA|SREBF2|GGPS1|IDI1|HMGCR|DHCR7
REGULATION OF PLATELET-DERIVED GROWTH FACTOR PRODUCTION%GOBP%GO:0090361,0.421476510067114,0.873054719602436,0.7958204675782969,1.0572119871096,3139,1,PTGS2
BMP SIGNALING PATHWAY INVOLVED IN RENAL SYSTEM SEGMENTATION%GOBP%GO:0061151,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
ASPARTATE BIOSYNTHETIC PROCESS%GOBP%GO:0006532,0.950469798657718,1.0,0.526962946625496,0.7000467651081851,7080,1,GOT1
REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:0039533,0.596112542955327,0.948188586760759,0.36277105247591795,0.8921825710506031,5550,6,ANKRD17|TKFC|DHX58|DDX60
GLIAL CELL MIGRATION%GOBP%GO:0008347,0.9602906050955409,1.0,0.17738367014286302,0.541156916101634,9648,11,TGFB2|AZU1|CCL2
CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099622,0.315482998856192,0.8169998348799691,0.4147864362302329,1.1308191055186299,3033,8,KCNN2|KCNQ1|KCNH2
WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003306,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051090,0.0107142857142857,0.225852279407131,-0.148930292938922,-1.3432578980933,5,298,DHX33|MAD2L2|S100A9|SMAD3|BHLHE40|HAVCR2|C14orf39|GAS6|RHEBL1|PSMD10|PARK7|CYP1B1|TRIM62|RELA|CEBPG|TRAF6|OTULIN|SIK1|PRMT2|EIF2AK2|AGT|UBE2N|ARHGEF5|NTRK1|SETD6|PYCARD|HAND1|TRIM8|PHB2|NFKBIE|ITCH|NOD1|ID2|FZD1|BEX1|PRKCH|IL1B|CLU|IRAK1|VEGFA|TRIM13|PIM1|MTDH|NFKBIA|CX3CL1|BUD31|CTNNB1|DAB2IP|TRIB1|LGALS9|IRAK2|HMOX1|TNFAIP3|ARRB2|PRKD2|IRAK4|HDAC4|PSMA6|CRTC2|NFAM1|MAP3K13|RPS3|TRAF3|CAMK1D|S100A8|SPHK1|COMMD7|HDAC5|TCF7L2|BCL10|NKX6-1|MXI1|UBE2V1|MAP2K5|PPAP2B|DDIT3|IL6|PPARG|PRNP|ARRB1|CHP1|CYLD|SUMO1|RNF31|CAMK2A|G3BP2|POU4F2|MAVS|RIPK2|TMSB4X|KDM5A|ARID5B|NPM1|SMAD7|ARHGEF2|TNFRSF11A|PPARGC1A|TRIM25|MTPN|NLRP3|JUN|UBA52|ID1|CFLAR|STAT3|RELN|COMMD1|TNFRSF4|RBCK1|MAPK3|TAX1BP1|EDA2R|MYD88|DDRGK1|UBC|CD36|JMY|TNF|UBB
POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901098,0.832245879120879,0.9879452371959629,-0.28171189058019,-0.713134944371983,4846,5,CALCOCO2|FYCO1|UVRAG|SMCR8|ADRB2
REGULATION OF CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:2000606,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
GLOMERULAR EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072311,0.654039895224663,0.9640743070248079,0.286977208679549,0.8469438838113751,6491,10,BASP1|PTPRO|MAGI2
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1901800,0.0361024844720497,0.38395931615660706,-0.213371253954869,-1.44098051370592,92,72,PSMD10|EDEM1|RNF217|RAD23A|CSNK1D|CSNK1A1|RNF19B|FBXW7|CBFA2T3|CLU|PLK3|USP5|DAB2IP|TRIB1|ARIH1|PRICKLE1|CEBPA|STUB1|GLTSCR2|TRIB2|SUMO1|ECSCR|RNF144B|SMAD7|FMR1|SOCS5|ARIH2|PARK2|HSPBP1|DDRGK1|BCAP31|BBS7|CAV1|TRIB3
PARATHYROID GLAND DEVELOPMENT%GOBP%GO:0060017,0.326503340757238,0.826792328177465,-0.664074993107251,-1.1358647101282802,2198,2,TBX1|TGFBR1
VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014829,0.7424275441272611,0.974505008828563,0.340351021758169,0.7844586510060899,6813,5,EDN1|SLC8A1|PIK3C2A|EDNRB
RESPONSE TO HISTAMINE%GOBP%GO:0034776,0.0632688927943761,0.492154125677625,-0.5605693639057651,-1.5387252644411102,359,6,GABRG2|DRD2|HRH1
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045715,0.373422420193022,0.852609194081082,-0.63330576233802,-1.0832355887921,2514,2,ITGB3|ITGAV
ETHER BIOSYNTHETIC PROCESS%GOBP%GO:1901503,0.610061813186813,0.9508825506493929,-0.34434198614274303,-0.8716788724363179,3552,5,DHRS7B|PEX7
POSITIVE REGULATION OF HORMONE SECRETION%GOBP%GO:0046887,0.5268826251577621,0.9265056012720759,0.19997166083871104,0.956465205858245,6261,49,CARTPT|EDN1|GHRL|TFR2|INHA|INS|ADCY8
POSITIVE REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903527,0.0147682639434407,0.264001457476971,-0.8330208448218821,-1.6905910544297702,93,3,PLEKHM2|SH3GLB1|ASAP1
NEUTRAL LIPID CATABOLIC PROCESS%GOBP%GO:0046461,0.52733771251932,0.9265056012720759,0.279770780855587,0.948594173636636,5458,15,LPL|FABP5|FABP6|PNPLA2|APOE|ABHD16A|ABHD2|DAGLA
L-ASCORBIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0015882,0.796510067114094,0.9828629179253789,0.602999558888399,0.80105801226568,5933,1,SLC23A2
REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031056,0.957908728400532,1.0,-0.09531809434577199,-0.683966790703886,2161,90,BRD7|CHTOP|NOC2L|UBE2N|RNF20|CAMK2D|SPI1|FLCN|IL1B|VEGFA|SIN3A|CDK9|CTNNB1|WBP2|WDR70|PRKD2|LIF|CTBP1|HDAC5|TRIP12|ARRB1|RUVBL2|KDM5A|SNCA|FMR1|PPARGC1A|TADA2B|MAPK3|IGF2|TWIST1
N-ACETYLNEURAMINATE CATABOLIC PROCESS%GOBP%GO:0019262,0.569802405498282,0.940264810428163,0.37074623572886206,0.911796372787673,5305,6,AMDHD2|NPL|RENBP|GNPDA1|GNPDA2|NAGK
ASYMMETRIC CELL DIVISION%GOBP%GO:0008356,0.6001410437235539,0.9503412745667059,0.30228870543464803,0.89213206648413,5956,10,RGS14|FGF13|DOCK7|SOX5|ING2
CARDIOBLAST ANTERIOR-LATERAL MIGRATION%GOBP%GO:0003259,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
"POSITIVE REGULATION OF ACTIVATED CD8-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905404",0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042531,0.35118273979724496,0.842847021021096,-0.208323404049971,-1.06614733162991,1350,29,IL6R|SOCS3|VEGFA|CRLF1|LIF|ARL2BP|TNFRSF18|IL6|LYN|IGF1|STAT3|TNF
NEGATIVE REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:2000360,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
MEIOTIC DNA DOUBLE-STRAND BREAK PROCESSING INVOLVED IN RECIPROCAL MEIOTIC RECOMBINATION%GOBP%GO:0010705,0.433047054554252,0.878651088001772,0.629152883934588,1.0283331049503,3579,2,BLM|C14orf39
PHOSPHATIDIC ACID METABOLIC PROCESS%GOBP%GO:0046473,0.4380274261603379,0.878999860395433,-0.19370591790504002,-1.0049525098402,1660,30,ABHD5|DGKQ|PLD6|PLA2G2A|AGPAT3|LPCAT1|GPAT2|PLD2
POSITIVE REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903435,0.6923076923076921,0.96731875442989,-0.648599470666079,-0.8676512875420891,5228,1,RAB27A
N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018076,0.67541241162608,0.9647315640607691,-0.4099481636704529,-0.831977618074335,4298,3,KAT2B|EP300|CREBBP
CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048738,0.88369431957499,0.996316041142784,0.137375283135007,0.694605245777432,10811,62,RYR2|NEB|IGSF22|MYLK2|TBX2|MAML1|PROX1|TCAP|TGFB2|TAZ|NEBL|HEY2|CXADR|OBSL1|TNNI3|NRG1|SLC8A1|MYOM2|FGFR2
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:1902817,0.269636228656273,0.784543299601953,-0.6969396195202651,-1.19207789349093,1815,2,TTBK2|MAP1A
UNCOATING OF VIRUS%GOBP%GO:0019061,0.673374817953131,0.9647315640607691,-0.658524481693869,-0.880928277405013,5085,1,PPIA
NEGATIVE REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046603,0.0193288590604027,0.289864965388082,0.991012351124835,1.3165156962738702,143,1,KIF25
HEART CONTRACTION%GOBP%GO:0060047,0.0486564380774773,0.434393138005985,0.316789587705682,1.49485951253469,573,46,RYR2|KCNN2|SCN1A|CACNA1G|GAA|CACNB2|FGF12|MYLK2|KCNQ1|TCAP|CACNA2D1|TAZ|KCNH2|CACNA1D
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0003229,0.41225286795215993,0.867015886388254,-0.21495810975652602,-1.0303935273844,1688,24,ADAMTS9|TNNT2|SMAD7|ZFPM2|RBPJ|FKBP1A
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009182,0.123487824037706,0.607607158836689,-0.6864453512738499,-1.3931204452232098,785,3,AK5|AK9|NUDT18
MAMMARY GLAND MORPHOGENESIS%GOBP%GO:0060443,0.240335806325654,0.7525432574322471,-0.367166652361271,-1.18524685641485,1230,9,FGF10|CAV1
REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060765,0.489301648001457,0.908938677284213,0.24538233619616895,0.977813311415874,5373,25,SAFB2|SIRT1|KDM5D|TRIM68|HEYL|HDAC6|RNF14|SMARCA4|DAB2|DDX5|TAF1|NCOR1
REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051890,0.8240129674655551,0.9876441563834109,0.393241003767261,0.747509780760706,7116,3,TGFB2|DHX36
REGULATION OF EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:1903551,0.922787800687285,1.0,0.24979317191550401,0.614329927455426,8592,6,TSG101|SDC4|STAM|SDC1|SDCBP|PDCD6IP
ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:0097695,0.36663844199830703,0.8510019955058101,0.657678522194651,1.07495747704125,3030,2,ATR|ATM
NEGATIVE REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902100,0.0646168401135289,0.495456803258629,0.4056776926465,1.48281403540498,682,19,TPR|CENPF|BUB1|CDC20|APC|FBXO5|BUB1B|KLHL22|PLK1|TEX14|ATM
PURINE-CONTAINING COMPOUND SALVAGE%GOBP%GO:0043101,0.624403403195684,0.9537930378808901,-0.23152854463435002,-0.8719320735704541,3008,13,AMPD3|GMPR2|GMPR|ADK|AMPD2|DGUOK|ADA|APRT|PNP|HPRT1
IMP SALVAGE%GOBP%GO:0032264,0.21580828809744498,0.7322272196643679,-0.8911557123952359,-1.19212616758099,1629,1,HPRT1
ESTABLISHMENT OF SPINDLE ORIENTATION%GOBP%GO:0051294,0.0828237909949972,0.5420718842622351,0.37265894307079606,1.42719730657433,893,22,KIF25|SAPCD2|NUMA1|DYNLT1|NDC80|CENPA|GPSM2|CDK5RAP2|SPDL1
TOOTH MINERALIZATION%GOBP%GO:0034505,0.30494505494505497,0.808356844223606,-0.44246516328321206,-1.1200711796533,1775,5,TBX1|STIM1|FAM20A|FAM20C
REGULATION OF MICROTUBULE-BASED PROCESS%GOBP%GO:0032886,0.269822744182654,0.7846089815823771,0.187175808552724,1.1297012228516599,3698,162,KIF25|AKAP9|NAV3|CLIP1|CAMSAP3|PRKAA2|GNAI1|KAT2A|CENPJ|TPR|FSD1|PSRC1|XRCC3|CEP85|SPAG5|BORA|KLHL42|CEP295|CCSAP|MARK2|FGF13|CDK2AP2|CEP131|NUMA1|CDK5R1|MAP10|KIF11|NEK2|STIL|GEN1|APC|MAP6|GPSM2|CDK5RAP2|SKA3|TRIM37|TRIM46|HDAC6|TAOK1|SKA2|STMN1|FBXW5|CCNF|MACF1|CEP97|PLK1|FAM179B|SKA1|APC2|CAMSAP2|CLTC|TBCD|AURKA|DYNC1H1|EFNA5|TUBB4A|MDM1|PRUNE
NEGATIVE REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:2000536,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
MITOTIC NUCLEAR ENVELOPE REASSEMBLY%GOBP%GO:0007084,0.705593897566291,0.968941691852291,-0.27760617760617795,-0.8097895363430541,3884,7,VRK1|ANKLE2|REEP3|REEP4|EMD|BANF1|LMNA
CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006695,0.18350515463917497,0.689876118998471,0.304210774130532,1.2601434673138001,2046,29,TM7SF2|EBP|MVD|LBR|DHCR24|PPAPDC2|APOE|NSDHL|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7
GAS TRANSPORT%GOBP%GO:0015669,0.558031569173631,0.936434965680841,-0.29197012349588203,-0.907570269787713,3004,8,AQP5|AQP1
REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031396,0.0209840810419682,0.304839794856171,-0.17548387177023902,-1.39780869221711,28,149,APITD1|DCUN1D2|ISG15|MAGEC2|WFS1|SPOPL|MAD2L2|CUL3|HSP90AA1|PSMD10|PARK7|SASH1|RPL11|TRAF6|NDFIP2|UBE2N|RNF20|AMER1|NDNL2|SENP2|DCUN1D5|BMI1|UBE2D1|FBXW7|VPS28|PINX1|PTTG1IP|ZER1|CDK9|MAGEA2|TGFBR1|WDR70|ARRDC3|TNFAIP3|ARRB2|PRICKLE1|ABL1|DCUN1D3|RPS3|SPHK1|STUB1|TRIP12|BCL10|ARRB1|CHP1|RAB1A|BAG5|RIPK2|LIMK1|PRMT3|SMAD7|GNL3L|ADRB2|NXN|COMMD1|UBE2L3|TSPYL5|PARK2|HSPBP1|PER2|HSP90AB1|CAV1|FKBP1A|TRIB3|UBB
CELLULAR RESPONSE TO XENOBIOTIC STIMULUS%GOBP%GO:0071466,0.00023967404330111098,0.0784645998831315,0.38766345370814204,2.04250117250978,2,75,RYR2|DPEP1|AKR7A3|CYP2D7|CRYZ|MGST1|CYP2C8|GSTA4|GSTO2|CRHBP|AS3MT|AKR7L|CYP3A5|ACY1|GGT1|ADCY8|PDE2A|POR|CYP2R1|N6AMT1|BCHE|EPHX1|RORA|ARNT2|SULT1A3|AOC2|AKR1C1|CDO1|NAT1|MGST3|NQO2|GRIN1|GSTP1|MGST2
PROTEASOME ASSEMBLY%GOBP%GO:0043248,0.7787619426751591,0.9814327553627009,0.245393255447647,0.748638571088516,7824,11,PSMD11|PSMD13
POSITIVE REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032730,0.8997315436241609,0.998912093067348,0.551720335244817,0.73293585138354,6702,1,ISL1
NEGATIVE REGULATION OF AUTOPHAGY%GOBP%GO:0010507,0.4892110586648689,0.908887630979233,-0.15881429467334301,-0.9850924745927541,1450,54,EIF4G1|HGF|TBC1D14|ATG7|SNCA|LEPR|BCL2|BMF|CHMP4B|KIAA0226|MET
REGULATION OF MUSCLE FILAMENT SLIDING%GOBP%GO:0032971,0.0748993288590604,0.524498745055867,0.96344287604764,1.2798908785953,557,1,MYLK2
REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 1 PRODUCTION%GOBP%GO:2000338,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
ALPHA-AMINO ACID CATABOLIC PROCESS%GOBP%GO:1901606,0.22289370778528303,0.7355723797115551,-0.18210429648631302,-1.1648290229716698,626,60,ALDH4A1|MTRR|SDS|CBS|SDSL|SHMT2|TDO2|GCDH|PAH|PCBD1|NOS3|QDPR|GLUL|DDAH1
LATE ENDOSOMAL MICROAUTOPHAGY%GOBP%GO:0061738,0.8518188567186341,0.991298302704726,-0.4145574855252279,-0.709078376712147,5736,2,HSPA8|VPS4A
CELLULAR RESPONSE TO ESTRADIOL STIMULUS%GOBP%GO:0071392,0.48270042194092794,0.905630643226885,-0.24995842107114496,-0.968405096623549,2287,14,RAMP3|GPER1|ZNF703|POU4F2|RUVBL2|NRIP1
HEMIDESMOSOME ASSEMBLY%GOBP%GO:0031581,0.240140570089809,0.7525035503527309,-0.36728242257554905,-1.18562057304096,1229,9,LAMC1|ITGA6|LAMC2
CELLULAR RESPONSE TO PYRIMIDINE RIBONUCLEOTIDE%GOBP%GO:1905835,0.601610738255034,0.9506035145731909,0.704289810322011,0.935617592416746,4481,1,P2RY6
POSITIVE REGULATION OF N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000761,0.783000132397723,0.981487311948134,-0.605535950595501,-0.8100439037479571,5913,1,SOX4
POSITIVE REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002904,0.783529723288759,0.981487311948134,-0.6052051168945739,-0.8096013374191929,5917,1,FNIP1
AGE-DEPENDENT RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0001306,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
CELL-CELL JUNCTION ASSEMBLY%GOBP%GO:0007043,0.37372262773722603,0.852609194081082,-0.163034776401984,-1.05565380326204,1023,63,RHOA|WDR1|STRN|CDH5|PARD6B|RHOC|CTNNA1|RAMP2|PRKCA|CD9|PKP4|GJC1|TLN2|DLG1|CDH13|PARD3
GLYCOLIPID TRANSPORT%GOBP%GO:0046836,0.691256380701466,0.96731875442989,-0.35443666243864796,-0.8151302791964861,4197,4,CPTP|NPC2|RFT1|PSAP
EMBRYONIC HEART TUBE ANTERIOR/POSTERIOR PATTERN SPECIFICATION%GOBP%GO:0035054,0.793856745663975,0.9819233677232551,-0.5999117776797529,-0.802520276158967,5995,1,BMP2
PROLINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035524,0.48203701463650706,0.905285511598575,0.6108880386441751,0.9984797170877721,3984,2,SLC36A1|SLC36A4
POST-EMBRYONIC HEMOPOIESIS%GOBP%GO:0035166,0.8761073825503359,0.9941329456747149,0.562748125275695,0.747585778454968,6526,1,KLF4
STABILIZATION OF MEMBRANE POTENTIAL%GOBP%GO:0030322,0.285077951002227,0.794258537514783,-0.68833746898263,-1.17736437569802,1919,2,KCNN4|CHCHD10
UDP-GALACTOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0072334,0.591387444054675,0.945418171231938,0.570384048490606,0.932277057891465,4888,2,SLC35B1
REGULATION OF GLUTAMATE-CYSTEINE LIGASE ACTIVITY%GOBP%GO:0035227,0.590891036674169,0.945418171231938,-0.6985002205558011,-0.934405042130679,4462,1,GCLM
MRNA LOCALIZATION RESULTING IN POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION%GOBP%GO:0010609,0.519535502600702,0.924170511124621,0.596278972037038,0.974601599052943,4294,2,MEX3D
UBIQUINONE METABOLIC PROCESS%GOBP%GO:0006743,0.28419629057186996,0.79342123536088,0.342519365739083,1.1613502800548898,2941,15,FDXR|COQ3|COQ2|COQ6|COQ9|COQ5|PDSS1
POSITIVE REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0045951,0.698265589831855,0.96731875442989,-0.64622849580944,-0.8644795621859459,5273,1,ERCC2
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS%GOBP%GO:0048646,0.0718816067653277,0.515023940206536,-0.132654956168071,-1.21365159303857,33,329,BCAS3|CTNNB1|DAB2IP|SKI|TGFBR1|FAM20A|PTK2B|HMOX1|PDPN|DLC1|CELSR1|PRICKLE1|EIF2AK3|MEGF11|COL23A1|CALCRL|TCTA|CITED2|MBOAT7|HES7|NRP1|MMP2|TENM4|RFX2|ITGA5|WDR1|AAMP|BCL10|CASP3|COL6A1|FAIM2|CLIC4|APOD|FGF2|NOLC1|PODXL|ITGA6|MMP9|SMAD2|TNNT2|EFNA1|SNAI1|PAX8|MYOM1|FOXC2|PGK1|CBLN1|RAMP2|FGFR1|BHLHE41|LEPR|ATOH8|ADAM17|CXCL8|ID1|CFLAR|ADM2|TBX20|CD9|PMP22|TMOD1|SCG2|COBL|WNT3|MYH11|MCAM|FGF10|GREM1|MYH9|SFRP2|BMPER|PTPRM|ACVRL1|FAM20C|SOX7|PGF|OLFM1|TWIST1|SOX17|CDH13|ITGA7|RBPJ|FKBP1A|EPHB2|RAMP1
MUSCLE HYPERPLASIA%GOBP%GO:0014900,0.0847809948032665,0.545265264053164,-0.8241521918941271,-1.40966818546685,570,2,HMOX1|NOS3
SNRNA 3'-END PROCESSING%GOBP%GO:0034472,0.9448157341989691,1.0,0.162281281777214,0.572342645378509,9895,17,INTS7|DDX26B|INTS6|INTS1|INTS2|TOE1|EXOSC2|CPSF3L
RADIAL GLIA GUIDED MIGRATION OF CEREBELLAR GRANULE CELL%GOBP%GO:0021933,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007195,0.813982717989002,0.986276922067025,-0.35938795104067495,-0.7293671687520892,5180,3,DRD2
POSITIVE REGULATION OF L-DOPA BIOSYNTHETIC PROCESS%GOBP%GO:1903197,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
RESPONSE TO RAPAMYCIN%GOBP%GO:1901355,0.7773154362416109,0.9810334506628041,0.6130348478164979,0.8143894459006801,5790,1,LARP1
POSITIVE REGULATION OF ACONITATE HYDRATASE ACTIVITY%GOBP%GO:1904234,0.15808288097444698,0.6597808951153779,-0.918063520070578,-1.22812156232048,1193,1,FXN
AROMATIC AMINO ACID TRANSPORT%GOBP%GO:0015801,0.8462628023534541,0.991298302704726,0.30199804308159,0.69606072065972,7766,5,SLC25A29|SLC15A4
PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035196,0.7285650022492131,0.972554563883587,0.19616159995457103,0.804385812395346,8097,28,LIN28B|ZCCHC11|DROSHA|C9orf114|METTL3|SRRT|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6
FEMALE GAMETE GENERATION%GOBP%GO:0007292,0.906420587470756,1.0,-0.13317593240732,-0.6815612754644239,3486,29,PLD6|DIAPH2|DMC1|POMZP3|PDE3A
PORE COMPLEX ASSEMBLY%GOBP%GO:0046931,0.531377899045021,0.9265056012720759,0.284612424820859,0.943009408713823,5452,14,TPR|GSDMD|NUP205|NDC1|BAD|NUP107
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009159,0.15865771812080498,0.6608477036716949,0.9212064402293779,1.22378165791173,1181,1,DNPH1
PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT%GOBP%GO:0044860,0.0835820895522388,0.544318908798516,-0.7292881788070741,-1.48006869078558,531,3,CAV1
UROGENITAL SYSTEM DEVELOPMENT%GOBP%GO:0001655,0.806081601231717,0.984682960940884,0.13979310037323903,0.783843232735187,10470,104,GREB1L|CITED1|WNT4|BASP1|BMP4|PYGO1|PROX1|PKD2|CENPF|AHI1|MPV17|PTPRO|CEP290|AGTR1|KLHL3|ROBO2|TGFB2|CEP55|C5orf42|NF1|NIPBL|VANGL2|COL4A1|ACTA2|MAGI2|NPHP3|GPC3|TFAP2B|BAG6|FGFR2|ACD|ITGA3|SEC61A1|EGR1|GATA3|ITGA8|SULF1
SOCIAL BEHAVIOR%GOBP%GO:0035176,0.6144849302744039,0.9511905259737851,0.21663310212185,0.8883318339693621,6829,28,GNG8|OXTR|MSS51|DNAJC9|DRD4|NLGN4Y|NRXN3|NPAS4|SHANK1|NLGN3|CIC
FATTY ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1902001,0.848282265552461,0.991298302704726,-0.225495947031321,-0.700939585985202,4567,8,SLC27A5|MID1IP1
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0086010,0.0330479609684249,0.371559593752943,0.409670676664861,1.59329253867564,358,23,SCN1A|CACNA1G|CACNB2|HCN2|CACNA1I|CACNA1H|CACNA2D1|KCNH2|CACNA1D|SCN3B|SLC8A1|SCN8A
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031112,0.326337107612998,0.8267506255436541,0.287134437260359,1.1167241946828799,3544,23,AKAP9|NAV3|CLIP1|PSRC1|NUMA1|CDK5R1|CDK5RAP2
REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032965,0.4957496136012371,0.911498395855878,0.28702799069698304,0.97320055658826,5131,15,WNT4|BMP4|F2R|SUCO
PROGRAMMED DNA ELIMINATION%GOBP%GO:0031049,0.7134228187919459,0.971081608033886,0.6467798853109841,0.859218222739249,5314,1,RFWD3
REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090196,0.8900904648019129,0.997300970905927,0.23750679919055398,0.647507253747751,8559,8,LPL|F2RL1|C5|CSF1R
T-HELPER 1 CELL ACTIVATION%GOBP%GO:0035711,0.9739597315436239,1.0,0.5157146007940011,0.685103839495328,7255,1,HMGB1
POSITIVE REGULATION OF TOLERANCE INDUCTION TO TUMOR CELL%GOBP%GO:0002845,0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010985,0.825176391533207,0.9876441563834109,0.343129652489148,0.7271245110766942,7367,4,KHSRP|APOC1|APOC2
CELLULAR RESPONSE TO CISPLATIN%GOBP%GO:0072719,0.9975686002084059,1.0,0.23972043658904701,0.45568333231240205,8615,3,TIMELESS|DDX11
NEGATIVE REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045665,0.856405443453778,0.991298302704726,-0.109855072035627,-0.7942328573120229,1824,95,SEMA7A|YWHAH|EFNA1|POU4F2|BAG5|SPOCK1|SEMA6B|ID1|FKBP4|ASCL1|MYLIP|ZNF365|SEMA3A|SEMA3G|LINGO1|RTN4RL2
MITOCHONDRIAL NCRNA SURVEILLANCE%GOBP%GO:0035945,0.675704697986577,0.9647315640607691,0.666850463167181,0.885881090009248,5033,1,SUPV3L1
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900180,0.735745182854896,0.974262605126702,-0.12532786031903698,-0.8482260066603051,1870,73,IPO5|DMAP1|PSEN1|POLR1A|SMAD3|GAS6|PARK7|MFHAS1|OTUD7B|PIK3R2|TXN|FLCN|CCT4|PINX1|SIN3A|PRKCD|LIF|EIF2AK3|CCT7|NMD3|APOD|CHP1|TCP1|IGF1|MAVS|ZPR1|BAG3|CABP1|SESN2|PIK3R1
ACETYLCHOLINE-MEDIATED VASODILATION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003069,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003308,0.22262372348782397,0.7355723797115551,-0.599977941987427,-1.21763740713596,1416,3,BMP2|MESP1|DKK1
REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0033139,0.33615781808552897,0.8311444145897029,-0.8328187031318921,-1.11408697160892,2538,1,LIF
POSITIVE REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000259,0.78829604130809,0.9819233677232551,-0.6028892809880899,-0.8065033731178441,5953,1,PHB
REGULATION OF FERROCHELATASE ACTIVITY%GOBP%GO:0010722,0.15808288097444698,0.6597808951153779,-0.918063520070578,-1.22812156232048,1193,1,FXN
DERMATAN SULFATE METABOLIC PROCESS%GOBP%GO:0030205,0.6556318126766251,0.9640743070248079,-0.23915127456362198,-0.841603130876043,3247,11,CSPG4|NCAN
"NEGATIVE REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902957",0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
DETECTION OF LIGHT STIMULUS INVOLVED IN VISUAL PERCEPTION%GOBP%GO:0050908,0.935945990449531,1.0,-0.26668934758732105,-0.613329786094605,5683,4,CACNA2D4|EYS
CERAMIDE 1-PHOSPHATE TRANSPORT%GOBP%GO:1902389,0.716644295302014,0.971081608033886,0.645621967357742,0.8576799803967491,5338,1,CPTP
GERM-LINE STEM CELL POPULATION MAINTENANCE%GOBP%GO:0030718,0.742953020134228,0.974505008828563,0.631340979267755,0.83870832483925,5534,1,PIWIL2
POSITIVE REGULATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:1903109,0.551436515291937,0.932156795932405,-0.7185156594618441,-0.961180305020909,4164,1,CHCHD10
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090101,0.0132352941176471,0.250789137165164,-0.239828546743511,-1.5778339145442701,35,66,SMAD2|LDLRAD4|PPM1A|SMAD7|ADAM17|UBA52|DKK1|SNX6|RBPMS2|GREM1|BMPER|IGSF1|UBC|SNX25|CAV1|DACT2|NBL1|UBB
HISTONE H2A K63-LINKED DEUBIQUITINATION%GOBP%GO:0070537,0.819150167882367,0.987153241368501,0.395843986069555,0.7524577762939051,7074,3,BRCC3|UIMC1
REGULATION OF HEPATIC STELLATE CELL ACTIVATION%GOBP%GO:2000489,0.785912882298424,0.981487311948134,-0.603936921041023,-0.8079048331589301,5935,1,RPS6KA1
PEPTIDYL-GLUTAMIC ACID CARBOXYLATION%GOBP%GO:0017187,0.38271798900235704,0.858136016229086,-0.514946336190246,-1.04506828957055,2435,3,VKORC1L1|GGCX
DNA REPLICATION-INDEPENDENT NUCLEOSOME ASSEMBLY%GOBP%GO:0006336,0.10539650367367599,0.578657302371004,0.287248153234127,1.36247490949051,1247,47,RBBP7|ASF1B|CENPL|CENPT|CENPK|ASF1A|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|H3F3A|MIS18BP1|NASP|HJURP|STRA13|CENPM
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010524,0.8592328278322929,0.99166790097654,0.164380619145389,0.689236633524114,9631,30,P2RX5|F2R|CXCL9|PKD2|PDPK1|GRIN1|CXCL10|PLCG1|TRPC1|P2RY6|P2RX3|GSTM2|CXCL11|XCL1|P2RX7
GLUCOSE-6-PHOSPHATE TRANSPORT%GOBP%GO:0015760,0.631121917332407,0.9575013258325501,0.47016902004521705,0.8937418471815419,5450,3,SLC37A2|SLC37A3|SLC37A1
CELLULAR CHEMICAL HOMEOSTASIS%GOBP%GO:0055082,0.8891553058847711,0.997300970905927,0.118438300978835,0.7839667262094058,12978,358,CARTPT|THADA|TAC1|RYR2|CHRNA10|CALB1|SIRT1|EDN1|RGN|CXCL13|GHRL|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|PRKAA2|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|CXCR4|UNC13B|F2R|DMXL2|CXCL9|OCM|AGER|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|ERN1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|C1QTNF3|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|TMEM178A|MT1E|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|XPR1|SLC39A7|SLC46A1|GCK|DMPK|SLC40A1|GRIN1|CCL19|CXCL10|ATP2A2|TCIRG1|PLCG1|C3AR1|SLC39A13|MT2A|ORMDL1|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1
POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048714,0.5472113118617439,0.9305779599215391,-0.45417855863696704,-0.921741890516128,3482,3,TENM4|ZNF365
REGULATION OF MELANOSOME TRANSPORT%GOBP%GO:1902908,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
REGULATION OF GLUTAMATE UPTAKE INVOLVED IN TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051946,0.0616973388057726,0.48425100851298497,-0.9681848257609179,-1.29517036112824,465,1,PER2
RUFFLE ASSEMBLY%GOBP%GO:0097178,0.0353251318101933,0.382137421231133,-0.60545832896866,-1.66194245946517,200,6,AIF1L|ARF6|PIP5K1A|INPP5K|RAC1
FATTY ACID METABOLIC PROCESS%GOBP%GO:0006631,0.0471561230412072,0.42721693308831105,0.225772595709933,1.3741645155488202,649,172,ACSM3|FAAH2|EDN1|HACD1|CROT|CYP2D7|MGST1|GLYATL2|CYP2C8|LPL|OXSM|SLC27A2|ETFDH|HSD17B4|CBR4|ACADVL|BDH2|SCD5|PLA2G4A|ELOVL6|GPAM|GGT1|ETFA|ALKBH7|FADS2|DECR2|FADS3|ABHD3|AMACR|ACADM|ACOT1|DECR1|AIG1|FADS1|ALDH3A2|HADH|ETFB|GNPAT|ACOX2|ACOT2|ACACA|PTGS2|GSTP1|ECHDC2|MCEE|GGT5|LTA4H|ABHD16A|EHHADH|ADIPOR2|ACAD11|ACAD10|PON2|IVD|AASDH|TECR|FAAH|MSMO1|AOAH|ECI1|ELOVL4|ECI2|HADHB|ACAT2|HIBCH|PLA2G4B|ABHD2|CYP2E1|DAGLA|ACADS|CYP2D6|PCK2|ELOVL2
PROTEIN ACYLATION%GOBP%GO:0043543,0.538393121849985,0.9270460065458102,0.163207877928803,0.9623551448311429,7263,138,CPA4|SIRT1|JADE3|AK6|KAT2A|ZDHHC8|ZDHHC21|GOLGA7B|NAA40|TADA1|OGT|TAF6L|NAA10|PORCN|YEATS4|GTF2B|ZDHHC16|TRRAP|MAP3K7|EP400|LEF1|ZDHHC22|ABHD17A|ZDHHC15|CLOCK|ING5|APBB1|YEATS2|DLD|ESCO2|ZDHHC17|BRPF3|DSCC1|EHHADH|ATAT1|NAA25|MSL1|KAT8|BRCA2
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION%GOBP%GO:0051129,0.35897435897435903,0.8472245060530649,-0.10963239296858199,-1.04588902066437,83,447,MAPRE1|TERF2|DCP2|ERCC1|PPFIA1|PPIF|ADD1|PINX1|CLU|SIN3A|MTMR2|IMPACT|NECAB2|CLIP3|BCAS3|PRKCD|SIRPA|DNM2|LPAR1|RTN4|SPEF1|CD300LF|NR1H3|DLC1|PFN1|SRGAP2C|SEMA3F|AURKAIP1|CTBP1|DYRK1A|FYN|RHOA|CCP110|BAG4|MPV17L|SLX1A|DDX3X|SMAD6|INPP5K|VAT1|TNFRSF1B|TRIP12|TMSB10|MYADM|NME6|TRIM54|BUB3|SEMA7A|APOD|H1F0|HGF|YWHAH|DFFA|FCGR2B|PRNP|GLTSCR2|EFNA1|LDLRAD4|BCL2L1|MAD1L1|BAG5|IGF1|SPOCK1|ACAA2|PPM1A|TMSB4X|KDM5A|NPM1|LRPAP1|SNCA|ARHGEF2|TWF1|CDC42|LGALS3|FXN|TRAF3IP1|SEMA6B|GNL3L|NR1H2|HNRNPC|ARPIN|CFLAR|DYSF|H1FX|DKK1|TWF2|DNAJB6|SLC35F6|SIAH3|RAB7A|MFI2|PARK2|CHMP4B|FKBP4|KIAA0226|MAP4|ACVRL1|ACE|MYLIP|TMEFF2|ZNF365|SEMA3A|DNAJA4|PEX5|RAC1|MET|CORO1C|MCTP1|SEMA3G|TWIST1|MID1IP1|TNF|CAV1|LINGO1|RTN4RL2
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS%GOBP%GO:1901522,0.0225631768953069,0.31559862547565604,-0.38527951916247494,-1.6896330135605702,99,19,SMAD4|SMAD9|RELA|ATF4|HIF1A|DLX5|NOTCH1|CREB3|VEGFA|SMAD1|SESN2|RBPJ
SPERM CAPACITATION%GOBP%GO:0048240,0.21129250285951998,0.7259782447835071,0.455026664402645,1.2405247633057,2031,8,ROPN1B|CABYR|PCSK4|PEBP1|ABHD2
RESPONSE TO LAMINAR FLUID SHEAR STRESS%GOBP%GO:0034616,0.0833333333333333,0.543815846291824,-0.4319077074050999,-1.46120842209039,422,10,MAPK7|SMAD6|MAP2K5|ASS1|ABCA1|SMAD7
REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050854,0.25969447708578103,0.771256701247223,-0.203777669163815,-1.14976600193895,883,39,RELA|EZR|THY1|ELF1|PVRL2|BLK|PRKCH|PRKD2|NFAM1|RPS3|RUNX1|LYN|PRNP|LGALS3|DUSP3|CBFB|CD22
ENDOTHELIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0086100,0.9439957632728722,1.0,-0.525529333921482,-0.7030166132418301,7129,1,EDNRB
POSITIVE REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000078,0.9872741555380992,1.0,-0.260289423085073,-0.5282496506127651,6283,3,NKX6-1
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045600,0.8937747887566819,0.9976191001250191,0.146984339389396,0.662937299443877,10365,39,LMO3|RARRES2|INS|TMEM64|NAPEPLD|FNDC5|AAMDC|PTGS2
CONVERGENT EXTENSION INVOLVED IN GASTRULATION%GOBP%GO:0060027,0.810054988216811,0.984682960940884,-0.36094476172133294,-0.7325266697736078,5155,3,MKKS
CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:0090110,0.80329961700874,0.984522820758988,0.22542370403105502,0.727526083237421,8179,13,SEC31B|MIA3|SEC31A|SEC24D|SEC24C
TRIGLYCERIDE MOBILIZATION%GOBP%GO:0006642,0.602292462660646,0.9508825506493929,0.479172496376027,0.9108565085562521,5201,3,SIRT1
L-LYSINE METABOLIC PROCESS%GOBP%GO:0046440,0.855838926174497,0.991298302704726,0.5731693868548741,0.761429959537468,6375,1,PIPOX
NEGATIVE REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043407,0.76117919841007,0.977763214485385,0.160861560891014,0.794587203990145,9191,56,RGS2|BMP4|STK38|RGS14|DUSP16|DUSP8|DUSP19|RGS3|NF1|APOE|ZNF675|GSTP1|SMPD1|PTPRJ|CDK5RAP3|PTPN22|DUSP1|SORL1|SPRY4|DNAJA1|PPP2R1A|SPRY1
CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033631,0.630195669792752,0.957141460696787,0.47032339133604206,0.8940352907661501,5442,3,ITGB1|ADAM9
POSITIVE REGULATION OF SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:1901307,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106072,0.975962293794187,1.0,-0.27502421844015,-0.5581534799958979,6211,3,ATP2B4
INTESTINAL EPITHELIAL CELL MIGRATION%GOBP%GO:0061582,0.9582947173308621,1.0,-0.518857520952801,-0.6940915256117529,7237,1,ARSB
CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:0035729,0.0674793956043956,0.502793556475766,-0.597284591245693,-1.5119862810014901,392,5,BCAR1|NRP1|HGF
SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051145,0.8865919629057192,0.996643473105967,0.190233137423021,0.645006763180328,9177,15,HES1|BMP4|HEY2|TMEM204|GATA6
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0045943,0.9379752851711031,1.0,-0.134971018492962,-0.625285690040183,3946,22,NOL11|MARS|HEATR1|SMARCA4|RASL11A|TAF1|UBTF|DDX11|PHF8|MTOR|WDR75|IPPK|PWP1|PIH1D1|ERBB2|SMARCB1|DHX33|NCL|ATF4|UTP15|EIF2AK3|WDR43
REGULATION OF ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:1903224,0.86661440250868,0.9929671171385601,0.32319613053617197,0.684883473909111,7737,4,COL5A2|COL5A1
DETECTION OF CELL DENSITY%GOBP%GO:0060245,0.831457698927579,0.9879179006160809,-0.5827084252315841,-0.779506827063232,6279,1,SMO
NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002835,0.0809395973154362,0.5374028338839121,0.960630789589766,1.2761551471920902,602,1,CEACAM1
REGULATION OF URINE VOLUME%GOBP%GO:0035809,0.7363796133567659,0.974262605126702,-0.28437559123719,-0.7805919035215061,4189,6,INPP5K|ADM
REGULATION OF HEART CONTRACTION%GOBP%GO:0008016,0.15329578322423498,0.6502898222276021,0.21856441508802,1.24462633147479,2013,113,RGS2|RYR2|KCNN2|TNNI3K|KCNK6|EDN1|CACNA1G|AKAP9|CACNB2|NPR2|KCNK3|ATP2B1|TBX2|KCNQ1|ADORA3|SLC8A3|S100A1|FGF13|ATP2A1|CACNA1H|FOXN4|CACNA2D1|TGFB2|KCNH2|CACNA1D|ATP2B3|GJA1|DMPK|RNLS|GJC3|CXADR|ATP2A2|TH|SPTBN4|DMD|TRPC1|SCN3B|PEBP1|TNNI3|SLC8A1
NEGATIVE REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904530,0.621872103799815,0.9536478716552259,-0.682454786060873,-0.912940575185619,4696,1,CRMP1
NEGATIVE REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0051001,0.0292223095051061,0.350886057103154,-0.796962037984618,-1.6174107773077397,185,3,NOSIP|ATP2B4
"NEGATIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043518",0.672151898734177,0.9647315640607691,-0.216471164150487,-0.838666597976702,3185,14,PSMD10|CD44|SNAI2|PTTG1IP|DYRK1A|SNAI1|TWIST1
PRIMARY ALCOHOL CATABOLIC PROCESS%GOBP%GO:0034310,0.8849815208869979,0.996643473105967,0.314785277185661,0.667060072212805,7901,4,SULT1A3|AKR1C3|SULT1C4
NEGATIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035021,0.919227913882702,1.0,-0.372925282602702,-0.637868723291334,6190,2,ARHGAP44|STMN3
REGULATION OF SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:2000097,0.34736842105263205,0.842847021021096,-0.530799719450741,-1.07724225987302,2210,3,PLAU|APOD
REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032660,0.9890018676073872,1.0,-0.135124696534981,-0.508877024327154,4765,13,SLAMF6|PRKCQ|TLR4|FOXP3|NCKAP1L|LY9|IL15|OSM|IL18|TGFB1|C10orf54|PRNP|MYD88
MAINTENANCE OF CELL POLARITY%GOBP%GO:0030011,0.9327762302692671,1.0,-0.19760075987725198,-0.614229198538474,5022,8,GSK3B|PDCD6IP|SLC9A1|WDR1
TREHALOSE METABOLISM IN RESPONSE TO STRESS%GOBP%GO:0070413,0.8147755858599229,0.986438955875882,-0.589986766651963,-0.7892432862960429,6153,1,BRAF
FERRIC IRON IMPORT%GOBP%GO:0033216,0.0962138084632517,0.5684612493613671,-0.811798529325703,-1.3885379072633999,647,2,STEAP3
REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055021,0.32709677419354805,0.827662288375761,-0.271824131126693,-1.08405891942279,1520,15,AKAP6|NOTCH1|PIM1|TGFBR1|FGF2|IGF1|TBX20|RBPJ
ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0035768,0.0355704697986577,0.3821688062173221,0.981859285399206,1.30435625680459,264,1,CXCL13
REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION%GOBP%GO:2000589,0.41728201099764295,0.8709670999109399,-0.49961398477997104,-1.01395173792756,2655,3,PDGFB|PDGFA|PDGFRB
MESONEPHROS DEVELOPMENT%GOBP%GO:0001823,0.763573819263667,0.978421368343614,0.20355867244475398,0.7695602798087059,8212,21,CITED1|BMP4|PKD2|ROBO2
MODULATION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039519,0.33214550853749103,0.8293509737209019,-0.660104769782189,-1.1290738557623201,2236,2,EIF2AK4|ATG7
MONOCARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0032787,0.13692628650903998,0.62388141596544,0.18684095208074,1.20996676381408,1968,280,ACSM3|ALDH1A2|FAAH2|EDN1|HACD1|ASNS|CROT|CYP2D7|MGST1|GLYATL2|CYP2C8|LPL|NR4A3|D2HGDH|OXSM|SLC27A2|ASRGL1|ETFDH|AS3MT|VCAN|BCO2|HSD17B4|MCCC2|CBR4|ACADVL|IDNK|BDH2|SCD5|PLA2G4A|ELOVL6|GPAM|GGT1|ETFA|ALKBH7|FADS2|DECR2|FADS3|ABHD3|OSBPL3|ALDH8A1|N6AMT1|GBA2|AMACR|ACADM|ME1|ACOT1|DECR1|PDHX|AIG1|AKR1C1|FADS1|ALDH3A2|HADH|ETFB|GCK|BSG|PCCB|GNPAT|PDHA1|ACOX2|ACOT2|OSBPL9|ACACA|PTGS2|GSTP1|ECHDC2|CYP7B1|DLD|MCEE|ABAT|GGT5|LTA4H|ABHD16A|EHHADH|ADIPOR2|ACAD11|ACAD10|HAGH|ME3|PON2|IVD|AASDH|TECR|ABHD10|FAAH|PFKFB2|MSMO1|MCCC1|AKR1A1|AOAH|ECI1|ELOVL4|ECI2|HADHB|ACAT2|OSBPL6|HIBCH|OSBP|PLA2G4B|ABHD2|PCCA|CYP2E1|DAGLA|ACADS|BGN|CYP2D6|PCK2|ELOVL2|BPGM
CARNOSINE METABOLIC PROCESS%GOBP%GO:0035498,0.583489932885906,0.9439064862850342,0.712229819144244,0.9461655399081741,4346,1,C9orf41
REGULATION OF HIPPO SIGNALING%GOBP%GO:0035330,0.417862055413637,0.871453658192324,0.328859420132026,1.03668241549781,4252,12,NF2|DLG5|MOB3B|MARK3|AJUBA|WTIP|NEK8|WWC3
POSITIVE REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060399,0.0609007757323145,0.48170831577441997,0.754198512407957,1.43365203338202,525,3,GHRL|JAK2
POSITIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000049,0.170650263620387,0.673371221305033,-0.469752795180791,-1.2894398811777,970,6,FLOT1|PTPRU|SERPINF2|DENND6A
AUXIN CATABOLIC PROCESS%GOBP%GO:0009852,0.7995973154362421,0.9839175016931591,0.6015659461843851,0.7991535217463951,5956,1,ACAA1
REGULATION OF FERROUS IRON BINDING%GOBP%GO:1904432,0.35070527097253196,0.842847021021096,-0.649574373533067,-1.1110621769501399,2361,2,B2M
EPINEPHRINE SECRETION%GOBP%GO:0048242,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
METANEPHRIC PART OF URETERIC BUD DEVELOPMENT%GOBP%GO:0035502,0.19595984032901897,0.709508289394159,0.7361182501468101,1.2031650575136699,1619,2,PKD2|FOXJ1
CEREBELLUM DEVELOPMENT%GOBP%GO:0021549,0.0386566803575743,0.394693762886429,-0.334134897658034,-1.5700719427158099,159,23,TTBK2|CLP1|SDF4|DLL1|NLGN4X|FOXC1|OPHN1|AARS|ADCK4|FAIM2|FCGR2B|CBLN1|ZNF365|TRNP1|SCN5A
PROTEIN K27-LINKED UBIQUITINATION%GOBP%GO:0044314,0.917925824175824,1.0,-0.25284613391744,-0.64006319816507,5345,5,PARK2
INTERMEDIATE FILAMENT-BASED PROCESS%GOBP%GO:0045103,0.210786622703721,0.7255949404689929,-0.26595832563958,-1.20792845646518,894,21,KRT9|NEFH|DNAJB6|EVPL|DES
NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0001787,0.17397060770554698,0.676682497340677,-0.9103992059991179,-1.21786877570411,1313,1,ELF4
NEGATIVE REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903609,0.0115186018800477,0.23212667146341198,-0.995037494486105,-1.3310919948129298,86,1,CAV1
POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:0097106,0.5092626225935339,0.918404893008545,-0.32323538455576895,-0.94289195739879,2803,7,TMEM108
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010823,0.00451407328730749,0.156396585169664,-0.361272428841841,-1.89976359727763,16,31,OPA1|PSMD10|BNIP3|MUL1|SLC25A5|FLCN|PPIF|CLU|BAG4|MPV17L|VAT1|HGF|BCL2L1|IGF1|ACAA2|FXN|SLC35F6|SIAH3|PARK2
NEGATIVE REGULATION OF ISOPRENOID METABOLIC PROCESS%GOBP%GO:0045827,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
REGULATION OF EPITHELIUM REGENERATION%GOBP%GO:1905041,0.06130014563749501,0.48227634769717603,-0.968405381561535,-1.29546540534742,462,1,DUSP10
ANION HOMEOSTASIS%GOBP%GO:0055081,0.13446439851998898,0.6216819943856899,0.327126185085399,1.3299353571972201,1489,27,FGFR4|SIRT1|SLC12A2|PRKAA2|INS|POLD1|CETP|XPR1|PQLC2|APOE
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000675,0.10746268656716401,0.583887648372312,-0.703705746112275,-1.42814990371894,683,3,WFS1|CAST|TCF7L2
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS%GOBP%GO:0003222,0.8295264623955431,0.9876441563834109,-0.23035410720527696,-0.7160408630849159,4466,8,ENG|NOTCH1|TGFBR1|RBPJ
PEPTIDYL-SERINE TRANS-AUTOPHOSPHORYLATION%GOBP%GO:1990579,0.20416107382550303,0.720304973077154,0.899867666519629,1.19543404902852,1520,1,ERN1
RESPONSE TO CAMP%GOBP%GO:0051591,0.0905126379494482,0.560245248761167,0.33216043702419396,1.4040397867101397,1016,31,CITED1|AKAP9|CRHBP|HCN2|KCNQ1|PKD2|PDE2A|HCN3|NDUFS4|IGFBP5|DUOX1
NEGATIVE REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051126,0.898896756133707,0.998912093067348,-0.28603422807027,-0.657818969918297,5458,4,ARPIN
DOPAMINE TRANSPORT%GOBP%GO:0015872,0.9858747250202622,1.0,0.272685631922333,0.5183467008325929,8514,3,SLC6A2|SLC18A2
HISTAMINE SECRETION BY MAST CELL%GOBP%GO:0002553,0.961744966442953,1.0,0.521449051610057,0.6927218015724711,7164,1,SNAP23
CARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0046394,0.618686507368722,0.9532238181782521,0.149136739949597,0.928647267597813,8647,203,ACSM3|EDN1|RGN|HACD1|ASNS|CTH|MGST1|CYP2C8|LPL|OXSM|SLC27A2|GAMT|SERINC5|VCAN|HSD17B4|CBR4|RIMKLB|SLC35D1|SCD5|ELOVL6|GGT1|GPT|DECR2|FADS3|GLS|APIP|ABHD3|DHFR|OSBPL3|GLS2|MTHFD1|AMACR|CAD|CDO1|MTR|FADS1|MGST3|GCK|ACOX2|OSBPL9|ACACA|PTGS2|MGST2|CYP7B1|MTAP|GGT5|PSAT1|LTA4H|BCAT2|NAALAD2|PYCR2|PHGDH|ABCC5|TECR|NAGS|PFKFB2|RIMKLA|SEPHS1|AKR1A1|ELOVL4|CCBL1|AASS|OSBPL6|OSBP|ALDH18A1|ABHD2|CYP2E1|BGN|CYP2D6|ELOVL2|BPGM|ENOPH1
CYTOKINE SECRETION%GOBP%GO:0050663,0.485398021667452,0.9067242420344581,-0.21364298744955998,-0.970322863343186,2060,21,PNP|ABCA1|RAB1A|FOXP1|CHI3L1|CD36
PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:0071539,0.0713194577047928,0.514511211182091,0.417182603760766,1.47134279707086,746,17,CEP83|CCDC14|GOLGB1|SPAG5|CEP131|STIL|CEP192|PCM1|C2CD3|HOOK3|SNX10|PIBF1|BBS4|KIAA0753
NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0046007,0.8655524605385331,0.9929389166575431,-0.220310000551602,-0.684819406326582,4660,8,BTN2A2|RC3H1|PDCD1LG2|FOXP3|PRKAR1A|CD274|LGALS9|PRNP
GLYCOSAMINOGLYCAN CATABOLIC PROCESS%GOBP%GO:0006027,0.9778471138845551,1.0,-0.0995147540526018,-0.5885125034177271,3133,46,SLC9A1|FGF2|CHP1|CEMIP|CSPG4|SDC2|TMEM2|NCAN
METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT%GOBP%GO:0072243,0.7830265138358229,0.981487311948134,0.41170874221997095,0.782615008826143,6762,3,PKD2|PKD1
CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072202,0.332455770850885,0.8293509737209019,0.42889665278648204,1.11632787596639,3156,7,WNT4|BMP4
REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051493,0.9813371616078749,1.0,0.0997420927887141,0.662066786936527,14354,371,TENM1|NF2|NEB|KIF25|RHOBTB1|EDN1|CTGF|WASH1|AKAP9|CD47|NAV3|NEXN|CLIP1|CAMSAP3|PRKAA2|GNAI1|KAT2A|ARAP1|CENPJ|RAC3|ACTN2|TPR|FSD1|KATNBL1|PSRC1|EVL|HIP1R|XRCC3|PROX1|CEP85|SPAG5|BORA|TRIM27|CEP295|C15orf62|CCSAP|MARK2|FGF13|CDK2AP2|CEP131|EPHA5|PAK3|NUMA1|CDK5R1|SEMA5A|LIMA1|CDK10|CTTN|KIF11|NEK2|STIL|CCL21|F2RL1|GEN1|APC|MAP6|GPSM2|CDK5RAP2
POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:1904261,0.271978021978022,0.7866273178445721,-0.45659607324067897,-1.15584263986994,1583,5,CLASP2|CLASP1|PHLDB2|DAG1|PHLDB1
ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS%GOBP%GO:1901616,0.9869914198726819,1.0,-0.0987681599734851,-0.5314602924367,3565,34,TKFC|SRD5A3|SULT1A3|APOE|MOXD1|IMPA1|LRTOMT|IMPA2|PDXP|COMT|DBH|MAOA|OCRL|NUDT3|FAH|CYP46A1|AKR1C3|INPP5J|PTEN|SULT1C4|MAOB|HSD3B7|SYNJ1|TRERF1|SNX17|INPP5B|SCARF1|SYNJ2|SULT1A1|INPP1|INPP5K|INPP5A|SORD|TPI1
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CONTROLLING TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:2000079,0.6974712034953001,0.96731875442989,-0.646724746360829,-0.865143411679092,5267,1,SFRP1
OPTIC PLACODE FORMATION%GOBP%GO:0001743,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:1900218,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
LIVER REGENERATION%GOBP%GO:0097421,0.715297217190845,0.971081608033886,-0.348249909403718,-0.800902039674128,4343,4,SULF2
POSITIVE REGULATION OF POLYSOME BINDING%GOBP%GO:1905698,0.19409395973154395,0.7049101024373008,0.9051058667842958,1.20239276438745,1445,1,DHX9
GANGLION DEVELOPMENT%GOBP%GO:0061548,0.009653270291568159,0.21484293761490603,-0.556487416899133,-1.8826802263976898,48,10,CTNNB1|SEMA3F|NRP1|POU4F2|ASCL1|SEMA3A|INSM1
REGULATION OF HISTAMINE SECRETION BY MAST CELL%GOBP%GO:1903593,0.0490333919156415,0.435177922569635,-0.5813678068807651,-1.5958155938941598,278,6,VAMP2|VAMP3|SNX6
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:2000795,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
GMP SALVAGE%GOBP%GO:0032263,0.21580828809744498,0.7322272196643679,-0.8911557123952359,-1.19212616758099,1629,1,HPRT1
INFLAMMATORY RESPONSE%GOBP%GO:0006954,0.875,0.9937342763776691,-0.0990855220228143,-0.828330261349903,986,189,FPR1|PNMA1|PLSCR1|RELA|MFHAS1|TBXA2R|NFATC3|PIK3CD|CYBA|TLR1|CD44|ADGRE5|IL6R|IL17D|PJA2|NRROS|HIF1A|ITCH|NOD1|IL1B|CLU|PARP4|CX3CL1|ABCF1|F11R|C5AR1|LGALS9|ITGAM|HMOX1|PTGFR|HP|HDAC4|NFAM1|S100A8|CCL14|HDAC5|MGLL|PXK|RELB|IL6|FCGR2B|REL|C2CD4A|SLC11A1|TPST1|NFE2L1|RIPK2|CRH|SNCA|CXCL8|NLRP3|STAT3|KLRG1|TNFRSF4|ANO6|SCG2|CHI3L1|BDKRB2|RAC1|LIAS|CCL18|CD36|TNF|HRH1
POSITIVE REGULATION OF HISTONE H3-K79 METHYLATION%GOBP%GO:2001162,0.23575662271682601,0.750277765814412,0.716190924099935,1.1705943905257299,1948,2,WDR61|CTR9
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051828,0.38370253164557,0.8582519754973359,-0.200730186550715,-1.04139464068271,1454,30,PPIA|VAMP8|CD4|WWP2|CD81|GAS6|PVRL1|ITCH|PVRL2|ZNF639|CBLL1|CTNNB1|GRB2|CAV2|MET|CAV1
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071635,0.9353889736326,1.0,0.26037505167033104,0.600125895711511,8584,5,CDH3|GATA6|LAPTM4B
PROTEIN UNFOLDING%GOBP%GO:0043335,0.55195355026007,0.9321968967758479,0.5850538904949419,0.956254511643417,4562,2,ERP29|HSP90AA1
L-CYSTEINE CATABOLIC PROCESS TO HYPOTAURINE%GOBP%GO:0019449,0.450814245994969,0.88620227509476,-0.7735443317159242,-1.0347938377053398,3404,1,CSAD
CELLULAR RESPONSE TO INTERLEUKIN-7%GOBP%GO:0098761,0.0410958904109589,0.402256981537283,0.420756462220614,1.5624788076868399,437,20,HIST1H3E|IL7R|CISH|HIST2H3C|HIST2H3A|SOCS2|IL7|IRS1|SOCS1|SMARCA4|STAT5B|HIST1H3H
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0045840,0.139227288548556,0.628096738123843,0.296160604254422,1.31676037047499,1599,37,EDN1|INS|ANAPC5|NUMA1|FAM178A|DLGAP5|NUSAP1|RB1|ESPL1|NIPBL|CDCA5|PEBP1|AURKA|UBE2C|ANKRD32
TRYPTOPHAN METABOLIC PROCESS%GOBP%GO:0006568,0.9007085020242921,0.998912093067348,0.221725683551266,0.6327293423375839,8898,9,IDO1|CCBL1|AFMID|AADAT|ATP7A
HISTAMINE SECRETION%GOBP%GO:0001821,0.40237564959168504,0.865238688875249,-0.613199314282982,-1.04884458622644,2709,2,ADCYAP1
LUTEOLYSIS%GOBP%GO:0001554,0.33731343283582105,0.831781977545269,-0.535315658748622,-1.08640722450362,2146,3,SLIT3
MEMBRANE BENDING%GOBP%GO:0097753,0.430822189858334,0.8785877309899279,-0.782752536391707,-1.04711193385595,3253,1,PICALM
KIDNEY DEVELOPMENT%GOBP%GO:0001822,0.522244017261671,0.9251240799994541,0.177348062318918,0.9680524783446289,6655,90,GREB1L|CITED1|WNT4|BASP1|BMP4|PYGO1|PROX1|PKD2|CENPF|AHI1|MPV17|PTPRO|CEP290|AGTR1|KLHL3|ROBO2|TGFB2|C5orf42|NF1|NIPBL|VANGL2|ACTA2|MAGI2|NPHP3|GPC3|TFAP2B|BAG6|FGFR2|ITGA3|SEC61A1|EGR1|GATA3|ITGA8|SULF1
IMP METABOLIC PROCESS%GOBP%GO:0046040,0.993321616871705,1.0,-0.17765153604324102,-0.4876415380103739,5651,6,ADSSL1|ADSS|PFAS|NT5C2|AMPD2|HPRT1
POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0016441,0.8750415420405451,0.9937342763776691,0.142238365408705,0.696728462925782,10531,54,LIN28B|ZCCHC11|CELF1|DHX9|DROSHA|TERT|TNRC6A|C9orf114|METTL3|SRRT|NRDE2|TNRC6C|AJUBA|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6|CNOT1|RBM4|ZC3H7A|XPO5|AGO4|CNOT8|WTIP
G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000082,0.151010886469673,0.647396140518835,0.22860084580063,1.25844083550315,1941,94,CDK6|CCNA1|RCC1|CDC7|CDC34|POLE|CDKN2C|DHFR|CDKN3|POLE2|ORC1|CDC45|E2F7|CDKN2A|CCNE1|CRLF3|FBXO5|RB1|POLA2|MCM6|CDC6|CDK3|PIM2|ORC6|DBF4|NASP|CUL4B|MCM10|MCM3|MCM2|SPDYA|CCNE2|E2F1|PRIM2|TYMS|GMNN|RRM2
SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:0001501,0.781224489795918,0.981487311948134,-0.105555522213236,-0.865687050786506,956,171,RPS6KA3|SCARA3|RUNX3|SH3PXD2B|COL14A1|CD44|HOXA4|FOXC1|PTHLH|ZBTB16|COL6A2|VWA1|DLX5|FUZ|LRP5|RAB33B|PAPSS1|RARA|ITGB8|IGFBP4|CTNNB1|SKI|TGFBR1|FAM101B|DYM|EIF2AK3|ZNF385A|RHOA|BMP8B|KLF10|EVC|COL6A1|FGF2|NFIB|SBDS|ADAMTS4|IGF1|FOXP1|WNT11|TEAD4|FGFR1|AKAP13|RYR1|FAM101A|COMP|COL21A1|PRDX1|CHI3L1|GNAS|DDRGK1|IGF2|WWOX|ETS2|TWIST1|SULF2|DLL3|STC1
APOPTOTIC MITOCHONDRIAL CHANGES%GOBP%GO:0008637,0.000309789343246592,0.0784645998831315,-0.40775836403114296,-2.37686968038637,0,44,THEM4|BAX|PPIF|CLU|TIMM50|BBC3|ATG3|BCL2L1|CAMK2A|BOK|SOD2|BID|ACAA2|HK2|BCL2|NDUFS1|BNIP3L|BMF|BIK|BCL2L11|PMAIP1
POSITIVE REGULATION OF CELLULAR GLUCURONIDATION%GOBP%GO:2001031,0.6084999338011391,0.9508825506493929,-0.6895125716806351,-0.9223819901992529,4595,1,PRKCE
REGULATION OF ROOT HAIR ELONGATION%GOBP%GO:1902890,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
GALACTOLIPID METABOLIC PROCESS%GOBP%GO:0019374,0.17364690721649498,0.676682497340677,0.524840714628839,1.2907693019433402,1616,6,B3GALT2|B3GALT1|B4GALT3|ALDH5A1|GALC
GLYCOLATE METABOLIC PROCESS%GOBP%GO:0009441,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|IGF1
HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034113,0.32530235215693704,0.826621597878865,0.31137613810400394,1.11696968794838,3415,18,ITGB1|MADCAM1|CD2|ITGA4|CD200|CXADR|CD1D
NEGATIVE REGULATION OF DNA RECOMBINATION AT TELOMERE%GOBP%GO:0048239,0.28968077208611703,0.7989014598698071,-0.685470085470086,-1.17245986976705,1950,2,TERF2IP|TERF2
MEMBRANE INVAGINATION%GOBP%GO:0010324,0.563645328293204,0.9377667552605741,0.186616628508035,0.933184993677022,6858,59,IGHV3-21|RHOBTB1|IGHV4-61|IGHG1|RAC3|IGLL5|IGHG4|ADGRB1|ARHGAP25|FNBP1L|IGHV1-18|IGHV3-43|AURKB|IGHV1-24|ALKBH4|GULP1|IGHG2|SPIRE2|THBS1|SPIRE1|ELMO1|IGHV1OR15-1
REGULATION OF EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:1903015,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
CALCITONIN GENE-RELATED PEPTIDE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1990408,0.0681514476614699,0.50364937614461,-0.8440033085194371,-1.44362245729664,458,2,CALCRL|RAMP1
REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043300,0.12598826829890303,0.607607158836689,-0.264164209235342,-1.31638230853354,493,27,LGALS9|ITGAM|LAMP1|FGR|LYN|FCGR2B|VAMP2|VAMP3|SNX6|GAB2
NEGATIVE REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903946,0.0960653303637713,0.5684612493613671,-0.8118555279845602,-1.3886354004167198,646,2,KCNE3|BIN1
ADULT HEART DEVELOPMENT%GOBP%GO:0007512,0.7524918803897409,0.9769690538700708,0.372406993541488,0.7891659934839371,6718,4,TCAP|HAND2|SCUBE1
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900076,0.19161155586495002,0.701122177790417,0.280609899535299,1.24762034505315,2201,37,SIRT1|MZB1|GRB14|INS|CISH|OGT|FAM132A|SOCS2|PRKCB|PRKCQ
CELLULAR RESPONSE TO RETINOIC ACID%GOBP%GO:0071300,0.131704726500266,0.6161474507262421,-0.247981741135943,-1.30402058665216,495,31,ADNP2|TESC|RARA|PTK2B|RET|PTK7|LYN|WNT6|WNT11|TWF2|WNT3|AQP1
NEGATIVE REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905032,0.372037600953264,0.852609194081082,-0.81181076312307,-1.0859840097324,2809,1,KCNE3
CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042398,0.48059807760769,0.9046812288131709,0.233937412962198,0.9888517679636909,5399,31,PTDSS2|GAMT|GGT1|DHFR|MTHFD1|ACADM|MGST2|OPLAH|HAGH|ALDH9A1
REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060167,0.24988864142539002,0.7613646381106121,-0.7071408877860491,-1.2095266165145702,1682,2,ADA|NECAB2
ARGININE CATABOLIC PROCESS%GOBP%GO:0006527,0.0503869586695208,0.44079050471084996,-0.691225332957157,-1.5896738637713101,305,4,NOS3|DDAH1
EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030855,0.0217176702862784,0.30979012714130605,-0.16014026962151098,-1.3543854602023997,21,204,RAB25|RAB10|MTSS1|LAMA5|TDRD7|RAP1B|SOD1|NOTCH1|OPHN1|FURIN|ID2|HNRNPH3|VEGFA|CAPNS1|RAB13|F11R|CTNNB1|KRT17|ACVR1|PDPN|SLC4A7|COL23A1|ANXA7|IRF6|CES1|RHOA|NRP1|PSAP|ZNF703|NKX6-1|SIPA1L3|RILPL2|CASP3|MYADM|CLIC4|TJP2|KAZN|PPARG|RAP2B|PODXL|NFIB|RAB1A|SPINK5|PAX8|ICAM1|RAP1A|KRT9|WNT11|PGK1|CDC42|LGALS3|MSN|RAPGEF1|GSTM3|PKP4|ASCL1|EVPL|ACVRL1|SLC9A3R1|MET|TAGLN2|SH3BP1|SOX17|RILPL1|PDE4D|INSM1|RBPJ|DACT2|STC1
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0045820,0.008397826444920141,0.202735282440703,-0.793911652787735,-1.8258309474580101,50,4,CBFA2T3|HDAC4|FBP1|PPARA
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902108,0.0302155076649633,0.35738308321874895,-0.37952606463189,-1.63263680750108,135,18,CAMK2A|ACAA2|BNIP3L|BMF|BCL2L11|PMAIP1
NEGATIVE REGULATION OF DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:1903073,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
ESTABLISHMENT OF BLOOD-BRAIN BARRIER%GOBP%GO:0060856,0.661456524256107,0.964618776001639,0.45948599061479906,0.873434532046832,5712,3,MFSD2A|MXRA8
RESPONSE TO OXYGEN RADICAL%GOBP%GO:0000305,0.322375590265165,0.822751772025005,-0.37342224188541395,-1.0892892468177,1774,7,SOD1|SOD3|SOD2|NOS3
NEGATIVE REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902948,0.642684563758389,0.9620807249753851,0.6838883987648879,0.908515227334604,4787,1,SORL1
MAINTENANCE OF UNFOLDED PROTEIN INVOLVED IN ERAD PATHWAY%GOBP%GO:1904378,0.111497047585967,0.5855068018166539,0.70524980699239,1.34060569359756,962,3,USP13|BAG6|GET4
REGULATION OF ESTRADIOL SECRETION%GOBP%GO:2000864,0.8550244935787099,0.991298302704726,-0.570963828848699,-0.763795722392105,6457,1,SPP1
MICROTUBULE ANCHORING AT CENTROSOME%GOBP%GO:0034454,0.649304855933911,0.963755998259649,0.288219182065636,0.8506092681394308,6444,10,CCDC68|CCDC120|NINL|PCM1|HOOK3
GLUCURONATE METABOLIC PROCESS%GOBP%GO:0019585,0.6771528998242529,0.9647315640607691,-0.29961775373439004,-0.8224306161399529,3852,6,SORD|XYLB
CARDIAC PACEMAKER CELL DIFFERENTIATION%GOBP%GO:0060920,0.22124107898875,0.73556947110949,0.722717608473246,1.1812620768353899,1828,2,MAML1|MESP1
"NEGATIVE REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0045814",0.0277958387516255,0.342627407098241,0.29857172918219,1.53795069630862,341,68,RBBP7|SIRT4|HIST1H3E|SIRT1|MBD3|RRP8|DOT1L|TRIM27|MTF2|HIST2H3C|CREBZF|HIST2H3A|PCGF2|DNMT3B|EZH2|H2AFY2|HIST1H4I|HELLS|PHF19|H3F3A|JARID2|NRDE2|KMT2D|RIF1|SUZ12|EED|HIST1H3H|UBR2|HIRA|MBD1|PCGF1|DNMT1|PPM1D|SUV39H1|PHF1
SPEMANN ORGANIZER FORMATION%GOBP%GO:0060061,0.6731100225076129,0.9647315640607691,-0.658689898544332,-0.881149560569395,5083,1,FZD5
STEROL IMPORT%GOBP%GO:0035376,0.6432774024842011,0.9621972042482541,0.37321239621836,0.8601992477173391,5903,5,SCARB1|STARD5|LDLR
REGULATION OF ANATOMICAL STRUCTURE SIZE%GOBP%GO:0090066,0.0783475783475783,0.532203813468543,-0.137393101206271,-1.22090798142401,54,264,PRKCD|DNM2|RTN4|RAP1GAP2|CFL2|PTK2B|HMOX1|VASP|PFN1|ABL1|VAV1|SEMA3F|MAP3K13|RHOA|ADRA1B|NRP1|WDR1|TMSB10|MYADM|WHAMM|NAT6|SEMA7A|DOCK5|ARPC5|VIP|POU4F2|LAMTOR5|ISLR2|SOD2|BIN1|SERPINF2|WIPF1|TMSB4X|LIMK1|VAV3|ARPC5L|VAV2|ARPC4|TWF1|MSN|SEMA6B|EDNRA|ADRB2|MTPN|ARPIN|SSH3|TWF2|NOS3|ANO6|ADCYAP1|RAB22A|RAB5A|BDKRB2|PER2|ACE|SLC9A3R1|SEMA3A|RAC1|SEMA3G|ACTR2|BRK1|ADM|SH3BP1|OLFM1|JMY|AQP1|CAV1
POSITIVE REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000627,0.803193419620177,0.984522820758988,0.48574579542321505,0.793938158401641,6639,2,PNPT1|ZC3H12A
GLUTAMATE BIOSYNTHETIC PROCESS%GOBP%GO:0006537,0.0846358689359731,0.545178773025535,0.7287672749054749,1.3853099261555701,730,3,GLS|GLS2
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0090407,0.972451790633609,1.0,-0.0846148467147294,-0.781021991277901,352,378,APOA1BP|SLC44A5|CMPK2|ATP5J|AGPAT4|LDHA|PCYT2|PAPSS1|SYNJ2|SCD|MTMR2|ADCY7|PIK3C3|LHPP|CMPK1|PIGA|ACSL1|DPM1|PIGG|PIGZ|PIGY|PFKL|COX5B|GPI|MOCS3|GMPS|RRM2B|GUCY1A3|ATIC|DPM2|PRPS1|G6PD|ABHD5|CDIPT|INPP5K|GARS|DGKQ|CPNE6|MPPE1|CPNE3|PKM|FGF2|PNP|ENO1|PLD6|NAMPT|DCTD|ACSL4|HPRT1|PIP4K2A|ATP5I|PRPSAP1|PIGT|LPIN1|PDHB|GAPDH|PGK1|PLA2G2A|CDADC1|SORD|PANK2|KARS|XYLB|CYC1|HK1|PCYT1A|NMNAT3|HK2|TPI1|PNPO|ACLY|ADCY2|AGPAT3|ARF3|AK7|PDXK|ALDOA|RAB5A|TKT|SLC25A13|LPCAT1|GPAT2|ACSL3|PLD2|PMVK|MTMR14|ADM|PGAM2|CDS2|AK4|NMNAT2
REGULATION OF PEROXISOME SIZE%GOBP%GO:0044375,0.539307629964108,0.928041735228137,0.501488915848682,0.9532776743745601,4657,3,PEX11G|PEX11B|PEX11A
REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045685,0.11469334815638302,0.592093684170156,0.35675437237240293,1.3662864901695901,1237,22,SLC45A3|CXCR4|HES1|SERPINE2|CDK1|AGER
MITOTIC NUCLEAR ENVELOPE DISASSEMBLY%GOBP%GO:0007077,0.190607191982708,0.6986011331863089,0.403848409867027,1.27307450967292,1939,12,CCNB1|CDK1|PRKCB|CCNB2|PLK1|VRK1|CNEP1R1|NEK9
NEGATIVE REGULATION OF CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090349,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
5-PHOSPHORIBOSE 1-DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046391,0.3754322410670179,0.852871276063039,-0.456539295033466,-1.0499450041774698,2279,4,PRPS1|PRPSAP1
AORTA MORPHOGENESIS%GOBP%GO:0035909,0.613718070009461,0.9508825506493929,0.241747003055517,0.883622283516022,6486,19,TBX2|HES1|PROX1|TGFB2|HEY2|MYLK|TFAP2B|DLL4|JAG1|LRP1|BMPR1A|HEY1
SECONDARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902653,0.113826940231936,0.590080021815051,0.325382182825824,1.3643051198222,1275,30,TM7SF2|C14orf1|EBP|MVD|LBR|DHCR24|PPAPDC2|APOE|NSDHL|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7
SPINDLE ORGANIZATION%GOBP%GO:0007051,0.0134536003669164,0.25405367808039003,0.27461425254571803,1.5561559700524898,175,110,CEP63|ASPM|CCNB1|RCC1|CEP126|SPAG5|RGS14|TBCE|WDR62|CKAP5|NUMA1|KIF4A|MAP10|NUF2|KIF23|PRC1|KIF11|TTK|TUBGCP3|NEK2|STIL|HAUS5|NDC80|GPSM2|WRAP73|CENPE|INO80|AURKB|GOLGA8A|CEP72|KIFC1|TUBG2|HDAC3|ASUN|TUBGCP6|HAUS8|CEP192|STMN1|CHEK2|TUBGCP2|RACGAP1|AURKA|GOLGA8N|DYNC1H1|SPC25|TUBGCP4|FAM175B|GOLGA8B|TPX2|CCDC69|CHD3
VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0047496,0.0447098028325465,0.41504430757275895,-0.27465467168068397,-1.49302470729918,160,35,BLOC1S4|HAP1|RAB1A|AP3S2|BLOC1S6|KIF3B|TRAK1|HTT|BLOC1S3|KIF13A
ISOLEUCINE METABOLIC PROCESS%GOBP%GO:0006549,0.999338011386204,1.0,-0.500551389501544,-0.669602855420138,7547,1,ACAT1
REGULATION OF RESPONSE TO ALCOHOL%GOBP%GO:1901419,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
CAMERA-TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0060219,0.5030798521670959,0.9164921159310329,0.46019568029733293,0.9751986067318629,4491,4,DSCAM|TOPORS|SDK2
RRNA METHYLATION%GOBP%GO:0031167,0.10658379373849,0.5814012543159189,-0.305267398419198,-1.36207428101235,462,20,FTSJ2|METTL16|NSUN5|NSUN3|TRMT112|WBSCR22|RNMTL1|EMG1
UDP-GLUCURONATE BIOSYNTHETIC PROCESS%GOBP%GO:0006065,0.776658562000695,0.980802382590629,0.4142326168498521,0.7874126289959019,6707,3,SLC35D1
REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000973,0.46617445054945095,0.894322345600068,-0.384991742093267,-0.9745810303424279,2714,5,FLCN|NOTCH1|NUDT21
ISOPRENOID BIOSYNTHETIC PROCESS VIA MEVALONATE%GOBP%GO:1902767,0.9267114093959731,1.0,0.539589766210851,0.71682093160497,6903,1,HMGCS1
REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051438,0.4412981228126,0.880402968441571,-0.168161082349362,-1.0108866782641899,1386,48,DCUN1D2|MAGEC2|MAD2L2|PARK7|RPL11|UBE2N|DCUN1D5|BMI1|FBXW7|ZER1|MAGEA2|ARRDC3|ABL1|DCUN1D3|RAB1A|BAG5|LIMK1|SMAD7|UBE2L3|TRIB3
METANEPHRIC MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072209,0.6561247216035639,0.9640743070248079,-0.4995864350703061,-0.854515841049754,4418,2,PDGFB|CD34
NEGATIVE REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032682,0.7329816878980892,0.9733535228116099,0.257449204497839,0.785418508065947,7364,11,SIGIRR|C1QTNF3|F2RL1|GSTP1
ACETATE METABOLIC PROCESS%GOBP%GO:0006083,0.899194630872483,0.998912093067348,0.5520511689457429,0.733375349195683,6698,1,ALDH5A1
QUORUM SENSING INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0052106,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
NEGATIVE REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001183,0.820468687938567,0.987153241368501,-0.587450374944861,-0.785850277775518,6196,1,LILRB1
REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902105,0.9948486799742429,1.0,-0.0776423195063389,-0.612255065842864,1544,136,RUNX1|FAM213A|UBASH3B|TNFRSF18|PNP|FCGR2B|POU4F2|SPINK5|FOXP1|CAMK4|SMAD7|LGALS3|NLRP3|PRKCA|NFATC2|SOCS5|BCL6|NKAP|DUSP10|CBFB|TNF
DETERMINATION OF LEFT/RIGHT ASYMMETRY IN LATERAL MESODERM%GOBP%GO:0003140,0.460430586488493,0.8904234666384399,-0.582740556934105,-0.996746513047881,3100,2,SMO|CITED2
MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002281,0.0908091123330715,0.560322217247896,-0.7199123044261059,-1.4610406322988603,577,3,SBNO2|DYSF
NITROGEN CYCLE METABOLIC PROCESS%GOBP%GO:0071941,0.22442882249560603,0.738039263175087,-0.44081447912733,-1.21000614667678,1276,6,ASS1|SLC25A15|ASL
CAAX-BOX PROTEIN MATURATION%GOBP%GO:0080120,0.36724325632031,0.851186780857897,0.6575339481300461,1.07472117470433,3035,2,RCE1|ZMPSTE24
NEURAL CREST FORMATION%GOBP%GO:0014029,0.6460225208863061,0.963344312748158,-0.290623276337562,-0.8477609908586429,3556,7,KLHL12|LRP6|PEF1|PDCD6|TCOF1|KBTBD8|NOLC1
REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904748,0.431833791208791,0.8785877309899279,-0.396546343223345,-1.00383073583824,2514,5,NOTCH1|TNFRSF1B|PAX8
LUNG CELL DIFFERENTIATION%GOBP%GO:0060479,0.0903377847604085,0.560121322881739,-0.7211054908410791,-1.46346216867693,574,3,NFIB|ASCL1
RESPONSE TO HYDROGEN SULFIDE%GOBP%GO:1904880,0.39017608897127004,0.8607749921056059,-0.802492280546978,-1.07351839147221,2946,1,KDR
PROGESTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0006701,0.0346882033629022,0.379769573488262,-0.982741508601676,-1.31464327959387,261,1,ADM
ADAPTIVE THERMOGENESIS%GOBP%GO:1990845,0.0399484536082474,0.39854598807601505,0.633814138347695,1.5587735671296599,371,6,THADA|OMA1|UCP3
LEUKEMIA INHIBITORY FACTOR SIGNALING PATHWAY%GOBP%GO:0048861,0.10871956009426599,0.58452352834625,-0.702051395169295,-1.42479244763309,691,3,LIFR|IL6ST|LIF
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904684,0.818376420220649,0.987153241368501,-0.316163900071693,-0.7271109212126109,4969,4,SORL1|RECK|TIMP3|PICALM
COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032964,0.190292096219931,0.698434241409875,0.515867768589163,1.26870164794246,1771,6,COL5A1|P3H4|COL1A1|TRAM2|P3H3
CELL WALL MACROMOLECULE METABOLIC PROCESS%GOBP%GO:0044036,0.68852062416838,0.96731875442989,0.5338847532395921,0.872619962497978,5691,2,MPI|MANBA
GLYCEROL METABOLIC PROCESS%GOBP%GO:0006071,0.297267206477733,0.802059662182752,0.40348831541443,1.15141778960417,2936,9,COQ3|TKFC|COQ2|PGP|PCK2|GK5|GOT1|GK
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034136,0.0717989002356638,0.515023940206536,-0.739936031763538,-1.5016781919991202,456,3,MFHAS1|TNFAIP3|LYN
REGULATION OF OLIGOPEPTIDE TRANSPORT%GOBP%GO:0090088,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
CHONDROCYTE MORPHOGENESIS%GOBP%GO:0090171,0.5572139303482591,0.9361453421204542,-0.250488266088233,-0.912553879821217,2687,12,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS%GOBP%GO:0006515,0.0925066011108076,0.5622489437340121,0.354901897392096,1.41423300835849,1015,25,OMA1|SDF2|CLPP|LONP1|POMT2|ATXN3|RNF126|NGLY1|HDAC6|ANKZF1|BAG6
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT%GOBP%GO:0060706,0.13226565124874,0.617376395245317,0.6263166218833239,1.32722475065172,1180,4,E2F8|E2F7
REGULATION OF DNA N-GLYCOSYLASE ACTIVITY%GOBP%GO:1902544,0.49606870690697996,0.911504921234493,0.6055462851620921,0.98974876776786,4100,2,TDG
PROPIONYL-COA METABOLIC PROCESS%GOBP%GO:1902858,0.999338011386204,1.0,-0.500551389501544,-0.669602855420138,7547,1,ACAT1
POSITIVE REGULATION OF SPINDLE ASSEMBLY%GOBP%GO:1905832,0.0391981184903125,0.396089810860281,0.7190757183036449,1.52379013677694,349,4,SPAG5|NUMA1|GPSM2|DYNC1H1
POSITIVE REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000066,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
KERATAN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0018146,0.614781368821293,0.9511905259737851,-0.19122274358266603,-0.885885329365723,2586,22,B4GALT6|PRELP|B4GALT4|ST3GAL4|B3GNT4|FMOD|ST3GAL6|B4GALT3|OGN|ST3GAL3|LUM|CHST2|SLC35D2|B4GALT2|ST3GAL1|B4GAT1|CHST1|B4GALT1|B4GALT5|ST3GAL2|B3GNT7|B3GNT2
CELLULAR KETONE BODY METABOLIC PROCESS%GOBP%GO:0046950,0.653296193129062,0.9640743070248079,-0.271148265491724,-0.8428468691190079,3517,8,SLC27A5|BDH1|OXCT1
POSITIVE REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060168,0.38368860055606996,0.8582519754973359,-0.805855756506396,-1.07801781581464,2897,1,NECAB2
NEGATIVE REGULATION OF INTRACELLULAR CALCIUM ACTIVATED CHLORIDE CHANNEL ACTIVITY%GOBP%GO:1902939,0.18644295302013397,0.692707054555662,0.9089104543449491,1.20744698922709,1388,1,ANO9
NEGATIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0010920,0.5371375612339471,0.9265056012720759,-0.7271724746360829,-0.972760790623571,4056,1,PLEK
T CELL COSTIMULATION%GOBP%GO:0031295,0.163565676201055,0.6657191357988879,-0.229987578124163,-1.2502140757703502,588,35,PTPN6|CD274|ICOSLG|MAP3K8|GRB2|VAV1|FYN|LYN|YES1|CDC42|RAC1|PIK3R1|CAV1|PAK2
SULFATE TRANSPORT%GOBP%GO:0008272,0.8478744939271259,0.991298302704726,0.24119946005586698,0.6883008467444549,8376,9,SLC26A2|SLC25A10|RACGAP1|SLC25A30|SLC13A4|SLC26A6
POSITIVE REGULATION OF TONGUE MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001037,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
POSITIVE REGULATION OF DNA RECOMBINATION%GOBP%GO:0045911,0.910960860870393,1.0,0.172528824100254,0.618896065674097,9565,18,MMS19|BLM|WRAP53|PAXIP1|RIF1|C5orf45|FAM35A|TP53BP1|WAS
NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:1904673,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
POSITIVE REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032892,0.12386487468216499,0.607607158836689,-0.47111548749113,-1.3742647785046398,681,7,RAB3GAP1|IL1B|TNFRSF11A|TRH
PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:0045040,0.0302980405071629,0.35738308321874895,-0.725914079302928,-1.66945073363363,183,4,HSP90AA1|HSPA4|TOMM22|SAMM50
VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099625,0.18362857473659802,0.689876118998471,0.655122973420095,1.2453198561215901,1585,3,KCNQ1|KCNH2|KCNJ8
LUNG MORPHOGENESIS%GOBP%GO:0060425,0.448317307692308,0.8850378987593649,-0.39054235727609904,-0.9886320440979621,2610,5,CTSH|FGF10
CELLULAR RESPONSE TO CAFFEINE%GOBP%GO:0071313,0.661104266995184,0.964618776001639,0.4065415024789771,0.86150027862066,5902,4,RYR2|SLC8A1|GSTM2
NEGATIVE REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046600,0.135593220338983,0.623227463256235,0.49256719223643697,1.3428703136846398,1303,8,KAT2A|CDK5RAP2|TRIM37|MDM1|BRCA1|KAT2B
ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0001973,0.309148682642659,0.8114708447293539,-0.8459417732686371,-1.1316421026499,2334,1,GNAI2
REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032434,0.0290512936904222,0.350071841748197,-0.196923909387938,-1.41528249988424,63,92,CCAR2|PSMD10|PARK7|RPL11|RYBP|RNF217|RAD23A|CSNK1D|MAP1A|CSNK1A1|TAF9|RNF19B|CBFA2T3|CLU|PLK3|USP5|TRIB1|STYX|ARIH1|PRICKLE1|CEBPA|STUB1|GLTSCR2|TRIB2|SUMO1|RNF144B|BAG5|RAD23B|SMAD7|COMMD1|SOCS5|ARIH2|GNA12|PARK2|HSPBP1|DDRGK1|BCAP31|HSP90AB1|BBS7|CAV1|TRIB3
LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:0071887,0.181801670904468,0.6873049536419911,-0.43644422963054796,-1.2731271811015301,1000,7,BAX|CTSL|IL6|TNFRSF21
SODIUM ION HOMEOSTASIS%GOBP%GO:0055078,0.9219635627530369,1.0,0.211671983705556,0.604039518093726,9108,9,ATP1B3|SLC8A1|TFAP2B|ATP1A3|ATP1A1|ATP1B1
REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043567,0.25698380566801604,0.7674783969184241,0.4179423714820229,1.19266472700574,2538,9,CDH3|ZFAND2B|IGFBP5|KIAA1161|IGFBP2
ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043542,0.15343245808288503,0.650702929144856,-0.20815162659053896,-1.2432153392378702,484,47,VEGFA|KDR|RAB13|ABL1|RHOA|NRP1|FGF2|PXN|PTP4A3|ID1|NOS3|SCG2|GREM1|MYH9|CDH13|PRSS3
SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX%GOBP%GO:0035582,0.47052709725315506,0.8975514817191559,-0.5781043107469389,-0.988816462246196,3168,2,NBL1
NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048011,0.0993982153973853,0.570215774831708,-0.371496358419775,-1.39904818488964,478,13,ZFYVE27|NGF|SORT1|NGFR|SOS1|NTRK2|FRS2|NTRK1|BCAR1|DDIT4|GRB2|CASP3|HAP1
POSITIVE REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048672,0.68852062416838,0.96731875442989,0.533829611248966,0.872529834429139,5691,2,NGF|SEMA4D
REGULATION OF PEPTIDE TRANSPORT%GOBP%GO:0090087,0.0383386581469649,0.393143354533675,-0.131501301725359,-1.23702070192149,11,408,PLK3|CX3CL1|ADRA2C|BCAS3|PRKCD|TMEM30A|UBE2J1|LGALS9|ITGAM|TNFAIP3|NR1H3|UBL5|OS9|PARL|PFKL|SSC5D|FGR|GPI|MYO1C|ATG13|STXBP4|ANO1|FYN|FAM65A|BAG4|INPP5K|ICE1|RAB11FIP1|TCF7L2|TNFRSF1B|UHMK1|VPS11|ARL2BP|APOD|GCC2|MYRIP|IL6|CSNK2A2|SLC25A4|FCGR2B|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|PANX1|MIEF1|VAMP3|MBP|IGF1|MAVS|PAX8|UQCC2|MYOM1|FOXP1|CEMIP|RIPK2|BAP1|RAP1A|LEPROT|TMSB4X|ZPR1|DPH3|PDCD10|GAPDH|PTPN1|CRH|KARS|BAG3|GIPR|NLRP1|NLRP3|PRKCA|TP53|RANGAP1|UBE2L3|YWHAE|TNFRSF4|UBE2D3|ADCYAP1|SIAH3|DRD2|PPP1R11|CABP1|ARIH2|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|ACSL3|CD22|NR1D1|CACNA1E|BCAP31|TWIST1|PIK3R1|TNF|SNX12|SNAP25|TNFRSF21|INHBB|TRH
TETRAPYRROLE BIOSYNTHETIC PROCESS%GOBP%GO:0033014,0.942194891201514,1.0,0.15836326253138597,0.578841954168487,9958,19,ALAS1|ABCB6|CPOX|ATPIF1|UROD|IREB2|UROS|ALAD|HMBS|SUCLA2|PPOX
T CELL APOPTOTIC PROCESS%GOBP%GO:0070231,0.411757590419741,0.867015886388254,0.637772263578715,1.0424212441904201,3403,2,RIPK1|AKT1
REGULATION OF TIMING OF ANAGEN%GOBP%GO:0051884,0.20892360651396805,0.7243363294845151,-0.89396779885311,-1.19588798137549,1577,1,SPINK5
REGULATION OF CELLULAR PH REDUCTION%GOBP%GO:0032847,0.127763802462598,0.6076669536424699,-0.933722981914424,-1.24906970188198,964,1,BCL2
REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051133,0.783479789103691,0.981487311948134,-0.273233688158403,-0.7500081276943169,4457,6,RASAL3|HSPH1|CD300A|ZBTB7B|IL18|IL6R
GLUTATHIONE DERIVATIVE METABOLIC PROCESS%GOBP%GO:1901685,0.447202596906626,0.88473565970262,0.286809047940881,1.01153409326857,4683,17,MGST1|GSTA4|GSTO2|MGST3|GSTP1|MGST2|GSTZ1|AKR1A1
ASTROCYTE DEVELOPMENT%GOBP%GO:0014002,0.6859311740890689,0.9665006495129341,0.28958038469748903,0.8263634750330721,6776,9,CDK6|EIF2B5|NF1|LRP1|MAPT
POSITIVE REGULATION OF LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:1901248,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
NEUROTRANSMITTER REUPTAKE%GOBP%GO:0098810,0.504535782282451,0.917139342610024,0.459629288989636,0.973998369446335,4504,4,SLC6A2|SLC29A2|SLC29A1
REGULATION OF PROTEIN MONOUBIQUITINATION%GOBP%GO:1902525,0.43664148351648396,0.878651088001772,-0.39459834135197,-0.9988994984548331,2542,5,UBB
POSITIVE REGULATION OF CORTISOL SECRETION%GOBP%GO:0051464,0.569076239091059,0.940076901516441,-0.389468712991345,-0.895696677015979,3455,4,CRH|GAL
INHIBITION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1990001,0.0983874482458052,0.570215774831708,0.609144054709905,1.40398674567705,902,5,NOL3|BIRC2|BCL2L12|XIAP|BIRC3
POSITIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045745,0.112236286919831,0.587535723436545,-0.355589301263133,-1.3776470909536298,531,14,MRAP2|FZD2|CHGA|C3|KLK14|PHB|PRMT5|VPS35|UBQLN2|GPER1|NECAB2|PRKCA|CAV2
FLOOR PLATE DEVELOPMENT%GOBP%GO:0033504,0.8719560094265508,0.9934031064448321,-0.334647696913652,-0.679157558066527,5549,3,COBL
POSITIVE REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070572,0.523765391235271,0.92593403131991,-0.733458314953683,-0.98116955087009,3955,1,SCARF1
PHOSPHATIDYLSERINE ACYL-CHAIN REMODELING%GOBP%GO:0036150,0.41471079249729903,0.8695737743071128,0.323157885732114,1.0429506155288,4222,13,LPCAT4|PLA2G4A|OSBPL5|OSBPL8|PLA2G2D|PLA2G12A|PLA2G4B
RESPONSE TO PROTOZOAN%GOBP%GO:0001562,0.390625,0.860837094563899,-0.4096186660046311,-1.03692245291218,2274,5,CLEC7A|BATF|SLC11A1
ANATOMICAL STRUCTURE HOMEOSTASIS%GOBP%GO:0060249,0.38298180763934203,0.8582519754973359,0.173002536167109,1.05597085702391,5283,176,PCDH15|CALB1|GCNT2|STK39|CDH3|IQCB1|ADGRV1|F2R|XRCC3|ATR|PIWIL4|BLM|SERPINA3|DFNB31|EXO1|CDH23|RFC4|DNA2|DCLRE1A|ORAOV1|NAPSA|POLD1|TERT|PARP1|SRC|TYRO3|FEN1|POLD3|BBS10|POLA2|SLX1B|HIST1H4I|RAD51|JCHAIN|IL7|ZNF675|RTEL1-TNFRSF6B|CXADR|DCLRE1C|SRF|SLC6A2|TAOK1|CALB2|TF|DMD|SLX4|NPHP3|CNGB1|WRAP53|ACTG1|TEN1|PRR4|TNKS1BP1|TELO2|CTC1|PRIM2|RIF1|BBS1|PRKDC|LARGE|ACD|RFC3|LCN1|SMC6|RFC5
ANTIGEN PROCESSING AND PRESENTATION OF POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002505,0.7904923188581109,0.9819233677232551,0.49004687069203207,0.800968147771073,6534,2,HLA-DRB1|HLA-DRA
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045639,0.97912053147738,1.0,-0.0960023103537935,-0.573387519420593,3094,47,HIF1A|TESC|HAX1|ZNF16|LIF|RUNX1|POU4F2|ETS1|PRKCA|STAT3|TNF|FOXO3
TELOMERIC DNA-CONTAINING DOUBLE MINUTES FORMATION%GOBP%GO:0061819,0.548032665181886,0.9305779599215391,-0.542597187758478,-0.9280834300143019,3690,2,ERCC4|ERCC1
RESPONSE TO MURAMYL DIPEPTIDE%GOBP%GO:0032495,0.106984255147356,0.5822715745664481,-0.39545496891851395,-1.39165530507666,529,11,VIM|RIPK2|LDOC1|ARHGEF2|NLRP1
PROTEASE LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033375,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
POSITIVE REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:1902953,0.420581304006284,0.8727872721376851,-0.498059683109188,-1.01079732886703,2676,3,STX18|TBC1D20
REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034110,0.7626112759643922,0.978421368343614,0.219823500757594,0.762068463213791,7966,16,CEACAM1|SERPINE2|PRKCQ|CCL5|ANK3
COPPER ION TRANSPORT%GOBP%GO:0006825,0.323701679031628,0.8239814796253909,-0.33999626996957205,-1.0975384272581,1657,9,SLC31A1|STEAP3
REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904526,0.577006901561933,0.942692029750853,-0.30660617082477004,-0.8943838031743578,3176,7,ABL1|PPP2CA|PPP2CB
REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0043555,0.0593484125337207,0.476295606439141,-0.403181996245913,-1.51837569129184,285,13,RPS6KA3|ATF4|DNAJC3|EIF2S1|IMPACT|EIF2AK3|SESN2
FOREBRAIN DORSAL/VENTRAL PATTERN FORMATION%GOBP%GO:0021798,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045648,0.9461325966850831,1.0,-0.138778679654129,-0.619217352683585,4109,20,ETS1|STAT3|FOXO3
NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042308,0.5520891364902509,0.9321968967758479,-0.29323442437199104,-0.9115002673966609,2972,8,APOD|CHP1|CABP1
NEGATIVE REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050858,0.7187291712952679,0.971081608033886,-0.187854445803159,-0.808108088619487,3234,18,PRNP|LGALS3|DUSP3|CD22
REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097746,0.00892857142857143,0.207969158127386,-0.302520595105399,-1.7336843340181003,29,41,DOCK5|VIP|SOD2|SERPINF2|EDNRA|ADRB2|NOS3|ADCYAP1|BDKRB2|PER2|ACE|ADM|CAV1
POLYOL TRANSPORT%GOBP%GO:0015791,0.22981099656357395,0.743397546142977,0.496795216359321,1.22179548338279,2139,6,SLC2A13|PGAP1
POSITIVE REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001114,0.354163908380776,0.842911430859438,-0.8222871636524041,-1.0999986101432602,2674,1,CNKSR3
POSITIVE REGULATION BY ORGANISM OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052330,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:2000042,0.696000772797527,0.96731875442989,0.240449844952625,0.8152721355545319,7204,15,FBXO18|POLQ|RMI2|PARPBP|RIF1|RECQL5|FAM35A|MAGEF1|TP53BP1
TUBE MORPHOGENESIS%GOBP%GO:0035239,0.0373333333333333,0.38702164012069,-0.14692745268269,-1.2940808180231298,27,252,HAND1|RAMP3|MTSS1|LAMA5|NRARP|FUZ|NOTCH1|LRP5|ID2|STRA6|VEGFA|ITGB8|KDR|IFT122|BCAS3|CTNNB1|DAB2IP|SKI|TGFBR1|PTK2B|ACVR1|HMOX1|DLC1|CELSR1|PRKD2|PRICKLE1|EIF2AK3|COL23A1|CALCRL|RHOA|NRP1|ITGA5|AAMP|BCL10|CLIC4|APOD|FGF2|ADAMTS9|PODXL|MICAL2|APLNR|PAX8|SERPINF2|WNT11|SMAD7|RAMP2|NPNT|FGFR1|LEPR|ATOH8|CCDC103|CXCL8|CTSH|ID1|ADM2|TBX20|MKKS|RBPMS2|SCG2|COBL|FLT1|MCAM|FGF10|GREM1|MYH9|SFRP2|BMPER|ACVRL1|MET|ADM|PGF|SOX17|CDH13|DNAAF1|BBS7|RBPJ|CAV1|EPHB2|RAMP1
POLYAMINE HOMEOSTASIS%GOBP%GO:0010509,0.0146961472262677,0.264001457476971,-0.9931076312307009,-1.3285103578951398,110,1,EIF5A2
POSITIVE REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031065,0.9298811202901469,1.0,0.201131838750045,0.593592018867616,9229,10,AKAP8L|NIPBL|ING2|PRKD1
T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033077,0.307231283159756,0.810217844381334,0.36190656702920704,1.14085883245106,3126,12,LIG4|JAG2|CD3D|CD3G|CD3E|ZAP70|RIPK3|FADD|PTPRC|ZFP36L1|ZFP36L2
RESPONSE TO HEPATOCYTE GROWTH FACTOR%GOBP%GO:0035728,0.0674793956043956,0.502793556475766,-0.597284591245693,-1.5119862810014901,392,5,BCAR1|NRP1|HGF
ASYMMETRIC GOLGI RIBBON FORMATION%GOBP%GO:0090164,0.5547141796585,0.93388446979002,-0.539674662255307,-0.923084606661583,3735,2,MYO18A|GOLPH3
PROTEIN TYROSINYLATION%GOBP%GO:0018322,0.4873560174764989,0.907789754052198,-0.75452139391266,-1.00934627380141,3680,1,TTL
NEGATIVE REGULATION OF INTRALUMENAL VESICLE FORMATION%GOBP%GO:1905366,0.00400890868596882,0.148195394527521,-0.956217259443066,-1.63555841055671,26,2,RAB7A|PARK2
REGULATION OF TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:1905838,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
CELLULAR RESPONSE TO OXYGEN RADICAL%GOBP%GO:0071450,0.322375590265165,0.822751772025005,-0.37342224188541395,-1.0892892468177,1774,7,SOD1|SOD3|SOD2|NOS3
PROTEIN C-LINKED GLYCOSYLATION VIA TRYPTOPHAN%GOBP%GO:0018317,0.9905563186813191,1.0,-0.19832340613280397,-0.50204253327362,5768,5,DPY19L3|DPY19L2|DPY19L4|DPM3|DPY19L1
REGULATION OF HEART RATE%GOBP%GO:0002027,0.33881270760582594,0.8326275783736579,0.23670700223773003,1.09739734223333,3977,43,RYR2|TNNI3K|EDN1|CACNA1G|AKAP9|CACNB2|KCNQ1|CACNA2D1|KCNH2|CACNA1D|RNLS|ATP2A2|SPTBN4|DMD|SCN3B|SLC8A1
NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034183,0.484543244182008,0.9064456896937672,0.522444027793096,0.993111137785857,4184,3,NAA10|ATRX|TNKS
CELL-CELL SIGNALING INVOLVED IN CELL FATE COMMITMENT%GOBP%GO:0045168,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905342,0.482360846679359,0.9053012218786121,0.46772052171872797,0.9911444645141031,4306,4,NDC80|CENPQ|CDT1|TRAPPC12
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL%GOBP%GO:0086036,0.29964850615114197,0.802472218138634,-0.408093771231257,-1.12019000053693,1704,6,SLC9A1|PLN|EHD3
FUCOSE CATABOLIC PROCESS%GOBP%GO:0019317,0.0044229149115417,0.155321503601441,0.704831306259653,1.8345278050541398,41,7,FUT9|FUT7|FUT2|FUT8|FUT10
T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0042088,0.286436394271272,0.7957186177819849,0.446844695310134,1.16304285976962,2719,7,IL18BP|EBI3|LEF1|TLR4|HMGB1
CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060352,0.792400370713624,0.9819233677232551,-0.600794000882223,-0.803700453035671,5984,1,GOLPH3
ECTODERMAL PLACODE DEVELOPMENT%GOBP%GO:0071696,0.43487321986801,0.878651088001772,0.5408044290019051,1.02801232904209,3755,3,PROX1|HDAC2|HDAC1
NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070244,0.100845200879935,0.5713242454960451,0.714573749712439,1.3583295278664198,870,3,BMP4|BLM|JAK3
AXIS ELONGATION INVOLVED IN SOMITOGENESIS%GOBP%GO:0090245,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086005,0.803397819895905,0.984522820758988,0.225382955500739,0.7273945725838008,8180,13,RYR2|KCNQ1|KCNH2
PHARYNGEAL SYSTEM DEVELOPMENT%GOBP%GO:0060037,0.479896496815287,0.9046812288131709,0.32337747345904405,0.986550543986903,4821,11,HES1|BMP4|TGFB2|GATA3|PTCH1|ISL1|BMPR1A|BMPR2|BMP7
MEIOSIS II CELL CYCLE PROCESS%GOBP%GO:0061983,0.0791097133180114,0.532203813468543,0.825034463744141,1.3484961659672299,653,2,BUB1|BUB1B
BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0086043,0.43189316575019604,0.8785877309899279,-0.49383828267253294,-1.00223012210416,2748,3,SCN5A
REGULATION OF PROTEIN KINASE A SIGNALING%GOBP%GO:0010738,0.28513136942675205,0.794258537514783,0.37999164957956605,1.1592674177123201,2864,11,AKAP5|ADGRV1|C8orf4
PURINE-CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT%GOBP%GO:0072530,0.353020134228188,0.842847021021096,0.827911336568152,1.0998432748874498,2629,1,SLC25A42
FOLIC ACID-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0006760,0.8936446173800259,0.9976191001250191,0.169647002238771,0.649708665699689,9645,22,GGH|FTCD|DHFR|MTHFD1|SLC46A1|TYMS|MTHFD2L|SLC19A1|PM20D2|MTHFR|ALDH1L2|FOLR2|MTHFS
LEUKOTRIENE METABOLIC PROCESS%GOBP%GO:0006691,0.275262692723166,0.7884684708511421,0.36371021164176004,1.1738280445996498,2802,13,DPEP1|GGT1|MGST3|MGST2|GGT5|LTA4H
PROSTAGLANDIN TRANSPORT%GOBP%GO:0015732,0.7885310290651999,0.9819233677232551,-0.3689156730249629,-0.748703397438149,5018,3,ABCC4
REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035065,0.223413503332367,0.7360157208449051,-0.211076940685083,-1.18154907588105,770,38,SET|BRD7|NOC2L|SPI1|FLCN|IL1B|SIN3A|WBP2|LIF|CTBP1|HDAC5|ARRB1|RUVBL2|SNCA|PPARGC1A|TADA2B|MAPK3
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008543,0.197227036395147,0.7110878876919859,-0.18908681421537302,-1.1918034511631201,568,57,ANOS1|GRB2|FGF7|HNRNPF|FGF2|SHOC2|POLR2A|FGFR1|POLR2K|FLRT1|POLR2F|MAPK3|NCBP2|POLR2I|POLR2D|FGF10|SPRED2
CELLULAR POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0044264,0.15070975536091802,0.6462724646639479,-0.219308230009161,-1.26279263643893,498,42,PYGB|B3GNT5|B3GNT7|CSGALNACT1|PER2|B3GNT8|B3GNT2|NR1D1
POSITIVE REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051222,0.4606741573033711,0.8905215852839309,-0.11540476833608501,-1.0049456068034799,368,238,GPER1|FBXW7|OAZ2|BLK|HPS4|CD274|VPS28|IL1B|C2CD2L|PLK3|BCAS3|PRKCD|TMEM30A|LGALS9|ITGAM|UBL5|FGR|GPI|MYO1C|ATG13|ANO1|FYN|FAM65A|ICE1|TCF7L2|VPS11|MYRIP|IL6|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|PANX1|MIEF1|VAMP3|MBP|IGF1|MAVS|MYOM1|CEMIP|RIPK2|BAP1|LEPROT|ZPR1|PDCD10|GAPDH|KARS|BAG3|NLRP1|NLRP3|TP53|UBE2L3|YWHAE|TNFRSF4|UBE2D3|DRD2|ARIH2|ACSL3|BCAP31|TWIST1|PIK3R1|TNF|TRH
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002703,0.9392127553562529,1.0,-0.0995633507068034,-0.733673439054489,1884,103,LGALS9|ITGAM|ARRB2|LAMP1|FGR|ULBP3|C20orf196|TNFRSF1B|IL6|LYN|FCGR2B|VAMP2|VAMP3|MAVS|SMAD7|TFRC|ULBP2|NLRP3|SNX6|GAB2|B2M|TICAM1
POSITIVE REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900127,0.6561247216035639,0.9640743070248079,-0.4995864350703061,-0.854515841049754,4418,2,PDGFB|NFKB1
CELLULAR METAL ION HOMEOSTASIS%GOBP%GO:0006875,0.8891514351240529,0.997300970905927,0.11865980283073,0.7699657401651329,12793,285,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|ATP1B3|P2RX5|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|TMEM178A|MT1E|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|SLC39A7|SLC46A1|DMPK|SLC40A1|GRIN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|SLC39A13|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1|ACO1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1
NCRNA 5'-END PROCESSING%GOBP%GO:0034471,0.137171561051005,0.62388141596544,0.39664687313703095,1.3448756574876002,1419,15,RPP30|RPP25|POP1
L-ASCORBIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0019853,0.25196564654651,0.763905256448548,0.708795147504825,1.1585061968548898,2082,2,RGN|AKR1A1
REGULATION OF ACTION POTENTIAL%GOBP%GO:0098900,0.201742444867955,0.7158895713430921,-0.22563446506929397,-1.20686696275945,740,33,CHRNB2|KCNE3|PTPN3|RANGRF|SUMO1|BIN1|FMR1|SLMAP|SCN5A|CD36|DLG1|CAV1
POSITIVE REGULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044148,0.66,0.9643779777660141,0.675727834142038,0.8976742813017479,4916,1,OSBP
DENDRITE MORPHOGENESIS%GOBP%GO:0048813,0.5061072756240039,0.9172434440873181,-0.182081584456327,-0.957482327100572,1905,31,CHRNA7|ARC|CDC42|SDC2|ZNF365|SEMA3A|EPHB2
"VACUOLE FUSION, NON-AUTOPHAGIC%GOBP%GO:0042144",0.47731543624161105,0.904028012305274,0.766100573445082,1.0177304336521,3555,1,VPS41
NEGATIVE REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051444,0.544516129032258,0.929758904310055,-0.232301666805307,-0.9264398008126071,2531,15,MAD2L2|PARK7|RPL11|ABL1|BAG5|LIMK1|SMAD7
CELLULAR RESPONSE TO INTERLEUKIN-13%GOBP%GO:0035963,0.21930215293244198,0.734713083559597,-0.7263303005238492,-1.24234907928337,1476,2,SHPK|CD300LF
POLYPRENOL CATABOLIC PROCESS%GOBP%GO:0016095,0.599612918833918,0.9503391896930079,0.566766298410073,0.9263639447702429,4956,2,SRD5A3|AKR1C3
REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901983,0.671793193717278,0.964671573446318,-0.14429144846726502,-0.879283353671232,2052,51,RPS6KA5|TERF2IP|GSK3B|SMAD4|SET|PARK7|BRD7|NOC2L|SPI1|FLCN|IL1B|SIN3A|MAGEA2|WBP2|PRKAA1|LIF|CTBP1|HDAC5|ARRB1|RUVBL2|SNCA|PPARGC1A|TADA2B|MAPK3
LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002232,0.7844295302013421,0.981487311948134,0.60967137185708,0.8099212181438941,5843,1,SLAMF8
REGULATION OF LIPID TRANSPORT BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072369,0.855976243504083,0.991298302704726,-0.41218637992831497,-0.7050227275769221,5764,2,HNRNPK|PPARA
POLYNUCLEOTIDE DEPHOSPHORYLATION%GOBP%GO:0098501,0.9491544405868519,1.0,0.278148493276742,0.589423227381862,8474,4,PNKP|POLB|DUSP11
CELLULAR RESPONSE TO ACTINOMYCIN D%GOBP%GO:0072717,0.7293008641005501,0.972554563883587,-0.38867432299467,-0.788802990496397,4641,3,TP53
REGULATION OF T-HELPER 1 CELL ACTIVATION%GOBP%GO:2000517,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
REGULATION OF PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0090065,0.29503355704698,0.800447413278835,0.856197617997353,1.13742033782567,2197,1,TERT
MEMBRANE RAFT POLARIZATION%GOBP%GO:0001766,0.8261763638562959,0.9876441563834109,0.47552018329844703,0.7772246762977059,6829,2,CD2
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN MAMMARY GLAND ALVEOLUS DEVELOPMENT%GOBP%GO:0061030,0.421686746987952,0.8732717540161898,-0.788156153506837,-1.05434051722576,3184,1,ID2
FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:0021879,0.125829187396352,0.607607158836689,-0.371008210625002,-1.35162012711652,606,12,DRD2|ASCL1|SLIT3
CELL DIVISION%GOBP%GO:0051301,0.105618318295549,0.578674426247723,0.22701753521841297,1.29980478551987,1392,117,SEPT12|ROPN1B|UNC119|GNAI1|CENPJ|SEPT11|RGS14|SAPCD2|ECT2|FGF13|KIF4A|TGFB2|KIF23|ANLN|APC|CENPA|NUSAP1|CEP55|ESPL1|LEF1|AURKB|DOCK7|INCENP|SEPT2|CNTROB|KLHL22|SPG20|ANK3|SOX5|SKA2|KIF20A|STMN1|SON|PLK1|ING2|SKA1|RACGAP1|SEPT3|ALKBH4|BRCA2|CUL7|SEPT5|CIT|FGFR2|KLHDC8B|SPIRE2|SPIRE1|MITD1
CAP-INDEPENDENT TRANSLATIONAL INITIATION OF LINEAR MRNA%GOBP%GO:0110017,0.73006711409396,0.972554563883587,0.638674459638289,0.84845052634175,5438,1,RBM4
NEGATIVE REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900134,0.133154362416107,0.6189080538796391,0.9342743714159681,1.2411418214913799,991,1,F2R
HETEROCYCLE CATABOLIC PROCESS%GOBP%GO:0046700,0.912371134020619,1.0,-0.08950655490729902,-0.8172114357665708,353,359,CNOT10|PPP2R2A|DCP1A|RPS4X|NUDT7|SMUG1|LDHA|DCP2|RPL9|METTL16|KPNA1|SIDT2|RPS28|ENTPD4|HBS1L|SAMD4A|RPL35|HMOX1|RPL7|PFKL|DERA|EXOSC6|GPI|PRPF18|RPS9|RPS3|RPL14|WIBG|NUDT4|EXOSC4|MAGOH|GSPT1|CASP3|EIF4G1|PKM|ALDH4A1|H1F0|PAPD7|DFFA|RPL15|PNP|RPL8|ENO1|CDA|EXOG|NBAS|HPRT1|PPP2CA|ZPR1|NUDT18|RPL35A|CNOT7|GAPDH|EXOSC9|HELZ2|PGK1|CDADC1|TDO2|HK1|MTPAP|HK2|TPI1|RNASEH1|ETF1|PDE12|PDE9A|CSDE1|UBA52|MRTO4|BLVRA|UPP1|NCBP2|ENTPD3|ALDOA|POLR2D|RBM8A|RNPS1|ITPA|PABPC1|EXOSC5|DDX6|NT5E|NEIL2|PDE4D|PGAM2|ENPP4
"MITOCHONDRIAL TRNA 3'-TRAILER CLEAVAGE, ENDONUCLEOLYTIC%GOBP%GO:0072684",0.459287700251556,0.890371861972445,-0.769574327304808,-1.02948304176017,3468,1,ELAC2
MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010742,0.9994552190019609,1.0,0.174983332351962,0.40331064127935295,9172,5,SOAT1|STAT1|EP300
COLLATERAL SPROUTING%GOBP%GO:0048668,0.0711210096510765,0.514407987767174,-0.8414006695798921,-1.43917078277897,478,2,COBL
"SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0035249",0.29946257961783396,0.802472218138634,0.37479829267451203,1.1434236762636798,3008,11,UNC13B|GRIK2|GRIA2|UNC13A
PHOSPHATIDYLINOSITOL PHOSPHORYLATION%GOBP%GO:0046854,0.991703835860839,1.0,0.10930078664285199,0.458290683043515,11116,30,CISH|EFR3B|PIK3R3|SOCS2|SOCS1|TTC7A|SOCS7|SLA2|PIK3C2B|PIK3C2A|IP6K2|FAM126A
ADENINE BIOSYNTHETIC PROCESS%GOBP%GO:0046084,0.15035349567949696,0.645245981328882,-0.6619090396877428,-1.3433247298650401,956,3,APRT|HPRT1
PROTEIN-LIPID COMPLEX ASSEMBLY%GOBP%GO:0065005,0.572221690437446,0.940734934957679,0.263968893775029,0.9151085690206009,5977,16,ZDHHC8|ABCA7|DGAT1|SOAT1|APOE|APOC1|APOM
NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0006913,0.9380969225327199,1.0,0.11156510643452199,0.702450396742776,13259,219,CITED1|SIX3|RANBP17|EGR2|NXF2|TPR|THOC3|U2AF1L4|RGS14|SMN1|ZC3H11A|DDX20|RITA1|THOC1|NUP133|NXF2B|DUSP16|CCHCR1|UPF3B|WDR33|NXT2|PPP1R10|CPSF1|STRADA|SRSF1|NUP205|STRADB|ANKLE1|NUP188|C11orf73|NUP160|ABCE1|FIP1L1|NUP85|GEMIN5|NUPL2|GLE1|SRSF6|IPO13|NDC1|SRSF2|THOC2|SMN2|SPRN|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|CEP57|TNPO3|NUP210|HEATR3|RANBP6|POM121|NUP54|KPNA5|SNRPD1|RANBP3|CSE1L|CPSF2|DDX39B|GEMIN8|IPO9|XPO6|TNPO1|NUPL1|ZC3H3|NUP37|TNPO2|AKT1|YTHDC1|AAAS|XPOT|UPF2|XPO4|U2AF2|NEMF|RPSA|RPAIN|XPO5|SRSF9|KPNA2|SRSF5|SRSF4|SNRPE|NUP62|CPSF4|SARNP
PULMONARY ARTERY ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:0061155,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051882,0.98657312205153,1.0,0.331104527414723,0.541181254085905,8155,2,ATPIF1
RESPONSE TO UV-A%GOBP%GO:0070141,0.504794072782741,0.9172434440873181,0.42085220133785906,0.9700019363215441,4632,5,AKT1|CERS1|CCND1|PPID|EGFR
INTERLEUKIN-9-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038113,0.373592444605885,0.852609194081082,-0.35900915781270104,-1.04724564112722,2056,7,STAT5A|STAT3
FMN METABOLIC PROCESS%GOBP%GO:0046444,0.36348993288590603,0.849828746111777,0.82399647110719,1.0946425507771,2707,1,RFK
NEGATIVE REGULATION OF ECTODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042666,0.61935654706739,0.9532238181782521,-0.6834472871636529,-0.9142682741719109,4677,1,FZD7
OXIDATIVE RNA DEMETHYLATION%GOBP%GO:0035513,0.8042333967969542,0.984530683443403,0.351209924192442,0.744247378683745,7180,4,ALKBH3|ALKBH1|FTO
POSITIVE REGULATION OF ARGINASE ACTIVITY%GOBP%GO:0150072,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
REGULATION OF TELOMERE CAPPING%GOBP%GO:1904353,0.7788170563961491,0.9814327553627009,0.19303138879054302,0.759674604242547,8492,24,PNKP|PRKCQ|NEK2|AURKB|MAP3K4|TNKS2|MAP2K7|ATM|MAPKAPK5|NEK7|RAD50|TNKS|NBN|ERCC4|RTEL1|USP7|NABP2
REGULATION OF AXON EXTENSION%GOBP%GO:0030516,0.8787041687594169,0.9956508825790341,0.143598320834077,0.693718662916207,10496,51,SEMA3D|DSCAM|SEMA5A|CTTN|SEMA3E|RUFY3|APOE|SEMA4G|TRIM46|SEMA6A|SEMA4C|SHTN1|RTN4R|GOLGA4|MACF1|NTN1|PTPRS
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION%GOBP%GO:0086067,0.34364295788837396,0.8390197590431021,0.37580156577652,1.10908750951219,3410,10,CACNA1G|CACNB2|GJC3|CXADR
REGULATION OF COPII VESICLE COATING%GOBP%GO:0003400,0.950206043956044,1.0,-0.234874080149436,-0.594568137457125,5533,5,SEC23A
SYNAPTIC VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0099517,0.535698924731183,0.9265056012720759,-0.233652378967996,-0.931826561588652,2490,15,BLOC1S1|BLOC1S5|BLOC1S4|AP3S2|BLOC1S6|BLOC1S3
MEIOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0045144,0.0791097133180114,0.532203813468543,0.825034463744141,1.3484961659672299,653,2,BUB1|BUB1B
NEGATIVE REGULATION OF SYNAPSE ORGANIZATION%GOBP%GO:1905809,0.731488853503185,0.9726603499749559,0.257860951971893,0.7866746552247711,7349,11,SLIT1|ROBO2|APOE
NEGATIVE REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0045837,0.293321616871705,0.8004058897916541,-0.41122938613424503,-1.12879705290449,1668,6,ARL6IP5|MAPT|HEBP2|PRELID1|BNIP3|PMAIP1
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:1901392,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
MEIOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:0044778,0.0092678405931418,0.212136117579847,-0.996029995588884,-1.33241969379923,69,1,HUS1
NEGATIVE REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:1900186,0.203580500786259,0.719175911587293,0.731484534730235,1.19559137696089,1682,2,UNC119|UBQLN2
REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE%GOBP%GO:1905244,0.038695866952083,0.394850432897995,-0.709947971078633,-1.63273202015459,234,4,ABL1|RHOA|FMR1
CARBON CATABOLITE ACTIVATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0000436,0.33369992144540506,0.8295413387957591,-0.537222896217051,-1.09027790627928,2123,3,USF2|NCOA1|USF1
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901797,0.78302831648912,0.981487311948134,0.189357732555365,0.7545633250640391,8599,25,SIRT1|AK6|RNF34|MARCH7|MUC1
REGULATION OF RENAL PHOSPHATE EXCRETION%GOBP%GO:1903402,0.007281874751754271,0.19188606346941398,-0.9966916629907371,-1.33330482645675,54,1,STC1
EXOCYTIC INSERTION OF NEUROTRANSMITTER RECEPTOR TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098967,0.579049231885811,0.942692029750853,0.5752412462089879,0.9402160141271328,4786,2,STX3|STX1B
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0099149,0.373422420193022,0.852609194081082,-0.63330576233802,-1.0832355887921,2514,2,ITGB3|OPHN1
PROTEIN LOCALIZATION TO CYTOSOLIC PROTEASOME COMPLEX%GOBP%GO:1904327,0.251239869360106,0.7634465094445358,0.70912599944858,1.1590469652679198,2076,2,ATXN3|BAG6
POSITIVE REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032740,0.7651034626182801,0.9792023527373521,0.27854434575759496,0.759386615385945,7357,8,SLAMF6|PRKCQ
POSITIVE REGULATION OF EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:1902955,0.642684563758389,0.9620807249753851,0.6838883987648879,0.908515227334604,4787,1,SORL1
GLYCEROLIPID METABOLIC PROCESS%GOBP%GO:0046486,0.999929957273937,1.0,0.0716330655092501,0.459708573286615,14275,257,ENPP2|SIRT1|PTDSS2|LPL|SERINC5|LPCAT4|FABP5|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|CISH|GPAM|EFR3B|NAPEPLD|DGAT1|PIK3R3|CEPT1|ABHD3|PIGC|INPP5E|SOCS2|PNPLA6|RARRES3|TAZ|PIGF|FABP6|FAR1|CHKB|CETP|CPNE7|PGP|OSBPL5|PIGQ|PNPLA2|PIGB|GNPAT|APOE|MTMR4|PLEKHA1|LPGAT1|PTPN13|OSBPL8|ABHD16A|AGK|LMF1|RAB4A|CPNE1|ETNK1|DGKE|PLA2G2D|IMPA1|SLC44A3|SOCS1|TTC7A|DGKZ|SOCS7|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|ABHD2|PIP4K2B|DAGLA|MTMR7|FIG4|SMPD4|CSF1R|SERAC1|PCK2|PIGK|TMEM86B|LPCAT2|PLD1|PIGH|PIP5K1C
SUBSTANTIA NIGRA DEVELOPMENT%GOBP%GO:0021762,0.601499583449042,0.9506035145731909,-0.167090066470613,-0.908302764552725,2165,35,ATP5J|MAPKAP1|CNP|HSPA5|RHOA|COX6B1|G6PD|YWHAH|MBP|YWHAQ|CDC42|YWHAE
SMOOTH MUSCLE CONTRACTION INVOLVED IN MICTURITION%GOBP%GO:0060083,0.619463087248322,0.9532238181782521,0.694640494044993,0.922798906229247,4614,1,KCNMA1
NEGATIVE REGULATION OF CHROMATIN SILENCING AT RDNA%GOBP%GO:0061188,0.6311842264424821,0.9575013258325501,0.554948993658671,0.907048884794428,5217,2,PHF2|PHF8
MITOCHONDRIAL TRANSLATION%GOBP%GO:0032543,0.542542619065821,0.929666156674115,0.169246984896276,0.9600679310789009,7096,111,MRPL50|MTERF3|NDUFA7|MRPS36|MRPS11|CHCHD1|MRPL42|MRPL46|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|WARS2|ERAL1|NOA1|MRPL16|MRPS31|GATC|MTIF3|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|MTERF4|MRPL21|MRPS9|MRPL19|MRPS34|MRPS18C|MRPL55|MRPL23|MRPL1|MRPS27|MRPS7|OXA1L|AARS2|QRSL1|MRPL52|MRPS28|GADD45GIP1|DARS2|MRPL45|MRPL27|MRPL40
NEGATIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900477,0.9075863895141,1.0,-0.544552271724746,-0.7284641771457679,6854,1,NACC2
OBSERVATIONAL LEARNING%GOBP%GO:0098597,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
LOCOMOTOR RHYTHM%GOBP%GO:0045475,0.443409490333919,0.8808089923737601,-0.359882418666901,-0.9878530749033629,2522,6,ID2|CIART|USP2
PULMONARY ARTERY MORPHOGENESIS%GOBP%GO:0061156,0.612386605442939,0.9508825506493929,0.42361164831418796,0.897673548270763,5467,4,BMP4|HEY2|JAG1
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009138,0.866457187745483,0.9929671171385601,-0.33788227306390695,-0.6857220342599921,5514,3,CMPK2|ENTPD4
REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0042053,0.0906284053759535,0.560245248761167,-0.497717067278469,-1.45186276694905,498,7,ITGB2|PARK7|CHRNB2|ITGAM|HPRT1|PARK2
GANGLIOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0001574,0.169595507954664,0.673117535978459,0.473796382472082,1.2916960503685502,1630,8,B4GALNT1|ST3GAL5|ST8SIA3|ST8SIA2|ST8SIA4|ST6GALNAC6|B3GALT4
REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION%GOBP%GO:0003266,0.8486754566348129,0.991298302704726,0.46351912544815793,0.757609276929753,7015,2,HAND2|GNG5
MITOCHONDRIAL GENE EXPRESSION%GOBP%GO:0140053,0.6131696428571429,0.9508825506493929,0.15661776632247698,0.9191379702928771,8240,134,POLRMT|MRPL50|MTERF3|NDUFA7|MRPS36|MRPS11|CHCHD1|MRPL42|MTERF1|MRPL46|TEFM|TRIT1|MRPL17|GFM2|MRPS5|MRRF|MRPL38|MRPL35|PTCD3|WARS2|ERAL1|NOA1|MRPL16|MRPS31|MTERF2|GATC|MTIF3|MRPL33|MRPL34|MRPS14|ICT1|MRPL57|PUS1|MTERF4|MRPL21|MRPS9|MRPL19|MTO1|MRPS34|MRPS18C|MRPL55|MRPL23|SUPV3L1|MRPL1|MRPS27|MRPS7|OXA1L|AARS2|QRSL1|MRPL52|MRPS28|GADD45GIP1|DARS2|MRPL45|MRPL27|MRPL40|HSD17B10|MRPL13
REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903376,0.5118053033054849,0.9184859575763928,-0.32217585174981,-0.939801253196611,2817,7,PARK7|HIF1A|FBXW7|PARK2
VEIN SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014826,0.148300471755171,0.640631124912461,0.7677634665656741,1.25488829440536,1225,2,EDN1|EDNRB
PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0006213,0.8862876254180602,0.996643473105967,-0.138825998122481,-0.7019383714199839,3444,28,TK1|CAD|AK3|CTPS2|UCKL1|DCK|UMPS|UCK1|CTPS1|NT5M|APOBEC3C|DPYD|ERH|NT5C3A|APOBEC3G|HDHD1|TK2|TYMP|NT5C|UCK2|NT5C1A|DHODH|DHFRL1|ENTPD4|CDA|CDADC1|UPP1|NT5E
P GRANULE ORGANIZATION%GOBP%GO:0030719,0.226929696809215,0.7398172623753029,-0.8857520952801059,-1.18489758421118,1713,1,PLD6
LYMPH NODE DEVELOPMENT%GOBP%GO:0048535,0.7727646961962791,0.979946273879301,-0.330833287376606,-0.7608474474715601,4692,4,RIPK3|FADD|TGFB1|PDPN
NEGATIVE REGULATION OF PINOCYTOSIS%GOBP%GO:0048550,0.35491071428571397,0.842911430859438,-0.424301658706206,-1.07409147393535,2066,5,NR1H3|NR1H2|CAV1
FASCICULATION OF MOTOR NEURON AXON%GOBP%GO:0097156,0.392873051224944,0.8621064456029929,-0.618307140887786,-1.05758125007626,2645,2,EPHA3|EPHA4
TELENCEPHALON CELL MIGRATION%GOBP%GO:0022029,0.10131081981781802,0.571655361840848,-0.321246779994753,-1.38193227339824,455,18,DAB2IP|RTN4|SRGAP2C|MBOAT7|RELN|DRD2|SLIT3
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY%GOBP%GO:0060135,0.8581678278049291,0.99166790097654,0.24803105236144896,0.676199191375038,8252,8,GHRL|STOX2|CYP27B1|SPP1|APOL2|HAVCR2|PPARD|LGALS9
INTERLEUKIN-33-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038172,0.903786191536748,1.0,-0.38494623655914,-0.658429921232708,6086,2,IL1RAP|IL33
DORSAL AORTA DEVELOPMENT%GOBP%GO:0035907,0.242281147838721,0.7565220534116759,-0.406929910802799,-1.18703260364976,1333,7,ACVRL1|RBPJ
PROTEIN CATABOLIC PROCESS%GOBP%GO:0030163,0.916919754336235,1.0,0.11545484769553199,0.783526624045504,13585,499,SIRT1|ENC1|HACE1|OMA1|FBXO18|SDF2|LYPLAL1|ARNTL|UBR4|SPSB4|CEACAM1|SIAH2|TRIM9|BRSK2|TRIM3|ANAPC15|VLDLR|CLPP|NOTUM|CCNB1|SGTA|IDE|CDC34|CDK1|BTRC|KIF14|PSMD11|LONP1|ANAPC5|RNF34|KLHL42|UBE2Z|AP2A2|PCYOX1L|PSMD13|PSMB9|MTA1|KLHL3|POMT2|CLN6|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|USE1|FBXL19|NAPSA|RNF126|USP13|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|GZMA|NGLY1|GPC1|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|APOE|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|TCIRG1|AUP1|HDAC6|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|CHEK2|PLK1|CUL4B|TSG101|BIRC2|HERC2|KEAP1|CTSC|MAN1B1|RIPK1|CLTC|ZRANB1|UBXN4|VPS37A|HERPUD1|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|RNF123|ANKZF1|PSMC6|ANAPC10|BAG6|GET4|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|TRIM24|NPLOC4|RBX1|PSMA5|GSK3A|FAP|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|FBXO44|UBA6|LACE1|KCTD2|FBXO11|MDM2|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|AP2M1|CBL
REGULATION OF RNA STABILITY%GOBP%GO:0043487,0.00898520084566596,0.208853543990274,-0.203415473459341,-1.5370478543535802,16,112,EXOSC7|EXOSC1|DIS3|MAPKAPK2|YTHDF3|HNRNPM|EXOSC8|SET|MOV10|PUM1|ZC3H12D|HNRNPD|SYNCRIP|PARN|AXIN2|TNFSF13|YTHDF2|SMG6|HSPB1|DCP1A|NAF1|APEX1|DCP2|METTL16|PRKCD|SAMD4A|EXOSC6|EXOSC4|CCRN4L|EIF4G1|VIM|SLC11A1|VIP|YBX1|SERBP1|NPM1|EXOSC9|YWHAB|FMR1|HNRNPC|PDE12|UBA52|RBM38|PRKCA|YWHAZ|PABPC1|EXOSC5|CARHSP1|MYD88|UBC|RBM24|UBB
POSITIVE REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120162,0.18167701863354002,0.6873049536419911,-0.17661813164950305,-1.19277213475022,467,72,LEPR|PPARGC1A|ADRB2|HSF1|GPR3|ZNF516|ADCYAP1|GNAS|PER2|CD36|EBF2|TRPV2|EPAS1|CAV1
ISOLEUCINE CATABOLIC PROCESS%GOBP%GO:0006550,0.999338011386204,1.0,-0.500551389501544,-0.669602855420138,7547,1,ACAT1
NEGATIVE REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0060547,0.0724664002905921,0.517068528742997,-0.513504029117269,-1.4979140350366202,398,7,FTH1|SLC25A4|ARHGEF2|PELI1
DNA UNWINDING INVOLVED IN DNA REPLICATION%GOBP%GO:0006268,0.9413815646110258,1.0,0.256893889256563,0.5921023324005179,8639,5,RAD51|PURA|RPA1|RPA2|HMGA1
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 SIGNALING PATHWAY%GOBP%GO:0036324,0.466221232368226,0.894322345600068,-0.579818031430935,-0.9917476896951608,3139,2,PDCD6|DAB2IP
PROTEIN MATURATION BY COPPER ION TRANSFER%GOBP%GO:0015680,0.493165598161365,0.910654969509744,0.606672180865729,0.9915890133652919,4076,2,CCS|ATOX1
SULFATE ASSIMILATION%GOBP%GO:0000103,0.986331196322729,1.0,0.331653416330512,0.542078397939901,8153,2,PAPSS2|PAPSS1
POSITIVE REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061047,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061052,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
POSITIVE REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902751,0.13952195664257902,0.6281603901381739,0.346798886797004,1.3281592897815702,1505,22,CCNB1|CDC7|CDK1|ATAD5|CDC25C|DTL|DBF4B|FBXO5|RAD51C
MAINTENANCE OF ORGANELLE LOCATION%GOBP%GO:0051657,0.132473744410939,0.617839712913552,0.494241291979157,1.3474343587166298,1273,8,AKAP9|ATP2A1|GPSM2|C9orf114
POSITIVE REGULATION OF DNA REPLICATION%GOBP%GO:0045740,0.0336836179395759,0.37587925780947296,0.4295760559233329,1.59523036230392,358,20,CDC7|E2F8|DHX9|ATAD5|DNA2|E2F7|DBF4B|INO80|DBF4|CTC1|WIZ|FAF1|NPM2|CDT1|STOML2|ATRX
CELLULAR RESPONSE TO TOXIC SUBSTANCE%GOBP%GO:0097237,0.00437956204379562,0.155321503601441,-0.268095703160247,-1.7359256406836199,11,63,PPIF|ADCY7|KDR|IMPACT|MAPK7|PRKCD|SIRPA|TNFAIP3|SOD3|ADIRF|ABL1|RPS3|ZNF580|IL6|SOD2|PDCD10|FXN|NET1|HSF1|NOS3|GSTM3|GSTM1|PARK2|SESN2|AQP1|TNF
CELLULAR GLUCURONIDATION%GOBP%GO:0052695,0.546174496644295,0.930420772651609,0.730039700044111,0.96982517212853,4068,1,ABHD10
CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0005975,0.745451981384854,0.9749763305090959,0.13588625469719,0.861076659669033,10571,231,B3GALT2|FUT9|GAL3ST3|RGN|FUT7|OMA1|GHRL|GALM|GAA|GALNT3|GSTO2|AKR1B1|PGM5|IDNK|B4GALNT1|COQ3|SLC35A1|FUT2|GAL3ST4|FUT8|RBKS|PPIP5K2|B3GALT1|ALDH1A1|GNPTAB|TKFC|CHST15|ST3GAL5|ISYNA1|PHKG2|GALE|COQ2|KCNJ11|PHKA2|EXT1|ME1|CASD1|SLC25A10|FUT10|FPGT|PGP|AGL|PIGQ|MPDU1|GNPTG|GCK
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB%GOBP%GO:0002428,0.607710481099656,0.9508825506493929,0.35949478793227096,0.8841250755474649,5658,6,TAP2|HLA-F|HLA-C|HLA-B|HLA-A
MUSCULAR SEPTUM MORPHOGENESIS%GOBP%GO:0003150,0.20991084867430804,0.7248363921442859,0.64069735410008,1.21789827131244,1812,3,BMP4|HEY2
MITOTIC CLEAVAGE FURROW FORMATION%GOBP%GO:1903673,0.306765523632994,0.809874675097403,-0.8473753859726509,-1.13355989007454,2316,1,RHOA
REGULATION OF CARDIAC MUSCLE TISSUE REGENERATION%GOBP%GO:1905178,0.148032665181886,0.6402258061318559,-0.768072787427626,-1.31374736754768,996,2,CDKN1B|CDKN1A
MEMBRANE DEPOLARIZATION%GOBP%GO:0051899,0.21954214542584,0.734713083559597,0.27777547229916305,1.21697774518937,2502,35,SCN1A|CACNA1G|CACNB4|CACNB2|HCN2|CACNA1I|CACNA1H|CACNA2D1|KCNH2|CACNA1D|ATPIF1|SCN3B|SLC8A1|SCN8A
NEGATIVE REGULATION OF BLOOD PRESSURE%GOBP%GO:0045776,0.0559495665878645,0.460281293309471,-0.458637047713719,-1.5516377812017,283,10,SOD2|ADRB2|NOS3|DRD2
PLASMA MEMBRANE RAFT DISTRIBUTION%GOBP%GO:0044855,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
NEGATIVE REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060192,0.740147655193927,0.974456759704921,0.285972864178344,0.7796387495497941,7117,8,RGS2|APOC1|SORT1|ANXA1|PLA2R1
UREA CYCLE%GOBP%GO:0000050,0.22442882249560603,0.738039263175087,-0.44081447912733,-1.21000614667678,1276,6,ASS1|SLC25A15|ASL
VIRAL PROCESS%GOBP%GO:0016032,0.06640625,0.49812594405445004,-0.148087075325712,-1.25295123502621,67,203,CCNK|XRCC6|ITCH|PVRL2|MON1B|FURIN|EIF3D|HTATSF1|ZNF639|VPS28|KPNA1|NEDD4L|AP1M1|BANF1|USF1|RAB43|PCBP2|CTBP1|VPS4A|FYN|VPS37D|TBC1D20|RXRA|SEH1L|EIF3G|BCL2L1|ATG7|EIF3B|RAB1A|VPS4B|ICAM1|AP1S1|CDC42|AP2S1|KPNA4|NEDD4|EIF3A|UBA52|TP53|B2M|CAV2|RAB7A|VAPB|PARK2|RAB5A|CHMP4B|CHMP1B|PCBP1|RAC1|DDX6|UBC|PC|HSP90AB1|BICD1|CAV1|PAK2|UBB
MALE SEX DIFFERENTIATION%GOBP%GO:0046661,0.648157370517928,0.963755998259649,-0.17728402111494998,-0.8705165385888309,2602,26,KITLG|MAMLD1|LRRC6|CSDE1|MEA1|BIK
NEGATIVE REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060331,0.162431318681319,0.664367762084791,-0.5131023215309211,-1.29888445520879,945,5,NR1H3|PPARG|NR1H2
MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086013,0.315482998856192,0.8169998348799691,0.4147864362302329,1.1308191055186299,3033,8,KCNN2|KCNQ1|KCNH2
OPIOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038003,0.22305552195476,0.7355723797115551,0.722139509236284,1.1803171895138898,1843,2,ADCY8|OPRL1
SPROUTING ANGIOGENESIS%GOBP%GO:0002040,0.36051538526744104,0.848418604328854,0.22871232263289398,1.07924251424364,4252,46,EGR3|ESM1|FIGF|BMP4|NR4A1|E2F8|PIK3R3|MIA3|SEMA5A|E2F7|SEMA3E|LOXL2|LEF1
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086021,0.149220489977728,0.642214276122962,-0.766922678388105,-1.31178016763148,1004,2,GJC1
REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061046,0.653303637713437,0.9640743070248079,-0.500755848882082,-0.8565160607449991,4399,2,TNF
HEART FORMATION%GOBP%GO:0060914,0.745707417582418,0.9749763305090959,-0.306748521392989,-0.776513512756782,4342,5,SOX17
PROTEIN ALKYLATION%GOBP%GO:0008213,0.985525227460711,1.0,-0.0863486286130213,-0.5949949793091279,2382,78,GSPT1|WDR82|RAB6A|TRMT112|METTL12|DYDC2|PRMT3|COPRS|ASH2L|SNRPB|ETF1|SETD7|METTL21B
TRANS-SYNAPTIC SIGNALING%GOBP%GO:0099537,0.6896771002614289,0.96731875442989,0.140812205726782,0.8902613574785291,9760,226,SYT17|PCDHB4|CHRNA10|RIT2|SLC1A2|AKAP9|CACNB4|PCDHB6|CACNB2|RIMS2|PCDHB14|KCNK3|UNC119|CRHBP|PCDHB13|GRM4|PCDHB9|AKAP5|APBA3|UNC13B|SYT3|GRIK2|LIN7A|LIN7B|PENK|GRIA2|DLG3|BZRAP1|DLGAP1|NPY|GPR176|DVL1|UNC13A|PPFIA3|ATXN3|DOC2A|CPLX3|PTPRD|SPG11|ZACN|STAC3|SLC6A9|APOE|NPTX2|GRIN1|PCLO|CASK|DLGAP2|SNAP47|PRRT2|STX2|SLC6A2|DRD4|DLG4|TH|KCND2|MYCBPAP|BRSK1|NOVA1|RIMBP2|CACNB1|SYNJ2BP-COX16|PCDHB16|SLC1A3|SYT1|SEPT5|CORT|GRIK5|SLC6A1|RIMS4|PCDHB11|NPAS4|SYNJ2BP|PLP1|GSK3A|RIC3|APBA2|RAB3A|DAGLA|SLC1A1|NLGN3|SYT7|STX3|SNAPIN|GABRB3|PIP5K1C|STX1A|AKT1|MINK1|PCDHB3|SLC18A2|LRP6|DTNA|MPP2|RIMS1
RESPONSE TO INORGANIC SUBSTANCE%GOBP%GO:0010035,0.10440835266821301,0.576535954147525,-0.138583997647117,-1.19263517152631,89,224,SYT11|PPIF|ADD1|MT1M|ADCY7|NEDD4L|KDR|IMPACT|MAPK7|PRKCD|SIRPA|CPNE2|STK26|PRKAA1|HMOX1|TNFAIP3|SOD3|HP|ABL1|RPS3|ANXA7|FYN|ZNF580|FBP1|CPNE6|FOXO1|CPNE3|CLIC4|IL6|PRNP|MMP9|TNNT2|HVCN1|SUMO1|PPP2CA|PPP2CB|SOD2|ATP2B4|PDCD10|ITPKB|SNCA|FMR1|RYR1|FXN|NEDD4|NET1|HSF1|BCL2|JUN|ANXA11|B2M|NOS3|GUCA1A|MAPK3|SYT2|PARK2|SLC25A13|CRIP1|STK24|CPNE9|SCN5A|AQP1|CPNE8|SYT9|CAV1|NDRG1|HOMER1
INTERLEUKIN-1 ALPHA SECRETION%GOBP%GO:0050703,0.8056375838926171,0.984682960940884,0.598312748125276,0.7948317932603242,6001,1,S100A13
PEYER'S PATCH MORPHOGENESIS%GOBP%GO:0061146,0.314974182444062,0.8164430838831159,-0.843239964711072,-1.12802781096499,2378,1,RET
REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001044,0.602760427160991,0.9508825506493929,0.301428807855685,0.8895942865727641,5982,10,LOXL3|BST1|PRKD1|FLNA|TIMP1|ITGB1BP1|DMTN|PHACTR4|CD63|EMP2
PROTEIN LOCALIZATION TO NUCLEOPLASM%GOBP%GO:1990173,0.8328358208955219,0.9881090453690059,-0.351995961413406,-0.7143653454292042,5300,3,TBRG1|GLTSCR2
DTDP METABOLIC PROCESS%GOBP%GO:0046072,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME%GOBP%GO:1900095,0.427247451343837,0.875915454531478,-0.7856749007498901,-1.05102126976003,3226,1,RLIM
REGULATION OF TRANSLATION INVOLVED IN CELLULAR RESPONSE TO UV%GOBP%GO:1904803,0.9955704697986579,1.0,0.5018747243052489,0.666718181020686,7416,1,RPL26
RESPONSE TO CALCIUM ION%GOBP%GO:0051592,0.6061779112024019,0.9508825506493929,0.16890751339291502,0.908291570966261,7672,83,RYR2|SYT17|DPEP1|D2HGDH|CRHBP|PRKAA2|ADGRV1|KCNH1|SYT3|ADCY8|PKD2|RASGRP2|ECT2|SYT15|HPCA|RASA4|MCOLN1|CPNE7|ALG2
TRNA IMPORT INTO MITOCHONDRION%GOBP%GO:0016031,0.33298027273930897,0.8293509737209019,-0.8346382884869871,-1.11652108641712,2514,1,TOMM20
RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0046685,0.8614620938628159,0.991915800284466,-0.161231660774801,-0.7070771305687299,3817,19,ATF4|PPIF|DDX3X|CPEB2|HSF1|RNF4
"NEGATIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, REM SLEEP%GOBP%GO:0042322",0.5006652957542039,0.9144253281295329,0.603662873716546,0.986670383500455,4138,2,GHRL
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001236,0.00046926325668700096,0.0784645998831315,-0.296163179088596,-2.1412077166711296,0,95,MAPK7|TGFBR1|ACVR1|HMOX1|TNFAIP3|PML|RET|PSME3|TCF7L2|BCL10|FAIM2|TNFRSF10A|MAP2K5|UNC5B|ITGA6|CYLD|BCL2L1|IGF1|ICAM1|BID|ARHGEF2|PPP2R1B|LGALS3|EYA4|BCL2|CFLAR|TNFRSF4|NOS3|TNFRSF10B|SCG2|HTT|EYA1|PEA15|WWOX|TNF|PMAIP1|CAV1|PAK2
ACTIVATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1990051,0.33324506818482696,0.8293509737209019,-0.8344728716365241,-1.11629980325274,2516,1,ABL1
ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION%GOBP%GO:0071787,0.9524022846903349,1.0,0.27612927244292895,0.5851443055489879,8503,4,RTN3|ZFYVE27|ARL6IP1
MEIOTIC SPINDLE ORGANIZATION%GOBP%GO:0000212,0.876809077225889,0.99444152362265,0.364276567073372,0.692451433549994,7572,3,TUBG2|GOLGA2|TUBG1
CORTICOSTEROID HORMONE SECRETION%GOBP%GO:0035930,0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
POSITIVE REGULATION BLOOD VESSEL BRANCHING%GOBP%GO:1905555,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
NEGATIVE REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902567,0.898450946643718,0.998912093067348,-0.548191442434936,-0.733332406762173,6785,1,CD300A
CELLULAR DETOXIFICATION%GOBP%GO:1990748,0.0609704641350211,0.48170831577441997,-0.3909283172768,-1.5145597945570701,288,14,SOD1|SOD3|SOD2|NOS3|GSTM3|GSTM1|SESN2
SIDEROPHORE BIOSYNTHETIC PROCESS%GOBP%GO:0019290,0.135838926174497,0.623227463256235,0.933006175562417,1.23945707987816,1011,1,BDH2
PYRIMIDINE DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046127,0.930872483221476,1.0,0.537163652404058,0.713597947649256,6934,1,DPYD
MYOBLAST DIFFERENTIATION%GOBP%GO:0045445,0.5494583137070179,0.931359181171847,-0.20428815369267697,-0.9278351169142429,2332,21,NOTCH1|MBNL1|PLEKHM3|TCF7L2|IGF1|GREM1|EPAS1|RBPJ
FAT-SOLUBLE VITAMIN CATABOLIC PROCESS%GOBP%GO:0042363,0.841255130411757,0.9901937608208321,-0.5775253639170711,-0.772573287912594,6353,1,CYP26B1
ACYL CARNITINE TRANSPORT%GOBP%GO:0006844,0.38611346316680795,0.8596647264526249,0.648702968402932,1.06028718094157,3191,2,SLC25A29|SLC25A45
EYE PIGMENT METABOLIC PROCESS%GOBP%GO:0042441,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
RETROGRADE TRANS-SYNAPTIC SIGNALING%GOBP%GO:0098917,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
POSITIVE REGULATION OF INVADOPODIUM DISASSEMBLY%GOBP%GO:1905929,0.0520805369127517,0.44586532408291796,0.9738641376268191,1.2937350596778001,387,1,NAV3
POSITIVE REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001046,0.8478971453475699,0.991298302704726,0.3013456871828811,0.694557137019414,7781,5,LOXL3|FLNA|DMTN|CD63|EMP2
NEGATIVE REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000283,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033623,0.0024880573248407603,0.12586582153175,0.63170451533702,1.9271856712172901,24,11,CXCL13|KIF14|SKAP1|FBLIM1|FARP2|SRC|PIEZO1
POSITIVE REGULATION OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE ACTIVITY%GOBP%GO:0150074,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002821,0.9992547201059949,1.0,0.0776532243489752,0.38357366467478105,12066,56,SIRT1|SKAP1|CD1E|PRKCQ|MAP3K7|ZP3|ZBTB1|CCL19|IL12RB1|CD1D|PAXIP1|RIF1|TRAF2|HLA-F|NFKBID|FAM35A|IL1R1|XCL1|TP53BP1|ANXA1|HSPD1|FADD|HLA-C|PRKCZ
MAGNESIUM ION HOMEOSTASIS%GOBP%GO:0010960,0.26811513047373703,0.7829905950315309,0.5506381808079069,1.1668549048315602,2393,4,CNNM2|ANK3|TFAP2B|SLC41A1
ELASTIN CATABOLIC PROCESS%GOBP%GO:0060309,0.126175029789488,0.607607158836689,-0.9345500661667401,-1.25017611770389,952,1,MMP12
REGULATION OF TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032213,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
POSITIVE REGULATION OF INTERLEUKIN-12 BIOSYNTHETIC PROCESS%GOBP%GO:0045084,0.5108261763638561,0.918404893008545,0.6001102839812521,0.9808637731734658,4222,2,LTB|TLR4
REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000722,0.943631305189307,1.0,0.40275061748256497,0.658284820068562,7800,2,HEY2|GPER1
INTERNAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018393,0.540049218067794,0.928637097809937,0.17900890696171698,0.9534178955562378,6802,79,CPA4|JADE3|AK6|KAT2A|NAA40|TADA1|OGT|TAF6L|YEATS4|TRRAP|MAP3K7|EP400|LEF1|ING5|APBB1|YEATS2|BRPF3|ATAT1|MSL1|KAT8|BRCA2|BAG6|SUPT3H|WDR5
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032233,0.0907697025452315,0.560322217247896,-0.233293471267347,-1.3486720839217299,295,43,ARHGEF5|PPM1F|S100A10|SYNPO|CX3CL1|LPAR1|TGFBR1|PFN1|ABL1|RHOA|NRP1|PXN|SERPINF2|RHOC|LIMK1|WNT11|CDC42|SORBS3|RAC1
ETHANOL CATABOLIC PROCESS%GOBP%GO:0006068,0.7268727567442399,0.972554563883587,0.434182892473867,0.8253360042669331,6277,3,SULT1A3|SULT1C4
CHONDROCYTE DEVELOPMENT%GOBP%GO:0002063,0.397747349823322,0.8638522656500329,-0.244337863918138,-1.02814562827939,1800,17,SCARA3|COL14A1|COL6A2|VWA1|EIF2AK3|COL6A1|COL21A1|SULF2
REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000152,0.32882953652788693,0.828303707528737,-0.540255872945848,-1.09643324243668,2092,3,UBXN1|PARK7|TANK
PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0046530,0.919055328063994,1.0,0.16994039244288198,0.609610833612913,9650,18,DSCAM|AHI1|CEP290|DCX|TH|MYO7A|TOPORS
REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051147,0.145675902602855,0.636418541205714,-0.17626050190024897,-1.22625876453066,346,81,CTNNB1|FOXO4|ABL1|HDAC4|BOC|CDON|HDAC5|EHD1|IGF1|SOD2|CTNNA1|EHD2|CDC42|AKAP13|BHLHE41|PDCD4|SOX6|CFLAR|NFATC2|BNIP2|DKK1|RBPMS2|GREM1|IGF2|RBM24
REGULATION OF KETONE BIOSYNTHETIC PROCESS%GOBP%GO:0010566,0.476214574898785,0.9024070154961379,0.346079393203839,0.98759234091086,4704,9,WNT4|CLCN2|EGR1|REST|SIRT5|AKR1C3
POSITIVE REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:0090238,0.9706077055474649,1.0,-0.513123070136745,-0.6864203759131751,7330,1,PLA2R1
POSITIVE REGULATION OF POTASSIUM ION IMPORT%GOBP%GO:1903288,0.40356529209621994,0.865506967418479,0.42784139135683297,1.05221359294633,3757,6,ATP1B3|WNK3|WNK2|WNK1|ATP1B1
"BASE-EXCISION REPAIR, GAP-FILLING%GOBP%GO:0006287",0.0463657744428268,0.42353204111839704,0.708562376899947,1.5015113620558,413,4,POLG|POLE|POLD1
MONOCYTE CHEMOTAXIS%GOBP%GO:0002548,0.9061532860003639,1.0,0.157956226950881,0.635059692390987,9954,26,PTPRO|XCL2|CCL21|CCL5|CCL19|RPS19|CCL2|CCL3L3|CCL11|CCL4L2|XCL1|ANXA1|CCL4|CCL8|CCL24|FOLR2|PDGFB
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033630,0.266966593280368,0.781274739585822,0.33954435997145804,1.17710821502064,2788,16,CXCL13|RAC3|SKAP1|TGFB2|CCL21|CCL5|PIEZO1|CD3E|ADAM9
REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902855,0.144639718804921,0.634873676948925,-0.486806859174501,-1.33625214174378,822,6,HAP1|SEPT9|MAP4
T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001913,0.0930362116991643,0.5622489437340121,-0.4623531358596721,-1.43719485824472,500,8,MICA|CADM1|HFE|MICB|EMP2|ULBP3|ULBP2|CTSH
REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035303,0.846351218775942,0.991298302704726,0.131874611608836,0.758111147538258,11214,119,TMEM132D|PPP1R17|NUAK1|CAMSAP3|ITGA1|CNST|ELFN2|CSRNP3|DLG3|PPP1R35|HSP90B1|ELFN1|TGFB2|CASC5|PKMYT1|ZCCHC9|BOD1|MTMR4|LMTK3|PIN1|CEP192|MAGI2|FARP1|TIPRL|SFI1|PPP1R12A|RIMBP2|SYTL2|SMPD1|FCRL3|CNEP1R1|MPHOSPH10|CDCA2|CDK5RAP3
POSITIVE REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000060,0.0309784661881375,0.36053013249595595,-0.21928072953956398,-1.46397844542907,81,69,RNF217|RAD23A|CSNK1D|CSNK1A1|RNF19B|FBXW7|CBFA2T3|CLU|PLK3|USP5|TRIB1|ARIH1|PRICKLE1|CEBPA|STUB1|RNF139|GLTSCR2|TRIB2|SUMO1|RNF144B|SMAD7|SOCS5|ARIH2|PARK2|HSPBP1|DDRGK1|BCAP31|BBS7|CAV1|TRIB3
FLAVIN-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042728,0.6985234899328859,0.96731875442989,0.6546096162329069,0.8696196709599631,5203,1,VCP
TRNA EXPORT FROM NUCLEUS%GOBP%GO:0006409,0.615017289642681,0.951274991479634,-0.375392930017096,-0.86332531670927,3734,4,XPOT|NOL6|SSB|RAN
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, NON-REM SLEEP%GOBP%GO:0046010",0.0370469798657718,0.386113929236656,0.9809770621967359,1.30318426263887,275,1,GHRL
NEGATIVE REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032074,0.523904802021904,0.92593403131991,0.36452264154694497,0.9487758496971491,4974,7,GZMA|ABCE1|NEIL1
BONE MARROW DEVELOPMENT%GOBP%GO:0048539,0.706902472527473,0.969403752544852,-0.31673284800353,-0.801788172577976,4116,5,LRRC17|PTPRC|LRP5L|LRP5|SBDS
SEPTIN RING ASSEMBLY%GOBP%GO:0000921,0.331729352842974,0.8293509737209019,0.34662348112710806,1.1186828140654899,3377,13,SEPT12|SEPT11|ANLN|SEPT2|SEPT3|SEPT5
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0097201,0.0339711050370949,0.376148295095164,-0.515367127853056,-1.66365127186539,173,9,IMPACT|CITED2|VHL|BAG3|JUN
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, WAKEFULNESS%GOBP%GO:0010841",0.174632596319343,0.677040796053356,-0.910123511248346,-1.21749997043014,1318,1,CRH
NEGATIVE REGULATION OF ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0070236,0.44959168522642895,0.8859850407237599,-0.586710185722576,-1.00353635049084,3027,2,TNFRSF4
NEGATIVE REGULATION OF NEURAL RETINA DEVELOPMENT%GOBP%GO:0061076,0.21647027671124106,0.7328218014339442,-0.890604322893692,-1.19138855703305,1634,1,POU4F2
POSITIVE REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902961,0.237434094903339,0.7507739897770379,-0.43436495689691296,-1.19230264120803,1350,6,PICALM|LYN|EFNA1
EOSINOPHIL FATE COMMITMENT%GOBP%GO:0035854,0.489871574208924,0.908938677284213,-0.752977503308337,-1.00728096426717,3699,1,GATA2
POSITIVE REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003104,0.8787773532476559,0.9956508825790341,0.363533092613813,0.691038166812949,7589,3,F2RL1|PDGFB|GAS6
RESPONSE TO INTERLEUKIN-11%GOBP%GO:0071105,0.372807548082739,0.852609194081082,0.654968699601537,1.0705283464559898,3081,2,CITED1
MAST CELL DIFFERENTIATION%GOBP%GO:0060374,0.8492802709568159,0.991298302704726,0.463132515329654,0.7569773733118591,7020,2,KIT|PIK3CD
REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033006,0.159972924187726,0.661454203640901,-0.290983881773478,-1.27610202101384,708,19,LGALS9|FGR|LYN|VAMP2|VAMP3|SNX6|GAB2
REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:1905634,0.0628221649484536,0.489368708236755,0.6049581857894101,1.48780655427718,584,6,HDAC8|RB1|NIPBL|CDCA5
"REGULATION OF COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001868",0.533036377134373,0.9265056012720759,-0.548552522746071,-0.93826971156324,3589,2,SERPING1|A2M
RESPONSE TO PARATHYROID HORMONE%GOBP%GO:0071107,0.15567920648361,0.656198355453056,0.7620083347361991,1.2454816895328,1286,2,CITED1|MEF2C
ESTABLISHMENT OF CELL POLARITY%GOBP%GO:0030010,0.104185146359165,0.5762893149145369,0.25682388834488395,1.33696687171242,1291,71,KIF25|CAMSAP3|SDCCAG8|BRSK2|SAPCD2|MARK2|FGF13|NUMA1|DYNLT1|AMOT|AMOTL2|FAM89B|CCL21|NDC80|CENPA|GPSM2|CDK5RAP2|SYNE4|DOCK7|CYTH3|STK11|CCL19|SPDL1|ARHGEF11
GLYCOPROTEIN CATABOLIC PROCESS%GOBP%GO:0006516,0.9681668496158069,1.0,-0.139948126483086,-0.573134613180058,4409,16,EDEM3|NGLY1|GPC1|MAN1B1|STT3B|MANBA|ADAMTS12|HPSE|MGEA5|EDEM2|SGSH|EDEM1|FBXO2|ADAMTS9|NEU4|MMP12
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001268,0.597355769230769,0.9492236513366701,-0.347128633627534,-0.8787330855011558,3478,5,MMP9|PLAUR
REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0150065,0.188857938718663,0.69611511841804,-0.40600874694499106,-1.26205196473205,1016,8,CAMK2D|VEGFA|PRKD2|KDM5A
NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0072078,0.162480680061824,0.6644055660503371,0.38565818075565794,1.30761726496721,1681,15,CITED1|BMP4|PKD2|AHI1|KLHL3
CIS ASSEMBLY OF PRE-CATALYTIC SPLICEOSOME%GOBP%GO:0000354,0.46711210096510797,0.8949379342993,-0.5792114695340501,-0.9907101980559179,3145,2,SNRNP200|DDX23
THREONINE CATABOLIC PROCESS%GOBP%GO:0006567,0.483267871170464,0.9061819762742349,-0.474679818361231,-0.9633485880073441,3075,3,SDS|SDSL
REGULATION OF MULTIVESICULAR BODY SIZE%GOBP%GO:0010796,0.807855459544383,0.984682960940884,-0.361696261166869,-0.7340518155702941,5141,3,SNF8|RILP|RAB11A
NEGATIVE REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032277,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
PEPTIDYL-LYSINE HYDROXYLATION TO 5-HYDROXY-L-LYSINE%GOBP%GO:0018395,0.8375838926174499,0.9889652677625541,0.581550507278341,0.7725639041117529,6239,1,JMJD6
REGULATION OF DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048070,0.0901442307692308,0.560121322881739,-0.5703855638582579,-1.4438931793575,524,5,ZEB2|HPS4|BLOC1S5|BLOC1S6
DENDRITIC CELL HOMEOSTASIS%GOBP%GO:0036145,0.49040116509996007,0.908938677284213,-0.7526466696074109,-1.0068383979384101,3703,1,GPR183
PURINE NUCLEOBASE SALVAGE%GOBP%GO:0043096,0.512432076403754,0.9189160303470669,-0.40777493874723303,-0.9377971719500029,3111,4,ADA|APRT|HPRT1
SUCROSE METABOLIC PROCESS%GOBP%GO:0005985,0.422644248215798,0.873470206885489,0.633419514648721,1.03530679564135,3493,2,GAA
POSITIVE REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032967,0.3613866247667679,0.848418604328854,0.3386212854268739,1.09285675411267,3679,13,WNT4|BMP4|F2R|SUCO
REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0046885,0.758507135016465,0.977664504547119,-0.19153164611694,-0.7843864628101279,3454,16,STC2|TNF
NEGATIVE REGULATION OF INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000660,0.8404412975465171,0.989869022734363,-0.30820170975686306,-0.708799546848325,5103,4,OTUD4|IL1RN|IL6
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DEDIFFERENTIATION%GOBP%GO:1905176,0.998926174496644,1.0,0.500441111601235,0.6648136905014,7441,1,PDGFB
OLFACTORY PLACODE FORMATION%GOBP%GO:0030910,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
PROTEIN AUTOPROCESSING%GOBP%GO:0016540,0.21101804123711299,0.7257004702836279,0.505277759626776,1.24265706318569,1964,6,PIDD1|F12
NEGATIVE REGULATION OF HEART RATE%GOBP%GO:0010459,0.7948145604395601,0.982260302987182,-0.293125206927826,-0.7420269968228349,4628,5,SRI|FKBP1B|PLN
POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044829,0.841032904772282,0.990143309585111,0.304520568526625,0.701874767867565,7718,5,YTHDC2|PPIB|NUCKS1|VAPA
CELLULAR DIVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0072503,0.6814521825116538,0.965271928233355,0.141652813349224,0.895844446410987,9647,227,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|P2RX5|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|MT1F|SLC30A5|AGTR1|ATP2A1|CDH23|HSP90B1|PDPK1|CACNA2D1|PTGER1|TMEM178A|MT1E|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|SLC39A7|DMPK|GRIN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|SLC39A13|MT2A|CALB2|CD55|DRD4|DLG4|TRPC1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1|FPR3|MICU1|SLC39A10|P2RY6|SLC8A2|RMDN3
REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902267,0.6264906796341321,0.954674488895214,0.47206504330944105,0.897345987952672,5410,3,OAZ3|AZIN2
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY%GOBP%GO:0032878,0.7801651341715141,0.981487311948134,0.20337691955956197,0.7552400386374358,8314,20,KIF20B|DOCK8|KRIT1|RUFY3|SHTN1|LLGL2
HISTONE UBIQUITINATION%GOBP%GO:0016574,0.828750435085277,0.9876441563834109,0.163407032371685,0.726524397212245,9523,37,PCGF2|DDB2|UHRF1|HUWE1|DDB1|TRIM37|CUL4B|RNF40|CDC73|UBE2B|UBR2|PCGF1|PCGF3|RNF8|PHC1|PCGF5|KDM2B|BCOR|COMMD3-BMI1|LEO1|CTR9|PCGF6|PAF1
PMA-INDUCIBLE MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051088,0.34611154752553003,0.8422206315449059,-0.531137684458209,-1.07792814981429,2202,3,ADAM10|ADAM17
CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0008652,0.0769736842105263,0.5274146397230149,0.281772199600055,1.4045781083949398,935,58,ASNS|CTH|GAMT|SERINC5|RIMKLB|GGT1|GPT|GLS|APIP|GLS2|MTHFD1|CAD|CDO1|MTR|MTAP|GGT5|PSAT1|BCAT2|NAALAD2|PYCR2|PHGDH|NAGS|RIMKLA|SEPHS1|CCBL1|AASS
RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:0071166,0.978643121273866,1.0,0.10366224230328801,0.595925936844006,12967,119,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|ABCE1|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|RPS15|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|XPOT|UPF2|U2AF2|RPSA|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
CAP2 MRNA METHYLATION%GOBP%GO:0097310,0.144295302013423,0.6340340930337739,0.928705337450375,1.2337436083203,1074,1,CMTR2
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901723,0.787658192406765,0.9819233677232551,0.35787901438368397,0.7583798178636729,7032,4,BMP4|GATA3|BMP7
RESPONSE TO CORTISOL%GOBP%GO:0051414,0.109501070311214,0.5847943326101279,-0.610318370912546,-1.4036047531251201,664,4,KLF9|SLIT3
REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0002026,0.639685102947114,0.96058002537611,-0.242182488059891,-0.852270348826142,3168,11,SLC9A1|PLN|ATP2B4|MYL4
B CELL APOPTOTIC PROCESS%GOBP%GO:0001783,0.132739420935412,0.618193911729853,-0.7781086297215329,-1.3309131383060802,893,2,BAX|TNFRSF21
5-METHYLCYTOSINE CATABOLIC PROCESS%GOBP%GO:0006211,0.790783836980433,0.9819233677232551,0.40801808757031,0.775599462579433,6829,3,TET2|TET1|TET3
ADENOSINE TO INOSINE EDITING%GOBP%GO:0006382,0.820004358247984,0.987153241368501,0.31331347893227396,0.7221411228783481,7525,5,METTL3|ADAT2|NUDT16|ADAR
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000650,0.561024337086814,0.936434965680841,-0.31020125569486795,-0.9048708252398421,3088,7,CAMK2D|HECW2|NEDD4L|NEDD4
REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:2001279,0.24940074090215697,0.7613646381106121,0.519137436576219,1.1965348335951203,2288,5,SIRT1|PTGS2|PIBF1|ANXA1|ABCD1
GRANULOCYTE ACTIVATION%GOBP%GO:0036230,0.0159744408945687,0.268309042246402,-0.13876689376344298,-1.3053674608121002,4,408,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|KARS|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CXCL8|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031116,0.241911491260692,0.756190299503268,0.317841420387557,1.20160998040813,2601,21,AKAP9|NAV3|CLIP1|PSRC1|NUMA1|CDK5R1|CDK5RAP2
POSITIVE REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901341,0.43306438333607794,0.878651088001772,-0.43655214250262,-1.00397872881895,2629,4,STIM2|TMEM110|STIM1|CRACR2A
REGULATION OF CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045583,0.5903614457831329,0.945418171231938,-0.698775915306573,-0.9347738474046491,4458,1,SART1
PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0061734,0.40144903671990795,0.864213895374807,-0.44787896312945397,-1.0300280500049501,2437,4,MFN2|PARK2
ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030041,0.936573690509067,1.0,0.151635592237845,0.5897416424262769,10173,23,TTC17|JAK2|MSRB2|MICALL2|DIAPH3|WASF1|WASF3|PSTPIP1
ESTABLISHMENT OF SYNAPTIC SPECIFICITY AT NEUROMUSCULAR JUNCTION%GOBP%GO:0007529,0.0101608806096528,0.220543045578585,0.9343258891645991,1.5271299984058797,83,2,GPHN|F2R
REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0050999,0.0472650026553372,0.4277111233594871,-0.287981932026426,-1.5143629777986598,177,31,NOSIP|ATP2B4|FCER2|SPR|DDAH2|NOS3|TNF|CAV1|DDAH1
PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:0006627,0.521246458923513,0.9251240799994541,0.415161053859649,0.9568846850485179,4783,5,MIPEP|IMMP1L|IMMP2L
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0006356,0.881856540084388,0.9957670620803951,-0.135030651129397,-0.700543345425143,3343,30,NOL11|MARS|H2AFY2|MED1|POLR2L|HEATR1|SMARCA4|RASL11A|TAF1|FLNA|UBTF|DDX11|PHF8|MTOR|WDR75|IPPK|PWP1|PIH1D1|TAF1C|ERBB2|SMARCB1|H2AFY|DHX33|NCL|ATF4|UTP15|EIF2AK3|GLTSCR2|WDR43|POLR2K
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM%GOBP%GO:0014808,0.0837873174983657,0.54493407160435,0.621455775117319,1.4323634361082198,768,5,RYR2|NOL3|CCR5
REGULATION OF LACTATION%GOBP%GO:1903487,0.763177431328879,0.978421368343614,-0.453818582850841,-0.7762323809977341,5139,2,XBP1|OAS2
NEGATIVE REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048817,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
POSITIVE REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051891,0.319341962017661,0.8219996514077841,0.6787441345545849,1.1093886417373402,2639,2,TGFB2|DHX36
DNA PROTECTION%GOBP%GO:0042262,0.495364010989011,0.911223412567636,-0.375819220242114,-0.951361400363016,2884,5,DCTPP1|NUDT1|NUDT15|CBS
NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070944,0.334496644295302,0.830568091460343,0.837284958094398,1.1122957128981699,2491,1,AZU1
REGULATION OF ACROSOME REACTION%GOBP%GO:0060046,0.30322802197802196,0.8055436753253159,-0.44347385770723297,-1.12262462260695,1765,5,PLCB1|POMZP3
MIDBRAIN MORPHOGENESIS%GOBP%GO:1904693,0.295512277730737,0.800447413278835,0.689164598842018,1.12642060434825,2442,2,FZD6|FZD3
SPERMINE CATABOLIC PROCESS%GOBP%GO:0046208,0.100668151447661,0.570947005522165,-0.8079969186704921,-1.38203545583891,677,2,SMOX
NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS%GOBP%GO:0000956,0.6137566137566141,0.9508825506493929,-0.11325238207385199,-0.945805533881846,695,188,RPS10|TNKS1BP1|CNOT3|RPL28|RPS3A|UPF3A|RPL37|RPL27A|XRN1|GSPT2|POLR2G|PPP2R1A|ATM|ZCCHC6|DDX5|CNOT1|RPL7A|RPL19|RC3H1|UPF2|EXOSC10|RPLP1|SAMD4B|RPSA|RPL6|RPL5|CNOT2|EXOSC2|EDC4|TUT1|RPL18|CNOT8|RPS27A|PELO|PATL2|RPS26|PAN2|RPL22|PNRC2|RPS12|CNOT6|SKIV2L|RPL4|DCPS|RPL37A|RPL23|EXOSC3|RPL10|RPL24|SMG8|RPL26|RPS25|NT5C3B|ERI1|RPL13|CNOT4|RPS5|EIF3E|RPLP2|RPS2|LSM1|PCID2|ZC3H12A|SMG7|LSM2|SMG1|PAN3|RPS8|RPL21|RPL39|RPS20|ZFP36L1|RPS15A|RPS11|RPS6|CTIF|PATL1|RPL30|PAPD5|RPL41|RPS29|RPL34|LSM6|RPS7|RPL27|EDC3|RPL13A|CASC3|SSB|UPF1|RQCD1|CNOT11|RPS18|RPL10A|LSM5|DCP1B|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SMG5|DIS3L2|MAGOHB|RPL29|RPL31|RPL17|EIF4A3|EXOSC7|RPS14|RPS17|EXOSC1|DIS3|RPL32|EXOSC8|AGO1|RPL18A|NCBP1|RPL11|PARN|CNOT6L|SMG6|RPS16|RPL12|LSM3|CNOT10|PPP2R2A|DCP1A|RPS4X|DCP2|RPL9|RPS28|HBS1L|SAMD4A|RPL35|RPL7|EXOSC6|PRPF18|RPS9|RPS3|RPL14|WIBG|EXOSC4|MAGOH|GSPT1|EIF4G1|PAPD7|RPL15|RPL8|NBAS|PPP2CA|RPL35A|CNOT7|EXOSC9|HELZ2|MTPAP|ETF1|PDE12|CSDE1|UBA52|MRTO4|NCBP2|POLR2D|RBM8A|RNPS1|PABPC1|EXOSC5|DDX6
LEUCINE TRANSPORT%GOBP%GO:0015820,0.531781868704411,0.9265056012720759,0.5039767266428711,0.9580067409864399,4592,3,SLC6A17|SLC6A15
POSITIVE REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900273,0.42995559144126,0.8781703910979691,-0.28677458629022995,-1.0091954981964102,2129,11,SQSTM1|CHRNA7|RELN|EPHB2
REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0045995,0.7385980770811079,0.9744283926676119,0.16273261694748198,0.813751900520715,8987,59,WNT4|TBX2|TDG|EHMT1|HES1|CDK1|CCSAP|POGLUT1|DVL1|RPS6KA6|NIPBL|COL5A2|LFNG|NPHP3|COL5A1|RACGAP1|BAG6|FZD3|RNF207|DVL3|GATA3|SULF1|DVL2
ADHERENS JUNCTION ORGANIZATION%GOBP%GO:0034332,0.664638157894737,0.964618776001639,0.172979259434319,0.862267041790046,8081,58,PTPRK|CDH4|CDH6|CDH10|CAMSAP3|CDH3|ACTN2|CDH2
PROTEIN LIPOYLATION%GOBP%GO:0009249,0.114235500878735,0.5906506806283871,-0.5113642184076861,-1.4036604439327902,649,6,GCSH|GLRX5|LIAS
STRESS-INDUCED MITOCHONDRIAL FUSION%GOBP%GO:1990046,0.8343624161073829,0.988613522932093,0.5830392589325101,0.774541644266396,6215,1,STOML2
POSITIVE REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0031117,0.70569735091327,0.968941691852291,0.526606010476978,0.860723057411246,5833,2,STMN2|KATNB1
MEMBRANE RAFT ORGANIZATION%GOBP%GO:0031579,0.0443010752688172,0.41504430757275895,-0.39569649585021993,-1.57807297657044,205,15,FLOT1|S100A10|MYADM|MAL|RFTN1|CAV2|CAV1
EVASION OR TOLERANCE OF HOST DEFENSE RESPONSE%GOBP%GO:0030682,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
DETOXIFICATION OF COPPER ION%GOBP%GO:0010273,0.583861911198919,0.9439064862850342,0.33260225378472197,0.9067629755124201,5614,8,MT1F|MT1E|MT2A|ATP7A|MT1X|MT1G
PRIMITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0060319,0.39811995233682,0.8638522656500329,-0.79923908248787,-1.06916648923936,3006,1,VEGFA
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902043,0.504569420035149,0.917139342610024,-0.345414893463283,-0.948140689642709,2870,6,PMAIP1
SPHINGOSINE METABOLIC PROCESS%GOBP%GO:0006670,0.0124419684308264,0.242128600684977,-0.592103238217409,-1.8405146705318,66,8,SPHK1|SGPP2|ACER3|ASAH2|ASAH2B
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051149,0.17430880476393,0.676682497340677,0.26922175697563605,1.2619471139102398,2048,45,EDN1|CTH|MAPK11|BMP4|MAPK12|MAML1|OLFM2|CDH2|PROX1|ADGRB1
REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032661,0.6986222067847628,0.96731875442989,0.44580172990544,0.847422191968533,6033,3,DHX9|TLR2
RETINOIC ACID METABOLIC PROCESS%GOBP%GO:0042573,0.00279209621993127,0.13060107565888002,0.761801292256053,1.87353933263403,25,6,ALDH1A2|BCO2|ALDH8A1
ALCOHOL CATABOLIC PROCESS%GOBP%GO:0046164,0.813745019920319,0.986276922067025,-0.153557467864808,-0.75401220346567,3267,26,HSD3B7|SYNJ1|TRERF1|SNX17|INPP5B|SCARF1|SYNJ2|SULT1A1|INPP1|INPP5K|INPP5A|SORD|TPI1
POSITIVE REGULATION OF SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014718,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|CAPN3
ACYL CARNITINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902616,0.08174496644295301,0.539385377100419,0.9600242611380679,1.2753494012031599,608,1,SLC25A29
REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:1904259,0.271978021978022,0.7866273178445721,-0.45659607324067897,-1.15584263986994,1583,5,CLASP2|CLASP1|PHLDB2|DAG1|PHLDB1
POSITIVE REGULATION OF MAPK CASCADE%GOBP%GO:0043410,0.00886917960088692,0.207969158127386,-0.14799180439711201,-1.3509551110088,3,338,CRKL|DUSP7|PHB2|RAMP3|PIK3R5|IL1RN|NOD1|GPER1|SOD1|FBXW7|NOTCH1|TIE1|IL1B|WWC1|IRAK1|IL11|VEGFA|PKN1|PLCE1|KDR|NECAB2|CX3CL1|ADRA2C|ARHGAP8|LPAR1|DAB2IP|IGF1R|C5AR1|TGFBR1|LGALS9|IRAK2|PTK2B|PRKAA1|ARRB2|GDF15|PRKD2|LIF|MARCO|MAP3K13|RPS3|RET|CCL14|ADRA1B|NRP1|PDE8A|UBE2V1|SEMA7A|FGF2|MAP2K5|RASSF2|IL6|FCGR2B|ARRB1|DFNA5|CHRNA7|GLIPR2|MST1R|IGF1|DIRAS1|SERPINF2|ICAM1|CRK|RIPK2|RAP1A|PDCD10|PLA2G2A|KARS|NPNT|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|ADRB2|RAPGEF1|SHC1|UBA52|PRKCA|EPHA8|ACKR3|DKK1|PELI2|ZNF622|ADCYAP1|MAPK3|CAV2|FLT1|CHI3L1|ADRA2A|FGF10|PEA15|EPHA7|BMPER|RELL2|AAED1|EDA2R|SEMA3A|MET|MAP3K11|PLCB1|IGF2|RELL1|UBC|CCL18|MAP2K1|CD36|TNF|EPHB2|UBB|ADORA2B
METANEPHRIC TUBULE FORMATION%GOBP%GO:0072174,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060396,0.0524828421477594,0.447307566936778,-0.44475786607541395,-1.5651583427845701,259,11,PXN|LYN|PTPN1|STAT5A|STAT3|PIK3R1
CO-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:0043686,0.5984716915595689,0.9493714402140542,0.480258078747105,0.912920086444693,5168,3,STT3A|STT3B|PDF
DETECTION OF CALCIUM ION%GOBP%GO:0005513,0.5237328178694161,0.92593403131991,0.385548421565395,0.9482001931219399,4876,6,RYR2|SYT1|KCNIP2
REGULATION OF NEURON MIGRATION%GOBP%GO:2001222,0.316533207724918,0.8176737565328901,-0.24267395758422602,-1.1021756070394901,1343,21,IGSF10|CX3CL1|DAB2IP|NSMF|SRGAP2C|ULK4|CAMK2A|ARHGEF2|SEMA3A
TRANSEPITHELIAL TRANSPORT%GOBP%GO:0070633,0.590412810647811,0.945418171231938,0.33102508706620803,0.9024631959099491,5677,8,SLC12A2|RHBG|CXADR|BEST1|SLC23A2|GPLD1
DEADENYLATION-DEPENDENT DECAPPING OF NUCLEAR-TRANSCRIBED MRNA%GOBP%GO:0000290,0.13574744661095597,0.623227463256235,-0.434607534888852,-1.35094944978647,730,8,PATL2|DCPS|LSM1|PAN3|PATL1|DCP1B|DCP1A|DCP2
REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL NEURAL TUBE PATTERNING%GOBP%GO:1901620,0.11253806434529301,0.587889099677873,-0.9423246581385091,-1.2605764264298502,849,1,GPR161
REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051588,0.000677048070412999,0.0806484601749226,-0.34542502758045696,-2.1591328328277,1,55,NAPB|SYN1|VPS18|SLC30A1|NAPA|VAMP2|HTR1B|CAMK2A|VAMP3|SNCA|FMR1|PNKD|HRH3|CHRNA3|SNX6|DRD2|PARK2|RAB5A|PER2|MCTP1|CPLX1|TRH
TOXIN TRANSPORT%GOBP%GO:1901998,0.226229141001232,0.7398172623753029,0.570947995367562,1.20989334197804,2019,4,ANTXR1|RAB40B|ANTXR2|RAB29
INHIBITORY SYNAPSE ASSEMBLY%GOBP%GO:1904862,0.598255033557047,0.949262093257606,0.706219673577415,0.9381813296542459,4456,1,NPAS4
REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045667,0.702153998514484,0.968941691852291,0.169144119871825,0.839743713223121,8507,57,CITED1|CYR61|WNT4|CDK6|BMP4|TMEM64|DDR2|SUCO|C14orf169|SMOC1|MEN1|FBXO5|BMPR1B
PROTEIN-DNA COMPLEX DISASSEMBLY%GOBP%GO:0032986,0.834036880693179,0.988613522932093,-0.170862447210567,-0.735012285931524,3753,18,SMARCC1|PBRM1
REGULATION OF MUSCLE HYPERPLASIA%GOBP%GO:0014738,0.0954587581093605,0.567034610132396,-0.950485222761359,-1.2714930625393601,720,1,NOS3
ASSEMBLY OF LARGE SUBUNIT PRECURSOR OF PRERIBOSOME%GOBP%GO:1902626,0.442733699921445,0.8805227338055791,-0.49045990956214897,-0.995373814252507,2817,3,RPL24|EIF6|RSL24D1
CELL GROWTH%GOBP%GO:0016049,0.0353460972017673,0.382137421231133,-0.268531875502932,-1.5271693537878899,119,40,ALCAM|FLRT1|COBL|ARIH2|SEMA3A|HSP90AB1|TMEM108|SLIT3
REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903037,0.88295165394402,0.996290954620626,-0.0990717695778621,-0.814599151894745,1040,177,CD274|ICOSLG|IL1B|RARA|FAM49B|IRAK1|SIRPA|MAP3K8|LGALS9|GRB2|VAV1|RPS3|FYN|RHOA|PPARA|RUNX1|IL6|PNP|LYN|FCGR2B|PRNP|ASS1|CD276|YES1|IGF1|ETS1|SMAD7|CDC42|LGALS3|TFRC|NLRP3|DUSP3|SOCS5|BCL6|NKAP|DUSP10|CBFB|RAC1|IGF2|PIK3R1|TNF|TNFRSF21|CAV1|PAK2
RESPONSE TO NITROSATIVE STRESS%GOBP%GO:0051409,0.9582776540460279,1.0,-0.34237661979597495,-0.585616871642155,6453,2,ATM|DUSP6
REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900736,0.227616926503341,0.740582302519023,-0.720621812570332,-1.23258501636594,1532,2,BICD1
REGULATION OF DNA REPLICATION%GOBP%GO:0006275,0.0553784860557769,0.458062256682211,0.271051026591905,1.43176477023201,694,76,FBXO18|CDC7|E2F8|ATR|ANKRD17|BLM|DHX9|ATAD5|RFC4|DNA2|E2F7|DONSON|ZNF830|DBF4B|FBXO5|INO80|CDC6|MSH6|ESCO2|DBF4|WDR18|TIMELESS|DSCC1|CHEK2|ZRANB3|CHTF18|EHMT2|CTC1|GMNN|RFC3|RAD17|RFC5|SMC3|CDAN1|PPP2R1A|WIZ|WRNIP1|FAF1|NPM2|CCNA2|CDT1|STOML2|TICRR|MSH3|SLFN11|ATRX|CCDC88A|NUCKS1|NBN|LIG3|SMC1A|ZBTB38
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002718,0.0368468740561764,0.386113929236656,-0.26035475684941395,-1.4991415041631397,121,42,TNFRSF1B|BCL10|SEMA7A|IL6|MAVS|SMAD7|KARS|NLRP3|B2M|TICAM1|GPRC5B|TNF
DNA INTEGRITY CHECKPOINT%GOBP%GO:0031570,0.00313245823389022,0.13515773385565,0.286283818033716,1.67262515154216,41,130,BTG2|MUS81|TAOK3|INTS7|EME2|CEP63|CCNB1|PIDD1|CDK1|E2F8|ATR|BLM|DOT1L|BRIP1|ORC1|CDC25C|DNA2|MUC1|CDC45|RAD9A|DTL|TOP2A|E2F7|DONSON|GEN1|ZNF830|NEK11|NAE1|GTSE1|CDC6|MSH6|CLOCK|H2AFX|TIMELESS|TAOK1|RPS27L|BRCC3|CHEK2|TOPBP1|PLK1|PRMT1|TIPRL|EME1|BRSK1|CARM1|AURKA|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|TOP2B|C5orf45|PRKDC|CHEK1|RAD17|RAD1|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1|UIMC1|BRCA1|BRE
REGULATION OF MICROTUBULE NUCLEATION%GOBP%GO:0010968,0.07162851967726,0.515023940206536,-0.6588842751848979,-1.5152961871787398,434,4,DCTN1|MECP2|RANGRF
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1902514,0.692186183656276,0.96731875442989,0.31182811726730897,0.8116230741229609,6572,7,CACNB2|CACNA2D1|CACNB1
"TRANSCRIPTION, RNA-TEMPLATED%GOBP%GO:0001172",0.29503355704698,0.800447413278835,0.856197617997353,1.13742033782567,2197,1,TERT
NEGATIVE REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032078,0.348724832214765,0.842847021021096,0.8297309219232472,1.10226051285424,2597,1,GZMA
POSITIVE REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032346,0.0659060402684564,0.495991045493396,0.9675231583590649,1.28531135161173,490,1,WNT4
NEGATIVE REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014050,0.0105419450631032,0.22424275249482103,-0.928701406120761,-1.58849401710375,70,2,HRH3|TRH
NODAL SIGNALING PATHWAY%GOBP%GO:0038092,0.829326923076923,0.9876441563834109,-0.28273649966245695,-0.7157286742262009,4829,5,CITED2|SMAD2
POSITIVE REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050924,0.6921752945849329,0.96731875442989,-0.6487097485663871,-0.867798809651677,5227,1,SLIT2
RESPONSE TO EXOGENOUS DSRNA%GOBP%GO:0043330,0.0037544169611307397,0.143595610377104,-0.479817874879195,-2.01901843012195,16,17,MAVS|RFTN1|COLEC12|RALB|SLC3A2|TICAM1|CAV1
INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060333,0.9857664233576641,1.0,-0.0906963764035962,-0.5872610543929111,2700,63,HLA-DRB1|TRIM21|GBP2|HLA-F|STAT1|CIITA|HLA-DRB5|IRF9|HLA-DPB1|HLA-DQA1|NCAM1|HLA-C|IRF2|TRIM22|HLA-DRA|IFNGR1|HLA-DPA1|OAS1|CAMK2B|IRF5|FCGR1A|JAK1|IRF7|OAS2|IRF8|HLA-B|PTAFR|HCK|HLA-A|TRIM26|HLA-E|IRF1|IRF3|SP100|CAMK2G|IFNGR2|TRIM62|VCAM1|CD44|CAMK2D|TRIM8|IFI30|PRKCD|PML|IRF6|HLA-DQB1|OASL|CAMK2A|ICAM1|OAS3|TRIM25|B2M|HLA-DQA2|HLA-DQB2
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900015,0.24102209944751396,0.753979408566354,-0.26364733399077395,-1.17636948703305,1046,20,IL17D|PYCARD|ADCY7|SIRPA|APOD|KARS|PDCD4|TICAM1|MYD88
ENZYME ACTIVE SITE FORMATION%GOBP%GO:0018307,0.33019992056136604,0.8291761235173739,-0.836733568592854,-1.11932400649929,2493,1,MOCS3
PROTEIN FARNESYLATION%GOBP%GO:0018343,0.737752509979436,0.974393437895322,0.5123793768955061,0.837470015650817,6098,2,FNTB|FNTA
LIVER MORPHOGENESIS%GOBP%GO:0072576,0.736179992742228,0.974262605126702,0.512953394774976,0.8384082321056171,6085,2,CEBPB|RPS6KA1
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0045986,0.0958340194302651,0.568131581797149,-0.6296545382227211,-1.44807389847167,581,4,SOD1|DOCK5|ADRB2
CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061049,0.57106568283537,0.9404752161333092,0.578108629721533,0.9449026737067551,4720,2,SORBS2|PDLIM5
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002675,0.8098276354632891,0.984682960940884,0.202726029164608,0.7272195965747801,8503,18,PTGER3|F12|ZP3|PTGS2|KLKB1
REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:2000172,0.0923533778767632,0.5622489437340121,-0.815219189412738,-1.39438876314344,621,2,RTN4|MAP3K13
PROEPICARDIUM DEVELOPMENT%GOBP%GO:0003342,0.363166953528399,0.849828746111777,-0.817159241288046,-1.09313883204742,2742,1,TGFBR1
PROTEIN TRANSPORT FROM CILIARY MEMBRANE TO PLASMA MEMBRANE%GOBP%GO:1903445,0.0510764662212324,0.443301756236231,-0.8621450234353459,-1.4746528890522,343,2,RILPL2|RILPL1
REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1900044,0.612145748987854,0.9508825506493929,0.308606699398252,0.880658076339095,6047,9,BIRC2|PARP10|PTPN22|PLAA|UBR5|GPS2
SYNAPSE ASSEMBLY%GOBP%GO:0007416,0.0446752808039862,0.41504430757275895,0.318123847036475,1.50892444326531,528,47,PCDHB4|PCDHB6|SLITRK6|PCDHB14|SDK1|PCDHB13|PCDHB9|CDH2|DSCAM|DNM3|DVL1|KIRREL3|PTPRD|FARP1|NLGN4Y|PCDHB16|SLITRK1|PCDHB11|NPAS4|SHANK1|SPOCK2|NLGN3|SDK2|PCDHB3|PCDHB10|ADGRL3|RAB29|NRXN2|NLGN2|NRCAM
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0010804,0.13640381027202197,0.62388141596544,0.416750258915602,1.3450079922175402,1388,13,HIST1H2BJ|F2RL1|ZNF675|GSTP1|TRAIP|CARD16|CCDC3
NADH DEHYDROGENASE COMPLEX ASSEMBLY%GOBP%GO:0010257,0.895423770291215,0.9981901628831992,0.134952984478627,0.6866597680101719,10976,64,NDUFA7|NDUFS7|NDUFB11|NDUFS2|NDUFC1|NDUFAF1|NDUFS4|TAZ|NDUFA11|NDUFS8|NDUFB2|BCS1L|MT-ND2|NDUFV1|NDUFS3|NDUFB7|NDUFA12|OXA1L|ECSIT|TIMM21|ACAD9|NDUFB1|TMEM126B|NDUFB3|NDUFA1|NDUFB6|NDUFAF7|MT-ND3|FOXRED1|C17orf89
POST-EMBRYONIC CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0031077,0.39811995233682,0.8638522656500329,-0.79923908248787,-1.06916648923936,3006,1,VEGFA
BLOOD VESSEL MATURATION%GOBP%GO:0001955,0.017124979417092,0.277422272849102,-0.758531741801718,-1.74446454331247,103,4,ACVRL1|S1PR1
POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062043,0.603160188884853,0.9508825506493929,-0.300593818509948,-0.8768455047282141,3320,7,ENG|NOTCH1|TGFBR1|ACVR1
CATECHOL-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0019614,0.08287700084246,0.5420718842622351,0.5570215236873121,1.44980999587091,786,7,SULT1A3|MOXD1|LRTOMT|COMT|DBH|MAOA
REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051052,0.640791476407915,0.96102887115448,0.14218593196898496,0.926351347525208,9261,299,FGFR4|SIRT1|FBXO18|IL7R|ZNF93|NAT10|PIF1|CDC7|MMS19|SIRT6|NPAS2|E2F8|ATR|NVL|ANKRD17|BLM|DHX9|THOC1|ATAD5|HMBOX1|RFC4|ST20|DNA2|FAM178A|PNKP|E2F7|DONSON|PPP1R10|PRKCQ|MEN1|PARP1|SRC|TMEM161A|NEK2|ZNF830|DBF4B|POLQ|GZMA|FBXO5|HDAC8|SLX1B|INO80|AURKB|CDC6|MSH6|RAD51|RTEL1-TNFRSF6B|H2AFX|SMARCAD1|ESCO2|RMI2|DBF4|WDR18|TIMELESS|MAP3K4|ZNF91|PARPBP|BRCC3|RAD51AP1|DSCC1|TNKS2|MAP2K7|CHEK2|SLX4|ZRANB3|WRAP53|KDM1A|CHTF18|HNRNPA2B1|TEN1|NUDT16L1|PAXIP1|ANKRD32|EHMT2|CTC1|RIF1|GMNN|C5orf45|ACD|CHEK1|RECQL5|XRCC1|SPIRE2|RFC3|MPHOSPH8|SPIRE1|XRN1|RAD17|RFC5|FOXM1|SUPT6H|SMC3|SPIDR|CDAN1|PPP2R1A|FMN2|FIGN|ATM|WIZ|WRNIP1|UIMC1|BRCA1|AKT1|FAM35A|BRE|MAPKAPK5|PARP9|DNMT1|FAF1|EYA3|PARG|EXOSC10|RAD52|NPM2|PARP3|POT1|UBR5|RNF8|SETMAR|CCNA2|CDT1|FAM168A|KPNA2|MAGEF1|UBE2V2|CCT2|STOML2|MGMT|CERS1|USP1|TP53BP1|TICRR|KLF4|NDFIP1|WAS|DDX11|AUNIP|TET1|MSH3|FBXO4|NEK7|SLFN11|ATRX|ZNF304|CCDC88A|APLF|POLH|RAD50|NUCKS1
TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0019226,0.7896377808344799,0.9819233677232551,0.190601356177158,0.7501112162597109,8610,24,SCN1A|CACNA1G|CACNA1I
NEGATIVE REGULATION OF MESODERMAL CELL DIFFERENTIATION%GOBP%GO:1905771,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071638,0.503762880629848,0.9168938417530409,0.5151926334335271,0.9793269999263691,4350,3,C1QTNF3|GSTP1
REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060264,0.267801319902744,0.7826111979723571,0.609738612551009,1.15904896036502,2312,3,INS|RPS19|SLAMF8
RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0032800,0.0415738678544915,0.402998391331252,-0.875654811138682,-1.49776065738081,279,2,PPARG|TNF
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043553,0.411493495801087,0.867015886388254,-0.4435882508309729,-1.02016030807965,2498,4,DAB2IP|PIK3IP1|KIAA0226
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010922,0.976537369914853,1.0,0.139704263765887,0.510640458849403,10321,19,ITGA1|MAGI2|PPP1R12A|FCRL3|RIPK3|PPP2R4|GPLD1|MTOR|MEF2C|PTPRC|CD300A
NEGATIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062044,0.274765100671141,0.7884684708511421,0.865846934274371,1.15023902401317,2046,1,TGFB2
TERPENE METABOLIC PROCESS%GOBP%GO:0042214,0.0842953020134228,0.545178773025535,0.9588112042346708,1.2737379092253,627,1,BCO2
REGULATION OF SCHWANN CELL MIGRATION%GOBP%GO:1900147,0.6948993288590601,0.96731875442989,0.657201146890163,0.873062403821749,5176,1,CERS2
INORGANIC ION HOMEOSTASIS%GOBP%GO:0098771,0.819534947527265,0.987153241368501,0.126104854377914,0.833071289545856,11947,350,THADA|TAC1|RYR2|FGFR4|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|SLC12A2|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|TMTC2|CXCR4|F2R|BDH2|DMXL2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|KCNH2|TMEM178A|MT1E|CCR5|CNNM2|PTH1R|PDK4|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|XPR1|SLC39A7|SLC46A1|DMPK|SLC40A1|NEO1|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|TCIRG1|PLCG1|C3AR1|SLC39A13|ANK3|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1
LEUKOTRIENE D4 BIOSYNTHETIC PROCESS%GOBP%GO:1901750,0.10362394349889999,0.575794607412397,0.7122364089366829,1.3538864889307298,894,3,GGT1|GGT5
POSITIVE REGULATION OF CELL DEVELOPMENT%GOBP%GO:0010720,0.10869565217391301,0.58452352834625,-0.134022898211577,-1.1791909633054098,79,253,FZD1|ZEB1|PRKCH|ADD1|IL1B|VEGFA|NEDD4L|IMPACT|CX3CL1|ADRA2C|CTNNB1|DAB2IP|TUBB2B|NSMF|PTK2B|SRGAP2C|ABL1|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|RHOA|SERPINI1|NRP1|TENM4|C1QBP|CPNE6|NKX6-1|MYADM|SEMA7A|PTK7|DOCK5|CDH5|IL6|LYN|POU4F2|ISLR2|IGF1|BIN1|TCF4|CRK|RAP1A|LIMK1|AMIGO1|SERPINF1|ARHGEF2|FMR1|TWF1|CDC42|C21orf91|FGFR1|PLXNA1|PROC|RAPGEF1|LIMS1|PLXNA4|RELN|TWF2|ADCYAP1|COBL|DRD2|SYT2|ASCL1|ZNF365|SEMA3A|RAC1|CPNE9|PCP4|GPRC5B|PDE3A|TNF|NBL1|FOXO6
REGULATION OF LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:1901246,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
POSITIVE REGULATION OF INTERLEUKIN-6 SECRETION%GOBP%GO:2000778,0.5748387096774189,0.941940408834489,-0.22717122469649803,-0.905979139334234,2672,15,MBP|MAVS|TWIST1|TNF
T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002309,0.372086117297699,0.852609194081082,-0.634452972160496,-1.08519782975282,2505,2,SLC11A1
CHITIN CATABOLIC PROCESS%GOBP%GO:0006032,0.75962293794187,0.977664504547119,-0.37828052886863106,-0.7677090941307869,4834,3,CTBS|CHIT1
POST-TRANSLATIONAL PROTEIN ACETYLATION%GOBP%GO:0034421,0.296167650804678,0.8009197362795991,0.597042264978539,1.1349145392353899,2557,3,ESCO2|DSCC1|ESCO1
TIRAP-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035664,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
EPITHELIAL CELL PROLIFERATION INVOLVED IN LIVER MORPHOGENESIS%GOBP%GO:0072575,0.736179992742228,0.974262605126702,0.512953394774976,0.8384082321056171,6085,2,CEBPB|RPS6KA1
REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:1902423,0.29146250927988104,0.8000726114371469,-0.6847814486831459,-1.17128199342402,1962,2,BECN1
NUCLEOTIDE-SUGAR METABOLIC PROCESS%GOBP%GO:0009225,0.660663750964754,0.964618776001639,-0.171307085684972,-0.866170734334098,2567,28,GFPT2|NANS|CSGALNACT1|UGDH|PMM2
REGULATION OF GOLGI ORGANIZATION%GOBP%GO:1903358,0.6308925811437399,0.9575013258325501,0.256080202491031,0.8682686137694681,6530,15,AKAP9|CAMSAP3|MAP2K2|USP6NL|MYO5A|CAMSAP2
"POSITIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:1902164",0.6599851521900519,0.9643779777660141,-0.498152743314034,-0.852063588084269,4444,2,RPL26|ZNF385A
POSITIVE REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000522,0.8906394810009269,0.997300970905927,-0.552823114247905,-0.7395283353648711,6726,1,CCR7
T CELL SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033371,0.40328346352442695,0.865238688875249,-0.796757829730922,-1.06584724177363,3045,1,SRGN
ENDOCHONDRAL BONE GROWTH%GOBP%GO:0003416,0.18185920577617298,0.6873049536419911,-0.28330355717460903,-1.24242016316341,805,19,SCARA3|COL14A1|COL6A2|VWA1|EVC|COL6A1|COMP|COL21A1|STC1
RNA IMPORT INTO MITOCHONDRION%GOBP%GO:0035927,0.9572180535334301,1.0,0.272551298916142,0.5775622378598879,8546,4,TST|PNPT1|MRPL18|TOMM20
REGULATION OF NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:2000819,0.777046979865772,0.9810334506628041,0.6132554036171151,0.814682444442108,5788,1,RAD52
MULLERIAN DUCT REGRESSION%GOBP%GO:0001880,0.36733481811432794,0.851186780857897,-0.637386269644334,-1.09021507800156,2473,2,AMH|AMHR2
REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032675,0.179767600820232,0.68489956912038,-0.19348542869239396,-1.2148186958423999,525,56,CYBA|TLR1|IL6R|IL17D|PYCARD|IL1RN|PTPN6|SYT11|IL1B|CX3CL1|SIRPA|LGALS9|TNFAIP3|IL6|ARRB1|MBP|MAVS|ARHGEF2|STAT3|ADCYAP1|MYD88|TWIST1|TNF
PHOSPHOANANDAMIDE DEPHOSPHORYLATION%GOBP%GO:0035644,0.616241610738255,0.9518465519698142,0.696239523599471,0.924923145654604,4590,1,PTPN22
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001113,0.98738255033557,1.0,0.507057785619762,0.6736036467442571,7355,1,ADAMTS12
CELL PROLIFERATION IN HINDBRAIN%GOBP%GO:0021534,0.825835189309577,0.9876441563834109,-0.42832272411671796,-0.7326230801038679,5561,2,ATF5
CELL AGING%GOBP%GO:0007569,0.8453014945885591,0.991298302704726,0.15661288293637196,0.7152385673560491,9840,41,SIRT1|TBX3|ARNTL|TBX2|ATR|CDKN2A|TERT|HRAS|CDKN2B|SRF|CHEK2
MEMBRANE BIOGENESIS%GOBP%GO:0044091,0.351292582749456,0.842847021021096,-0.22835703919903502,-1.07303063128413,1453,23,SERINC1|FLOT1|NLGN4X|S100A10|PEX16|CLIP3|RFTN1|CAV2|CAV1
NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051799,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
INTRACELLULAR PROTEIN TRANSPORT IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051708,0.582920043546631,0.9439064862850342,0.573531844499587,0.9374220439931279,4818,2,DYNLT1|IFIT1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900038,0.200351493848858,0.7127864854201791,-0.452099455389031,-1.24098264878441,1139,6,HYOU1|ENO1|DDAH1
REGULATION OF MYOFIBROBLAST CONTRACTION%GOBP%GO:1904328,0.35032437442076,0.842847021021096,-0.8247132774591971,-1.1032440965541999,2645,1,PDPN
REGULATION OF RESTRICTION ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032072,0.9739597315436239,1.0,0.5157146007940011,0.685103839495328,7255,1,HMGB1
REGULATION OF CALCIUM ION BINDING%GOBP%GO:1901876,0.292201774129485,0.8000726114371469,-0.853936921041023,-1.14233745559503,2206,1,PLN
POSITIVE REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032411,0.859053244728854,0.99166790097654,0.14307635714818098,0.7180682546632579,10470,60,RYR2|AKAP9|CACNB2|STK39|ATP1B3|ACTN2|LRRC55|PKD2
REGULATION OF PINOCYTOSIS%GOBP%GO:0048548,0.507520891364903,0.9178828745106641,-0.303183464840223,-0.9424262170581129,2732,8,NR1H3|NR1H2|CAV1
ER-ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS%GOBP%GO:0071712,0.7045183121019108,0.968941691852291,0.264731182593464,0.807634153994202,7078,11,SDF2|POMT2|BAG6|VCP|DERL1|UFD1L|UGGT2|RNF185|TOR1A|RNF5|UGGT1
METANEPHRIC MESENCHYME DEVELOPMENT%GOBP%GO:0072075,0.0197110538694143,0.29306776028311,0.762824940989114,1.61649891879094,175,4,WNT4|BASP1|PKD2
DNA 3' DEPHOSPHORYLATION%GOBP%GO:0098503,0.287114093959732,0.796019542850327,0.859505955006617,1.14181531594709,2138,1,PNKP
REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0042176,0.0071530758226037204,0.190147814924784,-0.159334130999518,-1.4222558453313898,4,270,SNX9|ERLEC1|AZIN1|CCAR2|HSP90AA1|PSMD10|PARK7|RPL11|RILP|EDEM1|RYBP|GBA|RNF217|PRKACA|RAD23A|EZR|CSNK1D|MAP1A|CSNK1A1|AMER1|TIMP3|TAF9|RNF19B|SNX3|EEF1A2|CDKN1B|NUDT15|HECW2|ITCH|FBXW7|OAZ2|OPHN1|FURIN|TRIM39|CBFA2T3|VPS28|IL1B|CLU|PTTG1IP|NEDD4L|PLK3|USP5|DAB2IP|TRIB1|PTPN3|UBE2J1|NELL1|PTK2B|STYX|TNFAIP3|FAM192A|ARIH1|OS9|PRICKLE1|CEBPA|PML|PDCL3|PSME3|STUB1|TNFRSF1B|VPS11|FOXO1|RNF139|CSNK2A2|GLTSCR2|EFNA1|TRIB2|SUMO1|ECSCR|VIP|ATG7|RNF144B|BAG5|UQCC2|RAD23B|TIMP2|SMAD7|SNCA|FMR1|MSN|NEDD4|ODC1|COMMD1|SOCS5|DYX1C1|RAB7A|ARIH2|GNA12|PARK2|ADRA2A|HSPBP1|DDRGK1|BCAP31|CSNK2A1|PLK2|HSP90AB1|TNF|GABARAPL2|SNX12|BBS7|PSMF1|CAV1|TRIB3|UBB
RNA MODIFICATION%GOBP%GO:0009451,0.174646354733406,0.677040796053356,-0.153104277252198,-1.16578249178178,320,116,NAF1|THUMPD1|TSR3|FTSJ2|KIAA1456|METTL1|CBLL1|METTL16|AARS|APOBEC3F|ZC3H13|NSUN5|C9orf64|TRMT12|MOCS3|GAR1|TRMT61B|NSUN3|TRMT112|WBSCR22|RBM15B|APOBEC3B|ELP3|URM1|CDKAL1|RPUSD2|DPH3|NSUN2|NHP2|RBM15|ALKBH5|RNMTL1|WDR4|TRMT6|EMG1|HENMT1|TRDMT1
"RNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0000394",0.727732793522267,0.972554563883587,0.27735836327747604,0.7914860018812842,7189,9,ERN1|TSEN54
REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904338,0.36435439560439603,0.85007225273817,-0.41984313675438895,-1.06280502167541,2121,5,TIAM1|GSK3B|CSNK1D|DKK1
REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071671,0.292065985860173,0.8000726114371469,-0.558508878350061,-1.1334771745839198,1858,3,AIF1|CORO1B|SLIT2
CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:0072584,0.0335913057796806,0.375579079090274,-0.720711333420229,-1.65748550499511,203,4,MAPK3|CAV1
HEME OXIDATION%GOBP%GO:0006788,0.5156644394951749,0.921938765246636,-0.5564378274055689,-0.951757102873407,3472,2,HMOX2|HMOX1
POSITIVE REGULATION OF HISTONE H2B UBIQUITINATION%GOBP%GO:2001168,0.937427959822164,1.0,-0.266310042464016,-0.612457463550619,5692,4,RNF40|CTR9|RNF20|CDK9
MEMBRANE DEPOLARIZATION DURING PURKINJE MYOCYTE CELL ACTION POTENTIAL%GOBP%GO:0086047,0.0238805970149254,0.32397355287938,-0.806946836029614,-1.63767462827869,151,3,SCN1B|SCN5A
POSITIVE REGULATION OF RENAL SODIUM EXCRETION%GOBP%GO:0035815,0.617635376671521,0.9529166894361422,-0.6843295103661229,-0.9154484510486149,4664,1,NPR1
BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060442,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
GLUTAMYL-TRNA AMINOACYLATION%GOBP%GO:0006424,0.6103535019197671,0.9508825506493929,-0.688464931627702,-0.920980530158167,4609,1,EARS2
"EXONUCLEOLYTIC TRIMMING TO GENERATE MATURE 3'-END OF 5.8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000467",0.222302942244824,0.7355723797115551,-0.41616105901820205,-1.21396027254289,1223,7,EXOSC2|EXOSC3|ERI1|ERI3|EXOSC7|EXOSC8|EXOSC9
N-TERMINAL PROTEIN AMINO ACID METHYLATION%GOBP%GO:0006480,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
PROLYL-TRNA AMINOACYLATION%GOBP%GO:0006433,0.281117696867062,0.7892585111044429,0.6945749228793999,1.13526363035705,2323,2,EPRS|PARS2
KINETOCHORE ASSEMBLY%GOBP%GO:0051382,0.108973692419674,0.58452352834625,0.510880626068526,1.39279764750296,1047,8,CENPF|CENPT|CENPA|CENPE|POGZ|CENPW|MIS12|CENPC
NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001199,0.384112843355605,0.858705831373134,-0.6245095986396579,-1.06819022187844,2586,2,FCGR2B
BONE GROWTH%GOBP%GO:0098868,0.0916206261510129,0.5622489437340121,-0.313345211882415,-1.39811672125339,397,20,SCARA3|COL14A1|COL6A2|VWA1|EVC|COL6A1|LEPR|COMP|COL21A1|STC1
POSITIVE REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097755,0.0046103183315038395,0.15878634024306199,-0.4818914029813571,-1.97350725431752,20,16,GPER1|SOD1|HMOX1|DOCK5|VIP|SOD2|ADRB2|NOS3|ADCYAP1|ADM
RESPONSE TO PAIN%GOBP%GO:0048265,0.184182776801406,0.6906809521658801,-0.46219336324318,-1.2686897480877,1047,6,RET|RELN|THBS4
REGULATION OF INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:1904580,0.566889383815887,0.938919400477539,-0.5352633030052389,-0.9155392129216291,3817,2,ZFP36L1|DHX36
PEPTIDYL-LYSINE MONOMETHYLATION%GOBP%GO:0018026,0.855525185474424,0.991298302704726,-0.215055464217075,-0.694218310074967,4381,9,SETD6|SETD2|METTL12|SETD7
EMBRYONIC CAMERA-TYPE EYE MORPHOGENESIS%GOBP%GO:0048596,0.31150513802135804,0.8143712300420921,0.38597100272881796,1.13910014524792,3091,10,SIX3|TBX2|PROX1
L-METHIONINE SALVAGE FROM METHYLTHIOADENOSINE%GOBP%GO:0019509,0.368162998474613,0.851675851059934,0.47016180961613296,1.0836532736726,3378,5,APIP|MTAP|ENOPH1|MRI1|ADI1
GOLGI VESICLE FUSION TO TARGET MEMBRANE%GOBP%GO:0048210,0.566535742340927,0.9388612723386429,-0.448182263807127,-0.90957258831671,3605,3,RAB8B|RAB8A
CELL JUNCTION ASSEMBLY%GOBP%GO:0034329,0.0507509062661833,0.442360925618033,-0.178047056343495,-1.3349627203648797,97,109,F11R|CTNNB1|CDH22|VASP|DLC1|RHOA|TESK2|ZNF703|WDR1|WHAMM|STRN|CDH5|PARD6B|LAMC1|ITGA6|RHOC|CTNNA1|SMAD7|RAMP2|CDC42|FLNC|PRKCA|LIMS1|CD9|PKP4|GJC1|LAMC2|SH3BP1|TLN2|DLG1|CDH13|PEAK1|PARD3
RNA-DEPENDENT DNA BIOSYNTHETIC PROCESS%GOBP%GO:0006278,0.325682532012563,0.826621597878865,-0.23318446547732602,-1.0957143036817099,1347,23,SMG5|RPA2|PPIA|TERF2IP|PTGES3|HSP90AA1|SMG6|RFC1|PINX1|MRE11A|GAR1|NHP2|HSP90AB1
REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046634,0.9998338318378199,1.0,0.0648181014642679,0.31749954432619604,12033,54,SH3RF1|AGER|BLM|PRKCQ|LOXL3|EBI3|CCL19|CD55|IL12RB1|RASAL3|SOCS1|ZNF683|NFKBID|RC3H1|TNFRSF14|XCL1|ANXA1|JAK3|MYB|FOXP3|PRKCZ|HMGB1|NCKAP1L|ZC3H12A|HSPH1|HFE|MAPK8IP1
GAMETE GENERATION%GOBP%GO:0007276,0.149742324163461,0.643776991770958,0.20177131290253503,1.2270999498691102,2062,171,HSPA2|INSL3|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|ZCCHC11|HERC4|CCT6B|CABYR|GGT1|PYGO1|RHOXF1|CELF1|USP9Y|PIWIL4|TRIM27|MTL5|TSSK3|SPATA25|DEAF1|JAG2|PCSK4|DZIP1|WDR33|CASC5|DAZAP1|TYRO3|YTHDC2|ZNF830|PTTG1|ZP3|KIT|DNAH1|BMPR1B|PIM2|CLOCK|CXADR|METTL3|REC8|SRPK1|FANCF|MYBL1|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|KMT2D|TEX14|MYCBP|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|ABHD2|AZIN2|ZNF35|C1orf111|FMN2
RECOMBINATIONAL INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:0036298,0.309576837416481,0.81178854572317,-0.675323959194927,-1.15510546416516,2084,2,MCM8|MCM9
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048635,0.5591397849462371,0.936434965680841,-0.22993056206980197,-0.916983623295345,2599,15,TGFB1|FZD7|SMAD4|FRS2|AKIRIN1|SFMBT1|SOX6|DKK1
NEGATIVE REGULATION OF HEMOPOIESIS%GOBP%GO:1903707,0.45589533670439003,0.88900512246363,0.192453869318887,1.00818706903213,5679,73,CARTPT|HOXA5|CEACAM1|CDK6|INHA|WDR61|HES1|BMP4|MEIS2|TMEM178A|LOXL3|FBN1|HIST1H4I|DPF2|ZNF675|MEIS1|PRMT1|N4BP2L2|FSTL3|CDC73|SOCS1
RESPONSE TO X-RAY%GOBP%GO:0010165,0.0964724225297213,0.5693042257394499,0.427141752741932,1.41525336409219,989,14,LIG4|BLM|NIPBL|XRCC4|BRCC3|IKBIP|RECQL5|ATM|ANXA1|NUCKS1
RESPONSE TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0071774,0.7146881287726361,0.971081608033886,-0.127638058185434,-0.869774705752637,1775,75,HNRNPF|FGF2|SHOC2|POLR2A|FGFR1|POLR2K|CXCL8|FLRT1|POLR2F|MAPK3|NCBP2|POLR2I|POLR2D|FGF10|SPRED2
POSITIVE REGULATION OF INTERFERON-ALPHA SECRETION%GOBP%GO:1902741,0.788647851727043,0.9819233677232551,0.2819811537093211,0.7339376988320451,7488,7,DHX9|CHUK|DDX58|IFIH1|HMGB1
CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS%GOBP%GO:0071374,0.9845094664371771,1.0,-0.508050286722541,-0.679634358872125,7435,1,MEF2C
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME%GOBP%GO:0072663,0.7033390762162609,0.968941691852291,0.16713320233819298,0.838804183244424,8572,60,CROT|SLC27A2|HSD17B4|IDE|PEX3|DECR2|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0045953,0.781908171861837,0.981487311948134,0.28483145315506897,0.741356429441082,7424,7,CEACAM1|MICA|LILRB1|HLA-E|SERPINB9|LGALS9|ARRB2
POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031646,0.516343439861604,0.922356132838748,0.240185894039281,0.9571062369305071,5670,25,CARTPT|RIMS2|UNC13B|CUX2|GRIN1|DLG4|MYRF|DICER1|RNF10|SHANK1|NLGN3|RIMS1
NEGATIVE REGULATION OF CHROMATIN BINDING%GOBP%GO:0035562,0.762649067963413,0.978421368343614,0.42048086467409296,0.7992898908187841,6586,3,BTAF1|ZNF304|WAPAL
REGULATION OF CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1902080,0.292201774129485,0.8000726114371469,-0.853936921041023,-1.14233745559503,2206,1,PLN
REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905340,0.482360846679359,0.9053012218786121,0.46772052171872797,0.9911444645141031,4306,4,NDC80|CENPQ|CDT1|TRAPPC12
G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION%GOBP%GO:0070315,0.43718120805369104,0.878651088001772,0.7879907366563741,1.04681053888888,3256,1,ZNF503
NEGATIVE REGULATION OF MUSCLE HYPERPLASIA%GOBP%GO:0014740,0.0954587581093605,0.567034610132396,-0.950485222761359,-1.2714930625393601,720,1,NOS3
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION%GOBP%GO:0010639,0.951020980983791,1.0,0.10833223937168301,0.69127090791179,13552,244,KIF25|SIRT1|OMA1|NAV3|TBC1D30|CAMSAP3|NOL3|KAT2A|ARAP1|EVI5L|NAT10|TPR|PIF1|BMP4|HIP1R|FBXO43|CENPF|NAA10|FGF13|MTF2|TAF7|ASF1A|LIMA1|DNMT3B|BUB1|TOP2A|CDK10|PARP1|SRC|NEK2|CDC20|APC|CDK5RAP2|PTTG1|FBXO5|BUB1B|SLX1B|ESPL1|CORO1A|ATAD2|RTEL1-TNFRSF6B|TRIM37|JARID2|PRRT2|KLHL22|TAOK1|TMSB15B|STMN1|TNKS2|CCNF|SLX4|CEP97|PLK1|TCHP|ATAD2B|ARHGAP28|APC2|CAMSAP2|TEN1|TBCD|TMSB15A|ANKRD27|CTC1|TUBB4A|MDM1|TEX14|PHF2|ACD|CHEK1|SHANK1|XRN1|SUPT6H|KANK3|RAD1|CAMSAP1|TMEM67|STYXL1|ATM|TBC1D7
NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0007263,0.0042951971885982,0.15430099921990198,-0.613891756387693,-1.9816976017788703,21,9,FPR1|AGT|GUCY1B3|GUCY1A3|DDAH2|NOS3|CD36|DDAH1
REGULATION OF MICROVILLUS LENGTH%GOBP%GO:0032532,0.603241804765937,0.9508825506493929,0.565112848928511,0.923661427015544,4986,2,CDHR2
DSRNA PROCESSING%GOBP%GO:0031050,0.7314897413024091,0.9726603499749559,0.190614658788785,0.7992341579376179,8199,30,LIN28B|ZCCHC11|DROSHA|TERT|C9orf114|METTL3|SRRT|HNRNPA2B1|DICER1|DGCR8|TARBP2|ZCCHC6
GAS HOMEOSTASIS%GOBP%GO:0033483,0.5718804920913879,0.9405604256499541,-0.32660311286206,-0.896503615011048,3253,6,SOD2|CAV1
REGULATION OF TUBE DIAMETER%GOBP%GO:0035296,0.00892857142857143,0.207969158127386,-0.302520595105399,-1.7336843340181003,29,41,DOCK5|VIP|SOD2|SERPINF2|EDNRA|ADRB2|NOS3|ADCYAP1|BDKRB2|PER2|ACE|ADM|CAV1
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901989,0.0987603979774914,0.570215774831708,0.2668137440688,1.35449436003718,1210,63,CCNB1|CDC7|CDK1|ANAPC5|ANKRD17|LSM11|ATAD5|CDC25C|CDC45|DTL|CDK10|EZH2|DLGAP5|CCNE1|PAGR1|DBF4B|FBXO5|RB1|ESPL1|CDC6|RAD51C
PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009222,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
BEHAVIORAL RESPONSE TO COCAINE%GOBP%GO:0048148,0.81162440662267,0.9855701659458179,0.39926209856372497,0.758955248573384,7009,3,ABAT|DRD4
MODULATION BY VIRUS OF HOST MOLECULAR FUNCTION%GOBP%GO:0039506,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
REGULATION OF L-DOPA DECARBOXYLASE ACTIVITY%GOBP%GO:1903198,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046831,0.233775092574547,0.747962124891127,0.3681947365797821,1.21994358135343,2398,14,TPR|DHX9|AKAP8L|CPSF6|SUPT6H|ZC3H3|RBM26|RIOK2
RESPONSE TO UV%GOBP%GO:0009411,0.197187381223869,0.7110878876919859,0.21072613843656102,1.2020438957068502,2593,114,GTF2H2|PTPRK|SIRT1|REV1|ATR|SPRTN|USP47|ST20|DDB2|DTL|POLD1|MEN1|PARP1|TMEM161A|FEN1|GEN1|INO80|AURKB|MSH6|DDB1|ZBTB1|STK11|MAP4K3|CIRBP|METTL3|PRIMPOL|MAP3K4|MC1R|MAP2K7|MFAP4|ZRANB3|CUL4B|BRSK1|KDM1A|CASP9|CARD16|CAT|ERCC5|MAPK13|UBE2B|CHEK1|XPA
LONG-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0001676,0.576218259511875,0.942162964865338,0.18499568116752804,0.925079372298077,7011,59,FAAH2|CYP2D7|GLYATL2|CYP2C8|SLC27A2|HSD17B4|PLA2G4A|ELOVL6|FADS2|ACOT1|AIG1|FADS1|ACOT2|PTGS2|GSTP1
POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:1900244,0.615119819939097,0.9513447271209741,-0.6857079841199821,-0.9172924774184659,4645,1,TOR1A
NEGATIVE REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905940,0.37946050562477296,0.855758937340731,0.6516669148720071,1.0651316700209001,3136,2,WNT4|HYAL3
NEGATIVE REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051097,0.7005263747340129,0.9683987722846401,0.39308954439569205,0.8329942944441908,6254,4,SIRT1|MNAT1|IFIT1
POSITIVE REGULATION OF SECRETION%GOBP%GO:0051047,0.6882998171846441,0.96731875442989,-0.110008209649384,-0.920874112284403,752,192,VIP|PANX1|VPS4B|VAMP3|MBP|IGF1|MAVS|MYOM1|RIPK2|GAPDH|CRH|RAB2B|KARS|TNFRSF11A|NLRP1|NLRP3|GAB2|TNFRSF4|ADCYAP1|DRD2|RAB7A|RAB5A|ACSL3|TWIST1|AQP1|TNF|GAL|INHBB|TRH
NEGATIVE REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070171,0.299745977984759,0.802472218138634,0.6870661450182379,1.12299073922118,2477,2,ASPN|BCOR
REGULATION OF PLASMACYTOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002736,0.7605369127516779,0.977664504547119,0.622353330392589,0.8267686342760359,5665,1,BST2
TRANSLATIONAL READTHROUGH%GOBP%GO:0006451,0.5848857644991209,0.9439064862850342,-0.323232024468327,-0.887250203722284,3327,6,TRNAU1AP|SEPSECS|EEFSEC
POSITIVE REGULATION OF ANOIKIS%GOBP%GO:2000210,0.5192307692307689,0.923826898284354,-0.36951246415177597,-0.9353962661104709,3023,5,PTRH2|AES|BRMS1|SIK1|MYBBP1A
REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090308,0.525604706907823,0.9265056012720759,0.4139125722556789,0.954007120028155,4823,5,DNMT1|TET1|ZNF304|SETDB1|TRIM28
REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0016202,0.12288266091777,0.607607158836689,-0.219226721989434,-1.28843101512051,398,45,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|TGFBR1|AKIRIN1|FGF2|IGF1|UQCC2|SOX6|MTPN|TBX20|DKK1|GREM1|NR1D2|RBM24|RBPJ
NEGATIVE REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:1904428,0.7304289394109079,0.972554563883587,0.381590399853555,0.808626508703883,6521,4,PRKAA2|MAPT
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0051881,0.696907216494845,0.96731875442989,-0.15058027936770002,-0.856366073876615,2365,40,BCL2L1|TCL1A|SLC25A33|BCL2|NDUFS1|PMAIP1|UBB
PEPTIDYL-S-DIACYLGLYCEROL-L-CYSTEINE BIOSYNTHETIC PROCESS FROM PEPTIDYL-CYSTEINE%GOBP%GO:0018231,0.481939163498099,0.9052279104788491,-0.209453466762978,-0.970343537142582,2027,22,CLIP3|ZDHHC3|ZDHHC9|ZDHHC11B|ZDHHC7|ZDHHC4|GOLGA7
EPITHELIUM MIGRATION%GOBP%GO:0090132,0.564419343452171,0.9380162603437769,-0.147718895299987,-0.941042612238188,1598,59,VEGFA|PKN1|KDR|RAB13|ABL1|RHOA|NRP1|FGF2|PXN|PTP4A3|ID1|NOS3|SCG2|GREM1|MYH9|CDH13|PRSS3
REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:0080164,0.5610738255033559,0.936434965680841,0.7229819144243491,0.960449218802816,4179,1,VIMP
CARBON CATABOLITE REGULATION OF TRANSCRIPTION%GOBP%GO:0045990,0.33369992144540506,0.8295413387957591,-0.537222896217051,-1.09027790627928,2123,3,USF2|NCOA1|USF1
CILIUM MOVEMENT%GOBP%GO:0003341,0.040273370759092,0.400580956841635,-0.324505976232072,-1.5555070608213202,164,24,DNAI1|LRRC6|CCDC103|DYX1C1|MAATS1|DNAAF1|CFAP61
MALONYL-COA CATABOLIC PROCESS%GOBP%GO:2001294,0.814378392691646,0.986276922067025,-0.590041905602117,-0.789317047350837,6150,1,MLYCD
RESPONSE TO BACTERIAL LIPOPROTEIN%GOBP%GO:0032493,0.108611599297012,0.58452352834625,-0.515746511499641,-1.41568954422074,617,6,TLR2|CD14|TIRAP|TLR1|SSC5D|CD36
POSITIVE REGULATION OF FIBRINOLYSIS%GOBP%GO:0051919,0.145760251602758,0.636418541205714,0.76989247311828,1.2583680971283602,1204,2,F12|KLKB1
CELLULAR IRON ION HOMEOSTASIS%GOBP%GO:0006879,0.996687616782742,1.0,0.0920273023181268,0.429247626696058,11734,44,TFR2|FLVCR1|ABCB6|CAND1|SLC46A1|SLC40A1|FAM132B|TF|ACO1|ISCU|ATP6AP1|ABCB7|IREB2|ATP6V0A2|ATP13A2|CYBRD1|TMEM199|HAMP|NDFIP1
SNORNA SPLICING%GOBP%GO:0034247,0.10452858203414998,0.576535954147525,-0.804356217259443,-1.3758082310588,703,2,CPSF3|RNF113A
ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1990262,0.6980007943863371,0.96731875442989,-0.646338773709749,-0.864627084295534,5271,1,AMHR2
"ANTERIOR/POSTERIOR AXIS SPECIFICATION, EMBRYO%GOBP%GO:0008595",0.0131837001525387,0.250097661198388,0.733051236243746,1.6895744309259297,120,5,TBX3|BASP1|HOXD8
PEPTIDYL-TYROSINE DEPHOSPHORYLATION%GOBP%GO:0035335,0.409933460076046,0.867015886388254,-0.221126470285216,-1.02442153213544,1724,22,PTPN9|DUSP22|DUSP4|DUSP7|PTPN6|UBASH3B|PTPN12|PTPN1|DUSP3|DUSP10
REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0090107,0.216205481265722,0.7328218014339442,-0.89082487869431,-1.19168360125223,1632,1,ABCA1
HISTONE H3-K79 METHYLATION%GOBP%GO:0034729,0.18724832214765103,0.6940517434063481,0.9085244816938691,1.20693424177959,1394,1,DOT1L
ACTIN POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0008154,0.6966096783541,0.96731875442989,-0.151695016663714,-0.849145843089428,2403,38,ABI1|CFL2|CAP2|WDR1|MICAL2|TWF1|DSTN|TWF2|COBL|RAC1
"PEPTIDYL-PYROGLUTAMIC ACID BIOSYNTHETIC PROCESS, USING GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE%GOBP%GO:0017186",0.769265033407572,0.9792236089291529,-0.4509511993382961,-0.7713278750667649,5180,2,QPCT|QPCTL
REGULATION OF CILIUM MOVEMENT%GOBP%GO:0003352,0.16887934400624802,0.672849066072304,-0.39798321030296707,-1.2847254669886201,864,9,MKKS|CFAP20|DNAAF1
PEPTIDYL-ARGININE MODIFICATION%GOBP%GO:0018195,0.651758114374034,0.9640743070248079,0.251190615960006,0.8516899228831741,6746,15,ART4|PRMT9
NEGATIVE REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901880,0.9500711997152009,1.0,0.136948565888111,0.578880606499796,10674,31,NAV3|CAMSAP3|FGF13|LIMA1|APC|TAOK1|APC2|CAMSAP2
POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0045899,0.693191580756014,0.96731875442989,0.332775339325458,0.81841248301181,6454,6,PSMC3|PSMC6|PSMC2|PSMC5
SYMBIONT INTRACELLULAR PROTEIN TRANSPORT IN HOST%GOBP%GO:0030581,0.582920043546631,0.9439064862850342,0.573531844499587,0.9374220439931279,4818,2,DYNLT1|IFIT1
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0000904,0.36188811188811204,0.848418604328854,-0.114970184209435,-1.03446225793982,206,293,PARD6B|LAMC1|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|VAMP3|RAB8A|CDC42|NEFH|ALCAM|S100A6|PLXNA1|COL21A1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|MYH9|SDC2|PTPRM|EFNB1|ZNF365|SEMA3A|RAC1|MET|DOK5|PTPRA|PIK3R1|RILPL1|HSP90AB1|PEAK1|NTNG2|CDHR1|GFRA2|DACT2|STC1|SLIT3|EPHB2|PARD3
POSITIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902261,0.9076197957580521,1.0,-0.317469945957869,-0.6442958228751611,5776,3,RNF207|NOS1AP|AKAP6
NEGATIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032685,0.5029789487620809,0.9164921159310329,-0.7449823555359509,-0.9965856113220402,3798,1,CD84
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902338,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
CLUSTERING OF VOLTAGE-GATED POTASSIUM CHANNELS%GOBP%GO:0045163,0.7398271798900241,0.9744283926676119,-0.38568434984007893,-0.78273492881516,4708,3,KCNIP2|CNTN2|CNTNAP2
CHEMOKINE SECRETION%GOBP%GO:0090195,0.9545179629853641,1.0,0.386676557966111,0.6320122113691651,7890,2,F2RL1
NEGATIVE REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0071930,0.11068658098876899,0.584830174998513,0.706407852652476,1.34280701657556,955,3,E2F7|RB1|E2F1
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048298,0.311655530809206,0.8143712300420921,-0.673614557485525,-1.15218162409093,2098,2,TGFB1|TNFSF13
REGULATION OF CYSTATHIONINE BETA-SYNTHASE ACTIVITY%GOBP%GO:1904041,0.245068184827221,0.757467559003634,-0.877040141155712,-1.1732433375537201,1850,1,MTRR
REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904429,0.78350837059374,0.981487311948134,0.27295851475301003,0.7441581414811771,7534,8,SLX1B|RTEL1-TNFRSF6B|SLX4
POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010870,0.420814023775942,0.8727872721376851,0.35071669967349106,1.03505558892887,4176,10,EDN1|HOXA5|HDAC6|CNPY2|HNRNPK|HDAC2|SCAP
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0031334,0.80164533820841,0.9841161968820359,-0.10362973093411099,-0.8674801342951921,876,192,CDC42EP5|MAPRE1|PSMC4|ERCC1|CLU|ANKRD53|VEGFA|BCLAF1|TRABD2A|CTNNB1|PTK2B|WARS|VASP|PFN1|RPA3|RPS3|STUB1|HRK|MITF|ICE1|FOSL1|EIF4G1|WHAMM|SLAIN2|SUMO1|ARPC5|SH3GLB1|TCL1A|BIN1|BID|WIPF1|RHOC|ARPC5L|ARPC4|CAPG|JUN|TP53|TPPP3|ASAP1|BMF|RAC1|MET|ACTR2|BRK1|CD36|BIK|TWIST1|JMY|TNF|BCL2L11|PMAIP1
DIOL BIOSYNTHETIC PROCESS%GOBP%GO:0034312,0.0236318407960199,0.32381765070033003,-0.46867289121803096,-1.7074223552547199,113,12,ACER3|SPR|ASAH2|QDPR|ASAH2B
CELLULAR RESPONSE TO RAFFINOSE%GOBP%GO:0097403,0.925989672977625,1.0,-0.535233789148655,-0.7159985588855781,6993,1,ZFP36L1
POLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0000272,0.960699548044803,1.0,0.172657685875463,0.5442787279007469,9777,12,GAA|AGL|AOAH|PYGL|PGM2L1|MANBA|PGM2|PYGM|PGM1
IRON INCORPORATION INTO METALLO-SULFUR CLUSTER%GOBP%GO:0018283,0.25107646622123203,0.7633701775454069,-0.7065343258891651,-1.20848912487533,1690,2,NFS1|FXN
MITOTIC SPINDLE DISASSEMBLY%GOBP%GO:0051228,0.8607717430748759,0.9916689277956879,0.457347670250896,0.7475222029496209,7115,2,VCP|SPAST
ASSOCIATIVE LEARNING%GOBP%GO:0008306,0.6827064715702641,0.9661028689801879,0.255341896713232,0.8240832116599419,6951,13,RGS14|NF1|GRIN1|BRSK1|SHANK1
GOLGI VESICLE TRANSPORT%GOBP%GO:0048193,0.995035852178709,1.0,0.0906471919676314,0.5934762242641379,14431,314,COG2|GRIA1|CNIH3|PGAP1|INS|GOLGB1|GOLT1A|PREB|KLC1|KIF2C|CCDC93|KIF18A|TRAPPC11|SEC31B|BET1|DOPEY1|ERGIC2|CUX2|MIA3|BGLAP|COPB1|KIF4A|RABIF|YIF1A|SPTBN5|KIF23|TRAPPC5|USE1|SCYL1|KIF11|NKD2|KLHL20|DCTN4|AP3D1|AP3B2|CENPE|COPB2|OSBPL5|GGA3|GOPC|VPS13A|KIF15|KIFAP3|COG6|ARF5|CYTH3|GOLGA5|TRAPPC8|ANKFY1|SEC31A|KIF22|KLC2|USO1|CNIH2|ANK3|RAB26|GOLGA4|CD55|SEC24D|MYO5A|SPTBN4|MACF1|VPS13C|GGA2|NRBP2|SPTAN1|CTSC|RACGAP1|GBF1|RER1|MON2|BET1L|SEC24C|YIF1B|DYNC1H1|LMAN2L|COPG2|TMED9|TRIM23|KLHL12|KIF16B|SPTBN2|TICAM2|BBS1|RABEP1
CADMIUM ION TRANSPORT%GOBP%GO:0015691,0.0394344069128044,0.396089810860281,-0.7788478808830559,-1.58064863366537,250,3,SLC30A1|SLC11A1
NEUROBLAST DIVISION IN SUBVENTRICULAR ZONE%GOBP%GO:0021849,0.56362286562732,0.9377667552605741,-0.536255858836504,-0.917236926513119,3795,2,NUMBL|NUMB
NEGATIVE REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032900,0.4267178604528,0.875696962448429,-0.786116012351125,-1.05161135819838,3222,1,FURIN
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050961,0.684524744697565,0.966495577318169,-0.40619830153303205,-0.824367384279735,4356,3,MMP24|EPHB1|ANO1
LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045713,0.24904011650999602,0.7613646381106121,-0.875606528451698,-1.17132555012908,1880,1,PPARG
ATRIOVENTRICULAR VALVE MORPHOGENESIS%GOBP%GO:0003181,0.47106890459364004,0.898051355931307,-0.23043486716211103,-0.969643417015558,2132,17,NOTCH1|ACVR1|SMAD6|EFNA1|OLFM1|SLIT3
POSITIVE REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902269,0.9716406829992579,1.0,-0.32837055417700606,-0.561660246517802,6543,2,AZIN2|AZIN1
PEPTIDYL-ASPARAGINE MODIFICATION%GOBP%GO:0018196,0.5405060986710359,0.928807195199472,0.234510488716335,0.9428444937024659,5937,26,ASGR1|FUT8|DERL3|NUDT14|MGAT2|SYVN1|OSTC|ALG5|RPN2|VCP|STT3A
FOLIC ACID METABOLIC PROCESS%GOBP%GO:0046655,0.984225727616085,1.0,-0.12306197873580901,-0.529385290791209,4429,18,SLC25A32|MTRR|SHMT2|FPGS
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:1903916,0.7093869985436251,0.9698418353073279,-0.6409351565946179,-0.85739850092572,5357,1,PPP1R15A
LIPOPOLYSACCHARIDE TRANSPORT%GOBP%GO:0015920,0.21838926174496598,0.7341474817293291,0.8920379355977059,1.18503260080781,1626,1,SCARB1
NEGATIVE REGULATION OF SCHWANN CELL MIGRATION%GOBP%GO:1900148,0.6948993288590601,0.96731875442989,0.657201146890163,0.873062403821749,5176,1,CERS2
POSITIVE REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900036,0.0214484310869853,0.308339815305177,-0.989744155271284,-1.32401093355271,161,1,IER5
CELLULAR RESPONSE TO ALKALINE PH%GOBP%GO:0071469,0.849993380113862,0.991298302704726,-0.5737207763564179,-0.7674837751318059,6419,1,INSRR
SOMATIC CELL DNA RECOMBINATION%GOBP%GO:0016444,0.856501814015658,0.991298302704726,0.19230044710549601,0.6782159063478829,8970,17,LIG4|EXO1|MSH6|LIG1|PRKDC|RNF8|HMGB2|HSPD1|EXOSC3|HMGB1|LIG3
NUCLEOBASE-CONTAINING SMALL MOLECULE CATABOLIC PROCESS%GOBP%GO:0034656,0.0265707168557985,0.3377111602831,-0.29538749809272496,-1.58944670185866,95,34,ENTPD6|NUDT1|NUDT15|ENTPD1|ENTPD4|DERA|PNP|CDA|HPRT1|NUDT18|CDADC1|UPP1|ENTPD3|NT5E|ENPP4
L-ARGININE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903400,0.6797299522476539,0.9647315640607691,-0.35769069984137697,-0.822613885430537,4127,4,SLC7A1
POSITIVE REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070318,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|RHNO1
REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:0060312,0.455981695358466,0.88900512246363,0.437675371913791,1.008776850607,4184,5,CEACAM1|FLT4|CST3|TGFB1|TMBIM1
REGULATION OF FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:1904542,0.777181208053691,0.9810334506628041,0.6132002646669611,0.814609194806751,5789,1,PINK1
REGULATION OF CELLULAR RESPONSE TO MANGANESE ION%GOBP%GO:1905802,0.8091275167785229,0.984682960940884,0.596162329069255,0.791975057481395,6027,1,SLC30A10
RESPONSE TO BILE ACID%GOBP%GO:1903412,0.0164509495584855,0.272990155949979,0.914254204576785,1.4943233813485302,135,2,FGFR4|ABCB4
LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:0050901,0.643636717988696,0.9622492597510809,0.257968829909688,0.8547308990914549,6604,14,ITGB1|MADCAM1|ITGA4
REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA%GOBP%GO:0070920,0.8227441044630679,0.987616425875001,0.21309787515324696,0.7060594820233859,8442,14,BMP4|MAP2K2|TERT|MYCN|DDX5|NCOR1|ZC3H12A|BCDIN3D
NEGATIVE REGULATION OF PANCREATIC JUICE SECRETION%GOBP%GO:0090188,0.345028465510393,0.841038624862765,-0.828021614468461,-1.1076697598418401,2605,1,NR1H3
FORMIN-NUCLEATED ACTIN CABLE ORGANIZATION%GOBP%GO:0110009,0.17054532823897198,0.673117535978459,0.661464652034852,1.2573747200487,1472,3,SPIRE2|SPIRE1|FMN2
EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:0061502,0.7413422818791949,0.974505008828563,0.632388619320688,0.8401000679110359,5522,1,MYO1D
"COMPLEMENT ACTIVATION, CLASSICAL PATHWAY%GOBP%GO:0006958",0.0623935454952936,0.48722934276585206,0.35600367173656206,1.4746870900964901,695,29,IGHV3-21|IGKV4-1|IGHV4-61|IGHG1|IGLL5|IGHG4|IGHV1-18|IGHV3-43|IGKV3-11|IGKV2D-28|IGKV2-28|IGHV1-24
MRNA CLEAVAGE INVOLVED IN GENE SILENCING%GOBP%GO:0098795,0.362293956043956,0.849009509840662,-0.420637546878447,-1.06481601815292,2109,5,AGO4|AGO3|AGO1|MOV10|AGO2
REGULATION OF ENDOTHELIAL CELL-MATRIX ADHESION VIA FIBRONECTIN%GOBP%GO:1904904,0.126175029789488,0.607607158836689,-0.9345500661667401,-1.25017611770389,952,1,MMP12
POSITIVE REGULATION OF ALDOSTERONE SECRETION%GOBP%GO:2000860,0.95061564941083,1.0,-0.5224966916629911,-0.698959755228159,7179,1,C1QTNF1
NEGATIVE REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001045,0.67363961339865,0.9647315640607691,-0.658359064843405,-0.880706994240631,5087,1,PHACTR4
PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE FROM MATRIX SIDE%GOBP%GO:0032979,0.892947865005443,0.9976191001250191,0.439757375241246,0.71877134899002,7381,2,C2orf47|COX18
POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061051,0.48836401528308504,0.9081289531892159,0.5211058245235081,0.99056735414407,4217,3,EDN1
ACTIVATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0007190,0.0165837479270315,0.274095258901765,-0.482799170827001,-1.75888580887639,79,12,CAP2|CRHR1|EDNRA|ADRB2|GIPR|ADCYAP1|ADORA2B
ALCOHOL METABOLIC PROCESS%GOBP%GO:0006066,0.623130244436337,0.9536478716552259,0.15233967338813,0.9157918718693789,8539,157,PLCB3|TM7SF2|C14orf1|FDX1|AKR1B1|CBR4|EBP|COQ3|PPIP5K2|NAPEPLD|ALDH1A1|DHFR|TKFC|DHRS4|ISYNA1|CLN6|MVD|LBR|CACNA1H|DHCR24|COQ2|SRD5A3|SOAT1|ADH1B|PPAPDC2|SULT1A3|AKR1C1|CETP|PGP|OSBPL5|ALDH3A2|LDLRAP1|APOE|NSDHL|GDPD1|PLCD4|ACSS1|MINPP1|PLCG1|GGPS1
SPHINGOID CATABOLIC PROCESS%GOBP%GO:0046521,0.311664239375083,0.8143712300420921,-0.8447287163652409,-1.1300193594444299,2353,1,SPHK1
REGULATION OF GASTRULATION%GOBP%GO:0010470,0.31417804992934495,0.8164430838831159,-0.243037812899841,-1.1038281636523002,1333,21,IL1RN|PHLDB1|MAPK7|TENM4|MYADM|MAP2K5|MBP|DKK1
SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007210,0.226664901363697,0.7398172623753029,-0.885917512130569,-1.1851188673755602,1711,1,HTR1B
CILIARY NEUROTROPHIC FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070120,0.339206323069323,0.832810902324958,-0.47057850328130996,-1.08223225025418,2059,4,CNTFR|LIFR|IL6ST|IL6R
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046827,0.550384193194292,0.931421923167331,-0.22544822639820497,-0.923286258101369,2506,16,EMD|ANP32B|GSK3B|GAS6|IL1B|TCF7L2|BAG3|TP53|YWHAE
POSITIVE REGULATION OF LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0043017,0.48775321064477706,0.907808599852568,-0.7542456991618879,-1.00897746852744,3683,1,CD86
RESPONSE TO ANTIBIOTIC%GOBP%GO:0046677,0.8552754435107379,0.991298302704726,-0.11013254251150201,-0.793233819572027,1831,94,SOD1|AHR|PPIF|CHRNB2|ADCY7|IMPACT|MAPK7|PRKCD|SIRPA|STK26|HMOX1|TNFAIP3|HP|ABL1|RPS3|FYN|ZNF580|IL6|PDCD10|FXN|NET1|HSF1|TP53|ADCY2|ADCYAP1|DRD2|CRIP1|STK24|AQP1
REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031347,0.10593220338982999,0.578991161828047,-0.120564669714252,-1.14748120123195,24,443,IL6ST|PLSCR1|GBA|RELA|RNF135|PRKACA|TRAF6|OTULIN|MAPKAPK3|MFHAS1|CTSS|RPS6KA3|SCARA3|AGT|ZMPSTE24|UBE2N|CYBA|TLR1|CREBBP|FLOT1|MUL1|IL17D|SETD6|PYCARD|RIOK3|PJA2|SOCS3|POLR3C|XRCC6|PHB2|ITCH|HEXIM1|NOD1|GPER1|PLA2G7|RNASEL|PVRL2|PTPN6|TRAF3IP2|PPARD|IL1B|CLU|IRAK1|SIN3A|ADCY7|APOBEC3F|POLR3D|FCER1G|NFKBIA|PIK3C3|CX3CL1|MAPK7|PRKCD|SIRPA|CD19|DAB2IP|C5AR1|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|ARRB2|CD300LF|NR1H3|IFNAR2|IRAK4|LAMP1|PCBP2|CR2|FGR|CEBPA|PSMA6|ULBP3|TRAF3|S100A8|CCL14|FYN|C1QBP|MGLL|TNFRSF1B|BCL10|PPARA|UBE2V1|SEMA7A|APOD|RELB|METRNL|CDH5|IL6|PPARG|LYN|FCGR2B|SBNO2|MMP9|CYLD|TANK|GLTSCR2|C2CD4A|VAMP2|RNF216|SUMO1|CDC37|VAMP3|MAVS|CNPY3|TNIP1|GPATCH3|FOXP1|RIPK2|MUC4|ETS1|TMSB4X|CNOT7|PTPN1|PLA2G2A|SNCA|KARS|MUC3A|TNFRSF11A|TRAF3IP1|NR1H2|RFTN1|PDCD4|ULBP2|PROC|NLRP1|KRAS|NLRP3|UBA52|WDFY1|COLEC12|SNX6|ADCYAP1|BCL6|TNIP2|TICAM1|MUC12|MYD88|NR1D1|NR1D2|UBC|CCL18|CD36|GPRC5B|HSP90AB1|UBE2K|TNF|SPATA2|CAV1|PAK2|UBB
"VESICLE TARGETING, TRANS-GOLGI TO PERICILIARY MEMBRANE COMPARTMENT%GOBP%GO:0097712",0.246259764332054,0.7585951535148171,-0.8766541685046321,-1.17272701017017,1859,1,CEP19
NEGATIVE REGULATION OF AXONOGENESIS%GOBP%GO:0050771,0.822986721848595,0.987616425875001,0.162361543390029,0.73229245752076,9544,39,SEMA3D|PTPRO|FGF13|SEMA5A|SEMA3E|RUFY3|SEMA4G|TRIM46|SEMA6A|SEMA4C|RTN4R|PTPRS|SEMA4A|CDKL3|GDI1|SEMA4F|SEMA5B|SEMA3B|NGFR|SEMA3C|SEMA4D|EFNB3
REGULATION OF OVULATION%GOBP%GO:0060278,0.0118782479584261,0.23670963874364498,-0.925884460835633,-1.5836757830594799,79,2,INHBB
REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905661,0.866504573347227,0.9929671171385601,0.37085605197800897,0.704958342217878,7483,3,HNRNPA2B1|PARP3
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS%GOBP%GO:0002200,0.899251026818072,0.998912093067348,-0.143510434537369,-0.674343531110839,3721,23,MLH1|BATF|VPRBP|EXOSC6|CTNNBL1|PMS2|RNF168
MOLTING CYCLE PROCESS%GOBP%GO:0022404,0.543230497150717,0.929698169790548,0.29668771105343295,0.9352656914006271,5528,12,CDH3|TGFB2|APCDD1|FGFR2|HDAC2|ATP7A|SOX18
DOLICHYL MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0043048,0.69111611280286,0.96731875442989,-0.6490957212174681,-0.868315137035235,5219,1,DOLK
SKELETAL MUSCLE THIN FILAMENT ASSEMBLY%GOBP%GO:0030240,0.0934278350515464,0.5622489437340121,0.578880312503995,1.42367182280806,869,6,IGSF22|PROX1|TCAP|OBSL1|MYOM2
FEMALE MEIOTIC NUCLEAR DIVISION%GOBP%GO:0007143,0.401176726955764,0.8638522656500329,0.45689807593643605,1.05308233377669,3681,5,SPIRE2|SPIRE1|FMN2|C17orf104
POSITIVE REGULATION OF MRNA PROCESSING%GOBP%GO:0050685,0.87210153771052,0.9934031064448321,-0.145647288462595,-0.698154740395366,3572,24,CELF4|RBM3|CPEB1|TRA2B|HSF1|NCBP2|NUDT21
RECEPTOR-MEDIATED VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0046813,0.108091123330715,0.58452352834625,-0.7024925554207571,-1.42568776925598,687,3,CD81|GAS6|ICAM1
PIRNA BIOSYNTHETIC PROCESS%GOBP%GO:1990511,0.745797329143755,0.9749763305090959,-0.383750674822527,-0.7788105928190451,4746,3,GPAT2
REGULATION OF INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902214,0.8674090571640679,0.993084774742015,-0.4055693410532121,-0.693704636966991,5841,2,PARP14|CD300LF
NEGATIVE REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046636,0.227483524530144,0.7402937020522141,-0.24743316221975897,-1.18606145681253,931,24,RC3H1|TNFRSF14|XCL1|ANXA1|JAK3|FOXP3|HMGB1|ZC3H12A|HFE|CD300A|LILRB1|TWSG1|ZBTB7B|RC3H2|C10orf54|RUNX3|CD274|LGALS9|RUNX1|SMAD7|SOCS5|CBFB
POSITIVE REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:2001247,0.0516351118760757,0.44584415421255996,-0.973753859726511,-1.30262022766244,389,1,ACSL3
UDP METABOLIC PROCESS%GOBP%GO:0046048,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
PROTEIN K6-LINKED DEUBIQUITINATION%GOBP%GO:0044313,0.258075720736367,0.76925702143898,0.6142053600970551,1.1675397775658503,2228,3,USP13|OTUD3|USP30
VENTRICULAR ZONE NEUROBLAST DIVISION%GOBP%GO:0021847,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
CELLULAR METABOLIC COMPOUND SALVAGE%GOBP%GO:0043094,0.856443574225703,0.991298302704726,0.16400569909145302,0.6932509146320711,9622,31,NAPRT|APIP|TK1|UCKL1|DCK|MTAP|HDDC2|UCK1|ENOPH1|PRTFDC1|FUK
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009149,0.7953308334341359,0.9825058878489269,0.48865853019196004,0.7986989433636491,6574,2,DUT|DCTPP1
NEGATIVE REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000666,0.0119157950483252,0.23670963874364498,-0.9948720776356421,-1.33087071164855,89,1,TNFRSF21
FRUCTOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015755,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051962,0.9146538976128441,1.0,0.115596737123167,0.734904599662514,12988,238,SYT17|RIT2|HOXD3|GHRL|FAM150B|RIMS2|BRINP3|LRRC7|VLDLR|CXCR4|HES1|SERPINE2|AGER|LIG4|SYT3|PROX1|DSCAM|RGS14|SMARCD3|PLXNC1|ECT2|ZNF804A|MARK2|KIF20B|CUX2|BRINP1|DVL1|ROBO2|UNC13A|SEMA5A|CPEB3|CDC20|MAP6|CLSTN2|PTPRD|PLXNA3|HEYL|GRIP1|DLG5|CAPRIN2|RUFY3|APOE|NIPBL|P3H1|ADGRL1|SEMA6A|PLXNB2|OBSL1|DPYSL3|SHTN1|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|ZNF335|LRP8|MYRF|KDM1A|PLXNA2|NAP1L1|NTN1|CPNE1|DICER1|CUL7|SLITRK1|SYT1|RNF10
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904351,0.596503415537803,0.948415232788167,0.48108525421859494,0.9144924600004021,5151,3,LAPTM4B|ATP13A2|MGAT3
POSITIVE REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:1904595,0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
RESPONSE TO HYDROSTATIC PRESSURE%GOBP%GO:0051599,0.7783960324180479,0.9811398289380491,0.49486701466309396,0.808846540674673,6434,2,PKD2
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010518,0.7594668549739609,0.977664504547119,0.180583674372727,0.7784102308631851,8603,33,AGTR1|PDPK1|CCL5|KIT|HRAS|PLCG1|NTRK3|ARL1|S1PR4|LPAR2|P2RY6|FGFR2
LOW-DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS%GOBP%GO:0032799,0.4355791962174939,0.878651088001772,-0.295436160311517,-0.999504751213752,2210,10,PPARG|CLTA|AP2S1|MYLIP
NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010593,0.579654046207814,0.942746898746279,0.5746493174722571,0.9392485228681802,4791,2,PLXNB3|SLIT2
REGULATION OF ADENYLATE CYCLASE ACTIVITY INVOLVED IN G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010578,0.33205348867999496,0.8293509737209019,-0.8350242611380679,-1.11703741380068,2507,1,CRHR1
PIGMENT GRANULE ORGANIZATION%GOBP%GO:0048753,0.033609576427256,0.375579079090274,-0.35896972425808504,-1.60168898351408,145,20,HPS1|AP1G1|BLOC1S1|HPS4|PMEL|AP1M1|BLOC1S5|TRAPPC6A|BLOC1S4|BLOC1S6|BLOC1S3|KIF13A
EPITHELIAL CILIUM MOVEMENT%GOBP%GO:0003351,0.0561774461028192,0.46132606014672706,-0.422259157024435,-1.53833246582877,270,12,LRRC6|CCDC103|DYX1C1|DNAAF1
ER-DEPENDENT PEROXISOME ORGANIZATION%GOBP%GO:0032581,0.422878326492784,0.873470206885489,-0.7874944861049851,-1.05345538456823,3193,1,PEX16
RECRUITMENT OF 3'-END PROCESSING FACTORS TO RNA POLYMERASE II HOLOENZYME COMPLEX%GOBP%GO:0034402,0.6123236822568671,0.9508825506493929,-0.516514717698997,-0.8834707618653042,4123,2,POLR2D
CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0051305,0.35681487288610203,0.8445764484419659,0.51288241021558,1.0868468203273,3185,4,DLGAP5|CENPE|FMN2
RESPONSE TO VITAMIN D%GOBP%GO:0033280,0.911718831236352,1.0,0.22788898389061898,0.6212865089390179,8767,8,BGLAP|CDKN2D|CYP27B1|ALPL|SPP1|AQP3|SFRP1
NEGATIVE REGULATION OF ROOT HAIR ELONGATION%GOBP%GO:1902891,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
CARDIAC CELL DEVELOPMENT%GOBP%GO:0055006,0.353546389875262,0.842847021021096,0.274087769477327,1.09220033375573,3882,25,NEB|IGSF22|MAML1|PROX1|TCAP|NEBL|HEY2|CXADR|OBSL1|SLC8A1|MYOM2|SPRY1|SORBS2|JAG1|PDLIM5
GUANINE METABOLIC PROCESS%GOBP%GO:0046098,0.829250185597624,0.9876441563834109,-0.42657159577855,-0.7296278688658671,5584,2,HPRT1
CELLULAR RESPONSE TO DITHIOTHREITOL%GOBP%GO:0072721,0.841879194630872,0.9907170711491421,0.579786060873401,0.770219915780324,6271,1,CERS1
CYTOKINESIS%GOBP%GO:0000910,0.23265564433193603,0.746122594132505,0.220494477871475,1.18314999697547,2940,82,SEPT12|ROPN1B|UNC119|SEPT11|ECT2|KIF4A|KIF23|ANLN|APC|CENPA|NUSAP1|CEP55|ESPL1|AURKB|INCENP|SEPT2|CNTROB|ANK3|KIF20A|STMN1|SON|PLK1|RACGAP1|SEPT3|ALKBH4|BRCA2|CUL7|SEPT5|CIT|KLHDC8B|SPIRE2|SPIRE1|MITD1|FMN2
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050996,0.44125958821154604,0.880402968441571,-0.28383808934731897,-0.9988615995982429,2185,11,IL1B|PRKCD|ABHD5|PPARA|TWIST1
CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0055013,0.0991743291424282,0.570215774831708,0.37738208719554,1.40140809847976,1056,20,NEB|IGSF22|MAML1|PROX1|TCAP|NEBL|HEY2|CXADR|OBSL1|SLC8A1|MYOM2
REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:2001245,0.0516351118760757,0.44584415421255996,-0.973753859726511,-1.30262022766244,389,1,ACSL3
REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0031998,0.543144208037825,0.929698169790548,-0.271473492580129,-0.9184354595467329,2756,10,IRS1|AKT2|METTL20|LONP2|AKT1|TYSND1|ABCD1|IRS2|PPARA|TWIST1
PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:0070262,0.9367744610281921,1.0,-0.168986243012202,-0.615633834292568,4518,12,PPM1F|PPP1R15B|PPP2R2A|PPP2CA|PPP2CB
POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002711,0.9030801911842801,1.0,-0.129791229426709,-0.682511681561829,3400,31,CD1E|MAP3K7|ZP3|ZBTB1|IL12RB1|CD1D|TRAF2|HLA-F|IL1R1|XCL1|HSPD1|FADD|HLA-C|PRKCZ|STX7|HLA-B|MALT1|PVR|HLA-A|HLA-E|RSAD2|FZD5|IL18|CD1C|TRAF6|PVRL2|IL1B|FAM49B|IL6|NLRP3|B2M
REGULATION OF STEROL IMPORT%GOBP%GO:2000909,0.8539597315436239,0.991298302704726,0.57399647110719,0.7625287040678249,6361,1,LAMTOR1
COBALAMIN TRANSPORT%GOBP%GO:0015889,0.65573968791581,0.9640743070248079,0.545968025837624,0.8923697396125451,5420,2,CD320
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN%GOBP%GO:0002478,0.737615677735438,0.974306231601101,-0.11555962304085601,-0.8782728457968929,1354,115,KIF5A|CANX|DCTN1|CAPZB|DCTN3|AP1G1|RILP|CTSS|CTSF|AP2A1|OSBPL1A|CAPZA2|CALR|IFI30|SEC13|CTSD|KIF26A|FCER1G|CTSL|AP1M1|DNM2|DYNC1LI2|DCTN6|TAPBP|HLA-DQB1|DCTN5|FCGR2B|VAMP3|CLTA|AP1S1|AP2S1|KIF3C|KIF3B|DYNLL2|B2M|SEC23A|HLA-DQA2|RAB7A|HLA-DQB2|CTSV|DYNC1LI1|CD36
STRESS RESPONSE TO METAL ION%GOBP%GO:0097501,0.583861911198919,0.9439064862850342,0.33260225378472197,0.9067629755124201,5614,8,MT1F|MT1E|MT2A|ATP7A|MT1X|MT1G
NEGATIVE REGULATION OF PLATELET AGGREGATION%GOBP%GO:0090331,0.43030498281786894,0.878486294433769,0.41770270321596703,1.02727896602154,4006,6,CEACAM1|SERPINE2
HEAD MORPHOGENESIS%GOBP%GO:0060323,0.946996466431095,1.0,-0.1459853297351,-0.614289476682807,4287,17,RAB3GAP1|CRISPLD1|STRA6|MSX1|SKI|ATP6AP2|CRISPLD2
MRNA CLEAVAGE INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035279,0.362293956043956,0.849009509840662,-0.420637546878447,-1.06481601815292,2109,5,AGO4|AGO3|AGO1|MOV10|AGO2
VESICLE TETHERING TO GOLGI%GOBP%GO:0099041,0.987008623586068,1.0,0.240130017311492,0.508858445097452,8812,4,WDR11|C17orf75|TBC1D23
NEGATIVE REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904848,0.0355704697986577,0.3821688062173221,0.981859285399206,1.30435625680459,264,1,CXCL13
MODIFICATION OF POSTSYNAPTIC STRUCTURE%GOBP%GO:0099010,0.919227913882702,1.0,-0.372925282602702,-0.637868723291334,6190,2,ARHGAP44|SYNPO
CELLULAR RESPONSE TO SODIUM DODECYL SULFATE%GOBP%GO:0072707,0.374685555408447,0.852609194081082,-0.810542567269519,-1.08428750547213,2829,1,ZNF16
PROTEIN LOCALIZATION TO CELL DIVISION SITE%GOBP%GO:0072741,0.748155316317891,0.9749763305090959,0.5080197697450349,0.8303443575287859,6184,2,ANLN|RTKN
GROWTH INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003241,0.12930086410055,0.6100112725887421,-0.6810411381934489,-1.38215275534275,822,3,MESP1|NOTCH1|S1PR1
NEGATIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0034244,0.115465729349736,0.593539945084925,-0.509857529932205,-1.3995246852343202,656,6,EAPP|RNF168
POSITIVE REGULATION OF URETERIC BUD FORMATION%GOBP%GO:0072107,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
EYE PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0001754,0.973387017578317,1.0,0.160089210314314,0.516667387084099,9911,13,DSCAM|CEP290|TH|MYO7A|TOPORS|SDK2|AGTPBP1|BBS4
SYNAPTIC VESICLE CYCLE%GOBP%GO:0099504,0.23091178650852498,0.7439941821727,-0.173289603411809,-1.1533096476291498,622,68,VAMP2|STX11|SNCA|BLOC1S6|OTOF|SNPH|SYT2|RAB5A|SYNDIG1|PLD2|AMPH|SYT9|SNAP25|CPLX1
INORGANIC ANION TRANSPORT%GOBP%GO:0015698,0.960047003525264,1.0,0.12120043357031801,0.582422505137974,11437,50,SLC12A2|ANO4|ANO9|ANO8|SLC37A2|SLC26A2|TTYH1|SLC25A10|XPR1|ANO5|RACGAP1|SLC1A3|CLCN7|BEST1
DNA ALKYLATION%GOBP%GO:0006305,0.897660020030957,0.998912093067348,0.160765576230132,0.6406276950986229,9858,25,EHMT1|PIWIL4|N6AMT1|DNMT3B|FOS|EHMT2|ATF7IP|DNMT1|PPM1D|PIWIL2|PICK1|PRMT7|ATRX|KMT2E|TDRD12
REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT%GOBP%GO:0060850,0.9465587044534409,1.0,0.19842204426893398,0.566228718138255,9351,9,PROX1|RORA|CEBPB
GLYCINE METABOLIC PROCESS%GOBP%GO:0006544,0.022841225626741,0.31609926985007897,-0.55842697230646,-1.7358341731840101,122,8,AMT|GCSH|SLC25A32|SDS|SDSL|SHMT2
SINGLE FERTILIZATION%GOBP%GO:0007338,0.6346474668539821,0.95916055221954,0.20025929334682896,0.8709286807790841,7227,34,CATSPERG|ROPN1B|SERPINA5|CDK1|OVGP1|PCSK4|TUBGCP3|ZP3
POSITIVE REGULATION OF CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903679,0.849253212921153,0.991298302704726,0.37995841840133004,0.7222609832556041,7334,3,METTL3|NCK1
POSITIVE REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903896,0.00404217926186292,0.148761179457137,-0.7281427598415581,-1.99870298455416,22,6,BAX|DAB2IP|PTPN1|BCL2L11|TMEM33
PODOSOME ASSEMBLY%GOBP%GO:0071800,0.905891594658288,1.0,-0.318469027717734,-0.646323429622784,5765,3,SH3PXD2B|DBNL
REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001023,0.18876755070202803,0.69611511841804,-0.20377554888337898,-1.20509224536986,604,46,CRH|SNCA|CHRNA3|DRD2|SYT2|PARK2|PER2|MET|GAL|SYT9
SOMATIC RECOMBINATION OF T CELL RECEPTOR GENE SEGMENTS%GOBP%GO:0002681,0.151812080536913,0.6481463948883249,0.9246250551389499,1.22832313530388,1130,1,LIG4
PLASMA MEMBRANE RAFT ASSEMBLY%GOBP%GO:0044854,0.0753777472527472,0.525408291492683,-0.587737005299817,-1.4878172011718203,438,5,CAV2|CAV1
METANEPHRIC GLOMERULAR MESANGIAL CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072262,0.7087250099298291,0.9695170059473192,-0.641100573445082,-0.857619784090102,5352,1,PDGFRB
NEGATIVE REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001136,0.293922944525354,0.8004058897916541,-0.852999558888399,-1.14108351766353,2219,1,ARHGAP1
CHANGES TO DNA METHYLATION INVOLVED IN EMBRYO DEVELOPMENT%GOBP%GO:1901538,0.9384299020200799,1.0,0.40799558864075,0.666857581338829,7757,2,PICK1|TET3
POSITIVE REGULATION OF CYTOKINESIS%GOBP%GO:0032467,0.146043886005645,0.637320894898416,0.329476454288445,1.3129162750483898,1603,25,KIF14|ECT2|KIF20B|CSPP1|MAP10|KIF23|AURKB|CDC6|CENPV|RACGAP1|PKN2|SVIL|CIT
LYTIC VACUOLE ORGANIZATION%GOBP%GO:0080171,0.9927847448891941,1.0,0.101493883596351,0.46351448576774,11557,41,GAA|TMEM165|GNPTAB|HOOK1|CLN6|CORO1A|HOOK2|MYO7A|CLVS1|LAPTM4B|FAM160A2|SYT7|HOOK3|VPS33A|TMEM199|LAMTOR1|TMEM106B|RAB34|RAB20|RAB7B|ARSB|MBTPS1|TPP1|ZKSCAN3|TPCN2|RAB14
"REGULATION OF ACTIVATED CD8-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905402",0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060049,0.430826369545033,0.8785877309899279,-0.32120929983494,-0.998458360804269,2319,8,CHP1|RAMP1
PRESYNAPTIC DENSE CORE VESICLE EXOCYTOSIS%GOBP%GO:0099525,0.0416112253538164,0.402998391331252,0.8712985938792389,1.4241136157230498,343,2,UNC13B|UNC13A
REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031344,0.116352201257862,0.595821909765648,-0.12290446825277801,-1.15475769929948,36,406,CX3CL1|BCAS3|PRKCD|DNM2|LPAR1|DAB2IP|TUBB2B|RTN4|NSMF|PTK2B|PDPN|AKIRIN1|PFN1|SRGAP2C|TCTEX1D2|ABL1|EPS8L1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|FYN|RHOA|SERPINI1|CCP110|NRP1|CPNE6|ATG3|TBC1D20|TBC1D8|SEMA7A|PTK7|YWHAH|TBC1D14|LYN|FCGR2B|PODXL|PRNP|CYLD|EFNA1|ULK4|KIF13B|POU4F2|HAP1|BAG5|ISLR2|ARC|SPOCK1|TBC1D19|RAP1A|RALA|LIMK1|AMIGO1|MARK4|TBC1D5|FMR1|TWF1|CDC42|C21orf91|NEDD4|SEMA6B|PLXNA1|TBC1D2|CHRNA3|SEPT9|RAPGEF1|ARPIN|SSH3|PLXNA4|TBC1D15|RELN|TWF2|ADCYAP1|HTT|COBL|NCS1|SYT2|RAB5A|FKBP4|MAP4|SDC2|FBXO7|KCTD17|STK24|MYLIP|RHOQ|ZNF365|SEMA3A|RAC1|CORO1C|SEMA3G|CPNE9|BRK1|OLFM1|GPRC5B|TBC1D1|CAV1|LINGO1|FOXO6|HOMER1|RTN4RL2
REGULATION OF RETROGRADE TRANS-SYNAPTIC SIGNALING BY ENDOCANABINOID%GOBP%GO:0099178,0.0845637583892617,0.545178773025535,0.9587560652845171,1.27366465958995,629,1,FABP5
REGULATION OF CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:1905957,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
REGULATION OF LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902606,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
POSITIVE REGULATION OF TRANSCRIPTION BY GALACTOSE%GOBP%GO:0000411,0.758771349132795,0.977664504547119,-0.617390824878694,-0.825902530528672,5730,1,NCOA1
REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000269,0.0536675951717735,0.45277078127342796,-0.503015073286816,-1.5635898642781498,288,8,GAS6|BTG1|STK17B|IER3IP1|BCL2L11
HYPOMETHYLATION OF CPG ISLAND%GOBP%GO:0044029,0.4967562557924,0.911815944636073,-0.7489523599470671,-1.0018964072672099,3751,1,FAM129B
RESPONSE TO CATECHOLAMINE%GOBP%GO:0071869,0.6663539125539499,0.964618776001639,0.22714798976272602,0.8435138900536651,7101,20,RYR2|NR4A3|KCNQ1
NEGATIVE REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905775,0.8048322147651009,0.984682960940884,0.598753859726511,0.7954177903431809,5995,1,MNAT1
NEPHRON DEVELOPMENT%GOBP%GO:0072006,0.644316351614817,0.9625261061153929,0.18488961884574498,0.872452934776548,7600,46,CITED1|BASP1|BMP4|PKD2|AHI1|MPV17|PTPRO|KLHL3
NEGATIVE REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032304,0.9706077055474649,1.0,-0.513123070136745,-0.6864203759131751,7330,1,PLA2R1
SIALIC ACID TRANSPORT%GOBP%GO:0015739,0.7407652588375481,0.974505008828563,-0.624834583149537,-0.8358602729258651,5594,1,SLC17A5
MATING BEHAVIOR%GOBP%GO:0007617,0.7203760095326359,0.9713637233549571,-0.635090427878253,-0.8495798291175529,5440,1,APP
MODULATION BY SYMBIONT OF HOST MOLECULAR FUNCTION%GOBP%GO:0052055,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
PROTEIN LOCALIZATION TO PEROXISOME%GOBP%GO:0072662,0.7033390762162609,0.968941691852291,0.16713320233819298,0.838804183244424,8572,60,CROT|SLC27A2|HSD17B4|IDE|PEX3|DECR2|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
REGULATION OF LYMPHOCYTE ANERGY%GOBP%GO:0002911,0.957315436241611,1.0,0.523654609616233,0.695651786986756,7131,1,FOXP3
"POSITIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043517",0.323175787728027,0.8236556202776,-0.3023480133228,-1.1014841410446399,1558,12,SPRED2|PMAIP1
REGULATION OF ENDOCRINE PROCESS%GOBP%GO:0044060,0.128393454815917,0.608160579951936,0.35552060600788704,1.3440573852801299,1380,21,GHRL|CRHBP|INHA|F2R|AGTR1|C1QTNF3|RAB11FIP3|F2RL1|UCN
POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901881,0.891289403908475,0.997300970905927,0.198493200165022,0.640611337153018,9075,13,ACTN2|SEMA5A|F2RL1|PDXP|FAM21C|STMN2|KATNB1
ERYTHROCYTE DEVELOPMENT%GOBP%GO:0048821,0.654657293497364,0.9640743070248079,-0.305263705084659,-0.8379283734985309,3724,6,G6PD|LYAR
SURFACTANT HOMEOSTASIS%GOBP%GO:0043129,0.714803227399967,0.971081608033886,-0.34860974936177297,-0.8017295964044541,4340,4,RCN3|VEGFA|CTSH
TRANSCRIPTIONAL OPEN COMPLEX FORMATION AT RNA POLYMERASE II PROMOTER%GOBP%GO:0001113,0.724573125463994,0.972554563883587,-0.469864902122967,-0.8036787507268159,4879,2,GTF2E1|ERCC3
NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046826,0.14226905977276502,0.6324244126031129,-0.5814261291567859,-1.3371586328875902,863,4,BARD1|SP100|PARK7|RANGAP1
FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:0038096,0.0012330456226880401,0.0929735131311543,-0.270811590021827,-1.8596973008444,2,77,PRKCD|ABI1|GRB2|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|LYN|FCGR2B|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1
NEGATIVE REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050765,0.3902679275019699,0.8607749921056059,-0.306627753705578,-1.03736758682339,1980,10,SNX3|SIRPA|CD300LF|FCGR2B|DYSF
REGULATION OF MEMORY T CELL ACTIVATION%GOBP%GO:2000567,0.399443929564412,0.8638522656500329,-0.798522276135862,-1.06820759552704,3016,1,FAM49B
CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0033962,0.9253128784820351,1.0,-0.179962484828423,-0.6333104055087989,4583,11,ATXN2|LSM4|DYNC1H1|RC3H1|PATL2|LSM14A|PATL1|EDC3|LSM3|LIMD1|DDX6
REGULATION OF MRNA STABILITY INVOLVED IN CELLULAR RESPONSE TO UV%GOBP%GO:1902629,0.180855289289024,0.6863300746827521,-0.907256285840318,-1.2136643955808502,1365,1,NPM1
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048485,0.210752688172043,0.7255949404689929,-0.30392376203481,-1.21207511523251,979,15,CTNNB1|SEMA3F|NRP1|ASCL1|SEMA3A|INSM1
NEGATIVE REGULATION OF RENAL PHOSPHATE EXCRETION%GOBP%GO:1903403,0.007281874751754271,0.19188606346941398,-0.9966916629907371,-1.33330482645675,54,1,STC1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904777,0.17181208053691296,0.674580338020818,0.9153617115130129,1.2160171965638797,1279,1,SAPCD2
POSITIVE REGULATION OF CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045585,0.5903614457831329,0.945418171231938,-0.698775915306573,-0.9347738474046491,4458,1,SART1
ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0006924,0.73248322147651,0.972811555656631,0.637737097485664,0.847205282540678,5456,1,AKT1
MITOCHONDRIAL FISSION%GOBP%GO:0000266,0.405591397849462,0.8663957682383929,-0.25551377307517303,-1.01901175436264,1885,15,MFF|FIS1|DNM1L|OPA1|MX1|MUL1|MTFP1|MX2|MIEF1|PARK2
MANNOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0006057,0.828724832214765,0.9876441563834109,0.586843846493163,0.779595869106038,6173,1,MPI
ACIDIC AMINO ACID TRANSPORT%GOBP%GO:0015800,0.45073515371395795,0.88620227509476,0.285898925013282,1.0083242211360801,4720,17,SLC1A2|SLC25A22|GLS|GLS2|LRRC8D|SLC1A3|SYT1|RAB3A|SLC1A1|ARL6IP5|GIPC1|SLC38A2
INOSITOL LIPID-MEDIATED SIGNALING%GOBP%GO:0048017,0.9688056285496309,1.0,0.118283545255203,0.5581537072656021,11428,46,EDN1|PITPNM2|KCNH1|OGT|TYRO3|ZP3|NF1|PLEKHA1|IRS1|RPS6KB1|GATA3|NYAP1|CSF1R|ERBB3|AKT1|NGF|PIK3C2B|INPP5F|PIK3C2A
PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM%GOBP%GO:1905719,0.26013363028953196,0.7716430150492808,-0.7014612627515849,-1.19981192207438,1751,2,RNF26|SQSTM1
ASTROCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002265,0.670384917517675,0.964618776001639,-0.41182309473916395,-0.835782734971635,4266,3,LRP1|APP|PSEN1
MITOCHONDRIA-NUCLEUS SIGNALING PATHWAY%GOBP%GO:0031930,0.131206143254336,0.6149266898174119,-0.932179091310102,-1.24700439234775,990,1,SLC25A33
NEGATIVE REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032695,0.7364042840802741,0.974262605126702,0.286942913366432,0.782283363884708,7081,8,TIGIT|THBS1|PIBF1|JAK3|CMKLR1|LILRB1|IRAK3
MEMBRANE REPOLARIZATION%GOBP%GO:0086009,0.259972489683631,0.7715310051543051,0.37685451029421896,1.1879800915120802,2645,12,KCNN2|KCNQ1|ATP1B3|KCNH2
'DE NOVO' POSTTRANSLATIONAL PROTEIN FOLDING%GOBP%GO:0051084,0.8685923888124709,0.993084774742015,0.17145913393173903,0.6747770428917171,9471,24,HSPA2|DNAJB5
REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:2000295,0.0761692650334076,0.525661416287861,-0.8338571822442791,-1.4262680516947401,512,2,HP|SNCA
B CELL MEDIATED IMMUNITY%GOBP%GO:0019724,0.10100498268727301,0.571491553833428,0.28857614339288296,1.36877382995696,1195,47,IGHV3-21|IGKV4-1|IGHV4-61|IGHG1|CD27|IGLL5|LIG4|IGHG4|EXO1|IGHV1-18|IGHV3-43|IGKV3-11|ZP3|MSH6|IGKV2D-28|IGKV2-28
EPITHELIAL CELL-CELL ADHESION%GOBP%GO:0090136,0.493829617834395,0.91071489001692,0.319515927420727,0.9747698522028309,4961,11,NOV|CAMSAP3|ITGB5|KIT
NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:1901166,0.527910423184587,0.9265056012720759,-0.403181444510162,-0.9272330948192992,3205,4,NRP1|SEMA3A
REGULATION OF TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:1904073,0.209982788296041,0.7248363921442859,-0.893581826202029,-1.19537165399193,1585,1,IGF1
REGULATION OF COBALAMIN METABOLIC PROCESS%GOBP%GO:0106064,0.920031775453462,1.0,-0.538597265108072,-0.7204979832280141,6948,1,CLYBL
RNA POLYMERASE III PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0070898,0.522519393307862,0.9251240799994541,0.50804762021754,0.965745081429957,4512,3,BDP1|TBPL1
GDP-L-FUCOSE METABOLIC PROCESS%GOBP%GO:0046368,0.625489976481129,0.954110852066186,0.41856688490991206,0.886983212716192,5584,4,FUT8|FUK|GMDS|TSTA3
NEGATIVE REGULATION BY SYMBIONT OF HOST MOLECULAR FUNCTION%GOBP%GO:0052056,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
ASPARTATE CATABOLIC PROCESS%GOBP%GO:0006533,0.7171492204899781,0.971081608033886,-0.47306313757926705,-0.809149161188282,4829,2,GOT1|GOT2
REGULATION OF POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING%GOBP%GO:1902897,0.196478220574606,0.7100128962886071,-0.900419056021173,-1.2045180247863898,1483,1,CRIPT
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070875,0.847495614889885,0.991298302704726,0.20653061780386198,0.684300117604166,8696,14,INS|PHKG2|GCK|IRS1|AKT2|AKT1|PPP1R3E|SORBS1
POSITIVE REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904535,0.904011650999603,1.0,-0.54559991177768,-0.729865637186854,6827,1,RTEL1
CELLULAR RESPONSE TO BILE ACID%GOBP%GO:1903413,0.17409395973154398,0.676682497340677,0.914203793559771,1.2144789542213799,1296,1,ABCB4
SPINAL CORD DORSAL/VENTRAL PATTERNING%GOBP%GO:0021513,0.9329152200694371,1.0,0.28997408362051097,0.614482782959556,8329,4,FOXN4|DLL4|CHRD
REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0052547,0.0193756727664155,0.289864965388082,-0.158616108770624,-1.35620328925635,17,214,LGALS9|CIDEB|DLC1|MAGEA3|EIF2AK3|BBC3|SPOCK3|RPS3|CYFIP2|S100A8|PSME3|FYN|SERPINI1|DDX3X|TNFRSF10A|MAP2K5|HGF|PPARG|LYN|MMP9|TANK|EFNA1|BOK|LAMTOR5|MBP|BIN1|SPOCK1|SERPINF2|RIPK2|CRADD|TIMP2|GAPDH|SERPINF1|PLAUR|SNCA|KARS|SERPINA1|NLRP1|CSTB|NLRP3|CTSH|STAT3|YWHAE|DNAJB6|TNFRSF10B|MTCH1|EPHA7|DDRGK1|SOX7|BCAP31|CSNK2A1|AQP1|TNF|PMAIP1|CAV1|PAK2|EGLN3
CEREBELLAR GRANULAR LAYER MATURATION%GOBP%GO:0021686,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090069,0.504046482672754,0.9170017397928191,-0.25209054719206797,-0.949368182173073,2428,13,TRMT112|SHQ1|WBSCR22|WDR43
POSITIVE REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051446,0.848096564531105,0.991298302704726,-0.22554103318941898,-0.701079733395419,4566,8,CDC25B|PLCB1
POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032770,0.0933244452909247,0.5622489437340121,0.394240063250607,1.4142194810017699,979,18,CDH3|INS|DHFR|POR|S100A1|SCARB1|TERT|APOE
REGULATION OF PROTEIN IMPORT%GOBP%GO:1904589,0.7955346650998829,0.98268438791073,-0.138743217375341,-0.782824904182975,2707,39,APOD|CHP1|IGF1|MAVS|ZPR1|BAG3|CABP1|PIK3R1
TERMINAL BUTTON ORGANIZATION%GOBP%GO:0072553,0.8880536912751679,0.997300970905927,0.556958535509484,0.7398945667424691,6615,1,NLGN2
REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:0061013,0.0275983558426307,0.34134157663167,-0.18258869884521897,-1.40421886847124,46,123,EXOSC4|CCRN4L|EIF4G1|VIM|SLC11A1|VIP|NBAS|YBX1|SERBP1|CNOT7|NPM1|EXOSC9|YWHAB|FMR1|AGO2|HNRNPC|PDE12|UBA52|RBM38|PRKCA|YWHAZ|ZC3HAV1|PABPC1|EXOSC5|CARHSP1|MYD88|UBC|RBM24|UBB
REGULATION OF URETERIC BUD FORMATION%GOBP%GO:0072106,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061888,0.6635432556112439,0.964618776001639,0.36654260461665505,0.8448263668153321,6089,5,AGER|LDLR
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903566,0.20952277184571802,0.7248363921442859,0.53987425545996,1.24433012706498,1922,5,CROCC|GAS8|EFCAB7|SDCCAG3|CCDC88A
POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0061092,0.17409395973154398,0.676682497340677,0.914203793559771,1.2144789542213799,1296,1,ABCB4
NEGATIVE REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903517,0.4120217132265329,0.867015886388254,-0.7927878253198059,-1.06053644582846,3111,1,TERF2
POSITIVE REGULATION OF PROTEIN PROCESSING IN PHAGOCYTIC VESICLE%GOBP%GO:1903923,0.246473645137342,0.7585951535148171,-0.709181141439206,-1.2130163611193,1659,2,GSN|MYH9
CELLULAR DETOXIFICATION OF METHYLGLYOXAL%GOBP%GO:0140041,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
PRINCIPAL SENSORY NUCLEUS OF TRIGEMINAL NERVE DEVELOPMENT%GOBP%GO:0021740,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
RESPONSE TO ERYTHROPOIETIN%GOBP%GO:0036017,0.286905175408128,0.796019542850327,0.601007377670519,1.1424518013486398,2477,3,KIT|MT2A|MT1X
NEGATIVE REGULATION OF FEEDING BEHAVIOR%GOBP%GO:2000252,0.0920527398088787,0.5622489437340121,0.81345464571271,1.32956927151107,760,2,INS|UCN
NEGATIVE REGULATION OF POSITIVE THYMIC T CELL SELECTION%GOBP%GO:1902233,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0046137,0.36607142857142894,0.8510019955058101,-0.418872711228767,-1.06034845389687,2131,5,CYP27B1|AKR1C3|NFKB1|SNAI2|SNAI1
NEGATIVE REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900372,0.0466763530693789,0.425275525480742,-0.544137703399012,-1.5872738220089702,256,7,FLCN|CBFA2T3|HDAC4|FBP1|PPARA
POSITIVE REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033864,0.37025422779706607,0.852609194081082,0.507856289834834,1.07619599112046,3305,4,AGTR1|RFK
UDP-XYLOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015790,0.914228187919463,1.0,0.544938244375827,0.723926146234612,6810,1,SLC35B4
NEGATIVE REGULATION OF VIRAL PROCESS%GOBP%GO:0048525,0.37682271680736795,0.853585147455453,-0.157297683637981,-1.05096588369947,981,70,IFI16|ISG15|TRIM11|GSN|TRIM62|PLSCR1|MX1|EIF2AK2|SNX3|CCNK|TRIM8|RNASEL|ZNF639|TRIM13|APOBEC3F|BANF1|PML|INPP5K|IFITM2|IFITM3|OASL|MAVS|TRIM35|TNIP1|OAS3|JUN|ZC3HAV1|PARK2|IFITM1|TNF
MRNA EXPORT FROM NUCLEUS%GOBP%GO:0006406,0.801467748165315,0.9841161968820359,0.140696822288634,0.784935168546516,10374,101,NXF2|TPR|THOC3|U2AF1L4|ZC3H11A|THOC1|NUP133|NXF2B|UPF3B|WDR33|CPSF1|SRSF1|NUP205|NUP188|NUP160|FIP1L1|NUP85|NUPL2|GLE1|SRSF6|NDC1|SRSF2|THOC2|HNRNPA2B1|PABPN1|NUP107|NUP35|SRSF11|NUP210|POM121|NUP54|CPSF2|DDX39B|NUPL1|ZC3H3|NUP37|YTHDC1|AAAS|UPF2|U2AF2|SRSF9|SRSF5|SRSF4|NUP62|CPSF4|SARNP
CELLULAR RESPONSE TO FLUID SHEAR STRESS%GOBP%GO:0071498,0.772093949044586,0.979693198874896,0.24746172643251002,0.7549490019095291,7757,11,PKD2|HDAC3|NFE2L2|SREBF2
POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051152,0.29370704467354,0.8004058897916541,0.468782614069086,1.15290256769245,2734,6,CTH|OLFM2|KIT
POSITIVE REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:1901529,0.44925607838393605,0.8858223310328521,0.622718500137855,1.0178162813974,3713,2,TCAF1|ABCB1
RESPONSE TO CARBOHYDRATE%GOBP%GO:0009743,0.733535711274138,0.9734087938149171,0.17023174012313,0.810819981514801,8698,48,LPL|PRKAA2|UNC13B|AGER|ADCY8|ERN1|EIF2B5|ME1|EIF2B1
POSITIVE REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046881,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
MITOCHONDRIAL PYRUVATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0006850,0.821579775009072,0.987153241368501,0.477639922801213,0.780689332282326,6791,2,MPC2|MPC1
CARBON DIOXIDE TRANSPORT%GOBP%GO:0015670,0.00252412769116555,0.12586582153175,-0.9676316515026191,-1.6550821168588399,16,2,AQP5|AQP1
HINDGUT DEVELOPMENT%GOBP%GO:0061525,0.316510067114094,0.8176737565328901,0.8458314953683279,1.12364940637852,2357,1,DACT1
ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0008291,0.442316258351893,0.880423444399886,-0.590239867659223,-1.0095736824058001,2978,2,COLQ|ACHE
ATRIOVENTRICULAR NODE CELL DEVELOPMENT%GOBP%GO:0060928,0.13033557046979902,0.612163182799301,0.9357079841199821,1.2430463120106598,970,1,MAML1
SNRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0042795,0.421578904927022,0.8731576093667349,0.19841172493607398,1.0328864067450798,5227,71,INTS7|POU2F2|SNAPC2|AK6|INTS9|INTS10|GTF2B|POLR2B|TAF5|INTS6|NABP1|ZNF143|INTS3|ASUN|CDK7|GTF2E2|SRRT|POLR2L|INTS1|INTS8|POU2F1|POLR2J|CCNT2|SNAPC3|INTS2|SNAPC5|POLR2G|POLR2H|SP1|GTF2A1
NEGATIVE REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0090219,0.355769230769231,0.843990005840027,-0.4238362556211,-1.0729133369297599,2071,5,PPP2R5A|DAB2IP|PIK3IP1|KIAA0226
CELLULAR RESPONSE TO FORSKOLIN%GOBP%GO:1904322,0.623271290423209,0.9536478716552259,0.321644890384495,0.876890263203645,5993,8,GNAI1|ADCY8|ADCY1|ADCY6
THYMIDINE CATABOLIC PROCESS%GOBP%GO:0006214,0.930872483221476,1.0,0.537163652404058,0.713597947649256,6934,1,DPYD
REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS%GOBP%GO:0106049,0.40415738678544894,0.865585453523601,-0.6119742487123521,-1.0467491771781898,2721,2,ARHGEF2
NEGATIVE REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:0010360,0.13256917911311802,0.6180963331341071,0.688959099933812,1.30963877319727,1144,3,ANO9|GOPC
HISTONE H3-R17 METHYLATION%GOBP%GO:0034971,0.531812080536913,0.9265056012720759,0.7369320688134101,0.978981376548173,3961,1,CARM1
POSITIVE REGULATION OF INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060731,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
PHENYLALANYL-TRNA AMINOACYLATION%GOBP%GO:0006432,0.130086410054988,0.612163182799301,-0.680528518738231,-1.38111240938898,827,3,FARSA|FARS2
NEGATIVE REGULATION OF GENE SILENCING%GOBP%GO:0060969,0.857947082004128,0.99166790097654,0.183941862838014,0.6830679700414031,9143,20,ASF1A|TERT|DND1|ATAD2|ELAVL1|ATAD2B|PHF2|NCOR1|TET1|PHF8|ZC3H12A|BCDIN3D
POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0046886,0.8530755711775041,0.991298302704726,-0.25330257593478894,-0.695298562916815,4853,6,HIF1A|IL1B|TNF
SALIVARY GLAND DEVELOPMENT%GOBP%GO:0007431,0.879385487034212,0.9956508825790341,0.287510803813252,0.662669781756302,8070,5,TGFB2|FGFR2|TGFB3
POSITIVE REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900223,0.8328611898017,0.9881090453690059,0.30773008007369607,0.7092722162007541,7643,5,ABCA7|LDLR|LRP1|ROCK1
POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010676,0.5804324894514771,0.942746898746279,-0.175943518029255,-0.9128006100479309,2200,30,ARPP19|IGF1|SNCA|PPARGC1A|IGF2|HRH1|PMAIP1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GLUCOSE%GOBP%GO:0000432,0.561098737936154,0.936434965680841,-0.537193272677144,-0.918840322682859,3778,2,USF2|USF1
MUSCULOSKELETAL MOVEMENT%GOBP%GO:0050881,0.0636546376950321,0.493545616162616,0.433679975524992,1.50345086551674,664,16,CCDC78|GAA|JSRP1|MYH3|TCAP|TNNC2|STAC3
AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS%GOBP%GO:0009074,0.635858698067096,0.95916055221954,-0.20184794884526897,-0.868305029650628,2861,18,TDO2|PAH|PCBD1|QDPR
POSITIVE REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0071931,0.12249443207127002,0.607607158836689,-0.7881996140060659,-1.34817322648622,824,2,ID2|ZPR1
MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072007,0.9588977654278108,1.0,0.306054924451307,0.58177821561236,8281,3,ACTA2|PDGFB|CD34
NEGATIVE REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:1902569,0.898450946643718,0.998912093067348,-0.548191442434936,-0.733332406762173,6785,1,CD300A
REGULATION OF ESTABLISHMENT OF BLOOD-BRAIN BARRIER%GOBP%GO:0090210,0.911409395973154,1.0,0.5459858844287611,0.7253178893063978,6789,1,ADGRA2
POSITIVE REGULATION OF GLUCOCORTICOID SECRETION%GOBP%GO:2000851,0.569076239091059,0.940076901516441,-0.389468712991345,-0.895696677015979,3455,4,CRH|GAL
POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045606,0.48050672689777096,0.9046812288131709,0.305548042793086,0.9861171067595,4892,13,BMP4|NUMA1|H2AFY2|MED1
TOLERANCE INDUCTION%GOBP%GO:0002507,0.0228471001757469,0.31609926985007897,-0.640780982847058,-1.7589007726186099,129,6,HLA-E|FOXJ1|HAVCR2|LGALS9|TNFAIP3|LYN
CUT CATABOLIC PROCESS%GOBP%GO:0071034,0.590317800098798,0.945418171231938,-0.382893067887277,-0.8805740669770029,3584,4,EXOSC10|EXOSC2|EXOSC3|DIS3
DNA STRAND RENATURATION%GOBP%GO:0000733,0.663000785545954,0.964618776001639,-0.413645345664246,-0.839480939082636,4219,3,TP53
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ACETYLCHOLINE%GOBP%GO:0003068,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
MIRNA LOADING ONTO RISC INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035280,0.73719578641482,0.974306231601101,-0.269111969111969,-0.785011553311695,4058,7,DICER1|TARBP2|AGO4|AGO3|ADAR|AGO1|AGO2
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:0042771,0.61687725631769,0.9520939168601509,-0.20162330329605496,-0.884213597163692,2733,19,DDIT4|PML|TP53|BCL3|CDIP1
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0045833,0.165267752224274,0.668049608148938,0.263093191160518,1.2642809185294799,1968,50,SIRT4|SIRT1|WASH1|FGF19|WNT4|CEACAM1|ACADVL|PDE3B|INS|PROX1
HOMOSERINE METABOLIC PROCESS%GOBP%GO:0009092,0.461231401959598,0.8908856132322029,0.618954095104579,1.01166346478477,3812,2,CTH
EXTRAEMBRYONIC MEMBRANE DEVELOPMENT%GOBP%GO:1903867,0.0942456871598935,0.5630268609168221,0.720395555797538,1.36939616880318,813,3,E2F8|E2F7
REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014743,0.35831673306772904,0.846205501155666,-0.215983128382415,-1.0605405051769299,1438,26,IL6ST|AGT|AKAP6|CAMK2D|NOTCH1|SLC9A1|FOXO1|IGF1|ATP2B4|LMNA|MTPN|PDE9A|PRKCA
PROTEIN O-LINKED MANNOSYLATION%GOBP%GO:0035269,0.33057525610717103,0.8293509737209019,-0.322936641532526,-1.0925429954560302,1677,10,B4GAT1|GYLTL1B|POMGNT2|TMEM5|DPM1|DPM2
POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001916,0.792600463678516,0.9819233677232551,0.21646728362976,0.7339565747580071,8204,15,CD1E|IL12RB1|CD1D|HLA-F|XCL1|FADD|HLA-C|STX7
REGULATION OF CELL PROJECTION SIZE%GOBP%GO:0032536,0.603241804765937,0.9508825506493929,0.565112848928511,0.923661427015544,4986,2,CDHR2
BLASTOCYST FORMATION%GOBP%GO:0001825,0.221542096219931,0.73556947110949,0.501001229553046,1.23213956028595,2062,6,HOPX|ZP3|SRF
REGULATION OF SOMATOSTATIN SECRETION%GOBP%GO:0090273,0.09108963325830802,0.5609783360513879,-0.9526907807675341,-1.2744435047311202,687,1,ADCYAP1
REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033081,0.9931493048559341,1.0,0.15277828219851,0.45088818126921004,9857,10,BMP4|TESPA1|ZC3H8|KIAA0922|PTPN2|ADAM8
NEGATIVE REGULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052204,0.442471126607104,0.880423444399886,0.44144020357821995,1.01745422948921,4060,5,SUGT1|PTX3|RAB9A|ANXA2|CASP8
DNA DEALKYLATION INVOLVED IN DNA REPAIR%GOBP%GO:0006307,0.757203304452952,0.977664504547119,0.258241974818998,0.762138784897547,7515,10,ALKBH3|ALKBH1|MPG|FTO|ASCC1|MGMT|ASCC3
REGULATION OF RECEPTOR BINDING%GOBP%GO:1900120,0.108746583365873,0.58452352834625,-0.43309964696300796,-1.39808447138658,556,9,NRP1|MMP9|RUVBL2|B2M
INDOLE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042435,0.325503355704698,0.826621597878865,0.8414755183061321,1.1178626851853102,2424,1,DDC
LACTATION%GOBP%GO:0007595,0.739485726737851,0.9744283926676119,0.341466453366708,0.787029555510516,6786,5,OXTR|APLN|ZBTB7B|AGPAT6|VEGFA
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904357,0.5084378666185361,0.918237678197337,0.237854071278678,0.9669985273855171,5633,27,NAT10|PIF1|PARP1|SRC|SLX1B|TNKS2|SLX4|TEN1|CTC1|ACD|XRN1|EXOSC10|POT1
POSITIVE REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060282,0.22642910170749803,0.7398172623753029,-0.721897247104406,-1.23476657882857,1524,2,PDE3A
POSITIVE REGULATION OF EYE PIGMENTATION%GOBP%GO:0048075,0.42711505362107793,0.875860872092455,-0.785785178650199,-1.05116879186962,3225,1,HPS4
MAST CELL MEDIATED IMMUNITY%GOBP%GO:0002448,0.5946760944161379,0.9473459395438281,0.32972903325702696,0.898929805516277,5718,8,NR4A3|KIT|MILR1|S100A13|SNAP23|CHGA
POSITIVE REGULATION OF SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014040,0.543758389261745,0.929698169790548,0.7309770621967359,0.9710704159296021,4050,1,DICER1
CHLORIDE TRANSPORT%GOBP%GO:0006821,0.975840044432102,1.0,-0.103854208260014,-0.564552199095545,3513,35,ANO1|ANO10|CLIC1|CLIC4|GABRG2|ANO6|GABRA3
SPERMATOGENESIS%GOBP%GO:0007283,0.209821428571429,0.7248363921442859,0.20164487938539602,1.1833872331995199,2819,134,HSPA2|INSL3|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|HERC4|CCT6B|CABYR|GGT1|PYGO1|USP9Y|PIWIL4|TRIM27|MTL5|TSSK3|SPATA25|JAG2|PCSK4|WDR33|CASC5|DAZAP1|TYRO3|YTHDC2|PTTG1|KIT|DNAH1|CLOCK|METTL3|REC8|SRPK1|FANCF|MYBL1|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|BRCA2|CEP57|BAG6|MYCBP|UBE2B|UBR2|CDK16|ABHD2|AZIN2|ZNF35|C1orf111
REGULATION OF GAMMA-DELTA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:2001191,0.820468687938567,0.987153241368501,-0.587450374944861,-0.785850277775518,6196,1,LILRB1
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO UV-INDUCED DNA DAMAGE%GOBP%GO:0010767,0.9187745483110759,1.0,-0.31179000772030396,-0.6327685569803989,5847,3,CHEK1|TAF1|NEDD4
MONOSACCHARIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015749,0.9760702524698129,1.0,-0.136287212443892,-0.5581419397912349,4445,16,PPARD|SLC2A3|SLC2A6|SLC5A2|SLC2A1
LYMPHOCYTE COSTIMULATION%GOBP%GO:0031294,0.23880179171332602,0.751719534796501,-0.212174710138566,-1.16715016949102,852,36,PTPN6|CD274|ICOSLG|MAP3K8|GRB2|VAV1|FYN|LYN|YES1|CDC42|RAC1|PIK3R1|CAV1|PAK2
POSITIVE REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090184,0.815338140713311,0.986631695793843,0.21523537153316,0.713141671771843,8366,14,BASP1|BMP4
POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET%GOBP%GO:0007221,0.9949398510597671,1.0,0.121709520164739,0.429251901241863,10420,17,MAML1|DLGAP5|HEYL|MAML3|STAT1|KAT2B|SNW1
METANEPHRIC PROXIMAL TUBULE DEVELOPMENT%GOBP%GO:0072237,0.868264265854627,0.993084774742015,-0.5633546537273929,-0.75361669683053,6557,1,PKD1
INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032613,0.564663656362163,0.9380162603437769,0.49308566036132895,0.9373039696823969,4876,3,F2RL1|CD46|TLR2
SYNAPTIC VESICLE LUMEN ACIDIFICATION%GOBP%GO:0097401,0.989530201342282,1.0,0.505679311865902,0.6717724058603289,7371,1,CLCN3
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009202,0.9513720041681141,1.0,0.313027782133239,0.595032884548619,8216,3,DTYMK|AK9|CMPK2
OXALOACETATE TRANSPORT%GOBP%GO:0015729,0.805951140442283,0.984682960940884,0.40175253926615506,0.763689314364176,6960,3,SLC25A10|SLC25A30
NADP CATABOLIC PROCESS%GOBP%GO:0006742,0.49848796419499203,0.913423777265461,0.604358334143756,0.9878070944633142,4120,2,NUDT17|NUDT12
LACTATE OXIDATION%GOBP%GO:0019516,0.0681879194630873,0.50364937614461,0.9667512130569029,1.28428585671673,507,1,D2HGDH
VESICLE-MEDIATED CHOLESTEROL TRANSPORT%GOBP%GO:0090119,0.952041573867854,1.0,-0.348276812792942,-0.595708835769343,6411,2,SYT7|CES1
SKELETAL MUSCLE CONTRACTION%GOBP%GO:0003009,0.008249042521850141,0.20219929830704503,0.5652305341681461,1.82420903079871,83,13,CCDC78|GAA|JSRP1|MYH3|TCAP|TNNC2|STAC3
U4 SNRNA 3'-END PROCESSING%GOBP%GO:0034475,0.0739090064995358,0.521028830085029,-0.479513688118763,-1.4905373264980102,397,8,EXOSC7|EXOSC8|EXOSC6|EXOSC4|EXOSC9|EXOSC5
GLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006114,0.47157577862683797,0.898272347254494,0.527021065402007,1.0018116047941101,4072,3,PGP|PCK2|GOT1
MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002318,0.12458625711637801,0.607607158836689,-0.9360939567710631,-1.2522414272381202,940,1,MLF1
REGULATION OF COAGULATION%GOBP%GO:0050818,0.255829015544041,0.767206100763278,-0.187097250028122,-1.1333342457753002,789,50,FCER1G|PRKCD|USF1|PDPN|PLAU|LYN|SERPINF2|PLAUR|THBD|PROC|PRKCA|CD9|NOS3|ANO6|CAV1|ENPP4
LATERAL SPROUTING FROM AN EPITHELIUM%GOBP%GO:0060601,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
POSITIVE REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905954,0.5851509708322641,0.9439064862850342,0.19813780521266602,0.911900608060932,6840,42,SIRT1|GHRL|LPL|FITM1|ABCA7|ABCB4|SCARB1|LDLRAP1|UCN|APOE
REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045682,0.745406824146982,0.9749763305090959,0.179609021073893,0.7928007579167691,8519,36,FST|CDH3|BMP4|TMEM79|NUMA1|TGFB2|H2AFY2|MED1
CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003413,0.7040879850591409,0.968941691852291,-0.216632297024654,-0.815833089804744,3392,13,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061314,0.697579070675517,0.96731875442989,-0.25101619248038104,-0.810302763427053,3572,9,DLL4|JAG1|NOTCH2|HEY1|GALNT11|NOTCH1|SNAI1|RBPJ
NEGATIVE REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034316,0.8512156767872259,0.991298302704726,0.46228621643896994,0.7555941210242281,7036,2,PICK1|CORO1B
PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0019856,0.42815544853847,0.8769245997339999,0.487293776353662,1.03262206082023,3822,4,CAD|CTPS2|CTPS1
NEGATIVE REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902714,0.9688865351515951,1.0,-0.514280988089987,-0.68796935806385,7317,1,ZC3H12A
NEGATIVE REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901726,0.18787236859526002,0.694498726854041,-0.904113365681518,-1.20946001545759,1418,1,KDM5A
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904358,0.639388884010888,0.9605702441869879,0.199616375289048,0.8681326268903771,7281,34,ATR|HMBOX1|PNKP|PRKCQ|NEK2|AURKB|MAP3K4|TNKS2|MAP2K7|HNRNPA2B1|ACD|ATM|MAPKAPK5|POT1|CCT2|FBXO4|NEK7
POSITIVE REGULATION OF MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002735,0.144069128043991,0.6340340930337739,-0.66743417229994,-1.3545378223425901,916,3,MAVS|TICAM1
FATTY ACID DERIVATIVE TRANSPORT%GOBP%GO:1901571,0.0443186255368996,0.41504430757275895,-0.49823752027079204,-1.6083553635688999,226,9,ABCC4|DRD2|BDKRB2|ACE
LONG-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036116,0.722147651006711,0.971401508276304,0.642148213498015,0.85306525336925,5379,1,ACOT7
G PROTEIN-COUPLED RECEPTOR CATABOLIC PROCESS%GOBP%GO:1990172,0.737986577181208,0.9744283926676119,0.634704455227173,0.8431765525960359,5497,1,GPRASP1
RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0007265,0.000975609756097561,0.0849637591935908,-0.19034465551323299,-1.60134964242802,0,200,KPNB1|RAB11A|MYO9B|USP8|RTKN|RABL2B|RHOJ|RREB1|RAP2C|RAB25|RAB10|CRKL|RND1|RHOG|RASSF1|RAP1B|RAB3C|ARHGAP5|ARHGDIA|CDC42EP5|RAB3D|RAB33B|GNA13|PLCE1|RAB13|BRAP|RAB21|NRAS|PDPN|RAB43|GRB2|EPS8L1|RAB8B|RIT1|RHOA|FAM65A|ARHGAP1|RANGRF|RAB30|ARHGAP29|RAB18|FGF2|RAB6A|RND2|RAP2B|DNAJC27|G3BP2|SHOC2|RAB1A|IGF1|RAB39A|RHOC|RAP1A|LIMK1|RAB8A|RAB37|RAB12|RAB2B|CDC42|DBNL|RAB36|RAB5C|KRAS|RAPGEF1|SHC1|JUN|TP53|RAB7A|CDKN1A|RAB22A|RAB2A|GNA12|RAB5A|ADRA2A|RHOQ|RAC1|BRK1|PLK2|CDH13
RESPONSE TO MOLECULE OF FUNGAL ORIGIN%GOBP%GO:0002238,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
LEUKOCYTE PROLIFERATION%GOBP%GO:0070661,0.29635297118082105,0.801159248404437,-0.222902518066739,-1.11076717076847,1161,27,CLU|CX3CL1|CR2|SLC11A1|MS4A1|ELF4|MSN|BCL2|TNFRSF4|ACE
REGULATION OF PROSTAGLANDIN-E SYNTHASE ACTIVITY%GOBP%GO:2000361,0.299034892353378,0.8023890191280308,-0.6807830162668871,-1.16444288891835,2013,2,ITGB2|ITGAM
HISTONE H4-R3 DEMETHYLATION%GOBP%GO:0070079,0.8375838926174499,0.9889652677625541,0.581550507278341,0.7725639041117529,6239,1,JMJD6
REGULATION OF PHOSPHOLIPID EFFLUX%GOBP%GO:1902994,0.0996734002661183,0.570215774831708,0.807003032809485,1.3190242874569198,823,2,ABCA7|APOE
REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071071,0.201485608170845,0.7153093055622209,-0.399977667984514,-1.24330474534627,1084,8,ACSL3|FABP3
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000544,0.707694030686527,0.9695170059473192,0.39069211451826297,0.827913911519486,6318,4,CXCL13
"PEPTIDYL-ARGININE METHYLATION, TO SYMMETRICAL-DIMETHYL ARGININE%GOBP%GO:0019918",0.8624161073825501,0.991943445125448,0.569750771945302,0.7568884821453249,6424,1,NDUFAF7
GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0009101,0.186918542717137,0.693783430081947,0.18892582760668603,1.18362115132819,2631,211,B3GALT2|GALNT10|GALNT8|GLCE|FUT9|MUC15|GAL3ST3|GALNT13|FUT7|SDF2|GCNT2|GALNT3|TMEM165|VCAN|B3GAT3|C1GALT1C1|HS3ST5|B3GLCT|FUT2|GAL3ST4|ALG6|ASGR1|FUT8|ALG1L|MGAT5B|B3GALT1|OGT|CHST15|ST3GAL5|POGLUT1|MVD|MOGS|ALG14|ALG13|DERL3|MUC1|EXT1|SRD5A3|DPAGT1|PXYLP1|CHPF2|FUT10|NUDT14|XYLT2|MPDU1|ALG2|BMPR1B|DPY19L3|MGAT2|DOLPP1|ST8SIA3|SYVN1
"CD4-POSITIVE OR CD8-POSITIVE, ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0043369",0.785886722376973,0.981487311948134,-0.24050791235151897,-0.747603310521689,4231,8,ZFPM1|FOXP3|LY9|SPN|BATF|IL6|STAT3
NUCLEAR RETENTION OF PRE-MRNA AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071033,0.47132554945055,0.8982304285903969,-0.382914184866534,-0.9693218321798509,2744,5,EXOSC10|EXOSC2|EXOSC3|PCID2|PRPF18
POSITIVE REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090232,0.0736099410278012,0.520821259294202,0.564545919797558,1.4693944180693799,698,7,TPR|XRCC3|GEN1|NDC80
NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT%GOBP%GO:0051271,0.10546875,0.578674426247723,-0.14113739427257802,-1.1941506176231698,107,203,CX3CL1|KCNE3|PTPRG|DAB2IP|STK26|TRIB1|HMOX1|DLC1|PTPRU|SRGAP2C|SEMA3F|SPOCK3|MMRN2|IGFBP3|CITED2|RHOA|MITF|HDAC5|CLIC4|SEMA7A|APOD|FGF2|MAP2K5|ADAMTS9|PPARG|LDLRAD4|BIN1|MEOX2|CRK|PDCD10|WNT11|SMAD7|SEMA6B|ARPIN|DUSP3|CD9|DRD2|GREM1|SFRP2|PTPRM|ACVRL1|DUSP10|STK24|TMEFF2|SEMA3A|IFITM1|CORO1C|MCTP1|PLCB1|SEMA3G|NBL1|STC1|ANGPT2|FOXO3
RECEPTOR RECYCLING%GOBP%GO:0001881,0.995682392586352,1.0,0.16660413904762397,0.43363557039189793,9454,7,PLEKHJ1|FAM109B|FAM109A|RAB11B|LMTK2
PROTEIN RETENTION IN ER LUMEN%GOBP%GO:0006621,0.602370801705314,0.9508825506493929,0.32746175846402803,0.892748606158154,5792,8,PDIA2|RER1|GPAA1|ANKRD13C|KDELR3|KDELR2
GOLGI TO VACUOLE TRANSPORT%GOBP%GO:0006896,0.24261603375527402,0.7565220534116759,-0.302387652685934,-1.17152981988849,1149,14,GAK|AP1G1|GOSR2|VTI1B|LAMP1|EHD3|RBSN|VTI1A
MITOCHONDRIAL RNA 3'-END PROCESSING%GOBP%GO:0000965,0.557964698191327,0.936434965680841,0.40235162009786896,0.9273608391173092,5120,5,SUPV3L1|HSD17B10|PNPT1|TRNT1
CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS%GOBP%GO:0044270,0.984375,1.0,-0.0834441691673605,-0.762134659013591,377,361,RPL7|PFKL|DERA|EXOSC6|GPI|PRPF18|RPS9|RPS3|RPL14|WIBG|NUDT4|EXOSC4|MAGOH|GSPT1|CASP3|EIF4G1|PKM|H1F0|PAPD7|DFFA|RPL15|PNP|RPL8|ENO1|CDA|EXOG|NBAS|HPRT1|PPP2CA|ZPR1|NUDT18|RPL35A|CNOT7|GAPDH|EXOSC9|HELZ2|PGK1|CDADC1|TDO2|HK1|MTPAP|HK2|TPI1|RNASEH1|ETF1|PDE12|PDE9A|CSDE1|UBA52|MRTO4|BLVRA|UPP1|NCBP2|ENTPD3|ALDOA|POLR2D|RBM8A|RNPS1|ITPA|PABPC1|EXOSC5|DDX6|NT5E|NEIL2|PDE4D|PGAM2|ENPP4
NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0045717,0.31396761133603196,0.816422962704093,0.39758859026345594,1.13458198982239,3101,9,SIRT1|CEACAM1|ACADVL|APOC1|BRCA1|ERLIN1|PIBF1
REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905276,0.131980240549828,0.616407751583866,0.550479830299949,1.35382497295897,1228,6,DVL1|NPHP3|DVL3|GATA3|DVL2
CELLULAR RESPONSE TO HYDROPEROXIDE%GOBP%GO:0071447,0.61630641729197,0.9518465519698142,0.422313155971618,0.8949219189584041,5502,4,MGST1|PRKD1|DAPK1
XYLULOSE METABOLIC PROCESS%GOBP%GO:0005997,0.20879301827762198,0.724302717992397,-0.5362578145529651,-1.23328094529025,1267,4,XYLB|TKT
REGULATION OF EYE PIGMENTATION%GOBP%GO:0048073,0.42711505362107793,0.875860872092455,-0.785785178650199,-1.05116879186962,3225,1,HPS4
CELL CYCLE PHASE TRANSITION%GOBP%GO:0044770,0.0108772425483825,0.227160168781543,0.23509734190150802,1.4868087906536698,153,227,TPD52L1|AKAP9|CDK6|CCNA1|SDCCAG8|CEP63|BRSK2|CEP70|CENPJ|CCNB1|RCC1|CDC7|CDC34|CDK1|BTRC|POLE|CDKN2C|BORA|DHFR|WEE1|CDKN3|CKAP5|CEP290|CEP131|CEP152|POLE2|ORC1|CDC25C|CDC45|E2F7|CDKN2A|NEK2|CDC23|CCNE1|PKMYT1|HAUS5|CRLF3|NEK11|CDK5RAP2|FBXL15|PRKAR2B|FBXO5|RB1|POLA2|AKAP8L|MCM6|CDC6|CDK3|PIM2|CDKN2B|CEP72|MELK|CCNB2|ORC6|PPP2R2D|HAUS8|CEP164|CEP78|DBF4|TIMELESS|CEP192|FGFR1OP|CHEK2|NASP|CNTRL|PLK1|CUL4B|MCM10|AJUBA|MCM3|SFI1|AURKA|MCM2|CEP41|SPDYA|TAF2|CEP57|UBE2C|CCNE2|DYNC1H1|NINL|E2F1|TUBB4A|PRIM2|TYMS|GMNN|CEP135|CDK14|KDM8|RRM2|PCM1|FBXL7|RPS6KB1|FOXM1|NEDD1|PPP2R1A|SKP2|CDK2|SSNA1
CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS%GOBP%GO:0006575,0.773601992302468,0.980081287830567,0.141299618002912,0.812292936783354,10250,119,PTDSS2|DPEP1|CROT|MGST1|GSTA4|GAMT|SERINC5|LPCAT4|GGH|GLRX2|PLA2G4A|GGT1|FTCD|DHFR|PCYOX1L|MTHFD1|ACADM|EGLN2|DUOX1|P4HA3|OSBPL5|CPT1B|SLC46A1|GSTP1|MGST2|OPLAH|SARDH|GGT5|GSTZ1|OSBPL8|HAGH|ALDH9A1|CKB|PLA2G2D|C9orf41|TYMS|MTHFD2L|P4HA1|PLA2G12A|CPT1C|PLA2G4B|SLC19A1|EGLN1
SENSORY PERCEPTION OF BITTER TASTE%GOBP%GO:0050913,0.0504422914911542,0.44079050471084996,0.5912300055157199,1.5388474868642301,478,7,RTP5|TAS2R4|RTP4|TAS2R5|TAS2R20|TAS2R14|TAS2R19
PYRIMIDINE-CONTAINING COMPOUND SALVAGE%GOBP%GO:0008655,0.41560509554140096,0.8704737558190401,0.341069289190168,1.04052421830305,4175,11,TK1|UCKL1|DCK|HDDC2|UCK1
PRIMARY NEURAL TUBE FORMATION%GOBP%GO:0014020,0.8319357716324709,0.9879179006160809,0.17070547006855802,0.7157562985581709,9325,30,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C
NEGATIVE REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:2000104,0.333885666942833,0.829878512718035,0.28529929219987604,1.10958694249764,3626,23,FBXO18|BLM|DONSON|ZNF830|FBXO5|MSH6|TIMELESS|CHEK2|ZRANB3|GMNN|SMC3
NEGATIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:1903237,0.7117454941333009,0.970341332123494,0.5234680924338161,0.8555942165733491,5883,2,CCL21|CXCL12
CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:0055003,0.0485668789808917,0.43406156654211997,0.506526632923808,1.54529664639156,487,11,NEB|IGSF22|PROX1|TCAP|NEBL|OBSL1|MYOM2
POSITIVE REGULATION OF GTPASE ACTIVITY%GOBP%GO:0043547,0.870793093356746,0.9934031064448321,0.12565201347885302,0.751269705398417,11901,151,DOCK10|TBC1D3D|RGS16|ITGB1|CXCL13|TBC1D30|TBC1D4|SGSM3|ARAP1|EVI5L|GRTP1|F2R|RASGRP2|TBC1D3B|ECT2|RGS1|TBCK|DOCK8|USP6NL|EZH2|XCL2|CCL21|F2RL1|CCL5|DOCK7|NF1|HRAS|TBC1D10C|TBC1D13|CCL19|CCL2|PIN1|RTN4R|RGS7|NTRK3|APC2|CCL3L3|CCL11|TBC1D9B|ARHGAP27|RAP1GAP|AGRN|TBC1D22B|TBC1D10B|RASGRP1|DVL3|CCDC125|RAPGEF6|CCL4L2|TBC1D7|TBC1D12|TBC1D2B|EPHA1|LARS|SGSM1|SIPA1L1|SYDE1|SCRIB|MLLT4|ALS2|SNX18|XCL1|RAP1GDS1
"REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900151",0.7375323059251461,0.974306231601101,0.22562280972271398,0.782173094681855,7704,16,BTG2|NANOS3|CPEB3|TNRC6A|TNRC6C|POLR2G|CNOT1|TOB1|NANOS1
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905066,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
ENTRY OF SYMBIONT INTO HOST CELL BY PROMOTION OF HOST PHAGOCYTOSIS%GOBP%GO:0052066,0.712564543889845,0.9707100537727641,-0.639170710189678,-0.855038147172311,5381,1,ITGAV
MALE MEIOTIC NUCLEAR DIVISION%GOBP%GO:0007140,0.183882284155135,0.6903572731305279,0.387176060645976,1.28283460656266,1886,14,HSPA2|CCNA1|PIM2|MYBL1|ING2|SPDYA|TEX14|UBR2
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010662,0.860538532961931,0.9916689277956879,-0.221743716814406,-0.689276020722097,4633,8,ENG|CAMK2D|CAMK2A|BAG3
NEGATIVE REGULATION OF CATABOLIC PROCESS%GOBP%GO:0009895,0.0146341463414634,0.263430540827147,-0.16521630033436902,-1.38994742326942,14,200,NAF1|OPHN1|FURIN|TRIM39|CBFA2T3|IL1B|MTMR2|DAB2IP|PTPN3|UBE2J1|NELL1|PRKAA1|STYX|FAM192A|OS9|HP|HDAC4|PML|PDCL3|FBP1|CCRN4L|PPARA|EIF4G1|HGF|DFFA|CSNK2A2|TBC1D14|GLTSCR2|EFNA1|SLC11A1|VIP|NBAS|ATG7|BAG5|YBX1|ATP2B4|TIMP2|SNCA|FMR1|LEPR|HNRNPC|BCL2|RBM38|BMF|ADRA2A|CHMP4B|KIAA0226|PABPC1|MET|MYD88|DDRGK1|CSNK2A1|HSP90AB1|TNF|GABARAPL2|SNX12|RBM24|PSMF1
HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION%GOBP%GO:0021932,0.5358942770746999,0.9265056012720759,0.4489644979794621,0.9513986585418621,4784,4,LEF1|CEND1|ARL13B|CTNNA2
PROTEIN LOCALIZATION TO MITOTIC ACTOMYOSIN CONTRACTILE RING%GOBP%GO:1904498,0.748155316317891,0.9749763305090959,0.5080197697450349,0.8303443575287859,6184,2,ANLN|RTKN
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003307,0.22262372348782397,0.7355723797115551,-0.599977941987427,-1.21763740713596,1416,3,BMP2|MESP1|DKK1
POSITIVE REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032874,0.6112388837779821,0.9508825506493929,0.161843903299211,0.9139373350060142,7972,108,SH3RF1|EDN1|CTGF|TPD52L1|FGF19|TAOK3|MAP3K10|CD27|AGER|ERN1|MAP3K9|DUSP19|TGFB2|MAP3K5|MAP3K7|CCL21|F2RL1|EMC10|HRAS|MID1|CCL19|HAND2|GADD45B|GADD45G|SEMA4C|MAP3K4|TAOK1|MAP2K7|CARD9|PRMT1|TRAF4|RIPK1|MAP3K12|TAOK2|KLHDC10|TRAF2|RASGRP1|DVL3|UNC5CL|TNFRSF19|DVL2|SPAG9|TNIK|MINK1
D-GLUCURONATE CATABOLIC PROCESS%GOBP%GO:0042840,0.591946308724832,0.9458918196441479,0.7087560652845171,0.941550812880674,4409,1,AKR1A1
NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090278,0.6207190160832551,0.9536478716552259,0.24039203258460398,0.878669659134033,6560,19,SIRT4|NOV|CRHBP|KCNJ11|UCN|MIDN
REGULATION OF MONOCYTE EXTRAVASATION%GOBP%GO:2000437,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0070936,0.122733160621762,0.607607158836689,-0.211544239971666,-1.28142092746078,378,50,AMFR|RNF216|UBE2E2|UBE2Q2|UBE2E1|UBE2D3|ARIH2|PARK2|RNF4|BFAR|PELI1|UBE2K
PYRIDINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0019364,0.49848796419499203,0.913423777265461,0.604358334143756,0.9878070944633142,4120,2,NUDT17|NUDT12
POSITIVE REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000370,0.8351720731104889,0.988613522932093,-0.310042464015883,-0.7130328970970351,5071,4,DAB2|SCYL2|WASL|PICALM
AUTOCRINE SIGNALING%GOBP%GO:0035425,0.0501178318931658,0.440378626703493,-0.762931509870961,-1.5483468315924702,318,3,HILPDA|FZD1|CX3CL1
APOPTOTIC DNA FRAGMENTATION%GOBP%GO:0006309,0.957902942896122,1.0,0.16528975721840397,0.547656330601472,9829,14,DFFB|ENDOG|FEN1|DICER1|DNASE1L3
ESTABLISHMENT OF RNA LOCALIZATION%GOBP%GO:0051236,0.9008649367930809,0.998912093067348,-0.0984472590488458,-0.7794421601700591,1353,139,PA2G4|MAGOH|DDX19B|THOC5|SEH1L|NMD3|RBM15B|AGFG1|ARC|ZNF593|NPM1|FMR1|PHAX|RFTN1|EIF5A|RRS1|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
RIGHTING REFLEX%GOBP%GO:0060013,0.9663709784191709,1.0,-0.5158248786943099,-0.690034667598082,7298,1,AUTS2
TELOMERE FORMATION VIA TELOMERASE%GOBP%GO:0032203,0.511409395973154,0.918404893008545,0.7479047198941329,0.993558053984244,3809,1,WRAP53
ENTRAINMENT OF CIRCADIAN CLOCK%GOBP%GO:0009649,0.0494296577946768,0.4368220718984221,-0.328568059248247,-1.52217052183627,207,22,ARNTL2|PER1|BHLHE40|SIK1|FBXL3|ID2|PML|GNAQ|PER3|TP53|PER2|PPP1CB|USP2
POSITIVE REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904734,0.7266518188567191,0.972554563883587,-0.4689826302729529,-0.8021696719788249,4893,2,COX17|CHCHD10
BRANCH ELONGATION OF AN EPITHELIUM%GOBP%GO:0060602,0.616025137470542,0.9518465519698142,-0.42985654937748796,-0.8723810953626451,3920,3,FGF10
PYRIDOXAL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0042822,0.149096622152396,0.6418479749066359,-0.663301226488095,-1.34615013161266,948,3,PNPO|PDXK
NEGATIVE REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035548,0.820468687938567,0.987153241368501,-0.587450374944861,-0.785850277775518,6196,1,LILRB1
PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE%GOBP%GO:1903539,0.666280539174389,0.964618776001639,0.31977290153901194,0.8323016783821,6326,7,LRRC7|STX3|ARHGAP44|SCRIB|STX1B
HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS%GOBP%GO:0030200,0.5395391918490221,0.9280749458041251,0.50139410727947,0.953097453257975,4659,3,GPC1|HPSE
CAVEOLA ASSEMBLY%GOBP%GO:0070836,0.053021570887535,0.449202695711989,-0.6856529100672231,-1.5768584552443798,321,4,CAV2|CAV1
ASYMMETRIC STEM CELL DIVISION%GOBP%GO:0098722,0.44713563605728707,0.88473565970262,0.390261917681114,1.01576977764947,4245,7,FGF13|DOCK7|SOX5|ING2|TEAD3
REGULATION OF GROOMING BEHAVIOR%GOBP%GO:2000821,0.825906040268457,0.9876441563834109,0.5883877370974859,0.7816468588960379,6152,1,CNTNAP4
POSITIVE REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060193,0.383946682121124,0.8584502501158281,-0.18706793831626398,-1.04715346416889,1324,38,GNA13|LPAR1|C5AR1|NR1H3|GNAQ|RHOA|FGF2|GNA15|RHOC|FGFR1|EDNRA|NR1H2|FLT1
LIMB JOINT MORPHOGENESIS%GOBP%GO:0036022,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
ISG15-PROTEIN CONJUGATION%GOBP%GO:0032020,0.30597539543058,0.809555201431097,-0.4061152500869051,-1.11475909284366,1740,6,UBE2E2|UBE2E1
NEGATIVE REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:0060313,0.8187475175426979,0.987153241368501,-0.588056903396559,-0.786661649378252,6183,1,CST3
RNA EXPORT FROM NUCLEUS%GOBP%GO:0006405,0.862550960978451,0.991943445125448,-0.10505354854696901,-0.804608184680668,1480,121,PA2G4|MAGOH|DDX19B|THOC5|SEH1L|NMD3|RBM15B|AGFG1|ZNF593|NPM1|PHAX|EIF5A|RRS1|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|SLBP|FYTTD1
GALACTOSE CATABOLIC PROCESS%GOBP%GO:0019388,0.11943319838056699,0.6048725377310601,0.481487924068605,1.37400202204801,1179,9,GALM|PGM5|GALE|GALK1|GALT
PIGMENT METABOLIC PROCESS INVOLVED IN DEVELOPMENTAL PIGMENTATION%GOBP%GO:0043324,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
ULTRADIAN RHYTHM%GOBP%GO:0007624,0.45531576856878103,0.88900512246363,-0.771393912659903,-1.03191715656838,3438,1,ENOX2
ORGANOPHOSPHATE ESTER TRANSPORT%GOBP%GO:0015748,0.23296901964006897,0.746122594132505,0.23716659223048803,1.1859624013166599,2834,59,ATP10A|ATP11C|SLMO1|STARD10|MFSD2A|ABCA7|SLC25A19|ABCB4|SCARB1|ATP10D|SLC37A2|CETP|SLC25A42|OSBPL5|APOE|ATP8B3|PRELID2|OSBPL8|APOC1|LDLR
CELLULAR LACTAM CATABOLIC PROCESS%GOBP%GO:0072340,0.0296644295302013,0.353942807960853,0.985277900308778,1.30889773419673,220,1,DPEP1
EPINEPHRINE METABOLIC PROCESS%GOBP%GO:0042414,0.701705576388049,0.968941691852291,0.528535980148883,0.863877539820607,5800,2,TH|ATP7A
NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060253,0.902880316106894,1.0,0.232534123774589,0.633950406477086,8682,8,HES1|DICER1|RNF10|CERS2
PROTEIN DEGLUTAMYLATION%GOBP%GO:0035608,0.251717032967033,0.763905256448548,-0.46527390442264294,-1.17780999326945,1465,5,AGBL4|AGBL5|FOLH1|AGBL2
REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070570,0.846761133603239,0.991298302704726,0.24163856327329397,0.689553897295617,8365,9,RTN4RL1|RTN4R|PTPRS|CERS2|INPP5F
SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0030730,0.113140311804009,0.588848744118853,-0.7965260545905709,-1.36241515717039,761,2,IL1B|TNF
CELLULAR PROTEIN-CONTAINING COMPLEX LOCALIZATION%GOBP%GO:0034629,0.6926519076778139,0.96731875442989,-0.18355540105191898,-0.8336711841424459,2940,21,EXOC3L4|EXOC1|EXOC3L2|EXOC8|MZT1|GSG2|NACC2|RCC2|TNFAIP2|EXOC3L1|MIOS|EZR|SEC13|KLHL21|SEH1L|EXOC3|SMAD7|DLG1
SYNAPTIC VESICLE LOCALIZATION%GOBP%GO:0097479,0.34389974198304496,0.8393009815539341,-0.16374016873374098,-1.0722224611505,932,65,VAMP2|STX11|AP3S2|BLOC1S6|OTOF|SNPH|SYT2|BLOC1S3|SYNDIG1|TMEM230|SYT9|SNAP25|CPLX1
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001185",0.9024343122102009,0.9998805542592591,0.184954469692742,0.627108848901386,9341,15,SH3RF1
REGULATION OF MESODERMAL CELL DIFFERENTIATION%GOBP%GO:1905770,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
"REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033158",0.567914979757085,0.9398422263548051,0.319912566109777,0.9129211569816479,5610,9,SIRT1|PDE2A
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905313,0.6409373758771351,0.96102887115448,-0.6735774150860171,-0.9010650453637808,4840,1,TGFB1
PROTEIN BRANCHING POINT DEGLUTAMYLATION%GOBP%GO:0035611,0.49569707401032703,0.911498395855878,-0.749393471548302,-1.00248649570556,3743,1,AGBL5
NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0045988,0.457928536143586,0.890371861972445,-0.42734241438261705,-0.98279827812254,2780,4,ADRBK1|ZC3H12A|KCNE3|BIN1
CEREBELLAR MOLECULAR LAYER MORPHOGENESIS%GOBP%GO:0021687,0.19049740163325898,0.698434241409875,-0.7433691756272399,-1.2714931626039399,1282,2,DLL1|ZNF365
REGULATION OF CILIUM ASSEMBLY%GOBP%GO:1902017,0.154639175257732,0.6538333887772321,-0.192446842370849,-1.2309850547083,434,60,TCTEX1D2|CCP110|ATG3|TBC1D20|TBC1D8|TBC1D14|CYLD|HAP1|TBC1D19|MARK4|TBC1D5|TBC1D2|SEPT9|TBC1D15|HTT|MAP4|KCTD17|TBC1D1
ETHANOL METABOLIC PROCESS%GOBP%GO:0006067,0.392000805964135,0.8620270014038021,0.35974234196648797,1.0616925911239101,3890,10,ALDH1A1|ADH1B|SULT1A3|ACSS1
REGULATION OF CELL PROLIFERATION INVOLVED IN HEART VALVE MORPHOGENESIS%GOBP%GO:0003250,0.509725315515961,0.918404893008545,-0.55869864902123,-0.955624117165133,3432,2,BMPR2|NOTCH1
REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR%GOBP%GO:0090325,0.15664429530201301,0.6578589353509621,0.9221438023820029,1.2250269017128101,1166,1,GNB3
POSITIVE REGULATION OF INTERLEUKIN-1 BETA BIOSYNTHETIC PROCESS%GOBP%GO:0050725,0.331680174186525,0.8293509737209019,0.6735042735042739,1.10082423279801,2741,2,AZU1|EGR1
INTERMEDIATE FILAMENT ORGANIZATION%GOBP%GO:0045109,0.00917610308473253,0.21165103507835,-0.587131936764978,-1.89531450603181,46,9,KRT9|NEFH|DNAJB6|DES
REGULATION OF T CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002625,0.885234899328859,0.996643473105967,0.5586678429642701,0.74216530543854,6594,1,WAS
REGULATION OF CELL ACTIVATION%GOBP%GO:0050865,0.892494929006085,0.9976191001250191,-0.0919044601544595,-0.839926596004272,439,322,IGHV4-4|CD274|CHRNB2|ICOSLG|IL1B|RARA|FAM49B|FCER1G|CX3CL1|PRKCD|SIRPA|MAP3K8|IGHV2-26|LGALS9|ITGAM|TNFAIP3|PDPN|CD300LF|NR1H3|LAMP1|GRB2|FGR|CEBPA|ABL1|VAV1|RPS3|IGHV1-69-2|IGHV3-15|FYN|IGHV3-73|C20orf196|TNFRSF1B|RUNX1|TNFRSF18|IL6|PNP|LYN|FCGR2B|PRNP|VAMP2|CD276|YES1|VAMP3|IGF1|SPINK5|CAMK4|VAV3|SMAD7|KARS|CDC42|LGALS3|TFRC|THBD|IGHV1-3|NLRP3|BCL2|PRKCA|DUSP3|NFATC2|CD9|SNX6|GAB2|SOCS5|TNFRSF4|NOS3|BCL6|NKAP|TNIP2|FGF10|DUSP10|CBFB|RAC1|IGF2|CD22|PIK3R1|TNF|TNFRSF21|CAV1|PAK2
POSITIVE REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000617,0.673637411493496,0.9647315640607691,-0.359234544752661,-0.8261644062059921,4090,4,BRCA1|PIH1D1|SMARCB1|SMAD4
CILIUM MOVEMENT INVOLVED IN CELL MOTILITY%GOBP%GO:0060294,0.509351551125546,0.918404893008545,0.457826554937089,0.97017820378286,4547,4,TEKT3|GAS8
NEGATIVE REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010972,0.0109755026780227,0.228061856776328,0.398743780500027,1.73413872043533,124,34,TAOK3|BLM|ORC1|USP47|DONSON|ZNF830|NAE1|AURKB|CDC6|MSH6|TAOK1|TOPBP1|BRSK1|AURKA|CLSPN|CDK5RAP3|TAOK2|C5orf45|FHL1|RBX1|FBXL7|RAD17|ATM
STRESS GRANULE DISASSEMBLY%GOBP%GO:0035617,0.6380494505494511,0.9601484712040809,-0.33633195890458695,-0.8514020203760941,3715,5,DYRK3
AUTOPHAGOSOME MEMBRANE DOCKING%GOBP%GO:0016240,0.19644327350568105,0.7100128962886071,-0.544146032096178,-1.25142219773327,1192,4,STX17|ATG14|SNAP29|VAMP8
SKELETAL MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0060538,0.686503984063745,0.9665349594178531,-0.172215664084158,-0.8456294190896819,2756,26,RYR1|POPDC3|CFLAR|CAV2|CAV1
CATECHOLAMINE UPTAKE%GOBP%GO:0090493,0.866815144766147,0.9929671171385601,-0.406429802486307,-0.6951764101649339,5837,2,SNCA
NEGATIVE REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071157,0.11241166077738499,0.587656563188088,-0.323620309050773,-1.36175703854255,508,17,ZNF268|TFAP4|PHOX2B|MDM2|SETMAR|HMGN5|CCND1|EVI2B|RPL23|MIF|CDK4|CALR|CCNK|GPER1|CDK9|FGF10|HSP90AB1
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002864,0.72611696331275,0.972554563883587,-0.27164496506422897,-0.792400414883246,3997,7,FCGR2B|ADCYAP1
NEGATIVE REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000723,0.435570469798658,0.878651088001772,0.7889832377591529,1.04812903232531,3244,1,HEY2
INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032621,0.256778523489933,0.767462394426418,0.873786943096603,1.16078697150459,1912,1,GBP5
SYNAPTIC SIGNALING%GOBP%GO:0099536,0.730682299759853,0.972575443350537,0.137174637227618,0.868049228545675,10344,228,SYT17|PCDHB4|CHRNA10|RIT2|SLC1A2|AKAP9|CACNB4|PCDHB6|CACNB2|RIMS2|PCDHB14|KCNK3|UNC119|CRHBP|PCDHB13|GRM4|PCDHB9|AKAP5|APBA3|UNC13B|SYT3|GRIK2|LIN7A|LIN7B|PENK|GRIA2|DLG3|BZRAP1|DLGAP1|NPY|GPR176|DVL1|UNC13A|PPFIA3|ATXN3|DOC2A|CPLX3|PTPRD|SPG11|ZACN|STAC3|SLC6A9|APOE|NPTX2|GRIN1|PCLO|CASK|DLGAP2|SNAP47|PRRT2|STX2|SLC6A2|DRD4|DLG4|TH|KCND2|MYCBPAP|BRSK1|NOVA1|RIMBP2|CACNB1|SYNJ2BP-COX16|PCDHB16|SLC1A3|SYT1|SEPT5|CORT|GRIK5|SLC6A1|RIMS4|PCDHB11|NPAS4|SYNJ2BP|PLP1|GSK3A|RIC3|APBA2|RAB3A|DAGLA|SLC1A1|NLGN3|SYT7|STX3|SNAPIN|GABRB3|PIP5K1C|STX1A|AKT1|MINK1|PCDHB3|SLC18A2|LRP6|DTNA|MPP2|RIMS1
AMP METABOLIC PROCESS%GOBP%GO:0046033,0.667595171773445,0.964618776001639,-0.268047363656149,-0.8332079160583259,3594,8,AK4
TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034154,0.308240534521158,0.811337431037228,-0.676040805073063,-1.1563315906479,2075,2,PIK3AP1|UNC93B1
DE NOVO CENTRIOLE ASSEMBLY%GOBP%GO:0097742,0.0151192742748348,0.264387156924099,0.777602734969028,1.6478144758828102,134,4,CCDC78|CEP63|CEP152
NEGATIVE REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032714,0.44780994803266494,0.8850378987593649,-0.5873962238636129,-1.0047097819892299,3015,2,TNFRSF21
NEGATIVE REGULATION OF MAST CELL DIFFERENTIATION%GOBP%GO:0060377,0.873825503355705,0.9934031064448321,0.5641817379797089,0.749490268974254,6509,1,ZFPM1
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST%GOBP%GO:0006977",0.808847941567065,0.984682960940884,0.154351736117441,0.758836687815707,9744,55,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032805,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
REGULATION OF HEART GROWTH%GOBP%GO:0060420,0.493857727835444,0.91071489001692,0.27199278706591395,0.9756935786510059,5185,18,EDN1|TBX2|BASP1|PROX1
REGULATION OF LIPOPROTEIN OXIDATION%GOBP%GO:0034442,0.26201509334039497,0.771967970256231,-0.869320688134098,-1.16291678988256,1978,1,APOD
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE%GOBP%GO:0070973,0.9168814432989691,1.0,0.252821808565993,0.62177841821887,8537,6,MIA3|GBF1|SEC16A|CTAGE5|BCAP29
NUCLEUS LOCALIZATION%GOBP%GO:0051647,0.546276282177245,0.930420772651609,0.295941270442866,0.9329126438434749,5559,12,KIF25|DCTN4|DOCK7|SYNE2|PCM1|HOOK3|TMEM201|SYNE3|PAFAH1B1
NEGATIVE REGULATION OF CILIUM ASSEMBLY%GOBP%GO:1902018,0.34261133603238897,0.836994591537452,0.387270518571925,1.1051377386602699,3384,9,TBC1D30|EVI5L|CDK10|CEP97|TCHP|TBC1D7
RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:0072396,0.0186855670103093,0.286111698549296,0.671131267416147,1.65054961135725,173,6,MUS81|FBXO18|APAF1|SLX4|EME1
ISOPEPTIDE CROSS-LINKING%GOBP%GO:0018262,0.326227988878591,0.826621597878865,-0.8384980149977941,-1.1216843602527,2463,1,RNF113A
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051985,0.0268596922516617,0.339762187668294,0.407794237336692,1.62500137445805,294,25,TPR|CENPF|NAA10|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|ESPL1|KLHL22|PLK1
PROTEIN O-LINKED FUCOSYLATION%GOBP%GO:0036066,0.404170176916596,0.865585453523601,0.403698428472219,1.0507421922262299,3837,7,B3GLCT|RFNG|LFNG
ISOPRENOID BIOSYNTHETIC PROCESS%GOBP%GO:0008299,0.478444466267308,0.9046812288131709,0.30595172820539,0.987419949635482,4871,13,MVD|SRD5A3|IDI1|HMGCR|PDSS1|MVK|HMGCS1|FDPS|NUS1
POSITIVE REGULATION OF VASCULOGENESIS%GOBP%GO:2001214,0.33327279331638204,0.8293509737209019,-0.370158189596451,-1.07976786147796,1834,7,RAPGEF2|HIF1AN|CD34|KDR|TMEM100|RAP1A
REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS%GOBP%GO:0050690,0.399153386454183,0.8638522656500329,-0.210332735004997,-1.03279541651276,1602,26,AP1S1|AP2S1|B2M|RAC1|PAK2
"HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0015014",0.981293134762078,1.0,-0.17983581812680102,-0.5245890600654111,5402,7,CSGALNACT1
POSTSYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097104,0.710158934707904,0.9700296616429409,0.32698787304562105,0.804179052559812,6612,6,NLGN4Y|NLGN3|NRXN2|NLGN2|NRXN1
POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904340,0.8481069042316259,0.991298302704726,-0.41659773917838394,-0.7125681213168751,5711,2,CSNK1E|CSNK1D
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904037,0.704720087815587,0.968941691852291,-0.200755031185399,-0.822159324557303,3209,16,IL6|ECSCR|PDCD4|ANO6
REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905330,0.7101846625272159,0.9700296616429409,0.16125400001024698,0.8394517244256521,8806,71,MLLT3|TBX2|AJAP1|BMP4|SIRT6|SAPCD2|AP2A2|AHI1|DVL1|CELSR2|DACT1|DAAM1|CXCL10|MAGI2|NPHP3|CLTC|FZD6|FGFR2|DAB2|FZD3|RNF207|DVL3|GATA3|SULF1|DVL2|CELSR3|STAT1|SMURF2|ROR2|AP2M1|AP2B1
"FATTY ACID ELONGATION, POLYUNSATURATED FATTY ACID%GOBP%GO:0034626",0.256591850076269,0.767319904137432,0.515488863315952,1.18812541310018,2354,5,ELOVL6|ELOVL4|ELOVL2|ELOVL1|ELOVL5
NEGATIVE REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051892,0.341983317886932,0.8359038216207221,-0.8303925893250992,-1.11084148519798,2582,1,PRICKLE1
DNA RECOMBINATION%GOBP%GO:0006310,0.0620299352148336,0.485898561056649,0.233422023795233,1.36820634794029,832,133,MUS81|FBXO18|EME2|MLH3|CDC7|XRCC3|LIG4|RAD54B|BLM|RAD54L|C11orf80|ENDOG|EXO1|BRIP1|CDC45|TOP2A|PARP1|TONSL|FEN1|GEN1|POLQ|NABP1|POLN|SLX1B|INO80|MSH6|MMS22L|RAD51C|RAD51|NIPBL|MND1|FANCM|REC8|LIG1|PGBD5|RAD51AP1|SLX4|SFPQ|EXD2|EME1|RMI1|PALB2|STRA13|BRCA2|XRCC2|IGHMBP2|TOP2B|PRKDC|GINS2|UBR2|RECQL5|XRCC1|ZFYVE26|SMC6|SUPV3L1|SPIDR|ATM|WRNIP1|RFWD3|BRCA1|CCNB1IP1|HMGB3|THAP9|POLL|RAD52|YY1|RPAIN|RNF8|NCOA6|RAD51D|HMGB2|HSPD1|AUNIP|MSH3|TEP1|RBBP8|SWI5|RAD50|NUCKS1|EXOSC3|PSMD14|NBN|HMGB1|LIG3
REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904062,0.0008802816901408449,0.0849637591935908,-0.218534205967905,-1.81783853149319,0,186,CRHR1|SCN1B|DNAJC30|FYN|KCNE4|SESTD1|SLC9A1|PLN|RANGRF|UBASH3B|YWHAH|SLC30A1|KCNAB1|PRNP|APLNR|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|BIN1|CRACR2A|ATP2B4|CEMIP|CAB39|TMSB4X|KCNAB2|CRH|AMIGO1|SNCA|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|SNTA1|RELN|COMMD1|FXYD5|YWHAE|KCNG1|ANO6|HTT|ADRA2A|JPH1|SLC9A3R1|CACNG3|SCN5A|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
MEDIUM-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0051793,0.0556766179995642,0.45915848992626795,0.648837977087658,1.49547535247112,510,5,GLYATL2|ABHD3|ACADM|ABHD2
RESPONSE TO ISCHEMIA%GOBP%GO:0002931,0.0840860215053763,0.545178773025535,-0.35917316050078996,-1.43241465223953,390,15,PPIF|BVES|CX3CL1|STUB1|HYOU1|CAMK2A|PER2
HISTONE DEPHOSPHORYLATION%GOBP%GO:0016576,0.13385703063629198,0.6199122719148871,-0.676519769135018,-1.37297677117444,851,3,EYA4|EYA1
NEGATIVE REGULATION OF CALCIUM-DEPENDENT CELL-CELL ADHESION%GOBP%GO:0046588,0.103402621474911,0.5756137190742839,-0.9464049404499342,-1.26603474448461,780,1,FXYD5
RESPIRATORY GASEOUS EXCHANGE%GOBP%GO:0007585,0.441029166257488,0.880402968441571,0.315951176799458,1.0196918870585898,4490,13,GAA|ELN|ECEL1|UCP3|NDUFA12|COX11|BPGM
REGULATION OF NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043321,0.213956941351151,0.7301341244006608,-0.7295285359801491,-1.24781948974484,1440,2,AP1G1|LAMP1
REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010611,0.35831673306772904,0.846205501155666,-0.215983128382415,-1.0605405051769299,1438,26,IL6ST|AGT|AKAP6|CAMK2D|NOTCH1|SLC9A1|FOXO1|IGF1|ATP2B4|LMNA|MTPN|PDE9A|PRKCA
MEDIUM-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036114,0.722147651006711,0.971401508276304,0.642148213498015,0.85306525336925,5379,1,ACOT7
DNA HYPERMETHYLATION%GOBP%GO:0044026,0.46630477955779204,0.894322345600068,-0.7651080723423029,-1.0235083963218599,3521,1,SPI1
SECRETORY GRANULE MATURATION%GOBP%GO:0061792,0.679968578161823,0.9647315640607691,-0.40834895775890606,-0.828732077191344,4327,3,BAIAP3|SNX19|PTPRN
HISTONE H3-T6 PHOSPHORYLATION%GOBP%GO:0035408,0.840089086859688,0.98953921193435,-0.421261447509115,-0.720545144644349,5657,2,PRKCA
INTERNAL PROTEIN AMINO ACID ACETYLATION%GOBP%GO:0006475,0.45267814820666796,0.8874890379518141,0.188105902707957,1.01152993402485,5729,83,CPA4|JADE3|AK6|KAT2A|NAA40|TADA1|OGT|TAF6L|NAA10|YEATS4|TRRAP|MAP3K7|EP400|LEF1|ING5|APBB1|YEATS2|BRPF3|EHHADH|ATAT1|MSL1|KAT8|BRCA2|BAG6|SUPT3H|WDR5
RESPONSE TO PHORBOL 13-ACETATE 12-MYRISTATE%GOBP%GO:1904627,0.9092778516995279,1.0,0.4298869589192171,0.7026384246678621,7516,2,ADAM15|MAP4K1
NEGATIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905166,0.596503415537803,0.948415232788167,0.48108525421859494,0.9144924600004021,5151,3,LAPTM4B|ATP13A2|MGAT3
REGULATION OF SARCOMERE ORGANIZATION%GOBP%GO:0060297,0.15746208174134502,0.658351309194249,0.6700587980949712,1.27371128763875,1359,3,EDN1|PROX1
CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0030038,0.349602278306982,0.842847021021096,0.342073669273483,1.10399888004194,3559,13,ITGB1|FHDC1|TNFAIP1|SRC|ITGB5
NEGATIVE REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:1902373,0.0269534440511843,0.339785941813865,-0.295140231382933,-1.57863735279914,98,33,CCRN4L|SLC11A1|VIP|NBAS|YBX1|FMR1|HNRNPC|RBM38|PABPC1|MYD88|RBM24
NEGATIVE REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901984,0.48989247311828005,0.908938677284213,-0.24070259982336498,-0.9599434722193779,2277,15,KLF15|GSK3B|SET|PARK7|NOC2L|SPI1|SIN3A|MAGEA2|CTBP1|SNCA
TRYPSINOGEN ACTIVATION%GOBP%GO:0032023,0.0218791946308725,0.310715277412964,0.9899095721217471,1.31505070356673,162,1,CUZD1
METANEPHROS DEVELOPMENT%GOBP%GO:0001656,0.17693086624321103,0.68127227990091,0.32785251794656606,1.27508508757051,1921,23,CITED1|WNT4|BASP1|BMP4|PKD2|ROBO2|NF1|NIPBL
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002865,0.279968578161822,0.788916642629372,-0.5646697741035179,-1.14598052946731,1781,3,FCGR2B|ADCYAP1
NEGATIVE REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045578,0.0598587472502026,0.47655410709209,0.7554184576644158,1.43597102098113,516,3,INHA|INHBA|SFRP1
REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903201,0.22826086956521696,0.74151201664762,-0.20948904043344602,-1.18199102707159,776,39,TRAP1|PARK7|NUP93|ATF4|HIF1A|TXN|HSPB1|SOD1|FBXW7|MAPK7|STK26|FYN|PDE8A|P4HB|HGF|BAG5|SOD2|PARK2|FBXO7|MET
AMMONIUM TRANSMEMBRANE TRANSPORT%GOBP%GO:0072488,0.0585731884869526,0.47368184492677795,0.6918321195497459,1.4660583485732799,522,4,SLC25A29|RHBG
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY%GOBP%GO:0007163,0.546914877645999,0.9305779599215391,0.16518934511125302,0.9580596641032251,7285,125,KIF25|FSCN2|CAMSAP3|SDCCAG8|BRSK2|LRRC7|SAPCD2|KIF2C|MTCL1|MARK2|FGF13|CKAP5|DLG3|NUMA1|DYNLT1|AMOT|AMOTL2|FAM89B|CCL21|NDC80|CENPA|GPSM2|CDK5RAP2|SYNE4|DLG5|DOCK7|CYTH3|RHOBTB3|STK11|CCL19|SPDL1|ARHGEF11|SHTN1|CDC42BPB|BRSK1|ERBB2IP|GBF1
RNA REPAIR%GOBP%GO:0042245,0.407040038708117,0.8669681570015609,0.639426523297491,1.0451250862555799,3364,2,ALKBH1|FTO
ACTIVATION OF NF-KAPPAB-INDUCING KINASE ACTIVITY%GOBP%GO:0007250,0.29985474164764503,0.80250393930618,-0.29625167565847,-1.1156781478653501,1444,13,TNFRSF10B|CHI3L1|COPS8
CELL-SUBSTRATE ADHESION%GOBP%GO:0031589,0.7081640475277879,0.9695170059473192,0.15111851890665398,0.8522492947153699,9237,107,PTPRK|HOXD3|CUZD1|ITGB1|ITGA1|STRC|MADCAM1|ACTN2|KIF14|ILK|PPFIA2|ITGA2|SGCE|ITGA4|DDR1|CTTN|TYRO3|CCL21|ITGA11|ITGB5|CORO1A|ITGBL1|FBLN5
EPITHELIUM DEVELOPMENT%GOBP%GO:0060429,0.13842482100238698,0.6263534045411271,-0.125268430549702,-1.14953540594023,57,352,RAB25|RAB10|HAND1|MTSS1|LAMA5|TDRD7|RAP1B|NRARP|SOD1|FUZ|NOTCH1|OPHN1|LRP5|FURIN|ID2|STRA6|RARA|HNRNPH3|VEGFA|KDR|CAPNS1|RAB13|IFT122|F11R|CTNNB1|SKI|KRT17|ACVR1|PDPN|DLC1|CELSR1|PRKD2|PRICKLE1|SLC4A7|COL23A1|ANXA7|IRF6|CITED2|CES1|RHOA|HES7|NRP1|MEOX1|PSAP|ITGA5|ZNF703|BCL10|NKX6-1|SIPA1L3|RILPL2|CASP3|MYADM|ATP6AP2|CLIC4|FGF2|PTK7|TJP2|KAZN|PPARG|RAP2B|PODXL|MICAL2|NFIB|RAB1A|SPINK5|PAX8|ICAM1|MEOX2|RHOC|RAP1A|KRT9|PDCD10|WNT11|PGK1|CDC42|NPNT|LGALS3|BHLHE41|TRAF3IP1|MSN|CCDC103|ADAM17|CTSH|MMP12|RAPGEF1|TBX20|MKKS|GSTM3|COBL|WNT3|FGF10|SFRP2|PKP4|ASCL1|EVPL|ACVRL1|SLC9A3R1|TMEFF2|MET|TAGLN2|SH3BP1|SOX17|RILPL1|PDE4D|DNAAF1|BBS7|INSM1|RBPJ|DACT2|STC1
RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009188,0.613266251820469,0.9508825506493929,-0.686369651521835,-0.918177610075994,4631,1,AK5
DNA INTEGRATION%GOBP%GO:0015074,0.59344640210769,0.9464278097528599,-0.381955550653505,-0.878417973193537,3603,4,THAP9|SETMAR|SMARCB1|RLF
TOLL-LIKE RECEPTOR TLR6:TLR2 SIGNALING PATHWAY%GOBP%GO:0038124,0.29379418695993703,0.8004058897916541,-0.557388744676568,-1.1312038965742,1869,3,CD36
MAMMARY GLAND EPITHELIUM DEVELOPMENT%GOBP%GO:0061180,0.7647171436776109,0.979010560949668,0.21934242730568698,0.76040071201829,7988,16,WNT4|JAK2|AKT2|FGFR2|CSF1R|AKT1|LRP6|SCRIB
CELL MORPHOGENESIS%GOBP%GO:0000902,0.202631578947368,0.7169847518722969,-0.120596693815487,-1.1084804115295601,76,368,PARD6B|LAMC1|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|VAMP3|MAP4K4|NYAP2|RAB8A|ARHGEF2|CDC42|DBNL|NEFH|STK4|VHL|ALCAM|S100A6|PLXNA1|COL21A1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|WNT3|GREM1|MYH9|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|MET|DOK5|PTPRA|PIK3R1|RILPL1|HSP90AB1|PEAK1|TMEM108|NTNG2|CDHR1|GFRA2|DACT2|NBL1|STC1|SLIT3|EPHB2|PARD3|UBB
DETECTION OF GLUCOSE%GOBP%GO:0051594,0.966372323696625,1.0,0.368113385361802,0.6016712157076031,7988,2,GCK
CELLULAR RESPONSE TO INTERLEUKIN-3%GOBP%GO:0036016,0.522056269538034,0.9251240799994541,0.508185630364514,0.966007424201231,4508,3,MT2A|GSK3A|GSK3B
REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900407,0.39594383775351005,0.8638522656500329,-0.17581886896850102,-1.0397614274365001,1268,46,ATF4|HIF1A|TXN|HSPB1|SOD1|FBXW7|MAPK7|STK26|FYN|PDE8A|P4HB|HGF|BAG5|SOD2|PARK2|FBXO7|MET|TNF
POSITIVE REGULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044794,0.666873963515755,0.964618776001639,-0.229279878616418,-0.835289596849417,3216,12,CAV2|PC
NEGATIVE REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033234,0.0231985940246046,0.319627217671777,-0.63923666648282,-1.7546617278920298,131,6,PIAS3|CAPN3|PARK7|MAGEA2|CTNNB1|GNL3L
POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050861,0.9381789674095641,1.0,0.286288607805865,0.606672907653329,8376,4,PRKCB|SLC39A10
CELL MIGRATION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003273,0.636100497858053,0.95916055221954,0.46843570626359904,0.890447000020452,5493,3,DCHS1|SNAI2|NOTCH1
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090272,0.6544419435985699,0.9640743070248079,-0.666629907366564,-0.891771152459734,4942,1,RGCC
RESPONSE TO MITOCHONDRIAL DEPOLARISATION%GOBP%GO:0098780,0.298402158124092,0.8023890191280308,-0.29696207426663107,-1.1183534954448602,1437,13,SQSTM1|MFN2|BECN1|HK2|PARK2
CELLULAR RESPONSE TO UV%GOBP%GO:0034644,0.590530149736949,0.945418171231938,0.17734858813029103,0.9170967491450991,7295,69,PTPRK|SIRT1|ATR|USP47|ST20|DDB2|POLD1|PARP1|TMEM161A|GEN1|INO80|AURKB|DDB1|ZBTB1|STK11|METTL3|MC1R|MFAP4|CUL4B|KDM1A|CASP9|CARD16|MAPK13|CHEK1|XPA|HIST3H2A
HISTONE H2A-T120 PHOSPHORYLATION%GOBP%GO:1990245,0.345293260955912,0.8411448613059059,-0.827911336568152,-1.10752223773225,2607,1,VPRBP
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904468,0.353181461115475,0.842847021021096,-0.52810250644639,-1.07176834621841,2247,3,SYT11|CX3CL1
NEGATIVE REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001960,0.9727742989381979,1.0,-0.10953702468062701,-0.585888402489473,3572,33,NR1H3|RNF113A|IL6|PPARG|CNOT7|NR1H2|SLIT3
NEGATIVE REGULATION OF CELL MIGRATION%GOBP%GO:0030336,0.1535974130962,0.6507359320251149,-0.143108771286758,-1.1678298033807801,189,169,CX3CL1|PTPRG|DAB2IP|STK26|TRIB1|HMOX1|DLC1|PTPRU|SRGAP2C|MMRN2|IGFBP3|CITED2|RHOA|MITF|HDAC5|CLIC4|APOD|FGF2|MAP2K5|ADAMTS9|PPARG|LDLRAD4|MEOX2|PDCD10|WNT11|SMAD7|ARPIN|DUSP3|DRD2|GREM1|SFRP2|PTPRM|ACVRL1|DUSP10|STK24|TMEFF2|IFITM1|CORO1C|MCTP1|PLCB1|NBL1|STC1|ANGPT2|FOXO3
REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902175,0.8929848693259971,0.9976191001250191,0.164810214856548,0.648610236556571,9737,24,SIRT1|NOL3|INS|PDIA2
MEMORY%GOBP%GO:0007613,0.26584779247552,0.779649746770441,0.254352783949388,1.16160891354572,3094,41,CALB1|SLC8A3|KAT2A|VLDLR|ABCA7|ADCY8|RGS14|FGF13|CUX2|CPEB3|FEN1|APOE|SHISA7|TH|LDLR|NPAS4|SLC8A2|SHANK1
CRANIAL NERVE DEVELOPMENT%GOBP%GO:0021545,0.7114484766559219,0.970341332123494,0.294752886110094,0.8035754448707199,6841,8,CHD7|ERBB3|PHOX2B|TMEM126A|ISL1
CARTILAGE CONDENSATION%GOBP%GO:0001502,0.161861757554707,0.664367762084791,0.667620129050962,1.2690756343244398,1397,3,MGP|BMPR1B|BMP1
REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:1903371,0.318681318681319,0.8209179217112019,-0.436410765497463,-1.10474487369137,1855,5,KIAA1715|RAB3GAP2|RAB3GAP1|ATL3|TMEM33
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:1901201,0.0326236263736264,0.36828894094998404,-0.666776968894772,-1.6879016204889,189,5,RGCC|TGFB1|SMAD3|AGT|NOTCH1
REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045616,0.7322185586434291,0.972769769206295,-0.177289687231506,-0.8052135902485821,3108,21,TRIM16|FOXC1|PRKCH|CTSL|CTSK|RUNX1|CTSV|CBFB
EMBRYONIC EYE MORPHOGENESIS%GOBP%GO:0048048,0.23734544049459,0.7507739897770379,0.35738920826602705,1.21176814692725,2456,15,SIX3|TBX2|PROX1|EFEMP1|FBN1|TH|MFAP2|LRP6
ATP GENERATION FROM ADP%GOBP%GO:0006757,0.00373505976095618,0.143595610377104,-0.40022182053165006,-1.96520651825147,14,26,PFKP|ENO3|AK9|LDHA|PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
REGULATION OF RIBONUCLEASE ACTIVITY%GOBP%GO:0060700,0.221576462041409,0.73556947110949,-0.41629844815609096,-1.21436104275351,1219,7,OASL|NPM1|OAS3
ARTERY MORPHOGENESIS%GOBP%GO:0048844,0.7504906333630691,0.97622649654938,0.18744673361777103,0.785951265517105,8412,30,TBX2|HES1|BMP4|PROX1|PKD2|TGFB2|NF1|HEY2|MYLK|TFAP2B
NUCLEOSOME ASSEMBLY%GOBP%GO:0006334,0.0354418308963764,0.3821688062173221,0.280213691163748,1.4884836305230302,445,78,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|ASF1B|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|ASF1A|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|H2AFX|H3F3A|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|HIST1H2BK|STRA13|CENPM|HIST1H3H|HIRA|HIST1H2BN
POSITIVE REGULATION OF DNA TOPOISOMERASE (ATP-HYDROLYZING) ACTIVITY%GOBP%GO:2000373,0.442471126607104,0.880423444399886,0.441438673321355,1.01745070247399,4060,5,DHX9|UHRF1|SETMAR
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0030206,0.178924259055982,0.68489956912038,-0.306523187923372,-1.2553154740689798,814,16,CSPG4|CSGALNACT1|CHSY1|NCAN
ESCRT III COMPLEX DISASSEMBLY%GOBP%GO:1904903,0.0437352245862884,0.412001737413835,-0.475809565841011,-1.60973498040857,221,10,CHMP5|IST1|CHMP2B|CHMP7|CHMP2A|CHMP1A|VTA1|VPS4A|VPS4B|CHMP1B
REGULATION OF SYNAPTIC VESICLE CYCLE%GOBP%GO:0098693,0.958704453441296,1.0,0.137514062555605,0.563894059541685,10655,28,RIMS2|BRSK2|UNC13B|BRSK1|RAB3B|SEPT5|RIMS4|RAB3A|PLD1|PLAA|RIMS1|RIMS3|STX1B
DICARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0043649,0.18163908589440497,0.6873049536419911,-0.37534034012175393,-1.2698325515681799,921,10,ACOT8|GLUL
HISTONE BIOTINYLATION%GOBP%GO:0071110,0.35098636303455605,0.842847021021096,-0.8240516100573442,-1.10235896389667,2650,1,HLCS
AGGREPHAGY%GOBP%GO:0035973,0.7680140597539541,0.9792236089291529,-0.27648778335447605,-0.758940400511024,4369,6,WDFY3|ATG5|ACBD5|UBQLN1|WDR81|SQSTM1
INNER MEDULLARY COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072061,0.0112538064345293,0.22992267312754103,-0.995202911336568,-1.33131327797732,84,1,DACT2
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1904925,0.36081708449396505,0.848418604328854,-0.3418027108686861,-1.06247164882143,1942,8,MFN2|HK2|PARK2
NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001915,0.609698734460746,0.9508825506493929,0.424170166843581,0.8988571023870151,5443,4,CEACAM1|PTPRC|LILRB1
NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061002,0.30306362922231,0.8055436753253159,-0.552939230175361,-1.1221737390948798,1928,3,NGEF|PTEN|EFNA1
PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009219,0.8359203885344251,0.988613522932093,0.19588305453718,0.702672451502012,8777,18,TDG|MBD4|DTYMK|DUT|NEIL1|HDDC2|TYMS|NTHL1|UNG|NT5M
NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:2000272,0.36048298572996706,0.848418604328854,-0.256471530123871,-1.05033711349475,1641,16,SNX6|SOCS5|EPHB2
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION%GOBP%GO:0032471,0.423324742268041,0.873470206885489,0.420103954780761,1.03318449453655,3941,6,THADA|ATP2A1
CHOLESTEROL TRANSPORT INVOLVED IN CHOLESTEROL STORAGE%GOBP%GO:0010879,0.485105256189594,0.9064456896937672,-0.7557895897662109,-1.01104277806167,3663,1,STARD4
MAMMARY GLAND DEVELOPMENT%GOBP%GO:0030879,0.79336620349619,0.9819233677232551,0.18141098756924104,0.7514653994017759,8849,29,TBX3|WNT4|OXTR|JAK2|LEF1|NRG1|AKT2|FGFR2|CSF1R|TGFB3|AKT1|LRP6|SCRIB|APLN
BRUSH BORDER ASSEMBLY%GOBP%GO:1904970,0.0409395973154362,0.402256981537283,0.9789920599911779,1.30054727576602,304,1,CDHR2
POLYADENYLATION-DEPENDENT SNORNA 3'-END PROCESSING%GOBP%GO:0071051,0.165202108963093,0.668049608148938,-0.473310574731749,-1.29920574715766,939,6,PARN|EXOSC6|EXOSC4|EXOSC5
IMIDAZOLE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0052803,0.523299851803063,0.925894107447705,-0.404243383336414,-0.929675332272888,3177,4,TRH
ORGANELLE DISASSEMBLY%GOBP%GO:1903008,0.0117850953206239,0.23571613961938698,-0.256417371047287,-1.61618412696005,33,57,SQSTM1|RB1CC1|CTSK|ATG13|MAP1LC3B2|ATG9B|MAP1LC3A|ATG3|ATG7|BECN1|GABARAPL1|GABARAP|PARK2|FBXO7|WIPI2|MAP1LC3B|KIF9|GABARAPL2|DYRK3|SPATA18
RESPONSE TO INTERLEUKIN-17%GOBP%GO:0097396,0.9079532356331301,1.0,-0.281200022059229,-0.646701305993913,5513,4,IL17RC|IL17RE|IL17RB|IL17RA
REGULATION OF ROOT DEVELOPMENT%GOBP%GO:2000280,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
POSTERIOR MIDGUT DEVELOPMENT%GOBP%GO:0007497,0.314974182444062,0.8164430838831159,-0.843239964711072,-1.12802781096499,2378,1,RET
REGULATION OF GLUCONEOGENESIS%GOBP%GO:0006111,0.222108590554109,0.73556947110949,0.323585579602045,1.22332596390948,2388,21,INS|OGT|C1QTNF3|FAM132A|CLK2|SDHAF3|PGP|GCK|SUPT20H|VIMP
"POSITIVE REGULATION OF WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:2000096",0.7412295936088921,0.974505008828563,0.42832347163817597,0.81419786164622,6401,3,MLLT3|DAB2
REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000278,0.962012400910447,1.0,0.112386807421719,0.612598937827156,12256,89,FGFR4|NAT10|PIF1|ATR|NVL|HMBOX1|RFC4|PNKP|PRKCQ|MEN1|SRC|NEK2|AURKB|MAP3K4|DSCC1|TNKS2|MAP2K7|WRAP53|CHTF18|HNRNPA2B1|TEN1
MODULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052040,0.0739338053680224,0.521028830085029,-0.6556554348425521,-1.50787052891972,448,4,CASP8|SERPINB9|BCL2L1|GAPDH
AMINE TRANSPORT%GOBP%GO:0015837,0.9217520415738679,1.0,-0.371546732837055,-0.635510787747598,6207,2,SLC18A2|SLC18A1
REGULATION OF ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0060408,0.533422818791946,0.9265056012720759,0.7364358182620201,0.9783221298299591,3973,1,PEBP1
REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0042659,0.0571381524781821,0.465205963201509,-0.681078696299564,-1.56633871916549,346,4,MESP1|FZD7|FGF2|DKK1
CELLULAR RESPONSE TO NERVE GROWTH FACTOR STIMULUS%GOBP%GO:1990090,0.435243682310469,0.878651088001772,-0.22905397946793202,-1.0045100929261601,1928,19,MAGI2|NTRK3|ACAP2|WASF1|AKT1|NGF|STMN2|MAPT|CIB1|KIDINS220|SH3GL2|RAPGEF2|NTRK2|RAB35|NTRK1|EHD1|RAP1A|RAPGEF1|TMEM108
N-TERMINAL PEPTIDYL-PROLINE DIMETHYLATION%GOBP%GO:0018016,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
POSITIVE REGULATION OF FEEDING BEHAVIOR%GOBP%GO:2000253,0.7715642005325921,0.979693198874896,0.41657139044448205,0.791858391569545,6663,3,NR4A3
BEHAVIORAL FEAR RESPONSE%GOBP%GO:0001662,0.790877655195126,0.9819233677232551,-0.325788717648334,-0.749245990944065,4802,4,ADCYAP1
INACTIVATION OF X CHROMOSOME BY GENETIC IMPRINTING%GOBP%GO:0060819,0.675697580178303,0.9647315640607691,0.453733318627992,0.8624993077582891,5835,3,PCGF3|PCGF5|PCGF6
REGULATION OF MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032763,0.47538405709447207,0.9012976954254781,0.613672197209136,1.00303034777689,3929,2,NR4A3
COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:0030199,0.472433886149709,0.898894483975796,0.240435123421433,0.9959632460693191,5269,29,DDR2|DPT|TGFB2|LOXL3|LOXL2|NF1|COL5A2|COL5A1|COL11A2|P3H4|COL12A1|COL11A1|COL1A1|LUM|COL3A1|SERPINH1|ATP7A|SCX
NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0033866,0.438285860918655,0.878999860395433,0.22149392522802497,1.01939377435037,5123,42,HACD1|SCD5|ELOVL6|SLC35B3|SLC26A2|PDHX|PDHA1|SLC25A1|ACACA|DLD|ACSS1|PANK3|PAPSS2|TECR
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO NON-ANTIGENIC STIMULUS%GOBP%GO:0002877,0.09108963325830802,0.5609783360513879,-0.9526907807675341,-1.2744435047311202,687,1,ADCYAP1
REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903764,0.30322802197802196,0.8055436753253159,-0.443445838683325,-1.12255369430849,1765,5,KCNE3|ANO6|DLG1
REGULATION OF NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0032817,0.9187217783952759,1.0,0.3374434034606811,0.6414444122651279,7934,3,PTPN22|HLA-E|IL18
REGULATION OF SA NODE CELL ACTION POTENTIAL%GOBP%GO:0098907,0.20503205515906603,0.7211951452265429,0.730650065633792,1.19422746014696,1694,2,RYR2|ANK2
PROTEIN COMPLEX OLIGOMERIZATION%GOBP%GO:0051259,0.763887923242717,0.978421368343614,0.13239266884822698,0.8587163199523091,10986,284,KIF25|HIST1H3E|SLC1A2|CTH|CRYZ|MGST1|TMEM120A|NOL3|DFFB|MAT2A|MCCC2|CBR4|ACTN2|TMCC1|SEPT11|RCC1|FSD1|IDE|LONP1|ADCY8|PKD2|KCNC3|KCNC1|BLM|HBB|GLS|TRIM27|APIP|ECT2|DISP1|TRAPPC11|DHRS4|HBA2|C1QTNF3|TRIM34|GBP5|SPTBN5|TK1|DPAGT1|GSDMD|DECR1|GBP1|APC|IKZF4|AKR1C1|POLQ|MCOLN1|CCL5|GOPC|HIST1H4I|HBA1|RAD51|ZBTB1|GRIN1|LY6G5C|ACACA|TRIM4|ASIC1|RPS19|SMARCAD1|CPSF6|STX2|DPYSL3|ELAVL1|MAGI2|NLRC4|ATPIF1|CD3D|TOR2A|PRMT1|PRF1|RIPK1|PANX2|HMGCR|MCCC1|CAT|SYT1|CD79A|MICU1|IGHMBP2|AASS|CD3G|CD3E|TRAF2|HIST1H3H|RASGRP1|QPRT|HMGCL|C2orf44|HBQ1|CRYAB|RIPK3|CPSF7|TRPV1|WIZ|TRIM21|PEX11B|OXA1L|IKBKE
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032211,0.7429161193469691,0.974505008828563,0.21182066089833,0.7865958657821579,7917,20,NAT10|PIF1|SRC|TEN1|CTC1|ACD|XRN1|EXOSC10|POT1
NEGATIVE REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1903026,0.0685096153846154,0.5037729184803449,-0.595260329912536,-1.50686199785447,398,5,HAND1|DDIT3|ZNF593|TMSB4X
INTERMICROVILLAR ADHESION%GOBP%GO:0090675,0.0409395973154362,0.402256981537283,0.9789920599911779,1.30054727576602,304,1,CDHR2
NEGATIVE REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061185,0.0673904408844168,0.502793556475766,-0.9653727393030441,-1.29140854733375,508,1,SFRP2
HISTONE EXCHANGE%GOBP%GO:0043486,0.243875561583453,0.7571583779245891,0.25112090727645603,1.18498363458623,2876,46,RBBP7|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|MIS18BP1|NASP|HJURP|STRA13|CENPM
SERTOLI CELL DIFFERENTIATION%GOBP%GO:0060008,0.695916852264291,0.96731875442989,-0.48183071408877903,-0.8241456312464399,4686,2,SCX|RAB13
NEURON MIGRATION%GOBP%GO:0001764,0.5286721864458761,0.9265056012720759,-0.16465195970419,-0.9518547622002299,1723,43,LRP12|POMGNT2|VEGFA|TUBB2B|DDIT4|NRP1|ELP3|SPOCK1|FGFR1|RELN|DYX1C1|DRD2|SEMA3A|RAC1
PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0018105,0.7653205941628721,0.9792236089291529,0.140667730252124,0.8203075111948029,10252,128,STK39|MAP3K10|CDC7|MAPK12|CDK1|MAP2K2|STK38|ATR|ERN1|MARK2|PDPK1|CDK5R1|PRKCB|PRKCQ|MAST1|NLK|AURKB|TBK1|DMPK|ULK1|SBK1|PLK1|MARK3|RIPK1|AKT3|PKN2|VRK2|AKT2|CLSPN|MAP3K12|VRK1|MAPK13|MAPK9|DCLK3|RPS6KA4|PRKDC|VRK3|RPS6KB1|CDK2|ATM|IKBKE|CHUK|AKT1|MAPKAPK5|PRKD1|MASTL|PINK1|TLK2|SGK2|MORC3|TAF1|MAST2|TOP1|WNK1|CSNK1E|MAPK14
NEGATIVE REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071441,0.0251006711409396,0.329326373353219,0.987924569916189,1.31241371669387,186,1,SIRT1
ESTABLISHMENT OF SKIN BARRIER%GOBP%GO:0061436,0.8385269121813029,0.989395884107905,0.305558788251021,0.704267710425048,7695,5,TMEM79|STMN1
MITOTIC CELL CYCLE ARREST%GOBP%GO:0071850,0.6190080929653461,0.9532238181782521,-0.23247982948168103,-0.8755145941222909,2982,13,GADD45A|MCPH1|CDKN1A
NEGATIVE REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903141,0.547067390440884,0.9305779599215391,-0.7207763564181741,-0.964204508267465,4131,1,S1PR3
SENSORY PERCEPTION OF SOUR TASTE%GOBP%GO:0050915,0.6700148196937261,0.964618776001639,-0.36039423339323795,-0.8288314478118759,4068,4,ASIC2|PKD2L1
RETROTRAPEZOID NUCLEUS DEVELOPMENT%GOBP%GO:0061451,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
INTRACILIARY RETROGRADE TRANSPORT%GOBP%GO:0035721,0.340819542947203,0.8345870842449541,-0.32004210522586496,-1.08275034587645,1729,10,DYNC2LI1|TTC21A|DYNC2H1|IFT122|WDR35|WDR19
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN NEPHRON MORPHOGENESIS%GOBP%GO:0072040,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
INSULIN METABOLIC PROCESS%GOBP%GO:1901142,0.0508825452168228,0.44304197231114795,0.656252481056145,1.51256468498128,466,5,CEACAM1|IDE|ERN1
METANEPHRIC DISTAL TUBULE MORPHOGENESIS%GOBP%GO:0072287,0.868264265854627,0.993084774742015,-0.5633546537273929,-0.75361669683053,6557,1,PKD1
DISRUPTION BY HOST OF SYMBIONT CELLS%GOBP%GO:0051852,0.917297698589458,1.0,-0.374155206518955,-0.6399724422795731,6177,2,GAPDH
SCLEROTOME DEVELOPMENT%GOBP%GO:0061056,0.0608760207869339,0.48170831577441997,-0.8513371932726771,-1.4561666743893102,409,2,MEOX1|SFRP2
RESPONSE TO LINOLEIC ACID%GOBP%GO:0070543,0.0350853965311797,0.381265913354899,-0.9821901191001321,-1.3139056690459299,264,1,CD36
POSITIVE REGULATION OF PRO-T CELL DIFFERENTIATION%GOBP%GO:2000176,0.39785234899328903,0.8638522656500329,0.8084472871636529,1.0739861536063802,2963,1,ZBTB1
CMP-N-ACETYLNEURAMINATE BIOSYNTHETIC PROCESS%GOBP%GO:0006055,0.127763802462598,0.6076669536424699,-0.934053815615351,-1.24951226821074,964,1,NANS
REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060398,0.439202440618871,0.879896414106183,0.44244568643542,1.01977171842077,4030,5,GHRL|JAK2
NEGATIVE REGULATION OF PROTEIN BINDING%GOBP%GO:0032091,0.768717568569311,0.9792236089291529,-0.124301289501356,-0.8272733826620831,2073,68,DVL1|ITGA4|DACT1|LEF1|AURKB|PIN1|STMN1|KDM1A|AURKA|CARD16|DAB2|SORL1|CAMK1|MITD1|AKT1|ADAM15|USP33|CSNK1E|PEX14|IFIT1|DNAJB2|ZFPM1|DDX11|SYMPK|ISL1|ROCK1|BAG2|TMC8|PDGFB|TFIP11|MAP2|HFE|PPP1CA|ITGB1BP1|IFIT2|AES|TTBK1|GTF2F1|MAPK8|DISC1|PTPRF|ACTB|GOLGA2|CRMP1|GSK3B|CTNNBIP1|TTBK2|FAM65B|CTSZ|GPSM1|PARK7|TMBIM6|BAX|PRKCD|NES|STYX|ARRB2|HSPA5|FAM192A|RUVBL2|LRPAP1|GNL3L|ADRB2|DKK1|B2M|RALB|MET|CAV1
REGULATION OF PHOSPHOLIPID SCRAMBLASE ACTIVITY%GOBP%GO:1900161,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
FAD BIOSYNTHETIC PROCESS%GOBP%GO:0006747,0.5008605851979351,0.9144253281295329,-0.7461954124393471,-0.9982083545275091,3782,1,FLAD1
REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:0050773,0.792967206637693,0.9819233677232551,-0.11951143173793699,-0.812551673849107,2006,74,CDK5|DCC|HECW2|CHRNB2|NEDD4L|DAB2IP|NSMF|SRGAP2C|CAMK1D|BHLHB9|YWHAH|EFNA1|ARC|FMR1|C21orf91|NEDD4|CHRNA3|RELN|COBL|SDC2|FOXO6
POSITIVE REGULATION OF BONE RESORPTION%GOBP%GO:0045780,0.41727019498607204,0.8709670999109399,-0.324850551368351,-1.0097769559981,2246,8,PRKCA|MC4R
CENTRIOLE REPLICATION%GOBP%GO:0007099,0.031396573178903,0.3625267385964289,0.466617507708271,1.6176363572701697,327,16,CEP63|CENPJ|WDR62|CEP152|CDK5RAP2|CEP72|SASS6|CNTROB|RTTN|CEP135|CDK2|C2CD3
ANTERIOR/POSTERIOR PATTERN SPECIFICATION INVOLVED IN URETERIC BUD DEVELOPMENT%GOBP%GO:0072099,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046884,0.0318120805369128,0.36484755247355394,0.9839545655050731,1.30713974294816,236,1,TBX3
CARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1905039,0.7771981489272191,0.9810334506628041,0.16278650135635,0.778608448205698,9236,49,SLC1A2|SLC25A29|SLC36A1|SLC25A22|LRRC8D|SLC25A10|CPT1B|SLC46A1|SLC25A1|ACACA|SLC38A6|SLC16A7|SLC5A6|MPC2|SLC38A10|SLC1A3|SLC1A1|SLC19A1|SLC38A1|SLC25A30|SLC23A2|SLC36A4|ARL6IP5
POSITIVE REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060332,0.7963864886095842,0.9828568923066779,-0.36649387890151097,-0.7437884382192671,5068,3,PARP9|TXK|NLRC5
REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0008593,0.7658881926926521,0.9792236089291529,0.15593375010751098,0.796021539236842,9411,65,DTX1|NOV|DLK2|MAML1|C8orf4|RITA1|POGLUT1|ROBO2|JAG2|TGFB2|DLK1
REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046890,0.2763197586727,0.7884684708511421,0.19743112349304798,1.1362352779078702,3663,120,FGFR4|NSMAF|SIRT4|SLC45A3|SIRT1|STAR|TM7SF2|FGF19|WNT4|CEACAM1|PRKAA2|ACADVL|NFYB|INS|ELOVL6|CLCN2|GPAM|PROX1|SCARB1|MVD|IDH1|PDK4|ZP3|APOE|ACACA|PTGS2|LPGAT1|SREBF2|GGPS1|ORMDL1|SMPD3|ADIPOR2|APOC1|IDI1|LDLR|HMGCR|PRKAB2|CNEP1R1|HSD17B13|DHCR7
GUANINE TRANSPORT%GOBP%GO:0015854,0.547785234899329,0.9305779599215391,0.7293228936921041,0.968872926868888,4080,1,SLC29A2
HINDLIMB MORPHOGENESIS%GOBP%GO:0035137,0.643833464257659,0.9624087012881211,-0.42092284173772404,-0.854250401139856,4097,3,AFF3
POSITIVE REGULATION OF MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:1905618,0.0492947290274685,0.435862257033585,-0.8641852770885029,-1.47814263365693,331,2,EIF4G1|AGO2
METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT%GOBP%GO:0072223,0.41728201099764295,0.8709670999109399,-0.49961398477997104,-1.01395173792756,2655,3,PDGFB|PDGFRB|CD34
POSITIVE REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000158,0.23778631007546697,0.7507739897770379,-0.8810652845169828,-1.1786278945536899,1795,1,TANK
FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA%GOBP%GO:0001325,0.0446060129691491,0.41504430757275895,0.497074388762308,1.5669561109647598,453,12,XRCC3|BLM|EXO1|DNA2|SLX1B|SLX4
ODONTOGENESIS OF DENTIN-CONTAINING TOOTH%GOBP%GO:0042475,0.0862030659853366,0.55013562738819,-0.329212428941995,-1.41619872537305,387,18,SERPINE1|LRP6|HDAC2|ROGDI|EDA|ITGB4|BMP2|HDAC1|TBX1|ANKRD11|STIM1|FOXC1|MSX1|FAM20A|ITGA6|WNT6|FAM20C|SCN5A
FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0002431,0.0024948024948025,0.12586582153175,-0.26140283181655605,-1.80716503384925,5,79,MYO10|MYO1G|PPAPDC1A|FCER1G|PRKCD|ABI1|GRB2|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|LYN|FCGR2B|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061097,0.0142487046632124,0.260455626851502,-0.272370641554894,-1.64987446673616,43,50,RAP2B|PRNP|EFNA1|DOCK3|PTPN1|ADAM17|SHC1|RELN|SNX6|SOCS5|ADRA2A|ACE|GPRC5B|CAV1
NEUROBLAST DIFFERENTIATION%GOBP%GO:0014016,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
PLASMA MEMBRANE INVAGINATION%GOBP%GO:0099024,0.462039045553145,0.8912739660615641,0.20637204036952303,1.0016634579499,5537,52,IGHV3-21|RHOBTB1|IGHV4-61|IGHG1|RAC3|IGLL5|IGHG4|ADGRB1|ARHGAP25|IGHV1-18|IGHV3-43|AURKB|IGHV1-24|ALKBH4|GULP1|IGHG2|SPIRE2|THBS1|SPIRE1|ELMO1|IGHV1OR15-1
REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051386,0.0215239591516104,0.30888933059776397,-0.8142118381088091,-1.65241873414572,136,3,DOK5|TMEM108
RRNA 3'-END PROCESSING%GOBP%GO:0031125,0.182350644279578,0.6875931283957409,-0.391218005295675,-1.26288677898053,933,9,RPSA|EXOSC2|EXOSC3|ERI1|RPS21|ERI3|EXOSC7|EXOSC8|EXOSC9
POSITIVE REGULATION OF STEROL TRANSPORT%GOBP%GO:0032373,0.41605486862442004,0.8709670999109399,0.30651309047813596,1.03926697020231,4306,15,SIRT1|ABCA7|ABCB4|LDLRAP1|APOE
LIPOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042158,0.688933601609658,0.96731875442989,-0.129767468586966,-0.884285325326062,1711,75,CLIP3|PIK3C3|ZDHHC3|PIGA|DPM1|PIGG|PIGZ|PIGY|DPM2|ZDHHC9|ZDHHC11B|MPPE1|ZDHHC7|ATG7|PIGT|PPM1A|ZDHHC4|WIPI2|GOLGA7|GLUL
DOXORUBICIN METABOLIC PROCESS%GOBP%GO:0044598,0.0751718213058419,0.524840022194793,0.593141402246151,1.4587448961012701,699,6,AKR1B1|CBR4|AKR1C1
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905067,0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
NEGATIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048261,0.698709677419355,0.96731875442989,-0.206162498256746,-0.8221944613943921,3248,15,SDCBP|PSEN1|UBQLN2|ARF6|PICALM|MTMR2|NECAB2|LRPAP1|RAC1
REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045076,0.763208762886598,0.978421368343614,0.30993291805738205,0.7622348745811429,7106,6,GLMN|FOXP3|PTPRC|CD4|CD86|IL1B
"RETROGRADE TRANSPORT, VESICLE RECYCLING WITHIN GOLGI%GOBP%GO:0000301",0.40966442953020094,0.867015886388254,0.802492280546978,1.06607519298781,3051,1,GOLGA5
POSITIVE REGULATION OF PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:1903638,0.41489932885906006,0.8695737743071128,0.799735333039259,1.06241271121996,3090,1,PDCD5
PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018394,0.473854916541413,0.8998407605598371,0.18560378965884902,0.9959302622603821,5989,82,CPA4|SIRT1|JADE3|AK6|KAT2A|NAA40|TADA1|OGT|TAF6L|YEATS4|TRRAP|MAP3K7|EP400|LEF1|ING5|APBB1|YEATS2|BRPF3|ATAT1|MSL1|KAT8|BRCA2|BAG6|SUPT3H|WDR5
AMEBOIDAL-TYPE CELL MIGRATION%GOBP%GO:0001667,0.9359024162846709,1.0,0.118389657402122,0.652878672710758,12045,95,SEMA3D|EGR3|CXCL13|NOV|NR4A1|PIK3R3|MIA3|SEMA5A|ITGA4|AMOT|AMOTL2|ANLN|SEMA3E|LOXL2|KIT|NUP188|SEMA4G|CENPV|SEMA6A|PDXDC1|SEMA4C|SRF
DETERMINATION OF BILATERAL SYMMETRY%GOBP%GO:0009855,0.018032268269535,0.283230741510052,-0.273495818819529,-1.6334928664415902,56,47,DNAI1|LRRC6|CCDC103|KIF3B|TBX20|MKKS|DYX1C1|GREM1|SOX17|DNAAF1|BBS7|NBL1
DOLICHYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006489,0.0478096040438079,0.43054641249021397,0.594467482016131,1.54727395800061,453,7,MVD|SRD5A3|DPAGT1|DOLPP1
NEGATIVE REGULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0052403,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007215,0.159140834757139,0.661359103221672,-0.262914493211166,-1.26027062838977,651,24,FMR1|GRM2|HOMER2|PLCB1|GRM8|HOMER1
POSITIVE REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:2000637,0.21525270758122697,0.732094216765764,-0.27308307331012,-1.19759850487869,953,19,LIMD1|EIF4G1|FMR1|AGO2|STAT3|TP53|MAP2K1
CELLULAR RESPONSE TO MAGNESIUM ION%GOBP%GO:0071286,0.999371563236449,1.0,-0.22421969780522802,-0.45504721483592203,6360,3,ANK3|SLC41A1|FBP1
POSITIVE REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900135,0.32093959731543603,0.822183858873702,0.8434605205116891,1.12049967205817,2390,1,F2RL1
POSITIVE T CELL SELECTION%GOBP%GO:0043368,0.9357437610532521,1.0,0.185385388728953,0.584400995745766,9523,12,SLAMF6|CD3D|CD3G|CD3E|ZAP70|ZFPM1|FOXP3|LY9
POLYOL METABOLIC PROCESS%GOBP%GO:0019751,0.0515196441808747,0.4457514150034171,-0.21147740264812,-1.40746429057273,138,68,SPHK1|NUDT4|INPP1|ITPK1|INPP5K|FGF2|INPP5A|SGPP2|PLCD1|ITPKB|SORD|ACER3|SPR|TPI1|PLCB4|PLCB1|ASAH2|QDPR|ASAH2B
REGULATION OF NEUTROPHIL DEGRANULATION%GOBP%GO:0043313,0.274941084053417,0.7884684708511421,-0.566615197970663,-1.1499287094046,1749,3,SYK|ITGB2|ITGAM
REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900363,0.3635159010600711,0.849828746111777,-0.250503035045867,-1.0540879592833599,1645,17,NELFE|HSF1|NCBP2|NUDT21
ENDOTHELIAL TIP CELL FATE SPECIFICATION%GOBP%GO:0097102,0.19049740163325898,0.698434241409875,-0.7433691756272399,-1.2714931626039399,1282,2,DLL1|NRP1
REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035304,0.0763714593044102,0.52629264794328,-0.21028116835561103,-1.34922578352817,212,61,PPP1R8|GBA|MFHAS1|AKAP6|PPP2R5A|ENSA|PPP1R15B|PPP6R1|PPP1R2|PRKCD|FKBP1B|NSMF|DLC1|MGAT5|ARPP19|YWHAB|LGALS3|CAMTA1|PPP1R7|YWHAE|HTT|PPP1R11|HSP90AB1|TNF|FKBP1A
RNA LOCALIZATION TO NUCLEUS%GOBP%GO:0090685,0.9194711538461541,1.0,-0.25215089344804803,-0.638303243083146,5354,5,WRAP53|CCT2|DKC1|CCT4|TCP1
POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048711,0.0545546558704453,0.45643561302544805,0.535584275485978,1.528374525526,538,9,HES1|SERPINE2|AGER
PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:0006626,0.18717277486911,0.6940517434063481,-0.196735723657619,-1.19886832325932,571,51,TOMM40|TSPO|MFF|NDUFA13|TIMM10|FIS1|DNAJC15|GRPEL1|TIMM8B|TOMM5|SLC25A6|HSP90AA1|HSPA4|TOMM34|TOMM22|TIMM50|ROMO1|SAMM50|TOMM20|TIMM10B|AIP|C19orf52|TIMM23|MFN2|PMPCA|DNLZ|TIMM22|TIMM23B|FBXO7
REGULATION OF PROTEIN REFOLDING%GOBP%GO:0061083,0.780400890868597,0.981487311948134,-0.44653389974633595,-0.7637723206901509,5255,2,BAG5
NEGATIVE REGULATION OF GLUCONEOGENESIS%GOBP%GO:0045721,0.00536437246963563,0.168826383791782,0.648671317458743,1.85108630409985,52,9,INS|C1QTNF3|FAM132A|CLK2|PGP|GCK
REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002831,0.999366085578447,1.0,0.0742824116070724,0.39748329755526296,12611,81,TRIM5|AIM2|CEACAM1|ANKRD17|SIGIRR|DHX9|TKFC|KLRK1
NEGATIVE REGULATION OF COAGULATION%GOBP%GO:0050819,0.296520963425513,0.8013070063650121,0.272800009579991,1.14383168286985,3323,30,EDN1|CEACAM1|SERPINE2|HS3ST5|PLAT|F12
GLYCINE RECEPTOR CLUSTERING%GOBP%GO:0072579,0.041744966442952995,0.402998391331252,0.9785509483899429,1.29996127868316,310,1,GPHN
RNA EXON LIGATION%GOBP%GO:0000378,0.22957765126439802,0.743365122901021,-0.884483899426555,-1.1832010799509198,1733,1,RTCB
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000725,0.3980645161290321,0.8638522656500329,-0.25708195080470997,-1.02526578724743,1850,15,IGF1|SOX6|DKK1|GREM1
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903169,0.135044173327724,0.622258254449182,-0.17950459757257997,-1.24367304952665,320,80,CX3CL1|FKBP1B|PTK2B|CRHR1|FYN|SESTD1|SLC9A1|PLN|UBASH3B|PRNP|APLNR|HAP1|BIN1|CRACR2A|CEMIP|SNCA|FMR1|PDE4B|GNB5|JPH3|YWHAE|HTT|ADRA2A|JPH1|PDE4D|STAC|FKBP1A
DEFENSE RESPONSE TO GRAM-POSITIVE BACTERIUM%GOBP%GO:0050830,0.675847997959704,0.9647315640607691,-0.17154248893282198,-0.85483002503113,2649,27,ROMO1|FGR|IL6|PLA2G2A|ADAM17|PPP1R11|HIST1H2BC|MYD88
NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038007,0.158619891165914,0.6608477036716949,0.6697364067497521,1.27309845560579,1369,3,SHTN1|UNC5A|PTK2
CELL-CELL SIGNALING INVOLVED IN CELL-CELL JUNCTION ORGANIZATION%GOBP%GO:1901350,0.9373758771349129,1.0,-0.528561976179974,-0.7070734712555021,7079,1,TJP1
REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010749,0.923646907216495,1.0,0.249187276269833,0.612839815355098,8600,6,INS|THBS1
EPITHELIAL CELL MIGRATION%GOBP%GO:0010631,0.564419343452171,0.9380162603437769,-0.147718895299987,-0.941042612238188,1598,59,VEGFA|PKN1|KDR|RAB13|ABL1|RHOA|NRP1|FGF2|PXN|PTP4A3|ID1|NOS3|SCG2|GREM1|MYH9|CDH13|PRSS3
REGULATION OF PURKINJE MYOCYTE ACTION POTENTIAL%GOBP%GO:0098906,0.8529061300145641,0.991298302704726,-0.5721217468019411,-0.765344704542779,6441,1,GJA5
RESPONSE TO LIPID%GOBP%GO:0033993,0.0993914807302231,0.570215774831708,-0.128824949467173,-1.17734766195822,48,322,ADNP2|IL1RN|INSIG1|GPER1|AHR|OTUD5|TESC|TADA3|PPARD|CD274|IL1B|RARA|IRAK1|PDK3|SCD|PIM1|MTDH|SIRPA|CTNNB1|WBP2|DAB2IP|TGFBR1|TRIB1|LGALS9|PTK2B|TNFAIP3|NR1H3|PTGFR|RET|RHOA|ZNF703|IFNAR1|TNFRSF1B|BCL10|CCRN4L|PPARA|RXRA|VIM|PTK7|YWHAH|IL6|PPARG|LYN|SBNO2|SMAD2|SLC11A1|POU4F2|VPS4B|RUVBL2|FOXP1|WNT6|WNT11|LDOC1|SNCA|PDE4B|DGAT2|TNFRSF11A|MSN|NRIP1|NEDD4|NR1H2|PPARGC1A|PDCD4|ADAM17|CXCL8|NLRP3|NR3C1|CTSH|JUN|STAT3|KLF9|UBE2L3|TWF2|ADCY2|NOS3|ADCYAP1|WNT3|ABCG1|TNIP2|ASCL1|RNF4|TICAM1|PMVK|NR1D1|NR1D2|LIAS|CD36|AQP1|TNF|BCL2L11|CAV1|SLIT3
NEGATIVE REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901340,0.820998278829604,0.987153241368501,-0.58706440229378,-0.7853339503919591,6200,1,UBQLN1
REGULATION OF TELOMERIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:1905547,0.13973154362416101,0.6281603901381739,0.9311865902073221,1.23703984191138,1040,1,SIRT6
SEMINAL CLOT LIQUEFACTION%GOBP%GO:0070684,0.8582020389249309,0.99166790097654,-0.569199382443758,-0.7614353686386959,6481,1,KLK14
DOXORUBICIN TRANSPORT%GOBP%GO:1900753,0.439295644114921,0.879896414106183,-0.778617115130128,-1.04157985474639,3317,1,RALBP1
POSITIVE REGULATION OF PENILE ERECTION%GOBP%GO:0060406,0.221501390176089,0.73556947110949,-0.8884539038376709,-1.1885118758960902,1672,1,VIP
REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045402,0.8071269487750559,0.984682960940884,-0.43584229390681,-0.745484901507423,5435,2,ZFPM1|CD86
NUCLEAR PORE DISTRIBUTION%GOBP%GO:0031081,0.45999768438115096,0.890371861972445,0.531122344080001,1.00960770412266,3972,3,NUP133|NDC1
SINOATRIAL NODE DEVELOPMENT%GOBP%GO:0003163,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
NEGATIVE REGULATION OF TELOMERE CAPPING%GOBP%GO:1904354,0.43661460225208903,0.878651088001772,-0.342471042471042,-0.9990032249461591,2403,7,ATM|RAD50|NBN|ERCC4|SMG6|TERF2|ERCC1
CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0008203,0.20807740849810702,0.7238327250928481,0.254453089838185,1.21705008566011,2472,49,TM7SF2|FDX1|EBP|CLN6|MVD|LBR|DHCR24|SOAT1|PPAPDC2|CETP|OSBPL5|LDLRAP1|APOE|NSDHL|GGPS1|HMGCR|ARV1|MSMO1|DHCR7|ACAT2|HSD17B7|LCAT
TUBE DEVELOPMENT%GOBP%GO:0035295,0.00880281690140845,0.207373329593493,-0.151540566602232,-1.3674033852802399,4,296,BCAS3|CTNNB1|DAB2IP|SKI|TGFBR1|PTK2B|ACVR1|HMOX1|PDPN|DLC1|CELSR1|PRKD2|PRICKLE1|CEBPA|EIF2AK3|COL23A1|RET|CALCRL|CITED2|FGF7|RHOA|NRP1|ITGA5|AAMP|BCL10|ATP6AP2|CLIC4|APOD|FGF2|ADAMTS9|PODXL|ITGA6|MICAL2|APLNR|NFIB|PAX8|SERPINF2|CLMP|WNT11|SMAD7|RAMP2|NPNT|FGFR1|LEPR|ATOH8|CCDC103|CXCL8|CTSH|ID1|ADM2|TBX20|MKKS|RBPMS2|SCG2|COBL|FLT1|CHI3L1|MCAM|FGF10|GREM1|MYH9|SFRP2|BMPER|ASCL1|ACVRL1|MET|ATXN1L|ADM|PGF|SOX17|CDH13|TNF|HECA|DNAAF1|BBS7|RBPJ|CAV1|DACT2|EPHB2|RAMP1
INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032958,0.9329152200694371,1.0,0.28990758913946196,0.6143418748023289,8329,4,PPIP5K2|PPIP5K1|IPPK
MALE GAMETE GENERATION%GOBP%GO:0048232,0.144455144825543,0.634231615444277,0.21013681497660297,1.24072067757071,1949,139,HSPA2|INSL3|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|ARNTL|CCNA1|HERC4|CCT6B|CABYR|GGT1|PYGO1|USP9Y|PIWIL4|TRIM27|MTL5|TSSK3|SPATA25|JAG2|PCSK4|WDR33|CASC5|DAZAP1|TYRO3|YTHDC2|PTTG1|KIT|DNAH1|PIM2|CLOCK|METTL3|REC8|SRPK1|FANCF|MYBL1|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|TEX14|MYCBP|UBE2B|UBR2|CDK16|ABHD2|AZIN2|ZNF35|C1orf111
APOPTOTIC CELL CLEARANCE%GOBP%GO:0043277,0.330549821730156,0.8293509737209019,0.30008527504114696,1.11436644437044,3522,20,RHOBTB1|RAC3|ADGRB1|SCARB1|TYRO3
RRNA 5'-END PROCESSING%GOBP%GO:0000967,0.32914375490966197,0.828303707528737,-0.5401540234430939,-1.0962265418969201,2094,3,NOP14
NEGATIVE REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903526,0.580846325167038,0.942746898746279,-0.529473393989523,-0.90563588363794,3911,2,WASL|DNM2
REGULATION OF CHONDROCYTE DEVELOPMENT%GOBP%GO:0061181,0.0460329929300864,0.421305382128188,-0.7686665931399579,-1.55998601269009,292,3,PTHLH|FAM101B|FAM101A
POSITIVE REGULATION OF SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0045887,0.619731543624161,0.9532238181782521,0.694309660344067,0.9223594084171041,4616,1,AGRN
"FAST, CALCIUM ION-DEPENDENT EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:0098746",0.581208053691275,0.9430181813638879,0.7133877370974859,0.9477037822506741,4329,1,SYT1
MITOCHONDRIAL THREONYL-TRNA AMINOACYLATION%GOBP%GO:0070159,0.741162452005826,0.974505008828563,-0.6247243052492281,-0.8357127508162769,5597,1,TARS2
PERICARDIUM DEVELOPMENT%GOBP%GO:0060039,0.32818743189248106,0.828303707528737,-0.37170435741864294,-1.08427810161252,1806,7,LRP6|DLL4|FLRT3|BMP7|BMP2|NOTCH1|TBX20
THREONINE TRANSPORT%GOBP%GO:0015826,0.843638289421422,0.991298302704726,-0.575981473312748,-0.770507978378361,6371,1,SLC1A4
PROLINE TRANSPORT%GOBP%GO:0015824,0.0696230115493572,0.5065946660817761,0.633958101386522,1.46117944479512,638,5,SLC36A1|SLC6A17|SLC6A15
DETECTION OF BIOTIC STIMULUS%GOBP%GO:0009595,0.965022597759874,1.0,0.17011341700768098,0.5362582831938,9821,12,SCARB1|NLRC4|CD1D|C4B
REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000772,0.20304106346171397,0.7175864987119879,0.31217961169301195,1.24399084546181,2229,25,SIRT1|NUAK1|ARNTL|CDK6|CDKN2A|TERT|VASH1|FBXO5|ING2|AKT3
HISTONE DEUBIQUITINATION%GOBP%GO:0016578,0.9884194923105429,1.0,0.12137462150729698,0.46483664520238,10668,22,KAT2A|TRRAP|BRCC3|MYSM1|SUPT3H|UIMC1|USP49|USP21
PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009221,0.7010320134793601,0.9687742969986379,0.30919661243320196,0.804773819919253,6656,7,DTYMK|DUT|HDDC2|TYMS
POSITIVE REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0032812,0.14092173702673302,0.6296802030037281,0.7732823997609649,1.2639088390991,1164,2,CARTPT
RESPONSE TO MERCURY ION%GOBP%GO:0046689,0.218856718634002,0.7341474817293291,-0.726826578439482,-1.24319793607912,1473,2,PARK7|AQP1
REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034091,0.543100759072476,0.929698169790548,0.34383509939734497,0.937386726239516,5222,8,NAA10|FAM178A|ANKRD32|ATRX|TNKS
NUCLEOID ORGANIZATION%GOBP%GO:0090143,0.551436515291937,0.932156795932405,-0.7185156594618441,-0.961180305020909,4164,1,CHCHD10
REGULATION OF SYNAPSE MATURATION%GOBP%GO:0090128,0.779550827423168,0.981487311948134,-0.22300171065439198,-0.754448166036399,3956,10,RELN|YWHAZ
REGULATION OF HAIR CYCLE BY CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060901,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0070588,0.286973088830674,0.796019542850327,0.212907697682418,1.1339659713999901,3614,79,RYR2|CACNA1G|NOL3|SLC8A3|F2R|PKD2|IBTK|ATP2A1|CACNA2D1|CCR5|CACNA1D|CCL21|MCOLN1|NALCN|GRIN1|CCL19|TRPM7|ATP2A2|TRPC1|SPG7|SLC24A1|SLC8A1|MICU1|SLC8A2|LCK|MICU3|TRPV1|ITPR2|MCUR1|TRPC4AP|CHERP|MCOLN2|MICU2|MCU|FAM155B|XCL1|STOML2|P2RX7|SLC24A3|C2orf47|GRIN2D|TRPM2|FAM155A|P2RX4|ATP2C1|ITPR1|SLC8B1
REGULATION OF POSTSYNAPSE ORGANIZATION%GOBP%GO:0099175,0.109447318268445,0.584695818659266,-0.25046782668184503,-1.3396949139115202,401,33,BHLHB9|FYN|FCGR2B|PRNP|EFNA1|ARC|CRIPT|RELN|ARHGAP22|HOMER1
L-FUCOSE METABOLIC PROCESS%GOBP%GO:0042354,0.0044229149115417,0.155321503601441,0.704831306259653,1.8345278050541398,41,7,FUT9|FUT7|FUT2|FUT8|FUT10
POSITIVE REGULATION OF ISOMERASE ACTIVITY%GOBP%GO:0010912,0.7206192080876159,0.9713637233549571,0.30359433133684305,0.790192259265341,6842,7,DHX9|UHRF1
NECROPTOTIC PROCESS%GOBP%GO:0070266,0.26838480337702697,0.7834868198002729,-0.26696672846409997,-1.14843155157574,1207,18,PPIF|PGAM5|ITPK1|CYLD|MLKL|TICAM1|TNF
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000009,0.5620567375886529,0.9368177970215049,-0.266978607393309,-0.9032285901653778,2852,10,GPM6B|PICALM|NEDD4L|LEPROT|COMMD1
OUTFLOW TRACT SEPTUM MORPHOGENESIS%GOBP%GO:0003148,0.883134994421718,0.996316041142784,0.17436141843346398,0.659179097338223,9498,21,TBX2|BMP4|ROBO2|TGFB2|GATA6|FGFR2|NRP2
NEGATIVE REGULATION OF TISSUE REMODELING%GOBP%GO:0034104,0.398149110949361,0.8638522656500329,0.38680348278669996,1.05453006706699,3828,8,CARTPT
'DE NOVO' GDP-L-FUCOSE BIOSYNTHETIC PROCESS%GOBP%GO:0042351,0.5655530809205639,0.938638245695344,-0.5357595809208711,-0.916388069717374,3808,2,GMDS|TSTA3
ACTIN CORTICAL PATCH ORGANIZATION%GOBP%GO:0044396,0.22337434094903302,0.7360157208449051,-0.441453863548618,-1.21176121398169,1270,6,WAS|WASL|WIPF3|TIGD5|WIPF2|WIPF1
REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902003,0.17712093862815897,0.6816871635186941,-0.284568730203563,-1.24796854560075,784,19,TMED10|PICALM|CLU|CASP3|PRNP|EFNA1|CHRNA7|HAP1|BIN1
CHOLESTEROL IMPORT%GOBP%GO:0070508,0.6432774024842011,0.9621972042482541,0.37321239621836,0.8601992477173391,5903,5,SCARB1|STARD5|LDLR
NEGATIVE REGULATION OF CELL KILLING%GOBP%GO:0031342,0.7983209683717299,0.9835585148939309,-0.22959494977324602,-0.741153072364831,4088,9,LGALS9|ARRB2|FCGR2B
ASTROCYTE DIFFERENTIATION%GOBP%GO:0048708,0.8540197461212979,0.991298302704726,0.23006870317987804,0.6789921816829569,8476,10,CDK6|EIF2B5|NF1
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT%GOBP%GO:0070296,0.132476832350463,0.617839712913552,0.521739671146937,1.35797874642965,1257,7,RYR2|NOL3|CCR5|ATP2A2
SPECIFICATION OF URETERIC BUD ANTERIOR/POSTERIOR SYMMETRY%GOBP%GO:0072100,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
NUCLEAR DNA REPLICATION%GOBP%GO:0033260,0.030717627328096,0.35952485149978897,0.367427260838284,1.58380396194747,347,33,RFC4|DNA2|CDC45|POLD1|DONSON|FEN1|ZNF830|POLD3|POLA2|WDR18|LIG1|BRCA2|PRIM2|GMNN|ACD|RFC3|GINS1|RFC5
RIBOSE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019693,0.909980430528376,1.0,-0.0914187024870525,-0.8254311821200929,464,311,PFKL|DERA|COX5B|GPI|MOCS3|NDUFB10|SDHC|GMPS|GTPBP1|GUCY1A3|UQCRC1|PRPS1|ACOT11|NUDT4|G6PD|PKM|ACOT9|ENO1|SULT4A1|TPST1|MT-ND5|PGD|ACSL4|HPRT1|ATP5I|EFTUD1|COX4I1|PRPSAP1|NUDT18|PDHB|GAPDH|PGK1|PANK2|DGAT2|TDO2|NDUFB9|CYC1|HK1|HK2|TPI1|PDE9A|NDUFA9|OGDH|ACLY|NDUFS1|NDUFV3|ADCY2|ADCYAP1|NDUFS5|ALDOA|COX10|TKT|SLC25A13|ACOT8|RHOQ|ACSL3|PMVK|ADM|COX4I2|NDUFS6|PDE4D|PGAM2|AK4
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN%GOBP%GO:0050966,0.0138255033557047,0.256136946817111,0.993493603881782,1.31981192986494,102,1,SCN1A
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY VASOPRESSIN%GOBP%GO:0001992,0.0939597315436242,0.562743160240921,0.95351786501985,1.26670594423102,699,1,OXTR
HOMEOSTASIS OF NUMBER OF CELLS%GOBP%GO:0048872,0.968033527816583,1.0,0.114957782659266,0.574851654655164,11779,59,DOCK10|NOV|INHA|F2R|NAPEPLD|FLVCR1|JAK2|TAL1|MED1|KIT|RPS24|RPS19|ATPIF1
REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051223,0.0339506172839506,0.376148295095164,-0.134286098526777,-1.2489287449481399,10,394,PLK3|CX3CL1|ADRA2C|BCAS3|PRKCD|TMEM30A|UBE2J1|LGALS9|ITGAM|TNFAIP3|NR1H3|UBL5|OS9|PARL|PFKL|SSC5D|FGR|GPI|MYO1C|ATG13|STXBP4|ANO1|FYN|FAM65A|BAG4|INPP5K|ICE1|RAB11FIP1|TCF7L2|TNFRSF1B|UHMK1|VPS11|ARL2BP|APOD|GCC2|MYRIP|IL6|CSNK2A2|SLC25A4|FCGR2B|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|PANX1|MIEF1|VAMP3|MBP|IGF1|MAVS|UQCC2|MYOM1|FOXP1|CEMIP|RIPK2|BAP1|RAP1A|LEPROT|TMSB4X|ZPR1|DPH3|PDCD10|GAPDH|PTPN1|KARS|BAG3|GIPR|NLRP1|NLRP3|PRKCA|TP53|RANGAP1|UBE2L3|YWHAE|TNFRSF4|UBE2D3|SIAH3|DRD2|PPP1R11|CABP1|ARIH2|PARK2|ADRA2A|SLC2A1|PER2|RAB11FIP5|ACSL3|CD22|NR1D1|CACNA1E|BCAP31|TWIST1|PIK3R1|TNF|SNX12|SNAP25|TNFRSF21|INHBB|TRH
GOLGI CALCIUM ION HOMEOSTASIS%GOBP%GO:0032468,0.9459060402684559,1.0,0.529995588883988,0.704075495052827,7046,1,ATP2C1
ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0001736,0.390269587194608,0.8607749921056059,0.40861395503557796,1.06353627511795,3705,7,BRSK2|C5orf42|VANGL2|BRSK1
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:1905168,0.517933848797251,0.9236031517100541,0.387252695317031,0.9523916062105309,4822,6,MMS19|BLM|WRAP53|C5orf45|WAS
VALINE METABOLIC PROCESS%GOBP%GO:0006573,0.9810637246830229,1.0,-0.233496939281972,-0.536994181129286,5957,4,BCAT2|HIBADH|ALDH6A1|BCAT1
MONOCARBOXYLIC ACID TRANSPORT%GOBP%GO:0015718,0.209043736100815,0.7243363294845151,-0.175799221362005,-1.17001213027577,563,68,ATP8B1|STRA6|PPARD|SLC16A1|ACSL1|SLCO1A2|SLC16A8|SLC27A5|PPARA|RXRA|PPARG|FABP4|SLC16A3|SLC10A4|ABCC4|DRD2|BDKRB2|ACE|SLC9A3R1|ACSL3|CD36|MID1IP1|FABP3
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060043,0.15260395639887,0.648319130045528,-0.37096507676007795,-1.30547232339294,755,11,NOTCH1|PIM1|TGFBR1|FGF2|TBX20|RBPJ
REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090036,0.547637641546271,0.9305779599215391,-0.283918398196516,-0.916514031916088,2804,9,VEGFA|MYADM|ULK4|WNT11
SENSORY PERCEPTION OF TOUCH%GOBP%GO:0050975,0.909664429530201,1.0,0.546923246581385,0.7265631331074691,6776,1,P2RX4
ESOPHAGUS SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014846,0.38634001484780994,0.8596647264526249,-0.622967688710412,-1.06555286752388,2601,2,SULF2
RESPONSE TO ANTIMETABOLITE%GOBP%GO:0097329,0.608805668016194,0.9508825506493929,0.309458952196657,0.883090114630749,6014,9,BLM|DHFR|TIMELESS|SPIDR|DDX11|ATRX|KAT7
POSITIVE REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071673,0.880180060902952,0.9956508825790341,-0.5584472871636529,-0.7470519629538621,6647,1,AIF1
ECTODERM DEVELOPMENT%GOBP%GO:0007398,0.264620414093716,0.776879751428121,-0.397443793108128,-1.1593611774736399,1456,7,ITGAM|ITGA6|EDA2R
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098901,0.857884009634982,0.99166790097654,0.179719768788408,0.6882850250134739,9259,22,RYR2|AKAP9|FGF13|CXADR|ATP2A2|ANK3
REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION%GOBP%GO:0060304,0.8885378078012641,0.997300970905927,0.282806183861718,0.651826330187942,8154,5,MTMR4|MTMR1|MTMR3|MTMR9
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM MEMBRANE%GOBP%GO:0097051,0.458130400628437,0.890371861972445,-0.48428366604169004,-0.982839311531989,2915,3,RAB3GAP2|RAB3GAP1|RAB10
CLATHRIN-COATED PIT ASSEMBLY%GOBP%GO:1905224,0.5314444591553029,0.9265056012720759,-0.729378032642259,-0.975711232815332,4013,1,GAK
REGULATION OF LUNG BLOOD PRESSURE%GOBP%GO:0014916,0.8796504700119159,0.9956508825790341,-0.5586678429642701,-0.7473470071730379,6643,1,BMPR2
REGULATION OF PLASMA MEMBRANE RAFT POLARIZATION%GOBP%GO:1903906,0.569575003309943,0.940076901516441,-0.709142037935598,-0.948640925705926,4301,1,GSN
MAMMARY GLAND BUD MORPHOGENESIS%GOBP%GO:0060648,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000465,0.38804920913884,0.859991269020751,-0.375323175760824,-1.0302369163551601,2207,6,INPP5K|IGF2
MITOTIC G2/M TRANSITION CHECKPOINT%GOBP%GO:0044818,0.0180428979103378,0.283230741510052,0.434975871661449,1.69170958601237,195,23,TAOK3|BLM|ORC1|DONSON|ZNF830|NAE1|CDC6|MSH6|TAOK1|TOPBP1|BRSK1|CLSPN|CDK5RAP3|TAOK2|C5orf45|RAD17|ATM
POSITIVE REGULATION OF LENS EPITHELIAL CELL PROLIFERATION%GOBP%GO:2001111,0.9157950483251691,1.0,-0.540968239964711,-0.7236697085841569,6916,1,SOX11
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0060351,0.152164310954064,0.648319130045528,-0.30624444595049,-1.2886414051419,688,17,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COMP|COL21A1|STC1
NUCLEAR RETENTION OF UNSPLICED PRE-MRNA AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071048,0.9061618411284341,1.0,-0.38285084091535704,-0.65484585920623,6102,2,EXOSC10|PRPF18
MODULATION OF DEVELOPMENT OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044145,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045651,0.7192200557103071,0.9713637233549571,-0.256384797837719,-0.796955583526778,3872,8,RIPK1|CSF1|FADD|IL34|CASP8|TGFB1|LIF|PRKCA
PROLINE CATABOLIC PROCESS%GOBP%GO:0006562,0.735115070527097,0.974251014964729,-0.46506754893851704,-0.795473135034616,4950,2,PRODH|ALDH4A1
REGULATION OF T CELL ACTIVATION%GOBP%GO:0050863,0.950389948006933,1.0,0.11048841294728098,0.6779981855830429,13160,183,SH3RF1|CD47|IDO1|PAG1|CEACAM1|GLMN|CD209|SIRPG|KAT2A|BMP4|GRAP2|AGER|BLM|CD2|KLRK1|PAK3|PDPK1|MARCH7|DOCK8|CCDC88B|PRKCQ|LOXL3|SRC|CCL21|CARD11|SIT1|EBI3|CCL5|ZP3|DLG5|ZBTB1|TIGIT|IL7|CCL19|CCL2|METTL3|TMIGD2|BTN2A2|CD55|IL12RB1|LAT|CD1D|RASAL3|TNFAIP8L2|PLA2G2D|TESPA1|CEBPB|SOCS1|HLA-DMB|IGFBP2|CD3E|PTPN22|CD46|ZAP70|CTLA4|ZNF683|LCK
REGULATION OF MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000527,0.319865771812081,0.8219996514077841,0.843625937362153,1.12071942096424,2382,1,CCL21
GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0005980,0.9399556719725971,1.0,0.196045826853635,0.578581883782405,9329,10,GAA|AGL|PYGL|PGM2L1|PGM2|PYGM|PGM1
PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:0097090,0.46777590564448207,0.895691614450025,0.382794289084562,0.996333109362285,4441,7,PTPRD|NLGN4Y|NLGN3|NLGN2|CNTN2
REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:1902033,0.6932323398649761,0.96731875442989,-0.353989110219407,-0.8141010025891658,4209,4,ACE
MULTICELLULAR ORGANISM AGING%GOBP%GO:0010259,0.248496563573883,0.7613646381106121,0.488274009537853,1.2008388161996102,2313,6,IDE|CISD2|MSH6
POSITIVE REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0045834,0.653575661793757,0.9640743070248079,0.16342833341180898,0.88029519770748,8270,84,NSMAF|SIRT4|SLC45A3|STAR|NR4A3|WNT4|INS|AGTR1|SCARB1|CCL21|ZP3|LDLRAP1|PNPLA2|PTCHD2|KIT|APOE|AMBRA1|PTGS2|CCL19|LPGAT1|SMPD3|APOC1|LDLR|IRS1|AKT2|CNEP1R1|HSD17B13|DGKZ
CD40 SIGNALING PATHWAY%GOBP%GO:0023035,0.0341499628804751,0.377541745836815,-0.884808381582575,-1.51341734939121,229,2,RNF31|TNIP2
NEGATIVE REGULATION OF ODONTOGENESIS%GOBP%GO:0042483,0.299745977984759,0.802472218138634,0.6870661450182379,1.12299073922118,2477,2,ASPN|BCOR
NEGATIVE REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046642,0.281692698873956,0.789893800550555,-0.391340319911749,-1.1415570753733302,1550,7,TNFRSF14|XCL1|TWSG1|ZBTB7B|C10orf54|CD274|LGALS9
TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0070897,0.697338701757832,0.96731875442989,0.25175018472890803,0.8124914220417909,7100,13,BDP1|TAF7|GTF2B|TAF1|TAF6|TBPL1|MED6|TAF12
SUPPRESSION BY VIRUS OF HOST CATALYTIC ACTIVITY%GOBP%GO:0039513,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
MITRAL VALVE FORMATION%GOBP%GO:0003192,0.674539770753734,0.9647315640607691,0.454105737953974,0.863207237719938,5825,3,DCHS1|ZFPM1
DEFINITIVE HEMOPOIESIS%GOBP%GO:0060216,0.13725834797891,0.62388141596544,-0.491975070321549,-1.3504385343224299,780,6,TEK|ZFP36L2|LYL1|TGFBR3|HIPK1|MFAP5
INTESTINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014827,0.0480536912751678,0.431337225587021,0.9752977503308341,1.29563955019709,357,1,PTGER3
CATION HOMEOSTASIS%GOBP%GO:0055080,0.875677158335048,0.9941329456747149,0.120016331421933,0.7925395142204671,12769,347,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|SLC12A2|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|TMTC2|CXCR4|F2R|BDH2|DMXL2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|ATP2A1|MTL5|CLN6|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|KCNH2|TMEM178A|MT1E|CCR5|CNNM2|PTH1R|PDK4|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|CAND1|SLC39A7|SLC46A1|DMPK|SLC40A1|NEO1|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|TCIRG1|PLCG1|C3AR1|SLC39A13|ANK3|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1
BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0001569,0.452943615257048,0.8874890379518141,-0.272204957037203,-0.9916699633481809,2184,12,NOTCH4|ENG|NRARP|VEGFA|CTNNB1|NRP1|SFRP2
ZYGOTIC SPECIFICATION OF DORSAL/VENTRAL AXIS%GOBP%GO:0007352,0.0571640682999258,0.465205963201509,-0.8547559966914811,-1.4620143545377702,384,2,SMAD6|SMAD2
ASPARTATE METABOLIC PROCESS%GOBP%GO:0006531,0.0453427065026362,0.4190278528102411,-0.586934526551964,-1.61109586561371,257,6,ASS1|NMNAT3|NMNAT2
REGULATION OF EXONUCLEASE ACTIVITY%GOBP%GO:1905777,0.2778025241276911,0.7884684708511421,-0.692801063707935,-1.18499911542081,1870,2,TERF2
DNA PACKAGING%GOBP%GO:0006323,0.00609756097560976,0.17804916190196898,0.28020811076388696,1.61742060981971,80,122,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|DFFB|AIFM1|ASF1B|NCAPD3|NAA10|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|ASF1A|CASC5|CENPU|TOP2A|CDKN2A|OIP5|SMC2|ITGB3BP|CENPA|NUSAP1|AKAP8L|HIST1H4I|HELLS|NCAPH2|NIPBL|CENPV|CENPQ|CENPI|H2AFX|H3F3A|CDCA5|SRPK1|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|NCAPG|NCAPH|HIST1H2BK|ACIN1|STRA13|CENPM|SMC4
POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032461,0.0023551577955723,0.12234570424564199,-0.4633407357335789,-2.10439909480619,9,21,BAX|MMP1|CLU|TRABD2A|HRK|SH3GLB1|TCL1A|BID|RHOC|TP53|BMF|BIK|BCL2L11|PMAIP1
REGULATION OF CHROMOSOME CONDENSATION%GOBP%GO:0060623,0.837150801006223,0.9889652677625541,-0.5795655050727829,-0.7753024469399721,6322,1,WAPAL
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032387,0.0143948296122209,0.26197008044834097,-0.29908514846983697,-1.68751530433417,48,39,ERLEC1|GAS6|PARK7|CD84|SNX3|INSIG1|UBE2J1|LGALS9|OS9|BAG4|ARHGAP1|PLN|INPP5K|APOD|CHP1|FMR1|RANGAP1|SIAH3|CABP1|SNX12
POSITIVE REGULATION OF MACROPHAGE TOLERANCE INDUCTION%GOBP%GO:0010933,0.7615517013107371,0.977763214485385,-0.6161226290251429,-0.8242060262684101,5751,1,IRAK3
LATERAL ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0099607,0.342013422818792,0.8359038216207221,0.8331495368328191,1.10680199024638,2547,1,CENPE
POSITIVE REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010756,0.23918269230769199,0.75206086335821,-0.470896653025379,-1.19204360798756,1392,5,ENO1|CLEC3B|MFI2
"REGULATION OF SYMBIOSIS, ENCOMPASSING MUTUALISM THROUGH PARASITISM%GOBP%GO:0043903",0.0224887556221889,0.31540045468680394,-0.17363688873924502,-1.38301028428354,29,151,FBXL2|SNX3|LGALS1|CCNK|TRIM8|RNASEL|PVRL2|CTDP1|ZNF639|TRIM13|CDK9|APOBEC3F|C9orf69|BANF1|LGALS9|PML|VPS4A|DDX3X|RSF1|INPP5K|IFITM2|TBC1D20|IFITM3|P4HB|OASL|VPS4B|MAVS|TRIM35|TNIP1|PPIH|CNOT7|GAPDH|FMR1|OAS3|TRIM25|CXCL8|PDE12|JUN|CAV2|RAB7A|VAPB|ZC3HAV1|PARK2|CHMP4B|STAU1|PABPC1|IFITM1|PC|TNF|CAV1
REGULATION OF B CELL TOLERANCE INDUCTION%GOBP%GO:0002661,0.3738678544914629,0.852609194081082,-0.632974910394265,-1.0826696842616,2517,2,TGFBR2|FOXJ1
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0045945,0.0638811513463324,0.494362498806828,-0.491863864526449,-1.52892705213173,343,8,MTOR|ZC3H8|ICE2|CHD8|RPTOR|CEBPA|ELL|ICE1
NEURON FATE COMMITMENT%GOBP%GO:0048663,0.9662619426751591,1.0,0.17418399997054598,0.531395455863504,9708,11,FOXN4|JAG2|MYT1L
DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:0042742,0.519447731755424,0.9241136411646341,0.178868023748224,0.966221713279436,6583,85,IGHV3-21|HIST1H2BJ|IGHV4-61|CXCL13|IGHG1|RARRES2|IGLL5|IGHG4|ADGRB1|ANKRD17|KLRK1|DROSHA|GSDMD|IGHV1-18|IGHV3-43|AZU1|MPEG1|JCHAIN|RPS19|STAB1|NLRC4|HIST1H2BF|RNASE6|IGHV1-24|HIST1H2BK
FOCAL ADHESION ASSEMBLY%GOBP%GO:0048041,0.7427238391468559,0.974505008828563,-0.18468963885958803,-0.794493792300419,3342,18,ACTN1|PIP5K1A|THY1|LAMA5|DLC1|TESK2|WHAMM|PEAK1
VASCULOGENESIS%GOBP%GO:0001570,0.136849962677283,0.62388141596544,-0.267764408283744,-1.2989978175023997,549,25,NOTCH1|VEGFA|ITGB8|KDR|APLNR|RAMP2|ADM|SOX17|CAV1
VISUAL BEHAVIOR%GOBP%GO:0007632,0.7826919202095508,0.981487311948134,0.250926134730356,0.740547850737558,7768,10,RGS14|NF1|GRIN1|NPHP4
VENTRICULAR SEPTUM DEVELOPMENT%GOBP%GO:0003281,0.6907216494845361,0.96731875442989,0.200810129333857,0.831823177117057,7704,29,HES1|BMP4|PROX1|ROBO2|TGFB2|HEYL|C5orf42|HEY2
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:1903751,0.7355852317360569,0.974262605126702,-0.386842395500165,-0.7850851480752571,4681,3,PINK1|TRAP1|PARK7
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902038,0.46577518866675505,0.8939277899536601,-0.765494044993383,-1.02402472370542,3517,1,FOXC1
MODULATION BY SYMBIONT OF HOST CATALYTIC ACTIVITY%GOBP%GO:0052148,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
NEGATIVE REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0071866,0.27531147937583195,0.7884684708511421,0.6977667493796529,1.14048058308711,2275,2,LEF1|FGFR2
REGULATION OF RECEPTOR CLUSTERING%GOBP%GO:1903909,0.39423410906564793,0.863562957467761,0.5561187001479189,1.05712314748981,3404,3,SHISA7|MESDC2
"PEPTIDYL-ARGININE METHYLATION, TO ASYMMETRICAL-DIMETHYL ARGININE%GOBP%GO:0019919",0.785488626790228,0.981487311948134,0.283436403891714,0.7377254093085821,7458,7,PRMT9|PRMT1|CARM1
REGULATION OF T CELL COSTIMULATION%GOBP%GO:2000523,0.8906394810009269,0.997300970905927,-0.552823114247905,-0.7395283353648711,6726,1,CCR7
REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0006448,0.34701492537313394,0.842847021021096,-0.296386531786855,-1.07976586581336,1673,12,USP16|DPH2|AARS|CPEB2|DPH6|DPH3|EIF5A
MAINTENANCE OF CELL NUMBER%GOBP%GO:0098727,0.657872046904639,0.9643779777660141,0.190726233576383,0.86022452967089,7629,39,ZCCHC11|HES1|LIG4|CDH2|PROX1|ZNF358|MTF2
REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032875,0.315789473684211,0.817022961971678,0.39699185008969606,1.13287909725874,3119,9,E2F8|E2F7|FBXO5|MSH6
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901550,0.25938991492010804,0.770912532778873,-0.30754912546169205,-1.15822412788063,1249,13,ADD1|IL1B|CDH5|PROC|TNF
RESPONSE TO MERCAPTOETHANOL%GOBP%GO:0072704,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031063,0.872362869198312,0.9934031064448321,-0.177292004072203,-0.686876159636394,4134,14,CAMK2D|VEGFA|PRKD2|CTBP1|KDM5A
PROTEIN REFOLDING%GOBP%GO:0042026,0.12197289491224199,0.607607158836689,-0.31224767322278496,-1.34322011547359,548,18,HSPA13|FKBP1B|HSPA5|DNAJA2|HSPA6|DNAJA4|FKBP1A
CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS%GOBP%GO:0071389,0.437177280550775,0.878651088001772,-0.7793890604322891,-1.04261250951351,3301,1,GPER1
EMBRYONIC APPENDAGE MORPHOGENESIS%GOBP%GO:0035113,0.35754596759512103,0.845419584429298,0.270119886777432,1.08601133058786,3927,26,TBX3|TBX2|MYH3|ZNF358|TGFB2|LEF1|C5orf42|NIPBL
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN REGULATION OF HEART RATE%GOBP%GO:0140200,0.0238315900966503,0.32397355287938,-0.9889170710189681,-1.3229045177308,179,1,PDE4D
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046822,0.27445652173913004,0.7884684708511421,-0.165248263013492,-1.1159869125414499,706,72,TCF7L2|UHMK1|MX2|APOD|CHP1|IGF1|MAVS|ZPR1|NEDD4|BAG3|TP53|RANGAP1|YWHAE|NCBP2|CABP1|PIK3R1
REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001106,0.297698589458055,0.8023890191280308,-0.6817204301075269,-1.1660462850880902,2004,2,EPHA4|FAM65B
HYDROXYLYSINE METABOLIC PROCESS%GOBP%GO:0046946,0.244933228593873,0.757467559003634,-0.584647623249145,-1.1865249807404,1558,3,PLOD1|PLOD3|PLOD2
SIALYLATION%GOBP%GO:0097503,0.9671391752577321,1.0,0.22085717132758398,0.543166048131935,9005,6,ST8SIA3|ST3GAL4|ST6GALNAC2|ST6GAL1
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED SIGNALING PATHWAY%GOBP%GO:0051482,0.5157201807820789,0.9219388939909341,0.303431657037319,0.9565250192001901,5248,12,F2R|AGTR1|F2RL1|C3AR1|OPRL1|LPAR6
POSITIVE REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032877,0.0518930688278698,0.44586532408291796,0.8569616763165151,1.40068031782494,428,2,E2F8|E2F7
MICROTUBULE ORGANIZING CENTER LOCALIZATION%GOBP%GO:0061842,0.635876328132478,0.95916055221954,0.248081415006047,0.8600309886522901,6642,16,AKAP9|GPSM2|C9orf114|ASUN|SYNE2|NDE1|IFT20|RANBP2|TBCCD1
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0001658,0.18947368421052602,0.6973744226246139,0.445108044542382,1.27018627604029,1871,9,CITED1|BMP4|PKD2
EXECUTION PHASE OF APOPTOSIS%GOBP%GO:0097194,0.7072456276384941,0.9695156155378671,0.181823875183313,0.8249665953839141,8208,40,COLEC11|DFFB|CASP6|ENDOG|BLCAP|TOP2A|FEN1|CAPN10|TAOK1|ACIN1|DICER1|CDK5RAP3|MADD|DNASE1L3|CASP2
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030857,0.24645390070922,0.7585951535148171,-0.349225470194099,-1.1814820377296,1250,10,GSK3B|NOTCH4|S1PR3|DLL1|ZEB1|FOXJ2|CAV1
NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051898,0.169089517980107,0.673117535978459,-0.25062397935041303,-1.2489086748963703,662,27,MUL1|THEM4|GPER1|FLCN|ARRB2|INPP5K|DDIT3|GLTSCR2|DRD2|SLC9A3R1|TRIB3
RETROGRADE TRANS-SYNAPTIC SIGNALING BY LIPID%GOBP%GO:0098920,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
SIGNAL TRANSDUCTION INVOLVED IN INTRA-S DNA DAMAGE CHECKPOINT%GOBP%GO:0072428,0.484295302013423,0.9064456896937672,0.7616343184825759,1.01179721318817,3607,1,CHEK2
MUSCLE CELL FATE DETERMINATION%GOBP%GO:0007521,0.269626224749002,0.784543299601953,0.7004547366102691,1.14487402437222,2228,2,TBX2|MEF2C
REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045652,0.9909738323948329,1.0,0.0995054032702022,0.4915140679254629,11966,56,HIST1H3E|NR4A3|HIST2H3C|HIST2H3A|PRKCQ|KMT2B|HIST1H4I|TNRC6A|H3F3A|ITGA2B|TNRC6C|PRMT1|KMT2D|WDR5|HIST1H3H|THBS1|KAT2B|AGO4|MYL9|KMT2C|HMGB2|ZFPM1|L3MBTL1
MACROMOLECULE DEACYLATION%GOBP%GO:0098732,0.246009627565239,0.758407565545035,0.248914333097838,1.1806500046736499,2912,47,SIRT4|SIRT1|HDAC10|LYPLAL1|MTA2|NOTUM|MIER2|MTA1|HDAC8|HDAC3|SIRT3|SMARCAD1|HDAC6
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO UV-INDUCED DNA DAMAGE%GOBP%GO:0010768,0.650631031922791,0.963755998259649,-0.5018093990689679,-0.8583181019151279,4381,2,NEDD4
POSITIVE REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031058,0.96652719665272,1.0,0.11550615676017402,0.579699581683775,11780,60,SIRT1|WDR61|OGT|MTF2|SART3|MUC1|DNMT3B|AKAP8L|PHF19|NIPBL|JARID2|ING2|KDM1A|RNF40|PAXIP1|RPS6KA4|RIF1
STRIATED MUSCLE ADAPTATION%GOBP%GO:0014888,0.9841990555757361,1.0,-0.17698425003624105,-0.516270909432679,5418,7,HDAC4|CFLAR
FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION%GOBP%GO:0007342,0.230562714776632,0.743397546142977,0.49635910051184007,1.2207229199700702,2146,6,ROPN1B|SERPINA5
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000177,0.666941769830353,0.964618776001639,0.21470363387595698,0.8449656769093579,7272,24,SIX3|PROX1|SMARCD3|PTCHD2|SHCBP1|NF1|ZNF335|KDM1A|NAP1L1
LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002449,0.7862996260641261,0.981626008042485,0.14869024985807097,0.7879161068643349,9882,77,IGHV3-21|IGKV4-1|IGHV4-61|IGHG1|CD27|IGLL5|LIG4|IGHG4|KLRK1|EXO1|IGHV1-18|IGHV3-43|IGKV3-11|ZP3|CORO1A|MSH6|IGKV2D-28
REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090181,0.5879570982180561,0.945418171231938,0.19249654646303602,0.9130492633861809,6961,47,TM7SF2|ACADVL|NFYB|ELOVL6|GPAM|GNB3|MVD|LDLRAP1|APOE|ACACA|SREBF2|GGPS1|IDI1|HMGCR|ARV1|DHCR7
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE VIA TNFSF11-MEDIATED SIGNALING%GOBP%GO:0071848,0.15742089236065102,0.658345302622411,-0.9184494927216591,-1.22863788970404,1188,1,TNFRSF11A
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS%GOBP%GO:0071384,0.00574204946996466,0.17352934538701598,-0.46164016581415207,-1.94252872112777,25,17,NR3C1|KLF9|UBE2L3|ADCYAP1|AQP1|BCL2L11
OXIDOREDUCTION COENZYME METABOLIC PROCESS%GOBP%GO:0006733,0.123416236508681,0.607607158836689,-0.171496519500735,-1.2398896853662098,262,95,ADCK4|PFKL|DERA|GPI|G6PD|MDH1B|PKM|PNP|ENO1|NAMPT|PGD|PDHB|GAPDH|KCNAB2|PGK1|TP53I3|HK1|NMNAT3|HK2|TPI1|NDUFA9|ALDOA|TKT|NT5E|PGAM2|NMNAT2
POSITIVE REGULATION OF LYASE ACTIVITY%GOBP%GO:0051349,0.41016548463357,0.867015886388254,-0.302093279958098,-1.0220267834157,2081,10,FXN|NOS3|GUCA1A
NEGATIVE REGULATION OF ESTROGEN RECEPTOR BINDING%GOBP%GO:0071899,0.9397178916109871,1.0,-0.35847767612949394,-0.61315686618322,6328,2,RUVBL2
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904469,0.999584069876261,1.0,0.137035074136311,0.37359437634428394,9612,8,DHX9|C1QTNF4|DDX58|IFIH1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904377,0.271396754692969,0.7864992130359009,-0.18778152743917398,-1.12883338915476,852,48,ACSL3|PIK3R1|DLG1|TNF|STAC|EPHB2
DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0006261,0.0006917755572636429,0.0806484601749226,0.32629719345380104,1.83302300448946,8,105,POLG|FBXO18|EME2|LRWD1|CDC7|CDC34|POLE|BLM|TEFM|THOC1|POLE2|ORC1|RFC4|DNA2|REV3L|CDC45|PNKP|POLD1|DONSON|TONSL|MGME1|FEN1|RNASEH2A|GEN1|ZNF830|POLQ|POLD3|POLN|POLA2|MSH6|MMS22L|RAD51|WDHD1|FANCM|ORC6|PRIMPOL|WDR18|TIMELESS|LIG1|POLG2|ZRANB3|MCM10|EME1|STRA13|MCM2|BRCA2|PRIM2|GMNN|GINS2|ACD|RFC3|GINS1
"REGULATION OF PROTEIN CATABOLIC PROCESS AT PRESYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099575",0.4657718120805371,0.8939277899536601,0.772331274812528,1.02600764244746,3469,1,RAB26
THYMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:0046105,0.37495035085396505,0.852609194081082,-0.810377150419056,-1.08406622230775,2831,1,DHFRL1
C-TERMINAL PROTEIN DEGLUTAMYLATION%GOBP%GO:0035609,0.5352710133542811,0.9265056012720759,-0.45820006617403797,-0.9299034205783759,3406,3,AGTPBP1|AGBL4|FOLH1
CELLULAR RESPONSE TO POTASSIUM ION%GOBP%GO:0035865,0.174329919372412,0.676682497340677,0.557925823604897,1.2859363156474901,1599,5,CRHBP|CACNA1H|DLG4|DLG2|CARF
EFFERENT AXON DEVELOPMENT IN A LATERAL LINE NERVE%GOBP%GO:0048894,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
PURINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0009113,0.534113847396044,0.9265056012720759,-0.263454011333362,-0.927127489429391,2645,11,ADA|MTHFD1L|APRT|GMPS|PRPS1|HPRT1
POSITIVE REGULATION OF NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0033031,0.6111547525530239,0.9508825506493929,-0.431509870960626,-0.875736462393284,3889,3,ANXA1|PIK3CB|PIK3CD
CARBOXYLIC ACID TRANSPORT%GOBP%GO:0046942,0.544493260853377,0.929758904310055,0.163574017775896,0.958791316432965,7311,133,ABCC3|SLC16A9|SLC1A2|SLC27A2|CEACAM1|SLC25A29|SLC36A1|SLC25A22|SLC16A13|MFSD2A|ABCB4|SLC43A1|GLS|SLC16A14|EPRS|GLS2|LRRC8D|STARD5|SLC16A2|SLC6A17|SLC6A15|SLC13A3|SLC25A10|AKR1C1|SLC6A9|SLC7A9|CPT1B|SLC15A4|PQLC2|SLC46A1|APOE|SLC25A1|ACACA|SLC38A6|SLC16A7
PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:0035418,0.6961906549071121,0.96731875442989,0.22109784814337,0.8210466936763191,7419,20,LRRC7|DLG4|RAB27B|SHANK1|STX3|ARHGAP44|SCRIB|STX1B|NRXN2|NLGN2|DLG2
ESTABLISHMENT OF BLOOD-NERVE BARRIER%GOBP%GO:0008065,0.0929432013769363,0.5622489437340121,-0.95213939126599,-1.2737058941831798,701,1,GSTM3
RESPONSE TO DENERVATION INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014894,0.0991358994501178,0.570215774831708,-0.7119223557957429,-1.4448252689453402,630,3,FBXO32|HDAC4|SCN5A
NEPHRON EPITHELIUM DEVELOPMENT%GOBP%GO:0072009,0.24466002135991502,0.757467559003634,0.282307537226895,1.19331193656228,2748,31,CITED1|BASP1|BMP4|PKD2|AHI1|PTPRO|KLHL3
CELLULAR RESPONSE TO MERCAPTOETHANOL%GOBP%GO:0072705,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
INNER EAR RECEPTOR CELL FATE COMMITMENT%GOBP%GO:0060120,0.264026845637584,0.775687172361899,0.8703131892368771,1.15617224447709,1966,1,JAG2
ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:0035767,0.009514170040485829,0.21235063347774397,0.6183987988457971,1.7646988793952,93,9,EGR3|CXCL13|NOV|NR4A1
MEMBRANE DEPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098912,0.63251128864189,0.958176387547329,0.469677266212286,0.892807074875702,5462,3,CACNB2
INTERLEUKIN-1 SECRETION%GOBP%GO:0050701,0.573671623167308,0.941417936126209,0.335244591445425,0.9139666968710799,5516,8,AIM2|GBP5|F2RL1|NLRC4|TLR4|S100A13
REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042752,0.8442061124102901,0.991298302704726,0.142278118542845,0.7406675924394991,10468,71,GHRL|ARNTL|SPSB4|SIAH2|PRKAA2|BTRC|PROX1|RBM4B|MTA1|MAPK10|TOP2A|RORA|EZH2
PYRIMIDINE NUCLEOSIDE SALVAGE%GOBP%GO:0043097,0.6327825911746929,0.958316380324396,0.292149912866014,0.862209870241621,6280,10,TK1|UCKL1|DCK|UCK1
CHYLOMICRON ASSEMBLY%GOBP%GO:0034378,0.9797383350700469,1.0,0.283080452021932,0.538106160347901,8461,3,APOE|APOC2
VERY LONG-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036113,0.9664429530201339,1.0,0.5190229378032639,0.6894988176167571,7199,1,ABCD1
LABYRINTHINE LAYER MORPHOGENESIS%GOBP%GO:0060713,0.459071436841496,0.890371861972445,0.531529647775165,1.0103819456004202,3964,3,LEF1|FGFR2|BMP7
POSITIVE REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051054,0.227295936975709,0.7400748230621691,0.19229356153521304,1.16058946555394,3115,162,FGFR4|SIRT1|CDC7|MMS19|SIRT6|NPAS2|E2F8|ATR|NVL|BLM|DHX9|ATAD5|HMBOX1|RFC4|ST20|DNA2|FAM178A|PNKP|E2F7|PPP1R10|PRKCQ|PARP1|TMEM161A|NEK2|DBF4B|SLX1B|INO80|AURKB|RAD51|H2AFX|DBF4|TIMELESS|MAP3K4|BRCC3|DSCC1|TNKS2|MAP2K7|SLX4|WRAP53|CHTF18|HNRNPA2B1|PAXIP1|ANKRD32|CTC1|RIF1|C5orf45|ACD|XRCC1|SPIRE2|RFC3|SPIRE1|RFC5|FOXM1|SPIDR|FMN2|ATM|WIZ|UIMC1|BRCA1|AKT1|FAM35A|BRE|MAPKAPK5|PARP9|DNMT1|FAF1|EYA3|NPM2|PARP3|POT1|RNF8|SETMAR|CDT1|FAM168A|CCT2|STOML2|MGMT|TP53BP1|KLF4|WAS|DDX11|FBXO4|NEK7|ATRX|ZNF304|APLF|RAD50|TNKS|NBN|HMGB1|ERCC6
NEGATIVE REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0031914,0.166577181208054,0.6682860217990739,0.9182289369210409,1.21982617760245,1240,1,RGS14
PRENYLATED PROTEIN CATABOLIC PROCESS%GOBP%GO:0030327,0.72299504052256,0.971955586175348,0.518356595015685,0.847239614464462,5976,2,PCYOX1L
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:1900212,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF DNA-DIRECTED DNA POLYMERASE ACTIVITY%GOBP%GO:1900262,0.0369415807560138,0.386113929236656,0.6387088724603679,1.57081145283043,343,6,RFC4|DSCC1|CHTF18|RFC3|RFC5
"ALTERNATIVE MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000380",0.36934105862712396,0.852268858837246,0.33614814644305696,1.08487501534242,3760,13,DHX9|SRSF1|DDX17|SRSF6|CDK13|SFPQ|DDX5|PQBP1|RBM17
FC-GAMMA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038094,0.00124069478908189,0.0929735131311543,-0.27404989024620396,-1.88837172513149,2,78,MYO10|MYO1G|PPAPDC1A|FCER1G|PRKCD|ABI1|GRB2|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|LYN|FCGR2B|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1
REGULATION OF OXIDATIVE PHOSPHORYLATION UNCOUPLER ACTIVITY%GOBP%GO:2000275,0.408446974712035,0.867015886388254,-0.794441993824438,-1.06274927747228,3084,1,PPIF
LYMPHOCYTE MIGRATION%GOBP%GO:0072676,0.714348206474191,0.971081608033886,0.18470336655700895,0.815287384345417,8164,36,CXCL13|SLC12A2|XCL2|CCL21|CCL5|CCL19|CYP7B1|CXCL10|CCL2|CCL3L3|CCL11|ZAP70|GATA3|CCL4L2|CXCL11|CKLF|XCL1|WNK1|CCL4|CCL8|CCL24
SITE-SPECIFIC DNA REPLICATION TERMINATION%GOBP%GO:0071170,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000394,0.404531786941581,0.8656739790075619,0.427464818035624,1.05128746570543,3766,6,ENPP2|SRC
REGULATION OF CYTOKINETIC PROCESS%GOBP%GO:0032954,0.564775613886537,0.9380162603437769,0.5800385993934379,0.948057156116115,4668,2,KIF20B|NUP62
METHIONINE METABOLIC PROCESS%GOBP%GO:0006555,0.308901552367852,0.8114708447293539,0.36120893923983,1.13865966035035,3143,12,CTH|APIP|MTHFD1|MTR|MTAP
POSITIVE REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905917,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
RETINAL CONE CELL DIFFERENTIATION%GOBP%GO:0042670,0.9940608760207871,1.0,-0.297325613454646,-0.508559538072878,6694,2,TOPORS|THY1
MITOPHAGY%GOBP%GO:0000423,0.22682005494505497,0.7398172623753029,-0.476273294536575,-1.2056542189457902,1320,5,SQSTM1|ATG13|BECN1
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003332,0.158900049398979,0.661359103221672,-0.5693487012628909,-1.3093830717947,964,4,TNFRSF1A|ADTRP|NOTCH1|TNFRSF1B
DIADENOSINE HEXAPHOSPHATE METABOLIC PROCESS%GOBP%GO:1901908,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051924,0.0338680926916221,0.37600329791737297,-0.177221713292436,-1.36875500515298,56,124,CX3CL1|FKBP1B|CTNNB1|PTK2B|CRHR1|PML|FYN|SESTD1|SLC9A1|PLN|INPP5K|UBASH3B|SLC30A1|PRNP|APLNR|CAMK2A|HAP1|BIN1|CRACR2A|CEMIP|SNCA|FMR1|PDE4B|LGALS3|GNB5|JPH3|BCL2|YWHAE|HOMER2|HTT|ADRA2A|JPH1|PDE4D|CAV1|STAC|FKBP1A|STC1|HOMER1
POSITIVE REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0010952,0.0499119201409278,0.43920898483204296,-0.17291378003437602,-1.32981282017232,84,123,LGALS9|CIDEB|DLC1|EIF2AK3|BBC3|RPS3|CYFIP2|S100A8|PSME3|FYN|DDX3X|TNFRSF10A|PPARG|LYN|TANK|EFNA1|BOK|MBP|RIPK2|CRADD|SNCA|KARS|NLRP1|NLRP3|CTSH|STAT3|TNFRSF10B|MTCH1|DDRGK1|SOX7|BCAP31|TNF|PMAIP1|EGLN3
NEGATIVE REGULATION OF SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:1904049,0.0791738382099828,0.532203813468543,-0.959142037935598,-1.28307354814202,597,1,PARK2
NEGATIVE REGULATION OF SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0010991,0.0189362753169768,0.286396032442422,-0.7520625713406679,-1.7295868027091001,114,4,SMAD6|LDLRAD4|PPM1A
INDUCTION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039520,0.6692704885475971,0.964618776001639,-0.660068372298191,-0.8829935869392459,5054,1,EIF2AK4
ZYGOTE ASYMMETRIC CELL DIVISION%GOBP%GO:0010070,0.166577181208054,0.6682860217990739,0.9182289369210409,1.21982617760245,1240,1,RGS14
POSITIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901258,0.7765404602821079,0.980802382590629,-0.448304383788255,-0.766800638822792,5229,2,ISL1|CD34
DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0015961,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
POST-EMBRYONIC DEVELOPMENT%GOBP%GO:0009791,0.10129691491452199,0.571655361840848,0.449339932116346,1.4164800449352601,1030,12,BMP4|EFEMP1|FBN1|SZT2|FGFR2|MFAP2|IREB2|SCUBE1|STK36|KLF4
REGULATION OF CELLULAR KETONE METABOLIC PROCESS%GOBP%GO:0010565,0.22714615323414802,0.7400326826672471,0.22373200364374302,1.1855656269338601,2854,77,FGFR4|SIRT4|SLC45A3|SIRT1|STAR|FGF19|NR4A3|WNT4|CEACAM1|PRKAA2|ACADVL|INS|CLCN2|PROX1
ENDODERMAL-MESODERMAL CELL SIGNALING INVOLVED IN HEART INDUCTION%GOBP%GO:0003134,0.127494859078263,0.6076669536424699,0.7818332732196001,1.2778850068610002,1053,2,BMP4|BMP2
PEPTIDYL-CYSTEINE METHYLATION%GOBP%GO:0018125,0.26029392294452497,0.7717385447946792,-0.8703683281870308,-1.16431824992365,1965,1,RAB6A
POSITIVE REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032273,0.845923591965341,0.991298302704726,0.137047466358029,0.7433627933407829,10738,87,TENM1|RHOBTB1|WASH1|AKAP9|NAV3|CLIP1|RAC3|PSRC1|TRIM27|C15orf62|NUMA1|CDK5R1|CTTN|CCL21|CDK5RAP2
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070665,0.9082071713147409,1.0,0.128909487522527,0.680934749091741,11397,76,CD209|CD38|AGER|CD320|BLM|TNFSF13B|CCDC88B|EBI3|CCL5|BST1|ZP3|IL7|CCL19|TMIGD2|CD55|ZNF335|IL12RB1|CD1D|FCRL3|RASAL3|HLA-DMB|IGFBP2|CD3E|CD46
CELLULAR RESPONSE TO CYTOCHALASIN B%GOBP%GO:0072749,0.6577518866675489,0.9643779777660141,-0.6648654609616229,-0.889410798706325,4967,1,ACTB
TAURINE TRANSPORT%GOBP%GO:0015734,0.883633724446595,0.996316041142784,0.44508884904473206,0.727485496457664,7304,2,LRRC8D
CELLULAR RESPONSE TO BACTERIAL LIPOPROTEIN%GOBP%GO:0071220,0.15848214285714302,0.6604486079157379,-0.5157180675049641,-1.3055060424476101,922,5,TLR2|CD14|TIRAP|TLR1|CD36
MAINTENANCE OF TRANSLATIONAL FIDELITY%GOBP%GO:1990145,0.704223487356018,0.968941691852291,-0.6428098808998679,-0.8599063767887171,5318,1,RPS23
POSITIVE REGULATION OF EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904891,0.620018535681186,0.9532238181782521,-0.683281870313189,-0.9140469910075291,4682,1,VSTM5
DISACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046351,0.0612725844461901,0.48227634769717603,-0.751571633395831,-1.5252922998029501,389,3,B4GALT1|FBP1|SLC2A1
POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032793,0.794199291662678,0.9819883545684358,0.21218344571761102,0.7355824642959191,8296,16,ADCY8|EPHA5|CD200|LRP8|ADCY1|RPS6KA4|PRKD1
NUCLEOBASE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0034655,0.743099787685775,0.974505008828563,-0.0994913678726858,-0.908805229300805,349,333,CNOT10|PPP2R2A|DCP1A|RPS4X|NUDT7|SMUG1|LDHA|DCP2|RPL9|METTL16|KPNA1|SIDT2|RPS28|ENTPD4|HBS1L|SAMD4A|RPL35|RPL7|PFKL|DERA|EXOSC6|GPI|PRPF18|RPS9|RPS3|RPL14|WIBG|NUDT4|EXOSC4|MAGOH|GSPT1|CASP3|EIF4G1|PKM|H1F0|PAPD7|DFFA|RPL15|PNP|RPL8|ENO1|CDA|EXOG|NBAS|HPRT1|PPP2CA|ZPR1|NUDT18|RPL35A|CNOT7|GAPDH|EXOSC9|HELZ2|PGK1|CDADC1|HK1|MTPAP|HK2|TPI1|RNASEH1|ETF1|PDE12|PDE9A|CSDE1|UBA52|MRTO4|UPP1|NCBP2|ENTPD3|ALDOA|POLR2D|RBM8A|RNPS1|ITPA|PABPC1|EXOSC5|DDX6|NT5E|NEIL2|PDE4D|PGAM2|ENPP4
NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070943,0.334496644295302,0.830568091460343,0.837284958094398,1.1122957128981699,2491,1,AZU1
MDA-5 SIGNALING PATHWAY%GOBP%GO:0039530,0.558994501178319,0.936434965680841,-0.45053490680489705,-0.9143472073805908,3557,3,IFIH1|IRF7|IRF3
REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051341,0.372273047149894,0.852609194081082,-0.16540588155282998,-1.0503165708652,1057,58,NOSIP|ATP2B4|SNCA|FXN|FCER2|SPR|DDAH2|NOS3|PARK2|TNF|CAV1|DDAH1
CARBON TETRACHLORIDE METABOLIC PROCESS%GOBP%GO:0018885,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
POSITIVE REGULATION OF SULFUR METABOLIC PROCESS%GOBP%GO:0051176,0.678255033557047,0.9647315640607691,0.665527128363476,0.884123098760677,5052,1,SP1
POSITIVE REGULATION OF PROGRAMMED CELL DEATH%GOBP%GO:0043068,0.00304878048780488,0.133833341414569,-0.18677932918793202,-1.74342084160466,0,396,PIK3CD|ARHGEF5|BTG1|NTRK1|PPM1F|TIMP3|IFT57|MUL1|DEDD2|PYCARD|PREX1|ZNF205|CDK5|CAMK2D|ATF4|STK17B|BAX|NOD1|GPER1|SOD1|FLCN|FBXW7|NOTCH1|TRIM39|CD274|PPIF|TP53BP2|GZMB|KALRN|GNA13|BCLAF1|CLIP3|DNM2|MSX1|CTNNB1|DAB2IP|ABR|TGFBR1|LGALS9|CIDEB|SQSTM1|DLC1|FGD4|EIF2AK3|ABL1|VAV1|BBC3|PML|TRIO|DCUN1D3|RPS3|MYBBP1A|RET|S100A8|IGFBP3|HRK|DDX3X|C1QBP|TNFRSF1B|BCL10|FOXO1|MFN2|TNFRSF10A|YWHAH|RASSF2|DDIT3|SHQ1|IL6|PPARG|SAV1|LYN|ITGA6|PRNP|DFNA5|MMP9|CYLD|BCL2L1|ECSCR|CAMK2A|ATG7|POU4F2|BOK|SOD2|BIN1|BID|TRIM35|ATF6|CRADD|GAPDH|YWHAQ|YWHAB|MARK4|VAV3|PLAUR|SNCA|ARHGEF2|KLF11|VAV2|PPP2R1B|GADD45A|AKAP13|STK4|USP27X|PDCD4|NET1|NLRP1|NLRP3|BCL2|JUN|UBA52|CTNNBL1|TP53|YWHAZ|RASGRF2|YWHAE|ZNF622|TNFRSF10B|ANO6|HTT|MTCH1|BCL6|BNIP3L|BMF|EPHA7|SFRP2|RNPS1|SAP18|SLC9A3R1|MAP3K11|WWOX|SOX7|UBC|BCAP31|BIK|JMY|TNF|BCL2L11|PMAIP1|TFDP2|CAV1|RPS6KA2|PAK2|UBB|FOXO3|EGLN3
REGULATION OF OPSONIZATION%GOBP%GO:1903027,0.918178207334834,1.0,-0.539644905161006,-0.7218994432691,6934,1,MYO18A
FATTY ACID OXIDATION%GOBP%GO:0019395,0.0726261620185923,0.5174726300536271,0.288033232835709,1.41605264627278,874,55,CROT|SLC27A2|ETFDH|HSD17B4|ACADVL|BDH2|ETFA|DECR2|AMACR|ACADM|DECR1|ALDH3A2|HADH|ETFB|ACOX2|ECHDC2|EHHADH|ADIPOR2|ACAD11|ACAD10|IVD|ECI1|ECI2|HADHB|ACAT2|HIBCH|ACADS
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0031554",0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
RENAL PHOSPHATE ION ABSORPTION%GOBP%GO:0097291,0.05573944128161,0.45915848992626795,-0.971879135421262,-1.30011235179944,420,1,SLC9A3R1
NEGATIVE REGULATION OF NEUROGENESIS%GOBP%GO:0050768,0.85038084874864,0.991298302704726,-0.106723748861794,-0.8126270546671359,1562,116,CALR|THY1|DCC|NOTCH1|ARHGDIA|ID2|RNF6|IL1B|CX3CL1|LPAR1|RTN4|SKI|SRGAP2C|SEMA3F|RHOA|SEMA7A|YWHAH|IL6|EFNA1|POU4F2|BAG5|SPOCK1|SEMA6B|ID1|ADCYAP1|FKBP4|ASCL1|MYLIP|ZNF365|SEMA3A|SEMA3G|TNF|LINGO1|RTN4RL2
MAST CELL DEGRANULATION%GOBP%GO:0043303,0.4470303285593929,0.88473565970262,0.390280680500403,1.0158186133260099,4244,7,NR4A3|KIT|MILR1|S100A13|SNAP23|CHGA
RESPONSE TO OXYGEN-GLUCOSE DEPRIVATION%GOBP%GO:0090649,0.9263336155800171,1.0,0.417369727047146,0.682179353041437,7657,2,IREB2|TSC1
DETOXIFICATION OF NITROGEN COMPOUND%GOBP%GO:0051410,0.23557692307692302,0.750277765814412,-0.472318875768865,-1.19564387042225,1371,5,GSTM3|GSTM1
CELLULAR RESPONSE TO IONIZING RADIATION%GOBP%GO:0071479,0.6162484049340711,0.9518465519698142,0.190499458104547,0.8929450727054459,7243,45,SIRT1|INTS7|LIG4|ATR|BLM|ECT2|RAD9A|INO80|RAD51|CLOCK|HRAS|NIPBL|RAD51AP1|KDM1A|TNKS1BP1|CRYAB|SPIDR|RAD1|ATM|MDM2|TLK2|MAPK14|EEF1D|RHOB|SWI5|NUCKS1|YAP1
REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010543,0.332461977186312,0.8293509737209019,-0.23494779088147502,-1.08845212242657,1398,22,FCER1G|PRKCD|PDPN|LYN|THBD|PRKCA|CD9|NOS3
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY REGULATING CELL SHAPE%GOBP%GO:0071963,0.646909398814564,0.96344123684964,0.5493367206223639,0.8978757786947429,5347,2,MARK2
REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040014,0.986441344075457,1.0,0.152532915948103,0.480838261177131,10039,12,GHRL|STAT5B|FGFR2|BBS2|PTCH1|PPIB
DEMETHYLATION%GOBP%GO:0070988,0.499871696176546,0.9143688619793578,0.211370779544188,0.9728034596213259,5843,42,CYP2C8|TDG|CYP3A5|KDM5D|C14orf169|KDM5B|KDM4B|ALKBH3|ALKBH1|KDM1A|ALKBH4|KDM3B|KDM8|PHF2|KDM4A|CYP2D6|FTO|TET2|APOBEC3D|JMJD6|APOBEC3C|TET1|PHF8
CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002374,0.96650337614193,1.0,-0.5156043228936921,-0.6897396233789059,7299,1,TLR2
CHEMICAL HOMEOSTASIS WITHIN A TISSUE%GOBP%GO:0048875,0.714803227399967,0.971081608033886,-0.34860974936177297,-0.8017295964044541,4340,4,RCN3|VEGFA|CTSH
POSITIVE REGULATION OF LONG-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048170,0.632151929357687,0.95809026474745,0.554507857733664,0.906327860243717,5225,2,NEURL1|NPTN
REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:0014842,0.017124979417092,0.277422272849102,-0.758522568757139,-1.7444434472262498,103,4,AKIRIN1|FGF2|CFLAR
RETICULOPHAGY%GOBP%GO:0061709,0.9202672605790649,1.0,-0.37237386269644296,-0.6369255490738399,6197,2,FAM134B|RB1CC1
PHENOL-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0018958,0.23976608187134502,0.7525035503527309,0.290678134128123,1.19196298929232,2664,28,CITED1|SNCAIP|PNMT|TGFB2|SULT1A3|DDC|DUOX1|HAND2|DRD4|TH|TRPC1|MOXD1|LRTOMT|GATA3|COMT|DBH|MAOA
MUSCLE CELL FATE COMMITMENT%GOBP%GO:0042693,0.550901556725277,0.931763873811087,0.44353341231961496,0.9398896692243109,4918,4,TBX2|MEF2C|TBX1
REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002837,0.465353833192923,0.8935333137980291,0.383889919561145,0.9991848053007409,4418,7,CEACAM1|KLRK1
ENDOSOME TO PIGMENT GRANULE TRANSPORT%GOBP%GO:0043485,0.10454967502321301,0.576535954147525,-0.45371784859952397,-1.4103526255719,562,8,CD63|AP1G1|AP1M1|BLOC1S5|BLOC1S6|BLOC1S3
RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009119,0.141347025067955,0.630107155356772,-0.22135609981533103,-1.27458441876972,467,42,MOCS3|GMPS|GTPBP1|PNP|MTRR|CDA|HPRT1|EFTUD1|NUDT18|CDADC1|RHOQ|ENPP4|AK4
RESPONSE TO NOREPINEPHRINE%GOBP%GO:0071873,0.53758389261745,0.9265056012720759,0.734505955006617,0.9757583925924592,4004,1,APLP1
POSITIVE REGULATION OF HEART INDUCTION%GOBP%GO:1901321,0.8267742466655691,0.9876441563834109,-0.31280895061539193,-0.7193952383366109,5020,4,DKK1
LATERAL LINE NERVE DEVELOPMENT%GOBP%GO:0048892,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904847,0.707694030686527,0.9695170059473192,0.39069211451826297,0.827913911519486,6318,4,CXCL13
ORGANELLE LOCALIZATION BY MEMBRANE TETHERING%GOBP%GO:0140056,0.4742983751846379,0.9003511540468891,0.16933592939909,1.00372033504982,6421,143,TMEM216|CEP83|AKAP9|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|UNC13B|CDK1|AHI1|RAB3IP|CKAP5|CEP290|CEP131|CEP152|MKS1|UNC13A|KIF24|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP162|CEP72|USO1|HAUS8|CEP164|CEP78|STX2|CEP192|FGFR1OP|CEP97|CNTRL|NPHP4|PLK1|RAB3B|SFI1|SYTL2|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|RAB3A|NEDD1|PPP2R1A|TMEM67|SSNA1|STX3|C2CD3|NDE1|STX1A|CEP250
STRESS GRANULE ASSEMBLY%GOBP%GO:0034063,0.8996683250414591,0.998912093067348,-0.179972413793103,-0.655657556469474,4339,12,ATXN2|CIRBP|DYNC1H1|ATXN2L|MAPT|C9orf72|G3BP1|RPS23|OGFOD1|EIF2S1|DDX3X|BICD1
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009184,0.184562425526281,0.6906809521658801,-0.905877812086458,-1.2118203692110001,1393,1,NUDT18
VISUAL LEARNING%GOBP%GO:0008542,0.49399747262005106,0.91071489001692,0.37354235240508504,0.9722522620185821,4690,7,RGS14|NF1|GRIN1
NEGATIVE REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:1904057,0.0719463087248322,0.515023940206536,0.9648213498015,1.28172211947923,535,1,NOV
NEGATIVE REGULATION OF MITOPHAGY%GOBP%GO:1901525,0.795710313782603,0.982694209546621,-0.598919276576974,-0.8011925771726741,6009,1,TSC2
PENETRATION OF ZONA PELLUCIDA%GOBP%GO:0007341,0.844832214765101,0.991298302704726,0.578352448169387,0.768315425261039,6293,1,HYAL3
REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051988,0.18451562192965199,0.6906809521658801,0.406621116019608,1.2818150703373201,1877,12,CCNB1|SPAG5|ECT2|NEK2|APC|RACGAP1
D-SERINE METABOLIC PROCESS%GOBP%GO:0070178,0.9756388190123131,1.0,-0.511027790030878,-0.6836174558310022,7368,1,SRR
NEGATIVE REGULATION OF BETA-GALACTOSIDASE ACTIVITY%GOBP%GO:1903770,0.4120217132265329,0.867015886388254,-0.7927878253198059,-1.06053644582846,3111,1,TERF2
MRNA METHYLATION%GOBP%GO:0080009,0.634778999792488,0.95916055221954,-0.229744793744313,-0.8652145018138521,3058,13,CBLL1|METTL16|ZC3H13|TRMT61B|TRMT6
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001020,0.986808726534754,1.0,0.0959784588483198,0.585832194667927,13614,176,SIRT1|FBXO18|AK6|MMS19|SIRT6|NPAS2|ATR|BLM|DHX9|THOC1|MARCH7|MUC1|FAM178A|PPP1R10|PARP1|TMEM161A|POLQ|WDR76|FBXO5|ANKLE1|RAD51|RTEL1-TNFRSF6B|NSMCE4A|H2AFX|RMI2|TIMELESS|SETD8|PARPBP|BRCC3|RAD51AP1|ING2|WRAP53|KDM1A|CASP9|NUDT16L1|SMYD2|ANKRD32|RIF1|C5orf45|CHEK1|RECQL5|XRCC1|SPIRE2|SPIRE1|DDX39B|FOXM1|SPIDR|FMN2|FIGN|ATM|WRNIP1|DDX5|CDKN2D|RFWD3|UIMC1|BRCA1|FAM35A|BRE|PARP9|EYA3|PARG|DDIAS|MDM2|RAD52|UBR5|RNF8|SETMAR|FAM168A|MAPT|MAGEF1|UBE2V2|MGMT|USP1|TP53BP1|TRIAP1|ARMT1|WAS|DDX11|AUNIP|IER3
REGULATION OF T-HELPER 1 CELL CYTOKINE PRODUCTION%GOBP%GO:2000554,0.632306932323399,0.95809026474745,-0.371256824573981,-0.853813138252799,3839,4,IL1R1|XCL1|IL18|IL1B
NEGATIVE REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903434,0.40778498609823904,0.867015886388254,-0.794772827525364,-1.0631918438010401,3079,1,RAB33B
REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:1900217,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0010901,0.7877852348993291,0.9819233677232551,0.607962064402294,0.807650479447823,5868,1,APOC2
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:1904951,0.03795620437956201,0.39140267791402705,-0.14291673573879002,-1.2772022850513,25,272,GPER1|FBXW7|OAZ2|BLK|HPS4|CD274|CCT4|TP53BP2|VPS28|IL1B|GZMB|C2CD2L|PLK3|BCAS3|PRKCD|TMEM30A|LGALS9|ITGAM|UBL5|FGR|GPI|BBC3|MYO1C|ATG13|CCT7|ANO1|FYN|FAM65A|ICE1|TCF7L2|VPS11|MYRIP|YWHAH|IL6|CSNK2A2|PRNP|CHP1|VAMP2|SH3GLB1|RNF31|TCP1|PANX1|MIEF1|VAMP3|MBP|IGF1|MAVS|MYOM1|BID|CEMIP|RIPK2|BAP1|LEPROT|ZPR1|PDCD10|GAPDH|YWHAQ|YWHAB|KARS|BAG3|PTP4A3|NLRP1|NLRP3|BCL2|TP53|YWHAZ|UBE2L3|YWHAE|TNFRSF4|UBE2D3|DRD2|ARIH2|ACSL3|BCAP31|TWIST1|PIK3R1|TNF|PMAIP1|TFDP2|TRH
RIBOFLAVIN BIOSYNTHETIC PROCESS%GOBP%GO:0009231,0.36348993288590603,0.849828746111777,0.82399647110719,1.0946425507771,2707,1,RFK
HEME EXPORT%GOBP%GO:0097037,0.0405225595742107,0.401971380179507,0.872511717673008,1.4260964332375,334,2,FLVCR1|FLVCR2
TRANSEPITHELIAL L-ASCORBIC ACID TRANSPORT%GOBP%GO:0070904,0.796510067114094,0.9828629179253789,0.602999558888399,0.80105801226568,5933,1,SLC23A2
INTERNEURON MIGRATION%GOBP%GO:1904936,0.24335560504825499,0.7565220534116759,-0.711000827129859,-1.2161288360370301,1638,2,LHX6|DRD2
LYMPHATIC ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060838,0.6252170892671071,0.954110852066186,0.47251150165086603,0.898194658294065,5399,3,PROX1
BIOTIN METABOLIC PROCESS%GOBP%GO:0006768,0.685551811288964,0.966495577318169,0.313714879018352,0.8165339185520601,6509,7,MCCC2|PCCB|MCCC1|PCCA
CELL-SUBSTRATE ADHERENS JUNCTION ASSEMBLY%GOBP%GO:0007045,0.7427238391468559,0.974505008828563,-0.18468963885958803,-0.794493792300419,3342,18,ACTN1|PIP5K1A|THY1|LAMA5|DLC1|TESK2|WHAMM|PEAK1
LYSOBISPHOSPHATIDIC ACID METABOLIC PROCESS%GOBP%GO:2001311,0.669667681715875,0.964618776001639,-0.659847816497574,-0.8826985427200691,5057,1,ACP6
CELLULAR RESPONSE TO NICOTINE%GOBP%GO:0071316,0.431088424172567,0.8785877309899279,-0.437135635979859,-1.00532064192054,2617,4,TNF
AXON EXTENSION%GOBP%GO:0048675,0.24234573716439,0.7565220534116759,-0.258146326501398,-1.17244795011818,1028,21,SEMA3F|NRP1|ALCAM|SEMA3A|HSP90AB1|SLIT3
TYPE B PANCREATIC CELL DIFFERENTIATION%GOBP%GO:0003309,0.474504249291785,0.9003511540468891,0.43070330502010296,0.9927072699667171,4354,5,CDK6|BMP4
POSITIVE REGULATION OF PROTEIN LIPIDATION%GOBP%GO:1903061,0.900708052033591,0.998912093067348,-0.285280979429769,-0.656086655404297,5469,4,SVIP|RAB3GAP2|RAB3GAP1|GBA
RESPONSE TO CALORIC RESTRICTION%GOBP%GO:0061771,0.44818802825054993,0.8850378987593649,0.535111793819728,1.01719122840352,3870,3,APOE|LDLR|SIRT2
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070664,0.999310225901017,1.0,0.0849982834733147,0.38336419197615296,11589,39,GLMN|BMP4|MARCH7|DLG5|GSTP1|BTN2A2|PLA2G2D|CEBPB|CTLA4|ATM|RC3H1|TNFRSF14|XCL1|MNDA|PDCD1LG2|NDFIP1|FOXP3|SDC4|LILRB2|KIAA0922|LST1|SOX11|CD300A
NEGATIVE REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045623,0.846544318625537,0.991298302704726,-0.21662045203748498,-0.699270231001175,4335,9,SMAD7|SOCS5
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051043,0.274819494584838,0.7884684708511421,-0.25843962757984,-1.13338006577777,1217,19,SNX9|TIMP3|FURIN|IL1B|PTPN3|TNFRSF1B|TIMP2|ADRA2A|TNF
REGULATION OF NEURONAL ACTION POTENTIAL%GOBP%GO:0098908,0.668171818918606,0.964618776001639,0.456893914966437,0.868507268915418,5770,3,FGF12
VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION%GOBP%GO:0021514,0.881113123662111,0.9956508825790341,-0.293383297694127,-0.674720294778746,5350,4,ASCL1
DNA SYNTHESIS INVOLVED IN UV-DAMAGE EXCISION REPAIR%GOBP%GO:1904161,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
EGG ACTIVATION%GOBP%GO:0007343,0.302746844840386,0.8054013181463249,-0.678892295302485,-1.16120891196928,2038,2,PLCB1
MITOCHONDRION-ENDOPLASMIC RETICULUM MEMBRANE TETHERING%GOBP%GO:1990456,0.10379981464318801,0.5762751358718871,-0.946294662549625,-1.2658872223750202,783,1,PDZD8
CGMP-MEDIATED SIGNALING%GOBP%GO:0019934,0.0155429955591441,0.26480477175586303,-0.5116380878643689,-1.80051817581902,76,11,PRKAR2A|PDE9A|PRKAR1B|CD36|PDE3A|AQP1
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:0060373,0.21784949777704601,0.7341474817293291,-0.53134525369631,-1.22198308158985,1322,4,SMAD7|SCN5A
EOSINOPHIL DEGRANULATION%GOBP%GO:0043308,0.29540589494483804,0.800447413278835,-0.489439144101914,-1.12560778401569,1793,4,VAMP7|CCL3|VAMP8|VAMP2
NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006809,0.0437329168293635,0.412001737413835,-0.49900488381301394,-1.61083248184829,223,9,GCH1|CYP1B1|GCHFR|NQO1|SPR|DDAH2|NOS3
FRUCTOSE 6-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006002,0.04551845342706501,0.4190278528102411,-0.58674531282236,-1.61057648663072,258,6,GFPT1|PFKP|PFKL|FBP1|GFPT2
HISTONE LYSINE DEMETHYLATION%GOBP%GO:0070076,0.705960264900662,0.968941691852291,0.22288289374193102,0.814671077761718,7461,19,KDM5D|C14orf169|KDM5B|KDM4B|KDM1A|KDM3B|KDM8|KDM4A
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903589,0.58844896476571,0.945418171231938,-0.30374782630309005,-0.8860458853914058,3239,7,GATA2|VEGFA|HMOX1|APLNR
GENE LOOPING%GOBP%GO:0090202,0.9937156323644929,1.0,-0.245844412136359,-0.498933930072475,6324,3,RUVBL2
REGULATION OF VACUOLE ORGANIZATION%GOBP%GO:0044088,0.00941046221976197,0.21235063347774397,-0.32856432635474797,-1.7679674605220903,33,34,PIP4K2B|LAPTM4B|SEC22B|PINK1|IFT20|SCFD1|KIAA1324|PIKFYVE|FEZ2|RAB3GAP2|MTMR3|LRSAM1|NPRL2|SCARB2|MTM1|RAB1B|C9orf72|PIP4K2C|ANXA2|NPRL3|PHF23|SMCR8|FEZ1|CHMP4A|UBQLN2|IFT88|RAB3GAP1|TBC1D14|SH3GLB1|PIP4K2A|VPS16|RALB|RAB5A|CHMP4B
CHRONIC INFLAMMATORY RESPONSE%GOBP%GO:0002544,0.816487206205859,0.9866358717238399,0.397148451519635,0.7549374278898942,7051,3,CXCL13|THBS1
REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BINDING%GOBP%GO:1905858,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042996,0.399162371134021,0.8638522656500329,0.4301767176473,1.05795698785022,3716,6,CNST|PKDCC|GOPC
POSITIVE REGULATION OF OLIGOPEPTIDE TRANSPORT%GOBP%GO:2000878,0.591239792130661,0.945418171231938,-0.5252274607113321,-0.898373442163235,3981,2,CA2|SLC26A6
MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:0072497,0.118782479584261,0.602329212916938,-0.7907361455748549,-1.3525118278867,799,2,FZD1|WNT3
CELLULAR RESPONSE TO MURAMYL DIPEPTIDE%GOBP%GO:0071225,0.128876508820799,0.609284573959819,-0.439285560874021,-1.36549079139567,693,8,NOD1|VIM|RIPK2|LDOC1|ARHGEF2
NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090209,0.527101335428123,0.9265056012720759,-0.460791882651373,-0.935163435112879,3354,3,GPLD1|SIK1|FBXW7
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030178,0.871354166666667,0.9934031064448321,-0.107204446086783,-0.8055361219990659,1672,110,NXN|DKK1|PARK2|GREM1|SFRP2|SLC9A3R1|RBMS3|WWOX|SOX17|CAV1|TLE3
MUSCLE HYPERTROPHY%GOBP%GO:0014896,0.6651821862348181,0.964618776001639,0.29436653653818606,0.840021517069467,6571,9,RYR2|TCAP|SORBS2|INPP5F|PDLIM5
REGULATION OF PRESYNAPSE ASSEMBLY%GOBP%GO:1905606,0.8183799491463859,0.987153241368501,-0.24768503388670898,-0.722508232632962,4505,7,EIF4G1|SNCA
HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0042446,0.0851908672502482,0.547051551970283,0.35088054209544,1.42650897531615,943,27,FDXR|CYP21A2|STAR|FDX1|AKR1B1|BZRAP1|CACNA1H|HSD17B11|SRD5A3|HSD11B1
CELLULAR RESPONSE TO ORGANONITROGEN COMPOUND%GOBP%GO:0071417,0.00495049504950495,0.16299234297187198,-0.16820037017919398,-1.51694711809342,2,287,ADCY7|IMPACT|RAB13|RRAGD|PRKCD|CTNNB1|IGF1R|CPEB1|NSMF|USF1|BCAR1|FOXO4|RRAGC|GRB2|ABL1|CRHR1|RAB8B|FYN|SLC9A1|INPP5K|HDAC5|FOXO1|CASP3|PKM|VIM|CPEB2|ATP6V0C|PXN|ATP6V1F|PPARG|SH3BP4|LYN|FCGR2B|PRNP|VAMP2|HTR1B|NAMPT|CAMK2A|PRKAR2A|GCGR|LAMTOR5|IGF1|FOXC2|LPIN1|ATP2B4|RIPK2|RAP1A|CTNNA1|RAB8A|PTPN1|SHMT2|LDOC1|SNCA|ARHGEF2|PDE4B|RYR1|ADRB2|SLC25A33|STAT5A|RAPGEF1|SHC1|ATP6V1E2|ATP6V0D1|GABRG2|STAT3|TP53|PRKAR1B|ADCY2|MAPK3|CAV2|PARK2|ATP6V1E1|RHOQ|IGF2|CD36|SESN2|PIK3R1|PDE3A|AQP1|HRH1|CAV1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903409,0.117204301075269,0.59848124656036,-0.34115983367121694,-1.3605758955510199,544,15,GCH1|CYP1B1|GCHFR|CYBA|SOD1|NQO1|SPR|DDAH2|NOS3
CLATHRIN COAT DISASSEMBLY%GOBP%GO:0072318,0.123487824037706,0.607607158836689,-0.686279916179552,-1.3927846996146203,785,3,SYNJ1|DNAJC6|GAK
REGULATION OF PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901629,0.400402684563758,0.8638522656500329,0.8069585355094839,1.07200841345174,2982,1,APOE
NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY%GOBP%GO:0034356,0.717273887852303,0.971081608033886,0.24632328656145996,0.7949768044692421,7303,13,PARP16|NAPRT|RNLS|PTGS2|PARP10|PARP9|NUDT12
B CELL ADHESION%GOBP%GO:0097323,0.0883221476510067,0.556932119338259,0.95666078517865,1.27088117344637,657,1,CD209
INDUCTION BY VIRUS OF HOST CELL-CELL FUSION%GOBP%GO:0006948,0.639878194095062,0.96058002537611,-0.6743493603881779,-0.902097700130897,4832,1,CD4
NEGATIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010561,0.869534412955466,0.993389838333952,0.233878685152357,0.6674098565086359,8590,9,ABCA7|ITM2C|ACER2|TMEM59|ITM2B|JAK3
BRAINSTEM DEVELOPMENT%GOBP%GO:0003360,0.48028279654359796,0.9046812288131709,-0.4755989336239149,-0.965213905124847,3056,3,SCN5A
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051044,0.5227848101265821,0.925279388747069,-0.24278738001426897,-0.940622585124972,2477,14,FURIN|IL1B|TNFRSF1B|ADRA2A|TNF
B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050853,0.5914215478511489,0.945418171231938,0.19234286148693,0.90762312689712,6976,46,IGHV3-21|IGHV4-61|IGHG1|LIME1|CD38|IGLL5|IGHG4|PRKCB|IGHV1-18|IGHV3-43|PLEKHA1|IGHV1-24|CD79A|IGHG2|CTLA4|LCK|BTK|IGHV1OR15-1
GLOMERULAR MESANGIUM DEVELOPMENT%GOBP%GO:0072109,0.8371104815864019,0.9889652677625541,0.306088682991396,0.705489039249222,7682,5,ACTA2|EGR1|PDGFB|PDGFRB|CD34
NEUROMUSCULAR PROCESS CONTROLLING POSTURE%GOBP%GO:0050884,0.250434178534213,0.761997433073433,0.6186419144741679,1.17597320072874,2162,3,TMEM150C|PRRT2
PURINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0042278,0.0338745800671893,0.37600329791737297,-0.28047588492111303,-1.5428675566943502,120,36,MOCS3|GMPS|GTPBP1|OARD1|PNP|MTRR|HPRT1|EFTUD1|NUDT18|MACROD2|RHOQ|ENPP4|AK4
STEM CELL POPULATION MAINTENANCE%GOBP%GO:0019827,0.6066141459613891,0.9508825506493929,0.19985969331195802,0.895328916387621,7006,38,ZCCHC11|HES1|LIG4|CDH2|PROX1|ZNF358|MTF2
POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071805,0.00129073894804776,0.0945022140486112,0.366901770034059,1.9046416128792,15,70,KCNK2|KCNN2|KCNK6|KCNH8|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|KCNQ1|SLC9A5|SLC9A7|ATP1B3|KCNH1|LRRC55|PKD2|KCNC3|KCNC1|KCND1|KCNB2|HCN3|KCNJ11|KCNH2
ADENOSINE METABOLIC PROCESS%GOBP%GO:0046085,0.518359953894286,0.9236324326350509,-0.40605525836872,-0.9338422663332391,3147,4,ADAL|CECR1|NT5C2|ADA
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUR TASTE%GOBP%GO:0001581,0.10459420097974301,0.576535954147525,-0.9459086898985442,-1.26537089499146,789,1,PKD2L1
REGULATION OF LENS EPITHELIAL CELL PROLIFERATION%GOBP%GO:2001109,0.9157950483251691,1.0,-0.540968239964711,-0.7236697085841569,6916,1,SOX11
CELLULAR RESPONSE TO UV-B%GOBP%GO:0071493,0.44115510352342896,0.880402968441571,-0.34158526592280897,-0.9964193754566321,2428,7,CDKN1A|CRIP1
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042985,0.624210067552844,0.9536478716552259,0.379682526333142,0.8751119384901109,5728,5,ABCA7|ITM2C
KERATAN SULFATE CATABOLIC PROCESS%GOBP%GO:0042340,0.307388663967611,0.8104595718432149,0.40021827691246203,1.1420862170157802,3036,9,PRELP|FMOD|HEXA|OGN|LUM|GNS
POSITIVE REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901978,0.103982530934803,0.5762893149145369,0.514848974185785,1.40361642911291,999,8,TPR|XRCC3|GEN1|NDC80
PANCREAS DEVELOPMENT%GOBP%GO:0031016,0.250225631768953,0.7617622587730941,-0.26411584035680397,-1.15827294490304,1108,19,EIF2AK3|TCF7L2|NKX6-1|FOXO1|IL6|DNAAF1|INSM1
CELLULAR ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0044108,0.364582073303496,0.85007225273817,0.6583416905456011,1.07604140749258,3013,2,C14orf1|CYP27B1
POSITIVE REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050766,0.35042735042734996,0.842847021021096,-0.19285764347201803,-1.0713158002546999,1229,37,CYBA|GATA2|PYCARD|CALR|IL1B|FCER1G|SIRPA|ITGAM|CD300LF|CAMK1D|FCGR2B|SLC11A1|LMAN2|ANO6|LYAR|TNF
POSITIVE REGULATION OF CELL ADHESION%GOBP%GO:0045785,0.00125,0.0932488738738739,-0.17424634657135799,-1.50395553904077,0,234,IL6ST|TRIOBP|CXCL12|RELA|TRAF6|VCAM1|RUNX3|CD44|PPM1F|FLOT1|CD86|IL6R|RREB1|PYCARD|MMRN1|CALR|ARL2|THY1|CRKL|S100A10|NCK2|FLCN|PTPN6|CD274|ICOSLG|IL1B|RARA|FAM49B|IRAK1|VEGFA|KDR|CX3CL1|SIRPA|MAP3K8|COL16A1|LGALS9|PTK2B|PDPN|EPB41L4B|PRKD2|GRB2|PTPRU|ABL1|VAV1|MMRN2|RPS3|RET|CITED2|FYN|RHOA|NRP1|C1QBP|MYADM|RUNX1|PPAP2B|DOCK5|TNFRSF18|IL6|PNP|TFE3|LYN|PODXL|CD276|YES1|IGF1|SERPINF2|FOXC2|MAP4K4|CRK|EMILIN2|ETS1|SMAD7|CDC42|NPNT|TFRC|NLRP3|PRKCA|LIMS1|SOCS5|BCL6|NKAP|SFRP2|DUSP10|DENND6A|CBFB|RAC1|IGF2|CD36|PIK3R1|CDH13|TNF|EMILIN3|CAV1|PAK2
MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0098828,0.16116026430731303,0.663924163480949,0.607226902800508,1.2867718123702498,1438,4,RIMS2|UNC13B|RIMS1|NLGN2
STRIATED MUSCLE MYOSIN THICK FILAMENT ASSEMBLY%GOBP%GO:0071688,0.462951030927835,0.891507554237553,0.40642550920516496,0.9995443497170571,4310,6,IGSF22|TCAP|OBSL1|MYOM2
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000766,0.18198700092850498,0.6875189360012,-0.40958035701071205,-1.2731540839218798,979,8,CPEB1|CPEB2|FMR1|RBM24
MYELIN MAINTENANCE%GOBP%GO:0043217,0.8519376579612471,0.991298302704726,0.261666715872594,0.6810634852088061,8089,7,CXCR4|MYRF
"REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903689",0.194903339191564,0.7067646595908679,-0.45662125641167106,-1.25339468897482,1108,6,CLASP2|MTOR|PTEN|CLASP1|PHLDB2|RREB1
NEGATIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0045719,0.618108520374809,0.9532238181782521,0.38206959655291794,0.88061378148382,5672,5,PASK|VIMP|GSK3A
INTERCELLULAR TRANSPORT%GOBP%GO:0010496,0.211439163246392,0.726180834202302,-0.893250992501103,-1.19492908766317,1596,1,ARC
NEGATIVE REGULATION OF EXOCYTOSIS%GOBP%GO:0045920,0.0362190812720848,0.384256377288275,-0.38287000020745,-1.6110729241887098,163,17,CD84|STXBP3|RAB33B|LGALS9|FCGR2B|VPS4B|SNCA|FMR1|RAB7A|PARK2|ADRA2A
NEGATIVE REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:0039534,0.9718893493112328,1.0,0.259116161579263,0.549091898451856,8677,4,TKFC|DHX58
TENDON FORMATION%GOBP%GO:0035992,0.410789887504536,0.867015886388254,0.638082480104241,1.04292828457924,3395,2,BMP4|SCX
PROTEIN TO MEMBRANE DOCKING%GOBP%GO:0022615,0.0483896307934014,0.433647551715109,-0.764806440939671,-1.55215194848977,307,3,SNX3|PEX16|RAB7A
SEQUESTERING OF CALCIUM ION%GOBP%GO:0051208,0.255760101887229,0.767206100763278,0.615934797130714,1.17082725543689,2208,3,HSP90B1|ATP7B
REGULATION OF CORTICOTROPIN-RELEASING HORMONE RECEPTOR ACTIVITY%GOBP%GO:1900010,0.07624161073825501,0.525661416287861,0.962781208645787,1.27901188297102,567,1,CRHBP
"FATTY ACID ELONGATION, SATURATED FATTY ACID%GOBP%GO:0019367",0.256591850076269,0.767319904137432,0.515488863315952,1.18812541310018,2354,5,ELOVL6|ELOVL4|ELOVL2|ELOVL1|ELOVL5
G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:0002031,0.485591964432735,0.9067242420344581,-0.41738677405945895,-0.95990238518539,2948,4,ARRB2|ARRB1|ADM
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061098,0.0413346613545817,0.402998391331252,-0.313163205496299,-1.5377231853583602,165,26,FYN|PRNP|EFNA1|DOCK3|PTPN1|ADAM17|RELN|ADRA2A|ACE|GPRC5B
GENITALIA DEVELOPMENT%GOBP%GO:0048806,0.263179785795986,0.774572673283691,0.434042089585705,1.18331518253963,2530,8,TBX3|DNAJC19|NIPBL|CHD7|LRP6
GLYCOSYLATION%GOBP%GO:0070085,0.20265853127042896,0.7169847518722969,0.19386237307204102,1.17799990123665,2789,170,B3GALT2|GALNT10|GALNT8|FUT9|MUC15|GALNT13|FUT7|SDF2|GCNT2|GALNT3|TMEM165|C1GALT1C1|B3GLCT|FUT2|ALG6|ASGR1|FUT8|ALG1L|MGAT5B|B3GALT1|OGT|ST3GAL5|POGLUT1|MVD|MOGS|ALG14|ALG13|DERL3|MUC1|SRD5A3|DPAGT1|FUT10|NUDT14|MPDU1|ALG2|COG6|PIGB|DPY19L3|MGAT2|DOLPP1|ST8SIA3|SYVN1|RFNG|LFNG|B3GALNT1|B3GALT6|OSTC|ALG5|ST3GAL4
BONE REGENERATION%GOBP%GO:1990523,0.0719463087248322,0.515023940206536,0.9648213498015,1.28172211947923,535,1,NOV
POSITIVE REGULATION OF MEMORY T CELL ACTIVATION%GOBP%GO:2000568,0.399443929564412,0.8638522656500329,-0.798522276135862,-1.06820759552704,3016,1,FAM49B
NEGATIVE REGULATION OF PLASMA LIPOPROTEIN OXIDATION%GOBP%GO:0034445,0.57744966442953,0.942692029750853,0.7155932951036609,0.95063376766496,4301,1,APOM
REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046880,0.3534956794972511,0.842847021021096,-0.527928307625151,-1.07141481488637,2249,3,INHBB
GLUCOSE HOMEOSTASIS%GOBP%GO:0042593,0.0164989939637827,0.27351335238659197,-0.22064027325019603,-1.50352748601492,40,75,PTPRN|IGF1R|USF1|PRKAA1|FOXO4|CEBPA|CRTC2|ADRA1B|INPP5K|TCF7L2|FOXO1|RAB11FIP2|PPARG|GCGR|TRA2B|LEPR|HK1|PPARGC1A|HK2|STAT3|ADRA2A|RAB11FIP5|GPRC5B|PIK3R1|FOXO6|FOXO3
CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0007268,0.648499433748584,0.963755998259649,0.144883939566359,0.912649716343452,9161,220,SYT17|PCDHB4|CHRNA10|RIT2|SLC1A2|AKAP9|CACNB4|PCDHB6|CACNB2|RIMS2|PCDHB14|KCNK3|UNC119|CRHBP|PCDHB13|GRM4|PCDHB9|AKAP5|APBA3|UNC13B|SYT3|GRIK2|LIN7A|LIN7B|PENK|GRIA2|DLG3|BZRAP1|DLGAP1|NPY|GPR176|DVL1|UNC13A|PPFIA3|ATXN3|DOC2A|CPLX3|SPG11|ZACN|STAC3|SLC6A9|APOE|NPTX2|GRIN1|PCLO|CASK|DLGAP2|SNAP47|PRRT2|STX2|SLC6A2|DRD4|DLG4|TH|KCND2|MYCBPAP|BRSK1|NOVA1|RIMBP2|CACNB1|SYNJ2BP-COX16|PCDHB16|SLC1A3|SYT1|SEPT5|CORT|GRIK5|SLC6A1|RIMS4|PCDHB11|NPAS4|SYNJ2BP|PLP1|GSK3A|RIC3|APBA2|RAB3A|SLC1A1|NLGN3|SYT7|STX3|SNAPIN|GABRB3|PIP5K1C|STX1A|AKT1|MINK1|PCDHB3|SLC18A2|LRP6|DTNA|MPP2|RIMS1
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045743,0.32915521978022,0.828303707528737,-0.432439885285683,-1.0946928541152499,1916,5,DSTYK|NPTN|SMOC2|FGFBP3|PRKD2
L-PHENYLALANINE METABOLIC PROCESS%GOBP%GO:0006558,0.273537604456825,0.7884684708511421,-0.370611533417495,-1.1520220128786498,1472,8,PAH|PCBD1|QDPR
MEMBRANE RAFT ASSEMBLY%GOBP%GO:0001765,0.0183522061694651,0.285037997475661,-0.5552461929525239,-1.7923844676551899,93,9,EMP2|FLOT1|S100A10|RFTN1|CAV2|CAV1
REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048021,0.371425263401644,0.852609194081082,0.564426359228422,1.07291513346891,3207,3,CDH3|RAPGEF2|ZEB2
NEGATIVE REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051572,0.6832962138084631,0.9663106118043521,-0.48822718500137896,-0.8350864521693729,4601,2,BCOR|H2AFY
NEGATIVE REGULATION BY HOST OF VIRAL EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:0044869,0.813020134228188,0.985971473561293,0.594894133215704,0.7902903158681809,6056,1,PTX3
MESENCHYME DEVELOPMENT%GOBP%GO:0060485,0.5070281124497991,0.917492632242256,-0.131625341964725,-0.9767463440821229,1009,105,CTNNB1|TGFBR1|ACVR1|SEMA3F|CITED2|NRP1|MEOX1|SEMA7A|HGF|NOLC1|SMAD2|EFNA1|SNAI1|WNT11|SEMA6B|PDCD4|TBX20|LIMS1|NOS3|S100A4|SFRP2|ACVRL1|SEMA3A|CORO1C|SEMA3G|OLFM1|RBPJ
POSITIVE REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0090073,0.85103475204998,0.991298302704726,-0.21596117493462696,-0.69714202543391,4358,9,LGALS3|GNL3L
RETINA VASCULATURE DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061298,0.39442874444893,0.863562957467761,-0.29511282703751696,-1.03853880624157,1953,11,PDGFRA|ACVR2B|BMPR2|FZD4|LRP5L|PDGFRB|CYP1B1|LRP5|NRP1|ACVRL1
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0032056,0.494333791208791,0.91071489001692,-0.376185748952129,-0.9522892434536601,2878,5,NCK1|PPP1R15A|EIF2AK4|DNAJC3|IMPACT
NEGATIVE REGULATION OF MRNA PROCESSING%GOBP%GO:0050686,0.883317490494297,0.996316041142784,-0.14738711526028603,-0.6828062431296371,3716,22,NELFE|RNPS1|SAP18
ANTIBIOTIC TRANSPORT%GOBP%GO:0042891,0.6222488559599039,0.9536478716552259,0.38033092508971705,0.876606401504409,5710,5,SLC13A3|SLC25A1|SLC13A4|SLC26A6
ENDOCARDIAL CELL FATE COMMITMENT%GOBP%GO:0060957,0.35350191976698,0.842847021021096,-0.822838553153948,-1.1007362206912,2669,1,ACVR1
CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:0060379,0.49854703959317104,0.913423777265461,-0.326443718209003,-0.95225080900609,2744,7,GREM1|RBPJ
METANEPHRIC NEPHRON DEVELOPMENT%GOBP%GO:0072210,0.443825910931174,0.881002146821428,0.35566597713374,1.0149491759336702,4384,9,BMP4|PKD2
POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051894,0.0013172338090011,0.0945022140486112,-0.526171975194933,-2.15485107981051,5,16,PPM1F|THY1|S100A10|VEGFA|KDR|COL16A1|ABL1|NRP1|MAP4K4|LIMS1|RAC1
POSITIVE REGULATION OF MONOPHENOL MONOOXYGENASE ACTIVITY%GOBP%GO:0032773,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
LOCALIZATION WITHIN MEMBRANE%GOBP%GO:0051668,0.8254979437142171,0.9876441563834109,0.14545590123878,0.757210407896999,10236,71,GPHN|LRRC7|MADCAM1|CD2|NUP133|DNM3|DLG3|SEC31B|DNAJA3|MIA3|DVL1|ITGA4|AP3D1|APOE|SEC31A|MAGI2|SEC24D|DLG4|NDC1|SYNJ2BP-COX16|SEC24C|SYNJ2BP|AGRN|DNM1|HIP1
CYTOSOL TO ER TRANSPORT%GOBP%GO:0046967,0.5188097254142979,0.9236815018871851,0.596581196581197,0.9750955767677779,4288,2,TAP2|TAP1
POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:1902459,0.750604026845638,0.97622649654938,0.627701808557565,0.8338738489056792,5591,1,NCOA3
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:1900145,0.238448298689263,0.750892237039908,-0.880458756065285,-1.17781652295095,1800,1,SMAD2
DETECTION OF OTHER ORGANISM%GOBP%GO:0098543,0.8852161278605161,0.996643473105967,-0.229067843353558,-0.668201061878145,4873,7,NLRC4|CD1D|TLR4|TLR2|TLR1|NOD1|SSC5D
REGULATION OF TONGUE MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001035,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
MONONUCLEAR CELL DIFFERENTIATION%GOBP%GO:1903131,0.741184767277856,0.974505008828563,0.26274071937398497,0.775415742336807,7356,10,BMP4|PIR|PDE1B
PHOSPHATIDYLCHOLINE METABOLIC PROCESS%GOBP%GO:0046470,0.636984568682014,0.959271399361425,0.18467632928485897,0.879620086058355,7553,48,ENPP2|LPCAT4|STARD10|MFSD2A|PLA2G4A|CEPT1|ABHD3|RARRES3|CHKB|CETP
NEGATIVE REGULATION OF CELL SIZE%GOBP%GO:0045792,0.9083104395604399,1.0,-0.256066622545775,-0.6482156512762571,5289,5,DEPTOR|RDX|PTEN|AKT1S1|RHOA
FERROUS IRON EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903988,0.398389261744966,0.8638522656500329,0.808226731363035,1.07369315506495,2967,1,SLC40A1
PUTRESCINE BIOSYNTHETIC PROCESS FROM ORNITHINE%GOBP%GO:0033387,0.76967792615868,0.9792758096555699,-0.374830032449325,-0.7607064141665558,4898,3,ODC1
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS%GOBP%GO:0006782,0.398209749606871,0.8638522656500329,0.6430658946787979,1.05107353879895,3291,2,CPOX|IREB2
NEGATIVE REGULATION OF CELLULAR PH REDUCTION%GOBP%GO:0032848,0.127763802462598,0.6076669536424699,-0.933722981914424,-1.24906970188198,964,1,BCL2
REGULATION OF SPINDLE ELONGATION%GOBP%GO:0032887,0.25181208053691295,0.763905256448548,0.8767093074547858,1.1646692021785199,1875,1,NUMA1
OLIGOPEPTIDE TRANSPORT%GOBP%GO:0006857,0.0846325167037862,0.545178773025535,-0.824262475875379,-1.4098568203103403,569,2,ABCC1|SLC9A3R1
EVASION OR TOLERANCE OF HOST IMMUNE RESPONSE%GOBP%GO:0020012,0.504302925989673,0.9170017397928191,-0.744320688134098,-0.9957004786645121,3808,1,EIF2AK2
REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903433,0.35159613956941405,0.842847021021096,-0.64863523573201,-1.10945583203844,2367,2,RAB27A|RAB33B
ALPHA-BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002287,0.9288172043010748,1.0,-0.16044665225361998,-0.6398755833270551,4318,15,RORC|GPR183|BATF|IL6|FOXP1|STAT3
CELLULAR RESPONSE TO OLEIC ACID%GOBP%GO:0071400,0.160201244538594,0.661454203640901,-0.9171812968681079,-1.22694138544377,1209,1,DGAT2
TRIGEMINAL NERVE DEVELOPMENT%GOBP%GO:0021559,0.8997315436241609,0.998912093067348,0.551720335244817,0.73293585138354,6702,1,ISL1
HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034384,0.544998910438004,0.9301996244217031,0.406786349354367,0.937582232642614,5001,5,SCARB1|APOE|APOM|APOC2
ADHESION OF SYMBIONT TO HOST%GOBP%GO:0044406,0.868927125506073,0.9931871192124442,0.23418257011309898,0.66827704035616,8584,9,CD209|SCARB1
GUANINE SALVAGE%GOBP%GO:0006178,0.829250185597624,0.9876441563834109,-0.42657159577855,-0.7296278688658671,5584,2,HPRT1
DSRNA TRANSPORT%GOBP%GO:0033227,0.17149220489977698,0.674379448319819,-0.7534050179211469,-1.28865893336234,1154,2,FLOT1|RFTN1
CORONARY VASCULATURE DEVELOPMENT%GOBP%GO:0060976,0.916136114160263,1.0,-0.159461908691905,-0.6530501097214351,4172,16,TBX1|MESP1|TGFBR3|NDST1|NOTCH1|VEGFA|TGFBR1|NRP1|APLNR
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007207,0.148939512961508,0.641505142823287,-0.6633562470093339,-1.34626179412579,947,3,GNA15|CHRM1
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:1905706,0.314709386998544,0.8164430838831159,-0.8435707984119979,-1.12847037729375,2376,1,DNAJC30
PROTEIN-DNA COMPLEX REMODELING%GOBP%GO:0001120,0.724573125463994,0.972554563883587,-0.469864902122967,-0.8036787507268159,4879,2,GTF2E1|ERCC3
POSITIVE REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061087,0.20516452386140802,0.7211951452265429,0.541749393337745,1.24865204190002,1882,5,OGT|MTF2|PHF19|PHF1|ZNF304
MICROTUBULE-BASED MOVEMENT%GOBP%GO:0007018,0.0353356890459364,0.382137421231133,-0.158517600124642,-1.3195007637391298,39,187,DNAL4|KIF13B|HAP1|RAB1A|DYNLRB2|WDR19|DNAI1|AP3S2|FMR1|CDC42|TRAF3IP1|LRRC6|BLOC1S6|CCDC103|BAG3|KIF3C|DYNLRB1|KIF3B|TTC30A|DYNLL2|TTC30B|TRAK1|DYX1C1|HTT|BLOC1S3|MAP4|KIF9|DYNC1LI1|KIF7|MAATS1|KIF13A|BICD1|TMEM108|DNAAF1|CFAP61|UBB
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903672,0.377323420074349,0.85375124052253,-0.199838695530709,-1.05085871156498,1420,31,FGF1|SRPX2|DLL1|GATA2|RHOJ|VEGFA|KDR|HMOX1|ITGA5|PKM|FGF2|SMAD1|APLNR|FOXC2|BMPER
T-HELPER CELL DIFFERENTIATION%GOBP%GO:0042093,0.9288172043010748,1.0,-0.16044665225361998,-0.6398755833270551,4318,15,RORC|GPR183|BATF|IL6|FOXP1|STAT3
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901020,0.162408353699178,0.664367762084791,-0.295737737092654,-1.2721980383952098,730,18,FKBP1B|CRHR1|PLN|FMR1|GNB5|YWHAE|ADRA2A|FKBP1A
REGULATION OF ACTIN FILAMENT LENGTH%GOBP%GO:0030832,0.9680088251516821,1.0,-0.0907862450790882,-0.6923762295172089,1754,117,CAPZB|ARF6|PLEK|TRIOBP|FCHSD1|CXCL12|KANK4|ARPC1B|PYCARD|CAPZA2|RLTPR|NCK2|HAX1|CDC42EP5|ADD1|PRKCD|CFL2|PTK2B|VASP|PFN1|WDR1|TMSB10|MYADM|WHAMM|NAT6|ARPC5|BIN1|WIPF1|TMSB4X|ARPC5L|ARPC4|TWF1|MTPN|ARPIN|SSH3|TWF2|ACTR2|BRK1|SH3BP1|JMY
REVERSE CHOLESTEROL TRANSPORT%GOBP%GO:0043691,0.477735240781785,0.9043208329627141,0.334575936375322,0.987420026445245,4741,10,ABCA5|SCARB1|CETP|APOE|APOM|LCAT|APOC2
REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905562,0.6374193548387099,0.9594603334792429,-0.21631076485311299,-0.862666655216453,2963,15,FGF2|PPARG|FGFR1|ADAM17|FLT1
TRANSCRIPTIONAL START SITE SELECTION AT RNA POLYMERASE II PROMOTER%GOBP%GO:0001174,0.25355704697986603,0.7641083395392759,0.87549625055139,1.1630577102006698,1888,1,GTF2B
XYLULOSE 5-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:1901159,0.45982142857142894,0.890371861972445,-0.386675650267416,-0.978843732068032,2677,5,SORD|XYLB
REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0060142,0.7654420670165519,0.9792236089291529,-0.216651587884091,-0.762423930230864,3791,11,EHD1|EHD2|CFLAR
RESPONSE TO MUSCLE ACTIVITY INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014873,0.50006619886138,0.9143688619793578,-0.746471107190119,-0.998577159801479,3776,1,AGT
CELLULAR RESPONSE TO BACTERIAL LIPOPEPTIDE%GOBP%GO:0071221,0.15848214285714302,0.6604486079157379,-0.5157180675049641,-1.3055060424476101,922,5,TLR2|CD14|TIRAP|TLR1|CD36
NEGATIVE REGULATION OF OLIGODENDROCYTE PROGENITOR PROLIFERATION%GOBP%GO:0070446,0.9683569442605591,1.0,-0.514666960741067,-0.688485685447408,7313,1,SIRT2
NEGATIVE REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090310,0.8920805369127521,0.9976191001250191,0.555249228054698,0.7376238280463969,6645,1,TET1
COBALAMIN METABOLIC PROCESS%GOBP%GO:0009235,0.169329736459846,0.673117535978459,-0.33850931567629194,-1.27481961244426,815,13,ABCC1|TCN2|MMACHC|MTRR|MMAA|PRSS3
"PHAGOCYTOSIS, RECOGNITION%GOBP%GO:0006910",0.0903877662479519,0.5602214808504239,0.35221910771154,1.41608952375822,992,26,IGHV3-21|IGHV4-61|IGHG1|IGLL5|IGHG4|ADGRB1|SCARB1|IGHV1-18|IGHV3-43
DENDRITIC TRANSPORT%GOBP%GO:0098935,0.7464257659073059,0.9749763305090959,-0.38342340355134,-0.778146405497828,4750,3,KIF17|KIF5C|KIF5A
REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032412,0.00141442715700141,0.0961252072968491,-0.20659244601721696,-1.6426728539809499,1,147,KCNE4|SLC9A1|PLN|RANGRF|YWHAH|KCNAB1|PRNP|MMP9|CHP1|VAMP2|SUMO1|HAP1|ARC|CRACR2A|CAB39|TMSB4X|CRH|FMR1|PDE4B|GNB5|NEDD4|JPH3|ADRB2|SLMAP|RELN|FXYD5|YWHAE|KCNG1|HTT|ADRA2A|JPH1|SLC9A3R1|CACNG3|DLG1|CACNG7|PDE4D|GAL|CAV1|STAC|FKBP1A|EPHB2|HOMER1
ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009067,0.205174718350201,0.7211951452265429,0.353101248196332,1.24533711014549,2148,17,ASNS|CTH|APIP|MTHFD1|MTR|MTAP|AASS|ENOPH1|MTHFR|GOT1|AASDHPPT|MRI1|ADI1|PLOD1
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002285,0.9217597694329069,1.0,0.134512129349465,0.6347327813569389,10873,46,DOCK10|LIG4|EXO1|SLAMF6|RORA|F2RL1|LEF1|CORO1A|MSH6
NEGATIVE REGULATION OF NITROSATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1905259,0.9766889383815891,1.0,-0.32368348497380794,-0.5536432656691012,6577,2,DNAJA1|PARK7
POSITIVE REGULATION OF CARDIAC CONDUCTION%GOBP%GO:1903781,0.486633603483731,0.907092544497897,0.6091478163594201,0.995635371570044,4022,2,RNF207|TRPM4
SUPPRESSION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039521,0.21845624255262802,0.7341474817293291,-0.8898323775915308,-1.19035590226594,1649,1,ATG7
ACTIN FILAMENT CAPPING%GOBP%GO:0051693,0.0474364150181671,0.42835031031399495,-0.45059143870065993,-1.58568741165346,234,11,CAPZA1|GSN|CAPZB|TRIOBP|CAPZA2|ADD1|TWF1|TWF2
METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072284,0.7723478891980159,0.979693198874896,0.497391121058716,0.812972123237057,6384,2,PKD2
HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:0042744,0.5234995692543309,0.92593403131991,0.27475980097047104,0.9525177178821741,5468,16,HBB|HBA2|PRDX4|PRDX3|HBA1|CAT|HBQ1|GPX3|PRDX2
CELL PROLIFERATION INVOLVED IN HEART VALVE DEVELOPMENT%GOBP%GO:2000793,0.0315106580166821,0.362898475253319,-0.984395677106308,-1.31685611123769,237,1,TWIST1
PTERIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042558,0.9001494023904381,0.998912093067348,-0.13847439655750698,-0.679949899693766,3614,26,SLC25A32|MTRR|SHMT2|FPGS|SPR|QDPR
POSITIVE REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903721,0.35333857030636295,0.842847021021096,-0.528064858201116,-1.0716919402232,2248,3,CX3CL1|DDRGK1
REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903050,0.00232018561484919,0.12234570424564199,-0.190975717041692,-1.53911140714468,2,159,CCAR2|PSMD10|PARK7|RPL11|EDEM1|RYBP|GBA|RNF217|PRKACA|RAD23A|CSNK1D|MAP1A|CSNK1A1|TAF9|RNF19B|NUDT15|FBXW7|OPHN1|TRIM39|CBFA2T3|CLU|PLK3|USP5|DAB2IP|TRIB1|UBE2J1|PTK2B|STYX|FAM192A|ARIH1|OS9|PRICKLE1|CEBPA|PML|PDCL3|PSME3|STUB1|RNF139|CSNK2A2|GLTSCR2|EFNA1|TRIB2|SUMO1|ECSCR|RNF144B|BAG5|RAD23B|SMAD7|FMR1|COMMD1|SOCS5|DYX1C1|ARIH2|GNA12|PARK2|HSPBP1|DDRGK1|BCAP31|CSNK2A1|HSP90AB1|GABARAPL2|BBS7|PSMF1|CAV1|TRIB3|UBB
"FRUCTOSE 1,6-BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0030388",0.0664729386124228,0.49812594405445004,-0.519828955740911,-1.5163641266092602,365,7,PFKP|TIGAR|PFKL|FBP1|ALDOA
REGULATION OF ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042663,0.275723830734967,0.7884684708511421,-0.693791933464067,-1.1866939450710903,1856,2,DKK1
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030514,0.306406029203957,0.809874675097403,-0.244299524079942,-1.10955859842857,1300,21,SMAD7|RBPMS2|GREM1|BMPER|NBL1
NEGATIVE REGULATION OF INSULIN SECRETION%GOBP%GO:0046676,0.437849462365591,0.878999860395433,-0.24965061940750402,-0.9956289737278291,2035,15,PARK2|ADRA2A|INHBB
TRANSEPITHELIAL CHLORIDE TRANSPORT%GOBP%GO:0030321,0.43163135347921705,0.8785877309899279,0.542035970940252,1.03035336071354,3727,3,SLC12A2|BEST1|SLC26A6
INTERLEUKIN-17 SECRETION%GOBP%GO:0072615,0.778366212101152,0.9811398289380491,-0.6074658138509039,-0.812625540665748,5878,1,ZBTB7B
LIPOPROTEIN TRANSPORT%GOBP%GO:0042953,0.4684413018612871,0.896021389039524,0.36376518035199606,0.99172147383368,4504,8,UNC119|MIA3|PRKCB|ZDHHC17
REGULATION OF CELL-CELL ADHESION INVOLVED IN GASTRULATION%GOBP%GO:0070587,0.0648383581547403,0.4956987271622679,-0.5210801433654679,-1.52001389642024,356,7,IL1RN|MAPK7|MYADM|MAP2K5|MBP
ICOSANOID CATABOLIC PROCESS%GOBP%GO:1901523,0.481476510067114,0.904752640722988,0.763288486987208,1.01399470224889,3586,1,ABHD16A
HETERODUPLEX FORMATION%GOBP%GO:0030491,0.6737720111214089,0.9647315640607691,-0.658138509042788,-0.880411950021455,5088,1,RPA2
IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002377,0.16292277697719798,0.664859563055667,0.270448927010644,1.27618825519059,1921,46,IGKV2-24|IGKV4-1|VPREB3|IGKV2D-29|IGLV9-49|IGKV1D-13|LIG4|IGLV5-52|EXO1|IGLV11-55|POLQ|IGKV3-11|MSH6|IGKV2D-28|TMIGD2|IGKV2-28
AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048846,0.0434540389972145,0.411224194190211,-0.517202313447128,-1.60768998392625,233,8,SEMA3F|NRP1|ALCAM|SEMA3A|SLIT3
MEMBRANE FUSION INVOLVED IN VIRAL ENTRY INTO HOST CELL%GOBP%GO:0039663,0.5800336983993261,0.942746898746279,0.34716906916801604,0.903608146782379,5507,7,CXCR4|CCR5
REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010975,0.260196905766526,0.7716907156875781,-0.12259360737708802,-1.0807624621722098,184,259,CX3CL1|DNM2|LPAR1|DAB2IP|TUBB2B|RTN4|NSMF|PTK2B|SRGAP2C|ABL1|SEMA3F|SCN1B|MAP3K13|CAMK1D|RET|BHLHB9|RHOA|SERPINI1|NRP1|CPNE6|SEMA7A|PTK7|YWHAH|LYN|EFNA1|ULK4|KIF13B|POU4F2|BAG5|ISLR2|ARC|SPOCK1|RAP1A|LIMK1|AMIGO1|FMR1|TWF1|C21orf91|NEDD4|SEMA6B|PLXNA1|CHRNA3|RAPGEF1|SSH3|PLXNA4|RELN|TWF2|ADCYAP1|COBL|NCS1|SYT2|FKBP4|SDC2|FBXO7|STK24|MYLIP|ZNF365|SEMA3A|SEMA3G|CPNE9|OLFM1|GPRC5B|LINGO1|FOXO6|RTN4RL2
ANGIOGENESIS%GOBP%GO:0001525,0.26925485284909195,0.784543299601953,-0.140130847496043,-1.09757121612724,429,132,RAMP2|FGFR1|LEPR|CXCL8|ID1|ADM2|SCG2|MCAM|GREM1|MYH9|SFRP2|BMPER|ACVRL1|PGF|SOX17|CDH13|RBPJ|EPHB2|RAMP1
VENTRAL SPINAL CORD DEVELOPMENT%GOBP%GO:0021517,0.633932057789926,0.95859649461824,-0.265647001049711,-0.857532324587042,3246,9,TBX20|ASCL1
HEPARIN CATABOLIC PROCESS%GOBP%GO:0030211,0.46153846153846206,0.891063005541905,-0.768416409351566,-1.0279340596095001,3485,1,IDUA
CELLULAR RESPONSE TO INTERLEUKIN-18%GOBP%GO:0071351,0.964457417582418,1.0,-0.22513750653304898,-0.5699206478889871,5616,5,ALOX5
REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032673,0.9476590106007071,1.0,-0.145419426048565,-0.611908219058597,4290,17,PRKCQ|ZP3|LEF1|CEBPB|GATA3|ZFPM1|NDFIP1|FOXP3|PRKCZ|SYK|HLA-E|HAVCR2|CD86|RARA|FCER1G|LGALS9|NLRP3
CELLULAR RESPONSE TO OXIDISED LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0140052,0.0610243370868144,0.48170831577441997,-0.526026518969948,-1.5344426935092301,335,7,TICAM1|MYD88|CD36
CELLULAR RESPONSE TO HYPEROXIA%GOBP%GO:0071455,0.10044459081178998,0.570947005522165,-0.6212369099728149,-1.4287151120010302,609,4,FOXO1|ATG7|CAV1
REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046320,0.732501666507952,0.972811555656631,0.22057089405766397,0.791232764996891,7691,18,SIRT4|NR4A3|ACADVL|PDK4|IRS1|AKT2|METTL20|LONP2|AKT1
POLY-N-ACETYLLACTOSAMINE METABOLIC PROCESS%GOBP%GO:0030309,0.0685236768802229,0.5037729184803449,-0.486690675238823,-1.51284652738071,368,8,B3GNT5|B3GNT7|B3GNT8|B3GNT2
METABOLISM OF MACROMOLECULE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052229,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010762,0.597219340112057,0.949097926455788,-0.23628910158165,-0.889860240038935,2877,13,FGF2|GNA12|CORO1C
NEGATIVE REGULATION OF MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1904290,0.29691275167785197,0.801756412936069,0.855039700044111,1.1358820954831699,2211,1,PPP1R10
AMINO ACID SALVAGE%GOBP%GO:0043102,0.368162998474613,0.851675851059934,0.47016180961613296,1.0836532736726,3378,5,APIP|MTAP|ENOPH1|MRI1|ADI1
NEGATIVE REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032205,0.760804899387577,0.977763214485385,0.177256918650512,0.782418492188659,8695,36,NAT10|PIF1|PARP1|SRC|SLX1B|RTEL1-TNFRSF6B|TNKS2|SLX4|TEN1|CTC1|ACD|XRN1|ATM|EXOSC10|POT1
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001028,0.0174310022826313,0.278447181841778,-0.4730482911608879,-1.7814908224913502,83,13,HSPB1|VEGFA|KDR|PRKD2|FGF2|TMSB4X|FGFR1|MET
CGMP BIOSYNTHETIC PROCESS%GOBP%GO:0006182,0.575652368686303,0.941940408834489,0.435969053971096,0.9238600712986429,5139,4,NPR2
POSITIVE REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000386,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION%GOBP%GO:1904465,0.34751677852349,0.842847021021096,0.8301720335244821,1.1028465099371,2588,1,CD200
T CELL CYTOKINE PRODUCTION%GOBP%GO:0002369,0.62356637863315,0.9536478716552259,-0.427681112717109,-0.8679661112954681,3968,3,DENND1B|SLC11A1
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010641,0.133379645710316,0.6194479383419461,0.6885408624682919,1.30884374777224,1151,3,HIP1R|F3|HIP1
NEPHRON MORPHOGENESIS%GOBP%GO:0072028,0.16483200918924099,0.667429120754799,0.3746359466469079,1.2987612295406001,1721,16,CITED1|BMP4|PKD2|AHI1|KLHL3
NEGATIVE REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900453,0.766299745977985,0.9792236089291529,0.49968192511698795,0.8167163795382341,6334,2,AGER
SNRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042796,0.13585237258347999,0.623227463256235,-0.492912690971265,-1.35301224004928,772,6,ZC3H8|ICE2|SNAPC4|SNAPC1|ELL|ICE1
POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION%GOBP%GO:0002666,0.66369710467706,0.964618776001639,-0.496443341604632,-0.849139748010037,4469,2,LILRB2|TGFBR2
CENTROSOME SEPARATION%GOBP%GO:0051299,0.769759450171821,0.9792758096555699,0.30826246723130496,0.7581266440521329,7167,6,NEK2|CNTROB|NDE1|NUP62
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046626,0.167016622922135,0.669562404312146,0.289367399264729,1.27727823514555,1908,36,SIRT1|MZB1|GRB14|INS|CISH|OGT|FAM132A|SOCS2|PRKCB|PRKCQ
NUCLEAR DIVISION%GOBP%GO:0000280,7.16794495018278e-05,0.0784645998831315,0.32183342786434804,1.99529002574759,0,196,HSPA2|KIF25|MUS81|SYCP2|EME2|MLH3|CCNA1|CCNB1|PSRC1|KIF14|NCAPD3|ZWINT|SPAG5|RAD54B|BLM|KIF2C|C11orf80|KIF18A|NSL1|BRIP1|KIF4A|MAP10|NUF2|KIF23|BUB1|TOP2A|PRC1|KIF11|DLGAP5|TUBGCP3|CDC23|SMC2|CCNE1|NDC80|WRAP73|NUSAP1|CENPE|KIF18B|PTTG1|RB1|CEP55|BUB1B|AKAP8L|INO80|ESPL1|AURKB|RAD51C|RAD51|BOD1|PIM2|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|MND1|TUBG2|FANCM|SPDL1|KIF22|PPP2R2D|REC8|TUBGCP6|CDCA5|KLHL22|CEP192|MYBL1|DSCC1|CHEK2|SLX4|PLK1|TUBGCP2|NCAPG|POGZ|NCAPH|EME1|ING2|RMI1|RACGAP1|STRA13|SPDYA|UBE2C|CCNE2|SMC4|BAG6|STAG3|TOP2B|KLHDC8B|TEX14|P3H4|TUBGCP4|FAM175B|UBR2|RECQL5|HIRA|SPIRE2|SPIRE1|SGOL1|TPX2|PDS5B
HISTONE H3-K9 METHYLATION%GOBP%GO:0051567,0.49030289823491,0.908938677284213,0.425876902713435,0.9815831281229709,4499,5,SETDB2|SUV39H1|SUV39H2|PRDM5|BEND3
PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0009395,0.23353064731716602,0.7474876401661371,0.34369503215092195,1.21216274452874,2445,17,ENPP2|PLA2G4A|PNPLA6|SMPDL3A|SMPD3|SMPD1|PLA2G4B|SMPD4|INPP5F|PLA2G4C|PNPLA8
REGULATION OF EXTENT OF CELL GROWTH%GOBP%GO:0061387,0.853439680957129,0.991298302704726,0.146431111039711,0.7172658559880241,10271,54,SEMA3D|DSCAM|FGF13|SEMA5A|CTTN|SEMA3E|RUFY3|APOE|SEMA4G|TRIM46|SEMA6A|SEMA4C|SHTN1|RTN4R|GOLGA4|MACF1|NTN1|PTPRS
CELL VOLUME HOMEOSTASIS%GOBP%GO:0006884,0.870967741935484,0.9934031064448321,-0.174946456343838,-0.697702097436496,4049,15,ANO6|AQP1
REGULATION OF CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:1901301,0.4437971666887329,0.881002146821428,-0.776521835024261,-1.03877693466422,3351,1,INSIG1
POSITIVE REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048023,0.376678359743559,0.853374872190571,0.6529445672492281,1.06721995773231,3113,2,CDH3
DNA-TEMPLATED TRANSCRIPTIONAL START SITE SELECTION%GOBP%GO:0001173,0.25355704697986603,0.7641083395392759,0.87549625055139,1.1630577102006698,1888,1,GTF2B
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035357,0.252232142857143,0.763905256448548,-0.4649713478077321,-1.1770440912896,1468,5,PDK3|RXRA|PPARG
REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070372,0.005859375,0.175005706363229,-0.17550811436070302,-1.48436371851282,5,202,ARHGEF5|CD44|GPR183|NTRK1|TIMP3|PYCARD|DUSP4|CRKL|PHB2|RAMP3|GPER1|FLCN|FBXW7|NOTCH1|PTPN6|TIE1|IL1B|KDR|NECAB2|CX3CL1|SIRPA|ARHGAP8|DAB2IP|IGF1R|C5AR1|LGALS9|PTK2B|CNKSR3|STYX|ARRB2|PRKD2|MARCO|RET|CCL14|NRP1|PDE8A|SEMA7A|FGF2|LYN|ARRB1|CHRNA7|GLIPR2|MST1R|SERPINF2|ICAM1|TNIP1|RAP1A|PTPN1|PLA2G2A|KARS|NPNT|FGFR1|TNFRSF11A|SHC1|PRKCA|DUSP3|EPHA8|ACKR3|ADCYAP1|MAPK3|FLT1|CHI3L1|FGF10|EPHA7|BMPER|DUSP10|AAED1|SLC9A3R1|MET|CCL18|MAP2K1|CD36|DLG1|TNF|EPHB2
NEGATIVE REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051224,0.0238568588469185,0.32397355287938,-0.19254317405184102,-1.4259103045164498,47,104,SYT11|IL1B|SRGN|CX3CL1|UBE2J1|TNFAIP3|NR1H3|OS9|PFKL|SSC5D|BAG4|INPP5K|RAB11FIP1|APOD|FCGR2B|CHP1|TMSB4X|DPH3|NLRP3|RANGAP1|TNFRSF4|SIAH3|DRD2|PPP1R11|CABP1|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|SNX12|TNFRSF21|INHBB
SUBSTRATE-DEPENDENT CELL MIGRATION%GOBP%GO:0006929,0.727960179955968,0.972554563883587,0.22789250003517103,0.7900414954780601,7604,16,CUZD1|ITGA2|ITGA11|SHTN1|NTN1
REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903516,0.7312724325576009,0.9726603499749559,0.43242585128185995,0.8219960537947221,6315,3,PARP1|XRCC1
COUMARIN METABOLIC PROCESS%GOBP%GO:0009804,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION%GOBP%GO:0046940,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
DCTP CATABOLIC PROCESS%GOBP%GO:0006253,0.548258969945717,0.9305779599215391,-0.7201698279664759,-0.96339313666473,4140,1,DCTPP1
RESPONSE TO BENOMYL%GOBP%GO:1901561,0.38858731629815996,0.8602318600740309,-0.8031539479488309,-1.07440352412973,2934,1,IMPACT
CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE%GOBP%GO:0070192,0.0789326887318706,0.532203813468543,0.38189130707597396,1.443752691056,848,21,SYCP2|NCAPD3|BUB1|CCNE1|BUB1B|RAD51|NCAPH2|CCNE2|BAG6|STAG3|P3H4|CCNB1IP1|SYCE2|C17orf104|RAD50|TRIP13|NCAPD2
LEPTIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0033210,0.250087873462214,0.76165135686672,-0.428955503129137,-1.1774540538337501,1422,6,LEPR|STAT3|MKKS
SINUS VENOSUS DEVELOPMENT%GOBP%GO:0003235,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
NEGATIVE REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904876,0.987819409506157,1.0,-0.506396118217909,-0.677421527228304,7460,1,TFIP11
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0036481,0.600742390497402,0.950415218201239,-0.5210174463884429,-0.8911724381378778,4045,2,PDCD10
ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034220,0.350518983884185,0.842847021021096,0.16027754953922502,1.0661939954991801,5132,380,KCNK2|RYR2|KCNN2|SCN1A|CHRNA10|KCNK6|KCNH8|CACNA1G|SLC1A2|KCNT2|SLC12A2|KCNH3|ATP10A|KCNK3|ATP2B1|HCN2|NDUFS7|SLC25A29|KCNQ1|NOL3|RHBG|ATP11C|SLC9A5|SLC9A7|SLC36A1|SLC8A3|SLC25A22|ATP1B3|P2RX5|PIDD1|SLC35A1|F2R|KCNH1|ANO4|SLC39A3|CLCN2|SLC35B1|ATP5G1|LRRC55|PKD2|SLC25A19|KCNC3|KCNC1|ANO9|IBTK|KCND1|KCNB2|ATP2A1|HCN3|ATP5D|ATP10D|NNT|LRRC8D|CACNA1H|ANO8|CACNA2D1|KCNJ11|MRS2|KCNH2|SLC37A2|MT-ATP8|SLC26A2|CCR5|CACNA1D|CCL21|TTYH1|SLC25A10|ZACN|MCOLN1|ATP2B3|UCP3|SLC25A42|ATP7B|NALCN|XPR1|UNC79|SLC39A7|CPT1B|GJA1|SLC46A1|SLC40A1|GRIN1|SLC25A1|ACACA|CCL19|TRPM7|SLC38A6|ASIC1|SLC16A7|ATP2A2|TCIRG1
REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000414,0.680197594501718,0.9647315640607691,0.336701885610402,0.8280692517532541,6333,6,NSD1|PAXIP1|WHSC1L1|BCOR|IWS1|BRD4
DNA ENDOREDUPLICATION%GOBP%GO:0042023,0.18747517542698303,0.6940517434063481,-0.9043890604322891,-1.20982882073156,1415,1,ZPR1
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002582,0.486711210096511,0.907092544497897,-0.569120485249518,-0.9734501098757741,3277,2,TREM2|PYCARD
GOLGI CALCIUM ION TRANSPORT%GOBP%GO:0032472,0.33663965162695103,0.8311444145897029,0.671067397601759,1.09684122608024,2782,2,TMEM165|ATP2C1
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061311,0.74704641350211,0.9749763305090959,-0.20368101091306898,-0.789114158300399,3540,14,NOTCH1|CTNNB1|ACVR1|SNAI1|RBPJ
C-X-C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY%GOBP%GO:0038159,0.11154362416107401,0.5855068018166539,0.943978826643141,1.25403375731423,830,1,CXCR4
PEPTIDYL-CYSTEINE DEGLYCATION%GOBP%GO:0036526,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
HISTONE H3 DEACETYLATION%GOBP%GO:0070932,0.6284350029234069,0.9555836714381641,0.26150094882432895,0.86643390668608,6448,14,SIRT1|HDAC8|HDAC3|SMARCAD1|SFPQ|HDAC9|ELK4|HDAC2|SIRT7|SIRT2
NEGATIVE REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901859,0.980805369127517,1.0,0.5117445963828849,0.6798298657496139,7306,1,LIG3
MHC CLASS IB PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002398,0.30888388719714,0.8114708447293539,-0.846162329069255,-1.13193714686907,2332,1,TAPBP
LYMPHOCYTE CHEMOTAXIS ACROSS HIGH ENDOTHELIAL VENULE%GOBP%GO:0002518,0.0355704697986577,0.3821688062173221,0.981859285399206,1.30435625680459,264,1,CXCL13
TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034138,0.024599765716517005,0.329326373353219,-0.536194834614245,-1.73088497570607,125,9,RFTN1|COLEC12|TNIP2|TICAM1
POSITIVE REGULATION OF ODONTOBLAST DIFFERENTIATION%GOBP%GO:1901331,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:0034446,0.9295886075949371,1.0,-0.125545218030161,-0.651332614523923,3524,30,LAMA5|PARVB|BVES|NRP1|LAMC1|EFNA1|VAMP3|RAC1|PEAK1
SYNAPSE ASSEMBLY INVOLVED IN INNERVATION%GOBP%GO:0060386,0.0989010989010989,0.570215774831708,-0.949106749007499,-1.26964903616951,746,1,FBXO45
SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:0000491,0.0609608397254744,0.48170831577441997,-0.43347633247885897,-1.5254572205000703,301,11,TAF9|NAF1|RUVBL1|ZNHIT6|NUFIP1|SHQ1|RUVBL2|PIH1D2
REGULATION OF TRANSLATION AT SYNAPSE%GOBP%GO:0140243,0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043900,0.00250941028858218,0.12586582153175,-0.16873661842938698,-1.46808184210142,1,239,RIOK3|CALR|FBXL2|SNX3|LGALS1|CCNK|TRIM8|ITCH|RNASEL|PVRL2|TRAF3IP2|CTDP1|RHBDD1|ZNF639|SIN3A|TRIM13|CDK9|APOBEC3F|C9orf69|CX3CL1|TRIB1|BANF1|LGALS9|TNFAIP3|PCBP2|PML|TRAF3|VPS4A|DDX3X|RSF1|C1QBP|INPP5K|IFITM2|TBC1D20|IFITM3|P4HB|OASL|GLTSCR2|RNF216|VIP|VPS4B|IGF1|MAVS|TRIM35|TNIP1|GPATCH3|FOXP1|PPIH|CNOT7|GAPDH|FMR1|OAS3|FCER2|TRAF3IP1|AGO2|TRIM25|CXCL8|PDE12|JUN|PRKCA|CAV2|RAB7A|VAPB|ZC3HAV1|PARK2|CHMP4B|STAU1|PABPC1|IFITM1|PLCB1|CFAP69|POMZP3|CD36|PC|PDE3A|TNF|CAV1|INHBB
CELLULAR STRESS RESPONSE TO ACID CHEMICAL%GOBP%GO:0097533,0.612769116555308,0.9508825506493929,-0.516349600220568,-0.883188337261578,4126,2,KLF2|VEGFA
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010976,0.878138847858198,0.995540625642088,0.125064085775976,0.741303789002247,11889,143,SYT17|RIT2|FAM150B|RIMS2|LRRC7|VLDLR|SYT3|DSCAM|PLXNC1|ZNF804A|MARK2|CUX2|DVL1|ROBO2|UNC13A|SEMA5A|CPEB3|MAP6|PTPRD|PLXNA3|GRIP1|DLG5|CAPRIN2|RUFY3|APOE|P3H1|PLXNB2|OBSL1|DPYSL3|SHTN1|MAGI2|GOLGA4|PLXNB3|DLG4|MACF1|LRP8|PLXNA2|NTN1|CUL7|SLITRK1|SYT1|CAMK1|SHANK1|DVL3|STYXL1|CDKL3|DVL2|PLAA|SS18L1|PRKD1|ZFYVE27|RIMS1|NEURL1|NGF|L1CAM|DBN1|STMN2|SETX|CPNE5|MAPT|SYT4
TELOMERE TETHERING AT NUCLEAR PERIPHERY%GOBP%GO:0034398,0.8738249702105121,0.9934031064448321,-0.5609285399206,-0.750371210419593,6599,1,NUP98
NEGATIVE REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0150066,0.18787236859526002,0.694498726854041,-0.904113365681518,-1.20946001545759,1418,1,KDM5A
REGULATION OF INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032377,0.232925257731959,0.746122594132505,0.49541443489602,1.21839965246525,2168,6,ABCA2|LDLRAP1|ARV1|NUS1|ANXA2|SCP2
COCHLEA MORPHOGENESIS%GOBP%GO:0090103,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
TRANSEPITHELIAL WATER TRANSPORT%GOBP%GO:0035377,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
ONCOGENE-INDUCED CELL SENESCENCE%GOBP%GO:0090402,0.50642128955382,0.9172434440873181,-0.743162770180856,-0.994151496513838,3824,1,HMGA1
ONCOSIS%GOBP%GO:0070267,0.833840857937244,0.988613522932093,-0.581495368328187,-0.777884083857763,6297,1,TMEM123
BONE REMODELING%GOBP%GO:0046849,0.420721836015618,0.8727872721376851,0.28929650055389394,1.03776552665802,4417,18,EFNA2|SRC|IL7|ZNF675|EFNA4|P3H4|TGFB3|LRP6|LGR4|NOTCH2
ERROR-FREE TRANSLESION SYNTHESIS%GOBP%GO:0070987,0.530685920577617,0.9265056012720759,-0.21389078936600198,-0.9380123288020469,2351,19,UBA52|UBC|UBB
RELEASE FROM VIRAL LATENCY%GOBP%GO:0019046,0.726503340757238,0.972554563883587,-0.469092914254205,-0.8023583068223241,4892,2,NUCKS1|HCFC1
MUSCLE CELL DEVELOPMENT%GOBP%GO:0055001,0.243931022936548,0.7571583779245891,0.24375279515949697,1.1775615631015601,2913,51,NEB|IGSF22|ACTN2|HES1|MAML1|MYH3|PROX1|TCAP|OBSCN|KRT19|NEBL|SEPN1|HEY2|CXADR|LMOD1|OBSL1|DMD|KDM1A|KIAA1161|SLC8A1|MYOM2
REGULATION OF CARDIAC CONDUCTION%GOBP%GO:1903779,0.687992381611982,0.96731875442989,0.187179755902998,0.838525493786012,7946,38,RYR2|TNNI3K|NPR2|ATP2B1|SLC8A3|ATP2A1|ATP2B3|DMPK|CXADR|ATP2A2|TRPC1|SLC8A1|SLC8A2|RNF207
POSITIVE REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000382,0.238448298689263,0.750892237039908,-0.880458756065285,-1.17781652295095,1800,1,SMAD2
MEDULLARY RETICULAR FORMATION DEVELOPMENT%GOBP%GO:0021723,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
RESPONSE TO INTERLEUKIN-1%GOBP%GO:0070555,0.051045211473019,0.443301756236231,-0.180835469364089,-1.32829272726007,104,101,IL1B|IRAK1|NFKBIA|CX3CL1|SIRPA|MAP3K8|DAB2IP|LGALS9|IRAK2|USP10|SQSTM1|IRAK4|HDAC4|CCL14|UBE2V1|TANK|RIPK2|SNCA|TNFRSF11A|CXCL8|UBA52|PRKCA|PELI2|MAPK3|CHI3L1|TNIP2|PELI1|MYD88|PLCB1|UBC|CCL18|UBB
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000545,0.0355704697986577,0.3821688062173221,0.981859285399206,1.30435625680459,264,1,CXCL13
NCRNA METABOLIC PROCESS%GOBP%GO:0034660,0.0039215686274509795,0.147602495543672,-0.147563381039037,-1.4044595001465499,0,433,NAF1|UTP15|QARS|C1D|THUMPD1|TSR3|FTSJ2|RPRD1B|WDR12|DARS|KIAA1456|METTL1|PES1|METTL16|RRP1|AARS|CDK9|RPS28|CPSF3|ISG20L2|RPAP2|MPHOSPH6|CARS|RPF2|ADAT1|RPL35|NSUN5|WARS|UTP3|RPL7|C9orf64|TRMT12|EXOSC6|POP5|MOCS3|RRP36|RNF113A|ELL3|RPS9|KIAA0391|RPL14|NARS|DHX37|GAR1|ELL|DDX47|HARS|ZNHIT6|TSEN2|FARS2|PIWIL1|EXOSC4|GARS|ICE1|TRMT61B|AIMP2|NOB1|NSUN3|PTRF|PAPD7|NHP2L1|TRMT112|SMAD1|NOLC1|WBSCR22|SMAD2|SBDS|GLTSCR2|RTCB|ELP3|PLD6|MOV10L1|YARS|PWP2|URM1|TBL3|CDKAL1|SRFBP1|RPUSD2|RCL1|POLR2A|RSL1D1|TAF1B|DPH3|FCF1|RPL35A|NSUN2|EXOSC9|UTP14A|WDR43|EBNA1BP2|NHP2|KARS|RRP7A|PHAX|POLR2K|KRI1|AGO2|NOL10|PIH1D2|RRS1|CIRH1A|MRTO4|POLR2F|BYSL|IMP4|TSR1|NOL9|SARS|TSR2|RNMTL1|TDRKH|NCBP2|POLR2I|POLR2D|RPP14|WDR4|LYAR|EMG1|HENMT1|RRP9|RPF1|NOP14|GPAT2|NOP56|EXOSC5|DTD2|CD3EAP|TAF8|TAF13|TRDMT1
CENTRAL NERVOUS SYSTEM MATURATION%GOBP%GO:0021626,0.7605369127516779,0.977664504547119,0.6221327745919721,0.8264756357346079,5665,1,CEND1
NEUROFILAMENT BUNDLE ASSEMBLY%GOBP%GO:0033693,0.527415553809898,0.9265056012720759,-0.46051615749421,-0.9346038590985699,3356,3,NEFL|NEFM|NEFH
CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS%GOBP%GO:0036294,0.00043122035360068997,0.0784645998831315,-0.277521862057957,-1.9611838641813302,0,86,VEGFA|PDK3|PLK3|CPEB1|HMOX1|LIMD1|HIGD1A|CITED2|STUB1|HYOU1|BACH1|CPEB2|P4HB|GLTSCR2|LMNA|ACAA2|PGK1|VHL|GNGT1|TCEB1|UBA52|TP53|BNIP3L|UBC|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|NDRG1|UBB|EGLN3
GROWTH HORMONE SECRETION%GOBP%GO:0030252,0.6211221861350661,0.9536478716552259,0.42062859659360996,0.89135217671891,5545,4,GHRL|CDK16|LTBP4
ADENINE TRANSPORT%GOBP%GO:0015853,0.29043183742591,0.7998377855773342,0.690984284532672,1.12939483061993,2400,2,SLC29A2|VDAC3
HISTONE H2B UBIQUITINATION%GOBP%GO:0033523,0.5648148148148149,0.9380162603437769,-0.266398190544492,-0.901264953089042,2866,10,RNF40|CDC73|RNF8|LEO1|CTR9|PAF1|WAC|DTX3L|RNF20|UBE2E1
FUCOSE METABOLIC PROCESS%GOBP%GO:0006004,0.00139331210191083,0.0961252072968491,0.6439948331778239,1.96468061365073,13,11,FUT9|FUT7|FUT2|FUT8|FUT10|FPGT
NEGATIVE REGULATION OF FIBRINOLYSIS%GOBP%GO:0051918,0.315762362637363,0.817022961971678,-0.437320105668094,-1.10704680795003,1838,5,USF1|SERPINF2|THBD
REGULATION OF GERMINAL CENTER FORMATION%GOBP%GO:0002634,0.49845467032967,0.913423777265461,-0.37508272667107895,-0.949497015793629,2902,5,RC3H1|MEF2C|FOXJ1|TNFAIP3|BCL6
POSITIVE REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010455,0.9625835189309581,1.0,-0.338763106412482,-0.5794361505270881,6482,2,FGF2
REGULATION OF RHODOPSIN GENE EXPRESSION%GOBP%GO:0007468,0.24202303720376,0.75639621044187,-0.8787494486104979,-1.17552993025234,1827,1,NRL
REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032374,0.40312246187167206,0.865238688875249,0.257548686712821,1.04706721832639,4466,27,SIRT1|ABCA7|ABCB4|CETP|ABCA2|LDLRAP1|APOE|SREBF2|APOC1|ARV1|APOC2|LRP1|PTCH1|LAMTOR1|GPS2|PLTP
NEGATIVE REGULATION OF SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0090341,0.345028465510393,0.841038624862765,-0.828021614468461,-1.1076697598418401,2605,1,NR1H3
EXTRACELLULAR VESICLE BIOGENESIS%GOBP%GO:0140112,0.39647657101343997,0.8638522656500329,-0.35267512410369606,-1.02876898378253,2182,7,ARRDC1|ATP13A2|COPS5|ARRDC4|RAB27A|CD34|RAB11A
SUCROSE TRANSPORT%GOBP%GO:0015770,0.505382847465828,0.9172434440873181,0.601988280657825,0.9839333071497379,4177,2,SLC45A3
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051155,0.38967136150234705,0.8603316114971841,0.273316895395573,1.06298496556541,4232,23,EDN1|BMP4|MAML1|PROX1|ADGRB1
PALMITIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900535,0.9410541945063101,1.0,-0.357871519161842,-0.6121200671537421,6337,2,ACOT7|ACOT11
REGULATION OF HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:1902464,0.9221476510067109,1.0,0.541629907366564,0.7195311681131841,6869,1,ZNF304
DESMOSOME ASSEMBLY%GOBP%GO:0002159,0.54548311076198,0.930420772651609,-0.45489136428807797,-0.9231885084066701,3471,3,JUP|PKP2|PRKCA
CENTRAL NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0007417,0.894621445700583,0.9979675173277209,0.11758657941031299,0.7778223131457042,13056,354,NR4A2|SIX3|PPP1R17|EGR2|BTBD3|SMG9|PSPN|SLIT1|SHROOM2|VCAN|CDK6|BASP1|SLC8A3|HAPLN2|CXCR4|HES1|CCDC14|BMP4|SNTG2|NPAS2|PRDM8|KIF14|MFSD2A|LIG4|BPTF|PROX1|PKD2|CENPF|WDR62|AHI1|S100A1|FGF13|CEP290|ARHGAP11B|ADGRL2|EIF2B5|EPHA5|NPY|ZDHHC16|CDK5R1|FOXN4|ROBO2|GBA2|ABCB6|SEMA5A|NDUFS4|EIF2B1|SLC6A17|DCX|LOXL3|RORA|PCDH18|TYRO3|KIRREL3|ARNT2|H2AFY2|STIL|RPS6KA6|CDK5RAP2|CCDC85C|ALDH3A2|LEF1|C5orf42|INA|DOCK7|PAFAH1B3|NF1|GRIN1|NIPBL|KLHL17|EIF2B4|GSTP1|METTL3|JARID2|COL4A1|PLXNB2|FGF9|SEMA4C
UDP-GLUCURONATE METABOLIC PROCESS%GOBP%GO:0046398,0.219002140622427,0.7343378114695319,-0.530391747637242,-1.21979021684839,1329,4,CSGALNACT1|UGDH
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009139,0.835611467279545,0.988613522932093,0.47017974182504796,0.7684958714199449,6907,2,DTYMK|CMPK2
NEGATIVE REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002838,0.0809395973154362,0.5374028338839121,0.960630789589766,1.2761551471920902,602,1,CEACAM1
RESPONSE TO BREFELDIN A%GOBP%GO:0031001,0.873825503355705,0.9934031064448321,0.564126599029555,0.749417019338897,6509,1,HID1
HISTONE H4-K20 DEMETHYLATION%GOBP%GO:0035574,0.783964365256125,0.981487311948134,-0.445106148331955,-0.7613302283613259,5279,2,PHF8|KDM7A
SECRETION BY LUNG EPITHELIAL CELL INVOLVED IN LUNG GROWTH%GOBP%GO:0061033,0.0653303637713437,0.495991045493396,-0.84637441411635,-1.44767810643186,439,2,FGF7|FGF10
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002855,0.0991152424683615,0.570215774831708,0.651030018412327,1.3795947986433101,884,4,CEACAM1|KLRK1
PROTEIN CARBOXYLATION%GOBP%GO:0018214,0.38271798900235704,0.858136016229086,-0.514946336190246,-1.04506828957055,2435,3,VKORC1L1|GGCX
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010743,0.0651140684410646,0.4956987271622679,-0.318770938903513,-1.4767830066232601,273,22,PRKCH|NFKBIA|NR1H3|PPARA|PPARG|ABCA1|PLA2G2A|NR1H2|ABCG1|CD36
POSITIVE REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902805,0.322366033627676,0.822751772025005,0.677474435478593,1.1073133534783,2664,2,UNC13B|MAP2
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS%GOBP%GO:0045936,0.0657894736842105,0.495991045493396,-0.130189454102981,-1.1881509958761203,24,362,PPP2R5A|PPM1F|TIMP3|ENSA|PYCARD|PIK3R2|DUSP4|STRAP|SOCS3|THY1|CDKN1B|CRKL|DUSP7|PPP1R15B|NCK2|ITCH|HSPB1|HEXIM1|GPER1|DNAJC3|FLCN|PTPN6|QARS|ZGPAT|LRP5|CBFA2T3|PPIF|IL1B|HEG1|IMPACT|PRKCD|SIRPA|FKBP1B|DAB2IP|IGF1R|TRIB1|CNKSR3|WARS|DDIT4|RGS4|CEBPA|ABL1|HDAC4|MGAT5|GNAQ|FAM129A|IGFBP3|ELL|FBP1|SMAD6|INPP5K|DGKQ|PPARA|FOXO1|MYADM|EIF4G1|ARPP19|PPAP2B|UBASH3B|RASSF2|LYN|PRNP|CHP1|CYLD|LDLRAD4|TRIB2|CDA|PIK3IP1|PPP2CA|PRKAR2A|TNIP1|NPM1|PCIF1|PTPN1|YWHAB|SMAD7|SNCA|LGALS3|TRAF3IP1|CDKN1C|PDCD4|PDE12|MECOM|DUSP3|UCHL1|DKK1|SNX6|PRKAR1B|PKIG|SOCS5|YWHAE|PPP1R11|CDKN1A|DBNDD2|PARK2|KIAA0226|GREM1|SFRP2|DUSP10|SLC9A3R1|CORO1C|FKBP8|SNX25|TWIST1|DLG1|TNF|PDE4D|SPRED2|INSM1|CAV1|FKBP1A|EPHB2|PAK2|PARD3|TRIB3
SEQUESTERING OF ACTIN MONOMERS%GOBP%GO:0042989,0.101162368325463,0.571596718470827,-0.486738937203633,-1.4198390744654297,556,7,TMSB10|TMSB4X|TWF1|TWF2
MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0000070,0.000541502282045332,0.0784645998831315,0.33866854699972493,1.87973361782466,6,98,KIF25|CCNB1|PSRC1|KIF14|NCAPD3|ZWINT|SPAG5|KIF2C|KIF18A|NSL1|KIF4A|MAP10|NUF2|KIF23|PRC1|DLGAP5|CDC23|SMC2|NDC80|NUSAP1|CENPE|KIF18B|RB1|CEP55|AKAP8L|INO80|ESPL1|AURKB|BOD1|DSN1|NCAPH2|NIPBL|KIFC1|CDCA8|TUBG2|SPDL1|KIF22|CDCA5|KLHL22|DSCC1|PLK1|NCAPG|POGZ|NCAPH|RACGAP1
REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:1904396,0.584577978464745,0.9439064862850342,0.48602444402679496,0.9238813402425259,5048,3,MESDC2|AGRN
SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:0006685,0.0857878821816553,0.549432448560602,0.6628246842772839,1.40458882229634,765,4,SMPDL3A|SMPD3|SMPD1|SMPD4
HISTONE ACETYLATION%GOBP%GO:0016573,0.687166839048453,0.9668424839233579,0.16136071852295802,0.8550574718974421,8636,77,CPA4|JADE3|AK6|KAT2A|NAA40|TADA1|OGT|TAF6L|YEATS4|TRRAP|MAP3K7|EP400|LEF1|ING5|APBB1|YEATS2|BRPF3|MSL1|KAT8|BRCA2|SUPT3H|WDR5
METANEPHRIC RENAL VESICLE MORPHOGENESIS%GOBP%GO:0072283,0.663772143105245,0.964618776001639,0.458480948843475,0.871524053365971,5732,3,BMP4|SMO
REFLEX%GOBP%GO:0060004,0.32739420935412,0.828288344197004,-0.663324247644172,-1.13458060022103,2204,2,TMC2
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048483,0.39331135186057503,0.8625038795236991,-0.22758343155492203,-1.03363751645711,1669,21,KIF26A|CTNNB1|SEMA3F|NRP1|ASCL1|SEMA3A|INSM1
NEGATIVE REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL%GOBP%GO:0003108,0.8562416107382549,0.991298302704726,0.5727282752536391,0.760843962454611,6378,1,ADRBK1
NEGATIVE REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032876,0.962931760741365,1.0,0.212364868920679,0.552741135916772,9143,7,FBXO5|MSH6|SMC3
REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090025,0.610785198555957,0.9508825506493929,-0.20229665466317803,-0.887166561551962,2706,19,ANO6|GREM1|NBL1
NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045590,0.823878069432684,0.9876441563834109,0.4765225931254671,0.7788630876221619,6810,2,CTLA4|IRF1
REGULATION OF PLANT ORGAN MORPHOGENESIS%GOBP%GO:1905421,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
CAMERA-TYPE EYE MORPHOGENESIS%GOBP%GO:0048593,0.15711889840232998,0.6578589353509621,0.300660593282784,1.29600465070646,1779,33,SIX3|TSPAN12|SHROOM2|TBX2|SDK1|PROX1|DSCAM|AHI1|FOXN4
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:0008630,0.34743875278396397,0.842847021021096,-0.17902217726194602,-1.0761772675319499,1091,48,DDIT4|CIDEB|ABL1|PML|BCL2L1|BOK|BCL2|TP53|BCL3|CDIP1|CRIP1|BCL2L11
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009147,0.06862847041697,0.5037729184803449,0.5435671639869729,1.4819099191273002,659,8,CAD|AK3|DTYMK|CTPS2|DUT
NEGATIVE REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051141,0.778366212101152,0.9811398289380491,-0.6074658138509039,-0.812625540665748,5878,1,ZBTB7B
HEMOGLOBIN METABOLIC PROCESS%GOBP%GO:0020027,0.00254718073405118,0.12621943783915598,0.9118915672651121,1.7334099419787699,21,3,HPX|INHA
LIPOPROTEIN PARTICLE MEDIATED SIGNALING%GOBP%GO:0055095,0.7689609289947991,0.9792236089291529,0.49867896751023205,0.8150770728828491,6356,2,LPL
CYCLIC NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009214,0.227179890023566,0.7400326826672471,-0.5962239584109449,-1.21001880900325,1445,3,PDE9A|PDE4D
PURINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072523,0.0550788818156657,0.457996676929382,-0.269914969848753,-1.45238190979128,198,34,NUDT11|GPX1|SAMHD1|NT5C|NUDT10|NT5C2|NT5C1A|ADA|NUDT1|NUDT15|NUDT7|NUDT4|PNP|HPRT1|NUDT18|PDE9A|ITPA|NT5E|PDE4D|ENPP4
ARSONOACETATE METABOLIC PROCESS%GOBP%GO:0018872,0.0384661908794,0.393719769563501,0.8749379652605459,1.43006206826641,317,2,AS3MT|N6AMT1
RNA 5'-END PROCESSING%GOBP%GO:0000966,0.18942142447966398,0.6973744226246139,0.358677344962924,1.26500319818305,1983,17,RPP30|RPP25|POP1
PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0018108,0.457192374350087,0.88985710965551,-0.159199487557798,-1.00342532863594,1318,57,PTPN6|BLK|KDR|IGF1R|ABI1|PTK2B|TNK2|FGR|ABL1|DYRK1A|FYN|LYN|YES1|FGFR1|RELN|MAPK3|FLT1|EPHB2
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048660,0.0011057869517139699,0.0893009762660318,-0.30063942571084196,-1.96868213491786,2,65,CDKN1B|XRCC6|GPER1|ID2|CX3CL1|CTNNB1|TRIB1|HMOX1|TNFAIP3|IGFBP3|MMP2|TCF7L2|MFN2|APOD|FGF2|IL6|PPARG|MMP9|HTR1B|VIP|MEF2D|IGF1|SOD2|SERPINF2|FOXP1|FOXJ2|PDCD4|JUN|RBPMS2|CDKN1A|CDH13|TNF
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034140,0.8940365307850491,0.9976191001250191,0.43845568775349997,0.716643776550745,7390,2,F2RL1
POSITIVE REGULATION OF SUMO TRANSFERASE ACTIVITY%GOBP%GO:1903755,0.279359195021846,0.788692060817727,-0.860222761358624,-1.15074621584155,2109,1,UBE2I
REGULATION OF DNA-DEPENDENT DNA REPLICATION INITIATION%GOBP%GO:0030174,0.248420135105688,0.7613646381106121,0.5196889477167439,1.19780598501719,2279,5,WDR18|WRNIP1|CDT1|TICRR|NBN
POSITIVE REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090023,0.37365532381997796,0.852609194081082,-0.253772043769754,-1.039281809603,1701,16,CAMK1D|C1QBP|CXCL8|THBS4|RAC1
RESPONSE TO HEPARIN%GOBP%GO:0071503,0.803785418299922,0.984522820758988,0.351348370374455,0.7445407593684991,7176,4,EGR1|GPIHBP1|SFRP1|SLIT2
REGULATION OF BLEB ASSEMBLY%GOBP%GO:1904170,0.560541913632515,0.936434965680841,0.581362007168459,0.9502202297682479,4633,2,ANLN|P2RX7
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY%GOBP%GO:0061245,0.223101265822785,0.7355723797115551,-0.227508840322618,-1.1803231546345,845,30,RHOA|WDR1|CLIC4|CDC42|MSN|SLC9A3R1|SH3BP1|DLG1|PARD3
PIGMENT CATABOLIC PROCESS%GOBP%GO:0046149,0.178330314506834,0.6837991059383349,-0.556499200352948,-1.27983190405659,1082,4,HMOX2|BLVRB|HMOX1|BLVRA
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF WOUND HEALING%GOBP%GO:0044330,0.25738117304382396,0.7678777890071629,-0.872077635641817,-1.16660484262226,1943,1,PPAP2B
INSULIN RECEPTOR INTERNALIZATION%GOBP%GO:0038016,0.0809395973154362,0.5374028338839121,0.960630789589766,1.2761551471920902,602,1,CEACAM1
MULTI-ORGANISM BEHAVIOR%GOBP%GO:0051705,0.6165031222123101,0.9519727931895641,0.211434204643518,0.8865290821873291,6910,30,GNG8|OXTR|MSS51|DNAJC9|DRD4|NLGN4Y|NRXN3|NPAS4|SHANK1|NLGN3|CIC|UBR3
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000352,0.26083092646078604,0.771967970256231,-0.26875094545763395,-1.1561068566672,1173,18,IL11|KDR|MAPK7|TNFAIP3|ICAM1|RAMP2|SCG2|TNIP2
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042535,0.9623067010309281,1.0,0.22522112349455498,0.553898552938196,8960,6,AZU1|THBS1|TLR4|SPN|TLR1|HSPB1
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE METABOLIC PROCESS%GOBP%GO:0050427,0.965253182731885,1.0,0.15336115012680201,0.5316615174949351,10083,16,SLC35B3|SLC26A2|SULT1A3|PAPSS2|SLC35B2|SULT1A4|BPNT1|IMPAD1|ABHD14B|TPST2
HAIR FOLLICLE MORPHOGENESIS%GOBP%GO:0031069,0.9016687199014449,0.9995003795373381,0.30639638057438595,0.6492831989443579,8050,4,TGFB2|FGFR2|ATP7A
CMP PHOSPHORYLATION%GOBP%GO:0061566,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
NEGATIVE REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900025,0.472951150585386,0.8991555510095941,-0.27703073850140997,-0.974905683848506,2342,11,MFI2|CORO1C
GALACTOSE CATABOLIC PROCESS VIA UDP-GALACTOSE%GOBP%GO:0033499,0.252981359268264,0.7641083395392759,0.617558157342732,1.1739130924288501,2184,3,GALM|GALK1|GALK2
L-LYSINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903401,0.08174496644295301,0.539385377100419,0.9600242611380679,1.2753494012031599,608,1,SLC25A29
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070374,0.0038080731150038102,0.144314642694687,-0.192881063105596,-1.54366824010002,4,154,CD44|GPR183|NTRK1|PYCARD|CRKL|PHB2|RAMP3|GPER1|FBXW7|NOTCH1|TIE1|KDR|NECAB2|CX3CL1|ARHGAP8|IGF1R|C5AR1|LGALS9|PTK2B|ARRB2|PRKD2|MARCO|RET|CCL14|NRP1|PDE8A|SEMA7A|FGF2|ARRB1|CHRNA7|GLIPR2|MST1R|SERPINF2|ICAM1|RAP1A|PLA2G2A|KARS|NPNT|FGFR1|TNFRSF11A|SHC1|PRKCA|EPHA8|ACKR3|ADCYAP1|MAPK3|FLT1|CHI3L1|FGF10|EPHA7|BMPER|AAED1|MET|CCL18|MAP2K1|CD36|TNF|EPHB2
REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903525,0.0216346153846154,0.30940489238740504,-0.69441611092612,-1.7578682732078201,125,5,DNM2|PLEKHM2|SH3GLB1|ASAP1
POSITIVE REGULATION OF BLOOD COAGULATION%GOBP%GO:0030194,0.25642151481888,0.767319904137432,-0.282295870736133,-1.15609646761677,1167,16,USF1|PDPN|SERPINF2|THBD|ANO6|ENPP4
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051154,0.135675082327113,0.623227463256235,-0.32250620564506605,-1.32077130337928,617,16,FZD7|SMAD4|FRS2|NOTCH1|HDAC4|HDAC5|BHLHE41|SOX6|CFLAR|DKK1
OPTIC NERVE DEVELOPMENT%GOBP%GO:0021554,0.8283593170007428,0.9876441563834109,-0.427350427350427,-0.7309600185580121,5578,2,TMEM126A|CHRNB2
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034122,0.839882841103246,0.98953921193435,-0.150748148703479,-0.722605520048445,3440,24,DAB2IP|TNFAIP3|CD300LF|LYN|TICAM1|NR1D1
POSITIVE REGULATION OF HYDROLASE ACTIVITY%GOBP%GO:0051345,0.443213296398892,0.8808089923737601,-0.109837903159419,-1.01198058143075,159,374,CX3CL1|BCAS3|PRKCD|LPAR1|F11R|C5AR1|LGALS9|CIDEB|NR1H3|DLC1|PRKD2|PFN1|EIF2AK3|BBC3|RPS3|TBC1D9|GNAQ|CYFIP2|S100A8|CCL14|PSME3|RALGAPA2|FYN|RHOA|DDX3X|TBC1D20|TNFRSF10A|TBC1D25|TBC1D8|FGF2|DOCK9|GNA15|PPARG|TBC1D14|LYN|TOR1AIP2|SSBP1|ITGA6|TNNT2|TANK|EFNA1|DNAL4|BOK|MBP|MAP4K4|RIPK2|RHOC|RAP1A|TMSB4X|CRADD|WNT11|SNCA|TBC1D5|KARS|FGFR1|GNB5|MTSS1L|EDNRA|NR1H2|NET1|TBC1D2|NLRP1|NLRP3|CTSH|RAPGEF1|STAT3|LIMS1|TBC1D15|DYNLL2|RANGAP1|TNFRSF10B|ADCYAP1|MTCH1|CAV2|FLT1|FGF10|PKP4|CORO1C|MYL4|DDRGK1|SOX7|CCL18|BCAP31|SH3BP1|HSP90AB1|TNF|GABARAPL2|PMAIP1|TBC1D1|EGLN3
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060050,0.0559752747252747,0.460281293309471,-0.6123740645440029,-1.5501842806636,325,5,CHP1|RAMP1
ENDOPLASMIC RETICULUM TUBULAR NETWORK MAINTENANCE%GOBP%GO:0071788,0.8740939597315441,0.9934031064448321,0.5636854874283189,0.7488310222560399,6511,1,KIAA1715
UBIQUITIN-INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0090611,0.0194302651078544,0.29015745757545297,-0.750399823526168,-1.72576283009594,117,4,PDCD6IP|VPS4A|VPS4B|CHMP4B
SEMINIFEROUS TUBULE DEVELOPMENT%GOBP%GO:0072520,0.511275167785235,0.918404893008545,0.748180414644905,0.993924302161029,3808,1,ING2
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY%GOBP%GO:0007169,0.00238663484486874,0.123131026996483,-0.20421814494446602,-1.8715386538487802,0,348,PTPRG|DGKD|DAB2IP|IGF1R|ANOS1|ABI1|BCAR1|PTK2B|ANKS1A|FOXO4|DDIT4|GDF15|PRKD2|GRB2|FGR|EIF2AK3|ABL1|VAV1|MYO1C|RET|CYFIP2|FGF7|FYN|RHOA|CUL5|STUB1|NRP1|MMP2|FOXO1|CASP3|HNRNPF|CPNE3|FGF2|UBASH3B|HGF|ATP6V0C|PXN|ATP6V1F|HBEGF|LYN|MMP9|EFNA1|ARPC5|MST1R|YES1|NAMPT|CDC37|SHOC2|HAP1|PTPN12|POLR2A|IGF1|FOXC2|CRK|PTPN1|VAV3|VAV2|ARPC4|CDC42|FGFR1|AP2S1|SHB|POLR2K|ADAM17|ADRB2|CHRNA3|FLRT1|STAT5A|RAPGEF1|SHC1|ATP6V1E2|ATP6V0D1|PRKCA|POLR2F|STAT3|EPHA8|MAPK3|NCBP2|CAV2|FLT1|POLR2I|POLR2D|ATP6V1E1|FGF10|BDKRB2|EPHA7|SDC2|EFNB1|RHOQ|RAC1|PLCB1|IGF2|CD3EAP|ACTR2|BRK1|PGF|PIK3R1|SULF2|SPRED2|GFRA2|EPHB2|FOXO6|ANGPT2|PAK2|APPL1|FOXO3
DNA CONFORMATION CHANGE%GOBP%GO:0071103,0.0188954548770701,0.286396032442422,0.245843568878115,1.4825140126257101,258,161,RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|DFFB|AIFM1|PIF1|ASF1B|NCAPD3|MTERF1|BLM|DHX9|NAA10|CENPL|CENPT|NAP1L4|HIST2H3C|HIST2H3A|SART3|CENPK|DNA2|ASF1A|CASC5|CENPU|TOP2A|CDKN2A|OIP5|SMC2|ITGB3BP|CENPA|NUSAP1|AKAP8L|HIST1H4I|RAD51|HELLS|NCAPH2|NIPBL|RTEL1-TNFRSF6B|CENPV|CENPQ|CENPI|H2AFX|H3F3A|CDCA5|SRPK1|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|ZRANB3|NCAPG|NCAPH|HNRNPA2B1|HIST1H2BK|ACIN1|STRA13|CENPM|SMC4|TOP3B|TOP2B|HIST1H3H|RECQL5|HIRA|HIST1H2BN
BICARBONATE TRANSPORT%GOBP%GO:0015701,0.8580315485447679,0.99166790097654,-0.166580256235211,-0.716591251766462,3861,18,SLC4A3|SLC4A8|CA13|CYB5R4|SLC4A7|CA5B|CYB5R2|AQP1
NEURAL TUBE CLOSURE%GOBP%GO:0001843,0.7912730544309491,0.9819233677232551,0.183688607671823,0.753238706984895,8794,28,MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C|DVL3|DVL2|LRP6|SCRIB|MTHFR
CHONDROCYTE MORPHOGENESIS INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003414,0.5572139303482591,0.9361453421204542,-0.250488266088233,-0.912553879821217,2687,12,SCARA3|COL14A1|COL6A2|VWA1|COL6A1|COL21A1
TRNA 3'-TRAILER CLEAVAGE%GOBP%GO:0042779,0.459287700251556,0.890371861972445,-0.769574327304808,-1.02948304176017,3468,1,ELAC2
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DEDIFFERENTIATION%GOBP%GO:1905174,0.39288738357324293,0.8621064456029929,0.645697003676957,1.05537401417565,3247,2,OLFM2|PDGFB
NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010760,0.42759547541717996,0.876195083937629,0.48753105884356296,1.0331248850827301,3817,4,C5|DDT|SLAMF8|MIF
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:2001252,0.340348007138608,0.833925631931127,0.185149061638977,1.08742717677153,4576,135,GTF2H2|SIRT1|WDR61|TPR|SIRT6|LIG4|ANAPC5|ATR|OGT|MTF2|HMBOX1|NUMA1|SART3|MUC1|FAM178A|PNKP|DNMT3B|PPP1R10|PRKCQ|DLGAP5|NEK2|FEN1|TAL1|RB1|AKAP8L|SLX1B|ESPL1|AURKB|PHF19|NIPBL|JARID2|MAP3K4|TNKS2|MAP2K7|SLX4|ING2|KDM1A|HNRNPA2B1|RNF40|PAXIP1|ANKRD32
PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:0034504,0.988690476190476,1.0,-0.0839474072387781,-0.6502091140475269,1660,125,IPO8|HHEX|IPO5|CBLB|SKP1|RAN|CHCHD10|PARK7|CTDNEP1|RPL11|KPNB1|NUP93|TBRG1|NXT1|CALR|ARL2|PHB2|TOR1AIP1|PINX1|KPNA1|PTTG1IP|RGPD8|MSX1|RPF2|PRICKLE1|PML|SUPT7L|ARL2BP|TOR1AIP2|GLTSCR2|RGPD1|LMNA|KPNA4|RRS1|MMP12|STAT3|BCL3|RANGAP1|YWHAE|BCL6|RGPD6|NUTF2|TAF8|TNF
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903170,0.0508747697974217,0.44304197231114795,-0.343961746360251,-1.5347248045336201,220,20,FKBP1B|CRHR1|SESTD1|PLN|BIN1|FMR1|GNB5|YWHAE|ADRA2A|FKBP1A
REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032095,0.262243943017573,0.772504791944864,0.434329739937859,1.18409939457145,2521,8,CARTPT|GHRL|NPY
DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009186,0.46188186813186793,0.8912739660615641,-0.38604851166571996,-0.9772561723419849,2689,5,AK5|AK9|CMPK2|NUDT18
CELL-CELL FUSION%GOBP%GO:0140253,0.693355516273266,0.96731875442989,0.300389028116737,0.8189410800647059,6667,8,KCNH1|CACNA1H|VASH2
NEGATIVE REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032692,0.665903662420382,0.964618776001639,0.274778466734211,0.838286114777427,6690,11,GHRL|CEACAM1|GSTP1|CARD16|CPTP
DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:0071542,0.883851512945825,0.996316041142784,0.23966604516774398,0.653393937571627,8499,8,NR4A2|PHOX2A|LRP6|PHOX2B
PLASMA MEMBRANE RAFT LOCALIZATION%GOBP%GO:0044856,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
REGULATION OF RESPONSE TO OSMOTIC STRESS%GOBP%GO:0047484,0.7619795758051849,0.9782281980550129,-0.377357450093747,-0.7658357331830341,4849,3,ABCB1|YBX3|ARHGEF2
EPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:0042418,0.48228187919463106,0.9053012218786121,0.7630127922364358,1.0136284540721,3592,1,TH
L-SERINE TRANSPORT%GOBP%GO:0015825,0.843638289421422,0.991298302704726,-0.575981473312748,-0.770507978378361,6371,1,SLC1A4
REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1900825,0.37800471327572704,0.854043118220915,-0.5171684845841239,-1.04957807371299,2405,3,RANGRF|SLMAP
POSITIVE REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902824,0.716778523489933,0.971081608033886,0.645401411557124,0.8573869818553209,5339,1,SNAPIN
REGULATION OF HISTONE H4-K20 METHYLATION%GOBP%GO:0070510,0.7255033557046979,0.972554563883587,0.64082487869431,0.851307262120678,5404,1,BRCA1
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MYOCARDIAL PRECURSOR CELL DIFFERENTIATION%GOBP%GO:0003256,0.337225274725275,0.831781977545269,-0.430169503679717,-1.08894553384085,1963,5,GREM1|RBPJ
NEGATIVE REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901895,0.193661545905407,0.7046839209256791,0.7375409613567929,1.2054904399022301,1600,2,THADA
REGULATION OF SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0062025,0.35283993115318396,0.842847021021096,-0.823334803705338,-1.1014000701843503,2664,1,STYX
"REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, TELOMERIC%GOBP%GO:1904907",0.714769565743317,0.971081608033886,0.5224152191894129,0.853873324179492,5908,2,ATRX|TNKS
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003337,0.663772143105245,0.964618776001639,0.458480948843475,0.871524053365971,5732,3,BMP4|SMO
HISTONE H4-K16 ACETYLATION%GOBP%GO:0043984,0.943330179754021,1.0,0.157513583854076,0.575736248601881,9970,19,JADE3|OGT|MSL1|KAT8|WDR5|MEAF6|KANSL1|KAT7|MCRS1|MSL2|KANSL3|KMT2A|MSL3|JADE2|HCFC1|KANSL2|ING4
POSITIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060213,0.706011146496815,0.968941691852291,0.264219329678186,0.806072608081286,7093,11,BTG2|CPEB3|TNRC6A|TNRC6C|POLR2G|CNOT1
INITIATION OF NEURAL TUBE CLOSURE%GOBP%GO:0021993,0.9798657718120809,1.0,0.512957653286281,0.6814413577274712,7299,1,KDM2B
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904998,0.8761073825503359,0.9941329456747149,0.562748125275695,0.747585778454968,6526,1,KLF4
REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061085,0.131107834877843,0.6149266898174119,0.522741307959637,1.3605857966091002,1244,7,OGT|MTF2|PHF19|SUPT6H|PHF1|ZNF304
TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0006368,0.129580657347941,0.6110436407571899,-0.18771091701122697,-1.25320969632482,342,69,AFF4|SETD2|CCNK|SUPT16H|CTDP1|NELFCD|CDK9|ADRM1|ELL3|ELL|NELFA|ELP3|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|ELP2|NCBP2|TCEA1|POLR2I|POLR2D|PBRM1|EAF1
MODIFICATION BY HOST OF SYMBIONT MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0051851,0.813553929366847,0.986276922067025,-0.12989743663432401,-0.7808678821506371,2556,48,GAPDH|FMR1|JUN|CAV2|PARK2|PC|AQP1
"VESICLE TARGETING, TRANS-GOLGI TO ENDOSOME%GOBP%GO:0048203",0.261172976985895,0.771967970256231,-0.701075268817204,-1.19915170012214,1758,2,AP1AR|WIPI1
MONOCYTE DIFFERENTIATION%GOBP%GO:0030224,0.741184767277856,0.974505008828563,0.26274071937398497,0.775415742336807,7356,10,BMP4|PIR|PDE1B
DAUNORUBICIN METABOLIC PROCESS%GOBP%GO:0044597,0.0751718213058419,0.524840022194793,0.593141402246151,1.4587448961012701,699,6,AKR1B1|CBR4|AKR1C1
FRUCTOSE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990539,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070857,0.00263268744734625,0.127485195366963,0.730865230764524,1.9022886408097401,24,7,FGFR4|SIRT1|STAR|FGF19|PROX1
NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE%GOBP%GO:0098877,0.683685140896329,0.966495577318169,0.303272943529676,0.826803407187287,6574,8,LRRC7|STX3|ARHGAP44|SCRIB|STX1B
POSITIVE REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:1902524,0.506442953020134,0.9172434440873181,0.750385972651081,0.9968542875753149,3772,1,BIRC2
NEGATIVE REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043116,0.187976752633491,0.694597388648806,-0.43347119809024104,-1.26445471619704,1034,7,RAMP2|PDE3A|DDAH1
DEPHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:0070940,0.0681662087912088,0.50364937614461,-0.595655264731663,-1.50786174912407,396,5,SSU72|CTDP1|RPRD1B|RPAP2
EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0098976,0.8890169603161541,0.997300970905927,-0.290026412594732,-0.6670001603279979,5398,4,GRIN2C|PDLIM4
MODULATION BY VIRUS OF HOST PROCESS%GOBP%GO:0019054,0.239057987113975,0.75206086335821,-0.274354875034356,-1.18021371663339,1075,18,CASP8|EIF2AK4|CD4|SLC25A6|KPNB1|CCNK|KPNA1|BCL2L1|ATG7|KPNA4|PARK2
NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903671,0.46460497704759596,0.8927164433095759,-0.21045421668062303,-0.988906765358741,1922,23,MMRN2|RHOA|HDAC5|MAP2K5|ADAMTS9|MEOX2|PDCD10
HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:0030213,0.8712225274725279,0.9934031064448321,-0.270113897418322,-0.6837753948290761,5073,5,IL1B|CEMIP
CELLULAR HYPEROSMOTIC SALINITY RESPONSE%GOBP%GO:0071475,0.08724832214765099,0.5536089896886011,0.957432730480812,1.27190666834137,649,1,AKR1B1
POSITIVE REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031442,0.215327029156816,0.732094216765764,-0.360215169915573,-1.21866183682543,1092,10,HSF1|NCBP2|NUDT21
POSITIVE REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046635,0.8934403542762249,0.9976191001250191,-0.13045411333762402,-0.7019588219786259,3227,34,RUNX3|CD86|IL6R|RARA|LGALS9|RUNX1|PNP|NLRP3|SOCS5|NKAP|CBFB
NEGATIVE REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000435,0.881217520415739,0.9956508825790341,-0.398014888337469,-0.680783150187321,5934,2,RPL5|RPL11
ORNITHINE BIOSYNTHETIC PROCESS%GOBP%GO:0006592,0.6616107382550339,0.964618776001639,0.6749558888398771,0.8966487864067479,4928,1,ALDH18A1
NEGATIVE REGULATION OF JNK CASCADE%GOBP%GO:0046329,0.8397256565291941,0.98953921193435,0.17345408669818901,0.705179631798822,9304,27,TAOK3|DUSP19|MEN1|DACT1|F2RL1|ZNF675|HDAC3|GSTP1
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:2000473,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
RADIAL GLIA GUIDED MIGRATION OF PURKINJE CELL%GOBP%GO:0021942,0.783794518734278,0.981487311948134,-0.605094838994266,-0.809453815309605,5919,1,CTNNA2
LIPID PHOSPHORYLATION%GOBP%GO:0046834,0.36642120765832104,0.8510019955058101,-0.186420607522803,-1.0601938343079,1243,40,PI4K2B|PI4K2A|PIK3CD|PIK3R2|SOCS3|SOCS6|DGKI|PIK3C3|DGKD|IP6K1|DGKQ|DGKG|SOCS5|DGKB|PIK3R1|DGKK
REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905912,0.0998278829604131,0.570215774831708,-0.948279664755183,-1.2685426203476002,753,1,YWHAE
POSITIVE REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900042,0.7109757712167349,0.9702900492064559,-0.6398875165416851,-0.8559970408846329,5369,1,SPTBN1
HEART DEVELOPMENT%GOBP%GO:0007507,0.197033898305085,0.7110073451187049,-0.13231048795171,-1.12045716410767,185,209,TMEM65|ADAMTS9|MICAL2|APLNR|TNNT2|EFNA1|POU4F2|SNAI1|MEF2D|MYOM1|FOXC2|SMAD7|RAMP2|AKAP13|RYR1|CCDC103|ALPK3|PDCD4|POPDC3|TBX20|MKKS|NOS3|DYX1C1|CDKN1A|MYH11|GREM1|SFRP2|CRIP1|ACVRL1|S1PR1|SCN5A|OLFM1|TWIST1|SOX17|ZFPM2|DNAAF1|BBS7|RBPJ|FKBP1A|SLIT3
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0007171,0.533179647620616,0.9265056012720759,-0.40085623688151,-0.921885603026288,3237,4,ADRB2|CHRNA3
POSITIVE REGULATION OF INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902216,0.8674090571640679,0.993084774742015,-0.4055693410532121,-0.693704636966991,5841,2,PARP14|CD300LF
DIGESTIVE TRACT DEVELOPMENT%GOBP%GO:0048565,0.0591133004926108,0.475550457504474,-0.256638872376657,-1.4365918963370001,203,38,ITGA6|CLMP|WNT11|CCDC103|CXCL8|RBPMS2|COBL|SOX17|TNF|DNAAF1|BBS7
REGULATION OF BLOOD VESSEL SIZE%GOBP%GO:0050880,0.0127013630731103,0.24430577683365803,-0.28625935531754104,-1.66863819948337,40,44,TBXA2R|AGT|GCLC|GPER1|SOD1|HMOX1|ADRA1B|DOCK5|VIP|SOD2|SERPINF2|EDNRA|ADRB2|NOS3|ADCYAP1|BDKRB2|PER2|ACE|ADM|CAV1
POSITIVE REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:1904058,0.49529988084205,0.911223412567636,-0.749614027348919,-1.00278153992474,3740,1,FAM173B
REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902806,0.8177040318342221,0.987153241368501,0.134877311564062,0.7814380879693,10890,124,BTG2|CCNB1|PIDD1|CDK1|C8orf4|KIF14|E2F8|PKD2|ANKRD17|WEE1|LSM11|CDK2AP2|CDC25C|MUC1|CDC45|CDK10|E2F7|EZH2|DACT1|CCNE1|PAGR1|RB1|INO80|GTSE1|CDC6|CCL2|RPS27L|CHEK2|PRMT1|CARM1|AURKA|CDC73|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|FHL1|FAM83D|CASP2|CDK2|ATM|RFWD3|CNOT1|CCND2
GANGLIOSIDE METABOLIC PROCESS%GOBP%GO:0001573,0.341422676360778,0.835569815754521,0.35084126780102604,1.10597705491989,3474,12,B4GALNT1|ST3GAL5|CLN6|ST8SIA3
REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001179,0.0604569420035149,0.479974792195691,-0.5629100274381801,-1.5451502286735201,343,6,PYCARD|CD274|LGALS9|TNFRSF21
RETROTRAPEZOID NUCLEUS NEURON DIFFERENTIATION%GOBP%GO:0061452,0.7668456375838929,0.9792236089291529,0.6187692986325539,0.822007407977822,5712,1,PHOX2B
INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0090594,0.7531638481352891,0.9769690538700708,0.37218588655236995,0.788697446652755,6724,4,F2R
REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032768,0.0635327635327635,0.49351130247002706,-0.257161196452985,-1.4285192332159702,222,37,NOSIP|ATP2B4|SNCA|FCER2|SPR|DDAH2|NOS3|TNF|CAV1|DDAH1
REGULATION OF GLYCOLYTIC PROCESS BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072362,0.845234899328859,0.991298302704726,0.578187031318924,0.768095676354967,6296,1,NCOR1
ACTIVATION OF MEIOSIS INVOLVED IN EGG ACTIVATION%GOBP%GO:0060466,0.0444856348470806,0.41504430757275895,-0.9772276135862371,-1.30726717411446,335,1,PLCB1
NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000629,0.502147651006712,0.9159769483621171,0.7523709748566391,0.999491274448172,3740,1,PAPD4
"REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043516",0.531772575250836,0.9265056012720759,-0.187717163740514,-0.9491441227553291,2066,28,HIC1|PSMD10|CD44|SNAI2|PTTG1IP|MSX1|ZNF385A|DYRK1A|SNAI1|TWIST1|SPRED2|PMAIP1
COP9 SIGNALOSOME ASSEMBLY%GOBP%GO:0010387,0.566308724832215,0.9388612723386429,0.720721217468019,0.9574459837531741,4218,1,TESPA1
POSITIVE REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002885,0.6364478406854229,0.9592476055325171,0.46815094591929207,0.8899057005615879,5496,3,ZP3|CCR7|HLA-E
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002580,0.6929945054945059,0.96731875442989,-0.320372821530995,-0.8110025238560792,4035,5,THBS1|HLA-DOB|HLA-DOA|TREM2|PYCARD
POSITIVE REGULATION OF DNA STRAND ELONGATION%GOBP%GO:0060383,0.78751677852349,0.9819233677232551,0.6081274812527571,0.8078702283538941,5866,1,POT1
MOTOR NEURON AXON GUIDANCE%GOBP%GO:0008045,0.0640662453693615,0.49514893278583205,0.640302585744853,1.47580254072519,587,5,SLIT1|CHN1|RNF165
ISOPRENOID TRANSPORT%GOBP%GO:0046864,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0060994,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF HORMONE LEVELS%GOBP%GO:0010817,0.575377238753349,0.941940408834489,0.150385096615354,0.952603899738319,8159,230,CARTPT|ALDH1A2|FDXR|SIRT4|EDN1|CYP21A2|TBX3|STAR|GHRL|TFR2|RIMS2|WNT4|ARNTL|NOV|CRHBP|FDX1|BCO2|HSD17B4|AKR1B1|INHA|BRSK2|IDE|INS|CLCN2|GNB3|ADCY8|AGTR1|BZRAP1|C1QTNF3|EPHA5|CACNA1H|SLC16A2|HSD17B11|ALDH8A1|RAB11FIP3|KCNJ11|SRD5A3|HSD11B1|CACNA1D|DUOX1|AKR1C1|CCL5|PASK|CAPN10|MED1|UCN|GCK
NEGATIVE REGULATION OF SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT CATABOLIC PROCESS%GOBP%GO:0062026,0.35283993115318396,0.842847021021096,-0.823334803705338,-1.1014000701843503,2664,1,STYX
TYROSINE METABOLIC PROCESS%GOBP%GO:0006570,0.866142969363708,0.9929671171385601,-0.3380247900874,-0.686011268324804,5512,3,PAH
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007186,0.00852272727272727,0.20298122046820802,-0.14729853674286802,-1.35709445527167,2,382,KALRN|GNA13|PLCE1|ADCY7|OXER1|NMB|CX3CL1|ADRA2C|GNAZ|DGKD|LPAR1|ABR|C5AR1|GNRH2|UCN2|HCRT|CXCL16|BCAR1|PDE7B|TULP3|ARRB2|CELSR1|FGD4|PTGFR|VAV1|CRHR1|CCR10|MARCO|TRIO|GNAQ|CALCRL|CCL14|ANO1|GNAI2|RHOA|ADRA1B|PSAP|INPP5K|DGKQ|GNAL|PDE8A|GNA15|ADCYAP1R1|P2RY14|PDE6B|ARRB1|APLNR|LANCL1|GPR61|HTR1B|VIP|CAMK2A|ABCA1|GCGR|RHOC|VIPR1|PNOC|CRH|VAV3|ARHGEF2|VAV2|RAMP2|PDE4B|AKAP13|GRM2|GNB5|EDNRA|GNGT1|NET1|CXCL8|HRH3|ADRB2|GIPR|GABRG2|MC4R|ADM2|ACKR3|GPR161|GPR3|CALCB|RASGRF2|ADCY2|HOMER2|ADCYAP1|DRD2|GABRA3|PDE10A|GNA12|MCHR1|UCN3|ADRA2A|TAC3|BDKRB2|GNAS|S1PR1|GPR4|PLCB4|CHRM1|PLCB1|NPB|CCL18|ADM|BDKRB1|PIK3R1|PDE3A|PDE4D|HRH1|GRM8|GAL|CAV1|PARD3|TRH|HOMER1|RAMP1|ADORA2B
RESPONSE TO GAMMA RADIATION%GOBP%GO:0010332,0.97588262265016,1.0,0.130911963426981,0.515203742925558,10641,24,LIG4|ATR|MEN1|HRAS|FANCD2|KDM1A|CRYAB|ATM|MDM2|TLK2
POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048842,0.505774678579211,0.9172434440873181,0.42034315804126704,0.968828666984243,4641,5,DSCAM|SEMA5A
POSITIVE REGULATION OF RENAL WATER TRANSPORT%GOBP%GO:2001153,0.28942142195154197,0.7989014598698071,-0.8558116453462729,-1.14484533145803,2185,1,INPP5K
POSITIVE REGULATION OF METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072300,0.969858945805494,1.0,-0.33039754822818,-0.565127311283478,6531,2,RET
CELLULAR RESPONSE TO NITROSATIVE STRESS%GOBP%GO:0071500,0.693825503355705,0.96731875442989,0.6576422584913979,0.8736484009046059,5168,1,ATM
ENTERIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048484,0.6806318681318679,0.9650163074981261,-0.324178248400618,-0.820635709283187,3963,5,SOX10|PHOX2B|EDNRB|PHACTR4|KIF26A
PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1902463,0.721435191314709,0.9713770803161691,-0.634428760476401,-0.848694696460025,5448,1,CORO1B
RESPONSE TO SODIUM ARSENITE%GOBP%GO:1903935,0.7632211538461541,0.978421368343614,-0.30228124816651597,-0.7652049072261659,4444,5,HSF1
RESPONSE TO INSULIN%GOBP%GO:0032868,0.0155579399141631,0.26480477175586303,-0.194554791386005,-1.4728273458744698,28,113,IGF1R|CPEB1|USF1|BCAR1|FOXO4|GRB2|RAB8B|INPP5K|HDAC5|FOXO1|PKM|CPEB2|ATP6V0C|ATP6V1F|PPARG|VAMP2|NAMPT|FOXC2|LPIN1|RAB8A|SLC25A33|SHC1|ATP6V1E2|ATP6V0D1|CAV2|ATP6V1E1|RHOQ|IGF2|PIK3R1|FOXO6|TRIB3|INHBB|APPL1|FOXO3
POSITIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000676,0.252350059578975,0.763905256448548,-0.874834583149537,-1.17029289536196,1905,1,IL6
ACTIN ROD ASSEMBLY%GOBP%GO:0031247,0.352606749727834,0.842847021021096,0.663358147229115,1.08424066813165,2914,2,HSP90B1|PDXP
NEUROFILAMENT CYTOSKELETON ORGANIZATION%GOBP%GO:0060052,0.43691248510525604,0.878651088001772,-0.779444199382444,-1.0426862705683,3299,1,SOD1
REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010591,0.0393814931142788,0.396089810860281,-0.33356752263914896,-1.5674058949476999,162,23,TWF1|CDC42|SSH3|TWF2|RAC1|BRK1
REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0060368,0.685007626933973,0.966495577318169,0.3594407324110971,0.82845760417372,6286,5,CD47|PTPRJ|CSK|PTPRC
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903054,0.22686450605232297,0.7398172623753029,-0.37226019965340706,-1.20168928351759,1161,9,DPP4|TNFRSF1A|CST3|CHADL|TGFB1|ADTRP|NOTCH1|TNFRSF1B
BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904837,0.648498431196773,0.963755998259649,0.208330969947234,0.862977031528503,7233,29,PYGO1|TRRAP|TERT|MEN1|LEF1|TLE4|BCL9|CDC73|SMARCA4|TLE1|KMT2D
ACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0046463,0.544731415103604,0.9298388956432471,0.28896676488806605,0.932603159674112,5546,13,LPL|GPAM|DGAT1
POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045654,0.441462209780998,0.880423444399886,-0.43324325814812803,-0.996368986053772,2680,4,HMGB2|RAB7B|TESC|ZNF16
CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0071363,0.0069084628670120895,0.186946165915992,-0.161030243502251,-1.4515920641271,3,292,F11R|CTNNB1|DAB2IP|SKI|TGFBR1|ANOS1|RGMA|BCAR1|ACVR1|ARRB2|DDIT4|GDF15|PRKD2|GRB2|TMEM100|MYO1C|FAM83G|FGF7|RHOA|BMP8B|NRP1|SMAD6|INPP5K|KLF10|CASP3|HNRNPF|CPNE3|PDE8A|FGF2|MAP2K5|HGF|CDH5|EHD1|PXN|SMAD1|SMAD2|CHRDL1|SHOC2|HAP1|PTPN12|POLR2A|RAP1A|ZPR1|SMAD7|RAMP2|FGFR1|MAP2K3|MTSS1L|POLR2K|PDCD4|CXCL8|SOX6|FLRT1|NR3C1|RAPGEF1|SHC1|JUN|UBA52|ID1|POLR2F|DUSP3|LIMS1|CLEC3B|TWF2|ZYX|UBE2D3|MAPK3|NCBP2|FLT1|POLR2I|POLR2D|FGF10|ACVRL1|WWOX|UBC|PGF|PDE3A|TMEM108|SPRED2|PARD3|UBB
ADENYLATE CYCLASE-INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007198,0.226664901363697,0.7398172623753029,-0.885917512130569,-1.1851188673755602,1711,1,HTR1B
REGULATION OF CAMKK-AMPK SIGNALING CASCADE%GOBP%GO:1905289,0.090295246921753,0.560121322881739,-0.9530216144684599,-1.27488607105989,681,1,HTT
CELL JUNCTION ORGANIZATION%GOBP%GO:0034330,0.186092715231788,0.6922162303225631,-0.146483336800034,-1.15687564575424,280,138,MYO9A|ACTN1|PIP5K1A|PVRL1|PDCD6IP|NLGN4X|PLEC|SNAI2|ARL2|THY1|GJA4|LAMA5|FLCN|PVRL2|OPHN1|RAB13|F11R|CTNNB1|CDH22|VASP|DLC1|RAB8B|RHOA|TESK2|ZNF703|WDR1|MYADM|WHAMM|STRN|CDH5|PARD6B|LAMC1|ITGA6|RHOC|CTNNA1|SMAD7|RAMP2|CDC42|FLNC|PRKCA|PVRL3|LIMS1|CD9|PKP4|GJC1|LAMC2|SH3BP1|TLN2|DLG1|CDH13|PEAK1|PVRL4|PARD3
POTASSIUM ION HOMEOSTASIS%GOBP%GO:0055075,0.5671367851622879,0.938953543844111,0.270310691716381,0.916518681649622,5870,15,SLC12A2|ATP1B3|KCNH2|TFAP2B|KCNMA1|SLC12A5|ATP1A3|SLC12A9|ATP1A1|SLC12A4|ATP1B1
REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:1904393,0.525503355704698,0.9265056012720759,0.741177767975298,0.984621598470673,3914,1,MESDC2
CELLULAR CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0044275,0.7634640645524491,0.978421368343614,0.207229537291986,0.7695467317046351,8136,20,GAA|IDNK|TKFC|AGL|ENOSF1|ABHD10|AOAH|ATHL1|PYGL|PGM2L1|MANBA
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048633,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090153,0.900766358813126,0.998912093067348,0.19871631801935502,0.626424848892671,9167,12,NSMAF|ORMDL1|SMPD3
EXTRACELLULAR NEGATIVE REGULATION OF SIGNAL TRANSDUCTION%GOBP%GO:1900116,0.6776244097348351,0.9647315640607691,-0.28325765786030294,-0.82627515497771,3730,7,LRPAP1|NBL1
NEGATIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0017055,0.691610987379362,0.96731875442989,-0.48431210366694205,-0.828389915225164,4657,2,HMGB1|THRA
NEGATIVE REGULATION OF MYELINATION%GOBP%GO:0031642,0.0767631774313289,0.527286041772797,-0.833526330300524,-1.42570214716425,516,2,EIF2AK3|TNFRSF21
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032786",0.8487630706452439,0.991298302704726,-0.14650534260678302,-0.730064991285015,3327,27,CCNK|SUPT16H|CDK9|ELL3|ELL|THOC5|SUPT4H1|TCEB1|EAPP
POSITIVE REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0033605,0.26127577319587597,0.771967970256231,0.483218925111015,1.1884065722539199,2432,6,CARTPT|STX1A|ADRBK1
CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0033173,0.909732016925247,1.0,0.209737299029224,0.618988955385215,9029,10,ADGRB2|NFATC4|NFAT5|NFATC1|PPP3CA|PPP3CB
REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070302,0.217928902627512,0.7341474817293291,-0.140500374249632,-1.1292304499813501,281,158,RASSF2|LYN|FCGR2B|CYLD|ULK4|SERPINF2|MAP4K4|RIPK2|PDCD10|KARS|GADD45A|DBNL|MLKL|TNFRSF11A|PDCD4|MECOM|DUSP3|DKK1|ZNF622|MAPK3|PARK2|GREM1|RELL2|DUSP10|EDA2R|SEMA3A|MAP3K11|PLCB1|RELL1|MAP2K1|DLG1|TNF
REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001817,0.0982142857142857,0.570215774831708,-0.128285566155797,-1.18614452874995,32,387,IL6ST|GBA|RELA|RNF135|CEBPG|TRIM16|TRAF6|EZR|DLL1|EIF2AK2|CD84|AGT|CYBA|TLR1|CREBBP|FLOT1|CD86|MUL1|IL6R|IL17D|OTUD7B|IL17RA|SNAI2|PYCARD|RIOK3|HILPDA|SETD2|POLR3C|ATF4|HIF1A|XRCC6|ITCH|IL1RN|HSPB1|SOD1|PTPN6|OTUD5|FURIN|CD274|SYT11|IL1B|RARA|SRGN|CLU|FAM49B|IRAK1|ITGB8|ADCY7|POLR3D|FCER1G|LURAP1|CX3CL1|SIRPA|CTNNB1|LGALS9|MRE11A|ARFGEF2|HMOX1|TNFAIP3|PRKD2|SSC5D|PCBP2|FGR|EIF2AK3|NFAM1|RPS3|TRAF3|ZNF580|DDX3X|C1QBP|TNFRSF1B|BCL10|ATP6AP2|RUNX1|SEMA7A|APOD|RELB|MAP2K5|DDIT3|IL6|LYN|FCGR2B|PRNP|ARRB1|REL|CYLD|GLTSCR2|TRIB2|RNF216|CHRNA7|SLC11A1|CD276|PANX1|MBP|MAVS|SERPINF2|GPATCH3|FOXP1|TREX1|RIPK2|TMSB4X|GAPDH|SMAD7|ARHGEF2|KARS|PDE4B|TRAF3IP1|PDCD4|ADAM17|TRIM25|NLRP1|NLRP3|STAT3|BCL3|B2M|SARS|TNFRSF4|HOMER2|ADCYAP1|DRD2|PPP1R11|ADRA2A|TAX1BP1|RAC1|TICAM1|MYD88|PLCB1|TWIST1|GPRC5B|HSP90AB1|SULF2|TNF|PDE4D|LRRFIP1|TNFRSF21|INHBB
ARGININE CATABOLIC PROCESS TO PROLINE%GOBP%GO:0019493,0.655103932212366,0.9640743070248079,-0.666354212615792,-0.891402347185764,4947,1,OAT
2-OXOBUTYRATE METABOLIC PROCESS%GOBP%GO:0046361,0.484575665298557,0.9064456896937672,-0.756175562417292,-1.01155910544523,3659,1,THNSL2
POSITIVE REGULATION OF FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:1904544,0.777181208053691,0.9810334506628041,0.6132002646669611,0.814609194806751,5789,1,PINK1
MEIOTIC GENE CONVERSION%GOBP%GO:0006311,0.66079703429101,0.964618776001639,-0.663652404058227,-0.887788055500857,4990,1,RNF212
"BASE-EXCISION REPAIR, AP SITE FORMATION%GOBP%GO:0006285",0.519645375780778,0.924266681162653,0.323888014094359,0.9558772065531559,5157,10,TDG|MUTYH|MBD4|NEIL1|MPG|NTHL1|UNG
RESPONSE TO L-GLUTAMATE%GOBP%GO:1902065,0.20148478099480302,0.7153093055622209,-0.7370829886958921,-1.26074097652451,1356,2,TMBIM6|FYN
REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903952,0.645503355704698,0.9628191546271729,0.6825650639611819,0.906757236086033,4808,1,RNF207
NEGATIVE REGULATION OF SECRETION%GOBP%GO:0051048,0.0004970178926441349,0.0784645998831315,-0.24099109416560396,-1.7846993857850701,0,104,SYT11|RAB33B|IL1B|SRGN|IL11|CX3CL1|ADRA2C|LGALS9|TNFAIP3|NR1H3|PFKL|SSC5D|LIF|RAB11FIP1|TNFRSF1B|SLC30A1|FCGR2B|HTR1B|VPS4B|VAMP3|TMSB4X|DPH3|CRH|SNCA|FMR1|PNKD|HRH3|NLRP3|TNFRSF4|DRD2|PPP1R11|RAB7A|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|TNFRSF21|INHBB|TRH
CELLULAR CALCIUM ION HOMEOSTASIS%GOBP%GO:0006874,0.714804270462634,0.971081608033886,0.13969232199888798,0.873505970707688,10042,208,THADA|TAC1|RYR2|CHRNA10|CALB1|EDN1|RGN|CXCL13|GHRL|PTGER3|ATP2B1|TMEM165|NOL3|SLC8A3|P2RX5|CXCR4|F2R|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|AGTR1|ATP2A1|CDH23|HSP90B1|PDPK1|CACNA2D1|PTGER1|TMEM178A|CCR5|PTH1R|CCL21|F2RL1|JPH4|CCL5|ATP2B3|ATP7B|DMPK|GRIN1|CCL19|CXCL10|ATP2A2|PLCG1|C3AR1|CALB2|CD55|DRD4|DLG4|TRPC1|S1PR4|PTGIR|HERPUD1|TNNI3|SLC24A1|SLC8A1|CCL11|LPAR2|OPRL1
GLYCOSIDE TRANSPORT%GOBP%GO:1901656,0.439295644114921,0.879896414106183,-0.778617115130128,-1.04157985474639,3317,1,RALBP1
POSITIVE REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000324,0.0264429530201342,0.337668602007655,0.9869320688134101,1.31109522325744,196,1,LMO3
RESPONSE TO FATTY ACID%GOBP%GO:0070542,0.873763542157325,0.9934031064448321,-0.15373150805917402,-0.6982171465902289,3709,21,PDK4|CCL21|CCL19|ADCY6|GNG2|PPP5C|PTGER2|ZC3H12A|AKR1C3|CCR7|PTGER4|PID1|SFRP1|TGFBR3|GNB1|AKR1C2|PDK3|SCD|PTGFR|DGAT2|CD36
MITRAL VALVE MORPHOGENESIS%GOBP%GO:0003183,0.608551347130027,0.9508825506493929,-0.270500127377055,-0.873198651270788,3116,9,NOTCH1|ACVR1|SMAD6|EFNA1
REGULATION OF IMMUNOGLOBULIN PRODUCTION IN MUCOSAL TISSUE%GOBP%GO:2000557,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
CELL CYCLE DNA REPLICATION INITIATION%GOBP%GO:1902292,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
CLOACA DEVELOPMENT%GOBP%GO:0035844,0.8448046449739929,0.991298302704726,0.46542518941768796,0.760724686125311,6983,2,AHI1
DETECTION OF NODAL FLOW%GOBP%GO:0003127,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
VITAMIN CATABOLIC PROCESS%GOBP%GO:0009111,0.615522454922164,0.951600300570769,0.422544532068604,0.8954122270101149,5495,4,PDXP|PM20D2|MTHFS|CYP26B1
AXON GUIDANCE%GOBP%GO:0007411,0.6463748290013679,0.963344312748158,-0.117487641826981,-0.9322344976510691,944,143,ALCAM|PLXNA1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|MAPK3|PTPRM|EFNB1|SEMA3A|DOK5|PTPRA|PIK3R1|GFRA2|SLIT3|EPHB2
PHAGOCYTOSIS%GOBP%GO:0006909,0.012937595129376001,0.247127465902647,-0.18009939463560604,-1.44364856832228,16,156,MYO10|MYO1G|PPAPDC1A|XKR8|CLEC7A|IGHV4-4|RARA|PRKCD|ABI1|IGHV2-26|ITGAM|NR1H3|GRB2|FGR|ABL1|VAV1|MYO1C|IGHV1-69-2|CYFIP2|IGHV3-15|FYN|IGHV3-73|LYN|FCGR2B|ARPC5|SLC11A1|YES1|RAB39A|WIPF1|CRK|LIMK1|VAV3|CD93|VAV2|ARPC4|CDC42|IGHV1-3|ANXA11|COLEC12|MAPK3|RAB7A|MYH9|RAC1|PLD2|MET|CORO1C|ACTR2|BRK1|CD36|SH3BP1|PIK3R1|HSP90AB1
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS%GOBP%GO:0048704,0.31526589810338396,0.816693029640254,0.29848522778230296,1.12843325539597,3390,21,HOXD3|HOXB3|HOXD4|HOXC4|MTHFD1
SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE%GOBP%GO:0031629,0.777957206297941,0.9811398289380491,-0.21444334105704502,-0.754652834522594,3853,11,SNAP47|PRRT2|STX2|STX3|STX1A|STX1B|SNAP23|STX4|SNAP29|STX11|SNAP25
NUCLEOSIDE TRANSPORT%GOBP%GO:0015858,0.236361437038829,0.7504566255368191,0.7157981803143101,1.16995246159742,1953,2,SLC29A2|SLC29A1
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902306,0.234168987929434,0.7481332891296201,-0.38673345855236,-1.2021359758038799,1260,8,CAMK2D|HECW2|NEDD4L|NEDD4|COMMD1
REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045646,0.941999103541013,1.0,0.143026191427424,0.5924626479688909,10507,29,HOXA5|CDK6|MAPK11|TAL1|MED1|PRMT1|STAT5B|ACVR2A|STAT1|MAPK14|LDB1|ANKRD54|HMGB2|ZFPM1
MELANIN METABOLIC PROCESS%GOBP%GO:0006582,0.157130760856417,0.6578589353509621,0.7609594706368901,1.2437673499764599,1298,2,CITED1|TRPC1
REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060281,0.113946978429112,0.590080021815051,-0.605645332811064,-1.3928577417235601,691,4,YTHDF2|IGF1|PDE3A
HISTONE H3-K9 DIMETHYLATION%GOBP%GO:0036123,0.5895730010886661,0.945418171231938,0.5712158808933,0.933636665101895,4873,2,SUV39H1|SUV39H2
RESPONSE TO ANESTHETIC%GOBP%GO:0072347,0.319081718618366,0.821565973575677,0.434010566771231,1.12963831963476,3029,7,CRHBP|ADCY8|ABAT|DRD4
REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002673,0.312962812271137,0.8158652929227931,0.218366635650047,1.11473331019279,3845,65,IGKV4-1|PTGER3|IGHG1|F12|INS|IGHG4|IGKV3-11|SUSD4|ZP3|IGKV2D-28|PTGS2|GSTP1|IGKV2-28|C3AR1|C7|KLKB1|CD55|C5|VIMP|C4A|C4B|IGHG2|CD46|DNASE1L3
REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034143,0.0819672131147541,0.539604343254557,-0.38525087880047904,-1.45084744573437,394,13,MFHAS1|FLOT1|DAB2IP|TNFAIP3|NR1H3|LYN|WDFY1|NR1D1
TERPENOID BIOSYNTHETIC PROCESS%GOBP%GO:0016114,0.527415553809898,0.9265056012720759,-0.46046101246277704,-0.934491943895708,3356,3,HMGCS1|FDPS|ALDH1A3
PRESYNAPTIC ENDOCYTOSIS%GOBP%GO:0140238,0.7049060288015621,0.968941691852291,-0.17281801185011997,-0.828396570045653,2887,24,CANX|DNAJC6|GAK|PACSIN1|NLGN4X|CDK5|OPHN1|DNM2|SNCA|SYT2|AMPH
NEGATIVE REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903976,0.6948993288590601,0.96731875442989,0.657201146890163,0.873062403821749,5176,1,CERS2
NEGATIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010871,0.0048076923076923106,0.161174478355652,-0.7686452190914291,-1.94577433146197,27,5,PPARA|PPARG|NR1D1
CELLULAR POTASSIUM ION HOMEOSTASIS%GOBP%GO:0030007,0.610502577319588,0.9508825506493929,0.35843775670118705,0.881525461176381,5684,6,ATP1B3|KCNMA1|ATP1A3|ATP1A1|ATP1B1
GLYCOSIDE CATABOLIC PROCESS%GOBP%GO:0016139,0.223458458978892,0.736017410332025,0.44976459864350105,1.2261789603208701,2148,8,GBA2|KIAA1161|ABHD10|GUSB|FUCA2|GLA|NAGA|FUCA1
POSITIVE REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904028,0.9527035200193541,1.0,0.38983778626715204,0.637179152183193,7875,2,RB1
LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031663,0.261704946996466,0.771967970256231,-0.275104009405324,-1.1576060298496298,1184,17,CCL3|IL18|TGFB1|CD6|PRKCE|IL1B|IRAK1|MTDH|BCL10|LYN|TNF
GLUCURONATE CATABOLIC PROCESS%GOBP%GO:0006064,0.45982142857142894,0.890371861972445,-0.386675650267416,-0.978843732068032,2677,5,SORD|XYLB
PURINE RIBONUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034036,0.417418384879725,0.8709670999109399,0.42227179798537,1.03851598918234,3886,6,SLC35B3|SLC26A2|PAPSS2|SLC35B2
REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032890,0.229461130742049,0.743365122901021,-0.28386983334784804,-1.1944916087781299,1038,17,TNFRSF11A|HRH3|PER2|TRH
PROTEIN-PYRIDOXAL-5-PHOSPHATE LINKAGE%GOBP%GO:0018352,0.0394630872483222,0.396089810860281,0.9797640052933391,1.30157277066102,293,1,CTH
THIAMINE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0042357,0.29101707498144,0.800055408161957,-0.685028949545079,-1.17170533039306,1959,2,THTPA|TPK1
REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902713,0.600239703639137,0.9503412745667059,0.388924996841332,0.896414462893783,5508,5,CD2|PTPN22|RASGRP1|ZC3H12A
CELLULAR RESPONSE TO VITAMIN D%GOBP%GO:0071305,0.35397178916109895,0.842911430859438,-0.646760408050731,-1.10624903969896,2383,2,SFRP1|PIM1
POSITIVE REGULATION OF XENOPHAGY%GOBP%GO:1904417,0.602227171492205,0.9508825506493929,-0.52031982354563,-0.8899791916275358,4055,2,LRSAM1|OPTN
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION%GOBP%GO:0014857,0.017124979417092,0.277422272849102,-0.758522568757139,-1.7444434472262498,103,4,AKIRIN1|FGF2|CFLAR
NEGATIVE REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000346,0.378613765573969,0.854868503740915,0.65208095863933,1.06580841318414,3129,2,CEACAM1
ADENOHYPOPHYSIS DEVELOPMENT%GOBP%GO:0021984,0.137787676317743,0.6243233125849921,-0.774496354423103,-1.32473453486921,927,2,DRD2
VITAMIN K BIOSYNTHETIC PROCESS%GOBP%GO:0042371,0.561101549053356,0.936434965680841,-0.7133877370974859,-0.954320526925065,4237,1,UBIAD1
NEGATIVE REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032717,0.308250414593698,0.811337431037228,-0.30643039581424897,-1.11635666996451,1486,12,SSC5D|MAP2K5|ARRB1|TMSB4X|BCL3
NEGATIVE REGULATION OF RENAL ALBUMIN ABSORPTION%GOBP%GO:2000533,0.544287038262942,0.929758904310055,-0.722761358623732,-0.966859906240049,4110,1,GAS6
POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905665,0.451476234608765,0.886411023801201,-0.773323775915307,-1.03449879348617,3409,1,RAMP3
GLYCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0046477,0.22031944673143397,0.7354368651705759,-0.5297523851541389,-1.21831981670475,1337,4,GALC|GLA|NAGA|GBA
URETERIC BUD ELONGATION%GOBP%GO:0060677,0.552760492519529,0.9324056413710201,-0.7178539920599909,-0.9602951723633809,4174,1,FGF1
INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0065002,0.623926185173401,0.9536478716552259,-0.150395672207806,-0.9040913591862141,1960,48,PEX16|TIMM50|ROMO1|SRP72|TOMM20|C19orf52|TIMM23|PEX26|DNLZ|PEX7|TIMM22|TIMM23B|SRP54|PEX5
POSITIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034184,0.571802135541512,0.9405604256499541,0.3984262609112679,0.9183134680933341,5247,5,FAM178A|ANKRD32
ATRIAL SEPTUM DEVELOPMENT%GOBP%GO:0003283,0.87871943435137,0.9956508825790341,0.20300670763492398,0.6551781034358921,8947,13,TGFB2|HEY2|NPHP3|NOTCH2|ANK2|ZFPM1|ISL1|NPHP3-ACAD11|BMPR2|GJA5|SOX4
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090185,0.965098797250859,1.0,0.222807527667156,0.5479626655070751,8986,6,BMP4|GATA3|STAT1
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901030,0.000527426160337553,0.0784645998831315,-0.42409727227055294,-2.20023023970599,1,30,GSK3B|NMT1|SFN|CHCHD10|YWHAG|ZNF205|BAX|TP53BP2|GZMB|BBC3|YWHAH|BOK|BID|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|PMAIP1|TFDP2
REPLICATIVE SENESCENCE%GOBP%GO:0090399,0.132995951417004,0.618866521892949,0.47317794094015797,1.35028816952771,1313,9,ATR|CDKN2A|TERT|CHEK2|CHEK1|SERPINE1|ATM
POSITIVE REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032741,0.46449739929841494,0.8926133012045779,0.617640287848203,1.0095160829166199,3839,2,DHX9|TLR2
NEGATIVE REGULATION OF MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034125,0.533778767631774,0.9265056012720759,-0.5482216708023161,-0.9377038070327429,3594,2,CD300A|CD300LF
REGULATION OF POLYAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0010967,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
MRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0042789,0.865947291969288,0.9929671171385601,-0.184451555947914,-0.694641034024367,4172,13,MED1|ZBTB1|SRF|SUPT6H|TFCP2|ARNT|SOX18|LMO2|ATF4|HIF1A|C5AR1|DDIT3|SOX17
"BLOOD COAGULATION, INTRINSIC PATHWAY%GOBP%GO:0007597",0.9899254483175501,1.0,0.15935239622454,0.470290090192376,9825,10,F12|KLKB1|GP1BB
GLUTATHIONE CATABOLIC PROCESS%GOBP%GO:0006751,0.745696230115494,0.9749763305090959,0.339205868310003,0.7818192420673341,6843,5,GGT1|GGT5|CHAC2
DETERMINATION OF DORSAL/VENTRAL ASYMMETRY%GOBP%GO:0048262,0.00296956198960653,0.13156768405007002,-0.9642679900744421,-1.64932875413212,19,2,GREM1|NBL1
NEGATIVE REGULATION OF RNA SPLICING%GOBP%GO:0033119,0.605643190402133,0.9508825506493929,-0.20544540088667396,-0.8837804690561291,2725,18,RBMX|U2AF2|SRSF9|PTBP2|SRSF4|SRSF10|RPS26|SRSF12|PTBP1|RPS13|SRSF7|TMBIM6|PTBP3|C1QBP|RNPS1|SAP18
REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:0090559,0.000361402240693892,0.0784645998831315,-0.3635661923038879,-2.34388079281681,0,62,GSK3B|NMT1|SFN|RASIP1|CHCHD10|YWHAG|BNIP3|PDCD6IP|MUL1|SLC25A5|ZNF205|THEM4|BAX|PPIF|TP53BP2|HEG1|GZMB|F11R|BBC3|MPV17L|TJP2|YWHAH|BCL2L1|CAMK2A|BOK|BID|ACAA2|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|SLC35F6|BNIP3L|BMF|BCL2L11|PMAIP1|TFDP2
NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0046929,0.00274725274725275,0.129967667001507,-0.7932384734171629,-2.00803052171148,15,5,SYT11|SLC30A1|FMR1|PNKD|PARK2
NEURAL TUBE PATTERNING%GOBP%GO:0021532,0.510130494505495,0.918404893008545,-0.37166335759982305,-0.940841110047532,2970,5,LRP6|PTCH1|ARL13B|KDM2B|ATP6AP2
RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0042542,0.22081619740588396,0.73556947110949,-0.196588683523302,-1.1741540091710099,697,47,SOD1|PPIF|IMPACT|MAPK7|PRKCD|SIRPA|STK26|HMOX1|TNFAIP3|HP|ABL1|RPS3|FYN|ZNF580|IL6|PDCD10|FXN|NET1|STK24|AQP1
POSITIVE REGULATION OF GRANZYME B PRODUCTION%GOBP%GO:0071663,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
LIMB MORPHOGENESIS%GOBP%GO:0035108,0.412244539952636,0.867015886388254,0.237151757110008,1.03899890169066,4699,35,TBX3|TBX2|MYH3|ZNF141|ZNF358|TGFB2|LEF1|C5orf42|BMPR1B|NIPBL
REGULATION OF CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:1903248,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
DIGESTIVE SYSTEM DEVELOPMENT%GOBP%GO:0055123,0.0591133004926108,0.475550457504474,-0.256638872376657,-1.4365918963370001,203,38,ITGA6|CLMP|WNT11|CCDC103|CXCL8|RBPMS2|COBL|SOX17|TNF|DNAAF1|BBS7
REGULATION OF METANEPHRIC DCT CELL DIFFERENTIATION%GOBP%GO:2000592,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
GLUCAN BIOSYNTHETIC PROCESS%GOBP%GO:0009250,0.5889188628346129,0.945418171231938,-0.237079317343526,-0.8928361774936829,2837,13,PER2|NR1D1
HISTAMINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002349,0.961744966442953,1.0,0.521449051610057,0.6927218015724711,7164,1,SNAP23
CELLULAR RESPONSE TO SUCROSE STIMULUS%GOBP%GO:0071329,0.313915000661989,0.816422962704093,-0.8439567710630791,-1.1289867046773099,2370,1,CALCRL
POLYSACCHARIDE DIGESTION%GOBP%GO:0044245,0.23699192373891198,0.7507739897770379,-0.881616674018527,-1.1793655051016299,1789,1,CHIT1
VACUOLAR TRANSPORT%GOBP%GO:0007034,0.093973442288049,0.562743160240921,-0.168356726750325,-1.25902145557084,183,108,VPS4A|VPS18|VPS11|GCC2|EHD3|VPS4B|BECN1|BIN1|LEPROT|RBSN|VPS16|RAB12|NEDD4|ADRB2|ATP6V0D1|TRAK1|RAB7A|PARK2|CHMP1B|VTI1A|CACNG3|VPS53|KIF13A|CACNG7
REGULATION OF TRANSPOSON INTEGRATION%GOBP%GO:0070894,0.137050925365913,0.62388141596544,0.775902950096499,1.2681920566318001,1132,2,ZNF93|ZNF91
REGULATION OF MUSCLE SYSTEM PROCESS%GOBP%GO:0090257,0.313618290258449,0.8163836065655741,-0.145618894111834,-1.0784047924256601,630,104,HDAC4|SPHK1|ADRA1B|SLC9A1|PLN|FOXO1|RANGRF|DOCK5|ENO1|IGF1|BIN1|ATP2B4|LMNA|SMAD7|PDE4B|ADRB2|MTPN|CHRNA3|PDE9A|PRKCA|NOS3|SCN5A|DLG1|PDE4D|CAV1|STC1
VITAMIN B6 METABOLIC PROCESS%GOBP%GO:0042816,0.30709698666227603,0.8101040452554871,-0.48433528155408,-1.1138699663898999,1864,4,PNPO|PDXK
REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046599,0.466225165562914,0.894322345600068,0.272734414738935,0.9968860143001609,4927,19,KAT2A|CENPJ|CEP295|STIL|CDK5RAP2|TRIM37|MDM1|CEP120|BRCA1|KAT2B|NUP62
REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000001,0.7470033405384159,0.9749763305090959,0.24512329187507897,0.772716214769862,7602,12,THOC1|PPP1R10|WDR76|DDX39B|RFWD3
CARDIAC RIGHT ATRIUM MORPHOGENESIS%GOBP%GO:0003213,0.43148417847213,0.8785877309899279,-0.7824217026907809,-1.04666936752718,3258,1,NOTCH1
NCRNA DEADENYLATION%GOBP%GO:0110008,0.5004633920296571,0.9144253281295329,-0.7463608292898101,-0.9984296376918911,3779,1,PARN
NEGATIVE REGULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044146,0.6987951807228922,0.96731875442989,-0.645897662108513,-0.864036995857182,5277,1,TIRAP
GLOMERULAR PARIETAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072016,0.669667681715875,0.964618776001639,-0.659902955447728,-0.8827723037748629,5057,1,FOXJ1
NEGATIVE REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010454,0.8282562160382021,0.9876441563834109,-0.312332702534951,-0.7182999672433059,5029,4,DKK1
PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS%GOBP%GO:0034727,0.0147682639434407,0.264001457476971,-0.8332965699790451,-1.69115063044408,93,3,RB1CC1|ATG13|ATG7
DNA DOUBLE-STRAND BREAK PROCESSING INVOLVED IN REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:0010792,0.972938144329897,1.0,0.214990400474593,0.528737579631866,9059,6,SLX1B|SLX4|RAD52|RBBP8
THYROID HORMONE METABOLIC PROCESS%GOBP%GO:0042403,0.746671297904365,0.9749763305090959,0.42652969451496103,0.81078808003326,6448,3,DUOX1|CPQ|DIO2
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002720,0.0397857689364958,0.397881714587746,-0.30975077635696696,-1.54354915539515,155,27,BCL10|SEMA7A|IL6|MAVS|KARS|NLRP3|B2M|TICAM1|GPRC5B
NEGATIVE REGULATION OF MATURE B CELL APOPTOTIC PROCESS%GOBP%GO:0002906,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
MITOCHONDRIAL TRYPTOPHANYL-TRNA AMINOACYLATION%GOBP%GO:0070183,0.337986577181208,0.832232043362884,0.835244816938685,1.10958547638995,2517,1,WARS2
REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION%GOBP%GO:0110020,0.0817497310864109,0.539385377100419,-0.20871754419263003,-1.3391931113067799,227,61,LPAR1|TGFBR1|DLC1|PFN1|ABL1|RHOA|NRP1|SLC9A1|INPP5K|PXN|SERPINF2|RHOC|LIMK1|WNT11|CDC42|AKAP13|SORBS3|TMEFF2|RAC1|MET
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000703,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS%GOBP%GO:0021692,0.9944187026116259,1.0,0.17099611320550598,0.4450669563705821,9442,7,KIF14|CEND1|AGTPBP1|ATP7A
RESPONSE TO SUCROSE%GOBP%GO:0009744,0.127691165553081,0.6076669536424699,-0.782890816063623,-1.33909281192671,859,2,CALCRL
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS%GOBP%GO:0010563,0.0678851174934726,0.50364937614461,-0.129046668708443,-1.1852605509832301,25,363,PPP2R5A|PPM1F|TIMP3|ENSA|PYCARD|PIK3R2|DUSP4|STRAP|SOCS3|THY1|CDKN1B|CRKL|DUSP7|PPP1R15B|NCK2|ITCH|HSPB1|HEXIM1|GPER1|DNAJC3|FLCN|PTPN6|QARS|ZGPAT|LRP5|CBFA2T3|PPIF|IL1B|HEG1|IMPACT|PRKCD|SIRPA|FKBP1B|DAB2IP|IGF1R|TRIB1|CNKSR3|WARS|DDIT4|RGS4|CEBPA|ABL1|HDAC4|MGAT5|GNAQ|FAM129A|IGFBP3|ELL|FBP1|SMAD6|INPP5K|DGKQ|PPARA|FOXO1|MYADM|EIF4G1|ARPP19|PPAP2B|UBASH3B|RASSF2|LYN|PRNP|CHP1|CYLD|LDLRAD4|TRIB2|CDA|PIK3IP1|PPP2CA|PRKAR2A|TNIP1|NPM1|PCIF1|PTPN1|YWHAB|SMAD7|SNCA|LGALS3|TRAF3IP1|CDKN1C|PDCD4|PDE12|MECOM|DUSP3|UCHL1|DKK1|SNX6|PRKAR1B|PKIG|SOCS5|YWHAE|PPP1R11|CDKN1A|DBNDD2|PARK2|KIAA0226|GREM1|SFRP2|DUSP10|SLC9A3R1|CORO1C|FKBP8|SNX25|TWIST1|DLG1|TNF|PDE4D|SPRED2|INSM1|CAV1|FKBP1A|EPHB2|PAK2|PARD3|TRIB3
URETER SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0072193,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
EMBRYONIC DIGIT MORPHOGENESIS%GOBP%GO:0042733,0.45587044534413,0.88900512246363,0.352289048830822,1.00531257637513,4503,9,TBX3|TBX2|C5orf42
CAJAL BODY ORGANIZATION%GOBP%GO:0030576,0.9519245875883741,1.0,-0.29373798905262605,-0.5961325214433759,6058,3,ZPR1
MATURATION OF 5.8S RRNA%GOBP%GO:0000460,0.0644438915153023,0.495456803258629,-0.301529525428141,-1.4628015648316899,258,25,ERI3|EXOSC7|FTSJ3|EXOSC8|URB1|C1D|WDR12|PES1|MPHOSPH6|EXOSC4|EXOSC9|KRI1|RRS1|NOL9|NOP14
BASIC AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1990822,0.6797299522476539,0.9647315640607691,-0.35769069984137697,-0.822613885430537,4127,4,SLC7A1
DETECTION OF BACTERIAL LIPOPEPTIDE%GOBP%GO:0070340,0.6148478099480329,0.9511905259737851,-0.515632754342432,-0.881962210778835,4140,2,TLR2|TLR1
STAT CASCADE%GOBP%GO:0097696,0.9596515359926641,1.0,0.140845546400608,0.55429733677826,10464,24,PIAS1|PKD2|SOCS2|JAK2
NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045671,0.20941336971350602,0.7248363921442859,0.37695007336327596,1.2489527328987,2148,14,CARTPT|TMEM178A|FBN1|ZNF675|FSTL3|LRRC17
REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032647,0.8187322611163671,0.987153241368501,0.19695791886231895,0.7199113280495091,8653,19,DHX9|TBK1|NLRC3|PTPRS|CHUK|STAT1|TLR4|HSPD1|DDX58|IFIH1|HMGB1
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072364,0.26369710467706,0.775130946140716,-0.6993658671078029,-1.19622786004791,1775,2,NCOR2|PPARA
POSITIVE REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:2000170,0.123236822568671,0.607607158836689,-0.787546487715895,-1.34705608894609,829,2,ACE
GLIAL CELL ACTIVATION%GOBP%GO:0061900,0.20149253731343303,0.7153093055622209,-0.33984962666717,-1.2381062802425902,971,12,CLU|CX3CL1|ITGAM|SNCA|TNF
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043281,0.49866131191432395,0.913532078165168,-0.124103279333751,-0.985601999860673,744,141,DLC1|MAGEA3|EIF2AK3|BBC3|RPS3|S100A8|DDX3X|TNFRSF10A|MAP2K5|HGF|PPARG|MMP9|BOK|LAMTOR5|CRADD|PLAUR|SNCA|NLRP1|NLRP3|YWHAE|DNAJB6|TNFRSF10B|MTCH1|EPHA7|SOX7|BCAP31|CSNK2A1|AQP1|TNF|PMAIP1|PAK2|EGLN3
ATRIAL SEPTUM PRIMUM MORPHOGENESIS%GOBP%GO:0003289,0.792288989232372,0.9819233677232551,0.4074674848754051,0.774552824777648,6842,3,TGFB2|SOX4
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010771,0.9146919431279621,1.0,-0.11341347283491801,-0.708908542609428,2701,55,THY1|DCC|ARHGDIA|RNF6|RTN4|SEMA3F|RHOA|SEMA7A|YWHAH|EFNA1|SEMA6B|MFI2|SEMA3A|CORO1C|SEMA3G|LINGO1
EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060502,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
DENDRITIC CELL MIGRATION%GOBP%GO:0036336,0.161328355276086,0.6642861491116989,0.41693682177222496,1.31433386135414,1641,12,CXCR4|CCR5|CCL21|CCL5|CCL19|CCR1|TRPM2|HMGB1|EPS8|CCR7
PHOSPHATIDIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006654,0.42500649857031503,0.875112846303989,-0.197986973398064,-1.0132480522217,1634,29,ABHD5|DGKQ|PLD6|PLA2G2A|AGPAT3|LPCAT1|GPAT2|PLD2
ERBB SIGNALING PATHWAY%GOBP%GO:0038127,0.288536269430052,0.7980646072929201,-0.18282796488946101,-1.10747321867897,890,50,MATK|PLCE1|DGKD|BCAR1|PTK2B|GRB2|CUL5|STUB1|CPNE3|HBEGF|CDC37|PTPN12|ADAM17|SHC1|PRKCA|PIK3R1
REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:1904672,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002730,0.38186813186813207,0.857178152269066,-0.412565033055391,-1.04438098545234,2223,5,MAVS|TICAM1
TRABECULA MORPHOGENESIS%GOBP%GO:0061383,0.201855123674912,0.7160679679335791,-0.29122134335444705,-1.22542591733486,913,17,S1PR1|RBPJ|FKBP1A
NUCLEOSIDE DIPHOSPHATE PHOSPHORYLATION%GOBP%GO:0006165,0.000544514021236047,0.0784645998831315,-0.415393931206766,-2.22184679078286,1,33,CMPK2|LDHA|CMPK1|PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|AK7|ALDOA|PGAM2|AK4
HISTONE H3-K14 ACETYLATION%GOBP%GO:0044154,0.755838926174497,0.9774674727764979,0.625165416850463,0.830504365679251,5630,1,MEAF6
SNRNA EXPORT FROM NUCLEUS%GOBP%GO:0006408,0.0124721603563474,0.242431276597969,-0.922194651226909,-1.5773645613373202,83,2,PHAX|NCBP2
RENAL CONTROL OF PERIPHERAL VASCULAR RESISTANCE INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003072,0.9099224267685542,1.0,0.34334404564237697,0.652660912328274,7858,3,AGTR1
ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:0043652,0.0547680412371134,0.456473845459404,0.614826998523725,1.51207746194312,509,6,RHOBTB1|RAC3|ADGRB1
STEROID ESTERIFICATION%GOBP%GO:0034433,0.297084794967945,0.801828762950478,0.6885580369451341,1.12542919559102,2455,2,SOAT1|LCAT
TISSUE HOMEOSTASIS%GOBP%GO:0001894,0.222659775207154,0.7355723797115551,0.23850628098013396,1.19700971092139,2713,60,PCDH15|GCNT2|STK39|CDH3|IQCB1|ADGRV1|F2R|PIWIL4|SERPINA3|DFNB31|CDH23|NAPSA|SRC|BBS10|JCHAIN|IL7|ZNF675|CXADR|TF|NPHP3|CNGB1|ACTG1
POSITIVE REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045627,0.8578161822466619,0.99166790097654,-0.341752026582043,-0.6935755840496222,5459,3,SOCS5
REGULATION OF PYRUVATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904182,0.0170469798657718,0.277422272849102,0.992170269078077,1.31805393861637,126,1,SIRT4
NUCLEAR PORE COMPLEX ASSEMBLY%GOBP%GO:0051292,0.627140842232521,0.954953980159321,0.293520213262955,0.8662539807321858,6224,10,TPR|NUP205|NDC1|NUP107
NEGATIVE REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904979,0.00400890868596882,0.148195394527521,-0.956217259443066,-1.63555841055671,26,2,RAB7A|PARK2
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010759,0.8358256107834878,0.988613522932093,0.26713078479966895,0.695285308624463,7936,7,RARRES2|CCL5|THBS1|CSF1|CMKLR1
ANDROGEN BIOSYNTHETIC PROCESS%GOBP%GO:0006702,0.9094573981259529,1.0,0.274031029061649,0.631600899215905,8346,5,SRD5A3|MED1
REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032204,0.610199203187251,0.9508825506493929,0.171080150349324,0.903691586178528,7657,76,NAT10|PIF1|SIRT6|ATR|HMBOX1|PNKP|PPP1R10|PRKCQ|PARP1|SRC|NEK2|HDAC8|SLX1B|AURKB|RTEL1-TNFRSF6B|MAP3K4|TNKS2|MAP2K7|SLX4|HNRNPA2B1|TEN1
STEROL HOMEOSTASIS%GOBP%GO:0055092,0.160013589264481,0.661454203640901,0.274697458658627,1.28128532748948,1883,44,ACSM3|FGFR4|SIRT1|LPL|SCARB1|LIMA1|SOAT1|RORA|GRAMD1B|AKR1C1|CETP|ABCA2|LDLRAP1|PTCHD2|APOE|CYP7B1
REGULATION OF UDP-GLUCOSE CATABOLIC PROCESS%GOBP%GO:0010904,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:0097694,0.36663844199830703,0.8510019955058101,0.657678522194651,1.07495747704125,3030,2,ATR|ATM
ALDITOL METABOLIC PROCESS%GOBP%GO:0019400,0.4814628249042921,0.904752640722988,0.333550984774734,0.984395129474104,4778,10,COQ3|TKFC|COQ2|PGP|PCK2|GK5|GOT1|GK
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034764,0.605949095369519,0.9508825506493929,0.16248005963894196,0.917529728775125,7903,108,RYR2|FGF19|AKAP9|CACNB2|NR4A3|KCNQ1|STK39|ATP1B3|ACTN2|F2R|INS|CXCL9|LRRC55|PKD2|FAM132A|PDPK1|CACNA2D1|STAC2|KCNH2|C2CD5|STAC3|CAPN10|CXCL10|WNK3|PLCG1|ANK3|DRD4|OSBPL8|DMD|TRPC1
MICROGLIA DEVELOPMENT%GOBP%GO:0014005,0.38067556952081705,0.856455387424841,-0.515661188926878,-1.04651906196033,2422,3,TLR2|APP|NRROS
REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051983,0.000941841299740994,0.0849637591935908,0.34246904835732295,1.8667331164158503,11,89,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|MKI67|SPAG5|CENPF|ECT2|NAA10|KIF2C|NUMA1|USP44|FAM178A|BUB1|DLGAP5|NEK2|CDC23|CDC20|FEN1|GEN1|APC|NDC80|CDK5RAP2|CENPE|PTTG1|FBXO5|HDAC8|RB1|BUB1B|ESPL1|AURKB|CDC6|NIPBL|CDCA5|RMI2|KLHL22
RESPONSE TO STEROL DEPLETION%GOBP%GO:0006991,0.35413005272407705,0.842911430859438,-0.387347636644421,-1.06324325409713,2014,6,ERLIN1|SCAP|ARHGEF10L|INSIG2|ERLIN2|INSIG1
MELANOCYTE APOPTOTIC PROCESS%GOBP%GO:1902362,0.6508724832214771,0.963755998259649,0.6801940891045439,0.9036075017656758,4848,1,FAP
MONOVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0055067,0.9258684102983241,1.0,0.128037031881574,0.647388612923271,11327,62,SLC12A2|TMEM165|SLC9A5|SLC9A7|ATP1B3|DMXL2|CLN6|KCNH2|PDK4|TCIRG1|SLC8A1|TFAP2B|GPR89B|ATP6V0E2|KCNMA1|ATP6AP1|SLC4A2|ATP6V0A2|SLAMF8|VPS33A|DMXL1|TMEM199|SLC12A5|ATP1A3|RAB20|SLC9A6|CLCN3|ATP6V0A1|SLC12A9|CA2|ATP1A1|SLC12A4|SLC26A6
LEUCYL-TRNA AMINOACYLATION%GOBP%GO:0006429,0.782145881214467,0.981487311948134,0.49324510614833206,0.806195575763728,6465,2,LARS|LARS2
CARDIAC CHAMBER DEVELOPMENT%GOBP%GO:0003205,0.8235738571968271,0.9876441563834109,-0.118434939128797,-0.7907042193553979,2179,69,SFRP2|SCN5A|ZFPM2|RBPJ|FKBP1A|SLIT3
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002820,0.631654128178269,0.9579569038493009,0.242855285614166,0.8711714206515891,6632,18,CEACAM1|TRIM27|THOC1|LOXL3|RC3H1|XCL1|NDFIP1|JAK3|FOXP3|ZC3H12A|PTPRC|HFE
NEGATIVE REGULATION OF PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0120094,0.306765523632994,0.809874675097403,-0.847430524922805,-1.1336336511293301,2316,1,CDYL
INNER DYNEIN ARM ASSEMBLY%GOBP%GO:0036159,0.0378758297540023,0.390817206576967,-0.507585817108823,-1.6385325034830298,193,9,LRRC6|CCDC103|DYX1C1|DNAAF1
POSITIVE REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905776,0.20200798354904997,0.716083967316356,0.7324338415649692,1.19714299290328,1669,2,GTF2H2|POT1
EGG COAT FORMATION%GOBP%GO:0035803,0.592130660727543,0.945987625636678,-0.524959353699389,-0.8979148594781999,3987,2,POMZP3
REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0046006,0.918579366996859,1.0,-0.139489945580471,-0.655451589707927,3801,23,IL6R|PYCARD|CD274|ICOSLG|LGALS9|RPS3|PRNP|IGF1|IGF2
DETECTION OF EXTERNAL BIOTIC STIMULUS%GOBP%GO:0098581,0.782389683659077,0.981487311948134,0.251010611128888,0.740797162414234,7765,10,SCARB1|NLRC4|CD1D|C4B|TLR4
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION%GOBP%GO:0032470,0.12156767872263198,0.607607158836689,0.7872070581748,1.28666831074376,1004,2,ATP2A1|ATP2A2
"NEGATIVE REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903690",0.3754322410670179,0.852871276063039,-0.45657089284729496,-1.0500176725482702,2279,4,CLASP2|PTEN|CLASP1|PHLDB2
VOLUNTARY MUSCULOSKELETAL MOVEMENT%GOBP%GO:0050882,0.552553024351925,0.9323791977088509,-0.452836593785146,-0.9190184127208841,3516,3,VTI1A
CARNITINE SHUTTLE%GOBP%GO:0006853,0.799854703959317,0.9839175016931591,-0.252542428006392,-0.7366774667830519,4403,7,MID1IP1
TRIF-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035666,0.126901140684411,0.6076669536424699,-0.287834039179839,-1.3334603814596202,533,22,CD300LF|TRAF3|TANK|UBA52|TICAM1|UBC|UBB
PROTEIN TARGETING TO PEROXISOME%GOBP%GO:0006625,0.7033390762162609,0.968941691852291,0.16713320233819298,0.838804183244424,8572,60,CROT|SLC27A2|HSD17B4|IDE|PEX3|DECR2|MPV17|DHRS4|PEX1|AMACR|IDH1|ZFAND6|GNPAT|ACOX2|ACOT2
NEGATIVE REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903542,0.0032992930086410102,0.13867916628452698,-0.891584868203375,-1.8094449998689601,20,3,VPS4B|RAB7A|PARK2
JUN PHOSPHORYLATION%GOBP%GO:0007258,0.7690983715080101,0.9792236089291529,-0.611656374062638,-0.8182313808300931,5808,1,MAPK8
MULTI-ORGANISM INTRACELLULAR TRANSPORT%GOBP%GO:1902583,0.8586017282010999,0.99166790097654,-0.341478683942827,-0.6930208432846999,5464,3,RAB7A
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS BY MESENCHYMAL-EPITHELIAL SIGNALING%GOBP%GO:0060665,0.25632199126175004,0.767319904137432,-0.8725738861932071,-1.16726869211541,1935,1,HGF
HYALURONAN CATABOLIC PROCESS%GOBP%GO:0030214,0.225161290322581,0.7390599693491929,-0.298765490709253,-1.19150346835151,1046,15,SLC9A1|FGF2|CHP1|CEMIP|TMEM2
NEGATIVE REGULATION OF INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902206,0.9696809214881501,1.0,-0.513619320688134,-0.687084225406321,7323,1,PTPN2
PURINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072522,0.8256513026052099,0.9876441563834109,-0.10427155938808902,-0.8264388360817451,1235,140,PFKL|COX5B|GPI|GMPS|GUCY1A3|PRPS1|PKM|PNP|ENO1|ACSL4|HPRT1|ATP5I|PRPSAP1|PDHB|GAPDH|PGK1|PANK2|CYC1|HK1|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2
CATABOLISM BY HOST OF SUBSTANCE IN SYMBIONT%GOBP%GO:0052364,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071672,0.292065985860173,0.8000726114371469,-0.558508878350061,-1.1334771745839198,1858,3,AIF1|CORO1B|SLIT2
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0045879,0.8871466431095409,0.996908008445583,-0.16304072112780701,-0.6860566019977801,4016,17,IFT122|TULP3|KCTD6|GPR161|KIF7
MYOBLAST PROLIFERATION%GOBP%GO:0051450,0.0273199703043801,0.339785941813865,-0.8936311000827131,-1.52850813687112,183,2,IGF1|ATOH8
TRNA METHYLTHIOLATION%GOBP%GO:0035600,0.21964782205746103,0.734713083559597,-0.8894464049404499,-1.18983957488238,1658,1,CDKAL1
PRO-B CELL DIFFERENTIATION%GOBP%GO:0002328,0.13523648239990302,0.6224657604778089,0.7768013366105121,1.2696604447088302,1117,2,LIG4|SOX4
MORPHOGENESIS OF A BRANCHING STRUCTURE%GOBP%GO:0001763,0.06298992161254201,0.490444801046219,-0.261402738752214,-1.4379482391695602,224,36,RASIP1|NOTCH4|FGF1|ENG|NRARP|LRP5|VEGFA|CTNNB1|NRP1|FGF2|PAX8|NPNT|CTSH|DRD2|FGF10|EPHA7|SFRP2|MET
REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000380,0.35971840659340704,0.8481344720377859,-0.42165105256702795,-1.0673816405033199,2094,5,SMAD2|DKK1
B CELL PROLIFERATION%GOBP%GO:0042100,0.8938640132669989,0.9976191001250191,-0.18184827586206898,-0.662491510154318,4311,12,LEF1|CD79A|CD180|CTPS1|HSPD1|MEF2C|PTPRC|CD40|GAPT|CR2|MS4A1|BCL2
HEART FIELD SPECIFICATION%GOBP%GO:0003128,0.657520439018927,0.9643779777660141,0.407519251474581,0.8635722221417959,5870,4,BMP4|ISL1|MEF2C|MESP1
RESPONSE TO PYRIMIDINE RIBONUCLEOTIDE%GOBP%GO:1905834,0.601610738255034,0.9506035145731909,0.704289810322011,0.935617592416746,4481,1,P2RY6
DNA STRAND ELONGATION INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902296,0.64,0.96058002537611,0.684880899867667,0.909833720771033,4767,1,GINS1
POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0051712,0.556397167791866,0.9353866100701541,-0.393541501333568,-0.9050632393678051,3378,4,GAPDH|FCER2
ASPARAGINE CATABOLIC PROCESS%GOBP%GO:0006530,0.0755704697986577,0.525408291492683,0.962946625496251,1.27923163187709,562,1,ASRGL1
WNT PROTEIN SECRETION%GOBP%GO:0061355,0.548993288590604,0.931134965065115,0.728495809439788,0.96777418233853,4089,1,WLS
ACETYL-COA CATABOLIC PROCESS%GOBP%GO:0046356,0.6537490720118779,0.9640743070248079,-0.500578990901572,-0.8562135546412429,4402,2,ACAT1|NUDT7
NEGATIVE REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090191,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002526,0.7057475654000379,0.968941691852291,0.23016536539732002,0.811760004994674,7391,17,F12|INS|SIGIRR|F3|KLKB1|CEBPB
REGULATION OF VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:0003056,0.331814611154753,0.8293509737209019,-0.538546376971435,-1.09296387114796,2111,3,DOCK4|CHRM3|DOCK5
LIPID DIGESTION%GOBP%GO:0044241,0.5525814760891479,0.9323791977088509,0.44294712296894395,0.9386472660849641,4933,4,LIMA1|AKR1C1|LDLR
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION INVOLVED IN HEART VALVE FORMATION%GOBP%GO:0003199,0.237521514629948,0.7507739897770379,-0.8814512571680629,-1.17914422193725,1793,1,EFNA1
HISTONE H4-R3 METHYLATION%GOBP%GO:0043985,0.8272682364564471,0.9876441563834109,-0.312636406969123,-0.7189984239958241,5023,4,COPRS
REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903978,0.33018124507486196,0.8291761235173739,-0.323081228252759,-1.09303215397231,1675,10,CX3CL1|ITGAM|IL6|TNF
MESENCHYME MORPHOGENESIS%GOBP%GO:0072132,0.649736027671582,0.963755998259649,0.21390664959404,0.860007191320289,7137,26,TBX2|DCHS1|BMP4|ROBO2|TGFB2|HEYL|LEF1|ACTA2
ENDOCARDIAL CUSHION DEVELOPMENT%GOBP%GO:0003197,0.7731949376308841,0.979946273879301,0.19136765184165103,0.76257256429237,8491,25,TBX2|DCHS1|BMP4|ROBO2|TGFB2|HEYL
MULTI-ORGANISM REPRODUCTIVE PROCESS%GOBP%GO:0044703,0.46334765157383295,0.8920600392599679,0.15912792772844697,1.01049208665325,6579,235,TAC1|HSPA2|INSL3|TEKT3|GHRL|CATSPERG|ROPN1B|NANOS3|ZNF296|PMFBP1|SERPINA5|IDO1|ARNTL|CRHBP|CCNA1|ZCCHC11|OXTR|HERC4|CCT6B|CABYR|CDK1|GGT1|PYGO1|RHOXF1|CELF1|USP9Y|PIWIL4|OVGP1|TRIM27|MTL5|TSSK3|SPATA25|DEAF1|JAG2|PCSK4|DZIP1|WDR33|CASC5|DAZAP1|TYRO3|TUBGCP3|YTHDC2|ZNF830|FUT10|PTTG1|ZP3|KIT|DNAH1|BMPR1B|PIM2|CLOCK|CXADR|METTL3|REC8|SRPK1|STX2|TRO|FANCF|MYBL1|STOX2|MYCBPAP|ING2|RACGAP1|TDRP|PEBP1|SPDYA|BRCA2|CEP57|BAG6|KMT2D|TEX14|MYCBP|UBE2B|UBR2|SPIRE2|CDK16|SPIRE1|PLA2G4B|ABHD2|AZIN2|ZNF35
REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010921,0.350942206102657,0.842847021021096,0.20035006816578002,1.08441201599022,4450,86,TMEM132D|PPP1R17|NUAK1|CAMSAP3|ITGA1|CNST|ELFN2|CSRNP3|DLG3|PPP1R35|HSP90B1|ELFN1|TGFB2|CASC5|PKMYT1|ZCCHC9|BOD1|LMTK3|CEP192|MAGI2|FARP1|TIPRL|SFI1|PPP1R12A|RIMBP2|SYTL2|FCRL3|MPHOSPH10|CDK5RAP3
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE REGENERATION%GOBP%GO:1905179,0.148032665181886,0.6402258061318559,-0.768072787427626,-1.31374736754768,996,2,CDKN1B|CDKN1A
NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902744,0.826444920138317,0.9876441563834109,-0.313103298105599,-0.720072176072743,5018,4,ARPIN
PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008654,0.9988423413645899,1.0,0.0801960298766539,0.490758671347116,13804,179,PTDSS2|LPCAT4|FITM1|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|GPAM|CEPT1|ABHD3|PIGC|MVD|INPP5E|TAZ|SRD5A3|PIGF|DPAGT1|FAR1|CHKB|CPNE7|FADS1|PIGQ|PIGB|GNPAT|MTMR4|DOLPP1|PLEKHA1|PTPN13|AGK|IDI1|RAB4A|CPNE1|ETNK1|DGKE|PLA2G2D|IMPA1|SLC44A3|DGKZ|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|PIP4K2B|MTMR7|FIG4|PIGK|LPCAT2|PLD1|PIGH|PIP5K1C|CDS1|MVK|GPAA1|PIK3C2B|INPP5F|TAMM41|OCRL|PIK3C2A|RUFY1|MTMR6|CRLS1|DGKA|CHKA|PIKFYVE|PGS1|PIGN|HMGCS1|STARD7|LCLAT1|PIGU|ETNK2|AGPAT2|FDPS|PIGS|PIGO|SLC27A1|AGPAT1|SLC44A1|NUS1|MTMR3|PLEKHA8|GPD1|INPPL1|PCTP|CHPT1|AGPAT5|PYURF|PCYT1B|FITM2|INPP5J
CELLULAR RESPONSE TO HEXOSE STIMULUS%GOBP%GO:0071331,0.450252177900046,0.88620227509476,0.256937925718374,1.01117863917358,4909,24,PRKAA2|UNC13B|AGER|ADCY8|ERN1
HEART VALVE DEVELOPMENT%GOBP%GO:0003170,0.3276955602537,0.828303707528737,-0.18876302611236398,-1.08691114508866,1084,42,SMAD6|TNFRSF1B|ADAMTS9|EFNA1|SNAI1|TBX20|NOS3|OLFM1|TWIST1|SLIT3
POSITIVE REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0032308,0.36040848389630803,0.848418604328854,-0.52405597495123,-1.06355603077671,2293,3,IL1B|TNFRSF11A
PYRUVATE TRANSMEMBRANE TRANSPORT%GOBP%GO:1901475,0.39157114738914,0.861425315078579,0.5569465891858921,1.05869687746034,3381,3,SLC16A7|MPC2|MPC1
TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071604,0.42435040831477394,0.8740879492662891,-0.600716845878136,-1.0274939925381898,2857,2,LTBP3|NRROS
INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA%GOBP%GO:0048312,0.6681853888452479,0.964618776001639,-0.41248483511635603,-0.8371257174059759,4252,3,MAPT|CLUH|DNM1L
IRON-SULFUR CLUSTER ASSEMBLY%GOBP%GO:0016226,0.0682995760715968,0.50364937614461,-0.321024758865129,-1.45802896198318,289,21,HSPA9|FAM96B|NUBPL|HSCB|BOLA2|BOLA2B|CIAO1|IBA57|FXN|ISCA1
FATTY ACID ELONGATION%GOBP%GO:0030497,0.148700382832964,0.64074876264986,0.451135227551892,1.3314166079773302,1475,10,HACD1|ELOVL6|TECR|ELOVL4|ELOVL2|HACD2|ABCD1|HACD3
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:2000171,0.24014972419227698,0.7525035503527309,-0.35115643178801903,-1.1880147698281298,1218,10,KIAA0319|NGEF|GORASP1|PTEN|RAPGEF2|DCC|SRGAP2C|YWHAH|EFNA1
PARAXIAL MESODERM MORPHOGENESIS%GOBP%GO:0048340,0.968186766662635,1.0,0.3650502132134171,0.5966645449813299,8003,2,LEF1
NEGATIVE REGULATION OF T-HELPER 1 CELL ACTIVATION%GOBP%GO:2000518,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN SERINE 2 RESIDUES%GOBP%GO:2001163,0.4591553025287971,0.890371861972445,-0.7696846052051171,-1.02963056386976,3467,1,CCNK
THIAMINE TRANSPORT%GOBP%GO:0015888,0.891859199225838,0.9976191001250191,0.44037592359026795,0.7197823492739791,7372,2,SLC19A2|SLC35F3
POSITIVE REGULATION OF FERROUS IRON BINDING%GOBP%GO:1904434,0.35070527097253196,0.842847021021096,-0.649574373533067,-1.1110621769501399,2361,2,B2M
CELLULAR RESPONSE TO ALDEHYDE%GOBP%GO:0110096,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
GLOMERULUS MORPHOGENESIS%GOBP%GO:0072102,0.723904990193942,0.972389532208766,0.346425640834452,0.798459747466269,6643,5,BMP4|PDGFRA|MEF2C|PDGFRB
REGULATION OF PEROXIDASE ACTIVITY%GOBP%GO:2000468,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014048,0.0411626080125687,0.402256981537283,-0.775878050191497,-1.5746214505143898,261,3,HRH3|TRH
COCHLEA DEVELOPMENT%GOBP%GO:0090102,0.808152897060602,0.984682960940884,0.483744935874489,0.790667808436075,6680,2,MCM2|TBX1
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS%GOBP%GO:1901615,0.185403220086531,0.6921618552848171,0.18829985467091698,1.18295949565127,2613,216,FDXR|CITED1|PLCB3|CYP21A2|SNCAIP|TM7SF2|PNMT|C14orf1|D2HGDH|SLC27A2|FDX1|HSD17B4|AKR1B1|CBR4|EBP|COQ3|PPIP5K2|NAPEPLD|ALDH1A1|DHFR|TKFC|DHRS4|ISYNA1|OSBPL3|CLN6|MVD|LBR|CYP2R1|CACNA1H|GBA2|AMACR|DHCR24|COQ2|TGFB2|SRD5A3|SOAT1|ADH1B|PPAPDC2|SULT1A3|DDC|DUOX1|AKR1C1|CETP|PGP|OSBPL5|ALDH3A2|LDLRAP1|APOE|NSDHL|ACOX2|OSBPL9|PIAS4|HAND2|GDPD1|CYP7B1|PLCD4|ACSS1|MINPP1|PLCG1|GGPS1|PSAT1|DRD4|TH|TRPC1
REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:2000790,0.238183503243744,0.7507739897770379,-0.8806241729157479,-1.17803780611534,1798,1,NFIB
VITAMIN B6 BIOSYNTHETIC PROCESS%GOBP%GO:0042819,0.19277297721916697,0.7027916199946072,-0.6257553859080021,-1.26995196369128,1226,3,PNPO|PDXK
MODULATION BY HOST OF VIRAL RNA GENOME REPLICATION%GOBP%GO:0044830,0.152635486265776,0.648319130045528,-0.7645988420181971,-1.30780536997747,1027,2,FBXL2|FMR1
REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032814,0.8356505499066199,0.988613522932093,-0.19167954094019,-0.721861487346889,4026,13,ZBTB1|PTPN22|ZNF683|PIBF1|MICA|AXL|HLA-E|IL18|PRDM1|GAS6|AP1G1|IL6R|LAMP1
REGULATION OF SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903276,0.414828088251764,0.8695737743071128,0.491961412115926,1.04251322687626,3703,4,ATP1B3|FXYD1|ATP1B1|ATP1B2
PML BODY ORGANIZATION%GOBP%GO:0030578,0.100549882168107,0.570947005522165,-0.710122985999751,-1.4411735014059999,639,3,PML|ETS1
CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:0044843,0.172247688602284,0.6757264818753511,0.223470271479522,1.23236250053755,2216,95,CDK6|CCNA1|RCC1|CDC7|CDC34|POLE|CDKN2C|DHFR|CDKN3|POLE2|ORC1|CDC45|E2F7|CDKN2A|CCNE1|CRLF3|FBXO5|RB1|POLA2|MCM6|CDC6|CDK3|PIM2|ORC6|DBF4|NASP|CUL4B|MCM10|MCM3|MCM2|SPDYA|CCNE2|E2F1|PRIM2|TYMS|GMNN|RRM2
ADRENAL CORTEX DEVELOPMENT%GOBP%GO:0035801,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
L-HISTIDINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0089709,0.08174496644295301,0.539385377100419,0.9600242611380679,1.2753494012031599,608,1,SLC25A29
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1904018,0.0355270821199767,0.3821688062173221,-0.17929858670829002,-1.37325309199494,60,121,CYP1B1|SASH1|SRPX2|ENG|DLL1|MYDGF|BTG1|GATA2|RHOJ|HIPK1|HIF1A|HSPB1|GPER1|IL1B|VEGFA|ITGB8|KDR|MTDH|HMOX1|PRKD2|TMEM100|PDCL3|SPHK1|ITGA5|PKM|RUNX1|FGF2|CDH5|SMAD1|APLNR|CHRNA7|SOD2|FOXC2|RAP1A|ETS1|RAMP2|AGO2|HK2|CXCL8|CTSH|PRKCA|ADM2|NOS3|FLT1|CHI3L1|SFRP2|BMPER|PGF|TWIST1|AQP1
TRANSITION METAL ION HOMEOSTASIS%GOBP%GO:0055076,0.925692695214106,1.0,-0.102879944180384,-0.7157442074970229,2204,81,PRND|S100A8|CP|FTH1|NEDD8|SLC30A1|PRNP|SLC11A1|SLC39A4|FTL|FXN|TFRC|ATP6V0D1|COMMD1|B2M|PARK2|SLC30A9
POSITIVE REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901387,0.259161752316765,0.770912532778873,0.458134317352873,1.1924273739959599,2460,7,CACNB2|CACNA2D1|STAC2|STAC3
POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010726,0.8026708562450899,0.984522820758988,-0.363651709831633,-0.738020340536502,5108,3,ZNF205|SNCA
POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING%GOBP%GO:1903423,0.9410541945063101,1.0,-0.357816377171216,-0.612025749731993,6337,2,PLAA|TOR1A
NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0010957,0.48394533179647603,0.9064456896937672,-0.41884961120608794,-0.9632666050252541,2938,4,CYP27B1|NFKB1|SNAI2|SNAI1
"REGULATION OF ACTIVATED CD4-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905399",0.411756917781014,0.867015886388254,-0.792898103220115,-1.06068396793805,3109,1,CD274
"CD4-POSITIVE, ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0043373",0.785886722376973,0.981487311948134,-0.24050791235151897,-0.747603310521689,4231,8,ZFPM1|FOXP3|LY9|SPN|BATF|IL6|STAT3
NEGATIVE REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032873,0.6948069980560961,0.96731875442989,-0.15650601117906102,-0.850767766305621,2501,35,PDCD4|MECOM|DUSP3|PARK2|DUSP10|DLG1
POSITIVE REGULATION OF PROTEIN FOLDING%GOBP%GO:1903334,0.579170194750212,0.942692029750853,0.575210906291909,0.9401664243661528,4787,2,SGTA
REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:0033044,0.10034287313693901,0.570947005522165,0.194923717638745,1.25203677982637,1433,259,GTF2H2|SIRT1|WDR61|ANAPC15|CCNB1|NAT10|TPR|PIF1|SIRT6|XRCC3|LIG4|ANAPC5|ATR|MKI67|NAA40|CENPF|OGT|NAA10|MTF2|HMBOX1|TAF7|NUMA1|SART3|USP44|ASF1A|MUC1|FAM178A|CDC45|PNKP|DNMT3B|BUB1|TOP2A|PPP1R10|PRKCQ|PARP1|SRC|DLGAP5|NEK2|CDC23|CDC20|FEN1|GEN1|APC|NDC80|CDK5RAP2|CENPE|TAL1|PTTG1|FBXO5|HDAC8|RB1|BUB1B|AKAP8L|SLX1B|ESPL1|AURKB|CDC6|ZNF274|PHF19|NIPBL|ATAD2|RTEL1-TNFRSF6B|CENPV|JARID2|CDCA5|RMI2|MAP3K4|KLHL22|TNKS2|MAP2K7|SLX4|PLK1|ATAD2B|ING2|KDM1A|HNRNPA2B1|TEN1|RNF40|NSD1|PAXIP1|PARP10|ANKRD32|CTC1|RPS6KA4|RIF1|TEX14|DUSP1|PHF2|ACD|CHEK1|HIRA|CAMK1
ACTIVATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032431,0.37431328878990394,0.852609194081082,-0.6322580645161291,-1.0814435577788601,2520,2,EGFR|ANG
L-CYSTEINE CATABOLIC PROCESS TO TAURINE%GOBP%GO:0019452,0.450814245994969,0.88620227509476,-0.7735443317159242,-1.0347938377053398,3404,1,CSAD
NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071676,0.0721031601888849,0.515142552151908,-0.5137781211125759,-1.49871357354729,396,7,GREM1|PLCB1|NBL1
NEGATIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:2000816,0.0403452805404391,0.400814751667794,0.42191980436848103,1.5667988778826498,429,20,TPR|CENPF|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|KLHL22|PLK1|TEX14|ATM
ESTABLISHMENT OF CELL POLARITY INVOLVED IN AMEBOIDAL CELL MIGRATION%GOBP%GO:0003365,0.217320828991548,0.734050632047527,0.6370989496294389,1.21105808295169,1876,3,AMOT|AMOTL2|AMOTL1
NEGATIVE REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032460,0.99094347133758,1.0,0.15144411330194898,0.46202127428203205,9956,11,INS|SRC|SORL1|CRYAB|PEX14|TMC8|EP300
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION%GOBP%GO:0044387,0.21976026153287304,0.734713083559597,-0.41741436579145497,-1.2176162240046298,1209,7,ADAR|DUSP26|ADARB1|PPM1F|NPM1|CORO1C
POSITIVE REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904477,0.623063683304647,0.9536478716552259,-0.681682840758712,-0.9119079204185021,4705,1,EPHA4
NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901991,0.0378285799389381,0.39057301269872496,0.2434453347501,1.42695812060018,507,133,BTG2|TAOK3|CCNB1|PIDD1|TPR|CDK1|E2F8|PKD2|BLM|CENPF|WEE1|CDK2AP2|ORC1|CDC25C|USP47|MUC1|BUB1|E2F7|DONSON|DACT1|CDC20|APC|ZNF830|FBXO5|RB1|BUB1B|NAE1|GTSE1|AURKB|CDC6|MSH6|CCL2|KLHL22|TAOK1|RPS27L|CHEK2|TOPBP1|PLK1|PRMT1|BRSK1|CARM1|AURKA|CDC73|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|C5orf45|TEX14|PRKDC|FHL1|RBX1|FBXL7|RAD17|CASP2|CDK2|ATM|RFWD3|CNOT1
EXIT FROM HOST%GOBP%GO:0035890,0.0597539543057996,0.476295606439141,-0.564586846383722,-1.5497529840888797,339,6,VPS4A|VPS4B|RAB7A
PORPHYRIN-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0006779,0.859251499857157,0.99166790097654,0.18914118017834,0.6784879737040881,9022,18,ALAS1|ABCB6|CPOX|ATPIF1|UROD|IREB2|UROS|ALAD|HMBS|SUCLA2|PPOX
HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034109,0.6850262939385551,0.966495577318169,-0.158243342259252,-0.8514895182398879,2474,34,GAS6|PLEK|ACTN1|STXBP3|GP1BA|HSPB1|MEGF11|CLIC1|PPAP2B|UBASH3B|RAP2B|CSRP1|MYH9|GNAS
REGULATION OF NEURON DEATH%GOBP%GO:1901214,0.055207026348807996,0.458057897476257,-0.168171526917645,-1.30823907345847,87,130,ATF4|DCC|HIF1A|BAX|SOD1|FBXW7|PICALM|CLU|EIF2S1|AARS|CX3CL1|CRLF1|CTNNB1|NSMF|PTK2B|ITGAM|DDIT4|BHLHB9|FYN|EIF4G1|FAIM2|DDIT3|UNC5B|FCGR2B|PRNP|CHP1|CHRNA7|SOD2|ZPR1|SNCA|PPARGC1A|BCL2|DKK1|PARK2|CHMP4B|EPHA7|FBXO7|TOX3|RRAS2|RILPL1|UBB|FOXO3|EGLN3
MODULATION BY VIRUS OF HOST CATALYTIC ACTIVITY%GOBP%GO:0039516,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
MALTOSE METABOLIC PROCESS%GOBP%GO:0000023,0.045503355704698,0.4190278528102411,0.9769519188354651,1.2978370392578,338,1,GAA
NEGATIVE REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045829,0.618362162816016,0.9532238181782521,0.5594154948993659,0.9143492583703772,5111,2,THOC1|NDFIP1
RESPONSE TO HERBICIDE%GOBP%GO:0009635,0.7632211538461541,0.978421368343614,-0.30228124816651597,-0.7652049072261659,4444,5,HSF1
REGULATION OF CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090347,0.696778523489933,0.96731875442989,0.6562637847375389,0.871817160020677,5190,1,CYP2D6
RESPIRATORY CHAIN COMPLEX IV ASSEMBLY%GOBP%GO:0008535,0.818926631685538,0.987153241368501,0.186174704489714,0.7240712710230601,8895,23,COX20|COA6|COX16|BCS1L|PET100|COX11|SURF1|TIMM21|COX19|SCO2|COX17|MT-CO3
QUATERNARY AMMONIUM GROUP TRANSPORT%GOBP%GO:0015697,0.6128651202749139,0.9508825506493929,0.357347292516195,0.878843623324202,5706,6,SLC25A29|SLC22A3
RIBOSOME DISASSEMBLY%GOBP%GO:0032790,0.0520952479983363,0.44586532408291796,0.5606827930393801,1.5285717157649499,500,8,DENR|GFM2|MRRF|MCTS1|MTIF3|EIF2D
PRE-REPLICATIVE COMPLEX ASSEMBLY INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0006267,0.3849716336690979,0.8593496731626808,0.559295772594672,1.06316242799561,3324,3,CDC45|WDR18|ORC3
NEGATIVE REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0090260,0.187371476956574,0.6940517434063481,0.741186097866572,1.2114483153897,1548,2,PTPRO|SLIT2
CELL DIFFERENTIATION IN SPINAL CORD%GOBP%GO:0021515,0.7255713159968481,0.972554563883587,-0.234253953368388,-0.7925161873733599,3682,10,TBX20|ASCL1
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM%GOBP%GO:0035821,0.8938014737754659,0.9976191001250191,-0.106800945030667,-0.7586391594415408,2061,87,INPP5K|TBC1D20|RXRA|BCL2L1|ATG7|TNIP1|GAPDH|FMR1|KPNA4|JUN|CAV2|VAPB|PARK2|PC|AQP1
RESPONSE TO LEPTIN%GOBP%GO:0044321,0.29393223010244296,0.8004058897916541,-0.33474950509177004,-1.1325076810261898,1491,10,LEPR|STAT3|MKKS|NR1D1
SOMITE DEVELOPMENT%GOBP%GO:0061053,0.6559199555308511,0.9640743070248079,0.222176634631038,0.8508849725066879,7079,22,RIPPLY2|HES1|MTHFD1|LOXL3|LEF1|HES6|LFNG
NUCLEOSOME DISASSEMBLY%GOBP%GO:0006337,0.7848518111964871,0.981487311948134,-0.18714500485299104,-0.7664216925259242,3574,16,SMARCC1|PBRM1
MEMBRANE TUBULATION%GOBP%GO:0097749,0.5679862306368331,0.9398422263548051,-0.7099691221879141,-0.9497473415278359,4289,1,OPA1
POSITIVE REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002693,0.19876977152899802,0.711592141628341,-0.452484694721747,-1.24204010488578,1130,6,FADD|ADAM8|FAM65B|THY1|ICAM1|PLVAP
MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0044003,0.0218654857459175,0.310715277412964,-0.300620766471961,-1.61760632682257,78,34,CASP8|DAG1|RRAGA|EIF2AK4|INSR|TGFB1|CD4|SERPINB9|SMAD3|SLC25A6|KPNB1|EIF2AK2|CCNK|KPNA1|RXRA|BCL2L1|ATG7|TNIP1|GAPDH|KPNA4|VAPB|PARK2
REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:2000303,0.900766358813126,0.998912093067348,0.19871631801935502,0.626424848892671,9167,12,NSMAF|ORMDL1|SMPD3
REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902566,0.6802130369341209,0.9647315640607691,0.451858387559281,0.8589352610320151,5874,3,F2RL1|STX4|CD300A
N-TERMINAL PEPTIDYL-GLYCINE N-MYRISTOYLATION%GOBP%GO:0018008,0.6242019302152929,0.9536478716552259,-0.512048524951751,-0.8758315783651229,4203,2,NMT2|NMT1
OLIGODENDROCYTE DEVELOPMENT%GOBP%GO:0014003,0.245761060222179,0.7583471060815179,0.364607262888496,1.2080571661819,2521,14,PRDM8|EIF2B5|EIF2B1|EIF2B4|MYRF|PLP1|SOX10
LIMB BUD FORMATION%GOBP%GO:0060174,0.575333443108842,0.941940408834489,-0.38750650702206796,-0.8911840132058281,3493,4,WNT3
"REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0040029",0.389852464915437,0.8606167250685891,0.17010292129448404,1.05029430256142,5416,191,LIN28B|LRIF1|RBBP7|SIRT4|HIST1H3E|SIRT1|MBD3|GLMN|TDG|ZCCHC11|TAF1D|RRP8|KAT2A|CELF1|DOT1L|TRIM27|DHX9|MTF2|MTA1|HIST2H3C|CREBZF|HIST2H3A|PCGF2|ASF1A|SLC50A1|DROSHA|DNMT3B|TERT|EZH2|H2AFY2|KMT2B|HIST1H4I|TNRC6A|HELLS|PHF19|C9orf114|ATAD2|H3F3A|METTL3|JARID2|HDAC6|SRRT|POLR2L|ZNF335|NRDE2|TNRC6C|ATAD2B|AJUBA|HNRNPA2B1|TAF1A|DICER1|ZNRD1|KMT2D|RIF1|SUZ12|DGCR8|SF3B1|EED|PHF2|HIST1H3H|UBR2|CHEK1|HIRA|ARID1A|POLR2H|TARBP2|MBD1|ZCCHC6|PCGF1|PCGF3|CNOT1|BRCA1|SMARCD1|RBM4|YTHDC1|DNMT1|PPM1D
POSITIVE REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002836,0.951078666376117,1.0,0.24980997622179102,0.5757749629852739,8728,5,KLRK1|HSPD1|PVR|PVRL2|CD274
"HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, ENZYMATIC MODIFICATION%GOBP%GO:0015015",0.33361950549450503,0.8295413387957591,-0.431330236138162,-1.0918838509828,1942,5,HS6ST2|HS6ST3
CYCLIC PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0052652,0.9772183401933571,1.0,0.144893138716234,0.50230521837365,10208,16,NPR2|ADCY8|ADORA2A|ADCY1|ADCY6
ENDOPLASMIC RETICULUM LOCALIZATION%GOBP%GO:0051643,0.491857540050311,0.909315999193258,-0.7517644464049399,-1.00565822106171,3714,1,POLR2M
NEURON PROJECTION MORPHOGENESIS%GOBP%GO:0048812,0.16231884057971,0.664367762084791,-0.12842313899063001,-1.1426745472426698,111,266,PARD6B|TUBB3|NFIB|EFNA1|CHRNA7|POU4F2|UNC5C|ARC|MAP4K4|NYAP2|RAB8A|CDC42|DBNL|NEFH|ALCAM|S100A6|PLXNA1|FLRT1|SHC1|PRKCA|PLXNA4|EPHA8|RELN|GAB2|COBL|DRD2|MAPK3|SDC2|PTPRM|STK24|EFNB1|ZNF365|SEMA3A|RAC1|DOK5|PTPRA|PIK3R1|HSP90AB1|TMEM108|NTNG2|GFRA2|NBL1|SLIT3|EPHB2|PARD3|UBB
REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902115,0.090293453724605,0.560121322881739,-0.15438981484310502,-1.23715304080613,119,155,ATG3|VPS11|TBC1D20|TBC1D8|TBC1D14|CYLD|SH3GLB1|HAP1|VPS4B|PIP4K2A|TBC1D19|NPM1|MARK4|TBC1D5|AKAP13|MSN|CAPG|TBC1D2|SEPT9|TBC1D15|ASAP1|RALB|HTT|RAB5A|CHMP4B|CHMP1B|MAP4|KCTD17|RNF4|KIF9|PLK2|TNF|TBC1D1
B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002322,0.9819765332043059,1.0,0.339092330201497,0.5542370983031071,8117,2,CD180|GAPT
NEGATIVE REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070433,0.277851699528245,0.7884684708511421,0.696277915632754,1.13804712522846,2296,2,ERBB2IP|PTPN22
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045428,0.0607133133678192,0.48154845914006394,-0.270946977519978,-1.4492331910728502,222,33,DDAH2|RAC1|CD36|HSP90AB1|TNF|CAV1|DDAH1
INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0042228,0.4391632463921621,0.879896414106183,-0.778782531980591,-1.04180113791078,3316,1,NOD1
TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0006641,0.48768161718256503,0.907808599852568,0.24204833556790803,0.984050358238557,5403,27,SIRT1|LPL|FABP5|GPAM|DGAT1|FABP6|CETP|PNPLA2|APOE
REGULATION OF PRE-MIRNA PROCESSING%GOBP%GO:2000631,0.953396001588773,1.0,-0.5209528010586679,-0.6968944456939261,7200,1,BCDIN3D
HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:0070535,0.28195991091314004,0.7899371443259041,-0.689981051463573,-1.18017563550703,1898,2,RNF168
POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032109,0.254563780938515,0.764845931807465,0.557168036200767,1.18069229217331,2272,4,GHRL|NPY|CYP27B1|SNW1
REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090296,0.7393250272166451,0.9744283926676119,0.511772814998621,0.8364786068935891,6111,2,STOML2|LIG3
PYRAMIDAL NEURON DIFFERENTIATION%GOBP%GO:0021859,0.701705576388049,0.968941691852291,0.528535980148883,0.863877539820607,5800,2,FGFR2|ATP7A
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032210,0.784539197582676,0.981487311948134,0.161222645325887,0.774747203533686,9346,50,NAT10|PIF1|ATR|HMBOX1|PNKP|PRKCQ|SRC|NEK2|AURKB|MAP3K4|TNKS2|MAP2K7|TEN1|CTC1|ACD|XRN1|ATM|MAPKAPK5|EXOSC10|POT1
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0007204,0.784792073262273,0.981487311948134,0.139132468694922,0.806935859779188,10454,125,TAC1|RYR2|CHRNA10|EDN1|CXCL13|GHRL|PTGER3|NOL3|P2RX5|CXCR4|F2R|CXCL9|ADCY8|PKD2|IBTK|AGTR1|PDPK1|CACNA2D1|PTGER1|CCR5|CCL21|F2RL1|JPH4|GRIN1|CCL19|CXCL10|PLCG1|C3AR1|CD55|DLG4|TRPC1|S1PR4|PTGIR|SLC8A1|LPAR2|OPRL1
TRAM-DEPENDENT TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0035669,0.950405225595742,1.0,0.393624952743464,0.643369171749176,7856,2,TICAM2|PRKCE
CELLULAR ANION HOMEOSTASIS%GOBP%GO:0030002,0.6904560299987901,0.96731875442989,0.532947339398952,0.871087785327717,5707,2,XPR1|SLC12A5
POSITIVE REGULATION OF ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1904992,0.730173441016815,0.972554563883587,-0.630017644464049,-0.8427938120765028,5514,1,PRMT5
REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070316,0.37953423945978704,0.855758937340731,0.23771182273965302,1.06489840517175,4383,38,RBBP7|EHMT1|CDC7|APAF1|PCGF2|EZH2|RAD51|E2F6|EHMT2|E2F1|SUZ12|EED|RRM2|CHEK1|MGA|UXT|BRCA1
NEGATIVE REGULATION OF GASTRULATION%GOBP%GO:2000542,0.9242754412726079,1.0,0.267058316125706,0.6155298295439909,8482,5,COL5A2|COL5A1
POSITIVE REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071442,0.369124851052562,0.852268858837246,-0.8140714600794001,-1.08900821297895,2787,1,WBP2
POSITIVE REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903977,0.7990573448546741,0.9839175016931591,-0.36517039814712704,-0.7411024733505841,5085,3,CSF1|P2RX4|CRKL
PROTEIN DEAMINATION%GOBP%GO:0018277,0.220402684563758,0.7354368651705759,0.8913211292456991,1.1840803555481598,1641,1,LOXL1
REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904688,0.9530398779690559,1.0,0.24850489024835298,0.572766933284403,8746,5,METTL3|NCK1|MTOR|RPL13A
DOPAMINE CATABOLIC PROCESS%GOBP%GO:0042420,0.21976465460884698,0.734713083559597,0.534883300056044,1.23282671472567,2016,5,SULT1A3|MOXD1|DBH|MAOA
REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE%GOBP%GO:0098696,0.3413982717989,0.835569815754521,-0.532963479627531,-1.08163354686368,2172,3,IQSEC2|RAP1A
DNA SYNTHESIS INVOLVED IN DNA REPAIR%GOBP%GO:0000731,0.178435195388658,0.6840428867665671,0.266323630106378,1.25672189783954,2104,46,SIRT1|FAAP20|POLE|REV1|BLM|SPRTN|POLE2|RFC4|REV3L|DTL|POLD1|POLD3|POLN|ZBTB1|PRIMPOL|NPLOC4|RFC3|RFC5|WRNIP1|VCP|CDKN2D
ROSTROCAUDAL NEURAL TUBE PATTERNING%GOBP%GO:0021903,0.780989787902592,0.981487311948134,-0.371622366824749,-0.7541965520854109,4970,3,LRP6|KDM2B|ATP6AP2
BETA-CATENIN DESTRUCTION COMPLEX DISASSEMBLY%GOBP%GO:1904886,0.9790194346289749,1.0,-0.131587255484974,-0.553704036266301,4432,17,CSNK1A1|AMER1|FZD1|FRAT1|CTNNB1|CAV1
REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1902275,0.9556365846247341,1.0,0.11229085787068101,0.6420934611305941,12579,116,SIRT1|WDR61|TPR|SIRT6|MKI67|NAA40|OGT|MTF2|TAF7|SART3|ASF1A|MUC1|CDC45|DNMT3B|TAL1|AKAP8L|ZNF274|PHF19|NIPBL|ATAD2|JARID2|ATAD2B|ING2|KDM1A|RNF40|NSD1|PAXIP1|PARP10|RPS6KA4|RIF1|PHF2|CHEK1|HIRA|CAMK1
POSITIVE REGULATION OF VASOCONSTRICTION%GOBP%GO:0045907,0.55360151642797,0.932816793297168,0.355130609602101,0.924330363811729,5256,7,OXTR|F2R
HYDROXYPROLINE TRANSPORT%GOBP%GO:0034589,0.843638289421422,0.991298302704726,-0.575981473312748,-0.770507978378361,6371,1,SLC1A4
POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE%GOBP%GO:0046016,0.561098737936154,0.936434965680841,-0.537193272677144,-0.918840322682859,3778,2,USF2|USF1
CALCIUM-DEPENDENT CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES%GOBP%GO:0016339,0.00291493684303507,0.13103871184697197,0.451248689163196,1.92938771650554,32,32,PCDHB4|CDH4|CDH6|PCDHB6|PCDHB14|CDH10|PCDHB13|CDH3|PCDHB9|DCHS1|CDH2|PCDHGB4|CDH23
UNSATURATED FATTY ACID METABOLIC PROCESS%GOBP%GO:0033559,0.0698906922822127,0.507657787230581,0.28787073729181395,1.4219581296383,843,56,FAAH2|EDN1|CYP2D7|MGST1|GLYATL2|CYP2C8|HSD17B4|SCD5|PLA2G4A|FADS2|DECR2|FADS3
POSITIVE REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061890,0.154799120064837,0.654320629758492,0.671997452612583,1.27739646593793,1336,3,AGER|TTBK1|APP
HIPPO SIGNALING%GOBP%GO:0035329,0.155129482071713,0.6552153411348229,-0.259604988626291,-1.27473663265354,622,26,CASP3|TJP2|SAV1|YWHAB|TEAD4|STK4|YWHAE|FAT4
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046889,0.669842620161633,0.964618776001639,0.182418419603774,0.8550661013770979,7873,45,NSMAF|SIRT4|SLC45A3|STAR|WNT4|INS|SCARB1|ZP3|APOE|PTGS2|LPGAT1|SMPD3|LDLR|CNEP1R1|HSD17B13
NEGATIVE REGULATION OF SYNAPSE MATURATION%GOBP%GO:2000297,0.6368330464716011,0.959271399361425,-0.675727834142038,-0.903941726500748,4809,1,ARHGEF15
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0032516,0.934498674261023,1.0,0.1805250154321,0.5826213262186379,9515,13,ITGA1|MAGI2|PPP1R12A|FCRL3|PPP2R4|MTOR|PTPRC|CD300A
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009213,0.7953308334341359,0.9825058878489269,0.48865853019196004,0.7986989433636491,6574,2,DUT|DCTPP1
DNA REPLICATION TERMINATION%GOBP%GO:0006274,0.0991658943466172,0.570215774831708,-0.9490516100573442,-1.26957527511472,748,1,RTFDC1
NCRNA POLYADENYLATION INVOLVED IN POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0043630,0.8593936184297629,0.99166790097654,-0.568041464490516,-0.7598863864880219,6490,1,PAPD5
REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060330,0.45126353790613705,0.886411023801201,-0.22648110636597,-0.993226826838649,1999,19,NR1H3|PPARG|SUMO1|CDC37|NR1H2|HSP90AB1
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0072201,0.679171008452009,0.9647315640607691,0.45209774716103396,0.859390258455263,5865,3,BMP4
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031345,0.7043641482871892,0.968941691852291,-0.12210692550339501,-0.8828116038984141,1500,95,PRKCD|LPAR1|RTN4|SRGAP2C|SEMA3F|FYN|RHOA|CCP110|SEMA7A|YWHAH|PRNP|EFNA1|BAG5|SPOCK1|SEMA6B|ARPIN|FKBP4|MAP4|MYLIP|ZNF365|SEMA3A|SEMA3G|LINGO1|RTN4RL2
SPINE APPARATUS ASSEMBLY%GOBP%GO:1905355,0.43413213292731395,0.878651088001772,-0.780988089986767,-1.0447515801025402,3278,1,SYNPO
REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051023,0.00594243268337976,0.175567154622165,-0.6354626229074101,-1.97529451714678,31,8,GPI|IL6|VAMP3|TNFRSF4|CD22
"CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043374",0.581755593803787,0.943249589738259,-0.703076753418615,-0.9405272096785829,4393,1,TNFSF8
REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060211,0.706011146496815,0.968941691852291,0.264219329678186,0.806072608081286,7093,11,BTG2|CPEB3|TNRC6A|TNRC6C|POLR2G|CNOT1
PORPHYRIN-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0006787,0.178330314506834,0.6837991059383349,-0.556499200352948,-1.27983190405659,1082,4,HMOX2|BLVRB|HMOX1|BLVRA
REGULATION OF ANTEROGRADE DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901951,0.832103544211927,0.9879179006160809,0.472029131302715,0.771518647715491,6878,2,TRIM46|MAP2
SIGNAL TRANSDUCTION INVOLVED IN CELLULAR RESPONSE TO AMMONIUM ION%GOBP%GO:1903831,0.0779826705176627,0.5314695499765479,-0.333684961132215,-1.43543856515472,350,18,CHRM4|CHRNB2|GNAQ|GNA15|CHRNA7|HRH3|CHRNA3|CHRM1|PLCB1
POSITIVE REGULATION OF NEURON MATURATION%GOBP%GO:0014042,0.326095591155832,0.826621597878865,-0.838608292898103,-1.12183188236229,2462,1,MAP3K13
NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002638,0.7220123626373629,0.971401508276304,-0.31265702214228497,-0.791470490058994,4204,5,FCGR2B|CD22
GLYCINE DECARBOXYLATION VIA GLYCINE CLEAVAGE SYSTEM%GOBP%GO:0019464,0.42195154243346994,0.873470206885489,-0.788101014556683,-1.05426675617097,3186,1,AMT
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903055,0.17311827956989198,0.676682497340677,-0.316890150006616,-1.2637862288678998,804,15,CLASP1|PHLDB2|DAG1|RGCC|TGFB1|SMAD3|FSCN1|RLTPR|PHLDB1|PDPN|COLGALT1|MFI2
POSITIVE REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070094,0.9918120805369129,1.0,0.504741949713278,0.6705271620592571,7388,1,AIMP1
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903557,0.9919642857142859,1.0,-0.0909593280282935,-0.521269508875998,3332,41,CD2|DHX9|JAK2|AZU1|CCL19|RIPK1|C1QTNF4|PTPRJ|RASGRP1|THBS1|DDT|TLR4|DDX58|ISL1|IFIH1|FADD|HMGB1|TLR2|PTPRC|ADAM8|CD14|MIF|PTPN11|HLA-E|TIRAP|FZD5|CCL3|LY96|SPN|HAVCR2|CYBA|TLR1|CD86|PYCARD|HSPB1|CLU|LGALS9|ARFGEF2|MAVS|ARHGEF2|TWIST1
REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010389,0.000224820143884892,0.0784645998831315,0.326114460599478,1.8947674450902598,2,126,AKAP9|TAOK3|SDCCAG8|CEP63|CEP70|CENPJ|CCNB1|CDC7|CDK1|KIF14|BLM|CENPF|CKAP5|CEP290|CEP131|CEP152|ORC1|CDC25C|USP47|DTL|DONSON|HMMR|NEK2|HAUS5|ZNF830|DBF4B|CDK5RAP2|PRKAR2B|FBXO5|NAE1|AURKB|CDC6|MSH6|RAD51C|CEP72|HAUS8|CEP164|CEP78|TAOK1|CEP192|FGFR1OP|TOPBP1|CNTRL|PLK1|BRSK1|SFI1|AURKA|CEP41|CLSPN|CEP57|DYNC1H1|NINL|CDK5RAP3|TAOK2|TUBB4A|CEP135|C5orf45|FHL1|RBX1|PCM1|FBXL7|RAD17|TPX2|NEDD1|PPP2R1A|CDK2|ATM|SSNA1
HYPEROSMOTIC RESPONSE%GOBP%GO:0006972,0.446748681898067,0.8846831186074241,-0.35903396749922,-0.985524133417408,2541,6,ICOSLG|ARHGEF2|AQP1
SYNAPSE MATURATION%GOBP%GO:0060074,0.921732082899155,1.0,0.33572608175919505,0.638179964366066,7960,3,SHANK1|PTEN|IGSF21
REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904994,0.10835303388494902,0.58452352834625,-0.41433874263195997,-1.4017699845404898,549,10,CXCL12|RELA|TRAF6|IRAK1|RHOA|ETS1|TNF
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051590,0.24430107526881698,0.757467559003634,-0.293784751279577,-1.17163983453181,1135,15,DRD2|PARK2|TRH
CELL-CELL ADHESION%GOBP%GO:0098609,0.10257489651301499,0.574198697765381,0.195552859823446,1.25120346936816,1461,251,TENM1|CLDN12|PCDHB4|VMP1|ITGB1|PCDHA7|CDH4|CDH6|CLDN15|CDHR2|PCDHB6|ROPN1B|PCDHB14|NOV|CDH10|NEXN|SDK1|CEACAM1|CAMSAP3|CD209|PCDHB13|CDH3|LRRC7|PCDHB9|MADCAM1|DCHS1|ADGRV1|ILK|IGSF9|CDH2|CLDN11|DSCAM|PCDHGB4|CD2|HBB|FBLIM1|DLG3|CLDN7|FIBP|CDH23|CDK5R1|ROBO2|ITGA4|TGFB2|TENM2|CELSR2|CTNND1|TYRO3|KIRREL3|CTNND2|CDH7|PTPRD|ITGB5|CCL5|CD200|LEF1|DLG5|KIT|HMCN1|BSG|PALLD|ADGRL1|CXADR|PLXNB2|AMICA1|TRO|LRRC4C|MYOT|PLXNB3|DLG4|CDHR3|NPHP4|RAC2|NLGN4Y|ACTG1|NRXN3|CD1D|NCAM2|PTPRS|SYNJ2BP-COX16|PCDHB16|CSTA|SLITRK1|PCDHGC3|PCDHB11|SYNJ2BP|MYL12A
TETRAHYDROFOLYLPOLYGLUTAMATE METABOLIC PROCESS%GOBP%GO:0046900,0.676787226321519,0.9647315640607691,0.537911193812994,0.8792010690024109,5594,2,GGH
"DNA REPLICATION, REMOVAL OF RNA PRIMER%GOBP%GO:0043137",0.163960129913764,0.666385698695266,0.6052073837619971,1.2824922586131398,1463,4,DNA2|FEN1|RNASEH2A
PROTEIN GERANYLGERANYLATION%GOBP%GO:0018344,0.7550472508591071,0.9771370084125129,0.31267408625711895,0.768976378555707,7030,6,CHML|RABGGTA|CHM|FNTA|PGGT1B
CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:0060923,0.35350191976698,0.842847021021096,-0.822838553153948,-1.1007362206912,2669,1,ACVR1
SELENOCYSTEINE BIOSYNTHETIC PROCESS%GOBP%GO:0016260,0.5845637583892621,0.9439064862850342,0.7117887075430078,0.9455795428253171,4354,1,SEPHS1
REGULATION OF SULFUR METABOLIC PROCESS%GOBP%GO:0042762,0.819230769230769,0.987153241368501,0.25045328720025,0.7147081075966569,8093,9,PDK4|GSTZ1|PDP1|SP1|PDK1
REGULATION OF POLYSOME BINDING%GOBP%GO:1905696,0.7675093746219909,0.9792236089291529,0.4992553363506889,0.8160191319187979,6344,2,DHX9
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901253,0.7605369127516779,0.977664504547119,0.622353330392589,0.8267686342760359,5665,1,BST2
REGULATION OF GLUTATHIONE PEROXIDASE ACTIVITY%GOBP%GO:1903282,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
CELLULAR RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0071496,0.00829875518672199,0.20219929830704503,-0.17996788903239302,-1.4828446969872497,9,176,IL1B|EIF2S1|KIF26A|PIM1|IMPACT|PIK3C3|RRAGD|STK26|UCN2|USF1|PRKAA1|HSPA5|RRAGC|SIK2|EIF2AK3|MYBBP1A|MAP1LC3B2|FYN|FAM65A|SLC9A1|MAP1LC3A|KLF10|BCL10|FOXO1|SEH1L|EIF4G1|TNFRSF10A|NUAK2|CBS|SH3GLB1|HABP4|ATG7|BECN1|CRADD|GADD45A|C12orf66|TP53|GABARAPL1|TNFRSF10B|RALB|MAPK3|GABARAP|CDKN1A|UCN3|WIPI2|MAP1LC3B|STK24|MYD88|SESN2|AQP1|GABARAPL2|PMAIP1|INHBB
INDUCTION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050930,0.28504490433424395,0.794258537514783,-0.352331572901415,-1.13735789051509,1459,9,CXCL8|SCG2|PGF
RESPONSE TO SELENIUM ION%GOBP%GO:0010269,0.599955202150297,0.9503412745667059,0.4278005615829811,0.9065502556331779,5356,4,SEPP1|MIEN1|GPX1|SEPW1
TRNA WOBBLE ADENOSINE TO INOSINE EDITING%GOBP%GO:0002100,0.902147651006711,0.999822188724968,0.550727834142038,0.731617357947112,6720,1,ADAT2
POSITIVE REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:1900245,0.329628343174714,0.8290015172841959,0.5835998676519251,1.10936195600461,2846,3,ANKRD17|DHX58|DDX60
MUSCLE CELL CELLULAR HOMEOSTASIS%GOBP%GO:0046716,0.289795114263199,0.7989507053958459,-0.33579986337046197,-1.13606120030061,1470,10,SOD1|GYLTL1B|PGK1|BAG3|ALDOA
GRANULOCYTE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:0038158,0.20769323817588,0.7232762929610351,0.72930425512529,1.1920277698423898,1716,2,CEACAM1|JAGN1
CATECHOLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042423,0.5806641776380429,0.942746898746279,0.28675503868012603,0.9039543584785681,5909,12,PNMT|TGFB2|DDC|HAND2|TH|MOXD1|GATA3|DBH
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903954,0.645503355704698,0.9628191546271729,0.6825650639611819,0.906757236086033,4808,1,RNF207
REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901580,0.912080536912752,1.0,0.545710189677989,0.7249516411296121,6794,1,ATRX
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN%GOBP%GO:0002483,0.642237982663515,0.9620807249753851,-0.250651381111655,-0.847991139795563,3259,10,B2M|ERAP2
REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010982,0.9271140939597321,1.0,0.539258932509925,0.7163814337928269,6906,1,GPLD1
MODULATION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052255,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
NEGATIVE REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046322,0.116586403852615,0.596135728622196,0.637842607400871,1.3516494149829,1040,4,SIRT4|ACADVL|METTL20|AKT1
VAGUS NERVE DEVELOPMENT%GOBP%GO:0021564,0.659473057063419,0.9643779777660141,-0.664038376709307,-0.888304382884415,4980,1,TBX1
HEPATOCYTE APOPTOTIC PROCESS%GOBP%GO:0097284,0.569575003309943,0.940076901516441,-0.709142037935598,-0.948640925705926,4301,1,GSN
DNA BIOSYNTHETIC PROCESS%GOBP%GO:0071897,0.653120936280884,0.9640743070248079,0.16986639363401998,0.87498618534463,8035,68,SIRT1|FAAP20|POLE|REV1|BLM|SPRTN|POLE2|RFC4|REV3L|DTL|POLD1|TERT|POLD3|POLN|ZBTB1|PRIMPOL|WRAP53|TNKS1BP1|TYMS|NPLOC4|RFC3|RFC5|WRNIP1|VCP|CDKN2D
NEGATIVE REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1905524,0.507923067618241,0.9179996794142941,0.601213123793769,0.9826663345502429,4198,2,MARCH7|TAF1
DNA METHYLATION ON CYTOSINE WITHIN A CG SEQUENCE%GOBP%GO:0010424,0.741208053691275,0.974505008828563,0.632829730921923,0.8406860649938929,5521,1,DNMT1
NEGATIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072125,0.240232248699649,0.7525035503527309,0.714172524578177,1.1672953719560901,1985,2,BMP4|BMP7
AMINOGLYCAN CATABOLIC PROCESS%GOBP%GO:0006026,0.9550850176451721,1.0,-0.104340396082886,-0.629153603927527,2976,49,SLC9A1|FGF2|CHP1|CHIT1|CEMIP|CSPG4|SDC2|TMEM2|NCAN
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN BONE TRABECULA MORPHOGENESIS%GOBP%GO:1900220,0.732293986636971,0.972769769206295,-0.46622553074166,-0.797453800891354,4931,2,SEMA4D|PLXNB1
POSITIVE REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000284,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
MEDIUM-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0051791,0.036772113640943,0.386113929236656,0.537742499514961,1.58701704266069,364,10,CROT|GLYATL2|OXSM|ABHD3|ACADM|ABHD2|ACOT7|ACAD9
RESPONSE TO ARACHIDONIC ACID%GOBP%GO:1904550,0.9622818791946309,1.0,0.521007940008822,0.6921358044896141,7168,1,PPP5C
HISTONE H3-K4 DEMETHYLATION%GOBP%GO:0034720,0.352990732940185,0.842847021021096,0.421904762030872,1.0981294533266,3351,7,KDM5D|C14orf169|KDM5B|KDM1A
MISMATCH REPAIR%GOBP%GO:0006298,0.143145346171481,0.632949331968897,0.334704565978631,1.31722908015697,1560,24,MLH3|TDG|MUTYH|EXO1|RNASEH2A|POLD3|MSH6|LIG1|PMS1
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003198,0.3568833999273521,0.8445764484419659,-0.36382125973624796,-1.06128275593175,1964,7,ENG|SNAI2|NOTCH1|SNAI1|RBPJ
ARGININE CATABOLIC PROCESS TO GLUTAMATE%GOBP%GO:0019544,0.655103932212366,0.9640743070248079,-0.666354212615792,-0.891402347185764,4947,1,OAT
NEGATIVE REGULATION OF TORC1 SIGNALING%GOBP%GO:1904262,0.854327666151468,0.991298302704726,0.20022316001983104,0.678879053920813,8843,15,C7orf60|STK11|SZT2|GATS|KPTN|ATM
POSITIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051006,0.5601844228552609,0.936434965680841,-0.392617094017659,-0.9029372956566659,3401,4,NR1H3|NR1H2
ESTABLISHMENT OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035089,0.0934599156118143,0.5622489437340121,-0.367210104424836,-1.42266915886567,442,14,FSCN1|MYO9A|EZR|OPHN1|RHOA|CDC42|MSN|SLC9A3R1|SH3BP1
POSITIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045429,0.12737642585551298,0.6076669536424699,-0.28774493308878,-1.33304757607179,535,22,DDAH2|CD36|HSP90AB1|TNF|DDAH1
POSITIVE REGULATION OF AXON EXTENSION%GOBP%GO:0045773,0.5616942909760589,0.936738331587711,-0.206683325103726,-0.922201463031158,2439,20,VEGFA|MAP3K13|NRP1|SEMA7A|POU4F2|ISLR2|LIMK1|TWF2
POSITIVE REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900029,0.884160756501182,0.9964332282011619,-0.196723120207425,-0.6655437611753,4487,10,HRAS|DEF8|EPS8|NDEL1|EPS8L2|FAM98A|PLEKHM1|RLTPR|PFN1|EPS8L1
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN CARDIAC FIBROBLAST DEVELOPMENT%GOBP%GO:0060940,0.69977728285078,0.967789953250095,-0.479462807674015,-0.820095454140943,4712,2,PDCD4
REGULATION OF GLUTAMATE METABOLIC PROCESS%GOBP%GO:2000211,0.717315436241611,0.971081608033886,0.64485002205558,0.856654485501749,5343,1,ATCAY
NEGATIVE REGULATION OF GTPASE ACTIVITY%GOBP%GO:0034260,0.298634008478568,0.8023890191280308,-0.24591032957571898,-1.1168745483673401,1267,21,BCAS3|F11R|DAB2IP|GMIP|CPEB2|SH3BP4|TMED2|ADCYAP1
REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900133,0.0620539494375227,0.485898561056649,0.843507030603805,1.37868906902826,512,2,F2R|F2RL1
SUBPALLIUM DEVELOPMENT%GOBP%GO:0021544,0.460508241758242,0.8904234666384399,-0.38638870505184203,-0.97811734930895,2681,5,BBS2|BBS4|INHBA|CNTNAP2|MKKS
EPOXYGENASE P450 PATHWAY%GOBP%GO:0019373,0.5912196214581701,0.945418171231938,0.4305639272257701,0.912406091400687,5278,4,CYP2C8|CYP2E1|EPHX2
INNER EAR DEVELOPMENT%GOBP%GO:0048839,0.0102886278794501,0.22191532995385502,0.443926048269791,1.7689814434541398,112,25,KCNQ1|STRC|ADGRV1|PROX1|AHI1|MPV17|CEP290|DFNB31|JAG2|TGFB2|PDZD7
HISTONE ARGININE DEMETHYLATION%GOBP%GO:0070077,0.8375838926174499,0.9889652677625541,0.581550507278341,0.7725639041117529,6239,1,JMJD6
DGDP METABOLIC PROCESS%GOBP%GO:0046066,0.163177431328879,0.6652834663312571,-0.758147229114971,-1.29677023163279,1098,2,AK9|NUDT18
POSITIVE REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000350,0.8583344366476899,0.99166790097654,-0.56908910454345,-0.7612878465291079,6482,1,TREM2
REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048841,0.78495811470128,0.981487311948134,0.19348844576533197,0.7525158975682479,8526,23,SEMA3D|DSCAM|SEMA5A|SEMA3E|SEMA4G|SEMA6A|SEMA4C
POSITIVE REGULATION OF HEMOSTASIS%GOBP%GO:1900048,0.25642151481888,0.767319904137432,-0.282295870736133,-1.15609646761677,1167,16,USF1|PDPN|SERPINF2|THBD|ANO6|ENPP4
CELLULAR RESPONSE TO GONADOTROPIN STIMULUS%GOBP%GO:0071371,0.0375490966221524,0.38859310205237607,-0.782507996029558,-1.5880767286083999,238,3,NOTCH1|NSMF|PAX8
COLLAGEN CATABOLIC PROCESS%GOBP%GO:0030574,0.0304770318021201,0.35824396749211296,-0.392229031376868,-1.6504546508988702,137,17,CTSS|CTSD|MMP1|FURIN|CTSL|CTSK|MMP2|MMP9|COL15A1|MMP12
LIPOOLIGOSACCHARIDE METABOLIC PROCESS%GOBP%GO:1901269,0.737587713491328,0.974306231601101,-0.626433612704014,-0.8379993435148921,5570,1,NDUFAB1
POSITIVE REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903905,0.192330954397,0.7023096717844329,0.7381789449617541,1.2065332065781,1589,2,DOCK8|FLOT2
LIPOOLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:1901271,0.737587713491328,0.974306231601101,-0.626433612704014,-0.8379993435148921,5570,1,NDUFAB1
MAINTENANCE OF DNA REPEAT ELEMENTS%GOBP%GO:0043570,0.994505494505495,1.0,-0.189299477895355,-0.47919905816017605,5791,5,AXIN2|TCF7L2
DIACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006651,0.336599851521901,0.8311444145897029,-0.657733664185277,-1.1250182066270902,2266,2,ANG|PLCE1
DETECTION OF MUSCLE STRETCH%GOBP%GO:0035995,0.19973154362416098,0.711592141628341,0.902459197176886,1.19887678189031,1487,1,TCAP
CYTOPLASMIC ACTIN-BASED CONTRACTION INVOLVED IN CELL MOTILITY%GOBP%GO:0060327,0.45610738255033595,0.88900512246363,0.7772937803264229,1.0326001096296,3397,1,SHTN1
INTRA-S DNA DAMAGE CHECKPOINT%GOBP%GO:0031573,0.24847710748673604,0.7613646381106121,0.38081884515761705,1.2004770917208,2528,12,MUS81|EME2|RAD9A|NEK11|CHEK2|EME1
RESPONSE TO MORPHINE%GOBP%GO:0043278,0.889429199953688,0.997300970905927,0.356948758185233,0.678522039710204,7681,3,ADCY8|SRR
N-TERMINAL PEPTIDYL-SERINE ACETYLATION%GOBP%GO:0017198,0.19852348993288602,0.711592141628341,0.9029554477282751,1.19953602860852,1478,1,NAA10
REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045577,0.136108964451314,0.6237835799077729,0.39714897806826704,1.34657810050495,1408,15,INHA|CD27|FCRL3|IKZF3|BTK|SLAMF8|XBP1|NCKAP1L|PPP2R3C|ZFP36L1|ZFP36L2|MMP14|SYK
MODULATION BY VIRUS OF HOST IMMUNE RESPONSE%GOBP%GO:0075528,0.5416390838077589,0.928807195199472,-0.72474636082929,-0.969515304212634,4090,1,SLC25A6
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, ENDONUCLEOLYTIC CLEAVAGE-DEPENDENT DECAY%GOBP%GO:0000294",0.61796585003712,0.953164984862134,-0.514309346567411,-0.8796985926568491,4161,2,ZC3H12A|UPF1
MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042775,0.909650134563629,1.0,-0.107859318218399,-0.7252285530094971,2365,71,COX5B|NDUFB10|SDHC|UQCRC1|MT-ND5|COX4I1|NDUFB9|CYC1|NDUFA9|NDUFS1|NDUFV3|NDUFS5|COX10|COX4I2|NDUFS6
URETER MORPHOGENESIS%GOBP%GO:0072197,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060260,0.265846736045412,0.779649746770441,0.321937709674552,1.17673158540549,2809,19,TAF7|GTF2B|HEY2|PSMC3|SRF|PAXIP1|PSMC6|ATF7IP|PSMC2|PSMC5|TAF1|SUB1
PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:0070534,0.129059350503919,0.6096268978024549,-0.23520493334337902,-1.2938369404985501,460,36,UBE2E2|NEDD4|ARIH2|PARK2|RNF4|BFAR|PELI1|RNF168
REGULATION OF INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032672,0.54627300410433,0.930420772651609,-0.721217468019409,-0.964794596705817,4125,1,HAVCR2
NEGATIVE REGULATION OF METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000005,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
HEPATOCYTE PROLIFERATION%GOBP%GO:0072574,0.736179992742228,0.974262605126702,0.512953394774976,0.8384082321056171,6085,2,CEBPB|RPS6KA1
STRIATED MUSCLE CELL DEVELOPMENT%GOBP%GO:0055002,0.194071683370138,0.7049101024373008,0.266433669712557,1.24274011641336,2284,44,NEB|IGSF22|ACTN2|MAML1|MYH3|PROX1|TCAP|OBSCN|KRT19|NEBL|SEPN1|HEY2|CXADR|LMOD1|OBSL1|DMD|KIAA1161|SLC8A1|MYOM2
NEGATIVE REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090071,0.9721916732128829,1.0,-0.278813278923569,-0.5658432656690661,6187,3,MALSU1|NUDT16|SHQ1
POSITIVE REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:1904395,0.525503355704698,0.9265056012720759,0.741177767975298,0.984621598470673,3914,1,MESDC2
HEART LOOPING%GOBP%GO:0001947,0.29166666666666696,0.8000726114371469,-0.215853860426297,-1.11985674542192,1105,30,CCDC103|TBX20|MKKS|SOX17|DNAAF1|BBS7
NEGATIVE REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051134,0.533778767631774,0.9265056012720759,-0.5482216708023161,-0.9377038070327429,3594,2,CD300A|ZBTB7B
REGULATION OF FLAGELLATED SPERM MOTILITY%GOBP%GO:1901317,0.172383073496659,0.6757284283763572,-0.7531676206665601,-1.28825287807255,1160,2,CFAP69
NEGATIVE REGULATION OF DNA REPLICATION%GOBP%GO:0008156,0.279568942672909,0.788916642629372,0.27047645674605897,1.15646641371419,3164,32,FBXO18|ATR|BLM|DONSON|ZNF830|FBXO5|CDC6|MSH6|TIMELESS|CHEK2|ZRANB3|GMNN|RAD17|SMC3|CDAN1
REGULATION OF CARDIAC CHAMBER FORMATION%GOBP%GO:1901210,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904996,0.0210679258990193,0.305521822078509,-0.5963887701230811,-1.7396925018120601,115,7,RELA|TRAF6|IRAK1|RHOA|ETS1|TNF
REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY%GOBP%GO:0060296,0.387019230769231,0.859991269020751,-0.41067822950686894,-1.03960466755946,2253,5,MKKS|CFAP20
"DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0006354",0.09017651573292401,0.560121322881739,-0.195669316878002,-1.3073414164117199,234,70,AFF4|SETD2|CCNK|SUPT16H|CTDP1|NELFCD|CDK9|ADRM1|TCEA2|ELL3|ELL|NELFA|ELP3|POLR2A|SUPT4H1|POLR2K|NELFE|TCEB1|POLR2F|ELP2|NCBP2|TCEA1|POLR2I|POLR2D|PBRM1|EAF1
OSSIFICATION INVOLVED IN BONE MATURATION%GOBP%GO:0043931,0.12223029422448199,0.607607158836689,-0.472752791317887,-1.3790408664078602,672,7,RHOA|IGF1|RYR1
NEGATIVE REGULATION OF EOSINOPHIL EXTRAVASATION%GOBP%GO:2000420,0.77545346220045,0.9805314293977441,-0.6090648434053821,-0.8147646112547751,5856,1,PTGER4
MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0042438,0.157130760856417,0.6578589353509621,0.7609594706368901,1.2437673499764599,1298,2,CITED1|TRPC1
GLOMERULAR ENDOTHELIUM DEVELOPMENT%GOBP%GO:0072011,0.5998940818217929,0.9503391896930079,-0.693978826643141,-0.9283566356375691,4530,1,CD34
NOTOCHORD DEVELOPMENT%GOBP%GO:0030903,0.7280305661688091,0.972554563883587,0.433863081707284,0.8247280776424879,6287,3,STIL|COL5A2
SIGNAL RELEASE FROM SYNAPSE%GOBP%GO:0099643,0.544503473641193,0.929758904310055,0.18717899311005498,0.9464257874235509,6661,62,SYT17|RIMS2|GRM4|UNC13B|SYT3|LIN7A|LIN7B|DVL1|UNC13A|PPFIA3|CPLX3|SLC6A9|PCLO|CASK|SNAP47|PRRT2|STX2|BRSK1|SYT1|SEPT5|RIMS4|RAB3A|SYT7|STX3|SNAPIN|PIP5K1C|STX1A|SLC18A2|RIMS1|RIMS3|SYT4|LIN7C|STX1B
DENSE CORE GRANULE MATURATION%GOBP%GO:1990502,0.679968578161823,0.9647315640607691,-0.40834895775890606,-0.828732077191344,4327,3,BAIAP3|SNX19|PTPRN
RENAL TUBULE MORPHOGENESIS%GOBP%GO:0061333,0.298066850776117,0.8023890191280308,0.318857762015239,1.14380779820424,3129,18,CITED1|BMP4|PKD2|AHI1|KLHL3
ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071577,0.980286366466072,1.0,-0.14280099031358498,-0.5377857999698471,4723,13,SLC30A3|SLC39A8|SLC39A1|SLC39A4|SLC39A11
NEGATIVE REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070093,0.9000742390497399,0.998912093067348,-0.38738957607823,-0.662609122623216,6061,2,CRH
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:0097202,0.5787728026534,0.942692029750853,-0.24568275862069,-0.895046934076814,2791,12,BAD|PERP|ASPH|FADD|BAK1|LGMN|CASP8|IFI16|TBC1D10A|CIDEB|CYFIP2|RIPK2
L-PROLINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1904271,0.803221476510067,0.984522820758988,0.5993052492280551,0.796150286696752,5983,1,SLC36A4
NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051490,0.0917517674783975,0.5622489437340121,-0.718870629756259,-1.4589265845059198,583,3,CAPZB|PRKCD|SRGAP2C
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:0006978",0.381369426751592,0.8569686670872622,0.350159703573401,1.06825698879852,3831,11,MUC1|RPS6KA6|RPS27L|FOXM1|TFAP4|BRCA1
"CELL CYCLE SWITCHING, MITOTIC TO MEIOTIC CELL CYCLE%GOBP%GO:0051728",0.5906616668682719,0.945418171231938,0.5708298869589189,0.9330057686200229,4882,2,YTHDC2|C17orf104
ENAMEL MINERALIZATION%GOBP%GO:0070166,0.0683352544047423,0.50364937614461,-0.6641482380190811,-1.527402202017,414,4,TBX1|STIM1|FAM20A|FAM20C
NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901097,0.583072616499259,0.9439064862850342,-0.385437498889182,-0.886425726731129,3540,4,KIAA0226
COENZYME CATABOLIC PROCESS%GOBP%GO:0009109,0.238263147289946,0.7508803010977719,0.41180305492123903,1.2153372050176898,2364,10,NUDT17|PDXP|VCP|ACOT7|PM20D2|NUDT12|ABCD1|MTHFS|ACAT1
POSITIVE REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046326,0.747019867549669,0.9749763305090959,0.213453057769784,0.78020358451641,7895,19,FGF19|INS|FAM132A|CAPN10|OSBPL8|IRS1|AKT2
REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0006940,0.12432310469314098,0.607607158836689,-0.305181560033398,-1.33836555881107,550,19,GPER1|SOD1|PLCE1|SPHK1|ADRA1B|DOCK5|ADRB2|CHRNA3|CAV1
CHOLESTEROL TRANSPORT%GOBP%GO:0030301,0.144181977252843,0.6340340930337739,0.29640833959588103,1.30835720210171,1647,36,STAR|ABCA7|ABCA5|SCARB1|STARD5|LIMA1|SOAT1|AKR1C1|CETP|OSBPL5|LDLRAP1|APOE|APOC1|LDLR|APOM|LCAT|OSBP|SERAC1|SYT7|LRP6|STARD3|APOC2
REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0017158,0.29437726189425395,0.800447413278835,0.264959292072542,1.14211334124168,3334,33,CACNA1G|C19orf26|RIMS2|CACNA1I|UNC13B|CACNA1H|DOC2A|ZP3|SEPT5|SCAMP5|RIMS4|RAB3A|STX1A|RIMS1|REST|RIMS3|BAIAP3|SYT4|HYAL3|STX1B
RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031118,0.0228471001757469,0.31609926985007897,-0.640121474671131,-1.75709046695842,129,6,NAF1|GAR1|RPUSD2|NHP2
OSTEOCLAST DIFFERENTIATION%GOBP%GO:0030316,0.581986692015209,0.943249589738259,-0.19609943779545003,-0.9084777876579058,2448,22,TYROBP|TCTA|SBNO2|FOXP1|TNFRSF11A|GAB2|OSCAR
NEGATIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000048,0.502832861189802,0.9164921159310329,0.42173452473941103,0.972035560965177,4614,5,KIAA2022|EPCAM|RGCC|MAD2L2|PPM1F
REGULATION OF CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060353,0.0182776222624732,0.284990707385907,-0.75348811559036,-1.7328652566767702,110,4,FLOT1|IL1B|COLEC12|CAV1
REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0008589,0.9974804031354979,1.0,-0.0827842933471865,-0.455387458515964,3562,36,FUZ|PDCL|IFT122|TULP3|KCTD6|EVC|GPR161|INTU|KIF7
RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0034341,0.9603594080338271,1.0,-0.0927797435945009,-0.701062231865599,1816,112,CX3CL1|PRKCD|SIRPA|CXCL16|LGALS9|PML|CCL14|IRF6|HLA-DQB1|IFITM2|IFITM3|OASL|SLC11A1|CAMK2A|ICAM1|GAPDH|SNCA|OAS3|TRIM25|PDE12|B2M|HLA-DQA2|HLA-DQB2|IFITM1|CCL18
CELLULAR RESPONSE TO CATECHOLAMINE STIMULUS%GOBP%GO:0071870,0.6663539125539499,0.964618776001639,0.22714798976272602,0.8435138900536651,7101,20,RYR2|NR4A3|KCNQ1
PROTEIN TARGETING TO ER%GOBP%GO:0045047,0.567015445939213,0.938953543844111,-0.128626869146861,-0.947839910688552,1137,103,RPS4Y1|RPS24|RPL36A|RPS19|RPLP0|RPL36|RPS15|RPS10|RPL28|RPS3A|SPCS2|RPL37|RPL27A|SEC61A1|RPL7A|SEC61A2|RPL19|SRP19|RPLP1|RPSA|RPL6|RPL5|RPL18|RPS27A|RPS26|RPL22|RPS12|RPL4|RPL37A|RPL23|RPL10|RPL24|RPL26|RPS25|RPL13|RPS5|RPLP2|RPS2|RPS8|RPL21|SEC61B|RPL39|SRP9|RPS20|RPS15A|RPS11|RPS6|RPL30|RPL41|RPS29|RPL34|RPS7|RPL27|SRP68|RPL13A|RPS18|RPL10A|RPL38|RPS13|RPS27|RPS23|RPS21|RPL3|SPCS3|RPL29|SEC61G|RPL31|RPL17|SRPR|RPS14|RPS17|CHMP4A|RPL32|RPL18A|RPL11|SRP14|SPCS1|RPS16|RPL12|RPS4X|RPL9|RPS28|PMM1|RPL35|RPL7|SRP72|SGTB|RPS9|RPS3|RPL14|SEC63|SEC62|RPL15|RPL8|RPL35A|UBA52|ASNA1|CHMP4B|PMM2|SRP54
PURKINJE MYOCYTE ACTION POTENTIAL%GOBP%GO:0086017,0.0238805970149254,0.32397355287938,-0.806946836029614,-1.63767462827869,151,3,SCN1B|SCN5A
SECRETORY GRANULE LOCALIZATION%GOBP%GO:0032252,0.522641198748559,0.9251240799994541,-0.404455964264049,-0.9301642239967359,3173,4,KIF1C|KIF1A|KIF5B|KIF5A
OLFACTORY LEARNING%GOBP%GO:0008355,0.6815834767641998,0.965271928233355,-0.6542787825319809,-0.8752486761858729,5147,1,ADCY3
CHROMOSOME SEGREGATION%GOBP%GO:0007059,7.20772668300418e-05,0.0784645998831315,0.32738057488338396,2.01815088320925,0,189,KIF25|MUS81|SYCP2|EME2|CCNB1|RCC1|MMS19|PSRC1|KIF14|GEM|NCAPD3|ZWINT|SPAG5|RGS14|BLM|CENPF|KIF2C|KIF18A|CENPT|NSL1|KIF4A|MAP10|NUF2|KIF23|CASC5|BUB1|TOP2A|PRC1|DLGAP5|NEK2|CDC23|OIP5|SMC2|CCNE1|NDC80|NUSAP1|CDK5RAP2|CENPE|KIF18B|PTTG1|HDAC8|RB1|CEP55|BUB1B|AKAP8L|INO80|ESPL1|AURKB|SKA3|RAD51C|BOD1|DSN1|NCAPH2|NIPBL|INCENP|KIFC1|CDCA8|TUBG2|CENPQ|FANCM|SPDL1|KIF22|SMARCAD1|REC8|CDCA5|ESCO2|SRPK1|KLHL22|SKA2|DSCC1|SLX4|HJURP|PLK1|NCAPG|POGZ|NCAPH|EME1|RMI1|SKA1|RACGAP1|STRA13|CCNE2|SMC4|BAG6|STAG3|SPC25|TOP2B|KLHDC8B|TEX14|P3H4|FAM175B|RECQL5|HIRA|SGOL1|PDS5B|FAM83D|SMC3|PPP2R1A|FMN2
NEGATIVE REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046639,0.48602150537634403,0.9067604918222419,-0.241215577866028,-0.961989274482451,2259,15,RUNX1|SMAD7|SOCS5|CBFB
GLYCEROL ETHER BIOSYNTHETIC PROCESS%GOBP%GO:0046504,0.610061813186813,0.9508825506493929,-0.34434198614274303,-0.8716788724363179,3552,5,DHRS7B|PEX7
NEGATIVE REGULATION OF MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION%GOBP%GO:0071641,0.372037600953264,0.852609194081082,-0.8117556241729159,-1.0859102486776,2809,1,SIRPA
POSITIVE REGULATION OF METANEPHRIC URETERIC BUD DEVELOPMENT%GOBP%GO:2001076,0.102281879194631,0.573450707099996,0.9485553595059549,1.2601134770488798,761,1,BASP1
CYTOPLASMIC RNA SURVEILLANCE%GOBP%GO:0071026,0.675704697986577,0.9647315640607691,0.666850463167181,0.885881090009248,5033,1,SUPV3L1
EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:0097010,0.0219747587230883,0.310715277412964,-0.90272952853598,-1.54407051145977,147,2,EIF4H|EIF4B
POSITIVE REGULATION OF PROTEOLYSIS%GOBP%GO:0045862,0.00878293601003764,0.20719971974677104,-0.15867807318574098,-1.3805681312803602,6,239,BAX|NOD1|GPER1|FBXW7|PICALM|FURIN|TBC1D10A|RHBDD1|CBFA2T3|IL1B|CLU|PLK3|USP5|DAB2IP|TRIB1|LGALS9|CIDEB|ARIH1|DLC1|PRICKLE1|WDR48|CEBPA|EIF2AK3|BBC3|AURKAIP1|RPS3|CYFIP2|S100A8|PSME3|FYN|STUB1|DDX3X|TNFRSF1B|RNF139|TNFRSF10A|PPARG|LYN|ENO1|TANK|GLTSCR2|EFNA1|TRIB2|SUMO1|ECSCR|RNF144B|BOK|MBP|TNIP1|RIPK2|CRADD|SMAD7|SNCA|FMR1|KARS|NLRP1|NLRP3|CTSH|STAT3|CLEC3B|SOCS5|TNFRSF10B|MTCH1|MFI2|ARIH2|PARK2|ADRA2A|MYH9|HSPBP1|DDRGK1|SOX7|BCAP31|TNF|PMAIP1|BBS7|CAV1|TRIB3|EGLN3
HEART TRABECULA FORMATION%GOBP%GO:0060347,0.28387946649102597,0.7932053053075551,-0.49470665389792606,-1.13772195612517,1723,4,FKBP1A
MANNITOL TRANSPORT%GOBP%GO:0015797,0.9139414802065401,1.0,-0.541574768416409,-0.724481080186891,6902,1,SLC26A6
LIPID GLYCOSYLATION%GOBP%GO:0030259,0.650464777690671,0.963755998259649,0.409558231657384,0.867893015922691,5807,4,B3GALT1|ST3GAL4
CELLULAR RESPONSE TO GLYOXAL%GOBP%GO:0036471,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
STEROID HORMONE MEDIATED SIGNALING PATHWAY%GOBP%GO:0043401,0.25309705472147,0.7641083395392759,0.23237145417101202,1.16622038648447,3084,60,PIAS1|SAFB|BMP4|RHOXF1|EGLN2|MED12|SRC|CCNE1|RB1|DDX17|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2|THRAP3|ABHD2|ARID1A|MED30|TRIP4|DDX5|MED14|BRCA1|RBFOX2|NCOA3|MED16|UBR5
CELL FATE COMMITMENT%GOBP%GO:0045165,0.731196054254007,0.9726603499749559,-0.125034185602741,-0.858625502180146,1778,77,C17orf96|ID2|BATF|SOX12|TGFBR1|ACVR1|PDPN|NRP1|TCF7L2|IL6|PPARG|SMAD2|WNT6|WNT11|ARHGEF2|SOX6|STAT3|WNT3|ASCL1|SOX17|EPAS1|RBPJ
POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060391,0.9007085020242921,0.998912093067348,0.221766204237872,0.63284497453218,8898,9,BMP4|DAB2|TGFB3|RBPMS|BMPR1A
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000106,0.5452233618716621,0.930420772651609,0.19938872763888002,0.940871000091341,6431,46,SIRT1|IDO1|CD27|BMP4|BLM|CDKN2A|MERTK|PRKCQ|CCL21|CCL5|AURKB|CCL19
POSITIVE REGULATION OF SOMATOSTATIN SECRETION%GOBP%GO:0090274,0.09108963325830802,0.5609783360513879,-0.9526907807675341,-1.2744435047311202,687,1,ADCYAP1
"MEIOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:0051754",0.0791097133180114,0.532203813468543,0.825034463744141,1.3484961659672299,653,2,BUB1|BUB1B
DETECTION OF VIRUS%GOBP%GO:0009597,0.6875349983200811,0.966986590843215,0.39718806576113597,0.841679452728726,6138,4,SERINC5|DDX58|IFIH1
POSITIVE REGULATION OF VIRAL TRANSLATION%GOBP%GO:1904973,0.19409395973154395,0.7049101024373008,0.9051058667842958,1.20239276438745,1445,1,DHX9
POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048087,0.0141610406718261,0.259243632817479,-0.766999393371202,-1.7639383729679001,85,4,ZEB2|HPS4|BLOC1S5|BLOC1S6
SNRNA TRANSPORT%GOBP%GO:0051030,0.0689709347996858,0.504517513788691,-0.742817868590953,-1.50752679421722,438,3,PHAX|NCBP2
REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:1902692,0.37997611464968195,0.856277647940315,0.35065540482463897,1.06976925968688,3817,11,SIX3|SMARCD3|NF1|ZNF335|KDM1A|FZD3
MITRAL VALVE DEVELOPMENT%GOBP%GO:0003174,0.669424743892829,0.964618776001639,-0.245082294309021,-0.8291500855614279,3397,10,NOTCH1|ACVR1|SMAD6|EFNA1
"CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0050653",0.0179658500371195,0.282827765314948,-0.91006863589275,-1.55662366153608,120,2,CSGALNACT1
REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051547,0.00948728300363343,0.21235063347774397,-0.539592965167523,-1.89889487192703,46,11,ARF6|MAPRE2|EPB41L4B|FGF7|MMP9|MAP4K4|IQSEC1|FGF10
"TRANS-SYNAPTIC SIGNALING BY SOLUBLE GAS, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099554",0.4798093472792271,0.9046812288131709,-0.7589876488751659,-1.01532091923972,3623,1,GUCY1B3
REGULATION OF T CELL ANERGY%GOBP%GO:0002667,0.957315436241611,1.0,0.523654609616233,0.695651786986756,7131,1,FOXP3
REGULATION OF BLOOD VOLUME BY RENIN-ANGIOTENSIN%GOBP%GO:0002016,0.752710133542812,0.9769690538700708,-0.38091230831223705,-0.773050212317984,4790,3,ACE
REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905818,0.00225262806607709,0.11976563223178699,0.39372448332377796,1.9110119119793099,26,52,ANAPC15|CCNB1|TPR|XRCC3|ANAPC5|CENPF|NUMA1|USP44|BUB1|DLGAP5|CDC23|CDC20|GEN1|APC|NDC80|CDK5RAP2|CENPE|PTTG1|FBXO5|RB1|BUB1B|ESPL1|CDC6
REGULATION OF DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:1903179,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
MESODERM MORPHOGENESIS%GOBP%GO:0048332,0.37407868287546703,0.852609194081082,0.31003589470242704,1.0748103683306,3907,16,ITGB1|TBX3|BMP4|ITGA2|LEF1
ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION%GOBP%GO:0000132,0.0759022341034944,0.525661416287861,0.41439007004185996,1.46149393392113,794,17,SAPCD2|NUMA1|DYNLT1|NDC80|CENPA|GPSM2|CDK5RAP2|SPDL1
INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070498,0.00187207488299532,0.110761102193686,-0.33662504524827197,-1.99074046836763,5,46,RELA|TRAF6|UBE2N|IL1RN|NOD1|IL1B|IRAK1|NFKBIA|MAP3K8|IRAK2|SQSTM1|IRAK4|UBE2V1|RIPK2|UBA52|PELI2|MAPK3|TNIP2|PELI1|MYD88|PLCB1|UBC|UBB
NEGATIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904021,0.243058648849295,0.7565220534116759,-0.7112213950923629,-1.21650610572403,1636,2,UBQLN2|NECAB2
REGULATION OF MULTIVESICULAR BODY SIZE INVOLVED IN ENDOSOME TRANSPORT%GOBP%GO:0010797,0.731275167785235,0.9726603499749559,0.638343625937362,0.8480110285296071,5447,1,SNF8
HYPOTHALAMUS DEVELOPMENT%GOBP%GO:0021854,0.5358135840063549,0.9265056012720759,-0.7278341420379358,-0.973645923281099,4046,1,RAB3GAP1
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1903206,0.457504145936982,0.890018343810919,-0.271467984122952,-0.988985097095861,2206,12,TRAP1|PARK7|NUP93|TXN|PDE8A|HGF|MET
METANEPHRIC GLOMERULUS MORPHOGENESIS%GOBP%GO:0072275,0.7363028953229399,0.974262605126702,-0.464460987041632,-0.794435643395373,4958,2,PDGFRA|PDGFRB
CELLULAR CHLORIDE ION HOMEOSTASIS%GOBP%GO:0030644,0.9402684563758391,1.0,0.53291795324217,0.707957725726756,7004,1,SLC12A5
LYSOSOMAL LUMEN ACIDIFICATION%GOBP%GO:0007042,0.711340206185567,0.9703327035763342,0.326733219348078,0.8035527688774441,6623,6,CLN6|TMEM199|CLN5|PPT1|CLN3|CCDC115
MYOBLAST FATE DETERMINATION%GOBP%GO:0007518,0.601218059049384,0.9506035145731909,-0.6934274371415969,-0.927619025089629,4540,1,IFRD1
PHOSPHATE ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035435,0.46866814426757997,0.89605323680621,0.336960566557307,0.9944576861851141,4651,10,SLC37A2|SLC25A10|XPR1|SLC25A30|SLC37A3|SLC20A1|SLC25A3|SLC37A1
EMBRYONIC OLFACTORY BULB INTERNEURON PRECURSOR MIGRATION%GOBP%GO:0021831,0.45043205027494104,0.88620227509476,-0.48748676924957796,-0.9893399143240219,2866,3,SLIT3
REGULATION OF PRESYNAPSE ORGANIZATION%GOBP%GO:0099174,0.8183799491463859,0.987153241368501,-0.24768503388670898,-0.722508232632962,4505,7,EIF4G1|SNCA
PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0001516,0.5727002967359051,0.940734934957679,0.263864666070843,0.914747239835687,5982,16,EDN1|MGST1
CELLULAR RESPONSE TO DISACCHARIDE STIMULUS%GOBP%GO:0071324,0.313915000661989,0.816422962704093,-0.8439567710630791,-1.1289867046773099,2370,1,CALCRL
ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:0008333,0.134266624244353,0.621139169838541,-0.211410830810792,-1.27087902576292,421,48,VPS18|VPS11|VPS4B|BIN1|VPS16|RAB12|ADRB2|TRAK1|RAB7A|CACNG3|KIF13A|CACNG7
NEUROTRANSMITTER BIOSYNTHETIC PROCESS%GOBP%GO:0042136,0.0688735836480782,0.5040280242137971,-0.339378176889313,-1.45992951443142,309,18,NQO1|SHMT2|SPR|PAH|DDAH2|NOS3
REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050704,0.615572370026849,0.951600300570769,-0.18522890711161102,-0.8878877246755951,2521,24,LGALS9|TNFAIP3|PANX1|FOXP1|RIPK2|NLRP1|NLRP3
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0061136,0.0115236875800256,0.23212667146341198,-0.19008137621893398,-1.4932750734471398,17,134,CCAR2|PSMD10|PARK7|RPL11|EDEM1|RYBP|RNF217|PRKACA|RAD23A|CSNK1D|MAP1A|CSNK1A1|TAF9|RNF19B|NUDT15|FBXW7|OPHN1|CBFA2T3|CLU|PLK3|USP5|DAB2IP|TRIB1|UBE2J1|STYX|FAM192A|ARIH1|OS9|PRICKLE1|CEBPA|PSME3|STUB1|GLTSCR2|TRIB2|SUMO1|ECSCR|RNF144B|BAG5|RAD23B|SMAD7|FMR1|COMMD1|SOCS5|DYX1C1|ARIH2|GNA12|PARK2|HSPBP1|DDRGK1|BCAP31|HSP90AB1|GABARAPL2|BBS7|PSMF1|CAV1|TRIB3|UBB
MRNA MODIFICATION%GOBP%GO:0016556,0.957787158409242,1.0,-0.139642780602332,-0.6007122165227111,4310,18,CBLL1|METTL16|ZC3H13|TRMT61B|TRMT6
TRANSFORMING GROWTH FACTOR BETA RECEPTOR COMPLEX ASSEMBLY%GOBP%GO:0007181,0.302770049594774,0.8054013181463249,0.685745795423215,1.12083266408024,2502,2,EID2|FMOD
CARDIAC SEPTUM MORPHOGENESIS%GOBP%GO:0060411,0.9803566813130009,1.0,0.115112096447888,0.522283634084785,11378,40,TBX2|HES1|BMP4|PROX1|ROBO2|TGFB2
GDP-L-FUCOSE SALVAGE%GOBP%GO:0042352,0.7209395973154359,0.9713770803161691,0.642754741949713,0.8538709993581779,5370,1,FUK
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:2000054,0.6974712034953001,0.96731875442989,-0.646724746360829,-0.865143411679092,5267,1,SFRP1
MITOCHONDRIAL ASPARAGINYL-TRNA AMINOACYLATION%GOBP%GO:0070145,0.7753020134228191,0.9805314293977441,0.614027348919277,0.8157079393371078,5775,1,DARS2
MEVALONATE TRANSPORT%GOBP%GO:0015728,0.387925327684364,0.859991269020751,-0.803539920599912,-1.07491985151329,2929,1,SLC16A1
POSTTRANSCRIPTIONAL TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY%GOBP%GO:0000973,0.7148315387287251,0.971081608033886,0.439119885298335,0.834720708274095,6173,3,NUP107|PCID2|NUP98
PURINE NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0006144,0.7180762852404641,0.971081608033886,-0.21910684218423299,-0.7982282046703411,3463,12,ADA|MTHFD1L|APRT|GMPS|PRPS1|HPRT1
BRANCHED-CHAIN AMINO ACID METABOLIC PROCESS%GOBP%GO:0009081,0.307095553453169,0.8101040452554871,0.310484714395923,1.13486913535114,3245,19,MCCC2|BCKDHA|BCAT2|IVD|HMGCLL1|MCCC1|PPM1K|HMGCL|HIBCH|HIBADH|HSD17B10|ACAD8|AUH|ACADSB|ACAT1
REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071675,0.11551324929251401,0.5935510150584289,-0.2632975988245,-1.3312973810179498,448,28,KARS|LGALS3|ANO6|GREM1|PLCB1|TNF|NBL1
DENDRITE DEVELOPMENT%GOBP%GO:0016358,0.44399375975038996,0.8812297046052501,-0.17031128766051698,-1.0071905740570601,1422,46,NRP1|STRN|CHRNA7|CAMK2A|ARC|CDC42|FLRT1|SDC2|ZNF365|SEMA3A|EPHB2
POSITIVE REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045630,0.20844780219780198,0.7238327250928481,-0.48430791958064295,-1.22599333871831,1213,5,IL18|CD86|RARA|NLRP3
THIOESTER BIOSYNTHETIC PROCESS%GOBP%GO:0035384,0.4664276109368,0.894350777437112,0.24158143983546104,1.00071167467031,5202,29,HACD1|SCD5|ELOVL6|PDHX|PDHA1|SLC25A1|ACACA|DLD|ACSS1|TECR
GLYCINE BIOSYNTHETIC PROCESS%GOBP%GO:0006545,0.27720861172977,0.7884684708511421,-0.693168064088269,-1.18562684991609,1866,2,SHMT2
POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002606,0.8064937894966221,0.984682960940884,0.31844313678369396,0.733964223797688,7401,5,CCL21|CCL19
MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010657,0.84974016332591,0.991298302704726,-0.41534568300251296,-0.710426546283887,5722,2,GNGT1
RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000056,0.811072056239016,0.9852684165902109,-0.26622911036346597,-0.7307810319702199,4614,6,RPS15|XPO1|LTV1|NUP88|RAN|NPM1
CELLULAR RESPONSE TO UNFOLDED PROTEIN%GOBP%GO:0034620,0.611139499233521,0.9508825506493929,-0.124912630899857,-0.930648060857586,1195,107,TMBIM6|CTDSP2|TSPYL2|GOSR2|MYDGF|HSPA9|WIPI1|CALR|ATF4|BAX|DNAJC3|CREB3|RHBDD1|ADD1|EIF2S1|KLHDC3|HSPA13|DAB2IP|HSPA5|EIF2AK3|TATDN2|HYOU1|DDIT3|AMFR|ATF6|LMNA|PTPN1|BAG3|CREBRF|CXCL8|HSF1|SHC1|ATP6V0D1|ASNA1|HSPA6|SSR1|VAPB|PARK2|HSPB8
OLIGOSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0009313,0.280594243268338,0.7890335436983149,-0.368029124606983,-1.1439947618955801,1510,8,ATHL1|MAN2C1|NEU3|MANBA|MAN2B1|NEU1|MAN2B2|NEU4
COPULATION%GOBP%GO:0007620,0.0643522438611346,0.495456803258629,0.841150043541603,1.37483663842531,531,2,TAC1|KLK14
FOLIC ACID-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0009396,0.7298862679022751,0.972554563883587,0.300867047819675,0.783093713272739,6930,7,DHFR|MTHFD1
HEME A METABOLIC PROCESS%GOBP%GO:0046160,0.2634001484781,0.77467054856079,-0.699781473107176,-1.1969387318513998,1773,2,COX10
TRANS-SYNAPTIC SIGNALING BY LIPID%GOBP%GO:0099541,0.633603483730495,0.958362160385489,0.553956437827406,0.905426579555328,5237,2,DAGLA|DAGLB
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY%GOBP%GO:0098962,0.541382013663344,0.928807195199472,0.44723450424605,0.9477326365631491,4833,4,AKAP9|NPTX2|NPTXR
GLUTATHIONE BIOSYNTHETIC PROCESS%GOBP%GO:0006750,0.847531847133758,0.991298302704726,0.223904123046592,0.6830801540680049,8515,11,GGT1|MGST2|OPLAH|HAGH
NEGATIVE REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902856,0.0677876340526943,0.50364937614461,-0.9651521835024258,-1.2911135031145702,511,1,MAP4
RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071826,0.9693978282329709,1.0,-0.0870672952611817,-0.736371176591633,981,204,SNUPN|HSP90AA1|NCBP1|RPL11|SCAF11|GEMIN4|ZRSR2|EIF2A|CD2BP2|EIF6|TAF9|CELF2|OGFOD1|STRAP|SNRPD3|RPL12|LSM3|DHX8|PRPF19|NAF1|CELF4|ISY1|EIF2S1|RPS28|RUVBL1|FAM103A1|MRPS2|RPF2|RSL24D1|LIMD1|PRPF18|MRPL22|CRNKL1|ZNHIT6|DDX3X|NUFIP1|C1QBP|PRPF6|SHQ1|SBDS|GLTSCR2|PLD6|EFTUD1|RUVBL2|PPAN|EIF4H|NPM1|DDX28|EIF4B|RRP7A|TXNL4A|AGO2|SNRPB|PIH1D2|EIF3A|RRS1|MRTO4|EIF2S3|NUDT21|POLR2D|SF3A1|RPF1|SLU7|DDX6|HSP90AB1|BICD1|DYRK3
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904035,0.0412371134020619,0.40243243079054,-0.262326766744936,-1.4918802399186901,139,40,PRKCI|WFS1|GSN|GAS6|CAST|GATA2|GPER1|IL11|KDR|MAPK7|TNFAIP3|TCF7L2|IL6|ECSCR|BOK|ICAM1|RAMP2|PDCD4|ANO6|SCG2|TNIP2|TNF
ACTIN CROSSLINK FORMATION%GOBP%GO:0051764,0.53661941580756,0.9265056012720759,0.38163839206091704,0.938584044996614,4996,6,DPYSL3|BAIAP2L2|BAIAP2L1|FLNA|EPS8
POSITIVE REGULATION OF CATABOLIC PROCESS%GOBP%GO:0009896,0.007352941176470591,0.19328898225957103,-0.156286909240582,-1.4122213464681699,3,300,HIF1A|TRIM8|HECW2|ITCH|BAX|FLCN|FBXW7|GNAI3|OAZ2|FURIN|CBFA2T3|VPS28|IL1B|CLU|METTL16|PTTG1IP|TRIM13|NEDD4L|KDR|MTDH|PLK3|USP5|PRKCD|DAB2IP|TRIB1|PRKAA1|TNFAIP3|PFKFB4|ARIH1|PRICKLE1|CEBPA|GTPBP1|STUB1|ABHD5|TNFRSF1B|PPARA|VPS11|FOXO1|RNF139|MFN2|SH3BP4|GLTSCR2|TRIB2|DHRSX|SUMO1|SH3GLB1|ECSCR|VIP|ATG7|RNF144B|PIP4K2A|IGF1|UQCC2|CNOT7|PTPN1|SMAD7|SNCA|FMR1|MSN|NEDD4|AGO2|BAG3|HK2|ADRB2|PAFAH1B2|PLEKHF1|TFEB|SOCS5|RALB|HTT|RAB7A|ARIH2|ZC3HAV1|PARK2|SPTLC1|BNIP3L|ADRA2A|HSPBP1|FBXO7|AAED1|PABPC1|TICAM1|DDRGK1|HSPB8|BCAP31|SESN2|CSNK2A1|TWIST1|PLK2|TNF|BBS7|RBM24|CAV1|TRIB3
MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098915,0.18362857473659802,0.689876118998471,0.655122973420095,1.2453198561215901,1585,3,KCNQ1|KCNH2|KCNJ8
REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904714,0.279513258263712,0.788916642629372,-0.392443463872035,-1.1447749952475301,1538,7,SNRNP70|ATP13A2|CTSA|EEF1A1|EEF1A2|PLK3|SNCA
REGULATION OF SYNAPTIC VESICLE CLUSTERING%GOBP%GO:2000807,0.116128285284242,0.595418121545615,0.7010311298223901,1.33258643208557,1002,3,BRSK2|BRSK1|PTEN
POSITIVE REGULATION OF GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:1902661,0.8278337385666321,0.9876441563834109,0.391419433109077,0.744047166561538,7149,3,SMARCA4|PIH1D1|SMARCB1
PROTEIN MATURATION%GOBP%GO:0051604,0.220868240670221,0.73556947110949,-0.140856735335248,-1.1273064615065802,289,154,FAM96B|FURIN|TBC1D10A|TESC|TSPAN15|SRGN|KLK1|FKBP1B|CIDEB|GCSH|SDE2|HSCB|PCSK7|PCSK1|BOLA2|CYFIP2|STUB1|BOLA2B|CIAO1|AIP|YME1L1|PLAU|ATP6AP2|TSPAN5|NAT6|NCSTN|AGA|XPNPEP3|PSEN2|TSPAN33|NAA50|RIPK2|PGK1|PMPCA|FXN|GLRX5|NAA20|CTSH|ACE|CPXM1|LIAS|TASP1|ISCA1|PRSS3|FKBP1A
REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901725,0.0943760984182777,0.5630268609168221,-0.52886626671028,-1.4517023913468101,536,6,CAMK2D|VEGFA|PRKD2|KDM5A
POSITIVE REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010729,0.906374742953913,1.0,0.431460330117049,0.705210056667683,7492,2,DUOXA1|ZNF205
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0072413,0.7554653858893671,0.9771370084125129,0.16167288265464003,0.7985947859638929,9122,56,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|GTSE1|CHEK2|PRMT1|CARM1|AURKA|ARID3A|TNKS1BP1|CNOT3|E2F1|PRKDC|CASP2|CDK2|ATM|CNOT1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|CNOT6|E2F4
HISTONE H4-K8 ACETYLATION%GOBP%GO:0043982,0.955564142194745,1.0,0.162934418302634,0.552447397880818,9891,15,JADE3|OGT|KAT8|WDR5|MEAF6|KANSL1|KAT7|MCRS1|KANSL3|JADE2|HCFC1|KANSL2|ING4
POSITIVE REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010886,0.184680758335149,0.690839705636971,0.5516860611248771,1.27155458812281,1694,5,LPL|SCARB1|SREBF2
NEGATIVE REGULATION OF LIPID STORAGE%GOBP%GO:0010888,0.000662544169611308,0.0806484601749226,-0.5582378619044449,-2.3490007158668598,2,17,PPARD|NFKBIA|NR1H3|ABHD5|PPARA|IL6|PPARG|ABCA1|NR1H2|ABCG1|TNF
PRE-MRNA CATABOLIC PROCESS%GOBP%GO:1990261,0.18747517542698303,0.6940517434063481,-0.9043890604322891,-1.20982882073156,1415,1,ZPR1
POSITIVE REGULATION OF DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:1903181,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
UDP CATABOLIC PROCESS%GOBP%GO:0006256,0.37495035085396505,0.852609194081082,-0.81043228936921,-1.08413998336255,2831,1,ENTPD4
CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:0035926,0.9545179629853641,1.0,0.386676557966111,0.6320122113691651,7890,2,F2RL1
NEGATIVE REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905953,0.0495517928286853,0.437434563451949,-0.30511289594078006,-1.49819380439799,198,26,PPARD|NFKBIA|NR1H3|ABHD5|PPARA|IL6|PPARG|ABCA1|NR1H2|ABCG1|TNF
LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002320,0.0791801993504312,0.532203813468543,0.6696947950788039,1.4191472433519399,706,4,BMP4|LIG4
CELLULAR RESPONSE TO MYCOPHENOLIC ACID%GOBP%GO:0071506,0.763880488689972,0.978421368343614,0.50046870692032,0.81800235278162,6314,2,EGR1|PDGFB
MONOCARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0072329,0.0437667878021804,0.412064680381984,0.271536056289732,1.46017134576874,553,83,CROT|GLYATL2|SLC27A2|ASRGL1|ETFDH|HSD17B4|ACADVL|IDNK|BDH2|ETFA|DECR2|ABHD3|AMACR|ACADM|DECR1|AIG1|ALDH3A2|HADH|ETFB|ACOX2|ECHDC2|MCEE|ABAT|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|FAAH|AKR1A1|ECI1|ECI2|HADHB|ACAT2|HIBCH|ABHD2|ACADS|PCK2|ACOT7|ECHS1
REGULATION OF MAST CELL APOPTOTIC PROCESS%GOBP%GO:0033025,0.139414802065404,0.6281603901381739,-0.9276025584472869,-1.2408822247998401,1052,1,ADAM17
POSITIVE REGULATION OF ACROSOMAL VESICLE EXOCYTOSIS%GOBP%GO:2000368,0.5703399056489661,0.940402148292764,0.578384339674662,0.945353314050949,4714,2,ZP3|HYAL3
N-TERMINAL PEPTIDYL-SERINE TRIMETHYLATION%GOBP%GO:0035573,0.8857407652588379,0.996643473105967,-0.5555249228054701,-0.743142627049779,6689,1,NTMT1
NEGATIVE REGULATION OF ERAD PATHWAY%GOBP%GO:1904293,0.9373157791314599,1.0,0.18452327246228603,0.5816832971820172,9539,12,SGTA|DERL3|SVIP|UBAC2|USP14|UBXN1|UBE2G2|USP25|DERL2|ERLEC1|UBE2J1|OS9
TEAR SECRETION%GOBP%GO:0070075,0.0720243611809877,0.515023940206536,-0.962946625496251,-1.28816306092281,543,1,FGF10
NEGATIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010677,0.320844179992562,0.822183858873702,0.29706121700176696,1.12304973563943,3450,21,INS|C1QTNF3|FAM132A|CLK2|PGP|PASK|GCK|MIDN
OSTEOBLAST PROLIFERATION%GOBP%GO:0033687,0.9329865731220519,1.0,0.41233742609390994,0.6739541953787671,7712,2,LRRC17|FIGNL1
CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0071219,0.0788671023965142,0.532203813468543,-0.18279508480367399,-1.30411457290706,180,88,CD274|IL1B|IRAK1|MTDH|SIRPA|DAB2IP|TNFAIP3|NR1H3|RHOA|TNFRSF1B|BCL10|VIM|IL6|LYN|FCGR2B|SBNO2|LDOC1|PDE4B|NR1H2|PDCD4|CXCL8|NLRP3|TNIP2|TICAM1|NR1D1|CD36|TNF
POSITIVE REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903997,0.647949942367858,0.963755998259649,-0.36658791899678794,-0.8430756307937959,3934,4,FYN|DOCK3
REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032069,0.7364180478821359,0.974262605126702,-0.18021082539563898,-0.804083671242013,3198,20,TERF2|PRKCD|RPS3|DFFA|OASL|NPM1|OAS3
HISTIDINE TRANSPORT%GOBP%GO:0015817,0.379597315436242,0.855773365224557,0.816442434936039,1.0846073507331702,2827,1,SLC15A4
N-GLYCAN FUCOSYLATION%GOBP%GO:0036071,0.15140939597315398,0.6477631120411801,0.924900749889722,1.2286893834806598,1127,1,FUT8
CELLULAR RESPONSE TO MORPHINE%GOBP%GO:0071315,0.162953020134228,0.664859563055667,0.919386854874283,1.2213644199449498,1213,1,ADCY8
ISLET AMYLOID POLYPEPTIDE PROCESSING%GOBP%GO:0034231,0.47186548391367705,0.898272347254494,-0.7627370974856641,-1.02033667096572,3563,1,PCSK2
REGULATION OF GTPASE ACTIVITY%GOBP%GO:0043087,0.9296306858690999,1.0,0.113540370936687,0.7091975983735991,13038,207,DOCK10|TBC1D3D|RGS16|ITGB1|FGD6|CXCL13|PROM2|TBC1D30|TBC1D4|SGSM3|ARAP1|EVI5L|GRTP1|F2R|PLXNC1|RASGRP2|TBC1D3B|ECT2|RGS1|KLRK1|EPHA5|TBCK|DOCK8|USP6NL|FGD1|EZH2|XCL2|CCL21|F2RL1|RASA4|CCL5|PLXNA3|DOCK7|NF1|HRAS|TBC1D10C|TBC1D13|FICD|CCL19|CCL2|PLXNB2|PIN1|RTN4R|FGD2|PLXNB3|RGS7|NTRK3|APC2|PLXNA2|CCL3L3|CCL11|EFNA5|TBC1D9B|ARHGAP27|RAP1GAP|AGRN|TBC1D22B|TBC1D10B|RASGRP1|DVL3|CCDC125|RAPGEF6|PTK2|ADAP1|CCL4L2|TBC1D7|ARHGAP15|TBC1D12|TBC1D2B|PRKG1|EPHA1|ARHGAP9|LARS|SGSM1|SIPA1L1|SYDE1|SCRIB|MLLT4|ALS2|SNX18|XCL1|WNK1|RAP1GDS1|OCRL
NEGATIVE REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010764,0.7274155538098979,0.972554563883587,-0.38943421197750105,-0.7903451626097601,4629,3,HYAL2|ITGB1BP1|FGF2
THIAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042723,0.517751147944899,0.923376778065417,0.454595033013165,0.963330300135006,4622,4,SLC25A19|SLC19A2
POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902884,0.6440087579617839,0.9624969804715359,0.280468747624004,0.8556458573940531,6470,11,ACOX2|SEPN1|HDAC6|SFPQ|RIPK1
CELLULAR RESPONSE TO IRON(III) ION%GOBP%GO:0071283,0.7202684563758391,0.9713637233549571,0.643030436700485,0.8542372475349641,5365,1,IREB2
REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002819,0.9980307207562029,1.0,0.084478218443657,0.4582205429079121,12669,87,SIRT1|CEACAM1|AGER|SKAP1|TRIM27|THOC1|CD1E|PRKCQ|MAP3K7|LOXL3|ZP3|ZBTB1|CCL19|IL12RB1|CD1D|PAXIP1|RIF1|TRAF2|SUPT6H|RIPK3|BTK|HLA-F|NFKBID|FAM35A|IL1R1|RC3H1|XCL1|TP53BP1|ANXA1|HSPD1|NDFIP1|WAS|FADD|JAK3|HLA-C|FOXP3|PRKCZ|HMGB1|STX7|MEF2C|ZC3H12A|PTPRC
POSITIVE REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051984,0.0421445476060441,0.40376460791238894,0.38561639946653004,1.55036263370792,462,26,CCNB1|ANAPC5|NUMA1|FAM178A|DLGAP5|FEN1|RB1|ESPL1|CDC6|NIPBL
TELOMERE MAINTENANCE VIA TELOMERE TRIMMING%GOBP%GO:0090737,0.0446060129691491,0.41504430757275895,0.497074388762308,1.5669561109647598,453,12,XRCC3|BLM|EXO1|DNA2|SLX1B|SLX4
NEGATIVE REGULATION OF NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072183,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
SOMATIC MUSCLE DEVELOPMENT%GOBP%GO:0007525,0.406072335792912,0.8663957682383929,0.6397915045272801,1.0457216380490502,3356,2,NEB
PRONEPHRIC FIELD SPECIFICATION%GOBP%GO:0039003,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
SLOW AXONAL TRANSPORT%GOBP%GO:1990832,0.8311409395973149,0.9879179006160809,0.585465372739303,0.77776462822211,6191,1,HSPA8
EPITHELIAL FLUID TRANSPORT%GOBP%GO:0042045,0.179955456570156,0.685385002351581,-0.7489449378665881,-1.2810302052956202,1211,2,AQP1
ISOTYPE SWITCHING TO IGG ISOTYPES%GOBP%GO:0048291,0.8805369127516779,0.9956508825790341,0.560707984119982,0.744875541946754,6559,1,HSPD1
POSITIVE REGULATION OF STEROID HORMONE SECRETION%GOBP%GO:2000833,0.594951923076923,0.9473459395438281,-0.347847619775427,-0.88055315119141,3464,5,CRH|GAL
REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000018,0.466795693722027,0.8946422270258639,0.6168938665062739,1.00829607773863,3858,2,WNT4
N-ACETYLGLUCOSAMINE CATABOLIC PROCESS%GOBP%GO:0006046,0.375477596387635,0.852871276063039,0.5626647009080121,1.06956640632132,3242,3,AMDHD2|GNPDA1|GNPDA2
DEVELOPMENTAL CELL GROWTH%GOBP%GO:0048588,0.0343713278495887,0.378473112045903,-0.27009161780936203,-1.52392634992921,116,39,ALCAM|FLRT1|COBL|ARIH2|SEMA3A|HSP90AB1|TMEM108|SLIT3
POSITIVE REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000321,0.590435659088364,0.945418171231938,0.430885855091556,0.9130882873004399,5271,4,IL12RB1|NFKBID|MALT1|NFKBIZ
PROTEIN DEACETYLATION%GOBP%GO:0006476,0.468052347959969,0.8957057061714878,0.21689680565515002,0.998236196020817,5471,42,SIRT4|SIRT1|HDAC10|MTA2|MIER2|MTA1|HDAC8|HDAC3|SIRT3|SMARCAD1|HDAC6|SFPQ
MONOSACCHARIDE METABOLIC PROCESS%GOBP%GO:0005996,0.13982392542723998,0.6281603901381739,-0.16003941358391,-1.19994486463961,269,109,PFKL|SLC2A3|GPI|CRTC2|FBP1|G6PD|PKM|APOD|ENO1|FGGY|DHDH|GAPDH|PGK1|SORD|XYLB|HK1|PPARGC1A|HK2|MAN2B2|TPI1|G6PC3|CYB5A|ALDOA|TKT|SLC25A13|SLC2A1|PMM2|PER2|PC|PGAM2
NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002903,0.147978910369069,0.6402258061318559,-0.48418313090708504,-1.32905018382019,841,6,IRS2|NOC2L|BCL10|FOXP1|BCL6
REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901385,0.2296392711045,0.743365122901021,0.32135100083553103,1.2148780651284499,2469,21,C19orf26|CACNB4|CACNB2|CACNA2D1|STAC2|HPCA|STAC3|DRD4|DMD|CACNB1
POSTSYNAPTIC ENDOCYTOSIS%GOBP%GO:0140239,0.813192966737597,0.9860366614541909,0.347399458772657,0.736172638464598,7260,4,DNM3|DNM1
VESICLE-MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS%GOBP%GO:0098927,0.883317490494297,0.996316041142784,-0.14754610081719902,-0.6835427819419762,3716,22,EEA1|HOOK2|ANKRD27|KIF16B|FAM160A2|SNF8|HOOK3|MYO1D|SNX16|LMTK2|WDR91|AKTIP|PTPN23|WDR81|EMP2|RILP|PIK3C3|STX8|BECN1|RAB7A|RAB5A
NEGATIVE REGULATION OF GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0043002,0.35785234899328905,0.8457817541997791,0.825981473312748,1.09727953764995,2665,1,GOPC
DETECTION OF LIPOPOLYSACCHARIDE%GOBP%GO:0032497,0.705105939562348,0.968941691852291,0.44324070248593705,0.842553948254031,6089,3,SCARB1|TLR4|LY96
INTRACELLULAR TRANSPORT OF VIRAL PROTEIN IN HOST CELL%GOBP%GO:0019060,0.582920043546631,0.9439064862850342,0.573531844499587,0.9374220439931279,4818,2,DYNLT1|IFIT1
RESPONSE TO INACTIVITY%GOBP%GO:0014854,0.0991358994501178,0.570215774831708,-0.7119223557957429,-1.4448252689453402,630,3,FBXO32|HDAC4|SCN5A
"RNA PHOSPHODIESTER BOND HYDROLYSIS, EXONUCLEOLYTIC%GOBP%GO:0090503",0.24212271973466,0.7565220534116759,-0.325406896551724,-1.1854899656827,1167,12,XRN1|TOE1|EXOSC2|EXOSC3|ERI1|C19orf43|ERI3|EXOSC7|EXOSC8|PARN|EXOSC9|PDE12
POSITIVE REGULATION OF TRANSFERASE ACTIVITY%GOBP%GO:0051347,0.130769230769231,0.614025866393317,-0.12167030630501802,-1.14953373866127,33,425,MAPKAP1|IL1B|CLU|IRAK1|VEGFA|PKN1|PLCE1|MAGEA2|CACUL1|ADRA2C|ZNF16|PRKCD|MAP3K8|DAB2IP|STK26|C5AR1|TGFBR1|IRAK2|PTK2B|MRE11A|PRKAA1|ARRDC3|GDF15|PRKAG1|FGR|ABL1|MAP3K13|ATG13|DCUN1D3|RPS3|RET|FYN|RHOA|STK10|DDX3X|UBE2I|TNFRSF10A|UBE2V1|FGF2|MAP2K5|RASSF2|PRNP|EFNA1|DOCK3|CHRNA7|SLC11A1|MST1R|TCL1A|TCP1|RAB1A|PPP2CA|PRKAR2A|IGF1|DIRAS1|MAP4K4|ATP2B4|CEMIP|CRK|RIPK2|CAB39|RAP1A|PRR5|PDCD10|PTPN1|CCNYL1|SNCA|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|STK4|CCNY|ADAM17|ADRB2|CHRNA3|RAPGEF1|SHC1|UBA52|EPHA8|RELN|DKK1|PRKAR1B|UBE2L3|ZNF622|TNFRSF10B|RALB|ADCYAP1|MAPK3|OXSR1|FLT1|CDKN1A|CHI3L1|ADRA2A|COPS8|FGF10|PEA15|GREM1|STK24|ACE|MAP3K11|IGF2|UBC|MAP2K1|GPRC5B|HSP90AB1|CAMKK1|TNF|PAK2|TRIB3|UBB|ADORA2B
NEGATIVE REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:0060965,0.964271768840297,1.0,-0.17762577228596602,-0.5733919103662289,4938,9,DND1|ELAVL1|NCOR1|ZC3H12A|BCDIN3D|ZC3H10|TGFB1|NCOR2|PPARG
POSITIVE REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051496,0.181106925528832,0.686812867800089,-0.21922365781823103,-1.2271520966037,624,38,LPAR1|TGFBR1|ABL1|RHOA|NRP1|PXN|SERPINF2|RHOC|LIMK1|WNT11|CDC42|SORBS3|RAC1
INTERLEUKIN-12 SECRETION%GOBP%GO:0072610,0.745494133301077,0.9749763305090959,0.50902624513976,0.831989413911968,6162,2,CCL19|CCR7
REGULATION OF TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034155,0.690983715080101,0.96731875442989,-0.649150860167622,-0.8683888980900291,5218,1,RSAD2
ALPHA-AMINO ACID METABOLIC PROCESS%GOBP%GO:1901605,0.38456420492348603,0.8592509171259929,-0.13074251390255198,-1.03513524344753,577,139,SLC25A32|ALDH4A1|P4HB|MTRR|SDS|CBS|ASS1|SLC6A8|SMS|SDSL|SHMT2|TDO2|FPGS|GCDH|PSPH|NMNAT3|ODC1|PAH|PCBD1|DDAH2|SARS|NOS3|QDPR|ASL|GLUL|DDAH1|EGLN3|NMNAT2
LIPID A METABOLIC PROCESS%GOBP%GO:0046493,0.737587713491328,0.974306231601101,-0.626433612704014,-0.8379993435148921,5570,1,NDUFAB1
NEGATIVE REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010544,0.6237562189054731,0.9536478716552259,-0.23764687967185397,-0.8657714209877059,3008,12,THBD|CD9|NOS3
GLOMERULAR FILTRATION%GOBP%GO:0003094,0.17864438254410397,0.684586375558882,-0.410776402119698,-1.27687191288755,961,8,XPNPEP3|MCAM|SULF2
UBIQUITIN-DEPENDENT GLYCOPROTEIN ERAD PATHWAY%GOBP%GO:0097466,0.5108074812409,0.918404893008545,0.457237750997105,0.9689304719885521,4560,4,EDEM3|MAN1B1
NEGATIVE REGULATION OF PRIMARY AMINE OXIDASE ACTIVITY%GOBP%GO:1902283,0.426429101707498,0.875696962448429,-0.59929252031561,-1.02505775994549,2871,2,PARK2
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0030330",0.953928886748535,1.0,0.11742930349654401,0.6151640688215849,11884,73,BTG2|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|E2F7|RPS6KA6|GTSE1|RPS27L|CHEK2|PRMT1|CARM1|AURKA|ARID3A|PAXIP1|TNKS1BP1|CNOT3|E2F1|FOXM1|CASP2|CDK2|ATM|TFAP4|CNOT1|BRCA1|PCBP4|MDM2|CNOT2|CNOT8|TRIAP1|RBL2|ATRX|CNOT6|E2F4
INTERKINETIC NUCLEAR MIGRATION%GOBP%GO:0022027,0.22241519045965,0.7355723797115551,0.634443586632844,1.2060105172288702,1920,3,DOCK7|PCM1|HOOK3
MITOCHONDRIAL DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0097552,0.35456110154905296,0.842911430859438,-0.8218460520511691,-1.09940852170491,2677,1,MRE11A
POSITIVE REGULATION OF GROWTH HORMONE SECRETION%GOBP%GO:0060124,0.32930086410055,0.828303707528737,-0.5399434371769051,-1.0957991633264799,2095,3,ADCYAP1|DRD2
TERPENOID METABOLIC PROCESS%GOBP%GO:0006721,0.0468443914487693,0.42579032205437295,0.323131460427792,1.49806977619234,549,43,ALDH1A2|RBP1|BCO2|RARRES2|NAPEPLD|ALDH1A1|GPC2|ALDH8A1|GPC6|AKR1C1|GPC1|ALDH3A2|APOE|LRP8|GPC3|RDH11|APOM|AGRN|CYP2E1|CYP2D6
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0045747,0.679245283018868,0.9647315640607691,0.198190081173178,0.8377480526923381,7631,31,NOV|MAML1|POGLUT1|ROBO2|JAG2|TGFB2
REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000756,0.307762005436424,0.810954108517521,-0.19190624715878402,-1.1050100390150501,1018,42,BRD7|NOC2L|SPI1|FLCN|IL1B|SIN3A|WBP2|PRKAA1|LIF|CTBP1|HDAC5|ARRB1|RUVBL2|SNCA|PPARGC1A|TADA2B|MAPK3
NEUROTROPHIN PRODUCTION%GOBP%GO:0032898,0.214699331848552,0.731747191309112,-0.729032258064516,-1.2469706329490902,1445,2,PCSK6|FURIN
NLRP1 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1904784,0.13305971137296402,0.6189080538796391,-0.9314071460079398,-1.2459717375806298,1004,1,NLRP1
RENIN-ANGIOTENSIN REGULATION OF ALDOSTERONE PRODUCTION%GOBP%GO:0002018,0.570823757106568,0.9404752161333092,0.578185779345371,0.9450287726474929,4718,2,AGTR1|AGT
REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051004,0.976223226567105,1.0,0.162709106758469,0.5129172512380561,9935,12,LPL|APOC1|LMF1|APOC2|SORT1|GPIHBP1
TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019432,0.468949044585987,0.896113819860135,0.32631400753454304,0.9955092363121,4711,11,LPL|GPAM|DGAT1
MUSCLE ADAPTATION%GOBP%GO:0043500,0.298714759535655,0.8023890191280308,-0.30855079762967796,-1.12408150647549,1440,12,CAMTA2|GSN|CYBA|IL1B|HMOX1|HDAC4|CFLAR|NOS3
REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001032,0.332814930015552,0.8293509737209019,-0.25233180639108105,-1.0854753683831702,1497,18,WRAP53|NUDT16L1|RIF1|C5orf45|FAM35A|PARP9|SETMAR|WAS|AUNIP|USP51|TFIP11|SMCHD1|DTX3L|MAD2L2|C20orf196|C7orf49|HSF1|ACTR2
RESPONSE TO LITHIUM ION%GOBP%GO:0010226,0.148032665181886,0.6402258061318559,-0.768072787427626,-1.31374736754768,996,2,CDKN1B|ADCY7
INOSITOL PHOSPHORYLATION%GOBP%GO:0052746,0.566740905716407,0.9388612723386429,-0.535318444995864,-0.9156335303433791,3816,2,IPPK|ITPK1
"REGULATION OF WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0008591",0.11081689394942401,0.584830174998513,-0.942931186590207,-1.26138779803258,836,1,DKK1
REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:1904594,0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0043001,0.597573839662447,0.9492590312650558,-0.17424200585409,-0.9039731103543259,2265,30,GGA3|ANK3|RAB26|GOLGA4|MACF1|GGA2|BBS1|SEC16A|C16orf70|BBS2|VAMP5|VAMP4|GOLPH3L|RAB34|KRT18|BLZF1|RAB31|GOLPH3|SYS1|SPTBN1|NSF|ARFRP1|OPTN|GGA1|SYS1-DBNDD2|RAB10|GCC2|VAMP2|KIF13A|GOLGA7
POSITIVE REGULATION OF INTERLEUKIN-17 SECRETION%GOBP%GO:1905078,0.820468687938567,0.987153241368501,-0.587395235994707,-0.7857765167207241,6196,1,OSM
CARDIAC ATRIUM FORMATION%GOBP%GO:0003210,0.624122865086721,0.9536478716552259,-0.6809660344067049,-0.9109490267061802,4713,1,MESP1
SNORNA 3'-END PROCESSING%GOBP%GO:0031126,0.0344112769485904,0.378661234249572,-0.44963631830344203,-1.63807021056947,165,12,FBL|PARN|CPSF3|EXOSC6|EXOSC4|PAPD7|EXOSC5
EPITHELIAL TUBE FORMATION%GOBP%GO:0072175,0.635713053974823,0.95916055221954,0.194208152936608,0.875928884482691,7372,39,BMP4|PROX1|CEP290|MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C|FGFR2|DVL3|GATA3|DVL2|LRP6|SCRIB|MTHFR
MODULATION BY VIRUS OF HOST GENE EXPRESSION%GOBP%GO:0039656,0.5726382000725779,0.940734934957679,0.577502067824649,0.9439112649495269,4733,2,PABPN1|CPSF4
REGULATION OF FEEDING BEHAVIOR%GOBP%GO:0060259,0.41700404858299606,0.8709670999109399,0.36390223330042293,1.0384526368958902,4119,9,NR4A3|INS|GNB3|UCN
DICARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0043648,0.967705382436261,1.0,0.11342668022350098,0.58654675966674,11955,69,D2HGDH|FH|MRPS36|GGT1|GLS|DHFR|GLS2|MTHFD1|ME1|SDHAF3|IDH1|CPOX|SLC46A1|SUCLG1|SDHA|GGT5|ME3|NAGS|NMNAT1|MTHFD2L|QPRT|ALDH18A1|SLC19A1|PM20D2|NIT2|AADAT
POSITIVE REGULATION OF ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:1903116,0.8204237582493921,0.987153241368501,0.39536968415891105,0.7515561782564599,7085,3,RNF207|TRPM4|NOS1AP
RESPONSE TO IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052564,0.22212323682256896,0.73556947110949,-0.724786324786325,-1.23970819147439,1495,2,SLC25A6|EIF2AK2
LIPID TRANSPORT%GOBP%GO:0006869,0.5870761451516949,0.945418171231938,0.15890704606099,0.9349453296003201,7894,137,ABCC3|STAR|GHRL|ATP10A|NME4|SLC27A2|CEACAM1|ATP11C|SLMO1|STARD10|ABCA10|MFSD2A|ABCA7|ABCA5|ABCB4|SCARB1|ABCA9|EPRS|ATP10D|ABCA6|STARD5|LIMA1|SOAT1|AKR1C1|CETP|OSBPL5|ABCA2|LDLRAP1|CPT1B|APOE|ATP8B3|ACACA|PRELID2
MITOTIC CHROMOSOME CONDENSATION%GOBP%GO:0007076,0.053206002728513,0.44956357713617495,0.460615100369889,1.5261609668582299,545,14,NCAPD3|SMC2|NUSAP1|AKAP8L|NIPBL|CDCA5|NCAPG|NCAPH|SMC4
TRYPTOPHANYL-TRNA AMINOACYLATION%GOBP%GO:0006436,0.912543849038345,1.0,0.427032183310223,0.697972372360235,7543,2,WARS2
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904747,0.24021995286724304,0.7525035503527309,-0.5872433622079101,-1.1917929558344198,1528,3,NOTCH1|TNFRSF1B
POSITIVE REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051574,0.23915885813902804,0.75206086335821,0.524652547981469,1.2092463478158302,2194,5,SIRT1|JARID2|RIF1|ZNF304|MYB
POSITIVE REGULATION OF T CELL CHEMOTAXIS%GOBP%GO:0010820,0.213177513600645,0.7285251346967141,0.42199658512220395,1.24542094615476,2115,10,CXCL13|STK39|XCL2|CCL21|CCL5
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:0044338,0.118782479584261,0.602329212916938,-0.7907361455748549,-1.3525118278867,799,2,FZD1|WNT3
CELL KILLING%GOBP%GO:0001906,0.9561869357408391,1.0,-0.11716223758359101,-0.616101689936436,3600,31,GZMB|ROMO1|ULBP3|VAMP2|GAPDH|ULBP2|CTSH|TUBB4B
REPLICATION FORK PROTECTION%GOBP%GO:0048478,0.0186128730373297,0.285944146912076,0.618591901005457,1.68644748013838,178,8,FBXO18|BLM|DONSON|ZNF830|TIMELESS|ZRANB3
KIDNEY MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0072135,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
REGULATION OF PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:1902528,0.510467706013363,0.918404893008545,-0.558484254312792,-0.9552574064985971,3437,2,PARK2
PROTEIN LOCALIZATION TO NUCLEAR PORE%GOBP%GO:0090204,0.0428968621739706,0.40875427759673605,-0.97788928098809,-1.30815230677199,323,1,NUTF2
CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098703,0.602126288659794,0.9508825506493929,0.36109129131999795,0.888051443121261,5606,6,CACNA2D1|TRPV1|FAM155B|TRPM2|FAM155A
MAINTENANCE OF GASTROINTESTINAL EPITHELIUM%GOBP%GO:0030277,0.961865330137285,1.0,0.24112865203171802,0.555765797659687,8827,5,SERPINA3|PBLD|TLR4
7-METHYLGUANOSINE RNA CAPPING%GOBP%GO:0009452,0.753056234718827,0.9769690538700708,-0.152817580111341,-0.809030112888478,2771,32,POLR2A|POLR2K|POLR2F|NCBP2|POLR2I|POLR2D
PHOSPHOLIPASE C-ACTIVATING ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0086097,0.0268537558969396,0.339762187668294,0.893024538185829,1.4596240748455602,221,2,ACTN2|AGTR1
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050906,0.0788629069234296,0.532203813468543,0.36546246339335203,1.43827671749857,859,24,SCN1A|RTP5|PIEZO2|TAS2R4|ADGRV1|DFNB31|RTP4|PDZD7|KIT|TAS2R5|TAS2R20|CNGB1|REEP6|COL11A1|TAS2R14|MMP24|TAS2R19
PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009137,0.49339272457312605,0.910654969509744,-0.5652562806304671,-0.9668405948284491,3322,2,NUDT18
ANTIBIOTIC METABOLIC PROCESS%GOBP%GO:0016999,0.448563927122285,0.88526084286089,0.19145184994345102,1.01451168723846,5637,77,DPEP1|FH|AKR1B1|CBR4|ALDH1A1|HBB|HBA2|NNT|ADH1B|PRDX4|SULT1A3|DUOX1|AKR1C1|AMDHD2|PRDX3|HBA1|PDHA1|SUCLG1|ACSS1|SDHA|ACO1|ME3|DHTKD1
POSITIVE REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060545,0.339663723236966,0.8330383695817521,0.6692583402260821,1.09388437149741,2807,2,RIPK1|RIPK3
CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055017,0.92462767889575,1.0,-0.215085535055173,-0.627414048233161,5090,7,S1PR1
DNA STRAND ELONGATION INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1902983,0.64,0.96058002537611,0.684880899867667,0.909833720771033,4767,1,GINS1
REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031113,0.5293247476505399,0.9265056012720759,0.21402126426599105,0.9515604546184491,6082,37,AKAP9|NAV3|CLIP1|CAMSAP3|PSRC1|NUMA1|CDK5R1|CDK5RAP2|STMN1|FAM179B|CAMSAP2|TBCD|TUBB4A|PRUNE
REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030834,0.26076138342871397,0.771967970256231,-0.23598368605967202,-1.1448209085086798,1047,25,GSN|CAPZB|PLEK|TRIOBP|CAPZA2|RLTPR|ADD1|CFL2|WDR1|TWF1|MTPN|TWF2|SH3BP1
"REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:1902162",0.6599851521900519,0.9643779777660141,-0.498152743314034,-0.852063588084269,4444,2,RPL26|ZNF385A
POSITIVE REGULATION OF OXYGEN METABOLIC PROCESS%GOBP%GO:2000376,0.8143624161073829,0.986276922067025,0.593956771063079,0.7890450720671099,6066,1,LIPT2
BENZENE METABOLIC PROCESS%GOBP%GO:0018910,0.671006711409396,0.964618776001639,0.669166299073666,0.888957574694248,4998,1,CYP2E1
ACTIN FILAMENT BUNDLE DISTRIBUTION%GOBP%GO:0070650,0.45610738255033595,0.88900512246363,0.7772937803264229,1.0326001096296,3397,1,SHTN1
NEGATIVE REGULATION OF CELL-CELL ADHESION BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900387,0.480206540447504,0.9046812288131709,-0.7588773709748571,-1.01517339713013,3626,1,SNAI2
U1 SNRNA 3'-END PROCESSING%GOBP%GO:0034473,0.11547525530243499,0.593539945084925,-0.694441380831587,-1.40934814963816,734,3,EXOSC7|EXOSC8|EXOSC9
POSITIVE REGULATION OF HOMOPHILIC CELL ADHESION%GOBP%GO:1903387,0.646895273401298,0.96344123684964,-0.6709307454786059,-0.897524514733668,4885,1,PTPN23
REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905915,0.969896954961213,1.0,0.292743860652271,0.556475283601744,8376,3,FGF9|DNMT1
PARTURITION%GOBP%GO:0007567,0.10105448154657301,0.571491553833428,-0.522705237498745,-1.434790779844,574,6,PTGFR|CRHR1|MAFF|CRH
VESICLE BUDDING FROM MEMBRANE%GOBP%GO:0006900,0.9987107864202841,1.0,-0.0690146020541497,-0.48526213498900705,2323,85,PPP6C|CHMP4A|CTSZ|CUL3|SAR1A|RILP|CSNK1D|GOSR2|TRAPPC1|SNX3|S100A10|PPP6R1|TMED10|SEC13|PICALM|DNM2|VPS4A|TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|VAPB|ANKRD28
METANEPHRIC ASCENDING THIN LIMB DEVELOPMENT%GOBP%GO:0072218,0.299262126527156,0.8023890191280308,0.68727731268848,1.1233358869770702,2473,2,PKD2|PKD1
PROSTANOID METABOLIC PROCESS%GOBP%GO:0006692,0.8372243839169909,0.9889652677625541,0.18481208128190302,0.70778740060404,9036,22,EDN1|MGST1
GLYCOSPHINGOLIPID CATABOLIC PROCESS%GOBP%GO:0046479,0.14384308027606302,0.6340340930337739,-0.459183673469388,-1.33945914763678,791,7,NEU3|GALC|GLA|NAGA|NEU1|GBA|NEU4
PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:0051603,0.788899430740038,0.9819233677232551,0.128442112082961,0.864223804188222,11640,438,SIRT1|ENC1|HACE1|OMA1|FBXO18|SDF2|ARNTL|UBR4|SPSB4|SIAH2|TRIM9|BRSK2|TRIM3|ANAPC15|CLPP|CCNB1|SGTA|IDE|CDC34|CDK1|BTRC|KIF14|PSMD11|LONP1|ANAPC5|RNF34|KLHL42|UBE2Z|PCYOX1L|PSMD13|PSMB9|MTA1|KLHL3|POMT2|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|FBXL19|RNF126|USP13|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|GZMA|NGLY1|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|AUP1|HDAC6|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|PLK1|CUL4B|TSG101|BIRC2|HERC2|KEAP1|CTSC|MAN1B1|ZRANB1|UBXN4|VPS37A|HERPUD1|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|RNF123|ANKZF1|PSMC6|ANAPC10|BAG6|GET4|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FAP|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|FBXO44|UBA6|KCTD2|FBXO11|MDM2|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|CBL
DETECTION OF CARBOHYDRATE STIMULUS%GOBP%GO:0009730,0.966372323696625,1.0,0.368113385361802,0.6016712157076031,7988,2,GCK
NEGATIVE REGULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052199,0.8685968819599108,0.993084774742015,-0.405128205128205,-0.6929500975929959,5849,2,PTX3|CASP8
UROPORPHYRINOGEN III METABOLIC PROCESS%GOBP%GO:0046502,0.591387444054675,0.945418171231938,0.5704438930245379,0.932374872138151,4888,2,UROS|SUCLA2
CELLULAR POTASSIUM ION TRANSPORT%GOBP%GO:0071804,0.00129073894804776,0.0945022140486112,0.366901770034059,1.9046416128792,15,70,KCNK2|KCNN2|KCNK6|KCNH8|KCNT2|SLC12A2|KCNH3|KCNK3|HCN2|KCNQ1|SLC9A5|SLC9A7|ATP1B3|KCNH1|LRRC55|PKD2|KCNC3|KCNC1|KCND1|KCNB2|HCN3|KCNJ11|KCNH2
POSITIVE REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902715,0.43733900772762896,0.878651088001772,0.483806047338622,1.02523122987212,3904,4,CD2|PTPN22|RASGRP1
SPINDLE DISASSEMBLY%GOBP%GO:0051230,0.8607717430748759,0.9916689277956879,0.457347670250896,0.7475222029496209,7115,2,VCP|SPAST
"MITOCHONDRIAL ELECTRON TRANSPORT, CYTOCHROME C TO OXYGEN%GOBP%GO:0006123",0.763021373728989,0.978421368343614,-0.206407180012452,-0.7773254945834699,3676,13,COX5B|COX4I1|COX10|COX4I2
REGULATION OF INTERMEDIATE FILAMENT DEPOLYMERIZATION%GOBP%GO:0030842,0.37097841917119007,0.852609194081082,-0.8125275694750771,-1.08694290344472,2801,1,NES
POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0032825,0.7817529234687971,0.981487311948134,0.412217044533228,0.7835812380522479,6751,3,ZBTB1|AXL|GAS6
7-METHYLGUANOSINE CAP HYPERMETHYLATION%GOBP%GO:0036261,0.6456375838926179,0.962932639305263,0.6825099250110279,0.9066839864506758,4809,1,TGS1
CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098704,0.998676022772408,1.0,-0.5009373621526251,-0.670119182803696,7542,1,SLC2A5
REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000083,0.215497478221,0.732222760939264,0.312263613843048,1.22891276259204,2349,24,CCNA1|DHFR|ORC1|CDC45|E2F7|CCNE1|FBXO5|RB1|CDC6|E2F1|TYMS|RRM2
RIBOSOMAL LARGE SUBUNIT BIOGENESIS%GOBP%GO:0042273,0.007720588235294121,0.198167223413272,-0.247295674616677,-1.62696020815068,20,66,SDAD1|RPL12|URB1|WDR12|PES1|RPF2|RPL35|RPL7|RSL24D1|RPL14|ZNHIT6|AAMP|NHP2L1|GLTSCR2|RSL1D1|PPAN|RPL35A|NPM1|DDX28|EBNA1BP2|NHP2|RRS1|MRTO4|NOL9|ZNF622|NIP7|RPF1
NEGATIVE REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046606,0.0688402239025827,0.5040280242137971,0.458838559320266,1.48084258190783,700,13,KIF25|KAT2A|NEK2|CDK5RAP2|TRIM37|CCNF|MDM1|TMEM67|BRCA1|KAT2B
POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045542,0.0925373134328358,0.5622489437340121,-0.717933164221904,-1.4570240260572698,588,3,FGF1|PRKAA1|ABCG1
CELLULAR RESPONSE TO CAMP%GOBP%GO:0071320,0.0454629973968018,0.4190278528102411,0.409365548937276,1.5476199692239299,488,21,AKAP9|CRHBP|HCN2|KCNQ1|PKD2|PDE2A|HCN3|IGFBP5
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002707,0.912843029637761,1.0,-0.16053743235481502,-0.657454740594309,4157,16,XCL1|NDFIP1|MICA|FOXP3|PTPRC|HFE|LILRB1|HLA-E|FOXJ1|SERPINB9|LGALS9|ARRB2|FCGR2B|SMAD7
POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030854,0.711775043936731,0.970341332123494,-0.29081915749500103,-0.798279060245363,4049,6,TESC|HAX1|RUNX1
FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX%GOBP%GO:0001732,0.127763802462598,0.6076669536424699,-0.9337781208645791,-1.24914346293677,964,1,EIF3A
REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090231,0.00633404794387059,0.17992824699561,0.561298204299322,1.85975537814835,64,14,ANAPC15|CCNB1|TPR|XRCC3|USP44|GEN1|NDC80|CDK5RAP2
MULTI-ORGANISM CELLULAR PROCESS%GOBP%GO:0044764,0.940489050378081,1.0,0.17838225557272103,0.575705843685366,9576,13,CXCR4|CCR5|HYAL2|DDX58|IFIH1|IRF7|IRF3|PPIA|CD4|GAS6|SLC22A5|PVRL2|ROMO1
RAN PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0031291,0.9528672427336999,1.0,-0.29265103173283397,-0.5939265738577769,6064,3,KPNB1|RANGRF
NEGATIVE REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106057,0.13178445919562698,0.6161723401295239,-0.418378464846251,-1.3505631763169301,674,9,PRNP|CHP1|ATP2B4|HOMER2
NEGATIVE REGULATION OF MYOBLAST FUSION%GOBP%GO:1901740,0.12379187077982301,0.607607158836689,-0.936645346272607,-1.2529790377860601,934,1,CFLAR
RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009191,0.43372303639058096,0.878651088001772,-0.43649699443004497,-1.00385189977286,2633,4,NUDT5|NUDT16|ENTPD4|NUDT18
T-CIRCLE FORMATION%GOBP%GO:0090656,0.0446060129691491,0.41504430757275895,0.497074388762308,1.5669561109647598,453,12,XRCC3|BLM|EXO1|DNA2|SLX1B|SLX4
NEGATIVE REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000415,0.980536912751678,1.0,0.511799735333039,0.6799031153849711,7304,1,BCOR
"REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032225",0.606870937790158,0.9508825506493929,-0.28074825009001897,-0.8726878011551759,3267,8,FLOT1|CHRNB2|SNCA|DRD2
POSITIVE REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051571,0.44829617990768894,0.8850378987593649,0.31370534761436103,1.01244376150021,4564,13,WDR61|DNMT3B|PAXIP1|BRCA1|DNMT1|SNW1|MYB|KMT2E|AUTS2|CTR9
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007193,0.212690951821387,0.7279184739702909,-0.21219188047535698,-1.19724114550517,723,39,ADCY7|OXER1|LPAR1|MARCO|GNAI2|PSAP|GNAL|HTR1B|HRH3|ADCY2|DRD2|MCHR1|ADRA2A|CHRM1|GRM8
MONONUCLEAR CELL MIGRATION%GOBP%GO:0071674,0.7331241595696999,0.973373390498726,0.19305926888226396,0.79971650307814,8177,29,CD47|PTPRO|XCL2|CCL21|CCL5|CCL19|RPS19|CCL2|AMICA1|CCL3L3|CCL11
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002702,0.0356257744733581,0.3821688062173221,-0.257018904337524,-1.4981922993965302,114,44,GPI|C20orf196|BCL10|SEMA7A|IL6|VAMP3|MAVS|KARS|TFRC|NLRP3|B2M|TNFRSF4|TICAM1|GPRC5B
REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014066,0.320626853028378,0.822183858873702,-0.154829529464169,-1.07940220450297,756,82,AGT|MYDGF|PIK3CD|FBXL2|PIK3R5|GPER1|STAMBP|PTPN6|HAX1|KDR|DAB2IP|FGR|PPP2R5C|HGF|UNC5B|LYN|GLTSCR2|PIK3IP1|PIP4K2A|IGF1|BECN1|FGFR1|NEDD4|MAPK3|FLT1|SLC9A3R1|TWIST1|PIK3R1|TNF
MITOCHONDRIAL MEMBRANE FUSION%GOBP%GO:1990613,0.8513366396516271,0.991298302704726,0.46224303642661996,0.7555235444802659,7037,2,MFN1|WBSCR16
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0045762,0.12457044673539501,0.607607158836689,0.5554715702183821,1.3661014303114798,1159,6,AKAP5|CACNA1D|NF1
TUBE FORMATION%GOBP%GO:0035148,0.747902008985335,0.9749763305090959,0.169030074991407,0.797615279388883,8822,46,SDCCAG8|BMP4|PROX1|CEP290|MTHFD1|DVL1|DEAF1|TGFB2|STIL|VANGL2|PLXNB2|SEMA4C
REGULATION OF ODONTOGENESIS%GOBP%GO:0042481,0.657332752233602,0.9643779777660141,0.368525361692695,0.8493963279487181,6032,5,ASPN
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045621,0.6430577223088921,0.9621972042482541,-0.14986372220632,-0.8862673195225009,2060,46,ZBTB1|IL7|CCL19|IL12RB1|TESPA1|SOCS1|CD46|ZAP70|BTK|GATA3|NFKBID|ANXA1|ZMIZ1|XBP1|MYB|FOXP3|PRKCZ|NCKAP1L|LILRB2|ADAM8|PPP2R3C|MMP14|SYK|MALT1|ZBTB7B|AXL|LILRB4|TGFBR2|NFKBIZ|IL18|SART1|GAS6|C10orf54|RUNX3|CD86|RARA|LGALS9|RUNX1|PNP|NLRP3|SOCS5|BCL6|NKAP|DUSP10|CBFB
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0032208,0.4120217132265329,0.867015886388254,-0.7927878253198059,-1.06053644582846,3111,1,TERF2
POSITIVE REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902568,0.604088544816741,0.9508825506493929,0.5649361283526679,0.923372582089127,4993,2,F2RL1|STX4
INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION%GOBP%GO:0042491,0.10088458298230801,0.5713242454960451,0.544031832058858,1.41600055769777,957,7,STRC|DFNB31|JAG2|PDZD7
MESODERMAL CELL DIFFERENTIATION%GOBP%GO:0048333,0.172267206477733,0.6757264818753511,0.45376907605692207,1.29490190070942,1701,9,ITGB1|BMP4|ITGA2|ITGA3|ITGA8|KLF4|KDM6B
MEGAKARYOCYTE DEVELOPMENT%GOBP%GO:0035855,0.430705105939562,0.8785877309899279,0.542497303032105,1.0312303044898399,3719,3,MED1|KIT
GLUTATHIONE DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901687,0.447202596906626,0.88473565970262,0.286809047940881,1.01153409326857,4683,17,MGST1|GSTA4|GSTO2|MGST3|GSTP1|MGST2|GSTZ1|AKR1A1
INTERLEUKIN-35-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070757,0.956882591093117,1.0,0.192452752203633,0.549194398152382,9453,9,JAK2|EBI3
NEGATIVE REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033004,0.410017574692443,0.867015886388254,-0.369367381832221,-1.01388866192346,2332,6,MILR1|FER|CD300A|CD84|LGALS9|CD300LF
REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS%GOBP%GO:0110089,0.37640672580431606,0.853374872190571,-0.809605205116895,-1.0830335675406402,2842,1,CX3CL1
POSITIVE REGULATION OF GUANYLATE CYCLASE ACTIVITY%GOBP%GO:0031284,0.00549368968077209,0.170696050287554,-0.9505376344086022,-1.6258437161165202,36,2,NOS3|GUCA1A
"FARNESYL DIPHOSPHATE BIOSYNTHETIC PROCESS, MEVALONATE PATHWAY%GOBP%GO:0010142",0.9267114093959731,1.0,0.539589766210851,0.71682093160497,6903,1,HMGCS1
AUDITORY RECEPTOR CELL MORPHOGENESIS%GOBP%GO:0002093,0.0418859894725053,0.402998391331252,0.714961286984638,1.515071263781,373,4,STRC|DFNB31|PDZD7
PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009135,0.00474683544303798,0.159787349002354,-0.367903558551818,-1.90869545207721,17,30,PFKL|GPI|PKM|ENO1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
CELLULAR RESPONSE TO NITRIC OXIDE%GOBP%GO:0071732,0.9018470790378009,0.9995642802800841,0.260100823887022,0.6396800963144879,8397,6,DPEP1|MTR
REGULATION OF NATURAL KILLER CELL CYTOKINE PRODUCTION%GOBP%GO:0002727,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
POSITIVE REGULATION OF 3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:1905870,0.0145637495035085,0.262734483145539,-0.993162770180856,-1.3285841189499399,109,1,RBM24
CELL-CELL RECOGNITION%GOBP%GO:0009988,0.137083560895685,0.62388141596544,0.33132122949321097,1.33207004336709,1505,26,PCDHA7|CATSPERG|PCDHB6|CD209|OVGP1|PCSK4|CCL21|ZP3|CORO1A|CCL19|PRF1
MAINTENANCE OF MITOCHONDRION LOCATION%GOBP%GO:0051659,0.21865771812080498,0.7341474817293291,0.891982796647552,1.1849593511724499,1628,1,ATP2A1
NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001205,0.829917795530856,0.9879179006160809,0.39046591096780603,0.742234621277747,7167,3,FBN1|LILRB1
EMBRYONIC SKELETAL JOINT DEVELOPMENT%GOBP%GO:0072498,0.369654441943599,0.852268858837246,-0.8137406263784741,-1.0885656466501898,2791,1,CTNNB1
PROTEIN UFMYLATION%GOBP%GO:0071569,0.707205623901582,0.9695156155378671,-0.29226187193205,-0.802239214503873,4023,6,CDK5RAP3|UFL1|UBA5|UFM1|UFC1|DDRGK1
SEGMENT SPECIFICATION%GOBP%GO:0007379,0.9538942861847521,1.0,-0.254094781102799,-0.5843649142773051,5792,4,COBL
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002705,0.925,1.0,-0.108184383819379,-0.7117459207091209,2515,66,KLRK1|CD1E|SLAMF6|MAP3K7|F2RL1|ZP3|ZBTB1|IL12RB1|NCR3|CD1D|PAXIP1|RIF1|TRAF2|RASGRP1|HLA-F|FAM35A|IL1R1|XCL1|TP53BP1|HSPD1|DDX58|FADD|MICA|HLA-C|PRKCZ|VAMP7|STX7|CADM1|HFE|STX4|SNX4|SYK|MICB|CLCF1|HLA-B|MALT1|PVR|HLA-A|HLA-E|RSAD2|FZD5|IL18|VAMP8|TGFB1|ITGB2|CD1C|MAD2L2|AP1G1|TRAF6|TNFSF13|PVRL2|IL1B|FAM49B|ITGAM|LAMP1|FGR|ULBP3|C20orf196|IL6|MAVS|TFRC|ULBP2|NLRP3|GAB2|B2M|TICAM1
ANTIBIOTIC CATABOLIC PROCESS%GOBP%GO:0017001,0.40014439130042406,0.8638522656500329,0.258160401985156,1.0495541539686801,4433,27,HBB|HBA2|PRDX4|SULT1A3|AMDHD2|PRDX3|HBA1|CAT|HBQ1|PCK2|GPX3|PRDX2|PXDN|AKR1C3|NPL|PRDX6|PRDX5|RENBP|PXDNL|GNPDA1|GNPDA2
THROMBOPOIETIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038163,0.11581291759465501,0.5947217762124271,-0.7935653959985649,-1.3573511092114898,779,2,RBM15
PROTEIN DEMANNOSYLATION%GOBP%GO:0036507,0.818139963167588,0.987153241368501,-0.166544248433671,-0.743104696461972,3553,20,MAN1A2|RNF185|EDEM2|DERL2|RNF5|EDEM1|UGGT1|TRIM13|OS9|RNF139|AMFR|RNF103
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:0014898,0.914100123194087,1.0,0.300610484309057,0.6370223320605171,8161,4,TCAP|INPP5F
REGULATION OF CYTOKINE ACTIVITY%GOBP%GO:0060300,0.301204819277108,0.804106030578379,-0.850187472430525,-1.13732170386904,2274,1,NRP1
REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000615,0.3691883372734439,0.852268858837246,-0.31191040988580604,-1.05523960338899,1873,10,CHEK1|CAMK1|BRCA1|PIH1D1|RAPGEF3|ZNF451|SMARCB1|KMT2A|SMAD4|HDAC5
REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033003,0.269953624603368,0.7846089815823771,-0.23873449487531898,-1.14436472558088,1105,24,FES|PLSCR1|CD84|PVRL2|LGALS9|CD300LF|FGR|LYN|VAMP2|VAMP3|SNX6|GAB2
ENDOCARDIAL CUSHION CELL DEVELOPMENT%GOBP%GO:0061444,0.7998657718120809,0.9839175016931591,0.6013453903837671,0.7988605232049659,5958,1,JAG1
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0043255,0.8748843079511991,0.9937342763776691,0.14539721794717803,0.695435440260859,10397,49,INS|OGT|C1QTNF3|FAM132A|CLK2|SDHAF3|PTH1R|PGP|PASK|GCK|SUPT20H|CLTC|IRS1|AKT2|VIMP|P2RY6
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048010,0.000364564345607,0.0784645998831315,-0.327254202019712,-2.13208269842577,0,64,MAPKAPK3|NCF2|CYBA|SH2D2A|PIK3R2|NCK2|HSPB1|VEGFA|KDR|DAB2IP|ABI1|BCAR1|PTK2B|PRKD2|VAV1|CYFIP2|FYN|RHOA|NRP1|PXN|CRK|VAV3|VAV2|CDC42|SHB|FLT1|RAC1|BRK1|PGF|PIK3R1|PAK2
HISTONE H3-S28 PHOSPHORYLATION%GOBP%GO:0043988,0.416116707189997,0.8709670999109399,0.54818397466613,1.04204006905072,3593,3,AURKB|RPS6KA4|RPS6KA5
ARACHIDONATE TRANSPORT%GOBP%GO:1903963,0.0644991212653779,0.495456803258629,-0.559531822544421,-1.53587728307002,366,6,DRD2|BDKRB2|ACE
NEGATIVE REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031947,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
REGULATION OF IP-10 PRODUCTION%GOBP%GO:0071658,0.209056004236727,0.7243363294845151,-0.8939126599029559,-1.1958142203207,1578,1,MAVS
POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902047,0.7891275167785241,0.9819233677232551,0.6070247022496689,0.8064052356467521,5878,1,ATP13A2
NAD SALVAGE%GOBP%GO:0034355,0.19369127516778498,0.7046839209256791,0.9052712836347601,1.2026125132935201,1442,1,NAPRT
REGULATION OF TYPE IV HYPERSENSITIVITY%GOBP%GO:0001807,0.36187919463087204,0.848418604328854,0.8247684164093522,1.0956680456721,2695,1,ZP3
CARDIAC CELL FATE DETERMINATION%GOBP%GO:0060913,0.285938727415554,0.7952025633465971,-0.5606842145692591,-1.1378919548087099,1819,3,SOX17
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002577,0.9393548387096771,1.0,-0.156494868116102,-0.624115515138287,4367,15,CCL21|CCL19|THBS1|HLA-DOB|WAS|LILRB2|HFE|HLA-DOA|CCR7|TREM2|PYCARD|NOD1|TAPBPL|FCGR2B|SLC11A1
HISTONE DEMETHYLATION%GOBP%GO:0016577,0.8016513417151441,0.9841161968820359,0.19808407537367,0.73558506571272,8543,20,KDM5D|C14orf169|KDM5B|KDM4B|KDM1A|KDM3B|KDM8|KDM4A
NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900060,0.9841923266919151,1.0,-0.227430651298737,-0.523042986059796,5976,4,ORMDL1|ORMDL2|ORMDL3|PRKAA1
PROXIMAL/DISTAL AXIS SPECIFICATION%GOBP%GO:0009946,0.0271140939597315,0.339785941813865,0.9866012351124829,1.3106557254453,201,1,SIX3
PLATELET-DERIVED GROWTH FACTOR RECEPTOR-ALPHA SIGNALING PATHWAY%GOBP%GO:0035790,0.9346308724832221,1.0,0.5355646228495811,0.711473708223898,6962,1,PDGFRA
REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901861,0.12288266091777,0.607607158836689,-0.219226721989434,-1.28843101512051,398,45,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|TGFBR1|AKIRIN1|FGF2|IGF1|UQCC2|SOX6|MTPN|TBX20|DKK1|GREM1|NR1D2|RBM24|RBPJ
PHYTOSTEROID METABOLIC PROCESS%GOBP%GO:0016128,0.24785290915688898,0.7605506815911129,0.710449407223601,1.1612100389200501,2048,2,C14orf1|DHCR7
METAL INCORPORATION INTO METALLO-MOLYBDOPTERIN COMPLEX%GOBP%GO:0042040,0.041744966442952995,0.402998391331252,0.9785509483899429,1.29996127868316,310,1,GPHN
OLFACTORY LOBE DEVELOPMENT%GOBP%GO:0021988,0.55,0.931359181171847,0.324403202399672,0.925735898606859,5433,9,SLIT1|KIF14|ROBO2
NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0010700,0.0978470675575353,0.570215774831708,-0.81053212020954,-1.3863717822947401,658,2,ADRA2C|ADRA2A
FEMALE SEX DIFFERENTIATION%GOBP%GO:0046660,0.315765725115062,0.817022961971678,0.275358819239514,1.11947452181826,3498,27,TBX3|INHA|EIF2B5|ROBO2|ZNF830|KIT|BMPR1B|EIF2B4|FANCF|NUP107|BRCA2|CEBPB
RESPONSE TO CHOLESTEROL%GOBP%GO:0070723,0.9498924731182801,1.0,-0.152190707427436,-0.606950137782579,4416,15,CCR5|GRAMD1B|ABCA2|LRP6|PTCH1|GPLD1|OSBPL7|GRAMD1A|SMO|TGFBR2|CCL3|TGFB1|TGFBR1|SMAD2|PMVK
ADULT FEEDING BEHAVIOR%GOBP%GO:0008343,0.00590482806530045,0.17556527394872698,0.879728686445351,1.6722716889484701,50,3,CARTPT|GHRL|NPY
POSITIVE REGULATION OF INTERLEUKIN-1 BIOSYNTHETIC PROCESS%GOBP%GO:0045362,0.331680174186525,0.8293509737209019,0.6735042735042739,1.10082423279801,2741,2,AZU1|EGR1
CONVERSION OF DS SIRNA TO SS SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0033168,0.543758389261745,0.929698169790548,0.7309770621967359,0.9710704159296021,4050,1,DICER1
POSITIVE REGULATION OF LEUKOTRIENE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0035491,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048486,0.9092798812175201,1.0,-0.38125172318720707,-0.6521106539754971,6123,2,PHOX2B|TBX1
CARDIOGENIC PLATE MORPHOGENESIS%GOBP%GO:0003142,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:2000036,0.512753036437247,0.9189160303470669,0.335678958351086,0.957913053428202,5065,9,LOXL2|ELAVL1|CNOT3|CNOT1|NCOA3|CNOT2|ZNF706
DNA DEMETHYLATION%GOBP%GO:0080111,0.704443578249854,0.968941691852291,0.243371476884108,0.8063653322891501,7228,14,TDG|ALKBH3|ALKBH1|FTO|TET2|APOBEC3D|APOBEC3C|TET1
REGULATION OF ENDOSOME SIZE%GOBP%GO:0051036,0.546016483516484,0.930420772651609,-0.361736157070373,-0.9157110611072511,3179,5,SNF8|ALS2|RILP|RAB11A|RAB5A
HETEROCHROMATIN MAINTENANCE%GOBP%GO:0070829,0.816375838926174,0.9866358717238399,0.592853992059991,0.7875800793599671,6081,1,MTHFR
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034763,0.00462140063988624,0.15878634024306199,-0.274648115555924,-1.75678499781066,12,60,CAMK2D|SRI|HECW2|PPIF|IL1B|NEDD4L|KCNE3|FKBP1B|CRHR1|KCNE4|SESTD1|PLN|INPP5K|SLC30A1|KCNAB1|MMP9|SUMO1|BIN1|CAB39|FMR1|GNB5|NEDD4|COMMD1|YWHAE|ADRA2A|PEA15|CAV1|FKBP1A|EPHB2
CELLULAR RESPONSE TO KETONE%GOBP%GO:1901655,0.511339662447257,0.918404893008545,-0.18362864384775304,-0.9526712890817199,1938,30,MSN|NR3C1|KLF9|ADCY2|AQP1
NEGATIVE REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903300,0.6809205642167779,0.9650599455707372,-0.489153135505649,-0.8366702409161909,4585,2,PARK2
REGULATION OF FIBRINOLYSIS%GOBP%GO:0051917,0.6510346261828011,0.9638156637515591,0.313549110437315,0.854818995103488,6260,8,F12|KLKB1|FAP|THBS1|SERPINE1
CARBOHYDRATE MEDIATED SIGNALING%GOBP%GO:0009756,0.349087243812297,0.842847021021096,0.516277766520152,1.09404190467802,3116,4,AGER|ADCY8
LIPID MODIFICATION%GOBP%GO:0030258,0.5697630969284809,0.940264810428163,0.162379870375615,0.945540152989806,7623,127,CROT|CYP2C8|SLC27A2|ETFDH|HSD17B4|ACADVL|CYP3A5|BDH2|CISH|ETFA|PPAP2C|EFR3B|DECR2|B3GALT1|PIK3R3|SOCS2|AMACR|ACADM|SOAT1|DECR1|PPAPDC2|ALDH3A2|HADH|ETFB|ACOX2|ECHDC2|EHHADH|ADIPOR2|ACAD11|ACAD10|IVD|ST3GAL4|DGKE|SOCS1|TTC7A|DGKZ|ECI1|SOCS7|ECI2|MTMR1|HADHB|ACAT2|LCAT|HIBCH|PPAPDC1B|ACADS|ECHS1|ACOX3|SLA2|ACAA1|PIK3C2B|INPP5F|PEX2|OCRL|PIK3C2A|CRAT|MTMR6|IP6K2|FAM126A|PPAP2A|DGKA|MECR
DEVELOPMENTAL GROWTH%GOBP%GO:0048589,0.00719424460431655,0.190935712968087,-0.218698962106276,-1.5968881325014401,14,99,PRMT2|SCARA3|DLL1|COL14A1|NLGN4X|CDK5|COL6A2|VWA1|NOTCH1|STRA6|IMPACT|CTNNB1|AKIRIN1|SEMA3F|FGF7|NRP1|EYS|PSAP|EVC|COL6A1|APOD|PTK7|IGF1|ZPR1|LEPR|ALCAM|COMP|COL21A1|FLRT1|CFLAR|COBL|ARIH2|FGF10|GNAS|S1PR1|SEMA3A|HSP90AB1|TMEM108|STC1|SLIT3
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902339,0.24021995286724304,0.7525035503527309,-0.5872433622079101,-1.1917929558344198,1528,3,NOTCH1|TNFRSF1B
REGULATION OF TUBE SIZE%GOBP%GO:0035150,0.0127013630731103,0.24430577683365803,-0.28625935531754104,-1.66863819948337,40,44,TBXA2R|AGT|GCLC|GPER1|SOD1|HMOX1|ADRA1B|DOCK5|VIP|SOD2|SERPINF2|EDNRA|ADRB2|NOS3|ADCYAP1|BDKRB2|PER2|ACE|ADM|CAV1
CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING%GOBP%GO:0002248,0.499942109528772,0.9143688619793578,0.516605890646455,0.9820134532190681,4317,3,F2R|TGFB1|HIF1A
AVOIDANCE OF HOST DEFENSES%GOBP%GO:0044413,0.137313432835821,0.62388141596544,-0.6736517039814711,-1.3671561181592802,873,3,TGFB1|SMAD3|EIF2AK2
POSITIVE REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051795,0.522197475872309,0.9251240799994541,-0.55376854133615,-0.9471914320094821,3516,2,GAL
ALVEOLAR PRIMARY SEPTUM DEVELOPMENT%GOBP%GO:0061143,0.418641599364491,0.871698849372662,-0.789369210410234,-1.05596326043123,3161,1,STRA6
REGULATION OF RNA SPLICING%GOBP%GO:0043484,0.798792141273603,0.983870923215532,0.139937028915905,0.793804710405668,10448,111,RBM20|CELF5|FASTK|SFSWAP|CELF1|RBM4B|ERN1|ZNF326|RBM25|CLK4|SART3|CLK2|DAZAP1|SRSF1|DDX17|RBFOX1|CIRBP|SRPK1|TIA1|SRSF6|SON|SRSF2|HNRNPH1|TRA2A|THRAP3|AKAP17A|RBM5|SRRM4|MBNL3|CLK1|DDX5|RBFOX2|RBM4|YTHDC1|NSRP1|PQBP1|CELF3|RBMX|U2AF2|REST|RBM11|SNRNP70|CLK3|RBM17|SRSF9|SRSF5|SETX|PTBP2|JMJD6|SRSF4|SRSF10|CELF6
REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045091,0.9062209842154131,1.0,-0.207429709098965,-0.644781852317124,4879,8,APOBEC3F|INPP5K|CXCL8
POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1905898,0.00597868468936834,0.175866780001117,-0.35949842040379903,-1.8398234388813002,22,29,DDIT3|FCGR2B|BOK|ATF6|PTPN1|BCAP31|PIK3R1|BCL2L11|PMAIP1|TMEM33|CAV1
PROTEIN-LIPID COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071825,0.25033841711036897,0.76196554415821,0.291154903755185,1.18369368940701,2773,27,LPL|ZDHHC8|ABCA7|ABCA5|DGAT1|AGTR1|SCARB1|SOAT1|CETP|APOE
POSITIVE REGULATION OF VESICLE FUSION%GOBP%GO:0031340,0.34852727069100703,0.842847021021096,0.516338589304564,1.0941707939682799,3111,4,C2CD5|AKT2|ANXA1|ANXA2
NUCLEAR ENVELOPE REASSEMBLY%GOBP%GO:0031468,0.129032258064516,0.6096268978024549,-0.335275283984655,-1.33710778568137,599,15,BANF1|VPS4A|LMNA|CHMP4B|NSFL1C
POSITIVE REGULATION OF PROTEIN SERINE/THREONINE PHOSPHATASE ACTIVITY%GOBP%GO:1905184,0.5515436241610739,0.9321968967758479,0.7273930304367,0.9663091896313879,4108,1,FCRL3
OOCYTE DEVELOPMENT%GOBP%GO:0048599,0.8286318758815229,0.9876441563834109,0.237357989883297,0.7005047499430451,8224,10,ZCCHC11|YTHDC2|ZP3|KMT2D|ZCCHC6|C17orf104
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061037,0.0205894226887364,0.301753477122268,-0.497221773339113,-1.7497853688863,101,11,SNAI2|PTHLH|TGFBR1|FAM101B|WNT11|FAM101A|GREM1
MALE GERM-LINE STEM CELL ASYMMETRIC DIVISION%GOBP%GO:0048133,0.511275167785235,0.918404893008545,0.748180414644905,0.993924302161029,3808,1,ING2
CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR%GOBP%GO:0042994,0.9903225806451609,1.0,-0.125122419685506,-0.49899938801465293,4604,15,NFKBIE|NFKBIA|MXI1|G3BP2|TMSB4X
EVASION OR TOLERANCE OF DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051834,0.137313432835821,0.62388141596544,-0.6736517039814711,-1.3671561181592802,873,3,TGFB1|SMAD3|EIF2AK2
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038084,0.216651943462898,0.7328375889887759,-0.287212600726987,-1.20855758943337,980,17,FOXC1|HSPB1|VEGFA|KDR|PRKD2|MYO1C|NRP1|PGF
REGULATION OF PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:1905764,0.548032665181886,0.9305779599215391,-0.542597187758478,-0.9280834300143019,3690,2,ERCC4|ERCC1
NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903147,0.9449618966977141,1.0,0.40110283981251704,0.6555915727339691,7811,2,PINK1|TSC2
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904356,0.600740131578947,0.950415218201239,0.18217154275021802,0.908088737223456,7304,58,NAT10|PIF1|ATR|HMBOX1|PNKP|PRKCQ|PARP1|SRC|NEK2|SLX1B|AURKB|MAP3K4|TNKS2|MAP2K7|SLX4|HNRNPA2B1|TEN1|CTC1|ACD|XRN1|ATM|MAPKAPK5|EXOSC10|POT1
C-TERMINAL PROTEIN LIPIDATION%GOBP%GO:0006501,0.75712168615182,0.977664504547119,-0.33530028125517,-0.771120600204548,4597,4,ATG12|ATG5|GPLD1|ATG7
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1900739,0.00047528517110266203,0.0784645998831315,-0.512378139276586,-2.37371490529111,1,22,TP53BP2|GZMB|BBC3|YWHAH|BID|YWHAQ|YWHAB|BCL2|TP53|YWHAZ|YWHAE|PMAIP1|TFDP2
POSITIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903961,0.52888734514299,0.9265056012720759,0.505079905736838,0.9601037683939878,4567,3,TCAF1|ABCB1|ARL6IP1
POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033145,0.9050607287449391,1.0,0.21963122418735298,0.626752470941109,8941,9,LMO3|PAGR1|KMT2D|TAF1|YAP1
REGULATION OF PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0010746,0.401164744092284,0.8638522656500329,0.49663894853611895,1.05242537337221,3581,4,AKT2|THBS1|AKT1
ERBB3 SIGNALING PATHWAY%GOBP%GO:0038129,0.546979865771812,0.9305779599215391,0.7297640052933391,0.969458923951745,4074,1,NRG1
BLOOD VESSEL DEVELOPMENT%GOBP%GO:0001568,0.39581351094196,0.8638522656500329,-0.122758932667535,-1.0286494071173,415,196,SMAD7|RAMP2|FGFR1|LEPR|CXCL8|ID1|ADM2|TBX20|SCG2|FLT1|MCAM|GREM1|MYH9|SFRP2|BMPER|ACVRL1|S1PR1|ADM|PGF|SOX17|CDH13|RBPJ|CAV1|EPHB2|ANGPT2|RAMP1
VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:0039702,0.598756906077348,0.949445913591245,-0.20157464593261104,-0.8994070193894441,2600,20,VPS28|VPS4A|VPS37D|VPS4B|CHMP4B|CHMP1B
NEGATIVE REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032240,0.0662876496915447,0.49786383970143805,0.8384124504929928,1.37036211779344,547,2,TPR|NUP153
SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1990926,0.70255033557047,0.968941691852291,0.6517423908248791,0.8658106899213921,5233,1,SYT7
BLASTOCYST GROWTH%GOBP%GO:0001832,0.18747517542698303,0.6940517434063481,-0.9043890604322891,-1.20982882073156,1415,1,ZPR1
POSITIVE REGULATION OF UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000397,0.40778498609823904,0.867015886388254,-0.79471768857521,-1.06311808274625,3079,1,VPS28
REGULATION OF DNA REPLICATION ORIGIN BINDING%GOBP%GO:1902595,0.876763177431329,0.99444152362265,-0.40088227185001396,-0.68568765611829,5904,2,CDT1|MAPK8
SPERMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006597,0.124721603563474,0.607607158836689,-0.7868210642404191,-1.34581529094249,839,2,AMD1|SMS
REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000191,0.541174152876281,0.928807195199472,-0.27213548849782104,-0.920675090823823,2746,10,AKT2|THBS1|AKT1|NCOR1|P2RX4|PLA2R1|SYK|IRS2|IL1B|TNFRSF11A
ALKANESULFONATE BIOSYNTHETIC PROCESS%GOBP%GO:0046305,0.336510067114094,0.8311444145897029,0.836237318041465,1.1109039698263798,2506,1,CDO1
POSITIVE REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000484,0.553742038216561,0.932816793297168,0.303570942617146,0.9261253586220871,5563,11,F2R|CD2|F2RL1
PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT%GOBP%GO:0048935,0.975135847192491,1.0,-0.23906689461203304,-0.549803914784,5921,4,ETV1|ISL1|RUNX3|RUNX1
ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN TRNA PROCESSING%GOBP%GO:1905267,0.459287700251556,0.890371861972445,-0.769574327304808,-1.02948304176017,3468,1,ELAC2
ALPHA-TUBULIN ACETYLATION%GOBP%GO:0071929,0.519060402684564,0.9238030410013001,0.7444861049845609,0.989016576592101,3866,1,ATAT1
FUCOSYLATION%GOBP%GO:0036065,0.0141667464343831,0.259243632817479,0.501696813034428,1.73924679568272,147,16,FUT9|FUT7|B3GLCT|FUT2|FUT8|FUT10|RFNG|LFNG
CYTOPLASMIC MICROTUBULE ORGANIZATION%GOBP%GO:0031122,0.19000171791788395,0.698434241409875,0.27280866366145,1.2458954467928898,2211,41,CAMSAP3|FSD1|CEP126|HOOK1|NUMA1|MAP10|CCDC88B|TUBGCP3|TUBGCP6|HOOK2|TUBGCP2|CAMSAP2|DYNC1H1|TUBGCP4|PCM1|DST|CAMSAP1|FIGN|HOOK3|KATNA1|KATNAL1|TUBGCP5|MAPT
ESTABLISHMENT OF MONOPOLAR CELL POLARITY%GOBP%GO:0061162,0.16752688172042998,0.6711206309076059,-0.31915749331007504,-1.2728285965242299,778,15,FSCN1|MYO9A|EZR|OPHN1|RHOA|CDC42|MSN|SLC9A3R1|SH3BP1
POSITIVE REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0045764,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902188,0.16434599156118102,0.666438287523194,-0.32994665249170396,-1.27830068103967,778,14,VPS4A|VPS4B|CAV2|CHMP4B|PC
HISTONE H3-T3 PHOSPHORYLATION INVOLVED IN CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO KINETOCHORE%GOBP%GO:2000751,0.92360651396796,1.0,-0.536722540802823,-0.7179901073650171,6975,1,GSG2
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PHAGOCYTIC VESICLE%GOBP%GO:1905171,0.41096253144445893,0.867015886388254,-0.793063520070578,-1.0609052511024302,3103,1,SYT11
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000142",0.7176294820717131,0.971081608033886,-0.167444487875891,-0.8222015445880919,2881,26,PSMC4|BCLAF1|CTNNB1|DR1|MITF|FOSL1|JUN|TP53|TWIST1
NEUROBLAST DIVISION%GOBP%GO:0055057,0.4091275438243,0.867015886388254,0.3542636624547771,1.04552359245967,4060,10,FGF13|LEF1|DOCK7|SOX5|FGFR2|TEAD3
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0070059,0.41628412660062797,0.8709670999109399,-0.217777128737364,-1.02331651674913,1722,23,ATF4|BAX|DAB2IP|BBC3|DDIT3|CHAC1|BCL2|TNFRSF10B|TRIB3
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043376",0.45957820738137106,0.890371861972445,-0.355771335800889,-0.976568428475188,2614,6,RUNX3|RUNX1|CBFB
LIPOPHAGY%GOBP%GO:0061724,0.0849993380113862,0.5460333734703521,-0.956164534627261,-1.27909045118315,641,1,RAB7A
REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140192,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION%GOBP%GO:1902913,0.668187919463087,0.964618776001639,0.6710961623290689,0.891521311931748,4977,1,SERPINE1
EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0060079,0.7477419354838709,0.9749763305090959,-0.197530749714735,-0.787770277057278,3476,15,NPAS4|GSK3A|AKT1|MPP2|GRIN2D|NPFF|MEF2C|MAPK8IP2|GSK3B|RAB3GAP1|GRIN2C|ARRB2|CHRNA3|DRD2
REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050923,0.41194859326154903,0.867015886388254,0.549437573874689,1.0444230292725,3557,3,ROBO2|SLIT2|ROBO1
POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051284,0.506477732793522,0.9172434440873181,0.337638622263365,0.963505264662187,5003,9,RYR2|PKD2|LINC00116
DRUG TRANSPORT%GOBP%GO:0015893,0.12971391417425202,0.61127985986266,0.252227931294227,1.29923259521243,1595,68,SLC15A2|EDN1|SLC1A2|GHRL|SLC47A1|SLC25A29|SLC36A1|SLC25A22|CD320|HBB|HBA2|TAF7|SLC6A17|SLC13A3|SLC25A10|SLC25A42|SLC6A9|HBA1|SLC46A1|SLC22A3|SLC25A1|SLC6A2|SLC5A6|SLC19A2
TDP PHOSPHORYLATION%GOBP%GO:0061571,0.481265722229578,0.9046812288131709,-0.7581054256726949,-1.01414074236302,3634,1,AK9
MESONEPHRIC TUBULE FORMATION%GOBP%GO:0072172,0.68013422818792,0.9647315640607691,0.664534627260697,0.882804605324248,5066,1,GATA3
"NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:2000623",0.381775333857031,0.857178152269066,-0.515257993640766,-1.04570078910663,2429,3,NBAS|PABPC1
CEREBRAL CORTEX NEURON DIFFERENTIATION%GOBP%GO:0021895,0.00843585237258348,0.20298122046820802,-0.700126854558491,-1.92180120568261,47,6,CHD5|LHX6|OPHN1|C21orf91|DRD2|ASCL1
RENAL ABSORPTION%GOBP%GO:0070293,0.32208341728793105,0.822751772025005,0.382574224785491,1.1290753759744099,3196,10,KCNQ1|HBB|KLHL3
EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048013,0.0213509316770186,0.30747198217661403,-0.22200238657711302,-1.4992699678349901,54,72,FYN|RHOA|MMP2|LYN|MMP9|EFNA1|ARPC5|YES1|CRK|VAV3|VAV2|ARPC4|CDC42|AP2S1|EPHA8|EPHA7|SDC2|EFNB1|RAC1|ACTR2|EPHB2
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002704,0.773941068139963,0.980173768720877,-0.173650837811353,-0.774813626623472,3361,20,BST2|XCL1|NDFIP1|JAK3|MICA|FOXP3|PTPRC|HFE|CD300A|LILRB1|HLA-E|FOXJ1|SERPINB9|CD84|LGALS9|ARRB2|FCGR2B|SMAD7
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0120187,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
CELLULAR RESPONSE TO LIPOTEICHOIC ACID%GOBP%GO:0071223,0.37070741758241793,0.852609194081082,-0.416887271122877,-1.05532244410881,2158,5,MAPK14|TLR2|CD14|TIRAP|RELA
HEXOSE METABOLIC PROCESS%GOBP%GO:0019318,0.627658739502394,0.9553884638359259,0.16477515897656697,0.8981577970319531,7996,89,FUT9|FUT7|OMA1|GHRL|GALM|GAA|AKR1B1|PGM5|FUT2|FUT8|ALDH1A1|TKFC|CHST15|GALE|KCNJ11|SLC25A10|FUT10|FPGT
MULTICELLULAR ORGANISMAL IRON ION HOMEOSTASIS%GOBP%GO:0060586,0.995718755145727,1.0,-0.20240362052342198,-0.46548604360643797,6046,4,SLC11A1
SPHINGANINE-1-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006669,0.893155037733351,0.9976191001250191,-0.5518306131451259,-0.7382006363785791,6745,1,SPHK2
PROTEIN LOCALIZATION TO ACTOMYOSIN CONTRACTILE RING%GOBP%GO:1990179,0.748155316317891,0.9749763305090959,0.5080197697450349,0.8303443575287859,6184,2,ANLN|RTKN
RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0060041,0.5309225219034529,0.9265056012720759,0.208046917982675,0.95013371039996,6180,41,TSPAN12|SDK1|PROX1|DSCAM|SMARCD3|AHI1|FOXN4|TGFB2|DCX|COL4A1|TFAP2B|SMARCA4|CHD7|MDM1|TOPORS
POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0110110,0.455655868295274,0.88900512246363,-0.18882594278713,-0.992947769301437,1715,31,NOTCH1|VEGFA|PIM1|TGFBR1|ACVR1|LIF|FGF7|PAX8|WNT6|DKK1|RBPJ
GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5-PHOSPHATE%GOBP%GO:0019640,0.45982142857142894,0.890371861972445,-0.386675650267416,-0.978843732068032,2677,5,SORD|XYLB
NUCLEAR ENVELOPE DISASSEMBLY%GOBP%GO:0051081,0.148703956343793,0.64074876264986,0.401184236729731,1.3292480470658798,1525,14,CCNB1|CDK1|PRKCB|AKAP8L|CCNB2|PLK1|VRK1|CNEP1R1|NEK9
BOX H/ACA SNORNA 3'-END PROCESSING%GOBP%GO:0000495,0.47260579064588004,0.898911737554429,-0.5766749379652609,-0.986371596655444,3182,2,DKC1|PARN
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS%GOBP%GO:0010907,0.7979274611398961,0.9835585148939309,-0.167131596789115,-0.759077615827761,3387,21,ARPP19|IGF1|PPARGC1A|IGF2|PMAIP1
IMITATIVE LEARNING%GOBP%GO:0098596,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
POSITIVE REGULATION OF MINERALOCORTICOID SECRETION%GOBP%GO:2000857,0.95061564941083,1.0,-0.5224966916629911,-0.698959755228159,7179,1,C1QTNF1
3'-UTR-MEDIATED MRNA DESTABILIZATION%GOBP%GO:0061158,0.899461028192371,0.998912093067348,-0.18002764632845103,-0.655858774136115,4338,12,RBM24
HISTONE-TYROSINE PHOSPHORYLATION%GOBP%GO:0035406,0.262013422818792,0.771967970256231,0.871140273489193,1.15727098900745,1951,1,JAK2
DNA REPLICATION CHECKPOINT%GOBP%GO:0000076,0.0924459041731066,0.5622489437340121,0.420777331187201,1.42669267870609,956,15,ORC1|DNA2|CDC45|RAD9A|ZNF830|NAE1|CDC6|TIMELESS|TOPBP1|CLSPN|RAD17
PROTEIN-DNA COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071824,0.212827776567153,0.7279184739702909,0.192485592519547,1.16963392836032,2929,170,GTF2H2|RBBP7|HIST1H3E|HIST1H2BJ|HIST3H2BB|BDP1|ASF1B|SMARCD3|CENPF|CENPL|CENPT|NAP1L4|HIST2H3C|TAF7|HIST2H3A|SART3|GTF2B|CENPK|GTF2H1|DDB2|ASF1A|CDC45|CASC5|CENPU|PARP1|OIP5|ARID2|ITGB3BP|CENPA|CENPE|HIST1H4I|INO80|DDB1|RAD51|CHD1L|HELLS|CENPV|CENPQ|CENPI|H2AFX|H3F3A|WDR18|CDK7|CHAF1A|MIS18BP1|HIST1H2BF|NASP|HJURP|CUL4B|POGZ|HIST1H2BK|STRA13|CENPM|ERCC5|SMARCA4|GMNN|HIST1H3H|ACD|XPA|RBX1|HIRA|HIST1H2BN|HIST3H2A|ARID1A|SUPT6H
REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000047,0.449535728704077,0.8859850407237599,-0.282383436276445,-0.9937424942076508,2226,11,MAD2L2|PPM1F|FLOT1|PTPRU|SERPINF2|DENND6A
SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION%GOBP%GO:0021527,0.889530201342282,0.997300970905927,0.55640714600794,0.7391620703888969,6626,1,MDGA1
LIPID HOMEOSTASIS%GOBP%GO:0055088,0.055528730082085996,0.458430358369604,0.27496611724972303,1.43570028269539,689,72,ACSM3|THADA|FGFR4|SIRT1|RBP1|LPL|PRKAA2|INS|ABCB4|SCARB1|C1QTNF3|LIMA1|SOAT1|POLD1|RORA|GRAMD1B|AKR1C1|CETP|ABCA2|LDLRAP1|PNPLA2|PTCHD2|APOE|ACOX2|CYP7B1
"GLYCINE SECRETION, NEUROTRANSMISSION%GOBP%GO:0061537",0.367651006711409,0.8512048542076959,0.821239523599471,1.09098006900924,2738,1,SLC6A9
REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:1900157,0.0149253731343284,0.264326813346421,-0.8317525090989301,-1.6880170047639498,94,3,FAM101B|FAM101A|GREM1
ACTIN FILAMENT BUNDLE RETROGRADE TRANSPORT%GOBP%GO:0061573,0.45610738255033595,0.88900512246363,0.7772937803264229,1.0326001096296,3397,1,SHTN1
PROTEIN-CONTAINING COMPLEX LOCALIZATION%GOBP%GO:0031503,0.8064864864864859,0.984682960940884,-0.101934227864899,-0.869450917827718,745,212,PA2G4|RPGR|MAGOH|DDX19B|THOC5|SEH1L|NMD3|EXOC3|RBM15B|AGFG1|ZNF593|DYNLRB2|NPM1|RAB8A|WDR19|SMAD7|TRAF3IP1|EIF5A|KIF3C|DYNLRB1|KIF3B|RRS1|TTC30A|DYNLL2|TTC30B|ALKBH5|NCBP2|POLR2D|RBM8A|RNPS1|SLU7|THOC7|CACNG3|DLG1|CACNG7|SLBP|FYTTD1
REGULATION OF GTP CYCLOHYDROLASE I ACTIVITY%GOBP%GO:0043095,0.49490268767377205,0.91071489001692,-0.749834583149537,-1.00307658414391,3737,1,GCHFR
POSITIVE REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0050434,0.9404203415274909,1.0,0.156963504508359,0.5828838565668331,10022,20,DHX9|GTF2B|LEF1|SMARCA4|SP1|TFAP4|CHD1|SNW1|NUCKS1|MDFIC|EP300|RRP1B
REGULATION OF B CELL CYTOKINE PRODUCTION%GOBP%GO:0002721,0.679597315436242,0.9647315640607691,0.6648654609616229,0.883244103136391,5062,1,BTK
MITOCHONDRIAL TRNA WOBBLE URIDINE MODIFICATION%GOBP%GO:0070899,0.6387919463087249,0.960516115253472,0.685377150419056,0.910492967489247,4758,1,MTO1
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009217,0.24090235468467,0.7538896250817869,-0.518336734131142,-1.19206620416489,1462,4,NUDT16|SAMHD1|NUDT1|NUDT15
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050855,0.137650933040615,0.6243233125849921,-0.321504477093401,-1.31666888828879,626,16,ELF1|BLK|PRKCH|NFAM1|RUNX1|LYN|CBFB|CD22
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000678,0.21103963477899998,0.7257004702836279,-0.32323115705710104,-1.21728235911678,1016,13,PSEN1|MAD2L2|HAND1|SIN3A|DDIT3|ZNF593|TMSB4X|PER2
HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0001942,0.874370340519847,0.993649022805818,0.22258401104844802,0.65690292152152,8678,10,TGFB2|APCDD1|FGFR2|HDAC2|ATP7A
EXONUCLEOLYTIC NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS INVOLVED IN DEADENYLATION-DEPENDENT DECAY%GOBP%GO:0043928,0.34059352028314693,0.8342803267873399,-0.201357094059531,-1.07701287772267,1250,33,EXOSC2|EDC4|CNOT8|CNOT6|SKIV2L|DCPS|EXOSC3|NT5C3B|LSM1|LSM2|PATL1|LSM6|EDC3|LSM5|DCP1B|EXOSC7|EXOSC1|DIS3|EXOSC8|LSM3|DCP1A|DCP2|HBS1L|EXOSC6|EXOSC4|CNOT7|EXOSC9|EXOSC5|DDX6
REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033127,0.0821513002364066,0.539994451302385,-0.43384424158162394,-1.4677600070699799,416,10,IL1B|CDK9|FMR1|MAPK3|TWIST1
REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042269,0.982428412049089,1.0,0.13081660587671698,0.494556496232968,10566,21,CEACAM1|KLRK1|SLAMF6
NEGATIVE REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:1900275,0.0754268745360059,0.525408291492683,-0.834518886131789,-1.42739986075574,507,2,ABL1|BICD1
REGULATION OF GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046643,0.669042316258352,0.964618776001639,-0.49456851392335294,-0.845932955670557,4505,2,NCKAP1L|LILRB1
HISTONE-THREONINE PHOSPHORYLATION%GOBP%GO:0035405,0.663268892794376,0.964618776001639,-0.303252996318703,-0.8324091129452009,3773,6,PKN1|VPRBP|PRKCA
NEGATIVE REGULATION OF P38MAPK CASCADE%GOBP%GO:1903753,0.146397188049209,0.638087384443229,-0.4851576725902171,-1.3317252353047,832,6,CYLD|DUSP10|DLG1
REGULATION OF MICROVILLUS ASSEMBLY%GOBP%GO:0032534,0.765625,0.9792236089291529,-0.301455989410986,-0.763115819486543,4458,5,RAP1GAP|PLD1|FSCN1|ATP8B1|PODXL
FEMALE MEIOSIS I%GOBP%GO:0007144,0.8606711409395971,0.9916689277956879,0.570798411998236,0.7582802252171109,6411,1,C17orf104
ANTIMICROBIAL HUMORAL RESPONSE%GOBP%GO:0019730,0.481893429901707,0.9052279104788491,0.218533415879526,0.9856420974047699,5588,39,HIST1H2BJ|CXCL13|COLEC11|LEAP2|RARRES2|CXCL9|AZU1|JCHAIN|CXCL10|RPS19|HIST1H2BF|RNASE6|HIST1H2BK
POSITIVE REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032097,0.0350792306761824,0.381265913354899,0.87968017645437,1.43781308218656,289,2,GHRL|NPY
MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:0044773,0.14257581725088597,0.6324244126031129,0.234526661912845,1.2721022806578102,1809,87,BTG2|MUS81|TAOK3|EME2|CCNB1|PIDD1|CDK1|E2F8|BLM|CDC25C|MUC1|RAD9A|E2F7|DONSON|ZNF830|NEK11|GTSE1|MSH6|TAOK1|RPS27L|CHEK2|PRMT1|EME1|BRSK1|CARM1|AURKA|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|C5orf45|PRKDC|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1
PROTEIN IMPORT INTO PEROXISOME MATRIX%GOBP%GO:0016558,0.58955223880597,0.945418171231938,-0.24406036979893497,-0.889136408857443,2843,12,PEX26|PEX7|PEX5
POSITIVE REGULATION OF SYNAPSE MATURATION%GOBP%GO:0090129,0.95237600083186,1.0,0.20700201264267803,0.5643430216874741,9158,8,CDC20|ADGRL1|ANAPC2|NEURL1
POSITIVE REGULATION OF T CELL EXTRAVASATION%GOBP%GO:2000409,0.908322147651007,1.0,0.547640052933392,0.7275153783671121,6766,1,FADD
ARGININE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903826,0.6797299522476539,0.9647315640607691,-0.35769069984137697,-0.822613885430537,4127,4,SLC7A1
EPIDERMIS DEVELOPMENT%GOBP%GO:0008544,0.839203187250996,0.989395884107905,0.14136339648694501,0.7467196617376409,10531,76,KRT7|CTGF|FABP5|CDH3|STRC|KRT8|DFNB31|JAG2|TGFB2|PDZD7|KRT19|APCDD1|PPL|ALDH3A2|MED1|ATP2A2|KRTAP5-1
REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901674,0.10838901262063799,0.58452352834625,-0.800882271850014,-1.36986623348859,729,2,SIN3A|LIF
REGULATION OF CELL ADHESION%GOBP%GO:0030155,0.0669014084507042,0.500883465349056,-0.12647934333363,-1.1941782968679,18,418,CD44|PPM1F|FLOT1|PRKX|YTHDF2|CD86|IL6R|RREB1|SNAI2|PYCARD|MMRN1|CALR|ARL2|THY1|CRKL|S100A10|RND1|GPM6B|NCK2|IL1RN|FLCN|NOTCH1|PTPN6|ARHGDIA|TESC|CD274|ICOSLG|IL1B|RARA|CBLL1|FAM49B|IRAK1|VEGFA|KDR|CX3CL1|MAPK7|BCAS3|PRKCD|SIRPA|PTPRG|MAP3K8|COL16A1|LGALS9|PTK2B|CD164|PDPN|EPB41L4B|DLC1|PRKD2|GRB2|PTPRU|ABL1|VAV1|MMRN2|RPS3|ADAM10|RET|CITED2|FYN|RHOA|NRP1|SLC9A1|C1QBP|ZNF703|PLAU|PPARA|MYADM|RUNX1|APOD|MAP2K5|PPAP2B|DOCK5|TNFRSF18|IL6|PNP|TFE3|LYN|FCGR2B|PODXL|PRNP|EFNA1|C2CD4A|ASS1|CD276|YES1|PPP2CA|MBP|IGF1|SPOCK1|SERPINF2|FOXC2|MAP4K4|CRK|EMILIN2|ETS1|SMAD7|CDC42|NPNT|LGALS3|TFRC|PLXNA1|CXCL8|NLRP3|MMP12|PRKCA|DUSP3|LIMS1|PLXNA4|EPHA8|CD9|FXYD5|SOCS5|BCL6|MFI2|NKAP|EPHA7|SFRP2|PKP4|ACVRL1|DUSP10|DENND6A|CBFB|PPP1CB|RAC1|CORO1C|IGF2|CD36|PIK3R1|CDH13|PEAK1|TNF|EMILIN3|TNFRSF21|CAV1|DACT2|PAK2
RESPONSE TO MONOAMINE%GOBP%GO:0071867,0.6663539125539499,0.964618776001639,0.22714798976272602,0.8435138900536651,7101,20,RYR2|NR4A3|KCNQ1
NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009141,0.850212765957447,0.991298302704726,-0.101512695045944,-0.835949595178777,998,178,PFKL|COX5B|GPI|MOCS3|NDUFB10|SDHC|GTPBP1|UQCRC1|PKM|ENO1|MT-ND5|ATP5I|EFTUD1|COX4I1|GAPDH|PGK1|NDUFB9|CYC1|HK1|HK2|TPI1|NDUFA9|NDUFS1|NDUFV3|ADCYAP1|NDUFS5|AK7|ALDOA|COX10|SLC25A13|ITPA|RHOQ|COX4I2|NDUFS6|PGAM2|AK4
GLUTAMATE SECRETION%GOBP%GO:0014047,0.14346161595808998,0.6334904564746021,0.45363976927566996,1.3388081576563602,1423,10,SLC1A2|GLS|GLS2|SLC1A3|SYT1|RAB3A|SLC1A1|GIPC1|SLC38A2
REGULATION OF LIPID BINDING%GOBP%GO:1900130,0.124718654839137,0.607607158836689,-0.9357631230701371,-1.25179886090936,941,1,PEX19
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000588,0.297205757832346,0.802024532419989,0.6885028949545079,1.12533906752218,2456,2,HIP1R|HIP1
INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032637,0.0394344069128044,0.396089810860281,-0.7788684239550021,-1.5806903252195201,250,3,NOD1|RAB1A|CHI3L1
TRNA N1-GUANINE METHYLATION%GOBP%GO:0002939,0.733615781808553,0.9734087938149171,-0.628473753859726,-0.8407285025422699,5540,1,TRMT5
T-HELPER 1 CELL LINEAGE COMMITMENT%GOBP%GO:0002296,0.604660399841123,0.9508825506493929,-0.6913872959858841,-0.92488986606225,4566,1,SPN
REGULATION OF NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048168,0.295582133268245,0.800447413278835,-0.233671161748,-1.12009383072006,1210,24,CAMK2A|ARC|DRD2|RAB5A|MCTP1|EPHB2
NEGATIVE REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035305,0.6822984395318601,0.9658555822794358,0.16613650910509,0.8557734537034569,8394,68,TMEM132D|CAMSAP3|CNST|ELFN2|CSRNP3|DLG3|PPP1R35|ELFN1|TGFB2|CASC5|PKMYT1|ZCCHC9|BOD1|LMTK3|CEP192|FARP1|TIPRL|SFI1|RIMBP2|SYTL2
POSTSYNAPTIC SIGNAL TRANSDUCTION%GOBP%GO:0098926,0.870378619153675,0.9934031064448321,-0.404190791287565,-0.6913467014232559,5861,2,KPNA2|KPNA1
VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0019062,0.33962949509625895,0.8330383695817521,-0.36807294545081803,-1.07368511179128,1869,7,CD81|GAS6|PVRL2|ICAM1|HSP90AB1
RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000054,0.10188835858061801,0.572767517465588,-0.370700293729656,-1.39605022048293,490,13,PA2G4|NMD3|ZNF593|NPM1|RRS1
EYE MORPHOGENESIS%GOBP%GO:0048592,0.12024622649464502,0.606646975444992,0.28008466320670394,1.3340534572435,1425,48,SIX3|TSPAN12|SHROOM2|TBX2|SDK1|PROX1|DSCAM|AHI1|CEP290|FOXN4|EFEMP1|FBN1|NF1|NIPBL|COL5A2|TH|COL5A1|TFAP2B|MYO7A|TOPORS|WNT2B|MFAP2
BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:0070830,0.5499293452661329,0.931359181171847,-0.20413119140498898,-0.927122226225697,2334,21,PDCD6IP|ARL2|RAB13|F11R|STRN|PARD6B|RAMP2|DLG1|PARD3
REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0035480,0.37643643401475707,0.853374872190571,0.653221020852213,1.06767181355176,3111,2,ROBO2|ROBO1
POSITIVE REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0045956,0.0278057626435624,0.342627407098241,0.5530858792048671,1.63229932011107,275,10,CACNA1G|CACNA1I|UNC13B|CACNA1H|ZP3|SCAMP5|STX1A|SYT4|HYAL3
NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060149,0.7594197058230909,0.977664504547119,0.25746901908551,0.7598575928337371,7537,10,TERT|DND1|ELAVL1|NCOR1|ZC3H12A|BCDIN3D
ABDUCENS NERVE MORPHOGENESIS%GOBP%GO:0021598,0.6536475572620151,0.9640743070248079,-0.6671812968681079,-0.8925087630076741,4936,1,MAFB
NEGATIVE REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0010956,0.8446919079435781,0.991298302704726,-0.41880341880341904,-0.716340818186852,5688,2,CYP27B1|NFKB1
HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:0060218,0.0335913057796806,0.375579079090274,-0.720525364517155,-1.6570578153683,203,4,BATF|MEOX1|ACE
GLYCEROL-3-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006072,0.9300762804213589,1.0,-0.212737321004901,-0.620564203667739,5120,7,GPAT2
NEGATIVE REGULATION OF HIPPO SIGNALING%GOBP%GO:0035331,0.9039201414162421,1.0,0.231868639985203,0.632136119128902,8692,8,DLG5|MARK3|AJUBA|WTIP|WWC3
PROTEIN ACETYLATION%GOBP%GO:0006473,0.317720833010761,0.8195209505928199,0.199318038743282,1.1079197650545098,4103,99,CPA4|SIRT1|JADE3|AK6|KAT2A|NAA40|TADA1|OGT|TAF6L|NAA10|YEATS4|GTF2B|TRRAP|MAP3K7|EP400|LEF1|CLOCK|ING5|APBB1|YEATS2|ESCO2|BRPF3|DSCC1|EHHADH|ATAT1|NAA25|MSL1|KAT8|BRCA2|BAG6|SUPT3H|WDR5
CILIARY BASAL BODY-PLASMA MEMBRANE DOCKING%GOBP%GO:0097711,0.0100311041990669,0.21951586544159402,0.292412143207549,1.6097201238280001,128,94,TMEM216|CEP83|AKAP9|SDCCAG8|CEP63|IQCB1|CEP70|CENPJ|CDK1|AHI1|RAB3IP|CKAP5|CEP290|CEP131|CEP152|MKS1|KIF24|NEK2|HAUS5|CDK5RAP2|PRKAR2B|CEP162|CEP72|HAUS8|CEP164|CEP78|CEP192|FGFR1OP|CEP97|CNTRL|NPHP4|PLK1|SFI1|CEP41|CEP57|DYNC1H1|NINL|TUBB4A|CEP135|PCM1|NEDD1|PPP2R1A|TMEM67|SSNA1|C2CD3|NDE1|CEP250
NEGATIVE REGULATION OF CATALYTIC ACTIVITY%GOBP%GO:0043086,0.606060606060606,0.9508825506493929,-0.100725389589101,-0.9501811156886509,179,415,MAPK7|BCAS3|PRKCD|NES|FKBP1B|F11R|DAB2IP|IGF1R|TRIB1|STYX|WARS|RGS4|MAGEA3|CEBPA|HP|ABL1|SPOCK3|MGAT5|GNAQ|GNAI2|SERPINI1|ELL|DDX3X|PLN|INPP5K|EIF4A2|GMIP|PXK|CPEB2|MAP2K5|UBASH3B|HGF|DFFA|SH3BP4|MTRR|LYN|PRNP|MMP9|CHP1|TNNT2|TRIB2|PIK3IP1|PPP2CA|BAG5|PRKAR2A|LAMTOR5|BIN1|SPOCK1|SERPINF2|NOSIP|ATP2B4|KDM5A|LIMK1|NPM1|TIMP2|GAPDH|PCIF1|PTPN1|SERPINF1|SMAD7|PLAUR|SNCA|LGALS3|SERPINA1|GRM2|CDKN1C|PDCD4|CSTB|DUSP3|TP53|UCHL1|SNX6|PRKAR1B|TMED2|PKIG|SOCS5|YWHAE|DNAJB6|ADCYAP1|PPP1R11|CDKN1A|DBNDD2|PARK2|KIAA0226|DUSP10|CORO1C|CSNK2A1|BICD1|AQP1|TNF|SPRED2|CAV1|FKBP1A|EPHB2|PAK2|TRIB3
"SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0051932",0.0182246661429694,0.284804933176101,-0.824954430544286,-1.6742205063170799,115,3,GABRG2|GABRA3
BMP SIGNALING PATHWAY INVOLVED IN SPINAL CORD DORSAL/VENTRAL PATTERNING%GOBP%GO:0021919,0.7946308724832221,0.9821540323303699,0.603992059991178,0.802376505702109,5919,1,CHRD
POSITIVE REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905033,0.895004233700254,0.998125596923226,0.43804795714577704,0.715977352073438,7398,2,RNF207|NOS1AP
REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032107,0.36716447239143296,0.851186780857897,0.34292941774261,1.0810360761079598,3736,12,CARTPT|GHRL|NPY
TRANSCRIPTION INITIATION FROM RNA POLYMERASE III PROMOTER%GOBP%GO:0006384,0.8313834726090992,0.9879179006160809,-0.229911885575349,-0.714666245712514,4476,8,CRCP
KIDNEY FIELD SPECIFICATION%GOBP%GO:0072004,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051971,0.0523769202854724,0.447307566936778,0.8554232006757891,1.3981657216545702,432,2,CARTPT|GBA
REGULATION OF PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1905871,0.578975241625844,0.942692029750853,-0.7041795324217031,-0.9420024307744641,4372,1,FAM65B
NEGATIVE REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902750,0.0103031838527151,0.22191532995385502,0.363494212234051,1.7241250756110098,121,47,TAOK3|BLM|ORC1|USP47|DTL|DONSON|ZNF830|NAE1|AURKB|CDC6|MSH6|TAOK1|BRCC3|TOPBP1|PLK1|BRSK1|AURKA|CLSPN|CDK5RAP3|TAOK2|C5orf45|FHL1|CHEK1|RBX1|FBXL7|RAD17|ATM|UIMC1|BRCA1|BRE
REGULATION OF INHIBITORY SYNAPSE ASSEMBLY%GOBP%GO:1905702,0.49106315371375603,0.9092105079917561,-0.752481252756948,-1.00661711477403,3708,1,LHFPL4
POSITIVE REGULATION OF CALCIUM:SODIUM ANTIPORTER ACTIVITY%GOBP%GO:1903281,0.516109873793615,0.922205682736145,-0.5561621174524399,-0.9512855157646601,3475,2,ATP1B1|SLC9A1
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010832,0.286411557985162,0.7957186177819849,-0.35157371021917405,-1.13491144186311,1466,9,NOTCH1|HDAC4|HDAC5|BHLHE41|CFLAR
GLYCOLYTIC PROCESS THROUGH GLUCOSE-6-PHOSPHATE%GOBP%GO:0061620,0.00047528517110266203,0.0784645998831315,-0.4768837663179679,-2.2092786897554704,1,22,PFKL|GPI|PKM|ENO1|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
FLUID TRANSPORT%GOBP%GO:0042044,0.117508172902288,0.599708120627057,-0.47571310899764596,-1.38767624441706,646,7,PDPN|AQP5|AQP1
PLASMA MEMBRANE ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042774,0.22510067114094,0.7390599693491929,0.8890604322893689,1.18107712049852,1676,1,COA6
PROTEIN DEACYLATION%GOBP%GO:0035601,0.246009627565239,0.758407565545035,0.248914333097838,1.1806500046736499,2912,47,SIRT4|SIRT1|HDAC10|LYPLAL1|MTA2|NOTUM|MIER2|MTA1|HDAC8|HDAC3|SIRT3|SMARCAD1|HDAC6
REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030888,0.19883365731741198,0.711592141628341,-0.22263239764655102,-1.21023126349004,715,35,LYN|FCGR2B|VAV3|TFRC|BCL2|NFATC2|TNFRSF4|CD22|TNFRSF21
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032104,0.36716447239143296,0.851186780857897,0.34292941774261,1.0810360761079598,3736,12,CARTPT|GHRL|NPY
BIOLOGICAL ADHESION%GOBP%GO:0022610,0.00398540934882464,0.148195394527521,0.21048656415831,1.424283988847,58,476,PCDHGA5|TENM1|PCDHA12|CLDN12|PCDHGA11|PCDH15|PTPRK|PCDHB4|VMP1|PCDHB15|PCDHA10|HOXD3|CUZD1|ITGB1|PCDHA7|PCDHA2|CTGF|CDH4|PCDHB8|PCDH17|LRRN2|CDH6|PCDH8|CLDN15|CDHR2|PCDHGA7|PCDHB6|CYR61|ROPN1B|PCDHB7|PCDHGA1|PCDHB14|NOV|CDH10|NEXN|SDK1|CEACAM1|CAMSAP3|PCDHA6|CD209|PCDHB13|CDH3|WISP1|ITGA1|LRRC7|PCDHB9|STRC|PCDHA11|MADCAM1|ACTN2|DCHS1|PCDHGA2|PCDHB12|PCDHA1|PCDHA3|ADGRV1|KIF14|ILK|IGSF9|CDH2|CLDN11|ITGA9|DSCAM|PCDHGB4|PLXNC1|ADGRB1|PCDH9|CD2|HBB|FBLIM1|DDR2|PPFIA2|PCDH20|DLG3|CLDN7|SCARB1|FIBP|ITGA2|CDH23|PCDHAC2|BGLAP|SGCE|PCDHGC5|CDK5R1|ROBO2|SEMA5A|ITGA4|TGFB2|TENM2|PCDHGA3|CELSR2|DDR1|FARP2|CTTN|PCDH18|CTNND1|TYRO3|KIRREL3|CTNND2|FBN1|PCDHGA6|CDH7|CCL21|APC|PCDHA5|ITGB3BP|PTPRD|ITGA11|ITGB5|CCL5|CD200|LOXL2|LEF1|CORO1A|IGFBP7|DLG5|KIT|HMCN1|BSG|TNXB|ITGBL1|PALLD|CASK|FBLN5|CCL2|ADGRL1|CXADR|STAB1|ATP2A2|PLXNB2
CARBON DIOXIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035378,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
NUCLEOSIDE SALVAGE%GOBP%GO:0043174,0.6491723859507471,0.963755998259649,-0.24017084366539396,-0.8451911215725659,3215,11,CDA|HPRT1|UPP1
PROTEIN ADENYLYLATION%GOBP%GO:0018117,0.423221476510067,0.873470206885489,0.7952690780767528,1.05647949075603,3152,1,FICD
AUTOPHAGY OF NUCLEUS%GOBP%GO:0044804,0.004464285714285711,0.155321503601441,-0.773271894692816,-1.95748645351982,25,5,RB1CC1|ATG13|ATG9B|ATG7
PEPTIDE SECRETION%GOBP%GO:0002790,0.535135135135135,0.9265056012720759,-0.140235492568111,-0.9694947713939258,1286,79,CRHR1|RAB8B|TVP23C|RAB11FIP2|IL6|PNP|VIP|ABCA1|RAB1A|FOXP1|RAB8A|ADCYAP1|SCG2|ARL4D|CHI3L1|RAB11FIP5|CD36|GAL|STEAP3
DUTP METABOLIC PROCESS%GOBP%GO:0046080,0.405369127516779,0.866234596232951,0.8044221438023821,1.06863893022531,3019,1,DUT
NEGATIVE REGULATION OF HEART LOOPING%GOBP%GO:1901208,0.07624161073825501,0.525661416287861,0.9627260696956329,1.27893863333566,567,1,TBX2
REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002685,0.0387755102040816,0.39517613814756697,-0.184631110326153,-1.3717801152562699,75,106,LGALS9|PTK2B|HMOX1|AKIRIN1|ADAM10|CAMK1D|ZNF580|RHOA|STK10|C1QBP|APOD|TNFRSF18|IL6|LYN|ICAM1|KARS|LGALS3|MSN|ADAM17|CXCL8|MTUS1|ANO6|OXSR1|PLVAP|GREM1|THBS4|RAC1|PLCB1|PGF|TNF|NBL1
SLOW ENDOCYTIC RECYCLING%GOBP%GO:0032458,0.00900304514762346,0.208853543990274,-0.996140273489193,-1.33256721590881,67,1,MICALL1
NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904178,0.710446180325698,0.9700296616429409,-0.64032862814292,-0.856587129322985,5365,1,KLF7
AUDITORY RECEPTOR CELL DEVELOPMENT%GOBP%GO:0060117,0.262779209621993,0.7739438894806742,0.48255169533717296,1.18676561779781,2446,6,STRC|DFNB31|PDZD7|LRTOMT
MEIOTIC NUCLEAR DIVISION%GOBP%GO:0140013,8.06711842529848e-05,0.0784645998831315,0.396047231766642,2.0559400359893,0,70,HSPA2|MUS81|SYCP2|EME2|MLH3|CCNA1|RAD54B|BLM|C11orf80|BRIP1|NUF2|BUB1|TOP2A|CCNE1|PTTG1|BUB1B|ESPL1|RAD51C|RAD51|PIM2|MND1|FANCM|REC8|MYBL1|SLX4|EME1|ING2|RMI1|STRA13|SPDYA|CCNE2|BAG6|STAG3|TOP2B|TEX14|P3H4|UBR2|SPIRE2|SPIRE1|SGOL1|FMN2|ATM
SEROTONIN SECRETION BY PLATELET%GOBP%GO:0002554,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
POSITIVE REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043306,0.140773286467487,0.6296802030037281,-0.489493133307595,-1.34362578386901,800,6,VAMP7|SNX4|SYK|VAMP8|FGR|GAB2
NEGATIVE REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000157,0.553377876763177,0.932706603479095,-0.540226082161566,-0.924027780879077,3726,2,UBXN1|PARK7
INSEMINATION%GOBP%GO:0007320,0.0643522438611346,0.495456803258629,0.841150043541603,1.37483663842531,531,2,TAC1|KLK14
VALINE BIOSYNTHETIC PROCESS%GOBP%GO:0009099,0.9796782387806942,1.0,0.3448432506553111,0.563636819797839,8098,2,BCAT2|BCAT1
NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061099,0.44246389891696797,0.880423444399886,-0.22786258827650602,-0.999285278761432,1960,19,SNX6|SOCS5|CAV1
REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0106014,0.539463087248322,0.9280749458041251,0.733403176003529,0.9742933998853159,4018,1,SIGLEC10
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051926,0.0113197838950347,0.22999530340982602,-0.345310518831912,-1.7459748642269,43,28,FKBP1B|CRHR1|SESTD1|PLN|INPP5K|SLC30A1|BIN1|FMR1|GNB5|YWHAE|ADRA2A|FKBP1A|STC1
PENTOSE-PHOSPHATE SHUNT%GOBP%GO:0006098,0.6715785224061359,0.964671573446318,-0.235903688466939,-0.8301744707873828,3326,11,DERA|G6PD|PGD|TKT
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING%GOBP%GO:0086028,0.43189316575019604,0.8785877309899279,-0.49383828267253294,-1.00223012210416,2748,3,SCN5A
THYMINE METABOLIC PROCESS%GOBP%GO:0019859,0.740014847809948,0.9744283926676119,-0.46286186931348205,-0.791700438164639,4983,2,DPYD|ALDH6A1
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION%GOBP%GO:0014859,0.389012620638456,0.8603316114971841,-0.621252693217147,-1.0626194595819398,2619,2,AKIRIN1
ADRENOMEDULLIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1990410,0.0121850815083155,0.23962061927625303,-0.7734517178624609,-1.7787773713599997,73,4,RAMP3|CALCRL|RAMP2|ADM
POSITIVE REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902004,0.0906225374310481,0.560245248761167,-0.426536936394651,-1.44303829986512,459,10,PICALM|CLU|CASP3|EFNA1|CHRNA7
NEGATIVE REGULATION OF FAS SIGNALING PATHWAY%GOBP%GO:1902045,0.5949953660797029,0.9473459395438281,-0.696404940449934,-0.931602122048506,4493,1,TMBIM1
DORSAL SPINAL CORD DEVELOPMENT%GOBP%GO:0021516,0.8266323216485609,0.9876441563834109,0.342198093289068,0.7251504481445559,7380,4,PROX1|MDGA1|DRAXIN
TRANSCRIPTION FACTOR CATABOLIC PROCESS%GOBP%GO:0036369,0.507923067618241,0.9179996794142941,0.601213123793769,0.9826663345502429,4198,2,MDM2|TAF1
PRE-REPLICATIVE COMPLEX ASSEMBLY INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902299,0.3849716336690979,0.8593496731626808,0.559295772594672,1.06316242799561,3324,3,CDC45|WDR18|ORC3
FUSION OF VIRUS MEMBRANE WITH HOST PLASMA MEMBRANE%GOBP%GO:0019064,0.5800336983993261,0.942746898746279,0.34716906916801604,0.903608146782379,5507,7,CXCR4|CCR5
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070168,0.10909893992932901,0.58452352834625,-0.325715197920981,-1.37057208995987,493,17,NOTCH1|SRGN|PTK2B|FAM101B|FAM101A|NOS3|GREM1
POLY-N-ACETYLLACTOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0030311,0.0136215038140211,0.256136946817111,-0.6238527064876489,-1.8198060226515298,74,7,B3GNT5|B3GNT7|B3GNT8|B3GNT2
CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061684,0.494154454141281,0.91071489001692,-0.41460320961782393,-0.9535007684766109,3000,4,HSPA8|LAMP2|HSP90AA1|CLU
DNA CYTOSINE DEAMINATION%GOBP%GO:0070383,0.45157967032967,0.886411023801201,-0.389035958526362,-0.984818695693025,2629,5,APOBEC3D|APOBEC3C|APOBEC3G|APOBEC3F|CDADC1
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903762,0.895004233700254,0.998125596923226,0.43804795714577704,0.715977352073438,7398,2,RNF207|NOS1AP
MITOCHONDRIAL TRANSPORT%GOBP%GO:0006839,0.000821018062397373,0.0849637591935908,-0.193915712452382,-1.59017010726731,0,172,MUL1|SLC25A5|ZNF205|ATP5F1|THEM4|HSPA4|BAX|ATP5J|TOMM34|PPIF|TP53BP2|TOMM22|GZMB|TIMM50|MRPL18|ROMO1|UCP2|SAMM50|COX5B|TOMM20|BBC3|MPV17L|TIMM10B|AIP|C19orf52|TIMM23|SLC25A32|MFN2|YWHAH|CCDC109B|BCL2L1|CAMK2A|ATP5I|BOK|BID|ACAA2|SLC25A15|YWHAQ|YWHAB|PMPCA|DNLZ|CYC1|TIMM22|SLC25A33|BCL2|TP53|YWHAZ|YWHAE|SLC35F6|PARK2|BNIP3L|BMF|SLC25A13|SLC25A16|TIMM23B|FBXO7|SLC25A18|LETM1|MID1IP1|BCL2L11|PMAIP1|TFDP2
POSITIVE REGULATION OF SYNAPSE STRUCTURAL PLASTICITY%GOBP%GO:0051835,0.643221476510067,0.9621972042482541,0.6836127040141159,0.9081489791578191,4791,1,CAMK1
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0006509,0.700812274368231,0.968713135448817,-0.188704955619901,-0.827560529381289,3105,19,ADAM10|NCSTN|PSEN2|ADAM17|MYH9
PEROXISOME TRANSPORT ALONG MICROTUBULE%GOBP%GO:0036250,0.851677852348993,0.991298302704726,0.574823555359506,0.7636274485981821,6344,1,PEX14
ORGANELLE INHERITANCE%GOBP%GO:0048308,0.7169030732860521,0.971081608033886,-0.23586092937091102,-0.7979528277220391,3638,10,PLK3|VCPIP1|PDCD10|YWHAZ
POSITIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901033,0.6942203194467309,0.96731875442989,-0.35373509797575303,-0.8135168274937781,4215,4,TNF
NEUROLOGICAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001976,0.24980361351139002,0.7613646381106121,-0.5815387130912819,-1.18021553994479,1589,3,SOD2|DRD2
NEGATIVE REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051585,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
CTP METABOLIC PROCESS%GOBP%GO:0046036,0.37655739687915796,0.853374872190571,0.653101736972705,1.06747684732762,3112,2,CTPS2|CTPS1
TRACHEA CARTILAGE DEVELOPMENT%GOBP%GO:0060534,0.749261744966443,0.9749763305090959,0.628418614909572,0.834826094165322,5581,1,LRP6
REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071877,0.0036241610738255,0.143595610377104,0.9979047198941329,1.32567190069352,26,1,RGS2
CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS%GOBP%GO:0071499,0.8107519070105341,0.9852684165902109,-0.249891920724456,-0.7289458194493341,4463,7,MAPK7|MAP2K5|ASS1
PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1990778,0.914699162223915,1.0,-0.0969334128118417,-0.7757787537713109,1200,154,INPP5K|RILPL2|MYADM|TSPAN5|GCC2|EHD3|TSPAN33|VAMP2|RAB8A|EHD2|RAMP2|SLMAP|PVRL3|PLEKHF1|MAP7|TMED2|PDZD11|SLC9A3R1|KIF13A|DLG1|RILPL1|GOLGA7|TNF|CAV1|RAMP1
NEGATIVE REGULATION OF RESPIRATORY BURST%GOBP%GO:0060268,0.267801319902744,0.7826111979723571,0.609738612551009,1.15904896036502,2312,3,INS|RPS19|SLAMF8
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:1902474,0.39133958550422604,0.861275178639796,0.557019962501379,1.0588363524145,3379,3,DVL1|MAPT|NLGN2
FIBROBLAST ACTIVATION%GOBP%GO:0072537,0.321603563474388,0.822751772025005,-0.666666666666667,-1.1402976289505,2165,2,RGCC|IL17RA
REGULATION OF 1-PHOSPHATIDYLINOSITOL-3-KINASE ACTIVITY%GOBP%GO:0061901,0.997219647822057,1.0,-0.5016541685046321,-0.6710780765160179,7531,1,AGAP2
REGULATION OF IRON ION TRANSPORT%GOBP%GO:0034756,0.8906635929524119,0.997300970905927,-0.289289259744028,-0.6653048627680059,5408,4,B2M
AMYLOID FIBRIL FORMATION%GOBP%GO:1990000,0.174001857010214,0.676682497340677,-0.412731603673755,-1.2829495306268501,936,8,CD36|FKBP1A
SOMITOGENESIS%GOBP%GO:0001756,0.51428852008249,0.920771046603905,0.29695720310231394,0.9583912738493701,5236,13,RIPPLY2|HES1|LEF1|HES6|LFNG
"PROTEIN IMPORT INTO PEROXISOME MATRIX, TRANSLOCATION%GOBP%GO:0016561",0.89234305068344,0.9976191001250191,0.440182895257446,0.71946684976678,7376,2,PEX14|PEX6
METANEPHRIC GLOMERULAR MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072254,0.6561247216035639,0.9640743070248079,-0.4995864350703061,-0.854515841049754,4418,2,PDGFB|CD34
POSITIVE REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903974,0.587935625795994,0.945418171231938,0.484449101135988,0.9208867791269519,5077,3,CSF1|TLR4|TLR2
POSITIVE REGULATION OF RNA INTERFERENCE%GOBP%GO:1900370,0.8057718120805369,0.984682960940884,0.598037053374504,0.794465545083538,6002,1,XPO5
GLYCINE BIOSYNTHETIC PROCESS FROM SERINE%GOBP%GO:0019264,0.27720861172977,0.7884684708511421,-0.693168064088269,-1.18562684991609,1866,2,SHMT2
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061428,0.241561007739173,0.7552372756595149,-0.518253257097652,-1.19187422442683,1466,4,CITED2|VHL
CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY%GOBP%GO:0097646,0.004464285714285711,0.155321503601441,-0.773494374586367,-1.95804964659692,25,5,RAMP3|CALCRL|RAMP2|ADM|RAMP1
OVARIAN CUMULUS EXPANSION%GOBP%GO:0001550,0.39557046979865795,0.8638522656500329,0.8097154830172031,1.0756708952196,2946,1,BMPR1B
SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060395,0.37867975022301503,0.854868503740915,0.254968325782389,1.069064658785,4244,30,CITED1|LEFTY1|INHA|BMP4|SLC33A1|TGFB2|GDF11|FOS
REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0048814,0.75564747056952,0.977296193682297,-0.13617319631862299,-0.8185941013935991,2374,48,CDK5|HECW2|CHRNB2|NEDD4L|NSMF|BHLHB9|YWHAH|EFNA1|ARC|FMR1|NEDD4|CHRNA3|RELN|SDC2
REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904020,0.649332285938727,0.963755998259649,-0.41899194882541096,-0.850331711343664,4132,3,APLN|UBQLN2|NECAB2
CLUSTERING OF VOLTAGE-GATED SODIUM CHANNELS%GOBP%GO:0045162,0.40963297441241203,0.867015886388254,0.55023712363516,1.04594288925768,3537,3,SPTBN4|AGRN|NRCAM
METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072224,0.3528733739502721,0.842847021021096,-0.464512215298075,-1.06828105518469,2142,4,PDGFRA|PDGFB|PDGFRB|CD34
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001235,0.0005285412262156451,0.0784645998831315,-0.32547214520992,-2.45933238971006,0,112,TIMP3|DEDD2|PYCARD|ZNF205|BAX|GPER1|SOD1|FBXW7|TRIM39|PPIF|TP53BP2|GZMB|BCLAF1|MSX1|DAB2IP|TGFBR1|LGALS9|CIDEB|BBC3|PML|RPS3|RET|S100A8|HRK|BCL10|YWHAH|DDIT3|DFNA5|MMP9|CYLD|BCL2L1|BOK|BID|CRADD|YWHAQ|YWHAB|PLAUR|PPP2R1B|BCL2|TP53|YWHAZ|YWHAE|BMF|SLC9A3R1|WWOX|BCAP31|BIK|BCL2L11|PMAIP1|TFDP2|CAV1|PAK2|UBB
LEUKOCYTE MIGRATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002522,0.766582814775586,0.9792236089291529,-0.6129245699161889,-0.819927885090356,5789,1,HCK
RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046390,0.679127725856698,0.9647315640607691,-0.11649683030927198,-0.910445782665158,1089,131,AK9|GUCY1B3|ATP5F1|DHODH|HSD17B12|ATP5J|LDHA|PAPSS1|SCD|ADCY7|CMPK1|ACSL1|PFKL|COX5B|GPI|GMPS|GUCY1A3|PRPS1|G6PD|PKM|ENO1|ACSL4|HPRT1|ATP5I|PRPSAP1|PDHB|GAPDH|PGK1|PANK2|CYC1|HK1|HK2|TPI1|ACLY|ADCY2|ALDOA|SLC25A13|ACSL3|ADM|PGAM2
NEGATIVE REGULATION BY SYMBIONT OF HOST CATALYTIC ACTIVITY%GOBP%GO:0052053,0.679200317754535,0.9647315640607691,-0.655546978385532,-0.876945180446136,5129,1,CASP8
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000697,0.7598657718120809,0.977664504547119,0.622959858844288,0.827574380264965,5660,1,STAT1
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903209,0.754317607413648,0.977083996023335,0.293001556986998,0.7626214931758221,7162,7,HDAC6|SFPQ|RIPK1|TLR4
POSITIVE REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:2001262,0.428322147651007,0.8769245997339999,0.7929532421702691,1.05340300607103,3190,1,HAND2
PEROXISOMAL LONG-CHAIN FATTY ACID IMPORT%GOBP%GO:0015910,0.9664429530201339,1.0,0.5190229378032639,0.6894988176167571,7199,1,ABCD1
WATER-SOLUBLE VITAMIN METABOLIC PROCESS%GOBP%GO:0006767,0.34694615106613697,0.842847021021096,-0.166646460564784,-1.0743557744836099,959,62,DHFRL1|HLCS|ABCC1|TCN2|SLC2A3|MMACHC|SLC25A32|MTRR|ACP5|SHMT2|PANK2|FPGS|PNPO|MMAA|CYB5A|PDXK|SLC2A1|PC|PRSS3
ALKALOID METABOLIC PROCESS%GOBP%GO:0009820,0.181660298714832,0.6873049536419911,0.656336164111614,1.2476260040033,1568,3,CYP3A5|BCHE|CYP2D6
SMOOTH MUSCLE HYPERTROPHY%GOBP%GO:0014895,0.493446312723421,0.910654969509744,-0.7508822232024699,-1.004478044185,3726,1,CYBA
NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903215,0.13134328358209,0.614977698445854,-0.679513941460148,-1.3790533549475301,835,3,BAG4|SIAH3
RESPONSE TO HORMONE%GOBP%GO:0009725,0.0130548302872063,0.24907954422399,-0.145415277166981,-1.33560202104651,4,363,INPP5K|HDAC5|ZNF703|PPARA|FOXO1|PKM|CPEB2|GNA15|ATP6V0C|YWHAH|PXN|ATP6V1F|IL6|PPARG|LYN|VAMP2|CHRNA7|NAMPT|CAMK2A|POU4F2|PRKAR2A|GCGR|RUVBL2|PAX8|FOXC2|LPIN1|TIMP2|RAB8A|PTPN1|RAMP2|LEPR|MSN|NRIP1|NEDD4|PPARGC1A|HRH3|CHRNA3|SLC25A33|STAT5A|NR3C1|CTSH|SHC1|JUN|ATP6V1E2|ATP6V0D1|STAT3|MKKS|PRKAR1B|KLF9|UBE2L3|ADCY2|NOS3|ADCYAP1|CAV2|ATP6V1E1|ABCG1|UCN3|ADRA2A|RNF4|RHOQ|CHRM1|PLCB1|IGF2|NR1D1|NR1D2|PIK3R1|AQP1|TNF|BCL2L11|CAV1|SLIT3|FOXO6|TRIB3|INHBB|APPL1|FOXO3|RAMP1
S-ADENOSYLMETHIONINE METABOLIC PROCESS%GOBP%GO:0046500,0.30530498281786894,0.8085598515544019,0.464785811703344,1.1430730143521,2842,6,GAMT|MAT2A
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:2000691,0.341983317886932,0.8359038216207221,-0.8303925893250992,-1.11084148519798,2582,1,PRICKLE1
NEUTROPHIL DEGRANULATION%GOBP%GO:0043312,0.0185758513931889,0.285640366687651,-0.140352781480572,-1.30784914371378,5,398,TYROBP|PRKCD|AP1M1|SIRPA|GM2A|TMEM30A|C5AR1|ITGAX|NRAS|ITGAM|GHDC|A1BG|PFKL|SLC2A3|LAMP1|DERA|ATP11A|ARL8A|FGR|HP|GPI|NFAM1|ADAM10|S100A8|RHOA|STK10|DDX3X|PSAP|PA2G4|VAT1|TNFRSF1B|PLAU|FTH1|ATP6AP2|CPNE3|PKM|RAB18|RAB6A|ATP6V0C|NCSTN|AGA|PNP|CD68|RAP2B|MMP9|CHIT1|VAMP2|CDA|HVCN1|TOM1|ARPC5|SLC11A1|ATG7|CRACR2A|CAB39|RAP1A|TIMP2|KCNAB2|RAB37|YPEL5|PLAUR|CPPED1|CD93|CFD|LGALS3|FTL|DBNL|SERPINA1|RAB5C|STOM|CSTB|CTSH|PYGB|COTL1|PAFAH1B2|ACLY|ALOX5|TUBB4B|B2M|OSCAR|ANO6|HSPA6|CRISPLD2|RAB7A|PDXK|ALDOA|ANPEP|CHI3L1|PSMD6|LPCAT1|RAC1|DYNC1LI1|ACTR2|CD36|HSP90AB1|GOLGA7|PRSS3|SNAP25|ENPP4
TAXIS%GOBP%GO:0042330,0.244107744107744,0.7571583779245891,-0.121610467325855,-1.0954369819740901,144,289,FCER1G|RAB13|CX3CL1|MAPK7|DOK1|PRKCD|LPAR1|C5AR1|ANOS1|CXCL16|BCAR1|ABCC1|ARRB2|VASP|GRB2|SEMA3F|CCR10|SCN1B|RET|CYFIP2|S100A8|CCL14|FGF7|FYN|RHOA|NRP1|FOSL1|PLAU|SEMA7A|FGF2|HGF|IL6|HBEGF|TUBB3|NFIB|SBDS|EFNA1|POU4F2|UNC5C|RALA|PLAUR|PDE4B|LGALS3|TNFRSF11A|SEMA6B|ALCAM|PLXNA1|CXCL8|SHC1|PRKCA|PLXNA4|EPHA8|RELN|ACKR3|CXCL14|GAB2|SCG2|MAPK3|FLT1|FGF10|EPHA7|PTPRM|S1PR1|EFNB1|SEMA3A|MET|SEMA3G|CCL18|MAP2K1|DOK5|PTPRA|PIK3R1|GFRA2|SLIT3|EPHB2
NEGATIVE REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000320,0.99914089347079,1.0,0.16152378746065302,0.39724423158609795,9303,6,LOXL3|RC3H1|FOXP3|ZC3H12A
DIPHOSPHOINOSITOL POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0071543,0.35353202700477504,0.842847021021096,-0.46434677108035105,-1.06790056804643,2146,4,NUDT3|NUDT11|NUDT10|NUDT4
POSITIVE REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002839,0.951078666376117,1.0,0.24980997622179102,0.5757749629852739,8728,5,KLRK1|HSPD1|PVR|PVRL2|CD274
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0098815,0.8438530381535558,0.991298302704726,-0.158577778987358,-0.7202279204504409,3582,21,MTMR2|PTK2B|CHRNA7|CBLN1|RELN|TMEM108
"RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:0030970",0.727168841062756,0.972554563883587,0.22182922054192897,0.795746638632247,7635,18,HSP90B1|SYVN1|AUP1|HERPUD1|VIMP|NPLOC4|VCP|FAF2|SEL1L|SEC61B|DERL1|UFD1L
POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION%GOBP%GO:0043382,0.280875771138261,0.789038489620028,0.6947339398952299,1.13552353930097,2321,2,IL12RB1|CD46
NEGATIVE REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032463,0.72611696331275,0.972554563883587,-0.271591057792602,-0.7922431649802629,3997,7,GBA|RIOK3|CLU|PEX5
POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070863,0.408043732916829,0.867015886388254,-0.316251103265666,-1.02088690128248,2089,9,SORL1|SEC16A|SAR1B|TM9SF4|EDEM2|SAR1A|EDEM1|TMEM30A|BCAP31
MUSCLE CELL DIFFERENTIATION%GOBP%GO:0042692,0.0698098256735341,0.5072929017022371,0.260367423732333,1.3932194704249798,880,81,NEB|IGSF22|TBX2|GLMN|ACTN2|HES1|BMP4|MAML1|KCNH1|SYNE1|MYH3|PROX1|TCAP|CACNA1H|RORA|OBSCN|KRT19|NEBL|SEPN1|HEY2|CXADR|LMOD1|OBSL1|SEMA4C|DMD|KDM1A|KIAA1161|NRG1|SLC8A1|TMEM204|MYEF2|GATA6|MYOM2
CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0086003,0.0330295099720242,0.371559593752943,0.391881273825359,1.59319793292541,365,27,RYR2|KCNN2|SCN1A|CACNA1G|CACNB2|FGF12|KCNQ1|CACNA2D1|KCNH2|CACNA1D|GJA1
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0060566",0.823355704697987,0.987616425875001,0.5898213498015,0.783551349415324,6133,1,SETX
NEGATIVE REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000626,0.502147651006712,0.9159769483621171,0.7523709748566391,0.999491274448172,3740,1,PAPD4
MONOUBIQUITINATED HISTONE H2A DEUBIQUITINATION%GOBP%GO:0035522,0.603161534661617,0.9508825506493929,-0.379323977210276,-0.8723659040290591,3662,4,ASXL1|USP16|BAP1
ER-NUCLEUS SIGNALING PATHWAY%GOBP%GO:0006984,0.6780063291139239,0.9647315640607691,-0.16505196150681398,-0.856294865764683,2570,30,TMCO1|CALR|ERLIN2|ATF4|INSIG1|EIF2S1|HSPA5|EIF2AK3|DDIT3|ATF6|CXCL8|TP53
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS%GOBP%GO:0031293,0.105821299638989,0.578958223759927,-0.31335281099312107,-1.3742003610700901,468,19,NFKB1|APH1A|TGFB1|PSEN1|PSENEN|APH1B|RELA|TRAF6|RHBDD1|ADAM10|NCSTN|PSEN2|ADAM17
MRNA 3'-SPLICE SITE RECOGNITION%GOBP%GO:0000389,0.0434094903339192,0.411224194190211,-0.58927954547788,-1.61753278510885,246,6,ISY1|SF3A1|SLU7
POSITIVE REGULATION OF L-DOPA DECARBOXYLASE ACTIVITY%GOBP%GO:1903200,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0002042,0.584113041817835,0.9439064862850342,0.25750406041838797,0.9081796342839921,6117,17,EGR3|NR4A1|PIK3R3|MIA3
CELLULAR COMPONENT MAINTENANCE%GOBP%GO:0043954,0.9141121237227281,1.0,0.160294451529494,0.623417706369005,9929,23,CAMSAP3|F2R|F2RL1|RAB3A|SUPT6H|SUPV3L1|CSF1R|PICK1|MTHFR|KIAA1715|NLGN2|KIFC3|PLEKHA7|PKP2
PHOSPHORELAY SIGNAL TRANSDUCTION SYSTEM%GOBP%GO:0000160,0.13194630872483198,0.616407751583866,0.934936038817821,1.24202081711566,982,1,MMS19
REGULATION OF SPINDLE ORGANIZATION%GOBP%GO:0090224,0.455099199443091,0.88900512246363,0.22582368507919098,1.0040352260068102,5229,37,GNAI1|TPR|FSD1|PSRC1|SPAG5|BORA|CCSAP|NUMA1|GPSM2|CEP97|PLK1|CLTC|DYNC1H1|TPX2|SMC3
CARDIAC CONDUCTION%GOBP%GO:0061337,0.0573205008091304,0.466249908595289,0.31646285301848803,1.46715344512403,672,43,RYR2|KCNN2|TNNI3K|KCNK6|CACNA1G|AKAP9|CACNB2|KCNK3|KCNQ1|CACNA2D1|KCNH2|CACNA1D|GJA1|GJC3|CXADR|SPTBN4|SCN3B|SLC8A1
LOCOMOTORY BEHAVIOR%GOBP%GO:0007626,0.181093998937865,0.686812867800089,-0.23318543909438397,-1.22621371917824,681,31,CIART|CHRNA3|DRD2|PARK2|USP2|RASD2|GPRC5B
CHONDROITIN SULFATE CATABOLIC PROCESS%GOBP%GO:0030207,0.7929104477611941,0.9819233677232551,-0.20451206555906,-0.7450579694237379,3824,12,CSPG4|NCAN
CELLULAR RESPONSE TO FRUCTOSE STIMULUS%GOBP%GO:0071332,0.663772143105245,0.964618776001639,0.458475791331201,0.8715142494776871,5732,3,XBP1|SLC2A5|SLC26A6
POSITIVE REGULATION OF ODONTOGENESIS%GOBP%GO:0042482,0.22262372348782397,0.7355723797115551,-0.599977941987427,-1.21763740713596,1416,3,BMP2|CD34|WNT6
MEMBRANE LIPID CATABOLIC PROCESS%GOBP%GO:0046466,0.6197053406998161,0.9532238181782521,-0.19788044378208303,-0.882923838531771,2691,20,SMPDL3A|MGST2|PDXDC1|SMPD3|SMPD1|SMPD4|NEU3|GALC|PPT1|GLA|NAGA|FUCA1|NEU1|CYP1B1|GBA|SGPL1|SPHK1|NEU4|ASAH2|ASAH2B
VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010573,0.9092798812175201,1.0,-0.38108629721533,-0.651827701710248,6123,2,ADGRG1|HIF1A
PROTEIN DEMALONYLATION%GOBP%GO:0036046,0.9663709784191709,1.0,-0.515659461843847,-0.6898133844337,7298,1,SIRT5
SMALL RNA LOADING ONTO RISC%GOBP%GO:0070922,0.973886639676113,1.0,0.18056291402143804,0.515264862462029,9621,9,DHX9|DICER1|TARBP2|AGO4
REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046984,0.915444058685183,1.0,0.299663922502065,0.635016477171206,8173,4,PRMT1|LDB1|KLF4
NEGATIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904030,0.9249539594843459,1.0,-0.143787602803996,-0.641566694386405,4017,20,CDKN2A|MEN1|APC|PLK1|INCA1|TFAP4|CAMK2N1|CDK5RAP1|LATS2|HEXIM2|LATS1|IPO7|NR2F2|HHEX|IPO5|CDKN1B|HEXIM1|CEBPA|CDKN1C|CDKN1A
REGULATION OF INTERMEDIATE FILAMENT POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0045108,0.37097841917119007,0.852609194081082,-0.8125275694750771,-1.08694290344472,2801,1,NES
HETEROCHROMATIN ASSEMBLY INVOLVED IN CHROMATIN SILENCING%GOBP%GO:0070869,0.45531576856878103,0.88900512246363,-0.771338773709749,-1.03184339551358,3438,1,POLE3
DISRUPTION BY SYMBIONT OF HOST CELL%GOBP%GO:0044004,0.179663709784192,0.68489956912038,-0.907697397441553,-1.2142544840192,1356,1,GAPDH
SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:0035019,0.23818407960198998,0.7507739897770379,-0.326656226453313,-1.19004139983438,1148,12,SKI|FGF2|SMAD2|FOXP1|STAT3
EMBRYONIC ORGAN DEVELOPMENT%GOBP%GO:0048568,0.179467738266737,0.68489956912038,0.212534862189233,1.2168832275338899,2366,117,RYR2|HOXD3|SIX3|TBX2|HOXB3|HOXD4|STRC|HES1|RARRES2|RARB|HOXC4|E2F8|PROX1|PKD2|AHI1|CEP290|DFNB31|MTHFD1|PKDCC|FOXN4|EFEMP1|TGFB2|PDZD7|E2F7|FBN1|STIL|TAL1|LEF1|BBS5|KIT|NIPBL|VANGL2|HEY2|COL5A2|SRF
REGULATION OF MITOTIC CYTOKINESIS%GOBP%GO:1902412,0.9665733574839449,1.0,-0.246582946929232,-0.567089264955228,5869,4,ANKRD53|MAP9
"ENDONUCLEOLYTIC CLEAVAGE TO GENERATE MATURE 5'-END OF SSU-RRNA FROM (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000472",0.32914375490966197,0.828303707528737,-0.5401540234430939,-1.0962265418969201,2094,3,NOP14
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:1901844,0.0151490202535814,0.264387156924099,-0.764628026250483,-1.75848472398619,91,4,CAMK2D|SRI|PDE4D|CAV1
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF HEART RATE%GOBP%GO:0086024,0.0238315900966503,0.32397355287938,-0.9889170710189681,-1.3229045177308,179,1,PDE4D
NEGATIVE REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010693,0.68852062416838,0.96731875442989,0.533829611248966,0.872529834429139,5691,2,TGFB2|SEMA4D
INOSITOL PHOSPHATE DEPHOSPHORYLATION%GOBP%GO:0046855,0.45962858296326203,0.890371861972445,-0.28075692375593103,-0.988018594001925,2276,11,IMPA1|IMPA2|OCRL|INPP5J|PTEN|SYNJ1|INPP5B|SYNJ2|INPP1|INPP5K|INPP5A
GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009064,0.829192277724872,0.9876441563834109,0.162473494715578,0.727846698625472,9577,38,SIRT4|ART4|ASRGL1|GGT1|GLS|GLS2|CAD|CPOX
ORGANIC ACID CATABOLIC PROCESS%GOBP%GO:0016054,0.39447218001591794,0.863562957467761,0.171227753973586,1.04782624734757,5451,179,CROT|CTH|GLYATL2|IDO1|SLC27A2|ASRGL1|ETFDH|HSD17B4|MCCC2|ACADVL|IDNK|BDH2|ETFA|FTCD|DECR2|TST|GLS|HRSP12|ABHD3|PCYOX1L|GLS2|AMACR|ACADM|DECR1|HMMR|AIG1|CDO1|ALDH3A2|HADH|AMDHD2|ETFB|TXN2|BCKDHA|ACOX2|ECHDC2|MCEE|SARDH|ABAT|GSTZ1|BCAT2|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|ABHD10|ADO|FAAH|HMGCLL1|MCCC1|C9orf41|AKR1A1|PHYKPL|ECI1|PPM1K|CCBL1|AASS|ECI2|HADHB|ACAT2|QPRT|HMGCL|HIBCH|ABHD2|AFMID|ACADS|LYVE1|PCK2|ACOT7|PM20D2|HIBADH|ECHS1
POSITIVE REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060335,0.7963864886095842,0.9828568923066779,-0.36649387890151097,-0.7437884382192671,5068,3,PARP9|TXK|NLRC5
POSITIVE REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001040,0.18582841264327898,0.6921962082288221,0.6537201204637559,1.24265318022618,1604,3,HDAC6|RIPK1|KMT2A
CEREBROSPINAL FLUID SECRETION%GOBP%GO:0033326,0.025155567324242,0.329326373353219,-0.988034847816498,-1.3217243408540902,189,1,AQP1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904750,0.560307162716801,0.936434965680841,-0.713608292898103,-0.9546155711442409,4231,1,POLR1A
POSITIVE REGULATION OF DNA BINDING%GOBP%GO:0043388,0.0473727198475361,0.42809843010511295,-0.278539615536052,-1.4898444690483899,173,33,PARK7|CEBPG|TRAF6|FAM129B|FOXC1|TXN|PINX1|CTNNB1|SKI|H1F0|PPARG|MMP9|POU4F2|IGF1|PLAUR|PARK2|DDRGK1|TWIST1
REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051340,0.6920913884007031,0.96731875442989,-0.295712503917635,-0.8117109676113091,3937,6,MID1IP1
PEPTIDYL-SERINE ACETYLATION%GOBP%GO:0030920,0.19852348993288602,0.711592141628341,0.9029554477282751,1.19953602860852,1478,1,NAA10
POSITIVE REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045830,0.535460992907801,0.9265056012720759,-0.273624979312628,-0.9257142611972758,2717,10,PAXIP1|RIF1|FAM35A|TP53BP1|CLCF1|TGFB1|MAD2L2|TNFSF13|C20orf196|TFRC
POSITIVE REGULATION OF RECEPTOR BINDING%GOBP%GO:1900122,0.0319368131868132,0.365066918595497,-0.669136850367608,-1.69387550373319,185,5,NRP1|MMP9|B2M
CHEMOKINE (C-C MOTIF) LIGAND 21 SIGNALING PATHWAY%GOBP%GO:0038116,0.8611154752553021,0.991915800284466,-0.340432505297096,-0.690897654806522,5480,3,OXSR1
NEGATIVE REGULATION OF CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1902081,0.292201774129485,0.8000726114371469,-0.853936921041023,-1.14233745559503,2206,1,PLN
REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090283,0.636100497858053,0.95916055221954,0.468457042020514,0.89048755704991,5493,3,ACER2|TMEM59|ARFGEF1
NEGATIVE REGULATION OF CELL AGING%GOBP%GO:0090344,0.43539271097252,0.878651088001772,0.3090150995963061,1.0238630535450899,4467,14,SIRT1|CDK6|TERT|FBXO5|AKT3|FOXM1|MARCH5|SLC30A10
SPERM MOTILITY%GOBP%GO:0097722,0.6708650190114069,0.964618776001639,-0.183003298821151,-0.847806775563308,2822,22,ATP2B4|SORD|DNAI1|LRRC6|IQCG
CONSTITUTIVE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051089,0.319475705017874,0.8219996514077841,-0.8415306572562858,-1.1257412182663702,2412,1,ADAM10
POSITIVE REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071657,0.7765404602821079,0.980802382590629,-0.448304383788255,-0.766800638822792,5229,2,ISL1|CD34
SPLICEOSOMAL TRI-SNRNP COMPLEX ASSEMBLY%GOBP%GO:0000244,0.573098840636667,0.941109558729187,0.289348773984654,0.912130739071773,5832,12,DDX20|PRPF8|SART3|PRPF3|SRSF10|SRSF12|PRPF31
"REGULATION OF INOSITOL 1,4,5-TRISPHOSPHATE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0031585",0.606784126461387,0.9508825506493929,-0.377627394630659,-0.868464118524457,3684,4,HAP1|HTT
POSITIVE REGULATION OF MITOTIC COHESIN LOADING%GOBP%GO:1905406,0.41006711409396,0.867015886388254,0.8022717247463609,1.06578219444638,3054,1,NIPBL
NEGATIVE REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050711,0.7081365782782421,0.9695170059473192,-0.276613348041919,-0.806893408456271,3898,7,CARD16|CPTP|ZC3H12A|CARD8|GAS6|TNFAIP3|NLRP3
HYPOTONIC SALINITY RESPONSE%GOBP%GO:0042539,0.622798887859129,0.9536478716552259,-0.682068813409793,-0.9124242478020609,4703,1,SLC12A6
NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901533,0.193974689214918,0.7049101024373008,0.5886512146580211,1.24740815475414,1731,4,HES1|DPF2|N4BP2L2
N-ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0070292,0.18013422818791897,0.6854786197196999,0.9116122629025141,1.2110362213595902,1341,1,NAPEPLD
PALMITIC ACID METABOLIC PROCESS%GOBP%GO:1900533,0.9410541945063101,1.0,-0.357871519161842,-0.6121200671537421,6337,2,ACOT7|ACOT11
REGULATION OF TYROSINE 3-MONOOXYGENASE ACTIVITY%GOBP%GO:1903176,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA CYTOTOXIC T CELL EXTRAVASATION%GOBP%GO:2000454",0.908322147651007,1.0,0.547640052933392,0.7275153783671121,6766,1,FADD
POSITIVE REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000664,0.7233579291157609,0.97235201976979,0.518169285911221,0.8469334628788989,5979,2,GATA3|PRKCZ
REGULATION OF ATP:ADP ANTIPORTER ACTIVITY%GOBP%GO:0070926,0.520671140939597,0.9249983657048559,0.7437141596824001,0.987991081697101,3878,1,RIPK1
COLON EPITHELIAL CELL MIGRATION%GOBP%GO:0061580,0.9582947173308621,1.0,-0.518857520952801,-0.6940915256117529,7237,1,ARSB
NEGATIVE REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905025,0.372037600953264,0.852609194081082,-0.81181076312307,-1.0859840097324,2809,1,KCNE3
GLUCOSAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:1901071,0.9178173507285021,1.0,0.170321321251473,0.610977302909672,9637,18,OVGP1|EXTL2|AMDHD2|LARGE|PGM3
MODULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043921,0.6627235213204951,0.964618776001639,0.215514882655552,0.848158344689672,7226,24,GTF2B|CCL5|LEF1|PSMC3|SMARCA4|SP1|TFAP4|TARDBP|REST|CCL4|CHD1|SNW1|NUCKS1|EP300|RRP1B
"POSITIVE REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902958",0.900816629547142,0.998912093067348,-0.38682106424041895,-0.661636713572188,6066,2,PINK1|PARK7
ZONULA ADHERENS MAINTENANCE%GOBP%GO:0045218,0.503762880629848,0.9168938417530409,0.515160281793884,0.979265502862674,4350,3,CAMSAP3|KIFC3|PLEKHA7
PRONEPHROS MORPHOGENESIS%GOBP%GO:0072114,0.19852348993288602,0.711592141628341,0.90301058667843,1.1996092782438799,1478,1,AHI1
POSITIVE REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903036,0.483762597984323,0.9064456896937672,-0.17830863454276502,-0.9808565445541859,1727,36,USF1|PDPN|PPAP2B|HBEGF|SERPINF2|FOXC2|THBD|ANO6|ADRA2A|ENPP4
CEREBRAL CORTEX TANGENTIAL MIGRATION%GOBP%GO:0021800,0.0803556726494319,0.536105877813735,-0.648817073843269,-1.49214372720502,487,4,SLIT2|ROBO1|LHX6|RELN
NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:0007406,0.40013422818792,0.8638522656500329,0.807234230260256,1.0723746616285301,2980,1,NF1
THERMOCEPTION%GOBP%GO:0050955,0.675704697986577,0.9647315640607691,0.666795324217027,0.885807840373891,5033,1,TRPV1
NEGATIVE REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010826,0.18471337579617803,0.690839705636971,0.418124124055139,1.2756008562633798,1855,11,KAT2A|CDK5RAP2|TRIM37|CCNF|MDM1|TMEM67|BRCA1|KAT2B
PHENYLACETATE CATABOLIC PROCESS%GOBP%GO:0010124,0.7995973154362421,0.9839175016931591,0.6015659461843851,0.7991535217463951,5956,1,ACAA1
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901889,0.0239410681399632,0.32397355287938,-0.374140583440556,-1.66937992339272,103,20,BCAS3|DLC1|APOD|ACVRL1|ACE|CORO1C|TNF
NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032351,0.577295703454086,0.942692029750853,0.347986762272477,0.905736430135874,5481,7,WNT4|REST|CYP27B1|AKR1C3|BMP2|DKK3|NFKB1
COFACTOR CATABOLIC PROCESS%GOBP%GO:0051187,0.528462415577581,0.9265056012720759,0.21669429708234303,0.9493715729322819,6024,35,NUDT17|GGT1|HBB|HBA2|PRDX4|PRDX3|HBA1|GGT5|CAT|HBQ1|PDXP|VCP|ACOT7|PM20D2|GPX3|NUDT12|PRDX2|CHAC2|ABCD1|MTHFS|ACAT1|PXDN
DIACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046339,0.0686837455830389,0.5037729184803449,-0.349612456965686,-1.47112900742111,310,17,PLCE1|DGKI|DGKD|DGKQ|DGAT2|DGKG|DGKB|DGKK
DISACCHARIDE METABOLIC PROCESS%GOBP%GO:0005984,0.606792589901925,0.9508825506493929,-0.29950863050102194,-0.873679963160764,3340,7,B4GALT1|IDUA|FBP1|SLC2A1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905476,0.9806683236674949,1.0,0.12766301477757,0.49650741558039,10652,23,PKDCC|GBP1|GOPC|CLTC|DAB2|TMEM59|GDI1|CSK|AP2M1
SUCCINYL-COA PATHWAY%GOBP%GO:0006781,0.8613422818791949,0.991915800284466,0.570412439347155,0.7577674777696111,6416,1,SUCLA2
REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060828,0.9466357308584692,1.0,-0.0910288665230884,-0.7365811467570749,1223,162,IGFBP4|FRAT1|RUVBL1|CTNNB1|DAB2IP|GID8|PRICKLE1|PTPRU|LIMD1|GNAQ|DDX3X|ZNF703|TCF7L2|TBL1X|PTK7|DDIT3|CYLD|RUVBL2|PPM1A|RSPO4|JADE1|WNT11|STK4|CCNY|DKK1|PARK2|GREM1|SFRP2|SLC9A3R1|RBMS3|SOX7|SOX17|GPRC5B|SULF2|CAV1|TLE3
CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:0071456,0.000426621160409556,0.0784645998831315,-0.28859796584318703,-2.01710088149409,0,83,VEGFA|PDK3|PLK3|CPEB1|HMOX1|LIMD1|HIGD1A|CITED2|STUB1|HYOU1|BACH1|CPEB2|P4HB|GLTSCR2|LMNA|ACAA2|PGK1|VHL|GNGT1|TCEB1|UBA52|TP53|BNIP3L|UBC|TWIST1|AQP1|EPAS1|PMAIP1|RBPJ|NDRG1|UBB|EGLN3
NEGATIVE REGULATION OF GASTRIC ACID SECRETION%GOBP%GO:0060455,0.0480536912751678,0.431337225587021,0.9752977503308341,1.29563955019709,357,1,PTGER3
FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:0001731,0.40446785325099893,0.8656490201201591,-0.35055072773067103,-1.02257202531153,2226,7,EIF4H|EIF4B|EIF2S3
NEUTRAL AMINO ACID TRANSPORT%GOBP%GO:0015804,0.573324422379225,0.9412682428400659,0.259766000351038,0.916157169773989,6004,17,SLC36A1|SLC43A1|SLC6A17|SLC6A15|SLC6A9|SLC7A9
RNA BIOSYNTHETIC PROCESS%GOBP%GO:0032774,0.975845410628019,1.0,-0.0836970352123427,-0.8089996353928709,201,473,ICE1|POLR3H|FOSL1|CCRN4L|PPARA|KLF13|NELFA|RXRA|PTRF|DDIT3|NRBF2|PPARG|NRL|ARRB1|POLR1B|ELP3|MAFF|NFE2L1|POLR2A|TCF4|TAF1B|PAX8|SUPT4H1|YBX1|TTF2|ETS1|ZNF217|KLF11|TEAD4|DDX21|ASH2L|PHAX|NR1H2|POLR2K|PPARGC1A|NELFE|SNRPB|TCEB1|SLC25A33|TCFL5|HSF1|NR3C1|MLF1|POLR2F|NFKBIB|ELP2|POLR1E|TP53|COPS2|BCL3|TAF4B|MAPK3|NCBP2|NFYA|NUDT21|CDKN1A|TCEA1|POLR2I|POLR2D|RNPS1|CBFB|TRIM29|NR1D1|NR1D2|CD3EAP|SOX17|TAF8|SLBP|TAF13|EPAS1|RBPJ|PBRM1|CRCP|MED10|EAF1|FOXO3|CREB5
UDP-N-ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1990569,0.760504825538233,0.977664504547119,-0.455086848635236,-0.778401681697971,5121,2,SLC35B4|SLC35A3
METHIONYL-TRNA AMINOACYLATION%GOBP%GO:0006431,0.64811902745857,0.963755998259649,0.548795340203228,0.896990907272255,5357,2,MARS|MARS2
MOLYBDENUM INCORPORATION INTO MOLYBDENUM-MOLYBDOPTERIN COMPLEX%GOBP%GO:0018315,0.041744966442952995,0.402998391331252,0.9785509483899429,1.29996127868316,310,1,GPHN
REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048634,0.0795631825273011,0.533892166059414,-0.23026423250714603,-1.3617415951077199,254,46,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|TGFBR1|AKIRIN1|SFMBT1|FGF2|IGF1|UQCC2|SOX6|MTPN|TBX20|DKK1|GREM1|NR1D2|RBM24|RBPJ
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS%GOBP%GO:0071383,0.8677319832291751,0.993084774742015,0.134722252216111,0.7229053255244409,10968,82,PIAS1|MGARP|SAFB|BMP4|RHOXF1|EGLN2|MED12|SRC|CCNE1|SSTR2|RB1|DDX17|MED1|GRIP1|MED17|RNF14|CDK7|MED24|FHL2|THRAP3|ABHD2|ARID1A|MED30|TRIP4|PCK2|DDX5|MED14|BRCA1|RBFOX2|NCOA3|MED16|REST|UBR5|NCOA6|URI1|ANXA1|PPAP2A|ISL1|MED13
INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0042226,0.279359195021846,0.788692060817727,-0.860277900308778,-1.15081997689634,2109,1,BCL10
GOLGI VESICLE DOCKING%GOBP%GO:0048211,0.511310027821459,0.918404893008545,0.5997257590657579,0.9802352777626079,4226,2,USO1|NSF
CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090346,0.20308724832214803,0.7175864987119879,0.900639611821791,1.19645954392352,1512,1,POR
CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0030004,0.928991102904146,1.0,0.13161003846963001,0.63244533083551,11067,50,TMEM165|SLC9A5|SLC9A7|ATP1B3|DMXL2
NEGATIVE REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002792,0.0920031055900621,0.5622489437340121,-0.194181991506452,-1.3113878307740099,236,72,SYT11|IL1B|SRGN|CX3CL1|TNFAIP3|NR1H3|PFKL|SSC5D|RAB11FIP1|FCGR2B|TMSB4X|DPH3|CRH|NLRP3|TNFRSF4|DRD2|PPP1R11|PARK2|ADRA2A|RAB11FIP5|CD22|TNF|TNFRSF21|INHBB
SPERM CHROMATIN CONDENSATION%GOBP%GO:0035092,0.707908611599297,0.9695170059473192,-0.292122446692279,-0.8018565015824219,4027,6,CHD5|PSME4|TSSK6|PIWIL1
CHOLINE CATABOLIC PROCESS%GOBP%GO:0042426,0.999214454045562,1.0,-0.225432888496746,-0.4575093492988811,6359,3,SARDH|SLC44A1|ALDH7A1
NEGATIVE REGULATION OF HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:1901315,0.7164179104477609,0.971081608033886,-0.3937355244292489,-0.7990745484329771,4559,3,UBR5|OTUB1|TRIP12
POSITIVE REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010572,0.418612637362637,0.871698849372662,-0.40001103022281104,-1.01260136091034,2437,5,TLR4|SELP|DMTN|PLEK|PDPN
SARCOMERE ORGANIZATION%GOBP%GO:0045214,0.115146831530139,0.593398236603313,0.407775446906759,1.38260833352534,1191,15,IGSF22|ACTN2|MYH3|TCAP|OBSCN|KRT19|OBSL1
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035872",0.00927507932633634,0.212136117579847,-0.38374670768459707,-1.83947525497477,37,24,RELA|TRAF6|OTULIN|UBE2N|ITCH|NOD1|IRAK1|IRAK2|TNFAIP3|UBE2V1|CYLD|RIPK2|UBA52|UBC|UBB
POSITIVE REGULATION OF GTP BINDING%GOBP%GO:1904426,0.442910170749814,0.8806621848706541,-0.589909015715467,-1.00900777787531,2982,2,CLN5|EPHA4
PEPTIDYL-GLUTAMINE METHYLATION%GOBP%GO:0018364,0.926419531862471,1.0,0.293311790973602,0.621555703675173,8271,4,N6AMT1
S-ADENOSYLHOMOCYSTEINE METABOLIC PROCESS%GOBP%GO:0046498,0.7289568137084641,0.972554563883587,0.4334810526565229,0.82400188060494,6295,3,GAMT|GNMT
POSITIVE REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901676,0.33615781808552897,0.8311444145897029,-0.8328187031318921,-1.11408697160892,2538,1,LIF
NEGATIVE REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0045763,0.7988121752041569,0.983870923215532,-0.43900636194877296,-0.7508968704365558,5379,2,ATP2B4
POSITIVE REGULATION OF OOCYTE MATURATION%GOBP%GO:1900195,0.9683569442605591,1.0,-0.514666960741067,-0.688485685447408,7313,1,SIRT2
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061216,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
PROTEIN PALMITOLEYLATION%GOBP%GO:0045234,0.217046979865772,0.733424818109987,0.892754741949713,1.1859848460674498,1616,1,PORCN
POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION%GOBP%GO:2000491,0.785912882298424,0.981487311948134,-0.603936921041023,-0.8079048331589301,5935,1,RPS6KA1
DEFENSE RESPONSE TO GRAM-NEGATIVE BACTERIUM%GOBP%GO:0050829,0.29743164871582395,0.802372623290889,0.29412409136875,1.1439083803548602,3230,23,HIST1H2BJ|RARRES2|ADGRB1|DROSHA|GSDMD|AZU1|RPS19|RNASE6|HIST1H2BK
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902042,0.0211653386454183,0.306397878764662,-0.34113812581982,-1.67508824879823,84,26,HMOX1|TNFAIP3|FAIM2|TNFRSF10A|BCL2L1|ICAM1|ARHGEF2|CFLAR|NOS3|TNFRSF10B|PEA15
TRIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035443,0.350589169866278,0.842847021021096,-0.8242170269078081,-1.1025802470610502,2647,1,ABCC1
MITOCHONDRIAL MRNA CATABOLIC PROCESS%GOBP%GO:0000958,0.8400628436763551,0.98953921193435,-0.348593510455945,-0.7074601723022931,5346,3,PDE12
PYRUVATE BIOSYNTHETIC PROCESS%GOBP%GO:0042866,0.0018008747105737102,0.110460318821523,-0.41279463692283896,-2.08719115361145,6,28,PFKL|GPI|PKM|ENO1|SDS|GAPDH|PGK1|HK1|HK2|TPI1|ALDOA|PGAM2
PEPTIDYL-ARGININE METHYLATION%GOBP%GO:0018216,0.954418789808917,1.0,0.18141177122543103,0.553445729146448,9589,11,PRMT9|PRMT1|CARM1|PRMT7|NDUFAF7
POSITIVE REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010694,0.785653804282085,0.981487311948134,0.491976840363937,0.8041226301804342,6494,2,GPLD1|MEF2C
POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031274,0.0986441344075457,0.570215774831708,0.45113737534134796,1.4221462283259199,1003,12,WASH1|C15orf62|CCL21|F2RL1|APC
PROTEIN TARGETING TO LYSOSOME%GOBP%GO:0006622,0.962230615418796,1.0,-0.137264736866997,-0.590482400723576,4330,18,SORL1|HGS|AP4M1|LARS|HSPA8|SNX16|AP3M1|SCARB2|NCOA4|LAMP2|NAGPA|CLU|VPS4A|GCC2|NEDD4|RAB7A
PENTOSE CATABOLIC PROCESS%GOBP%GO:0019323,0.33311378231516603,0.8293509737209019,-0.472873966426887,-1.08751133594996,2022,4,DHDH|XYLB
HISTONE MRNA METABOLIC PROCESS%GOBP%GO:0008334,0.7694307252404471,0.9792236089291529,-0.155334790351198,-0.79496479523009,2959,29,XRN1|CPSF2|ATM|ZCCHC6|EXOSC10|SNRPE|TUT1|ERI1|LSM1|ZNF473|SNRPG|PAPD5|SNRPF|SSB|UPF1|LSM10|NCBP1|SNRPD3|DCP2|CPSF3|EXOSC4|PAPD7|MTPAP|SNRPB|NCBP2|SLBP
RESPONSE TO ALKALINE PH%GOBP%GO:0010446,0.849993380113862,0.991298302704726,-0.5737207763564179,-0.7674837751318059,6419,1,INSRR
MUCUS SECRETION%GOBP%GO:0070254,0.0746268656716418,0.5243110386449029,-0.7364522091278639,-1.49460787746893,474,3,VAMP2|VAMP3
REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:0002082,0.0983534577387486,0.570215774831708,-0.34259076108832104,-1.40302430814711,447,16,DNAJC30|UQCC2|SHMT2|SNCA|PDE12|SLC25A33|COX7A2L
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051195,0.00557103064066852,0.171809755009518,-0.639578508821588,-1.9880884826553797,29,8,CBFA2T3|HP|HDAC4|FYN|FBP1|MPV17L|PPARA
SYNAPTIC VESICLE TO ENDOSOME FUSION%GOBP%GO:0016189,0.45838926174496597,0.890371861972445,0.7759704455227171,1.03084211838103,3414,1,EEA1
REGULATION OF SCHWANN CELL PROLIFERATION%GOBP%GO:0010624,0.561205062157017,0.936434965680841,0.43993581520359204,0.932266017275077,5010,4,DICER1|RNF10|CERS2
NLS-BEARING PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006607,0.128630705394191,0.6084698977529829,-0.27532711312317104,-1.3197700500663898,526,24,NUP35|RANBP6|NUP54|KPNA5|TNPO1|TNPO2|KPNA2|RANBP2|FYB|RGPD5|RERE|KPNA6|RGPD2|KPNA3|NCKIPSD|IPO4|IPO5|CBLB|KPNB1|KPNA1|RGPD8|RGPD1|KPNA4|RGPD6
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900408,0.128119372266529,0.608160579951936,-0.258849648716192,-1.3088074519167199,497,28,TRAP1|PARK7|NUP93|ATF4|HIF1A|TXN|HSPB1|MAPK7|FYN|PDE8A|HGF|BAG5|SOD2|PARK2|FBXO7|MET
NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060392,0.337551797513719,0.8319981126097199,0.520708101251861,1.10343020718213,3013,4,NOV|FAM89B|PBLD|CILP
NEGATIVE REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042754,0.9704815635704209,1.0,0.177451153571331,0.523704198964224,9632,10,GHRL|CIPC|SFPQ|SUV39H1|SUV39H2
MULTIVESICULAR BODY ASSEMBLY%GOBP%GO:0036258,0.519105796724721,0.9238030410013001,-0.18555334658714398,-0.9496158448497191,1996,29,VPS36|VPS37B|TSG101|VPS37A|STAM2|MVB12A|SNF8|HGS|CHMP5|VPS37C|CHMP6|IST1|CHMP3|CHMP2B|CHMP7|CHMP2A|STAM|CHMP1A|VPS25|VTA1|CHMP4A|RAB11A|PDCD6IP|VPS28|VPS4A|VPS37D|VPS4B|CHMP4B|CHMP1B
REGULATION OF RENAL SYSTEM PROCESS%GOBP%GO:0098801,0.39311305732484103,0.862183199888318,0.346963015228722,1.05850462543299,3949,11,F2R|PTPRO|AGTR1|F2RL1
COPPER ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035434,0.948322147651007,1.0,0.528506837229819,0.7020977548981849,7064,1,ATP7A
"RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:0042147",0.6983592763988221,0.96731875442989,-0.126935068770089,-0.879452260298458,1659,80,GCC2|EHD3|RAB6A|HEATR5A|TBC1D14|VAMP3|YKT6|RBSN|TBC1D5|SNX6|TRAPPC10|SNX8|RAB7A|VTI1A|VPS53
PROTEIN TARGETING TO VACUOLE%GOBP%GO:0006623,0.967355266513644,1.0,-0.118450964879194,-0.5902644989154611,3792,27,NAGPA|GOSR2|VTI1B|CLU|VPS4A|GCC2|NEDD4|RAB7A|VTI1A
REGULATION OF INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903795,0.7759767751300349,0.980614374126555,0.49584456982929603,0.8104443277388191,6414,2,ANO9
REGULATION OF MICROGLIA DIFFERENTIATION%GOBP%GO:0014006,0.6409373758771351,0.96102887115448,-0.6735774150860171,-0.9010650453637808,4840,1,TGFB1
POSITIVE REGULATION OF BLOOD PRESSURE%GOBP%GO:0045777,0.5291701769165971,0.9265056012720759,0.363203620375775,0.945342714715095,5024,7,CARTPT
AUDITORY BEHAVIOR%GOBP%GO:0031223,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
PURINE RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009169,0.381946966945151,0.857178152269066,-0.356811913954771,-1.04083618331079,2102,7,PRTFDC1|NUDT3|AMPD3|NUDT11|NUDT10|NUDT4|HPRT1
POSITIVE REGULATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106120,0.0925373134328358,0.5622489437340121,-0.717933164221904,-1.4570240260572698,588,3,FGF1|PRKAA1|ABCG1
STRIATAL MEDIUM SPINY NEURON DIFFERENTIATION%GOBP%GO:0021773,0.7215675890374692,0.9713770803161691,-0.634318482576092,-0.848547174350437,5449,1,INHBA
PYRIMIDINE DEOXYRIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046126,0.37495035085396505,0.852609194081082,-0.810377150419056,-1.08406622230775,2831,1,DHFRL1
FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION%GOBP%GO:0021869,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030838,0.9854253664128392,1.0,0.10465166480251402,0.527185591702144,12034,61,TENM1|RHOBTB1|WASH1|RAC3|TRIM27|C15orf62|CTTN|CCL21|LMOD1|ARPC1A|CDC42EP1|CCL11|WASF1|PFN2|BAIAP2L2|FAM21C|BAIAP2L1|NCK1|FER|ACTR3|IQGAP2|NCKAP1
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140199,0.199655765920826,0.711592141628341,-0.8985443317159242,-1.2020101489233899,1507,1,ATP2B4
PROTEIN SULFATION%GOBP%GO:0006477,0.659951372004168,0.9643779777660141,0.46047293088305497,0.875310601674566,5699,3,HS3ST5|TPST2
REGULATION OF THE FORCE OF HEART CONTRACTION BY CARDIAC CONDUCTION%GOBP%GO:0086092,0.29670329670329704,0.80135016114552,-0.852062196735774,-1.1398295797320301,2240,1,SLC9A1
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043525,0.0742049469964664,0.5224901036862729,-0.345692626730255,-1.4546348126388202,335,17,CDK5|ATF4|BAX|FBXW7|CTNNB1|DDIT3|PRNP|EPHA7|FOXO3
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905477,0.000443066016836509,0.0784645998831315,-0.267173836248118,-1.9171389503002199,0,90,RAMP3|RHOG|GPER1|PRKCH|TP53BP2|GZMB|NECAB2|CLIP3|ITGAM|SQSTM1|BBC3|MYO1C|FYN|RANGRF|YWHAH|PRNP|CHP1|MIEF1|BID|CEMIP|YWHAQ|YWHAB|LGALS3|BCL2|TP53|YWHAZ|YWHAE|PARK2|ACSL3|PIK3R1|DLG1|TNF|PMAIP1|TFDP2|STAC|EPHB2
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900747,0.980176951506328,1.0,0.24945328184320897,0.528615333244792,8751,4,SEMA6A|DCN
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:1904046,0.0996954852376539,0.570215774831708,-0.948500220555801,-1.26883766456678,752,1,SARS
NEGATIVE REGULATION OF CELL VOLUME%GOBP%GO:0045794,0.8498271035731929,0.991298302704726,-0.305410025919594,-0.702379257225788,5160,4,KCNMA1|P2RX7|CLCN3|ANO6
REGULATION OF TRAIL PRODUCTION%GOBP%GO:0032679,0.7096517939891429,0.9698418353073279,-0.6406043228936921,-0.8569559345969548,5359,1,HLA-E
PROEPICARDIUM CELL MIGRATION INVOLVED IN PERICARDIUM MORPHOGENESIS%GOBP%GO:0003345,0.9942281879194631,1.0,0.503032642258491,0.668256423363186,7406,1,FLRT3
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905563,0.411493495801087,0.867015886388254,-0.443574868505293,-1.02012953152624,2498,4,PPARG|FLT1
SYMMETRIC CELL DIVISION%GOBP%GO:0098725,0.17181208053691296,0.674580338020818,0.9153617115130129,1.2160171965638797,1279,1,SAPCD2
RESPONSE TO PLATELET-DERIVED GROWTH FACTOR%GOBP%GO:0036119,0.9942003514938491,1.0,-0.175486021086846,-0.481697344858766,5656,6,MTSS1L
SPLICEOSOMAL SNRNP ASSEMBLY%GOBP%GO:0000387,0.668639053254438,0.964618776001639,0.191522327173145,0.8515278766317479,7683,37,SMN1|DDX20|PRPF8|SART3|GEMIN5|LSM4|SMN2|SNRPD1|TGS1|GEMIN8|PRPF3|PRMT7|SNRPE|SRSF10|SRSF12|GEMIN2|PRPF31|CLNS1A|GEMIN6|SNRPC|SNRPD2|SNRPG
PHAGOSOME-LYSOSOME FUSION%GOBP%GO:0090385,0.49156414762741707,0.909315999193258,-0.34861822187509806,-0.9569336110453671,2796,6,RAB39A|RAB7A
INTERLEUKIN-17-MEDIATED SIGNALING PATHWAY%GOBP%GO:0097400,0.9079532356331301,1.0,-0.281200022059229,-0.646701305993913,5513,4,IL17RC|IL17RE|IL17RB|IL17RA
NEGATIVE REGULATION OF UDP-GLUCOSE CATABOLIC PROCESS%GOBP%GO:0010905,0.649664429530201,0.963755998259649,0.680910895456551,0.904559747025319,4839,1,GSK3A
CELLULAR RESPONSE TO FIBROBLAST GROWTH FACTOR STIMULUS%GOBP%GO:0044344,0.637042862760519,0.959271399361425,-0.13423205034934402,-0.9084900655273871,1619,73,HNRNPF|FGF2|SHOC2|POLR2A|FGFR1|POLR2K|CXCL8|FLRT1|POLR2F|MAPK3|NCBP2|POLR2I|POLR2D|FGF10|SPRED2
PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0032527,0.6889738687061819,0.96731875442989,0.20861587274884802,0.8313042434455741,7566,25,PREB|HSP90B1|SYVN1|AUP1|HERPUD1|VIMP|TMED9|NPLOC4|SEC16A|VCP|FAF2|CTAGE5|SEL1L|SEC61B|DERL1|UFD1L|LMAN1
AXONAL FASCICULATION%GOBP%GO:0007413,0.6859452736318411,0.9665006495129341,-0.22555044289023898,-0.82170288839949,3308,12,AMIGO1|EPHB2
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045716,0.5611902280884571,0.936434965680841,0.49443035182530104,0.9398600866991759,4846,3,CNPY2|HNRNPK|SCAP
REACTIVE NITROGEN SPECIES METABOLIC PROCESS%GOBP%GO:2001057,0.10213968510294698,0.573450707099996,-0.398287363063518,-1.4016228529589,505,11,MARC2|GCH1|CYP1B1|GCHFR|NQO1|SPR|DDAH2|NOS3
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034121,0.395910780669145,0.8638522656500329,-0.179240422594953,-1.0448127213229799,1277,44,MFHAS1|CYBA|TLR1|FLOT1|PJA2|DAB2IP|TNFAIP3|CD300LF|NR1H3|LYN|WDFY1|TICAM1|NR1D1|CD36|CAV1
CHOLINE TRANSPORT%GOBP%GO:0015871,0.410997643362137,0.867015886388254,-0.502591816477335,-1.01999515888209,2615,3,SLC44A1|SEC14L1|SLC44A2
ENDODERMAL-MESODERMAL CELL SIGNALING%GOBP%GO:0003133,0.127494859078263,0.6076669536424699,0.7818332732196001,1.2778850068610002,1053,2,BMP4|BMP2
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001242,0.000544069640914037,0.0784645998831315,-0.25385132319284,-1.9329011142280301,0,116,CCAR2|TRAP1|PARK7|SIAH1|CXCL12|BCL2A1|TMBIM6|NOC2L|CD44|TAF9|SNAI2|PYCARD|HIF1A|HSPB1|BAX|SOD1|FBXW7|CREB3|PPIF|CLU|PTTG1IP|BCLAF1|MAPK7|MSX1|MAGEA3|EIF2AK3|ZNF385A|RPS3|S100A8|DDX3X|HYOU1|P4HB|DDIT3|ENO1|DFNA5|MMP9|CYLD|BCL2L1|SNAI1|BAG5|BOK|SOD2|BID|PLAUR|ARHGEF2|BCL2|ACKR3|TP53|PARK2|BMF|SFRP2|SLC9A3R1|BCAP31|BCL2L11|PMAIP1|CAV1|UBB
HISTONE MONOUBIQUITINATION%GOBP%GO:0010390,0.9378753922008071,1.0,0.144502995850668,0.5985800691935981,10461,29,PCGF2|DDB2|UHRF1|DDB1|TRIM37|CUL4B|RNF40|CDC73|PCGF1|PCGF3|PCGF5|KDM2B|BCOR|COMMD3-BMI1|LEO1|CTR9|PCGF6|PAF1
NEGATIVE REGULATION OF SYNAPTIC VESICLE CLUSTERING%GOBP%GO:2000808,0.7465907586389509,0.9749763305090959,-0.6216916629907371,-0.8316558928026059,5638,1,PTEN
INACTIVATION OF MAPKK ACTIVITY%GOBP%GO:0051389,0.0930957683741648,0.5622489437340121,-0.814998621450234,-1.39401149345644,626,2,IGF1R|EPHB2
STEROID CATABOLIC PROCESS%GOBP%GO:0006706,0.950456053067993,1.0,-0.16328658956581601,-0.5948694250555141,4584,12,HSD3B7|STS|TRERF1|SNX17|SCARF1|HSD17B6|YWHAH
QUINOLINATE BIOSYNTHETIC PROCESS%GOBP%GO:0019805,0.321009651076466,0.822183858873702,-0.667493796526055,-1.14171239027674,2161,2,KYNU|HAAO
POSITIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048636,0.31500373227170897,0.8164430838831159,-0.22709897025771397,-1.10171874078652,1265,25,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|FGF2|IGF1|TBX20|GREM1|RBM24|RBPJ
POSITIVE REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903947,0.895004233700254,0.998125596923226,0.43804795714577704,0.715977352073438,7398,2,RNF207|NOS1AP
INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050702,0.453559393428812,0.8877670623536891,0.3879406383003449,1.0097279751224,4306,7,AIM2|GBP5|F2RL1|NLRC4
REGULATION OF NODAL SIGNALING PATHWAY%GOBP%GO:1900107,0.274469756480754,0.7884684708511421,-0.5670324064131639,-1.15077542154285,1746,3,SMAD2|DACT2
AMINO-ACID BETAINE METABOLIC PROCESS%GOBP%GO:0006577,0.409919028340081,0.867015886388254,0.36581828381748793,1.0439203904016199,4049,9,CROT|ACADM|CPT1B|ALDH9A1|CPT1C|CRAT
GAP JUNCTION ASSEMBLY%GOBP%GO:0016264,0.534956794972506,0.9265056012720759,-0.45845192312657795,-0.9304145567805571,3404,3,GJC1
LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING%GOBP%GO:0098598,0.31438873626373603,0.8164430838831159,-0.437899845576881,-1.10851438103241,1830,5,NRXN2|NRXN1|CNTNAP2|STRA6|HTT
REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901858,0.7393250272166451,0.9744283926676119,0.511772814998621,0.8364786068935891,6111,2,STOML2|LIG3
ANATOMICAL STRUCTURE ARRANGEMENT%GOBP%GO:0048532,0.416596104995766,0.8709670999109399,0.6357077650432099,1.03904687804923,3443,2,KIF14|DLL1
REGULATION OF AMINO ACID UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051941,0.0616973388057726,0.48425100851298497,-0.9681848257609179,-1.29517036112824,465,1,PER2
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0045746,0.9832145113256929,1.0,0.122460084185085,0.49786291415521206,10894,27,DLK2|C8orf4|RITA1|DLK1|METTL3|LFNG|ARRDC1|AKT1|NEURL1|DLL4
PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901162,0.666979865771812,0.964618776001639,0.6716475518306129,0.8922538082853191,4968,1,AZIN2
'DE NOVO' NAD BIOSYNTHETIC PROCESS%GOBP%GO:0034627,0.0968219990120204,0.5696160304220501,-0.627557386493294,-1.4432508876043302,587,4,NMNAT3|NMNAT2
ENDOTHELIAL CELL ACTIVATION%GOBP%GO:0042118,0.59498728659644,0.9473459395438281,-0.302212814001423,-0.8815681864051421,3275,7,TGFBR1|FOXP1|BMPER
NEGATIVE REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010812,0.8287752675386449,0.9876441563834109,0.156732988331287,0.7310576488879029,9757,44,NF2|GCNT2|KIAA2022|AJAP1|PTPRO|CDKN2A|GBP1|SRC|SEMA3E|CASK|ACER2|TBCD|EFNA5|THBS1|SERPINE1
POSITIVE REGULATION OF HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:1902466,0.9221476510067109,1.0,0.541629907366564,0.7195311681131841,6869,1,ZNF304
CELLULAR AMMONIA HOMEOSTASIS%GOBP%GO:0097275,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
POSITIVE REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043032,0.48383084577114394,0.9064456896937672,-0.26544209009655395,-0.9670321607006508,2333,12,ITGAM|CEBPA|KARS|TNIP2
CHYLOMICRON REMODELING%GOBP%GO:0034371,0.271158967233993,0.786158299673311,0.608029116576597,1.15579938834989,2341,3,LPL|APOE|APOC2
RECEPTOR METABOLIC PROCESS%GOBP%GO:0043112,0.000384467512495194,0.0784645998831315,-0.321226503896911,-2.15987488570754,0,71,FCER1G|DNM2|ARFGEF2|ARRB2|GRB2|CALCRL|EHD3|PPARG|ARRB1|SH3GLB1|BECN1|CLTA|SNCA|RAMP2|AP2S1|TFRC|NEDD4|CXCL8|CD9|ACKR3|RAB5A|MYLIP|CACNG3|CD36|ADM|SNX25|CACNG7|TNF|CAV1|RAMP1
CHEMOKINE PRODUCTION%GOBP%GO:0032602,0.557520604395604,0.9361453421204542,-0.35816677755134596,-0.906675413873826,3246,5,IL18|S100A9|S100A8|FOXP1
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903053,0.933110367892977,1.0,-0.128191214481058,-0.648166291185574,3626,28,PHLDB2|CHADL|DAG1|RGCC|TGFB1|ADTRP|SMAD3|FSCN1|AGT|RLTPR|PHLDB1|NOTCH1|PDPN|COLGALT1|TNFRSF1B|MFI2
POSITIVE REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0045933,0.137264286398009,0.62388141596544,0.38785750996432294,1.34459680400767,1433,16,RGS2|KCNQ1|F2R|ATP2A1|CTTN|SRF
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0006367,0.9022159428911359,0.999822188724968,0.12194222915970099,0.7161974941192221,12132,135,GTF2H2|NR4A2|CTGF|NR4A3|CDK8|ESRRG|AK6|NR2C1|MAML1|NR4A1|RARB|NR2F6|ZNF45|E2F3|TAF7|GTF2B|GTF2H1|POLR2B|RORA|MED12|TAF5|GTF2I|E2F2|MED1|MED17|CDK7|GTF2E2|MED24|POLR2L|NR2F1|THRAP3|NR2C2AP|TAF2|POLR2J|RXRB|CCNC|ESRRA|MAML3|MED7|TAF4|MED23|POLR2G|POLR2H|MED30|RXRG|GTF2A1
DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0050655,0.35337552742615996,0.842847021021096,-0.275346899622376,-1.06676678381604,1674,14,CSPG4|CSGALNACT1|NCAN
ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901617,0.188024883359254,0.694597388648806,0.22130357202265602,1.21826956107989,2417,94,CITED1|TM7SF2|PNMT|C14orf1|SLC27A2|HSD17B4|EBP|PPIP5K2|DHFR|ISYNA1|OSBPL3|MVD|LBR|CACNA1H|AMACR|DHCR24|TGFB2|SRD5A3|PPAPDC2|DDC|PGP|APOE|NSDHL|ACOX2|OSBPL9|HAND2|CYP7B1|GGPS1|PSAT1|TH|TRPC1|ACER2|HMGCR|MOXD1|ARV1|MSMO1|DHCR7|ACAT2|OSBPL6|HSD17B7|PTS|OSBP|GATA3|PCK2|PPIP5K1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION%GOBP%GO:0044339,0.118782479584261,0.602329212916938,-0.7907361455748549,-1.3525118278867,799,2,FZD1|WNT3
POSITIVE REGULATION OF STAT CASCADE%GOBP%GO:1904894,0.311680911680912,0.8143712300420921,-0.19824481416294898,-1.10124129854433,1093,37,CYP1B1|IL6ST|AGT|IL6R|SOCS3|NOTCH1|VEGFA|CRLF1|PTK2B|LIF|MGAT5|ARL2BP|TNFRSF18|IL6|LYN|IGF1|STAT3|TNF
ASPARAGINYL-TRNA AMINOACYLATION%GOBP%GO:0006421,0.47465827990806797,0.9005402421305441,0.614061207609595,1.0036661745897,3923,2,NARS2|DARS2
PEPTIDYL-DIPHTHAMIDE METABOLIC PROCESS%GOBP%GO:0017182,0.8483304042179259,0.991298302704726,-0.254650160876719,-0.698997593098702,4826,6,DPH2|DPH6|DPH3
NEGATIVE REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061889,0.532885906040268,0.9265056012720759,0.736656374062638,0.9786151283713871,3969,1,LDLR
REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043304,0.159972924187726,0.661454203640901,-0.290983881773478,-1.27610202101384,708,19,LGALS9|FGR|LYN|VAMP2|VAMP3|SNX6|GAB2
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0002087,0.254563780938515,0.764845931807465,0.557050681078696,1.1804436054593,2272,4,TSHZ3|NLGN3|PHOX2B|NLGN2
MICROTUBULE-BASED PROCESS%GOBP%GO:0007017,0.407209883210693,0.8669681570015609,0.152872830463266,1.03517449418481,6031,481,KIF25|TEKT3|KIF21B|CCDC78|AKAP9|NCKAP5|CALML4|CNTLN|CCDC68|MGARP|CLIP1|CAMSAP3|SDCCAG8|CEP63|BRSK2|ASPM|CENPJ|CCNB1|RCC1|FSD1|PSRC1|CABYR|CDK1|KIF14|CEP126|SPAG5|RGS14|PKD2|SKAP1|SAPCD2|TBCE|KLC1|WDR62|KIF2C|MTCL1|HOOK1|CCSAP|LRRC49|KIF18A|MARK2|FGF13|ICK|DCLK2|CKAP5|DNAH14|KIF20B|CEP131|CEP152|KIFC2|NUMA1|PEX1|CDK5R1|KIF4A|KIF24|RHOT1|DYNLT1|MAP10|CROCC|ATXN3|NUF2|KIF23|CCDC88B|DCX|PRC1|KIF11|TTK|DLGAP5|TUBGCP3|NEK2|STIL|EML3|WDR66|HAUS5|NDC80|AP3D1|CENPA|GPSM2|WRAP73|SPG11|NUSAP1|CDK5RAP2|AP3B2|CUL9|CENPE|KIF18B|CETN3|DNAH10|KIF15|INO80|GTSE1|ESPL1|KIFAP3|AURKB|DNAH1|GOLGA8A|DOCK7|CEP72|KIFC1|MID1|TUBG2|HDAC3|TUBE1|RSPH4A|SPDL1|KIF22|ASUN|TUBGCP6|KLC2|CCDC120|HAUS8|OBSL1|SASS6|CNTROB|PIN1|TAOK1|CEP192|KIF20A|STMN1|SYNE2|SON|CHEK2|NPHP3|TACC2|RAB27B|HOOK2|NAV1|PLK1|TUBGCP2|MARK3|FAM179B|RTTN|BRSK1|APC2|RACGAP1|CAMSAP2|PPP1R12A|TBCD|AURKA|AP3S1|BRCA2|GOLGA8N|DYNC1H1|CUL7|DNAH17|NINL|LLGL2|COPG2|VBP1|KIF16B|SPC25|TUBB4A|XRCC2|CEP135|KIF27|TUBGCP4|FAM175B|TTLL3|GOLGA8B|SPIRE2|SRRD|PCM1|SPIRE1|SGOL1|WDR34|TPX2|RNF19A|DST|CCDC69|CHD3|TNPO1|COPG1|FMN2|CAMSAP1|FIGN|CDK2|CEP120|MAP7D1|GAS8|VCP
RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009259,0.99494529843512,1.0,0.0903937898293917,0.58837477260634,14368,295,ACSM3|HACD1|CROT|GPHN|NPR2|ACSF2|NDUFA7|OXSM|IMPDH1|NDUFS7|HSD17B4|NDUFA4|SCD5|ELOVL6|MYH3|ATP5G1|NDUFS2|ADCY8|COX5A|DGAT1|PDE2A|TEFM|FAR2|ACBD6|COA6|ATP5D|MVD|SLC35B3|NDUFC1|NDUFAF1|NDUFS4|TAZ|CAD|ACOT1|PARP1|AK3|MT-ATP8|SLC26A2|SULT1A3|PDHX|FAR1|COX6A1|CTPS2|RFK|ADSSL1|GCK|NDUFS8|PDHA1|NDUFB2|ACOT2|SLC25A1|UQCC3|ACACA|SUCLG1|DLD|ACSS1|MCEE|NADK|SDHA|PANK3|ADORA2A|MT-ND2|BAD|HINT1|PAPSS2|NDUFV1|UMPS|TECR
VESTIBULOCOCHLEAR NERVE DEVELOPMENT%GOBP%GO:0021562,0.407520190652721,0.867015886388254,-0.794938244375827,-1.0634131269654201,3077,1,CHRNB2
NEGATIVE REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000381,0.786645718774548,0.9818102154363779,-0.3702407544797221,-0.7513926108806829,5006,3,DKK1
CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060070,0.969374734155678,1.0,0.11872099103932901,0.5564914726271629,11394,45,NR4A2|WNT4|CDH3|DVL1|APC|FRAT2|LEF1|FZD6|WNT2B|FZD3|DVL3|GATA3|SCYL2|FRZB|DVL2|LRP6
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002440,0.169740777666999,0.673117535978459,0.25703975957941505,1.2590619702918602,2042,54,IGKV2-24|IGKV4-1|SIRT1|VPREB3|IGKV2D-29|IGLV9-49|IGKV1D-13|LIG4|IGLV5-52|EXO1|IGLV11-55|POLQ|IGKV3-11|MSH6|KIT|IGKV2D-28|TMIGD2|IGKV2-28|CD55|IGKV1-8
EPIDERMAL GROWTH FACTOR CATABOLIC PROCESS%GOBP%GO:0007174,0.0849993380113862,0.5460333734703521,-0.956164534627261,-1.27909045118315,641,1,RAB7A
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER%GOBP%GO:0060795,0.7393752270250641,0.9744283926676119,-0.268560397131826,-0.783402593374593,4070,7,CDC73|KLF4|RTF1|LEO1|CTR9|PAF1|SOX17
RESPONSE TO ACIDIC PH%GOBP%GO:0010447,0.0417805544709098,0.402998391331252,-0.5029500425930991,-1.62356780792456,213,9,CTSS|IMPACT|SLC9A1|CHP1|PKD2L1|RAB11FIP5
NEGATIVE REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903895,0.36590730557737605,0.8510019955058101,-0.5212490866756779,-1.0578595344177901,2328,3,HSPA5|BFAR
PEPTIDE ANTIGEN TRANSPORT%GOBP%GO:0046968,0.0499015861989117,0.43920898483204296,0.76975593723426,1.46322506139716,430,3,CD209|TAP2
NEGATIVE REGULATION OF SISTER CHROMATID SEGREGATION%GOBP%GO:0033046,0.0268596922516617,0.339762187668294,0.407794237336692,1.62500137445805,294,25,TPR|CENPF|NAA10|BUB1|CDC20|APC|PTTG1|FBXO5|BUB1B|ESPL1|KLHL22|PLK1
PHOTOPERIODISM%GOBP%GO:0009648,0.10612338858195199,0.579844750348304,-0.305458764006541,-1.36292813617717,460,20,PER1|BHLHE40|SIK1|FBXL3|ID2|PML|PER3|TP53|PER2|PPP1CB|USP2
ENDODERMAL DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0061031,0.12249443207127002,0.607607158836689,-0.7881996140060659,-1.34817322648622,824,2,ID2|SOX17
HISTONE H4-K20 METHYLATION%GOBP%GO:0034770,0.84866940288627,0.991298302704726,-0.574217026907808,-0.7681476246249521,6409,1,BEND3
SPINDLE ELONGATION%GOBP%GO:0051231,0.0151821862348178,0.264387156924099,0.600144842370477,1.71260832456772,149,9,KIF4A|MAP10|KIF23|PRC1|AURKB|RACGAP1
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002824,0.811528497409326,0.9855701659458179,-0.12992757228949,-0.78703116760931,2505,50,CD1E|PRKCQ|MAP3K7|ZP3|ZBTB1|CCL19|IL12RB1|CD1D|PAXIP1|RIF1|TRAF2|HLA-F|NFKBID|FAM35A|IL1R1|XCL1|TP53BP1|ANXA1|HSPD1|FADD|HLA-C|PRKCZ|STX7|CLCF1|HLA-B|MALT1|PVR|HLA-A|NFKBIZ|HLA-E|RSAD2|FZD5|IL18|TGFB1|CD1C|MAD2L2|TRAF6|TNFSF13|IL6R|PVRL2|CD274|IL1B|FAM49B|C20orf196|IL6|SLC11A1|TFRC|NLRP3|SOCS5|B2M
REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090030,0.209407216494845,0.7248363921442859,0.505793660960555,1.2439258473823303,1949,6,WNT4|CLCN2
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009209,0.18605997452819298,0.6922162303225631,0.6531377522885191,1.2415461595878898,1606,3,CAD|CTPS2|CTPS1
GUANOSINE METABOLIC PROCESS%GOBP%GO:0008617,0.5781808552892889,0.942692029750853,-0.7047860608734009,-0.942813802377198,4366,1,DGUOK
REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032928,0.6331757289204101,0.958362160385489,-0.25233323132019797,-0.8536810907903799,3213,10,SOD1|PRKCD|ITGAM|AATF
MITOCHONDRIAL MRNA POLYADENYLATION%GOBP%GO:0097222,0.9029530201342281,1.0,0.5503418614909571,0.7311046104996121,6726,1,PNPT1
MAST CELL PROLIFERATION%GOBP%GO:0070662,0.389664429530201,0.8603316114971841,0.8120864578738419,1.0788206295399498,2902,1,KIT
VESICLE LOCALIZATION%GOBP%GO:0051648,0.234854771784232,0.748831319891928,-0.134270272281478,-1.10631936778336,282,176,CEP19|FAM91A1|NAPA|VAMP2|STX11|HAP1|RAB1A|YKT6|AP3S2|SERPINA1|BLOC1S6|OTOF|KIF3B|SEC23IP|SNPH|MKKS|TMED2|SEC23A|TRAK1|TRAPPC10|HTT|SYT2|BLOC1S3|SYNDIG1|KIF13A|ANKRD28|BBS7|TMEM230|SYT9|SNAP25|CPLX1
DISTAL CONVOLUTED TUBULE DEVELOPMENT%GOBP%GO:0072025,0.20680524294982103,0.7211951452265429,-0.894905161005734,-1.19714191930699,1561,1,PAX8
TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034162,0.00354609929078014,0.143586675683643,-0.600609221897147,-2.0319508968570603,17,10,PIK3AP1|UNC93B1|TRAF6|IRAK1|PIK3C3|IRAK2|IRAK4|TNIP2|MYD88
EAR MORPHOGENESIS%GOBP%GO:0042471,0.332586240498928,0.8293509737209019,0.3362326663914339,1.11404331038475,3412,14,STRC|PROX1|CEP290|DFNB31|PDZD7|NIPBL|CHD7|FGFR2
PROGESTERONE METABOLIC PROCESS%GOBP%GO:0042448,0.609583401943027,0.9508825506493929,-0.376871999114044,-0.866726866643893,3701,4,ADM
NEGATIVE REGULATION OF AMNIOTIC STEM CELL DIFFERENTIATION%GOBP%GO:2000798,0.7809395973154358,0.981487311948134,0.610994706660785,0.811679209392466,5817,1,REST
REGULATION OF MEMBRANE LIPID METABOLIC PROCESS%GOBP%GO:1905038,0.900766358813126,0.998912093067348,0.19871631801935502,0.626424848892671,9167,12,NSMAF|ORMDL1|SMPD3
POSITIVE REGULATION OF MELANOSOME TRANSPORT%GOBP%GO:1902910,0.0930201342281879,0.5622489437340121,0.9539038376709309,1.26721869167852,692,1,CDH3
HEMATOPOIETIC STEM CELL HOMEOSTASIS%GOBP%GO:0061484,0.440909640740293,0.880402968441571,0.6265109726611701,1.0240149735514499,3644,2,NOV
SEX DETERMINATION%GOBP%GO:0007530,0.5475053515560679,0.9305779599215391,-0.39690895061802095,-0.9128076692372479,3324,4,CITED2|SRD5A1
PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:0038083,0.0109479970141826,0.228061856776328,-0.367106769527099,-1.78093457402572,43,25,TNK1|ITK|ABL2|NTRK1|BLK|KDR|IGF1R|PTK2B|TNK2|FGR|ABL1|DYRK1A|FYN|LYN|YES1|MAPK3
ACETYLCHOLINE CATABOLIC PROCESS IN SYNAPTIC CLEFT%GOBP%GO:0001507,0.442316258351893,0.880423444399886,-0.590239867659223,-1.0095736824058001,2978,2,COLQ|ACHE
MESODERMAL CELL FATE COMMITMENT%GOBP%GO:0001710,0.8761073825503359,0.9941329456747149,0.562748125275695,0.747585778454968,6526,1,KLF4
POSITIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060265,0.434093959731544,0.878651088001772,0.789920599911778,1.04937427612638,3233,1,RPS19
REGULATION OF DNA BINDING%GOBP%GO:0051101,0.140218303946264,0.628783181453404,-0.177074367105048,-1.23192089149486,333,81,FOXC1|HAND1|TXN|ID2|PINX1|SIN3A|NFKBIA|CTNNB1|SKI|RSF1|H1F0|DDIT3|PPARG|MMP9|SUMO1|HABP4|POU4F2|IGF1|ZNF593|TMSB4X|PLAUR|JUN|ID1|BCL3|PARK2|PER2|DDRGK1|TWIST1|SUMO3
POSTSYNAPSE ASSEMBLY%GOBP%GO:0099068,0.600607287449393,0.950415218201239,0.31125973200502,0.8882289249191709,5933,9,NLGN4Y|SHANK1|NLGN3|NRXN2|NLGN2|NRXN1|PTEN
PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050931,0.5346032353785779,0.9265056012720759,0.272394987195185,0.944319549836866,5584,16,CITED1|USP13|AP3D1|KIT|C10orf11
POST-EMBRYONIC EYE MORPHOGENESIS%GOBP%GO:0048050,0.145536644668288,0.636418541205714,0.6786147568104111,1.28997526510373,1256,3,EFEMP1|FBN1|MFAP2
COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY%GOBP%GO:0002430,0.9190292096219929,1.0,0.25162876465150097,0.6188443004612839,8557,6,C3AR1|FPR3|GPLD1|CMKLR1
POSITIVE REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905663,0.954034111527761,1.0,0.3883243174822679,0.6347054290317199,7886,2,HNRNPA2B1|HNRNPD
NEGATIVE REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903523,0.0935483870967742,0.5622489437340121,-0.35503204101796204,-1.4158994977786399,434,15,SRI|KCNE3|FKBP1B|PLN|DOCK5|BIN1|ADM|PDE4D
NEGATIVE REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032703,0.8804095826893349,0.9956508825790341,0.19239517552368998,0.652337395561606,9113,15,NAV3|TRIM27|GBP1
CILIUM-DEPENDENT CELL MOTILITY%GOBP%GO:0060285,0.8149880573248409,0.9864798433969221,0.23483888639590497,0.716439610480476,8188,11,TEKT3|DNAH1|DNAH17|GAS8|CCDC65
CELLULAR RESPONSE TO IRON ION%GOBP%GO:0071281,0.798104162126825,0.9835585148939309,0.321436635293113,0.740863794101184,7324,5,TFR2|TF|IREB2
AEROBIC ELECTRON TRANSPORT CHAIN%GOBP%GO:0019646,0.763021373728989,0.978421368343614,-0.206407180012452,-0.7773254945834699,3676,13,COX5B|COX4I1|COX10|COX4I2
NEGATIVE REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903898,0.548164004610571,0.9305779599215391,-0.39679078718395205,-0.9125359180240958,3328,4,PPP1R15B|PTPN1
POSITIVE REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000020,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
REGULATION OF INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000492,0.610872483221477,0.9508825506493929,0.6997132774591971,0.9295378726821031,4550,1,TICAM2
MAMMARY GLAND INVOLUTION%GOBP%GO:0060056,0.0115186018800477,0.23212667146341198,-0.995037494486105,-1.3310919948129298,86,1,CAV1
POSITIVE REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904431,0.8349199238436559,0.988613522932093,0.338142366356787,0.7165559753518291,7454,4,SLX1B|SLX4
MACROPHAGE MIGRATION%GOBP%GO:1905517,0.563395113732098,0.9377667552605741,0.352323933231785,0.9170251749028281,5349,7,AZU1|CCL5|CCL2
POSITIVE REGULATION OF POLYNUCLEOTIDE ADENYLYLTRANSFERASE ACTIVITY%GOBP%GO:1904247,0.528456375838926,0.9265056012720759,0.73919276576974,0.9819846115978159,3936,1,PABPN1
PROTEIN INSERTION INTO MEMBRANE%GOBP%GO:0051205,0.3839146856254171,0.8584502501158281,-0.242916744028587,-1.04497386192449,1727,18,ASNA1|BMF|BCL2L11|PMAIP1
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000300,0.648522550544324,0.963755998259649,-0.19955846326679502,-0.8584561713665899,2918,18,NAPB|SYN1|VPS18|NAPA|FMR1|RAB5A
MUSCLE CELL MIGRATION%GOBP%GO:0014812,0.533041401273885,0.9265056012720759,0.309352188015085,0.943762613101352,5355,11,NOV|PLAT|DDR1
GLUCOSE 6-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0051156,0.28333333333333305,0.7924936804394509,-0.291490115106498,-1.12930987431775,1342,14,DERA|GPI|G6PD|PGD|G6PC3|TKT
SMOOTH MUSCLE CONTRACTION%GOBP%GO:0006939,0.17596089757831598,0.67909482081261,-0.291974402882247,-1.25600901075412,791,18,EDNRA|DRD2|MYH11|BDKRB2|SULF2
T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:0035745,0.37799549847742603,0.854043118220915,-0.808171592412881,-1.08111578011599,2854,1,DENND1B
VESICLE-MEDIATED INTERCELLULAR TRANSPORT%GOBP%GO:0110077,0.211439163246392,0.726180834202302,-0.893250992501103,-1.19492908766317,1596,1,ARC
RELAXATION OF VASCULAR SMOOTH MUSCLE%GOBP%GO:0060087,0.43691248510525604,0.878651088001772,-0.779444199382444,-1.0426862705683,3299,1,SOD1
ESTABLISHMENT OF LYMPHOCYTE POLARITY%GOBP%GO:0001767,0.4737372606114911,0.8998407605598371,0.47097364329082103,0.9980381398797309,4229,4,CCL21|CCL19
CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0071333,0.392903464887901,0.8621064456029929,0.276767934615198,1.05995698794731,4240,22,PRKAA2|UNC13B|AGER|ADCY8|ERN1
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION%GOBP%GO:0050806,0.7979970688812901,0.9835585148939309,0.150858289944727,0.7722092151222241,9800,66,RIMS2|LGI1|SLC8A3|UNC13B|INS|AGER|ADCY8|RGS14|GRIK2|CUX2|CLSTN2|GRIN1|SHISA7|DRD4|DLG4|RAB3B|SLC24A1|SYT1|RIMS4|KCTD13|ADCY1|SLC8A2|TSHZ3|SHANK1|NLGN3|MPP2|RIMS1|RIMS3|BAIAP3|STX1B|GRIN2D|CACNG4|NLGN2|NPTN
CREATININE HOMEOSTASIS%GOBP%GO:0097273,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
CARDIAC ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0003348,0.28137082601054497,0.7892585111044429,-0.41555136370032303,-1.1406605911238,1600,6,NOTCH1|ACVR1|SOX17
POLYADENYLATION-DEPENDENT RNA CATABOLIC PROCESS%GOBP%GO:0043633,0.245125348189415,0.757467559003634,-0.382977549782117,-1.1904609759953602,1319,8,EXOSC10|EXOSC2|PNPT1|EXOSC3|PAPD5|EXOSC7|EXOSC8|EXOSC9
AMINOPHOSPHOLIPID TRANSPORT%GOBP%GO:0015917,0.43142183817753293,0.8785877309899279,-0.49398919157383897,-1.00253638723566,2745,3,ATP11B|SCARB2|TMEM30A
MAPK CASCADE%GOBP%GO:0000165,0.136585365853659,0.62388141596544,-0.134774040472518,-1.16132189490044,111,231,IL1B|IRAK1|PKN1|KDR|BRAP|MAP3K8|DAB2IP|STK26|TRIB1|LGALS9|IRAK2|NRAS|GRB2|MAP3K13|RET|FGF7|FYN|IL3RA|UBE2V1|FGF2|HGF|KITLG|HBEGF|IL17RD|CAMK2A|CSF2RB|POU4F2|MBP|IGF1|MAP4K4|RIPK2|YWHAB|KARS|FGFR1|MAP2K3|DBNL|MLKL|KRAS|HSF1|CTSH|SHC1|UBA52|RASA3|RASGRF2|YWHAE|SCG2|MAPK3|PLVAP|TNIP2|RASGRP3|FGF10|PEA15|STK24|MET|MAP3K11|UBC|MAP2K1|PTPRA|DLG1|TNF|GFRA2|UBB|ADORA2B
PYRIMIDINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009223,0.7408135193554731,0.974505008828563,0.24691804227361802,0.7783739094091899,7539,12,TDG|MBD4|DUT|NEIL1|NTHL1|UNG|NT5M
SPONTANEOUS SYNAPTIC TRANSMISSION%GOBP%GO:0098814,0.056241610738255,0.46132606014672706,0.9719342743714158,1.2911713224403,418,1,RIMS2
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA%GOBP%GO:1990144,0.5131735734145371,0.9194706858507141,-0.739799294221438,-0.9896520721714019,3875,1,BNIP3
SPINDLE CHECKPOINT%GOBP%GO:0031577,0.10475192838777302,0.576535954147525,0.387052859176194,1.38843751472427,1099,18,TPR|CENPF|BUB1|CDC20|APC|BUB1B|KLHL22|PLK1|TEX14|ATM
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND%GOBP%GO:0038034,0.145081227436823,0.636215339087768,-0.29701129437386103,-1.3025350775596298,642,19,BCL2A1|DCC|BAX|CASP3|BCL2L1|BOK|BCL2|APPL1
NEGATIVE REGULATION OF GROWTH%GOBP%GO:0045926,0.6706586826347309,0.964618776001639,-0.115184618073116,-0.9119578177867529,1007,139,FLCN|NOTCH1|RNF6|WWC1|MT1M|GNG4|MSX1|RTN4|GDF15|OSGIN2|SEMA3F|PML|DCUN1D3|FBP1|DDX3X|CCDC85B|NME6|SEMA7A|SH3BP4|ENO1|CDA|PPP2CA|JADE1|WNT11|SEMA6B|TP53|BCL6|CDKN1A|SERTAD2|SFRP2|ACVRL1|DUSP10|SEMA3A|SEMA3G|ING1|SESN2|SOX17|GAL|SLIT3
"ZYGOTIC DETERMINATION OF ANTERIOR/POSTERIOR AXIS, EMBRYO%GOBP%GO:0007354",0.102281879194631,0.573450707099996,0.9485553595059549,1.2601134770488798,761,1,BASP1
CELLULAR RESPONSE TO ANGIOTENSIN%GOBP%GO:1904385,0.7869227707006371,0.9819233677232551,0.24303164102074698,0.741433826822861,7906,11,ACTN2|AGTR1|SRC
RESPONSE TO PURINE-CONTAINING COMPOUND%GOBP%GO:0014074,0.242322254943206,0.7565220534116759,0.247215519939539,1.18243276161535,2879,49,RYR2|CITED1|AKAP9|CRHBP|HCN2|KCNQ1|PKD2|PDE2A|HCN3|HSP90B1|NDUFS4|KCNJ11|IGFBP5|DUOX1
REGULATION OF PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1905089,0.49342281879194605,0.910654969509744,0.757443758270843,1.00623024090103,3675,1,VPS13C
CEREBELLAR GRANULAR LAYER STRUCTURAL ORGANIZATION%GOBP%GO:0021685,0.142953020134228,0.632949331968897,0.9297529775033081,1.23513535139209,1064,1,KIF14
PHAGOSOME ACIDIFICATION%GOBP%GO:0090383,0.260003293265273,0.7715310051543051,-0.508266098450623,-1.16890584592919,1578,4,RAB39A|RAB7A
CARDIOLIPIN ACYL-CHAIN REMODELING%GOBP%GO:0035965,0.15977770059048302,0.661454203640901,0.6687189254131889,1.27116433062,1379,3,PLA2G4A|TAZ|LCLAT1
ENTRY INTO HOST%GOBP%GO:0044409,0.38370253164557,0.8582519754973359,-0.200730186550715,-1.04139464068271,1454,30,PPIA|VAMP8|CD4|WWP2|CD81|GAS6|PVRL1|ITCH|PVRL2|ZNF639|CBLL1|CTNNB1|GRB2|CAV2|MET|CAV1
REGULATION OF CHROMATIN BINDING%GOBP%GO:0035561,0.274531533346766,0.7884684708511421,0.398338728396961,1.17560049891533,2724,10,HMBOX1|BTAF1|GMNN|PARP9|CDT1|DDX11|ZNF304|MED25|WAPAL
TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION%GOBP%GO:0002949,0.397967823878069,0.8638522656500329,0.6431775067254711,1.05125596562307,3289,2,OSGEP|TPRKB
MEMBRANE LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046467,0.922101028854336,1.0,0.120965519755377,0.671402632739908,11919,98,SPTSSB|B3GALT2|HACD1|PGAP1|B4GALNT1|CERS4|ELOVL6|PPAP2C|B3GALT1|ST3GAL5|CERS6|PIGC|PIGF|ALDH3A2|PIGQ|PIGB|B4GALT6|ST8SIA3|CERS5|ACER2|ST3GAL4|SMPD1|PPM1L|ELOVL4|PIGL|LARGE|ST3GAL6|SMPD4|CERS2|ELOVL2|PIGK|B4GALT3|PIGH|PRKD1
GLUCOSE METABOLIC PROCESS%GOBP%GO:0006006,0.0148252735615955,0.264001457476971,-0.248842237623072,-1.58524844673702,41,59,PFKL|GPI|CRTC2|FBP1|PKM|APOD|ENO1|GAPDH|PGK1|SORD|HK1|PPARGC1A|HK2|TPI1|G6PC3|ALDOA|SLC25A13|PER2|PC|PGAM2
HEART GROWTH%GOBP%GO:0060419,0.9591956267083169,1.0,-0.18069384300978,-0.583295917599109,4912,9,SORBS2|PDLIM5|C3orf58|NDRG4|MESP1|TGFBR3|NOTCH1|S1PR1
NERVE GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038180,0.5285143479840171,0.9265056012720759,-0.3174572256935,-0.9260368116439591,2909,7,RAP1A|RAPGEF1
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN%GOBP%GO:0035966,0.961810466760962,1.0,-0.0896103826760665,-0.712516579839283,1359,147,DCTN1|CUL3|YOD1|HSP90AA1|EDEM1|TMBIM6|CTDSP2|UGGT1|TSPYL2|GOSR2|MYDGF|HSPA9|WIPI1|HSPB7|CALR|ATF4|HSPA4|HSPB1|BAX|DNAJC3|CREB3|RHBDD1|ADD1|CLU|EIF2S1|KLHDC3|HSPA13|DAB2IP|HSPA5|EIF2AK3|TATDN2|STUB1|HYOU1|DDIT3|AMFR|ATF6|LMNA|PTPN1|HSPA4L|BAG3|CREBRF|CXCL8|HSF1|SHC1|ATP6V0D1|ASNA1|HSPA6|KLHL15|SSR1|VAPB|PARK2|HSPB8|HSP90AB1
REGULATION OF MACROPINOCYTOSIS%GOBP%GO:1905301,0.8511409395973148,0.991298302704726,0.575209528010587,0.764140196045682,6340,1,STX1B
DN2 THYMOCYTE DIFFERENTIATION%GOBP%GO:1904155,0.9638554216867471,1.0,-0.516376268195854,-0.6907722781460219,7279,1,PTPRC
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:1903265,0.168097527472527,0.672026878249637,-0.5087983210586591,-1.28798916381359,978,5,ADAM17|PARK2
REGULATION OF VOLTAGE-GATED SODIUM CHANNEL ACTIVITY%GOBP%GO:1905150,0.658763759525826,0.9643779777660141,0.544720510747781,0.890330710469441,5445,2,FGF12
OLFACTORY BEHAVIOR%GOBP%GO:0042048,0.09680772086117301,0.5696160304220501,-0.811507311749364,-1.3880397951956898,651,2,CFAP69
"TRNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0006388",0.800185701021356,0.9840257959912879,-0.23707497611127998,-0.7369322499610609,4308,8,C14orf166|DDX1|TSEN34|ZBTB8OS|CLP1|TSEN2|RTCB
POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090208,0.9347612497543721,1.0,0.185737837295871,0.585512039581897,9513,12,SCARB1|PNPLA2|LDLR|CNEP1R1|APOC2|GPLD1|SREBF1|SLC27A1
REGULATION OF MAINTENANCE OF PERMEABILITY OF BLOOD-BRAIN BARRIER%GOBP%GO:1905603,0.252350059578975,0.763905256448548,-0.874834583149537,-1.17029289536196,1905,1,IL6
LIPID TRANSPORT INVOLVED IN LIPID STORAGE%GOBP%GO:0010877,0.8719003265997339,0.9934031064448321,0.45181613667052,0.738481063272613,7207,2,APOE|STARD4
POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:0043687,0.9964705882352941,1.0,0.0888112182047728,0.578834760308787,14398,301,RBBP7|CYR61|SPSB4|VCAN|DCAF6|TMEM132A|TNC|NOTUM|BMP4|BTRC|CISH|PSMD11|LMO7|CDH2|KLHL42|PENK|PSMD13|PSMB9|UBA3|KLHL3|ASB2|PSMA4|MIA3|HSP90B1|ANO8|SOCS2|DDB2|PSMD3|CHML|SPSB3|DTL|LAMB2|FBXL19|MEN1|GAN|LRR1|IGFBP5|FBN1|KLHL20|UBD|CUL9|FBXL15|PSMD1|KLHL25|CAND1|NAE1|IGFBP7|PNPLA2|DDB1|APOE|QSOX1|RNF7|PSMA1|DCAF5|FBXL8|PSMC3|ESCO2|OBSL1|KLHL22|RABGGTA|EVA1A|TF|FBXW5|DSCC1|CCNF|CUL4B|GPR75-ASB3|KEAP1|FSTL3|GPC3|PSMA3|FN1|C4A|FBXO9|CUL7|PSMC6|PSMC1|LTBP1|KLHL9|PSMD2|WDR5|DCAF17|DCUN1D1|COPS7B|BTBD6|RBX1|CKAP4|PSMA5|FBXL7|RAB3A|PSMC2|ATG12|PSMC5|PRSS23|SKP2
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051897,0.0735820132856413,0.520821259294202,-0.17340524060458098,-1.2919370102818,143,107,FGF1|GAS6|HSP90AA1|FRS2|PARK7|ENG|TNFAIP8L3|MFHAS1|MYDGF|PIK3CD|CD86|PIK3R2|TXN|RAMP3|RHOG|PIK3R5|HAX1|MTDH|CX3CL1|CD19|RTN4|TGFBR1|GDF15|GRB2|VAV1|RET|FGF7|FYN|C1QBP|TCF7L2|FGF2|HGF|KITLG|HBEGF|MST1R|FGFR1|TSPYL5|CHI3L1|FGF10|RAC1|MET|IGF2|RASD2|PIK3R1|HSP90AB1|TNF
CILIUM ASSEMBLY%GOBP%GO:0060271,0.49926578560939794,0.914249271904946,-0.11067970478943902,-0.990397004640072,339,274,DYNLRB2|RAB8A|WDR19|MARK4|DNAI1|CETN2|SEPT10|TRAF3IP1|LRRC6|CCDC103|KIF3C|CC2D2A|DYNLRB1|SEPT9|KIF3B|ATP6V0D1|MKKS|DYNLL2|TMEM231|HAUS3|TTC30B|TUBB4B|YWHAE|ASAP1|ABCC4|DYX1C1|WDPCP|DNAL1|HAUS2|IQCG|INTU|CFAP20|RSPH1|CCDC113|ACTR2|B9D2|RILPL1|RSG1|DNAAF1|BBS7
SYNAPTIC VESICLE TRANSPORT%GOBP%GO:0048489,0.524608093328473,0.925993329275615,-0.147528323106108,-0.961156749954745,1438,64,VAMP2|STX11|AP3S2|BLOC1S6|OTOF|SNPH|SYT2|BLOC1S3|TMEM230|SYT9|SNAP25|CPLX1
CORTICOTROPIN SECRETION%GOBP%GO:0051458,0.33205348867999496,0.8293509737209019,-0.8350242611380679,-1.11703741380068,2507,1,CRHR1
VISCERAL MOTOR NEURON DIFFERENTIATION%GOBP%GO:0021524,0.11981993909704801,0.6056190749402529,-0.938795765328628,-1.25585571892303,904,1,TBX20
PRE-MRNA CLEAVAGE REQUIRED FOR POLYADENYLATION%GOBP%GO:0098789,0.8886815920398009,0.997300970905927,-0.182879277123348,-0.6662475511688289,4286,12,NCBP2|NUDT21
SYNAPTIC TRANSMISSION INVOLVED IN MICTURITION%GOBP%GO:0060084,0.0791830322073841,0.532203813468543,-0.7329326127715892,-1.4874649612356698,503,3,CHRNB4|CHRNB2|CHRNA3
REGULATION OF SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0008582,0.619731543624161,0.9532238181782521,0.694309660344067,0.9223594084171041,4616,1,AGRN
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART VALVE MORPHOGENESIS%GOBP%GO:0003252,0.509725315515961,0.918404893008545,-0.55869864902123,-0.955624117165133,3432,2,BMPR2|NOTCH1
AMP TRANSPORT%GOBP%GO:0080121,0.353020134228188,0.842847021021096,0.827911336568152,1.0998432748874498,2629,1,SLC25A42
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033599,0.9870021836331501,1.0,0.177798728112316,0.48472703329845207,9491,8,DEAF1|BRCA2|GATA3
REGULATION OF POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030860,0.0214104269989113,0.30806088751431,0.903060380479735,1.47602738337424,176,2,AJAP1|AHI1
REGULATION OF TOR SIGNALING%GOBP%GO:0032006,0.9817416845280621,1.0,0.10534924787611501,0.5610997794090671,12366,79,SIRT1|ARNTL|PRKAA2|C7orf60|TBCK|STK11|HDAC3|KLHL22|RRAGB|SZT2|DEPTOR|ARAF|FBXO9|WDR24|CLEC16A|TELO2|GATS|LAMTOR4|UBR2|GSK3A|FAM83D|KPTN|ATM|TBC1D7|MAPKAPK5|LAMTOR3|LARS
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND%GOBP%GO:0050910,0.35941449031171,0.8476588060800551,0.41975241886082,1.0925273562625,3412,7,ADGRV1|DFNB31|PDZD7|KIT
NEGATIVE REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002826,0.653441393492198,0.9640743070248079,0.546732837055418,0.893619802537435,5401,2,XCL1|JAK3
MYOSIN FILAMENT ASSEMBLY%GOBP%GO:0031034,0.462951030927835,0.891507554237553,0.40642550920516496,0.9995443497170571,4310,6,IGSF22|TCAP|OBSL1|MYOM2
POSITIVE REGULATION OF GROWTH RATE%GOBP%GO:0040010,0.14788825632199099,0.6402258061318559,-0.9231914424349359,-1.2349813404163201,1116,1,RFTN1
NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051497,0.23924050632911398,0.752099852945417,-0.303335576454864,-1.1752023275203998,1133,14,PPFIA1|DLC1|PFN1|INPP5K|TMEFF2|MET
AMINOACYL-TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY%GOBP%GO:0106074,0.0470011915795048,0.4265829660873479,-0.9759042787825319,-1.30549690879941,354,1,DTD2
"SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:0006931",0.0218791946308725,0.310715277412964,0.9899095721217471,1.31505070356673,162,1,CUZD1
NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900164,0.30928108036541807,0.8114708447293539,-0.8458866343184829,-1.1315683415951001,2335,1,CITED2
REGULATION OF CHOLINE O-ACETYLTRANSFERASE ACTIVITY%GOBP%GO:1902769,0.642684563758389,0.9620807249753851,0.6838883987648879,0.908515227334604,4787,1,SORL1
SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048659,0.0870932623684529,0.553293724109832,0.8173626108095742,1.33595673310381,719,2,NOV|NAA35
XENOPHAGY%GOBP%GO:0098792,0.23164388532720498,0.744434191743215,0.7183898538737249,1.17418848083285,1914,2,LGALS8|CALCOCO2
CORTICOSPINAL NEURON AXON GUIDANCE%GOBP%GO:0021966,0.351447661469933,0.842847021021096,-0.6487455197132621,-1.1096444668819399,2366,2,SLIT2|SCN1B
POSITIVE REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032722,0.0179282868525896,0.282771770062607,-0.348173052370731,-1.7096318014084,71,26,EIF2AK2|IL6R|PYCARD|HIF1A|IL1B|LGALS9|HMOX1|DDX3X|IL6|MBP|MAVS|ADAM17|ADCYAP1|TWIST1|TNF
RESPONSE TO ESTRADIOL%GOBP%GO:0032355,0.8239068441064641,0.9876441563834109,-0.160119931666259,-0.741794076084152,3466,22,RAMP3|GPER1|CTNNB1|ZNF703|POU4F2|RUVBL2|NRIP1|STAT3
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002922,0.98801657520439,1.0,0.238719871147775,0.505870210672357,8821,4,ZP3|CCR7|PHB
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034447,0.121962145817001,0.607607158836689,0.6344279957340171,1.3444135266801398,1088,4,VLDLR|APOE|APOC1
REGULATION OF GLUCOSE METABOLIC PROCESS%GOBP%GO:0010906,0.277956589914995,0.788483986984073,0.230738332900815,1.14553828179113,3367,57,SLC45A3|SIRT1|INS|GNB3|OGT|PHKG2|C1QTNF3|FAM132A|CLK2|SDHAF3|RORA|PDK4|PGP|PASK|GCK|MIDN|SUPT20H|BAD|IRS1|AKT2|VIMP
CORPUS CALLOSUM DEVELOPMENT%GOBP%GO:0022038,0.6015817223198591,0.9506035145731909,-0.318447663730604,-0.874117454743563,3422,6,EPHB2
ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034087,0.923088344469191,1.0,-0.37086983695651204,-0.6343529935961529,6216,2,NAA50
GLYCERALDEHYDE-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046166,0.0100965107646622,0.22001094049154102,-0.930079955886407,-1.59085195264748,67,2,TPI1|TKT
DNA MODIFICATION%GOBP%GO:0006304,0.959148304035652,1.0,0.11806368911907698,0.5861465404342939,11621,57,TDG|EHMT1|MUTYH|PIWIL4|N6AMT1|MBD4|DNMT3B|FOS|NEIL1|ALKBH3|ALKBH1|EHMT2|MPG|ATF7IP|FTO|DNMT1|PPM1D|PIWIL2|PICK1|TET2|APOBEC3D|NTHL1|PRMT7|ASCC1|MGMT|UNG|APOBEC3C|TET1|ATRX|EXOSC3|ASCC3|KMT2E|TDRD12
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904999,0.0239639878194095,0.32397355287938,-0.9888067931186592,-1.32275699562121,180,1,TNF
IMMUNE RESPONSE-REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:0002433,0.0012330456226880401,0.0929735131311543,-0.270811590021827,-1.8596973008444,2,77,PRKCD|ABI1|GRB2|FGR|ABL1|VAV1|MYO1C|CYFIP2|FYN|LYN|FCGR2B|ARPC5|YES1|WIPF1|CRK|LIMK1|VAV3|VAV2|ARPC4|CDC42|MAPK3|RAC1|PLD2|ACTR2|BRK1|PIK3R1|HSP90AB1
PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0042451,0.849620893007582,0.991298302704726,0.262507411964268,0.683251640505088,8067,7,IMPDH1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0044334,0.0942835931700074,0.5630268609168221,-0.813785497656465,-1.39193651017795,634,2,CTNNB1|TCF7L2
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050728,0.7633111822134709,0.978421368343614,0.15849677689089903,0.7954598944249591,9303,60,GHRL|NOV|INS|FNDC4|C1QTNF3|RORA|TYRO3|CHID1|CD200|RB1|APOE|CUEDC2|GSTP1|RPS19|NLRC3|LDLR|SIGLEC10|TNFAIP8L2|VIMP
SORBITOL METABOLIC PROCESS%GOBP%GO:0006060,0.171587448695882,0.674379448319819,-0.911391707101897,-1.2191964746903998,1295,1,SORD
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086023,0.0705420267085625,0.511491464238399,-0.7416733070631041,-1.5052039406028699,448,3,AKAP13|PDE4D
POSITIVE REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904528,0.0142969363707777,0.260761633520319,-0.8345649057019959,-1.6937246801099,90,3,ABL1|PPP2CA|PPP2CB
REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001952,0.368111064366849,0.851675851059934,-0.15149328579924698,-1.04960050762255,874,80,VEGFA|KDR|CX3CL1|BCAS3|COL16A1|PTK2B|DLC1|ABL1|RHOA|NRP1|SLC9A1|PLAU|APOD|MAP4K4|MMP12|DUSP3|LIMS1|ACVRL1|RAC1|CORO1C|CD36|CDH13|PEAK1
POSITIVE REGULATION OF CELL DIVISION%GOBP%GO:0051781,0.12415956969968599,0.607607158836689,0.324833782059981,1.34557091081225,1384,29,KIF14|ECT2|KIF20B|CSPP1|MAP10|KIF23|TAL1|AURKB|CDC6|CENPV|RACGAP1|PKN2|SVIL|CIT|FGFR2
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055023,0.37061631043785,0.852609194081082,-0.279533097409811,-1.05271630174601,1785,13,AKAP6|NOTCH1|PIM1|FGF2|IGF1|TBX20|RBPJ
POSITIVE REGULATION OF RESPONSE TO ALCOHOL%GOBP%GO:1901421,0.435323712432146,0.878651088001772,-0.780381561535068,-1.0439402084998002,3287,1,LANCL2
"BASE-EXCISION REPAIR, BASE-FREE SUGAR-PHOSPHATE REMOVAL%GOBP%GO:0006286",0.820786933927246,0.987153241368501,-0.4303832368348499,-0.736147476754231,5527,2,POLB|APEX1
CHROMATIN SILENCING AT RDNA%GOBP%GO:0000183,0.281610264038676,0.7897963730304,0.30679494967373805,1.1598484332761498,3028,21,HIST1H3E|SIRT1|RRP8|HIST2H3C|HIST2H3A|HIST1H4I|H3F3A
INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032632,0.230372037600953,0.743397546142977,-0.884318482576092,-1.18297979678654,1739,1,SLC11A1
THYMIC T CELL SELECTION%GOBP%GO:0045061,0.0297450424929179,0.354139215474632,0.6854180454445179,1.5797869873494301,272,5,JAG2|CD3D|CD3G|CD3E|ZAP70
CELLULAR RESPONSE TO LEUCINE STARVATION%GOBP%GO:1990253,0.9196217494089829,1.0,-0.186545647889175,-0.631111848958761,4667,10,IMPACT|RRAGD|SESN2
VESICLE UNCOATING%GOBP%GO:0072319,0.053021570887535,0.449202695711989,-0.6863177631941759,-1.5783874785436898,321,4,SYNJ1|DNAJC6|GAK|VPS4A
BLASTOCYST DEVELOPMENT%GOBP%GO:0001824,0.435222672064777,0.878651088001772,0.3580637206852079,1.02179151677626,4299,9,HOPX|ZP3|SRF|NASP|NPM2|TET1
MONOACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0052651,0.284383694205879,0.7935431103190501,0.6931366766009951,1.1329128563259399,2350,2,ABHD16A|ABHD12
REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:1901407,0.12710133542812302,0.6076669536424699,-0.682971214293592,-1.38606978744292,808,3,BRD4|PPIL4|CCNK
REGULATION OF INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070103,0.524026845637584,0.92593403131991,0.7418945743273051,0.9855738437303159,3903,1,C1QTNF4
"REGULATION OF RETROGRADE VESICLE-MEDIATED TRANSPORT, GOLGI TO ER%GOBP%GO:2000156",0.9970968912543849,1.0,0.29893356947815397,0.48859870712649606,8242,2,BET1L|RAB33B
FATTY ACID HOMEOSTASIS%GOBP%GO:0055089,0.0935222672064777,0.5622489437340121,0.49954967350625107,1.4255440836626598,923,9,SIRT1|PRKAA2|INS|POLD1|APOE
NICOTINAMIDE RIBOSIDE CATABOLIC PROCESS%GOBP%GO:0006738,0.961098737936154,1.0,-0.340225806213163,-0.581938020198962,6472,2,PNP
ENDOCYTOSIS%GOBP%GO:0006897,0.00425531914893617,0.153200740055504,-0.157278562309738,-1.4359491440738401,1,331,RAMP3|MYO10|MYO1G|RALBP1|PPAPDC1A|XKR8|PICALM|OPHN1|CLEC7A|SGIP1|LRP12|IGHV4-4|RARA|FCER1G|PIK3C3|DENND1B|PRKCD|DNM2|ABI1|IGHV2-26|CXCL16|ITGAM|ARRB2|NR1H3|DPYSL2|GRB2|FGR|HP|ABL1|VAV1|MYO1C|MARCO|IGHV1-69-2|CYFIP2|CALCRL|RABEPK|IGHV3-15|FYN|IGHV3-73|HYOU1|RIN3|HEATR5A|EHD1|LYN|FCGR2B|ARRB1|TOM1|ARPC5|SLC11A1|YES1|RAB1A|BIN1|RAB39A|WIPF1|CRK|CLTA|DENND1A|AP1S1|LIMK1|VAV3|SNCA|CD93|VAV2|ARPC4|RAMP2|CDC42|AP2S1|TFRC|NEDD4|CXCL8|IGHV1-3|ADRB2|ANXA11|CD9|ACKR3|COLEC12|RINL|MAPK3|CAV2|RAB7A|SYT2|RAB22A|RAB5A|MYH9|RHOQ|RAC1|PLD2|MET|CORO1C|CACNG3|ACTR2|BRK1|CD36|ADM|SH3BP1|PIK3R1|CACNG7|HSP90AB1|TMEM108|AMPH|CAV1|MICALL1|RAMP1
PROTEIN K69-LINKED UFMYLATION%GOBP%GO:1990592,0.639938186813187,0.96058002537611,-0.33588750175215304,-0.8502769066081809,3726,5,UFC1|DDRGK1
INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035655,0.964457417582418,1.0,-0.22513750653304898,-0.5699206478889871,5616,5,ALOX5
POSITIVE REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0032000,0.6922671353251321,0.96731875442989,-0.295670576925991,-0.8115958808344391,3938,6,PPARA|TWIST1
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001272,0.32172646630478,0.822751772025005,-0.8402073224525799,-1.1239709529513202,2429,1,RPS3
PROTEIN KINASE C DEACTIVATION%GOBP%GO:0042313,0.0252348993288591,0.329326373353219,0.987759153065726,1.3121939677878,187,1,EDN1
REGULATION OF TRANSPOSITION%GOBP%GO:0010528,0.42624676940748496,0.875696962448429,0.297038670356508,1.02975251623924,4452,16,ZCCHC11|ZNF93|PIWIL4|ZNF91|MYBL1|UBR2|ZCCHC6|PIWIL2|APOBEC3D|APOBEC3C
ION HOMEOSTASIS%GOBP%GO:0050801,0.7920278479284691,0.9819233677232551,0.128479089888671,0.8558618446511121,11603,389,THADA|TAC1|RYR2|FGFR4|CHRNA10|CALB1|SIRT1|EDN1|RGN|CXCL13|GHRL|SLC12A2|TFR2|PTGER3|ATP2B1|TMEM165|NOL3|PRKAA2|SLC9A5|SLC9A7|SLC8A3|ATP1B3|P2RX5|TMTC2|CXCR4|F2R|BDH2|INS|DMXL2|CXCL9|OCM|ADCY8|PKD2|SLC35G1|IBTK|FLVCR1|MT1F|SLC30A5|AGTR1|KLHL3|ATP2A1|MTL5|CLN6|CDH23|HSP90B1|PDPK1|CACNA2D1|ABCB6|PTGER1|KCNH2|TMEM178A|POLD1|SRC|MT1E|CCR5|CNNM2|PTH1R|PDK4|CCL21|F2RL1|JPH4|AP3D1|CETP|CCL5|ATP2B3|ATP7B|CAND1|XPR1|SLC39A7|PQLC2|SLC46A1|DMPK|SLC40A1|NEO1|APOE|GRIN1|SEPN1|CCL19|CXCL10|ATP2A2|WNK3|TCIRG1|PLCG1|C3AR1|SLC39A13|ANK3|MT2A|CALB2|CD55|FAM132B|TF|DRD4|DLG4|TRPC1
POSITIVE REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002687,0.131187122736419,0.6149266898174119,-0.18342333853234102,-1.2499170119648602,325,75,IL6R|PYCARD|CALR|THY1|PLA2G7|CREB3|VEGFA|LGALS9|PTK2B|AKIRIN1|ADAM10|CAMK1D|ZNF580|RHOA|C1QBP|TNFRSF18|IL6|ICAM1|KARS|LGALS3|ADAM17|CXCL8|ANO6|OXSR1|PLVAP|THBS4|RAC1|PGF|TNF
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN SPERMATOGENESIS%GOBP%GO:1902064,0.6774791473586661,0.9647315640607691,-0.656208645787384,-0.8778303131036641,5116,1,DHX36
"REGULATION OF ALTERNATIVE MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000381",0.8734375,0.9934031064448321,0.14068842425571498,0.701303681110627,10620,58,CELF5|CELF1|RBM4B|RBM25|SART3|SRSF1|DDX17|RBFOX1|SRSF6|SRSF2|THRAP3|RBM5|SRRM4|MBNL3|DDX5|RBFOX2|RBM4|NSRP1|CELF3|RBMX|REST|RBM11|RBM17|SRSF9|SRSF5|SRSF4|SRSF10|CELF6
"REGULATION OF TRANSLATION AT SYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099547",0.166423937508275,0.6682860217990739,-0.9137626819585359,-1.2223682000465401,1256,1,FMR1
PLASMA KALLIKREIN-KININ CASCADE%GOBP%GO:0002353,0.145760251602758,0.636418541205714,0.76989247311828,1.2583680971283602,1204,2,F12|KLKB1
METANEPHRIC GLOMERULAR MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072255,0.998926174496644,1.0,0.500441111601235,0.6648136905014,7441,1,PDGFB
POSITIVE REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0046136,0.113140311804009,0.588848744118853,-0.7965260545905709,-1.36241515717039,761,2,IL1B|TNF
NEGATIVE REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902511,0.252747252747253,0.7641083395392759,-0.874614027348919,-1.16999785114279,1908,1,DFFA
RENAL ARTERY MORPHOGENESIS%GOBP%GO:0061441,0.16832214765100698,0.672026878249637,0.9172915747684158,1.21858093380138,1253,1,PKD2
REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090022,0.652163904235728,0.9640743070248079,-0.19288618309205802,-0.860639919339021,2832,20,CAMK1D|C1QBP|CXCL8|THBS4|RAC1
HEXOSE MEDIATED SIGNALING%GOBP%GO:0009757,0.0139107294060723,0.256136946817111,0.9194375516956159,1.5027954198193798,114,2,AGER|ADCY8
COHESIN LOADING%GOBP%GO:0071921,0.563203096649329,0.9377667552605741,0.580479735318445,0.948778180666826,4655,2,NIPBL|MAU2
NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE%GOBP%GO:0098700,0.9217520415738679,1.0,-0.371546732837055,-0.635510787747598,6207,2,SLC18A2|SLC18A1
NEGATIVE REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034115,0.0648383581547403,0.4956987271622679,-0.5210801433654679,-1.52001389642024,356,7,IL1RN|MAPK7|MYADM|MAP2K5|MBP
PROTEIN MONOUBIQUITINATION%GOBP%GO:0006513,0.452309737454304,0.887237803928201,0.20617180677817498,1.00989466254368,5443,54,FANCL|UBE3D|PCGF2|DDB2|DTL|RNF126|UBE2T|UHRF1|HUWE1|DDB1|TRIM37|KLHL22|CUL4B|RNF40|CDC73|KLHL12|TOPORS|UBE2B|RBX1|TRIM21|PCGF1|PCGF3|UBE2O|NEURL1
SIGNAL CLUSTERING%GOBP%GO:1990256,0.26335570469798697,0.77467054856079,0.87047860608734,1.15639199338317,1961,1,SEMA5A
FRUCTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0046370,0.635538889560905,0.95916055221954,0.55292766709691,0.9037450820583179,5253,2,AKR1B1
NEGATIVE REGULATION OF GROWTH RATE%GOBP%GO:0045967,0.8540460282108392,0.991298302704726,-0.413399503722084,-0.7070977108554091,5751,2,NOTCH2|NOTCH1
OPTIC PLACODE FORMATION INVOLVED IN CAMERA-TYPE EYE FORMATION%GOBP%GO:0046619,0.16241610738254997,0.664367762084791,0.919552271724746,1.22158416885102,1209,1,PROX1
REGULATION OF EMBRYONIC CELL SHAPE%GOBP%GO:0016476,0.13762765121759601,0.6243233125849921,-0.6732393651529419,-1.3663192887579,875,3,WDPCP
DETOXIFICATION OF INORGANIC COMPOUND%GOBP%GO:0061687,0.583861911198919,0.9439064862850342,0.33260225378472197,0.9067629755124201,5614,8,MT1F|MT1E|MT2A|ATP7A|MT1X|MT1G
CELLULAR RESPONSE TO DOPAMINE%GOBP%GO:1903351,0.182164911006175,0.6875189360012,-0.436026283633156,-1.2719080140845602,1002,7,ATF4|ABL1|MAPK3|PARK2
LABYRINTHINE LAYER DEVELOPMENT%GOBP%GO:0060711,0.780784598619688,0.981487311948134,-0.257830296776294,-0.752102414586254,4298,7,RBPJ
IDP METABOLIC PROCESS%GOBP%GO:0046707,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
ZYMOGEN ACTIVATION%GOBP%GO:0031638,0.477684264218312,0.9043208329627141,-0.19702931008358,-0.981835877037853,1872,27,FURIN|TBC1D10A|KLK1|CIDEB|CYFIP2|PLAU|RIPK2|PGK1|CTSH|PRSS3
NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0045900,0.8839966130397969,0.996316041142784,0.44479311860484005,0.727002133177851,7307,2,CPEB3
NICOTINAMIDE RIBOSIDE METABOLIC PROCESS%GOBP%GO:0046495,0.961098737936154,1.0,-0.340225806213163,-0.581938020198962,6472,2,PNP
REGULATION OF SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:1901304,0.772408314576989,0.979693198874896,-0.6101124834583149,-0.816166071295861,5833,1,PAOX
CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0034382,0.160152312688991,0.661454203640901,0.608062648210445,1.28854283672847,1429,4,APOE|APOC1|LDLR|APOC2
REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002688,0.325206449075895,0.826621597878865,-0.159342421203972,-1.07843846759506,826,73,LGALS9|PTK2B|AKIRIN1|ADAM10|CAMK1D|ZNF580|C1QBP|IL6|LYN|KARS|ADAM17|CXCL8|MTUS1|ANO6|OXSR1|GREM1|THBS4|RAC1|PGF|NBL1
POSITIVE REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031349,0.017379679144385,0.278447181841778,-0.15358719430572598,-1.3476740642542901,12,248,POLR3F|PUM1|S100A9|MB21D1|UNC93B1|SLC25A6|PARK7|AP1G1|IL6ST|PLSCR1|RELA|PRKACA|TRAF6|OTULIN|MAPKAPK3|MFHAS1|CTSS|RPS6KA3|SCARA3|AGT|UBE2N|CYBA|TLR1|CREBBP|FLOT1|IL17D|PYCARD|RIOK3|PJA2|POLR3C|XRCC6|ITCH|HEXIM1|NOD1|PLA2G7|PVRL2|IL1B|IRAK1|SIN3A|POLR3D|FCER1G|NFKBIA|PIK3C3|CX3CL1|PRKCD|LGALS9|IRAK2|NRAS|ITGAM|TNFAIP3|CD300LF|NR1H3|IRAK4|LAMP1|CEBPA|ULBP3|TRAF3|S100A8|CCL14|FYN|BCL10|UBE2V1|RELB|IL6|LYN|CYLD|TANK|C2CD4A|MAVS|CNPY3|TNIP1|RIPK2|MUC4|ETS1|PLA2G2A|SNCA|KARS|MUC3A|TNFRSF11A|RFTN1|PDCD4|ULBP2|KRAS|UBA52|WDFY1|COLEC12|TNIP2|TICAM1|MUC12|MYD88|UBC|CCL18|CD36|GPRC5B|UBE2K|TNF|CAV1|PAK2|UBB
PROTEIN SUCCINYLATION%GOBP%GO:0018335,0.6675999552021501,0.964618776001639,0.40454011884773106,0.857259155523925,5960,4,KAT2A|DLD
SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:0071340,0.22590604026845604,0.7398172623753029,0.8884539038376709,1.18027137450959,1682,1,DNAJA3
POSITIVE REGULATION OF INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000494,0.610872483221477,0.9508825506493929,0.6997132774591971,0.9295378726821031,4550,1,TICAM2
EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904861,0.644866838487973,0.9625632908696992,0.347360873641829,0.854283480484494,6004,6,SHANK1|NRXN2|NLGN2|NRXN1|PTEN|SHANK2
POSITIVE REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051041,0.37640672580431606,0.853374872190571,-0.809605205116895,-1.0830335675406402,2842,1,CX3CL1
REGULATION OF SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:1904048,0.0791738382099828,0.532203813468543,-0.959142037935598,-1.28307354814202,597,1,PARK2
PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE%GOBP%GO:0090435,0.704393673110721,0.968941691852291,-0.29297001234111203,-0.8041830123785959,4007,6,TOR1AIP2|NUTF2
METABOLISM BY ORGANISM OF PROTEIN IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052418,0.7186548391367671,0.971081608033886,-0.635752095280106,-0.850464961775082,5427,1,ANXA2
BOX H/ACA SNORNA PROCESSING%GOBP%GO:0034964,0.47260579064588004,0.898911737554429,-0.5766749379652609,-0.986371596655444,3182,2,DKC1|PARN
XYLULOSE BIOSYNTHETIC PROCESS%GOBP%GO:0005999,0.421083890126206,0.8727872721376851,-0.602540700374069,-1.03061359797409,2835,2,TKT
PHYTOSPHINGOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0071602,0.146961472262677,0.638549298625996,-0.9235774150860171,-1.23549766779988,1109,1,ACER3
ADP TRANSPORT%GOBP%GO:0015866,0.9583887746461841,1.0,0.381378248293308,0.6233522697620479,7922,2,SLC25A42
PIGMENT METABOLIC PROCESS INVOLVED IN PIGMENTATION%GOBP%GO:0043474,0.328590604026846,0.828303707528737,0.8398213498015,1.1156651961246002,2447,1,AP3D1
PYRIDINE NUCLEOTIDE SALVAGE%GOBP%GO:0019365,0.19369127516778498,0.7046839209256791,0.9052712836347601,1.2026125132935201,1442,1,NAPRT
NUCLEOBASE-CONTAINING SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0055086,0.995269311346895,1.0,0.0927971066130222,0.6276609062063161,14726,474,ACSM3|NME3|HACD1|CROT|GPHN|NPR2|NME4|ACSF2|NDUFA7|OXSM|IMPDH1|GAMT|NDUFS7|TDG|HSD17B4|AK6|NDUFA4|NUDT17|PARP16|SLC35D1|CD38|RRM1|SCD5|ELOVL6|FUT8|MYH3|ATP5G1|DNPH1|NDUFS2|ADCY8|RBKS|COX5A|DGAT1|PDE2A|TEFM|NAPRT|FAR2|ACBD6|COA6|ATP5D|MVD|NNT|MTHFD1|SLC35B3|NDUFC1|NDUFAF1|NDUFS4|MBD4|TAZ|ME1|TK1|PNKP|CAD|ACOT1|EXTL2|PARP1|AK3|PGLS|MT-ATP8|SLC26A2|IDH1|SULT1A3|PDHX|DTYMK|FAR1|GMPPB|COX6A1|BST1|NUDT14|CTPS2|RFK|ADSSL1|AMDHD2|GCK|NDUFS8|UCKL1|RNLS|PDHA1|NDUFB2|DUT|SMPDL3A|ACOT2|SLC25A1|UQCC3|ACACA|PTGS2|MACROD1|GUK1|DCK|SUCLG1|SMARCAD1|DLD|ACSS1|MTAP|MCEE|NADK
POSITIVE REGULATION OF P38MAPK CASCADE%GOBP%GO:1900745,0.85269281291049,0.991298302704726,0.18535433933871698,0.688313200470087,9087,20,AGER|EMC10|HAND2|GADD45B|GADD45G|MAP3K4|PRMT1
GLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006041,0.8433483848558531,0.991298302704726,0.383147678394177,0.7283234310044471,7283,3,PGM3|GNPDA1|GNPDA2
SULFATE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902358,0.30872483221476504,0.8114708447293539,0.849580943978827,1.12863038158281,2299,1,SLC26A2
PROTEIN DENEDDYLATION%GOBP%GO:0000338,0.140464933018125,0.629393873299015,-0.394975487794827,-1.33626119513478,712,10,COPS7A|COPS2|COPS8
CIRCADIAN TEMPERATURE HOMEOSTASIS%GOBP%GO:0060086,0.16496465043205,0.667429120754799,-0.649829921428578,-1.31881051824442,1049,3,TNFRSF11A|NR1D1
AMYLOID-BETA METABOLIC PROCESS%GOBP%GO:0050435,0.0932835820895522,0.5622489437340121,-0.391837733463303,-1.42750416822454,449,12,APH1A|APEH|PSEN1|PSENEN|BACE2|DYRK1A|NCSTN|PSEN2|ACE
POSITIVE REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905451,0.8082738599250029,0.984682960940884,0.483650399779432,0.7905132917857641,6681,2,PTPRJ|PTPRC
NEGATIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION%GOBP%GO:0051562,0.7773154362416109,0.9810334506628041,0.613145125716806,0.814535945171394,5790,1,MICU2
MEMORY T CELL PROLIFERATION%GOBP%GO:0061485,0.28456375838926196,0.793663380147364,0.860829289810322,1.14357330719567,2119,1,DOCK8
REPLICATIVE CELL AGING%GOBP%GO:0001302,0.9832117633437539,1.0,0.27629895601411797,0.525215249823651,8491,3,CHEK2|WRN
GLYCOSIDE METABOLIC PROCESS%GOBP%GO:0016137,0.0445332293899825,0.41504430757275895,0.469740542970988,1.5563963939901702,456,14,AKR1B1|CBR4|GBA2|AKR1C1|KIAA1161|ABHD10
REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0052548,0.11241446725317698,0.587656563188088,-0.14028134618080498,-1.18537111337174,114,201,LGALS9|CIDEB|DLC1|MAGEA3|EIF2AK3|BBC3|SPOCK3|RPS3|CYFIP2|S100A8|PSME3|FYN|SERPINI1|DDX3X|TNFRSF10A|MAP2K5|HGF|PPARG|LYN|MMP9|EFNA1|BOK|LAMTOR5|MBP|BIN1|SPOCK1|SERPINF2|RIPK2|CRADD|TIMP2|GAPDH|SERPINF1|PLAUR|SNCA|SERPINA1|NLRP1|NLRP3|STAT3|YWHAE|DNAJB6|TNFRSF10B|MTCH1|EPHA7|SOX7|BCAP31|CSNK2A1|AQP1|TNF|PMAIP1|PAK2|EGLN3
CENP-A CONTAINING CHROMATIN ORGANIZATION%GOBP%GO:0061641,0.0812739296902193,0.538175749540073,0.320119370422614,1.4232834980029498,933,37,RBBP7|CENPL|CENPT|CENPK|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|MIS18BP1|NASP|HJURP|STRA13|CENPM
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001938,0.7142857142857142,0.971081608033886,-0.13021371044248198,-0.8598564838609141,1929,67,VEGFA|KDR|TGFBR1|NRAS|HMOX1|PRKD2|PDCL3|ZNF580|NRP1|FGF2|APLNR|VIP|FGFR1|ADAM17|STAT5A|PRKCA|SCG2|THBS4|PGF|CDH13
I-KAPPAB PHOSPHORYLATION%GOBP%GO:0007252,0.7302021903959559,0.972554563883587,0.30077934520995503,0.7828654418059671,6933,7,PRDX4|MAP3K7|CHUK|TLR4|TLR2
SESQUITERPENOID METABOLIC PROCESS%GOBP%GO:0006714,0.9529988084204949,1.0,-0.521063078958977,-0.697041967803514,7197,1,AKR1C3
OXALATE TRANSPORT%GOBP%GO:0019532,0.5508537490720121,0.931763873811087,-0.541604631927213,-0.926385716422813,3709,2,SLC26A6|SLC26A1
DNA REPLICATION-INDEPENDENT NUCLEOSOME ORGANIZATION%GOBP%GO:0034724,0.125389999156759,0.607607158836689,0.278271611776686,1.3254178272140602,1486,48,RBBP7|ASF1B|CENPL|CENPT|CENPK|ASF1A|CASC5|CENPU|OIP5|ITGB3BP|CENPA|HIST1H4I|CENPQ|CENPI|H3F3A|MIS18BP1|NASP|HJURP|STRA13|CENPM
ER TO GOLGI CERAMIDE TRANSPORT%GOBP%GO:0035621,0.388216810683425,0.860097613635053,-0.512683357229514,-1.0404756410058,2470,3,PLEKHA8|COL4A3BP|PLEKHA3
AMINO-ACID BETAINE TRANSPORT%GOBP%GO:0015838,0.48863254563780895,0.9084242914579891,0.46545105015281896,0.9863352374747221,4362,4,SLC25A29|SLC22A4|PDZK1|SLC22A5
ASCENDING AORTA DEVELOPMENT%GOBP%GO:0035905,0.0321424571620562,0.365598374354954,0.72929186624061,1.54543913015266,286,4,HES1|TGFB2|HEY2
REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031644,0.288463168602187,0.7980646072929201,0.241956891030882,1.14174068283099,3402,46,CARTPT|AKAP9|ZFHX2|RIMS2|NOV|FGF12|UNC13B|F2R
PEPTIDE CROSS-LINKING%GOBP%GO:0018149,0.6319665605095539,0.9580150657116279,0.28362141768330895,0.865263931061179,6349,11,ABCA7|TGM1|FN1|CSTA|THBS1|COL3A1|ANXA1
MATURE NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:0035782,0.8216107382550341,0.987153241368501,0.590427878253198,0.7843570954042521,6120,1,XCL1
SUGAR MEDIATED SIGNALING PATHWAY%GOBP%GO:0010182,0.0139107294060723,0.256136946817111,0.9194375516956159,1.5027954198193798,114,2,AGER|ADCY8
DNA REPLICATION-DEPENDENT NUCLEOSOME ASSEMBLY%GOBP%GO:0006335,0.463765355680411,0.8921382338742359,0.27869339409757105,0.999730022133116,4869,18,HIST1H3E|ASF1B|ASF1A|HIST1H4I|CHAF1A|NASP
VENTRICULAR CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:0055005,0.47284383694205895,0.8990547397930471,0.61496362262161,1.00514114713605,3908,2,PROX1|MEF2A
DETERMINATION OF AFFECT%GOBP%GO:0050894,0.6449664429530201,0.9626003629998371,0.6828407587119539,0.9071234842628192,4804,1,SHANK1
REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000074,0.44119787875636896,0.880402968441571,0.372545384807137,1.01565866676234,4242,8,ARNTL|CLOCK|BAD|GSK3A
NEGATIVE REGULATION OF IMMUNE RESPONSE%GOBP%GO:0050777,0.9030593438997421,1.0,-0.11209129458389301,-0.7340092823998721,2449,65,LGALS9|TNFAIP3|ARRB2|NR1H3|PPARG|LYN|FCGR2B|SPINK5|CNOT7|SMAD7|LGALS3|NR1H2|SOCS5|ADCYAP1|TNF
PERIPHERAL NERVOUS SYSTEM MYELIN FORMATION%GOBP%GO:0032290,0.543758389261745,0.929698169790548,0.7309770621967359,0.9710704159296021,4050,1,DICER1
REGULATION OF CELL GROWTH%GOBP%GO:0001558,0.0875179340028694,0.5548945271904749,-0.136482333972148,-1.2014609890505301,60,260,ZNF639|RAB33B|VEGFA|KIF26A|PLCE1|NEDD4L|GNG4|ATAD3A|DNM2|MSX1|RTN4|TGFBR1|CXCL16|BCAR1|OSGIN2|ABL1|SEMA3F|PML|MAP3K13|DCUN1D3|ADAM10|S100A8|SPHK1|FBP1|NRP1|DDX3X|EXOSC4|CPNE6|CCDC85B|EIF4G1|NME6|SEMA7A|SH3BP4|ENO1|CDA|POU4F2|PPP2CA|ISLR2|IGF1|SPOCK1|BAP1|JADE1|LIMK1|WNT11|EXOSC9|CDC42|FXN|TFRC|SEMA6B|NET1|ADAM17|MTPN|SLC25A33|BCL2|TP53|TWF2|OGFR|BCL6|CDKN1A|MFI2|SYT2|SERTAD2|SFRP2|ACVRL1|H3F3B|SEMA3A|MUC12|SEMA3G|CPNE9|ING1|SESN2|CSNK2A1|OLFM1|SOX17|GAL|SLIT3
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045668,0.6334209044848941,0.958362160385489,0.234150788257353,0.869518777024644,6750,20,CITED1|CDK6|TMEM64|C14orf169|MEN1
NEGATIVE REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904430,0.9956322096539371,1.0,0.218098931666826,0.462172470097454,8889,4,RTEL1-TNFRSF6B|RTEL1|XRCC5|TERF2
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009176,0.8459359337546309,0.991298302704726,0.302324394779506,0.6968129129445501,7763,5,DUT|HDDC2|TYMS
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS%GOBP%GO:0021952,0.661485668146952,0.964618776001639,-0.23800066203244,-0.8375539820248191,3276,11,SPTBN4|SZT2|MYCBP2|PAFAH1B1|EPHB1|SLIT2|EPHA4|C12orf57|CHRNB2|SCN1B|NFIB
BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060837,0.25377855887522,0.7641083395392759,-0.42722240542409,-1.1726968170024,1443,6,DLL1|NOTCH1|NRP1|RBPJ
CDP-DIACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0016024,0.7553020134228191,0.9771370084125129,0.6253859726510811,0.8307973642206791,5626,1,CDS1
"POSITIVE REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032834",0.354958294717331,0.842911430859438,-0.821460079400088,-1.09889219432135,2680,1,LGALS9
EMBRYONIC LIVER DEVELOPMENT%GOBP%GO:1990402,0.6409373758771351,0.96102887115448,-0.6735774150860171,-0.9010650453637808,4840,1,TGFB1
GLYCEROPHOSPHATE SHUTTLE%GOBP%GO:0006127,0.8290745399179141,0.9876441563834109,-0.5837009263343629,-0.7808345260495241,6261,1,GPD2
REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905165,0.614153780068729,0.951043054263351,0.357012431110922,0.8780200804658,5718,6,LDLR|LAPTM4B|ATP13A2|LRP1|MGAT3
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN DEFINITIVE ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0060807,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:0044257,0.868671848597499,0.99309394259051,0.120872260256594,0.81643280686285,12851,463,SIRT1|ENC1|HACE1|OMA1|FBXO18|SDF2|ARNTL|UBR4|SPSB4|SIAH2|TRIM9|BRSK2|TRIM3|ANAPC15|VLDLR|CLPP|CCNB1|SGTA|IDE|CDC34|CDK1|BTRC|KIF14|PSMD11|LONP1|ANAPC5|RNF34|KLHL42|UBE2Z|AP2A2|PCYOX1L|PSMD13|PSMB9|MTA1|KLHL3|POMT2|PSMA4|NHLRC3|HSP90B1|ZFAND2B|DERL3|USP44|PSMD3|UBAP1L|ATXN3|TNFAIP1|BIRC6|EDEM3|SPSB3|DTL|FBXL19|RNF126|USP13|KLHL20|CDC23|TTC3|CDC20|UBD|RNF111|RNF146|ANAPC7|ANAPC16|UHRF1|FBXL15|GZMA|NGLY1|PTTG1|FBXO5|PSMD1|FBXL6|KLHL25|BUB1B|RNF121|AURKB|HUWE1|VPS36|KLHL8|DDB1|RNF7|CLOCK|PSMA1|RNF150|RNF144A|SYVN1|FBXL8|TCIRG1|AUP1|HDAC6|RNF14|NFE2L2|KLHL22|UBE3B|FBXW5|CCNF|CHEK2|PLK1|CUL4B|TSG101|BIRC2|HERC2|KEAP1|CTSC|MAN1B1|RIPK1|CLTC|ZRANB1|UBXN4|VPS37A|HERPUD1|TMUB1|SPOP|RNF40|AURKA|RMND5B|CHFR|PSMA3|RNF215|JKAMP|VIMP|UBE2C|FBXO9|RNF123|ANKZF1|PSMC6|ANAPC10|BAG6|GET4|KCTD13|TOPORS|PSMD2|MVB12B|DNAJB9|UBE2B|UBE2H|UBR2|NPLOC4|RBX1|PSMA5|GSK3A|FAP|FBXL7|MVB12A|ANKIB1|RNF19A|AREL1|PSMC2|PSMC5|SKP2|TMEM67|CDK2|VCP|MARCH6|ARRDC1|UBR3|CDC16|PLAA|SNF8|KCTD5|ANAPC2|TRPC4AP|PSMA2|PSMB6|CUL2|PSMB3|FAF1|FBXO44|UBA6|LACE1|KCTD2|FBXO11|MDM2|PSMA7|PINK1|ERLIN1|NEMF|SMURF2|FBXO8|PSMB4|SHARPIN|USP33|UBR5|RNF8|FAF2|TAF1|AP2M1|CBL
INNATE IMMUNE RESPONSE IN MUCOSA%GOBP%GO:0002227,0.43277529375065,0.878651088001772,0.375627527616501,1.02406141494871,4161,8,HIST1H2BJ|HIST1H2BF|HIST1H2BK|HIST1H2BG|HIST2H2BE
BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006699,0.284449100085706,0.7935919047370921,0.322794507964752,1.15792970851354,2986,18,SLC27A2|HSD17B4|OSBPL3|AMACR|ACOX2|OSBPL9|CYP7B1|OSBPL6|OSBP
EMBRYONIC NEUROCRANIUM MORPHOGENESIS%GOBP%GO:0048702,0.742387403033461,0.974505008828563,0.427950937042111,0.8134897125682691,6411,3,MTHFD1|MTHFD1L|NDST1
VITAMIN K METABOLIC PROCESS%GOBP%GO:0042373,0.3808661287666721,0.856651359297142,-0.45469585837975,-1.0457054849813299,2312,4,VKORC1|CBR1|UBIAD1|VKORC1L1
VERY LONG-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0042760,0.443050733564789,0.8808089923737601,0.481560273174992,1.02047221989187,3955,4,SLC27A2|ABCD1|ABCD3|SLC27A4
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046824,0.279334770557438,0.788692060817727,-0.19175672365285798,-1.12698537783246,906,45,IGF1|MAVS|ZPR1|NEDD4|BAG3|TP53|YWHAE|NCBP2|PIK3R1
POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION%GOBP%GO:1902462,0.792532768436383,0.9819233677232551,-0.6006837229819139,-0.803552930926083,5985,1,LTBP3
CADMIUM ION HOMEOSTASIS%GOBP%GO:0055073,0.230372037600953,0.743397546142977,-0.884318482576092,-1.18297979678654,1739,1,SLC11A1
PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0061462,0.21044303797468397,0.7251658659797621,-0.230246549426964,-1.1945264772039899,797,30,VPS4A|GCC2|SH3BP4|LAMTOR5|NEDD4|C12orf66|RAB7A|CACNG3|CACNG7
CRANIAL SUTURE MORPHOGENESIS%GOBP%GO:0060363,0.0315106580166821,0.362898475253319,-0.984395677106308,-1.31685611123769,237,1,TWIST1
PROTEIN ACTIVATION CASCADE%GOBP%GO:0072376,0.175714402685663,0.678685257108795,0.24759521708308,1.2472676021626798,2145,61,IGHV3-21|IGKV4-1|IGHV4-61|COLEC11|IGHG1|F12|IGLL5|IGHG4|IGHV1-18|IGHV3-43|IGKV3-11|COL20A1|IGKV2D-28|F3|IGKV2-28|C7|KLKB1|IGHV1-24|GP1BB|C4A|C4B
PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006221,0.596439169139466,0.948415232788167,0.258258145231956,0.8953109525190841,6230,16,CAD|DTYMK|CTPS2|DUT|UMPS|HDDC2|TYMS|CTPS1|CDS1
CHAPERONE MEDIATED PROTEIN FOLDING INDEPENDENT OF COFACTOR%GOBP%GO:0051086,0.8343624161073829,0.988613522932093,0.5830943978826639,0.774614893901753,6215,1,CCT2
REGULATION OF OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:1900141,0.544287038262942,0.929758904310055,-0.722761358623732,-0.966859906240049,4110,1,GAS6
NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048715,0.45100235188710897,0.886411023801201,0.47872478540864793,1.01446355045508,4026,4,HES1|NF1
AEROBIC RESPIRATION%GOBP%GO:0009060,0.7490891023517721,0.9749763305090959,0.162531252056004,0.802834763114696,9045,56,MTFR1|COX20|FH|NDUFS7|COX5A|NNT|COX6A1|NDUFS8|PDHA1|SUCLG1|SIRT3|SDHA|ACO1|ME3|DHTKD1|MT-CO2|MTFR1L|MTFR2|ACO2|OXA1L|IREB2|SURF1|LACE1|MT-CO1|CYCS|UQCR10|MDH1|COX7C|SDHB|UQCRB|CS|MDH2|MT-CO3|MT-ND1|MT-ND4|IDH2
NEGATIVE REGULATION OF HEMOSTASIS%GOBP%GO:1900047,0.46207827260458795,0.8912739660615641,0.243713897222543,0.999380109332268,5135,28,EDN1|CEACAM1|SERPINE2|PLAT|F12
POSITIVE REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051096,0.606530102942706,0.9508825506493929,0.32639948733596397,0.889852570073241,5832,8,GTF2H2|MSH6|POT1|MSH3
MITOTIC DNA REPLICATION INITIATION%GOBP%GO:1902975,0.8932874354561099,0.9976191001250191,-0.551720335244817,-0.7380531142689909,6746,1,POLA1
QUORUM SENSING%GOBP%GO:0009372,0.485105256189594,0.9064456896937672,-0.755955006616674,-1.0112640612260502,3663,1,SLC22A5
POSITIVE REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043406,0.27473363774733606,0.7884684708511421,-0.135842809021815,-1.08889470260579,360,156,IL1B|IRAK1|VEGFA|PKN1|PLCE1|DAB2IP|C5AR1|TGFBR1|IRAK2|PRKAA1|GDF15|MAP3K13|RPS3|RET|UBE2V1|FGF2|MAP2K5|CHRNA7|MST1R|IGF1|DIRAS1|CRK|RIPK2|PDCD10|KARS|FGFR1|MAP2K3|GADD45A|DBNL|MLKL|TNFRSF11A|RAPGEF1|SHC1|UBA52|DKK1|MAPK3|FLT1|ADRA2A|FGF10|PEA15|MAP3K11|UBC|MAP2K1|TNF|UBB|ADORA2B
DNA DEMETHYLATION OF MALE PRONUCLEUS%GOBP%GO:0044727,0.810936051899907,0.9852684165902109,-0.5920269078076751,-0.7919724453234219,6124,1,TET3
HISTONE H3-K4 ACETYLATION%GOBP%GO:0043973,0.8597315436241609,0.9916689277956879,0.5715152183502429,0.759232470476754,6404,1,LDB1
CUT METABOLIC PROCESS%GOBP%GO:0071043,0.590317800098798,0.945418171231938,-0.382893067887277,-0.8805740669770029,3584,4,EXOSC10|EXOSC2|EXOSC3|DIS3
POSITIVE REGULATION OF TRANSCRIPTION INVOLVED IN EXIT FROM MITOSIS%GOBP%GO:0007072,0.943355704697987,1.0,0.530988089986767,0.705393988489256,7027,1,SIRT7
PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009078,0.446180325698398,0.883874685872149,-0.775474194971328,-1.0373754746231398,3369,1,GPT2
MATERNAL PLACENTA DEVELOPMENT%GOBP%GO:0001893,0.669426890390063,0.964618776001639,0.364806973430257,0.8408259942232571,6143,5,GHRL|STOX2|CYP27B1|SPP1
IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036498,0.997667055490752,1.0,0.0874434136690783,0.426490018153039,11973,53,ACADVL|PARP16|PREB|ERN1|YIF1A|EXTL2|SULT1A3|SYVN1|SEC31A|PDIA5|CUL7|EXTL1|DNAJB9|GSK3A|PLA2G4B|TLN1|ZBTB17|KDELR3|SRPRB|EXTL3|DDX11|DNAJB11|PPP2R5B|XBP1
INNER EAR RECEPTOR CELL DIFFERENTIATION%GOBP%GO:0060113,0.0401821862348178,0.40015465197523603,0.55323683050687,1.57874888608746,396,9,STRC|ADGRV1|DFNB31|JAG2|PDZD7
ERYTHROCYTE HOMEOSTASIS%GOBP%GO:0034101,0.928346456692913,1.0,0.14052707441140802,0.6202916225202011,10610,36,INHA|FLVCR1|JAK2|TAL1|MED1|KIT|RPS24|RPS19|ATPIF1|ACIN1
POSITIVE REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0045940,0.583414539076204,0.9439064862850342,0.271429517468963,0.8993303399772242,5986,14,STAR|WNT4|AGTR1|LDLRAP1|APOE|APOC1
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032226",0.9525142793145931,1.0,0.275945050087347,0.584753920779674,8504,4,DRD4|RAB3B
OVULATION CYCLE%GOBP%GO:0042698,0.46813316311499603,0.895754282420271,0.308624993313221,0.996047569795104,4766,13,ROBO2|TGFB2|TYRO3|ZNF830|BMPR1B|EGR1|TGFB3|ANXA1|PDGFRA
MODULATION BY HOST OF VIRAL MOLECULAR FUNCTION%GOBP%GO:0044868,0.6958993588968189,0.96731875442989,0.530962227736421,0.8678431748495179,5752,2,PTX3|NUCKS1
PHOSPHOLIPID DEPHOSPHORYLATION%GOBP%GO:0046839,0.8772650398647021,0.994743247302385,-0.147983149300135,-0.6953604437590281,3630,23,MTMR1|PPAPDC1B|INPP5F|OCRL|MTMR6|PPAP2A|TMEM55B|MTMR3|EPHX2|INPP5J|SACM1L|MTM1|PTEN|SYNJ1|INPP5B|TMEM55A|PPAPDC1A|SYNJ2|MTMR2|INPP5K|PPAP2B
LYMPHANGIOGENESIS%GOBP%GO:0001946,0.46505271378367796,0.8931622397044531,-0.30255181765070693,-0.976664379694971,2381,9,FLT4|SOX18|CCBE1|ACVR2B|BMPR2|PDPN|FOXC2|ACVRL1
PYRIMIDINE-CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT%GOBP%GO:0072531,0.8242804345391421,0.9876441563834109,0.34359362010634303,0.7281077027780279,7359,4,SLC25A19|SLC19A2
HISTONE H2A-S1 PHOSPHORYLATION%GOBP%GO:0043990,0.627830001323977,0.9553884638359259,-0.679367004852228,-0.908809956117153,4741,1,RPS6KA5
POSITIVE REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051785,0.30033600413543604,0.803321166778425,0.250278100087107,1.13555533848266,3485,40,EDN1|INS|ANAPC5|NUMA1|FAM178A|DLGAP5|NUSAP1|RB1|ESPL1|NIPBL|CDCA5|PEBP1|AURKA|UBE2C|ANKRD32
REGULATION OF METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000006,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
"REGULATION OF TRANSPOSITION, RNA-MEDIATED%GOBP%GO:0010525",0.6301937506999661,0.957141460696787,0.417230388083593,0.8841510482723941,5626,4,ZCCHC11|ZCCHC6|ERCC3
CELLULAR RESPONSE TO LIPOPOLYSACCHARIDE%GOBP%GO:0071222,0.149768615902398,0.643776991770958,-0.177148937136732,-1.22735217843188,355,80,CD274|IL1B|IRAK1|MTDH|SIRPA|DAB2IP|TNFAIP3|NR1H3|RHOA|TNFRSF1B|BCL10|VIM|IL6|LYN|SBNO2|LDOC1|PDE4B|NR1H2|PDCD4|CXCL8|NLRP3|TNIP2|TICAM1|NR1D1|TNF
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036493,0.9153674832962141,1.0,-0.376123518059002,-0.6433391337528,6164,2,NCK1|DNAJC3
NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031944,0.7277297721916729,0.972554563883587,-0.3890481967574721,-0.789561756189727,4631,3,REST|BMP2|DKK3
NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040015,0.7376276512175959,0.974306231601101,-0.386346090217271,-0.784077911249501,4694,3,BBS2|PTCH1|GDF15
GASTRO-INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014831,0.841032766006715,0.990143309585111,0.384983162035614,0.731812492321187,7263,3,PTGER3|SULF1
VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS%GOBP%GO:0060979,0.253260015710919,0.7641083395392759,-0.5795742803573399,-1.17622878207711,1611,3,SPRED1|TGFBR3|NOTCH1
OXIDATIVE STRESS-INDUCED PREMATURE SENESCENCE%GOBP%GO:0090403,0.697232835475281,0.96731875442989,0.446346751395863,0.8484582204877191,6021,3,ARNTL|PLA2R1
PROTEIN K33-LINKED UBIQUITINATION%GOBP%GO:1990390,0.31744966442953004,0.8190953247261821,0.845445522717247,1.12313665893102,2364,1,KLHL20
CELLULAR RESPONSE TO INTERLEUKIN-17%GOBP%GO:0097398,0.9079532356331301,1.0,-0.281200022059229,-0.646701305993913,5513,4,IL17RC|IL17RE|IL17RB|IL17RA
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0048178,0.0029127499007017103,0.13103871184697197,-0.998786943096603,-1.33610774653893,21,1,INHBB
REGULATION OF CELL DIVISION%GOBP%GO:0051302,0.409166337416041,0.867015886388254,0.193392997887494,1.04169775066869,5177,84,FSD1|KIF14|E2F8|BLM|ECT2|CDK2AP2|KIF20B|MYO19|CSPP1|RAB11FIP3|MAP10|KIF23|BIRC6|E2F7|PRC1|TAL1|KIF18B|GIT1|AURKB|CDC6|CENPV|ORC6|PIN1|KIF20A|PLK1|RACGAP1|PKN2|AURKA|SVIL|KLHL9|CIT|FGFR2|ZFYVE26|RAB11FIP4|PDXP
GLUCAN METABOLIC PROCESS%GOBP%GO:0044042,0.9084319884029959,1.0,-0.14153251070253697,-0.665049432410989,3759,23,PYGB|PER2|NR1D1
RENAL FILTRATION CELL DIFFERENTIATION%GOBP%GO:0061318,0.611842105263158,0.9508825506493929,0.30867208813673397,0.8808446734569101,6044,9,BASP1|PTPRO|MAGI2
RETINA HOMEOSTASIS%GOBP%GO:0001895,0.30006183199364,0.8029284213357041,0.26622010713896105,1.13826769348229,3396,32,PCDH15|CDH3|IQCB1|ADGRV1|DFNB31|CDH23|BBS10|JCHAIN|TF|NPHP3|CNGB1|ACTG1|PRR4|BBS1|LCN1
TAURINE METABOLIC PROCESS%GOBP%GO:0019530,0.9802889461305859,1.0,0.248891188961807,0.527424204735191,8752,4,CDO1|STAT5B
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:2000053,0.6974712034953001,0.96731875442989,-0.646724746360829,-0.865143411679092,5267,1,SFRP1
PHYTOSTEROID BIOSYNTHETIC PROCESS%GOBP%GO:0016129,0.24785290915688898,0.7605506815911129,0.710449407223601,1.1612100389200501,2048,2,C14orf1|DHCR7
POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903980,0.614621921987361,0.9511905259737851,0.3831001920893521,0.8829891514182711,5640,5,AGER|TTBK1|APP|ITGB2
SNORNA CATABOLIC PROCESS%GOBP%GO:0016077,0.9592215013901759,1.0,-0.518250992501103,-0.693280154009019,7244,1,NUDT16
REGULATION OF AMNIOTIC STEM CELL DIFFERENTIATION%GOBP%GO:2000797,0.7809395973154358,0.981487311948134,0.610994706660785,0.811679209392466,5817,1,REST
PEPTIDYL-GLYCINE MODIFICATION%GOBP%GO:0018201,0.253416762720237,0.7641083395392759,-0.5121050019301819,-1.1777345219571398,1538,4,NMT2|NTMT1|NMT1|RNF113A
CMP-N-ACETYLNEURAMINATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015782,0.124697986577181,0.607607158836689,0.938520070577856,1.2467820434138799,928,1,SLC35A1
PROSTATE GLAND GROWTH%GOBP%GO:0060736,0.9630289532293991,1.0,-0.337943849973839,-0.5780348562653579,6485,2,PSAP
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034379,0.6604924820222271,0.964586948392425,0.36744414891043,0.8469042927662029,6061,5,DGAT1|SOAT1|APOC1
REGULATION OF GAMMA-AMINOBUTYRIC ACID SECRETION%GOBP%GO:0014052,0.0025155567324242,0.12586582153175,-0.9989523599470671,-1.3363290297033101,18,1,TRH
CALCIUM ION IMPORT INTO CYTOSOL%GOBP%GO:1902656,0.602126288659794,0.9508825506493929,0.36109129131999795,0.888051443121261,5606,6,CACNA2D1|TRPV1|FAM155B|TRPM2|FAM155A
ACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0046464,0.52733771251932,0.9265056012720759,0.279770780855587,0.948594173636636,5458,15,LPL|FABP5|FABP6|PNPLA2|APOE|ABHD16A|ABHD2|DAGLA
N-TERMINAL PEPTIDYL-METHIONINE ACETYLATION%GOBP%GO:0017196,0.8052724077328649,0.984682960940884,-0.267332193480779,-0.733808921060629,4581,6,NAA25|NAA16|NAA15|NAA30|NAA60|NAA20
XENOBIOTIC CATABOLIC PROCESS%GOBP%GO:0042178,0.11006175081728999,0.584830174998513,-0.48055331124974293,-1.40179532912667,605,7,GSTM3|GSTM1|GSTM4
CELL-CELL JUNCTION ORGANIZATION%GOBP%GO:0045216,0.615293185419968,0.9514351488085991,0.168625445184255,0.902310473683927,7764,81,OCLN|CDH4|CDH6|CDH10|SDK1|CAMSAP3|CDH3|F2R|CDH2|ECT2|PTPRO|TGFB2|CTNND1|CTNND2|CDH7|F2RL1|APC
REGULATION OF PANCREATIC JUICE SECRETION%GOBP%GO:0090186,0.345028465510393,0.841038624862765,-0.828021614468461,-1.1076697598418401,2605,1,NR1H3
NEGATIVE REGULATION OF PROLACTIN SECRETION%GOBP%GO:1902721,0.8633655501125379,0.991943445125448,-0.565725628584032,-0.756788422186673,6520,1,ANXA5
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002700,0.017863652934743,0.28229003459186897,-0.235443069887245,-1.5339271204854097,48,64,C20orf196|TNFRSF1B|BCL10|SEMA7A|IL6|FCGR2B|VAMP3|MAVS|SMAD7|KARS|TFRC|NLRP3|B2M|TNFRSF4|TICAM1|CD22|GPRC5B|TNF
EARLY VIRAL TRANSCRIPTION%GOBP%GO:0019085,0.9924276169265028,1.0,-0.30057899090157203,-0.514124265956094,6683,2,CCNT2|MON1B
SEROTONIN METABOLIC PROCESS%GOBP%GO:0042428,0.948322147651007,1.0,0.528506837229819,0.7020977548981849,7064,1,ATP7A
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903320,0.0106122448979592,0.224456433914562,-0.17762463910364198,-1.45674377567873,12,171,HSP90AA1|PSMD10|PARK7|SASH1|RPL11|TRAF6|NDFIP2|UBE2N|RNF20|AMER1|NDNL2|MUL1|SENP2|DCUN1D5|BMI1|ITCH|UBE2D1|FBXW7|VPS28|PINX1|PTTG1IP|ZER1|CDK9|MAGEA2|CTNNB1|TGFBR1|WDR70|ARRDC3|TNFAIP3|ARRB2|PRICKLE1|WDR48|ABL1|HDAC4|DCUN1D3|RPS3|SPHK1|STUB1|TRIP12|UBE2I|BCL10|ARRB1|CHP1|TANK|GLTSCR2|RAB1A|BAG5|TNIP1|RIPK2|LIMK1|PRMT3|SMAD7|GNL3L|ADRB2|NXN|COMMD1|UBE2L3|TSPYL5|PARK2|HSPBP1|PER2|RASD2|HSP90AB1|CAV1|FKBP1A|TRIB3|UBB
TRANSLATIONAL INITIATION%GOBP%GO:0006413,0.908984145625367,1.0,-0.100326608379444,-0.7715730348435451,1547,123,EIF2S2|EIF4E|RPS16|RPL12|EIF5|EIF3H|RPS4X|EIF3D|EIF2B3|RPL9|EIF2S1|RPS28|EIF4A1|RPL35|EIF3K|RPL7|RPS9|RPS3|RPL14|DDX3X|EIF4A2|EIF4G1|EIF3G|RPL15|RPL8|EIF3B|EIF4H|RPL35A|EIF4B|EIF1AX|EIF3A|UBA52|EIF3I|EIF2S3|PABPC1
POSITIVE REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000975,0.0871177015755329,0.553293724109832,-0.9551720335244821,-1.27776275219685,657,1,NUDT21
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE%GOBP%GO:0042770,0.860150726439282,0.9916689277956879,0.13376816304633998,0.7376858980511309,11070,95,BTG2|CEP63|CCNB1|PIDD1|CDK1|E2F8|CDC25C|MUC1|DTL|E2F7|GEN1|RPS6KA6|GTSE1|RPS27L|BRCC3|CHEK2|PLK1|PRMT1|CASP9|CARM1|AURKA|ARID3A|PAXIP1|TNKS1BP1|CNOT3|E2F1|PRKDC|CHEK1|FOXM1|CASP2|CDK2|ATM|TFAP4|CNOT1|UIMC1|BRCA1|BRE|PCBP4|MDM2
MESONEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0072180,0.536241610738255,0.9265056012720759,0.7351676224084692,0.9766373882167441,3994,1,GPC3
OLFACTORY BULB DEVELOPMENT%GOBP%GO:0021772,0.55,0.931359181171847,0.324403202399672,0.925735898606859,5433,9,SLIT1|KIF14|ROBO2
CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0043010,0.21768871720585897,0.7341474817293291,0.22935336459768102,1.19753915021819,2704,72,SIX3|TSPAN12|NHS|SHROOM2|TBX2|SDK1|WNT5B|PROX1|DSCAM|SMARCD3|AHI1|FOXN4|EFEMP1|TGFB2|DCX|FBN1|MED1|NF1|COL4A1|TH|TFAP2B|SMARCA4|CHD7|MDM1|TOPORS|WNT2B
INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032610,0.8056375838926171,0.984682960940884,0.598312748125276,0.7948317932603242,6001,1,S100A13
POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902905,0.74040749553837,0.974505008828563,0.142987716804768,0.8412823806788381,9956,137,TENM1|NF2|RHOBTB1|EDN1|CTGF|WASH1|AKAP9|CD47|NAV3|CLIP1|RAC3|ACTN2|PSRC1|EVL|PROX1|TRIM27|C15orf62|NUMA1|CDK5R1|SEMA5A|CTTN|CCL21|F2RL1|CDK5RAP2|RB1
INCLUSION BODY ASSEMBLY%GOBP%GO:0070841,0.7910223367697591,0.9819233677232551,0.300627963222894,0.739350693301837,7365,6,UBD|TRIM37|HDAC6
ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045446,0.000654450261780105,0.0806484601749226,-0.36443840409893796,-2.22081506261547,1,51,ENG|EZR|DLL1|RAP2C|LAMA5|RAP1B|NOTCH1|F11R|ACVR1|PDPN|COL23A1|NRP1|MYADM|TJP2|RAP2B|RAB1A|ICAM1|RAP1A|MSN|RAPGEF1|GSTM3|ACVRL1|MET|SOX17|PDE4D|RBPJ|STC1
REGULATION OF CYTOTOXIC T CELL DEGRANULATION%GOBP%GO:0043317,0.556066287649692,0.9351151289364891,0.5831556441818829,0.9531518801925991,4596,2,CEACAM1
PLATELET ACTIVATING FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0006663,0.6124811855968512,0.9508825506493929,0.47601191132678905,0.9048485688587199,5289,3,PLA2G4A|LPCAT2|CHPT1
NEGATIVE REGULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044793,0.307732864674868,0.810954108517521,-0.40521758314489,-1.11229505736176,1750,6,PTX3|VAPA|ZC3H12A|EIF2AK4|CCNK|PARK2
URETER UROTHELIUM DEVELOPMENT%GOBP%GO:0072190,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002752,0.8556864821925061,0.991298302704726,-0.570688134097927,-0.7634269171181349,6462,1,FCN1
POSITIVE REGULATION OF LIPID TRANSPORTER ACTIVITY%GOBP%GO:0110113,0.37230239639878204,0.852609194081082,-0.811590207322453,-1.08568896551322,2811,1,PRKCD
TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002513,0.24414140076790697,0.7571583779245891,-0.8775363917071021,-1.1739071870468702,1843,1,LYN
"REGULATION OF WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:2000095",0.39808848797250895,0.8638522656500329,0.430561826259325,1.05890410639583,3706,6,MLLT3|DACT1|NPHP3|DAB2
TRIVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0072512,0.392556370551481,0.8621064456029929,-0.196391158102612,-1.0397125821145201,1444,32,ARHGAP1|ATP6V0C|ATP6V1F|TFRC|ATP6V1E2|ATP6V0D1|ATP6V1E1|STEAP3
NEGATIVE REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060394,0.00195236235845373,0.112650093274223,-0.645002092220755,-2.08212455371204,9,9,SMAD6|LDLRAD4|SMAD7|DKK1|GREM1|SNX25
PROTEIN PEPTIDYL-PROLYL ISOMERIZATION%GOBP%GO:0000413,0.6525270758122739,0.9640743070248079,-0.19611939808536605,-0.8600763682559541,2891,19,PPIH|PPIL3|FKBP4|FKBP1A
MITOCHONDRIAL TRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0070902,0.583087248322148,0.9439064862850342,0.7125055138950149,0.94653178808496,4343,1,PUS1
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION%GOBP%GO:0023019,0.8341056533827621,0.988613522932093,-0.581219673577415,-0.7775152785837929,6299,1,EPCAM
DETOXIFICATION OF MERCURY ION%GOBP%GO:0050787,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050974,0.0554655870445344,0.458212274160356,0.534566610908758,1.5254704585349699,547,9,SCN1A|PIEZO2|ADGRV1|DFNB31|PDZD7|KIT
POSITIVE REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:1904398,0.584577978464745,0.9439064862850342,0.48602444402679496,0.9238813402425259,5048,3,MESDC2|AGRN
TRICUSPID VALVE MORPHOGENESIS%GOBP%GO:0003186,0.574417084332099,0.941780153808918,0.397411928449802,0.915975582135821,5271,5,HEY2|ZFPM1|BMPR1A|BMPR2|TGFBR2
NEUTROPHIL AGGREGATION%GOBP%GO:0070488,0.234446919079436,0.7482511903785959,-0.716625310173697,-1.22574921305547,1578,2,S100A9|S100A8
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045669,0.8030437878248492,0.984522820758988,0.175567717718162,0.7421234845022779,9022,31,CYR61|WNT4|BMP4|DDR2|SUCO|FBXO5|BMPR1B
NEGATIVE REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010637,0.41517857142857106,0.869910465767785,-0.400763494639352,-1.0145061746146,2417,5,BNIP3|MUL1|VAT1|PARK2
DNA DAMAGE CHECKPOINT%GOBP%GO:0000077,0.0169632714880727,0.277340114229305,0.266082506366075,1.52573492176952,223,118,BTG2|MUS81|TAOK3|INTS7|EME2|CEP63|CCNB1|PIDD1|CDK1|E2F8|ATR|BLM|DOT1L|BRIP1|CDC25C|MUC1|RAD9A|DTL|E2F7|DONSON|GEN1|ZNF830|NEK11|GTSE1|MSH6|CLOCK|H2AFX|TAOK1|RPS27L|BRCC3|CHEK2|PLK1|PRMT1|TIPRL|EME1|BRSK1|CARM1|AURKA|ARID3A|CLSPN|TNKS1BP1|CNOT3|CDK5RAP3|TAOK2|E2F1|C5orf45|PRKDC|CHEK1|RAD17|RAD1|CASP2|CDK2|ATM|RFWD3|MDC1|CNOT1|UIMC1|BRCA1|BRE
PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009146,0.24090235468467,0.7538896250817869,-0.518336734131142,-1.19206620416489,1462,4,NUDT16|SAMHD1|NUDT1|NUDT15
"REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:2000718",0.19852348993288602,0.711592141628341,0.9029554477282751,1.19953602860852,1478,1,NAA10
FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036115,0.721301560420951,0.9713770803161691,0.519051557761235,0.8483755119803209,5962,2,ACOT7|ABCD1
REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010692,0.41449210437899003,0.8695723005599759,0.492031103512932,1.04266090960379,3700,4,TGFB2|GPLD1|SEMA4D|MEF2C
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042986,0.285234899328859,0.794258537514783,0.860112483458315,1.14262106193602,2124,1,SOAT1
AMINE BIOSYNTHETIC PROCESS%GOBP%GO:0009309,0.6940298507462691,0.96731875442989,-0.22394238551229,-0.8158445740674929,3347,12,SMS|ODC1|SMOX
MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:0002408,0.745494133301077,0.9749763305090959,0.50902624513976,0.831989413911968,6162,2,CCL19|CCR7
POSITIVE REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900114,0.9221476510067109,1.0,0.541629907366564,0.7195311681131841,6869,1,ZNF304
INTRACELLULAR SEQUESTERING OF IRON ION%GOBP%GO:0006880,0.0421052631578947,0.40376460791238894,-0.774732546597551,-1.57229668500489,267,3,SRI|FTH1|FTL
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902992,0.421434494195688,0.873054719602436,-0.27956481445054304,-1.0184826621718,2032,12,PICALM|CLU|PRNP|CHRNA7|HAP1|BIN1
RESPONSE TO G1 DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072432,0.14255033557047,0.6324244126031129,0.929863255403617,1.23528185066281,1061,1,APAF1
REGULATION OF MEMORY T CELL DIFFERENTIATION%GOBP%GO:0043380,0.280875771138261,0.789038489620028,0.6947339398952299,1.13552353930097,2321,2,IL12RB1|CD46
POSITIVE REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000962,0.6434014757469461,0.9621972042482541,0.550372208436725,0.899568255080801,5318,2,SUPV3L1|PNPT1
IODIDE TRANSPORT%GOBP%GO:0015705,0.30928108036541807,0.8114708447293539,-0.8458314953683279,-1.13149458054031,2335,1,ANO1
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060716,0.480597014925373,0.9046812288131709,-0.4753015056961189,-0.9646102839823579,3058,3,RBPJ
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000726,0.175808209226299,0.678685257108795,-0.439959920885508,-1.28338260846928,967,7,FZD7|SMAD4|FRS2|SOX6|DKK1
NEGATIVE REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904715,0.720031421838178,0.9713637233549571,-0.39235689864343204,-0.796276668361433,4582,3,SNRNP70|CTSA|SNCA
APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003278,0.126577181208054,0.607607158836689,0.937637847375386,1.2456100492481599,942,1,BMP4
CELLULAR RESPIRATION%GOBP%GO:0045333,0.913602526505752,1.0,0.12076206386332199,0.698475333722497,12149,123,MTFR1|COX20|NR4A3|NDUFA7|D2HGDH|FH|NDUFS7|ETFDH|SLC25A22|NDUFA4|NDUFS2|COX5A|COA6|NNT|NDUFC1|NDUFAF1|NDUFS4|TAZ|FASTKD1|COX6A1|NDUFS8|PDHA1|NDUFB2|UQCC3|SUCLG1|SIRT3|SDHA|MT-ND2|ACO1|ME3|NDUFV1
REGULATION OF HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:1901314,0.7164179104477609,0.971081608033886,-0.3937355244292489,-0.7990745484329771,4559,3,UBR5|OTUB1|TRIP12
POSITIVE REGULATION OF ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0060409,0.533422818791946,0.9265056012720759,0.7364358182620201,0.9783221298299591,3973,1,PEBP1
HETEROCHROMATIN ORGANIZATION%GOBP%GO:0070828,0.7799174690508941,0.981487311948134,0.236464513999127,0.7454206525503059,7937,12,CDKN2A|LOXL2|HELLS|CENPV
"REGULATION OF VESICLE TARGETING, TO, FROM OR WITHIN GOLGI%GOBP%GO:0048209",0.920210896309315,1.0,-0.22893147365757502,-0.6284015235657111,5235,6,SEC23A
NEGATIVE REGULATION OF CELL ACTIVATION%GOBP%GO:0050866,0.9972764412165229,1.0,-0.07277171823457598,-0.5230067777143689,2196,92,CX3CL1|PRKCD|LGALS9|TNFAIP3|CD300LF|NR1H3|RUNX1|LYN|FCGR2B|PRNP|SMAD7|LGALS3|THBD|DUSP3|CD9|SOCS5|NOS3|CBFB|TNFRSF21
LONG-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042759,0.22795698924731198,0.740988338612706,-0.297989468877649,-1.1884086239580802,1059,15,ALOX5|GSTM4|ASAH2|ASAH2B
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION%GOBP%GO:0086068,0.502832861189802,0.9164921159310329,0.421715332172067,0.9719913249425849,4614,5,RYR2
PLASMA MEMBRANE RAFT ORGANIZATION%GOBP%GO:0044857,0.0753777472527472,0.525408291492683,-0.587737005299817,-1.4878172011718203,438,5,CAV2|CAV1
REGULATION OF RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:2000197,0.24515585509688298,0.757467559003634,0.46375427291044397,1.207054937559,2327,7,TPR|AKAP8L|SUPT6H|ZC3H3|RIOK2
INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032620,0.17772828507795102,0.6833893961402241,-0.749921974869059,-1.2827013747616,1196,2,RFTN1
NEGATIVE REGULATION OF ORGAN GROWTH%GOBP%GO:0046621,0.697630494505495,0.96731875442989,-0.31915949702184004,-0.807931073430044,4062,5,GSK3A|WWC3|PTEN|WWC2|WWC1
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY%GOBP%GO:1905598,0.370898292501856,0.852609194081082,-0.635125448028674,-1.08634806370983,2497,2,APP|PSEN1
NEGATIVE REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000192,0.6464371322728261,0.963344312748158,0.371955352271709,0.857301947766391,5932,5,AKT2|THBS1|AKT1|PLA2R1
POST-EMBRYONIC ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0048563,0.145536644668288,0.636418541205714,0.6786147568104111,1.28997526510373,1256,3,EFEMP1|FBN1|MFAP2
REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:0072593,0.965201015311553,1.0,0.11595307189569,0.584116735575735,11787,61,NOXA1|HBB|HBA2|GLS2|NNT|NDUFS4|PRDX4|PDK4|DUOX1|CCS|PRDX3|HBA1
PEROXISOMAL MEMBRANE TRANSPORT%GOBP%GO:0015919,0.44127332601536795,0.880402968441571,-0.242939215284952,-0.994917736147298,2009,16,PEX16|RAB8B|PEX26|PEX7|PEX19|PEX5
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT%GOBP%GO:0060742,0.9630289532293991,1.0,-0.337943849973839,-0.5780348562653579,6485,2,PSAP
POSITIVE REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090070,0.578875439281531,0.942692029750853,-0.27643420412163106,-0.892354382767648,2964,9,UTP15|TRMT112|WBSCR22|WDR43
MODULATION BY SYMBIONT OF HOST I-KAPPAB KINASE/NF-KAPPAB CASCADE%GOBP%GO:0085032,0.20230372037601002,0.716346357311758,-0.897441552712836,-1.20053492782751,1527,1,TNIP1
RESPONSE TO MYCOPHENOLIC ACID%GOBP%GO:0071505,0.763880488689972,0.978421368343614,0.50046870692032,0.81800235278162,6314,2,EGR1|PDGFB
DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0048546,0.252957045030089,0.7641083395392759,-0.30981709299265303,-1.1667652502514598,1218,13,WNT11|RBPMS2|SOX17|BBS7
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION INVOLVED IN AXON REGENERATION%GOBP%GO:1905045,0.6948993288590601,0.96731875442989,0.657201146890163,0.873062403821749,5176,1,CERS2
POSITIVE REGULATION OF ACTIVATED T CELL AUTONOMOUS CELL DEATH%GOBP%GO:0070241,0.354958294717331,0.842911430859438,-0.821460079400088,-1.09889219432135,2680,1,LGALS9
NUCLEAR MIGRATION%GOBP%GO:0007097,0.803542993630573,0.984522820758988,0.238330825154102,0.7270927151776558,8073,11,DCTN4|DOCK7|SYNE2|PCM1|HOOK3|TMEM201|SYNE3|PAFAH1B1
REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032899,0.125760950259837,0.607607158836689,-0.7861593603529091,-1.3446834818814901,846,2,FURIN|HAP1
G-QUADRUPLEX DNA UNWINDING%GOBP%GO:0044806,0.0894060657118787,0.5589482273516129,0.552639273727803,1.43840391993754,848,7,BLM|DHX9|DNA2|HNRNPA2B1
"VESICLE TARGETING, ROUGH ER TO CIS-GOLGI%GOBP%GO:0048207",0.8828289936664321,0.996220425464008,-0.116208625763548,-0.737917202043048,2508,58,TRAPPC2L|TRAPPC6A|TBC1D20|NAPA|RAB1A|SERPINA1|SEC23IP|TMED2|SEC23A|TRAPPC10|ANKRD28
REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051783,0.0016827626573017302,0.10596286071320901,0.28768546231040504,1.7200629463348702,22,151,KIF25|EDN1|CCNA1|ANAPC15|CCNB1|RCC1|TPR|BMP4|INS|XRCC3|ANAPC5|FBXO43|MKI67|CEP85|BORA|CENPF|NAA10|CCSAP|KIF20B|NUMA1|CDC25C|USP44|FAM178A|BUB1|KIF11|DLGAP5|NEK2|CDC23|CDC20|CCNE1|PKMYT1|GEN1|ANLN|APC|NDC80|NUSAP1|CDK5RAP2|CUL9|CENPE|PTTG1|FBXO5|RB1|BUB1B|ESPL1|CDC6|NIPBL|CCNB2|CDCA5|OBSL1|CCNI2|KLHL22|PIN1|CDK13|CCNF|CEP97|PLK1|KNTC1|PEBP1|AURKA|UBE2C|ANKRD32|CCNE2|CUL7
REGULATION OF SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048631,0.506156494108301,0.9172434440873181,-0.7433281870313191,-0.99437277967822,3822,1,DLL1
ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:0001547,0.39557046979865795,0.8638522656500329,0.8097154830172031,1.0756708952196,2946,1,BMPR1B
NEGATIVE REGULATION OF PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0010900,0.499865771812081,0.9143688619793578,0.7538045875606529,1.0013957649674599,3723,1,APOC1
"SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, SIGNAL SEQUENCE RECOGNITION%GOBP%GO:0006617",0.448255382331106,0.8850378987593649,-0.587216609482071,-1.00440256120914,3018,2,SRP54
GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006682,0.0860252402454556,0.549638890318283,0.7272747028234109,1.3824727036402602,742,3,B3GALT2|B3GALT1|B4GALT3
REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070170,0.665624638184555,0.964618776001639,0.457793337031658,0.870216975645753,5748,3,ASPN|BCOR
REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS%GOBP%GO:0099072,0.721264641462718,0.9713770803161691,0.22336981263332698,0.8012730565461651,7573,18,GPHN|LRRC7|DNM3|CTNND1|DLG4|DNM1|STX3|ARHGAP44|SCRIB|STX1B|CACNG4
NEGATIVE REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070100,0.07887370327679902,0.532203813468543,-0.650768289171325,-1.49663111483639,478,4,RNF113A|SLIT3
ACETYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0006085,0.42830404492045293,0.8769245997339999,0.37711164531162394,1.0281075179499,4118,8,PDHX|PDHA1|DLD|ACSS1
REGULATION OF ERK5 CASCADE%GOBP%GO:0070376,0.0497986577181208,0.438727695219498,0.9746360829289809,1.2947605545728,370,1,FAM150B
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009177,0.8459359337546309,0.991298302704726,0.302324394779506,0.6968129129445501,7763,5,DUT|HDDC2|TYMS
GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0009100,0.491748251748252,0.909315999193258,0.154920735849523,0.9965110148804,7031,264,B3GALT2|HS3ST4|GALNT10|GALNT8|GLCE|FUT9|MUC15|GAL3ST3|GALNT13|FUT7|SDF2|GCNT2|GALNT3|TMEM165|VCAN|B3GAT3|C1GALT1C1|HS3ST5|B3GLCT|FUT2|GAL3ST4|ALG6|ASGR1|FUT8|ALG1L|MGAT5B|B3GALT1|OGT|GNPTAB|CHST15|ST3GAL5|POGLUT1|MVD|MOGS|ALG14|ALG13|DERL3|MUC1|EXT1|SRD5A3|DPAGT1|EDEM3|PXYLP1|CHPF2|FUT10|NUDT14|NGLY1|GPC1|XYLT2|MPDU1|ALG2|GANAB|BMPR1B|DPY19L3|MGAT2|DOLPP1|ST8SIA3|SYVN1
CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045065,0.618389261744967,0.9532238181782521,0.6955227172474641,0.923970900394961,4606,1,CD8A
CELLULAR RESPONSE TO UV-A%GOBP%GO:0071492,0.850127011007621,0.991298302704726,0.462751585332231,0.7563547536958299,7027,2,CERS1|PPID
DETECTION OF VISIBLE LIGHT%GOBP%GO:0009584,0.188988676298321,0.696293986246161,-0.38766895490793696,-1.2514301262908798,967,9,CACNA2D4|GNAQ|EYS|PDE6B|GNGT1
POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032077,0.543440934065934,0.929698169790548,-0.36234281932495,-0.9172467863202679,3164,5,AKT1|DDX11|PCNA|PRKCD|RPS3
AMP BIOSYNTHETIC PROCESS%GOBP%GO:0006167,0.942658752379886,1.0,0.282723765404497,0.59911866607334,8416,4,ADSSL1|ADSS|APRT|ADSL
LATE VIRAL TRANSCRIPTION%GOBP%GO:0019086,0.863000164663264,0.991943445125448,-0.30061214360558103,-0.691345130216282,5240,4,CCNT2|USF2|MON1B|USF1
GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030851,0.835910652920962,0.988613522932093,0.28540508541428006,0.7019122423301201,7783,6,TAL1|LEF1
MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002756,0.133848755738101,0.6199122719148871,-0.277575485684919,-1.30430399552469,553,23,CD300LF|TRAF3|TANK|UBA52|TICAM1|UBC|UBB
REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903299,0.9517324035737629,1.0,0.249478780001693,0.575011604794972,8734,5,MIDN|BAD
POSITIVE REGULATION OF LOCOMOTION%GOBP%GO:0040017,0.00271739130434783,0.129967667001507,-0.16937449423046202,-1.5563166373302701,0,373,DAB2IP|TUBB2B|IGF1R|RTN4|NSMF|TGFBR1|CXCL16|LGALS9|BCAR1|PTK2B|ACVR1|HMOX1|PDPN|HSPA5|ELP6|AKIRIN1|EPB41L4B|PRKD2|PFN1|SRGAP2C|FGR|ABL1|SEMA3F|GPI|MYO1C|MGAT5|ADAM10|VPS4A|CAMK1D|RET|SPHK1|FGF7|ZNF580|RHOA|FAM65A|NRP1|C1QBP|ZNF703|AAMP|PLAU|MYADM|CPNE3|PTRF|SEMA7A|FGF2|PPAP2B|HGF|DOCK5|TNFRSF18|IL6|HBEGF|PODXL|ITGA6|MMP9|ELP3|GLIPR2|VPS4B|SNAI1|IGF1|SOD2|ICAM1|FOXC2|MAP4K4|FOXP1|CEMIP|RHOC|ETS1|TMSB4X|PDCD10|WNT11|ARHGEF2|KARS|FGFR1|MAP2K3|LGALS3|ATOH8|SEMA6B|IQSEC1|AGO2|ADAM17|CXCL8|STAT5A|CTSH|PRKCA|STAT3|NOS3|ANO6|SCG2|OXSR1|CAV2|FLT1|PLVAP|ADRA2A|CHMP4B|FGF10|CFAP20|THBS4|SEMA3A|RAC1|MET|DDRGK1|CFAP69|SEMA3G|LAMC2|PGF|TWIST1|PC|CDH13|TNF|CAV1
NEUROPEPTIDE SIGNALING PATHWAY%GOBP%GO:0007218,0.7857939754555601,0.981487311948134,0.19882900597101896,0.751679619597991,8451,21,CYSLTR2|PENK|NPY|SSTR2|NXPH4|SORCS1
OXIDATION-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0070407,0.148993288590604,0.641569904406915,0.9262792236435821,1.23052062436459,1109,1,LONP1
REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL%GOBP%GO:0003057,0.8562416107382549,0.991298302704726,0.5727282752536391,0.760843962454611,6378,1,ADRBK1
RESPONSE TO TEMPERATURE STIMULUS%GOBP%GO:0009266,0.193762993762994,0.704790015310551,-0.171937481509149,-1.1886612032171398,465,79,GCLC|SOD1|DNAJC3|EIF2B3|NFKBIA|HSPA13|RBM3|HMOX1|HSPA5|UCP2|EIF2AK3|ANO1|ACOT11|STUB1|FOXO1|METRNL|SUMO1|IGF1|HSBP1|BAG3|HSF1|YWHAE|NOS3|HSPA6|POLR2D|SLU7|TRPV2|IER5
MANNOSYLATION%GOBP%GO:0097502,0.793548387096774,0.9819233677232551,-0.18993488577419698,-0.7574772930557059,3689,15,PIGB|DPY19L3|LARGE|FKTN|FKRP|DPY19L2|DPY19L4|DPM3|B4GAT1|GYLTL1B|POMGNT2|TMEM5|DPM1|DPM2|DPY19L1
URETERIC BUD MORPHOGENESIS%GOBP%GO:0060675,0.3776871019108279,0.85375124052253,0.351371527079026,1.07195398452893,3794,11,CITED1|BMP4|PKD2
PEPTIDYL-ARGININE DEGLYCATION%GOBP%GO:0036527,0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034249,0.9951033732317741,1.0,-0.07580689605486,-0.5772167424918111,1828,116,EIF2AK2|SYNCRIP|EIF6|YTHDF2|CALR|NCL|ATF4|CNOT10|CLU|METTL16|EIF2S1|CPEB1|SAMD4A|PRKAA1|EIF2AK3|RPS3|DDX3X|EIF2AK1|PAIP2B|RNF139|EIF4EBP1|CPEB2|PRNP|CHRNA7|HAP1|BIN1|EIF4E2|CNOT7|GAPDH|SNCA|FMR1|AGO2|STAT3|SESN2|RBM24
POSITIVE REGULATION OF EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:1903553,0.300181129589989,0.803117881605784,-0.48756410963436797,-1.12129559644875,1822,4,SDC4|SDC1|SDCBP|PDCD6IP
MICROTUBULE NUCLEATION BY SPINDLE POLE BODY%GOBP%GO:0051417,0.9310207864424731,1.0,-0.531925452139391,-0.7115728955979369,7031,1,MZT1
POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0010893,0.18566966028895002,0.6921962082288221,-0.38929766820676,-1.25668775877198,950,9,FGF1|STARD4|IL1B|PRKAA1|ABCG1|NR1D1|TNF
CMP-N-ACETYLNEURAMINATE METABOLIC PROCESS%GOBP%GO:0046381,0.127763802462598,0.6076669536424699,-0.934053815615351,-1.24951226821074,964,1,NANS
DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046121,0.740014847809948,0.9744283926676119,-0.46286186931348205,-0.791700438164639,4983,2,DPYD|DERA
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050680,0.6640625,0.964618776001639,0.173083405996931,0.862786191593029,8074,58,PTPRK|GHRL|CEACAM1|CDK6|MCC|MAGED1|TGFB2|KRIT1|VASH1|MED1|NF1|APOE|CDKN2B|CASK|CCL2|ATPIF1|NLRC3|CDC73|BRCA2|SYNJ2BP|SPARC|THBS1|GATA3|SULF1|PBLD|STAT1|ATP5A1|DLL4|PEX2
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905461,0.051510989010989,0.4457514150034171,-0.6206339304016999,-1.5710935825990502,299,5,MFN2|PPARG|SOD2|PDCD4
POSITIVE REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030513,0.8251172585431221,0.9876441563834109,0.204083068550226,0.707500653397053,8619,16,CYR61|BMP4|NUMA1|FBXL15|RNF165
PHOSPHATE ION TRANSPORT%GOBP%GO:0006817,0.46866814426757997,0.89605323680621,0.336960566557307,0.9944576861851141,4651,10,SLC37A2|SLC25A10|XPR1|SLC25A30|SLC37A3|SLC20A1|SLC25A3|SLC37A1
REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061035,0.36028862901219205,0.848418604328854,-0.220032134391993,-1.06743560201891,1447,25,SNAI2|PTHLH|ZBTB16|TGFBR1|FAM101B|WNT11|FAM101A|SOX6|GREM1|ACVRL1
MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0010463,0.764872521246459,0.9790689018689871,0.33216479249806397,0.7655906061004649,7019,5,GPC3|FGFR2|STAT1
FOREGUT MORPHOGENESIS%GOBP%GO:0007440,0.0308486694028863,0.35952485149978897,-0.984836788707543,-1.31744619967604,232,1,SOX17
VIRAL TRANSLATION%GOBP%GO:0019081,0.487653040049803,0.907808599852568,-0.255342258160566,-0.961614063526029,2349,13,EIF3D|PCBP2|EIF3G|EIF3B|EIF3A
NEGATIVE REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000663,0.0119157950483252,0.23670963874364498,-0.9948720776356421,-1.33087071164855,89,1,TNFRSF21
REGULATION OF WHITE FAT CELL PROLIFERATION%GOBP%GO:0070350,0.622798887859129,0.9536478716552259,-0.682013674459638,-0.912350486747267,4703,1,VSTM2A
LACTATE TRANSPORT%GOBP%GO:0015727,0.7057467479005429,0.968941691852291,-0.351073750753078,-0.807396284856535,4285,4,SLC16A1|SLC16A8
G0 TO G1 TRANSITION%GOBP%GO:0045023,0.462682956332406,0.891507554237553,0.618495905670941,1.01091456674269,3824,2,CDK3|MDM4
POSITIVE CHEMOTAXIS%GOBP%GO:0050918,0.11097046413502099,0.584908292979021,-0.356382937606591,-1.3807218482535701,525,14,VEGFA|FGF7|NRP1|LGALS3|SCG2|FGF10|MET
MITOCHONDRIAL RNA SURVEILLANCE%GOBP%GO:2000827,0.675704697986577,0.9647315640607691,0.666850463167181,0.885881090009248,5033,1,SUPV3L1
SULFUR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0000097,0.0363214837712519,0.384708132326922,0.470844009065661,1.59644935874111,375,15,CTH|GGT1|APIP|MTHFD1|CDO1|MTR|MTAP|GGT5
"GUANINE DEGLYCATION, METHYLGLYOXAL REMOVAL%GOBP%GO:0106045",0.537799549847743,0.9265056012720759,-0.726786501985002,-0.972244463240013,4061,1,PARK7
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0010716,0.858214805689327,0.99166790097654,0.32647658964319204,0.691835080122668,7662,4,FAP|DPP4|CST3|TGFB1
EMBRYONIC NAIL PLATE MORPHOGENESIS%GOBP%GO:0035880,0.37084602144843104,0.852609194081082,-0.8127481252756948,-1.08723794766389,2800,1,MSX1
IN UTERO EMBRYONIC DEVELOPMENT%GOBP%GO:0001701,0.4820791574656021,0.905285511598575,0.211338663139347,0.985757675130868,5675,44,HOPX|RARRES2|E2F8|FUT8|LIG4|PKD2|E2F7|ARNT2|STIL|ZP3|LEF1|HEY2|SRF|NASP
NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000110,0.880125801378977,0.9956508825790341,0.44728412036649895,0.731073607125461,7275,2,VIMP|IRF7
POSITIVE REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904253,0.692254254949635,0.96731875442989,0.44809302839873605,0.851777709368735,5978,3,STAR
NEGATIVE REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050925,0.37643643401475707,0.853374872190571,0.653221020852213,1.06767181355176,3111,2,ROBO2|ROBO1
DETECTION OF HEXOSE STIMULUS%GOBP%GO:0009732,0.966372323696625,1.0,0.368113385361802,0.6016712157076031,7988,2,GCK
CHONDROCYTE PROLIFERATION%GOBP%GO:0035988,0.49339272457312605,0.910654969509744,-0.5650731707191979,-0.9665273951319631,3322,2,STC1
ENDOPLASMIC RETICULUM MEMBRANE FUSION%GOBP%GO:0016320,0.439049740163326,0.879896414106183,-0.5921698373311279,-1.01287479216703,2956,2,BNIP1|VCPIP1
SEROTONIN PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002351,0.8619091751621871,0.991915800284466,-0.566552712836348,-0.757894838008583,6509,1,SYK
CALCIUM-MEDIATED SIGNALING USING EXTRACELLULAR CALCIUM SOURCE%GOBP%GO:0035585,0.650903377847604,0.963755998259649,-0.41871622366824796,-0.849772135329355,4142,3,P2RX7|CACNA1C|DMTN
REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030111,0.88,0.9956508825790341,-0.0974159926597304,-0.830488633849635,813,213,IGFBP4|FRAT1|RUVBL1|TRABD2A|CTNNB1|DAB2IP|SKI|GID8|TNFAIP3|PRICKLE1|PTPRU|LIMD1|GNAQ|DDX3X|ZNF703|TCF7L2|ATP6AP2|TBL1X|RUNX1|PTK7|ATP6V0C|DDIT3|CYLD|PPP2CA|RUVBL2|PPM1A|RSPO4|JADE1|WNT11|STK4|CCNY|NXN|DKK1|PARK2|GREM1|SFRP2|CBFB|SLC9A3R1|RBMS3|WWOX|SOX7|CSNK2A1|SOX17|GPRC5B|SULF2|CAV1|DACT2|TLE3
RIBOSOME BIOGENESIS%GOBP%GO:0042254,0.00118483412322275,0.09181648161563599,-0.24711797416804998,-2.11960088730853,0,228,SDAD1|RIOK3|TEX10|RPS16|RPL12|URB1|NAF1|UTP15|C1D|THUMPD1|TSR3|FTSJ2|WDR12|PES1|METTL16|RRP1|RPS28|ISG20L2|MRPS2|MPHOSPH6|RPF2|RPL35|NSUN5|UTP3|RPL7|RSL24D1|EXOSC6|POP5|RRP36|RPS9|MRPL22|RPL14|DHX37|GAR1|DDX47|ZNHIT6|DDX3X|EXOSC4|C1QBP|PA2G4|AAMP|NOB1|NSUN3|NMD3|NHP2L1|TRMT112|NOLC1|WBSCR22|SBDS|GLTSCR2|PWP2|TBL3|SRFBP1|RPUSD2|RCL1|EFTUD1|RSL1D1|PPAN|ZNF593|FCF1|RPL35A|NPM1|EXOSC9|DDX28|UTP14A|WDR43|EBNA1BP2|NHP2|RRP7A|KRI1|NOL10|PIH1D2|RRS1|CIRH1A|MRTO4|BYSL|IMP4|TSR1|NOL9|NOM1|TSR2|RNMTL1|ZNF622|NIP7|LYAR|EMG1|RRP9|RPF1|NOP14|NOP56|EXOSC5
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0044328,0.25738117304382396,0.7678777890071629,-0.872077635641817,-1.16660484262226,1943,1,PPAP2B
POSITIVE REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:1903285,0.170263471468291,0.673117535978459,-0.9118879576532859,-1.21986032418355,1285,1,SNCA
NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009166,0.00652340752110514,0.18180901488453102,-0.24807460938596598,-1.65748118501708,16,70,NUDT7|SMUG1|LDHA|ENTPD4|PFKL|DERA|GPI|NUDT4|PKM|PNP|ENO1|HPRT1|NUDT18|GAPDH|PGK1|HK1|HK2|TPI1|PDE9A|ALDOA|ITPA|NT5E|NEIL2|PDE4D|PGAM2
POSITIVE REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0045844,0.31500373227170897,0.8164430838831159,-0.22709897025771397,-1.10171874078652,1265,25,DLL1|FAM129B|AKAP6|FLOT1|NOTCH1|PIM1|FGF2|IGF1|TBX20|GREM1|RBM24|RBPJ
NEGATIVE REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:1900158,0.0149253731343284,0.264326813346421,-0.8317525090989301,-1.6880170047639498,94,3,FAM101B|FAM101A|GREM1
RIBONUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034030,0.438285860918655,0.878999860395433,0.22149392522802497,1.01939377435037,5123,42,HACD1|SCD5|ELOVL6|SLC35B3|SLC26A2|PDHX|PDHA1|SLC25A1|ACACA|DLD|ACSS1|PANK3|PAPSS2|TECR
REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:0010469,0.0064223649414431394,0.180481691368788,-0.24863982490409098,-1.6599878388728797,16,69,RAMP3|NCK2|FBXW7|SHISA9|ZGPAT|NPTX1|ADRA2C|PRKCD|BUD31|PTK2B|NRP1|PLAU|FCGR2B|ARC|CRH|ADAM17|ADRB2|SHC1|RELN|SNX6|SOCS5|ADRA2A|GREM1|CACNG3|CACNG7|BICD1|PDE4D|EPHB2
NCRNA CATABOLIC PROCESS%GOBP%GO:0034661,0.585602934433746,0.944044602078971,0.23056027453464198,0.907369451199525,6385,24,LIN28B|POP1|ZCCHC11
NEGATIVE REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902997,0.642684563758389,0.9620807249753851,0.6838883987648879,0.908515227334604,4787,1,SORL1
WATER-SOLUBLE VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0042364,0.672177759056445,0.9647315640607691,0.31746100219988505,0.826284290132672,6382,7,RGN|RFK|PSAT1|AKR1A1
REGULATION OF PLANT EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:1903888,0.0154905335628227,0.264745847609811,-0.9924459638288491,-1.32762522523761,116,1,GAL
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III ASSEMBLY%GOBP%GO:0034551,0.9076532604451392,1.0,-0.200242718446602,-0.646401439325904,4648,9,UQCC3|BCS1L|UQCR10|UQCRB|UQCC1|LYRM7|TTC19|UQCC2|SLC25A33
ADIPONECTIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0033211,0.46175383581588103,0.8912128193953879,0.474935201014725,1.00643305912439,4122,4,ADIPOR2|CSNK2B|SLC27A1|ADIPOR1
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION%GOBP%GO:0003006,0.7284681130834979,0.972554563883587,0.141969477006539,0.85121858152086,9971,154,CITED1|TBX3|GHRL|ROPN1B|NANOS3|WNT4|INHA|ZCCHC11|BASP1|CABYR|E2F8|PYGO1|CELF1|PKD2|DNAJC19|EIF2B5|DEAF1|ROBO2|PCSK4|DZIP1|TGFB2|CASC5|E2F7|YTHDC2|ZNF830|ZP3|LEF1|KIT|DNAH1|BMPR1B|NIPBL|EIF2B4|CENPI|HEY2|FGF9|SRPK1|FANCF|STOX2|ING2|PEBP1|NUP107|CDKL2|BRCA2|CEP57|CUL7|CEBPB|GATA6|CHD7|KMT2D|FGFR2|WNT2B
NEURON-NEURON SYNAPTIC TRANSMISSION%GOBP%GO:0007270,0.656841758603656,0.9643779777660141,-0.36435306095798403,-0.837935924182744,3988,4,DRD2
POLYADENYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:0071047,0.396344475547505,0.8638522656500329,-0.44973253184801204,-1.0342908708335699,2406,4,PNPT1|EXOSC7|EXOSC8|EXOSC9
CARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0046395,0.39447218001591794,0.863562957467761,0.171227753973586,1.04782624734757,5451,179,CROT|CTH|GLYATL2|IDO1|SLC27A2|ASRGL1|ETFDH|HSD17B4|MCCC2|ACADVL|IDNK|BDH2|ETFA|FTCD|DECR2|TST|GLS|HRSP12|ABHD3|PCYOX1L|GLS2|AMACR|ACADM|DECR1|HMMR|AIG1|CDO1|ALDH3A2|HADH|AMDHD2|ETFB|TXN2|BCKDHA|ACOX2|ECHDC2|MCEE|SARDH|ABAT|GSTZ1|BCAT2|ABHD16A|EHHADH|ACAD11|ACAD10|IVD|ABHD10|ADO|FAAH|HMGCLL1|MCCC1|C9orf41|AKR1A1|PHYKPL|ECI1|PPM1K|CCBL1|AASS|ECI2|HADHB|ACAT2|QPRT|HMGCL|HIBCH|ABHD2|AFMID|ACADS|LYVE1|PCK2|ACOT7|PM20D2|HIBADH|ECHS1
"NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:2000719",0.19852348993288602,0.711592141628341,0.9029554477282751,1.19953602860852,1478,1,NAA10
LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032511,0.941132776230269,1.0,-0.193306794502245,-0.600881684528501,5067,8,VPS25|TMEM50A|TMEM50B|VPS28|LEPROT
ASPARTYL-TRNA AMINOACYLATION%GOBP%GO:0006422,0.408182179266517,0.867015886388254,-0.7946074106749008,-1.06297056063666,3082,1,DARS
GLOMERULAR CAPILLARY FORMATION%GOBP%GO:0072104,0.36910964455250705,0.852268858837246,0.565384293331948,1.07473606542883,3187,3,BMP4|PDGFRA|PDGFRB
PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:0006644,0.9969252271139059,1.0,0.0886452506070198,0.569954517333071,14265,261,ENPP2|PTDSS2|LPL|SERINC5|LPCAT4|FITM1|PITPNM2|PGAP1|STARD10|MFSD2A|PLA2G4A|CISH|GPAM|PPAP2C|EFR3B|NAPEPLD|PIK3R3|CEPT1|ABHD3|PIGC|MVD|INPP5E|SOCS2|PNPLA6|RARRES3|TAZ|SRD5A3|PIGF|DPAGT1|FAR1|CHKB|CETP|CPNE7|PGP|OSBPL5|FADS1|PIGQ|PIGB|GNPAT|MTMR4|SMPDL3A|DOLPP1|PLEKHA1|LPGAT1|PTPN13|SMPD3|OSBPL8|AGK|IDI1|RAB4A|SMPD1|CPNE1|ETNK1|DGKE|PLA2G2D|IMPA1|SLC44A3|SOCS1|TTC7A|DGKZ|SOCS7|PIGL|MTMR1|LCAT|PLA2G12A|CECR5|PLA2G4B|PPAPDC1B|PIP4K2B|MTMR7|FIG4|SMPD4|CSF1R|SERAC1|PIGK|TMEM86B|LPCAT2|PLD1|PIGH|PLAA|PIP5K1C
NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0045835,0.334191958785978,0.83026598101629,0.522233212321442,1.10666206322478,2983,4,FBXO43|FBXO5|RAD1|TRIP13
L-ASPARTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0070778,0.35659852425305394,0.844559957061487,0.661759029500965,1.08162695413533,2947,2,SLC1A3|SLC1A1
REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904529,0.296065330363771,0.800773793263828,-0.6824924179762889,-1.16736672899258,1993,2,CRMP1|ABL1
DETERMINATION OF ADULT LIFESPAN%GOBP%GO:0008340,0.5949008498583571,0.9473459395438281,0.390711493422779,0.9005320726810829,5459,5,IDE|MSH6
DETERMINATION OF PANCREATIC LEFT/RIGHT ASYMMETRY%GOBP%GO:0035469,0.428124485427301,0.8769245997339999,-0.437871632064224,-1.00701327915961,2599,4,DNAAF1
PHOTOTRANSDUCTION%GOBP%GO:0007602,0.991708126036484,1.0,-0.136310252303488,-0.49659192241420597,4783,12,GNAQ|PDE6B|GNGT1
LOW-DENSITY LIPOPROTEIN PARTICLE MEDIATED SIGNALING%GOBP%GO:0055096,0.7689609289947991,0.9792236089291529,0.49867896751023205,0.8150770728828491,6356,2,LPL
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:0060915,0.613959731543624,0.9508825506493929,0.6977282752536391,0.926900885809246,4573,1,FGFR2
PHOTORECEPTOR CELL DEVELOPMENT%GOBP%GO:0042461,0.8453517832781129,0.991298302704726,0.207261387734589,0.686721385476481,8674,14,AHI1|CEP290|DCX|TH|MYO7A|TOPORS
POSITIVE REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:1905710,0.07553003533568901,0.525408291492683,-0.344795577177352,-1.45086013129645,341,17,BNIP3L|BMF|BCL2L11|PMAIP1
NEGATIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900543,0.00197005516154452,0.112650093274223,-0.6278937434183071,-2.1242585171099,9,10,FLCN|CBFA2T3|PPIF|HDAC4|FBP1|PPARA|SNCA|PDE12
CALCIUM-INDEPENDENT CELL-MATRIX ADHESION%GOBP%GO:0007161,0.104028063384541,0.5762893149145369,0.803149881440605,1.3127264173967501,859,2,ITGB1|PKD1
MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL%GOBP%GO:0086046,0.584723933251204,0.9439064862850342,0.432935358541001,0.9174313808885841,5220,4,CACNA1G|CACNA1D
OSTEOCLAST DEVELOPMENT%GOBP%GO:0036035,0.880629848326965,0.9956508825790341,0.36210181737344,0.688317463145504,7605,3,SRC|ANXA2
PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:0006656,0.817973406694177,0.987153241368501,0.183624535401223,0.722653953505515,8919,24,STARD10|MFSD2A|CEPT1|ABHD3|CHKB
INTERLEUKIN-21 SECRETION%GOBP%GO:0072619,0.199258572752549,0.711592141628341,-0.8990405822673141,-1.20267399841654,1504,1,FOXP1
CELLULAR CREATININE HOMEOSTASIS%GOBP%GO:0097276,0.564429530201342,0.9380162603437769,0.721382884869872,0.9583249793774591,4204,1,TFAP2B
HEME A BIOSYNTHETIC PROCESS%GOBP%GO:0006784,0.2634001484781,0.77467054856079,-0.699781473107176,-1.1969387318513998,1773,2,COX10
CHOLESTEROL CATABOLIC PROCESS%GOBP%GO:0006707,0.886490549828179,0.996643473105967,0.266615189454525,0.655701229701817,8254,6,APOE|CYP46A1|HSD3B7|TRERF1|SNX17|SCARF1
REGULATION OF ISOPRENOID METABOLIC PROCESS%GOBP%GO:0019747,0.6230141054194511,0.9536478716552259,-0.51232423490488,-0.87630316547387,4195,2,NPC2|AKR1C3
ENDOTHELIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002264,0.139865771812081,0.6281603901381739,0.9309660344067049,1.23674684336995,1041,1,C8orf4
CORTICOSPINAL NEURON AXON GUIDANCE THROUGH SPINAL CORD%GOBP%GO:0021972,0.6921752945849329,0.96731875442989,-0.6487097485663871,-0.867798809651677,5227,1,SLIT2
PEYER'S PATCH DEVELOPMENT%GOBP%GO:0048541,0.314974182444062,0.8164430838831159,-0.843239964711072,-1.12802781096499,2378,1,RET
REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046605,0.381622446384674,0.857178152269066,0.22513324443529897,1.0623536413216201,4501,46,KIF25|KAT2A|CENPJ|XRCC3|CEP85|CEP295|CEP131|KIF11|NEK2|STIL|GEN1|CDK5RAP2|TRIM37|FBXW5|CCNF|AURKA|MDM1|CHEK1|TMEM67|CEP120|BRCA1|CEP250
MITOCHONDRIAL DNA REPAIR%GOBP%GO:0043504,0.0507335647888901,0.442360925618033,0.703158002610579,1.4900589766838999,452,4,DNA2|PARP1|MGME1
REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043416,0.7551596139569409,0.9771370084125129,-0.45679625034463706,-0.781325521772203,5085,2,SOX15|CAPN3
ENSHEATHMENT OF NEURONS%GOBP%GO:0007272,0.372676579925651,0.852609194081082,-0.182187966672561,-1.06199428954492,1202,44,SOD1|PPARD|CLU|SKI|PLLP|TENM4|MBP|MAL|AMIGO1|MALL|CD9|PMP22|POU3F1|TNFRSF21|PARD3
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903587,0.7957206297941058,0.982694209546621,-0.210813117646825,-0.7418776260550849,3941,11,GATA2|VEGFA|HMOX1|APLNR|PDCD10
"NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904815",0.387824795842613,0.859991269020751,-0.6218362282878411,-1.0636175650682198,2611,2,H2AFY|TERF1
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051148,0.0624840601887274,0.487652460313626,-0.293448351569768,-1.46231096026573,244,27,FOXO4|HDAC4|HDAC5|BHLHE41|PDCD4|SOX6|CFLAR|NFATC2|DKK1|RBPMS2
XENOBIOTIC METABOLIC PROCESS%GOBP%GO:0006805,8.15727220817359e-05,0.0784645998831315,0.412146318553807,2.0970584428181,0,64,DPEP1|AKR7A3|CYP2D7|CRYZ|MGST1|CYP2C8|GSTA4|GSTO2|AS3MT|AKR7L|CYP3A5|ACY1|GGT1|POR|CYP2R1|N6AMT1|BCHE|EPHX1|RORA|ARNT2|SULT1A3|AOC2|AKR1C1|CDO1|NAT1|MGST3|NQO2|GRIN1|GSTP1|MGST2
AGE-DEPENDENT GENERAL METABOLIC DECLINE%GOBP%GO:0007571,0.20852641334569,0.7238327250928481,-0.8941883546537271,-1.19618302559467,1574,1,SOD2
KININ CASCADE%GOBP%GO:0002254,0.145760251602758,0.636418541205714,0.76989247311828,1.2583680971283602,1204,2,F12|KLKB1
NEUROENDOCRINE CELL DIFFERENTIATION%GOBP%GO:0061101,0.0521982545694056,0.446196452441803,-0.687377230854447,-1.58082403283176,316,4,WNT11|INSM1
FATTY ACID DERIVATIVE CATABOLIC PROCESS%GOBP%GO:1901569,0.35641476274165207,0.844559957061487,-0.386087284944195,-1.0597836733064399,2027,6,BDH1|OXCT1
REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902947,0.43552488194696704,0.878651088001772,-0.34266281160397605,-0.99956262401495,2397,7,DKK1|HSP90AB1
POSITIVE REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0045948,0.666038624587847,0.964618776001639,-0.18774955228954396,-0.852720163408139,2827,21,YTHDF3|CDC123|YTHDF2|DNAJC3|IMPACT|DDX3X|UHMK1|YTHDF1|HABP4|POLR2D
ADAPTATION OF SIGNALING PATHWAY%GOBP%GO:0023058,0.270474516695958,0.7852960152527629,-0.42058544688090505,-1.15447881144053,1538,6,ARRB2|ARRB1|ADRB2|ADM
REGULATION OF INTRACELLULAR PH%GOBP%GO:0051453,0.962107604139937,1.0,0.123269162012586,0.567328499847804,11247,42,TMEM165|SLC9A5|SLC9A7|DMXL2
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0110057,0.18562160730835398,0.6921962082288221,-0.9052712836347601,-1.21100899760826,1401,1,FOXJ2
